PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Hagenbuchner, J; Kiechl-Kohlendorfer, U; Obexer, P; Ausserlechner, MJ				Hagenbuchner, J.; Kiechl-Kohlendorfer, U.; Obexer, P.; Ausserlechner, M. J.			BIRC5/Survivin as a target for glycolysis inhibition in high-stage neuroblastoma	ONCOGENE			English	Article							SURVIVIN SUPPRESSANT; PANCREATIC-CANCER; PROTEIN SURVIVIN; OXIDATIVE STRESS; DRUG-RESISTANCE; CELL-CYCLE; IN-VITRO; BECLIN 1; APOPTOSIS; AUTOPHAGY	Adverse forms of neuroblastoma (NB), a childhood malignancy that develops from immature neuronal progenitor cells frequently carry a gain of chromosome 17q, which leads to overexpression of the antiapoptotic protein BIRC5/Survivin. We have recently shown that high Survivin expression shuts down mitochondrial complex I activity and shifts NB cells from oxidative phosphorylation to aerobic glycolysis, which further increases resistance to cell death induction. This increased glucose consumption sensitized tumor cells to glycolysis inhibitors. Interestingly, in Survivin-overexpressing cells 2-deoxy-D-glucose (2DG) treatment induces re-fusion of mitochondrial networks after 4 h, which coincides with Survivin repression. 2DG selectively acts on Survivin-expressing NB cells and induces autophagic degradation of Survivin via activation of the E3-ubiquitin ligase Parkin, a downstream target of PINK1. Survivin degradation further releases bound Beclin-1, which enhances autophagy and cell death induction. Knockdown of Parkin, however, reduces the sensitivity of Survivin-expressing NB cells to glycolysis inhibition. The selective activity of 2DG treatment on Survivin-overexpressing tumor cells was also confirmed in a xenograft mouse model, which further supports our hypothesis that glycolysis inhibitors might be useful drugs in the treatment of NB.	[Hagenbuchner, J.; Kiechl-Kohlendorfer, U.; Obexer, P.] Med Univ Innsbruck, Dept Pediat 2, Innrain 66, A-6020 Innsbruck, Austria; [Obexer, P.] Tyrolean Canc Res Inst, Innsbruck, Austria; [Ausserlechner, M. J.] Med Univ Innsbruck, Dept Pediat 1, A-6020 Innsbruck, Austria	Medical University of Innsbruck; Medical University of Innsbruck	Hagenbuchner, J (corresponding author), Med Univ Innsbruck, Dept Pediat 2, Innrain 66, A-6020 Innsbruck, Austria.	judith.hagenbuchner@i-med.ac.at		Hagenbuchner, Judith/0000-0003-1396-3407; Ausserlechner, Michael/0000-0002-1015-2302	Medical University Innsbruck for young scientists MUI-START [P2012032014]; Provita Kinderleukamie Stiftung; Medizinische Forschungsfond Tirol; SVP-Frauen-Initiative; Tiroler Landeskrankenanstalten Ges.m.b.H. (TILAK); Tyrolean Cancer Society	Medical University Innsbruck for young scientists MUI-START; Provita Kinderleukamie Stiftung; Medizinische Forschungsfond Tirol; SVP-Frauen-Initiative; Tiroler Landeskrankenanstalten Ges.m.b.H. (TILAK); Tyrolean Cancer Society	We thank Dr Hermann Dietrich and his team for the animal care. This work was supported by the intramural funding program of the Medical University Innsbruck for young scientists MUI-START (P2012032014) and by grants from the 'Provita Kinderleukamie Stiftung', the 'Medizinische Forschungsfond Tirol' and 'SVP-Frauen-Initiative'. This study is supported by the 'Tiroler Landeskrankenanstalten Ges.m.b.H. (TILAK)' and the 'Tyrolean Cancer Society'.	Abe A, 2012, ONCOL REP, V29, P1333; Altieri DC, 2003, ONCOGENE, V22, P8581, DOI 10.1038/sj.onc.1207113; Ausserlechner MJ, 2006, MOL CANCER THER, V5, P1927, DOI 10.1158/1535-7163.MCT-05-0500; Bean JF, 2014, J PEDIATR SURG, V49, P981, DOI 10.1016/j.jpedsurg.2014.01.037; Blanc-Brude OP, 2003, CLIN CANCER RES, V9, P2683; Caldas H, 2006, J MED GENET, V43, P119, DOI 10.1136/jmg.2005.034686; Chang CC, 2004, P NATL ACAD SCI USA, V101, P13239, DOI 10.1073/pnas.0405407101; Cheng Y, 2013, INT J MED SCI, V10, P634, DOI 10.7150/ijms.5547; Chuang JH, 2013, INT J BIOCHEM CELL B, V45, P944, DOI 10.1016/j.biocel.2013.01.019; De Lena M, 2001, EUR J CANCER, V37, P364, DOI 10.1016/S0959-8049(00)00400-7; Debnath J, 2005, AUTOPHAGY, V1, P66, DOI 10.4161/auto.1.2.1738; Denton D, 2015, IMMUNOL CELL BIOL, V93, P35, DOI 10.1038/icb.2014.85; Dohi T, 2004, J CLIN INVEST, V114, P1117, DOI 10.1172/JCI200422222; Eckelman BP, 2006, EMBO REP, V7, P988, DOI 10.1038/sj.embor.7400795; Fortugno P, 2003, P NATL ACAD SCI USA, V100, P13791, DOI 10.1073/pnas.2434345100; Fukuda S, 2002, BLOOD, V100, P2463, DOI 10.1182/blood.V100.7.2463; Ganapathy-Kanniappan S, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-152; Geiger K, 2012, MOL BIOL CELL, V23, P2226, DOI 10.1091/mbc.E11-06-0535; Grignani F, 1998, CANCER RES, V58, P14; Groner B, 2014, BIODRUGS, V28, P27, DOI 10.1007/s40259-013-0058-x; Gurbuxani S, 2005, P NATL ACAD SCI USA, V102, P11480, DOI 10.1073/pnas.0500303102; Hagenbuchner J, 2013, ONCOGENE, V32, P4748, DOI 10.1038/onc.2012.500; Hagenbuchner J, 2013, ONCOTARGET, V4, P1241, DOI 10.18632/oncotarget.1147; Hagenbuchner J, 2012, J CELL SCI, V125, P1191, DOI 10.1242/jcs.092098; Hagenbuchner J, 2010, J BIOL CHEM, V285, P6904, DOI 10.1074/jbc.M109.038331; Hoepken HH, 2007, NEUROBIOL DIS, V25, P401, DOI 10.1016/j.nbd.2006.10.007; Huang CY, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.149; Islam A, 2000, ONCOGENE, V19, P617, DOI 10.1038/sj.onc.1203358; Kang BH, 2006, J BIOL CHEM, V281, P24721, DOI 10.1074/jbc.M603175200; Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191; Maher JC, 2004, CANCER CHEMOTH PHARM, V53, P116, DOI 10.1007/s00280-003-0724-7; Mesri M, 2001, AM J PATHOL, V158, P1757, DOI 10.1016/S0002-9440(10)64131-4; Michiorri S, 2010, CELL DEATH DIFFER, V17, P962, DOI 10.1038/cdd.2009.200; Morgillo F, 2006, CANCER RES, V66, P10100, DOI 10.1158/0008-5472.CAN-06-1684; Nakahara T, 2007, CANCER RES, V67, P8014, DOI 10.1158/0008-5472.CAN-07-1343; Niu TK, 2010, FEBS LETT, V584, P3519, DOI 10.1016/j.febslet.2010.07.018; Novak I, 2012, ANTIOXID REDOX SIGN, V17, P794, DOI 10.1089/ars.2011.4407; Obexer P, 2009, MOL BIOL CELL, V20, P2041, DOI 10.1091/mbc.E08-07-0699; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Park E, 2011, BLOOD, V118, P2191, DOI 10.1182/blood-2011-04-351239; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Plescia J, 2005, CANCER CELL, V7, P457, DOI 10.1016/j.ccr.2005.03.035; Ramirez-Peinado S, 2013, J BIOL CHEM, V288, P30387, DOI 10.1074/jbc.M113.490581; Ramirez-Peinado S, 2011, CANCER RES, V71, P6796, DOI 10.1158/0008-5472.CAN-11-0759; Rodel F, 2008, INT J RADIAT ONCOL, V71, P247, DOI 10.1016/j.ijrobp.2008.02.011; Sachita K, 2015, J ORAL PATHOL MED, V44, P785, DOI 10.1111/jop.12299; Saita S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2400; Sandebring A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005701; Satoh T, 2009, CLIN CANCER RES, V15, P3872, DOI 10.1158/1078-0432.CCR-08-1946; Sheen JH, 2011, CANCER CELL, V19, P613, DOI 10.1016/j.ccr.2011.03.012; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Shutt DC, 2010, CANCER BIOL THER, V9, P853, DOI 10.4161/cbt.9.11.11632; Singh R, 2011, CELL METAB, V13, P495, DOI 10.1016/j.cmet.2011.04.004; Stein M, 2010, PROSTATE, V70, P1388, DOI 10.1002/pros.21172; Stern R, 2002, EXP CELL RES, V276, P24, DOI 10.1006/excr.2002.5508; Stock C, 2008, AM J PATHOL, V172, P203, DOI 10.2353/ajpath.2008.061263; Tolcher AW, 2012, ANN ONCOL, V23, P968, DOI 10.1093/annonc/mdr353; Tran J, 2002, P NATL ACAD SCI USA, V99, P4349, DOI 10.1073/pnas.072586399; Uchida H, 2004, MOL THER, V10, P162, DOI 10.1016/j.ymthe.2004.05.006; Velculescu VE, 1999, NAT GENET, V23, P387, DOI 10.1038/70487; Verdecia MA, 2000, NAT STRUCT BIOL, V7, P602; Wang X, 2007, BRAIN RES, V1132, P1, DOI 10.1016/j.brainres.2006.11.032; Wobser M, 2006, CANCER IMMUNOL IMMUN, V55, P1294, DOI 10.1007/s00262-005-0102-x; Xing Z, 2004, J EXP MED, V199, P69, DOI 10.1084/jem.20031588; Yamamoto A, 2005, J BIOL CHEM, V280, P3390, DOI 10.1074/jbc.M407724200; Zhang C, 2011, P NATL ACAD SCI USA, V108, P16259, DOI 10.1073/pnas.1113884108; Zhou W, 2014, SEMIN CELL DEV BIOL, V35, P14, DOI 10.1016/j.semcdb.2014.07.013	67	44	48	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 21	2016	35	16					2052	2061		10.1038/onc.2015.264	http://dx.doi.org/10.1038/onc.2015.264			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DJ9AH	26148234				2022-12-26	WOS:000374505600005
J	Foda, BM; Singh, U				Foda, Bardees M.; Singh, Upinder			Dimethylated H3K27 Is a Repressive Epigenetic Histone Mark in the Protist Entamoeba histolytica and Is Significantly Enriched in Genes Silenced via the RNAi Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERASE-II INITIATION; ANTISENSE SMALL RNAS; DNA ELIMINATION; JMJC DOMAIN; HETEROCHROMATIN; METHYLATION; TRANSCRIPTION; CHROMATIN; H3; INTERFERENCE	RNA interference (RNAi) is a fundamental biological process that plays a crucial role in regulation of gene expression in many organisms. Transcriptional gene silencing (TGS) is one of the important nuclear roles of RNAi. Our previous data show that Entamoeba histolytica has a robust RNAi pathway that links to TGS via Argonaute 2-2 (Ago2-2) associated 27-nucleotide small RNAs with 5'-polyphosphate termini. Here, we report the first repressive histone mark to be identified in E. histolytica, dimethylation of H3K27 (H3K27Me2), and demonstrate that it is enriched at genes that are silenced by RNAi-mediated TGS. An RNAi-silencing trigger can induce H3K27Me2 deposits at both episomal and chromosomal loci, mediating gene silencing. Our data support two phases of RNAi-mediated TGS: an active silencing phase where the RNAi trigger is present and both H3K27Me2 and Ago2-2 concurrently enrich at chromosomal loci; and an established silencing phase in which the RNAi trigger is removed, but gene silencing with H3K27Me2 enrichment persist independently of Ago2-2 deposition. Importantly, some genes display resistance to chromosomal silencing despite induction of functional small RNAs. In those situations, the RNAi-triggering plasmid that is maintained episomally gets partially silenced and has H3K27Me2 enrichment, but the chromosomal copy displays no repressive histone enrichment. Our data are consistent with a model in which H3K27Me2 is a repressive histone modification, which is strongly associated with transcriptional repression. This is the first example of an epigenetic histone modification that functions to mediate RNAi-mediated TGS in the deep-branching eukaryote E. histolytica.	[Foda, Bardees M.; Singh, Upinder] Stanford Univ, Dept Internal Med, Div Infect Dis, Sch Med, Stanford, CA 94305 USA; [Singh, Upinder] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA; [Foda, Bardees M.] Natl Res Ctr, Dept Mol Genet & Enzymol, Dokki, Egypt	Stanford University; Stanford University; Egyptian Knowledge Bank (EKB); National Research Centre (NRC)	Singh, U (corresponding author), Stanford Univ, Dept Internal Med, Div Infect Dis, Sch Med, Stanford, CA 94305 USA.	usingh@stanford.edu	Regan, Clinton/E-6250-2012; Foda, Bardees/B-2182-2019	Foda, Bardees/0000-0001-8869-3697; Singh, Upinder/0000-0003-0630-0306	National Institutes of Health [R01AI053724, R21 AI102277]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI102277, R01AI053724] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants R01AI053724 and R21 AI102277 (to U.S.). The authors declare that they have no conflicts of interest with the contents of this article.	Ayoub N, 2003, MOL CELL BIOL, V23, P4356, DOI 10.1128/MCB.23.12.4356-4370.2003; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Batista TM, 2011, J PROTEOMICS, V74, P1504, DOI 10.1016/j.jprot.2011.02.032; Bazer FW, 2010, MOL HUM REPROD, V16, P135, DOI 10.1093/molehr/gap095; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boros J, 2014, MOL CELL BIOL, V34, P3662, DOI 10.1128/MCB.00205-14; Cam HP, 2005, NAT GENET, V37, P809, DOI 10.1038/ng1602; Castel SE, 2013, NAT REV GENET, V14, P100, DOI 10.1038/nrg3355; Chan FL, 2012, NUCLEIC ACIDS RES, V40, P11178, DOI 10.1093/nar/gks921; Chen ES, 2008, NATURE, V451, P734, DOI 10.1038/nature06561; Chujo T, 2014, MOL MICROBIOL, V92, P413, DOI 10.1111/mmi.12567; Deshpande G, 2005, GENE DEV, V19, P1680, DOI 10.1101/gad.1316805; DIAMOND LS, 1978, T ROY SOC TROP MED H, V72, P431, DOI 10.1016/0035-9203(78)90144-X; Djupedal I, 2009, CELL RES, V19, P282, DOI 10.1038/cr.2009.13; Eichten SR, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003127; Ellison TJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111502; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; FODINGER M, 1993, MOL BIOCHEM PARASIT, V59, P315, DOI 10.1016/0166-6851(93)90229-Q; Fukagawa T, 2004, NAT CELL BIOL, V6, P784, DOI 10.1038/ncb1155; Furuhashi H, 2010, EPIGENET CHROMATIN, V3, DOI 10.1186/1756-8935-3-15; Gao L, 2008, MOL CELL BIOL, V28, P3979, DOI 10.1128/MCB.00019-08; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Hemming SA, 2000, J BIOL CHEM, V275, P35506, DOI 10.1074/jbc.M004721200; Horwich MD, 2007, CURR BIOL, V17, P1265, DOI 10.1016/j.cub.2007.06.030; Huguenin M, 2010, PARASITOLOGY, V137, P619, DOI 10.1017/S0031182009991363; Janowski BA, 2006, NAT STRUCT MOL BIOL, V13, P787, DOI 10.1038/nsmb1140; Jhingan GD, 2009, MOL BIOCHEM PARASIT, V167, P72, DOI 10.1016/j.molbiopara.2009.04.011; Johnson A, 2013, J BIOL CHEM, V288, P28771, DOI 10.1074/jbc.M113.460071; Jorgensen S, 2013, NUCLEIC ACIDS RES, V41, P2797, DOI 10.1093/nar/gkt012; Kim DH, 2006, NAT STRUCT MOL BIOL, V13, P793, DOI 10.1038/nsmb1142; Kosar M, 2011, CELL CYCLE, V10, P457, DOI 10.4161/cc.10.3.14707; Kotake Y, 2007, GENE DEV, V21, P49, DOI 10.1101/gad.1499407; Liu X, 2006, RNA, V12, P1514, DOI 10.1261/rna.101606; Liu Y, 2007, GENE DEV, V21, P1530, DOI 10.1101/gad.1544207; Lund AH, 2004, CURR OPIN CELL BIOL, V16, P239, DOI 10.1016/j.ceb.2004.03.010; Lyko F, 2006, CURR TOP MICROBIOL, V310, P23; MacFarlane RC, 2006, INFECT IMMUN, V74, P340, DOI 10.1128/IAI.74.1.340-351.2006; Maison C, 2002, NAT GENET, V30, P329, DOI 10.1038/ng843; Matzke MA, 2005, NAT REV GENET, V6, P24, DOI 10.1038/nrg1500; Moazed D, 2006, COLD SPRING HARB SYM, V71, P461, DOI 10.1101/sqb.2006.71.044; Mochizuki K, 2002, CELL, V110, P689, DOI 10.1016/S0092-8674(02)00909-1; Morf L, 2013, NUCLEIC ACIDS RES, V41, P9424, DOI 10.1093/nar/gkt717; Morris KV, 2004, SCIENCE, V305, P1289, DOI 10.1126/science.1101372; Neumann P, 2007, GENETICS, V176, P749, DOI 10.1534/genetics.107.071902; Pal-Bhadra M, 2004, SCIENCE, V303, P669, DOI 10.1126/science.1092653; Papazyan R, 2014, ELIFE, V3, DOI 10.7554/eLife.02996; Pearson RJ, 2013, J BIOL CHEM, V288, P4462, DOI 10.1074/jbc.M112.423467; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Pokholok DK, 2002, MOL CELL, V9, P799, DOI 10.1016/S1097-2765(02)00502-6; Pompey JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106477; Rechtsteiner A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001091; Reinhart BJ, 2002, SCIENCE, V297, P1831, DOI 10.1126/science.1077183; Rosenfeld JA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-143; Saito-Nakano Y, 2004, J BIOL CHEM, V279, P49497, DOI 10.1074/jbc.M403987200; Saze H, 2008, SCIENCE, V319, P462, DOI 10.1126/science.1150987; Sharma S, 2010, CARCINOGENESIS, V31, P27, DOI 10.1093/carcin/bgp220; Shi Y, 2007, NAT REV GENET, V8, P829, DOI 10.1038/nrg2218; Talbert PB, 2006, NAT REV GENET, V7, P793, DOI 10.1038/nrg1920; Taverna SD, 2002, CELL, V110, P701, DOI 10.1016/S0092-8674(02)00941-8; Tomari Y, 2007, CELL, V130, P299, DOI 10.1016/j.cell.2007.05.057; Tovy A, 2010, FUTURE MICROBIOL, V5, P1875, DOI 10.2217/FMB.10.140; Vance V, 2001, SCIENCE, V292, P2277, DOI 10.1126/science.1061334; Vastenhouw NL, 2006, NATURE, V442, P882, DOI 10.1038/442882a; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Wang JB, 2011, GENOME RES, V21, P1462, DOI 10.1101/gr.121426.111; Wang JY, 2015, ELIFE, V4, DOI 10.7554/eLife.06179; Wang JY, 2014, CELL MOL LIFE SCI, V71, P4841, DOI 10.1007/s00018-014-1725-x; Weinberg MS, 2006, RNA, V12, P256, DOI 10.1261/rna.2235106; Zhang HB, 2011, J BIOL CHEM, V286, P44467, DOI 10.1074/jbc.M111.278184; Zhang HB, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000219	71	24	24	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2015	290	34					21114	21130		10.1074/jbc.M115.647263	http://dx.doi.org/10.1074/jbc.M115.647263			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP6QC	26149683	hybrid, Green Published			2022-12-26	WOS:000360011800043
J	Kittappa, S; Cui, MC; Ramalingam, M; Ibrahim, S; Khim, J; Yoon, Y; Snyder, SA; Jang, M				Kittappa, Shanmuga; Cui, Mingcan; Ramalingam, Malarvili; Ibrahim, Shaliza; Khim, Jeehyeong; Yoon, Yeomin; Snyder, Shane A.; Jang, Min			Synthesis Mechanism and Thermal Optimization of an Economical Mesoporous Material Using Silica: Implications for the Effective Removal or Delivery of Ibuprofen	PLOS ONE			English	Article							DRUG-DELIVERY; ACTIVATED CARBONS; PHARMACEUTICAL COMPOUNDS; SURFACE-CHEMISTRY; MOLECULAR-SIEVES; ADSORPTION; SBA-15; MCM-41; NANOPARTICLES; COPOLYMER	Mesoporous silica materials (MSMs) were synthesized economically using silica (SiO2) as a precursor via a modified alkaline fusion method. The MSM prepared at 500 degrees C (MSM-500) had the highest surface area, pore size, and volume, and the results of isotherms and the kinetics of ibuprofen (IBP) removal indicated that MSM-500 had the highest sorption capacity and fastest removal speed vs. SBA-15 and zeolite. Compared with commercial granular activated carbon (GAC), MSM-500 had a similar to 100 times higher sorption rate at neutral pH. IBP uptake by MSM-500 was thermodynamically favorable at room temperature, which was interpreted as indicating relatively weak bonding because the entropy (Delta(adsS), -0.07 J mol(-1) K-1) was much smaller. Five times recycling tests revealed that MSM-500 had 83-87% recovery efficiencies and slower uptake speeds due to slight deformation of the outer pore structure. In the IBP delivery test, MSM-500 drug loading was 41%, higher than the reported value of SBA-15 (31%). The in vitro release of IBP was faster, almost 100%, reaching equilibrium within a few hours, indicating its effective loading and unloading characteristics. A cost analysis study revealed that the MSM was similar to 10-70 times cheaper than any other mesoporous silica material for the removal or delivery of IBP.	[Kittappa, Shanmuga; Ibrahim, Shaliza; Jang, Min] Univ Malaya, Fac Engn, Dept Civil Engn, Kuala Lumpur, Malaysia; [Cui, Mingcan; Khim, Jeehyeong] Korea Univ, Sch Civil Environm & Architectural Engn, Seoul, South Korea; [Yoon, Yeomin] Univ S Carolina, Dept Civil & Environm Engn, Columbia, SC 29208 USA; [Snyder, Shane A.] Univ Arizona, Dept Chem & Environm Engn, Tucson, AZ USA; [Jang, Min] Univ Malaya, Nanotechnol & Catalysis Res Ctr NANOCAT, Kuala Lumpur, Malaysia	Universiti Malaya; Korea University; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of Arizona; Universiti Malaya	Jang, M (corresponding author), Univ Malaya, Fac Engn, Dept Civil Engn, Kuala Lumpur, Malaysia.	minjang@um.edu.my	Cui, Mingcan/K-2890-2013; Yoon, Yeomin/C-3331-2012; Ibrahim, Shaliza/A-5854-2010; Park, Jeonghyuk/AAE-3814-2020; Snyder, Shane A/AAE-8252-2021; Jang, Min/M-6690-2018; Snyder, Shane/A-3302-2011	Cui, Mingcan/0000-0001-9619-154X; Ibrahim, Shaliza/0000-0001-9413-957X; Jang, Min/0000-0003-2700-7256; Jang, Min/0000-0002-5900-0991; Snyder, Shane/0000-0003-2709-9840	Malaysian Government Ministry of Higher Education through the High Impact Research Grant [D000062-16001]; National Research Foundation of Korea (NRF) grant - Korea government (MEST) [KRF-2009-0092799]	Malaysian Government Ministry of Higher Education through the High Impact Research Grant; National Research Foundation of Korea (NRF) grant - Korea government (MEST)	This research was funded by the Malaysian Government Ministry of Higher Education through the High Impact Research Grant (D000062-16001), and partly supported by the Basic Science Research Program through a National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST, No. KRF-2009-0092799). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Khateeb LA, 2014, J IND ENG CHEM, V20, P916, DOI 10.1016/j.jiec.2013.06.023; Alyoshina NA, 2013, J SOLID STATE CHEM, V205, P211, DOI 10.1016/j.jssc.2013.03.044; Andersson J, 2004, CHEM MATER, V16, P4160, DOI 10.1021/cm0401490; Attia TMS, 2013, CHEMOSPHERE, V93, P2076, DOI 10.1016/j.chemosphere.2013.07.046; Babonneau F, 2003, MRS P; Baccar R, 2012, CHEM ENG J, V211, P310, DOI 10.1016/j.cej.2012.09.099; Bui TX, 2009, J HAZARD MATER, V168, P602, DOI 10.1016/j.jhazmat.2009.02.072; Doadrio AL, 2004, J CONTROL RELEASE, V97, P125, DOI 10.1016/j.jconrel.2004.03.005; Foo KY, 2010, CHEM ENG J, V156, P2, DOI 10.1016/j.cej.2009.09.013; Guedidi H, 2013, CARBON, V54, P432, DOI 10.1016/j.carbon.2012.11.059; Jaroniec M., 2006, ACCESS NANOPOROUS MA, V188, P255, DOI [10.1007/0-306-47066-7_17., DOI 10.1007/0-306-47066-7_17]; Kamarudin NHN, 2014, J COLLOID INTERF SCI, V421, P6, DOI 10.1016/j.jcis.2014.01.034; Katiyar A, 2006, J CHROMATOGR A, V1122, P13, DOI 10.1016/j.chroma.2006.04.055; Kim SS, 2001, CHEM COMMUN, P2418, DOI 10.1039/b107896h; Kim Y, 2014, CHEM ENG J, V256, P475, DOI 10.1016/j.cej.2014.06.100; KRESGE CT, 1992, NATURE, V359, P710, DOI 10.1038/359710a0; Kruk M, 1997, LANGMUIR, V13, P6267, DOI 10.1021/la970776m; Kwon M, 2015, CHEM ENG J, V269, P379, DOI 10.1016/j.cej.2015.01.125; Lim MH, 1999, CHEM MATER, V11, P3285, DOI 10.1021/cm990369r; Liu TH, 2013, J RADIOANAL NUCL CH, V297, P119, DOI 10.1007/s10967-012-2316-7; Liu Y, 2008, SEP PURIF TECHNOL, V61, P229, DOI 10.1016/j.seppur.2007.10.002; Margolese D, 2000, CHEM MATER, V12, P2448, DOI 10.1021/cm0010304; Mestre AS, 2007, CARBON, V45, P1979, DOI 10.1016/j.carbon.2007.06.005; Mestre AS, 2014, CHEM ENG J, V253, P408, DOI 10.1016/j.cej.2014.05.051; Mestre AS, 2009, BIORESOURCE TECHNOL, V100, P1720, DOI 10.1016/j.biortech.2008.09.039; Munoz B, 2003, CHEM MATER, V15, P500, DOI 10.1021/cm021217q; NAKASHIMA H, 1994, ARCH TOXICOL, V68, P277, DOI 10.1007/s002040050069; Neng NR, 2011, J CHROMATOGR A, V1218, P6263, DOI 10.1016/j.chroma.2011.07.025; Park J, 2012, J NANOMATER, V2012, DOI 10.1155/2012/528174; Reijenga JC, 1997, J CHROMATOGR A, V792, P371, DOI 10.1016/S0021-9673(97)00644-4; Sadecka J, 2001, J PHARMACEUT BIOMED, V25, P881, DOI 10.1016/S0731-7085(01)00374-0; Slowing II, 2007, ADV FUNCT MATER, V17, P1225, DOI 10.1002/adfm.200601191; Son SJ, 2006, J CONTROL RELEASE, V114, P143, DOI 10.1016/j.jconrel.2006.06.004; Song SW, 2005, LANGMUIR, V21, P9568, DOI 10.1021/la051167e; Thommes M, 2010, CHEM-ING-TECH, V82, P1059, DOI 10.1002/cite.201000064; Vallet-Regi M, 2001, CHEM MATER, V13, P308, DOI 10.1021/cm0011559; Vallet-Regi M, 2007, ANGEW CHEM INT EDIT, V46, P7548, DOI 10.1002/anie.200604488; Walas S.M., 1985, PHASE EQUILIBRIA CHE, DOI 10.1016/C2013-0-04304-6; Wang XF, 2011, MICROPOR MESOPOR MAT, V142, P334, DOI 10.1016/j.micromeso.2010.12.018; Yang PP, 2007, INORG CHEM, V46, P3203, DOI 10.1021/ic0622959; Yang PP, 2012, CHEM SOC REV, V41, P3679, DOI 10.1039/c2cs15308d; Zhang L, 2013, SEP PURIF TECHNOL, V116, P145, DOI 10.1016/j.seppur.2013.05.036; Zhao DY, 1998, SCIENCE, V279, P548, DOI 10.1126/science.279.5350.548; Zhao DY, 1998, J AM CHEM SOC, V120, P6024, DOI 10.1021/ja974025i; Zhao XS, 1997, J PHYS CHEM B, V101, P6525, DOI 10.1021/jp971366+; Zhu YF, 2005, MICROPOR MESOPOR MAT, V85, P75, DOI 10.1016/j.micromeso.2005.06.015	46	6	6	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0130253	10.1371/journal.pone.0130253	http://dx.doi.org/10.1371/journal.pone.0130253			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161510	gold, Green Submitted, Green Published			2022-12-26	WOS:000358162300016
J	Pohjanen, VM; Koivurova, OP; Huhta, H; Helminen, O; Makinen, JM; Karhukorpi, JM; Joensuu, T; Koistinen, PO; Valtonen, JM; Niemela, SE; Karttunen, RA; Karttunen, TJ				Pohjanen, Vesa-Matti; Koivurova, Olli-Pekka; Huhta, Heikki; Helminen, Olli; Makinen, Johanna M.; Karhukorpi, Jari M.; Joensuu, Tapio; Koistinen, Pentti O.; Valtonen, Jarno M.; Niemela, Seppo E.; Karttunen, Riitta A.; Karttunen, Tuomo J.			Toll-Like Receptor 4 Wild Type Homozygozity of Polymorphisms+896 and+1196 Is Associated with High Gastrin Serum Levels and Peptic Ulcer Risk	PLOS ONE			English	Article							GENETIC POLYMORPHISMS; PRECANCEROUS LESIONS; TLR4; DISEASES; CANCER; PATHOGENESIS; SECRETION; CYTOKINE; GENOTYPE	Toll-like receptor 4 is a part of the innate immune system and recognizes Helicobacter pylori lipopolysaccharide. The goal of this study was to analyze the role of Toll-like receptor 4 polymorphisms +896 (rs4986790) and +1196 (rs4986791) in the pathogenesis of Helicobacter pylori related gastroduodenal diseases in relation to gastric secretion and inflammation. Toll-like receptor 4 polymorphisms, serum gastrin-17 and pepsinogen I and II concentrations were determined, and gastroscopies with histopathological analyses were performed to 216 dyspeptic patients. As genotype controls, 179 controls and 61 gastric cancer patients were studied. In our study, the Toll-like receptor 4 +896 and +1196 polymorphisms were in total linkage disequilibrium. The homozygous wild types displayed higher gastrin-17 serum concentrations than the mutants (p = 0.001) and this effect was independent of Helicobacter pylori. The homozygous wild types also displayed an increased risk for peptic ulcers (OR: 4.390). Toll-like receptor 4 genotypes did not show any association with Helicobacter pylori positivity or the features of gastric inflammation. Toll-like receptor 4 expression was seen in gastrin and somatostatin expressing cells of antral mucosa by immunohistochemistry. Our results suggest a role for Toll-like receptor 4 in gastric acid regulation and that the Toll-like receptor 4 +896 and +1196 wild type homozygozity increases peptic ulcer risk via gastrin secretion.	[Pohjanen, Vesa-Matti; Huhta, Heikki; Helminen, Olli; Makinen, Johanna M.; Joensuu, Tapio; Karttunen, Tuomo J.] Oulu Univ Hosp, Med Res Ctr Oulu, Oulu, Finland; [Pohjanen, Vesa-Matti; Huhta, Heikki; Helminen, Olli; Makinen, Johanna M.; Joensuu, Tapio; Karttunen, Tuomo J.] Univ Oulu, Oulu, Finland; [Koivurova, Olli-Pekka; Niemela, Seppo E.] Oulu Univ Hosp, Dept Internal Med, Oulu, Finland; [Karhukorpi, Jari M.; Karttunen, Riitta A.] Univ Oulu, Inst Diagnost, Dept Med Microbiol & Immunol, Oulu, Finland; [Karhukorpi, Jari M.] Eastern Finland Lab Ctr Joint Author Enterprise I, Joensuu, Finland; [Joensuu, Tapio] Pietarsaari City Hosp, Dept Internal Med, Pietarsaari, Finland; [Koistinen, Pentti O.; Valtonen, Jarno M.] Oulu City Hosp, Oulu, Finland	University of Oulu; University of Oulu; University of Oulu; University of Oulu	Karttunen, TJ (corresponding author), Oulu Univ Hosp, Med Res Ctr Oulu, Oulu, Finland.	tuomo.karttunen@oulu.fi	Helminen, Olli/AGO-2713-2022	Karttunen, Tuomo/0000-0002-8843-7957; Helminen, Olli/0000-0001-9544-6475; Pohjanen, Vesa-Matti/0000-0002-4129-4346; Huhta, Heikki/0000-0002-6273-198X				Achyut BR, 2007, HUM IMMUNOL, V68, P901, DOI 10.1016/j.humimm.2007.10.006; Bagheri N, 2014, CLIN RES HEPATOL GAS, V38, P366, DOI 10.1016/j.clinre.2013.12.004; Chen J, 2013, CANCER BIOTHER RADIO, V28, P674, DOI 10.1089/cbr.2012.1395; Chu SJ, 2013, CURR OPIN GASTROEN, V29, P636, DOI 10.1097/MOG.0b013e328365efc7; Eiro N, 2012, DIGEST DIS SCI, V57, P2278, DOI 10.1007/s10620-012-2184-6; El-Omar EM, 2008, ONCOGENE, V27, P244, DOI 10.1038/sj.onc.1210912; Ferwerda B, 2007, P NATL ACAD SCI USA, V104, P16645, DOI 10.1073/pnas.0704828104; Fukui T, 2006, GUT, V55, P607, DOI 10.1136/gut.2005.077917; Hofner P, 2007, HELICOBACTER, V12, P124, DOI 10.1111/j.1523-5378.2007.00481.x; Karhukorpi J, 2000, EUR J CLIN MICROBIOL, V19, P790, DOI 10.1007/s100960000366; Kato I, 2007, DIGEST DIS SCI, V52, P254, DOI 10.1007/s10620-006-9303-1; Kidd M, 2009, GASTROENTEROLOGY, V137, P231, DOI 10.1053/j.gastro.2009.01.005; Koivurova OP, 2003, SCAND J GASTROENTERO, V38, P1217, DOI 10.1080/00365520310006504; Koskela RM, 2011, SCAND J GASTROENTERO, V46, P567, DOI 10.3109/00365521.2011.551889; Kutikhin AG, 2011, HUM IMMUNOL, V72, P193, DOI 10.1016/j.humimm.2010.11.003; Lorenz E, 2001, BIOTECHNIQUES, V31, P22, DOI 10.2144/01311bm01; McColl KEL, 2000, BEST PRACT RES CL GA, V14, P13, DOI 10.1053/bega.1999.0056; MISIEWICZ JJ, 1991, J GASTROEN HEPATOL, V6, P207, DOI 10.1111/j.1440-1746.1991.tb01467.x; Murphy G, 2009, EUR J GASTROEN HEPAT, V21, P630, DOI 10.1097/MEG.0b013e3283140eea; Peri F, 2013, J MED CHEM REFERENCE; Pohjanen VM, 2013, GENE CHROMOSOME CANC, V52, P976, DOI 10.1002/gcc.22093; Rigoli L, 2010, ANTICANCER RES, V30, P513; Schmausser B, 2004, CLIN EXP IMMUNOL, V136, P521, DOI 10.1111/j.1365-2249.2004.02464.x; Trejo-de la O A, 2008, CLIN IMMUNOL, V129, P333, DOI 10.1016/j.clim.2008.07.009; Wallace JL, 2012, BRIT J PHARMACOL, V165, P67, DOI 10.1111/j.1476-5381.2011.01509.x; Zavros Y, 2005, BIOCHEM PHARMACOL, V69, P365, DOI 10.1016/j.bcp.2004.07.043	26	11	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131553	10.1371/journal.pone.0131553	http://dx.doi.org/10.1371/journal.pone.0131553			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161647	gold, Green Published, Green Submitted			2022-12-26	WOS:000358162300047
J	Qi, Y; Zhang, F; Zhang, L; Harrison, TJ; Huang, WJ; Zhao, CY; Kong, W; Jiang, CL; Wang, YC				Qi, Ying; Zhang, Feng; Zhang, Li; Harrison, Tim J.; Huang, Weijin; Zhao, Chenyan; Kong, Wei; Jiang, Chunlai; Wang, Youchun			Hepatitis E Virus Produced from Cell Culture Has a Lipid Envelope	PLOS ONE			English	Article							ORF3 PROTEIN; CAPSID PROTEIN; IN-VITRO; HEV; EXPRESSION; PARTICLES; GLYCOSYLATION; HEPATOMA; REVEALS; RELEASE	The absence of a productive cell culture system hampered detailed analysis of the structure and protein composition of the hepatitis E virion. In this study, hepatitis E virus from a robust HEV cell culture system and from the feces of infected monkeys at the peak of virus excretion was purified by ultra-centrifugation. The common feature of the two samples after ultracentrifugation was that the ORF2 protein mainly remained in the top fractions. The ORF2 protein from cell culture system was glycosylated, with an apparent molecular weight of 88 kDa, and was not infectious in PLC/PRF/5 cells. The ORF2 protein in this fraction can bind to and protect HEV RNA from digestion by RNase A. The RNA-ORF2 product has a similar sedimentation coefficient to the virus from feces. The viral RNA in the cell culture supernatant was mainly in the fraction of 1.15g/cm(3) but that from the feces was mainly in the fraction of 1.21 g/cm(3). Both were infectious in PLC/PRF/5 cells. And the fraction in the middle of the gradient (1.06g/cm3) from the cell culture supernatant, but not that from the feces, also has ORF2 protein and HEV RNA but was not infectious in PLC/PRF/5. The infectious RNA-rich fraction from the cell culture contained ORF3 protein and lipid but the corresponding fraction from feces had no lipid and little ORF3 protein. The lipid on the surface of the virus has no effect on its binding to cells but the ORF3 protein interferes with binding. The result suggests that most of the secreted ORF2 protein is not associated with HEV RNA and that hepatitis E virus produced in cell culture differs in structure from the virus found in feces in that it has a lipid envelope.	[Qi, Ying; Kong, Wei; Jiang, Chunlai] Jilin Univ, Natl Engn Lab AIDS Vaccine, Changchun 130012, Peoples R China; [Qi, Ying; Zhang, Feng; Zhang, Li; Huang, Weijin; Zhao, Chenyan; Wang, Youchun] Natl Inst Food & Drug Control, Div HIV AIDS & Sexually Transmitted Virus Vaccine, Beijing 100050, Peoples R China; [Harrison, Tim J.] UCL, Sch Med, Div Med, London WC1E 6BT, England	Jilin University; National Institute of Food & Drug Control - China; University of London; University College London; UCL Medical School	Wang, YC (corresponding author), Natl Inst Food & Drug Control, Div HIV AIDS & Sexually Transmitted Virus Vaccine, Beijing 100050, Peoples R China.	wangyc@nifdc.org.cn	huang, weijin/AAY-5028-2020	huang, weijin/0000-0002-4246-8889	National Natural Science Foundation of China [81171549]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (grant: 81171549). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal R, 2009, J GASTROEN HEPATOL, V24, P1484, DOI 10.1111/j.1440-1746.2009.05933.x; Agrawal S, 2001, VIROLOGY, V282, P87, DOI 10.1006/viro.2000.0819; Emerson SU, 2006, J VIROL, V80, P10457, DOI 10.1128/JVI.00892-06; Emerson SU, 2010, J VIROL, V84, P9059, DOI 10.1128/JVI.00593-10; Feng ZD, 2014, TRENDS MICROBIOL, V22, P59, DOI 10.1016/j.tim.2013.10.005; Graff J, 2008, J VIROL, V82, P1185, DOI 10.1128/JVI.01219-07; Graff J, 2006, J VIROL, V80, P5919, DOI 10.1128/JVI.00046-06; Jameel S, 1996, J VIROL, V70, P207, DOI 10.1128/JVI.70.1.207-216.1996; Khudyakov YE, 1999, J CLIN MICROBIOL, V37, P2863, DOI 10.1128/JCM.37.9.2863-2871.1999; Li TC, 1997, J VIROL, V71, P7207, DOI 10.1128/JVI.71.10.7207-7213.1997; Ma HX, 2011, J MED VIROL, V83, P827, DOI 10.1002/jmv.22032; Ma HX, 2009, J MED VIROL, V81, P1052, DOI 10.1002/jmv.21484; Meng XJ, 2013, SEMIN LIVER DIS, V33, P41, DOI 10.1055/s-0033-1338113; Parvez MK, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-159; Robinson RA, 1998, PROTEIN EXPRES PURIF, V12, P75, DOI 10.1006/prep.1997.0817; Shiota T, 2013, J VIROL, V87, P6031, DOI 10.1128/JVI.00444-13; Smith JL, 2001, J FOOD PROTECT, V64, P572, DOI 10.4315/0362-028X-64.4.572; Takahashi M, 2008, ARCH VIROL, V153, P1703, DOI 10.1007/s00705-008-0179-6; Takahashi M, 2010, J CLIN MICROBIOL, V48, P1112, DOI 10.1128/JCM.02002-09; Torresi J, 1997, J VIROL METHODS, V69, P81, DOI 10.1016/S0166-0934(97)00142-0; Torresi J, 1999, J GEN VIROL, V80, P1185, DOI 10.1099/0022-1317-80-5-1185; Touze A, 1998, NUCLEIC ACIDS RES, V26, P1317, DOI 10.1093/nar/26.5.1317; Wang YC, 2000, J GEN VIROL, V81, P1675, DOI 10.1099/0022-1317-81-7-1675; Xing L, 2010, J BIOL CHEM, V285, P33175, DOI 10.1074/jbc.M110.106336; Yamada K, 2009, J GEN VIROL, V90, P1880, DOI 10.1099/vir.0.010561-0; Zafrullah M, 1999, J VIROL, V73, P4074, DOI 10.1128/JVI.73.5.4074-4082.1999; Zhang F, 2006, J MED VIROL, V78, P1441, DOI 10.1002/jmv.20717; Zhao CY, 2007, J MED VIROL, V79, P1966, DOI 10.1002/jmv.21040	28	36	39	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132503	10.1371/journal.pone.0132503	http://dx.doi.org/10.1371/journal.pone.0132503			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161670	Green Submitted, Green Published, gold			2022-12-26	WOS:000358162300143
J	Lee, JT; Hamid, F; Pati, S; Atun, R; Millett, C				Lee, John Tayu; Hamid, Fozia; Pati, Sanghamitra; Atun, Rifat; Millett, Christopher			Impact of Noncommunicable Disease Multimorbidity on Healthcare Utilisation and Out-Of-Pocket Expenditures in Middle-Income Countries: Cross Sectional Analysis	PLOS ONE			English	Article							MULTIPLE CHRONIC CONDITIONS; UNIVERSAL HEALTH; PREVALENCE; COVERAGE; POPULATION; PRIORITY; BURDEN	Background The burden of non-communicable disease (NCDs) has grown rapidly in low-and middle-income countries (LMICs), where populations are ageing, with rising prevalence of multimorbidity (more than two co-existing chronic conditions) that will significantly increase pressure on already stretched health systems. We assess the impact of NCD multimorbidity on healthcare utilisation and out-of-pocket expenditures in six middle-income countries: China, Ghana, India, Mexico, Russia and South Africa. Methods Secondary analyses of cross-sectional data from adult participants (>18 years) in the WHO Study on Global Ageing and Adult Health (SAGE) 2007-2010. We used multiple logistic regression to determine socio-demographic correlates of multimorbidity. Association between the number of NCDs and healthcare utilisation as well as out-of-pocket spending was assessed using logistic, negative binominal and log-linear models. Results The prevalence of multimorbidity in the adult population varied from 3.9% in Ghana to 33.6% in Russia. Number of visits to doctors in primary and secondary care rose substantially for persons with increasing numbers of co-existing NCDs. Multimorbidity was associated with more outpatient visits in China (coefficient for number of NCD = 0.56, 95% CI = 0.46, 0.66), a higher likelihood of being hospitalised in India (AOR = 1.59, 95% CI = 1.45, 1.75), higher out-of-pocket expenditures for outpatient visits in India and China, and higher expenditures for hospital visits in Russia. Medicines constituted the largest proportion of out-of-pocket expenditures in persons with multimorbidity (88.3% for outpatient, 55.9% for inpatient visit in China) in most countries. Conclusion Multimorbidity is associated with higher levels of healthcare utilisation and greater financial burden for individuals in middle-income countries. Our study supports the WHO call for universal health insurance and health service coverage in LMICs, particularly for vulnerable groups such as the elderly with multimorbidity.	[Lee, John Tayu; Hamid, Fozia; Millett, Christopher] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Primary Care & Publ Hlth, London, England; [Pati, Sanghamitra] Publ Hlth Fdn India, Indian Inst Publ Hlth, Bhubaneswar, Orissa, India; [Atun, Rifat] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Millett, Christopher] Publ Hlth Fdn India, Gurgaon, India	Imperial College London; Public Health Foundation of India; Harvard University; Harvard T.H. Chan School of Public Health; Public Health Foundation of India	Lee, JT (corresponding author), Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Primary Care & Publ Hlth, London, England.	t.lee@imperial.ac.uk	Atun, Rifat/AAH-5537-2021	Atun, Rifat/0000-0002-1531-5983; Millett, Christopher/0000-0002-0793-9884; Lee, John Tayu/0000-0002-1551-4923	Higher Education Funding Council for England; National Institute for Health Research; Wellcome Trust [084674/Z/08/Z]; National Institute for Health Research [IPF-12-05] Funding Source: researchfish	Higher Education Funding Council for England(UK Research & Innovation (UKRI)Higher Education Funding Council for England (HEFCE)); National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	CM is funded by the Higher Education Funding Council for England and the National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care scheme. The South Asia Network for Chronic Disease (CM) is supported by a Wellcome Trust strategic award 084674/Z/08/Z. Funding sources had no role in the design of the study, analysis, interpretation of the results or writing of the manuscript.	Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; Akbari A, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005471.pub2; [Anonymous], WHO GLOBAL HEALTH OB; Atun R., 2014, LANCET; Atun R, 2013, LANCET, V381, P690, DOI 10.1016/S0140-6736(13)60063-X; Atun R, 2012, LANCET, V380, P2044, DOI 10.1016/S0140-6736(12)61460-3; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Barton P, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4044; Basu S, 2013, HYPERTENSION, V62, P18, DOI 10.1161/HYPERTENSIONAHA.113.01374; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Blank L, 2014, REFERRAL INTERVENTIO, V2014, pe765; Chandra A, 2010, AM ECON REV, V100, P193, DOI 10.1257/aer.100.1.193; Choudhry NK, 2011, NEW ENGL J MED, V365, P2088, DOI 10.1056/NEJMsa1107913; Di Cesare M, 2013, LANCET, V381, P585, DOI 10.1016/S0140-6736(12)61851-0; Ebrahim S, 2005, INT J EPIDEMIOL, V34, P961, DOI 10.1093/ije/dyi188; Ebrahim S, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001377; FARRAR DE, 1967, REV ECON STAT, V49, P92, DOI 10.2307/1937887; Fortin M, 2005, ANN FAM MED, V3, P223, DOI 10.1370/afm.272; Fortin M, 2012, ANN FAM MED, V10, P142, DOI 10.1370/afm.1337; Frenk J, 2006, LANCET, V368, P1524, DOI 10.1016/S0140-6736(06)69564-0; Garcia-Diaz R, 2011, J HEALTH ECON, V30, P707, DOI 10.1016/j.jhealeco.2011.04.003; Glynn LG, 2011, FAM PRACT, V28, P516, DOI 10.1093/fampra/cmr013; Goldman DP, 2007, JAMA-J AM MED ASSOC, V298, P61, DOI 10.1001/jama.298.1.61; Goldman N, 2003, J CLIN EPIDEMIOL, V56, P148, DOI 10.1016/S0895-4356(02)00580-2; Guthrie B, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6341; Hogerzeil HV, 2013, LANCET, V381, P680, DOI 10.1016/S0140-6736(12)62128-X; Hosseinpoor AR, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-474; Howitt P, 2012, LANCET, V380, P507, DOI 10.1016/S0140-6736(12)61127-1; Hwang W, 2001, HEALTH AFFAIR, V20, P267, DOI 10.1377/hlthaff.20.6.267; Iezzoni LI, 2010, HEALTH SERV RES, V45, P1523, DOI 10.1111/j.1475-6773.2010.01145.x; Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4; Kowal P, AGEING AND ADULT HEA; Kowal P, 2012, INT J EPIDEMIOL, V41, P1639, DOI 10.1093/ije/dys210; Lagomarsino G, 2012, LANCET, V380, P933, DOI 10.1016/S0140-6736(12)61147-7; Lee JT, 2012, LANCET, V380, P1643, DOI 10.1016/S0140-6736(12)61941-2; Lehnert T, 2011, MED CARE RES REV, V68, P387, DOI 10.1177/1077558711399580; Li Y, 2012, B WORLD HEALTH ORGAN, V90, P664, DOI 10.2471/BLT.12.102178; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Maimaris W, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001490; Marengoni A, 2008, AM J PUBLIC HEALTH, V98, P1198, DOI 10.2105/AJPH.2007.121137; Knaul FM, 2012, LANCET, V380, P1259, DOI 10.1016/S0140-6736(12)61068-X; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Moreno-Serra R, 2012, LANCET, V380, P917, DOI 10.1016/S0140-6736(12)61039-3; Moreno-Serra R, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001087; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Niens LM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000333; Paez KA, 2009, HEALTH AFFAIR, V28, P15, DOI 10.1377/hlthaff.28.1.15; Payne RA, 2013, CAN MED ASSOC J, V185, pE221, DOI 10.1503/cmaj.121349; Raina P, 2002, HEALTH SERV RES, V37, P751, DOI 10.1111/1475-6773.00047; Reddy KS, 2011, LANCET, V377, P760, DOI 10.1016/S0140-6736(10)61960-5; Roland M, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2510; Sachs JD, 2012, LANCET, V380, P944, DOI 10.1016/S0140-6736(12)61149-0; Salive ME, 2013, EPIDEMIOL REV, V35, P75, DOI 10.1093/epirev/mxs009; Tinetti ME, 2004, NEW ENGL J MED, V351, P2870, DOI 10.1056/NEJMsb042458; Trivedi AN, 2010, NEW ENGL J MED, V362, P320, DOI 10.1056/NEJMsa0904533; Vellakkal S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068219; Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3; Ward BW, 2010, PREV CHRONIC DIS, V10, pE65, DOI DOI 10.5888/PCD10.120203; Wolff JL, 2002, ARCH INTERN MED, V162, P2269, DOI 10.1001/archinte.162.20.2269; World Health Organization, WHO GLOBAL STATUS RE; Xu K, 2003, LANCET, V362, P111, DOI 10.1016/S0140-6736(03)13861-5; Yip W, 2009, SOC SCI MED, V68, P201, DOI 10.1016/j.socscimed.2008.09.066; Yip WCM, 2012, LANCET, V379, P833, DOI 10.1016/S0140-6736(11)61880-1	63	117	119	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0127199	10.1371/journal.pone.0127199	http://dx.doi.org/10.1371/journal.pone.0127199			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1EJ	26154083	Green Published, gold			2022-12-26	WOS:000358159700003
J	Miao, CL; Bao, MH; Xing, AJ; Chen, SH; Wu, YT; Cai, J; Chen, YR; Yang, XC				Miao, Congliang; Bao, Minghui; Xing, Aijun; Chen, Shuohua; Wu, Yuntao; Cai, Jun; Chen, Youren; Yang, Xinchun			Cardiovascular Health Score and the Risk of Cardiovascular Diseases	PLOS ONE			English	Article							NUTRITION EXAMINATION SURVEYS; C-REACTIVE PROTEIN; NATIONAL-HEALTH; HEART-RATE; URIC-ACID; PREVALENCE; EVENTS; STROKE; ADULTS; DEATH	In 2010 the American Heart Association proposed a definition of ideal health behaviors and health factors to measure cardiovascular health, from which Huffman et al. created the Cardiovascular Health Score (CVH score) to estimate these metrics on an individual level. We performed a prospective cohort study among employees of the Kailuan Group Corporation, who underwent a physical examination in 2006-2007 to investigate the relationship between the CVH score and the risk of cardiovascular disease (CVD). A total of 91,598 individuals free of stroke and myocardial infarction at baseline were included in the final analysis. We calculated baseline CVH score for each metric (poor=0, intermediate=1, ideal=2 points; range=0-14 points for all seven metrics) and categorized them into three groups: inadequate (0-4 points), average (5-9 points), and optimum (10-14 points). Incidence of total number of CVD events, myocardial infarction, and stroke was analyzed among these three groups and each incremental point on the CVH score. During an average 6.81 years of follow-up, there were 3276 CVD events, 2579 strokes and 747 myocardial infarction occurred. After adjusting for several confounding factors, each better health category of the CVH score was associated with reduced odds of 47% for all CVD events, and each point higher on the CVH score was associated with reduced odds of 18%. Similar trends were detected in the risks for myocardial infarction and stroke. A higher CVH score is therefore a protective factor for CVD, myocardial infarction, and stroke.	[Miao, Congliang; Chen, Youren] Shantou Univ, Coll Med, Affiliated Hosp 2, Dept Cardiol, Shantou, Guangdong, Peoples R China; [Bao, Minghui; Cai, Jun; Yang, Xinchun] Capital Med Univ, Chaoyang Hosp, Dept Cardiol, Beijing, Peoples R China; [Xing, Aijun; Chen, Shuohua; Wu, Yuntao] Hebei United Univ, Kailuan Hosp, Dept Cardiol, Tangshan, Peoples R China	Shantou University; Capital Medical University; North China University of Science & Technology	Chen, YR (corresponding author), Shantou Univ, Coll Med, Affiliated Hosp 2, Dept Cardiol, Shantou, Guangdong, Peoples R China.	13902779840@139.com; bmh891219@sina.com			National Natural Science Foundation of China [81270346]; Projects of Science and Technology Plans of Guangdong Province [2009B030801310]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Projects of Science and Technology Plans of Guangdong Province	This work is supported by grants from the National Natural Science Foundation of China (No. 81270346; URLs: (http://www.nsfc.gov.cn/); YX received the funding), and the Projects of Science and Technology Plans of Guangdong Province (No. 2009B030801310; URLs: (http://pro.gdstc.gov.cn/egrantweb/); CY received the funding). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1989, Stroke, V20, P1407; Bambs C, 2011, CIRCULATION, V123, P850, DOI 10.1161/CIRCULATIONAHA.110.980151; Chien KL, 2005, ATHEROSCLEROSIS, V183, P147, DOI 10.1016/j.atherosclerosis.2005.01.018; Cook NR, 2006, ANN INTERN MED, V145, P21, DOI 10.7326/0003-4819-145-1-200607040-00128; Culleton BF, 1999, ANN INTERN MED, V131, P7, DOI 10.7326/0003-4819-131-1-199907060-00003; Dong CH, 2012, CIRCULATION, V125, P2975, DOI 10.1161/CIRCULATIONAHA.111.081083; Du SF, 2014, AM J CLIN NUTR, V99, P334, DOI 10.3945/ajcn.113.059121; Fang J, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.005371; Feig DI, 2008, NEW ENGL J MED, V359, P1811, DOI 10.1056/NEJMra0800885; Folsom AR, 2011, J AM COLL CARDIOL, V57, P1690, DOI 10.1016/j.jacc.2010.11.041; Ford ES, 2012, CIRCULATION, V125, P987, DOI 10.1161/CIRCULATIONAHA.111.049122; Heidenreich PA, 2011, CIRCULATION, V123, P933, DOI 10.1161/CIR.0b013e31820a55f5; Huffman MD, 2012, CIRCULATION, V125, P2595, DOI 10.1161/CIRCULATIONAHA.111.070722; Inoue T, 2012, CLIN EXP NEPHROL, V16, P938, DOI 10.1007/s10157-012-0641-3; Jacqueline I, 2013, J AM HEART ASSOC, V2, DOI [10.1161/JAHA.113.000058, DOI 10.1161/JAHA.113.000058]; Kochanek K, 2011, NATL VITAL STAT REP, V59, P1; Kulshreshtha A, 2013, STROKE, V44, P1909, DOI 10.1161/STROKEAHA.111.000352; Lloyd-Jones DM, 2010, CIRCULATION, V121, P586, DOI 10.1161/CIRCULATIONAHA.109.192703; Mao QX, 2010, INT J EPIDEMIOL, V39, P1638, DOI 10.1093/ije/dyq119; Saito M, 2003, ATHEROSCLEROSIS, V167, P73, DOI 10.1016/S0021-9150(02)00380-5; Shay CM, 2012, CIRCULATION, V125, P45, DOI 10.1161/CIRCULATIONAHA.111.035733; Wu HY, 2013, INT J CARDIOL, V168, P760, DOI 10.1016/j.ijcard.2012.09.235; Wu SL, 2012, CIRC-CARDIOVASC QUAL, V5, P487, DOI 10.1161/CIRCOUTCOMES.111.963694; Wu SL, 2012, INT J CARDIOL, V157, P75, DOI 10.1016/j.ijcard.2010.12.019; Xanthakis V, 2014, CIRCULATION, V130, P1676, DOI 10.1161/CIRCULATIONAHA.114.009273; Zhang Q, 2013, STROKE, V44, P2451, DOI 10.1161/STROKEAHA.113.678839	26	33	36	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0131537	10.1371/journal.pone.0131537	http://dx.doi.org/10.1371/journal.pone.0131537			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154254	gold, Green Published, Green Submitted			2022-12-26	WOS:000358159700071
J	Zengin, E; Bickel, C; Schnabel, RB; Zeller, T; Lackner, KJ; Rupprecht, HJ; Blankenberg, S; Westermann, D				Zengin, Elvin; Bickel, Christoph; Schnabel, Renate B.; Zeller, Tanja; Lackner, Karl-J.; Rupprecht, Hans-J.; Blankenberg, Stefan; Westermann, Dirk		Christoph Sinning AtheroGene-Study	Risk Factors of Coronary Artery Disease in Secondary Prevention-Results from the AtheroGene-Study	PLOS ONE			English	Article							C-REACTIVE PROTEIN; BLOOD-PRESSURE; CARDIOVASCULAR-DISEASE; HEART-DISEASE; MULTIFACTORIAL INTERVENTION; MYOCARDIAL-INFARCTION; LOWER TARGETS; MORTALITY; EVENTS; PREDICTION	Background Risk factors are important in cardiovascular (CV) medicine for risk stratification of patients. We aimed to compare the traditional risk factors to clinical variables for the prediction of secondary cardiovascular events. Methods and Results For this study, 3229 patients with known coronary artery disease (CAD) were included. We calculated whether the traditional risk factors, diabetes mellitus, increased LDL/HDL ratio, arterial hypertension and smoking alone and in combination with the clinical variables, ejection fraction, creatinine clearance, multi-vessel disease and CRP concentration predict the outcome cardiovascular death or non-fatal myocardial infarction (N = 432) during the mean follow-up time of 4.2 +/- 2.0 years. In this cohort diabetes mellitus was the risk factor with the strongest influence regarding occurrence of secondary events (hazard ratio; HR: 1.70, confidence interval; CI 95%: 1.36-2.11; P<0.0001), followed by LDL/HDL ratio and smoking. However, risk stratification is further improved by using additional clinical variables like ejection fraction (HR:3.30 CI 95%: 2.51-4.33; P>0.0001) or calculated creatinine clearence (Cockroft-Gault formula) (HR:2.26 CI 95%: 1.78-2.89; P<0.0001). Further ameliorating risk stratification from the clinical variables were CRP and multi-vessel disease. The most precise risk prediction was achieved when all clinical variables were added to the CV risk factors. Conclusion Diabetes mellitus has the strongest influence to predict secondary cardiovascular events in patients with known CAD. Risk stratification can further be improved by adding CV risk factors and clinical variables together. Control of risk factors is of paramount importance in patients with known CAD, while clinical variables can further enhance prediction of events.	[Zengin, Elvin; Schnabel, Renate B.; Zeller, Tanja; Blankenberg, Stefan; Westermann, Dirk; Christoph Sinning AtheroGene-Study] Univ Heart Ctr Hamburg, Dept Gen & Intervent Cardiol, Hamburg, Germany; [Bickel, Christoph] Fed Armed Forces Cent Hosp Koblenz, Dept Med, Koblenz, Germany; [Lackner, Karl-J.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Clin Chem & Lab Med, D-55122 Mainz, Germany; [Rupprecht, Hans-J.] GPR Klinikum Ruesselsheim, Dept Med 2, Russelsheim, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Johannes Gutenberg University of Mainz	Bickel, C (corresponding author), Fed Armed Forces Cent Hosp Koblenz, Dept Med, Koblenz, Germany.	cbickel@t-online.de	Westermann, Dirk/D-1344-2011; Schnabel, Renate B/ABE-6668-2021	Schnabel, Renate B/0000-0001-7170-9509; Westermann, Dirk/0000-0002-7542-1956; Zeller, Tanja/0000-0003-3379-2641	"Stiftung Rheinland-Pfalz fur Innovation," Ministry of Science and Education, Mainz [AZ 15202-386261/545]; MAIFOR grant of the Johannes Gutenberg-University Mainz, Germany; Fondation de France [2002004994]; French Ministry of Research [ACIIMPBIO 032619]; Institut National de la Sante et de la Recherche Medicale (Programme National de Recherches sur les Maladies Cardiovasculaires) [A04052DS]	"Stiftung Rheinland-Pfalz fur Innovation," Ministry of Science and Education, Mainz; MAIFOR grant of the Johannes Gutenberg-University Mainz, Germany; Fondation de France(Fondation de France); French Ministry of Research(Ministry of Research, FranceEuropean Commission); Institut National de la Sante et de la Recherche Medicale (Programme National de Recherches sur les Maladies Cardiovasculaires)	The AtheroGene study is supported by a grant of the "Stiftung Rheinland-Pfalz fur Innovation," Ministry of Science and Education (AZ 15202-386261/545), Mainz, by the MAIFOR grant 2001 of the Johannes Gutenberg-University Mainz, Germany, and by grants from the Fondation de France (no. 2002004994), the French Ministry of Research (ACIIMPBIO 032619) and the Institut National de la Sante et de la Recherche Medicale (Programme National de Recherches sur les Maladies Cardiovasculaires A04052DS).	Bangalore S, 2011, CIRCULATION, V123, P2799, DOI 10.1161/CIRCULATIONAHA.110.016337; Bhatt DL, 2006, JAMA-J AM MED ASSOC, V295, P180, DOI 10.1001/jama.295.2.180; Blankenberg S, 2006, CIRCULATION, V114, P201, DOI 10.1161/CIRCULATIONAHA.105.590927; Bowker TJ, 1996, HEART, V75, P334, DOI 10.1136/hrt.75.4.334; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Coresh J, 2006, CURR OPIN NEPHROL HY, V15, P276, DOI 10.1097/01.mnh.0000222695.84464.61; Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; Fried LP, 1998, JAMA-J AM MED ASSOC, V279, P585, DOI 10.1001/jama.279.8.585; Gaede P, 2003, NEW ENGL J MED, V348, P383, DOI 10.1056/NEJMoa021778; Gaede P, 2008, NEW ENGL J MED, V358, P580, DOI 10.1056/NEJMoa0706245; Germano G, 2012, EUR HEART J, V33, P137; Giannuzzi P, 2008, ARCH INTERN MED, V168, P2194, DOI 10.1001/archinte.168.20.2194; Greenland P, 2003, JAMA-J AM MED ASSOC, V290, P891, DOI 10.1001/jama.290.7.891; Howard BV, 2008, JAMA-J AM MED ASSOC, V299, P1678, DOI 10.1001/jama.299.14.1678; Kaplan RC, 2002, J CLIN EPIDEMIOL, V55, P654, DOI 10.1016/S0895-4356(02)00405-5; Keller T, 2009, EUR HEART J, V30, P314, DOI 10.1093/eurheartj/ehn598; Kotseva K, 2001, EUR HEART J, V22, P554, DOI 10.1053/euhj.2001.2610; Kotseva K, 2016, EUR J PREV CARDIOL, V23, P636, DOI 10.1177/2047487315569401; Kotseva K, 2009, EUR J CARDIOV PREV R, V16, P121, DOI 10.1097/HJR.0b013e3283294b1d; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; Leander K, 2007, EUR J CARDIOV PREV R, V14, P532, DOI 10.1097/HJR.0b013e328012e3cc; Liu Jing, 2009, Zhonghua Yi Xue Za Zhi, V89, P1676; Mehta RH, 2008, EUR HEART J, V29, P3052, DOI 10.1093/eurheartj/ehn478; Mielniczuk LM, 2008, AM HEART J, V155, P725, DOI 10.1016/j.ahj.2007.11.031; Miura K, 2001, ARCH INTERN MED, V161, P1501, DOI 10.1001/archinte.161.12.1501; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Preis SR, 2009, CIRCULATION, V120, P212, DOI 10.1161/CIRCULATIONAHA.108.846519; Prugger C, 2008, EUR J EPIDEMIOL, V23, P731, DOI 10.1007/s10654-008-9291-x; Rosvall M, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-189; Russell M, 2006, AM HEART J, V152, P867, DOI 10.1016/j.ahj.2006.05.021; Sabatine MS, 2007, CIRCULATION, V115, P1528, DOI 10.1161/CIRCULATIONAHA.106.649939; Sinning C, 2013, CLIN RES CARDIOL, V102, P495, DOI 10.1007/s00392-013-0555-4; The sixth report of the Joint National Committee, 1997, ARCH INTERN MED, V157, P2413, DOI DOI 10.1001/ARCHINTE.1997.00440420033005; Turnbull F, 2003, LANCET, V362, P1527; Volzke H, 2007, INT J CARDIOL, V116, P46, DOI 10.1016/j.ijcard.2006.02.008; Wood D, 1997, EUR HEART J, V18, P1569; Wood D, 2001, ATHEROSCLEROSIS SUPP, V2, P3, DOI 10.1016/S1567-5688(00)00003-9; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	42	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0131434	10.1371/journal.pone.0131434	http://dx.doi.org/10.1371/journal.pone.0131434			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154343	gold, Green Published, Green Submitted			2022-12-26	WOS:000358159700062
J	Barragan, S; Rueda, C; Fernandez, MA; Peddada, SD				Barragan, Sandra; Rueda, Cristina; Fernandez, Miguel A.; Peddada, Shyamal D.			Determination of Temporal Order among the Components of an Oscillatory System	PLOS ONE			English	Article							CYCLE-REGULATED GENES; CELL-CYCLE; CIRCADIAN CLOCK; FISSION YEAST; EXPRESSION; IDENTIFICATION; PREDICTION; NETWORK; FAMILY; BRAIN	Oscillatory systems in biology are tightly regulated process where the individual components (e.g. genes) express in an orderly manner by virtue of their functions. The temporal order among the components of an oscillatory system may potentially be disrupted for various reasons (e.g. environmental factors). As a result some components of the system may go out of order or even cease to participate in the oscillatory process. In this article, we develop a novel framework to evaluate whether the temporal order is unchanged in different populations (or experimental conditions). We also develop methodology to estimate the order among the components with a suitable notion of "confidence." Using publicly available data on S. pombe, S. cerevisiae and Homo sapiens we discover that the temporal order among the genes cdc18; mik1; hhf1; hta2; fkh2 and klp5 is evolutionarily conserved from yeast to humans.	[Barragan, Sandra; Rueda, Cristina; Fernandez, Miguel A.] Univ Valladolid, Dept Estadist & Invest Operat, Valladolid, Spain; [Peddada, Shyamal D.] NIEHS, Biostat Branch, NIH, Res Triangle Pk, NC 27709 USA	Universidad de Valladolid; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Peddada, SD (corresponding author), NIEHS, Biostat Branch, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.	peddada@niehs.nih.gov	Fernández, Miguel/I-2874-2015	Fernández, Miguel/0000-0002-1272-8950; Peddada, Shyamal/0000-0002-5014-6513; Rueda Sabater, Cristina/0000-0001-9179-3154	Spanish Ministerio de Ciencia e Innovacion [MTM2012-37129]; Junta de Castilla y Leon, Consejeria de Educacion; European Social Fund within the Programa Operativo Castilla y Leon; Intramural Research Program of the National Institute of Environmental Health Sciences [Z01 ES101744-04]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES101744, Z01ES101744] Funding Source: NIH RePORTER	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Junta de Castilla y Leon, Consejeria de Educacion(Junta de Castilla y Leon); European Social Fund within the Programa Operativo Castilla y Leon; Intramural Research Program of the National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The research of SB, MAF and CR was funded by the Spanish Ministerio de Ciencia e Innovacion grant (MTM2012-37129). SB was also funded by the Junta de Castilla y Leon, Consejeria de Educacion and the European Social Fund within the Programa Operativo Castilla y Leon 2007-2013. The research of SDP was supported by the Intramural Research Program of the National Institute of Environmental Health Sciences (Z01 ES101744-04).	Aravind L, 2000, P NATL ACAD SCI USA, V97, P11319, DOI 10.1073/pnas.200346997; Baayen C, 2012, J MOTOR BEHAV, V44, P351, DOI 10.1080/00222895.2012.709549; Bahler J, 2005, ANNU REV GENET, V39, P69, DOI 10.1146/annurev.genet.39.110304.095808; BARTHOLDI J, 1989, SOC CHOICE WELFARE, V6, P157, DOI 10.1007/BF00303169; Borda JC, 1781, MEMORIE ELECTIONS SC; Bushel PR, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-93; Caretta-Cartozo C, 2007, PLOS COMPUT BIOL, V3, P968, DOI 10.1371/journal.pcbi.0030103; Cermakian N, 2011, J BIOL RHYTHM, V26, P160, DOI 10.1177/0748730410395732; CHARTRAND G, 1993, J GRAPH THEOR, V17, P509, DOI 10.1002/jgt.3190170408; Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; Chu LH, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-56; Condorcet J.-A.-N.d.C, 1785, ESSAI APPL ANAL PROB; de Lichtenberg U, 2005, YEAST, V22, P1191, DOI 10.1002/yea.1302; de Lichtenberg U, 2005, BIOINFORMATICS, V21, P1164, DOI 10.1093/bioinformatics/bti093; DIACONIS P, 1977, J ROY STAT SOC B MET, V39, P262, DOI 10.1111/j.2517-6161.1977.tb01624.x; Dwork C., 2001, P 10 INT C WORLD WID, P613, DOI DOI 10.1145/371920.372165; Fernandez MA, 2012, NUCLEIC ACIDS RES, V40, P2823, DOI 10.1093/nar/gkr1077; Fisher NI, 1995, STAT ANAL CIRCULAR D; Forsburg SL, 1999, TRENDS GENET, V15, P340, DOI 10.1016/S0168-9525(99)01798-9; Forsburg Susan L, 2005, Gravit Space Biol Bull, V18, P3; Gauthier NP, 2008, NUCLEIC ACIDS RES, V36, pD854, DOI 10.1093/nar/gkm729; Grosheva I, 2001, J CELL SCI, V114, P695; Hahsler M, 2011, TRAVELING SALESPERSO; Hastings MH, 2003, NAT REV NEUROSCI, V4, P649, DOI 10.1038/nrn1177; Hughes ME, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000442; Jensen LJ, 2006, NATURE, V443, P594, DOI 10.1038/nature05186; Karp RM, 1972, COMPLEXITY COMPUTER; Kondratova AA, 2012, NAT REV NEUROSCI, V13, P325, DOI 10.1038/nrn3208; Lawler EL, 1985, TRAVELING SALEMAN PR; Lehmann R, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-133; Liu DL, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-87; Liu DL, 2004, P NATL ACAD SCI USA, V101, P7240, DOI 10.1073/pnas.0402285101; Mardia KV, 2000, DIRECTIONAL STAT; McDowall MD, 2009, NUCLEIC ACIDS RES, V37, pD651, DOI 10.1093/nar/gkn870; Moller-Levet CS, 2013, P NATL ACAD SCI USA, V110, pE1132, DOI 10.1073/pnas.1217154110; Oliva A, 2005, PLOS BIOL, V3, P1239, DOI 10.1371/journal.pbio.0030225; Papadimitriou C.H., 1998, COMBINATORIAL OPTIMI, VUnabridged edition; Peng X, 2005, MOL BIOL CELL, V16, P1026, DOI 10.1091/mbc.E04-04-0299; Pihur V, 2007, BIOINFORMATICS, V23, P1607, DOI 10.1093/bioinformatics/btm158; Pramila T, 2006, GENE DEV, V20, P2266, DOI 10.1101/gad.1450606; Reinelt G., 1994, TRAVELING SALESMAN C; Roux AE, 2010, J GERONTOL A-BIOL, V65, P1, DOI 10.1093/gerona/glp152; Rueda C, 2009, J AM STAT ASSOC, V104, P338, DOI 10.1198/jasa.2009.0120; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Rustici G, 2004, NAT GENET, V36, P809, DOI 10.1038/ng1377; SARDET C, 1995, P NATL ACAD SCI USA, V92, P2403, DOI 10.1073/pnas.92.6.2403; Schalekamp F., 2009, P 11 WORKSH ALG ENG, P38, DOI DOI 10.1137/1.9781611972894.4; Scott MS, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-239; Slavov N, 2012, MOL BIOL CELL, V23, P1986, DOI 10.1091/mbc.E11-11-0961; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Stokes M., 2007, EVOLUTIONARY PSYCHOL, V5, P453; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Xiao EN, 1998, J CLIN ENDOCR METAB, V83, P2454, DOI 10.1210/jc.83.7.2454	54	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2015	10	7							e0124842	10.1371/journal.pone.0124842	http://dx.doi.org/10.1371/journal.pone.0124842			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EC	26151635	Green Published, Green Submitted, gold			2022-12-26	WOS:000358158900002
J	Fu, JJ; Chu, XT; Sun, YF; Miao, YJ; Xu, YF; Hu, TM				Fu, Juanjuan; Chu, Xitong; Sun, Yongfang; Miao, Yanjun; Xu, Yuefei; Hu, Tianming			Nitric Oxide Mediates 5-Aminolevulinic Acid-Induced Antioxidant Defense in Leaves of Elymus nutans Griseb. Exposed to Chilling Stress	PLOS ONE			English	Article							SPINACH SPINACIA-OLERACEA; INDUCED OXIDATIVE DAMAGE; MEMBRANE H+-ATPASE; HEAT-STRESS; HYDROGEN-PEROXIDE; ABSCISIC-ACID; SUPEROXIDE-DISMUTASE; LIPID-PEROXIDATION; ENZYME-ACTIVITY; SALICYLIC-ACID	Nitric oxide (NO) and 5-aminolevulinic acid (ALA) are both extremely important signalling molecules employed by plants to control many aspects of physiology. In the present study, the role of NO in ALA-induced antioxidant defense in leaves of two sources of Elymus nutans Griseb. (Damxung, DX and Zhengdao, ZD) was investigated. Chilling stress enhanced electrolyte leakage, accumulation of malondialdehyde (MDA), hydrogen peroxide (H2O2) and superoxide radical in two E. nutans, which were substantially alleviated by exogenous ALA and NO application. Pretreatment with NO scavenger PTIO or NOS inhibitor L-NNA alone and in combination with ALA induced enhancements in electrolyte leakage and the accumulation of MDA, H2O2 and superoxide radical in leaves of DX and ZD exposed to chilling stress, indicating that the inhibition of NO biosynthesis reduced the chilling resistance of E. nutans and the ALA-enhanced chilling resistance. Further analyses showed that ALA and NO enhanced antioxidant defense and activated plasma membrane (PM) H+-ATPase and decreased the accumulation of ROS induced by chilling stress. A pronounced increase in nitric oxide synthase (NOS) activity and NO release by exogenous ALA treatment was found in chilling-resistant DX plants exposed to chilling stress, while only a little increase was observed in chilling-sensitive ZD. Furthermore, inhibition of NO accumulation by PTIO or L-NNA blocked the protective effect of exogenous ALA, while both exogenous NO treatment and inhibition of endogenous NO accumulation did not induce ALA production. These results suggested that NO might be a downstream signal mediating ALA-induced chilling resistance in E. nutans.	[Fu, Juanjuan; Chu, Xitong; Sun, Yongfang; Xu, Yuefei; Hu, Tianming] Northwest A&F Univ, Coll Anim Sci & Technol, Dept Grassland Sci, Yangling, Shaanxi, Peoples R China; [Miao, Yanjun] Tibet Agr & Anim Husb Coll, Coll Plant Sci, Linzhi 860000, Tibet, Peoples R China	Northwest A&F University - China; Tibet Agriculture & Animal Husbandry University	Xu, YF (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Dept Grassland Sci, Yangling, Shaanxi, Peoples R China.	xuyuefei1980@163.com; hutianming@126.com		Fu, Juanjuan/0000-0001-8178-6698	National Natural Science Foundation of China [31402129]; Northwest A&F University Fundamental Research Special Fund [QN2011100]; Key Projects in the National Science & Technology Pillar Program in the Twelfth Five-year Plan Period [2011BAD17B05]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Northwest A&F University Fundamental Research Special Fund; Key Projects in the National Science & Technology Pillar Program in the Twelfth Five-year Plan Period	This work was supported by the National Natural Science Foundation of China (No. 31402129), Northwest A&F University Fundamental Research Special Fund (No. QN2011100), and Key Projects in the National Science & Technology Pillar Program in the Twelfth Five-year Plan Period (No. 2011BAD17B05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SJ, 1999, PHYSIOL PLANTARUM, V106, P35, DOI 10.1034/j.1399-3054.1999.106105.x; Akram NA, 2013, J PLANT GROWTH REGUL, V32, P663, DOI 10.1007/s00344-013-9325-9; Ali B, 2013, ECOTOX ENVIRON SAFE, V92, P271, DOI 10.1016/j.ecoenv.2013.02.006; Arasimowicz-Jelonek M, 2009, PLANT SCI, V177, P682, DOI 10.1016/j.plantsci.2009.09.007; Aroca R, 2001, PLANT SCI, V161, P719, DOI 10.1016/S0168-9452(01)00460-5; Bai XG, 2012, FREE RADICAL BIO MED, V53, P710, DOI 10.1016/j.freeradbiomed.2012.05.042; Balestrasse KB, 2010, PHYTOCHEMISTRY, V71, P2038, DOI 10.1016/j.phytochem.2010.07.012; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; Bhyan SB, 2012, J PLANT PHYSIOL, V169, P137, DOI 10.1016/j.jplph.2011.08.004; Bindu RC, 1998, PLANT GROWTH REGUL, V26, P15, DOI 10.1023/A:1006098005335; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CAKMAK I, 1992, PLANT PHYSIOL, V98, P1222, DOI 10.1104/pp.98.4.1222; Corpas FJ, 2009, NEW PHYTOL, V184, P9, DOI 10.1111/j.1469-8137.2009.02989.x; DHINDSA RS, 1981, J EXP BOT, V32, P93, DOI 10.1093/jxb/32.1.93; Erdal S, 2011, BIOL TRACE ELEM RES, V143, P500, DOI 10.1007/s12011-010-8857-0; Fadzillah NM, 1996, PLANTA, V199, P552, DOI 10.1007/BF00195186; Farooq M, 2008, J AGRON CROP SCI, V194, P350, DOI 10.1111/j.1439-037X.2008.00322.x; Fu JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107152; HAMPP R, 1975, PHYSIOL PLANTARUM, V33, P53, DOI 10.1111/j.1399-3054.1975.tb03764.x; HAREL E, 1972, BIOCHEM BIOPH RES CO, V49, P364, DOI 10.1016/0006-291X(72)90419-6; HAYAT S, 2007, ROLE SALICYLIC ACID, P91; Janda T, 1999, PLANTA, V208, P175, DOI 10.1007/s004250050547; Janicka-Russak M, 2012, J PLANT RES, V125, P291, DOI 10.1007/s10265-011-0438-6; KAMPFENKEL K, 1995, ANAL BIOCHEM, V225, P165, DOI 10.1006/abio.1995.1127; Kang HM, 2002, PHYSIOL PLANTARUM, V115, P571, DOI 10.1034/j.1399-3054.2002.1150411.x; Khan MN, 2012, NITRIC OXIDE-BIOL CH, V27, P210, DOI 10.1016/j.niox.2012.07.005; Kim HS, 2013, J PLANT PHYSIOL, V170, P828, DOI 10.1016/j.jplph.2013.01.007; Kong WW, 2012, FUNGAL GENET BIOL, V49, P15, DOI 10.1016/j.fgb.2011.12.003; Korkmaz A, 2010, ENVIRON EXP BOT, V67, P495, DOI 10.1016/j.envexpbot.2009.07.009; Lamotte O, 2005, PLANTA, V221, P1, DOI 10.1007/s00425-005-1494-8; LAW MY, 1983, BIOCHEM J, V210, P899, DOI 10.1042/bj2100899; Liu D, 2011, J AGRON CROP SCI, V197, P284, DOI 10.1111/j.1439-037X.2011.00465.x; Liu YJ, 2011, J PLANT PHYSIOL, V168, P853, DOI 10.1016/j.jplph.2010.09.020; Liu ZJ, 2010, J PLANT GROWTH REGUL, V29, P171, DOI 10.1007/s00344-009-9121-8; Ma FF, 2012, J EXP BOT, V63, P4835, DOI 10.1093/jxb/ers161; Memon SA, 2009, ACTA PHYSIOL PLANT, V31, P51, DOI 10.1007/s11738-008-0198-7; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; MURPHY ME, 1994, METHOD ENZYMOL, V233, P240; Naeem MS, 2011, ACTA PHYSIOL PLANT, V33, P517, DOI 10.1007/s11738-010-0575-x; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Nishihara E, 2003, J PLANT PHYSIOL, V160, P1085, DOI 10.1078/0176-1617-00991; Nunez M, 2003, BIOL PLANTARUM, V47, P67, DOI 10.1023/A:1027380831429; PALMGREN MG, 1990, PLANT PHYSIOL, V92, P871, DOI 10.1104/pp.92.4.871; REBEIZ CA, 1984, ENZYME MICROB TECH, V6, P390, DOI 10.1016/0141-0229(84)90012-7; Santa-Cruz DM, 2010, PHYTOCHEMISTRY, V71, P1700, DOI 10.1016/j.phytochem.2010.07.009; Schaedle M, 1997, PLANT PHYSIOL, V59, P1011, DOI DOI 10.1104/PP.59.5.1011; Song LL, 2006, PLANT SCI, V171, P449, DOI 10.1016/j.plantsci.2006.05.002; Sun YP, 2009, PHOTOSYNTHETICA, V47, P347, DOI 10.1007/s11099-009-0055-y; Tartoura KAH, 2011, SCI HORTIC-AMSTERDAM, V130, P862, DOI 10.1016/j.scienta.2011.08.015; Vital SA, 2008, ENVIRON EXP BOT, V62, P60, DOI 10.1016/j.envexpbot.2007.07.006; Wendehenne D, 2001, TRENDS PLANT SCI, V6, P177, DOI 10.1016/S1360-1385(01)01893-3; Xu MJ, 2012, POSTHARVEST BIOL TEC, V65, P5, DOI 10.1016/j.postharvbio.2011.10.008; Xu S, 2006, ENVIRON EXP BOT, V56, P274, DOI 10.1016/j.envexpbot.2005.03.002; Xu YF, 2010, J PLANT PHYSIOL, V167, P512, DOI 10.1016/j.jplph.2009.10.010; Yu CW, 2003, FUNCT PLANT BIOL, V30, P955, DOI 10.1071/FP03091; Zhang AY, 2007, NEW PHYTOL, V175, P36, DOI 10.1111/j.1469-8137.2007.02071.x; Zhang AY, 2011, PLANT CELL PHYSIOL, V52, P181, DOI 10.1093/pcp/pcq187; Zhang J, 2012, BIOL PLANTARUM, V56, P780, DOI 10.1007/s10535-012-0136-9; Zhang LG, 2009, J PLANT BIOL, V52, P135, DOI 10.1007/s12374-009-9013-2; Zhang WF, 2008, J PLANT GROWTH REGUL, V27, P159, DOI 10.1007/s00344-008-9042-y; Zhang YK, 2009, SCI HORTIC-AMSTERDAM, V123, P217, DOI 10.1016/j.scienta.2009.08.015; Zhao L, 2008, J PLANT PHYSIOL, V165, P182, DOI 10.1016/j.jplph.2007.03.002; Zhou WJ, 1999, PLANT GROWTH REGUL, V27, P99, DOI 10.1023/A:1006165603300	63	12	15	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2015	10	7							e0130367	10.1371/journal.pone.0130367	http://dx.doi.org/10.1371/journal.pone.0130367			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EC	26151364	Green Published, Green Submitted, gold			2022-12-26	WOS:000358158900009
J	Xiao, NC; Cai, SS; Moritz, M; Garabed, R; Pomeroy, LW				Xiao, Ningchuan; Cai, Shanshan; Moritz, Mark; Garabed, Rebecca; Pomeroy, Laura W.			Spatial and Temporal Characteristics of Pastoral Mobility in the Far North Region, Cameroon: Data Analysis and Modeling	PLOS ONE			English	Article							MOUTH-DISEASE; SPACE-TIME; TRANSMISSION; MOVEMENTS; ACCESSIBILITY; EPIDEMIOLOGY; TRANSHUMANCE; OUTBREAKS; SPREAD; RISK	Modeling the movements of humans and animals is critical to understanding the transmission of infectious diseases in complex social and ecological systems. In this paper, we focus on the movements of pastoralists in the Far North Region of Cameroon, who follow an annual transhumance by moving between rainy and dry season pastures. Describing, summarizing, and modeling the transhumance movements in the region are important steps for understanding the role these movements may play in the transmission of infectious diseases affecting humans and animals. We collected data on this transhumance system for four years using a combination of surveys and GPS mapping. An analysis on the spatial and temporal characteristics of pastoral mobility suggests four transhumance modes, each with its own properties. Modes M1 and M2 represent the type of transhumance movements where pastoralists settle in a campsite for a relatively long period of time (>= 20 days) and then move around the area without specific directions within a seasonal grazing area. Modes M3 and M4 on the other hand are the situations when pastoralists stay in a campsite for a relatively short period of time (<20 days) when moving between seasonal grazing areas. These four modes are used to develop a spatial-temporal mobility (STM) model that can be used to estimate the probability of a mobile pastoralist residing at a location at any time. We compare the STM model with two reference models and the experiments suggest that the STM model can effectively capture and predict the space-time dynamics of pastoral mobility in our study area.	[Xiao, Ningchuan] Ohio State Univ, Dept Geog, Columbus, OH 43210 USA; [Cai, Shanshan] Nipissing Univ, Dept Geog, North Bay, ON, Canada; [Moritz, Mark] Ohio State Univ, Dept Anthropol, Columbus, OH 43210 USA; [Moritz, Mark] NIAS, Wassenaar, Netherlands; [Garabed, Rebecca; Pomeroy, Laura W.] Ohio State Univ, Dept Vet Prevent Med, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; Nipissing University; University System of Ohio; Ohio State University; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Advanced Study in the Humanities & Social Sciences (NIAS-KNAW); University System of Ohio; Ohio State University	Xiao, NC (corresponding author), Ohio State Univ, Dept Geog, Columbus, OH 43210 USA.	xiao.37@osu.edu	Moritz, Mark/X-4052-2019	Moritz, Mark/0000-0003-0644-0069; Garabed, Rebecca/0000-0002-8964-3576	National Science Foundation [BCS-0748594, DEB-1015908]; National Geographic Society [8306-07]; Ohio State University; Centre d'Appuia la Recherche et au Pastoralisme; Division Of Environmental Biology [1015908] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); National Geographic Society(National Geographic Society); Ohio State University(Ohio State University); Centre d'Appuia la Recherche et au Pastoralisme; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The research presented in this paper has been supported by the National Science Foundation (BCS-0748594, DEB-1015908), the National Geographic Society (8306-07), and the Ohio State University. We would like to thank pastoralists in Cameroon for participating in this study, the Centre d'Appuia la Recherche et au Pastoralisme for research support, and the Ministry of Scientific Research and Innovation, the Garoua Wildlife College, and the Higher Institute of the Sahel at the University of Maroua for granting research permission and research affiliation (2008-2013).	Adriansen HK, 2002, HUM ECOL, V30, P215, DOI 10.1023/A:1015692730088; Aidaros HA, 2002, REV SCI TECH OIE, V21, P451, DOI 10.20506/rst.21.3.1348; Anderson D. M., 2013, POSITIONING, V4, P115, DOI [10.4236/pos.2013.41012, DOI 10.4236/POS.2013.41012]; Aune K, 2012, J WILDLIFE MANAGE, V76, P253, DOI 10.1002/jwmg.274; Barabasi AL, 2005, NATURE, V435, P207, DOI 10.1038/nature03459; Barth F, 1961, NOMADS OF SOUTH PERS; Bassett TJ, 2007, HUM ECOL, V35, P33, DOI 10.1007/s10745-006-9067-4; Behnke RH, 2011, ANIMAL MIGRATION: A SYNTHESIS, P144; Boutrais J, 1996, HAUTES TERRES D ELEV; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; Bronsvoort BMD, 2004, PREV VET MED, V66, P127, DOI 10.1016/j.prevetmed.2004.09.010; Brottem L, 2014, HUM ECOL, V42, P351, DOI 10.1007/s10745-014-9640-1; Brown CT, 2007, HUM ECOL, V35, P129, DOI 10.1007/s10745-006-9083-4; Butt B, 2010, J ARID ENVIRON, V74, P403, DOI 10.1016/j.jaridenv.2009.09.025; Chevalier V, 2004, MED VET ENTOMOL, V18, P247, DOI 10.1111/j.0269-283X.2004.00511.x; Cho Eunjoon, 2011, KDD, P1082, DOI [10.1145/2020408.2020579, DOI 10.1145/2020408.2020579]; Coppolillo PB, 2000, HUM ECOL, V28, P527, DOI 10.1023/A:1026435714109; COUGHENOUR MB, 1985, SCIENCE, V230, P619, DOI 10.1126/science.230.4726.619; Dalziel BD, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0763; DEBOER WF, 1989, HUM ECOL, V17, P445, DOI 10.1007/BF00889500; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Downs JA, 2010, LECT NOTES COMPUT SC, V6292, P16, DOI 10.1007/978-3-642-15300-6_2; ELLIS JE, 1988, J RANGE MANAGE, V41, P450, DOI 10.2307/3899515; Eubank S, 2004, NATURE, V429, P180, DOI 10.1038/nature02541; Fraley C, 2012, MCLUST VERSION 4 FOR; Galaty J.G., 2013, DRYLAND AFRICA PASTO, P473; Giere RN, 2004, PHILOS SCI, V71, P742, DOI 10.1086/425063; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Hagerstrand T., 1970, PAPERS REGIONAL SCI, VXXIV, P6, DOI [DOI 10.1007/BF01936872, 10/bkqqfc]; Horne JS, 2007, ECOLOGY, V88, P2354, DOI 10.1890/06-0957.1; Jiang B, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.021136; Keeling M.J., 2008, MODELING INFECT DIS; Kwan MP, 2014, GEOGR ANAL, V46, P297, DOI 10.1111/gean.12040; Kwan MP, 1998, GEOGR ANAL, V30, P191, DOI 10.1111/j.1538-4632.1998.tb00396.x; LEVINS R, 1966, AM SCI, V54, P421; Macpherson CNL, 1995, PREV VET MED, V25, P213, DOI 10.1016/0167-5877(95)00539-0; Mazeri S, 2013, TROP ANIM HEALTH PRO, V45, P617, DOI 10.1007/s11250-012-0268-0; McCabe JT, 2004, CATTLE BRING US TO O; McLachlan G., 2000, WILEY SER PROB STAT; Merler S, 2010, P ROY SOC B-BIOL SCI, V277, P557, DOI 10.1098/rspb.2009.1605; Miller HJ, 2005, GEOGR ANAL, V37, P17, DOI 10.1111/j.1538-4632.2005.00575.x; MILLER HJ, 1991, INT J GEOGR INF SYST, V5, P287, DOI 10.1080/02693799108927856; Moritz M, 2014, CURR ANTHROPOL, V55, P115, DOI 10.1086/674717; Moritz M, 2013, HUM ECOL, V41, P351, DOI 10.1007/s10745-012-9550-z; Moritz M, 2010, HUM ECOL, V38, P775, DOI 10.1007/s10745-010-9361-z; Msami HM, 2001, TROP ANIM HEALTH PRO, V33, P21, DOI 10.1023/A:1010377325566; Papoulis A., 2002, PROBABILITY RANDOM V; Perry BD, 2007, VET REC, V160, P238, DOI 10.1136/vr.160.7.238; Peters P. E., 2004, Journal of Agrarian Change, V4, P269, DOI 10.1111/j.1471-0366.2004.00080.x; PYKE GH, 1984, ANNU REV ECOL SYST, V15, P523, DOI 10.1146/annurev.es.15.110184.002515; Rebaudet S, 2013, J INFECT DIS, V208, pS46, DOI 10.1093/infdis/jit195; Rivas AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039778; Sawyer H, 2009, ECOL APPL, V19, P2016, DOI 10.1890/08-2034.1; Schareika N, 2003, KNOW TO MOVE MOVE TO; Scholte P, 2006, HUM ECOL, V34, P27, DOI 10.1007/s10745-005-9001-1; Seignobos C, 2000, ATLAS PROVINCE EXTRE; Spergser J, 2013, VET MICROBIOL, V164, P299, DOI 10.1016/j.vetmic.2013.02.007; Stenning Derrick, 1957, J ROYAL ANTHR I GREA, V87, P57, DOI DOI 10.2307/2843971; Stoddard ST, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000481; Tatem AJ, 2006, P NATL ACAD SCI USA, V103, P6242, DOI 10.1073/pnas.0508391103; Tottrup AP, 2012, P ROY SOC B-BIOL SCI, V279, P1008, DOI 10.1098/rspb.2011.1323; Vosloo W, 2002, REV SCI TECH OIE, V21, P437, DOI 10.20506/rst.21.3.1349; Wand MP., 1994, KERNEL SMOOTHING; Wang Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112608; Winter S, 2010, INT J GEOGR INF SCI, V24, P1349, DOI 10.1080/13658811003619150; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; WORTON BJ, 1987, ECOL MODEL, V38, P277, DOI 10.1016/0304-3800(87)90101-3; Zhou HX, 2000, ANN TROP MED PARASIT, V94, P715, DOI 10.1080/00034983.2000.11813595	69	14	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2015	10	7							e0131697	10.1371/journal.pone.0131697	http://dx.doi.org/10.1371/journal.pone.0131697			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EC	26151750	Green Published, Green Submitted, gold			2022-12-26	WOS:000358158900023
J	Nichols, TC; Merricks, EP; Bellinger, DA; Raymer, RA; Yu, J; Lam, D; Koch, GG; Busby, WH; Clemmons, DR				Nichols, Timothy C.; Merricks, Elizabeth P.; Bellinger, Dwight A.; Raymer, Robin A.; Yu, Jing; Lam, Diana; Koch, Gary G.; Busby, Walker H., Jr.; Clemmons, David R.			Oxidized LDL and Fructosamine Associated with Severity of Coronary Artery Atherosclerosis in Insulin Resistant Pigs Fed a High Fat/High NaCl Diet	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; TYPE-2 DIABETES-MELLITUS; IMPAIRED GLUCOSE-TOLERANCE; ADIPOSE-TISSUE CELLULARITY; LOW-GRADE INFLAMMATION; VON-WILLEBRAND-FACTOR; METABOLIC-SYNDROME; OXIDATIVE STRESS; ACCELERATED ATHEROSCLEROSIS; CARDIOVASCULAR-DISEASE	Background Insulin-resistant subjects develop more severe and diffuse coronary artery atherosclerosis than insulin-sensitive controls but the mechanisms that mediate this atherosclerosis phenotype are unknown. Research Objective To determine the metabolic parameters that associate with the severity of coronary atherosclerosis in insulin resistant pigs fed a high fat/high NaCl diet. Key Methods The primary endpoint was severity of coronary atherosclerosis in adult pigs (Sus scrofa, n = 37) fed a high fat diet that also contained high NaCl (56% above recommended levels) for 1 year. Principal Findings Twenty pigs developed severe and diffuse distal coronary artery atherosclerosis (i.e., severe = intimal area as a percent medial area > 200% in at least 2 coronary artery cross sections and diffuse distal = intimal area as a percent medial area >= 150% over 3 sections separated by 2 cm in the distal half of the coronary artery). The other 17 pigs had substantially less coronary artery atherosclerosis. All 37 pigs had blood pressure in a range that would be considered hypertensive in humans and developed elevations in total and LDL and HDL cholesterol, weight gain, increased backfat, and increased insulin resistance (Bergman Si) without overt diabetes. Insulin resistance was not associated with atherosclerosis severity. Five additional pigs fed regular pig chow also developed increased insulin resistance but essentially no change in the other variables and little to no detectible coronary atherosclerosis. Most importantly, the 20 high fat/high NaCl diet -fed pigs with severe and diffuse distal coronary artery atherosclerosis had substantially greater increases (p<0.05) in oxidized LDL (oxLDL) and fructosamine consistent with increased protein glycation. Conclusion In pigs fed a high fat/high NaCl diet, glycated proteins are induced in the absence of overt diabetes and this degree of increase is associated with the development of severe and diffuse distal coronary artery atherosclerosis.	[Nichols, Timothy C.; Merricks, Elizabeth P.; Bellinger, Dwight A.; Raymer, Robin A.] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA; [Nichols, Timothy C.; Busby, Walker H., Jr.; Clemmons, David R.] Univ N Carolina, Dept Med, Chapel Hill, NC USA; [Yu, Jing; Lam, Diana; Koch, Gary G.] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Nichols, TC (corresponding author), Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA.	tnichols@med.unc.edu			National Heart, Lung, and Blood institute of the National Institutes of Health [HL069364]; North Carolina Biotechnology Center (NCBC) [MRG1101]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069364] Funding Source: NIH RePORTER	National Heart, Lung, and Blood institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); North Carolina Biotechnology Center (NCBC); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Heart, Lung, and Blood institute of the National Institutes of Health (HL069364, DRC, TCN) and the North Carolina Biotechnology Center (NCBC MRG1101, TCN and DRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akanji AO, 2002, CLIN CHIM ACTA, V317, P171, DOI 10.1016/S0009-8981(01)00792-6; ARMBRUSTER DA, 1987, CLIN CHEM, V33, P2153; Behme MT, 1996, J NUTR, V126, P1549, DOI 10.1093/jn/126.6.1549; Bellinger DA, 2006, ILAR J, V47, P243, DOI 10.1093/ilar.47.3.243; BERGMAN RN, 1985, ENDOCR REV, V6, P45, DOI 10.1210/edrv-6-1-45; BERGMAN RN, 1987, J CLIN INVEST, V79, P790, DOI 10.1172/JCI112886; Black MH, 2008, DIABETES, V57, P1048, DOI 10.2337/db07-0848; Bonnet F, 2006, J HYPERTENS, V24, P1157, DOI 10.1097/01.hjh.0000226206.03560.ac; Brodala N, 2005, ARTERIOSCLER THROMB, V25, P1456; BUHLINGER CA, 1978, GROWTH, V42, P225; Burke AP, 2004, ARTERIOSCL THROM VAS, V24, P1266, DOI 10.1161/01.ATV.0000131783.74034.97; Carson AP, 2014, DIABETES CARE; Chade AR, 2005, HYPERTENSION, V46, P772, DOI 10.1161/01.HYP.0000184250.37607.da; Chade AR, 2005, J AM SOC NEPHROL, V16, P1005, DOI 10.1681/ASN.2004080674; Christoffersen B, 2009, AM J PHYSIOL-REG I, V297, pR1195, DOI 10.1152/ajpregu.90851.2008; Council NR, 1998, NUTRIENT REQUIREMENT; Daghini E, 2006, AM J PHYSIOL-REG I, V290, pR609, DOI 10.1152/ajpregu.00436.2005; de Castro Simone H, 2005, Rev Diabet Stud, V2, P157; Dixon JL, 1999, ARTERIOSCL THROM VAS, V19, P2981, DOI 10.1161/01.ATV.19.12.2981; Dyson MC, 2006, COMPARATIVE MED, V56, P35; Edwards IJ, 1999, DIABETES RES CLIN PR, V46, P9, DOI 10.1016/S0168-8227(99)00074-1; Edwards IJ, 2002, METABOLISM, V51, P1223, DOI 10.1053/meta.2002.35177; Ersen BOC, 2007, COMPARATIVE MED, V57, P493; ETHERTON TD, 1980, GROWTH, V44, P182; ETHERTON TD, 1980, LIPIDS, V15, P823, DOI 10.1007/BF02534372; Fink LN, 2014, OBESITY, V22, P747, DOI 10.1002/oby.20615; Finn AV, 2005, J AM COLL CARDIOL, V45, P479, DOI 10.1016/j.jacc.2004.10.060; Flaherty JD, 2005, JAMA-J AM MED ASSOC, V293, P1501, DOI 10.1001/jama.293.12.1501; Fu RB, 2011, EUROPACE, V13, P31, DOI 10.1093/europace/euq346; Furusyo N, 2013, INT J CARDIOL, V167, P2066, DOI 10.1016/j.ijcard.2012.05.045; Gerrity RG, 2001, DIABETES, V50, P1654, DOI 10.2337/diabetes.50.7.1654; GLAGOV S, 1987, NEW ENGL J MED, V316, P1371, DOI 10.1056/NEJM198705283162204; Gokulakrishnan K, 2007, METABOLISM, V56, P245, DOI 10.1016/j.metabol.2006.10.002; Graner M, 2007, ANN MED, V39, P137, DOI 10.1080/07853890601083451; Gregg EW, 2014, NEW ENGL J MED, V370, P1514, DOI 10.1056/NEJMoa1310799; Grunwald KAA, 1999, J LIPID RES, V40, P475; Hanssen NM, 2014, DIABETES; Hasler-Rapacz J, 1998, AM J MED GENET, V76, P379, DOI 10.1002/(SICI)1096-8628(19980413)76:5<379::AID-AJMG3>3.0.CO;2-I; HASLERRAPACZ JO, 1994, ARTERIOSCLER THROMB, V14, P923, DOI 10.1161/01.ATV.14.6.923; HAUSMAN GJ, 1983, J LIPID RES, V24, P223; Herdzik E, 2002, ACTA DIABETOL, V39, P15, DOI 10.1007/s005920200007; HIGGINS PJ, 1982, DIABETES, V31, P743, DOI 10.2337/diabetes.31.9.743; Ho RC, 2002, METABOLISM, V51, P1478, DOI 10.1053/meta.2002.35577; Holvoet P, 1998, ARTERIOSCL THROM VAS, V18, P415, DOI 10.1161/01.ATV.18.3.415; Howard BV, 1999, AM J CARDIOL, V84, p28J; Hussein OA, 2007, CLIN CHIM ACTA, V377, P114, DOI 10.1016/j.cca.2006.09.002; Inokuchi-Shimizu S, 2014, THE JOURNAL OF CLINI; Inoue I, 2006, METABOLISM, V55, P946, DOI 10.1016/j.metabol.2006.03.002; Ishigaki Y, 2008, CIRCULATION, V118, P75, DOI 10.1161/CIRCULATIONAHA.107.745174; Jais A, 2014, CELL, V158, P25, DOI 10.1016/j.cell.2014.04.043; Juutilainen A, 2004, DIABETES CARE, V27, P2898, DOI 10.2337/diacare.27.12.2898; Kalela A, 2000, EUR J CLIN INVEST, V30, P99; Karolkiewicz J, 2006, AGING MALE, V9, P159, DOI 10.1080/13685530600884309; Kilhovd BK, 2005, ARTERIOSCL THROM VAS, V25, P815, DOI 10.1161/01.ATV.0000158380.44231.fe; Knopp RH, 2006, AM J CLIN NUTR, V83, P1; Kohen-Avramoglu R, 2003, CLIN BIOCHEM, V36, P413, DOI 10.1016/S0009-9120(03)00038-9; Kohler KA, 2000, AM J KIDNEY DIS, V36, P903, DOI 10.1053/ajkd.2000.19080; KREGE JH, 1995, HYPERTENSION, V25, P1111, DOI 10.1161/01.HYP.25.5.1111; Kurella M, 2005, J AM SOC NEPHROL, V16, P2134, DOI 10.1681/ASN.2005010106; Laakso M, 2014, NAT REV ENDOCRINOL, V10, P293, DOI 10.1038/nrendo.2014.29; LABERLAIRD K, 1992, LAB ANIM SCI, V42, P579; Lau CL, 2003, AM J TRANSPLANT, V3, P1065, DOI 10.1034/j.1600-6143.2003.00190.x; LaVange LM, 2006, CIRCULATION, V114, P2528, DOI 10.1161/CIRCULATIONAHA.106.613638; Lee B, 2014, AM J PHYSIOL-ENDOC M, V306, pE1144, DOI 10.1152/ajpendo.00002.2014; Lee YS, 2014, CELL, V157, P1339, DOI 10.1016/j.cell.2014.05.012; Li JP, 2007, CIRC J, V71, P1067, DOI 10.1253/circj.71.1067; Lomax MA, 2013, J NUTR BIOCHEM, V24, P656, DOI 10.1016/j.jnutbio.2012.03.013; Lopes-Virella MF, 2011, DIABETES, V60, P582, DOI 10.2337/db10-0915; Lucove J, 2008, AM J KIDNEY DIS, V51, P21, DOI 10.1053/j.ajkd.2007.09.014; MCNAMARA JP, 1982, J ANIM SCI, V55, P1057, DOI 10.2527/jas1982.5551057x; Meigs JB, 2002, DIABETES CARE, V25, P1313, DOI 10.2337/diacare.25.8.1313; Meisinger C, 2005, CIRCULATION, V112, P651, DOI 10.1161/CIRCULATIONAHA.104.529297; Mesangeau D, 2000, CARDIOVASC RES, V45, P889, DOI 10.1016/S0008-6363(99)00406-X; Moreno PR, 2004, J AM COLL CARDIOL, V44, P2293, DOI 10.1016/j.jacc.2004.07.060; Moses AC, 1996, DIABETES, V45, P91, DOI 10.2337/diabetes.45.1.91; Negrean M, 2007, AM J CLIN NUTR, V85, P1236, DOI 10.1093/ajcn/85.5.1236; Nichols TC, 1999, CIRC RES, V85, P1040; NICHOLS TC, 1992, AM J PATHOL, V140, P403; Nilsson J, 2007, CURR PHARM DESIGN, V13, P1021, DOI 10.2174/138161207780487557; Nin JWM, 2009, DIABETOLOGIA, V52, P705, DOI 10.1007/s00125-009-1263-5; O'Connell T, 2002, J CLIN ENDOCR METAB, V87, P4356, DOI 10.1210/jc.2002-020343; Oh DY, 2014, NATURE MED; Okopien B., 2003, Research Communications in Molecular Pathology and Pharmacology, V113, P87; Otis CR, 2003, COMPARATIVE MED, V53, P53; Paniagua JA, 2005, DIABETIC MED, V22, P1647, DOI 10.1111/j.1464-5491.2005.01703.x; Patschan S, 2008, AM J PHYSIOL-HEART C, V294, pH1119, DOI 10.1152/ajpheart.00713.2007; Pinhas-Hamiel O, 2007, LANCET, V369, P1823, DOI 10.1016/S0140-6736(07)60821-6; Renard C, 2006, DIABETES METAB, V32, P15, DOI 10.1016/S1262-3636(07)70243-4; Sam S, 2008, METABOLISM, V57, P84, DOI 10.1016/j.metabol.2007.08.010; Schindhelm RK, 2007, DIABETES CARE, V30, P1789, DOI 10.2337/dc06-2585; Schwenke DC, 2003, DIABETES CARE, V26, P1449, DOI 10.2337/diacare.26.5.1449; Selvin E, 2014, LANCET DIABETES ENDO, V2, P279, DOI 10.1016/S2213-8587(13)70199-2; Serin O, 2007, HORM METAB RES, V39, P207, DOI 10.1055/s-2007-970419; Shin MJ, 2006, INT J OBESITY, V30, P1529, DOI 10.1038/sj.ijo.0803304; Sies H, 2005, J NUTR, V135, P969, DOI 10.1093/jn/135.5.969; Song SO, 2012, ATHEROSCLEROSIS, V225, P450, DOI 10.1016/j.atherosclerosis.2012.09.005; Song YM, 2013, ENDOCRINOLOGY, V154, P2626, DOI 10.1210/en.2013-1031; Sosenko JM, 2002, DIABETES CARE, V25, P1078, DOI 10.2337/diacare.25.6.1078; Spijkerman AMW, 2003, DIABETES CARE, V26, P2604, DOI 10.2337/diacare.26.9.2604; Springett R, 2001, PHYS MED BIOL, V46, P2209, DOI 10.1088/0031-9155/46/8/312; Suzuki LA, 2001, DIABETES, V50, P851, DOI 10.2337/diabetes.50.4.851; TASKINEN MR, 1995, CURR OPIN LIPIDOL, V6, P153, DOI 10.1097/00041433-199506000-00007; Thornalley Paul J, 2004, Diab Vasc Dis Res, V1, P21, DOI 10.3132/dvdr.2004.002; Thornalley PJ, 2003, ARCH BIOCHEM BIOPHYS, V419, P31, DOI 10.1016/j.abb.2003.08.013; Tushuizen ME, 2006, J THROMB HAEMOST, V4, P1003, DOI 10.1111/j.1538-7836.2006.01914.x; Veiraiah A, 2005, ANGIOLOGY, V56, P431, DOI 10.1177/000331970505600411; Verhamme P, 2002, CARDIOVASC RES, V56, P135, DOI 10.1016/S0008-6363(02)00515-1; Virmani R, 2000, ARTERIOSCL THROM VAS, V20, P1262, DOI 10.1161/01.ATV.20.5.1262; Wahid ST, 2002, DIABETIC MED, V19, P543, DOI 10.1046/j.1464-5491.2002.00730.x; Weckbach S, 2009, INVEST RADIOL, P44; Yamagishi S, 2004, INT J CLIN PHARM RES, V24, P129; YEGIN A, 1995, INT J CLIN LAB RES, V25, P157, DOI 10.1007/BF02592559; Zhang H, 2014, ANN THORAC SURG, V97, P2073, DOI 10.1016/j.athoracsur.2014.02.047; Zhang LF, 2003, CIRCULATION, V108, P472, DOI 10.1161/01.CIR.0000080378.96063.23; Zhang YF, 2006, CLIN ENDOCRINOL, V64, P153, DOI 10.1111/j.1365-2265.2005.02440.x; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a; Zoungas S, 2014, NEW ENGL J MED, V371, P1392, DOI 10.1056/NEJMoa1407963	117	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132302	10.1371/journal.pone.0132302	http://dx.doi.org/10.1371/journal.pone.0132302			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147990	gold, Green Published, Green Submitted			2022-12-26	WOS:000358157600235
J	Ogawa, R; Nagao, K; Taniuchi, K; Tsuchiya, M; Kato, U; Hara, Y; Inaba, T; Kobayashi, T; Sasaki, Y; Akiyoshi, K; Watanabe-Takahashi, M; Nishikawa, K; Umeda, M				Ogawa, Rina; Nagao, Kohjiro; Taniuchi, Kentaro; Tsuchiya, Masaki; Kato, Utako; Hara, Yuji; Inaba, Takehiko; Kobayashi, Toshihide; Sasaki, Yoshihiro; Akiyoshi, Kazunari; Watanabe-Takahashi, Miho; Nishikawa, Kiyotaka; Umeda, Masato			Development of a Novel Tetravalent Synthetic Peptide That Binds to Phosphatidic Acid	PLOS ONE			English	Article							PHOSPHOLIPASE-D; MONOCLONAL-ANTIBODIES; MEMBRANE; CYTOKINESIS; PROTEINS; PHOSPHATIDYLETHANOLAMINE; REDISTRIBUTION; RECOGNITION; METABOLISM; BIOSENSOR	We employed a multivalent peptide-library screening technique to identify a peptide motif that binds to phosphatidic acid (PA), but not to other phospholipids such as phosphatidylcholine (PC), phosphatidylethanolamine (PE), and phosphatidylserine (PS). A tetravalent peptide with the sequence motif of MARWHRHHH, designated as PAB-TP (phosphatidic acid-binding tetravalent peptide), was shown to bind as low as 1 mol% of PA in the bilayer membrane composed of PC and cholesterol. Kinetic analysis of the interaction between PAB-TP and the membranes containing 10 mol% of PA showed that PAB-TP associated with PA with a low dissociation constant of K-D = 38 +/- 5 nM. Coexistence of cholesterol or PE with PA in the membrane enhanced the PAB-TP binding to PA by increasing the ionization of the phosphomonoester head group as well as by changing the microenvironment of PA molecules in the membrane. Amino acid replacement analysis demonstrated that the tryptophan residue at position 4 of PAB-TP was involved in the interaction with PA. Furthermore, a series of amino acid substitutions at positions 5 to 9 of PAB-TP revealed the involvement of consecutive histidine and arginine residues in recognition of the phosphomonoester head group of PA. Our results demonstrate that the recognition of PA by PABTP is achieved by a combination of hydrophobic, electrostatic and hydrogen-bond interactions, and that the tetravalent structure of PAB-TP contributes to the high affinity binding to PA in the membrane. The novel PA-binding tetravalent peptide PAB-TP will provide insight into the molecular mechanism underlying the recognition of PA by PA-binding proteins that are involved in various cellular events.	[Ogawa, Rina; Nagao, Kohjiro; Taniuchi, Kentaro; Tsuchiya, Masaki; Kato, Utako; Hara, Yuji; Umeda, Masato] Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Kyoto, Japan; [Inaba, Takehiko; Kobayashi, Toshihide] RIKEN, Lipid Biol Lab, Wako, Saitama, Japan; [Sasaki, Yoshihiro; Akiyoshi, Kazunari] Kyoto Univ, Dept Polymer Chem, Grad Sch Engn, Kyoto, Japan; [Watanabe-Takahashi, Miho; Nishikawa, Kiyotaka] Doshisha Univ, Fac Life & Med Sci, Kyoto, Japan	Kyoto University; RIKEN; Kyoto University; Doshisha University	Umeda, M (corresponding author), Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Kyoto, Japan.	umeda@sbchem.kyoto-u.ac.jp	KOBAYASHI, TOSHIHIDE/S-8313-2019	KOBAYASHI, TOSHIHIDE/0000-0002-4811-7270; Inaba, Takehiko/0000-0002-8770-4662	Ministry of Education, Culture, Sports, Science and Technology, Japan [25293012, 25116714, 25670119, 15K13741]; Grants-in-Aid for Scientific Research [15H04846] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grant-in-Aid for Scientific Research, a Grant-in-Aid for Scientific Research on Innovative Areas, and Grant-in-Aid for Challenging Exploratory Research from The Ministry of Education, Culture, Sports, Science and Technology, Japan (scientific research grants 25293012, 25116714, 25670119 and 15K13741) [http://www.mext.go.jp/english/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alwarawrah M, 2010, J PHYS CHEM B, V114, P7516, DOI 10.1021/jp101415g; BLUME A, 1992, BIOCHEMISTRY-US, V31, P4636, DOI 10.1021/bi00134a014; Carman GM, 2007, J BIOL CHEM, V282, P37293, DOI 10.1074/jbc.R700038200; Cockcroft S, 2009, BBA-MOL CELL BIOL L, V1791, P837, DOI 10.1016/j.bbalip.2009.08.003; Emoto K, 1996, P NATL ACAD SCI USA, V93, P12867, DOI 10.1073/pnas.93.23.12867; Emoto K, 2000, J CELL BIOL, V149, P1215, DOI 10.1083/jcb.149.6.1215; Fan JP, 2014, P NATL ACAD SCI USA, V111, P7636, DOI 10.1073/pnas.1403097111; Ghosh S, 2003, J BIOL CHEM, V278, P45690, DOI 10.1074/jbc.M302933200; Gottlin EB, 1998, P NATL ACAD SCI USA, V95, P9202, DOI 10.1073/pnas.95.16.9202; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Horchani H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113484; Jang JH, 2012, PROG LIPID RES, V51, P71, DOI 10.1016/j.plipres.2011.12.003; Kassas N, 2012, METHOD CELL BIOL, V108, P445, DOI 10.1016/B978-0-12-386487-1.00020-1; Kato U, 2013, J BIOL CHEM, V288, P4922, DOI 10.1074/jbc.M112.402701; Kobayashi S, 2013, FUNGAL GENET BIOL, V61, P100, DOI 10.1016/j.fgb.2013.09.008; Kooijman EE, 2008, BIOPHYS J, V94, P4320, DOI 10.1529/biophysj.107.121046; Kooijman EE, 2007, J BIOL CHEM, V282, P11356, DOI 10.1074/jbc.M609737200; Kooijman EE, 2009, BBA-MOL CELL BIOL L, V1791, P881, DOI 10.1016/j.bbalip.2009.04.001; Kooijman EE, 2005, BIOCHEMISTRY-US, V44, P17007, DOI 10.1021/bi0518794; Kraft CA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.299pl4; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; Makino A, 2015, FASEB J, V29, P477, DOI 10.1096/fj.13-247585; MIYAZAWA A, 1988, MOL IMMUNOL, V25, P1025; Murate M, 2015, J CELL SCI, V128, P1627, DOI 10.1242/jcs.163105; Nagao K, 2014, BBA-MOL CELL BIOL L, V1841, P80, DOI 10.1016/j.bbalip.2013.10.005; Nakanishi H, 2004, MOL BIOL CELL, V15, P1802, DOI 10.1091/mbc.e03-11-0798; NAM KS, 1990, BIOCHIM BIOPHYS ACTA, V1046, P89, DOI 10.1016/0005-2760(90)90098-I; Nishikawa K, 2006, FASEB J, V20, P2597, DOI 10.1096/fj.06-6572fje; Nishikimi A, 2009, SCIENCE, V324, P384, DOI 10.1126/science.1170179; Nishioka T, 2010, J BIOL CHEM, V285, P35979, DOI 10.1074/jbc.M110.153007; Pleskot R, 2013, TRENDS PLANT SCI, V18, P496, DOI 10.1016/j.tplants.2013.04.005; Stace CL, 2006, BBA-MOL CELL BIOL L, V1761, P913, DOI 10.1016/j.bbalip.2006.03.006; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; Toita S, 2010, BIOMACROMOLECULES, V11, P397, DOI 10.1021/bm901109z; UMEDA M, 1989, J IMMUNOL, V143, P2273; Watanabe-Takahashi M, 2010, INFECT IMMUN, V78, P177, DOI 10.1128/IAI.01022-09; Yamaji A, 1998, J BIOL CHEM, V273, P5300, DOI 10.1074/jbc.273.9.5300; Yang CY, 2012, INT J BIOCHEM CELL B, V44, P1346, DOI 10.1016/j.biocel.2012.05.006; Yang JS, 2008, NAT CELL BIOL, V10, P1146, DOI 10.1038/ncb1774; Young BP, 2010, SCIENCE, V329, P1085, DOI 10.1126/science.1191026; YU L, 1991, P NATL ACAD SCI USA, V88, P9325, DOI 10.1073/pnas.88.20.9325	42	5	5	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131668	10.1371/journal.pone.0131668	http://dx.doi.org/10.1371/journal.pone.0131668			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147860	Green Published, Green Submitted, gold			2022-12-26	WOS:000358157600124
J	Shuai, B; Shen, L; Yang, YP; Ma, C; Zhu, R; Xu, XJ				Shuai, Bo; Shen, Lin; Yang, Yanping; Ma, Chen; Zhu, Rui; Xu, Xiaojuan			Assessment of the Impact of Zoledronic Acid on Ovariectomized Osteoporosis Model Using Micro-CT Scanning	PLOS ONE			English	Article							BONE-MINERAL DENSITY; WNT/BETA-CATENIN; BETA-CATENIN; RAT MODEL; TRABECULAR MICROARCHITECTURE; COMPUTED-TOMOGRAPHY; CORTICAL BONE; DENOSUMAB; ASSOCIATION; RECEPTOR	Purpose/Objective Prompted by preliminary findings, this study was conducted to investigate the impact of zoledronic acid on the cancellous bone microstructure and its effect on the level of beta-catenin in a mouse model of postmenopausal osteoporosis. Methods and Materials 96 8-week-old specific-pathogen-free C57BL/6 mice were randomly divided into 4 groups (24 per group): a sham group, an ovariectomized osteoporosis model group, an estradiol-treated group, and a zoledronic acid-treated group. Five months after surgery, the third lumbar vertebra and left femur of the animals were dissected and scanned using micro-computed tomography (micro-CT) to acquire three-dimensional imagery of their cancellous bone microstructure. The impact of ovariectomy, the effect of estradiol, and the effect of zoledronic acid intervention on cancellous bone microstructure, as well as on the expression of beta-catenin, were evaluated. Results The estradiol-treated and the zoledronic acid-treated group exhibited a significant increase in the bone volume fraction, trabecular number, trabecular thickness, bone surface to bone volume ratio (BS/BV), and beta-catenin expression, when compared with those of the control group (P <0.01). In contrast, the structure model index, trabecular separation, and BS/BV were significantly lower compared with those of the model group (P <0.01). No differences were observed in the above parameters between animals of the zoledronic acid-treated and the estradiol-treated group. Conclusion These results suggest that increased beta-catenin expression may be the mechanism underlying zoledronic acid-related improvement in the cancellous bone microstructure in ovariectomized mice. Our findings provide a scientific rationale for using zoledronic acid as a therapeutic intervention to prevent bone loss in post-menopausal women.	[Shuai, Bo; Shen, Lin; Yang, Yanping; Ma, Chen; Zhu, Rui; Xu, Xiaojuan] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Integrated Tradit Chinese & Western Med, Wuhan 430022, Peoples R China	Huazhong University of Science & Technology	Shen, L (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Integrated Tradit Chinese & Western Med, Wuhan 430022, Peoples R China.	18971511705@126.com		Shuai, Bo/0000-0002-9298-8129	National Natural Science Foundation of China [81403257, 81473492, 81072493]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was funded by the National Natural Science Foundation of China (Project Number: 81403257 to Bo Shuai, 81473492 to Lin Shen, and 81072493 to Ping Yan Yang) (http://www.nsfc.gov.cn/publish/portal0/tab117/).	Anastasilakis AD, 2013, J CLIN ENDOCR METAB, V98, P3206, DOI 10.1210/jc.2013-1402; Audran M, 2001, CALCIFIED TISSUE INT, V69, P214, DOI 10.1007/s00223-001-1058-2; Bolotin HH, 2001, J BONE MINER RES, V16, P799, DOI 10.1359/jbmr.2001.16.5.799; Brand L, 2013, INT J COLORECTAL DIS, V28, P1091, DOI 10.1007/s00384-013-1667-z; Chang KV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081124; Chen Q, 2014, CHIN J INTEGR MED, V20, P743, DOI 10.1007/s11655-014-1810-x; Contrera JF, 2004, REGUL TOXICOL PHARM, V40, P185, DOI 10.1016/j.yrtph.2004.08.004; Du LY, 2007, PHYS MED BIOL, V52, P7087, DOI 10.1088/0031-9155/52/23/021; Effendy NM, 2014, J X-RAY SCI TECHNOL, V22, P503, DOI 10.3233/XST-140441; HAHN M, 1992, BONE, V13, P327, DOI 10.1016/8756-3282(92)90078-B; Holmen SL, 2005, J BIOL CHEM, V280, P21162, DOI 10.1074/jbc.M501900200; Ibrahim NI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115595; Ito M, 1998, BONE, V23, P163, DOI 10.1016/S8756-3282(98)00083-0; Khajuria DK, 2014, J ORTHOP SCI, V19, P646, DOI 10.1007/s00776-014-0557-8; Khajuria Deepak Kumar, 2014, Sci Pharm, V82, P357, DOI 10.3797/scipharm.1310-06; Kinney JH, 2000, J BONE MINER RES, V15, P1981, DOI 10.1359/jbmr.2000.15.10.1981; Knapp KM, 2015, J CLIN DENSITOM, V18, P209, DOI 10.1016/j.jocd.2014.06.001; Kouzmenko AP, 2004, J BIOL CHEM, V279, P40255, DOI 10.1074/jbc.C400331200; Laib A, 2000, MED BIOL ENG COMPUT, V38, P326, DOI 10.1007/BF02347054; Legrand E, 2000, J BONE MINER RES, V15, P13, DOI 10.1359/jbmr.2000.15.1.13; Li FL, 2011, CHIN J INTEGR MED, V17, P261, DOI 10.1007/s11655-011-0703-5; Liedert A, 2010, BIOCHEM BIOPH RES CO, V394, P755, DOI 10.1016/j.bbrc.2010.03.065; Liu ZS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116194; Medical Advisory Secretariat, 2006, Ont Health Technol Assess Ser, V6, P1; Mittra E, 2005, J BIOMECH, V38, P1229, DOI 10.1016/j.jbiomech.2004.06.007; Neves AA, 2014, DENT MATER, V30, P799, DOI 10.1016/j.dental.2014.05.003; Park YS, 2014, IMAGNG SCI DENT, V44, P143, DOI 10.5624/isd.2014.44.2.143; Poole KES, 2015, J BONE MINER RES, V30, P46, DOI 10.1002/jbmr.2325; Ramli R, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/501858; Ruegsegger P, 1996, CALCIFIED TISSUE INT, V58, P24, DOI 10.1007/s002239900006; Scagliotti GV, 2012, J THORAC ONCOL, V7, P1823, DOI 10.1097/JTO.0b013e31826aec2b; Schreiber JJ, 2014, NEUROSURG FOCUS, V37, DOI 10.3171/2014.5.FOCUS1483; Shuai B, 2015, OSTEOPOROSIS INT, V26, P1063, DOI 10.1007/s00198-014-2992-y; Shuai Bo, 2014, Chinese Medicine, V5, P145; Shuai B, 2010, J RHEUMATOL, V37, P2151, DOI 10.3899/jrheum.100342; Silva BC, 2014, J BONE MINER RES, V29, P518, DOI 10.1002/jbmr.2176; Tai TW, 2014, BONE, V67, P166, DOI 10.1016/j.bone.2014.07.003; Tian J, 2015, J HUAZHONG U SCI-MED, V35, P212, DOI 10.1007/s11596-015-1413-6; Vasconcelos ACU, 2012, J ORAL PATHOL MED, V41, P702, DOI 10.1111/j.1600-0714.2012.01140.x; Vasquez Sergio X, 2013, Methods Mol Biol, V947, P223, DOI 10.1007/978-1-62703-131-8_18; Verborgt O, 2000, J BONE MINER RES, V15, P60, DOI 10.1359/jbmr.2000.15.1.60; Warden SJ, 2005, J BONE MINER RES, V20, P809, DOI 10.1359/JBMR.041222; Wurnig MC, 2014, NMR BIOMED, V27, P1159, DOI 10.1002/nbm.3169; Xu XJ, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/534352; Xu YX, 2012, CHIN J INTEGR MED, V18, P909, DOI 10.1007/s11655-012-1294-2	45	20	24	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132104	10.1371/journal.pone.0132104	http://dx.doi.org/10.1371/journal.pone.0132104			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148020	Green Published, gold, Green Submitted			2022-12-26	WOS:000358157600200
J	Zeng, QY; Fan, TT; Zhu, P; He, RQ; Bao, YX; Zheng, RY; Xu, HQ				Zeng, Qing-Yi; Fan, Tian-Tian; Zhu, Pan; He, Ru-Qian; Bao, Yi-Xin; Zheng, Rong-Yuan; Xu, Hui-Qin			Comparative Long-Term Effectiveness of a Monotherapy with Five Antiepileptic Drugs for Focal Epilepsy in Adult Patients: A Prospective Cohort Study	PLOS ONE			English	Article							TECHNOLOGY-ASSESSMENT SUBCOMMITTEE; QUALITY STANDARDS SUBCOMMITTEE; RETENTION RATES; AMERICAN ACADEMY; ILAE-COMMISSION; EFFICACY; TOLERABILITY; TOPIRAMATE; THERAPY; LAMOTRIGINE	Objective To evaluate and compare long-term effectiveness of five antiepileptic drugs (AEDs) for monotherapy of adult patients with focal epilepsy in routine clinical practice. Methods Adult patients with focal epilepsy, who were prescribed with carbamazepine (CBZ), valproate (VPA), lamotrigine (LTG), topiramate (TPM), or oxcarbazepine (OXC) as monotherapy, during the period from January 2004 to June 2012 registered in Wenzhou Epilepsy Follow Up Registry Database (WEFURD), were included in the study. Prospective long-term follow-up was conducted until June 2013. The endpoints were time to treatment failure, time to seizure remission, and time to first seizure. Results This study included 654 patients: CBZ (n=125), VPA (n=151), LTG (n=135), TPM (n=76), and OXC (n=167). The retention rates of CBZ, VPA, LTG, TPM, and OXC at the third year were 36.1%, 32.4%, 57.6%, 37.9%, and 41.8%, respectively. For time to treatment failure, LTG was significantly better than CBZ and VPA (LTG vs. CBZ, hazard ratio, [HR] 0.80 [95% confidence interval: 0.67-0.96], LTG vs. VPA, 0.53 [0.37-0.74]); TPM was worse than LTG (TPM vs. LTG, 1.77 [1.15-2.74]), and OXC was better than VPA (0.86 [0.78-0.96]). After initial target doses, the seizure remission rates of CBZ, VPA, LTG, TPM, and OXC were 63.0%, 77.0%, 83.6%, 67.9%, and 75.3%, respectively. LTG was significantly better than CBZ (1.44 [1.15-1.82]) and OXC (LTG vs. OXC, 0.76 [0.63-0.93]); OXC was less effective than LTG in preventing the first seizure (1.20 [1.02-1.40]). Conclusion LTG was the best, OXC was better than VPA only, while VPA was the worst. The others were equivalent for comparisons between five AEDs regarding the long-term treatment outcomes of monotherapy for adult patients with focal epilepsy in a clinical practice. For selecting AEDs for these patients among the first-line drugs, LTG is an appropriate first choice; others are reservation in the first-line but VPA is not.	[Zeng, Qing-Yi; Zhu, Pan; He, Ru-Qian; Bao, Yi-Xin; Zheng, Rong-Yuan; Xu, Hui-Qin] Wenzhou Med Univ, Affiliated Hosp 1, Dept Neurol, Wenzhou, Zhejiang, Peoples R China; [Fan, Tian-Tian] First Hosp Zibo, Rehabil Ctr, Zibo, Shandong, Peoples R China	Wenzhou Medical University	Zheng, RY (corresponding author), Wenzhou Med Univ, Affiliated Hosp 1, Dept Neurol, Wenzhou, Zhejiang, Peoples R China.	zhengry2013@163.com; xuhuiqin1972@163.com	Zeng, Qingyi/U-7280-2017	Zeng, Qingyi/0000-0002-1291-9861	Wenzhou Medical Association	Wenzhou Medical Association	The study was funded by grants from Wenzhou Medical Association (RYZ). The funder had no role in the study design; in the collection, analysis and interpretation of data; in the writing of the manuscript; or in the decision to submit the paper for publication.	Andrew T, 2012, SEIZURE-EUR J EPILEP, V21, P610, DOI 10.1016/j.seizure.2012.06.013; [Anonymous], 1981, Epilepsia, V22, P489; [Anonymous], 1989, EPILEPSIA, V30, P389, DOI 10.1111/j.1528-1157.1989.tb05316.x; Ben-Menachem E, 2010, EPILEPSY BEHAV, V18, P24, DOI 10.1016/j.yebeh.2010.04.001; Bergin P, 2012, EPILEPSIA, V53, P1829, DOI 10.1111/j.1528-1167.2012.03636.x; BERKOVIC SF, 1997, EPILEPSIA S10, V38, P1; Bootsma HP, 2009, SEIZURE-EUR J EPILEP, V18, P327, DOI 10.1016/j.seizure.2008.11.006; Brodie MJ, 2012, NEUROLOGY, V78, P1548, DOI 10.1212/WNL.0b013e3182563b19; Brodie MJ, 1996, NEW ENGL J MED, V334, P168, DOI 10.1056/NEJM199601183340308; Chinese Medical Association, 2007, BOOK EP CHIN CLIN PR; Cho YJ, 2009, EPILEPSIA, V50, P1910, DOI 10.1111/j.1528-1167.2009.02177.x; Chung S, 2007, SEIZURE-EUR J EPILEP, V16, P296, DOI 10.1016/j.seizure.2007.01.004; Dichter MA, 1996, NEW ENGL J MED, V334, P1583, DOI 10.1056/NEJM199606133342407; Dreyer NA, 2009, JAMA-J AM MED ASSOC, V302, P790, DOI 10.1001/jama.2009.1092; French JA, 2004, NEUROLOGY, V62, P1252, DOI 10.1212/01.WNL.0000123693.82339.FC; French JA, 2004, NEUROLOGY, V62, P1261, DOI 10.1212/01.WNL.0000123695.22623.32; Gilliam FG, 2004, NEUROLOGY, V62, P23, DOI 10.1212/WNL.62.1.23; Glauser T, 2013, EPILEPSIA, V54, P551, DOI 10.1111/epi.12074; Hsieh FY, 2000, CONTROL CLIN TRIALS, V21, P552, DOI 10.1016/S0197-2456(00)00104-5; Hu YD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047982; Hu YD, 2011, SEIZURE-EUR J EPILEP, V20, P208, DOI 10.1016/j.seizure.2010.11.020; Hu YD, 2010, EPILEPSY RES, V90, P278, DOI 10.1016/j.eplepsyres.2010.06.004; Kwan P, 2010, EPILEPSIA, V51, P1069, DOI 10.1111/j.1528-1167.2009.02397.x; Lhatoo SD, 2000, EPILEPSIA, V41, P1592; Li J, 2012, CHINESE J PHARMACOEP, V21, P587; Marson AG, 2007, LANCET, V369, P1016, DOI 10.1016/S0140-6736(07)60461-9; Marson AG, 2007, LANCET, V369, P1000, DOI 10.1016/S0140-6736(07)60460-7; Mohanraj R, 2005, EPILEPSY BEHAV, V6, P382, DOI 10.1016/j.yebeh.2005.01.008; Mohanraj R, 2003, SEIZURE-EUR J EPILEP, V12, P413, DOI 10.1016/S1059-1311(03)00047-5; National Institute for Clinical Excellence, 2014, EP DIAGN MAN EP AD C; Patsalos PN, 2008, EPILEPSIA, V49, P1239, DOI 10.1111/j.1528-1167.2008.01561.x; Perucca E, 2001, CNS DRUGS, V15, P609, DOI 10.2165/00023210-200115080-00004; Perucca E, 1996, BAILLIERE CLIN NEUR, V5, P693; Sander JW, 2005, ACTA NEUROL SCAND, V112, P26, DOI 10.1111/j.1600-0404.2005.00505.x; Sander JW, 2004, EPILEPSIA, V45, P28, DOI 10.1111/j.0013-9580.2004.455005.x; Shorvon S, 2000, SEIZURE-EUR J EPILEP, V9, P75, DOI 10.1053/seiz.2000.0391; Shorvon SD, 2011, EPILEPSIA, V52, P1052, DOI 10.1111/j.1528-1167.2011.03041.x; Simister RJ, 2007, EPILEPSY BEHAV, V10, P336, DOI 10.1016/j.yebeh.2006.12.005; Tatum WO, 2001, EPILEPSIA, V42, P1134, DOI 10.1046/j.1528-1157.2001.41700.x; Tomson T, 2010, EPILEPSIA, V51, P909, DOI 10.1111/j.1528-1167.2010.02525.x; Vajda FJE, 2010, ACTA NEUROL SCAND, V121, P89, DOI 10.1111/j.1600-0404.2009.01260.x; Wieshmann UC, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002564; World Health Organization, 2014, EPILEPSY; Zaccara G, 2006, ACTA NEUROL SCAND, V114, P157, DOI 10.1111/j.1600-0404.2006.00705.x	44	22	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131566	10.1371/journal.pone.0131566	http://dx.doi.org/10.1371/journal.pone.0131566			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147937	Green Published, Green Submitted, gold			2022-12-26	WOS:000358157600107
J	Chakrabarti, R; Sanyal, S; Ghosh, A; Bhar, K; Das, C; Siddhanta, A				Chakrabarti, Rajarshi; Sanyal, Sulagna; Ghosh, Amit; Bhar, Kaushik; Das, Chandrima; Siddhanta, Anirban			Phosphatidylinositol-4-phosphate 5-Kinase 1 alpha Modulates Ribosomal RNA Gene Silencing through Its Interaction with Histone H3 Lysine 9 Trimethylation and Heterochromatin Protein HP1-alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE; NUCLEOLAR CAPS; 4,5-BISPHOSPHATE; PHOSPHOINOSITIDES; EXPRESSION; KINASE; TRANSCRIPTION; INHIBITION; REVERSES; BINDING	Phosphoinositide signaling has been implicated in the regulation of numerous cellular processes including cytoskeletal dynamics, cellular motility, vesicle trafficking, and gene transcription. Studies have also shown that nuclear phosphoinositide(s) regulates processes such as mRNA export, cell cycle progression, gene transcription, and DNA repair. We have shown previously that the nuclear form of phosphatidylinositol-4-phosphate 5-kinase 1 alpha (PIP5K), the enzyme responsible for phosphatidylinositol 4,5-bisphosphate synthesis, is modified by small ubiquitin-like modifier (SUMO)-1. In this study, we have shown that due to the site-specific Lys to Ala mutations of PIP5K at Lys-244 and Lys-490, it is unable to localize in the nucleus and nucleolus, respectively. Furthermore, by using chromatin immunoprecipitation assays, we have observed that PIP5K associates with the chromatin silencing complex constituted of H3K9me3 and heterochromatin protein 1 alpha at multiple ribosomal DNA (rDNA) loci. These interactions followed a definite cyclical pattern of occupancy (mostly G(1)) and release from the rDNA loci (G(1)/S) throughout the cell cycle. Moreover, the immunoprecipitation results clearly demonstrate that PIP5K SUMOylated at Lys-490 interacts with components of the chromatin silencing machinery, H3K9me3 and heterochromatin protein 1 alpha. However, PIP5K does not interact with the gene activation signature protein H3K4me3. This study, for the first time, demonstrates that PIP5K, an enzyme actively associated with lipid modification pathway, has additional roles in rDNA silencing.	[Chakrabarti, Rajarshi; Ghosh, Amit; Bhar, Kaushik; Siddhanta, Anirban] Univ Calcutta, Dept Biochem, Kolkata 700019, India; [Sanyal, Sulagna; Das, Chandrima] Saha Inst Nucl Phys, Biophys & Struct Genom Div, Kolkata 700064, India	University of Calcutta; Saha Institute of Nuclear Physics	Siddhanta, A (corresponding author), Univ Calcutta, Dept Biochem, Kolkata 700019, India.	chandrima.das@saha.ac.in; asiddhanto@yahoo.com	Das, Chandrima/AAI-7398-2021; Chakrabarti, Rajarshi/J-3240-2019	Chakrabarti, Rajarshi/0000-0002-4184-8492; Das, Chandrima/0000-0002-8117-2810	Department of Biotechnology Grant (DBT) [BT/PR11415/BRB/10/656/2008]; Department of Science and Technology Grant, Government of India [SR/SO/HS-51/2008]; Center for Advanced Studies in Biochemistry (University Potential for Excellence) (University Grants Commission); Center for Modern Biology (University Potential for Excellence) (University Grants Commission); Calcutta University (CU)-DBT-Interdisciplinary Program in Life Sciences (IPLS); Council of Scientific and Industrial Research, Government of India; Biomolecular Assembly, Recognition and Dynamics Project Grant from the Department of Atomic Energy, Government of India [12-RD-SIN-5.040103]; Department of Biotechnology, Government of India	Department of Biotechnology Grant (DBT)(Department of Biotechnology (DBT) India); Department of Science and Technology Grant, Government of India(Department of Science & Technology (India)); Center for Advanced Studies in Biochemistry (University Potential for Excellence) (University Grants Commission); Center for Modern Biology (University Potential for Excellence) (University Grants Commission); Calcutta University (CU)-DBT-Interdisciplinary Program in Life Sciences (IPLS); Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); Biomolecular Assembly, Recognition and Dynamics Project Grant from the Department of Atomic Energy, Government of India; Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported in part by Department of Biotechnology Grant (DBT) BT/PR11415/BRB/10/656/2008 and Department of Science and Technology Grant SR/SO/HS-51/2008, Government of India; the Center for Advanced Studies in Biochemistry and Center for Modern Biology (University Potential for Excellence) (University Grants Commission); and Calcutta University (CU)-DBT-Interdisciplinary Program in Life Sciences (IPLS). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the Council of Scientific and Industrial Research, Government of India.; Supported by Biomolecular Assembly, Recognition and Dynamics Project Grant 12-R&D-SIN-5.040103 from the Department of Atomic Energy, Government of India and the Ramalingaswami Fellowship from the Department of Biotechnology, Government of India.	Barlow CA, 2010, TRENDS CELL BIOL, V20, P25, DOI 10.1016/j.tcb.2009.09.009; Boronenkov IV, 1998, MOL BIOL CELL, V9, P3547, DOI 10.1091/mbc.9.12.3547; Chakrabarti R, 2013, BIOCHEM BIOPH RES CO, V439, P209, DOI 10.1016/j.bbrc.2013.08.058; Christensen MO, 2004, J BIOL CHEM, V279, P21873, DOI 10.1074/jbc.M400498200; Cong R, 2014, NUCLEIC ACIDS RES, V42, P181, DOI 10.1093/nar/gkt863; Coppolino MG, 2002, J BIOL CHEM, V277, P43849, DOI 10.1074/jbc.M209046200; Cui YP, 2010, J BIOL CHEM, V285, P32988, DOI 10.1074/jbc.M110.140905; Das C, 2010, J MOL BIOL, V397, P1, DOI 10.1016/j.jmb.2009.12.058; Divecha N, 2002, CURR BIOL, V12, P582, DOI 10.1016/S0960-9822(02)00769-8; Doughman RL, 2003, J BIOL CHEM, V278, P23036, DOI 10.1074/jbc.M211397200; Falkenburger BH, 2010, J PHYSIOL-LONDON, V588, P3179, DOI 10.1113/jphysiol.2010.192153; Ferrero GO, 2014, BIOCHEM J, V461, P521, DOI 10.1042/BJ20131376; Fruman DA, 1998, ANNU REV BIOCHEM, V67, P481, DOI 10.1146/annurev.biochem.67.1.481; Ghosh S, 2001, PROTEIN EXPRES PURIF, V21, P40, DOI 10.1006/prep.2000.1319; Grant PA, 2001, GENOME BIOL, V2; Haindl M, 2008, EMBO REP, V9, P273, DOI 10.1038/embor.2008.3; Kalt I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030825; Klein J, 1999, P NATL ACAD SCI USA, V96, P6096, DOI 10.1073/pnas.96.11.6096; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Logan MR, 2006, BIOL CELL, V98, P377, DOI 10.1042/BC20050081; Malik MQ, 2014, J BIOL CHEM, V289, P35468, DOI 10.1074/jbc.M114.609123; Mayer C, 2006, MOL CELL, V22, P351, DOI 10.1016/j.molcel.2006.03.028; Mellman DL, 2008, NATURE, V451, P1013, DOI 10.1038/nature06666; REYNOLDS RC, 1964, CANCER RES, V24, P1269; Roth MG, 2004, PHYSIOL REV, V84, P699, DOI 10.1152/physrev.00033.2003; Scheer U, 1999, CURR OPIN CELL BIOL, V11, P385, DOI 10.1016/S0955-0674(99)80054-4; Semenas J, 2014, P NATL ACAD SCI USA, V111, pE3689, DOI 10.1073/pnas.1405801111; Shah ZH, 2013, FEBS J, V280, P6295, DOI 10.1111/febs.12543; Shav-Tal Y, 2005, MOL BIOL CELL, V16, P2395, DOI 10.1091/mbc.E04-11-0992; Sobol M, 2013, NUCLEUS-PHILA, V4, P478, DOI 10.4161/nucl.27154; Thapa N, 2013, J BIOL CHEM, V288, P34707, DOI 10.1074/jbc.M113.512848; Tsai WW, 2010, NATURE, V468, P927, DOI 10.1038/nature09542; Watt SA, 2002, BIOCHEM J, V363, P657, DOI 10.1042/0264-6021:3630657; Yildirim S, 2013, J CELL SCI, V126, P2730, DOI 10.1242/jcs.123661; YORK JD, 1994, J BIOL CHEM, V269, P7847; Yu HY, 1998, EUR J BIOCHEM, V251, P281, DOI 10.1046/j.1432-1327.1998.2510281.x; Zhao KJ, 1998, CELL, V95, P625, DOI 10.1016/S0092-8674(00)81633-5	37	17	18	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2015	290	34					20893	20903		10.1074/jbc.M114.633727	http://dx.doi.org/10.1074/jbc.M114.633727			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP6QC	26157143	Green Published, hybrid			2022-12-26	WOS:000360011800025
J	Fan, LL; Peng, GH; Hussain, A; Fazli, L; Guns, E; Gleave, M; Qi, JF				Fan, Lingling; Peng, Guihong; Hussain, Arif; Fazli, Ladan; Guns, Emma; Gleave, Martin; Qi, Jianfei			The Steroidogenic Enzyme AKR1C3 Regulates Stability of the Ubiquitin Ligase Siah2 in Prostate Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ABSENTIA HOMOLOG 2; ANDROGEN RECEPTOR; IN-VITRO; EXPRESSION; INHIBITORS; TUMORIGENESIS; ABIRATERONE; RESISTANCE; HYPOXIA; TARGET	Re-activation of androgen receptor (AR) activity is the main driver for development of castration-resistant prostate cancer. We previously reported that the ubiquitin ligase Siah2 enhanced AR transcriptional activity and prostate cancer cell growth. Among the genes we found to be regulated by Siah2 was AKR1C3, which encodes a key androgen biosynthetic enzyme implicated in castration-resistant prostate cancer development. Here, we found that Siah2 inhibition in CWR22Rv1 prostate cancer cells decreased AKR1C3 expression as well as intracellular androgen levels, concomitant with inhibition of cell growth in vitro and in orthotopic prostate tumors. Re-expression of either wild-type or catalytically inactive forms of AKR1C3 partially rescued AR activity and growth defects in Siah2 knockdown cells, suggesting a nonenzymatic role for AKR1C3 in these outcomes. Unexpectedly, AKR1C3 re-expression in Siah2 knockdown cells elevated Siah2 protein levels, whereas AKR1C3 knockdown had the opposite effect. We further found that AKR1C3 can bind Siah2 and inhibit its self-ubiquitination and degradation, thereby increasing Siah2 protein levels. We observed parallel expression of Siah2 and AKR1C3 in human prostate cancer tissues. Collectively, our findings identify a new role for AKR1C3 in regulating Siah2 stability and thus enhancing Siah2-dependent regulation of AR activity in prostate cancer cells.	[Fan, Lingling; Peng, Guihong; Hussain, Arif; Qi, Jianfei] Univ Maryland, Sch Med, Marlene & Stewart Greenebaum Canc Ctr, Baltimore, MD 21201 USA; [Fan, Lingling; Peng, Guihong; Hussain, Arif; Qi, Jianfei] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Hussain, Arif] Baltimore Vet Affairs Med Ctr, Baltimore, MD 21201 USA; [Fazli, Ladan; Guns, Emma; Gleave, Martin] Univ British Columbia, Vancouver Prostate Ctr, Vancouver, BC V6H 3Z6, Canada	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; US Department of Veterans Affairs; Veterans Health Administration (VHA); Baltimore VA Medical Center; University of British Columbia	Qi, JF (corresponding author), Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Marlene & Stewart Greenebaum Canc Ctr, 655 W Baltimore St, Baltimore, MD 21201 USA.	JQI@som.umaryland.edu		qi, jianfei/0000-0001-7884-7656; Gleave, Martin/0000-0003-4235-0167	National Institutes of Health from NCI [CA154888]; Department of Veterans Affairs; NATIONAL CANCER INSTITUTE [K99CA154888, R00CA154888] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA154888 from NCI (to J. Q.). This work was also supported by a Merit Review Award from the Department of Veterans Affairs (to A. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Adeniji AO, 2013, J STEROID BIOCHEM, V137, P136, DOI 10.1016/j.jsbmb.2013.05.012; Ahmed AU, 2008, JNCI-J NATL CANCER I, V100, P1606, DOI 10.1093/jnci/djn365; Antonarakis ES, 2014, NEW ENGL J MED, V371, P1028, DOI 10.1056/NEJMoa1315815; Baba K, 2013, J BIOL CHEM, V288, P18393, DOI 10.1074/jbc.M112.438762; Bauman DR, 2006, MOL ENDOCRINOL, V20, P444, DOI 10.1210/me.2005-0287; Cai CM, 2011, CANCER CELL, V20, P457, DOI 10.1016/j.ccr.2011.09.001; Cai CM, 2011, CANCER RES, V71, P6503, DOI 10.1158/0008-5472.CAN-11-0532; Chan P, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2828; de Bie P, 2011, CELL DEATH DIFFER, V18, P1393, DOI 10.1038/cdd.2011.16; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; Depaux A, 2006, BIOCHEM BIOPH RES CO, V348, P857, DOI 10.1016/j.bbrc.2006.07.092; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Habelhah H, 2002, EMBO J, V21, P5756, DOI 10.1093/emboj/cdf576; Hofland J, 2010, CANCER RES, V70, P1256, DOI 10.1158/0008-5472.CAN-09-2092; Hu G, 1999, MOL CELL BIOL, V19, P724; Kang N, 2014, MOL CELLS, V37, P389, DOI 10.14348/molcells.2014.0032; Kikuchi A, 2014, INVEST NEW DRUG, V32, P860, DOI 10.1007/s10637-014-0130-5; Kilroy G, 2012, ENDOCRINOLOGY, V153, P1206, DOI 10.1210/en.2011-1725; Labrie F, 1997, STEROIDS, V62, P148, DOI 10.1016/S0039-128X(96)00174-2; Liedtke AJ, 2013, J MED CHEM, V56, P2429, DOI 10.1021/jm3017656; Liu CF, 2015, CANCER RES, V75, P1413, DOI 10.1158/0008-5472.CAN-14-3080; Ma B, 2015, NAT CELL BIOL, V17, P95, DOI 10.1038/ncb3073; Ming DS, 2014, J STEROID BIOCHEM, V143, P19, DOI 10.1016/j.jsbmb.2014.02.006; Mitsiades N, 2012, CANCER RES, V72, P6142, DOI 10.1158/0008-5472.CAN-12-1335; Montgomery RB, 2008, CANCER RES, V68, P4447, DOI 10.1158/0008-5472.CAN-08-0249; Muller S, 2014, ONCOTARGET, V5, P3184; Nakayama K, 2004, CELL, V117, P941, DOI 10.1016/j.cell.2004.06.001; PAWLOWSKI JE, 1994, J BIOL CHEM, V269, P13502; Pham S, 2014, J STEROID BIOCHEM, V144, P436, DOI 10.1016/j.jsbmb.2014.09.004; Qi JF, 2008, P NATL ACAD SCI USA, V105, P16713, DOI 10.1073/pnas.0804063105; Qi JF, 2013, CELL BIOCHEM BIOPHYS, V67, P15, DOI 10.1007/s12013-013-9636-2; Qi JF, 2013, CANCER CELL, V23, P332, DOI 10.1016/j.ccr.2013.02.016; Qi JF, 2010, CANCER CELL, V18, P23, DOI 10.1016/j.ccr.2010.05.024; Rizner TL, 2014, STEROIDS, V79, P49, DOI 10.1016/j.steroids.2013.10.012; Rizzardi AE, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-244; Sarkar TR, 2012, MOL CELL BIOL, V32, P320, DOI 10.1128/MCB.05790-11; Schmidt RL, 2007, CANCER RES, V67, P11798, DOI 10.1158/0008-5472.CAN-06-4471; Scortegagna M, 2011, J BIOL CHEM, V286, P27333, DOI 10.1074/jbc.M111.218214; Shah M, 2009, PIGM CELL MELANOMA R, V22, P799, DOI 10.1111/j.1755-148X.2009.00628.x; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sramkoski RM, 1999, IN VITRO CELL DEV-AN, V35, P403; Stanbrough M, 2006, CANCER RES, V66, P2815, DOI 10.1158/0008-5472.CAN-05-4000; Stein MN, 2014, ASIAN J ANDROL, V16, P387, DOI 10.4103/1008-682X.129133; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Tian YT, 2014, DIAGN PATHOL, V9, DOI 10.1186/1746-1596-9-42; Wako K, 2008, J CLIN PATHOL, V61, P448, DOI 10.1136/jcp.2007.050906; Wong CSF, 2012, CANCER RES, V72, P1694, DOI 10.1158/0008-5472.CAN-11-3310; Yepuru M, 2013, CLIN CANCER RES, V19, P5613, DOI 10.1158/1078-0432.CCR-13-1151; Yuan X, 2014, ONCOGENE, V33, P2815, DOI 10.1038/onc.2013.235; Zang TZ, 2015, CHEM-BIOL INTERACT, V234, P339, DOI 10.1016/j.cbi.2014.12.015; Zhang JS, 1998, GENE DEV, V12, P1775, DOI 10.1101/gad.12.12.1775; Zhao HL, 2010, BIOCHEM BIOPH RES CO, V399, P623, DOI 10.1016/j.bbrc.2010.07.127	52	21	22	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2015	290	34					20865	20879		10.1074/jbc.M115.662155	http://dx.doi.org/10.1074/jbc.M115.662155			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP6QC	26160177	Green Published, hybrid			2022-12-26	WOS:000360011800023
J	Florea, OA; Rosca, IC				Florea, Olivia Ana; Rosca, Ileana Constanta			Stokes' Second Problem for a Micropolar Fluid with Slip	PLOS ONE			English	Article							FREE-CONVECTION FLOW; STATE-SPACE APPROACH	In this paper is presented the model of an incompressible micropolar fluid flow with slip using the initial and boundary conditions when the wall velocity is considered depending on the frequency of the vibration. Regarding the boundary conditions of the velocity at the wall, we remark that there is a discontinuity of the velocity at the fluid-wall interface. The solutions for velocity and microrotation with the given conditions are obtained using the method of numerical inversion of Laplace transform.	[Florea, Olivia Ana] Transilvania Univ Brasov, Fac Math & Comp Sci, Brasov, Romania; [Rosca, Ileana Constanta] Transilvania Univ Brasov, Fac Prod Design & Environm, Brasov, Romania	Transylvania University of Brasov; Transylvania University of Brasov	Florea, OA (corresponding author), Transilvania Univ Brasov, Fac Math & Comp Sci, Brasov, Romania.	olivia.florea@unitbv.ro	Rosca, Ileana Constanta G/H-3746-2016		Sectorial Operational Programme Human Resources Development (SOP HRD); European Social Fund; Romanian Government [POSDRU/159/1.5/S/134378]	Sectorial Operational Programme Human Resources Development (SOP HRD); European Social Fund(European Social Fund (ESF)); Romanian Government(Romanian Government)	This paper is supported by the Sectorial Operational Programme Human Resources Development (SOP HRD), financed from the European Social Fund and by the Romanian Government under the project number POSDRU/159/1.5/S/134378.	Devakar M, 2009, APPL MATH MODEL, V33, P924, DOI 10.1016/j.apm.2007.12.016; ERINGEN AC, 1966, J MATH MECH, V16, P1; Florea O, 2014, OSTEOARTHR CARTILAGE, V22, pS109, DOI 10.1016/j.joca.2014.02.204; Helmy KA, 2002, CAN J PHYS, V80, P1661, DOI 10.1139/P02-054; Helmy KA, 2000, ACTA MECH, V140, P41, DOI 10.1007/BF01175979; HONIG G, 1984, J COMPUT APPL MATH, V10, P113, DOI 10.1016/0377-0427(84)90075-X; Ibrahem FS, 2006, APPL MATH COMPUT, V173, P916, DOI 10.1016/j.amc.2005.04.024; Ibrahem FS, 2005, J APPL MECH-T ASME, V72, P468, DOI 10.1115/1.1875412; Lok YY, 2010, MECCANICA, V45, P187, DOI 10.1007/s11012-009-9236-9; Marin M, 2014, AN STI U OVID CO-MAT, V22, P169, DOI 10.2478/auom-2014-0014; Mekheimer K, 2008, ACTA MECH SINICA-PRC, V24, P637, DOI 10.1007/s10409-008-0185-7; Mekheimer KS, 2008, J APPL MATH, DOI 10.1155/2008/570825; PURI P, 1995, ACTA MECH, V112, P1, DOI 10.1007/BF01177474; Schlichting H, 1979, SERIES MECH ENG; Sharma K, 2014, AN STI U OVID CO-MAT, V22, P151, DOI 10.2478/auom-2014-0040	21	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131860	10.1371/journal.pone.0131860	http://dx.doi.org/10.1371/journal.pone.0131860			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161780	Green Published, Green Submitted, gold			2022-12-26	WOS:000358162300066
J	Mascotti, ML; Lapadula, WJ; Ayub, MJ				Laura Mascotti, Maria; Jesus Lapadula, Walter; Juri Ayub, Maximiliano			The Origin and Evolution of Baeyer-Villiger Monooxygenases (BVMOs): An Ancestral Family of Flavin Monooxygenases	PLOS ONE			English	Article							HORIZONTAL GENE-TRANSFER; ASPERGILLUS-FUMIGATUS AF293; RHODOCOCCUS-JOSTII RHA1; PRODRUG ACTIVATOR ETAA; FLAVOPROTEIN MONOOXYGENASES; MYCOBACTERIUM-TUBERCULOSIS; SUBSTRATE-SPECIFICITY; EUKARYOTIC EVOLUTION; OXYGEN ACTIVATION; PROTEIN-SEQUENCE	The Baeyer-Villiger Monooxygenases (BVMOs) are enzymes belonging to the "Class B" of flavin monooxygenases and are capable of performing exquisite selective oxidations. These enzymes have been studied from a biotechnological perspective, but their physiological substrates and functional roles are widely unknown. Here, we investigated the origin, taxonomic distribution and evolutionary history of the BVMO genes. By using in silico approaches, 98 BVMO encoding genes were detected in the three domains of life: Archaea, Bacteria and Eukarya. We found evidence for the presence of these genes in Metazoa (Hydra vulgaris, Oikopleura dioica and Adineta vaga) and Haptophyta (Emiliania huxleyi) for the first time. Furthermore, a search for other "Class B" monooxygenases (flavoprotein monooxygenases-FMOs - and N-hydroxylating monooxygenases - NMOs) was conducted. These sequences were also found in the three domains of life. Phylogenetic analyses of all "Class B" monooxygenases revealed that NMOs and BVMOs are monophyletic, whereas FMOs form a paraphyletic group. Based on these results, we propose that BVMO genes were already present in the last universal common ancestor (LUCA) and their current taxonomic distribution is the result of differential duplication and loss of paralogous genes.	[Laura Mascotti, Maria; Jesus Lapadula, Walter; Juri Ayub, Maximiliano] Univ Nacl San Luis, IMIBIO SL CONICET, Fac Quim Bioquim & Farm, San Luis, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional de San Luis	Ayub, MJ (corresponding author), Univ Nacl San Luis, IMIBIO SL CONICET, Fac Quim Bioquim & Farm, San Luis, Argentina.	mjuriayub@hotmail.com	; Mascotti, Maria Laura/H-9501-2017	Lapadula, Walter/0000-0003-4180-9490; Juri Ayub, Maximiliano/0000-0002-5787-0993; Mascotti, Maria Laura/0000-0002-5817-4631	CONICET [PIP 0021]; National Agency for Scientific and Technological Promotion (Agencia Nacional de Promocion Cientifica y Tecnologica); FONCyT [PICT 2010-1468]	CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); National Agency for Scientific and Technological Promotion (Agencia Nacional de Promocion Cientifica y Tecnologica); FONCyT(FONCyT)	MJA is a member of the scientific career of the National Council for Research from Argentina (Consejo Nacional de Investigaciones Cientificas y Tecnicas; CONICET). MLM and WJL have postdoctoral and doctoral fellowships, respectively, from CONICET. Grants from CONICET (Grant Code PIP 0021) and the National Agency for Scientific and Technological Promotion (Agencia Nacional de Promocion Cientifica y Tecnologica); FONCyT (Grant Code PICT 2010-1468) to MJA are acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balke K, 2012, ORG BIOMOL CHEM, V10, P6249, DOI 10.1039/c2ob25704a; Beneventi E, 2013, J MOL CATAL B-ENZYM, V98, P145, DOI 10.1016/j.molcatb.2013.10.006; Bisagni S, 2014, AMB EXPRESS, V4, DOI 10.1186/s13568-014-0023-1; Bosserman MA, 2013, ACS CHEM BIOL, V8, P2466, DOI 10.1021/cb400399b; Ceccoli RD, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00025; Chen H, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0239-x; Choi IG, 2007, P NATL ACAD SCI USA, V104, P4489, DOI 10.1073/pnas.0611557104; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Diminic J, 2014, J IND MICROBIOL BIOT, V41, P211, DOI 10.1007/s10295-013-1337-8; Ferroni FM, 2014, J MOL CATAL B-ENZYM, V107, P47, DOI 10.1016/j.molcatb.2014.05.015; Fink MJ, 2011, J MOL CATAL B-ENZYM, V73, P9, DOI 10.1016/j.molcatb.2011.07.003; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Forterre P, 2013, ARCHAEA, V2013, DOI 10.1155/2013/372396; Fraaije MW, 2004, J BIOL CHEM, V279, P3354, DOI 10.1074/jbc.M307770200; Fraaije MW, 2002, FEBS LETT, V518, P43, DOI 10.1016/S0014-5793(02)02623-6; Franceschini S, 2012, BIOCHEMISTRY-US, V51, P7043, DOI 10.1021/bi301072w; Frederick RE, 2014, BIOCHEMISTRY-US, V53, P2007, DOI 10.1021/bi401256b; Furnham N, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002403; Ge RL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2860; Gibson M, 2005, J AM CHEM SOC, V127, P17594, DOI 10.1021/ja055750t; Gladyshev EA, 2008, SCIENCE, V320, P1210, DOI 10.1126/science.1156407; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hu YC, 2014, NAT CHEM BIOL, V10, P552, DOI [10.1038/NCHEMBIO.1527, 10.1038/nchembio.1527]; Huijbers MME, 2014, ARCH BIOCHEM BIOPHYS, V544, P2, DOI 10.1016/j.abb.2013.12.005; Jordan IK, 2002, GENOME RES, V12, P962, DOI 10.1101/gr.87702; Kamerbeek NM, 2003, APPL ENVIRON MICROB, V69, P419, DOI 10.1128/AEM.69.1.419-426.2003; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; Koonin EV, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-64; Krylov DM, 2003, GENOME RES, V13, P2229, DOI 10.1101/gr.1589103; Kurland CG, 2003, P NATL ACAD SCI USA, V100, P9658, DOI 10.1073/pnas.1632870100; Mascotti ML, 2014, BIOCHIMIE, V107, P270, DOI 10.1016/j.biochi.2014.09.005; Laurence M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097876; Leipold F, 2012, APPL MICROBIOL BIOT, V94, P705, DOI 10.1007/s00253-011-3670-z; Leisch H, 2012, APPL ENVIRON MICROB, V78, P2200, DOI 10.1128/AEM.07694-11; Leisch H, 2011, CHEM REV, V111, P4165, DOI 10.1021/cr1003437; Mascotti ML, 2013, AMB EXPRESS, V3, DOI 10.1186/2191-0855-3-33; MEI BG, 1993, P NATL ACAD SCI USA, V90, P903, DOI 10.1073/pnas.90.3.903; Mihovilovic MD, 2005, ANGEW CHEM INT EDIT, V44, P3609, DOI 10.1002/anie.200462964; Minerdi D, 2012, MICROB BIOTECHNOL, V5, P700, DOI 10.1111/j.1751-7915.2012.00356.x; Nasir A, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003452; Noda-Garcia L, 2013, MOL BIOL EVOL, V30, P2024, DOI 10.1093/molbev/mst115; Olucha J, 2011, BIOORG CHEM, V39, P171, DOI 10.1016/j.bioorg.2011.07.006; Orru R, 2010, J BIOL CHEM, V285, P35021, DOI 10.1074/jbc.M110.161372; Pace NR, 2012, P NATL ACAD SCI USA, V109, P1011, DOI 10.1073/pnas.1109716109; Pazmino DET, 2010, CURR OPIN CHEM BIOL, V14, P138, DOI 10.1016/j.cbpa.2009.11.017; Read BA, 2013, NATURE, V499, P209, DOI 10.1038/nature12221; Rebehmed J, 2013, BIOCHIMIE, V95, P1394, DOI 10.1016/j.biochi.2013.03.005; Riebel A, 2012, APPL MICROBIOL BIOT, V95, P1479, DOI 10.1007/s00253-011-3823-0; Riebel A, 2013, J MOL CATAL B-ENZYM, V88, P20, DOI 10.1016/j.molcatb.2012.11.009; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Schlaich NL, 2007, TRENDS PLANT SCI, V12, P412, DOI 10.1016/j.tplants.2007.08.009; Schlenk D, 1998, COMP BIOCHEM PHYS C, V121, P185, DOI 10.1016/S0742-8413(98)10060-9; Szolkowy C, 2009, CHEMBIOCHEM, V10, P1208, DOI 10.1002/cbic.200900011; Tang MC, 2013, ACS CATAL, V3, P444, DOI 10.1021/cs300819e; Weiss M, 2012, APPL ENVIRON MICROB, V78, P8254, DOI 10.1128/AEM.02412-12; Wiemann P, 2013, P NATL ACAD SCI USA, V110, P17065, DOI 10.1073/pnas.1313258110; Woese C, 1998, P NATL ACAD SCI USA, V95, P6854, DOI 10.1073/pnas.95.12.6854; Woese CR, 2002, P NATL ACAD SCI USA, V99, P8742, DOI 10.1073/pnas.132266999	60	33	34	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132689	10.1371/journal.pone.0132689	http://dx.doi.org/10.1371/journal.pone.0132689			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161776	gold, Green Published, Green Submitted			2022-12-26	WOS:000358162300168
J	Azerkan, F; Widmark, C; Sparen, P; Weiderpass, E; Tillgren, P; Faxelid, E				Azerkan, Fatima; Widmark, Catarina; Sparen, Par; Weiderpass, Elisabete; Tillgren, Per; Faxelid, Elisabeth			When Life Got in the Way: How Danish and Norwegian Immigrant Women in Sweden Reason about Cervical Screening and Why They Postpone Attendance	PLOS ONE			English	Article							QUALITATIVE CONTENT-ANALYSIS; PAP-SMEAR; HISPANIC WOMEN; CANCER; ACCULTURATION; PROGRAM; RISK; DISPARITIES; KNOWLEDGE; AGE	Introduction Danish and Norwegian immigrant women in Sweden have an increased risk of cervical cancer compared to Swedish-born women. In addition, Danish and Norwegian immigrant women follow the national recommendations for attendance at cervical screening to much lesser extent than Swedish-born women. The aim of this study was to explore how Danish and Norwegian immigrant women in Sweden reason about attending cervical screening, focusing on women's perceptions as to why they and their compatriots do not attend. Methods Eight focus group discussions (FGDs) were conducted with Danish and Norwegian immigrant women living in Stockholm. The women were between 26 and 66 years of age at the time of the FGDs, and were aged between <1 and 48 years old when they immigrated to Sweden. A FGD guide was used, which included questions related to cervical screening, and obstacles and motivators to attend cervical screening. The FGDs were tape recorded and transcribed, and the results analysed according to the principles of qualitative content analysis. Results The main theme was "Women have a comprehensive rationale for postponing cervical screening, yet do not view themselves as non-attenders". Investigation of women's rationale for non-attendance after being invited to cervical screening revealed some complex reasons related to immigration itself, including competing needs, organisational and structural factors and differences in mentality, but also reasons stemming from other factors. Postponing attendance at cervical screening was the category that linked all these factors as the reasons to why women did not attend to cervical screening according to the recommendations of the authorities. Conclusions The rationale used to postpone cervical screening, in combination with the fact that women do not consider themselves to be non-attenders, indicates that they have not actively taken a stance against cervical screening, and reveals an opportunity to motivate these women to attend.	[Azerkan, Fatima; Sparen, Par; Weiderpass, Elisabete] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Widmark, Catarina] Karolinska Univ Hosp, Dept Qual & Patient Safety, Stockholm, Sweden; [Widmark, Catarina] Karolinska Inst, Med Management Ctr, Dept Learning Informat Management & Eth, Stockholm, Sweden; [Weiderpass, Elisabete] Arctic Univ Norway, Univ Tromso, Fac Hlth Sci, Dept Community Med, Tromso, Norway; [Weiderpass, Elisabete] Canc Registry Norway, Dept Res, Oslo, Norway; [Weiderpass, Elisabete] Samfundet Folkhalsan, Helsinki, Finland; [Tillgren, Per] Malardalen Univ, Sch Hlth Care & Social Welf, Vasteras, Sweden; [Tillgren, Per] Karolinska Inst, Dept Publ Hlth Sci, Div Social Med, Stockholm, Sweden; [Faxelid, Elisabeth] Karolinska Inst, Dept PublicHlth Sci, Global Hlth IHCAR, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; UiT The Arctic University of Tromso; University of Oslo; Samfundet Folkhalsan; Malardalen University; Karolinska Institutet; Karolinska Institutet	Azerkan, F (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden.	fatimaazerkan@gmail.com	Weiderpass, Elisabete/AAP-2747-2021; Weiderpass, Elisabete/M-4029-2016	Weiderpass, Elisabete/0000-0003-2237-0128; Weiderpass, Elisabete/0000-0003-2237-0128; Sparen, Par/0000-0002-5184-8971	Swedish Research Council [K2010-70X-21418-01-3, 2008-4438, 521-2009-4410]; Swedish Council for Working Life and Social Research [2007-2029]; Health Care Sciences Postgraduate School, Karolinska Institutet [2/2005]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Health Care Sciences Postgraduate School, Karolinska Institutet	This work was supported by The Swedish Research Council, (grant number: K2010-70X-21418-01-3, http://www.vr.se/) to FA, EW. The Swedish Research Council, (grant number: 2008-4438, http://www.vr.se/); The Swedish Council for Working Life and Social Research, (grant number: 2007-2029, http://fas.se) to CW. The Swedish Research Council, (grant number 521-2009-4410, http://www.vr.se/); Health Care Sciences Postgraduate School, Karolinska Institutet, (grant number: "Karolinska Institutet FFU ordforandebeslut Nr 2/2005", www.ki.se) to FA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allahverdipour H, 2008, WOMEN HEALTH, V47, P23, DOI 10.1080/03630240802132302; Anttila A, 2009, EUR J CANCER, V45, P2649, DOI 10.1016/j.ejca.2009.07.020; Anttila A, 2009, EUR J CANCER, V45, P2685, DOI 10.1016/j.ejca.2009.07.017; Arbyn M, 2009, EUR J CANCER, V45, P2671, DOI 10.1016/j.ejca.2009.07.016; Austin LT, 2002, WOMEN HEALTH ISS, V12, P122, DOI 10.1016/S1049-3867(02)00132-9; Azerkan F, 2008, INT J CANCER, V123, P2664, DOI 10.1002/ijc.23843; Azerkan F, 2012, INT J CANCER, V130, P937, DOI 10.1002/ijc.26084; Barbour R., 2007, DOING FOCUS GROUPS; Bergstrom R, 1999, BRIT J CANCER, V81, P159, DOI 10.1038/sj.bjc.6690666; Blomberg K, 2008, PSYCHO-ONCOLOGY, V17, P561, DOI 10.1002/pon.1270; Blomberg K, 2011, ACTA ONCOL, V50, P112, DOI 10.3109/0284186X.2010.528790; Blomberg K, 2011, CANCER NURS, V34, pE11, DOI 10.1097/NCC.0b013e3181f70f83; Brown DR, 2000, ANN EPIDEMIOL, V10, pS13, DOI 10.1016/S1047-2797(00)00197-6; Caplan Susan, 2007, Policy Polit Nurs Pract, V8, P93, DOI 10.1177/1527154407301751; Documet Patricia I, 2004, J Immigr Health, V6, P5, DOI 10.1023/B:JOIH.0000014638.87569.2e; Donnelly TT, 2007, NURS INQ, V14, P2, DOI 10.1111/j.1440-1800.2007.00347.x; Elo S, 2008, J ADV NURS, V62, P107, DOI 10.1111/j.1365-2648.2007.04569.x; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Gupta Abha, 2002, Health Care Women Int, V23, P123, DOI 10.1080/073993302753429004; GUSTAFSSON L, 1990, BRIT J CANCER, V61, P903, DOI 10.1038/bjc.1990.202; Hansen BT, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-264; Harmon MP, 1996, WOMEN HEALTH, V24, P37; Idestrom M, 2002, ACTA OBSTET GYN SCAN, V81, P962, DOI 10.1034/j.1600-0412.2002.811011.x; Karwalajtys TL, 2010, CAN FAM PHYSICIAN, V56, pE130; Kaufert PA, 1997, J PSYCHOSOM OBST GYN, V18, P81, DOI 10.3109/01674829709085573; Krueger RA, 1994, FOCUS GROUPS PRACTIC, V2nd; Lum T, 2004, GERONTOLOGIST, V44, P391; MAHLCK CG, 1994, INT J GYNECOL OBSTET, V44, P267, DOI 10.1016/0020-7292(94)90177-5; Mandelblatt J S, 2000, J Am Med Womens Assoc (1972), V55, P210; Martin LM, 1996, AM J PREV MED, V12, P82, DOI 10.1016/S0749-3797(18)30349-0; Morgan D.L, 1996, FOCUS GROUPS QUALITA; Nordic Council of Ministers, 2011, NORD STAT YB, V49; Nygard JF, 2002, J MED SCREEN, V9, P86, DOI 10.1136/jms.9.2.86; Oscarsson MG, 2008, J PSYCHOSOM OBST GYN, V29, P23, DOI 10.1080/01674820701504619; Owusu GA, 2005, MATERN CHILD HLTH J, V9, P285, DOI 10.1007/s10995-005-0004-8; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pol Louis G, 2002, J Immigr Health, V4, P103, DOI 10.1023/A:1014502710289; Shin Hosung, 2005, J Immigr Health, V7, P65, DOI 10.1007/s10903-005-2638-4; Sigurdsson K, 1999, Laeknabladid, V85, P862; SIGURDSSON K, 1993, INT J CANCER, V54, P563, DOI 10.1002/ijc.2910540408; SUAREZ L, 1994, AM J PUBLIC HEALTH, V84, P742, DOI 10.2105/AJPH.84.5.742; Swedish Cervical Cancer Screening Register, 2008, CERV CANC SCR SWED 2; Swedish Government Inquiries, 2009, NAT CANC STRAT FUT S; Swedish Tax Agency, 2007, 717B SKV SWED TAX AG; von Euler-Chelpin M, 2011, SCAND J PUBLIC HEALT, V39, P158, DOI 10.1177/1403494811401479; WIDMARK C, 2008, INT J QUAL STUD HEAL, V3, P89, DOI DOI 10.3402/QHW.V3I2.4978; World Health Organization, 2005, B WHO BLT, V84, P81	48	21	21	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2015	10	7							e0107624	10.1371/journal.pone.0107624	http://dx.doi.org/10.1371/journal.pone.0107624			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1EW	26158449	gold, Green Published, Green Submitted			2022-12-26	WOS:000358161200001
J	Benn, P; Curnow, KJ; Chapman, S; Michalopoulos, SN; Hornberger, J; Rabinowitz, M				Benn, Peter; Curnow, Kirsten J.; Chapman, Steven; Michalopoulos, Steven N.; Hornberger, John; Rabinowitz, Matthew			An Economic Analysis of Cell-Free DNA Non-Invasive Prenatal Testing in the US General Pregnancy Population	PLOS ONE			English	Article							COST-EFFECTIVENESS ANALYSIS; DOWN-SYNDROME; HIGH-RISK; STRATEGIES; SERUM; 1ST-TRIMESTER; ANEUPLOIDIES	Objective Analyze the economic value of replacing conventional fetal aneuploidy screening approaches with non-invasive prenatal testing (NIPT) in the general pregnancy population. Methods Using decision-analysis modeling, we compared conventional screening to NIPT with cellfree DNA (cfDNA) analysis in the annual US pregnancy population. Sensitivity and specificity for fetal aneuploidies, trisomy 21, trisomy 18, trisomy 13, and monosomy X, were estimated using published data and modeling of both first-and second trimester screening. Costs were assigned for each prenatal test component and for an affected birth. The overall cost to the healthcare system considered screening costs, the number of aneuploid cases detected, invasive procedures performed, procedure-related euploid losses, and affected pregnancies averted. Sensitivity analyses evaluated the effect of variation in parameters. Costs were reported in 2014 US Dollars. Results Replacing conventional screening with NIPT would reduce healthcare costs if it can be provided for $744 or less in the general pregnancy population. The most influential variables were timing of screening entry, screening costs, and pregnancy termination rates. Of the 13,176 affected pregnancies undergoing screening, NIPT detected 96.5% (12,717/13,176) of cases, compared with 85.9% (11,314/13,176) by conventional approaches. NIPT reduced invasive procedures by 60.0%, with NIPT and conventional methods resulting in 24,596 and 61,430 invasive procedures, respectively. The number of procedure-related euploid fetal losses was reduced by 73.5% (194/ 264) in the general screening population. Conclusion Based on our analysis, universal application of NIPT would increase fetal aneuploidy detection rates and can be economically justified. Offering this testing to all pregnant women is associated with substantial prenatal healthcare benefits.	[Benn, Peter] Univ Connecticut, Div Human Genet, Dept Genet & Genome Sci, Ctr Hlth, Farmington, CT 06030 USA; [Curnow, Kirsten J.] Illumina Inc, San Francisco, CA USA; [Chapman, Steven; Rabinowitz, Matthew] Natera Inc, San Carlos, CA USA; [Michalopoulos, Steven N.] Cedar Associates, Menlo Pk, CA USA; [Hornberger, John] Cedar Associates, Menlo Pk, CA USA; [Hornberger, John] Stanford Univ, Stanford, CA 94305 USA	University of Connecticut; Illumina; Stanford University	Benn, P (corresponding author), Univ Connecticut, Div Human Genet, Dept Genet & Genome Sci, Ctr Hlth, Farmington, CT 06030 USA.	benn@nso1.uchc.edu	Michalopoulos, Efstathios/AAA-4674-2020; Hornberger, John/M-4932-2019		Natera, Inc.	Natera, Inc.	This study was funded by Natera, Inc. (http://www.natera.com). Cedar Associates received research funding to develop the economic analysis and manuscript. Peter Benn, Steven Chapman, John Hornberger, and Matthew Rabinowitz were involved in the initial design of the study. All authors contributed to the analysis and the preparation of the manuscript.	ACOG Committee on Practice Bulletins, 2007, Obstet Gynecol, V109, P217; Agency for Healthcare Research and Quality, 2014, HEALTHC COST UT PROJ; American College of Obstetricians and Gynecologists Committee on Genetics, 2012, Obstet Gynecol, V120, P1532, DOI 10.1097/01.AOG.0000423819.85283.f4; Ayres AC, 2014, AUST NZ J OBSTET GYN, V54, P412, DOI 10.1111/ajo.12223; Benn P, 2005, PRENATAL DIAG, V25, P645, DOI 10.1002/pd.1215; Benn P, 2015, PRENATAL DIAG, V35, P725, DOI 10.1002/pd.4608; Benn P, 2014, J CLIN MED, V3, P537, DOI 10.3390/jcm3020537; Benn P, 2013, PRENATAL DIAG, V33, P622, DOI 10.1002/pd.4139; Beulen L, 2014, EUR J OBSTET GYN R B, V182, P53, DOI 10.1016/j.ejogrb.2014.08.028; Bianchi DW, 2014, NEW ENGL J MED, V370, P799, DOI 10.1056/NEJMoa1311037; Biggio JR, 2004, AM J OBSTET GYNECOL, V190, P721, DOI 10.1016/j.ajog.2003.09.028; Centers for Disease Control and Prevention, 2014, VIT STATS BIRTHS 201; Centers for Medicare and Medicaid Services, 2014, PHYS FEE SCHED 2014; Cuckle H, 2013, PRENATAL DIAG, V33, P636, DOI 10.1002/pd.4157; Dar P, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.08.006; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI DOI 10.1007/s00134-012-2769-8; Evans MI, 2015, ULTRASOUND OBST GYN, V45, P74, DOI 10.1002/uog.14693; Fairbrother G, 2016, J MATERN-FETAL NEO M, V29, P1160, DOI 10.3109/14767058.2015.1038703; Garfield SS, 2012, J MANAGED CARE MED, V15, P34; Gregg AR, 2013, GENET MED, V15, P395, DOI 10.1038/gim.2013.29; Martin JA, 2013, BIRTHS FINAL DATA 20; Morris S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093559; Neyt M, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005922; Nicolaides KH, 2014, FETAL DIAGN THER, V35, P212, DOI 10.1159/000355655; Norton ME, 2015, NEW ENGL J MED, V372, P1589, DOI 10.1056/NEJMoa1407349; O'Leary P, 2013, AUST NZ J OBSTET GYN, V53, P425, DOI 10.1111/ajo.12136; Ohno M, 2013, PRENATAL DIAG, V33, P630, DOI 10.1002/pd.4156; Okun N, 2014, PRENATAL DIAG, V34, P350, DOI 10.1002/pd.4311; Palomaki GE, 2015, PRENATAL DIAG, V35, P289, DOI 10.1002/pd.4541; Palomaki GE, 2013, ARCH PATHOL LAB MED, V137, P921, DOI 10.5858/arpa.2012-0319-CP; Palomaki GE, 2011, GENET MED, V13, P913, DOI 10.1097/GIM.0b013e3182368a0e; Pergament E, 2014, OBSTET GYNECOL, V124, P210, DOI 10.1097/AOG.0000000000000363; Rava RP, 2014, CLIN CHEM, V60, P243, DOI 10.1373/clinchem.2013.207951; Saenger P, 2001, J CLIN ENDOCR METAB, V86, P3061, DOI 10.1210/jc.86.7.3061; Shaffer BL, 2006, PRENATAL DIAG, V26, P667, DOI 10.1002/pd.1462; Song K, 2013, J MATERN-FETAL NEO M, V26, P1180, DOI 10.3109/14767058.2013.770464; Spencer K, 2002, PRENATAL DIAG, V22, P877, DOI 10.1002/pd.420; WAITZMAN NJ, 1994, INQUIRY-J HEALTH CAR, V31, P188; Wald NJ, 2003, J MED SCREEN, V10, P56, DOI 10.1258/096914103321824133; Walker BS, 2015, PRENATAL DIAG, V35, P440, DOI 10.1002/pd.4511; Wallerstein R, 2014, J PREGNANCY, V2014, DOI 10.1155/2014/962720; Zhang H, 2015, ULTRASOUND OBST GYN, V45, P530, DOI 10.1002/uog.14792	42	33	34	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2015	10	7							e0132313	10.1371/journal.pone.0132313	http://dx.doi.org/10.1371/journal.pone.0132313			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EW	26158465	Green Published, Green Submitted, gold			2022-12-26	WOS:000358161200050
J	Sithambaram, S; Hilmi, I; Goh, KL				Sithambaram, Suresh; Hilmi, Ida; Goh, Khean-Lee			The Diagnostic Accuracy of the M2 Pyruvate Kinase Quick Stool Test-A Rapid Office Based Assay Test for the Detection of Colorectal Cancer	PLOS ONE			English	Article							OCCULT BLOOD-TEST; SENSITIVE SCREENING TOOL; ISOENZYME TYPE M2; PROSPECTIVE MULTICENTER; TUMOR M2-PK; POPULATION; PERFORMANCE; BIOMARKER; NEOPLASIA; ADENOMAS	Background M2 pyruvate kinase (M2PK) is an oncoprotein secreted by colorectal cancers in stools. This the first report on the accuracy of a rapid stool test in the detection of colorectal cancer (CRC). Objective To determine the sensitivity, specificity and positive and negative predictive value of a rapid, point of care stool test M2 PK-the M2PK Quick. Methods Consecutive cases of endoscopically diagnosed and histological proven CRC were recruited. Stools were collected by patients and tested with the immunochromatographic M2PK Quick Test (Schebo Biotech AC, Giessen, Germany). Controls were consecutively chosen from patients without any significant colorectal or gastrointestinal disease undergoing colonoscopy. CRC was staged according to the AJCC staging manual (7th Edition) and location of tumor defined as proximal or distal. Results The sensitivity, specificity, positive predictive value, negative predictive value and overall accuracy were: 93%, 97.5%, 94.9%, 96.5% and 96.0% respectively. The positive predictive value for proximal tumors was significantly lower compared to distal tumors. No differences were seen between the different stages of the tumor. Conclusions The M2-PK Quick, rapid, point-of-care test is a highly accurate test in the detection of CRC. It is easy and convenient to perform and a useful diagnostic test for the detection of CRC in a clinical practice setting.	[Sithambaram, Suresh; Hilmi, Ida; Goh, Khean-Lee] Univ Malaya, Dept Med, Div Gastroenterol & Hepatol, Kuala Lumpur, Malaysia	Universiti Malaya	Goh, KL (corresponding author), Univ Malaya, Dept Med, Div Gastroenterol & Hepatol, Kuala Lumpur, Malaysia.	klgoh56@gmail.com	Goh, Khean-Lee/B-6404-2009; Hilmi, Ida/AAN-7129-2020	Goh, Khean-Lee/0000-0002-9965-1561; 	Alere Company	Alere Company	The study was funded by Alere Company. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah Murdhani, 2012, Acta Med Indones, V44, P94; Allison JE, 1996, NEW ENGL J MED, V334, P155, DOI 10.1056/NEJM199601183340304; Hardt PD, 2004, BRIT J CANCER, V91, P980, DOI 10.1038/sj.bjc.6602033; Hardt PD, 2003, ANTICANCER RES, V23, P851; Haug U, 2008, BRIT J CANCER, V99, P133, DOI 10.1038/sj.bjc.6604427; Imperiale TF, 2007, ANN INTERN MED, V146, P309, DOI 10.7326/0003-4819-146-4-200702200-00013; Koss K, 2008, COLORECTAL DIS, V10, P244, DOI 10.1111/j.1463-1318.2007.01334.x; Kumar Y, 2007, EUR J GASTROEN HEPAT, V19, P265, DOI 10.1097/MEG.0b013e3280102f78; Leen R, 2014, EUR J GASTROEN HEPAT, V26, P514, DOI 10.1097/MEG.0000000000000025; Levi Z, 2007, ANN INTERN MED, V146, P244, DOI 10.7326/0003-4819-146-4-200702200-00003; Mazurek S, 2005, SEMIN CANCER BIOL, V15, P300, DOI 10.1016/j.semcancer.2005.04.009; Morikawa T, 2005, GASTROENTEROLOGY, V129, P422, DOI 10.1053/j.gastro.2005.05.056; Mulder SA, 2007, EUR J GASTROEN HEPAT, V19, P878, DOI 10.1097/MEG.0b013e3282cfa49c; Naumann M, 2004, DEUT MED WOCHENSCHR, V129, P1806, DOI 10.1055/s-2004-829033; Shastri YM, 2008, AM J GASTROENTEROL, V103, P1496, DOI 10.1111/j.1572-0241.2008.01824.x; Shastri YM, 2006, INT J CANCER, V119, P2651, DOI 10.1002/ijc.22243; Shastri YM, 2008, CLIN LAB, V54, P389; Tonus C, 2006, WORLD J GASTROENTERO, V12, P7007, DOI 10.3748/wjg.v12.i43.7007; Tonus C, 2012, WORLD J GASTROENTERO, V18, P4004, DOI 10.3748/wjg.v18.i30.4004; Vilkin A, 2005, AM J GASTROENTEROL, V100, P2519, DOI 10.1111/j.1572-0241.2005.00231.x; Vogel T, 2005, DEUT MED WOCHENSCHR, V130, P872, DOI 10.1055/s-2005-865100; Walkowiak J, 2005, SCAND J GASTROENTERO, V40, P1493, DOI 10.1080/00365520500319112; Zappa M, 2001, INT J CANCER, V92, P151, DOI 10.1002/1097-0215(200102)9999:9999<::AID-IJC1149>3.3.CO;2-Y	23	23	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2015	10	7							e0131616	10.1371/journal.pone.0131616	http://dx.doi.org/10.1371/journal.pone.0131616			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EW	26158845	Green Published, gold, Green Submitted			2022-12-26	WOS:000358161200034
J	Hegg, JC; Giarrizzo, T; Kennedy, BP				Hegg, Jens C.; Giarrizzo, Tommaso; Kennedy, Brian P.			Diverse Early Life-History Strategies in Migratory Amazonian Catfish: Implications for Conservation and Management	PLOS ONE			English	Article							BRACHYPLATYSTOMA-ROUSSEAUXII; HYDROELECTRIC DEVELOPMENT; FISH; RIVER; CHALLENGES; ISOTOPES; BRAZIL; WATER; BIODIVERSITY; SR-87/SR-86	Animal migrations provide important ecological functions and can allow for increased biodiversity through habitat and niche diversification. However, aquatic migrations in general, and those of the world's largest fish in particular, are imperiled worldwide and are often poorly understood. Several species of large Amazonian catfish carry out some of the longest freshwater fish migrations in the world, travelling from the Amazon River estuary to the Andes foothills. These species are important apex predators in the main stem rivers of the Amazon Basin and make up the region's largest fishery. They are also the only species to utilize the entire Amazon Basin to complete their life cycle. Studies indicate both that the fisheries may be declining due to overfishing, and that the proposed and completed dams in their upstream range threaten spawning migrations. Despite this, surprisingly little is known about the details of these species' migrations, or their life history. Otolith microchemistry has been an effective method for quantifying and reconstructing fish migrations worldwide across multiple spatial scales and may provide a powerful tool to understand the movements of Amazonian migratory catfish. Our objective was to describe the migratory behaviors of the three most populous and commercially important migratory catfish species, Dourada (Brachyplatystoma rousseauxii), Piramutaba (Brachyplatystoma vaillantii), and Piraiba (Brachyplatystoma filamentosum). We collected fish from the mouth of the Amazon River and the Central Amazon and used strontium isotope signatures (Sr-87/Sr-86) recorded in their otoliths to determine the location of early rearing and subsequent. Fish location was determined through discriminant function classification, using water chemistry data from the literature as a training set. Where water chemistry data was unavailable, we successfully in predicted 87Sr/86Sr isotope values using a regression-based approach that related the geology of the upstream watershed to the Sr isotope ratio. Our results provide the first reported otolith microchemical reconstruction of Brachyplatystoma migratory movements in the Amazon Basin. Our results indicate that juveniles exhibit diverse rearing strategies, rearing in both upstream and estuary environments. This contrasts with the prevailing understanding that juveniles rear in the estuary before migrating upstream; however, it is supported by some fisheries data that has indicated the presence of alternate spawning and rearing life-histories. The presence of alternate juvenile rearing strategies may have important implications for conservation and management of the fisheries in the region.	[Hegg, Jens C.; Kennedy, Brian P.] Univ Idaho, Dept Fish & Wildlife Sci, Moscow, ID 83843 USA; [Giarrizzo, Tommaso] Fed Univ Para, UFPA, Lab Biol Pesqueira Manejo Recursos Aquat, BR-66059 Belem, PA, Brazil; [Kennedy, Brian P.] Univ Idaho, Dept Geol Sci, Moscow, ID 83843 USA; [Kennedy, Brian P.] Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA	Idaho; University of Idaho; Universidade Federal do Para; Idaho; University of Idaho; Idaho; University of Idaho	Hegg, JC (corresponding author), Univ Idaho, Dept Fish & Wildlife Sci, Moscow, ID 83843 USA.	hegg1432@vandals.uidaho.edu	Hegg, Jens/G-3380-2018; Giarrizzo, Tommaso/G-8482-2016	Hegg, Jens/0000-0003-0125-9287; Giarrizzo, Tommaso/0000-0002-5116-5206	CNPq [308278/2012-7]; CAPES	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Giarrizzo received a productivity grant from CNPq (process: 308278/2012-7) and was funded by CAPES (PNPD and Pro-Amazonia: biodiversidade e sustentabilidade), which were used for sample permitting and collection. All other research activities were completed without specific funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cordoba EA, 2013, NEOTROP ICHTHYOL, V11, P637, DOI 10.1590/S1679-62252013000300017; Agudelo E, 2000, BAGRES AMAZONIA COLO; Allan JD, 2005, BIOSCIENCE, V55, P1041, DOI 10.1641/0006-3568(2005)055[1041:OOIW]2.0.CO;2; Alonso JC, 2002, PADRAO ESPACO TEMPOR; Queiroz Maria Mireide Andrade, 2009, Acta Amaz., V39, P943, DOI 10.1590/S0044-59672009000400022; Angelini R, 2006, AFR J AGR RES, V1, P151; Barnett-Johnson R, 2008, LIMNOL OCEANOGR, V53, P1633, DOI 10.4319/lo.2008.53.4.1633; Barthem R., 1997, CATFISH CONNECTION E; BARTHEM RB, 1991, BIOL CONSERV, V55, P339, DOI 10.1016/0006-3207(91)90037-A; Barthem Ronaldo Borges, 1995, P329; Bataille CP, 2012, CHEM GEOL, V304, P39, DOI 10.1016/j.chemgeo.2012.01.028; Batista JS, 2006, GENET MOL RES, V5, P723; Bauer S, 2014, SCIENCE, V344, P54, DOI 10.1126/science.1242552; Beechie T, 2006, BIOL CONSERV, V130, P560, DOI 10.1016/j.biocon.2006.01.019; Bouchez J, 2010, EARTH PLANET SC LETT, V290, P37, DOI 10.1016/j.epsl.2009.11.054; Bowlin MS, 2010, INTEGR COMP BIOL, V50, P261, DOI 10.1093/icb/icq013; Burke JL, 2004, LIFE HIST JUVENILE C; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Calcagno V, 2010, J STAT SOFTW, V34, P1; Carpenter SR, 2011, ANNU REV ENV RESOUR, V36, P75, DOI 10.1146/annurev-environ-021810-094524; Carvajal F, 2013, MADERA BASIN MONTPEL, V2; Cohen K.M., 2013, INT CHRONOSTRATIGRAP; Collins SM, 2013, T AM FISH SOC, V142, P1192, DOI 10.1080/00028487.2013.804005; Copeland T, 2009, CAN J FISH AQUAT SCI, V66, P1658, DOI 10.1139/F09-110; Crook DA, 2013, CAN J FISH AQUAT SCI, V70, P953, DOI 10.1139/cjfas-2012-0504; de Merona B, 2001, ENVIRON BIOL FISH, V60, P375, DOI 10.1023/A:1011033025706; Dudgeon D, 2011, J FISH BIOL, V79, P1487, DOI 10.1111/j.1095-8649.2011.03086.x; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; FabrU N.N., 2005, MANEJO PESCA GRANDES; Faure G., 2004, ISOTOPES PRINCIPLES; Fearnside PM, 2006, ENVIRON MANAGE, V38, P705, DOI 10.1007/s00267-005-0295-y; Fearnside PM, 2014, ENVIRON SCI POLICY, V38, P164, DOI 10.1016/j.envsci.2013.11.004; Finer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035126; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Forero J, 2013, WASHINGTON POST; Freeman MC, 2003, AM FISH S S, V35, P255; Gaillardet J, 1997, CHEM GEOL, V142, P141, DOI 10.1016/S0009-2541(97)00074-0; Garcez RCS, 2014, ECOL FRESHW FISH; Vasquez AG, 2009, J FISH BIOL, V75, P2527, DOI 10.1111/j.1095-8649.2009.02444.x; Godoy M.P, 1979, B FCAP, V11, P3; Hamann EJ, 2012, ECOLOGY, V93, P733, DOI 10.1890/11-1009.1; Hegg JC, 2013, CHEM GEOL, V360, P89, DOI 10.1016/j.chemgeo.2013.10.010; Hegg JC, 2013, OECOLOGIA, V172, P1017, DOI 10.1007/s00442-012-2564-9; Hilborn R, 2003, P NATL ACAD SCI USA, V100, P6564, DOI 10.1073/pnas.1037274100; Hobbs JA, 2010, ENVIRON BIOL FISH, V89, P557, DOI 10.1007/s10641-010-9672-3; Hobson KA, 2010, ISOSCAPES: UNDERSTANDING MOVEMENT, PATTERN, AND PROCESS ON EARTH THROUGH ISOTOPE MAPPING, P273, DOI 10.1007/978-90-481-3354-3_13; Hogan Z, 2007, J FISH BIOL, V71, P818, DOI 10.1111/j.1095-8649.2007.01549.x; Hughes JM, 2014, MOL ECOL, V23, P1000, DOI 10.1111/mec.12661; JICA, 1998, FISH RES STUD AM TOC FISH RES STUD AM TOC; Jimenez EA, 2013, BRAZ J OCEANOGR, V61, P129, DOI 10.1590/S1679-87592013000200005; Junk WJ, 2011, WETLANDS, V31, P623, DOI 10.1007/s13157-011-0190-7; Kennedy BP, 2002, CAN J FISH AQUAT SCI, V59, P925, DOI [10.1139/f02-070, 10.1139/F02-070]; Kennedy BP, 1997, NATURE, V387, P766, DOI 10.1038/42835; Kennedy BP, 2000, CAN J FISH AQUAT SCI, V57, P2280, DOI 10.1139/cjfas-57-11-2280; Killick R, 2014, J STAT SOFTW, V58, P1; Lehner B., 2008, EOS T AM GEOPHYS UN, V89, P93, DOI [10.1029/2008EO100001, DOI 10.1029/2008EO100001, DOI 10.1111/j.1469-8137.2009.03092.x]; Muhlfeld CC, 2012, CAN J FISH AQUAT SCI, V69, P906, DOI 10.1139/F2012-033; Petrere M, 2004, REV FISH BIOL FISHER, V14, P403, DOI 10.1007/s11160-004-8362-7; Pikitch EK, 2005, FISH FISH, V6, P233, DOI 10.1111/j.1467-2979.2005.00190.x; Pirker LEM, 2008, MORFOMETRIA DESCRICA; PIRKER LEM, 2001, DETERMINACAO IDADE C; Poiani KA, 2000, BIOSCIENCE, V50, P133, DOI 10.1641/0006-3568(2000)050[0133:BCAMSF]2.3.CO;2; Pompeu PS, 2012, RIVER RES APPL, V28, P504, DOI 10.1002/rra.1557; Rosenberg DM, 2000, BIOSCIENCE, V50, P746, DOI 10.1641/0006-3568(2000)050[0746:GSEEOH]2.0.CO;2; Santos RV, 2013, HYDROL PROCESS; Secor DH, 1991, MANUAL OTOLITH REMOV, V1, P85; SIOLI HARALD, 1956, BOL TECN INST AGRON NORTE [BELEM], V32, P117; Stone R, 2007, SCIENCE, V316, P1684, DOI 10.1126/science.316.5832.1684; Tang KS, 1996, IEEE SIGNAL PROC MAG, V13, P22, DOI 10.1109/79.543973; Tavener B, 2012, RIO TIMES; Thorrold SR, 2001, SCIENCE, V291, P297, DOI 10.1126/science.291.5502.297; Tockner K., 2011, Ecohydrology and Hydrobiology, V11, P167; USGS, 1996, GTOPO30 30 ARC 2 EL; USGS, 1999, GEOL MAP AM REG; Walther BD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018351; Webster MS, 2002, TRENDS ECOL EVOL, V17, P76, DOI 10.1016/S0169-5347(01)02380-1; Wilcove DS, 2008, PLOS BIOL, V6, P1361, DOI 10.1371/journal.pbio.0060188; Winemiller KO, 2005, CAN J FISH AQUAT SCI, V62, P872, DOI 10.1139/F05-040	78	38	40	1	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0129697	10.1371/journal.pone.0129697	http://dx.doi.org/10.1371/journal.pone.0129697			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26153984	Green Published, Green Submitted, gold			2022-12-26	WOS:000358159700016
J	Kalo, D; Hadas, R; Furman, O; Ben-Ari, J; Maor, Y; Patterson, DG; Tomey, C; Roth, Z				Kalo, Dorit; Hadas, Ron; Furman, Ori; Ben-Ari, Julius; Maor, Yehoshua; Patterson, Donald G.; Tomey, Cynthia; Roth, Zvi			Carryover Effects of Acute DEHP Exposure on Ovarian Function and Oocyte Developmental Competence in Lactating Cows	PLOS ONE			English	Article							DI(2-ETHYLHEXYL) PHTHALATE DEHP; IN-VITRO MATURATION; DI-(2-ETHYLHEXYL) PHTHALATE; MONO-(2-ETHYLHEXYL) PHTHALATE; MONO(2-ETHYLHEXYL) PHTHALATE; DIETHYLHEXYL PHTHALATE; REPRODUCTIVE HORMONES; LIQUID-CHROMATOGRAPHY; DISRUPTING COMPOUNDS; INDUCED MASTITIS	We examined acute exposure of Holstein cows to di(2-ethylhexyl)phthalate (DEHP) and its carryover effects on ovarian function and oocyte developmental competence. Synchronized cows were tube-fed with water or 100 mg/kg DEHP per day for 3 days. Blood, urine and milk samples were collected before, during and after DEHP exposure to examine its clearance pattern. Ovarian follicular dynamics was monitored through an entire estrous cycle by ultrasonographic scanning. Follicular fluids were aspirated from the preovulatory follicles on days 0 and 29 of the experiment and analyzed for phthalate metabolites and estradiol concentration. The aspirated follicular fluid was used as maturation medium for in-vitro embryo production. Findings revealed that DEHP impairs the pattern of follicular development, with a prominent effect on dominant follicles. The diameter and growth rate of the first- and second-wave dominant follicles were lower (P < 0.05) in the DEHP-treated group. Estradiol concentration in the follicular fluid was lower in the DEHP-treated group than in controls, and associated with a higher number of follicular pathologies (follicle diameter >25 mm). The pattern of growth and regression of the corpus luteum differed between groups, with a lower volume in the DEHP-treated group (P < 0.05). The follicular fluid aspirated from the DEHP-treated group, but not the controls, contained 23 nM mono(2-ethylhexyl) phthalate. Culturing of cumulus oocyte complexes in the follicular fluid aspirated from DEHP-treated cows reduced the proportion of oocytes progressing to the MII stage, and the proportions of 2- to 4-cell-stage embryos (P < 0.04) and 7-day blastocysts (P < 0.06). The results describe the risk associated with acute exposure to DEHP and its deleterious carryover effects on ovarian function, nuclear maturation and oocyte developmental competence.	[Kalo, Dorit; Hadas, Ron; Furman, Ori; Roth, Zvi] Hebrew Univ Jerusalem, Dept Anim Sci, Robert H Smith Fac Agr Food & Environm, IL-76100 Rehovot, Israel; [Kalo, Dorit; Maor, Yehoshua; Roth, Zvi] Hebrew Univ Jerusalem, Ctr Excellence Agr & Environm Hlth, Robert H Smith Fac Agr Food & Environm, IL-76100 Rehovot, Israel; [Ben-Ari, Julius] Hebrew Univ Jerusalem, Interdept Equipment Facil, Robert H Smith Fac Agr Food & Environm, IL-76100 Rehovot, Israel; [Patterson, Donald G.; Tomey, Cynthia] AXYS Analyt Serv Inc, Sidney, BC V8L 5X2, Canada	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem	Roth, Z (corresponding author), Hebrew Univ Jerusalem, Dept Anim Sci, Robert H Smith Fac Agr Food & Environm, IL-76100 Rehovot, Israel.	roth@agri.huji.ac.il	Roth, Zvi/AAA-1581-2020; Roth, Zvi/R-8025-2019		Environment and Health Fund, Jerusalem, Israel; Israeli Dairy Board [821-130-10]; AXYS Analytical Services Inc.	Environment and Health Fund, Jerusalem, Israel; Israeli Dairy Board; AXYS Analytical Services Inc.	The study was conducted in the framework of The Hebrew University Center of Excellence in Agriculture and Environmental Health funded by the Environment and Health Fund, Jerusalem, Israel, and by the Israeli Dairy Board (project #821-130-10). The author who received the funding is ZR. AXYS Analytical Services Inc., provided support in the form of salaries for authors DP and CT, but did not have any additional role in the study design, data collection and data analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ambruosi B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027452; Anas MKI, 2003, REPROD TOXICOL, V17, P305, DOI 10.1016/S0890-6238(03)00014-5; Asaf S, 2014, REPRODUCTION, V147, P33, DOI 10.1530/REP-13-0383; ATSDR, 2002, TOXICOLOGICAL PROFIL; Beker ARCL, 2002, THERIOGENOLOGY, V58, P1663, DOI 10.1016/S0093-691X(02)01082-8; Bosnir J, 2003, COLLEGIUM ANTROPOL, V27, P23; Carnevali O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010201; Clarke HG, 2006, REPRODUCTION, V132, P119, DOI 10.1530/rep.1.00960; Cobellis L, 2003, HUM REPROD, V18, P1512, DOI 10.1093/humrep/deg254; DAVIS BJ, 1994, TOXICOL APPL PHARM, V128, P216, DOI 10.1006/taap.1994.1200; Duty SM, 2005, HUM REPROD, V20, P604, DOI 10.1093/humrep/deh656; ECHA, 2008, EUROPEAN UNION SUMMA; EDWARDS RG, 1974, J REPROD FERTIL, V37, P189, DOI 10.1530/jrf.0.0370189; Frederiksen H, 2010, J ANAL TOXICOL, V34, P400, DOI 10.1093/jat/34.7.400; Gendelman M, 2010, REPRODUCTION, V140, P73, DOI 10.1530/REP-10-0055; Grande SW, 2007, TOXICOLOGY, V229, P114, DOI 10.1016/j.tox.2006.10.005; Grossman D, 2012, CELL BIOL TOXICOL, V28, P383, DOI 10.1007/s10565-012-9230-1; Gupta RK, 2010, TOXICOL APPL PHARM, V242, P224, DOI 10.1016/j.taap.2009.10.011; Hannon PR, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00008; Hannon PR, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.114.119032; HEINDEL JJ, 1989, FUND APPL TOXICOL, V12, P508, DOI 10.1016/0272-0590(89)90024-9; Herreros MA, 2013, REPROD BIOL, V13, P66, DOI 10.1016/j.repbio.2013.01.177; Hirosawa N, 2006, PROTEOMICS, V6, P958, DOI 10.1002/pmic.200401344; Hoppin JA, 2002, ENVIRON HEALTH PERSP, V110, P515, DOI 10.1289/ehp.02110515; Inada H, 2012, J TOXICOL SCI, V37, P483; Ito Y, 2005, ARCH TOXICOL, V79, P147, DOI 10.1007/s00204-004-0615-7; Izadyar F, 1998, MOL REPROD DEV, V49, P444, DOI 10.1002/(SICI)1098-2795(199804)49:4&lt;444::AID-MRD12&gt;3.0.CO;2-U; Jarosova A, 2006, CZECH J FOOD SCI, V24, P223, DOI 10.17221/3318-CJFS; Kalo D, 2015, REPROD TOXICOL, V53, P141, DOI 10.1016/j.reprotox.2015.04.007; Kalo D, 2011, REPROD FERT DEVELOP, V23, P876, DOI 10.1071/RD10330; Kato K, 2005, ANAL CHEM, V77, P2985, DOI 10.1021/ac0481248; Kavlock R, 2002, REPROD TOXICOL, V16, P529, DOI 10.1016/S0890-6238(02)00032-1; Kessler W, 2012, TOXICOL APPL PHARM, V264, P284, DOI 10.1016/j.taap.2012.08.009; Koch HM, 2006, INT J ANDROL, V29, P155, DOI 10.1111/j.1365-2605.2005.00607.x; Koch HM, 2005, ARCH TOXICOL, V79, P367, DOI 10.1007/s00204-004-0642-4; Koch HM, 2009, PHILOS T R SOC B, V364, P2063, DOI 10.1098/rstb.2008.0208; Krejcikova M, 2013, MENDELNET 2013, P592; Krotz SP, 2012, J ASSIST REPROD GEN, V29, P773, DOI 10.1007/s10815-012-9775-1; Kurata Y, 2012, J TOXICOL SCI, V37, P33, DOI 10.2131/jts.37.33; LASKEY JW, 1993, REPROD TOXICOL, V7, P25, DOI 10.1016/0890-6238(93)90006-S; Latini G, 2003, ENVIRON HEALTH PERSP, V111, P1783, DOI 10.1289/ehp.6202; Lavon Y, 2011, THERIOGENOLOGY, V76, P942, DOI 10.1016/j.theriogenology.2011.05.001; Lenie S, 2009, TOXICOL LETT, V185, P143, DOI 10.1016/j.toxlet.2008.12.015; Li N, 2012, ENVIRON TOXICOL PHAR, V34, P869, DOI 10.1016/j.etap.2012.08.013; Liang P, 2008, ANAL CHIM ACTA, V609, P53, DOI 10.1016/j.aca.2007.12.025; LINDGREN A, 1982, TOXICOLOGY, V23, P149, DOI 10.1016/0300-483X(82)90094-4; Liu T, 2014, REPROD TOXICOL, V46, P141, DOI 10.1016/j.reprotox.2014.03.006; Ljungvall K, 2004, ARCH TOXICOL, V78, P384, DOI 10.1007/s00204-004-0558-z; Lovekamp TN, 2001, TOXICOL APPL PHARM, V172, P217, DOI 10.1006/taap.2001.9156; Lovekamp-Swan T, 2003, ENVIRON HEALTH PERSP, V111, P139, DOI 10.1289/ehp.5658; LUSSIER JG, 1987, J REPROD FERTIL, V81, P301, DOI 10.1530/jrf.0.0810301; Lyche JL, 2009, J TOXICOL ENV HEAL B, V12, P225, DOI 10.1080/10937400903094091; Ma MY, 2006, TOXICOL SCI, V93, P164, DOI 10.1093/toxsci/kfl036; Main KM, 2006, ENVIRON HEALTH PERSP, V114, P270, DOI 10.1289/ehp.8075; Martino-Andrade AJ, 2010, MOL NUTR FOOD RES, V54, P148, DOI 10.1002/mnfr.200800312; Mlynarcikova A, 2009, TOXICOL IN VITRO, V23, P371, DOI 10.1016/j.tiv.2008.12.017; Moore RW, 2001, ENVIRON HEALTH PERSP, V109, P229, DOI 10.2307/3434690; Peters JM, 1997, TERATOLOGY, V56, P311, DOI 10.1002/(SICI)1096-9926(199711)56:5<311::AID-TERA4>3.0.CO;2-#; Reinsberg J, 2009, TOXICOL APPL PHARM, V239, P116, DOI 10.1016/j.taap.2009.05.022; Rhind SM, 2010, ANIMAL, V4, P1227, DOI 10.1017/S1751731110000595; Rhind SM, 2005, REPROD DOMEST ANIM, V40, P282, DOI 10.1111/j.1439-0531.2005.00594.x; Rhind SM, 2005, ENVIRON HEALTH PERSP, V113, P447, DOI 10.1289/ehp.7469; RHODES C, 1986, ENVIRON HEALTH PERSP, V65, P299, DOI 10.2307/3430197; Roth Z, 2012, J DAIRY SCI, V95, P1729, DOI 10.3168/jds.2011-4513; Roth Z, 2001, REPRODUCTION, V122, P737, DOI 10.1530/rep.0.1220737; Rudel RA, 2009, ATMOS ENVIRON, V43, P170, DOI 10.1016/j.atmosenv.2008.09.025; Silva MJ, 2004, B ENVIRON CONTAM TOX, V72, P1226, DOI 10.1007/s00128-004-0374-4; SIROIS J, 1988, BIOL REPROD, V39, P308, DOI 10.1095/biolreprod39.2.308; Svechnikova I, 2007, J ENDOCRINOL, V194, P603, DOI 10.1677/JOE-07-0238; TOMITA I, 1986, ENVIRON HEALTH PERSP, V65, P249, DOI 10.2307/3430190; van Woudenberg AB, 2012, REPROD TOXICOL, V34, P251, DOI 10.1016/j.reprotox.2012.05.098; Wang W, 2012, TOXICOL APPL PHARM, V258, P288, DOI 10.1016/j.taap.2011.11.008; World Health Organization, 2003, DI 2 ETHYLHEXYL PHTH; Xu CA, 2010, TOXICOL LETT, V199, P323, DOI 10.1016/j.toxlet.2010.09.015; Zeng F, 2009, J HAZARD MATER, V164, P1171, DOI 10.1016/j.jhazmat.2008.09.029; Zhang T, 2014, ENVIRON MOL MUTAGEN, V55, P343, DOI 10.1002/em.21847; Zhang XF, 2013, ENVIRON MOL MUTAGEN, V54, P354, DOI 10.1002/em.21776	77	23	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0130896	10.1371/journal.pone.0130896	http://dx.doi.org/10.1371/journal.pone.0130896			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154164	Green Published, Green Submitted, gold			2022-12-26	WOS:000358159700043
J	Cremaschi, P; Oliverio, M; Leva, V; Bione, S; Carriero, R; Mazzucco, G; Palamidessi, A; Scita, G; Biamonti, G; Montecucco, A				Cremaschi, Paolo; Oliverio, Matteo; Leva, Valentina; Bione, Silvia; Carriero, Roberta; Mazzucco, Giulia; Palamidessi, Andrea; Scita, Giorgio; Biamonti, Giuseppe; Montecucco, Alessandra			Chronic Replication Problems Impact Cell Morphology and Adhesion of DNA Ligase I Defective Cells	PLOS ONE			English	Article							DAMAGE RESPONSE; GENOMIC INSTABILITY; EXPRESSION ANALYSIS; RNA-SEQ; GENE; PHOSPHORYLATION; CANCER; CYCLE; ATM; PROLIFERATION	Moderate DNA damage resulting from metabolic activities or sub-lethal doses of exogenous insults may eventually lead to cancer onset. Human 46BR.1G1 cells bear a mutation in replicative DNA ligase I (LigI) which results in low levels of replication-dependent DNA damage. This replication stress elicits a constitutive phosphorylation of the ataxia telangiectasia mutated (ATM) checkpoint kinase that fails to arrest cell cycle progression or to activate apoptosis or cell senescence. Stable transfection of wild type Ligl, as in 7A3 cells, prevents DNA damage and ATM activation. Here we show that parental 46BR.1G1 and 7A3 cells differ in important features such as cell morphology, adhesion and migration. Comparison of gene expression profiles in the two cell lines detects Bio-Functional categories consistent with the morphological and migration properties of LigI deficient cells. Interestingly, ATM inhibition makes 46BR.1G1 more similar to 7A3 cells for what concerns morphology, adhesion and expression of cell-cell adhesion receptors. These observations extend the influence of the DNA damage response checkpoint pathways and unveil a role for ATM kinase activity in modulating cell biology parameters relevant to cancer progression.	[Cremaschi, Paolo; Oliverio, Matteo; Leva, Valentina; Bione, Silvia; Carriero, Roberta; Mazzucco, Giulia; Biamonti, Giuseppe; Montecucco, Alessandra] CNR, Ist Genet Mol, I-27100 Pavia, Italy; [Cremaschi, Paolo; Mazzucco, Giulia] Univ Pavia, Dipartimento Biol & Biotecnol L Spallanzani, I-27100 Pavia, Italy; [Carriero, Roberta] IUSS, Pavia, Italy; [Palamidessi, Andrea; Scita, Giorgio] IFOM, Fdn Ist FIRC Oncol Mol, Milan, Italy; [Scita, Giorgio] Univ Milan, Dipartimento Sci Salute, Milan, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); University of Pavia; IUSS PAVIA; IFOM - FIRC Institute of Molecular Oncology; University of Milan	Montecucco, A (corresponding author), CNR, Ist Genet Mol, I-27100 Pavia, Italy.	montecucco@igm.cnr.it	Carriero, Roberta/AAA-4709-2019; Palamidessi, Andrea/F-1203-2018	palamidessi, andrea/0000-0002-7134-7023; Oliverio, Matteo/0000-0002-7969-2796; Cremaschi, Paolo/0000-0001-5349-4188; BIAMONTI, GIUSEPPE/0000-0001-6804-4315; Montecucco, Alessandra/0000-0002-9388-9149; Carriero, Roberta/0000-0001-8619-6152; Bione, Silvia/0000-0002-3924-4606	Associazione Italiana per la Ricerca sul Cancro; Italian Ministry of Education-University-Research (MIUR); PNR-CNR Aging Program CNR-MIUR; Flagship project Epigen CNR-MIUR; Association for International Cancer Research; CARIPLO Foundation; Fondazione Adriano Buzzati Traverso	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of Education-University-Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); PNR-CNR Aging Program CNR-MIUR; Flagship project Epigen CNR-MIUR; Association for International Cancer Research; CARIPLO Foundation(Fondazione Cariplo); Fondazione Adriano Buzzati Traverso	This work was supported by grants from the Associazione Italiana per la Ricerca sul Cancro (to GB, GS, AP), the Italian Ministry of Education-University-Research (MIUR) (to GS), PNR-CNR Aging Program CNR-MIUR and Flagship project Epigen CNR-MIUR (to GB), the Association for International Cancer Research (to GS), and the CARIPLO Foundation (to GB, GS, AP). VL was supported by a postdoctoral fellowship from Fondazione Adriano Buzzati Traverso; MO was supported by a fellowship from PNR-CNR Aging Program CNR-MIUR; PC is a student of the PhD program in Genetics, Molecular and Cellular Biology of the University of Pavia; RC is a student of the PhD program in Scienze Biomolecolari e Biotecnologia, IUSS, Pavia.	Alzu A, 2012, CELL, V151, P835, DOI 10.1016/j.cell.2012.09.041; BARNES DE, 1992, CELL, V69, P495, DOI 10.1016/0092-8674(92)90450-Q; Bennetzen MV, 2010, MOL CELL PROTEOMICS, V9, P1314, DOI 10.1074/mcp.M900616-MCP200; Bensimon A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001034; Biamonti G, 2014, SEMIN CELL DEV BIOL, V32, P30, DOI 10.1016/j.semcdb.2014.03.016; Bonacci TM, 2012, CELL SIGNAL, V24, P2102, DOI 10.1016/j.cellsig.2012.07.015; Camarda G, 2004, J CELL BIOL, V167, P417, DOI 10.1083/jcb.200408164; Chikh A, 2011, EMBO J, V30, P4261, DOI 10.1038/emboj.2011.302; GARIBOLDI M, 1995, MOL CARCINOGEN, V14, P71, DOI 10.1002/mc.2940140202; Ghigna C, 2005, MOL CELL, V20, P881, DOI 10.1016/j.molcel.2005.10.026; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Greer SN, 2012, EMBO J, V31, P2448, DOI 10.1038/emboj.2012.125; Harrison C, 2002, CANCER RES, V62, P4065; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; House NCM, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00296; Imanirad P, 2013, BLOOD CELL MOL DIS, V51, P256, DOI 10.1016/j.bcmd.2013.08.005; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Karni R, 2007, NAT STRUCT MOL BIOL, V14, P185, DOI 10.1038/nsmb1209; Leva V, 2012, NUCLEIC ACIDS RES, V40, P1106, DOI 10.1093/nar/gkr837; Li XL, 2005, CELL, V122, P365, DOI 10.1016/j.cell.2005.06.008; Lidonnici MR, 2004, J CELL SCI, V117, P5221, DOI 10.1242/jcs.01405; Lin YL, 2013, UROL INT, V90, P225, DOI 10.1159/000345054; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; MONTECUCCO A, 1992, NUCLEIC ACIDS RES, V20, P6209, DOI 10.1093/nar/20.23.6209; Montecucco Alessandra, 2013, Frontiers in Genetics, V4, P102, DOI 10.3389/fgene.2013.00102; Moore MJ, 2010, CELL, V142, P625, DOI 10.1016/j.cell.2010.07.019; Peng XA, 2011, INT REV CEL MOL BIO, V287, P191, DOI 10.1016/B978-0-12-386043-9.00005-0; Reinhardt HC, 2010, MOL CELL, V40, P34, DOI 10.1016/j.molcel.2010.09.018; Rossi R, 2006, CANCER RES, V66, P1675, DOI 10.1158/0008-5472.CAN-05-2741; Saito M, 2012, J CELL SCI, V125, P2547, DOI 10.1242/jcs.066654; Santos MA, 2014, NATURE, V514, P107, DOI 10.1038/nature13483; Semenza GL, 2012, TRENDS MOL MED, V18, P534, DOI 10.1016/j.molmed.2012.08.001; Sherman MH, 2011, TRENDS CELL BIOL, V21, P312, DOI 10.1016/j.tcb.2011.01.004; Shultz JC, 2010, CANCER RES, V70, P9185, DOI 10.1158/0008-5472.CAN-10-1545; Soza S, 2009, MOL CELL BIOL, V29, P2032, DOI 10.1128/MCB.01730-08; Sulli G, 2012, NAT REV CANCER, V12, DOI 10.1038/nrc3344; Sun DY, 2001, CLIN CANCER RES, V7, P4143; Thedieck C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000657; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vijayakumar S, 2009, MOL CELL BIOL, V29, P2042, DOI 10.1128/MCB.01732-08; Vitolo B, 2005, EUR J HISTOCHEM, V49, P349; Wang JF, 2011, ONCOL REP, V26, P101, DOI 10.3892/or.2011.1286; WEBSTER ADB, 1992, LANCET, V339, P1508, DOI 10.1016/0140-6736(92)91266-B; Zhao SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0078644; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114	46	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2015	10	7							e0130561	10.1371/journal.pone.0130561	http://dx.doi.org/10.1371/journal.pone.0130561			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EC	26151554	Green Published, gold, Green Submitted			2022-12-26	WOS:000358158900011
J	Stutz, C; Reinz, E; Honegger, A; Bulkescher, J; Schweizer, J; Zanier, K; Trave, G; Lohrey, C; Hoppe-Seyler, K; Hoppe-Seyler, F				Stutz, Christina; Reinz, Eileen; Honegger, Anja; Bulkescher, Julia; Schweizer, Johannes; Zanier, Katia; Trave, Gilles; Lohrey, Claudia; Hoppe-Seyler, Karin; Hoppe-Seyler, Felix			Intracellular Analysis of the Interaction between the Human Papillomavirus Type 16 E6 Oncoprotein and Inhibitory Peptides	PLOS ONE			English	Article							POSITIVE CANCER-CELLS; CERVICAL-CANCER; E6-MEDIATED DEGRADATION; NUCLEAR-LOCALIZATION; P53; PROTEIN; AGGRESOMES; ASSOCIATION; INDUCTION; APOPTOSIS	Oncogenic types of human papillomaviruses (HPVs) cause cervical cancer and other malignancies in humans. The HPV E6 oncoprotein is considered to be an attractive therapeutic target since its inhibition can lead to the apoptotic cell death of HPV-positive cancer cells. The HPV type 16 (HPV16) E6-binding peptide pep11, and variants thereof, induce cell death specifically in HPV16-positive cancer cells. Although they do not encompass the LxxLL binding motif found in cellular HPV16 E6 interaction partners, such as E6AP, the pep11 variants strongly bind to HPV16 E6 by contacting the recently identified E6AP binding pocket. Thus, these peptides can serve as prototype E6-inhibitory molecules which target the E6AP pocket. We here analyzed their intracellular interaction with HPV16 E6. By comprehensive intracellular binding studies and GST pull-down assays, we show that E6-binding competent pep11 variants induce the formation of a trimeric complex, consisting of pep11, HPV16 E6 and p53. These findings indicate that peptides, which do not contain the LxxLL motif, can reshape E6 to enable its interaction with p53. The formation of the trimeric HPV16 E6 / peptide / p53 complex was associated with an increase of endogenous HPV16 E6 protein amounts. Yet, total cellular p53 amounts were also increased, indicating that the E6 / E6AP-mediated degradation of p53 is blocked. These findings suggest that inhibition of oncogenic activities by targeting the E6AP pocket on HPV16 E6 could be a strategy for therapeutic intervention.	[Stutz, Christina; Reinz, Eileen; Honegger, Anja; Bulkescher, Julia; Lohrey, Claudia; Hoppe-Seyler, Karin; Hoppe-Seyler, Felix] German Canc Res Ctr, Program Infect & Canc, Mol Therapy Virus Associated Canc F065, D-69120 Heidelberg, Germany; [Schweizer, Johannes] Arbor Vita Corp, Fremont, CA 94085 USA; [Zanier, Katia; Trave, Gilles] IREBS, F-67412 Illkirch Graffenstaden, France	Helmholtz Association; German Cancer Research Center (DKFZ)	Hoppe-Seyler, F (corresponding author), German Canc Res Ctr, Program Infect & Canc, Mol Therapy Virus Associated Canc F065, D-69120 Heidelberg, Germany.	hoppe-seyler@dkfz.de	TRAVE, Gilles/P-8577-2016	Hoppe-Seyler, Felix/0000-0002-1864-300X	Deutsche Krebshilfe [109392]	Deutsche Krebshilfe(Deutsche Krebshilfe)	This work was supported by a grant of the Deutsche Krebshilfe (http://www.krebshilfe.de/metanavigation/english.html) to F.H.S (# 109392). One author (Dr. J. Schweizer) is employed by a commercial company (Arbor Vita Corporation). He provided antibodies for E6 detection. The funder provided support in the form of salary for JS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Ansari T, 2012, J VIROL, V86, P11386, DOI 10.1128/JVI.01236-12; Butz K, 2000, P NATL ACAD SCI USA, V97, P6693, DOI 10.1073/pnas.110538897; Butz K, 2003, ONCOGENE, V22, P5938, DOI 10.1038/sj.onc.1206894; Camus S, 2007, ONCOGENE, V26, P4059, DOI 10.1038/sj.onc.1210188; Dymalla S, 2009, J MOL MED, V87, P321, DOI 10.1007/s00109-008-0432-1; Garcia-Mata R, 2002, TRAFFIC, V3, P388, DOI 10.1034/j.1600-0854.2002.30602.x; Griffin H, 2006, J MOL BIOL, V355, P360, DOI 10.1016/j.jmb.2005.10.077; Hellner K, 2011, J CLIN ONCOL, V29, P1785, DOI 10.1200/JCO.2010.28.2186; Hoppe-Seyler F, 2011, INT J CANCER, V129, P1289, DOI 10.1002/ijc.26087; HUIBREGTSE JM, 1993, MOL CELL BIOL, V13, P775, DOI 10.1128/MCB.13.2.775; HUIBREGTSE JM, 1991, EMBO J, V10, P4129, DOI 10.1002/j.1460-2075.1991.tb04990.x; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Kuballa P, 2007, J BIOL CHEM, V282, P65, DOI 10.1074/jbc.M605117200; Lagrange M, 2007, BIOCHEM BIOPH RES CO, V361, P487, DOI 10.1016/j.bbrc.2007.07.040; Li XQ, 1996, J VIROL, V70, P4509, DOI 10.1128/JVI.70.7.4509-4516.1996; Massimi P, 2008, ONCOGENE, V27, P1800, DOI 10.1038/sj.onc.1210810; Masson M, 2003, J GEN VIROL, V84, P2099, DOI 10.1099/vir.0.18961-0; McLaughlin-Drubin ME, 2009, VIRUS RES, V143, P195, DOI 10.1016/j.virusres.2009.06.008; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; Schiffman M, 2007, LANCET, V370, P890, DOI [10.1016/S0140-6736(07)61416-0, 10.1016/S0140-6736(13)60022-7]; Shal A, 2007, ONCOGENE, V26, P3321, DOI 10.1038/sj.onc.1210130; Spangle JM, 2012, J VIROL, V86, P7466, DOI 10.1128/JVI.00487-12; Stanley MA, 2012, J GEN VIROL, V93, P681, DOI 10.1099/vir.0.039677-0; Tao MF, 2003, J VIROL, V77, P13232, DOI 10.1128/JVI.77.24.13232-13247.2003; Tomai E, 2006, J BIOL CHEM, V281, P21345, DOI 10.1074/jbc.M604258200; Tomaic V, 2009, VIROLOGY, V393, P7, DOI 10.1016/j.virol.2009.07.029; Yamato K, 2006, CANCER GENE THER, V13, P234, DOI 10.1038/sj.cgt.7700891; Zanier K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112514; Zanier K, 2013, SCIENCE, V339, P694, DOI 10.1126/science.1229934; Zanier K, 2012, STRUCTURE, V20, P604, DOI 10.1016/j.str.2012.02.001; Zimmer M, 2002, CHEM REV, V102, P759, DOI 10.1021/cr010142r; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	32	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2015	10	7							e0132339	10.1371/journal.pone.0132339	http://dx.doi.org/10.1371/journal.pone.0132339			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EC	26151636	Green Published, Green Submitted, gold			2022-12-26	WOS:000358158900042
J	Suvorova, IA; Korostelev, YD; Gelfand, MS				Suvorova, Inna A.; Korostelev, Yuri D.; Gelfand, Mikhail S.			GntR Family of Bacterial Transcription Factors and Their DNA Binding Motifs: Structure, Positioning and Co-Evolution	PLOS ONE			English	Article							ESCHERICHIA-COLI; BACILLUS-SUBTILIS; COMPARATIVE GENOMICS; ARABINOSE REGULON; REGULATORY SITES; GENE-REGULATION; PROTEIN; RECOGNITION; METABOLISM; SPECIFICITY	The GNTR family of transcription factors (TFs) is a large group of proteins present in diverse bacteria and regulating various biological processes. Here we use the comparative genomics approach to reconstruct regulons and identify binding motifs of regulators from three subfamilies of the GNTR family, FADR, HUTC, and YTRA. Using these data, we attempt to predict DNA-protein contacts by analyzing correlations between binding motifs in DNA and amino acid sequences of TFs. We identify pairs of positions with high correlation between amino acids and nucleotides for FADR, HUTC, and YTRA subfamilies and show that the most predicted DNA-protein interactions are quite similar in all subfamilies and conform well to the experimentally identified contacts formed by FadR from E. coli and AraR from B. subtilis. The most frequent predicted contacts in the analyzed subfamilies are Arg-G, Asn-A, Asp-C. We also analyze the divergon structure and preferred site positions relative to regulated genes in the FADR and HUTC subfamilies. A single site in a divergon usually regulates both operons and is approximately in the middle of the intergenic area. Double sites are either involved in the co-operative regulation of both operons and then are in the center of the intergenic area, or each site in the pair independently regulates its own operon and tends to be near it. We also identify additional candidate TF-binding boxes near palindromic binding sites of TFs from the FADR, HUTC, and YTRA subfamilies, which may play role in the binding of additional TF-subunits.	[Suvorova, Inna A.; Korostelev, Yuri D.; Gelfand, Mikhail S.] RAS, Res & Training Ctr Bioinformat, Kharkevich Inst, Inst Informat Transmiss Problems, Moscow 117901, Russia; [Gelfand, Mikhail S.] Moscow MV Lomonosov State Univ, Fac Bioengn & Bioinformat, Moscow, Russia	Kharkevich Institute for Information Transmission Problems of the RAS; Russian Academy of Sciences; Lomonosov Moscow State University	Suvorova, IA (corresponding author), RAS, Res & Training Ctr Bioinformat, Kharkevich Inst, Inst Informat Transmiss Problems, Moscow 117901, Russia.	inn1313@yandex.ru	Gelfand, Mikhail S/F-3425-2012	Gelfand, Mikhail/0000-0003-4181-0846	Russian Science Foundation [14-24-00155]	Russian Science Foundation(Russian Science Foundation (RSF))	This research was supported by the Russian Science Foundation via grant 14-24-00155 (http://PHdp.pdp/, to MSG). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aravind L, 2003, FEMS MICROBIOL LETT, V222, P17, DOI 10.1016/S0378-1097(03)00242-8; Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Belitsky BR, 2004, J MOL BIOL, V340, P655, DOI 10.1016/j.jmb.2004.05.020; Benson DA, 1999, NUCLEIC ACIDS RES, V27, P12, DOI 10.1093/nar/27.1.12; Bramucci E, 2011, BIOCHEM BIOPH RES CO, V415, P88, DOI 10.1016/j.bbrc.2011.10.017; Brinkman AB, 2003, MOL MICROBIOL, V48, P287, DOI 10.1046/j.1365-2958.2003.03442.x; Camas FM, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000989; Condemine G, 2005, J BACTERIOL, V187, P1959, DOI 10.1128/JB.187.6.1959-1965.2005; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Desai TA, 2009, NUCLEIC ACIDS RES, V37, P2493, DOI 10.1093/nar/gkp079; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Felsenstein J, 1996, METHOD ENZYMOL, V266, P418; Feng YJ, 2013, MOL MICROBIOL, V88, P77, DOI 10.1111/mmi.12170; Franco IS, 2007, NUCLEIC ACIDS RES, V35, P4755, DOI 10.1093/nar/gkm509; Franco IS, 2006, J BACTERIOL, V188, P3024, DOI 10.1128/JB.188.8.3024-3036.2006; Gelfand MS, 2000, NUCLEIC ACIDS RES, V28, P695, DOI 10.1093/nar/28.3.695; Gromiha MM, 2011, J CHEM INF MODEL, V51, P721, DOI 10.1021/ci1003703; Hill T., 2007, STAT METHODS APPL; Huang N, 2009, STRUCTURE, V17, P939, DOI 10.1016/j.str.2009.05.012; Jain D, 2013, NUCLEIC ACIDS RES, V41, P639, DOI 10.1093/nar/gks962; Jochmann N, 2011, MICROBIOL-SGM, V157, P77, DOI 10.1099/mic.0.044818-0; Konig B, 2009, NUCLEIC ACIDS RES, V37, P1915, DOI 10.1093/nar/gkp044; Lee MH, 2003, J BACTERIOL, V185, P4315, DOI 10.1128/JB.185.15.4315-4325.2003; Luscombe NM, 2002, J MOL BIOL, V320, P991, DOI 10.1016/S0022-2836(02)00571-5; LUSTIG B, 1995, NUCLEIC ACIDS RES, V23, P4707, DOI 10.1093/nar/23.22.4707; Madar D, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-111; Magarvey N, 2001, MICROBIOL-SGM, V147, P2103, DOI 10.1099/00221287-147-8-2103; Mahony S, 2007, BIOINFORMATICS, V23, pI297, DOI 10.1093/bioinformatics/btm215; Marabotti A, 2008, J COMPUT CHEM, V29, P1955, DOI 10.1002/jcc.20954; Martinez-Antonio A, 2008, J MOL BIOL, V381, P238, DOI 10.1016/j.jmb.2008.05.054; Mirny LA, 2002, NUCLEIC ACIDS RES, V30, P1704, DOI 10.1093/nar/30.7.1704; Mironov A. A., 2000, Molekulyarnaya Biologiya (Moscow), V34, P253; Morozov AV, 2007, P NATL ACAD SCI USA, V104, P7068, DOI 10.1073/pnas.0701356104; Morozov AV, 2005, NUCLEIC ACIDS RES, V33, P5781, DOI 10.1093/nar/gki875; Mota LJ, 2001, J BACTERIOL, V183, P4190, DOI 10.1128/JB.183.14.4190-4201.2001; Novichkov PS, 2010, NUCLEIC ACIDS RES, V38, pW299, DOI 10.1093/nar/gkq531; Ofran Y, 2007, BIOINFORMATICS, V23, pI347, DOI 10.1093/bioinformatics/btm174; Perez-Rueda E, 2000, NUCLEIC ACIDS RES, V28, P1838, DOI 10.1093/nar/28.8.1838; QUAIL MA, 1994, FEBS LETT, V356, P183, DOI 10.1016/0014-5793(94)01264-4; Ravcheev DA, 2012, J BACTERIOL, V194, P1145, DOI 10.1128/JB.06412-11; Rigali S, 2004, NUCLEIC ACIDS RES, V32, P3418, DOI 10.1093/nar/gkh673; Rigali S, 2002, J BIOL CHEM, V277, P12507, DOI 10.1074/jbc.M110968200; Rodionov DA, 2006, FEMS MICROBIOL LETT, V255, P102, DOI 10.1111/j.1574-6968.2005.00070.x; Rodionov DA, 2007, CHEM REV, V107, P3467, DOI 10.1021/cr068309+; Rohs R, 2010, ANNU REV BIOCHEM, V79, P233, DOI 10.1146/annurev-biochem-060408-091030; SEEMAN NC, 1976, P NATL ACAD SCI USA, V73, P804, DOI 10.1073/pnas.73.3.804; Sharadamma N, 2011, FEBS J, V278, P3447, DOI 10.1111/j.1742-4658.2011.08267.x; Suvorova IA, 2012, J BACTERIOL, V194, P3234, DOI 10.1128/JB.00163-12; Tan K, 2005, GENOME RES, V15, P312, DOI 10.1101/gr.3069205; Thieffry D, 1998, BIOESSAYS, V20, P433, DOI 10.1002/(SICI)1521-1878(199805)20:5<433::AID-BIES10>3.0.CO;2-2; van Aalten DMF, 2001, EMBO J, V20, P2041, DOI 10.1093/emboj/20.8.2041; Wiethaus J, 2008, J BACTERIOL, V190, P487, DOI 10.1128/JB.01510-07; Xu YB, 2001, J BIOL CHEM, V276, P17373, DOI 10.1074/jbc.M100195200; Yang C, 2006, J BIOL CHEM, V281, P29872, DOI 10.1074/jbc.M605052200; Zhang L, 2012, J BACTERIOL, V194, P1055, DOI 10.1128/JB.06241-11; Zheng MY, 2009, ACTA CRYSTALLOGR D, V65, P356, DOI 10.1107/S0907444909004727	57	50	56	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2015	10	7							e0132618	10.1371/journal.pone.0132618	http://dx.doi.org/10.1371/journal.pone.0132618			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EC	26151451	Green Published, gold, Green Submitted			2022-12-26	WOS:000358158900050
J	Becerra-Fajardo, L; Ivorra, A				Becerra-Fajardo, Laura; Ivorra, Antoni			In Vivo Demonstration of Addressable Microstimulators Powered by Rectification of Epidermically Applied Currents for Miniaturized Neuroprostheses	PLOS ONE			English	Article							FUNCTIONAL ELECTRICAL-STIMULATION; FREQUENCY; NERVES; SYSTEM	Electrical stimulation is used in order to restore nerve mediated functions in patients with neurological disorders, but its applicability is constrained by the invasiveness of the systems required to perform it. As an alternative to implantable systems consisting of central stimulation units wired to the stimulation electrodes, networks of wireless microstimulators have been devised for fine movement restoration. Miniaturization of these microstimulators is currently hampered by the available methods for powering them. Previously, we have proposed and demonstrated a heterodox electrical stimulation method based on electronic rectification of high frequency current bursts. These bursts can be delivered through textile electrodes on the skin. This approach has the potential to result in an unprecedented level of miniaturization as no bulky parts such as coils or batteries are included in the implant. We envision microstimulators designs based on application-specific integrated circuits (ASICs) that will be flexible, thread-like (diameters <0.5 mm) and not only with controlled stimulation capabilities but also with sensing capabilities for artificial proprioception. We in vivo demonstrate that neuroprostheses composed of addressable microstimulators based on this electrical stimulation method are feasible and can perform controlled charge-balanced electrical stimulation of muscles. We developed miniature external circuit prototypes connected to two bipolar probes that were percutaneously implanted in agonist and antagonist muscles of the hindlimb of an anesthetized rabbit. The electronic implant architecture was able to decode commands that were amplitude modulated on the high frequency (1 MHz) auxiliary current bursts. The devices were capable of independently stimulating the target tissues, accomplishing controlled dorsiflexion and plantarflexion joint movements. In addition, we numerically show that the high frequency current bursts comply with safety standards both in terms of tissue heating and unwanted electro-stimulation. We demonstrate that addressable microstimulators powered by rectification of epidermically applied currents are feasible.	[Becerra-Fajardo, Laura; Ivorra, Antoni] Univ Pompeu Fabra, Dept Informat & Commun Technol, Barcelona, Spain	Pompeu Fabra University	Becerra-Fajardo, L (corresponding author), Univ Pompeu Fabra, Dept Informat & Commun Technol, Barcelona, Spain.	laura.becerra.fajardo@gmail.com	Ivorra, Antoni/A-3155-2008	Ivorra, Antoni/0000-0001-7718-8767; Becerra-Fajardo, Laura/0000-0002-5414-8380	Ramon y Cajal fellowship from the Spanish government [RYC-2009-04271]; Marie Curie grant from the European Commission [IRG 256376]	Ramon y Cajal fellowship from the Spanish government; Marie Curie grant from the European Commission	This work was supported in part by the Ramon y Cajal fellowship (RYC-2009-04271) from the Spanish government and by a Marie Curie grant (IRG 256376) from the European Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdo A, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/5/056012; [Anonymous], 2010, HLTH PHYS, V99; Becerra-Fajardo L, 2014, IEEE ENG MED BIO, P3973, DOI 10.1109/EMBC.2014.6944494; BRINDLEY GS, 1994, PARAPLEGIA, V32, P795, DOI 10.1038/sc.1994.126; BRINDLEY GS, 1995, BAILLIERE CLIN NEUR, V4, P1; Cho N, 2007, IEEE T MICROW THEORY, V55, P1080, DOI 10.1109/TMTT.2007.895640; Cogan SF, 2008, ANNU REV BIOMED ENG, V10, P275, DOI 10.1146/annurev.bioeng.10.061807.160518; Constandinou TG, 2008, IEEE T BIOMED CIRC S, V2, P106, DOI 10.1109/TBCAS.2008.927238; Davis R, 1999, ARTIF ORGANS, V23, P418, DOI 10.1046/j.1525-1594.1999.06368.x; Gabriel S, 1996, PHYS MED BIOL, V41, P2251, DOI 10.1088/0031-9155/41/11/002; Ho CH, 2014, PHYS MED REH CLIN N, V25, P631, DOI 10.1016/j.pmr.2014.05.001; Ibrahiem A, 2005, PROG ELECTROMAGN RES, V52, P23, DOI 10.2528/PIER04062501; IEEE, 2006, IEEE STANDARD SAFETY, V1, P238; Ivorra A, 2013, WORLD C MED PHYS BIO, P1581; Ivorra A., 2013, 18 IFESS ANN C, P213; Ivorra A, 2014, BIOSYST BIOROBOT, V7, P447, DOI 10.1007/978-3-319-08072-7_67; Ivorra A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023456; Kane MJ, 2011, MED ENG PHYS, V33, P7, DOI 10.1016/j.medengphy.2010.08.010; Kesar T, 2008, J ELECTROMYOGR KINES, V18, P662, DOI 10.1016/j.jelekin.2007.01.001; Loeb GE, 2001, MED ENG PHYS, V23, P9, DOI 10.1016/S1350-4533(01)00011-X; Loeb GE., 2006, NEUROSURG FOCUS, V20, P1, DOI [10.3171/foc.2006.20.5.3, DOI 10.3171/FOC.2006.20.5.3]; Mortimer JT, 2009, NEUROMODULATION, VOLS 1 AND 2, P109; NIH; American Heart Association; The Centers for Disease Control and Prevention, 2015, HEART DIS STROKE STA; PALTI Y, 1962, B RES COUNC ISRAEL, VE 10, P54; Peckham PH, 2013, IEEE T BIO-MED ENG, V60, P602, DOI 10.1109/TBME.2013.2245128; Peckham PH, 2005, ANNU REV BIOMED ENG, V7, P327, DOI 10.1146/annurev.bioeng.6.040803.140103; Reardon S, 2014, NATURE, V511, P18, DOI 10.1038/511018a; Riso RR, 2000, IEEE T REHABIL ENG, V8, P244, DOI 10.1109/86.847826; Schuder JC, 1964, ASAIO J, V10; Schulman JH, 2008, P IEEE, V96, P1226, DOI 10.1109/JPROC.2008.922588; Smith B, 2005, I IEEE EMBS C NEUR E, P454; van Swigchem R, 2012, PHYS THER, V92, P398, DOI 10.2522/ptj.20100405; Ziaie B, 1997, IEEE T BIO-MED ENG, V44, P909, DOI 10.1109/10.634643; Zimmerman TG, 1996, IBM SYST J, V35, P609, DOI 10.1147/sj.353.0609	34	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131666	10.1371/journal.pone.0131666	http://dx.doi.org/10.1371/journal.pone.0131666			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147771	Green Published, Green Submitted, gold			2022-12-26	WOS:000358157600123
J	Jung, M; Hwang, J; Tani, J				Jung, Minju; Hwang, Jungsik; Tani, Jun			Self-Organization of Spatio-Temporal Hierarchy via Learning of Dynamic Visual Image Patterns on Action Sequences	PLOS ONE			English	Article							CORTEX; MECHANISMS; GRADIENT	It is well known that the visual cortex efficiently processes high-dimensional spatial information by using a hierarchical structure. Recently, computational models that were inspired by the spatial hierarchy of the visual cortex have shown remarkable performance in image recognition. Up to now, however, most biological and computational modeling studies have mainly focused on the spatial domain and do not discuss temporal domain processing of the visual cortex. Several studies on the visual cortex and other brain areas associated with motor control support that the brain also uses its hierarchical structure as a processing mechanism for temporal information. Based on the success of previous computational models using spatial hierarchy and temporal hierarchy observed in the brain, the current report introduces a novel neural network model for the recognition of dynamic visual image patterns based solely on the learning of exemplars. This model is characterized by the application of both spatial and temporal constraints on local neural activities, resulting in the self-organization of a spatio-temporal hierarchy necessary for the recognition of complex dynamic visual image patterns. The evaluation with the Weizmann dataset in recognition of a set of prototypical human movement patterns showed that the proposed model is significantly robust in recognizing dynamically occluded visual patterns compared to other baseline models. Furthermore, an evaluation test for the recognition of concatenated sequences of those prototypical movement patterns indicated that the model is endowed with a remarkable capability for the contextual recognition of long-range dynamic visual image patterns.	[Jung, Minju; Hwang, Jungsik; Tani, Jun] Korea Adv Inst Sci & Technol, Dept Elect Engn, Taejon 305701, South Korea	Korea Advanced Institute of Science & Technology (KAIST)	Tani, J (corresponding author), Korea Adv Inst Sci & Technol, Dept Elect Engn, Taejon 305701, South Korea.	tani1216jp@gmail.com	Tani, Jun/AAI-8287-2020; Tani, Jun/H-3681-2012		National Research Foundation of Korea (NRF) grant - Korea government (MSIP) [2014R1A2A2A01005491]	National Research Foundation of Korea (NRF) grant - Korea government (MSIP)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (No. 2014R1A2A2A01005491). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baccouche Moez, 2011, Human Behavior Unterstanding. Proceedings Second International Workshop, HBU 2011, P29, DOI 10.1007/978-3-642-25446-8_4; Badre D, 2009, NAT REV NEUROSCI, V10, P659, DOI 10.1038/nrn2667; Barnsley M, 1993, FRACTALS EVERYWHERE; Blank M, 2005, IEEE I CONF COMP VIS, P1395; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Friston KJ, 2000, PHILOS T ROY SOC B, V355, P253, DOI 10.1098/rstb.2000.0562; Giese MA, 2003, NAT REV NEUROSCI, V4, P179, DOI 10.1038/nrn1057; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Hasson U, 2008, J NEUROSCI, V28, P2539, DOI 10.1523/JNEUROSCI.5487-07.2008; Hinton GE, 2006, SCIENCE, V313, P504, DOI 10.1126/science.1127647; Hinton GE, 2006, NEURAL COMPUT, V18, P1527, DOI 10.1162/neco.2006.18.7.1527; Hubel David H, 1995, EYE BRAIN VISION, P6; Ji SW, 2013, IEEE T PATTERN ANAL, V35, P221, DOI 10.1109/TPAMI.2012.59; Karpathy A, 2014, PROC CVPR IEEE, P1725, DOI 10.1109/CVPR.2014.223; Kiebel SJ, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000209; Krizhevsky A, 2017, COMMUN ACM, V60, P84, DOI 10.1145/3065386; Kruger N, 2013, IEEE T PATTERN ANAL, V35, P1847, DOI 10.1109/TPAMI.2012.272; LeCun Y, 1998, LECT NOTES COMPUT SC, V1524, P9, DOI 10.1007/3-540-49430-8_2; Lecun Y, 1998, P IEEE, V86, P2278, DOI 10.1109/5.726791; Lee H., 2009, P ANN INT C MACH LEA, P609; MISHKIN M, 1982, BEHAV BRAIN RES, V6, P57, DOI 10.1016/0166-4328(82)90081-X; POLLACK JB, 1991, MACH LEARN, V7, P227, DOI 10.1007/BF00114845; Rao RPN, 1999, NAT NEUROSCI, V2, P79, DOI 10.1038/4580; Rumelhart D., 1986, PARALLEL DISTRIBUTED; Scherer D, 2010, LECT NOTES COMPUT SC, V6354, P92, DOI 10.1007/978-3-642-15825-4_10; Schindler K., 2008, IEEE C COMP VIS PATT, P1, DOI DOI 10.1109/CVPR.2008.4587730; Simonyan Karen, 2014, ADV NEURAL INFORM PR, P568, DOI DOI 10.1002/14651858.CD001941.PUB3; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; TANAKA K, 1993, SCIENCE, V262, P685, DOI 10.1126/science.8235589; TANJI J, 1994, NATURE, V371, P413, DOI 10.1038/371413a0; Udden J, 2012, PHILOS T R SOC B, V367, P2023, DOI 10.1098/rstb.2012.0009; Yamashita Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000220	33	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131214	10.1371/journal.pone.0131214	http://dx.doi.org/10.1371/journal.pone.0131214			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147887	Green Published, Green Submitted, gold			2022-12-26	WOS:000358157600070
J	Li, R; Tang, CL; Zhang, Y; Ma, KS; Zhang, XH; Guo, DY; Yan, XC				Li, Rui; Tang, Chun-Lin; Zhang, Yi; Ma, Kuan-sheng; Zhang, Xiao-Hang; Guo, De-Yu; Yan, Xiao-Chu			Diagnosis of Hepatic Angiomyolipoma by Combination of Baseline and Contrast-Enhanced Ultrasound-A Prospective Study in Non-Cirrhotic Patients	PLOS ONE			English	Article							FOCAL LIVER-LESIONS; MALIGNANT ANGIOMYOLIPOMA; HEPATOCELLULAR ADENOMA; NODULAR HYPERPLASIA; MULTICENTER TRIAL; FEATURES; DELINEATION; SONOGRAPHY; PATTERNS; SONOVUE	Objectives Hepatic angiomyolipoma (HAML) is a rare, benign mesenchymal tumor of the liver and its diagnosis has been considered challenging. The aim of this study was to investigate prospectively the diagnostic efficacy of the incorporation of both baseline ultrasound (US) and contrast-enhanced ultrasound (CEUS) features of HAML in patients without cirrhosis. Materials and Methods Consecutive 1748 non-cirrhotic patients with focal liver lesions (FLLs) were prospectively enrolled. Baseline US and CEUS were performed before resection or biopsy. Ultrasound imaging diagnosis of FLLs was compared with the pathological results. Results Final diagnoses were established in 41 patients with HAML (2.3%) with normal alpha fetal protein (AFP) level and in 1707 patients with FLL other than HAML. Diagnostic criteria for HAML was based on the combination of baseline US and CEUS appearance of the nodule: (1) Well-defined, marked hyper-echoic nodule without surrounding hypo-echoic halo on baseline US; (2) hyper-enhancement in the arterial phase (exclude initial peripheral nodular enhancement and spoke-wheel arteries) and remains hyper-enhancement or iso-enhancement in the late phase. The diagnostic criteria were fulfilled in 31 HAMLs, 1 hepatocellular adenoma and 1 hemangioma. Ten HAMLs were misdiagnosed as other liver tumors because they did not meet the diagnostic criteria mentioned above and consequently yielded a sensitivity, specificity, positive predictive values, negative predictive values and Youden index of 75.61%, 99.88%, 93.94%, 99.42%, and 0.75 respectively. Conclusion The combination of baseline US and CEUS may lead to the correct diagnosis noninvasively in the majority of HAMLs in non-cirrhotic patients with normal AFP level.	[Li, Rui; Ma, Kuan-sheng] Third Mil Med Univ, Southwest Hosp, Dept Hepatobiliary Pancreat Surg, Chongqing, Peoples R China; [Tang, Chun-Lin; Zhang, Yi; Zhang, Xiao-Hang] Third Mil Med Univ, Southwest Hosp, Dept Ultrasound, Chongqing, Peoples R China; [Guo, De-Yu; Yan, Xiao-Chu] Third Mil Med Univ, Southwest Hosp, Dept Pathol, Chongqing, Peoples R China	Army Medical University; Army Medical University; Army Medical University	Li, R (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Hepatobiliary Pancreat Surg, Chongqing, Peoples R China.	raylee7991@163.com						Chang ZG, 2011, J GASTROINTEST LIVER, V20, P65; Claudon M, 2013, ULTRASCHALL MED, V34, P11, DOI 10.1055/s-0032-1325499; Croquet V, 2000, EUR J GASTROEN HEPAT, V12, P579, DOI 10.1097/00042737-200012050-00018; Dalle I, 2000, HISTOPATHOLOGY, V36, P443; Deng YF, 2008, PATHOL RES PRACT, V204, P911, DOI 10.1016/j.prp.2008.06.007; Dhingra S, 2014, ARCH PATHOL LAB MED, V138, P1090, DOI 10.5858/arpa.2013-0183-RA; Dietrich CF, 2005, BRIT J RADIOL, V78, P704, DOI 10.1259/bjr/88181612; Dietrich CF, 2007, HEPATOLOGY, V45, P1139, DOI 10.1002/hep.21615; Hirche TO, 2007, LIVER INT, V27, P748, DOI 10.1111/j.1478-3231.2007.01491.x; Hogemann D, 2001, EUR RADIOL, V11, P1389, DOI 10.1007/s003300000750; Leen E, 2006, AM J ROENTGENOL, V186, P1551, DOI 10.2214/AJR.05.0138; Li R, 2014, PLOS ONE, V9, P1; Li R, 2010, ABDOM IMAGING, V35, P676, DOI 10.1007/s00261-009-9592-x; Lin HM, 2011, J GASTROEN HEPATOL, V26, P28, DOI 10.1111/j.1440-1746.2010.06502.x; NONOMURA A, 1994, J GASTROENTEROL, V29, P95, DOI 10.1007/BF01229084; Nonomura A, 2012, HISTOPATHOLOGY, V61, P863, DOI 10.1111/j.1365-2559.2012.04306.x; Petrolla AA, 2008, ARCH PATHOL LAB MED, V132, P1679, DOI 10.1043/1543-2165(2008)132[1679:HA]2.0.CO;2; Ricci P, 2005, AM J ROENTGENOL, V184, P821, DOI 10.2214/ajr.184.3.01840821; Salvatore V, 2012, CURR PHARM DESIGN, V18, P2236, DOI 10.2174/138161212800099892; Strobel D, 2008, ULTRASCHALL MED, V29, P499, DOI 10.1055/s-2008-1027806; Tranquart F, 2009, J RADIOL, V90, P109, DOI 10.1016/S0221-0363(09)70089-7; Tsui WMS, 1999, AM J SURG PATHOL, V23, P34, DOI 10.1097/00000478-199901000-00004; Wang W, 2013, EUR RADIOL, V23, P2546, DOI 10.1007/s00330-013-2849-3; Wang Z, 2010, BRIT J RADIOL, V83, P411, DOI 10.1259/bjr/81174247; Wei RX, 2012, ASIAN PAC J CANCER P, V13, P493, DOI 10.7314/APJCP.2012.13.2.493; Zhou YM, 2008, HEPATOB PANCREAT DIS, V7, P284	26	3	5	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132290	10.1371/journal.pone.0132290	http://dx.doi.org/10.1371/journal.pone.0132290			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147859	gold, Green Submitted, Green Published			2022-12-26	WOS:000358157600232
J	Nakajima, Y; Shinzato, C; Satoh, N; Mitarai, S				Nakajima, Yuichi; Shinzato, Chuya; Satoh, Noriyuki; Mitarai, Satoshi			Novel Polymorphic Microsatellite Markers Reveal Genetic Differentiation between Two Sympatric Types of Galaxea fascicularis	PLOS ONE			English	Article							MULTILOCUS GENOTYPE DATA; POPULATION-STRUCTURE; SCLERACTINIAN CORAL; MORPHOLOGICAL CONVERGENCE; EVOLUTIONARY HISTORY; ACROPORA-HYACINTHUS; NUCLEOTIDE-SEQUENCE; SELF-FERTILIZATION; SPAWNING CORALS; CARIBBEAN CORAL	The reef-building, scleractinian coral, Galaxea fascicularis, is classified into soft and hard types, based on nematocyst morphology. This character is correlated with the length of the mitochondrial non-coding region (mt-Long: soft colony type, and nematocysts with wide capsules and long shafts; mt-Short: hard colony type, and nematocysts with thin capsules and short shafts). We isolated and characterized novel polymorphic microsatellite markers for G. fascicularis using next-generation sequencing. Based upon the mitochondrial non-coding region, 53 of the 97 colonies collected were mt-Long (mt-L) and 44 were mt-Short (mt-S). Among the 53 mt-L colonies, 27 loci were identified as amplifiable, polymorphic microsatellite loci, devoid of somatic mutations and free of scoring errors. Eleven of those 27 loci were also amplifiable and polymorphic in the 44 mt-S colonies; these 11 are cross-type microsatellite loci. The other 16 loci were considered useful only for mt-L colonies. These 27 loci identified 10 multilocus lineages (MLLs) among the 53 mt-L colonies (N-MLL/N = 0.189), and the 11 cross-type loci identified 7 MLLs in 44 mt-S colonies (N-MLL/N = 0.159). Significant genetic differentiation between the two types was detected based on the genetic differentiation index (F-ST = 0.080, P = 0.001). Bayesian clustering also indicated that these two types are genetically isolated. While nuclear microsatellite genotypes also showed genetic differentiation between mitochondrial types, the mechanism of divergence is not yet clear. These markers will be useful to estimate genetic diversity, differentiation, and connectivity among populations, and to understand evolutionary processes, including divergence of types in G. fascicularis.	[Nakajima, Yuichi; Mitarai, Satoshi] Grad Univ, Okinawa Inst Sci & Technol, Marine Biophys Unit, Okinawa, Japan; [Shinzato, Chuya; Satoh, Noriyuki] Grad Univ, Okinawa Inst Sci & Technol, Marine Genom Unit, Okinawa, Japan	Okinawa Institute of Science & Technology Graduate University; Okinawa Institute of Science & Technology Graduate University	Nakajima, Y (corresponding author), Grad Univ, Okinawa Inst Sci & Technol, Marine Biophys Unit, Okinawa, Japan.	yuichi.nakajima@oist.jp	Nakajima, Yuichi/A-4330-2013; Satoh, Nori/C-4123-2009; Mitarai, Satoshi/G-8560-2015	Nakajima, Yuichi/0000-0001-6558-5378; Satoh, Nori/0000-0002-4480-3572; Mitarai, Satoshi/0000-0003-3033-2332; Shinzato, Chuya/0000-0001-7843-3381	Japan Society for the Promotion of Science (JSPS) KAKENHI grant [25840152, 25660172, 26290065]; Pro Natura Foundation grant for natural conservation of the Nansei Islands; Okinawa Institute of Science and Technology Graduate University; Grants-in-Aid for Scientific Research [25840152] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS) KAKENHI grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Pro Natura Foundation grant for natural conservation of the Nansei Islands; Okinawa Institute of Science and Technology Graduate University(Okinawa Institute of Science & Technology Graduate University); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a Japan Society for the Promotion of Science (JSPS) KAKENHI grant (25840152 to YN, 25660172 and 26290065 to CS), a Pro Natura Foundation grant for natural conservation of the Nansei Islands to YN (http://www.pronaturajapan.com/), and by the Okinawa Institute of Science and Technology Graduate University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2008, FISHERIES SCI, V74, P1342, DOI 10.1111/j.1444-2906.2008.01663.x; Abe Mariko, 2008, Plankton & Benthos Research, V3, P174, DOI 10.3800/pbr.3.174; Aranceta-Garza F, 2012, CORAL REEFS, V31, P1157, DOI 10.1007/s00338-012-0941-9; Arnaud-Haond S, 2007, MOL ECOL, V16, P5115, DOI 10.1111/j.1365-294X.2007.03535.x; Aronesty E., 2011, EA UTILS COMMAND LIN; Ayre DJ, 2000, EVOLUTION, V54, P1590; Baums IB, 2006, ECOL MONOGR, V76, P503, DOI 10.1890/0012-9615(2006)076[0503:GVICSI]2.0.CO;2; Ben-Haim Y, 2003, APPL ENVIRON MICROB, V69, P4236, DOI 10.1128/AEM.69.7.4236-4242.2003; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bird CE, 2011, MOL ECOL, V20, P2128, DOI 10.1111/j.1365-294X.2011.05081.x; Castoe TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030953; Chen DD, 2013, CONSERV GENET RESOUR, V5, P741, DOI 10.1007/s12686-013-9895-7; Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485; Cristescu R, 2010, CONSERV GENET, V11, P1043, DOI 10.1007/s10592-009-9949-2; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Estoup A, 2002, MOL ECOL, V11, P1591, DOI 10.1046/j.1365-294X.2002.01576.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Flot JF, 2008, CORAL REEFS, V27, P789, DOI 10.1007/s00338-008-0407-2; Flot Jean-Francois, 2011, BMC Ecology, V11, P22, DOI 10.1186/1472-6785-11-22; Harrison PL, 1988, P 6 INT CORAL REEF S, V2, P699; Hatta M, 1999, MOL BIOL EVOL, V16, P1607, DOI 10.1093/oxfordjournals.molbev.a026073; Hayakawa H, 2007, ZOOL SCI, V24, P249, DOI 10.2108/zsj.24.249; Hayashibara T, 2002, CORAL REEFS, V21, P224; HEYWARD AJ, 1986, MAR BIOL, V90, P191, DOI 10.1007/BF00569127; HIDAKA M, 1984, CORAL REEFS, V3, P77, DOI 10.1007/BF00263757; Hidaka Michio, 1992, Galaxea, V11, P21; Isomura N, 2013, MAR BIOL RES, V9, P181, DOI 10.1080/17451000.2012.707321; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Keshavmurthy S, 2012, ZOOL STUD, V51, P143; Knowlton N, 2001, P NATL ACAD SCI USA, V98, P5419, DOI 10.1073/pnas.091092998; Marquez LM, 2002, P ROY SOC B-BIOL SCI, V269, P1289, DOI 10.1098/rspb.2002.2014; Marquez LM, 2002, MOL ECOL, V11, P1339, DOI 10.1046/j.1365-294X.2002.01526.x; Nakajima Y, 2012, MOL PHYLOGENET EVOL, V63, P527, DOI 10.1016/j.ympev.2012.01.006; Nishihira M., 1995, HERMATYPIC CORALS JA; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pinzon JH, 2011, MOL ECOL, V20, P311, DOI 10.1111/j.1365-294X.2010.04939.x; Pritchard JK, 2000, GENETICS, V155, P945; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Schmidt-Roach S, 2013, CORAL REEFS, V32, P161, DOI 10.1007/s00338-012-0959-z; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Shinzato C, 2011, NATURE, V476, P320, DOI 10.1038/nature10249; STODDART JA, 1988, MAR BIOL, V99, P489, DOI 10.1007/BF00392556; van Oppen MJH, 2001, MOL BIOL EVOL, V18, P1315, DOI 10.1093/oxfordjournals.molbev.a003916; Veron J.E.N., 2000, CORALS WORLD, V1-3; Vollmer SV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003718; Watanabe T, 2005, MAR BIOTECHNOL, V7, P33, DOI 10.1007/s10126-004-3200-4; Wewengkang DS, 2007, GALAXEA, V9, P49; Williams DE, 2008, CORAL REEFS, V27, P697, DOI 10.1007/s00338-008-0386-3; Yasuda N, 2014, B MAR SCI, V90, P233, DOI 10.5343/bms.2012.1105	53	11	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0130176	10.1371/journal.pone.0130176	http://dx.doi.org/10.1371/journal.pone.0130176			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147677	Green Submitted, Green Published, gold			2022-12-26	WOS:000358157600032
J	Negri, I; Mavris, C; Di Prisco, G; Caprio, E; Pellecchia, M				Negri, Ilaria; Mavris, Christian; Di Prisco, Gennaro; Caprio, Emilio; Pellecchia, Marco			Honey Bees (Apis mellifera, L.) as Active Samplers of Airborne Particulate Matter	PLOS ONE			English	Article							HEAVY-METALS; PARTICLES; SARDINIA; MIDGUT	Honey bees (Apis mellifera L.) are bioindicators of environmental pollution levels. During their wide-ranging foraging activity, these hymenopterans are exposed to pollutants, thus becoming a useful tool to trace the environmental contaminants as heavy metals, pesticides, radionuclides and volatile organic compounds. In the present work we demonstrate that bees can also be used as active samplers of airborne particulate matter. Worker bees were collected from hives located in a polluted postmining area in South West Sardinia (Italy) that is also exposed to dust emissions from industrial plants. The area is included in an official list of sites of national interest for environmental remediation, and has been characterized for the effects of pollutants on the health of the resident population. The head, wings, hind legs and alimentary canal of the bees were investigated with Scanning Electron Microscopy coupled with Xray spectroscopy (SEM-EDX). The analyses pointed to specific morphological and chemical features of the particulate, and resulted into the identification of three categories of particles: industry -, postmining -, and soil -derived. With the exception of the gut, all the analyzed body districts displayed inorganic particles, mostly concentrated in specific areas of the body (i.e. along the costal margin of the fore wings, the medial plane of the head, and the inner surface of the hind legs). The role of both past mining activities and the industrial activity close to the study area as sources of the particulate matter is also discussed. We conclude that honey bees are able to collect samples of the main airborne particles emitted from different sources, therefore could be an ideal tool for monitoring such a kind of pollutants.	[Negri, Ilaria; Pellecchia, Marco] Koine Environm Consulting Snc, Parma, Italy; [Mavris, Christian] Nat Hist Museum, Dept Earth Sci, London SW7 5BD, England; [Di Prisco, Gennaro; Caprio, Emilio] Univ Naples Federico II, Dipartimento Agr, Lab Entomol E Tremblay, Naples, Italy	Natural History Museum London; University of Naples Federico II	Negri, I (corresponding author), Koine Environm Consulting Snc, Parma, Italy.	ilarianegri@koineambiente.com	Di Prisco, Gennaro/AGY-3511-2022; Negri, Ilaria/E-5099-2012	Negri, Ilaria/0000-0001-5188-1408; Mavris, Christian/0000-0002-0254-8673	Koine-Environmental Consulting S.n.c., Parma, Italy; Koine-Environmental Consulting S.n.c.	Koine-Environmental Consulting S.n.c., Parma, Italy; Koine-Environmental Consulting S.n.c.	The study was funded by Koine-Environmental Consulting S.n.c., Parma, Italy www.koineambiente.com. The authors declare that the funder of this study, Koine-Environmental Consulting S.n.c., provided support in the form of salaries for authors Ilaria Negri and Marco Pellecchia, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DL, 2005, P NATL ACAD SCI USA, V102, P18213, DOI 10.1073/pnas.0506590102; Ardau C, 2001, RENDICONTI SEMIN S71; Ballan-Dufrancais CN, 2002, MICROSC RES TECHNIQ, V56, P403, DOI 10.1002/jemt.10041; BARBATTINI R, 1991, APICOLTURA, V7, P113; Bomphrey RJ, 2009, EXP FLUIDS, V46, P811, DOI 10.1007/s00348-009-0631-8; Boni M, 2011, HIST RES MONERAL RES, V13, P25; BROMENSHENK JJ, 1985, SCIENCE, V227, P632, DOI 10.1126/science.227.4687.632; Cadelis G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091136; Casteel DB, 1912, BAHV HONEY POLLEN CO; Casteel DB, 1912, BUREAU ENTOMOLOGY B, V161; Cherchi A, 2009, MAR POLLUT BULL, V59, P281, DOI 10.1016/j.marpolbul.2009.09.016; Choel M, 2007, ATMOS ENVIRON, V41, P2820, DOI 10.1016/j.atmosenv.2006.11.038; Chou M-S, 2012, SUSTAIN ENV RES, V22, P225; Cidu R., 2005, MINE WATER ENVIRON, V24, P77, DOI DOI 10.1007/S10230-005-0075-1; Costa E, 1981, INTRODUZIONE LETTURA; Costa LG, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/736385; Couvillon MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093495; DaCruzLandim C, 1997, NETH J ZOOL, V47, P21, DOI 10.1163/156854297X00210; Dickinson M, 2006, CURR BIOL, V16, pR309, DOI 10.1016/j.cub.2006.03.087; Fernandez-Caliani JC, 2013, MINERAL MAG, V77, P2793, DOI 10.1180/minmag.2013.077.6.07; Grandi G, 1978, I ENTOMOLOGIA GEN; Heal MR, 2012, CHEM SOC REV, V41, P6606, DOI 10.1039/c2cs35076a; Kloog I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088578; Kutchko B, FUEL, V85, P2537; Lambert O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067007; Leita L, 1996, ENVIRON MONIT ASSESS, V43, P1, DOI 10.1007/BF00399566; Lipovsek S, 2012, MICROSC RES TECHNIQ, V75, P397, DOI 10.1002/jemt.21069; Miousse IR, 2014, ENVIRON MOL MUTAGEN, V55, P428, DOI 10.1002/em.21855; Negri I, 2009, Italian patent, Patent No. 0001356726; Okuyama Y, 2007, ATMOS ENVIRON, V41, P253, DOI 10.1016/j.atmosenv.2006.08.009; Pirastu R, 2011, Epidemiol Prev, V35, P29; Porrini C, 2002, HONEY BEES: ESTIMATING THE ENVIRONMENTAL IMPACT OF CHEMICALS, P186; Porrini C, 2014, B INSECTOL, V67, P137; Satta A, 2012, ENVIRON SCI POLLUT R, V19, P3977, DOI 10.1007/s11356-012-0921-1; Schintu M, 1999, SCI TOTAL ENVIRON, V241, P129, DOI 10.1016/S0048-9697(99)00336-8; SCHONITZER K, 1984, APIDOLOGIE, V15, P23, DOI 10.1051/apido:19840103; Societa Geologica Italiana, 1994, APP LIG EM, V6; Stara P., 1996, IGLESIENTE ARBURESE; Valavanidis A, 2008, J ENVIRON SCI HEAL C, V26, P339, DOI 10.1080/10590500802494538; Varrica D, 2014, ENVIRON RES, V134, P366, DOI 10.1016/j.envres.2014.08.013; Jacobson LDV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104177; Wang TH, 2013, J AGR FOOD CHEM, V61, P5009, DOI 10.1021/jf400695w; Wang Y, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000983; Yu XB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095682	44	49	49	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132491	10.1371/journal.pone.0132491	http://dx.doi.org/10.1371/journal.pone.0132491			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147982	Green Published, Green Submitted, gold			2022-12-26	WOS:000358157600288
J	Stuqui, B; de Paula-Silva, M; Carlos, CP; Ullah, A; Arni, RK; Gil, CD; Oliani, SM				Stuqui, Bruna; de Paula-Silva, Marina; Carlos, Carla Patricia; Ullah, Anwar; Arni, Raghuvir Krishnaswamy; Gil, Cristiane Damas; Oliani, Sonia Maria			Ac2-26 Mimetic Peptide of Annexin A1 Inhibits Local and Systemic Inflammatory Processes Induced by Bothrops moojeni Venom and the Lys-49 Phospholipase A(2) in a Rat Model	PLOS ONE			English	Article							ASPER SNAKE-VENOM; MAST-CELLS; MYOTOXIN-II; ADHESION MOLECULES; HEPARIN-BINDING; EXPRESSION; RELEASE; EDEMA; PROTEIN; INJURY	Annexin A1 (AnxA1) is an endogenous glucocorticoid regulated protein that modulates antiinflammatory process and its therapeutic potential has recently been recognized in a range of systemic inflammatory disorders. The effect of the N-terminal peptide Ac2-26 of AnxA1 on the toxic activities of Bothrops moojeni crude venom (CV) and its myotoxin II (MjTX-II) were evaluated using a peritonitis rat model. Peritonitis was induced by the intraperitoneal injection of either CV or MjTX-II, a Lys-49 phospholipase A2. Fifteen minutes after the injection, the rats were treated with either Ac2-26 or PBS. Four hours later, the CV and MjTX-II-induced peritonitis were characterized by neutrophilia (in the peritoneal exudate, blood and mesentery) and increased number of mesenteric degranulated mast cells and macrophages. At 24 hours post-injection, the local inflammatory response was attenuated in the CV-induced peritonitis while the MjTX-II group exhibited neutrophilia (peritoneal exudates and blood). Ac2-26 treatment prevented the influx of neutrophils in MjTX-II-induced peritonitis and diminished the proportion of mesenteric degranulated mast cells and macrophages in CV-induced peritonitis. Additionally, CV and MjTX-II promoted increased levels of IL-1 beta and IL-6 in the peritoneal exudates which were significantly reduced after Ac2-26 treatment. At 4 and 24 hours, the endogenous expression of AnxA1 was upregulated in the mesenteric neutrophils (CV and MjTX-II groups) and mast cells (CV group). In the kidneys, CV and MjTX-II administrations were associated with an increased number of macrophages and morphological alterations in the juxtamedullary nephrons in proximal and distal tubules. Ac2-26 promoted significant recovery of the juxtamedullary structures, decreased the number of macrophages and diminished the AnxA1 in epithelial cells from distal tubules and renal capsules. Our results show that Ac2-26 treatment significantly attenuates local and systemic inflammatory processes and indicate this peptide as a potential target for the development of new therapeutic strategies for the snakebite envenomation treatment.	[Stuqui, Bruna; de Paula-Silva, Marina; Carlos, Carla Patricia; Oliani, Sonia Maria] Sao Paulo State Univ UNESP, Dept Biol, Lab Immunomorphol, Sao Paulo, Brazil; [Ullah, Anwar; Arni, Raghuvir Krishnaswamy] Sao Paulo State Univ UNESP, Dept Phys, Multiuser Ctr Biomol Innovat, Sao Paulo, Brazil; [Gil, Cristiane Damas] Sao Paulo Fed Univ UNIFESP, Dept Morphol & Genet, Sao Paulo, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Federal de Sao Paulo (UNIFESP)	Oliani, SM (corresponding author), Sao Paulo State Univ UNESP, Dept Biol, Lab Immunomorphol, Sao Paulo, Brazil.	smoliani@ibilce.unesp.br	Ullah, Anwar/B-1720-2013; Arni, Raghuvir K/N-9338-2018; DAMAS GIL, CRISTIANE/GQA-9650-2022; Silva, Marina/P-7857-2017; Oliani, Sonia Maria/E-3476-2012; Carlos, Carla P/K-1403-2014; Damas Gil, Cristiane/E-1187-2012; Arni, Raghuvir K/B-2222-2013	Ullah, Anwar/0000-0003-3793-7393; Arni, Raghuvir K/0000-0003-2460-1145; Oliani, Sonia Maria/0000-0003-0918-2130; Carlos, Carla P/0000-0003-0516-4533; Damas Gil, Cristiane/0000-0001-6979-4126; Arni, Raghuvir K/0000-0003-2460-1145	State of Sao Paulo Research Foundation (FAPESP); National Council for Scientific and Technological Development (CNPq), Brazil	State of Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Council for Scientific and Technological Development (CNPq), Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the State of Sao Paulo Research Foundation (FAPESP) and by the National Council for Scientific and Technological Development (CNPq), Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajuebor MN, 1999, J IMMUNOL, V162, P1685; ANTUNES E, 1990, BRIT J PHARMACOL, V101, P986, DOI 10.1111/j.1476-5381.1990.tb14193.x; Araujo LP, 2010, AM J NEPHROL, V31, P527, DOI 10.1159/000309756; Araujo LP, 2012, INFLAMM RES, V61, P189, DOI 10.1007/s00011-011-0400-z; Araujo SD, 2007, INFLAMM RES, V56, P409, DOI 10.1007/s00011-007-7054-x; ASSAKURA MT, 1985, TOXICON, V23, P691, DOI 10.1016/0041-0101(85)90374-5; Bandeira-Melo C, 2005, J PHARMACOL EXP THER, V313, P1416, DOI 10.1124/jpet.104.080473; Boer-Lima PA, 1999, AM J TROP MED HYG, V61, P698, DOI 10.4269/ajtmh.1999.61.698; Carlos CP, 2010, TRANSPLANTATION, V89, P1362, DOI 10.1097/TP.0b013e3181da0587; Carneiro AS, 2008, TOXICON, V52, P619, DOI 10.1016/j.toxicon.2008.07.012; Chutipongtanate S, 2012, J PROTEOME RES, V11, P3650, DOI 10.1021/pr3000738; COLEMAN JW, 1981, BIOCHEM J, V198, P615, DOI 10.1042/bj1980615; Collares-Buzato CB, 2002, TOXICOL APPL PHARM, V181, P124, DOI 10.1006/taap.2002.9404; da Silva PS, 2011, MOL VIS, V17, P1310; Damazo AS, 2006, J IMMUNOL, V176, P4410, DOI 10.4049/jimmunol.176.7.4410; de Castroa I, 2004, TOXICON, V43, P833, DOI 10.1016/j.toxicon.2004.03.015; dos Santos JI, 2011, PROTEINS, V79, P61, DOI 10.1002/prot.22858; ENNIS M, 1980, BRIT J PHARMACOL, V70, P329, DOI 10.1111/j.1476-5381.1980.tb07940.x; Facio FN, 2011, J MOL MED, V89, P51, DOI 10.1007/s00109-010-0684-4; Fernandes CM, 2006, TOXICON, V47, P549, DOI 10.1016/j.toxicon.2006.01.009; Fundacao Nacional de Saude, 1999, MAN DIAGN TRAT AC AN; Gastardelo TS, 2009, AM J PATHOL, V174, P177, DOI 10.2353/ajpath.2009.080342; Gil CD, 2006, CELL BIOL INT, V30, P338, DOI 10.1016/j.cellbi.2005.12.010; Girol AP, 2013, J IMMUNOL, V190, P5689, DOI 10.4049/jimmunol.1202030; Guido BC, 2013, J INFLAMM-LOND, V10, DOI 10.1186/1476-9255-10-10; GUTIERREZ J M, 1989, Memorias do Instituto Butantan (Sao Paulo), V51, P211; GUTIERREZ JM, 1986, REV BIOL TROP, V34, P209; GUTIERREZ JM, 1995, TOXICON, V33, P1405, DOI 10.1016/0041-0101(95)00085-Z; ITO NMK, 1989, RES VET SCI, V46, P192, DOI 10.1016/S0034-5288(18)31144-5; Kamiguti AS, 1996, TOXICON, V34, P627, DOI 10.1016/0041-0101(96)00017-7; Kanaoka Y, 2003, PROSTAG LEUKOTR ESS, V69, P163, DOI 10.1016/S0952-3278(03)00077-2; Kanashiro MM, 2002, BIOCHEM PHARMACOL, V64, P1179, DOI 10.1016/S0006-2952(02)01288-1; KINI RM, 1989, TOXICON, V27, P613, DOI 10.1016/0041-0101(89)90013-5; Kumar V, 2010, ROBBINS COTRAN PATOL, V8th; Landucci ECT, 1998, EUR J PHARMACOL, V343, P257, DOI 10.1016/S0014-2999(97)01546-X; Landucci ECT, 2000, BIOCHEM PHARMACOL, V59, P1289, DOI 10.1016/S0006-2952(00)00248-3; Leoni G, 2015, J CLIN INVEST, V125, P1215, DOI 10.1172/JCI76693; Lomonte B, 2003, TOXICON, V42, P885, DOI 10.1016/j.toxicon.2003.11.008; LOMONTE B, 1994, J BIOL CHEM, V269, P29867; Lomonte B, 2012, TOXICON, V60, P520, DOI 10.1016/j.toxicon.2012.02.007; Maria DA, 2003, TOXICON, V42, P579, DOI 10.1016/S0041-0101(03)00237-X; Markoff A, 2005, AM J PHYSIOL-RENAL, V289, pF949, DOI 10.1152/ajprenal.00089.2005; MEBS D, 1990, PHARMACOL THERAPEUT, V48, P223, DOI 10.1016/0163-7258(90)90081-C; Metz M, 2006, SCIENCE, V313, P526, DOI 10.1126/science.1128877; MOLITORIS BA, 1991, AM J PHYSIOL, V260, pF769; Moreira V, 2008, TOXICON, V52, P428, DOI 10.1016/j.toxicon.2008.06.012; MORENO JJ, 1992, AGENTS ACTIONS, V36, P258; Murakami M, 2002, J BIOCHEM, V131, P285, DOI 10.1093/oxfordjournals.jbchem.a003101; Murakami M, 1996, J BIOL CHEM, V271, P30041, DOI 10.1074/jbc.271.47.30041; Nascimento NG, 2010, TOXICON, V55, P343, DOI 10.1016/j.toxicon.2009.08.009; Nourshargh S, 2005, TRENDS IMMUNOL, V26, P157, DOI 10.1016/j.it.2005.01.006; Oliani SM, 2008, INFLAMM RES, V57, P450, DOI 10.1007/s00011-008-7222-7; Oliani SM, 2001, AM J PATHOL, V158, P603, DOI 10.1016/S0002-9440(10)64002-3; PALLER MS, 1994, J MEMBRANE BIOL, V142, P127; Perretti M, 2004, J LEUKOCYTE BIOL, V76, P25, DOI 10.1189/jlb.1103552; Polli-Lopes AC, 2013, INT J CLIN EXP PATHO, V6, P13; Santos NA, 2008, TOXICON, V52, P908, DOI 10.1016/j.toxicon.2008.08.020; Saude Md, 2011, AC AN PEC SERPENTES2; SCHWARTZ LB, 1994, CURR OPIN IMMUNOL, V6, P91, DOI 10.1016/0952-7915(94)90039-6; Sena AAS, 2006, CLIN EXP ALLERGY, V36, P1260, DOI 10.1111/j.1365-2222.2006.02570.x; Sgrignolli LR, 2011, NEPHRON CLIN PRACT, V119, pC131, DOI 10.1159/000324228; Silistino-Souza R, 2007, INT J CANCER, V120, P2582, DOI 10.1002/ijc.22639; Soares AM, 1998, TOXICON, V36, P503, DOI 10.1016/S0041-0101(97)00133-5; Soerensen B., 1990, ANIMAIS PECONHENTOS, P138; Solito E, 2003, FASEB J, V17, P1544, DOI 10.1096/fj.02-0941fje; Voronov E., 1999, J VENOM ANIM TOXINS, V5, P5, DOI [10.1590/S0104-79301999000100002, DOI 10.1590/S0104-79301999000100002]; Watanabe L, 2005, BIOCHIMIE, V87, P161, DOI 10.1016/j.biochi.2004.11.005; Yang YH, 2009, J IMMUNOL, V183, P1435, DOI 10.4049/jimmunol.0804000; Zamuner SR, 2005, TOXICON, V46, P806, DOI 10.1016/j.toxicon.2005.08.011	69	19	21	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0130803	10.1371/journal.pone.0130803	http://dx.doi.org/10.1371/journal.pone.0130803			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147724	gold, Green Published, Green Submitted			2022-12-26	WOS:000358157600050
J	Navab, R; Strumpf, D; To, C; Pasko, E; Kim, KS; Park, CJ; Hai, J; Liu, J; Jonkman, J; Barczyk, M; Bandarchi, B; Wang, YH; Venkat, K; Ibrahimov, E; Pham, NA; Ng, C; Radulovich, N; Zhu, CQ; Pintilie, M; Wang, D; Lu, A; Jurisica, I; Walker, GC; Gullberg, D; Tsao, MS				Navab, R.; Strumpf, D.; To, C.; Pasko, E.; Kim, K. S.; Park, C. J.; Hai, J.; Liu, J.; Jonkman, J.; Barczyk, M.; Bandarchi, B.; Wang, Y. H.; Venkat, K.; Ibrahimov, E.; Pham, N-A; Ng, C.; Radulovich, N.; Zhu, C-Q; Pintilie, M.; Wang, D.; Lu, A.; Jurisica, I.; Walker, G. C.; Gullberg, D.; Tsao, M-S			Integrin alpha 11 beta 1 regulates cancer stromal stiffness and promotes tumorigenicity and metastasis in non-small cell lung cancer	ONCOGENE			English	Article							FOCAL ADHESION KINASE; COLLAGEN-BINDING; LYSYL OXIDASE; FIBROBLASTS; RECEPTOR; GROWTH; ALPHA-2-BETA-1; REORGANIZATION; MACROPHAGES; EXPRESSION	Integrin alpha 11 beta 1 is a stromal cell-specific receptor for fibrillar collagens and is overexpressed in carcinoma-associated fibroblasts (CAFs). We have investigated its direct role in cancer progression by generating severe combined immune deficient (SCID) mice deficient in integrin alpha 11 (alpha 11) expression. The growth of A549 lung adenocarcinoma cells and two patient-derived non-small cell lung carcinoma (NSCLC) xenografts in these alpha 11 knockout (alpha 11(-/-)) mice was significantly impeded, as compared with wild-type (alpha 11(+/+)) SCID mice. Orthotopic implantation of a spontaneously metastatic NCI-H460SM cell line into the lungs of alpha 11(-/-) and alpha 11(+/+) mice showed significant reduction in the metastatic potential of these cells in the alpha 11(-/-) mice. We identified that collagen cross-linking is associated with stromal alpha 11 expression, and the loss of tumor stromal alpha 11 expression was correlated with decreased collagen reorganization and stiffness. This study shows the role of integrin alpha 11 beta 1, a receptor for fibrillar collagen in differentiation of fibroblasts into CAFs. Furthermore, our data support an important role for alpha 11 signaling pathway in CAFs, promoting tumor growth and metastatic potential of NSCLC cells and being closely associated with collagen cross-linking and the organization and stiffness of fibrillar collagen matrices.	[Navab, R.; Strumpf, D.; To, C.; Pasko, E.; Park, C. J.; Hai, J.; Liu, J.; Jonkman, J.; Bandarchi, B.; Wang, Y. H.; Venkat, K.; Ibrahimov, E.; Pham, N-A; Ng, C.; Radulovich, N.; Zhu, C-Q; Pintilie, M.; Wang, D.; Lu, A.; Jurisica, I.; Tsao, M-S] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON M5G 2C4, Canada; [Navab, R.; Strumpf, D.; To, C.; Pasko, E.; Park, C. J.; Hai, J.; Liu, J.; Jonkman, J.; Bandarchi, B.; Wang, Y. H.; Venkat, K.; Ibrahimov, E.; Pham, N-A; Ng, C.; Radulovich, N.; Zhu, C-Q; Pintilie, M.; Wang, D.; Lu, A.; Jurisica, I.; Tsao, M-S] Univ Hlth Network, Campbell Family Inst Canc Res, Toronto, ON M5G 2C4, Canada; [Pasko, E.; Tsao, M-S] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Kim, K. S.; Walker, G. C.] Univ Toronto, Dept Chem, 80 St George St, Toronto, ON M5S 1A1, Canada; [Barczyk, M.; Gullberg, D.] Univ Bergen, Dept Biomed, Bergen, Norway; [Barczyk, M.; Gullberg, D.] Univ Bergen, Ctr Canc Biomarkers, Bergen, Norway; [Jurisica, I.] Univ Toronto, Dept Comp Sci, Toronto, ON, Canada; [Jurisica, I.; Tsao, M-S] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University of Bergen; University of Bergen; University of Toronto; University of Toronto	Tsao, MS (corresponding author), Univ Hlth Network, Dept Med Biophys & Lab Med & Pathobiol, 200 Elizabeth St,11th Floor, Toronto, ON M5G 2C4, Canada.	ming.tsao@uhn.on.ca	Hai, Josephine/AAO-9919-2020; Gullberg, Donald/H-2495-2016; Tsao, Ming-Sound/M-3503-2017; Navab, Roya/AGD-7380-2022; Tsao, Ming Sound/AFQ-7332-2022	Gullberg, Donald/0000-0002-7245-4437; Tsao, Ming Sound/0000-0002-9160-5405; Wang, Dennis/0000-0003-0068-1005; Hai, Josephine/0000-0002-5842-7686; Zhu, ChangQi/0000-0002-9992-0258; Pham, Nhu-An/0000-0003-3063-0292; Kim, Kris/0000-0002-8912-520X	Canadian Cancer Society [019293, 020527]; Canadian Institutes of Health Research [MOP-115174]; Terry Fox Foundation STIHR; CIHR [TGT-53912]; Norwegian Centre of Excellence; Research Council of Norway [223250]; Ontario Ministry of Health and Long Term Care	Canadian Cancer Society(Canadian Cancer Society (CCS)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Terry Fox Foundation STIHR; CIHR(Canadian Institutes of Health Research (CIHR)); Norwegian Centre of Excellence; Research Council of Norway(Research Council of Norway); Ontario Ministry of Health and Long Term Care(Ministry of Health and Long-Term Care, Ontario)	This work was supported by grants from the Canadian Cancer Society (# 019293 and # 020527), Canadian Institutes of Health Research grant MOP-115174, Terry Fox Foundation STIHR, CIHR grant TGT-53912 (BB), Norwegian Centre of Excellence grant, The Research Council of Norway grants 223250 (DG) and the Ontario Ministry of Health and Long Term Care. Dr Tsao is the M. Qasim Choksi chair in Lung Cancer Translational research. Dr Jurisica is the Canada Research Chair in Integrative Computational Biology. The data reported in this paper have been deposited into the Gene Expression Omnibus (GEO) database, http://ncbi.nlm.nih.gov/geo/(accession no. GSE51722).	Barczyk MM, 2009, J DENT RES, V88, P621, DOI 10.1177/0022034509339291; Barczyk M, 2010, CELL TISSUE RES, V339, P269, DOI 10.1007/s00441-009-0834-6; Blumbach K, 2012, J BIOL CHEM, V287, P6431, DOI 10.1074/jbc.M111.283119; Brown E, 2003, NAT MED, V9, P796, DOI 10.1038/nm879; Campagnola PJ, 2003, NAT BIOTECHNOL, V21, P1356, DOI 10.1038/nbt894; Carracedo S, 2010, J BIOL CHEM, V285, P10434, DOI 10.1074/jbc.M109.078766; Cheng T, 2014, J MOL CELL BIOL, V6, P506, DOI 10.1093/jmcb/mju039; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Egeblad M, 2008, DIS MODEL MECH, V1, P155, DOI 10.1242/dmm.000596; Erler JT, 2009, CANCER CELL, V15, P35, DOI 10.1016/j.ccr.2008.11.012; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; Gullberg DE, 2002, PROG HISTOCHEM CYTO, V37, P9; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Hertz H., 1882, J ANGEW MATH, V92, P156, DOI [10.1515/9783112342404-004, DOI 10.1515/CRLL.1882.92.156, 10.1515/crll.1882.92.156]; John T, 2011, CLIN CANCER RES, V17, P134, DOI 10.1158/1078-0432.CCR-10-2224; Jokinen J, 2004, J BIOL CHEM, V279, P31956, DOI 10.1074/jbc.M401409200; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Knight CG, 2000, J BIOL CHEM, V275, P35, DOI 10.1074/jbc.275.1.35; Knight CG, 1998, J BIOL CHEM, V273, P33287, DOI 10.1074/jbc.273.50.33287; Kojima Y, 2010, P NATL ACAD SCI USA, V107, P20009, DOI 10.1073/pnas.1013805107; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Lin EY, 2006, CANCER RES, V66, P11238, DOI 10.1158/0008-5472.CAN-06-1278; Littell RC, 1998, J ANIM SCI, V76, P1216; Liu J, 2004, ONCOGENE, V23, P6316, DOI 10.1038/sj.onc.1207795; Lu N, 2010, MATRIX BIOL, V29, P166, DOI 10.1016/j.matbio.2009.11.003; Malkoski SP, 2012, CLIN CANCER RES, V18, P2173, DOI 10.1158/1078-0432.CCR-11-2557; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Nakasone ES, 2012, CANCER CELL, V21, P488, DOI 10.1016/j.ccr.2012.02.017; Navab R, 2011, P NATL ACAD SCI USA, V108, P7160, DOI 10.1073/pnas.1014506108; Navab R, 2009, NEOPLASIA, V11, P1292, DOI 10.1593/neo.09622; Ostman A, 2009, CURR OPIN GENET DEV, V19, P67, DOI 10.1016/j.gde.2009.01.003; Owen KA, 2007, J CELL BIOL, V179, P1275, DOI 10.1083/jcb.200708093; Pietras K, 2010, EXP CELL RES, V316, P1324, DOI 10.1016/j.yexcr.2010.02.045; Popova SN, 2007, ACTA PHYSIOL, V190, P179, DOI 10.1111/j.1748-1716.2007.01718.x; Popova SN, 2004, DEV BIOL, V270, P427, DOI 10.1016/j.ydbio.2004.03.006; Popova SN, 2007, MOL CELL BIOL, V27, P4306, DOI 10.1128/MCB.00041-07; Provenzano PP, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-38; Provenzano PP, 2012, CANCER CELL, V21, P418, DOI 10.1016/j.ccr.2012.01.007; Schulz JN, 2015, J INVEST DERMATOL, V135, P1435, DOI 10.1038/jid.2015.24; Sneddon IN., 1965, INT J ENG SCI, V3, P47, DOI [10.1016/0020-7225(65)90019-4, DOI 10.1016/0020-7225(65)90019-4, 10.1016/0020-7225(65)90019-4.477, DOI 10.1016/0020-7225(65)90019-4.477]; Svendsen OS, 2009, ARTERIOSCL THROM VAS, V29, P1864, DOI 10.1161/ATVBAHA.109.194308; Talior-Volodarsky I, 2012, CARDIOVASC RES, V96, P265, DOI 10.1093/cvr/cvs259; Tiger CF, 2001, DEV BIOL, V237, P116, DOI 10.1006/dbio.2001.0363; Tilghman RW, 2005, J CELL SCI, V118, P2613, DOI 10.1242/jcs.02380; Velling T, 1999, J BIOL CHEM, V274, P25735, DOI 10.1074/jbc.274.36.25735; Wang K, 2002, ONCOGENE, V21, P7598, DOI 10.1038/sj.onc.1205953; Wilgus ML, 2011, CANCER-AM CANCER SOC, V117, P2186, DOI 10.1002/cncr.25768; Williams RM, 2005, BIOPHYS J, V88, P1377, DOI 10.1529/biophysj.104.047308; Xiao Q, 2012, CANCER MICROENVIRON, V5, P261, DOI 10.1007/s12307-012-0105-z; Xing F, 2010, FRONT BIOSCI-LANDMRK, V15, P166, DOI 10.2741/3613; Yamauchi Mitsuo, 2008, V446, P95, DOI 10.1007/978-1-60327-084-7_7; Zeltz C, 2014, ADV EXP MED BIOL, V819, P73, DOI 10.1007/978-94-017-9153-3_5; Zeltz C, 2014, BBA-GEN SUBJECTS, V1840, P2533, DOI 10.1016/j.bbagen.2013.12.022; Zhang WM, 2003, J BIOL CHEM, V278, P7270, DOI 10.1074/jbc.M210313200; Zhu CQ, 2007, P NATL ACAD SCI USA, V104, P11754, DOI 10.1073/pnas.0703040104; Zweers MC, 2007, J INVEST DERMATOL, V127, P467, DOI 10.1038/sj.jid.5700546	57	101	102	1	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 14	2016	35	15					1899	1908		10.1038/onc.2015.254	http://dx.doi.org/10.1038/onc.2015.254			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DJ2CC	26148229	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000374010300003
J	Arredouani, A; Ruas, M; Collins, SC; Parkesh, R; Clough, F; Pillinger, T; Coltart, G; Rietdorf, K; Royle, A; Johnson, P; Braun, M; Zhang, Q; Sones, W; Shimomura, K; Morgan, AJ; Lewis, AM; Chuang, KT; Tunn, R; Gadea, J; Teboul, L; Heister, PM; Tynan, PW; Bellomo, EA; Rutter, GA; Rorsman, P; Churchill, GC; Parrington, J; Galione, A				Arredouani, Abdelilah; Ruas, Margarida; Collins, Stephan C.; Parkesh, Raman; Clough, Frederick; Pillinger, Toby; Coltart, George; Rietdorf, Katja; Royle, Andrew; Johnson, Paul; Braun, Matthias; Zhang, Quan; Sones, William; Shimomura, Kenju; Morgan, Anthony J.; Lewis, Alexander M.; Chuang, Kai-Ting; Tunn, Ruth; Gadea, Joaquin; Teboul, Lydia; Heister, Paula M.; Tynan, Patricia W.; Bellomo, Elisa A.; Rutter, Guy A.; Rorsman, Patrik; Churchill, Grant C.; Parrington, John; Galione, Antony			Nicotinic Acid Adenine Dinucleotide Phosphate (NAADP) and Endolysosomal Two-pore Channels Modulate Membrane Excitability and Stimulus-Secretion Coupling in Mouse Pancreatic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						diabetes; endosome; insulin; lysosome; nicotinic acid adenine dinucleotide phosphate (NAADP); TPC1; TPC2	CYCLIC ADP-RIBOSE; INDUCED INSULIN-SECRETION; CYTOSOLIC CA2+ CONCENTRATION; GLUCAGON-LIKE PEPTIDE-1; ENDOPLASMIC-RETICULUM; BETA-CELL; MOBILIZES CA2+; INTRACELLULAR MESSENGER; INOSITOL TRISPHOSPHATE; ELECTRICAL-ACTIVITY	Background: TPCs are regulated by NAADP and other factors. Results: NAADP-induced Ca2+ release from acidic stores evokes depolarizing currents in pancreatic cells. Inhibition of NAADP signaling or TPC knock out attenuates Ca2+ signaling and insulin secretion. Conclusion: NAADP-evoked Ca2+ release enhances cell excitability and insulin secretion in response to glucose or sulfonylureas. Significance: NAADP signaling pathways offer novel therapeutic targets for diabetes treatment. Pancreatic cells are electrically excitable and respond to elevated glucose concentrations with bursts of Ca2+ action potentials due to the activation of voltage-dependent Ca2+ channels (VDCCs), which leads to the exocytosis of insulin granules. We have examined the possible role of nicotinic acid adenine dinucleotide phosphate (NAADP)-mediated Ca2+ release from intracellular stores during stimulus-secretion coupling in primary mouse pancreatic cells. NAADP-regulated Ca2+ release channels, likely two-pore channels (TPCs), have recently been shown to be a major mechanism for mobilizing Ca2+ from the endolysosomal system, resulting in localized Ca2+ signals. We show here that NAADP-mediated Ca2+ release from endolysosomal Ca2+ stores activates inward membrane currents and depolarizes the cell to the threshold for VDCC activation and thereby contributes to glucose-evoked depolarization of the membrane potential during stimulus-response coupling. Selective pharmacological inhibition of NAADP-evoked Ca2+ release or genetic ablation of endolysosomal TPC1 or TPC2 channels attenuates glucose- and sulfonylurea-induced membrane currents, depolarization, cytoplasmic Ca2+ signals, and insulin secretion. Our findings implicate NAADP-evoked Ca2+ release from acidic Ca2+ storage organelles in stimulus-secretion coupling in cells.	[Arredouani, Abdelilah; Ruas, Margarida; Parkesh, Raman; Clough, Frederick; Pillinger, Toby; Coltart, George; Rietdorf, Katja; Royle, Andrew; Morgan, Anthony J.; Lewis, Alexander M.; Chuang, Kai-Ting; Tunn, Ruth; Gadea, Joaquin; Heister, Paula M.; Tynan, Patricia W.; Churchill, Grant C.; Parrington, John; Galione, Antony] Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England; [Teboul, Lydia] MRC Harwell, Mary Lyon Ctr, Didcot OX11 0RD, Oxon, England; [Johnson, Paul] John Radcliffe Hosp, Nuffield Dept Surg, Oxford OX3 9DU, England; [Shimomura, Kenju] Univ Oxford, Henry Wellcome Ctr Gene Funct, Dept Physiol Anat & Genet, Oxford OX1 3QX, England; [Collins, Stephan C.; Bellomo, Elisa A.] Ctr Sci Gout & Alimentat, Equipe 5, F-21000 Dijon, France; [Rutter, Guy A.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Div Diabet Endocrinol & Med, Sect Cell Biol & Funct Genom, London W12 0NN, England; [Braun, Matthias; Zhang, Quan; Sones, William; Rorsman, Patrik] Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England	University of Oxford; MRC Harwell; University of Oxford; University of Oxford; Institut Agro; AgroSup Dijon; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne; Imperial College London; University of Oxford	Arredouani, A (corresponding author), Qatar Fdn, Qatar Biomed Res Inst, POB 5825, Doha, Qatar.	aarredouani@qf.org.qa; john.parrington@pharm.ox.ac.uk; antony.galione@pharm.ox.ac.uk	arredouani, abdelilah/Q-9650-2019; collins, stephan c/P-4409-2016; Gadea, Joaquin/C-9731-2009; Rorsman, Patrik/A-4331-2016; Zhang, Quan/AAZ-1154-2021; Teboul, Lydia/P-2428-2019	collins, stephan c/0000-0002-1533-3380; Gadea, Joaquin/0000-0002-3474-7626; Rorsman, Patrik/0000-0001-7578-0767; Teboul, Lydia/0000-0002-2789-8637; Rutter, Guy/0000-0001-6360-0343; Pillinger, Toby/0000-0002-6074-2626; Coltart, George/0000-0001-7648-8741; Zhang, Quan/0000-0002-3626-4855; Heister, Paula/0000-0001-7207-869X; Ruas, Margarida/0000-0002-4872-7618; arredouani, abdelilah/0000-0002-5060-916X; Galione, Antony/0000-0002-4132-7646; Bellomo, Elisa/0000-0003-4823-2209	Wellcome Trust; Medical Research Council; Royal Society; BBSRC [BB/G008523/1] Funding Source: UKRI; MRC [MC_UP_1502/1, MR/K001981/1, G0901521] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G008523/1] Funding Source: researchfish; Medical Research Council [G0901521, MR/K001981/1, MC_UP_1502/1] Funding Source: researchfish; Wellcome Trust [102828/Z/13/Z, 095531/Z/11/Z] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal Society(Royal Society of London); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by grants from The Wellcome Trust, the Medical Research Council, and The Royal Society. The authors declare that they have no conflicts of interest with the contents of this article.	Aarhus R, 1995, J BIOL CHEM, V270, P30327, DOI 10.1074/jbc.270.51.30327; AMMALA C, 1991, NATURE, V353, P849, DOI 10.1038/353849a0; Arredouani A, 2002, DIABETES, V51, P3245, DOI 10.2337/diabetes.51.11.3245; Arredouani A, 2002, AM J PHYSIOL-ENDOC M, V282, pE982, DOI 10.1152/ajpendo.00347.2001; Arredouani A, 2010, ISLETS, V2, P323, DOI 10.4161/isl.2.5.12747; Ashcroft FM, 2012, CELL, V148, P1160, DOI 10.1016/j.cell.2012.02.010; Ashcroft SJH, 2000, J MEMBRANE BIOL, V176, P187, DOI 10.1007/s002320001095; Best L, 2005, J PHYSIOL-LONDON, V568, P137, DOI 10.1113/jphysiol.2005.093740; Brailoiu E, 2009, J CELL BIOL, V186, P201, DOI 10.1083/jcb.200904073; Brixel LR, 2010, PFLUG ARCH EUR J PHY, V460, P69, DOI 10.1007/s00424-010-0835-z; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Cancela JM, 1999, NATURE, V398, P74, DOI 10.1038/18032; Cang CL, 2013, CELL, V152, P778, DOI 10.1016/j.cell.2013.01.023; Cheng H, 2007, CELL CALCIUM, V41, P51, DOI 10.1016/j.ceca.2006.04.032; Churchill GC, 2002, CELL, V111, P703, DOI 10.1016/S0092-8674(02)01082-6; Colsoul B, 2010, P NATL ACAD SCI USA, V107, P5208, DOI 10.1073/pnas.0913107107; Cross SE, 2008, TRANSPLANTATION, V86, P907, DOI 10.1097/TP.0b013e318186df87; Davis LC, 2008, CURR BIOL, V18, P1612, DOI 10.1016/j.cub.2008.09.024; Davis LC, 2012, CURR BIOL, V22, P2331, DOI 10.1016/j.cub.2012.10.035; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; Dufer M, 2004, DIABETOLOGIA, V47, P488, DOI 10.1007/s00125-004-1348-0; Duman JG, 2006, TRAFFIC, V7, P859, DOI 10.1111/j.1600-0854.2006.00432.x; Dunne MJ, 2004, PHYSIOL REV, V84, P239, DOI 10.1152/physrev.00022.2003; Durlu-Kandilci NT, 2010, J BIOL CHEM, V285, P24925, DOI 10.1074/jbc.M110.129833; Galione A, 2006, BIOCHEM SOC T, V34, P922, DOI 10.1042/BST0340922; Galione A, 2015, CELL CALCIUM, V58, P27, DOI 10.1016/j.ceca.2014.09.010; Galione A, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004036; Galione A, 2010, BIOCHEM SOC T, V38, P1424, DOI 10.1042/BST0381424; Genazzani AA, 1996, BIOCHEM J, V315, P721, DOI 10.1042/bj3150721; Gilon P, 1999, J BIOL CHEM, V274, P20197, DOI 10.1074/jbc.274.29.20197; Gilon P, 2001, ENDOCR REV, V22, P565, DOI 10.1210/er.22.5.565; Girard CA, 2009, J CLIN INVEST, V119, P80, DOI 10.1172/JCI35772; Grand T, 2008, BRIT J PHARMACOL, V153, P1697, DOI 10.1038/bjp.2008.38; Grimm C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5699; Guinamard R, 2010, PHYSIOLOGY, V25, P155, DOI 10.1152/physiol.00004.2010; Guse AH, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002890; Guse AH, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.144re10; Henquin JC, 2009, DIABETES OBES METAB, V11, P168, DOI 10.1111/j.1463-1326.2009.01109.x; Henquin JC, 1998, ENDOCRINOLOGY, V139, P993, DOI 10.1210/en.139.3.993; Henquin JC, 2003, EUR J CLIN INVEST, V33, P742, DOI 10.1046/j.1365-2362.2003.01207.x; Hockey LN, 2015, J CELL SCI, V128, P232, DOI 10.1242/jcs.164152; Holz G, 2004, HORM METAB RES, V36, P787, DOI 10.1055/s-2004-826165; Ikehata F, 1998, J CLIN INVEST, V102, P395, DOI 10.1172/JCI1656; Islam MS, 2010, ADV EXP MED BIOL, V654, P235, DOI 10.1007/978-90-481-3271-3_11; Jha A, 2014, EMBO J, V33, P501, DOI 10.1002/embj.201387035; Johnson JD, 2002, P NATL ACAD SCI USA, V99, P14566, DOI 10.1073/pnas.222099799; Kato I, 1999, J BIOL CHEM, V274, P1869, DOI 10.1074/jbc.274.4.1869; Kim BJ, 2008, DIABETES, V57, P868, DOI 10.2337/db07-0443; Krishnan K, 2014, PANCREAS, V43, P597, DOI 10.1097/MPA.0000000000000027; LEE HC, 1995, J BIOL CHEM, V270, P2152, DOI 10.1074/jbc.270.5.2152; Lee HC, 2000, J CELL SCI, V113, P4413; Leech CA, 1997, J BIOL CHEM, V272, P17987, DOI 10.1074/jbc.272.29.17987; Lin-Moshier Y, 2014, P NATL ACAD SCI USA, V111, P13087, DOI 10.1073/pnas.1407004111; Lin-Moshier Y, 2012, J BIOL CHEM, V287, P2296, DOI 10.1074/jbc.M111.305813; Marchant Jonathan S, 2013, Messenger (Los Angel), V2, P113; Marchant Jonathan S, 2012, Messenger (Los Angel), V1, P63; Marigo V, 2009, MOL CELL ENDOCRINOL, V299, P194, DOI 10.1016/j.mce.2008.11.011; Masgrau R, 2003, CURR BIOL, V13, P247, DOI 10.1016/S0960-9822(03)00041-1; Meur G, 2010, DIABETES, V59, P653, DOI 10.2337/db09-1091; Miki T, 1998, P NATL ACAD SCI USA, V95, P10402, DOI 10.1073/pnas.95.18.10402; Mitchell KJ, 2003, J BIOL CHEM, V278, P11057, DOI 10.1074/jbc.M210257200; Mitchell KJ, 2001, J CELL BIOL, V155, P41, DOI 10.1083/jcb.200103145; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Morgan AJ, 2014, BIOESSAYS, V36, P173, DOI 10.1002/bies.201300118; Morgan AJ, 2013, J CELL BIOL, V200, P789, DOI 10.1083/jcb.201204078; Morgan AJ, 2011, BIOCHEM J, V439, P349, DOI 10.1042/BJ20110949; Naylor E, 2009, NAT CHEM BIOL, V5, P220, DOI 10.1038/nchembio.150; Ogunbayo OA, 2015, J BIOL CHEM, V290, P1086, DOI 10.1074/jbc.M114.610493; Palade P, 2007, AM J PHYSIOL-CELL PH, V292, pC4, DOI 10.1152/ajpcell.00390.2006; Park DR, 2015, DIABETES, V64, P1224, DOI 10.2337/db14-0939; Park KH, 2013, J BIOL CHEM, V288, P35548, DOI 10.1074/jbc.M113.489278; Parkesh R, 2008, CELL CALCIUM, V43, P531, DOI 10.1016/j.ceca.2007.08.006; Patel S, 2001, TRENDS BIOCHEM SCI, V26, P482, DOI 10.1016/S0968-0004(01)01896-5; Patel S, 2011, CELL CALCIUM, V50, P157, DOI 10.1016/j.ceca.2011.03.011; Pitt SJ, 2010, J BIOL CHEM, V285, P35039, DOI 10.1074/jbc.M110.156927; Pupilli C, 1999, DIABETES, V48, P2309, DOI 10.2337/diabetes.48.12.2309; Ronco V, 2015, CELL CALCIUM, V57, P89, DOI 10.1016/j.ceca.2015.01.001; Ruas M, 2015, EMBO J, V34, P1743, DOI 10.15252/embj.201490009; Ruas M, 2014, MOL CELL BIOL, V34, P3981, DOI 10.1128/MCB.00113-14; Ruas M, 2010, CURR BIOL, V20, P703, DOI 10.1016/j.cub.2010.02.049; Rutter GA, 2006, BIOCHEM SOC T, V34, P675, DOI 10.1042/BST0340675; Rybalchenko V, 2012, J BIOL CHEM, V287, P20407, DOI 10.1074/jbc.M112.359612; Sakurai Y, 2015, SCIENCE, V347, P995, DOI 10.1126/science.1258758; Shawl AI, 2012, ISLETS, V4, P145, DOI 10.4161/isl.19490; Song EK, 2012, CELL REP, V2, P1607, DOI 10.1016/j.celrep.2012.10.018; Szollosi A, 2007, J BIOL CHEM, V282, P14768, DOI 10.1074/jbc.M701382200; TAKASAWA S, 1993, SCIENCE, V259, P370, DOI 10.1126/science.8420005; Tsaih SW, 2014, GENETICS, V198, P17, DOI 10.1534/genetics.114.162982; Walseth TF, 2012, J BIOL CHEM, V287, P2308, DOI 10.1074/jbc.M111.306563; Wang X, 2012, CELL, V151, P372, DOI 10.1016/j.cell.2012.08.036; WORLEY JF, 1994, J BIOL CHEM, V269, P14359; Yagui K, 1998, DIABETOLOGIA, V41, P1024, DOI 10.1007/s001250051026; Yamasaki M, 2004, J BIOL CHEM, V279, P7234, DOI 10.1074/jbc.M311088200; Zhang Q, 2013, CELL METAB, V18, P871, DOI 10.1016/j.cmet.2013.10.014; Zhao YJ, 2012, ACTA BIOCH BIOPH SIN, V44, P719, DOI 10.1093/abbs/gms044; Zong XG, 2009, PFLUG ARCH EUR J PHY, V458, P891, DOI 10.1007/s00424-009-0690-y	96	37	37	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2015	290	35					21376	21392		10.1074/jbc.M115.671248	http://dx.doi.org/10.1074/jbc.M115.671248			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ5IS	26152717	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000360637600015
J	Chen, X; Hnida, K; Graewert, MA; Andersen, JT; Iversen, R; Tuukkanen, A; Svergun, D; Sollid, LM				Chen, Xi; Hnida, Kathrin; Graewert, Melissa Ann; Andersen, Jan Terje; Iversen, Rasmus; Tuukkanen, Anne; Svergun, Dmitri; Sollid, Ludvig M.			Structural Basis for Antigen Recognition by Transglutaminase 2-specific Autoantibodies in Celiac Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antibody; epitope mapping; mutagenesis; small-angle x-ray scattering (SAXS); surface plasmon resonance (SPR); transglutaminase; celiac disease	TISSUE TRANSGLUTAMINASE; BIOLOGICAL MACROMOLECULES; SOLUTION SCATTERING; CELLS; RESOLUTION; DYNAMICS; EPITOPES; BINDING; SURFACE; SYSTEM	Background: Knowledge of how celiac disease autoantibodies recognize transglutaminase 2 (TG2) is limited. Results: The interaction between TG2 and a celiac disease epitope 1 anti-TG2 antibody was studied by small angle x-ray scattering and mutational analysis. Conclusion: TG2 residues Arg-116 and His-134 are part of epitope 1. Significance: The study gives insights into key aspects of celiac disease. Antibodies to the autoantigen transglutaminase 2 (TG2) are a hallmark of celiac disease. We have studied the interaction between TG2 and an anti-TG2 antibody (679-14-E06) derived from a single gut IgA plasma cell of a celiac disease patient. The antibody recognizes one of four identified epitopes targeted by antibodies of plasma cells of the disease lesion. The binding interface was identified by small angle x-ray scattering, ab initio and rigid body modeling using the known crystal structure of TG2 and the crystal structure of the antibody Fab fragment, which was solved at 2.4 angstrom resolution. The result was confirmed by testing binding of the antibody to TG2 mutants by ELISA and surface plasmon resonance. TG2 residues Arg-116 and His-134 were identified to be critical for binding of 679-14-E06 as well as other epitope 1 antibodies. In contrast, antibodies directed toward the two other main epitopes (epitopes 2 and 3) were not affected by these mutations. Molecular dynamics simulations suggest interactions of 679-14-E06 with the N-terminal domain of TG2 via the CDR2 and CDR3 loops of the heavy chain and the CDR2 loop of the light chain. In addition there were contacts of the framework 3 region of the heavy chain with the catalytic domain of TG2. The results provide an explanation for the biased usage of certain heavy and light chain gene segments by epitope 1-specific antibodies in celiac disease.	[Chen, Xi; Hnida, Kathrin; Andersen, Jan Terje; Iversen, Rasmus; Sollid, Ludvig M.] Univ Oslo, Ctr Immune Regulat, N-0372 Oslo, Norway; [Chen, Xi; Hnida, Kathrin; Andersen, Jan Terje; Iversen, Rasmus; Sollid, Ludvig M.] Univ Oslo, Dept Immunol, N-0372 Oslo, Norway; [Chen, Xi; Hnida, Kathrin; Andersen, Jan Terje; Iversen, Rasmus; Sollid, Ludvig M.] Oslo Univ Hosp, N-0372 Oslo, Norway; [Graewert, Melissa Ann; Tuukkanen, Anne; Svergun, Dmitri] European Mol Biol Lab, Hamburg Outstn, D-22607 Hamburg, Germany	University of Oslo; University of Oslo; University of Oslo; European Molecular Biology Laboratory (EMBL)	Sollid, LM (corresponding author), Oslo Univ Hosp, Rikshosp, Ctr Immune Regulat, N-0372 Oslo, Norway.	l.m.sollid@medisin.uio.no	Andersen, Jan Terje/AAB-6209-2020; Sollid, Ludvig/N-9691-2015	Sollid, Ludvig/0000-0001-8860-704X; Andersen, Jan Terje/0000-0003-1710-1628; Iversen, Rasmus/0000-0002-3292-1766	Regional Core Facility for Structural Biology and Bioinformatics at the South-Eastern Norway Regional Health Authority [2012085, 2015095]	Regional Core Facility for Structural Biology and Bioinformatics at the South-Eastern Norway Regional Health Authority	We thank Bjorg Simonsen for help with antibody production, Dr Bjorn Dalhus for access to crystallization screening at the Regional Core Facility for Structural Biology and Bioinformatics at the South-Eastern Norway Regional Health Authority (Grants 2012085 and 2015095) and Dr. Hyun Ho Park for providing the structure of TG2 with GTP (PDB code 4PYG) before public release. We also acknowledge the European Synchrotron Radiation Facility (ESRF) for providing beam time (MX-1587), and we thank the staff of ESRF for assistance and support in using beamline BM30.	Abadie V, 2011, ANNU REV IMMUNOL, V29, P493, DOI 10.1146/annurev-immunol-040210-092915; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Akimov SS, 2001, BLOOD, V98, P1567, DOI 10.1182/blood.V98.5.1567; Blanchet CE, 2015, J APPL CRYSTALLOGR, V48, P431, DOI 10.1107/S160057671500254X; Burkovitz A, 2014, FEBS J, V281, P306, DOI 10.1111/febs.12597; Di Niro R, 2012, NAT MED, V18, P441, DOI 10.1038/nm.2656; Dieterich W, 1998, GASTROENTEROLOGY, V115, P1317, DOI 10.1016/S0016-5085(98)70007-1; Dieterich W, 1997, NAT MED, V3, P797, DOI 10.1038/nm0797-797; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Fesus L, 2002, TRENDS BIOCHEM SCI, V27, P534, DOI 10.1016/S0968-0004(02)02182-5; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Gundemir S, 2012, BBA-MOL CELL RES, V1823, P406, DOI 10.1016/j.bbamcr.2011.09.012; Han BG, 2010, INT J BIOL MACROMOL, V47, P190, DOI 10.1016/j.ijbiomac.2010.04.023; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Husby S, 2012, J PEDIATR GASTR NUTR, V54, P136, DOI 10.1097/MPG.0b013e31821a23d0; Iversen R, 2014, P NATL ACAD SCI USA, V111, P17146, DOI 10.1073/pnas.1407457111; Iversen R, 2013, J IMMUNOL, V190, P5981, DOI 10.4049/jimmunol.1300183; Jang TH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107005; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Lefranc MP, 2009, NUCLEIC ACIDS RES, V37, pD1006, DOI 10.1093/nar/gkn838; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Liu SP, 2002, P NATL ACAD SCI USA, V99, P2743, DOI 10.1073/pnas.042454899; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mariani P, 2000, BIOPHYS J, V78, P3240, DOI 10.1016/S0006-3495(00)76860-3; Marzari R, 2001, J IMMUNOL, V166, P4170, DOI 10.4049/jimmunol.166.6.4170; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Molberg O, 1998, NAT MED, V4, P713, DOI 10.1038/nm0698-713; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pinkas DM, 2007, PLOS BIOL, V5, P2788, DOI 10.1371/journal.pbio.0050327; Raposo B, 2014, J EXP MED, V211, P405, DOI 10.1084/jem.20130968; Sarang Z, 2005, HEPATOLOGY, V42, P578, DOI 10.1002/hep.20812; Sela-Culang I, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00302; Simon-Vecsei Z, 2012, P NATL ACAD SCI USA, V109, P431, DOI 10.1073/pnas.1107811108; Sollid LM, 2013, NAT REV IMMUNOL, V13, P294, DOI 10.1038/nri3407; Stamnaes J, 2010, J BIOL CHEM, V285, P25402, DOI 10.1074/jbc.M109.097162; Sulkanen S, 1998, GASTROENTEROLOGY, V115, P1322, DOI 10.1016/S0016-5085(98)70008-3; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zhang L, 1996, PROTEINS, V24, P433, DOI 10.1002/(SICI)1097-0134(199604)24:4<433::AID-PROT3>3.0.CO;2-F	48	23	23	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2015	290	35					21365	21375		10.1074/jbc.M115.669895	http://dx.doi.org/10.1074/jbc.M115.669895			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ5IS	26160175	Green Published, hybrid			2022-12-26	WOS:000360637600014
J	Latge, C; Cabral, KMS; de Oliveira, GAP; Raymundo, DP; Freitas, JA; Johanson, L; Romao, LF; Palhano, FL; Herrmann, T; Almeida, MS; Foguel, D				Latge, Cristiane; Cabral, Katia M. S.; de Oliveira, Guilherme A. P.; Raymundo, Diana P.; Freitas, Julia A.; Johanson, Laizes; Romao, Luciana F.; Palhano, Fernando L.; Herrmann, Torsten; Almeida, Marcius S.; Foguel, Debora			The Solution Structure and Dynamics of Full-length Human Cerebral Dopamine Neurotrophic Factor and Its Neuroprotective Role against alpha-Synuclein Oligomers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARKINSONS-DISEASE; PRACTICAL ASPECTS; CDNF PROTECTS; FACTOR MANF; RAT MODEL; RELAXATION; AUTOPHAGY; NEURONS; AGGREGATION; BINDING	Cerebral dopamine neurotrophic factor (CDNF) is a promising therapeutic agent for Parkinson disease. As such, there has been great interest in studying its mode of action, which remains unknown. The three-dimensional crystal structure of the N terminus (residues 9-107) of CDNF has been determined, but there have been no published structural studies on the full-length protein due to proteolysis of its C-terminal domain, which is considered intrinsically disordered. An improved purification protocol enabled us to obtain active full-length CDNF and to determine its three-dimensional structure in solution. CDNF contains two well folded domains (residues 10-100 and 111-157) that are linked by a loop of intermediate flexibility. We identified two surface patches on the N-terminal domain that were characterized by increased conformational dynamics that should allow them to embrace active sites. One of these patches is formed by residues Ser-33, Leu-34, Ala-66, Lys-68, Ile-69, Leu-70, Ser-71, and Glu-72. The other includes a flexibly disordered N-terminal tail (residues 1-9), followed by the N-terminal portion of alpha-helix 1 (residues Cys-11, Glu-12, Val-13, Lys-15, and Glu-16) and residue Glu-88. The surface of the C-terminal domain contains two conserved active sites, which have previously been identified in mesencephalic astrocyte-derived neurotrophic factor, a CDNF paralog, which corresponds to its intracellular mode of action. We also showed that CDNF was able to protect dopaminergic neurons against injury caused by alpha-synuclein oligomers. This advises its use against physiological damages caused by alpha-synuclein oligomers, as observed in Parkinson disease and several other neurodegenerative diseases.	[Latge, Cristiane; Cabral, Katia M. S.; de Oliveira, Guilherme A. P.; Raymundo, Diana P.; Freitas, Julia A.; Johanson, Laizes; Palhano, Fernando L.; Almeida, Marcius S.; Foguel, Debora] Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo de Meis, BR-21941902 Rio De Janeiro, Brazil; [Romao, Luciana F.] Univ Fed Rio de Janeiro, UFRJ Polo Xerem, BR-25245390 Rio De Janeiro, Brazil; [Herrmann, Torsten] UMR 5280 CNRS, Inst Sci Analyt, F-69100 Villeurbanne, France; [Almeida, Marcius S.] Univ Fed Rio de Janeiro, Ctr Nacl Biol Estrutural & Bioimagem CENABIO, BR-21941902 Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universidade Federal do Rio de Janeiro	Almeida, MS (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo de Meis, BR-21941902 Rio De Janeiro, Brazil.	msalmeida@bioqmed.ufrj.br; foguel@bioqmed.ufrj.br	de Oliveira, Guilherme A. P./O-1192-2013; Palhano, Fernando/AAB-3144-2021; Herrmann, Torsten/B-9978-2008	de Oliveira, Guilherme A. P./0000-0002-0063-5888; Palhano, Fernando/0000-0001-5336-632X; almeida, marcius/0000-0003-4921-8185; Herrmann, Torsten/0000-0003-2115-4781; Foguel, Debora/0000-0001-7312-7115	European Union FP7 IRSES Grant [247546]	European Union FP7 IRSES Grant	The 1 GHz NMR spectra were collected at the RALF-NMR large scale facility for high-field NMR in Lyon was supported by proposal European Union FP7 IRSES Grant 247546 (WW-NMR). SAXS data were collected at the Brazilian Synchrotron Light Laboratory (LNLS) under proposal SAXS1-14200. We thank Dr. Luciana Ferreira Romao for the primary cultures of dopaminergic neurons. The Centro Nacional de Ressonancia Magnetica Nuclear Jiri Jonas (CNRMN) is gratefully acknowledged for providing access to NMR instrumentation.	Airavaara M, 2012, CELL TRANSPLANT, V21, P1213, DOI 10.3727/096368911X600948; Baba M, 1998, AM J PATHOL, V152, P879; Back S, 2013, BRAIN BEHAV, V3, P75, DOI 10.1002/brb3.117; BAX A, 1993, ACCOUNTS CHEM RES, V26, P131, DOI 10.1021/ar00028a001; Boehr DD, 2008, SCIENCE, V320, P1429, DOI 10.1126/science.1158818; Bordner AJ, 2005, PROTEINS, V60, P353, DOI 10.1002/prot.20433; Braga CA, 2011, J MOL BIOL, V405, P254, DOI 10.1016/j.jmb.2010.10.027; Bruhn H, 2005, BIOCHEM J, V389, P249, DOI 10.1042/BJ20050051; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Chakrabarti P, 2002, PROTEINS, V47, P334, DOI 10.1002/prot.10085; Chambraud B, 2010, P NATL ACAD SCI USA, V107, P2658, DOI 10.1073/pnas.0914957107; Cohen HY, 2004, MOL CELL, V13, P627, DOI 10.1016/S1097-2765(04)00094-2; Conway KA, 2001, SCIENCE, V294, P1346, DOI 10.1126/science.1063522; Cordero-Llana O, 2015, MOL THER, V23, P244, DOI 10.1038/mt.2014.206; Csermely P, 2010, TRENDS BIOCHEM SCI, V35, P539, DOI 10.1016/j.tibs.2010.04.009; De S, 2005, BMC STRUCT BIOL, V5, DOI 10.1186/1472-6807-5-15; Decressac M, 2013, P NATL ACAD SCI USA, V110, pE1817, DOI 10.1073/pnas.1305623110; Fahn S, 2003, ANN NY ACAD SCI, V991, P1, DOI 10.1111/j.1749-6632.2003.tb07458.x; FRAICHARD A, 1995, J CELL SCI, V108, P3181; Guerry P, 2012, METHODS MOL BIOL, V831, P429, DOI 10.1007/978-1-61779-480-3_22; Hellman M, 2011, J BIOL CHEM, V286, P2675, DOI 10.1074/jbc.M110.146738; Henderson MJ, 2013, J BIOL CHEM, V288, P4209, DOI 10.1074/jbc.M112.400648; Hoseki J, 2010, FEBS LETT, V584, P1536, DOI 10.1016/j.febslet.2010.03.008; IWAI A, 1995, NEURON, V14, P467, DOI 10.1016/0896-6273(95)90302-X; Jameson DM, 2003, METHOD ENZYMOL, V360, P1; Jarymowycz VA, 2006, CHEM REV, V106, P1624, DOI 10.1021/cr040421p; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lashuel HA, 2013, NAT REV NEUROSCI, V14, P38, DOI 10.1038/nrn3406; Latge C, 2013, BIOMOL NMR ASSIGN, V7, P101, DOI 10.1007/s12104-012-9388-8; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Lin DW, 2000, ACTA CRYSTALLOGR D, V56, P828, DOI 10.1107/S0907444900005655; Lindholm P, 2007, NATURE, V448, P73, DOI 10.1038/nature05957; LINDSAY RM, 1993, EXP NEUROL, V124, P103, DOI 10.1006/exnr.1993.1181; Lindstrom R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073928; LUGINBUHL P, 1995, J MAGN RESON SER B, V109, P229, DOI 10.1006/jmrb.1995.0016; Mei JM, 2014, NEUROL SCI, V35, P1275, DOI 10.1007/s10072-014-1700-1; MEIBOOM S, 1958, REV SCI INSTRUM, V29, P688, DOI 10.1063/1.1716296; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nadella R, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0209-0; Narhi L, 1999, J BIOL CHEM, V274, P9843, DOI 10.1074/jbc.274.14.9843; Nederveen AJ, 2005, PROTEINS, V59, P662, DOI 10.1002/prot.20408; Palgi M, 2009, P NATL ACAD SCI USA, V106, P2429, DOI 10.1073/pnas.0810996106; Parkash V, 2009, PROTEIN ENG DES SEL, V22, P233, DOI 10.1093/protein/gzn080; PENG JW, 1994, METHOD ENZYMOL, V239, P563; Petrova PS, 2003, J MOL NEUROSCI, V20, P173, DOI 10.1385/JMN:20:2:173; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Ren XM, 2013, EXP NEUROL, V248, P148, DOI 10.1016/j.expneurol.2013.06.002; Renner C, 2002, J BIOMOL NMR, V23, P23, DOI 10.1023/A:1015385910220; Romao LF, 2008, J NEUROCHEM, V106, P746, DOI 10.1111/j.1471-4159.2008.05428.x; Sawada M, 2003, NAT CELL BIOL, V5, P352, DOI 10.1038/ncb955; Serrano P, 2012, J BIOMOL NMR, V53, P341, DOI 10.1007/s10858-012-9645-2; Shaltiel-Karyo R, 2013, J BIOL CHEM, V288, P17579, DOI 10.1074/jbc.M112.434787; Smeyne RJ, 2005, MOL BRAIN RES, V134, P57, DOI 10.1016/j.molbrainres.2004.09.017; Spencer B, 2009, J NEUROSCI, V29, P13578, DOI 10.1523/JNEUROSCI.4390-09.2009; SPERA S, 1991, J AM CHEM SOC, V113, P5490, DOI 10.1021/ja00014a071; Sun ZP, 2011, J NEUROCHEM, V117, P121, DOI 10.1111/j.1471-4159.2011.07179.x; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Ulrich EL, 2008, NUCLEIC ACIDS RES, V36, pD402, DOI 10.1093/nar/gkm957; van Rooijen BD, 2009, J MOL BIOL, V394, P826, DOI 10.1016/j.jmb.2009.10.021; VOLD RL, 1968, J CHEM PHYS, V48, P3831, DOI 10.1063/1.1669699; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Voutilainen MH, 2011, EXP NEUROL, V228, P99, DOI 10.1016/j.expneurol.2010.12.013; Wan OW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038545; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Winner B, 2011, P NATL ACAD SCI USA, V108, P4194, DOI 10.1073/pnas.1100976108; Xilouri M, 2013, BRAIN, V136, P2130, DOI 10.1093/brain/awt131; Xilouri M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005515; Zhu G, 2000, J MAGN RESON, V143, P423, DOI 10.1006/jmre.2000.2022	70	30	30	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2015	290	33					20527	20540		10.1074/jbc.M115.662254	http://dx.doi.org/10.1074/jbc.M115.662254			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP1AT	26149686	hybrid, Green Published			2022-12-26	WOS:000359608900049
J	Arandjelovic, O				Arandjelovic, Ognjen			Clinical Trial Adaptation by Matching Evidence in Complementary Patient Subgroups of Auxiliary Blinding Questionnaire Responses	PLOS ONE			English	Article							DESIGN; SUCCESS	Clinical trial adaptation refers to any adjustment of the trial protocol after the onset of the trial. Such adjustment may take on various forms, including the change in the dose of administered medicines, the frequency of administering an intervention, the number of trial participants, or the duration of the trial, to name just some possibilities. The main goal is to make the process of introducing new medical interventions to patients more efficient, either by reducing the cost or the time associated with evaluating their safety and efficacy. The principal challenge, which is an outstanding research problem, is to be found in the question of how adaptation should be performed so as to minimize the chance of distorting the outcome of the trial. In this paper we propose a novel method for achieving this. Unlike most of the previously published work, our approach focuses on trial adaptation by sample size adjustment i.e. by reducing the number of trial participants in a statistically informed manner. We adopt a stratification framework recently proposed for the analysis of trial outcomes in the presence of imperfect blinding and based on the administration of a generic auxiliary questionnaire that allows the participants to express their belief concerning the assigned intervention (treatment or control). We show that this data, together with the primary measured variables, can be used to make the probabilistically optimal choice of the particular sub-group a participant should be removed from if trial size reduction is desired. Extensive experiments on a series of simulated trials are used to illustrate the effectiveness of our method.	Deakin Univ, Ctr Pattern Recognit & Data Analyt, Sch Informat Technol, Geelong, Vic 3217, Australia	Deakin University	Arandjelovic, O (corresponding author), Deakin Univ, Ctr Pattern Recognit & Data Analyt, Sch Informat Technol, Geelong, Vic 3217, Australia.	ognjen.arandjelovic@gmail.com	Arandjelović, Ognjen/V-5255-2019	Arandjelović, Ognjen/0000-0002-9314-194X				Aitchison J, 1996, LOG NORMAL DISTRIBUT; [Anonymous], 2013, BAYESIAN DIS MAPPING; Arandjelovic O, 2012, ADV NEURAL INF PROC, V25, P530; Arandjelovic O, 2015, AAAI CONF ARTIF INTE, P1693; Arandjelovic Ognjen, 2012, PLoS One, V7, pe48984, DOI 10.1371/journal.pone.0048984; Bang HJ, 2004, CONTROL CLIN TRIALS, V25, P143, DOI 10.1016/j.cct.2003.10.016; Berger VW, 2005, STAT PRACT, P1, DOI 10.1002/0470863641; Berry DA, 2006, NAT REV DRUG DISCOV, V5, P27, DOI 10.1038/nrd1927; Berry DA, 2012, NAT REV CLIN ONCOL, V9, P199, DOI 10.1038/nrclinonc.2011.165; Berry DA, 2011, J CLIN ONCOL, V29, P606, DOI 10.1200/JCO.2010.32.2685; Berry SM, 2010, CH CRC BIOSTAT SER, P1, DOI 10.1201/EBK1439825488; Bhattacharyya A., 1943, B CALCUTTA MATH SOC, V35, P99; Biswas S, 2009, CLIN TRIALS, V6, P205, DOI 10.1177/1740774509104992; Broglio KR, 2014, J BIOPHARM STAT, V24, P685, DOI 10.1080/10543406.2014.888569; Chen MH, 2010, FRONTIERS OF STATISTICAL DECISION MAKING AND BAYESIAN ANALYSIS: IN HONOR OF JAMES O. BERGER, P257, DOI 10.1007/978-1-4419-6944-6_8; Chow SC, 2012, CH CRC BIOSTAT SER, P1; Cohen SB, 2008, ARTHRITIS RHEUM, V58, P1299, DOI 10.1002/art.23417; Cui L, 1999, BIOMETRICS, V55, P853, DOI 10.1111/j.0006-341X.1999.00853.x; Fisher LD, 1998, STAT MED, V17, P1551, DOI 10.1002/(SICI)1097-0258(19980730)17:14<1551::AID-SIM868>3.0.CO;2-E; Friedman L. M., 1998, FUNDAMENTALS CLIN TR; Gao P, 2008, J BIOPHARM STAT, V18, P1184, DOI 10.1080/10543400802369053; Gelman A., 2021, BAYESIAN DATA ANAL; Gilks W. R., 1995, MARKOV CHAIN MONTE C, DOI 10.1201/b14835; Haahr MT, 2006, CLIN TRIALS, V3, P360, DOI 10.1177/1740774506069153; Hellinger E, 1909, J REINE ANGEW MATH, V136, P210, DOI 10.1515/crll.1909.136.210; Hemila H, 2005, CONTEMP CLIN TRIALS, V26, P512, DOI 10.1016/j.cct.2005.04.002; Henneicke-von Zeplin HH, 2005, CONTEMP CLIN TRIALS, V26, P512, DOI 10.1016/j.cct.2005.04.004; Hrobjartsson A, 2007, INT J EPIDEMIOL, V36, P654, DOI 10.1093/ije/dym020; Hung HMJ, 2006, PHARM STAT, V5, P99, DOI 10.1002/pst.219; James KE, 1996, STAT MED, V15, P1421; Jennison C, 2003, STAT MED, V22, P971, DOI 10.1002/sim.1457; Kadane JB, 2011, BAYESIAN METHODS ETH; Kolahi J, 2009, COMMUNITY DENT ORAL, V37, P477, DOI 10.1111/j.1600-0528.2009.00494.x; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; Lang T, 2011, AM J TROP MED HYG, V85, P967, DOI 10.4269/ajtmh.2011.11-0151; Lee JJ, 2012, STAT MED, V31, P2955, DOI 10.1002/sim.5404; Leon AC, 2008, SCHIZOPHRENIA BULL, V34, P664, DOI 10.1093/schbul/sbn035; Ly LP, 2001, J CLIN ENDOCR METAB, V86, P4078, DOI 10.1210/jc.86.9.4078; Meinert CL, 1986, CLIN TRIALS DESIGN C; Meurer WJ, 2012, ANN EMERG MED, V60, P451, DOI 10.1016/j.annemergmed.2012.01.020; Nelson NJ, 2010, J NATL CANCER I, V102, P1217, DOI 10.1093/jnci/djq319; Nissen SE, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010035; Onisko A, 2013, ARTIF INTELL MED, V57, P197, DOI 10.1016/j.artmed.2013.01.004; Orloff J, 2009, NAT REV DRUG DISCOV, V8, P949, DOI 10.1038/nrd3025; Penston J, 2005, MED HYPOTHESES, V64, P651, DOI 10.1016/j.mehy.2004.09.006; PIANTADOSI S, 1997, CLIN TRIALS METHODOL; Sackett DL, 2007, INT J EPIDEMIOL, V36, P664, DOI 10.1093/ije/dym088; Spiegelhalter DJ, 2004, BAYESIAN APPROACHES, DOI DOI 10.1002/0470092602; U S Department of Health and Human Services, 2010, GUIDANCE IND ADAPTIV; Wickens C.D., 1992, ENG PSYCHOL HUMAN PE, V2nd ed.; Yin G, 2013, CLIN TRIAL DESIGN BA; Zang Y, 2014, CHIN CLIN ONCOL, V3, DOI 10.3978/j.issn.2304-3865.2014.06.04	52	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131524	10.1371/journal.pone.0131524	http://dx.doi.org/10.1371/journal.pone.0131524			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161797	Green Submitted, gold, Green Published			2022-12-26	WOS:000358162300042
J	Raimondi, D; Orlando, G; Vranken, WF				Raimondi, Daniele; Orlando, Gabriele; Vranken, Wim F.			An Evolutionary View on Disulfide Bond Connectivities Prediction Using Phylogenetic Trees and a Simple Cysteine Mutation Model	PLOS ONE			English	Article							RECURSIVE NEURAL-NETWORKS; WEB SERVER; PROTEINS; STATE	Disulfide bonds are crucial for many structural and functional aspects of proteins. They have a stabilizing role during folding, can regulate enzymatic activity and can trigger allosteric changes in the protein structure. Moreover, knowledge of the topology of the disulfide connectivity can be relevant in genomic annotation tasks and can provide long range constraints for ab-initio protein structure predictors. In this paper we describe PhyloCys, a novel unsupervised predictor of disulfide bond connectivity from known cysteine oxidation states. For each query protein, PhyloCys retrieves and aligns homologs with HHblits and builds a phylogenetic tree using ClustalW. A simplified model of cysteine co-evolution is then applied to the tree in order to hypothesize the presence of oxidized cysteines in the inner nodes of the tree, which represent ancestral protein sequences. The tree is then traversed from the leaves to the root and the putative disulfide connectivity is inferred by observing repeated patterns of tandem mutations between a sequence and its ancestors. A final correction is applied using the Edmonds-Gabow maximum weight perfect matching algorithm. The evolutionary approach applied in PhyloCys results in disulfide bond predictions equivalent to Sephiroth, another approach that takes whole sequence information into account, and is 26-29% better than state of the art methods based on cysteine covariance patterns in multiple sequence alignments, while requiring one order of magnitude fewer homologous sequences (10(3) instead of 10(4)), thus extending its range of applicability.	[Raimondi, Daniele; Orlando, Gabriele; Vranken, Wim F.] ULB VUB, Interuniv Inst Bioinformat Brussels, Brussels, Belgium; [Raimondi, Daniele; Orlando, Gabriele; Vranken, Wim F.] Vrije Univ Brussel, Struct Biol Brussels, Brussels, Belgium; [Raimondi, Daniele; Orlando, Gabriele; Vranken, Wim F.] VIB, Dept Biol Struct, Brussels, Belgium; [Raimondi, Daniele; Orlando, Gabriele] ULB, Machine Learning Grp, Brussels, Belgium	Universite Libre de Bruxelles; Vrije Universiteit Brussel; Flanders Institute for Biotechnology (VIB); Universite Libre de Bruxelles	Vranken, WF (corresponding author), ULB VUB, Interuniv Inst Bioinformat Brussels, Brussels, Belgium.	wvranken@vub.ac.be	Vranken, Wim F/J-5051-2016; Orlando, Gabriele/GVU-4650-2022	Vranken, Wim F/0000-0001-7470-4324; 	Agency for Innovation by Science and Technology in Flanders (IWT); Brussels Institute for Research and Innovation (Innoviris) grant [BB2B2010-1-12]	Agency for Innovation by Science and Technology in Flanders (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Brussels Institute for Research and Innovation (Innoviris) grant(Innoviris)	DR is funded by the Agency for Innovation by Science and Technology in Flanders (IWT) (http://www.iwt.be/). WFV is funded by the Brussels Institute for Research and Innovation (Innoviris) grant BB2B2010-1-12 (http://www.innoviris.be/nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashkenazy H, 2012, NUCLEIC ACIDS RES, V40, pW580, DOI 10.1093/nar/gks498; Ceroni A, 2006, NUCLEIC ACIDS RES, V34, pW177, DOI 10.1093/nar/gkl266; Cheng JL, 2006, PROTEINS, V62, P617, DOI 10.1002/prot.20787; Chuang CC, 2003, PROTEINS, V53, P1, DOI 10.1002/prot.10492; Ekeberg M, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.012707; Elias I, 2005, P INT C AUT LANG PRO; Fariselli P, 2001, BIOINFORMATICS, V17, P957, DOI 10.1093/bioinformatics/17.10.957; Felsenstein J., 2004, INFERRING PHYLOGENIE; Ferre F, 2005, NUCL ACIDS RES, V33; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; GABOW HN, 1976, J ACM, V23, P221, DOI 10.1145/321941.321942; GOBEL U, 1994, PROTEINS, V18, P309, DOI 10.1002/prot.340180402; Huerta-Cepas J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-24; Jones DT, 2012, BIOINFORMATICS, V28, P184, DOI 10.1093/bioinformatics/btr638; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Martelli PL, 2002, PROTEIN SCI, V11, P2735, DOI 10.1110/ps.0219602; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Raimondi D., 2014, BIOINFORMATICS, V2014, P1; Remmert M, 2012, NATURE METHODS; Rubinstein R, 2008, BIOINFORMATICS, V24, P498, DOI 10.1093/bioinformatics/btm637; Savojardo C, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S1-S10; Savojardo C, 2011, BIOINFORMATICS, V27, P2224, DOI 10.1093/bioinformatics/btr387; Singh Rahul, 2008, Briefings in Functional Genomics & Proteomics, V7, P157, DOI 10.1093/bfgp/eln008; Tsai CH, 2007, CURR PROTEIN PEPT SC, V8, P243, DOI 10.2174/138920307780831848; van Vlijmen HWT, 2004, J MOL BIOL, V335, P1083, DOI 10.1016/j.jmb.2003.10.077; Velankar S, 2012, NUCL ACIDS RES; Vullo A, 2004, BIOINFORMATICS, V20, P653, DOI 10.1093/bioinformatics/btg463; Wedemeyer WJ, 2000, BIOCHEMISTRY-US, V39, P7032, DOI 10.1021/bi005111p; Zhao E, 2005, BIOINFORMATICS, V21, P1415, DOI 10.1093/bioinformatics/bti179	29	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131792	10.1371/journal.pone.0131792	http://dx.doi.org/10.1371/journal.pone.0131792			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161671	Green Submitted, Green Published, gold			2022-12-26	WOS:000358162300059
J	Viarouge, C; Breard, E; Zientara, S; Vitour, D; Sailleau, C				Viarouge, Cyril; Breard, Emmanuel; Zientara, Stephan; Vitour, Damien; Sailleau, Corinne			Duplex Real-Time RT-PCR Assays for the Detection and Typing of Epizootic Haemorrhagic Disease Virus	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; BLUETONGUE-VIRUS; NUCLEIC-ACID; SEROTYPES; CATTLE; ASSIGNMENT; PROTEINS; SEGMENTS; GENOME; ISLAND	Epizootic haemorrhagic disease virus (EHDV) may cause severe clinical episodes in some species of deer and sometimes in cattle. Laboratory diagnosis provides a basis for the design and timely implementation of disease control measures. There are seven distinct EHDV serotypes, VP2 coding segment 2 being the target for serotype specificity. This paper reports the development and validation of eight duplex real-time RT-PCR assays to simultaneously amplify the EHDV target (S9 for the pan-EHDV real-time RT-PCR assay and S2 for the serotyping assays) and endogenous control gene Beta-actin. Analytical and diagnostic sensitivity and specificity, inter-and intra-assay variation and efficiency were evaluated for each assay. All were shown to be highly specific and sensitive.	[Viarouge, Cyril; Breard, Emmanuel; Zientara, Stephan; Vitour, Damien; Sailleau, Corinne] ANSES INRA ENVA UPEC, UMR Virol 1161, F-94700 Maisons Alfort, France	INRAE; Universite Paris-Est-Creteil-Val-de-Marne (UPEC)	Sailleau, C (corresponding author), ANSES INRA ENVA UPEC, UMR Virol 1161, 23 Ave Gen Gaulle, F-94700 Maisons Alfort, France.	corinne.sailleau@anses.fr	breard, emmanuel/E-2123-2011; Zientara, Stephan/A-5336-2016; Zientara, Stephan/AAA-7661-2021	Zientara, Stephan/0000-0003-0089-8175; Zientara, Stephan/0000-0002-6733-8503	EU [FP7-613996 Vmerge]	EU(European Commission)	This study was partially funded by EU grant FP7-613996 Vmerge (catalogued by the VMERGE Steering Committee as Vmerge004) and the additional funding has come from the laboratory's own resources.	Allison AB, 2010, J GEN VIROL, V91, P430, DOI 10.1099/vir.0.015651-0; Anthony SJ, 2009, VIRUS RES, V145, P200, DOI 10.1016/j.virusres.2009.07.012; BallagiPordany A, 1996, MOL CELL PROBE, V10, P159, DOI 10.1006/mcpr.1996.0022; Belhouchet M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025697; Breard E, 2004, VET REC, V155, P422, DOI 10.1136/vr.155.14.422; Breard E, 2013, RES VET SCI, V95, P794, DOI 10.1016/j.rvsc.2013.06.026; Cetre-Sossah C, 2014, VET MICROBIOL, V170, P383, DOI 10.1016/j.vetmic.2014.02.007; Chalmers G. A., 1964, Wildlife Diseases; Clavijo A, 2010, J VET DIAGN INVEST, V22, P588, DOI 10.1177/104063871002200414; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; HUISMANS H, 1979, ONDERSTEPOORT J VET, V46, P95; Maan Narender S, 2010, PLoS One, V5, DOI 10.1371/journal.pone.0012782; MECHAM JO, 1988, J GEN VIROL, V69, P1255, DOI 10.1099/0022-1317-69-6-1255; MERTENS PPC, 1984, VIROLOGY, V135, P207, DOI 10.1016/0042-6822(84)90131-4; Mertens PPC., 2005, VIRUS TAXONOMY, P466; OIE (World Organization for Animal Health), 2014, MAN DIAGN TESTS VACC; Ratinier M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002477; Sailleau C, 2012, VET MICROBIOL, V155, P191, DOI 10.1016/j.vetmic.2011.09.006; Savini G, 2011, RES VET SCI, V91, P1, DOI 10.1016/j.rvsc.2011.05.004; Schroeder ME, 2013, J VET DIAGN INVEST, V25, P709, DOI 10.1177/1040638713503654; Shope RE, 1955, NEW JERSEY OUTDOORS, P21; SUGIYAMA M, 1989, RES VET SCI, V46, P283, DOI 10.1016/S0034-5288(18)31161-5; Sun F, 2014, J WILDLIFE DIS, V50, P639, DOI 10.7589/2013-11-302; Temizel EM, 2009, EMERG INFECT DIS, V15, P317, DOI 10.3201/eid1502.080572; Toussaint JF, 2007, J VIROL METHODS, V140, P115, DOI 10.1016/j.jviromet.2006.11.007; Toye PG, 2013, RES VET SCI, V94, P769, DOI 10.1016/j.rvsc.2012.11.001; Viarouge C, 2014, VET MICROBIOL, V174, P78, DOI 10.1016/j.vetmic.2014.09.006; Wilson WC, 2009, J VET DIAGN INVEST, V21, P760, DOI 10.1177/104063870902100602; Yadin H, 2008, VET REC, V162, P53, DOI 10.1136/vr.162.2.53	29	11	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132540	10.1371/journal.pone.0132540	http://dx.doi.org/10.1371/journal.pone.0132540			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161784	Green Published, gold, Green Submitted			2022-12-26	WOS:000358162300150
J	Wu, WW; Xu, H; Wang, ZM; Mao, Y; Yuan, LS; Luo, W; Cui, ZQ; Cui, TX; Wang, XL; Shen, YH				Wu, Weiwei; Xu, Hao; Wang, Zemin; Mao, Yun; Yuan, Liangshuai; Luo, Wei; Cui, Zhaoqiang; Cui, Taixing; Wang, Xing Li; Shen, Ying H.			PINK1-Parkin-Mediated Mitophagy Protects Mitochondrial Integrity and Prevents Metabolic Stress-Induced Endothelial Injury	PLOS ONE			English	Article							MUTATIONS; DISEASE; PARKIN; REGULATORS; AUTOPHAGY; MEMBRANE	Mitochondrial injury and dysfunction, a significant feature in metabolic syndrome, triggers endothelial cell dysfunction and cell death. Increasing evidence suggests that mitophagy, a process of autophagic turnover of damaged mitochondria, maintains mitochondrial integrity. PINK1 (phosphatase and tensin homolog (PTEN)-induced putative kinase 1) and Parkin signaling is a key pathway in mitophagy control. In this study, we examined whether this pathway could protect mitochondria under metabolic stress. We found that palmitic acid (PA) induced significant mitophagy and activated PINK1 and Parkin in endothelial cells. Knocking down PINK1 or Parkin reduced mitophagy, leading to impaired clearance of damaged mitochondria and intracellular accumulation of mitochondrial fragments. Furthermore, PINK1 and Parkin prevented PA-induced mitochondrial dysfunction, ROS production and apoptosis. Finally, we show that PINK1 and Parkin were up-regulated in vascular wall of obese mice and diabetic mice. Our study demonstrates that PINK1-Parkin pathway is activated in response to metabolic stress. Through induction of mitophagy, this pathway protects mitochondrial integrity and prevents metabolic stress-induced endothelial injury.	[Wu, Weiwei; Xu, Hao; Wang, Zemin; Mao, Yun; Yuan, Liangshuai; Luo, Wei; Cui, Zhaoqiang; Cui, Taixing; Wang, Xing Li] Shandong Univ, Res Ctr Cell Therapy, Key Lab Cardiovasc Remodeling & Funct Res, Qilu Hosp, Jinan 250012, Peoples R China; [Cui, Taixing] Univ S Carolina, Dept Cell Biol & Anat, Columbus, SC 29209 USA; [Wang, Xing Li; Shen, Ying H.] Baylor Coll Med, Div Cardiothorac Surg, Michael E DeBakey Dept Surg, Houston, TX 77030 USA; [Wang, Xing Li; Shen, Ying H.] Texas Heart Inst, Houston, TX 77025 USA	Shandong University; University of South Carolina; Baylor College of Medicine; Texas Heart Institute	Wang, XL (corresponding author), Shandong Univ, Res Ctr Cell Therapy, Key Lab Cardiovasc Remodeling & Funct Res, Qilu Hosp, Jinan 250012, Peoples R China.	xingliwang@sdu.edu.cn; hyshen@bcm.edu	shen, ying/HHS-5635-2022		Shandong University National Qianren Scholar Fund; National 973 Program Grant [2014CB542401]	Shandong University National Qianren Scholar Fund; National 973 Program Grant	This work was supported by the Shandong University National Qianren Scholar Fund (XLW) and by the National 973 Program Grant (2014CB542401). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beilina A, 2005, P NATL ACAD SCI USA, V102, P5703, DOI 10.1073/pnas.0500617102; Chen YR, 2014, CIRC RES, V114, P524, DOI 10.1161/CIRCRESAHA.114.300559; Davidson SM, 2007, CIRC RES, V100, P1128, DOI 10.1161/01.RES.0000261970.18328.1d; Dorn G.W., 2014, CIRC RES; Galluzzi L, 2012, NAT REV MOL CELL BIO, V13, P780, DOI 10.1038/nrm3479; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Green DR, 2014, SCIENCE, V345, P1466, DOI 10.1126/science.1250256; Green DR, 2011, SCIENCE, V333, P1109, DOI 10.1126/science.1201940; HAYWOOD LJ, 1988, JAMA-J AM MED ASSOC, V259, P1328; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kluge MA, 2013, CIRC RES, V112, P1171, DOI 10.1161/CIRCRESAHA.111.300233; Kubli DA, 2012, CIRC RES, V111, P1208, DOI 10.1161/CIRCRESAHA.112.265819; LI X, 2009, DIABETES; Lupfer C, 2013, NAT IMMUNOL, V14, P480, DOI 10.1038/ni.2563; Madamanchi NR, 2007, CIRC RES, V100, P460, DOI 10.1161/01.RES.0000258450.44413.96; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Rizzuto R, 2012, NAT REV MOL CELL BIO, V13, P566, DOI 10.1038/nrm3412; Shen YH, 2013, CIRC RES, V112, P618, DOI 10.1161/CIRCRESAHA.112.300735; Springer W, 2011, AUTOPHAGY, V7, P266, DOI 10.4161/auto.7.3.14348; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Wang K, 2011, AUTOPHAGY, V7, P297, DOI 10.4161/auto.7.3.14502; Yoshii SR, 2011, J BIOL CHEM, V286, P19630, DOI 10.1074/jbc.M110.209338; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Zhu JH, 2011, METHODS MOL BIOL, V793, P325, DOI 10.1007/978-1-61779-328-8_21	26	98	104	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132499	10.1371/journal.pone.0132499	http://dx.doi.org/10.1371/journal.pone.0132499			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161534	Green Published, gold, Green Submitted			2022-12-26	WOS:000358162300142
J	Gao, CX; Li, TT; Liu, J; Guo, Q; Tian, LM				Gao, Cuixia; Li, Tingting; Liu, Jing; Guo, Qian; Tian, Limin			Endothelial Functioning and Hemodynamic Parameters in Rats with Subclinical Hypothyroid and the Effects of Thyroxine Replacement	PLOS ONE			English	Article							LEFT-VENTRICULAR FUNCTION; CORONARY-HEART-DISEASE; THYROID-HORMONE ACTION; CARDIOVASCULAR RISK-FACTORS; VASCULAR SMOOTH-MUSCLE; CARDIAC-FUNCTION; STIMULATING HORMONE; OXIDATIVE STRESS; DYSFUNCTION; ATHEROSCLEROSIS	Objective Subclinical hypothyroidism (SCH) and its associations with atherosclerosis (AS) and cardiovascular disease remain controversial. The purpose of our study was to observe changes in endothelial functioning and hemodynamics in rats with SCH and to determine whether L-thyroxine (L-T4) administration affects these changes. Methods In total, sixty male Wistar rats were randomly divided into the following three groups with 20 rats each: control euthyroid rats, SCH rats and SCH rats that had been treated with thyroxine (SCH+T4). The SCH rats were induced by administration of 10 mg.kg(-1). d(-1) methimazole (MMI) once daily by gavage for 3 months. The SCH+T4 rats were administered the same dose of MMI for three months in addition to 2 mu g.kg(-1). d(-1) L-T4 once daily by gavage after 45 days of MMI administration. The control rats received physiological saline via gavage. Results The SCH group had significantly higher thyroid-stimulating hormone (TSH), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), and endothelin (ET) levels and a lower nitric oxide (NO) level than the control and SCH+T4 groups. The tail and carotid artery blood pressures, left ventricular systolic pressure, heart rate and aorta ventralis blood flow were significantly lower in the SCH group than in the control and SCH+T4 groups. ACH treatment caused concentration-dependent relaxation, which was reduced in the SCH arteries compared with the control and SCH+T4 arteries. Histopathological examination revealed the absence of pathological changes in the SCH rat arteries. Conclusions These findings demonstrate that L-T4 treatment ameliorates endothelial dysfunction and hemodynamic changes in SCH rats.	[Gao, Cuixia] Gansu Prov Hosp, Dept Ultrason Diag, Lanzhou, Gansu, Peoples R China; [Li, Tingting] Gansu Univ Chinese Med, Dept Clin Med, Lanzhou, Gansu, Peoples R China; [Liu, Jing; Guo, Qian; Tian, Limin] Gansu Prov Hosp, Dept Endocrinol, Lanzhou, Gansu, Peoples R China	Gansu University of Chinese Medicine	Tian, LM (corresponding author), Gansu Prov Hosp, Dept Endocrinol, Lanzhou, Gansu, Peoples R China.	tlm7066@sina.com	Tian, Limin/K-4855-2019		National Natural Science Foundation of China [81160100, 81360125]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was funded by grants from the National Natural Science Foundation of China (81160100, 81360125). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed OM, 2012, J DIABETES COMPLICAT, V26, P491, DOI 10.1016/j.jdiacomp.2012.05.021; BELL GM, 1983, CLIN ENDOCRINOL, V18, P511, DOI 10.1111/j.1365-2265.1983.tb02881.x; Billic-Komarica Edina, 2012, Mater Sociomed, V24, P212, DOI 10.5455/msm.2012.24.212-219; Biondi B, 2002, ANN INTERN MED, V137, P904, DOI 10.7326/0003-4819-137-11-200212030-00011; Biondi B, 1999, J CLIN ENDOCR METAB, V84, P2064, DOI 10.1210/jc.84.6.2064; Biondi B, 2008, ENDOCR REV, V29, P76, DOI 10.1210/er.2006-0043; Biondi B, 2007, THYROID, V17, P625, DOI 10.1089/thy.2007.0158; Biondi B, 2009, EUR J ENDOCRINOL, V161, P323, DOI 10.1530/EJE-09-0196; Bonetti PO, 2003, ARTERIOSCL THROM VAS, V23, P168, DOI 10.1161/01.ATV.0000051384.43104.FC; Cabral MD, 2011, CLINICS, V66, P1321, DOI 10.1590/S1807-59322011000800003; Cai YF, 2011, HYPERTENS RES, V34, P1098, DOI 10.1038/hr.2011.91; Cappola AR, 2006, JAMA-J AM MED ASSOC, V295, P1033, DOI 10.1001/jama.295.9.1033; Cappola AR, 2003, J CLIN ENDOCR METAB, V88, P2438, DOI 10.1210/jc.2003-030398; Chen X, 2013, J CARDIOL, V61, P8, DOI 10.1016/j.jjcc.2012.08.017; Chopra S, 2011, INDIAN J ENDOCRINOL, V15, P354; DILLMANN WH, 1990, AM J MED, V88, P626, DOI 10.1016/0002-9343(90)90530-Q; Dorr M, 2005, J CLIN ENDOCR METAB, V90, P673, DOI 10.1210/jc.2004-1554; Drexler H, 1997, PROG CARDIOVASC DIS, V39, P287, DOI 10.1016/S0033-0620(97)80030-8; Fazio S, 2004, RECENT PROG HORM RES, V59, P31, DOI 10.1210/rp.59.1.31; FOLDES J, 1987, ACTA MED HUNG, V44, P337; Fraczek Magdalena Maria, 2014, Pol Merkur Lekarski, V37, P170; Gerdes AM, 2015, AM J PHYSIOL-HEART C, V308, pH1, DOI 10.1152/ajpheart.00704.2014; GRAETTINGER JS, 1958, J CLIN INVEST, V37, P502, DOI 10.1172/JCI103631; Gunaldi M, 2016, J ONCOL PHARM PRACT, V22, P242, DOI 10.1177/1078155214567162; Gussekloo J, 2004, JAMA-J AM MED ASSOC, V292, P2591, DOI 10.1001/jama.292.21.2591; HEALY B, 1990, J AM COLL CARDIOL, V16, P357, DOI 10.1016/0735-1097(90)90585-D; Heitzer T, 2001, CIRCULATION, V104, P2673, DOI 10.1161/hc4601.099485; Herwig A, 2014, THYROID, V24, P1575, DOI 10.1089/thy.2014.0169; Imaizumi M, 2004, J CLIN ENDOCR METAB, V89, P3365, DOI 10.1210/jc.2003-031089; Iqbal A, 2007, J CLIN ENDOCR METAB, V92, P3504, DOI 10.1210/jc.2007-0727; Kahaly GJ, 2005, ENDOCR REV, V26, P704, DOI 10.1210/er.2003-0033; Karthick N, 2013, J CLIN DIAGN RES, V7, P2122, DOI 10.7860/JCDR/2013/5777.3448; KLEIN I, 1994, J CLIN ENDOCR METAB, V78, P1026, DOI 10.1210/jc.78.5.1026; Klein I, 2007, CIRCULATION, V116, P1725, DOI 10.1161/CIRCULATIONAHA.106.678326; Leal ALRC, 2007, ENDOCRINE, V31, P174, DOI 10.1007/s12020-007-0029-4; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Lombardi A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116498; Mariotti S, 2008, INT J CARDIOL, V126, P190, DOI 10.1016/j.ijcard.2007.03.130; Martins RM, 2011, ARQ BRAS ENDOCRINOL, V55, P460, DOI 10.1590/S0004-27302011000700005; Meena C L, 2012, Acta Inform Med, V20, P218, DOI 10.5455/aim.2012.20.21-218-220; Monzani F, 2001, J CLIN ENDOCR METAB, V86, P1110, DOI 10.1210/jc.86.3.1110; Nam SM, 2013, NEURAL REGEN RES, V8, P2458, DOI 10.3969/j.issn.1673-5374.2013.26.007; Ochs N, 2008, ANN INTERN MED, V148, P832, DOI 10.7326/0003-4819-148-11-200806030-00225; Ojamaa K, 1996, THYROID, V6, P505, DOI 10.1089/thy.1996.6.505; OJAMAA K, 1993, ENDOCRINOLOGY, V132, P1002, DOI 10.1210/en.132.3.1002; Osman Faizel, 2001, Current Opinion in Pharmacology, V1, P626, DOI 10.1016/S1471-4892(01)00107-2; Owen PJD, 2006, J CLIN ENDOCR METAB, V91, P2126, DOI 10.1210/jc.2005-2108; Razvi S, 2007, J CLIN ENDOCR METAB, V92, P1715, DOI 10.1210/jc.2006-1869; Roos A, 2007, J CLIN ENDOCR METAB, V92, P491, DOI 10.1210/jc.2006-1718; Santi A, 2014, EXP CLIN ENDOCR DIAB, V122, P533, DOI 10.1055/s-0034-1376968; Schachinger V, 2000, CIRCULATION, V101, P1899, DOI 10.1161/01.CIR.101.16.1899; Schultz M, 2011, HORM METAB RES, V43, P653, DOI 10.1055/s-0031-1283162; Sigal GA, 2011, THYROID, V21, P347, DOI 10.1089/thy.2010.0313; Silva JF, 2014, J OVARIAN RES, V7, DOI 10.1186/1757-2215-7-75; Sunbul M, 2013, EUR REV MED PHARMACO, V17, P3323; Tian LM, 2014, ENDOCRINE, V46, P651, DOI 10.1007/s12020-013-0135-4; Tian LM, 2014, J MOL ENDOCRINOL, V52, P215, DOI 10.1530/JME-13-0119; Torrens C, 2006, HYPERTENSION, V47, P982, DOI 10.1161/01.HYP.0000215580.43711.d1; Torrens C, 2009, HYPERTENSION, V53, P661, DOI 10.1161/HYPERTENSIONAHA.108.122820; Treskatsch S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087531; Tsujio M, 2008, VET PATHOL, V45, P505, DOI 10.1354/vp.45-4-505; Valentina VN, 2011, ARQ BRAS ENDOCRINOL, V55, P475, DOI 10.1590/S0004-27302011000700007; Vanhoutte PM, 2009, CIRC J, V73, P595, DOI 10.1253/circj.CJ-08-1169; Walsh JP, 2005, ARCH INTERN MED, V165, P2467, DOI 10.1001/archinte.165.21.2467; Wu S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055599; Xu C, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-44; Yang SS, 2014, NEUROENDOCRINOL LETT, V35, P80; Yazici M, 2004, INT J CARDIOL, V95, P135, DOI 10.1016/j.ijcard.2003.05.015; Yen PM, 2001, PHYSIOL REV, V81, P1097, DOI 10.1152/physrev.2001.81.3.1097; Yonetci N, 2002, EXP TOXICOL PATHOL, V54, P197, DOI 10.1078/0940-2993-00248; Yotani K, 2014, J PHYSIOL ANTHROPOL, V33, DOI 10.1186/1880-6805-33-23; Zaki SM, 2013, FOLIA MORPHOL, V72, P333, DOI 10.5603/FM.2013.0056	73	5	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2015	10	7							e0131776	10.1371/journal.pone.0131776	http://dx.doi.org/10.1371/journal.pone.0131776			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EW	26158620	Green Submitted, Green Published, gold			2022-12-26	WOS:000358161200038
J	Baldeck, CA; Asner, GP; Martin, RE; Anderson, CB; Knapp, DE; Kellner, JR; Wright, SJ				Baldeck, Claire A.; Asner, Gregory P.; Martin, Robin E.; Anderson, Christopher B.; Knapp, David E.; Kellner, James R.; Wright, S. Joseph			Operational Tree Species Mapping in a Diverse Tropical Forest with Airborne Imaging Spectroscopy	PLOS ONE			English	Article							VECTOR DOMAIN DESCRIPTION; REMOTE-SENSING IMAGES; HYPERSPECTRAL DATA; LIDAR DATA; AERIAL-PHOTOGRAPHY; CLASSIFICATION; DISCRIMINATION; IDENTIFICATION; LEAF; BIODIVERSITY	Remote identification and mapping of canopy tree species can contribute valuable information towards our understanding of ecosystem biodiversity and function over large spatial scales. However, the extreme challenges posed by highly diverse, closed-canopy tropical forests have prevented automated remote species mapping of non-flowering tree crowns in these ecosystems. We set out to identify individuals of three focal canopy tree species amongst a diverse background of tree and liana species on Barro Colorado Island, Panama, using airborne imaging spectroscopy data. First, we compared two leading singleclass classification methods-binary support vector machine (SVM) and biased SVM-for their performance in identifying pixels of a single focal species. From this comparison we determined that biased SVM was more precise and created a multi-species classification model by combining the three biased SVM models. This model was applied to the imagery to identify pixels belonging to the three focal species and the prediction results were then processed to create a map of focal species crown objects. Crown-level cross-validation of the training data indicated that the multi-species classification model had pixel-level producer's accuracies of 94-97% for the three focal species, and field validation of the predicted crown objects indicated that these had user's accuracies of 94-100%. Our results demonstrate the ability of high spatial and spectral resolution remote sensing to accurately detect non-flowering crowns of focal species within a diverse tropical forest. We attribute the success of our model to recent classification and mapping techniques adapted to species detection in diverse closed-canopy forests, which can pave the way for remote species mapping in a wider variety of ecosystems.	[Baldeck, Claire A.; Asner, Gregory P.; Martin, Robin E.; Anderson, Christopher B.; Knapp, David E.] Carnegie Inst Sci, Dept Plant Biol, Dept Global Ecol, Stanford, CA 94305 USA; [Kellner, James R.] Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA; [Wright, S. Joseph] Smithsonian Trop Res Inst, Washington, DC USA	Carnegie Institution for Science; Brown University; Smithsonian Institution; Smithsonian Tropical Research Institute	Baldeck, CA (corresponding author), Carnegie Inst Sci, Dept Plant Biol, Dept Global Ecol, 290 Panama St, Stanford, CA 94305 USA.	cbaldeck@carnegiescience.edu	Asner, Gregory/G-9268-2013; Wright, Stuart Joseph/M-3311-2013; Martin, Roberta/A-5073-2015	Asner, Gregory/0000-0001-7893-6421; Wright, Stuart Joseph/0000-0003-4260-5676; Martin, Roberta/0000-0003-3509-8530	Avatar Alliance Foundation; Gordon and Betty Moore Foundation; John D. and Catherine R. MacArthur Foundation; Grantham Foundation for the Protection of the Environment; W. M. Keck Foundation; Margaret A. Cargill Foundation; Direct For Biological Sciences [1358915] Funding Source: National Science Foundation	Avatar Alliance Foundation; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); John D. and Catherine R. MacArthur Foundation; Grantham Foundation for the Protection of the Environment; W. M. Keck Foundation(W.M. Keck Foundation); Margaret A. Cargill Foundation; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This study has been supported by the Avatar Alliance Foundation, Gordon and Betty Moore Foundation, John D. and Catherine R. MacArthur Foundation, Grantham Foundation for the Protection of the Environment, W. M. Keck Foundation, Margaret A. Cargill Foundation, Mary Anne Nyburg Baker and G. Leonard Baker Jr., and William R. Hearst III. There are no grant numbers or URLs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizerman A., 1964, AUTOMAT REM CONTR, V25, P821; Alonzo M, 2014, REMOTE SENS ENVIRON, V148, P70, DOI 10.1016/j.rse.2014.03.018; Asner GP, 2014, NEW PHYTOL, V204, P127, DOI 10.1111/nph.12895; Asner GP, 2012, REMOTE SENS ENVIRON, V124, P454, DOI 10.1016/j.rse.2012.06.012; Asner GP, 2011, NEW PHYTOL, V189, P999, DOI 10.1111/j.1469-8137.2010.03549.x; Baldeck CA, 2014, ECOL APPL, V24, P84, DOI 10.1890/13-0307.1; Baldeck CA, 2015, IEEE J-STARS, V8, P2501, DOI 10.1109/JSTARS.2014.2346475; Baldeck CA, 2014, REMOTE SENS-BASEL, V6, P2682, DOI 10.3390/rs6042682; Bing L, 2003, THIRD IEEE INTERNATIONAL CONFERENCE ON DATA MINING, PROCEEDINGS, P179, DOI 10.1109/icdm.2003.1250918; BOSER B, 1992, P 5 ANN WORKSH COMP, V5, P144; Bunting P, 2006, REMOTE SENS ENVIRON, V101, P230, DOI 10.1016/j.rse.2005.12.015; Caillaud D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015002; Camps-Valls G, 2004, IEEE T GEOSCI REMOTE, V42, P1530, DOI 10.1109/TGRS.2004.827262; Castro-Esau KL, 2006, AM J BOT, V93, P517, DOI 10.3732/ajb.93.4.517; Castro-Esau KL, 2004, REMOTE SENS ENVIRON, V90, P353, DOI 10.1016/j.rse.2004.01.013; Clark ML, 2005, REMOTE SENS ENVIRON, V96, P375, DOI 10.1016/j.rse.2005.03.009; Cochrane MA, 2000, INT J REMOTE SENS, V21, P2075, DOI 10.1080/01431160050021303; Colgan MS, 2012, REMOTE SENS-BASEL, V4, P3462, DOI 10.3390/rs4113462; Condit R, 2000, J VEG SCI, V11, P649, DOI 10.2307/3236572; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Croat T.B., 1978, FLORA BARRO COLORADO; Dalponte M, 2013, IEEE T GEOSCI REMOTE, V51, P2632, DOI 10.1109/TGRS.2012.2216272; Dalponte M, 2012, REMOTE SENS ENVIRON, V123, P258, DOI 10.1016/j.rse.2012.03.013; Duin RPW, 2000, LECT NOTES COMPUT SC, V1857, P16; Feret JB, 2013, IEEE T GEOSCI REMOTE, V51, P73, DOI 10.1109/TGRS.2012.2199323; Feret JB, 2012, REMOTE SENS-BASEL, V4, P2457, DOI 10.3390/rs4082457; Ferreira MP, 2014, INT GEOSCI REMOTE SE, P784, DOI 10.1109/IGARSS.2014.6946541; Foody GM, 2005, ECOL APPL, V15, P1233, DOI 10.1890/04-1061; Fung T, 1998, INT GEOSCI REMOTE SE, P1298, DOI 10.1109/IGARSS.1998.691383; Garwood N.C., 2009, SEEDLINGS BARRO COLO; Garzon-Lopez CX, 2014, J VEG SCI, V25, P349, DOI 10.1111/jvs.12090; Garzon-Lopez CX, 2013, BIOTROPICA, V45, P308, DOI 10.1111/btp.12009; Gillespie TW, 2008, PROG PHYS GEOG, V32, P203, DOI 10.1177/0309133308093606; Gougeon F.A., 1995, CANADIAN J REMOTE SE, V21, P274, DOI [DOI 10.1080/07038992.1995.10874622, 10.1080/07038992.1995.10874622]; Ingwell LL, 2010, J ECOL, V98, P879, DOI 10.1111/j.1365-2745.2010.01676.x; Kalacska M, 2007, REMOTE SENS ENVIRON, V109, P406, DOI 10.1016/j.rse.2007.01.012; Kellner JR, 2008, POPULATION COMMUNITY; Leckie DG, 2003, REMOTE SENS ENVIRON, V85, P355, DOI 10.1016/S0034-4257(03)00013-0; Lee WS, 2003, 20 INT C MACH LEARN, V3, P448; Lucas R, 2008, REMOTE SENS ENVIRON, V112, P2088, DOI 10.1016/j.rse.2007.10.011; McGraw JB, 1998, TRENDS ECOL EVOL, V13, P300, DOI 10.1016/S0169-5347(98)01414-1; Melgani F, 2004, IEEE T GEOSCI REMOTE, V42, P1778, DOI 10.1109/TGRS.2004.831865; Meyer P, 1996, ISPRS J PHOTOGRAMM, V51, P5, DOI 10.1016/0924-2716(96)00003-2; Mountrakis G, 2011, ISPRS J PHOTOGRAMM, V66, P247, DOI 10.1016/j.isprsjprs.2010.11.001; Munoz-Mari J, 2007, IEEE T GEOSCI REMOTE, V45, P2683, DOI 10.1109/TGRS.2007.897425; Munoz-Mari J, 2010, IEEE T GEOSCI REMOTE, V48, P3188, DOI 10.1109/TGRS.2010.2045764; Nagendra H, 2008, BIODIVERS CONSERV, V17, P3431, DOI 10.1007/s10531-008-9479-0; Papes M, 2013, IEEE J-STARS, V6, P339, DOI 10.1109/JSTARS.2012.2228468; Sanchez-Azofeifa A, 2011, SENSORS-BASEL, V11, P3831, DOI 10.3390/s110403831; Schimel DS, 2013, FRONT ECOL ENVIRON, V11, P129, DOI 10.1890/120111; Schnitzer SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052114; Tax DMJ, 1999, PATTERN RECOGN LETT, V20, P1191, DOI 10.1016/S0167-8655(99)00087-2; Thorington Jr RW, 1982, ECOLOGY TROPICAL FOR; Turner W, 2003, TRENDS ECOL EVOL, V18, P306, DOI 10.1016/S0169-5347(03)00070-3; VALENCIA R, 1994, BIODIVERS CONSERV, V3, P21, DOI 10.1007/BF00115330; Vapnik V., 1998, STAT LEARNING THEORY; Wang L, 2004, PHOTOGRAMM ENG REM S, V70, P351, DOI 10.14358/PERS.70.3.351; Zhang JK, 2006, REMOTE SENS ENVIRON, V105, P129, DOI 10.1016/j.rse.2006.06.010	58	81	81	2	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0118403	10.1371/journal.pone.0118403	http://dx.doi.org/10.1371/journal.pone.0118403			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26153693	Green Published, gold, Green Submitted			2022-12-26	WOS:000358159700001
J	Cubo, J; Woodward, H; Wolff, E; Horner, JR				Cubo, Jorge; Woodward, Holly; Wolff, Ewan; Horner, John R.			First Reported Cases of Biomechanically Adaptive Bone Modeling in Non-Avian Dinosaurs	PLOS ONE			English	Article							CROSS-SECTIONAL GEOMETRY; GROWTH-RATE; ADAPTATION; DISEASES; ABSCESS; LOAD; AGE	Predator confrontation or predator evasion frequently produces bone fractures in potential prey in the wild. Although there are reports of healed bone injuries and pathologies in nonavian dinosaurs, no previously published instances of biomechanically adaptive bone modeling exist. Two tibiae from an ontogenetic sample of fifty specimens of the herbivorous dinosaur Maiasaura peeblesorum (Ornithopoda: Hadrosaurinae) exhibit exostoses. We show that these outgrowths are cases of biomechanically adaptive periosteal bone modeling resulting from overstrain on the tibia after a fibula fracture. Histological and biomechanical results are congruent with predictions derived from this hypothesis. Histologically, the outgrowths are constituted by radial fibrolamellar periosteal bone tissue formed at very high growth rates, as expected in a process of rapid strain equilibration response. These outgrowths show greater compactness at the periphery, where tensile and compressive biomechanical constraints are higher. Moreover, these outgrowths increase the maximum bending strength in the direction of the stresses derived from locomotion. They are located on the antero-lateral side of the tibia, as expected in a presumably bipedal one year old individual, and in the posterior position of the tibia, as expected in a presumably quadrupedal individual at least four years of age. These results reinforce myological evidence suggesting that Maiasaura underwent an ontogenetic shift from the primitive ornithischian bipedal condition when young to a derived quadrupedal posture when older.	[Cubo, Jorge] Univ Paris 06, Sorbonne Univ, ISTeP, UMR 7193, 4 Pl Jussieu,BC19, F-75005 Paris, France; [Cubo, Jorge] CNRS, ISTeP, UMR 7193, F-75005 Paris, France; [Woodward, Holly; Horner, John R.] Montana State Univ, Museum Rockies, Bozeman, MT 59717 USA; [Woodward, Holly] Oklahoma State Univ, Ctr Hlth Sci, Dept Anat & Cell Biol, Tulsa, OK 74107 USA; [Wolff, Ewan] Purdue Univ, Coll Vet Med, Small Anim Internal Med, W Lafayette, IN 47907 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; Montana State University System; Montana State University Bozeman; Oklahoma State University System; Oklahoma State University Center for Health Sciences; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Cubo, J (corresponding author), Univ Paris 06, Sorbonne Univ, ISTeP, UMR 7193, 4 Pl Jussieu,BC19, F-75005 Paris, France.	jorge.cubo_garcia@upmc.fr	Ballard, HollyNoelle/AED-7676-2022; CUBO, Jorge/I-8498-2016	Ballard, HollyNoelle/0000-0003-0413-0681; CUBO, Jorge/0000-0002-8160-779X; Wolff, Ewan/0000-0002-5726-4766	Gerry Ohrstrom; Museum of the Rockies; Jurassic Foundation; Geological Society of America; NSF [EAR 8705986]; CNRS (France); UPMC-Sorbonne Universites (France); Spanish Ministry of Economy and Competitiveness [CGL-2011-23919, CGL-2012-34459]	Gerry Ohrstrom; Museum of the Rockies; Jurassic Foundation; Geological Society of America; NSF(National Science Foundation (NSF)); CNRS (France)(Centre National de la Recherche Scientifique (CNRS)); UPMC-Sorbonne Universites (France); Spanish Ministry of Economy and Competitiveness(Spanish Government)	Funding and support for HW was provided by Gerry Ohrstrom, the Museum of the Rockies, the Jurassic Foundation, the Geological Society of America, and NSF grant #EAR 8705986. Funding and support for JC was provided by the CNRS (France), the UPMC-Sorbonne Universites (France) and by the grants CGL-2011-23919 and CGL-2012-34459 of the Spanish Ministry of Economy and Competitiveness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERTRAM JEA, 1988, J THEOR BIOL, V131, P75, DOI 10.1016/S0022-5193(88)80122-X; Bourdon E, 2009, BIOL LETTERS, V5, P639, DOI 10.1098/rsbl.2009.0310; BOYDE A, 1978, METAB BONE DIS RELAT, V1, P235, DOI 10.1016/0221-8747(78)90008-5; Brothwell Don, 2002, Acta Zoologica Cracoviensia, V45, P315; Bybee PJ, 2006, J MORPHOL, V267, P347, DOI 10.1002/jmor.10406; Campbell JG, 1965, J ROYAL MICROSCOPICA, V85, P163; Casinos A, 2001, COMP BIOCHEM PHYS A, V131, P159, DOI 10.1016/S1095-6433(01)00463-9; Castanet J, 2006, CR PALEVOL, V5, P629, DOI 10.1016/j.crpv.2005.10.006; Chinsamy A, 2009, ANAT REC, V292, P1478, DOI 10.1002/ar.20991; Cubo J, 1997, NETH J ZOOL, V47, P209, DOI 10.1163/156854297X00175; Cubo J, 1998, EUR J MORPHOL, V36, P19, DOI 10.1076/ejom.36.1.19.9029; de Margerie E, 2004, J EXP BIOL, V207, P869, DOI 10.1242/jeb.00841; de Margerie E, 2002, CR BIOL, V325, P221, DOI 10.1016/S1631-0691(02)01429-4; Dilkes DW, 2001, CAN J EARTH SCI, V38, P1205, DOI 10.1139/e01-016; Doube M, 2010, BONE, V47, P1076, DOI 10.1016/j.bone.2010.08.023; EDEIKEN J, 1966, AMER J ROENTGENOL RA, V97, P708, DOI 10.2214/ajr.97.3.708; GOODSHIP AE, 1979, J BONE JOINT SURG AM, V61, P539, DOI 10.2106/00004623-197961040-00008; Horner JR, 2004, P ROY SOC B-BIOL SCI, V271, P1875, DOI 10.1098/rspb.2004.2829; Horner JR, 2000, J VERTEBR PALEONTOL, V20, P115, DOI 10.1671/0272-4634(2000)020[0115:LBHOTH]2.0.CO;2; Horner JR, 1999, PALEOBIOLOGY, V25, P295, DOI 10.1017/S0094837300021308; Huchzermeyer FW, 2000, VET REC, V147, P515, DOI 10.1136/vr.147.18.515; Judex S, 1997, J BONE MINER RES, V12, P1737, DOI 10.1359/jbmr.1997.12.10.1737; LANYON LE, 1982, J BIOMECH, V15, P141, DOI 10.1016/0021-9290(82)90246-9; Lee TC, 2002, J ANAT, V201, P437, DOI 10.1046/j.1469-7580.2002.00123.x; Lieberman DE, 2004, AM J PHYS ANTHROPOL, V123, P156, DOI 10.1002/ajpa.10316; Lieberman DE, 2003, J EXP BIOL, V206, P3125, DOI 10.1242/jeb.00514; Main RP, 2007, J ANAT, V210, P272, DOI 10.1111/j.1469-7580.2007.00696.x; McWhinney Lorrie, 2001, P364; Mead AJ, 2009, J WILDLIFE DIS, V45, P325, DOI 10.7589/0090-3558-45.2.325; MILLER WB, 1979, RADIOLOGY, V132, P15, DOI 10.1148/132.1.15; Montes L, 2007, BIOL J LINN SOC, V92, P63, DOI 10.1111/j.1095-8312.2007.00881.x; Redelstorff R, 2015, LETHAIA, V48, P47, DOI 10.1111/let.12086; REECE RL, 1992, J ZOO WILDLIFE MED, V23, P301; Rothschild BM, 1998, J RHEUMATOL, V25, P2221; RUFF CB, 1983, AM J PHYS ANTHROPOL, V60, P359, DOI 10.1002/ajpa.1330600308; SCHMIDT EV, 1982, AM J PATHOL, V106, P297; Schmitt James G., 2014, P486; Schultz AH., 1939, B HIST MED, V7, P571; TAYLOR ME, 1971, CAN J ZOOLOG, V49, P1035, DOI 10.1139/z71-159; Wallace IJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099108; Wolff EDS, 2008, HIST BIOL, V20, P185, DOI 10.1080/08912960802556642; Wolff EDS, 2009, HIST BIOL, V21, P235, DOI 10.1080/08912960903471196; Yang PF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094525	43	18	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0131131	10.1371/journal.pone.0131131	http://dx.doi.org/10.1371/journal.pone.0131131			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26153689	Green Published, Green Submitted, gold			2022-12-26	WOS:000358159700053
J	Zhang, XP; Yang, J; Zhao, JM; Zhang, PH; Huang, XY				Zhang, Xipeng; Yang, Jie; Zhao, Jiming; Zhang, Pihong; Huang, Xiaoyuan			MicroRNA-23b Inhibits the Proliferation and Migration of Heat-Denatured Fibroblasts by Targeting Smad3	PLOS ONE			English	Article							CELLS IN-VITRO; EXPRESSED MICRORNAS; CANCER; SKIN; BIOGENESIS; PROTEIN; MIR-23B; GROWTH	Background Skin grafting with the preservation of denatured dermis is a novel strategy for the treatment of burn-injured skin. Denatured dermis has the ability to restore to the morphology and function of normal skin, but the underlying molecular mechanism is elusive. MicroRNAs (miRNA) are small noncoding RNAs and regulate normal physiology as well as disease development. In this study, we assessed the potential role of miRNA-23b (miR-23b) in the regulation of cell proliferation and migration of heat-denatured fibroblasts and identified the underlying mechanism. Methods The expression of miR-23b in denatured dermis and heat-denatured fibroblasts was detected by quantitative real-time polymerase chain reaction (RT-PCR). The effects of miR-23b on cell proliferation and migration of heat-denatured fibroblasts were assessed by transient transfection of miR-23b mimics and inhibitor. The target gene of miR-23b and the downstream pathway were further investigated. Results miR-23b was downregulated in denatured dermis and heat-denatured fibroblasts. Downregulation of miR-23b dramatically promoted the proliferation and migration of heat-denatured fibroblasts. Subsequent analyses demonstrated that Smad3 was a direct and functional target of miR-23b in heat-denatured fibroblasts, which was validated by the dual luciferase reporter assay. Moreover, immunohistochemistry analysis showed that denatured dermis from rats displayed enhanced staining of Smad3. In addition, miR-23b modulated denatured dermis by activating the Notch1 and TGF-beta signaling pathways. Conclusions Our findings suggest that downregulation of miR-23b contributes to the recovery of denatured dermis, which may be valuable for treatment of skin burns.	[Zhang, Xipeng; Zhang, Pihong; Huang, Xiaoyuan] Cent S Univ, Xiangya Hosp, Dept Burns & Plast Surg, Changsha 410008, Hunan, Peoples R China; [Yang, Jie] Southern Med Univ, Zhujiang Hosp, Dept Pathol, Guangzhou 510282, Guangdong, Peoples R China; [Zhao, Jiming] Jinzhou Tradit Chinese Med Hosp, Dept Tradit Chinese Med, Zhangjiajie 427000, Hunan, Peoples R China	Central South University; Southern Medical University - China	Huang, XY (corresponding author), Cent S Univ, Xiangya Hosp, Dept Burns & Plast Surg, Changsha 410008, Hunan, Peoples R China.	huxzhongxy@163.com			National Nature Science Foundation of China [30973121]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Nature Science Foundation of China (No: 30973121). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bai XZ, 2015, EXP DERMATOL, V24, P355, DOI 10.1111/exd.12665; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bartels CL, 2009, CLIN CHEM, V55, P623, DOI 10.1373/clinchem.2008.112805; Chen LY, 2014, ONCOL REP, V31, P1573, DOI 10.3892/or.2014.3012; Cubison TCS, 2006, BURNS, V32, P714, DOI 10.1016/j.burns.2006.01.023; Fan Peng-Ju, 2008, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V33, P596; Gridley T, 2007, DEVELOPMENT, V134, P2709, DOI 10.1242/dev.004184; Huang XY, 2001, ZHONGHUA SHAO SHANG, V17, P60; Kimura Hitomi, 2004, Nucleic Acids Symp Ser (Oxf), P213; Lai WF, 2014, J BIOSCIENCES, V39, P519, DOI 10.1007/s12038-014-9421-4; Leone V, 2012, J CLIN ENDOCR METAB, V97, P3292, DOI 10.1210/jc.2012-1349; Leong KG, 2006, BLOOD, V107, P2223, DOI 10.1182/blood-2005-08-3329; Li C, 2013, ACTA BIOCH BIOPH SIN, V45, P692, DOI 10.1093/abbs/gmt057; [李德全 Li Dequan], 2008, [中国组织工程研究与临床康复, Journal of Clinical Rehabilitative Tissue Engineering Research], V12, P2056; Li WP, 2014, FEBS LETT, V588, P1608, DOI 10.1016/j.febslet.2014.02.055; Liang PF, 2012, BURNS, V38, P534, DOI 10.1016/j.burns.2011.10.014; Liu W, 2010, ONCOGENE, V29, P4914, DOI 10.1038/onc.2010.237; Liu Ying, 2005, Zhonghua Shao Shang Za Zhi, V21, P14; MacFarlane LA, 2010, CURR GENOMICS, V11, P537, DOI 10.2174/138920210793175895; Moura J, 2014, GENES-BASEL, V5, P926, DOI 10.3390/genes5040926; Proksch E, 2008, EXP DERMATOL, V17, P1063, DOI 10.1111/j.1600-0625.2008.00786.x; Rogler CE, 2009, HEPATOLOGY, V50, P575, DOI 10.1002/hep.22982; RUDOLPH R, 1979, PLAST RECONSTR SURG, V63, P473, DOI 10.1097/00006534-197904000-00005; Salvi A, 2009, FEBS J, V276, P2966, DOI 10.1111/j.1742-4658.2009.07014.x; Sand M, 2009, J DERMATOL SCI, V53, P169, DOI 10.1016/j.jdermsci.2008.10.004; Wang JF, 2008, LAB INVEST, V88, P1278, DOI 10.1038/labinvest.2008.101; Wang KC, 2010, P NATL ACAD SCI USA, V107, P3234, DOI 10.1073/pnas.0914825107; Yang Xing-Hua, 2005, Zhonghua Shao Shang Za Zhi, V21, P27; Yi R, 2006, NAT GENET, V38, P356, DOI 10.1038/ng1744; Yuan B, 2011, FEBS LETT, V585, P927, DOI 10.1016/j.febslet.2011.02.031; Zhao Yao-hua, 2013, Zhonghua Shao Shang Za Zhi, V29, P365; Zheng J, 2012, ALLERGY, V67, P362, DOI 10.1111/j.1398-9995.2011.02776.x	33	9	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0131867	10.1371/journal.pone.0131867	http://dx.doi.org/10.1371/journal.pone.0131867			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26153982	Green Submitted, Green Published, gold			2022-12-26	WOS:000358159700081
J	Fujigaki, JLZ; Valerio, AGA; Alvarenga, JCL; Reyes, EGG; Kershenobich, D; Ruiz, JH				Zaldivar Fujigaki, Jose Luis; Arroyo Valerio, America Guadalupe; Lopez Alvarenga, Juan Carlos; Gutierrez Reyes, Esperanza Gabriela; Kershenobich, David; Hernandez Ruiz, Joselin			Alterations in Activation, Cytotoxic Capacity and Trafficking Profile of Peripheral CD8 T Cells in Young Adult Binge Drinkers	PLOS ONE			English	Article							ALCOHOLIC LIVER-DISEASE; HEPATIC-FIBROSIS; ETHANOL EXPOSURE; IMMUNE CELLS; MICE; EXPRESSION; CONSUMPTION; INNATE; MEMORY; CD69	Background Excess of alcohol consumption is a public health problem and has documented effects on the immune system of humans and animals. Animal and in vitro studies suggest that alcohol abuse changes CD8 T cell (CD8) characteristics, however it remains unknown if the CD8 profile of binge drinkers is different in terms of activation, trafficking and cytotoxic capacity. Aim To analyze the peripheral CD8 cytotoxic capacity, activation and trafficking phenotypic profile of Mexican young adults with regard to alcohol consumption pattern. Methods 55 Mexican young adults were stratified as Light (20), Intermediate (18) or Binge drinkers (17) according to their reported alcohol consumption pattern. Blood samples were obtained and hematic biometry and liver enzyme analysis were performed. Peripheral CD8 profile was established by expression of Granzyme B (GB), CD137, CD127, CD69, TLR4, PD1, CCR2, CCR4, CCR5 and CXCR4 by FACS. Data was analyzed by ANOVA, posthoc DMS and Tamhane, and principal component analysis (PCA) with varimax rotation, p<0.05. Results The Binge drinking group showed increased. GT together with increased expression of CD69 and reduced expression of TLR4, PD1, CCR2 and CXCR4 in peripheral CD8 cells. Other parameters were also specific to Binge drinkers. PCA established 3 factors associated with alcohol consumption: "Early Activation" represented by CD69 and TLR4 expression in the CD8 population; "Effector Activation" by CD69 expression in CD8 CD127(+)CD137(+) and CD8 CD25(+)CD137(+); and Trafficking by CXCR4 expression on total CD8 and CD8 GB(+-)CXCR4(+), and CCR2 expression on total CD8. Binge drinking pattern showed low expression of Early Activation and Trafficking factors while Light drinking pattern exhibited high expression of Effector Activation factor. Conclusions Alcohol consumption affects the immune phenotype of CD8 cells since binge drinking pattern was found to be associated with high CD69 and low TLR4, CXCR4 and CCR2 expression, which suggest recent activation, decreased sensitivity to LPS and lower migration capacity in response to chemokines SDF-1 and MCP-1. These results indicate that a binge-drinking pattern of alcohol consumption may induce an altered immune profile that could be related with liver damage and the increased susceptibility to infection reported to this behavior.	[Zaldivar Fujigaki, Jose Luis; Gutierrez Reyes, Esperanza Gabriela; Hernandez Ruiz, Joselin] Univ Nacl Autonoma Mexico, Fac Med, Dept Expt Med, Lab Liver Pancreas & Motil, Mexico City 04510, DF, Mexico; [Arroyo Valerio, America Guadalupe; Lopez Alvarenga, Juan Carlos; Hernandez Ruiz, Joselin] Hosp Gen Mexico Dr Eduardo Liceaga, Direcc Invest, Mexico City, DF, Mexico; [Kershenobich, David] Inst Nacl Ciencias Med & Nutr Salvador Zubrian, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico	Ruiz, JH (corresponding author), Univ Nacl Autonoma Mexico, Fac Med, Dept Expt Med, Lab Liver Pancreas & Motil, Mexico City 04510, DF, Mexico.	joselin.hernandezr@hgm.mx		Lopez-Alvarenga, Juan/0000-0002-0966-8766; Hernandez Ruiz, Joselin/0000-0002-0571-2563; Zaldivar Fujigaki, Jose Luis/0000-0001-7210-5475	Instituto de Ciencia y Tecnologia del Distrito Federal [PICSA 10-164, 231]	Instituto de Ciencia y Tecnologia del Distrito Federal	This research was funded by the Instituto de Ciencia y Tecnologia del Distrito Federal, number: PICSA 10-164, agreement 231. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Albano E, 2010, GENES NUTR, V5, P141, DOI 10.1007/s12263-009-0151-4; Amsen D, 2013, ADV EXP MED BIOL, V785, P107, DOI 10.1007/978-1-4614-6217-0_12; Babor T., 2001, BRIEF INTERVENTION H; Babor TF, 2001, AUDIT ALC USE DISORD; Boring L, 1997, J CLIN INVEST, V100, P2552, DOI 10.1172/JCI119798; Chen CP, 2006, ALCOHOL CLIN EXP RES, V30, P1925, DOI 10.1111/j.1530-0277.2006.00237.x; Craston R, 1997, J IMMUNOL METHODS, V209, P37, DOI 10.1016/S0022-1759(97)00143-9; Gao B, 2011, GASTROENTEROLOGY, V141, P1572, DOI 10.1053/j.gastro.2011.09.002; Gonzalez-Amaro R, 2013, TRENDS MOL MED, V19, P625, DOI 10.1016/j.molmed.2013.07.006; Gonzalez-Reimers E, 2012, ALCOHOL ALCOHOLISM, V47, P390, DOI 10.1093/alcalc/ags041; Haringer B, 2009, J EXP MED, V206, P1009, DOI 10.1084/jem.20082238; Hemann EA, 2014, ALCOHOL CLIN EXP RES, V38, P2403, DOI 10.1111/acer.12522; Hritz I, 2008, HEPATOLOGY, V48, P1224, DOI 10.1002/hep.22470; Inokuchi S, 2011, ALCOHOL CLIN EXP RES, V35, P1509, DOI 10.1111/j.1530-0277.2011.01487.x; Laso FJ, 2010, ALCOHOL CLIN EXP RES, V34, P876, DOI 10.1111/j.1530-0277.2010.01160.x; Jenkins MK, 2001, ANNU REV IMMUNOL, V19, P23, DOI 10.1146/annurev.immunol.19.1.23; Jerrells TR, 2002, ALCOHOL, V27, P47, DOI 10.1016/S0741-8329(02)00210-0; Jiang Q, 2004, MOL CELL BIOL, V24, P6501, DOI 10.1128/MCB.24.14.6501-6513.2004; Jimenez-Ortega V, 2011, ALCOHOL, V45, P183, DOI 10.1016/j.alcohol.2010.08.008; Kaech SM, 2012, NAT REV IMMUNOL, V12, P749, DOI 10.1038/nri3307; Karim S, 2013, TOXICOL SCI, V132, P131, DOI 10.1093/toxsci/kfs337; Kobayashi N, 2004, EUR J IMMUNOL, V34, P3370, DOI 10.1002/eji.200425587; Komai-Koma M, 2009, EUR J IMMUNOL, V39, P1564, DOI 10.1002/eji.200838866; Li TK, 2008, J GASTROEN HEPATOL, V23, pS2, DOI 10.1111/j.1440-1746.2007.05298.x; Markwick LJL, 2015, GASTROENTEROLOGY, V148, P590, DOI 10.1053/j.gastro.2014.11.041; Moreno C, 2005, HEPATOLOGY, V42, P854, DOI 10.1002/hep.20865; National Institute on Alcohol Abuse and Alcoholism, 2004, NIAAA COUNC APPR DEF; Nelson S, 2002, NAT REV IMMUNOL, V2, P205, DOI 10.1038/nri744; Parlet CP, 2014, ALCOHOL CLIN EXP RES, V38, P1356, DOI 10.1111/acer.12358; Petrasek J, 2013, ADV CLIN CHEM, V59, P155, DOI 10.1016/B978-0-12-405211-6.00006-1; Pruett SB, 2010, TOXICOL SCI, V117, P314, DOI 10.1093/toxsci/kfq215; Rabin RL, 1999, J IMMUNOL, V162, P3840; Rehm J, 2011, ALCOHOL RES HEALTH, V34, P135; RUIZ JH, 2012, REV GASTROENTEROL S3, V77, P43; Sacanella E, 1998, ALCOHOL CLIN EXP RES, V22, P897, DOI 10.1097/00000374-199806000-00020; Safadi R, 2004, GASTROENTEROLOGY, V127, P870, DOI 10.1053/j.gastro.2004.04.062; Sancho D, 2005, TRENDS IMMUNOL, V26, P136, DOI 10.1016/j.it.2004.12.006; Secretaria de Salud, 2012, ENC NAC AD 2011 REP; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Seki E, 2009, HEPATOLOGY, V50, P185, DOI 10.1002/hep.22952; Setshedi M, 2010, OXID MED CELL LONGEV, V3, P178, DOI 10.4161/oxim.3.3.12288; Singh M, 2013, J CLIN DIAGN RES, V7, P1568, DOI 10.7860/JCDR/2013/5596.3210; Taylor AL, 2012, IMMUNOLOGY, V135, P158, DOI 10.1111/j.1365-2567.2011.03529.x; Thiele GM, 2010, ALCOHOL CLIN EXP RES, V34, P2126, DOI 10.1111/j.1530-0277.2010.01309.x; Topic A, 2013, CLIN LAB, V59, P233, DOI 10.7754/Clin.Lab.2012.120318; United States Department of Agriculture and United States Department of Health and Human Services, 2005, DIET GUID AM 2005; van Beek JHDA, 2014, DRUG ALCOHOL DEPEN, V134, P99, DOI 10.1016/j.drugalcdep.2013.09.016; Vidali M, 2008, TRENDS MOL MED, V14, P63, DOI 10.1016/j.molmed.2007.12.005; Viola A, 2008, ANNU REV PHARMACOL, V48, P171, DOI 10.1146/annurev.pharmtox.48.121806.154841; Ward RJ, 2014, ALCOHOL ALCOHOLISM, V49, P193, DOI 10.1093/alcalc/agu002; Watanabe K, 2008, INT J HEMATOL, V88, P311, DOI 10.1007/s12185-008-0134-z; WHO, 2011, WORLD MALARIA REPORT 2011, P1; Wolfl M, 2008, CYTOM PART A, V73A, P1043, DOI 10.1002/cyto.a.20594; Zhang H, 2005, J LEUKOCYTE BIOL, V78, P1070, DOI 10.1189/jlb0605-317; Zhang H, 2015, TOXICOL APPL PHARM, V282, P139, DOI 10.1016/j.taap.2014.11.013	55	9	9	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2015	10	7							e0132521	10.1371/journal.pone.0132521	http://dx.doi.org/10.1371/journal.pone.0132521			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EC	26151816	gold, Green Published, Green Submitted			2022-12-26	WOS:000358158900044
J	Mualif, SA; Teow, SY; Omar, TC; Chew, YW; Yusoff, NM; Ali, SA				Mualif, Siti Aisyah; Teow, Sin-Yeang; Omar, Tasyriq Che; Chew, Yik Wei; Yusoff, Narazah Mohd; Ali, Syed A.			Engineering and Validation of a Vector for Concomitant Expression of Rare Transfer RNA (tRNA) and HIV-1 nef Genes in Escherichia coli	PLOS ONE			English	Article							HETEROLOGOUS PROTEIN EXPRESSION; CODON USAGE; CLUSTERS; YEAST	Relative ease in handling and manipulation of Escherichia coli strains make them primary candidate to express proteins heterologously. Overexpression of heterologous genes that contain codons infrequently used by E. coli is related with difficulties such as mRNA instability, early termination of transcription and/or translation, deletions and/or misincorporation, and cell growth inhibition. These codon bias-associated problems are addressed by co-expressing ColE1-compatible, rare tRNA expressing helper plasmids. However, this approach has inadequacies, which we have addressed by engineering an expression vector that concomitantly expresses the heterologous protein of interest, and rare tRNA genes in E. coli. The expression vector contains three (argU, ileY, leuW) rare tRNA genes and a useful multiple cloning site for easy in-frame cloning. To maintain the overall size of the parental plasmid vector, the rare tRNA genes replaced the non-essential DNA segments in the vector. The cloned gene is expressed under the control of T7 promoter and resulting recombinant protein has a C-terminal 6His tag for IMAC-mediated purification. We have evaluated the usefulness of this expression vector by expressing three HIV-1 genes namely HIV-1 p27 (nef), HIV-1 p24 (ca), and HIV-1 vif in NiCo21(DE3) E. coli and demonstrated the advantages of using expression vector that concomitantly expresses rare tRNA and heterologous genes.	[Mualif, Siti Aisyah; Teow, Sin-Yeang; Omar, Tasyriq Che; Chew, Yik Wei; Ali, Syed A.] Univ Sains Malaysia, Adv Med & Dent Inst, Oncol & Radiol Sci, George Town, Malaysia; [Yusoff, Narazah Mohd] Univ Sains Malaysia, Adv Med & Dent Inst, Regenerat Med, George Town, Malaysia	Universiti Sains Malaysia; Universiti Sains Malaysia	Ali, SA (corresponding author), Univ Sains Malaysia, Adv Med & Dent Inst, Oncol & Radiol Sci, George Town, Malaysia.	ali2@amdi.usm.edu.my	Omar, Mohammad Tasyriq Che/L-3839-2017; Teow, Sin-Yeang/L-3736-2016; Mualif, Siti Aisyah/AAB-7313-2021; Chew, Yik Wei/M-9669-2017; Teow, Sin-Yeang/J-2253-2019; Omar, Mohammad Tasyriq Che/AFP-0240-2022; Mohd Yusoff, Narazah/I-3203-2017	Omar, Mohammad Tasyriq Che/0000-0002-1294-7520; Teow, Sin-Yeang/0000-0002-3824-0224; Chew, Yik Wei/0000-0003-4772-0702; Teow, Sin-Yeang/0000-0002-3824-0224; Omar, Mohammad Tasyriq Che/0000-0002-1294-7520; Mohd Yusoff, Narazah/0000-0001-6801-2508	FRGS grant from Ministry of Higher Education (MOHE), Government of Malaysia [203/CIPPT/6711206]; MyPhD scholarship (KPT) under MyBrain15 program of MOHE [890416075223]; USM [USM/IPPT/2000/G-2/xiv, 1001/CIPPT/846048]; MOHE scholarship (KPT (BS)) [841003015520]; ASTS (Academic Staff Training Scheme) of Universiti Sains Malaysia; SLAB from Ministry of Education, Malaysia; AMDI	FRGS grant from Ministry of Higher Education (MOHE), Government of Malaysia; MyPhD scholarship (KPT) under MyBrain15 program of MOHE; USM; MOHE scholarship (KPT (BS)); ASTS (Academic Staff Training Scheme) of Universiti Sains Malaysia(Universiti Sains Malaysia); SLAB from Ministry of Education, Malaysia; AMDI	This work was supported by the FRGS grant (203/CIPPT/6711206) from Ministry of Higher Education (MOHE), Government of Malaysia to Syed A Ali and Narazah Mohd Yusoff. Sin-Yeang Teow is a recipient of MyPhD scholarship (KPT (B) 890416075223) under MyBrain15 program of MOHE and part of his research is supported by AMDI, USM under a Research Student Fund (USM/IPPT/2000/G-2/xiv) and RU-PRGS grant (1001/CIPPT/846048) from USM. Siti Aisyah Mualif is a recipient of MOHE scholarship (KPT (BS) 841003015520) and part of her research is funded by AMDI, USM (USM/IPPT/2000/G-2/xiv). Tasyriq Che Omar is a recipient of ASTS (Academic Staff Training Scheme) of Universiti Sains Malaysia together with SLAB from Ministry of Education, Malaysia.	Angov E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002189; BENTLEY WE, 1990, BIOTECHNOL BIOENG, V35, P668, DOI 10.1002/bit.260350704; Bouchet J, 2011, BLOOD, V117, P3559, DOI 10.1182/blood-2010-07-296749; Chen JQ, 2002, J MOL MICROB BIOTECH, V4, P519; DELTITO BJD, 1995, J BACTERIOL, V177, P7086, DOI 10.1128/jb.177.24.7086-7091.1995; Emert-Sedlak LA, 2013, CHEM BIOL, V20, P82, DOI 10.1016/j.chembiol.2012.11.005; Eschenfeldt William H., 2013, Journal of Structural and Functional Genomics, V14, P135, DOI 10.1007/s10969-013-9163-9; Gorry PR, 2007, JAIDS-J ACQ IMM DEF, V46, P390, DOI 10.1097/QAI.0b013e31815aba08; Huang YP, 2012, PROTEIN SCI, V21, P625, DOI 10.1002/pro.2046; Iyer PC, 2014, BIOORG MED CHEM LETT, V24, P1702, DOI 10.1016/j.bmcl.2014.02.045; KANE JF, 1995, CURR OPIN BIOTECH, V6, P494, DOI 10.1016/0958-1669(95)80082-4; Kim S, 2006, PROTEIN EXPRES PURIF, V50, P49, DOI 10.1016/j.pep.2006.07.014; Kolmsee T, 2011, RNA BIOL, V8, P913, DOI 10.4161/rna.8.5.16265; Lawrence Ann-Marie, 2009, J Vis Exp, DOI 10.3791/1350; Lulf S, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-24; Macreadie I, 1998, BIOCHEM MOL BIOL INT, V46, P277; Macreadie IG, 1997, BIOCHEM BIOPH RES CO, V232, P707, DOI 10.1006/bbrc.1997.6349; McNulty DE, 2003, PROTEIN EXPRES PURIF, V27, P365, DOI 10.1016/S1046-5928(02)00610-1; Perrakis Anastassis, 2008, V426, P247, DOI 10.1007/978-1-60327-058-8_15; Puigbo P, 2007, NUCLEIC ACIDS RES, V35, pW126, DOI 10.1093/nar/gkm219; Sambrook J, 2013, MOL CLONING LAB MANU; Samuelson JC, 2011, METHODS MOL BIOL, V705, P195, DOI 10.1007/978-1-61737-967-3_11; Smithgall Thomas E, 2013, Drug Discov Today Technol, V10, pe523, DOI 10.1016/j.ddtec.2013.07.002; Sorensen HP, 2005, J BIOTECHNOL, V115, P113, DOI 10.1016/j.jbiotec.2004.08.004; SORENSEN MA, 1989, J MOL BIOL, V207, P365, DOI 10.1016/0022-2836(89)90260-X; Teow SY, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-107; Terpe K, 2006, APPL MICROBIOL BIOT, V72, P211, DOI 10.1007/s00253-006-0465-8; Thangadurai C, 2008, BIOCHEM BIOPH RES CO, V376, P647, DOI 10.1016/j.bbrc.2008.09.024; Thomas JG, 1997, PROTEIN EXPRES PURIF, V11, P289, DOI 10.1006/prep.1997.0796; Trinh T, 1994, FOCUS, V16, P78; Winter J, 2000, J BIOTECHNOL, V84, P175, DOI 10.1016/S0168-1656(00)00356-4; Witkowski W, 2013, EXPERT OPIN THER TAR, V17, P1345, DOI 10.1517/14728222.2013.830712; Zaunders J, 2011, CURR OPIN HIV AIDS, V6, P151, DOI 10.1097/COH.0b013e3283454d5b	33	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0130446	10.1371/journal.pone.0130446	http://dx.doi.org/10.1371/journal.pone.0130446			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147991	Green Published, Green Submitted, gold			2022-12-26	WOS:000358157600037
J	Queiroz, MA; Delso, G; Wollenweber, S; Deller, T; Zeimpekis, K; Huellner, M; Barbosa, FD; von Schulthess, G; Veit-Haibach, P				Queiroz, Marcelo A.; Delso, Gaspar; Wollenweber, Scott; Deller, Timothy; Zeimpekis, Konstantinos; Huellner, Martin; Barbosa, Felipe de Galiza; von Schulthess, Gustav; Veit-Haibach, Patrick			Dose Optimization in TOF-PET/MR Compared to TOF-PET/CT	PLOS ONE			English	Article								Purpose To evaluate the possible activity reduction in FDG-imaging in a Time-of-Flight (TOF) PET/MR, based on cross-evaluation of patient-based NECR (noise equivalent count rate) measurements in PET/CT, cross referencing with phantom-based NECR curves as well as initial evaluation of TOF-PET/MR with reduced activity. Materials and Methods A total of 75 consecutive patients were evaluated in this study. PET/CT imaging was performed on a PET/CT (time-of-flight (TOF) Discovery D 690 PET/CT). Initial PET/MR imaging was performed on a newly available simultaneous TOF-PET/MR (Signa PET/MR). An optimal NECR for diagnostic purposes was defined in clinical patients (NECRP) in PET/CT. Subsequent optimal activity concentration at the acquisition time ([A](0)) and target NECR (NECRT) were obtained. These data were used to predict the theoretical FDG activity requirement of the new TOF-PET/MR system. Twenty-five initial patients were acquired with (retrospectively reconstructed) different imaging times equivalent for different activities on the simultaneous PET/MR for the evaluation of clinically realistic FDG-activities. Results The obtained values for NECRP, [A](0) and NECRT were 114.6 (+/- 14.2) kcps (Kilocounts per second), 4.0 (+/- 0.7) kBq/mL and 45 kcps, respectively. Evaluating the NECRT together with the phantom curve of the TOF-PET/MR device, the theoretical optimal activity concentration was found to be approximately 1.3 kBq/mL, which represents 35% of the activity concentration required by the TOF-PET/CT. Initial evaluation on patients in the simultaneous TOF-PET/MR shows clinically realistic activities of 1.8 kBq/mL, which represent 44% of the required activity. Conclusion The new TOF-PET/MR device requires significantly less activity to generate PET-images with good-to-excellent image quality, due to improvements in detector geometry and detector technologies. The theoretically achievable dose reduction accounts for up to 65% but cannot be fully translated into clinical routine based on the coils within the FOV and MR-sequences applied at the same time. The clinically realistic reduction in activity is slightly more than 50%. Further studies in a larger number of patients are needed to confirm our findings.	[Queiroz, Marcelo A.; Zeimpekis, Konstantinos; Huellner, Martin; Barbosa, Felipe de Galiza; von Schulthess, Gustav; Veit-Haibach, Patrick] Univ Zurich Hosp, Dept Med Imaging, Nucl Med, CH-8091 Zurich, Switzerland; [Delso, Gaspar; Wollenweber, Scott; Deller, Timothy] GE Healthcare, Waukesha, WI USA; [Huellner, Martin; Veit-Haibach, Patrick] Univ Zurich Hosp, Dept Med Imaging Diagnost & Intervent Radiol, CH-8091 Zurich, Switzerland	University of Zurich; University Zurich Hospital; General Electric; University of Zurich; University Zurich Hospital	Queiroz, MA (corresponding author), Univ Zurich Hosp, Dept Med Imaging, Nucl Med, CH-8091 Zurich, Switzerland.	marcelo.araujoqueiroz@gmail.com	Delso, Gaspar/I-1814-2013	Delso, Gaspar/0000-0003-0438-8244; Queiroz, Marcelo/0000-0003-0052-0682; Zeimpekis, Konstantinos/0000-0003-2769-7533	GE Healthcare	GE Healthcare(General ElectricGE Healthcare)	This research project was supported by an institutional research grant from GE Healthcare. Coauthors Gaspar Delso, Scott D. Wollenweber and Timothy Deller are employed by GE Healthcare. GE Healthcare provided support in the form of salaries for authors GD, SDW and TD, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Akamatsu G, CLIN NUCL MED, V38, P407, DOI [10.1097/RLU.0b013e31828da3bd, DOI 10.1097/RLU.OB013E31828DA3BD]; Badawi RD, 2005, J NUCL MED, V46, P1767; Boellaard R, 2010, EUR J NUCL MED MOL I, V37, P181, DOI 10.1007/s00259-009-1297-4; Chang TT, 2012, MED PHYS, V39, P5891, DOI 10.1118/1.4750053; Chang TT, 2011, PHYS MED BIOL, V56, P5275, DOI 10.1088/0031-9155/56/16/013; Danna M, 2006, IEEE T NUCL SCI, V53, P86, DOI 10.1109/TNS.2005.862966; Daube-Witherspoon ME, J NUCL MED, V43, P1398; de Groot E, EJNMMI RES, V3, P1, DOI [10.1186/2191-219X-3-1, DOI 10.1186/2191-219X-3-1]; Delso G, 2010, PHYS MED BIOL, V55, P4361, DOI 10.1088/0031-9155/55/15/011; Delso G, 2011, J NUCL MED, V52, P1914, DOI 10.2967/jnumed.111.092726; Delso G, 2009, MED PHYS, V36, P4126, DOI 10.1118/1.3193676; Everaert H, 2003, EUR J NUCL MED MOL I, V30, P1615, DOI 10.1007/s00259-003-1317-8; Kalemis A, 2013, MAGN RESON MATER PHY, V26, P5, DOI 10.1007/s10334-012-0330-y; Kuhn FP, 2014, J NUCL MED, V55, P551, DOI 10.2967/jnumed.113.125443; Lartizien C, 2002, J NUCL MED, V43, P1268; Li X, IEEE T NUCL SCI, V58, P590; MacDonald LR, 2011, MED PHYS, V38, P2948, DOI 10.1118/1.3583697; McDermott GM, 2013, ANN NUCL MED, V27, P855, DOI 10.1007/s12149-013-0760-2; Mizuta T, 2009, MOL IMAGING BIOL, V11, P480, DOI 10.1007/s11307-009-0214-3; Paulus DH, 2012, MED PHYS, V39, P4306, DOI 10.1118/1.4729716; Queiroz M, EJNMMI PHYS, V1, P1; Queiroz M, 2014, EUR J NUCL MED MOL I, V41, P1066, DOI 10.1007/s00259-014-2707-9; Reiner CS, 2014, EUR J NUCL MED MOL I, V41, P649, DOI 10.1007/s00259-013-2654-x; Schaart DR, 2009, PHYS MED BIOL, V54, P3501, DOI 10.1088/0031-9155/54/11/015; STROTHER SC, 1990, IEEE T NUCL SCI, V37, P783, DOI 10.1109/23.106715; Tellmann L, THE EFFECT OF MR SUR; Wagadarikar AA, 2014, IEEE T NUCL SCI, V61, P121, DOI 10.1109/TNS.2013.2282119; Walker MD, 2009, J NUCL MED, V50, P1409, DOI 10.2967/jnumed.109.062679; Watson CC, 2005, J NUCL MED, V46, P1825; Weirich C, 2012, IEEE T MED IMAGING, V31, P1372, DOI 10.1109/TMI.2012.2188903; Wollenweber SD, 2014, MAGN RESON MATER PHY, V27, P149, DOI 10.1007/s10334-013-0388-1	31	24	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0128842	10.1371/journal.pone.0128842	http://dx.doi.org/10.1371/journal.pone.0128842			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147919	gold, Green Accepted, Green Published, Green Submitted			2022-12-26	WOS:000358157600017
J	Haraguchi, M; Sato, M; Ozawa, M				Haraguchi, Misako; Sato, Masahiro; Ozawa, Masayuki			CRISPR/Cas9n-Mediated Deletion of the Snail 1Gene (SNAI1) Reveals Its Role in Regulating Cell Morphology, Cell-Cell Interactions, and Gene Expression in Ovarian Cancer (RMG-1) Cells	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITIONS; TRANSCRIPTION FACTOR; TGF-BETA; GENOME; SCATTERING; DIFFERENTIATION; MECHANISMS; PROTEINS; SURVIVAL; MOTILITY	Snail1 is a transcription factor that induces the epithelial to mesenchymal transition (EMT). During EMT, epithelial cells lose their junctions, reorganize their cytoskeletons, and reprogram gene expression. Although Snail1 is a prominent repressor of E-cadherin transcription, its precise roles in each of the phenomena of EMT are not completely understood, particularly in cytoskeletal changes. Previous studies have employed gene knockdown systems to determine the functions of Snail1. However, incomplete protein knockdown is often associated with these systems, which may cause incorrect interpretation of the data. To more precisely evaluate the functions of Snail1, we generated a stable cell line with a targeted ablation of Snail1 (Snail1 KO) by using the CRISPR/Cas9n system. Snail1 KO cells show increased cell-cell adhesion, decreased cell-substrate adhesion and cell migration, changes to their cytoskeletal organization that include few stress fibers and abundant cortical actin, and upregulation of epithelial marker genes such as E-cadherin, occludin, and claudin-1. However, morphological changes were induced by treatment of Snail1 KO cells with TGF-beta. Other transcription factors that induce EMT were also induced by treatment with TGF-beta. The precise deletion of Snail1 by the CRISPR/Cas9n system provides clear evidence that loss of Snail1 causes changes in the actin cytoskeleton, decreases cell-substrate adhesion, and increases cell-cell adhesion. Treatment of RMG1 cells with TGF-beta suggests redundancy among the transcription factors that induce EMT.	[Haraguchi, Misako; Ozawa, Masayuki] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Biochem & Mol Biol, Kagoshima 890, Japan; [Sato, Masahiro] Kagoshima Univ, Frontier Sci Res Ctr, Sect Gene Express Regulat, Kagoshima 890, Japan	Kagoshima University; Kagoshima University	Haraguchi, M (corresponding author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Biochem & Mol Biol, Kagoshima 890, Japan.	haraguci@m3.kufm.kagoshima-u.ac.jp		Sato, Masahiro/0000-0003-1334-2950	Ministry of Education, Culture, Sports, Science and Technology of Japan [22590287]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Ministry of Education, Culture, Sports, Science and Technology of Japan. Grant number: 22590287 to MH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Nieto MA, 2009, INT J DEV BIOL, V53, P1541, DOI 10.1387/ijdb.072410mn; Barrallo-Gimeno A, 2005, DEVELOPMENT, V132, P3151, DOI 10.1242/dev.01907; Batlle R, 2013, ONCOGENE, V32, P3381, DOI 10.1038/onc.2012.342; Baygi ME, 2010, CELL BIOL TOXICOL, V26, P553, DOI 10.1007/s10565-010-9163-5; Capecchi MR, 2005, NAT REV GENET, V6, P507, DOI 10.1038/nrg1619; Carver EA, 2001, MOL CELL BIOL, V21, P8184, DOI 10.1128/MCB.21.23.8184-8188.2001; Chen A, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-552; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dave N, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.168625; Engl W, 2014, NAT CELL BIOL, V16, P584, DOI 10.1038/ncb2973; Feng Y, 2015, J ORTHOP RES, V33, P199, DOI 10.1002/jor.22745; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Grotegut S, 2006, EMBO J, V25, P3534, DOI 10.1038/sj.emboj.7601213; Haraguchi M, 2008, J BIOL CHEM, V283, P23514, DOI 10.1074/jbc.M801125200; Heldin CH, 2012, FEBS LETT, V586, P1959, DOI 10.1016/j.febslet.2012.02.037; Ishii K, 2005, J INVEST DERMATOL, V124, P939, DOI 10.1111/j.0022-202X.2005.23714.x; Kiguchi K, 1998, JPN J CANCER RES, V89, P923, DOI 10.1111/j.1349-7006.1998.tb00650.x; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Li HS, 2011, J NAT GAS CHEM, V20, P1, DOI 10.1016/S1003-9953(10)60156-9; Li YY, 2014, BIOCHEM BIOPH RES CO, V452, P490, DOI 10.1016/j.bbrc.2014.08.110; Masuda M, 2005, J BIOL CHEM, V280, P42164, DOI 10.1074/jbc.M507136200; McGrail DJ, 2015, FASEB J, V29, P1280, DOI 10.1096/fj.14-257345; Nobusue H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4368; O'Connor JW, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0083188, 10.1371/journal.pone.0080504]; Ohkubo T, 2004, J CELL SCI, V117, P1675, DOI 10.1242/jcs.01004; Olmeda D, 2007, ONCOGENE, V26, P1862, DOI 10.1038/sj.onc.1209997; Peinado H, 2003, J BIOL CHEM, V278, P21113, DOI 10.1074/jbc.M211304200; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Sakuma T, 2014, SCI REP-UK, V4, DOI 10.1038/srep05400; Shields MA, 2012, J BIOL CHEM, V287, P6218, DOI 10.1074/jbc.M111.308940; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822	33	19	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132260	10.1371/journal.pone.0132260	http://dx.doi.org/10.1371/journal.pone.0132260			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161782	Green Published, gold, Green Submitted			2022-12-26	WOS:000358162300108
J	Zhao, J; Zhu, TH; Chen, WJ; Fan, BJ; He, LM; Yang, BC; Deng, ZH				Zhao, Jun; Zhu, Tianhui; Chen, Wenjie; Fan, Bao Jian; He, Liumei; Yang, Baocheng; Deng, Zhihui			Human Leukocyte Antigens-B and -C Loci Associated with Posner-Schlossman Syndrome in a Southern Chinese Population	PLOS ONE			English	Article							ACUTE ANTERIOR UVEITIS; OPEN-ANGLE GLAUCOMA; VASCULAR ENDOTHELIAL DYSFUNCTION; BIRDSHOT RETINOCHOROIDOPATHY; GLAUCOMATOCYCLITIC CRISIS; HLA; CYTOMEGALOVIRUS; SUSCEPTIBILITY; HLA-B27; FLOW	The etiology of Posner-Schlossman syndrome (PSS) remains unknown. The association of human leukocyte antigens (HLA) allelic diversity with PSS has been poorly investigated. To evaluate the association of allelic polymorphisms of class I HLA-A, -B and -C and class II HLA-DRB1 and -DQB1 with PSS, 100 unrelated patients with PSS and 128 age-and ethnically matched control subjects were recruited from a southern Chinese Han population. Polymorphisms in exons 2-4 for HLA-A, -B, -C loci, exon 2 for HLA-DRB1 and exons 2,3 for HLA-DQB1 were analyzed for association with PSS at allele and haplotype levels. The allele frequency of HLA-C* 1402 in PSS patients was significantly higher than that in controls (P = 0.002, OR = 4.12). This association survived the Bonferroni correction (P-C = 0.04). The allele frequency of HLA-B* 1301 in PSS patients was lower than that in the control group (P = 0.003, OR = 0.21), although this association did not survive the Bonferroni correction (P-C = 0.16). In PSS patients, the haplotype frequencies of HLA-A* 1101 similar to C* 1402 and B* 5101 similar to C* 1402 were higher than that in controls (P = 0.03, OR = 4.44; P = 0.02, OR = 3.20; respectively), while the HLA-B* 1301 similar to C* 0304 was lower than that in controls (P = 0.007, OR = 0.23), although these associations did not survive the Bonferroni correction (P-C > 0.16). This study for the first time demonstrated that polymorphisms at the HLA-B and HLA-C loci were nominally associated with PSS in the southern Chinese Han population. Our results suggest that HLA-C* 1402, A* 1101 similar to C* 1402 and B* 5101 similar to C* 1402 might be risk factors for PSS, whereas HLA-B* 1301 plus B* 1301 similar to C* 0304 might be protective factors against PSS, but even larger datasets are required to confirm these findings. Findings from this study provide valuable new clues for investigating the mechanisms and development of new diagnosis and treatment for PSS.	[Zhao, Jun; Zhu, Tianhui; Chen, Wenjie] Jinan Univ, Shenzhen Eye Hosp, Shenzhen Key Lab Ophthalmol, Shenzhen, Guangdong, Peoples R China; [Zhao, Jun] Shenzhen Univ, Sch Ophthalmol & Optometry, Shenzhen, Guangdong, Peoples R China; [Fan, Bao Jian] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Boston, MA 02114 USA; [He, Liumei; Yang, Baocheng; Deng, Zhihui] Shenzhen Blood Ctr, Immunogenet Lab, Shenzhen, Guangdong, Peoples R China	Jinan University; Shenzhen University; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary	Zhao, J (corresponding author), Jinan Univ, Shenzhen Eye Hosp, Shenzhen Key Lab Ophthalmol, Shenzhen, Guangdong, Peoples R China.	doctorzhaojun@163.com; zhihui_deng@aliyun.com	陈, 文杰·/HHN-5495-2022	陈, 文杰·/0000-0003-0556-7391; deng, zhihui/0000-0002-2046-1467	Shenzhen Science & Technology Project, People's Republic of China [201102188]; Guangdong Nature Science Foundation, People's Republic of China [S2013010013464]	Shenzhen Science & Technology Project, People's Republic of China; Guangdong Nature Science Foundation, People's Republic of China	The funders, Shenzhen Science & Technology Project, People's Republic of China (No. 201102188) and Guangdong Nature Science Foundation, People's Republic of China (No. S2013010013464), had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. JZ is the author who received the funding.	Chang JH, 2005, SURV OPHTHALMOL, V50, P364, DOI 10.1016/j.survophthal.2005.04.003; Chee SP, 2008, AM J OPHTHALMOL, V146, P883, DOI 10.1016/j.ajo.2008.09.001; Chung YM, 2009, SCAND J RHEUMATOL, V38, P84, DOI 10.1080/03009740802385423; Donvito B, 2010, INVEST OPHTH VIS SCI, V51, P2525, DOI 10.1167/iovs.09-4329; Ferreri G, 1998, ACTA OPHTHALMOL SCAN, V76, P17; Flammer J, 2002, PROG RETIN EYE RES, V21, P359, DOI 10.1016/S1350-9462(02)00008-3; Gil-Carrasco F, 1999, AM J OPHTHALMOL, V128, P297, DOI 10.1016/S0002-9394(99)00180-4; GILCARRASCO F, 1994, AM J OPHTHALMOL, V118, P744, DOI 10.1016/S0002-9394(14)72553-X; HIROSE S, 1985, ARCH OPHTHALMOL-CHIC, V103, P1837; Jap A, 2001, OPHTHALMOLOGY, V108, P913, DOI 10.1016/S0161-6420(01)00551-6; Kang EH, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3292; Kim Tae-Hyup, 2012, Korean J Ophthalmol, V26, P473, DOI 10.3341/kjo.2012.26.6.473; Knox D L, 1988, Trans Am Ophthalmol Soc, V86, P473; LEHOANG P, 1992, AM J OPHTHALMOL, V113, P33, DOI 10.1016/S0002-9394(14)75749-6; Levinson RD, 2004, AM J OPHTHALMOL, V138, P631, DOI 10.1016/j.ajo.2004.06.016; MIELANTS H, 1990, J RHEUMATOL, V17, P841; Oruc S, 2003, OCUL IMMUNOL INFLAMM, V11, P287, DOI 10.1076/ocii.11.4.287.18270; POSNER A, 1948, ARCH OPHTHALMOL-CHIC, V39, P517; Sacca SC, 2005, ARCH OPHTHALMOL-CHIC, V123, P458, DOI 10.1001/archopht.123.4.458; Shazly TA, 2011, SEMIN OPHTHALMOL, V26, P282, DOI 10.3109/08820538.2011.605821; Shen SC, 2010, INVEST OPHTH VIS SCI, V51, P272, DOI 10.1167/iovs.09-3849; Su WW, 2008, OPHTHALMOLOGY, V115, P1173, DOI 10.1016/j.ophtha.2007.10.026; Su WW, 2006, INVEST OPHTH VIS SCI, V47, P3390, DOI 10.1167/iovs.06-0024; Takusagawa Hana L, 2011, Int Ophthalmol Clin, V51, P105, DOI 10.1097/IIO.0b013e31822d6ab4; Teoh SCB, 2005, EYE, V19, P1338, DOI 10.1038/sj.eye.6701757; van Boxtel LAA, 2007, OPHTHALMOLOGY, V114, P1358, DOI 10.1016/j.ophtha.2006.09.035; Yabuki K, 2000, INT OPHTHALMOL CLIN, V40, P19, DOI 10.1097/00004397-200004000-00004; YAMAMOTO S, 1995, AM J OPHTHALMOL, V119, P796, DOI 10.1016/S0002-9394(14)72788-6; Zamecki KJ, 2010, AM J OPHTHALMOL, V149, P189, DOI 10.1016/j.ajo.2009.09.018	29	9	14	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132179	10.1371/journal.pone.0132179	http://dx.doi.org/10.1371/journal.pone.0132179			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161794	Green Published, gold, Green Submitted			2022-12-26	WOS:000358162300102
J	Allender, S; Owen, B; Kuhlberg, J; Lowe, J; Nagorcka-Smith, P; Whelan, J; Bell, C				Allender, Steven; Owen, Brynle; Kuhlberg, Jill; Lowe, Janette; Nagorcka-Smith, Phoebe; Whelan, Jill; Bell, Colin			A Community Based Systems Diagram of Obesity Causes	PLOS ONE			English	Article							HEALTH; SCRIPTS; SCIENCE	Introduction Application of system thinking to the development, implementation and evaluation of childhood obesity prevention efforts represents the cutting edge of community-based prevention. We report on an approach to developing a system oriented community perspective on the causes of obesity. Methods Group model building sessions were conducted in a rural Australian community to address increasing childhood obesity. Stakeholders (n = 12) built a community model that progressed from connection circles to causal loop diagrams using scripts from the system dynamics literature. Participants began this work in identifying change over time in causes and effects of childhood obesity within their community. The initial causal loop diagram was then reviewed and elaborated by 50 community leaders over a full day session. Results The process created a causal loop diagram representing community perceptions of determinants and causes of obesity. The causal loop diagram can be broken down into four separate domains; social influences; fast food and junk food; participation in sport; and general physical activity. Discussion This causal loop diagram can provide the basis for community led planning of a prevention response that engages with multiple levels of existing settings and systems.	[Allender, Steven; Owen, Brynle; Whelan, Jill] Deakin Univ, WHO, Collaborating Ctr Obes Prevent, Geelong, Vic 3217, Australia; [Kuhlberg, Jill] Washington Univ, George Warren Brown Sch Social Work, St Louis, MO USA; [Lowe, Janette] Southern Grampians Glenelg Primary Care Partnersh, Hamilton, Vic, Australia; [Nagorcka-Smith, Phoebe] Portland Dist Hlth, Portland, Vic, Australia; [Bell, Colin] Deakin Univ, Sch Med, Geelong, Vic 3217, Australia	Deakin University; World Health Organization; Washington University (WUSTL); Deakin University	Allender, S (corresponding author), Deakin Univ, WHO, Collaborating Ctr Obes Prevent, Geelong, Vic 3217, Australia.	steven.allender@deakin.edu.au	Allender, Steven/G-9881-2011; Whelan, Jill/O-7030-2019; Bell, Colin/X-9902-2019	Whelan, Jill/0000-0001-9434-109X; Bell, Colin/0000-0003-2731-9858; Nagorcka-Smith, Phoebe/0000-0003-1696-4624; Allender, Steven/0000-0002-4842-3294	Australian National Health and Medical Research Council/Australian National Heart Foundation [APP1045836]; US National Institutes of Health [1R01HL115485-01A1]; NHMRC Centre for Research Excellence in Obesity Policy and Food Systems [APP1041020]; Southern Grampians Glenelg Primary Care; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115485] Funding Source: NIH RePORTER	Australian National Health and Medical Research Council/Australian National Heart Foundation(National Health and Medical Research Council (NHMRC) of Australia); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHMRC Centre for Research Excellence in Obesity Policy and Food Systems(National Health and Medical Research Council (NHMRC) of Australia); Southern Grampians Glenelg Primary Care; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	SA is supported by funding from an Australian National Health and Medical Research Council/Australian National Heart Foundation Career Development Fellowship (APP1045836). He is also a researcher on the US National Institutes of Health grant titled, "Systems Science to Guide Whole-of-Community Childhood Obesity Interventions" (1R01HL115485-01A1) and within a NHMRC Centre for Research Excellence in Obesity Policy and Food Systems (APP1041020). The Southern Grampians Glenelg Primary Care Partnership provided support in the form of salaries for author JL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the'author contributions' section.	Andersen DF, 1997, SYST DYNAM REV, V13, P107, DOI 10.1002/(SICI)1099-1727(199722)13:2<107::AID-SDR120>3.3.CO;2-Z; Carr Wilfred., 2003, BECOMING CRITICAL ED; Finegood DT, 2010, OBESITY, V18, pS13, DOI 10.1038/oby.2009.426; Green LW, 2006, AM J PUBLIC HEALTH, V96, P406, DOI 10.2105/AJPH.2005.066035; Hammond RA, 2009, PREV CHRONIC DIS, V6; Hawe P, 2009, AM J COMMUN PSYCHOL, V43, P267, DOI 10.1007/s10464-009-9229-9; Hovmand P., 2013, SCRIPTAPEDIA 4 0 6; Hovmand PS, 2012, SYST RES BEHAV SCI, V29, P179, DOI 10.1002/sres.2105; HOVMAND PETER S., 2014, COMMUNITY BASED SYST; Institute of Medicine, 2012, INT FRAM ASS VAL COM; Ison R, 2010, SYSTEMS PRACTICE: HOW TO ACT IN A CLIMATE-CHANGE WORLD, P1, DOI 10.1007/978-1-84996-125-7; Kemmis S., 2004, ACTION RES PLANNER; King L, 2011, OBES REV, V12, P329, DOI 10.1111/j.1467-789X.2010.00798.x; Mabry PL, 2008, AM J PREV MED, V35, pS211, DOI 10.1016/j.amepre.2008.05.018; Merzel C, 2003, AM J PUBLIC HEALTH, V93, P557, DOI 10.2105/AJPH.93.4.557; National Institute for Health and Clinical Excellence United Kingdom, 2012, OB WORK LOC COMM; Public Health England, 2014, PRET WHOL SYST APPR; RICHARDSON GP, 1995, SYST DYNAM REV, V11, P113, DOI 10.1002/sdr.4260110203; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Vennix J.A., 1996, ENCY LIFE SUPPORT SY, V2, P97; Ventana Systems Inc, 2014, VENS SOFTW; Victorian Department of Health, 2014, HLTH TOG VICT; Waters E, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001871.pub3; World Health Organization, 2014, 1 M AD HOC WORK GROU	24	127	127	3	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0129683	10.1371/journal.pone.0129683	http://dx.doi.org/10.1371/journal.pone.0129683			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1EJ	26153893	Green Published, Green Submitted, gold			2022-12-26	WOS:000358159700015
J	Aze, J; Sola, C; Zhang, J; Lafosse-Marin, F; Yasmin, M; Siddiqui, R; Kremer, K; van Soolingen, D; Refregier, G				Aze, Jerome; Sola, Christophe; Zhang, Jian; Lafosse-Marin, Florian; Yasmin, Memona; Siddiqui, Rubina; Kremer, Kristin; van Soolingen, Dick; Refregier, Guislaine			Genomics and Machine Learning for Taxonomy Consensus: The Mycobacterium tuberculosis Complex Paradigm	PLOS ONE			English	Article							VARIABLE-NUMBER; GENETIC DIVERSITY; MOLECULAR EPIDEMIOLOGY; STRAIN DIFFERENTIATION; DISCRIMINATORY POWER; GLOBAL DISTRIBUTION; DNA POLYMORPHISM; CLASSIFICATION; HYBRIDIZATION; TOOL	Infra-species taxonomy is a prerequisite to compare features such as virulence in different pathogen lineages. Mycobacterium tuberculosis complex taxonomy has rapidly evolved in the last 20 years through intensive clinical isolation, advances in sequencing and in the description of fast-evolving loci (CRISPR and MIRU-VNTR). On-line tools to describe new isolates have been set up based on known diversity either on CRISPRs (also known as spoligotypes) or on MIRU-VNTR profiles. The underlying taxonomies are largely concordant but use different names and offer different depths. The objectives of this study were 1) to explicit the consensus that exists between the alternative taxonomies, and 2) to provide an on-line tool to ease classification of new isolates. Genotyping (24-VNTR, 43-spacers spoligotypes, IS6110-RFLP) was undertaken for 3,454 clinical isolates from the Netherlands (2004-2008). The resulting database was enlarged with African isolates to include most human tuberculosis diversity. Assignations were obtained using TB-Lineage, MIRU-VNTRPlus, SITVITWEB and an algorithm from Borile et al. By identifying the recurrent concordances between the alternative taxonomies, we proposed a consensus including 22 sublineages. Original and consensus assignations of the all isolates from the database were subsequently implemented into an ensemble learning approach based on Machine Learning tool Weka to derive a classification scheme. All assignations were reproduced with very good sensibilities and specificities. When applied to independent datasets, it was able to suggest new sublineages such as pseudo-Beijing. This Lineage Prediction tool, efficient on 15-MIRU, 24-VNTR and spoligotype data is available on the web interface "TBminer." Another section of this website helps summarizing key molecular epidemiological data, easing tuberculosis surveillance. Altogether, we successfully used Machine Learning on a large dataset to set up and make available the first consensual taxonomy for human Mycobacterium tuberculosis complex. Additional developments using SNPs will help stabilizing it.	[Aze, Jerome] LIRMM UM CNRS, UMR 5506, F-34095 Montpellier 2, France; [Sola, Christophe; Zhang, Jian; Lafosse-Marin, Florian; Refregier, Guislaine] Univ Paris 11, CNRS, CEA, Inst Integrat Biol Cell I2BC, F-91405 Orsay, France; [Yasmin, Memona] PIEAS, Islamabad, Pakistan; [Yasmin, Memona; Siddiqui, Rubina] NIBGE, Hlth Biotechnol Div, Faisalabad, Pakistan; [Kremer, Kristin; van Soolingen, Dick] Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands; [van Soolingen, Dick] Radbout Univ Nijmegen, Univ Lung Ctr Dekkerswald, Med Ctr, Dept Pulm Dis, NL-6500 HB Nijmegen, Netherlands; [van Soolingen, Dick] Radbout Univ Nijmegen, Univ Lung Ctr Dekkerswald, Med Ctr, Dept Microbiol, NL-6500 HB Nijmegen, Netherlands	Centre National de la Recherche Scientifique (CNRS); Universite Paul-Valery; Universite Perpignan Via Domitia; Universite de Montpellier; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Pakistan Institute of Engineering & Applied Science; Pakistan Institute of Engineering & Applied Science; Netherlands National Institute for Public Health & the Environment; Radboud University Nijmegen; Radboud University Nijmegen	Refregier, G (corresponding author), Univ Paris 11, CNRS, CEA, Inst Integrat Biol Cell I2BC, Rue Gregor Mendal,Bat 400, F-91405 Orsay, France.	guislaine.refregier@u-psud.fr	Refregier, Guislaine/AAU-8777-2021; Sola, Christophe/A-7992-2016	Refregier, Guislaine/0000-0003-3749-7981; Sola, Christophe/0000-0003-4672-2140	National Institute for Public Health and the Environment, The Netherlands	National Institute for Public Health and the Environment, The Netherlands(Netherlands Government)	This work was supported by National Institute for Public Health and the Environment, The Netherlands, www.rivm.nl/ (CS). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadia E, 2010, INFECT GENET EVOL, V10, P1066, DOI 10.1016/j.meegid.2010.07.006; Alexander KA, 2010, EMERG INFECT DIS, V16, P1296, DOI 10.3201/eid1608.100314; Allix-Beguec C, 2008, J CLIN MICROBIOL; Allix-Beguec C, 2008, J CLIN MICROBIOL, V46, P1398, DOI 10.1128/JCM.02089-07; Amancio DR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094137; Amarreh I, 2014, NEUROIMAGE-CLIN, V4, P757, DOI 10.1016/j.nicl.2014.02.006; [Anonymous], [No title captured]; Aranaz A, 1999, INT J SYST BACTERIOL, V49, P1263, DOI 10.1099/00207713-49-3-1263; Blouin Y, 2014, EMERG INFECT DIS, V20, P21, DOI 10.3201/eid2001.130652; Blouin Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052841; Borgdorff MW, 2005, EMERG INFECT DIS, V11, P597, DOI 10.3201/eid1104.041103; Borile C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-224; Bouckaert RR, 2010, BIOINFORMATICS, V26, P1372, DOI 10.1093/bioinformatics/btq110; Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Bryant JM, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-110; Castets M, 1968, Rev Tuberc Pneumol (Paris), V32, P179; Coll F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5812; Coll F, 2014, TUBERCULOSIS, V94, P346, DOI 10.1016/j.tube.2014.02.005; Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815; Cousins DV, 2003, INT J SYST EVOL MICR, V53, P1305, DOI 10.1099/ijs.0.02401-0; Cowan LS, 2004, J CLIN MICROBIOL, V42, P474, DOI 10.1128/JCM.42.1.474-477.2004; de Beer JL, 2013, J CLIN MICROBIOL, V51, P1193, DOI 10.1128/JCM.03061-12; Demay C, 2012, INFECT GENE IN PRESS; DOWNEY JC, 1962, SYST ZOOL, V11, P150, DOI 10.2307/2411462; Evans JT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017930; Fenner L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024737; Filliol I, 2003, J CLIN MICROBIOL, V41, P1963, DOI 10.1128/JCM.41.5.1963-1970.2003; Filliol I, 2000, J CLIN MICROBIOL, V38, P2520, DOI 10.1128/JCM.38.7.2520-2524.2000; Filliol I, 2002, EMERG INFECT DIS, V8, P1347, DOI 10.3201/eid0811.020125; Frothingham R, 1998, MICROBIOL-UK, V144, P1189, DOI 10.1099/00221287-144-5-1189; Ghorbani M, 2013, J NUCLEIC ACIDS, V2013, DOI 10.1155/2013/689798; Goris J, 2007, INT J SYST EVOL MICR, V57, P81, DOI 10.1099/ijs.0.64483-0; GROENEN PMA, 1993, MOL MICROBIOL, V10, P1057, DOI 10.1111/j.1365-2958.1993.tb00976.x; Hershberg R, 2008, PLOS BIOL, V6, P2658, DOI 10.1371/journal.pbio.0060311; Homolka S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039855; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; KARLSON A G, 1970, International Journal of Systematic Bacteriology, V20, P273; Kato-Maeda M, 2011, INT J TUBERC LUNG D, V15, P131; Kremer K, 2005, J CLIN MICROBIOL, V43, P5628, DOI 10.1128/JCM.43.11.5628-5638.2005; Kremer K, 1999, J CLIN MICROBIOL, V37, P2607, DOI 10.1128/JCM.37.8.2607-2618.1999; Lan NTN, 2003, EMERG INFECT DIS, V9, P1633, DOI 10.3201/eid0912.030169; LASZLO A, 1983, J CLIN MICROBIOL, V18, P1335, DOI 10.1128/JCM.18.6.1335-1339.1983; Lawson L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038409; Lehmann K. B., 1907, LEHMANNS MED HANDATL; Mazars E, 2001, P NATL ACAD SCI USA, V98, P1901, DOI 10.1073/pnas.98.4.1901; Mokrousov I, 2014, J BACTERIOL, V196, P1833, DOI 10.1128/JB.01485-13; Murray M, 2002, EMERG INFECT DIS, V8, P363, DOI 10.3201/eid0804.000444; Niemann S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007407; Niobe-Eyangoh SN, 2004, J CLIN MICROBIOL, V42, P5029, DOI 10.1128/JCM.42.11.5029-5035.2004; Niobe-Eyangoh SN, 2003, J CLIN MICROBIOL, V41, P2547, DOI 10.1128/JCM.41.6.2547-2553.2003; Oelemann MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018256; Parsons SDC, 2013, EMERG INFECT DIS, V19, P2004, DOI 10.3201/eid1912.130268; Reed GB., 1957, BERGEYS MANUAL DETER, P703; Reyes JF, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-496; Schurch AC, 2011, J CLIN MICROBIOL, V49, P1318, DOI 10.1128/JCM.01848-10; Schurch AC, 2010, J CLIN MICROBIOL, V48, P3403, DOI 10.1128/JCM.00370-10; Sebban M, 2002, BIOINFORMATICS, V18, P235, DOI 10.1093/bioinformatics/18.2.235; Shabbeer A, 2012, INFECT GENET EVOL, V12, P789, DOI 10.1016/j.meegid.2012.02.010; Sloot R, 2013, J CLIN MICROBIOL, V51, P2427, DOI 10.1128/JCM.00489-13; SMALL PM, 1994, NEW ENGL J MED, V330, P1703, DOI 10.1056/NEJM199406163302402; Sola C, 1999, EMERG INFECT DIS, V5, P404, DOI 10.3201/eid0503.990311; Sola C, 2003, INFECT GENET EVOL, V3, P125, DOI 10.1016/S1567-1348(03)00011-X; STACKEBRANDT E, 1994, INT J SYST BACTERIOL, V44, P846, DOI 10.1099/00207713-44-4-846; Streicher EM, 2007, J CLIN MICROBIOL, V45, P237, DOI 10.1128/JCM.01429-06; Supply P, 2000, MOL MICROBIOL, V36, P762, DOI 10.1046/j.1365-2958.2000.01905.x; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Supply P, 2013, NAT GENET, V45, P172, DOI 10.1038/ng.2517; Tsolaki AG, 2004, P NATL ACAD SCI USA, V101, P4865, DOI 10.1073/pnas.0305634101; van der Zanden AGM, 2002, J CLIN MICROBIOL, V40, P4628, DOI 10.1128/JCM.40.12.4628-4639.2002; van Embden JDA, 2000, J BACTERIOL, V182, P2393, DOI 10.1128/JB.182.9.2393-2401.2000; van Ingen J, 2012, EMERG INFECT DIS, V18, P653, DOI 10.3201/eid1804.110888; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; VANSOOLINGEN D, 1995, J CLIN MICROBIOL, V33, P3234, DOI 10.1128/JCM.33.12.3234-3238.1995; VANSOOLINGEN D, 1991, J CLIN MICROBIOL, V29, P2578, DOI 10.1128/JCM.29.11.2578-2586.1991; vanSoolingen D, 1997, INT J SYST BACTERIOL, V47, P1236, DOI 10.1099/00207713-47-4-1236; Vitol I, 2006, INFECT GENET EVOL, V6, P491, DOI 10.1016/j.meegid.2006.03.003; Walker TM, 2013, CLIN MICROBIOL INFEC, V19, P796, DOI 10.1111/1469-0691.12183; Walker TM, 2013, LANCET INFECT DIS, V13, P137, DOI 10.1016/S1473-3099(12)70277-3; Warren RM, 2002, J CLIN MICROBIOL, V40, P4457, DOI 10.1128/JCM.40.12.4457-4465.2002; Weniger T, 2010, NUCLEIC ACIDS RES, V38, pW326, DOI 10.1093/nar/gkq351; WHO, 2006, WHOCDSTB2002295; Wirth T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000160; Yasmin M, 2014, INFECT GENET EVOL, V27, P6, DOI 10.1016/j.meegid.2014.06.017; Zhang J, 2010, J MED MICROBIOL, V59, P285, DOI 10.1099/jmm.0.016949-0	85	23	23	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0130912	10.1371/journal.pone.0130912	http://dx.doi.org/10.1371/journal.pone.0130912			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154264	Green Published, Green Submitted, gold			2022-12-26	WOS:000358159700045
J	Estupinan, M; Alvarez-Garcia, D; Barril, X; Diaz, P; Manresa, A				Estupinan, Monica; Alvarez-Garcia, Daniel; Barril, Xavier; Diaz, Pilar; Manresa, Angeles			In Silico/In Vivo Insights into the Functional and Evolutionary Pathway of Pseudomonas aeruginosa Oleate-Diol Synthase. Discovery of a New Bacterial Di-Heme Cytochrome C Peroxidase Subfamily	PLOS ONE			English	Article							RUBBER OXYGENASE ROXA; UNSATURATED FATTY-ACIDS; PALINDROMIC REPEATS; IDENTIFICATION; OXIDATION; ISOMERASE; EXPRESSION; GENERATION; PREDICTION; OXYLIPINS	As previously reported, P. aeruginosa genes PA2077 and PA2078 code for 10S-DOX (10S-Dioxygenase) and 7,10-DS (7,10-Diol Synthase) enzymes involved in long-chain fatty acid oxygenation through the recently described oleate-diol synthase pathway. Analysis of the amino acid sequence of both enzymes revealed the presence of two heme-binding motifs (CXXCH) on each protein. Phylogenetic analysis showed the relation of both proteins to bacterial di-heme cytochrome c peroxidases (Ccps), similar to Xanthomonas sp. 35Y rubber oxidase RoxA. Structural homology modelling of PA2077 and PA2078 was achieved using RoxA (pdb 4b2n) as a template. From the 3D model obtained, presence of significant amino acid variations in the predicted heme-environment was found. Moreover, the presence of palindromic repeats located in enzyme-coding regions, acting as protein evolution elements, is reported here for the first time in P. aeruginosa genome. These observations and the constructed phylogenetic tree of the two proteins, allow the proposal of an evolutionary pathway for P. aeruginosa oleate-diol synthase operon. Taking together the in silico and in vivo results obtained we conclude that enzymes PA2077 and PA2078 are the first described members of a new subfamily of bacterial peroxidases, designated as Fatty acid-di-heme Cytochrome c peroxidases (FadCcp).	[Estupinan, Monica; Manresa, Angeles] Univ Barcelona, Fac Farm, Unitat Microbiol & Parasitol Sanitaries, E-08028 Barcelona, Spain; [Estupinan, Monica; Diaz, Pilar] Univ Barcelona, Fac Biol, Dept Microbiol, Barcelona, Spain; [Alvarez-Garcia, Daniel; Barril, Xavier] Univ Barcelona, Fac Pharm, Dept Fisicoquim, Barcelona, Spain; [Alvarez-Garcia, Daniel; Barril, Xavier] Univ Barcelona IBUB, Inst Biomed, PCB, Barcelona, Spain; [Barril, Xavier] Catalan Inst Res & Adv Studies ICREA, Barcelona, Spain	University of Barcelona; University of Barcelona; University of Barcelona; University of Barcelona; ICREA	Diaz, P (corresponding author), Univ Barcelona, Fac Biol, Dept Microbiol, Barcelona, Spain.	pdiaz@ub.edu	Estupiñán Romero, Mónica/L-1438-2017; Barril, Xavier/K-9607-2014; Diaz, Pilar/I-2465-2014	Estupiñán Romero, Mónica/0000-0001-7347-3341; Barril, Xavier/0000-0002-0281-1347; Manresa, Angeles/0000-0003-2337-9060; Alvarez-Garcia, Daniel/0000-0002-2867-5005; Diaz, Pilar/0000-0003-4008-0669	Ministerio de Economia y Competitividad (MINECO) [CTQ2010-21183-CO2-01/02, CTQ2014-59632]; IV Pla de Recerca de Catalunya (Generalitat de Catalunya) [2009SGR-819]; "Comissionat per a Universitats i Recerca" (CUR) of "Departament d'Innovacio, Universitats i Empresa" (DIUE); Generalitat de Catalunya; European Social Source (FI-DGR); ICREA Funding Source: Custom	Ministerio de Economia y Competitividad (MINECO)(Spanish Government); IV Pla de Recerca de Catalunya (Generalitat de Catalunya)(Generalitat de Catalunya); "Comissionat per a Universitats i Recerca" (CUR) of "Departament d'Innovacio, Universitats i Empresa" (DIUE); Generalitat de Catalunya(Generalitat de Catalunya); European Social Source (FI-DGR); ICREA(ICREA)	This work was partially funded by the Ministerio de Economia y Competitividad (MINECO, projects CTQ2010-21183-CO2-01/02 and CTQ2014-59632), by the IV Pla de Recerca de Catalunya (Generalitat de Catalunya), grant 2009SGR-819, to the "Xarxa de Referencia en Biotecnologia" (XRB). ME acknowledges a fellowship from the "Comissionat per a Universitats i Recerca" (CUR) of "Departament d'Innovacio, Universitats i Empresa" (DIUE) from Generalitat de Catalunya and European Social Source (FI-DGR2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alves T, 1999, BBA-PROTEIN STRUCT M, V1434, P248, DOI 10.1016/S0167-4838(99)00188-0; Andreou A, 2009, PROG LIPID RES, V48, P148, DOI 10.1016/j.plipres.2009.02.002; Atack JM, 2007, ADV MICROB PHYSIOL, V52, P73, DOI 10.1016/S0065-2911(06)52002-8; BERNSTEIN FC, 1978, ARCH BIOCHEM BIOPHYS, V185, P584, DOI 10.1016/0003-9861(78)90204-7; Birke J, 2012, APPL ENVIRON MICROB, V78, P7876, DOI 10.1128/AEM.02385-12; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brodhun F, 2011, FEBS J, V278, P1047, DOI 10.1111/j.1742-4658.2011.08027.x; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Cao YJ, 2013, APPL MICROBIOL BIOT, V97, P3323, DOI 10.1007/s00253-013-4815-z; Claverie JM, 2003, TRENDS BIOCHEM SCI, V28, P75, DOI 10.1016/S0968-0004(02)00036-1; De Smet L, 2006, J BIOL CHEM, V281, P4371, DOI 10.1074/jbc.M509582200; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Estupinan M, 2014, BBA-MOL CELL BIOL L, V1841, P1360, DOI 10.1016/j.bbalip.2014.06.010; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Folkesson A, 2012, NAT REV MICROBIOL, V10, P841, DOI 10.1038/nrmicro2907; Frimmersdorf E, 2010, ENVIRON MICROBIOL, V12, P1734, DOI 10.1111/j.1462-2920.2010.02253.x; Gardy JL, 2005, BIOINFORMATICS, V21, P617, DOI 10.1093/bioinformatics/bti057; Garreta A, 2013, FASEB J, P1; Garscha U, 2007, J BIOL CHEM, V282, P34707, DOI 10.1074/jbc.M705366200; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; GILMOUR R, 1994, BIOCHEM J, V300, P907, DOI 10.1042/bj3000907; Hambsch N, 2010, J APPL MICROBIOL, V109, P1067, DOI 10.1111/j.1365-2672.2010.04732.x; Hiseni A, 2014, BIOTECHNOL J, V9, P814, DOI 10.1002/biot.201300412; Hoffmann I, 2012, BBA-MOL CELL BIOL L, V1821, P1508, DOI 10.1016/j.bbalip.2012.09.001; Hoffmann I, 2011, ARCH BIOCHEM BIOPHYS, V506, P216, DOI 10.1016/j.abb.2010.11.022; Hofmann, 1993, BIOL CHEM HOPPE SEYL, V374; Hou CT, 2009, NEW BIOTECHNOL, V26, P2, DOI 10.1016/j.nbt.2009.05.001; Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055; Jendrossek D, 2003, FEMS MICROBIOL LETT, V224, P61, DOI 10.1016/S0378-1097(03)00424-5; Jerneren F, 2012, LIPIDS, V47, P707, DOI 10.1007/s11745-012-3673-2; Jerneren F, 2010, BBA-MOL CELL BIOL L, V1801, P503, DOI 10.1016/j.bbalip.2009.12.012; Jerneren F, 2010, J BIOL CHEM, V285, P5308, DOI 10.1074/jbc.M109.062810; Lewenza S, 2005, GENOME RES, V15, P321, DOI 10.1101/gr.3257305; Lucchetti-Miganeh C, 2014, PATHOGENS, V3, P309, DOI 10.3390/pathogens3020309; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Marchler-Bauer Aron, 2011, Nucleic Acids Res, V39, pD225, DOI 10.1093/nar/gkq1189; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Martin-Arjol I, 2010, CHEM PHYS LIPIDS, V163, P341, DOI 10.1016/j.chemphyslip.2010.02.003; Martin-Arjol I, 2014, APPL MICROBIOL BIOTE; Martinez E, 2013, BIOCHIMIE, V95, P290, DOI 10.1016/j.biochi.2012.09.032; Martinez E, 2010, J BIOL CHEM, V285, P9339, DOI 10.1074/jbc.M109.078147; Massey KA, 2011, BIOCHEM SOC T, V39, P1240, DOI 10.1042/BST0391240; Mosblech A, 2009, PLANT PHYSIOL BIOCH, V47, P511, DOI 10.1016/j.plaphy.2008.12.011; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Noverr MC, 2003, CLIN MICROBIOL REV, V16, P517, DOI 10.1128/CMR.16.3.517-533.2003; Ogata H, 2005, TRENDS MICROBIOL, V13, P253, DOI 10.1016/j.tim.2005.03.013; Oliw EH, 2011, J LIPID RES, V52, P1995, DOI 10.1194/jlr.M018259; Pearson CE, 1996, J CELL BIOCHEM, V63, P1; RAVICHANDRAN KG, 1993, SCIENCE, V261, P731, DOI 10.1126/science.8342039; Sambrook J., 2001, MOL CLONING LAB MANU; Seidel J, 2013, P NATL ACAD SCI USA, V110, P13833, DOI 10.1073/pnas.1305560110; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Wang YT, 2003, BIOCHEMISTRY-US, V42, P7318, DOI 10.1021/bi034243q; Winsor GL, 2011, NUCLEIC ACIDS RES, V39, pD596, DOI 10.1093/nar/gkq869	58	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0131462	10.1371/journal.pone.0131462	http://dx.doi.org/10.1371/journal.pone.0131462			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154497	Green Published, gold			2022-12-26	WOS:000358159700063
J	Lee, HF; Pei, Q; Zhang, DD; Choi, KPK				Lee, Harry F.; Pei, Qing; Zhang, David D.; Choi, Kan P. K.			Quantifying the Intra-Regional Precipitation Variability in Northwestern China over the Past 1,400 Years	PLOS ONE			English	Article							EAST-ASIAN WINTER; NORTH CENTRAL CHINA; ICE-AGE; HIGH-RESOLUTION; MONSOON PRECIPITATION; SURFACE TEMPERATURES; DROUGHT VARIABILITY; TROPICAL PACIFIC; TIBETAN PLATEAU; INDIAN MONSOON	There has been a surge of paleo-climatic/environmental studies of Northwestern China (NW China), a region characterized by a diverse assortment of hydro-climatic systems. Their common approach, however, focuses on "deducing regional resemblance" rather than "exploring regional variance." To date, efforts to produce a quantitative assessment of long-term intra-regional precipitation variability (IRPV) in NW China has been inadequate. In the present study, we base on historical flood/drought records to compile a decadal IRPV index for NW China spanned AD580-1979 and to find its major determinants via wavelet analysis. Results show that our IRPV index captures the footprints of internal hydro-climatic disparity in NW China. In addition, we find distinct similar to 120-200 year periodicities in the IRPV index over the Little Ice Age, which are attributable to the change of hydro-climatic influence of ocean-atmospheric modes during the period. Also, we offer statistical evidence of El Nino Southern Oscillation (Indo-Pacific warm pool sea surface temperature and China-wide land surface temperature) as the prominent multi-decadal to centennial (centennial to multi-centennial) determinant of the IRPV in NW China. The present study contributes to the quantitative validation of the long-term IRPV in NW China and its driving forces, covering the periods with and without instrumental records. It may help to comprehend the complex hydro-climatic regimes in the region.	[Lee, Harry F.; Pei, Qing; Zhang, David D.; Choi, Kan P. K.] Univ Hong Kong, Dept Geog, Hong Kong, Hong Kong, Peoples R China; [Lee, Harry F.; Pei, Qing; Zhang, David D.] Univ Hong Kong, Int Ctr China Dev Studies, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Lee, HF (corresponding author), Univ Hong Kong, Dept Geog, Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China.	harrylee@hku.hk	Lee, Harry F./M-9979-2019	Lee, Harry F./0000-0001-5415-7845; Pei, Qing/0000-0002-9699-2950	Hui Oi-Chow Trust Fund [201205172003, 201302172003]; HKU Seed Funding Programme for Basic Research [201109159014]; Research Grants Council of The Government of the Hong Kong Special Administrative Region of the People's Republic of China [HKU758712H, HKU745113H]; CAS/SAFEA International Partnership Program for Creative Research Teams	Hui Oi-Chow Trust Fund; HKU Seed Funding Programme for Basic Research; Research Grants Council of The Government of the Hong Kong Special Administrative Region of the People's Republic of China(Hong Kong Research Grants Council); CAS/SAFEA International Partnership Program for Creative Research Teams(Chinese Academy of Sciences)	This research was supported by the Hui Oi-Chow Trust Fund (201205172003 and 201302172003), HKU Seed Funding Programme for Basic Research (201109159014), Research Grants Council of The Government of the Hong Kong Special Administrative Region of the People's Republic of China (HKU758712H and HKU745113H), and the CAS/SAFEA International Partnership Program for Creative Research Teams. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnihotri R, 2002, EARTH PLANET SC LETT, V198, P521, DOI 10.1016/S0012-821X(02)00530-7; Agung I.G.N., 2009, TIME SERIES DATA ANA; [Anonymous], 2013, CONTRIBUTION WORKING, P1535; Bai H.Z., 2010, YEARLY CHARTS DRYNES; Boos WR, 2010, NATURE, V463, P218, DOI 10.1038/nature08707; Cai YJ, 2010, EARTH PLANET SC LETT, V291, P21, DOI 10.1016/j.epsl.2009.12.039; Cazelles B, 2008, OECOLOGIA, V156, P287, DOI 10.1007/s00442-008-0993-2; Cazelles B, 2007, J R SOC INTERFACE, V4, P625, DOI 10.1098/rsif.2007.0212; Chen FH, 2010, QUATERNARY SCI REV, V29, P1055, DOI 10.1016/j.quascirev.2010.01.005; Chen FH, 2008, QUATERNARY SCI REV, V27, P351, DOI 10.1016/j.quascirev.2007.10.017; Chen FH, 2006, SCI CHINA SER D, V49, P1280, DOI 10.1007/s11430-006-2027-4; Chen F, 2013, HOLOCENE, V23, P1095, DOI 10.1177/0959683613483614; Chen JH, 2015, QUATERNARY SCI REV, V107, P98, DOI 10.1016/j.quascirev.2014.10.012; Chen JH, 2009, CHINESE SCI BULL, V54, P3749, DOI [10.1007/s11434-009-0201-8, 10.1007/S11434-009-0201-8]; [陈建徽 CHEN Jianhui], 2008, [地理学报, Acta Geographica Sinica], V63, P23; Chen JM, 2009, ADV ATMOS SCI, V26, P803, DOI 10.1007/s00376-009-9018-2; Chinese National Meteorological Administration, 1981, YEARLY CHARTS DRYNES; Chu GQ, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034475; Conroy JL, 2009, NAT GEOSCI, V2, P46, DOI 10.1038/NGEO390; Cook ER, 2010, SCIENCE, V328, P486, DOI 10.1126/science.1185188; Cosford J, 2008, EARTH PLANET SC LETT, V275, P296, DOI 10.1016/j.epsl.2008.08.018; Deng XN, 2005, AGR SYST, V84, P155, DOI 10.1016/j.agsy.2004.05.004; Dykoski CA, 2005, EARTH PLANET SC LETT, V233, P71, DOI 10.1016/j.epsl.2005.01.036; EDDY JA, 1976, SCIENCE, V192, P1189, DOI 10.1126/science.192.4245.1189; Fang KY, 2012, GLOBAL PLANET CHANGE, V80-81, P190, DOI 10.1016/j.gloplacha.2011.10.009; Fang KY, 2010, CLIM DYNAM, V35, P577, DOI 10.1007/s00382-009-0636-2; Fang KY, 2009, CLIM RES, V38, P129, DOI 10.3354/cr00781; Fox J., 2019, R COMPANION APPL REG, V.; Ge Q, 2013, CLIM PAST, V9, P1153, DOI 10.5194/cp-9-1153-2013; Grinsted A, 2004, NONLINEAR PROC GEOPH, V11, P561, DOI 10.5194/npg-11-561-2004; Huang RH, 2004, ADV ATMOS SCI, V21, P407, DOI 10.1007/BF02915568; Jiang T, 2005, THEOR APPL CLIMATOL, V82, P131, DOI 10.1007/s00704-005-0125-4; Kang SY, 2014, J ARID ENVIRON, V110, P53, DOI 10.1016/j.jaridenv.2014.06.003; Kang SY, 2013, QUATERN INT, V283, P85, DOI 10.1016/j.quaint.2012.03.011; Kang SY, 2012, CLIMATIC CHANGE, V115, P519, DOI 10.1007/s10584-012-0440-6; Lee HF, 2011, J ARID ENVIRON, V75, P1114, DOI 10.1016/j.jaridenv.2011.06.008; Lee HF, 2012, ASIAN GEOGR, V29, P89, DOI 10.1080/10225706.2012.742615; Lee HF, 2015, HOLOCENE, V25, P1271, DOI 10.1177/0959683615581203; Lee HF, 2010, CLIM RES, V41, P245, DOI 10.3354/cr00858; Li CY, 2000, CHINESE SCI BULL, V45, P1448, DOI 10.1007/BF02898885; Li JB, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025803; Li JB, 2007, INT J CLIMATOL, V27, P903, DOI 10.1002/joc.1450; Li JB, 2013, NAT CLIM CHANGE, V3, P822, DOI [10.1038/nclimate1936, 10.1038/NCLIMATE1936]; Li Y, 2000, CLIMATIC ENV RES, V5, P205; MacDonald GM, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022478; Mann ME, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017814; Mann ME, 2009, SCIENCE, V326, P1256, DOI 10.1126/science.1177303; McPhaden MJ, 2006, SCIENCE, V314, P1740, DOI 10.1126/science.1132588; Moberg A, 2005, NATURE, V433, P613, DOI 10.1038/nature03265; Nie JS, 2014, SCI REP-UK, V4, DOI 10.1038/srep05474; Oppo DW, 2009, NATURE, V460, P1113, DOI 10.1038/nature08233; Osborn TJ, 2006, SCIENCE, V311, P841, DOI 10.1126/science.1120514; Rigozo NR, 2008, J ATMOS SOL-TERR PHY, V70, P1012, DOI 10.1016/j.jastp.2008.01.002; Sachs JP, 2009, NAT GEOSCI, V2, P519, DOI 10.1038/ngeo554; Sheppard PR, 2004, CLIM DYNAM, V23, P869, DOI 10.1007/s00382-004-0473-2; Shi YF, 2007, CLIMATIC CHANGE, V80, P379, DOI 10.1007/s10584-006-9121-7; Su MF, 2007, SCI CHINA SER D, V50, P145, DOI 10.1007/s11430-007-2006-4; Tan L, 2011, CLIM PAST, V7, P685, DOI 10.5194/cp-7-685-2011; Tan LC, 2008, CLIM PAST, V4, P19; Tan LC, 2011, HOLOCENE, V21, P287, DOI 10.1177/0959683610378880; Thompson LG, 2006, P NATL ACAD SCI USA, V103, P10536, DOI 10.1073/pnas.0603900103; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Torrence C, 1999, J CLIMATE, V12, P2679, DOI 10.1175/1520-0442(1999)012<2679:ICITEM>2.0.CO;2; Trouet V, 2009, SCIENCE, V324, P78, DOI 10.1126/science.1166349; Wang B, 2003, J CLIMATE, V16, P1195, DOI 10.1175/1520-0442(2003)16&lt;1195:AOIAII&gt;2.0.CO;2; Wang B., 2006, ASIAN MONSOON, P1; Wang L, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035287; WANG WC, 1990, J CLIMATE, V3, P769, DOI 10.1175/1520-0442(1990)003<0769:PFOSRI>2.0.CO;2; Xu ZX, 2007, HYDROL PROCESS, V21, P61, DOI 10.1002/hyp.6180; Yadava MG, 2007, NEW ASTRON, V12, P544, DOI 10.1016/j.newast.2007.04.001; Yan Z, 1993, SCI ATMOSPHERICA SIN, V17, P663; Yang B, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014485; Yang B, 2014, CLIM DYNAM, V43, P845, DOI 10.1007/s00382-013-1962-y; Yang B, 2014, P NATL ACAD SCI USA, V111, P2903, DOI 10.1073/pnas.1319238111; Yang B, 2011, INT J CLIMATOL, V31, P1166, DOI 10.1002/joc.2143; Yang MX, 2000, CLIMATIC CHANGE, V47, P401, DOI 10.1023/A:1005696702385; Yao TD, 1996, SCI CHINA SER D, V39, P587; Yi L, 2012, CLIMATIC CHANGE, V110, P469, DOI 10.1007/s10584-011-0052-6; Yu YT, 2006, PALAEOGEOGR PALAEOCL, V233, P149, DOI 10.1016/j.palaeo.2005.09.008; Yuan L, 1994, HIST DROUGHT FAMINE; Zhang DE, 2010, CHINESE SCI BULL, V55, P77, DOI 10.1007/s11434-009-0584-6; Zhang JW, 2009, QUATERN INT, V194, P119, DOI 10.1016/j.quaint.2008.05.003; Zhang PZ, 2008, SCIENCE, V322, P940, DOI 10.1126/science.1163965; Zhang ZB, 2009, P ROY SOC B-BIOL SCI, V276, P823, DOI 10.1098/rspb.2008.1284; Zhao S, 1986, PHYS GEOGRAPHYS CHIN; Zhou W, 2007, METEOROL ATMOS PHYS, V98, P283, DOI 10.1007/s00703-007-0263-6	86	10	11	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0131693	10.1371/journal.pone.0131693	http://dx.doi.org/10.1371/journal.pone.0131693			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154711	Green Submitted, Green Published, gold			2022-12-26	WOS:000358159700077
J	Novak, J; Bailoo, JD; Melotti, L; Rommen, J; Wurbel, H				Novak, Janja; Bailoo, Jeremy D.; Melotti, Luca; Rommen, Jonas; Wuerbel, Hanno			An Exploration Based Cognitive Bias Test for Mice: Effects of Handling Method and Stereotypic Behaviour	PLOS ONE			English	Article							AMBIGUOUS-CUE INTERPRETATION; CAGE-INDUCED STEREOTYPIES; ENVIRONMENTAL ENRICHMENT; JUDGMENT BIAS; ANIMAL-MODEL; LABORATORY RATS; RISK-ASSESSMENT; BASAL GANGLIA; PLUS-MAZE; STRESS	Behavioural tests to assess affective states are widely used in human research and have recently been extended to animals. These tests assume that affective state influences cognitive processing, and that animals in a negative affective state interpret ambiguous information as expecting a negative outcome (displaying a negative cognitive bias). Most of these tests however, require long discrimination training. The aim of the study was to validate an exploration based cognitive bias test, using two different handling methods, as previous studies have shown that standard tail handling of mice increases physiological and behavioural measures of anxiety compared to cupped handling. Therefore, we hypothesised that tail handled mice would display a negative cognitive bias. We handled 28 female CD-1 mice for 16 weeks using either tail handling or cupped handling. The mice were then trained in an eight arm radial maze, where two adjacent arms predicted a positive outcome (darkness and food), while the two opposite arms predicted a negative outcome (no food, white noise and light). After six days of training, the mice were also given access to the four previously unavailable intermediate ambiguous arms of the radial maze and tested for cognitive bias. We were unable to validate this test, as mice from both handling groups displayed a similar pattern of exploration. Furthermore, we examined whether maze exploration is affected by the expression of stereotypic behaviour in the home cage. Mice with higher levels of stereotypic behaviour spent more time in positive arms and avoided ambiguous arms, displaying a negative cognitive bias. While this test needs further validation, our results indicate that it may allow the assessment of affective state in mice with minimal training-a major confound in current cognitive bias paradigms.	[Novak, Janja; Bailoo, Jeremy D.; Melotti, Luca; Wuerbel, Hanno] Univ Bern, VPH Inst, Div Anim Welf, CH-3012 Bern, Switzerland; [Rommen, Jonas] Univ Marburg, Fac Biol, Dept Zool Systemat & Evolut, D-35037 Marburg, Germany	University of Bern; Philipps University Marburg	Novak, J (corresponding author), Univ Bern, VPH Inst, Div Anim Welf, Langgassstr 120, CH-3012 Bern, Switzerland.	j.novak2@gmail.com	Bailoo, Jeremy D./H-5011-2019; Wuerbel, Hanno/D-6281-2012	Bailoo, Jeremy D./0000-0002-3767-2922; Wuerbel, Hanno/0000-0002-2934-3010	German Research Foundation DFG project [WU494/4-1]; ERC	German Research Foundation DFG project(German Research Foundation (DFG)); ERC(European Research Council (ERC)European Commission)	The authors were funded by the German Research Foundation DFG project WU494/4-1 (JN) and an ERC Advanced Grant "REFINE" (JDB).	ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; ARCHER J, 1973, ANIM BEHAV, V21, P205, DOI 10.1016/S0003-3472(73)80065-X; Augustsson H, 2004, PHYSIOL BEHAV, V81, P685, DOI 10.1016/j.physbeh.2004.03.014; Bailoo JD, 2010, J NEUROSCI METH, V188, P45, DOI 10.1016/j.jneumeth.2010.01.035; Bates Douglas, 2014, LME4 LINEAR MIXED EF; Bateson M, 2007, ANIM WELFARE, V16, P33; Bayne K, 2014, REV SCI TECH OIE, V33, P273, DOI 10.20506/rst.33.1.2282; Belzung C, 1997, BEHAV PHARMACOL, V8, P541, DOI 10.1097/00008877-199711000-00012; Birrell JM, 2000, J NEUROSCI, V20, P4320; Boleij H, 2012, BEHAV BRAIN RES, V233, P45, DOI 10.1016/j.bbr.2012.04.039; Burman OHP, 2008, ANIM BEHAV, V76, P801, DOI 10.1016/j.anbehav.2008.02.014; Burman OHP, 2009, PHYSIOL BEHAV, V98, P345, DOI 10.1016/j.physbeh.2009.06.012; Cabib S, 2006, STEREOTYPIC ANIMAL BEHAVIOUR: FUNDAMENTALS AND APPLICATIONS TO WELFARE, 2ND EDIITON, P227, DOI 10.1079/9780851990040.0227; Calvo-Torrent A, 1999, PHYSIOL BEHAV, V67, P189, DOI 10.1016/S0031-9384(99)00051-7; Coles ME, 2002, CLIN PSYCHOL REV, V22, P587, DOI 10.1016/S0272-7358(01)00113-1; Dallaire JA, 2011, BEHAV BRAIN RES, V224, P213, DOI 10.1016/j.bbr.2011.03.061; Deacon RMJ, 2006, NAT PROTOC, V1, P936, DOI 10.1038/nprot.2006.120; Dunn BD, 2009, BEHAV RES THER, V47, P374, DOI 10.1016/j.brat.2009.01.016; Enkel T, 2010, NEUROPSYCHOPHARMACOL, V35, P1008, DOI 10.1038/npp.2009.204; EYSENCK MW, 1991, J ABNORM PSYCHOL, V100, P144, DOI 10.1037/0021-843X.100.2.144; Franks B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083578; Fridgeirsdottir GA, 2014, UPSALA J MED SCI, V119, P1, DOI 10.3109/03009734.2013.847511; Garner JP, 2011, BEHAV BRAIN RES, V219, P189, DOI 10.1016/j.bbr.2011.01.002; Garner JP, 2002, BEHAV BRAIN RES, V136, P83, DOI 10.1016/S0166-4328(02)00111-0; Gouveia K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066401; Graybiel AM, 2005, CURR OPIN NEUROBIOL, V15, P638, DOI 10.1016/j.conb.2005.10.006; GRIEBEL G, 1993, BEHAV PHARMACOL, V4, P637; Gross AN, 2012, BEHAV BRAIN RES, V234, P61, DOI 10.1016/j.bbr.2012.06.007; Gross AN, 2011, BEHAV BRAIN RES, V216, P613, DOI 10.1016/j.bbr.2010.09.003; Harding EJ, 2004, NATURE, V427, P312, DOI 10.1038/427312a; Hogg S, 1996, PHARMACOL BIOCHEM BE, V54, P21, DOI 10.1016/0091-3057(95)02126-4; Horvath J, 2013, BEHAV BRAIN RES, V250, P32, DOI 10.1016/j.bbr.2013.04.014; Hurst JL, 2010, NAT METHODS, V7, P825, DOI [10.1038/nmeth.1500, 10.1038/NMETH.1500]; Kloke V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105431; Latham N, 2010, BEHAV BRAIN RES, V211, P96, DOI 10.1016/j.bbr.2010.03.018; Lewis M, 2009, J NEURODEV DISORD, V1, P114, DOI 10.1007/s11689-009-9019-6; LISTER RG, 1990, PHARMACOL THERAPEUT, V46, P321, DOI 10.1016/0163-7258(90)90021-S; Martin P., 1993, MEASURING BEHAV, V2nd, DOI [10.1017/CBO9781139168342, DOI 10.1017/CBO9781139168342]; Mason GJ, 2004, ANIM WELFARE, V13, pS57; Matheson SM, 2008, APPL ANIM BEHAV SCI, V109, P374, DOI 10.1016/j.applanim.2007.03.007; Maurer BM, 2008, APPL ANIM BEHAV SCI, V114, P554, DOI 10.1016/j.applanim.2008.04.013; Meijer MK, 2007, LAB ANIM-UK, V41, P161, DOI 10.1258/002367707780378168; Mendl M, 2010, P ROY SOC B-BIOL SCI, V277, P2895, DOI 10.1098/rspb.2010.0303; Mendl M, 2009, APPL ANIM BEHAV SCI, V118, P161, DOI 10.1016/j.applanim.2009.02.023; Moberg Gary P MJA, 2000, BIOL ANIMAL STRESS B; Nevison CM, 1999, BEHAV PROCESS, V47, P95, DOI 10.1016/S0376-6357(99)00053-4; ODBERG FO, 1986, BIOL BEHAV, V11, P130; OLTON DS, 1976, J EXP PSYCHOL-ANIM B, V2, P97, DOI 10.1037/0097-7403.2.2.97; Parker RMA, 2014, BEHAV BRAIN RES, V274, P73, DOI 10.1016/j.bbr.2014.07.048; Paul ES, 2005, NEUROSCI BIOBEHAV R, V29, P469, DOI 10.1016/j.neubiorev.2005.01.002; Pomerantz O, 2012, ANIM COGN, V15, P689, DOI 10.1007/s10071-012-0497-7; Powell SB, 2004, BEHAV BRAIN RES, V152, P341, DOI 10.1016/j.bbr.2003.10.020; Presti MF, 2005, BEHAV BRAIN RES, V157, P363, DOI 10.1016/j.bbr.2004.08.003; Redbo I, 1998, PHYSIOL BEHAV, V64, P273, DOI 10.1016/S0031-9384(98)00059-6; Richter SH, 2012, COGN AFFECT BEHAV NE, V12, P527, DOI 10.3758/s13415-012-0101-2; Rodgers RJ, 1997, BEHAV PHARMACOL, V8, P477, DOI 10.1097/00008877-199711000-00003; Rommen J, 2014, EFFECTS 2 DIFFERENT; ROWAN AN, 1990, FUND APPL TOXICOL, V15, P25, DOI 10.1016/0272-0590(90)90159-H; Roy V, 2004, BEHAV BRAIN RES, V154, P439, DOI 10.1016/j.bbr.2004.03.010; Rygula R, 2014, EUR NEUROPSYCHOPHARM, V24, P1103, DOI 10.1016/j.euroneuro.2014.01.012; Rygula R, 2013, NEUROPSYCHOPHARMACOL, V38, P2188, DOI 10.1038/npp.2013.116; Schmidt MV, 2010, HORM BEHAV, V57, P415, DOI 10.1016/j.yhbeh.2010.01.010; Steiner H, 1998, EXP BRAIN RES, V123, P60, DOI 10.1007/s002210050545; Stuart SA, 2013, NEUROPSYCHOPHARMACOL, V38, P1625, DOI 10.1038/npp.2013.69; Taylor K, 2008, ATLA-ALTERN LAB ANIM, V36, P327, DOI 10.1177/026119290803600310; Tilly SLC, 2010, ANIM BEHAV, V80, P363, DOI 10.1016/j.anbehav.2010.06.008; Vestergaard KS, 1997, PHYSIOL BEHAV, V62, P413, DOI 10.1016/S0031-9384(97)00041-3; Vickery SS, 2005, APPL ANIM BEHAV SCI, V91, P247, DOI 10.1016/j.applanim.2005.01.005; Voikar V, 2004, GENES BRAIN BEHAV, V3, P27, DOI 10.1046/j.1601-183X.2003.0044.x; Wiedenmayer C, 1997, BEHAV PROCESS, V39, P215, DOI 10.1016/S0376-6357(96)00751-6; Wurbel H, 1996, ETHOLOGY, V102, P371; Wurbel H, 1997, ANIM BEHAV, V53, P891, DOI 10.1006/anbe.1996.0424; Wurbel H, 1998, BEHAV PROCESS, V43, P61, DOI 10.1016/S0376-6357(97)00086-7	73	27	27	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0130718	10.1371/journal.pone.0130718	http://dx.doi.org/10.1371/journal.pone.0130718			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154309	Green Published, gold			2022-12-26	WOS:000358159700036
J	Paparazzo, F; Tellier, A; Stephan, W; Hutter, S				Paparazzo, Francesco; Tellier, Aurelien; Stephan, Wolfgang; Hutter, Stephan			Survival Rate and Transcriptional Response upon Infection with the Generalist Parasite Beauveria bassiana in a World-Wide Sample of Drosophila melanogaster	PLOS ONE			English	Article							GENETIC-VARIATION; GEOGRAPHICAL VARIATION; NATURAL-SELECTION; IMMUNE-RESPONSE; LIFE-HISTORY; HOST; RESISTANCE; EVOLUTION; POPULATIONS; EXPRESSION	The ability to cope with infection by a parasite is one of the major challenges for any host species and is a major driver of evolution. Parasite pressure differs between habitats. It is thought to be higher in tropical regions compared to temporal ones. We infected Drosophila melanogaster from two tropical (Malaysia and Zimbabwe) and two temperate populations (the Netherlands and North Carolina) with the generalist entomopathogenic fungus Beauveria bassiana to examine if adaptation to local parasite pressures led to differences in resistance. Contrary to previous findings we observed increased survival in temperate populations. This, however, is not due to increased resistance to infection per se, but rather the consequence of a higher general vigor of the temperate populations. We also assessed transcriptional response to infection within these flies eight and 24 hours after infection. Only few genes were induced at the earlier time point, most of which are involved in detoxification. In contrast, we identified more than 4,000 genes that changed their expression state after 24 hours. This response was generally conserved over all populations with only few genes being uniquely regulated in the temperate populations. We furthermore found that the American population was transcriptionally highly diverged from all other populations concerning basal levels of gene expression. This was particularly true for stress and immune response genes, which might be the genetic basis for their elevated vigor.	[Paparazzo, Francesco; Stephan, Wolfgang; Hutter, Stephan] Univ Munich, Dept Biol 2, D-82152 Planegg Martinsried, Germany; [Tellier, Aurelien] Tech Univ Munich, Sect Populat Genet, D-85354 Freising Weihenstephan, Germany	University of Munich; Technical University of Munich	Hutter, S (corresponding author), Univ Munich, Dept Biol 2, D-82152 Planegg Martinsried, Germany.	hutter@bio.lmu.de	Tellier, Aurelien/C-3852-2017; Stephan, Wolfgang/GOV-6503-2022	Tellier, Aurelien/0000-0002-8895-0785; Hutter, Stephan/0000-0003-2432-8898	Deutsche Forschungsgemeinschaft from Priority Program 1399 [HU 1776/1-1]	Deutsche Forschungsgemeinschaft from Priority Program 1399	This research was supported by the Deutsche Forschungsgemeinschaft (www.dfg.de) grant HU 1776/1-1 from the Priority Program 1399 to SH and WS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apidianakis Y, 2005, P NATL ACAD SCI USA, V102, P2573, DOI 10.1073/pnas.0409588102; Valencia JWA, 2011, CURR MICROBIOL, V63, P306, DOI 10.1007/s00284-011-9977-2; Beaver LM, 2010, TOXICOL SCI, V115, P513, DOI 10.1093/toxsci/kfq083; BEGUN DJ, 1993, NATURE, V365, P548, DOI 10.1038/365548a0; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bubliy OA, 2000, GENETICA, V110, P79, DOI 10.1023/A:1017990814142; Buteler M, 2011, PESTICIDES IN THE MODERN WORLD - PESTICIDES USE AND MANAGEMENT, P119; Clancy David J., 2001, Drosophila Information Service, V84, P168; COHET Y, 1980, J THERM BIOL, V5, P69, DOI 10.1016/0306-4565(80)90002-9; Corby-Harris V, 2008, J ANIM ECOL, V77, P768, DOI 10.1111/j.1365-2656.2008.01399.x; Cornet S, 2009, OECOLOGIA, V159, P257, DOI 10.1007/s00442-008-1211-y; COX DR, 1972, J R STAT SOC B, V34, P187; DAVID JR, 1988, TRENDS GENET, V4, P106, DOI 10.1016/0168-9525(88)90098-4; De Gregorio E, 2001, P NATL ACAD SCI USA, V98, P12590, DOI 10.1073/pnas.221458698; Duchen P, 2013, GENETICS, V193, P291, DOI 10.1534/genetics.112.145912; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Gibert P, 2004, GENETICA, V120, P165, DOI 10.1023/B:GENE.0000017639.62427.8b; Gillespie JP, 2000, ARCH INSECT BIOCHEM, V44, P49, DOI 10.1002/1520-6327(200006)44:2&lt;49::AID-ARCH1&gt;3.0.CO;2-F; Glinka S, 2005, J GENET, V84, P173, DOI 10.1007/BF02715842; Glinka S, 2003, GENETICS, V165, P1269; Goel Manish Kumar, 2010, Int J Ayurveda Res, V1, P274, DOI 10.4103/0974-7788.76794; Haddrill PR, 2005, GENOME RES, V15, P790, DOI 10.1101/gr.3541005; Hoffmann AA, 1999, HEREDITY, V83, P637, DOI 10.1038/sj.hdy.6886490; Horrocks NPC, 2012, PHYSIOL BIOCHEM ZOOL, V85, P504, DOI 10.1086/666988; Hutter S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r12; Jordan KW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r172; Kawecki TJ, 1998, AM NAT, V152, P635, DOI 10.1086/286195; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Klein JP, 2003, SURVIVAL ANAL TECHNI, Vxv; Kraaijeveld AR, 1999, AM NAT, V153, pS61, DOI 10.1086/303212; LANGE BW, 1990, GENETICS, V126, P921; Laurent SJY, 2011, MOL BIOL EVOL, V28, P2041, DOI 10.1093/molbev/msr031; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Lockyer AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051102; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lovegrove FE, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-295; Luong LT, 2007, J EVOLUTION BIOL, V20, P79, DOI 10.1111/j.1420-9101.2006.01226.x; McDade TW, 2003, YEARB PHYS ANTHROPOL, V46, P100, DOI 10.1002/ajpa.10398; McDonald MJ, 2001, CELL, V107, P567, DOI 10.1016/S0092-8674(01)00545-1; Moller AP, 2006, OIKOS, V115, P463, DOI 10.1111/j.2006.0030-1299.15312.x; Moller AP, 1998, OIKOS, V82, P265, DOI 10.2307/3546966; Moscou MJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002208; Muller L, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-81; Obbard DJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000698; Obbard DJ, 2006, CURR BIOL, V16, P580, DOI 10.1016/j.cub.2006.01.065; Okado K, 2009, BIOCHEM BIOPH RES CO, V379, P6, DOI 10.1016/j.bbrc.2008.11.097; Parkash R, 2008, J INSECT PHYSIOL, V54, P1050, DOI 10.1016/j.jinsphys.2008.04.008; Parvez H., 2001, MOLECULAR RESPONSES; Polesani M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-117; R Core Team, 2013, R LANG ENV STAT COMP; Roxstrom-Lindquist K, 2004, EMBO REP, V5, P207, DOI 10.1038/sj.embor.7400073; Schemske DW, 2009, ANNU REV ECOL EVOL S, V40, P245, DOI 10.1146/annurev.ecolsys.39.110707.173430; Schlotterer C, 1997, GENETICS, V146, P309; Schmid-Hempel P, 2005, ANNU REV ENTOMOL, V50, P529, DOI 10.1146/annurev.ento.50.071803.130420; Schulenburg H, 2009, PHILOS T R SOC B, V364, P3, DOI 10.1098/rstb.2008.0249; Sedlazeck FJ, 2013, BIOINFORMATICS, V29, P2790, DOI 10.1093/bioinformatics/btt468; Shirasu-Hiza MM, 2007, CURR BIOL, V17, pR353, DOI 10.1016/j.cub.2007.03.049; Sokal RR, 1995, FREEMAN, V3, P1995, DOI DOI 10.1016/J.JIP.2003.08.007; St Pierre SE, 2014, NUCLEIC ACIDS RES, V42, pD780, DOI 10.1093/nar/gkt1092; Stephan W, 2007, HEREDITY, V98, P65, DOI 10.1038/sj.hdy.6800901; Stone EF, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002445; Thompson J. N., 2005, INTERSPEC INTERACT; Tinsley MC, 2006, PARASITOLOGY, V132, P767, DOI 10.1017/S0031182006009929; Ueda HR, 2002, J BIOL CHEM, V277, P14048, DOI 10.1074/jbc.C100765200; Ulvila J, 2011, APMIS, V119, P651, DOI 10.1111/j.1600-0463.2011.02792.x; Wilfert L, 2013, EVOLUTION, V67, P761, DOI 10.1111/j.1558-5646.2012.01832.x; Williams KD, 2009, CURR BIOL, V19, pR63, DOI 10.1016/j.cub.2008.11.035; Zuk M, 2002, AM NAT, V160, pS9, DOI 10.1086/342131	70	11	11	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0132129	10.1371/journal.pone.0132129	http://dx.doi.org/10.1371/journal.pone.0132129			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154519	Green Published, gold			2022-12-26	WOS:000358159700089
J	Pavlova, MA; Scheffler, K; Sokolov, AN				Pavlova, Marina A.; Scheffler, Klaus; Sokolov, Alexander N.			Face-n-Food: Gender Differences in Tuning to Faces	PLOS ONE			English	Article							FACIAL EMOTION RECOGNITION; SEX-DIFFERENCES; PERCEPTION; CHILDREN; EXPRESSIONS; INTENSITY; ADHD; FEAR; EPIDEMIOLOGY; PERFORMANCE	Faces represent valuable signals for social cognition and non-verbal communication. A wealth of research indicates that women tend to excel in recognition of facial expressions. However, it remains unclear whether females are better tuned to faces. We presented healthy adult females and males with a set of newly created food-plate images resembling faces (slightly bordering on the Giuseppe Arcimboldo style). In a spontaneous recognition task, participants were shown a set of images in a predetermined order from the least to most resembling a face. Females not only more readily recognized the images as a face (they reported resembling a face on images, on which males still did not), but gave on overall more face responses. The findings are discussed in the light of gender differences in deficient face perception. As most neuropsychiatric, neurodevelopmental and psychosomatic disorders characterized by social brain abnormalities are sex specific, the task may serve as a valuable tool for uncovering impairments in visual face processing.	[Pavlova, Marina A.; Scheffler, Klaus] Univ Tubingen, Sch Med, Dept Biomed Magnet, Tubingen, Germany; [Scheffler, Klaus] Max Planck Inst Biol Cybernet, High Field Magnet Resonance Ctr, D-72076 Tubingen, Germany; [Sokolov, Alexander N.] Univ Tubingen, Univ Hosp, Womens Hlth Res Inst, Dept Womens Hlth, Tubingen, Germany	Eberhard Karls University of Tubingen; Max Planck Society; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Pavlova, MA (corresponding author), Univ Tubingen, Sch Med, Dept Biomed Magnet, Tubingen, Germany.	marina.pavlova@uni-tuebingen.de		Scheffler, Klaus/0000-0001-6316-8773; Pavlova, Marina/0000-0001-8239-3589	Else Kroner-Fresenius Foundation [P2013_127]; Reinhold Beitlich Foundation; Heidehof Foundation [59073.01.1/3.13]	Else Kroner-Fresenius Foundation; Reinhold Beitlich Foundation; Heidehof Foundation	This work was made possible by financial support from the Else Kroner-Fresenius Foundation (Grant P2013_127 to MAP), the Reinhold Beitlich Foundation, and the Heidehof Foundation (grant 59073.01.1/3.13). The authors greatly appreciate donation made by Dr. Michael Klett. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors acknowledge support toward open access publishing by the Deutsche Forschungsgemeinschaft (DFG) and the Open Access Publishing Fund of Eberhard Karls University of Tubingen.	Alaerts K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020989; Anderson LC, 2013, NEUROIMAGE, V83, P751, DOI 10.1016/j.neuroimage.2013.07.040; Arrais KC, 2010, J PSYCHIATR RES, V44, P535, DOI 10.1016/j.jpsychires.2009.11.003; Beesdo-Baum K, 2012, CHILD ADOL PSYCH CL, V21, P457, DOI 10.1016/j.chc.2012.05.001; Biele C, 2006, EXP BRAIN RES, V171, P1, DOI 10.1007/s00221-005-0254-0; Bloom B, 2012, VITAL HLTH STAT, V10, P10; Bourne VJ, 2005, NEUROPSYCHOLOGIA, V43, P953, DOI 10.1016/j.neuropsychologia.2004.08.007; BOYATZIS CJ, 1993, J GENET PSYCHOL, V154, P375; Briceno EM, 2015, AM J GERIAT PSYCHIAT, V23, P304, DOI 10.1016/j.jagp.2014.05.007; Bruce V, 1988, RECOGNISING FACES; Buchala S, 2005, PROC IEEE ICMI, V7; Campbell R, 2002, NEUROPSYCHOLOGIA, V40, P575, DOI 10.1016/S0028-3932(01)00164-6; Coffman MC, 2015, J AUTISM DEV DISORD, V45, P589, DOI 10.1007/s10803-013-2006-5; Collignon O, 2010, NEUROPSYCHOLOGIA, V48, P220, DOI 10.1016/j.neuropsychologia.2009.09.007; Craske M. G., 2003, ORIGINS OF PHOBIAS A; Derntl B, 2009, PSYCHONEUROENDOCRINO, V34, P687, DOI 10.1016/j.psyneuen.2008.11.007; Diflorio A, 2010, INT REV PSYCHIATR, V22, P437, DOI 10.3109/09540261.2010.514601; Farzin F, 2009, J VISION, V9, DOI 10.1167/9.6.18; Fazzi E, 2009, DEV MED CHILD NEUROL, V51, P974, DOI 10.1111/j.1469-8749.2009.03272.x; Feuerriegel D, 2015, CLIN NEUROPHYSIOL, V126, P1141, DOI 10.1016/j.clinph.2014.09.015; FOREMAN N, 1991, J GEN PSYCHOL, V118, P13, DOI 10.1080/00221309.1991.9711129; Gilboa-Schechtman E, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00904; Golan O, 2006, J AUTISM DEV DISORD, V36, P169, DOI 10.1007/s10803-005-0057-y; Goos LM, 2002, J NONVERBAL BEHAV, V26, P27, DOI 10.1023/A:1014418503754; Hadjikhani N, 2009, NEUROREPORT, V20, P403, DOI 10.1097/WNR.0b013e328325a8e1; Hall JA, 2004, EMOTION, V4, P201, DOI 10.1037/1528-3542.4.2.201; HALL JA, 1978, PSYCHOL BULL, V85, P845, DOI 10.1037/0033-2909.85.4.845; Halliday DWR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094013; Hampson E, 2006, EVOL HUM BEHAV, V27, P401, DOI 10.1016/j.evolhumbehav.2006.05.002; Han DH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091214; Hoffmann H, 2010, ACTA PSYCHOL, V135, P278, DOI 10.1016/j.actpsy.2010.07.012; Hudson JI, 2007, BIOL PSYCHIAT, V61, P348, DOI 10.1016/j.biopsych.2006.03.040; Ino T, 2010, BRAIN IMAGING BEHAV, V4, P55, DOI 10.1007/s11682-009-9085-0; Jones Lynne, 2008, Eat Behav, V9, P389, DOI 10.1016/j.eatbeh.2008.03.001; Kana RK, 2012, SOC COGN AFFECT NEUR, V7, P446, DOI 10.1093/scan/nsr022; Killgore WDS, 2001, NEUROREPORT, V12, P427, DOI 10.1097/00001756-200102120-00047; Kochel A, 2014, J CHILD NEUROL, V29, P459, DOI 10.1177/0883073813476139; Kret ME, 2012, NEUROPSYCHOLOGIA, V50, P1211, DOI 10.1016/j.neuropsychologia.2011.12.022; Kret ME, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00003; Kruger S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081716; Kucharska-Pietura K, 2004, INT J EAT DISORDER, V35, P42, DOI 10.1002/eat.10219; Kuhnpast N, 2012, PSYCHOSOM MED, V74, P736, DOI 10.1097/PSY.0b013e31825ca15a; Lai MC, 2013, BRAIN, V136, P2799, DOI 10.1093/brain/awt216; Lazar SM, 2014, BEHAV BRAIN RES, V263, P1, DOI 10.1016/j.bbr.2014.01.010; Legenbauer T, 2008, J CLIN PSYCHOL, V64, P687, DOI 10.1002/jclp.20483; Lewin C, 2002, BRAIN COGNITION, V50, P121, DOI 10.1016/S0278-2626(02)00016-7; Liu JG, 2014, CORTEX, V53, P60, DOI 10.1016/j.cortex.2014.01.013; LoBue V, 2009, DEVELOPMENTAL SCI, V12, P305, DOI 10.1111/j.1467-7687.2008.00767.x; MANDAL MK, 1985, PERCEPT MOTOR SKILL, V60, P96, DOI 10.2466/pms.1985.60.1.96; Marsh PJ, 2006, NEUROSCI BIOBEHAV R, V30, P651, DOI 10.1016/j.neubiorev.2005.11.004; McBain R, 2009, ACTA PSYCHOL, V130, P168, DOI 10.1016/j.actpsy.2008.12.005; McClure EB, 2000, PSYCHOL BULL, V126, P424, DOI 10.1037/0033-2909.126.3.424; Montagne Barbara, 2005, Cogn Process, V6, P136, DOI 10.1007/s10339-005-0050-6; Nelson NL, 2011, J EXP CHILD PSYCHOL, V110, P52, DOI 10.1016/j.jecp.2011.03.014; Newschaffer CJ, 2007, ANNU REV PUBL HEALTH, V28, P235, DOI 10.1146/annurev.publhealth.28.021406.144007; NOWICKI S, 1988, J SOC PSYCHOL, V128, P363, DOI 10.1080/00224545.1988.9713753; Okazaki Y, 2010, BRAIN TOPOGR, V23, P14, DOI 10.1007/s10548-009-0112-7; Pavlova M, 2010, NEUROIMAGE, V50, P1327, DOI 10.1016/j.neuroimage.2009.12.096; Pavlova MA, 2015, CEREB CORTEX, V25, P3468, DOI 10.1093/cercor/bhu175; Pavlova MA, 2013, BRAIN, V136, P998, DOI 10.1093/brain/aws334; Pavlova MA, 2012, CEREB CORTEX, V22, P981, DOI 10.1093/cercor/bhr156; Picchioni MM, 2007, BMJ-BRIT MED J, V335, P91, DOI 10.1136/bmj.39227.616447.BE; Pollatos O, 2008, PSYCHOSOM MED, V70, P701, DOI 10.1097/PSY.0b013e31817e41e6; Proverbio AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011242; Rahko J, 2010, BRAIN IMAGING BEHAV, V4, P164, DOI 10.1007/s11682-010-9096-x; Rehnman J, 2006, MEMORY, V14, P289, DOI 10.1080/09658210500233581; Rehnman J, 2007, ACTA PSYCHOL, V124, P344, DOI 10.1016/j.actpsy.2006.04.004; Rhodes G, 2013, NEUROPSYCHOLOGIA, V51, P2702, DOI 10.1016/j.neuropsychologia.2013.08.016; Ridout N, 2012, APPETITE, V59, P181, DOI 10.1016/j.appet.2012.04.013; Rose SA, 2002, DEV PSYCHOL, V38, P895, DOI 10.1037//0012-1649.38.6.895; ROTTER NG, 1988, J NONVERBAL BEHAV, V12, P139, DOI 10.1007/BF00986931; Sokolov AA, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00016; Thayer JF, 2000, SCAND J PSYCHOL, V41, P243, DOI 10.1111/1467-9450.00193; Tiedt HO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069107; Uekermann J, 2010, NEUROSCI BIOBEHAV R, V34, P734, DOI 10.1016/j.neubiorev.2009.10.009; Verhallen RJ, 2014, NEUROPSYCHOLOGIA, V63, P19, DOI 10.1016/j.neuropsychologia.2014.08.011; WAGNER HL, 1986, J PERS SOC PSYCHOL, V50, P737, DOI 10.1037/0022-3514.50.4.737; Weigelt S, 2012, NEUROSCI BIOBEHAV R, V36, P1060, DOI 10.1016/j.neubiorev.2011.12.008; Wild B, 2001, PSYCHIAT RES, V102, P109, DOI 10.1016/S0165-1781(01)00225-6; Yuill N, 2007, EUR CHILD ADOLES PSY, V16, P398, DOI 10.1007/s00787-007-0612-5	80	24	25	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0130363	10.1371/journal.pone.0130363	http://dx.doi.org/10.1371/journal.pone.0130363			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1EJ	26154177	gold, Green Published, Green Submitted			2022-12-26	WOS:000358159700032
J	Hu, JD; Ma, LZ; Wang, S; Yang, JM; Chang, KK; Hu, XR; Sun, XH; Chen, RP; Jiang, M; Zhu, JH; Zhao, YY				Hu, Jiandong; Ma, Liuzheng; Wang, Shun; Yang, Jianming; Chang, Keke; Hu, Xinran; Sun, Xiaohui; Chen, Ruipeng; Jiang, Min; Zhu, Juanhua; Zhao, Yuanyuan			Biomolecular Interaction Analysis Using an Optical Surface Plasmon Resonance Biosensor: The Marquardt Algorithm vs Newton Iteration Algorithm	PLOS ONE			English	Article							QUANTITATIVE-ANALYSIS; KINETIC-ANALYSIS; DNA; ELLIPSOMETRY; ANTIGEN; KINASE	Kinetic analysis of biomolecular interactions are powerfully used to quantify the binding kinetic constants for the determination of a complex formed or dissociated within a given time span. Surface plasmon resonance biosensors provide an essential approach in the analysis of the biomolecular interactions including the interaction process of antigen-antibody and receptors-ligand. The binding affinity of the antibody to the antigen (or the receptor to the ligand) reflects the biological activities of the control antibodies (or receptors) and the corresponding immune signal responses in the pathologic process. Moreover, both the association rate and dissociation rate of the receptor to ligand are the substantial parameters for the study of signal transmission between cells. A number of experimental data may lead to complicated real-time curves that do not fit well to the kinetic model. This paper presented an analysis approach of biomolecular interactions established by utilizing the Marquardt algorithm. This algorithm was intensively considered to implement in the homemade bioanalyzer to perform the nonlinear curve-fitting of the association and disassociation process of the receptor to ligand. Compared with the results from the Newton iteration algorithm, it shows that the Marquardt algorithm does not only reduce the dependence of the initial value to avoid the divergence but also can greatly reduce the iterative regression times. The association and dissociation rate constants, k(a), k(d) and the affinity parameters for the biomolecular interaction, K-A, K-D, were experimentally obtained 6.969x10(5) mL.g(-1).s(-1), 0.00073 s(-1), 9.5466x10(8) mL.g(-1) and 1.0475x10(-9) g.mL(-1), respectively from the injection of the HBsAg solution with the concentration of 16ng.mL(-1). The kinetic constants were evaluated distinctly by using the obtained data from the curve-fitting results.	[Hu, Jiandong; Ma, Liuzheng; Wang, Shun; Chang, Keke; Sun, Xiaohui; Chen, Ruipeng; Zhu, Juanhua] Henan Agr Univ, Dept Elect Engn, Zhengzhou, Peoples R China; [Hu, Jiandong] State Key Lab Wheat & Maize Crop Sci, Zhengzhou, Peoples R China; [Yang, Jianming] Shanghai Univ, Sch Mat Sci & Engn, Shanghai, Peoples R China; [Hu, Xinran] McGill Univ, Sch Human Nutr & Dietet, Ste Anne De Bellevue, PQ, Canada; [Jiang, Min] Henan Agr Univ, Coll Life Sci, Zhengzhou, Peoples R China; [Zhao, Yuanyuan] Hanan Mech & Elect Vocat Coll, Zhengzhou, Peoples R China	Henan Agricultural University; Shanghai University; McGill University; Henan Agricultural University	Hu, JD (corresponding author), Henan Agr Univ, Dept Elect Engn, Zhengzhou, Peoples R China.	jiandonghu@163.com	ZHAO, YUAN/HCI-5831-2022		State Key Laboratory of Wheat and Maize Crop Science [SKL2014ZH-06]; Henan Province Joint Funding Program (National Natural Science Foundation of China) [U1304305]	State Key Laboratory of Wheat and Maize Crop Science; Henan Province Joint Funding Program (National Natural Science Foundation of China)	This study was funded by the State Key Laboratory of Wheat and Maize Crop Science (Grant No. SKL2014ZH-06) and the Henan Province Joint Funding Program (Grant No. U1304305 of the National Natural Science Foundation of China). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahi H, 2014, SPECTROCHIM ACTA A, V127, P137, DOI 10.1016/j.saa.2014.02.020; Adeyemi OS, 2013, INT J BIOL MACROMOL, V62, P450, DOI 10.1016/j.ijbiomac.2013.09.008; Bakthisaran R, 2015, BBA-PROTEINS PROTEOM, V1854, P291, DOI 10.1016/j.bbapap.2014.12.019; Balevicius Z, 2014, THIN SOLID FILMS, V571, P744, DOI 10.1016/j.tsf.2013.10.090; Bhattarai JK, 2015, CARBOHYD RES, V405, P55, DOI 10.1016/j.carres.2014.08.019; Blancas-Mejia LM, 2014, J MOL BIOL, V426, P347, DOI 10.1016/j.jmb.2013.10.016; Boozer C, 2006, CURR OPIN BIOTECH, V17, P400, DOI 10.1016/j.copbio.2006.06.012; Campagnolo C, 2004, J BIOCHEM BIOPH METH, V61, P283, DOI 10.1016/j.jbbm.2004.05.006; Ensafi AA, 2014, SENSOR ACTUAT B-CHEM, V202, P224, DOI 10.1016/j.snb.2014.05.001; Esadze A, 2014, J MOL BIOL, V426, P230, DOI 10.1016/j.jmb.2013.09.019; Gill A, 1996, J BIOTECHNOL, V48, P117, DOI 10.1016/0168-1656(96)01410-1; Glass TR, 2014, ANAL BIOCHEM, V456, P38, DOI 10.1016/j.ab.2014.04.011; Hu JD, 2009, BIOSENS BIOELECTRON, V24, P1974, DOI 10.1016/j.bios.2008.10.033; Hudson CS, 2013, BBA-PROTEINS PROTEOM, V1834, P1107, DOI 10.1016/j.bbapap.2013.02.008; Kalyani D, 2014, SPECTROCHIM ACTA A, V124, P148, DOI 10.1016/j.saa.2014.01.013; Katsamba PS, 2006, ANAL BIOCHEM, V352, P208, DOI 10.1016/j.ab.2006.01.034; Moirangthem RS, 2010, BIOSENS BIOELECTRON, V25, P2633, DOI 10.1016/j.bios.2010.04.037; Oluwole OO, 2007, COMBUST THEOR MODEL, V11, P127, DOI 10.1080/13647830600924601; Reverte C, 2007, J ANAL APPL PYROL, V79, P297, DOI 10.1016/j.jaap.2006.12.021; Ritz P, 2007, DIABETES RES CLIN PR, V77, P405, DOI 10.1016/j.diabres.2007.01.007; Scarano S, 2010, BIOSENS BIOELECTRON, V25, P957, DOI 10.1016/j.bios.2009.08.039; Tanious FA, 2008, METHOD CELL BIOL, V84, P53, DOI 10.1016/S009911-679X(07)84003-9; Villiers MB, 2010, BIOSENS BIOELECTRON, V26, P1554, DOI 10.1016/j.bios.2010.07.110; Xue TY, 2014, BIOSENS BIOELECTRON, V58, P374, DOI 10.1016/j.bios.2014.03.002; Zanier K, 2005, J MOL BIOL, V349, P401, DOI 10.1016/j.jmb.2005.03.071; Zhao YY, 2010, SPIE, V7656; Zheng XW, 2014, J CHROMATOGR B, V968, P49, DOI 10.1016/j.jchromb.2014.01.026; Zordok WA, 2014, SPECTROCHIM ACTA A, V129, P519, DOI 10.1016/j.saa.2014.02.087	28	6	6	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132098	10.1371/journal.pone.0132098	http://dx.doi.org/10.1371/journal.pone.0132098			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147997	Green Published, Green Submitted, gold			2022-12-26	WOS:000358157600199
J	Karbin, S; Guillet, C; Kammann, CI; Niklaus, PA				Karbin, Saeed; Guillet, Cecile; Kammann, Claudia I.; Niklaus, Pascal A.			Effects of Long-Term CO2 Enrichment on Soil-Atmosphere CH4 Fluxes and the Spatial Micro-Distribution of Methanotrophic Bacteria	PLOS ONE			English	Article							CARBON-DIOXIDE ENRICHMENT; METHANE OXIDATION; ELEVATED CO2; GRASSLAND; N2O; AIR; CONSUMPTION; ECOSYSTEMS; EMISSIONS; DYNAMICS	Background Effects of elevated atmospheric CO2 concentrations on plant growth and associated C cycling have intensively been studied, but less is known about effects on the fluxes of radiatively active trace gases other than CO2. Net soil-atmosphere CH4 fluxes are determined by the balance of soil microbially-driven methane (CH4) oxidation and methanogenesis, and both might change under elevated CO2. Methods and Results Here, we studied CH4 dynamics in a permanent grassland exposed to elevated CO2 for 14 years. Soil-atmosphere fluxes of CH4 were measured using large static chambers, over a period of four years. The ecosystem was a net sink for atmospheric CH4 for most of the time except summer to fall when net CH4 emissions occurred. We did not detect any elevated CO2 effects on CH4 fluxes, but emissions were difficult to quantify due to their discontinuous nature, most likely because of ebullition from the saturated zone. Potential methanotrophic activity, determined by incubation of fresh sieved soil under standardized conditions, also did not reveal any effect of the CO2 treatment. Finally, we determined the spatial micro-distribution of methanotrophic activity at less than 5x atmospheric (10 ppm) and elevated (10000 ppm) CH4 concentrations, using a novel auto-radiographic technique. These analyses indicated that domains of net CH4 assimilation were distributed throughout the analyzed top 15 cm of soils, with no dependence on CH4 concentration or CO2 treatment. Conclusions Our investigations suggest that elevated CO2 exerts no or only minor effects on CH4 fluxes in the type of ecosystem we studied, at least as long as soil moisture differences are small or absent as was the case here. The autoradiographic analyses further indicate that the spatial niche of CH4 oxidation does not shift in response to CO2 enrichment or CH4 concentration, and that the same type of methanotrophs may oxidize CH4 from atmospheric and soil- internal sources.	[Karbin, Saeed; Niklaus, Pascal A.] Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland; [Guillet, Cecile; Kammann, Claudia I.] Univ Giessen, Inst Plant Ecol, D-35390 Giessen, Germany; [Kammann, Claudia I.] Hsch Geisenheim Univ, Climate Change Res Special Crops, Geisenheim, Germany	University of Zurich; Justus Liebig University Giessen	Kammann, CI (corresponding author), Univ Giessen, Inst Plant Ecol, D-35390 Giessen, Germany.	Claudia.Kamman@hs-gm.de; Pascal.Niklaus@ieu.uzh.ch	Kammann, Claudia/GSD-6286-2022; Niklaus, Pascal A/G-5786-2010	Niklaus, Pascal A/0000-0002-2360-1357	Aga Khan Foundation; University of Zurich	Aga Khan Foundation; University of Zurich	SK has been funded by a stipend of Aga Khan Foundation. PAN supported the study from regular funds from the University of Zurich. The Hessian Agency for the Environment and Geology (HLUG) contributed to the running costs of the Giessen Free Air CO2 Enrichment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral JA, 1998, APPL ENVIRON MICROB, V64, P520; Ambus P, 1999, PLANT SOIL, V209, P1, DOI 10.1023/A:1004518730970; Baani M, 2008, P NATL ACAD SCI USA, V105, P10203, DOI 10.1073/pnas.0702643105; Barnard R, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002282; BENDER M, 1992, FEMS MICROBIOL ECOL, V101, P261, DOI 10.1111/j.1574-6968.1992.tb05783.x; Billings SA, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002137; Bodelier PLE, 2004, FEMS MICROBIOL ECOL, V47, P265, DOI 10.1016/S0168-6496(03)00304-0; Conrad R, 1996, MICROBIOL REV, V60, P609, DOI 10.1128/MMBR.60.4.609-640.1996; Czepiel PM, 2003, WASTE MANAGE, V23, P593, DOI 10.1016/S0956-053X(03)00103-X; Davidson EA, 2002, AGR FOREST METEOROL, V113, P21, DOI 10.1016/S0168-1923(02)00100-4; DIAZ S, 1993, NATURE, V364, P616, DOI 10.1038/364616a0; Dijkstra FA, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001288; DORR H, 1993, CHEMOSPHERE, V26, P697, DOI 10.1016/0045-6535(93)90454-D; Dubbs LL, 2010, BIOL FERT SOILS, V46, P597, DOI 10.1007/s00374-010-0467-7; Dunfield PF, 2007, GREENHOUSE GAS SINKS, P152, DOI 10.1079/9781845931896.0152; Dunfield PF, 1999, APPL ENVIRON MICROB, V65, P1009; Dutaur L, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002734; EAMUS D, 1991, PLANT CELL ENVIRON, V14, P843, DOI 10.1111/j.1365-3040.1991.tb01447.x; Horz HP, 2002, FEMS MICROBIOL ECOL, V41, P247, DOI 10.1111/j.1574-6941.2002.tb00986.x; HUTCHINSON GL, 1981, SOIL SCI SOC AM J, V45, P311, DOI 10.2136/sssaj1981.03615995004500020017x; Ineson P, 1998, PLANT SOIL, V198, P89, DOI 10.1023/A:1004298309606; Jackel U, 2004, SOIL BIOL BIOCHEM, V36, P835, DOI 10.1016/j.soilbio.2004.01.013; Jager HJ, 2003, J APPL BOT-ANGEW BOT, V77, P117; Kammann C, 2001, ENVIRON POLLUT, V115, P261, DOI 10.1016/S0269-7491(01)00103-8; Kammann C, 2009, SOIL BIOL BIOCHEM, V41, P622, DOI 10.1016/j.soilbio.2008.12.025; Keppler F, 2006, NATURE, V439, P187, DOI 10.1038/nature04420; Lam SK, 2011, SOIL BIOL BIOCHEM, V43, P458, DOI 10.1016/j.soilbio.2010.10.012; Le Mer J, 2001, EUR J SOIL BIOL, V37, P25, DOI 10.1016/S1164-5563(01)01067-6; Lenhart K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2049; McLain JET, 2008, BIOL FERT SOILS, V44, P623, DOI 10.1007/s00374-007-0246-2; Morgan JA, 2004, OECOLOGIA, V140, P11, DOI 10.1007/s00442-004-1550-2; Mosier AR, 2002, PLANT SOIL, V240, P201, DOI 10.1023/A:1015783801324; Niklaus PA, 1998, OECOLOGIA, V117, P201, DOI 10.1007/s004420050649; Niklaus PA, 2001, OECOLOGIA, V127, P540, DOI 10.1007/s004420000612; ROGERS HH, 1994, ENVIRON POLLUT, V83, P155, DOI 10.1016/0269-7491(94)90034-5; Shrestha PM, 2012, ISME J, V6, P1115, DOI 10.1038/ismej.2011.179; Smith KA, 2000, GLOBAL CHANGE BIOL, V6, P791, DOI 10.1046/j.1365-2486.2000.00356.x; Smith KE, 2010, SOIL SCI, V175, P349, DOI 10.1097/SS.0b013e3181e93d3c; Stiehl-Braun PA, 2011, SOIL BIOL BIOCHEM, V43, P1034, DOI 10.1016/j.soilbio.2011.01.020; Stiehl-Braun PA, 2011, GLOBAL CHANGE BIOL, V17, P2629, DOI 10.1111/j.1365-2486.2011.02410.x; Wang B, 2013, ATMOS ENVIRON, V80, P290, DOI 10.1016/j.atmosenv.2013.08.010; Weber HE, 2000, J VEG SCI, V11, P739, DOI 10.2307/3236580; West AE, 2002, MICROB ECOL, V43, P408, DOI 10.1007/s00248-001-1049-x; Wieczorek AS, 2011, FEMS MICROBIOL ECOL, V77, P28, DOI 10.1111/j.1574-6941.2011.01080.x	44	5	5	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131665	10.1371/journal.pone.0131665	http://dx.doi.org/10.1371/journal.pone.0131665			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147694	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000358157600122
J	Kljashtorny, V; Nikonov, S; Ovchinnikov, L; Lyabin, D; Vodovar, N; Curmi, P; Manivet, P				Kljashtorny, Vladislav; Nikonov, Stanislav; Ovchinnikov, Lev; Lyabin, Dmitry; Vodovar, Nicolas; Curmi, Patrick; Manivet, Philippe			The Cold Shock Domain of YB-1 Segregates RNA from DNA by Non-Bonded Interactions	PLOS ONE			English	Article							MESSENGER-RIBONUCLEOPROTEIN PARTICLES; SINGLE STRANDS BIND; MAJOR CORE PROTEIN; Y-BOX PROTEIN; Y-BOX-BINDING-PROTEIN-1 YB-1; MOLECULAR-DYNAMICS; P50; RECOGNITION; CELLS; SITE	The human YB-1 protein plays multiple cellular roles, of which many are dictated by its binding to RNA and DNA through its Cold Shock Domain (CSD). Using molecular dynamics simulation approaches validated by experimental assays, the YB1 CSD was found to interact with nucleic acids in a sequence-dependent manner and with a higher affinity for RNA than DNA. The binding properties of the YB1 CSD were close to those observed for the related bacterial Cold Shock Proteins (CSP), albeit some differences in sequence specificity. The results provide insights in the molecular mechanisms whereby YB-1 interacts with nucleic acids.	[Kljashtorny, Vladislav; Nikonov, Stanislav; Ovchinnikov, Lev; Lyabin, Dmitry] Russian Acad Sci, Inst Prot Res, Pushchino 142290, Moscow Region, Russia; [Kljashtorny, Vladislav; Curmi, Patrick] INSERM, UMR 829, Lab Struct Activite Biomol Normales & Patholog, F-91025 Evry, France; [Kljashtorny, Vladislav; Vodovar, Nicolas; Manivet, Philippe] Hop Lariboisiere, INSERM, UMRS 942, F-75475 Paris 10, France; [Kljashtorny, Vladislav; Manivet, Philippe] Hop Lariboisiere, AP HP, Serv Biochim & Biol Mol, F-75475 Paris, France; [Manivet, Philippe] Ctr Ressources Biol BB 0033 00064, Unite Biol Clin Struct, F-75475 Paris 10, France	Russian Academy of Sciences; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite	Manivet, P (corresponding author), Hop Lariboisiere, INSERM, UMRS 942, 41 Blvd Chapelle, F-75475 Paris 10, France.	philippe.manivet@lrb.aphp.fr	Ovchinnikov, Lev/L-2397-2015; Manivet, Philippe/AAA-1884-2021; Lyabin, Dmitry/K-3178-2013; Vodovar, Nicolas/S-2947-2019	CURMI, Patrick A./0000-0001-5045-8501; Vodovar, Nicolas/0000-0001-8087-387X	GDRI "Early Events in Human Diseases (EEHD)"; Presidium of Russian Academy of Sciences	GDRI "Early Events in Human Diseases (EEHD)"; Presidium of Russian Academy of Sciences(Russian Academy of Sciences)	VK receive a PhD grant from the GDRI "Early Events in Human Diseases (EEHD)" and the Programs on "Molecular and Cellular Biology" and on "Basic Sciences to Medicine" from the Presidium of Russian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; BOUVET P, 1995, J BIOL CHEM, V270, P28297; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Chansky HA, 2001, CANCER RES, V61, P3586; Cohen J.E., 1988, STAT POWER ANAL BEHA; Das S, 2007, J BIOL CHEM, V282, P28474, DOI 10.1074/jbc.M704672200; Davydova EK, 1997, NUCLEIC ACIDS RES, V25, P2911, DOI 10.1093/nar/25.14.2911; Doreleijers JF, 2009, J BIOMOL NMR, V45, P389, DOI 10.1007/s10858-009-9378-z; DUNN OJ, 1959, ANN MATH STAT, V30, P192, DOI 10.1214/aoms/1177706374; Eliseeva IA, 2011, BIOCHEMISTRY-MOSCOW+, V76, P1402, DOI 10.1134/S0006297911130049; Evdokimova V, 2001, EMBO J, V20, P5491, DOI 10.1093/emboj/20.19.5491; Evdokimova V, 2006, MOL CELL BIOL, V26, P277, DOI 10.1128/MCB.26.1.277-292.2006; Evdokimova VM, 1998, J BIOL CHEM, V273, P3574, DOI 10.1074/jbc.273.6.3574; EVDOKIMOVA VM, 1995, J BIOL CHEM, V270, P3186, DOI 10.1074/jbc.270.7.3186; Gaudreault I, 2004, NUCLEIC ACIDS RES, V32, P316, DOI 10.1093/nar/gkh170; Guryanov SG, 2013, BBA-PROTEINS PROTEOM, V1834, P559, DOI 10.1016/j.bbapap.2012.11.007; HASEGAWA SL, 1991, NUCLEIC ACIDS RES, V19, P4915, DOI 10.1093/nar/19.18.4915; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hou TJ, 2011, J CHEM INF MODEL, V51, P69, DOI 10.1021/ci100275a; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kloks CPAM, 2002, J MOL BIOL, V316, P317, DOI 10.1006/jmbi.2001.5334; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lim VI, 2006, MOL BIOL+, V40, P572; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Matsumoto Ken, 2005, J Mol Genet Med, V1, P11; Max KEA, 2007, FEBS J, V274, P1265, DOI 10.1111/j.1742-4658.2007.05672.x; Max KEA, 2006, J MOL BIOL, V360, P702, DOI 10.1016/j.jmb.2006.05.044; MINICH WB, 1993, EUR J BIOCHEM, V212, P633, DOI 10.1111/j.1432-1033.1993.tb17701.x; Nekrasov MP, 2003, J BIOL CHEM, V278, P13936, DOI 10.1074/jbc.M209145200; Raffetseder U, 2003, J BIOL CHEM, V278, P18241, DOI 10.1074/jbc.M212518200; Sachs R, 2012, RNA, V18, P65, DOI 10.1261/rna.02809212; Shen Y, 2007, J BIOMOL NMR, V38, P289, DOI 10.1007/s10858-007-9166-6; Shibahara K, 2004, CANCER SCI, V95, P348, DOI 10.1111/j.1349-7006.2004.tb03214.x; SITKOFF D, 1994, J PHYS CHEM-US, V98, P1978, DOI 10.1021/j100058a043; Skabkin MA, 2006, MOL BIOL+, V40, P620; Skabkin MA, 2001, J BIOL CHEM, V276, P44841, DOI 10.1074/jbc.M107581200; SOMMERVILLE J, 1993, J CELL BIOL, V120, P277, DOI 10.1083/jcb.120.2.277; Soop T, 2003, J CELL SCI, V116, P1493, DOI 10.1242/jcs.00353; Sutherland BW, 2005, ONCOGENE, V24, P4281, DOI 10.1038/sj.onc.1208590; Svitkin YV, 2009, EMBO J, V28, P58, DOI 10.1038/emboj.2008.259; Theobald DL, 2003, ANNU REV BIOPH BIOM, V32, P115, DOI 10.1146/annurev.biophys.32.110601.142506; Yamanaka K, 1998, MOL MICROBIOL, V27, P247, DOI 10.1046/j.1365-2958.1998.00683.x; Zasedateleva OA, 2002, J MOL BIOL, V324, P73, DOI 10.1016/S0022-2836(02)00937-3	46	9	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0130318	10.1371/journal.pone.0130318	http://dx.doi.org/10.1371/journal.pone.0130318			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147853	Green Published, gold, Green Submitted			2022-12-26	WOS:000358157600034
J	Marquez, EA; Kane, KP				Marquez, Elsa A.; Kane, Kevin P.			Identities of P2 and P3 Residues of H-2K(b)-Bound Peptides Determine Mouse Ly49C Recognition	PLOS ONE			English	Article							MHC CLASS-I; H-2-DEFICIENT LYMPHOMA VARIANTS; CYTOTOXIC T-LYMPHOCYTES; KILLER-CELL RECEPTORS; CRYSTAL-STRUCTURE; BINDING; IDENTIFICATION; SPECIFICITY; MOLECULES; SELF	Ly49 receptors can be peptide selective in their recognition of MHC-I-peptide complexes, affording them a level of discrimination beyond detecting the presence or absence of specific MHC-I allele products. Despite this ability, little is understood regarding the properties that enable some peptides, when bound to MHC-I molecules, to support Ly49 recognition, but not others. Using RMA-S target cells expressing MHC-I molecules loaded with individual peptides and effector cells expressing the ectodomain of the inhibitory Ly49C receptor, we found that two adjacent amino acid residues, P2 and P3, both buried in the peptide binding groove of H-2K(b), determine mouse Ly49C specificity. If both are aliphatic residues, this is supportive. Whereas, small amino acids at P2 and aromatic amino acids at the P3 auxiliary anchor residue are detrimental to Ly49C recognition. These results resemble those with a rat Ly49 where the identity of a peptide anchor residue determines recognition, suggesting that dependence on specific peptide residues buried in the MHC-I peptide-binding groove may be fundamental to Ly49 peptide selectivity and recognition.	[Marquez, Elsa A.; Kane, Kevin P.] Univ Alberta, Med Microbiol & Immunol, Edmonton, AB, Canada	University of Alberta	Kane, KP (corresponding author), Univ Alberta, Med Microbiol & Immunol, Edmonton, AB, Canada.	kevin.kane@ualberta.ca			Canadian Institutes of Health Research grant [43864]	Canadian Institutes of Health Research grant(Canadian Institutes of Health Research (CIHR))	This work was funded by Canadian Institutes of Health Research grant 43864 to KPK (http://cihr-irsc.gc.ca/e/193.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biron CA, 1997, CURR OPIN IMMUNOL, V9, P24, DOI 10.1016/S0952-7915(97)80155-0; Caron E, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.68; Cerwenka A, 2001, NAT REV IMMUNOL, V1, P41, DOI 10.1038/35095564; Dam J, 2003, NAT IMMUNOL, V4, P1213, DOI 10.1038/ni1006; de Verteuil D, 2012, AUTOIMMUN REV, V11, P627, DOI 10.1016/j.autrev.2011.11.003; Deng L, 2008, J BIOL CHEM, V283, P16840, DOI 10.1074/jbc.M801526200; Franksson L, 1999, EUR J IMMUNOL, V29, P2748, DOI 10.1002/(SICI)1521-4141(199909)29:09<2748::AID-IMMU2748>3.0.CO;2-C; FREMONT DH, 1995, P NATL ACAD SCI USA, V92, P2479, DOI 10.1073/pnas.92.7.2479; Granados DP, 2012, BLOOD, V119, pE181, DOI 10.1182/blood-2012-02-412593; Guimezanes A, 2001, EUR J IMMUNOL, V31, P421, DOI 10.1002/1521-4141(200102)31:2<421::AID-IMMU421>3.0.CO;2-4; Hanke T, 1999, IMMUNITY, V11, P67, DOI 10.1016/S1074-7613(00)80082-5; Hogquist KA, 1997, IMMUNITY, V6, P389, DOI 10.1016/S1074-7613(00)80282-4; Hoof I, 2009, IMMUNOGENETICS, V61, P1, DOI 10.1007/s00251-008-0341-z; JAMESON SC, 1992, EUR J IMMUNOL, V22, P2663, DOI 10.1002/eji.1830221028; Johansson S, 2005, J EXP MED, V201, P1145, DOI 10.1084/jem.20050167; KARRE K, 1986, NATURE, V319, P675, DOI 10.1038/319675a0; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Liu LZ, 1999, J IMMUNOL, V163, P868; LJUNGGREN HG, 1985, J EXP MED, V162, P1745, DOI 10.1084/jem.162.6.1745; LJUNGGREN HG, 1990, NATURE, V346, P476, DOI 10.1038/346476a0; Ma BJ, 2011, J IMMUNOL, V187, P3267, DOI 10.4049/jimmunol.1002809; Madhurantakam C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032805; Malarkannan S, 1996, P NATL ACAD SCI USA, V93, P13991, DOI 10.1073/pnas.93.24.13991; MALNATI MS, 1995, SCIENCE, V267, P1016, DOI 10.1126/science.7863326; MATSUMURA M, 1992, SCIENCE, V257, P927, DOI 10.1126/science.1323878; Meiring HD, 2006, MOL CELL PROTEOMICS, V5, P902, DOI 10.1074/mcp.T500014-MCP200; Michaelsson J, 2000, EUR J IMMUNOL, V30, P300; Natarajan K, 2002, ANNU REV IMMUNOL, V20, P853, DOI 10.1146/annurev.immunol.20.100301.064812; NUCHTERN JG, 1989, NATURE, V339, P223, DOI 10.1038/339223a0; Obst R, 2000, J EXP MED, V191, P805, DOI 10.1084/jem.191.5.805; Pyzik M, 2011, J EXP MED, V208, P1105, DOI 10.1084/jem.20101831; REYNOLDS CW, 1984, J IMMUNOL, V132, P534; ROTZSCHKE O, 1991, EUR J IMMUNOL, V21, P2891, DOI 10.1002/eji.1830211136; Sadovnikova E, 1996, P NATL ACAD SCI USA, V93, P13114, DOI 10.1073/pnas.93.23.13114; SIJTS AJAM, 1994, J IMMUNOL, V152, P106; Silver ET, 2000, J IMMUNOL, V165, P1771, DOI 10.4049/jimmunol.165.4.1771; Silver ET, 2001, J IMMUNOL, V166, P2333, DOI 10.4049/jimmunol.166.4.2333; Tallquist MD, 1996, J EXP MED, V184, P1017, DOI 10.1084/jem.184.3.1017; Thananchai H, 2007, J IMMUNOL, V178, P33, DOI 10.4049/jimmunol.178.1.33; VANBLEEK GM, 1990, NATURE, V348, P213; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; YEWDELL JW, 1989, SCIENCE, V244, P1072, DOI 10.1126/science.2471266; Zarling AL, 2000, J EXP MED, V192, P1755, DOI 10.1084/jem.192.12.1755	43	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131308	10.1371/journal.pone.0131308	http://dx.doi.org/10.1371/journal.pone.0131308			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147851	Green Published, gold, Green Submitted			2022-12-26	WOS:000358157600088
J	Rafiq, RA; Quadri, A; Nazir, LA; Peerzada, K; Ganai, BA; Tasduq, SA				Rafiq, Rather A.; Quadri, Afnan; Nazir, Lone A.; Peerzada, Kaiser; Ganai, Bashir A.; Tasduq, Sheikh A.			A Potent Inhibitor of Phosphoinositide 3-Kinase (PI3K) and Mitogen Activated Protein (MAP) Kinase Signalling, Quercetin (3, 3 ', 4 ', 5, 7-Pentahydroxyflavone) Promotes Cell Death in Ultraviolet (UV)-B-Irradiated B16F10 Melanoma Cells	PLOS ONE			English	Article							NF-KAPPA-B; INDUCED APOPTOSIS; MOLECULAR-MECHANISMS; ANTIOXIDANT DEFENSE; UVB IRRADIATION; RADIATION; TRANSLOCATION; KERATINOCYTES; PREVENTION; RESISTANCE	Ultraviolet (UV) radiation-induced skin damage contributes strongly to the formation of melanoma, a highly lethal form of skin cancer. Quercetin (Qu), the most widely consumed dietary bioflavonoid and well known inhibitor of phosphoinositide 3-kinase (PI3K) and mitogen activated protein (MAP) kinase signalling, has been reported to be chemopreventive in several forms of non-melanoma skin cancers. Here, we report that the treatment of ultraviolet (UV)-B-irradiated B16F10 melanoma cells with quercetin resulted in a dose dependent reduction in cell viability and increased apoptosis. The present study has brought out that the pro-apoptotic effects of quercetin in UVB-irradiated B16F10 cells are mediated through the elevation of intracellular reactive oxygen species (ROS) formation, calcium homeostasis imbalance, modulation of anti-oxidant defence response and depolarization of mitochondrial membrane potential (Delta psi(M)). Promotion of UVB-induced cell death by quercetin was further revealed by cleavage of chromosomal DNA, caspase activation, poly (ADP) ribose polymerase (PARP) cleavage, and an increase in sub-G1 cells. Quercetin markedly attenuated MEK-ERK signalling, influenced PI3K/Akt pathway, and potentially enhanced the UVB-induced NF-kappa B nuclear translocation. Furthermore, combined UVB and quercetin treatment decreased the ratio of Bcl-2 to that of Bax, and upregulated the expression of Bim and apoptosis inducing factor (AIF). Overall, these results suggest the possibility of using quercetin in combination with UVB as a possible treatment option for melanoma in future.	[Rafiq, Rather A.; Quadri, Afnan; Nazir, Lone A.; Peerzada, Kaiser; Tasduq, Sheikh A.] CSIR, Indian Inst Integrat Med, PK PD & Toxicol Div, Jammu, Jammu & Kashmir, India; [Nazir, Lone A.; Tasduq, Sheikh A.] Acad Sci & Innovat Res AcSIR, New Delhi, India; [Ganai, Bashir A.] Univ Kashmir, Ctr Res Dev CORD, Srinagar 190006, Jammu & Kashmir, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Integrative Medicine (IIIM); Academy of Scientific & Innovative Research (AcSIR); University of Kashmir	Tasduq, SA (corresponding author), CSIR, Indian Inst Integrat Med, PK PD & Toxicol Div, Jammu, Jammu & Kashmir, India.	stabdullah@iiim.ac.in	LONE, NAZIR A./ABD-6296-2020	LONE, NAZIR A./0000-0003-3341-8879; Abdullah, Tasduq/0000-0001-6474-1009	Council of Scientific and Industrial Research (CSIR), New Delhi, India [BSC 0302]; Council of Scientific and Industrial Research (CSIR); Human Resource Development Group (HRDG), Pusa, New Delhi, India	Council of Scientific and Industrial Research (CSIR), New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India); Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Human Resource Development Group (HRDG), Pusa, New Delhi, India	This study was funded by Council of Scientific and Industrial Research (CSIR), New Delhi, India, under its 12th Five Year Plan Project titled, "Towards Understanding Skin Cell Homeostasis (TOUCH)," Project No. BSC 0302. Financial assistance to RAR by Council of Scientific and Industrial Research (CSIR), Human Resource Development Group (HRDG), Pusa, New Delhi, India is highly acknowledged.	Adil MD, 2010, J ETHNOPHARMACOL, V132, P109, DOI 10.1016/j.jep.2010.07.047; Aggarwal BB, 2006, BIOCHEM PHARMACOL, V71, P1397, DOI 10.1016/j.bcp.2006.02.009; Beani JC, 2001, B ACAD NAT MED PARIS, V185, P1507, DOI 10.1016/S0001-4079(19)34432-2; Beani JC, 2001, B ACAD NATL MED, V185, P26; Bivik CA, 2006, J INVEST DERMATOL, V126, P1119, DOI 10.1038/sj.jid.5700124; Cao HH, 2014, BIOCHEM PHARMACOL, V87, P424, DOI 10.1016/j.bcp.2013.11.008; Clydesdale GJ, 2001, IMMUNOL CELL BIOL, V79, P547, DOI 10.1046/j.1440-1711.2001.01047.x; Collins JA, 1997, J HISTOCHEM CYTOCHEM, V45, P923, DOI 10.1177/002215549704500702; Cosentino K, 2014, CHEM PHYS LIPIDS, V181, P62, DOI 10.1016/j.chemphyslip.2014.04.001; D'Anneo A, 2013, J CELL PHYSIOL, V228, P952, DOI 10.1002/jcp.24131; Danial NN, 2007, CLIN CANCER RES, V13, P7254, DOI 10.1158/1078-0432.CCR-07-1598; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; Ferraresi R, 2005, FREE RADICAL RES, V39, P1249, DOI 10.1080/10715760500306935; Fishman D, 2001, P NATL ACAD SCI USA, V98, P1740, DOI 10.1073/pnas.041591298; Gibellini L, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/neq053; Grossman D, 2001, CANCER METAST REV, V20, P3, DOI 10.1023/A:1013123532723; Heck DE, 2004, TOXICOL APPL PHARM, V195, P288, DOI 10.1016/j.taap.2003.09.028; Hirota A, 2005, J INVEST DERMATOL, V124, P825, DOI 10.1111/j.0022-202X.2005.23670.x; Kitagawa D, 2002, J BIOL CHEM, V277, P366, DOI 10.1074/jbc.M107110200; Kulms D, 2000, PHOTODERMATOL PHOTO, V16, P195, DOI 10.1034/j.1600-0781.2000.160501.x; Lee CH, 2013, INT J MOL SCI, V14, P6414, DOI 10.3390/ijms14036414; Lee DH, 2005, J CATARACT REFR SURG, V31, P614, DOI 10.1016/j.jcrs.2004.05.053; Lee JM, 2005, FASEB J, V19, P1061, DOI 10.1096/fj.04-2591hyp; Li NX, 1999, FASEB J, V13, P1137, DOI 10.1096/fasebj.13.10.1137; Ly JD, 2003, APOPTOSIS, V8, P115, DOI 10.1023/A:1022945107762; Masaki H, 2009, J INVEST DERM SYMP P, V14, P50, DOI 10.1038/jidsymp.2009.12; MENON LG, 1995, CANCER LETT, V95, P221, DOI 10.1016/0304-3835(95)03887-3; Morgan MJ, 2011, CELL RES, V21, P103, DOI 10.1038/cr.2010.178; Murakami A, 2008, CANCER LETT, V269, P315, DOI 10.1016/j.canlet.2008.03.046; Olson ER, 2008, CANCER PREV RES, V1, P362, DOI 10.1158/1940-6207.CAPR-08-0101; Panka DJ, 2006, CLIN CANCER RES, V12, p2371S, DOI 10.1158/1078-0432.CCR-05-2539; Placzek M, 2007, BRIT J DERMATOL, V156, P843, DOI 10.1111/j.1365-2133.2007.07795.x; Plotz M, 2013, CANCER LETT, V335, P100, DOI 10.1016/j.canlet.2013.02.005; Rastogi RP, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/592980; Rieber M, 2000, INT J CANCER, V86, P462, DOI 10.1002/(SICI)1097-0215(20000515)86:4<462::AID-IJC3>3.0.CO;2-B; Russo GL, 2014, CANCER TREAT RES, V159, P185, DOI 10.1007/978-3-642-38007-5_11; Russo M, 2003, ONCOGENE, V22, P3330, DOI 10.1038/sj.onc.1206493; Ryu HC, 2010, J INVEST DERMATOL, V130, P1095, DOI 10.1038/jid.2009.436; Salucci S, 2013, INT J MOL SCI, V14, P532, DOI 10.3390/ijms14010532; Sarkar M, 2006, CYTOM PART B-CLIN CY, V70B, P20, DOI 10.1002/cyto.b.20082; SHINDO Y, 1993, J INVEST DERMATOL, V100, P260, DOI 10.1111/1523-1747.ep12469048; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Smalley KSM, 2010, J INVEST DERMATOL, V130, P28, DOI 10.1038/jid.2009.177; Uchide N, 2009, INTERVIROLOGY, V52, P164, DOI 10.1159/000224644; Ueda Y, 2006, PIGM CELL RES, V19, P112, DOI 10.1111/j.1600-0749.2006.00304.x; van den Berg R, 2001, BRIT J NUTR, V86, pS121, DOI 10.1079/BJN2001340; Vermeulen K, 2003, CELL PROLIFERAT, V36, P165, DOI 10.1046/j.1365-2184.2003.00267.x; Yu WP, 2003, CANCER RES, V63, P2483; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257; Zhang W, 2009, EUR J GYNAECOL ONCOL, V30, P60	50	36	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131253	10.1371/journal.pone.0131253	http://dx.doi.org/10.1371/journal.pone.0131253			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148186	Green Published, gold, Green Submitted			2022-12-26	WOS:000358157600076
J	Kern, G; Palmer, T; Ehmann, DE; Shapiro, AB; Andrews, B; Basarab, GS; Doig, P; Fan, J; Gao, N; Mills, SD; Mueller, J; Sriram, S; Thresher, J; Walkup, GK				Kern, Gunther; Palmer, Tiffany; Ehmann, David E.; Shapiro, Adam B.; Andrews, Beth; Basarab, Gregory S.; Doig, Peter; Fan, Jun; Gao, Ning; Mills, Scott D.; Mueller, John; Sriram, Shubha; Thresher, Jason; Walkup, Grant K.			Inhibition of Neisseria gonorrhoeae Type II Topoisomerases by the Novel Spiropyrimidinetrione AZD0914	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUPERCOILED DNA RELAXATION; ANISOTROPY-BASED ASSAY; METAL ION BRIDGE; ESCHERICHIA-COLI; QUINOLONE RESISTANCE; ANTIBACTERIAL ACTIVITY; STAPHYLOCOCCUS-AUREUS; GYRASE INHIBITOR; 2-GATE MECHANISM; POLYMERASE-V	We characterized the inhibition of Neisseria gonorrhoeae type II topoisomerases gyrase and topoisomerase IV by AZD0914 (AZD0914 will be henceforth known as ETX0914 (Entasis Therapeutics)), a novel spiropyrimidinetrione antibacterial compound that is currently in clinical trials for treatment of drug-resistant gonorrhea. AZD0914 has potent bactericidal activity against N. gonorrhoeae, including multidrug-resistant strains and key Gram-positive, fastidious Gram-negative, atypical, and anaerobic bacterial species (Huband, M. D., Bradford, P. A., Otterson, L. G., Basrab, G. S., Giacobe, R. A., Patey, S. A., Kutschke, A. C., Johnstone, M. R., Potter, M. E., Miller, P. F., and Mueller, J. P. (2014) In Vitro Antibacterial Activity of AZD0914: A New Spiropyrimidinetrione DNA Gyrase/Topoisomerase Inhibitor with Potent Activity against Gram-positive, Fastidious Gram-negative, and Atypical Bacteria. Antimicrob. Agents Chemother. 59, 467-474). AZD0914 inhibited DNA biosynthesis preferentially to other macromolecules in Escherichia coli and induced the SOS response to DNA damage in E. coli. AZD0914 stabilized the enzyme-DNA cleaved complex for N. gonorrhoeae gyrase and topoisomerase IV. The potency of AZD0914 for inhibition of supercoiling and the stabilization of cleaved complex by N. gonorrhoeae gyrase increased in a fluoroquinolone-resistant mutant enzyme. When a mutation, conferring mild resistance to AZD0914, was present in the fluoroquinolone-resistant mutant, the potency of ciprofloxacin for inhibition of supercoiling and stabilization of cleaved complex was increased greater than 20-fold. In contrast to ciprofloxacin, religation of the cleaved DNA did not occur in the presence of AZD0914 upon removal of magnesium from the DNA-gyrase-inhibitor complex. AZD0914 had relatively low potency for inhibition of human type II topoisomerases alpha and beta.	[Kern, Gunther; Palmer, Tiffany; Ehmann, David E.; Shapiro, Adam B.; Andrews, Beth; Fan, Jun; Mills, Scott D.; Mueller, John; Sriram, Shubha; Walkup, Grant K.] AstraZeneca R&D Boston, Dept Biosci, Waltham, MA 02451 USA; [Basarab, Gregory S.] AstraZeneca R&D Boston, Dept Chem, Infect Innovat Med Unit, Waltham, MA 02451 USA; [Doig, Peter; Gao, Ning; Thresher, Jason] AstraZeneca R&D Boston, Dept Struct & Biophys, Discovery Sci, Waltham, MA 02451 USA	AstraZeneca; AstraZeneca; AstraZeneca	Kern, G (corresponding author), AstraZeneca R&D Boston, Dept Biosci, Infect Innovat Med Unit, 35 Gatehouse Dr, Waltham, MA 02451 USA.	gunther.kern@gmail.com	Fan, Jianqing/B-2115-2008	Basarab, Greg/0000-0001-5684-6046; Gao, Ning/0000-0003-1605-4137; Shapiro, Adam/0000-0002-2662-6146				Aedo S, 2012, ANTIMICROB AGENTS CH, V56, P5458, DOI 10.1128/AAC.01182-12; Aldred KJ, 2014, ANTIMICROB AGENTS CH, V58, P7182, DOI 10.1128/AAC.03734-14; Aldred KJ, 2014, BIOCHEMISTRY-US, V53, P1565, DOI 10.1021/bi5000564; Aldred KJ, 2013, ACS CHEM BIOL, V8, P2660, DOI 10.1021/cb400592n; Aldred KJ, 2013, NUCLEIC ACIDS RES, V41, P4628, DOI 10.1093/nar/gkt124; Aldred KJ, 2012, BIOCHEMISTRY-US, V51, P370, DOI 10.1021/bi2013905; Alm RA, 2015, ANTIMICROB AGENTS CH, V59, P1478, DOI 10.1128/AAC.04456-14; Anderson VE, 1999, J BIOL CHEM, V274, P35927, DOI 10.1074/jbc.274.50.35927; Basarab GS, 2014, J MED CHEM, V57, P9078, DOI 10.1021/jm501174m; BELLAND RJ, 1994, MOL MICROBIOL, V14, P371, DOI 10.1111/j.1365-2958.1994.tb01297.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cambau E, 2009, J ANTIMICROB CHEMOTH, V63, P443, DOI 10.1093/jac/dkn528; Centers for Disease Control and Prevention, 2013, NEISS GON INF FREQ U; Centers for Disease Control and Prevention, 2013, ANT RES THREATS US; CHU DTW, 1992, DRUG EXP CLIN RES, V18, P275; Deguchi T, 1997, CHEMOTHERAPY, V43, P239, DOI 10.1159/000239573; Ehmann DE, 2014, CURR OPIN PHARMACOL, V18, P76, DOI 10.1016/j.coph.2014.09.007; Emami S, 2006, MINI-REV MED CHEM, V6, P375, DOI 10.2174/138955706776361493; Endimiani A, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-106; Fan J, 2014, ANTIMICROB AGENTS CH, V58, P7264, DOI 10.1128/AAC.03475-14; GELLERT M, 1979, P NATL ACAD SCI USA, V76, P6289, DOI 10.1073/pnas.76.12.6289; GELLERT M, 1977, P NATL ACAD SCI USA, V74, P4772, DOI 10.1073/pnas.74.11.4772; Hilliard JJ, 1999, ANTIMICROB AGENTS CH, V43, P1693, DOI 10.1128/AAC.43.7.1693; HOSHINO K, 1989, ANTIMICROB AGENTS CH, V33, P1816, DOI 10.1128/AAC.33.10.1816; Huband MD, 2015, ANTIMICROB AGENTS CH, V59, P467, DOI 10.1128/AAC.04124-14; Jacobsson S, 2014, ANTIMICROB AGENTS CH, V58, P5585, DOI 10.1128/AAC.03090-14; Janion C, 2008, INT J BIOL SCI, V4, P338; Khodursky AB, 1998, J BIOL CHEM, V273, P27668, DOI 10.1074/jbc.273.42.27668; Lowndes C., 2014, UPDATE HLTH PROTECTI; MARTELL AE, 2001, NIST CRITICAL STABIL; Maxwell A, 1997, TRENDS MICROBIOL, V5, P102, DOI 10.1016/S0966-842X(96)10085-8; Maxwell A, 2003, CURR TOP MED CHEM, V3, P283, DOI 10.2174/1568026033452500; Maxwell A, 1999, BIOCHEM SOC T, V27, P48, DOI 10.1042/bst0270048; Mitscher LA, 2005, CHEM REV, V105, P559, DOI 10.1021/cr030101q; MIZUUCHI K, 1984, COLD SPRING HARB SYM, V49, P835, DOI 10.1101/SQB.1984.049.01.094; PALU G, 1992, P NATL ACAD SCI USA, V89, P9671, DOI 10.1073/pnas.89.20.9671; Patrzykat A, 2002, ANTIMICROB AGENTS CH, V46, P605, DOI 10.1128/AAC.46.3.605-614.2002; Pierrat OA, 2003, J BIOL CHEM, V278, P35016, DOI 10.1074/jbc.M304516200; Roca J, 1996, P NATL ACAD SCI USA, V93, P4057, DOI 10.1073/pnas.93.9.4057; ROCA J, 1994, CELL, V77, P609, DOI 10.1016/0092-8674(94)90222-4; ROCA J, 1992, CELL, V71, P833, DOI 10.1016/0092-8674(92)90558-T; Schlacher K, 2006, CHEM REV, V106, P406, DOI 10.1021/cr0404951; Schlacher K, 2006, NATURE, V442, P883, DOI 10.1038/nature05042; Schwarzenbach G., 1969, COMPLEXOMETRIC TITRA; Segev S, 1999, CLIN INFECT DIS, V28, P299, DOI 10.1086/515132; Shapiro A, 2010, J BIOMOL SCREEN, V15, P1088, DOI 10.1177/1087057110378624; Shapiro AB, 2014, ANAL BIOCHEM, V448, P23, DOI 10.1016/j.ab.2013.11.029; Shapiro AB, 2013, BIOCHEM PHARMACOL, V85, P1269, DOI 10.1016/j.bcp.2013.02.006; Shultz TR, 2001, ANTIMICROB AGENTS CH, V45, P734, DOI 10.1128/AAC.45.3.734-738.2001; Wiener JJM, 2007, BIOORG MED CHEM LETT, V17, P2718, DOI 10.1016/j.bmcl.2007.03.004; Wohlkonig A, 2010, NAT STRUCT MOL BIOL, V17, P1152, DOI 10.1038/nsmb.1892	51	24	24	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2015	290	34					20984	20994		10.1074/jbc.M115.663534	http://dx.doi.org/10.1074/jbc.M115.663534			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP6QC	26149691	Green Published, hybrid			2022-12-26	WOS:000360011800032
J	Chatterjee, S; Saxena, RK				Chatterjee, Sreoshi; Saxena, Rajiv K.			Preferential Elimination of Older Erythrocytes in Circulation and Depressed Bone Marrow Erythropoietic Activity Contribute to Cadmium Induced Anemia in Mice	PLOS ONE			English	Article							ITAI-ITAI DISEASE; OXIDATIVE STRESS; EXPOSURE; EXPRESSION; CLEARANCE; IRON; INTOXICATION; POPULATION; MECHANISMS; EXPANSION	Feeding cadmium chloride (50 or 1000 ppm CdCl2 in drinking water, ad libitum) to C57BL/6 mice resulted in a significant and sustained fall in blood erythrocyte count and hemoglobin levels that started 4 and 3 weeks after the start of 50 and 1000 ppm cadmium doses respectively. A transient yet significant reticulocytosis occurred during the first 4 weeks of cadmium treatment. Using the recently developed double in vivo biotinylation (DIB) technique, turnover of erythrocyte cohorts of different age groups was simultaneously monitored in control and cadmium treated mice. A significant accumulation of younger erythrocytes and a concomitant decline in the relative proportions of older erythrocytes in circulation was observed in both 50 and 1000 ppm cadmium groups indicating that older erythrocytes were preferentially eliminated in cadmium induced anemia. A significant increase in the erythropoietin levels in plasma was seen in mice exposed to 1000 ppm cadmium. Levels of inflammatory cytokines (IL1A, IL6, TNF alpha, IFN gamma) were however not significantly altered in cadmium treated mice. A significant increase in cellular levels of reactive oxygen species (ROS) was observed in older erythrocytes in circulation but not in younger erythrocytes. Erythropoietic activity in the bone marrows and spleens of cadmium treated mice was examined by monitoring the relative proportion of cells belonging to the erythroid line of differentiation in these organs. Erythroid cells in bone marrow declined markedly (about 30%) in mice in the 1000 ppm cadmium group but the decline was not significant in the 50 ppm cadmium group. Cells representing various stages of erythroid differentiation in bone marrow and spleen were enumerated flow cytometrically by double staining with anti-Ter119 and anti-transferrin receptor (CD71) monoclonal antibodies. Decline of erythroid cells was essentially confined to pro-erythroblast and erythroblast-A, along with a concurrent increase in the splenic erythroid population indicating a stress response. In short cadmium exposure causes preferential clearance of older erythrocytes from circulation along with a depressed erythropoietic activity at higher doses.	[Chatterjee, Sreoshi] Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India; [Saxena, Rajiv K.] South Asian Univ, Fac Life Sci & Biotechnol, New Delhi, India	Jawaharlal Nehru University, New Delhi; South Asian University (SAU)	Saxena, RK (corresponding author), South Asian Univ, Fac Life Sci & Biotechnol, New Delhi, India.	rajivksaxena@hotmail.com		Chatterjee, Sreoshi/0000-0001-7731-1243	Department of Science and Technology, Government of India [SR/S0/HS/0261/2012]; Council of Scientific and Industrial Research, New Delhi	Department of Science and Technology, Government of India(Department of Science & Technology (India)); Council of Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by a grant supported by Department of Science and Technology, Government of India, (Grants SR/S0/HS/0261/2012) to RKS. SC received Senior Research Fellowship from Council of Scientific and Industrial Research, New Delhi.	Beyersmann D, 1997, TOXICOL APPL PHARM, V144, P247, DOI 10.1006/taap.1997.8125; Bhardwaj N, 2015, NANOTOXICOL IN PRESS; Bhardwaj N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099364; Bhardwaj N, 2013, CURR SCI INDIA, V105, P1611; Casalino E, 2002, TOXICOLOGY, V179, P37, DOI 10.1016/S0300-483X(02)00245-7; Cuypers A, 2010, BIOMETALS, V23, P927, DOI 10.1007/s10534-010-9329-x; Faroon O., 2012, TOXICOLOGICAL PROFIL; Franz E, 2008, J FOOD PROTECT, V71, P2504, DOI 10.4315/0362-028X-71.12.2504; Gluhcheva Y, 2011, CLIN HEMORHEOL MICRO, V49, P417, DOI 10.3233/CH-2011-1491; HAMILTON DL, 1974, AM J PHYSIOL, V227, P1033, DOI 10.1152/ajplegacy.1974.227.5.1033; HORIGUCHI H, 1994, ARCH TOXICOL, V68, P632, DOI 10.1007/s002040050124; Horiguchi H, 1996, ARCH TOXICOL, V71, P11, DOI 10.1007/s002040050352; Horiguchi H, 2011, TOXICOL SCI, V122, P198, DOI 10.1093/toxsci/kfr100; Horiguchi H, 2010, INT ARCH OCC ENV HEA, V83, P953, DOI 10.1007/s00420-010-0510-x; IARC, 2012, IARC MONOGR EVAL CAR, V100C, P121; Jarup L, 2009, TOXICOL APPL PHARM, V238, P201, DOI 10.1016/j.taap.2009.04.020; Jarup Lars, 1998, Scandinavian Journal of Work Environment and Health, V24, P1; Jin TY, 1998, NEUROTOXICOLOGY, V19, P529; Kalfa TA, 2010, HAEMATOL-HEMATOL J, V95, P27, DOI 10.3324/haematol.2009.006239; Kasuya M, 2000, WATER SCI TECHNOL, V42, P147, DOI 10.2166/wst.2000.0563; Khandelwal S, 2008, EXP GERONTOL, V43, P764, DOI 10.1016/j.exger.2008.05.002; Khandelwal S, 2007, TRANSFUSION, V47, P1725, DOI 10.1111/j.1537-2995.2007.01348.x; Khandelwal S, 2006, EXP GERONTOL, V41, P855, DOI 10.1016/j.exger.2006.06.045; KUNIMOTO M, 1985, TOXICOL APPL PHARM, V77, P451, DOI 10.1016/0041-008X(85)90185-1; Liu J, 2009, TOXICOL APPL PHARM, V238, P209, DOI 10.1016/j.taap.2009.01.029; Liu Y, 2006, BLOOD, V108, P123, DOI 10.1182/blood-2005-11-4458; Lutton JD, 1984, ENVIRON RES, V39, P86; Marinkovic D, 2007, J CLIN INVEST, V117, P2133, DOI 10.1172/JCI31807; Nawrot TS, 2010, BIOMETALS, V23, P769, DOI 10.1007/s10534-010-9343-z; Nordberg GF, 1986, CADMIUM HLTH TOXICOL, P103; Nordberg G, 2012, J TRACE ELEM MED BIO, V26, P197, DOI 10.1016/j.jtemb.2012.03.007; Nordberg GF, 2009, TOXICOL APPL PHARM, V238, P192, DOI 10.1016/j.taap.2009.03.015; Paulson RF, 2011, CURR OPIN HEMATOL, V18, P139, DOI 10.1097/MOH.0b013e32834521c8; Sachar S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022032; SAKATA S, 1988, EXP HEMATOL, V16, P581; Satarug S, 2004, ENVIRON HEALTH PERSP, V112, P1099, DOI 10.1289/ehp.6751; Saxena RK, 2012, TRANSFUS MED HEMOTH, V39, P335, DOI 10.1159/000342524; Saxena RK, 2009, CURR SCI INDIA, V97, P500; Schauder A, 2010, J ENVIRON PATHOL TOX, V29, P137, DOI 10.1615/JEnvironPatholToxicolOncol.v29.i2.70; Socolovsky M, 2001, BLOOD, V98, P3261, DOI 10.1182/blood.V98.12.3261; Sorahan T, 1997, OCCUP ENVIRON MED, V54, P194, DOI 10.1136/oem.54.3.194; Stohs Sidney J., 2000, Journal of Environmental Pathology Toxicology and Oncology, V19, P201; Valko M, 2006, CHEM-BIOL INTERACT, V160, P1, DOI 10.1016/j.cbi.2005.12.009; Waalkes MP, 2000, J INORG BIOCHEM, V79, P241, DOI 10.1016/S0162-0134(00)00009-X; Waisberg M, 2003, TOXICOLOGY, V192, P95, DOI 10.1016/S0300-483X(03)00305-6; Wang YD, 2004, FREE RADICAL BIO MED, V36, P1434, DOI 10.1016/j.freeradbiomed.2004.03.010; WHO, 2010, EXP CADM MAJ PUBL HL; WHO INT AGCY RES CANC, 1993, IARC MONOG EVAL CARC, V58, P119; Zhang GC, 2002, J OCCUP HEALTH, V44, P15, DOI 10.1539/joh.44.15	49	9	9	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132697	10.1371/journal.pone.0132697	http://dx.doi.org/10.1371/journal.pone.0132697			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161863	Green Published, gold, Green Submitted			2022-12-26	WOS:000358162300169
J	Fuentes, TI; Appleby, N; Raya, M; Bailey, L; Hasaniya, N; Stodieck, L; Kearns-Jonker, M				Fuentes, Tania I.; Appleby, Nancy; Raya, Michael; Bailey, Leonard; Hasaniya, Nahidh; Stodieck, Louis; Kearns-Jonker, Mary			Simulated Microgravity Exerts an Age-Dependent Effect on the Differentiation of Cardiovascular Progenitors Isolated from the Human Heart	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; CARDIOSPHERE-DERIVED CELLS; MODELED MICROGRAVITY; OSTEOGENIC DIFFERENTIATION; FLOW-CYTOMETRY; EXPRESSION; MICRORNA; PHOSPHORYLATION; SPECIFICATION; MULTIPOTENT	Microgravity has a profound effect on cardiovascular function, however, little is known about the impact of microgravity on progenitors that reside within the heart. We investigated the effect of simulated microgravity exposure on progenitors isolated from the neonatal and adult human heart by quantifying changes in functional parameters, gene expression and protein levels after 6-7 days of 2D clinorotation. Utilization of neonatal and adult cardiovascular progenitors in ground-based studies has provided novel insight into how microgravity may affect cells differently depending on age. Simulated microgravity exposure did not impact AKT or ERK phosphorylation levels and did not influence cell migration, but elevated transcripts for paracrine factors were identified in neonatal and adult cardiovascular progenitors. Age-dependent responses surfaced when comparing the impact of microgravity on differentiation. Endothelial cell tube formation was unchanged or increased in progenitors from adults whereas neonatal cardiovascular progenitors showed a decline in tube formation (p<0.05). Von Willebrand Factor, an endothelial differentiation marker, and MLC2v and Troponin T, markers for cardiomyogenic differentiation, were elevated in expression in adult progenitors after simulated microgravity. DNA repair genes and telomerase reverse transcriptase which are highly expressed in early stem cells were increased in expression in neonatal but not adult cardiac progenitors after growth under simulated microgravity conditions. Neonatal cardiac progenitors demonstrated higher levels of MESP1, OCT4, and brachyury, markers for early stem cells. Micro-RNA profiling was used to further investigate the impact of simulated microgravity on cardiovascular progenitors. Fifteen microRNAs were significantly altered in expression, including microRNAs-99a and 100 (which play a critical role in cell dedifferentiation). These microRNAs were unchanged in adult cardiac progenitors. The effect of exposure to simulated microgravity in cardiovascular progenitors is age-dependent. Adult cardiac progenitors showed elevated expression of markers for endothelial and cardiomyogenic differentiation whereas neonatal progenitors acquired characteristics of dedifferentiating cells.	[Fuentes, Tania I.; Appleby, Nancy; Raya, Michael; Kearns-Jonker, Mary] Loma Linda Univ, Sch Med, Dept Pathol & Human Anat, Loma Linda, CA 92534 USA; [Bailey, Leonard; Hasaniya, Nahidh] Loma Linda Univ, Sch Med, Dept & Cardiothorac Surg, Loma Linda, CA USA; [Stodieck, Louis] Univ Colorado, Dept Aerosp Engn Sci, BioServe Space Technol, Boulder, CO 80309 USA	Loma Linda University; Loma Linda University; University of Colorado System; University of Colorado Boulder	Kearns-Jonker, M (corresponding author), Loma Linda Univ, Sch Med, Dept Pathol & Human Anat, Loma Linda, CA 92534 USA.	mkearnsjonker@llu.edu		Kearns-Jonker, Mary/0000-0002-8989-3698	Center for the Advancement of Science In Space [GA-2014-130]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM060507] Funding Source: NIH RePORTER	Center for the Advancement of Science In Space; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the Center for the Advancement of Science In Space, GA-2014-130, www.iss-casis.org.	Abrahamsen I, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-36; Aguirre A, 2014, CELL STEM CELL, V15, P589, DOI 10.1016/j.stem.2014.10.003; Allen DL, 2009, J APPL PHYSIOL, V106, P582, DOI 10.1152/japplphysiol.90780.2008; Amir G, 2008, ANN THORAC SURG, V86, P1311, DOI 10.1016/j.athoracsur.2008.06.058; Bier A, 2013, ONCOTARGET, V4, P665, DOI 10.18632/oncotarget.928; Boissart C, 2012, DEVELOPMENT, V139, P1247, DOI 10.1242/dev.073627; Bondue A, 2011, J CELL BIOL, V192, P751, DOI 10.1083/jcb.201007063; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Bradamante Silvia, 2014, Life-Basel, V4, P267, DOI 10.3390/life4020267; Cheng K, 2014, JACC-HEART FAIL, V2, P49, DOI 10.1016/j.jchf.2013.08.008; Chimenti I, 2010, CIRC RES, V106, P971, DOI 10.1161/CIRCRESAHA.109.210682; Dai ZQ, 2007, CELL PROLIFERAT, V40, P671, DOI 10.1111/j.1365-2184.2007.00461.x; David R, 2011, CARDIOVASC RES, V92, P115, DOI 10.1093/cvr/cvr158; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Espinosa-Jeffrey A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076963; Fuentes TI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077464; Gallego ME, 2001, P NATL ACAD SCI USA, V98, P1711, DOI 10.1073/pnas.98.4.1711; Gershovich JG, 2007, B EXP BIOL MED+, V144, P608, DOI 10.1007/s10517-007-0387-1; Ghosh G, 2010, J CLIN INVEST, V120, P4141, DOI 10.1172/JCI42980; Girardi C, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/296747; Hu XF, 2007, CIRCULATION, V116, P654, DOI 10.1161/CIRCULATIONAHA.106.672451; Huang Y, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-87; Hwang YS, 2009, BIOMATERIALS, V30, P499, DOI 10.1016/j.biomaterials.2008.07.028; Jesty SA, 2012, P NATL ACAD SCI USA, V109, P13380, DOI 10.1073/pnas.1208114109; Jin Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064434; Jun HS, 2011, BLOOD, V117, P3881, DOI 10.1182/blood-2010-08-302059; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Kong W, 2014, ONCOGENE, V33, P679, DOI 10.1038/onc.2012.636; Krutzik PO, 2004, CLIN IMMUNOL, V110, P206, DOI 10.1016/j.clim.2003.11.009; Krutzik PO, 2003, CYTOM PART A, V55A, P61, DOI 10.1002/cyto.a.10072; Kuehbacher A, 2007, CIRC RES, V101, P59, DOI 10.1161/CIRCRESAHA.107.153916; Kumari R, 2009, J CELL BIOCHEM, V107, P723, DOI 10.1002/jcb.22171; Li YQ, 2013, STEM CELLS, V31, P1213, DOI 10.1002/stem.1362; Lin Shi-Lung, 2013, Methods Mol Biol, V936, P295; Linke A, 2005, P NATL ACAD SCI USA, V102, P8966, DOI 10.1073/pnas.0502678102; Mangala LS, 2011, J BIOL CHEM, V286, P32483, DOI 10.1074/jbc.M111.267765; McGuckin CP, 2005, CELL PROLIFERAT, V38, P245, DOI 10.1111/j.1365-2184.2005.00346.x; Meyers VE, 2004, J CELL BIOCHEM, V93, P697, DOI 10.1002/jcb.20229; Mishra R, 2011, CIRCULATION, V123, P364, DOI 10.1161/CIRCULATIONAHA.110.971622; Mitsuhara T, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt184; Ontiveros C, 2003, J CELL BIOCHEM, V88, P427, DOI 10.1002/jcb.10410; Pisanu ME, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/470253; Plett PA, 2004, EXP HEMATOL, V32, P773, DOI 10.1016/j.exphem.2004.03.014; Rosa A, 2007, P NATL ACAD SCI USA, V104, P19849, DOI 10.1073/pnas.0706963104; Saxena R, 2007, ANN NY ACAD SCI, V1116, P494, DOI 10.1196/annals.1402.033; Shyh-Chang N, 2013, CELL, V155, P778, DOI 10.1016/j.cell.2013.09.059; Simpson DL, 2012, CIRCULATION, V126, pS46, DOI 10.1161/CIRCULATIONAHA.111.084699; Smits AM, 2009, NAT PROTOC, V4, P232, DOI 10.1038/nprot.2008.229; Sun LW, 2008, ACTA ASTRONAUT, V63, P968, DOI 10.1016/j.actaastro.2007.12.008; Talbot NC, 2010, IN VITRO CELL DEV-AN, V46, P502, DOI 10.1007/s11626-010-9302-6; Tang JM, 2009, EXP CELL RES, V315, P3521, DOI 10.1016/j.yexcr.2009.09.026; Tarantino C, 2010, FASEB J, V24, P3255, DOI 10.1096/fj.09-152207; Vannier JB, 2006, EMBO J, V25, P4577, DOI 10.1038/sj.emboj.7601345; Versari S, 2007, BBA-MOL CELL RES, V1773, P1645, DOI 10.1016/j.bbamcr.2007.05.014; Versari S, 2013, FASEB J, V27, P4466, DOI 10.1096/fj.13-229195; Vlachos IS, 2012, NUCLEIC ACIDS RES, V40, pW498, DOI 10.1093/nar/gks494; White RJ, 2001, NATURE, V409, P1115, DOI 10.1038/35059243; Yuge L, 2011, STEM CELLS DEV, V20, P893, DOI 10.1089/scd.2010.0294; Zayzafoon M, 2004, ENDOCRINOLOGY, V145, P2421, DOI 10.1210/en.2003-1156; Zeng XM, 2007, STEM CELL REV, V3, P270, DOI 10.1007/s12015-007-9005-x; Zhang SC, 2015, BIOMATERIALS, V41, P15, DOI 10.1016/j.biomaterials.2014.11.019; Zhang XF, 2013, NATURWISSENSCHAFTEN, V100, P125, DOI 10.1007/s00114-012-1002-5; Zhong XM, 2010, J BIOL CHEM, V285, P41961, DOI 10.1074/jbc.M110.169607; Zhu WY, 2014, CANCER INVEST, V32, P394, DOI 10.3109/07357907.2014.922569	64	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132378	10.1371/journal.pone.0132378	http://dx.doi.org/10.1371/journal.pone.0132378			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161778	Green Submitted, Green Published, gold			2022-12-26	WOS:000358162300126
J	Lin, MF; Lin, YY; Lan, CY				Lin, Ming-Feng; Lin, Yun-You; Lan, Chung-Yu			The Role of the Two-Component System BaeSR in Disposing Chemicals through Regulating Transporter Systems in Acinetobacter baumannii	PLOS ONE			English	Article							MULTIDRUG EFFLUX PUMP; ESCHERICHIA-COLI; ANTIBIOTIC-RESISTANCE; TIGECYCLINE; EXPRESSION; ADEABC; ENVELOPE; TANNINS; FAMILY; ADEIJK	Bacterial two-component regulatory systems (TCSs) facilitate changes in gene expression in response to environmental stimuli. TCS BaeR regulons influence tigecycline susceptibility in Acinetobacter baumannii through positively regulating the pump genes adeA and adeB. In this study, we demonstrate that an additional two transport systems, AdeIJK and MacAB-TolC, are also regulated by BaeSR. In the wild type and clinical tigecycline-resistant A. baumannii strains, gene expression of AdeIJK and MacAB-TolC increased after tigecycline induction, implicating their importance to tigecycline resistance in addition to AdeABC. Phenotypic microarray results showed that A. baumannii is vulnerable to certain chemicals, especially tannic acid, after deleting baeR, which was confirmed using the spot assay. The wild-type strain of A. baumannii also exhibited 1.6-fold and 4.4-fold increase in gene expression of adeJ and macB in the medium with 100 mu g/mL tannic acid, but the increase was fully inhibited by baeR deletion. An electrophoretic motility shift assay based on an interaction between His-BaeR and the adeA, adeI and macA promoter regions did not demonstrate direct binding. In conclusion, A. baumannii can use the TCS BaeSR in disposing chemicals, such as tannic acid and tigecycline, through regulating the efflux pumps.	[Lin, Ming-Feng] Natl Taiwan Univ Hosp, Dept Med, Chu Tung Branch, Hsinchu, Taiwan; [Lin, Ming-Feng; Lin, Yun-You; Lan, Chung-Yu] Natl Tsing Hua Univ, Inst Mol & Cellular Biol, Hsinchu, Taiwan; [Lan, Chung-Yu] Natl Tsing Hua Univ, Dept Life Sci, Hsinchu, Taiwan	National Taiwan University; National Taiwan University Hospital; National Tsing Hua University; National Tsing Hua University	Lan, CY (corresponding author), Natl Tsing Hua Univ, Inst Mol & Cellular Biol, Hsinchu, Taiwan.	cylan@life.nthu.edu.tw	林, 明鋒/AAX-7999-2020	林, 明鋒/0000-0002-4819-4057; Lan, Chung-Yu/0000-0002-1533-3049	National Taiwan University Hospital Chu-Tung Branch	National Taiwan University Hospital Chu-Tung Branch	This study was supported by a grant from National Taiwan University Hospital Chu-Tung Branch. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2009, ANTIMICROB AGENTS CH, V53, P3628, DOI 10.1128/AAC.00284-09; Akiyama H, 2001, J ANTIMICROB CHEMOTH, V48, P487, DOI 10.1093/jac/48.4.487; Alm E, 2006, PLOS COMPUT BIOL, V2, P1329, DOI 10.1371/journal.pcbi.0020143; Anthony KB, 2008, CLIN INFECT DIS, V46, P567, DOI 10.1086/526775; Appia-Ayme C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023713; Baranova N, 2002, J BACTERIOL, V184, P4168, DOI 10.1128/JB.184.15.4168-4176.2002; Barrett JF, 1998, P NATL ACAD SCI USA, V95, P5317, DOI 10.1073/pnas.95.9.5317; Beceiro A, 2011, ANTIMICROB AGENTS CH, V55, P3370, DOI 10.1128/AAC.00079-11; Bury-Mone S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000651; Cerqueira GM, 2014, J INFECT DIS, V210, P46, DOI 10.1093/infdis/jiu024; Chusri S, 2009, J ANTIMICROB CHEMOTH, V64, P1203, DOI 10.1093/jac/dkp381; Clinical and Laboratory Standards Institute (CLSI), 2012, CLSI DOCUMENT M07 A9; Coyne S, 2011, ANTIMICROB AGENTS CH, V55, P947, DOI 10.1128/AAC.01388-10; Coyne S, 2010, ANTIMICROB AGENTS CH, V54, P4389, DOI 10.1128/AAC.00155-10; Damier-Piolle L, 2008, ANTIMICROB AGENTS CH, V52, P557, DOI 10.1128/AAC.00732-07; Deng M, 2014, ANTIMICROB AGENTS CH, V58, P297, DOI 10.1128/AAC.01727-13; Harris TL, 2014, ACS CHEM BIOL, V9, P122, DOI 10.1021/cb400490k; Henry R, 2012, ANTIMICROB AGENTS CH, V56, P59, DOI 10.1128/AAC.05191-11; Hooper DC, 2005, CLIN INFECT DIS, V40, P1811, DOI 10.1086/430381; Hou PF, 2012, CHEMOTHERAPY, V58, P152, DOI 10.1159/000335599; HUPKENS P, 1995, BURNS, V21, P57, DOI 10.1016/0305-4179(95)90784-W; Kim TJ, 2010, FOOD CHEM, V118, P740, DOI 10.1016/j.foodchem.2009.05.060; Leblanc SKD, 2011, J BACTERIOL, V193, P3367, DOI 10.1128/JB.01534-10; Lin MF, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-119; Liou ML, 2014, J MICROBIOL IMMUNOL, V47, P275, DOI 10.1016/j.jmii.2012.12.004; Ma D, 1996, MOL MICROBIOL, V19, P101, DOI 10.1046/j.1365-2958.1996.357881.x; Magnet S, 2001, ANTIMICROB AGENTS CH, V45, P3375, DOI 10.1128/AAC.45.12.3375-3380.2001; Marchand I, 2004, ANTIMICROB AGENTS CH, V48, P3298, DOI 10.1128/AAC.48.9.3298-3304.2004; Nishino K, 2005, J BACTERIOL, V187, P1763, DOI 10.1128/JB.187.5.1763-1772.2005; Nishino K, 2007, J BACTERIOL, V189, P9066, DOI 10.1128/JB.01045-07; Pachon-Ibanez ME, 2004, ANTIMICROB AGENTS CH, V48, P4479, DOI 10.1128/AAC.48.11.4479-4481.2004; Piddock LJV, 2006, NAT REV MICROBIOL, V4, P629, DOI 10.1038/nrmicro1464; Rajamohan G, 2010, J ANTIMICROB CHEMOTH, V65, P1919, DOI 10.1093/jac/dkq195; Roca I, 2009, ANTIMICROB AGENTS CH, V53, P4013, DOI 10.1128/AAC.00584-09; Roca I, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00148; Rosenfeld N, 2012, ANTIMICROB AGENTS CH, V56, P2504, DOI 10.1128/AAC.06422-11; Rowley G, 2006, NAT REV MICROBIOL, V4, P383, DOI 10.1038/nrmicro1394; Ruzin A, 2007, J ANTIMICROB CHEMOTH, V59, P1001, DOI 10.1093/jac/dkm058; Sambrook J., 2001, MOL CLONING LAB MANU; Srinivasan VB, 2009, ANTIMICROB AGENTS CH, V53, P5312, DOI 10.1128/AAC.00748-09; Stephenson K, 2002, PHARMACOL THERAPEUT, V93, P293, DOI 10.1016/S0163-7258(02)00198-5; Su XZ, 2005, ANTIMICROB AGENTS CH, V49, P4362, DOI 10.1128/AAC.49.10.4362-4364.2005; Sun JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049534; Tomaras AP, 2008, MICROBIOL-SGM, V154, P3398, DOI 10.1099/mic.0.2008/019471-0; Vila J, 2007, J ANTIMICROB CHEMOTH, V59, P1210, DOI 10.1093/jac/dkl509; Wang D, 2013, METALLOMICS, V5, P372, DOI 10.1039/c3mt20217h; West AH, 2001, TRENDS BIOCHEM SCI, V26, P369, DOI 10.1016/S0968-0004(01)01852-7; Wieczorek P, 2008, FOLIA HISTOCHEM CYTO, V46, P257, DOI 10.2478/v10042-008-0056-x; Zhou L, 2003, J BACTERIOL, V185, P4956, DOI 10.1128/JB.185.16.4956-4972.2003; Zoetendal EG, 2008, APPL ENVIRON MICROB, V74, P535, DOI 10.1128/AEM.02271-07	50	35	40	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132843	10.1371/journal.pone.0132843	http://dx.doi.org/10.1371/journal.pone.0132843			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161744	Green Submitted, Green Published, gold			2022-12-26	WOS:000358162300180
J	Moya-Perez, A; Neef, A; Sanz, Y				Moya-Perez, Angela; Neef, Alexander; Sanz, Yolanda			Bifidobacterium pseudocatenulatum CECT 7765 Reduces Obesity-Associated Inflammation by Restoring the Lymphocyte-Macrophage Balance and Gut Microbiota Structure in High-Fat Diet-Fed Mice	PLOS ONE			English	Article							INDUCED HEPATIC STEATOSIS; GROUP-SPECIFIC PRIMERS; LEPTIN-RESISTANT MICE; ADIPOSE-TISSUE; INSULIN-RESISTANCE; T-CELLS; PREDOMINANT BACTERIA; HUMAN FECES; LIVER; PROBIOTICS	Background/Objectives The role of intestinal dysbiosis in obesity-associated systemic inflammation via the crosstalk with peripheral tissues is under debate. Our objective was to decipher the mechanisms by which intervention in the gut ecosystem with a specific Bifidobacterium strain reduces systemic inflammation and improves metabolic dysfunction in obese high-fat diet (HFD) fed mice. Methods Adult male wild-type C57BL-6 mice were fed either a standard or HFD, supplemented with placebo or Bifidobacterium pseudocatenulatum CECT 7765, for 14 weeks. Lymphocytes, macrophages and cytokine/chemokine concentrations were quantified in blood, gut, liver and adipose tissue using bead-based multiplex assays. Biochemical parameters in serum were determined by ELISA and enzymatic assays. Histology was assessed by hematoxylin-eosin staining. Microbiota was analyzed by 16S rRNA gene pyrosequencing and quantitative PCR. Results B. pseudocatenulatum CECT 7765 reduced obesity-associated systemic inflammation by restoring the balance between regulatory T cells (Tregs) and B lymphocytes and reducing pro-inflammatory cytokines of adaptive (IL-17A) and innate (TNF-alpha) immunity and endotoxemia. In the gut, the bifidobacterial administration partially restored the HFD-induced alterations in microbiota, reducing abundances of Firmicutes and of LPS-producing Proteobacteria, paralleled to reductions in B cells, macrophages, and cytokines (IL-6, MCP-1, TNF-alpha, IL-17A), which could contribute to systemic effects. In adipose tissue, bifidobacterial administration reduced B cells whereas in liver the treatment increased Tregs and shifted different cytokines (MCP-1 plus ILP-10 in adipose tissue and INF-gamma plus IL-1 beta in liver). In both tissues, the bifidobacteria reduced pro-inflammatory macrophages and, TNF-alpha and IL-17A concentrations. These effects were accompanied by reductions in body weight gain and in serum cholesterol, triglyceride, glucose and insulin levels and improved oral glucose tolerance and insulin sensitivity in obese mice. Conclusions Here, we provide evidence of the immune cellular mechanisms by which the inflammatory cascade associated with diet-induced obesity is attenuated by the administration of a specific Bifidobacterium strain and that these effects are associated with modulation of gut microbiota structure.	[Moya-Perez, Angela; Neef, Alexander; Sanz, Yolanda] CSIC, Natl Res Council IATA, Inst Agrochem & Food Technol, Microbial Ecol Nutr & Hlth Res Grp, Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Instituto de Agroquimica y Tecnologia de los Alimentos (IATA)	Sanz, Y (corresponding author), CSIC, Natl Res Council IATA, Inst Agrochem & Food Technol, Microbial Ecol Nutr & Hlth Res Grp, Valencia, Spain.	yolsanz@iata.csic.es	Neef, Alexander/A-7900-2012; Sanz, Yolanda/H-5498-2012	Neef, Alexander/0000-0002-4170-9425; Sanz, Yolanda/0000-0002-1615-1976; MOYA PEREZ, ANGELA/0000-0002-2265-3630	Spanish Ministry of Science and Innovation (MICINN, Spain) [AGL2011-25169, Consolider Fun-C-Food CSD2007-00063]; Spanish Ministry of Education, Culture and Sport (MECD)	Spanish Ministry of Science and Innovation (MICINN, Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ministry of Education, Culture and Sport (MECD)(Spanish Government)	This study was supported by public grants AGL2011-25169 and Consolider Fun-C-Food CSD2007-00063 from the Spanish Ministry of Science and Innovation (MICINN, Spain). The scholarship of A. Moya from Spanish Ministry of Education, Culture and Sport (MECD) is fully acknowledged.	Arndt T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064305; Borst SE, 2005, LIFE SCI, V77, P2156, DOI 10.1016/j.lfs.2005.03.021; Cani PD, 2007, DIABETOLOGIA, V50, P2374, DOI 10.1007/s00125-007-0791-0; Cani PD, 2009, CURR OPIN PHARMACOL, V9, P737, DOI 10.1016/j.coph.2009.06.016; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Corridoni D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042067; DeFuria J, 2013, P NATL ACAD SCI USA, V110, P5133, DOI 10.1073/pnas.1215840110; Ding SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012191; Duffaut C, 2009, ARTERIOSCL THROM VAS, V29, P1608, DOI 10.1161/ATVBAHA.109.192583; Ericksen RE, 2014, GUT, V63, P385, DOI 10.1136/gutjnl-2013-305092; Esposito E, 2009, J NUTR, V139, P905, DOI 10.3945/jn.108.101808; Everard A, 2011, DIABETES, V60, P2775, DOI 10.2337/db11-0227; Feuerer M, 2009, NAT IMMUNOL, V10, P689, DOI 10.1038/ni.1760; Cano PG, 2013, OBESITY, V21, P2310, DOI 10.1002/oby.20330; Gerner RR, 2013, CAN J PHYSIOL PHARM, V91, P867, DOI 10.1139/cjpp-2013-0050; Geurts L, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00149; Goel A, 2014, J GASTROEN HEPATOL, V29, P1139, DOI 10.1111/jgh.12556; Jialal I, 2014, J CLIN ENDOCR METAB, V99, P39, DOI 10.1210/jc.2013-3092; Kanneganti TD, 2012, NAT IMMUNOL, V13, P707, DOI 10.1038/ni.2343; Kim KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047713; Li H, 2008, METABOLISM, V57, P1704, DOI 10.1016/j.metabol.2008.07.029; LI XM, 1991, HEPATOLOGY, V14, P121, DOI 10.1002/hep.1840140120; Ma X, 2008, J HEPATOL, V49, P821, DOI 10.1016/j.jhep.2008.05.025; Matarese G, 2005, J IMMUNOL, V174, P3137, DOI 10.4049/jimmunol.174.6.3137; Matsuki T, 2004, APPL ENVIRON MICROB, V70, P7220, DOI 10.1128/AEM.70.12.7220-7228.2004; Matsuki T, 2002, APPL ENVIRON MICROB, V68, P5445, DOI 10.1128/AEM.68.11.5445-5451.2002; Maury E, 2010, MOL CELL ENDOCRINOL, V314, P1, DOI 10.1016/j.mce.2009.07.031; MIURA S, 1993, IMMUNOLOGY, V78, P142; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Obstfeld AE, 2010, DIABETES, V59, P916, DOI 10.2337/db09-1403; Oh DY, 2012, DIABETES, V61, P346, DOI 10.2337/db11-0860; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Paul G, 2006, INFLAMM BOWEL DIS, V12, P471, DOI 10.1097/00054725-200606000-00005; Poutahidis T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068596; Santacruz A, 2010, BRIT J NUTR, V104, P83, DOI 10.1017/S0007114510000176; Sanz Y, 2013, PHARMACOL RES, V69, P144, DOI 10.1016/j.phrs.2012.10.021; Sanz Y, 2009, INT REV IMMUNOL, V28, P397, DOI 10.3109/08830180903215613; Schlegel PM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082580; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shim JO, 2013, PEDIATR GASTROENTERO, V16, P17, DOI 10.5223/pghn.2013.16.1.17; Shin NR, 2014, GUT, V63, P727, DOI 10.1136/gutjnl-2012-303839; Sim K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032543; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Winer D A, 2012, Int J Obes Suppl, V2, pS4; Winer DA, 2011, NAT MED, V17, P610, DOI 10.1038/nm.2353; Wolowczuk I, 2008, CLIN DEV IMMUNOL, P1, DOI 10.1155/2008/639803; Zhang X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042529	50	132	140	2	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0126976	10.1371/journal.pone.0126976	http://dx.doi.org/10.1371/journal.pone.0126976			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161548	Green Submitted, Green Published, gold			2022-12-26	WOS:000358162300004
J	Muriel, C; Jalvo, B; Redondo-Nieto, M; Rivilla, R; Martin, M				Muriel, Candela; Jalvo, Blanca; Redondo-Nieto, Miguel; Rivilla, Rafael; Martin, Marta			Chemotactic Motility of Pseudomonas fluorescens F113 under Aerobic and Denitrification Conditions	PLOS ONE			English	Article							COMPETITIVE COLONIZATION ABILITY; ROOT COLONIZATION; RHIZOSPHERE COLONIZATION; SENSORY PROTEINS; AERUGINOSA; GENES; IDENTIFICATION; GROWTH; INVOLVEMENT; SELECTION	The sequence of the genome of Pseudomonas fluorescens F113 has shown the presence of multiple traits relevant for rhizosphere colonization and plant growth promotion. Among these traits are denitrification and chemotactic motility. Besides aerobic growth, F113 is able to grow anaerobically using nitrate and nitrite as final electron acceptors. F113 is able to perform swimming motility under aerobic conditions and under anaerobic conditions when nitrate is used as the electron acceptor. However, nitrite can not support swimming motility. Regulation of swimming motility is similar under aerobic and anaerobic conditions, since mutants that are hypermotile under aerobic conditions, such as gacS, sadB, kinB, algU and wspR, are also hypermotile under anaerobic conditions. However, chemotactic behavior is different under aerobic and denitrification conditions. Unlike most pseudomonads, the F113 genome encode three complete chemotaxis systems, Che1, Che2 and Che3. Mutations in each of the cheA genes of the three Che systems has shown that the three systems are functional and independent. Mutation of the cheA1 gene completely abolished swimming motility both under aerobic and denitrification conditions. Mutation of the cheA2 gene, showed only a decrease in swimming motility under both conditions, indicating that this system is not essential for chemotactic motility but is necessary for optimal motility. Mutation of the cheA3 gene abolished motility under denitrification conditions but only produced a decrease in motility under aerobic conditions. The three Che systems proved to be implicated in competitive rhizosphere colonization, being the cheA1 mutant the most affected.	[Muriel, Candela; Jalvo, Blanca; Redondo-Nieto, Miguel; Rivilla, Rafael; Martin, Marta] Univ Autonoma Madrid, Dept Biol, Madrid, Spain	Autonomous University of Madrid	Martin, M (corresponding author), Univ Autonoma Madrid, Dept Biol, Madrid, Spain.	m.martin@uam.es	Rivilla, Rafael/A-1659-2008; Jalvo Sánchez, Blanca/AGH-8156-2022; martin, marta/H-2169-2015; Basanta, Marta Martin/AAI-5459-2020; Redondo-Nieto, Miguel/A-6169-2011	Rivilla, Rafael/0000-0003-0701-2939; martin, marta/0000-0003-2498-9768; Basanta, Marta Martin/0000-0003-2498-9768; Redondo-Nieto, Miguel/0000-0002-3361-520X	Spanish Ministry of Economy and Competitiveness [BIO2012-31634]	Spanish Ministry of Economy and Competitiveness(Spanish Government)	This work was funded by the Spanish Ministry of Economy and Competitiveness, grant BIO2012-31634. Candela Muriel is the recipient of an FPI fellowship from the Spanish Ministry of Economy and Competitiveness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barahona E, 2011, APPL ENVIRON MICROB, V77, P5412, DOI 10.1128/AEM.00320-11; Barahona E, 2010, ENVIRON MICROBIOL, V12, P3185, DOI 10.1111/j.1462-2920.2010.02291.x; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; Bloemberg GV, 2001, CURR OPIN PLANT BIOL, V4, P343, DOI 10.1016/S1369-5266(00)00183-7; Capdevila S, 2004, MICROBIOL-SGM, V150, P3889, DOI 10.1099/mic.0.27362-0; CARLSON CA, 1983, APPL ENVIRON MICROB, V45, P1247, DOI 10.1128/AEM.45.4.1247-1253.1983; De La Fuente L, 2006, PHYTOPATHOLOGY, V96, P751, DOI 10.1094/PHYTO-96-0751; de Weert S, 2002, MOL PLANT MICROBE IN, V15, P1173, DOI 10.1094/MPMI.2002.15.11.1173; Ditty JL, 1998, FEMS MICROBIOL LETT, V159, P267, DOI 10.1016/S0378-1097(97)00581-8; FAHRAEUS G, 1957, J GEN MICROBIOL, V16, P374, DOI 10.1099/00221287-16-2-374; Ferrandez A, 2002, J BACTERIOL, V184, P4374, DOI 10.1128/JB.184.16.4374-4383.2002; FINAN TM, 1986, J BACTERIOL, V167, P66, DOI 10.1128/jb.167.1.66-72.1986; Ghiglione JF, 2002, FEMS MICROBIOL ECOL, V39, P121, DOI 10.1111/j.1574-6941.2002.tb00913.x; Ghirardi S, 2012, MICROB ECOL, V64, P725, DOI 10.1007/s00248-012-0065-3; GREENBERG EP, 1977, CAN J MICROBIOL, V23, P903, DOI 10.1139/m77-133; Guvener ZT, 2006, MOL MICROBIOL, V61, P106, DOI 10.1111/j.1365-2958.2006.05218.x; Hong CS, 2005, J BACTERIOL, V187, P1533, DOI 10.1128/JB.187.4.1533-1535.2005; Hong CS, 2004, J BIOSCI BIOENG, V97, P184, DOI 10.1263/jbb.97.184; Kato J, 1999, BIOSCI BIOTECH BIOCH, V63, P155, DOI 10.1271/bbb.63.155; Line L, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00554; Loper JE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002784; Martinez-Granero F, 2005, MICROBIOL-SGM, V151, P975, DOI 10.1099/mic.0.27583-0; Martinez-Granero F, 2006, APPL ENVIRON MICROB, V72, P3429, DOI 10.1128/AEM.72.5.3429-3434.2006; Martinez-Granero F, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-237; Martinez-Granero F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087608; Martinez-Granero F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031765; Miller SH, 2010, ENV MICROBIOL REP, V2, P403, DOI 10.1111/j.1758-2229.2009.00105.x; Naseby DC, 2001, MICROB ECOL, V42, P193; Navazo A, 2009, MICROB BIOTECHNOL, V2, P489, DOI 10.1111/j.1751-7915.2009.00103.x; Oku S, 2014, MICROBES ENVIRON, V29, P413, DOI 10.1264/jsme2.ME14128; Oku S, 2012, MICROBES ENVIRON, V27, P462, DOI 10.1264/jsme2.ME12005; Philippot L, 2001, BBA-GENE STRUCT EXPR, V1517, P436, DOI 10.1016/S0167-4781(00)00286-4; Redondo-Nieto M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-54; Sanchez-Contreras M, 2002, J BACTERIOL, V184, P1587, DOI 10.1128/JB.184.6.1587-1596.2002; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; SCHER FM, 1982, PHYTOPATHOLOGY, V72, P1567, DOI 10.1094/Phyto-72-1567; Shimizu TS, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.37; Silby MW, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r51; Simons M, 1996, MOL PLANT MICROBE IN, V9, P600, DOI 10.1094/MPMI-9-0600; von Felten A, 2011, J MICROBIOL METH, V84, P379, DOI 10.1016/j.mimet.2010.11.012; WILLIAMS DR, 1978, APPL ENVIRON MICROB, V36, P257, DOI 10.1128/AEM.36.2.257-263.1978	41	18	18	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132242	10.1371/journal.pone.0132242	http://dx.doi.org/10.1371/journal.pone.0132242			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161531	Green Submitted, gold, Green Published			2022-12-26	WOS:000358162300106
J	Yao, ZJ; Hu, B; Zheng, JX; Zheng, WH; Chen, XJ; Gao, X; Xie, YW; Fang, L				Yao, Zhijun; Hu, Bin; Zheng, Jiaxiang; Zheng, Weihao; Chen, Xuejiao; Gao, Xiang; Xie, Yuanwei; Fang, Lei		Alzheimer's Dis Neuroimaging Initi	A FDG-PET Study of Metabolic Networks in Apolipoprotein E epsilon 4 Allele Carriers	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; SMALL-WORLD; FUNCTIONAL CONNECTIVITY; TOPOLOGICAL PATTERNS; GENETIC INFLUENCE; AUDITORY-CORTEX; HESCHLS GYRUS; APOE GENOTYPE; FMRI EVIDENCE	Recently, some studies have applied the graph theory in brain network analysis in Alzheimer's disease (AD) and Mild Cognitive Impairment (MCI). However, relatively little research has specifically explored the properties of the metabolic network in apolipoprotein E (APOE) epsilon 4 allele carriers. In our study, all the subjects, including ADs, MCIs and NCs (normal controls) were divided into 165 APOE epsilon 4 carriers and 165 APOE epsilon 4 noncarriers. To establish the metabolic network for all brain regions except the cerebellum, cerebral glucose metabolism data obtained from FDG-PET (F-18-fluorodeoxyglu-cose positron emission tomography) were segmented into 90 areas with automated anatomical labeling (AAL) template. Then, the properties of the networks were computed to explore the between-group differences. Our results suggested that both APOE epsilon 4 carriers and noncarriers showed the small-world properties. Besides, compared with APOE epsilon 4 noncarriers, the carriers showed a lower clustering coefficient. In addition, significant changes in 6 hub brain regions were found in between-group nodal centrality. Namely, compared with APOE epsilon 4 noncarriers, significant decreases of the nodal centrality were found in left insula, right insula, right anterior cingulate, right paracingulate gyri, left cuneus, as well as significant increases in left paracentral lobule and left heschl gyrus in APOE epsilon 4 carriers. Increased local short distance inter-regional correlations and disrupted long distance inter-regional correlations were found, which may support the point that the APOE epsilon 4 carriers were more similar with AD or MCI in FDG uptake. In summary, the organization of metabolic network in APOE epsilon 4 carriers indicated a less optimal pattern and APOE epsilon 4 might be a risk factor for AD.	[Yao, Zhijun; Hu, Bin; Zheng, Jiaxiang; Zheng, Weihao; Chen, Xuejiao; Gao, Xiang; Xie, Yuanwei] Lanzhou Univ, Sch Informat Sci & Engn, Lanzhou 730000, Peoples R China; [Fang, Lei] Lanzhou Mil Area Command, Affiliated Lanzhou Gen Hosp, PET CT Ctr, Lanzhou, Peoples R China	Lanzhou University	Hu, B (corresponding author), Lanzhou Univ, Sch Informat Sci & Engn, Lanzhou 730000, Peoples R China.	bh@lzu.edu.cn	Preda, Adrian/K-8889-2013; Hsiung, Robin/AAT-1661-2021	Preda, Adrian/0000-0003-3373-2438; Hsiung, Robin/0000-0002-8017-0856; Ponto, Laura/0000-0003-1197-6714	National Basic Research Program of China [2014CB744600]; International Cooperation Project of Ministry of Science and Technology [2013DFA11140]; National Natural Science Foundation of China [61210010]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR000096] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005134] Funding Source: NIH RePORTER	National Basic Research Program of China(National Basic Research Program of China); International Cooperation Project of Ministry of Science and Technology; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Basic Research Program of China (2014CB744600), the International Cooperation Project of Ministry of Science and Technology (2013DFA11140) and the National Natural Science Foundation of China (61210010).	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Adamson MM, 2011, NEUROPSYCHOLOGIA, V49, P2448, DOI 10.1016/j.neuropsychologia.2011.04.022; ADOLPHS R, 1995, J NEUROSCI, V15, P5879; Alata W, 2015, J CEREBR BLOOD F MET, V35, P86, DOI 10.1038/jcbfm.2014.172; Augustine JR, 1996, BRAIN RES REV, V22, P229, DOI 10.1016/S0165-0173(96)00011-2; Bassettt DS, 2006, P NATL ACAD SCI USA, V103, P19518, DOI 10.1073/pnas.0606005103; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Bokde ALW, 2006, BRAIN, V129, P1113, DOI 10.1093/brain/awl051; Bondi MW, 2005, NEUROLOGY, V64, P501, DOI 10.1212/01.WNL.0000150885.00929.7E; Carbonell F, 2014, J CEREBR BLOOD F MET, V34, P1169, DOI 10.1038/jcbfm.2014.66; Caselli RJ, 2007, ARCH NEUROL-CHICAGO, V64, P1306, DOI 10.1001/archneur.64.9.1306; Caselli RJ, 2009, NEW ENGL J MED, V361, P255, DOI 10.1056/NEJMoa0809437; Chen KW, 2007, AM J PSYCHIAT, V164, P916, DOI 10.1176/appi.ajp.164.6.916; Chen KW, 2012, NEUROIMAGE, V60, P2316, DOI 10.1016/j.neuroimage.2012.02.005; Chen YJ, 2015, J NEUROSCI, V35, P1423, DOI 10.1523/JNEUROSCI.1946-14.2015; Choo IH, 2013, J ALZHEIMERS DIS, V33, P929, DOI 10.3233/JAD-2012-121489; CORBETTA M, 1995, SCIENCE, V270, P802, DOI 10.1126/science.270.5237.802; Da Costa S, 2011, J NEUROSCI, V31, P14067, DOI 10.1523/JNEUROSCI.2000-11.2011; Ewers M, 2011, TRENDS NEUROSCI, V34, P430, DOI 10.1016/j.tins.2011.05.005; Forster S, 2010, J PSYCHIATR RES, V44, P462, DOI 10.1016/j.jpsychires.2009.09.012; Ge JJ, 2014, NEURAL REGEN RES, V9, P763, DOI 10.4103/1673-5374.131586; GERDES LU, 1992, GENET EPIDEMIOL, V9, P155, DOI 10.1002/gepi.1370090302; GOLDMANRAKIC PS, 1988, ANNU REV NEUROSCI, V11, P137, DOI 10.1146/annurev.neuro.11.1.137; Grady CL, 2001, BRAIN, V124, P739, DOI 10.1093/brain/124.4.739; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Han SD, 2007, NEUROBIOL AGING, V28, P238, DOI 10.1016/j.neurobiolaging.2005.12.013; He Y, 2008, J NEUROSCI, V28, P4756, DOI 10.1523/JNEUROSCI.0141-08.2008; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; Indefrey P, 2001, P NATL ACAD SCI USA, V98, P5933, DOI 10.1073/pnas.101118098; Ito K, 2012, J PHARMACOKINET PHAR, V39, P601, DOI 10.1007/s10928-012-9271-3; Kim J, 2014, MOL CELLS, V37, P767, DOI 10.14348/molcells.2014.0248; Kim J, 2009, NEURON, V63, P287, DOI 10.1016/j.neuron.2009.06.026; Kim SM, 2013, NEURORADIOLOGY, V55, P25, DOI 10.1007/s00234-012-1077-x; Linden DEJ, 2012, NEURON, V73, P8, DOI 10.1016/j.neuron.2011.12.014; Morra JH, 2009, HUM BRAIN MAPP, V30, P2766, DOI 10.1002/hbm.20708; Morra JH, 2009, NEUROIMAGE, V45, pS3, DOI 10.1016/j.neuroimage.2008.10.043; Mosconi L, 2004, J NEUROL NEUROSUR PS, V75, P370, DOI 10.1136/jnnp.2003.014993; Mosconi L, 2008, BIOL PSYCHIAT, V63, P609, DOI 10.1016/j.biopsych.2007.05.030; Mosconi L, 2010, J ALZHEIMERS DIS, V20, P843, DOI 10.3233/JAD-2010-091504; Ossenkoppele R, 2013, NEUROLOGY, V80, P359, DOI 10.1212/WNL.0b013e31827f0889; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Reiman EM, 2001, P NATL ACAD SCI USA, V98, P3334, DOI 10.1073/pnas.061509598; Sanabria-Diaz G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068860; Saykin AJ, 2004, BRAIN, V127, P1574, DOI 10.1093/brain/awh177; Scarmeas N, 2004, NEUROLOGY, V63, P913, DOI 10.1212/01.WNL.0000137274.93125.46; Schneider P, 2002, NAT NEUROSCI, V5, P688, DOI 10.1038/nn871; Schuit AJ, 2001, MED SCI SPORT EXER, V33, P772; Seo EH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083205; Seo EH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053922, 10.1371/journal.pone.0076875]; Shi J, 2014, HUM BRAIN MAPP, V35, P3903, DOI 10.1002/hbm.22447; Shi J, 2013, NEUROIMAGE, V78, P111, DOI 10.1016/j.neuroimage.2013.04.018; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Sporns O, 2004, NEUROINFORMATICS, V2, P145, DOI 10.1385/NI:2:2:145; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Trachtenberg AJ, 2012, NEUROIMAGE, V59, P565, DOI 10.1016/j.neuroimage.2011.07.059; Vanni S, 2001, P NATL ACAD SCI USA, V98, P2776, DOI 10.1073/pnas.041600898; Vincent JL, 2006, J NEUROPHYSIOL, V96, P3517, DOI 10.1152/jn.00048.2006; Wang K, 2007, HUM BRAIN MAPP, V28, P967, DOI 10.1002/hbm.20324; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Westlye ET, 2011, J NEUROSCI, V31, P7775, DOI 10.1523/JNEUROSCI.1230-11.2011; Yao ZJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001006; Zhu WL, 2012, NEUROBIOL AGING, V33, P899, DOI 10.1016/j.neurobiolaging.2010.06.022	63	27	27	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132300	10.1371/journal.pone.0132300	http://dx.doi.org/10.1371/journal.pone.0132300			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161964	gold, Green Published			2022-12-26	WOS:000358162300116
J	Zengin, T; Ekinci, B; Kucukkose, C; Yalcin-Ozuysal, O				Zengin, Talip; Ekinci, Burcu; Kucukkose, Cansu; Yalcin-Ozuysal, Ozden			IRF6 Is Involved in the Regulation of Cell Proliferation and Transformation in MCF10A Cells Downstream of Notch Signaling	PLOS ONE			English	Article							HUMAN BREAST-CANCER; EPITHELIAL-CELLS; P53 HOMOLOG; P63; DIFFERENTIATION; MICE; LIMB; IDENTIFICATION; COMMITMENT; ACTIVATION	IRF6, a member of Interferon Regulatory Factors (IRF) family, is involved in orofacial and epidermal development. In breast cancer cell lines ectopic expression of IRF6 reduces cell numbers suggesting a role as negative regulator of cell cycle. IRF6 is a direct target of canonical Notch signaling in keratinocyte differentiation. Notch is involved in luminal cell fate determination and stem cell regulation in the normal breast and is implicated as an oncogene in breast cancer. Notch activation is sufficient to induce proliferation and transformation in non-tumorigenic breast epithelial cell line, MCF10A. Delta Np63, which is downregulated by Notch activation in the breast, regulates IRF6 expression in keratinocytes. In this report, we investigate Notch-IRF6 and Delta Np63-IRF6 interactions in MCF10A and MDA MB 231 cells. We observed that in these cells, IRF6 expression is partially regulated by canonical Notch signaling and Delta Np63 downregulation. Furthermore, we demonstrate that IRF6 abrogation impairs Notch-induced proliferation and transformation in MCF10A cells. Thus, we confirm the previous findings by showing a tissue independent regulation of IRF6 by Notch signaling, and extend them by proposing a context dependent role for IRF6, which acts as a positive regulator of proliferation and transformation in MCF10A cells downstream of Notch signaling.	[Zengin, Talip; Ekinci, Burcu; Kucukkose, Cansu; Yalcin-Ozuysal, Ozden] Izmir Inst Technol, Dept Mol Biol & Genet, Izmir, Turkey	Izmir Institute of Technology	Yalcin-Ozuysal, O (corresponding author), Izmir Inst Technol, Dept Mol Biol & Genet, Izmir, Turkey.	ozdenyalcin@iyte.edu.tr	Zengin, Talip/AAR-2547-2021; Yalcin Ozuysal, Ozden/D-5528-2019	Zengin, Talip/0000-0003-4764-4615; Yalcin-Ozuysal, Ozden/0000-0003-0552-368X	Scientific and Technological Research Council of Turkey [110T895]; Izmir Institute of Technology	Scientific and Technological Research Council of Turkey(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); Izmir Institute of Technology(Izmir Institute of Technology)	This work was supported by the Scientific and Technological Research Council of Turkey, 110T895, (OYO), and the Izmir Institute of Technology, (OYO).	ALLEY MC, 1988, CANCER RES, V48, P589; Bailey CM, 2008, MOL CELL BIOL, V28, P2235, DOI 10.1128/MCB.01866-07; Bailey CM, 2009, DEV GROWTH DIFFER, V51, P473, DOI 10.1111/j.1440-169X.2009.01110.x; Bailey CM, 2005, J BIOL CHEM, V280, P34210, DOI 10.1074/jbc.M503523200; Biggs LC, 2012, J INVEST DERMATOL, V132, P50, DOI 10.1038/jid.2011.272; Botti E, 2011, P NATL ACAD SCI USA, V108, P13710, DOI 10.1073/pnas.1110931108; Bouras T, 2008, CELL STEM CELL, V3, P429, DOI 10.1016/j.stem.2008.08.001; Carroll DK, 2006, NAT CELL BIOL, V8, P551, DOI 10.1038/ncb1420; de la Garza G, 2013, J INVEST DERMATOL, V133, P68, DOI 10.1038/jid.2012.269; Dontu G, 2004, BREAST CANCER RES, V6, pR605, DOI 10.1186/bcr920; Dotto GP, 2008, ONCOGENE, V27, P5115, DOI 10.1038/onc.2008.225; GALLAHAN D, 1987, J VIROL, V61, P66, DOI 10.1128/JVI.61.1.66-74.1987; Gallahan D, 1997, ONCOGENE, V14, P1883, DOI 10.1038/sj.onc.1201035; Guo SC, 2011, BBA-REV CANCER, V1815, P197, DOI 10.1016/j.bbcan.2010.12.002; Han LF, 2014, CANCER RES, V74, P6509, DOI 10.1158/0008-5472.CAN-14-0816; Ingraham CR, 2006, NAT GENET, V38, P1335, DOI 10.1038/ng1903; Iwata J, 2013, DEVELOPMENT, V140, P1220, DOI 10.1242/dev.089615; Jiang RL, 1998, GENE DEV, V12, P1046, DOI 10.1101/gad.12.7.1046; Kondo S, 2002, NAT GENET, V32, P285, DOI 10.1038/ng985; Mangold E, 2011, TRENDS MOL MED, V17, P725, DOI 10.1016/j.molmed.2011.07.007; Mazzone M, 2010, P NATL ACAD SCI USA, V107, P5012, DOI 10.1073/pnas.1000896107; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Moretti F, 2010, J CLIN INVEST, V120, P1570, DOI 10.1172/JCI40267; Pece S, 2004, J CELL BIOL, V167, P215, DOI 10.1083/jcb.200406140; Ranganathan P, 2011, NAT REV CANCER, V11, P338, DOI 10.1038/nrc3035; Raouf A, 2008, CELL STEM CELL, V3, P109, DOI 10.1016/j.stem.2008.05.018; Reedijk M, 2005, CANCER RES, V65, P8530, DOI 10.1158/0008-5472.CAN-05-1069; Restivo G, 2011, EMBO J, V30, P4571, DOI 10.1038/emboj.2011.325; Richardson RJ, 2006, NAT GENET, V38, P1329, DOI 10.1038/ng1894; Richardson RJ, 2009, HUM MOL GENET, V18, P2632, DOI 10.1093/hmg/ddp201; Rinne T, 2007, CELL CYCLE, V6, P262, DOI 10.4161/cc.6.3.3796; Savitsky D, 2010, CANCER IMMUNOL IMMUN, V59, P489, DOI 10.1007/s00262-009-0804-6; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SOULE HD, 1990, CANCER RES, V50, P6075; Stylianou S, 2006, CANCER RES, V66, P1517, DOI 10.1158/0008-5472.CAN-05-3054; Sun YP, 2005, ONCOGENE, V24, P5365, DOI 10.1038/sj.onc.1208528; Thomason HA, 2010, J CLIN INVEST, V120, P1561, DOI 10.1172/JCI40266; Yalcin-Ozuysal O, 2010, CELL DEATH DIFFER, V17, P1600, DOI 10.1038/cdd.2010.37; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0	40	15	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132757	10.1371/journal.pone.0132757	http://dx.doi.org/10.1371/journal.pone.0132757			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161746	Green Submitted, Green Published, gold			2022-12-26	WOS:000358162300174
J	Chappell, J; Phillips, AC; van Noordwijk, MA; Setia, TM; Thorpe, SKS				Chappell, Jackie; Phillips, Abigail C.; van Noordwijk, Maria A.; Setia, Tatang Mitra; Thorpe, Susannah K. S.			The Ontogeny of Gap Crossing Behaviour in Bornean Orangutans (Pongo pygmaeus wurmbii)	PLOS ONE			English	Article							POSITIONAL BEHAVIOR; WILD ORANGUTANS; SUMATRAN ORANGUTANS; POSTURAL BEHAVIOR; LOCOMOTOR ECOLOGY; BODY SIZE; PRIMATES; INDONESIA; ABELII; COMPETENCE	For orangutans, the largest predominantly arboreal primates, discontinuous canopy presents a particular challenge. The shortest gaps between trees lie between thin peripheral branches, which offer the least stability to large animals. The affordances of the forest canopy experienced by orangutans of different ages however, must vary substantially as adult males are an order of magnitude larger in size than infants during the early stages of locomotor independence. Orangutans have developed a diverse range of locomotor behaviour to cross gaps between trees, which vary in their physical and cognitive demands. The aims of this study were to examine the ontogeny of orangutan gap crossing behaviours and to determine which factors influence the distance orangutans crossed. A non-invasive photographic technique was used to quantify forearm length as a measure of body size. We also recorded locomotor behaviour, support use and the distance crossed between trees. Our results suggest that gap crossing varies with both physical and cognitive development. More complex locomotor behaviours, which utilized compliant trunks and lianas, were used to cross the largest gaps, but these peaked in frequency much earlier than expected, between the ages of 4 and 5 years old, which probably reflects play behaviour to perfect locomotor techniques. Smaller individuals also crossed disproportionately large gaps relative to their size, by using support deformation. Our results suggest that orangutans acquire the full repertoire of gap crossing techniques, including the more cognitively demanding ones, before weaning, but adjust the frequency of the use of these techniques to their increasing body size.	[Chappell, Jackie; Phillips, Abigail C.; Thorpe, Susannah K. S.] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England; [van Noordwijk, Maria A.] Univ Zurich, Anthropol Inst & Museum, Zurich, Switzerland; [Setia, Tatang Mitra] Univ Nas, Fac Biol, Jakarta, Indonesia	University of Birmingham; University of Zurich; Universitas Nasional Pionir Perubahan	Thorpe, SKS (corresponding author), Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England.	S.K.Thorpe@bham.ac.uk	Chappell, Jackie/W-6772-2019	Chappell, Jackie/0000-0001-7338-9449; Thorpe, Susannah/0000-0002-6160-4452; Mitra Setia, Tatang/0000-0003-2667-5199	NERC [NE/H526427/1]; A.H. Schultz foundation; NERC [NE/F003307/1] Funding Source: UKRI; Natural Environment Research Council [NE/F003307/1] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); A.H. Schultz foundation; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was funded by NERC (NE/H526427/1; www.nerc.ac.uk) and the A.H. Schultz foundation, who provide major financial support for the Tuanan orangutan research project.	ADOLPH KE, 1993, CHILD DEV, V64, P1158, DOI 10.2307/1131332; ALEXANDER R M, 1991, Zeitschrift fuer Morphologie und Anthropologie, V78, P315; BARD KA, 1995, PRIMATES, V36, P297, DOI 10.1007/BF02382855; CANNON CH, 1994, AM J PHYS ANTHROPOL, V93, P505, DOI 10.1002/ajpa.1330930409; CANT JGH, 1992, AM J PHYS ANTHROPOL, V88, P273, DOI 10.1002/ajpa.1330880302; CANT JGH, 1987, AM J PHYS ANTHROPOL, V74, P143, DOI 10.1002/ajpa.1330740202; CANT JGH, 1987, AM J PRIMATOL, V12, P71, DOI 10.1002/ajp.1350120104; CANT JGH, 1994, CURRENT PRIMATOLOGY, V1, P187; CHEVALIERSKOLNIKOFF S, 1982, J HUM EVOL, V11, P639, DOI 10.1016/S0047-2484(82)80010-9; CHEVALIERSKOLNIKOFF S, 1983, J HUM EVOL, V12, P545, DOI 10.1016/S0047-2484(83)80034-7; DEMES B, 1995, AM J PHYS ANTHROPOL, V96, P419, DOI 10.1002/ajpa.1330960407; GEBO DL, 1992, AM J PRIMATOL, V26, P277, DOI 10.1002/ajp.1350260405; GIBSON EJ, 1988, ANNU REV PSYCHOL, V39, P1, DOI 10.1146/annurev.ps.39.020188.000245; GRAND TI, 1972, J MAMMAL, V53, P198, DOI 10.2307/1378849; Hunt KD, 1996, PRIMATES, V37, P363, DOI 10.1007/BF02381373; Jaeggi AV, 2010, AM J PRIMATOL, V72, P62, DOI 10.1002/ajp.20752; MACKINNON J, 1974, ANIM BEHAV, V22, P3, DOI 10.1016/S0003-3472(74)80054-0; Manduell KL, 2012, AM J PRIMATOL, V74, P1128, DOI 10.1002/ajp.22072; Manduell KL, 2011, AM J PHYS ANTHROPOL, V145, P348, DOI 10.1002/ajpa.21495; Manduell KL, 2012, THESIS U BIRMINGHAM; Myatt JP, 2011, AM J PHYS ANTHROPOL, V146, P73, DOI 10.1002/ajpa.21548; PALMER CF, 1989, DEV PSYCHOL, V25, P885, DOI 10.1037/0012-1649.25.6.885; Phillips AC, 2011, THESIS U BIRMINGHAM; Rothman JM, 2008, AM J PRIMATOL, V70, P1191, DOI 10.1002/ajp.20611; Schuppli C, 2012, J HUM EVOL, V63, P843, DOI 10.1016/j.jhevol.2012.08.009; SUGARDJITO J, 1986, FOLIA PRIMATOL, V47, P14, DOI 10.1159/000156260; TEMERIN LA, 1983, AM NAT, V122, P335, DOI 10.1086/284139; Thorpe SKS, 2007, BIOLOGY LETT, V3, P253, DOI 10.1098/rsbl.2007.0049; Thorpe SKS, 2005, AM J PHYS ANTHROPOL, V127, P58, DOI 10.1002/ajpa.20151; Thorpe SKS, 2006, AM J PHYS ANTHROPOL, V131, P384, DOI 10.1002/ajpa.20422; Thorpe SKS, 2009, P NATL ACAD SCI USA, V106, P12646, DOI 10.1073/pnas.0811537106; van Noordwijk MA, 2005, AM J PHYS ANTHROPOL, V127, P79, DOI 10.1002/ajpa.10426; van Noordwijk MA, 2013, BEHAV ECOL SOCIOBIOL, V67, P805, DOI 10.1007/s00265-013-1504-y; van Noordwijk Maria A., 2009, P189; van Schaik CP, 2005, PRIMATES, V46, P249, DOI 10.1007/s10329-005-0134-z; Wich SA, 2004, J HUM EVOL, V47, P385, DOI 10.1016/j.jhevol.2004.08.006	36	14	14	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0130291	10.1371/journal.pone.0130291	http://dx.doi.org/10.1371/journal.pone.0130291			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154061	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000358159700029
J	van der Zee, R; Gray, A; Pisa, L; de Rijk, T				van der Zee, Romee; Gray, Alison; Pisa, Lennard; de Rijk, Theo			An Observational Study of Honey Bee Colony Winter Losses and Their Association with Varroa destructor, Neonicotinoids and Other Risk Factors	PLOS ONE			English	Article							APIS-MELLIFERA; INSECTICIDES; POLLEN; TOXICITY; RESIDUES	This article presents results of an analysis of honey bee losses over the winter of 2011-2012 in the Netherlands, from a sample of 86 colonies, located at 43 apiaries. The apiaries were selected using spatially stratified random sampling. Colony winter loss data were collected and related to various measures of colony strength recorded in summer, as well as data from laboratory analysis of sample material taken from two selected colonies in each of the 43 apiaries. The logistic regression model which best explained the risk of winter loss included, in order of statistical importance, the variables (1) Varroa destructor mite infestation rate in October 2011, (2) presence of the cyano-substituted neonicotinoids acetamiprid or thiacloprid in the first 2 weeks of August 2011 in at least one of the honey bee matrices honey, bees or bee bread (pollen), (3) presence of Brassica napus (oilseed rape) or Sinapis arvensis (wild mustard) pollen in bee bread in early August 2011, and (4) a measure of the unexplained winter losses for the postal code area where the colonies were located, obtained from a different dataset. We consider in the discussion that reduced opportunities for foraging in July and August because of bad weather may have added substantially to the adverse effects of acetamiprid and thiacloprid. A novel feature of this work is its use of postal code random effects from two other independent datasets collected in the annual national monitoring by questionnaires of winter losses of honey bees in the Netherlands. These were used to plan the sample selection and also in the model fitting of the data in this study. It should however be noted that the results of the present pilot study are based on limited data, which may consequently reveal strong factors but fail to demonstrate possible interaction effects.	[van der Zee, Romee; Pisa, Lennard] Netherlands Ctr Bee Res, Tersoal, Netherlands; [Gray, Alison] Univ Strathclyde, Dept Math & Stat, Glasgow, Lanark, Scotland; [de Rijk, Theo] RIKILT Wageningen UR, Inst Food Safety, Wageningen, Netherlands	University of Strathclyde; Wageningen University & Research	van der Zee, R (corresponding author), Netherlands Ctr Bee Res, Tersoal, Netherlands.	romee.van.der.zee@beemonitoring.org	Gray, Alison/GWQ-4596-2022; Gray, Alison/L-1063-2017	Gray, Alison/0000-0002-6273-0637	Dutch Ministry of Economic Affairs	Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands)	This research was funded by an award from the Dutch Ministry of Economic Affairs (http://www.government.nl/ministries/ez). The funders had no role in study design, data collection or analysis, decision to publish or manuscript preparation.	Becher MA, 2013, J APPL ECOL, V50, P868, DOI 10.1111/1365-2664.12112; Blacquiere T, 2012, ECOTOXICOLOGY, V21, P973, DOI 10.1007/s10646-012-0863-x; Bleker H, 2011, BEANTWOORDING VRAGEN; Botias C, 2012, ENVIRON MICROBIOL, V14, P845, DOI 10.1111/j.1462-2920.2011.02647.x; CBS PBL Wageningen UR, 2011, GERBRUIK GEWASBESCHE; Chantawannakul P, 2006, J INVERTEBR PATHOL, V91, P69, DOI 10.1016/j.jip.2005.11.001; Chauzat MP, 2009, ENVIRON ENTOMOL, V38, P514, DOI 10.1603/022.038.0302; Drager K, 2012, LANG VAR CHANGE, V24, P59, DOI 10.1017/S0954394512000014; FLURI P, 1982, J INSECT PHYSIOL, V28, P61, DOI 10.1016/0022-1910(82)90023-3; Genersch E, 2010, APIDOLOGIE, V41, P332, DOI 10.1051/apido/2010014; Goulson D, 2013, J APPL ECOL, V50, P977, DOI 10.1111/1365-2664.12111; Iwasa T, 2004, CROP PROT, V23, P371, DOI 10.1016/j.cropro.2003.08.018; Jeschke P, 2011, J AGR FOOD CHEM, V59, P2897, DOI 10.1021/jf101303g; Kleijn D, 2008, ECOLOGY, V89, P1811, DOI 10.1890/07-1275.1; Laurino D, 2011, B INSECTOL, V64, P107; Liebig G., 2001, APIDOLOGIE, V32, P484, DOI [10.1051/apido:2001156, DOI 10.1051/APIDO:2001156]; Maccagnani B., 2008, Informatore Agrario, V64, P53; Nguyen BK, 2009, J ECON ENTOMOL, V102, P616, DOI 10.1603/029.102.0220; OIE Terrestrial Manual, 2008, OIE TERRESTRIAL MANU, P428; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ramirez-Romero R, 2005, APIDOLOGIE, V36, P601, DOI 10.1051/apido:2005039; Ravoet J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072443; Retschnig G, 2015, ENVIRON MICROBIOL, V17, P4322, DOI 10.1111/1462-2920.12825; Rijksinstituut voor Volksgezondheid en Milieu ( RIVM), 2013, MIN HLTH WELF SPORT; Rortais A, 2005, APIDOLOGIE, V36, P71, DOI 10.1051/apido:2004071; SANCO, SANCO125712013; Simon-Delso N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103073; Van Der Zee R, 2011, NCB REPORTS MONITOR; Van Der Zee R, 2013, NCB REPORTS MONITOR; Van Der Zee R, 2012, NCB REPORTS MONITOR; van der Zee R, 2014, J APICULT RES, V53, P19, DOI 10.3896/IBRA.1.53.1.02; van der Zee R, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.4.18; van der Zee R, 2012, J APICULT RES, V51, P91, DOI 10.3896/IBRA.1.51.1.12; van der Zee R, 2010, J APICULT RES, V49, P121, DOI 10.3896/IBRA.1.49.1.25; Van Dijk TC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062374; van Dooremalen C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036285; Wallner K, 1999, APIDOLOGIE, V30, P235, DOI 10.1051/apido:19990212; WILLE H, 1985, REV SUISSE ZOOL, V92, P897, DOI 10.5962/bhl.part.81921; Wille M, 1983, BIENENZTG, V5, P253; Zuur Alain F., 2009, P1	40	47	50	3	108	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0131611	10.1371/journal.pone.0131611	http://dx.doi.org/10.1371/journal.pone.0131611			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154346	gold, Green Published			2022-12-26	WOS:000358159700074
J	Acosta-Herrera, M; Lorenzo-Diaz, F; Pino-Yanes, M; Corrales, A; Valladares, F; Klassert, TE; Valladares, B; Slevogt, H; Ma, SF; Villar, J; Flores, C				Acosta-Herrera, Marialbert; Lorenzo-Diaz, Fabian; Pino-Yanes, Maria; Corrales, Almudena; Valladares, Francisco; Klassert, Tilman E.; Valladares, Basilio; Slevogt, Hortense; Ma, Shwu-Fan; Villar, Jesus; Flores, Carlos			Lung Transcriptomics during Protective Ventilatory Support in Sepsis-Induced Acute Lung Injury	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; GENE-EXPRESSION; MECHANICAL VENTILATION; NEUROEPITHELIAL BODIES; ANGIOGENESIS; RESPONSES; MODELS; MICROARRAYS; VALIDATION; RECEPTORS	Acute lung injury (ALI) is a severe inflammatory process of the lung. The only proven life-saving support is mechanical ventilation (MV) using low tidal volumes (LVT) plus moderate to high levels of positive end-expiratory pressure (PEEP). However, it is currently unknown how they exert the protective effects. To identify the molecular mechanisms modulated by protective MV, this study reports transcriptomic analyses based on microarray and microRNA sequencing in lung tissues from a clinically relevant animal model of sepsis-induced ALI. Sepsis was induced by cecal ligation and puncture (CLP) in male Sprague-Dawley rats. At 24 hours post-CLP, septic animals were randomized to three ventilatory strategies: spontaneous breathing, LVT (6 ml/kg) plus 10 cmH(2)O PEEP and high tidal volume (HVT, 20 ml/kg) plus 2 cmH2O PEEP. Healthy, non-septic, non-ventilated animals served as controls. After 4 hours of ventilation, lung samples were obtained for histological examination and gene expression analysis using microarray and microRNA sequencing. Validations were assessed using parallel analyses on existing publicly available genome-wide association study findings and transcriptomic human data. The catalogue of deregulated processes differed among experimental groups. The 'response to microorganisms' was the most prominent biological process in septic, non-ventilated and in HVT animals. Unexpectedly, the 'neuron projection morphogenesis' process was one of the most significantly deregulated in LVT. Further support for the key role of the latter process was obtained by microRNA studies, as four species targeting many of its genes (Mir-27a, Mir-103, Mir-17-5p and Mir-130a) were found deregulated. Additional analyses revealed 'VEGF signaling' as a central underlying response mechanism to all the septic groups (spontaneously breathing or mechanically ventilated). Based on this data, we conclude that a co-deregulation of 'VEGF signaling' along with 'neuron projection morphogenesis', which have been never anticipated in ALI pathogenesis, promotes lung-protective effects of LVT with high levels of PEEP.	[Acosta-Herrera, Marialbert; Lorenzo-Diaz, Fabian; Pino-Yanes, Maria; Corrales, Almudena; Valladares, Francisco; Villar, Jesus; Flores, Carlos] Inst Salud Carlos III, CIBER Enfermedades Resp, Madrid, Spain; [Acosta-Herrera, Marialbert; Lorenzo-Diaz, Fabian; Pino-Yanes, Maria; Corrales, Almudena; Flores, Carlos] Hosp Univ NS Candelaria, Res Unit, Santa Cruz De Tenerife, Spain; [Acosta-Herrera, Marialbert; Villar, Jesus] Hosp Univ Dr Negrin, Res Unit, Las Palmas Gran Canaria, Spain; [Lorenzo-Diaz, Fabian; Valladares, Basilio; Flores, Carlos] Univ La Laguna, Inst Univ Enfermedades Trop & Salud Publ Canarias, Santa Cruz De Tenerife, Spain; [Pino-Yanes, Maria] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Valladares, Francisco] Univ La Laguna, Dept Anat Pathol & Histol, Santa Cruz De Tenerife, Spain; [Klassert, Tilman E.; Slevogt, Hortense] Jena Univ Hosp, Sept Res Ctr, Jena, Germany; [Ma, Shwu-Fan] Univ Chicago, Sect Pulm & Crit Care Med, Chicago, IL 60637 USA; [Villar, Jesus] St Michaels Hosp, Li KaShing Knowledge Inst, Keenan Res Ctr Biomed Sci, Toronto, ON M5B 1W8, Canada	CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III; Universidad de la Laguna; University of California System; University of California San Francisco; Universidad de la Laguna; Friedrich Schiller University of Jena; University of Chicago; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Flores, C (corresponding author), Inst Salud Carlos III, CIBER Enfermedades Resp, Madrid, Spain.	cflores@ull.edu.es	Diaz, Fabian Lorenzo/M-2259-2016; Flores, Carlos/R-1159-2019; Villar, Jesús/R-4526-2019; Pino-Yanes, Maria/C-8498-2017; Corrales, Almudena/G-5391-2017	Diaz, Fabian Lorenzo/0000-0002-3398-198X; Villar, Jesús/0000-0001-5687-3562; Pino-Yanes, Maria/0000-0003-0332-437X; Corrales, Almudena/0000-0002-2207-5463; Flores, Carlos/0000-0001-5352-069X	Instituto de Salud Carlos III, Spain [CB06/06/1088, PI10/0393, PI14/00844]; European Regional Development Funds; European Union; Instituto de Salud Carlos III [FI11/00074, CD13/00304]; Fundacion Ramon Areces; German Research Foundation (Collaborative Research Center) [Transregio 124, A5]; German Federal Ministry of Education and Research (BMBF) [03Z2JN22]	Instituto de Salud Carlos III, Spain(Instituto de Salud Carlos III); European Regional Development Funds(European Commission); European Union(European Commission); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Fundacion Ramon Areces; German Research Foundation (Collaborative Research Center)(German Research Foundation (DFG)); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by CB06/06/1088, PI10/0393 and PI14/00844 from Instituto de Salud Carlos III, Spain, and co-financed by the European Regional Development Funds, "A way of making Europe" from the European Union to JV and CF. MAH and FLD were supported with fellowships from Instituto de Salud Carlos III (FI11/00074 and Sara Borrell CD13/00304, respectively). MPY was funded by Fundacion Ramon Areces. TEK and HS were supported by the German Research Foundation (Collaborative Research Center/Transregio 124, A5) and the German Federal Ministry of Education and Research (BMBF 03Z2JN22). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Herrera M, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00020; Adriaensen D, 2006, J APPL PHYSIOL, V101, P960, DOI 10.1152/japplphysiol.00267.2006; Altemeier WA, 2004, AM J PHYSIOL-LUNG C, V287, pL533, DOI 10.1152/ajplung.00004.2004; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barratt S, 2014, RESPIRATION, V87, P329, DOI 10.1159/000356034; Becker PM, 2001, AM J PHYSIOL-LUNG C, V281, pL1500, DOI 10.1152/ajplung.2001.281.6.L1500; Bigham A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001116; Bregeon F, 2005, ANESTHESIOLOGY, V102, P331; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Christie JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028268; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Copland IB, 2003, AM J RESP CRIT CARE, V168, P1051, DOI 10.1164/rccm.200208-964OC; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; de Paulis A, 2006, J IMMUNOL, V177, P7322, DOI 10.4049/jimmunol.177.10.7322; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; dos Santos CC, 2004, PHYSIOL GENOMICS, V19, P331, DOI 10.1152/physiolgenomics.00153.2004; Eichstaedt CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093314; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gharib SA, 2006, AM J RESP CRIT CARE, V173, P653, DOI 10.1164/rccm.200509-1473OC; Glaab E, 2012, BIOINFORMATICS, V28, pI451, DOI 10.1093/bioinformatics/bts389; Grigoryev DN, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-r34; Herrera MT, 2003, INTENS CARE MED, V29, P1345, DOI 10.1007/s00134-003-1756-5; Hoshino M, 2001, J ALLERGY CLIN IMMUN, V107, P1034, DOI 10.1067/mai.2001.115626; Howrylak JA, 2009, PHYSIOL GENOMICS, V37, P133, DOI 10.1152/physiolgenomics.90275.2008; Huang CQ, 2014, BMC MED GENOMICS, V7, DOI 10.1186/1755-8794-7-46; HUDSON LD, 1995, AM J RESP CRIT CARE, V151, P293, DOI 10.1164/ajrccm.151.2.7842182; Isella C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-382; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Larrivee B, 2009, CIRC RES, V104, P428, DOI 10.1161/CIRCRESAHA.108.188144; Liu J, 2014, RESP PHYSIOL NEUROBI, V193, P52, DOI 10.1016/j.resp.2014.01.002; Madala SK, 2012, AM J RESP CELL MOL, V46, P380, DOI 10.1165/rcmb.2011-0237OC; Morey JS, 2006, BIOL PROCED ONLINE, V8, P175, DOI 10.1251/bpo126; Nagy JA, 2003, TRENDS CARDIOVAS MED, V13, P169, DOI 10.1016/S1050-1738(03)00056-2; PARKER JC, 1993, CRIT CARE MED, V21, P131, DOI 10.1097/00003246-199301000-00024; Pogach MS, 2007, J CELL BIOCHEM, V100, P1415, DOI 10.1002/jcb.21142; Poli-De-Figueiredo LF, 2008, SHOCK, V30, P53, DOI 10.1097/SHK.0b013e318181a343; R Core Team, 2019, R LANG ENV STAT COMP; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Reynolds SD, 2000, AM J PATHOL, V156, P269, DOI 10.1016/S0002-9440(10)64727-X; Rittirsch D, 2009, NAT PROTOC, V4, P31, DOI 10.1038/nprot.2008.214; Segura I, 2009, TRENDS MOL MED, V15, P439, DOI 10.1016/j.molmed.2009.08.005; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thickett DR, 2002, AM J RESP CRIT CARE, V166, P1332, DOI 10.1164/rccm.2105057; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Ushio-Fukai M, 2006, CARDIOVASC RES, V71, P226, DOI 10.1016/j.cardiores.2006.04.015; Villar J, 2011, INTENS CARE MED, V37, P1932, DOI 10.1007/s00134-011-2380-4; Villar J, 2011, INTENS CARE MED, V37, P1201, DOI 10.1007/s00134-011-2234-0; Villar J, 2010, INTENS CARE MED, V36, P1049, DOI 10.1007/s00134-010-1799-3; Villar J, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-27; Villar J, 2009, ANESTHESIOLOGY, V110, P1341, DOI 10.1097/ALN.0b013e31819fcba9; Wang HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038885; Wurfel Mark M, 2007, Proc Am Thorac Soc, V4, P77, DOI 10.1513/pats.200608-149JG; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Xing GQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002342; Yang GH, 2015, GENE, V562, P138, DOI 10.1016/j.gene.2015.02.065; Zacchigna S, 2008, NAT REV NEUROSCI, V9, P169, DOI 10.1038/nrn2336; Zhang R, 2015, AM J RESP CRIT CARE	59	20	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132296	10.1371/journal.pone.0132296	http://dx.doi.org/10.1371/journal.pone.0132296			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147972	Green Published, gold, Green Submitted			2022-12-26	WOS:000358157600234
J	Hinton, JW; van Manen, FT; Chamberlain, MJ				Hinton, Joseph W.; van Manen, Frank T.; Chamberlain, Michael J.			Space Use and Habitat Selection by Resident and Transient Coyotes (Canis latrans)	PLOS ONE			English	Article							HOME-RANGE; RED WOLF; BODY-SIZE; BEHAVIORAL-RESPONSES; NATIONAL-PARK; SPATIAL-USE; DISPERSAL; SURVIVAL; MOVEMENTS; PATTERNS	Little information exists on coyote (Canis latrans) space use and habitat selection in the southeastern United States and most studies conducted in the Southeast have been carried out within small study areas (e.g., <= 1,000 km(2)). Therefore, studying the placement, size, and habitat composition of coyote home ranges over broad geographic areas could provide relevant insights regarding how coyote populations adjust to regionally varying ecological conditions. Despite an increasing number of studies of coyote ecology, few studies have assessed the role of transiency as a life-history strategy among coyotes. During 2009-2011, we used GPS radio-telemetry to study coyote space use and habitat selection on the Albemarle Peninsula of northeastern North Carolina. We quantified space use and 2nd- and 3rd-order habitat selection for resident and transient coyotes to describe space use patterns in a predominantly agricultural landscape. The upper limit of coyote home-range size was approximately 47 km(2) and coyotes exhibiting shifting patterns of space use of areas >65 km(2) were transients. Transients exhibited localized space use patterns for short durations prior to establishing home ranges, which we defined as "biding" areas. Resident and transient coyotes demonstrated similar habitat selection, notably selection of agricultural over forested habitats. However, transients exhibited stronger selection for roads than resident coyotes. Although transient coyotes are less likely to contribute reproductively to their population, transiency may be an important life history trait that facilitates metapopulation dynamics through dispersal and the eventual replacement of breeding residents lost to mortality.	[Hinton, Joseph W.; Chamberlain, Michael J.] Univ Georgia, Warnell Sch Forestry & Nat Resources, Athens, GA 30602 USA; [van Manen, Frank T.] US Geol Survey, Northern Rocky Mt Sci Ctr, Interagency Grizzly Bear Study Team, Bozeman, MT USA	University System of Georgia; University of Georgia; United States Department of the Interior; United States Geological Survey	Hinton, JW (corresponding author), Univ Georgia, Warnell Sch Forestry & Nat Resources, Athens, GA 30602 USA.	jhinton@uga.edu		T. van Manen, Frank/0000-0001-5340-8489	U.S. Fish and Wildlife Service Red Wolf Recovery Program	U.S. Fish and Wildlife Service Red Wolf Recovery Program	We particularly appreciate the support of the U.S. Fish and Wildlife Service Red Wolf Recovery Program, specifically R. Bartel, A. Beyer, C. Lucash, F. Mauney, M. Morse, R. Nordsven, and D. Rabon. We thank Weyerhaeuser Company for providing access to their properties. The findings and conclusions in this article are those of the authors and do not necessarily represent the views of the U.S. Fish and Wildlife Service or Weyerhaeuser Company. Any use of trade, product, or firm names is for descriptive purposes only and does not imply endorsement by the U.S. Government. We thank E. Beever for review of this manuscript for the U.S. Geological Survey's Fundamental Science Practices.	Abbott KC, 2011, ECOL LETT, V14, P1158, DOI 10.1111/j.1461-0248.2011.01670.x; ANDELT WF, 1985, WILDLIFE MONOGR, P1; Arjo WM, 1999, CAN J ZOOL, V77, P1919, DOI 10.1139/z99-177; BAKER M, 1995, CONDOR, V97, P663, DOI 10.2307/1369175; BASSET A, 1995, ECOLOGY, V76, P1027, DOI 10.2307/1940913; BEKOFF M, 1980, SCI AM, V242, P130, DOI 10.1038/scientificamerican0480-130; BEKOFF M, 1981, OECOLOGIA, V50, P386, DOI 10.1007/BF00344981; Bekoff M, 2003, WILD MAMMALS N AM BI, P467; Benson JF, 2015, OIKOS, V124, P1664, DOI 10.1111/oik.01883; Benson JF, 2013, METHODS ECOL EVOL, V4, P244, DOI 10.1111/2041-210x.12006; BOWEN WD, 1982, J WILDLIFE MANAGE, V46, P201, DOI 10.2307/3808423; Boyce MS, 2002, ECOL MODEL, V157, P281, DOI 10.1016/S0304-3800(02)00200-4; Bromley C, 2001, J WILDLIFE MANAGE, V65, P510, DOI 10.2307/3803104; Burnham KP, 2007, MODEL SELECTION MULT; Byrne ME, 2014, J ANIM ECOL, V83, P1234, DOI 10.1111/1365-2656.12205; Camenzind F.J., 1978, P267; Chamberlain MJ, 2000, CAN J ZOOL, V78, P2087, DOI 10.1139/cjz-78-12-2087; Collier B, 2013, MOVEUD CREATES DYNAM; Crete M, 2001, ECOSCIENCE, V8, P311, DOI 10.1080/11956860.2001.11682658; Dellinger JA, 2013, BIOL CONSERV, V157, P324, DOI 10.1016/j.biocon.2012.09.004; Frair JL, 2010, PHILOS T R SOC B, V365, P2187, DOI 10.1098/rstb.2010.0084; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; GASTON AJ, 1978, AM NAT, V112, P1091, DOI 10.1086/283348; Geffen E, 1996, AM NAT, V147, P140, DOI 10.1086/285844; Gehrt SD, 2009, J MAMMAL, V90, P1045, DOI 10.1644/08-MAMM-A-277.1; Gelman A, 2008, STAT MED, V27, P2865, DOI 10.1002/sim.3107; GESE EM, 1988, J WILDLIFE MANAGE, V52, P640, DOI 10.2307/3800923; Gese EM, 2001, CAN J ZOOL, V79, P980, DOI 10.1139/cjz-79-6-980; Gese EM, 2015, CURR ZOOL, V61, P191, DOI 10.1093/czoolo/61.1.191; Gier H. T., 1968, AGR EXPT STATION B, V393, P1; Gittleman J.L., 1989, P183; GOMPPER ME, 1991, OECOLOGIA, V87, P343, DOI 10.1007/BF00634589; Gosselink TE, 2003, J WILDLIFE MANAGE, V67, P90, DOI 10.2307/3803065; Hackshaw A, 2008, EUR RESPIR J, V32, P1141, DOI 10.1183/09031936.00136408; HANSKI I, 1991, BIOL J LINN SOC, V42, P3, DOI 10.1111/j.1095-8312.1991.tb00548.x; Hinton J. W., 2014, THESIS; Hinton JW, 2014, J MAMMAL, V95, P855, DOI 10.1644/13-MAMM-A-202; Hinton Joseph W., 2013, Animals, V3, P722, DOI 10.3390/ani3030722; Hinton JW, 2012, AM MIDL NAT, V168, P281; Hirzel AH, 2006, ECOL MODEL, V199, P142, DOI 10.1016/j.ecolmodel.2006.05.017; HOLZMAN S, 1992, J WILDLIFE MANAGE, V56, P139, DOI 10.2307/3808801; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.2307/2336663; James ARC, 2000, J WILDLIFE MANAGE, V64, P154, DOI 10.2307/3802985; Johnson CJ, 2006, J WILDLIFE MANAGE, V70, P347, DOI 10.2193/0022-541X(2006)70[347:RSFBOU]2.0.CO;2; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; Kamler JF, 2000, CAN J ZOOL, V78, P2106, DOI 10.1139/cjz-78-12-2106; Kamler JF, 2005, AM MIDL NAT, V153, P396, DOI 10.1674/0003-0031(2005)153[0396:HRAHUO]2.0.CO;2; Karlin M, 2012, J ZOOL, V286, P266, DOI 10.1111/j.1469-7998.2011.00876.x; Kleiman DG, 2011, BEHAV GENET, V41, P803, DOI 10.1007/s10519-011-9459-0; Kranstauber B., 2013, MOVE VISUALIZING ANA; Leopold B.D., 2001, WILDLIFE SO FORESTS, P248; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Manly B.F.J., 2002, RESOURCE SELECTION A; McKerrow AJ, 2006, N CAROLINA GAP ANAL; MCNAB BK, 1963, AM NAT, V97, P133, DOI 10.1086/282264; Pearce J, 2000, ECOL MODEL, V133, P225, DOI 10.1016/S0304-3800(00)00322-7; PERSON DK, 1991, J WILDLIFE MANAGE, V55, P433, DOI 10.2307/3808971; R Core Team, 2021, R LANGUAGE ENV STAT; Sacks BN, 1999, J WILDLIFE MANAGE, V63, P593, DOI 10.2307/3802648; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Schrecengost JD, 2009, AM MIDL NAT, V162, P346, DOI 10.1674/0003-0031-162.2.346; Seidler RG, 2012, J ETHOL, V30, P345, DOI 10.1007/s10164-012-0330-4; SWIHART RK, 1988, ECOLOGY, V69, P393, DOI 10.2307/1940437; TAYLOR AD, 1990, ECOLOGY, V71, P429, DOI 10.2307/1940297; Tigas LA, 2002, BIOL CONSERV, V108, P299, DOI 10.1016/S0006-3207(02)00120-9; Van Deelen TR, 2006, CAN J ZOOL, V84, P1630, DOI 10.1139/Z06-170; Way JG, 2009, CAN FIELD NAT, V123, P206, DOI 10.22621/cfn.v123i3.965; Whittington J, 2005, ECOL APPL, V15, P543, DOI 10.1890/03-5317; WINDBERG LA, 1988, J WILDLIFE MANAGE, V52, P632, DOI 10.2307/3800922; Zar J.H., 1999, ZAR KUHR 5 2019, V4th	70	55	57	2	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132203	10.1371/journal.pone.0132203	http://dx.doi.org/10.1371/journal.pone.0132203			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148130	Green Published, Green Submitted, gold			2022-12-26	WOS:000358157600218
J	Krueger, MC; Hofmann, U; Moeder, M; Schlosser, D				Krueger, Martin C.; Hofmann, Ulrike; Moeder, Monika; Schlosser, Dietmar			Potential of Wood-Rotting Fungi to Attack Polystyrene Sulfonate and Its Depolymerisation by Gloeophyllum trabeum via Hydroquinone-Driven Fenton Chemistry	PLOS ONE			English	Article							BROWN-ROT FUNGUS; POLYVINYL-ALCOHOL; FLUOROQUINOLONE ENROFLOXACIN; DEGRADATION; LIGNIN; HYDROXYL; LACCASE; BIODEGRADATION; OXIDATION; 2,5-DIMETHOXYHYDROQUINONE	Synthetic polymers often pose environmental hazards due to low biodegradation rates and resulting accumulation. In this study, a selection of wood-rotting fungi representing different lignocellulose decay types was screened for oxidative biodegradation of the polymer polystyrene sulfonate (PSS). Brown-rot basidiomycetes showed PSS depolymerisation of up to 50% reduction in number-average molecular mass (M-n) within 20 days. In-depth investigations with the most efficient depolymeriser, a Gloeophyllum trabeum strain, pointed at extracellular hydroquinone-driven Fenton chemistry responsible for depolymerisation. Detection of hydroxyl radicals present in the culture supernatants showed good compliance with depolymerisation over the time course of PSS degradation. 2,5-Dimethoxy-1,4-hydroquinone (2,5-DMHQ), which was detected in supernatants of active cultures via liquid chromatography and mass spectrometry, was demonstrated to drive the Fenton processes in G. trabeum cultures. Up to 80% reduction in Mn of PSS where observed when fungal cultures were additionally supplemented with 2,5-dimethoxy benzoquinone, the oxidized from of 2,5-DMHQ. Furthermore, 2,5-DMHQ could initiate the Fenton's reagent-mediated PSS depolymerisation in cell-free systems. In contrast, white-rot fungi were unable to cause substantial depolymerising effects despite the expression of lignin-modifying exo-enzymes. Detailed investigations with laccase from Trametes versicolor revealed that only in presence of certain redox mediators limited PSS depolymerisation occurred. Our results indicate that brown-rot fungi might be suitable organisms for the biodegradation of recalcitrant synthetic polymeric pollutants.	[Krueger, Martin C.; Hofmann, Ulrike; Schlosser, Dietmar] UFZ Helmholtz Ctr Environm Res, Dept Environm Microbiol, Leipzig, Germany; [Moeder, Monika] UFZ Helmholtz Ctr Environm Res, Dept Analyt Chem, Leipzig, Germany	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Helmholtz Association; Helmholtz Center for Environmental Research (UFZ)	Schlosser, D (corresponding author), UFZ Helmholtz Ctr Environm Res, Dept Environm Microbiol, Leipzig, Germany.	dietmar.schlosser@ufz.de		Schlosser, Dietmar/0000-0003-1353-8136; Krueger, Martin/0000-0001-8613-5800; Moeder, Monika/0000-0002-1154-9168	European Commission [312100]; Helmholtz Association	European Commission(European CommissionEuropean Commission Joint Research Centre); Helmholtz Association(Helmholtz Association)	The European Commission provided resources for this research as part of the BIOCLEAN project under the 7th Framework Programme (EC grant agreement 312100). This work was further supported by the Helmholtz Association and contributes to the integrated project `Controlling Chemicals' Fate' in the CITE (Chemicals In The Environment) research program conducted at the Helmholtz Centre for Environmental Research - UFZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cole M, 2011, MAR POLLUT BULL, V62, P2588, DOI 10.1016/j.marpolbul.2011.09.025; Deguchi T, 1998, APPL ENVIRON MICROB, V64, P1366; Deguchi T, 1997, APPL ENVIRON MICROB, V63, P329, DOI 10.1128/AEM.63.1.329-331.1997; Dockheer SM, 2013, PHYS CHEM CHEM PHYS, V15, P4975, DOI 10.1039/c3cp44341h; Dockheer SM, 2010, PHYS CHEM CHEM PHYS, V12, P11609, DOI 10.1039/c0cp00082e; Fahr K, 1999, FEMS MICROBIOL LETT, V175, P127, DOI 10.1111/j.1574-6968.1999.tb13611.x; Feng HM, 2011, ENVIRON SCI TECHNOL, V45, P744, DOI 10.1021/es102182g; Fichou D., 1999, HDB OLIGO POLYTHIOPH; Floudas D, 2012, SCIENCE, V336, P1715, DOI 10.1126/science.1221748; Friedrich J, 2007, CHEMOSPHERE, V67, P2089, DOI 10.1016/j.chemosphere.2006.09.038; Fujisawa M, 2001, J POLYM ENVIRON, V9, P103, DOI 10.1023/A:1020472426516; Giardina P, 2010, CELL MOL LIFE SCI, V67, P369, DOI 10.1007/s00018-009-0169-1; Gomez-Toribio V, 2009, APPL ENVIRON MICROB, V75, P3944, DOI 10.1128/AEM.02137-08; Gusse AC, 2006, ENVIRON SCI TECHNOL, V40, P4196, DOI 10.1021/es060408h; Gutierrez A, 2012, BIORESOURCE TECHNOL, V119, P114, DOI 10.1016/j.biortech.2012.05.112; GUTTERIDGE JMC, 1984, BIOCHEM J, V224, P761, DOI 10.1042/bj2240761; HALLIWELL B, 1981, FEBS LETT, V128, P347, DOI 10.1016/0014-5793(81)80114-7; Harms H, 2011, NAT REV MICROBIOL, V9, P177, DOI 10.1038/nrmicro2519; Hofer C, 1999, FEBS LETT, V451, P186, DOI 10.1016/S0014-5793(99)00566-9; Hofrichter M, 2010, APPL MICROBIOL BIOT, V87, P871, DOI 10.1007/s00253-010-2633-0; Huang MH, 2002, J ENVIRON SCI HEAL A, V37, P29, DOI 10.1081/ESE-100108480; Inagaki Y, 1999, LANGMUIR, V15, P4171, DOI 10.1021/la981185e; Jahangiri E, 2014, MOLECULES, V19, P11860, DOI 10.3390/molecules190811860; Jensen KA, 2001, APPL ENVIRON MICROB, V67, P2705, DOI 10.1128/AEM.67.6.2705-2711.2001; Junghanns C, 2005, MICROBIOL-SGM, V151, P45, DOI 10.1099/mic.0.27431-0; Kawai F, 2009, APPL MICROBIOL BIOT, V84, P227, DOI 10.1007/s00253-009-2113-6; Kerem Z, 1998, P NATL ACAD SCI USA, V95, P10373, DOI 10.1073/pnas.95.18.10373; Kerem Z, 1999, FEBS LETT, V446, P49, DOI 10.1016/S0014-5793(99)00180-5; KLANING UK, 1985, J PHYS CHEM-US, V89, P760, DOI 10.1021/j100251a008; Korripally P, 2013, APPL ENVIRON MICROB, V79, P2377, DOI 10.1128/AEM.03880-12; Kramer C, 2004, APPL MICROBIOL BIOT, V64, P387, DOI 10.1007/s00253-003-1445-x; Larking DM, 1999, APPL ENVIRON MICROB, V65, P1798; Martens R, 1996, APPL ENVIRON MICROB, V62, P4206, DOI 10.1128/AEM.62.11.4206-4209.1996; Paszczynski A, 1999, APPL ENVIRON MICROB, V65, P674; Ruiz-Duenas FJ, 2009, MICROB BIOTECHNOL, V2, P164, DOI 10.1111/j.1751-7915.2008.00078.x; Salvachua D, 2013, APPL ENVIRON MICROB, V79, P4316, DOI 10.1128/AEM.00699-13; Schlosser D, 2002, APPL ENVIRON MICROB, V68, P3514, DOI 10.1128/AEM.68.7.3514-3521.2002; Shah AA, 2008, BIOTECHNOL ADV, V26, P246, DOI 10.1016/j.biotechadv.2007.12.005; Sterns RH, 2010, J AM SOC NEPHROL, V21, P733, DOI 10.1681/ASN.2010010079; Strittmatter E, 2013, J BIOL CHEM, V288, P4095, DOI 10.1074/jbc.M112.400176; Sundarapandiyan S, 2010, J POLYM ENVIRON, V18, P674, DOI 10.1007/s10924-010-0241-9; Suzuki MR, 2006, ENVIRON MICROBIOL, V8, P2214, DOI 10.1111/j.1462-2920.2006.01160.x; Tokiwa Y, 2009, INT J MOL SCI, V10, P3722, DOI 10.3390/ijms10093722; Tsujiyama S, 2013, BIOTECHNOL LETT, V35, P1907, DOI 10.1007/s10529-013-1281-8; Wei DS, 2010, APPL ENVIRON MICROB, V76, P2091, DOI 10.1128/AEM.02929-09; Wetzstein HG, 1997, APPL ENVIRON MICROB, V63, P4272, DOI 10.1128/AEM.63.11.4272-4281.1997; Yelle DJ, 2008, ENVIRON MICROBIOL, V10, P1844, DOI 10.1111/j.1462-2920.2008.01605.x; Yelle DJ, 2011, ENVIRON MICROBIOL, V13, P1091, DOI 10.1111/j.1462-2920.2010.02417.x	48	41	41	5	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131773	10.1371/journal.pone.0131773	http://dx.doi.org/10.1371/journal.pone.0131773			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147966	Green Published, gold, Green Submitted			2022-12-26	WOS:000358157600143
J	Oluyinka, OO; Tong, HV; Tien, SB; Fagbami, AH; Adekanle, O; Ojurongbe, O; Bock, CT; Kremsner, PG; Velavan, TP				Oluyinka, Opaleye O.; Hoang Van Tong; Tien, Sy Bui; Fagbami, Ademola H.; Adekanle, Olusegun; Ojurongbe, Olusola; Bock, C. -Thomas; Kremsner, Peter G.; Velavan, Thirumalaisamy P.			Occult Hepatitis B Virus Infection in Nigerian Blood Donors and Hepatitis B Virus Transmission Risks	PLOS ONE			English	Article							GENOTYPE-E; ANTI-HBC; WEST-AFRICA; TRANSFUSION; POPULATION; PREVALENCE; MECHANISMS; STRAINS; ADULTS; KOREA	Background Occult hepatitis B virus infection (OBI) characterized by the absence of detectable HBsAg remains a potential threat in blood safety. We investigated the actual prevalence, viral factors and genotype of OBI infections in Nigerian blood donors. Methods Serum collected from two blood banks were reconfirmed as HBsAg seronegative by ELISA. Forty HBsAg positive samples were employed as controls. HBV-DNA was amplified from all donors and viral loads were determined using quantitative real-time PCR. Antibodies to the HBV core, surface and HBe antigen (anti-HBc, anti-HBs, HBeAg) were measured. The PreS/S and PreC/C regions of the HBV genome were sequenced. Results Of the 429 blood donors, 72(17%) were confirmed as OBI by DNA detection in different reference labs and excluded the concern of possible contamination. Of the 72 OBI samples, 48(67%) were positive for anti-HBc, 25(35%) positive for anti-HBs, and 2(3%) positive for HBeAg. Of the 72 OBI samples, 31(43%) were seropositive for either anti-HBc, anti-HBs or HBeAg, 21 (30%) positive for both anti-HBc and anti-HBs, one positive for both anti-HBc and HBeAg. None of the OBI samples were positive for all three serological markers. The viral load was <50copies/ml in the OBI samples and genotype E was predominant. The L217R polymorphism in the reverse transcriptase domain of the HBV polymerase gene was observed significantly higher in OBI compared with HBsAg positive individuals (P<0.0001). Conclusion High incidence of OBI is relevant in high endemic areas worldwide and is a general burden in blood safety. This study signifies the high prevalence of OBI and proposes blood donor samples in Nigeria should be pre-tested for OBI by nucleic acid testing (NAT) and/or anti-HBc prior to transfusion to minimize the HBV infection risk.	[Oluyinka, Opaleye O.; Hoang Van Tong; Ojurongbe, Olusola; Kremsner, Peter G.; Velavan, Thirumalaisamy P.] Univ Tubingen, Inst Trop Med, Tubingen, Germany; [Oluyinka, Opaleye O.; Fagbami, Ademola H.; Ojurongbe, Olusola] Ladoke Akintola Univ Technol, Deparment Med Microbiol & Parasitol, Ogbomosho, Nigeria; [Tien, Sy Bui; Bock, C. -Thomas] Robert Koch Inst, Dept Infect Dis, Berlin, Germany; [Adekanle, Olusegun] Obafemi Awolowo Univ, Ife, Nigeria; [Bock, C. -Thomas] Univ Tubingen, Dept Mol Pathol, Tubingen, Germany; [Velavan, Thirumalaisamy P.] Fdn Congolaise Rech Med, Brazzaville, Rep Congo; [Tien, Sy Bui] 108 Mil Cent Hosp, Dept Mol Biol, Hanoi, Vietnam	Eberhard Karls University of Tubingen; Robert Koch Institute; Obafemi Awolowo University; Eberhard Karls University of Tubingen	Velavan, TP (corresponding author), Univ Tubingen, Inst Trop Med, Tubingen, Germany.	velavan@medizin.uni-tuebingen.de	Velavan, Thirumalaisamy P/C-1223-2010; van Tong, Hoang/E-9448-2011	Velavan, Thirumalaisamy P/0000-0002-9809-9883; van Tong, Hoang/0000-0002-7170-8810	Deutscher Akademischer Austausch Dienst (DAAD); Vietnam Ministry of Education and Training, Vietnam [322]; Deutsche Forschungsgemeinschaft (DFG); Tuebingen University	Deutscher Akademischer Austausch Dienst (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Vietnam Ministry of Education and Training, Vietnam; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Tuebingen University	Opaleye Oluyinka received support from Deutscher Akademischer Austausch Dienst (DAAD) (https://www.daad.de/en/) for this work period. Sy Bui Tien was supported by a scholarship from project 322 of Vietnam Ministry of Education and Training, Vietnam (www.moet.gov.vn). The authors acknowledge the support by the Deutsche Forschungsgemeinschaft (DFG) and Open Access Publishing Fund of Tuebingen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allain JP, 2009, BLOOD TRANSFUS-ITALY, V7, P174, DOI 10.2450/2008.0062-08; Antar W, 2010, TRANSFUSION MED, V20, P409, DOI 10.1111/j.1365-3148.2010.01021.x; Besharat S, 2014, HEPAT MON, V14, DOI 10.5812/hepatmon.15275; Brechot C, 2001, HEPATOLOGY, V34, P194, DOI 10.1053/jhep.2001.25172; Brojer E, 2006, HEPATOLOGY, V44, P1666, DOI 10.1002/hep.21413; Candotti D, 2008, J HEPATOL, V49, P537, DOI 10.1016/j.jhep.2008.04.017; Candotti D, 2012, GUT, V61, P1744, DOI 10.1136/gutjnl-2011-301281; Delfino CM, 2012, J CLIN VIROL, V54, P174, DOI 10.1016/j.jcv.2012.02.023; Emechebe GO, 2009, NIGERIAN MED J, V50, P18; Fang Y, 2009, J INFECTION, V58, P383, DOI 10.1016/j.jinf.2009.02.013; Huang CH, 2012, J HEPATOL, V57, P720, DOI 10.1016/j.jhep.2012.05.009; Jutavijittum P, 2014, VOX SANG, V106, P31, DOI 10.1111/vox.12073; Kang SY, 2010, J MED VIROL, V82, P1508, DOI 10.1002/jmv.21862; Kim DW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047372; Kimbi GC, 2004, J GEN VIROL, V85, P1211, DOI 10.1099/vir.0.19749-0; Kurbanov F, 2005, J GEN VIROL, V86, P2047, DOI 10.1099/vir.0.80922-0; Lee WM, 1997, NEW ENGL J MED, V337, P1733, DOI 10.1056/NEJM199712113372406; Levicnik-Stezinar S, 2008, J HEPATOL, V48, P1022, DOI 10.1016/j.jhep.2008.02.016; Li L, 2008, TRANSFUSION, V48, P1198, DOI 10.1111/j.1537-2995.2008.01672.x; Lok ASF, 2000, J HEPATOL, V32, P89, DOI 10.1016/S0168-8278(00)80418-3; Makuwa M, 2006, J MED VIROL, V78, P1175, DOI 10.1002/jmv.20678; Marusawa H, 2000, HEPATOLOGY, V31, P488, DOI 10.1002/hep.510310232; Minuk GY, 2005, J HEPATOL, V42, P480, DOI 10.1016/j.jhep.2004.11.037; Mudawi H, 2014, INT J INFECT DIS, V29, P65, DOI 10.1016/j.ijid.2014.07.004; Mulders MN, 2004, J INFECT DIS, V190, P400, DOI 10.1086/421502; N'Dri-Yoman T, 2010, ANTIVIR THER, V15, P1029, DOI 10.3851/IMP1641; Nna E, 2014, PATHOG GLOB HEALTH, V108, P223, DOI 10.1179/2047773214Y.0000000144; Odemuyiwa SO, 2001, J MED VIROL, V65, P463, DOI 10.1002/jmv.2058; Ola SO, 2009, J INFECT DEV COUNTR, V3, P442, DOI 10.3855/jidc.415; Panhotra BR, 2005, J INFECTION, V51, P263, DOI 10.1016/j.jinf.2005.07.023; Pollicino T, 2007, HEPATOLOGY, V45, P277, DOI 10.1002/hep.21529; Ponde RAA, 2010, ARCH VIROL, V155, P149, DOI 10.1007/s00705-009-0559-6; Prati D, 2006, J HEPATOL, V44, P818, DOI 10.1016/j.jhep.2005.12.009; Raimondo G, 2008, J HEPATOL, V49, P652, DOI 10.1016/j.jhep.2008.07.014; Raimondo G, 2007, J HEPATOL, V46, P160, DOI 10.1016/j.jhep.2006.10.007; Samal J, 2012, CLIN MICROBIOL REV, V25, P142, DOI 10.1128/CMR.00018-11; Song EY, 2009, INTERVIROLOGY, V52, P57, DOI 10.1159/000214633; Torbenson M, 2002, LANCET INFECT DIS, V2, P479, DOI 10.1016/S1473-3099(02)00345-6; Tramuto F, 2013, J IMMIGR MINOR HEALT, V15, P725, DOI 10.1007/s10903-012-9699-y; Yuen MF, 2010, GUT, V59, P1389, DOI 10.1136/gut.2010.209148; Zahn A, 2008, J GEN VIROL, V89, P409, DOI 10.1099/vir.0.83347-0	41	40	40	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131912	10.1371/journal.pone.0131912	http://dx.doi.org/10.1371/journal.pone.0131912			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148052	Green Published, gold			2022-12-26	WOS:000358157600164
J	Morrison, MM; Williams, MM; Vaught, DB; Hicks, D; Lim, J; McKernan, C; Aurisicchio, L; Ciliberto, G; Simion, C; Sweeney, C; Cook, RS				Morrison, M. M.; Williams, M. M.; Vaught, D. B.; Hicks, D.; Lim, J.; McKernan, C.; Aurisicchio, L.; Ciliberto, G.; Simion, C.; Sweeney, C.; Cook, R. S.			Decreased LRIG1 in fulvestrant-treated luminal breast cancer cells permits ErbB3 upregulation and increased growth	ONCOGENE			English	Article							FACTOR RECEPTOR FAMILY; ANTI-ERBB3 MONOCLONAL-ANTIBODIES; LEUCINE-RICH REPEAT; NEGATIVE REGULATOR; DOWN-REGULATION; RESISTANCE; OVEREXPRESSION; DEGRADATION; INHIBITION; ACTIVATION	ErbB3, a member of the ErbB family of receptor tyrosine kinases, is a potent activator of phosphatidyl inositol-3 kinase (PI3K) and mammalian target of rapamycin (mTOR) signaling, driving tumor cell survival and therapeutic resistance in breast cancers. In luminal breast cancers, ErbB3 upregulation following treatment with the antiestrogen fulvestrant enhances PI3K/mTOR-mediated cell survival. However, the mechanism by which ErbB3 is upregulated in fulvestrant-treated cells is unknown. We found that ErbB3 protein levels and cell surface presentation were increased following fulvestrant treatment, focusing our attention on proteins that regulate ErbB3 at the cell surface, including Nrdp1, NEDD4 and LRIG1. Among these, only LRIG1 correlated positively with ER alpha, but inversely with ErbB3 in clinical breast cancer data sets. LRIG1, an estrogen-inducible ErbB downregulator, was decreased in a panel of fulvestrant-treated luminal breast cancer cells. Ectopic LRIG1 expression from an estrogen-independent promoter uncoupled LRIG1 from estrogen regulation, thus sustaining LRIG1 and maintaining low ErbB3 levels in fulvestrant-treated cells. An LRIG1 mutant lacking the ErbB3 interaction motif was insufficient to downregulate ErbB3. Importantly, LRIG1 overexpression improved fulvestrant-mediated growth inhibition, whereas cells expressing the LRIG1 mutant were poorly sensitive to fulvestrant, despite effective ER alpha downregulation. Consistent with these results, LRIG1 expression correlated positively with increased disease-free survival in antiestrogen-treated breast cancer patients. These data suggest that ER alpha-dependent expression of LRIG1 dampens ErbB3 signaling in luminal breast cancer cells, and by blocking ER alpha activity with fulvestrant, LRIG1 is decreased thus permitting ErbB3 accumulation, enhanced ErbB3 signaling to cell survival pathways and blunting therapeutic response to fulvestrant.	[Morrison, M. M.; Williams, M. M.; Vaught, D. B.; Hicks, D.; Lim, J.; McKernan, C.; Cook, R. S.] Vanderbilt Univ, Sch Med, Dept Canc Biol, 2220 Pierce Ave,759 PRB, Nashville, TN USA; [Aurisicchio, L.] Takis Biotech, Via Castel Romano 100, I-00128 Rome, Italy; [Ciliberto, G.] IRCCS Natl Canc Inst G Pascale, Via Mariano Semmola, I-83131 Naples, Italy; [Simion, C.; Sweeney, C.] Univ Calif Davis, Ctr Canc, Basic Sci, Sacramento, CA 95817 USA; [Cook, R. S.] Vanderbilt Ingram Canc Ctr, Nashville, TN USA	Vanderbilt University; IRCCS Fondazione Pascale; University of California System; University of California Davis; Vanderbilt University	Cook, RS (corresponding author), Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Dept Canc Biol, 2220 Pierce Ave,759 PRB, Nashville, TN 37232 USA.	rebecca.cook@vanderbilt.edu	Williams, Michelle/AAI-2839-2020; Ciliberto, Gennaro/J-4131-2017	Williams, Michelle/0000-0002-7063-9147; Ciliberto, Gennaro/0000-0003-2851-8605; Aurisicchio, Luigi/0000-0003-3110-4534	National Institutes of Health [R01CA143126]; Susan G. Komen for the Cure grant [KG100677]; NATIONAL CANCER INSTITUTE [R01CA118384, R01CA143126] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen for the Cure grant(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health R01CA143126 (RSC) and Susan G. Komen for the Cure grant KG100677 (RSC).	ALI S, 1993, EMBO J, V12, P1153, DOI 10.1002/j.1460-2075.1993.tb05756.x; Aurisicchio L, 2012, J CELL PHYSIOL, V227, P3381, DOI 10.1002/jcp.24037; Balko JM, 2012, P NATL ACAD SCI USA, V109, P221, DOI 10.1073/pnas.1115802109; Baselga J, 2012, NEW ENGL J MED, V366, P520, DOI 10.1056/NEJMoa1109653; Belleudi F, 2012, CELL CYCLE, V11, P1455, DOI 10.4161/cc.19861; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Cook RS, 2011, CANCER RES, V71, P3941, DOI 10.1158/0008-5472.CAN-10-3775; Diamonti AJ, 2002, P NATL ACAD SCI USA, V99, P2866, DOI 10.1073/pnas.052709799; Fattore L, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-180; Ghasimi S, 2012, J NEURO-ONCOL, V108, P435, DOI 10.1007/s11060-012-0856-x; Hamburger AW, 2008, J MAMMARY GLAND BIOL, V13, P225, DOI 10.1007/s10911-008-9077-5; Hellyer NJ, 1998, BIOCHEM J, V333, P757, DOI 10.1042/bj3330757; Huang Z, 2015, ONCOGENE, V34, P1105, DOI 10.1038/onc.2014.56; Hutcheson IR, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2848; KIM HH, 1994, J BIOL CHEM, V269, P24747; Kim HH, 1998, BIOCHEM J, V334, P189, DOI 10.1042/bj3340189; Klempner SJ, 2013, CANCER DISCOV, V3, P1345, DOI 10.1158/2159-8290.CD-13-0063; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; KRAUS MH, 1989, P NATL ACAD SCI USA, V86, P9193, DOI 10.1073/pnas.86.23.9193; Krig SR, 2011, MOL CANCER RES, V9, P1406, DOI 10.1158/1541-7786.MCR-11-0227; Laederich MB, 2004, J BIOL CHEM, V279, P47050, DOI 10.1074/jbc.M409703200; Liu BL, 2007, INT J CANCER, V120, P1874, DOI 10.1002/ijc.22423; Miller JK, 2008, CANCER RES, V68, P8286, DOI 10.1158/0008-5472.CAN-07-6316; Morrison MM, 2013, J CLIN INVEST, V123, P4329, DOI 10.1172/JCI66764; Noto A, 2013, ONCOTARGET, V4, P1253, DOI 10.18632/oncotarget.1141; Qiu XB, 2002, P NATL ACAD SCI USA, V99, P14843, DOI 10.1073/pnas.232580999; Rafidi H, 2013, J BIOL CHEM, V288, P21593, DOI 10.1074/jbc.M113.486050; Shattuck DL, 2007, MOL CELL BIOL, V27, P1934, DOI 10.1128/MCB.00757-06; Stern DF, 2008, J MAMMARY GLAND BIOL, V13, P215, DOI 10.1007/s10911-008-9083-7; Stutz MA, 2008, ONCOGENE, V27, P5741, DOI 10.1038/onc.2008.185; Sundvall M, 2008, J MAMMARY GLAND BIOL, V13, P259, DOI 10.1007/s10911-008-9079-3; Sutherland RL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2878; Tovey S, 2005, CLIN CANCER RES, V11, P4835, DOI 10.1158/1078-0432.CCR-05-0196; Wiseman SM, 2005, CANCER-AM CANCER SOC, V103, P1770, DOI 10.1002/cncr.20970; Wong KK, 2010, CURR OPIN GENET DEV, V20, P87, DOI 10.1016/j.gde.2009.11.002; Wong VWY, 2012, NAT CELL BIOL, V14, P401, DOI 10.1038/ncb2464	36	9	11	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 3	2016	35	9					1143	1152		10.1038/onc.2015.169	http://dx.doi.org/10.1038/onc.2015.169			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DF4WH	26148232	Green Accepted			2022-12-26	WOS:000371351700008
J	Cho, Y; Park, D; Cavalli, V				Cho, Yongcheol; Park, Dongeun; Cavalli, Valeria			Filamin A Is Required in Injured Axons for HDAC5 Activity and Axon Regeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN-BINDING PROTEIN; KINASE-C; HISTONE DEACETYLASE-5; NUCLEAR EXPORT; CELL-ADHESION; GROWTH; NEURONS; MICROTUBULES; TRANSPORT; VIMENTIN	Microtubule dynamics are important for axon growth during development as well as axon regeneration after injury. We have previously identified HDAC5 as an injury-regulated tubulin deacetylase that functions at the injury site to promote axon regeneration. However, the mechanisms involved in the spatial control of HDAC5 activity remain poorly understood. Here we reveal that HDAC5 interacts with the actin binding protein filamin A via its C-terminal domain. Filamin A plays critical roles in HDAC5-dependent tubulin deacetylation because, in cells lacking filamin A, the levels of acetylated tubulin are elevated markedly. We found that nerve injury increases filamin A axonal expression in a protein synthesis-dependent manner. Reducing filamin A levels or interfering with the interaction between HDAC5 and filamin A prevents injury-induced tubulin deacetylation as well as HDAC5 localization at the injured axon tips. In addition, neurons lacking filamin A display reduced axon regeneration. Our findings suggest a model in which filamin A local translation following axon injury controls localized HDAC5 activity to promote axon regeneration.	[Cho, Yongcheol; Cavalli, Valeria] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; [Park, Dongeun] Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea	Washington University (WUSTL); Seoul National University (SNU)	Park, D (corresponding author), Seoul Natl Univ, Coll Nat Sci, Sch Biol Sci, Seoul 151742, South Korea.	depark@snu.ac.kr; cavalli@pcg.wustl.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [NS082446]; National Research Foundation of Korea [NRF-2012R1A6A3A03039290, M103KV010013-04K2201-01310]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS082446] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Foundation of Korea(National Research Foundation of Korea); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS082446 (to V.C.). This work was also supported by National Research Foundation of Korea Grants NRF-2012R1A6A3A03039290 (to Y.C.) and M103KV010013-04K2201-01310 (to D.P.). The authors declare that they have no conflicts of interest with the contents of this article.	Andrews MR, 2009, J NEUROSCI, V29, P5546, DOI 10.1523/JNEUROSCI.0759-09.2009; Bellanger JM, 2000, NAT CELL BIOL, V2, P888, DOI 10.1038/35046533; Chang SR, 2004, MOL CELL BIOL, V24, P8467, DOI 10.1128/MCB.24.19.8467-8476.2004; Cho Y, 2014, J BIOL CHEM, V289, P15820, DOI 10.1074/jbc.M113.536607; Cho Y, 2013, CELL, V155, P894, DOI 10.1016/j.cell.2013.10.004; Cho Y, 2012, EMBO J, V31, P3063, DOI 10.1038/emboj.2012.160; CUNNINGHAM CC, 1992, SCIENCE, V255, P325, DOI 10.1126/science.1549777; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Dent EW, 1999, J NEUROSCI, V19, P8894, DOI 10.1523/JNEUROSCI.19-20-08894.1999; Donnelly CJ, 2013, J NEUROSCI, V33, P3311, DOI 10.1523/JNEUROSCI.1722-12.2013; Erturk A, 2007, J NEUROSCI, V27, P9169, DOI 10.1523/JNEUROSCI.0612-07.2007; Eva R, 2012, J NEUROSCI, V32, P10352, DOI 10.1523/JNEUROSCI.1409-12.2012; Eva R, 2010, J NEUROSCI, V30, P11654, DOI 10.1523/JNEUROSCI.2425-10.2010; Feng YY, 2006, P NATL ACAD SCI USA, V103, P19836, DOI 10.1073/pnas.0609628104; Fischle W, 1999, J BIOL CHEM, V274, P11713, DOI 10.1074/jbc.274.17.11713; Flanagan LA, 2001, J CELL BIOL, V155, P511, DOI 10.1083/jcb.200105148; Flynn KC, 2012, NEURON, V76, P1091, DOI 10.1016/j.neuron.2012.09.038; Fox JW, 1998, NEURON, V21, P1315, DOI 10.1016/S0896-6273(00)80651-0; GORLIN JB, 1990, J CELL BIOL, V111, P1089, DOI 10.1083/jcb.111.3.1089; Gumy LF, 2011, RNA, V17, P85, DOI 10.1261/rna.2386111; Gumy LF, 2010, EXP NEUROL, V223, P28, DOI 10.1016/j.expneurol.2009.06.004; Hammond JW, 2008, CURR OPIN CELL BIOL, V20, P71, DOI 10.1016/j.ceb.2007.11.010; Hart AW, 2006, HUM MOL GENET, V15, P2457, DOI 10.1093/hmg/ddl168; HARTWIG JH, 1980, J CELL BIOL, V87, P841, DOI 10.1083/jcb.87.3.841; HARTWIG JH, 1975, J BIOL CHEM, V250, P5696; Hellal F, 2011, SCIENCE, V331, P928, DOI 10.1126/science.1201148; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Hur EM, 2011, GENE DEV, V25, P1968, DOI 10.1101/gad.17015911; Janke C, 2010, TRENDS NEUROSCI, V33, P362, DOI 10.1016/j.tins.2010.05.001; Kim C, 2005, EMBO REP, V6, P1045, DOI 10.1038/sj.embor.7400534; Kim C, 2011, BLOOD, V117, P1415, DOI 10.1182/blood-2010-03-275289; Kim H, 2011, FEBS LETT, V585, P18, DOI 10.1016/j.febslet.2010.11.033; Kim H, 2010, EXP CELL RES, V316, P1829, DOI 10.1016/j.yexcr.2010.02.007; Kim H, 2010, AM J PHYSIOL-CELL PH, V298, pC221, DOI 10.1152/ajpcell.00323.2009; Liz MA, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-47; Lynch CD, 2011, MOL BIOL CELL, V22, P1263, DOI 10.1091/mbc.E10-08-0661; Merianda TT, 2013, J CELL SCI, V126, P90, DOI 10.1242/jcs.107268; Perlson E, 2005, NEURON, V45, P715, DOI 10.1016/j.neuron.2005.01.023; Rivieccio MA, 2009, P NATL ACAD SCI USA, V106, P19599, DOI 10.1073/pnas.0907935106; Saijilafu, 2013, NEUROSCI BULL, V29, P411, DOI 10.1007/s12264-013-1357-4; Sengottuvel V, 2011, J NEUROSCI, V31, P2688, DOI 10.1523/JNEUROSCI.4885-10.2011; Sheen VL, 2001, HUM MOL GENET, V10, P1775, DOI 10.1093/hmg/10.17.1775; Shin JE, 2014, EXP NEUROL, V252, P1, DOI 10.1016/j.expneurol.2013.11.007; Tigges U, 2003, J BIOL CHEM, V278, P23561, DOI 10.1074/jbc.M302302200; van Haren J, 2014, CURR BIOL, V24, P1778, DOI 10.1016/j.cub.2014.06.037; Vega RB, 2004, MOL CELL BIOL, V24, P8374, DOI 10.1128/MCB.24.19.8374-8385.2004; Williamson T, 1996, P NATL ACAD SCI USA, V93, P15221, DOI 10.1073/pnas.93.26.15221; Yang XJ, 2005, MOL CELL BIOL, V25, P2873, DOI 10.1128/MCB.25.8.2873-2884.2005; Zhang JP, 2013, J NEUROSCI, V33, P15735, DOI 10.1523/JNEUROSCI.1939-13.2013; Zhou AX, 2010, TRENDS CELL BIOL, V20, P113, DOI 10.1016/j.tcb.2009.12.001; Zou HY, 2009, J NEUROSCI, V29, P7116, DOI 10.1523/JNEUROSCI.5397-08.2009	51	15	15	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 11	2015	290	37					22759	22770		10.1074/jbc.M115.638445	http://dx.doi.org/10.1074/jbc.M115.638445			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR2PB	26157139	Green Published, hybrid			2022-12-26	WOS:000361171500039
J	Gerbin, KA; Yang, XL; Murry, CE; Coulombe, KLK				Gerbin, Kaytlyn A.; Yang, Xiulan; Murry, Charles E.; Coulombe, Kareen L. K.			Enhanced Electrical Integration of Engineered Human Myocardium via Intramyocardial versus Epicardial Delivery in Infarcted Rat Hearts	PLOS ONE			English	Article							CELL-DERIVED CARDIOMYOCYTES; CARDIAC PATCH; SCAFFOLD-FREE; STEM-CELLS; TISSUE; TRANSPLANTATION; IMPROVES; MATURATION; SURVIVAL; PLATFORM	Cardiac tissue engineering is a promising approach to provide large-scale tissues for transplantation to regenerate the heart after ischemic injury, however, integration with the host myocardium will be required to achieve electromechanical benefits. To test the ability of engineered heart tissues to electrically integrate with the host, 10 million human embryonic stem cell (hESC)-derived cardiomyocytes were used to form either scaffold-free tissue patches implanted on the epicardium or micro-tissue particles (similar to 1000 cells/particle) delivered by intramyocardial injection into the left ventricular wall of the ischemia/reperfusion injured athymic rat heart. Results were compared to intramyocardial injection of 10 million dispersed hESC-cardiomyocytes. Graft size was not significantly different between treatment groups and correlated inversely with infarct size. After implantation on the epicardial surface, hESC-cardiac tissue patches were electromechanically active, but they beat slowly and were not electrically coupled to the host at 4 weeks based on ex vivo fluorescent imaging of their graft-autonomous GCaMP3 calcium reporter. Histologically, scar tissue physically separated the patch graft and host myocardium. In contrast, following intramyocardial injection of micro-tissue particles and suspended cardiomyocytes, 100% of the grafts detected by fluorescent GCaMP3 imaging were electrically coupled to the host heart at spontaneous rate and could follow host pacing up to a maximum of 300-390 beats per minute (5-6.5 Hz). Gap junctions between intramyocardial graft and host tissue were identified histologically. The extensive coupling and rapid response rate of the human myocardial grafts after intramyocardial delivery suggest electrophysiological adaptation of hESC-derived cardiomyocytes to the rat heart's pacemaking activity. These data support the use of the rat model for studying electromechanical integration of human cardiomyocytes, and they identify lack of electrical integration as a challenge to overcome in tissue engineered patches.	[Gerbin, Kaytlyn A.; Yang, Xiulan; Murry, Charles E.; Coulombe, Kareen L. K.] Univ Washington, Ctr Cardiovasc Biol, Seattle, WA 98195 USA; [Gerbin, Kaytlyn A.; Yang, Xiulan; Murry, Charles E.; Coulombe, Kareen L. K.] Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA; [Gerbin, Kaytlyn A.; Murry, Charles E.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; [Yang, Xiulan; Murry, Charles E.; Coulombe, Kareen L. K.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Murry, Charles E.] Univ Washington, Dept Med Cardiol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Murry, CE (corresponding author), Univ Washington, Ctr Cardiovasc Biol, Seattle, WA 98195 USA.	murry@uw.edu; kareen_coulombe@brown.edu			National Institutes of Health (NIH) [K99 HL115123]; NSF Graduate Research Fellowship [DGE-0718124, DGE-1256082]; AHA Postdoctoral Fellowship [12POST11940060, 14POST20310023]; NIH [R01 HL084642, P01 HL094374, P01 GM81619, U01 HL100405]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL115123, R01HL084642, P01HL094374, K99HL115123, U01HL100405] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB001650] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK017047] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM081619] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF Graduate Research Fellowship(National Science Foundation (NSF)); AHA Postdoctoral Fellowship(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors gratefully acknowledge funding from National Institutes of Health (NIH) K99 HL115123 (to KLKC), NSF Graduate Research Fellowship DGE-0718124 and DGE-1256082 (to KAG), AHA Postdoctoral Fellowship 12POST11940060 and 14POST20310023 (to XY), and NIH R01 HL084642, P01 HL094374, P01 GM81619, and U01 HL100405 (to CEM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bian WN, 2014, BIOFABRICATION, V6, DOI 10.1088/1758-5082/6/2/024109; Bian WN, 2014, BIOMATERIALS, V35, P3819, DOI 10.1016/j.biomaterials.2014.01.045; Boudou T, 2012, TISSUE ENG PT A, V18, P910, DOI [10.1089/ten.TEA.2011.0341, 10.1089/ten.tea.2011.0341]; Caspi O, 2007, J AM COLL CARDIOL, V50, P1884, DOI 10.1016/j.jacc.2007.07.054; Chong JJH, 2014, NATURE, V510, P273, DOI 10.1038/nature13233; Coulombe KLK, 2014, ANNU REV BIOMED ENG, V16, P1, DOI 10.1146/annurev-bioeng-071812-152344; Dvir T, 2009, P NATL ACAD SCI USA, V106, P14990, DOI 10.1073/pnas.0812242106; Fernandes S, 2009, J CELL MOL MED, V13, P3703, DOI 10.1111/j.1582-4934.2009.00740.x; Haraguchi Y, 2011, CARDIOL RES PRACT, V2011, DOI 10.4061/2011/845170; Hirt MN, 2014, CIRC RES, V114, P354, DOI 10.1161/CIRCRESAHA.114.300522; Janse MJ, 1998, CARDIOVASC RES, V39, P165, DOI 10.1016/S0008-6363(97)00313-1; Kreutziger KL, 2011, TISSUE ENG PT A, V17, P1219, DOI [10.1089/ten.tea.2010.0557, 10.1089/ten.TEA.2010.0557]; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Laflamme MA, 2011, NATURE, V473, P326, DOI 10.1038/nature10147; Lal H, 2015, CIRC RES, V116, P138, DOI 10.1161/CIRCRESAHA.116.303613; Leor J, 2007, HEART, V93, P1278, DOI 10.1136/hrt.2006.093161; Lesman A, 2010, TISSUE ENG PT A, V16, P115, DOI [10.1089/ten.tea.2009.0130, 10.1089/ten.TEA.2009.0130]; Madden LR, 2010, P NATL ACAD SCI USA, V107, P15211, DOI 10.1073/pnas.1006442107; Moon SH, 2013, BIOMATERIALS, V34, P4013, DOI 10.1016/j.biomaterials.2013.02.022; Nunes SS, 2013, NAT METHODS, V10, P781, DOI [10.1038/NMETH.2524, 10.1038/nmeth.2524]; Radisic M, 2004, P NATL ACAD SCI USA, V101, P18129, DOI 10.1073/pnas.0407817101; Radisic M, 2008, J BIOMED MATER RES A, V86A, P713, DOI 10.1002/jbm.a.31578; Robey TE, 2008, J MOL CELL CARDIOL, V45, P567, DOI 10.1016/j.yjmcc.2008.03.009; Schaaf S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026397; Sekine H, 2011, TISSUE ENG PT A, V17, P2973, DOI 10.1089/ten.tea.2010.0659; Shiba Y, 2014, J CARDIOVASC PHARM T, V19, P368, DOI 10.1177/1074248413520344; Shiba Y, 2012, NATURE, V489, P322, DOI 10.1038/nature11317; Shimizu T, 2002, CIRC RES, V90, pE40, DOI 10.1161/hh0302.105722; Song H, 2010, P NATL ACAD SCI USA, V107, P3329, DOI 10.1073/pnas.0905729106; Stevens KR, 2009, P NATL ACAD SCI USA, V106, P16568, DOI 10.1073/pnas.0908381106; Stevens KR, 2009, TISSUE ENG PT A, V15, P1211, DOI 10.1089/ten.tea.2008.0151; Thavandiran N, 2013, P NATL ACAD SCI USA, V110, pE4698, DOI 10.1073/pnas.1311120110; Thomson KS, 2013, TISSUE ENG PT A, V19, P967, DOI 10.1089/ten.tea.2012.0286; Tulloch NL, 2011, CIRC RES, V109, P47, DOI 10.1161/CIRCRESAHA.110.237206; van Laake LW, 2007, STEM CELL RES, V1, P9, DOI 10.1016/j.scr.2007.06.001; Vunjak-Noyakovic G, 2011, ANNU REV BIOMED ENG, V13, P245, DOI 10.1146/annurev-bioeng-071910-124701; Xu CH, 2011, REGEN MED, V6, P53, DOI 10.2217/RME.10.91; Zhang DH, 2013, BIOMATERIALS, V34, P5813, DOI 10.1016/j.biomaterials.2013.04.026; Zimmermann WH, 2006, NAT MED, V12, P452, DOI 10.1038/nm1394; Zimmermann WH, 2000, BIOTECHNOL BIOENG, V68, P106; Zwi-Dantsis L, 2013, EUR HEART J, V34, P1575, DOI 10.1093/eurheartj/ehs096	41	66	67	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131446	10.1371/journal.pone.0131446	http://dx.doi.org/10.1371/journal.pone.0131446			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161513	gold, Green Submitted, Green Published			2022-12-26	WOS:000358162300040
J	Jin, YH; Elalaf, H; Watanabe, M; Tamaki, S; Hineno, S; Matsunaga, K; Woltjen, K; Kobayashi, Y; Nagata, S; Ikeya, M; Kato, T; Okamoto, T; Matsuda, S; Toguchida, J				Jin, Yonghui; Elalaf, Hassan; Watanabe, Makoto; Tamaki, Sakura; Hineno, Sho; Matsunaga, Kazuhito; Woltjen, Knut; Kobayashi, Yukiko; Nagata, Sanae; Ikeya, Makoto; Kato, Tomohisa, Jr.; Okamoto, Takeshi; Matsuda, Shuichi; Toguchida, Junya			Mutant IDH1 Dysregulates the Differentiation of Mesenchymal Stem Cells in Association with Gene-Specific Histone Modifications to Cartilage- and Bone-Related Genes	PLOS ONE			English	Article							ONCOMETABOLITE 2-HYDROXYGLUTARATE; MYELOPROLIFERATIVE NEOPLASMS; MAFFUCCI SYNDROME; OLLIER DISEASE; MUTATIONS; CANCER; GLIOBLASTOMA; EXPRESSION; PROMOTER; COL2A1	Somatic mutations in the isocitrate dehydrogenase (IDH) 1/2 genes endow encoding proteins with neomorphic activity to produce the potential oncometabolite, 2-hydroxyglutarate (2-HG), which induces the hypermethylation of histones and DNA. The incidence of IDH1/2 mutations in cartilaginous tumors was previously shown to be the highest among various types of tumors, except for those in the central nervous system. Mutations have been detected in both benign (enchondromas) and malignant (chondrosarcomas) types of cartilaginous tumors, whereas they have rarely been found in other mesenchymal tumors such as osteosarcomas. To address this unique tumor specificity, we herein examined the effects of IDH1 R132C, which is the most prevalent mutant in cartilaginous tumors, on the differentiation properties of human mesenchymal stem cells (hMSCs). The induction of the IDH1 R132C gene into MSCs markedly increased the amount of 2-HG and up-regulated global histone methylation. The induction of IDH1 R132C promoted the chondrogenic differentiation of hMSCs by enhancing the expression of SOX9 and COL2A1 genes in association with an increase in the active mark (H3K4me3), but disrupted cartilage matrix formation. On the other hand, IDH1 R132C inhibited expression of the ALPL gene in association with an increase in the repressive mark (H3K9me3), and subsequently inhibited the osteogenic properties of hMSCs and human osteosarcoma cells. Since osteogenic properties are an indispensable feature for the diagnosis of osteosarcoma, the inhibitory effects of IDH1 R132C on osteogenic properties may contribute to the lack of osteosarcomas with the IDH1 R132C mutation. These results suggested that IDH1 R132C contributed to the formation of cartilaginous tumors by dysregulating the chondrogenic and osteogenic differentiation of hMSCs via gene-specific histone modulation.	[Jin, Yonghui; Elalaf, Hassan; Tamaki, Sakura; Hineno, Sho; Matsunaga, Kazuhito; Kobayashi, Yukiko; Kato, Tomohisa, Jr.; Toguchida, Junya] Kyoto Univ, Inst Frontier Med Sci, Dept Tissue Regenerat, Kyoto, Japan; [Watanabe, Makoto; Matsunaga, Kazuhito; Nagata, Sanae; Ikeya, Makoto; Toguchida, Junya] Kyoto Univ, Dept Cell Growth & Differentiat, Ctr iPS Cell Res & Applicat, Kyoto, Japan; [Okamoto, Takeshi; Matsuda, Shuichi; Toguchida, Junya] Kyoto Univ, Grad Sch Med, Dept Orthopaed Surg, Kyoto, Japan; [Watanabe, Makoto] Shimadzu Cooperat, Life Sci Res Ctr, Kyoto, Japan; [Woltjen, Knut] Kyoto Univ, Dept Reprogramming Sci, Ctr iPS Cell Res & Applicat, Kyoto, Japan; [Matsunaga, Kazuhito] Yamaguchi Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Ube, Yamaguchi 755, Japan	Kyoto University; Kyoto University; Kyoto University; Shimadzu Corporation; Kyoto University; Yamaguchi University	Toguchida, J (corresponding author), Kyoto Univ, Inst Frontier Med Sci, Dept Tissue Regenerat, Kyoto, Japan.	togjun@frontier.kyoto-u.ac.jp		Kato, Tomohisa/0000-0002-3047-9847; Matsuda, Shuichi/0000-0003-0802-1255; Ikeya, Makoto/0000-0002-3930-8032; Woltjen, Knut/0000-0003-2293-1183	Japan Society of Promotion of Science [25670642]; Life Science Research Center; Shimadzu Cooperation; Grants-in-Aid for Scientific Research [15H04956] Funding Source: KAKEN	Japan Society of Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Life Science Research Center; Shimadzu Cooperation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research from the Japan Society of the Promotion of Science to TO and JT (#25670642) (http://mhlw-grants.niph.go.jp/). One of the coauthors, Makoto Watanabe, is an employee of Shimadzu Cooperation. The Life Science Research Center, Shimadzu Cooperation provided support in the form of his salary, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of Makoto Watanabe (performed the experiments and analyzed the data) are articulated in the Authors Contributions section.	Abbas S, 2010, BLOOD, V116, P2122, DOI 10.1182/blood-2009-11-250878; Abdel-Wahab O, 2010, CANCER RES, V70, P447, DOI 10.1158/0008-5472.CAN-09-3783; Amary MF, 2011, NAT GENET, V43, P1262, DOI 10.1038/ng.994; Amary MF, 2011, J PATHOL, V224, P334, DOI 10.1002/path.2913; Aoyama T, 2004, J BIOL CHEM, V279, P28789, DOI 10.1074/jbc.M401273200; CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504; Caterson E, 2002, MOL BIOTECHNOL, V20, P245, DOI 10.1385/MB:20:3:245; Chen X, 2014, CELL REP, V7, P104, DOI 10.1016/j.celrep.2014.03.003; Chowdhury R, 2011, EMBO REP, V12, P463, DOI 10.1038/embor.2011.43; Delgado-Calle J, 2011, BONE, V49, P830, DOI 10.1016/j.bone.2011.06.006; FLETCHER CDM, 2002, WHO CLASSIFICATION T, P233; Furumatsu T, 2010, INT J BIOCHEM CELL B, V42, P148, DOI 10.1016/j.biocel.2009.10.003; Ghayor C, 2000, J BIOL CHEM, V275, P27421; Green A, 2010, NEW ENGL J MED, V362, P369, DOI 10.1056/NEJMc0910063; Kang MR, 2009, INT J CANCER, V125, P353, DOI 10.1002/ijc.24379; Kats LM, 2014, CELL STEM CELL, V14, P329, DOI 10.1016/j.stem.2013.12.016; Kim KI, 2013, J BONE MINER RES, V28, P1050, DOI 10.1002/jbmr.1843; Lu C, 2013, GENE DEV, V27, P1986, DOI 10.1101/gad.226753.113; Lu C, 2012, NATURE, V483, P474, DOI 10.1038/nature10860; Millan JL, 2013, CALCIFIED TISSUE INT, V93, P299, DOI 10.1007/s00223-012-9672-8; Murugan AK, 2010, BIOCHEM BIOPH RES CO, V393, P555, DOI 10.1016/j.bbrc.2010.02.095; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Ohgaki H, 2013, CLIN CANCER RES, V19, P764, DOI 10.1158/1078-0432.CCR-12-3002; Okamoto T, 2002, BIOCHEM BIOPH RES CO, V295, P354, DOI 10.1016/S0006-291X(02)00661-7; Pansuriya TC, 2011, NAT GENET, V43, P1256, DOI 10.1038/ng.1004; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pusch S, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-19; Reitman ZJ, 2010, JNCI-J NATL CANCER I, V102, P932, DOI 10.1093/jnci/djq187; Saha SK, 2014, NATURE, V513, P110, DOI 10.1038/nature13441; Sasaki M, 2012, GENE DEV, V26, P2038, DOI 10.1101/gad.198200.112; Tarpey PS, 2013, NAT GENET, V45, P923, DOI 10.1038/ng.2668; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yen KE, 2010, ONCOGENE, V29, P6409, DOI 10.1038/onc.2010.444; Zhao SM, 2009, SCIENCE, V324, P261, DOI 10.1126/science.1170944	36	19	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131998	10.1371/journal.pone.0131998	http://dx.doi.org/10.1371/journal.pone.0131998			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161668	Green Published, gold, Green Submitted			2022-12-26	WOS:000358162300083
J	Yeh, JSM; Sennoga, CA; McConnell, E; Eckersley, R; Tang, MX; Nourshargh, S; Seddon, JM; Haskard, DO; Nihoyannopoulos, P				Yeh, James Shue-Min; Sennoga, Charles A.; McConnell, Ellen; Eckersley, Robert; Tang, Meng-Xing; Nourshargh, Sussan; Seddon, John M.; Haskard, Dorian O.; Nihoyannopoulos, Petros			A Targeting Microbubble for Ultrasound Molecular Imaging	PLOS ONE			English	Article							INTRACAPILLARY BLOOD-VOLUME; CONTRAST AGENT; IN-VIVO; E-SELECTIN; MYOCARDIAL-ISCHEMIA; GENE TRANSFECTION; P-SELECTIN; EXPRESSION; ANGIOGENESIS; BR55	Rationale Microbubbles conjugated with targeting ligands are used as contrast agents for ultrasound molecular imaging. However, they often contain immunogenic (strept) avidin, which impedes application in humans. Although targeting bubbles not employing the biotin( strept) avidin conjugation chemistry have been explored, only a few reached the stage of ultrasound imaging in vivo, none were reported/evaluated to show all three of the following properties desired for clinical applications: (i) low degree of non-specific bubble retention in more than one non-reticuloendothelial tissue; (ii) effective for real-time imaging; and (iii) effective for acoustic quantification of molecular targets to a high degree of quantification. Furthermore, disclosures of the compositions and methodologies enabling reproduction of the bubbles are often withheld. Objective To develop and evaluate a targeting microbubble based on maleimide-thiol conjugation chemistry for ultrasound molecular imaging. Methods and Results Microbubbles with a previously unreported generic (non-targeting components) composition were grafted with anti-E-selectin F(ab')(2) using maleimide-thiol conjugation, to produce E-selectin targeting microbubbles. The resulting targeting bubbles showed high specificity to E-selectin in vitro and in vivo. Non-specific bubble retention was minimal in at least three non-reticuloendothelial tissues with inflammation (mouse heart, kidneys, cremaster). The bubbles were effective for real-time ultrasound imaging of E-selectin expression in the inflamed mouse heart and kidneys, using a clinical ultrasound scanner. The acoustic signal intensity of the targeted bubbles retained in the heart correlated strongly with the level of E-selectin expression (vertical bar r vertical bar >= 0.8), demonstrating a high degree of non-invasive molecular quantification. Conclusions Targeting microbubbles for ultrasound molecular imaging, based on maleimide-thiol conjugation chemistry and the generic composition described, may possess properties (i)-(iii) desired for clinical applications.	[Yeh, James Shue-Min; McConnell, Ellen; Nourshargh, Sussan; Haskard, Dorian O.; Nihoyannopoulos, Petros] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Yeh, James Shue-Min; Nihoyannopoulos, Petros] Hammersmith Hosp, Dept Cardiol, London, England; [Yeh, James Shue-Min; Sennoga, Charles A.; Eckersley, Robert] Univ London Imperial Coll Sci Technol & Med, MRC, Imaging Sci Dept, London, England; [Sennoga, Charles A.; Seddon, John M.] Univ London Imperial Coll Sci Technol & Med, Dept Chem, London SW7 2AY, England; [Tang, Meng-Xing] Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London, England; [Nourshargh, Sussan] Univ London, William Harvey Res Inst, London, England	Imperial College London; Imperial College London; Imperial College London; Imperial College London; Imperial College London; University of London; Queen Mary University London	Nihoyannopoulos, P (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England.	p.nihoyannopoulos@imperial.ac.uk		Nourshargh, Sussan/0000-0001-5677-1806; Seddon, John/0000-0002-7099-3402; Eckersley, Robert/0000-0001-9247-5350	Bristol-Myers Squibb Cardiovascular Prize Fellowship; British Heart Foundation Project Grant; Hammersmith Hospitals Trustees' Research Committee Small Project Grant; British Heart Foundation	Bristol-Myers Squibb Cardiovascular Prize Fellowship; British Heart Foundation Project Grant(British Heart Foundation); Hammersmith Hospitals Trustees' Research Committee Small Project Grant; British Heart Foundation(British Heart Foundation)	The work was supported by the following: Bristol-Myers Squibb Cardiovascular Prize Fellowship (JY); British Heart Foundation Project Grant (PN, MB, DOH, SN, JS, CS, EM, JY); and Hammersmith Hospitals Trustees' Research Committee Small Project Grant (PN, MB, DOH). DH receives professorial support from the British Heart Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso A, 2007, STROKE, V38, P1508, DOI 10.1161/STROKEAHA.106.471391; Anderson CR, 2011, INVEST RADIOL, V46, P215, DOI 10.1097/RLI.0b013e3182034fed; Anderson CR, 2010, INVEST RADIOL, V45, P579, DOI 10.1097/RLI.0b013e3181efd581; Bettinger T, 2012, INVEST RADIOL, V47, P516, DOI 10.1097/RLI.0b013e31825cc605; Boeckler C, 1996, J IMMUNOL METHODS, V191, P1, DOI 10.1016/0022-1759(95)00284-7; Borden MA, 2013, MOL IMAGING, V12, DOI 10.2310/7290.2013.00052; Bracco International B.V., 2005, SON SUMM PROD CHAR, P9; Bzyl J, 2013, EUR RADIOL, V23, P468, DOI 10.1007/s00330-012-2594-z; Bzyl J, 2011, EUR RADIOL, V21, P1988, DOI 10.1007/s00330-011-2138-y; Coulden R, 1997, FUNCTIONAL COMPUTED, P133; Davidson BP, 2014, J AM SOC ECHOCARDIOG, V27, P786, DOI 10.1016/j.echo.2014.03.013; Davidson BP, 2012, J AM COLL CARDIOL, V60, P1690, DOI 10.1016/j.jacc.2012.07.027; Della Martina A, 2008, EUR J PHARM BIOPHARM, V68, P555, DOI 10.1016/j.ejpb.2007.07.008; Eppihimer MJ, 1996, CIRC RES, V79, P560, DOI 10.1161/01.RES.79.3.560; Fisher NG, 2002, J AM COLL CARDIOL, V40, P811, DOI 10.1016/S0735-1097(02)02038-7; Fokong S, 2013, INVEST RADIOL, V48, P843, DOI 10.1097/RLI.0b013e31829d03ec; French RR, 1996, LEUKEMIA RES, V20, P607, DOI 10.1016/0145-2126(96)00007-0; Friedrich MG, 1998, CIRCULATION, V97, P1802, DOI 10.1161/01.CIR.97.18.1802; Frinking PJA, 2012, ULTRASOUND MED BIOL, V38, P1460, DOI 10.1016/j.ultrasmedbio.2012.03.018; Hu GQ, 2012, THROMB HAEMOSTASIS, V107, P172, DOI 10.1160/TH10-11-0701; Hu XW, 2012, INVEST RADIOL, V47, P398, DOI 10.1097/RLI.0b013e31824bd237; Hyvelin JM, 2014, INVEST RADIOL, V49, P224, DOI 10.1097/RLI.0000000000000018; Jamar F, 2002, RHEUMATOLOGY, V41, P53, DOI 10.1093/rheumatology/41.1.53; Kansas G, 2001, PHYSL INFLAMMATION, P222; Klibanov AL, 1999, PROCEED INTL SYMP CO, V26, P230; KNIGHT CG, 1976, BIOCHEM J, V159, P323, DOI 10.1042/bj1590323; Knowles JA, 2012, ARCH OTOLARYNGOL, V138, P662, DOI 10.1001/archoto.2012.1081; LABOW MA, 1994, IMMUNITY, V1, P709, DOI 10.1016/1074-7613(94)90041-8; Leng XP, 2014, MOL IMAGING, V13, DOI 10.2310/7290.2014.00006; Lindner JR, 2001, CIRCULATION, V104, P2107, DOI 10.1161/hc4201.097061; Lukac R, 2011, LANGMUIR, V27, P4829, DOI 10.1021/la104677b; PEETERS JM, 1989, J IMMUNOL METHODS, V120, P133, DOI 10.1016/0022-1759(89)90298-6; Pillai R, 2010, BIOCONJUGATE CHEM, V21, P556, DOI 10.1021/bc9005688; Pochon S, 2010, INVEST RADIOL, V45, P89, DOI 10.1097/RLI.0b013e3181c5927c; Reynolds PR, 2006, RADIOLOGY, V241, P469, DOI 10.1148/radiol.2412050490; Riviere JE, 1999, COMP PHARMACOKINETIC, P107; Sennoga CA, 2012, ULTRASOUND MED BIOL, V38, P834, DOI 10.1016/j.ultrasmedbio.2012.01.012; Sirsi SR, 2012, ULTRASOUND MED BIOL, V38, P1019, DOI 10.1016/j.ultrasmedbio.2012.01.014; St Michael F, 2011, GLYCOCONJUGATE J, V28, P397, DOI 10.1007/s10719-011-9339-0; Streif JUG, 2005, MAGN RESON MED, V53, P584, DOI 10.1002/mrm.20327; Tardy I, 2002, ACAD RADIOL, V9, pS294, DOI 10.1016/S1076-6332(03)80207-6; Timoshanko JR, 2003, J AM SOC NEPHROL, V14, P1785, DOI 10.1097/01.ASN.0000073902.38428.33; Unnikrishnan S, 2012, AM J ROENTGENOL, V199, P292, DOI 10.2214/AJR.12.8826; van Wamel A, 2007, IEEE ULTR S, P4; Vandegriff KD, 2009, ARTIF ORGANS, V33, P133, DOI 10.1111/j.1525-1594.2008.00697.x; Villanueva FS, 2007, CIRCULATION, V115, P345, DOI 10.1161/CIRCULATIONAHA.106.633917; Waller C, 2000, RADIOLOGY, V215, P189, DOI 10.1148/radiology.215.1.r00ap07189; Wang HJ, 2013, RADIOLOGY, V267, P818, DOI 10.1148/radiol.13122509; Wu WL, 2013, INVEST RADIOL, V48, P803, DOI 10.1097/RLI.0b013e318298652d; Xie A, 2012, JACC-CARDIOVASC IMAG, V5, P1253, DOI 10.1016/j.jcmg.2012.05.017; Yan P, 2014, BIOMATERIALS, V35, P1063, DOI 10.1016/j.biomaterials.2013.10.043; Yeh JS, 2005, J AM COLL CARDIOL, V45, p142A; Yeh JSM, 2010, THESIS U LONDON LOND	53	29	33	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0129681	10.1371/journal.pone.0129681	http://dx.doi.org/10.1371/journal.pone.0129681			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161541	Green Submitted, Green Published, gold			2022-12-26	WOS:000358162300010
J	Mayo, M; Collier, ZA; Winton, C; Chappell, MA				Mayo, Michael; Collier, Zachary A.; Winton, Corey; Chappell, Mark A.			Data-Driven Method to Estimate Nonlinear Chemical Equivalence	PLOS ONE			English	Article							LIFE-CYCLE ASSESSMENT; SELENIUM TOXICITY; IMPACT ASSESSMENT; DECISION-ANALYSIS; MULTIMEDIA FATE; RISK-ASSESSMENT; PART I; SUBSTANCES; POTENTIALS; EMISSIONS	There is great need to express the impacts of chemicals found in the environment in terms of effects from alternative chemicals of interest. Methods currently employed in fields such as life-cycle assessment, risk assessment, mixtures toxicology, and pharmacology rely mostly on heuristic arguments to justify the use of linear relationships in the construction of "equivalency factors," which aim to model these concentration-concentration correlations. However, the use of linear models, even at low concentrations, oversimplifies the nonlinear nature of the concentration-response curve, therefore introducing error into calculations involving these factors. We address this problem by reporting a method to determine a concentration-concentration relationship between two chemicals based on the full extent of experimentally derived concentration-response curves. Although this method can be easily generalized, we develop and illustrate it from the perspective of toxicology, in which we provide equations relating the sigmoid and non-monotone, or "biphasic," responses typical of the field. The resulting concentration-concentration relationships are manifestly nonlinear for nearly any chemical level, even at the very low concentrations common to environmental measurements. We demonstrate the method using real-world examples of toxicological data which may exhibit sigmoid and biphasic mortality curves. Finally, we use our models to calculate equivalency factors, and show that traditional results are recovered only when the concentration-response curves are "parallel," which has been noted before, but we make formal here by providing mathematical conditions on the validity of this approach.	[Mayo, Michael; Collier, Zachary A.; Chappell, Mark A.] US Army, Environm Lab, Engn Res & Dev Ctr, Vicksburg, MS 39183 USA; [Winton, Corey] US Army, Informat Technol Lab, Engn Res & Dev Ctr, Vicksburg, MS 39183 USA	United States Department of Defense; United States Army; U.S. Army Corps of Engineers; U.S. Army Engineer Research & Development Center (ERDC); United States Department of Defense; United States Army; U.S. Army Corps of Engineers; U.S. Army Engineer Research & Development Center (ERDC)	Mayo, M (corresponding author), US Army, Environm Lab, Engn Res & Dev Ctr, Vicksburg, MS 39183 USA.	Michael.L.Mayo@usace.army.mil			Military Materials in the Environment (MME) Program for the U.S Army Engineer Research & Development (ERDC) Laboratory	Military Materials in the Environment (MME) Program for the U.S Army Engineer Research & Development (ERDC) Laboratory	This work was funded through the Military Materials in the Environment (MME) Program for the U.S Army Engineer Research & Development (ERDC) Laboratory.	Ankley GT, 2010, ENVIRON TOXICOL CHEM, V29, P730, DOI 10.1002/etc.34; [Anonymous], 1925, J ECON ENTOMOL; Beckon W, 2008, ENVIRON SCI TECHNOL, V42, P1308, DOI 10.1021/es071148m; Bennett MR, 2007, BIOPHYS J, V92, P3501, DOI 10.1529/biophysj.106.095638; Bjorklund AE, 2002, INT J LIFE CYCLE ASS, V7, P64, DOI 10.1065/lca2001.12/071; Brandes L. J., 1996, 719101029 RIVM; Brentrup F, 2001, EUR J AGRON, V14, P221, DOI 10.1016/S1161-0301(00)00098-8; Calabrese EJ, 2003, ANNU REV PHARMACOL, V43, P175, DOI 10.1146/annurev.pharmtox.43.100901.140223; CARLSON AR, 1987, ARCH ENVIRON CON TOX, V16, P129, DOI 10.1007/BF01055794; Ciliberto A, 2007, PLOS COMPUT BIOL, V3, P463, DOI 10.1371/journal.pcbi.0030045; Conolly RB, 2004, TOXICOL SCI, V77, P151, DOI 10.1093/toxsci/kfh007; de Bruijn H., 2002, HDB LIFE CYCLE ASSES, V7; Ekvall T, 2007, WASTE MANAGE, V27, P989, DOI 10.1016/j.wasman.2007.02.015; GUINEE J, 1993, CHEMOSPHERE, V26, P1925, DOI 10.1016/0045-6535(93)90086-K; Hamilton SJ, 2004, SCI TOTAL ENVIRON, V326, P1, DOI 10.1016/j.scitotenv.2004.01.019; Hamilton SJ, 2003, ECOTOX ENVIRON SAFE, V56, P201, DOI 10.1016/S0147-6513(02)00091-X; HAMILTON SJ, 1990, ENVIRON TOXICOL CHEM, V9, P347, DOI 10.1002/etc.5620090310; Harding LE, 2008, SCI TOTAL ENVIRON, V389, P350, DOI 10.1016/j.scitotenv.2007.09.026; HILTON JW, 1980, J NUTR, V110, P2527, DOI 10.1093/jn/110.12.2527; HOWARD RA, 1988, MANAGE SCI, V34, P679, DOI 10.1287/mnsc.34.6.679; Huijbregts MAJ, 2000, CHEMOSPHERE, V41, P541, DOI 10.1016/S0045-6535(00)00030-8; Huijbregts MAJ, 2005, INTEGR ENVIRON ASSES, V1, P181, DOI 10.1897/2004-007R.1; Huijbregts MAJ, 2011, ENVIRON SCI TECHNOL, V45, P3833, DOI 10.1021/es200918b; Humbert S, 2009, SCI TOTAL ENVIRON, V407, P4812, DOI 10.1016/j.scitotenv.2009.05.024; ISO, 2006, ISO140402006; Jolliet O, 2003, INT J LIFE CYCLE ASS, V8, P324, DOI 10.1007/BF02978505; Jordan JD, 2000, CELL, V103, P193, DOI 10.1016/S0092-8674(00)00112-4; Lagarias JC, 1998, SIAM J OPTIMIZ, V9, P112, DOI 10.1137/S1052623496303470; LEBLANC GA, 1983, ARCH ENVIRON CON TOX, V12, P305, DOI 10.1007/BF01059407; Manneh R, 2010, ENVIRON SCI TECHNOL, V44, P4217, DOI 10.1021/es902983b; Mattson MP, 2010, HORMESIS: A REVOLUTION IN BIOLOGY, TOXICOLOGY AND MEDICINE, P1, DOI 10.1007/978-1-60761-495-1_1; Mayo M, 2014, SCI TOTAL ENVIRON, V494, P104, DOI 10.1016/j.scitotenv.2014.06.061; Myhre G, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P659; Norris G., 2002, MANY DIMENSIONS UNCE; OWENS JW, 1996, INT J LCA, V1, P151; Pennington DW, 2004, ENVIRON TOXICOL CHEM, V23, P1796, DOI 10.1897/03-157; Peters SA., 2012, PHYSL BASED PHARMACO, P273; POSTON HA, 1976, J NUTR, V106, P892, DOI 10.1093/jn/106.7.892; Potting J, 1997, INT J LIFE CYCLE ASS, V2, P171, DOI 10.1007/BF02978815; Puntener W, 1981, MANUAL FIELD TRIALS, P205; Safe SH, 2004, ENVIRON HEALTH PER S, V106, P1051; Schultz TW, 2010, ISSUES TOXICOL, V7, P346; Seager TP, 2008, J IND ECOL, V12, P282, DOI 10.1111/j.1530-9290.2008.00048.x; Seppala J, 2004, INT J LIFE CYCLE ASS, V9, P90, DOI 10.1065/lca2004.02.145; Smadbeck P, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4770273; Smith SJ, 2000, CLIMATIC CHANGE, V44, P445, DOI 10.1023/A:1005584914078; Tallarida RJ, 2012, J PHARMACOL EXP THER, V342, P2, DOI 10.1124/jpet.112.193474; Udo de Haes H A, 1999, INT J LCA, V4, P66, DOI DOI 10.1007/BF02979403; Uhlman BW, 2010, CHEM ENG PROG, V106, P17	49	4	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2015	10	7							e0130494	10.1371/journal.pone.0130494	http://dx.doi.org/10.1371/journal.pone.0130494			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EW	26158701	Green Submitted, Green Published, gold			2022-12-26	WOS:000358161200012
J	Panneton, WM; Gan, Q; Ariel, M				Panneton, W. Michael; Gan, Qi; Ariel, Michael			Injections of Algesic Solutions into Muscle Activate the Lateral Reticular Formation: A Nociceptive Relay of the Spinoreticulothalamic Tract	PLOS ONE			English	Article							C-FOS EXPRESSION; DISTINCT CENTRAL REPRESENTATIONS; PUNCTATE MIDLINE MYELOTOMY; BRAIN-STEM PROJECTIONS; CERVICAL-SPINAL CORD; PARABRACHIAL NUCLEUS; PERIAQUEDUCTAL GRAY; SKELETAL-MUSCLE; REFERRED PAIN; DORSAL-HORN	Although musculoskeletal pain disorders are common clinically, the central processing of muscle pain is little understood. The present study reports on central neurons activated by injections of algesic solutions into the gastrocnemius muscle of the rat, and their subsequent localization by c-Fos immunohistochemistry in the spinal cord and brainstem. An injection (300 mu l) of an algesic solution (6% hypertonic saline, pH 4.0 acetate buffer, or 0.05% capsaicin) was made into the gastrocnemius muscle and the distribution of immunolabeled neurons compared to that obtained after control injections of phosphate buffered saline [pH 7.0]. Most labeled neurons in the spinal cord were found in laminae IV-V, VI, VII and X, comparing favorably with other studies, with fewer labeled neurons in laminae I and II. This finding is consistent with the diffuse pain perception due to noxious stimuli to muscles mediated by sensory fibers to deep spinal neurons as compared to more restricted pain localization during noxious stimuli to skin mediated by sensory fibers to superficial laminae. Numerous neurons were immunolabeled in the brainstem, predominantly in the lateral reticular formation (LRF). Labeled neurons were found bilaterally in the caudalmost ventrolateral medulla, where neurons responsive to noxious stimulation of cutaneous and visceral structures lie. Immunolabeled neurons in the LRF continued rostrally and dorsally along the intermediate reticular nucleus in the medulla, including the subnucleus reticularis dorsalis caudally and the parvicellular reticular nucleus more rostrally, and through the pons medial and lateral to the motor trigeminal nucleus, including the subcoerulear network. Immunolabeled neurons, many of them catecholaminergic, were found bilaterally in the nucleus tractus solitarii, the gracile nucleus, the A1 area, the CVLM and RVLM, the superior salivatory nucleus, the nucleus locus coeruleus, the A5 area, and the nucleus raphe magnus in the pons. The external lateral and superior lateral subnuclei of the parabrachial nuclear complex were consistently labeled in experimental data, but they also were labeled in many control cases. The internal lateral subnucleus of the parabrachial complex was labeled moderately. Few immunolabeled neurons were found in the medial reticular formation, however, but the rostroventromedial medulla was labeled consistently. These data are discussed in terms of an interoceptive, multisynaptic spinoreticulothalamic path, with its large receptive fields and role in the motivational-affective components of pain perceptions.	[Panneton, W. Michael; Gan, Qi; Ariel, Michael] St Louis Univ, Dept Pharmacol & Physiol Sci, St Louis, MO 63103 USA	Saint Louis University	Panneton, WM (corresponding author), St Louis Univ, Dept Pharmacol & Physiol Sci, St Louis, MO 63103 USA.	pannetwm@slu.edu		Ariel, Michael/0000-0001-8155-3261	National Institutes of Health [HL64772]; Presidential Research Fund of Saint Louis University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064772] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Presidential Research Fund of Saint Louis University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	National Institutes of Health grant HL64772 TO WMP. Presidential Research Fund of Saint Louis University to WMP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida TF, 2004, BRAIN RES, V1000, P40, DOI 10.1016/j.brainres.2003.10.073; Arendt-Nielsen L, 2001, CLIN J PAIN, V17, P11, DOI 10.1097/00002508-200103000-00003; Ariel M, 2014, NEUROSCI ABSTR, V39; BELCZYNSKI CR, 1990, BRAIN RES, V527, P204, DOI 10.1016/0006-8993(90)91139-8; Bellavance LL, 1996, J COMP NEUROL, V366, P431, DOI 10.1002/(SICI)1096-9861(19960311)366:3<431::AID-CNE5>3.0.CO;2-5; BERNARD JF, 1995, J COMP NEUROL, V353, P480, DOI 10.1002/cne.903530403; Bester H, 1999, J COMP NEUROL, V405, P421; BESTER H, 1995, J NEUROPHYSIOL, V73, P568, DOI 10.1152/jn.1995.73.2.568; BLOMQVIST A, 1992, BRAIN RES, V579, P17, DOI 10.1016/0006-8993(92)90737-T; Braz J, 2014, NEURON, V82, P522, DOI 10.1016/j.neuron.2014.01.018; BULLITT E, 1992, BRAIN RES, V580, P172, DOI 10.1016/0006-8993(92)90941-2; CASEY KL, 1969, EXP NEUROL, V25, P35, DOI 10.1016/0014-4886(69)90070-3; CECHETTO DF, 1985, J COMP NEUROL, V240, P153, DOI 10.1002/cne.902400205; CERVERO F, 1984, BRAIN RES, V294, P370, DOI 10.1016/0006-8993(84)91053-9; Cervero F, 2009, DIGEST DIS, V27, P3, DOI 10.1159/000268115; Chaitow L, 2014, J BODYW MOV THER, V18, P149, DOI 10.1016/j.jbmt.2014.02.001; Chen YK, 2013, EUR J PAIN, V17, P336, DOI 10.1002/j.1532-2149.2012.00207.x; Clement CI, 1996, J COMP NEUROL, V366, P495, DOI 10.1002/(SICI)1096-9861(19960311)366:3<495::AID-CNE9>3.0.CO;2-#; Craig AD, 2003, CURR OPIN NEUROBIOL, V13, P500, DOI 10.1016/S0959-4388(03)00090-4; DRAGUNOW M, 1989, J NEUROSCI METH, V29, P261, DOI 10.1016/0165-0270(89)90150-7; FIELDS HL, 1975, EXP NEUROL, V47, P118, DOI 10.1016/0014-4886(75)90241-1; Furuta S, 2009, NEUROSCIENCE, V164, P1252, DOI 10.1016/j.neuroscience.2009.09.021; Gao ZH, 2006, J APPL PHYSIOL, V100, P421, DOI 10.1152/japplphysiol.00659.2005; Gauriau C, 2002, EXP PHYSIOL, V87, P251, DOI 10.1113/eph8702357; Gerdle B, 2014, J PAIN RES, V7, P313, DOI 10.2147/JPR.S59144; GIESLER GJ, 1981, J NEUROPHYSIOL, V46, P1285, DOI 10.1152/jn.1981.46.6.1285; Graven-Nielsen T, 2006, SCAND J RHEUMATOL, V35, P1, DOI 10.1080/03009740600865980; GravenNielsen T, 1997, PAIN, V69, P137, DOI 10.1016/S0304-3959(96)03270-8; Grob GN, 2011, PERSPECT BIOL MED, V54, P417, DOI 10.1353/pbm.2011.0044; Han F, 2003, WORLD J GASTROENTERO, V9, P1045; Henderson LA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00569; Hermanson O, 1997, J COMP NEUROL, V387, P114; Hermanson O, 1996, J COMP NEUROL, V368, P45, DOI 10.1002/(SICI)1096-9861(19960422)368:1<45::AID-CNE4>3.0.CO;2-K; Hirshberg RM, 1996, PAIN, V67, P291, DOI 10.1016/0304-3959(96)03127-2; Hoheisel U, 2004, PAIN, V110, P149, DOI 10.1016/j.pain.2004.03.043; HOLSTEGE G, 1977, BRAIN, V100, P265, DOI 10.1093/brain/100.2.265; Hoskin KL, 1999, BRAIN RES, V824, P133, DOI 10.1016/S0006-8993(99)01135-X; Hwang SL, 2004, J PAIN SYMPTOM MANAG, V27, P79, DOI 10.1016/j.jpainsymman.2003.05.005; KAUFMAN MP, 1982, CIRC RES, V50, P133, DOI 10.1161/01.RES.50.1.133; Keay KA, 2000, NEUROSCI LETT, V290, P157, DOI 10.1016/S0304-3940(00)01329-X; Keay KA, 2002, EXP PHYSIOL, V87, P275, DOI 10.1113/eph8702355; Kellgren JH, 1938, CLIN SCI, V3, P175; KEVETTER GA, 1982, J COMP NEUROL, V207, P61, DOI 10.1002/cne.902070106; KITAMURA T, 1993, J COMP NEUROL, V328, P449, DOI 10.1002/cne.903280310; Knight YE, 2005, BRAIN RES, V1045, P1, DOI 10.1016/j.brainres.2005.01.091; Krout KE, 2002, J COMP NEUROL, V448, P53, DOI 10.1002/cne.10236; Lewis T, 1939, CLIN SCI, V4, P47; Light AR, 2008, J NEUROPHYSIOL, V100, P1184, DOI 10.1152/jn.01344.2007; Lu GW, 1999, BRAIN RES REV, V29, P50, DOI 10.1016/S0165-0173(98)00048-4; Maisky VA, 2002, AUTON NEUROSCI-BASIC, V101, P1, DOI 10.1016/S1566-0702(02)00146-7; Marchettini P, 1996, BRAIN RES, V740, P109, DOI 10.1016/S0006-8993(96)00851-7; MARTIN GF, 1979, J COMP NEUROL, V187, P373, DOI 10.1002/cne.901870208; MARTIN GF, 1981, J COMP NEUROL, V196, P663, DOI 10.1002/cne.901960411; McCulloch PF, 1997, NEUROSCIENCE, V78, P913, DOI 10.1016/S0306-4522(96)00633-1; MEHLER WR, 1960, BRAIN, V83, P718, DOI 10.1093/brain/83.4.718; MENSE S, 1993, PAIN, V54, P241, DOI 10.1016/0304-3959(93)90027-M; Mense S, 2009, EXP BRAIN RES, V196, P89, DOI 10.1007/s00221-008-1674-4; Mense S, 1986, PROGR SENSORY PHYSL, V6, P139; Millan MJ, 1999, PROG NEUROBIOL, V57, P1, DOI 10.1016/S0301-0082(98)00048-3; MORGAN C, 1981, J COMP NEUROL, V201, P415, DOI 10.1002/cne.902010308; Multon S, 2005, ACTA NEUROL BELG, V105, P62; Nauta HJW, 2000, J NEUROSURG, V92, P125, DOI 10.3171/spi.2000.92.2.0125; Panfil C, 2006, CEPHALALGIA, V26, P128, DOI 10.1111/j.1468-2982.2005.01005.x; Panneton WM, 2006, NEUROSCIENCE, V141, P889, DOI 10.1016/j.neuroscience.2006.04.055; Panneton WM, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00111; Panneton WM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024499; Panneton WM, 2010, EXP EYE RES, V90, P388, DOI 10.1016/j.exer.2009.11.018; PANNETON WM, 1991, J COMP NEUROL, V308, P51, DOI 10.1002/cne.903080106; Panneton WM, 2005, NEUROSCIENCE, V134, P175, DOI 10.1016/j.neuroscience.2005.02.032; PANNETON WM, 1981, J COMP NEUROL, V199, P199, DOI 10.1002/cne.901990303; Panneton WM, 2012, NEUROSCI ABSTR, V37; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Perl ER, 2007, NAT REV NEUROSCI, V8, P71, DOI 10.1038/nrn2042; Pinto M, 2003, EUR J NEUROSCI, V17, P1393, DOI 10.1046/j.1460-9568.2003.02586.x; Reeh PW, 1996, PROG BRAIN RES, V113, P143, DOI 10.1016/S0079-6123(08)61085-7; Ren Y, 2009, J NEUROPHYSIOL, V102, P244, DOI 10.1152/jn.90985.2008; Rinaman L, 2011, AM J PHYSIOL-REG I, V300, pR222, DOI 10.1152/ajpregu.00556.2010; ROTTOPERCELAY DM, 1992, BRAIN RES, V574, P291, DOI 10.1016/0006-8993(92)90829-X; Sabbatini M, 2004, EXP BRAIN RES, V157, P315, DOI 10.1007/s00221-004-1845-x; SANDOZ PA, 1986, ANAT EMBRYOL, V174, P207, DOI 10.1007/BF00824336; SCHAIBLE HG, 1993, PAIN, V55, P5, DOI 10.1016/0304-3959(93)90183-P; Shin DS, 2008, J KOREAN NEUROSURG S, V43, P97, DOI 10.3340/jkns.2008.43.2.97; SLUGG RM, 1994, J COMP NEUROL, V339, P49, DOI 10.1002/cne.903390106; Sluka KA, 2003, PAIN, V106, P229, DOI 10.1016/S0304-3959(03)00269-0; Sluka KA, 2001, MUSCLE NERVE, V24, P37, DOI 10.1002/1097-4598(200101)24:1<37::AID-MUS4>3.0.CO;2-8; STACEY MJ, 1969, J ANAT, V105, P231; Sun W, 2005, J COMP NEUROL, V482, P273, DOI 10.1002/cne.20434; Svendsen O, 2005, BASIC CLIN PHARMACOL, V97, P52, DOI 10.1111/j.1742-7843.2005.pto_97108.x; TABER E, 1961, J COMP NEUROL, V116, P27, DOI 10.1002/cne.901160104; TAKAYAMA K, 1994, NEUROSCI LETT, V176, P59, DOI 10.1016/0304-3940(94)90871-0; Tesarz J, 2013, EXP BRAIN RES, V224, P571, DOI 10.1007/s00221-012-3337-8; Todd AJ, 2010, NAT REV NEUROSCI, V11, P823, DOI 10.1038/nrn2947; Walder RY, 2010, J PAIN, V11, P210, DOI 10.1016/j.jpain.2009.07.004; Wang CC, 1999, J COMP NEUROL, V415, P341, DOI 10.1002/(SICI)1096-9861(19991220)415:3<341::AID-CNE3>3.0.CO;2-7; Wang LX, 2009, BRAIN RES, V1247, P79, DOI 10.1016/j.brainres.2008.09.094; Willis WD, 1999, P NATL ACAD SCI USA, V96, P7675, DOI 10.1073/pnas.96.14.7675; Willis WD, 1997, J CLIN NEUROPHYSIOL, V14, P2, DOI 10.1097/00004691-199701000-00002; WILLIS WD, 1979, J COMP NEUROL, V188, P543, DOI 10.1002/cne.901880404; Yeo SS, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00416; Zhang MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059234	100	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0130939	10.1371/journal.pone.0130939	http://dx.doi.org/10.1371/journal.pone.0130939			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154308	Green Submitted, Green Published, gold			2022-12-26	WOS:000358159700047
J	Pells, S; Koutsouraki, E; Morfopoulou, S; Valencia-Cadavid, S; Tomlinson, SR; Kalathur, R; Futschik, ME; De Sousa, PA				Pells, Steve; Koutsouraki, Eirini; Morfopoulou, Sofia; Valencia-Cadavid, Sara; Tomlinson, Simon R.; Kalathur, Ravi; Futschik, Matthias E.; De Sousa, Paul A.			Novel Human Embryonic Stem Cell Regulators Identified by Conserved and Distinct CpG Island Methylation State	PLOS ONE			English	Article							DNA METHYLATION; TRANSCRIPTION FACTOR; EPIGENETIC SIGNATURE; GENE-EXPRESSION; SOMATIC-CELLS; HUMAN ES; CULTURE; DIFFERENTIATION; LINES; PLURIPOTENCY	Human embryonic stem cells (hESCs) undergo epigenetic changes in vitro which may compromise function, so an epigenetic pluripotency "signature" would be invaluable for line validation. We assessed Cytosine-phosphate-Guanine Island (CGI) methylation in hESCs by genomic DNA hybridisation to a CGI array, and saw substantial variation in CGI methylation between lines. Comparison of hESC CGI methylation profiles to corresponding somatic tissue data and hESC mRNA expression profiles identified a conserved hESC-specific methylation pattern associated with expressed genes. Transcriptional repressors and activators were over-represented amongst genes whose associated CGIs were methylated or unmethylated specifically in hESCs, respectively. Knockdown of candidate transcriptional regulators (HMGA1, GLIS2, PFDN5) induced differentiation in hESCs, whereas ectopic expression in fibroblasts modulated iPSC colony formation. Chromatin immunoprecipitation confirmed interaction between the candidates and the core pluripotency transcription factor network. We thus identify novel pluripotency genes on the basis of a conserved and distinct epigenetic configuration in human stem cells.	[Pells, Steve; Koutsouraki, Eirini; Morfopoulou, Sofia; Valencia-Cadavid, Sara; Tomlinson, Simon R.; De Sousa, Paul A.] Univ Edinburgh, Sch Clin Studies, MRC Ctr Regenerat Med, Edinburgh EH16 4SB, Midlothian, Scotland; [Pells, Steve; De Sousa, Paul A.] Univ Edinburgh, Ctr Clin Brain Sci, Edinburgh EH16 4SB, Midlothian, Scotland; [Kalathur, Ravi; Futschik, Matthias E.] Univ Algarve, Ctr Mol & Struct Biomed, P-8005139 Faro, Portugal	University of Edinburgh; University of Edinburgh; Universidade do Algarve	Pells, S (corresponding author), Univ Edinburgh, Sch Clin Studies, MRC Ctr Regenerat Med, Edinburgh EH16 4SB, Midlothian, Scotland.	steve.pells@ed.ac.uk; paul.desousa@ed.ac.uk	Futschik, Matthias/AAK-8837-2020; De Sousa, Paul A/H-7416-2013	Futschik, Matthias/0000-0002-6245-8071; De Sousa, Paul A/0000-0003-0745-2504; Pells, Stephen/0000-0001-5866-5759; Morfopoulou, Sofia/0000-0001-8181-4548	EUFP7; Portuguese FCT [PTDC/BIA-GEN/116519/2010]; ESNATS (Embryonic Stem Cell Novel Alternative Testing Strategies) [FP7-201619]; MRC [G0300484] Funding Source: UKRI; Medical Research Council [G0300484] Funding Source: researchfish; Fundação para a Ciência e a Tecnologia [PTDC/BIA-GEN/116519/2010] Funding Source: FCT	EUFP7(European Commission); Portuguese FCT(Portuguese Foundation for Science and Technology); ESNATS (Embryonic Stem Cell Novel Alternative Testing Strategies); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Fundação para a Ciência e a Tecnologia	This work was supported by EUFP7 funding to PDS and ST as part of the ESNATS (Embryonic Stem Cell Novel Alternative Testing Strategies) consortium (FP7-201619) and by the Portuguese FCT to MF (PTDC/BIA-GEN/116519/ 2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allegrucci C, 2007, HUM MOL GENET, V16, P1253, DOI 10.1093/hmg/ddm074; Amps K, 2011, NAT BIOTECHNOL, V29, P1132, DOI 10.1038/nbt.2051; Au KF, 2013, P NATL ACAD SCI USA, V110, pE4821, DOI 10.1073/pnas.1320101110; Baker DEC, 2007, NAT BIOTECHNOL, V25, P207, DOI 10.1038/nbt1285; Bibikova M, 2006, GENOME RES, V16, P1075, DOI 10.1101/gr.5319906; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chia NY, 2010, NATURE, V468, P316, DOI 10.1038/nature09531; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Cleynen I, 2008, INT J ONCOL, V32, P289; De Sousa PA, 2009, STEM CELL RES, V2, P188, DOI 10.1016/j.scr.2009.01.002; Edwards CA, 2007, CURR OPIN CELL BIOL, V19, P281, DOI 10.1016/j.ceb.2007.04.013; Enver T, 2005, HUM MOL GENET, V14, P3129, DOI 10.1093/hmg/ddi345; Ermakov A, 2012, STEM CELL RES, V9, P171, DOI 10.1016/j.scr.2012.06.007; Ezkurdia I, 2014, HUM MOL GENET, V23, P5866, DOI 10.1093/hmg/ddu309; Fletcher JM, 2006, CLONING STEM CELLS, V8, P319, DOI 10.1089/clo.2006.8.319; Fouse SD, 2008, CELL STEM CELL, V2, P160, DOI 10.1016/j.stem.2007.12.011; Hanson C, 2005, APMIS, V113, P751, DOI 10.1111/j.1600-0463.2005.apm_305.x; Hay DC, 2004, STEM CELLS, V22, P225, DOI 10.1634/stemcells.22-2-225; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; Illingworth R, 2008, PLOS BIOL, V6, P37, DOI 10.1371/journal.pbio.0060022; Illingworth RS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001134; Imreh MP, 2006, J CELL BIOCHEM, V99, P508, DOI 10.1002/jcb.20897; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Kim KP, 2007, GENOME RES, V17, P1731, DOI 10.1101/gr.6609207; Kunarso G, 2010, NAT GENET, V42, P631, DOI 10.1038/ng.600; Lee SH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011353; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Maekawa M, 2011, NATURE, V474, P225, DOI 10.1038/nature10106; Maitra A, 2005, NAT GENET, V37, P1099, DOI 10.1038/ng1631; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; Minoguchi S, 2008, STEM CELLS, V26, P1166, DOI 10.1634/stemcells.2007-1106; Monk D, 2006, P NATL ACAD SCI USA, V103, P6623, DOI 10.1073/pnas.0511031103; Mullen AC, 2011, CELL, V147, P565, DOI 10.1016/j.cell.2011.08.050; NORRIS DP, 1991, MAMM GENOME, V1, P78, DOI 10.1007/BF02443782; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]; Rais Y, 2013, NATURE, V502, P65, DOI 10.1038/nature12587; Redmer T, 2011, EMBO REP, V12, P720, DOI 10.1038/embor.2011.88; Rugg-Gunn PJ, 2007, HUM MOL GENET, V16, pR243, DOI 10.1093/hmg/ddm245; Ruiz S, 2012, P NATL ACAD SCI USA, V109, P16196, DOI 10.1073/pnas.1202352109; Ruzov A, 2011, CELL RES, V21, P1332, DOI 10.1038/cr.2011.113; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; Shah SN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048533; Shen Y, 2006, HUM MOL GENET, V15, P2623, DOI 10.1093/hmg/ddl188; Tang X, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S5-S3; Wolffe AP, 1999, SCIENCE, V286, P481, DOI 10.1126/science.286.5439.481; Yeo S, 2007, BIOCHEM BIOPH RES CO, V359, P536, DOI 10.1016/j.bbrc.2007.05.120; Yoshida T, 2008, EXP CELL RES, V314, P1217, DOI 10.1016/j.yexcr.2008.01.002; Zhang F, 2002, J BIOL CHEM, V277, P10139, DOI 10.1074/jbc.M108062200; Zhang R, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2341	53	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2015	10	7							e0131102	10.1371/journal.pone.0131102	http://dx.doi.org/10.1371/journal.pone.0131102			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EC	26151932	gold, Green Published, Green Submitted			2022-12-26	WOS:000358158900017
J	Wu, LJ; Yin, XM; Zheng, L; Zou, JH; Jin, P; Hu, YW; Kudinha, T; Kong, FR; Chen, X; Wang, Q				Wu, Lijuan; Yin, Xiaomao; Zheng, Lei; Zou, Jianhua; Jin, Ping; Hu, Yanwei; Kudinha, Timothy; Kong, Fanrong; Chen, Xu; Wang, Qian			Practical Prediction of Ten Common Streptococcus pneumoniae Serotypes/Serogroups in One PCR Reaction by Multiplex Ligation-Dependent Probe Amplification and Melting Curve (MLPA-MC) Assay in Shenzhen, China	PLOS ONE			English	Article							ANTIMICROBIAL RESISTANCE; SEROTYPE DISTRIBUTION; CAPSULAR SEROTYPES; INVASIVE DISEASE; CHILDREN; EPIDEMIOLOGY; VACCINE; YOUNGER; 19A; 6C	Background Streptococcus pneumoniae has more than 95 distinct serotypes described to date. However, only certain serotypes are more likely to cause pneumococcal diseases. Thus serotype surveillance is important for vaccine formula design as well as in post-vaccine serotype shift monitor. The goal of this study was to develop a practical screening assay for ten Shenzhen China common pneumococcal serotypes/serogroups in one molecular reaction. Methods A molecular assay, based on multiplex ligation-dependent probe amplification (MLPA) and melting curve (MC) analysis, was developed in an integrated approach (MLPA-MC) for the detection of ten capsular serotypes/serogroups 4, 6 (6A/6B/6C/6D), 9V/9A, 14, 15F/15A, 15B/15C, 18 (18F/18A/18B/18C), 19F, 19A and 23F. We designed serotype/serogroupspecific MLPA probes and fluorescent detection probes to discriminate the different serotypes/serogroups in one molecular reaction. The three steps of MLPA-MC assay are continuous reactions in one well detected by LightCycler 480. A total of 210 S. pneumoniae isolates from our local Maternity and Child Health Hospital were randomly chosen to evaluate the assay against published multiplex PCR assays. Results Our results showed that 198 (94.3%) of S. pneumoniae isolates were type-able by our assays and the results were in complete concordance with the published multiplex PCRs. Using the MLPA-MC assay, 96 S. pneumoniae isolates could be typed within 3 hours with limited hands-on time. This serotype/serogroup-screening assay can be easily modified or extended by modification of the serotype/serogroup-specific MLPA probes combinations according to the needs of different laboratories. Conclusions We recommend use of this assay as a starting point for screening serotype/serogroup frequencies. There is a need for this assay to be combined with other molecular typing assays, like published serotype specific PCRs, or even the Quellung reaction for serotype confirmation.	[Wu, Lijuan; Zheng, Lei; Hu, Yanwei; Wang, Qian] Southern Med Univ, Nanfang Hosp, Lab Med Ctr, Guangzhou, Guangdong, Peoples R China; [Wu, Lijuan; Zou, Jianhua; Jin, Ping; Chen, Xu] Baoan Matern & Child Hlth Hosp, Clin Lab, Shenzhen, Guangdong, Peoples R China; [Yin, Xiaomao] Southern Med Univ, Affiliated Hosp 1, Clin Lab, Guangzhou, Guangdong, Peoples R China; [Kudinha, Timothy] Charles Sturt Univ, Orange, NSW, Australia; [Kong, Fanrong] Westmead Hosp, Inst Clin Pathol & Med Res Pathol West, Ctr Infect Dis & Microbiol, Westmead, NSW, Australia	Southern Medical University - China; Southern Medical University - China; Charles Sturt University; University of Sydney	Wang, Q (corresponding author), Southern Med Univ, Nanfang Hosp, Lab Med Ctr, Guangzhou, Guangdong, Peoples R China.	nfyyWangQian@163.com			Science and Technology plan of Bureau of Health of Shenzhen Municipality; China [201302168]	Science and Technology plan of Bureau of Health of Shenzhen Municipality; China	This work was supported by the grant of Science and Technology plan of Bureau of Health of Shenzhen Municipality; China (201302168) to LW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azzari C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009282; Carvalho MD, 2010, J CLIN MICROBIOL, V48, P1611, DOI 10.1128/JCM.02243-09; Croucher NJ, 2013, NAT GENET, V45, P656, DOI 10.1038/ng.2625; Dortet L, 2009, DIAGN MICR INFEC DIS, V65, P49, DOI 10.1016/j.diagmicrobio.2009.05.009; Elberse K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025018; Jin P, 2009, J INFECT DIS, V200, P1375, DOI 10.1086/606118; Jin P, 2009, J CLIN MICROBIOL, V47, P2470, DOI 10.1128/JCM.00484-09; Kim SH, 2012, ANTIMICROB AGENTS CH, V56, P1418, DOI 10.1128/AAC.05658-11; Kong FR, 2006, J CLIN MICROBIOL, V44, P1887, DOI 10.1128/JCM.44.5.1887-1891.2006; Kong FR, 2005, J MED MICROBIOL, V54, P351, DOI 10.1099/jmm.0.45924-0; Kyaw MH, 2006, NEW ENGL J MED, V354, P1455, DOI 10.1056/NEJMoa051642; Liu YD, 2008, DIAGN MICR INFEC DIS, V61, P256, DOI 10.1016/j.diagmicrobio.2008.02.004; Ma X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067507; McEllistrem MC, 2009, FUTURE MICROBIOL, V4, P857, DOI 10.2217/FMB.09.58; Miernyk K, 2011, J CLIN MICROBIOL, V49, P3209, DOI 10.1128/JCM.00610-11; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Pai R, 2006, J CLIN MICROBIOL, V44, P124, DOI 10.1128/JCM.44.1.124-131.2006; Reijans M, 2008, J CLIN MICROBIOL, V46, P1232, DOI 10.1128/JCM.02294-07; Schouten JP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf056; Selva L, 2012, J CLIN MICROBIOL, V50, P3451, DOI 10.1128/JCM.01368-12; Siira L, 2012, J CLIN MICROBIOL, V50, P2727, DOI 10.1128/JCM.00689-12; Tan TQ, 2012, CLIN MICROBIOL REV, V25, P409, DOI 10.1128/CMR.00018-12; Thomas JC, 2011, J BACTERIOL, V193, P3409, DOI 10.1128/JB.05079-11; Tyrrell GJ, 2011, J INFECT DIS, V203, P1345, DOI 10.1093/infdis/jir056; van Selm S, 2003, INFECT IMMUN, V71, P6192, DOI 10.1128/IAI.71.11.6192-6198.2003; Xue L, 2010, CLIN INFECT DIS, V50, P741, DOI 10.1086/650534; Yao KH, 2011, VACCINE, V29, P2296, DOI 10.1016/j.vaccine.2011.01.027	27	1	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2015	10	7							e0130664	10.1371/journal.pone.0130664	http://dx.doi.org/10.1371/journal.pone.0130664			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EC	26151828	gold, Green Published, Green Submitted			2022-12-26	WOS:000358158900014
J	Beaulieu, LM; Clancy, L; Tanriverdi, K; Benjamin, EJ; Kramer, CD; Weinberg, EO; He, XB; Mekasha, S; Mick, E; Ingalls, RR; Genco, CA; Freedman, JE				Beaulieu, Lea M.; Clancy, Lauren; Tanriverdi, Kahraman; Benjamin, Emelia J.; Kramer, Carolyn D.; Weinberg, Ellen O.; He, Xianbao; Mekasha, Samrawit; Mick, Eric; Ingalls, Robin R.; Genco, Caroline A.; Freedman, Jane E.			Specific Inflammatory Stimuli Lead to Distinct Platelet Responses in Mice and Humans	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; APOLIPOPROTEIN-E; PORPHYROMONAS-GINGIVALIS; CHLAMYDIA-PNEUMONIAE; CHLAMYDOPHILA-PNEUMONIAE; ACCELERATES ATHEROSCLEROSIS; GENECHIP DATA; INFECTION; EXPRESSION; PROGRESSION	Introduction Diverse and multi-factorial processes contribute to the progression of cardiovascular disease. These processes affect cells involved in the development of this disease in varying ways, ultimately leading to atherothrombosis. The goal of our study was to compare the differential effects of specific stimuli - two bacterial infections and a Western diet - on platelet responses in ApoE(-/-) mice, specifically examining inflammatory function and gene expression. Results from murine studies were verified using platelets from participants of the Framingham Heart Study (FHS; n = 1819 participants). Methods Blood and spleen samples were collected at weeks 1 and 9 from ApoE(-/-) mice infected with Porphyromonas gingivalis or Chlamydia pneumoniae and from mice fed a Western diet for 9 weeks. Transcripts based on data from a Western diet in ApoE(-/-) mice were measured in platelet samples from FHS using high throughput qRT-PCR. Results At week 1, both bacterial infections increased circulating platelet-neutrophil aggregates. At week 9, these cells individually localized to the spleen, while Western diet resulted in increased platelet-neutrophil aggregates in the spleen only. Microarray analysis of platelet RNA from infected or Western diet-fed mice at week 1 and 9 showed differential profiles. Genes, such as Serpina1a, Ttr, Fgg, Rpl21, and Alb, were uniquely affected by infection and diet. Results were reinforced in platelets obtained from participants of the FHS. Conclusion Using both human studies and animal models, results demonstrate that variable sources of inflammatory stimuli have the ability to influence the platelet phenotype in distinct ways, indicative of the diverse function of platelets in thrombosis, hemostasis, and immunity.	[Beaulieu, Lea M.; Clancy, Lauren; Tanriverdi, Kahraman; Freedman, Jane E.] Univ Massachusetts, Sch Med, Dept Med, Div Cardiovasc Med, Worcester, MA 01655 USA; [Benjamin, Emelia J.] NHLBI, Framingham, MA USA; [Benjamin, Emelia J.] Boston Univ, Framingham Heart Inst, Framingham, MA USA; [Benjamin, Emelia J.] Boston Univ, Sch Med, Dept Med, Cardiol & Prevent Med Sect, Boston, MA 02118 USA; [Kramer, Carolyn D.; Weinberg, Ellen O.; Ingalls, Robin R.; Genco, Caroline A.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [He, Xianbao; Genco, Caroline A.] Boston Univ, Sch Med, Dept Med, Infect Dis Sect, Boston, MA 02118 USA; [Mekasha, Samrawit; Ingalls, Robin R.] Boston Med Ctr, Boston, MA USA; [Mick, Eric] Univ Massachusetts, Sch Med, Dept Quantitat Hlth Sci, Worcester, MA USA; [Genco, Caroline A.] Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02118 USA	University of Massachusetts System; University of Massachusetts Worcester; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Boston University; Framingham Heart Study; Boston University; Boston University; Boston University; Boston Medical Center; University of Massachusetts System; University of Massachusetts Worcester; Boston University	Beaulieu, LM (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Div Cardiovasc Med, Worcester, MA 01655 USA.	lea.beaulieu@umassmed.edu	He, Xianbao/AAE-4838-2019; Benjamin, Emelia/E-7103-2011	Benjamin, Emelia/0000-0003-4076-2336; Weinberg, Ellen/0000-0002-6937-0371	National Institutes of Health [N01-HC 25195, RFA-HL-12-008, RFA-RM-12-013, P-01-HL085381, P01 AI078894, 1RO1 HL64753, R01 HL076784, 1 R01 AG028321]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076784, R01HL064753, U54HL112311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI078894] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028321] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The work presented was supported by N01-HC 25195, RFA-HL-12-008 (JEF, EM), RFA-RM-12-013 (JEF), P-01-HL085381 (JEF), P01 AI078894 (LMB, CDK, EOW, XH, SM, RI, CAG, and JEF), 1RO1 HL64753, R01 HL076784, and 1 R01 AG028321 (EJB), from the National Institutes of Health (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwala R, 2018, NUCLEIC ACIDS RES, V46, pD8, DOI [10.1093/nar/gkx1095, 10.1093/nar/gkv1290]; Beaulieu LM, 2014, ARTERIOSCL THROM VAS, V34, P552, DOI 10.1161/ATVBAHA.113.302700; Beaulieu LM, 2011, BLOOD, V117, P5963, DOI 10.1182/blood-2010-09-304949; Bertola A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013577; Blair P, 2009, CIRC RES, V104, P346, DOI 10.1161/CIRCRESAHA.108.185785; Brettschneider J, 2008, TECHNOMETRICS, V50, P241, DOI 10.1198/004017008000000334; Browning LM, 2008, OBESITY FACTS, V1, P259, DOI 10.1159/000169832; Cheng C, 2011, CIRC RES, V109, P385, DOI 10.1161/CIRCRESAHA.111.243444; Ciervo A, 2008, INT J IMMUNOPATH PH, V21, P421, DOI 10.1177/039463200802100222; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Dhingra R, 2007, AM J MED, V120, P1054, DOI 10.1016/j.amjmed.2007.08.037; Eitzman DT, 2000, ARTERIOSCL THROM VAS, V20, P1831, DOI 10.1161/01.ATV.20.7.1831; Freedman JE, 2010, CIRCULATION, V122, P119, DOI 10.1161/CIRCULATIONAHA.109.928192; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gibson FC, 2004, CIRCULATION, V109, P2801, DOI 10.1161/01.CIR.0000129769.17895.F0; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Haraszthy VI, 2000, J PERIODONTOL, V71, P1554, DOI 10.1902/jop.2000.71.10.1554; Hayashi C, 2010, MOL ORAL MICROBIOL, V25, P305, DOI 10.1111/j.2041-1014.2010.00582.x; Hayashi C, 2012, J IMMUNOL, V189, P3681, DOI 10.4049/jimmunol.1201541; Hayashi C, 2011, ATHEROSCLEROSIS, V215, P52, DOI 10.1016/j.atherosclerosis.2010.12.009; He XB, 2010, J IMMUNOL, V184, P5743, DOI 10.4049/jimmunol.0903937; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jha HC, 2009, APMIS, V117, P905, DOI 10.1111/j.1600-0463.2009.02553.x; Kalvegren H, 2003, ARTERIOSCL THROM VAS, V23, P1677, DOI 10.1161/01.ATV.0000084810.52464.D5; Karshovska E, 2015, CIRC RES, V116, P587, DOI 10.1161/CIRCRESAHA.116.304035; Kramer CD, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1176; Li L, 2002, CIRCULATION, V105, P861, DOI 10.1161/hc0702.104178; Lindemann S, 2001, J CELL BIOL, V154, P485, DOI 10.1083/jcb.200105058; McManus DD, 2013, ARTERIOSCL THROM VAS, V33, P2666, DOI 10.1161/ATVBAHA.112.301112; Moazed TC, 1997, J INFECT DIS, V175, P883, DOI 10.1086/513986; Moustardas P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108240; Naiki Y, 2008, J IMMUNOL, V181, P7176, DOI 10.4049/jimmunol.181.10.7176; Nakano K, 2008, ORAL MICROBIOL IMMUN, V23, P170, DOI 10.1111/j.1399-302X.2007.00406.x; NAKASHIMA Y, 1994, ARTERIOSCLER THROMB, V14, P133, DOI 10.1161/01.ATV.14.1.133; Nassar H, 2002, INFECT IMMUN, V70, P268, DOI 10.1128/IAI.70.1.268-276.2002; Nie P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097009; Ohki T, 2012, AM HEART J, V163, P164, DOI 10.1016/j.ahj.2011.10.012; Player MS, 2014, EUR J PREV CARDIOL, V21, P559, DOI 10.1177/2047487312472078; Risitano A, 2012, BLOOD, V119, P6288, DOI 10.1182/blood-2011-12-396440; Rowley JW, 2011, BLOOD, V118, pE101, DOI 10.1182/blood-2011-03-339705; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sakurai-Komada N, 2014, ATHEROSCLEROSIS, V233, P338, DOI 10.1016/j.atherosclerosis.2014.01.023; Sarwar N, 2012, LANCET, V379, P1205, DOI 10.1016/S0140-6736(11)61931-4; Scott NJA, 2012, AM J PHYSIOL-ENDOC M, V302, pE576, DOI 10.1152/ajpendo.00222.2011; Semple JW, 2011, NAT REV IMMUNOL, V11, P264, DOI 10.1038/nri2956; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Subramanian A, 2007, BIOINFORMATICS, V23, P3251, DOI 10.1093/bioinformatics/btm369; Sullivan PM, 1997, J BIOL CHEM, V272, P17972, DOI 10.1074/jbc.272.29.17972; Velsko IM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097811; Yakob M, 2011, J PERIODONTAL RES, V46, P749, DOI 10.1111/j.1600-0765.2011.01398.x	50	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131688	10.1371/journal.pone.0131688	http://dx.doi.org/10.1371/journal.pone.0131688			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148065	Green Submitted, Green Published, gold			2022-12-26	WOS:000358157600129
J	Li, N; Cheng, WL; Huang, TQ; Yuan, J; Wang, X; Song, MY				Li, Na; Cheng, Wenli; Huang, Tiequn; Yuan, Jie; Wang, Xi; Song, Meiyue			Vascular Adventitia Calcification and Its Underlying Mechanism	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; TRANSFORMING GROWTH-FACTOR-BETA-1; AORTIC DISTENSIBILITY; MOLECULAR-MECHANISMS; DISEASE; AGE; FIBROBLASTS; TGF-BETA-1	Previous research on vascular calcification has mainly focused on the vascular intima and media. However, we show here that vascular calcification may also occur in the adventitia. The purpose of this work is to help elucidate the pathogenic mechanisms underlying vascular calcification. The calcified lesions were examined by Von Kossa staining in ApoE-/-mice which were fed high fat diets (HFD) for 48 weeks and human subjects aged 60 years and older that had died of coronary heart disease, heart failure or acute renal failure. Explant cultured fibroblasts and smooth muscle cells (SMCs) were obtained from rat adventitia and media, respectively. After calcification induction, cells were collected for Alizarin Red S staining. Calcified lesions were observed in the aorta adventitia and coronary artery adventitia of ApoE-/-mice, as well as in the aorta adventitia of human subjects examined. Explant culture of fibroblasts, the primary cell type comprising the adventitia, was successfully induced for calcification after incubation with TGF-beta 1 (20 ng/ml) + mineralization media for 4 days, and the phenotype conversion vascular adventitia fibroblasts into myofibroblasts was identified. Culture of SMCs, which comprise only a small percentage of all cells in the adventitia, in calcifying medium for 14 days resulted in significant calcification. Vascular calcification can occur in the adventitia. Adventitia calcification may arise from the fibroblasts which were transformed into myofibroblasts or smooth muscle cells.	[Li, Na; Huang, Tiequn] Minist Hlth, China Japan Friendship Hosp, Dept Hlth Care, Beijing, Peoples R China; [Cheng, Wenli] Minist Hlth, China Japan Friendship Hosp, Ctr Cardiovasc Dis, Beijing, Peoples R China; [Yuan, Jie; Wang, Xi; Song, Meiyue] Beijing Univ Tradit Chinese Med, Grad Sch, Beijing, Peoples R China	China-Japan Friendship Hospital; China-Japan Friendship Hospital; Beijing University of Chinese Medicine	Cheng, WL (corresponding author), Minist Hlth, China Japan Friendship Hosp, Ctr Cardiovasc Dis, Beijing, Peoples R China.	chengwenli2013@163.com			general program of the national natural science foundation of China [81173420]	general program of the national natural science foundation of China(National Natural Science Foundation of China (NSFC))	Supported by the general program of the national natural science foundation of China, No: 81173420. The funder has an role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bulick AS, 2009, TISSUE ENG PT A, V15, P815, DOI 10.1089/ten.tea.2008.0179; Cai Y, 2010, CARDIOVASC RES, V85, P864, DOI 10.1093/cvr/cvp366; Cianciolo G, 2010, MINERVA UROL NEFROL, V62, P51; DART AM, 1991, LANCET, V338, P270, DOI 10.1016/0140-6736(91)90415-L; Demer LL, 2008, CIRCULATION, V117, P2938, DOI 10.1161/CIRCULATIONAHA.107.743161; Dourron HM, 2005, AM J PHYSIOL-HEART C, V288, pH946, DOI 10.1152/ajpheart.00413.2004; Dunkern TR, 2007, EUR J PHARMACOL, V572, P12, DOI 10.1016/j.ejphar.2007.06.036; El-Hamamsy I, 2009, NAT REV CARDIOL, V6, P771, DOI 10.1038/nrcardio.2009.191; Ellam T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088767; Harvey A, 2015, J MOL CELL CARDIOL, V83, P112, DOI 10.1016/j.yjmcc.2015.04.011; Hruska KA, 2009, CIRC RES, V104, P710, DOI 10.1161/CIRCRESAHA.109.195487; Iribarren C, 2000, JAMA-J AM MED ASSOC, V283, P2810, DOI 10.1001/jama.283.21.2810; Jiang LQ, 2012, HYPERTENSION, V60, P1192, DOI 10.1161/HYPERTENSIONAHA.112.196840; Johnson RC, 2006, CIRC RES, V99, P1044, DOI 10.1161/01.RES.0000249379.55535.21; Lacolley P, 2012, CARDIOVASC RES, V95, P194, DOI 10.1093/cvr/cvs135; Lai CF, 2012, ENDOCRINOLOGY, V153, P3897, DOI 10.1210/en.2012-1216; Lanzer P, 2014, EUR HEART J, V35, P1515, DOI 10.1093/eurheartj/ehu163; Maiellaro K, 2007, CARDIOVASC RES, V75, P640, DOI 10.1016/j.cardiores.2007.06.023; MITCHELL JRA, 1977, ATHEROSCLEROSIS, V27, P437, DOI 10.1016/0021-9150(77)90162-9; Moe SM, 2004, NEPHROL DIAL TRANSPL, V19, P2387, DOI 10.1093/ndt/gfh303; Moreno PR, 2002, CIRCULATION, V105, P2504, DOI 10.1161/01.CIR.0000017265.52501.37; Nesti LJ, 2007, J CELL BIOCHEM, V101, P348, DOI 10.1002/jcb.21180; Newman AB, 2001, CIRCULATION, V104, P2679, DOI 10.1161/hc4601.099464; OHTSUKA S, 1994, J AM COLL CARDIOL, V24, P1406, DOI 10.1016/0735-1097(94)90127-9; Persy V, 2009, TRENDS MOL MED, V15, P405, DOI 10.1016/j.molmed.2009.07.001; Rayner K, 2000, J VASC RES, V37, P93, DOI 10.1159/000025720; Sakamoto S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105739; Sata M, 2003, TRENDS CARDIOVAS MED, V13, P249, DOI 10.1016/S1050-1738(03)00106-3; Shao JS, 2006, ARTERIOSCL THROM VAS, V26, P1423, DOI 10.1161/01.ATV.0000220441.42041.20; Simionescu A, 2007, AM J PATHOL, V171, P116, DOI 10.2353/ajpath.2007.060930; SIMONSON E, 1960, CIRCULATION, V22, P126, DOI 10.1161/01.CIR.22.1.126; Sui YB, 2013, PEPTIDES, V42, P25, DOI 10.1016/j.peptides.2012.12.023; Wang HD, 1999, HYPERTENSION, V33, P1225, DOI 10.1161/01.HYP.33.5.1225; Wang MY, 2006, ARTERIOSCL THROM VAS, V26, P1503, DOI 10.1161/01.ATV.0000225777.58488.f2; Wang MY, 2010, CURR HYPERTENS REV, V6, P266, DOI 10.2174/157340210793611668; Weaver M, 2006, AM J PHYSIOL-HEART C, V290, pH1933, DOI 10.1152/ajpheart.00690.2005; Wilcox JN, 1996, INT J CARDIOL, V54, pS21, DOI 10.1016/S0167-5273(96)02811-2; Yan JY, 2011, ARTERIOSCL THROM VAS, V31, P608, DOI 10.1161/ATVBAHA.110.220749; Zhang YG, 2010, CHINESE MED J-PEKING, V123, P3634, DOI 10.3760/cma.j.issn.0366-6999.2010.24.023	39	20	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132506	10.1371/journal.pone.0132506	http://dx.doi.org/10.1371/journal.pone.0132506			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148272	Green Published, gold, Green Submitted			2022-12-26	WOS:000358157600292
J	Tseng, CY; Chang, JF; Wang, JS; Chang, YJ; Gordon, MK; Chao, MW				Tseng, Chia-Yi; Chang, Jing-Fen; Wang, Jhih-Syuan; Chang, Yu-Jung; Gordon, Marion K.; Chao, Ming-Wei			Protective Effects of N-Acetyl Cysteine against Diesel Exhaust Particles-Induced Intracellular ROS Generates Pro-Inflammatory Cytokines to Mediate the Vascular Permeability of Capillary-Like Endothelial Tubes	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; HEME OXYGENASE-1; OXIDATIVE STRESS; VE-CADHERIN; AIR-POLLUTION; IN-VITRO; MICROVASCULAR PERMEABILITY; PULMONARY INFLAMMATION; PARTICULATE MATTER; LUNG INFLAMMATION	Exposure to diesel exhaust particles (DEP) is associated with pulmonary and cardiovascular diseases. Previous studies using in vitro endothelial tubes as a simplified model of capillaries have found that DEP-induced ROS increase vascular permeability with rearrangement or internalization of adherens junctional VE-cadherin away from the plasma membrane. This allows DEPs to penetrate into the cell and capillary lumen. In addition, pro-inflammatory cytokines are up-regulated and mediate vascular permeability in response to DEP. However, the mechanisms through which these DEP-induced pro-inflammatory cytokines increase vascular permeability remain unknown. Hence, we examined the ability of DEP to induce permeability of human umbilical vein endothelial cell tube cells to investigate these mechanisms. Furthermore, supplementation with NAC reduces ROS production following exposure to DEP. HUVEC tube cells contributed to a pro-inflammatory response to DEP-induced intracellular ROS generation. Endothelial oxidative stress induced the release of TNF-alpha and IL-6 from tube cells, subsequently stimulating the secretion of VEGF-A independent of HO-1. Our data suggests that DEP-induced intracellular ROS and release of the pro-inflammatory cytokines TNF- alpha and IL-6, which would contribute to VEGF-A secretion and disrupt cell-cell borders and increase vasculature permeability. Addition of NAC suppresses DEP-induced ROS efficiently and reduces subsequent damages by increasing endogenous glutathione.	[Tseng, Chia-Yi] Chung Yuan Christian Univ, Coll Engn, Dept Biomed Engn, Taoyuan, Taiwan; [Tseng, Chia-Yi; Chao, Ming-Wei] Chung Yuan Christian Univ, Ctr Nanotechnol, Taoyuan, Taiwan; [Chang, Jing-Fen; Wang, Jhih-Syuan; Chang, Yu-Jung; Chao, Ming-Wei] Chung Yuan Christian Univ, Coll Sci, Dept Biosci Technol, Taoyuan, Taiwan; [Gordon, Marion K.] Rutgers State Univ, Joint Program Toxicol, Piscataway, NJ USA	Chung Yuan Christian University; Chung Yuan Christian University; Chung Yuan Christian University; Rutgers State University New Brunswick	Chao, MW (corresponding author), Chung Yuan Christian Univ, Ctr Nanotechnol, Taoyuan, Taiwan.	chao@cycu.edu.tw			Ministry of Science and Technology in Taiwan [NSC-102-2320-B-033-001-MY3]	Ministry of Science and Technology in Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by a grant from Ministry of Science and Technology (NSC-102-2320-B-033-001-MY3) in Taiwan.	Alagappan VKT, 2005, CELL BIOCHEM BIOPHYS, V43, P119, DOI 10.1385/CBB:43:1:119; Alfaro-Moreno E, 2002, ENVIRON HEALTH PERSP, V110, P715, DOI 10.1289/ehp.02110715; Bai YS, 2001, FREE RADICAL BIO MED, V30, P555, DOI 10.1016/S0891-5849(00)00499-8; Beck-Speier I, 2005, FREE RADICAL BIO MED, V38, P1080, DOI 10.1016/j.freeradbiomed.2005.01.004; Becker S, 2005, ENVIRON HEALTH PERSP, V113, P1032, DOI 10.1289/ehp.7996; Becker Susanne, 2005, Toxicol Appl Pharmacol, V207, P269, DOI 10.1016/j.taap.2005.01.023; Brook RD, 2002, CIRCULATION, V105, P1534, DOI 10.1161/01.CIR.0000013838.94747.64; Brouard S, 2002, J BIOL CHEM, V277, P17950, DOI 10.1074/jbc.M108317200; Bussolati B, 2004, BLOOD, V103, P761, DOI 10.1182/blood-2003-06-1974; Carmeliet P, 1999, CELL, V98, P147, DOI 10.1016/S0092-8674(00)81010-7; Chao MW, 2012, TOXICOLOGY, V297, P34, DOI 10.1016/j.tox.2012.03.009; Chao MW, 2015, J APPL TOXICOL, V35, P466, DOI 10.1002/jat.3046; Chao MW, 2011, TOXICOLOGY, V279, P73, DOI 10.1016/j.tox.2010.09.011; Cisowski J, 2005, BIOCHEM BIOPH RES CO, V326, P670, DOI 10.1016/j.bbrc.2004.11.083; CONNOLLY DT, 1989, J CLIN INVEST, V84, P1470, DOI 10.1172/JCI114322; Cromer WE, 2014, ANGIOGENESIS, V17, P395, DOI 10.1007/s10456-013-9393-2; Davin JC, 2016, PEDIATR NEPHROL, V31, P207, DOI 10.1007/s00467-015-3082-x; Dean O, 2011, J PSYCHIATR NEUROSCI, V36, P78, DOI 10.1503/jpn.100057; Dejana E, 2004, NAT REV MOL CELL BIO, V5, P261, DOI 10.1038/nrm1357; Dejana E, 2008, J CELL SCI, V121, P2115, DOI 10.1242/jcs.017897; Dodd S, 2008, EXPERT OPIN BIOL TH, V8, P1955, DOI 10.1517/14728220802517901 ; Du YP, 2015, FASEB J, V29, P2194, DOI 10.1096/fj.14-269431; Dudek SM, 2001, J APPL PHYSIOL, V91, P1487, DOI 10.1152/jappl.2001.91.4.1487; Dulak J, 2008, CURR OPIN LIPIDOL, V19, P505, DOI 10.1097/MOL.0b013e32830d81e9; FERRARA N, 1989, BIOCHEM BIOPH RES CO, V161, P851, DOI 10.1016/0006-291X(89)92678-8; FLECK A, 1985, LANCET, V1, P781; Forchhammer L, 2012, TOXICOL LETT, V209, P121, DOI 10.1016/j.toxlet.2011.12.003; Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486; Gavard J, 2013, CELL ADHES MIGR, V7, P455, DOI 10.4161/cam.27330; Harris ES, 2010, CURR OPIN CELL BIOL, V22, P651, DOI 10.1016/j.ceb.2010.07.006; Hartz AMS, 2008, FASEB J, V22, P2723, DOI 10.1096/fj.08-106997; Inoue KI, 2006, EXP BIOL MED, V231, P1626; Jozkowicz A, 2003, ANTIOXID REDOX SIGN, V5, P155, DOI 10.1089/152308603764816514; KECK PJ, 1989, SCIENCE, V246, P1309, DOI 10.1126/science.2479987; Kelly FJ, 2011, CLIN EXP ALLERGY, V41, P1059, DOI 10.1111/j.1365-2222.2011.03776.x; Kerkar S, 2006, J SURG RES, V132, P40, DOI 10.1016/j.jss.2005.06.033; Kleemann R, 2008, CARDIOVASC RES, V79, P360, DOI 10.1093/cvr/cvn120; Krishnan RM, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-7; Kuhnert F, 2008, P NATL ACAD SCI USA, V105, P10185, DOI 10.1073/pnas.0803194105; Lampugnani MG, 2007, NOVART FDN SYMP, V283, P238; Lee GB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060632; Li YJ, 2013, OXID MED CELL LONGEV, V2013, DOI [DOI 10.1155/2013/323607, 10.1155/2013/323607]; Lin HH, 2008, J MOL CELL CARDIOL, V45, P44, DOI 10.1016/j.yjmcc.2008.04.011; Ma JYC, 2002, J ENVIRON SCI HEAL C, V20, P117, DOI 10.1081/GNC-120016202; MARUO N, 1992, ENDOCRINOLOGY, V131, P710, DOI 10.1210/en.131.2.710; Masha A, 2014, CURR MED CHEM, V21, P3616, DOI 10.2174/0929867321666140706132900; Matsunaga T, 2009, CHEM-BIOL INTERACT, V181, P52, DOI 10.1016/j.cbi.2009.05.005; McWhinney RD, 2013, ENVIRON SCI TECHNOL, V47, P3362, DOI 10.1021/es304676x; Muller WA, 2011, ANNU REV PATHOL-MECH, V6, P323, DOI 10.1146/annurev-pathol-011110-130224; Nagy JA, 2002, COLD SPRING HARB SYM, V67, P227, DOI 10.1101/sqb.2002.67.227; Nemmar A, 2003, AM J RESP CRIT CARE, V168, P1366, DOI 10.1164/rccm.200306-801OC; NEMMAR A, 2013, BIOMED RES INT, V2013, DOI DOI 10.1155/2013/279371; Nemmar A, 2008, TOXICOL LETT, V176, P20, DOI 10.1016/j.toxlet.2007.09.006; Nemmar A, 2012, TOXICOLOGY, V292, P162, DOI 10.1016/j.tox.2011.12.009; Nwariaku FE, 2002, SURGERY, V132, P180, DOI 10.1067/msy.2002.125305; Paolicchi A, 2002, BIOCHEM PHARMACOL, V64, P1027, DOI 10.1016/S0006-2952(02)01173-5; Ristovski ZD, 2006, ENVIRON SCI TECHNOL, V40, P1314, DOI 10.1021/es050094i; Rusznak C, 2000, AM J RESP CELL MOL, V23, P530, DOI 10.1165/ajrcmb.23.4.3959; Salvi S, 1999, AM J RESP CRIT CARE, V159, P702, DOI 10.1164/ajrccm.159.3.9709083; Scallan J., 2010, FLUID EXCHANGE REGUL; Schwarze PE, 2013, BIOMED RES INT, V2013, DOI [DOI 10.1155/2013/685142, 10.1155/2013/685142]; SENGER DR, 1983, SCIENCE, V219, P983, DOI 10.1126/science.6823562; Sheikpranbabu Sardarpasha, 2009, Journal of Nanobiotechnology, V7, P8, DOI 10.1186/1477-3155-7-8; Silva G, 2006, J IMMUNOL, V177, P1894, DOI 10.4049/jimmunol.177.3.1894; Singh P, 2004, ENVIRON HEALTH PERSP, V112, P820, DOI 10.1289/ehp.6579; Suarez S, 2001, J CELL SCI, V114, P1229; Terry CM, 1999, AM J PHYSIOL-HEART C, V276, pH1493, DOI 10.1152/ajpheart.1999.276.5.H1493; Terry CM, 1998, AM J PHYSIOL-HEART C, V274, pH883, DOI 10.1152/ajpheart.1998.274.3.H883; Tornqvist H, 2007, AM J RESP CRIT CARE, V176, P395, DOI 10.1164/rccm.200606-872OC; Toyooka T, 2012, TOXICOL APPL PHARM, V264, P404, DOI 10.1016/j.taap.2012.08.017; Tseng CY, 2015, CARDIOVASC TOXICOL, V15, P345, DOI 10.1007/s12012-014-9302-y; Ulrich MMW, 2002, J TOXICOL ENV HEAL A, V65, P1571, DOI 10.1080/00984100290071676; Vandenbroucke E, 2008, ANN NY ACAD SCI, V1123, P134, DOI 10.1196/annals.1420.016; Wang Z, 2007, AM J PHYSIOL-HEART C, V292, pH2083, DOI 10.1152/ajpheart.00944.2006; Weis SM, 2005, NATURE, V437, P497, DOI 10.1038/nature03987; Wichmann HE, 2007, INHAL TOXICOL, V19, P241, DOI 10.1080/08958370701498075; Wilson SJ, 2003, VASC PHARMACOL, V40, P109, DOI 10.1016/S1537-1891(02)00340-3; Wong SS, 2004, LUNG, V182, P319, DOI 10.1007/s00408-004-2512-5; Xu M, 2012, TOXICOL SCI, V127, P42, DOI 10.1093/toxsci/kfs087; Yokota S, 2008, J TOXICOL SCI, V33, P1, DOI 10.2131/jts.33.1	80	46	48	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131911	10.1371/journal.pone.0131911	http://dx.doi.org/10.1371/journal.pone.0131911			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148005	Green Published, Green Submitted, gold			2022-12-26	WOS:000358157600163
J	Aebischer, B; Hill, JC; Hilfiker, R; Karstens, S				Aebischer, Bernhard; Hill, Jonathan C.; Hilfiker, Roger; Karstens, Sven			German Translation and Cross-Cultural Adaptation of the STarT Back Screening Tool	PLOS ONE			English	Article							PAIN CATASTROPHIZING SCALE; PSYCHOSOCIAL RISK-FACTORS; PRIMARY-CARE; GUIDELINES; MANAGEMENT; QUESTIONNAIRE; VALIDATION; VERSION; TRIAL	Background Although evidence based treatment approaches for acute low back pain are available, the prevention of persistent disabling symptoms remains a challenge. Subgroup targeted treatment using adequate screening tools may be a key component for the development of new treatment concepts and is demonstrating promising early evidence. The Keele STarT Back Screening Tool is a practical instrument, developed to stratify patients with back pain according to their risk of persistent disabling symptoms. The aim of this study was to translate and cross-culturally adapt the STarT tool into German (STarT-G) and to investigate its psychometric properties. Methods The translation was performed according to internationally accepted guidelines and pretested to assess face validity among patients. Psychometric testing was then performed within a cross-sectional cohort of adult patients attending physiotherapy practices for back pain. Patients completed a booklet containing STarT-G and 5 reference standard questionnaires. Measurement properties of the STarT-G were explored including construct validity, floor and ceiling effects, and discriminative abilities. Results The pretests (n=25) showed good face validity including strong comprehension and acceptability of the STarT-G with only item 5 (fear avoidance) manifesting some ambiguities. The questionnaires were sent to 74 and completed by 50 patients (68%) of whom mean age was 46 (SD 14.5) years and 52% were male. Spearman's rank correlations for construct validity ranged from 0.35 to 0.56. AUCs for discriminative ability ranged from 0.79 to 0.91. Neither floor nor ceiling effects were observed. There were 28 (57%) participants defined as low risk, 17 (35%) as medium risk, and 4 (8%) as high risk. Conclusion STarT-G is linguistically valid for German speaking countries. For the selected population, the correlations indicate acceptable validity and AUC showed satisfying discrimination. Data for psychometric properties have to be confirmed in a large scale study with a representative sample.	[Aebischer, Bernhard] Univ Appl Sci, Hlth Div, Bern, Switzerland; [Hill, Jonathan C.] Keele Univ, Inst Primary Care & Hlth Sci, Great Britain, Staffs, England; [Hilfiker, Roger] Univ Appl Sci & Arts Western Switzerland Valais, Sch Hlth Sci, Wallis, Switzerland; [Karstens, Sven] Univ Hosp, Dept Gen Practice & Hlth Serv Res, Heidelberg, Germany	Keele University; Ruprecht Karls University Heidelberg	Karstens, S (corresponding author), Univ Hosp, Dept Gen Practice & Hlth Serv Res, Heidelberg, Germany.	sven.karstens@med.uni-heidelberg.de	Hill, Jonathan/AAT-2744-2020; Karstens, Sven/AAF-7211-2020; Hilfiker, Roger/E-2846-2010	Karstens, Sven/0000-0001-7403-3452; Hilfiker, Roger/0000-0001-8662-6116	Deutsche Forschungsgemeinschaft; Ruprecht-Karls-Universitat Heidelberg	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ruprecht-Karls-Universitat Heidelberg	The authors acknowledge financial support for the publication by Deutsche Forschungsgemeinschaft and Ruprecht-Karls-Universitat Heidelberg within the funding programme "Open Access Publishing".	Ammon U, 2004, STANDARDSPRACHE OSTE; Balague F, 2012, LANCET, V379, P482, DOI 10.1016/S0140-6736(11)60610-7; Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; Bergbom S, 2011, PHYS THER, V91, P754, DOI 10.2522/ptj.20100136; Bergstrom C, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-81; Bundesamt fur Statistik, 2007, SCHWEIZ GES 2007; Dagenais S, 2010, SPINE J, V10, P514, DOI 10.1016/j.spinee.2010.03.032; Denis A, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-234; Exner V, 2000, SCHMERZ, V14, P392, DOI 10.1007/s004820070004; Foster NE, 2014, ANN FAM MED, V12, P102, DOI 10.1370/afm.1625; Grotle M, 2007, EUR J PAIN, V11, P290, DOI 10.1016/j.ejpain.2006.03.004; Hill J, 2008, THESIS KEELE U STAFF; Hill JC, 2011, LANCET, V378, P1560, DOI 10.1016/S0140-6736(11)60937-9; Hingorani AD, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e5793; Jensen MP, 2003, J PAIN, V4, P407, DOI 10.1016/S1526-5900(03)00716-8; Kent P, 2012, MANUAL THER, V17, P385, DOI 10.1016/j.math.2012.02.008; Kent P, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-62; Koes BW, 2010, EUR SPINE J, V19, P2075, DOI 10.1007/s00586-010-1502-y; Lowe B, 2005, J PSYCHOSOM RES, V58, P163, DOI 10.1016/j.jpsychores.2004.09.006; Meyer K, 2008, J PSYCHOSOM RES, V64, P469, DOI 10.1016/j.jpsychores.2007.12.004; Morso L, 2011, EUR SPINE J, V20, P2166, DOI 10.1007/s00586-011-1911-6; Nigbur K, 2009, EUR J PAIN, V13, pS239; Oesch P, 2011, ASSESSMENTS REHABILI, VVerlag Hans Huber, P305; Ramond A, 2011, FAM PRACT, V28, P12, DOI 10.1093/fampra/cmq072; Robert Koch Institut, 2006, GES DEUTSCHL; Sanders T, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-49; Snaith R, 2011, HOSP ANXIETY DEPRESS; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; Vibe Fersum K, 2012, EUR J PAIN, P1; Wieser S, 2011, EUR J HEALTH ECON, V12, P455, DOI 10.1007/s10198-010-0258-y; Wiesinger, 1999, PHYS MED REHABIL, V24	32	28	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132068	10.1371/journal.pone.0132068	http://dx.doi.org/10.1371/journal.pone.0132068			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1FD	26161669	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000358162300089
J	Churchill, NW; Spring, R; Afshin-Pour, B; Dong, F; Strother, SC				Churchill, Nathan W.; Spring, Robyn; Afshin-Pour, Babak; Dong, Fan; Strother, Stephen C.			An Automated, Adaptive Framework for Optimizing Preprocessing Pipelines in Task-Based Functional MRI	PLOS ONE			English	Article							NEUROIMAGING EXPERIMENTS; QUANTITATIVE-EVALUATION; PHYSIOLOGICAL NOISE; COMPONENT ANALYSIS; DEFAULT MODE; HEAD MOTION; FMRI; BRAIN; STATE; CONNECTIVITY	BOLD fMRI is sensitive to blood-oxygenation changes correlated with brain function; however, it is limited by relatively weak signal and significant noise confounds. Many preprocessing algorithms have been developed to control noise and improve signal detection in fMRI. Although the chosen set of preprocessing and analysis steps (the "pipeline") significantly affects signal detection, pipelines are rarely quantitatively validated in the neuroimaging literature, due to complex preprocessing interactions. This paper outlines and validates an adaptive resampling framework for evaluating and optimizing preprocessing choices by optimizing data-driven metrics of task prediction and spatial reproducibility. Compared to standard "fixed" preprocessing pipelines, this optimization approach significantly improves independent validation measures of within-subject test-retest, and between-subject activation overlap, and behavioural prediction accuracy. We demonstrate that preprocessing choices function as implicit model regularizers, and that improvements due to pipeline optimization generalize across a range of simple to complex experimental tasks and analysis models. Results are shown for brief scanning sessions (<3 minutes each), demonstrating that with pipeline optimization, it is possible to obtain reliable results and brain-behaviour correlations in relatively small datasets.	[Churchill, Nathan W.; Spring, Robyn; Afshin-Pour, Babak; Dong, Fan; Strother, Stephen C.] Baycrest Hosp, Rotman Res Inst, Toronto, ON, Canada; [Churchill, Nathan W.; Strother, Stephen C.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Spring, Robyn; Strother, Stephen C.] Univ Toronto, Inst Med Sci, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Baycrest; University of Toronto; University of Toronto	Churchill, NW (corresponding author), St Michaels Hosp, Neurosci Res Program, 30 Bond St, Toronto, ON M5B 1W8, Canada.	nchurchill.research@gmail.com	Strother, Stephen C/D-6752-2011; Strother, Stephen/ABF-3371-2021	Strother, Stephen C/0000-0002-3198-217X; Strother, Stephen/0000-0002-3198-217X	CIHR [MOP84483]; Bridging CIHR [IAO123872]; James S. McDonnell Foundation; Ontario Brain Institute; Heart and Stroke Foundation of Ontario	CIHR(Canadian Institutes of Health Research (CIHR)); Bridging CIHR; James S. McDonnell Foundation; Ontario Brain Institute; Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario)	This work was partially supported by CIHR grant #MOP84483, a Bridging CIHR grant #IAO123872, and a Brain, Mind and Behaviour grant from the James S. McDonnell Foundation. S.C.S., R.S. and F.D. acknowledge partial support from the Ontario Brain Institute, and S.C.S. and R.S. also acknowledge support of the Heart and Stroke Foundation of Ontario, through the Canadian Partnership for Stroke Recovery. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshin-Pour B, 2011, HUM BRAIN MAPP, V32, P699, DOI 10.1002/hbm.21057; Ardekani BA, 2001, MAGN RESON IMAGING, V19, P959, DOI 10.1016/S0730-725X(01)00418-0; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Bennett CM, 2010, ANN NY ACAD SCI, V1191, P133, DOI 10.1111/j.1749-6632.2010.05446.x; Birn RM, 2009, NEUROIMAGE, V47, P1092, DOI 10.1016/j.neuroimage.2009.05.030; Birn RM, 2006, NEUROIMAGE, V31, P1536, DOI 10.1016/j.neuroimage.2006.02.048; Bowie CR, 2006, NAT PROTOC, V1, P2277, DOI 10.1038/nprot.2006.390; Bullmore ET, 1999, HUM BRAIN MAPP, V7, P38, DOI 10.1002/(SICI)1097-0193(1999)7:1<38::AID-HBM4>3.3.CO;2-H; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Caceres A, 2009, NEUROIMAGE, V45, P758, DOI 10.1016/j.neuroimage.2008.12.035; Campbell KL, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00073; Carbonell F, 2011, BRAIN CONNECT, V1, P496, DOI 10.1089/brain.2011.0065; Carp J, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00149; Carp J, 2012, NEUROIMAGE, V63, P289, DOI 10.1016/j.neuroimage.2012.07.004; Churchill N, 2013, SPRINGER P MATH STAT, V56, P171, DOI 10.1007/978-1-4614-8283-3_11; Churchill NW, 2013, NEUROIMAGE, V82, P306, DOI 10.1016/j.neuroimage.2013.05.102; Churchill NW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031147; Churchill NW, 2012, HUM BRAIN MAPP, V33, P609, DOI 10.1002/hbm.21238; Churchill NW, 2014, P 20 ANN M OHBM HAMB; Churchill NW, 2014, OHBM, V2014; D'Esposito M, 2003, NAT REV NEUROSCI, V4, P863, DOI 10.1038/nrn1246; Evans JW, 2010, NEUROIMAGE, V50, P479, DOI 10.1016/j.neuroimage.2009.11.039; Fassbender C, 2004, COGNITIVE BRAIN RES, V20, P132, DOI 10.1016/j.cogbrainres.2004.02.007; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Freire L, 2001, NEUROIMAGE, V14, P709, DOI 10.1006/nimg.2001.0869; Friedman L, 2006, J MAGN RESON IMAGING, V23, P827, DOI 10.1002/jmri.20583; FRISTON KJ, 1995, NEUROIMAGE, V2, P166, DOI 10.1006/nimg.1995.1019; Glover GH, 2000, MAGNET RESON MED, V44, P162, DOI 10.1002/1522-2594(200007)44:1<162::AID-MRM23>3.0.CO;2-E; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Hallquist MN, 2013, NEUROIMAGE, V82, P208, DOI 10.1016/j.neuroimage.2013.05.116; He HJ, 2012, NEUROIMAGE, V59, P2339, DOI 10.1016/j.neuroimage.2011.09.018; Himmanen SA, 2003, J CLIN EXP NEUROPSYC, V25, P1178, DOI 10.1076/jcen.25.8.1178.16729; Johnstone T, 2006, HUM BRAIN MAPP, V27, P779, DOI 10.1002/hbm.20219; Jones, 2009, NEUROIMAGE, V42, P582; Kjems U, 2002, NEUROIMAGE, V15, P772, DOI 10.1006/nimg.2001.1033; Krishnan A, 2011, NEUROIMAGE, V56, P455, DOI 10.1016/j.neuroimage.2010.07.034; LaConte S, 2003, NEUROIMAGE, V18, P10, DOI 10.1006/nimg.2002.1300; Le TH, 1997, NMR BIOMED, V10, P160, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<160::AID-NBM458>3.0.CO;2-A; Lund TE, 2006, NEUROIMAGE, V29, P54, DOI 10.1016/j.neuroimage.2005.07.005; Mazaika P, 2007, OHBM, V13; Morgan VL, 2007, COMPUT MED IMAG GRAP, V31, P436, DOI 10.1016/j.compmedimag.2007.04.002; Nichols TE, 2009, PERSPECT PSYCHOL SCI, V4, P291, DOI 10.1111/j.1745-6924.2009.01126.x; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Ollinger J. M., 2009, NEUROIMAGE, V47, pS122, DOI DOI 10.1016/S1053-8119(09)71160-71167; Pereira F, 2009, NEUROIMAGE, V45, pS199, DOI 10.1016/j.neuroimage.2008.11.007; Poldrack RA, 2008, NEUROIMAGE, V40, P409, DOI 10.1016/j.neuroimage.2007.11.048; Poline JB, 2006, HUM BRAIN MAPP, V27, P351, DOI 10.1002/hbm.20268; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rasmussen PM, 2012, PATTERN RECOGN, V45, P2085, DOI 10.1016/j.patcog.2011.09.011; Salimi-Khorshidi G, 2014, NEUROIMAGE, V90, P449, DOI 10.1016/j.neuroimage.2013.11.046; Sarty G. E, 2007, COMPUTING BRAIN ACTI; Satterthwaite TD, 2013, NEUROIMAGE, V64, P240, DOI 10.1016/j.neuroimage.2012.08.052; Scholvinck ML, 2010, P NATL ACAD SCI USA, V107, P10238, DOI 10.1073/pnas.0913110107; Seto E, 2001, NEUROIMAGE, V14, P284, DOI 10.1006/nimg.2001.0829; Shaw ME, 2003, NEUROIMAGE, V19, P988, DOI 10.1016/S1053-8119(03)00116-2; Sladky R, 2011, NEUROIMAGE, V58, P588, DOI 10.1016/j.neuroimage.2011.06.078; Specht K, 2003, J MAGN RESON IMAGING, V17, P463, DOI 10.1002/jmri.10277; Strother S, 2004, NEUROIMAGE, V23, pS196, DOI 10.1016/j.neuroimage.2004.07.022; Strothert SC, 2002, NEUROIMAGE, V15, P747, DOI 10.1006/nimg.2001.1034; Tam F, 2011, HUM BRAIN MAPP, V32, P240, DOI 10.1002/hbm.21013; Tanabe J, 2002, NEUROIMAGE, V15, P902, DOI 10.1006/nimg.2002.1053; Tegeler C, 1999, HUM BRAIN MAPP, V7, P267, DOI 10.1002/(SICI)1097-0193(1999)7:4<267::AID-HBM5>3.0.CO;2-3; TURIN GL, 1976, P IEEE, V64, P1092, DOI 10.1109/PROC.1976.10274; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; White T, 2001, NEUROIMAGE, V13, P577, DOI 10.1006/nimg.2000.0716; Wong CW, 2013, NEUROIMAGE, V83, P983, DOI 10.1016/j.neuroimage.2013.07.057; WORSLEY KJ, 1995, NEUROIMAGE, V2, P173, DOI 10.1006/nimg.1995.1023; Yourganov G, 2011, NEUROIMAGE, V56, P531, DOI 10.1016/j.neuroimage.2010.09.034; Yue Y, 2010, STAT INTERFACE, V3, P3; Zhang J, 2009, MAGN RESON IMAGING, V27, P264, DOI 10.1016/j.mri.2008.05.021	72	36	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131520	10.1371/journal.pone.0131520	http://dx.doi.org/10.1371/journal.pone.0131520			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161667	Green Published, gold, Green Submitted			2022-12-26	WOS:000358162300041
J	Qubbaj, MR; Muneepeerakul, R; Aggarwal, RM; Anderies, JM				Qubbaj, Murad R.; Muneepeerakul, Rachata; Aggarwal, Rimjhim M.; Anderies, John M.			How Does a Divided Population Respond to Change?	PLOS ONE			English	Article							REGIME SHIFTS; DYNAMICS	Most studies on the response of socioeconomic systems to a sudden shift focus on long-term equilibria or end points. Such narrow focus forgoes many valuable insights. Here we examine the transient dynamics of regime shift on a divided population, exemplified by societies divided ideologically, politically, economically, or technologically. Replicator dynamics is used to investigate the complex transient dynamics of the population response. Though simple, our modeling approach exhibits a surprisingly rich and diverse array of dynamics. Our results highlight the critical roles played by diversity in strategies and the magnitude of the shift. Importantly, it allows for a variety of strategies to arise organically as an integral part of the transient dynamics-as opposed to an independent process-of population response to a regime shift, providing a link between the population's past and future diversity patterns. Several combinations of different populations' strategy distributions and shifts were systematically investigated. Such rich dynamics highlight the challenges of anticipating the response of a divided population to a change. The findings in this paper can potentially improve our understanding of a wide range of socio-ecological and technological transitions.	[Qubbaj, Murad R.; Muneepeerakul, Rachata; Aggarwal, Rimjhim M.; Anderies, John M.] Arizona State Univ, Sch Sustainabil, Tempe, AZ 85287 USA; [Muneepeerakul, Rachata] Arizona State Univ, Math Computat & Modeling Sci Ctr, Tempe, AZ 85287 USA; [Anderies, John M.] Arizona State Univ, Sch Human Evolut & Social Change, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Qubbaj, MR (corresponding author), Arizona State Univ, Sch Sustainabil, Tempe, AZ 85287 USA.	murad.qubbaj@asu.edu	Qubbaj, Murad/L-5917-2019; Aggarwal, Rimjhim M/D-4812-2012	Aggarwal, Rimjhim M/0000-0002-3579-5363	National Science Foundation (NSF) [GEO-1115054]	National Science Foundation (NSF)(National Science Foundation (NSF))	This work was supported by National Science Foundation (NSF) grant GEO-1115054. The authors who received funding are: JMA, RM, and RMA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal RM, 2011, ROUTLEDGE HDB S AS E, P44; Anderies JM, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/4/044048; [Anonymous], WORLD SOCIAL SCI REP; [Anonymous], 2014, SCI MAGAZINE    0523, V344; [Anonymous], 1998, THEORY LEARNING GAME; Barnes DF, 1999, J INT AFFAIRS, V53, P237; Barrett CB, 2008, FOOD POLICY, V33, P299, DOI 10.1016/j.foodpol.2007.10.005; Chowdhury RR, 2010, P NATL ACAD SCI USA, V107, P5780, DOI 10.1073/pnas.0905892107; DEJANVRY A, 1991, ECON J, V101, P1400, DOI 10.2307/2234892; DiMaggio P, 1996, AM J SOCIOL, V102, P690, DOI 10.1086/230995; Doherty C, 2014, TECHNICAL REPORT; Fiorina MP, 2008, ANNU REV POLIT SCI, V11, P563, DOI 10.1146/annurev.polisci.11.053106.153836; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; Grubler A, 1998, TECHNOLOGY GLOBAL CH; Heltberg R, 2005, ENVIRON DEV ECON, V10, P337, DOI 10.1017/S1355770X04001858; Heltberg R, 2003, 042 ESMAP WORLD BANK; Karev GP, 2010, B MATH BIOL, V72, P1124, DOI 10.1007/s11538-009-9484-9; Karev GP, 2010, J MATH BIOL, V60, P107, DOI 10.1007/s00285-009-0252-0; KINZIG AP, 2006, ECOLOGY SOC, V11; Lenton TM, 2008, P NATL ACAD SCI USA, V105, P1786, DOI 10.1073/pnas.0705414105; Lewis W. Arthur, 1954, MANCH SCH, V22, P139, DOI [10.1111/j.1467-9957.1954.tb00021.x, DOI 10.1111/J.1467-9957.1954.TB00021.X]; Manderscheid A, 2002, RANGIFER SPECIAL ISS, V15, P29; Muneepeerakul R, 2012, J R SOC INTERFACE, V9, P3303, DOI 10.1098/rsif.2012.0431; Piketty T, 2014, SCIENCE, V344, P838, DOI 10.1126/science.1251936; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Safarzynska K, 2011, J ECON BEHAV ORGAN, V78, P229, DOI 10.1016/j.jebo.2011.01.008; Scheffer M, 2003, TRENDS ECOL EVOL, V18, P648, DOI 10.1016/j.tree.2003.09.002; SCHUSTER P, 1983, J THEOR BIOL, V100, P533, DOI 10.1016/0022-5193(83)90445-9; Singer HW, 1999, DUAL EC, P202; Stiglitz Joseph E., 2012, PRICE INEQUALITY TOD; Stirling A., 1998, SPRU ELECT WORKING P, V28; TAYLOR PD, 1978, MATH BIOSCI, V40, P145, DOI 10.1016/0025-5564(78)90077-9; The Nature Conservancy, 2014, TECHNICAL REPORT; Walker B., 2004, ECOLOGY SOC, V9; [No title captured]	35	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0128121	10.1371/journal.pone.0128121	http://dx.doi.org/10.1371/journal.pone.0128121			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1FD	26161859	Green Published, Green Submitted, gold			2022-12-26	WOS:000358162300007
J	Yucel, M; Beaton, AD; Dengler, M; Mowlem, MC; Sohl, F; Sommer, S				Yuecel, Mustafa; Beaton, Alexander D.; Dengler, Marcus; Mowlem, Matthew C.; Sohl, Frank; Sommer, Stefan			Nitrate and Nitrite Variability at the Seafloor of an Oxygen Minimum Zone Revealed by a Novel Microfluidic In-Situ Chemical Sensor	PLOS ONE			English	Article							ANALYZER; WATERS; CIRCULATION; ENCELADUS; PHOSPHATE; SEAWATER; SYSTEM	Microfluidics, or lab-on-a-chip (LOC) is a promising technology that allows the development of miniaturized chemical sensors. In contrast to the surging interest in biomedical sciences, the utilization of LOC sensors in aquatic sciences is still in infancy but a wider use of such sensors could mitigate the undersampling problem of ocean biogeochemical processes. Here we describe the first underwater test of a novel LOC sensor to obtain in situ calibrated time-series (up to 40 h) of nitrate+nitrite (Sigma NOx) and nitrite on the seafloor of the Mauritanian oxygen minimum zone, offshore Western Africa. Initial tests showed that the sensor successfully reproduced water column (160 m) nutrient profiles. Lander deployments at 50, 100 and 170 m depth indicated that the biogeochemical variability was high over the Mauritanian shelf: The 50 m site had the lowest Sigma NOx concentration, with 15.2 to 23.4 mu M (median=18.3 mu M); while at the 100 site Sigma NOx varied between 21.0 and 30.1 mu M over 40 hours (median = 25.1 mu M). The 170 m site had the highest median Sigma NOx level (25.8 mu M) with less variability (22.8 to 27.7 mu M). At the 50 m site, nitrite concentration decreased fivefold from 1 to 0.2 mu M in just 30 hours accompanied by decreasing oxygen and increasing nitrate concentrations. Taken together with the time series of oxygen, temperature, pressure and current velocities, we propose that the episodic intrusion of deeper waters via cross-shelf transport leads to intrusion of nitrate-rich, but oxygen-poor waters to shallower locations, with consequences for benthic nitrogen cycling. This first validation of an LOC sensor at elevated water depths revealed that when deployed for longer periods and as a part of a sensor network, LOC technology has the potential to contribute to the understanding of the benthic biogeochemical dynamics.	[Yuecel, Mustafa; Dengler, Marcus; Sommer, Stefan] GEOMAR Helmholtz Ctr Ocean Res, Kiel, Germany; [Yuecel, Mustafa] Middle E Tech Univ, Inst Marine Sci, Erdemli, Mersin, Turkey; [Beaton, Alexander D.; Mowlem, Matthew C.] Natl Oceanog Ctr Southampton, Ocean Technol & Engn Grp, Southampton, Hants, England; [Sohl, Frank] DLR German Aerosp Ctr, Inst Planetary Sci, Berlin, Germany	Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; Middle East Technical University; NERC National Oceanography Centre; University of Southampton; Helmholtz Association; German Aerospace Centre (DLR)	Yucel, M (corresponding author), GEOMAR Helmholtz Ctr Ocean Res, Kiel, Germany.	myucel@ims.metu.edu.tr	Dengler, Marcus/A-7327-2014; Yücel, Mustafa/F-7067-2010	Dengler, Marcus/0000-0001-5993-9088; Yücel, Mustafa/0000-0002-7478-902X; Beaton, Alexander/0000-0002-0206-7466; Mowlem, Matthew/0000-0001-7613-6121	Helmholtz-Alliance ROBEX (Robotic Exploration of Extreme Environments); collaborative research center Climate-Biogeochemistry Interactions in the Tropical Ocean [SFB754]; NERC [NE/J011975/1, noc010013, noc010003, NE/I012974/1] Funding Source: UKRI; Natural Environment Research Council [NE/I012974/1, noc010013, NE/J011975/1, noc010003] Funding Source: researchfish	Helmholtz-Alliance ROBEX (Robotic Exploration of Extreme Environments); collaborative research center Climate-Biogeochemistry Interactions in the Tropical Ocean; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was supported by the Helmholtz-Alliance ROBEX (Robotic Exploration of Extreme Environments - http://www.robex-allianz.de/en, funds to SS, FS) and the collaborative research center Climate-Biogeochemistry Interactions in the Tropical Ocean (SFB754 - www.sfb754.de, funds to SS, MD).	Barton E.D., 1989, POLEWARD FLOWS E OCE, P82; Beaton AD, 2012, ENVIRON SCI TECHNOL, V46, P9548, DOI 10.1021/es300419u; Beaton AD, 2011, SENSOR ACTUAT B-CHEM, V156, P1009, DOI 10.1016/j.snb.2011.02.042; Bellingham JG, 2007, SCIENCE, V318, P1098, DOI 10.1126/science.1146230; Bohlen L, 2011, GEOCHIM COSMOCHIM AC, V75, P6094, DOI 10.1016/j.gca.2011.08.010; Brandt P, 2015, BIOGEOSCIENCES, V12, P489, DOI 10.5194/bg-12-489-2015; Campos CDM, 2013, RSC ADV, V3, P18216, DOI 10.1039/c3ra41561a; Dale AW, 2014, GEOCHIM COSMOCHIM AC, V134, P234, DOI 10.1016/j.gca.2014.02.026; Dickey TD, 2008, LIMNOL OCEANOGR, V53, P2057, DOI 10.4319/lo.2008.53.5_part_2.2057; Fernandez C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020539; Floquet CFA, 2011, TALANTA, V84, P235, DOI 10.1016/j.talanta.2010.12.026; HOLLOWAY PE, 1985, J PHYS OCEANOGR, V15, P240, DOI 10.1175/1520-0485(1985)015<0240:ACOSIT>2.0.CO;2; Horstkotte B, 2013, ANAL LETT, V46, P2345, DOI 10.1080/00032719.2013.800539; Jackson C, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2007JC004220; Jang A, 2011, MEAS SCI TECHNOL, V22, DOI 10.1088/0957-0233/22/3/032001; Johnson KS, 2007, CHEM REV, V107, P623, DOI 10.1021/cr050354e; Johnson KS, 2013, J ATMOS OCEAN TECH, V30, P1854, DOI 10.1175/JTECH-D-12-00221.1; Johnson KS, 2010, NATURE, V465, P1062, DOI 10.1038/nature09170; Johnson KS, 2002, DEEP-SEA RES PT I, V49, P1291, DOI 10.1016/S0967-0637(02)00020-1; Jorgensen B.B., 2004, GEOL S AM, V379, P63, DOI DOI 10.1130/0-8137-2379-5.63; Le Bris N, 2000, MAR CHEM, V72, P1, DOI 10.1016/S0304-4203(00)00057-8; Legiret FE, 2013, TALANTA, V116, P382, DOI 10.1016/j.talanta.2013.05.004; Mann KH, 2006, DYNAMICS MARINE ECOS; Martz TR, 2010, LIMNOL OCEANOGR-METH, V8, P172, DOI 10.4319/lom.2010.8.172; Mason, 2013, SMART SENSORS REAL T, P125, DOI DOI 10.1007/978-3-642-37006-9_6; Milani A, 2015, TALANTA, V136, P15, DOI 10.1016/j.talanta.2014.12.045; MITTELSTAEDT E, 1991, PROG OCEANOGR, V26, P307, DOI 10.1016/0079-6611(91)90011-A; MITTELSTAEDT E, 1983, PROG OCEANOGR, V12, P307, DOI 10.1016/0079-6611(83)90012-5; Moore TS, 2009, ANNU REV MAR SCI, V1, P91, DOI 10.1146/annurev.marine.010908.163817; Ogilvie IRG, 2011, ANAL CHEM, V83, P4814, DOI 10.1021/ac200463y; Ogilvie IRG, 2010, J MICROMECH MICROENG, V20, DOI 10.1088/0960-1317/20/6/065016; Patey MD, 2008, TRAC-TREND ANAL CHEM, V27, P169, DOI 10.1016/j.trac.2007.12.006; Pejcic B, 2009, 09010 CSIRO PETR RES; Pfannkuche O and the Science Party, 2014, MERIAN BERICHTE, DOI [10.2312/cr_msm17_4, DOI 10.2312/CR_MSM17_4.]; Provin C, 2013, IEEE J OCEANIC ENG, V38, P178, DOI 10.1109/JOE.2012.2208849; R Core Team, 2021, R LANGUAGE ENV STAT; Sackmann EK, 2014, NATURE, V507, P181, DOI 10.1038/nature13118; Schafstall J, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005940; Sieben VJ, 2010, ANAL METHODS-UK, V2, P484, DOI 10.1039/c002672g; Sommer S, 2009, MAR ECOL PROG SER, V382, P69, DOI 10.3354/meps07956; Spencer JR, 2013, ANNU REV EARTH PL SC, V41, P693, DOI 10.1146/annurev-earth-050212-124025; Stramma L, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039593; Takeshita Y, 2013, J GEOPHYS RES-OCEANS, V118, P5640, DOI 10.1002/jgrc.20399; Tengberg A, 2006, LIMNOL OCEANOGR-METH, V4, P7, DOI 10.4319/lom.2006.4.7; Waite JH, 2009, NATURE, V460, P487, DOI 10.1038/nature08153; Wild-Allen K, 2014, MAR CHEM, V167, P135, DOI 10.1016/j.marchem.2014.06.011	46	26	26	3	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132785	10.1371/journal.pone.0132785	http://dx.doi.org/10.1371/journal.pone.0132785			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161958	gold, Green Published, Green Accepted			2022-12-26	WOS:000358162300176
J	Chan, RPY; Majid, SR				Chan, Rusi P. Y.; Majid, S. R.			Layer by Layer Ex-Situ Deposited Cobalt-Manganese Oxide as Composite Electrode Material for Electrochemical Capacitor	PLOS ONE			English	Article							PERFORMANCE; BEHAVIOR; NANOPARTICLES; FABRICATION; FILMS; RUO2	The composite metal oxide electrode films were fabricated using ex situ electrodeposition method with further heating treatment at 300 degrees C. The obtained composite metal oxide film had a spherical structure with mass loading from 0.13 to 0.21 mg cm(-2). The structure and elements of the composite was investigated using X-ray diffraction (XRD) and energy dispersive X-ray (EDX). The electrochemical performance of different composite metal oxides was studied by cyclic voltammetry (CV) and galvanostatic charge-discharge (CD). As an active electrode material for a supercapacitor, the Co-Mn composite electrode exhibits a specific capacitance of 285 Fg(-1) at current density of 1.85 Ag-1 in 0.5M Na2SO4 electrolyte. The best composite electrode, Co-Mn electrode was then further studied in various electrolytes (i.e., 0.5M KOH and 0.5M KOH/0.04M K3Fe(CN)(6) electrolytes). The pseudocapacitive nature of the material of Co-Mn lead to a high specific capacitance of 2.2 x 10(3) Fg(-1) and an energy density of 309 Whkg(-1) in a 0.5MKOH/0.04MK(3)Fe(CN)(6) electrolyte at a current density of 10 Ag-1. The specific capacitance retention obtained 67% of its initial value after 750 cycles. The results indicate that the ex situ deposited composite metal oxide nanoparticles have promising potential in future practical applications.	[Chan, Rusi P. Y.; Majid, S. R.] Univ Malaya, Fac Sci, Dept Phys, Ctr Ion, Kuala Lumpur, Malaysia	Universiti Malaya	Majid, SR (corresponding author), Univ Malaya, Fac Sci, Dept Phys, Ctr Ion, Kuala Lumpur, Malaysia.	shana@um.edu.my	MAJID, SITI ROHANA/B-9806-2010	MAJID, SITI ROHANA/0000-0003-0616-4260; , Rusi/0000-0001-8882-0393	University of Malaya [C/625/1/HIR/157, RP025B-14AFR, PG010-2013A]; Skim Bright Sparks University Malaya (SBSUM)	University of Malaya(Universiti Malaya); Skim Bright Sparks University Malaya (SBSUM)	The authors thank the University of Malaya for financial assistance through grants UM. C/625/1/HIR/157, RP025B-14AFR, and PG010-2013A. Rusi acknowledges the Skim Bright Sparks University Malaya (SBSUM) for the scholarship award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babakhani B, 2011, J POWER SOURCES, V196, P10762, DOI 10.1016/j.jpowsour.2011.08.102; Babakhani B, 2010, J POWER SOURCES, V195, P2110, DOI 10.1016/j.jpowsour.2009.10.045; Cai Y, 2014, CERAM INT, V40, P4109, DOI 10.1016/j.ceramint.2013.08.065; Chen KF, 2014, RSC ADV, V4, P23338, DOI 10.1039/c4ra03037k; Chen Y, 2013, ELECTROCHIM ACTA, V109, P678, DOI 10.1016/j.electacta.2013.07.174; Conway B. E., 1999, ELECTROCHEMICAL SUPE; Ding R, 2013, ELECTROCHIM ACTA, V107, P494, DOI 10.1016/j.electacta.2013.05.114; Dubal DP, 2013, ELECTROCHIM ACTA, V103, P103, DOI 10.1016/j.electacta.2013.04.055; Enachi M, 2015, PHYS STATUS SOLIDI-R, V9, P171, DOI 10.1002/pssr.201409562; Engstrom AM, 2013, J POWER SOURCES, V228, P120, DOI 10.1016/j.jpowsour.2012.11.075; Farsi H, 2010, J SOLID STATE ELECTR, V14, P681, DOI 10.1007/s10008-009-0828-z; Girija TC, 2006, J POWER SOURCES, V156, P705, DOI 10.1016/j.jpowsour.2005.05.051; Gobal F, 2012, J SOLID STATE ELECTR, V16, P1561, DOI 10.1007/s10008-011-1561-y; Gujar TP, 2007, ELECTROCHEM COMMUN, V9, P504, DOI 10.1016/j.elecom.2006.10.017; Hu CC, 2011, J POWER SOURCES, V196, P847, DOI 10.1016/j.jpowsour.2010.08.001; Hung CJ, 2013, J POWER SOURCES, V243, P594, DOI 10.1016/j.jpowsour.2013.06.055; Hwang BJ, J ELECTROCHEMICAL SO, V147, P2252; Hyun TS, 2010, J MATER CHEM, V20, P9172, DOI 10.1039/c0jm00494d; Jagadale AD, 2013, J COLLOID INTERF SCI, V406, P225, DOI 10.1016/j.jcis.2013.05.037; Kumar M, 2014, PLASMONICS, V9, P129, DOI 10.1007/s11468-013-9605-z; Lee HM, 2014, MATERIALS, V7, P265, DOI 10.3390/ma7010265; Li SH, 2012, CHINESE J ANAL CHEM, V40, P339, DOI 10.1016/S1872-2040(11)60534-3; Li Y, 2011, MATER LETT, V65, P403, DOI 10.1016/j.matlet.2010.10.048; Li ZP, 2014, J POWER SOURCES, V245, P224, DOI 10.1016/j.jpowsour.2013.06.121; LING HS, 2009, PHYS CHEM CHEM PHYS, V11, P2195, DOI DOI 10.1039/B814844A; Lokhande CD, 2014, CURRENT APPL PHYS, V11, P255; Lu XH, 2014, ENERG ENVIRON SCI, V7, P2160, DOI 10.1039/c4ee00960f; Lupan O, 2014, J NANOELECTRON OPTOE, V9, P257, DOI 10.1166/jno.2014.1579; Nithya VD, 2013, ELECTROCHIM ACTA, V109, P720, DOI 10.1016/j.electacta.2013.07.138; Prasad KR, 2004, ELECTROCHEM COMMUN, V6, P1004, DOI 10.1016/j.elecom.2004.07.017; Rusi, 2014, SOLID STATE IONICS, V262, P220, DOI 10.1016/j.ssi.2013.10.003; Rusi, 2013, MATER LETT, V108, P69, DOI 10.1016/j.matlet.2013.06.069; Saranya S, 2012, APPL SURF SCI, V258, P4881, DOI 10.1016/j.apsusc.2012.01.104; Sharma AS, 2012, ADV MAT LETT, V3, P82; Sugimoto W, 2005, J PHYS CHEM B, V109, P7330, DOI 10.1021/jp044252o; Trigilio J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048147; Wang Y, 2011, MATER LETT, V65, P222, DOI 10.1016/j.matlet.2010.09.090; Wei WF, 2011, CHEM SOC REV, V40, P1697, DOI 10.1039/c0cs00127a; Wu CH, 2012, CURR APPL PHYS, V12, P1190, DOI 10.1016/j.cap.2012.02.056; Wu ZY, 2014, NANO ENERGY, V8, P118, DOI 10.1016/j.nanoen.2014.05.019; Yun TG, 2013, J POWER SOURCES, V244, P783, DOI 10.1016/j.jpowsour.2013.02.087; Zhang YX, 2014, J POWER SOURCES, V246, P449, DOI 10.1016/j.jpowsour.2013.07.115; Zhao CM, 2013, SCI REP-UK, V3, DOI 10.1038/srep02986	43	3	3	3	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2015	10	7							e0129780	10.1371/journal.pone.0129780	http://dx.doi.org/10.1371/journal.pone.0129780			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EW	26158447	Green Published, gold, Green Submitted			2022-12-26	WOS:000358161200008
J	da Silva, CP; de Oliveira, LA; Nuvunga, JJ; Pamplona, AKA; Balestre, M				da Silva, Carlos Pereira; de Oliveira, Luciano Antonio; Nuvunga, Joel Jorge; Alves Pamplona, Andrezza Kellen; Balestre, Marcio			A Bayesian Shrinkage Approach for AMMI Models	PLOS ONE			English	Article							ENVIRONMENT INTERACTION PROCEED; LINEAR-BILINEAR MODELS; MULTIPLICATIVE INTERACTION; BIPLOT ANALYSIS; TRIALS	Linear-bilinear models, especially the additive main effects and multiplicative interaction (AMMI) model, are widely applicable to genotype-by-environment interaction (GEI) studies in plant breeding programs. These models allow a parsimonious modeling of GE interactions, retaining a small number of principal components in the analysis. However, one aspect of the AMMI model that is still debated is the selection criteria for determining the number of multiplicative terms required to describe the GE interaction pattern. Shrinkage estimators have been proposed as selection criteria for the GE interaction components. In this study, a Bayesian approach was combined with the AMMI model with shrinkage estimators for the principal components. A total of 55 maize genotypes were evaluated in nine different environments using a complete blocks design with three replicates. The results show that the traditional Bayesian AMMI model produces low shrinkage of singular values but avoids the usual pitfalls in determining the credible intervals in the biplot. On the other hand, Bayesian shrinkage AMMI models have difficulty with the credible interval for model parameters, but produce stronger shrinkage of the principal components, converging to GE matrices that have more shrinkage than those obtained using mixed models. This characteristic allowed more parsimonious models to be chosen, and resulted in models being selected that were similar to those obtained by the Cornelius F-test (alpha = 0.05) in traditional AMMI models and cross validation based on leave-one-out. This characteristic allowed more parsimonious models to be chosen and more GEI pattern retained on the first two components. The resulting model chosen by posterior distribution of singular value was also similar to those produced by the cross-validation approach in traditional AMMI models. Our method enables the estimation of credible interval for AMMI biplot plus the choice of AMMI model based on direct posterior distribution retaining more GEI pattern in the first components and discarding noise without Gaussian assumption as requested in F-based tests or deal with parametric problems as observed in traditional AMMI shrinkage method.	[da Silva, Carlos Pereira; Nuvunga, Joel Jorge; Alves Pamplona, Andrezza Kellen; Balestre, Marcio] Univ Fed Lavras, DEX, Lavras, MG, Brazil; [de Oliveira, Luciano Antonio] Fed Univ Grande Dourados, Fac Exact Sci & Technol FACET, Grande Dourados, MS, Brazil	Universidade Federal de Lavras; Universidade Federal da Grande Dourados	Balestre, M (corresponding author), Univ Fed Lavras, DEX, Lavras, MG, Brazil.	marciobalestre@dex.ufla.br						Balestre M, 2009, CROP BREED APPL BIOT, V9, P219, DOI 10.12702/1984-7033.v09n03a03; Burgueno J, 2008, CROP SCI, V48, P1291, DOI 10.2135/cropsci2007.11.0632; Chen MH, 1999, J COMPUT GRAPH STAT, V8, P69, DOI 10.2307/1390921; Cornelius P. L., 1996, P199; CORNELIUS PL, 1992, THEOR APPL GENET, V84, P161, DOI 10.1007/BF00223996; Cornelius PL, 1999, CROP SCI, V39, P998, DOI 10.2135/cropsci1999.0011183X003900040007x; Cornelius PL, 1997, J STAT COMPUT SIM, V58, P287, DOI 10.1080/00949659708811837; Crossa J, 2011, CROP SCI, V51, P1458, DOI 10.2135/cropsci2010.06.0343; de Oliveira LA, 2015, CROP SCI, V55, P465, DOI 10.2135/cropsci2014.05.0369; Dias CTD, 2003, CROP SCI, V43, P865, DOI 10.2135/cropsci2003.0865; Forkman J, 2014, BIOMETRICS; GABRIEL K.R., 2002, J SOC FRANCAISE STAT, V143, P5; GABRIEL KR, 1971, BIOMETRIKA, V58, P453, DOI 10.1093/biomet/58.3.453; Gauch HG, 2006, CROP SCI, V46, P1488, DOI 10.2135/cropsci2005.07-0193; Gauch HG, 2013, CROP SCI, V53, P1860, DOI 10.2135/cropsci2013.04.0241; GOLLOB HF, 1968, PSYCHOMETRIKA, V33, P73, DOI 10.1007/BF02289676; HEIDELBERGER P, 1983, OPER RES, V31, P1109, DOI 10.1287/opre.31.6.1109; James W., 1961, P 4 BERK S MATH STAT, V1, P361, DOI DOI 10.1007/978-1-4612-0919-5; Jaynes E. T., 2003, PROBABILITY THEORY T; Liu G., 2001, THESIS U KENTUCKY; MANDEL J, 1971, TECHNOMETRICS, V13, P1, DOI 10.2307/1267072; MANDEL J, 1969, J RES NBS B MATH SCI, VB 73, P309, DOI 10.6028/jres.073B.031; Mardia K., 1979, MULTIVARIATE ANAL, V15, P518; Ooms JCL, 2009, THESIS UTRECHT U; Perez-Elizalde S, 2012, J AGR BIOL ENVIR ST, V17, P15, DOI 10.1007/s13253-011-0063-9; Piepho HP, 1997, BIOMETRICS, V53, P761, DOI 10.2307/2533976; R Core Team, 2021, R LANGUAGE ENV STAT; Rodrigues PC, 2014, CROP SCI, V54, P1555, DOI 10.2135/cropsci2013.07.0462; Silverberg T. R., 1952, MACH DES, V24, P131; Smith A, 2001, AUST NZ J STAT, V43, P129, DOI 10.1111/1467-842X.00163; Stein C., 1956, INADMISSIBILITY USUA, DOI DOI 10.1525/9780520313880-018; ter Braak CJF, 2006, COMPUT STAT DATA AN, V51, P1232, DOI 10.1016/j.csda.2006.06.011; ter Braak CJF, 2005, GENETICS, V170, P1435, DOI 10.1534/genetics.105.040469; Viele K, 2000, J STAT PLAN INFER, V84, P201, DOI 10.1016/S0378-3758(99)00151-2; WILLIAMS EJ, 1952, BIOMETRIKA, V39, P65, DOI 10.1093/biomet/39.1-2.65; Yan WK, 2010, CROP SCI, V50, P1121, DOI 10.2135/cropsci2010.01.0001le; Yang RC, 2009, CROP SCI, V49, P1564, DOI 10.2135/cropsci2008.11.0665	38	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2015	10	7							e0131414	10.1371/journal.pone.0131414	http://dx.doi.org/10.1371/journal.pone.0131414			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EW	26158452	Green Published, gold, Green Submitted			2022-12-26	WOS:000358161200029
J	Lyu, ML; Yu, YJ; Jiang, JJ; Song, LM; Liang, Y; Ma, ZM; Xiong, XP; Cao, JS				Lyu, Meiling; Yu, Youjian; Jiang, Jingjing; Song, Limin; Liang, Ying; Ma, Zhiming; Xiong, Xingpeng; Cao, Jiashu			BcMF26a and BcMF26b Are Duplicated Polygalacturonase Genes with Divergent Expression Patterns and Functions in Pollen Development and Pollen Tube Formation in Brassica campestris	PLOS ONE			English	Article							CELL-SEPARATION; ARABIDOPSIS-THALIANA; PECTIC POLYSACCHARIDES; FAMILY; PROTEIN; GERMINATION; EVOLUTION; DYNAMICS; GENOME; POLYPLOIDY	Polygalacturonase (PG) is one of the cell wall hydrolytic enzymes involving in pectin degradation. A comparison of two highly conserved duplicated PG genes, namely, Brassica campestris Male Fertility 26a (BcMF26a) and BcMF26b, revealed the different features of their expression patterns and functions. We found that these two genes were orthologous genes of At4g33440, and they originated from a chromosomal segmental duplication. Although structurally similar, their regulatory and intron sequences largely diverged. QRT-PCR analysis showed that the expression level of BcMF26b was higher than that of BcMF26a in almost all the tested organs and tissues in Brassica campestris. Promoter activity analysis showed that, at reproductive development stages, BcMF26b promoter was active in tapetum, pollen grains, and pistils, whereas BcMF26a promoter was only active in pistils. In the subcellular localization experiment, BcMF26a and BcMF26b proteins could be localized to the cell wall. When the two genes were co-inhibited, pollen intine was formed abnormally and pollen tubes could not grow or stretch. Moreover, the knockout mutants of At4g33440 delayed the growth of pollen tubes. Therefore, BcMF26a/b can participate in the construction of pollen wall by modulating intine information and BcMF26b may play a major role in co-inhibiting transformed plants.	[Lyu, Meiling; Yu, Youjian; Song, Limin; Liang, Ying; Ma, Zhiming; Xiong, Xingpeng; Cao, Jiashu] Zhejiang Univ, Inst Vegetable Sci, Lab Cell & Mol Biol, Hangzhou 310003, Zhejiang, Peoples R China; [Lyu, Meiling; Song, Limin; Liang, Ying; Ma, Zhiming; Xiong, Xingpeng; Cao, Jiashu] Zhejiang Univ, Zhejiang Prov Key Lab Hort Plant Integrat Biol, Hangzhou 310003, Zhejiang, Peoples R China; [Yu, Youjian] Zhejiang A&F Univ, Coll Agr & Food Sci, Dept Hort, Linan, Peoples R China; [Jiang, Jingjing] Chinese Univ Hong Kong, Shenzhen Res Inst, State Key Lab Agrobiotechnol Shenzhen Base, Shenzhen, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang A&F University; Chinese University of Hong Kong, Shenzhen	Cao, JS (corresponding author), Zhejiang Univ, Inst Vegetable Sci, Lab Cell & Mol Biol, Hangzhou 310003, Zhejiang, Peoples R China.	jshcao@zju.edu.cn		ma, zhiming/0000-0002-8610-4876	National Program on Key Basic Research Projects [2012CB113900]; National Natural Science Foundation of China [31272176]; Ministry of Education of China [20120101110078]; Natural Science Foundation of China [31301790]; Guangdong Natural Science Foundation [S2013040016220]	National Program on Key Basic Research Projects(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province)	This work was funded by the National Program on Key Basic Research Projects (2012CB113900) to JSC; National Natural Science Foundation of China (31272176) to JSC; Specialized Research Fund for the Doctoral Program of Higher Education from the Ministry of Education of China (20120101110078) to JSC; Natural Science Foundation of China (31301790) to JJJ; Guangdong Natural Science Foundation (S2013040016220) to JJJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER MP, 1969, STAIN TECHNOL, V44, P117, DOI 10.3109/10520296909063335; Allen GC, 2006, NAT PROTOC, V1, P2320, DOI 10.1038/nprot.2006.384; Ariizumi T, 2011, ANNU REV PLANT BIOL, V62, P437, DOI 10.1146/annurev-arplant-042809-112312; Blanc G, 2004, PLANT CELL, V16, P1679, DOI 10.1105/tpc.021410; Blanc G, 2003, GENOME RES, V13, P137, DOI 10.1101/gr.751803; Bowers JE, 2003, NATURE, V422, P433, DOI 10.1038/nature01521; Caffall KH, 2009, CARBOHYD RES, V344, P1879, DOI 10.1016/j.carres.2009.05.021; Cao J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046944; Carvajal F, 2014, PLANT BIOLOGY, V16, P457, DOI 10.1111/plb.12070; Castro AJ, 2013, ANN BOT-LONDON, V112, P503, DOI 10.1093/aob/mct118; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Danilevskaya ON, 2003, PLANT CELL, V15, P425, DOI 10.1105/tpc.006759; Demura T, 2002, P NATL ACAD SCI USA, V99, P15794, DOI 10.1073/pnas.232590499; Dick-Perez M, 2012, MAGN RESON CHEM, V50, P539, DOI 10.1002/mrc.3836; Duarte JM, 2006, MOL BIOL EVOL, V23, P469, DOI 10.1093/molbev/msj051; Freeling M, 2009, ANNU REV PLANT BIOL, V60, P433, DOI 10.1146/annurev.arplant.043008.092122; Geitmann A, 2010, SEX PLANT REPROD, V23, P63, DOI 10.1007/s00497-009-0121-4; Gonzalez-Carranza ZH, 2007, J EXP BOT, V58, P3719, DOI 10.1093/jxb/erm222; Gu X, 2003, TRENDS GENET, V19, P354, DOI 10.1016/S0168-9525(03)00139-2; Hadfield KA, 1998, PLANT PHYSIOL, V117, P337, DOI 10.1104/pp.117.2.337; HESLOPHARRISON J, 1987, INT REV CYTOL, V107, P1, DOI 10.1016/S0074-7696(08)61072-4; Honys D, 2003, PLANT PHYSIOL, V132, P640, DOI 10.1104/pp.103.020925; Huang L, 2008, PLANT BIOLOGY, V10, P342, DOI 10.1111/j.1438-8677.2008.00039.x; Huang L, 2009, J EXP BOT, V60, P301, DOI 10.1093/jxb/ern295; Huang L, 2010, PLANT SYST EVOL, V286, P103, DOI 10.1007/s00606-010-0283-4; Huang L, 2009, ANN BOT-LONDON, V104, P1339, DOI 10.1093/aob/mcp244; Jiang JJ, 2014, J INTEGR PLANT BIOL, V56, P1095, DOI 10.1111/jipb.12209; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Kim J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9r87; Kim J, 2006, PLANT SIGNAL BEHAV, V1, P281, DOI 10.4161/psb.1.6.3541; Kirik V, 2004, PLANT MOL BIOL, V55, P389, DOI 10.1007/s11103-004-0893-8; Li S, 2013, PLANT J, V74, P486, DOI 10.1111/tpj.12139; LI YQ, 1994, SEX PLANT REPROD, V7, P145; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Maere S, 2005, P NATL ACAD SCI USA, V102, P5454, DOI 10.1073/pnas.0501102102; Markovic O, 2001, PROTEIN ENG, V14, P615, DOI 10.1093/protein/14.9.615; Moon S, 2013, PLANT PHYSIOL, V161, P663, DOI 10.1104/pp.112.210948; Nickel W, 2003, EUR J BIOCHEM, V270, P2109, DOI 10.1046/j.1432-1033.2003.03577.x; Nickel W, 2005, TRAFFIC, V6, P607, DOI 10.1111/j.1600-0854.2005.00302.x; Ogawa M, 2009, PLANT CELL, V21, P216, DOI 10.1105/tpc.108.063768; OWEN HA, 1995, PROTOPLASMA, V185, P7, DOI 10.1007/BF01272749; Park KC, 2008, GENOME, V51, P30, DOI [10.1139/G07-093, 10.1139/g07-093]; Park KC, 2010, GENES GENOM, V32, P570, DOI 10.1007/s13258-010-0076-8; Qi Ming-Fang, 2014, ScientificWorldJournal, V2014, P389896, DOI 10.1155/2014/389896; Rhee SY, 2003, PLANT PHYSIOL, V133, P1170, DOI 10.1104/pp.103.028266; Rhee SY, 1998, PLANT J, V15, P79, DOI 10.1046/j.1365-313X.1998.00183.x; Saleh A, 2008, PLANT CELL, V20, P568, DOI 10.1105/tpc.107.056614; Sander L, 2001, PLANT MOL BIOL, V46, P469, DOI 10.1023/A:1010619002833; Schwab R, 2006, PLANT CELL, V18, P1121, DOI 10.1105/tpc.105.039834; Simillion C, 2002, P NATL ACAD SCI USA, V99, P13627, DOI 10.1073/pnas.212522399; Sun LX, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-152; Taylor LP, 1997, ANNU REV PLANT PHYS, V48, P461, DOI 10.1146/annurev.arplant.48.1.461; Torki M, 2000, GENE, V242, P427, DOI 10.1016/S0378-1119(99)00497-7; Ueda K, 2013, PLANT PHYSIOL, V162, P858, DOI 10.1104/pp.113.216523; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Xu GX, 2012, P NATL ACAD SCI USA, V109, P1187, DOI 10.1073/pnas.1109047109; Yang ZL, 2013, NEW PHYTOL, V197, P1353, DOI 10.1111/nph.12107; Yeung EC, 2011, SEX PLANT REPROD, V24, P307, DOI 10.1007/s00497-011-0168-x; Yu XL, 2004, J HORTIC SCI BIOTECH, V79, P833, DOI 10.1080/14620316.2004.11511851; Yu YJ, 2014, PLANT MOL BIOL REP, V32, P476, DOI 10.1007/s11105-013-0666-0; Zhang AH, 2012, PLANT MOL BIOL REP, V30, P330, DOI 10.1007/s11105-011-0341-2; Zhang AH, 2011, PLANT MOL BIOL REP, V29, P943, DOI 10.1007/s11105-011-0298-1; Zhang Q, 2008, PLANT CELL REP, V27, P1207, DOI 10.1007/s00299-008-0541-x	65	18	24	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0131173	10.1371/journal.pone.0131173	http://dx.doi.org/10.1371/journal.pone.0131173			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26153985	gold, Green Submitted, Green Published			2022-12-26	WOS:000358159700055
J	Minnerup, J; Wersching, H; Unrath, M; Berger, K				Minnerup, Jens; Wersching, Heike; Unrath, Michael; Berger, Klaus			Explaining the Decrease of In-Hospital Mortality from Ischemic Stroke	PLOS ONE			English	Article							TRENDS; MANAGEMENT; DECLINE	Background Mortality from ischemic stroke has declined over time. However, little is known about the reasons for the decreased mortality. We therefore aimed to evaluate trends in in-hospital mortality and to identify factors associated with these trends. Methods This study was based on a prospective database of 26 hospitals of the Stroke Register of Northwestern Germany, which included 73,614 patients admitted between 2000 and 2011. Time trends in observed (crude) and risk-adjusted in-hospital mortality were assessed. Independent factors associated with death after stroke were evaluated using multivariable logistic regression analysis. Results The observed in-hospital mortality decreased from 6.6% in 2000 to 4.6% in 2008 (P < 0.001 for trend) and then remained fairly stable. The risk-adjusted mortality decreased from 2.85% in 2000 to 1.86% in 2008 (P < 0.01 for trend) and then increased to 2.32% in 2011. Use of in-hospital treatments including antiplatelets within 48 hours, antihypertensive therapy, statins, antidiabetics, physiotherapy and anticoagulants increased over time and was significantly associated with a decrease in mortality. The association of the year of admission with mortality became insignificant after adjustment for antiplatelet therapy within 48 hours (from OR 0.96; 95% CI, 0.94-0.98, to OR 0.99; 95% CI, 0.97-1.01) and physiotherapy (from OR 0.96; 95% CI, 0.94-0.97, to OR 0.99; 95% CI, 0.97-1.00). Conclusions In-hospital mortality decreased by approximately one third between 2000 and 2008. This decline was paralleled by improvements in different in-hospital managements, and we demonstrated that it was partly mediated by early antiplatelet therapy and physiotherapy use.	[Minnerup, Jens] Univ Munster, Dept Neurol, D-48149 Munster, Germany; [Wersching, Heike; Unrath, Michael; Berger, Klaus] Univ Munster, Inst Epidemiol & Social Med, D-48149 Munster, Germany	University of Munster; University of Munster	Minnerup, J (corresponding author), Univ Munster, Dept Neurol, Albert Schweitzer Campus 1, D-48149 Munster, Germany.	minnerup@uni-muenster.de	Wersching, Heike/B-7775-2017	Wersching, Heike/0000-0002-9706-7599	Deutsche Forschungsgemeinschaft; Open Access Publication Fund of Universtiy of Muenster	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publication Fund of Universtiy of Muenster	We acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publication Fund of Universtiy of Muenster.	Carandang R, 2006, JAMA-J AM MED ASSOC, V296, P2939, DOI 10.1001/jama.296.24.2939; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; HATANO S, 1976, B WORLD HEALTH ORGAN, V54, P541; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Lackland DT, 2014, STROKE, V45, P315, DOI 10.1161/01.str.0000437068.30550.cf; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Minnerup J, 2011, STROKE, V42, P2838, DOI 10.1161/STROKEAHA.111.616565; Ovbiagele B, 2010, STROKE, V41, P1748, DOI 10.1161/STROKEAHA.110.585455; Sandercock PAG, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000029.pub2; Saunders DH, 2013, COCHRANE DATABASE SY, P10; Schmidt M, 2014, NEUROLOGY, V82, P340, DOI 10.1212/WNL.0000000000000062; Tanne D, 2012, STROKE, V43, P2136, DOI 10.1161/STROKEAHA.111.647610; Teuschl Y, 2013, STROKE, V44, P1070, DOI 10.1161/STROKEAHA.111.676114; Towfighi A, 2011, STROKE, V42, P2740, DOI 10.1161/STROKEAHA.110.612648; Vaartjes I, 2013, STROKE, V44, P591, DOI 10.1161/STROKEAHA.112.677724	15	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0131473	10.1371/journal.pone.0131473	http://dx.doi.org/10.1371/journal.pone.0131473			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154704	Green Published, Green Submitted, gold			2022-12-26	WOS:000358159700065
J	Ortiz, A; Pilbrow, V; Villamil, CI; Korsgaard, JG; Bailey, SE; Harrison, T				Ortiz, Alejandra; Pilbrow, Varsha; Villamil, Catalina I.; Korsgaard, Jessica G.; Bailey, Shara E.; Harrison, Terry			The Taxonomic and Phylogenetic Affinities of Bunopithecus sericus, a Fossil Hylobatid from the Pleistocene of China	PLOS ONE			English	Article							DENTAL MORPHOLOGY; PLIOPLEISTOCENE HOMINIDS; MOLECULAR PHYLOGENY; MANDIBULAR MOLARS; DIVERGENCE DATES; EVOLUTION; GIBBONS; GIGANTOPITHECUS; BIOGEOGRAPHY; SEQUENCES	Fossil hylobatids are rare, but are known from late Miocene and Pleistocene sites throughout East Asia. The best-known fossil hylobatid from the Pleistocene of China is a left mandibular fragment with M2-3 (AMNH 18534), recovered from a pit deposit near the village of Yanjinggou in Wanzhou District, Chongqing Province. Matthew and Granger described this specimen in 1923 as a new genus and species, Bunopithecus sericus. Establishing the age of Bunopithecus has proved difficult because the Yanjinggou collection represents a mixed fauna of different ages, but it likely comes from early or middle Pleistocene deposits. Although the Bunopithecus specimen has featured prominently in discussions of hylobatid evolution and nomenclature, its systematic status has never been satisfactorily resolved. The present study reexamines the taxonomic and phylogenetic relationships of Bunopithecus by carrying out a detailed comparative morphometric study of its lower molars in relation to a large sample of modern hylobatids. Our results show that differences in M-2 and M-3 discriminate extant hylobatids fairly well, at least at the generic level, and that AMNH 18534 is not attributable to Hylobates, Nomascus or Symphalangus. Support for a close relationship between Bunopithecus and Hoolock is more equivocal. In most multivariate analyses, Bunopithecus presents a unique morphological pattern that falls outside the range of variation of any hylobatid taxon, although its distance from the cluster represented by extant hoolocks is relatively small. Our results support the generic distinction of Bunopithecus, which most likely represents an extinct crown hylobatid, and one that may possibly represent the sister taxon to Hoolock.	[Ortiz, Alejandra; Villamil, Catalina I.; Korsgaard, Jessica G.; Bailey, Shara E.; Harrison, Terry] NYU, Dept Anthropol, Ctr Study Human Origins, New York, NY 10003 USA; [Ortiz, Alejandra; Villamil, Catalina I.; Bailey, Shara E.; Harrison, Terry] NYCEP, New York, NY USA; [Pilbrow, Varsha] Univ Melbourne, Dept Anat & Neurosci, Melbourne, Vic, Australia	New York University; University of Melbourne	Ortiz, A (corresponding author), NYU, Dept Anthropol, Ctr Study Human Origins, New York, NY 10003 USA.	ao706@nyu.edu	Pilbrow, Varsha/AAI-9897-2020; Villamil, Catalina/K-8880-2019	Pilbrow, Varsha/0000-0002-6677-9390; Bailey, Shara/0000-0002-4626-9262	National Science Foundation [SBR-9815546]; Wenner-Gren Foundation; Leakey Foundation; Center for the Study of Human Origins at New York University	National Science Foundation(National Science Foundation (NSF)); Wenner-Gren Foundation; Leakey Foundation; Center for the Study of Human Origins at New York University	This research was supported by the National Science Foundation (SBR-9815546), the Wenner-Gren Foundation, the Leakey Foundation, and the Center for the Study of Human Origins at New York University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacon AM, 2008, CR PALEVOL, V7, P277, DOI 10.1016/j.crpv.2008.03.009; Badoux DM, 1959, FOSSIL MAMMALS 2 FIS; Bailey S, 2002, THESIS ARIZONA STATE; Bailey SE, 2004, J HUM EVOL, V47, P183, DOI 10.1016/j.jhevol.2004.07.001; Bailey SE, 2004, J ANAT, V205, P323, DOI 10.1111/j.0021-8782.2004.00334.x; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Carbone L, 2014, NATURE, V513, P195, DOI 10.1038/nature13679; Chan YC, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-150; Chan YC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014419; Chatterjee HJ, 2006, INT J PRIMATOL, V27, P699, DOI 10.1007/s10764-006-9044-1; Chatterjee Helen J., 2009, P13, DOI 10.1007/978-0-387-88604-6_2; Chen SK, 2013, CHINESE SCI BULL, V58, P3780, DOI 10.1007/s11434-013-5839-6; Ciochon R, 1996, P NATL ACAD SCI USA, V93, P3016, DOI 10.1073/pnas.93.7.3016; CIOCHON RL, 1986, J HUM EVOL, V15, P623, DOI 10.1016/S0047-2484(86)80075-6; Colbert E. H., 1940, American Museum Novitates, Vno. 1099; COLBERT EH, 1953, B AM MUS NAT HIST, V102, P1; DAHLBERG AA, 1945, J AM DENT ASSOC, V32, P676, DOI 10.14219/jada.archive.1945.0112; Fabre PH, 2009, MOL PHYLOGENET EVOL, V53, P808, DOI 10.1016/j.ympev.2009.08.004; Fan Peng-Fei, 2009, Gibbon Journal, V5, P44; Finstermeier K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069504; Frisch, 1973, GIBBON SIAMANG, V2, P55; FRISCH JE, 1965, BIBL PRIMATOL, P1; GAO Y-T, 1981, Zoological Research, V2, P1; Geissmann Thomas, 1995, IZN (International Zoo News), V42, P467; Geissmann Thomas, 2007, Gibbon Journal, V3, P5; Groves C.P., 1972, P1; Groves C.P., 2001, PRIMATE TAXONOMY; Gu Yumin, 1996, Vertebrata Palasiatica, V34, P235; Gu Yumin, 1986, Acta Anthropologica Sinica, V5, P208; Gu Yumin, 1989, Human Evolution, V4, P509; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Harrison T, 2008, AM J PHYS ANTHROPOL, P113; Harrison T., 2000, B INDOPACIFIC PREHIS, V20, P133; Harrison T., EVOLUTION GIBBIONS S; HARRISON T, 1996, B INDOPACIFIC PREHIS, V14, P90, DOI DOI 10.7152/BIPPA.V14I0.11592; HARRISON T, 1998, B INDOPACIFIC PREHIS, V17, P85, DOI DOI 10.7152/BIPPA.V17I0.11670; Harrison T, 2014, QUATERN INT, V354, P59, DOI 10.1016/j.quaint.2014.01.013; Harrison T, 2006, DEV PRIMATOL, P331; HAYASHI S, 1995, J MOL EVOL, V41, P359, DOI 10.1007/BF01215183; Hooijer D. A., 1960, Zoologische Verhandelingen, VNo. 46, P1; Hooijer D. A., 1962, Sarawak Museum Journal, V10, P428; Hooijer D. A., 1961, Sarawak Museum Journal, V9, P408; Ingicco T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099531; Israfil H, 2011, MOL PHYLOGENET EVOL, V58, P447, DOI 10.1016/j.ympev.2010.11.005; Jablonski NG, 2000, J HUM EVOL, V39, P131, DOI 10.1006/jhev.2000.0405; Jablonski Nina G., 2009, P111, DOI 10.1007/978-0-387-88604-6_7; Ji WZ, 2004, INT J PRIMATOL, V25, P1077, DOI 10.1023/B:IJOP.0000043352.64428.8c; Kahlke HD, 1961, VERTEBRAT PALASIATIC, V6, P83; Marshall J., 1986, P137; Matsudaira K, 2010, MOL PHYLOGENET EVOL, V55, P454, DOI 10.1016/j.ympev.2010.01.032; Matthew WD, 1923, B AM MUS NAT HIST, V48, P563; Meyer TJ, 2012, MOL BIOL EVOL, V29, P3441, DOI 10.1093/molbev/mss149; Mittermeier R., 2013, HDB MAMMALS WORLD, V3; Mootnick A, 2005, INT J PRIMATOL, V26, P971, DOI 10.1007/s10764-005-5332-4; NISBETT RA, 1993, INT J PRIMATOL, V14, P765, DOI 10.1007/BF02192190; Pan Y., 2006, LUFENGPITHECUS HUDIE, p[131, 320]; Perelman P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001342; Pilbrow V, 2006, J HUM EVOL, V51, P646, DOI 10.1016/j.jhevol.2006.07.008; Pilbrow V, 2010, J HUM EVOL, V59, P16, DOI 10.1016/j.jhevol.2010.01.009; PILBROW VC, 2003, THESIS NEW YORK U; Porter CA, 1997, INT J PRIMATOL, V18, P261, DOI 10.1023/A:1026328804319; PROUTY LA, 1983, CYTOGENET CELL GENET, V35, P141, DOI 10.1159/000131856; PROUTY LA, 1983, AM J PRIMATOL, V5, P83, DOI 10.1002/ajp.1350050110; PURVIS A, 1995, PHILOS T ROY SOC B, V348, P405, DOI 10.1098/rstb.1995.0078; Quam R, 2009, J ANAT, V214, P655, DOI 10.1111/j.1469-7580.2009.01064.x; Raaum RL, 2005, J HUM EVOL, V48, P237, DOI 10.1016/j.jhevol.2004.11.007; Roos C, 2001, MOL PHYLOGENET EVOL, V19, P486, DOI 10.1006/mpev.2001.0939; Schwartz Jeffrey H., 1994, Anthropological Papers of the American Museum of Natural History, V73, P1; Springer MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049521; Storm Paul, 2006, Senckenbergiana Lethaea, V86, P271; Swindler D.R., 2002, PRIMATE DENTITION; Takai M, 2014, QUATERN INT, V354, P75, DOI 10.1016/j.quaint.2014.02.021; Teilhard de Chardin P., 1935, B GEOL SOC CHINA, V2, P179; Thinh VN, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-74; Tougard C, 2001, PALAEOGEOGR PALAEOCL, V168, P337, DOI 10.1016/S0031-0182(00)00243-1; Uchida A., 1996, CAMBRIDGE PEABODY MU, V4; van Gulik R. H., 2015, GIBBON CHINA ESSAY C; WOOD BA, 1988, J ANAT, V161, P1; WOOD BA, 1983, J ANAT, V137, P287; WOOD BA, 1983, J ANAT, V136, P197; Wu X, 1995, HUMAN EVOLUTION CHIN, P241; Zeitoun V, 2010, QUATERN INT, V220, P160, DOI 10.1016/j.quaint.2009.11.022; Zhang YQ, 2014, QUATERN INT, V354, P35, DOI 10.1016/j.quaint.2013.12.008	83	8	9	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0131206	10.1371/journal.pone.0131206	http://dx.doi.org/10.1371/journal.pone.0131206			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154175	Green Published, gold, Green Submitted			2022-12-26	WOS:000358159700058
J	Xiang, LB; Li, JJ; Yang, WT; Xu, XL; Wu, XH; Wang, HY; Li, ZT; Yang, HJ				Xiang, Libing; Li, Jiajia; Yang, Wentao; Xu, Xiaoli; Wu, Xiaohua; Wang, Huaying; Li, Ziting; Yang, Huijuan			Conization Using an Electrosurgical Knife for Cervical Intraepithelial Neoplasia and Microinvasive Carcinoma	PLOS ONE			English	Article							LARGE-LOOP EXCISION; TERM-FOLLOW-UP; COLD-KNIFE; TRANSFORMATION ZONE; RESIDUAL DISEASE; RISK-FACTORS; RECURRENCE; MANAGEMENT; SPECIMENS; BIOPSY	Objective The aim of the present study was to evaluate the incidences of margin involvement, disease relapse, and complications in patients who had undergone conization using an electrosurgical knife (EKC) for cervical intraepithelial neoplasia (CIN) or microinvasive carcinomas (micro-CAs). Materials and Methods A retrospective case series analysis was performed with a total of 1359 patients who underwent EKC in Fudan University Shanghai Cancer Center between June 2004 and July 2010. Results The median age of the patients was 39 years old (range: 19-72). Conization revealed the presence of CIN in 1113 (81.9%) patients, micro-CA in 72 (5.3%) patients and invasive carcinomas in 44 (3.2%) patients. The remaining 130 (9.6%) patients were free of diseases in the cone specimens. Positive surgical margins, or endocervical curettages (ECCs) were found in 90 (7.6%) patients with CINs or micro-CAs. Three factors were associated with positive margins and ECCs and included age (>50 years; odds ratio (OR), 3.0, P<0.01), postmenopausal status (OR, 3.1, P<0.01) and microinvasive disease (OR, 2.7, P<0.01). One thousand and eighty-nine (92.0%) patients were followed-up regularly for a median follow-up duration of 46 months (range: 24-106 months). Disease relapse was documented in 50 (4.6%) patients. Eighty-two (6.0%) cases experienced surgical complications that needed to be addressed, including early or late hemorrhages, infections, cervical stenosis, etc. Conclusions Our patients demonstrated that EKC was an alternative technique for diagnosis and treatment of CIN or micro-CAs with relatively low rate of recurrence and acceptable rate of complications. A randomized clinical trial is warranted to compare EKC, CKC and LEEP in the management of CIN or micro-CA.	[Xiang, Libing; Li, Jiajia; Wu, Xiaohua; Wang, Huaying; Li, Ziting; Yang, Huijuan] Fudan Univ, Shanghai Med Coll, Shanghai Canc Ctr, Dept Oncol,Dept Gynecol Oncol, Shanghai 200032, Peoples R China; [Yang, Wentao; Xu, Xiaoli] Fudan Univ, Shanghai Med Coll, Shanghai Canc Ctr, Dept Oncol,Dept Pathol, Shanghai 200032, Peoples R China	Fudan University; Fudan University	Yang, HJ (corresponding author), Fudan Univ, Shanghai Med Coll, Shanghai Canc Ctr, Dept Oncol,Dept Gynecol Oncol, Shanghai 200032, Peoples R China.	huijuanyang@hotmail.com			Shanghai Municipal Health Bureau [2007140]	Shanghai Municipal Health Bureau	This study was supported by a grant from Shanghai Municipal Health Bureau (2007140, YHJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae HS, 2013, ACTA OBSTET GYN SCAN, V92, P185, DOI 10.1111/aogs.12025; Chen YX, 2009, INT J GYNECOL OBSTET, V107, P107, DOI 10.1016/j.ijgo.2009.05.027; Dane C, 2008, AUST NZ J OBSTET GYN, V48, P343, DOI 10.1111/j.1479-828X.2008.00853.x; Ghaem-Maghami S, 2011, BJOG-INT J OBSTET GY, V118, P679, DOI 10.1111/j.1471-0528.2010.02770.x; Ghaem-Maghami S, 2007, LANCET ONCOL, V8, P985, DOI 10.1016/S1470-2045(07)70283-8; Grimm C, 2013, ARCH GYNECOL OBSTET, V288, P1081, DOI 10.1007/s00404-013-2873-1; Katki HA, 2013, J LOW GENIT TRACT DI, V17, pS78, DOI 10.1097/LGT.0b013e31828543c5; Leguevaque P, 2010, EJSO-EUR J SURG ONC, V36, P1073, DOI 10.1016/j.ejso.2010.08.135; Malapati R, 2011, J LOW GENIT TRACT DI, V15, P177, DOI 10.1097/LGT.0b013e3181fee61d; Manchanda R, 2008, BJOG-INT J OBSTET GY, V115, P1238, DOI 10.1111/j.1471-0528.2008.01853.x; Mathevet P, 2003, EUR J OBSTET GYN R B, V106, P214, DOI 10.1016/S0301-2115(02)00245-2; Melnikow J, 2009, JNCI-J NATL CANCER I, V101, P721, DOI 10.1093/jnci/djp089; Miroshnichenko GG, 2009, J LOW GENIT TRACT DI, V13, P10, DOI 10.1097/LGT.0b013e31817ff940; Nasu K, 2010, ARCH GYNECOL OBSTET, V281, P887, DOI 10.1007/s00404-009-1205-y; Panna S, 2009, ASIAN PAC J CANCER P, V10, P637; PAPAKONSTANTINO.K, 2014, AM J OBSTET GYNECOL, V211, P621; Papoutsis D, 2013, GYNECOL OBSTET INVES, V75, P163, DOI 10.1159/000345864; Papoutsis D, 2011, IN VIVO, V25, P691; Park JY, 2009, OBSTET GYNECOL, V114, P87, DOI 10.1097/AOG.0b013e3181ab6dca; Serati M, 2012, EUR J OBSTET GYN R B, V165, P86, DOI 10.1016/j.ejogrb.2012.06.026; Shi JF, 2012, INT J CANCER, V130, P641, DOI 10.1002/ijc.26042; Shin JW, 2009, J OBSTET GYNAECOL RE, V35, P126, DOI 10.1111/j.1447-0756.2008.00834.x; Socolov D, 2009, CHIRURGIA-BUCHAREST, V104, P295; Monteiro ACS, 2008, SAO PAULO MED J, V126, P209, DOI 10.1590/S1516-31802008000400002; van Hamont D, 2006, INT J GYNECOL CANCER, V16, P615, DOI 10.1111/j.1525-1438.2006.00404.x; [向礼兵 Xiang Libing], 2013, [中国癌症杂志, China Oncology], V23, P370; Yang H, 2006, CHINA ONCOLOGY, V16, P922; Zeng SY, 2012, EUR J GYNAECOL ONCOL, V33, P257	28	15	22	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0131790	10.1371/journal.pone.0131790	http://dx.doi.org/10.1371/journal.pone.0131790			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26153692	Green Published, Green Submitted, gold			2022-12-26	WOS:000358159700079
J	Dong, Z; Zhao, DB; Yang, CD; Zhou, JR; Qian, QX; Ma, YY; He, HJ; Ji, HD; Yang, YJ; Wang, XF; Xu, X; Pang, YF; Zou, HJ; Jin, L; Wang, JC				Dong, Zheng; Zhao, Dongbao; Yang, Chengde; Zhou, Jingru; Qian, Qiaoxia; Ma, Yanyun; He, Hongjun; Ji, Hengdong; Yang, Yajun; Wang, Xiaofeng; Xu, Xia; Pang, Yafei; Zou, Hejian; Jin, Li; Wang, Jiucun			Common Variants in LRP2 and COMT Genes Affect the Susceptibility of Gout in a Chinese Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; EXCRETION	Gout is a common inflammation disease resulting from an increase in serum uric acid. Nearly 70% of uric acid is excreted via the kidneys. To date, evidence for an association between genetic loci and gout is absent, equivocal or not replicated. Our study aims to test variants in two genes abundantly expressed in the kidney, LRP2 and COMT, for their association with uric acid and gout. In total, 1318 Chinese individuals were genotyped for rs2544390 in LRP2 and rs4680 in COMT. These LRP2 and COMT gene polymorphisms showed no significant effect on uric acid (P = 0.204 and 0.188, separately); however, rs2544390 in LRP2 did influence uric acid levels in individuals with BMI >= 25 (P = 0.009). In addition, the allele frequency distributions of the two loci showed a significant difference between gout patients and healthy controls. A missense variation in rs4680 (G > A) decreased the risk of gout (OR = 0.77, P = 0.015), whereas the T allele of rs2544390 was associated with gout pathogenesis risk (OR = 1.26, P = 0.020). The present study provides the first evidence for an association between COMT and gout. Rs2544390 in LRP2 only influenced uric acid levels in individuals with BMI >= 25, which might explain the discrepant results among previous studies. In addition, we are the first to identify the association between LRP2 and gout in a Chinese population and to confirm this association in Asians.	[Dong, Zheng; Zhou, Jingru; Qian, Qiaoxia; Ma, Yanyun; Yang, Yajun; Wang, Xiaofeng; Jin, Li; Wang, Jiucun] Fudan Univ, Sch Life Sci, Minist Educ, Collaborat Innovat Ctr Genet & Dev,Key Lab Contem, Shanghai 200433, Peoples R China; [Zhao, Dongbao; Xu, Xia; Pang, Yafei] Changhai Hosp, Div Rheumatol & Immunol, Shanghai, Peoples R China; [Yang, Chengde] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Div Rheumatol, Shanghai 200030, Peoples R China; [He, Hongjun; Wang, Jiucun] Taixing Peoples Hosp, Div Rheumatol, Taizhou, Jiangsu, Peoples R China; [Ji, Hengdong] Taizhou Peoples Hosp, Div Rheumatol, Taizhou, Jiangsu, Peoples R China; [Yang, Yajun; Wang, Xiaofeng; Jin, Li] Fudan Taizhou Inst Hlth Sci, Taizhou, Jiangsu, Peoples R China; [Zou, Hejian] Fudan Univ, Huashan Hosp, Div Rheumatol, Shanghai 200433, Peoples R China; [Zou, Hejian; Wang, Jiucun] Fudan Univ, Inst Rheumatol Immunol & Allergy, Shanghai 200433, Peoples R China	Fudan University; Naval Medical University; Shanghai Jiao Tong University; Fudan University; Fudan University	Wang, JC (corresponding author), Fudan Univ, Sch Life Sci, Minist Educ, Collaborat Innovat Ctr Genet & Dev,Key Lab Contem, Shanghai 200433, Peoples R China.	jcwang@fudan.edu.cn	Jin, Li/M-5063-2019; Jin, Li/C-1468-2009; Wang, Jiucun/J-8744-2012; MA, YAN/HHN-2912-2022	Jin, Li/0000-0002-4546-2415; Wang, Jiucun/0000-0003-2765-0620; 	Science and Technology Committee of Shanghai Municipality [11DJ1400100]; International S&T Cooperation Program of China [2013DFA30870]; Ministry of Science and Technology [2011BAI09B00]; Program for 2012 Outstanding Medical Academic Leader for Hejian Zou; Fudan University High-End Computing Center	Science and Technology Committee of Shanghai Municipality(Shanghai Science & Technology Committee); International S&T Cooperation Program of China; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Program for 2012 Outstanding Medical Academic Leader for Hejian Zou; Fudan University High-End Computing Center	This research was supported by grants from the Science and Technology Committee of Shanghai Municipality (11DJ1400100), International S&T Cooperation Program of China (2013DFA30870), Ministry of Science and Technology (2011BAI09B00), and Program for 2012 Outstanding Medical Academic Leader for Hejian Zou. The computations involved in this study were supported by Fudan University High-End Computing Center.	[Anonymous], 2006, PUBLIC HEALTH NUTR, V9, P658, DOI 10.1079/PHN2006967; Eklof AC, 1997, KIDNEY INT, V52, P742, DOI 10.1038/ki.1997.390; Hamajima N, 2012, GENE, V503, P131, DOI 10.1016/j.gene.2012.04.064; Kamatani Y, 2010, NAT GENET, V42, P210, DOI 10.1038/ng.531; Kottgen A, 2013, NAT GENET, V45, P145, DOI 10.1038/ng.2500; Kornek M, 2013, DIS MARKERS, V2013, P129, DOI 10.1155/2013/279046; Mandell Brian F, 2008, Cleve Clin J Med, V75 Suppl 5, pS5; Marzolo MP, 2011, BIOL RES, V44, P89, DOI 10.4067/S0716-97602011000100012; May P, 2007, ANN MED, V39, P219, DOI 10.1080/07853890701214881; Nakayama A, 2014, RHEUMATOL INT, V34, P473, DOI 10.1007/s00296-013-2924-8; Pascual E, 2006, ANN RHEUM DIS, V65, P981, DOI 10.1136/ard.2005.049023; Pestana M, 2001, NEPHROL DIAL TRANSPL, V16, P53, DOI 10.1093/ndt/16.suppl_1.53; Phipps-Green AJ, 2016, ANN RHEUM DIS, V75, P124, DOI 10.1136/annrheumdis-2014-205877; Rasheed H, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4366; SCANLON PD, 1979, SCIENCE, V203, P63, DOI 10.1126/science.758679; Sulikowska B, 2008, AM J NEPHROL, V28, P391, DOI 10.1159/000112271; Tu HP, 2010, HUM GENET, V127, P223, DOI 10.1007/s00439-009-0765-z; Urano W, 2013, J RHEUMATOL, V40, P1374, DOI 10.3899/jrheum.121244; Vitart V, 2008, NAT GENET, V40, P437, DOI 10.1038/ng.106; WALLACE SL, 1977, ARTHRITIS RHEUM, V20, P895, DOI 10.1002/art.1780200320; Wang XF, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-223; Yang BY, 2014, BMC MED GENOMICS, V7, DOI 10.1186/1755-8794-7-10; Zeng CY, 2007, CLIN SCI, V112, P583, DOI 10.1042/CS20070018	23	7	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131302	10.1371/journal.pone.0131302	http://dx.doi.org/10.1371/journal.pone.0131302			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147675	Green Published, gold, Green Submitted			2022-12-26	WOS:000358157600086
J	Gou, XL; Tan, B; Wu, FZ; Yang, WQ; Xu, ZF; Li, ZP; Zhang, XT				Gou, Xiaolin; Tan, Bo; Wu, Fuzhong; Yang, Wanqin; Xu, Zhengfeng; Li, Zhiping; Zhang, Xitao			Seasonal Dynamics of Soil Microbial Biomass C and N along an Elevational Gradient on the Eastern Tibetan Plateau, China	PLOS ONE			English	Article							LATE WINTER; SNOW COVER; TEMPERATURE; COMMUNITY; NITROGEN; DECLINE; MEADOW; WET	Little information is available on the seasonal response of soil microbial biomass to climate warming even though it is very sensitive to climate change. A two-year field experiment was conducted in the subalpine and alpine forests of the eastern Tibetan Plateau, China. The intact soil cores from 3,600 m site were incubated in three elevations (3,000 m, 3,300 m and 3,600 m) to simulate climate warming. Soil microbial biomass carbon (MBC) and nitrogen (MBN) were measured at different periods (early growing season [EG], late growing season [LG], onset of soil freezing period [OF], deep soil frozen period [DF] and soil thawing period [ET]) from May 2010 to August 2012. Average air temperature and soil temperature increased with the decrease of elevation during the experimental period. MBC and MBN showed a sharp decrease during the OF and ET in both organic layer and mineral layer at the three sites. Additionally, a relatively high MBC was observed during the DF. MBC and MBN in the soil organic layer decreased with the decrease of elevation but the opposite was true in the mineral soil layer. Warming had stronger effects on soil microbial biomass in the organic layer than in the mineral soil layer. The results indicated that future warming would alter soil microbial biomass and biogeochemical cycling in the forest ecosystems on the eastern Tibetan Plateau.	[Gou, Xiaolin; Tan, Bo; Wu, Fuzhong; Yang, Wanqin; Xu, Zhengfeng; Li, Zhiping; Zhang, Xitao] Sichuan Agr Univ, Key Lab Ecol Forestry Engn, Inst Ecol & Forestry, Chengdu 611130, Peoples R China	Sichuan Agricultural University	Yang, WQ (corresponding author), Sichuan Agr Univ, Key Lab Ecol Forestry Engn, Inst Ecol & Forestry, 211 Huimin Rd, Chengdu 611130, Peoples R China.	scyangwq@163.com			National Natural Science Foundation of China [31170423, 31270498, 31200474]; National Key Technologies RD Program [2011BAC09B05]; Program of Sichuan Youth Sci-tech Foundation [2012JQ0008, 2012JQ0059]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technologies RD Program(National Key Technology R&D Program); Program of Sichuan Youth Sci-tech Foundation	The project was financially supported by the National Natural Science Foundation of China (No. 31170423; No. 31270498; No. 31200474), http://www.nsfc.gov.cn/Portal0/default166.htm; National Key Technologies R&D Program (No. 2011BAC09B05), http://www.most.gov.cn; and Program of Sichuan Youth Sci-tech Foundation (No. 2012JQ0008; No.2012JQ0059), http://xmgl.scst.gov.cn/.	Allison SD, 2008, GLOBAL CHANGE BIOL, V14, P2898, DOI 10.1111/j.1365-2486.2008.01716.x; Beniston M., 2003, CLIMATIC CHANGE MOUN; BROOKES PC, 1985, SOIL BIOL BIOCHEM, V17, P837, DOI 10.1016/0038-0717(85)90144-0; CABRERA ML, 1993, SOIL SCI SOC AM J, V57, P1007, DOI 10.2136/sssaj1993.03615995005700040021x; Edwards KA, 2006, SOIL BIOL BIOCHEM, V38, P2843, DOI 10.1016/j.soilbio.2006.04.042; Edwards KA, 2013, SOIL BIOL BIOCHEM, V57, P83, DOI 10.1016/j.soilbio.2012.07.018; GOODRICH LE, 1982, CAN GEOTECH J, V19, P421, DOI 10.1139/t82-047; Groffman PM, 2001, BIOGEOCHEMISTRY, V56, P135, DOI 10.1023/A:1013039830323; Hentschel K, 2008, J PLANT NUTR SOIL SC, V171, P699, DOI 10.1002/jpln.200700154; IPCC, 2007, CLIM CHANG 2007 PHYS; IUSS Working Group WRB, 2006, WORLD SOIL RES REP; Jefferies RL, 2010, SOIL BIOL BIOCHEM, V42, P129, DOI 10.1016/j.soilbio.2009.10.008; Kaarlejarvi E, 2012, ECOSYSTEMS, V15, P1219, DOI 10.1007/s10021-012-9580-9; KOCH O, 2007, GLOBAL BIOGEOCHEMICA, V21, P497; Korner C, 2007, TRENDS ECOL EVOL, V22, P569, DOI 10.1016/j.tree.2007.09.006; Lipson DA, 2002, MICROB ECOL, V43, P307, DOI 10.1007/s00248-001-1057-x; Lipson DA, 2000, SOIL BIOL BIOCHEM, V32, P441, DOI 10.1016/S0038-0717(99)00068-1; Schindlbacher A, 2011, SOIL BIOL BIOCHEM, V43, P1417, DOI 10.1016/j.soilbio.2011.03.005; Schlesinger WH, 2000, BIOGEOCHEMISTRY, V48, P7, DOI 10.1023/A:1006247623877; Tan B, 2011, ACTA AGR SCAND B-S P, V61, P670, DOI 10.1080/09064710.2010.541489; Templer PH, 2012, PLANT SOIL, V353, P15, DOI 10.1007/s11104-011-1064-8; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Wu FZ, 2011, AFR J MICROBIOL RES, V5, P5575, DOI 10.5897/AJMR11.288; Wu FZ, 2010, ACTA OECOL, V36, P135, DOI 10.1016/j.actao.2009.11.002; Xu ZF, 2010, PLANT SOIL, V336, P183, DOI 10.1007/s11104-010-0461-8; Yergeau E, 2012, ISME J, V6, P692, DOI 10.1038/ismej.2011.124; Yu XF, 2011, PEDOSPHERE, V21, P251, DOI 10.1016/S1002-0160(11)60125-2; Zhang W, 2005, GLOBAL CHANGE BIOL, V11, P266, DOI 10.1111/j.1365-2486.2005.00902.x; Zhang Y, 2008, COLD REG SCI TECHNOL, V52, P355, DOI 10.1016/j.coldregions.2007.07.001; Zhu JX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062073; Zogg GP, 1997, SOIL SCI SOC AM J, V61, P475, DOI 10.2136/sssaj1997.03615995006100020015x	31	8	11	4	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132443	10.1371/journal.pone.0132443	http://dx.doi.org/10.1371/journal.pone.0132443			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147974	Green Published, gold, Green Submitted			2022-12-26	WOS:000358157600270
J	Xie, ZL; Feng, J; Yang, WS; Xiang, F; Yang, F; Zhao, YH; Cao, ZJ; Li, WX; Chen, ZY; Wu, YL				Xie, Zili; Feng, Jing; Yang, Weishan; Xiang, Fang; Yang, Fan; Zhao, Yonghui; Cao, Zhijian; Li, Wenxin; Chen, Zongyun; Wu, Yingliang			Human alpha-defensins are immune-related Kv1.3 channel inhibitors: new support for their roles in adaptive immunity	FASEB JOURNAL			English	Article						HNP1; HD5; potassium channel modifier; immune modulation; interaction mechanism	SEA-ANEMONE TOXIN; POTASSIUM CHANNEL; PEPTIDE; SELECTIVITY; RESIDUES; SHK	Defensins form a major family of antimicrobial peptides. Recently, human beta-defensin 2 and fungal plectasin were shown to be immune-related potassium voltage-gated channel subfamily A member 3 (Kv1.3) channel inhibitors. This work continued to show that the human alpha-defensins human neutrophil peptide (HNP) 1 and human defensin (HD) 5 are selective Kv1.3 channel inhibitors with 50% inhibition concentration values of 102.0 +/- 30.3 nM and 2.2 +/- 0.2 mM, respectively. Furthermore, HNP1 was found to inhibit Kv1.3 currents and IL-2 secretion in human CD3(+) T cells. Despite the structural similarity between HNP1 and HD5, HNP1 could simultaneously bind to the S1-S2 linker and the pore region of the Kv1.3 channel as both a toxinlike blocker and a novel modifier, whereas HD5 could only bind to the channel pore region as a toxinlike blocker. As a channel modifier, HNP1 could shift the conductance-voltage relationship curve of the Kv1.3 channel by similar to 9.5 mV in the positive direction and could increase the time constant for channel activation through the electrostatic repulsion between the cationic HNP1 anchored in the S1-S2 linker and the positively charged S4 domain of the Kv1.3 channel. Together, these findings reveal that human alpha-defensins are novel endogenous inhibitors of Kv1.3 channels with distinct interaction mechanisms, which facilitates future research into their adaptive immune functions.	[Xie, Zili; Feng, Jing; Yang, Weishan; Xiang, Fang; Yang, Fan; Zhao, Yonghui; Cao, Zhijian; Li, Wenxin; Chen, Zongyun; Wu, Yingliang] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China; [Cao, Zhijian; Li, Wenxin; Wu, Yingliang] Wuhan Univ, Ctr BioDrug Res, Wuhan 430072, Peoples R China	Wuhan University; Wuhan University	Chen, ZY (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China.	chenzy2005@126.com; ylwu@whu.edu.cn	Feng, Jing/C-1729-2018	Feng, Jing/0000-0001-6726-7912	National Natural Sciences Foundation of China [31470812, 31170789]; National Science Fund for Excellent Young Scholars [31422049]; Wuhan University Natural Sciences Foundation [2042015kf0168]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Fund for Excellent Young Scholars; Wuhan University Natural Sciences Foundation	This work was supported by grants from the National Natural Sciences Foundation of China (31470812 and 31170789), National Science Fund for Excellent Young Scholars (31422049), and Wuhan University Natural Sciences Foundation (2042015kf0168).	Ayabe T, 2002, J BIOL CHEM, V277, P3793, DOI 10.1074/jbc.M107507200; Beeton Christine, 2011, Inflammation & Allergy Drug Targets, V10, P313; Beisner J, 2014, AM J PHYSIOL-GASTR L, V307, pG487, DOI 10.1152/ajpgi.00347.2013; Cahalan MD, 2009, IMMUNOL REV, V231, P59, DOI 10.1111/j.1600-065X.2009.00816.x; Chang TL, 2005, J CLIN INVEST, V115, P765, DOI 10.1172/JCI200521948; Chen ZY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035154; Chen ZY, 2012, J BIOL CHEM, V287, P13813, DOI 10.1074/jbc.M112.343996; Chen ZY, 2014, BIOCHEM BIOPH RES CO, V447, P70, DOI 10.1016/j.bbrc.2014.03.101; Chi V, 2012, TOXICON, V59, P529, DOI 10.1016/j.toxicon.2011.07.016; Ding J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076038; Ericksen B, 2005, ANTIMICROB AGENTS CH, V49, P269, DOI 10.1128/AAC.49.1.269-275.2005; Feller M, 2010, CLIN INFECT DIS, V50, P473, DOI 10.1086/649923; Feng J, 2013, J BIOL CHEM, V288, P12544, DOI 10.1074/jbc.M112.433888; Furci L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045208; Jin L, 2007, J CHEM INF MODEL, V47, P1967, DOI 10.1021/ci700178w; Kanda N, 2011, J LEUKOCYTE BIOL, V89, P935, DOI 10.1189/jlb.0111004; Kubo S, 2008, INT J PEPT RES THER, V14, P341, DOI 10.1007/s10989-008-9146-z; Li Z, 2012, J BIOL CHEM, V287, P29479, DOI 10.1074/jbc.M112.379594; Ma J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084903; Mouhat S, 2008, CURR PHARM DESIGN, V14, P2503, DOI 10.2174/138161208785777441; PARTISETI M, 1992, J IMMUNOL, V148, P3361; Ren YZR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004009; Wehkamp J, 2005, P NATL ACAD SCI USA, V102, P18129, DOI 10.1073/pnas.0505256102; Wulff H, 2003, J CLIN INVEST, V111, P1703, DOI 10.1172/JCI200316921; Xiang F, 2015, TOXINS, V7, P34, DOI 10.3390/toxins7010034; Yang WS, 2015, CELL MOL LIFE SCI, V72, P845, DOI 10.1007/s00018-014-1715-z; Yin SJ, 2008, J PROTEOME RES, V7, P4890, DOI 10.1021/pr800494a; Zsiros E, 2009, J IMMUNOL, V183, P4483, DOI 10.4049/jimmunol.0803003	28	20	21	1	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2015	29	10					4324	4333		10.1096/fj.15-274787	http://dx.doi.org/10.1096/fj.15-274787			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CR5FY	26148969				2022-12-26	WOS:000361367300021
J	Kim, YB; Shin, YJ; Roy, A; Kim, JH				Kim, Yong-Bae; Shin, Yong Jae; Roy, Adhiraj; Kim, Jeong-Ho			The Role of the Pleckstrin Homology Domain-containing Protein CKIP-1 in Activation of p21-activated Kinase 1 (PAK1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN-CAPPING PROTEIN; KINASE CK2; ADAPTER PROTEIN; CYTOSKELETAL REORGANIZATION; CELL MORPHOLOGY; PROSTATE-CANCER; ARP2/3 COMPLEX; VCA DOMAIN; PHOSPHORYLATION; INHIBITION	Upon growth factor stimulation, PAK1 is recruited to the plasma membrane and activated by a mechanism that requires its phosphorylation at Ser-223 by the protein kinase CK2. However, the upstream signaling molecules that regulate this phosphorylation event are not clearly defined. Here, we demonstrate a major role of the CK2 alpha-interacting protein CKIP-1 in activation of PAK1. CK2 alpha, CKIP-1, and PAK1 are translocated to membrane ruffles in response to the epidermal growth factor (EGF), where CKIP-1 mediates the interaction between CK2 alpha and PAK1 in a PI3K-dependent manner. Consistently, PAK1 mediates phosphorylation and modulation of the activity of p41-Arc, one of its plasma membrane substrate, in a fashion that requires PI3K and CKIP-1. Moreover, CKIP-1 knockdown or PI3K inhibition suppresses PAK1-mediated cell migration and invasion, demonstrating the physiological significance of the PI3K-CKIP-1-CK2-PAK1 signaling pathway. Taken together, these findings identify a novel mechanism for the activation of PAK1 at the plasma membrane, which is critical for cell migration and invasion.	[Kim, Yong-Bae; Roy, Adhiraj; Kim, Jeong-Ho] George Washington Univ, Med Ctr, Dept Biochem & Mol Med, Washington, DC 20037 USA; [Shin, Yong Jae] Samsung Med Ctr, Samsung Biomed Res Inst, Seoul, South Korea; [Shin, Yong Jae] Samsung Med Ctr, Inst Refractory Canc Res, Seoul, South Korea	George Washington University; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Kim, JH (corresponding author), George Washington Univ, Med Ctr, Dept Biochem & Mol Med, 2300 Eye St, Washington, DC 20037 USA.	jh_kim@gwu.edu	Roy, Adhiraj/AAR-7311-2021; Regan, Clinton/E-6250-2012	Roy, Adhiraj/0000-0001-7584-8872	National Institutes of Health [GM087470]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087470] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM087470 (to J. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Adam L, 1998, J BIOL CHEM, V273, P28238, DOI 10.1074/jbc.273.43.28238; Adi S, 2001, ENDOCRINOLOGY, V142, P498, DOI 10.1210/en.142.1.498; Baas D, 2012, J CELL SCI, V125, P3790, DOI 10.1242/jcs.101048; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Bokoch GM, 1996, J BIOL CHEM, V271, P25746, DOI 10.1074/jbc.271.42.25746; Bosc DG, 2000, J BIOL CHEM, V275, P14295, DOI 10.1074/jbc.275.19.14295; Canton DA, 2005, MOL CELL BIOL, V25, P3519, DOI 10.1128/MCB.25.9.3519-3534.2005; Canton DA, 2006, J BIOL CHEM, V281, P36347, DOI 10.1074/jbc.M607595200; Chong C, 2001, J BIOL CHEM, V276, P17347, DOI 10.1074/jbc.M009316200; Chung CY, 2001, MOL CELL, V7, P937, DOI 10.1016/S1097-2765(01)00247-7; Cory GOC, 2003, MOL CELL, V11, P1229, DOI 10.1016/S1097-2765(03)00172-2; Daniels RH, 1998, EMBO J, V17, P754, DOI 10.1093/emboj/17.3.754; Duncan JS, 2008, BBA-PROTEINS PROTEOM, V1784, P33, DOI 10.1016/j.bbapap.2007.08.017; Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963; Filhol O, 2009, CELL MOL LIFE SCI, V66, P1830, DOI 10.1007/s00018-009-9151-1; Galisteo ML, 1996, J BIOL CHEM, V271, P20997, DOI 10.1074/jbc.271.35.20997; Gan Y, 2010, ONCOGENE, V29, P4947, DOI 10.1038/onc.2010.240; Goc A, 2013, J BIOL CHEM, V288, P3025, DOI 10.1074/jbc.M112.424770; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; King CC, 2000, J BIOL CHEM, V275, P18108, DOI 10.1074/jbc.M909663199; King CC, 2000, J BIOL CHEM, V275, P41201, DOI 10.1074/jbc.M006553200; Kumar R, 2006, NAT REV CANCER, V6, P459, DOI 10.1038/nrc1892; Laramas M, 2007, EUR J CANCER, V43, P928, DOI 10.1016/j.ejca.2006.11.021; Lei M, 2000, CELL, V102, P387, DOI 10.1016/S0092-8674(00)00043-X; Lin KY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017193; Lu WG, 1997, CURR BIOL, V7, P85, DOI 10.1016/S0960-9822(06)00052-2; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; Morreale A, 2000, NAT STRUCT BIOL, V7, P384; Nie J, 2013, AGEING RES REV, V12, P276, DOI 10.1016/j.arr.2012.07.002; Olsten MEK, 2004, J BIOL CHEM, V279, P42114, DOI 10.1074/jbc.M407628200; Papakonstanti EA, 2002, MOL BIOL CELL, V13, P2946, DOI 10.1091/mbc.02-01-0599; Parrini Maria Carla, 2012, Cell Logist, V2, P78; Parrini MC, 2002, MOL CELL, V9, P73, DOI 10.1016/S1097-2765(01)00428-2; Pocha SM, 2009, CELL MOTIL CYTOSKEL, V66, P36, DOI 10.1002/cm.20323; Puto LA, 2003, J BIOL CHEM, V278, P9388, DOI 10.1074/jbc.M208414200; Radu M, 2014, NAT REV CANCER, V14, P13, DOI 10.1038/nrc3645; Safi A, 2004, MOL CELL BIOL, V24, P1245, DOI 10.1128/MCB.24.3.1245-1255.2004; Sanders LC, 1999, SCIENCE, V283, P2083, DOI 10.1126/science.283.5410.2083; Sells MA, 1997, CURR BIOL, V7, P202, DOI 10.1016/S0960-9822(97)70091-5; Sells MA, 1999, J CELL BIOL, V145, P837, DOI 10.1083/jcb.145.4.837; Shin YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071495; Shin YJ, 2013, MOL BIOL CELL, V24, P2990, DOI 10.1091/mbc.E13-04-0204; Shin YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030393; Strochlic TI, 2010, MOL CELL, V40, P493, DOI 10.1016/j.molcel.2010.10.015; Vadlamudi RK, 2004, EMBO REP, V5, P154, DOI 10.1038/sj.embor.7400079; Wang DJ, 2009, CANCER RES, V69, P8200, DOI 10.1158/0008-5472.CAN-09-1976; Xavier CP, 2012, SCI REP-UK, V2, DOI 10.1038/srep00241; Ye Diana Zi, 2012, Cell Logist, V2, P105; Zenke FT, 1999, J BIOL CHEM, V274, P32565, DOI 10.1074/jbc.274.46.32565; Zhang L, 2013, BIOCHEM BIOPH RES CO, V436, P382, DOI 10.1016/j.bbrc.2013.05.109	50	21	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2015	290	34					21076	21085		10.1074/jbc.M115.675124	http://dx.doi.org/10.1074/jbc.M115.675124			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP6QC	26160174	hybrid, Green Published			2022-12-26	WOS:000360011800040
J	Rojo, D; Canuto, GAB; Castilho-Martins, EA; Tavares, MFM; Barbas, C; Lopez-Gonzalvez, A; Rivas, L				Rojo, David; Canuto, Gisele A. B.; Castilho-Martins, Emerson A.; Tavares, Marina F. M.; Barbas, Coral; Lopez-Gonzalvez, Angeles; Rivas, Luis			A Multiplatform Metabolomic Approach to the Basis of Antimonial Action and Resistance in Leishmania infantum	PLOS ONE			English	Article							VISCERAL LEISHMANIASIS; DRUG-RESISTANCE; GENE-EXPRESSION; TRYPAREDOXIN PEROXIDASE; DONOVANI AMASTIGOTES; ENERGY-METABOLISM; ELEVATED LEVELS; IN-VITRO; TRYPANOTHIONE; MILTEFOSINE	There is a rising resistance against antimony drugs, the gold-standard for treatment until some years ago. That is a serious problem due to the paucity of drugs in current clinical use. In a research to reveal how these drugs affect the parasite during treatment and to unravel the underlying basis for their resistance, we have employed metabolomics to study treatment in Leishmania infantum promastigotes. This was accomplished first through the untargeted analysis of metabolic snapshots of treated and untreated parasites both resistant and responders, utilizing a multiplatform approach to give the widest as possible coverage of the metabolome, and additionally through novel monitoring of the origin of the detected alterations through a C-13 traceability experiment. Our data stress a multi-target metabolic alteration with treatment, affecting in particular the cell redox system that is essential to cope with detoxification and biosynthetic processes. Additionally, relevant changes were noted in amino acid metabolism. Our results are in agreement with other authors studying other Leishmania species.	[Rojo, David; Canuto, Gisele A. B.; Castilho-Martins, Emerson A.; Barbas, Coral; Lopez-Gonzalvez, Angeles] Univ CEU San Pablo, Fac Farm, CEMBIO, Unidad Asociada Interacciones Metab & Bioanal CSI, Madrid 28668, Spain; [Canuto, Gisele A. B.; Tavares, Marina F. M.] Univ Sao Paulo, Inst Chem, BR-05508000 Sao Paulo, SP, Brazil; [Castilho-Martins, Emerson A.] Univ Fed Amapa, Colegiado Med, Macapa, AP, Brazil; [Rivas, Luis] CSIC, Unidad Asociada Interacciones Metab & Bioanal CSI, E-28040 Madrid, Spain	San Pablo CEU University; Universidade de Sao Paulo; Fundacao Universidade Federal do Amapa; Consejo Superior de Investigaciones Cientificas (CSIC)	Lopez-Gonzalvez, A (corresponding author), Univ CEU San Pablo, Fac Farm, CEMBIO, Unidad Asociada Interacciones Metab & Bioanal CSI, Campus Monteprincipe,Boadilla Monte, Madrid 28668, Spain.	alopgon@ceu.es; luis.rivas@cib.csic.es	Castilho-Martins, Emerson Augusto/I-2094-2014; Barbas, Coral/K-3871-2014; Canuto, Gisele A B/N-7338-2015; Rivas, Luis/O-8657-2017; Lopez-Gonzalvez, Angeles/K-4361-2014	Castilho-Martins, Emerson Augusto/0000-0003-0542-4294; Barbas, Coral/0000-0003-4722-491X; Canuto, Gisele A B/0000-0002-6616-3705; Rivas, Luis/0000-0002-2958-3233; Lopez-Gonzalvez, Angeles/0000-0002-6363-7135	Spanish Ministry of Economy and Competitiveness [CTQ2014-55279-R]; European Aeronautic Defence and Space Company - Construcciones Aeronauticas SA; Brazilian Air Force; FIS [PS12-02706]; VI PN de I+D+I; Instituto de Salud Carlos III Subdireccion General de Redes y Proyectos Cooperativos RD [12/0018/0007]; FAPESP;  [RD06/0021/0006-FEDER]	Spanish Ministry of Economy and Competitiveness(Spanish Government); European Aeronautic Defence and Space Company - Construcciones Aeronauticas SA; Brazilian Air Force; FIS(Instituto de Salud Carlos III); VI PN de I+D+I; Instituto de Salud Carlos III Subdireccion General de Redes y Proyectos Cooperativos RD; FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); 	This work was supported by grants from Spanish Ministry of Economy and Competitiveness (CTQ2014-55279-R) (CB) and European Aeronautic Defence and Space Company - Construcciones Aeronauticas SA and Brazilian Air Force (FAB) (GC and EC) and from FIS PS12-02706 and VI PN de I+D+I 2008-2011, Instituto de Salud Carlos III Subdireccion General de Redes y Proyectos Cooperativos RD 12/0018/0007 (http://www.isciii.es/ISCIII/es/) and RD06/0021/0006-FEDER (LR). DR received a fellowship from the Spanish Ministry of Economy and Competitiveness (formerly MICINN). GABC is thankful to FAPESP for a graduate fellowship (http://www.fapesp.br/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Gomez MA, 2014, J ANTIMICROB CHEMOTH, V69, P139, DOI 10.1093/jac/dkt334; Alvar J, 2008, CLIN MICROBIOL REV, V21, P334, DOI 10.1128/CMR.00061-07; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Ashutosh, 2007, J MED MICROBIOL, V56, P143, DOI 10.1099/jmm.0.46841-0; Ashutosh, 2012, ANTIMICROB AGENTS CH, V56, P518, DOI 10.1128/AAC.00736-11; Berg M, 2013, MOL MICROBIOL, V90, P428, DOI 10.1111/mmi.12374; Berg M, 2013, PARASITOLOGY, V140, P1492, DOI 10.1017/S0031182013000140; Biyani N, 2011, MOL BIOCHEM PARASIT, V179, P91, DOI 10.1016/j.molbiopara.2011.06.004; Boitz JM, 2012, TRENDS PARASITOL, V28, P345, DOI 10.1016/j.pt.2012.05.005; Brannigan JA, 2010, J MOL BIOL, V396, P985, DOI 10.1016/j.jmb.2009.12.032; Brotherton MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081899; Canuto GAB, 2012, ELECTROPHORESIS, V33, P1901, DOI 10.1002/elps.201200007; Carter NS, 2008, ADV EXP MED BIOL, V625, P141, DOI 10.1007/978-0-387-77570-8_12; Castilho-Martins EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027818; Choudhury K, 2008, INT J PARASITOL, V38, P1411, DOI 10.1016/j.ijpara.2008.03.005; Das S, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002527; De Gaudenzi JG, 2011, ESSAYS BIOCHEM, V51, P31, DOI [10.1042/bse0510031, 10.1042/BSE0510031]; Downing T, 2012, INFECT GENET EVOL, V12, P149, DOI 10.1016/j.meegid.2011.11.005; El Fadili K, 2009, EXP PARASITOL, V123, P51, DOI 10.1016/j.exppara.2009.05.013; Flohe L, 2012, INT J MED MICROBIOL, V302, P216, DOI 10.1016/j.ijmm.2012.07.008; Fyfe PK, 2012, P NATL ACAD SCI USA, V109, P11693, DOI 10.1073/pnas.1202593109; Gika HG, 2008, J CHROMATOGR B, V871, P299, DOI 10.1016/j.jchromb.2008.05.048; Ginger ML, 2001, J BIOL CHEM, V276, P11674, DOI 10.1074/jbc.M006850200; Gonzalez U, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004834.pub2; Guimond C, 2003, NUCLEIC ACIDS RES, V31, P5886, DOI 10.1093/nar/gkg806; Haimeur A, 1999, MOL MICROBIOL, V34, P726, DOI 10.1046/j.1365-2958.1999.01634.x; HART DT, 1982, EXP PARASITOL, V54, P397, DOI 10.1016/0014-4894(82)90049-2; Manzano JI, 2011, ANTIMICROB AGENTS CH, V55, P1045, DOI 10.1128/AAC.01545-10; Krauth-Siegel RL, 2012, ANTIOXID REDOX SIGN, V17, P583, DOI 10.1089/ars.2011.4392; Kumar A, 2010, BRIT J CLIN PHARMACO, V70, P609, DOI 10.1111/j.1365-2125.2010.03716.x; Kumar D, 2009, ANTIMICROB AGENTS CH, V53, P835, DOI 10.1128/AAC.01233-08; Lefurgey A, 2005, J EUKARYOT MICROBIOL, V52, P277, DOI 10.1111/j.1550-7408.2005.00030.x; Manta B, 2013, BBA-GEN SUBJECTS, V1830, P3199, DOI 10.1016/j.bbagen.2013.01.013; Marquis N, 2005, MOL MICROBIOL, V57, P1690, DOI 10.1111/j.1365-2958.2005.04782.x; Matrangolo FSV, 2013, MOL BIOCHEM PARASIT, V190, P63, DOI 10.1016/j.molbiopara.2013.06.006; Maugeri DA, 2003, MOL BIOCHEM PARASIT, V130, P117, DOI 10.1016/S0166-6851(03)00173-7; Mehta A, 2006, FREE RADICAL BIO MED, V40, P1857, DOI 10.1016/j.freeradbiomed.2006.01.024; Mina JG, 2011, ORG BIOMOL CHEM, V9, P1823, DOI 10.1039/c0ob00871k; Moreira DS, 2013, INT J PARASITOL-DRUG, V3, P143, DOI 10.1016/j.ijpddr.2013.08.001; Mukherjee B, 2013, P NATL ACAD SCI USA, V110, pE575, DOI [10.1073/pnas.1213839110, 10.]; Muniz-Junqueira MI, 2008, INT IMMUNOPHARMACOL, V8, P1633, DOI 10.1016/j.intimp.2008.07.011; Novozhilova NM, 2010, BIOCHEMISTRY-MOSCOW+, V75, P686, DOI 10.1134/S0006297910060027; Opperdoes Fred R., 2008, P123; Pathak MK, 2001, J IMMUNOL, V167, P3391, DOI 10.4049/jimmunol.167.6.3391; Perez-Pertejo Y, 2006, BBA-GEN SUBJECTS, V1760, P10, DOI 10.1016/j.bbagen.2005.09.003; Perry MR, 2013, P NATL ACAD SCI USA, V110, P19932, DOI 10.1073/pnas.1311535110; Rai S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074862; Requena JM, 2012, FRONT BIOSCI, V17, P2069, DOI DOI 10.2741/3840; Saunders EC, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003888; Scheltema RA, 2010, PARASITOLOGY, V137, P1291, DOI 10.1017/S0031182009992022; Seblova V, 2014, ANTIMICROB AGENTS CH, V58, P6273, DOI 10.1128/AAC.02406-13; Singh N, 2007, PARASITOLOGY, V134, P777, DOI 10.1017/S0031182007002284; Solano-Gallego L, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-86; Sudhandiran G, 2003, J BIOL CHEM, V278, P25120, DOI 10.1074/jbc.M301975200; Sundar S, 2001, TROP MED INT HEALTH, V6, P849, DOI 10.1046/j.1365-3156.2001.00778.x; t'Kindt R, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000904; Tielens AGM, 1998, PARASITOL TODAY, V14, P265, DOI 10.1016/S0169-4758(98)01263-0; van Griensven J, 2010, LANCET INFECT DIS, V10, P184, DOI 10.1016/S1473-3099(10)70011-6; Vanaerschot M, 2014, FEMS MICROBIOL REV, V38, P41, DOI 10.1111/1574-6976.12032; Vanaerschot M, 2012, J INFECT DIS, V206, P752, DOI 10.1093/infdis/jis424; Vincent IM, 2015, J BIOMOL SCREEN, V20, P44, DOI 10.1177/1087057114551519; Vincent IM, 2014, INT J PARASITOL-DRUG, V4, P20, DOI 10.1016/j.ijpddr.2013.11.002; Walker J, 2012, MOL BIOCHEM PARASIT, V183, P166, DOI 10.1016/j.molbiopara.2012.03.002; Williams RAM, 2009, BIOCHEM J, V420, P451, DOI 10.1042/BJ20082441; Wyllie S, 2004, J BIOL CHEM, V279, P39925, DOI 10.1074/jbc.M405635200; Wyllie S, 2008, ANTIMICROB AGENTS CH, V52, P1359, DOI 10.1128/AAC.01563-07; Wyllie S, 2010, MOL BIOCHEM PARASIT, V173, P162, DOI 10.1016/j.molbiopara.2010.05.015; Zhang K, 2010, ADV EXP MED BIOL, V688, P238; Zhou Y, 2004, J BIOL CHEM, V279, P37445, DOI 10.1074/jbc.M404383200	69	27	27	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0130675	10.1371/journal.pone.0130675	http://dx.doi.org/10.1371/journal.pone.0130675			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161866	Green Published, Green Submitted, gold			2022-12-26	WOS:000358162300019
J	Serok, N; Blumenfeld-Lieberthal, E				Serok, Nimrod; Blumenfeld-Lieberthal, Efrat			A Simulation Model for Intra-Urban Movements	PLOS ONE			English	Article							MOBILITY; EMERGENCE	Human mobility patterns (HMP) have become of interest to a variety of disciplines. The increasing availability of empirical data enables researchers to analyze patterns of people's movements. Recent work suggested that HMP follow a Levy-flight distribution and present regularity. Here, we present an innovative agent-based model that simulates HMP for various purposes. It is based on the combination of regular movements with spatial considerations, represented by an expanded gravitation model. The agents in this model have different attributes that affect their choice of destination and the duration they stay in each location. Thus, their movement mimics real-life situations. This is a stochastic, bottom-up model, yet it yields HMP that qualitatively fit HMP empirical data in terms of individuals, as well as the entire population. Our results also correspond to real-life phenomena in terms of urban spatial dynamics, that is, the emergence of popular locations in the city due to bottom-up behavior of people. Our model is novel in being based on the assumption that HMP are space-dependent as well as follow high regularity. To our knowledge, we are the first to succeed in simulating HMP not only at the inter-city scale but also at the intra-urban one.	[Serok, Nimrod; Blumenfeld-Lieberthal, Efrat] Tel Aviv Univ, Yolanda & David Katz Fac Arts, David Azrieli Sch Architecture, IL-69978 Tel Aviv, Israel	Tel Aviv University	Blumenfeld-Lieberthal, E (corresponding author), Tel Aviv Univ, Yolanda & David Katz Fac Arts, David Azrieli Sch Architecture, IL-69978 Tel Aviv, Israel.	efratbl@post.tau.ac.il	Lieberthal, Efrat Blumenfeld/AAW-1116-2021	Blumenfeld-Lieberthal, Efrat/0000-0003-3660-0035				Adamic L. A, 2000, ZIPF POWER LAWS PARE; Balcan D, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-45; Batty M, 2003, INT J GEOGR INF SCI, V17, P673, DOI 10.1080/1365881031000135474; Batty M., 2007, CITIES COMPLEXITY UN; Benenson I., 2004, COMPUT ENVIRON URBAN, V28, P1, DOI [10.1016/S01989715(02)00067-4, DOI 10.1016/S0198-9715(02)00067-4, DOI 10.1016/S01989715(02)00067-4]; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; Brockmann D, 2008, IEEE PERVAS COMPUT, V7, P28, DOI 10.1109/MPRV.2008.77; Brown DG, 2005, INT J GEOGR INF SCI, V19, P153, DOI 10.1080/13658810410001713399; Camp T, 2002, WIREL COMMUN MOB COM, V2, P483, DOI 10.1002/wcm.72; Chen X, 2008, J OPER RES SOC, V59, P25, DOI 10.1057/palgrave.jors.2602321; Dai J, 2013, PHYSICA A; Elsenbroich C, 2014, MODELLING NORMS, P65; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Groenevelt R, 2006, WIREL NETW, V12, P561, DOI 10.1007/s11276-006-6535-0; Han XP, 2010, PHYSCS PROC, V3, P1907, DOI 10.1016/j.phpro.2010.07.035; Hui P, 2005, P 2005 ACM SIGCOMM W, P244, DOI DOI 10.1145/1080139.1080142; Ioannidis S, 2006, INFOCOM; Janssen M. A., 2005, MODELLING ECOLOGICAL, P155; Jia T, 2012, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2012/11/P11024; Jiang B, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.021136; Kleinberg J, 2007, NATURE, V449, P287, DOI 10.1038/449287a; Lee K, 2009, IEEE INFOCOM SER, P855, DOI 10.1109/INFCOM.2009.5061995; Masucci AP, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.022812; Matthews RB, 2007, LANDSCAPE ECOL, V22, P1447, DOI 10.1007/s10980-007-9135-1; Noulas A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037027; Portugali J., 1999, SELF ORG CITY; Portugali J, 2011, UNDERST COMPLEX SYST, P1, DOI 10.1007/978-3-642-19451-1; Scafetta N, 2011, CHAOS INTERDISCIPLIN, V21; Sengupta RR, 2003, INT J GEOGR INF SCI, V17, P157, DOI 10.1080/1365881022000015990; Simini F, 2012, NATURE, V484, P96, DOI 10.1038/nature10856; Troisi A, 2005, P NATL ACAD SCI USA, V102, P255, DOI 10.1073/pnas.0408308102; Wei JR, 2013, PHYSICA A; Yang SS, 2010, IEEE NETWORK, V24, P6, DOI 10.1109/MNET.2010.5578912; Zhao M, 2008, MILITARY COMMUNICATI, P1	35	5	5	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132576	10.1371/journal.pone.0132576	http://dx.doi.org/10.1371/journal.pone.0132576			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1FD	26161640	Green Published, Green Submitted, gold			2022-12-26	WOS:000358162300155
J	Wang, W; Ding, JH; Zhu, XL; Li, Y; Gu, YJ; Peng, WJ				Wang, Wei; Ding, Jianhui; Zhu, Xiaoli; Li, Yuan; Gu, Yajia; Peng, Weijun			Magnetic Resonance Imaging Characteristics of Ovarian Clear Cell Carcinoma	PLOS ONE			English	Article							CT; DIAGNOSIS; TUMORS; MRI; CANCER; MASSES; COMMON	Purpose To probe the magnetic resonance imaging (MRI) features of ovarian clear cell carcinoma (OCCC). Methods This study retrospectively collected MRI data for 21 pathology-confirmed OCCCs from 19 female patients. The MRI findings were analyzed to determine the tumor size, shape/edge, shape and number of protrusions within the cyst, cystic or necrotic components, signal intensity (SI) and enhancement features. Results The age of the 19 patients ranged from 28 to 63 years (mean age: 53 years). Unilateral tumors were found in 17 patients (17/19, 89%); the average size of all tumors was 10.8 cm. The tumors on MRI were classified into two categories: (a) "cystic adnexal mass with solid protrusions" in 12 (57%) and (b) "solid adnexal mass with cystic areas or necrosis" in 9 (43%). For group a, high to very high SI was observed for most tumors (10/12, 83%) on T1-weighted images (T1WIs), and very high SI was observed on T2-weighted images (T2WIs) for all 12 tumors. Most solid protrusions were irregular and few in number and exhibited heterogeneous intermediate SI on T1WIs and T2WIs and prolonged enhanced SI in the contrast study. All 9 OCCCs in group b were predominantly solid masses with unequally sized necrotic or cystic areas in which some cysts were located at the periphery of the tumor (4/9, 44%). The solid components in all 9 tumors showed iso- or slightly high SI on T1WIs, heterogeneous iso-high SI on T2WIs and heterogeneous prolonged enhancement. According to FIGO classification, 14 tumors (14/19, 74%) were stages I-II, and 5 (5/19, 26%) were stages III-IV. Conclusions On MRI, OCCCs present as large unilateral multilocular or unilocular cystic masses with irregular intermediate SI solid protrusions or predominantly solid masses with cysts or necrosis at an early FIGO stage.	[Wang, Wei; Ding, Jianhui; Gu, Yajia; Peng, Weijun] Fudan Univ, Shanghai Canc Ctr, Dept Radiol, Shanghai 200032, Peoples R China; [Wang, Wei; Ding, Jianhui; Zhu, Xiaoli; Li, Yuan; Gu, Yajia; Peng, Weijun] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200032, Peoples R China; [Zhu, Xiaoli; Li, Yuan] Fudan Univ, Shanghai Canc Ctr, Dept Pathol, Shanghai 200032, Peoples R China	Fudan University; Fudan University; Fudan University	Peng, WJ (corresponding author), Fudan Univ, Shanghai Canc Ctr, Dept Radiol, Shanghai 200032, Peoples R China.	pengweijun601@163.com						Bazot M, 2013, CLIN RADIOL, V68, pE1, DOI 10.1016/j.crad.2012.08.021; Behbakht K, 1998, GYNECOL ONCOL, V70, P255, DOI 10.1006/gyno.1998.5071; Brown DL, 2001, RADIOLOGY, V219, P213, DOI 10.1148/radiology.219.1.r01ap28213; Choi HJ, 2006, J COMPUT ASSIST TOMO, V30, P875, DOI 10.1097/01.rct.0000220795.45782.1d; del Carmen MG, 2012, GYNECOL ONCOL, V126, P481, DOI 10.1016/j.ygyno.2012.04.021; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; HERRMANN UJ, 1987, OBSTET GYNECOL, V69, P777; Jeong YY, 2003, RADIOGRAPHICS, V23, P969, DOI 10.1148/rg.234035001; Jeong YY, 2000, RADIOGRAPHICS, V20, P1445, DOI 10.1148/radiographics.20.5.g00se101445; Jung SE, 2002, RADIOGRAPHICS, V22, P1305, DOI 10.1148/rg.226025033; Kobel M, 2008, PLOS MED, V5, P1749, DOI 10.1371/journal.pmed.0050232; Kurtz AB, 1999, RADIOLOGY, V212, P19, DOI 10.1148/radiology.212.1.r99jl3619; Lalwani N, 2011, RADIOGRAPHICS, V31, P625, DOI 10.1148/rg.313105066; Ma FH, 2014, J MAGN RESON IMAGING, V40, P745, DOI 10.1002/jmri.24408; Matsuoka Y, 2001, EUR RADIOL, V11, P946, DOI 10.1007/s003300000671; Pectasides D, 2006, ONCOLOGIST, V11, P1089, DOI 10.1634/theoncologist.11-10-1089; RICHARDSON GS, 1985, NEW ENGL J MED, V312, P474, DOI 10.1056/NEJM198502213120804; SCHWARTZ LB, 1994, RADIOLOGY, V192, P55, DOI 10.1148/radiology.192.1.8208966; Serov SF, 1973, INT HISTOLOGICAL CLA, P1; Shaaban Akram, 2010, Top Magn Reson Imaging, V21, P247, DOI 10.1097/RMR.0b013e31823d8063; Szklaruk J, 2003, RADIOGRAPHICS, V23, P403, DOI 10.1148/rg.232025089; Takano M, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-53; Takemori M, 2002, ACTA OBSTET GYN SCAN, V81, P157, DOI 10.1034/j.1600-0412.2002.810212.x; Tanaka YO, 2011, EUR J RADIOL, V80, pE91, DOI 10.1016/j.ejrad.2010.05.032; Tanaka YO, 2011, J MAGN RESON IMAGING, V33, P633, DOI 10.1002/jmri.22430; Tavasolli FA, 2003, WHO CLASSIFICATION T, P8; Wagner BJ, 1994, RADIOGRAPHICS, V14, P75, DOI DOI 10.1148/RADI0GRAPHICS.14.6.7855346; WAGNER PJ, 1994, RADIOGRAPHICS, V14, P1351, DOI 10.1148/radiographics.14.6.7855346	28	1	2	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132406	10.1371/journal.pone.0132406	http://dx.doi.org/10.1371/journal.pone.0132406			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161555	Green Published, gold, Green Submitted			2022-12-26	WOS:000358162300130
J	Ashina, K; Tsubosaka, Y; Nakamura, T; Omori, K; Kobayashi, K; Hori, M; Ozaki, H; Murata, T				Ashina, Kohei; Tsubosaka, Yoshiki; Nakamura, Tatsuro; Omori, Keisuke; Kobayashi, Koji; Hori, Masatoshi; Ozaki, Hiroshi; Murata, Takahisa			Histamine Induces Vascular Hyperpermeability by Increasing Blood Flow and Endothelial Barrier Disruption In Vivo	PLOS ONE			English	Article							NITRIC-OXIDE; VE-CADHERIN; MICROVASCULAR PERMEABILITY; THROMBIN; ADHESION; LEAKAGE; INFLAMMATION; BRADYKININ; JUNCTIONS; ADHERENS	Histamine is a mediator of allergic inflammation released mainly from mast cells. Although histamine strongly increases vascular permeability, its precise mechanism under in vivo situation remains unknown. We here attempted to reveal how histamine induces vascular hyperpermeability focusing on the key regulators of vascular permeability, blood flow and endothelial barrier. Degranulation of mast cells by antigen-stimulation or histamine treatment induced vascular hyperpermeability and tissue swelling in mouse ears. These were abolished by histamine H1 receptor antagonism. Intravital imaging showed that histamine dilated vasculature, increased blood flow, while it induced hyperpermeability in venula. Whole-mount staining showed that histamine disrupted endothelial barrier formation of venula indicated by changes in vascular endothelial cadherin (VE-cadherin) localization at endothelial cell junction. Inhibition of nitric oxide synthesis (NOS) by L-NAME or vasoconstriction by phenylephrine strongly inhibited the histamine-induced blood flow increase and hyperpermeability without changing the VE-cadherin localization. In vitro, measurements of trans-endothelial electrical resistance of human dermal microvascular endothelial cells (HDMECs) showed that histamine disrupted endothelial barrier. Inhibition of protein kinase C (PKC) or Rho-associated protein kinase (ROCK), NOS attenuated the histamine-induced barrier disruption. These observations suggested that histamine increases vascular permeability mainly by nitric oxide (NO)-dependent vascular dilation and subsequent blood flow increase and maybe partially by PKC/ROCK/NO-dependent endothelial barrier disruption.	[Ashina, Kohei; Hori, Masatoshi; Ozaki, Hiroshi] Univ Tokyo, Dept Vet Pharmacol, Grad Sch Agr & Life Sci, Tokyo 1138657, Japan; [Tsubosaka, Yoshiki; Nakamura, Tatsuro; Omori, Keisuke; Kobayashi, Koji; Murata, Takahisa] Univ Tokyo, Dept Anim Radiol, Grad Sch Agr & Life Sci, Tokyo 1138657, Japan	University of Tokyo; University of Tokyo	Murata, T (corresponding author), Univ Tokyo, Dept Anim Radiol, Grad Sch Agr & Life Sci, Tokyo 1138657, Japan.	amurata@mail.ecc.u-tokyo.ac.jp		Murata, Takahisa/0000-0002-3328-0796	Program for Promotion of Basic and Applied Researches for innovations in Bio-oriented Industry [26029A]; Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry [26029A]; Japan Society for the Promotion of Science [25252049, 26660225]; Japan Health Foundation; SENSHIN Medical Research Foundation; Takeda Science Foundation;  [23-3505];  [24-1079]	Program for Promotion of Basic and Applied Researches for innovations in Bio-oriented Industry; Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Health Foundation(Japan Health Foundation); SENSHIN Medical Research Foundation(SENSHIN Medical Research Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF)); ; 	This work was supported by a Grant-in-Aid for JSPS Fellows [23-3505 to Y.T., 24-1079 to K.K.] http://www.mext.go.jp/english/; the Program for Promotion of Basic and Applied Researches for innovations in Bio-oriented Industry [26029A to T.M.] http://www.naro.affrc.go.jp/english/index.html; the Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry [26029A to T.M.] http://www.s.affrc.go.jp/docs/research_fund/2015/sinki_koubo_2015.htm; a Grant-in-Aid from the Japan Society for the Promotion of Science [25252049 and 26660225 to T.M.] http://www.mext.go.jp/english/; the Japan Health Foundation [to T.M.] http://www.jnhf.or.jp/; the SENSHIN Medical Research Foundation [to T.M.] http://www.mt-pharma.co.jp/zaidan/; and the Takeda Science Foundation [to T.M.] http://www.takeda-sci.or.jp/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amerongen GPV, 2000, CIRC RES, V87, P335, DOI 10.1161/01.RES.87.4.335; Amerongen GPV, 1998, CIRC RES, V83, P1115, DOI 10.1161/01.RES.83.11.1115; Aschner JL, 1997, J CELL PHYSIOL, V173, P387, DOI 10.1002/(SICI)1097-4652(199712)173:3<387::AID-JCP11>3.0.CO;2-9; Curry FRE, 2010, CARDIOVASC RES, V87, P218, DOI 10.1093/cvr/cvq115; DAHLEN SE, 1981, P NATL ACAD SCI-BIOL, V78, P3887, DOI 10.1073/pnas.78.6.3887; Di Lorenzo A, 2013, J CELL SCI, V126, P5541, DOI 10.1242/jcs.115972; Di Lorenzo A, 2009, P NATL ACAD SCI USA, V106, P14552, DOI 10.1073/pnas.0904073106; Feletou M, 1996, BRIT J PHARMACOL, V118, P1371, DOI 10.1111/j.1476-5381.1996.tb15547.x; Kevil CG, 1998, MICROCIRCULATION-LON, V5, P197, DOI 10.1038/sj.mn.7300011; Kobayashi K, 2013, ARTERIOSCL THROM VAS, V33, P565, DOI 10.1161/ATVBAHA.112.300993; Kolosova IA, 2004, AM J PHYSIOL-LUNG C, V287, pL970, DOI 10.1152/ajplung.00398.2003; LEACH L, 1995, MICROVASC RES, V50, P323, DOI 10.1006/mvre.1995.1062; Mikelis CM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7725; MILES AA, 1952, J PHYSIOL-LONDON, V118, P228, DOI 10.1113/jphysiol.1952.sp004789; Moy AB, 1996, J CLIN INVEST, V97, P1020, DOI 10.1172/JCI118493; Murata T, 2007, J EXP MED, V204, P2373, DOI 10.1084/jem.20062340; Nathan RA, 2008, CLIN THER, V30, P573, DOI 10.1016/j.clinthera.2008.04.011; Omori K, 2014, BRIT J PHARMACOL, V171, P4879, DOI 10.1111/bph.12815; Orsenigo F, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2199; RAMIREZ MM, 1995, MICROVASC RES, V50, P223, DOI 10.1006/mvre.1995.1055; RILEY JF, 1953, J PHYSIOL-LONDON, V120, P528, DOI 10.1113/jphysiol.1953.sp004915; SALOGA J, 1993, J CLIN INVEST, V91, P133, DOI 10.1172/JCI116162; Singleton PA, 2005, FASEB J, V19, P1646, DOI 10.1096/fj.05-3928com; Thibeault S, 2010, MOL CELL, V39, P468, DOI 10.1016/j.molcel.2010.07.013; Wallez Y, 2008, BBA-BIOMEMBRANES, V1778, P794, DOI 10.1016/j.bbamem.2007.09.003; Wessel F, 2014, NAT IMMUNOL, V15, P223, DOI 10.1038/ni.2824	26	103	107	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2015	10	7							e0132367	10.1371/journal.pone.0132367	http://dx.doi.org/10.1371/journal.pone.0132367			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EW	26158531	Green Published, Green Submitted, gold			2022-12-26	WOS:000358161200051
J	Arndt, DL; Peterson, CJ; Cain, ME				Arndt, David L.; Peterson, Christy J.; Cain, Mary E.			Differential Rearing Alters Forced Swim Test Behavior, Fluoxetine Efficacy, and Post-Test Weight Gain in Male Rats	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; DEPRESSIVE-LIKE BEHAVIOR; ENVIRONMENTAL-ENRICHMENT; SOCIAL-ISOLATION; ANIMAL-MODEL; ANTIDEPRESSANTS; SEROTONIN; ANXIETY; STRESS; PATHOPHYSIOLOGY	Environmental factors play a key role in the etiology of depression. The rodent forced swim test (FST) is commonly used as a preclinical model of depression, with increases in escape-directed behavior reflecting antidepressant effects, and increases in immobility reflecting behavioral despair. Environmental enrichment leads to serotonergic alterations in rats, but it is unknown whether these alterations may influence the efficacy of common antidepressants. Male Sprague-Dawley rats were reared in enriched (EC), standard (SC), or isolated (IC) conditions. Following the rearing period, fluoxetine (10 or 20 mg/kg, i.p.) was administered 23.5 hrs, 5 hrs, and 1 hr before locomotor and FST measures. Following locomotor testing and FST exposure, rats were weighed to assess fluoxetine-, FST-, and environmental condition-induced moderations in weight gain. Results revealed an antidepressant effect of environmental enrichment and a depressant effect of isolation. Regardless of significant fluoxetine effects on locomotor activity, fluoxetine generally decreased swimming and increased immobility in all three environmental conditions, with IC-fluoxetine (10 mg/kg) rats and EC-fluoxetine (20 mg/kg) rats swimming less than vehicle counterparts. Subchronic 20 mg/kg fluoxetine also induced significant weight loss, and differential rearing appeared to moderate weight gain following FST stress. These results suggest that differential rearing has the ability to alter FST behaviors, fluoxetine efficacy, and post-stressor well-being. Moreover, 20 mg/kg fluoxetine, administered subchronically, may lead to atypical effects of those commonly observed in the FST, highlighting the importance and impact of both environmental condition and dosing regimen in common animal models of depression.	[Arndt, David L.; Peterson, Christy J.; Cain, Mary E.] Kansas State Univ, Dept Psychol Sci, Manhattan, KS 66506 USA	Kansas State University	Arndt, DL (corresponding author), Kansas State Univ, Dept Psychol Sci, Manhattan, KS 66506 USA.	david23@ksu.edu		Cain, Mary/0000-0002-2165-990X	Kansas State University; Mark Chapman Scholars Program through Kansas State University; Kansas State University Open Access Publishing Fund	Kansas State University; Mark Chapman Scholars Program through Kansas State University; Kansas State University Open Access Publishing Fund	Research reported in this article was supported by Kansas State University. CJP was supported by the Mark Chapman Scholars Program through Kansas State University. Publication of this article was funded in part by the Kansas State University Open Access Publishing Fund.	Arndt DL, 2014, EXP CLIN PSYCHOPHARM, V22, P257, DOI 10.1037/a0035273; Artola A, 2006, EUR J NEUROSCI, V23, P261, DOI 10.1111/j.1460-9568.2005.04552.x; Bach-Mizrachi H, 2006, NEUROPSYCHOPHARMACOL, V31, P814, DOI 10.1038/sj.npp.1300897; Bogdanova OV, 2013, PHYSIOL BEHAV, V118, P227, DOI 10.1016/j.physbeh.2013.05.012; Brenes JC, 2008, PHARMACOL BIOCHEM BE, V89, P85, DOI 10.1016/j.pbb.2007.11.004; Brenes JC, 2009, BEHAV BRAIN RES, V197, P125, DOI 10.1016/j.bbr.2008.08.014; Campbell S, 2004, J PSYCHIATR NEUROSCI, V29, P417; Cote F, 2003, P NATL ACAD SCI USA, V100, P13525, DOI 10.1073/pnas.2233056100; Crofton EJ, 2015, NEUROSCI BIOBEHAV R, V49, P19, DOI 10.1016/j.neubiorev.2014.11.017; Cryan JF, 2005, NEUROSCI BIOBEHAV R, V29, P547, DOI 10.1016/j.neubiorev.2005.03.008; Cryan JF, 2002, TRENDS PHARMACOL SCI, V23, P238, DOI 10.1016/S0165-6147(02)02017-5; Cui MH, 2006, NEUROSCI LETT, V404, P208, DOI 10.1016/j.neulet.2006.05.048; D'Souza DN, 2002, PSYCHOPHARMACOLOGY, V164, P392, DOI 10.1007/s00213-002-1232-x; D'Souza DN, 2004, AM J PHYSIOL-REG I, V286, pR390, DOI 10.1152/ajpregu.00335.2003; David DJ, 2009, NEURON, V62, P479, DOI 10.1016/j.neuron.2009.04.017; Detke MJ, 1996, BEHAV BRAIN RES, V73, P43; Detke MJ, 1997, EXP CLIN PSYCHOPHARM, V5, P107, DOI 10.1037/1064-1297.5.2.107; DETKE MJ, 1995, PSYCHOPHARMACOLOGY, V121, P66, DOI 10.1007/BF02245592; DREVETS WC, 1992, J NEUROSCI, V12, P3628; Fone KCF, 2008, NEUROSCI BIOBEHAV R, V32, P1087, DOI 10.1016/j.neubiorev.2008.03.003; FULLER RW, 1974, LIFE SCI, V15, P1161, DOI 10.1016/S0024-3205(74)80012-3; Furay AR, 2011, BEHAV BRAIN RES, V224, P350, DOI 10.1016/j.bbr.2011.06.016; Gill MJ, 2012, PSYCHOPHARMACOLOGY, V221, P227, DOI 10.1007/s00213-011-2565-0; GREEN EJ, 1986, J NEUROPHYSIOL, V55, P739, DOI 10.1152/jn.1986.55.4.739; Green TA, 2010, BIOL PSYCHIAT, V67, P28, DOI 10.1016/j.biopsych.2009.06.022; Homberg JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016646; Homberg JR, 2010, TRENDS PHARMACOL SCI, V31, P60, DOI 10.1016/j.tips.2009.11.003; Huang GJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035901; Institute of Laboratory Animal Resources. Commission on Life Sciences National Research Council, 1996, GUIDE CARE USE LAB A; Jang DP, 2009, NEUROSCI LETT, V451, P60, DOI 10.1016/j.neulet.2008.12.024; Klomp A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097603; Knapska E, 2010, LEARN MEMORY, V17, P824, DOI 10.1101/lm.1670910; Kokare DM, 2010, NEUROPHARMACOLOGY, V58, P1009, DOI 10.1016/j.neuropharm.2010.01.006; Konkle ATM, 2010, J AM ASSOC LAB ANIM, V49, P427; Krishnan V, 2008, NATURE, V455, P894, DOI 10.1038/nature07455; Kulkarni SK, 2007, PROG NEURO-PSYCHOPH, V31, P1248, DOI 10.1016/j.pnpbp.2007.05.002; Licinio J, 2005, NAT REV DRUG DISCOV, V4, P165, DOI 10.1038/nrd1634; Lin X, 1999, CARCINOGENESIS, V20, P1793, DOI 10.1093/carcin/20.9.1793; Llorens-Martin MV, 2007, NEUROSCIENCE, V147, P631, DOI 10.1016/j.neuroscience.2007.04.054; Lucki I, 1997, BEHAV PHARMACOL, V8, P523, DOI 10.1097/00008877-199711000-00010; Macgillivray L, 2012, SYNAPSE, V66, P465, DOI 10.1002/syn.21511; Mason SS, 2009, EUR J PHARMACOL, V602, P306, DOI 10.1016/j.ejphar.2008.11.010; Mosaferi B, 2015, PHYSL BEHAV IN PRESS; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Olivier JDA, 2011, PROG NEURO-PSYCHOPH, V35, P1400, DOI 10.1016/j.pnpbp.2010.09.013; Page ME, 1999, PSYCHOPHARMACOLOGY, V147, P162, DOI 10.1007/s002130051156; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; PRENDERGAST MA, 2002, MED SCI MONITOR, V8, P385; Rasmuson S, 1998, MOL BRAIN RES, V53, P285, DOI 10.1016/S0169-328X(97)00317-3; Raz S, 2010, PHARMACOL BIOCHEM BE, V96, P59, DOI 10.1016/j.pbb.2010.04.007; Refaey HE, 2011, BAHRAIN MED B, V33, P1; Reneric JP, 1998, PSYCHOPHARMACOLOGY, V136, P190, DOI 10.1007/s002130050555; Renner M.J., 1987, ENRICHED IMPOVERISHE; Ressler KJ, 2000, DEPRESS ANXIETY, V12, P2, DOI 10.1002/1520-6394(2000)12:1+<2::AID-DA2>3.3.CO;2-W; Riad N, 2000, J COMP NEUROL, V417, P181, DOI 10.1002/(SICI)1096-9861(20000207)417:2<181::AID-CNE4>3.0.CO;2-A; ROSENZWEIG MR, 1972, J COMP PHYSIOL PSYCH, V79, P56, DOI 10.1037/h0032527; Schiller L, 2006, BRAIN RES, V1103, P76, DOI 10.1016/j.brainres.2006.05.051; SHARP PE, 1985, BRAIN RES, V339, P361, DOI 10.1016/0006-8993(85)90105-2; Slattery DA, 2012, NAT PROTOC, V7, P1009, DOI 10.1038/nprot.2012.044; Stahl SM, 1997, J CLIN PSYCHIAT, V58, P20; Tanti A, 2013, HIPPOCAMPUS, V23, P797, DOI 10.1002/hipo.22134; Tatsumi M, 1997, EUR J PHARMACOL, V340, P249, DOI 10.1016/S0014-2999(97)01393-9; TROUVIN JH, 1993, LIFE SCI, V52, pPL187, DOI 10.1016/0024-3205(93)90116-K; Van de Kar LD, 2002, NEUROPHARMACOLOGY, V43, P45, DOI 10.1016/S0028-3908(02)00075-8; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; VORHEES CV, 1994, FUND APPL TOXICOL, V23, P194, DOI 10.1006/faat.1994.1098; WONG DT, 1974, LIFE SCI, V15, P471, DOI 10.1016/0024-3205(74)90345-2; YEN TT, 1992, AM J CLIN NUTR, V55, P177, DOI 10.1093/ajcn/55.1.177s; Yildirim E, 2012, PHARMACOL BIOCHEM BE, V101, P278, DOI 10.1016/j.pbb.2011.12.017	69	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0131709	10.1371/journal.pone.0131709	http://dx.doi.org/10.1371/journal.pone.0131709			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154768	gold, Green Submitted, Green Published			2022-12-26	WOS:000358159700078
J	Martin, NL; Bass, P; Liss, SN				Martin, Nancy L.; Bass, Paul; Liss, Steven N.			Antibacterial Properties and Mechanism of Activity of a Novel Silver-Stabilized Hydrogen Peroxide	PLOS ONE			English	Article							DISINFECTION BY-PRODUCTS; WATER DISTRIBUTION-SYSTEMS; OXIDATIVE STRESS-RESPONSE; DRINKING-WATER; ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; PHYSICAL-CHARACTERIZATION; RESPIRATORY-CHAIN; RESISTANCE; CATALASE	Huwa-San peroxide (hydrogen peroxide; HSP) is a NSF Standard 60 (maximum 8mg/L-1) new generation peroxide stabilized with ionic silver suitable for continuous disinfection of potable water. Experiments were undertaken to examine the mechanism of HSP against planktonic and biofilm cultures of indicator bacterial strains. Contact/kill time (CT) relationships that achieve effective control were explored to determine the potential utility in primary disinfection. Inhibitory assays were conducted using both nutrient rich media and a medium based on synthetic wastewater. Assays were compared for exposures to three disinfectants (HSP, laboratory grade hydrogen peroxide (HP) and sodium hypochlorite) at concentrations of 20 ppm (therefore at 2.5 and 5 times the NSF limit for HP and sodium hypochlorite, respectively) and at pH 7.0 and 8.5 in dechlorinated tap water. HSP was found to be more or equally effective as hypochlorite or HP. Results from CT assays comparing HSP and HP at different bacterial concentrations with neutralization of residual peroxide with catalase suggested that at a high bacterial concentration HSP, but not HP, was protected from catalase degradation possibly through sequestration by bacterial cells. Consistent with this hypothesis, at a low bacterial cell density residual HSP was more effectively neutralized as less HSP was associated with bacteria and therefore accessible to catalase. Silver in HSP may facilitate this association through electrostatic interactions at the cell surface. This was supported by experiments where the addition of mono (K+) and divalent (Ca+2) cations (0.005-0.05M) reduced the killing efficacy of HSP but not HP. Experiments designed to distinguish any inhibitory effect of silver from that of peroxide in HSP were carried out by monitoring the metabolic activity of established P. aeruginosa PAO1 biofilms. Concentrations of 70-500 ppm HSP had a pronounced effect on metabolic activity while the equivalent concentrations of ionic silver (50-375 ppb) had a negligible effect, demonstrating that the microbiocidal activity of HSP was due to peroxide rather than silver. Overall, it was found that the antimicrobial activity of HSP is enhanced over that of hydrogen peroxide; the presence of the ionic silver enhances interactions of HSP with the bacterial cell surface rather than acting directly as a biocide at the tested concentrations.	[Martin, Nancy L.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada; [Bass, Paul; Liss, Steven N.] Queens Univ, Sch Environm Studies, Kingston, ON, Canada; [Liss, Steven N.] Queens Univ, Dept Chem Engn, Kingston, ON K7L 3N6, Canada	Queens University - Canada; Queens University - Canada; Queens University - Canada	Martin, NL (corresponding author), Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada.	nancy.martin@queensu.ca; steven.liss@queensu.ca			Natural Sciences and Engineering Research Council (Canada); Engage Program FedDev Ontario ARC (Canada)	Natural Sciences and Engineering Research Council (Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Engage Program FedDev Ontario ARC (Canada)	Funding was provided by two federal programs: Natural Sciences and Engineering Research Council (Canada) and Engage Program FedDev Ontario ARC (Canada). Supplies of the new generation peroxide were provided by: SanEcoTec. The funding agency did not play any role in the design, data collection and analysis, decision to publish or preparation of the manuscript. The authors regularly discussed the progress of the work with SanEcoTec and they provided a copy of the draft manuscript for review of statements of fact. They did not design, collect data, analyze or contribute to the preparation of the manuscript.	Andrews JM, 2001, J ANTIMICROB CHEMOTH, V48, P5, DOI 10.1093/jac/48.suppl_1.5; Armon R, 2000, WATER SCI TECHNOL, V42, P187, DOI 10.2166/wst.2000.0312; BALDRY MGC, 1983, J APPL BACTERIOL, V54, P417, DOI 10.1111/j.1365-2672.1983.tb02637.x; Batarseh KI, 2012, CURR MED CHEM, V19, P3635; Berry D, 2006, CURR OPIN BIOTECH, V17, P297, DOI 10.1016/j.copbio.2006.05.007; Bester E, 2010, APPL ENVIRON MICROB, V76, P1189, DOI 10.1128/AEM.01719-09; Bonvillain RW, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-112; BRAGG PD, 1974, CAN J MICROBIOL, V20, P883, DOI 10.1139/m74-135; BROWN SM, 1995, J BACTERIOL, V177, P6536, DOI 10.1128/jb.177.22.6536-6544.1995; Committee NRCUSDW, 1987, DRINKING WATER AND H; Cosgrove K, 2007, J BACTERIOL, V189, P1025, DOI 10.1128/JB.01524-06; Davoudi M, 2012, ANTIBACTERIAL EFFECT; Ehdaie B, 2014, ENVIRON SCI TECHNOL, V48, P13901, DOI 10.1021/es503534c; Emtiazi F, 2004, WATER RES, V38, P1197, DOI 10.1016/j.watres.2003.10.056; Fernandes PN, 2007, REDOX REP, V12, P236, DOI 10.1179/135100007X200344; Flemming HC, 2002, APPL MICROBIOL BIOT, V59, P629, DOI 10.1007/s00253-002-1066-9; Florentin A, 2011, INT J HYG ENVIR HEAL, V214, P461, DOI 10.1016/j.ijheh.2011.07.012; Fu FL, 2014, J HAZARD MATER, V267, P194, DOI 10.1016/j.jhazmat.2013.12.062; Gadd G M, 1989, Biol Met, V2, P168, DOI 10.1007/BF01142556; GHANDOUR W, 1988, APPL MICROBIOL BIOT, V28, P559, DOI 10.1007/BF00250412; Hare NJ, 2011, PROTEOMICS, V11, P3056, DOI 10.1002/pmic.201000807; Holt KB, 2005, BIOCHEMISTRY-US, V44, P13214, DOI 10.1021/bi0508542; Imlay JA, 2013, NAT REV MICROBIOL, V11, P443, DOI 10.1038/nrmicro3032; Jin X, 2010, ENVIRON SCI TECHNOL, V44, P7321, DOI 10.1021/es100854g; Juven BJ, 1996, J FOOD PROTECT, V59, P1233, DOI 10.4315/0362-028X-59.11.1233; Kim M-J, 2001, THESIS U TORONTO; Kroukamp O, 2010, APPL ENVIRON MICROB, V76, P6025, DOI 10.1128/AEM.00070-10; Kroukamp O, 2009, APPL ENVIRON MICROB, V75, P4391, DOI 10.1128/AEM.01567-08; Kumari P, 2015, J BIOCHEM, V157, P113, DOI 10.1093/jb/mvu072; Linley E, 2012, J ANTIMICROB CHEMOTH, V67, P1589, DOI 10.1093/jac/dks129; Liu G, 2013, APPL MICROBIOL BIOT, V97, P9265, DOI 10.1007/s00253-013-5217-y; LOEWEN PC, 1987, J BACTERIOL, V169, P3601, DOI 10.1128/jb.169.8.3601-3607.1987; Loo SL, 2013, ENVIRON SCI TECHNOL, V47, P9363, DOI 10.1021/es401219s; Maillard JY, 2013, CRIT REV MICROBIOL, V39, P373, DOI 10.3109/1040841X.2012.713323; Mishra S, 2012, ARCH BIOCHEM BIOPHYS, V525, P145, DOI 10.1016/j.abb.2012.04.014; MULVEY MR, 1988, GENE, V73, P337, DOI 10.1016/0378-1119(88)90498-2; Munoz M, 2011, J HAZARD MATER, V190, P993, DOI 10.1016/j.jhazmat.2011.04.038; Nabizadeh R, 2008, IRAN J ENVIRON HEALT, V5, P235; Ochsner UA, 2000, J BACTERIOL, V182, P4533, DOI 10.1128/JB.182.16.4533-4544.2000; Park S, 2005, P NATL ACAD SCI USA, V102, P9317, DOI 10.1073/pnas.0502051102; Pedahzur R, 1997, WATER SCI TECHNOL, V35, P87, DOI 10.2166/wst.1997.0715; PEDAHZUR R, 1995, WATER SCI TECHNOL, V31, P123, DOI 10.1016/0273-1223(95)00252-I; Pomposiello PJ, 2001, TRENDS BIOTECHNOL, V19, P109, DOI 10.1016/S0167-7799(00)01542-0; Richardson SD, 2003, TRAC-TREND ANAL CHEM, V22, P666, DOI 10.1016/S0165-9936(03)01003-3; Richardson SD, 2007, MUTAT RES-REV MUTAT, V636, P178, DOI 10.1016/j.mrrev.2007.09.001; Roeder RS, 2010, INT J HYG ENVIR HEAL, V213, P183, DOI 10.1016/j.ijheh.2010.04.007; Morones-Ramirez JR, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006276; Sadiq R, 2004, SCI TOTAL ENVIRON, V321, P21, DOI 10.1016/j.scitotenv.2003.05.001; Schel AJ, 2006, APPL ENVIRON MICROB, V72, P1380, DOI 10.1128/AEM.72.2.1380-1387.2006; Schoenen D, 2002, WATER RES, V36, P3874, DOI 10.1016/S0043-1354(02)00076-3; Schwartz T, 1998, WATER RES, V32, P2787, DOI 10.1016/S0043-1354(98)00026-8; Seaver LC, 2001, J BACTERIOL, V183, P7182, DOI 10.1128/JB.183.24.7182-7189.2001; Shuval H, 2009, INT J INFECTION CONT, V5; Silver S, 2006, J IND MICROBIOL BIOT, V33, P627, DOI 10.1007/s10295-006-0139-7; Silvestry-Rodriguez N, 2007, J ENVIRON SCI HEAL A, V42, P1579, DOI 10.1080/10934520701517689; SLAWSON RM, 1992, PLASMID, V27, P72, DOI 10.1016/0147-619X(92)90008-X; Smaill F, 2000, CAN J GASTROENTEROL, V14, P871, DOI 10.1155/2000/382415; Smith EM, 2010, ENVIRON SCI TECHNOL, V44, P8446, DOI 10.1021/es102746u; STEINER AA, 1970, PLANT PHYSIOL, V46, P862, DOI 10.1104/pp.46.6.862; Szabo J, 2014, ENVIRON INT, V72, P124, DOI 10.1016/j.envint.2014.01.031; Szewzyk U, 2000, ANNU REV MICROBIOL, V54, P81, DOI 10.1146/annurev.micro.54.1.81; Tao K, 1999, FEBS LETT, V457, P90, DOI 10.1016/S0014-5793(99)01013-3; Tote K, 2010, APPL ENVIRON MICROB, V76, P3135, DOI 10.1128/AEM.02095-09; TRIGGSRAINE BL, 1987, GENE, V52, P121, DOI 10.1016/0378-1119(87)90038-2; Tugulea AM, 2014, ENVIRON SCI POLLUT R, V21, P11823, DOI 10.1007/s11356-014-2508-5; Vatansever F, 2013, FEMS MICROBIOL REV, V37, P955, DOI 10.1111/1574-6976.12026; Vianna ME, 2004, ORAL SURG ORAL MED O, V97, P79, DOI 10.1016/S1079-2104(03)00360-3; WALLING C, 1975, ACCOUNTS CHEM RES, V8, P125, DOI 10.1021/ar50088a003; White G.C., 1999, HDB CHLORINATION ALT; Wingender J, 2011, INT J HYG ENVIR HEAL, V214, P417, DOI 10.1016/j.ijheh.2011.05.009; Winter J, 2008, CELL, V135, P691, DOI 10.1016/j.cell.2008.09.024; World Health Organization, 2004, GUID DRINK WAT QUAL, P237; Yudkin J., 1937, ENZYMOLOGIA, V2, P161	73	22	22	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0131345	10.1371/journal.pone.0131345	http://dx.doi.org/10.1371/journal.pone.0131345			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154263	Green Submitted, gold, Green Published			2022-12-26	WOS:000358159700059
J	Murayama, S; Ishikawa, S; Chumsakul, O; Ogasawara, N; Oshima, T				Murayama, Satohiko; Ishikawa, Shu; Chumsakul, Onuma; Ogasawara, Naotake; Oshima, Taku			The Role of alpha-CTD in the Genome-Wide Transcriptional Regulation of the Bacillus subtilis Cells	PLOS ONE			English	Article							COLI RNA-POLYMERASE; C-TERMINAL DOMAIN; DNA-BINDING PROTEIN; ESCHERICHIA-COLI; BACTERIAL PROMOTERS; CATABOLITE REPRESSION; DEPENDENT REGULATION; RIBOSOME SYNTHESIS; SUBUNIT; EXPRESSION	The amino acid sequence of the RNA polymerase (RNAP) alpha-subunit is well conserved throughout the Eubacteria. Its C-terminal domain (alpha-CTD) is important for the transcriptional regulation of specific promoters in both Escherichia coli and Bacillus subtilis, through interactions with transcription factors and/or a DNA element called the "UP element". However, there is only limited information regarding the alpha-CTD regulated genes in B. subtilis and the importance of this subunit in the transcriptional regulation of B. subtilis. Here, we established strains and the growth conditions in which the alpha-subunit of RNAP was replaced with a C-terminally truncated version. Transcriptomic and ChAP-chip analyses revealed that alpha-CTD deficiency reduced the transcription and RNAP binding of genes related to the utilization of secondary carbon sources, transition state responses, and ribosome synthesis. In E. coli, it is known that alpha-CTD also contributes to the expression of genes related to the utilization of secondary carbon sources and ribosome synthesis. Our results suggest that the biological importance of alpha-CTD is conserved in B. subtilis and E. coli, but that its specific roles have diversified between these two bacteria.	[Murayama, Satohiko; Ishikawa, Shu; Chumsakul, Onuma; Ogasawara, Naotake; Oshima, Taku] Nara Inst Sci & Technol, Grad Sch Biol Sci, Ikoma, Nara 6300192, Japan	Nara Institute of Science & Technology	Oshima, T (corresponding author), Nara Inst Sci & Technol, Grad Sch Biol Sci, 8916-5 Takayama, Ikoma, Nara 6300192, Japan.	taku@bs.naist.jp	Ishikawa, Shu/K-5383-2017	Ishikawa, Shu/0000-0002-2239-1116	JSPS KAKENHI [23241062]; JST Advanced Low Carbon Technology Research and Development Program, ALCA	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JST Advanced Low Carbon Technology Research and Development Program, ALCA	This work was supported by JSPS KAKENHI, Grant Numbers 23241062 (to TO, SI and NO) and JST Advanced Low Carbon Technology Research and Development Program, ALCA, (to NO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allenby NEE, 2006, J BACTERIOL, V188, P5299, DOI 10.1128/JB.00084-06; Ball MS, 2007, J PROTEOME RES, V6, P4313, DOI 10.1021/pr070398z; BANNER CDB, 1983, J MOL BIOL, V168, P351, DOI 10.1016/S0022-2836(83)80023-0; BLATTER EE, 1994, CELL, V78, P889, DOI 10.1016/S0092-8674(94)90682-3; BOYLAN SA, 1989, J BACTERIOL, V171, P2553, DOI 10.1128/jb.171.5.2553-2562.1989; Brill J, 2011, J BACTERIOL, V193, P5335, DOI 10.1128/JB.05490-11; Browning DF, 2004, NAT REV MICROBIOL, V2, P57, DOI 10.1038/nrmicro787; Busby S, 1999, J MOL BIOL, V293, P199, DOI 10.1006/jmbi.1999.3161; Butcher BG, 2007, J BACTERIOL, V189, P8616, DOI 10.1128/JB.01181-07; Caramori T, 1998, MOL GEN GENET, V258, P385, DOI 10.1007/s004380050745; Caspi R, 2014, NUCLEIC ACIDS RES, V42, pD459, DOI 10.1093/nar/gkt1103; Comella N, 2005, MOL MICROBIOL, V57, P1159, DOI 10.1111/j.1365-2958.2005.04749.x; Darbon E, 2002, MOL MICROBIOL, V43, P1039, DOI 10.1046/j.1365-2958.2002.02800.x; DOMBROSKI AJ, 1992, CELL, V70, P501, DOI 10.1016/0092-8674(92)90174-B; EBRIGHT RH, 1995, CURR OPIN GENET DEV, V5, P197, DOI 10.1016/0959-437X(95)80008-5; Estrem ST, 1999, GENE DEV, V13, P2134, DOI 10.1101/gad.13.16.2134; Estrem ST, 1998, P NATL ACAD SCI USA, V95, P9761, DOI 10.1073/pnas.95.17.9761; FREDRICK K, 1995, P NATL ACAD SCI USA, V92, P2582, DOI 10.1073/pnas.92.7.2582; FRISBY D, 1991, J BACTERIOL, V173, P7557, DOI 10.1128/jb.173.23.7557-7564.1991; Gaal T, 1996, GENE DEV, V10, P16, DOI 10.1101/gad.10.1.16; Gaugue I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063025; Gorke B, 2008, NAT REV MICROBIOL, V6, P613, DOI 10.1038/nrmicro1932; Gourse RL, 2000, MOL MICROBIOL, V37, P687, DOI 10.1046/j.1365-2958.2000.01972.x; Gourse RL, 1996, ANNU REV MICROBIOL, V50, P645, DOI 10.1146/annurev.micro.50.1.645; GueroutFleury AM, 1995, GENE, V167, P335, DOI 10.1016/0378-1119(95)00652-4; HAYWARD RS, 1991, J MOL BIOL, V221, P23, DOI 10.1016/0022-2836(91)80197-3; IGARASHI K, 1991, J MOL BIOL, V218, P1, DOI 10.1016/0022-2836(91)90865-4; Irnov I, 2010, NUCLEIC ACIDS RES, V38, P6637, DOI 10.1093/nar/gkq454; ISHIHAMA A, 1993, J BACTERIOL, V175, P2483, DOI 10.1128/JB.175.9.2483-2489.1993; ISHIHAMA A, 1992, MOL MICROBIOL, V6, P3283, DOI 10.1111/j.1365-2958.1992.tb02196.x; Ishikawa S, 2010, J BACTERIOL, V192, P5778, DOI 10.1128/JB.00489-10; Jeon YH, 1997, J MOL BIOL, V267, P953, DOI 10.1006/jmbi.1997.0902; Joyet P, 2010, MOL MICROBIOL, V76, P1279, DOI 10.1111/j.1365-2958.2010.07175.x; Krasny L, 2004, EMBO J, V23, P4473, DOI 10.1038/sj.emboj.7600423; Kusuya Y, 2011, J BACTERIOL, V193, P3090, DOI 10.1128/JB.00086-11; Lei Y, 2013, THESIS NARA I SCI TE; Lemke JJ, 2011, P NATL ACAD SCI USA, V108, P5712, DOI 10.1073/pnas.1019383108; Ludwig H, 2002, MOL MICROBIOL, V45, P543, DOI 10.1046/j.1365-2958.2002.03034.x; Meijer WJJ, 2004, NUCLEIC ACIDS RES, V32, P1166, DOI 10.1093/nar/gkh290; Mencia M, 1998, J MOL BIOL, V275, P177, DOI 10.1006/jmbi.1997.1463; Mencia M, 1996, P NATL ACAD SCI USA, V93, P6616, DOI 10.1073/pnas.93.13.6616; MORAN CP, 1982, MOL GEN GENET, V186, P339, DOI 10.1007/BF00729452; Msadek T, 1999, TRENDS MICROBIOL, V7, P201, DOI 10.1016/S0966-842X(99)01479-1; NEGISHI T, 1995, J MOL BIOL, V248, P723, DOI 10.1006/jmbi.1995.0254; Newberry KJ, 2005, P NATL ACAD SCI USA, V102, P15839, DOI 10.1073/pnas.0506592102; Niu W, 1996, CELL, V87, P1123, DOI 10.1016/S0092-8674(00)81806-1; Ohtsubo Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-376; Osmundson J, 2012, CELL, V151, P1005, DOI 10.1016/j.cell.2012.10.034; Reizer J, 1999, MICROBIOL-UK, V145, P3419, DOI 10.1099/00221287-145-12-3419; ROSS W, 1993, SCIENCE, V262, P1407, DOI 10.1126/science.8248780; Ross W, 1998, J BACTERIOL, V180, P5375, DOI 10.1128/JB.180.20.5375-5383.1998; Sadaie Y, 2008, FEMS MICROBIOL LETT, V279, P103, DOI 10.1111/j.1574-6968.2007.01018.x; Schmiedel D, 1996, MOL GEN GENET, V250, P259; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Sierro N, 2008, NUCLEIC ACIDS RES, V36, pD93, DOI 10.1093/nar/gkm910; STRAUCH MA, 1995, J BACTERIOL, V177, P6727, DOI 10.1128/jb.177.23.6727-6731.1995; Tagami H, 1998, EMBO J, V17, P1759, DOI 10.1093/emboj/17.6.1759; Ujiie H, 2009, J BIOCHEM, V145, P59, DOI 10.1093/jb/mvn143; Wenzel M, 2013, MOL MICROBIOL, V88, P562, DOI 10.1111/mmi.12209; Winkelman JT, 2013, MOL MICROBIOL, V88, P984, DOI 10.1111/mmi.12235; Zhang GY, 1998, SCIENCE, V281, P262, DOI 10.1126/science.281.5374.262; Zhang Y, 2006, J BACTERIOL, V188, P4300, DOI 10.1128/JB.00220-06	62	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0131588	10.1371/journal.pone.0131588	http://dx.doi.org/10.1371/journal.pone.0131588			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154296	Green Published, Green Submitted, gold			2022-12-26	WOS:000358159700073
J	Moustafa, AM; Seemann, T; Gladman, S; Adler, B; Harper, M; Boyce, JD; Bennett, MD				Moustafa, Ahmed M.; Seemann, Torsten; Gladman, Simon; Adler, Ben; Harper, Marina; Boyce, John D.; Bennett, Mark D.			Comparative Genomic Analysis of Asian Haemorrhagic Septicaemia-Associated Strains of Pasteurella multocida Identifies More than 90 Haemorrhagic Septicaemia-Specific Genes	PLOS ONE			English	Article							CONJUGATIVE ELEMENT ICE; SEQUENCE; PHAGE; ORGANIZATION; VIRULENCE; ICEPMU1	Pasteurella multocida is the primary causative agent of a range of economically important diseases in animals, including haemorrhagic septicaemia (HS), a rapidly fatal disease of ungulates. There is limited information available on the diversity of P. multocida strains that cause HS. Therefore, we determined draft genome sequences of ten disease-causing isolates and two vaccine strains and compared these genomes using a range of bioinformatic analyses. The draft genomes of the 12 HS strains were between 2,298,035 and 2,410,300 bp in length. Comparison of these genomes with the North American HS strain, M1404, and other available P. multocida genomes (Pm70, 3480, 36950 and HN06) identified a core set of 1,824 genes. A set of 96 genes was present in all HS isolates and vaccine strains examined in this study, but absent from Pm70, 3480, 36950 and HN06. Moreover, 59 genes were shared only by the Asian B: 2 strains. In two Pakistani isolates, genes with high similarity to genes in the integrative and conjugative element, ICEPmu1 from strain 36950 were identified along with a range of other antimicrobial resistance genes. Phylogenetic analysis indicated that the HS strains formed clades based on their country of isolation. Future analysis of the 96 genes unique to the HS isolates will aid the identification of HS-specific virulence attributes and facilitate the development of disease-specific diagnostic tests.	[Moustafa, Ahmed M.; Bennett, Mark D.] Murdoch Univ, Sch Vet & Life Sci, Perth, WA, Australia; [Seemann, Torsten; Gladman, Simon] Monash Univ, Victorian Bioinformat Consortium, Melbourne, Vic 3004, Australia; [Adler, Ben; Harper, Marina; Boyce, John D.] Monash Univ, Australian Res Council, Ctr Excellence Struct & Funct Microbial Genom, Melbourne, Vic 3004, Australia; [Adler, Ben; Harper, Marina; Boyce, John D.] Monash Univ, Dept Microbiol, Melbourne, Vic 3004, Australia; [Seemann, Torsten; Gladman, Simon] Victorian Life Sci Computat Initiat, Melbourne, Vic, Australia	Murdoch University; Monash University; Monash University; Monash University	Boyce, JD (corresponding author), Monash Univ, Australian Res Council, Ctr Excellence Struct & Funct Microbial Genom, Wellington Rd, Melbourne, Vic 3004, Australia.	john.boyce@monash.edu	Seemann, Torsten/B-2318-2010; Moustafa, Ahmed/S-2185-2018; Boyce, John D/F-5058-2012	Seemann, Torsten/0000-0001-6046-610X; Moustafa, Ahmed/0000-0002-9949-6936; Boyce, John D/0000-0002-8614-3074; Harper, Marina/0000-0001-8396-0311	Australian Research Council Centre of Excellence in Structural and Functional Microbial Genomics [CE0562063]; Australian Research Council	Australian Research Council Centre of Excellence in Structural and Functional Microbial Genomics(Australian Research Council); Australian Research Council(Australian Research Council)	Funding was provided by the Australian Research Council Centre of Excellence in Structural and Functional Microbial Genomics, Grant number CE0562063; Australian Research Council, http://www.arc.gov.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahante Juan E, 2013, Genome Announc, V1, DOI 10.1128/genomeA.00058-12; Ahir VB, 2011, J BACTERIOL, V193, P5604, DOI 10.1128/JB.05706-11; Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ANBA J, 1995, J BACTERIOL, V177, P3818, DOI 10.1128/jb.177.13.3818-3823.1995; Angiuoli SV, 2008, OMICS, V12, P137, DOI 10.1089/omi.2008.0017; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Benkirane A, 2002, VET MED-CZECH, V47, P234, DOI 10.17221/5830-VETMED; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Boyce JD, 2012, CURR TOP MICROBIOL, V361, P23, DOI 10.1007/82_2012_203; Boyce JD, 2000, VET MICROBIOL, V72, P121, DOI 10.1016/S0378-1135(99)00193-5; Boyd EF, 2002, TRENDS MICROBIOL, V10, P521, DOI 10.1016/S0966-842X(02)02459-9; Campoy S, 2006, APPL ENVIRON MICROB, V72, P3154, DOI 10.1128/AEM.72.5.3154-3160.2006; CARTER GR, 1955, AM J VET RES, V16, P481; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; De Alwis MCL, 1999, HAEMORRHAGIC SEPTICA, P11; Dziva F, 2008, VET MICROBIOL, V128, P1, DOI 10.1016/j.vetmic.2007.10.018; GARVEY P, 1995, APPL ENVIRON MICROB, V61, P4321, DOI 10.1128/AEM.61.12.4321-4328.1995; Gurevich A, 2013, BIOINFORMATICS, V29, P1072, DOI 10.1093/bioinformatics/btt086; Harper M, 2007, INFECT IMMUN, V75, P3885, DOI 10.1128/IAI.00212-07; Harper M, 2010, INFECT IMMUN, V78, P3669, DOI 10.1128/IAI.00457-10; HEDDLESTON KL, 1972, AVIAN DIS, V16, P925, DOI 10.2307/1588773; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Liu WJ, 2012, J BACTERIOL, V194, P3292, DOI 10.1128/JB.00215-12; May BJ, 2001, P NATL ACAD SCI USA, V98, P3460, DOI 10.1073/pnas.051634598; Michael FS, 2009, J BACTERIOL, V191, P6950, DOI 10.1128/JB.00787-09; Michael GB, 2012, J ANTIMICROB CHEMOTH, V67, P84, DOI 10.1093/jac/dkr406; Michael GB, 2012, J ANTIMICROB CHEMOTH, V67, P91, DOI 10.1093/jac/dkr411; Mohd-Zain Z, 2004, J BACTERIOL, V186, P8114, DOI 10.1128/JB.186.23.8114-8122.2004; Moustafa AM, 2013, RES VET SCI, V95, P986, DOI 10.1016/j.rvsc.2013.07.003; Neramitmansook P, 1993, ACIAR P, V43, P234; Pullinger GD, 2004, MOL MICROBIOL, V51, P255, DOI 10.1046/j.1365-2958.2003.03829.x; Rimler R. B., 1989, PASTEURELLA PASTEURE, P37; Rissman AI, 2009, BIOINFORMATICS, V25, P2071, DOI 10.1093/bioinformatics/btp356; Townsend KM, 1998, J CLIN MICROBIOL, V36, P1096, DOI 10.1128/JCM.36.4.1096-1100.1998; Townsend KM, 2001, J CLIN MICROBIOL, V39, P924, DOI 10.1128/JCM.39.3.924-929.2001; Vaid R K, 2014, Genome Announc, V2, DOI 10.1128/genomeA.00755-14; Wilson BA, 2013, CLIN MICROBIOL REV, V26, P631, DOI 10.1128/CMR.00024-13; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485	41	28	29	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2015	10	7							e0130296	10.1371/journal.pone.0130296	http://dx.doi.org/10.1371/journal.pone.0130296			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EC	26151935	Green Published, gold			2022-12-26	WOS:000358158900007
J	Li, Q; Wu, L; Hao, JJ; Luo, LX; Cao, YS; Li, JQ				Li, Qian; Wu, Lei; Hao, Jianjun; Luo, Laixin; Cao, Yongsong; Li, Jianqiang			Biofumigation on Post-Harvest Diseases of Fruits Using a New Volatile-Producing Fungus of Ceratocystis fimbriata	PLOS ONE			English	Article							MUSCODOR-ALBUS; RHIZOCTONIA-SOLANI; BIOLOGICAL-CONTROL; IN-VITRO; GROWTH; BIOCONTROL; TRICHODERMA; METABOLITES; ANTIFUNGAL; AGENT	A variety of volatile organic compounds (VOCs) produced by Ceratocystis fimbriata have strong bioactivity against a wide range of fungi, bacteria and oomycetes. Mycelial growth, conidial production, and spore germination of fungi and oomycetes were significantly inhibited after exposure to cultures of C. fimbriata, and colony formation of bacteria was also inhibited. Two post-harvest diseases, peach brown rot caused by Monilinia fructicola and citrus green mold caused by Penicillium digitatum, were controlled during a 4-day storage by enclosing wound-inoculated fruits with 10 standard diameter Petri plate cultures of C. fimbriata in a 15 L box. The fruits were freshly inoculated at onset of storage and the cultures of C. fimbriata were 6 days old. Percentage of control was 92 and 97%, respectively. After exposure to C. fimbriata VOCs, severely misshapen hyphae and conidia of these two post-harvest pathogens were observed by scanning electron microscopy, and their pathogenicity was lost or greatly reduced.	[Li, Qian; Luo, Laixin; Cao, Yongsong; Li, Jianqiang] Beijing Engn Res Ctr Seed & Plant Hlth BERC SPH, Beijing Key Lab Seed Dis Testing & Control BKL SD, Beijing, Peoples R China; [Wu, Lei] Zhejiang Univ, Lab Fruit Qual Biol, State Agr Minist, Lab Hort Plant Growth Dev & Qual Improvement, Hangzhou 310003, Zhejiang, Peoples R China; [Hao, Jianjun] Univ Maine, Sch Food & Agr, Orono, ME USA	Zhejiang University; University of Maine System; University of Maine Orono	Li, JQ (corresponding author), Beijing Engn Res Ctr Seed & Plant Hlth BERC SPH, Beijing Key Lab Seed Dis Testing & Control BKL SD, Beijing, Peoples R China.	lijq231@cau.edu.cn	LI, JIAN/GRY-2197-2022; li, jian/GSE-0245-2022; cao, yongsong/P-8718-2019		Natural Science Foundation of China [31071726]; Program for Changjiang Scholars and Innovative Research Team in University [IRT1042]; Chinese Ministry of Education	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Chinese Ministry of Education(Ministry of Education, China)	This work was supported by the Natural Science Foundation of China (Grant No. 31071726): http://www.nsfc.gov.cn/; Program for Changjiang Scholars and Innovative Research Team in University (Grant No. IRT1042); and Project for Ph.D. graduate academic new artist (supported by Chinese Ministry of Education). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altomare C, 1999, APPL ENVIRON MICROB, V65, P2926; Boukaew S, 2013, BIOCONTROL, V58, P471, DOI 10.1007/s10526-013-9510-6; Bruce A, 2003, INT BIODETER BIODEGR, V51, P101, DOI 10.1016/S0964-8305(02)00088-4; Chaurasia B, 2005, MICROBIOL RES, V160, P75, DOI 10.1016/j.micres.2004.09.013; Deng J, 2007, PLANT PROTECTION, V32, P97; Dicke M, 1988, FUNCT ECOL, V2, P131, DOI 10.2307/2389687; Grimme E, 2007, PLANT DIS, V91, P220, DOI 10.1094/PDIS-91-2-0220; Hashem M, 2011, MYCOPATHOLOGIA, V172, P37, DOI 10.1007/s11046-010-9390-6; Howell CR, 2003, PLANT DIS, V87, P4, DOI 10.1094/PDIS.2003.87.1.4; Janisiewicz WJ, 2002, ANNU REV PHYTOPATHOL, V40, P411, DOI 10.1146/annurev.phyto.40.120401.130158; Khan MSA, 2011, PHYTOMEDICINE, V19, P48, DOI 10.1016/j.phymed.2011.07.005; Korpi A, 2009, CRIT REV TOXICOL, V39, P139, DOI [10.1080/10408440802291497, 10.1080/10408440802291497 ]; Kumar S, 2012, PHYTOCHEM REV, V11, P507, DOI 10.1007/s11101-013-9271-y; Lacey LA, 2006, J INVERTEBR PATHOL, V91, P195, DOI 10.1016/j.jip.2006.01.002; Mercier J, 2005, CROP PROT, V24, P355, DOI 10.1016/j.cropro.2004.09.004; Mercier J, 2004, POSTHARVEST BIOL TEC, V31, P1, DOI 10.1016/j.postharvbio.2003.08.004; Mercier J, 2007, CAN J MICROBIOL, V53, P404, DOI 10.1139/W06-124; Minerdi D, 2011, FEMS MICROBIOL ECOL, V76, P342, DOI 10.1111/j.1574-6941.2011.01051.x; Minerdi D, 2009, ENVIRON MICROBIOL, V11, P844, DOI 10.1111/j.1462-2920.2008.01805.x; Mitchell AM, 2010, MICROBIOL-SGM, V156, P270, DOI 10.1099/mic.0.032540-0; Morath Shannon U., 2012, Fungal Biology Reviews, V26, P73, DOI 10.1016/j.fbr.2012.07.001; Nalini S, 2014, BIORESOURCE TECHNOL, V173, P231, DOI 10.1016/j.biortech.2014.09.051; Naznin HA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086882; Plodpai P, 2013, CROP PROT, V43, P65, DOI 10.1016/j.cropro.2012.09.004; Riga E, 2008, BIOL CONTROL, V45, P380, DOI 10.1016/j.biocontrol.2008.01.002; Ryu CM, 2004, PLANT PHYSIOL, V134, P1017, DOI 10.1104/pp.103.026583; Ryu CM, 2003, P NATL ACAD SCI USA, V100, P4927, DOI 10.1073/pnas.0730845100; Samtani JB, 2011, CROP PROT, V30, P45, DOI 10.1016/j.cropro.2010.08.023; SPRECHER E, 1983, A VAN LEEUW J MICROB, V49, P493; Strobel GA, 2001, MICROBIOL-SGM, V147, P2943, DOI 10.1099/00221287-147-11-2943; Strobel G, 2014, CURR OPIN MICROBIOL, V19, P52, DOI 10.1016/j.mib.2014.06.003; Van Wees SCM, 2008, CURR OPIN PLANT BIOL, V11, P443, DOI 10.1016/j.pbi.2008.05.005; Verma M, 2007, BIOCHEM ENG J, V37, P1, DOI 10.1016/j.bej.2007.05.012; Zhao ZZ, 2010, BIORESOURCE TECHNOL, V101, P292, DOI 10.1016/j.biortech.2009.07.071	34	25	27	4	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132009	10.1371/journal.pone.0132009	http://dx.doi.org/10.1371/journal.pone.0132009			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147922	Green Published, gold, Green Submitted			2022-12-26	WOS:000358157600179
J	Kelly, B; Tannahill, GM; Murphy, MP; O'Neill, LAJ				Kelly, Beth; Tannahill, Gillian M.; Murphy, Michael P.; O'Neill, Luke A. J.			Metformin Inhibits the Production of Reactive Oxygen Species from NADH:Ubiquinone Oxidoreductase to Limit Induction of Interleukin-1 beta (IL-1 beta) and Boosts Interleukin-10 (IL-10) in Lipopolysaccharide (LPS)-activated Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; MITOCHONDRIA-TARGETED ANTIOXIDANT; ELECTRON TRANSFER REACTIONS; NLRP3 INFLAMMASOME; HEPATIC GLUCONEOGENESIS; RESPIRATORY-CHAIN; MULTIPLE-SCLEROSIS; INSULIN-RESISTANCE; COMPLEX-I; MECHANISM	Metformin, a frontline treatment for type II diabetes mellitus, decreases production of the pro-form of the inflammatory cytokine IL-1 beta in response to LPS in macrophages. We found that it specifically inhibited pro-IL-1 beta production, having no effect on TNF-alpha. Furthermore, metformin boosted induction of the anti-inflammatory cytokine IL-10 in response to LPS. We ruled out a role for AMP-activated protein kinase (AMPK) in the effect of metformin because activation of AMPK with A769662 did not mimic metformin here. Furthermore, metformin was still inhibitory in AMKP alpha 1- or AMPK beta 1-deficient cells. The activity of NADH: ubiquinone oxidoreductase (complex I) was inhibited by metformin. Another complex I inhibitor, rotenone, mimicked the effect of metformin on pro-IL-1 beta and IL-10. LPS induced reactive oxygen species production, an effect inhibited by metformin or rotenone pretreatment. MitoQ, a mitochondrially targeted antioxidant, decreased LPS-induced IL-1 beta without affecting TNF-alpha. These results, therefore, implicate complex I in LPS action in macrophages.	[Kelly, Beth; Tannahill, Gillian M.; O'Neill, Luke A. J.] Univ Dublin Trinity Coll, Sch Biochem & Immunol, Trinity Biomed Sci Inst, Dublin 2, Ireland; [Murphy, Michael P.] MRC, Mitochondrial Biol Unit, Cambridge CB2 0XY, England	Trinity College Dublin	O'Neill, LAJ (corresponding author), Univ Dublin Trinity Coll, Sch Biochem & Immunol, Trinity Biomed Sci Inst, Dublin 2, Ireland.	kellyb3@tcd.ie	Murphy, Michael/C-2120-2009	Murphy, Michael/0000-0003-1115-9618; Kelly, Beth/0000-0002-3195-6860; O'Neill, Luke/0000-0002-4333-2748	European Research Council; Science Foundation Ireland; Medical Research Council [MC_U105663142] Funding Source: researchfish; MRC [MC_U105663142] Funding Source: UKRI	European Research Council(European Research Council (ERC)European Commission); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the European Research Council and Science Foundation Ireland. The authors declare that they have no conflicts of interest with the contents of this article.	Batandier C, 2006, J BIOENERG BIOMEMBR, V38, P33, DOI 10.1007/s10863-006-9003-8; Bauernfeind F, 2011, J IMMUNOL, V187, P613, DOI 10.4049/jimmunol.1100613; BENDTZEN K, 1986, SCIENCE, V232, P1545, DOI 10.1126/science.3086977; Carroll KC, 2013, J LEUKOCYTE BIOL, V94, P1113, DOI 10.1189/jlb.0313157; CHANCE B, 1961, J BIOL CHEM, V236, P1534; CHANCE B, 1961, J BIOL CHEM, V236, P1562; Dashdorj A, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-178; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; Fullerton MD, 2013, NAT MED, V19, P1649, DOI 10.1038/nm.3372; Galic S, 2011, J CLIN INVEST, V121, P4903, DOI 10.1172/JCI58577; Goransson O, 2007, J BIOL CHEM, V282, P32549, DOI 10.1074/jbc.M706536200; Guo Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086881; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hawley SA, 2012, SCIENCE, V336, P918, DOI 10.1126/science.1215327; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hundal RS, 2000, DIABETES, V49, P2063, DOI 10.2337/diabetes.49.12.2063; Kim J, 2014, J BIOL CHEM, V289, P23246, DOI 10.1074/jbc.M114.577908; Kim YD, 2008, DIABETES, V57, P306, DOI 10.2337/db07-0381; Lambert AJ, 2004, J BIOL CHEM, V279, P39414, DOI 10.1074/jbc.M406576200; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Lee HM, 2013, DIABETES, V62, P194, DOI 10.2337/db12-0420; Lee JM, 2010, J BIOL CHEM, V285, P32182, DOI 10.1074/jbc.M110.134890; Mao PZ, 2013, BBA-MOL BASIS DIS, V1832, P2322, DOI 10.1016/j.bbadis.2013.09.005; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; Meng SM, 2015, J BIOL CHEM, V290, P3793, DOI 10.1074/jbc.M114.604421; Moran A, 2013, LANCET, V381, P1905, DOI 10.1016/S0140-6736(13)60023-9; Murphy MP, 2007, ANNU REV PHARMACOL, V47, P629, DOI 10.1146/annurev.pharmtox.47.120505.105110; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Nath N, 2009, J IMMUNOL, V182, P8005, DOI 10.4049/jimmunol.0803563; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Park SH, 2002, J APPL PHYSIOL, V92, P2475, DOI 10.1152/japplphysiol.00071.2002; Sag D, 2008, J IMMUNOL, V181, P8633, DOI 10.4049/jimmunol.181.12.8633; Stephenne X, 2011, DIABETOLOGIA, V54, P3101, DOI 10.1007/s00125-011-2311-5; Tsoyi K, 2011, BRIT J PHARMACOL, V162, P1498, DOI 10.1111/j.1476-5381.2010.01126.x; Viollet B, 2009, FRONT BIOSCI-LANDMRK, V14, P19, DOI 10.2741/3229; Woo SL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091111; Zarrouk M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106710; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	41	186	189	5	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2015	290	33					20348	20359		10.1074/jbc.M115.662114	http://dx.doi.org/10.1074/jbc.M115.662114			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP1AT	26152715	Green Published, hybrid			2022-12-26	WOS:000359608900033
J	Guo, HC; Jin, Y; Han, SC; Sun, SQ; Wei, YQ; Liu, XJ; Feng, X; Liu, DX; Liu, XT				Guo, Hui-Chen; Jin, Ye; Han, Shi-Chong; Sun, Shi-Qi; Wei, Yan-Quan; Liu, Xian-Ji; Feng, Xia; Liu, Ding Xiang; Liu, Xiang-Tao			Quantitative Proteomic Analysis of BHK-21 Cells Infected with Foot-and-Mouth Disease Virus Serotype Asia 1	PLOS ONE			English	Article							PROTEIN-KINASE PKR; TRANSFER-RNA SYNTHETASES; ENDOPLASMIC-RETICULUM STRESS; RESPIRATORY SYNCYTIAL VIRUS; POLIOVIRUS INFECTION; SECRETORY PATHWAY; ESCRT MACHINERY; VIRAL-PROTEINS; HOST PROTEINS; 2B	Stable isotope labeling with amino acids in cell culture (SILAC) was used to quantitatively study the host cell gene expression profile, in order to achieve an unbiased overview of the protein expression changes in BHK-21 cells infected with FMDV serotype Asia 1. The SILAC-based approach identified overall 2,141 proteins, 153 of which showed significant alteration in the expression level 6 h post FMDV infection (57 up-regulated and 96 down-regulated). Among these proteins, six cellular proteins, including three down-regulated (VPS28, PKR, EVI5) and three up-regulated (LYPLA1, SEC62 and DARs), were selected according to the significance of the changes and/or the relationship with PKR. The expression level and pattern of the selected proteins were validated by immunoblotting and confocal microscopy. Furthermore, the functions of these cellular proteins were assessed by small interfering RNA-mediated depletion, and their functional importance in the replication of FMDV was demonstrated by western blot, reverse transcript PCR (RT-PCR) and 50% Tissue Culture Infective Dose (TCID50). The results suggest that FMDV infection may have effects on the expression of specific cellular proteins to create more favorable conditions for FMDV infection. This study provides novel data that can be utilized to understand the interactions between FMDV and the host cell.	[Guo, Hui-Chen; Jin, Ye; Han, Shi-Chong; Sun, Shi-Qi; Wei, Yan-Quan; Feng, Xia; Liu, Ding Xiang; Liu, Xiang-Tao] Chinese Acad Agr Sci, Lanzhou Vet Res Inst, Natl Foot & Mouth Dis Reference Lab, State Key Lab Vet Etiol Biol & OIE, Lanzhou, Gansu, Peoples R China; [Liu, Ding Xiang] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore; [Liu, Xian-Ji] Guangzhou Fitgene Biotechnol Co Ltd, Guangzhou Int Business Incubator A110, Guangzhou, Guangdong, Peoples R China	Chinese Academy of Agricultural Sciences; Lanzhou Veterinary Research Institute, CAAS; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Sun, SQ (corresponding author), Chinese Acad Agr Sci, Lanzhou Vet Res Inst, Natl Foot & Mouth Dis Reference Lab, State Key Lab Vet Etiol Biol & OIE, Lanzhou, Gansu, Peoples R China.	shiqisun21@hotmail.com	Ibrahim, Essam Hassan/G-1960-2018	Ibrahim, Essam Hassan/0000-0003-0130-2257	National Science and Technology Support Program [2013BAD12B00]; International Science & Technology Cooperation Program of China [2014DFA31890]; Fundamental Research Funds for the Chinese Academy of Agricultural Sciences [2015ZL062]; "Twelfth Five-Year" National Science and technology program in rural areas [2011AA10A211]; Guangzhou Fitgene biotechnology Co. Ltd.	National Science and Technology Support Program; International Science & Technology Cooperation Program of China; Fundamental Research Funds for the Chinese Academy of Agricultural Sciences; "Twelfth Five-Year" National Science and technology program in rural areas; Guangzhou Fitgene biotechnology Co. Ltd.	This research was supported by grants from the National Science and Technology Support Program (2013BAD12B00), International Science & Technology Cooperation Program of China (2014DFA31890), the Fundamental Research Funds for the Chinese Academy of Agricultural Sciences (2015ZL062), and the "Twelfth Five-Year" National Science and technology program in rural areas (2011AA10A211). Guangzhou Fitgene biotechnology Co. Ltd. provided support in the form of salaries for author [XJL], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Aldabe R, 1997, J VIROL, V71, P6214, DOI 10.1128/JVI.71.8.6214-6217.1997; Balachandran Siddharth, 2007, V383, P277, DOI 10.1007/978-1-59745-335-6_18; Belov GA, 2007, J VIROL, V81, P558, DOI 10.1128/JVI.01820-06; Belsham GJ, 2000, J VIROL, V74, P272, DOI 10.1128/JVI.74.1.272-280.2000; Beske O, 2007, J CELL SCI, V120, P3207, DOI 10.1242/jcs.03483; Bieniasz PD, 2006, VIROLOGY, V344, P55, DOI 10.1016/j.virol.2005.09.044; BIENZ K, 1990, J VIROL, V64, P1156, DOI 10.1128/JVI.64.3.1156-1163.1990; Bishop N, 2001, J BIOL CHEM, V276, P11735, DOI 10.1074/jbc.M009863200; Bonnet MC, 2000, MOL CELL BIOL, V20, P4532, DOI 10.1128/MCB.20.13.4532-4542.2000; Braakman I, 2000, TRAFFIC, V1, P533, DOI 10.1034/j.1600-0854.2000.010702.x; Brock SC, 2003, P NATL ACAD SCI USA, V100, P15143, DOI 10.1073/pnas.2434327100; Bruce EA, 2010, J VIROL, V84, P5848, DOI 10.1128/JVI.00307-10; Campanella M, 2004, J BIOL CHEM, V279, P18440, DOI 10.1074/jbc.M309494200; Chambers R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010994; Chinsangaram J, 2001, J VIROL, V75, P5498, DOI 10.1128/JVI.75.12.5498-5503.2001; Choe SS, 2005, VIROLOGY, V337, P18, DOI 10.1016/j.virol.2005.03.036; de los Santos T, 2006, J VIROL, V80, P1906, DOI 10.1128/JVI.80.4.1906-1914.2006; de los Santos T, 2009, J VIROL, V83, P1800, DOI 10.1128/JVI.02112-08; Doedens JR, 1997, J VIROL, V71, P9054, DOI 10.1128/JVI.71.12.9054-9064.1997; Donnelly MLL, 2001, J GEN VIROL, V82, P1013, DOI 10.1099/0022-1317-82-5-1013; Egger D, 2005, J GEN VIROL, V86, P707, DOI 10.1099/vir.0.80442-0; Fan HY, 2012, J PROTEOME RES, V11, P995, DOI 10.1021/pr200755d; Garcia MA, 2006, MICROBIOL MOL BIOL R, V70, P1032, DOI 10.1128/MMBR.00027-06; Goh KC, 2000, EMBO J, V19, P4292, DOI 10.1093/emboj/19.16.4292; Greaves J, 2007, J CELL BIOL, V176, P249, DOI 10.1083/jcb.200610151; GRUBMAN MJ, 1985, J VIROL, V56, P120, DOI 10.1128/JVI.56.1.120-126.1985; Grubman MJ, 2004, CLIN MICROBIOL REV, V17, P465, DOI 10.1128/CMR.17.2.465-493.2004; Guo M, 2010, NAT REV MOL CELL BIO, V11, P668, DOI 10.1038/nrm2956; He B, 2006, CELL DEATH DIFFER, V13, P393, DOI 10.1038/sj.cdd.4401833; Hruby Dennis E., 1993, Trends in Microbiology, V1, P20, DOI 10.1016/0966-842X(93)90020-R; Jaiswal JK, 2003, J BIOSCIENCES, V28, P697, DOI 10.1007/BF02708430; Johns HL, 2009, J VIROL, V83, P6247, DOI 10.1128/JVI.02460-08; Johnson N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075394; Karjalainen M, 2011, CELL MICROBIOL, V13, P1975, DOI 10.1111/j.1462-5822.2011.01685.x; Kim S, 2011, NAT REV CANCER, V11, P708, DOI 10.1038/nrc3124; Laflamme C, 2012, J CELL BIOL, V198, P57, DOI 10.1083/jcb.201112114; Lin J, 2010, J CHILD NEUROL, V25, P1425, DOI 10.1177/0883073810370897; Lin JY, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-103; Lin JH, 2008, ANNU REV PATHOL-MECH, V3, P399, DOI 10.1146/annurev.pathmechdis.3.121806.151434; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; LUBROTH J, 1995, RES VET SCI, V59, P70, DOI 10.1016/0034-5288(95)90034-9; McDonald B, 2009, J CELL SCI, V122, P2167, DOI 10.1242/jcs.028308; Messmer M, 2011, BIOCHEM J, V433, P441, DOI 10.1042/BJ20101902; Moffat K, 2007, J VIROL, V81, P1129, DOI 10.1128/JVI.00393-06; Muller L, 2010, MOL BIOL CELL, V21, P691, DOI 10.1091/mbc.E09-08-0730; Nakamura T, 2010, CELL, V140, P338, DOI 10.1016/j.cell.2010.01.001; Nieva JL, 2003, FEBS LETT, V552, P68, DOI 10.1016/S0014-5793(03)00852-4; O'Donnell VK, 2001, VIROLOGY, V287, P151, DOI 10.1006/viro.2001.1035; Rowe RK, 2008, VIROLOGY, V382, P239, DOI 10.1016/j.virol.2008.09.021; RWEYEMAMU MM, 1978, J HYG-CAMBRIDGE, V81, P107, DOI 10.1017/S002217240005381X; Saksena S, 2009, CELL, V136, P97, DOI 10.1016/j.cell.2008.11.013; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Smith JA, 2006, J VIROL, V80, P2019, DOI 10.1128/JVI.80.4.2019-2033.2006; Suhy DA, 2000, J VIROL, V74, P8953, DOI 10.1128/JVI.74.19.8953-8965.2000; Utley TJ, 2008, P NATL ACAD SCI USA, V105, P10209, DOI 10.1073/pnas.0712144105; van Kuppeveld FJM, 2005, TRENDS MICROBIOL, V13, P41, DOI 10.1016/j.tim.2004.12.005; vanKuppeveld FJM, 1997, EMBO J, V16, P3519, DOI 10.1093/emboj/16.12.3519; Veit M, 2001, VIROLOGY, V288, P89, DOI 10.1006/viro.2001.1063; Wang D, 2011, J VIROL, V85, P3758, DOI 10.1128/JVI.02589-10; Westlake CJ, 2007, P NATL ACAD SCI USA, V104, P1236, DOI 10.1073/pnas.0610500104; Woese CR, 2000, MICROBIOL MOL BIOL R, V64, P202, DOI 10.1128/MMBR.64.1.202-236.2000; Wollert T, 2009, J CELL SCI, V122, P2163, DOI 10.1242/jcs.029884; Ye Y, 2013, J PROTEOME RES, V12, P363, DOI 10.1021/pr300611e; Yoshida H, 2007, FEBS J, V274, P630, DOI 10.1111/j.1742-4658.2007.05639.x; Yu CY, 2006, J VIROL, V80, P11868, DOI 10.1128/JVI.00879-06; Zamanian-Daryoush M, 2000, MOL CELL BIOL, V20, P1278, DOI 10.1128/MCB.20.4.1278-1290.2000; Zhang P, 2008, J BIOL CHEM, V283, P34580, DOI 10.1074/jbc.M807029200	67	9	12	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132384	10.1371/journal.pone.0132384	http://dx.doi.org/10.1371/journal.pone.0132384			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161868	Green Submitted, Green Published, gold			2022-12-26	WOS:000358162300127
J	Li, SS; Wang, JK; Zhang, LY				Li, Shanshan; Wang, Jiankang; Zhang, Luyan			Inclusive Composite Interval Mapping of QTL by Environment Interactions in Biparental Populations	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; STATISTICAL POWER; DIGENIC EPISTASIS; REGRESSION; BARLEY; COVARIABLES; GENOTYPE; MARKERS; MAIZE; IDENTIFICATION	Identification of environment-specific QTL and stable QTL having consistent genetic effects across a wide range of environments is of great importance in plant breeding. Inclusive Composite Interval Mapping (ICIM) has been proposed for additive, dominant and epistatic QTL mapping in biparental populations for single environment. In this study, ICIM was extended to QTL by environment interaction (QEI) mapping for multi-environmental trials, where the QTL average effect and QEI effects could be properly estimated. Stepwise regression was firstly applied in each environment to identify the most significant marker variables which were then used to adjust the phenotypic values. One-dimensional scanning was then conducted on the adjusted phenotypic values across the environments in order to detect QTL with either average effect or QEI effects, or both average effect and QEI effects. In this way, the genetic background could be well controlled while the conventional interval mapping was applied. An empirical method to determine the threshold of logarithm of odds was developed, and the efficiency of the ICIM QEI mapping was demonstrated in simulated populations under different genetic models. One actual recombinant inbred line population was used to compare mapping results between QEI mapping and single-environment analysis.	[Zhang, Luyan] Chinese Acad Agr Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Inst Crop Sci, Beijing 100193, Peoples R China; Chinese Acad Agr Sci, CIMMYT China Off, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Chinese Academy of Agricultural Sciences	Zhang, LY (corresponding author), Chinese Acad Agr Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Inst Crop Sci, Beijing 100193, Peoples R China.	zhangluyan@caas.cn			National Natural Science Foundation of China [31271798]; National 973 Research Program of China [2014CB138105]; HarvestPlus Challenge Program of CGIAR	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 973 Research Program of China; HarvestPlus Challenge Program of CGIAR(CGIAR)	This study was funded by the National Natural Science Foundation of China (project no. 31271798); the National 973 Research Program of China (project no. 2014CB138105), and the HarvestPlus Challenge Program of CGIAR.	Alves AA, 2012, EUPHYTICA, V183, P27, DOI 10.1007/s10681-011-0455-5; Boer MP, 2007, GENETICS, V177, P1801, DOI 10.1534/genetics.107.071068; Chen X, 2010, GENETICS, V186, P1053, DOI 10.1534/genetics.110.120311; CHURCHILL GA, 1994, GENETICS, V138, P963; Collard BCY, 2008, PHILOS T R SOC B, V363, P557, DOI 10.1098/rstb.2007.2170; Crossa J, 1999, THEOR APPL GENET, V99, P611, DOI 10.1007/s001220051276; Gauch HG, 2011, CROP SCI, V51, P96, DOI 10.2135/cropsci2010.04.0206; Hackett CA, 2001, GENET RES, V77, P95, DOI 10.1017/S0016672300004869; HALEY CS, 1992, HEREDITY, V69, P315, DOI 10.1038/hdy.1992.131; JANSEN RC, 1995, THEOR APPL GENET, V91, P33, DOI 10.1007/BF00220855; JIANG CJ, 1995, GENETICS, V140, P1111; Korol AB, 1998, GENETICS, V148, P2015; Li H, 2010, HEREDITY, V105, P257, DOI 10.1038/hdy.2010.56; Li HH, 2008, THEOR APPL GENET, V116, P243, DOI 10.1007/s00122-007-0663-5; Li HH, 2007, GENETICS, V175, P361, DOI 10.1534/genetics.106.066811; Li HH, 2012, CHINESE SCI BULL, V57, P2701, DOI 10.1007/s11434-012-5239-3; Li Q, 2012, PLOS ONE, V7; Li XM, 2014, EUPHYTICA, V198, P199, DOI 10.1007/s10681-014-1092-6; Malosetti M, 2004, EUPHYTICA, V137, P139, DOI 10.1023/B:EUPH.0000040511.46388.ef; Meng L, 2015, THE CROP JOURNAL IN; Meng X, 1993, BIOMETRIKA, V80, P67; Messmer R, 2009, THEOR APPL GENET, V119, P913, DOI 10.1007/s00122-009-1099-x; Njau PN, 2013, EUPHYTICA, V190, P33, DOI 10.1007/s10681-012-0763-4; Piepho HP, 2000, GENETICS, V156, P2043; Piepho HP, 2001, GENETICS, V157, P425; Pillen K, 2003, THEOR APPL GENET, V107, P340, DOI 10.1007/s00122-003-1253-9; [秦永生 QIN Yong-Sheng], 2009, [作物学报, Acta Agronomica Sinica], V35, P1812; Sun ZiQi, 2013, Acta Agronomica Sinica, V39, P1, DOI 10.3724/SP.J.1006.2013.00001; Tinker NA, 1995, J QUANTITATIVE TRAIT; van Eeuwijk F. A., 2002, P245, DOI 10.1079/9780851996011.0245; Vargas M, 2006, THEOR APPL GENET, V112, P1009, DOI 10.1007/s00122-005-0204-z; Wang DL, 1999, THEOR APPL GENET, V99, P1255, DOI 10.1007/s001220051331; Wang J K, 2014, GENE MAPPING BREEDIN, P128; Wang JianKang, 2009, Acta Agronomica Sinica, V35, P239, DOI 10.3724/SP.J.1006.2009.00239; Whittaker JC, 1996, HEREDITY, V77, P23, DOI 10.1038/hdy.1996.104; Wu W, 1998, J BIOMATHEMATICS, V13, P592; Yuste-Lisbona FJ, 2011, MOL BREEDING, V27, P181, DOI 10.1007/s11032-010-9421-5; ZENG ZB, 1994, GENETICS, V136, P1457; Zhang LY, 2008, GENETICS, V180, P1177, DOI 10.1534/genetics.108.092122; Zhang LY, 2012, J INTEGR PLANT BIOL, V54, P270, DOI 10.1111/j.1744-7909.2012.01110.x; Zhao FP, 2012, G3-GENES GENOM GENET, V2, P779, DOI 10.1534/g3.112.002980	41	63	66	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132414	10.1371/journal.pone.0132414	http://dx.doi.org/10.1371/journal.pone.0132414			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161656	gold, Green Published, Green Submitted			2022-12-26	WOS:000358162300131
J	Xin, W; Xiao, XS; Li, SQ; Jia, XY; Guo, XM; Zhang, QJ				Xin, Wei; Xiao, Xueshan; Li, Shiqiang; Jia, Xiaoyun; Guo, Xiangming; Zhang, Qingjiong			Identification of Genetic Defects in 33 Probands with Stargardt Disease by WES-Based Bioinformatics Gene Panel Analysis	PLOS ONE			English	Article							MACULAR DYSTROPHY; ABCA4 MUTATIONS; DEGENERATION; ELOVL4; POPULATION; FAMILIES; SPECTRUM; COHORT; MYOPIA; PRPH2	Stargardt disease (STGD) is the most common hereditary macular degeneration in juveniles, with loss of central vision occurring in the first or second decade of life. The aim of this study is to identify the genetic defects in 33 probands with Stargardt disease. Clinical data and genomic DNA were collected from 33 probands from unrelated families with STGD. Variants in coding genes were initially screened by whole exome sequencing. Candidate variants were selected from all known genes associated with hereditary retinal dystrophy and then confirmed by Sanger sequencing. Putative pathogenic variants were further validated in available family members and controls. Potential pathogenic mutations were identified in 19 of the 33 probands (57.6%). These mutations were all present in ABCA4, but not in the other four STGD-associated genes or in genes responsible for other retinal dystrophies. Of the 19 probands, ABCA4 mutations were homozygous in one proband and compound heterozygous in 18 probands, involving 28 variants (13 novel and 15 known). Analysis of normal controls and available family members in 12 of the 19 families further support the pathogenicity of these variants. Clinical manifestation of all probands met the diagnostic criteria of STGD. This study provides an overview of a genetic basis for STGD in Chinese patients. Mutations in ABCA4 are the most common cause of STGD in this cohort. Genetic defects in approximately 42.4% of STGD patients await identification in future studies.	[Xin, Wei; Xiao, Xueshan; Li, Shiqiang; Jia, Xiaoyun; Guo, Xiangming; Zhang, Qingjiong] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Zhang, QJ (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China.	zhangqji@mail.sysu.edu.cn	Zhang, Qingjiong/AAR-6331-2021	Zhang, Qingjiong/0000-0001-7508-848X	National Natural Science Foundation of China [U1201221]; Natural Science Foundation of Guangdong [S2013030012978]; Guangdong Department of Science and Technology Translational Medicine Center [2011A080300002]; Fundamental Research Funds of State Key Laboratory of Ophthalmology	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong(National Natural Science Foundation of Guangdong Province); Guangdong Department of Science and Technology Translational Medicine Center; Fundamental Research Funds of State Key Laboratory of Ophthalmology	This study was supported by the National Natural Science Foundation of China (U1201221), Natural Science Foundation of Guangdong (S2013030012978), Guangdong Department of Science and Technology Translational Medicine Center (2011A080300002), and the Fundamental Research Funds of State Key Laboratory of Ophthalmology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allikmets R, 1997, SCIENCE, V277, P1805, DOI 10.1126/science.277.5333.1805; Burke TR, 2011, OPHTHALMIC GENET, V32, P165, DOI 10.3109/13816810.2011.565397; Chacon-Camacho OF, 2013, EXP EYE RES, V109, P77, DOI 10.1016/j.exer.2013.02.006; Coco RM, 2010, EUR J OPHTHALMOL, V20, P724, DOI 10.1177/112067211002000413; FISHMAN GA, 1987, OPHTHALMOLOGY, V94, P809, DOI 10.1016/s0161-6420(87)33533-x; Fujinami K, 2013, INVEST OPHTH VIS SCI, V54, P6662, DOI 10.1167/iovs.13-12570; Hargitai J, 2005, INVEST OPHTH VIS SCI, V46, P4402, DOI 10.1167/iovs.05-0504; Jiang D, 2015, INVEST OPHTH VIS SCI, V56, P339, DOI 10.1167/iovs.14-14850; Kniazeva M, 1999, AM J HUM GENET, V64, P1394, DOI 10.1086/302377; Koenekoop Robert K, 2003, Ophthalmic Genet, V24, P75, DOI 10.1076/opge.24.2.75.13996; Logan S, 2014, ADV EXP MED BIOL, V801, P447, DOI 10.1007/978-1-4614-3209-8_57; Maia-Lopes S, 2009, MOL VIS, V15, P584; Oldani M, 2012, GENET MOL RES, V11, P4342, DOI 10.4238/2012.October.9.3; Pang CP, 2002, HUM MUTAT, V19, P189, DOI 10.1002/humu.10053; Petrukhin K, 1998, NAT GENET, V19, P241, DOI 10.1038/915; Poloschek CM, 2010, INVEST OPHTH VIS SCI, V51, P4253, DOI 10.1167/iovs.09-4655; Riveiro-Alvarez R, 2013, OPHTHALMOLOGY, V120, P2332, DOI 10.1016/j.ophtha.2013.04.002; September AV, 2004, INVEST OPHTH VIS SCI, V45, P1705, DOI 10.1167/iovs.03-1167; Strom SP, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-67; Thiadens AAHJ, 2012, OPHTHALMOLOGY, V119, P819, DOI 10.1016/j.ophtha.2011.10.011; Utz VM, 2013, AM J OPHTHALMOL, V156, P1220, DOI 10.1016/j.ajo.2013.07.008; Valverde D, 2006, MOL VIS, V12, P902; Vasireddy V, 2010, PROG RETIN EYE RES, V29, P191, DOI 10.1016/j.preteyeres.2010.01.001; Walia S, 2009, OPHTHALMIC GENET, V30, P63, DOI 10.1080/13816810802695550; Wang Q, 2010, MOL VIS, V16, P303; Yang ZL, 2008, J CLIN INVEST, V118, P2908, DOI 10.1172/JCI35891; Yi JH, 2012, MOL MED REP, V6, P1045, DOI 10.3892/mmr.2012.1063; Zaneveld J, 2015, GENET MED, V17, P262, DOI 10.1038/gim.2014.174; Zhang K, 2001, NAT GENET, V27, P89, DOI 10.1038/83817; Zhang X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095528	30	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132635	10.1371/journal.pone.0132635	http://dx.doi.org/10.1371/journal.pone.0132635			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161775	Green Submitted, Green Published, gold			2022-12-26	WOS:000358162300162
J	Hopfner, S; Kesselring, S; Cazzoli, D; Gutbrod, K; Laube-Rosenpflanzer, A; Chechlacz, M; Nef, T; Mosimann, U; Bohlhalter, S; Muri, RM; Nyffeler, T				Hopfner, Simone; Kesselring, Sonja; Cazzoli, Dario; Gutbrod, Klemens; Laube-Rosenpflanzer, Annett; Chechlacz, Magdalena; Nef, Tobias; Mosimann, Urs; Bohlhalter, Stephan; Muri, Rene M.; Nyffeler, Thomas			Neglect and Motion Stimuli - Insights from a Touchscreen-Based Cancellation Task	PLOS ONE			English	Article							UNILATERAL SPATIAL NEGLECT; RIGHT-HEMISPHERE STROKE; VISUAL-FIELD DEFICITS; SUPERIOR COLLICULUS; LINE BISECTION; VISUOSPATIAL NEGLECT; BRAIN NETWORKS; ANATOMY; TRACTOGRAPHY; HEMIANOPIA	Background and Purpose In stroke patients, neglect diagnostic is often performed by means of paper-pencil cancellation tasks. These tasks entail static stimuli, and provide no information concerning possible changes in the severity of neglect symptoms when patients are confronted with motion. We therefore aimed to directly contrast the cancellation behaviour of neglect patients under static and dynamic conditions. Since visual field deficits often occur in neglect patients, we analysed whether the integrity of the optic radiation would influence cancellation behaviour. Methods Twenty-five patients with left spatial neglect after right-hemispheric stroke were tested with a touchscreen cancellation task, once when the evenly distributed targets were stationary, and once when the identic targets moved with constant speed on a random path. The integrity of the right optic radiation was analysed by means of a hodologic probabilistic approach. Results Motion influenced the cancellation behaviour of neglect patients, and the direction of this influence (i.e., an increase or decrease of neglect severity) was modulated by the integrity of the right optic radiation. In patients with an intact optic radiation, the severity of neglect significantly decreased in the dynamic condition. Conversely, in patients with damage to the optic radiation, the severity of neglect significantly increased in the dynamic condition. Conclusion Motion may influence neglect in stroke patients. The integrity of the optic radiation may be a predictor of whether motion increases or decreases the severity of neglect symptoms.	[Hopfner, Simone; Kesselring, Sonja; Bohlhalter, Stephan; Muri, Rene M.; Nyffeler, Thomas] Univ Hosp Bern, Percept & Eye Movement Lab, Dept Neurol & Clin Res, Inselspital, CH-3010 Bern, Switzerland; [Hopfner, Simone; Kesselring, Sonja; Gutbrod, Klemens; Bohlhalter, Stephan; Muri, Rene M.; Nyffeler, Thomas] Univ Bern, Bern, Switzerland; [Cazzoli, Dario; Nef, Tobias; Mosimann, Urs; Muri, Rene M.; Nyffeler, Thomas] Univ Bern, Gerontechnol & Rehabil Grp, Bern, Switzerland; [Cazzoli, Dario] Univ Oxford, Nuffield Dept Clin Neurosci, Oxford, England; [Gutbrod, Klemens; Muri, Rene M.] Univ Hosp Bern, Div Cognit & Restorat Neurol, Dept Neurol, Inselspital, CH-3010 Bern, Switzerland; [Laube-Rosenpflanzer, Annett] Bern Univ Appl Sci, Inst ICT Based Management, Div Comp Sci, Biel, Switzerland; [Chechlacz, Magdalena] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England; [Nef, Tobias] Univ Bern, ARTORG Ctr Biomed Engn Res, Bern, Switzerland; [Mosimann, Urs] Univ Bern, Univ Hosp Old Age Psychiat & Psychotherapy, Bern, Switzerland; [Bohlhalter, Stephan; Nyffeler, Thomas] Luzerner Kantonsspital, Ctr Neurol & Neurorehabilitat, Luzern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University of Bern; University of Oxford; University of Bern; University Hospital of Bern; University of Oxford; University of Bern; University of Bern; University Hospital of Bern; Lucerne Cantonal Hospital	Nyffeler, T (corresponding author), Univ Hosp Bern, Percept & Eye Movement Lab, Dept Neurol & Clin Res, Inselspital, CH-3010 Bern, Switzerland.	thomas.nyffeler@luks.ch	Chechlacz, Magdalena/ABB-6360-2021; Muri, Rene/E-9320-2012	Chechlacz, Magdalena/0000-0003-1811-3946; Nyffeler, Thomas/0000-0003-2504-8935; Nef, Tobias/0000-0002-8069-9450; Bohlhalter, Stephan/0000-0002-0723-8164; Muri, Rene/0000-0001-6990-4188; Cazzoli, Dario/0000-0001-7217-7153; Gutbrod, Klemens/0000-0002-5723-3468	Swiss National Science Foundation [320030_140696]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was funded by the Swiss National Science Foundation (http://www.snf.ch); Grant Nb: No. 320030_140696. Prof. Thomas Nyffeler received the funding.	Azouvi P, 2002, J NEUROL NEUROSUR PS, V73, P160, DOI 10.1136/jnnp.73.2.160; Bird CM, 2006, J NEUROL NEUROSUR PS, V77, P1008, DOI 10.1136/jnnp.2006.094417; BUTTER CM, 1990, RESTOR NEUROL NEUROS, V2, P39, DOI 10.3233/RNN-1990-2105; Butter CM, 1995, J CLIN EXP NEUROPSYC, V17, P856, DOI 10.1080/01688639508402435; BUTTER CM, 1988, J NEUROL NEUROSUR PS, V51, P1581, DOI 10.1136/jnnp.51.12.1581; Cassidy TP, 1999, AGE AGEING, V28, P257, DOI 10.1093/ageing/28.3.257; CYNADER M, 1972, J NEUROPHYSIOL, V35, P187, DOI 10.1152/jn.1972.35.2.187; Doricchi F, 2008, CORTEX, V44, P983, DOI 10.1016/j.cortex.2008.03.006; Ferber S, 2001, J CLIN EXP NEUROPSYC, V23, P599, DOI 10.1076/jcen.23.5.599.1243; GAUTHIER L, 1989, INT J CLIN NEUROPSYC, V11, P49; HALLIGAN PW, 1990, J NEUROL NEUROSUR PS, V53, P487, DOI 10.1136/jnnp.53.6.487; Halligan PW, 1999, J NEUROL NEUROSUR PS, V67, P565, DOI 10.1136/jnnp.67.5.565; Heilman K, 2003, CLIN NEUROPSYCHOLOGY, P296, DOI DOI 10.1016/J.NEUR0PSYCHOLOGIA.2011.09.030; Heilman KM, 2002, COGNITIVE NEURAL BAS, P416; Karnath HO, 2012, NEUROPSYCHOLOGIA, V50, P1010, DOI 10.1016/j.neuropsychologia.2011.06.027; Karnath HO, 2002, BRAIN, V125, P350, DOI 10.1093/brain/awf032; Karnath HO, 2004, CEREB CORTEX, V14, P1164, DOI 10.1093/cercor/bhh076; Kerkhoff G, 1997, FORTSCHR NEUROL PSYC, V65, P278, DOI 10.1055/s-2007-996332; Krauzlis RJ, 2013, ANNU REV NEUROSCI, V36, P165, DOI 10.1146/annurev-neuro-062012-170249; Lovejoy LP, 2010, NAT NEUROSCI, V13, P261, DOI 10.1038/nn.2470; MATTINGLEY JB, 1994, J NEUROL NEUROSUR PS, V57, P1228, DOI 10.1136/jnnp.57.10.1228; MATTINGLEY JB, 1993, NEUROPSYCHOLOGIA, V31, P1201, DOI 10.1016/0028-3932(93)90068-B; Muller-Oehring EM, 2003, J CLIN EXP NEUROPSYC, V25, P1154, DOI 10.1076/jcen.25.8.1154.16727; Plummer P, 2006, BRAIN COGNITION, V60, P156, DOI 10.1016/j.bandc.2005.11.001; RIDDOCH MJ, 1983, NEUROPSYCHOLOGIA, V21, P589, DOI 10.1016/0028-3932(83)90056-8; Rorden C, 2000, BEHAV NEUROL, V12, P191, DOI 10.1155/2000/421719; Rorden C, 2007, J COGNITIVE NEUROSCI, V19, P1081, DOI 10.1162/jocn.2007.19.7.1081; SCHILLER PH, 1971, J NEUROPHYSIOL, V34, P920, DOI 10.1152/jn.1971.34.5.920; Thiebaut de Schotten M, 2014, CEREB CORTEX, V24, P691, DOI 10.1093/cercor/bhs351; Thiebaut de Schotten M, 2011, NEUROIMAGE, V54, P49, DOI 10.1016/j.neuroimage.2010.07.055; Urbanski M, 2008, J NEUROL NEUROSUR PS, V79, P598, DOI 10.1136/jnnp.2007.126276; VALLAR G, 1986, NEUROPSYCHOLOGIA, V24, P609, DOI 10.1016/0028-3932(86)90001-1; Vuilleumier P, 2007, BEHAVIORAL AND COGNITIVE NEUROLOGY OF STROKE, P148, DOI 10.1017/CBO9780511544880.010; Wilson B. A., 1987, BEHAV INATTENTION TE; Wolfe JM, 2004, NAT REV NEUROSCI, V5, P495, DOI 10.1038/nrn1411	35	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2015	10	7							e0132025	10.1371/journal.pone.0132025	http://dx.doi.org/10.1371/journal.pone.0132025			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EW	26158619	Green Published, gold			2022-12-26	WOS:000358161200045
J	Kim, MH; Ahn, JY; Song, JE; Choi, H; Ann, HW; Kim, JK; Kim, JH; Jeon, YD; Kim, SB; Jeong, SJ; Ku, NS; Han, SH; Song, YG; Choi, JY; Kim, YS; Kim, JM				Kim, Min Hyung; Ahn, Jin Young; Song, Je Eun; Choi, Heun; Ann, Hea Won; Kim, Jae Kyoung; Kim, Jung Ho; Jeon, Yong Duk; Kim, Sun Bean; Jeong, Su Jin; Ku, Nam Su; Han, Sang Hoon; Song, Young Goo; Choi, Jun Young; Kim, Young Sam; Kim, June Myung			The C-Reactive Protein/Albumin Ratio as an Independent Predictor of Mortality in Patients with Severe Sepsis or Septic Shock Treated with Early Goal-Directed Therapy	PLOS ONE			English	Article							SURVIVING SEPSIS; INTENSIVE-CARE; BLOOD LACTATE; PROTEIN; MARKER; INFECTION; DISCHARGE; CAMPAIGN	Background Sepsis, including severe sepsis and septic shock, is a major cause of morbidity and mortality. Albumin and C-reactive protein (CRP) are considered as good diagnostic markers for sepsis. Thus, initial CRP and albumin levels were combined to ascertain their value as an independent predictor of 180-day mortality in patients with severe sepsis and septic shock. Materials and Methods We conducted a retrospective cohort study involving 670 patients (>18 years old) who were admitted to the emergency department and who had received a standardized resuscitation algorithm (early goal-directed therapy) for severe sepsis and septic shock, from November 2007 to February 2013, at a tertiary hospital in Seoul, Korea. The outcome measured was 180-day all-cause mortality. A multivariate Cox proportional hazard model was used to identify the independent risk factors for mortality. A receiver operating characteristic (ROC) curve analysis was conducted to compare the predictive accuracy of the CRP/albumin ratio at admission. Results The 180-day mortality was 28.35% (190/670). Based on the multivariate Cox proportional hazard analysis, age, the CRP/albumin ratio at admission (adjusted HR 1.06, 95% CI 1.031-10, p<0.001), lactate level at admission (adjusted HR 1.10, 95% CI 1.05-1.14, p<0.001), and the Sequential Organ Failure Assessment (SOFA) score at admission (adjusted HR 1.12, 95% CI 1.07-1.18, p<0.001) were independent predictors of 180-day mortality. The area under the curve of CRP alone and the CRP/albumin ratio at admission for 180-day mortality were 0.5620 ( P<0.001) and 0.6211 (P<0.001), respectively. Conclusion The CRP/albumin ratio was an independent predictor of mortality in patients with severe sepsis or septic shock.	[Kim, Min Hyung] Bundang Jesaeng Hosp, Seongam, Gyeonggi, South Korea; [Ahn, Jin Young; Song, Je Eun; Choi, Heun; Ann, Hea Won; Kim, Jae Kyoung; Kim, Jung Ho; Jeon, Yong Duk; Kim, Sun Bean; Jeong, Su Jin; Ku, Nam Su; Han, Sang Hoon; Song, Young Goo; Choi, Jun Young; Kim, Young Sam; Kim, June Myung] Yonsei Univ, Dept Internal Med, Coll Med, Seoul 120749, South Korea; [Ahn, Jin Young; Song, Je Eun; Choi, Heun; Ann, Hea Won; Kim, Jae Kyoung; Kim, Jung Ho; Jeon, Yong Duk; Kim, Sun Bean; Jeong, Su Jin; Ku, Nam Su; Han, Sang Hoon; Song, Young Goo; Choi, Jun Young; Kim, June Myung] Yonsei Univ, AIDS Res Inst, Coll Med, Seoul 120749, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Ku, NS (corresponding author), Yonsei Univ, Dept Internal Med, Coll Med, Seoul 120749, South Korea.	smileboy9@yuhs.ac	Song, Young Goo/AGV-5104-2022	Song, Young Goo/0000-0002-0733-4156; Choi, Jun Yong/0000-0002-2775-3315; Kim, Young Sam/0000-0001-9656-8482; Kim, Jung Ho/0000-0002-5033-3482; Choi, Heun/0000-0002-9622-9381; Ahn, Jin Young/0000-0002-3740-2826; Ku, Nam Su/0000-0002-9717-4327; Han, Sang Hoon/0000-0002-4278-5198; Jeong, Su Jin/0000-0003-4025-4542				Al-Subaie N, 2010, BRIT J ANAESTH, V105, P318, DOI 10.1093/bja/aeq171; ALTMAN DG, 1994, BRIT MED J, V308, P1552, DOI 10.1136/bmj.308.6943.1552; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Artero A, 2010, J CRIT CARE, V25, P276, DOI 10.1016/j.jcrc.2009.12.004; Barbosa-Silva MCG, 2008, CURR OPIN CLIN NUTR, V11, P248, DOI 10.1097/MCO.0b013e3282fba5d7; Chen YX, 2009, AM J EMERG MED, V27, P701, DOI 10.1016/j.ajem.2009.02.001; Dellinger RP, 2013, INTENS CARE MED, V39, P165, DOI [10.1007/s00134-012-2769-8, 10.1097/CCM.0b013e31827e83af]; Dellinger RP, 2004, CRIT CARE MED, V32, P858, DOI 10.1097/01.CCM.0000117317.18092.E4; Gradel KO, 2011, CLIN MICROBIOL INFEC, V17, P627, DOI 10.1111/j.1469-0691.2010.03284.x; Ho KM, 2008, INTENS CARE MED, V34, P481, DOI 10.1007/s00134-007-0928-0; Hofhuis JGM, 2008, ANESTH ANALG, V107, P1957, DOI 10.1213/ane.0b013e318187bbd8; Juvela S, 2012, ACTA NEUROCHIR, V154, P397, DOI 10.1007/s00701-011-1243-7; Kaplan V, 2002, CRIT CARE MED, V30, P703, DOI 10.1097/00003246-200203000-00037; Kumar G, 2011, CHEST, V140, P1223, DOI 10.1378/chest.11-0352; Levy MM, 2010, INTENS CARE MED, V36, P222, DOI 10.1007/s00134-009-1738-3; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; McMillan DC, 2001, NUTR CANCER, V39, P210, DOI 10.1207/S15327914nc392_8; Mtove G, 2011, CLIN INFECT DIS, V53, P548, DOI 10.1093/cid/cir471; Osborn TM, 2005, ANN EMERG MED, V46, P228, DOI 10.1016/j.annemergmed.2005.04.007; PARKER MM, 1987, CRIT CARE MED, V15, P923, DOI 10.1097/00003246-198710000-00006; Povoa P, 2011, CRIT CARE, V15, DOI 10.1186/cc10313; Qian Su-yun, 2012, Zhonghua Er Ke Za Zhi, V50, P184; Ranzani OT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059321; Rodelo JR, 2012, AM J EMERG MED, V30, P1991, DOI 10.1016/j.ajem.2012.04.033; Routsi C, 2007, INFECTION, V35, P240, DOI 10.1007/s15010-007-6217-6; Schmidt H, 2008, CRIT CARE MED, V36, P967, DOI 10.1097/CCM.0B013E3181653263; Thiem U, 2009, AGE AGEING, V38, P693, DOI 10.1093/ageing/afp164; VIGUSHIN DM, 1993, J CLIN INVEST, V91, P1351, DOI 10.1172/JCI116336; Villacorta H, 2007, ARQ BRAS CARDIOL, V88, P585, DOI 10.1590/S0066-782X2007000500014; Vincent JL, 2009, JAMA-J AM MED ASSOC, V302, P2323, DOI 10.1001/jama.2009.1754; Vladimirova SG, 2013, TERAPEVT ARKH, V85, P34; Wacharasint P, 2012, SHOCK, V38, P4, DOI 10.1097/SHK.0b013e318254d41a; Xie QH, 2011, BMC NEPHROL, V12, DOI 10.1186/1471-2369-12-30	33	100	109	4	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2015	10	7							e0132109	10.1371/journal.pone.0132109	http://dx.doi.org/10.1371/journal.pone.0132109			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EW	26158725	Green Submitted, Green Published, gold			2022-12-26	WOS:000358161200047
J	Vetter, SG; Ruf, T; Bieber, C; Arnold, W				Vetter, Sebastian G.; Ruf, Thomas; Bieber, Claudia; Arnold, Walter			What Is a Mild Winter? Regional Differences in Within-Species Responses to Climate Change	PLOS ONE			English	Article							BOAR SUS-SCROFA; WILD BOAR; BODY-SIZE; POPULATION-DENSITY; RED DEER; PULSED RESOURCES; BERGMANNS RULE; LITTER SIZE; TEMPERATURE; EVOLUTION	Climate change is known to affect ecosystems globally, but our knowledge of its impact on large and widespread mammals, and possibly population-specific responses is still sparse. We investigated large-scale and long-term effects of climate change on local population dynamics using the wild boar (Sus scrofa L.) as a model species. Our results show that population increases across Europe are strongly associated with increasingly mild winters, yet with region-specific threshold temperatures for the onset of exponential growth. Additionally, we found that abundant availability of critical food resources, e.g. beech nuts, can outweigh the negative effects of cold winters on population growth of wild boar. Availability of beech nuts is highly variable and highest in years of beech mast which increased in frequency since 1980, according to our data. We conclude that climate change drives population growth of wild boar directly by relaxing the negative effect of cold winters on survival and reproduction, and indirectly by increasing food availability. However, region-specific responses need to be considered in order to fully understand a species' demographic response to climate change.	[Vetter, Sebastian G.; Ruf, Thomas; Bieber, Claudia; Arnold, Walter] Univ Vet Med, Res Inst Wildlife Ecol, Dept Integrat Biol & Evolut, Vienna, Austria	University of Veterinary Medicine Vienna	Vetter, SG (corresponding author), Univ Vet Med, Res Inst Wildlife Ecol, Dept Integrat Biol & Evolut, Savoyenstr 1, Vienna, Austria.	sebastian.vetter@vetmeduni.ac.at	Arnold, Walter/C-3394-2013	Arnold, Walter/0000-0001-6785-5685; Vetter, Sebastian G./0000-0001-5374-5872; Bieber, Claudia/0000-0001-8919-3117; Ruf, Thomas/0000-0002-9235-7079	Austrian Research Promotion Agency (FFG) [829644]; governments of Lower Austria and Vienna	Austrian Research Promotion Agency (FFG); governments of Lower Austria and Vienna	This work was supported by the Austrian Research Promotion Agency (FFG, Grant #829644, https://www.ffg.at/en-CB) and the governments of Lower Austria and Vienna. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen R, 2000, J ANIM ECOL, V69, P672, DOI 10.1046/j.1365-2656.2000.00425.x; Ballari SA, 2014, MAMMAL REV, V44, P124, DOI 10.1111/mam.12015; Barton K, 2013, MUMIN MULTIMODEL INF; Bergmann C. G. L. C., 1848, UEBER VERHALTNISSE W; Bieber C, 2005, J APPL ECOL, V42, P1203, DOI 10.1111/j.1365-2664.2005.01094.x; BLAND JM, 1994, BRIT MED J, V308, P1499, DOI 10.1136/bmj.308.6942.1499; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Briedermann L, 2009, SCHWARZWILD; BRUINDERINK GWTAG, 1994, J ZOOL, V233, P631; Bruinderink GWTAG, 1996, CONSERV BIOL, V10, P1059, DOI 10.1046/j.1523-1739.1996.10041059.x; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Bywater KA, 2010, MAMMAL REV, V40, P212, DOI 10.1111/j.1365-2907.2010.00160.x; Choquenot D, 1998, J ANIM ECOL, V67, P887, DOI 10.1046/j.1365-2656.1998.6760887.x; CLUTTONBROCK TH, 1992, J ANIM ECOL, V61, P381, DOI 10.2307/5330; Coulson T, 2003, EVOLUTION, V57, P2879, DOI 10.1111/j.0014-3820.2003.tb01528.x; DAVIS SJM, 1981, PALEOBIOLOGY, V7, P101, DOI 10.1017/S0094837300003821; Fernandez-Llario P, 1998, ACTA THERIOL, V43, P439, DOI 10.4098/AT.arch.98-54; Focardi S, 2008, J MAMMAL, V89, P1113, DOI 10.1644/07-MAMM-A-164.1; Forchhammer MC, 2001, J ANIM ECOL, V70, P721, DOI 10.1046/j.0021-8790.2001.00532.x; Forchhammer MC, 1998, P ROY SOC B-BIOL SCI, V265, P341, DOI 10.1098/rspb.1998.0301; Gaillard JM, 2013, ECOL LETT, V16, P48, DOI 10.1111/ele.12059; GAILLARD JM, 1993, FOLIA ZOOL, V42, P204; Gamelon M, 2011, EVOLUTION, V65, P3100, DOI 10.1111/j.1558-5646.2011.01366.x; Geisser H, 2005, J ZOOL, V267, P89, DOI 10.1017/S095283690500734X; Genuer R, 2010, PATTERN RECOGN LETT, V31, P2225, DOI 10.1016/j.patrec.2010.03.014; Gethoffer F, 2005, THESIS; Grenfell BT, 1998, NATURE, V394, P674, DOI 10.1038/29291; Grueber CE, 2011, J EVOLUTION BIOL, V24, P699, DOI 10.1111/j.1420-9101.2010.02210.x; Guthrie RD, 2003, NATURE, V426, P169, DOI 10.1038/nature02098; Husby A, 2011, AM NAT, V178, P202, DOI 10.1086/660834; Jedrzejewska B, 1997, ACTA THERIOL, V42, P399; JEDRZEJEWSKI W, 1992, OECOLOGIA, V90, P27, DOI 10.1007/BF00317805; Jensen LF, 2008, P ROY SOC B-BIOL SCI, V275, P2859, DOI 10.1098/rspb.2008.0870; KENDEIGH SC, 1974, COMP BIOCHEM PHYSIOL, V48, P175; Koskinen MT, 2002, NATURE, V419, P826, DOI 10.1038/nature01029; Luterbacher J, 2004, SCIENCE, V303, P1499, DOI 10.1126/science.1093877; Massei Giovanna, 2004, Galemys, V16, P135; Massei G, 2015, PEST MANAG SCI, V71, P492, DOI 10.1002/ps.3965; Melis C, 2006, J BIOGEOGR, V33, P803, DOI 10.1111/j.1365-2699.2006.01434.x; Milner JM, 1999, J ANIM ECOL, V68, P1235, DOI 10.1046/j.1365-2656.1999.00366.x; Morellet N, 2013, J ANIM ECOL, V82, P1326, DOI 10.1111/1365-2656.12105; Nakagawa S, 2011, BEHAV ECOL SOCIOBIOL, V65, P103, DOI 10.1007/s00265-010-1044-7; Ostfeld RS, 2000, TRENDS ECOL EVOL, V15, P232, DOI 10.1016/S0169-5347(00)01862-0; Overgaard R, 2007, FORESTRY, V80, P553, DOI 10.1093/forestry/cpm020; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Patterson BR, 2002, OECOLOGIA, V130, P62, DOI 10.1007/s004420100783; Pebesma EJ, 2004, COMPUT GEOSCI-UK, V30, P683, DOI 10.1016/j.cageo.2004.03.012; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Pettorelli N, 2005, P ROY SOC B-BIOL SCI, V272, P2357, DOI 10.1098/rspb.2005.3218; R Core Team, 2021, R LANGUAGE ENV STAT; SAEZROYUELA C, 1986, MAMMAL REV, V16, P97; Scandura M, 2008, MOL ECOL, V17, P1745, DOI 10.1111/j.1365-294X.2008.03703.x; Scandura M, 2011, MAMMAL REV, V41, P125, DOI 10.1111/j.1365-2907.2010.00182.x; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Schley L, 2003, MAMMAL REV, V33, P43, DOI 10.1046/j.1365-2907.2003.00010.x; Servanty S, 2011, J APPL ECOL, V48, P835, DOI 10.1111/j.1365-2664.2011.02017.x; Servanty S, 2009, J ANIM ECOL, V78, P1278, DOI 10.1111/j.1365-2656.2009.01579.x; Sheridan JA, 2011, NAT CLIM CHANGE, V1, P401, DOI 10.1038/NCLIMATE1259; SMITH FA, 1995, SCIENCE, V270, P2012, DOI 10.1126/science.270.5244.2012; Speakman John R, 2010, Integr Comp Biol, V50, P793, DOI 10.1093/icb/icq049; Staudinger MD, 2013, FRONT ECOL ENVIRON, V11, P465, DOI 10.1890/120272; Tafani M, 2013, ECOLOGY, V94, P580, DOI 10.1890/12-0833.1; Teplitsky C, 2008, P NATL ACAD SCI USA, V105, P13492, DOI 10.1073/pnas.0800999105; Toigo C, 2008, J WILDLIFE MANAGE, V72, P1532, DOI 10.2193/2007-378; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a	65	83	84	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2015	10	7							e0132178	10.1371/journal.pone.0132178	http://dx.doi.org/10.1371/journal.pone.0132178			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EW	26158846	Green Submitted, gold, Green Published			2022-12-26	WOS:000358161200048
J	Yu, W; Zeng, L				Yu, Wei; Zeng, Li			l(0) Gradient Minimization Based Image Reconstruction for Limited-Angle Computed Tomography	PLOS ONE			English	Article							TOMOSYNTHESIS; INVERSION	In medical and industrial applications of computed tomography (CT) imaging, limited by the scanning environment and the risk of excessive X-ray radiation exposure imposed to the patients, reconstructing high quality CT images from limited projection data has become a hot topic. X-ray imaging in limited scanning angular range is an effective imaging modality to reduce the radiation dose to the patients. As the projection data available in this modality are incomplete, limited-angle CT image reconstruction is actually an ill-posed inverse problem. To solve the problem, image reconstructed by conventional filtered back projection (FBP) algorithm frequently results in conspicuous streak artifacts and gradual changed artifacts nearby edges. Image reconstruction based on total variation minimization (TVM) can significantly reduce streak artifacts in few-view CT, but it suffers from the gradual changed artifacts nearby edges in limited-angle CT. To suppress this kind of artifacts, we develop an image reconstruction algorithm based on l(0) gradient minimization for limited-angle CT in this paper. The l(0)-norm of the image gradient is taken as the regularization function in the framework of developed reconstruction model. We transformed the optimization problem into a few optimization sub-problems and then, solved these sub-problems in the manner of alternating iteration. Numerical experiments are performed to validate the efficiency and the feasibility of the developed algorithm. From the statistical analysis results of the performance evaluations peak signal-to-noise ratio (PSNR) and normalized root mean square distance (NRMSD), it shows that there are significant statistical differences between different algorithms from different scanning angular ranges (p<0.0001). From the experimental results, it also indicates that the developed algorithm outperforms classical reconstruction algorithms in suppressing the streak artifacts and the gradual changed artifacts nearby edges simultaneously.	[Yu, Wei] Hubei Univ Sci & Technol, Sch Biomed Engn, Xianning, Peoples R China; [Zeng, Li] Chongqing Univ, Coll Math & Stat, Chongqing 630044, Peoples R China; [Yu, Wei; Zeng, Li] Chongqing Univ, Engn Res Ctr Ind Computed Tomog Nondestruct Testi, Educ Minist China, Chongqing 630044, Peoples R China	Hubei University of Science & Technology; Chongqing University; Chongqing University	Zeng, L (corresponding author), Chongqing Univ, Coll Math & Stat, Chongqing 630044, Peoples R China.	drlizeng@cqu.edu.cn			National Natural Science Foundation of China [61271313]; National Instrumentation Program of China [2013YQ030629]; Chongqing science and technology research plan project [cstc2012gg-yyjs70016]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Instrumentation Program of China; Chongqing science and technology research plan project	This work is supported by the National Natural Science Foundation of China under grant (61271313) (http://www.nsfc.gov.cn), National Instrumentation Program of China (2013YQ030629) (http://www.most.gov.cn), and Chongqing science and technology research plan project (cstc2012gg-yyjs70016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN AH, 1984, ULTRASONIC IMAGING, V6, P81, DOI 10.1016/0161-7346(84)90008-7; Armitage P., 2002, STAT METHODS MED RES; Bachar G, 2007, MED PHYS, V34, P4664, DOI 10.1118/1.2799492; Cai X, 2015, INF INFERENCE, V4, P43, DOI 10.1093/imaiai/iau010; Chen GH, 2008, MED PHYS, V35, P660, DOI 10.1118/1.2836423; Chen JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092414; Chen ZQ, 2013, PHYS MED BIOL, V58, P2119, DOI 10.1088/0031-9155/58/7/2119; Cho MK, 2012, J INSTRUM, V7, DOI 10.1088/1748-0221/7/03/P03007; Faramarzi E, 2013, IEEE T IMAGE PROCESS, V22, P2101, DOI 10.1109/TIP.2013.2237915; Frikel J, 2013, APPL COMPUT HARMON A, V34, P117, DOI 10.1016/j.acha.2012.03.005; Han Y, 2013, PATTERN RECOGN, V46, P1971, DOI 10.1016/j.patcog.2012.12.002; Herman GT, 2009, ADV PATTERN RECOGNIT, P1, DOI 10.1007/978-1-84628-723-7; Jiang M, 2003, IEEE T IMAGE PROCESS, V12, P957, DOI 10.1109/TIP.2003.815295; Kak A.V., 1988, PRINCIPLES COMPUTERI, DOI DOI 10.1137/1.9780898719277.CH7; Kolehmainen V, 2003, PHYS MED BIOL, V48, P1465, DOI 10.1088/0031-9155/48/10/315; Lu XQ, 2011, PATTERN RECOGN, V44, P2427, DOI 10.1016/j.patcog.2010.12.016; Lu XQ, 2011, NEUROCOMPUTING, V74, P661, DOI 10.1016/j.neucom.2010.08.003; Lu XQ, 2010, IMAGE VISION COMPUT, V28, P696, DOI 10.1016/j.imavis.2009.10.011; Ning PG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092568; Noo F, 2002, PHYS MED BIOL, V47, P2525, DOI 10.1088/0031-9155/47/14/311; Pan XC, 2009, INVERSE PROBL, V25, DOI 10.1088/0266-5611/25/12/123009; Pei SC, 2012, IEEE SIGNAL PROC LET, V19, P813, DOI 10.1109/LSP.2012.2220352; Rantala M, 2006, IEEE T MED IMAGING, V25, P210, DOI 10.1109/TMI.2005.862206; RUDIN LI, 1992, PHYSICA D, V60, P259, DOI 10.1016/0167-2789(92)90242-F; Segars W P, 2001, J NUCL MED, V42, P7; Segars WP, 2001, IEEE T NUCL SCI, V48, P89, DOI 10.1109/23.910837; Sidky EY, 2006, J X-RAY SCI TECHNOL, V14, P119; Tingberg A, 2010, RADIAT PROT DOSIM, V139, P100, DOI 10.1093/rpd/ncq099; TUY HK, 1983, SIAM J APPL MATH, V43, P546, DOI 10.1137/0143035; Wang YL, 2008, SIAM J IMAGING SCI, V1, P248, DOI 10.1137/080724265; Wright SJ, 2009, IEEE T SIGNAL PROCES, V57, P2479, DOI 10.1109/TSP.2009.2016892; Wu DF, 2013, PHYS MED BIOL, V58, P4047, DOI 10.1088/0031-9155/58/12/4047; Xu L, 2011, ACM T GRAPHIC, V30, DOI 10.1145/2024156.2024208; Yu W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109345; Zeng L, 2013, J INVERSE ILL-POSE P, V21, P735, DOI 10.1515/jip-2011-0010	35	30	30	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2015	10	7							e0130793	10.1371/journal.pone.0130793	http://dx.doi.org/10.1371/journal.pone.0130793			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EW	26158543	Green Submitted, gold, Green Published			2022-12-26	WOS:000358161200017
J	Arrieta, J; Cartwright, JHE; Gouillart, E; Piro, N; Piro, O; Tuval, I				Arrieta, Jorge; Cartwright, Julyan H. E.; Gouillart, Emmanuelle; Piro, Nicolas; Piro, Oreste; Tuval, Idan			Geometric Mixing, Peristalsis, and the Geometric Phase of the Stomach	PLOS ONE			English	Article							STOKES-FLOW; FLUID; TRANSPORT; MIXER	Mixing fluid in a container at low Reynolds number-in an inertialess environment-is not a trivial task. Reciprocating motions merely lead to cycles of mixing and unmixing, so continuous rotation, as used in many technological applications, would appear to be necessary. However, there is another solution: movement of the walls in a cyclical fashion to introduce a geometric phase. We show using journal-bearing flow as a model that such geometric mixing is a general tool for using deformable boundaries that return to the same position to mix fluid at low Reynolds number. We then simulate a biological example: we show that mixing in the stomach functions because of the "belly phase," peristaltic movement of the walls in a cyclical fashion introduces a geometric phase that avoids unmixing.	[Arrieta, Jorge; Tuval, Idan] UIB, CSIC, Mediterranean Inst Adv Studies, E-07190 Esporles, Spain; [Arrieta, Jorge] Univ Carlos III Madrid, Area Mecan Fluidos, E-28911 Leganes, Spain; [Cartwright, Julyan H. E.] Univ Granada, CSIC, Inst Andaluz Ciencias Tierra, E-18071 Granada, Spain; [Gouillart, Emmanuelle] CNRS St Gobain, Surface Verre Interfaces, UMR 125, F-93303 Aubervilliers, France; [Piro, Nicolas] Ecole Polytech Fed Lausanne, CH-1015 Lausanne, Switzerland; [Piro, Oreste] Univ Illes Balears, Dept Fis, E-07071 Palma De Mallorca, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Universitat de les Illes Balears; Universidad Carlos III de Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Andaluz de Ciencias de la Tierra (IACT); University of Granada; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Sorbonne Universite; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Universitat de les Illes Balears	Piro, N (corresponding author), Ecole Polytech Fed Lausanne, CH-1015 Lausanne, Switzerland.	nicolas.piro@gmail.com	Arrieta, Jorge/E-4113-2013; Cartwright, Julyan/C-1387-2016; Sanagustin, Jorge Arrieta/AAA-9490-2020; P, N/AAQ-5967-2021; Piro, Oreste/B-4899-2014; Tuval, Idan/G-9732-2011	Arrieta, Jorge/0000-0003-1260-6168; Cartwright, Julyan/0000-0001-7392-0957; Sanagustin, Jorge Arrieta/0000-0003-1260-6168; Piro, Oreste/0000-0002-6966-2796; Tuval, Idan/0000-0002-6629-0851	Ministry of Science and Innovation (MICINN) [FIS2010-22322-C02-01/02]; subprograma Ramon y Cajal	Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); subprograma Ramon y Cajal(Spanish Government)	The authors acknowledge the financial support of the grant FIS2010-22322-C02-01/02 from The Ministry of Science and Innovation (MICINN) and from the "subprograma Ramon y Cajal" (IT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alim K, 2013, P NATL ACAD SCI USA, V110, P13306, DOI 10.1073/pnas.1305049110; ANDERSON D., 1984, COMPUTATIONAL FLUID; AREF H, 1986, PHYS FLUIDS, V29, P3515, DOI 10.1063/1.865828; BALLAL BY, 1976, ARCH RATION MECH AN, V62, P237, DOI 10.1007/BF00280016; Barrett KE., 2013, GASTROINTESTINAL PHY; Cartwright JHE, 1992, INT J BIFURCAT CHAOS, V2, P427; CHAIKEN J, 1986, P ROY SOC LOND A MAT, V408, P165, DOI 10.1098/rspa.1986.0115; Dillard S, 2007, WORLD J GASTROENTERO, V13, P1365, DOI 10.3748/wjg.v13.i9.1365; Finn MD, 2001, J ENG MATH, V41, P75, DOI 10.1023/A:1011840630170; GHIA U, 1982, J COMPUT PHYS, V48, P387, DOI 10.1016/0021-9991(82)90058-4; Heller JP, 1960, AM J PHYS, V28, P348, DOI [10.1119/1.1935802, DOI 10.1119/1.1935802]; Imai Y, 2013, AM J PHYSIOL-GASTR L, V304, pG536, DOI 10.1152/ajpgi.00350.2012; Indireshkumar K, 2000, AM J PHYSIOL-GASTR L, V278, pG604, DOI 10.1152/ajpgi.2000.278.4.G604; Ishikawa T, 2011, J THEOR BIOL, V279, P63, DOI 10.1016/j.jtbi.2011.03.026; JAFFRIN MY, 1971, ANNU REV FLUID MECH, V3, P13, DOI 10.1146/annurev.fl.03.010171.000305; Jeffery GB, 1922, P R SOC LOND A-CONTA, V102, P161, DOI 10.1098/rspa.1922.0078; Jose J., 1998, CLASSICAL DYNAMICS C; Koiller K, 1996, J NONLINEAR SCI, V6, P507, DOI [10.1007/BF02434055, DOI 10.1007/BF02434055]; Kumar S, 2007, J FLUID ENG-T ASME, V129, P1361, DOI 10.1115/1.2786480; Kwiatek MA, 2006, J MAGN RESON IMAGING, V24, P1101, DOI 10.1002/jmri.20738; Leal L, 2007, ADV TRANSPORT PHENOM, V1st; Lichtenberg A. J., 2010, REGULAR CHAOTIC DYNA; Lin ZY, 2003, DIGEST DIS SCI, V48, P837, DOI 10.1023/A:1023099206939; OTTINO JM, 1988, NATURE, V333, P419, DOI 10.1038/333419a0; Ottino JM, 1989, KINEMATICS MIXING ST; Pal A, 2004, P ROY SOC B-BIOL SCI, V271, P2587, DOI 10.1098/rspb.2004.2886; Pal A, 2007, J BIOMECH, V40, P1202, DOI 10.1016/j.jbiomech.2006.06.006; Rinaldi M, 2009, NUTR THERAPY METABOL, V27, P134; Schulze K, 2006, NEUROGASTROENT MOTIL, V18, P172, DOI 10.1111/j.1365-2982.2006.00759.x; Shapere A, 1989, GEOMETRIC PHASES PHY; Shapiro H, 1969, J FLUID MECH, V37, P799, DOI 10.1017/S0022112069000899; Stroock AD, 2002, SCIENCE, V295, P647, DOI 10.1126/science.1066238; Tabor M, 1989, CHAOS INTEGRABILITY; Tams TR, 2003, HDB SMALL ANIMAL GAS; Taylor GI, 1960, LOW REYNOLDS NUMBER; Yamada T, 2011, TXB GASTROENTEROLOGY	37	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0130735	10.1371/journal.pone.0130735	http://dx.doi.org/10.1371/journal.pone.0130735			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154384	Green Submitted, Green Published, gold			2022-12-26	WOS:000358159700037
J	Kim, ES; Sonstegard, TS; Van Tassell, CP; Wiggans, G; Rothschild, MF				Kim, Eui-Soo; Sonstegard, Tad S.; Van Tassell, Curtis P.; Wiggans, George; Rothschild, Max F.			The Relationship between Runs of Homozygosity and Inbreeding in Jersey Cattle under Selection	PLOS ONE			English	Article							COMPLEX VERTEBRAL MALFORMATION; DEPRESSION; FERTILITY; HOLSTEIN; MUTATION; HETEROZYGOSITY; GENETICS; SURVIVAL; FITNESS; TRAITS	Inbreeding is often an inevitable outcome of strong directional artificial selection but on average it reduces population fitness with increased frequency of recessive deleterious alleles. Runs of homozygosity (ROH) representing genomic autozygosity that occur from mating between selected and genomically related individuals may be able to reveal the regions affecting fitness. To examine the influence of genomic autozygosity on fitness, we used a genome-wide association test to evaluate potential negative correlations between ROH and daughter pregnancy rate (DPR) or somatic cell score (SCS) in US Jersey cattle. In addition, relationships between changes of local ROH and inbreeding coefficients (F) were assessed to locate genomic regions with increased inbreeding. Despite finding some decreases in fertility associated with incremental increases in F, most emerging local ROH were not significantly associated with DPR or SCS. Furthermore, the analyses of ROH could be approximated with the most frequent haplotype(s), including the associations of ROH and F or traits. The analysis of the most frequent haplotype revealed that associations of ROH and fertility could be accounted for by the additive genetic effect on the trait. Thus, we suggest that a change of autozygosity is more likely to demonstrate footprints of selected haplotypes for production rather than highlight the possible increased local autozygosity of a recessive detrimental allele resulting from the mating between closely related animals in Jersey cattle.	[Kim, Eui-Soo; Sonstegard, Tad S.; Van Tassell, Curtis P.; Wiggans, George] ARS, Anim Genom & Improvement Lab, Beltsville Agr Res Ctr, USDA, Beltsville, MD USA; [Kim, Eui-Soo; Rothschild, Max F.] Iowa State Univ, Dept Anim Sci, Ames, IA 50011 USA	United States Department of Agriculture (USDA); Iowa State University	Rothschild, MF (corresponding author), Iowa State Univ, Dept Anim Sci, Ames, IA 50011 USA.	mfrothsc@iastate.edu	Van Tassell, Curtis P./O-4247-2019	Van Tassell, Curtis P./0000-0002-8416-2087	USDA-ARS-BFGL [1265-31000-104]; College of Agriculture and Life Sciences; State of Iowa and Hatch funds; Next-Generation BioGreen 21 Program [PJ011044]; Rural Development Administration, Republic of Korea	USDA-ARS-BFGL; College of Agriculture and Life Sciences; State of Iowa and Hatch funds; Next-Generation BioGreen 21 Program(Rural Development Administration (RDA), Republic of Korea); Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This work was supported by the USDA-ARS-BFGL applied genomics project 1265-31000-104, the College of Agriculture and Life Sciences, the State of Iowa and Hatch funds. E.-S. Kim was partially supported by a grant from the Next-Generation BioGreen 21 Program (No. PJ011044), Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agerholm JS, 2001, J VET DIAGN INVEST, V13, P283, DOI 10.1177/104063870101300401; Andersson L, 2004, NAT REV GENET, V5, P202, DOI 10.1038/nrg1294; Charlesworth D, 2009, NAT REV GENET, V10, P783, DOI 10.1038/nrg2664; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Chun S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002240; CHURCHILL GA, 1994, GENETICS, V138, P963; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Curik I, 2014, LIVEST SCI, V166, P26, DOI 10.1016/j.livsci.2014.05.034; David P, 1998, HEREDITY, V80, P531, DOI 10.1046/j.1365-2540.1998.00393.x; Druet T, 2008, GENETICS, V178, P2227, DOI 10.1534/genetics.107.085035; Gillespie JH, 1998, POPULATION GENETICS; GURTNER GC, 1995, GENE DEV, V9, P1, DOI 10.1101/gad.9.1.1; Hedrick P, 2001, EVOLUTION, V55, P1256; Hedrick P.W., 2011, GENETICS POPULATIONS; Holmberg M, 2006, J DAIRY SCI, V89, P3664, DOI 10.3168/jds.S0022-0302(06)72406-7; HOULE D, 1992, NATURE, V359, P58, DOI 10.1038/359058a0; Howard JT, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1352-4; Jombart T, 2011, BIOINFORMATICS, V27, P3070, DOI 10.1093/bioinformatics/btr521; Karkkainen K, 1996, EVOLUTION, V50, P111, DOI 10.1111/j.1558-5646.1996.tb04477.x; Keller MC, 2012, PLOS GENET, V8, P425, DOI 10.1371/journal.pgen.1002656; Keller MC, 2011, GENETICS, V189, P237, DOI 10.1534/genetics.111.130922; Khatib H, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-13; Kim ES, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1500-x; Kim ES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080813; Kinghorn B.P., 1994, P 5 WORLD C GEN APPL, VVolume 22, P85; Kristensen TN, 2010, TRENDS ECOL EVOL, V25, P44, DOI 10.1016/j.tree.2009.06.014; Kuhn C, 2004, GENETICS, V167, P1873, DOI 10.1534/genetics.103.022749; Leroy G, 2014, ANIM GENET, V45, P618, DOI 10.1111/age.12178; Lettre G, 2007, GENET EPIDEMIOL, V31, P358, DOI 10.1002/gepi.20217; Markert JA, 2004, HEREDITY, V92, P306, DOI 10.1038/sj.hdy.6800409; Mc Parland S, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-16; McQuillan R, 2008, AM J HUM GENET, V83, P359, DOI 10.1016/j.ajhg.2008.08.007; Morris JA, 2001, MED HYPOTHESES, V56, P646, DOI 10.1054/mehy.2000.1200; Nielsen US, 2003, LIVEST PROD SCI, V79, P233, DOI 10.1016/S0301-6226(02)00170-7; Nothnagel M, 2010, HUM MOL GENET, V19, P2927, DOI 10.1093/hmg/ddq198; Palucci V, 2007, GENET SEL EVOL, V39, P181, DOI 10.1051/gse:2006041; Pemberton J, 2004, TRENDS ECOL EVOL, V19, P613, DOI 10.1016/j.tree.2004.09.010; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pryce JE, 2014, GENET SEL EVOL, V46, DOI 10.1186/s12711-014-0071-7; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purfield DC, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-70; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Slate J, 2002, J EVOLUTION BIOL, V15, P20, DOI 10.1046/j.1420-9101.2002.00373.x; Sonstegard TS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054872; Thomsen B, 2006, GENOME RES, V16, P97, DOI 10.1101/gr.3690506; VanRaden PM, 2011, J DAIRY SCI, V94, P6153, DOI 10.3168/jds.2011-4624; VanRaden PM, 2011, J DAIRY SCI, V94, P5673, DOI 10.3168/jds.2011-4500; VanRaden PM, 2004, J DAIRY SCI, V87, P2285, DOI 10.3168/jds.S0022-0302(04)70049-1; VanRaden PM, 2003, INTERBULL B, V30, P43; Vermeulen CJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-297; Weigel KA, 2006, ANIM REPROD SCI, V96, P323, DOI 10.1016/j.anireprosci.2006.08.010; Wright S, 1922, AM NAT, V56, P330, DOI 10.1086/279872; Xue YL, 2012, AM J HUM GENET, V91, P1022, DOI 10.1016/j.ajhg.2012.10.015	53	49	52	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0129967	10.1371/journal.pone.0129967	http://dx.doi.org/10.1371/journal.pone.0129967			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154171	Green Published, Green Submitted, gold			2022-12-26	WOS:000358159700018
J	Liu, TX; Babaniyi, OA; Hall, TJ; Barbone, PE; Oberai, AA				Liu, Tengxiao; Babaniyi, Olalekan A.; Hall, Timothy J.; Barbone, Paul E.; Oberai, Assad A.			Noninvasive In-Vivo Quantification of Mechanical Heterogeneity of Invasive Breast Carcinomas	PLOS ONE			English	Article							ELASTOGRAPHY; US; ELASTICITY; TISSUE	Heterogeneity is a hallmark of cancer whether one considers the genotype of cancerous cells, the composition of their microenvironment, the distribution of blood and lymphatic microvasculature, or the spatial distribution of the desmoplastic reaction. It is logical to expect that this heterogeneity in tumor microenvironment will lead to spatial heterogeneity in its mechanical properties. In this study we seek to quantify the mechanical heterogeneity within malignant and benign tumors using ultrasound based elasticity imaging. By creating in-vivo elastic modulus images for ten human subjects with breast tumors, we show that Young's modulus distribution in cancerous breast tumors is more heterogeneous when compared with tumors that are not malignant, and that this signature may be used to distinguish malignant breast tumors. Our results complement the view of cancer as a heterogeneous disease on multiple length scales by demonstrating that mechanical properties within cancerous tumors are also spatially heterogeneous.	[Liu, Tengxiao; Oberai, Assad A.] Rensselaer Polytech Inst, Sci Computat Res Ctr, Troy, NY 12180 USA; [Babaniyi, Olalekan A.; Barbone, Paul E.] Boston Univ, Mech Engn, Boston, MA 02215 USA; [Hall, Timothy J.] Univ Wisconsin, Med Phys, Madison, WI USA	Rensselaer Polytechnic Institute; Boston University; University of Wisconsin System; University of Wisconsin Madison	Oberai, AA (corresponding author), Rensselaer Polytech Inst, Sci Computat Res Ctr, Troy, NY 12180 USA.	oberaa@rpi.edu		Babaniyi, Olalekan/0000-0003-1991-4403; Oberai, Assad/0000-0002-7668-7713	National Institutes of Health [NCI-R01CA100373, NCI-R01CA140271]; National Science Foundation [1148124, 1148111]; NATIONAL CANCER INSTITUTE [R01CA100373, R01CA140271] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health (NCI-R01CA100373 & NCI-R01CA140271) and National Science Foundation (grant nos. 1148124 and 1148111).	Barbone PE, 2010, COMPUTATIONAL MODELING IN BIOMECHANICS, P375, DOI 10.1007/978-90-481-3575-2_13; Berg WA, 2004, RADIOLOGY, V233, P830, DOI 10.1148/radiol.2333031484; Berg WA, 2012, RADIOLOGY, V262, P435, DOI 10.1148/radiol.11110640; Burnside ES, 2007, RADIOLOGY, V245, P401, DOI 10.1148/radiol.2452061805; Gokhale NH, 2008, INVERSE PROBL, V24, DOI 10.1088/0266-5611/24/4/045010; Jiang JF, 2009, ULTRASOUND MED BIOL, V35, P1863, DOI 10.1016/j.ultrasmedbio.2009.05.016; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kass L, 2007, INT J BIOCHEM CELL B, V39, P1987, DOI 10.1016/j.biocel.2007.06.025; Lopez JI, 2011, INTEGR BIOL-UK, V3, P910, DOI 10.1039/c1ib00043h; MUTHUPILLAI R, 1995, SCIENCE, V269, P1854, DOI 10.1126/science.7569924; Oberai AA, 2003, INVERSE PROBL, V19, P297, DOI 10.1088/0266-5611/19/2/304; OPHIR J, 1991, ULTRASONIC IMAGING, V13, P111, DOI 10.1016/0161-7346(91)90079-W; Parker KJ, 2011, PHYS MED BIOL, V56, pR1, DOI 10.1088/0031-9155/56/1/R01; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Rudnick JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024605; Schedin P, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003228; Schnitt SJ, 2009, BIOPSY INTERPRETATIO; Shore SW, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4004231; Sinkus R, 2005, MAGNET RESON MED, V53, P372, DOI 10.1002/mrm.20355; Weaver J, 2002, MED PHYS, V29, P1291; Zhu CY, 1997, ACM T MATH SOFTWARE, V23, P550, DOI 10.1145/279232.279236; Zhu YN, 2002, ULTRASONIC IMAGING, V24, P161, DOI 10.1177/016173460202400303	22	24	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0130258	10.1371/journal.pone.0130258	http://dx.doi.org/10.1371/journal.pone.0130258			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154737	Green Published, gold, Green Submitted			2022-12-26	WOS:000358159700026
J	Wang, HY; Wang, C; Yang, K; Liu, J; Zhang, Y; Wang, YN; Xu, XW; Michal, JJ; Jiang, ZH; Liu, B				Wang, Hongyang; Wang, Chao; Yang, Kui; Liu, Jing; Zhang, Yu; Wang, Yanan; Xu, Xuewen; Michal, Jennifer J.; Jiang, Zhihua; Liu, Bang			Genome Wide Distributions and Functional Characterization of Copy Number Variations between Chinese and Western Pigs	PLOS ONE			English	Article							GENE-EXPRESSION; IDENTIFICATION; VARIANTS; POLYMORPHISMS; DUPLICATION; ASSOCIATION; EXPANSION; SELECTION; PATTERNS; PROTEIN	Copy number variations (CNVs) refer to large insertions, deletions and duplications in the genomic structure ranging from one thousand to several million bases in size. Since the development of next generation sequencing technology, several methods have been well built for detection of copy number variations with high credibility and accuracy. Evidence has shown that CNV occurring in gene region could lead to phenotypic changes due to the alteration in gene structure and dosage. However, it still remains unexplored whether CNVs underlie the phenotypic differences between Chinese and Western domestic pigs. Based on the read-depth methods, we investigated copy number variations using 49 individuals derived from both Chinese and Western pig breeds. A total of 3,131 copy number variation regions (CNVRs) were identified with an average size of 13.4 Kb in all individuals during domestication, harboring 1,363 genes. Among them, 129 and 147 CNVRs were Chinese and Western pig specific, respectively. Gene functional enrichments revealed that these CNVRs contribute to strong disease resistance and high prolificacy in Chinese domestic pigs, but strong muscle tissue development in Western domestic pigs. This finding is strongly consistent with the morphologic characteristics of Chinese and Western pigs, indicating that these group-specific CNVRs might have been preserved by artificial selection for the favored phenotypes during independent domestication of Chinese and Western pigs. In this study, we built high-resolution CNV maps in several domestic pig breeds and discovered the group specific CNVs by comparing Chinese and Western pigs, which could provide new insight into genomic variations during pigs' independent domestication, and facilitate further functional studies of CNV-associated genes.	[Wang, Hongyang; Wang, Chao; Liu, Jing; Zhang, Yu; Wang, Yanan; Xu, Xuewen; Jiang, Zhihua; Liu, Bang] Huazhong Agr Univ, Key Lab Agr Anim Genet Breeding & Reprod, Minist Educ, Wuhan, Peoples R China; [Wang, Hongyang; Wang, Chao; Liu, Jing; Zhang, Yu; Wang, Yanan; Xu, Xuewen; Liu, Bang] Huazhong Agr Univ, Cooperat Innovat Ctr Sustainable Pig Prod, Wuhan, Peoples R China; [Yang, Kui] Huazhong Agr Univ, Modern Educ & Technol Ctr, Wuhan, Peoples R China; [Michal, Jennifer J.; Jiang, Zhihua] Washington State Univ, Dept Anim Sci, Pullman, WA 99164 USA	Huazhong Agricultural University; Huazhong Agricultural University; Huazhong Agricultural University; Washington State University	Liu, B (corresponding author), Huazhong Agr Univ, Key Lab Agr Anim Genet Breeding & Reprod, Minist Educ, Wuhan, Peoples R China.	liubang@mail.hzau.edu.cn	Jiang, Zhihua/A-3378-2008	Jiang, Zhihua/0000-0003-1986-088X	Major International Cooperation NSFC [31210103917]; National High Technology Research and Development Program of China [2011AA100304, 2013AA102502]	Major International Cooperation NSFC; National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This work was supported by the Major International Cooperation NSFC (31210103917) (http://www.nsfc.gov.cn/) and the National High Technology Research and Development Program of China (2011AA100304, 2013AA102502) (http://program.most.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abyzov A, 2011, GENOME RES, V21, P974, DOI 10.1101/gr.114876.110; Bae JS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-232; Bickhart DM, 2012, GENOME RES, V22, P778, DOI 10.1101/gr.133967.111; Cahan P, 2009, NAT GENET, V41, P430, DOI 10.1038/ng.350; Chen CY, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-733; Chen WK, 2009, GENOME RES, V19, P500, DOI 10.1101/gr.083741.108; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Nguyen DT, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-584; Dong K, 2015, ANIM GENET, V46, P101, DOI 10.1111/age.12247; Durkin K, 2012, NATURE, V482, P81, DOI 10.1038/nature10757; Giuffra E, 2002, MAMM GENOME, V13, P569, DOI 10.1007/s00335-002-2184-5; Groenen MAM, 2012, NATURE, V491, P393, DOI 10.1038/nature11622; Guberman JM, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar041; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Imsland F, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002775; Jarick I, 2011, HUM MOL GENET, V20, P840, DOI 10.1093/hmg/ddq518; Jia X, 2013, ANIM GENET, V44, P276, DOI 10.1111/age.12009; Kim PM, 2008, GENOME RES, V18, P1865, DOI 10.1101/gr.081422.108; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Lachke SA, 2012, HUM GENET, V131, P235, DOI 10.1007/s00439-011-1064-z; Larson G, 2005, SCIENCE, V307, P1618, DOI 10.1126/science.1106927; Larson G, 2010, P NATL ACAD SCI USA, V107, P7686, DOI 10.1073/pnas.0912264107; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li JZ, 2004, NAT GENET, V36, P952, DOI 10.1038/ng1417; Li MZ, 2013, NAT GENET, V45, P1431, DOI 10.1038/ng.2811; Li Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-725; Liu GE, 2010, GENOME RES, V20, P693, DOI 10.1101/gr.105403.110; Liu WN, 2009, CANCER RES, V69, P2176, DOI 10.1158/0008-5472.CAN-08-3151; Martin TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082696; Misra A, 2012, INT J BIOCHEM CELL B, V44, P928, DOI 10.1016/j.biocel.2012.02.020; Nicholas TJ, 2009, GENOME RES, V19, P491, DOI 10.1101/gr.084715.108; Orozco LD, 2009, HUM MOL GENET, V18, P4118, DOI 10.1093/hmg/ddp360; Paudel Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-449; Peiffer DA, 2006, GENOME RES, V16, P1136, DOI 10.1101/gr.5402306; Pinto D, 2011, NAT BIOTECHNOL, V29, P512, DOI 10.1038/nbt.1852; Ramayo-Caldas Y, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-593; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rubin CJ, 2012, P NATL ACAD SCI USA, V109, P19529, DOI 10.1073/pnas.1217149109; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sha BY, 2009, J HUM GENET, V54, P199, DOI 10.1038/jhg.2009.10; Smit A, 1996, REPEATMASKER OPEN 30; Snijders AM, 2005, GENOME RES, V15, P302, DOI 10.1101/gr.2902505; Sudmant PH, 2010, SCIENCE, V330, P641, DOI 10.1126/science.1197005; Sundstrom E, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-365; Tang ZL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r115; Tardif S, 2011, MOL HUM REPROD, V17, P661, DOI 10.1093/molehr/gar039; Wang C, 2014, MOL ECOL RESOUR; Wang YN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106780; Winchester Laura, 2009, Briefings in Functional Genomics & Proteomics, V8, P353, DOI 10.1093/bfgp/elp017; Wright D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000512; Wu ATH, 2007, J BIOL CHEM, V282, P12164, DOI 10.1074/jbc.M609132200; Xie C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-80; Xu LY, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-683; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Yoon ST, 2009, GENOME RES, V19, P1586, DOI 10.1101/gr.092981.109; Zhao M, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S11-S1; Zhao X, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0019774, 10.1371/journal.pone.0021739]	61	15	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0131522	10.1371/journal.pone.0131522	http://dx.doi.org/10.1371/journal.pone.0131522			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154170	Green Submitted, gold, Green Published			2022-12-26	WOS:000358159700070
J	Coll, A; Wilson, ML; Gruden, K; Peccoud, J				Coll, Anna; Wilson, Mandy L.; Gruden, Kristina; Peccoud, Jean			Rule-Based Design of Plant Expression Vectors Using GenoCAD	PLOS ONE			English	Article							BIMOLECULAR FLUORESCENCE COMPLEMENTATION; PROTEIN-PROTEIN INTERACTIONS; PHYTOPHTHORA-INFESTANS; LIVING CELLS; INTERACTOME; STANDARD; BIFC; DNA; VISUALIZATION; CONSTRUCTS	Plant synthetic biology requires software tools to assist on the design of complex multigenic expression plasmids. Here a vector design strategy to express genes in plants is formalized and implemented as a grammar in GenoCAD, a Computer-Aided Design software for synthetic biology. It includes a library of plant biological parts organized in structural categories and a set of rules describing how to assemble these parts into large constructs. Rules developed here are organized and divided into three main subsections according to the aim of the final construct: protein localization studies, promoter analysis and protein-protein interaction experiments. The GenoCAD plant grammar guides the user through the design while allowing users to customize vectors according to their needs. Therefore the plant grammar implemented in GenoCAD will help plant biologists take advantage of methods from synthetic biology to design expression vectors supporting their research projects.	[Coll, Anna; Gruden, Kristina] Natl Inst Biol, Dept Biotechnol & Syst Biol, Ljubljana, Slovenia; [Wilson, Mandy L.; Peccoud, Jean] Virginia Tech, Virginia Bioinformat Inst, Blacksburg, VA USA	National Institute of Biology - Slovenia; Virginia Polytechnic Institute & State University	Coll, A (corresponding author), Natl Inst Biol, Dept Biotechnol & Syst Biol, Ljubljana, Slovenia.	anna.coll@nib.si	Gruden, kristina/AAI-6439-2020; Peccoud, Jean/A-2374-2008; Coll, Anna/ABD-4199-2021	Peccoud, Jean/0000-0001-7649-6127; Coll, Anna/0000-0003-0672-1530; gruden, kristina/0000-0001-5906-8569	National Science Foundation [1241328]; Slovenian Research Agency [P4-0165, N4-0026]; Direct For Biological Sciences [1241328] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Slovenian Research Agency(Slovenian Research Agency - Slovenia); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work is supported by National Science Foundation Awards 1241328, JP and The Slovenian Research Agency Program P4-0165 and Project N4-0026, KG.	Adames NR, 2015, NUCLEIC ACIDS RES, V43, P4823, DOI 10.1093/nar/gkv272; Ball DA, 2010, BIOCOMPUT-PAC SYM, P385; Baltes NJ, 2015, TRENDS BIOTECHNOL, V33, P120, DOI 10.1016/j.tibtech.2014.11.008; Braun P, 2013, ANNU REV PLANT BIOL, V64, P161, DOI 10.1146/annurev-arplant-050312-120140; Braun P, 2011, SCIENCE, V333, P601, DOI 10.1126/science.1203877; Cai Y, 2007, BIOINFORMATICS, V23, P2760, DOI 10.1093/bioinformatics/btm446; Cai YZ, 2010, NUCLEIC ACIDS RES, V38, P2637, DOI 10.1093/nar/gkq086; Chen XY, 2013, ADV DRUG DELIVER REV, V65, P1357, DOI 10.1016/j.addr.2012.09.039; Czar MJ, 2009, NUCLEIC ACIDS RES, V37, pW40, DOI 10.1093/nar/gkp361; Czar MJ, 2009, TRENDS BIOTECHNOL, V27, P63, DOI 10.1016/j.tibtech.2008.10.007; Dreze M, 2010, METHOD ENZYMOL, V470, P281, DOI 10.1016/S0076-6879(10)70012-4; Fukao Y, 2012, PLANT CELL PHYSIOL, V53, P617, DOI 10.1093/pcp/pcs026; Galdzicki M, 2014, NAT BIOTECHNOL, V32, P545, DOI 10.1038/nbt.2891; Horstman A, 2014, INT J MOL SCI, V15, P9628, DOI 10.3390/ijms15069628; Hu Y, 2013, INT SYMP QUAL, P8, DOI 10.1109/ISQED.2013.6523583; Karimi M, 2005, TRENDS PLANT SCI, V10, P103, DOI 10.1016/j.tplants.2005.01.008; Kerppola TK, 2008, ANNU REV BIOPHYS, V37, P465, DOI 10.1146/annurev.biophys.37.032807.125842; Kerppola TK, 2006, NAT PROTOC, V1, P1278, DOI 10.1038/nprot.2006.201; Kerppola TK, 2009, CHEM SOC REV, V38, P2876, DOI 10.1039/b909638h; King SRF, 2014, PLANT CELL, V26, P1345, DOI 10.1105/tpc.113.120055; Kodama Y, 2012, BIOTECHNIQUES, V53, P285, DOI [10.2144/0000113943, 10.2144/000113943]; Lazar A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104553; Lee LY, 2008, PLANT PHYSIOL, V146, P325, DOI 10.1104/pp.107.113001; Overend C, 2012, TRENDS BIOTECHNOL, V30, P497, DOI 10.1016/j.tibtech.2012.06.002; Pan YL, 2015, PLANTA, V241, P57, DOI 10.1007/s00425-014-2164-5; Patron NJ, 2014, CURR OPIN PLANT BIOL, V19, P14, DOI 10.1016/j.pbi.2014.02.004; Peccoud J, 2012, METHOD MOL BIOL, P297, DOI [10.1007/978-1-62703-239-1_1, DOI 10.1007/978-1-62703-239-1_]; Purcell O, 2014, ACS SYNTH BIOL, V3, P737, DOI 10.1021/sb400134k; RANSONE LJ, 1995, ELSEVIER, P491, DOI DOI 10.1016/0076-6879(95)54034-2; Runions John, 2007, V390, P239; Silver PA, 2014, NATURE, V509, P166, DOI 10.1038/509166a; Speth C, 2014, METHODS MOL BIOL, V1158, P175, DOI 10.1007/978-1-4939-0700-7_11; Tian ZD, 2015, PLANT CELL PHYSIOL, V56, P992, DOI 10.1093/pcp/pcv025; Voss U, 2013, INT J DEV BIOL, V57, P525, DOI 10.1387/ijdb.130208dw; Walter M, 2004, PLANT J, V40, P428, DOI 10.1111/j.1365-313X.2004.02219.x; Wilson ML, 2014, BIOINFORMATICS, V30, P251, DOI 10.1093/bioinformatics/btt646; Xu X, 2011, NATURE, V475, P189, DOI 10.1038/nature10158; Zhang YX, 2010, CURR GENOMICS, V11, P40, DOI 10.2174/138920210790218016	38	8	8	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132502	10.1371/journal.pone.0132502	http://dx.doi.org/10.1371/journal.pone.0132502			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148190	Green Published, Green Submitted, gold			2022-12-26	WOS:000358157600291
J	Hinna, KH; Rich, K; Fex-Svenningsen, A; Benedikz, E				Hinna, Katja Hvid; Rich, Karen; Fex-Svenningsen, Asa; Benedikz, Eirikur			The Rat Homolog of the Schizophrenia Susceptibility Gene ZNF804A Is Highly Expressed during Brain Development, Particularly in Growth Cones	PLOS ONE			English	Article							STEM-CELLS; ASSOCIATION; RISK; ARC; CONSOLIDATION; NEUROBIOLOGY; DYNAMICS; TISSUES; MEMORY; PCR	A single nucleotide polymorphism in the ZNF804A gene, rs1344706, is associated with schizophrenia. The polymorphism has been suggested to alter fetal expression of ZNF804A. It has also been reported to be associated with altered cortical functioning and neural connectivity in the brain. Since developmental mechanisms are suggested in the pathophysiology for schizophrenia, expression of Zfp804A, the rat homolog of ZNF804A, was investigated in the developing rat brain. We found that expression of Zfp804A in most brain regions is developmentally regulated and peaks around birth, where after it decreases towards adult levels. This time point is developmentally the equivalent to the second trimester of fetal development in humans. An exception to this expression pattern is the hippocampus where the expression of Zfp804A appears to increase again in the adult brain. Using laser capture and quantitative PCR we found that Zfp804A mRNA expression in the adult rat hippocampus is highest in the CA1 sub region, where the overall firing rates of neurons is higher than in the CA3 region. In cultured cortical neurons Zfp804A mRNA expression peaked at day 4 and then decreased. The ZFP804A protein expression was therefore investigated with immunochemistry in such cultures. Interestingly, before day 4, the protein is mostly found in the perinuclear region of the cell but at day 4, ZFP804A was instead found throughout the cell and particularly in the growth cones. In conclusion we demonstrate that Zfp804A increases in the rat brain at the time of birth, coinciding with neuronal differentiation. We also show that ZFP804A is localized to growth cones of growing neurites. These data implicate ZFP804A in growth cone function and neurite elongation. The polymorphism rs1344706 lowers expression of ZNF804A during prenatal brain development. This may affect ZNF804A's role in cone function and neurite elongation leading to synaptic deficits and altered neural connectivity.	[Hinna, Katja Hvid; Rich, Karen; Fex-Svenningsen, Asa; Benedikz, Eirikur] Univ Southern Denmark, Inst Mol Med, Neurobiol Res, Odense, Denmark	University of Southern Denmark	Benedikz, E (corresponding author), Univ Southern Denmark, Inst Mol Med, Neurobiol Res, Odense, Denmark.	ebenedikz@health.sdu.dk	Svenningsen, Åsa Fex/H-5443-2015	Svenningsen, Åsa Fex/0000-0002-5651-265X; Benedikz, Eirikur/0000-0001-6789-8837	Lundbeckfonden [R67-A6538]; Fonden til laegevidenskabens fremme	Lundbeckfonden(Lundbeckfonden); Fonden til laegevidenskabens fremme	This work was supported by Lundbeckfonden (R67-A6538) and Fonden til laegevidenskabens fremme to EB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber RD, 2005, PHYSIOL GENOMICS, V21, P389, DOI 10.1152/physiolgenomics.00025.2005; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cardno AG, 2000, AM J MED GENET, V97, P12, DOI 10.1002/(SICI)1096-8628(200021)97:1<12::AID-AJMG3>3.3.CO;2-L; del Re EC, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2013.117; Donohoe G, 2010, SCHIZOPHRENIA BULL, V36, P904, DOI 10.1093/schbul/sbq080; Esslinger C, 2009, SCIENCE, V324, P605, DOI 10.1126/science.1167768; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Girgenti MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032404; Guzowski JF, 1999, NAT NEUROSCI, V2, P1120, DOI 10.1038/16046; Guzowski JF, 2000, J NEUROSCI, V20, P3993; Hill MJ, 2012, AM J PSYCHIAT, V169, P1301, DOI 10.1176/appi.ajp.2012.11121845; Hill MJ, 2012, HUM MOL GENET, V21, P1018, DOI 10.1093/hmg/ddr532; Kindlundh-Hogberg AMS, 2010, CELL MOL NEUROBIOL, V30, P13, DOI 10.1007/s10571-009-9426-y; Kraemer N, 2012, NEUROL RES, V34, P664, DOI 10.1179/1743132812Y.0000000060; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lewis DA, 2000, NEURON, V28, P325, DOI 10.1016/S0896-6273(00)00111-2; Mizuseki K, 2012, HIPPOCAMPUS, V22, P1659, DOI 10.1002/hipo.22002; MURRAY RM, 1987, BRIT MED J, V295, P681, DOI 10.1136/bmj.295.6600.681; Nieratschker Vanessa, 2010, Front Behav Neurosci, V4, P23, DOI 10.3389/fnbeh.2010.00023; O'Donoghue T, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2013.115; O'Donovan MC, 2008, NAT GENET, V40, P1053, DOI 10.1038/ng.201; Pantelis C, 2005, SCHIZOPHRENIA BULL, V31, P672, DOI 10.1093/schbul/sbi034; Pevzner A, 2012, NEUROBIOL LEARN MEM, V97, P313, DOI 10.1016/j.nlm.2012.02.004; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Plath N, 2006, NEURON, V52, P437, DOI 10.1016/j.neuron.2006.08.024; Rasetti R, 2011, ARCH GEN PSYCHIAT, V68, P1207, DOI 10.1001/archgenpsychiatry.2011.103; Riley B, 2010, MOL PSYCHIATR, V15, P29, DOI 10.1038/mp.2009.109; Ross CA, 2006, NEURON, V52, P139, DOI 10.1016/j.neuron.2006.09.015; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Steinberg S, 2011, MOL PSYCHIATR, V16, P59, DOI 10.1038/mp.2009.149; Svenningsen AF, 2003, J NEUROSCI RES, V72, P565, DOI 10.1002/jnr.10610; Tao R, 2014, JAMA PSYCHIAT, V71, P1112, DOI 10.1001/jamapsychiatry.2014.1079; Umeda-Yano S, 2014, NEUROSCI LETT, V568, P12, DOI 10.1016/j.neulet.2014.03.031; Umeda-Yano S, 2013, SCHIZOPHR RES, V146, P273, DOI 10.1016/j.schres.2013.01.026; Walters JTR, 2010, ARCH GEN PSYCHIAT, V67, P692, DOI 10.1001/archgenpsychiatry.2010.81; WEINBERGER DR, 1987, ARCH GEN PSYCHIAT, V44, P660, DOI 10.1001/archpsyc.1987.01800190080012; Williams HJ, 2011, MOL PSYCHIATR, V16, P429, DOI 10.1038/mp.2010.36; Zhang R, 2011, MOL PSYCHIATR, V16, P360, DOI 10.1038/mp.2010.55	38	10	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132456	10.1371/journal.pone.0132456	http://dx.doi.org/10.1371/journal.pone.0132456			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148198	Green Published, Green Submitted, gold			2022-12-26	WOS:000358157600274
J	Iguchi, T; Wang, CY; Delongchamps, NB; Kato, M; Tamada, S; Yamasaki, T; de la Roza, G; Nakatani, T; Haas, GP				Iguchi, Taro; Wang, Ching Y.; Delongchamps, Nicolas B.; Kato, Minoru; Tamada, Satoshi; Yamasaki, Takeshi; de la Roza, Gustavo; Nakatani, Tatsuya; Haas, Gabriel P.			Association of MnSOD AA Genotype with the Progression of Prostate Cancer	PLOS ONE			English	Article							MANGANESE SUPEROXIDE-DISMUTASE; GENE POLYMORPHISM; RISK; DIMORPHISM; LUNG; MPO	Purpose To investigate whether manganese superoxide dismutase (MnSOD) genetic polymorphism is associated with the clinical significance of prostate cancer. Materials and Methods Prostates were obtained from 194 deceased men 45 years or older who did not have a history of prostate cancer. Serial sections and histological examinations of the prostate were performed. The MnSOD genotypes of the specimens were determined by polymerase chain reaction restriction fragment length polymorphism analysis. Results Of the 194 men, 31 and 26 had clinically insignificant and significant prostate cancer. Clinically significant cancer comprised 29% and 58% of the cancers in men <70 and >70 years old, respectively. The age-specific proportion of significant cancer significantly increased with the advance of age (p<0.001). MnSOD AA, as compared with the other genotypes (VA and VV together), was associated with significant prostate cancer across all ages, odds ratio (OR) 2.34, 95% confidence interval (CI) 0.99-5.49, and in men older than 69 years (OR 4.89, 95% CI 1.51-15.8), but not in men younger than 70 years. The genotype was not associated with clinically insignificant cancer regardless of age. The comparison between significant and insignificant cancer, the OR (95% CI) for MnSOD AA was 5.04 (1.05-24.2) (sensitivity 0.57, specificity 0.78, positive predictive value 0.78) in men older than 69 years. Conclusions MnSOD polymorphism is strongly associated with the clinical significance of prostate cancer in men older than 69 years, but not in men younger than 70 years suggesting that oxidative stress may be involved in the progression of the disease. MnSOD may be a clinically useful marker to predict the potential of progression of prostate cancer.	[Iguchi, Taro; Wang, Ching Y.; Delongchamps, Nicolas B.; Haas, Gabriel P.] SUNY Upstate Med Univ, Dept Urol, Syracuse, NY 13210 USA; [Iguchi, Taro; Kato, Minoru; Tamada, Satoshi; Yamasaki, Takeshi; Nakatani, Tatsuya] Osaka City Univ, Grad Sch Med, Dept Urol, Osaka 558, Japan; [Delongchamps, Nicolas B.] Cochin Hosp, Dept Urol, Paris, France; [de la Roza, Gustavo] SUNY Upstate Med Univ, Dept Pathol, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Osaka Metropolitan University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Iguchi, T (corresponding author), SUNY Upstate Med Univ, Dept Urol, Syracuse, NY 13210 USA.	taro@msic.med.osaka-cu.ac.jp	Delongchamps, Nicolas Barry/AAE-8651-2020; Iguchi, Taro/AAS-5209-2021		National Cancer Institute [CA097751]; National Institute on Aging [AG021389]; Ministry of Education, Science, Sports and Culture [21791524]; Osaka Medical Research Foundation for Incurable Disease; NATIONAL CANCER INSTITUTE [R03CA097751] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG021389] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Osaka Medical Research Foundation for Incurable Disease; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by research grants from the National Cancer Institute (CA097751; GPH) and the National Institute on Aging (AG021389; GPH), the Ministry of Education, Science, Sports and Culture (Grant-in-Aid for Young Scientists (B) 21791524; TI) and the Osaka Medical Research Foundation for Incurable Disease (TI).	Choi JY, 2008, CARCINOGENESIS, V29, P964, DOI 10.1093/carcin/bgn056; Chou R, 2011, ANN INTERN MED, V155, P762, DOI 10.7326/0003-4819-155-11-201112060-00375; Costello LC, 2000, ONCOLOGY-BASEL, V59, P269, DOI 10.1159/000012183; EPSTEIN JI, 1994, JAMA-J AM MED ASSOC, V271, P368, DOI 10.1001/jama.271.5.368; FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525; Haas GP, 2008, CAN J UROL, V15, P3866; Haas GP, 2007, JNCI-J NATL CANCER I, V99, P1484, DOI 10.1093/jnci/djm153; Hung RJ, 2004, CARCINOGENESIS, V25, P973, DOI 10.1093/carcin/bgh080; Iguchi T, 2008, ANTICANCER RES, V28, P3007; Iguchi T, 2008, UROLOGY, V72, P238, DOI 10.1016/j.urology.2008.03.064; Iguchi T, 2009, IN VIVO, V23, P7; Kang D, 2007, CANCER EPIDEM BIOMAR, V16, P1581, DOI 10.1158/1055-9965.EPI-07-0160; Kaplan SA, 2009, UROLOGY, V73, P935, DOI 10.1016/j.urology.2008.09.079; KUROSAWA K, 1990, J BIOCHEM-TOKYO, V108, P9, DOI 10.1093/oxfordjournals.jbchem.a123169; Li HJ, 2005, CANCER RES, V65, P2498, DOI 10.1158/0008-5472.CAN-04-3535; Lin K, 2008, ANN INTERN MED, V149, P192, DOI 10.7326/0003-4819-149-3-200808050-00009; Liu LW, 2009, UROLOGY, V74, P884, DOI 10.1016/j.urology.2008.11.016; Mao C, 2010, J CANCER RES CLIN, V136, P975, DOI 10.1007/s00432-009-0742-x; Miar A, 2015, FREE RADICAL BIO MED, V85, P45, DOI 10.1016/j.freeradbiomed.2015.04.001; Mikhak B, 2008, CARCINOGENESIS, V29, P2335, DOI 10.1093/carcin/bgn212; Mitrunen K, 2001, CARCINOGENESIS, V22, P827, DOI 10.1093/carcin/22.5.827; Murphy SJ, 2007, CARCINOGENESIS, V28, P1323, DOI 10.1093/carcin/bgm007; ShimodaMatsubayashi S, 1996, BIOCHEM BIOPH RES CO, V226, P561, DOI 10.1006/bbrc.1996.1394; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; STAMEY TA, 1993, CANCER, V71, P933, DOI 10.1002/1097-0142(19930201)71:3+<933::AID-CNCR2820711408>3.0.CO;2-L; Sutton A, 2003, PHARMACOGENETICS, V13, P145, DOI 10.1097/00008571-200303000-00004; Tong SY, 2009, GYNECOL ONCOL, V115, P272, DOI 10.1016/j.ygyno.2009.07.032; Wang LI, 2001, J NATL CANCER I, V93, P1818, DOI 10.1093/jnci/93.23.1818; Wang SM, 2009, EUR J CANCER, V45, P2874, DOI 10.1016/j.ejca.2009.04.024; Woodson K, 2003, CANCER CAUSE CONTROL, V14, P513, DOI 10.1023/A:1024840823328	30	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131325	10.1371/journal.pone.0131325	http://dx.doi.org/10.1371/journal.pone.0131325			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147925	Green Published, Green Submitted, gold			2022-12-26	WOS:000358157600089
J	Puncher, GN; Arrizabalaga, H; Alemany, F; Cariani, A; Oray, IK; Karakulak, FS; Basilone, G; Cuttitta, A; Mazzola, S; Tinti, F				Puncher, Gregory Neils; Arrizabalaga, Haritz; Alemany, Francisco; Cariani, Alessia; Oray, Isik K.; Karakulak, F. Saadet; Basilone, Gualtiero; Cuttitta, Angela; Mazzola, Salvatore; Tinti, Fausto			Molecular Identification of Atlantic Bluefin Tuna (Thunnus thynnus, Scombridae) Larvae and Development of a DNA Character-Based Identification Key for Mediterranean Scombrids	PLOS ONE			English	Article							GULF-OF-MEXICO; EGG-PRODUCTION METHOD; GADUS-MORHUA L.; PHYLOGENETIC-RELATIONSHIPS; SPECIES IDENTIFICATION; GENETIC IDENTIFICATION; POPULATION-STRUCTURE; SEQUENCE-ANALYSIS; FISH ASSEMBLAGES; WESTERN	The Atlantic bluefin tuna, Thunnus thynnus, is a commercially important species that has been severely over-exploited in the recent past. Although the eastern Atlantic and Mediterranean stock is now showing signs of recovery, its current status remains very uncertain and as a consequence their recovery is dependent upon severe management informed by rigorous scientific research. Monitoring of early life history stages can inform decision makers about the health of the species based upon recruitment and survival rates. Misidentification of fish larvae and eggs can lead to inaccurate estimates of stock biomass and productivity which can trigger demands for increased quotas and unsound management conclusions. Herein we used a molecular approach employing mitochondrial and nuclear genes (CO1 and ITS1, respectively) to identify larvae (n = 188) collected from three spawning areas in the Mediterranean Sea by different institutions working with a regional fisheries management organization. Several techniques were used to analyze the genetic sequences (sequence alignments using search algorithms, neighbour joining trees, and a genetic character-based identification key) and an extensive comparison of the results is presented. During this process various inaccuracies in related publications and online databases were uncovered. Our results reveal important differences in the accuracy of the taxonomic identifications carried out by different ichthyoplanktologists following morphology-based methods. While less than half of larvae provided were bluefin tuna, other dominant taxa were bullet tuna (Auxis rochei), albacore (Thunnus alalunga) and little tunny (Euthynnus alletteratus). We advocate an expansion of expertise for a new generation of morphology-based taxonomists, increased dialogue between morphology-based and molecular taxonomists and increased scrutiny of public sequence databases.	[Puncher, Gregory Neils; Cariani, Alessia; Tinti, Fausto] Univ Bologna, Dept Biol Geol & Environm Sci, Lab Genet & Genom Marine Resources & Environm Gen, Ravenna, Italy; [Arrizabalaga, Haritz] AZTI Tecnalia, Div Marine Res, Pasaia, Gipuzkoa, Spain; [Alemany, Francisco] Ctr Oceanog Baleares, Inst Espanol Oceanog, Palma De Mallorca, Spain; [Oray, Isik K.; Karakulak, F. Saadet] Istanbul Univ, Fac Fisheries, Istanbul, Turkey; [Basilone, Gualtiero; Cuttitta, Angela; Mazzola, Salvatore] CNR, Inst Marine & Coastal Environm IAMC CNR, Lab Mol Ecol & Biotechnol, Detached Unit Capo Granitola, Trapani, Italy	University of Bologna; AZTI; Spanish Institute of Oceanography; Istanbul University; Consiglio Nazionale delle Ricerche (CNR); L'Istituto per l'Ambiente Marino Costiero (IAMC-CNR)	Puncher, GN (corresponding author), Univ Bologna, Dept Biol Geol & Environm Sci, Lab Genet & Genom Marine Resources & Environm Gen, Ravenna, Italy.	gregoryneil.puncher2@unibo.it	Arrizabalaga, Haritz/B-8238-2009; Karakulak, F. Saadet/B-7602-2018; Cariani, Alessia/L-3459-2016; Cuttitta, Angela/AAK-2097-2020; Tinti, Fausto/D-4847-2012; Basilone, Gualtiero/D-2896-2017	Arrizabalaga, Haritz/0000-0002-3861-6316; Karakulak, F. Saadet/0000-0002-6053-5256; Cariani, Alessia/0000-0002-5513-0086; Cuttitta, Angela/0000-0002-4896-5114; Tinti, Fausto/0000-0002-8649-5387; Basilone, Gualtiero/0000-0002-5732-5055; Alemany, F. (Francisco)/0000-0001-6265-5545; PUNCHER, GREGORY NEILS/0000-0002-4372-8435; Mazzola, Salvatore/0000-0002-4622-8129	European Community [SI2/542789, NMFS NA11NMF4720107]; ICCAT Secretariat; Marine Ecosystem Health and Conservation (MARES) Joint Doctorate programme [FPA 2011-0016]	European Community(European Commission); ICCAT Secretariat; Marine Ecosystem Health and Conservation (MARES) Joint Doctorate programme	This work was carried out under the provision of the ICCAT Atlantic Wide Research Program for Bluefin Tuna (GBYP), funded by the European Community (Grant SI2/542789), Canada, Croatia, Japan, Norway, Turkey, United States (NMFS NA11NMF4720107), Chinese Taipei, and the ICCAT Secretariat (see: http://www.iccat.int/GBYP/en/Budget.htm). The contents of this paper do not necessarily reflect the point of view of ICCAT or of the other funders. This work was co-funded by the Marine Ecosystem Health and Conservation (MARES) Joint Doctorate programme selected under Erasmus Mundus and coordinated by Ghent University (FPA 2011-0016). The funders had no role in study design, data analysis, decision to publish, or preparation of the manuscript.	Aguilar R, 2009, BLUEFIN TUNA LARVAL; Alemany F, 2006, J PLANKTON RES, V28, P473, DOI 10.1093/plankt/fbi123; Alemany F, 2010, PROG OCEANOGR, V86, P21, DOI 10.1016/j.pocean.2010.04.014; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aranda G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076445; Armstrong MJ, 2001, ICES J MAR SCI, V58, P183, DOI 10.1006/jmsc.2000.1001; Block BA, 2005, NATURE, V434, P1121, DOI 10.1038/nature03463; BOEHLERT GW, 1994, MAR ECOL PROG SER, V107, P1, DOI 10.3354/meps107001; Boero F, 2001, TRENDS ECOL EVOL, V16, P266, DOI 10.1016/S0169-5347(01)02133-4; Bremer JRA, 1997, J FISH BIOL, V50, P540, DOI 10.1006/jfbi.1996.0321; Brown SDJ, 2012, MOL ECOL RESOUR, V12, P562, DOI 10.1111/j.1755-0998.2011.03108.x; Cermeno P, 2012, INT COMM CONS ATL CO, V68, P151; Chow S, 2006, J FISH BIOL, V68, P24, DOI 10.1111/j.0022-1112.2006.00945.x; Chow S, 1995, J MOL EVOL, V41, P741, DOI 10.1007/BF00173154; Collins RA, 2013, MOL ECOL RESOUR, V13, P969, DOI 10.1111/1755-0998.12046; Collins RA, 2012, METHODS ECOL EVOL, V3, P457, DOI 10.1111/j.2041-210X.2011.00176.x; Costa FO., 2007, GENOMICS SOC POLICY, V3, P29; Cuttitta A, 2004, HYDROBIOLOGIA, V527, P177, DOI 10.1023/B:HYDR.0000043299.65829.2f; D'Alessandro EK, 2010, MAR ECOL PROG SER, V410, P159, DOI 10.3354/meps08632; DANIEL LB, 1994, FISH B-NOAA, V92, P254; Elliott NG, 1995, MAR FRESHWATER RES, V46, P1021, DOI 10.1071/MF9951021; Fahay M.P., 1983, Journal of Northwest Atlantic Fishery Science, V4, P1; Fahay MP, 2007, EARLY STAGES FISHES, V1; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fox CJ, 2005, MOL ECOL, V14, P879, DOI 10.1111/j.1365-294X.2005.02439.x; Fromentin JM, 2014, MAR POLICY, V47, P8, DOI 10.1016/j.marpol.2014.01.018; Fromentin JM, 2014, FISH OCEANOGR, V23, P147, DOI 10.1111/fog.12050; Fromentin JM, 2005, FISH FISH, V6, P281, DOI 10.1111/j.1467-2979.2005.00197.x; Galuardi B, 2010, CAN J FISH AQUAT SCI, V67, P966, DOI 10.1139/F10-033; Garcia A, 2013, FISH OCEANOGR, V22, P273, DOI 10.1111/fog.12021; Garcia A., 2005, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V58, P535; Garcia A, 2005, COL VOL SCI PAP ICCA, V58, P1261; Giovanardi Otello, 2010, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V65, P740; Hopkins GW, 2002, ANIM CONSERV, V5, P245, DOI 10.1017/S1367943002002299; Hyde JR, 2005, MAR ECOL PROG SER, V286, P269, DOI 10.3354/meps286269; ICCAT, 2013, ICCAT 2013 BLUEF M B, P1; ICCAT, 2014, ICCAT REP STAND COMM; Ingram GW, 2010, AQUAT LIVING RESOUR, V23, P35, DOI 10.1051/alr/2009053; Ingram Jr GW, 2013, INT COMM CONS ATL CO, V69, P1057; Isari S, 2008, ESTUAR COAST SHELF S, V79, P607, DOI 10.1016/j.ecss.2008.06.001; Karakulak S, 2004, J APPL ICHTHYOL, V20, P318, DOI 10.1111/j.1439-0426.2004.00561.x; Kawamura G, 2003, BIG FISH BANG, P123; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Ko HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053451; Koched W, 2013, MEDITERR MAR SCI, V14, P5, DOI 10.12681/mms.314; Kohno H, 1982, JPN J ICHTHYOL, P1; Lindo-Atichati D, 2012, MAR ECOL PROG SER, V463, P245, DOI 10.3354/meps09860; Little DP, 2007, CLADISTICS, V23, P1, DOI 10.1111/j.1096-0031.2006.00126.x; Lowenstein JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007866; Mariani P, 2010, PROG OCEANOGR, V86, P45, DOI 10.1016/j.pocean.2010.04.027; Matarese AC, 2011, ICHTHYOL RES, V58, P170, DOI 10.1007/s10228-010-0198-7; Mather F.J., 1995, NOAA TECHNICAL MEMOR, V370, P1; MATSUMOTO WM, 1972, FISH BULL NATL OC AT, V70, P1; Muhling BA, 2013, MAR ECOL PROG SER, V486, P257, DOI 10.3354/meps10397; Nei M., 2000, MOL EVOLUTION PHYLOG; Oray IK, 2005, J APPL ICHTHYOL, V21, P236, DOI 10.1111/j.1439-0426.2005.00658.x; Paine MA, 2008, ICHTHYOL RES, V55, P7, DOI 10.1007/s10228-007-0003-4; Paine MA, 2007, B MAR SCI, V80, P353; Piccinetti C., 1997, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V46, P207; POTTHOFF T, 1970, B MAR SCI, V20, P389; POTTHOFF T, 1974, FISH B-NOAA, V72, P563; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Reglero P, 2012, MAR ECOL PROG SER, V463, P273, DOI 10.3354/meps09800; Riccioni G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080105; Riccioni G, 2010, P NATL ACAD SCI USA, V107, P2102, DOI 10.1073/pnas.0908281107; Richards W.J., 1974, P623; RICHARDS WJ, 1990, FISH B-NOAA, V88, P607; RICHARDS WJ, 2006, EARLY STAGES ATLANTI, P2187; Richardson DE, 2007, MOL ECOL NOTES, V7, P199, DOI 10.1111/j.1471-8286.2006.01620.x; Rooker JR, 2008, SCIENCE, V322, P742, DOI 10.1126/science.1161473; Rooker JR, 2014, MAR ECOL PROG SER, V504, P265, DOI 10.3354/meps10781; Ross HA, 2008, SYST BIOL, V57, P216, DOI 10.1080/10635150802032990; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sanzo L, 1932, UOVA PRIMI STADI LAR, P189; Scott Gerald P., 2003, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V55, P1123; SCOTT GP, 1993, B MAR SCI, V53, P912; Srivathsan A, 2012, CLADISTICS, V28, P190, DOI 10.1111/j.1096-0031.2011.00370.x; Stratoudakis Y, 2006, FISH FISH, V7, P35, DOI 10.1111/j.1467-2979.2006.00206.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tsuji S., 1997, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V46, P161; Vecchione M, 2000, ICES J MAR SCI, V57, P677, DOI 10.1006/jmsc.2000.0707; Vinas J, 2011, REV FISH BIOL FISHER, V21, P527, DOI 10.1007/s11160-010-9174-6; Vinas J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007606; Ward RD, 2009, J FISH BIOL, V74, P329, DOI 10.1111/j.1095-8649.2008.02080.x; Wilson EO, 2003, TRENDS ECOL EVOL, V18, P77, DOI 10.1016/S0169-5347(02)00040-X; Zhang AB, 2012, MOL ECOL, V21, P1848, DOI 10.1111/j.1365-294X.2011.05235.x	86	23	24	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0130407	10.1371/journal.pone.0130407	http://dx.doi.org/10.1371/journal.pone.0130407			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147931	Green Published, gold			2022-12-26	WOS:000358157600035
J	Takeuchi, F; Sekizuka, T; Ogasawara, Y; Yokoyama, H; Kamikawa, R; Inagaki, Y; Nozaki, T; Sugita-Konishi, Y; Ohnishi, T; Kuroda, M				Takeuchi, Fumihiko; Sekizuka, Tsuyoshi; Ogasawara, Yumiko; Yokoyama, Hiroshi; Kamikawa, Ryoma; Inagaki, Yuji; Nozaki, Tomoyoshi; Sugita-Konishi, Yoshiko; Ohnishi, Takahiro; Kuroda, Makoto			The Mitochondrial Genomes of a Myxozoan Genus Kudoa Are Extremely Divergent in Metazoa	PLOS ONE			English	Article							BASIC LOCAL ALIGNMENT; PHYLOGENETIC-RELATIONSHIPS; PARALICHTHYS-OLIVACEUS; CTENOPHORE MNEMIOPSIS; EVOLUTION; ANNOTATION; SEPTEMPUNCTATA; IDENTIFICATION; VISUALIZATION; CHAETOGNATHS	The Myxozoa are oligo-cellular parasites with alternate hosts-fish and annelid worms- and some myxozoan species harm farmed fish. The phylum Myxozoa, comprising 2,100 species, was difficult to position in the tree of life, due to its fast evolutionary rate. Recent phylogenomic studies utilizing an extensive number of nuclear-encoded genes have confirmed that Myxozoans belong to Cnidaria. Nevertheless, the evolution of parasitism and extreme body simplification in Myxozoa is not well understood, and no myxozoan mitochondrial DNA sequence has been reported to date. To further elucidate the evolution of Myxozoa, we sequenced the mitochondrial genomes of the myxozoan species Kudoa septempunctata, K. hexapunctata and K. iwatai and compared them with those of other metazoans. The Kudoa mitochondrial genomes code for ribosomal RNAs, transfer RNAs, eight proteins for oxidative phosphorylation and three proteins of unknown function, and they are among the metazoan mitochondrial genomes coding the fewest proteins. The mitochondrial- encoded proteins were extremely divergent, exhibiting the fastest evolutionary rate in Metazoa. Nevertheless, the dN/dS ratios of the protein genes in genus Kudoa were approximately 0.1 and similar to other cnidarians, indicating that the genes are under negative selection. Despite the divergent genetic content, active oxidative phosphorylation was indicated by the transcriptome, metabolism and structure of mitochondria in K. septempunctata. As possible causes, we attributed the divergence to the population genetic characteristics shared between the two most divergent clades, Ctenophora and Myxozoa, and to the parasitic lifestyle of Myxozoa. The fast-evolving, functional mitochondria of the genus Kudoa expanded our understanding of metazoan mitochondrial evolution.	[Takeuchi, Fumihiko; Sekizuka, Tsuyoshi; Ogasawara, Yumiko; Kuroda, Makoto] Natl Inst Infect Dis, Pathogen Genom Ctr, Shinjuku Ku, Tokyo, Japan; [Yokoyama, Hiroshi] Univ Tokyo, Dept Aquat Biosci, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo, Japan; [Kamikawa, Ryoma] Kyoto Univ, Grad Sch Human & Environm Studies, Grad Sch Global Environm Studies, Sakyou Ku, Kyoto, Japan; [Inagaki, Yuji; Nozaki, Tomoyoshi] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Nozaki, Tomoyoshi] Natl Inst Infect Dis, Dept Parasitol, Shinjuku Ku, Tokyo 1628640, Japan; [Sugita-Konishi, Yoshiko] Azabu Univ, Dept Food & Life Sci, Sagamihara, Kanagawa, Japan; [Ohnishi, Takahiro] Natl Inst Hlth Sci, Div Microbiol, Setagaya Ku, Tokyo 1588501, Japan	National Institute of Infectious Diseases (NIID); University of Tokyo; Kyoto University; University of Tsukuba; National Institute of Infectious Diseases (NIID); Azabu University; National Institute of Health Sciences - Japan	Takeuchi, F (corresponding author), Natl Inst Infect Dis, Pathogen Genom Ctr, Shinjuku Ku, Tokyo, Japan.	fumihiko@takeuchi.name		Sekizuka, Tsuyoshi/0000-0002-1302-5472; Inagaki, Yuji/0000-0003-0101-8483	Ministry of Health, Labor, and Welfare [H23-Shokuhin-Ippan-007]; Ministry of Education, Culture, Sports, Science and Technology of Japan (KAKENHI) [23117005, 15H05606, 15H14591]	Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology of Japan (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Ministry of Health, Labor, and Welfare (H23-Shokuhin-Ippan-007) and the Ministry of Education, Culture, Sports, Science and Technology of Japan (KAKENHI 23117005, 15H05606, 15H14591). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bawono P, 2014, METHODS MOL BIOL, V1079, P245, DOI 10.1007/978-1-62703-646-7_16; Bergsten J, 2005, CLADISTICS, V21, P163, DOI 10.1111/j.1096-0031.2005.00059.x; Birney E, 2000, GENOME RES, V10, P547, DOI 10.1101/gr.10.4.547; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Canning EU, 2004, ADV PARASIT, V56, P43, DOI 10.1016/S0065-308X(03)56002-X; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Carver T, 2009, BIOINFORMATICS, V25, P119, DOI 10.1093/bioinformatics/btn578; Chaisson MJ, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-238; Chazotte Brad, 2009, Cold Spring Harb Protoc, V2009, DOI 10.1101/pdb.prot4948; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Eitel M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057131; El-Matbouli M, 1998, INT J PARASITOL, V28, P195, DOI 10.1016/S0020-7519(97)00176-8; Evans NM, 2010, MOL BIOL EVOL, V27, P2733, DOI 10.1093/molbev/msq159; Feng JM, 2014, MOL PHYLOGENET EVOL, V81, P10, DOI 10.1016/j.ympev.2014.08.016; Gardner Paul P, 2011, Nucleic Acids Res, V39, pD141, DOI 10.1093/nar/gkq1129; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Han MV, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-356; Helfenbein KG, 2004, P NATL ACAD SCI USA, V101, P10639, DOI 10.1073/pnas.0400941101; Hwang Ui-Wook, 1999, Korean Journal of Parasitology, V37, P215, DOI 10.3347/kjp.1999.37.4.215; Jimenez-Guri E, 2007, SCIENCE, V317, P116, DOI 10.1126/science.1142024; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Kajitani R, 2014, GENOME RES, V24, P1384, DOI 10.1101/gr.170720.113; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kawai T, 2012, CLIN INFECT DIS, V54, P1046, DOI 10.1093/cid/cir1040; Kayal E, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-5; Kent ML, 2001, J EUKARYOT MICROBIOL, V48, P395, DOI 10.1111/j.1550-7408.2001.tb00173.x; Kofler R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015925; Kohn AB, 2012, MOL PHYLOGENET EVOL, V63, P203, DOI 10.1016/j.ympev.2011.12.009; Lavrov DV, 2011, KEY TRANSITIONS IN ANIMAL EVOLUTION, P34; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lom J, 2006, FOLIA PARASIT, V53, P1, DOI 10.14411/fp.2006.001; Makiuchi T, 2014, BIOCHIMIE, V100, P3, DOI 10.1016/j.biochi.2013.11.018; Miyamoto H, 2010, COMP BIOCHEM PHYS D, V5, P65, DOI 10.1016/j.cbd.2009.11.002; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Moroz LL, 2014, NATURE, V510, P109, DOI 10.1038/nature13400; Muller M, 2012, MICROBIOL MOL BIOL R, V76, P444, DOI 10.1128/MMBR.05024-11; Nesnidal MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054576; Ohnishi T, 2013, JPN J INFECT DIS, V66, P348, DOI 10.7883/yoken.66.348; OHTA T, 1972, J MOL EVOL, V1, P305, DOI 10.1007/BF01653959; Papillon D, 2004, MOL BIOL EVOL, V21, P2122, DOI 10.1093/molbev/msh229; Petkau A, 2010, BIOINFORMATICS, V26, P3125, DOI 10.1093/bioinformatics/btq588; Pett W, 2011, MITOCHONDR DNA, V22, P130, DOI 10.3109/19401736.2011.624611; Poyton RO, 2003, OXYGEN SENSING RESPO, P23; Purcell JE, 2001, HYDROBIOLOGIA, V451, P145, DOI 10.1023/A:1011826618539; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rota-Stabelli O, 2009, MOL PHYLOGENET EVOL, V52, P268, DOI 10.1016/j.ympev.2009.01.011; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Siddall ME, 1995, J PARASITOL, V81, P961, DOI 10.2307/3284049; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; SMOTHERS JF, 1994, SCIENCE, V265, P1719, DOI 10.1126/science.8085160; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Sugahara Junichi, 2006, In Silico Biology, V6, P411; Sugahara J, 2007, RNA, V13, P671, DOI 10.1261/rna.309507; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Torruella G, 2012, MOL BIOL EVOL, V29, P531, DOI 10.1093/molbev/msr185; Vaidya AB, 2009, ANNU REV MICROBIOL, V63, P249, DOI 10.1146/annurev.micro.091208.073424; Whelan NV, 2015, P NATL ACAD SCI USA, V112, P5773, DOI 10.1073/pnas.1503453112; Woolfit M, 2003, MOL BIOL EVOL, V20, P1545, DOI 10.1093/molbev/msg167; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yokoyama H, 2012, HEALTH AND ENVIRONMENT IN AQUACULTURE, P3; Zhang P, 2005, GENE, V346, P133, DOI 10.1016/j.gene.2004.10.012; Zhao YA, 2012, BIOINFORMATICS, V28, P125, DOI 10.1093/bioinformatics/btr595	68	21	21	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132030	10.1371/journal.pone.0132030	http://dx.doi.org/10.1371/journal.pone.0132030			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148004	Green Published, gold, Green Submitted			2022-12-26	WOS:000358157600182
J	Das, S; Sondarva, G; Viswakarma, N; Nair, RS; Osipo, C; Tzivion, G; Rana, B; Rana, A				Das, Subhasis; Sondarva, Gautam; Viswakarma, Navin; Nair, Rakesh Sathish; Osipo, Clodia; Tzivion, Guri; Rana, Basabi; Rana, Ajay			Human Epidermal Growth Factor Receptor 2 (HER2) Impedes MLK3 Kinase Activity to Support Breast Cancer Cell Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Akt PKB; c-Jun N-terminal kinase (JNK); epidermal growth factor receptor (EGFR); mitogen-activated protein kinase (MAPK); signal transduction	INHIBITOR; PHOSPHORYLATES; TRASTUZUMAB; HERCEPTIN; GDC-0941; FAMILY; ERBB3	Background: Amplification of HER2 suppresses downstream pro-apoptotic pathways for breast cancer cell survival. Results: The pro-apoptotic MLK3 kinase activity is suppressed by HER2. Conclusion: MLK3 mediates HER2-induced breast cancer cell viability. Significance: Understanding the mechanisms of MLK3 suppression by HER2 provides a basis to target MLK3 in HER2 positive breast cancer. Human epidermal growth factor receptor 2 (HER2) is amplified in approximate to 15-20% of human breast cancer and is important for tumor etiology and therapeutic options of breast cancer. Up-regulation of HER2 oncogene initiates cascades of events cumulating to the stimulation of transforming PI3K/AKT signaling, which also plays a dominant role in supporting cell survival and efficacy of HER2-directed therapies. Although investigating the underlying mechanisms by which HER2 promotes cell survival, we noticed a profound reduction in the kinase activity of a pro-apoptotic mixed lineage kinase 3 (MLK3) in HER2-positive (HER2+) but not in HER2-negative (HER2-) breast cancer tissues, whereas both HER2+ and HER2- tumors expressed a comparable level of MLK3 protein. Furthermore, the kinase activity of MLK3 was inversely correlated with HER2+ tumor grades. Moreover, HER2-directed drugs such as trastuzumab and lapatinib as well as depletion of HER2 or HER3 stimulated MLK3 kinase activity in HER2+ breast cancer cell lines. In addition, the noted inhibitory effect of HER2 on MLK3 kinase activity was mediated via its phosphorylation on Ser(674) by AKT and that pharmacological inhibitors of PI3K/AKT prevented trastuzumab- and lapatinib-induced stimulation of MLK3 activity. Consistent with the pro-apoptotic function of MLK3, stable knockdown of MLK3 in the HER2+ cell line blunted the pro-apoptotic effects of trastuzumab and lapatinib. These findings suggest that HER2 activation inhibits the pro-apoptotic function of MLK3, which plays a mechanistic role in mediating anti-tumor activities of HER2-directed therapies. In brief, MLK3 represents a newly recognized integral component of HER2 biology in HER2+ breast tumors.	[Das, Subhasis; Sondarva, Gautam; Viswakarma, Navin; Nair, Rakesh Sathish; Rana, Ajay] Loyola Univ Chicago, Dept Mol Pharmacol & Therapeut, Maywood, IL 60153 USA; [Osipo, Clodia] Loyola Univ Chicago, Dept Pathol, Maywood, IL 60153 USA; [Tzivion, Guri] Univ Mississippi, Inst Canc, Med Ctr, Jackson, MS 39216 USA; [Tzivion, Guri] Univ Mississippi, Dept Biochem, Med Ctr, Jackson, MS 39216 USA; [Rana, Basabi] Loyola Univ Chicago, Dept Med, Div Gastroenterol & Nutr, Maywood, IL 60153 USA; [Rana, Basabi; Rana, Ajay] Hines Vet Affairs Med Ctr, Hines, IL 60141 USA	Loyola University Chicago; Loyola University Chicago; University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center; Loyola University Chicago; US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital	Rana, A (corresponding author), Loyola Univ, Med Ctr, Dept Pharmacol, Bldg 102,2160 S First Ave, Maywood, IL 60153 USA.	arana@luc.edu	Rana, Ajay/ABE-3739-2020; DAS, SUBHASIS/O-8421-2017; Regan, Clinton/E-6250-2012	Rana, Ajay/0000-0003-0951-2566; DAS, SUBHASIS/0000-0003-1032-4407; 	National Institutes of Health [CA176846, CA178063]; Veterans Affairs Merit Award [BX000571]; NATIONAL CANCER INSTITUTE [R01CA178063, R01CA176846] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000571] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Award(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grant CA176846 (to A. R.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported through National Institutes of Health Grant CA178063 and Veterans Affairs Merit Award BX000571.	Barthwal MK, 2003, J BIOL CHEM, V278, P3897, DOI 10.1074/jbc.M211598200; Baselga J, 2009, NAT REV CANCER, V9, P463, DOI 10.1038/nrc2656; Choi BK, 2012, PROTEIN CELL, V3, P781, DOI 10.1007/s13238-012-2065-y; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Folkes AJ, 2008, J MED CHEM, V51, P5522, DOI 10.1021/jm800295d; Geyer CE, 2006, NEW ENGL J MED, V355, P2733, DOI 10.1056/NEJMoa064320; Gharbi SI, 2007, BIOCHEM J, V404, P15, DOI 10.1042/BJ20061489; Hynes Nancy E, 2005, Discov Med, V5, P483; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Junttila TT, 2009, CANCER CELL, V15, P429, DOI 10.1016/j.ccr.2009.03.020; KIM HH, 1994, J BIOL CHEM, V269, P24747; Lu YH, 2001, JNCI-J NATL CANCER I, V93, P1852, DOI 10.1093/jnci/93.24.1852; Mishra R, 2007, J BIOL CHEM, V282, P30393, DOI 10.1074/jbc.M705895200; Prat A, 2011, MOL ONCOL, V5, P5, DOI 10.1016/j.molonc.2010.11.003; Rana A, 1996, J BIOL CHEM, V271, P19025, DOI 10.1074/jbc.271.32.19025; Rana Ajay, 2013, Genes Cancer, V4, P334, DOI 10.1177/1947601913485415; Rangasamy V, 2012, P NATL ACAD SCI USA, V109, P8149, DOI 10.1073/pnas.1200804109; Rangasamy V, 2010, CANCER RES, V70, P1731, DOI 10.1158/0008-5472.CAN-09-3492; Renoir JM, 2013, BIOCHEM PHARMACOL, V85, P449, DOI 10.1016/j.bcp.2012.10.018; Tebbutt N, 2013, NAT REV CANCER, V13, P663, DOI 10.1038/nrc3559; Yakes FM, 2002, CANCER RES, V62, P4132; Zhang MH, 2014, BIOMED REP, V2, P41, DOI 10.3892/br.2013.187	22	11	11	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2015	290	35					21705	21712		10.1074/jbc.M115.655563	http://dx.doi.org/10.1074/jbc.M115.655563			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ5IS	26152725	Green Published, hybrid			2022-12-26	WOS:000360637600041
J	Glas, M; van Saparoea, HBV; McLaughlin, SH; Roseboom, W; Liu, F; Koningstein, GM; Fish, A; den Blaauwen, T; Heck, AJR; de Jong, L; Bitter, W; de Esch, IJP; Luirink, J				Glas, Marjolein; van Saparoea, H. Bart van den Berg; McLaughlin, Stephen H.; Roseboom, Winfried; Liu, Fan; Koningstein, Gregory M.; Fish, Alexander; den Blaauwen, Tanneke; Heck, Albert J. R.; de Jong, Luitzen; Bitter, Wilbert; de Esch, Iwan J. P.; Luirink, Joen			The Soluble Periplasmic Domains of Escherichia coli Cell Division Proteins FtsQ/FtsB/FtsL Form a Trimeric Complex with Submicromolar Affinity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						analytical ultracentrifugation; cell division; Escherichia coli (E; coli); mass spectrometry (MS); protein cross-linking; protein-protein interaction; surface plasmon resonance (SPR)	SIGNAL RECOGNITION PARTICLE; OF-FLIGHT INSTRUMENT; MASS-SPECTROMETRY; BACILLUS-SUBTILIS; SEPTAL LOCALIZATION; SEQUENCE DATABASES; MEMBRANE-PROTEINS; FTSQ PROTEIN; DIVISOME; DIVIB	Background: The FtsQBL complex plays a key role in bacterial cell division. Results: Periplasmic domains of FtsQ, FtsB, and FtsL form a trimeric complex with submicromolar affinity. Interactions are focused at the C termini of the subunits. Conclusion: FtsQ, FtsB, and FtsL form a complex with 1:1:1 stoichiometry. Significance: Insight into FtsQBL complex formation will facilitate drug design. Cell division in Escherichia coli involves a set of essential proteins that assembles at midcell to form the so-called divisome. The divisome regulates the invagination of the inner membrane, cell wall synthesis, and inward growth of the outer membrane. One of the divisome proteins, FtsQ, plays a central but enigmatic role in cell division. This protein associates with FtsB and FtsL, which, like FtsQ, are bitopic inner membrane proteins with a large periplasmic domain (denoted FtsQ(p), FtsB(p), and FtsL(p)) that is indispensable for the function of each protein. Considering the vital nature and accessible location of the FtsQBL complex, it is an attractive target for protein-protein interaction inhibitors intended to block bacterial cell division. In this study, we expressed FtsQ(p), FtsB(p), and FtsL(p) individually and in combination. Upon co-expression, FtsQ(p) was co-purified with FtsB(p) and FtsL(p) from E. coli extracts as a stable trimeric complex. FtsB(p) was also shown to interact with FtsQ(p) in the absence of FtsL(p) albeit with lower affinity. Interactions were mapped at the C terminus of the respective domains by site-specific cross-linking. The binding affinity and 1:1:1 stoichiometry of the FtsQ(p)B(p)L(p) complex and the FtsQ(p)B(p) subcomplex were determined in complementary surface plasmon resonance, analytical ultracentrifugation, and native mass spectrometry experiments.	[Glas, Marjolein; van Saparoea, H. Bart van den Berg; Koningstein, Gregory M.; Bitter, Wilbert; de Esch, Iwan J. P.; Luirink, Joen] Vrije Univ Amsterdam, Amsterdam Inst Mol Med & Syst, NL-1081 HV Amsterdam, Netherlands; [McLaughlin, Stephen H.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Roseboom, Winfried; de Jong, Luitzen] Univ Amsterdam, Dept Mass Spectrometry Biomacromol, Swammerdam Inst Life Sci, NL-1098 XH Amsterdam, Netherlands; [den Blaauwen, Tanneke] Univ Amsterdam, Swammerdam Inst Life Sci, Dept Bacterial Cell Biol, NL-1098 XH Amsterdam, Netherlands; [Liu, Fan; Heck, Albert J. R.] Univ Utrecht, Bijvoet Ctr Biomol Res, Biomol Mass Spectrometry & Prote, NL-3584 CH Utrecht, Netherlands; [Liu, Fan; Heck, Albert J. R.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, NL-3584 CH Utrecht, Netherlands; [Fish, Alexander] NKI Prot Facil, NL-1066 CX Amsterdam, Netherlands	Vrije Universiteit Amsterdam; MRC Laboratory Molecular Biology; University of Amsterdam; University of Amsterdam; Utrecht University; Utrecht University; Netherlands Cancer Institute	Luirink, J (corresponding author), Vrije Univ Amsterdam, Amsterdam Inst Mol Med & Syst, De Boelelaan 1085, NL-1081 HV Amsterdam, Netherlands.	s.luirink@vu.nl	Luirink, Joen/AAB-8658-2021; Heck, Albert/D-7098-2011; Liu, Fan/O-1138-2015; de Esch, Iwan/K-4909-2017; Bitter, Wilbert/AAA-6872-2019; Bitter, Wilbert/ABG-3726-2020; Bitter, W/CAJ-5778-2022	Heck, Albert/0000-0002-2405-4404; Bitter, Wilbert/0000-0001-8347-6511; Liu, Fan/0000-0002-2358-549X; McLaughlin, Stephen/0000-0001-9135-6253; de Esch, I.J.P./0000-0002-1969-0238; Luirink, J./0000-0001-8431-0804; van den Berg van Saparoea, Bart/0000-0003-3337-5506; den Blaauwen, Tanneke/0000-0002-5403-5597				Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Bottomley AL, 2014, MOL MICROBIOL, V94, P1041, DOI 10.1111/mmi.12813; Buddelmeijer N, 2004, MOL MICROBIOL, V52, P1315, DOI 10.1111/j.1365-2958.2004.04044.x; Buddelmeijer N, 2002, P NATL ACAD SCI USA, V99, P6316, DOI 10.1073/pnas.092128499; Buncherd H, 2014, J CHROMATOGR A, V1348, P34, DOI 10.1016/j.chroma.2014.04.083; Chen JC, 1999, J BACTERIOL, V181, P521, DOI 10.1128/JB.181.2.521-530.1999; D'Ulisse V, 2007, MICROBIOL-SGM, V153, P124, DOI 10.1099/mic.0.2006/000265-0; Daniel RA, 2000, MOL MICROBIOL, V36, P278, DOI 10.1046/j.1365-2958.2000.01857.x; Daniel RA, 2006, J BACTERIOL, V188, P7396, DOI 10.1128/JB.01031-06; DeLano W.L., PYMOL MOL GRAPHICS S; den Blaauwen T, 2008, FEMS MICROBIOL REV, V32, P321, DOI 10.1111/j.1574-6976.2007.00090.x; den Blaauwen T, 2014, BIOORG CHEM, V55, P27, DOI 10.1016/j.bioorg.2014.03.007; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; GEKKO K, 1981, BIOCHEMISTRY-US, V20, P4667, DOI 10.1021/bi00519a023; Ghigo JM, 2000, J BACTERIOL, V182, P116, DOI 10.1128/JB.182.1.116-129.2000; Goehring NW, 2006, MOL MICROBIOL, V61, P33, DOI 10.1111/j.1365-2958.2006.05206.x; Gonzalez MD, 2010, J BACTERIOL, V192, P2757, DOI 10.1128/JB.01609-09; Gonzalez MD, 2009, J BACTERIOL, V191, P2815, DOI 10.1128/JB.01597-08; Grenga L, 2010, NEW BIOTECHNOL, V27, P870, DOI 10.1016/j.nbt.2010.05.002; Guzman LM, 1997, J BACTERIOL, V179, P5094, DOI 10.1128/jb.179.16.5094-5103.1997; Kasper PT, 2007, CHEMBIOCHEM, V8, P1281, DOI 10.1002/cbic.200700150; Khadria AS, 2013, BIOCHEMISTRY-US, V52, P7542, DOI 10.1021/bi4009837; Koenig P, 2010, J BIOL CHEM, V285, P18016, DOI 10.1074/jbc.M110.112649; LaPointe LM, 2013, BIOCHEMISTRY-US, V52, P2574, DOI 10.1021/bi400222r; Li GW, 2014, CELL, V157, P624, DOI 10.1016/j.cell.2014.02.033; Liu B, 2015, MOL MICROBIOL, V95, P945, DOI 10.1111/mmi.12906; Luirink J, 2005, ANNU REV MICROBIOL, V59, P329, DOI 10.1146/annurev.micro.59.030804.121246; Maiolica A, 2007, MOL CELL PROTEOMICS, V6, P2200, DOI 10.1074/mcp.M700274-MCP200; Masson S, 2009, J BIOL CHEM, V284, P27687, DOI 10.1074/jbc.M109.019471; Natale P, 2013, ENVIRON MICROBIOL, V15, P3169, DOI 10.1111/1462-2920.12227; Noirclerc-Savoye M, 2005, MOL MICROBIOL, V55, P413, DOI 10.1111/j.1365-2958.2004.04408.x; OSHANNESSY DJ, 1992, ANAL BIOCHEM, V205, P132, DOI 10.1016/0003-2697(92)90589-Y; Panchaud A, 2010, J PROTEOME RES, V9, P2508, DOI 10.1021/pr9011816; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Robichon C, 2011, J BACTERIOL, V193, P4988, DOI 10.1128/JB.00324-11; Robson SA, 2002, MOL MICROBIOL, V44, P663, DOI 10.1046/j.1365-2958.2002.02920.x; Scheffers DJ, 2007, J BACTERIOL, V189, P7273, DOI 10.1128/JB.00723-07; Schierle CF, 2003, J BACTERIOL, V185, P5706, DOI 10.1128/JB.185.19.5706-5713.2003; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Tahallah N, 2001, RAPID COMMUN MASS SP, V15, P596, DOI 10.1002/rcm.275; Tsang MJ, 2015, MOL MICROBIOL, V95, P925, DOI 10.1111/mmi.12905; Valent QA, 1997, MOL MICROBIOL, V25, P53, DOI 10.1046/j.1365-2958.1997.4431808.x; van den Ent F, 2008, MOL MICROBIOL, V68, P110, DOI 10.1111/j.1365-2958.2008.06141.x; van den Heuvel RHH, 2006, ANAL CHEM, V78, P7473, DOI 10.1021/ac061039a; van Saparoea HBV, 2013, J BIOL CHEM, V288, P24340, DOI 10.1074/jbc.M113.485888; Vicente M, 2006, MOL MICROBIOL, V61, P5, DOI 10.1111/j.1365-2958.2006.05233.x; Villanelo F, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-28; Weiss DS, 1999, J BACTERIOL, V181, P508, DOI 10.1128/JB.181.2.508-520.1999; Young TS, 2010, J MOL BIOL, V395, P361, DOI 10.1016/j.jmb.2009.10.030	50	26	26	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2015	290	35					21498	21509		10.1074/jbc.M115.654756	http://dx.doi.org/10.1074/jbc.M115.654756			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ5IS	26160297	hybrid, Green Published			2022-12-26	WOS:000360637600025
J	Ruiz-Medina, BE; Ross, JA; Kirken, RA				Ruiz-Medina, Blanca E.; Ross, Jeremy A.; Kirken, Robert A.			Interleukin-2 Receptor beta Thr-450 Phosphorylation Is a Positive Regulator for Receptor Complex Stability and Activation of Signaling Molecules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NATURAL-KILLER-CELLS; HUMAN T-CELLS; IL-2 RECEPTOR; SERINE/THREONINE PHOSPHORYLATION; QUANTITATIVE PHOSPHOPROTEOMICS; GAMMA-CHAIN; PROTEIN; PATHWAY; IDENTIFICATION; PROLIFERATION	T, B, and natural killer cells are required for normal immune response and are regulated by cytokines such as IL-2. These cell signals are propagated following receptor-ligand engagement, controlling recruitment and activation of effector proteins. The IL-2 receptor beta subunit (IL-2R beta) serves in this capacity and is known to be phosphorylated. Tyrosine phosphorylation of the beta chain has been studied extensively. However, the identification and putative regulatory roles for serine and threonine phosphorylation sites have yet to be fully characterized. Using LC-MS/MS and phosphospecific antibodies, a novel IL-2/IL-15 inducible IL-2R beta phosphorylation site (Thr-450) was identified. IL-2 phosphokinetic analysis revealed that phosphorylation of IL-2R beta Thr-450 is rapid (2.5 min), transient (peaks at 15 min), and protracted compared with receptor tyrosine phosphorylation and occurs in multiple cell types, including primary human lymphocytes. Pharmacological and siRNA-mediated inhibition of various serine/threonine kinases revealed ERK1/2 as a positive regulator, whereas purified protein phosphatase 1 (PP1), dephosphorylated Thr-450 in vitro. Reconstitution assays demonstrated that Thr-450 is important for regulating IL-2R complex formation, recruitment of JAK3, and activation of AKT and ERK1/2 and a transcriptionally active STAT5. These results provide the first evidence of the identification and functional characterization for threonine phosphorylation of an interleukin receptor.	[Kirken, Robert A.] Univ Texas El Paso, Dept Biol Sci, El Paso, TX 79968 USA; Univ Texas El Paso, Border Biomed Res Ctr, El Paso, TX 79968 USA	University of Texas System; University of Texas El Paso; University of Texas System; University of Texas El Paso	Kirken, RA (corresponding author), Univ Texas El Paso, Dept Biol Sci, 500 W Univ Ave, El Paso, TX 79968 USA.	rkirken@utep.edu		Ruiz-Medina, Blanca E./0000-0003-1947-4014	National Institute on Minority Health and Health Disparities/National Institutes of Health [2G12MD007592]; Lizanell and Colbert Coldwell Foundation; Edward N. and Margaret G. Marsh Foundation; Woman's Auxiliary Fellowship; National Institute on Minority Health and Health Disparities [G12MD007592] Funding Source: NIH RePORTER	National Institute on Minority Health and Health Disparities/National Institutes of Health; Lizanell and Colbert Coldwell Foundation; Edward N. and Margaret G. Marsh Foundation; Woman's Auxiliary Fellowship; National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported, in whole or in part, by National Institute on Minority Health and Health Disparities/National Institutes of Health Grant 2G12MD007592. This work was also supported by grants from the Lizanell and Colbert Coldwell Foundation (to R. A. K.), the Edward N. and Margaret G. Marsh Foundation, and the Woman's Auxiliary Fellowship (to B. E. R.). The authors declare that they have no conflicts of interest with the contents of this article.	Amanchy R, 2007, NAT BIOTECHNOL, V25, P285, DOI 10.1038/nbt0307-285; Amu S, 2007, SCAND J IMMUNOL, V65, P182, DOI 10.1111/j.1365-3083.2006.01889.x; ASAO H, 1990, J EXP MED, V171, P637, DOI 10.1084/jem.171.3.637; Atkinson TP, 2012, CURR OPIN RHEUMATOL, V24, P515, DOI 10.1097/BOR.0b013e32835680c6; Barton A, 2008, NAT GENET, V40, P1156, DOI 10.1038/ng.218; Brockdorff J, 1997, TISSUE ANTIGENS, V49, P228, DOI 10.1111/j.1399-0039.1997.tb02743.x; Bucheton B, 2007, GENES IMMUN, V8, P79, DOI 10.1038/sj.gene.6364355; Buitenhuis M, 2004, INT J BIOCHEM CELL B, V36, P2120, DOI 10.1016/j.biocel.2003.11.008; Bunn PA, 1996, J CELL BIOCHEM, P12; Cheng H, 2008, MOL CELL BIOL, V28, P2271, DOI 10.1128/MCB.01789-07; Conlon KC, 2015, J CLIN ONCOL, V33, P74, DOI 10.1200/JCO.2014.57.3329; Delespine-Carmagnat M, 1999, FEBS LETT, V447, P241, DOI 10.1016/S0014-5793(99)00301-4; Depontieu FR, 2009, P NATL ACAD SCI USA, V106, P12073, DOI 10.1073/pnas.0903852106; DUPREZ V, 1992, J BIOL CHEM, V267, P18639; Espino-Paisan L, 2011, AUTOIMMUNITY, V44, P624, DOI 10.3109/08916934.2011.592515; Friedman MC, 1996, P NATL ACAD SCI USA, V93, P2077, DOI 10.1073/pnas.93.5.2077; Fujii H, 1998, EMBO J, V17, P6551, DOI 10.1093/emboj/17.22.6551; Fung MM, 2003, CELL SIGNAL, V15, P625, DOI 10.1016/S0898-6568(03)00003-2; Gaffen SL, 2001, CYTOKINE, V14, P63, DOI 10.1006/cyto.2001.0862; Gilmour KC, 2001, BLOOD, V98, P877, DOI 10.1182/blood.V98.3.877; Gregersen PK, 2009, ANNU REV IMMUNOL, V27, P363, DOI 10.1146/annurev.immunol.021908.132653; Heroes E, 2013, FEBS J, V280, P584, DOI 10.1111/j.1742-4658.2012.08547.x; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Kim HP, 2006, CYTOKINE GROWTH F R, V17, P349, DOI 10.1016/j.cytogfr.2006.07.003; KIRKEN RA, 1995, CYTOKINE, V7, P689, DOI 10.1006/cyto.1995.0081; Kirken RA, 1997, J BIOL CHEM, V272, P15459, DOI 10.1074/jbc.272.24.15459; KIRKEN RA, 1994, J BIOL CHEM, V269, P19136; Leonard WJ, 1996, NAT MED, V2, P968, DOI 10.1038/nm0996-968; Lin JX, 2000, ONCOGENE, V19, P2566, DOI 10.1038/sj.onc.1203523; Lockyer HM, 2007, J IMMUNOL, V179, P5301, DOI 10.4049/jimmunol.179.8.5301; LOWENTHAL JW, 1985, NATURE, V315, P669, DOI 10.1038/315669a0; Malabarba MG, 1996, BIOCHEM J, V319, P865, DOI 10.1042/bj3190865; Mazurkiewicz-Munoz AM, 2006, MOL CELL BIOL, V26, P4052, DOI 10.1128/MCB.01591-05; McCubrey JA, 2000, LEUKEMIA, V14, P9, DOI 10.1038/sj.leu.2401657; Mitra A, 2012, J BIOL CHEM, V287, P16596, DOI 10.1074/jbc.M111.319756; MIYOSHI I, 1981, GANN, V72, P978; Molina JR, 2006, J THORAC ONCOL, V1, P7, DOI 10.1097/01243894-200601000-00004; Morales JK, 2010, GENES IMMUN, V11, P599, DOI 10.1038/gene.2010.35; Morgan TM, 2009, CURR CANCER DRUG TAR, V9, P237, DOI 10.2174/156800909787580999; Nelson BH, 1998, ADV IMMUNOL, V70, P1, DOI 10.1016/S0065-2776(08)60386-7; Nifoussi SK, 2014, J BIOL CHEM, V289, P21950, DOI 10.1074/jbc.M114.587873; Nyga R, 2005, BIOCHEM J, V390, P359, DOI 10.1042/BJ20041523; Ohori M, 2005, BIOCHEM BIOPH RES CO, V336, P357, DOI 10.1016/j.bbrc.2005.08.082; Olejniczak K, 2008, MED SCI MONITOR, V14, pRA179; Osinalde N, 2015, PROTEOMICS, V15, P520, DOI 10.1002/pmic.201400194; Osinalde N, 2011, J PROTEOMICS, V75, P177, DOI 10.1016/j.jprot.2011.06.007; Pal Z, 2010, J NEUROIMMUNOL, V229, P107, DOI 10.1016/j.jneuroim.2010.07.015; Peti W, 2013, FEBS J, V280, P596, DOI 10.1111/j.1742-4658.2012.08509.x; Refaeli Y, 1998, IMMUNITY, V8, P615, DOI 10.1016/S1074-7613(00)80566-X; ROBB RJ, 1987, P NATL ACAD SCI USA, V84, P2002, DOI 10.1073/pnas.84.7.2002; Rodriguez G, 2013, J BIOL CHEM, V288, P7137, DOI 10.1074/jbc.M112.408765; ROSENBERG SA, 1994, JAMA-J AM MED ASSOC, V271, P907, DOI 10.1001/jama.271.12.907; Ross JA, 2008, J BIOL CHEM, V283, P4699, DOI 10.1074/jbc.M708232200; Ross JA, 2010, J BIOL CHEM, V285, P3582, DOI 10.1074/jbc.M109.053843; Shuai K, 2003, NAT REV IMMUNOL, V3, P900, DOI 10.1038/nri1226; Sliva D, 2000, BIOCHEM J, V345, P741, DOI 10.1042/0264-6021:3450741; STARKEBAUM G, 1991, INT J CANCER, V49, P246, DOI 10.1002/ijc.2910490218; TAKESHITA T, 1992, SCIENCE, V257, P379, DOI 10.1126/science.1631559; TANAKA N, 1994, P NATL ACAD SCI USA, V91, P7271, DOI 10.1073/pnas.91.15.7271; TRINCHIERI G, 1984, J EXP MED, V160, P1147, DOI 10.1084/jem.160.4.1147; VOSS SD, 1992, J EXP MED, V176, P531, DOI 10.1084/jem.176.2.531; Waldmann TA, 2006, NAT REV IMMUNOL, V6, P595, DOI 10.1038/nri1901; Wang XQ, 2005, SCIENCE, V310, P1159, DOI 10.1126/science.1117893; Wang YL, 2004, J BIOL CHEM, V279, P25196, DOI 10.1074/jbc.M313668200; Woetmann A, 2003, J BIOL CHEM, V278, P2787, DOI 10.1074/jbc.M210196200; Woetmann A, 1999, P NATL ACAD SCI USA, V96, P10620, DOI 10.1073/pnas.96.19.10620; Yang XY, 1998, J BIOL CHEM, V273, P29879, DOI 10.1074/jbc.273.45.29879; Yu AX, 2009, IMMUNITY, V30, P204, DOI 10.1016/j.immuni.2008.11.014	68	8	8	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2015	290	34					20972	20983		10.1074/jbc.M115.660654	http://dx.doi.org/10.1074/jbc.M115.660654			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP6QC	26152718	Green Published, hybrid			2022-12-26	WOS:000360011800031
J	Reed, BJ; Locke, MN; Gardner, RG				Reed, Benjamin J.; Locke, Melissa N.; Gardner, Richard G.			A Conserved Deubiquitinating Enzyme Uses Intrinsically Disordered Regions to Scaffold Multiple Protein Interaction Sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							QUALITY CONTROL DEGRADATION; RNA-POLYMERASE I; SACCHAROMYCES-CEREVISIAE; SECONDARY STRUCTURE; UBIQUITIN LIGASE; CELL-GROWTH; HISTONE H2B; WEB SERVER; SEQUENCE; ROLES	In the canonical view of protein function, it is generally accepted that the three-dimensional structure of a protein determines its function. However, the past decade has seen a dramatic growth in the identification of proteins with extensive intrinsically disordered regions (IDRs), which are conformationally plastic and do not appear to adopt single three-dimensional structures. One current paradigm for IDR function is that disorder enables IDRs to adopt multiple conformations, expanding the ability of a protein to interact with a wide variety of disparate proteins. The capacity for many interactions is an important feature of proteins that occupy the hubs of protein networks, in particular protein-modifying enzymes that usually have a broad spectrum of substrates. One such protein modification is ubiquitination, where ubiquitin is attached to proteins through ubiquitin ligases (E3s) and removed through deubiquitinating enzymes. Numerous proteomic studies have found that thousands of proteins are dynamically regulated by cycles of ubiquitination and deubiquitination. Thus, how these enzymes target their wide array of substrates is of considerable importance for understanding the function of the cell's diverse ubiquitination networks. Here, we characterize a yeast deubiquitinating enzyme, Ubp10, that possesses IDRs flanking its catalytic protease domain. We show that Ubp10 possesses multiple, distinct binding modules within its IDRs that are necessary and sufficient for directing protein interactions important for Ubp10's known roles in gene silencing and ribosome biogenesis. The human homolog of Ubp10, USP36, also has IDRs flanking its catalytic domain, and these IDRs similarly contain binding modules important for protein interactions. This work highlights the significant protein interaction scaffolding abilities of IDRs in the regulation of dynamic protein ubiquitination.	[Reed, Benjamin J.; Locke, Melissa N.; Gardner, Richard G.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Gardner, RG (corresponding author), Univ Washington, Dept Pharmacol, Box 357280,1959 NE Pacific St, Seattle, WA 98195 USA.	gardnerr@uw.edu		Gardner, Richard/0000-0003-2162-6275; Locke, Melissa/0000-0001-8162-1471	National Institutes of Health/NIGMS Training Grant [5T32GM007750]; Sidney Kimmel Scholar Award; Ellison Medical Foundation New Scholar Award in Aging; Marian E. Smith Junior Faculty Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007750] Funding Source: NIH RePORTER	National Institutes of Health/NIGMS Training Grant; Sidney Kimmel Scholar Award; Ellison Medical Foundation New Scholar Award in Aging; Marian E. Smith Junior Faculty Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This worked was supported by National Institutes of Health/NIGMS Training Grant 5T32GM007750 (to B. J. R.), a Sidney Kimmel Scholar Award (to R. G. G.), an Ellison Medical Foundation New Scholar Award in Aging (to R. G. G.), and a Marian E. Smith Junior Faculty Award (to R. G. G.). The authors declare that they have no conflicts of interest with the contents of this article.	[Anonymous], 1991, Methods Enzymol, V194, P1; Bhowmick P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065443; Bothner B, 2001, J MOL BIOL, V314, P263, DOI 10.1006/jmbi.2001.5110; Buszczak M, 2009, SCIENCE, V323, P248, DOI 10.1126/science.1165678; Canzio D, 2014, TRENDS CELL BIOL, V24, P377, DOI 10.1016/j.tcb.2014.01.002; Ciechanover A, 2006, NEUROLOGY, V66, pS7, DOI 10.1212/01.wnl.0000192261.02023.b8; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Cumberworth A, 2013, BIOCHEM J, V454, P361, DOI 10.1042/BJ20130545; Dang LC, 1998, BIOCHEMISTRY-US, V37, P1868, DOI 10.1021/bi9723360; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dosztanyi Z, 2006, J PROTEOME RES, V5, P2985, DOI 10.1021/pr060171o; Dosztanyi Z, 2009, BIOINFORMATICS, V25, P2745, DOI 10.1093/bioinformatics/btp518; Dunker AK, 2015, SEMIN CELL DEV BIOL, V37, P44, DOI 10.1016/j.semcdb.2014.09.025; Emre NCT, 2005, MOL CELL, V17, P585, DOI 10.1016/j.molcel.2005.01.007; Endo A, 2009, J BIOL CHEM, V284, P27918, DOI 10.1074/jbc.M109.037218; Endo A, 2009, J CELL SCI, V122, P678, DOI 10.1242/jcs.044461; Fontana A, 2004, ACTA BIOCHIM POL, V51, P299; Fredrickson EK, 2011, MOL BIOL CELL, V22, P2384, DOI 10.1091/mbc.E11-03-0256; Gallego-Sanchez A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002826; Gardner RG, 2005, MOL CELL BIOL, V25, P6123, DOI 10.1128/MCB.25.14.6123-6139.2005; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Habchi J, 2014, CHEM REV, V114, P6561, DOI 10.1021/cr400514h; Hsu WL, 2013, PROTEIN SCI, V22, P258, DOI 10.1002/pro.2207; Hu M, 2002, CELL, V111, P1041, DOI 10.1016/S0092-8674(02)01199-6; James P, 1996, GENETICS, V144, P1425; Kahana A, 1999, MOL CELL BIOL, V19, P6608; Kahana A, 2001, BIOCHEM BIOPH RES CO, V282, P916, DOI 10.1006/bbrc.2001.4669; Li Jianduan, 2008, Int J Med Sci, V5, P133; Lis ET, 2006, MOL CELL BIOL, V26, P4122, DOI 10.1128/MCB.01640-05; Mark WY, 2005, J MOL BIOL, V345, P275, DOI 10.1016/j.jmb.2004.10.045; Mittag T, 2010, STRUCTURE, V18, P494, DOI 10.1016/j.str.2010.01.020; Mosca R, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014969; Pancsa R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034687; Peltonen K, 2014, CANCER CELL, V25, P77, DOI 10.1016/j.ccr.2013.12.009; Phipps KR, 2011, WIRES RNA, V2, P1, DOI 10.1002/wrna.57; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Richardson LA, 2012, CELL REP, V2, P372, DOI 10.1016/j.celrep.2012.07.009; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Rosenbaum JC, 2011, MOL CELL, V41, P93, DOI 10.1016/j.molcel.2010.12.004; Schlessinger A, 2011, CURR OPIN STRUC BIOL, V21, P412, DOI 10.1016/j.sbi.2011.03.014; Schulze JM, 2011, GENE DEV, V25, P2242, DOI 10.1101/gad.177220.111; Singer MS, 1998, GENETICS, V150, P613; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Tompa P, 2009, BIOESSAYS, V31, P328, DOI 10.1002/bies.200800151; Uversky VN, 2015, FEBS J, V282, P1182, DOI 10.1111/febs.13202; Van Roey K, 2014, CHEM REV, V114, P6733, DOI 10.1021/cr400585q; Wright PE, 2015, NAT REV MOL CELL BIO, V16, P18, DOI 10.1038/nrm3920	48	18	21	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2015	290	33					20601	20612		10.1074/jbc.M115.650952	http://dx.doi.org/10.1074/jbc.M115.650952			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP1AT	26149687	hybrid, Green Published			2022-12-26	WOS:000359608900055
J	Ballard, SB; Reaves, EJ; Luna, CG; Silva, ME; Rocha, C; Heitzinger, K; Saito, M; Apaza, S; Espetia, S; Blazes, DL; Tilley, DH; Aguilar, RCG; Gilman, RH; Bausch, DG				Ballard, Sarah-Blythe; Reaves, Erik J.; Giannina Luna, C.; Silva, Maria E.; Rocha, Claudio; Heitzinger, Kristen; Saito, Mayuko; Apaza, Sonia; Espetia, Susan; Blazes, David L.; Tilley, Drake H.; Guzman Aguilar, Rene C.; Gilman, Robert H.; Bausch, Daniel G.			Epidemiology and Genetic Characterization of Noroviruses among Adults in an Endemic Setting, Peruvian Amazon Basin, 2004-2011	PLOS ONE			English	Article							GASTROENTERITIS; DIARRHEA; DISEASE; VACCINE; SHIPS	Background Successful vaccination strategies against norovirus will require understanding the burden of disease and relevant genotypes in populations. However, few data are available from cohort studies of adults living in low-and middle-income countries (LMIC). Materials and Methods We conducted a nested case-control study within a Peruvian military cohort to characterize the burden of norovirus infection, predominant genotypes, and associated symptoms from 2004 through 2011. Randomly selected case and control stools were tested for norovirus, bacteria, and parasites. The odds ratio of the association between norovirus infection and diarrhea was estimated using multiple logistic regression and co-infection adjusted attributable fractions were calculated. Results Of the 3,818 cohort study participants, 624 developed diarrhea. Overall and norovirus-associated diarrhea incidence rates were 42.3 and 6.0 per 100 person-years, respectively. The most prevalent norovirus genogroup was GII (72.5%, 29/40), which was associated with diarrhea (AOR 3.4, 95% CI: 1.3-8.7, P = 0.012). The co-infection adjusted GII attributable fraction was 6.4%. Discussion Norovirus was a frequent cause of diarrhea in an adult population followed longitudinally in an LMIC setting. Vaccine strategies should consider targeting adults in endemic settings and special populations that could serve as community transmission sources.	[Ballard, Sarah-Blythe; Gilman, Robert H.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21218 USA; [Ballard, Sarah-Blythe; Reaves, Erik J.; Giannina Luna, C.; Silva, Maria E.; Bausch, Daniel G.] US Med Res Unit 6, Emerging Infect Dis Dept, Lima, Peru; [Rocha, Claudio; Heitzinger, Kristen; Tilley, Drake H.] US Med Res Unit 6, Dept Bacteriol, Lima, Peru; [Heitzinger, Kristen] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Saito, Mayuko] Tohoku Univ, Grad Sch Med, Dept Virol, Sendai, Miyagi 980, Japan; [Saito, Mayuko; Apaza, Sonia; Espetia, Susan] Univ Peruana Cayetano Heredia, Labs Invest & Desarrollamiento, Lima, Peru; [Blazes, David L.] Uniformed Serv Univ Hlth Sci, Dept Prevent Med & Biometr, Bethesda, MD 20814 USA; [Guzman Aguilar, Rene C.] Policlin Militar Chorrillos, Chorrillos, Peru; [Gilman, Robert H.] Asociac Benef PRISMA, Lima, Peru; [Bausch, Daniel G.] Tulane Sch Publ Hlth & Trop Med, Dept Trop Med, New Orleans, LA USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Washington; University of Washington Seattle; Tohoku University; Universidad Peruana Cayetano Heredia; Uniformed Services University of the Health Sciences - USA; Tulane University	Ballard, SB (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21218 USA.	sballar3@jhu.edu	Rocha, Claudio A./N-4440-2017; Saito, Mayuko/J-4508-2018	Rocha, Claudio A./0000-0003-4221-3883; Saito, Mayuko/0000-0003-4622-7027; Espetia, Susan/0000-0002-1160-9677	Wenzhou Medical Association; Zhejiang Provincial Key Discipline-Neurobiology [437201203]; MRC [MR/K007467/1] Funding Source: UKRI; Medical Research Council [MR/K007467/1] Funding Source: researchfish	Wenzhou Medical Association; Zhejiang Provincial Key Discipline-Neurobiology; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study was funded by grants from Wenzhou Medical Association and partly supported by Zhejiang Provincial Key Discipline-Neurobiology (437201203). The funders had no role in the study design; in the collection, analysis and interpretation of data; in the writing of the manuscript; and in the decision to submit the paper for publication.	Apaza S, 2012, JOVE-J VIS EXP, DOI 10.3791/3232; Atmar RL, 2008, EMERG INFECT DIS, V14, P1553, DOI 10.3201/eid1410.080117; Atmar RL, 2006, GASTROENTEROL CLIN N, V35, P275, DOI 10.1016/j.gtc.2006.03.001; Atmar RL, 2011, NEW ENGL J MED, V365, P2178, DOI 10.1056/NEJMoa1101245; Fernandez MDB, 2011, INFECT GENET EVOL, V11, P1631, DOI 10.1016/j.meegid.2011.06.005; BRUZZI P, 1985, AM J EPIDEMIOL, V122, P904, DOI 10.1093/oxfordjournals.aje.a114174; Centers for Disease Control and Prevention, 2013, ISOLATION VIBRIO CHO, P16; Chan MCW, 2006, EMERG INFECT DIS, V12, P1278, DOI 10.3201/eid1708.060081; Chapman Alice S, 2011, MSMR, V18, P2; Cramer EH, 2003, AM J PREV MED, V24, P227, DOI 10.1016/S0749-3797(02)00644-X; Desai R, 2012, CLIN INFECT DIS, V55, P189, DOI 10.1093/cid/cis372; El-Kamary SS, 2010, J INFECT DIS, V202, P1649, DOI 10.1086/657087; Ferreira MSR, 2010, J MED VIROL, V82, P1442, DOI 10.1002/jmv.21831; Frey S, 2011, 49 ANN M INFECT DIS; GILMAN RH, 1976, T ROY SOC TROP MED H, V70, P313, DOI 10.1016/0035-9203(76)90085-7; Glass RI, 2009, NEW ENGL J MED, V361, P1776, DOI 10.1056/NEJMra0804575; Gray L, 1995, MANUAL CLIN MICROBIO; Hugh R, 1970, MANUAL CLIN MICROBIO; Jones FR, 2004, AM J TROP MED HYG, V70, P663, DOI 10.4269/ajtmh.2004.70.663; JUNG RC, 1951, PEDIATRICS, V8, P548; Kaufman SS, 2005, J PEDIATR GASTR NUTR, V40, P328, DOI 10.1097/01.MPG.0000155182.54001.48; Kroneman A, 2011, J CLIN VIROL, V51, P121, DOI 10.1016/j.jcv.2011.03.006; Lam TTY, 2012, J GEN VIROL, V93, P817, DOI 10.1099/vir.0.039057-0; Lee N, 2007, EMERG INFECT DIS, V13, P1399, DOI 10.3201/eid1309.061535; Lello J, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2813; Lindesmith LC, 2008, PLOS MED, V5, P269, DOI 10.1371/journal.pmed.0050031; Lopman BA, 2004, EMERG INFECT DIS, V10, P1827, DOI 10.3201/eid1010.030941; Lopman B, 2014, AM J EPIDEMIOL, V179, P507, DOI 10.1093/aje/kwt287; McAtee CL, MOL EPIDEMIOLOGY POS; Nachamkin I., 1999, MANUAL CLIN MICROBIO; Patel MM, 2009, J CLIN VIROL, V44, P1, DOI 10.1016/j.jcv.2008.10.009; Payne DC, 2013, NEW ENGL J MED, V368, P1121, DOI 10.1056/NEJMsa1206589; Riddle MS, 2004, MIL MED, V169, P787, DOI 10.7205/MILMED.169.10.787; RITCHIE LAWRENCE S., 1948, BULL U S ARMY MED DEPT, V8, P326; Saito M, 2014, CLIN INFECT DIS, V58, P483, DOI 10.1093/cid/cit763; STACYPHIPPS S, 1995, J CLIN MICROBIOL, V33, P1054, DOI 10.1128/JCM.33.5.1054-1059.1995; Vesikari T, 2011, 6 INT VACC ENT DIS C; Yori PP, 2009, PEDIATR INFECT DIS J, V28, P844, DOI 10.1097/INF.0b013e3181a24730	38	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131646	10.1371/journal.pone.0131646	http://dx.doi.org/10.1371/journal.pone.0131646			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161556	Green Published, gold, Green Submitted			2022-12-26	WOS:000358162300052
J	Castellano, R; Perruchot, MH; Conde-Aguilera, JA; van Milgen, J; Collin, A; Tesseraud, S; Mercier, Y; Gondret, F				Castellano, Rosa; Perruchot, Marie-Helene; Conde-Aguilera, Jose Alberto; van Milgen, Jaap; Collin, Anne; Tesseraud, Sophie; Mercier, Yves; Gondret, Florence			A Methionine Deficient Diet Enhances Adipose Tissue Lipid Metabolism and Alters Anti-Oxidant Pathways in Young Growing Pigs	PLOS ONE			English	Article							FATTY-ACID SYNTHESIS; OXIDATIVE STRESS; BODY PROTEIN; AMINO-ACIDS; RESTRICTION; GLUTATHIONE; MUSCLE; LIVER; SUPPLEMENTATION; EXPRESSION	Methionine is a rate-limiting amino-acid for protein synthesis but non-proteinogenic roles on lipid metabolism and oxidative stress have been demonstrated. Contrary to rodents where a dietary methionine deficiency led to a lower adiposity, an increased lipid accretion rate has been reported in growing pigs fed a methionine deficient diet. This study aimed to clarify the effects of a dietary methionine deficiency on different aspects of tissue lipid metabolism and anti-oxidant pathways in young pigs. Post-weaned pigs (9.8 kg initial body weight) were restrictively-fed diets providing either an adequate (CTRL) or a deficient methionine supply (MD) during 10 days (n=6 per group). At the end of the feeding trial, pigs fed the MD diet had higher lipid content in subcutaneous adipose tissue. Expression levels of genes involved in glucose uptake, lipogenesis but also lipolysis, and activities of NADPH enzyme suppliers were generally higher in subcutaneous and perirenal adipose tissues of MD pigs, suggesting an increased lipid turnover in those pigs. Activities of the anti-oxidant enzymes superoxide dismutase, catalase and glutathione reductase were increased in adipose tissues and muscle of MD pigs. Expression level and activity of the glutathione peroxidase were also higher in liver of MD pigs, but hepatic contents in the reduced and oxidized forms of glutathione and glutathione reductase activity were lower compared with control pigs. In plasma, superoxide dismutase activity was higher but total anti-oxidant power was lower in MD pigs. These results show that a dietary methionine deficiency resulted in increased levels of lipogenesis and lipolytic indicators in porcine adipose tissues. Decreased glutathione content in the liver and coordinated increase of enzymatic antioxidant activities in adipose tissues altered the cellular redox status of young pigs fed a methionine-deficient diet. These findings illustrate that a rapidly growing animal differently adapts tissue metabolisms when facing an insufficient methionine supply.	[Castellano, Rosa; Perruchot, Marie-Helene; Conde-Aguilera, Jose Alberto; van Milgen, Jaap; Gondret, Florence] INRA, UMR PEGASE 1348, St Gilles, France; [Castellano, Rosa; Perruchot, Marie-Helene; Conde-Aguilera, Jose Alberto; van Milgen, Jaap; Gondret, Florence] Agrocampus Ouest, UMR PEGASE 1348, Rennes, France; [Collin, Anne; Tesseraud, Sophie] INRA, UR83 Rech Avicoles URA, F-37380 Nouzilly, France; [Mercier, Yves] Adisseo France SAS, Antony, France	INRAE; Institut Agro; Agrocampus Ouest; INRAE; Adisseo France S.A.S.	Gondret, F (corresponding author), INRA, UMR PEGASE 1348, St Gilles, France.	Florence.gondret@rennes.inra.fr	van Milgen, Jaap/F-2787-2011	van Milgen, Jaap/0000-0002-6131-5255; Gondret, Florence/0000-0001-7997-1560; Perruchot, Marie-Helene/0000-0002-6608-9445	ADISSEO; INRA	ADISSEO(Adisseo France S.A.S.); INRA	The present study was supported by Research Grants from ADISSEO and INRA and both have contributed to the study design and manuscript preparation. The funder INRA also contributed to the conduct of the study, analysis of the samples and data, and interpretation of the findings. Funders did not interfere with the full presentation of this research, objective interpretation of the data and decision to submit for publication.	BASS A, 1969, EUR J BIOCHEM, V10, P198, DOI 10.1111/j.1432-1033.1969.tb00674.x; BATTERHAM ES, 1993, BRIT J NUTR, V70, P711, DOI 10.1079/BJN19930166; Bazin R, 2000, METH MOL B, V155, P121; Berg F, 2006, PLOS GENET, V2, P1178, DOI 10.1371/journal.pgen.0020129; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Conde-Aguilera JA, 2010, ANIMAL, V4, P1349, DOI 10.1017/S1751731110000340; Conde-Aguilera JA, 2015, EUR J NUTR; Corominas J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-843; Esworthy RS, 2001, CURR PROTOC TOXICOL; Flachs P, 2013, BBA-MOL CELL BIOL L, V1831, P986, DOI 10.1016/j.bbalip.2013.02.003; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Gardan D, 2008, DOMEST ANIM ENDOCRIN, V34, P45, DOI 10.1016/j.domaniend.2006.10.001; GRIFFITH OW, 1980, ANAL BIOCHEM, V106, P207, DOI 10.1016/0003-2697(80)90139-6; Hasek BE, 2013, DIABETES, V62, P3362, DOI 10.2337/db13-0501; Hasek BE, 2010, AM J PHYSIOL-REG I, V299, pR728, DOI 10.1152/ajpregu.00837.2009; Henry Y, 1993, INRA PROD ANIM, V6, P199; Hocquette JF, 2010, ANIMAL, V4, P303, DOI 10.1017/S1751731109991091; Kloareg M, 2007, BRIT J NUTR, V97, P35, DOI 10.1017/S0007114507205793; Lowenstein JM, 1969, METHOD ENZYMOL, P3, DOI [10.1016/0076-6879(69)13005-0, DOI 10.1016/0076-6879(69)13005-0]; Maddineni S, 2013, EXP BIOL MED, V238, P392, DOI 10.1177/1535370213477988; Malloy VL, 2006, AGING CELL, V5, P305, DOI 10.1111/j.1474-9726.2006.00220.x; Martinez-Ramirez HR, 2008, J ANIM SCI, V86, P2156, DOI 10.2527/jas.2007-0235; MASSEY V, 1965, J BIOL CHEM, V240, P4470; Metayer S, 2008, J NUTR BIOCHEM, V19, P207, DOI 10.1016/j.jnutbio.2007.05.006; Milani P, 2013, NEUROBIOL DIS, V60, P51, DOI 10.1016/j.nbd.2013.08.005; Morales FJ, 2001, FOOD CHEM, V72, P119, DOI 10.1016/S0308-8146(00)00239-9; Morand C, 1997, J NUTR BIOCHEM, V8, P246, DOI 10.1016/S0955-2863(97)89661-1; Mourot J, 1999, REPROD NUTR DEV, V39, P125, DOI 10.1051/rnd:19990145; National Research Council, 1998, NUTR REQ SWIN, Vtenth; OHEA EK, 1969, J NUTR, V99, P338, DOI 10.1093/jn/99.3.338; Park J, 2007, DIABETES RES CLIN PR, V77, pS11, DOI 10.1016/j.diabres.2007.01.037; Perrone CE, 2008, J LIPID RES, V49, P12, DOI 10.1194/jlr.M700194-JLR200; Perrone CE, 2013, EXP GERONTOL, V48, P654, DOI 10.1016/j.exger.2012.07.005; Perrone CE, 2012, J NUTRIGENET NUTRIGE, V5, P132, DOI 10.1159/000339347; Plaisance EP, 2010, AM J PHYSIOL-REG I, V299, pR740, DOI 10.1152/ajpregu.00838.2009; Richie JP, 2004, NUTRITION, V20, P800, DOI 10.1016/j.nut.2004.05.009; Sadi G, 2012, DIABETES-METAB RES, V28, P228, DOI 10.1002/dmrr.1302; Sahena F, 2009, J FOOD ENG, V95, P240, DOI 10.1016/j.jfoodeng.2009.06.026; SAS, 2002, V91 SV CAR; Sauvant D, 2004, TABLES COMPOSITION N; Sochor J, 2010, MOLECULES, V15, P8618, DOI 10.3390/molecules15128618; Tansey JT, 2004, IUBMB LIFE, V56, P379, DOI 10.1080/15216540400009968; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Jacob MHVM, 2011, J STEROID BIOCHEM, V127, P331, DOI 10.1016/j.jsbmb.2011.07.007; Vigilanza P, 2011, J CELL PHYSIOL, V226, P2016, DOI 10.1002/jcp.22542; Watt MJ, 2008, BIOCHEM J, V414, P313, DOI 10.1042/BJ20080305; Young JF, 2005, J AGR FOOD CHEM, V53, P745, DOI 10.1021/jf0490652; Zheng P, 2013, BRIT J NUTR, V109, P2253, DOI 10.1017/S0007114512004321	48	41	44	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0130514	10.1371/journal.pone.0130514	http://dx.doi.org/10.1371/journal.pone.0130514			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161654	Green Published, gold, Green Submitted			2022-12-26	WOS:000358162300017
J	Dambacher, F; Schuhmann, T; Lobbestael, J; Arntz, A; Brugman, S; Sack, AT				Dambacher, Franziska; Schuhmann, Teresa; Lobbestael, Jill; Arntz, Arnoud; Brugman, Suzanne; Sack, Alexander T.			No Effects of Bilateral tDCS over Inferior Frontal Gyrus on Response Inhibition and Aggression	PLOS ONE			English	Article							DIRECT-CURRENT STIMULATION; BRAIN ACTIVITY; PROACTIVE AGGRESSION; ACTION CANCELLATION; PREFRONTAL CORTEX; AFFECTIVE VALENCE; ACTION RESTRAINT; SEX-DIFFERENCES; STOP-SIGNAL; ANGER	Response inhibition is defined as the capacity to adequately withdraw pre-planned responses. It has been shown that individuals with deficits in inhibiting pre-planned responses tend to display more aggressive behaviour. The prefrontal cortex is involved in both, response inhibition and aggression. While response inhibition is mostly associated with predominantly right prefrontal activity, the neural components underlying aggression seem to be left-lateralized. These differences in hemispheric dominance are conceptualized in cortical asymmetry theories on motivational direction, which assign avoidance motivation (relevant to inhibit responses) to the right and approach motivation (relevant for aggressive actions) to the left prefrontal cortex. The current study aimed to directly address the inverse relationship between response inhibition and aggression by assessing them within one experiment. Sixty-nine healthy participants underwent bilateral transcranial Direct Current Stimulation (tDCS) to the inferior frontal cortex. In one group we induced right-hemispheric fronto-cortical dominance by means of a combined right prefrontal anodal and left prefrontal cathodal tDCS montage. In a second group we induced left-hemispheric fronto-cortical dominance by means of a combined left prefrontal anodal and right prefrontal cathodal tDCS montage. A control group received sham stimulation. Response inhibition was assessed with a go/no-go task (GNGT) and aggression with the Taylor Aggression Paradigm (TAP). We revealed that participants with poorer performance in the GNGT displayed more aggression during the TAP. No effects of bilateral prefrontal tDCS on either response inhibition or aggression were observed. This is at odds with previous brain stimulation studies applying unilateral protocols. Our results failed to provide evidence in support of the prefrontal cortical asymmetry model in the domain of response inhibition and aggression. The absence of tDCS effects might also indicate that the methodological approach of shifting cortical asymmetry by means of bilateral tDCS protocols has failed.	[Dambacher, Franziska; Schuhmann, Teresa; Sack, Alexander T.] Maastricht Univ, Dept Cognit Neurosci, Maastricht, Netherlands; [Lobbestael, Jill; Arntz, Arnoud; Brugman, Suzanne] Maastricht Univ, Dept Clin Psychol Sci, Maastricht, Netherlands; [Dambacher, Franziska; Schuhmann, Teresa; Sack, Alexander T.] Maastricht Brain Imaging Ctr, Maastricht, Netherlands; [Arntz, Arnoud] Univ Amsterdam, Dept Clin Psychol, NL-1018 WB Amsterdam, Netherlands	Maastricht University; Maastricht University; Maastricht University; University of Amsterdam	Dambacher, F (corresponding author), Maastricht Univ, Dept Cognit Neurosci, Maastricht, Netherlands.	franziska.dambacher@maastrichtuniversity.nl	Arntz, Arnoud/M-3011-2013	Arntz, Arnoud/0000-0002-7992-2272; Lobbestael, Jill/0000-0001-9205-3115; Sack, Alexander/0000-0002-1471-0885	Netherlands Organization for Scientific Research (NWO) [HCMI 10-19]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by a grant from the Netherlands Organization for Scientific Research (NWO; HCMI 10-19).	Anderson CA, 2002, ANNU REV PSYCHOL, V53, P27, DOI 10.1146/annurev.psych.53.100901.135231; Anderson CA, 1999, CURR DIR PSYCHOL SCI, V8, P3, DOI 10.1111/1467-8721.00002; Archer J, 2004, REV GEN PSYCHOL, V8, P291, DOI 10.1037/1089-2680.8.4.291; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Asahi S, 2004, EUR ARCH PSY CLIN N, V254, P245, DOI 10.1007/s00406-004-0488-z; Beeli G, 2008, BEHAV BRAIN FUNCT, V4, DOI 10.1186/1744-9081-4-33; BERNSTEIN S, 1987, AGGRESSIVE BEHAV, V13, P15, DOI 10.1002/1098-2337(1987)13:1<15::AID-AB2480130104>3.0.CO;2-K; BJORKQVIST K, 1994, SEX ROLES, V30, P177, DOI 10.1007/BF01420988; Carver CS, 2009, PSYCHOL BULL, V135, P183, DOI 10.1037/a0013965; Chambers CD, 2006, J COGNITIVE NEUROSCI, V18, P444, DOI 10.1162/jocn.2006.18.3.444; Chambers CD, 2007, J NEUROPHYSIOL, V98, P3638, DOI 10.1152/jn.00685.2007; d'Alfonso AAL, 2000, NEUROSCI LETT, V280, P195, DOI 10.1016/S0304-3940(00)00781-3; Dambacher F, 2015, SOCIAL COGN IN PRESS; Dambacher F, 2015, SOC COGN AFFECT NEUR, V10, P508, DOI 10.1093/scan/nsu077; Dambacher F, 2014, J COGNITIVE NEUROSCI, V26, P1775, DOI 10.1162/jocn_a_00595; Dambacher F, 2014, EUR J NEUROSCI, V39, P821, DOI 10.1111/ejn.12425; de Graaf TA, 2011, NEUROSCI BIOBEHAV R, V35, P871, DOI 10.1016/j.neubiorev.2010.10.006; Eagle DM, 2008, PSYCHOPHARMACOLOGY, V199, P439, DOI 10.1007/s00213-008-1127-6; EAGLY AH, 1986, PSYCHOL BULL, V100, P309, DOI 10.1037/0033-2909.100.3.309; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Giancola PR, 2008, AGGRESSIVE BEHAV, V34, P214, DOI 10.1002/ab.20235; GIANCOLA PR, 1995, AGGRESSIVE BEHAV, V21, P199, DOI 10.1002/1098-2337(1995)21:3<199::AID-AB2480210303>3.0.CO;2-Q; Harmon-Jones E, 1998, J PERS SOC PSYCHOL, V74, P1310, DOI 10.1037/0022-3514.74.5.1310; Harmon-Jones E, 2004, BIOL PSYCHOL, V67, P51, DOI 10.1016/j.biopsycho.2004.03.003; Harmon-Jones E, 2001, J PERS SOC PSYCHOL, V80, P797, DOI 10.1037/0022-3514.80.5.797; Hoaken PNS, 2003, AGGRESSIVE BEHAV, V29, P15, DOI 10.1002/ab.10023; Horn NR, 2003, NEUROPSYCHOLOGIA, V41, P1959, DOI 10.1016/S0028-3932(03)00077-0; Hortensius R, 2012, SOC COGN AFFECT NEUR, V7, P342, DOI 10.1093/scan/nsr012; Horvath JC, 2015, BRAIN STIMUL, V8, P535, DOI 10.1016/j.brs.2015.01.400; Horvath JC, 2015, NEUROPSYCHOLOGIA, V66, P213, DOI 10.1016/j.neuropsychologia.2014.11.021; Jacobson L, 2011, J COGNITIVE NEUROSCI, V23, P3380, DOI 10.1162/jocn_a_00020; Karabanov A, 2015, BRAIN STIMUL, V8, P442, DOI 10.1016/j.brs.2015.01.404; LAGERSPETZ KMJ, 1988, AGGRESSIVE BEHAV, V14, P403, DOI 10.1002/1098-2337(1988)14:6<403::AID-AB2480140602>3.0.CO;2-D; Logan GD, 1997, PSYCHOL SCI, V8, P60, DOI 10.1111/j.1467-9280.1997.tb00545.x; Pawliczek CM, 2013, NEUROIMAGE, V79, P264, DOI 10.1016/j.neuroimage.2013.04.104; Poulin F, 2000, PSYCHOL ASSESSMENT, V12, P115, DOI 10.1037/1040-3590.12.2.115; Raine A, 2006, AGGRESSIVE BEHAV, V32, P159, DOI 10.1002/ab.20115; TAYLOR SP, 1967, J PERS, V35, P297, DOI 10.1111/j.1467-6494.1967.tb01430.x; van Honk J, 2006, PSYCHOL SCI, V17, P963, DOI 10.1111/j.1467-9280.2006.01813.x; Verbruggen F, 2010, P NATL ACAD SCI USA, V107, P13966, DOI 10.1073/pnas.1001957107; Ye H, 2015, BEHAV BRAIN RES, V286, P17, DOI 10.1016/j.bbr.2015.02.037; Ziemann U, 2008, BRAIN STIMUL, V1, P60, DOI 10.1016/j.brs.2007.08.003	42	45	48	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132170	10.1371/journal.pone.0132170	http://dx.doi.org/10.1371/journal.pone.0132170			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1FD	26161664	Green Submitted, Green Published, gold			2022-12-26	WOS:000358162300101
J	Simo-Riudalbas, L; Diaz-Lagares, A; Gatto, S; Gagliardi, M; Crujeiras, AB; Matarazzo, MR; Esteller, M; Sandoval, J				Simo-Riudalbas, L.; Diaz-Lagares, A.; Gatto, S.; Gagliardi, M.; Crujeiras, A. B.; Matarazzo, M. R.; Esteller, M.; Sandoval, J.			Genome-Wide DNA Methylation Analysis Identifies Novel Hypomethylated Non-Pericentromeric Genes with Potential Clinical Implications in ICF Syndrome	PLOS ONE			English	Article							SATELLITE DNA; EXPRESSION PATTERN; CANCER; CPG; MUTATIONS; DEFECTS; HETEROCHROMATIN; CHROMOSOME; MEIOSIS; REGIONS	Introduction and Results Immunodeficiency, centromeric instability and facial anomalies syndrome (ICF) is a rare autosomal recessive disease, characterized by severe hypomethylation in pericentromeric regions of chromosomes (1, 16 and 9), marked immunodeficiency and facial anomalies. The majority of ICF patients present mutations in the DNMT3B gene, affecting the DNA methyltransferase activity of the protein. In the present study, we have used the Infinium 450K DNA methylation array to evaluate the methylation level of 450,000 CpGs in lymphoblastoid cell lines and untrasformed fibroblasts derived from ICF patients and healthy donors. Our results demonstrate that ICF-specific DNMT3B variants A603T/STP807ins and V699G/R54X cause global DNA hypomethylation compared to wild-type protein. We identified 181 novel differentially methylated positions (DMPs) including subtelomeric and intrachromosomic regions, outside the classical ICF-related pericentromeric hypomethylated positions. Interestingly, these sites were mainly located in intergenic regions and inside the CpG islands. Among the identified hypomethylated CpG-island associated genes, we confirmed the overexpression of three selected genes, BOLL, SYCP2 and NCRNA00221, in ICF compared to healthy controls, which are supposed to be expressed in germ line and silenced in somatic tissues. Conclusions In conclusion, this study contributes in clarifying the direct relationship between DNA methylation defect and gene expression impairment in ICF syndrome, identifying novel direct target genes of DNMT3B. A high percentage of the DMPs are located in the subtelomeric regions, indicating a specific role of DNMT3B in methylating these chromosomal sites. Therefore, we provide further evidence that hypomethylation in specific non-pericentromeric regions of chromosomes might be involved in the molecular pathogenesis of ICF syndrome. The detection of DNA hypomethylation at BOLL, SYCP2 and NCRNA00221 may pave the way for the development of specific clinical biomarkers with the aim to facilitate the identification of ICF patients.	[Simo-Riudalbas, L.; Diaz-Lagares, A.; Crujeiras, A. B.; Esteller, M.; Sandoval, J.] Bellvitge Biomed Res Inst IDIBELL, PEBC, Barcelona, Catalonia, Spain; [Gatto, S.; Gagliardi, M.; Matarazzo, M. R.] CNR, Inst Genet & Biophys ABT, I-80125 Naples, Italy; [Esteller, M.] Univ Barcelona, Sch Med, Dept Physiol Sci 2, Barcelona, Spain; [Esteller, M.] ICREA, Barcelona, Catalonia, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); University of Barcelona; ICREA	Esteller, M (corresponding author), Bellvitge Biomed Res Inst IDIBELL, PEBC, Barcelona, Catalonia, Spain.	mesteller@idibell.cat; juan.sandoval@uv.es	sandoval, juan/M-4593-2015; Esteller, Manel/L-5956-2014; Crujeiras, Ana/ABA-8866-2021	sandoval, juan/0000-0002-5100-973X; Esteller, Manel/0000-0003-4490-6093; Crujeiras, Ana/0000-0003-4392-0301	Cellex Foundation; Instituto de Sanidad Carlos III (ISCIII); Health and Science Departments of the Generalitat de Catalunya; "Sara Borrell" postdoctoral contract from the ISCIII at the Spanish Ministry of Economy and Competitiveness [CD12/00738, C09/00365]; Epigenomics Flagship Project EPIGEN, MIUR-CNR; ISCIII grant [CP13/00055]; ICREA Funding Source: Custom	Cellex Foundation(Foundation CELLEX); Instituto de Sanidad Carlos III (ISCIII); Health and Science Departments of the Generalitat de Catalunya; "Sara Borrell" postdoctoral contract from the ISCIII at the Spanish Ministry of Economy and Competitiveness; Epigenomics Flagship Project EPIGEN, MIUR-CNR; ISCIII grant; ICREA(ICREA)	The research leading to these results has received funding from the Cellex Foundation, Instituto de Sanidad Carlos III (ISCIII) and the Health and Science Departments of the Generalitat de Catalunya. ADL and ABC were supported by the "Sara Borrell" postdoctoral contract (CD12/00738) and (C09/00365) from the ISCIII at the Spanish Ministry of Economy and Competitiveness. MRM is supported by the Epigenomics Flagship Project EPIGEN, MIUR-CNR. ME is an ICREA Research Professor. JS is a "Miguel Servet" researcher and this work was supported by CP13/00055 ISCIII grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bibikova M, 2011, GENOMICS, V98, P288, DOI 10.1016/j.ygeno.2011.07.007; Brun ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019464; Della Ragione F, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00054; Ehrlich M, 2001, HUM MOL GENET, V10, P2917, DOI 10.1093/hmg/10.25.2917; Ehrlich M, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-2; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Gatto S, 2010, EPIGENETICS-US, V5, P427, DOI 10.4161/epi.5.5.11999; Hansen RS, 2000, HUM MOL GENET, V9, P2575, DOI 10.1093/hmg/9.18.2575; Heyn H, 2012, EPIGENETICS-US, V7, P542, DOI 10.4161/epi.20523; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; JEANPIERRE M, 1993, HUM MOL GENET, V2, P731, DOI 10.1093/hmg/2.6.731; Jin BL, 2008, HUM MOL GENET, V17, P690, DOI 10.1093/hmg/ddm341; Kondo T, 2000, HUM MOL GENET, V9, P597, DOI 10.1093/hmg/9.4.597; Li MZ, 2013, J CELL BIOCHEM, V114, P294, DOI 10.1002/jcb.24368; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Serra P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4608; Matarazzo MR, 2007, J CELL PHYSIOL, V210, P711, DOI 10.1002/jcp.20879; Matarazzo MR, 2002, HUM MOL GENET, V11, P3191, DOI 10.1093/hmg/11.25.3191; MINIOU P, 1994, HUM MOL GENET, V3, P2093, DOI 10.1093/hmg/3.12.2093; Miniou P, 1997, HUM GENET, V99, P738, DOI 10.1007/s004390050441; Moarefi AH, 2011, J MOL BIOL, V409, P758, DOI 10.1016/j.jmb.2011.04.050; Quintavalle C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074466; Sandoval J, 2012, CURR OPIN GENET DEV, V22, P50, DOI 10.1016/j.gde.2012.02.008; Sandoval J, 2011, EPIGENETICS-US, V6, P692, DOI 10.4161/epi.6.6.16196; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Stirzaker C, 2014, TRENDS GENET, V30, P75, DOI 10.1016/j.tig.2013.11.004; Velasco G, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-56; Velasco G, 2010, P NATL ACAD SCI USA, V107, P9281, DOI 10.1073/pnas.1000473107; Walton Emma L, 2014, Biology (Basel), V3, P578, DOI 10.3390/biology3030578; Wang H, 2005, INT J MOL MED, V15, P949; Weemaes CMR, 2013, EUR J HUM GENET, V21, P1219, DOI 10.1038/ejhg.2013.40; Yehezkel S, 2008, HUM MOL GENET, V17, P2776, DOI 10.1093/hmg/ddn177; Zheng YH, 2009, REPRODUCTION, V138, P483, DOI 10.1530/REP-09-0163	33	20	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132517	10.1371/journal.pone.0132517	http://dx.doi.org/10.1371/journal.pone.0132517			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161907	Green Published, gold, Green Submitted			2022-12-26	WOS:000358162300145
J	Vereshchaka, AL; Kulagin, DN; Lunina, AA				Vereshchaka, Alexander L.; Kulagin, Dmitry N.; Lunina, Anastasia A.			Phylogeny and New Classification of Hydrothermal Vent and Seep Shrimps of the Family Alvinocarididae (Decapoda)	PLOS ONE			English	Article							CENTRAL INDIAN RIDGE; MID-ATLANTIC RIDGE; CARIDEA ALVINOCARIDIDAE; RIMICARIS-EXOCULATA; RETINAL ANATOMY; HYBRID ZONE; CRUSTACEA; GENUS; BRESILIIDAE; PACIFIC	The paper addresses the phylogeny and classification of the hydrothermal vent shrimp family Alvinocarididae. Two morphological cladistic analyses were carried out, which use all 31 recognized species of Alvinocarididae as terminal taxa. As outgroups, two species were included, both representing major caridean clades: Acanthephyra purpurea (Acanthephyridae) and Alpheus echiurophilus (Alpheidae). For additional support of the clades we utilised available data on mitochondrial Cytochrome c Oxidase I gene (CO1) and 16S ribosomal markers. Both morphological and molecular methods resulted in similar tree topologies and nearly identical clades. We consider these clades as evolutionary units and thus erect two new subfamilies: Rimicaridinae (Alvinocaridinides, Manuscaris, Opaepele, Shinkaicaris, Rimicaris), Alvinocaridinae (Alvinocaris), whilst recognising Mirocaridinae (with genera Mirocaris and Nautilocaris) at subfamily level. One genus, Keldyshicaris could not be assigned to any subfamily and is thus left as incertae sedis. The monophyly of Alvinocardinae was supported by morphological data, but not supported by molecular data (two analyses); the monophyly of all subfamilies was supported both by morphological and molecular data. Chorocaris is herein synonymized with Rimicaris, whilst Opaepele vavilovi is herein transferred to a new genus Keldyshicaris. Morphological trends within Alvinocarididae are discussed and short biogeographical remarks are given. We provide emended diagnoses for all subfamilies and genera along with keys to all recognized species.	[Vereshchaka, Alexander L.; Kulagin, Dmitry N.; Lunina, Anastasia A.] Russian Acad Sci, PP Shirshov Inst Oceanol, Moscow 117997, Russia	Russian Academy of Sciences; Shirshov Institute of Oceanology	Vereshchaka, AL (corresponding author), Russian Acad Sci, PP Shirshov Inst Oceanol, Moscow 117997, Russia.	alv@ocean.ru	Vereshchaka, Alexander L/E-6205-2014; Kulagin, Dmitry N./E-3137-2014; Lunina, Anastasia/L-3699-2014	Vereshchaka, Alexander L/0000-0002-6756-2468; Kulagin, Dmitry N./0000-0002-5521-8598; Lunina, Anastasia/0000-0002-1105-8027	Russian Foundation for Basic Research [15-04-08228]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	The studies were supported by the Russian Foundation for Basic Research (grant number 15-04-08228). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahyong ST, 2009, CRUSTACEANA, V82, P775, DOI 10.1163/156854009X427333; Anker A, 2015, ZOOTAXA, V3914, P441, DOI 10.11646/zootaxa.3914.4.4; Audzijonyte A, 2007, POLAR BIOL, V30, P1137, DOI 10.1007/s00300-007-0271-5; Beedessee G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081570; Bonnivard E, 2009, GENOME, V52, P524, DOI [10.1139/G09-027, 10.1139/g09-027]; Bracken H. D., 2009, DECAPOD CRUSTACEAN P, V18, P274; Bucklin A, 2010, DEEP-SEA RES PT II, V57, P2234, DOI 10.1016/j.dsr2.2010.09.025; Chan TY, 2010, INVERTEBR SYST, V24, P172, DOI 10.1071/IS09049; Darling JA, 2011, INVAD NAT SPRING SER, V6, P661, DOI 10.1007/978-94-007-0591-3_24; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; De Grave S., 2011, Zoologische Mededelingen (Leiden), V85, P195; Desbruyeres D., 2006, HDB DEEP SEA HYDROTH; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fujikura Katsunori, 1996, JAMSTEC Journal of Deep Sea Research, V12, P133; Fujikura Katsunori, 1995, JAMSTEC Journal of Deep Sea Research, V11, P227; Gebruk AV, 1997, ADV MAR BIOL, V32, P93; GOLOBOFF P, 2000, TNT TREE ANAL USING; Hiraoka R, 2013, ALVINOCARIS DISSIMIL; KIKUCHI T, 1995, J CRUSTACEAN BIOL, V15, P771, DOI 10.2307/1548826; Kikuchi Tomohiko, 2000, Species Diversity, V5, P135; Kim S.-J., 2013, MITOCHONDR DNA, P1; Komai T, 2006, SCI MAR, V70, P109, DOI 10.3989/scimar.2006.70n1109; Komai T, 2005, ZOOTAXA, P27; Komai T, 2005, J NAT HIST, V39, P1111, DOI 10.1080/00222930400002499; Komai T, 2004, J MAR BIOL ASSOC UK, V84, P1179, DOI 10.1017/S0025315404010628h; Komai Tomoyuki, 2007, Species Diversity, V12, P237; Komai T, 2015, J NAT HIST, V49, P1789, DOI 10.1080/00222933.2015.1006702; Komai T, 2010, ZOOTAXA, P15; Kuenzler RO, 1997, J MAR BIOL ASSOC UK, V77, P707, DOI 10.1017/S0025315400036146; Lakin RC, 1997, J COMP NEUROL, V385, P503; Li CP, 2011, ZOOL ANZ, V250, P270, DOI 10.1016/j.jcz.2011.04.003; Lunina A, 2011, THESIS SHIRSHOV I OC; Lunina A A, 2008, Dokl Biol Sci, V421, P266, DOI 10.1134/S0012496608040133; Lunina AA, 2010, ZOOTAXA, P69; MADDISON W.P., 2001, MESQUITE MODULAR SYS; Martin J.W., 2005, CONTRIBUTIONS SCI NA, V145, P445, DOI 10.1111/j.1096-3642.2005.00178.x; Martin JW, 1997, P BIOL SOC WASH, V110, P399; Martin JW, 2005, ZOOL J LINN SOC-LOND, V145, P445, DOI 10.1111/j.1096-3642.2005.00178.x; Martin JW, 2005, P BIOL SOC WASH, V118, P183, DOI 10.2988/0006-324X(2005)118[183:ANSOTS]2.0.CO;2; MARTIN JW, 1995, P BIOL SOC WASH, V108, P220; Milne-Edwards A, 1881, CR HEBD ACAD SCI, V93, P931; Nixon KC, 1999, CLADISTICS, V15, P407, DOI 10.1111/j.1096-0031.1999.tb00277.x; Nye V, 2012, J MAR BIOL ASSOC UK, V92, P1; NYE V, 2011, J MAR BIOL ASSOC UK, V92, P1; O'Mullan GD, 2001, MOL ECOL, V10, P2819, DOI 10.1046/j.1365-294X.2001.t01-1-01401.x; ONEILL PJ, 1995, VISUAL NEUROSCI, V12, P861, DOI 10.1017/S0952523800009421; Pedersen RB, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1124; PELLI DG, 1989, NATURE, V337, P460, DOI 10.1038/337460a0; Plouviez S, 2015, DEEP-SEA RES PT I, V97, P124, DOI 10.1016/j.dsr.2014.11.011; RENNINGER GH, 1995, BIOL BULL, V189, P69, DOI 10.2307/1542456; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Shank TM, 1998, MOL MAR BIOL BIOTECH, V7, P88; Shank TM, 1999, MOL PHYLOGENET EVOL, V13, P244, DOI 10.1006/mpev.1999.0642; Teixeira S, 2013, MOL ECOL, V22, P4663, DOI 10.1111/mec.12419; Teixeira S, 2012, CONSERV GENET RESOUR, V4, P81, DOI 10.1007/s12686-011-9479-3; Teixeira S, 2011, J BIOGEOGR, V38, P564, DOI 10.1111/j.1365-2699.2010.02408.x; Tokuda G, 2006, BIOL LETTERS, V2, P257, DOI 10.1098/rsbl.2005.0420; Tsuchida S., 2008, DEEP SEA LIFE BIOL O, P100; Van Dover CL, 2003, DEEP-SEA RES PT I, V50, P281, DOI 10.1016/S0967-0637(02)00162-0; Vereshchaka AL, 1997, J MAR BIOL ASSOC UK, V77, P425, DOI 10.1017/S0025315400071770; Vereshchaka AL, 1996, J MAR BIOL ASSOC UK, V76, P951, DOI 10.1017/S002531540004090X; Vereshchaka AL, 2002, CAH BIOL MAR, V43, P303; Vereshchaka AL, 1997, DEEP-SEA RES PT I, V44, P1905, DOI 10.1016/S0967-0637(97)00031-9; Vereshchaka AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112057; Vereshchaka Alexander L., 2000, Galathea Report, V18, P69; Wang L, 1994, J Comput Biol, V1, P337, DOI 10.1089/cmb.1994.1.337; Watabe H, 2002, ZOOL SCI, V19, P1167, DOI 10.2108/zsj.19.1167; Watabe Hajime, 2000, JAMSTEC Journal of Deep Sea Research, V17, P29; Webber WR, 2004, ZOOTAXA, P1; WILLIAMS A B, 1982, Journal of Crustacean Biology, V2, P136, DOI 10.2307/1548118; WILLIAMS AB, 1995, P BIOL SOC WASH, V108, P228; WILLIAMS AB, 1988, FISH B-NOAA, V86, P263; WILLIAMS AB, 1986, J CRUSTACEAN BIOL, V6, P446, DOI 10.2307/1548184; Won Y, 2003, MOL ECOL, V12, P3185, DOI 10.1046/j.1365-294X.2003.01974.x; Wong JM, 2015, MOL PHYLOGENET EVOL, V83, P278, DOI 10.1016/j.ympev.2014.11.013; Yahagi T, 2014, ZOOTAXA, V3893, P101, DOI 10.11646/zootaxa.3893.1.4; Yang CH, 2012, MITOCHONDR DNA, V23, P417, DOI 10.3109/19401736.2012.710212; Yang JS, 2013, MOL BIOL EVOL, V30, P305, DOI 10.1093/molbev/mss224; Zelnio KA, 2009, P BIOL SOC WASH, V122, P52, DOI 10.2988/07-28.1	79	26	26	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0129975	10.1371/journal.pone.0129975	http://dx.doi.org/10.1371/journal.pone.0129975			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161742	Green Published, gold, Green Submitted			2022-12-26	WOS:000358162300012
J	Lin, HW; Chung, CL; Lin, YS; Yu, CM; Lee, CN; Bien, MY				Lin, Hui-Wen; Chung, Chi-Li; Lin, You Shuei; Yu, Chia-Ming; Lee, Chun-Nin; Bien, Mauo-Ying			Inhaled Pharmacotherapy and Stroke Risk in Patients with Chronic Obstructive Pulmonary Disease: A Nationwide Population Based Study Using Two-Stage Approach	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; COPD; INFLAMMATION; FLUTICASONE; PREVALENCE; SALMETEROL	Background and Purpose Patients with chronic obstructive pulmonary disease (COPD) are at higher risk of stroke than those without COPD. This study aims to explore the impact of inhaled pharmacotherapy on stroke risk in COPD patients during a three-year follow-up, using a nationwide, population- based study and a matched cohort design. Methods The study cohort comprised 10,413 patients who had received COPD treatment between 2004 and 2006; 41,652 randomly selected subjects comprised the comparison cohort. Cox proportional hazard regressions and two-stage propensity score calibration were performed to determine the impact of various inhaled therapies including short-acting muscarinic antagonists, long-acting muscarinic antagonists, short-acting beta-agonists (SABAs), long-acting beta-agonists (LABAs), and LABA plus inhaled corticosteroid (ICS), on the risk after adjustment for patient demographic characteristics and comorbid disorders. Results Of the 52,065 sampled patients, 2,689 (5.2%) developed stroke during follow-up, including 727 (7.0%) from the COPD cohort and 1,962 (4.7%) from the comparison cohort (p < 0.001). Treatment with SABA was associated with 1.67-fold (95% CI 1.45-1.91; p < 0.001) increased risk of stroke in COPD patients. By contrast, the cumulative incidence of stroke was significantly lower in those treated with LABA plus ICS than those treated without (adjusted hazard ratio 0.75, 95% CI 0.60-0.94, p = 0.014). Conclusions Among COPD patients, the use of inhaled SABA is associated with an increased risk of stroke, and combination treatment with inhaled LABA and ICS relates to a risk reduction. Further prospective research is needed to verify whether LABA plus ICS confers protection against stroke in patients with COPD.	[Lin, Hui-Wen] Soochow Univ, Dept Math, Taipei, Taiwan; [Chung, Chi-Li; Lee, Chun-Nin; Bien, Mauo-Ying] Taipei Med Univ, Coll Med, Sch Resp Therapy, Taipei, Taiwan; [Chung, Chi-Li; Bien, Mauo-Ying] Taipei Med Univ Hosp, Dept Internal Med, Div Pulm Med, Taipei, Taiwan; [Lin, You Shuei] Taipei Med Univ, Coll Med, Sch Med, Dept Physiol, Taipei, Taiwan; [Yu, Chia-Ming] Taipei Med Univ Hosp, Dept Neurol, Taipei, Taiwan; [Lee, Chun-Nin; Bien, Mauo-Ying] Taipei Med Univ, Wan Fang Hosp, Dept Internal Med, Div Pulm Med, Taipei, Taiwan; [Lee, Chun-Nin] Taipei Med Univ, Shuang Ho Hosp, Dept Internal Med, Div Pulm Med, Taipei, Taiwan	Soochow University; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Shuang Ho Hospital	Bien, MY (corresponding author), Taipei Med Univ, Coll Med, Sch Resp Therapy, Taipei, Taiwan.	mybien@tmu.edu.tw		Lin, You Shuei/0000-0003-1364-0245	National Science Council of Taiwan [NSC96-2314-B-038-029, NSC101-2314-B-038-044-MY3]; Wan Fang Hospital, Taipei, Taiwan [96TMU-WFH-16]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Wan Fang Hospital, Taipei, Taiwan	The work was supported by the following: NSC96-2314-B-038-029 from the National Science Council of Taiwan to Bien MY; 96TMU-WFH-16 from Wan Fang Hospital, Taipei, Taiwan to Bien MY; and NSC101-2314-B-038-044-MY3 from the National Science Council of Taiwan to Chung CL.	Calverley PMA, 2007, NEW ENGL J MED, V356, P775, DOI 10.1056/NEJMoa063070; Cook D, 2001, AM J RESP CRIT CARE, V163, P85, DOI 10.1164/ajrccm.163.1.2004214; Donaldson GC, 2010, CHEST, V137, P1091, DOI 10.1378/chest.09-2029; Feary JR, 2010, THORAX, V65, P956, DOI 10.1136/thx.2009.128082; Gross NJ, 2012, CHEST, V142, P1300, DOI 10.1378/chest.11-2766; Guo YH, 2012, EYE, V26, P684, DOI 10.1038/eye.2012.9; Halbert RJ, 2006, EUR RESPIR J, V28, P523, DOI 10.1183/09031936.06.00124605; Lin HW, 2014, AM J EPIDEMIOL, V180, P308, DOI 10.1093/aje/kwu130; Lin HW, 2010, HUM HERED, V69, P160, DOI 10.1159/000267996; Man S F Paul, 2005, Proc Am Thorac Soc, V2, P78, DOI 10.1513/pats.200406-034MS; Man SFP, 2012, CAN J CARDIOL, V28, P653, DOI 10.1016/j.cjca.2012.06.013; Pinto-Plata VM, 2006, THORAX, V61, P23, DOI 10.1136/thx.2005.042200; ROSNER B, 1990, AM J EPIDEMIOL, V132, P734, DOI 10.1093/oxfordjournals.aje.a115715; Salpeter SR, 2004, CHEST, V125, P2309, DOI 10.1378/chest.125.6.2309; Schnell K, 2012, BMC PULM MED, V12, DOI 10.1186/1471-2466-12-26; Sin DD, 2008, AM J RESP CRIT CARE, V177, P1207, DOI 10.1164/rccm.200709-1356OC; Sinden NJ, 2010, THORAX, V65, P930, DOI 10.1136/thx.2009.130260; Sturmer T, 2005, AM J EPIDEMIOL, V162, P279, DOI 10.1093/aje/kwi192; Suissa Samy, 2012, Rambam Maimonides Med J, V3, pe0014, DOI 10.5041/RMMJ.10082; Tashkin DP, 2008, NEW ENGL J MED, V359, P1543, DOI 10.1056/NEJMoa0805800; Van Eeden S, 2012, AM J RESP CRIT CARE, V186, P11, DOI 10.1164/rccm.201203-0455PP; Varela S, 2009, J INVESTIG ALLERGOL, V123, P124; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Wilchesky M, 2012, CHEST, V142, P305, DOI 10.1378/chest.11-1597	24	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2015	10	7							e0130102	10.1371/journal.pone.0130102	http://dx.doi.org/10.1371/journal.pone.0130102			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EW	26158649	Green Published, gold, Green Submitted			2022-12-26	WOS:000358161200011
J	Houston, K; Burton, RA; Sznajder, B; Rafalski, AJ; Dhugga, KS; Mather, DE; Taylor, J; Steffenson, BJ; Waugh, R; Fincher, GB				Houston, Kelly; Burton, Rachel A.; Sznajder, Beata; Rafalski, Antoni J.; Dhugga, Kanwarpal S.; Mather, Diane E.; Taylor, Jillian; Steffenson, Brian J.; Waugh, Robbie; Fincher, Geoffrey B.			A Genome-Wide Association Study for Culm Cellulose Content in Barley Reveals Candidate Genes Co-Expressed with Members of the CELLULOSE SYNTHASE A Gene Family	PLOS ONE			English	Article							CELL-WALL BIOSYNTHESIS; WOOD PROPERTY TRAITS; PINUS-TAEDA L.; POPULATION-STRUCTURE; ANCHORED PROTEIN; LINKAGE DISEQUILIBRIUM; PLASMA-MEMBRANE; QTL; EXPRESSION; KORRIGAN	Cellulose is a fundamentally important component of cell walls of higher plants. It provides a scaffold that allows the development and growth of the plant to occur in an ordered fashion. Cellulose also provides mechanical strength, which is crucial for both normal development and to enable the plant to withstand both abiotic and biotic stresses. We quantified the cellulose concentration in the culm of 288 two - rowed and 288 six - rowed spring type barley accessions that were part of the USDA funded barley Coordinated Agricultural Project (CAP) program in the USA. When the population structure of these accessions was analysed we identified six distinct populations, four of which we considered to be comprised of a sufficient number of accessions to be suitable for genome-wide association studies (GWAS). These lines had been genotyped with 3072 SNPs so we combined the trait and genetic data to carry out GWAS. The analysis allowed us to identify regions of the genome containing significant associations between molecular markers and cellulose concentration data, including one region cross-validated in multiple populations. To identify candidate genes we assembled the gene content of these regions and used these to query a comprehensive RNA-seq based gene expression atlas. This provided us with gene annotations and associated expression data across multiple tissues, which allowed us to formulate a supported list of candidate genes that regulate cellulose biosynthesis. Several regions identified by our analysis contain genes that are co-expressed with CELLULOSE SYNTHASE A (HvCesA) across a range of tissues and developmental stages. These genes are involved in both primary and secondary cell wall development. In addition, genes that have been previously linked with cellulose synthesis by biochemical methods, such as HvCOBRA, a gene of unknown function, were also associated with cellulose levels in the association panel. Our analyses provide new insights into the genes that contribute to cellulose content in cereal culms and to a greater understanding of the interactions between them.	[Houston, Kelly; Waugh, Robbie] Invergowrie, James Hutton Inst, Dundee DD2 5DA, Scotland; [Burton, Rachel A.; Taylor, Jillian; Fincher, Geoffrey B.] Univ Adelaide, Sch Agr Food & Wine, ARC Ctr Excellence Plant Cell Walls, Glen Osmond, SA 5064, Australia; [Sznajder, Beata; Mather, Diane E.] Univ Adelaide, Australian Ctr Plant Funct Genom, Glen Osmond, SA 5064, Australia; [Rafalski, Antoni J.] DuPont Pioneer, Genet Discovery Grp, DuPont Agr Biotechnol, DuPont Expt Stn, Wilmington, DE 19803 USA; [Dhugga, Kanwarpal S.] DuPont Pioneer, Genet Discovery Grp, DuPont Agr Biotechnol, Johnston, IA 50131 USA; [Steffenson, Brian J.] Univ Minnesota, Dept Plant Pathol, St Paul, MN 55108 USA; [Waugh, Robbie] Univ Dundee, James Hutton Inst, Div Plant Sci, Dundee DD2 5DA, Scotland	James Hutton Institute; University of Adelaide; University of Adelaide; DuPont; DuPont; Pioneer Hi-Bred International, Inc.; University of Minnesota System; University of Minnesota Twin Cities; James Hutton Institute; University of Dundee	Houston, K (corresponding author), Invergowrie, James Hutton Inst, Dundee DD2 5DA, Scotland.	Kelly.Houston@hutton.ac.uk	Burton, Rachel A/C-4441-2011; Mather, Diane/AAB-6606-2019	Burton, Rachel A/0000-0002-0638-4709; Mather, Diane/0000-0001-7506-2589; Dhugga, Kanwarpal/0000-0003-2477-3422; , Kelly/0000-0003-2136-245X; Steffenson, Brian/0000-0001-7961-5363	USDA National Institute of Food and Agriculture Barley Coordinated Agricultural Project DuPont Agricultural Biotechnology [2006-55606-16722]; Australian Research Council; BBSRC [BB/J014869/1]; Scottish Government Research Program; DuPont Pioneer; BBSRC [BB/L026317/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/L026317/1, BB/J014869/1] Funding Source: researchfish	USDA National Institute of Food and Agriculture Barley Coordinated Agricultural Project DuPont Agricultural Biotechnology; Australian Research Council(Australian Research Council); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Scottish Government Research Program; DuPont Pioneer; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the USDA National Institute of Food and Agriculture Barley Coordinated Agricultural Project (#2006-55606-16722) DuPont Agricultural Biotechnology, the Australian Research Council and the BBSRC responsive mode scheme Grant number BB/J014869/1 and the Scottish Government Research Program Work Package 5.2. During the period in which the research was undertaken, JAR and KSD were affiliated with the DuPont Agricultural Biotechnology division at the commercial company DuPont Pioneer. DuPont Pioneer provided support in the form of salaries for authors JAR and KSD, and reviewed and approved the manuscript for publication. The specific roles of these authors are articulated in the 'author contributions' section.	Appenzeller L, 2004, CELLULOSE, V11, P287, DOI 10.1023/B:CELL.0000046417.84715.27; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Brady SM, 2007, PLANT PHYSIOL, V143, P172, DOI 10.1104/pp.106.087262; Buchanan M, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-235; Burton RA, 2006, SCIENCE, V311, P1940, DOI 10.1126/science.1122975; Burton RA, 2004, PLANT PHYSIOL, V134, P224, DOI 10.1104/pp.103.032904; Burton RA, 2010, PLANT PHYSIOL, V153, P1716, DOI 10.1104/pp.110.158329; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Carpita NC, 2011, PLANT PHYSIOL, V155, P171, DOI 10.1104/pp.110.163360; Chagne D, 2003, MOL BREEDING, V12, P185, DOI 10.1023/A:1026318327911; Ching A, 2006, PLANTA, V224, P1174, DOI 10.1007/s00425-006-0299-8; Close TJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-582; Comadran J, 2012, NAT GENET, V44, P1388, DOI 10.1038/ng.2447; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Dabney A, 2010, QVALUE Q VALUE ESTIM; Doblin MS, 2002, PLANT CELL PHYSIOL, V43, P1407, DOI 10.1093/pcp/pcf164; Druka A, 2011, PLANT PHYSIOL, V155, P617, DOI 10.1104/pp.110.166249; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Fagard M, 2000, PLANT CELL, V12, P2409, DOI 10.1105/tpc.12.12.2409; GIDDINGS TH, 1980, J CELL BIOL, V84, P327, DOI 10.1083/jcb.84.2.327; Gonzalez-Martinez SC, 2007, GENETICS, V175, P399, DOI 10.1534/genetics.106.061127; Hamblin MT, 2010, CROP SCI, V50, P556, DOI 10.2135/cropsci2009.04.0198; Hazen SP, 2002, PLANT PHYSIOL, V128, P336, DOI 10.1104/pp.010875; Held MA, 2008, P NATL ACAD SCI USA, V105, P20534, DOI 10.1073/pnas.0809408105; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; Hirano K, 2013, PLANT CELL PHYSIOL, V54, P1803, DOI 10.1093/pcp/pct121; His I, 2001, PLANTA, V212, P348, DOI 10.1007/s004250000437; Komatsuda T, 2007, P NATL ACAD SCI USA, V104, P1424, DOI 10.1073/pnas.0608580104; Koppolu R, 2013, P NATL ACAD SCI USA, V110, P13198, DOI 10.1073/pnas.1221950110; Lane DR, 2001, PLANT PHYSIOL, V126, P278, DOI 10.1104/pp.126.1.278; Liu LF, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003704; Markussen T, 2003, SILVAE GENET, V52, P8; Mascher M, 2013, PLANT J, V76, P718, DOI 10.1111/tpj.12319; Mayer KFX, 2011, PLANT CELL, V23, P1249, DOI 10.1105/tpc.110.082537; McWilliams DA, 1999, CORN GROWTH MANAGEME, VA-1173; Mohammadi M, 2015, THEOR APPL GENET, P1, DOI [10.1007/s00122-014-2399-3, DOI 10.1007/S00122-014-2399-3]; Mohammadi M, 2014, MOL BREEDING, V34, P1229, DOI 10.1007/s11032-014-0112-5; Morgan JLW, 2013, NATURE, V493, P181, DOI 10.1038/nature11744; MUELLER SC, 1980, J CELL BIOL, V84, P315, DOI 10.1083/jcb.84.2.315; Murray SC, 2008, CROP SCI, V48, P2180, DOI 10.2135/cropsci2008.01.0068; Nicol F, 1998, EMBO J, V17, P5563, DOI 10.1093/emboj/17.19.5563; Park YW, 2003, PLANT J, V33, P1099, DOI 10.1046/j.1365-313X.2003.01696.x; Pauli D, 2014, PLANT GENOME-US, V7, DOI 10.3835/plantgenome2013.11.0037; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pear JR, 1996, P NATL ACAD SCI USA, V93, P12637, DOI 10.1073/pnas.93.22.12637; Pettolino FA, 2012, NAT PROTOC, V7, P1590, DOI 10.1038/nprot.2012.081; Porth I, 2013, NEW PHYTOL, V200, P710, DOI 10.1111/nph.12422; Pritchard JK, 2000, GENETICS, V155, P945; Ramsay L, 2011, NAT GENET, V43, P169, DOI 10.1038/ng.745; Richmond TA, 2000, PLANT PHYSIOL, V124, P495, DOI 10.1104/pp.124.2.495; Roudier F, 2005, PLANT CELL, V17, P1749, DOI 10.1105/tpc.105.031732; Sanchez-Rodriguez C, 2012, PLANT CELL, V24, P589, DOI 10.1105/tpc.111.094672; Sato S, 2001, PLANT CELL PHYSIOL, V42, P251, DOI 10.1093/pcp/pce045; Schindelman G, 2001, GENE DEV, V15, P1115, DOI 10.1101/gad.879101; Sewell MM, 2002, THEOR APPL GENET, V104, P214, DOI 10.1007/s001220100697; Shiringani AL, 2011, THEOR APPL GENET, V123, P999, DOI 10.1007/s00122-011-1642-4; Slavov GT, 2014, NEW PHYTOL, V201, P1227, DOI 10.1111/nph.12621; Szucs P, 2009, PLANT GENOME-US, V2, P134, DOI [10.3835/plantgenome2008.01.005, 10.3835/plantgenome2008.01.0005]; Szyjanowicz PMJ, 2004, PLANT J, V37, P730, DOI 10.1111/j.1365-313X.2003.02000.x; The International Barley Genome Sequencing Consortium, 2012, Nature (London), V491, P711; Thomas LH, 2013, PLANT PHYSIOL, V161, P465, DOI 10.1104/pp.112.206359; Thumma BR, 2010, TREE GENET GENOMES, V6, P305, DOI 10.1007/s11295-009-0250-9; Thumma BR, 2009, GENETICS, V183, P1153, DOI 10.1534/genetics.109.106591; UPDEGRAFF DM, 1969, ANAL BIOCHEM, V32, P420, DOI 10.1016/S0003-2697(69)80009-6; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; Wang HY, 2012, THEOR APPL GENET, V124, P111, DOI 10.1007/s00122-011-1691-8; Waugh R, 2014, GENOMICS PLANT GENET, V237; Wu B, 2012, PLANT PHYSIOL, V159, P1440, DOI 10.1104/pp.112.195529; Zhang QS, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-27; Zhong R, 2007, PLANT CELL, V19, P2776, DOI 10.1105/tpc.107.053678; Zhou H, 2012, J ZHEJIANG UNIV-SC B, V13, P438, DOI 10.1631/jzus.B1200003; Zhou HL, 2006, PLANT MOL BIOL, V60, P137, DOI 10.1007/s11103-005-2972-x	74	12	12	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0130890	10.1371/journal.pone.0130890	http://dx.doi.org/10.1371/journal.pone.0130890			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154104	Green Published, Green Submitted, gold			2022-12-26	WOS:000358159700042
J	Masi, S; Mundry, R; Ortmann, S; Cipolletta, C; Boitani, L; Robbins, MM				Masi, Shelly; Mundry, Roger; Ortmann, Sylvia; Cipolletta, Chloe; Boitani, Luigi; Robbins, Martha M.			The Influence of Seasonal Frugivory on Nutrient and Energy Intake in Wild Western Gorillas	PLOS ONE			English	Article							BAI-HOKOU; NATIONAL-PARK; ECOLOGICAL CONSTRAINTS; BEHAVIORAL ECOLOGY; FRUIT AVAILABILITY; GROUPING PATTERNS; TROPICAL FORESTS; SAMPLING METHODS; LEAF CHEMISTRY; FOOD SELECTION	The daily energy requirements of animals are determined by a combination of physical and physiological factors, but food availability may challenge the capacity to meet nutritional needs. Western gorillas (Gorilla gorilla) are an interesting model for investigating this topic because they are folivore-frugivores that adjust their diet and activities to seasonal variation in fruit availability. Observations of one habituated group of western gorillas in Bai-Hokou, Central African Republic (December 2004-December 2005) were used to examine seasonal variation in diet quality and nutritional intake. We tested if during the high fruit season the food consumed by western gorillas was higher in quality (higher in energy, sugar, fat but lower in fibre and antifeedants) than during the low fruit season. Food consumed during the high fruit season was higher in digestible energy, but not any other macronutrients. Second, we investigated whether the gorillas increased their daily intake of carbohydrates, metabolizable energy (KCal/g OM), or other nutrients during the high fruit season. Intake of dry matter, fibers, fat, protein and the majority of minerals and phenols decreased with increased frugivory and there was some indication of seasonal variation in intake of energy (KCal/g OM), tannins, protein/fiber ratio, and iron. Intake of non-structural carbohydrates and sugars was not influenced by fruit availability. Gorillas are probably able to extract large quantities of energy via fermentation since they rely on proteinaceous leaves during the low fruit season. Macronutrients and micronutrients, but not digestible energy, may be limited for them during times of low fruit availability because they are hind-gut fermenters. We discuss the advantages of seasonal frugivores having large dietary breath and flexibility, significant characteristics to consider in the conservation strategies of endangered species.	[Masi, Shelly; Mundry, Roger; Robbins, Martha M.] Max Planck Inst Evolutionary Anthropol, D-04103 Leipzig, Germany; [Ortmann, Sylvia] Leibniz Inst Zoo & Wildlife Res, RG Evolutionary Ecol, D-10315 Berlin, Germany; [Cipolletta, Chloe] WSC Rwanda Program, WCS Nyungwe Project, Kigali, Rwanda; [Masi, Shelly; Boitani, Luigi] Univ Roma La Sapienza, Dept Anim & Human Biol, I-00185 Rome, Italy	Max Planck Society; Leibniz Institut fur Zoo und Wildtierforschung; Sapienza University Rome	Masi, S (corresponding author), Max Planck Inst Evolutionary Anthropol, D-04103 Leipzig, Germany.	masi@mnhn.fr	Ortmann, Sylvia/B-7088-2015	Ortmann, Sylvia/0000-0003-2520-6251	University of Rome; Max Planck Society	University of Rome; Max Planck Society(Max Planck Society)	This study was funded both by the University of Rome "La Sapienza" and the Max Planck Society.	ALTMANN J, 1993, AM J PRIMATOL, V30, P149, DOI 10.1002/ajp.1350300207; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; [Anonymous], 2014, R LANG ENV STAT COMP; Arnold W, 2004, AM J PHYSIOL-REG I, V286, pR174, DOI 10.1152/ajpregu.00593.2002; Baayen R. H., 2008, ANAL LINGUISTIC DATA; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Bates Douglas, 2014, LME4 LINEAR MIXED EF; Breuer T, 2009, AM J PRIMATOL, V71, P106, DOI 10.1002/ajp.20628; Brockman DK, 2005, CAM S BIO EVOL ANTHR, V44, P1, DOI 10.1017/CBO9780511542343; Bronikowski AM, 1996, BEHAV ECOL SOCIOBIOL, V39, P11, DOI 10.1007/s002650050262; CALVERT JJ, 1985, OECOLOGIA, V65, P236, DOI 10.1007/BF00379223; Carpenter K, 1994, PROTEIN ENERGY STUDY; CHAPMAN CA, 1995, BEHAV ECOL SOCIOBIOL, V36, P59, DOI 10.1007/BF00175729; Chapman CA, 2002, INT J PRIMATOL, V23, P283, DOI 10.1023/A:1013831511405; Chapman CA, 2004, AM J PRIMATOL, V62, P55, DOI 10.1002/ajp.20006; CHAPMAN CA, 1994, BIOTROPICA, V26, P160, DOI 10.2307/2388805; Chapman CA, 2003, INT J PRIMATOL, V24, P317, DOI 10.1023/A:1023049200150; CHAPMAN CA, 1990, PRIMATES, V31, P121, DOI 10.1007/BF02381035; CHIVERS DJ, 1980, J MORPHOL, V166, P337, DOI 10.1002/jmor.1051660306; Cipolletta C, 2004, AM J PRIMATOL, V64, P193, DOI 10.1002/ajp.20072; Cipolletta C, 2007, INT J PRIMATOL, V28, P457, DOI 10.1007/s10764-007-9129-5; Conklin-Brittain Nancy Lou, 2006, P445; Conklin-Brittain NL, 1999, J CHEM ECOL, V25, P2601, DOI 10.1023/A:1020835120701; Conklin-Brittain NL, 1998, INT J PRIMATOL, V19, P917; Doran D, 1997, INT J PRIMATOL, V18, P183, DOI 10.1023/A:1026368518431; Doran DM, 2002, AM J PRIMATOL, V58, P91, DOI 10.1002/ajp.10053; Doran-Sheehy D, 2009, AM J PHYS ANTHROPOL, V140, P727, DOI 10.1002/ajpa.21118; Doran-Sheehy DM, 2004, AM J PRIMATOL, V64, P207, DOI 10.1002/ajp.20075; DUNBAR RIM, 1992, BEHAV ECOL SOCIOBIOL, V31, P35, DOI 10.1007/BF00167814; Felton AM, 2010, FOREST ECOL MANAG, V259, P1642, DOI 10.1016/j.foreco.2010.01.042; Felton AM, 2009, BEHAV ECOL, V20, P685, DOI 10.1093/beheco/arp021; Freeland WJ, 1974, AM NATUR, V108; Ganzhorn JU, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008253; GANZHORN JU, 1992, OECOLOGIA, V91, P540, DOI 10.1007/BF00650329; Goldsmith ML, 1999, INT J PRIMATOL, V20, P1, DOI 10.1023/A:1020528115829; Grueter CC, 2014, PHYSIOL BEHAV, V127, P13, DOI 10.1016/j.physbeh.2014.01.009; Haccou P, 1994, STAT ANAL BEHAV DATA; Harrison ME, 2010, INT J PRIMATOL, V31, P585, DOI 10.1007/s10764-010-9415-5; Head JS, 2011, INT J PRIMATOL, V32, P755, DOI 10.1007/s10764-011-9499-6; JANSON C, 1985, BEHAV ECOL SOCIOBIOL, V18, P125, DOI 10.1007/BF00299041; Janson C. H., 1999, PRIMATE COMMUNITIES; Kay RF, 1997, P NATL ACAD SCI USA, V94, P13023, DOI 10.1073/pnas.94.24.13023; Knott CD, 1998, INT J PRIMATOL, V19, P1061, DOI 10.1023/A:1020330404983; Knott CD, 2005, CAM S BIO EVOL ANTHR, V44, P351, DOI 10.1017/CBO9780511542343.013; Krief S, 2006, AM J PRIMATOL, V68, P51, DOI 10.1002/ajp.20206; Krief S, 2005, J NAT PROD, V68, P897, DOI 10.1021/np049576i; Krief S, 2004, ANTIMICROB AGENTS CH, V48, P3196, DOI 10.1128/AAC.48.8.3196-3199.2004; Lambert J. E., 2007, PRIMATES PERSPECTIVE; Lambert JE, 1998, EVOL ANTHROPOL, V7, P8, DOI 10.1002/(SICI)1520-6505(1998)7:1<8::AID-EVAN3>3.0.CO;2-C; Lechtig A, 1976, J Trop Pediatr Environ Child Health, V22, P121; Leonard WR, 1997, AM J PHYS ANTHROPOL, V102, P265, DOI 10.1002/(SICI)1096-8644(199702)102:2<265::AID-AJPA8>3.0.CO;2-X; MAKKAR HPS, 1993, J SCI FOOD AGR, V61, P161, DOI 10.1002/jsfa.2740610205; Masi S, 2008, THESIS U ROME SAPIEN; Masi S, 2013, PHYSIOL BEHAV, V105, P337; Masi S, 2013, COGN AFFECT BEHAV NE, V13, P916, DOI 10.3758/s13415-013-0171-9; Masi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049805; Masi S, 2011, ANIM COGN, V14, P921, DOI 10.1007/s10071-011-0457-7; Masi S, 2009, AM J PRIMATOL, V71, P91, DOI 10.1002/ajp.20629; McGregor PK., 1992, PLAYBACK STUDIES ANI; Miller KE, 2006, AM J PRIMATOL, V68, P1037, DOI 10.1002/ajp.20306; Milton K, 1999, NUTRITION, V15, P488, DOI 10.1016/S0899-9007(99)00078-7; MILTON K, 1979, AM NAT, V114, P362, DOI 10.1086/283485; MILTON K, 1981, BIOTROPICA, V13, P177, DOI 10.2307/2388122; MILTON K, 1993, SCI AM, V269, P86, DOI 10.1038/scientificamerican0893-86; MILTON K, 1990, J TROP ECOL, V6, P493, DOI 10.1017/S0266467400004909; Milton K, 2000, NUTRITION, V16, P480, DOI 10.1016/S0899-9007(00)00293-8; N. R. C. (National Research Council), 1980, REC DIET ALL RDA; N'guessan AK, 2009, INT J PRIMATOL, V30, P481, DOI 10.1007/s10764-009-9354-1; Parker KL, 2005, J MAMMAL, V86, P610, DOI 10.1644/1545-1542(2005)86[610:PCIFCR]2.0.CO;2; Popovich DG, 1997, MANAGEMENT GORILLAS; PORTER LJ, 1985, PHYTOCHEMISTRY, V25, P223, DOI 10.1016/S0031-9422(00)94533-3; Remis MJ, 1997, AM J PRIMATOL, V43, P111; Remis MJ, 2004, INT J PRIMATOL, V25, P825, DOI 10.1023/B:IJOP.0000029124.04610.c7; Remis MJ, 2002, INT J PRIMATOL, V23, P251, DOI 10.1023/A:1013827310497; Remis MJ, 2001, INT J PRIMATOL, V22, P807, DOI 10.1023/A:1012021617737; Rogers ME, 2004, AM J PRIMATOL, V64, P173, DOI 10.1002/ajp.20071; ROGERS ME, 1990, OECOLOGIA, V84, P326, DOI 10.1007/BF00329756; ROGERS ME, 1987, BIOTROPICA, V19, P278, DOI 10.2307/2388348; Rothman JM, 2008, OECOLOGIA, V155, P111, DOI 10.1007/s00442-007-0901-1; Rothman JM, 2006, AM J PRIMATOL, V68, P675, DOI 10.1002/ajp.20243; Rothman JM, 2011, BIOL LETTERS, V7, P847, DOI 10.1098/rsbl.2011.0321; Schielzeth H, 2009, BEHAV ECOL, V20, P416, DOI 10.1093/beheco/arn145; Schlulke O, 2006, AM J PRIMATOL, V68, P951, DOI 10.1002/ajp.20300; Simmen B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009860; Simpson SJ, 2003, APPETITE, V41, P123, DOI 10.1016/S0195-6663(03)00049-7; Steiner JE, 2001, NEUROSCI BIOBEHAV R, V25, P53, DOI 10.1016/S0149-7634(00)00051-8; Sterck EHM, 1997, BEHAVIOUR, V134, P749, DOI 10.1163/156853997X00052; Stevenson PR, 2004, INT J PRIMATOL, V25, P367, DOI 10.1023/B:IJOP.0000019157.35464.a0; Stoinski TS, 2013, AM J PHYS ANTHR, P00; Sun C, 1996, BIOTROPICA, V28, P668, DOI 10.2307/2389053; Tutin Caroline E. G., 1996, P58, DOI 10.1017/CBO9780511752414.007; Van Soest P.J., 1994, NUTR ECOLOGY RUMINAN; Van Soest PJ, 1982, NUTR ECOLOGY RUMINAN; Vogel ER, 2012, BIOL LETTERS, V8, P333, DOI 10.1098/rsbl.2011.1040; Waterman P.G., 1984, P177; WATERMAN PG, 1988, BIOL J LINN SOC, V34, P1, DOI 10.1111/j.1095-8312.1988.tb01946.x; Wrangham RW, 1998, INT J PRIMATOL, V19, P949, DOI 10.1023/A:1020318102257; Wright E, 2014, BEHAV ECOL SOCIOBIOL, DOI [10.1007/s00265014-1708-9, DOI 10.1007/S00265014-1708-9]; Wright E, 2014, BEHAV ECOL IN PRESS; Yamagiwa J, 2003, CAM S BIO EVOL ANTHR, V35, P328	100	26	27	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0129254	10.1371/journal.pone.0129254	http://dx.doi.org/10.1371/journal.pone.0129254			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154509	Green Submitted, Green Published, gold			2022-12-26	WOS:000358159700012
J	Mhurchu, CN; Eyles, H; Genc, M; Scarborough, P; Rayner, M; Mizdrak, A; Nnoaham, K; Blakely, T				Mhurchu, Cliona Ni; Eyles, Helen; Genc, Murat; Scarborough, Peter; Rayner, Mike; Mizdrak, Anja; Nnoaham, Kelechi; Blakely, Tony			Effects of Health-Related Food Taxes and Subsidies on Mortality from Diet-Related Disease in New Zealand: An Econometric-Epidemiologic Modelling Study	PLOS ONE			English	Article							COMPARATIVE RISK-ASSESSMENT; SUGAR-SWEETENED BEVERAGES; CARDIOVASCULAR-DISEASE; VEGETABLE CONSUMPTION; METAANALYSIS; OBESITY; IMPACT; REDUCTION; PATTERNS; FRUIT	Background Health-related food taxes and subsidies may promote healthier diets and reduce mortality. Our aim was to estimate the effects of health-related food taxes and subsidies on deaths prevented or postponed (DPP) in New Zealand. Methods A macrosimulation model based on household expenditure data, demand elasticities and population impact fractions for 18 diet-related diseases was used to estimate effects of five tax and subsidy regimens. We used price elasticity values for 24 major commonly consumed food groups in New Zealand, and food expenditure data from national Household Economic Surveys. Changes in mortality from cardiovascular disease, cancer, diabetes and other diet-related diseases were estimated. Findings A 20% subsidy on fruit and vegetables would result in 560 (95% uncertainty interval, 400 to 700) DPP each year (1.9% annual all-cause mortality). A 20% tax on major dietary sources of saturated fat would result in 1,500 (950 to 2,100) DPP (5.0%), and a 20% tax on major dietary sources of sodium would result in 2,000 (1300 to 2,700) DPP (6.8%). Combining taxes on saturated fat and sodium with a fruit and vegetable subsidy would result in 2,400 (1,800 to 3,000) DPP (8.1% mortality annually). A tax on major dietary sources of greenhouse gas emissions would generate 1,200 (750 to 1,700) DPP annually (4.0%). Effects were similar or greater for Maori and low-income households in relative terms. Conclusions Health-related food taxes and subsidies could improve diets and reduce mortality from dietrelated disease in New Zealand. Our study adds to the growing evidence base suggesting food pricing policies should improve population health and reduce inequalities, but there is still much work to be done to improve estimation of health impacts.	[Mhurchu, Cliona Ni; Eyles, Helen] Univ Auckland, Natl Inst Hlth Innovat, Auckland 1, New Zealand; [Genc, Murat] Univ Otago, Dept Econ, Dunedin, New Zealand; [Scarborough, Peter; Rayner, Mike; Mizdrak, Anja; Nnoaham, Kelechi] Univ Oxford, British Heart Fdn Ctr Populat Approaches Noncommu, Oxford, England; [Blakely, Tony] Univ Otago, Dept Publ Hlth, Wellington, New Zealand	University of Auckland; University of Otago; University of Oxford; University of Otago	Mhurchu, CN (corresponding author), Univ Auckland, Natl Inst Hlth Innovat, Auckland 1, New Zealand.	c.nimhurchu@auckland.ac.nz	Genc, Murat/AAE-1568-2019; Scarborough, Peter/ABD-6111-2021	Scarborough, Peter/0000-0002-2378-2944; Genc, Murat/0000-0002-5443-2146; Mizdrak, Anja/0000-0002-2897-3002; nnoaham, kelechi/0000-0002-5362-4605; Blakely, Tony/0000-0002-6995-4369; Ni Mhurchu, Cliona/0000-0002-1144-9167	Health Research Council of New Zealand [10/077]; New Zealand Heart Foundation [1463]; University of Otago; British Heart Foundation [FS/13/37/30295]	Health Research Council of New Zealand(Health Research Council of New Zealand); New Zealand Heart Foundation; University of Otago; British Heart Foundation(British Heart Foundation)	This research was funded by a Health Research Council of New Zealand (http://www.hrc.govt.nz/) programme grant (10/077). Helen Eyles was supported by a New Zealand Heart Foundation (http://www.heartfoundation.org.nz/) Postgraduate Scholarship (Grant 1463). Murat Genc was supported by a University of Otago (http://www.otago.ac.nz/) Research Grant. Anja Mizdrak is funded by a British Heart Foundation Non-Clinical PhD Studentship (FS/13/37/30295) and Peter Scarborough and Mike Rayner are also supported by the British Heart Foundation (http://www.bhf.org.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajwani S., 2003, DECADES DISPARITY ET; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Basu S, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001582; Basu S, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6048; Beaglehole R, 2011, LANCET, V378, P449, DOI 10.1016/S0140-6736(11)60879-9; Belanger M, PUBLIC HLTH; Berners-Lee M, 2012, ENERG POLICY, V43, P184, DOI 10.1016/j.enpol.2011.12.054; Blakely T, 2007, TRACKING DISPARITY T; Blakely T, 2008, BRIT MED J, V336, P371, DOI 10.1136/bmj.39455.596181.25; Briggs ADM, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-860; Briggs ADM, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6189; Briggs ADM, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003543; Cornelsen L, 2015, HEALTH ECON, V24, P1548, DOI 10.1002/hec.3107; Dauchet L, 2005, NEUROLOGY, V65, P1193, DOI 10.1212/01.wnl.0000180600.09719.53; Dauchet L, 2006, J NUTR, V136, P2588, DOI 10.1093/jn/136.10.2588; Epstein LH, 2012, AM J CLIN NUTR, V95, P789, DOI 10.3945/ajcn.111.024380; Eyles H, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001353; Gortmaker SL, 2011, LANCET, V378, P838, DOI 10.1016/S0140-6736(11)60815-5; He F, 2002, J HUM HYPERTENS, V16, P761, DOI 10.1038/sj.jhh.1001459; He FJ, 2003, HYPERTENSION, V42, P1093, DOI 10.1161/01.HYP.0000102864.05174.E8; Instituto Nacional de Salud Publica, 2014, RES PREL EF IMP PES; Irz X, 2014, TSE473; James W.P.T., 2004, COMP QUANTIFICATION, P497; Jensen JD, 2013, FOOD POLICY, V42, P18, DOI 10.1016/j.foodpol.2013.06.004; Kristensen A, 2014, AM J PREVENTIVE MED; LAW MR, 1994, BMJ-BRIT MED J, V308, P367, DOI 10.1136/bmj.308.6925.367; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; McLeod M, 2014, POPUL HEALTH METR, V12, DOI 10.1186/1478-7954-12-15; Mhurchu CN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075934; Ministry of Health, 2013, HLTH LOSS NZ REP NZ; Ministry of Health, 2013, NZ HLTH SURV ANN UPD; Ministry of Health, 2012, MORT DEM DAT 2009; Moskowitz P., 2014, GUARDIAN; Mozaffarian D, 2014, JAMA-J AM MED ASSOC, V312, P889, DOI 10.1001/jama.2014.8232; Mytton O, 2007, J EPIDEMIOL COMMUN H, V61, P689, DOI 10.1136/jech.2006.047746; Mytton OT, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-886; Mytton OT, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2931; National Health and Medical Research Council, 2006, NUTR REF VAL AUSTR N, DOI [10.1017/S1368980008003212, DOI 10.1017/S1368980008003212]; New Zealand Institute of Plant & Food Research Limited and the Ministry of Health, 2012, CONC NZ FOOD COMP TA; Nghiem N., 2011, PRICE ELASTICITIES H; Nnoaham KE, 2009, INT J EPIDEMIOL, V38, P1324, DOI 10.1093/ije/dyp214; OECD, 2012, OBESITY; OECD, 2014, OBESITY; Sacks G, 2011, INT J OBESITY, V35, P1001, DOI 10.1038/ijo.2010.228; Scarborough P, 2012, EUR J CLIN NUTR, V66, P710, DOI 10.1038/ejcn.2012.34; Scarborough P, 2014, SCIENTIFICA, V2014, DOI 10.1155/2014/748750; Scarborough P, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000263; Scarborough P, 2012, J EPIDEMIOL COMMUN H, V66, P420, DOI 10.1136/jech.2010.114520; Sharma A, 2014, HEALTH ECON, V23, P1159, DOI 10.1002/hec.3070; Shonkwiler JS, 1999, AM J AGR ECON, V81, P972, DOI 10.2307/1244339; Statistics New Zealand, 2007, 2006 NZ CENS POP DWE; Statistics New Zealand, 2008, FOOD PRIC IND; Statistics New Zealand, 2010, 2009 10 HOUS EC SURV; Statistics New Zealand, 2007, 2006 07 HOUS EC SURV; Thow AM, 2014, NUTR REV, V72, P551, DOI 10.1111/nure.12123; Thow AM, 2010, B WORLD HEALTH ORGAN, V88, P609, DOI 10.2471/BLT.09.070987; United Nations General Assembly, 2011, REPORT OF THE SECRET; University of Otago and Ministry of Health, 2011, FOC NUTR KEY FIND 20; World Cancer Research Fund and American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P	59	35	37	4	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0128477	10.1371/journal.pone.0128477	http://dx.doi.org/10.1371/journal.pone.0128477			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1EJ	26154289	Green Published, gold			2022-12-26	WOS:000358159700008
J	Qin, JY; Huang, ZP; Liu, CW; Su, SJ; Zhou, J				Qin, Jiangyi; Huang, Zhiping; Liu, Chunwu; Su, Shaojing; Zhou, Jing			Novel Blind Recognition Algorithm of Frame Synchronization Words Based on Soft-Decision in Digital Communication Systems	PLOS ONE			English	Article							THEORETICAL-ANALYSIS; CHANNELS	A novel blind recognition algorithm of frame synchronization words is proposed to recognize the frame synchronization words parameters in digital communication systems. In this paper, a blind recognition method of frame synchronization words based on the hard-decision is deduced in detail. And the standards of parameter recognition are given. Comparing with the blind recognition based on the hard-decision, utilizing the soft-decision can improve the accuracy of blind recognition. Therefore, combining with the characteristics of Quadrature Phase Shift Keying (QPSK) signal, an improved blind recognition algorithm based on the soft-decision is proposed. Meanwhile, the improved algorithm can be extended to other signal modulation forms. Then, the complete blind recognition steps of the hard-decision algorithm and the soft-decision algorithm are given in detail. Finally, the simulation results show that both the hard-decision algorithm and the soft-decision algorithm can recognize the parameters of frame synchronization words blindly. What's more, the improved algorithm can enhance the accuracy of blind recognition obviously.	[Qin, Jiangyi; Huang, Zhiping; Liu, Chunwu; Su, Shaojing; Zhou, Jing] Natl Univ Def Technol, Coll Mech Engn & Automat, Changsha 410073, Hunan, Peoples R China	National University of Defense Technology - China	Qin, JY (corresponding author), Natl Univ Def Technol, Coll Mech Engn & Automat, Changsha 410073, Hunan, Peoples R China.	qjyacmilan@163.com						Cassaro TM, 2004, IEEE T COMMUN, V52, P484, DOI 10.1109/TCOMM.2004.823636; Cluzeau M., 2009, P ISIT2009 SEOUL KOR; Houcke S., 2006, P EUSIPCO2006 FLOR I; Imad R., 2009, P ICC2009 DRESD GERM; Imad R., 2010, P SPAWC2010 MARR US; Imad R, 2009, IEEE T WIREL COMMUN, V8, P5472, DOI 10.1109/TWC.2009.090410; Imad R, 2009, IEEE T COMMUN, V57, P1574, DOI 10.1109/TCOMM.2009.06.070445; Jing Z., 2013, OPTIK, V124, P998; LUI GL, 1987, IEEE T COMMUN, V35, P818; MASSEY JL, 1972, IEEE T COMMUN, VCO20, P115, DOI 10.1109/TCOM.1972.1091127; Mostofa M., 2001, IEEE COMMUN LETT, V5, P307; Qi YH, 2011, IEEE T WIREL COMMUN, V10, P3127, DOI 10.1109/TWC.2011.081611.101809	12	11	15	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0132114	10.1371/journal.pone.0132114	http://dx.doi.org/10.1371/journal.pone.0132114			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154439	Green Published, Green Submitted, gold			2022-12-26	WOS:000358159700088
J	Faille, A; Pluot-Sigwalt, D				Faille, Arnaud; Pluot-Sigwalt, Dominique			Convergent Reduction of Ovariole Number Associated with Subterranean Life in Beetles	PLOS ONE			English	Article							COLEOPTERA CARABIDAE; REGRESSIVE EVOLUTION; SCARABAEIDAE; PHYLOGENY; TRECHINAE; LARVE	Background Some species of obligate cavernicolous beetles are known to possess a unique feature-a contraction of the larval cycle. In contrast to many other subterranean beetles, life-cycle contraction in Trechini ground beetles (Carabidae) is correlated with a reduction in the number of eggs and a drastic reduction in the number of ovarioles. This remarkable peculiarity has only been reported for a small number of closely related species. Results We give a description of the female internal reproductive system for six species of Trechini, including five subterranean species, with a particular focus on the western Pyrenean radiation of Aphaenops, a group for which nothing is known regarding the early life stages. We redescribe the internal female genitalia of A. crypticola Linder. Study of the ovarioles allowed us to infer the postembryonic development of the larvae for each species examined. We then used a phylogenetic framework to recognize two independent reductions in the number of ovarioles in the Pyrenean lineage. We discuss the multiple convergent evolutions in ovariole number and the potential link between a reduction of ovariole number and troglobiomorphism in a phylogenetic context. Conclusions There is an extreme reduction in ovariole number and size within the species studied; the eggs produced by small ovarioles have a remarkably large size. A reduction to one ovariole has occurred independently at least twice in this subterranean group. A reduction in the number of ovarioles in ground beetles is one of the striking consequences of subterranean specialization and it is correlated with another remarkable adaptation of subterranean beetles, a reduction in the number of larval instars.	[Faille, Arnaud] Zool Staatssammlung, Dept Entomol, Munich, Germany; [Pluot-Sigwalt, Dominique] CNRS, MNHN, Dept Syst & Evolut, Inst Syst Evolut Biodivers,UMR 7205, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite	Faille, A (corresponding author), Zool Staatssammlung, Dept Entomol, Munich, Germany.	arnaud1140@yahoo.fr			German Research Foundation project [FA 1042/1-1]	German Research Foundation project	This work has been funded by a German Research Foundation project to AF (FA 1042/1-1). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buning J., 1994, INSECT OVARY ULTRAST, Vfirst; Cabidoche M, 1966, THESIS; Casale A, 1998, ENCY BIOSPEOLOGICA, VII, P1047; Cieslak A, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2978; CULVER D C, 1990, Memoires de Biospeologie, V17, P13; DELEURANCE S, 1960, CR HEBD ACAD SCI, V251, P974; DELEURANCE S, 1958, CR HEBD ACAD SCI, V247, P752; DELEURANCE S, 1959, CR HEBD ACAD SCI, V249, P2620; DELEURANCE-GLACON SYLVIE, 1963, ANN SPELEOL, V18, P227; DELEURANCEGLACO.S, 1964, CR HEBD ACAD SCI, V258, P4369; Deuve Thierry, 1993, Memoires du Museum National d'Histoire Naturelle Serie A Zoologie, V155, P1; Faille A, 2010, MOL PHYLOGENET EVOL, V54, P97, DOI 10.1016/j.ympev.2009.10.008; Faille A, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-248; Faille A, 2011, ZOOL SCR, V40, P282, DOI 10.1111/j.1463-6409.2010.00467.x; FORSYTH D J, 1972, Transactions of the Zoological Society of London, V32, P249; Glacon S, 1953, RECHERCHES BIOL COLE, V3, P39; Green DA, 2012, DEV BIOL, V372, P120, DOI 10.1016/j.ydbio.2012.09.014; Green II DA, 2014, DEV GEN MECH OV NUMB; GRENIER AM, 1994, GENET SEL EVOL, V26, P413, DOI 10.1051/gse:19940503; Halffter G., 1982, PUBLICATION I ECOLOG, V10; HALFFTER GONZALO, 1966, FOLIA ENTOMOL MEX, V12/14, P1; Halffter G, 2013, COLEOPTS BULL, V67, P94, DOI 10.1649/0010-065X-67.2.94; Havill NP, 2007, ANNU REV ENTOMOL, V52, P325, DOI 10.1146/annurev.ento.52.110405.091303; Heymons R., 1930, Zeitschrift fuer Morphologie und Oekologie der Tiere Berlin, V18, P536, DOI 10.1007/BF00403096; HEYMONS R., 1929, ZOOL AM, V85, P35; Hinton H. E., 1981, BIOL INSECTS EGGS; Hodin J., 2009, PHENOTYPIC PLASTICIT, P423, DOI DOI 10.1201/B10201-12; Ikeda H, 2008, EVOLUTION, V62, P2065, DOI 10.1111/j.1558-5646.2008.00432.x; Iwata K., 1955, Mushi Fukuoka, V29, P17; IWATA KUNIO, 1966, JAP J ECOL, V16, P4; IZQUIERDO I, 1990, Memoires de Biospeologie, V17, P107; JAY SC, 1968, CAN J ZOOLOG, V46, P345, DOI 10.1139/z68-052; Jeannel R., 1920, Archives de Zoologie Experimentale Paris, V59; Jeannel R., 1927, Abeille Paris, V33, P1; Jeannel R., 1928, ABEILLE, V35, P1; Jeannel R., 1926, FAUNE CAVERNICOLE FR; Jeannel R., 1941, COLEOPTERES CARABIQU, V39; Jeannel R., 1943, FOSSILES VIVANTS CAV; JONES R, 1992, EVOLUTION, V46, P353, DOI 10.1111/j.1558-5646.1992.tb02043.x; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Larsen EB, 1952, T 9 INT C ENTOMOLOGY, V1, P502; LEATHER SR, 1988, J NAT HIST, V22, P381, DOI 10.1080/00222938800770271; LEITNER ELISABETH, 1943, ZOOL JAHRB ABT ANAT U ONTOG TIERE, V68, P227; Leys R, 2005, BIOL LETTERS, V1, P496, DOI 10.1098/rsbl.2005.0358; MAC ARTHUR ROBERT H., 1967; MARCHAL P., 1913, Ann. Sci. nat., Zool., V18, P153; Martinez I, 1998, P ENTOMOL SOC WASH, V100, P269; Moravec P., 2003, CATALOGUE PALAEARCTI, V1, P288; MURDOCH WW, 1966, J ANIM ECOL, V35, P127, DOI 10.2307/2694; NOIROT C, 1974, ANNU REV ENTOMOL, V19, P61, DOI 10.1146/annurev.en.19.010174.000425; Pesson P., 1951, TRAITE ZOOL, V10, P1390; PLUOT D, 1979, ANN SOC ENTOMOL FR, V15, P575; POULSON TL, 1969, SCIENCE, V165, P971; Queinnec E, 2011, COLEOPTERES CARABIQU, V1, P119; Racovitza E.G., 1907, ARCH ZOOLOGIE EXPT G, V6, P371; RITCHER PO, 1974, P ENTOMOL SOC WASH, V76, P480; ROBERTSON J, 1961, CAN J ZOOLOG, V39, P245, DOI 10.1139/z61-028; Serrano J., 2013, NEW CATALOGUE FAMILY; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; STEIN F, 1847, VERGLEICHENDE ANATOM, V1; STYS P, 1990, BIOL REV, V65, P401, DOI 10.1111/j.1469-185X.1990.tb01232.x; Tanaka ED, 2009, APIDOLOGIE, V40, P163, DOI 10.1051/apido/2008071; Vandel A., 1964, BIOSPEOLOGIE BIOLOGI; WARD SA, 1983, J ANIM ECOL, V52, P451, DOI 10.2307/4565; Weber H, 1930, BIOL HEMIPTEREN, V9; WELCH RC, 1993, INVERTEBR REPROD DEV, V23, P225, DOI 10.1080/07924259.1993.9672319; Williams Joseph L., 1945, PROC ENT SOC WASHINGTON, V47, P73; WYATT TD, 1989, BEHAVIOUR, V110, P76, DOI 10.1163/156853989X00394	69	8	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2015	10	7							e0131986	10.1371/journal.pone.0131986	http://dx.doi.org/10.1371/journal.pone.0131986			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EC	26151557	gold, Green Submitted, Green Published			2022-12-26	WOS:000358158900031
J	Deng, MJ; Lin, XD; Lin, QT; Wen, DF; Zhang, ML; Wang, XQ; Gao, HC; Xu, JP				Deng, Ming-Jie; Lin, Xiao-Dong; Lin, Qiu-Ting; Wen, De-Fu; Zhang, Mei-Ling; Wang, Xian-Qin; Gao, Hong-Chang; Xu, Jia-Ping			A H-1-NMR Based Study on Hemolymph Metabolomics in Eri Silkworm after Oral Administration of 1-Deoxynojirimycin	PLOS ONE			English	Article							SUGAR-MIMIC ALKALOIDS; TREHALOSE CONCENTRATION; ADIPOKINETIC HORMONE; POSSIBLE INVOLVEMENT; NMR-SPECTROSCOPY; MULBERRY LATEX; BOMBYX-MORI; SERUM; METABOLISM; URINE	We aimed to investigate whether 1-deoxynojirimycin (DNJ) modulates glycometabolism and has toxicity in Eri silkworm (Samia cynthia ricini, Saturniidae). In this paper, hemolymph metabolites were used to explore metabolic changes after oral administration of DNJ or mulberry latex and to characterize the biological function of DNJ at the metabolic and systemic levels. Hemolymph samples were collected from fourth-instar larvae of Eri silkworm and exvivo high-resolution H-1 nuclear magnetic resonance (NMR) spectra were acquired from the collected hemolymph samples. Then the obtained spectra were analyzed by principal component analysis (PCA) and independent-samples t-test. Metabolic pattern recognition analysis of hemolymph samples indicated that the groups of 0.25% DNJ, latex, and the mixture of 0.5% DNJ and latex (1:1) were significantly different from the control group. Moreover, compared to the control group, the groups of 0.25% DNJ, latex, and the mixture of 0.5% DNJ and latex (1:1) showed the decreased levels of citrate, succinate, fumarate, malate, and glutamine in hemolymph, the groups of 0.25% DNJ and the mixture of 0.5% DNJ and latex (1:1) showed the increased levels of trehalose and lactate. In addition, mulberry leaves exude latex was highly toxic to Eri silkworm because rich unidentified high-molecular-weight factor (s) acted as toxic substances. In our results, latex caused 20 deaths among 50 fourth-instar larvae of Eri silkmoth, but DNJ or the mixture did not caused death. All these results suggest that DNJ has a positive impact on the reverse glycometabolism by modulating glycometabolism and inhibiting glucogenesis and energy metabolism. DNJ is a secure substance as a single-ingredient antidiabetic medicine due to its nontoxicity and bioactivity.	[Deng, Ming-Jie; Wen, De-Fu; Wang, Xian-Qin; Xu, Jia-Ping] Anhui Agr Univ, Sch Life Sci, Hefei, Peoples R China; [Deng, Ming-Jie; Lin, Xiao-Dong; Lin, Qiu-Ting; Zhang, Mei-Ling; Wang, Xian-Qin; Gao, Hong-Chang] Wenzhou Med Univ, Analyt & Testing Ctr, Wenzhou, Peoples R China	Anhui Agricultural University; Wenzhou Medical University	Gao, HC (corresponding author), Wenzhou Med Univ, Analyt & Testing Ctr, Wenzhou, Peoples R China.	gaohc27@gmail.com; jiapingxu@163.com	Xu, Jiaping/T-4327-2019	Xu, Jiaping/0000-0001-9020-7248	National 863 plans projects of China [2011AA100306]; Natural Science Foundation of China [31472148]; International cooperation project of Anhui province [1403062018]	National 863 plans projects of China(National High Technology Research and Development Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International cooperation project of Anhui province	This work was supported by the National 863 plans projects of China (2011AA100306), the Natural Science Foundation of China (31472148) and International cooperation project of Anhui province (1403062018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asai A, 2011, J DIABETES INVEST, V2, P318, DOI 10.1111/j.2040-1124.2011.00101.x; Asano N, 2001, J AGR FOOD CHEM, V49, P4208, DOI 10.1021/jf010567e; Beckonert O, 2007, NAT PROTOC, V2, P2692, DOI 10.1038/nprot.2007.376; Brock EA, 2013, ORG BIOMOL CHEM, V11, P3187, DOI 10.1039/c3ob40205c; Carroll JD, 2007, FEBS J, V274, P1701, DOI 10.1111/j.1742-4658.2007.05715.x; Chih CP, 2003, J CEREBR BLOOD F MET, V23, P1263, DOI 10.1097/01.WCB.0000081369.51727.6F; Diao CF, 2014, MOL BIOSYST, V10, P686, DOI 10.1039/c3mb70609e; Gao HC, 2008, ANAL CHIM ACTA, V624, P269, DOI 10.1016/j.aca.2008.06.051; Griffin JL, 2008, PHYSIOL GENOMICS, V34, P1, DOI 10.1152/physiolgenomics.00009.2008; Guan MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060409; Hirayama C, 2007, INSECT BIOCHEM MOLEC, V37, P1348, DOI 10.1016/j.ibmb.2007.09.001; Hori M, 2014, APPL ENTOMOL ZOOL, V49, P571, DOI 10.1007/s13355-014-0288-5; KNOWLES JR, 1980, ANNU REV BIOCHEM, V49, P877, DOI 10.1146/annurev.bi.49.070180.004305; Kong WH, 2008, J AGR FOOD CHEM, V56, P2613, DOI 10.1021/jf073223i; Konno K, 2006, P NATL ACAD SCI USA, V103, P1337, DOI 10.1073/pnas.0506944103; Kwon HJ, 2011, J AGR FOOD CHEM, V59, P3014, DOI 10.1021/jf103463f; LEVINE RJ, 1967, J CLIN INVEST, V46, P2012, DOI 10.1172/JCI105690; Li Y. -B., 2013, ELECTRON J DIFFER EQ, V2013, P1, DOI DOI 10.1038/SREP01377; Li YG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065892; Liebl M, 2010, J INSECT PHYSIOL, V56, P567, DOI 10.1016/j.jinsphys.2009.11.021; Ma YL, 2012, MOL BIOL REP, V39, P7505, DOI 10.1007/s11033-012-1584-1; MILLER SG, 1990, ARCH INSECT BIOCHEM, V14, P151, DOI 10.1002/arch.940140304; Nakagawa K, 2013, BIOSCI BIOTECH BIOCH, V77, P900, DOI 10.1271/bbb.120908; NICHOLSON JK, 1995, ANAL CHEM, V67, P793, DOI 10.1021/ac00101a004; Oda Y, 2000, ARCH INSECT BIOCHEM, V45, P156, DOI 10.1002/1520-6327(200012)45:4&lt;156::AID-ARCH3&gt;3.0.CO;2-E; PORTER RK, 1995, BIOCHEM J, V310, P379, DOI 10.1042/bj3100379; Qian K, 2008, DIABETES, V57, pA400; SAMARANAYAKA M, 1976, J EXP BIOL, V65, P415; Schilman PE, 2008, J COMP PHYSIOL B, V178, P157, DOI 10.1007/s00360-007-0207-y; Shang Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070841; Shuang E, 2014, EXP GERONTOL, V55, P63, DOI 10.1016/j.exger.2014.03.025; Silva MCP, 2004, INSECT BIOCHEM MOLEC, V34, P1089, DOI 10.1016/j.ibmb.2004.07.001; Spiga L, 2013, J MATERN-FETAL NEO M, V26, P20, DOI 10.3109/14767058.2013.832062; Tang B, 2014, APPL ENTOMOL ZOOL, V49, P255, DOI 10.1007/s13355-014-0244-4; Tatun N, 2008, J INSECT PHYSIOL, V54, P351, DOI 10.1016/j.jinsphys.2007.10.006; Tatun N, 2009, APPL ENTOMOL ZOOL, V44, P85, DOI 10.1303/aez.2009.85; Tsuduki T, 2013, FOOD CHEM, V139, P16, DOI 10.1016/j.foodchem.2013.02.025; Tsuduki T, 2009, J AGR FOOD CHEM, V57, P11024, DOI 10.1021/jf903132r; Tyagi R, 2014, CHEM-BIOL INTERACT, V211, P20, DOI 10.1016/j.cbi.2013.12.016; Tyagi R, 2011, J APPL TOXICOL, V31, P663, DOI 10.1002/jat.1617; Tyagi R, 2012, METABOLOMICS, V8, P940, DOI 10.1007/s11306-011-0390-4; van Doorn M, 2007, BRIT J CLIN PHARMACO, V63, P562, DOI 10.1111/j.1365-2125.2006.02816.x; Zhang AH, 2012, ANAL BIOANAL CHEM, V404, P1239, DOI 10.1007/s00216-012-6117-1; Zhao LC, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/431894; Zhao LC, 2011, ANAL LETT, V44, P1579, DOI 10.1080/00032719.2010.520390	45	9	9	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131696	10.1371/journal.pone.0131696	http://dx.doi.org/10.1371/journal.pone.0131696			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148185	Green Published, Green Submitted, gold			2022-12-26	WOS:000358157600130
J	Morais-Santos, M; Nunes, AEB; Oliveira, AG; Moura-Cordeiro, JD; Mahecha, GAB; Avellar, MCW; Oliveira, CA				Morais-Santos, Monica; Nunes, Aryane E. B.; Oliveira, Andre G.; Moura-Cordeiro, Junia Dayrell; Mahecha, Germn A. B.; Avellar, Maria Christina W.; Oliveira, Cleida A.			Changes in Estrogen Receptor ER beta (ESR2) Expression without Changes in the Estradiol Levels in the Prostate of Aging Rats	PLOS ONE			English	Article							MALE REPRODUCTIVE-SYSTEM; DIFFERENTIAL EXPRESSION; INTRAEPITHELIAL NEOPLASIA; SPONTANEOUS HYPERPLASIA; ANDROGEN RECEPTOR; VENTRAL PROSTATE; CANINE PROSTATE; GROWTH-FACTOR; ALPHA; CANCER	Although the prostate is androgen-dependent, it is also influenced by estrogens, which act via the estrogen receptors ER alpha and ER beta. In the prostate, ER beta is highly expressed in the epithelium and appears to participate in the regulation of cell proliferation, apoptosis and differentiation. Evidence shows that ER beta is decreased in malignant prostate, suggesting that it plays an important role in protecting this tissue. Despite the relationship between reductions in ER beta and abnormal growth of the gland, little is known about the age-dependent variation of this receptor. Therefore, we aimed to investigate ER beta expression in the prostatic lobes of aging Wistar rats (3 to 24 months). Histopathological alterations, including hyperplasia, intraluminal concretions, nuclear atypia and prostate intraepithelial neoplasias (PIN), were observed in the prostates of aging rats. Epithelial proliferation led to cribriform architecture in some acini, especially in the ventral prostate (VP). In the VP, areas of epithelial atrophy were also observed. Furthermore, in the lateral prostate, there was frequent prostatitis. Immunohistochemistry revealed that the expression of ER beta is reduced in specific areas related to PIN, atrophic abnormalities and cellular atypia in the prostate epithelium of senile rats. Corroborating the involvement of the receptor with proliferative activity, the punctual reduction in ER beta paralleled the increase in cell proliferation especially in areas of PIN and nuclear atypies. The decrease in ER beta reactivity occurred in a hormonal milieu characterized by a constant concentration of estradiol and decreased plasmatic and tissue DHT. This paper is a pioneering study that reveals focal ER beta reduction in the prostate of aging rats and indicates a potential disorder in the ER beta pathway. These data corroborate previous data from humans and dogs that silencing of this receptor may be associated with premalignant or malignant conditions in the prostate.	[Morais-Santos, Monica; Nunes, Aryane E. B.; Oliveira, Andre G.; Moura-Cordeiro, Junia Dayrell; Mahecha, Germn A. B.; Oliveira, Cleida A.] Univ Fed Minas Gerais, Inst Biol Sci, Dept Morphol, Belo Horizonte, MG, Brazil; [Avellar, Maria Christina W.] Univ Fed Sao Paulo, Dept Pharmacol, Sect Expt Endocrinol, Escola Paulista Med, Sao Paulo, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Sao Paulo (UNIFESP)	Oliveira, CA (corresponding author), Univ Fed Minas Gerais, Inst Biol Sci, Dept Morphol, Belo Horizonte, MG, Brazil.	cleida@icb.ufmg.br	Mahecha, German/A-7350-2016; Avellar, Maria Christina W./E-2865-2013; Oliveira, Cleida A./AAA-3221-2020; Oliveira, Cleida A./C-4966-2013	Mahecha, German/0000-0003-2907-0945; Avellar, Maria Christina W./0000-0003-4392-7554; Oliveira, Cleida A./0000-0001-9610-7846; Oliveira, Cleida A./0000-0001-9610-7846	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq/Brazil; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais - FAPEMIG/Brazil	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq/Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais - FAPEMIG/Brazil(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This study was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq/Brazil (Grant and research fellowship to C.A.O.; doctoral fellowship to A.G.O. and M.M.S.) and Fundacao de Amparo a Pesquisa do Estado de Minas Gerais - FAPEMIG/Brazil (Grant to C.A.O.; PROBIC scholarship to A.E.B.N.).	Asgari M, 2011, DIAGN PATHOL, V6, DOI 10.1186/1746-1596-6-61; Banerjee PP, 2001, ENDOCRINOLOGY, V142, P4066, DOI 10.1210/en.142.9.4066; Banerjee PP, 1998, BIOL REPROD, V59, P1163, DOI 10.1095/biolreprod59.5.1163; Bianchi-Frias D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012501; Campos SGP, 2008, INT J EXP PATHOL, V89, P13, DOI 10.1111/j.1365-2613.2007.00550.x; Cheng J, 2004, FEBS LETT, V566, P169, DOI 10.1016/j.febslet.2004.04.025; Colciago A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/801473; Daniels G, 2014, AM J TRANSL RES, V6, P140; Dey P, 2013, J MOL ENDOCRINOL, V51, pT61, DOI 10.1530/JME-13-0150; Ellem SJ, 2010, J STEROID BIOCHEM, V118, P246, DOI 10.1016/j.jsbmb.2009.10.015; Ellem SJ, 2009, ANN NY ACAD SCI, V1155, P174, DOI 10.1111/j.1749-6632.2009.04360.x; Gallardo F, 2007, J COMP PATHOL, V136, P1, DOI 10.1016/j.jcpa.2006.08.007; Gaskell TL, 2003, J CLIN ENDOCR METAB, V88, P424, DOI 10.1210/jc.2002-020811; Gist DH, 2007, GEN COMP ENDOCR, V151, P27, DOI 10.1016/j.ygcen.2006.06.012; Grieco V, 2006, J COMP PATHOL, V135, P11, DOI 10.1016/j.jcpa.2006.02.005; Grover SK, 2014, PATHOL ONCOL RES; Hany J, 1999, TOXICOL APPL PHARM, V158, P231, DOI 10.1006/taap.1999.8710; Hetzl AC, 2012, MICROSC RES TECHNIQ, V75, P1197, DOI 10.1002/jemt.22049; Hetzl AC, 2013, MICROSC RES TECHNIQ, V76, P321, DOI 10.1002/jemt.22170; Horvath LG, 2001, CANCER RES, V61, P5331; Hussain S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040732; Imamov O, 2004, NEW ENGL J MED, V351, P2773, DOI 10.1056/NEJM200412233512622; ISAACS JT, 1984, CANCER RES, V44, P5785; Krege JH, 1998, P NATL ACAD SCI USA, V95, P15677, DOI 10.1073/pnas.95.26.15677; KRIEG M, 1993, J CLIN ENDOCR METAB, V77, P375, DOI 10.1210/jc.77.2.375; Kuiper GGJM, 1996, P NATL ACAD SCI USA, V93, P5925, DOI 10.1073/pnas.93.12.5925; Kuiper GGJM, 1998, FRONT NEUROENDOCRIN, V19, P253, DOI 10.1006/frne.1998.0170; Lau KM, 2003, LAB INVEST, V83, P743, DOI 10.1097/01.LAB.0000069519.06988.24; Leav I, 2001, AM J PATHOL, V159, P79, DOI 10.1016/S0002-9440(10)61676-8; Mak P, 2013, P NATL ACAD SCI USA, V110, P4708, DOI 10.1073/pnas.1221654110; Makela S, 2000, MOL CELL ENDOCRINOL, V164, P109, DOI 10.1016/S0303-7207(00)00233-1; Maruyama K, 1998, BIOCHEM BIOPH RES CO, V246, P142, DOI 10.1006/bbrc.1998.8590; McPherson SJ, 2008, DIFFERENTIATION, V76, P660, DOI 10.1111/j.1432-0436.2008.00291.x; McPherson SJ, 2007, ENDOCRINOLOGY, V148, P566, DOI 10.1210/en.2006-0906; McPherson SJ, 2010, P NATL ACAD SCI USA, V107, P3123, DOI 10.1073/pnas.0905524107; MITSUMORI K, 1988, ENVIRON HEALTH PERSP, V77, P11, DOI 10.2307/3430623; Muthusamy S, 2011, P NATL ACAD SCI USA, V108, P20090, DOI 10.1073/pnas.1117772108; Oliveira AG, 2007, STEROIDS, V72, P914, DOI 10.1016/j.steroids.2007.08.001; Pasquali D, 2001, J CLIN ENDOCR METAB, V86, P2051, DOI 10.1210/jc.86.5.2051; Pasquali D, 2001, MOL CELL ENDOCRINOL, V178, P47, DOI 10.1016/S0303-7207(01)00418-X; Petersen DN, 1998, ENDOCRINOLOGY, V139, P1082, DOI 10.1210/en.139.3.1082; Picciarelli-Lima P, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-51; POLLARD M, 1973, J NATL CANCER I, V51, P1235, DOI 10.1093/jnci/51.4.1235; Pravettoni A, 2007, MOL CELL ENDOCRINOL, V263, P46, DOI 10.1016/j.mce.2006.08.008; Prezioso D, 2007, INT J UROL, V14, P1, DOI 10.1111/j.1442-2042.2006.01476.x; Prins GS, 1998, ENDOCRINOLOGY, V139, P874, DOI 10.1210/en.139.3.874; Rago V, 2007, REPROD BIOL ENDOCRIN, V5, DOI 10.1186/1477-7827-5-23; Rittmaster RS, 2009, EUR UROL, V55, P1064, DOI 10.1016/j.eururo.2009.01.037; SAKR WA, 1993, J UROLOGY, V150, P379, DOI 10.1016/S0022-5347(17)35487-3; Sar M, 2000, ANDROLOGIA, V32, P295, DOI 10.1046/j.1439-0272.2000.00396.x; Saunders PTK, 2001, MOL HUM REPROD, V7, P227, DOI 10.1093/molehr/7.3.227; Saunders PTK, 2002, J CLIN ENDOCR METAB, V87, P2706, DOI 10.1210/jc.87.6.2706; Scobie GA, 2002, STEROIDS, V67, P985, DOI 10.1016/S0039-128X(02)00047-8; Shappell SB, 2004, CANCER RES, V64, P2270, DOI 10.1158/0008-5472.CAN-03-0946; Shibata Y, 2000, PROSTATE, V42, P45; Tsurusaki T, 2003, J CLIN ENDOCR METAB, V88, P1333, DOI 10.1210/jc.2002-021015; VERMEULE.A, 1972, J CLIN ENDOCR METAB, V34, P730, DOI 10.1210/jcem-34-4-730; Vermeulen A, 2002, Aging Male, V5, P98, DOI 10.1080/713604678; WARD JM, 1980, LAB INVEST, V43, P517; Weihua Z, 2002, P NATL ACAD SCI USA, V99, P13589, DOI 10.1073/pnas.162477299; Xie W, 2000, PROSTATE, V44, P31; Yang GS, 2007, CHINESE MED J-PEKING, V120, P1611, DOI 10.1097/00029330-200709020-00012; Yun H, 2015, ONCOTARGET; Zhang WH, 2001, P NATL ACAD SCI USA, V98, P6330; Zhou Q, 2002, J ANDROL, V23, P870	65	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131901	10.1371/journal.pone.0131901	http://dx.doi.org/10.1371/journal.pone.0131901			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147849	gold, Green Submitted, Green Published			2022-12-26	WOS:000358157600160
J	Sieswerda, E; Font-Gonzalez, A; Dijkgraaf, MGW; Geskus, RB; Heinen, RC; van der Pal, HJ; van Leeuwen, FE; Caron, HN; Kremer, LC; Reitsma, JB				Sieswerda, Elske; Font-Gonzalez, Anna; Dijkgraaf, Marcel G. W.; Geskus, Ronald B.; Heinen, Richard C.; van der Pal, Helena J.; van Leeuwen, Flora E.; Caron, Huib N.; Kremer, Leontien C.; Reitsma, Johannes B.			Studying Hospitalizations and Mortality in the Netherlands: Feasible and Valid Using Two-Step Medical Record Linkage with Nationwide Registers	PLOS ONE			English	Article							CHILDHOOD-CANCER; SURVIVORS	In the Netherlands, the postal code is needed to study hospitalizations of individuals in the nationwide hospitalization register. Studying hospitalizations longitudinally becomes troublesome if individuals change address. We aimed to report on the feasibility and validity of a two-step medical record linkage approach to examine longitudinal trends in hospitalizations and mortality in a study cohort. First, we linked a study cohort of 1564 survivors of childhood cancer with the Municipal Personal Records Database (GBA) which has postal code history and mortality data available. Within GBA, we sampled a reference population matched on year of birth, gender and calendar year. Second, we extracted hospitalizations from the Hospital Discharge Register (LMR) with a date of discharge during unique follow-up (based on date of birth, gender and postal code in GBA). We calculated the agreement of death and being hospitalized in survivors according to the registers and to available cohort data. We retrieved 1477 (94%) survivors from GBA. Median percentages of unique/potential follow-up were 87% (survivors) and 83% (reference persons). Characteristics of survivors and reference persons contributing to unique follow-up were comparable. Agreement of hospitalization during unique follow-up was 94% and agreement of death was 98%. In absence of unique identifiers in the Dutch hospitalization register, it is feasible and valid to study hospitalizations and mortality of individuals longitudinally using a two-step medical record linkage approach. Cohort studies in the Netherlands have the opportunity to study mortality and hospitalization rates over time. These outcomes provide insight into the burden of clinical events and healthcare use in studies on patients at risk of long-term morbidities.	[Sieswerda, Elske; Font-Gonzalez, Anna; Heinen, Richard C.; van der Pal, Helena J.; Caron, Huib N.; Kremer, Leontien C.] Emma Childrens Hosp, Acad Med Ctr, Dept Pediat Oncol, Amsterdam, Netherlands; [Dijkgraaf, Marcel G. W.] Univ Amsterdam, Acad Med Ctr, Clin Res Unit, NL-1105 AZ Amsterdam, Netherlands; [Geskus, Ronald B.] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, NL-1105 AZ Amsterdam, Netherlands; [van der Pal, Helena J.] Univ Amsterdam, Acad Med Ctr, Dept Med Oncol, NL-1105 AZ Amsterdam, Netherlands; [van Leeuwen, Flora E.] Netherlands Canc Inst, Dept Epidemiol, Amsterdam, Netherlands; [Reitsma, Johannes B.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands	Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Netherlands Cancer Institute; Utrecht University; Utrecht University Medical Center	Font-Gonzalez, A (corresponding author), Emma Childrens Hosp, Acad Med Ctr, Dept Pediat Oncol, Amsterdam, Netherlands.	a.fontgonzalez@amc.uva.nl	Geskus, Ronald B/H-3684-2019	Geskus, Ronald B/0000-0002-2740-3155; Reitsma, Johannes/0000-0003-4026-4345; kremer, leontien/0000-0002-7619-7845; Kremer, Leontien/0000-0001-7422-3248	Stichting Kinderen Kankervrij (KiKa)	Stichting Kinderen Kankervrij (KiKa)	This study was supported by the Stichting Kinderen Kankervrij (KiKa), Project 84, https://www. kika.nl/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, REC HOSP DEATH COH S; Council of the Federation of Medical Scientific Societies, 2004, COD COND MED RES; de Bruin A, 2003, KOPPELING LMR GBA GE; desBruin A., 2004, STAT J UN EC COMM EU, V21, P23; Dijkgraaf MGW, 1996, HEALTH POLICY, V35, P13, DOI 10.1016/0168-8510(95)00772-5; Dutch Hospital Data, 2013, DOC REP HOSP DISCH R; Geenen MM, 2007, JAMA-J AM MED ASSOC, V297, P2705, DOI 10.1001/jama.297.24.2705; Howards PP, 2007, AM J EPIDEMIOL, V165, P444, DOI 10.1093/aje/kwk027; Mertens AC, 2008, JNCI-J NATL CANCER I, V100, P1368, DOI 10.1093/jnci/djn310; Metcalfe C, 2003, EUR HEART J, V24, P105, DOI 10.1016/S0195-668X(02)00384-6; Oeffinger KC, 2006, NEW ENGL J MED, V355, P1572, DOI 10.1056/NEJMsa060185; Paas G, 2002, RES VALIDITY LMR; Prins CJ, 2000, DUTCH POPULATION STA; Reitsma J B, 2003, Ned Tijdschr Geneeskd, V147, P2286; Reulen RC, 2011, JAMA-J AM MED ASSOC, V305, P2311, DOI 10.1001/jama.2011.747; Reulen RC, 2010, JAMA-J AM MED ASSOC, V304, P172, DOI 10.1001/jama.2010.923; Sieswerda E, 2013, J CANCER SURVIV, V7, P439, DOI 10.1007/s11764-013-0283-9; Van Veen EB., 2011, PATIENT DATA HLTH RE	18	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132444	10.1371/journal.pone.0132444	http://dx.doi.org/10.1371/journal.pone.0132444			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147988	Green Published, Green Submitted, gold			2022-12-26	WOS:000358157600271
J	Kang, I; Barth, JL; Sproul, EP; Yoon, DW; Workman, GA; Braun, KR; Argraves, WS; Wight, TN				Kang, Inkyung; Barth, Jeremy L.; Sproul, Erin P.; Yoon, Dong Won; Workman, Gail A.; Braun, Kathleen R.; Argraves, W. Scott; Wight, Thomas N.			Expression of V3 Versican by Rat Arterial Smooth Muscle Cells Promotes Differentiated and Anti-inflammatory Phenotypes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						differentiation; extracellular matrix; inflammation; inflammatory bowel disease (IBD); microarray; proteoglycan; proteoglycan structure; versican (VCAN)	FOCAL ADHESION KINASE; NF-KAPPA-B; RETROVIRALLY MEDIATED OVEREXPRESSION; CHONDROITIN SULFATE PROTEOGLYCAN; EXTRACELLULAR-MATRIX; MOLECULAR REGULATION; SIGNALING PATHWAYS; ISOFORM EXPRESSION; ENDOTHELIAL-CELLS; MONOCYTE ADHESION	Background: Arterial smooth muscle cells (ASMCs) undergo phenotypic changes during pathophysiological processes. Results: V3 expression increases contractile SMC markers while decreasing a broad range of proinflammatory chemokines and transcription factors. Conclusion: V3 expression reprograms rat ASMCs promoting differentiated and anti-inflammatory phenotypes. Significance: Modifying ECM components via V3 expression could provide a potential therapeutic intervention against vascular and other diseases. Arterial smooth muscle cells (ASMCs) undergo phenotypic changes during development and pathological processes in vivo and during cell culture in vitro. Our previous studies demonstrated that retrovirally mediated expression of the versican V3 splice variant (V3) by ASMCs retards cell proliferation and migration in vitro and reduces neointimal thickening and macrophage and lipid accumulation in animal models of vascular injury and atherosclerosis. However, the molecular pathways induced by V3 expression that are responsible for these changes are not yet clear. In this study, we employed a microarray approach to examine how expression of V3 induced changes in gene expression and the molecular pathways in rat ASMCs. We found that forced expression of V3 by ASMCs affected expression of 521 genes by more than 1.5-fold. Gene ontology analysis showed that components of the extracellular matrix were the most significantly affected by V3 expression. In addition, genes regulating the formation of the cytoskeleton, which also serve as markers of contractile smooth muscle cells (SMCs), were significantly up-regulated. In contrast, components of the complement system, chemokines, chemokine receptors, and transcription factors crucial for regulating inflammatory processes were among the genes most down-regulated. Consistently, we found that the level of myocardin, a key transcription factor promoting contractile SMC phenotype, was greatly increased, and the proinflammatory transcription factors NFB1 and CCAAT/enhancer-binding protein were significantly attenuated in V3-expressing SMCs. Overall, these findings demonstrate that V3 expression reprograms ASMCs promoting differentiated and anti-inflammatory phenotypes.	[Kang, Inkyung; Yoon, Dong Won; Workman, Gail A.; Braun, Kathleen R.; Wight, Thomas N.] Benaroya Res Inst Virginia Mason, Matrix Biol Program, Seattle, WA 98101 USA; [Barth, Jeremy L.; Sproul, Erin P.; Argraves, W. Scott] Med Univ S Carolina, Dept Cell Biol & Anat, Charleston, SC 29425 USA	Benaroya Research Institute; Virginia Mason Medical Center; Medical University of South Carolina	Wight, TN (corresponding author), Benaroya Res Inst Virginia Mason, Matrix Biol Program, 1201 Ninth Ave, Seattle, WA 98101 USA.	twight@benaroyaresearch.org	Regan, Clinton/E-6250-2012		National Institutes of Health [EB012558, HL098067, HL106967, AI101990, GM103342, GM103499]; Medical University of South Carolina through the University Research Resource Facility program; MUSC Proteogenomics Facility; Ann Ramsay-Jenkins and William M. Jenkins Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R41HL106967, P01HL098067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI101990] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB012558] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK017047] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103499, P30GM103342] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical University of South Carolina through the University Research Resource Facility program; MUSC Proteogenomics Facility; Ann Ramsay-Jenkins and William M. Jenkins Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants EB012558, HL098067, and HL106967 and a Pilot Project under Grant AI101990 (to T. N. W.) and Grants GM103342 and GM103499 (to W. S. A. and J. L. B.). This work was also supported by Medical University of South Carolina through the University Research Resource Facility program to (to W. S. A. and J. L. B. and MUSC Proteogenomics Facility). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the Ann Ramsay-Jenkins and William M. Jenkins Fellowship for Matrix Biology.	Allen DL, 2009, J APPL PHYSIOL, V106, P582, DOI 10.1152/japplphysiol.90780.2008; Barth JL, 2010, DEV DYNAM, V239, P2024, DOI 10.1002/dvdy.22341; Beamish JA, 2010, TISSUE ENG PART B-RE, V16, P467, DOI [10.1089/ten.teb.2009.0630, 10.1089/ten.TEB.2009.0630]; BJORKERUD S, 1991, ARTERIOSCLER THROMB, V11, P892, DOI 10.1161/01.ATV.11.4.892; Campbell Julie H., 1994, Current Opinion in Lipidology, V5, P323, DOI 10.1097/00041433-199410000-00003; Cattaruzza S, 2002, J BIOL CHEM, V277, P47626, DOI 10.1074/jbc.M206521200; Chang MY, 2014, MATRIX BIOL, V34, P1, DOI 10.1016/j.matbio.2014.01.011; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; CLOWES MM, 1994, J CLIN INVEST, V93, P644, DOI 10.1172/JCI117016; DuFort CC, 2011, NAT REV MOL CELL BIO, V12, P308, DOI 10.1038/nrm3112; Edgar R, 2006, NAT BIOTECHNOL, V24, P1471, DOI 10.1038/nbt1206-1471; Evanko SP, 2001, ARCH BIOCHEM BIOPHYS, V394, P29, DOI 10.1006/abbi.2001.2507; Gacchina CE, 2011, TISSUE ENG PT A, V17, P1699, DOI 10.1089/ten.tea.2010.0526; Gonye Gregory E., 2007, V408, P49, DOI 10.1007/978-1-59745-547-3_4; Gupta N, 2015, CLIN CHIM ACTA, V442, P119, DOI 10.1016/j.cca.2015.01.012; Hartwig S, 2014, BBA-PROTEINS PROTEOM, V1844, P1011, DOI 10.1016/j.bbapap.2013.08.004; Hautmann MB, 1997, J BIOL CHEM, V272, P10948; Henderson DJ, 1997, MECH DEVELOP, V69, P39, DOI 10.1016/S0925-4773(97)00151-2; Henderson DJ, 1998, CIRC RES, V83, P523, DOI 10.1161/01.RES.83.5.523; Hernandez D, 2011, J BIOL CHEM, V286, P1475, DOI 10.1074/jbc.M110.127522; Hinek A, 2004, AM J PATHOL, V164, P119, DOI 10.1016/S0002-9440(10)63103-3; Hirose J, 2001, J BIOL CHEM, V276, P5228, DOI 10.1074/jbc.M007542200; Huang D, 2007, AM J PHYSIOL-CELL PH, V292, pC1339, DOI 10.1152/ajpcell.00144.2006; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Iwasaki H, 2000, AM J PHYSIOL-HEART C, V278, pH521, DOI 10.1152/ajpheart.2000.278.2.H521; Kamiya N, 2006, J BIOL CHEM, V281, P2390, DOI 10.1074/jbc.M509341200; Kang I, 2014, J BIOL CHEM, V289, P15393, DOI 10.1074/jbc.M113.544338; Keire PA, 2014, J BIOL CHEM, V289, P34089, DOI 10.1074/jbc.M114.607168; Keire PA, 2010, TISSUE ENG PT A, V16, P501, DOI [10.1089/ten.tea.2009.0129, 10.1089/ten.TEA.2009.0129]; Kern CB, 2007, DEV DYNAM, V236, P671, DOI 10.1002/dvdy.21059; Kim S, 2009, NATURE, V457, P102, DOI 10.1038/nature07623; Koga T, 2005, CURR EYE RES, V30, P455, DOI 10.1080/02713680590959376; Koshman YE, 2011, ARTERIOSCL THROM VAS, V31, P2432, DOI 10.1161/ATVBAHA.111.235549; Lemire JM, 2002, J CELL PHYSIOL, V190, P38, DOI 10.1002/jcp.10043; LIU RG, 1993, AM J PHYSIOL, V265, pL430, DOI 10.1152/ajplung.1993.265.5.L430; Mack CP, 2011, ARTERIOSCL THROM VAS, V31, P1495, DOI 10.1161/ATVBAHA.110.221135; Mayanil CSK, 2001, J BIOL CHEM, V276, P49299, DOI 10.1074/jbc.M107933200; McGowan S, 2000, AM J RESP CELL MOL, V23, P162, DOI 10.1165/ajrcmb.23.2.3904; Merrilees MJ, 2011, ARTERIOSCL THROM VAS, V31, P1309, DOI 10.1161/ATVBAHA.111.225573; Merrilees MJ, 2002, CIRC RES, V90, P481, DOI 10.1161/hh0402.105791; Miquel-Serra L, 2006, LAB INVEST, V86, P889, DOI 10.1038/labinvest.3700449; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Mjaatvedt CH, 1998, DEV BIOL, V202, P56, DOI 10.1006/dbio.1998.9001; Morla AO, 2000, BIOCHEM BIOPH RES CO, V272, P298, DOI 10.1006/bbrc.2000.2769; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Paszek MJ, 2014, NATURE, V511, P319, DOI 10.1038/nature13535; Paulus W, 1996, J NEUROPATH EXP NEUR, V55, P528, DOI 10.1097/00005072-199605000-00005; Perissinotto D, 2000, DEVELOPMENT, V127, P2823; Petzold T, 2009, AM J PHYSIOL-CELL PH, V297, pC814, DOI 10.1152/ajpcell.00226.2009; Potter-Perigo S, 2010, AM J RESP CELL MOL, V43, P109, DOI 10.1165/rcmb.2009-0081OC; Rangrez AY, 2011, CIRC-CARDIOVASC GENE, V4, P197, DOI 10.1161/CIRCGENETICS.110.958702; Sayers RL, 2008, ARTERIOSCL THROM VAS, V28, P2115, DOI 10.1161/ATVBAHA.108.175455; Selbi W, 2006, KIDNEY INT, V70, P1287, DOI 10.1038/sj.ki.5001760; Serra M, 2005, INT J CANCER, V114, P879, DOI 10.1002/ijc.20813; Shimizu-Hirota R, 2001, J AM SOC NEPHROL, V12, P2609, DOI 10.1681/ASN.V12122609; Taylor JM, 2001, MOL CELL BIOL, V21, P1565, DOI 10.1128/MCB.21.5.1565-1572.2001; Taylor KR, 2006, FASEB J, V20, P9, DOI 10.1096/fj.05-4682rev; Toeda K, 2005, MOL CELL BIOCHEM, V280, P47, DOI 10.1007/s11010-005-8051-4; Urbinati C, 2005, J CELL SCI, V118, P3949, DOI 10.1242/jcs.02518; Vadigepalli Rajanikanth, 2003, OMICS A Journal of Integrative Biology, V7, P235, DOI 10.1089/153623103322452378; Wang W, 2009, ARCH MED RES, V40, P321, DOI 10.1016/j.arcmed.2009.04.005; Wang XB, 2010, J BIOL CHEM, V285, P23239, DOI 10.1074/jbc.M109.084673; Wight TN, 2014, MATRIX BIOL, V35, P152, DOI 10.1016/j.matbio.2014.01.015; Wight TN, 2004, CIRC RES, V94, P1158, DOI 10.1161/01.RES.0000126921.29919.51; Wipff PJ, 2007, J CELL BIOL, V179, P1311, DOI 10.1083/jcb.200704042; Worth NF, 2001, CELL MOTIL CYTOSKEL, V49, P130, DOI 10.1002/cm.1027; Wu YJ, 2005, CELL RES, V15, P483, DOI 10.1038/sj.cr.7290318; ZAKO M, 1995, J BIOL CHEM, V270, P3914, DOI 10.1074/jbc.270.8.3914	68	13	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2015	290	35					21629	21641		10.1074/jbc.M115.657486	http://dx.doi.org/10.1074/jbc.M115.657486			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ5IS	26152723	hybrid, Green Published			2022-12-26	WOS:000360637600035
J	Dorywalska, M; Strop, P; Melton-Witt, JA; Hasa-Moreno, A; Farias, SE; Casas, MG; Delaria, K; Lui, V; Poulsen, K; Sutton, J; Bolton, G; Zhou, DH; Moine, L; Dushin, R; Tran, TT; Liu, SH; Rickert, M; Foletti, D; Shelton, DL; Pons, J; Rajpal, A				Dorywalska, Magdalena; Strop, Pavel; Melton-Witt, Jody A.; Hasa-Moreno, Adela; Farias, Santiago E.; Casas, Meritxell Galindo; Delaria, Kathy; Lui, Victor; Poulsen, Kris; Sutton, Janette; Bolton, Gary; Zhou, Dahui; Moine, Ludivine; Dushin, Russell; Thomas-Toan Tran; Liu, Shu-Hui; Rickert, Mathias; Foletti, Davide; Shelton, David L.; Pons, Jaume; Rajpal, Arvind			Site-Dependent Degradation of a Non-Cleavable Auristatin-Based Linker-Payload in Rodent Plasma and Its Effect on ADC Efficacy	PLOS ONE			English	Article							THERAPEUTIC ACTIVITY; STABILITY; ANTIBODIES; CONJUGATE	The efficacy of an antibody-drug conjugate (ADC) is dependent on the properties of its linker-payload which must remain stable while in systemic circulation but undergo efficient processing upon internalization into target cells. Here, we examine the stability of a non-cleavable Amino-PEG6-based linker bearing the monomethyl auristatin D (MMAD) payload site-specifically conjugated at multiple positions on an antibody. Enzymatic conjugation with transglutaminase allows us to create a stable amide linkage that remains intact across all tested conjugation sites on the antibody, and provides us with an opportunity to examine the stability of the auristatin payload itself. We report a position-dependent degradation of the C terminus of MMAD in rodent plasma that has a detrimental effect on its potency. The MMAD cleavage can be eliminated by either modifying the C terminus of the toxin, or by selection of conjugation site. Both approaches result in improved stability and potency in vitro and in vivo. Furthermore, we show that the MMAD metabolism in mouse plasma is likely mediated by a serine-based hydrolase, appears much less pronounced in rat, and was not detected in cynomolgus monkey or human plasma. Clarifying these species differences and controlling toxin degradation to optimize ADC stability in rodents is essential to make the best ADC selection from preclinical models. The data presented here demonstrate that site selection and toxin susceptibility to mouse plasma degradation are important considerations in the design of non-cleavable ADCs, and further highlight the benefits of site-specific conjugation methods.	[Dorywalska, Magdalena; Strop, Pavel; Melton-Witt, Jody A.; Hasa-Moreno, Adela; Farias, Santiago E.; Casas, Meritxell Galindo; Delaria, Kathy; Lui, Victor; Poulsen, Kris; Sutton, Janette; Bolton, Gary; Thomas-Toan Tran; Liu, Shu-Hui; Rickert, Mathias; Foletti, Davide; Shelton, David L.; Pons, Jaume; Rajpal, Arvind] Pfizer Inc, Rinat Labs, San Francisco, CA 94080 USA; [Zhou, Dahui; Moine, Ludivine; Dushin, Russell] Pfizer Inc, Worldwide Med Chem, Groton, CT 06340 USA	Pfizer; Pfizer	Strop, P (corresponding author), Pfizer Inc, Rinat Labs, 230 East Grand Ave, San Francisco, CA 94080 USA.	pavel.strop@pfizer.com		Galindo Casas, Meritxell/0000-0002-5034-1722	Pfizer Inc.	Pfizer Inc.(Pfizer)	Pfizer Inc. provided support in the form of salaries for authors M.D., P.S., J.A.M.-W., A. H.-M., S. E.F., M.G.C., K.D., V.L., K.P., J.S., G.B., D.Z., L.M., R. D., T.-T.T., S.-H.L M.R., D.F., D.L.S., J.P., and A.R., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alley SC, 2008, BIOCONJUGATE CHEM, V19, P759, DOI 10.1021/bc7004329; Bender B, 2014, AAPS J, V16, P994, DOI 10.1208/s12248-014-9618-3; Dennler P, 2014, BIOCONJUGATE CHEM, V25, P569, DOI 10.1021/bc400574z; Doronina SO, 2006, BIOCONJUGATE CHEM, V17, P114, DOI 10.1021/bc0502917; Doronina SO, 2003, NAT BIOTECHNOL, V21, P778, DOI 10.1038/nbt832; Dorywalska M, 2015, BIOCONJUGATE CHEM, V26, P650, DOI 10.1021/bc5005747; Ducry L, 2010, BIOCONJUGATE CHEM, V21, P5, DOI 10.1021/bc9002019; Farias SE, 2014, BIOCONJUGATE CHEM, V25, P240, DOI 10.1021/bc4003794; Girish S, 2012, CANCER CHEMOTH PHARM, V69, P1229, DOI 10.1007/s00280-011-1817-3; Jackson D, 2015, PHARM RES-DORDR, V32, P3458, DOI 10.1007/s11095-014-1536-7; Jeger S, 2010, ANGEW CHEM INT EDIT, V49, P9995, DOI 10.1002/anie.201004243; Junutula JR, 2010, CLIN CANCER RES, V16, P4769, DOI 10.1158/1078-0432.CCR-10-0987; Lambert JM, 2013, BRIT J CLIN PHARMACO, V76, P248, DOI 10.1111/bcp.12044; Lyon RP, 2014, NAT BIOTECHNOL, V32, P1059, DOI 10.1038/nbt.2968; Maderna A, 2014, J MED CHEM, V57, P10527, DOI 10.1021/jm501649k; McCombs JR, 2015, AAPS J, V17, P339, DOI 10.1208/s12248-014-9710-8; Panowski S, 2014, MABS-AUSTIN, V6, P34, DOI 10.4161/mabs.27022; PETTIT GR, 1987, J AM CHEM SOC, V109, P6883, DOI 10.1021/ja00256a070; Pillow TH, 2014, J MED CHEM, V57, P7890, DOI 10.1021/jm500552c; Rostami S, 2014, J ANTIBODY DRUG CONJ; Sanderson RJ, 2005, CLIN CANCER RES, V11, P843; Shen BQ, 2012, NAT BIOTECHNOL, V30, P184, DOI 10.1038/nbt.2108; Sievers EL, 2013, ANNU REV MED, V64, P15, DOI 10.1146/annurev-med-050311-201823; Sigma-Aldrich, 2009, LIFE SCI BIOFILES, V4; SMYTH DG, 1964, BIOCHEM J, V91, P589, DOI 10.1042/bj0910589; Strop P., 2012, Patent No. [WO 2012059882A2, 2012059882]; Strop P, 2013, CHEM BIOL, V20, P161, DOI 10.1016/j.chembiol.2013.01.010; Tannir NM, 2014, INVEST NEW DRUG, V32, P1246, DOI 10.1007/s10637-014-0151-0; Tumey LN, 2014, BIOCONJUGATE CHEM, V25, P1871, DOI 10.1021/bc500357n	29	39	41	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132282	10.1371/journal.pone.0132282	http://dx.doi.org/10.1371/journal.pone.0132282			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161543	Green Submitted, Green Published, gold			2022-12-26	WOS:000358162300112
J	Lopes, GN; Souza, MF; Gotelli, NJ; Lemos, LJU; Godoy, WAC; Zucchi, RA				Lopes, Gleidyane N.; Souza-Filho, Miguel F.; Gotelli, Nicholas J.; Lemos, Leandro J. U.; Godoy, Wesley A. C.; Zucchi, Roberto A.			Temporal Overlap and Co-Occurrence in a Guild of Sub-Tropical Tephritid Fruit Flies	PLOS ONE			English	Article							FRATERCULUS COMPLEX DIPTERA; NULL MODEL ANALYSIS; PARASITOIDS HYMENOPTERA; DIVERSITY; BIODIVERSITY	Studies of community assembly have emphasized snapshot comparisons of spatially replicated samples from "natural" assemblages. Agro-ecosystems are characterized by relatively little habitat heterogeneity and no dispersal barriers for actively flying insects. Therefore, dynamic patterns of species segregation and aggregation are more likely to reflect the direct or indirect effects of species interactions. We studied the temporal organization of a guild of 21 congeneric species of Anastrepha that colonized fruit orchards in Monte Alegre do Sul, Sao Paulo, Brazil. This assemblage also included the introduced Mediterranean fruit fly Ceratitis capitata. One hundred six consecutive weekly censuses (11 Jan 2002-16 Jan 2004) of flies in guava, loquat, and peach orchards revealed a pattern of minimum abundance during the coldest months of each year (June and July) and a maximum abundance during periods of flowering and fruit ripening. Overall, phenological overlap was greater than expected by chance. However, conditioned on the pattern of seasonal abundances, temporal occurrence and abundance matrices exhibited patterns of significant species segregation and anti-nestedness. In each year, the 3 orchards contained a small number of species pairs that exhibited statistically significant temporal segregation or aggregation. Most aggregated and segregated pairs reflected seasonal shifts in species presences that were not related to variation in air temperature. Most of the significant pair-wise associations involved C. capitata: 8 of the 11 segregated pairs and 2 of the 7 aggregated pairs. These results suggest that species interactions between introduced and native species can be an important determinant of species associations in agro-ecosystems.	[Lopes, Gleidyane N.; Lemos, Leandro J. U.; Godoy, Wesley A. C.; Zucchi, Roberto A.] Univ Sao Paulo, ESALQ, Dept Entomol & Acarol, Piracicaba, SP, Brazil; [Souza-Filho, Miguel F.] Secretaria Agr & Abastecimento, Inst Biol, Campinas, SP, Brazil; [Gotelli, Nicholas J.] Univ Vermont, Dept Biol, Burlington, VT USA	Universidade de Sao Paulo; Universidade de Sao Paulo; University of Vermont	Lopes, GN (corresponding author), Univ Sao Paulo, ESALQ, Dept Entomol & Acarol, Piracicaba, SP, Brazil.	gnlopesm@hotmail.com	Lopes Mielezrski, Gleidyane/O-9912-2015; Zucchi, Roberto/D-7738-2012; Godoy, Wesley AC/B-9787-2012; Filho, Miguel Souza/N-4312-2013	Zucchi, Roberto/0000-0001-9861-7460; Souza-Filho, Miguel Francisco de/0000-0001-7838-1489; Lopes-Mielezrski, Gleidyane/0000-0002-1455-3760	"Conselho Nacional de Desenvolvimento Cientifico e Tecnologico" (CNPq); US National Science Foundation [11-44055, 13-6703]	"Conselho Nacional de Desenvolvimento Cientifico e Tecnologico" (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); US National Science Foundation(National Science Foundation (NSF))	The "Conselho Nacional de Desenvolvimento Cientifico e Tecnologico" (CNPq) awarded a grant to the first author. NJG was supported by US National Science Foundation Grants 11-44055 and 13-6703. RAZ is a fellow of the CNPq.	ALUJA M, 1994, ANNU REV ENTOMOL, V39, P155, DOI 10.1146/annurev.en.39.010194.001103; Aluja M, 2003, ENVIRON ENTOMOL, V32, P1377, DOI 10.1603/0046-225X-32.6.1377; Baliraine FN, 2004, MOL ECOL, V13, P683, DOI 10.1046/j.1365-294X.2004.02105.x; Blois J, ECOGRAPHY IN PRESS; Cash FBJ, 2012, AUSTRAL ECOL, V37, P903, DOI 10.1111/j.1442-9993.2011.02349.x; Castro-Arellano I, 2010, METHODS ECOL EVOL, V1, P311, DOI 10.1111/j.2041-210X.2010.00031.x; Chase JM, 2003, OECOLOGIA, V136, P489, DOI 10.1007/s00442-003-1311-7; Cody M.L, 1974, COMPETITION STRUCTUR; Diamond J.M., 1975, P342; Duyck PF, 2004, ECOL ENTOMOL, V29, P511, DOI 10.1111/j.0307-6946.2004.00638.x; Ekesi S, 2009, J ECON ENTOMOL, V102, P981, DOI 10.1603/029.102.0317; Ellwood MDF, 2009, ECOL LETT, V12, P277, DOI 10.1111/j.1461-0248.2009.01284.x; Enkerlin WR, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P651, DOI 10.1007/1-4020-4051-2_25; FEINSINGER P, 1981, ECOLOGY, V62, P27, DOI 10.2307/1936664; Fox BJ, 2000, GLOBAL ECOL BIOGEOGR, V9, P19, DOI 10.1046/j.1365-2699.2000.00184.x; Gillespie RG, 2008, MOL ECOL, V17, P45, DOI 10.1111/j.1365-294X.2007.03466.x; Gotelli N. J., 2012, ECOSIM 7 72 ACQUIRED; Gotelli NJ, 2012, OIKOS, V121, P171, DOI 10.1111/j.1600-0706.2011.20301.x; Gotelli NJ, 2010, OECOLOGIA, V162, P463, DOI 10.1007/s00442-009-1474-y; Gotelli NJ, 2000, ECOLOGY, V81, P2606, DOI 10.1890/0012-9658(2000)081[2606:NMAOSC]2.0.CO;2; Gotelli NJ, 2000, ECOL LETT, V3, P257, DOI 10.1046/j.1461-0248.2000.00138.x; Hernandez-Ortiz V, 2012, ANN ENTOMOL SOC AM, V105, P305, DOI 10.1603/AN11123; Kukalova-Peck J, 2008, EVOL BIOL, V35, P4, DOI 10.1007/s11692-007-9013-4; MCCOY ED, 1987, J BIOGEOGR, V14, P79, DOI 10.2307/2844788; New TR, 2008, INSECT CONSERVATION, P3; Patrick CJ, 2011, J N AM BENTHOL SOC, V30, P259, DOI 10.1899/09-169.1; Planka E.R., 1973, Annual Rev Ecol Syst, V4, P53; Plummer CC, 1941, YELLOW CHAPOTE NATIV; Puzzi D., 1965, ARQ I BIO, V32, P9; R Core Team, 2021, R LANGUAGE ENV STAT; Ribas CR, 2002, OECOLOGIA, V131, P606, DOI 10.1007/s00442-002-0912-x; Sanders NJ, 2003, P NATL ACAD SCI USA, V100, P2474, DOI 10.1073/pnas.0437913100; Sax DF, 2003, TRENDS ECOL EVOL, V18, P561, DOI 10.1016/S0169-5347(03)00224-6; Selivon D, 2005, ANN ENTOMOL SOC AM, V98, P367, DOI 10.1603/0013-8746(2005)098[0367:AGCOTC]2.0.CO;2; Selivon D., 2000, MOSCAS DAS FRUTAS IM, P87; Silva RA, 2011, MOSCAS DAS FRUTAS AM, P199; Souza MF, 2009, BRAZ J BIOL, V69, P31, DOI 10.1590/S1519-69842009000100004; STONE L, 1990, OECOLOGIA, V85, P74, DOI 10.1007/BF00317345; Triantis Kostas A., 2011, P190; Tscharntke T, 2005, ECOL LETT, V8, P857, DOI 10.1111/j.1461-0248.2005.00782.x; Tscharntke T, 2002, ECOL RES, V17, P229, DOI 10.1046/j.1440-1703.2002.00482.x; Ulrich W, 2008, PAIRS FORTRAN PROGRA; Ulrich W, 2006, COOCCURRENCE FORTRAN; Ulrich W, 2010, ECOLOGY, V91, P3384, DOI 10.1890/09-2157.1; Weiher Evan, 1999, P251, DOI 10.1017/CBO9780511542237.010; Whittaker R. J., 2007, ISLAND BIOGEOGRAPHY; Zucchi, 2001, HIST IMPACTO PRAGAS, P173; Zucchi RA., 2012, FRUIT FLIES BRAZIL H; Zucchi RA, 2008, FRUIT FLIES BRAZIL A; ZUCOLOTO F. S., 2000, MOSCAS DAS FRUTAS IM, P67	50	13	13	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132124	10.1371/journal.pone.0132124	http://dx.doi.org/10.1371/journal.pone.0132124			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161855	Green Published, Green Submitted, gold			2022-12-26	WOS:000358162300097
J	Overholt, WA; Diaz, R; Rosskopf, E; Green, SJ; Overholt, WA				Overholt, Will A.; Diaz, Rodrigo; Rosskopf, Erin; Green, Stefan J.; Overholt, William A.			Deep Characterization of the Microbiomes of Calophya spp. (Hemiptera: Calophyidae) Gall-Inducing Psyllids Reveals the Absence of Plant Pathogenic Bacteria and Three Dominant Endosymbionts	PLOS ONE			English	Article							PHLOEM-SAP; DIAPHORINA-CITRI; LICE HEMIPTERA; GENOME; PSYLLOIDEA; SYMBIONTS; SEQUENCES; ANACARDIACEAE; LATIFORCEPS; DIVERSITY	Bacteria associated with sap-feeding insect herbivores include not only symbionts that may increase their hosts' fitness but also harmful plant pathogens. Calophya spp. gall-inducing psyllids (Hemiptera: Calophyidae) are being investigated for their potential as biological control agents of the noxious weed, Brazilian peppertree (Schinus terebinthifolia), in Florida. Although there are no examples of plant pathogen transmission by members of the family Calophyidae, several insects in the superfamily Psylloidea are known to transmit pathogenic bacteria in the genera Candidatus Liberibacter and Candidatus Phytoplasma. To determine whether Calophya spp. harbor potentially harmful plant pathogenic bacteria, we sequenced small subunit (SSU) ribosomal RNA (rRNA) gene amplicons generated from individuals from four Calophya spp. populations. All microbial SSU gene sequences fell into the bacterial domain, with 98-99% belonging to the Proteobacteria. The Calophya microbiomes contained a relatively simple community, with 49-79 operational taxonomic units (OTUs; 97%) detected, and only 5-8 OTUs with greater than 1% abundance. Candidatus Carsonella showed the highest relative abundance, with OTUs from this candidate genus representing between 51 - 65% of all recovered sequences. The next most abundant clade observed was an unclassified Enterobacteriacae group closely related to bacteria from the genera Buchnera and Blochmannia that ranged from 20-31% in relative abundance. Wolbachia populations were the third most abundant group and represented 7-27% of the diversity in microbial OTUs. No SSU rRNA gene sequences from putative pathogenic bacteria from the genera Ca. Liberibacter or Ca. Phytoplasma were detected in the microbiomes of the four Calophya populations. The probability that infected psyllids were present in our colonies, but were not sampled, was extremley low (1.39 x 10(-10)). As far as we are aware, our study is the first to characterize the microbiome of a candidate biological control agent, and coupled with previous work demonstrating a high degree of host specificity and absence of plant viruses, suggests that releasing Calophya spp. in United States poses minimal risk to non-target plants.	[Overholt, Will A.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Diaz, Rodrigo] Louisiana State Univ, Dept Entomol, Baton Rouge, LA 70803 USA; [Rosskopf, Erin] USDA, US Hort Res Lab, Ft Pierce, FL USA; [Green, Stefan J.] Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA; [Overholt, William A.] Univ Florida, Biol Control Res & Containment Lab, Ft Pierce, FL 34945 USA	University System of Georgia; Georgia Institute of Technology; Louisiana State University System; Louisiana State University; United States Department of Agriculture (USDA); University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; State University System of Florida; University of Florida	Overholt, WA (corresponding author), Univ Florida, Biol Control Res & Containment Lab, Ft Pierce, FL 34945 USA.	billover@ufl.edu	Overholt, Will/X-2461-2019; Diaz, Rodrigo/ABG-5508-2020	Overholt, Will/0000-0002-2897-6991; Diaz, Rodrigo/0000-0001-5493-9548; Green, Stefan/0000-0003-2781-359X	Florida Fish and Wildlife Conservation Commission; Florida Department of Agriculture and Consumer Services; National Science Foundation Graduate Research Fellowship [2013172310]; ARS [ARS-0426283] Funding Source: Federal RePORTER	Florida Fish and Wildlife Conservation Commission; Florida Department of Agriculture and Consumer Services; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This research was funded in part by grants from the Florida Fish and Wildlife Conservation Commission, the Florida Department of Agriculture and Consumer Services, and a National Science Foundation Graduate Research Fellowship, https://www.nsfgrfp.org/, (to WAO1) under Grant No. 2013172310. Any opinion, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aronesty E., 2011, COMMAND LINE TOOLS F; Arp AP, 2013, ENVIRON ENTOMOL, V42, P868, DOI 10.1603/EN12260; Bansal R, 2014, ENV MICROBIOL REP, V6, P57, DOI 10.1111/1758-2229.12108; Baumann P, 2005, ANNU REV MICROBIOL, V59, P155, DOI 10.1146/annurev.micro.59.030804.121041; Buchner P., 1965, ENDOSYMBIOSIS OF ANI; Burckhardt D, 2000, J NAT HIST, V34, P57, DOI 10.1080/002229300299688; Burckhardt D, 2011, FLA ENTOMOL, V94, P489, DOI 10.1653/024.094.0313; Burckhardt D, 2014, FLA ENTOMOL, V97, P242, DOI 10.1653/024.097.0132; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Carraro L., 1998, Journal of Plant Pathology, V80, P233; Clark MA, 2001, J BACTERIOL, V183, P1853, DOI 10.1128/JB.183.6.1853-1861.2001; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; CLARKE KR, 2001, CHANGES IN MARINE CO; Colman DR, 2012, MOL ECOL, V21, P5124, DOI 10.1111/j.1365-294X.2012.05752.x; Deng C, 2014, PRESEQR PREDICTING S; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Diaz R, 2015, FLA ENTOMOL, V98, P776, DOI 10.1653/024.098.0257; Diaz R, 2015, ENTOMOL EXP APPL, V154, P1, DOI 10.1111/eea.12249; Diaz R, 2014, BIOCONTROL SCI TECHN, V24, P536, DOI 10.1080/09583157.2013.878686; Doren RF, 1997, STRANGERS PARADISE I, P275; Douglas AE, 1998, ANNU REV ENTOMOL, V43, P17, DOI 10.1146/annurev.ento.43.1.17; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Fagen Jennie R, 2012, Open Microbiol J, V6, P29, DOI 10.2174/1874285801206010029; Feldhaar H, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-48; Gioeli K, 1997, SS AGR 17; Haapalainen M, 2014, ANN APPL BIOL, V165, P172, DOI 10.1111/aab.12149; Hail D, 2012, ENVIRON ENTOMOL, V41, P98, DOI 10.1603/EN11198; Hall DG, 2013, ENTOMOL EXP APPL, V146, P207, DOI 10.1111/eea.12025; Hardy NB, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-257; Hodkinson I, 2009, J NAT HIST, V43, P65, DOI 10.1080/00222930802354167; Jensen DD, 1963, CALIF AGR, V17, P1; Jing XF, 2014, MOL ECOL, V23, P1433, DOI 10.1111/mec.12637; Koyama Y, 2004, ENTOMOL EXP APPL, V113, P35, DOI 10.1111/j.0013-8703.2004.00207.x; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Manrique V., 2013, J FLORIDA STUD, V1, P1; Matos LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078994; McMurdie PJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003531; Moran NA, 2006, MOL ECOL, V15, P1251, DOI 10.1111/j.1365-294X.2005.02744.x; Moran NA, 1998, BIOSCIENCE, V48, P295, DOI 10.2307/1313356; Moran NA, 2008, ANNU REV GENET, V42, P165, DOI 10.1146/annurev.genet.41.110306.130119; Munyaneza JE, 2012, AM J POTATO RES, V89, P329, DOI 10.1007/s12230-012-9262-3; Munyaneza JE, 2010, SOUTHWEST ENTOMOL, V35, P471, DOI 10.3958/059.035.0335; Nachappa P, 2011, CURR MICROBIOL, V62, P1510, DOI 10.1007/s00284-011-9885-5; Nakabachi A, 2010, B ENTOMOL RES, V100, P27, DOI 10.1017/S0007485309006737; Nakabachi A, 2006, SCIENCE, V314, P267, DOI 10.1126/science.1134196; Nakabachi A, 2013, CURR BIOL, V23, P1478, DOI 10.1016/j.cub.2013.06.027; Oksanen J, 2013, VAGAN COMMUNITY ECOL; Paulson JN, 2013, NAT METHODS, V10, P1200, DOI [10.1038/NMETH.2658, 10.1038/nmeth.2658]; R Core Team, 2013, R LANGUAGE ENV STAT; Rodgers L, 2012, STATUS NONINDIGENOUS, P1; SANDSTROM J, 1994, J INSECT PHYSIOL, V40, P947, DOI 10.1016/0022-1910(94)90133-3; Sandstrom J, 1999, ENTOMOL EXP APPL, V91, P203, DOI 10.1023/A:1003605508487; Simberloff D, 1997, STRANGERS IN PARADIS; Sloan DB, 2014, MOL BIOL EVOL, V31, P857, DOI 10.1093/molbev/msu004; Sloan DB, 2012, MOL BIOL EVOL, V29, P3781, DOI 10.1093/molbev/mss180; Subandiyah S, 2000, ZOOL SCI, V17, P983, DOI 10.2108/zsj.17.983; Tamames J, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-181; Tedeschi R, 2009, EUR J PLANT PATHOL, V123, P301, DOI 10.1007/s10658-008-9367-1; Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002; Thao ML, 2000, APPL ENVIRON MICROB, V66, P2898, DOI 10.1128/AEM.66.7.2898-2905.2000; Thao ML, 2000, CURR MICROBIOL, V41, P300, DOI 10.1007/s002840010138; Thompson S., 2013, New Disease Reports, V27, P6, DOI 10.5197/j.2044-0588.2013.027.006; Walters WA, 2011, BIOINFORMATICS, V27, P1159, DOI 10.1093/bioinformatics/btr087; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Weintraub PG, 2006, ANNU REV ENTOMOL, V51, P91, DOI 10.1146/annurev.ento.51.110104.151039; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wickham H, 2011, J STAT SOFTW, V40, P1, DOI 10.18637/jss.v040.i01; Wilcove DS, 1998, BIOSCIENCE, V48, P607, DOI 10.2307/1313420; WOESE CR, 1975, NATURE, V254, P83, DOI 10.1038/254083a0; Workman R., 1979, TECHNICAL PROCEEDING; Wunderlin RP, 2008, ATLAS OF FLORIDA VAS	77	19	19	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132248	10.1371/journal.pone.0132248	http://dx.doi.org/10.1371/journal.pone.0132248			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161659	Green Published, Green Submitted, gold			2022-12-26	WOS:000358162300107
J	Plzakova, L; Krocova, Z; Kubelkova, K; Macela, A				Plzakova, Lenka; Krocova, Zuzana; Kubelkova, Klara; Macela, Ales			Entry of Francisella tularensis into Murine B Cells: The Role of B Cell Receptors and Complement Receptors	PLOS ONE			English	Article							LIVE VACCINE STRAIN; BRUCELLA-ABORTUS; NONPHAGOCYTIC CELLS; IN-VITRO; INFECTION; ANTIGEN; MACROPHAGES; SALMONELLA; VIRULENCE; ADHERENCE	Francisella tularensis, the etiological agent of tularemia, is an intracellular pathogen that dominantly infects and proliferates inside phagocytic cells but can be seen also in nonphagocytic cells, including B cells. Although protective immunity is known to be almost exclusively associated with the type 1 pathway of cellular immunity, a significant role of B cells in immune responses already has been demonstrated. Whether their role is associated with antibody-dependent or antibody-independent B cell functions is not yet fully understood. The character of early events during B cell-pathogen interaction may determine the type of B cell response regulating the induction of adaptive immunity. We used fluorescence microscopy and flow cytometry to identify the basic requirements for the entry of F. tularensis into B cells within in vivo and in vitro infection models. Here, we present data showing that Francisella tularensis subsp. holarctica strain LVS significantly infects individual subsets of murine peritoneal B cells early after infection. Depending on a given B cell subset, uptake of Francisella into B cells is mediated by B cell receptors (BCRs) with or without complement receptor CR1/2. However, F. tularensis strain FSC200 Delta iglC and.ftdsbA deletion mutants are defective in the ability to enter B cells. Once internalized into B cells, F. tularensis LVS intracellular trafficking occurs along the endosomal pathway, albeit without significant multiplication. The results strongly suggest that BCRs alone within the B-1a subset can ensure the internalization process while the BCRs on B-1b and B-2 cells need co-signaling from the co receptor containing CR1/2 to initiate F. tularensis engulfment. In this case, fluidity of the surface cell membrane is a prerequisite for the bacteria's internalization. The results substantially underline the functional heterogeneity of B cell subsets in relation to F. tularensis.	[Plzakova, Lenka; Krocova, Zuzana; Kubelkova, Klara; Macela, Ales] Univ Def, Fac Mil Hlth Sci, Dept Mol Pathol & Biol, Hradec Kralove, Czech Republic	University of Defence - Czech Republic	Kubelkova, K (corresponding author), Univ Def, Fac Mil Hlth Sci, Dept Mol Pathol & Biol, Hradec Kralove, Czech Republic.	klara.kubelkova@unob.cz	Krocova, Zuzana/R-6364-2016	Krocova, Zuzana/0000-0002-6369-2695; Horcickova, Lenka/0000-0003-4320-2262	Czech Science Foundation [P302/11/1631]; Czech Ministry of Education, Youth and Sports	Czech Science Foundation(Grant Agency of the Czech Republic); Czech Ministry of Education, Youth and Sports(Ministry of Education, Youth & Sports - Czech Republic)	Grant No. P302/11/1631 from the Czech Science Foundation. Grant "Long-term organization plan 1011" received from the Czech Ministry of Education, Youth and Sports.	Abplanalp AL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007920; Almeida SR, 2001, INT IMMUNOL, V13, P1193, DOI 10.1093/intimm/13.9.1193; BARD JA, 1985, INFECT IMMUN, V50, P935, DOI 10.1128/IAI.50.3.935-937.1985; Barel M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-145; Batista FD, 2009, NAT REV IMMUNOL, V9, P15, DOI 10.1038/nri2454; Batista FD, 2001, NATURE, V411, P489, DOI 10.1038/35078099; Bolger CE, 2005, J LEUKOCYTE BIOL, V77, P893, DOI 10.1189/jlb.1104637; Bonazzi M, 2009, CELL MICROBIOL, V11, P693, DOI 10.1111/j.1462-5822.2009.01293.x; BRATESCU A, 1981, INFECT IMMUN, V31, P816, DOI 10.1128/IAI.31.2.816-821.1981; Broms JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050473; Carroll MC, 2012, IMMUNITY, V37, P199, DOI 10.1016/j.immuni.2012.08.002; Castro-Eguiluz D, 2009, MICROB PATHOGENESIS, V47, P52, DOI 10.1016/j.micpath.2009.04.005; Chakraborty S, 2008, INFECT IMMUN, V76, P2852, DOI 10.1128/IAI.01726-07; Clemens DL, 2007, ANN NY ACAD SCI, V1105, P160, DOI 10.1196/annals.1409.001; Craven RR, 2008, INFECT IMMUN, V76, P2833, DOI 10.1128/IAI.00043-08; DETILLEUX PG, 1990, INFECT IMMUN, V58, P2320, DOI 10.1128/IAI.58.7.2320-2328.1990; Garcia-Perez BE, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-246; Forestal CA, 2007, J INFECT DIS, V196, P134, DOI 10.1086/518611; Geier H, 2011, INFECT IMMUN, V79, P2204, DOI 10.1128/IAI.01382-10; Gimpl G, 2007, BIOSCIENCE REP, V27, P335, DOI 10.1007/s10540-007-9060-1; Goenka R, 2012, J INFECT DIS, V206, P91, DOI 10.1093/infdis/jis310; Golovliov I, 2003, FEMS MICROBIOL LETT, V222, P273, DOI 10.1016/S0378-1097(03)00313-6; Hall JD, 2008, INFECT IMMUN, V76, P5843, DOI 10.1128/IAI.01176-08; HEYMAN B, 1993, IMMUNOL TODAY, V14, P515, DOI 10.1016/0167-5699(93)90269-Q; Horzempa J, 2011, J INFECT DIS, V204, P51, DOI 10.1093/infdis/jir221; Krocova Z, 2008, MICROB PATHOGENESIS, V45, P79, DOI 10.1016/j.micpath.2008.01.010; Law HT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104881; Law HT, 2011, SCI REP-UK, V1, DOI 10.1038/srep00192; Lindemann SR, 2007, INFECT IMMUN, V75, P3178, DOI 10.1128/IAI.01811-06; LOMBARDI G, 1987, RES CLIN LAB, V17, P1; Malik M, 2006, INFECT IMMUN, V74, P3657, DOI 10.1128/IAI.02030-05; Meibom KL, 2009, FUTURE MICROBIOL, V4, P713, DOI 10.2217/FMB.09.37; Melillo A, 2006, FEMS MICROBIOL LETT, V263, P102, DOI 10.1111/j.1574-6968.2006.00413.x; Menon A, 2003, COMP IMMUNOL MICROB, V26, P157, DOI 10.1016/S0147-9571(02)00039-5; Moreau GB, 2013, VIRULENCE, V4, P826, DOI 10.4161/viru.25629; Mostowy S, 2009, CELL MOTIL CYTOSKEL, V66, P816, DOI 10.1002/cm.20353; Parra D, 2012, J LEUKOCYTE BIOL, V91, P525, DOI 10.1189/jlb.0711372; Pike LJ, 2009, J LIPID RES, V50, pS323, DOI 10.1194/jlr.R800040-JLR200; Pizarro-Cerda J, 1998, INFECT IMMUN, V66, P5711; Pizarro-Cerda J, 2000, MICROBES INFECT, V2, P829, DOI 10.1016/S1286-4579(00)90368-X; Pizarro-Cerda J, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a010009; Plzakova L, 2014, MICROB PATHOGENESIS, V75, P49, DOI 10.1016/j.micpath.2014.08.009; Qin AP, 2014, J BACTERIOL, V196, P3571, DOI 10.1128/JB.01359-13; Qin AP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024611; Qin AP, 2009, INFECT IMMUN, V77, P152, DOI 10.1128/IAI.01113-08; Ramond E, 2012, FUTURE MICROBIOL, V7, P1255, DOI [10.2217/fmb.12.103, 10.2217/FMB.12.103]; Ren G, 2014, MOL MICROBIOL, V94, P926, DOI 10.1111/mmi.12808; Rosales-Reyes R, 2012, MICROB PATHOGENESIS, V52, P367, DOI 10.1016/j.micpath.2012.03.007; Santic M, 2005, CELL MICROBIOL, V7, P969, DOI 10.1111/j.1462-5822.2005.00526.x; Santic M, 2006, TRENDS MICROBIOL, V14, P37, DOI 10.1016/j.tim.2005.11.008; Santic M, 2010, CELL MICROBIOL, V12, P129, DOI 10.1111/j.1462-5822.2009.01400.x; Schmidt C, 2009, EMBO J, V28, P711, DOI 10.1038/emboj.2009.20; Schulert GS, 2006, J LEUKOCYTE BIOL, V80, P563, DOI 10.1189/jlb.0306219; Sjostedt A, 2006, MICROBES INFECT, V8, P561, DOI 10.1016/j.micinf.2005.08.001; Souwer Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050667; Souwer Y, 2009, J IMMUNOL, V182, P7473, DOI 10.4049/jimmunol.0802831; Straskova A, 2009, J PROTEOME RES, V8, P5336, DOI 10.1021/pr900570b; Sunyer J. Oriol, 2012, Infectious Disorders - Drug Targets, V12, P200; TEODORESCU M, 1982, ADV IMMUNOL, V33, P307, DOI 10.1016/S0065-2776(08)60838-X; VANNOESEL CJM, 1993, IMMUNOL TODAY, V14, P8, DOI 10.1016/0167-5699(93)90316-D; Veiga E, 2006, TRENDS CELL BIOL, V16, P499, DOI 10.1016/j.tcb.2006.08.005; Velge P, 2012, MICROBIOLOGYOPEN, V1, P243, DOI 10.1002/mbo3.28; VERJANS GMGM, 1994, INFECT IMMUN, V62, P2229, DOI 10.1128/IAI.62.6.2229-2235.1994; Vitry MA, 2014, INFECT IMMUN, V82, P3927, DOI 10.1128/IAI.01779-14; Zuidscherwoude M, 2014, J LEUKOCYTE BIOL, V95, P251, DOI 10.1189/jlb.0813440	65	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132571	10.1371/journal.pone.0132571	http://dx.doi.org/10.1371/journal.pone.0132571			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161475	gold, Green Submitted, Green Published			2022-12-26	WOS:000358162300154
J	Wielders, CCH; van Loenhout, JAF; Morroy, G; Rietveld, A; Notermans, DW; Wever, PC; Renders, NHM; Leenders, ACAP; van der Hoek, W; Schneeberger, PM				Wielders, Cornelia C. H.; van Loenhout, Joris A. F.; Morroy, Gabriella; Rietveld, Ariene; Notermans, Daan W.; Wever, Peter C.; Renders, Nicole H. M.; Leenders, Alexander C. A. P.; van der Hoek, Wim; Schneeberger, Peter M.			Long-Term Serological Follow-Up of Acute Q-Fever Patients after a Large Epidemic	PLOS ONE			English	Article							COXIELLA-BURNETII INFECTION; ENDOCARDITIS; DIAGNOSIS; NETHERLANDS; RESPONSES; ANEURYSMS; OUTBREAK; CRITERIA; DISEASE; GRAFTS	Background Serological follow-up of acute Q-fever patients is important for detection of chronic infection but there is no consensus on its frequency and duration. The 2007-2009 Q-fever epidemic in the Netherlands allowed for long-term follow-up of a large cohort of acute Q-fever patients. The aim of this study was to validate the current follow-up strategy targeted to identify patients with chronic Q-fever. Methods A cohort of adult acute Q-fever patients, diagnosed between 2007 and 2009, for whom a twelve-month follow-up sample was available, was invited to complete a questionnaire and provide a blood sample, four years after the acute episode. Antibody profiles, determined by immunofluorescence assay in serum, were investigated with a special focus on high titres of IgG antibodies against phase I of Coxiella burnetii, as these are considered indicative for possible chronic Q-fever. Results Of the invited 1,907 patients fulfilling inclusion criteria, 1,289 (67.6%) were included in the analysis. At any time during the four-year follow-up period, 58 (4.5%) patients were classified as possible, probable, or proven chronic Q-fever according to the Dutch Q-fever Consensus Group criteria (which uses IgG phase I >= 1: 1,024 to as serologic criterion for chronic Q-fever). Fifty-two (89.7%) of these were identified within the first year after the acute episode. Of the six patients that were detected for the first time at four-year follow-up, five had an IgG phase I titre of 1:512 at twelve months. Conclusions A twelve-month follow-up check after acute Q-fever is recommended as it adequately detects chronic Q-fever in patients without known risk factors. Additional serological and clinical follow-up is recommended for patients with IgG phase I >= 1:512, as they showed the highest risk to progress to chronic Q-fever.	[Wielders, Cornelia C. H.; Wever, Peter C.; Renders, Nicole H. M.; Leenders, Alexander C. A. P.; Schneeberger, Peter M.] Jeroen Bosch Hosp, Dept Med Microbiol & Infect Control, sHertogenbosch, Netherlands; [Wielders, Cornelia C. H.; Notermans, Daan W.; van der Hoek, Wim; Schneeberger, Peter M.] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Bilthoven, Netherlands; [van Loenhout, Joris A. F.; Morroy, Gabriella] Radboud Univ Nijmegen, Med Ctr, Radboudumc, Acad Collaborat Ctr AMPHI,Dept Primary & Communit, NL-6525 ED Nijmegen, Netherlands; [Morroy, Gabriella; Rietveld, Ariene] Municipal Hlth Serv GGD Hart voor Brabant, Dept Infect Dis Control, sHertogenbosch, Netherlands	Jeroen Bosch Ziekenhuis; Netherlands National Institute for Public Health & the Environment; Radboud University Nijmegen	van der Hoek, W (corresponding author), Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Bilthoven, Netherlands.	wim.van.der.hoek@rivm.nl; p.schneeberger@jbz.nl	van Loenhout, Joris/AAV-2075-2020; Wielders, Cornelia CH/I-1970-2019	van Loenhout, Joris/0000-0001-7810-7738; Wielders, Cornelia CH/0000-0002-2413-9088	ZonMw, Netherlands Organisation for Health Research and Development [205520006]	ZonMw, Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development)	This work was supported by ZonMw, the Netherlands Organisation for Health Research and Development (grant number 205520006, http://www.zonmw.nl/). The funding source had no role in the study design, data collection, analysis and interpretation of data, writing of the report, and in the decision to submit the paper for publication. The corresponding author had full access to all the study data and had final responsibility for the decision to submit for publication.	Anderson A, 2013, MMWR RECOMM REP, V62, P1; Barten DG, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-413; Botelho-Nevers E, 2007, EUR J CLIN MICROBIOL, V26, P635, DOI 10.1007/s10096-007-0357-6; BROUQUI P, 1993, ARCH INTERN MED, V153, P642, DOI 10.1001/archinte.153.5.642; Capuano AW, 2007, INFLUENZA OTHER RESP, V1, P87, DOI 10.1111/j.1750-2659.2007.00014.x; Dijkstra F, 2011, EPIDEMIOL INFECT, V139, P1332, DOI 10.1017/S0950268810002621; DUPUIS G, 1985, J CLIN MICROBIOL, V22, P484, DOI 10.1128/JCM.22.4.484-487.1985; Edouard S, 2014, J INFECTION, V68, P141, DOI 10.1016/j.jinf.2013.10.010; Fenollar F, 2001, CLIN INFECT DIS, V33, P312, DOI 10.1086/321889; Fournier PE, 1998, CLIN INFECT DIS, V26, P116, DOI 10.1086/516255; Hagenaars JCJP, 2014, EUR J CLIN MICROBIOL, V33, P1407, DOI 10.1007/s10096-014-2084-0; Jager MM, 2011, CLIN VACCINE IMMUNOL, V18, P963, DOI 10.1128/CVI.00009-11; Jaramillo-Gutierrez G, 2013, EURO SURVEILL, V18; Kampschreur LM, 2012, CLIN VACCINE IMMUNOL, V19, P1165, DOI 10.1128/CVI.00185-12; Kampschreur LM, 2012, EMERG INFECT DIS, V18, P563, DOI 10.3201/eid1804.111478; Landais C, 2007, CLIN INFECT DIS, V44, P1337, DOI 10.1086/515401; Lassche S, 2010, INFECT B, V21, P45; Li JS, 2000, CLIN INFECT DIS, V30, P633, DOI 10.1086/313753; Lloyd-Jones DM, 2006, CIRCULATION, V113, P791, DOI 10.1161/CIRCULATIONAHA.105.548206; Million M, 2013, CLIN INFECT DIS, V57, P836, DOI 10.1093/cid/cit419; Morroy G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060707; Raoult D, 2000, MEDICINE, V79, P109, DOI 10.1097/00005792-200003000-00005; Raoult D, 2011, CLIN INFECT DIS, V53, P1170, DOI 10.1093/cid/cir679; Schneeberger Peter M, 2010, Clin Vaccine Immunol, V17, P286, DOI 10.1128/CVI.00454-09; TISSOTDUPONT H, 1994, CLIN DIAGN LAB IMMUN, V1, P189; van der Hoek W, 2010, EUROSURVEILLANCE, V15, P4; van der Hoek W, 2012, EUROSURVEILLANCE, V17, P20059; van der Hoek W, 2011, CLIN INFECT DIS, V52, P1431, DOI 10.1093/cid/cir234; Wegdam-Blans MCA, 2013, EUR J CLIN MICROBIOL, V32, P353, DOI 10.1007/s10096-012-1749-9; Wegdam-Blans MCA, 2012, CLIN VACCINE IMMUNOL, V19, P1110, DOI 10.1128/CVI.05581-11; Wegdam-Blans MCA, 2012, J INFECTION, V64, P247, DOI 10.1016/j.jinf.2011.12.014; Weiskopf D, 2009, TRANSPL INT, V22, P1041, DOI 10.1111/j.1432-2277.2009.00927.x; Wielders CCH, 2012, CLIN VACCINE IMMUNOL, V19, P1661, DOI 10.1128/CVI.00322-12; Wielders CCH, 2013, EUR J CLIN INVEST, V43, P616, DOI 10.1111/eci.12073	34	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131848	10.1371/journal.pone.0131848	http://dx.doi.org/10.1371/journal.pone.0131848			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161658	Green Published, Green Submitted, gold			2022-12-26	WOS:000358162300065
J	Janardhan, B; Vaderhobli, S; Bhagat, R; Srinivasamurthy, PC; Reddihalli, PV; Gawari, R; Krishnamoorthy, L				Janardhan, Bhaskari; Vaderhobli, Shilpa; Bhagat, Rahul; Srinivasamurthy, Premalata Chennagiri; Reddihalli, Pallavi Venketeshiah; Gawari, Ramesh; Krishnamoorthy, Lakshmi			Investigating impact of Vascular Endothelial Growth Factor Polymorphisms in Epithelial Ovarian Cancers: A Study in the Indian Population	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; FACTOR GENE POLYMORPHISMS; SPLICE VARIANT; BREAST-CANCER; RISK; VEGF(165)B; CARCINOMA; ANGIOGENESIS; HAPLOTYPES; EXPRESSION	Epithelial ovarian cancer is one of the increasingly incident malignancies that is notorious because of its evasiveness for early diagnosis and high mortality rates. Epithelial ovarian cancers are highly dependent on pathologic vasculature and Vascular Endothelial Growth Factor is known to be one of the most efficient angiogenic factors. Polymorphisms of the VEGF gene, in this study, were assessed for association with the malignancy and other clinico-pathological factors. 300 case samples and 320 age and mensus status matched controls were inculcated into the study. rs699947, rs833061, rs1570360, rs2010963, rs1413711 and rs3025039 were the six single nucleotide polymorphisms that were scrutinized. Genotyping was carried out by polymerase chain reaction and restriction fragment length polymorphism. rs 3025039 showed immense promise as a marker for disease aggression and recurrence and a factor for poor prognosis. rs699947 showed least association with the disease and clinico-pathologic factors studied. rs833061, rs 1570360 showed significant association with some clinico-pathological factors such as bilateral affliction of ovaries and post operative CA-125 levels. rs2010963 associated with presence of ascites in higher volumes. The SNPs under consideration showed no formidable linkage in our study samples. A haplotype analysis (excluding rs699947 and rs1413711) revealed 5 frontrunners being present in >85% of the population with TGGC and CGCC associating significantly as protective and risk factors respectively. These haplotypes showed a dose dependent additive effect of their seeming functionality. This study is unique and a first of its kind carried out in the Indian population of South-east Asia.	[Janardhan, Bhaskari; Vaderhobli, Shilpa; Bhagat, Rahul; Gawari, Ramesh; Krishnamoorthy, Lakshmi] Kidwai Mem Inst Oncol, Dept Biochem, Bangalore 560029, Karnataka, India; [Srinivasamurthy, Premalata Chennagiri] Kidwai Mem Inst Oncol, Dept Pathol, Bangalore 560029, Karnataka, India; [Reddihalli, Pallavi Venketeshiah] Kidwai Mem Inst Oncol, Dept Gyneconcol, Bangalore 560029, Karnataka, India	Kidwai Memorial Institute of Oncology; Kidwai Memorial Institute of Oncology; Kidwai Memorial Institute of Oncology	Krishnamoorthy, L (corresponding author), Sri Shankara Canc Hosp & Res Ctr, Dept Biochem, Bangalore 560004, Karnataka, India.	vkrishlakshmi@gmail.com			Indian Council of Medical Research [5/13/28/2010-NCD-III]	Indian Council of Medical Research(Indian Council of Medical Research (ICMR))	This work was supported by the Indian Council of Medical Research, Ref No: 5/13/28/2010-NCD-III. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates DO, 2002, CANCER RES, V62, P4123; Bhaskari J, 2013, AUSTRAL ASIAN J CANC, V12, P269; Crawford Y, 2009, CELL TISSUE RES, V335, P261, DOI 10.1007/s00441-008-0675-8; Dekel YR, 2005, BBRC, V332, P271; Duhoux FP, 2010, J ONCOL, V2010, DOI 10.1155/2010/372547; Hoeben A, 2004, PHARMACOL REV, V56, P549, DOI 10.1124/pr.56.4.3; Hofmann G, 2008, J CANCER RES CLIN, V134, P591, DOI 10.1007/s00432-007-0322-x; Jacobs EJ, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1400; JAIN L, 2009, MCR, V10, P1158; Kataoka N, 2006, CANCER EPIDEM BIOMAR, V15, P1148, DOI 10.1158/1055-9965.EPI-05-0871; Kim A, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-14; Kong SY, 2007, HEPATOLOGY, V46, P446, DOI 10.1002/hep.21720; Langsenlehner T, 2008, EUR J CANCER, V44, P1572, DOI 10.1016/j.ejca.2008.04.021; Murthy NS, 2009, ASIAN PAC J CANCER P, V10, P1025; Park YS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047158; PERETZ D, 1992, BIOCHEM BIOPH RES CO, V182, P1340, DOI 10.1016/0006-291X(92)91880-Y; Rinck JS, 2015, J CANCER RES CLIN, V141, P69, DOI 10.1007/s00432-014-1786-0; Seo JS, 2005, RHEUMATOLOGY, V44, P1299, DOI 10.1093/rheumatology/kei013; Smerdel MP, 2009, INT J GYNECOL CANCER, V19, P578, DOI 10.1111/IGC.0b013e3181a13168; Steffensen KD, 2010, GYNECOL ONCOL, V117, P109, DOI 10.1016/j.ygyno.2009.11.011; Stemke-Hale K, 2013, MODERN PATHOL, V26, P544, DOI 10.1038/modpathol.2012.194; TISCHER E, 1991, J BIOL CHEM, V266, P11947; Varey AHR, 2008, BRIT J CANCER, V98, P1366, DOI 10.1038/sj.bjc.6604308; Woolard J, 2004, CANCER RES, V64, P7822, DOI 10.1158/0008-5472.CAN-04-0934; Yang XF, 2011, MOL VIS, V17, P3088; Zarbock R, 2009, HUM MOL GENET, V18, P3344, DOI 10.1093/hmg/ddp259; Zhai RH, 2008, CLIN CANCER RES, V14, P612, DOI 10.1158/1078-0432.CCR-07-1655	27	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2015	10	7							e0131190	10.1371/journal.pone.0131190	http://dx.doi.org/10.1371/journal.pone.0131190			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EW	26158818	Green Submitted, gold, Green Published			2022-12-26	WOS:000358161200026
J	Earley, ZM; Akhtar, S; Green, SJ; Naqib, A; Khan, O; Cannon, AR; Hammer, AM; Morris, NL; Li, XL; Eberhardt, JM; Gamelli, RL; Kennedy, RH; Choudhry, MA				Earley, Zachary M.; Akhtar, Suhail; Green, Stefan J.; Naqib, Ankur; Khan, Omair; Cannon, Abigail R.; Hammer, Adam M.; Morris, Niya L.; Li, Xiaoling; Eberhardt, Joshua M.; Gamelli, Richard L.; Kennedy, Richard H.; Choudhry, Mashkoor A.			Burn Injury Alters the Intestinal Microbiome and Increases Gut Permeability and Bacterial Translocation	PLOS ONE			English	Article							BARRIER FUNCTION; CROHNS-DISEASE; EPITHELIAL-CELLS; SEPSIS; INFLAMMATION; HOST; ENTEROBACTERIACEAE; MICROFLORA; EXPRESSION; MUTATIONS	Sepsis remains one of the leading causes of death in burn patients who survive the initial insult of injury. Disruption of the intestinal epithelial barrier has been shown after burn injury; this can lead to the translocation of bacteria or their products (e.g., endotoxin) from the intestinal lumen to the circulation, thereby increasing the risk for sepsis in immunocompromised individuals. Since the maintenance of the epithelial barrier is largely dependent on the intestinal microbiota, we examined the diversity of the intestinal microbiome of severely burned patients and a controlled mouse model of burn injury. We show that burn injury induces a dramatic dysbiosis of the intestinal microbiome of both humans and mice and allows for similar overgrowths of Gram-negative aerobic bacteria. Furthermore, we show that the bacteria increasing in abundance have the potential to translocate to extra-intestinal sites. This study provides an insight into how the diversity of the intestinal microbiome changes after burn injury and some of the consequences these gut bacteria can have in the host.	[Earley, Zachary M.; Akhtar, Suhail; Khan, Omair; Cannon, Abigail R.; Hammer, Adam M.; Morris, Niya L.; Li, Xiaoling; Gamelli, Richard L.; Kennedy, Richard H.; Choudhry, Mashkoor A.] Loyola Univ Chicago, Div Hlth Sci, Burn & Shock Trauma Res Inst, Maywood, IL 60153 USA; [Earley, Zachary M.; Hammer, Adam M.; Morris, Niya L.; Choudhry, Mashkoor A.] Loyola Univ Chicago, Div Hlth Sci, Integrat Cell Biol Program, Maywood, IL 60153 USA; [Akhtar, Suhail; Li, Xiaoling; Eberhardt, Joshua M.; Gamelli, Richard L.; Choudhry, Mashkoor A.] Loyola Univ Chicago, Div Hlth Sci, Dept Surg, Maywood, IL 60153 USA; [Cannon, Abigail R.; Choudhry, Mashkoor A.] Loyola Univ Chicago, Div Hlth Sci, Dept Microbiol, Maywood, IL 60153 USA; [Cannon, Abigail R.; Choudhry, Mashkoor A.] Loyola Univ Chicago, Div Hlth Sci, Dept Immunol, Maywood, IL 60153 USA; [Green, Stefan J.; Naqib, Ankur] Univ Illinois, DNA Serv Facil, Chicago, IL 60612 USA	Loyola University Chicago; Loyola University Chicago; Loyola University Chicago; Loyola University Chicago; Loyola University Chicago; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Choudhry, MA (corresponding author), Loyola Univ Chicago, Div Hlth Sci, Burn & Shock Trauma Res Inst, Maywood, IL 60153 USA.	mchoudhry@luc.edu		Green, Stefan/0000-0003-2781-359X; Khan, Omair/0000-0002-7597-3662	National Institutes of Health [R01AA015731, T32AA013527]; Department of Defense [W81XWH-09-1-0619]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA015731, T32AA013527] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Support for this study comes from National Institutes of Health under award numbers R01AA015731 (MAC), R01AA015731 (MAC) and T32AA013527. Support was also provided by the Department of Defense W81XWH-09-1-0619 (RHK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Barman M, 2008, INFECT IMMUN, V76, P907, DOI 10.1128/IAI.01432-07; Bybee SM, 2011, GENOME BIOL EVOL, V3, P1312, DOI 10.1093/gbe/evr106; Canny G, 2006, METH MOL B, V341, P17; Choudhry MA, 2004, ALCOHOL, V33, P199, DOI 10.1016/j.alcohol.2004.05.004; Church D, 2006, CLIN MICROBIOL REV, V19, P403, DOI 10.1128/CMR.19.2.403-434.2006; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; de Carcer DA, 2011, APPL ENVIRON MICROB, V77, P6310, DOI 10.1128/AEM.05146-11; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Faunce DE, 1999, BURNS, V25, P403, DOI 10.1016/S0305-4179(99)00014-5; Fedwick JP, 2005, INFECT IMMUN, V73, P7844, DOI 10.1128/IAI.73.12.7844-7852.2005; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Garrett WS, 2010, CELL HOST MICROBE, V8, P292, DOI 10.1016/j.chom.2010.08.004; Gihring TM, 2012, ENVIRON MICROBIOL, V14, P285, DOI 10.1111/j.1462-2920.2011.02550.x; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Gilpin DA, 1996, BURNS, V22, P607, DOI 10.1016/S0305-4179(96)00064-2; Honda K, 2012, ANNU REV IMMUNOL, V30, P759, DOI 10.1146/annurev-immunol-020711-074937; Hsiao EY, 2013, CELL, V155, P1451, DOI 10.1016/j.cell.2013.11.024; Ivanov II, 2012, CELL HOST MICROBE, V12, P496, DOI 10.1016/j.chom.2012.09.009; Lamb-Rosteski JM, 2008, INFECT IMMUN, V76, P3390, DOI 10.1128/IAI.01698-07; LEVIN J, 1970, NEW ENGL J MED, V283, P1313, DOI 10.1056/NEJM197012102832404; Loy A, 2007, NUCLEIC ACIDS RES, V35, pD800, DOI 10.1093/nar/gkl856; Lupp C, 2007, CELL HOST MICROBE, V2, P119, DOI 10.1016/j.chom.2007.06.010; MacFie J, 1999, GUT, V45, P223, DOI 10.1136/gut.45.2.223; Magnotti LJ, 2005, J BURN CARE REHABIL, V26, P383, DOI 10.1097/01.bcr.0000176878.79267.e8; McDonald D, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-7; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Moonsamy PV, 2013, TISSUE ANTIGENS, V81, P141, DOI 10.1111/tan.12071; Murphy TJ, 2004, J LEUKOCYTE BIOL, V75, P400, DOI 10.1189/jlb.0503233; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Raetz M, 2013, NAT IMMUNOL, V14, P136, DOI 10.1038/ni.2508; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Shankar R, 2007, J BURN CARE RES, V28, P566, DOI 10.1097/BCR.0B013E318093DF16; Sokol H, 2009, INFLAMM BOWEL DIS, V15, P1183, DOI 10.1002/ibd.20903; Song JQ, 2008, SHOCK, V30, P184, DOI 10.1097/SHK.0b013e318162a3f6; Song JQ, 2014, J SURG RES, V187, P128, DOI 10.1016/j.jss.2013.09.042; Stoecklein VM, 2012, J LEUKOCYTE BIOL, V92, P539, DOI 10.1189/jlb.0212072; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; Voigt RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097500; Wade CE, 2013, CRIT CARE, V17, DOI 10.1186/cc13048; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wehkamp J, 2005, P NATL ACAD SCI USA, V102, P18129, DOI 10.1073/pnas.0505256102; Wehkamp J, 2004, GUT, V53, P1658, DOI 10.1136/gut.2003.032805; Winter SE, 2013, SCIENCE, V339, P708, DOI 10.1126/science.1232467; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Zeissig S, 2007, GUT, V56, P61, DOI 10.1136/gut.2006.094375	53	154	163	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0129996	10.1371/journal.pone.0129996	http://dx.doi.org/10.1371/journal.pone.0129996			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154283	Green Published, gold, Green Submitted			2022-12-26	WOS:000358159700020
J	Eddy, MD; Hasselquist, L; Giles, G; Hayes, JF; Howe, J; Rourke, J; Coyne, M; O'Donovan, M; Batty, J; Brunye, TT; Mahoney, CR				Eddy, Marianna D.; Hasselquist, Leif; Giles, Grace; Hayes, Jacqueline F.; Howe, Jessica; Rourke, Jennifer; Coyne, Megan; O'Donovan, Meghan; Batty, Jessica; Brunye, Tad T.; Mahoney, Caroline R.			The Effects of Load Carriage and Physical Fatigue on Cognitive Performance	PLOS ONE			English	Article							CHOICE-REACTION TIME; ACUTE EXERCISE; ACUTE BOUTS; INTENSITY; DURATION	In the current study, ten participants walked for two hours while carrying no load or a 40 kg load. During the second hour, treadmill grade was manipulated between a constant downhill or changing between flat, uphill, and downhill grades. Throughout the prolonged walk, participants performed two cognitive tasks, an auditory go no/go task and a visual target detection task. The main findings were that the number of false alarms increased over time in the loaded condition relative to the unloaded condition on the go no/go auditory task. There were also shifts in response criterion towards responding yes and decreased sensitivity in responding in the loaded condition compared to the unloaded condition. In the visual target detection there were no reliable effects of load carriage in the overall analysis however, there were slower reaction times in the loaded compared to unloaded condition during the second hour.	[Eddy, Marianna D.; Hasselquist, Leif; Giles, Grace; Hayes, Jacqueline F.; Howe, Jessica; Rourke, Jennifer; Coyne, Megan; O'Donovan, Meghan; Batty, Jessica; Brunye, Tad T.; Mahoney, Caroline R.] US Army Natick Soldier Res Dev & Engn Ctr, Natick, MA USA; [Eddy, Marianna D.; Giles, Grace; Brunye, Tad T.; Mahoney, Caroline R.] Tufts Univ, Dept Psychol, Medford, MA 02155 USA	United States Department of Defense; US Army Research, Development & Engineering Command (RDECOM); Tufts University	Eddy, MD (corresponding author), US Army Natick Soldier Res Dev & Engn Ctr, Natick, MA USA.	marianna.d.eddy.civ@mail.mil		Hayes, Jacqueline/0000-0002-6241-1839	United States Army	United States Army(United States Department of DefenseUnited States Army)	This work was funded by the United States Army. The opinions expressed herein are those of the authors and not necessarily of the United States Army. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audiffren M, 2008, ACTA PSYCHOL, V129, P410, DOI 10.1016/j.actpsy.2008.09.006; Chang YK, 2012, BRAIN RES, V1453, P87, DOI 10.1016/j.brainres.2012.02.068; Coles K, 2008, J SPORT SCI, V26, P333, DOI 10.1080/02640410701591417; Collardeau M, 2001, PERCEPT MOTOR SKILL, V93, P679, DOI 10.2466/PMS.93.7.679-689; Delignieres D., 1994, J HUM MOV STUD, V27, P173; Dietrich A, 2004, BRAIN COGNITION, V55, P516, DOI 10.1016/j.bandc.2004.03.002; Dietrich A, 2003, CONSCIOUS COGN, V12, P231, DOI 10.1016/S1053-8100(02)00046-6; Dietrich A, 2011, NEUROSCI BIOBEHAV R, V35, P1305, DOI 10.1016/j.neubiorev.2011.02.001; Ehrlich R., 2000, SOLD LOAD C FORT BEN; Ferris LT, 2007, MED SCI SPORT EXER, V39, P728, DOI 10.1249/mss.0b013e31802f04c7; Grego F, 2004, NEUROSCI LETT, V364, P76, DOI 10.1016/j.neulet.2004.03.085; Grego F, 2005, INT J SPORTS MED, V26, P27, DOI 10.1055/s-2004-817915; Joyce J, 2009, BRAIN COGNITION, V71, P14, DOI 10.1016/j.bandc.2009.03.004; Knapik JJ, 1997, MIL MED, V162, P62, DOI 10.1093/milmed/162.1.62; Labelle V, 2013, BRAIN COGNITION, V81, P10, DOI 10.1016/j.bandc.2012.10.001; Lambourne K, 2010, BRAIN RES, V1341, P12, DOI 10.1016/j.brainres.2010.03.091; Lieberman HR, 2006, AVIAT SPACE ENVIR MD, V77, P929; Mahoney CR, 2007, AVIAT SPACE ENVIR MD, V78, pB51; May B, 2009, MIL MED, V174, P1308, DOI 10.7205/MILMED-D-00-0809; McMorris T, 2011, PHYSIOL BEHAV, V102, P421, DOI 10.1016/j.physbeh.2010.12.007; Pontifex MB, 2011, J COGNITIVE NEUROSCI, V23, P1332, DOI 10.1162/jocn.2010.21528; Tomporowski PD, 2003, ACTA PSYCHOL, V112, P297, DOI 10.1016/S0001-6918(02)00134-8; Yanagisawa H, 2010, NEUROIMAGE, V50, P1702, DOI 10.1016/j.neuroimage.2009.12.023	23	23	23	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0130817	10.1371/journal.pone.0130817	http://dx.doi.org/10.1371/journal.pone.0130817			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1EJ	26154515	Green Published, Green Submitted, gold			2022-12-26	WOS:000358159700039
J	Pi, EX; Qu, LQ; Tang, X; Peng, TT; Jiang, B; Guo, JF; Lu, HF; Du, LQ				Pi, Erxu; Qu, Liqun; Tang, Xi; Peng, Tingting; Jiang, Bo; Guo, Jiangfeng; Lu, Hongfei; Du, Liqun			Application of Genetic Algorithm to Predict Optimal Sowing Region and Timing for Kentucky Bluegrass in China	PLOS ONE			English	Article							POA-PRATENSIS L.; THERMAL-TIME MODEL; SEED-GERMINATION; HEAT TOLERANCE; DIFFERENTIAL RESPONSES; CONSTANT-TEMPERATURE; ANTIOXIDANT ENZYMES; HYDROTHERMAL TIME; DORMANCY RELEASE; DROUGHT STRESS	Temperature is a predominant environmental factor affecting grass germination and distribution. Various thermal-germination models for prediction of grass seed germination have been reported, in which the relationship between temperature and germination were defined with kernel functions, such as quadratic or quintic function. However, their prediction accuracies warrant further improvements. The purpose of this study is to evaluate the relative prediction accuracies of genetic algorithm (GA) models, which are automatically parameterized with observed germination data. The seeds of five P. pratensis (Kentucky bluegrass, KB) cultivars were germinated under 36 day/night temperature regimes ranging from 5/5 to 40/40 degrees C with 5 degrees C increments. Results showed that optimal germination percentages of all five tested KB cultivars were observed under a fluctuating temperature regime of 20/25 degrees C. Meanwhile, the constant temperature regimes (e.g., 5/5, 10/10, 15/15 degrees C, etc.) suppressed the germination of all five cultivars. Furthermore, the back propagation artificial neural network (BP-ANN) algorithm was integrated to optimize temperature-germination response models from these observed germination data. It was found that integrations of GA-BPANN (back propagation aided genetic algorithm artificial neural network) significantly reduced the Root Mean Square Error (RMSE) values from 0.21 similar to 0.23 to 0.02 similar to 0.09. In an effort to provide a more reliable prediction of optimum sowing time for the tested KB cultivars in various regions in the country, the optimized GA-BP-ANN models were applied to map spatial and temporal germination percentages of blue grass cultivars in China. Our results demonstrate that the GA-BP-ANN model is a convenient and reliable option for constructing thermal-germination response models since it automates model parameterization and has excellent prediction accuracy.	[Pi, Erxu; Qu, Liqun; Peng, Tingting; Du, Liqun] Hangzhou Normal Univ, Coll Life & Environm Sci, Hangzhou, Zhejiang, Peoples R China; [Tang, Xi; Lu, Hongfei] Zhejiang Sci Tech Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China; [Jiang, Bo] Coll Biol & Food Engn, Changshu Inst Technol, Changshu, Peoples R China; [Guo, Jiangfeng] Meteorol Bur Shaanxi Prov, Xian, Shaanxi, Peoples R China	Hangzhou Normal University; Zhejiang Sci-Tech University; Changshu Institute of Technology	Lu, HF (corresponding author), Zhejiang Sci Tech Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China.	luhongfei63@yahoo.com.cn; liqundu@msn.com	Qu, Liqun/HHN-2317-2022		National Science Foundation of China [31301053, U1130304]; Science and Technology Project of Changshu City [CN201302]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Project of Changshu City	This work was partially supported by grants 31301053 and U1130304 from the National Science Foundation of China, and grant CN201302 from the Science and Technology Project of Changshu City. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliabadi M, 2014, ENVIRON MONIT ASSESS, V186, P1855, DOI 10.1007/s10661-013-3499-2; Barnhart BL, 2012, AGR FOREST METEOROL, V162, P58, DOI 10.1016/j.agrformet.2012.04.003; Batlla D, 2003, SEED SCI RES, V13, P55, DOI 10.1079/SSR2002124; Blanco AM, 2014, ECOL MODEL, V272, P293, DOI 10.1016/j.ecolmodel.2013.10.013; Bonos SA, 2012, J PLANT REGIST, V6, P6, DOI 10.3198/jpr2011.04.0237crc; Bradford KJ, 2002, WEED SCI, V50, P248, DOI 10.1614/0043-1745(2002)050[0248:AOHTTQ]2.0.CO;2; Catalogna M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044587; Chai Q, 2010, J AM SOC HORTIC SCI, V135, P125, DOI 10.21273/JASHS.135.2.125; CHANG W, 1993, IEEE T NEURAL NETWOR, V4, P993, DOI 10.1109/72.286895; Chantre GR, 2009, ANN BOT-LONDON, V103, P1291, DOI 10.1093/aob/mcp070; Coppede F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074012; DEB K, 2000, P PAR PROBL SOLV NAT, V6, P849, DOI DOI 10.1007/3-540-45356-3_; ELLIS RH, 1987, J EXP BOT, V38, P1033, DOI 10.1093/jxb/38.6.1033; Gao N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062156; Garcia-Mozo H, 2009, AGR FOREST METEOROL, V149, P256, DOI 10.1016/j.agrformet.2008.08.013; GARCIAHUIDOBRO J, 1982, J EXP BOT, V33, P288, DOI 10.1093/jxb/33.2.288; Gazola S, 2011, CIENC RURAL, V41, P551, DOI 10.1590/S0103-84782011005000022; Grundy AC, 2000, NEW PHYTOL, V148, P433, DOI 10.1046/j.1469-8137.2000.00778.x; Guo B, 1987, POA ANNUA L; Hardegree SP, 1999, ENVIRON EXP BOT, V41, P209, DOI 10.1016/S0098-8472(99)00004-0; Hardegree SP, 1999, J RANGE MANAGE, V52, P83, DOI 10.2307/4003496; Hardegree SP, 2006, ANN BOT-LONDON, V97, P1115, DOI 10.1093/aob/mcl071; Hardegree SP, 2006, ANN BOT-LONDON, V98, P403, DOI 10.1093/aob/mcl112; Hardegree SP, 2006, ANN BOT-LONDON, V98, P827, DOI 10.1093/aob/mcl163; He YL, 2010, J AM SOC HORTIC SCI, V135, P116, DOI 10.21273/JASHS.135.2.116; Honig JA, 2012, HORTSCIENCE, V47, P1356, DOI 10.21273/HORTSCI.47.9.1356; HORN J, 1994, P 1 IEEE C EV COMP, P82, DOI [10.1109/ICEC.1994.350037, DOI 10.1109/ICEC.1994.350037]; Hu LX, 2012, CROP SCI, V52, P2332, DOI 10.2135/cropsci2012.02.0106; Jiang YW, 2001, J EXP BOT, V52, P341, DOI 10.1093/jexbot/52.355.341; Judson RA, 1999, ECON LETT, V65, P9, DOI 10.1016/S0165-1765(99)00130-5; Kang Y, 2011, MYCOLOGIA, V103, P1341, DOI 10.3852/10-352; Karnin E D, 1990, IEEE Trans Neural Netw, V1, P239, DOI 10.1109/72.80236; Li ZP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083739; Liu K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069364; Lu HF, 2008, AGR FOREST METEOROL, V148, P931, DOI 10.1016/j.agrformet.2008.01.004; Merewitz E, 2010, AGRON J, V102, P258, DOI 10.2134/agronj2009.0328; Modi YK, 2012, S AFR J IND ENG, V23, P230; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Ni XX, 2012, PLANT DIS, V96, P1821, DOI 10.1094/PDIS-04-12-0406-PDN; Onofri A, 2010, WEED RES, V50, P5, DOI 10.1111/j.1365-3180.2009.00758.x; Peng Y, 2012, CROP SCI, V52, P807, DOI 10.2135/cropsci2011.06.0327; Pi EX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082413; Porceddu A, 2002, THEOR APPL GENET, V104, P273, DOI 10.1007/s001220100659; Poss JA, 2010, HORTSCIENCE, V45, P952, DOI 10.21273/HORTSCI.45.6.952; Rasul G, 2012, PLANT BREEDING, V131, P244, DOI 10.1111/j.1439-0523.2011.01931.x; Recio M, 2010, AGR FOREST METEOROL, V150, P931, DOI 10.1016/j.agrformet.2010.02.012; Rivera-Reyes JG, 2009, PHYTON-INT J EXP BOT, V78, P37; ROBERTS EH, 1988, SYM SOC EXP BIOL, V42, P109; Shen H, 2009, HORTSCIENCE, V44, P2009, DOI 10.21273/HORTSCI.44.7.2009; Shen JB, 2008, GRASS FORAGE SCI, V63, P249, DOI 10.1111/j.1365-2494.2008.00630.x; Shetty N, 2012, J CHEMOMETR, V26, P462, DOI 10.1002/cem.1415; Shi HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035781; Shi H, 2012, DIABETES TECHNOL THE, V14, P293, DOI 10.1089/dia.2011.0071; Shortell RR, 2009, HORTSCIENCE, V44, P274, DOI 10.21273/HORTSCI.44.2.274; THOMPSON K, 1977, NATURE, V267, P147, DOI 10.1038/267147a0; van Oort PAJ, 2011, AGR FOREST METEOROL, V151, P1545, DOI 10.1016/j.agrformet.2011.06.012; Vandelook F, 2008, ANN BOT-LONDON, V102, P865, DOI 10.1093/aob/mcn165; Wang YQ, 2014, METEOROL APPL, V21, P360, DOI 10.1002/met.1345; Wang YQ, 2012, COMPUT GEOSCI-UK, V48, P330, DOI 10.1016/j.cageo.2011.12.003; Xu R, 2013, SOIL SCI PLANT NUTR, V59, P168, DOI 10.1080/00380768.2012.763215; Yang ZM, 2012, J AM SOC HORTIC SCI, V137, P96, DOI 10.21273/JASHS.137.2.96; Zhang PP, 2012, ECOTOXICOLOGY, V21, P1911, DOI 10.1007/s10646-012-0924-1	62	1	1	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0131489	10.1371/journal.pone.0131489	http://dx.doi.org/10.1371/journal.pone.0131489			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154163	Green Published, gold, Green Submitted			2022-12-26	WOS:000358159700069
J	van Schaik, J; Janssen, R; Bosch, T; Haarsma, AJ; Dekker, JJA; Kranstauber, B				van Schaik, Jaap; Janssen, Rene; Bosch, Thijs; Haarsma, Anne-Jifke; Dekker, Jasja J. A.; Kranstauber, Bart			Bats Swarm Where They Hibernate: Compositional Similarity between Autumn Swarming and Winter Hibernation Assemblages at Five Underground Sites	PLOS ONE			English	Article							EARED BAT; PLECOTUS-AURITUS; PIPISTRELLE BAT; MYOTIS-DAUBENTONII; POPULATION-SIZE; NATTERERS BATS; TEMPERATE ZONE; CATCHMENT-AREA; GENE FLOW; BEHAVIOR	During autumn in the temperate zone of both the new and old world, bats of many species assemble at underground sites in a behaviour known as swarming. Autumn swarming behaviour is thought to primarily serve as a promiscuous mating system, but may also be related to the localization and assessment of hibernacula. Bats subsequently make use of the same underground sites during winter hibernation, however it is currently unknown if the assemblages that make use of a site are comparable across swarming and hibernation seasons. Our purpose was to characterize the bat assemblages found at five underground sites during both the swarming and the hibernation season and compare the assemblages found during the two seasons both across sites and within species. We found that the relative abundance of individual species per site, as well as the relative proportion of a species that makes use of each site, were both significantly correlated between the swarming and hibernation seasons. These results suggest that swarming may indeed play a role in the localization of suitable hibernation sites. Additionally, these findings have important conservation implications, as this correlation can be used to improve monitoring of underground sites and predict the importance of certain sites for rare and cryptic bat species.	[van Schaik, Jaap] Max Planck Inst Ornithol, Dept Behav Ecol & Evolutionary Genet, D-82319 Seewiesen, Germany; [Janssen, Rene] Bionet Natuuronderzoek, NL-6171 EL Stein, Netherlands; [Bosch, Thijs] Ad Hoc Zoogdieronderzoek, NL-6824 HE Arnhem, Netherlands; [Haarsma, Anne-Jifke] Radboud Univ Nijmegen, Inst Water & Wetland Res, Anim Ecol & Ecophysiol Grp, NL-6500 GL Nijmegen, Netherlands; [Dekker, Jasja J. A.] Dutch Mammal Soc, NL-6503 GA Nijmegen, Netherlands; [Kranstauber, Bart] Max Planck Inst Ornithol, Dept Migrat & Immunoecol, D-78315 Radolfzell am Bodensee, Germany; [Kranstauber, Bart] Univ Konstanz, Dept Biol, Constance, Germany	Max Planck Society; Radboud University Nijmegen; Max Planck Society; University of Konstanz	van Schaik, J (corresponding author), Max Planck Inst Ornithol, Dept Behav Ecol & Evolutionary Genet, Eberhard Gwinner Str, D-82319 Seewiesen, Germany.	JaapvanSchaik@gmail.com	van Schaik, Jaap/H-5180-2019	van Schaik, Jaap/0000-0003-4825-7676; Bosch, Thijs/0000-0001-7905-7402; Kranstauber, Bart/0000-0001-8303-780X; Dekker, Jasja/0000-0001-6453-4480	province of Limburg (Landschap in Uitvoering); Bionet Natuuronderzoek; Ad Hoc Zoogdieronderzoek	province of Limburg (Landschap in Uitvoering); Bionet Natuuronderzoek; Ad Hoc Zoogdieronderzoek	This project was funded by a grant from the province of Limburg (Landschap in Uitvoering). Bionet Natuuronderzoek and Ad Hoc Zoogdieronderzoek provided support in the form of salaries for authors RJ and TB respectively, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Agosta SJ, 2005, J MAMMAL, V86, P1210, DOI 10.1644/05-MAMM-A-012R1.1; Angell RL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054194; Auguie B, 2017, GRIDEXTRA MISCELLANE; Boratynski JS, 2012, ACTA CHIROPTEROL, V14, P417, DOI 10.3161/150811012X661738; Boyles JG, 2007, J EXP BIOL, V210, P4345, DOI 10.1242/jeb.007294; Brunet-Rossinni Anja K., 2009, P315; Buechner H. K., 1965, Zeitschrift fuer Tierpsychologie, V22, P209; Clutton-Brock J, 1989, P ROYAL SOC B, V236, P339; CLUTTONBROCK TH, 1988, BEHAV ECOL SOCIOBIOL, V23, P281, DOI 10.1007/BF00300575; DAAN S, 1968, Zeitschrift fuer Saeugetierkunde, V33, P262; FENTON MB, 1969, CAN J ZOOLOG, V47, P597, DOI 10.1139/z69-103; Furmankiewicz J, 2008, CAN J ZOOL, V86, P207, DOI 10.1139/Z07-134; Furmankiewicz J, 2007, CONSERV GENET, V8, P913, DOI 10.1007/s10592-006-9246-2; Glover AM, 2008, BIOL CONSERV, V141, P1493, DOI 10.1016/j.biocon.2008.03.012; Haarsma Anne-Jifke, 2009, Lutra, V52, P47; HALL JS, 1968, J MAMMAL, V49, P779, DOI 10.2307/1378754; HORACEK I, 1978, FOLIA ZOOL, V27, P135; Humphrey SR, 1976, SPECIAL PUBLICATION, V4, P1; Hutterer R., 2005, BAT MIGRATIONS EUROP; Ingersoll TE, 2010, J MAMMAL, V91, P1242, DOI 10.1644/09-MAMM-A-288.1; Johnson JB, 2006, WILDLIFE SOC B, V34, P1368, DOI 10.2193/0091-7648(2006)34[1368:AEMECR]2.0.CO;2; Kerth G, 2003, CONSERV GENET, V4, P491, DOI 10.1023/A:1024771713152; Kokurewicz T, 2004, ACTA CHIROPTEROL, V6, P121, DOI 10.3161/001.006.0110; Kugelschafter K, 2009, BIERKELLER SULZTHAL; KUIPERS B, 1970, Bijdragen tot de Dierkunde, V40, P51; LESINSKI G, 1986, ACTA THERIOL, V31, P507, DOI 10.4098/AT.arch.86-45; Masing Matti, 2007, Acta Zoologica Lituanica, V17, P47; NAGEL A, 1991, COMP BIOCHEM PHYS A, V99, P323, DOI 10.1016/0300-9629(91)90008-Z; Oksanen J., **DATA OBJECT**; Orbons J, 2005, INVENTARISATIE INGAN; Parsons KN, 2003, ANIM CONSERV, V6, P283, DOI 10.1017/S1367943003003342; Parsons KN, 2003, J ZOOL, V261, P257, DOI 10.1017/S0952836903004199; Parsons KN, 2003, BIOL CONSERV, V111, P63, DOI 10.1016/S0006-3207(02)00250-1; Piksa K, 2008, ACTA CHIROPTEROL, V10, P69, DOI 10.3161/150811008X331108; Piksa K, 2011, ACTA CHIROPTEROL, V13, P113, DOI 10.3161/150811011X578660; Punt A, 1957, CELLULAR MOL LIFE SC, V13, P51; Randall J, 2014, ACTA CHIROPTEROL, V16, P109, DOI 10.3161/150811014X683327; Rivers NM, 2006, BIOL CONSERV, V127, P215, DOI 10.1016/j.biocon.2005.08.010; Rivers NM, 2005, MOL ECOL, V14, P4299, DOI 10.1111/j.1365-294X.2005.02748.x; Sachteleben J, 2006, ACTA CHIROPTEROL, V8, P391, DOI 10.3161/1733-5329(2006)8[391:SBAMSO]2.0.CO;2; Safi K, 2007, AM NAT, V170, P465, DOI 10.1086/520116; Sendor T, 2003, J ANIM ECOL, V72, P308, DOI 10.1046/j.1365-2656.2003.00702.x; Senior P, 2005, P ROY SOC B-BIOL SCI, V272, P2467, DOI 10.1098/rspb.2005.3237; Siivonen Y, 2008, MAMMALIA, V72, P50, DOI 10.1515/MAMM.2008.003; SPEAKMAN JR, 1989, J ANIM ECOL, V58, P797, DOI 10.2307/5125; THOMAS DW, 1992, PHYSIOL ZOOL, V65, P443, DOI 10.1086/physzool.65.2.30158262; Toth CA, 2013, J ZOOL, V291, P3, DOI 10.1111/jzo.12069; Veith M, 2004, HEREDITY, V93, P342, DOI 10.1038/sj.hdy.6800509; Webb PI, 1996, CAN J ZOOL, V74, P761, DOI 10.1139/z96-087; Zahn A, 1997, J ZOOL, V243, P659, DOI 10.1111/j.1469-7998.1997.tb01968.x	50	34	37	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0130850	10.1371/journal.pone.0130850	http://dx.doi.org/10.1371/journal.pone.0130850			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26153691	gold, Green Submitted, Green Published			2022-12-26	WOS:000358159700040
J	Aitken, SC; Wallis, CL; Stevens, W; de Wit, TR; Schuurman, R				Aitken, Susan C.; Wallis, Carole L.; Stevens, Wendy; de Wit, Tobias Rinke; Schuurman, Rob			Stability of HIV-1 Nucleic Acids in Dried Blood Spot Samples for HIV-1 Drug Resistance Genotyping	PLOS ONE			English	Article							VIRUS TYPE-1 RNA; DYNAMICS IN-VIVO; REVERSE-TRANSCRIPTASE; WHOLE-BLOOD; FILTER-PAPER; ANTIRETROVIRAL THERAPY; PERIPHERAL-BLOOD; VIRAL LOAD; STORAGE-CONDITIONS; MONONUCLEAR-CELLS	Dried blood spots (DBS) are an easy to collect sample-type that can stabilize biological material at ambient temperature for transport and storage, making them ideal for use in resource-limited settings (RLS). We investigated the effect of storage temperature and duration on ability to detect mixed HIV-1 viral RNA populations, and subsequently viral RNA populations in a background of proviral DNA. Part one of the study used DBS samples of whole blood spiked with specific quantities of HIV-1 subtype-B and -C RNA to study mixed virus population detection. Part two used DBS comprising of HIV-1 subtype-B proviral DNA containing U1 cells combined with HIV-1 subtype-C RNA to mimic HIV-1 infected clinical samples as a model system to study the relative stability of HIV-1 RNA and DNA in DBS. Prepared DBS were stored at -20 degrees C and +30 degrees C for periods of one day, one, two, and four weeks. Samples were genotyped to determine changes in the detection of mixtures in the sample over time. From two weeks onwards, storage at +30 degrees C resulted in gradual, time-related reduction in the detection of mixed virus population at log(10) VL 4.0 but not at log(10) 5.0. Proviral DNA and viral RNA were both stable for at least 52 weeks when stored at -20 degrees C, compared to progressive RNA decay over time at +30 degrees C. DBS storage conditions and duration had a significant effect on HIV-1 RNA amplification. Our results demonstrate that DBS storage at ambient temperature (+30 degrees C) should not exceed two weeks, with long-term storage at -20 degrees C or lower.	[Aitken, Susan C.; Schuurman, Rob] Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands; [Wallis, Carole L.] Lancet Labs, Johannesburg, South Africa; [Stevens, Wendy] Univ Witwatersrand, Dept Mol Med & Hematol, Johannesburg, South Africa; [Stevens, Wendy] Natl Hlth Lab Serv, Johannesburg, South Africa; [de Wit, Tobias Rinke] PharmAccess Int, Amsterdam, Netherlands; [de Wit, Tobias Rinke] Univ Amsterdam, Acad Med Ctr, Global Hlth Dept, AIGHD, NL-1105 AZ Amsterdam, Netherlands	Utrecht University; Utrecht University Medical Center; University of Witwatersrand; National Health Laboratory Service; University of Amsterdam; Academic Medical Center Amsterdam	Schuurman, R (corresponding author), Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands.	R.Schuurman-1@umcutrecht.nl	Schuurman, Rob/M-4687-2019	Schuurman, Rob/0000-0002-0060-9831; Wallis, Carole/0000-0001-8408-8772	NWO/WOTRO under the Netherlands African Partnership for Capacity Development and Clinical Interventions against Poverty related Diseases (NACCAP) [W.07.05.204.00]; Hague; Netherlands	NWO/WOTRO under the Netherlands African Partnership for Capacity Development and Clinical Interventions against Poverty related Diseases (NACCAP); Hague; Netherlands(Netherlands Government)	ART-A: Consortium to develop an Affordable Resistance Test for Africa, supported by NWO/WOTRO under the Netherlands African Partnership for Capacity Development and Clinical Interventions against Poverty related Diseases (NACCAP; grant: W.07.05.204.00), The Hague, The Netherlands. Lancet Laboratories provided support in the form of a salary for author CW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all authors are articulated in the 'author contributions' section.	Aitken SC, 2013, J CLIN MICROBIOL, V51, P1757, DOI 10.1128/JCM.00118-13; Aitken SC, 2012, J CLIN VIROL, V54, P21, DOI 10.1016/j.jcv.2012.01.010; Alvarez-Munoz MT, 2005, ARCH MED RES, V36, P382, DOI 10.1016/j.arcmed.2005.03.010; Ayele W, 2007, J CLIN MICROBIOL, V45, P891, DOI 10.1128/JCM.01919-06; Barth RE, 2012, ANTIVIR THER, V17, P377, DOI 10.3851/IMP2010; Bertagnolio S, 2007, ANTIVIR THER, V12, P107; Brambilla D, 2003, J CLIN MICROBIOL, V41, P1888, DOI 10.1128/JCM.41.5.1888-1893.2003; Buckton AJ, 2008, J ANTIMICROB CHEMOTH, V62, P1191, DOI 10.1093/jac/dkn412; Cassol S, 1997, J CLIN MICROBIOL, V35, P2795, DOI 10.1128/JCM.35.11.2795-2801.1997; Chew CB, 2005, J CLIN VIROL, V33, P206, DOI 10.1016/j.jcv.2004.11.006; CHUN TW, 1995, NAT MED, V1, P1284, DOI 10.1038/nm1295-1284; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; COFFIN JM, 1995, SCIENCE, V267, P483, DOI 10.1126/science.7824947; Drake JW, 1999, P NATL ACAD SCI USA, V96, P13910, DOI 10.1073/pnas.96.24.13910; Drosten C, 2006, CLIN CHEM, V52, P1258, DOI 10.1373/clinchem.2006.066498; Fiscus SA, 1998, J CLIN MICROBIOL, V36, P258, DOI 10.1128/JCM.36.1.258-260.1998; FOLKS TM, 1987, SCIENCE, V238, P800, DOI 10.1126/science.3313729; Grant RM, 2003, J CLIN MICROBIOL, V41, P1586, DOI 10.1128/JCM.41.4.1586-1593.2003; Hallack R, 2008, J CLIN VIROL, V41, P283, DOI 10.1016/j.jcv.2007.12.011; HARPER ME, 1986, P NATL ACAD SCI USA, V83, P772, DOI 10.1073/pnas.83.3.772; Hearps AC, 2010, CURR HIV RES, V8, P134, DOI 10.2174/157016210790442740; Kearney M, 2008, AIDS, V22, P497, DOI 10.1097/QAD.0b013e3282f29478; Korn K, 2003, J CLIN MICROBIOL, V41, P3559, DOI 10.1128/JCM.41.8.3559-3565.2003; Leelawiwat W, 2009, J VIROL METHODS, V155, P109, DOI 10.1016/j.jviromet.2008.09.022; Masciotra S, 2007, AIDS, V21, P2503, DOI 10.1097/QAD.0b013e3281c618db; McNulty A, 2007, J CLIN MICROBIOL, V45, P517, DOI 10.1128/JCM.02016-06; Monleau M, 2010, J ANTIMICROB CHEMOTH, V65, P1562, DOI 10.1093/jac/dkq205; Parisi SG, 2007, J CLIN MICROBIOL, V45, P1783, DOI 10.1128/JCM.00056-07; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Ribeiro RM, 1998, AIDS, V12, P461, DOI 10.1097/00002030-199805000-00006; Riva E, 2001, AIDS RES HUM RETROV, V17, P1599, DOI 10.1089/088922201753342004; Rottinghaus EK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109060; Sanchez G, 1997, J VIROL, V71, P2233, DOI 10.1128/JVI.71.3.2233-2240.1997; Saracino A, 2008, J MED VIROL, V80, P1695, DOI 10.1002/jmv.21261; Schuurman R, 1999, J CLIN MICROBIOL, V37, P2291, DOI 10.1128/JCM.37.7.2291-2296.1999; Schuurman R, 2002, AIDS RES HUM RETROV, V18, P243, DOI 10.1089/088922202753472801; Steegen K, 2006, J VIROL METHODS, V133, P137, DOI 10.1016/j.jviromet.2005.11.004; Steegen K, 2007, J CLIN MICROBIOL, V45, P3342, DOI 10.1128/JCM.00814-07; Venturi G, 2002, ANTIVIR THER, V7, P245; Viljoen J, 2010, JAIDS-J ACQ IMM DEF, V55, P290, DOI 10.1097/QAI.0b013e3181edaaf5; Wallis CL, 2010, J VIROL METHODS, V163, P505, DOI 10.1016/j.jviromet.2009.11.011; Waters L, 2007, JAIDS-J ACQ IMM DEF, V46, P590, DOI 10.1097/QAI.0b013e318159d7f4; Youngpairoj AS, 2008, J ANTIMICROB CHEMOTH, V61, P1217, DOI 10.1093/jac/dkn100; Ziemniak C, 2006, J VIROL METHODS, V136, P238, DOI 10.1016/j.jviromet.2006.05.030	44	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131541	10.1371/journal.pone.0131541	http://dx.doi.org/10.1371/journal.pone.0131541			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147689	Green Published, Green Submitted, gold			2022-12-26	WOS:000358157600104
J	Meuwese, CL; Olauson, H; Qureshi, AR; Ripsweden, J; Barany, P; Vermeer, C; Drummen, N; Stenvinkel, P				Meuwese, Christiaan Lucas; Olauson, Hannes; Qureshi, Abdul Rashid; Ripsweden, Jonaz; Barany, Peter; Vermeer, Cees; Drummen, Nadja; Stenvinkel, Peter			Associations between Thyroid Hormones, Calcification Inhibitor Levels and Vascular Calcification in End-Stage Renal Disease	PLOS ONE			English	Article							MATRIX GLA PROTEIN; CORONARY-ARTERY CALCIFICATION; CHRONIC KIDNEY-DISEASE; VITAMIN-K STATUS; HEMODIALYSIS-PATIENTS; NONTHYROIDAL ILLNESS; PERITONEAL-DIALYSIS; CARDIOVASCULAR-DISEASE; RISK-FACTOR; KLOTHO	Introduction Vascular calcification is a common, serious and elusive complication of end-stage renal disease (ESRD). As a pro-calcifying risk factor, non-thyroidal illness may promote vascular calcification through a systemic lowering of vascular calcification inhibitors such as matrix-gla protein (MGP) and Klotho. Methods and Material In 97 ESRD patients eligible for living donor kidney transplantation, blood levels of thyroid hormones (fT3, fT4 and TSH), total uncarboxylated MGP (t-ucMGP), desphospho-uncar-boxylated MGP (dp-ucMGP), descarboxyprothrombin (PIVKA-II), and soluble Klotho (sKlotho) were measured. The degree of coronary calcification and arterial stiffness were assessed by means of cardiac CT-scans and applanation tonometry, respectively. Results fT3 levels were inversely associated with coronary artery calcification (CAC) scores and measures of arterial stiffness, and positively with dp-ucMGP and sKlotho concentrations. Subfractions of MGP, PIVKA-II and sKlotho did not associate with CAC scores and arterial stiffness. fT4 and TSH levels were both inversely associated with CAC scores, but not with arterial stiffness. Discussion The positive associations between fT3 and dp-ucMGP and sKlotho suggest that synthesis of MGP and Klotho is influenced by thyroid hormones, and supports a link between non-thyroidal illness and alterations in calcification inhibitor levels. However, the absence of an association between serum calcification inhibitor levels and coronary calcification/arterial stiffness and the fact that MGP and Klotho undergo post-translational modifications underscore the complexity of this association. Further studies, measuring total levels of MGP and membrane bound Klotho, should examine this proposed pathway in further detail.	[Meuwese, Christiaan Lucas; Olauson, Hannes; Qureshi, Abdul Rashid; Barany, Peter; Stenvinkel, Peter] Karolinska Inst, Dept Renal Med, CLINTEC, Stockholm, Sweden; [Ripsweden, Jonaz] Karolinska Inst, Med Imaging & Technol, CLINTEC, Stockholm, Sweden; [Vermeer, Cees; Drummen, Nadja] Maastricht Univ, VitaK, Maastricht, Netherlands	Karolinska Institutet; Karolinska Institutet; Maastricht University	Stenvinkel, P (corresponding author), Karolinska Inst, Dept Renal Med, CLINTEC, Stockholm, Sweden.	peter.stenvinkel@ki.se	Qureshi, Abdul Rashid Tony/G-1358-2010	Qureshi, Abdul Rashid Tony/0000-0003-0536-5327; Stenvinkel, Peter/0000-0002-8785-4820; Ripsweden, Jonaz/0000-0003-2118-5414; Barany, Peter/0000-0001-6501-8293				AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Ammirati AL, 2006, NEPHRON CLIN PRACT, V104, pC33, DOI 10.1159/000093257; Barreto DV, 2005, KIDNEY INT, V67, P1576, DOI 10.1111/j.1523-1755.2005.00239.x; Budoff MJ, 2008, VASC HEALTH RISK MAN, V4, P315, DOI 10.2147/VHRM.S1160; Buiten MS, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-197; Chen CH, 1997, CIRCULATION, V95, P1827; Cranenburg ECM, 2012, KIDNEY INT, V82, P605, DOI 10.1038/ki.2012.191; Cranenburg ECM, 2010, THROMB HAEMOSTASIS, V104, P811, DOI 10.1160/TH09-11-0786; Cranenburg ECM, 2009, THROMB HAEMOSTASIS, V101, P359, DOI 10.1160/TH08-04-0241; Delanaye P, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-145; Hu MC, 2011, J AM SOC NEPHROL, V22, P124, DOI 10.1681/ASN.2009121311; Kaptein EM, 1996, ENDOCR REV, V17, P45, DOI 10.1210/er.17.1.45; Krueger T, 2009, KIDNEY INT, V76, P18, DOI 10.1038/ki.2009.126; Lanzer P, 2014, EUR HEART J, V35, P1515, DOI 10.1093/eurheartj/ehu163; Liu YP, 2015, HYPERTENSION, V65, P463, DOI 10.1161/HYPERTENSIONAHA.114.04494; Meuwese CL, 2013, J INTERN MED, V274, P584, DOI 10.1111/joim.12107; Meuwese CL, 2013, NAT REV NEPHROL, V9, P599, DOI 10.1038/nrneph.2013.170; Meuwese CL, 2012, CLIN J AM SOC NEPHRO, V7, P131, DOI 10.2215/CJN.05250511; MITCHELL JR, 1962, BRIT MED J, P1293; Mizuno I, 2001, LIFE SCI, V68, P2917, DOI 10.1016/S0024-3205(01)01092-X; Olauson H, 2013, CURR OPIN NEPHROL HY, V22, P397, DOI 10.1097/MNH.0b013e32836213ee; Rumberger JA, 1999, MAYO CLIN PROC, V74, P243, DOI 10.4065/74.3.243; Sato Y, 2005, CIRC RES, V97, P550, DOI 10.1161/01.RES.0000181431.04290.bd; Schlieper G, 2011, J AM SOC NEPHROL, V22, P387, DOI 10.1681/ASN.2010040339; Seiler S, 2013, KIDNEY INT, V83, P121, DOI 10.1038/ki.2012.288; Shanahan CM, 2013, NAT REV NEPHROL, V9, P661, DOI 10.1038/nrneph.2013.176; SOLBERG LA, 1968, ANN NY ACAD SCI, V149, P956, DOI 10.1111/j.1749-6632.1968.tb53849.x; Stenvinkel P, 2010, J INTERN MED, V268, P456, DOI 10.1111/j.1365-2796.2010.02269.x; Stenvinkel P, 2008, CLIN J AM SOC NEPHRO, V3, P505, DOI 10.2215/CJN.03670807; Stompor T, 2006, INT J ARTIF ORGANS, V29, P736, DOI 10.1177/039139880602900802; Tatar E, 2012, INT UROL NEPHROL, V44, P601, DOI 10.1007/s11255-011-0034-7; Tatar E, 2011, CLIN J AM SOC NEPHRO, V6, P2240, DOI 10.2215/CJN.02540311; Theuwissen E, 2014, FOOD FUNCT, V5, P229, DOI 10.1039/c3fo60464k; Ueland T, 2010, J INTERN MED, V268, P483, DOI 10.1111/j.1365-2796.2010.02264.x; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; Wallin R, 2010, OSTEOARTHR CARTILAGE, V18, P1096, DOI 10.1016/j.joca.2010.05.013; Warner MH, 2010, J ENDOCRINOL, V205, P1, DOI 10.1677/JOE-09-0412; Zhang J, 2015, CALCIFIED TISSUE INT, V96, P80, DOI 10.1007/s00223-014-9934-8; Zhang YY, 2014, ARTERIOSCL THROM VAS, V34, P2128, DOI 10.1161/ATVBAHA.114.303889; Zoccali C, 2006, KIDNEY INT, V70, P523, DOI 10.1038/sj.ki.5001566	40	22	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132353	10.1371/journal.pone.0132353	http://dx.doi.org/10.1371/journal.pone.0132353			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147960	Green Published, Green Submitted, gold			2022-12-26	WOS:000358157600251
J	Turjeman, K; Bavli, Y; Kizelsztein, P; Schilt, Y; Allon, N; Katzir, TB; Sasson, E; Raviv, U; Ovadia, H; Barenholz, Y				Turjeman, Keren; Bavli, Yaelle; Kizelsztein, Pablo; Schilt, Yaelle; Allon, Nahum; Katzir, Tamar Blumenfeld; Sasson, Efrat; Raviv, Uri; Ovadia, Haim; Barenholz, Yechezkel			Nano-Drugs Based on Nano Sterically Stabilized Liposomes for the Treatment of Inflammatory Neurodegenerative Diseases	PLOS ONE			English	Article							EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; DOSE INTRAVENOUS METHYLPREDNISOLONE; MYELIN BASIC-PROTEIN; MULTIPLE-SCLEROSIS; BLOOD-BRAIN; SPINAL-CORD; VASCULAR-PERMEABILITY; BARRIER PERMEABILITY; ALZHEIMERS-DISEASE	The present study shows the advantages of liposome-based nano-drugs as a novel strategy of delivering active pharmaceutical ingredients for treatment of neurodegenerative diseases that involve neuroinflammation. We used the most common animal model for multiple sclerosis (MS), mice experimental autoimmune encephalomyelitis (EAE). The main challenges to overcome are the drugs' unfavorable pharmacokinetics and biodistribution, which result in inadequate therapeutic efficacy and in drug toxicity (due to high and repeated dosage). We designed two different liposomal nano-drugs, i.e., nano sterically stabilized liposomes (NSSL), remote loaded with: (a) a "water-soluble" amphipathic weak acid glucocorticosteroid prodrug, methylprednisolone hemisuccinate (MPS) or (b) the amphipathic weak base nitroxide, Tempamine (TMN). For the NSSL-MPS we also compared the effect of passive targeting alone and of active targeting based on short peptide fragments of ApoE or of beta-amyloid. Our results clearly show that for NSSL-MPS, active targeting is not superior to passive targeting. For the NSSL-MPS and the NSSL-TMN it was demonstrated that these nano-drugs ameliorate the clinical signs and the pathology of EAE. We have further investigated the MPS nano-drug's therapeutic efficacy and its mechanism of action in both the acute and the adoptive transfer EAE models, as well as optimizing the perfomance of the TMN nano-drug. The highly efficacious anti-inflammatory therapeutic feature of these two nano-drugs meets the criteria of disease-modifying drugs and supports further development and evaluation of these nano-drugs as potential therapeutic agents for diseases with an inflammatory component.	[Turjeman, Keren; Bavli, Yaelle; Kizelsztein, Pablo; Allon, Nahum; Barenholz, Yechezkel] Hebrew Univ Jerusalem, Hadassah Med Sch, Inst Med Res Israel Canada, Lab Membrane & Liposome Res,Dept Biochem & Mol Bi, IL-91010 Jerusalem, Israel; [Schilt, Yaelle; Raviv, Uri] Hebrew Univ Jerusalem, Inst Chem, IL-91904 Jerusalem, Israel; [Katzir, Tamar Blumenfeld; Sasson, Efrat] BioImage MRI Res & Consulting, Tel Aviv, Israel; [Ovadia, Haim] Hadassah Univ Hosp, Dept Neurol, Agnes Ginges Ctr Human Neurogenet, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem	Turjeman, K (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Inst Med Res Israel Canada, Lab Membrane & Liposome Res,Dept Biochem & Mol Bi, IL-91010 Jerusalem, Israel.	kerenbarhum@gmail.com	Raviv, Uri/C-3600-2019	Bavli, Yaelle/0000-0002-2408-542X	Barenholz Fund; Hebrew University regular support system	Barenholz Fund; Hebrew University regular support system	This study was supported in part by the Barenholz Fund. The Barenholz Fund is a fund established by Professor Barenholz from royalties that the Hebrew University and Professor Barenholz get from various patents which are dedicated to support research in his lab. There are no connections between the patents for which he gets the royalties and this research, so it is basically a research fund. The other support was the Hebrew University regular support system. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors TBK and ES are employed by BioImage MRI Research & Consulting. The company was hired to perform the MRI and to process the data obtained but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	AFZAL V, 1984, INVEST RADIOL, V19, P549, DOI 10.1097/00004424-198411000-00014; Allon N, 2012, J CONTROL RELEASE, V160, P217, DOI 10.1016/j.jconrel.2011.10.033; ANDERSON BD, 1981, J PHARM SCI, V70, P181, DOI 10.1002/jps.2600700217; Avnir Y, 2008, ARTHRITIS RHEUM-US, V58, P119, DOI 10.1002/art.23230; Avnir Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025721; Barenholz Y, 2000, PHYSICAL CHEMISTRY OF BIOLOGICAL INTERFACES, P171; Barenholz Y, 2001, CURR OPIN COLLOID IN, V6, P66, DOI 10.1016/S1359-0294(00)00090-X; Barenholz Y, 2002, TEMPAMINE COMPOSITIO; Barenholz Y, 2000, PHYS CHEM BIOL INTER; Barenholz Y, 2011, J COLLOID INTERF SCI, V356, P46, DOI 10.1016/j.jcis.2010.11.062; BARLOW CF, 1956, J NEUROPATH EXP NEUR, V15, P196, DOI 10.1097/00005072-195604000-00005; BARNES MP, 1985, J NEUROL NEUROSUR PS, V48, P157, DOI 10.1136/jnnp.48.2.157; BARTLETT GR, 1959, J BIOL CHEM, V234, P466; Ben-Nun T, 2010, J APPL CRYSTALLOGR, V43, P1522, DOI 10.1107/S0021889810032772; Borlongan C V, 1996, J Fla Med Assoc, V83, P335; BRANN DW, 1995, J STEROID BIOCHEM, V52, P113, DOI 10.1016/0960-0760(94)00160-N; Brusaferri F, 2000, J NEUROL, V247, P435, DOI 10.1007/s004150070172; Buttgereit F, 1998, ARTHRITIS RHEUM, V41, P761, DOI 10.1002/1529-0131(199805)41:5<761::AID-ART2>3.0.CO;2-M; Cern A, 2011, J CONTROLLED RELEASE; Compston A, 2002, LANCET, V359, P1221, DOI 10.1016/S0140-6736(02)08220-X; CUTLER RWP, 1967, J NEUROPATH EXP NEUR, V26, P558, DOI 10.1097/00005072-196710000-00004; DEGRAFF WG, 1992, FREE RADICAL BIO MED, V13, P479, DOI 10.1016/0891-5849(92)90142-4; DURELLI L, 1986, NEUROLOGY, V36, P238, DOI 10.1212/WNL.36.2.238; Ebadi M, 1996, PROG NEUROBIOL, V48, P1, DOI 10.1016/0301-0082(95)00029-1; Emanuel N, 1996, PHARMACEUT RES, V13, P861, DOI 10.1023/A:1016096910822; Ferrante RJ, 1997, J NEUROCHEM, V69, P2064; Floris S, 2004, BRAIN, V127, P616, DOI 10.1093/brain/awh068; Gaillard PJ, 2012, J CONTROLLED RELEASE; Garbuzenko O, 2005, CHEM PHYS LIPIDS, V135, P117, DOI 10.1016/j.chemphyslip.2005.02.003; GASS A, 1994, ANN NEUROL, V36, P62, DOI 10.1002/ana.410360113; Gold R, 2001, J NEUROIMMUNOL, V117, P1, DOI 10.1016/S0165-5728(01)00330-7; Gold R, 2006, BRAIN, V129, P1953, DOI 10.1093/brain/awl075; Hahn SM, 1997, FREE RADICAL BIO MED, V23, P879, DOI 10.1016/S0891-5849(97)00079-8; Halliwell B, 2001, DRUG AGING, V18, P685, DOI 10.2165/00002512-200118090-00004; Hammersley AP, 1996, HIGH PRESSURE RES, V14, P235, DOI 10.1080/08957959608201408; HAWKINS CP, 1991, BRAIN, V114, P801, DOI 10.1093/brain/114.2.801; Hoven J.M., 2011, INT J PHARMACEUT, V416, P471, DOI DOI 10.1016/J.IJPHARM.2011.03.025; JUHLER M, 1984, BRAIN RES, V302, P347, DOI 10.1016/0006-8993(84)90249-X; Kappos L, 1990, MULTIPLE SCLEROSIS D, P127; Karlik SJ, 1999, MAGN RESON IMAGING, V17, P731, DOI 10.1016/S0730-725X(98)00216-1; KERMODE AG, 1990, BRAIN, V113, P1477, DOI 10.1093/brain/113.5.1477; KESSELRING J, 1989, J NEUROL NEUROSUR PS, V52, P14, DOI 10.1136/jnnp.52.1.14; Kizelsztein P, 2009, J NEUROIMMUNOL, V213, P20, DOI 10.1016/j.jneuroim.2009.05.019; Kornek B, 2000, AM J PATHOL, V157, P267, DOI 10.1016/S0002-9440(10)64537-3; KRISHNA MC, 1992, P NATL ACAD SCI USA, V89, P5537, DOI 10.1073/pnas.89.12.5537; LEIBOWITZ S, 1972, IMMUNOLOGY, V22, P859; Linker RA, 2008, EXP NEUROL, V211, P397, DOI 10.1016/j.expneurol.2008.02.005; Lu FM, 2000, J NEUROL SCI, V177, P95, DOI 10.1016/S0022-510X(00)00343-9; Mabrey S, 1978, METHODS MEMBR BIOL, P237, DOI [10.1007/978-1-4613-4036-2_3, DOI 10.1007/978-1-4613-4036-2_3]; Maier C, 2005, J CELL SCI, V118, P3353, DOI 10.1242/jcs.02462; Markesbery WR, 1999, BRAIN PATHOL, V9, P133; McCombe PA, 1996, J NEUROIMMUNOL, V70, P93, DOI 10.1016/S0165-5728(96)00043-4; MILLER DH, 1992, J NEUROL NEUROSUR PS, V55, P450, DOI 10.1136/jnnp.55.6.450; MILLER H, 1961, LANCET, V2, P1120; MILLIGAN NM, 1987, J NEUROL NEUROSUR PS, V50, P511, DOI 10.1136/jnnp.50.5.511; MITCHELL JB, 1991, ARCH BIOCHEM BIOPHYS, V289, P62, DOI 10.1016/0003-9861(91)90442-L; Morrissey SP, 1996, BRAIN, V119, P239, DOI 10.1093/brain/119.1.239; Nessler S, 2007, BRAIN, V130, P2186, DOI 10.1093/brain/awm105; NINOMIYA H, 1993, J CELL BIOL, V121, P879, DOI 10.1083/jcb.121.4.879; Pozzilli C, 2004, J NEUROL SCI, V223, P47, DOI 10.1016/j.jns.2004.04.019; Re F, 2011, J BIOTECHNOL, V156, P341, DOI 10.1016/j.jbiotec.2011.06.037; Reichardt Holger M, 2006, Expert Rev Neurother, V6, P1657, DOI 10.1586/14737175.6.11.1657; Saper G, 2013, NUCLEIC ACIDS RES, V41, P1569, DOI 10.1093/nar/gks1270; Sarsero JP, 2003, J GENE MED, V5, P72, DOI 10.1002/jgm.320; Schellenberg AE, 2007, MAGN RESON MED, V58, P298, DOI 10.1002/mrm.21289; Schmidt J, 2003, BRAIN, V126, P1895, DOI 10.1093/brain/awg176; Stein W., 2012, TRANSPORT DIFFUSION; Szekely P, 2010, LANGMUIR, V26, P13110, DOI 10.1021/la101433t; THOMPSON AJ, 1989, NEUROLOGY, V39, P969, DOI 10.1212/WNL.39.7.969; Tischner D, 2007, MOL CELL ENDOCRINOL, V275, P62, DOI 10.1016/j.mce.2007.03.007; TRIARHOU LC, 1986, ARCH NEUROL-CHICAGO, V43, P121, DOI 10.1001/archneur.1986.00520020015008; TROIANO R, 1984, ANN NEUROL, V15, P257, DOI 10.1002/ana.410150309; Ulmansky R, 2011, J CONTROLLED RELEASE; Vosoughi R, 2010, CLIN NEUROL NEUROSUR, V112, P365, DOI 10.1016/j.clineuro.2010.03.010; Wasserman V, 2007, LANGMUIR, V23, P1937, DOI 10.1021/la060218k; Yong VW, 2010, NEUROSCIENTIST, V16, P408, DOI 10.1177/1073858410371379; YOUL BD, 1991, BRAIN, V114, P2437, DOI 10.1093/brain/114.6.2437; Zamir E, 1999, FREE RADICAL BIO MED, V27, P7, DOI 10.1016/S0891-5849(99)00026-X; Zlokovic BV, 2008, NEUROTHERAPEUTICS, V5, P409, DOI 10.1016/j.nurt.2008.05.011; Zucker D, 2009, J CONTROL RELEASE, V139, P73, DOI 10.1016/j.jconrel.2009.05.036	80	49	49	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0130442	10.1371/journal.pone.0130442	http://dx.doi.org/10.1371/journal.pone.0130442			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147975	gold, Green Published, Green Submitted			2022-12-26	WOS:000358157600036
J	Karunarathna, U; Kongsema, M; Zona, S; Gong, C; Cabrera, E; Gomes, AR; Man, EPS; Khongkow, P; Tsang, JWH; Khoo, US; Medema, RH; Freire, R; Lam, EWF				Karunarathna, U.; Kongsema, M.; Zona, S.; Gong, C.; Cabrera, E.; Gomes, A. R.; Man, E. P. S.; Khongkow, P.; Tsang, J. W-H; Khoo, U-S; Medema, R. H.; Freire, R.; Lam, E. W-F			OTUB1 inhibits the ubiquitination and degradation of FOXM1 in breast cancer and epirubicin resistance	ONCOGENE			English	Article							EXPRESSION; PROTEIN; DOMAIN; BINDING; ENZYME; CELLS; OVEREXPRESSION; SPECIFICITY; DOXORUBICIN; MUTATIONS	The forkhead transcription factor FOXM1 has a key role in DNA damage response, and its deregulated overexpression is associated with genotoxic drug resistance in breast cancer. However, little is known about the posttranslational mechanisms by which FOXM1 expression is regulated by genotoxic agents and how they are deregulated in resistant cells. Initial co-immunoprecipitation studies verified previous proteomic analysis finding that the OTUB1 is a novel FOXM1-interacting protein. Western blot analysis showed that both OTUB1 and FOXM1 expression reduced upon genotoxic agent treatment in MCF-7 cells, but remained relatively constant in resistant cells. FOXM1 expression reduced upon OTUB1 depletion by siRNA and increased with OTUB1 overexpression in MCF-7 cells, arguing that OTUB1 positively regulates FOXM1 expression. In agreement, co-immunoprecipitation experiments demonstrated that FOXM1 expression is associated with OTUB1 binding but inversely correlates with conjugation to the protein degradation-associated Lys-48-linked ubiquitin-chains. Overexpression of wild-type (WT) OTUB1, but not the OTUB1( C91S) mutant, disrupted the formation of Lys48-linked ubiquitin-conjugates on FOXM1. Importantly, knockdown of OTUB1 by siRNA resulted in an increase in turnover of FOXM1 in MCF-7 cells treated with the protein synthesis inhibitor cycloheximide, whereas overexpression of WT OTUB1, but not the OTUB1( C91S) mutant, significantly enhances the half-life of FOXM1. In addition, proliferative and clonogenic assays also show that OTUB1 can enhance the proliferative rate and epirubicin resistance through targeting FOXM1, as OTUB1 has little effect on FOXM1-deficient cells. The physiological relevance of the regulation of FOXM1 by OTUB1 is further underscored by the significant correlations between FOXM1 and OTUB1 expression in breast cancer patient samples. Cox-regression survival analysis indicates that OTUB1 overexpression is linked to poorer outcome in particular in patients treated with chemotherapy. Collectively, these data suggest that OTUB1 limits the ubiquitination and degradation of FOXM1 in breast cancer and has a key role in genotoxic agent resistance.	[Karunarathna, U.; Kongsema, M.; Zona, S.; Gong, C.; Gomes, A. R.; Khongkow, P.; Lam, E. W-F] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, Hammersmith Hosp Campus, London, England; [Gong, C.; Man, E. P. S.; Khoo, U-S] Univ Hong Kong, Li Ka Shing Fac Med, Dept Pathol, Hong Kong, Hong Kong, Peoples R China; [Cabrera, E.; Freire, R.] Hosp Univ Canarias, Inst Tecnol Biomed, Unidad Invest, Ofra S-N, Tenerife, Spain; [Tsang, J. W-H] Univ Hong Kong, Li Ka Shing Fac Med, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China; [Medema, R. H.] Netherlands Canc Inst, Div Cell Biol, Amsterdam, Netherlands	Imperial College London; University of Hong Kong; Universidad de la Laguna; University of Hong Kong; Netherlands Cancer Institute	Lam, EWF (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, ICTEM, Hammersmith Hosp Campus,Room 134,1st Floor, London W12 0NN, England.	eric.lam@imperial.ac.uk	Kongsema, Mesayamas/H-3063-2017; Cabrera, Elisa/GPX-3455-2022; Khoo, Ui Soon/C-4293-2009; Freire, Raimundo/Q-7660-2019; Khoo, Ui Soon/C-1345-2014; Lam, Eric W-F/AAW-8566-2020; Khoo, Ui Soon/K-2041-2019	Khoo, Ui Soon/0000-0003-2200-7505; Freire, Raimundo/0000-0003-4473-8894; Khoo, Ui Soon/0000-0003-2200-7505; Lam, Eric W-F/0000-0003-1274-3576; Medema, Rene/0000-0002-6754-0381; Khongkow, Pasarat/0000-0003-3068-2412	Cancer Research UK; Breast Cancer Campaign; BBSRC studentship; Royal Thai Government Scholarship; Committee on Research and Conference Grants from the University of Hong Kong (CRCG) [201007176118]; Biotechnology and Biological Sciences Research Council [1243234, BBS/B/03785] Funding Source: researchfish; Cancer Research UK [12011] Funding Source: researchfish; Engineering and Physical Sciences Research Council [1234732] Funding Source: researchfish; Breast Cancer Campaign [2012NovPhD016, 2012MayPR070] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Breast Cancer Campaign; BBSRC studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Thai Government Scholarship; Committee on Research and Conference Grants from the University of Hong Kong (CRCG); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Breast Cancer Campaign	EW-F Lam and AR Gomes were supported by grants from Cancer Research UK, EW-F Lam and S Zona by grants from Breast Cancer Campaign. U Karunarathna is the recipient of a BBSRC studentship. P Khongkow and M Kongsema were supported by grants from the Royal Thai Government Scholarship. US Khoo received funding from Committee on Research and Conference Grants from the University of Hong Kong (CRCG) (201007176118). We also thank for help with this work.	CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; Cohen MM, 2011, J CELL SCI, V124, P1403, DOI 10.1242/jcs.079293; de Olano N, 2012, MOL CANCER RES, V10, P1189, DOI 10.1158/1541-7786.MCR-11-0559; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Edelmann MJ, 2009, BIOCHEM J, V418, P379, DOI 10.1042/BJ20081318; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Fox EM, 2008, STEROIDS, V73, P1039, DOI 10.1016/j.steroids.2008.04.006; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Hui RCY, 2008, MOL CANCER THER, V7, P670, DOI 10.1158/1535-7163.MCT-07-0397; Iglesias-Gato D, 2015, MOL CANCER, V14, DOI 10.1186/s12943-014-0280-2; Khasraw M, 2012, BREAST, V21, P142, DOI 10.1016/j.breast.2011.12.012; Khongkow P, 2016, ONCOGENE, V35, P990, DOI 10.1038/onc.2015.152; Khongkow P, 2014, ONCOGENE, V33, P4144, DOI 10.1038/onc.2013.457; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Kwok JMM, 2010, MOL CANCER RES, V8, P24, DOI 10.1158/1541-7786.MCR-09-0432; Kwok JMM, 2008, MOL CANCER THER, V7, P2022, DOI 10.1158/1535-7163.MCT-08-0188; Li YH, 2014, J BIOL CHEM, V289, P5097, DOI 10.1074/jbc.M113.533109; Lipkowitz S, 2011, NAT REV CANCER, V11, P629, DOI 10.1038/nrc3120; Liu X, 2014, PATHOL RES PRACT, V210, P770, DOI 10.1016/j.prp.2014.05.008; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; McGovern UB, 2009, MOL CANCER THER, V8, P582, DOI 10.1158/1535-7163.MCT-08-0805; Mevissen TET, 2013, CELL, V154, P169, DOI 10.1016/j.cell.2013.05.046; Millour J, 2011, MOL CANCER THER, V10, P1046, DOI 10.1158/1535-7163.MCT-11-0024; Monteiro LJ, 2013, ONCOGENE, V32, P4634, DOI 10.1038/onc.2012.491; Myatt SS, 2014, ONCOGENE, V33, P4316, DOI 10.1038/onc.2013.546; Myatt SS, 2008, NAT REV CANCER, V8, P244, DOI 10.1038/nrc2223-c2; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; Nakada S, 2010, NATURE, V466, P941, DOI 10.1038/nature09297; Salghetti SE, 1999, EMBO J, V18, P717, DOI 10.1093/emboj/18.3.717; Savarese DMF, 1997, J CLIN ONCOL, V15, P2981, DOI 10.1200/JCO.1997.15.8.2981; SINGH S, 1993, HUM GENET, V90, P635; Stanisic V, 2009, J BIOL CHEM, V284, P16135, DOI 10.1074/jbc.M109.007484; Sun XX, 2012, EMBO J, V31, P576, DOI 10.1038/emboj.2011.434; Wang T, 2009, J MOL BIOL, V386, P1011, DOI 10.1016/j.jmb.2008.12.085; Weissman AM, 2011, NAT REV MOL CELL BIO, V12, P605, DOI 10.1038/nrm3173; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Zhou Y, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-258	37	91	94	3	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 17	2016	35	11					1433	1444		10.1038/onc.2015.208	http://dx.doi.org/10.1038/onc.2015.208			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DG6LQ	26148240	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000372196400009
J	Yu, C; Cui, S; Zong, C; Gao, WN; Xu, TF; Gao, P; Chen, JC; Qin, DD; Guan, QB; Liu, YT; Fu, YC; Li, X; Wang, XD				Yu, Cong; Cui, Shang; Zong, Chen; Gao, Weina; Xu, Tongfu; Gao, Peng; Chen, Jicui; Qin, Dandan; Guan, Qingbo; Liu, Yuantao; Fu, Yuchang; Li, Xia; Wang, Xiangdong			The Orphan Nuclear Receptor NR4A1 Protects Pancreatic beta-Cells from Endoplasmic Reticulum (ER) Stress-mediated Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-SECRETION; GROWTH ARREST; CANCER CELL; NUR77; PALMITATE; SURVIVIN; BCL-2; IRE1; TRANSLOCATION; TRANSLATION	The role of NR4A1 in apoptosis is controversial. Pancreatic beta-cells often face endoplasmic reticulum (ER) stress under adverse conditions such as high free fatty acid (FFA) concentrations and sustained hyperglycemia. Severe ER stress results in beta-cell apoptosis. The aim of this study was to analyze the role of NR4A1 in ER stress-mediated beta-cell apoptosis and to characterize the related mechanisms. We confirmed that upon treatment with the ER stress inducers thapsigargin (TG) or palmitic acid (PA), the mRNA and protein levels of NR4A1 rapidly increased in both MIN6 cells and mouse islets. NR4A1 overexpression in MIN6 cells conferred resistance to cell loss induced by TG or PA, as assessed by MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay, and TUNEL assays indicated that NR4A1 overexpression also protected against ER stress-induced apoptosis. This conclusion was further confirmed by experiments exploiting siRNA to knockdown NR4A1 expression in MIN6 cells or exploiting NR4A1 knock-out mice. NR4A1 overexpression in MIN6 cells reduced C/EBP homologous protein (CHOP) expression and Caspase3 activation induced by TG or PA. NR4A1 overexpression in MIN6 cells or mouse islets resulted in Survivin up-regulation. A critical regulatory element was identified in Survivin promoter (-1872 bp to -1866 bp) with a putative NR4A1 binding site; ChIP assays demonstrated that NR4A1 physically associates with the Survivin promoter. In conclusion, NR4A1 protects pancreatic beta-cells against ER stress-mediated apoptosis by up-regulating Survivin expression and down-regulating CHOP expression, which we termed as "positive and negative regulation."	[Yu, Cong; Cui, Shang; Zong, Chen; Gao, Weina; Xu, Tongfu; Gao, Peng; Chen, Jicui; Qin, Dandan; Li, Xia; Wang, Xiangdong] Shandong Univ, Sch Med, Dept Cell Biol, Jinan 250012, Peoples R China; [Guan, Qingbo] Shandong Univ, Prov Hosp, Dept Endocrinol, Jinan 250021, Peoples R China; [Liu, Yuantao] Qingdao Municipal Hosp, Dept Endocrinol, Qingdao 266071, Peoples R China; [Fu, Yuchang] Univ Alabama Birmingham, Dept Nutr Sci, Birmingham, AL 35294 USA; [Wang, Xiangdong] Shandong Univ, Key Lab Prot Sci Chron Degenerat Dis, Jinan 250012, Peoples R China	Shandong University; Shandong University; Qingdao Municipal Hospital; University of Alabama System; University of Alabama Birmingham; Shandong University	Li, X (corresponding author), Shandong Univ, Sch Med, Dept Cell Biol, 44 Wenhua Rd West, Jinan 250012, Peoples R China.	lixia1666@sdu.edu.cn; xdongw@sdu.edu.cn	, 鹏鹏/AGR-5462-2022		National Natural Science Foundation of China [81170814, 81370881]; Education Department of China [20100131110037]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Education Department of China	This work was supported by the National Natural Science Foundation of China (81170814 and 81370881) and the Education Department of China for Ph.D. programs (20100131110037). The authors declare that there are no conflicts of interests with the contents of the article.	Bookout Angie L, 2003, Nucl Recept Signal, V1, pe012; Briand O, 2012, MOL ENDOCRINOL, V26, P399, DOI 10.1210/me.2011-1317; Brush MH, 2003, MOL CELL BIOL, V23, P1292, DOI 10.1128/MCB.23.4.1292-1303.2003; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Chen HZ, 2013, INT J BIOCHEM CELL B, V45, P1600, DOI 10.1016/j.biocel.2013.04.026; de Leseleuc L, 2006, CELL DEATH DIFFER, V13, P293, DOI 10.1038/sj.cdd.4401737; Gao WN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091462; Gwiazda KS, 2009, AM J PHYSIOL-ENDOC M, V296, pE690, DOI 10.1152/ajpendo.90525.2008; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; HAZEL TG, 1988, P NATL ACAD SCI USA, V85, P8444, DOI 10.1073/pnas.85.22.8444; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Jonas JC, 1998, DIABETES, V47, P1266, DOI 10.2337/diabetes.47.8.1266; Karaskov E, 2006, ENDOCRINOLOGY, V147, P3398, DOI 10.1210/en.2005-1494; Kolluri SK, 2008, CANCER CELL, V14, P285, DOI 10.1016/j.ccr.2008.09.002; Kuang AA, 1999, EUR J IMMUNOL, V29, P3722, DOI 10.1002/(SICI)1521-4141(199911)29:11<3722::AID-IMMU3722>3.0.CO;2-N; Laybutt DR, 2007, DIABETOLOGIA, V50, P752, DOI 10.1007/s00125-006-0590-z; Lee SO, 2014, MOL CANCER RES, V12, P527, DOI 10.1158/1541-7786.MCR-13-0567; Lee SO, 2010, CANCER RES, V70, P6824, DOI 10.1158/0008-5472.CAN-10-1992; Li H, 2000, SCIENCE, V289, P1159, DOI 10.1126/science.289.5482.1159; Li Y, 1998, MOL CELL BIOL, V18, P4719, DOI 10.1128/MCB.18.8.4719; Liang B, 2007, EXP CELL RES, V313, P2833, DOI 10.1016/j.yexcr.2007.04.032; Lin BZ, 2004, CELL, V116, P527, DOI 10.1016/S0092-8674(04)00162-X; Lin J. H., 2007, MOL CELL, V318, P944; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Liu CL, 2014, INT J MOL MED, V33, P499, DOI 10.3892/ijmm.2013.1603; Liu S, 2002, WORLD J GASTROENTERO, V8, P446, DOI 10.3748/wjg.v8.i3.446; Liu WF, 2001, EUR J IMMUNOL, V31, P1757, DOI 10.1002/1521-4141(200106)31:6<1757::AID-IMMU1757>3.0.CO;2-J; MILBRANDT J, 1988, NEURON, V1, P183, DOI 10.1016/0896-6273(88)90138-9; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; Roche E, 1999, DIABETES, V48, P2007, DOI 10.2337/diabetes.48.10.2007; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Schonthal AH, 2012, SCIENTIFICA, V2012, DOI 10.6064/2012/857516; Shin S, 2001, BIOCHEMISTRY-US, V40, P1117, DOI 10.1021/bi001603q; Shore GC, 2011, CURR OPIN CELL BIOL, V23, P143, DOI 10.1016/j.ceb.2010.11.003; Sohn J, 2003, CANCER LETT, V191, P83, DOI 10.1016/S0304-3835(02)00624-9; Song BB, 2008, J CLIN INVEST, V118, P3378, DOI 10.1172/JCI34587; Strom BO, 2012, BIOCHEM BIOPH RES CO, V417, P1292, DOI 10.1016/j.bbrc.2011.12.132; Suzuki S, 2003, P NATL ACAD SCI USA, V100, P8276, DOI 10.1073/pnas.0932598100; Tamm I, 1998, CANCER RES, V58, P5315; Viatour P, 2003, LEUKEMIA, V17, P1349, DOI 10.1038/sj.leu.2402982; Wu Q, 2002, CARCINOGENESIS, V23, P1583, DOI 10.1093/carcin/23.10.1583; Wu Q, 1997, EMBO J, V16, P1656, DOI 10.1093/emboj/16.7.1656; Yang L, 2010, FASEB J, V24, P3720, DOI 10.1096/fj.09-152363; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhang YD, 2013, SCI WORLD J, DOI 10.1155/2013/130134	45	25	25	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2015	290	34					20687	20699		10.1074/jbc.M115.654863	http://dx.doi.org/10.1074/jbc.M115.654863			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP6QC	26157144	Green Published, hybrid			2022-12-26	WOS:000360011800005
J	Chan, M; Chang, MC; Gonzalez, R; Lategan, B; del Barco, E; Vera-Badillo, F; Quesada, P; Goldstein, R; Cruz, I; Ocana, A; Cruz, JJ; Amir, E				Chan, Melissa; Chang, Martin C.; Gonzalez, Rosa; Lategan, Belinda; del Barco, Elvira; Vera-Badillo, Francisco; Quesada, Paula; Goldstein, Robyn; Cruz, Ignacio; Ocana, Alberto; Cruz, Juan J.; Amir, Eitan			Outcomes of Estrogen Receptor Negative and Progesterone Receptor Positive Breast Cancer	PLOS ONE			English	Article							ADJUVANT ENDOCRINE THERAPY; AMERICAN-SOCIETY; CHEMOTHERAPY; IMMUNOHISTOCHEMISTRY; RECOMMENDATIONS; TRASTUZUMAB; CARCINOMA; PATTERNS; PLUS	Purpose To describe the clinical features and outcomes of estrogen receptor negative (ER-) and progesterone receptor positive (PgR+) breast cancer. Methods We retrospectively reviewed a well-characterized database of sequential patients diagnosed with early stage invasive breast carcinoma. Outcomes of interest were time to relapse (TTR) and overall survival (OS). Multivariable Cox proportional hazards analysis was conducted to assess the association of ER-/PgR+ with TTR and OS in comparison to ER+ and to ER-and PgR negative (ER-/PgR-) tumors irrespective of HER2 status. ER and PgR expression was conservatively defined as 10% or greater staining of cancer cells. Results 815 patients were followed for a median of 40.5 months; 56 patients (7%) had ER-/PgR+, 624 (77%) had ER+ and 136 (17%) had ER-/PgR- phenotypes. Compared with ER+ tumors, ER-/PgR+ tumors were associated with younger age (50 versus 59 years, p = 0.03), high grade (50% versus 24%, p < 0.001) and more frequent HER2 overexpression/amplification (43% versus 14%, p < 0.001). TTR for ER-/PgR+ was intermediate between ER+ and ER-/PgR- tumors, but was not significantly different from ER+ tumors. Recurrences in the ER-/PgR+ and ER-/PgR- groups occurred early in follow-up while in ER+ tumors recurrences continued to occur over the duration of follow-up. OS of ER-/PgR+ was similar to ER+ tumors and better than that of ER-/PgR- tumors. Conclusions The ER-/PgR+ phenotype is associated with higher grade with HER2 overexpression/amplification and occurs more commonly in younger women. Risk of relapse and death more closely resembles ER+ than ER-/PgR- tumors suggesting this phenotype represents a group of more aggressive hormone receptor positive tumors.	[Chan, Melissa; Vera-Badillo, Francisco; Goldstein, Robyn; Amir, Eitan] Princess Margaret Canc Ctr, Div Med Oncol & Hematol, Toronto, ON, Canada; [Chan, Melissa; Vera-Badillo, Francisco; Amir, Eitan] Univ Toronto, Dept Med, Toronto, ON, Canada; [Chang, Martin C.; Lategan, Belinda] Mt Sinai Hosp, Dept Pathol & Lab Med, Toronto, ON M5G 1X5, Canada; [Chang, Martin C.; Lategan, Belinda] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Gonzalez, Rosa] Univ Salamanca, Escuela Enfermeria, E-37008 Salamanca, Spain; [del Barco, Elvira; Quesada, Paula; Cruz, Juan J.] Salamanca Univ Hosp, Dept Med Oncol, Salamanca, Spain; [Cruz, Ignacio] Complejo Hosp Salamanca, Serv Cardiol, Salamanca, Spain; [Ocana, Alberto] Albacete Univ Hosp, Dept Med Oncol, Albacete, Spain; [Ocana, Alberto] Albacete Univ Hosp, Translat Res Unit, Albacete, Spain	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Salamanca	Amir, E (corresponding author), Princess Margaret Canc Ctr, Div Med Oncol & Hematol, Toronto, ON, Canada.	eitan.amir@uhn.ca	Amir, Eitan/L-6052-2019; Chang, Martin/J-2329-2016	Amir, Eitan/0000-0002-3706-525X; Ocana, Alberto/0000-0002-1067-9630; Cruz Hernandez, Juan Jesus/0000-0003-1980-2751				Bardou VJ, 2003, J CLIN ONCOL, V21, P1973, DOI 10.1200/JCO.2003.09.099; Brenner H, 2004, J CLIN ONCOL, V22, P432, DOI 10.1200/JCO.2004.04.067; Colditz GA, 2004, JNCI-J NATL CANCER I, V96, P218, DOI 10.1093/jnci/djh025; Cserni G, 2011, PATHOL ONCOL RES, V17, P663, DOI 10.1007/s12253-011-9366-y; Cui XJ, 2005, J CLIN ONCOL, V23, P7721, DOI 10.1200/JCO.2005.09.004; Davies C, 2011, LANCET, V378, P771, DOI 10.1016/S0140-6736(11)60993-8; De Maeyer L, 2006, INT J GYNECOL CAN S2, V16, P589; De Maeyer L, 2008, J CLIN ONCOL, V26, P335, DOI 10.1200/JCO.2007.14.8411; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Hammond MEH, 2010, J CLIN ONCOL, V28, P2784, DOI 10.1200/JCO.2009.25.6529; Harvey JM, 1999, J CLIN ONCOL, V17, P1474, DOI 10.1200/JCO.1999.17.5.1474; Huang HJ, 2004, EJC SUPPL, V2, P103, DOI 10.1016/S1359-6349(04)90773-2; Maleki Z, 2012, ARCH IRAN MED, V15, P366, DOI 012156/AIM.0010; MARTIN MB, 1993, ADV EXP MED BIOL, V330, P143; Nadji M, 2005, AM J CLIN PATHOL, V123, P21, DOI 10.1309/4WV79N2GHJ3X1841; Ng Char Hong, 2012, Asian Pac J Cancer Prev, V13, P1111; OSBORNE CK, 1980, CANCER-AM CANCER SOC, V46, P2884, DOI 10.1002/1097-0142(19801215)46:12+<2884::AID-CNCR2820461429>3.0.CO;2-U; Piccart-Gebhart MJ, 2005, NEW ENGL J MED, V353, P1659, DOI 10.1056/NEJMoa052306; Pujol P, 1998, CANCER-AM CANCER SOC, V83, P698, DOI 10.1002/(SICI)1097-0142(19980815)83:4<698::AID-CNCR10>3.3.CO;2-I; Rakha EA, 2007, J CLIN ONCOL, V25, P4772, DOI 10.1200/JCO.2007.12.2747; RAVDIN PM, 1992, J CLIN ONCOL, V10, P1284, DOI 10.1200/JCO.1992.10.8.1284; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Wolff AC, 2013, J CLIN ONCOL, V31, P3997, DOI 10.1200/JCO.2013.50.9984	25	32	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132449	10.1371/journal.pone.0132449	http://dx.doi.org/10.1371/journal.pone.0132449			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161666	Green Published, Green Submitted, gold			2022-12-26	WOS:000358162300137
J	Hespeels, B; Li, X; Flot, JF; Pigneur, LM; Malaisse, J; Da Silva, C; Van Doninck, K				Hespeels, Boris; Li, Xiang; Flot, Jean-Francois; Pigneur, Lise-Marie; Malaisse, Jeremy; Da Silva, Corinne; Van Doninck, Karine			Against All Odds: Trehalose-6-Phosphate Synthase and Trehalase Genes in the Bdelloid Rotifer Adineta vaga Were Acquired by Horizontal Gene Transfer and Are Upregulated during Desiccation	PLOS ONE			English	Article							SWISS-MODEL; ABSCISIC-ACID; PROTEIN; TOLERANCE; ANHYDROBIOSIS; BIOSYNTHESIS; ARABIDOPSIS; 6-PHOSPHATE; PHOSPHATASE; METABOLISM	The disaccharide sugar trehalose is essential for desiccation resistance in most metazoans that survive dryness; however, neither trehalose nor the enzymes involved in its metabolism have ever been detected in bdelloid rotifers despite their extreme resistance to desiccation. Here we screened the genome of the bdelloid rotifer Adineta vaga for genes involved in trehalose metabolism. We discovered a total of four putative trehalose-6-phosphate synthase (TPS) and seven putative trehalase (TRE) gene copies in the genome of this ameiotic organism; however, no trehalose-6-phosphate phosphatase (TPP) gene or domain was detected. The four TPS copies of A. vaga appear more closely related to plant and fungi proteins, as well as to some protists, whereas the seven TRE copies fall in bacterial clades. Therefore, A. vaga likely acquired its trehalose biosynthesis and hydrolysis genes by horizontal gene transfers. Nearly all residues important for substrate binding in the predicted TPS domains are highly conserved, supporting the hypothesis that several copies of the genes might be functional. Besides, RNAseq library screening showed that trehalase genes were highly expressed compared to TPS genes, explaining probably why trehalose had not been detected in previous studies of bdelloids. A strong overexpression of their TPS genes was observed when bdelloids enter desiccation, suggesting a possible signaling role of trehalose-6-phosphate or trehalose in this process.	[Hespeels, Boris; Li, Xiang; Pigneur, Lise-Marie; Van Doninck, Karine] Univ Namur, URBE, Dept Biol, LEGE Lab, Namur, Belgium; [Flot, Jean-Francois] UCL, Dept Genet Evolut & Environm, London, England; [Malaisse, Jeremy] Cell & Tissue Lab, Res Unit Mol Physiol, Namur, Belgium; [Da Silva, Corinne] CEA, GENOSCOPE, Ctr Natl Sequencage, Inst Genom, Evry, France; [Van Doninck, Karine] Univ Namur, NaXys, Namur Ctr Complex Syst, Namur, Belgium	University of Namur; University of London; University College London; CEA; UDICE-French Research Universities; Universite Paris Saclay; University of Namur	Van Doninck, K (corresponding author), Univ Namur, URBE, Dept Biol, LEGE Lab, Namur, Belgium.	karine.vandoninck@unamur.be	; Van Doninck, Karine/B-3218-2016	Flot, Jean-Francois/0000-0003-4091-7916; Van Doninck, Karine/0000-0002-4790-8951; DA SILVA, Corinne/0000-0002-7618-7831	UNamur; Belgian National Fund for Scientific Research (Fonds National pour la Recherche Scientifique - FNRS) through PhD FRIA (Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture) thesis grant; FRFC (Fonds de la Recherche Fondamentale Collective) grant [2.4.655.09.F]; CDR research grant DAMAGE [19597258]	UNamur; Belgian National Fund for Scientific Research (Fonds National pour la Recherche Scientifique - FNRS) through PhD FRIA (Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture) thesis grant(Fonds de la Recherche Scientifique - FNRS); FRFC (Fonds de la Recherche Fondamentale Collective) grant(Fonds de la Recherche Scientifique - FNRS); CDR research grant DAMAGE	This work was supported by UNamur through an assistant PhD grant allocated to BH and a starting grant allocated to KVD and by the Belgian National Fund for Scientific Research (Fonds National pour la Recherche Scientifique - FNRS) through a PhD FRIA (Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture) thesis grant allocated to XL and an FRFC (Fonds de la Recherche Fondamentale Collective) grant 2.4.655.09.F and a CDR research grant DAMAGE (19597258) allocated to KVD.	Adhikari BN, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-69; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Alpert P, 2005, INTEGR COMP BIOL, V45, P685, DOI 10.1093/icb/45.5.685; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Avonce N, 2004, PLANT PHYSIOL, V136, P3649, DOI 10.1104/pp.104.052084; Avonce N, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-109; Avonce N, 2010, MOL BIOL EVOL, V27, P359, DOI 10.1093/molbev/msp241; Biasini Marco, 2014, Nucleic Acids Res, V42, pW252, DOI 10.1093/nar/gku340; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Blazquez MA, 1998, PLANT J, V13, P685, DOI 10.1046/j.1365-313X.1998.00063.x; Boschetti C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003035; Boschetti C, 2011, J EXP BIOL, V214, P59, DOI 10.1242/jeb.050328; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Caprioli M, 2004, COMP BIOCHEM PHYS A, V139, P527, DOI 10.1016/j.cbpb.2004.10.019; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; De Maesschalck C, 2009, UNRAVELING THE FUNCT; Delorge I, 2015, BIOCHEM J, V466, P283, DOI 10.1042/BJ20141322; Delorge I, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00147; Denekamp NY, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-108; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elbein AD, 2003, GLYCOBIOLOGY, V13, p17R, DOI 10.1093/glycob/cwg047; Fernandez J., 2011, Mycology - An International Journal on Fungal Biology, V2, P46, DOI 10.1080/21501203.2011.563431; Fernandez O, 2010, TRENDS PLANT SCI, V15, P409, DOI 10.1016/j.tplants.2010.04.004; Flot JF, 2013, NATURE, V500, P453, DOI 10.1038/nature12326; Friesen Vicki, 2000, P274; Gertz EM, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-41; Gibson RP, 2004, J BIOL CHEM, V279, P1950, DOI 10.1074/jbc.M307643200; Gibson RP, 2002, CHEM BIOL, V9, P1337, DOI 10.1016/S1074-5521(02)00292-2; Gladyshev E, 2008, P NATL ACAD SCI USA, V105, P5139, DOI 10.1073/pnas.0800966105; Gladyshev EA, 2010, J HERED, V101, pS85, DOI 10.1093/jhered/esq008; Goddijn OJM, 1999, TRENDS PLANT SCI, V4, P315, DOI 10.1016/S1360-1385(99)01446-6; Goddijn OJM, 1997, PLANT PHYSIOL, V113, P181, DOI 10.1104/pp.113.1.181; Gusev O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014008; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Helaers R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-379; Hengherr S, 2011, PHYSIOL BIOCHEM ZOOL, V84, P147, DOI 10.1086/658499; Hengherr S, 2008, FEBS J, V275, P281, DOI 10.1111/j.1742-4658.2007.06198.x; Hengherr S, 2011, PHYSIOL BIOCHEM ZOOL, V84, P249, DOI 10.1086/659314; Hespeels B, 2014, J EVOLUTION BIOL, V27, P1334, DOI 10.1111/jeb.12326; Hespeels B, 2014, EVOLUTIONARY BIOL GE, P207, DOI [10.1007/978-3-319-07623-2, DOI 10.1007/978-3-319-07623-2]; Howe KL, 2002, GENOME RES, V12, P1418, DOI 10.1101/gr.149502; HSU WS, 1956, BIOL BULL, V111, P364, DOI 10.2307/1539143; Hsu WS, 1956, CELLULE, V57, P283; Hur JH, 2009, MOL BIOL EVOL, V26, P375, DOI 10.1093/molbev/msn260; Jain NK, 2009, PROTEIN SCI, V18, P24, DOI 10.1002/pro.3; Jonsson I., 2014, OPEN ZOOL J, V3, P1, DOI [10.2174/1874336601003010001, DOI 10.2174/1874336601003010001]; KAASEN I, 1992, J BACTERIOL, V174, P889, DOI 10.1128/jb.174.3.889-898.1992; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Lapinski J, 2003, FEBS LETT, V553, P387, DOI 10.1016/S0014-5793(03)01062-7; Li HW, 2011, PLANTA, V234, P1007, DOI 10.1007/s00425-011-1458-0; Lunn JE, 2006, BIOCHEM J, V397, P139, DOI 10.1042/BJ20060083; Lunn JE, 2014, PLANT J, V79, P544, DOI 10.1111/tpj.12509; MADIN KAC, 1975, J EXP ZOOL, V193, P335, DOI 10.1002/jez.1401930309; Milne I, 2009, BIOINFORMATICS, V25, P126, DOI 10.1093/bioinformatics/btp666; Muller J, 2001, PLANT PHYSIOL, V125, P1086, DOI 10.1104/pp.125.2.1086; Ohtake S, 2011, J PHARM SCI-US, V100, P2020, DOI 10.1002/jps.22458; Pampurova S, 2014, J PLANT RES, V127, P803, DOI 10.1007/s10265-014-0663-x; Ponnu J, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00070; Potts M, 2005, INTEGR COMP BIOL, V45, P800, DOI 10.1093/icb/45.5.800; Potts M, 2001, TRENDS MICROBIOL, V9, P553, DOI 10.1016/S0966-842X(01)02231-4; Puttikamonkul S, 2010, MOL MICROBIOL, V77, P891, DOI 10.1111/j.1365-2958.2010.07254.x; Rao KN, 2006, PROTEIN SCI, V15, P1735, DOI 10.1110/ps.062096606; RICCI CN, 1987, HYDROBIOLOGIA, V147, P117, DOI 10.1007/BF00025734; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sakurai M, 2008, P NATL ACAD SCI USA, V105, P5093, DOI 10.1073/pnas.0706197105; Satoh-Nagasawa N, 2006, NATURE, V441, P227, DOI 10.1038/nature04725; Schluepmann H, 2003, P NATL ACAD SCI USA, V100, P6849, DOI 10.1073/pnas.1132018100; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; SEGERS H, 2007, ZOOTAXA, V1564, P104; Silvestro D., 2011, ORG DIVERS EVOL, V12, P335, DOI [10.1007/sI3127-011-0056-0, DOI 10.1007/S13127-011-0056-0]; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Suga K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000671; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tsai AYL, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00119; Tunnacliffe A, 2003, PHILOS T ROY SOC B, V358, P1755, DOI 10.1098/rstb.2002.1214; Van Dijck P, 2002, INFECT IMMUN, V70, P1772, DOI 10.1128/IAI.70.4.1772-1782.2002; Van Doninck K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000401; Van Houtte H, 2013, PLANT PHYSIOL, V161, P1158, DOI 10.1104/pp.112.211391; van Leeuwenhoek Antony, 1702, PHILOS T, V23, P1304; Vandesteene L, 2012, PLANT PHYSIOL, V160, P884, DOI 10.1104/pp.112.201400; Vandesteene L, 2010, MOL PLANT, V3, P406, DOI 10.1093/mp/ssp114; Wang YL, 2012, NUCLEIC ACIDS RES, V40, pD400, DOI [10.1093/nar/gkr1132, 10.1093/nar/gkr1293]; Wingler A, 2002, PHYTOCHEMISTRY, V60, P437, DOI 10.1016/S0031-9422(02)00137-1; Yadav UP, 2014, J EXP BOT, V65, P1051, DOI 10.1093/jxb/ert457; Zaparty M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061354	87	13	14	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131313	10.1371/journal.pone.0131313	http://dx.doi.org/10.1371/journal.pone.0131313			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161530	Green Submitted, Green Published, gold			2022-12-26	WOS:000358162300034
J	Ji, HF; Xuan, QJ; Nanding, A; Zhang, HY; Zhang, QY				Ji, Hongfei; Xuan, Qijia; Nanding, Abiyasi; Zhang, Haiyu; Zhang, Qingyuan			The Clinicopathologic and Prognostic Value of Altered Chromosome 17 Centromere Copy Number in HER2 Fish Equivocal Breast Carcinomas	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; POLYSOMY 17; GENE AMPLIFICATION; PROTEIN EXPRESSION; AMERICAN SOCIETY; HER-2/NEU STATUS; CANCER ANALYSIS; RECOMMENDATIONS; IMPACT; PATTERNS	Chromosome 17 centromere (CEP17) gain is frequently observed in breast cancer by fluorescence in situ hybridization (FISH). To address the biologic characteristics and clinical significance of CEP17 gain in a large population of breast cancer patients, we performed FISH on a series of 770 breast cancer tissues to evaluate the status of human epidermal growth factor receptor 2 (HER2) gene and CEP17 by immunohistochemistry (IHC) and FISH. Among the 770 specimens, 184 cases showed CEP17 gain (23.9%). Histological grade, nodal status, HER2 by IHC, Ki 67 index, and p53 expression were significantly different between CEP17 gain tumors and HER2-positive tumors. In contrast with HER2-negative tumors, CEP17 gain tumors showed higher histological grade, higher HER2 score by IHC, and higher Ki 67 index. The patients with CEP17 gain tumors had an intermediate survival between HER2-negative and HER2-positive patients. By comparison to HER2-negative and HER2-positive patients, survival in luminal B patients with CEP17 gain tumors also fell in between. In conclusion, CEP17 gain tumors show specific differences compared with HER2-negative and HER2-positive tumors in clinical parameters and prognosis.	[Ji, Hongfei; Zhang, Qingyuan] Harbin Med Univ, Inst Canc, Dept Canc Mol & Biol, Harbin, Peoples R China; [Xuan, Qijia; Zhang, Qingyuan] Harbin Med Univ, Tumor Hosp, Dept Med Oncol, Harbin, Peoples R China; [Nanding, Abiyasi] Harbin Med Univ, Tumor Hosp, Dept Pathol, Harbin, Peoples R China; [Zhang, Haiyu] Harbin Med Univ, Dept Biostat, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Medical University; Harbin Medical University	Zhang, QY (corresponding author), Harbin Med Univ, Inst Canc, Dept Canc Mol & Biol, Harbin, Peoples R China.	zqyxsci@126.com						Bartlett AI, 2011, AM J CLIN PATHOL, V136, P266, DOI 10.1309/AJCP0EN6AQMWETZZ; Bartlett JMS, 2008, AM J CLIN PATHOL, V130, P920, DOI 10.1309/AJCPSDG53BEANCYE; Chopra I, 2014, PATIENT-RELAT OUTCOM, V5, P71, DOI 10.2147/PROM.S49586; Cuadros M, 2011, CLIN TRANSL ONCOL, V13, P335, DOI 10.1007/s12094-011-0663-4; De Felice Francesca, 2014, J Clin Med Res, V6, P409, DOI 10.14740/jocmr1908w; DeSantis C, 2014, CA-CANCER J CLIN, V64, P52, DOI 10.3322/caac.21203; Egervari K, 2011, PATHOL RES PRACT, V207, P468, DOI 10.1016/j.prp.2011.05.008; Gaiser T, 2012, PATHOLOGE, V33, P307, DOI 10.1007/s00292-012-1663-z; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Gunn S, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-396; Hammond ME, 2011, J CLIN ONCOL, V29, pE458, DOI 10.1200/JCO.2011.35.2245; Hanna WM, 2014, MODERN PATHOL, V27, P4, DOI 10.1038/modpathol.2013.103; Hyun CL, 2008, J CLIN PATHOL, V61, P317, DOI 10.1136/jcp.2007.050336; Iqbal Nida, 2014, Mol Biol Int, V2014, P852748, DOI 10.1155/2014/852748; Jiang HY, 2014, ONCOL LETT, V7, P1954, DOI 10.3892/ol.2014.2001; Kim A, 2012, J BREAST CANCER, V15, P24, DOI 10.4048/jbc.2012.15.1.24; Krishnamurti U, 2009, MODERN PATHOL, V22, P1044, DOI 10.1038/modpathol.2009.61; Lin XH, 2013, INT J CLIN EXP PATHO, V6, P116; Ma Y, 2005, CLIN CANCER RES, V11, P4393, DOI 10.1158/1078-0432.CCR-04-2256; Mackay A, 2011, JNCI-J NATL CANCER I, V103, P662, DOI 10.1093/jnci/djr071; Marchio C, 2009, J PATHOL, V219, P16, DOI 10.1002/path.2574; Moelans CB, 2010, CLIN CANCER RES, V16, P6177, DOI 10.1158/1078-0432.CCR-10-0773; Moelans CB, 2010, BREAST CANCER RES TR, V120, P1, DOI 10.1007/s10549-009-0539-2; Murthy SS, 2011, INDIAN J PATHOL MICR, V54, P532, DOI 10.4103/0377-4929.85087; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Pathmanathan N, 2012, PATHOLOGY, V44, P587, DOI 10.1097/PAT.0b013e328359cf9a; Phipps AI, 2011, CANCER CAUSE CONTROL, V22, P399, DOI 10.1007/s10552-010-9709-0; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Sahoo R, 2011, ONKOLOGIE, V34, P356, DOI 10.1159/000329595; Sapino A, 2014, ONCOLOGIST, V19, P1118, DOI 10.1634/theoncologist.2014-0195; Shah SS, 2009, DIAGN MOL PATHOL, V18, P30, DOI 10.1097/PDM.0b013e31817c1af8; Sneige N, 2006, MODERN PATHOL, V19, P622, DOI 10.1038/modpathol.3800571; Torrisi R, 2007, EUR J CANCER, V43, P2339, DOI 10.1016/j.ejca.2007.07.033; Vanden Bempt I, 2008, J CLIN ONCOL, V26, P4869, DOI 10.1200/JCO.2007.13.4296; Viale G, 2009, J PATHOL, V219, P1, DOI 10.1002/path.2593; Vranic S, 2011, CANCER-AM CANCER SOC, V117, P48, DOI 10.1002/cncr.25580; Wang SJ, 2002, MODERN PATHOL, V15, P137, DOI 10.1038/modpathol.3880505; Wolff AC, 2013, J CLIN ONCOL, V31, P3997, DOI 10.1200/JCO.2013.50.9984; Yeh IT, 2009, MODERN PATHOL, V22, P1169, DOI 10.1038/modpathol.2009.78	39	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132824	10.1371/journal.pone.0132824	http://dx.doi.org/10.1371/journal.pone.0132824			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161550	Green Published, gold, Green Submitted			2022-12-26	WOS:000358162300178
J	Pandey, SP; Singh, HK; Prasad, S				Pandey, Surya P.; Singh, Hemant K.; Prasad, S.			Alterations in Hippocampal Oxidative Stress, Expression of AMPA Receptor GluR2 Subunit and Associated Spatial Memory Loss by Bacopa monnieri Extract (CDRI-08) in Streptozotocin-Induced Diabetes Mellitus Type 2 Mice	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; FMR-1 GENE-EXPRESSION; SYNAPTIC PLASTICITY; INSULIN-RESISTANCE; COGNITIVE DYSFUNCTION; STANDARDIZED EXTRACT; CEREBRAL-CORTEX; EPILEPTIC RATS; NMDA RECEPTOR; BRAIN	Bacopa monnieri extract has been implicated in the recovery of memory impairments due to various neurological disorders in animal models and humans. However, the precise molecular mechanism of the role of CDRI-08, a well characterized fraction of Bacopa monnieri extract, in recovery of the diabetes mellitus-induced memory impairments is not known. Here, we demonstrate that DM2 mice treated orally with lower dose of CDRI-08 (50- or 100 mg/kg BW) is able to significantly enhance spatial memory in STZ-DM2 mice and this is correlated with a significant decline in oxidative stress and up regulation of the AMPA receptor GluR2 subunit gene expression in the hippocampus. Treatment of DM2 mice with its higher dose (150 mg/kg BW or above) shows anti-diabetic effect in addition to its ability to recover the spatial memory impairment by reversing the DM2-induced elevated oxidative stress and decreased GluR2 subunit expression near to their values in normal and CDRI-08 treated control mice. Our results provide evidences towards molecular basis of the memory enhancing and anti diabetic role of the Bacopa monnieri extract in STZ-induced DM2 mice, which may have therapeutic implications.	[Pandey, Surya P.; Prasad, S.] Banaras Hindu Univ, Ctr Adv Study Zool, Biochem & Mol Biol Lab, Varanasi 221005, Uttar Pradesh, India; [Singh, Hemant K.] Lumen Res Fdn, Chennai 600083, Tamil Nadu, India	Banaras Hindu University (BHU)	Prasad, S (corresponding author), Banaras Hindu Univ, Ctr Adv Study Zool, Biochem & Mol Biol Lab, Varanasi 221005, Uttar Pradesh, India.	s.sprasadbhu@gmail.com			CSIR Project, Govt. of India [37/1389/09/EMR-II]; BRNS Project, Govt. of India [2009/37/55/3298]; UGC-UPE; Faculty of Science, Banaras Hindu University; Lumen Research Foundation, Chennai, India	CSIR Project, Govt. of India; BRNS Project, Govt. of India; UGC-UPE(University Grants Commission, India); Faculty of Science, Banaras Hindu University; Lumen Research Foundation, Chennai, India	The authors acknowledge CSIR (37/1389/09/EMR-II), BRNS (2009/37/55/3298) Projects, Govt. of India, UGC-UPE, Faculty of Science, Banaras Hindu University and Lumen Research Foundation, Chennai, India for partial financial support.	Arulmozhi D. K., 2004, Indian Journal of Pharmacology, V36, P217; Ayala JE, 2010, DIS MODEL MECH, V3, P525, DOI 10.1242/dmm.006239; Azizi R, 2014, IRAN RED CRESCENT ME, V16, DOI 10.5812/ircmj.15424; Bhattacharya SK, 2000, PHYTOTHER RES, V14, P174, DOI 10.1002/(SICI)1099-1573(200005)14:3&lt;174::AID-PTR624&gt;3.0.CO;2-O; Biessels GJ, 2006, LANCET NEUROL, V5, P64, DOI 10.1016/S1474-4422(05)70284-2; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bober Ece, 2005, Pediatr Endocrinol Rev, V2, P378; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brill J, 2008, J NEUROSCI, V28, P13918, DOI 10.1523/JNEUROSCI.3229-08.2008; CANTENYS D, 1981, VIRCHOWS ARCH B, V35, P109; Castilho AF, 2014, MOL VIS, V20, P894; Chakravarty AK, 2003, CHEM PHARM BULL, V51, P215, DOI 10.1248/cpb.51.215; Channa S, 2006, J ETHNOPHARMACOL, V104, P286, DOI 10.1016/j.jep.2005.10.009; Chung SSM, 2003, J AM SOC NEPHROL, V14, pS233, DOI 10.1097/01.ASN.0000077408.15865.06; Das Sidhartha, 1999, Journal of Nutritional and Environmental Medicine (Abingdon), V9, P229, DOI 10.1080/13590849961645; de la Monte SM, 2009, BMB REP, V42, P475, DOI 10.5483/BMBRep.2009.42.8.475; Dingledine R, 1999, PHARMACOL REV, V51, P7; Duarte Ana I, 2012, J Aging Res, V2012, P384017, DOI 10.1155/2012/384017; Dulcy CP, 2012, J NEUROSCI RES, V90, P2053, DOI 10.1002/jnr.23080; Farimani AR, 2015, IRAN J MED SCI, V40, P248; FOLLI F, 1994, J NEUROSCI, V14, P6412; Gaur P, 2014, MOL BIOL REP, V41, P6855, DOI 10.1007/s11033-014-3571-1; Gautam A, 2013, NEUROBIOL LEARN MEM, V106, P177, DOI 10.1016/j.nlm.2013.08.009; Gispen WH, 2000, TRENDS NEUROSCI, V23, P542, DOI 10.1016/S0166-2236(00)01656-8; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Huber JD, 2006, AM J PHYSIOL-HEART C, V291, pH2660, DOI 10.1152/ajpheart.00489.2006; Isaac JTR, 2007, NEURON, V54, P859, DOI 10.1016/j.neuron.2007.06.001; Jayanarayanan S, 2013, CHEM-BIOL INTERACT, V201, P39, DOI 10.1016/j.cbi.2012.11.024; KAKKAR R, 1995, MOL CELL BIOCHEM, V151, P113, DOI 10.1007/BF01322333; Kapoor R, 2009, ENVIRON TOXICOL PHAR, V27, P62, DOI 10.1016/j.etap.2008.08.007; Khan R, 2008, EPILEPSY BEHAV, V12, P54, DOI 10.1016/j.yebeh.2007.09.021; Kim B, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2015.3; Kodl CT, 2008, ENDOCR REV, V29, P494, DOI 10.1210/er.2007-0034; Krishnakumar A, 2015, NEUROCHEM RES, V40, P216, DOI 10.1007/s11064-014-1472-2; Li ZG, 2002, BRAIN RES, V946, P221, DOI 10.1016/S0006-8993(02)02887-1; Liu XJ, 2013, PHARMACOL BIOCHEM BE, V110, P224, DOI 10.1016/j.pbb.2013.07.007; Luiken JJFP, 2002, AM J PHYSIOL-ENDOC M, V283, pE612, DOI 10.1152/ajpendo.00011.2002; Manschot SM, 2003, BRAIN RES, V966, P274, DOI 10.1016/S0006-8993(02)04211-7; Maritim AC, 2003, J BIOCHEM MOL TOXIC, V17, P24, DOI 10.1002/jbt.10058; Massaad CA, 2011, ANTIOXID REDOX SIGN, V14, P2013, DOI 10.1089/ars.2010.3208; Mathew J, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-25; Matsuda S, 2000, EMBO J, V19, P2765, DOI 10.1093/emboj/19.12.2765; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Mukherjee A, 2015, TRENDS MOL MED, V21, P439, DOI 10.1016/j.molmed.2015.04.005; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Piyabhan Pritsana, 2014, Journal of the Medical Association of Thailand, V97, pS50; Preethi J, 2014, CELL MOL NEUROBIOL, V34, P577, DOI 10.1007/s10571-014-0042-0; Rai R, 2015, EVIDENCE COMPLEMENTA; Rajan KE, 2015, EVIDENCE COMPLEMENTA; Rajan KE, 2011, NEUROCHEM RES, V36, P2136, DOI 10.1007/s11064-011-0538-7; Rajathei DM, 2014, NAT PRODUCT BIOPROSP, V4, P251, DOI 10.1007/s13659-014-0031-5; Rani A, 2015, EVIDENCE COMPLEMENTA; Rosen P, 2001, DIABETES-METAB RES, V17, P189, DOI 10.1002/dmrr.196; Russo A, 2005, PHYTOMEDICINE, V12, P305, DOI 10.1016/j.phymed.2003.12.008; Russo A, 2003, PHYTOTHER RES, V17, P870, DOI 10.1002/ptr.1061; Russo A, 2003, LIFE SCI, V73, P1517, DOI 10.1016/S0024-3205(03)00476-4; RYAN CM, 1993, J CLIN EXP NEUROPSYC, V15, P685, DOI 10.1080/01688639308402589; RYAN CM, 1993, DIABETOLOGIA, V36, P329, DOI 10.1007/BF00400236; Sabina EP, 2014, INT J PHARM PHARM SC, V11, P347; Sacai H, 2014, NEUROSCI RES, V81-82, P55, DOI 10.1016/j.neures.2014.02.002; Sairam K, 2001, PHYTOMEDICINE, V8, P423, DOI 10.1078/S0944-7113(04)70060-4; Schindler TH, 2006, J AM COLL CARDIOL, V47, P1188, DOI 10.1016/j.jacc.2005.10.062; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; SHANMUGASUNDARAM ERB, 1991, J ETHNOPHARMACOL, V33, P269, DOI 10.1016/0378-8741(91)90088-U; Sima AAF, 2004, EUR J PHARMACOL, V490, P187, DOI 10.1016/j.ejphar.2004.02.056; Singh HK, 2013, NUTRIENTS, V5, P478, DOI 10.3390/nu5020478; Singh HK, 1997, INDIAN J PHARM, V29, P359; Singh K, 2007, MOL BIOL REP, V34, P173, DOI 10.1007/s11033-006-9032-8; Singh R, 1980, J RES AYUR SIDDHA, V1, P148; Sivarajan V, 1994, AYURVEDIC DRUGS PLAN; Skovso S, 2014, J DIABETES INVEST, V5, P349, DOI 10.1111/jdi.12235; Soares E, 2013, NEUROSCIENCE, V250, P565, DOI 10.1016/j.neuroscience.2013.07.055; Stewart R, 1999, DIABETIC MED, V16, P93, DOI 10.1046/j.1464-5491.1999.00027.x; Sumathy T, 2002, FITOTERAPIA, V73, P381, DOI 10.1016/S0367-326X(02)00114-4; Trudeau F, 2004, EUR J PHARMACOL, V490, P177, DOI 10.1016/j.ejphar.2004.02.055; UA O, 2012, AM J MED MED SCI, V2, P45; Vaithianathan T, 2003, SOC NEUROSCI; van der Heide LP, 2006, PROG NEUROBIOL, V79, P205, DOI 10.1016/j.pneurobio.2006.06.003; Wan LK, 2011, NEUROMETHODS, V57, P13; Wang YB, 2015, EXP THER MED, V9, P451, DOI 10.3892/etm.2014.2090; Yoshikawa M, 2001, CHEM PHARM BULL, V49, P863, DOI 10.1248/cpb.49.863; Zhang YQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036675	84	28	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131862	10.1371/journal.pone.0131862	http://dx.doi.org/10.1371/journal.pone.0131862			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161865	Green Published, Green Submitted, gold			2022-12-26	WOS:000358162300067
J	Zhu, CC; Tang, B; Su, J; Zhao, H; Bu, X; Li, Z; Zhao, J; Gong, WD; Wu, ZQ; Yao, LB; Li, W; Zhang, YQ				Zhu, Chu-chao; Tang, Bin; Su, Jin; Zhao, Hu; Bu, Xin; Li, Zhen; Zhao, Jie; Gong, Wei-dong; Wu, Zhi-qun; Yao, Li-bo; Li, Wei; Zhang, Yuan-qiang			Abnormal Accumulation of Collagen Type I Due to the Loss of Discoidin Domain Receptor 2 (Ddr2) Promotes Testicular Interstitial Dysfunction	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX PROTEINS; RAT LEYDIG-CELLS; HUMAN TESTIS; VASECTOMY; SPERMATOGENESIS; MOUSE; IMPAIRMENT; EXPRESSION; FIBROSIS; GENE	Background Loss of functional allele for discoidin domain receptor 2 (Ddr2) results in impaired Leydig cell response to luteinizing hormone (LH), low testosterone production and arrested spermatogenesis in older male Ddr2(slie/slie) mice. However, the underlying mechanism responsible for this phenotype remains unknown. Herein, we reported for the first time that the deregulated expression of Ddr2 cognate ligand, namely collagen type I (COL1), may account for the disruption of the testicular steroidogenesis in Ddr2(slie/slie) mutant testes. Methodology/Principal Findings Expression of Ddr2 increased gradually along postnatal development, whereas COL1 expression became negligible from adulthood onwards. In Ddr2(slie/slie) mutant testis, however, in contrast to the undetectable staining of Ddr2, COL1 expression was constantly detected, with the highest values detected during adulthood. In the experimental vasectomy model, Ddr2(slie/slie) mutant mice exhibited an early androgen deficiency than wild-type mice, along with the accumulation of fibrotic tissue in the interstitium. Functionally, ablation of endogenous Ddr2 resulted in a significant decrease of testosterone (T) level in TM3 cells in the presence of higher concentration of COL1 treatment. Conversely, overexpression of Ddr2 could help TM3 cells to maintain a normal testicular steroidogenesis even in the presence of high concentration of COL1. Additionally, attenuated expression of Ddr2 correlates to the deregulated level of serum T levels in human pathological testes. Conclusions Abnormal accumulation of interstitial COL1 may be responsible for the steroidogenic dysfunction in Ddr2(slie/slie) mutant testes.	[Zhu, Chu-chao; Li, Zhen; Zhao, Jie; Li, Wei; Zhang, Yuan-qiang] Fourth Mil Med Univ, Dept Human Anat Histol & Embryol, Xian 710032, Peoples R China; [Tang, Bin] China Japan Friendship Hosp, Dept Int Med, Beijing 100029, Peoples R China; [Su, Jin; Zhao, Hu; Bu, Xin; Yao, Li-bo] Fourth Mil Med Univ, Dept Biochem & Mol Biol, State Key Lab Canc Biol, Xian 710032, Peoples R China; [Gong, Wei-dong; Wu, Zhi-qun] Fourth Mil Med Univ, Dept Intervent Radiol, Tangdu Hosp, Xian 710038, Peoples R China	Air Force Military Medical University; China-Japan Friendship Hospital; Air Force Military Medical University; Air Force Military Medical University	Yao, LB (corresponding author), Fourth Mil Med Univ, Dept Biochem & Mol Biol, State Key Lab Canc Biol, Xian 710032, Peoples R China.	bioyao@fmmu.edu.cn; liweipepeyato@163.com; zhangyq@fmmu.edu.cn	Su, Jin/H-9027-2016	Su, Jin/0000-0002-2134-4895	Natural Science Foundation of China [31371216, 31171154, 31271248]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by Natural Science Foundation of China (No. 31371216, 31171154 and 31271248). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anbalagan M, 2004, REPROD BIOMED ONLINE, V9, P391, DOI 10.1016/S1472-6483(10)61274-6; Belleannee C, 2013, HUM REPROD, V28, P1455, DOI 10.1093/humrep/det088; Biernacka A, 2011, GROWTH FACTORS, V29, P196, DOI 10.3109/08977194.2011.595714; Cheng JH, 2008, AM J PHYSIOL-GASTR L, V294, pG39, DOI 10.1152/ajpgi.00263.2007; Cook LA, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004112.pub4; Diaz ES, 2005, MOL REPROD DEV, V72, P208, DOI 10.1002/mrd.20259; Diaz ES, 2002, MOL REPROD DEV, V61, P493, DOI 10.1002/mrd.10111; Erdogru T, 2002, ANDROLOGIA, V34, P98, DOI 10.1046/j.0303-4569.2001.00482.x; Evaul K, 2008, J BIOL CHEM, V283, P27525, DOI 10.1074/jbc.M803867200; Fagundes AKF, 2014, THERIOGENOLOGY, V81, P230, DOI 10.1016/j.theriogenology.2013.09.013; Flynn LA, 2010, J MOL BIOL, V395, P533, DOI 10.1016/j.jmb.2009.10.073; Guittot SM, 2008, REPRODUCTION, V135, P479, DOI 10.1530/REP-07-0561; Gulkesen KH, 2002, ASIAN J ANDROL, V4, P55; Guo SJ, 2012, MED HYPOTHESES, V78, P536, DOI 10.1016/j.mehy.2012.01.029; JAROW JP, 1994, UROLOGY, V43, P521, DOI 10.1016/0090-4295(94)90246-1; Kano K, 2008, MOL ENDOCRINOL, V22, P1866, DOI 10.1210/me.2007-0310; Kano K, 2010, MOL REPROD DEV, V77, P29, DOI 10.1002/mrd.21093; Khosravi R, 2014, BONE, V58, P33, DOI 10.1016/j.bone.2013.10.001; Kumar PA, 2006, HUM REPROD, V21, P1033, DOI 10.1093/humrep/dei444; Lee NPY, 2004, HUM REPROD UPDATE, V10, P349, DOI 10.1093/humupd/dmh026; Li W, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.223; Lui WY, 2003, INT J ANDROL, V26, P147, DOI 10.1046/j.1365-2605.2003.00410.x; Margarucci L, 2011, MOL BIOSYST, V7, P2311, DOI 10.1039/c1mb05145h; Mountain DJH, 2013, J SURG RES, V184, P619, DOI 10.1016/j.jss.2013.05.070; Odet F, 2006, ENDOCRINOLOGY, V147, P4374, DOI 10.1210/en.2006-0484; Olaso E, 2001, J CLIN INVEST, V108, P1369, DOI 10.1172/JCI12373; Qu N, 2008, REPRODUCTION, V135, P859, DOI 10.1530/REP-08-0018; Raleigh D, 2004, FERTIL STERIL, V81, P1595, DOI 10.1016/j.fertnstert.2003.10.046; Ruiz PA, 2011, J BIOL CHEM, V286, P12912, DOI 10.1074/jbc.M110.143693; Shiraishi K, 2003, AKTUEL UROL, V34, P262; Shiraishi K, 2002, CONTRACEPTION, V65, P245, DOI 10.1016/S0010-7824(01)00311-0; Suarez-Quian CA, 1999, J CLIN ENDOCR METAB, V84, P350, DOI 10.1210/jc.84.1.350; Svechnikov K, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/684504; Vogel W, 1997, MOL CELL, V1, P13, DOI 10.1016/S1097-2765(00)80003-9; Xiang Y, 2013, ASIAN J ANDROL, V15, P434, DOI 10.1038/aja.2012.154; Yan R, 2009, ARCH BIOCHEM BIOPHYS, V485, P41, DOI 10.1016/j.abb.2009.02.014; Yu XZ, 2009, TOXICOL APPL PHARM, V239, P325, DOI 10.1016/j.taap.2009.06.014; Zhang S, 2013, REPRODUCTION, V145, P177, DOI 10.1530/REP-12-0336; Zhang S, 2012, J BIOL CHEM, V287, P40471, DOI 10.1074/jbc.M112.383802; Zhang Y, 2014, BBA-MOL BASIS DIS, V1842, P1350, DOI 10.1016/j.bbadis.2014.04.018; Zhang Y, 2011, J BONE MINER RES, V26, P604, DOI 10.1002/jbmr.225; Zhou LL, 2013, J AM SOC NEPHROL, V24, P771, DOI 10.1681/ASN.2012080865; Zhu CC, 2013, FERTIL STERIL, V99, P918, DOI 10.1016/j.fertnstert.2012.11.022	43	5	5	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2015	10	7							e0131947	10.1371/journal.pone.0131947	http://dx.doi.org/10.1371/journal.pone.0131947			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EW	26158267	gold, Green Published, Green Submitted			2022-12-26	WOS:000358161200042
J	Negro, E; D'Agata, F; Caroppo, P; Coriasco, M; Ferrio, F; Celeghin, A; Diano, M; Rubino, E; de Gelder, B; Rainero, I; Pinessi, L; Tamietto, M				Negro, Elisa; D'Agata, Federico; Caroppo, Paola; Coriasco, Mario; Ferrio, Federica; Celeghin, Alessia; Diano, Matteo; Rubino, Elisa; de Gelder, Beatrice; Rainero, Innocenzo; Pinessi, Lorenzo; Tamietto, Marco			Neurofunctional Signature of Hyperfamiliarity for Unknown Faces	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; HUMAN NEURAL SYSTEM; DELUSIONAL MISIDENTIFICATIONS; STATISTICAL-ANALYSES; PERSONALLY FAMILIAR; RECOGNITION; RECOLLECTION; PERCEPTION; REPRESENTATIONS; PROSOPAGNOSIA	Hyperfamiliarity for unknown faces is a rare selective disorder that consists of the disturbing and abnormal feeling of familiarity for unknown faces, while recognition of known faces is normal. In one such patient we investigated with a multimodal neuroimaging design the hitherto undescribed neural signature associated with hyperfamiliarity feelings. Behaviorally, signal detection methods revealed that the patient's discrimination sensitivity between familiar and unfamiliar faces was significantly lower than that of matched controls, and her response criterion for familiarity decisions was significantly more liberal. At the neural level, while morphometric analysis and single-photon emission CT (SPECT) showed the atrophy and hypofunctioning of the left temporal regions, functional magnetic resonance imaging (fMRI) revealed that hyperfamiliarity feelings were selectively associated to enhanced activity in the right medial and inferior temporal cortices. We therefore characterize the neurofunctional signature of hyperfamiliarity for unknown faces as related to the loss of coordinated activity between the complementary face processing functions of the left and right temporal lobes.	[Negro, Elisa; Rubino, Elisa; Rainero, Innocenzo; Pinessi, Lorenzo] Univ Turin, Dept Neurosci, Turin, Italy; [D'Agata, Federico; Caroppo, Paola; Coriasco, Mario; Ferrio, Federica] Univ Turin, Dept Neurosci, Neuroradiol, Turin, Italy; [Celeghin, Alessia; Diano, Matteo; Tamietto, Marco] Univ Turin, Dept Psychol, Turin, Italy; [Celeghin, Alessia; Tamietto, Marco] Tilburg Univ, Dept Med & Clin Psychol, NL-5000 LE Tilburg, Netherlands; [Celeghin, Alessia; Tamietto, Marco] Tilburg Univ, CoRPS Ctr Res Psychol Somat Dis, NL-5000 LE Tilburg, Netherlands; [de Gelder, Beatrice] Maastricht Univ, Dept Cognit Neurosci, Maastricht, Netherlands; [Tamietto, Marco] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England	University of Turin; University of Turin; University of Turin; Tilburg University; Tilburg University; Maastricht University; University of Oxford	Tamietto, M (corresponding author), Univ Turin, Dept Psychol, Turin, Italy.	marco.tamietto@unito.it	Caroppo, Paola/J-5044-2018; D'Agata, Federico/ABG-8839-2021; Diano, Matteo/U-4333-2017; Rubino, Elisa/K-3282-2016	Caroppo, Paola/0000-0003-4274-9004; D'Agata, Federico/0000-0001-9432-0248; Diano, Matteo/0000-0001-7024-5183; Rubino, Elisa/0000-0002-7553-7553; Celeghin, Alessia/0000-0002-4624-3564; Tamietto, Marco/0000-0002-8815-8499; Coriasco, Mario/0000-0001-9000-7473	Netherlands Organization for Scientific Research (NWO) [452-11-015]; Italian Ministry of Education University and Research (MIUR) [RBFR12F0BD]; Advanced ERC grant from the EU	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Italian Ministry of Education University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); Advanced ERC grant from the EU	MT is supported by a Vidi grant from the Netherlands Organization for Scientific Research (NWO) (grant 452-11-015) and by a FIRB-Futuro in Ricerca 2012-grant from the Italian Ministry of Education University and Research (MIUR) (grant RBFR12F0BD). BdG is supported by an Advanced ERC grant from the EU-FP7.	Amlerova J, 2012, EPILEPSY BEHAV, V24, P332, DOI 10.1016/j.yebeh.2012.04.116; [Anonymous], 1994, ASSESSMENT CLIN MANU; Bowles B, 2007, P NATL ACAD SCI USA, V104, P16382, DOI 10.1073/pnas.0705273104; Bujarski K, 2008, EPILEPSY BEHAV, V13, P567, DOI 10.1016/j.yebeh.2008.06.003; Burra N, 2013, J NEUROSCI, V33, P10483, DOI 10.1523/JNEUROSCI.3994-12.2013; Corsi AT, 1972, HUMAN MEMORY MEDIAL; Crawford JR, 1998, CLIN NEUROPSYCHOL, V12, P482, DOI 10.1076/clin.12.4.482.7241; DERENZI E, 1991, CORTEX, V27, P213, DOI 10.1016/S0010-9452(13)80125-6; DERENZI E, 1962, BRAIN, V85, P665, DOI 10.1093/brain/85.4.665; Devinsky O, 2010, NEUROLOGY, V74, P970, DOI 10.1212/WNL.0b013e3181d5dc22; Devinsky O, 2009, NEUROLOGY, V72, P80, DOI 10.1212/01.wnl.0000338625.47892.74; Diana RA, 2007, TRENDS COGN SCI, V11, P379, DOI 10.1016/j.tics.2007.08.001; Dubois B, 2000, NEUROLOGY, V55, P1621, DOI 10.1212/WNL.55.11.1621; Dubois S, 1999, NEUROIMAGE, V9, P278, DOI 10.1006/nimg.1998.0409; ELLIS HD, 1990, BRIT J PSYCHIAT, V157, P239, DOI 10.1192/bjp.157.2.239; Evans S, 2007, SPATIAL VISION, V20, P61, DOI 10.1163/156856807779369742; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gainotti G, 2008, CORTEX, V44, P238, DOI 10.1016/j.cortex.2006.09.001; Gainotti G, 2007, BRAIN RES REV, V56, P214, DOI 10.1016/j.brainresrev.2007.07.009; Gobbini MI, 2007, NEUROPSYCHOLOGIA, V45, P32, DOI 10.1016/j.neuropsychologia.2006.04.015; Gobbini MI, 2004, NEUROIMAGE, V22, P1628, DOI 10.1016/j.neuroimage.2004.03.049; Green DM, 1966, SIGNAL DETECTION THE; Grill-Spector K, 2014, NAT REV NEUROSCI, V15, P536, DOI 10.1038/nrn3747; Handwerker DA, 2004, NEUROIMAGE, V21, P1639, DOI 10.1016/j.neuroimage.2003.11.029; Harvey LO, 2010, RSCOREPLUS; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Hoffman EA, 2000, NAT NEUROSCI, V3, P80, DOI 10.1038/71152; Julian JB, 2012, NEUROIMAGE, V60, P2357, DOI 10.1016/j.neuroimage.2012.02.055; Kosaka H, 2003, NEUROIMAGE, V20, P1734, DOI 10.1016/S1053-8119(03)00447-6; Kovalev VA, 2006, LECT NOTES COMPUT SC, V4191, P421; KRAEPELIN E, 1887, ARCH PSYCHIAT NERVEN, V18, P199; Lee TMC, 2002, EPILEPSIA, V43, P283, DOI 10.1046/j.1528-1157.2002.09901.x; Leveroni CL, 2000, J NEUROSCI, V20, P878, DOI 10.1523/JNEUROSCI.20-02-00878.2000; Michelucci R, 2010, EPILEPSY BEHAV, V19, P518, DOI 10.1016/j.yebeh.2010.08.008; NOVELLI G, 1986, Archivio di Psicologia Neurologia e Psichiatria, V47, P477; Ohta Y, 2008, ANN NUCL MED, V22, P495, DOI 10.1007/s12149-008-0140-5; Rey A., 1958, LEXAMEN CLINIQUE PSY; Roberts DJ, 2015, CORTEX J DEVOTED STU, DOI [10.1016/j.cortex.2015.02.003, DOI 10.1016/J.CORTEX.2015.02.003]; Rossion B, 2001, J COGNITIVE NEUROSCI, V13, P1019, DOI 10.1162/089892901753165917; Shah NJ, 2001, BRAIN, V124, P804, DOI 10.1093/brain/124.4.804; Spinnler H, 1987, ITALIAN J NEUROLOGIC, V8, P539; Street R. F., 1931, GESTALT COMPLETION T; Sugiura M, 2011, J COGNITIVE NEUROSCI, V23, P699, DOI 10.1162/jocn.2010.21469; Sugiura M, 2009, J COGNITIVE NEUROSCI, V21, P1855, DOI 10.1162/jocn.2008.21150; Tamietto M, 2005, NEUROCASE, V11, P399, DOI 10.1080/13554790500259717; Tamietto M, 2007, J COGNITIVE NEUROSCI, V19, P445, DOI 10.1162/jocn.2007.19.3.445; Taylor MJ, 2009, HUM BRAIN MAPP, V30, P2008, DOI 10.1002/hbm.20646; Todorov A, 2013, CURR OPIN NEUROBIOL, V23, P373, DOI 10.1016/j.conb.2012.12.010; TUOKKO H, 1992, J AM GERIATR SOC, V40, P579, DOI 10.1111/j.1532-5415.1992.tb02106.x; Van den Stock J, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00030; Van den Stock J, 2013, J NEUROPSYCH CLIN N, V25, pE52, DOI 10.1176/appi.neuropsych.12120390; Vuilleumier P, 2003, BRAIN, V126, P889, DOI 10.1093/brain/awg086; Wechsler D, 1987, WMS R WECHSLER MEMOR; Yonelinas AP, 2002, NAT NEUROSCI, V5, P1236, DOI 10.1038/nn961	54	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0129970	10.1371/journal.pone.0129970	http://dx.doi.org/10.1371/journal.pone.0129970			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154253	Green Published, gold, Green Submitted			2022-12-26	WOS:000358159700019
J	Todaro, MA; Dal Zotto, M; Leasi, F				Todaro, M. Antonio; Dal Zotto, Matteo; Leasi, Francesca			An Integrated Morphological and Molecular Approach to the Description and Systematisation of a Novel Genus and Species of Macrodasyida (Gastrotricha)	PLOS ONE			English	Article							ITALIAN MARINE GASTROTRICHA; NERVOUS-SYSTEM; DACTYLOPODOLA-BALTICA; MEDITERRANEAN SEA; MUSCULAR SYSTEM; CHAETONOTIDA; PHYLOGENY; FRESH; THAUMASTODERMATIDAE; KEY	Background Gastrotricha systematics is in a state of flux mainly due to the conflicts between cladistic studies base on molecular markers and the classical systematisation based on morphological traits. In sandy samples from Thailand, we found numerous macrodasyidan gastrotrichs belonging to an undescribed species of difficult taxonomic affiliation. The abundance and original nature of the specimens prompted us to undertake a deep survey of both morphological and molecular traits aiming at a reliable systematisation of the new taxon. Methodology/Principal Findings Using several microscopical techniques we investigated the external and internal anatomy, including the muscular and nervous systems of the new species. Additional specimens were used to obtain the 18S rRNA gene sequence; molecular data was analysed cladistically in conjunction with data from additional species belonging to the near complete Macrodasyida taxonomic spectrum. Specimens are vermiform, up to 806 mu m in total length, and show a well-defined head equipped with peculiar leaf-like sensorial organs and a single-lobed posterior end. The adhesive apparatus includes anterior, ventrolateral, dorsal and posterior tubes. Pharynx is about 1/4 of the total length and shows pores at its posterior 3/4. Adult specimens exhibit maturing eggs and a bulky, muscular caudal organ, but do not show sperm nor the frontal organ. Musculature and nervous system organisation resemble the usual macrodasyidan plan; however, the somatic circular muscles of the intestinal region surround all other muscular components and a third FMRFamide-IR commissure ventral to the pharyngo-intestinal junction appear to be an autoapomorphic traits of the new species. Conclusions/Significance While the anatomical characteristics of the Asian specimens appear so unique to grant the establishment of a new taxon, for which the name Thaidasys tongiorgii gen. et sp. nov. is proposed, the result of phylogenetic analyses based on the 18S rRNA gene unites the new genus with the family Macrodasyidae.	[Todaro, M. Antonio; Dal Zotto, Matteo] Univ Modena & Reggio Emilia, Dept Life Sci, Modena, Italy; [Dal Zotto, Matteo] Consorzio Interuniv Ctr Biol Marina & Ecol Applic, Livorno, Italy; [Leasi, Francesca] Smithsonian Inst, Natl Museum Nat Hist, Washington, DC 20560 USA	Universita di Modena e Reggio Emilia; Smithsonian Institution; Smithsonian National Museum of Natural History	Todaro, MA (corresponding author), Univ Modena & Reggio Emilia, Dept Life Sci, Modena, Italy.	antonio.todaro@unimore.it	Leasi, Francesca/E-4361-2017; Todaro, M. Antonio/H-1311-2013	Leasi, Francesca/0000-0001-6995-0934; Todaro, M. Antonio/0000-0002-6353-7281; Dal Zotto, Matteo/0000-0003-1386-7626	TIOME project (MAT, PI)	TIOME project (MAT, PI)	Funding for this research was provided by the TIOME project (MAT, PI); the study falls within the framework of the strategic research line Environment, food and health (WP2) - of UNIMORE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Todaro MA, 2013, ZOOKEYS, P77, DOI 10.3897/zookeys.315.5593; Appeltans W, 2012, CURR BIOL, V22, P2189, DOI 10.1016/j.cub.2012.09.036; Araujo TQ, 2014, MAR BIODIVERS, V44, P243, DOI 10.1007/s12526-013-0196-x; Atherton S, 2014, MAR BIOL RES, V10, P530, DOI 10.1080/17451000.2013.831179; Gilsa AVUZ, 2014, CAH BIOL MAR, V55, P333; Giribet G, 2004, CLADISTICS, V20, P1, DOI 10.1111/j.1096-0031.2004.00004.x; Guidi L., 2014, CONTRIBUTION ZOOLOGY, V83, P121; Hochberg R, 2005, MAR BIOL, V146, P315, DOI 10.1007/s00227-004-1437-0; Hochberg R, 2000, BIOL BULL, V198, P299, DOI 10.2307/1542532; Hochberg R, 2003, ACTA ZOOL-STOCKHOLM, V84, P171, DOI 10.1046/j.1463-6395.2003.00144.x; Hochberg R, 2001, ZOOL SCR, V30, P325, DOI 10.1046/j.1463-6409.2001.00066.x; Hochberg R, 2007, ZOOMORPHOLOGY, V126, P245, DOI 10.1007/s00435-007-0044-2; Hochberg R, 2014, MAR BIODIVERS, V44, P237, DOI 10.1007/s12526-013-0165-4; Hochberg R, 2014, MAR BIODIVERS, V44, P89, DOI 10.1007/s12526-013-0186-z; Hochberg R, 2013, ZOOKEYS, P1, DOI 10.3897/zookeys.289.4764; Hochberg R, 2011, ZOOL ANZ, V250, P111, DOI 10.1016/j.jcz.2010.12.002; HUMMON WD, 1992, B ZOOL, V59, P499, DOI 10.1080/11250009209386711; HUMMON WD, 1993, B ZOOL, V60, P109, DOI 10.1080/11250009309355798; Hummon WD, 2010, ZOOTAXA, P1; Kanneby T, 2014, MAR BIOL RES, V10, P983, DOI 10.1080/17451000.2013.872797; Kanneby T, 2013, ZOOTAXA, V3701, P551, DOI 10.11646/zootaxa.3701.5.3; Kanneby T, 2013, ZOOL SCR, V42, P88, DOI 10.1111/j.1463-6409.2012.00558.x; Kieneke A, 2014, HDB ZOOLOGY, V3, P1; Kieneke A, 2008, ZOOL SCR, V37, P429, DOI 10.1111/j.1463-6409.2008.00334.x; Kieneke Alexander, 2013, Meiofauna Marina, V20, P49; Kolicka M, 2013, ZOOTAXA, V3717, P231; Leasi F, 2008, BIOL J LINN SOC, V94, P379, DOI 10.1111/j.1095-8312.2008.00974.x; Leasi F, 2009, ZOOL ANZ, V248, P47, DOI 10.1016/j.jcz.2008.10.002; Leasi F, 2009, MAR BIOL, V156, P1335, DOI 10.1007/s00227-009-1175-4; Lee Jimin, 2014, Animal Systematics Evolution and Diversity, V30, DOI 10.5635/ASED.2014.30.2.103; Lee J, 2014, P BIOL SOC WASH, V127, P209, DOI 10.2988/0006-324X-127.1.209; Lee JM, 2013, ZOOTAXA, V3709, P483; Liesenjohann T, 2006, J MORPHOL, V267, P897, DOI 10.1002/jmor.10419; Nylander J.A.A., 2004, MRMODELTEST V2 PROGR; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Petrov NB, 2007, MOL BIOL+, V41, P445, DOI 10.1134/S0026893307030107; Remane A., 1936, Bolk Handbuch der Vergleichenden Anatomie der Wirbeltiere Wien, V4, P1; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rothe BH, 2011, ZOOMORPHOLOGY, V130, P51, DOI 10.1007/s00435-011-0123-2; Rothe Birgen H., 2010, Meiofauna Marina, V18, P49; Rothe BH, 2009, ZOOMORPHOLOGY, V128, P227, DOI 10.1007/s00435-008-0077-1; Rothe Birgen H., 2008, Meiofauna Marina, V16, P175; Ruppert E.E., 1991, P41; RUPPERT EE, 1978, ZOOMORPHOLOGIE, V89, P207, DOI 10.1007/BF00993948; Schmidt-Rhaesa A, 2014, DEEP METAZOAN PHYLOGENY: THE BACKBONE OF THE TREE OF LIFE, P93; Schwank P, 2014, ZOOTAXA, V3811, P463, DOI 10.11646/zootaxa.3811.4.3; SEWARDTHOMPSON BL, 1973, SEDIMENTOLOGY, V20, P161, DOI 10.1111/j.1365-3091.1973.tb01612.x; Sorensen MV, 2006, CLADISTICS, V22, P32, DOI 10.1111/j.1096-0031.2006.00085.x; Staden R, 1996, MOL BIOTECHNOL, V5, P233, DOI 10.1007/BF02900361; Suzuki TG, 2013, ZOOTAXA, V3691, P229, DOI 10.11646/zootaxa.3691.2.3; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Todaro MA, 2006, J MAR BIOL ASSOC UK, V86, P1005, DOI 10.1017/S0025315406013981; Todaro M. A., 2015, WORLD REGISTER MARIN; Todaro MA, 2006, ZOOL SCR, V35, P251, DOI 10.1111/j.1463-6409.2006.00228.x; Todaro MA, 2006, MAR BIOL, V149, P1079, DOI 10.1007/s00227-006-0299-z; Todaro MA, 2015, ZOOTAXA, V3905, P193, DOI 10.11646/zootaxa.3905.2.2; Todaro MA, 2014, SYST BIODIVERS, V12, P473, DOI 10.1080/14772000.2014.942718; Todaro M. Antonio, 2013, Meiofauna Marina, V20, P33; Todaro MA, 2013, ZOOKEYS, P13, DOI 10.3897/zookeys.289.4683; Todaro MA, 2012, ZOOMORPHOLOGY, V131, P115, DOI 10.1007/s00435-012-0147-2; Todaro MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031740; Todaro MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017892; Todaro M. Antonio, 2008, Meiofauna Marina, V16, P3; Todaro MA, 2002, J MAR BIOL ASSOC UK, V82, P555, DOI 10.1017/S0025315402005878; Todaro MA, 2015, GASTROTRICHA WORLD P	65	30	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0130278	10.1371/journal.pone.0130278	http://dx.doi.org/10.1371/journal.pone.0130278			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26153694	Green Published, gold			2022-12-26	WOS:000358159700027
J	Wittig, C; Scheuer, C; Parakenings, J; Menger, MD; Laschke, MW				Wittig, Christine; Scheuer, Claudia; Parakenings, Julia; Menger, Michael D.; Laschke, Matthias W.			Geraniol Suppresses Angiogenesis by Downregulating Vascular Endothelial Growth Factor (VEGF)/VEGFR-2 Signaling	PLOS ONE			English	Article							IN-VITRO; CHEMOPREVENTIVE EFFICACY; 4-HYDROXYBENZYL ALCOHOL; TUMOR ANGIOGENESIS; CELL-MIGRATION; ESSENTIAL OILS; CANCER CELLS; HOST TISSUE; LINE; CARCINOGENESIS	Geraniol exerts several direct pharmacological effects on tumor cells and, thus, has been suggested as a promising anti-cancer compound. Because vascularization is a major precondition for tumor growth, we analyzed in this study the anti-angiogenic action of geraniol. In vitro, geraniol reduced the migratory activity of endothelial-like eEND2 cells. Western blot analyses further revealed that geraniol downregulates proliferating cell nuclear antigen (PCNA) and upregulates cleaved caspase-3 (Casp-3) expression in eEND2 cells. Moreover, geraniol blocked vascular endothelial growth factor (VEGF)/VEGFR-2 signal transduction, resulting in a suppression of downstream AKT and ERK signaling pathways. In addition, geraniol significantly reduced vascular sprout formation in a rat aortic ring assay. In vivo, geraniol inhibited the vascularization of CT26 tumors in dorsal skinfold chambers of BALB/c mice, which was associated with a smaller tumor size when compared to vehicle-treated controls. Immunohistochemical analyses confirmed a decreased number of Ki67-positive cells and CD31-positive microvessels with reduced VEGFR-2 expression within geraniol-treated tumors. Taken together, these findings indicate that geraniol targets multiple angiogenic mechanisms and, therefore, is an attractive candidate for the anti-angiogenic treatment of tumors.	[Wittig, Christine; Scheuer, Claudia; Parakenings, Julia; Menger, Michael D.; Laschke, Matthias W.] Univ Saarland, Inst Clin & Expt Surg, Homburg, Germany	Saarland University	Laschke, MW (corresponding author), Univ Saarland, Inst Clin & Expt Surg, Homburg, Germany.	matthias.laschke@uks.eu						Ahmad ST, 2011, TOXICOLOGY, V290, P69, DOI 10.1016/j.tox.2011.08.020; Araujo FA, 2010, BIOMED PHARMACOTHER, V64, P29, DOI 10.1016/j.biopha.2009.03.003; Auerbach R, 2003, CLIN CHEM, V49, P32, DOI 10.1373/49.1.32; BAKER M, 1974, MICROVASC RES, V7, P131, DOI 10.1016/0026-2862(74)90043-0; Besser D, 1995, ONCOGENE, V11, P2383; Carnesecchi S, 2004, CANCER LETT, V215, P53, DOI 10.1016/j.canlet.2004.06.019; Chaudhary SC, 2013, J APPL TOXICOL, V33, P828, DOI 10.1002/jat.2739; Claesson-Welsh L, 2013, J INTERN MED, V273, P114, DOI 10.1111/joim.12019; De Vriese AS, 2000, J VASC RES, V37, P26, DOI 10.1159/000025710; Ehrmantraut S, 2010, EUR CELLS MATER, V19, P107, DOI 10.22203/eCM.v019a11; Feng Chong, 2006, Semin Ophthalmol, V21, P29, DOI 10.1080/08820530500509382; Folkman J, 2002, SEMIN ONCOL, V29, P15, DOI 10.1053/sonc.2002.37263; Galle M, 2014, NUTR CANC, V29, P1; GRISWOLD DP, 1975, CANCER, V36, P2441, DOI 10.1002/1097-0142(197512)36:6<2441::AID-CNCR2820360627>3.0.CO;2-P; Gu Y, 2013, ANTI-CANCER DRUG, V24, P781, DOI 10.1097/CAD.0b013e328362fb84; Jin XX, 2013, J INT MED RES, V41, P993, DOI 10.1177/0300060513480919; Katsukawa M, 2011, BIOSCI BIOTECH BIOCH, V75, P1010, DOI 10.1271/bbb.110039; Khan AQ, 2013, EXP MOL PATHOL, V94, P419, DOI 10.1016/j.yexmp.2013.01.006; Kim SH, 2012, INT J ONCOL, V40, P1683, DOI 10.3892/ijo.2011.1318; Kim SH, 2011, BIOCHEM BIOPH RES CO, V407, P129, DOI 10.1016/j.bbrc.2011.02.124; Koch S, 2011, BIOCHEM J, V437, P169, DOI 10.1042/BJ20110301; Kollmar O, 2007, NEOPLASIA, V9, P862, DOI 10.1593/neo.07559; Laschke MW, 2013, ACTA BIOMATER, V9, P6876, DOI 10.1016/j.actbio.2013.02.013; Laschke MW, 2011, EUR CELLS MATER, V22, P147, DOI 10.22203/eCM.v022a12; Laschke MW, 2011, BRIT J PHARMACOL, V163, P835, DOI 10.1111/j.1476-5381.2011.01292.x; Laschke MW, 2013, LIFE SCI, V93, P44, DOI 10.1016/j.lfs.2013.05.022; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lauro S, 2014, ANTICANCER RES, V34, P1537; Madankumar A, 2013, EUR J PHARMACOL, V705, P148, DOI 10.1016/j.ejphar.2013.02.048; Manoharan S, 2012, J ENVIRON BIOL, V33, P255; Marcuzzi A, 2011, IN VIVO, V25, P87; Marques I, 2013, WORLD J GASTROENTERO, V19, P7955, DOI 10.3748/wjg.v19.i44.7955; de Carvalho KIM, 2014, N-S ARCH PHARMACOL, V387, P355, DOI 10.1007/s00210-013-0947-z; Nenicu A, 2014, HUM REPROD, V29, P1011, DOI 10.1093/humrep/deu035; NICOSIA RF, 1995, LAB INVEST, V73, P658; Ong TP, 2012, CURR CANCER DRUG TAR, V12, P1173; Polo MP, 2011, CELL BIOCHEM FUNCT, V29, P452, DOI 10.1002/cbf.1772; RAK JW, 1995, ANTI-CANCER DRUG, V6, P3, DOI 10.1097/00001813-199502000-00001; Sagar S M, 2006, Curr Oncol, V13, P14; Saif Muhammad Wasif, 2013, Cancer Manag Res, V5, P103, DOI 10.2147/CMAR.S45193; Schmidt E, 2012, NAT PROD COMMUN, V7, P1095; Tsai ML, 2011, BIOSCI BIOTECH BIOCH, V75, P1977, DOI 10.1271/bbb.110377; Unger RE, 2002, MICROVASC RES, V64, P384, DOI 10.1006/mvre.2002.2434; Vinothkumar V, 2012, MOL CELL BIOCHEM, V369, P17, DOI 10.1007/s11010-012-1364-1; Vinothkumar V, 2011, REDOX REP, V16, P91, DOI 10.1179/174329211X13020951739839; Walser R, 2013, EUR CELLS MATER, V26, P222, DOI 10.22203/eCM.v026a16; Wiseman DA, 2007, J PHARMACOL EXP THER, V320, P1163, DOI 10.1124/jpet.106.111666; YU SG, 1995, J NUTR, V125, P2763; Zhang F, 2014, J CELL MOL MED, V18, P1392, DOI 10.1111/jcmm.12286	49	32	34	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0131946	10.1371/journal.pone.0131946	http://dx.doi.org/10.1371/journal.pone.0131946			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154255	Green Published, gold, Green Submitted			2022-12-26	WOS:000358159700084
J	Menoret, M; Bourguignon, M; Hari, R				Menoret, Mathilde; Bourguignon, Mathieu; Hari, Riitta			Modulation of Rolandic Beta-Band Oscillations during Motor Simulation of Joint Actions	PLOS ONE			English	Article							FUNCTIONAL-ORGANIZATION; NEURAL SIMULATION; INFERIOR AREA-6; MACAQUE MONKEY; MIRROR-IMAGE; REPRESENTATION; CORTEX; IMITATION; PREMOTOR; TASK	Successful joint actions require precise temporal and spatial coordination between individuals who aim to achieve a common goal. A growing number of behavioral data suggest that to efficiently couple and coordinate a joint task, the actors have to represent both own and the partner's actions. However it is unclear how the motor system is specifically recruited for joint actions. To find out how the goal and the presence of the partner's hand can impact the motor activity during joint action, we assessed the functional state of 16 participants' motor cortex during observation and associated motor imagery of joint actions, individual actions, and non-goal-directed actions performed with either 1 or 2 hands. As an indicator of the functional state of the motor cortex, we used the reactivity of the rolandic magnetoencephalographic (MEG) beta rhythm following median-nerve stimulation. Motor imagery combined with action observation was associated with activation of the observer's motor cortex, mainly in the hemisphere contralateral to the viewed (and at the same time imagined) hand actions. The motor-cortex involvement was enhanced when the goal of the actions was visible but also, in the ipsilateral hemisphere, when the partner's hand was visible in the display. During joint action, the partner's action, in addition to the participant's own action, thus seems to be represented in the motor cortex so that it can be triggered by the mere presence of an acting hand in the peripersonal space.	[Menoret, Mathilde; Bourguignon, Mathieu; Hari, Riitta] Aalto Univ, Dept Neurosci & Biomed Engn, Brain Res Unit, Aalto, Finland; [Menoret, Mathilde] CNRS UCBL, UMR5304, Lab Langage Cerveau & Cognit L2C2, Lyon, France; [Menoret, Mathilde; Bourguignon, Mathieu; Hari, Riitta] Aalto Univ, Aalto NeuroImaging, MEG Core, Aalto, Finland	Aalto University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Aalto University	Menoret, M (corresponding author), Aalto Univ, Dept Neurosci & Biomed Engn, Brain Res Unit, Aalto, Finland.	menoret@neuro.hut.fi	Bourguignon, Mathieu/I-6967-2012; Hari, Riitta K/J-1880-2012	Bourguignon, Mathieu/0000-0003-1694-5087; Hari, Riitta K/0000-0002-3142-2703; Menoret, Mathilde/0000-0002-9431-4339	Direction Generale de l'Armement (DGA); Academy of Finland [131483, 263800]; European Research Council [232946]	Direction Generale de l'Armement (DGA)(General Electric); Academy of Finland(Academy of Finland); European Research Council(European Research Council (ERC)European Commission)	This study was supported by a postdoctoral grant from the Direction Generale de l'Armement (DGA) and funding from Academy of Finland (Grants #131483, #263800), and European Research Council (Advanced Grant #232946). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avikainen S, 2003, CURR BIOL, V13, P339, DOI 10.1016/S0960-9822(03)00087-3; Aziz-Zadeh L, 2006, J NEUROSCI, V26, P2964, DOI 10.1523/JNEUROSCI.2921-05.2006; Bekkering H, 2009, TOP COGN SCI, V1, P340, DOI 10.1111/j.1756-8765.2009.01023.x; Blomberg O, 2011, REV PHILOS PSYCHOL, V2, P335, DOI 10.1007/s13164-011-0054-3; Brozzoli C, 2014, NEUROSCIENTIST, V20, P122, DOI 10.1177/1073858413511153; Buccino G, 2001, EUR J NEUROSCI, V13, P400, DOI 10.1046/j.1460-9568.2001.01385.x; Butterfill SA, 2011, REV PHILOS PSYCHOL, V2, P137, DOI 10.1007/s13164-011-0062-3; Caetano G, 2007, P NATL ACAD SCI USA, V104, P9058, DOI 10.1073/pnas.0702453104; Cattaneo L, 2009, J NEUROSCI, V29, P11134, DOI 10.1523/JNEUROSCI.2605-09.2009; Chiavarino C, 2007, NEUROPSYCHOLOGIA, V45, P784, DOI 10.1016/j.neuropsychologia.2006.08.007; de Bruijn ERA, 2008, CORTEX, V44, P580, DOI 10.1016/j.cortex.2007.09.003; de Vignemont F, 2014, NEUROPSYCHOLOGIA, V55, P128, DOI 10.1016/j.neuropsychologia.2013.08.013; Engel AK, 2010, CURR OPIN NEUROBIOL, V20, P156, DOI 10.1016/j.conb.2010.02.015; GENTILUCCI M, 1988, EXP BRAIN RES, V71, P475, DOI 10.1007/BF00248741; Gerloff C, 1998, BRAIN, V121, P1695, DOI 10.1093/brain/121.9.1695; Gilbert M, 2009, PHILOS STUD, V144, P167, DOI 10.1007/s11098-009-9372-z; HAMALAINEN M, 1993, REV MOD PHYS, V65, P413, DOI 10.1103/RevModPhys.65.413; Hari R, 1998, P NATL ACAD SCI USA, V95, P15061, DOI 10.1073/pnas.95.25.15061; Hari R, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0171; ISHIKURA T, 1995, PERCEPT MOTOR SKILL, V80, P651, DOI 10.2466/pms.1995.80.2.651; Jarvelainen J, 2004, NEUROIMAGE, V23, P187, DOI 10.1016/j.neuroimage.2004.06.010; Jeannerod M, 2001, NEUROIMAGE, V14, pS103, DOI 10.1006/nimg.2001.0832; Keller PE, 2007, CONSCIOUS COGN, V16, P102, DOI 10.1016/j.concog.2005.12.004; Kilner JM, 2006, SOC COGN AFFECT NEUR, V1, P143, DOI 10.1093/scan/nsl017; Knoblich G, 2011, PSYCHOL LEARN MOTIV, V54, P59, DOI 10.1016/B978-0-12-385527-5.00003-6; Koski L, 2003, J NEUROPHYSIOL, V89, P460, DOI 10.1152/jn.00248.2002; Koski L, 2002, CEREB CORTEX, V12, P847, DOI 10.1093/cercor/12.8.847; Kourtis D, 2014, J COGNITIVE NEUROSCI, V26, P2275, DOI 10.1162/jocn_a_00634; Kourtis D, 2013, NEUROPSYCHOLOGIA, V51, P1240, DOI 10.1016/j.neuropsychologia.2013.04.001; Lorey B, 2014, HUM BRAIN MAPP, V35, P1212, DOI 10.1002/hbm.22246; Menoret M, 2014, NEUROPSYCHOLOGIA, V55, P85, DOI 10.1016/j.neuropsychologia.2013.10.001; Mukamel R, 2010, CURR BIOL, V20, P750, DOI 10.1016/j.cub.2010.02.045; Muthukumaraswamy SD, 2004, COGNITIVE BRAIN RES, V19, P195, DOI 10.1016/j.cogbrainres.2003.12.001; Newman-Norlund RD, 2008, NEUROIMAGE, V41, P169, DOI 10.1016/j.neuroimage.2008.02.026; Newman-Norlund RD, 2007, NAT NEUROSCI, V10, P817, DOI 10.1038/nn1911; Nishitani N, 2000, P NATL ACAD SCI USA, V97, P913, DOI 10.1073/pnas.97.2.913; Novembre G, 2014, SOC COGN AFFECT NEUR, V9, P1062, DOI 10.1093/scan/nst086; Ocampo B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026945; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Pacherie E, 2011, REV PHILOS PSYCHOL, V2, P173, DOI 10.1007/s13164-011-0052-5; Pezzulo G, 2011, REV PHILOS PSYCHOL, V2, P303, DOI 10.1007/s13164-011-0060-5; Pogosyan A, 2009, CURR BIOL, V19, P1637, DOI 10.1016/j.cub.2009.07.074; RIZZOLATTI G, 1988, EXP BRAIN RES, V71, P491, DOI 10.1007/BF00248742; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rizzolatti G, 2010, NAT REV NEUROSCI, V11, P264, DOI 10.1038/nrn2805; SALMELIN R, 1994, NEUROSCIENCE, V60, P537, DOI 10.1016/0306-4522(94)90263-1; Sartori L, 2012, SOC NEUROSCI-UK, V7, P146, DOI 10.1080/17470919.2011.586579; Schnitzler A, 1997, NEUROIMAGE, V6, P201, DOI 10.1006/nimg.1997.0286; Schuch S, 2010, EXP BRAIN RES, V205, P235, DOI 10.1007/s00221-010-2358-4; Sebanz N, 2006, J COGNITIVE NEUROSCI, V18, P859, DOI 10.1162/jocn.2006.18.5.859; Sebanz N, 2006, TRENDS COGN SCI, V10, P70, DOI 10.1016/j.tics.2005.12.009; Streltsova A, 2010, EXP BRAIN RES, V205, P363, DOI 10.1007/s00221-010-2371-7; Taulu S, 2006, PHYS MED BIOL, V51, P1759, DOI 10.1088/0031-9155/51/7/008; Tsai CC, 2008, J COGNITIVE NEUROSCI, V20, P2015, DOI 10.1162/jocn.2008.20144; Uutela K, 2001, NEUROIMAGE, V14, P1424, DOI 10.1006/nimg.2001.0915; Valchev N, 2014, NEUROPSYCHOLOGIA C, V66C, P237, DOI [10.1016/j.neuropsychologia.2014.11.030, DOI 10.1016/J.NEUR0PSYCHOLOGIA.2014.11.030]; van Elk M, 2012, EXP BRAIN RES, V218, P189, DOI 10.1007/s00221-012-3016-9; Vesper C, 2014, NEUROPSYCHOLOGIA, V55, P115, DOI 10.1016/j.neuropsychologia.2013.05.024; Vesper C, 2013, J EXP PSYCHOL HUMAN, V39, P48, DOI 10.1037/a0028066; Vogt S, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00807; Wolpert DM, 2003, PHILOS T R SOC B, V358, P593, DOI 10.1098/rstb.2002.1238	62	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2015	10	7							e0131655	10.1371/journal.pone.0131655	http://dx.doi.org/10.1371/journal.pone.0131655			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EC	26151634	Green Published, gold, Green Submitted			2022-12-26	WOS:000358158900022
J	Mori, M; Adland, E; Paioni, P; Swordy, A; Mori, L; Laker, L; Muenchhoff, M; Matthews, PC; Tudor-Williams, G; Lavandier, N; van Zyl, A; Hurst, J; Walker, BD; Ndung'u, T; Prendergast, A; Goulder, P; Jooste, P				Mori, Masahiko; Adland, Emily; Paioni, Paolo; Swordy, Alice; Mori, Luisa; Laker, Leana; Muenchhoff, Maximilian; Matthews, Philippa C.; Tudor-Williams, Gareth; Lavandier, Nora; van Zyl, Anriette; Hurst, Jacob; Walker, Bruce D.; Ndung'u, Thumbi; Prendergast, Andrew; Goulder, Philip; Jooste, Pieter			Sex Differences in Antiretroviral Therapy Initiation in Pediatric HIV Infection	PLOS ONE			English	Article							GENDER-DIFFERENCES; RNA LEVELS; IMMUNOLOGICAL OUTCOMES; CHILDREN; PROGRESSION; WOMEN; MORTALITY; RISK; TRANSMISSION; SUPPRESSION	The incidence and severity of infections in childhood is typically greater in males. The basis for these observed sex differences is not well understood, and potentially may facilitate novel approaches to reducing disease from a range of conditions. We here investigated sex differences in HIV-infected children in relation to antiretroviral therapy (ART) initiation and post-treatment outcome. In a South African cohort of 2,101 HIV-infected children, we observed that absolute CD4+ count and CD4% were significantly higher in ART-naive female, compared to age-matched male, HIV-infected children. Absolute CD4 count and CD4% were also significantly higher in HIV-uninfected female versus male neonates. We next showed that significantly more male than female children were initiated on ART (47% female); and children not meeting criteria to start ART by >5yrs were more frequently female (59%; p<0.001). Among ART-treated children, immune reconstitution of CD4 T-cells was more rapid and more complete in female children, even after adjustment for pre-ART absolute CD4 count or CD4% (p=0.011, p=0.030, respectively). However, while ART was initiated as a result of meeting CD4 criteria less often in females (45%), ART initiation as a result of clinical disease in children whose CD4 counts were above treatment thresholds occurred more often in females (57%, p<0.001). The main sex difference in morbidity observed in children initiating ART above CD4 thresholds, above that of TB disease, was as a result of wasting and stunting observed in females with above-threshold CD4 counts (p=0.002). These findings suggest the possibility that optimal treatment of HIV-infected children might incorporate differential CD4 treatment thresholds for ART initiation according to sex.	[Mori, Masahiko; Adland, Emily; Paioni, Paolo; Swordy, Alice; Mori, Luisa; Muenchhoff, Maximilian; Matthews, Philippa C.; Lavandier, Nora; Goulder, Philip] Univ Oxford, Dept Paediat, Oxford, England; [Mori, Luisa; van Zyl, Anriette; Jooste, Pieter] Kimberley Hosp, Durban, South Africa; [Tudor-Williams, Gareth] Univ London Imperial Coll Sci Technol & Med, Dept Paediat, London, England; [Hurst, Jacob] Univ Oxford, Nuffield Dept Med, Oxford, England; [Walker, Bruce D.] MIT & Harvard, Ragon Inst MGH, Boston, MA USA; [Walker, Bruce D.; Ndung'u, Thumbi; Goulder, Philip] Univ KwaZulu Natal, Doris Duke Med Res Inst, Durban, South Africa; [Ndung'u, Thumbi] Univ KwaZulu Natal, KwaZulu Natal Res Inst TB & HIV K RITH, Durban, South Africa; [Ndung'u, Thumbi] Max Planck Inst Infect Biol, Berlin, Germany; [Prendergast, Andrew] Queen Mary Univ London, Ctr Paediat, Blizard Inst, London, England	University of Oxford; Imperial College London; University of Oxford; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; University of Kwazulu Natal; University of Kwazulu Natal; Max Planck Society; University of London; Queen Mary University London	Goulder, P (corresponding author), Univ Oxford, Dept Paediat, Oxford, England.	philip.goulder@paediatrics.ox.ac.uk	Laker, Leana/AAW-1247-2020; Matthews, Philippa/P-7810-2019	Matthews, Philippa/0000-0002-4036-4269; Muenchhoff, Maximilian/0000-0001-7016-0470; Ndung'u, Thumbi/0000-0003-2962-3992; Paioni, Paolo/0000-0002-3904-1606; Prendergast, Andrew/0000-0001-7904-7992	Medical Research Council [G0501777, G0500384] Funding Source: Medline; Wellcome Trust [104748] Funding Source: Medline; National Institute for Health Research [CL-2011-13-005, CL-2009-13-005] Funding Source: researchfish; MRC [G0500384, G0501777] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aaby P, 2011, J INFECT DIS, V204, P245, DOI 10.1093/infdis/jir240; Aaby P, 2011, HUM VACCINES, V7, P120, DOI 10.4161/hv.7.1.13848; Alonso LC, 2002, BEST PRACT RES CL EN, V16, P13, DOI 10.1053/beem.2002.0177; Babiker A, 2000, LANCET, V355, P1131, DOI 10.1016/S0140-6736(00)02061-4; Biggar RJ, 2006, JAIDS-J ACQ IMM DEF, V41, P509, DOI 10.1097/01.qai.0000191283.85578.46; Bong CN, 2007, AIDS, V21, P1805, DOI 10.1097/QAD.0b013e3282c3a9e4; Delmas MC, 1997, AIDS, V11, P1071; Farzadegan H, 1998, LANCET, V352, P1510, DOI 10.1016/S0140-6736(98)02372-1; Foca M, 2006, PEDIATRICS, V118, P146, DOI 10.1542/peds.2005-0294; Furman D, 2014, P NATL ACAD SCI USA, V111, P869, DOI 10.1073/pnas.1321060111; Gabrielli L, 2012, CLIN MICROBIOL INFEC, V18, pE419, DOI 10.1111/j.1469-0691.2012.03983.x; Galli L, 2005, JAIDS-J ACQ IMM DEF, V40, P479, DOI 10.1097/01.qai.0000164247.49098.0e; Gandhi M, 2002, CLIN INFECT DIS, V35, P313, DOI 10.1086/341249; Gandhi RT, 2006, JAIDS-J ACQ IMM DEF, V42, P426, DOI 10.1097/01.qai.0000226789.51992.3f; Giaquinto C, 2004, AIDS, V18, P2009, DOI 10.1097/00002030-200410210-00005; Hunt PW, 2003, AIDS, V17, P1907, DOI 10.1097/00002030-200309050-00009; Khosla S, 1998, J CLIN ENDOCR METAB, V83, P2266, DOI 10.1210/jc.83.7.2266; Kiboneka A, 2008, AIDS, V22, P2493, DOI 10.1097/QAD.0b013e328318f148; Klein SL, 2013, VACCINE, V31, P2599, DOI 10.1016/j.vaccine.2013.02.070; Klein SL, 2000, BEHAV PROCESS, V51, P149, DOI 10.1016/S0376-6357(00)00125-X; Leyenaar JK, 2010, PEDIATR INFECT DIS J, V29, P340, DOI 10.1097/INF.0b013e3181bf8ecb; Lowenthal ED, 2014, LANCET INFECT DIS, V14, P627, DOI 10.1016/S1473-3099(13)70363-3; Maini MK, 1996, GENITOURIN MED, V72, P27; Marinda E, 2007, PEDIATR INFECT DIS J, V26, P519, DOI 10.1097/01.inf.0000264527.69954.4c; Meier A, 2009, NAT MED, V15, P955, DOI 10.1038/nm.2004; Mphatswe W, 2007, AIDS, V21, P1253, DOI 10.1097/QAD.0b013e3281a3bec2; Muenchhoff M, 2014, J INFECT DIS, V209, pS120, DOI 10.1093/infdis/jiu232; Newell ML, 2004, LANCET, V364, P1236, DOI 10.1016/S0140-6736(04)17140-7; Ober C, 2008, NAT REV GENET, V9, P911, DOI 10.1038/nrg2415; Pernis AB, 2007, CURR OPIN RHEUMATOL, V19, P414, DOI 10.1097/BOR.0b013e328277ef2a; Picone O, 2005, PRENATAL DIAG, V25, P34, DOI 10.1002/pd.944; Piwoz EG, 2006, AIDS, V20, P1981, DOI 10.1097/01.aids.0000247123.04703.6e; Prendergast A, 2008, AIDS, V22, P1333, DOI 10.1097/QAD.0b013e32830437df; Prendergast AJ, 2012, NAT REV IMMUNOL, V12, P636, DOI 10.1038/nri3277; Puthanakit T, 2009, PEDIATR INFECT DIS J, V28, P488, DOI 10.1097/INF.0b013e318194eea6; Ruel TD, 2011, CLIN INFECT DIS, V53, P592, DOI 10.1093/cid/cir484; Shann F, 2010, ARCH DIS CHILD, V95, P662, DOI 10.1136/adc.2009.157537; Shearer WT, 2003, J ALLERGY CLIN IMMUN, V112, P973, DOI 10.1016/j.jaci.2003.07.003; Siberry GK, 2011, JAIDS-J ACQ IMM DEF, V57, P223, DOI 10.1097/QAI.0b013e318218e068; Sterling TR, 2001, NEW ENGL J MED, V344, P720, DOI 10.1056/NEJM200103083441003; Sterling TR, 1999, J INFECT DIS, V180, P666, DOI 10.1086/314967; Taha TE, 2005, PEDIATRICS, V115, pE167, DOI 10.1542/peds.2004-1590; van de Berg PJEJ, 2012, CLIN VACCINE IMMUNOL, V19, P772, DOI 10.1128/CVI.00011-12; Yin DE, 2014, PEDIATRICS, V134, pE1104, DOI 10.1542/peds.2014-0527; Zanoni BC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022706	45	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2015	10	7							e0131591	10.1371/journal.pone.0131591	http://dx.doi.org/10.1371/journal.pone.0131591			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EC	26151555	Green Published, Green Submitted, gold			2022-12-26	WOS:000358158900021
J	Froschauer, A; Kube, L; Kegler, A; Rieger, C; Gutzeit, HO				Froschauer, Alexander; Kube, Lisa; Kegler, Alexandra; Rieger, Christiane; Gutzeit, Herwig O.			Tunable Protein Stabilization In Vivo Mediated by Shield-1 in Transgenic Medaka	PLOS ONE			English	Article							GENE-EXPRESSION; ORYZIAS-LATIPES; STEM-CELLS; STABILITY; FISH; IDENTIFICATION; REPORTER; GONADS; SYSTEM	Techniques for conditional gene or protein expression are important tools in developmental biology and in the analysis of physiology and disease. On the protein level, the tunable and reversible expression of proteins can be achieved by the fusion of the protein of interest to a destabilizing domain (DD). In the absence of its specific ligand (Shield-1), the protein is degraded by the proteasome. The DD-Shield system has proven to be an excellent tool to regulate the expression of proteins of interests in mammalian systems but has not been applied in teleosts like the medaka. We present the application of the DD-Shield technique in transgenic medaka and show the ubiquitous conditional expression throughout life. Shield-1 administration to the water leads to concentration-dependent induction of a YFP reporter gene in various organs and in spermatogonia at the cellular level.	[Froschauer, Alexander; Kube, Lisa; Kegler, Alexandra; Rieger, Christiane; Gutzeit, Herwig O.] Tech Univ Dresden, Inst Zool, D-01062 Dresden, Germany	Technische Universitat Dresden	Froschauer, A (corresponding author), Tech Univ Dresden, Inst Zool, D-01062 Dresden, Germany.	alexander.froschauer@tu-dresden.de	Froschauer, Alexander/D-4856-2013	Froschauer, Alexander/0000-0001-9326-7967	Technische Universitat Dresden; German Research Foundation (DFG); Open Access Publication Funds of the TU Dresden	Technische Universitat Dresden; German Research Foundation (DFG)(German Research Foundation (DFG)); Open Access Publication Funds of the TU Dresden	This work was funded by Technische Universitat Dresden (to HG, http://tu-dresden.de/) and its research pool (to AF, http://tudresden.de/ forschung/forschungsfoerderung/forschungspool/). We acknowledge support by the German Research Foundation (DFG) and the Open Access Publication Funds of the TU Dresden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansai S, 2014, BIOL OPEN, V3, P362, DOI 10.1242/bio.20148177; Banaszynski LA, 2008, NAT MED, V14, P1123, DOI 10.1038/nm.1754; Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025; Chen CC, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt805; Cho U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072393; Emelyanov A, 2006, GENETICS, V174, P1095, DOI 10.1534/genetics.106.061184; Field CM, 2011, CURR BIOL, V21, pR825, DOI 10.1016/j.cub.2011.07.043; Froschauer A, 2013, MOL REPROD DEV, V80, P48, DOI 10.1002/mrd.22135; Froschauer A, 2012, TRANSGENIC RES, V21, P149, DOI 10.1007/s11248-011-9514-x; Gong Z, 2001, GENETICA, V111, P213, DOI 10.1023/A:1013796810782; Hardy ME, 2007, DEV DYNAM, V236, P3071, DOI 10.1002/dvdy.21318; Herpin A, 2013, MOL BIOL EVOL, V30, P2328, DOI 10.1093/molbev/mst130; Hwang WY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068708; Iwamoto M, 2010, CHEM BIOL, V17, P981, DOI 10.1016/j.chembiol.2010.07.009; Kinoshita M., 2009, MEDAKA BIOL MANAGEME; Lewandoski M, 2001, NAT REV GENET, V2, P743, DOI 10.1038/35093537; Liu YC, 2014, INT J PARASITOL, V44, P729, DOI 10.1016/j.ijpara.2014.05.002; Maynard-Smith LA, 2007, J BIOL CHEM, V282, P24866, DOI 10.1074/jbc.M703902200; Nakamura S, 2008, MOL REPROD DEV, V75, P472, DOI 10.1002/mrd.20764; Nakamura S, 2010, SCIENCE, V328, P1561, DOI 10.1126/science.1185473; Ng GHB, 2011, BIOCHIMIE, V93, P1858, DOI 10.1016/j.biochi.2011.07.006; Oda S, 2010, ZOOL SCI, V27, P410, DOI 10.2108/zsj.27.410; Park A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095101; Rodriguez S, 2012, CHEM BIOL, V19, P391, DOI 10.1016/j.chembiol.2011.12.022; Sanchez-Sanchez AV, 2010, DEV DYNAM, V239, P672, DOI 10.1002/dvdy.22198; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Scholz S, 2003, BIOL REPROD, V69, P673, DOI 10.1095/biolreprod.103.016873; Tai K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046269; Takeda H, 2010, ANNU REV GENET, V44, P217, DOI 10.1146/annurev-genet-051710-151001; Wada H, 1998, ZOOL SCI, V15, P123, DOI 10.2108/zsj.15.123; Wakamatsu Y, 2001, P NATL ACAD SCI USA, V98, P10046, DOI 10.1073/pnas.181204298; Wakamatsu Yuko, 2003, Environmental Sciences, V10, P291	32	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131252	10.1371/journal.pone.0131252	http://dx.doi.org/10.1371/journal.pone.0131252			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148066	Green Published, gold, Green Submitted			2022-12-26	WOS:000358157600075
J	Sherwani, MA; Tufail, S; Khan, AA; Owais, M				Sherwani, Mohd Asif; Tufail, Saba; Khan, Aijaz Ahmed; Owais, Mohammad			Gold Nanoparticle-Photosensitizer Conjugate Based Photodynamic Inactivation of Biofilm Producing Cells: Potential for Treatment of C. albicans Infection in BALB/c Mice	PLOS ONE			English	Article							CANDIDA-ALBICANS; METHYLENE-BLUE; FUNGAL-INFECTIONS; TOLUIDINE BLUE; THERAPY; EFFICACY; LIGHT; YEAST	Background Photodynamic therapy (PDT) has been found to be effective in inhibiting biofilm producing organisms. We investigated the photodynamic effect of gold nanoparticle (GNP) conjugated photosensitizers against Candida albicans biofilm. We also examined the photodynamic efficacy of photosensitizer (PS) conjugated GNPs (GNP-PS) to treat skin and oral C. albicans infection in BALB/c mice. Methods The biomimetically synthesized GNPs were conjugated to photosensitizers viz. methylene blue (MB) or toluidine blue O (TB). The conjugation of PSs with GNPs was characterized by spectroscopic and microscopic techniques. The efficacy of gold nanoparticle conjugates against C. albicans biofilm was demonstrated by XTT assay and microscopic studies. The therapeutic efficacy of the combination of the GNP conjugates against cutaneous C. albicans infection was examined in mouse model by enumerating residual fungal burden and histopathological studies. Results The GNP-PS conjugate based PDT was found to effectively kill both C. albicans planktonic cells and biofilm populating hyphal forms. The mixture of GNPs conjugated to two different PSs significantly depleted the hyphal C. albicans burden against superficial skin and oral C. albicans infection in mice. Conclusion The GNP-PS conjugate combination exhibits synergism in photodynamic inactivation of C. albicans. The GNP conjugate based PDT can be employed effectively in treatment of cutaneous C. albicans infections in model animals. The antibiofilm potential of PDT therapy can also be exploited in depletion of C. albicans on medical appliances such as implants and catheters etc.	[Sherwani, Mohd Asif; Tufail, Saba; Owais, Mohammad] Aligarh Muslim Univ, Interdisciplinary Biotechnol Unit, Aligarh 202002, Uttar Pradesh, India; [Khan, Aijaz Ahmed] Aligarh Muslim Univ, Jawaharlal Nehru Med Coll, Dept Anat, Fac Med, Aligarh 202002, Uttar Pradesh, India	Aligarh Muslim University; Aligarh Muslim University	Khan, AA (corresponding author), Aligarh Muslim Univ, Jawaharlal Nehru Med Coll, Dept Anat, Fac Med, Aligarh 202002, Uttar Pradesh, India.	aijazahmedkhan7@live.com; owais_lakhnawi@rediffmail.com	Sherwani, Mohammad Asif/AAQ-2949-2021; Sherwani, Mohammad/AAR-6089-2021	Sherwani, Mohammad Asif/0000-0001-5317-1557; Mohammad, Owais/0000-0001-7377-7388	DBT (Department of Biotechnology); ICMR (Indian Council of Medical Research); CSIR (Council of Scientific and Industrial Research)	DBT (Department of Biotechnology); ICMR (Indian Council of Medical Research)(Indian Council of Medical Research (ICMR)); CSIR (Council of Scientific and Industrial Research)(Council of Scientific & Industrial Research (CSIR) - India)	MAS is grateful to the funding agencies DBT (Department of Biotechnology) and ICMR (Indian Council of Medical Research) for financial assistance in the form of fellowships. ST also gratefully acknowledges CSIR (Council of Scientific and Industrial Research) for a Junior as well as a Senior Research Fellowship. No additional specific funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam M, 2013, NANOMED-NANOTECHNOL, V9, P247, DOI 10.1016/j.nano.2012.07.004; Allison RR, 2004, PHOTODIAGN PHOTODYN, V1, P27, DOI 10.1016/S1572-1000(04)00007-9; Bachmann SP, 2002, ANTIMICROB AGENTS CH, V46, P3591, DOI 10.1128/AAC.46.11.3591-3596.2002; Bailey DA, 1996, J BACTERIOL, V178, P5353, DOI 10.1128/jb.178.18.5353-5360.1996; Costa ACBP, 2012, OR SURG OR MED OR PA, V114, P67, DOI 10.1016/j.oooo.2012.02.002; Calzavara-Pinton PG, 2005, J PHOTOCH PHOTOBIO B, V78, P1, DOI 10.1016/j.jphotobiol.2004.06.006; Calzavara-Pinton P, 2012, PHOTOCHEM PHOTOBIOL, V88, P512, DOI 10.1111/j.1751-1097.2012.01107.x; Carvalho GG, 2009, J MICROBIOL, V47, P619, DOI 10.1007/s12275-009-0059-0; Chandra J, 2001, J BACTERIOL, V183, P5385, DOI 10.1128/JB.183.18.5385-5394.2001; Chandran SP, 2006, BIOTECHNOL PROGR, V22, P577, DOI 10.1021/bp0501423; Chauhan A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032049; Chauhan A, 2011, INT J NANOMED, V6, P2305, DOI 10.2147/IJN.S23195; Cheng Y, 2008, J AM CHEM SOC, V130, P10643, DOI 10.1021/ja801631c; Costa ACBP, 2013, VIRULENCE, V4, P391, DOI 10.4161/viru.25199; Cowen LE, 2002, ANNU REV MICROBIOL, V56, P139, DOI 10.1146/annurev.micro.56.012302.160907; Dai TH, 2011, ANTIMICROB AGENTS CH, V55, P5710, DOI 10.1128/AAC.05404-11; de Souza SC, 2006, J PHOTOCH PHOTOBIO B, V83, P34, DOI 10.1016/j.jphotobiol.2005.12.002; Dongari-Bagtzoglou A, 2008, EXPERT REV ANTI-INFE, V6, P201, DOI 10.1586/14787210.6.2.201; Dongari-Bagtzoglou A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007967; Dougherty TJ, 2008, JNCI-J NATL CANCER I, V90, P889; Douglas LJ, 2003, TRENDS MICROBIOL, V11, P30, DOI 10.1016/S0966-842X(02)00002-1; Farah CS, 2010, AUST DENT J, V55, P48, DOI 10.1111/j.1834-7819.2010.01198.x; Giroldo LM, 2009, LASER MED SCI, V24, P109, DOI 10.1007/s10103-007-0530-2; Jackson Z, 1999, LASER MED SCI, V14, P150, DOI 10.1007/s101030050037; Javed F, 2014, PHOTOCH PHOTOBIO SCI, V13, P726, DOI 10.1039/c3pp50426c; Jett BD, 1997, BIOTECHNIQUES, V23, P648, DOI 10.2144/97234bm22; Jin Y, 2005, MYCOPATHOLOGIA, V159, P353, DOI 10.1007/s11046-004-6987-7; Khan S, 2012, INT J NANOMED, V7, P3245, DOI 10.2147/IJN.S31219; Kuo WS, 2012, BIOMATERIALS, V33, P3270, DOI 10.1016/j.biomaterials.2012.01.035; Kurek A, 2011, POL J MICROBIOL, V60, P3, DOI 10.33073/pjm-2011-001; Li Y, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030186, 10.1371/journal.pone.0029003, 10.1371/journal.pone.0042558, 10.1371/journal.pone.0030835, 10.1371/journal.pone.0044441, 10.1371/journal.pone.0035543, 10.1371/journal.pone.0035122]; Liu YP, 2011, EUKARYOT CELL, V10, P168, DOI 10.1128/EC.00279-10; Lo HJ, 1997, CELL, V90, P939, DOI 10.1016/S0092-8674(00)80358-X; Mantareva V, 2011, EUR J MED CHEM, V46, P4430, DOI 10.1016/j.ejmech.2011.07.015; Maroof A, 2010, BIOSCIENCE REP, V30, P223, DOI 10.1042/BSR20090068; Narband N, 2009, PHYS CHEM CHEM PHYS, V11, P10513, DOI 10.1039/b909714g; Nobile CJ, 2005, CURR BIOL, V15, P1150, DOI 10.1016/j.cub.2005.05.047; Nusbaum A G, 2012, Skin Therapy Lett, V17, P1; O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49; Pasparakis G, 2013, SMALL, V9, P4130, DOI 10.1002/smll.201301365; Pupo Yasmine M, 2011, Acta odontol. latinoam., V24, P188; Samaranayake LP, 2009, PERIODONTOL 2000, V49, P39, DOI 10.1111/j.1600-0757.2008.00291.x; Sanchez AA, 2004, INFECT IMMUN, V72, P598, DOI 10.1128/IAI.72.1.598-601.2004; Seidler M, 2006, INT J ANTIMICROB AG, V28, P568, DOI 10.1016/j.ijantimicag.2006.07.024; Sellam A, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-25; Sims CR, 2005, ARCH MED RES, V36, P660, DOI 10.1016/j.arcmed.2005.05.015; Stoodley P, 2002, ANNU REV MICROBIOL, V56, P187, DOI 10.1146/annurev.micro.56.012302.160705; Tufail S, 2015, J BIOL CHEM, V290, P4131, DOI 10.1074/jbc.M113.540989; Wieder ME, 2006, PHOTOCH PHOTOBIO SCI, V5, P727, DOI 10.1039/b602830f; Wong TW, 2005, ANTIMICROB AGENTS CH, V49, P895, DOI 10.1128/AAC.49.3.895-902.2005	50	65	66	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131684	10.1371/journal.pone.0131684	http://dx.doi.org/10.1371/journal.pone.0131684			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148012	Green Submitted, Green Published, gold			2022-12-26	WOS:000358157600128
J	Yin, J; Wen, J; Hang, D; Han, J; Jiang, J; Song, C; Liu, Y; Liu, JB; Liu, L; Zhu, LG; Chen, JG; Zhai, XJ; Xie, SH; Hu, ZB; Shen, HB; Dai, M; Li, N				Yin, Jian; Wen, Juan; Hang, Dong; Han, Jing; Jiang, Jie; Song, Ci; Liu, Yao; Liu, Jibin; Liu, Li; Zhu, Liguo; Chen, Jianguo; Zhai, Xiangjun; Xie, Shuanghua; Hu, Zhibin; Shen, Hongbing; Dai, Min; Li, Ni			Expression Quantitative Trait Loci for CARD8 Contributes to Risk of Two Infection-Related Cancers-Hepatocellular Carcinoma and Cervical Cancer	PLOS ONE			English	Article							NF-KAPPA-B; NONCODING RNA HOTAIR; GENETIC-VARIANTS; ACTIVATION; PROTEIN; MEG3	Caspase recruitment domain family, member 8 (CARD8) can coordinate innate and adaptive immune responses and sensitize cells to apoptosis, which may participate in tumorigenesis of virus-induced hepatocellular carcinoma (HCC) and cervical cancer. By bioinformatics analyses, we identified several single nucleotide polymorphisms (SNPs) within a new identified long non-coding RNA (lncRNA) as expression quantitative trait loci (eQTLs) for CARD8. In this study, we therefore hypothesized that CARD8 eQTLs SNPs within lncRNA may influence the risk of HCC and cervical cancer. We performed two independent case-control studies of 1,300 cases with HBV-positive HCC and 1,344 normal controls, together with 1,486 cervical cancer patients and 1,536 control subjects to test the association between eQTLs SNP (rs7248320) for CARD8 and the risk of HCC and cervical cancer. The variant genotype of rs7248320 was significantly associated with increased risk of HCC and cervical cancer [GG vs. AA/GA: adjusted odds ratio (OR) = 1.28, 95% confidence interval (CI) = 1.03-1.61, P = 0.028 for HCC; adjusted OR = 1.34, 95% CI = 1.09-1.66, P = 0.006 for cervical cancer]. Moreover, the effect of rs7248320 on cervical cancer risk was more prominent in premenopausal women. Further interactive analysis detected a significantly multiplicative interaction between rs7248320 and menopausal status on cervical cancer risk (P = 0.018). These findings suggest that CARD8 eQTLs SNP may serve as a susceptibility marker for virus-related HCC and cervical cancer.	[Yin, Jian; Wen, Juan; Hang, Dong; Han, Jing; Jiang, Jie; Song, Ci; Hu, Zhibin; Shen, Hongbing] Nanjing Med Univ, Dept Epidemiol & Biostat, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Collaborat Innovat Ctr Canc Personalized Med,Sch, Nanjing, Jiangsu, Peoples R China; [Liu, Yao] Soochow Univ, Pathol Ctr, Suzhou, Peoples R China; [Liu, Yao] Soochow Univ, Dept Pathol, Suzhou, Peoples R China; [Liu, Jibin] Nantong Tumor Hosp, Dept Hepatobiliary Surg, Nantong, Peoples R China; [Liu, Li] Nanjing Med Univ, Digest Endoscopy Ctr, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China; [Zhu, Liguo; Zhai, Xiangjun] Jiangsu Prov Ctr Dis Prevent & Control, Dept Infect Dis, Nanjing, Jiangsu, Peoples R China; [Chen, Jianguo] Qidong Liver Canc Inst, Qidong, Peoples R China; [Xie, Shuanghua; Dai, Min; Li, Ni] Chinese Acad Med Sci, Natl Off Canc Prevent & Control, Canc Inst & Hosp, Beijing 100730, Peoples R China	Nanjing Medical University; Soochow University - China; Soochow University - China; Nanjing Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS	Dai, M (corresponding author), Chinese Acad Med Sci, Natl Off Canc Prevent & Control, Canc Inst & Hosp, Beijing 100730, Peoples R China.	daimin2002@hotmail.com; lini1240@hotmail.com	, 雷克思/ABG-3956-2020; DAI, M/GPS-8291-2022	, 雷克思/0000-0003-4102-8934; Li, Ni/0000-0001-5530-7745; Shen, Hongbing/0000-0002-2581-5906	National Natural Science Foundation of China [81172757, 30901236]; National Science Foundation for Distinguished Young Scholars of China [81225020]; National Natural Science Fund from the National Natural Science Foundation of China [81373079]; Foundation of Jiangsu Province for Distinguished Young Scholars [BK2012042]; National Key Basic Research Program For Youth [2013CB911400]; Foundation for the Program for New Century Excellent Talents in University [NCET-10-0178]; National Program for Support of Top-notch Young Professionals; Jiangsu Province Clinical Science and Technology Projects [BL2012008]; Collaborative Innovation Center For Cancer Personalized Medicine in Jiangsu Province; Priority Academic Program for the Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine); Beijing Natural Science Foundation [7123225]; Beijing Nova Program [xx2012067]; Scientific Research Foundation for Returned Scholars, Ministry of Education of China for the conduct of the research and preparation of the article	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation for Distinguished Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Natural Science Fund from the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of Jiangsu Province for Distinguished Young Scholars; National Key Basic Research Program For Youth(National Basic Research Program of China); Foundation for the Program for New Century Excellent Talents in University; National Program for Support of Top-notch Young Professionals; Jiangsu Province Clinical Science and Technology Projects; Collaborative Innovation Center For Cancer Personalized Medicine in Jiangsu Province; Priority Academic Program for the Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Beijing Nova Program(Beijing Municipal Science & Technology Commission); Scientific Research Foundation for Returned Scholars, Ministry of Education of China for the conduct of the research and preparation of the article	This work was supported by National Natural Science Fund from the National Natural Science Foundation of China (81172757); National Science Foundation for Distinguished Young Scholars of China (81225020); National Natural Science Fund from the National Natural Science Foundation of China (81373079); Foundation of Jiangsu Province for Distinguished Young Scholars (BK2012042); National Key Basic Research Program For Youth (2013CB911400); Foundation for the Program for New Century Excellent Talents in University (NCET-10-0178); National Program for Support of Top-notch Young Professionals; Jiangsu Province Clinical Science and Technology Projects (BL2012008); Collaborative Innovation Center For Cancer Personalized Medicine in Jiangsu Province and the Priority Academic Program for the Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine); National Natural Science Fund from the National Natural Science Foundation of China(30901236); Beijing Natural Science Foundation (7123225); Beijing Nova Program (xx2012067); Scientific Research Foundation for Returned Scholars, Ministry of Education of China for the conduct of the research and preparation of the article. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atianand MK, 2014, TRENDS MOL MED; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Braconi C, 2011, ONCOGENE, V30, P4750, DOI 10.1038/onc.2011.193; Dang TP, 2012, ADV EXP MED BIOL, V727, P199, DOI 10.1007/978-1-4614-0899-4_15; Elsharkawy AM, 2007, HEPATOLOGY, V46, P590, DOI 10.1002/hep.21802; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gaballah HH, 2014, ASIAN PAC J CANCER P, V15, P6911, DOI 10.7314/APJCP.2014.15.16.6911; Garg AK, 2010, INT J RADIAT ONCOL, V78, P1331, DOI 10.1016/j.ijrobp.2009.09.044; Hong A, 2012, BIOCHEM BIOPH RES CO, V423, P6, DOI 10.1016/j.bbrc.2012.05.021; Hu LM, 2012, HEPATOLOGY, V55, P1426, DOI 10.1002/hep.24799; Huang L, 2014, ARCH GYNECOL OBSTET, V290, P717, DOI 10.1007/s00404-014-3236-2; Ishibashi M, 2013, ONCOL REP, V29, P946, DOI 10.3892/or.2012.2219; Jiang J, 2013, GYNECOL ONCOL, V129, P401, DOI 10.1016/j.ygyno.2013.02.017; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kim SH, 2009, CARCINOGENESIS, V30, P753, DOI 10.1093/carcin/bgp066; Kuper H, 2000, INT J CANCER, V85, P498, DOI 10.1002/(SICI)1097-0215(20000215)85:4&lt;498::AID-IJC9&gt;3.0.CO;2-F; Mockelmann N, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-79; Parkin DM, 2006, VACCINE, V24, P11, DOI 10.1016/j.vaccine.2006.05.111; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Qin R, 2013, NEOPLASMA, V60, P486, DOI 10.4149/neo_2013_063; Ramdass B, 2007, GYNECOL ONCOL, V104, P352, DOI 10.1016/j.ygyno.2006.08.054; Razmara M, 2002, J BIOL CHEM, V277, P13952, DOI 10.1074/jbc.M107811200; Song RP, 2014, HEPATOLOGY, V60, P1659, DOI 10.1002/hep.27312; Verma D, 2008, ARTHRITIS RHEUM, V58, P888, DOI 10.1002/art.23286; Wang MR, 2012, EXP DIABETES RES, DOI 10.1155/2012/647914; Wang SM, 2012, MOL CARCINOGEN, V51, pE118, DOI 10.1002/mc.21872; Wang W, 2012, J BIOL CHEM, V287, P42856, DOI 10.1074/jbc.M112.399923; Wen J., 2014, MOL CARCINOG; Woodman CBJ, 2001, LANCET, V357, P1831, DOI 10.1016/S0140-6736(00)04956-4; Yang JD, 2010, NAT REV GASTRO HEPAT, V7, P448, DOI 10.1038/nrgastro.2010.100; Yang Z, 2011, ANN SURG ONCOL, V18, P1243, DOI 10.1245/s10434-011-1581-y; Yi MJ, 2015, INT J PSYCHIAT MED, V49, P208, DOI 10.1177/0091217415582190; Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	34	16	18	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132352	10.1371/journal.pone.0132352	http://dx.doi.org/10.1371/journal.pone.0132352			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147888	Green Submitted, Green Published, gold			2022-12-26	WOS:000358157600250
J	Alam, MS; Choudhary, V; Zeeshan, M; Tyagi, RK; Rathore, S; Sharma, YD				Alam, Mohd Shoeb; Choudhary, Vandana; Zeeshan, Mohammad; Tyagi, Rupesh K.; Rathore, Sumit; Sharma, Yagya D.			Interaction of Plasmodium vivax Tryptophan-rich Antigen PvTRAg38 with Band 3 on Human Erythrocyte Surface Facilitates Parasite Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RED-BLOOD-CELLS; SIALIC-ACID; INVASION; FALCIPARUM; MALARIA; MEMBRANE; RECEPTOR; BINDING; PROTEIN; MEROZOITES	Plasmodium tryptophan-rich proteins are involved in host-parasite interaction and thus potential drug/vaccine targets. Recently, we have described several P. vivax tryptophan-rich antigens (PvTRAgs), including merozoite expressed PvTRAg38, from this noncultivable human malaria parasite. PvTRAg38 is highly immunogenic in humans and binds to host erythrocytes, and this binding is inhibited by the patient sera. This binding is also affected if host erythrocytes were pretreated with chymotrypsin. Here, Band 3 has been identified as the chymotrypsinsensitive erythrocyte receptor for this parasite protein. Interaction of PvTRAg38 with Band 3 has been mapped to its three different ectodomains (loops 1, 3, and 6) exposed at the surface of the erythrocyte. The binding region of PvTRAg38 to Band 3 has been mapped to its sequence, KWVQWKNDKIR-SWLSSEW, present at amino acid positions 197-214. The recombinant PvTRAg38 was able to inhibit the parasite growth in in vitro Plasmodium falciparum culture probably by competing with the ligand(s) of this heterologous parasite for the erythrocyte Band 3 receptor. In conclusion, the host-parasite interaction at the molecular level is much more complicated than known so far and should be considered during the development of anti-malarial therapeutics.	[Alam, Mohd Shoeb; Choudhary, Vandana; Zeeshan, Mohammad; Tyagi, Rupesh K.; Rathore, Sumit; Sharma, Yagya D.] All India Inst Med Sci, Dept Biotechnol, New Delhi 110029, India	All India Institute of Medical Sciences (AIIMS) New Delhi	Sharma, YD (corresponding author), All India Inst Med Sci, Dept Biotechnol, New Delhi 110029, India.	ydsharma@hotmail.com		Tyagi, Rupesh/0000-0002-5095-8976	Department of Biotechnology [BT/PR9800/MED/29/44/2007]; Indian Council for Medical Research [61/4/2012-BMS]; DST-INSA INSPIRE faculty fellowship from the Department of Science and Technology; Council of Scientific and Industrial Research; Department of Biotechnology	Department of Biotechnology; Indian Council for Medical Research(Indian Council of Medical Research (ICMR)); DST-INSA INSPIRE faculty fellowship from the Department of Science and Technology; Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology	This work was supported by Department of Biotechnology Grant BT/PR9800/MED/29/44/2007, by Indian Council for Medical Research Grant 61/4/2012-BMS; by a DST-INSA INSPIRE faculty fellowship (to S. R.) from the Department of Science and Technology; by senior research fellowships from the Council of Scientific and Industrial Research (to M. S. A. and V. C.), and by funds from the Department of Biotechnology (to M. Z. and R. K. T.). The authors declare that they have no conflicts of interest with the contents of this article.	Baldwin M, 2014, BBA-MOL CELL RES, V1843, P2855, DOI 10.1016/j.bbamcr.2014.08.008; BENNETT V, 1980, J BIOL CHEM, V255, P2540; Bhalla K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7049; Bora H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016294; Bozdech Z, 2008, P NATL ACAD SCI USA, V105, P16290, DOI 10.1073/pnas.0807404105; Burns JM, 1997, INFECT IMMUN, V65, P3138, DOI 10.1128/IAI.65.8.3138-3145.1997; Burns JM, 1999, INFECT IMMUN, V67, P675, DOI 10.1128/IAI.67.2.675-680.1999; Carlton JM, 2008, NATURE, V455, P757, DOI 10.1038/nature07327; CASEY JR, 1989, METHOD ENZYMOL, V173, P494; CHITNIS CE, 1994, J EXP MED, V180, P497, DOI 10.1084/jem.180.2.497; CLOUGH B, 1995, MOL BIOCHEM PARASIT, V69, P19, DOI 10.1016/0166-6851(94)00185-P; COHEN GH, 1988, J VIROL, V62, P1932, DOI 10.1128/JVI.62.6.1932-1940.1988; Cowman AF, 2012, J CELL BIOL, V198, P961, DOI 10.1083/jcb.201206112; Curtidor H, 2006, BIOCHEM BIOPH RES CO, V339, P888, DOI 10.1016/j.bbrc.2005.11.089; DODGE JT, 1963, ARCH BIOCHEM BIOPHYS, V100, P119, DOI 10.1016/0003-9861(63)90042-0; Fujinaga J, 1999, J BIOL CHEM, V274, P6626, DOI 10.1074/jbc.274.10.6626; Goel VK, 2003, P NATL ACAD SCI USA, V100, P5164, DOI 10.1073/pnas.0834959100; Ipsaro JJ, 2008, BIOCHEMISTRY-US, V47, P7452, DOI 10.1021/bi702525z; JAROLIM P, 1991, P NATL ACAD SCI USA, V88, P11022, DOI 10.1073/pnas.88.24.11022; Koganei A, 2007, J IMMUNOTOXICOL, V4, P77, DOI 10.1080/15476910601161691; KORSGREN C, 1986, J BIOL CHEM, V261, P5536; Kushwaha A, 2002, MOL BIOCHEM PARASIT, V122, P45, DOI 10.1016/S0166-6851(02)00077-4; Li XR, 2004, J BIOL CHEM, V279, P5765, DOI 10.1074/jbc.M308716200; Li XR, 2008, MOL BIOCHEM PARASIT, V158, P22, DOI 10.1016/j.molbiopara.2007.11.007; Menard D, 2010, P NATL ACAD SCI USA, V107, P5967, DOI 10.1073/pnas.0912496107; MILLER LH, 1983, J CLIN INVEST, V72, P1357, DOI 10.1172/JCI111092; MILLER LH, 1976, NEW ENGL J MED, V295, P302, DOI 10.1056/NEJM197608052950602; Naing C, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003071; Ntumngia FB, 2004, MOL BIOCHEM PARASIT, V137, P349, DOI 10.1016/j.molbiopara.2004.06.008; OKOYE VCN, 1985, SCIENCE, V227, P169, DOI 10.1126/science.3880920; Persson KEM, 2006, J CLIN MICROBIOL, V44, P1665, DOI 10.1128/JCM.44.5.1665-1673.2006; Roggwiller E, 1996, MOL BIOCHEM PARASIT, V82, P13, DOI 10.1016/0166-6851(96)02714-4; Sahar T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017102; Sarin R, 2006, GENE, V376, P107, DOI 10.1016/j.gene.2006.02.012; SORETTE MP, 1991, BLOOD, V77, P628; Tran TM, 2005, CYTOM PART A, V63A, P59, DOI 10.1002/cyto.a.20098; Tyagi RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050754; Yajima A, 2008, MICROBIOL IMMUNOL, V52, P69, DOI 10.1111/j.1348-0421.2008.00015.x; Zeeshan M, 2015, J INFECT DIS, V211, P1111, DOI 10.1093/infdis/jiu558; Zeeshan M, 2013, J INFECT DIS, V207, P175, DOI 10.1093/infdis/jis650	40	24	25	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2015	290	33					20257	20272		10.1074/jbc.M115.644906	http://dx.doi.org/10.1074/jbc.M115.644906			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP1AT	26149684	hybrid, Green Published			2022-12-26	WOS:000359608900026
J	Coudrillier, B; Pijanka, JK; Jefferys, JL; Goel, A; Quigley, HA; Boote, C; Nguyen, TD				Coudrillier, Baptiste; Pijanka, Jacek K.; Jefferys, Joan L.; Goel, Adhiraj; Quigley, Harry A.; Boote, Craig; Nguyen, Thao D.			Glaucoma-related Changes in the Mechanical Properties and Collagen Micro-architecture of the Human Sclera	PLOS ONE			English	Article							OPTIC-NERVE HEAD; OPEN-ANGLE GLAUCOMA; HUMAN LAMINA-CRIBROSA; BIOMECHANICAL STRUCTURE; PERIPAPILLARY SCLERA; POSTERIOR SCLERA; OCULAR RIGIDITY; PULSE AMPLITUDE; IOP ELEVATIONS; MONKEY EYES	Objective The biomechanical behavior of the sclera determines the level of mechanical insult from intraocular pressure to the axons and tissues of the optic nerve head, as is of interest in glaucoma. In this study, we measure the collagen fiber structure and the strain response, and estimate the material properties of glaucomatous and normal human donor scleras. Methods Twenty-two posterior scleras from normal and diagnosed glaucoma donors were obtained from an eyebank. Optic nerve cross-sections were graded to determine the presence of axon loss. The specimens were subjected to pressure-controlled inflation testing. Full-field displacement maps were measured by digital image correlation (DIC) and spatially differentiated to compute surface strains. Maps of the collagen fiber structure across the posterior sclera of each inflated specimen were obtained using synchrotron wide-angle X-ray scattering (WAXS). Finite element (FE) models of the posterior scleras, incorporating a specimen-specific representation of the collagen structure, were constructed from the DIC-measured geometry. An inverse finite element analysis was developed to estimate the stiffness of the collagen fiber and inter-fiber matrix. Results The differences between glaucoma and non-glaucoma eyes were small in magnitude. Sectorial variations of degree of fiber alignment and peripapillary scleral strain significantly differed between normal and diagnosed glaucoma specimens. Meridional strains were on average larger in diagnosed glaucoma eyes compared with normal specimens. Non-glaucoma specimens had on average the lowest matrix and fiber stiffness, followed by undamaged glaucoma eyes, and damaged glaucoma eyes but the differences in stiffness were not significant. Conclusion The observed biomechanical and microstructural changes could be the result of tissue remodeling occuring in glaucoma and are likely to alter the mechanical environment of the optic nerve head and contribute to axonal damage.	[Coudrillier, Baptiste] Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA; [Pijanka, Jacek K.; Boote, Craig] Cardiff Univ, Struct Biophys Grp, Sch Optometry & Vis Sci, Cardiff CF10 3AX, S Glam, Wales; [Jefferys, Joan L.; Quigley, Harry A.] Johns Hopkins Univ, Sch Med, Wilmer Ophthalmol Inst, Glaucoma Ctr Excellence, Baltimore, MD 21205 USA; [Goel, Adhiraj; Nguyen, Thao D.] Johns Hopkins Univ, Dept Mech Engn, Baltimore, MD 21218 USA	University System of Georgia; Georgia Institute of Technology; Cardiff University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University	Nguyen, TD (corresponding author), Johns Hopkins Univ, Dept Mech Engn, Baltimore, MD 21218 USA.	vicky.nguyen@jhu.edu	Nguyen, Thao/GWN-0419-2022; Nguyen, Thao/A-3391-2010	Nguyen, Thao/0000-0002-0312-1583; Boote, Craig/0000-0003-0348-6547	Public Health Service Research Grants [EY021500, EY02120, EY01765]; Fight For Sight grant [1360]; Leonard Wagner Charitable Trust; MRC [MR/K000837/1] Funding Source: UKRI; Medical Research Council [MR/K000837/1] Funding Source: researchfish; Fight for Sight [1359/60] Funding Source: researchfish; NATIONAL EYE INSTITUTE [P30EY001765, R56EY002120, R01EY002120, R01EY021500] Funding Source: NIH RePORTER	Public Health Service Research Grants; Fight For Sight grant; Leonard Wagner Charitable Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Fight for Sight; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the Public Health Service Research Grants EY021500 (Thao D. Nguyen), EY02120 and EY01765 (Harry A. Quigley and Wilmer Institute), the Fight For Sight grant 1360 (Craig Boote), the Leonard Wagner Charitable Trust, William T. Forrester, and Saranne and Livingston Kosberg (Harry A. Quigley). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argento A, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4027615; Bellezza AJ, 2000, INVEST OPHTH VIS SCI, V41, P2991; Burgoyne CF, 2005, PROG RETIN EYE RES, V24, P39, DOI 10.1016/j.preteyeres.2004.06.001; Burgoyne CF, 2004, INVEST OPHTH VIS SCI, V45, P4388, DOI 10.1167/iovs.04-0022; Campbell IC, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.1009; Campbell IC, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026286; Coudrillier B, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4029986; Coudrillier B, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4029430; Coudrillier B, 2013, BIOMECH MODEL MECHAN, V12, P941, DOI 10.1007/s10237-012-0455-y; Coudrillier B, 2012, INVEST OPHTH VIS SCI, V53, P1714, DOI 10.1167/iovs.11-8009; Danford FL, 2013, INVEST OPHTH VIS SCI, V54, P7922, DOI 10.1167/iovs.13-12262; Dastiridou AI, 2013, INVEST OPHTH VIS SCI, V54, P4571, DOI 10.1167/iovs.13-12303; Downs JC, 2005, INVEST OPHTH VIS SCI, V46, P540, DOI 10.1167/iovs.04-0114; Fazio M. A., 2013, BIOMECH MODEL MECHAN, P1; FECHTNER RD, 1994, SURV OPHTHALMOL, V39, P23, DOI 10.1016/S0039-6257(05)80042-6; Girard MJA, 2015, CURR EYE RES, V40, P1, DOI 10.3109/02713683.2014.914543; Girard MJA, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0459; Girard MJA, 2011, INVEST OPHTH VIS SCI, V52, P5656, DOI 10.1167/iovs.10-6927; Girard MJA, 2009, INVEST OPHTH VIS SCI, V50, P5226, DOI 10.1167/iovs.08-3363; Girard MJA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3113683; Grytz R, 2014, INVEST OPHTH VIS SCI, V55, P8163, DOI 10.1167/iovs.14-14029; Grytz R, 2014, J MECH BEHAV BIOMED, V29, P602, DOI 10.1016/j.jmbbm.2013.03.027; Grytz R, 2011, BIOMECH MODEL MECHAN, V10, P371, DOI 10.1007/s10237-010-0240-8; HERNANDEZ MR, 1987, AM J OPHTHALMOL, V104, P567, DOI 10.1016/0002-9394(87)90165-6; Hommer A, 2008, INVEST OPHTH VIS SCI, V49, P4046, DOI 10.1167/iovs.07-1342; Jonas JB, 2005, INVEST OPHTH VIS SCI, V46, P1275, DOI 10.1167/iovs.04-0851; Jones HJ, QUANTITATIVE ANAL 3; KEELEY FW, 1984, EXP EYE RES, V39, P533, DOI 10.1016/0014-4835(84)90053-8; KENDELL KR, 1995, INVEST OPHTH VIS SCI, V36, P200; Kimball EC, 2014, EXP EYE RES, V128, P129, DOI 10.1016/j.exer.2014.08.016; Knepper PA, 1996, INVEST OPHTH VIS SCI, V37, P1360; Morris HJ, 2013, INVEST OPHTH VIS SCI, V54, P7215, DOI 10.1167/iovs.13-12441; Murienne BJ, 2015, ACTA BIOMATER, V12, P195, DOI 10.1016/j.actbio.2014.10.033; Myers KM, 2010, ACTA BIOMATER, V6, P4327, DOI 10.1016/j.actbio.2010.06.007; Nguyen C, 2013, INVEST OPHTH VIS SCI, V54, P1767, DOI 10.1167/iovs.12-10952; Norman RE, 2011, EXP EYE RES, V93, P4, DOI 10.1016/j.exer.2010.09.014; Petsche SJ, 2013, BIOMECHANICS MODELIN, P1; Pijanka JK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118648; Pijanka JK, 2014, INVEST OPHTH VIS SCI, V55, DOI 10.1167/iovs.14-15047; Pijanka JK, 2012, INVEST OPHTH VIS SCI, V53, P5258, DOI 10.1167/iovs.12-9705; Pyne JD, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026224; QUIGLEY HA, 1991, CURR EYE RES, V10, P877, DOI 10.3109/02713689109013884; QUIGLEY HA, 1991, BRIT J OPHTHALMOL, V75, P552, DOI 10.1136/bjo.75.9.552; Ren RJ, 2009, INVEST OPHTH VIS SCI, V50, P2175, DOI 10.1167/iovs.07-1429; Roberts MD, 2009, INVEST OPHTH VIS SCI, V50, P681, DOI 10.1167/iovs.08-1792; Sigal I, 2014, METHOD ESTIMAT BIOME; Sigal IA, 2005, INVEST OPHTH VIS SCI, V46, P4189, DOI 10.1167/iovs.05-0541; Sigal IA, 2014, INVEST OPHTH VIS SCI, V55, P1, DOI 10.1167/iovs.13-12724; Sigal IA, 2011, INVEST OPHTH VIS SCI, V52, P1896, DOI 10.1167/iovs.10-5500; Steinhart MR, 2012, MOL VIS, V18, P1093; Strouthidis NG, 2013, CURR OPIN PHARMACOL, V13, P83, DOI 10.1016/j.coph.2012.09.001; Sutton MA, 2008, J BIOMED MATER RES A, V84A, P178, DOI 10.1002/jbm.a.31268; Tang JH, 2012, J BIOMECH ENG-T ASME, V134, DOI 10.1115/1.4007365; Tonge TK, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025105; TRIER K, 1990, ACTA OPHTHALMOL, V68, P304; Vurgese S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029692; Watson PG, 2004, EXP EYE RES, V78, P609, DOI 10.1016/S0014-4835(03)00212-4; Zhang L, 2015, INVEST OPHTH VIS SCI, V56, P2031, DOI 10.1167/iovs.14-15734	58	64	67	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131396	10.1371/journal.pone.0131396	http://dx.doi.org/10.1371/journal.pone.0131396			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161963	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000358162300038
J	Jiang, JY; Cheng, YP; Mou, JH; Jin, K; Cui, J				Jiang, Jingyu; Cheng, Yuanping; Mou, Junhui; Jin, Kan; Cui, Jie			Effect of Water Invasion on Outburst Predictive Index of Low Rank Coals in Dalong Mine	PLOS ONE			English	Article							ADSORPTION; METHANE	To improve the coal permeability and outburst prevention, coal seam water injection and a series of outburst prevention measures were tested in outburst coal mines. These methods have become important technologies used for coal and gas outburst prevention and control by increasing the external moisture of coal or decreasing the stress of coal seam and changing the coal pore structure and gas desorption speed. In addition, techniques have had a significant impact on the gas extraction and outburst prevention indicators of coal seams. Globally, low rank coals reservoirs account for nearly half of hidden coal reserves and the most obvious feature of low rank coal is the high natural moisture content. Moisture will restrain the gas desorption and will affect the gas extraction and accuracy of the outburst prediction of coals. To study the influence of injected water on methane desorption dynamic characteristics and the outburst predictive index of coal, coal samples were collected from the Dalong Mine. The methane adsorption/desorption test was conducted on coal samples under conditions of different injected water contents. Selective analysis assessed the variations of the gas desorption quantities and the outburst prediction index (coal cutting desorption index). Adsorption tests indicated that the Langmuir volume of the Dalong coal sample is similar to 40.26 m(3)/t, indicating a strong gas adsorption ability. With the increase of injected water content, the gas desorption amount of the coal samples decreased under the same pressure and temperature. Higher moisture content lowered the accumulation desorption quantity after 120 minutes. The gas desorption volumes and moisture content conformed to a logarithmic relationship. After moisture correction, we obtained the long-flame coal outburst prediction (cutting desorption) index critical value. This value can provide a theoretical basis for outburst prediction and prevention of low rank coal mines and similar occurrence conditions of coal seams.	[Jiang, Jingyu; Cheng, Yuanping; Jin, Kan; Cui, Jie] China Univ Min & Technol, Fac Safety Engn, Key Lab Gas & Fire Control Coal Mine, Xuzhou 221116, Peoples R China; [Jiang, Jingyu; Cheng, Yuanping; Mou, Junhui] China Univ Min & Technol, Natl Engn Res Ctr Coal & Gas Control, Xuzhou 221116, Peoples R China; [Mou, Junhui] Chongqing Univ, State Key Lab Coal Mine Disaster Dynam & Control, Chongqing 400044, Peoples R China	China University of Mining & Technology; China University of Mining & Technology; Chongqing University	Cheng, YP (corresponding author), China Univ Min & Technol, Fac Safety Engn, Key Lab Gas & Fire Control Coal Mine, Xuzhou 221116, Peoples R China.	chengypcumt@163.com		Cheng, Yuanping/0000-0001-6519-6268	A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions; Fundamental Research Funds for the Central Universities [2013QNB01]; National Natural Science Foundation of China [51404260]; Basic Research Program of Jiangsu Province [BK20140206]; China Postdoctoral Science Foundation [2015M572112]	A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Basic Research Program of Jiangsu Province; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	Funding for this research was provided by "A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions", the Fundamental Research Funds for the Central Universities (No. 2013QNB01), the National Natural Science Foundation of China (No. 51404260), the Basic Research Program of Jiangsu Province (No. BK20140206), and the China Postdoctoral Science Foundation (No. 2015M572112).	[Anonymous], 2005, 117602005E ISO; [Anonymous], 1971, COAL MINE SAFETY, V3, P1; Chen LW, 2009, MINING SAFETY ENV PR, V36, P109; Chen XJ, 2015, NAT HAZARDS, V76, P1093, DOI 10.1007/s11069-014-1535-3; Cheng Y., 2007, J MINING SAFETY ENG, V24, P383; Chernov OH, 1979, PREPARATION COAL SEA; Duan KL, 2002, J CHINA COAL SOC, P50; Fang QC, 2009, COAL, V91, P1; Fu JH, 2007, MINING SAFETY ENG J, V24, P253; Hu QT, 2008, OPTIMIZATION MINE GA; Hughes AD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081172; Intelligence Institute of East Coal Company, 1988, PREV COAL GAS OUTB R; Intelligence Research Institute of Coal Ministry of China, 1984, SOV UN EXPL COAL MIN; JOUBERT JI, 1974, FUEL, V53, P186, DOI 10.1016/0016-2361(74)90009-X; JOUBERT JI, 1973, FUEL, V52, P181, DOI 10.1016/0016-2361(73)90076-8; Kang TH, 1995, CHINESE J ROCK MECH, V14, P260; Kong Y.F, 2013, ENERGY TECHNOL MANAG, V38, P41; Langmuir I, 1918, J AM CHEM SOC, V40, P1361, DOI 10.1021/ja02242a004; Li XH, 2009, J LIAONING TU, V28, P202; [李晓红 LI Xiao-hong], 2008, [煤炭学报, Journal of China Coal Society], V33, P1386; Limbri H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094641; [林柏泉 LIN Baiquan], 2007, [煤炭学报, Journal of China Coal Society], V32, P959; [刘明举 Liu Mingju], 2005, [煤炭学报, Journal of China Coal Society], V30, P451; Liu MJ, 2009, COAL ENG, V8, P61; MAHAJAN OP, 1971, FUEL, V50, P308, DOI 10.1016/0016-2361(71)90019-6; Rao ZH, 2015, PROG ENERG COMBUST, V46, P1, DOI 10.1016/j.pecs.2014.09.001; Ren PL, 2009, COAL SCI TECHNOLOGY, V37, P88; State Administration of Coal Mine Safety of China, 2015, FAIL AN REP CHIN COA; Stuart D, 1918, INT J COAL GEOL, V74, P203; Svabova M, 2011, FUEL, V90, P1892, DOI 10.1016/j.fuel.2011.01.005; Thomas JJ, 1976, 493 ILL STAT GEOL SU; Wang ZF, 2007, J HENAN POLYTECHNIC, V26, P117; Xie H., 2014, J CHINA COAL SOC, P1391; Yu BF, 2005, PREVENTION CONTROL G; Yu HL, 2000, J CHONGQING U, V23, P32; Yu QY, 2012, COLE MINE GAS CONTRO; Zhai JB, 2009, COAL TECHNOLOGY, V28, P92; Zhang HX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105139; [张占存 ZHANG Zhancun], 2008, [煤炭学报, Journal of China Coal Society], V33, P144; Zhou SN, 1979, CHINA MINING U J, V2, P53; Zhou YJ, 2009, COAL MINING TECHNOLO, V4, P86; Zimny T, 2005, J COLLOID INTERF SCI, V285, P56, DOI 10.1016/j.jcis.2004.11.029	42	9	9	6	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132355	10.1371/journal.pone.0132355	http://dx.doi.org/10.1371/journal.pone.0132355			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161959	Green Published, Green Submitted, gold			2022-12-26	WOS:000358162300122
J	Mamberti, S; Prati, P; Cremaschi, P; Seppi, C; Morelli, CF; Galizzi, A; Fabbi, M; Calvio, C				Mamberti, Stefania; Prati, Paola; Cremaschi, Paolo; Seppi, Claudio; Morelli, Carlo F.; Galizzi, Alessandro; Fabbi, Massimo; Calvio, Cinzia			gamma-PGA Hydrolases of Phage Origin in Bacillus subtilis and Other Microbial Genomes	PLOS ONE			English	Article							PROTEIN FAMILIES DATABASE; GLUTAMIC ACID; BACTERIOPHAGE PHI-NIT1; CAPSULE SYNTHESIS; CRYSTAL-STRUCTURE; ANTHRACIS; DEGRADATION; SEQUENCE; GENE; TRANSPEPTIDASE	Poly-gamma-glutamate (gamma-PGA) is an industrially interesting polymer secreted mainly by members of the class Bacilli which forms a shield able to protect bacteria from phagocytosis and phages. Few enzymes are known to degrade gamma-PGA; among them is a phage-encoded gamma-PGA hydrolase, PghP. The supposed role of PghP in phages is to ensure access to the surface of bacterial cells by dismantling the gamma-PGA barrier. We identified four unannotated B. subtilis genes through similarity of their encoded products to PghP; in fact these genes reside in prophage elements of B. subtilis genome. The recombinant products of two of them demonstrate efficient polymer degradation, confirming that sequence similarity reflects functional homology. Genes encoding similar gamma-PGA hydrolases were identified in phages specific for the order Bacillales and in numerous microbial genomes, not only belonging to that order. The distribution of the gamma-PGA biosynthesis operon was also investigated with a bioinformatics approach; it was found that the list of organisms endowed with gamma-PGA biosynthetic functions is larger than expected and includes several pathogenic species. Moreover in non-Bacillales bacteria the predicted gamma-PGA hydrolase genes are preferentially found in species that do not have the genetic asset for polymer production. Our findings suggest that gamma-PGA hydrolase genes might have spread across microbial genomes via horizontal exchanges rather than via phage infection. We hypothesize that, in natural habitats rich in gamma-PGA supplied by producer organisms, the availability of hydrolases that release glutamate oligomers from gamma-PGA might be a beneficial trait under positive selection.	[Mamberti, Stefania; Seppi, Claudio; Galizzi, Alessandro; Calvio, Cinzia] Univ Pavia, Dept Biol & Biotechnol, I-27100 Pavia, Italy; [Prati, Paola; Fabbi, Massimo] Ist Zooprofilatt Sperimentale Lombardia & dellEmi, Sez Diagnost Pavia, I-27100 Pavia, Italy; [Cremaschi, Paolo] Natl Res Council Italy, Inst Mol Genet, I-27100 Pavia, Italy; [Morelli, Carlo F.] Univ Milan, Dept Chem, I-20133 Milan, Italy; [Calvio, Cinzia] Italian Interuniv Consortium Mat Sci & Technol IN, Pavia Res Unit, I-27100 Pavia, Italy	University of Pavia; IZS Lombardia e Emilia; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); University of Milan; University of Pavia	Calvio, C (corresponding author), Univ Pavia, Dept Biol & Biotechnol, I-27100 Pavia, Italy.	cinzia.calvio@unipv.it	Morelli, Carlo F./R-2869-2016; Cinzia, Calvio/E-1353-2011	Morelli, Carlo F./0000-0001-6314-6902; Cinzia, Calvio/0000-0003-1631-0452; Mamberti, Stefania/0000-0001-9099-953X; Cremaschi, Paolo/0000-0001-5349-4188	"INSTM-Regione Lombardia" grant; "Piano di Sviluppo dell'Ateneo linea B" grant; Cariplo Foundation [0253/2010]	"INSTM-Regione Lombardia" grant; "Piano di Sviluppo dell'Ateneo linea B" grant; Cariplo Foundation(Fondazione Cariplo)	The work was supported by a "2012 INSTM-Regione Lombardia" grant to CC (http://www.instm.it/consorzio/accordi/0000000384.aspx) and by a "Piano di Sviluppo dell'Ateneo 2014-linea B" grant assigned by the Dept. of Chemistry of the University of Milan to CFM. PC was supported by a Cariplo Foundation (http://www.fondazionecariplo.it/en/index.html) grant n. 0253/2010.	Agarwala R, 2015, NUCLEIC ACIDS RES, V43, pD6, DOI 10.1093/nar/gku1130; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ashiuchi M, 2003, J MOL CATAL B-ENZYM, V23, P249, DOI 10.1016/S1381-1177(03)00087-0; Ashiuchi M, 2002, APPL MICROBIOL BIOT, V59, P9, DOI 10.1007/s00253-002-0984-x; Ashiuchi M, 2001, EUR J BIOCHEM, V268, P5321, DOI 10.1046/j.0014-2956.2001.02475.x; Ashiuchi M, 2006, J BIOSCI BIOENG, V102, P60, DOI 10.1263/jbb.102.60; Bateman A, 2010, ACTA CRYSTALLOGR F, V66, P1148, DOI 10.1107/S1744309110001685; Buescher JM, 2007, CRIT REV BIOTECHNOL, V27, P1, DOI 10.1080/07388550601166458; Cachat E, 2008, FEMS MICROBIOL LETT, V285, P220, DOI 10.1111/j.1574-6968.2008.01231.x; Calvio C, 2005, J BACTERIOL, V187, P5356, DOI 10.1128/JB.187.15.5356-5366.2005; Candela T, 2005, J BACTERIOL, V187, P7765, DOI 10.1128/JB.187.22.7765-7772.2005; Candela T, 2005, MOL MICROBIOL, V57, P717, DOI 10.1111/j.1365-2958.2005.04718.x; Candela T, 2006, MOL MICROBIOL, V60, P1091, DOI 10.1111/j.1365-2958.2006.05179.x; Candela T, 2014, MICROB DRUG RESIST, V20, P222, DOI 10.1089/mdr.2014.0063; Candela T, 2009, CAN J MICROBIOL, V55, P627, DOI [10.1139/W09-003, 10.1139/w09-003]; Chabot DJ, 2004, VACCINE, V23, P43, DOI 10.1016/j.vaccine.2004.05.029; Chibani-Chennoufi S, 2004, J BACTERIOL, V186, P3677, DOI 10.1128/JB.186.12.3677-3686.2004; Cumby Nichole, 2012, Bacteriophage, V2, P225; Drysdale M, 2005, EMBO J, V24, P221, DOI 10.1038/sj.emboj.7600495; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Fouet A, 1996, INFECT IMMUN, V64, P4928, DOI 10.1128/IAI.64.12.4928-4932.1996; Fujimoto Z, 2012, PROTEINS, V80, P722, DOI 10.1002/prot.23229; Fujimoto Z, 2009, ACTA CRYSTALLOGR F, V65, P913, DOI 10.1107/S1744309109029881; Garofolo Giuliano, 2011, BMC Res Notes, V4, P273, DOI 10.1186/1756-0500-4-273; GREEN BD, 1985, INFECT IMMUN, V49, P291, DOI 10.1128/IAI.49.2.291-297.1985; Hezayen FF, 2000, APPL MICROBIOL BIOT, V54, P319, DOI 10.1007/s002530000394; International Office of Epizootics, 2012, MAN DIAGN TESTS VACC, V7th; Kimura K, 2004, MICROBIOL-SGM, V150, P4115, DOI 10.1099/mic.0.27467-0; Kimura K, 2003, APPL ENVIRON MICROB, V69, P2491, DOI 10.1128/AEM.69.5.2491-2497.2003; Kimura K, 2010, MICROBIOL MONOGR, V15, P95, DOI 10.1007/978-3-642-12453-2_6; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Lazarevic V, 1999, MICROBIOL-UK, V145, P1055, DOI 10.1099/13500872-145-5-1055; MAKINO S, 1989, J BACTERIOL, V171, P722, DOI 10.1128/jb.171.2.722-730.1989; Mitchell A, 2015, NUCLEIC ACIDS RES, V43, pD213, DOI 10.1093/nar/gku1243; Nicolas P, 2012, SCIENCE, V335, P1103, DOI 10.1126/science.1206848; Obst M, 2004, BIOMACROMOLECULES, V5, P1166, DOI 10.1021/bm049949u; Ogunleye A, 2015, MICROBIOL-SGM, V161, P1, DOI 10.1099/mic.0.081448-0; Oppermann-Sanio FB, 2002, NATURWISSENSCHAFTEN, V89, P11, DOI 10.1007/s00114-001-0280-0; Osera C, 2009, MICROBIOL-SGM, V155, P2282, DOI 10.1099/mic.0.026435-0; Rasmussen S, 2009, MOL MICROBIOL, V73, P1043, DOI 10.1111/j.1365-2958.2009.06830.x; Rehm BHA, 2010, NAT REV MICROBIOL, V8, P578, DOI 10.1038/nrmicro2354; Scoffone V, 2013, BIOTECHNOL BIOENG, V110, P2006, DOI 10.1002/bit.24846; Scorpio A, 2008, ANTIMICROB AGENTS CH, V52, P1014, DOI 10.1128/AAC.00741-07; Scorpio A, 2007, ANTIMICROB AGENTS CH, V51, P215, DOI 10.1128/AAC.00706-06; Scorpio A, 2010, MICROBIOL-SGM, V156, P1459, DOI 10.1099/mic.0.035857-0; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sung MH, 2005, CHEM REC, V5, P352, DOI 10.1002/tcr.20061; Sutherland MD, 2009, INFECT IMMUN, V77, P532, DOI 10.1128/IAI.01009-08; Suzuki T, 2003, J BACTERIOL, V185, P2379, DOI 10.1128/JB.185.7.2379-2382.2003; Tjalsma H, 2004, MICROBIOL MOL BIOL R, V68, P207, DOI 10.1128/MMBR.68.2.207-233.2004; Toshiro N., 2012, BACTERIOPHAGE, P95; UCHIDA I, 1993, MOL MICROBIOL, V9, P487, DOI 10.1111/j.1365-2958.1993.tb01710.x; Wu RY, 2009, J BIOL CHEM, V284, P24406, DOI 10.1074/jbc.M109.019034; Xu K, 1996, J BACTERIOL, V178, P4319, DOI 10.1128/jb.178.14.4319-4322.1996; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485	55	13	14	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2015	10	7							e0130810	10.1371/journal.pone.0130810	http://dx.doi.org/10.1371/journal.pone.0130810			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EW	26158264	Green Published, Green Submitted, gold			2022-12-26	WOS:000358161200021
J	Lee, MTG; Wang, HM; Ho, JAA; Fan, NC; Yang, YL; Lee, CC; Chen, SC				Lee, Meng-Tse Gabriel; Wang, Hsuan-Mao; Ho, Ja-An Annie; Fan, Nien-Chu; Yang, Ya-Lin; Lee, Chien-Chang; Chen, Shyr-Chyr			Resuscitation Using Liposomal Vasopressin in an Animal Model of Uncontrolled Hemorrhagic Shock	PLOS ONE			English	Article							INJECTION IMMUNOANALYTICAL SYSTEM; MASSIVE SPLENIC INJURY; FLUID RESUSCITATION; RAT; AORTOTOMY; SURVIVAL; DELIVERY; CARRIERS; SWINE	Background Current research suggests that administration of vasopressin to patients with uncontrolled hemorrhagic shock (UHS) can avoid the detrimental effects associated with aggressive fluid resuscitation. However, vasopressin has a short half-life of 10 similar to 35 minutes in in vivo use and precludes its use in the pre-hospital setting. To increase the half-life of vasopressin, we proposed to synthesize liposome-encapsulated vasopressin and test it in a rat model of UHS. Methods The film hydration method was used to prepare liposomal vasopressin consisting of: Dipalmitoylphosphatidylcholine, cholesterol, and dipalmitoyl phosphatidylethanolamine (20: 20: 1 mole ratio). 42 rats were subjected to UHS and randomly received 5 different treatments (vasopressin, liposomal vasopressin, lactate ringer (LR), liposome only and sham). Outcome of UHS were measured using 4 common prognostic tests: mean arterial pressure (MAP), serum lactate level, inflammatory profile and pulmonary edema. Results The dynamic light scattering results confirmed that we had prepared a successful liposomal vasopressin complex. Comparing the serum vasopressin concentration of liposomal vasopressin and vasopressin treated animals by ELISA, we found that the concentration of vasopressin for the liposomal vasopressin treated group is higher at 60 minutes. However, there was no significant difference between the MAP profile of rats treated with vasopressin and liposomal vasopressin in UHS. We also observed that animals treated with liposomal vasopressin performed indifferently to vasopressin treated rats in serum lactate level, inflammatory profile and edema profile. For most of our assays, the liposome only control behaves similarly to LR resuscitation in UHS rats. Conclusion We have synthesized a liposomal vasopressin complex that can prolong the serum concentration of vasopressin in a rat model of UHS. Although UHS rats treated with either liposomal vasopressin or vasopressin showed no statistical differences, it would be worthwhile to repeat the experiments with different liposomal compositions.	[Lee, Meng-Tse Gabriel; Wang, Hsuan-Mao; Yang, Ya-Lin; Lee, Chien-Chang; Chen, Shyr-Chyr] Natl Taiwan Univ Hosp, Dept Emergency Med, Taipei, Taiwan; [Ho, Ja-An Annie; Fan, Nien-Chu] Natl Taiwan Univ, Dept Biochem Sci & Technol, Taipei 10764, Taiwan; [Lee, Chien-Chang] Natl Taiwan Univ Hosp, Yunlin Branch, Dept Emergency Med, Touliu, Taiwan; [Lee, Chien-Chang] Natl Taiwan Univ Hosp, Yunlin Branch, Dept Gen Med, Touliu, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Lee, CC (corresponding author), Natl Taiwan Univ Hosp, Dept Emergency Med, Taipei, Taiwan.	cclee100@gmail.com; scchen@ntu.edu.tw	Wang, Hsuan Mao/AAG-3017-2021; Hsiao, Wei-Hung/B-9931-2013; Lee, Chien-Chang/HHM-5986-2022	LEE, CHIEN-CHANG/0000-0002-1243-2463; Ho, Annie/0000-0001-6684-1118; CHEN, SHYR-CHYR/0000-0002-5858-3013	Taiwan National Science Foundation [NSC101-2314-B-002 -055-MY3]; National Taiwan University [UN102-024]; National Taiwan University Hospital Yunlin Branch Research Grant [NTUHYL104.S008]	Taiwan National Science Foundation; National Taiwan University(National Taiwan University); National Taiwan University Hospital Yunlin Branch Research Grant	This study is supported by Taiwan National Science Foundation Grant NSC101-2314-B-002 -055-MY3; National Taiwan University Grant UN102-024; and National Taiwan University Hospital Yunlin Branch Research Grant, NTUHYL104.S008. No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BADIN J, 2011, CRIT CARE, V15, P45384, DOI DOI 10.1186/cc10253; BICKELL WH, 1991, SURGERY, V110, P529; BICKELL WH, 1994, NEW ENGL J MED, V331, P1105, DOI 10.1056/NEJM199410273311701; BICKELL WH, 1989, CIRC SHOCK, V28, P321; Burris D, 1999, J TRAUMA, V46, P216, DOI 10.1097/00005373-199902000-00003; CAPONE A, 1995, RESUSCITATION, V29, P143, DOI 10.1016/0300-9572(95)00829-I; COUVREUR P, 1991, PHARMACEUT RES, V8, P1079, DOI 10.1023/A:1015885814417; DEAKIN CD, 1994, J ACCID EMERG MED, V11, P154; Delmas A, 2005, CRIT CARE, V9, P212, DOI 10.1188/cc2945; Haas T, 2004, J TRAUMA, V57, P177, DOI 10.1097/01.TA.0000044357.25191.1B; Ho JA, 2005, ANAL CHEM, V77, P3431, DOI 10.1021/ac0484474; Ho JAA, 2007, ANAL CHEM, V79, P246, DOI 10.1021/ac060889n; Ho JAA, 2012, TALANTA, V99, P683, DOI 10.1016/j.talanta.2012.06.077; Holmes JF, 2002, ACAD EMERG MED, V9, P267, DOI 10.1111/j.1553-2712.2002.tb01317.x; HSU MJ, 1982, BIOCHIM BIOPHYS ACTA, V720, P411, DOI 10.1016/0167-4889(82)90120-3; JANAKY T, 1982, J ENDOCRINOL, V93, P295, DOI 10.1677/joe.0.0930295; Jesorka A, 2008, ANNU REV ANAL CHEM, V1, P801, DOI 10.1146/annurev.anchem.1.031207.112747; Kim A, 1999, INT J PHARM, V180, P75, DOI 10.1016/S0378-5173(98)00408-6; Krausz MM, 2001, SHOCK, V16, P383, DOI 10.1097/00024382-200116050-00011; Krismer AC, 2005, ANAESTHESIST, V54, P220, DOI 10.1007/s00101-004-0793-y; Lee CC, 2005, SHOCK, V24, P177, DOI 10.1097/01.shk.0000171870.42900.15; Lee CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095821; Leppaniemi A, 1996, J SURG RES, V63, P413, DOI 10.1006/jsre.1996.0285; Mock C, 2004, LANCET, V363, P2172, DOI 10.1016/S0140-6736(04)16510-0; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; PANICO AM, 1992, INT J PHARM, V80, P93, DOI 10.1016/0378-5173(92)90266-5; Poloujadoff MP, 2007, ANESTHESIOLOGY, V107, P591, DOI 10.1097/01.anes.0000281926.54940.6a; Scarpati G, 2013, TRANSL MED UNISA, V5, P32; Silva-Barcellos NM, 2001, HYPERTENSION, V38, P1266, DOI 10.1161/hy1201.096056; Solomonov E, 2000, CRIT CARE MED, V28, P749, DOI 10.1097/00003246-200003000-00024; STERN SA, 1993, ANN EMERG MED, V22, P155, DOI 10.1016/S0196-0644(05)80195-7; Tamion F, 1997, AM J PHYSIOL-GASTR L, V273, pG314, DOI 10.1152/ajpgi.1997.273.2.G314; Torchilin VP, 2005, NAT REV DRUG DISCOV, V4, P145, DOI 10.1038/nrd1632; WEINER A L, 1989, Advanced Drug Delivery Reviews, V3, P307, DOI 10.1016/0169-409X(89)90026-4; Were LM, 2003, J AGR FOOD CHEM, V51, P8073, DOI 10.1021/jf0348368; WOODLE MC, 1992, PHARMACEUT RES, V9, P260, DOI 10.1023/A:1018953810705; Zingarelli B, 2010, AM J PHYSIOL-GASTR L, V298, pG133, DOI 10.1152/ajpgi.00262.2009	37	1	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0130655	10.1371/journal.pone.0130655	http://dx.doi.org/10.1371/journal.pone.0130655			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154286	Green Submitted, Green Published, gold			2022-12-26	WOS:000358159700034
J	Lotz, S				Lotz, Sebastian			Spontaneous Giving under Structural Inequality: Intuition Promotes Cooperation in Asymmetric Social Dilemmas	PLOS ONE			English	Article							EVOLUTION; HETEROGENEITY; REFLECTION; PUNISHMENT; BEHAVIOR; GAMES	The present research investigates the role of intuitive mental processing on cooperation in experimental games involving structural inequality. Results from an experiment using conceptual priming to induce intuitive mental processing provide the first evidence that cooperation is promoted by intuition in an asymmetric context that distributes the gains from cooperation unequally among a group. Therefore, the results extend our understanding of the cognitive underpinnings of human cooperation by demonstrating the robustness of intuitive cooperation in games involving structural inequality regarding asymmetric gains from cooperation. Additionally, the results provide the first successful conceptual replication of the intuition-cooperation link using conceptual priming, therefore also contributing to the debate about the validity of previous research in other contexts. Taken together, the present research contributes to the literature on psychological and institutional mechanisms that promote cooperation.	[Lotz, Sebastian] Stanford Univ, Dept Sociol, Stanford, CA 94305 USA; [Lotz, Sebastian] Univ Lausanne, Dept Econ, Lausanne, Switzerland	Stanford University; University of Lausanne	Lotz, S (corresponding author), Stanford Univ, Dept Sociol, Stanford, CA 94305 USA.	sebastian.lotz@stanford.edu			Deutsche Forschungsgemeinschaft [LO1826 1/1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This research was supported by Deutsche Forschungsgemeinschaft (www.dfg.de) through grant LO1826 1/1 awarded to SL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson L. R., 2008, J SOCIO-ECON, V37, P1010, DOI [10.1016/j.socec.2006.12.073, DOI 10.1016/J.SOCEC.2006.12.073, DOI 10.1016/j.socec.2006.12.073]; Bartlett MY, 2006, PSYCHOL SCI, V17, P319, DOI 10.1111/j.1467-9280.2006.01705.x; Brekke K. A., 2012, COOPERATION RE UNPUB; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Camerer C.F., 2003, BEHAV GAME THEORY EX, DOI 10.1257/jep.9.2.209; Chen S, 1999, DUAL-PROCESS THEORIES IN SOCIAL PSYCHOLOGY, P73; Cherry TL, 2005, J ECON BEHAV ORGAN, V57, P357, DOI 10.1016/j.jebo.2003.11.010; Cone J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115756; Cornelissen G, 2011, PERS SOC PSYCHOL B, V37, P1080, DOI 10.1177/0146167211405996; Evans A. T., 2015, REACTION TIMES REFLE; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fisher J, 1995, PUBLIC CHOICE, V85, P249, DOI 10.1007/BF01048198; Forgas JP, 1998, J PERS SOC PSYCHOL, V74, P565, DOI 10.1037/0022-3514.74.3.565; Frederick S, 2005, J ECON PERSPECT, V19, P25, DOI 10.1257/089533005775196732; Gervais WM, 2012, SCIENCE, V336, P493, DOI 10.1126/science.1215647; Guth W, 2007, J PUBLIC ECON, V91, P1023, DOI 10.1016/j.jpubeco.2006.10.007; Haigner SD, 2010, ECON LETT, V108, P93, DOI 10.1016/j.econlet.2010.04.025; Halali E., 2012, FRONT HUM NEUROSCI, V7, P240; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; HERTEL G, 1994, EUR J SOC PSYCHOL, V24, P131, DOI 10.1002/ejsp.2420240110; Johansson-Stenman O, 2010, ENVIRON RESOUR ECON, V46, P147, DOI 10.1007/s10640-010-9356-7; Kahneman D., 2011, THINKING FAST SLOW; Ledyard J., 1995, HDB EXPT EC; Lotz S, 2011, J EXP SOC PSYCHOL, V47, P477, DOI 10.1016/j.jesp.2010.10.004; Moxnes E, 2003, J CONFLICT RESOLUT, V47, P773, DOI 10.1177/0022002703258962; Nowak MA, 2005, NATURE, V437, P1291, DOI 10.1038/nature04131; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Ostrom E., 1990, GOVERNING COMMONS EV; Oxoby RJ, 2013, ECON INQ, V51, P2071, DOI 10.1111/j.1465-7295.2012.00493.x; Pashler H, 2012, PERSPECT PSYCHOL SCI, V7, P531, DOI 10.1177/1745691612463401; Peysakhovich A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5939; Rand D. G., 2014, NATURE COMMUNICATION, V5; Rand DG, 2015, J BEHAV DECIS MAKING, V28, P159, DOI 10.1002/bdm.1837; Rand DG, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00300; Rand DG, 2013, TRENDS COGN SCI, V17, P413, DOI 10.1016/j.tics.2013.06.003; Rand DG, 2013, NATURE, V498, pE2, DOI 10.1038/nature12195; Rand DG, 2012, NATURE, V489, P427, DOI 10.1038/nature11467; Rivas MF, 2011, ECON LETT, V112, P176, DOI 10.1016/j.econlet.2011.04.007; Roch SG, 2000, ORGAN BEHAV HUM DEC, V83, P185, DOI 10.1006/obhd.2000.2915; Schmidt S, 2009, REV GEN PSYCHOL, V13, P90, DOI 10.1037/a0015108; Schulz JF, 2014, J ECON PSYCHOL, V41, P77, DOI 10.1016/j.joep.2012.08.007; Shenhav A, 2012, J EXP PSYCHOL GEN, V141, P423, DOI 10.1037/a0025391; Simmons J. P., 2013, M SOC PERS SOC PSYCH; Simons DJ, 2014, PERSPECT PSYCHOL SCI, V9, P76, DOI 10.1177/1745691613514755; Sloman SA, 1996, PSYCHOL BULL, V119, P3, DOI 10.1037/0033-2909.119.1.3; Stanovich KE, 1998, J EXP PSYCHOL GEN, V127, P161, DOI 10.1037/0096-3445.127.2.161; Tan FF, 2008, ECONOMIST-NETHERLAND, V156, P269, DOI 10.1007/s10645-008-9094-1; Tan HB, 2010, J EXP SOC PSYCHOL, V46, P571, DOI 10.1016/j.jesp.2010.01.007; Tinghog G, 2013, NATURE, V498, pE1, DOI 10.1038/nature12194; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Van der Heijden E., 2003, 38 TILB U; Verkoeijen PPJL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096654; WILSON DS, 1975, P NATL ACAD SCI USA, V72, P143, DOI 10.1073/pnas.72.1.143	55	23	25	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0131562	10.1371/journal.pone.0131562	http://dx.doi.org/10.1371/journal.pone.0131562			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1EJ	26154284	Green Published, gold, Green Submitted			2022-12-26	WOS:000358159700072
J	Wojan, TR; Hamrick, KS				Wojan, Timothy R.; Hamrick, Karen S.			Can Walking or Biking to Work Really Make a Difference? Compact Development, Observed Commuter Choice and Body Mass Index	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; BUILT ENVIRONMENT; URBAN SPRAWL; PUBLIC-HEALTH; SMART GROWTH; LAND-USE; OBESITY; EXERCISE; DESIGN; SCHOOL	Objectives Promoting active commuting is viewed as one strategy to increase physical activity and improve the energy balance of more sedentary individuals thereby improving health outcomes. However, the potential effectiveness of promotion policies may be seriously undermined by the endogenous choice of commute mode. Policy to promote active commuting will be most effective if it can be demonstrated that 1) those in compact cities do not necessarily have a preference for more physical activity, and 2) that current active commuting is not explained by unobserved characteristics that may be the true source of a lower body mass index (BMI). Methods Daily time-use diaries are used in combination with geographical characteristics of where respondents live and work to test 1) whether residents of more compact settlements are characterized by higher activity levels; and 2) whether residents of more compact settlements are more likely to bike or walk to work. An endogenous treatment model of active commuting allows testing whether reductions in BMI associated with walking or biking to work are in fact attributable to that activity or are more strongly associated with unobserved characteristics of these active commuters. Results The analysis of general activity levels confirms that residents of more compact cities do not expend more energy than residents of more sprawling cities, indicating that those in compact cities do not necessarily have a preference for more physical activity. The endogenous treatment model is consistent with walking or biking to work having an independent effect on BMI, as unobserved factors that contribute to a higher likelihood of active commuting are not associated with lower BMI. Conclusions Despite evidence that more compact settlement patterns enable active commuting, only a small share of workers in these areas choose to walk or bike to work. In general, the activity level of residents in more compact cities and residents in more sprawling areas is very similar. But, there is a robust association between active commuting and lower body mass index that is not explained by unobserved attributes or preferences suggests that policies to promote active commuting may be effective. In particular, active commuting has a greater effect on BMI. Consequently, compact settlement appears to be an effective infrastructure for promoting more active lifestyles. The policy challenge is finding ways to ensure that this infrastructure is more widely utilized.	[Wojan, Timothy R.; Hamrick, Karen S.] US Dept Agr Econ Res Serv, Washington, DC USA		Wojan, TR (corresponding author), US Dept Agr Econ Res Serv, Washington, DC USA.	twojan@ers.usda.gov		Wojan, Timothy/0000-0001-9863-1457				Aarts H, 1997, HEALTH EDUC RES, V12, P363, DOI 10.1093/her/12.3.363; Adams SA, 2005, AM J EPIDEMIOL, V161, P389, DOI 10.1093/aje/kwi054; American Association of State Highway and Transportation Officials, 2013, COMMUTING AM 2013 NA; Arcaya M, 2014, PREV MED, V65, P40, DOI 10.1016/j.ypmed.2014.04.006; Brenner PS, 2013, 201302 CDE U WISC MA; Brenner PS, 2013, 201302 U WISC MAD CT; Buehler R, 2012, TRANSPORTATION, V39, P409, DOI 10.1007/s11116-011-9355-8; Burchfield M, 2006, Q J ECON, V121, P587, DOI 10.1162/qjec.2006.121.2.587; Clark A, 2014, URBAN STUD, V51, P284, DOI 10.1177/0042098013489742; Courtemanche C, 2011, J URBAN ECON, V69, P165, DOI 10.1016/j.jue.2010.09.005; Dietary Guidelines Advisory Committee, 2010, REPORT DIETARY GUIDE; Ding D, 2012, HEALTH PLACE, V18, P100, DOI 10.1016/j.healthplace.2011.08.021; Durand CP, 2011, OBES REV, V12, pe173, DOI 10.1111/j.1467-789X.2010.00826.x; Eid J, 2008, J URBAN ECON, V63, P385, DOI 10.1016/j.jue.2007.12.002; Ewing R, 2003, AM J HEALTH PROMOT, V18, P47, DOI 10.4278/0890-1171-18.1.47; Finlay KA, 2002, J APPL SOC PSYCHOL, V32, P342, DOI 10.1111/j.1559-1816.2002.tb00219.x; Forsyth A, 2008, URBAN STUD, V45, P1973, DOI 10.1177/0042098008093386; Forsyth A, 2007, URBAN STUD, V44, P679, DOI 10.1080/00420980601184729; Frank LD, 2004, AM J PREV MED, V27, P87, DOI 10.1016/j.amepre.2004.04.011; Frank LD, 2005, INT REGIONAL SCI REV, V28, P193, DOI 10.1177/0160017604273853; French SA, 2001, ANNU REV PUBL HEALTH, V22, P309, DOI 10.1146/annurev.publhealth.22.1.309; Gregory CA., 2013, ERR147 USDA EC RES S; Hamrick K, 2012, TB1934 USDA EC RES S, VTB-1934; Handy S, 2005, INT REGIONAL SCI REV, V28, P146, DOI 10.1177/0160017604273626; Heelan KA, 2005, CHILD CARE HLTH DEV, V31, P341, DOI 10.1111/j.1365-2214.2005.00513.x; Kerr J, 2006, MED SCI SPORT EXER, V38, P787, DOI 10.1249/01.mss.0000210208.63565.73; Lambe J, 2000, EUR J CLIN NUTR, V54, P166, DOI 10.1038/sj.ejcn.1600915; Lowy J, 2010, WASHINGTON POST; McKenzie B, 2014, ACS26 US BUR CENS, VACS-26; National Centers for Environmental Prediction/Environmental Modeling Center, 2012, N AM LAND DATA ASSIM; Neal DT, 2006, CURR DIR PSYCHOL SCI, V15, P198, DOI 10.1111/j.1467-8721.2006.00435.x; Owen N, 2014, BRIT J SPORT MED, V48, P174, DOI 10.1136/bjsports-2013-093107; Pinkston J, 2009, 31 INT ASS TIM US RE; Plantinga AJ, 2005, J REGIONAL SCI, V45, P473, DOI 10.1111/j.0022-4146.2005.00380.x; Plantinga AJ, 2007, J REGIONAL SCI, V47, P857, DOI 10.1111/j.1467-9787.2007.00533.x; Raux C, 2011, HALSHS00612610; Robinson J., 1999, TIME LIFE SURPRISING, V2nd; Robinson JP, 2011, MON LABOR REV, V134, P43; Saelens BE, 2008, MED SCI SPORT EXER, V40, pS550, DOI 10.1249/MSS.0b013e31817c67a4; Schmidt T., 2011, DTSCH BUNDESBANK DIS; SIVAK M, 1983, Journal of Safety Research, V14, P93, DOI 10.1016/0022-4375(83)90019-1; Sivak M, 2009, TRAFFIC INJ PREV, V10, P511, DOI 10.1080/15389580903277580; Sturm R, 2014, CA-CANCER J CLIN, V64, P337, DOI 10.3322/caac.21237; Sugiyama T, 2014, CURR OBES REP, V3, P183, DOI 10.1007/s13679-014-0096-9; Tudor-Locke C, 2009, J PHYS ACT HEALTH, V6, P347, DOI 10.1123/jpah.6.3.347; U.S. Census Bureau, 2003, CENSUS 2000 SUMMARY; U. S. Census Bureau, 2009, 2009 AM COMMUNITY SU; Wansink B, 2007, MINDLESS EATING WHY; Zhao ZX, 2010, J HEALTH ECON, V29, P779, DOI 10.1016/j.jhealeco.2010.07.006	49	17	17	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0130903	10.1371/journal.pone.0130903	http://dx.doi.org/10.1371/journal.pone.0130903			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1EJ	26154176	Green Published, Green Submitted, gold			2022-12-26	WOS:000358159700044
J	Carlsen, EM; Renault, KM; Jensen, RB; Norgaard, K; Jensen, JEB; Nilas, L; Cortes, D; Michaelsen, KF; Pryds, O				Carlsen, Emma M.; Renault, Kristina M.; Jensen, Rikke B.; Norgaard, Kirsten; Jensen, Jens-Erik B.; Nilas, Lisbeth; Cortes, Dina; Michaelsen, Kim F.; Pryds, Ole			The Association between Newborn Regional Body Composition and Cord Blood Concentrations of C-Peptide and Insulin-Like Growth Factor I	PLOS ONE			English	Article							GESTATIONAL WEIGHT-GAIN; MASS INDEX; CHILDHOOD OBESITY; BIRTH-WEIGHT; FETAL-GROWTH; ADIPOSITY; RISK; LIFE; INFANTS; UTERO	Background Third trimester fetal growth is partially regulated by C-peptide and insulin-like growth factor I (IGF-I). Prenatal exposures including maternal obesity and high gestational weight gain as well as high birth weight have been linked to subsequent metabolic disease. We evaluated the associations between newborn regional body composition and cord blood levels of C-peptide and IGF-I. Methods We prospectively included obese and normal-weight mothers and their newborns; cord blood was collected and frozen. Analyses of C-peptide and IGF-I were performed simultaneously, after recruitment was completed. Newborn regional body composition was assessed with dual-energy X-ray absorptiometry scanning (DXA) within 48 hours of birth. Results Three hundred thirty-six term infants were eligible to participate in the study; of whom 174 (52%) infants had cord blood taken. Total, abdominal and arm and leg fat mass were positively associated with C-peptide (p < 0.001). Arm and leg fat mass was associated with IGF-I concentration: 28 g [95% confidence interval: 4, 53] per doubling of IGF-I. There was no association between total or abdominal fat mass and IGF-I. Fat-free mass was positively associated with both C-peptide (p < 0.001) and IGF-I (p = 0.004). Conclusion Peripheral fat tissue accumulation was associated with cord blood C-peptide and IGF-I. Total and abdominal fat masses were related to C-peptide but not to IGF-I. Thus, newborn adiposity is partially mediated through C-peptide and early linear growth is associated with IGF-I.	[Carlsen, Emma M.; Cortes, Dina; Pryds, Ole] Univ Copenhagen, Hvidovre Univ Hosp, Dept Pediat, Hvidovre, Denmark; [Renault, Kristina M.] Univ Southern Denmark, Odense Univ Hosp, Dept Obstet & Gynecol, Odense, Denmark; [Jensen, Rikke B.] Univ Copenhagen, Rigshosp, Fac Hlth & Med Sci, Dept Growth & Reprod, DK-2100 Copenhagen, Denmark; [Norgaard, Kirsten; Jensen, Jens-Erik B.] Univ Copenhagen, Hvidovre Univ Hosp, Dept Endocrinol, Hvidovre, Denmark; [Nilas, Lisbeth; Cortes, Dina; Pryds, Ole] Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark; [Renault, Kristina M.; Nilas, Lisbeth] Univ Copenhagen, Hvidovre Univ Hosp, Dept Obstet & Gynecol, Hvidovre, Denmark; [Michaelsen, Kim F.] Univ Copenhagen, Fac Sci, Dept Nutr Exercise & Sports, Copenhagen, Denmark	University of Copenhagen; University of Southern Denmark; Odense University Hospital; Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen	Carlsen, EM (corresponding author), Univ Copenhagen, Hvidovre Univ Hosp, Dept Pediat, Hvidovre, Denmark.	emc@dadlnet.dk	Nørgaard, Kirsten/AAC-9803-2020; Jensen, Rikke Beck/AAB-3236-2020; Renault, Kristina Martha/H-7265-2019	Nørgaard, Kirsten/0000-0003-1620-8271; Jensen, Rikke Beck/0000-0002-4522-672X; Cortes, Dina/0000-0002-6852-6530; Carlsen, Emma Malchau/0000-0002-5563-1964; Jensen, Jens-Erik Beck/0000-0003-4290-0480; Renault, Kristina Martha/0000-0002-6387-9652; Michaelsen, Kim F/0000-0003-0449-0839	University of Copenhagen; Hvidovre University Hospital; Dagmar Marshalls Foundation; Dronning Louises Foundation	University of Copenhagen; Hvidovre University Hospital; Dagmar Marshalls Foundation; Dronning Louises Foundation	The study was supported by the University of Copenhagen, Hvidovre University Hospital, Dagmar Marshalls Foundation and Dronning Louises Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beltrand J, 2008, J CLIN ENDOCR METAB, V93, P4027, DOI 10.1210/jc.2008-0562; Bennet L, 2001, J PHYSIOL-LONDON, V531, P835, DOI 10.1111/j.1469-7793.2001.0835h.x; Canpolat FE, 2011, TWIN RES HUM GENET, V14, P94, DOI 10.1375/twin.14.1.94; Carlsen EM, 2014, ACTA PAEDIATR, V103, P939, DOI 10.1111/apa.12713; Catalano PM, 2009, AM J CLIN NUTR, V90, P1303, DOI 10.3945/ajcn.2008.27416; Catalano PM, 2003, AM J OBSTET GYNECOL, V189, P1698, DOI 10.1016/S0002-9378(03)00828-7; Cooke RJ, 2010, PEDIATR RES, V67, P660, DOI 10.1203/PDR.0b013e3181da8d01; Crozier SR, 2010, AM J CLIN NUTR, V91, P1745, DOI 10.3945/ajcn.2009.29128; de Onis M, 2006, ACTA PAEDIATR, V95, P76, DOI 10.1080/08035320500495548; Gaillard R, 2014, HYPERTENSION, V63, P683, DOI 10.1161/HYPERTENSIONAHA.113.02671; Gluckman PD, 2003, J NUTR, V133, p1741S, DOI 10.1093/jn/133.5.1741S; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Godang K, 2010, J CLIN DENSITOM, V13, P151, DOI 10.1016/j.jocd.2010.01.121; Grohmann M, 2005, J LIPID RES, V46, P93, DOI 10.1194/jlr.M400295-JLR200; Harder T, 2007, AM J EPIDEMIOL, V165, P849, DOI 10.1093/aje/kwk071; Hochner H, 2012, CIRCULATION, V125, P1381, DOI 10.1161/CIRCULATIONAHA.111.070060; Ibanez L, 2008, J CLIN ENDOCR METAB, V93, P2774, DOI 10.1210/jc.2008-0526; Institute of Medicine, 2009, WEIGHT GAIN PREGN RE; Jansson N, 2008, AM J CLIN NUTR, V87, P1743, DOI 10.1093/ajcn/87.6.1743; Javaid MK, 2004, J BONE MINER RES, V19, P56, DOI 10.1359/JBMR.0301211; Juul A, 2002, CIRCULATION, V106, P939, DOI 10.1161/01.CIR.0000027563.44593.CC; Kamath CC, 2008, J CLIN ENDOCR METAB, V93, P4606, DOI 10.1210/jc.2006-2411; Kullberg J, 2009, BRIT J RADIOL, V82, P123, DOI 10.1259/bjr/80083156; Lausten-Thomsen U, 2013, EUR J PEDIATR, V172, P747, DOI 10.1007/s00431-013-1949-z; LIND T, 1991, DIABETES, V40, P8, DOI 10.2337/diab.40.2.S8; Lobstein T., 2004, OBESITY REV OFFIC S1, V5, P4, DOI [10.1111/j.1467-789X.2004.00133.x, DOI 10.1111/J.1467-789X.2004.00133.X]; Madsen AL, 2011, GROWTH HORM IGF RES, V21, P199, DOI 10.1016/j.ghir.2011.05.003; Marsal K, 1996, ACTA PAEDIATR, V85, P843, DOI 10.1111/j.1651-2227.1996.tb14164.x; Melnik BC, 2009, MED HYPOTHESES, V73, P670, DOI 10.1016/j.mehy.2009.04.047; Metzger BE, 2009, DIABETES, V58, P453, DOI 10.2337/db08-1112; Ong KK, 2009, AM J CLIN NUTR, V90, P156, DOI 10.3945/ajcn.2008.27408; ORAHILLY S, 1987, DIABETOLOGIA, V30, P394, DOI 10.1007/BF00292540; PEDERSEN J, 1952, Nord Med, V47, P1049; PEDERSEN J, 1952, ACTA ENDOCRINOL-COP, V9, P342, DOI 10.1530/acta.0.0090342; Plagemann A, 2012, BEST PRACT RES CL EN, V26, P641, DOI 10.1016/j.beem.2012.03.008; Regnault N, 2011, DIABETES, V60, P2152, DOI 10.2337/db10-1189; Renault KM, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.09.029; Schack-Nielsen L, 2010, INT J OBESITY, V34, P67, DOI 10.1038/ijo.2009.206; Schellong K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047776; Sorensen TIA, 2009, P NUTR SOC, V68, P43, DOI 10.1017/S0029665108008847; Tounian P, 2011, ANN NUTR METAB, V58, P30, DOI 10.1159/000328038; Vatten LJ, 2002, PEDIATRICS, V109, P1131, DOI 10.1542/peds.109.6.1131	42	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2015	10	7							e0121350	10.1371/journal.pone.0121350	http://dx.doi.org/10.1371/journal.pone.0121350			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EC	26151559	Green Published, Green Submitted, gold			2022-12-26	WOS:000358158900001
J	Solano, CM; Okoth, SA; Abdallah, JF; Pava, Z; Dorado, E; Incardona, S; Huber, CS; de Oliveira, AM; Bell, D; Udhayakumar, V; Barnwell, JW				Murillo Solano, Claribel; Okoth, Sheila Akinyi; Abdallah, Joseph F.; Pava, Zuleima; Dorado, Erika; Incardona, Sandra; Huber, Curtis S.; de Oliveira, Alexandre Macedo; Bell, David; Udhayakumar, Venkatachalam; Barnwell, John W.			Deletion of Plasmodium falciparum Histidine-Rich Protein 2 (pfhrp2) and Histidine-Rich Protein 3 (pfhrp3) Genes in Colombian Parasites	PLOS ONE			English	Article							SULFADOXINE-PYRIMETHAMINE RESISTANCE; MICROSATELLITE MARKERS; MALARIA; POPULATION; ORIGIN; BREAKPOINTS; DIVERSITY; NETWORK; SENEGAL; REGION	A number of studies have analyzed the performance of malaria rapid diagnostic tests (RDTs) in Colombia with discrepancies in performance being attributed to a combination of factors such as parasite levels, interpretation of RDT results and/ or the handling and storage of RDT kits. However, some of the inconsistencies observed with results from Plasmodium falciparum histidine-rich protein 2 (PfHRP2)-based RDTs could also be explained by the deletion of the gene that encodes the protein, pfhrp2, and its structural homolog, pfhrp3, in some parasite isolates. Given that pfhrp2- and pfhrp3-negative P. falciparum isolates have been detected in the neighboring Peruvian and Brazilian Amazon regions, we hypothesized that parasites with deletions of pfhrp2 and pfhrp3 may also be present in Colombia. In this study we tested 100 historical samples collected between 1999 and 2009 from six Departments in Colombia for the presence of pfhrp2, pfhrp3 and their flanking genes. Seven neutral microsatellites were also used to determine the genetic background of these parasites. In total 18 of 100 parasite isolates were found to have deleted pfhrp2, a majority of which (14 of 18) were collected from Amazonas Department, which borders Peru and Brazil. pfhrp3 deletions were found in 52 of the100 samples collected from all regions of the country. pfhrp2 flanking genes PF3D7_0831900 and PF3D7_0831700 were deleted in 22 of 100 and in 1 of 100 samples, respectively. pfhrp3 flanking genes PF3D7_1372100 and PF3D7_1372400 were missing in 55 of 100 and in 57 of 100 samples. Structure analysis of microsatellite data indicated that Colombian samples tested in this study belonged to four clusters and they segregated mostly based on their geographic region. Most of the pfhrp2deleted parasites were assigned to a single cluster and originated from Amazonas Department although a few pfhrp2-negative parasites originated from the other three clusters. The presence of a high proportion of pfhrp2-negative isolates in the Colombian Amazon may have implications for the use of PfHRP2-based RDTs in the region and may explain inconsistencies observed when PfHRP2-based tests and assays are performed.	[Murillo Solano, Claribel; Pava, Zuleima; Dorado, Erika] Ctr Int Entrenamiento & Invest Med CIDEIM, Cali, Colombia; [Okoth, Sheila Akinyi; Abdallah, Joseph F.; Huber, Curtis S.; de Oliveira, Alexandre Macedo; Udhayakumar, Venkatachalam; Barnwell, John W.] Ctr Dis Control & Prevent, Ctr Global Hlth, Div Parasit Dis & Malaria, Malaria Branch, Atlanta, GA USA; [Okoth, Sheila Akinyi] Atlanta Res & Educ Fdn, Decatur, GA USA; [Incardona, Sandra; Bell, David] Fdn Innovat New Diagnost, CH-1202 Geneva, Switzerland; [Bell, David] Global Good Fund, Intellectual Ventures Lab, Bellevue, WA USA	Centers for Disease Control & Prevention - USA; Foundation For Innovative New Diagnostics; Intellectual Ventures	Solano, CM (corresponding author), Ctr Int Entrenamiento & Invest Med CIDEIM, Carrera 125 19-225 Av, Cali, Colombia.	claribel_murillo@cideim.org.co		Incardona, Sandra/0000-0003-4994-1736; Pava, Zuleima/0000-0002-4802-0647	Foundation for Innovative New Diagnostics; United States Agency for International Development; Instituto Colombiano para el Desarrollo de la Ciencia y la Tecnologia Francisco Jose de Caldas, Colciencias [512-2010]; CDC based American Society for Microbiology Postdoctoral Fellowship; Atlanta Research and Educational Foundation; FOGARTY INTERNATIONAL CENTER [D43TW006589] Funding Source: NIH RePORTER	Foundation for Innovative New Diagnostics; United States Agency for International Development(United States Agency for International Development (USAID)); Instituto Colombiano para el Desarrollo de la Ciencia y la Tecnologia Francisco Jose de Caldas, Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); CDC based American Society for Microbiology Postdoctoral Fellowship; Atlanta Research and Educational Foundation; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	Sample collection and training were supported by Foundation for Innovative New Diagnostics. Genotyping experiments and travel were supported by the Amazon Malaria Initiative, which is funded by the United States Agency for International Development. Instituto Colombiano para el Desarrollo de la Ciencia y la Tecnologia Francisco Jose de Caldas, Colciencias supported CMS (No. 512-2010). CDC based American Society for Microbiology Postdoctoral Fellowship partly supported SAO. Atlanta Research and Educational Foundation partly supported the laboratory work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah JF, 2015, MALARIA J, V14, DOI 10.1186/s12936-014-0537-7; Akinyi Okoth S, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0126805, DOI 10.1371/J0URNAL.P0NE.0126805]; Akinyi S, 2013, SCI REP-UK, V3, DOI 10.1038/srep02797; Anderson TJC, 2000, MOL BIOL EVOL, V17, P1467, DOI 10.1093/oxfordjournals.molbev.a026247; Anderson TJC, 1999, PARASITOLOGY, V119, P113, DOI 10.1017/S0031182099004552; [Anonymous], 2012, MAL RAP DIAGN TEST P; Aponte SL, 2011, MEM I OSWALDO CRUZ, V106, P123, DOI 10.1590/S0074-02762011000900016; Bell DR, 2005, AM J TROP MED HYG, V73, P199, DOI 10.4269/ajtmh.2005.73.199; BIGGS BA, 1989, P NATL ACAD SCI USA, V86, P2428, DOI 10.1073/pnas.86.7.2428; Bopp SER, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003293; Branch OH, 2011, MOL BIOL EVOL, V28, P1973, DOI 10.1093/molbev/msq311; Chaparro P, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-330; Cheng Q, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-283; Chiodini PL, 2007, T ROY SOC TROP MED H, V101, P331, DOI 10.1016/j.trstmh.2006.09.007; Corredor V, 2010, ANTIMICROB AGENTS CH, V54, P3121, DOI 10.1128/AAC.00036-10; Martha RCD, 2007, MEM I OSWALDO CRUZ, V102, P293, DOI 10.1590/S0074-02762007005000044; Deme AB, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-34; Dharia NV, 2010, GENOME RES, V20, P1534, DOI 10.1101/gr.105163.110; Earl DA, 2011, CONSERV GENET RESOUR, V4, P359, DOI DOI 10.1007/S12686-011-9548-7; Echeverry DF, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-2; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Gamboa D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008091; Griffing SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023486; Hoffmann EHE, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-24; Houze S, 2011, J CLIN MICROBIOL, V49, P2694, DOI 10.1128/JCM.00281-11; Koita OA, 2012, AM J TROP MED HYG, V86, P194, DOI 10.4269/ajtmh.2012.10-0665; Kumar N, 2013, ACTA TROP, V125, P119, DOI 10.1016/j.actatropica.2012.09.015; Ospina OL, 2012, BIOMEDICA, V32, P46, DOI 10.1590/S0120-41572012000500007; Machado RLD, 2004, J INFECT DIS, V190, P1547, DOI 10.1086/424601; Maltha J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043094; McCollum AM, 2007, ANTIMICROB AGENTS CH, V51, P2085, DOI 10.1128/AAC.01228-06; Pan American Health Organization, 2011, REP SIT MAL AM 2011; Pritchard JK, 2000, GENETICS, V155, P945; Ramutton T, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-276; Rennie W, 2007, T ROY SOC TROP MED H, V101, P9, DOI 10.1016/j.trstmh.2006.03.011; SCHERF A, 1992, NUCLEIC ACIDS RES, V20, P1491, DOI 10.1093/nar/20.7.1491; SHIRLEY MW, 1990, MOL BIOCHEM PARASIT, V40, P137, DOI 10.1016/0166-6851(90)90087-3; Singh B, 1999, AM J TROP MED HYG, V60, P687, DOI 10.4269/ajtmh.1999.60.687; WELLEMS TE, 1987, CELL, V49, P633, DOI 10.1016/0092-8674(87)90539-3; WELLEMS TE, 1991, P NATL ACAD SCI USA, V88, P3382, DOI 10.1073/pnas.88.8.3382; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Wurtz N, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-34	42	45	45	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2015	10	7							e0131576	10.1371/journal.pone.0131576	http://dx.doi.org/10.1371/journal.pone.0131576			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EC	26151448	Green Submitted, Green Published, gold			2022-12-26	WOS:000358158900020
J	Saarinen, PE; Kalliomaki, P; Tang, JW; Koskela, H				Saarinen, Pekka E.; Kalliomaki, Petri; Tang, Julian W.; Koskela, Hannu			Large Eddy Simulation of Air Escape through a Hospital Isolation Room Single Hinged Doorway-Validation by Using Tracer Gases and Simulated Smoke Videos	PLOS ONE			English	Article							ACUTE RESPIRATORY SYNDROME; INFLUENZA-A; AEROSOL TRANSMISSION; AIRBORNE TRANSMISSION; SARS; VIRUS; VENTILATION; PARTICLES; OUTBREAK; EXPOSURE	The use of hospital isolation rooms has increased considerably in recent years due to the worldwide outbreaks of various emerging infectious diseases. However, the passage of staff through isolation room doors is suspected to be a cause of containment failure, especially in case of hinged doors. It is therefore important to minimize inadvertent contaminant airflow leakage across the doorway during such movements. To this end, it is essential to investigate the behavior of such airflows, especially the overall volume of air that can potentially leak across the doorway during door-opening and human passage. Experimental measurements using full-scale mock-ups are expensive and labour intensive. A useful alternative approach is the application of Computational Fluid Dynamics (CFD) modelling using a time-resolved Large Eddy Simulation (LES) method. In this study simulated air flow patterns are qualitatively compared with experimental ones, and the simulated total volume of air that escapes is compared with the experimentally measured volume. It is shown that the LES method is able to reproduce, at room scale, the complex transient airflows generated during door-opening/ closing motions and the passage of a human figure through the doorway between two rooms. This was a basic test case that was performed in an isothermal environment without ventilation. However, the advantage of the CFD approach is that the addition of ventilation airflows and a temperature difference between the rooms is, in principle, a relatively simple task. A standard method to observe flow structures is dosing smoke into the flow. In this paper we introduce graphical methods to simulate smoke experiments by LES, making it very easy to compare the CFD simulation to the experiments. The results demonstrate that the transient CFD simulation is a promising tool to compare different isolation room scenarios without the need to construct full-scale experimental models. The CFD model is able to reproduce the complex airflows and estimate the volume of air escaping as a function of time. In this test, the calculated migrated air volume in the CFD model differed by 20% from the experimental tracer gas measurements. In the case containing only a hinged door operation, without passage, the difference was only 10%.	[Saarinen, Pekka E.; Kalliomaki, Petri; Koskela, Hannu] Finnish Inst Occupat Hlth, Turku, Finland; [Tang, Julian W.] Univ Hosp Leicester, Leicester Royal Infirm, Leicester, Leics, England	Finnish Institute of Occupational Health; University Hospitals of Leicester NHS Trust; University of Leicester	Saarinen, PE (corresponding author), Finnish Inst Occupat Hlth, Turku, Finland.	pekka.saarinen@ttl.fi		Saarinen, Pekka/0000-0003-0152-7237; Tang, Julian/0000-0002-4963-1028	Finnish Funding Agency for Technology and Innovation	Finnish Funding Agency for Technology and Innovation(Finnish Funding Agency for Technology & Innovation (TEKES))	This work was supported by the Finnish Funding Agency for Technology and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams NJ, 2011, AM J INFECT CONTROL, V39, P91, DOI 10.1016/j.ajic.2010.05.025; American Society of Heating Refrigerating and Air-Conditioning Engineers-ASHRAE, 2013, HVAC DES MAN HOSP CL, V2nd; Atkinson J, 2009, NATURAL VENTILATION FOR INFECTION CONTROL IN HEALTH-CARE SETTINGS, P1; Bischoff WE, 2013, J INFECT DIS, V207, P1037, DOI 10.1093/infdis/jis773; Booth TF, 2005, J INFECT DIS, V191, P1472, DOI 10.1086/429634; Brankston G, 2007, LANCET INFECT DIS, V7, P257, DOI 10.1016/S1473-3099(07)70029-4; Choi JI, 2008, INDOOR AIR, V18, P233, DOI 10.1111/j.1600-0668.2008.00527.x; Choi JI, 2012, INDOOR AIR, V22, P77, DOI 10.1111/j.1600-0668.2011.00741.x; Choi JI, 2007, J COMPUT PHYS, V224, P757, DOI 10.1016/j.jcp.2006.10.032; Hathway A, 2014, P IND AIR 2014 13 IN; Kalliomaki P, 2014, P IND AIR 2014 13 IN; Kalliomaki P, 2015, INT J VENT IN PRESS; Kiel DE., 1989, ASHRAE T, V95, P590; Kim SH, 2013, BUILD ENVIRON, V60, P305, DOI 10.1016/j.buildenv.2012.09.005; Lednicky John A, 2013, Influenza Res Treat, V2013, P656825, DOI 10.1155/2013/656825; Lemieux C, 2007, EMERG INFECT DIS, V13, P173, DOI 10.3201/eid1301.061202; Li Y, 2007, INDOOR AIR, V17, P2, DOI 10.1111/j.1600-0668.2006.00445.x; Li Y, 2005, INDOOR AIR, V15, P96, DOI 10.1111/j.1600-0668.2004.00318.x; Li Y, 2005, INDOOR AIR, V15, P83, DOI 10.1111/j.1600-0668.2004.00317.x; Lindsley WG, 2015, J OCCUP ENVIRON HYG, V12, P107, DOI 10.1080/15459624.2014.973113; Lindsley WG, 2012, J OCCUP ENVIRON HYG, V9, P443, DOI 10.1080/15459624.2012.684582; Lindsley WG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015100; Mittal R, 2005, ANNU REV FLUID MECH, V37, P239, DOI 10.1146/annurev.fluid.37.061903.175743; Morawska L, 2009, J AEROSOL SCI, V40, P256, DOI 10.1016/j.jaerosci.2008.11.002; Nielsen PV, 2012, P VENT 2012 10 INT C; Nikitin N, 2014, ADV VIROL, V2014, DOI 10.1155/2014/859090; Olmedo I, 2012, INDOOR AIR, V22, P64, DOI 10.1111/j.1600-0668.2011.00736.x; Papineni RS, 1996, J AEROSOL MED, V10, P105, DOI 10.1089/jam.1997.10.105; Saarinen P, 2014, P IND AIR 2014 13 IN; Fernandez AS, 2013, INT E-J CRIM SCI; Seto WH, 2015, J HOSP INFECT, V89, P225, DOI 10.1016/j.jhin.2014.11.005; Shih YC, 2007, BUILD ENVIRON, V42, P3194, DOI 10.1016/j.buildenv.2006.08.008; Tang JW, 2006, J HOSP INFECT, V64, P100, DOI 10.1016/j.jhin.2006.05.022; Tang JW, 2007, LANCET INFECT DIS, V7, P758, DOI 10.1016/S1473-3099(07)70268-2; Tang JLW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066663; Tang JW, 2005, J HOSP INFECT, V61, P283, DOI 10.1016/j.jhin.2005.05.017; Tellier R, 2006, EMERG INFECT DIS, V12, P1657, DOI 10.3201/eid1211.060426; Tellier R, 2009, J R SOC INTERFACE, V6, pS783, DOI 10.1098/rsif.2009.0302.focus; Wong TW, 2004, EMERG INFECT DIS, V10, P269, DOI 10.3201/eid1002.030452; Yu ITS, 2014, CLIN INFECT DIS, V58, P683, DOI 10.1093/cid/cit797; Yu ITS, 2004, NEW ENGL J MED, V350, P1731, DOI 10.1056/NEJMoa032867	41	18	18	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2015	10	7							e0130667	10.1371/journal.pone.0130667	http://dx.doi.org/10.1371/journal.pone.0130667			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EC	26151865	Green Published, Green Submitted, gold			2022-12-26	WOS:000358158900015
J	Stegeman, I; Bossuyt, PM; Yu, T; Boyd, C; Puhan, MA				Stegeman, Inge; Bossuyt, Patrick M.; Yu, Tsung; Boyd, Cynthia; Puhan, Milo A.			Aspirin for Primary Prevention of Cardiovascular Disease and Cancer. A Benefit and Harm Analysis	PLOS ONE			English	Article							COLORECTAL-CANCER; 5-YEAR SURVIVAL; RISK; STROKE; METAANALYSIS; METASTASIS; MORTALITY	Background Aspirin is widely used for prevention of cardiovascular disease. In recent years randomized trials also suggested a preventive effect for various types of cancer. We aimed to assess, in a quantitative way, benefits and harms of aspirin for primary prevention of both cardiovascular disease and cancer for a general US population between 40 and 85 years of age. Methods We used the Gail/National Cancer Institute approach for assessing benefits and harms. This approach provides a probability that a treatment is more beneficial than harmful and incorporates multiple outcomes, the importance of these outcomes, considers different outcome risks and treats mortality as a competing risk. Our main outcomes were the risks of seven types of cancer, myocardial infarction, ischemic and hemorrhagic stroke and gastrointestinal bleeding. We obtained effect estimates from recent meta-analyses of randomized trials and used baseline risks from the Centers for Disease Control. We conducted four sensitivity analyses to assess the influence of different assumptions about outcome risks and preferences and considered the sampling variation of the effect estimates for aspirin. Results The main analysis as well as the sensitivity analyses showed that aspirin has more benefits than harms. In the main analysis, the index (positive if number of prevented events > excess number of harm events over 10 years per 1,000 persons) ranged from 2 (95% CI 0.0 to 11.8; in women age 45 to 54 years) to 8 (95% CI -0.1 to 83.7; in men age 65 to 74 years). In the sensitivity analyses, the index was also positive for all age categories suggesting more benefits than harms. Conclusion This study suggests an overall benefit of aspirin for primary prevention of cardiovascular disease and cancer based on population-based data. For individual preventive counseling, additional benefit harm analyses should explore which individuals should or should not take aspirin based on their risk profile for cardiovascular, cancer and gastrointestinal outcomes and based on their outcome preferences. Thereby, risk-stratified and preference-sensitive prevention could become a reality.	[Stegeman, Inge; Bossuyt, Patrick M.] Univ Amsterdam, Acad Med Ctr, Clin Epidemiol Biostat & Bioinformat, NL-1105 AZ Amsterdam, Netherlands; [Stegeman, Inge] Univ Med Ctr Utrecht, Dept Otolaryngol Head & Neck Surg, Utrecht, Netherlands; [Yu, Tsung; Puhan, Milo A.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Boyd, Cynthia] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Puhan, Milo A.] Univ Zurich, Epidemiol Biostat & Prevent Inst, Zurich, Switzerland	University of Amsterdam; Academic Medical Center Amsterdam; Utrecht University; Utrecht University Medical Center; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; University of Zurich	Stegeman, I (corresponding author), Univ Amsterdam, Acad Med Ctr, Clin Epidemiol Biostat & Bioinformat, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	i.stegeman@umcutrecht.nl	Puhan, Milo/ABE-6298-2020; Stegeman, Inge/AAP-3949-2021; Bossuyt, Patrick M./B-4557-2016; Bossuyt, Patrick M/AAR-1183-2021	Puhan, Milo/0000-0003-4721-1879; Bossuyt, Patrick M./0000-0003-4427-0128; Bossuyt, Patrick M/0000-0003-4427-0128; Stegeman, Inge/0000-0001-5154-7178	Paul Beeson Career Development Award Program [NIA 1K23AG032910]; AFAR; John A. Hartford Foundation; Atlantic Philanthropies; Starr Foundation; NATIONAL INSTITUTE ON AGING [K23AG032910] Funding Source: NIH RePORTER	Paul Beeson Career Development Award Program; AFAR; John A. Hartford Foundation; Atlantic Philanthropies; Starr Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Dr. Boyd was supported by the Paul Beeson Career Development Award Program (NIA 1K23AG032910), AFAR, The John A. Hartford Foundation, The Atlantic Philanthropies and The Starr Foundation.	Algra AM, 2012, LANCET ONCOL, V13, P518, DOI 10.1016/S1470-2045(12)70112-2; [Anonymous], 2012, NATL VITAL STAT SYST; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Bata IR, 2006, CAN J CARDIOL, V22, P399, DOI 10.1016/S0828-282X(06)70925-4; Berger JS, 2011, AM HEART J, V162, P115, DOI 10.1016/j.ahj.2011.04.006; Boyd CM, 2012, METHODS BENEFIT HARM; Calonge N, 2009, ANN INTERN MED, V150, P396; Cappelen AW, 2006, HEALTH POLICY, V76, P312, DOI 10.1016/j.healthpol.2005.06.013; cdc, CANC INC RAT; Chen LY, 2013, JAMA INTERN MED, V173, P29, DOI 10.1001/2013.jamainternmed.744; Diehl AK, 2012, ANN INTERN MED, V157, pJC1; Estruch R, 2013, NEW ENGL J MED, V368, P1279, DOI 10.1056/NEJMoa1200303; Flossmann E, 2007, LANCET, V369, P1603, DOI 10.1016/S0140-6736(07)60747-8; Gail MH, 1999, J NATL CANCER I, V91, P1829, DOI 10.1093/jnci/91.21.1829; Hankey GJ, 2000, STROKE, V31, P2080, DOI 10.1161/01.STR.31.9.2080; He J, 1998, JAMA-J AM MED ASSOC, V280, P1930, DOI 10.1001/jama.280.22.1930; Hernandez-Diaz S, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-22; National Institutes of Health, 2006, IND PREV 2006 CHART; Puhan MA, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-173; Roberts SE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049507; Rodriguez LAG, 1998, BRIT J CLIN PHARMACO, V45, P419; Rothwell PM, 2012, LANCET, V379, P1591, DOI 10.1016/S0140-6736(12)60209-8; Rothwell PM, 2012, LANCET, V379, P1602, DOI 10.1016/S0140-6736(11)61720-0; Rothwell PM, 2011, LANCET, V377, P31, DOI 10.1016/S0140-6736(10)62110-1; Rothwell PM, 2010, LANCET, V376, P1741, DOI 10.1016/S0140-6736(10)61543-7; Seshasai SRK, 2012, ARCH INTERN MED, V172, P209, DOI 10.1001/archinternmed.2011.628; Smith SC, 2006, CIRCULATION, V113, P2363, DOI 10.1161/CIRCULATIONAHA.106.174516; Thiagarajan P, 2012, BEST PRACT RES CL GA, V26, P197, DOI 10.1016/j.bpg.2012.01.007; WOLF PA, 1991, STROKE, V22, P312, DOI 10.1161/01.STR.22.3.312; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	30	22	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2015	10	7							e0127194	10.1371/journal.pone.0127194	http://dx.doi.org/10.1371/journal.pone.0127194			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EC	26151751	gold, Green Published, Green Submitted			2022-12-26	WOS:000358158900003
J	Endres, L; Begley, U; Clark, R; Gu, C; Dziergowska, A; Malkiewicz, A; Melendez, JA; Dedon, PC; Begley, TJ				Endres, Lauren; Begley, Ulrike; Clark, Ryan; Gu, Chen; Dziergowska, Agnieszka; Malkiewicz, Andrzej; Melendez, J. Andres; Dedon, Peter C.; Begley, Thomas J.			Alkbh8 Regulates Selenocysteine-Protein Expression to Protect against Reactive Oxygen Species Damage	PLOS ONE			English	Article							TRANSFER-RNA; DNA-DAMAGE; OXIDATIVE STRESS; GLUTATHIONE-PEROXIDASE; ALKYLATION DAMAGE; CANCER; THIOREDOXIN; SELENIUM; MICE; METHYLTRANSFERASE	Environmental and metabolic sources of reactive oxygen species (ROS) can damage DNA, proteins and lipids to promote disease. Regulation of gene expression can prevent this damage and can include increased transcription, translation and post translational modification. Cellular responses to ROS play important roles in disease prevention, with deficiencies linked to cancer, neurodegeneration and ageing. Here we detail basal and damage-induced translational regulation of a group of oxidative-stress response enzymes by the tRNA methyltransferase Alkbh8. Using a new gene targeted knockout mouse cell system, we show that Alkbh8(-/-) embryonic fibroblasts (MEFs) display elevated ROS levels, increased DNA and lipid damage and hallmarks of cellular stress. We demonstrate that Alkbh8 is induced in response to ROS and is required for the efficient expression of selenocysteine-containing ROS detoxification enzymes belonging to the glutathione peroxidase (Gpx1, Gpx3, Gpx6 and likely Gpx4) and thioredoxin reductase (TrxR1) families. We also show that, in response to oxidative stress, the tRNA modification 5-methoxycarbonylmethyl-2'-Omethyluridine (mcm(5)Um) increases in normal MEFs to drive the expression of ROS detoxification enzymes, with this damage-induced reprogramming of tRNA and stop-codon recoding corrupted in Alkbh8(-/-) MEFS. These studies define Alkbh8 and tRNA modifications as central regulators of cellular oxidative stress responses in mammalian systems. In addition they highlight a new animal model for use in environmental and cancer studies and link translational regulation to the prevention of DNA and lipid damage.	[Endres, Lauren; Begley, Ulrike; Clark, Ryan; Melendez, J. Andres; Begley, Thomas J.] SUNY Albany, Polytech Inst, Coll Nanoscale Sci, Albany, NY 12203 USA; [Endres, Lauren; Begley, Ulrike; Clark, Ryan; Melendez, J. Andres; Begley, Thomas J.] SUNY Albany, Polytech Inst, Coll Engn, Albany, NY 12203 USA; [Endres, Lauren; Begley, Thomas J.] SUNY Albany, RNA Inst, Albany, NY 12222 USA; [Endres, Lauren; Begley, Thomas J.] SUNY Albany, Canc Res Ctr, Albany, NY 12222 USA; [Gu, Chen; Dedon, Peter C.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Dziergowska, Agnieszka] Lodz Univ Technol, Inst Organ Chem, Lodz, Poland; [Dedon, Peter C.] CREATE, Singapore MIT Alliance Res & Technol, Singapore, Singapore; [Dedon, Peter C.] MIT, Ctr Environm Hlth Sci, Cambridge, MA 02139 USA	State University of New York (SUNY) System; State University of New York (SUNY) Albany; State University of New York (SUNY) System; State University of New York (SUNY) Albany; State University of New York (SUNY) System; State University of New York (SUNY) Albany; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Massachusetts Institute of Technology (MIT); Lodz University of Technology; Singapore-MIT Alliance for Research & Technology Centre (SMART); Massachusetts Institute of Technology (MIT)	Begley, TJ (corresponding author), SUNY Albany, Polytech Inst, Coll Nanoscale Sci, Albany, NY 12203 USA.	tbegley@albany.edu	Gu, Chen/AAO-3580-2021; Dziergowska, Agnieszka/H-5240-2017	Dziergowska, Agnieszka/0000-0002-8888-380X; Melendez, Juan/0000-0001-8021-3097	National Institute of Environmental Health Sciences [ES002109, ES015037, ES017010]; MIT Westaway Fund; NRSA Post-doctoral Fellowship from NIEHS; Howard Hughes Graduate Fellowship; Singapore-MIT Alliance for Research and Technology; David H. Koch Cancer Research Graduate Fellowship; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES024615, R01ES015037, R01ES017010, P30ES002109] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); MIT Westaway Fund; NRSA Post-doctoral Fellowship from NIEHS; Howard Hughes Graduate Fellowship; Singapore-MIT Alliance for Research and Technology(Singapore-MIT Alliance for Research & Technology Centre (SMART)); David H. Koch Cancer Research Graduate Fellowship; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Financial support was provided by the National Institute of Environmental Health Sciences (ES002109, ES015037 and ES017010), the MIT Westaway Fund (P.C.D.), NRSA Post-doctoral Fellowship from NIEHS (L.E.), a David H. Koch Cancer Research Graduate Fellowship (C.G.), a Howard Hughes Graduate Fellowship (C.G.) and the Singapore-MIT Alliance for Research and Technology (P.C.D.) (www.nih.gov, http://ki.mit.edu, www.hhmi.org, http://web.mit.edu/sma//). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas PA, 2003, NATURE, V421, P859, DOI 10.1038/nature01363; ABRIL N, 1990, ENVIRON MOL MUTAGEN, V15, P184, DOI 10.1002/em.2850150403; Aravind L, 2001, GENOME BIOL, V2; Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Avval FZ, 2009, J BIOL CHEM, V284, P8233, DOI 10.1074/jbc.M809338200; Baker A, 1997, CANCER RES, V57, P5162; Begley U, 2007, MOL CELL, V28, P860, DOI 10.1016/j.molcel.2007.09.021; Bjornstad LG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049045; Carlson BA, 2005, J BIOL CHEM, V280, P5542, DOI 10.1074/jbc.M411725200; Carlson BA, 2009, MOLECULES, V14, P3509, DOI 10.3390/molecules14093509; Cavaluzzi MJ, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh015; Chan CTY, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1938; Chan CTY, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001247; Cheng WH, 1998, J NUTR, V128, P1070, DOI 10.1093/jn/128.7.1070; CHOI IS, 1994, BIOCHEMISTRY-US, V33, P601, DOI 10.1021/bi00168a027; Combs GF, 2001, BIOFACTORS, V14, P153, DOI 10.1002/biof.5520140120; Cortez D, 1999, SCIENCE, V286, P1162, DOI 10.1126/science.286.5442.1162; de Haan JB, 1998, J BIOL CHEM, V273, P22528, DOI 10.1074/jbc.273.35.22528; DIAMOND AM, 1993, J BIOL CHEM, V268, P14215; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Difilippantonio MJ, 2000, NATURE, V404, P510, DOI 10.1038/35006670; Driscoll DM, 2003, ANNU REV NUTR, V23, P17, DOI 10.1146/annurev.nutr.23.011702.073318; Duncan T, 2002, P NATL ACAD SCI USA, V99, P16660, DOI 10.1073/pnas.262589799; Falnes PO, 2002, NATURE, V419, P178, DOI 10.1038/nature01048; Fu D, 2013, GENE DEV, V27, P1089, DOI 10.1101/gad.215533.113; Fu D, 2010, MOL CELL BIOL, V30, P2449, DOI 10.1128/MCB.01604-09; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Gladyshev VN, 1999, J BIOMED SCI, V6, P151, DOI 10.1007/BF02255899; Gupta M, 1997, CLIN CANCER RES, V3, P1653; Holmgren A, 2010, BIOCHEM BIOPH RES CO, V396, P120, DOI 10.1016/j.bbrc.2010.03.083; Kalhor HR, 2003, MOL CELL BIOL, V23, P9283, DOI 10.1128/MCB.23.24.9283-9292.2003; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Kurowski MA, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-48; Loenarz C, 2008, NAT CHEM BIOL, V4, P152, DOI 10.1038/nchembio0308-152; Lukas C, 2003, NAT CELL BIOL, V5, P255, DOI 10.1038/ncb945; Martin-Romero FJ, 2001, J BIOL CHEM, V276, P29798, DOI 10.1074/jbc.M100422200; Moustafa ME, 2003, J NUTR, V133, p2494S, DOI 10.1093/jn/133.7.2494S; Moustafa ME, 2001, MOL CELL BIOL, V21, P3840, DOI 10.1128/MCB.21.11.3840-3852.2001; Nakamura H, 2006, SEMIN CANCER BIOL, V16, P444, DOI 10.1016/j.semcancer.2006.09.001; Niedernhofer LJ, 2003, J BIOL CHEM, V278, P31426, DOI 10.1074/jbc.M212549200; PAINTER RB, 1980, P NATL ACAD SCI-BIOL, V77, P7315, DOI 10.1073/pnas.77.12.7315; Pan ZS, 2008, DEV DYNAM, V237, P316, DOI 10.1002/dvdy.21418; Patil A, 2012, CELL CYCLE, V11, P3656, DOI 10.4161/cc.21919; Pelicano H, 2004, DRUG RESIST UPDATE, V7, P97, DOI 10.1016/j.drup.2004.01.004; Pouyet L, 2010, TRANSGENIC RES, V19, P155, DOI 10.1007/s11248-009-9308-6; Powis G, 2000, FREE RADICAL BIO MED, V29, P312, DOI 10.1016/S0891-5849(00)00313-0; Rayman MP, 2000, LANCET, V356, P233, DOI 10.1016/S0140-6736(00)02490-9; Ringvoll J, 2006, EMBO J, V25, P2189, DOI 10.1038/sj.emboj.7601109; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Seiler A, 2008, CELL METAB, V8, P237, DOI 10.1016/j.cmet.2008.07.005; Shimada K, 2009, CANCER RES, V69, P3157, DOI 10.1158/0008-5472.CAN-08-3530; Songe-Moller L, 2010, MOL CELL BIOL, V30, P1814, DOI 10.1128/MCB.01602-09; Stryke D, 2003, NUCLEIC ACIDS RES, V31, P278, DOI 10.1093/nar/gkg064; Su D, 2014, NAT PROTOC, V9, P828, DOI 10.1038/nprot.2014.047; Thalhammer A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016210; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; TOYOKUNI S, 1995, FEBS LETT, V358, P1, DOI 10.1016/0014-5793(94)01368-B; Trewick SC, 2002, NATURE, V419, P174, DOI 10.1038/nature00908; Ursini F, 1999, SCIENCE, V285, P1393, DOI 10.1126/science.285.5432.1393; van den Born E, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1173; Veal EA, 2007, MOL CELL, V26, P1, DOI 10.1016/j.molcel.2007.03.016; Westbye MP, 2008, J BIOL CHEM, V283, P25046, DOI 10.1074/jbc.M803776200; Zhang DD, 2006, DRUG METAB REV, V38, P769, DOI 10.1080/03602530600971974; Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015	64	42	44	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131335	10.1371/journal.pone.0131335	http://dx.doi.org/10.1371/journal.pone.0131335			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147969	Green Submitted, Green Published, gold			2022-12-26	WOS:000358157600090
J	Kalisya, LM; Nyavandu, K; Machumu, B; Kwiratuwe, S; Rej, PH				Kalisya, Luc Malemo; Nyavandu, Kavira; Machumu, Bahati; Kwiratuwe, Sylvain; Rej, Peter H.			Patterns of Congenital Malformations and Barriers to Care in Eastern Democratic Republic of Congo	PLOS ONE			English	Article							CLEFT-LIP; AWARENESS; PALATE	Background An increase of congenital anomalies in the eastern Democratic Republic of the Congo (DRC) has been reported. Congenital malformations (CMs) are not uncommon among new-borns and, if left untreated, can contribute to increased neonate morbidity and mortality. Methods Medical records of all individuals admitted with a diagnosed CM to HEAL Africa Teaching Hospital (Goma, DRC) from 2002 to 2014 (n=1301) were reviewed. Data were analysed using descriptive statistics to summarize chart records, and inferential statistics to investigate significant barriers to earlier treatment. Results Since 2012, the number of patients treated each year for CMs has increased by over 200% compared to the average annual number of cases treated from 2002-2011. Though delayed presentation of patients to HEAL Hospital was very obvious, with an average age of 8.2 years. We find that patient age has been significantly decreasing (p=0.037) over time. The average distance separating patients from HEAL Hospital was 178 km, with approximately one third living 350 km or further from the treatment center. Distance is the most significant (p=3.33x10(-6)) barrier to earlier treatment. When controlling for an interaction between gender and the use of mercy funds, we also find that female patients are at a significant (p=1.04x10(-3)) disadvantage to undergo earlier corrective surgery. This disadvantage is further illustrated by our finding that 89% of women and girls, and over 81% of all patients, required mercy funds to cover the cost of surgery in 2014. Lastly, the mortality rate for surgery was low and averaged less than 1.0%. Conclusion Despite a formal end to the war in 2009, and an overall increase in individuals undergoing corrective surgery, distance, poverty, and gender are still massive barriers to CM care at HEAL Hospital, Goma, DRC. We find that patients have been successfully treated earlier by HEAL, although the average age of CM correction in 2014 (4.9 years) is still above average for Sub-Saharan Africa. Thus, we advocate for further funding from the National Government and international health agencies to enable continued treatment of CMs in rural residents of the eastern DRC. Distance, the most significant barrier to care can be mitigated by the implementation of additional mobile clinics and the construction of regional surgery centers along with the associated hiring of surgeons trained in CM repair.	[Kalisya, Luc Malemo; Nyavandu, Kavira; Machumu, Bahati; Kwiratuwe, Sylvain] HEAL Africa, Goma, Nord Kivu, DEM REP CONGO; [Rej, Peter H.] Univ Florida, Dept Anthropol, Gainesville, FL 32611 USA; [Rej, Peter H.] Univ Florida, Genet Inst, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Rej, PH (corresponding author), Univ Florida, Dept Anthropol, Turlington Hall,Room 1112,PO 117305, Gainesville, FL 32611 USA.	peterrej@ufl.edu						Ahuka O L, 2006, East Afr Med J, V83, P95; Ambe J P, 2010, West Afr J Med, V29, P24; Donkor P, 2007, West Afr J Med, V26, P14; Enyinnah Michael, 2013, Glob J Health Sci, V5, P176, DOI 10.5539/gjhs.v5n4p176; Grover Neelam, 2000, Indian Journal of Pediatrics, V67, P249, DOI 10.1007/BF02758158; Hudgins I, 2008, PAK J MED SCI, V24, P33; Lawal TA, 2013, EUR J PEDIATR SURG, V23, P480, DOI 10.1055/s-0033-1337116; Mabula Joseph B, 2012, BMC Res Notes, V5, P585, DOI 10.1186/1756-0500-5-585; Male BD, 2007, E AFR J SURG, V9, P74; Malla BK, 2007, UNI MED J, V5, P557; Mbah N, 2007, West Afr J Med, V26, P288; Obuekwe On, 2004, Cent Afr J Med, V50, P65; Olasoji HO, 2007, BRIT J ORAL MAX SURG, V45, P302, DOI 10.1016/j.bjoms.2006.09.005; Olasoji H O, 2009, Afr J Med Med Sci, V38, P303; Onah I I, 2012, Niger J Med, V21, P296; Onyango J F, 2005, East Afr Med J, V82, P649; Owotade FJ, 2014, NIGER J CLIN PRACT, V17, P6, DOI 10.4103/1119-3077.122822; Rabiu TB, 2012, CHILD NERV SYST, V28, P2115, DOI 10.1007/s00381-012-1879-5; Turnpenny P, 2005, EMERYS ELEMENTS MED; Ugwu R O, 2007, Niger J Med, V16, P368; Westgren Magnus, 2011, Handb Exp Pharmacol, V205, P271, DOI 10.1007/978-3-642-20195-0_13	21	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132362	10.1371/journal.pone.0132362	http://dx.doi.org/10.1371/journal.pone.0132362			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147996	Green Published, Green Submitted, gold			2022-12-26	WOS:000358157600252
J	Liu, HJ; Zhou, HK; Wu, YS; Li, X; Zhao, J; Zuo, T; Zhang, X; Zhang, YZ; Liu, SS; Shen, Y; Lin, HJ; Zhang, ZM; Huang, KJ; Lubberstedt, T; Pan, GT				Liu, Hongjun; Zhou, Huangkai; Wu, Yongsheng; Li, Xiao; Zhao, Jing; Zuo, Tao; Zhang, Xuan; Zhang, Yongzhong; Liu, Sisi; Shen, Yaou; Lin, Haijian; Zhang, Zhiming; Huang, Kaijian; Luebberstedt, Thomas; Pan, Guangtang			The Impact of Genetic Relationship and Linkage Disequilibrium on Genomic Selection	PLOS ONE			English	Article							MARKER-ASSISTED SELECTION; BREEDING VALUE ESTIMATION; QUANTITATIVE TRAITS; RELATIONSHIP INFORMATION; MAIZE; PREDICTION; VALUES; POPULATION; ACCURACY; REGRESSION	Genomic selection is a promising research area due to its practical application in breeding. In this study, impact of realized genetic relationship and linkage disequilibrium (LD) on marker density and training population size required was investigated and their impact on practical application was further discussed. This study is based on experimental data of two populations derived from the same two founder lines (B73, Mo17). Two populations were genotyped with different marker sets at different density: IBM Syn4 and IBM Syn10. A high-density marker set in Syn10 was imputed into the Syn4 population with low marker density. Seven different prediction scenarios were carried out with a random regression best linear unbiased prediction (RR-BLUP) model. The result showed that the closer the real genetic relationship between training and validation population, the fewer markers were required to reach a good prediction accuracy. Taken the short-term cost for consideration, relationship information is more valuable than LD information. Meanwhile, the result indicated that accuracies based on high LD between QTL and markers were more stable over generations, thus LD information would provide more robust prediction capacity in practical applications.	[Liu, Hongjun; Zhang, Yongzhong; Liu, Sisi; Shen, Yaou; Lin, Haijian; Zhang, Zhiming; Pan, Guangtang] Sichuan Agr Univ, Maize Res Inst, Chengdu, Peoples R China; [Zhou, Huangkai; Zhang, Xuan] Guangzhou Genedenovo Biotechnol Co Ltd, Guangzhou, Guangdong, Peoples R China; [Wu, Yongsheng; Huang, Kaijian] Guangxi Acad Agr Sci, Guangxi Maize Res Inst, Nanning, Peoples R China; [Li, Xiao] Sichuan Acad Agr Sci, Inst Plant Protect, Chengdu, Peoples R China; [Zhao, Jing; Luebberstedt, Thomas] Iowa State Univ, Dept Agron, Ames, IA USA; [Zuo, Tao] Iowa State Univ, Interdept Genet Program, Ames, IA USA	Sichuan Agricultural University; Guangxi Academy of Agricultural Sciences; Sichuan Academy of Agricultural Sciences (SAAS); Iowa State University; Iowa State University	Pan, GT (corresponding author), Sichuan Agr Univ, Maize Res Inst, Chengdu, Peoples R China.	pangt@sicau.edu.cn			National Natural Science Foundation of China [31201221, 31271740, 31060191]; National Hi-Tech program of China [2012AA10307]; Maize Research & Development Center [CARS-02-07]; Key Laboratory Construction Program of Guangxi [12-071-09]; Guangzhou Genedenovo Biotechnology Co., Ltd	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Hi-Tech program of China; Maize Research & Development Center; Key Laboratory Construction Program of Guangxi; Guangzhou Genedenovo Biotechnology Co., Ltd	Funding for this research was provided by National Natural Science Foundation of China (31201221, 31271740, 31060191); the National Hi-Tech program of China (2012AA10307); Maize Research & Development Center, CARS-02-07; and the Key Laboratory Construction Program of Guangxi (12-071-09). Guangzhou Genedenovo Biotechnology Co., Ltd provided support in the form of salaries for authors HZ and XZ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2000, BIOINFORMATICS, V16, P182, DOI 10.1093/bioinformatics/16.2.182; Bennewitz J, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-20; Bernardo R, 2007, CROP SCI, V47, P1082, DOI 10.2135/cropsci2006.11.0690; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Calus MPL, 2007, J ANIM BREED GENET, V124, P362, DOI 10.1111/j.1439-0388.2007.00691.x; Combs E, 2013, PLANT GENOME-US, V6, DOI 10.3835/plantgenome2012.11.0030; Crossa J, 2010, GENETICS, V186, P713, DOI 10.1534/genetics.110.118521; Daetwyler HD, 2010, GENETICS, V185, P1021, DOI 10.1534/genetics.110.116855; Daetwyler HD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003395; Dekkers JCM, 2007, J ANIM BREED GENET, V124, P331, DOI 10.1111/j.1439-0388.2007.00701.x; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Ganal MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028334; Goddard M, 2009, GENETICA, V136, P245, DOI 10.1007/s10709-008-9308-0; Habier D, 2007, GENETICS, V177, P2389, DOI 10.1534/genetics.107.081190; Habier D, 2013, GENETICS; Habier D, 2010, GENET SEL EVOL, V42, DOI 10.1186/1297-9686-42-5; Hayes BJ, 2009, GENET RES, V91, P47, DOI 10.1017/S0016672308009981; Hayes BJ, 2009, J DAIRY SCI, V92, P433, DOI 10.3168/jds.2008-1646; Heffner EL, 2010, CROP SCI, V50, P1681, DOI 10.2135/cropsci2009.11.0662; Hill W, 2011, VARIATION ACTUAL REL; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; Huang XH, 2012, NATURE, V490, P497, DOI 10.1038/nature11532; Huang XH, 2009, GENOME RES, V19, P1068, DOI 10.1101/gr.089516.108; Hussain T, 2007, J PLANT REGIST, V1, P81, DOI 10.3198/jpr2005.11.0414crs; LANDE R, 1990, GENETICS, V124, P743; Lawrence CJ, 2008, INT J PLANT, P2008; Lee M, 2002, PLANT MOL BIOL, V48, P453, DOI 10.1023/A:1014893521186; Lee SH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000231; Long N, 2007, J ANIM BREED GENET, V124, P377, DOI 10.1111/j.1439-0388.2007.00694.x; Lorenzana RE, 2009, THEOR APPL GENET, V120, P151, DOI 10.1007/s00122-009-1166-3; Luan T, 2009, GENETICS, V183, P1119, DOI 10.1534/genetics.109.107391; Melchinger AE, 1998, GENETICS, V149, P383; Meuwissen THE, 2001, GENETICS, V157, P1819; Morrell PL, 2012, NAT REV GENET, V13, P85, DOI 10.1038/nrg3097; Riedelsheimer C, 2012, NAT GENET, V44, P217, DOI 10.1038/ng.1033; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Solberg TR, 2008, J ANIM SCI, V86, P2447, DOI 10.2527/jas.2007-0010; Team RDC, 2012, R LANG ENV STAT COMP; VanRaden PM, 2009, J DAIRY SCI, V92, P16, DOI 10.3168/jds.2008-1514; Wei Z, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000678; Whittaker JC, 2000, GENET RES, V75, P249, DOI 10.1017/S0016672399004462; Xu YB, 2008, CROP SCI, V48, P391, DOI 10.2135/cropsci2007.04.0191; Zhao YuSheng, 2012, TAG Theoretical and Applied Genetics, V124, P769, DOI 10.1007/s00122-011-1745-y; Zhong SQ, 2009, GENETICS, V182, P355, DOI 10.1534/genetics.108.098277	45	16	17	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132379	10.1371/journal.pone.0132379	http://dx.doi.org/10.1371/journal.pone.0132379			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148055	Green Published, gold			2022-12-26	WOS:000358157600253
J	Sabunciyan, S; Maher, B; Bahn, S; Dickerson, F; Yolken, RH				Sabunciyan, Sarven; Maher, Brion; Bahn, Sabine; Dickerson, Faith; Yolken, Robert H.			Association of DNA Methylation with Acute Mania and Inflammatory Markers	PLOS ONE			English	Article							CPG ISLAND HYPERMETHYLATION; BIPOLAR DISORDER; SERUM DNA; GABA(A) RECEPTORS; MEDIATED TRANSFER; WIDE ASSOCIATION; CANCER PATIENTS; SCHIZOPHRENIA; METAANALYSIS; MECHANISM	In order to determine whether epigenetic changes specific to the manic mood state can be detected in peripheral blood samples we assayed DNA methylation levels genome-wide in serum samples obtained from 20 patients hospitalized for mania and 20 unaffected controls using the Illumina 450K methylation arrays. We identified a methylation locus in the CYP11A1 gene, which is regulated by corticotropin, that is hypo-methylated in individuals hospitalized for mania compared with unaffected controls. DNA methylation levels at this locus appear to be state related as levels in follow-up samples collected from mania patients six months after hospitalization were similar to those observed in controls. In addition, we found that methylation levels at the CYP11A1 locus were significantly correlated with three inflammatory markers in serum in acute mania cases but not in unaffected controls. We conclude that mania is associated with alterations in levels of DNA methylation and inflammatory markers. Since epigenetic markers are potentially malleable, a better understanding of the role of epigenetics may lead to new methods for the prevention and treatment of mood disorders.	[Sabunciyan, Sarven; Yolken, Robert H.] Johns Hopkins Univ, Dept Pediat, Baltimore, MD 21218 USA; [Maher, Brion] Johns Hopkins Sch Publ Hlth, Dept Mental Hlth, Baltimore, MD USA; [Bahn, Sabine] Univ Cambridge, Dept Chem Engn & Biotechnol, Cambridge, England; [Dickerson, Faith] Sheppard Pratt Hlth Syst, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Cambridge	Sabunciyan, S (corresponding author), Johns Hopkins Univ, Dept Pediat, Baltimore, MD 21218 USA.	ssabunc1@jhmi.edu; rhyolken@gmail.com	Dickerson, Faith/C-8311-2019; yolken, robert/AAW-2556-2021	Dickerson, Faith/0000-0003-3800-2864; Sabunciyan, Sarven/0000-0002-7231-0820	Stanley Medical Research Institute	Stanley Medical Research Institute	This study was supported by the Stanley Medical Research Institute (www.stanleyresearch.org).	Aberg KA, 2014, JAMA PSYCHIAT, V71, P255, DOI 10.1001/jamapsychiatry.2013.3730; Avraham A, 2012, INT J CANCER, V131, pE1166, DOI 10.1002/ijc.27526; Balaj L, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1180; Bender R, 2001, J CLIN EPIDEMIOL, V54, P343, DOI 10.1016/S0895-4356(00)00314-0; Bergink V, 2014, BIOL PSYCHIAT, V75, P324, DOI 10.1016/j.biopsych.2013.09.037; Cai J, 2013, J MOL CELL BIOL, V5, P227, DOI 10.1093/jmcb/mjt011; Dargel AA, 2015, J CLIN PSYCHIAT, V76, P142, DOI 10.4088/JCP.14r09007; Davies G, 2003, SCHIZOPHRENIA BULL, V29, P587, DOI 10.1093/oxfordjournals.schbul.a007030; Dickerson F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073520; Dickerson F, 2012, SCHIZOPHR RES, V138, P198, DOI 10.1016/j.schres.2012.03.037; Eads CA, 2000, CANCER RES, V60, P5021; First M. B., 1998, STRUCTURED CLIN INTE; First MB, 1996, USERS GUIDE SCID 1 S; Fujiwara K, 2005, CLIN CANCER RES, V11, P1219; Furtado JM, 2011, J GLOB INFECT DIS, V3, P281, DOI 10.4103/0974-777X.83536; Glatt SJ, 2005, P NATL ACAD SCI USA, V102, P15533, DOI 10.1073/pnas.0507666102; Guerrero-Preston R, 2010, EPIGENETICS-US, V5, DOI 10.4161/epi.5.6.12378; Harney SC, 2003, NEUROPHARMACOLOGY, V45, P873, DOI 10.1016/S0028-3908(03)00251-X; Hayashi-Takagi A, 2014, BIOL PSYCHIAT, V75, P920, DOI 10.1016/j.biopsych.2013.09.035; Hwang Y, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.94; Ikoma H, 2006, ANTICANCER RES, V26, P2313; Johansson AGM, 2011, J AFFECT DISORDERS, V133, P346, DOI 10.1016/j.jad.2011.04.009; JOHN ME, 1986, P NATL ACAD SCI USA, V83, P4715, DOI 10.1073/pnas.83.13.4715; Kang GH, 2003, AM J PATHOL, V163, P1551, DOI 10.1016/S0002-9440(10)63511-0; KENDLER KS, 1983, AM J PSYCHIAT, V140, P1413; Lazaro-Ibanez E, 2014, PROSTATE, V74, P1379, DOI 10.1002/pros.22853; Lim HK, 2013, J GASTRIC CANCER, V13, P157, DOI 10.5230/jgc.2013.13.3.157; Marx CE, 2006, PHARMACOL BIOCHEM BE, V84, P598, DOI 10.1016/j.pbb.2006.07.026; Marx CE, 2006, PHARMACOL BIOCHEM BE, V84, P609, DOI 10.1016/j.pbb.2006.07.032; Marx CE, 2008, INT J NEUROPSYCHOPH, V11, P547, DOI 10.1017/S1461145708008444; Munkholm K, 2013, J AFFECT DISORDERS, V144, P16, DOI 10.1016/j.jad.2012.06.010; O'Dushlaine C, 2015, NAT NEUROSCI, V18, P199, DOI 10.1038/nn.3922; OLSEN RW, 1995, ADV BIOCHEM PSYCHOPH, V48, P57; Patte-Mensah C, 2003, J NEUROCHEM, V86, P1233, DOI 10.1046/j.1471-4159.2003.01935.x; Phiel CJ, 2001, J BIOL CHEM, V276, P36734, DOI 10.1074/jbc.M101287200; Rosin A, 2009, ISR MED ASSOC J, V11, P689; Sabath BF, 2002, J INFECT DIS, V186, pS180, DOI 10.1086/344280; Schwarz E, 2012, MOL PSYCHIATR, V17, P494, DOI 10.1038/mp.2011.42; Slominski A. T., 2014, J STEROID BIOCH MOL; Smoller JW, 2003, AM J MED GENET C, V123C, P48, DOI 10.1002/ajmg.c.20013; SUSSER ES, 1992, ARCH GEN PSYCHIAT, V49, P983; Uzunov DP, 1996, P NATL ACAD SCI USA, V93, P12599, DOI 10.1073/pnas.93.22.12599; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Waldenstrom A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034653	44	24	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132001	10.1371/journal.pone.0132001	http://dx.doi.org/10.1371/journal.pone.0132001			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147665	Green Submitted, gold, Green Published			2022-12-26	WOS:000358157600176
J	Tawani, A; Kumar, A				Tawani, Arpita; Kumar, Amit			Structural Insights Reveal the Dynamics of the Repeating r(CAG) Transcript Found in Huntington's Disease (HD) and Spinocerebellar Ataxias (SCAs)	PLOS ONE			English	Article							NEAREST-NEIGHBOR THERMODYNAMICS; CAG REPEATS; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; CUG REPEATS; TRINUCLEOTIDE REPEATS; MYOTONIC-DYSTROPHY; NUCLEOLAR STRESS; BINDING PROTEIN; RNA STRUCTURE	In humans, neurodegenerative disorders such as Huntington's disease (HD) and many spinocerebellar ataxias (SCAs) have been found to be associated with CAG trinucleotide repeat expansion. An important RNA-mediated mechanism that causes these diseases involves the binding of the splicing regulator protein MBNL1 (Muscleblind-like 1 protein) to expanded r(C (A) under barG) repeats. Moreover, mutant huntingtin protein translated from expanded r (C (A) under barG) also yields toxic effects. To discern the role of mutant RNA in these diseases, it is essential to gather information about its structure. Detailed insight into the different structures and conformations adopted by these mutant transcripts is vital for developing therapeutics targeting them. Here, we report the crystal structure of an RNA model with a r(C (A) under barG) motif, which is complemented by an NMR-based solution structure obtained from restrained Molecular Dynamics (rMD) simulation studies. Crystal structure data of the RNA model resolved at 2.3 angstrom reveals non-canonical pairing of adenine in 5'-CAG/3'-GAC motif samples in different syn and anti conformations. The overall RNA structure has helical parameters intermediate to the A-and B-forms of nucleic acids due to the global widening of major grooves and base-pair preferences near internal AA loops. The comprehension of structural behaviour by studying the spectral features and the dynamics also supports the flexible nature of the r(C (A) under barG) motif.	[Tawani, Arpita; Kumar, Amit] Indian Inst Technol, Ctr Biosci & Biomed Engn, Indore, Madhya Pradesh, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Indore	Kumar, A (corresponding author), Indian Inst Technol, Ctr Biosci & Biomed Engn, Indore, Madhya Pradesh, India.	amitk@iiti.ac.in	Tawani, Arpita/HGU-5783-2022	Tawani, Arpita/0000-0001-5227-321X; Kumar, Professor Amit/0000-0002-5913-4308	Department of Science & Technology (DST), India (AK) [SR/FT/LS-29/2012]	Department of Science & Technology (DST), India (AK)	This work was supported by the Fast Track Grant for Young Scientist SR/FT/LS-29/2012 awarded by the Department of Science & Technology (DST), India (AK).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Broda M, 2005, BIOCHEMISTRY-US, V44, P10873, DOI 10.1021/bi0502339; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Bullock SL, 2010, NAT STRUCT MOL BIOL, V17, P703, DOI 10.1038/nsmb.1813; CASKEY CT, 1992, SCIENCE, V256, P784, DOI 10.1126/science.1589758; Cheng AHD, 2005, ENG ANAL BOUND ELEM, V29, P268, DOI 10.1016/j.enganabound.2004.12.001; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Danihelova Martina, 2013, Interdiscip Toxicol, V6, P209, DOI 10.2478/intox-2013-0031; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Disney MD, 2013, DRUG DISCOV TODAY, V18, P1228, DOI 10.1016/j.drudis.2013.07.024; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fiszer A, 2013, J MOL MED, V91, P683, DOI 10.1007/s00109-013-1016-2; Fiszer A, 2011, NUCLEIC ACIDS RES, V39, P5578, DOI 10.1093/nar/gkr156; Furtig B, 2003, CHEMBIOCHEM, V4, P936, DOI 10.1002/cbic.200300700; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kazantsev A, 2002, NAT GENET, V30, P367, DOI 10.1038/ng864; Keel AY, 2007, STRUCTURE, V15, P761, DOI 10.1016/j.str.2007.06.003; Kiliszek A, 2010, NUCLEIC ACIDS RES, V38, P8370, DOI 10.1093/nar/gkq700; Kiliszek A, 2009, NUCLEIC ACIDS RES, V37, P4149, DOI 10.1093/nar/gkp350; Koob MD, 1999, NAT GENET, V21, P379, DOI 10.1038/7710; Koplin J, 2005, STRUCTURE, V13, P1255, DOI 10.1016/j.str.2005.05.015; Kratter IH, 2010, NEURON, V67, P897, DOI 10.1016/j.neuron.2010.09.012; Krol J, 2007, MOL CELL, V25, P575, DOI 10.1016/j.molcel.2007.01.031; Kumar A, 2012, ACS CHEM BIOL, V7, P496, DOI 10.1021/cb200413a; Kumar A, 2011, CHEMBIOCHEM, V12, P2140, DOI 10.1002/cbic.201100337; Kumar A, 2011, BIOCHEMISTRY-US, V50, P9928, DOI 10.1021/bi2013068; Li LB, 2008, NATURE, V453, P1107, DOI 10.1038/nature06909; Lu XJ, 2003, NUCLEIC ACIDS RES, V31, P5108, DOI 10.1093/nar/gkg680; Mariappan SVS, 1998, J BIOMOL STRUCT DYN, V15, P723; Matsuura T, 2000, NAT GENET, V26, P191, DOI 10.1038/79911; McCampbell A, 2000, HUM MOL GENET, V9, P2197, DOI 10.1093/hmg/9.14.2197; McLaughlin BA, 1996, AM J HUM GENET, V59, P561; Michlewski G, 2004, J MOL BIOL, V340, P665, DOI 10.1016/j.jmb.2004.05.021; Mooers BHM, 2005, P NATL ACAD SCI USA, V102, P16626, DOI 10.1073/pnas.0505873102; Mykowska A, 2011, NUCLEIC ACIDS RES, V39, P8938, DOI 10.1093/nar/gkr608; Nielsen JE, 2001, PROTEINS, V43, P403, DOI 10.1002/prot.1053; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parkesh R, 2011, BIOCHEMISTRY-US, V50, P599, DOI 10.1021/bi101896j; Peyret N, 1999, BIOCHEMISTRY-US, V38, P3468, DOI 10.1021/bi9825091; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; SantaLucia J, 1998, P NATL ACAD SCI USA, V95, P1460, DOI 10.1073/pnas.95.4.1460; Sobczak K, 2005, J BIOL CHEM, V280, P3898, DOI 10.1074/jbc.M409984200; Sobczak K, 2004, J BIOL CHEM, V279, P41563, DOI 10.1074/jbc.M405130200; Sobczak K, 2003, NUCLEIC ACIDS RES, V31, P5469, DOI 10.1093/nar/gkg766; Sobczak K, 2010, J BIOL CHEM, V285, P12755, DOI 10.1074/jbc.M109.078790; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Tanaka Y, 1999, NUCLEIC ACIDS RES, V27, P949, DOI 10.1093/nar/27.4.949; Thomas JR, 2008, CHEM REV, V108, P1171, DOI 10.1021/cr0681546; Todd PK, 2010, ANN NEUROL, V67, P291, DOI 10.1002/ana.21948; Tsoi H, 2013, CEREBELLUM, V12, P310, DOI 10.1007/s12311-012-0447-6; Tsoi H, 2012, P NATL ACAD SCI USA, V109, P13428, DOI 10.1073/pnas.1204089109; van Eyk CL, 2011, HUM MOL GENET, V20, P2783, DOI 10.1093/hmg/ddr177; Waragai M, 1999, HUM MOL GENET, V8, P977, DOI 10.1093/hmg/8.6.977; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yildirim I, 2013, J AM CHEM SOC, V135, P3528, DOI 10.1021/ja3108627; Zhang Q, 2006, SCIENCE, V311, P653, DOI 10.1126/science.1119488	60	20	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131788	10.1371/journal.pone.0131788	http://dx.doi.org/10.1371/journal.pone.0131788			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148061	Green Published, Green Submitted, gold			2022-12-26	WOS:000358157600146
J	Zhu, J; Zhao, C; Zhuang, T; Jonsson, P; Sinha, I; Williams, C; Stromblad, S; Dahlman-Wright, K				Zhu, J.; Zhao, C.; Zhuang, T.; Jonsson, P.; Sinha, I.; Williams, C.; Stromblad, S.; Dahlman-Wright, K.			RING finger protein 31 promotes p53 degradation in breast cancer cells	ONCOGENE			English	Article							ESTROGEN-RECEPTOR-ALPHA; UBIQUITIN LIGASE ACTIVITY; MDM2 ANTAGONIST NUTLIN-3; TRANSCRIPTIONAL REPRESSION; ONCOPROTEIN MDM2; E3; ACTIVATION; MUTATIONS; IDENTIFICATION; NEUROBLASTOMA	The atypical E3 ubiquitin ligase RNF31 is highly expressed in human breast cancer, the most frequent neoplastic lethality among women. Here, RNF31 depletion in breast cancer cells in combination with global gene expression profiling revealed p53 (TP53) signaling as a potential RNF31 target. Interestingly, RNF31 decreased p53 stability, whereas depletion of RNF31 in breast cancer cells caused cell cycle arrest and cisplatin-induced apoptosis in a p53-dependent manner. Furthermore, RNF31 associated with the p53/MDM2 complex and facilitated p53 polyubiquitination and degradation by stabilizing MDM2, suggesting a molecular mechanism by which RNF31 regulates cell death. Analysis of publically available clinical data sets displayed a negative correlation between RNF31 and p53 target genes, including IGFBP3 and BTG1, consistent with RNF31 regulating p53 function in vivo as well. Together, our findings suggest RNF31 as a potential therapeutic target to restore p53 function in breast cancer.	[Zhu, J.; Zhao, C.; Zhuang, T.; Sinha, I.; Stromblad, S.; Dahlman-Wright, K.] Karolinska Inst, Dept Biosci & Nutr, Stockholm, Sweden; [Jonsson, P.; Williams, C.] Univ Houston, Dept Biol & Biochem, Ctr Nucl Receptors & Cell Signaling, Houston, TX USA; [Williams, C.] Royal Inst Technol KTH, SciLifeLab, Dept Prote & Nanotechnol, Solna, Sweden; [Dahlman-Wright, K.] SciLifeLab, Sci Life Lab, Solna, Sweden	Karolinska Institutet; University of Houston System; University of Houston; Royal Institute of Technology; SciLifeLab; SciLifeLab	Dahlman-Wright, K (corresponding author), Karolinska Inst, Dept Biosci & Nutr, Novum, Halsovagen 7-9, SE-14183 Huddinge, Stockholmm, Sweden.	karin.dahlman-wright@ki.se	Williams, Cecilia/A-6677-2009; zhu, jian/D-7361-2017	Williams, Cecilia/0000-0002-0602-2062; zhu, jian/0000-0003-3596-4339; Zhuang, Ting/0000-0002-6308-1253; Stromblad, Staffan/0000-0002-1236-6339; Sinha, Indranil/0000-0002-2513-5927; Jonsson, Philip/0000-0002-1537-0624; zhu, jian/0000-0003-0171-4251	China Scholarship Council; Karolinska Institutet; Center for Innovative Medicine at Karolinska Institutet, Marie Curie Actions via the VINNOVA programme Mobility for Growth [GROWTH 291795]; Swedish Cancer Society; Swedish Research Council	China Scholarship Council(China Scholarship Council); Karolinska Institutet(Karolinska Institutet); Center for Innovative Medicine at Karolinska Institutet, Marie Curie Actions via the VINNOVA programme Mobility for Growth; Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission)	We thank members of the KDW, SS and ET group members for sharing materials and for valuable discussions. We thank Marie Franzen for assisting with manuscript submission and Lars-Arne Haldosen for critical comments. This study was supported by scholarships from the China Scholarship Council, a PhD student grant (KID) from the Karolinska Institutet, funding from the Center for Innovative Medicine at Karolinska Institutet, Marie Curie Actions FP7-PEOPLE-2011-COFUND [GROWTH 291795] via the VINNOVA programme Mobility for Growth, the Swedish Cancer Society, the Swedish Research Council and the Karolinska Institutet.	Barnes DM, 1996, J MAMMARY GLAND BIOL, V1, P163, DOI 10.1007/BF02013640; Carvajal D, 2005, CANCER RES, V65, P1918, DOI 10.1158/0008-5472.CAN-04-3576; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; DeSantis C, 2014, CA-CANCER J CLIN, V64, P52, DOI 10.3322/caac.21203; Di Leo A, 2007, ANN ONCOL, V18, P997, DOI 10.1093/annonc/mdm075; Dornan D, 2004, NATURE, V429, P86, DOI 10.1038/nature02514; Ehrlund A, 2009, MOL CELL BIOL, V29, P2230, DOI 10.1128/MCB.00743-08; Esser C, 2005, J BIOL CHEM, V280, P27443, DOI 10.1074/jbc.M501574200; Grossman SR, 2003, SCIENCE, V300, P342, DOI 10.1126/science.1080386; Grumati P, 2014, CANCER DISCOV, V4, P394, DOI 10.1158/2159-8290.CD-14-0177; Gustafsson N, 2010, CANCER RES, V70, P1265, DOI 10.1158/0008-5472.CAN-09-2674; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Huang BY, 2009, AGING-US, V1, P845, DOI 10.18632/aging.100091; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Jiang M, 2007, J BIOL CHEM, V282, P2636, DOI 10.1074/jbc.M606928200; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; MacKay C, 2014, CANCER RES, V74, P2246, DOI 10.1158/0008-5472.CAN-13-2131; Nie J, 2010, J BIOL CHEM, V285, P22816, DOI 10.1074/jbc.M110.126920; Nikulenkov F, 2012, CELL DEATH DIFFER, V19, P1992, DOI 10.1038/cdd.2012.89; Peirce SK, 2009, INT J ONCOL, V34, P1395, DOI 10.3892/ijo_00000267; Reinhardt HC, 2012, TRENDS GENET, V28, P128, DOI 10.1016/j.tig.2011.12.002; Roberts AM, 2009, CANCER RES, V69, P9056, DOI 10.1158/0008-5472.CAN-09-1770; Sayeed A, 2007, CANCER RES, V67, P7746, DOI 10.1158/0008-5472.CAN-06-3724; Selivanova G, 1997, NAT MED, V3, P632, DOI 10.1038/nm0697-632; Smit JJ, 2012, EMBO J, V31, P3833, DOI 10.1038/emboj.2012.217; Tatematsu K, 2008, J BIOL CHEM, V283, P11575, DOI 10.1074/jbc.M706961200; Thompson HGR, 2004, EXP CELL RES, V295, P448, DOI 10.1016/j.yexcr.2004.01.019; Uji K, 2014, CANCER LETT, V342, P19, DOI 10.1016/j.canlet.2013.08.028; Van Maerken T, 2009, JNCI-J NATL CANCER I, V101, P1562, DOI 10.1093/jnci/djp355; van Oijen MGCT, 2000, CLIN CANCER RES, V6, P2138; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Weller M, 1998, CELL TISSUE RES, V292, P435, DOI 10.1007/s004410051072; Wen W, 2014, ONCOGENE, V33, P421, DOI 10.1038/onc.2012.605; Williams C, 1998, CLIN CHEM, V44, P455; Yang YB, 2014, CANCER DISCOV, V4, P480, DOI 10.1158/2159-8290.CD-13-0915; Zhang HB, 1998, ONCOGENE, V16, P1713, DOI 10.1038/sj.onc.1201932; Zhang YP, 2003, MOL CELL BIOL, V23, P8902, DOI 10.1128/MCB.23.23.8902-8912.2003; Zhao CY, 2007, CANCER RES, V67, P3955, DOI 10.1158/0008-5472.CAN-06-3505; Zhu J, 2014, ONCOGENE, V33, P4340, DOI 10.1038/onc.2013.573	41	36	38	2	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 14	2016	35	15					1955	1964		10.1038/onc.2015.260	http://dx.doi.org/10.1038/onc.2015.260			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DJ2CC	26148235	hybrid, Green Published			2022-12-26	WOS:000374010300008
J	Miles, JA; Frost, MG; Carroll, E; Rowe, ML; Howard, MJ; Sidhu, A; Chaugule, VK; Alpi, AF; Walden, H				Miles, Jennifer A.; Frost, Mark G.; Carroll, Eilis; Rowe, Michelle L.; Howard, Mark J.; Sidhu, Ateesh; Chaugule, Viduth K.; Alpi, Arno F.; Walden, Helen			The Fanconi Anemia DNA Repair Pathway Is Regulated by an Interaction between Ubiquitin and the E2-like Fold Domain of FANCL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORE COMPLEX; BINDING DOMAINS; MONOUBIQUITINATION; LIGASE; UBE2T; PCNA; REPLICATION; DEFICIENT; MECHANISM; ALDEHYDES	The Fanconi Anemia (FA) DNArepair pathway is essential for the recognition and repair of DNA interstrand crosslinks (ICL). Inefficient repair of these ICL can lead to leukemia and bone marrow failure. A critical step in the pathway is the monoubiquitination of FANCD2 by the RING E3 ligase FANCL. FANCL comprises 3 domains, a RING domain that interacts with E2 conjugating enzymes, a central domain required for substrate interaction, and an N-terminal E2-like fold (ELF) domain. The ELF domain is found in all FANCL homologues, yet the function of the domain remains unknown. We report here that the ELF domain of FANCL is required to mediate a non-covalent interaction between FANCL and ubiquitin. The interaction involves the canonical Ile44 patch on ubiquitin, and a functionally conserved patch on FANCL. We show that the interaction is not necessary for the recognition of the core complex, it does not enhance the interaction between FANCL and Ube2T, and is not required for FANCD2 monoubiquitination in vitro. However, we demonstrate that the ELF domain is required to promote efficient DNA damage-induced FANCD2 monoubiquitination in vertebrate cells, suggesting an important function of ubiquitin binding by FANCL in vivo.	[Miles, Jennifer A.; Sidhu, Ateesh; Walden, Helen] London Res Inst, Prot Struct & Funct Lab, Lincolns Inn Fields Labs, Canc Res, London WC2A 3LY, England; [Frost, Mark G.; Carroll, Eilis; Chaugule, Viduth K.; Alpi, Arno F.; Walden, Helen] Univ Dundee, Coll Life Sci, Med Res Council, Prot Phosphorylat & Ubiquitylat Unit, Dundee DD1 5EH, Scotland; [Carroll, Eilis; Alpi, Arno F.] Univ Dundee, Coll Life Sci, Scottish Inst Cell Signalling, Dundee DD1 5EH, Scotland; [Rowe, Michelle L.; Howard, Mark J.] Univ Kent, Sch Biosci, Prot Sci Grp, Canterbury CT2 7NZ, Kent, England	University of Dundee; University of Dundee; University of Kent	Alpi, AF (corresponding author), Univ Dundee, Coll Life Sci, Med Res Council, Prot Phosphorylat & Ubiquitylat Unit, Dow St, Dundee DD1 5EH, Scotland.	A.F.Alpi@dundee.ac.uk; h.walden@dundee.ac.uk	Chaugule, Viduth K./AAG-2753-2019	Chaugule, Viduth K./0000-0001-7814-5865; Miles, Jennifer/0000-0001-8839-9201; Alpi, Arno/0000-0002-9572-7266; Howard, Mark/0000-0002-0762-2887	Cancer Research UK; Medical Research Council; Scottish Government; EMBO Young Investigator Programme; MRC [MC_UU_12016/12] Funding Source: UKRI; Cancer Research UK [17739] Funding Source: researchfish; Medical Research Council [MC_UU_12016/12] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Scottish Government; EMBO Young Investigator Programme(European Molecular Biology Organization (EMBO)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by Cancer Research UK (to H. W., J. A. M., A. S., M. F.), the Medical Research Council, and a grant from the Scottish Government to The Scottish Institute for Cell Signaling (SCILLS) (to E. C. and A. F. A.), and the EMBO Young Investigator Programme (to H. W.). The authors declare that they have no conflicts of interest with the contents of this article.	Alpi A, 2007, MOL CELL BIOL, V27, P8421, DOI 10.1128/MCB.00504-07; Alpi AF, 2008, MOL CELL, V32, P767, DOI 10.1016/j.molcel.2008.12.003; Alter BP, 1996, AM J HEMATOL, V53, P99, DOI 10.1002/(SICI)1096-8652(199610)53:2<99::AID-AJH7>3.3.CO;2-M; Cole AR, 2010, NAT STRUCT MOL BIOL, V17, P294, DOI 10.1038/nsmb.1759; Crossan GP, 2012, J PATHOL, V226, P326, DOI 10.1002/path.3002; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Garaycoechea JI, 2014, BLOOD, V123, P26, DOI 10.1182/blood-2013-09-427740; Garaycoechea JI, 2012, NATURE, V489, P571, DOI 10.1038/nature11368; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; Garner E, 2011, FEBS LETT, V585, P2853, DOI 10.1016/j.febslet.2011.04.078; Geng LY, 2010, J CELL BIOL, V191, P249, DOI 10.1083/jcb.201005101; Gurtan AM, 2006, J BIOL CHEM, V281, P10896, DOI 10.1074/jbc.M511411200; HERSHKO A, 1983, J BIOL CHEM, V258, P8206; Hodson C, 2014, STRUCTURE, V22, P337, DOI 10.1016/j.str.2013.12.004; Hodson C, 2011, J BIOL CHEM, V286, P32628, DOI 10.1074/jbc.M111.244632; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Howlett NG, 2009, J BIOL CHEM, V284, P28935, DOI 10.1074/jbc.M109.016352; Huang YL, 2014, CELL REP, V7, P1849, DOI 10.1016/j.celrep.2014.04.029; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Kee Y, 2012, J CLIN INVEST, V122, P3799, DOI 10.1172/JCI58321; Knipscheer P, 2009, SCIENCE, V326, P1698, DOI 10.1126/science.1182372; Kottemann MC, 2013, NATURE, V493, P356, DOI 10.1038/nature11863; Kupfer Gary M., 2013, Yale Journal of Biology and Medicine, V86, P491; Langevin F, 2011, NATURE, V475, P53, DOI 10.1038/nature10192; Longerich S, 2014, NUCLEIC ACIDS RES, V42, P5657, DOI 10.1093/nar/gku198; Machida YJ, 2006, MOL CELL, V23, P589, DOI 10.1016/j.molcel.2006.06.024; Mcvey M, 2010, ENVIRON MOL MUTAGEN, V51, P646, DOI 10.1002/em.20551; Meetei AR, 2003, NAT GENET, V35, P165, DOI 10.1038/ng1241; Park HK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013313; Rajendra E, 2014, MOL CELL, V54, P858, DOI 10.1016/j.molcel.2014.05.001; Rosado IV, 2011, NAT STRUCT MOL BIOL, V18, P1432, DOI 10.1038/nsmb.2173; Song IY, 2010, J BIOL CHEM, V285, P31525, DOI 10.1074/jbc.M110.138206; St-Laurent Pedneault C., 2013, J GENET SYNDR GENE T, V4; Stelter P, 2003, NATURE, V425, P188, DOI 10.1038/nature01965; Ulrich HD, 2010, NAT REV MOL CELL BIO, V11, P479, DOI 10.1038/nrm2921; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Walden H, 2014, ANNU REV BIOPHYS, V43, P257, DOI 10.1146/annurev-biophys-051013-022737; Wiener R, 2012, NATURE, V483, P618, DOI 10.1038/nature10911; Williams SA, 2011, BLOOD, V117, P5078, DOI 10.1182/blood-2010-10-311761; Zhang XY, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000645; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	43	20	20	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2015	290	34					20995	21006		10.1074/jbc.M115.675835	http://dx.doi.org/10.1074/jbc.M115.675835			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP6QC	26149689	Green Published, hybrid			2022-12-26	WOS:000360011800033
J	Tarantino, ME; Bilotti, K; Huang, J; Delaney, S				Tarantino, Mary E.; Bilotti, Katharina; Huang, Ji; Delaney, Sarah			Rate-determining Step of Flap Endonuclease 1 (FEN1) Reflects a Kinetic Bias against Long Flaps and Trinucleotide Repeat Sequences	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE EXCISION-REPAIR; CAG/CTG TRIPLET REPEATS; DNA-DAMAGE; SECONDARY STRUCTURE; STRUCTURAL BASIS; HUMAN-DISEASE; IN-VITRO; EXPANSION; SUBSTRATE; REPLICATION	Flap endonuclease 1 (FEN1) is a structure-specific nuclease responsible for removing 5'-flaps formed during Okazaki fragment maturation and long patch base excision repair. In this work, we use rapid quench flow techniques to examine the rates of 5'-flap removal on DNA substrates of varying length and sequence. Of particular interest are flaps containing trinucleotide repeats (TNR), which have been proposed to affect FEN1 activity and cause genetic instability. We report that FEN1 processes substrates containing flaps of 30 nucleotides or fewer at comparable single-turnover rates. However, for flaps longer than 30 nucleotides, FEN1 kinetically discriminates substrates based on flap length and flap sequence. In particular, FEN1 removes flaps containing TNR sequences at a rate slower than mixed sequence flaps of the same length. Furthermore, multiple-turnover kinetic analysis reveals that the rate-determining step of FEN1 switches as a function of flap length from product release to chemistry (or a step prior to chemistry). These results provide a kinetic perspective on the role of FEN1 in DNA replication and repair and contribute to our understanding of FEN1 in mediating genetic instability of TNR sequences.	[Tarantino, Mary E.; Bilotti, Katharina; Huang, Ji; Delaney, Sarah] Brown Univ, Dept Chem, Providence, RI 02912 USA	Brown University	Delaney, S (corresponding author), Brown Univ, 324 Brook St, Providence, RI 02912 USA.	sarah_delaney@brown.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [R01ES019296]; Summer Research Assistantship in the Biomedical Sciences from the Program in Liberal Medical Education at Brown University; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES019296] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Summer Research Assistantship in the Biomedical Sciences from the Program in Liberal Medical Education at Brown University; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01ES019296. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a Summer Research Assistantship in the Biomedical Sciences from the Program in Liberal Medical Education at Brown University.	Allawi HT, 2003, J MOL BIOL, V328, P537, DOI 10.1016/S0022-2836(03)00351-6; ANDREW SE, 1993, NAT GENET, V4, P398, DOI 10.1038/ng0893-398; Ayyagari R, 2003, J BIOL CHEM, V278, P1618, DOI 10.1074/jbc.M209801200; Balakrishnan L, 2013, ANNU REV BIOCHEM, V82, P119, DOI 10.1146/annurev-biochem-072511-122603; Balakrishnan L, 2009, J BIOL CHEM, V284, P15158, DOI 10.1074/jbc.M109.000505; Beddows A, 2012, CHEM COMMUN, V48, P8895, DOI 10.1039/c2cc33400c; Bornarth CJ, 1999, BIOCHEMISTRY-US, V38, P13347, DOI 10.1021/bi991321u; Canceill D, 1999, J BIOL CHEM, V274, P27481, DOI 10.1074/jbc.274.39.27481; CANTOR CR, 1970, BIOPOLYMERS, V9, P1059, DOI 10.1002/bip.1970.360090909; Cavaluzzi MJ, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh015; Ceska TA, 1996, NATURE, V382, P90, DOI 10.1038/382090a0; Chan NLS, 2013, J BIOL CHEM, V288, P15015, DOI 10.1074/jbc.M113.464370; Chapados BR, 2004, CELL, V116, P39, DOI 10.1016/S0092-8674(03)01036-5; Devos JM, 2007, J BIOL CHEM, V282, P31713, DOI 10.1074/jbc.M703209200; Figueroa AA, 2011, BIOCHEMISTRY-US, V50, P4441, DOI 10.1021/bi200397b; Finger LD, 2013, NUCLEIC ACIDS RES, V41, P9839, DOI 10.1093/nar/gkt737; Finger LD, 2009, J BIOL CHEM, V284, P22184, DOI 10.1074/jbc.M109.015065; GACY AM, 1995, CELL, V81, P533; Garg P, 2004, GENE DEV, V18, P2764, DOI 10.1101/gad.1252304; Gloor JW, 2010, J BIOL CHEM, V285, P34922, DOI 10.1074/jbc.M110.165902; Hartenstine MJ, 2002, J BIOL CHEM, V277, P41379, DOI 10.1074/jbc.M207013200; Henricksen LA, 2000, J BIOL CHEM, V275, P16420, DOI 10.1074/jbc.M909635199; Henricksen LA, 2002, J BIOL CHEM, V277, P22361, DOI 10.1074/jbc.M201765200; Jarem DA, 2011, BIOCHEM BIOPH RES CO, V416, P146, DOI 10.1016/j.bbrc.2011.11.013; Jarem DA, 2011, DNA REPAIR, V10, P887, DOI 10.1016/j.dnarep.2011.06.003; Jarem DA, 2009, BIOCHEMISTRY-US, V48, P6655, DOI 10.1021/bi9007403; Kao KI, 2002, J BIOL CHEM, V277, P14379, DOI 10.1074/jbc.M110662200; Kim JC, 2013, CURR OPIN GENET DEV, V23, P280, DOI 10.1016/j.gde.2013.04.009; Kovtun IV, 2007, NATURE, V447, P447, DOI 10.1038/nature05778; Lee BI, 1999, J BIOL CHEM, V274, P37763, DOI 10.1074/jbc.274.53.37763; Leipold MD, 2003, BIOCHEMISTRY-US, V42, P11373, DOI 10.1021/bi034951b; Liu GQ, 2010, NAT CHEM BIOL, V6, P652, DOI [10.1038/nchembio.416, 10.1038/NCHEMBIO.416]; Liu Y, 2004, ANNU REV BIOCHEM, V73, P589, DOI 10.1146/annurev.biochem.73.012803.092453; Liu Y, 2012, TRENDS BIOCHEM SCI, V37, P162, DOI 10.1016/j.tibs.2011.12.002; Liu Y, 2009, J BIOL CHEM, V284, P28352, DOI 10.1074/jbc.M109.050286; Mitas M, 1997, NUCLEIC ACIDS RES, V25, P2245, DOI 10.1093/nar/25.12.2245; Mueser TC, 1996, CELL, V85, P1101, DOI 10.1016/S0092-8674(00)81310-0; Murante RS, 1995, J BIOL CHEM, V270, P30377, DOI 10.1074/jbc.270.51.30377; Paiva AM, 2004, BIOCHEMISTRY-US, V43, P14218, DOI 10.1021/bi0494368; Patel N, 2012, NUCLEIC ACIDS RES, V40, P4507, DOI 10.1093/nar/gks051; Petruska J, 1998, J BIOL CHEM, V273, P5204, DOI 10.1074/jbc.273.9.5204; Ruggiero BL, 2004, J BIOL CHEM, V279, P23088, DOI 10.1074/jbc.M313170200; Sakurai S, 2005, EMBO J, V24, P683, DOI 10.1038/sj.emboj.7600519; Spiro C, 1999, MOL CELL, V4, P1079, DOI 10.1016/S1097-2765(00)80236-1; Tock MR, 2003, EMBO J, V22, P995, DOI 10.1093/emboj/cdg098; Tsutakawa SE, 2011, CELL, V145, P198, DOI 10.1016/j.cell.2011.03.004; Volle CB, 2012, BIOCHEMISTRY-US, V51, P52, DOI 10.1021/bi201552s; Xu M, 2014, NUCLEIC ACIDS RES, V42, P3675, DOI 10.1093/nar/gkt1372; Xu Meng, 2013, Nucleic Acids Res, V41, P1684, DOI 10.1093/nar/gks1306	49	9	10	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2015	290	34					21154	21162		10.1074/jbc.M115.666438	http://dx.doi.org/10.1074/jbc.M115.666438			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP6QC	26160176	hybrid, Green Published			2022-12-26	WOS:000360011800046
J	Gouin, M; Flamant, C; Gascoin, G; Rouger, V; Florin, A; Guimard, P; Roze, JC; Hanf, M				Gouin, Marion; Flamant, Cyril; Gascoin, Geraldine; Rouger, Valerie; Florin, Agnes; Guimard, Philippe; Roze, Jean-Christophe; Hanf, Matthieu			The Association of Urbanicity with Cognitive Development at Five Years of Age in Preterm Children	PLOS ONE			English	Article							BIRTH-WEIGHT; FOLLOW-UP; ENVIRONMENT; BORN; DISABILITIES; OUTCOMES; NEURODEVELOPMENT; DEPRIVATION; EXPOSURE; EPIPAGE	Objective To determine the association of urbanicity, defined as living in an urban area, with cognitive development at five years of age in preterm children who were free of any disabilities or neurodevelopmental delays. Design Prospective population-based cohort. Setting French regional Loire Infant Follow-up Team (LIFT) network. Participants Included in the study were 1738 surviving infants born between March 2003 and December 2008 before 35 weeks of gestational age. At two years of age, the children were free of any disabilities and neurodevelopmental delays and were living in the Pays de la Loire region from their birth to five years of age. Main Outcome Measures The cognitive development at five years of age was evaluated with the Global School Adaptation score (GSA). The urbanicity of the residence for each child was classified into three groups: urban, quasi-rural, and rural area. Results Quantile regression approaches were used to identify a significant association between urbanicity and the GSA score at five years of age (adjusting for child and family characteristics). We found that the negative impact of urbanicity on the GSA score was more important for the lower quantile of the GSA scores. Conclusions Urbanicity was significantly associated with cognitive neurodevelopment at five years of age in preterm children born before 35 weeks of gestation. Complementary results additionally suggest that this relation could be mediated at the residence level by a high socioeconomic deprivation level. If these results are confirmed, more personalized follow- ups could be developed for preterm children. Further studies are needed to finely identify the contextual characteristics of urbanicity that underlie this association.	[Gouin, Marion; Flamant, Cyril; Roze, Jean-Christophe] Nantes Univ Hosp, Dept Neonatal Med, Nantes, France; [Flamant, Cyril; Roze, Jean-Christophe; Hanf, Matthieu] Nantes Univ Hosp, Natl Inst Hlth & Med Res CIC 1413, Nantes, France; [Gascoin, Geraldine] Angers Univ Hosp, Dept Neonatal Med, Angers, France; [Rouger, Valerie] Nantes Univ Hosp, Reseau Grandir Ensemble, Nantes, France; [Florin, Agnes; Guimard, Philippe] Univ Nantes, Fac Psychol, Res Ctr Educ, CREN EA 2661, Nantes, France	Nantes Universite; CHU de Nantes; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Nantes Universite; CHU de Nantes; Nantes Universite	Hanf, M (corresponding author), Nantes Univ Hosp, Natl Inst Hlth & Med Res CIC 1413, Nantes, France.	matthieu@hanf.fr	Rozé, Jean-Christophe/AAS-1314-2021; Gascoin, Geraldine/ABE-4950-2020	Hanf, Matthieu/0000-0001-7133-1323; Roze, Jean-Christophe/0000-0003-3367-512X	Regional Health Agency of Pays de la Loire	Regional Health Agency of Pays de la Loire	The LIFT (Loire Infant Follow-Up Team) cohort is supported by grants from the Regional Health Agency of Pays de la Loire. The sponsor had no role in this manuscript (http://www.ars.paysdelaloire.sante.fr/Internet.paysdelaloire.O.html).	Aarnoudse-Moens CSH, 2009, PEDIATRICS, V124, P717, DOI 10.1542/peds.2008-2816; [Anonymous], [No title captured]; Bhutta AT, 2002, JAMA-J AM MED ASSOC, V288, P728, DOI 10.1001/jama.288.6.728; Bottino CJ, 2012, HEALTH PLACE, V18, P1000, DOI 10.1016/j.healthplace.2012.06.007; BOUCHER J, 1969, J VERB LEARN VERB BE, V8, P1, DOI 10.1016/S0022-5371(69)80002-2; Boussicault G, 2012, ARCH PEDIATRIE, V19, P381, DOI [10.1016/j.arcped.2012.01.023, 10.1016/.arcped.2012.01.023]; Boussicault G, 2013, J PEDIATR-US, V163, P460, DOI 10.1016/j.jpeds.2013.01.052; Charkaluk ML, 2011, EARLY HUM DEV, V87, P297, DOI 10.1016/j.earlhumdev.2011.01.033; Charkaluk ML, 2010, ACTA PAEDIATR, V99, P684, DOI 10.1111/j.1651-2227.2010.01695.x; Cummins SK, 2001, PEDIATR CLIN N AM, V48, P1241, DOI 10.1016/S0031-3955(05)70372-2; Dahly DL, 2007, SOC SCI MED, V64, P1407, DOI 10.1016/j.socscimed.2006.11.019; de Kieviet JF, 2012, J PEDIATR-US, V161, P824, DOI 10.1016/j.jpeds.2012.05.010; Evans GW, 2006, ANNU REV PSYCHOL, V57, P423, DOI 10.1146/annurev.psych.57.102904.190057; Ferguson KT, 2013, INT J PSYCHOL, V48, P437, DOI 10.1080/00207594.2013.804190; Flamant C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020004; Florin A, 1998, MAITRISE LANGUE ORAL; Geraci M, 2014, STAT COMPUT, V24, P461, DOI 10.1007/s11222-013-9381-9; GUIMARD P, 2001, PSYCHOL PSYCHOM, V22, P75; Guimard P, 2002, EUR REV APPL PSYCHOL, V52, P63; Hack M, 2005, PEDIATRICS, V116, P333, DOI 10.1542/peds.2005-0173; Hattie JAC, 2009, VISIBLE LEARNING: A SYNTHESIS OF OVER 800 META-ANALYSES RELATING TO ACHIEVEMENT, P1; Havard S, 2008, SOC SCI MED, V67, P2007, DOI 10.1016/j.socscimed.2008.09.031; Jefferis BJMH, 2002, BRIT MED J, V325, P305, DOI 10.1136/bmj.325.7359.305; Johnson S, 2006, EARLY HUM DEV, V82, P173, DOI 10.1016/j.earlhumdev.2006.01.008; Koenker R., 2010, ECONOMETRIC SOC MONO, V2005, P295; Larroque B, 2008, LANCET, V371, P813, DOI 10.1016/S0140-6736(08)60380-3; Luo W, 2009, HEALTH PLACE, V15, P1100, DOI 10.1016/j.healthplace.2009.06.002; Marlow N, 2005, NEW ENGL J MED, V352, P9, DOI 10.1056/NEJMoa041367; National Institute of Statistics and Economic Studies, 2014, URBAN UNIT; Orsini N, 2011, STATA J, V11, P327, DOI 10.1177/1536867X1101100301; Perera FP, 2006, ENVIRON HEALTH PERSP, V114, P1287, DOI 10.1289/ehp.9084; Perera FP, 2009, PEDIATRICS, V124, pE195, DOI 10.1542/peds.2008-3506; Potharst ES, 2012, DEV MED CHILD NEUROL, V54, P240, DOI 10.1111/j.1469-8749.2011.04181.x; Potharst ES, 2011, J PEDIATR-US, V159, P79, DOI 10.1016/j.jpeds.2010.12.055; Rey G, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-33; Roberts G, 2010, ARCH DIS CHILD, V95, P786, DOI 10.1136/adc.2009.160283; Salt A, 2006, EARLY HUM DEV, V82, P185, DOI 10.1016/j.earlhumdev.2005.12.015; Suglia SF, 2013, J DEV BEHAV PEDIATR, V34, P549, DOI 10.1097/DBP.0b013e3182a509c0; Vlahov D, 2002, J URBAN HEALTH, V79, pS1, DOI 10.1093/jurban/79.suppl_1.S1; Watson K, 2013, J INT COMP EDUC, V2, P72, DOI 10.14425/00.50.26; Zeka A, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-60	41	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131749	10.1371/journal.pone.0131749	http://dx.doi.org/10.1371/journal.pone.0131749			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1FD	26161862	Green Published, gold, Green Submitted			2022-12-26	WOS:000358162300055
J	Ren, P; Yao, SX; Li, JX; Valdes-Sosa, PA; Kendrick, KM				Ren, Peng; Yao, Shuxia; Li, Jingxuan; Valdes-Sosa, Pedro A.; Kendrick, Keith M.			Improved Prediction of Preterm Delivery Using Empirical Mode Decomposition Analysis of Uterine Electromyography Signals	PLOS ONE			English	Article							BIRTH; EPIDEMIOLOGY; TERM	Preterm delivery increases the risk of infant mortality and morbidity, and therefore developing reliable methods for predicting its likelihood are of great importance. Previous work using uterine electromyography (EMG) recordings has shown that they may provide a promising and objective way for predicting risk of preterm delivery. However, to date attempts at utilizing computational approaches to achieve sufficient predictive confidence, in terms of area under the curve (AUC) values, have not achieved the high discrimination accuracy that a clinical application requires. In our study, we propose a new analytical approach for assessing the risk of preterm delivery using EMG recordings which firstly employs Empirical Mode Decomposition (EMD) to obtain their Intrinsic Mode Functions (IMF). Next, the entropy values of both instantaneous amplitude and instantaneous frequency of the first ten IMF components are computed in order to derive ratios of these two distinct components as features. Discrimination accuracy of this approach compared to those proposed previously was then calculated using six differently representative classifiers. Finally, three different electrode positions were analyzed for their prediction accuracy of preterm delivery in order to establish which uterine EMG recording location was optimal signal data. Overall, our results show a clear improvement in prediction accuracy of preterm delivery risk compared with previous approaches, achieving an impressive maximum AUC value of 0.986 when using signals from an electrode positioned below the navel. In sum, this provides a promising new method for analyzing uterine EMG signals to permit accurate clinical assessment of preterm delivery risk.	[Ren, Peng; Yao, Shuxia; Valdes-Sosa, Pedro A.; Kendrick, Keith M.] Univ Elect Sci & Technol China, Ctr Informat Biomed, Minist Educ, Key Lab NeuroInformat, Chengdu 610054, Peoples R China; [Li, Jingxuan] Nanjing Univ Sci & Technol, Sch Comp Sci & Engn, Nanjing, Jiangsu, Peoples R China	University of Electronic Science & Technology of China; Nanjing University of Science & Technology	Ren, P (corresponding author), Univ Elect Sci & Technol China, Ctr Informat Biomed, Minist Educ, Key Lab NeuroInformat, Chengdu 610054, Peoples R China.	pren28@uestc.edu.cn; k.kendrick.uestc@gmail.com	Valdes-Sosa, Pedro A./AFT-6873-2022	Valdes-Sosa, Pedro A./0000-0001-5485-2661; Yao, Shuxia/0000-0002-5259-6374				Aarnoudse-Moens CSH, 2009, PEDIATRICS, V124, P717, DOI 10.1542/peds.2008-2816; Alamedine D, 2013, Comput Math Methods Med, V2013, P485684, DOI 10.1155/2013/485684; Amir F, 2011, INT J ADV SCI TECHNO; [Anonymous], 2008, B2812904 OR; [Anonymous], DAT AND STAT; Ante SE, 2008, BUSINESS WEEK; Baghamoradi S. Mohammad-Sina, 2011, 2011 18th Iranian Conference of Biomedical Engineering (ICBME), P81, DOI 10.1109/ICBME.2011.6168591; Berbel P, 2010, CEREB CORTEX, V20, P1462, DOI 10.1093/cercor/bhp212; Blinowska JK, 2012, PRACTICAL BIOMEDICAL; Boashash J, 2013, TIME FREQUENCY SIGNA; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Campbell MJ, 2005, MED STAT TXB HLTH SC; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chawla NV, 2010, DATA MINING AND KNOWLEDGE DISCOVERY HANDBOOK, SECOND EDITION, P875, DOI 10.1007/978-0-387-09823-4_45; Chawla NV, 2002, J ARTIF INTELL RES, V16, P321, DOI 10.1613/jair.953; Chen Zhibin, 2007, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, V24, P973; COVER T. M., 2012, ELEMENTS INFORM THEO, DOI 10.1002/0471200611; Deepa VB, 2010, INN COMP TECHN ICICT, P1; Diab A, 2012, IEEE ENG MED BIO, P1045, DOI 10.1109/EMBC.2012.6346113; Diab Mohamad O., 2010, Journal of Biomedical Science & Engineering, V3, P837, DOI 10.4236/jbise.2010.39113; Echeverria JC, 2001, MED BIOL ENG COMPUT, V39, P471, DOI 10.1007/BF02345370; Euliano TY, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2012.10.873; Fele-Zorz G, 2008, MED BIOL ENG COMPUT, V46, P911, DOI 10.1007/s11517-008-0350-y; Fergus P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077154; Friedman N, 1997, MACH LEARN, V29, P131, DOI 10.1023/A:1007465528199; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Hassan M, 2011, MED ENG PHYS, V33, P980, DOI 10.1016/j.medengphy.2011.03.010; Hassan M, 2013, IEEE T BIO-MED ENG, V60, P1160, DOI 10.1109/TBME.2012.2229279; Huang NE, 2005, HILBERT-HUANG TRANSFORM IN ENGINEERING, P1; Huang NE, 1999, ANNU REV FLUID MECH, V31, P417, DOI 10.1146/annurev.fluid.31.1.417; Huang NE, 1998, P ROY SOC A-MATH PHY, V454, P903, DOI 10.1098/rspa.1998.0193; Jerneja V, 2012, APPL EMG CLIN SPORTS; Jezewski J, 2005, PHYSIOL MEAS, V26, P753, DOI 10.1088/0967-3334/26/5/014; Kandil MA, 2012, EUR J OBSTET GYN R B, V160, P18, DOI 10.1016/j.ejogrb.2011.09.035; Kavsek G, THESIS U LJUBLJANA L; Khalil M, 2007, IEEE T BIOMEDICAL EN, V47, P748; La Rosa PS, 2008, IEEE T BIO-MED ENG, V55, P453, DOI 10.1109/TBME.2007.912663; Laforet J, 2011, IEEE T BIO-MED ENG, V58, P3487, DOI 10.1109/TBME.2011.2167970; Lau H, 2014, BMC PREGNANCY CHILDB, V14, P1082; Liang HL, 2005, NEUROCOMPUTING, V65, P801, DOI 10.1016/j.neucom.2004.10.077; Lin YY, 2014, COMP MATH MATH PHYS, V2014, P119; Lucovnik M, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.09.024; Mahsereci EM, 2014, J MED SYST, P38; McPheeters ML, 2005, AM J OBSTET GYNECOL, V192, P1325, DOI 10.1016/j.ajog.2004.12.055; Morra JH, 2010, IEEE T MED IMAGING, V29, P30, DOI 10.1109/TMI.2009.2021941; Moslem B., 2011, 2011 18th IEEE International Conference on Electronics, Circuits and Systems (ICECS 2011), P631, DOI 10.1109/ICECS.2011.6122354; Murray M, 2008, LABOR DELIVERY NURSI; Posner G, 2013, OXORN FOOTE HUMAN LA; Rabotti C, 2008, PHYSIOL MEAS, V29, P829, DOI 10.1088/0967-3334/29/7/011; Rabotti C, 2010, IEEE T BIO-MED ENG, V57, P2178, DOI 10.1109/TBME.2010.2049111; Reed RD, 1998, NEURALSMITHING SUPER; Rilling G, 2003, IEEE EURASIP WORKSH, V3; Saigal S, 2008, LANCET, V371, P261, DOI 10.1016/S0140-6736(08)60136-1; Seow WK, 1997, AUST DENT J, V42, P85, DOI 10.1111/j.1834-7819.1997.tb00102.x; Simhan HN, 2007, NEW ENGL J MED, V357, P477, DOI 10.1056/NEJMra050435; Small M, 2011, DYNAMICS BIOL SYSTEM; Smrdel A, 2015, PHYSIOL MEAS, V36, P341, DOI 10.1088/0967-3334/36/2/341; Stankovic L, 2013, ARTECH HSE RADAR LIB, P1; Strogatz S.H., 1994, NONLINEAR DYNAMICS C; Virk J, 2007, NEW ENGL J MED, V357, P648, DOI 10.1056/NEJMoa070445; Witten I.H., 2005, DATA MINING PRACTICA	62	41	41	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132116	10.1371/journal.pone.0132116	http://dx.doi.org/10.1371/journal.pone.0132116			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161639	gold, Green Published, Green Submitted			2022-12-26	WOS:000358162300095
J	Xu, Q; Zheng, TQ; Hu, X; Cheng, LR; Xu, JL; Shi, YM; Li, ZK				Xu, Qin; Zheng, Tian-Qing; Hu, Xia; Cheng, Li-Rui; Xu, Jian-Long; Shi, Yu-Min; Li, Zhi-Kang			Examining Two Sets of Introgression Lines in Rice (Oryza sativa L.) Reveals Favorable Alleles that Improve Grain Zn and Fe Concentrations	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCUS; BROWN RICE; CADMIUM ACCUMULATION; ZINC CONCENTRATIONS; IDENTIFICATION; TRANSLOCATION; IRON; MICRONUTRIENTS; EXPRESSION; CULTIVARS	In the modern world, the grain mineral concentration (GMC) in rice (Oryza sativa L.) not only includes important micronutrient elements such as iron (Fe) and zinc (Zn), but it also includes toxic heavy metal elements, especially cadmium (Cd) and lead (Pb). To date, the genetic mechanisms underlying the regulation of GMC, especially the genetic background and G x E effects of GMC, remain largely unknown. In this study, we adopted two sets of backcross introgression lines (BILs) derived from IR75862 (a Zn-dense rice variety) as the donor parent and two elite indica varieties, Ce258 and Zhongguangxiang1, as recurrent parents to detect QTL affecting GMC traits including Fe, Zn, Cd and Pb concentrations in two environments. We detected a total of 22 loci responsible for GMC traits, which are distributed on all 12 rice chromosomes except 5, 9 and 10. Six genetic overlap (GO) regions affecting multiple elements were found, in which most donor alleles had synergistic effects on GMC. Some toxic heavy metal-independent loci (such as qFe1, qFe2 and qZn12) and some regions that have opposite genetic effects on micronutrient (Fe and Zn) and heavy metal element (Pb) concentrations (such as GO-IV) may be useful for marker-assisted biofortification breeding in rice. We discuss three important points affecting biofortification breeding efforts in rice, including correlations between different GMC traits, the genetic background effect and the G x E effect.	[Xu, Qin; Zheng, Tian-Qing; Hu, Xia; Cheng, Li-Rui; Xu, Jian-Long; Li, Zhi-Kang] Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100193, Peoples R China; [Xu, Jian-Long; Li, Zhi-Kang] Chinese Acad Agr Sci, Inst Agr Genom Shenzhen, Shenzhen, Peoples R China; [Shi, Yu-Min] Guangxi Acad Agr Sci, Rice Res Inst, Nanning, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Chinese Academy of Agricultural Sciences; Agriculture Genomes Institute at Shenzhen, CAAS; Guangxi Academy of Agricultural Sciences	Xu, JL (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, 12 South Zhong Guan Cun St, Beijing 100193, Peoples R China.	xujlcaas@126.com	Xu, Jianlong/AAI-8310-2020		Harvest Plus Program [2014H8325.CAA]; "863" project from Chinese Ministry of Science Technology [2012AA101101]; "948" project from Chinese Ministry of Agriculture [2010-G2B]; Special Fund of Chinese Central Government for Basic Scientific Research Operations in Commonweal Research Institutes [2014JB04-012]; "Green Super Rice" project from Bill & Melinda Gates' Foundation [OPPGD1393]	Harvest Plus Program; "863" project from Chinese Ministry of Science Technology; "948" project from Chinese Ministry of Agriculture; Special Fund of Chinese Central Government for Basic Scientific Research Operations in Commonweal Research Institutes; "Green Super Rice" project from Bill & Melinda Gates' Foundation	Harvest Plus Program (2014H8325.CAA); "863" project from the Chinese Ministry of Science & Technology (2012AA101101); the "948" project from the Chinese Ministry of Agriculture (2010-G2B); the Special Fund of Chinese Central Government for Basic Scientific Research Operations in Commonweal Research Institutes (2014JB04-012); and the "Green Super Rice" project from Bill & Melinda Gates' Foundation (OPPGD1393). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2011, BREEDING SCI, V61, P43, DOI 10.1270/jsbbs.61.43; Al-Saleh I, 2001, BIOL TRACE ELEM RES, V83, P91, DOI 10.1385/BTER:83:1:91; [Anonymous], 2004, SAS STAT 9 1 USERS G; [Anonymous], 2014, CMAO GRAMENE DATABAS; Aoyama T, 2009, PLANT MOL BIOL, V70, P681, DOI 10.1007/s11103-009-9500-3; Bekele Berhanu D, 2013, Pak J Biol Sci, V16, P1714, DOI 10.3923/pjbs.2013.1714.1721; Belouchi A, 1997, PLANT MOL BIOL, V33, P1085, DOI 10.1023/A:1005723304911; Bhullar NK, 2013, BIOTECHNOL ADV, V31, P50, DOI 10.1016/j.biotechadv.2012.02.001; Chen Zhi-De, 2009, Yichuan, V31, P1135, DOI 10.3724/SP.J.1005.2009.01135; CHURCHILL GA, 1994, GENETICS, V138, P963; CLARKSON DT, 1980, ANNU REV PLANT PHYS, V31, P239, DOI 10.1146/annurev.pp.31.060180.001323; Dawe D., 2010, The rice crisis: markets, policies and food security, P15; De Steur H, 2012, NEW BIOTECHNOL, V29, P432, DOI 10.1016/j.nbt.2011.11.012; Fu JJ, 2008, CHEMOSPHERE, V71, P1269, DOI 10.1016/j.chemosphere.2007.11.065; Gomez-Becerra HF, 2010, EUPHYTICA, V171, P39, DOI 10.1007/s10681-009-9987-3; Gregorio G.B., 2003, RICE SCI INNOVATIONS, P1022; Hang XS, 2009, ENVIRON POLLUT, V157, P2542, DOI 10.1016/j.envpol.2009.03.002; HarvestPlus, 2014, BIOFORTIFICATION PRO; Huang SS, 2007, CHEMOSPHERE, V67, P2148, DOI 10.1016/j.chemosphere.2006.12.043; Impa SM, 2013, J EXP BOT, V64, P2739, DOI 10.1093/jxb/ert118; Ishikawa S, 2005, NEW PHYTOL, V168, P345, DOI 10.1111/j.1469-8137.2005.01516.x; Jia Qian, 2010, Acta Agronomica Sinica, V36, P979, DOI 10.1016/S1875-2780(09)60056-0; Kashiwagi T, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-8; Li B, 2012, J ENVIRON SCI-CHINA, V24, P1790, DOI 10.1016/S1001-0742(11)60972-8; Li HH, 2008, THEOR APPL GENET, V116, P243, DOI 10.1007/s00122-007-0663-5; Li ZK, 2003, THEOR APPL GENET, V108, P141, DOI 10.1007/s00122-003-1401-2; Lu R.Q, 1999, SOIL AGRO CHEM ANAL; Ma GS, 2008, PUBLIC HEALTH NUTR, V11, P632, DOI 10.1017/S1368980007001085; Malosetti M, 2013, FRONT PHYSIOL, P4, DOI [10.3389/fphys.2013.00414, DOI 10.3389/FPHYS.2013.00414]; Manly KF, 2001, MAMM GENOME, V12, P930, DOI 10.1007/s00335-001-1016-3; McLaughlin MJ, 1999, FIELD CROP RES, V60, P143, DOI 10.1016/S0378-4290(98)00137-3; Narayanan NN, 2007, PLANT PHYSIOL BIOCH, V45, P277, DOI 10.1016/j.plaphy.2007.03.021; Pfeiffer Wolfgang H., 2007, P61, DOI 10.1002/9780470376447.ch3; Ramesh SA, 2003, PLANT PHYSIOL, V133, P126, DOI 10.1104/pp.103.026815; [沈希宏 Shen Xihong], 2008, [分子植物育种, Molecular Plant Breeding], V6, P1061; Tang S. Q., 2007, QTL MAPPING COOKING; Temnykh S, 2000, THEOR APPL GENET, V100, P697, DOI 10.1007/s001220051342; Tezuka K, 2010, THEOR APPL GENET, V120, P1175, DOI 10.1007/s00122-009-1244-6; Ueno D, 2009, NEW PHYTOL, V182, P644, DOI 10.1111/j.1469-8137.2009.02784.x; Ueno D, 2010, P NATL ACAD SCI USA, V107, P16500, DOI 10.1073/pnas.1005396107; Uraguchi S, 2014, PHYSL PLANT; Uraguchi S, 2011, P NATL ACAD SCI USA, V108, P20959, DOI 10.1073/pnas.1116531109; Zhang XQ, 2011, EUPHYTICA, V180, P173, DOI 10.1007/s10681-011-0346-9; Zheng TQ, 2011, CROP SCI, V51, P2525, DOI 10.2135/cropsci2011.05.0259; Zhong L, 2010, ATL ANAL MINERAL ELE	53	22	26	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131846	10.1371/journal.pone.0131846	http://dx.doi.org/10.1371/journal.pone.0131846			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161553	Green Published, Green Submitted, gold			2022-12-26	WOS:000358162300064
J	Sun, J; Xu, GR; Wang, ZS; Li, Q; Cui, Y; Xie, LP; Zhang, RQ				Sun, Juan; Xu, Guangrui; Wang, Zeshi; Li, Qing; Cui, Yu; Xie, Liping; Zhang, Rongqing			The Effect of NF-kappa B Signalling Pathway on Expression and Regulation of Nacrein in Pearl Oyster, Pinctada fucata	PLOS ONE			English	Article							CARBONIC-ANHYDRASE; MATRIX PROTEINS; ACTIVATION; HOMOLOG; RANKL; LAYER; REL	Nacrein is the first identified and widely investigated molluscan matrix protein and is considered to play an important role in the shell formation of the pearl oyster, Pinctada fucata. Here, we investigate the effect of the NF-kappa B signalling pathway on Nacrein gene expression in P. fucata to elucidate the mechanisms involved in shell formation. Inhibition of NF-kappa B signalling decreased Nacrein promoter-dependent luciferase activity. However, co-transfection of the Nacrein promoter vector with Pf-IKK or Pf-Rel expression plasmids could enhance luciferase activity, thus proving NF-kappa B signalling could regulate the transcriptional activity of the Nacrein promoter. Gene silencing by RNA interference and subsequent observation of the inner surface of the nacreous layer of oyster shells by SEM, showed that suppression of the gene Pf-Rel lead to a partial inhibition of Nacrein expression, not only at the mRNA level but also at the protein level. The inner surface of the shells became abnormal. Electrophoretic mobility shift assays (EMSAs) revealed that Pf-Rel could directly bind to the relative sites of the Nacrein promoter. These results confirm that an important component of the NF-kappa B signalling pathway, Pf-Rel, can directly bind the Nacrein promoter in P. fucata, and regulate its transcription and shell formation.	[Sun, Juan; Xu, Guangrui; Wang, Zeshi; Li, Qing; Cui, Yu; Xie, Liping; Zhang, Rongqing] Tsinghua Univ, Sch Life Sci, Inst Marine Biotechnol, Beijing 100084, Peoples R China; [Xie, Liping; Zhang, Rongqing] Tsinghua Univ, Prot Sci Lab, Minist Educ, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University	Xie, LP (corresponding author), Tsinghua Univ, Sch Life Sci, Inst Marine Biotechnol, Beijing 100084, Peoples R China.	lpxie@mail.tsinghua.edu.cn; rqzhang@mail.tsinghua.edu.cn			National Basic Research Program of China [2010CB126405]; National High Technology Research and Development Program of China [2010AA09Z405]; National Natural Science Foundation of China [31172382, U0831001]; Independent Research Projects of Tsinghua University [20111080964]; Major Project of Ministry of Agriculture [2011ZX08011-006]	National Basic Research Program of China(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Independent Research Projects of Tsinghua University; Major Project of Ministry of Agriculture	This work was supported by National Basic Research Program of China Grant 2010CB126405, National High Technology Research and Development Program of China Grant 2010AA09Z405, National Natural Science Foundation of China Grants 31172382 and U0831001 (Joint Fund with Guangdong), and Independent Research Projects of Tsinghua University Grant 20111080964. Grant 2011ZX08011-006 is a Major Project of Ministry of Agriculture.	Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Batra S, 2011, ARCH IMMUNOL THER EX, V59, P335, DOI 10.1007/s00005-011-0136-z; Boyce BF, 1999, BONE, V25, P137, DOI 10.1016/S8756-3282(99)00105-2; DiDonato JA, 2012, IMMUNOL REV, V246, P379, DOI 10.1111/j.1600-065X.2012.01099.x; Fang D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021860; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Gong NP, 2008, J STRUCT BIOL, V164, P33, DOI 10.1016/j.jsb.2008.05.009; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Hetru C, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000232; Hou WT, 2006, CRYST GROWTH DES, V6, P1086, DOI 10.1021/cg0504861; Kim K, 2010, J IMMUNOL, V185, P7460, DOI 10.4049/jimmunol.1000885; Liu XJ, 2012, P ROY SOC B-BIOL SCI, V279, P1000, DOI 10.1098/rspb.2011.1661; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lowenstam HA, 1989, BIOMINERALIZATION; Marie B, 2009, CHEMBIOCHEM, V10, P1495, DOI 10.1002/cbic.200900009; Miyamoto H, 2005, ZOOL SCI, V22, P311, DOI 10.2108/zsj.22.311; Miyamoto H, 1996, P NATL ACAD SCI USA, V93, P9657, DOI 10.1073/pnas.93.18.9657; Mount AS, 2004, SCIENCE, V304, P297, DOI 10.1126/science.1090506; Nakashima T, 2003, CURR OPIN RHEUMATOL, V15, P280, DOI 10.1097/00002281-200305000-00016; OSNES T, 1993, SCAND J CLIN LAB INV, V53, P757, DOI 10.3109/00365519309092582; Reinhard K, 2012, INT J MED MICROBIOL, V302, P230, DOI 10.1016/j.ijmm.2012.07.006; Salles A, J PHYSL PARIS; SCHRECK R, 1992, J EXP MED, V175, P1181, DOI 10.1084/jem.175.5.1181; SEN R, 1986, CELL, V46, P705, DOI 10.1016/0092-8674(86)90346-6; Whiteside ST, 1997, SEMIN CANCER BIOL, V8, P75, DOI 10.1006/scbi.1997.0058; Wu X, 2007, ACTA BIOCH BIOPH SIN, V39, P533, DOI 10.1111/j.1745-7270.2007.00306.x; Xiong XH, 2008, DEV COMP IMMUNOL, V32, P15, DOI 10.1016/j.dci.2007.03.013; YAMAGUCHI A, 1991, J CELL BIOL, V113, P681, DOI 10.1083/jcb.113.3.681; Zhang DC, 2009, FISH SHELLFISH IMMUN, V26, P84, DOI 10.1016/j.fsi.2008.10.009	30	15	17	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2015	10	7							e0131711	10.1371/journal.pone.0131711	http://dx.doi.org/10.1371/journal.pone.0131711			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EW	26158525	Green Published, Green Submitted, gold			2022-12-26	WOS:000358161200037
J	Elbrecht, V; Leese, F				Elbrecht, Vasco; Leese, Florian			Can DNA-Based Ecosystem Assessments Quantify Species Abundance? Testing Primer Bias and Biomass-Sequence Relationships with an Innovative Metabarcoding Protocol	PLOS ONE			English	Article							BIODIVERSITY ASSESSMENT; TRICHOPTERA; MACROINVERTEBRATES; ARTHROPODS; INSIGHTS; BARCODE; SCIENCE; SAMPLES; PCR	Metabarcoding is an emerging genetic tool to rapidly assess biodiversity in ecosystems. It involves high-throughput sequencing of a standard gene from an environmental sample and comparison to a reference database. However, no consensus has emerged regarding laboratory pipelines to screen species diversity and infer species abundances from environmental samples. In particular, the effect of primer bias and the detection limit for specimens with a low biomass has not been systematically examined, when processing samples in bulk. We developed and tested a DNA metabarcoding protocol that utilises the standard cytochrome c oxidase subunit I (COI) barcoding fragment to detect freshwater macroinverte-brate taxa. DNA was extracted in bulk, amplified in a single PCR step, and purified, and the libraries were directly sequenced in two independent MiSeq runs (300-bp paired-end reads). Specifically, we assessed the influence of specimen biomass on sequence read abundance by sequencing 31 specimens of a stonefly species with known haplotypes spanning three orders of magnitude in biomass (experiment I). Then, we tested the recovery of 52 different freshwater invertebrate taxa of similar biomass using the same standard barcoding primers (experiment II). Each experiment was replicated ten times to maximise statistical power. The results of both experiments were consistent across replicates. We found a distinct positive correlation between species biomass and resulting numbers of MiSeq reads. Furthermore, we reliably recovered 83% of the 52 taxa used to test primer bias. However, sequence abundance varied by four orders of magnitudes between taxa despite the use of similar amounts of biomass. Our metabarcoding approach yielded reliable results for high-throughput assessments. However, the results indicated that primer efficiency is highly species-specific, which would prevent straightforward assessments of species abundance and biomass in a sample. Thus, PCR-based metabarcoding assessments of biodiversity should rely on presence-absence metrics.	[Elbrecht, Vasco; Leese, Florian] Ruhr Univ Bochum, Dept Anim Ecol Evolut & Biodivers, D-44801 Bochum, Germany	Ruhr University Bochum	Leese, F (corresponding author), Ruhr Univ Bochum, Dept Anim Ecol Evolut & Biodivers, Univ Str 150, D-44801 Bochum, Germany.	florian.leese@rub.de	Leese, Florian/D-4277-2012	Leese, Florian/0000-0002-5465-913X; Elbrecht, Vasco/0000-0003-4672-7099	Kurt Eberhard Bode Foundation	Kurt Eberhard Bode Foundation	This work was supported by a grant of the Kurt Eberhard Bode Foundation to FL.	Agnarsson I, 2007, SYST BIOL, V56, P531, DOI 10.1080/10635150701424546; Aylagas E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090529; Blaxter M, 2003, NATURE, V421, P122, DOI 10.1038/421122a; Bohmann K, 2014, TRENDS ECOL EVOL, V29, P358, DOI 10.1016/j.tree.2014.04.003; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Carew ME, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-45; Clarke LJ, 2014, MOL ECOL RESOUR, V14, P117, DOI 10.1111/1755-0998.12162; Deagle BE, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0562; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Ekrem T, 2010, ORG DIVERS EVOL, V10, P397, DOI 10.1007/s13127-010-0034-y; Elbrecht V, 2014, FRESHW SCI, V33, P181, DOI 10.1086/674536; Elbrecht V, 2015, MITOCHONDR DNA, V26, P469, DOI 10.3109/19401736.2013.830301; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gibson J, 2014, P NATL ACAD SCI USA, V111, P8007, DOI 10.1073/pnas.1406468111; Haase P, 2010, J N AM BENTHOL SOC, V29, P1279, DOI 10.1899/09-183.1; Hajibabaei M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017497; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hopkins GW, 2002, ANIM CONSERV, V5, P245, DOI 10.1017/S1367943002002299; Jackson JK, 2014, FRESHW SCI, V33, P312, DOI 10.1086/675225; Ji YQ, 2013, ECOL LETT, V16, P1245, DOI 10.1111/ele.12162; Jones FC, 2008, ENVIRON REV, V16, P45, DOI 10.1139/A07-010; Kenney Melissa A., 2009, Terrestrial Arthropod Reviews, V2, P99, DOI 10.1163/187498209X12525675906077; Krueger F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016607; Lundberg DS, 2013, NAT METHODS, V10, P999, DOI 10.1038/nmeth.2634; Machler E, 2014, FRESHW SCI, V33, P1174, DOI 10.1086/678128; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Meier C, 2006, METHODISCHES HDB FLI, P1; Merritt RW, 2009, INTRO AQUATIC INSECT; Meusnier I, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-214; Millennium Ecosystem Assessment, 2004, EC HUM WELL BEING SY; Pauls SU, 2008, MOL PHYLOGENET EVOL, V46, P776, DOI 10.1016/j.ympev.2007.11.003; PFRENDER ME, 2010, Q REV BIOL, V85, P319, DOI DOI 10.1086/655118; Pinol J, 2015, MOL ECOL RESOUR, V15, P819, DOI 10.1111/1755-0998.12355; Poisot T, 2013, ECOL EVOL, V3, P1125, DOI 10.1002/ece3.508; Polz MF, 1998, APPL ENVIRON MICROB, V64, P3724; Pompanon F, 2012, MOL ECOL, V21, P1931, DOI 10.1111/j.1365-294X.2011.05403.x; R Core Team, 2021, R LANGUAGE ENV STAT; Ranasinghe JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040875; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Stein ED, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095525; Sunnucks P, 1996, MOL BIOL EVOL, V13, P510, DOI 10.1093/oxfordjournals.molbev.a025612; Sweeney BW, 2011, J N AM BENTHOL SOC, V30, P195, DOI 10.1899/10-016.1; Taberlet P, 2012, MOL ECOL, V21, P2045, DOI 10.1111/j.1365-294X.2012.05470.x; Taberlet P, 2012, MOL ECOL, V21, P1789, DOI 10.1111/j.1365-294X.2012.05542.x; Vorosmarty CJ, 2010, NATURE, V467, P555, DOI 10.1038/nature09440; Yu DW, 2012, METHODS ECOL EVOL, V3, P613, DOI 10.1111/j.2041-210X.2012.00198.x; Zhou X, 2007, J N AM BENTHOL SOC, V26, P719, DOI 10.1899/06-089.1; Zhou X, 2013, GIGASCIENCE, V2, DOI 10.1186/2047-217X-2-4; Zhou X, 2010, J N AM BENTHOL SOC, V29, P814, DOI 10.1899/09-121.1; Zhou X, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-30; Zimmermann J, 2015, MOL ECOL RESOUR, V15, P526, DOI 10.1111/1755-0998.12336	56	343	375	7	183	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0130324	10.1371/journal.pone.0130324	http://dx.doi.org/10.1371/journal.pone.0130324			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154168	Green Published, gold, Green Submitted			2022-12-26	WOS:000358159700031
J	Ellis, W; FitzGibbon, S; Pye, G; Whipple, B; Barth, B; Johnston, S; Seddon, J; Melzer, A; Higgins, D; Bercovitch, F				Ellis, William; FitzGibbon, Sean; Pye, Geoff; Whipple, Bill; Barth, Ben; Johnston, Stephen; Seddon, Jenny; Melzer, Alistair; Higgins, Damien; Bercovitch, Fred			The Role of Bioacoustic Signals in Koala Sexual Selection: Insights from Seasonal Patterns of Associations Revealed with GPS-Proximity Units	PLOS ONE			English	Article							PHASCOLARCTOS-CINEREUS GOLDFUSS; HABITAT USE; BEHAVIOR; DYNAMICS; BELLOWS; COMPETITION; INTENSITY; EVOLUTION; CAPTIVITY; ECOLOGY	Despite being a charismatic and well-known species, the social system of the koala (Phascolarctos cinereus-the only extant member of the family Phascolarctidae) is poorly known and much of the koala's sociality and mating behaviors remain un-quantified. We evaluated these using proximity logging-GPS enabled tracking collars on wild koalas and discuss their implications for the mating system of this species. The frequency and duration of male-female encounters increased during the breeding season, with male-male encounters quite uncommon, suggesting little direct mating competition. By comparison, female-female interactions were very common across both seasons. Body mass of males was not correlated with their interactions with females during the breeding season, although male size is associated with a variety of acoustic parameters indicating individuality. We hypothesise that vocal advertising reduces the likelihood of male-male encounters in the breeding season while increasing the rate of male-female encounters. We suggest that male mating-season bellows function to reduce physical confrontations with other males allowing them to space themselves apart, while, at the same time, attracting females. We conclude that indirect male-male competition, female mate choice, and possibly female competition, mediate sexual selection in koalas.	[Ellis, William; FitzGibbon, Sean; Barth, Ben; Johnston, Stephen] Univ Queensland, Sch Agr & Food Sci, Brisbane, Qld 4072, Australia; [Pye, Geoff; Whipple, Bill] San Diego Zoo Global, San Diego, CA 92112 USA; [Seddon, Jenny] Univ Queensland, Fac Vet Sci, Brisbane, Qld 4072, Australia; [Higgins, Damien] CQUniversity, Koala Res Ctr Cent Queensland, Sch Med & Appl Sci, Rockhampton, Qld 4702, Australia; [Bercovitch, Fred] Kyoto Univ, Primate Res Inst, Inuyama, Aichi 4848506, Japan; [Bercovitch, Fred] Kyoto Univ, Wildlife Res Ctr, Inuyama, Aichi 4848506, Japan	University of Queensland; University of Queensland; Central Queensland University; Kyoto University; Kyoto University	Ellis, W (corresponding author), Univ Queensland, Sch Agr & Food Sci, Brisbane, Qld 4072, Australia.	w.ellis@uq.edu.au	Seddon, Jennifer/A-1402-2010; Barth, Benjamin/AAT-3366-2021; Higgins, Damien P/A-9601-2011; Seddon, Jennifer/AAM-3827-2021; Ellis, William/AAP-8955-2021	Seddon, Jennifer/0000-0003-3789-6878; Barth, Benjamin/0000-0002-3211-5828; Seddon, Jennifer/0000-0003-3789-6878; Higgins, Damien/0000-0003-1215-6523	Queensland Smart Futures through the Queensland State Government Koala [KRG024]; San Diego Zoo; Koala Education and Conservation Program EAZA/AZA	Queensland Smart Futures through the Queensland State Government Koala; San Diego Zoo; Koala Education and Conservation Program EAZA/AZA	This project was funded by Queensland Smart Futures through the Queensland State Government Koala Funding Grant KRG024 (http://www.ehp.qld.gov.au/wildlife/koalas/strategy/koala research-grant.html) and was also funded by San Diego Zoo and the Koala Education and Conservation Program EAZA/AZA partners (http://zoo.sandiegozoo.org/). Queensland Government had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AnalystSoft, 2010, STATPLLUS MAC LE FRE; Andersson Malte, 1994; ARNOLD SJ, 1994, AM NAT, V143, P317, DOI 10.1086/285606; BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; Berck L., 1995, ST BEES ISLAND ITS H; Bercovitch Fred B., 2007, Biodiversity (Ottawa), V8, P33; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Charlton BD, 2011, PLOS ONE, V6; Charlton BD, 2012, ANIM BEHAV, V84, P1565, DOI 10.1016/j.anbehav.2012.09.034; Charlton BD, 2012, ANIM COGN, V15, P999, DOI 10.1007/s10071-012-0527-5; Charlton BD, 2011, J EXP BIOL, V214, P3414, DOI 10.1242/jeb.061358; Clutton-Brock T, 2013, J ZOOL, V289, P151, DOI 10.1111/jzo.12023; Darwin C., 1871, P423; Ellis W, 2011, BEHAV ECOL, V22, P372, DOI 10.1093/beheco/arq216; Ellis WA, 2002, WILDLIFE RES, V29, P19, DOI 10.1071/WR01042; ELLIS WAH, 1995, AUST J ZOOL, V43, P59, DOI 10.1071/ZO9950059; Ellis W, 2010, J MAMMAL, V91, P177, DOI 10.1644/08-MAMM-A-358R.1; Ellis WAH, 2011, BEHAV ECOL SOCIOBIOL, V65, P1229, DOI 10.1007/s00265-010-1136-4; Ellis WAH, 2009, BEHAV ECOL SOCIOBIOL, V63, P1181, DOI 10.1007/s00265-009-0761-2; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; Feige S, 2007, APPL ANIM BEHAV SCI, V103, P131, DOI 10.1016/j.applanim.2006.03.014; Frey R, 2010, HBK BEHAV NEUROSCI, V19, P439, DOI 10.1016/B978-0-12-374593-4.00040-1; Gordon G., 1990, P189; Hynes EF, 2011, APPL ANIM BEHAV SCI, V134, P209, DOI 10.1016/j.applanim.2011.06.019; Johnston SD, 2000, J REPROD FERTIL, V120, P49, DOI 10.1530/reprod/120.1.49; Kemp J, 2009, VEGETATION SURVEY MA; Kollipara A, 2013, VET MICROBIOL, V167, P513, DOI 10.1016/j.vetmic.2013.08.009; LANDE R, 1980, EVOLUTION, V34, P292, DOI [10.2307/2407393, 10.1111/j.1558-5646.1980.tb04817.x]; Lee AK, 1988, KOALA NATURAL HIST; Lee AK, 1990, BIOL KOALA, P1; Lee KE, 2012, AUST J ZOOL, V60, P303, DOI 10.1071/ZO12075; McGowan MR, 1995, AUST VET J, V72, P472, DOI 10.1111/j.1751-0813.1995.tb03495.x; McLean N, 2006, AUST J ZOOL, V54, P385, DOI 10.1071/ZO06015; Melzer A., 2010, Queensland Naturalist, V48, P36; Melzer A, 2009, AUSTRALAS J ENVIRON, V16, P236; Melzer Alistair, 2003, Queensland Naturalist, V41, P38; Mitchell P., 1990, P151; Mitchell P., 1990, P171; Rosvall KA, 2011, BEHAV ECOL, V22, P1131, DOI 10.1093/beheco/arr106; Sharpe L, 1980, BEHAV KOALA PHASCOLA; SMITH M, 1980, AUST WILDLIFE RES, V7, P41; SMITH M, 1980, AUST WILDLIFE RES, V7, P35; Team RDC, 2019, R LANG ENV STAT COMP; Tobey JR, 2009, AUST J ZOOL, V57, P111, DOI 10.1071/ZO08090; TRAIL PW, 1985, AM NAT, V126, P434, DOI 10.1086/284429; Tucker G, 2007, AUST J ZOOL, V55, P285, DOI 10.1071/ZO07035; WADE MJ, 1980, ANIM BEHAV, V28, P446, DOI 10.1016/S0003-3472(80)80052-2; Weckerly FW, 2001, J MAMMAL, V82, P825, DOI 10.1644/1545-1542(2001)082<0825:SSIREC>2.0.CO;2; Wessa P, 2013, OFFICE RES DEV ED VE; Wheeler BC, 2013, BEHAV ECOL, V24, P1369, DOI 10.1093/beheco/art076	50	18	19	1	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0130657	10.1371/journal.pone.0130657	http://dx.doi.org/10.1371/journal.pone.0130657			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154295	Green Submitted, Green Published, gold			2022-12-26	WOS:000358159700035
J	Kinoshita-Kikuta, E; Kinoshita, E; Eguchi, Y; Yanagihara, S; Edahiro, K; Inoue, Y; Taniguchi, M; Yoshida, M; Yamamoto, K; Takahashi, H; Sawasaki, T; Utsumi, R; Koike, T				Kinoshita-Kikuta, Emiko; Kinoshita, Eiji; Eguchi, Yoko; Yanagihara, Shiho; Edahiro, Keisuke; Inoue, Yuki; Taniguchi, Momoka; Yoshida, Myu; Yamamoto, Kaneyoshi; Takahashi, Hirotaka; Sawasaki, Tatsuya; Utsumi, Ryutaro; Koike, Tohru			Functional Characterization of the Receiver Domain for Phosphorelay Control in Hybrid Sensor Kinases	PLOS ONE			English	Article							2-COMPONENT SIGNAL-TRANSDUCTION; ESCHERICHIA-COLI K-12; BORDETELLA-PERTUSSIS; HISTIDINE KINASE; PHOSPHOPROTEIN ISOTYPES; GEL-ELECTROPHORESIS; IN-VITRO; PROTEIN; PHOSPHORYLATION; ARCB	Hybrid sensor kinase, which contains a histidine kinase (HK) domain, a receiver domain, and a histidine-containing phosphotransmitter (HPt) domain, conveys signals to its cognate response regulator by means of a His-Asp-His-Asp phosphorelay. We examined the multi-step phosphorelay of a recombinant EvgAS system in Escherichia coli and performed in vitro quantitative analyses of phosphorylation by using Phos-tag SDS-PAGE. Replacement of Asp in the receiver domain of EvgS by Ala markedly promoted phosphorylation at His in the HK domain compared with that in wild-type EvgS. Similar Ala-substituted mutants of other hybrid sensor kinases BarA and ArcB showed similar characteristics. In the presence of sufficient ATP, autophosphorylation of the HK domain in the mutant progressed efficiently with nearly pseudo-first-order kinetics until the phosphorylation ratio reached a plateau value of more than 95% within 60 min, and the value was maintained until 180 min. However, both wild-type EvgS and the Ala-substituted mutant of His in the HPt domain showed a phosphorylation ratio of less than 25%, which gradually decreased after 10 min. These results showed that the phosphorylation level is regulated negatively by the receiver domain. The receiver domain therefore plays a crucial role in controlling the phosphorelay to the response regulator. Furthermore, our in vitro assays confirmed the existence of a similar hyperphosphorylation reaction in the HK domain of the EvgS mutant in which the Asp residue was replaced with Ala, confirming the validity of the control mechanism proposed from profiling of phosphorylation in vitro.	[Kinoshita-Kikuta, Emiko; Kinoshita, Eiji; Yanagihara, Shiho; Edahiro, Keisuke; Inoue, Yuki; Taniguchi, Momoka; Koike, Tohru] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Funct Mol Sci, Hiroshima, Japan; [Eguchi, Yoko] Kinki Univ, Fac Biol Oriented Sci & Technol, Dept Sci & Technol Food Safety, Kinokawa, Japan; [Yoshida, Myu; Yamamoto, Kaneyoshi] Hosei Univ, Dept Frontier Biosci, Koganei, Tokyo 184, Japan; [Takahashi, Hirotaka; Sawasaki, Tatsuya] Ehime Univ, Proteosci Ctr, Div Cell Free Sci, Matsuyama, Ehime, Japan; [Utsumi, Ryutaro] Kinki Univ, Grad Sch Agr, Dept Biosci, Nara, Japan	Hiroshima University; Kindai University (Kinki University); Hosei University; Ehime University; Kindai University (Kinki University)	Kinoshita, E (corresponding author), Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Funct Mol Sci, Hiroshima, Japan.	kinoeiji@hiroshima-u.ac.jp	Kinoshita, Eiji/H-2284-2019	Emiko, Kinoshita/0000-0001-7355-1784; Sawasaki, Tatsuya/0000-0002-7952-0556	KAKENHI [25293005, 25560417, 15K07887, 26460036]; Takeda Science Foundation	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported in part by KAKENHI Grants of no. 25293005 to EK, no. 25560417 to EK, no. 15K07887 to EK-K, and no. 26460036 to TK, and by research grants from the Takeda Science Foundation to EK and EK-K.	Bantscheff M, 2000, INT J MED MICROBIOL, V290, P317; BEIER D, 1995, J MOL BIOL, V248, P596, DOI 10.1006/jmbi.1995.0245; BOUCHER PE, 1994, J MOL BIOL, V241, P363, DOI 10.1006/jmbi.1994.1513; Cai SJ, 2003, J MOL BIOL, V329, P495, DOI 10.1016/S0022-2836(03)00446-7; Casino P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4258; Cotter PA, 2003, TRENDS MICROBIOL, V11, P367, DOI 10.1016/S0966-842X(03)00156-2; Eguchi Y, 2014, J BACTERIOL, V196, P3140, DOI 10.1128/JB.01742-14; Ferris HU, 2014, J STRUCT BIOL, V186, P376, DOI 10.1016/j.jsb.2014.03.014; Georgellis D, 1998, J BIOL CHEM, V273, P32864, DOI 10.1074/jbc.273.49.32864; IUCHI S, 1993, J BIOL CHEM, V268, P23972; Johnson MD, 2014, MOL MICROBIOL, V93, P911, DOI 10.1111/mmi.12704; Jourlin C, 1997, J MOL BIOL, V267, P770, DOI 10.1006/jmbi.1997.0919; Karimova G, 1996, MOL MICROBIOL, V20, P489, DOI 10.1046/j.1365-2958.1996.5231057.x; Kato A, 2000, BIOSCI BIOTECH BIOCH, V64, P1203, DOI 10.1271/bbb.64.1203; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Kinoshita E, 2008, PROTEOMICS, V8, P2994, DOI 10.1002/pmic.200800243; Kinoshita E, 2014, PROTEOMICS, V14, P668, DOI 10.1002/pmic.201300533; Kinoshita E, 2009, ELECTROPHORESIS, V30, P550, DOI 10.1002/elps.200800386; Kinoshita-Kikuta E, 2007, MOL CELL PROTEOMICS, V6, P356, DOI 10.1074/mcp.T600044-MCP200; LUKAT GS, 1992, P NATL ACAD SCI USA, V89, P718, DOI 10.1073/pnas.89.2.718; Mizuno T, 1998, J BIOCHEM, V123, P555; Ogino T, 1998, MOL MICROBIOL, V27, P573, DOI 10.1046/j.1365-2958.1998.00703.x; Pena-Sandoval GR, 2010, J BACTERIOL, V192, P1735, DOI 10.1128/JB.01401-09; Perraud AL, 1998, MOL MICROBIOL, V27, P875, DOI 10.1046/j.1365-2958.1998.00716.x; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Tomenius H, 2005, J BACTERIOL, V187, P7317, DOI 10.1128/JB.187.21.7317-7324.2005; Tsuzuki M, 1995, MOL MICROBIOL, V18, P953, DOI 10.1111/j.1365-2958.1995.18050953.x; Uhl MA, 1996, EMBO J, V15, P1028, DOI 10.1002/j.1460-2075.1996.tb00440.x; UTSUMI R, 1994, GENE, V140, P73, DOI 10.1016/0378-1119(94)90733-1; Wang C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001493; Yaginuma H, 2014, SCI REP-UK, V4, DOI 10.1038/srep06522; Yamamoto K, 2005, J BIOL CHEM, V280, P1448, DOI 10.1074/jbc.M410104200	32	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2015	10	7							e0132598	10.1371/journal.pone.0132598	http://dx.doi.org/10.1371/journal.pone.0132598			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EC	26151934	Green Published, Green Submitted, gold			2022-12-26	WOS:000358158900047
J	Kitagawa, H; Munekage, M; Ichikawa, K; Fukudome, I; Munekage, E; Takezaki, Y; Matsumoto, T; Igarashi, Y; Hanyu, H; Hanazaki, K				Kitagawa, Hiroyuki; Munekage, Masaya; Ichikawa, Kengo; Fukudome, Ian; Munekage, Eri; Takezaki, Yuka; Matsumoto, Takashi; Igarashi, Yasushi; Hanyu, Haruo; Hanazaki, Kazuhiro			Pharmacokinetics of Active Components of Yokukansan, a Traditional Japanese Herbal Medicine after a Single Oral Administration to Healthy Japanese Volunteers: A Cross-Over, Randomized Study	PLOS ONE			English	Article							GLYCYRRHETIC ACID; PSYCHOLOGICAL SYMPTOMS; RATS; DEMENTIA; LICORICE; DECOCTION; KAMPO; ROOT	Context Yokukansan (YKS) is a traditional Japanese herbal medicine called kampo medicine in Japan. Its extract comprises seven crude drugs: Atractylodis lanceae rhizoma, Poria, Cnidii rhizoma, Uncariae uncis cum ramulus, Angelicae radix, Bupleuri radix, and Glycyrrhizae radix. YKS is used to treat neurosis, insomnia, as well as behavioral and psychological symptoms of dementia. Objective To confirm the exposure and pharmacokinetics of the active components of YKS in healthy volunteers. Design, Setting, and Participants A randomized, open-label, 3-arm, 3-period, crossover trial was conducted on 21 healthy Japanese volunteers at the Kochi Medical University between May 2012 and November 2012. Interventions Single oral administration of YKS (2.5 g, 5.0 g, or 7.5 g/day) during each period. Main Outcome Measure Plasma concentrations of three active compounds in YKS, namely 18 beta-glycyrrhetinic acid (GA), geissoschizine methyl ether (GM), and hirsuteine (HTE). Results The mean maximum plasma concentrations (C-max) of GM and HTE increased dose-dependently (ranges: 0.650-1.98 ng/mL and 0.138-0.450 ng/mL, respectively). The times to maximum plasma concentration after drug administration (t(max)) were 0.500 h for GM and 0.975-1.00 h for HTE. The apparent elimination half-lives (t(1/2)) were 1.72-1.95 h for GM and 2.47-3.03 h for HTE. These data indicate the rapid absorption and elimination of GM and HTE. On the other hand, the C-max, t(max), and t(1/2) of GA were 57.7-108 ng/mL, 8.00-8.01 h, and 9.39-12.3 h, respectively. Conclusion We demonstrated that pharmacologically active components of YKS are detected in humans. Further, we determined the pharmacokinetics of GM, HTE, and GA. This information will be useful to elucidate the pharmacological effects of YKS.	[Kitagawa, Hiroyuki; Munekage, Masaya; Fukudome, Ian; Munekage, Eri; Takezaki, Yuka; Hanazaki, Kazuhiro] Kochi Univ, Kochi Med Sch, Dept Surg, Kochi 780, Japan; [Ichikawa, Kengo] Gifu Univ, Sch Med, Dept Surg Oncol, Gifu 500, Japan; [Matsumoto, Takashi] Tsumura & Co, Kampo Sci Strategies Div, Tsumura Res Labs, Ibaraki, Japan; [Igarashi, Yasushi] Tsumura & Co, Kampo Sci Strategies Div, Kampo Formulat Dev Ctr, Ibaraki, Japan; [Hanyu, Haruo] Tokyo Med Univ, Dept Elderly Gen Med, Tokyo 1608402, Japan	Kochi University; Gifu University; Tsumura & Company; Tsumura & Company; Tokyo Medical University	Matsumoto, T (corresponding author), Tsumura & Co, Kampo Sci Strategies Div, Tsumura Res Labs, Ibaraki, Japan.	matsumoto_takashi@mail.tsumura.co.jp			Tsumura Co.	Tsumura Co.(Tsumura & Company)	Tsumura & Co. provided support in the form of salaries for authors TM and YI. This study was funded by Tsumura & Co., which was responsible for the study design, and the collection, analysis and interpretation of data.	[Anonymous], 1995, DRUG INFORM J; CANTELLIFORTI G, 1994, ENVIRON HEALTH PERSP, V102, P65, DOI 10.1289/ehp.94102s965; Egashira N, 2008, PROG NEURO-PSYCHOPH, V32, P1516, DOI 10.1016/j.pnpbp.2008.05.010; GOLDSTEIN JA, 1994, PHARMACOGENETICS, V4, P285, DOI 10.1097/00008571-199412000-00001; HATTORI M, 1983, PLANTA MED, V48, P38, DOI 10.1055/s-2007-969875; Hou YC, 2005, LIFE SCI, V76, P1167, DOI 10.1016/j.lfs.2004.10.020; Imamura S, 2011, CELL MOL NEUROBIOL, V31, P787, DOI 10.1007/s10571-011-9676-3; Iwasaki K, 2012, PSYCHOGERIATRICS, V12, P235, DOI 10.1111/j.1479-8301.2012.00413.x; Kawakami Z, 2009, NEUROSCIENCE, V159, P1397, DOI 10.1016/j.neuroscience.2009.02.004; Kawakami Z, 2010, EUR J PHARMACOL, V626, P154, DOI 10.1016/j.ejphar.2009.09.046; KRAHENBUHL S, 1994, STEROIDS, V59, P121, DOI 10.1016/0039-128X(94)90088-4; Kushida H, 2013, BIOMED CHROMATOGR, V27, P1647, DOI 10.1002/bmc.2974; Matsuda Y, 2013, HUM PSYCHOPHARM CLIN, V28, P80, DOI 10.1002/hup.2286; Miyamura M, 1996, YAKUGAKU ZASSHI, V116, P209, DOI 10.1248/yakushi1947.116.3_209; Mizuhara Y, 2005, BIOL PHARM BULL, V28, P1897, DOI 10.1248/bpb.28.1897; Mizukami K, 2009, INT J NEUROPSYCHOPH, V12, P191, DOI 10.1017/S146114570800970X; Nakazawa T, 2006, BIOL PHARM BULL, V29, P1671, DOI 10.1248/bpb.29.1671; Nishi A, 2012, NEUROSCIENCE, V207, P124, DOI 10.1016/j.neuroscience.2012.01.037; Raggi M A, 1994, Boll Chim Farm, V133, P704; Smith BP, 2000, PHARMACEUT RES, V17, P1278, DOI 10.1023/A:1026451721686; Tabuchi M, 2012, CELL MOL NEUROBIOL, V32, P1139, DOI 10.1007/s10571-012-9839-x; Takeda A, 2008, NEUROCHEM INT, V53, P230, DOI 10.1016/j.neuint.2008.07.009; Takeda S, 1996, J PHARM PHARMACOL, V48, P902, DOI 10.1111/j.2042-7158.1996.tb05998.x; TERASAWA K, 1986, J PHARMACOBIO-DYNAM, V9, P95; Terawaki K, 2010, J ETHNOPHARMACOL, V127, P306, DOI 10.1016/j.jep.2009.11.003; Xu CH, 2013, J ETHNOPHARMACOL, V149, P443, DOI 10.1016/j.jep.2013.06.049	26	23	23	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2015	10	7							e0131165	10.1371/journal.pone.0131165	http://dx.doi.org/10.1371/journal.pone.0131165			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EC	26151135	gold, Green Published, Green Submitted			2022-12-26	WOS:000358158900018
J	Li, JB; Liu, RH; Ji, XK; Xue, H; Zhang, G; Wang, CX; Chen, QC; Xue, FZ; Cui, LQ				Li, Jiangbing; Liu, Ruihong; Ji, Xiaokang; Xue, Hao; Zhang, Guang; Wang, Chunxia; Chen, Qicai; Xue, Fuzhong; Cui, Lianqun			Insight into the Spectrum of Coronary Atherosclerosis in Asymptomatic Urban Han Chinese Population by Coronary Computed Tomography Angiography	PLOS ONE			English	Article							PROGNOSTIC VALUE; ARTERY-DISEASE; RISK STRATIFICATION; HEART-DISEASE; SEVERITY; QUANTIFICATION; PERFORMANCE; PREDICTION	Objectives Highlighted the spectrum of coronary atherosclerosis in asymptomatic population by Computed Tomography Angiography (CTA) and developed a surrogation of expensive CTA to early detect coronary atherosclerosis. Methods Three hundred and seven self-referred urban Han Chinese asymptomatic individuals underwent coronary CTA were consecutively enrolled. Total plaque score (TPS), Segment stenosis score (SSS) and Coronary Artery Disease severity (CADS) were used to measure and illustrate the spectrum of atherosclerosis burden by mapping their incidence and proportion onto coronary artery tree. Logistic regression model was further used to explore the association between lipid biomarkers and TPS (SSS) for developing a surrogation of CTA to early detect coronary atherosclerosis. Results We found that the incidence of TPS, SSS and CADS were up to 71.34%, 68.08%, and 71.34%; and high-risk individuals reached up to 11.07%, 15.31% and 16.29% respectively. All TPS, SSS and CADS were much higher in male than female, and have trend of increasing with age. The most lesion segment emerged on proximal LAD, followed by proximal RCA, mid LAD, proximal LCX, and mid RCA with mixed plaque as dominant. HDL-C was a predictor to both TPS [OR: 0.12 (0.02-0.82)] and SSS [OR: 0.15 (0.03-0.76)], and could identify the serious atherosclerosis subjects of TPS or SSS score >5 (AUC 0.73 and 0.70). Conclusions The atherosclerosis plaque burden was about one in ten as high-risk individuals in this specific urban Han Chinese population. As potential surrogation of CTA, HDL-C was recognized as a significant predictor to atherosclerosis burden and revealed a good performance for identifying high-risk individuals.	[Li, Jiangbing; Cui, Lianqun] Shandong Univ, Shandong Prov Hosp, Dept Cardiol, Jinan, Shandong, Peoples R China; [Liu, Ruihong; Ji, Xiaokang; Xue, Fuzhong] Shandong Univ, Sch Publ Hlth, Div Biostat, Jinan, Shandong, Peoples R China; [Xue, Hao] Shandong Univ, Qilu Hosp, Dept Neurosurg, Jinan, Shandong, Peoples R China; [Zhang, Guang] Shandong Prov Qianfoshan Hosp, Hlth Management Ctr, Jinan, Shandong, Peoples R China; [Wang, Chunxia] Jining Med Univ, Affiliated Hosp, Hlth Management Ctr, Jining, Shandong, Peoples R China; [Chen, Qicai] Shengli Qilfield Cent Hosp, Hlth Management Ctr, Shandong, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong University; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Jining Medical University	Cui, LQ (corresponding author), Shandong Univ, Shandong Prov Hosp, Dept Cardiol, Jinan, Shandong, Peoples R China.	cuilianqun19@163.com	Xue, Hao/GXV-4717-2022; Xue, Fuzhong/AAG-4808-2020	Xue, Fuzhong/0000-0003-0378-7956	National Natural Science Foundation of China [81273177]; Science and Technology Development Planning of Jinan, Shandong Province, China [2014GSF118119]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Development Planning of Jinan, Shandong Province, China	The study was supported by grant 81273177 from the National Natural Science Foundation of China and by grant 2014GSF118119 from Science and Technology Development Planning of Jinan, Shandong Province, China, to FX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach S, 2006, J AM COLL CARDIOL, V48, P1919, DOI 10.1016/j.jacc.2006.08.012; Achenbach S, 2008, JACC-CARDIOVASC IMAG, V1, P472, DOI 10.1016/j.jcmg.2008.05.008; AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Austen W G, 1975, Circulation, V51, P5; Burke AP, 2001, AM HEART J, V141, pS58, DOI 10.1067/mhj.2001.109946; Chang HJ, 2011, CIRC J, V75, P246, DOI 10.1253/circj.CJ-10-1206; Chow BJW, 2010, J AM COLL CARDIOL, V55, P1017, DOI 10.1016/j.jacc.2009.10.039; Coorperative Meta-analysis Group of China Obesity Task Force, 2003, CHIN J EPIDEMIOL, V23, P5; de Graaf MA, 2014, AM J CARDIOL, V113, P1947, DOI 10.1016/j.amjcard.2014.03.034; Descalzo M, 2013, REV ESP CARDIOL, V66, P504, DOI 10.1016/j.rec.2012.12.012; Di Angelantonio E, 2009, JAMA-J AM MED ASSOC, V302, P1993, DOI 10.1001/jama.2009.1619; Gijsen F, 2013, J BIOMECH, V46, P240, DOI 10.1016/j.jbiomech.2012.11.006; Gimbrone MA, 1997, ANN NY ACAD SCI, V811, P1, DOI 10.1111/j.1749-6632.1997.tb51983.x; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; Hadamitzky M, 2013, EUR HEART J; Hadamitzky M, 2009, JACC-CARDIOVASC IMAG, V2, P404, DOI 10.1016/j.jcmg.2008.11.015; Hellerstein M, 2014, CURR OPIN LIPIDOL, V25, P40, DOI 10.1097/MOL.0000000000000050; Hoffmann U, 2004, CIRCULATION, V110, P2638, DOI 10.1161/01.CIR.0000145614.07427.9F; Huxley RR, 2011, CIRCULATION, V124, P2056, DOI 10.1161/CIRCULATIONAHA.111.028373; Kim KJ, 2013, HEART, V99, P1113, DOI 10.1136/heartjnl-2013-303631; Lansky AJ, 2012, JACC-CARDIOVASC IMAG, V5, pS62, DOI 10.1016/j.jcmg.2012.02.003; Lawlor DA, 2003, J EPIDEMIOL COMMUN H, V57, P538, DOI 10.1136/jech.57.7.538; Lee BC, 2011, INT J CARDIOVAS IMAG, V27, P669, DOI 10.1007/s10554-011-9874-6; Lewis GF, 2005, CIRC RES, V96, P1221, DOI 10.1161/01.RES.0000170946.56981.5c; Manka R, 2012, EUR HEART J, V33, P2016, DOI 10.1093/eurheartj/ehs170; Maurovich-Horvat P., 2014, NAT REV CARDIOL; Meijboom WB, 2008, J AM COLL CARDIOL, V52, P2135, DOI 10.1016/j.jacc.2008.08.058; Min JK, 2007, J AM COLL CARDIOL, V50, P1161, DOI 10.1016/j.jacc.2007.03.067; Myerburg RJ, 1997, AM J CARDIOL, V80, pF10, DOI 10.1016/S0002-9149(97)00477-3; Normann J, 2012, AM HEART J, V164, P698, DOI 10.1016/j.ahj.2012.08.003; O'Rourke RA, 2000, CIRCULATION, V102, P126, DOI 10.1161/01.CIR.102.1.126; Ostrom MP, 2008, J AM COLL CARDIOL, V52, P1335, DOI 10.1016/j.jacc.2008.07.027; Plank F, 2014, OPEN HEART, V1, DOI 10.1136/openhrt-2014-000096; Rivera JJ, 2009, ATHEROSCLEROSIS, V206, P451, DOI 10.1016/j.atherosclerosis.2009.05.027; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998	35	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2015	10	7							e0132188	10.1371/journal.pone.0132188	http://dx.doi.org/10.1371/journal.pone.0132188			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EC	26151132	Green Published, gold, Green Submitted			2022-12-26	WOS:000358158900038
J	Tomita, H; Yamashiro, T; Matsuoka, S; Matsushita, S; Kurihara, Y; Nakajima, Y				Tomita, Hayato; Yamashiro, Tsuneo; Matsuoka, Shin; Matsushita, Shoichiro; Kurihara, Yasuyuki; Nakajima, Yasuo			Changes in Cross-Sectional Area and Transverse Diameter of the Heart on Inspiratory and Expiratory Chest CT: Correlation with Changes in Lung Size and Influence on Cardiothoracic Ratio Measurement	PLOS ONE			English	Article							LEFT-VENTRICULAR FUNCTION; SPONTANEOUS RESPIRATION; PRESSURE; RADIOGRAPHS; MORTALITY; MARKER	Objective The aim of this study was to investigate physiological changes in cardiac area and diameters between inspiratory and expiratory chest computed tomography (CT), and to assess their correlation with lung size change and influence on cardiothoracic ratio (CTR) measurements. Materials and Methods The institutional review board of our institution approved this study, and informed consent was waived. Forty-three subjects underwent inspiratory and expiratory chest CT as part of routine clinical care. On both inspiratory and expiratory scans, lung volumes and maximum lung diameters (transverse and vertical directions) were measured. The maximum cardiac cross-sectional area (CSA) and the maximum transverse cardiac diameter were measured on both scans, and the CT-based CTR was calculated. Changes in the lung and cardiac measurements were expressed as the expiratory/inspiratory (E/I) ratios. Comparisons between inspiratory and expiratory measurements were made by the Wilcoxon signed-rank test. Correlations between the E/I ratios of lung and heart measurements were evaluated by Spearman's rank correlation analysis. Results Cardiac CSA and transverse cardiac diameter was significantly larger on expiratory than on inspiratory CT (p< 0.0001). Significant negative correlations were found between the E/I ratios of these cardiac measurements and the E/I ratios of lung volume and vertical lung diameter (p< 0.01). CT-based CTR was significantly larger on expiration than on inspiration (p< 0.0001). Conclusions Heart size on chest CT depends on the phase of ventilation, and is correlated with changes in lung volume and craniocaudal lung diameter. The CTR is also significantly influenced by ventilation.	[Tomita, Hayato; Yamashiro, Tsuneo; Matsuoka, Shin; Matsushita, Shoichiro; Kurihara, Yasuyuki; Nakajima, Yasuo] St Marianna Univ, Sch Med, Dept Radiol, Kawasaki, Kanagawa, Japan; [Yamashiro, Tsuneo] Univ Ryukyus, Grad Sch Med Sci, Dept Radiol, Nishihara, Okinawa 90301, Japan	Saint Marianna University; University of the Ryukyus	Tomita, H (corresponding author), St Marianna Univ, Sch Med, Dept Radiol, Kawasaki, Kanagawa, Japan.	m04149@yahoo.co.jp	Yamashiro, Tsuneo/H-6409-2019; Tomita, Hayato/AAG-2617-2019	Yamashiro, Tsuneo/0000-0002-1904-2548; Tomita, Hayato/0000-0002-7024-3521				ANDERSEN K, 1984, CIRCULATION, V69, P874, DOI 10.1161/01.CIR.69.5.874; BRENNER JI, 1978, CIRCULATION, V57, P122, DOI 10.1161/01.CIR.57.1.122; Browne RFJ, 2004, J DIGIT IMAGING, V17, P120, DOI 10.1007/s10278-003-1900-3; BUDA AJ, 1979, NEW ENGL J MED, V301, P453, DOI 10.1056/NEJM197908303010901; Clark AL, 2000, POSTGRAD MED J, V76, P289, DOI 10.1136/pmj.76.895.289; Dimopoulos K, 2013, INT J CARDIOL, V166, P453, DOI 10.1016/j.ijcard.2011.10.125; Giamouzis G, 2008, AM J CARDIOL, V101, P343, DOI 10.1016/j.amjcard.2007.08.039; Gollub MJ, 2012, J COMPUT ASSIST TOMO, V36, P67, DOI 10.1097/RCT.0b013e318241e585; Hart C, 1998, BRIT MED J, V317, P1321, DOI 10.1136/bmj.317.7168.1321; Hemingway H, 1998, BRIT MED J, V316, P1353, DOI 10.1136/bmj.316.7141.1353; Iwano S, 2009, ACAD RADIOL, V16, P250, DOI 10.1016/j.acra.2008.09.019; JARDIN F, 1984, J APPL PHYSIOL, V56, P619, DOI 10.1152/jappl.1984.56.3.619; Kearney MT, 2002, J AM COLL CARDIOL, V40, P1801, DOI 10.1016/S0735-1097(02)02490-7; KIM BH, 1987, J NUCL MED, V28, P173; KONO T, 1992, JPN CIRC J, V56, P359, DOI 10.1253/jcj.56.359; ROSE CP, 1982, INVEST RADIOL, V17, P139, DOI 10.1097/00004424-198203000-00004; SANTAMORE WP, 1984, J APPL PHYSIOL, V57, P1520, DOI 10.1152/jappl.1984.57.5.1520; Silverman F.N., 1978, PEDIAT XRAY DIAGNOSI, V7th ed., P531; Tomita K., 2004, RIGAKURYOHO KAGAKU, V19, P237; Warnes CA, 2008, CIRCULATION, V118, P2395, DOI [10.1161/CIRCULATIONAHA.108.190811, 10.1016/j.jacc.2008.10.001]; Yamashiro T, 2011, ACAD RADIOL, V18, P299, DOI 10.1016/j.acra.2010.11.005; Yamashiro T, 2010, ACAD RADIOL, V17, P489, DOI 10.1016/j.acra.2009.11.004	22	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2015	10	7							e0131902	10.1371/journal.pone.0131902	http://dx.doi.org/10.1371/journal.pone.0131902			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EC	26151361	Green Published, Green Submitted, gold			2022-12-26	WOS:000358158900029
J	Zhang, JH; Wei, Q; Cai, J; Zhao, X; Ma, BH				Zhang, Junhong; Wei, Qiang; Cai, Jiao; Zhao, Xiaoe; Ma, Baohua			Effect of C-Type Natriuretic Peptide on Maturation and Developmental Competence of Goat Oocytes Matured In Vitro	PLOS ONE			English	Article							NPR2 GUANYLYL CYCLASE; MOUSE OOCYTES; MEIOTIC RESUMPTION; PHOSPHODIESTERASE 3-INHIBITOR; MAMMALIAN OOCYTES; GRANULOSA-CELLS; RECEPTOR NPR2; CUMULUS CELL; ARREST; EXPRESSION	The developmental competence of oocytes during in vitro maturation (IVM) is compromised due to asynchronous nuclear and cytoplasmic maturation. To improve IVM efficiency, a prematuration culture or two-step maturation strategy has been established, involving meiosis arrest induced by pharmacological agents to provide oocytes with sufficient time to synchronize the maturation of the nucleus and cytoplasm. C-type natriuretic peptide (CNP), which has been demonstrated to function as an oocyte maturation inhibitor (OMI) in many species, provides a new alternative to improve the developmental capacity of oocytes matured in vitro. However, the effect of CNP on meiosis arrest and the maturation of goat oocytes remains unclear. In the present study, CNP was shown to function as an OMI in goat oocytes. CNP could temporarily maintain the meiotic arrest of goat oocytes cultured in vitro for 4 hours. This transient effect was partly due to the reduction of natriuretic peptide receptor 2 (Npr2). Estradiol could delay the decrease in Npr2 expression and prolong the duration of meiosis arrest up to 6 hours. Based on the above results, a two-step method was established for goat oocyte maturation, in which the oocyte maturation rate was significantly increased. After parthenogenetic activation, the cleavage rate, blastocyst rate and total cell number of blastocysts were significantly improved. Our results suggested that CNP can be used to delay meiotic resumption and enhance the developmental competence of goat oocytes matured in vitro.	[Zhang, Junhong; Wei, Qiang; Cai, Jiao; Zhao, Xiaoe; Ma, Baohua] Northwest A&F Univ, Coll Vet Med, Yangling, Shaanxi, Peoples R China; [Zhang, Junhong; Wei, Qiang; Cai, Jiao; Zhao, Xiaoe; Ma, Baohua] Minist Agr, Key Lab Anim Biotechnol, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Ministry of Agriculture & Rural Affairs	Ma, BH (corresponding author), Northwest A&F Univ, Coll Vet Med, Yangling, Shaanxi, Peoples R China.	mabh@nwsuaf.edu.cn		Zhang, Junhong/0000-0003-0611-9478; Ma, Baohua/0000-0002-8332-4275	Chinese Universities Scientific Fund [QN2012016]; Natural Science Basic Research Plan in Shaanxi Province of China [2014JQ3101]	Chinese Universities Scientific Fund; Natural Science Basic Research Plan in Shaanxi Province of China	This work was supported in part by Natural Science Basic Research Plan in Shaanxi Province of China (Program No. 2014JQ3101). Chinese Universities Scientific Fund (Program No. QN2012016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuz FK, 2010, HUM REPROD, V25, P2999, DOI 10.1093/humrep/deq246; Duncan FE, 2006, DEV DYNAM, V235, P2961, DOI 10.1002/dvdy.20930; Egbert JR, 2014, DEVELOPMENT, V141, P3594, DOI 10.1242/dev.112219; EPPIG JJ, 1994, DEV BIOL, V164, P1, DOI 10.1006/dbio.1994.1175; Franciosi F, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.118869; Gharibi S, 2013, THERIOGENOLOGY, V80, P302, DOI 10.1016/j.theriogenology.2013.04.012; Gonzalez-Bulnes A, 2002, REPROD DOMEST ANIM, V37, P357, DOI 10.1046/j.1439-0531.2002.00385.x; Grondahl C, 2003, HUM REPROD, V18, P122, DOI 10.1093/humrep/deg028; Hiradate Y, 2014, ZYGOTE, V22, P372, DOI 10.1017/S0967199412000615; Jurema MW, 2006, FERTIL STERIL, V86, P1277, DOI 10.1016/j.fertnstert.2006.02.126; Kawamura K, 2011, HUM REPROD, V26, P3094, DOI 10.1093/humrep/der282; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lodde V, 2007, MOL REPROD DEV, V74, P740, DOI 10.1002/mrd.20639; Lucci CM, 1999, ANIM REPROD SCI, V56, P39, DOI 10.1016/S0378-4320(99)00031-7; Luciano AM, 2004, BIOL REPROD, V70, P465, DOI 10.1095/biolreprod.103.020644; Mehlmann LM, 2005, REPRODUCTION, V130, P791, DOI 10.1530/rep.1.00793; Nogueira D, 2006, BIOL REPROD, V74, P177, DOI 10.1095/biolreprod.105.040485; Nogueira D, 2003, BIOL REPROD, V69, P2045, DOI 10.1095/biolreprod.103.021105; Peng JY, 2013, GENE, V524, P105, DOI 10.1016/j.gene.2013.04.054; Robinson JW, 2012, DEV BIOL, V366, P308, DOI 10.1016/j.ydbio.2012.04.019; Sato Y, 2012, MOL ENDOCRINOL, V26, P1158, DOI 10.1210/me.2012-1027; Thompson IR, 2012, ENDOCR-RELAT CANCER, V19, P497, DOI 10.1530/ERC-12-0129; Tripathi A, 2010, J CELL PHYSIOL, V223, P592, DOI 10.1002/jcp.22108; Trounson A, 2001, REPRODUCTION, V121, P51, DOI 10.1530/rep.0.1210051; TSAFRIRI A, 1986, CLIN ENDOCRINOL META, V15, P157, DOI 10.1016/S0300-595X(86)80047-0; Vanhoutte L, 2008, MOL REPROD DEV, V75, P1021, DOI 10.1002/mrd.20851; Zeng HT, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.118471; Zhang MJ, 2011, ENDOCRINOLOGY, V152, P4377, DOI 10.1210/en.2011-1118; Zhang MJ, 2010, SCIENCE, V330, P366, DOI 10.1126/science.1193573; Zhang MJ, 2009, MOL HUM REPROD, V15, P399, DOI 10.1093/molehr/gap031; Zhang WQ, 2014, MOL REPROD DEV, V81, P1030, DOI 10.1002/mrd.22424	31	32	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2015	10	7							e0132318	10.1371/journal.pone.0132318	http://dx.doi.org/10.1371/journal.pone.0132318			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EC	26151446	gold, Green Submitted, Green Published			2022-12-26	WOS:000358158900040
J	Bricker-Anthony, C; Rex, TS				Bricker-Anthony, Courtney; Rex, Tonia S.			Neurodegeneration and Vision Loss after Mild Blunt Trauma in the C57Bl/6 and DBA/2J Mouse	PLOS ONE			English	Article							COMBAT OCULAR TRAUMA; COMMOTIO-RETINAE; INJURY; MODEL; GLOBE; MICE; EYE; GLAUCOMA; ETHANOL	Damage to the eye from blast exposure can occur as a result of the overpressure air-wave (primary injury), flying debris (secondary injury), blunt force trauma (tertiary injury), and/or chemical/thermal burns (quaternary injury). In this study, we investigated damage in the contralateral eye after a blast directed at the ipsilateral eye in the C57Bl/6J and DBA/2J mouse. Assessments of ocular health (gross pathology, electroretinogram recordings, optokinetic tracking, optical coherence tomography and histology) were performed at 3, 7, 14 and 28 days post-trauma. Olfactory epithelium and optic nerves were also examined. Anterior pathologies were more common in the DBA/2J than in the C57Bl/6 and could be prevented with non-medicated viscous eye drops. Visual acuity decreased over time in both strains, but was more rapid and severe in the DBA/2J. Retinal cell death was present in approximately 10% of the retina at 7 and 28 days post-blast in both strains. Approximately 60% of the cell death occurred in photoreceptors. Increased oxidative stress and microglial reactivity was detected in both strains, beginning at 3 days post-injury. However, there was no sign of injury to the olfactory epithelium or optic nerve in either strain. Although our model directs an overpressure air-wave at the left eye in a restrained and otherwise protected mouse, retinal damage was detected in the contralateral eye. The lack of damage to the olfactory epithelium and optic nerve, as well as the different timing of cell death as compared to the blast-exposed eye, suggests that the injuries were due to physical contact between the contralateral eye and the housing chamber of the blast device and not propagation of the blast wave through the head. Thus we describe a model of mild blunt eye trauma.	[Bricker-Anthony, Courtney; Rex, Tonia S.] Vanderbilt Univ, Vanderbilt Eye Inst, Nashville, TN 37235 USA; [Bricker-Anthony, Courtney; Rex, Tonia S.] Vanderbilt Univ, Vanderbilt Brain Inst, Nashville, TN 37235 USA	Vanderbilt University; Vanderbilt University	Rex, TS (corresponding author), Vanderbilt Univ, Vanderbilt Eye Inst, 221 Kirkland Hall, Nashville, TN 37235 USA.	tonia.rex@vanderbilt.edu	Bricker-Anthony, Courtney/AAS-9583-2021; Bricker-Anthony, Courtney/AHB-0825-2022; Bricker-Anthony, Courtney/GRR-9960-2022	Bricker-Anthony, Courtney/0000-0001-5000-3523	Department of Defense [W81XW-10-1-0528]; National Eye Institute [EY022349, P30-EY008126]; Research to Prevent Blindness Unrestricted Fund; NATIONAL EYE INSTITUTE [R01EY022349] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness Unrestricted Fund; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by Department of Defense W81XW-10-1-0528 (TSR); National Eye Institute EY022349 (TSR); Research to Prevent Blindness Unrestricted Funds (P. Sternberg); National Eye Institute P30-EY008126 (J. Schall). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airey DC, 2001, J NEUROSCI, V21, P5099, DOI 10.1523/JNEUROSCI.21-14-05099.2001; BELKNAP JK, 1993, BEHAV GENET, V23, P213, DOI 10.1007/BF01067426; Blanch RJ, 2012, INVEST OPHTH VIS SCI, V53, P7220, DOI 10.1167/iovs.12-9887; BLIGHT R, 1977, BRIT J OPHTHALMOL, V61, P573, DOI 10.1136/bjo.61.9.573; Bricker-Anthony C, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0192-5; Bricker-Anthony C, 2014, INVEST OPHTH VIS SCI, V55, P4853, DOI 10.1167/iovs.14-14353; BUNTMILAM AH, 1986, EXP EYE RES, V43, P397, DOI 10.1016/S0014-4835(86)80076-8; Chevallier A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053520; Cockerham GC, 2013, CLIN PRACT, V11, P225; CUNNINGHAM CL, 1995, PSYCHOPHARMACOLOGY, V120, P28, DOI 10.1007/BF02246142; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Gendler S, 2015, INJURY; Hines-Beard J, 2012, EXP EYE RES, V99, P63, DOI 10.1016/j.exer.2012.03.013; John SWM, 1998, INVEST OPHTH VIS SCI, V39, P951; Libby RT, 2005, VISUAL NEUROSCI, V22, P637, DOI 10.1017/S0952523805225130; May DR, 2000, GRAEF ARCH CLIN EXP, V238, P153, DOI 10.1007/PL00007884; Mo JS, 2003, J EXP MED, V197, P1335, DOI 10.1084/jem.20022041; Paranthan RR, 2011, MOL VIS, V17, P1901; Prusky GT, 2008, J NEUROSCI, V28, P9817, DOI 10.1523/JNEUROSCI.1940-08.2008; Scott R, 2011, PHILOS T R SOC B, V366, P251, DOI 10.1098/rstb.2010.0234; SIPPERLEY JO, 1978, ARCH OPHTHALMOL-CHIC, V96, P2267, DOI 10.1001/archopht.1978.03910060563021; Ward TP, 2007, OPHTHALMOL TIMES, V32, P8; Weichel EA, 2009, J HEAD TRAUMA REHAB, V24, P41, DOI 10.1097/HTR.0b013e3181956ffd; Weichel ED, 2008, CURR OPIN OPHTHALMOL, V19, P519, DOI 10.1097/ICU.0b013e3283140e98; Xia T, 2015, IOVS	25	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131921	10.1371/journal.pone.0131921	http://dx.doi.org/10.1371/journal.pone.0131921			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148200	Green Published, gold, Green Submitted			2022-12-26	WOS:000358157600166
J	Chang, S; Linderholm, A; Harper, R				Chang, Sandra; Linderholm, Angela; Harper, Richart			DUOX-Mediated Signaling Is Not Required for LPS-Induced Neutrophilic Response in the Airways	PLOS ONE			English	Article							HYDROGEN-PEROXIDE PRODUCTION; ACUTE LUNG INJURY; EPITHELIAL-CELLS; NADPH OXIDASE; ENDOTHELIAL-CELLS; OXIDATIVE STRESS; HOST-DEFENSE; WOUND REPAIR; IN-VIVO; EXPRESSION	Oxidant production from DUOX1 has been proposed to lead to neutrophil recruitment into the airways when lung homeostasis is compromised. The objective of this study was to determine whether DUOX-derived hydrogen peroxide is required for LPS-induced neutrophil recruitment, using a functional DUOX knock out mouse model. We found that LPS induced profound neutrophilic lung inflammation in both Duoxa+/+ and Duoxa-/-mice between 3h and 24h. Duoxa-/-mice had significantly higher neutrophil influx 24h after LPS instillation despite similar cytokine levels (KC, MIP-2, or TGF-alpha) between the two groups. These findings suggest that LPS-TLR-4-induced KC or MIP-2 cytokine induction and subsequent neutrophil recruitment in the airway does not require DUOX-derived hydrogen peroxide from airway epithelium.	[Chang, Sandra; Linderholm, Angela; Harper, Richart] Univ Calif Davis, Dept Internal Med, Sch Med, Div Pulm & Crit Care Med, Davis, CA 95616 USA	University of California System; University of California Davis	Harper, R (corresponding author), Univ Calif Davis, Dept Internal Med, Sch Med, Div Pulm & Crit Care Med, Davis, CA 95616 USA.	rwharper@ucdavis.edu			National Institutes of Health (Bethesda, MD) [NHLBI R01 HL085311, NHLBI T32 HL007013]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007013, R01HL085311] Funding Source: NIH RePORTER	National Institutes of Health (Bethesda, MD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants NHLBI R01 HL085311 and NHLBI T32 HL007013 from the National Institutes of Health (Bethesda, MD) (http://www.nhlbi.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldieri E, 2008, CURR DRUG METAB, V9, P686, DOI 10.2174/138920008786049285; Boots AW, 2009, J BIOL CHEM, V284, P17858, DOI 10.1074/jbc.M809761200; Call DR, 2001, SHOCK, V15, P278, DOI 10.1097/00024382-200115040-00005; Chang S, 2013, FREE RADICAL BIO MED, V65, P38, DOI 10.1016/j.freeradbiomed.2013.06.012; De Deken X, 2014, ANTIOXID REDOX SIGN, V20, P2776, DOI 10.1089/ars.2013.5602; de Oliveira S, 2015, J IMMUNOL, V194, P1523, DOI 10.4049/jimmunol.1402386; de Oliveira S, 2014, J IMMUNOL, V192, P5710, DOI 10.4049/jimmunol.1302902; Enyedi B, 2013, METHOD ENZYMOL, V528, P237, DOI 10.1016/B978-0-12-405881-1.00014-8; Fan J, 2003, J CLIN INVEST, V112, P1234, DOI 10.1172/JCI200318696; Fan Jie, 2010, Open Crit Care Med J, V2, P1; Finkel T, 2003, CURR OPIN CELL BIOL, V15, P247, DOI 10.1016/S0955-0674(03)00002-4; Fischer H, 2007, AM J PHYSIOL-LUNG C, V292, pL1506, DOI 10.1152/ajplung.00029.2007; Forteza R, 2005, AM J RESP CELL MOL, V32, P462, DOI 10.1165/rcmb.2004-0302OC; Gattas MV, 2009, FREE RADICAL BIO MED, V47, P1450, DOI 10.1016/j.freeradbiomed.2009.08.017; Gorissen SH, 2012, AM J RESP CELL MOL B; Grasberger H, 2012, MOL ENDOCRINOL, V26, P481, DOI 10.1210/me.2011-1320; Grommes J, 2011, MOL MED, V17, P293, DOI 10.2119/molmed.2010.00138; Hattori H, 2010, P NATL ACAD SCI USA, V107, P3546, DOI 10.1073/pnas.0914351107; Janssen-Heininger Y., 2013, J CELL BIOCHEM; Joo JH, 2011, ANTIOXID REDOX SIGNA; Kim HJ, 2008, AM J RESP CELL MOL, V39, P598, DOI 10.1165/rcmb.2007-0262OC; Klyubin IV, 1996, EUR J CELL BIOL, V70, P347; Koff JL, 2006, J IMMUNOL, V177, P8693, DOI 10.4049/jimmunol.177.12.8693; Li W., 2013, SCI REP, V3, P1, DOI DOI 10.1371/J0URNAL.P0NE.0063945; Looney MR, 2006, CRIT CARE MED, V34, pS132, DOI 10.1097/01.CCM.0000214287.58444.2D; Moskwa P, 2007, AM J RESP CRIT CARE, V175, P174, DOI 10.1164/rccm.200607-1029OC; Nakanaga T, 2007, AM J PHYSL LUNG CELL; Niethammer P, 2009, NATURE, V459, P996, DOI 10.1038/nature08119; Parinandi NL, 2003, AM J PHYSIOL-LUNG C, V284, pL26, DOI 10.1152/ajplung.00123.2002; Rada B, 2010, FEBS LETT, V584, P917, DOI 10.1016/j.febslet.2010.01.025; Razzell W, 2013, CURR BIOL, V23, P424, DOI 10.1016/j.cub.2013.01.058; Reutershan J, 2005, AM J PHYSIOL-LUNG C, V289, pL807, DOI 10.1152/ajplung.00477.2004; Robertson NM, 2002, J IMMUNOL, V169, P5986, DOI 10.4049/jimmunol.169.10.5986; Robertson NM, 2004, VITAM HORM, V67, P149; Rovai LE, 1998, J LEUKOCYTE BIOL, V64, P494, DOI 10.1002/jlb.64.4.494; Ryu JH, 2012, J ALLERGY CLIN IMMUN; Scarcella DL, 1999, CLIN CANCER RES, V5, P335; Tazzeo T, 2009, BRIT J PHARMACOL, V158, P790, DOI 10.1111/j.1476-5381.2009.00394.x; Tisato V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115387; ULICH TR, 1991, AM J PATHOL, V138, P1485; Ushio-Fukai M, 2009, ANTIOXID REDOX SIGN, V11, P2517, DOI [10.1089/ars.2009.2582, 10.1089/ARS.2009.2582]; Veal E, 2011, ANTIOXID REDOX SIGN, V15, P147, DOI 10.1089/ars.2011.3968; Wang XR, 2002, J IMMUNOL, V168, P810, DOI 10.4049/jimmunol.168.2.810; Weng TT, 2006, AM J PHYSIOL-LUNG C, V291, pL1027, DOI 10.1152/ajplung.00435.2005; Wesley UV, 2007, J BIOL CHEM, V282, P3213, DOI 10.1074/jbc.M606533200; Yi ES, 1996, INFLAMMATION, V20, P165, DOI 10.1007/BF01487403	46	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131810	10.1371/journal.pone.0131810	http://dx.doi.org/10.1371/journal.pone.0131810			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148206	Green Submitted, Green Published, gold			2022-12-26	WOS:000358157600148
J	Connolly, F; Rae, MT; Spath, K; Boswell, L; McNeilly, AS; Duncan, WC				Connolly, Fiona; Rae, Michael T.; Spaeth, Katharina; Boswell, Lyndsey; McNeilly, Alan S.; Duncan, W. Colin			In an Ovine Model of Polycystic Ovary Syndrome (PCOS) Prenatal Androgens Suppress Female Fetal Renal Gluconeogenesis	PLOS ONE			English	Article							PHOSPHOENOLPYRUVATE CARBOXYKINASE; INSULIN-RESISTANCE; GLUCOSE-PRODUCTION; GENE-EXPRESSION; LATE-GESTATION; EXCESS; SHEEP; PREVALENCE; TESTOSTERONE; SENSITIVITY	Increased maternal androgen exposure during pregnancy programmes a polycystic ovary syndrome (PCOS)-like condition, with metabolic dysfunction, in adult female offspring. Other in utero exposures associated with the development of insulin resistance, such as intrauterine growth restriction and exposure to prenatal glucocorticoids, are associated with altered fetal gluconeogenesis. We therefore aimed to assess the effect of maternal androgenisation on the expression of PEPCK and G6PC in the ovine fetus. Pregnant Scottish Greyface sheep were treated with twice weekly testosterone propionate (TP; 100mg) or vehicle control from day 62 to day102 of gestation. At day 90 and day 112 fetal plasma and liver and kidney tissue was collected for analysis. PEPCK and G6PC expression were analysed by quantitative RT-PCR, immunohistochemistry and western blotting. PEPCK and G6PC were localised to fetal hepatocytes but maternal androgens had no effect on female or male fetuses. PEPCK and G6PC were also localised to the renal tubules and renal PEPCK (P<0.01) and G6PC (P = 0.057) were lower in females after prenatal androgenisation with no change in male fetuses. These tissue and sex specific observations could not be explained by alterations in fetal insulin or cortisol. The sexual dimorphism may be related to the increase in circulating estrogen (P<0.01) and testosterone (P<0.001) in females but not males. The tissue specific effects may be related to the increased expression of ESR1 (P<0.01) and AR (P<0.05) in the kidney when compared to the fetal liver. After discontinuation of maternal androgenisation female fetal kidney PEPCK expression normalised. These data further highlight the fetal and sexual dimorphic effects of maternal androgenisation, an antecedent to adult disease and the plasticity of fetal development.	[Connolly, Fiona; Spaeth, Katharina; Boswell, Lyndsey; McNeilly, Alan S.; Duncan, W. Colin] Univ Edinburgh, MRC, Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland; [Rae, Michael T.] Edinburgh Napier Univ, Sch Hlth Life & Social Sci, Edinburgh, Midlothian, Scotland	University of Edinburgh; Edinburgh Napier University	Duncan, WC (corresponding author), Univ Edinburgh, MRC, Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland.	W.C.Duncan@ed.ac.uk			Medical Research Council [G0500717, G0901807]; Scottish Funding Council; MRC [G0500717, G0901807] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Scottish Funding Council; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was funded by the Medical Research Council (G0500717, G0901807) and WCD was supported by a Senior Clinical Fellowship from the Scottish Funding Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott DH, 2010, AM J PHYSIOL-ENDOC M, V299, pE741, DOI 10.1152/ajpendo.00058.2010; Azziz R, 2004, J CLIN ENDOCR METAB, V89, P2745, DOI 10.1210/jc.2003-032046; Barthel A, 2003, AM J PHYSIOL-ENDOC M, V285, pE685, DOI 10.1152/ajpendo.00253.2003; Carmina E, 2004, FERTIL STERIL, V82, P661, DOI 10.1016/j.fertnstert.2004.01.041; Chakravarty K, 2005, CRIT REV BIOCHEM MOL, V40, P129, DOI 10.1080/10409230590935479; Connolly F, 2013, ENDOCRINOLOGY, V154, P1921, DOI 10.1210/en.2012-2153; De Meyts P, 2002, GROWTH HORM IGF RES, V12, P81, DOI 10.1054/ghir.2002.0264; Demissie M, 2008, AM J PHYSIOL-ENDOC M, V295, pE262, DOI 10.1152/ajpendo.90208.2008; DeUgarte CM, 2005, FERTIL STERIL, V83, P1454, DOI 10.1016/j.fertnstert.2004.11.070; Diamanti-Kandarakis E, 2006, ENDOCRINE, V30, P13, DOI 10.1385/ENDO:30:1:13; Dumesic DA, 2014, SEMIN REPROD MED, V32, P159, DOI 10.1055/s-0034-1371087; Eisner JR, 2000, J CLIN ENDOCR METAB, V85, P1206, DOI 10.1210/jc.85.3.1206; Forhead AJ, 2003, J PHYSIOL-LONDON, V548, P941, DOI 10.1113/jphysiol.2002.035816; FOWDEN AL, 1993, J ENDOCRINOL, V137, P213, DOI 10.1677/joe.0.1370213; Franko KL, 2007, J ENDOCRINOL, V192, P67, DOI 10.1677/joe.1.07063; Gerich JE, 2001, DIABETES CARE, V24, P382, DOI 10.2337/diacare.24.2.382; Goodarzi MO, 2011, NAT REV ENDOCRINOL, V7, P219, DOI 10.1038/nrendo.2010.217; Hajarnis S, 2005, J BIOL CHEM, V280, P28272, DOI 10.1074/jbc.M501204200; Hogg K, 2012, ENDOCRINOLOGY, V153, P450, DOI 10.1210/en.2011-1607; Hogg K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024877; Hogg K, 2011, ENDOCRINOLOGY, V152, P2048, DOI 10.1210/en.2010-1219; JAUSSI R, 1992, MOL CELL ENDOCRINOL, V86, P187, DOI 10.1016/0303-7207(92)90143-T; Kwong WY, 2007, MOL REPROD DEV, V74, P48, DOI 10.1002/mrd.20606; LEMONS JA, 1986, PEDIATR RES, V20, P676, DOI 10.1203/00006450-198607000-00020; McNeilly AS, 2013, MOL CELL ENDOCRINOL, V373, P2, DOI 10.1016/j.mce.2012.10.007; Mutel E, 2011, DIABETES, V60, P3121, DOI 10.2337/db11-0571; Nicol LE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106527; Nordlie RC, 1999, ANNU REV NUTR, V19, P379, DOI 10.1146/annurev.nutr.19.1.379; Padmanabhan V, 2010, ENDOCRINOLOGY, V151, P595, DOI 10.1210/en.2009-1015; Peterside IE, 2003, AM J PHYSIOL-ENDOC M, V285, pE1258, DOI 10.1152/ajpendo.00437.2002; Rae M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056263; Rajas F, 2007, HISTOCHEM CELL BIOL, V127, P555, DOI 10.1007/s00418-006-0263-5; Recabarren SE, 2005, AM J PHYSIOL-ENDOC M, V289, pE801, DOI 10.1152/ajpendo.00107.2005; Roland AV, 2010, J ENDOCRINOL, V207, P213, DOI 10.1677/JOE-10-0217; ROSELLA G, 1993, MOL ENDOCRINOL, V7, P1456, DOI 10.1210/me.7.11.1456; Sunny NE, 2011, CELL METAB, V14, P804, DOI 10.1016/j.cmet.2011.11.004; Thorn SR, 2013, DIABETES, V62, P65, DOI 10.2337/db11-1727; Tomlinson JW, 2001, BEST PRACT RES CL EN, V15, P61, DOI 10.1053/beem.2000.0119; Xita N, 2006, J CLIN ENDOCR METAB, V91, P1660, DOI 10.1210/jc.2005-2757	39	11	11	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132113	10.1371/journal.pone.0132113	http://dx.doi.org/10.1371/journal.pone.0132113			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148093	Green Published, Green Submitted, gold			2022-12-26	WOS:000358157600201
J	de Groen, FLM; Timmer, LM; Menezes, RX; Diosdado, B; Hooijberg, E; Meijer, GA; Steenbergen, RDM; Carvalho, B				de Groen, Florence L. M.; Timmer, Lisette M.; Menezes, Renee X.; Diosdado, Begona; Hooijberg, Erik; Meijer, Gerrit A.; Steenbergen, Renske D. M.; Carvalho, Beatriz			Oncogenic Role of miR-15a-3p in 13q Amplicon-Driven Colorectal Adenoma-to-Carcinoma Progression	PLOS ONE			English	Article							DNA COPY NUMBER; CELL-PROLIFERATION; PROSTATE-CANCER; TUMOR-GROWTH; EXPRESSION; MICRORNA; GENE; CLUSTER; ANGIOGENESIS; CONTRIBUTES	Progression from colorectal adenoma to carcinoma is strongly associated with an accumulation of genomic alterations, including gain of chromosome 13. This gain affects the whole q arm and is present in 40%-60% of all colorectal cancers (CRCs). Several genes located at this amplicon are known to be overexpressed in carcinomas due to copy number dosage. A subset of these genes, including the mir-17 similar to 92 cluster, are functionally involved in CRC development. The present study set out to explore whether apart from mir-17 similar to 92, other miRNAs located at the 13q amplicon show a copy number dependent dosage effect that may contribute to 13q-driven colorectal adenoma-to-carcinoma progression. Integration of publically available miRNA expression, target mRNA expression and DNA copy number data from 125 CRCs yielded three miRNAs, miR-15a, -17, and -20a, of which high expression levels were significantly correlated with a 13q gain and which influenced target mRNA expression. These results could be confirmed by qRT-PCR in a series of 100 colon adenomas and carcinomas. Functional analysis of both mature miRNAs encoded by mir-15a, i.e. miR-15a-5p and miR-15a-3p, showed that silencing of miR-15a-3p significantly inhibited viability of CRC cells. Integration of miR-15a expression levels with mRNA expression data of predicted target genes identified mitochondrial uncoupling protein 2 (UCP2) and COP9 signalosome subunit 2 (COPS2) as candidates with significantly decreased expression in CRCs with 13q gain. Upon silencing of miR-15a-3p, mRNA expression of both genes increased in CRC cells, supporting miR-15a-3p mediated regulation of UPC2 and COPS2 expression. In conclusion, significant overexpression of miR-15a-3p due to gain of 13q is functionally relevant in CRC, with UCP2 and COPS2 as candidate target genes. Taken together our findings suggest that miR-15a-3p may contribute to adenoma-to-carcinoma progression.	[de Groen, Florence L. M.; Timmer, Lisette M.; Diosdado, Begona; Hooijberg, Erik; Meijer, Gerrit A.; Steenbergen, Renske D. M.; Carvalho, Beatriz] Vrije Univ Amsterdam Med Ctr, Dept Pathol, Amsterdam, Netherlands; [Menezes, Renee X.] Vrije Univ Amsterdam Med Ctr, Dept Epidemiol & Biostat, Amsterdam, Netherlands; [Diosdado, Begona; Meijer, Gerrit A.; Carvalho, Beatriz] Netherlands Canc Inst, Dept Pathol, NL-1066 CX Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Netherlands Cancer Institute	Carvalho, B (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Pathol, Amsterdam, Netherlands.	b.carvalho@nki.nl	Hooijberg, Erik/F-4503-2011; Carvalho, Beatriz/GXA-0720-2022	Hooijberg, Erik/0000-0002-4482-2191; Steenbergen, Renske/0000-0002-2327-9839; Meijer, Gerrit/0000-0003-0330-3130	VUmc Cancer Center Amsterdam (CCA); DeCoDe project [03O-101]	VUmc Cancer Center Amsterdam (CCA); DeCoDe project	This study was funded by the VUmc Cancer Center Amsterdam (CCA) and performed within the framework of CTMM, the Center for Translational Molecular Medicine. DeCoDe project (grant 03O-101).	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bonci D, 2008, NAT MED, V14, P1271, DOI 10.1038/nm.1880; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Camps J, 2013, CANCER RES, V73, P2003, DOI 10.1158/0008-5472.CAN-12-3159; Carvalho B, 2009, GUT, V58, P79, DOI 10.1136/gut.2007.143065; Chai HJ, 2011, ACTA BIOCH BIOPH SIN, V43, P217, DOI 10.1093/abbs/gmq125; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; de Groen FLM, 2014, GENE CHROMOSOME CANC, V53, P339, DOI 10.1002/gcc.22144; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Diosdado B, 2009, BRIT J CANCER, V101, P707, DOI 10.1038/sj.bjc.6605037; Druz A, 2013, RNA BIOL, V10, P287, DOI 10.4161/rna.23339; Dydensborg AB, 2006, AM J PHYSIOL-GASTR L, V290, pG1067, DOI 10.1152/ajpgi.00234.2005; Esteves P, 2014, CANCER RES, V74, P3971, DOI 10.1158/0008-5472.CAN-13-3383; Firestein R, 2008, NATURE, V455, P547, DOI 10.1038/nature07179; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Goeman JJ, 2004, BIOINFORMATICS, V20, P93, DOI 10.1093/bioinformatics/btg382; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Guo L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011387; Hermsen M, 2002, GASTROENTEROLOGY, V123, P1109, DOI 10.1053/gast.2002.36051; Hsu SD, 2011, NUCLEIC ACIDS RES, V39, pD163, DOI 10.1093/nar/gkq1107; Jansson MD, 2012, MOL ONCOL, V6, P590, DOI 10.1016/j.molonc.2012.09.006; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Klein U, 2010, CANCER CELL, V17, P28, DOI 10.1016/j.ccr.2009.11.019; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Leal JFM, 2008, ONCOGENE, V27, P1961, DOI 10.1038/sj.onc.1210846; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo HS, 2012, BIOCHEM J, V442, P311, DOI 10.1042/BJ20111517; Ma QY, 2013, ONCOL REP, V29, P1652, DOI 10.3892/or.2013.2262; Meijer GA, 1998, J CLIN PATHOL, V51, P901, DOI 10.1136/jcp.51.12.901; Menezes RX, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-203; Mogilyansky E, 2013, CELL DEATH DIFFER, V20, P1603, DOI 10.1038/cdd.2013.125; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nakao K, 2004, CARCINOGENESIS, V25, P1345, DOI 10.1093/carcin/bgh134; Qiang XF, 2014, J CELL BIOCHEM, V115, P1269, DOI 10.1002/jcb.24778; Rajagopalan H, 2003, NAT REV CANCER, V3, P695, DOI 10.1038/nrc1165; Ro S, 2007, NUCLEIC ACIDS RES, V35, P5944, DOI 10.1093/nar/gkm641; SCHOUTEN JP, 2002, NUCL ACIDS RES E, V57, P30; Shi L, 2014, CANCER RES, V74, P532, DOI 10.1158/0008-5472.CAN-13-2203; Sillars-Hardebol AH, 2012, GUT, V61, P1568, DOI 10.1136/gutjnl-2011-301153; Sun CY, 2013, CARCINOGENESIS, V34, P426, DOI 10.1093/carcin/bgs333; van Iterson M, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt525; Wilting SM, 2013, ONCOGENE, V32, P106, DOI 10.1038/onc.2012.20; Xu ZQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077890; Yang XL, 2013, NUCLEIC ACIDS RES, V41, P9688, DOI 10.1093/nar/gkt680; Young LE, 2012, MOL CANCER RES, V10, P167, DOI 10.1158/1541-7786.MCR-11-0337	47	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132495	10.1371/journal.pone.0132495	http://dx.doi.org/10.1371/journal.pone.0132495			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148070	Green Published, gold, Green Submitted			2022-12-26	WOS:000358157600290
J	Nicastro, E; Lo Vecchio, A; Liguoro, I; Chmielewska, A; De Bruyn, C; Dolinsek, J; Doroshina, E; Fessatou, S; Pop, TL; Prell, C; Tabbers, MM; Tavares, M; Urenden-Elicin, P; Bruzzese, D; Zakharova, I; Sandhu, B; Guarino, A				Nicastro, Emanuele; Lo Vecchio, Andrea; Liguoro, Ilaria; Chmielewska, Anna; De Bruyn, Caroline; Dolinsek, Jernej; Doroshina, Elena; Fessatou, Smaragdi; Pop, Tudor Lucian; Prell, Christine; Tabbers, Merit Monique; Tavares, Marta; Urenden-Elicin, Pinar; Bruzzese, Dario; Zakharova, Irina; Sandhu, Bhupinder; Guarino, Alfredo			The Impact of E-Learning on Adherence to Guidelines for Acute Gastroenteritis: A Single-Arm Intervention Study	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; EVIDENCE-BASED MEDICINE; PEDIATRIC GASTROENTERITIS; EMERGENCY-DEPARTMENT; ACUTE DIARRHEA; PRIMARY-CARE; CHILDREN; MANAGEMENT; IMPLEMENTATION; RESUSCITATION	Objective E-learning is a candidate tool for clinical practice guidelines (CPG) implementation due to its versatility, universal access and low costs. We aimed to assess the impact of a five-module e-learning course about CPG for acute gastroenteritis (AGE) on physicians' knowledge and clinical practice. Study design This work was conceived as a pre/post single-arm intervention study. Physicians from 11 European countries registered for the online course. Personal data, pre- and post-course questionnaires and clinical data about 3 to 5 children with AGE managed by each physician before and after the course were collected. Primary outcome measures included the proportion of participants fully adherent to CPG and number of patients managed with full adherence. Results Among the 149 physicians who signed up for the e-learning course, 59 took the course and reported on their case management of 519 children <5 years of age who were referred to their practice because of AGE (281 and 264 children seen before and after the course, respectively). The course improved knowledge scores (pre-course 8.6 +/- 2.7 versus post-course 12.8 +/- 2.1, P < 0.001), average adherence (from 87.0 +/- 7.7% to 90.6 +/- 7.1%, P = 0.001) and the number of patients managed in full adherence with the guidelines (from 33.6 +/- 31.7% to 43.9 +/- 36.1%, P = 0.037). Conclusions E-learning is effective in increasing knowledge and improving clinical practice in paediatric AGE and is an effective tool for implementing clinical practice guidelines.	[Nicastro, Emanuele; Lo Vecchio, Andrea; Liguoro, Ilaria; Guarino, Alfredo] Univ Naples Federico II, Dept Translat Med Sci, Sect Pediat, Naples, Italy; [Nicastro, Emanuele] Hosp Papa Giovanni XXIII, Paediat Hepatol Gastroenterol & Transplantat Unit, Bergamo, Italy; [Chmielewska, Anna] Med Univ Warsaw, Dept Pediat, Warsaw, Poland; [De Bruyn, Caroline] Vrije Univ Brussel, Univ Ziekenhuis Brussel Kinderen, Brussels, Belgium; [Dolinsek, Jernej] Univ Med Ctr, Maribor, Slovenia; [Doroshina, Elena; Zakharova, Irina] Russian Med Postgrad Acad, Moscow, Russia; [Fessatou, Smaragdi] Univ Athens, Dept Pediat 3, GR-10679 Athens, Greece; [Pop, Tudor Lucian] Univ Med & Pharm, Iuliu Ha Hatieganu, Pediat Clin 2, Cluj Napoca, Romania; [Prell, Christine] Univ Munich, Med Ctr, Dr von Hauner Childrens Hosp, Munich, Germany; [Tabbers, Merit Monique] Univ Amsterdam, Acad Med Ctr, Emmas Childrens Hosp, NL-1105 AZ Amsterdam, Netherlands; [Tavares, Marta] Hosp Sao Joao, Dept Pediat, Oporto, Portugal; [Urenden-Elicin, Pinar] Marmara Univ, Dept Pediat, Istanbul, Turkey; [Bruzzese, Dario] Univ Naples Federico II, Dept Publ Hlth, Naples, Italy; [Sandhu, Bhupinder] Bristol Royal Hosp Children, Dept Paediat Gastroenterol, Bristol, Avon, England	University of Naples Federico II; ASST Papa Giovanni XXIII; Medical University of Warsaw; University Hospital Brussels; Vrije Universiteit Brussel; National & Kapodistrian University of Athens; Iuliu Hatieganu University of Medicine & Pharmacy; University of Munich; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Sao Joao Hospital; Marmara University; University of Naples Federico II; Bristol Royal Hospital For Children	Guarino, A (corresponding author), Univ Naples Federico II, Dept Translat Med Sci, Sect Pediat, Naples, Italy.	alfguari@unina.it	Fessatou, Smaragdi/AAH-1592-2021; Dolinsek, Jernej/ABB-4843-2021; Nicastro, Emanuele/AAJ-2274-2020; Guarino, Alfredo/AAC-4812-2022; Nicastro, Emanuele/K-1260-2018; Vecchio, Andrea Lo/AAC-6042-2022; Pop, Tudor Lucian/I-4155-2015; Liguoro, Ilaria/AAW-1038-2021	Guarino, Alfredo/0000-0003-0199-0336; Nicastro, Emanuele/0000-0002-4518-9375; Pop, Tudor Lucian/0000-0002-4931-1219; Tabbers, Merit/0000-0001-9744-7308; Lo Vecchio, Andrea/0000-0003-4181-6842; Bruzzese, Dario/0000-0001-9911-4646; Liguoro, Ilaria/0000-0002-9177-0400	United European Gastroenterology federation; "Monothematic Initiative" educational grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD041041] Funding Source: NIH RePORTER	United European Gastroenterology federation; "Monothematic Initiative" educational grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The project was supported by the United European Gastroenterology federation with a "Monothematic Initiative" educational grant (2012-2014). This grant covered the expenses for the development of the educational material, the e-learning course, and the start-up meeting with international tutors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albano F, 2010, J PEDIATR-US, V156, P226, DOI 10.1016/j.jpeds.2009.07.065; Aparicio P, 2003, JEPHC, V1, P3; Asarbakhsh M, 2013, CLIN TEACH, V10, P47, DOI 10.1111/j.1743-498X.2012.00627.x; Balas EA, 1998, PEDIATR ANN, V27, P581, DOI 10.3928/0090-4481-19980901-11; Bruzzese E, 2013, CURR OPIN GASTROEN, V29, P23, DOI 10.1097/MOG.0b013e32835a352f; Doherty S, 2007, J PAEDIATR CHILD H, V43, P611, DOI 10.1111/j.1440-1754.2007.01151.x; Drug Safety Communication-FDA, 2011, MEDWATCH THE FDA SAF; Edmonds Marcia, 2009, Evid Based Med, V14, P44, DOI 10.1136/ebm.14.2.44; Fedorowicz Z, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005506.pub5; Freedman SB, 2013, J PEDIATR GASTR NUTR, V57, P612, DOI 10.1097/MPG.0b013e3182a1dd93; Freedman SB, 2011, PEDIATRICS, V127, pE287, DOI 10.1542/peds.2010-2214; Freedman Stephen B, 2010, Paediatr Drugs, V12, P405, DOI 10.2165/11537770-000000000-00000; Goldman RD, 2008, PEDIATRICS, V122, P545, DOI 10.1542/peds.2007-3141; Gordon M, 2011, ARCH DIS CHILD, V96, P1191, DOI 10.1136/archdischild-2011-300577; Guarino A, 2008, J PEDIATR GASTR NUTR, V46, pS81, DOI 10.1097/MPG.0b013e31816f7b16; Guarino A, 2012, J PEDIATR GASTR NUTR, V55, P621, DOI 10.1097/MPG.0b013e318272b5e2; Gutmann J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122624; Hansen MM, 2008, J MED INTERNET RES, V10, DOI 10.2196/jmir.1051; Jones O, 2010, BEST PRACT RES CL OB, V24, P731, DOI 10.1016/j.bpobgyn.2010.04.009; Kerfoot BP, 2014, CIRC-CARDIOVASC QUAL, V7, P468, DOI 10.1161/CIRCOUTCOMES.113.000814; Kerfoot BP, 2009, ANN SURG, V249, P744, DOI 10.1097/SLA.0b013e31819f6db8; Kind T, 2009, CURR OPIN PEDIATR, V21, P805, DOI 10.1097/MOP.0b013e328331e7b4; Kulier R, 2012, JAMA-J AM MED ASSOC, V308, P2218, DOI 10.1001/jama.2012.33640; Lannon CM, 2008, PEDIATRICS, V122, pE163, DOI 10.1542/peds.2007-2700; Lau F, 2004, J MED SYST, V28, P71, DOI 10.1023/B:JOMS.0000021522.30587.ff; Legido-Quigley H, 2012, HEALTH POLICY, V107, P146, DOI 10.1016/j.healthpol.2012.08.004; Lo Vecchio A, 2014, PEDIATR INFECT DIS J, V33, P1103, DOI 10.1097/INF.0000000000000396; Lo Vecchio A, 2011, J PEDIATR GASTR NUTR, V52, P183, DOI 10.1097/MPG.0b013e3181e233ac; Mangione-Smith R, 2007, NEW ENGL J MED, V357, P1515, DOI 10.1056/NEJMsa064637; McHugh SM, 2010, J CONTIN EDUC HEALTH, V30, P257, DOI 10.1002/chp.20091; Moule P, 2008, INT J NURS PRACT, V14, P427, DOI 10.1111/j.1440-172X.2008.00716.x; O'Leary FM, 2012, J PAEDIATR CHILD H, V48, P529, DOI 10.1111/j.1440-1754.2011.02250.x; O'Leary FM, 2010, EMERG MED AUSTRALAS, V22, P324, DOI 10.1111/j.1742-6723.2010.01302.x; Ogilvie I, 2011, HUM VACCINES, V7, P523, DOI 10.4161/hv.7.5.14819; Pathak D, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-32; Powell Colin V E, 2003, Paediatr Respir Rev, V4, P340, DOI 10.1016/S1526-0542(03)00092-7; Prior M, 2008, J EVAL CLIN PRACT, V14, P888, DOI 10.1111/j.1365-2753.2008.01014.x; Sanchez-Gonzalez P, 2013, J SURG RES, V182, P21, DOI 10.1016/j.jss.2012.07.047; Schroter S, 2011, BMC MED EDUC, V11, DOI 10.1186/1472-6920-11-35; Tieder JS, 2009, PEDIATRICS, V124, pE1081, DOI 10.1542/peds.2009-0473	40	23	23	4	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132213	10.1371/journal.pone.0132213	http://dx.doi.org/10.1371/journal.pone.0132213			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148301	Green Published, Green Submitted, gold			2022-12-26	WOS:000358157600220
J	Sajo, IE; Kovacs, J; Fitzsimmons, KE; Jager, V; Lengyel, G; Viola, B; Talamo, S; Hublin, JJ				Sajo, Istvan E.; Kovacs, Janos; Fitzsimmons, Kathryn E.; Jager, Viktor; Lengyel, Gyoergy; Viola, Bence; Talamo, Sahra; Hublin, Jean-Jacques			Core-Shell Processing of Natural Pigment: Upper Palaeolithic Red Ochre from Lovas, Hungary	PLOS ONE			English	Article							IRON-OXIDE COATINGS; MIDDLE STONE-AGE; GEOCHEMICAL CHARACTERIZATION; COLLAGEN EXTRACTION; UPPER PLEISTOCENE; EASTERN-EUROPE; LOESS; CAVE; BONE; ENVIRONMENTS	Ochre is the common archaeological term for prehistoric pigments. It is applied to a range of uses, from ritual burials to cave art to medications. While a substantial number of Palaeolithic paint mining pits have been identified across Europe, the link between ochre use and provenance, and their antiquity, has never yet been identified. Here we characterise the mineralogical signature of core-shell processed ochre from the Palaeolithic paint mining pits near Lovas in Hungary, using a novel integration of petrographic and mineralogical techniques. We present the first evidence for core-shell processed, natural pigment that was prepared by prehistoric people from hematitic red ochre. This involved combining the darker red outer shell with the less intensely coloured core to efficiently produce an economical, yet still strongly coloured, paint. We demonstrate the antiquity of the site as having operated between 14-13 kcal BP, during the Epigravettian period. This is based on new radiocarbon dating of bone artefacts associated with the quarry site. The dating results indicate the site to be the oldest known evidence for core-shell pigment processing. We show that the ochre mined at Lovas was exported from the site based on its characteristic signature at other archaeological sites in the region. Our discovery not only provides a methodological framework for future characterisation of ochre pigments, but also provides the earliest known evidence for "value-adding" of products for trade.	[Sajo, Istvan E.; Kovacs, Janos; Jager, Viktor] Univ Pecs, Environm Analyt & Geoanalyt Res Grp, Szentagothai Res Ctr, Pecs, Hungary; [Kovacs, Janos; Jager, Viktor] Univ Pecs, Dept Geol & Meteorol, Pecs, Hungary; [Fitzsimmons, Kathryn E.; Viola, Bence; Talamo, Sahra; Hublin, Jean-Jacques] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, Leipzig, Germany; [Lengyel, Gyoergy] Univ Miskolc, Hist Inst, Dept Prehist & Archaeol, Miskolc, Hungary; [Viola, Bence] Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, Leipzig, Germany	University of Pecs; University of Pecs; Max Planck Society; University of Miskolc; Max Planck Society	Kovacs, J (corresponding author), Univ Pecs, Environm Analyt & Geoanalyt Res Grp, Szentagothai Res Ctr, Pecs, Hungary.	jones@gamma.ttk.pte.hu; kathryn_fitzsimmons@eva.mpg.de	Lengyel, György/J-5604-2016; Kovács, János/A-8807-2010; Talamo, Sahra/AAD-1774-2022; Fitzsimmons, Kathryn/U-3565-2018; Sajó, István/M-8973-2018	Lengyel, György/0000-0002-7803-3043; Kovács, János/0000-0001-7742-5515; Talamo, Sahra/0000-0002-2406-3132; Fitzsimmons, Kathryn/0000-0002-9337-0793; Sajó, István/0000-0002-1228-1407; Viola, Bence/0000-0001-8052-707X	EU-funded Hungarian Social Renewal Operational Programme [SROP-4.2.2. A-11/1/KONV-2012-0065]; Max Planck Society	EU-funded Hungarian Social Renewal Operational Programme; Max Planck Society(Max Planck Society)	The mineralogical analyses were funded by the EU-funded Hungarian Social Renewal Operational Programme Grant SROP-4.2.2. A-11/1/KONV-2012-0065, "Synthesis of supramolecular systems, examination of their physicochemical properties and their utilisation for separation and sensor chemistry". The radiocarbon dating component of the research was funded by the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed NM, 2012, PROG ORG COAT, V73, P76, DOI 10.1016/j.porgcoat.2011.09.003; Ahmed NM, 2010, PIGM RESIN TECHNOL, V39, P15, DOI 10.1108/03699421011009555; Allsworth-Jones P., 1986, SZELETIAN TRANSITION; AMBROSE SH, 1990, J ARCHAEOL SCI, V17, P431, DOI 10.1016/0305-4403(90)90007-R; Bahn Paul G, 2012, CAVE ART GUIDE DECOR; Barnett JR, 2006, OPT LASER TECHNOL, V38, P445, DOI 10.1016/j.optlastec.2005.06.005; Bartosiewicz L, 2005, HOOVES HORNS MOLLUSC, P339; Brock F, 2007, RADIOCARBON, V49, P187, DOI 10.1017/S0033822200042107; BROWN TA, 1988, RADIOCARBON, V30, P171, DOI 10.1017/S0033822200044118; Budai T, 1999, BUDAPEST GEOLOGICAL; Buggle B, 2009, QUATERN INT, V196, P86, DOI 10.1016/j.quaint.2008.07.013; Burdukiewicz JM, 2011, QUATERN INT, V242, P302, DOI 10.1016/j.quaint.2011.02.013; Carney RP, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1338; Cornell R. M., 2006, IRON OXIDES STRUCTUR; Cserny T., 2003, ACTA GEOLOGICA HUNGA, V46, P215, DOI [DOI 10.1556/AGE0L.46.2003.2.8, DOI 10.1556/AGE01.46.2003.2.8]; d'Errico F, 2010, J ARCHAEOL SCI, V37, P3099, DOI 10.1016/j.jas.2010.07.011; de Faria DLA, 2007, VIB SPECTROSC, V45, P117, DOI 10.1016/j.vibspec.2007.07.003; Dobosi V., 1979, FOLIA ARCH BUD, V30, P7; Dobosi VT, 2006, STONE AGE MINING AGE, V19, P29; Dove P.M., 1994, SILICA PHYS BEHAV GE, V29, P1; Eerkens JW, 2014, ARCHAEOL ANTHROP SCI, V6, P241, DOI 10.1007/s12520-013-0151-6; Eiselt BS, 2011, J ARCHAEOL SCI, V38, P3019, DOI 10.1016/j.jas.2011.06.030; Erlandson JM, 1999, AM ANTIQUITY, V64, P517, DOI 10.2307/2694149; Feurdean A, 2014, QUATERNARY SCI REV, V106, P206, DOI 10.1016/j.quascirev.2014.06.003; Fitzsimmons KE, 2012, QUATERNARY SCI REV, V41, P104, DOI 10.1016/j.quascirev.2012.03.002; Frechen M, 1997, QUATERNARY RES, V48, P291, DOI 10.1006/qres.1997.1929; Fuchs M, 2008, BOREAS, V37, P66, DOI 10.1111/j.1502-3885.2007.00012.x; Gaborine-Csank V., 1993, JANKOVICHIEN CIVILIS, P198; Gialanella S, 2011, ARCHAEOMETRY, V53, P950, DOI 10.1111/j.1475-4754.2011.00594.x; Gyori O, 2014, GEOFLUIDS, V14, P459, DOI 10.1111/gfl.12088; Haas J, 1999, GEOL CARPATH, V50, P459; Haas J, 2012, PALAEOGEOGR PALAEOCL, V353, P31, DOI 10.1016/j.palaeo.2012.06.031; Haase D, 2007, QUATERNARY SCI REV, V26, P1301, DOI 10.1016/j.quascirev.2007.02.003; Harzhauser M, 2007, PALAEOGEOGR PALAEOCL, V253, P8, DOI 10.1016/j.palaeo.2007.03.031; Helwig K, 1997, STUD CONSERV, V42, P181, DOI 10.2307/1506714; Henshilwood CS, 2011, SCIENCE, V334, P219, DOI 10.1126/science.1211535; Hovers E, 2003, CURR ANTHROPOL, V44, P491, DOI 10.1086/375869; Hradil D, 2003, APPL CLAY SCI, V22, P223, DOI 10.1016/S0169-1317(03)00076-0; Iriarte E, 2009, ARCHAEOMETRY, V51, P231, DOI 10.1111/j.1475-4754.2008.00397.x; Julia CG, 2004, THERMOCHIM ACTA, V413, P185, DOI 10.1016/j.tca.2003.10.016; Kaminska L, 2007, STUDIES FINAL PALAEO, P111; Kiehn AV, 2007, ACS SYM SER, V968, P460, DOI 10.1021/bk-2007-0968.ch025; Kovacs J, 2012, QUATERN INT, V276, P145, DOI 10.1016/j.quaint.2012.04.009; Kozlowski SK, 2012, QUATERN INT, V272, P288, DOI 10.1016/j.quaint.2012.02.052; Kromer B, 2013, NUCL INSTRUM METH B, V294, P11, DOI 10.1016/j.nimb.2012.01.015; Larrahondo JM, 2011, ENG GEOL, V121, P7, DOI 10.1016/j.enggeo.2011.04.009; LONGIN R, 1971, NATURE, V230, P241, DOI 10.1038/230241a0; MacDonald BL, 2011, J ARCHAEOL SCI, V38, P3620, DOI 10.1016/j.jas.2011.08.032; Marean CW, 2007, NATURE, V449, P905, DOI 10.1038/nature06204; Markovic SB, 2012, NETH J GEOSCI, V91, P173; Mayer DEBY, 2009, J HUM EVOL, V56, P307, DOI 10.1016/j.jhevol.2008.10.005; Meszaros G., 1955, ACTA ARCHAEOL-HUNG, V5, P1; Patou-Mathis M., 2002, PRAEHISTORIA, V3, P161; Peile A., 1979, HEMISPHERE, V23, P214; Penn RL, 2001, GEOLOGY, V29, P843, DOI 10.1130/0091-7613(2001)029<0843:IOCOSG>2.0.CO;2; Pettitt P, 2011, PALAEOLITHIC ORIGINS OF HUMAN BURIAL, P1; Poltowicz-Bobak M, 2012, QUATERN INT, V272, P297, DOI 10.1016/j.quaint.2012.05.029; Pomies MP, 1998, EUR J SOL STATE INOR, V35, P9, DOI 10.1016/S0992-4361(98)80011-8; Popelka-Filcoff RS, 2007, J RADIOANAL NUCL CH, V272, P17, DOI 10.1007/s10967-006-6836-x; Popelka-Filcoff RS, 2008, J ARCHAEOL SCI, V35, P752, DOI 10.1016/j.jas.2007.05.018; Ramsey CB, 2015, ARCHAEOMETRY, V57, P177, DOI 10.1111/arcm.12134; Ramsey CB, 2013, RADIOCARBON, V55, P720, DOI 10.1017/S0033822200057878; Rasmussen SO, 2014, QUATERNARY SCI REV, V106, P14, DOI 10.1016/j.quascirev.2014.09.007; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Roebroeks W, 2012, P NATL ACAD SCI USA, V109, P1889, DOI 10.1073/pnas.1112261109; Roper D. C., 1992, N AM ARCHAEOL, V12, P289, DOI DOI 10.2190/AH7V-FPM6-PRDX-FNQE; Scadding R, 2015, J ARCHAEOL SCI, V54, P300, DOI 10.1016/j.jas.2014.11.017; Schild R., 1981, PRZEGLAD ARCHEOLOGIC, V29, P53; SCHWARCZ HP, 1982, NATURE, V295, P590, DOI 10.1038/295590a0; STUMM W, 1992, GEOCHIM COSMOCHIM AC, V56, P3233, DOI 10.1016/0016-7037(92)90301-X; Sumegi P, 2002, QUATERN INT, V91, P53, DOI 10.1016/S1040-6182(01)00102-1; Talamo S, 2011, RADIOCARBON, V53, P443, DOI 10.1017/S0033822200034573; Ujvari G, 2010, QUATERNARY SCI REV, V29, P3157, DOI 10.1016/j.quascirev.2010.07.005; Valoch K, 2005, ARCHEOLOGICKE ROZHLE, V57; Van Klinken GJ, 1999, J ARCHAEOL SCI, V26, P687, DOI 10.1006/jasc.1998.0385; Varga A, 2011, QUATERN INT, V240, P71, DOI 10.1016/j.quaint.2010.10.032; VELO J, 1984, CURR ANTHROPOL, V25, P674, DOI 10.1086/203205; Verpoorte A, 2004, ANTIQUITY, V78, P257, DOI 10.1017/S0003598X0011292X; Vertes L., 1959, B SOC PREHIST, V56, P604; Vertes L, 1962, WIATOWIT, V24, P159; Vouve J, 1995, ANTHROPOLOGIE, V99, P478; Wadley L, 2004, ANTIQUITY, V78, P661, DOI 10.1017/S0003598X00113298; Wadley L, 2009, P NATL ACAD SCI USA, V106, P9590, DOI 10.1073/pnas.0900957106; Watts I, 2010, J HUM EVOL, V59, P392, DOI 10.1016/j.jhevol.2010.07.006; Willis KJ, 2004, QUATERNARY SCI REV, V23, P2369, DOI 10.1016/j.quascirev.2004.06.002; Willis KJ, 2000, QUATERNARY RES, V53, P203, DOI 10.1006/qres.1999.2119; Zipkin AM, 2015, ARCHAEOMETRY, V57, P297, DOI 10.1111/arcm.12090	87	15	15	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131762	10.1371/journal.pone.0131762	http://dx.doi.org/10.1371/journal.pone.0131762			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147808	Green Published, gold, Green Submitted			2022-12-26	WOS:000358157600141
J	Li, YN; Zhou, Q; Hu, Z; Yang, B; Li, QS; Wang, JH; Zheng, JH; Cao, WW				Li, Yongning; Zhou, Qi; Hu, Zheng; Yang, Bin; Li, Qingsong; Wang, Jianhua; Zheng, Jinhua; Cao, Wenwu			5-Aminolevulinic Acid-Based Sonodynamic Therapy Induces the Apoptosis of Osteosarcoma in Mice	PLOS ONE			English	Article							LOW-INTENSITY ULTRASOUND; CELLS IN-VITRO; PROTOPORPHYRIN IX; TUMOR-GROWTH; K562 CELLS; HEMATOPORPHYRIN; SONOSENSITIZER; CANCER	Objective Sonodynamic therapy (SDT) is promising for treatment of cancer, but its effect on osteosarcoma is unclear. This study examined the effect of 5-Aminolevulinic Acid (5-ALA)-based SDT on the growth of implanted osteosarcoma and their potential mechanisms in vivo and in vitro. Methods The dose and metabolism of 5-ALA and ultrasound periods were optimized in a mouse model of induced osteosarcoma and in UMR-106 cells. The effects of ALA-SDT on the proliferation and apoptosis of UMR-106 cells and the growth of implanted osteosarcoma were examined. The levels of mitochondrial membrane potential (Delta psi M), ROS production, BcL-2, Bax, p53 and caspase 3 expression in UMR-106 cells were determined. Results Treatment with 5-ALA for eight hours was optimal for ALA-SDT in the mouse tumor model and treatment with 2 mM 5-ALA for 6 hours and ultrasound (1.0 MHz 2.0 W/cm(2)) for 7 min were optimal for UMR-106 cells. SDT, but not 5-ALA, alone inhibited the growth of implanted osteosarcoma in mice (P<0.01) and reduced the viability of UMR-106 cells (p<0.05). ALA-SDT further reduced the tumor volumes and viability of UMR-106 cells (p<0.01 for both). Pre-treatment with 5-ALA significantly enhanced the SDT-mediated apoptosis (p<0.01) and morphological changes. Furthermore, ALA-SDT significantly reduced the levels of Delta psi M, but increased levels of ROS in UMR-106 cells (p<0.05 or p<0.01 vs. the Control or the Ultrasound). Moreover, ALA-SDT inhibited the proliferation of osteosarcoma cells and BcL-2 expression, but increased levels of Bax, p53 and caspase 3 expression in the implanted osteosarcoma tissues (p<0.05 or p<0.01 vs. the Control or the Ultrasound). Conclusions The ALA-SDT significantly inhibited osteosarcoma growth in vivo and reduced UMR-106 cell survival by inducing osteosarcoma cell apoptosis through the ROS-related mitochondrial pathway.	[Li, Yongning; Cao, Wenwu] Harbin Inst Technol, Sch Life Sci & Technol, Harbin 150080, Peoples R China; [Zhou, Qi; Hu, Zheng; Yang, Bin] Harbin Inst Technol, Lab Photo & Sonotheranost Technol, Harbin 150080, Peoples R China; [Zhou, Qi; Hu, Zheng; Yang, Bin] Harbin Inst Technol, Condensed Matter Sci & Technol Inst, Harbin 150080, Peoples R China; [Li, Qingsong] Dalian Med Univ, Affiliated Hosp 1, Cardiovasc Inst, Dalian 116011, Peoples R China; [Wang, Jianhua; Zheng, Jinhua] Harbin Med Univ, Coll Basic Med Sci, Dept Anat, Harbin 150080, Peoples R China; [Cao, Wenwu] Penn State Univ, Mat Res Inst, University Pk, PA 16802 USA	Harbin Institute of Technology; Harbin Institute of Technology; Harbin Institute of Technology; Dalian Medical University; Harbin Medical University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Cao, WW (corresponding author), Harbin Inst Technol, Sch Life Sci & Technol, Harbin 150080, Peoples R China.	dzk@psu.edu	金华, 郑/GWM-7529-2022; Hu, Zheng/AAI-3025-2020; Cao, Wenwu/F-6091-2012	Hu, Zheng/0000-0002-3323-0369; Cao, Wenwu/0000-0002-2447-1486	National Key Technology R&D Program of China [2013BAI03B06]	National Key Technology R&D Program of China(National Key Technology R&D Program)	This work was supported by the National Key Technology R&D Program of China (Grant No. 2013BAI03B06).	Ahmadi F, 2012, PROG BIOPHYS MOL BIO, V108, P119, DOI 10.1016/j.pbiomolbio.2012.01.004; Cheng JL, 2013, INT J NANOMED, V8, P669, DOI 10.2147/IJN.S39844; Chou Alexander J, 2008, Paediatr Drugs, V10, P315, DOI 10.2165/00148581-200810050-00005; Gao ZXZ, 2013, CANCER LETT, V335, P93, DOI 10.1016/j.canlet.2013.02.006; Hagiya Y, 2013, PHOTODIAGN PHOTODYN, V10, P288, DOI 10.1016/j.pdpdt.2013.02.001; Hasanzadeh H, 2011, ULTRASON SONOCHEM, V18, P394, DOI 10.1016/j.ultsonch.2010.07.005; He Y, 2010, ULTRASONICS, V50, P777, DOI 10.1016/j.ultras.2010.03.004; Ketola A, 2008, CANCER RES, V68, P8342, DOI 10.1158/0008-5472.CAN-08-0251; Kinoshita M, 2006, RADIAT RES, V165, P299, DOI 10.1667/RR3510.1; Komori C, 2009, ANTICANCER RES, V29, P2411; Li HX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059473; Li YS, 2008, CANCER LETT, V266, P156, DOI 10.1016/j.canlet.2008.02.041; Lv YH, 2012, CELL PHYSIOL BIOCHEM, V30, P321, DOI 10.1159/000339067; Rosenthal I, 2004, ULTRASON SONOCHEM, V11, P349, DOI 10.1016/j.ultsonch.2004.03.004; Sakamoto A, 2008, REV RECENT CLIN TRIA, V3, P228, DOI 10.2174/157488708785700267; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Shibaguchi H, 2011, ANTICANCER RES, V31, P2425; Song W, 2011, ANTICANCER RES, V31, P39; Spierings D, 2005, SCIENCE, V310, P66, DOI 10.1126/science.1117105; Su XM, 2014, ULTRASONICS, V54, P275, DOI 10.1016/j.ultras.2013.07.015; Tang W, 2010, ULTRASONICS, V50, P567, DOI 10.1016/j.ultras.2009.12.001; Tang W, 2009, ULTRASONICS, V49, P786, DOI 10.1016/j.ultras.2009.06.002; Tian ZD, 2010, INTEGR CANCER THER, V9, P365, DOI 10.1177/1534735410379013; Tian ZD, 2009, J ULTRAS MED, V28, P1695, DOI 10.7863/jum.2009.28.12.1695; Tsuang YH, 2011, ARTIF ORGANS, V35, P373, DOI 10.1111/j.1525-1594.2010.01086.x; Tsuru H, 2012, FREE RADICAL BIO MED, V53, P464, DOI 10.1016/j.freeradbiomed.2012.04.025; Uto Y, 2014, ANTICANCER RES, V34, P4583; Wang S, 2014, ULTRASOUND MED BIOL, V40, P2125, DOI 10.1016/j.ultrasmedbio.2014.05.007; Wang XB, 2010, ULTRASOUND MED BIOL, V36, P667, DOI 10.1016/j.ultrasmedbio.2009.09.006; Wang XB, 2010, ULTRASONICS, V50, P803, DOI 10.1016/j.ultras.2010.04.004; Xiang JY, 2011, ULTRASONICS, V51, P390, DOI 10.1016/j.ultras.2010.11.005; YUMITA N, 1989, JPN J CANCER RES, V80, P219, DOI 10.1111/j.1349-7006.1989.tb02295.x	32	27	28	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132074	10.1371/journal.pone.0132074	http://dx.doi.org/10.1371/journal.pone.0132074			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161801	gold, Green Published, Green Submitted			2022-12-26	WOS:000358162300090
J	Torkamaneh, D; Belzile, F				Torkamaneh, Davoud; Belzile, Francois			Scanning and Filling: Ultra-Dense SNP Genotyping Combining Genotyping-By-Sequencing, SNP Array and Whole-Genome Resequencing Data	PLOS ONE			English	Article							GENETIC DIVERSITY ANALYSIS; LINKAGE DISEQUILIBRIUM; WIDE ASSOCIATION; IMPUTATION; PREDICTION; MARKERS; SELECTION; ACCURACY; PATTERNS; COVERAGE	Genotyping-by-sequencing (GBS) represents a highly cost-effective high-throughput geno-typing approach. By nature, however, GBS is subject to generating sizeable amounts of missing data and these will need to be imputed for many downstream analyses. The extent to which such missing data can be tolerated in calling SNPs has not been explored widely. In this work, we first explore the use of imputation to fill in missing genotypes in GBS data-sets. Importantly, we use whole genome resequencing data to assess the accuracy of the imputed data. Using a panel of 301 soybean accessions, we show that over 62,000 SNPs could be called when tolerating up to 80% missing data, a five-fold increase over the number called when tolerating up to 20% missing data. At all levels of missing data examined (between 20% and 80%), the resulting SNP datasets were of uniformly high accuracy (96-98%). We then used imputation to combine complementary SNP datasets derived from GBS and a SNP array (SoySNP50K). We thus produced an enhanced dataset of >100,000 SNPs and the genotypes at the previously untyped loci were again imputed with a high level of accuracy (95%). Of the >4,000,000 SNPs identified through resequencing 23 accessions (among the 301 used in the GBS analysis), 1.4 million tag SNPs were used as a reference to impute this large set of SNPs on the entire panel of 301 accessions. These previously untyped loci could be imputed with around 90% accuracy. Finally, we used the 100K SNP dataset (GBS + SoySNP50K) to perform a GWAS on seed oil content within this collection of soybean accessions. Both the number of significant marker-trait associations and the peak significance levels were improved considerably using this enhanced catalog of SNPs relative to a smaller catalog resulting from GBS alone at <= 20% missing data. Our results demonstrate that imputation can be used to fill in both missing genotypes and untyped loci with very high accuracy and that this leads to more powerful genetic analyses.	[Belzile, Francois] Univ Laval, Dept Phytol, Quebec City, PQ G1K 7P4, Canada; Univ Laval, IBIS, Quebec City, PQ, Canada	Laval University; Laval University	Belzile, F (corresponding author), Univ Laval, Dept Phytol, Quebec City, PQ G1K 7P4, Canada.	francois.belzile@fsaa.ulaval.ca		Belzile, Francois/0000-0001-6893-4529; Torkamaneh, Davoud/0000-0002-9782-5695	Canadian Field Crop Research Alliance [AIP CL-23]	Canadian Field Crop Research Alliance	1. Funding for this research was provided by the Canadian Field Crop Research Alliance (http://www.fieldcropresearch.ca/; Project no. AIP CL-23). 2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aflitos S, 2014, PLANT J, V80, P136, DOI 10.1111/tpj.12616; Ardlie KG, 2002, NAT REV GENET, V3, P299, DOI 10.1038/nrg777; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Crossa J, 2013, G3-GENES GENOM GENET, V3, P1903, DOI 10.1534/g3.113.008227; Daetwyler HD, 2014, NAT GENET, V46, P858, DOI 10.1038/ng.3034; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; De Donato M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062137; Delaneau O, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4934; Delaneau O, 2013, NAT METHODS, V10, P5, DOI 10.1038/nmeth.2307; Ellinghaus David, 2009, Hum Genomics, V3, P371; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Fu YB, 2014, G3-GENES GENOM GENET, V4, P891, DOI 10.1534/g3.114.010942; Fu YB, 2014, GENET RESOUR CROP EV, V61, P579, DOI 10.1007/s10722-013-0058-1; Fu YB, 2012, MOL ECOL RESOUR, V12, P492, DOI 10.1111/j.1755-0998.2011.03100.x; Fu YB, 2011, PLANT GENOME-US, V4, P226, DOI 10.3835/plantgenome2011.08.0022; Gore MA, 2009, SCIENCE, V326, P1115, DOI 10.1126/science.1177837; Hao K, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-27; He Sang, 2015, BMC Genomics, V16, P168, DOI 10.1186/s12864-015-1366-y; Howie B, 2011, G3-GENES GENOM GENET, V1, P457, DOI 10.1534/g3.111.001198; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Huang BE, 2014, GENETICS, V197, P401, DOI 10.1534/genetics.113.158014; Huang XH, 2012, NATURE, V490, P497, DOI 10.1038/nature11532; Jarquin D, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-740; Kim S, 2007, NAT GENET, V39, P1151, DOI 10.1038/ng2115; Kumar S., 2012, INT J COMP APP IRAFI, V5, P1; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Lipka AE, 2012, BIOINFORMATICS, V28, P2397, DOI 10.1093/bioinformatics/bts444; Ha NT, 2014, EUR J HUM GENET, V22, P1124, DOI 10.1038/ejhg.2013.304; Pei YF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003551; Poland J, 2012, PLANT GENOME-US, V5, P103, DOI 10.3835/plantgenome2012.06.0006; Porto-Neto LR, 2014, GENET SEL EVOL, V46, DOI 10.1186/1297-9686-46-22; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rutkoski JE, 2013, G3-GENES GENOM GENET, V3, P427, DOI 10.1534/g3.112.005363; Santana MHA, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-21; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Segura V, 2012, NAT GENET, V44, P825, DOI 10.1038/ng.2314; Shifman S, 2003, HUM MOL GENET, V12, P771, DOI 10.1093/hmg/ddg088; Sonah H, 2015, PLANT BIOTECHNOL J, V13, P211, DOI 10.1111/pbi.12249; Sonah H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054603; Song Q., 2015, FINGERPRINTING SOYBE; Song QJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054985; Wang M, 2012, PLANT SCI, V196, P125, DOI 10.1016/j.plantsci.2012.08.004; Xu X, 2012, NAT BIOTECHNOL, V30, P105, DOI 10.1038/nbt.2050; Yang ZY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-87; Zheng J, 2011, GENET EPIDEMIOL, V35, P102, DOI 10.1002/gepi.20552; Zhu QH, 2007, MOL BIOL EVOL, V24, P875, DOI 10.1093/molbev/msm005	48	44	45	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131533	10.1371/journal.pone.0131533	http://dx.doi.org/10.1371/journal.pone.0131533			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161900	Green Published, gold, Green Submitted			2022-12-26	WOS:000358162300043
J	Amelot, A; De Cremoux, P; Quillien, V; Polivka, M; Adle-Biassette, H; Lehmann-Che, J; Francoise, L; Carpentier, AF; George, B; Mandonnet, E; Froelich, S				Amelot, Aymeric; De Cremoux, Patricia; Quillien, Veronique; Polivka, Marc; Adle-Biassette, Homa; Lehmann-Che, Jacqueline; Francoise, Laurence; Carpentier, Antoine F.; George, Bernard; Mandonnet, Emmanuel; Froelich, Sebastien			IDH-Mutation Is a Weak Predictor of Long-Term Survival in Glioblastoma Patients	PLOS ONE			English	Article							PROGNOSTIC VALUE; GRADE GLIOMAS; MULTIFORME; TEMOZOLOMIDE; MGMT; RESECTION; METHYLATION; IMMUNOHISTOCHEMISTRY; METAANALYSIS; SERIES	Background A very small proportion of patients diagnosed with glioblastoma (GBM) survive more than 3 years. Isocitrate dehydrogenase 1 or 2 (IDH1/2) mutations define a small subgroup of GBM patients with favourable prognosis. However, it remains controversial whether long-term survivors (LTS) are found among those IDH1/2 mutated patients. Methods We retrospectively analyzed 207 GBM patients followed at Lariboisiere Hospital (Paris) between 2005 and 2010. Clinical parameters were obtained from medical records. Mutations of IDH1/2 were analyzed in these patients, by immunohistochemistry for the R132H mutation of IDH1 and by high-resolution melting-curve analysis, followed by Sanger sequencing for IDH1 and IDH2 exon 4 mutations. Mutation rates in LTS and non-LTS groups were compared by Chi square Pearson test. Results Seventeen patients with survival >3 years were identified (8.2% of the total series). The median overall survival in long-term survivors was 4.6 years. Subgroup analysis found that the median age at diagnosis was significantly higher for non long-term survivors (non-LTS) compared to LTS (60 versus 51 years, p <0.03). The difference in the rate of IDH mutation between non-LTS and LTS was statistically not significant (1.16% versus 5.9%, p = 0.144). Among LTS, 10 out of 16 tumors presented a methylation of MGMT promoter. Conclusions This study confirms that long-term survival in GBM patients is if at all only weakly correlated to IDH-mutation.	[Amelot, Aymeric; George, Bernard; Mandonnet, Emmanuel; Froelich, Sebastien] Lariboisiere Hosp, AP HP, Dept Neurosurg, Paris, France; [De Cremoux, Patricia; Lehmann-Che, Jacqueline; Francoise, Laurence] St Louis Hosp, AP HP, Dept Biochem, Mol Oncol Unit, Paris, France; [Quillien, Veronique] Ctr Eugene Marquis, Dept Biol, F-35042 Rennes, France; [Polivka, Marc; Adle-Biassette, Homa] Lariboisiere Hosp, AP HP, Dept Pathol, Paris, France; [Carpentier, Antoine F.] Avicennes Hosp, AP HP, Dept Neurol, Bobigny, France; [George, Bernard; Mandonnet, Emmanuel; Froelich, Sebastien] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France; [Mandonnet, Emmanuel] IMNC, UMR 8165, Orsay, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; UNICANCER; Centre Eugene Marquis; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay	Mandonnet, E (corresponding author), Lariboisiere Hosp, AP HP, Dept Neurosurg, Paris, France.	mandonnet@mac.com	Adle-Biassette, Homa/AAG-2751-2019	Quillien, Veronique/0000-0002-1465-3753; Carpentier, Antoine/0000-0003-2926-0060; Lehmann-Che, jacqueline/0000-0001-6685-3354				Barnholtz-Sloan JS, 2007, J NEURO-ONCOL, V85, P171, DOI 10.1007/s11060-007-9405-4; Burton EC, 2002, CLIN CANCER RES, V8, P180; Cheng HB, 2013, TUMOR BIOL, V34, P3555, DOI 10.1007/s13277-013-0934-5; Christensen BC, 2011, JNCI-J NATL CANCER I, V103, DOI 10.1093/jnci/djq497; Das P, 2011, J CLIN NEUROSCI, V18, P66, DOI 10.1016/j.jocn.2010.04.050; Frenel JS, 2013, J NEURO-ONCOL, V114, P85, DOI 10.1007/s11060-013-1152-0; Gerber NK, 2014, NEURO-ONCOLOGY, V16, P1186, DOI 10.1093/neuonc/nou043; Gilbert MR, 2013, J CLIN ONCOL, V31, P4085, DOI 10.1200/JCO.2013.49.6968; Hartmann C, 2013, CLIN CANCER RES, V19, P5146, DOI 10.1158/1078-0432.CCR-13-0017; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Houillier C, 2010, NEUROLOGY, V75, P1560, DOI 10.1212/WNL.0b013e3181f96282; Johnson DR, 2012, CANCER-AM CANCER SOC, V118, P5608, DOI 10.1002/cncr.27590; Johnson DR, 2012, J NEURO-ONCOL, V107, P359, DOI 10.1007/s11060-011-0749-4; Juratli TA, 2012, J NEURO-ONCOL, V110, P325, DOI 10.1007/s11060-012-0977-2; Kreth FW, 2013, ANN ONCOL, V24, P3117, DOI 10.1093/annonc/mdt388; Krex D, 2007, BRAIN, V130, P2596, DOI 10.1093/brain/awm204; Kuhnt D, 2011, NEURO-ONCOLOGY, V13, P1339, DOI 10.1093/neuonc/nor133; Lacroix M, 2001, J NEUROSURG, V95, P190, DOI 10.3171/jns.2001.95.2.0190; Loussouarn D, 2012, INT J ONCOL, V40, P2058, DOI 10.3892/ijo.2012.1404; Martinez R, 2007, J NEURO-ONCOL, V83, P91, DOI 10.1007/s11060-006-9292-0; McLendon RE, 2003, CANCER-AM CANCER SOC, V98, P1745, DOI 10.1002/cncr.11666; Molenaar RJ, 2014, NEURO-ONCOLOGY, V16, P1263, DOI 10.1093/neuonc/nou005; Omuro A, 2013, JAMA-J AM MED ASSOC, V310, P1842, DOI 10.1001/jama.2013.280319; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Qi ST, 2012, CANCER SCI, V103, P269, DOI 10.1111/j.1349-7006.2011.02134.x; Quillien V, 2014, J NEURO-ONCOL, V116, P487, DOI 10.1007/s11060-013-1332-y; Quillien V, 2012, CANCER-AM CANCER SOC, V118, P4201, DOI 10.1002/cncr.27392; Reifenberger G, 2014, INT J CANCER, V135, P1822, DOI 10.1002/ijc.28836; Ronning PA, 2012, NEURO-ONCOLOGY, V14, P1178, DOI 10.1093/neuonc/nos153; Sanson M, 2009, J CLIN ONCOL, V27, P4150, DOI 10.1200/JCO.2009.21.9832; Scoccianti S, 2010, NEUROSURGERY, V67, P446, DOI 10.1227/01.NEU.0000371990.86656.E8; Scott JN, 1999, ANN NEUROL, V46, P183, DOI 10.1002/1531-8249(199908)46:2<183::AID-ANA7>3.3.CO;2-Z; Shah N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016146; Shinojima N, 2004, J NEUROSURG, V101, P219, DOI 10.3171/jns.2004.101.2.0219; Siker ML, 2011, J NEURO-ONCOL, V104, P351, DOI 10.1007/s11060-010-0500-6; Solheim O, 2014, NEURO-ONCOLOGY, V16, P610, DOI 10.1093/neuonc/not312; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; The WHO, 2020, CLASSIFICATION TUMOU; Thumma SR, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-75; VERTOSICK FT, 1992, SURG NEUROL, V38, P359, DOI 10.1016/0090-3019(92)90022-F; Weller M, 2009, J CLIN ONCOL, V27, P5743, DOI 10.1200/JCO.2009.23.0805; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yan W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030339; Zhang K, 2013, FAM CANCER, V12, P449, DOI 10.1007/s10689-013-9607-1; Zou P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068782	45	36	41	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2015	10	7							e0130596	10.1371/journal.pone.0130596	http://dx.doi.org/10.1371/journal.pone.0130596			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EW	26158269	Green Published, Green Submitted, gold			2022-12-26	WOS:000358161200014
J	Farrell, KA; Harpole, WS; Stein, C; Suding, KN; Borer, ET				Farrell, Kelly Anne; Harpole, W. Stanley; Stein, Claudia; Suding, Katharine N.; Borer, Elizabeth T.			Grassland Arthropods Are Controlled by Direct and Indirect Interactions with Cattle but Are Largely Unaffected by Plant Provenance	PLOS ONE			English	Article							INSECT COMMUNITIES; LIFE-HISTORY; DIVERSITY; HERBIVORY; DOMINANCE; RICHNESS; INVASION; BIOMASS; DECOMPOSITION; CONSEQUENCES	Cattle grazing and invasion by non-native plant species are globally-ubiquitous changes occurring to plant communities that are likely to reverberate through whole food webs. We used a manipulative field experiment to quantify how arthropod community structure differed in native and non-native California grassland communities in the presence and absence of grazing. The arthropod community was strongly affected by cattle grazing: the biovolume of herbivorous arthropods was 79% higher in grazed than ungrazed plots, whereas the biovolume of predatory arthropods was 13% higher in ungrazed plots. In plots where non-native grasses were grazed, arthropod biovolume increased, possibly in response to increased plant productivity or increased nutritional quality of rapidly-growing annual plants. Grazing may thus affect plant biomass both through the direct removal of biomass, and through arthropod-mediated impacts. We also expected the arthropod community to differ between native and non-native plant communities; surprisingly, arthropod richness and diversity did not vary consistently between these grass community types, although arthropod abundance was slightly higher in plots with native and ungrazed grasses. These results suggest that whereas cattle grazing affects the arthropod community via direct and indirect pathways, arthropod community changes commonly associated with non-native plant invasions may not be due to the identity or dominance of the invasive species in those systems, but to accompanying changes in plant traits or functional group composition, not seen in this experiment because of the similarity of the plant communities.	[Farrell, Kelly Anne] Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA; [Harpole, W. Stanley] Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA USA; [Stein, Claudia] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Suding, Katharine N.] Univ Calif Berkeley, Policy & Management, Environm Sci, Berkeley, CA 94720 USA; [Borer, Elizabeth T.] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA	Oregon State University; Iowa State University; Washington University (WUSTL); University of California System; University of California Berkeley; University of Minnesota System; University of Minnesota Twin Cities	Farrell, KA (corresponding author), Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA.	kelfathetree@gmail.com	Suding, Katharine/O-6290-2017; Stein, Claudia/AAV-8970-2020; Harpole, William S/C-2814-2013	Suding, Katharine/0000-0002-5357-0176; Harpole, William S/0000-0002-3404-9174; Stein, Claudia/0000-0002-9586-8587; Borer, Elizabeth/0000-0003-2259-5853	United States Department of Agriculture [2006-01350]; University of California Integrated Hardwood and Range Management Program; University of Minnesota; Oregon State University	United States Department of Agriculture(United States Department of Agriculture (USDA)); University of California Integrated Hardwood and Range Management Program; University of Minnesota(University of Minnesota System); Oregon State University	The experiment and its design were funded by the United States Department of Agriculture (www. usda.gov) Managed Ecosystems Grant #2006-01350 to KNS and WSH, and athropod processing was funded by the University of California Integrated Hardwood and Range Management Program (http://ucanr.edu/sites/oak_range/) to ETB, Oregon State University, and the University of Minnesota.	Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Arnett R. H, 2000, AM INSECTS HDB INSEC, V2nd; Arnett RH, 2002, AM BEETLES, V2; ARNETT RH, 2000, AM BEETLES ARCHOSTEM, V1; BARTOLOME JW, 2002, CALIFORNIA GUIDELINE; Belovsky GE, 2000, P NATL ACAD SCI USA, V97, P14412, DOI 10.1073/pnas.250483797; Borer ET, 2007, P NATL ACAD SCI USA, V104, P5473, DOI 10.1073/pnas.0608573104; Borer ET, 2006, ECOLOGY, V87, P2813, DOI 10.1890/0012-9658(2006)87[2813:AICREO]2.0.CO;2; Borer ET, 2012, ECOL LETT, V15, P1457, DOI 10.1111/ele.12006; Borer ET, 2009, ECOL APPL, V19, P1187, DOI 10.1890/08-1205.1; Borer ET, 2009, P NATL ACAD SCI USA, V106, P503, DOI 10.1073/pnas.0808778106; Brusca R.C., 1990, INVERTEBRATES; Chapman SK, 2003, ECOLOGY, V84, P2867, DOI 10.1890/02-0046; Conant RT, 2001, ECOL APPL, V11, P343, DOI 10.1890/1051-0761(2001)011[0343:GMACIG]2.0.CO;2; Coupe MD, 2003, ECOL ENTOMOL, V28, P511, DOI 10.1046/j.1365-2311.2003.00540.x; Dennis P, 2001, AGR ECOSYST ENVIRON, V86, P39, DOI 10.1016/S0167-8809(00)00263-2; Dyer MI, 1982, ROLE HERBIVORES GRAS, P255; Gaertner M, 2009, PROG PHYS GEOG, V33, P319, DOI 10.1177/0309133309341607; GARDNER SM, 1995, J VEG SCI, V6, P349, DOI 10.2307/3236234; GARNIER E, 1994, PLANT CELL ENVIRON, V17, P399, DOI 10.1111/j.1365-3040.1994.tb00308.x; Gibson D. J., 2009, GRASSES GRASSLAND EC; Goulet H., 1993, HYMENOPTERA WORLD ID, V1894E; Gruner DS, 2008, ECOL LETT, V11, P740, DOI 10.1111/j.1461-0248.2008.01192.x; Gubler DJ, 1998, EMERG INFECT DIS, V4, P442, DOI 10.3201/eid0403.980326; Haddad NM, 2009, ECOL LETT, V12, P1029, DOI 10.1111/j.1461-0248.2009.01356.x; Haddad NM, 2001, AM NAT, V158, P17, DOI 10.1086/320866; Hawkins BA, 2003, AM NAT, V161, P40, DOI 10.1086/345479; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; HOLT RD, 1994, AM NAT, V144, P741, DOI 10.1086/285705; Kay AD, 2008, ECOLOGY, V89, P1188, DOI 10.1890/07-1622.1; Koricheva J, 2000, OECOLOGIA, V125, P271, DOI 10.1007/s004420000450; MacDougall AS, 2004, CONSERV BIOL, V18, P455, DOI 10.1111/j.1523-1739.2004.00483.x; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; MAJOR J, 1977, TERRESTRIAL VEGETATI; Malmstrom CM, 2005, OECOLOGIA, V145, P153, DOI 10.1007/s00442-005-0099-z; McAlpine J. F., 1981, AGR CANADA MONOGRAPH, V27, P1; McAlpine JF, 1987, MONOGRAPH AGR CANADA, V2, pvi; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; MCNAUGHTON SJ, 1979, AM NAT, V113, P691, DOI 10.1086/283426; Moran MD, 1998, OECOLOGIA, V113, P126, DOI 10.1007/s004420050360; MURDOCH WW, 1972, ECOLOGY, V53, P819, DOI 10.2307/1934297; Oldeman L. R., 1994, SOIL RESILIENCE SUST, P9; Oliver I, 2005, AGR ECOSYST ENVIRON, V109, P323, DOI 10.1016/j.agee.2005.02.022; Ollerton J, 2011, OIKOS, V120, P321, DOI 10.1111/j.1600-0706.2010.18644.x; Polis GA, 1999, OIKOS, V86, P3, DOI 10.2307/3546565; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; RITCHIE ME, 1995, ECOLOGY, V76, P2648, DOI 10.2307/2265835; Rosenthal JP, 1997, EVOL ECOL, V11, P337, DOI 10.1023/A:1018420504439; Schaffers AP, 2008, ECOLOGY, V89, P782, DOI 10.1890/07-0361.1; Schuh RT, 1995, TRUE BUGS WORLD HEMI; Seabloom EW, 2003, P NATL ACAD SCI USA, V100, P13384, DOI 10.1073/pnas.1835728100; Siemann E, 1998, AM NAT, V152, P738, DOI 10.1086/286204; Simao MCM, 2010, OIKOS, V119, P1553, DOI 10.1111/j.1600-0706.2010.18382.x; Spyreas G, 2010, BIOL INVASIONS, V12, P1253, DOI 10.1007/s10530-009-9544-y; STEWART AJA, 1995, ECOL ENTOMOL, V20, P98, DOI 10.1111/j.1365-2311.1995.tb00434.x; Triplehorn CA, 2004, BORROR DELONGS INTRO; TSCHARNTKE T, 1995, ANNU REV ENTOMOL, V40, P535, DOI 10.1146/annurev.en.40.010195.002535	57	9	10	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2015	10	7							e0129823	10.1371/journal.pone.0129823	http://dx.doi.org/10.1371/journal.pone.0129823			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EW	26158494	Green Published, Green Submitted, gold			2022-12-26	WOS:000358161200009
J	Giri, A; Edwards, TL; Motley, SS; Byerly, SH; Fowke, JH				Giri, Ayush; Edwards, Todd L.; Motley, Saundra S.; Byerly, Susan H.; Fowke, Jay H.			Genetic Determinants of Metabolism and Benign Prostate Enlargement: Associations with Prostate Volume	PLOS ONE			English	Article							URINARY-TRACT SYMPTOMS; CANCER PREVENTION TRIAL; X(C)(-) CYSTINE/GLUTAMATE ANTIPORTER; NUTRITION EXAMINATION SURVEY; RISK-FACTORS; BODY-SIZE; WHITE MEN; HYPERPLASIA; OBESITY; HEALTH	Prostate enlargement leading to clinical benign prostatic hyperplasia (BPH) is associated with metabolic dysregulation and obesity. The genetic basis of this association is unclear. Our objective was to evaluate whether single nucleotide polymorphisms (SNPs) previously associated with metabolic disorders are also associated with prostate volume (PV). Participants included 876 men referred for prostate biopsy and found to be prostate cancer free. PV was measured by transrectal ultrasound. Samples were genotyped using the Illumina Cardio-MetaboChip platform. Multivariable adjusted linear regression models were used to evaluate SNPs (additive coding) in relation to natural-log transformed (log) PV. We compared SNP-PV results from biopsy-negative men to 442 men with low-grade prostate cancer with similar levels of obesity and PV. Beta-coefficients from the discovery and replication samples were then aggregated with fixed effects inverse variance weighted meta-analysis. SNP rs11736129 (near the pseudo-gene LOC100131429) was significantly associated with log-PV (beta: 0.16, p-value 1.16x10(-8)) after adjusting for multiple testing. Other noteworthy SNPs that were nominally associated (p-value < 1x10(-4)) with log-PV included rs9583484 (intronic SNP in COL4A2), rs10146527 (intronic SNP in NRXN3), rs9909466 (SNP near RPL32P31), and rs2241606 (synonymous SNP in SLC12A7). We found several SNPs in metabolic loci associated with PV. Further studies are needed to confirm our results and elucidate the mechanism between these genetic loci, PV, and clinical BPH.	[Giri, Ayush; Edwards, Todd L.; Fowke, Jay H.] Vanderbilt Univ, Inst Med & Publ Hlth, Vanderbilt Epidemiol Ctr, Med Ctr, Nashville, TN 37235 USA; [Edwards, Todd L.] Vanderbilt Univ, Vanderbilt Genet Inst, Nashville, TN 37235 USA; [Edwards, Todd L.; Motley, Saundra S.; Byerly, Susan H.; Fowke, Jay H.] Vanderbilt Univ, Div Epidemiol, Dept Med, Med Ctr, Nashville, TN 37235 USA; [Fowke, Jay H.] Vanderbilt Univ, Dept Urol Surg, Med Ctr, Nashville, TN 37235 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Fowke, JH (corresponding author), Vanderbilt Univ, Inst Med & Publ Hlth, Vanderbilt Epidemiol Ctr, Med Ctr, 221 Kirkland Hall, Nashville, TN 37235 USA.	jay.fowke@vanderbilt.edu			National Institutes of Health [RO1CA121060, RO1DK087962]; NATIONAL CANCER INSTITUTE [R01CA121060] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087962] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding for the Nashville Men's Health Study (NMHS) was provided by the National Institutes of Health Grant numbers: RO1CA121060 and RO1DK087962. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; [Anonymous], 1993, SCAND J UROL NEPHR S; Berndt SI, 2013, NAT GENET, V45, P501, DOI 10.1038/ng.2606; Chambers KF, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-45; Comuzzie AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051954; Dahle SE, 2002, J UROLOGY, V168, P599, DOI 10.1016/S0022-5347(05)64687-3; Di Silverio F, 2003, EUR UROL, V43, P164, DOI 10.1016/S0302-2838(02)00548-1; Edwards TL, 2013, CANCER EPIDEM BIOMAR, V22, P1538, DOI 10.1158/1055-9965.EPI-13-0123; Fowke JH, 2007, PROSTATE CANCER P D, V10, P137, DOI 10.1038/sj.pcan.4500924; Fowke JH, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-23; Fowke JH, 2011, J GEN INTERN MED, V26, P1305, DOI 10.1007/s11606-011-1776-8; Gao XY, 2008, GENET EPIDEMIOL, V32, P361, DOI 10.1002/gepi.20310; GIOVANNUCCI E, 1994, AM J EPIDEMIOL, V140, P989, DOI 10.1093/oxfordjournals.aje.a117206; Gupta A, 2006, UROLOGY, V68, P1198, DOI 10.1016/j.urology.2006.09.034; Guyon I, 2005, U.S. Patent Application, Patent No. [11/214,931, 11214931]; Heard-Costa NL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000539; Heid IM, 2010, NAT GENET, V42, P949, DOI 10.1038/ng.685; Joseph MA, 2003, AM J EPIDEMIOL, V157, P906, DOI 10.1093/aje/kwg051; KAPLAN SA, 1995, J UROLOGY, V154, P1764, DOI 10.1016/S0022-5347(01)66779-X; Kristal AR, 2007, J UROLOGY, V177, P1395, DOI 10.1016/j.juro.2006.11.065; Kristal AR, 2010, PROSTATE, V70, P584, DOI 10.1002/pros.21092; Lo M, 2008, BRIT J CANCER, V99, P464, DOI 10.1038/sj.bjc.6604485; Mononen N, 2002, HUM GENET, V111, P166, DOI 10.1007/s00439-002-0776-5; Muller RL, 2013, EUR UROL, V63, P1115, DOI 10.1016/j.eururo.2013.02.038; Nandeesha H, 2006, CLIN CHIM ACTA, V370, P89, DOI 10.1016/j.cca.2006.01.019; Nickel JC, 2008, UROL CLIN N AM, V35, P109, DOI 10.1016/j.ucl.2007.09.012; Ozden C, 2007, EUR UROL, V51, P199, DOI 10.1016/j.eururo.2006.05.040; Parsons JK, 2008, EUR UROL, V53, P1228, DOI 10.1016/j.eururo.2008.02.019; Parsons JK, 2008, BJU INT, V101, P313, DOI 10.1111/j.1464-410X.2007.07332.x; Parsons JK, 2007, J UROLOGY, V178, P395, DOI 10.1016/j.juro.2007.03.103; Parsons JK, 2006, J CLIN ENDOCR METAB, V91, P2562, DOI 10.1210/jc.2005-2799; Parsons JK, 2010, CURR BLADDER DYSFUNC, V5, P212, DOI 10.1007/s11884-010-0067-2; Parsons JK, 2009, J UROLOGY, V182, pS27, DOI 10.1016/j.juro.2009.07.086; Parsons JK, 2009, J UROLOGY, V182, P1463, DOI 10.1016/j.juro.2009.06.038; PARTIN AW, 1994, UROLOGY, V44, P646; Pei BK, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r51; Pham AN, 2010, J PHARMACOL EXP THER, V332, P949, DOI 10.1124/jpet.109.162248; Platz EA, 2000, J UROLOGY, V163, P490, DOI 10.1016/S0022-5347(05)67909-8; Pritchard CC, 2008, DIFFERENTIATION, V76, P624, DOI 10.1111/j.1432-0436.2008.00274.x; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qi J, 2013, PROSTATE, V73, P1182, DOI 10.1002/pros.22666; Rebhan M, 1998, BIOINFORMATICS, V14, P656, DOI 10.1093/bioinformatics/14.8.656; Roberts RO, 2005, PROSTATE, V62, P380, DOI 10.1002/pros.20142; Roehrborn CG, 2008, INT J IMPOT RES, V20, pS19, DOI 10.1038/ijir.2008.53; Roehrborn CG, 2011, MED CLIN N AM, V95, P87, DOI 10.1016/j.mcna.2010.08.013; Rohrmann S, 2005, PROSTATE, V62, P27, DOI 10.1002/pros.20110; Rohrmann S, 2004, AM J EPIDEMIOL, V159, P390, DOI 10.1093/aje/kwh060; Salam MT, 2005, UROL ONCOL-SEMIN ORI, V23, P246, DOI 10.1016/j.urolonc.2004.12.014; Sarma AV, 2009, J UROLOGY, V182, pS32, DOI 10.1016/j.juro.2009.07.088; Sarma AV, 2003, UROLOGY, V61, P1086, DOI 10.1016/S0090-4295(03)00154-7; Sauver JLS, 2009, AM J EPIDEMIOL, V169, P1281, DOI 10.1093/aje/kwp085; Schenk JM, 2010, AM J EPIDEMIOL, V171, P571, DOI 10.1093/aje/kwp406; Seim A, 2005, BJU INT, V96, P88, DOI 10.1111/j.1464-410X.2005.05573.x; Singh AP, 2008, CANCER LETT, V259, P28, DOI 10.1016/j.canlet.2007.09.018; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; STAMEY TA, 1994, SCAND J UROL NEPHROL, P73; Timmerman LA, 2013, CANCER CELL, V24, P450, DOI 10.1016/j.ccr.2013.08.020; Voight BF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002793; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Wei JT, 2005, J UROLOGY, V173, P1256, DOI 10.1097/01.ju.0000155709.37840.fe	60	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2015	10	7							e0132028	10.1371/journal.pone.0132028	http://dx.doi.org/10.1371/journal.pone.0132028			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EW	26158673	Green Published, gold, Green Submitted			2022-12-26	WOS:000358161200046
J	Manjunath, S; Kulkarni, PG; Nagavelu, K; Samuel, RJ; Srinivasan, S; Ramasamy, N; Hegde, NR; Gudde, RS				Manjunath, Shrruthi; Kulkarni, Prachet G.; Nagavelu, Krishnaveni; Samuel, Rosa J.; Srinivasan, Sandhya; Ramasamy, Nandhini; Hegde, Nagendra R.; Gudde, Ramachandra S.			Sero-Prevalence of Rodent Pathogens in India	PLOS ONE			English	Article							LABORATORY MICE; INFECTIOUS AGENTS; CONTEMPORARY PREVALENCE; HEALTH SURVEILLANCE; SEROLOGICAL SURVEY; UNITED-KINGDOM; MURINE VIRUSES; RAT COLONIES; MOUSE; ANTIBODIES	Health monitoring is an integral part of laboratory animal quality standards. However, current or past prevalence data as well as regulatory requirements dictate the frequency, type and the expanse of health monitoring. In an effort to understand the prevalence of rodent pathogens in India, a preliminary study was carried out by sero-epidemiology. Sera samples obtained from 26 public and private animal facilities were analyzed for the presence of antibodies against minute virus of mice (MVM), ectromelia virus (ECTV), lymphocytic choriomeningitis virus (LCMV), mouse hepatitis virus (MHV), Sendai virus (SeV), and Mycoplasma pulmonis in mice, and SeV, rat parvo virus (RPV), Kilham's rat virus (KRV) and sialodacryoadenitis virus (SDAV) in rats, by sandwich ELISA. It was observed that MHV was the most prevalent agent followed by Mycoplasma pulmonis and MVM in mice, and SDAV followed by RPV were prevalent in rats. On the other hand, none of the samples were positive for ECTV in mice, or SeV or KRV in rats. Multiple infections were common in both mice and rats. The incidence of MHV and Mycoplasma pulmonis was higher in facilities maintained by public organizations than in vivaria of private organizations, although the difference was not statistically different. On the other hand the prevalence of rodent pathogens was significantly higher in the northern part of India than in the South. These studies form the groundwork for detailed sero-prevalence studies which should further lay the foundations for country-specific guidelines for health monitoring of laboratory animals.	[Manjunath, Shrruthi; Kulkarni, Prachet G.; Nagavelu, Krishnaveni; Samuel, Rosa J.; Srinivasan, Sandhya; Gudde, Ramachandra S.] Indian Inst Sci, Cent Anim Facil, Bengaluru, India; [Ramasamy, Nandhini; Hegde, Nagendra R.] Genome Valley, Ella Fdn, Hyderabad, Andhra Pradesh, India	Indian Institute of Science (IISC) - Bangalore	Gudde, RS (corresponding author), Indian Inst Sci, Cent Anim Facil, Bengaluru, India.	sgr@caf.iisc.ernet.in	Hegde, Nagendra R/H-3132-2019	Hegde, Nagendra R/0000-0001-5260-2159	Department of Biotechnology, Government of India [DBT/BT/PR13951/ADV/57/46/2010]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	Department of Biotechnology, Government of India. Grant number: DBT/BT/PR13951/ADV/57/46/2010. Fund receiver: RSG NRH (Website: www.dbtindia.nic.in). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker DG, 1998, CLIN MICROBIOL REV, V11, P231, DOI 10.1128/CMR.11.2.231; Cagliada MP, 2010, REV ARGENT MICROBIOL, V42, P27, DOI 10.1590/S0325-75412010000100006; CARTHEW P, 1978, LAB ANIM, V12, P29, DOI 10.1258/002367778780953323; CASEBOLT DB, 1988, LAB ANIM SCI, V38, P327; Clifford CB, 2008, ILAR J, V49, P291, DOI 10.1093/ilar.49.3.291; Coates ME, 1994, GUIDELINES BREEDING, P42; COLLINS MJ, 1972, J NATL CANCER I, V49, P1139; DESCOTEAUX JP, 1977, LAB ANIM SCI, V27, P621; Festing MFW, 1994, GUIDELINES BREEDING, P68; FUJIWARA K, 1976, LAB ANIM SCI, V26, P153; GANNON J, 1980, LAB ANIM, V14, P309, DOI 10.1258/002367780781071003; Gilioli R, 1996, LAB ANIM SCI, V46, P582; Hayashimoto N, 2013, EXP ANIM TOKYO, V62, P41, DOI 10.1538/expanim.62.41; Liang CT, 2009, J AM ASSOC LAB ANIM, V48, P381; Livingston RS, 2003, LAB ANIMAL, V32, P44, DOI 10.1038/laban0503-44; Loew FM, 1983, MOUSE BIOMEDICAL RES, V3, P69, DOI DOI 10.1016/B978-0-12-262503-9.50012-8; Mahler M, 2014, LAB ANIM-UK, V48, P178, DOI 10.1177/0023677213516312; Mahler M, 2009, LAB ANIMAL, V38, P161, DOI 10.1038/laban0509-161; McInnes EE, 2011, LAB ANIMAL, V40, P341, DOI 10.1038/laban1111-341; NAKAGAWA M, 1984, EXP ANIM TOKYO, V33, P115, DOI 10.1538/expanim1978.33.1_115; NICKLAS W, 1993, LAB ANIM SCI, V43, P296; Nicklas W., 1996, Scandinavian Journal of Laboratory Animal Science, V23, P69; Nicklas W, 1999, LAB ANIM-UK, V33, P39, DOI 10.1258/002367799780639987; POILEY SM, 1970, LAB ANIM CARE, V20, P643; Pritchett-Corning KR, 2009, LAB ANIM-UK, V43, P165, DOI 10.1258/la.2008.008009; ROWE W P, 1963, Lab Anim Care, V13, pSUPPL166; Selwyn M R, 1994, Contemp Top Lab Anim Sci, V33, P56; Seoki S, 2005, EXP ANIM TOKYO, V54, P85, DOI 10.1538/expanim.54.85; Small JD, 1984, LAB ANIMAL MED, P69; SMITH AL, 1983, LAB ANIM SCI, V33, P37; VANVUUREN M, 1990, J S AFR VET ASSOC, V61, P174; VOLLER A, 1978, J CLIN PATHOL, V31, P507, DOI 10.1136/jcp.31.6.507; Weisbroth S, 2000, LAB ANIMAL, V29, P43; Weisbroth Steven H., 1998, ILAR J, V39, P272; Won YS, 2006, EXP ANIM TOKYO, V55, P11, DOI 10.1538/expanim.55.11; YANG FC, 1995, LAB ANIM SCI, V45, P140	36	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2015	10	7							e0131706	10.1371/journal.pone.0131706	http://dx.doi.org/10.1371/journal.pone.0131706			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EW	26158453	gold, Green Published, Green Submitted			2022-12-26	WOS:000358161200036
J	Tsai, MJ; Huang, YB; Fang, JW; Fu, YS; Wu, PC				Tsai, Ming-Jun; Huang, Yaw-Bin; Fang, Jhih-Wun; Fu, Yaw-Syan; Wu, Pao-Chu			Preparation and Characterization of Naringenin-Loaded Elastic Liposomes for Topical Application	PLOS ONE			English	Article							ENHANCED SKIN DELIVERY; IN-VIVO; ANTIINFLAMMATORY ACTIVITY; ULTRADEFORMABLE VESICLES; FLAVONOID NARINGENIN; FLAVANONE NARINGENIN; POTENTIAL TREATMENT; SURFACE-CHARGE; MELANOMA-CELLS; VITRO	Excessive production of radical oxygen species in skin is a contributor to a variety of skin pathologies. Naringenin is a potent antioxidant. The purpose of the present study was to develop elastic liposomes for naringenin topical application. Naringenin-loaded elastic liposomes containing different amounts of Tween 80 and cholesterol were prepared. The physicochemical properties including vesicle size, surface charge, encapsulation efficiency, and permeability capacity were determined to evaluate the effect of components. The stability of formulation and skin irritation caused by drug-loaded elastic liposomes were also evaluated for assessment of the clinical utility of elastic liposomes. Saturated aqueous solution of naringenin and naringenin dissolved in 10% Tween 80 solution (5 mg/mL) were used as the control group. The result showed that in using elastic liposomes as carrier, the deposition amounts in the skin of naringenin were significantly increased about 7.3 +/- 11.8-fold and 1.2 +/- 1.9-fold respectively, when compared with the saturated aqueous solution and Tween 80 solution-treated groups. The level of drug was more than 98.89 +/- 3.90% after 3 months of storage at 4 degrees C. In a skin irritation test, the result showed experimental formulation exhibit considerably less irritating than the positive control (paraformaldehyde-treated) group, suggesting its potential therapeutic application.	[Tsai, Ming-Jun] China Med Univ Hosp, Dept Neurol, Taichung, Taiwan; [Tsai, Ming-Jun] China Med Univ, Coll Med, Sch Med, Taichung, Taiwan; [Huang, Yaw-Bin; Fang, Jhih-Wun; Wu, Pao-Chu] Kaohsiung Med Univ, Sch Pharm, Kaohsiung, Taiwan; [Fu, Yaw-Syan] Kaohsiung Med Univ, Dept Biomed Sci & Environm Biol, Kaohsiung, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Kaohsiung Medical University; Kaohsiung Medical University	Wu, PC (corresponding author), Kaohsiung Med Univ, Sch Pharm, Kaohsiung, Taiwan.	pachwu@kmu.edu.tw		Fu, Yaw-Syan/0000-0001-8715-9644; FANG, CHIH-WUN/0000-0002-1067-9024; Huang, Yaw-Bin/0000-0002-6024-0108	NSC [102-2320-B-037-006-MY2, NSC101-2320-B-037-33]; Ministry of Science and Technology of Taiwan	NSC(Ministry of Science and Technology, Taiwan); Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by NSC 102-2320-B-037-006-MY2 and NSC101-2320-B-037-33, the Ministry of Science and Technology of Taiwan, PCW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Suwayeh SA, 2014, SCI WORLD J, DOI 10.1155/2014/127495; Azeem A, 2009, AAPS PHARMSCITECH, V10, P1093, DOI 10.1208/s12249-009-9306-2; BANGHAM AD, 1965, J MOL BIOL, V13, P238, DOI 10.1016/S0022-2836(65)80093-6; Black HS, 1997, J PHOTOCH PHOTOBIO B, V40, P29, DOI 10.1016/S1011-1344(97)00021-3; Cavia-Saiz M, 2010, J SCI FOOD AGR, V90, P1238, DOI 10.1002/jsfa.3959; Celia C, 2012, BIOMED MICRODEVICES, V14, P119, DOI 10.1007/s10544-011-9590-y; CEVC G, 1992, BIOCHIM BIOPHYS ACTA, V1104, P226, DOI 10.1016/0005-2736(92)90154-E; Cevc G, 2001, BBA-BIOMEMBRANES, V1514, P191, DOI 10.1016/S0005-2736(01)00369-8; Coderch L, 2000, J CONTROL RELEASE, V68, P85, DOI 10.1016/S0168-3659(00)00240-6; Cosco D, 2012, INT J PHARMACEUT, V422, P229, DOI 10.1016/j.ijpharm.2011.10.056; De Paula D, 2008, BIOMED CHROMATOGR, V22, P1416, DOI 10.1002/bmc.1075; El Zaafarany GM, 2010, INT J PHARMACEUT, V397, P164, DOI 10.1016/j.ijpharm.2010.06.034; Elnaggar YSR, 2014, J CONTROL RELEASE, V180, P10, DOI 10.1016/j.jconrel.2014.02.004; Elsayed MMA, 2006, INT J PHARMACEUT, V322, P60, DOI 10.1016/j.ijpharm.2006.05.027; Felgines C, 2000, AM J PHYSIOL-GASTR L, V279, pG1148, DOI 10.1152/ajpgi.2000.279.6.G1148; Ge Y, 2015, J LIPOSOME RES, V25, P222, DOI 10.3109/08982104.2014.987786; Gesualdi NM, 2006, FREE RADICAL RES, V40, P467, DOI 10.1080/10715760600570547; Ghanbarzadeh S, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/616810; Gillet A, 2009, INT J PHARMACEUT, V380, P174, DOI 10.1016/j.ijpharm.2009.06.027; Hsiu SL, 2002, LIFE SCI, V70, P1481, DOI 10.1016/S0024-3205(01)01491-6; Huang YB, 2010, CHEM PHARM BULL, V58, P611, DOI 10.1248/cpb.58.611; Huang YC, 2011, PHYTOMEDICINE, V18, P1244, DOI 10.1016/j.phymed.2011.06.028; Krause MR, 2014, ACCOUNTS CHEM RES, V47, P3512, DOI 10.1021/ar500260t; Lademann J, 2009, EUR J PHARM BIOPHARM, V72, P317, DOI 10.1016/j.ejpb.2008.08.008; Lasic DD., 1997, LIPOSOMES GENE DELIV; Lewis GA., 1999, PHARM EXPT DESIGN; Li C, 2013, INT J NANOMED, V8, P1285, DOI 10.2147/IJN.S41695; Li LN, 1997, J DERMATOL SCI, V14, P101, DOI 10.1016/S0923-1811(96)00557-9; Magarkar A, 2014, SCI REP-UK, V4, DOI 10.1038/srep05005; Malakar J, 2012, SAUDI PHARM J, V20, P355, DOI 10.1016/j.jsps.2012.02.001; Manosroi A, 2008, INT J PHARMACEUT, V360, P156, DOI 10.1016/j.ijpharm.2008.04.033; Marianecci C, 2010, J CONTROL RELEASE, V147, P127, DOI 10.1016/j.jconrel.2010.06.022; Montenegro L., 2008, International Journal of Cosmetic Science, V30, P57, DOI 10.1111/j.1468-2494.2008.00417.x; Mura P, 2007, EUR J PHARM BIOPHARM, V67, P86, DOI 10.1016/j.ejpb.2007.01.020; Mura P, 2014, INT J PHARMACEUT, V475, P306, DOI 10.1016/j.ijpharm.2014.08.066; Mutalik S, 2004, J PHARM SCI-US, V93, P1577, DOI 10.1002/jps.20058; Nawaz A, 2013, PAK J PHARM SCI, V26, P617; Ohguchi K, 2006, BIOSCI BIOTECH BIOCH, V70, P1499, DOI 10.1271/bbb.50635; Paolino D, 2005, J CONTROL RELEASE, V106, P99, DOI 10.1016/j.jconrel.2005.04.007; Paolino D, 2002, INT J PHARMACEUT, V244, P21, DOI 10.1016/S0378-5173(02)00295-8; Paolino D, 2014, BIOMATERIALS, V35, P7101, DOI 10.1016/j.biomaterials.2014.04.088; Paolino D, 2012, J CONTROL RELEASE, V162, P143, DOI 10.1016/j.jconrel.2012.05.050; Paolino D, 2012, EUR J PHARM BIOPHARM, V81, P102, DOI 10.1016/j.ejpb.2012.02.008; Paolino D, 2010, J CONTROL RELEASE, V144, P144, DOI 10.1016/j.jconrel.2010.02.021; Pasut G, 2015, J CONTROL RELEASE, V199, P106, DOI 10.1016/j.jconrel.2014.12.008; Portugal M, 2007, BIOMED PHARMACOTHER, V61, P412, DOI 10.1016/j.biopha.2007.05.010; Renugadevi J, 2009, TOXICOLOGY, V256, P128, DOI 10.1016/j.tox.2008.11.012; Scharffetter-Kochanek K, 1997, BIOL CHEM, V378, P1247; Semple SC, 1996, BIOCHEMISTRY-US, V35, P2521, DOI 10.1021/bi950414i; Shulman M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018033; Song CK, 2012, COLLOID SURFACE B, V92, P299, DOI 10.1016/j.colsurfb.2011.12.004; TRENAM CW, 1992, J INVEST DERMATOL, V99, P675, DOI 10.1111/1523-1747.ep12613740; Tsai MJ, 2015, INT J PHARMACEUT, V481, P84, DOI 10.1016/j.ijpharm.2015.01.034; Verma DD, 2003, INT J PHARM, V258, P141, DOI 10.1016/S0378-5173(03)00183-2; Verma DD, 2003, EUR J PHARM BIOPHARM, V55, P271, DOI 10.1016/S0939-6411(03)00021-3; Vicentini FTMC, 2008, EUR J PHARM BIOPHARM, V69, P948, DOI 10.1016/j.ejpb.2008.01.012; Vrhovnik K, 1998, PHARMACEUT RES, V15, P525, DOI 10.1023/A:1011965423986; Xia SQ, 2015, COLLOID SURFACE B, V128, P172, DOI 10.1016/j.colsurfb.2015.02.004; YEAGLE PL, 1985, BIOCHIM BIOPHYS ACTA, V822, P267, DOI 10.1016/0304-4157(85)90011-5; Zhao YZ, 2013, INT J PHARMACEUT, V454, P302, DOI 10.1016/j.ijpharm.2013.06.052	60	47	47	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2015	10	7							e0131026	10.1371/journal.pone.0131026	http://dx.doi.org/10.1371/journal.pone.0131026			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EW	26158639	gold, Green Published, Green Submitted			2022-12-26	WOS:000358161200024
J	Vonhof, MJ; Russell, AL; Miller-Butterworth, CM				Vonhof, Maarten J.; Russell, Amy L.; Miller-Butterworth, Cassandra M.			Range-Wide Genetic Analysis of Little Brown Bat (Myotis lucifugus) Populations: Estimating the Risk of Spread of White-Nose Syndrome	PLOS ONE			English	Article							BIG-EARED BAT; SWARMING SITES; INFECTIOUS-DISEASES; MAXIMUM-LIKELIHOOD; F-STATISTICS; NUCLEAR-DNA; FLOW; MITOCHONDRIAL; SOFTWARE; PHYLOGEOGRAPHY	The little brown bat (Myotis lucifugus) is one of the most widespread bat species in North America and is experiencing severe population declines because of an emerging fungal disease, white-nose syndrome (WNS). To manage and conserve this species effectively it is important to understand patterns of gene flow and population connectivity to identify possible barriers to disease transmission. However, little is known about the population genetic structure of little brown bats, and to date, no studies have investigated population structure across their entire range. We examined mitochondrial DNA and nuclear microsatellites in 637 little brown bats (including all currently recognized subspecific lineages) from 29 locations across North America, to assess levels of genetic variation and population differentiation across the range of the species, including areas affected by WNS and those currently unaffected. We identified considerable spatial variation in patterns of female dispersal and significant genetic variation between populations in eastern versus western portions of the range. Overall levels of nuclear genetic differentiation were low, and there is no evidence for any major barriers to gene flow across their range. However, patterns of mtDNA differentiation are highly variable, with high FST values between most sample pairs (including between all western samples, between western and eastern samples, and between some eastern samples), while low mitochondrial differentiation was observed within two groups of samples found in central and eastern regions of North America. Furthermore, the Alaskan population was highly differentiated from all others, and western populations were characterized by isolation by distance while eastern populations were not. These data raise the possibility that the current patterns of spread of WNS observed in eastern North America may not apply to the entire range and that there may be broad-scale spatial variation in the risk of WNS transmission and occurrence if the disease continues to spread west.	[Vonhof, Maarten J.] Western Michigan Univ, Dept Biol Sci, Kalamazoo, MI 49008 USA; [Vonhof, Maarten J.] Western Michigan Univ, Environm & Sustainabil Studies Program, Kalamazoo, MI 49008 USA; [Russell, Amy L.] Grand Valley State Univ, Dept Biol, Allendale, MI 49401 USA; [Miller-Butterworth, Cassandra M.] Penn State Beaver, Monaca, PA USA	Western Michigan University; Western Michigan University; Grand Valley State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University	Vonhof, MJ (corresponding author), Western Michigan Univ, Dept Biol Sci, Kalamazoo, MI 49008 USA.	maarten.vonhof@wmich.edu	Russell, Amy L/B-2222-2010		Western Michigan University; Pennsylvania Game Commission State Wildlife Grant Program [231100]; Pennsylvania State University Research Development Grants	Western Michigan University; Pennsylvania Game Commission State Wildlife Grant Program; Pennsylvania State University Research Development Grants	Funding for this study was provided by Western Michigan University, the Pennsylvania Game Commission State Wildlife Grant Program (Cooperative Agreement No. 231100), and the Pennsylvania State University Research Development Grants.	Biek R, 2010, MOL ECOL, V19, P3515, DOI 10.1111/j.1365-294X.2010.04679.x; Bilgin R, 2008, ZOOL SCR, V37, P253, DOI 10.1111/j.1463-6409.2008.00326.x; Blehert DS, 2009, SCIENCE, V323, P227, DOI 10.1126/science.1163874; Bogdanowicz W, 2013, ACTA CHIROPTEROL, V15, P35, DOI 10.3161/150811013X667849; Bryja J, 2009, BIOL J LINN SOC, V96, P103, DOI 10.1111/j.1095-8312.2008.01093.x; Burns LE, 2014, ECOL EVOL, V4, P4130, DOI 10.1002/ece3.1266; Carstens BC, 2010, SYST BIOL, V59, P400, DOI 10.1093/sysbio/syq024; Castella V, 2000, MOL ECOL, V9, P1761, DOI 10.1046/j.1365-294x.2000.01069.x; Castella V, 2001, J EVOLUTION BIOL, V14, P708, DOI 10.1046/j.1420-9101.2001.00331.x; Cryan PM, 2013, J WILDLIFE DIS, V49, P398, DOI 10.7589/2012-04-121; Cryan PM, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-135; Cullingham CI, 2011, EVOL APPL, V4, P116, DOI 10.1111/j.1752-4571.2010.00142.x; Davis W. H., 1965, Journal of Mammalogy, V46, P296, DOI 10.2307/1377850; Dixon MD, 2011, ECOL EVOL, V1, P191, DOI 10.1002/ece3.20; Dixon MD, 2011, J MAMMAL, V92, P1343, DOI 10.1644/10-MAMM-A-426.1; Duchesne P, 2009, MOL ECOL RESOUR, V9, P1333, DOI 10.1111/j.1755-0998.2009.02571.x; Duchesne P, 2012, J HERED, V103, P734, DOI 10.1093/jhered/ess038; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falush D, 2003, GENETICS, V164, P1567; FENTON M B, 1980, Mammalian Species, P1, DOI 10.2307/3503792; Fontaine MC, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-30; Frantz AC, 2009, J APPL ECOL, V46, P493, DOI 10.1111/j.1365-2664.2008.01606.x; Frick WF, 2010, SCIENCE, V329, P679, DOI 10.1126/science.1188594; Furmankiewicz J, 2007, CONSERV GENET, V8, P913, DOI 10.1007/s10592-006-9246-2; Gibbs HL, 2000, MOL ECOL, V9, P2137, DOI 10.1046/j.1365-294X.2000.01136.x; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Gray RR, 2012, PARASITOLOGY, V139, P1939, DOI 10.1017/S0031182012001102; Guillot G, 2009, MOL ECOL, V18, P4734, DOI 10.1111/j.1365-294X.2009.04410.x; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Irwin DE, 2011, MOL ECOL, V20, P3102, DOI 10.1111/j.1365-294X.2011.05159.x; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Jones KL, 2005, MOL ECOL, V14, P2645, DOI 10.1111/j.1365-294X.2005.02622.x; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kerth G, 2003, CONSERV GENET, V4, P491, DOI 10.1023/A:1024771713152; Kerth G, 2002, MOL ECOL, V11, P1491, DOI 10.1046/j.1365-294X.2002.01528.x; Kerth G, 2008, MOL ECOL, V17, P2368, DOI 10.1111/j.1365-294X.2008.03768.x; Kimura M, 2002, MOL ECOL, V11, P1605, DOI 10.1046/j.1365-294X.2002.01551.x; Lack JB, 2010, ACTA CHIROPTEROL, V12, P401, DOI 10.3161/150811010X537981; Langwig KE, 2012, ECOL LETT, V15, P1050, DOI 10.1111/j.1461-0248.2012.01829.x; Lausen CL, 2008, CAN J ZOOL, V86, P700, DOI 10.1139/Z08-046; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lorch JM, 2011, NATURE, V480, P376, DOI 10.1038/nature10590; Mcrae BH, 2005, MOL ECOL, V14, P1965, DOI 10.1111/j.1365-294X.2005.02571.x; Meirmans PG, 2012, J HERED, V103, P744, DOI 10.1093/jhered/ess047; Meirmans PG, 2012, MOL ECOL, V21, P2839, DOI 10.1111/j.1365-294X.2012.05578.x; Meirmans PG, 2011, MOL ECOL RESOUR, V11, P5, DOI 10.1111/j.1755-0998.2010.02927.x; Meteyer CU, 2009, J VET DIAGN INVEST, V21, P411, DOI 10.1177/104063870902100401; Miller-Butterworth CM, 2014, J HERED, V105, P354, DOI 10.1093/jhered/esu012; Moussy C, 2013, MAMMAL REV, V43, P183, DOI 10.1111/j.1365-2907.2012.00218.x; Norquay KJO, 2013, J MAMMAL, V94, P506, DOI 10.1644/12-MAMM-A-065.1; Oyler-McCance SJ, 2011, CONSERV GENET RESOUR, V3, P243, DOI 10.1007/s12686-010-9332-0; Piaggio AJ, 2009, MOL ECOL RESOUR, V9, P1191, DOI 10.1111/j.1755-0998.2009.02625.x; Piaggio AJ, 2009, MOL ECOL RESOUR, V9, P258, DOI 10.1111/j.1755-0998.2008.02243.x; Pritchard JK, 2000, GENETICS, V155, P945; Real LA, 2007, J R SOC INTERFACE, V4, P935, DOI 10.1098/rsif.2007.1041; Reeder DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038920; Reid FA, 2006, MAMMALS N AM; Rivers NM, 2006, BIOL CONSERV, V127, P215, DOI 10.1016/j.biocon.2005.08.010; Rosenberg MS, 2011, METHODS ECOL EVOL, V2, P229, DOI 10.1111/j.2041-210X.2010.00081.x; Rousset F, 1997, GENETICS, V145, P1219; Schwartz MK, 2009, CONSERV GENET, V10, P441, DOI 10.1007/s10592-008-9622-1; Shafer ABA, 2010, MOL ECOL, V19, P4589, DOI 10.1111/j.1365-294X.2010.04828.x; Stadelmann B, 2007, MOL PHYLOGENET EVOL, V43, P32, DOI 10.1016/j.ympev.2006.06.019; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thogmartin WE, 2012, J WILDLIFE DIS, V48, P876, DOI 10.7589/2011-06-176; THOMAS DW, 1979, BEHAV ECOL SOCIOBIOL, V6, P129, DOI 10.1007/BF00292559; Trujillo RG, 2009, CONSERV GENET, V10, P1965, DOI 10.1007/s10592-009-9869-1; Turmelle AS, 2011, MOL ECOL, V20, P357, DOI 10.1111/j.1365-294X.2010.04947.x; Turner Gregory G., 2011, Bat Research News, V52, P13; U.S. Fish and Wildlife Service, 2014, CURR WNS OCC MAP; Veith M, 2004, HEREDITY, V93, P342, DOI 10.1038/sj.hdy.6800509; Verant ML, 2014, BMC PHYSL, V14, pe10; Villesen P, 2007, MOL ECOL NOTES, V7, P965, DOI 10.1111/j.1471-8286.2007.01821.x; Vollmer SA, 2011, ENVIRON MICROBIOL, V13, P184, DOI 10.1111/j.1462-2920.2010.02319.x; Vonhof MJ, 2008, J MAMMAL, V89, P1411, DOI 10.1644/08-MAMM-S-062.1; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wilder AP, 2011, BIOL LETTERS, V7, P950, DOI 10.1098/rsbl.2011.0355; Willis CKR, 2011, INTEGR COMP BIOL, V51, P364, DOI 10.1093/icb/icr076; Wilmer Jessica Worthington, 1996, Bat Research News, V37, P1; Wilson D.E., 2005, MAMMAL SPECIES WORLD	89	20	21	0	189	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0128713	10.1371/journal.pone.0128713	http://dx.doi.org/10.1371/journal.pone.0128713			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154307	Green Published, gold			2022-12-26	WOS:000358159700009
J	Yang, LH; Jin, MJ; Du, PF; Chen, G; Zhang, C; Wang, J; Jin, F; Shao, H; She, YX; Wang, SS; Zheng, LF; Wang, J				Yang, Lihua; Jin, Maojun; Du, Pengfei; Chen, Ge; Zhang, Chan; Wang, Jian; Jin, Fen; Shao, Hua; She, Yongxin; Wang, Shanshan; Zheng, Lufei; Wang, Jing			Study on Enhancement Principle and Stabilization for the Luminol-H2O2-HRP Chemiluminescence System	PLOS ONE			English	Article							LUMINOL SIGNAL ENHANCER; HORSERADISH-PEROXIDASE; ENZYME IMMUNOASSAYS; HYDROGEN-PEROXIDE; DERIVATIVES; INTENSITY; OXIDATION; KINETICS	A luminol-H2O2-HRP chemiluminescence system with high relative luminescent intensity (RLU) and long stabilization time was investigated. First, the comparative study on the enhancement effect of ten compounds as enhancers to the luminol-H2O2-HRP chemiluminescence system was carried out, and the results showed that 4-(imidazol-1-yl) phenol (4-IMP), 4-iodophenol (4-IOP), 4-bromophenol (4-BOP) and 4-hydroxy-4'-iodobiphenyl (HIOP) had the best performance. Based on the experiment, the four enhancers were dissolved in acetone, acetonitrile, methanol, and dimethylformamide (DMF) with various concentrations, the results indicated that 4-IMP, 4-IOP, 4-BOP and HIOP dissolved in DMF with the concentrations of 0.2%, 3.2%, 1.6% and 3.2% could get the highest RLU values. Subsequently, the influences of pH, ionic strength, HRP, 4-IMP, 4-IOP, 4-BOP, HIOP, H(2)O(2)and luminol on the stabilization of the luminol-H2O2-HRP chemiluminescence system were studied, and we found that pH value, ionic strength, 4-IMP, 4-IOP, 4-BOP, HIOP, H(2)O(2)and luminol have little influence on luminescent stabilization, while HRP has a great influence. In different ranges of HRP concentration, different enhancers should be selected. When the concentration is within the range of 0 similar to 6 ng/mL, 4-IMP should be selected. When the concentration of HRP ranges from 6 to 25ng/mL, 4-IOP was the best choice. And when the concentration is within the range of 25 similar to 80 ng/mL, HIOP should be selected as the enhancer. Finally, the three well-performing chemiluminescent enhanced solutions (CESs) have been further optimized according to the three enhancers (4-IMP, 4-IOP and HIOP) in their utilized HRP concentration ranges.	[Yang, Lihua; Jin, Maojun; Du, Pengfei; Chen, Ge; Zhang, Chan; Wang, Jian; Jin, Fen; Shao, Hua; She, Yongxin; Wang, Shanshan; Zheng, Lufei; Wang, Jing] Chinese Acad Agr Sci, Inst Qual Stand & Testing Technol AgroProd, Key Lab AgroProd Qual & Safety, Beijing 100081, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Quality Standards & Testing Technology for Agro-Products, CAAS	Jin, MJ (corresponding author), Chinese Acad Agr Sci, Inst Qual Stand & Testing Technol AgroProd, Key Lab AgroProd Qual & Safety, Beijing 100081, Peoples R China.	katonking@163.com; w_jing2001@126.com		Jin, Maojun/0000-0002-9102-8572	International Science & Technology Cooperation Program of China [2012DFA31140]; Chinese Public Interest Industrial Science & Technology Project [201203094]; National Natural Science Foundation of China [31201371]	International Science & Technology Cooperation Program of China; Chinese Public Interest Industrial Science & Technology Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by International Science & Technology Cooperation Program of China (No. 2012DFA31140), the Chinese Public Interest Industrial Science & Technology Project (201203094) and National Natural Science Foundation of China (No. 31201371). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpeeva IS, 2003, J BIOL INORG CHEM, V8, P683, DOI 10.1007/s00775-003-0467-2; Chen FM, 2012, ANAL CHIM ACTA, V739, P77, DOI 10.1016/j.aca.2012.06.022; Chuang JC, 2005, TALANTA, V67, P658, DOI 10.1016/j.talanta.2005.04.063; Deftereos NT, 2000, ANAL CHIM ACTA, V403, P137, DOI 10.1016/S0003-2670(99)00643-1; Diaz AN, 1996, ANAL CHIM ACTA, V321, P219; Diaz AN, 1998, J BIOLUM CHEMILUM, V13, P75, DOI 10.1002/(SICI)1099-1271(199803/04)13:2<75::AID-BIO469>3.0.CO;2-7; Dotsikas Y, 2004, ANAL CHIM ACTA, V509, P103, DOI 10.1016/j.aca.2003.12.007; Dotsikas Y, 2002, ANAL CHIM ACTA, V459, P177, DOI 10.1016/S0003-2670(02)00133-2; Dotsikas Y, 2007, TALANTA, V71, P906, DOI 10.1016/j.talanta.2006.05.068; Gui WJ, 2006, ANAL BIOCHEM, V357, P9, DOI 10.1016/j.ab.2006.07.023; IWATA R, 1995, ANAL BIOCHEM, V231, P170, DOI 10.1006/abio.1995.1517; Jin MJ, 2009, THESIS ZHEJIANG U; Kricka JL, 1996, ANAL BIOCHEM, V240, P119, DOI 10.1006/abio.1996.0338; Kuroda N, 1999, LUMINESCENCE, V14, P361, DOI 10.1002/(SICI)1522-7243(199911/12)14:6<361::AID-BIO563>3.3.CO;2-A; Kuroda N, 2000, ANAL CHIM ACTA, V403, P131, DOI 10.1016/S0003-2670(99)00649-2; Liang YL, 2012, J LUMIN, V132, P1021, DOI 10.1016/j.jlumin.2011.11.029; Marquette CA, 2006, BIOSENS BIOELECTRON, V21, P1424, DOI 10.1016/j.bios.2004.09.037; Marquette CA, 2009, BIOANALYSIS, V1, P1259, DOI [10.4155/bio.09.69, 10.4155/BIO.09.69]; Roda A, 2012, ANAL BIOANAL CHEM, V402, P69, DOI 10.1007/s00216-011-5455-8; RONGEN HAH, 1994, J PHARMACEUT BIOMED, V12, P433, DOI 10.1016/0731-7085(94)80027-8; THORPE GHG, 1985, ANAL BIOCHEM, V145, P96, DOI 10.1016/0003-2697(85)90332-X; Vdovenko MM, 2010, APPL BIOCHEM MICRO+, V46, P65, DOI 10.1134/S0003683810010114; Vdovenko MM, 2009, ANAL BIOCHEM, V392, P54, DOI 10.1016/j.ab.2009.05.031; Wu YJ, 2013, LUMINESCENCE, V28, P905, DOI 10.1002/bio.2455; Yang XY, 2009, ANAL BIOCHEM, V393, P56, DOI 10.1016/j.ab.2009.06.008; Zhao LX, 2009, TRAC-TREND ANAL CHEM, V28, P404, DOI 10.1016/j.trac.2008.12.006	26	21	22	3	105	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0131193	10.1371/journal.pone.0131193	http://dx.doi.org/10.1371/journal.pone.0131193			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154162	gold, Green Submitted, Green Published			2022-12-26	WOS:000358159700057
J	Chen, YF; Zhao, WL; Lin, LD; Xiao, X; Zhou, XY; Ming, HX; Huang, TT; Liao, J; Li, YC; Zeng, XY; Huang, GW; Ye, WM; Zhang, Z				Chen, Yufeng; Zhao, Weilin; Lin, Longde; Xiao, Xue; Zhou, Xiaoying; Ming, Huixin; Huang, Tingting; Liao, Jian; Li, Yancheng; Zeng, Xiaoyun; Huang, Guangwu; Ye, Weimin; Zhang, Zhe			Nasopharyngeal Epstein-Barr Virus Load: An Efficient Supplementary Method for Population-Based Nasopharyngeal Carcinoma Screening	PLOS ONE			English	Article							DNA LOAD; PLASMA; EBV; BRUSHINGS; INFECTION; DIAGNOSIS; BLOOD; GENE	Serological detection of Epstein-Barr virus (EBV) antibodies is frequently used in nasopharyngeal carcinoma (NPC) mass screening. However, the large number of seropositive subjects who require close follow-up is still a big burden. The present study aimed to detect the nasopharyngeal EBV load in a high-risk population seropositive for antibodies against EBV, as well as to examine whether assay for nasopharyngeal EBV DNA load might reduce the number of high-risk subjects for follow-up and improve early detection of NPC. A prospective and population-based cohort study was conducted in southern China from 2006 through 2013. Among 22,186 participants, 1045 subjects with serum immunoglobulin A (IgA) antibodies against viral capsid antigen (VCA) titers >= 1: 5 were defined as high-risk group, and were then followed-up for NPC occurrence. Qualified nasopharyngeal swab specimens were available from 905 participants and used for quantitative PCR assay. Our study revealed that 89% (802/905) subjects showed positive EBV DNA in nasopharyngeal swab. The nasopharyngeal EBV load in females was higher than that in males. The nasopharyngeal EBV load increased with increasing serum VCA/IgA titers. Eight cases of newly diagnosed NPC showed an extremely elevated EBV load, and 87.5% (7 of 8 patients) were early-stage NPCs. The EBV loads of 8 NPCs were significantly higher than those of 897 NPC-free subjects (mean, 2.8x10(6) copies/swab [range 4.8x10(4)-1.1x10(8)] vs. 5.6x10(3) [range 0-3.8x10(6)]). Using mean EBV load in NPC-free population plus two standard deviations as cut-off value, a higher diagnostic performance was obtained for EBV load test than serum VCA/IgA test (area under ROC, 0.980 vs 0.895). In conclusion, in a prospective and population-based study we demonstrated that an additional assay of EBV load in the nasopharynx among high-risk individuals may reduce the number of subjects needed to be closely followed up and could serve as part of a NPC screening program in high-risk populations.	[Chen, Yufeng; Zhao, Weilin; Xiao, Xue; Zhou, Xiaoying; Ming, Huixin; Huang, Tingting; Huang, Guangwu; Zhang, Zhe] Guangxi Med Univ, Affiliated Hosp 1, Dept Otolaryngol Head & Neck Surg, Nanning, Guangxi, Peoples R China; [Chen, Yufeng; Lin, Longde; Huang, Tingting; Zeng, Xiaoyun; Huang, Guangwu; Zhang, Zhe] Guangxi Med Univ, Minist Educ, Key Lab High Incidence Tumor Prevent & Treatment, Nanning, Guangxi, Peoples R China; [Chen, Yufeng; Lin, Longde; Zeng, Xiaoyun] Guangxi Med Univ, Sch Publ Hlth, Dept Epidemiol, Nanning, Guangxi, Peoples R China; [Liao, Jian; Li, Yancheng] Canc Inst Cangwu Cty, Wuzhou, Guangxi, Peoples R China; [Ye, Weimin] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Zhao, Weilin] Mie Univ, Grad Sch Med, Dept Environm & Mol Med, Tsu, Mie, Japan	Guangxi Medical University; Guangxi Medical University; Guangxi Medical University; Karolinska Institutet; Mie University	Zhang, Z (corresponding author), Guangxi Med Univ, Affiliated Hosp 1, Dept Otolaryngol Head & Neck Surg, Nanning, Guangxi, Peoples R China.	zhangzhe@gxmu.edu.cn	Zhou, Xiaoying/Y-4217-2019	Zhou, Xiaoying/0000-0003-3298-5089; Huang, Tingting/0000-0003-2314-4448	National Basic Research Program of China [2012CB526600, 2011CB504300]; Program for New Century Excellent Talents in University of the Ministry of Education of China [NCET-12-0654]; Natural Science Foundation of China [81272983]	National Basic Research Program of China(National Basic Research Program of China); Program for New Century Excellent Talents in University of the Ministry of Education of China(Program for New Century Excellent Talents in University (NCET)); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the National Basic Research Program of China (grant number: 2012CB526600, recipient: ZZ; grant number: 2011CB504300, recipient: GWH), Program for New Century Excellent Talents in University of the Ministry of Education of China (grant number: NCET-12-0654, recipient: ZZ) and Natural Science Foundation of China (grant number: 81272983, recipient: ZZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adham M, 2013, CLIN CANCER RES, V19, P2175, DOI 10.1158/1078-0432.CCR-12-2897; Cao SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019100; Cao Su-Mei, 2011, Chin J Cancer, V30, P114; Chang ET, 2006, CANCER EPIDEM BIOMAR, V15, P1765, DOI 10.1158/1055-9965.EPI-06-0353; Chien YC, 2001, NEW ENGL J MED, V345, P1877, DOI 10.1056/NEJMoa011610; Fachiroh J, 2008, J CLIN MICROBIOL, V46, P1374, DOI 10.1128/JCM.01368-07; Fachiroh J, 2010, J VIROL METHODS, V169, P79, DOI 10.1016/j.jviromet.2010.07.001; Hao SP, 2003, CANCER, V97, P1909, DOI 10.1002/cncr.11312; Hatton OL, 2014, IMMUNOL RES, V58, P268, DOI 10.1007/s12026-014-8496-1; Ji MF, 2007, BRIT J CANCER, V96, P623, DOI 10.1038/sj.bjc.6603609; Ji MF, 2014, CANCER-AM CANCER SOC, V120, P1353, DOI 10.1002/cncr.28564; King AD, 2011, RADIOLOGY, V258, P531, DOI 10.1148/radiol.10101241; Kutok JL, 2006, ANNU REV PATHOL-MECH, V1, P375, DOI 10.1146/annurev.pathol.1.110304.100209; Lin JC, 2004, NEW ENGL J MED, V350, P2461, DOI 10.1056/NEJMoa032260; Lin SY, 2001, HEAD NECK-J SCI SPEC, V23, P194, DOI 10.1002/1097-0347(200103)23:3<194::AID-HED1018>3.0.CO;2-X; Liu ZW, 2013, AM J EPIDEMIOL, V177, P242, DOI 10.1093/aje/kws404; Lo YMD, 1999, CANCER RES, V59, P1188; Lo YMD, 1998, AM J HUM GENET, V62, P768, DOI 10.1086/301800; MIDDELDORP JM, 1988, J VIROL METHODS, V21, P133, DOI 10.1016/0166-0934(88)90060-2; Ng RHW, 2014, OTOLARYNG HEAD NECK, V150, P602, DOI 10.1177/0194599813520136; Pak MW, 2009, LARYNGOSCOPE, V119, P523, DOI 10.1002/lary.20060; Paramita DK, 2009, CLIN VACCINE IMMUNOL, V16, P706, DOI 10.1128/CVI.00425-08; PATHMANATHAN R, 1995, NEW ENGL J MED, V333, P693, DOI 10.1056/NEJM199509143331103; Piazza C, 2008, ACTA OTORHINOLARYNGO, V28, P49; SHAM JST, 1989, CANCER, V64, P1838, DOI 10.1002/1097-0142(19891101)64:9<1838::AID-CNCR2820640914>3.0.CO;2-C; Stevens SJC, 2006, INT J CANCER, V119, P608, DOI 10.1002/ijc.21914; Wu HC, 2003, LAB INVEST, V83, P797, DOI 10.1097/01.LAB.0000074896.03561.FB; YI Z, 1980, INTERVIROLOGY, V13, P162, DOI 10.1159/000149121	28	27	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2015	10	7							e0132669	10.1371/journal.pone.0132669	http://dx.doi.org/10.1371/journal.pone.0132669			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EC	26151639	Green Published, Green Submitted, gold			2022-12-26	WOS:000358158900052
J	Lunden, K; Danielsson, M; Durling, MB; Ihrmark, K; Gorriz, MN; Stenlid, J; Asiegbu, FO; Elfstrand, M				Lunden, Karl; Danielsson, Marie; Durling, Mikael Brandstrom; Ihrmark, Katarina; Gorriz, Miguel Nemesio; Stenlid, Jan; Asiegbu, Frederick O.; Elfstrand, Malin			Transcriptional Responses Associated with Virulence and Defence in the Interaction between Heterobasidion annosum s. s. and Norway Spruce	PLOS ONE			English	Article							GENE-EXPRESSION; BETA-GLUCOSIDASE; ACID DESATURASE; PICEA-ABIES; DROUGHT; STRESS; IDENTIFICATION; DEHYDRINS; BARK; PINE	Heterobasidion annosum sensu lato is a serious pathogen causing root and stem rot to conifers in the northern hemisphere and rendering the timber defective for sawing and pulping. In this study we applied next-generation sequencing to i) identify transcriptional responses unique to Heterobasidion-inoculated Norway spruce and ii) investigate the H. annosum transcripts to identify putative virulence factors. To address these objectives we wounded or inoculated 30-year-old Norway spruce clones with H. annosumand 454-sequenced the transcriptome of the interaction at 0, 5 and 15 days post inoculation. The 491860 high-quality reads were de novo assembled and the relative expression was analysed. Overall, very few H. annosum transcripts were represented in our dataset. Three delta-12 fatty acid desaturase transcripts and one Clavaminate synthase-like transcript, both associated with virulence in other pathosystems, were found among the significantly induced transcripts. The analysis of the Norway spruce transcriptional responses produced a handful of differentially expressed transcripts. Most of these transcripts originated from genes known to respond to H. annosum. However, three genes that had not previously been reported to respond to H. annosum showed specific induction to inoculation: an oxophytodienoic acid-reductase (OPR), a beta-glucosidaseand a germin-like protein (GLP2) gene. Even in a small data set like ours, five novel highly expressed Norway spruce transcripts without significant alignment to any previously annotated protein in Genbank but present in the P. abies (v1.0) gene catalogue were identified. Their expression pattern suggests a role in defence. Therefore a more complete survey of the transcriptional responses in the interactions between Norway spruce and its major pathogen H. annosumwould probably provide a better understanding of gymnosperm defence than accumulated until now.	[Lunden, Karl; Durling, Mikael Brandstrom; Ihrmark, Katarina; Gorriz, Miguel Nemesio; Stenlid, Jan; Elfstrand, Malin] Swedish Univ Agr Sci, Uppsala Bioctr, Dept Forest Mycol & Plant Pathol, Uppsala, Sweden; [Danielsson, Marie] KTH Royal Inst Technol, Sch Chem Sci & Engn, Chem, Stockholm, Sweden; [Asiegbu, Frederick O.] Univ Helsinki, Dept Forest Sci, Helsinki, Finland	Swedish University of Agricultural Sciences; Royal Institute of Technology; University of Helsinki	Elfstrand, M (corresponding author), Swedish Univ Agr Sci, Uppsala Bioctr, Dept Forest Mycol & Plant Pathol, Uppsala, Sweden.	Malin.Elfstrand@slu.se	Gorriz, Miguel Nemesio/S-6139-2019; Brandström Durling, Mikael/C-1213-2008; Stenlid, Jan/K-5909-2019	Gorriz, Miguel Nemesio/0000-0001-8052-8101; Brandström Durling, Mikael/0000-0001-6485-197X; Asiegbu, Fred O/0000-0003-0223-7194; Lunden, Karl/0000-0002-0817-2419; Stenlid, Jan/0000-0002-5344-2094; Elfstrand, Malin/0000-0002-0214-5284	Swedish Research council Formas [brg0312st2]; Swedish Foundation for Strategic Research (SSF) [R8b08-0011]	Swedish Research council Formas(Swedish Research CouncilSwedish Research Council Formas); Swedish Foundation for Strategic Research (SSF)(Swedish Foundation for Strategic Research)	Financial support was received from the Swedish Research council Formas, grant brg0312st2 (http://www.formas.se/en/), and from the Swedish Foundation for Strategic Research (SSF), grant number R8b08-0011 (www.stratresearch.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adomas A, 2006, PHYSIOL MOL PLANT P, V69, P140, DOI 10.1016/j.pmpp.2007.04.001; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Arnerup J, 2013, PLANTA, V237, P1037, DOI 10.1007/s00425-012-1822-8; Bendz-Hellgren M, 1998, HETEROBASIDION ANNOSUM: BIOLOGY, ECOLOGY, IMPACT AND CONTROL, P333; Bottcher C, 2009, FEBS J, V276, P4693, DOI 10.1111/j.1742-4658.2009.07195.x; Bourgon R, 2010, P NATL ACAD SCI USA, V107, P9546, DOI 10.1073/pnas.0914005107; Calvo AM, 2001, J BIOL CHEM, V276, P25766, DOI 10.1074/jbc.M100732200; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dalman K, 2010, MOL ECOL, V19, P4979, DOI 10.1111/j.1365-294X.2010.04873.x; Damude HG, 2006, P NATL ACAD SCI USA, V103, P9446, DOI 10.1073/pnas.0511079103; Danielsson M, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-154; Deflorio G, 2011, PHYSIOL MOL PLANT P, V75, P180, DOI 10.1016/j.pmpp.2011.02.002; DHARMAWARDHANA DP, 1995, PLANT PHYSIOL, V107, P331, DOI 10.1104/pp.107.2.331; Eldhuset TD, 2013, PLANT SOIL, V366, P305, DOI 10.1007/s11104-012-1432-z; Fossdal CG, 2007, PHYSIOL MOL PLANT P, V70, P161, DOI 10.1016/j.pmpp.2007.09.002; Fossdal CG, 2012, TREE PHYSIOL, V32, P1137, DOI 10.1093/treephys/tps073; Franceschi VR, 2005, NEW PHYTOL, V167, P353, DOI 10.1111/j.1469-8137.2005.01436.x; Haas BJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-734; Hanin M, 2011, PLANT SIGNAL BEHAV, V6, P1503, DOI 10.4161/psb.6.10.17088; Hietala AM, 2004, APPL ENVIRON MICROB, V70, P3948, DOI 10.1128/AEM.70.7.3948-3953.2004; Huang YS, 1999, LIPIDS, V34, P649, DOI 10.1007/s11745-999-0410-8; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; Johnk N, 2005, TREE PHYSIOL, V25, P1533, DOI 10.1093/treephys/25.12.1533; Karlsson B., 1998, Forest Genetics, V5, P21; Karlsson M, 2003, FUNGAL GENET BIOL, V39, P51, DOI 10.1016/S1087-1845(02)00586-8; Koutaniemi S, 2007, PLANT MOL BIOL, V65, P311, DOI 10.1007/s11103-007-9220-5; Kumar S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-571; Marjamaa K, 2003, TREE PHYSIOL, V23, P977, DOI 10.1093/treephys/23.14.977; Minto RE, 2009, APPL ENVIRON MICROB, V75, P1156, DOI 10.1128/AEM.02049-08; Niemela T, 1998, HETEROBASIDION ANNOSUM: BIOLOGY, ECOLOGY, IMPACT AND CONTROL, P27; Nystedt B, 2013, NATURE, V497, P579, DOI 10.1038/nature12211; Olson A, 2012, NEW PHYTOL, V194, P1001, DOI 10.1111/j.1469-8137.2012.04128.x; Otrosina WJ, 2010, FUNGAL BIOL-UK, V114, P16, DOI 10.1016/j.mycres.2009.09.001; Palovaara J, 2008, PLANT MOL BIOL, V66, P533, DOI 10.1007/s11103-008-9289-5; PARADKAR AS, 1995, J BACTERIOL, V177, P1307, DOI 10.1128/jb.177.5.1307-1314.1995; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Raacke IC, 2006, J PHYTOPATHOL, V154, P740, DOI 10.1111/j.1439-0434.2006.01191.x; Ralph SG, 2007, PHYTOCHEMISTRY, V68, P1975, DOI 10.1016/j.phytochem.2007.04.042; Richard S, 2000, PLANT MOL BIOL, V43, P1, DOI 10.1023/A:1006453811911; Sakuradani E, 1999, EUR J BIOCHEM, V261, P812, DOI 10.1046/j.1432-1327.1999.00333.x; STENLID J, 1991, MYCOL RES, V95, P1153, DOI 10.1016/S0953-7562(09)80004-X; Stintzi A, 2001, P NATL ACAD SCI USA, V98, P12837, DOI 10.1073/pnas.211311098; Swedjemark G, 1999, EUR J FOREST PATHOL, V29, P249; Urano D, 2014, ANNU REV PLANT BIOL, V65, P365, DOI 10.1146/annurev-arplant-050213-040133; Velasco-Conde T, 2012, TREE GENET GENOMES, V8, P957, DOI 10.1007/s11295-012-0476-9; Vestman D, 2011, TREE GENET GENOMES, V7, P347, DOI 10.1007/s11295-010-0336-4; Wilson RA, 2004, MICROBIOL-SGM, V150, P2881, DOI 10.1099/mic.0.27207-0; Yakovlev IA, 2008, PLANTA, V228, P459, DOI 10.1007/s00425-008-0750-0; Yaqoob N, 2012, PHYSIOL MOL PLANT P, V77, P10, DOI 10.1016/j.pmpp.2011.11.001; Zhang S, 2007, FEBS LETT, V581, P315, DOI 10.1016/j.febslet.2006.12.031; Zhang ZH, 2000, NAT STRUCT BIOL, V7, P127	53	20	20	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2015	10	7							e0131182	10.1371/journal.pone.0131182	http://dx.doi.org/10.1371/journal.pone.0131182			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EC	26151363	Green Published, Green Submitted, gold			2022-12-26	WOS:000358158900019
J	Dietrich, S; Hertrich, I; Ackermann, H				Dietrich, Susanne; Hertrich, Ingo; Ackermann, Hermann			Network Modeling for Functional Magnetic Resonance Imaging (fMRI) Signals during Ultra-Fast Speech Comprehension in Late-Blind Listeners	PLOS ONE			English	Article							PRIMARY VISUAL-CORTEX; MACAQUE MONKEY; INFERIOR PULVINAR; MULTISENSORY CONVERGENCE; CORTICAL PROJECTIONS; ACTIVATION PATTERNS; SUPERIOR COLLICULUS; FUSIFORM GYRUS; RHESUS-MONKEY; AREA 17	In many functional magnetic resonance imaging (fMRI) studies blind humans were found to show cross-modal reorganization engaging the visual system in non-visual tasks. For example, blind people can manage to understand (synthetic) spoken language at very high speaking rates up to ca. 20 syllables/s (syl/s). FMRI data showed that hemodynamic activation within right-hemispheric primary visual cortex (V1), bilateral pulvinar (Pv), and left-hemispheric supplementary motor area (pre-SMA) covaried with their capability of ultra-fast speech (16 syllables/s) comprehension. It has been suggested that right V1 plays an important role with respect to the perception of ultra-fast speech features, particularly the detection of syllable onsets. Furthermore, left pre-SMA seems to be an interface between these syllabic representations and the frontal speech processing and working memory network. So far, little is known about the networks linking V1 to Pv, auditory cortex (A1), and (mesio-) frontal areas. Dynamic causal modeling (DCM) was applied to investigate (i) the input structure from A1 and Pv toward right V1 and (ii) output from right V1 and A1 to left pre-SMA. As concerns the input Pv was significantly connected to V1, in addition to A1, in blind participants, but not in sighted controls. Regarding the output V1 was significantly connected to pre-SMA in blind individuals, and the strength of V1-SMA connectivity correlated with the performance of ultra-fast speech comprehension. By contrast, in sighted controls, not understanding ultra-fast speech, pre-SMA did neither receive input from A1 nor V1. Taken together, right V1 might facilitate the "parsing" of the ultra-fast speech stream in blind subjects by receiving subcortical auditory input via the Pv (= secondary visual pathway) and transmitting this information toward contralateral pre-SMA.	[Dietrich, Susanne; Hertrich, Ingo; Ackermann, Hermann] Univ Tubingen, Dept Gen Neurol, Hertie Inst Clin Brain Res, Ctr Neurol, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Dietrich, S (corresponding author), Univ Tubingen, Dept Gen Neurol, Hertie Inst Clin Brain Res, Ctr Neurol, Hoppe Seyler Str 3, D-72076 Tubingen, Germany.	susanne.dietrich@med.uni-tuebingen.de	Hertrich, Ingo/T-1154-2018	Hertrich, Ingo/0000-0001-8965-6249	German Research Foundation (DFG) [AC 55 9/01, HE 1573/4-1, HE 1573/6-2]; Hertie Institute for Clinical Brain Research, Tubingen	German Research Foundation (DFG)(German Research Foundation (DFG)); Hertie Institute for Clinical Brain Research, Tubingen	This study was supported by the German Research Foundation (DFG; AC 55 9/01, HE 1573/4-1, HE 1573/6-2) and Hertie Institute for Clinical Brain Research, Tubingen.	Abler B, 2006, MAGN RESON IMAGING, V24, P181, DOI 10.1016/j.mri.2005.10.022; Adams MM, 2000, J COMP NEUROL, V419, P377, DOI 10.1002/(SICI)1096-9861(20000410)419:3<377::AID-CNE9>3.0.CO;2-E; Amedi A, 2003, NAT NEUROSCI, V6, P758, DOI 10.1038/nn1072; Bar M, 2006, PSYCHOL SCI, V17, P645, DOI 10.1111/j.1467-9280.2006.01759.x; Bedny M, 2012, BRAIN LANG, V122, P162, DOI 10.1016/j.bandl.2011.10.005; Bedny M, 2011, P NATL ACAD SCI USA, V108, P4429, DOI 10.1073/pnas.1014818108; Bell AH, 2005, J NEUROPHYSIOL, V93, P3659, DOI 10.1152/jn.01214.2004; BENDER DB, 1988, PROG BRAIN RES, V75, P55; BENDER DB, 1981, J NEUROPHYSIOL, V46, P672, DOI 10.1152/jn.1981.46.3.672; BENEVENTO LA, 1976, BRAIN RES, V108, P1, DOI 10.1016/0006-8993(76)90160-8; Berman RA, 2011, J NEUROSCI, V31, P373, DOI 10.1523/JNEUROSCI.4738-10.2011; Berman RA, 2008, PROG BRAIN RES, V171, P467, DOI 10.1016/S0079-6123(08)00668-7; Bernstein L. E., 2004, HDB MULTISENSORY PRO, P203; Bolognini N, 2010, NEUROSCI LETT, V477, P109, DOI 10.1016/j.neulet.2010.04.044; Buchel C, 1998, BRAIN, V121, P409, DOI 10.1093/brain/121.3.409; Burr D, 2006, PROG BRAIN RES, V155, P243, DOI 10.1016/S0079-6123(06)55014-9; Burton H, 2006, HUM BRAIN MAPP, V27, P325, DOI 10.1002/hbm.20188; Clos M, 2014, HUM BRAIN MAPP, V35, P61, DOI 10.1002/hbm.22151; DIAMOND IT, 1969, SCIENCE, V164, P251, DOI 10.1126/science.164.3877.251; Dietrich S, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00701; Dietrich S, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-74; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Foxe JJ, 2005, NEUROREPORT, V16, P419, DOI 10.1097/00001756-200504040-00001; Friederici AD, 2004, BRAIN LANG, V89, P267, DOI 10.1016/S0093-934X(03)00351-1; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Gizewski ER, 2003, NEUROIMAGE, V19, P968, DOI 10.1016/S1053-8119(03)00114-9; Gray D, 1999, J COMP NEUROL, V409, P452, DOI 10.1002/(SICI)1096-9861(19990705)409:3<452::AID-CNE9>3.0.CO;2-I; Hertrich I, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00530; Hertrich I, 2013, BRAIN LANG, V124, P9, DOI 10.1016/j.bandl.2012.10.006; Hertrich I, 2009, NEUROCASE, V15, P163, DOI 10.1080/13554790802709054; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Kaas JH, 2007, BRAIN RES REV, V55, P285, DOI 10.1016/j.brainresrev.2007.02.008; Klinge C, 2010, J NEUROSCI, V30, P12798, DOI 10.1523/JNEUROSCI.2384-10.2010; Kotz SA, 2010, TRENDS COGN SCI, V14, P392, DOI 10.1016/j.tics.2010.06.005; Kotz SAE, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00086; Krumbholz K, 2000, J ACOUST SOC AM, V108, P1170, DOI 10.1121/1.1287843; Lambert S, 2004, COGNITIVE BRAIN RES, V20, P1; Leh SE, 2008, INT J BIOMED IMAGING, V2008, DOI 10.1155/2008/789539; Leo F, 2008, BRAIN, V131, P855, DOI 10.1093/brain/awn003; LEVITT JB, 1995, EXP BRAIN RES, V104, P419; LUND JS, 1975, J COMP NEUROL, V164, P287, DOI 10.1002/cne.901640303; Maleki N, 2012, HUM BRAIN MAPP, V33, P75, DOI 10.1002/hbm.21194; Martin E, 2002, MRI OF THE NEONATAL; OGREN MP, 1977, BRAIN RES, V137, P343, DOI 10.1016/0006-8993(77)90344-4; Penny WD, 2004, NEUROIMAGE, V22, P1157, DOI 10.1016/j.neuroimage.2004.03.026; Penny WD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000709; Pessoa L, 2010, NAT REV NEUROSCI, V11, P773, DOI 10.1038/nrn2920; PETERSEN SE, 1985, J NEUROPHYSIOL, V54, P867, DOI 10.1152/jn.1985.54.4.867; Poeppel D, 2003, SPEECH COMMUN, V41, P245, DOI 10.1016/S0167-6393(02)00107-3; Poirier C, 2006, NEUROIMAGE, V31, P279, DOI 10.1016/j.neuroimage.2005.11.036; Raz N, 2005, CEREB CORTEX, V15, P1459, DOI 10.1093/cercor/bhi026; REZAK M, 1979, BRAIN RES, V167, P19, DOI 10.1016/0006-8993(79)90260-9; ROBINSON DL, 1993, PROG BRAIN RES, V95, P371, DOI 10.1016/S0079-6123(08)60382-9; Roder B, 2002, EUR J NEUROSCI, V16, P930, DOI 10.1046/j.1460-9568.2002.02147.x; Rosa MJ, 2010, NEUROIMAGE, V49, P217, DOI 10.1016/j.neuroimage.2009.08.051; Saalmann YB, 2012, SCIENCE, V337, P753, DOI 10.1126/science.1223082; Sadato N, 2005, NEUROSCIENTIST, V11, P577, DOI 10.1177/1073858405277314; Schroeder CE, 2003, INT J PSYCHOPHYSIOL, V50, P5, DOI 10.1016/S0167-8760(03)00120-X; Schroeder CE, 2005, CURR OPIN NEUROBIOL, V15, P454, DOI 10.1016/j.conb.2005.06.008; Schwartze M, 2012, INT J PSYCHOPHYSIOL, V83, P200, DOI 10.1016/j.ijpsycho.2011.11.003; Shipp S, 2004, TRENDS COGN SCI, V8, P223, DOI 10.1016/j.tics.2004.03.004; Stephan KE, 2010, NEUROIMAGE, V49, P3099, DOI 10.1016/j.neuroimage.2009.11.015; Stephan KE, 2009, NEUROIMAGE, V46, P1004, DOI 10.1016/j.neuroimage.2009.03.025; Wong M, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00052	64	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132196	10.1371/journal.pone.0132196	http://dx.doi.org/10.1371/journal.pone.0132196			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148062	Green Submitted, gold, Green Published			2022-12-26	WOS:000358157600217
J	Kis, V; Barti, B; Lippai, M; Sass, M				Kis, Viktor; Barti, Benjamin; Lippai, Monika; Sass, Miklos			Specialized Cortex Glial Cells Accumulate Lipid Droplets in Drosophila melanogaster	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; MICE LACKING; STORAGE; GENES; FABP7; NEURODEGENERATION; LOCALIZATION; ORGANIZATION; HOMEOSTASIS; METABOLISM	Lipid droplets (LDs) are common organelles of the majority of eukaryotic cell types. Their biological significance has been extensively studied in mammalian liver cells and white adipose tissue. Although the central nervous system contains the highest relative amount and the largest number of different lipid species, neither the spatial nor the temporal distribution of LDs has been described. In this study, we used the brain of the fruitfly, Drosophila melanogaster, to investigate the neuroanatomy of LDs. We demonstrated that LDs are exclusively localised in glial cells but not in neurons in the larval nervous system. We showed that the brain's LD pool, rather than being constant, changes dynamically during development and reaches its highest value at the beginning of metamorphosis. LDs are particularly enriched in cortex glial cells located close to the brain surface. These specialized superficial cortex glial cells contain the highest amount of LDs among glial cell types and encapsulate neuroblasts and their daughter cells. Superficial cortex glial cells, combined with subperineurial glial cells, express the Drosophila fatty acid binding protein (Dfabp), as we have demonstrated through light-and electron microscopic immunocytochemistry. To the best of our best knowledge this is the first study that describes LD neuroanatomy in the Drosophila larval brain.	[Kis, Viktor; Barti, Benjamin; Lippai, Monika; Sass, Miklos] Eotvos Lorand Univ, Dept Anat Cell & Dev Biol, Budapest, Hungary	Eotvos Lorand University	Kis, V (corresponding author), Eotvos Lorand Univ, Dept Anat Cell & Dev Biol, Budapest, Hungary.	kis.viktor@gmail.com	Lippai, Monika/J-3740-2018	Lippai, Monika/0000-0002-7307-4233; Barti, Benjamin/0000-0002-1669-2246	Hungarian Scientific Research Funds [NK78012]; European Union; European Social Fund [TAMOP 4.2.1./B-09/KMR-2010-0003]	Hungarian Scientific Research Funds(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); European Union(European Commission); European Social Fund(European Social Fund (ESF))	This work was supported by grants from the Hungarian Scientific Research Funds provided to M. Sass (NK78012). The European Union and the European Social Fund have provided financial support to this project under grant agreement no. TAMOP 4.2.1./B-09/KMR-2010-0003 (http://www.otka.hu/en http://palyazat.gov.hu/doc/5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altenhein B, 2006, DEV BIOL, V296, P545, DOI 10.1016/j.ydbio.2006.04.460; ASHWORTH CT, 1960, AM J PHYSIOL, V198, P1326, DOI 10.1152/ajplegacy.1960.198.6.1326; Awasaki T, 2008, J NEUROSCI, V28, P13742, DOI 10.1523/JNEUROSCI.4844-08.2008; Barba G, 1997, P NATL ACAD SCI USA, V94, P1200, DOI 10.1073/pnas.94.4.1200; Beller M, 2006, MOL CELL PROTEOMICS, V5, P1082, DOI 10.1074/mcp.M600011-MCP200; Boone JQ, 2008, DEV NEUROBIOL, V68, P1185, DOI 10.1002/dneu.20648; CARLSON SD, 1990, ANNU REV ENTOMOL, V35, P597, DOI 10.1146/annurev.en.35.010190.003121; Cermelli S, 2006, CURR BIOL, V16, P1783, DOI 10.1016/j.cub.2006.07.062; Chang YY, 2010, FEBS LETT, V584, P1342, DOI 10.1016/j.febslet.2010.01.006; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; D'Alessandro Rosalba, 2010, Commun Integr Biol, V3, P576, DOI 10.4161/cib.3.6.13093; Dubois L, 2001, CELL, V105, P613, DOI 10.1016/S0092-8674(01)00375-0; Duffy JB, 2002, GENESIS, V34, P1, DOI 10.1002/gene.10150; Egger B, 2002, DEVELOPMENT, V129, P3295; Farese RV, 2009, CELL, V139, P855, DOI 10.1016/j.cell.2009.11.005; FENG L, 1995, DEVELOPMENT, V121, P1719; Freeman MR, 2003, NEURON, V38, P567, DOI 10.1016/S0896-6273(03)00289-7; Gerstner JR, 2012, J NEUROSCI, V32, P1383, DOI 10.1523/JNEUROSCI.3228-11.2012; Greenberg AS, 2012, J CLIN INVEST, P121; Gronke S, 2003, CURR BIOL, V13, P603, DOI 10.1016/S0960-9822(03)00175-1; GUYTON JR, 1989, AM J PATHOL, V134, P705; Kearney JB, 2004, DEV BIOL, V275, P473, DOI 10.1016/j.ydbio.2004.08.047; KEITH AD, 1967, COMP BIOCHEM PHYSIOL, V21, P587, DOI 10.1016/0010-406X(67)90455-0; Kretzschmar D, 2002, BRAIN RES BULL, V57, P121, DOI 10.1016/S0361-9230(01)00643-8; Kretzschmar Doris, 2005, Invertebrate Neuroscience, V5, P97, DOI 10.1007/s10158-005-0005-8; Kunte AS, 2006, CELL METAB, V3, P439, DOI 10.1016/j.cmet.2006.04.011; Kurat CF, 2009, MOL CELL, V33, P53, DOI 10.1016/j.molcel.2008.12.019; LANG PD, 1970, J CLIN INVEST, V49, P1479, DOI 10.1172/JCI106365; Liu L, 2015, CELL, V160, P177, DOI 10.1016/j.cell.2014.12.019; Liu RZ, 2010, INT J DEV BIOL, V54, P1229, DOI 10.1387/ijdb.092976rl; Matsumata M, 2012, STEM CELLS, V30, P1532, DOI 10.1002/stem.1124; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Morin X, 2001, P NATL ACAD SCI USA, V98, P15050, DOI 10.1073/pnas.261408198; Muhlig-Versen M, 2005, J NEUROSCI, V25, P2865, DOI 10.1523/JNEUROSCI.5097-04.2005; Navarro JA, 2010, HUM MOL GENET, V19, P2828, DOI 10.1093/hmg/ddq183; Ohsaki Y, 2006, MOL BIOL CELL, V17, P2674, DOI 10.1091/mbc.E05-07-0659; Owada Y, 2006, EUR J NEUROSCI, V24, P175, DOI 10.1111/j.1460-9568.2006.04855.x; Palm W, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002828; Pereanu W, 2005, DEV BIOL, V283, P191, DOI 10.1016/j.ydbio.2005.04.024; Pfenninger KH, 2009, NAT REV NEUROSCI, V10, P251, DOI 10.1038/nrn2593; Reddy JK, 2006, AM J PHYSIOL-GASTR L, V290, pG852, DOI 10.1152/ajpgi.00521.2005; Sandoval H, 2015, ELIFE; Schaap FG, 1999, CIRC RES, V85, P329, DOI 10.1161/01.RES.85.4.329; Siegrist SE, 2010, CURR BIOL, V20, P643, DOI 10.1016/j.cub.2010.01.060; Sousa-Nunes R, 2010, CURR OPIN NEUROBIOL, V20, P50, DOI 10.1016/j.conb.2009.12.005; Stork T, 2008, J NEUROSCI, V28, P587, DOI 10.1523/JNEUROSCI.4367-07.2008; Tauchi-Sato K, 2002, J BIOL CHEM, V277, P44507, DOI 10.1074/jbc.M207712200; Thiele C, 2008, CURR OPIN CELL BIOL, V20, P378, DOI 10.1016/j.ceb.2008.05.009; Tschape JA, 2002, EMBO J, V21, P6367, DOI 10.1093/emboj/cdf636; Unhavaithaya Y, 2012, GENE DEV, V26, P31, DOI 10.1101/gad.177436.111; WAKE K, 1974, J CELL BIOL, V63, P683, DOI 10.1083/jcb.63.2.683; Watanabe A, 2007, PLOS BIOL, V5, P2469, DOI 10.1371/journal.pbio.0050297; Welte MA, 2005, CURR BIOL, V15, P1266, DOI 10.1016/j.cub.2005.06.062; XIONG WC, 1994, GENE DEV, V8, P981, DOI 10.1101/gad.8.8.981; YANG SY, 1987, J BIOL CHEM, V262, P13027; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	56	30	30	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131250	10.1371/journal.pone.0131250	http://dx.doi.org/10.1371/journal.pone.0131250			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148013	Green Published, Green Submitted, gold			2022-12-26	WOS:000358157600074
J	Liu, HL; Osmani, AH; Osmani, SA				Liu, Hui-Lin; Osmani, Aysha H.; Osmani, Stephen A.			The Inner Nuclear Membrane Protein Src1 Is Required for Stable Post-Mitotic Progression into G1 in Aspergillus nidulans	PLOS ONE			English	Article							PORE-COMPLEX; ENVELOPE FORMATION; CELL-CYCLE; SCHIZOSACCHAROMYCES-JAPONICUS; CAENORHABDITIS-ELEGANS; ENDOPLASMIC-RETICULUM; CLOSED MITOSIS; CDC14 RELEASE; IN-VIVO; CHROMATIN	How membranes and associated proteins of the nuclear envelope (NE) are assembled specifically and inclusively around segregated genomes during exit from mitosis is incompletely understood. Inner nuclear membrane (INM) proteins play key roles by providing links between DNA and the NE. In this study we have investigated the highly conserved INM protein Src1 in Aspergillus nidulans and have uncovered a novel cell cycle response during post mitotic formation of G1 nuclei. Live cell imaging indicates Src1 could have roles during mitotic exit as it preferentially locates to the NE abscission points during nucleokinesis and to the NE surrounding forming daughter G1 nuclei. Deletion analysis further supported this idea revealing that although Src1 is not required for interphase progression or mitosis it is required for stable post-mitotic G1 nuclear formation. This conclusion is based upon the observation that in the absence of Src1 newly formed G1 nuclei are structurally unstable and immediately undergo architectural modifications typical of mitosis. These changes include NPC modifications that stop nuclear transport as well as disassembly of nucleoli. More intriguingly, the newly generated G1 nuclei then cycle between mitotic-and interphase- like states. The findings indicate that defects in post-mitotic G1 nuclear formation caused by lack of Src1 promote repeated failed attempts to generate stable G1 nuclei. To explain this unexpected phenotype we suggest a type of regulation that promotes repetition of defective cell cycle transitions rather than preventing progression past the defective cell cycle transition. We suggest the term "reboot regulation" to define this mode of cell cycle regulation. The findings are discussed in relationship to recent studies showing the Cdk1 master oscillator can entrain subservient oscillators that when uncoupled cause cell cycle transitions to be repeated.	[Liu, Hui-Lin; Osmani, Aysha H.; Osmani, Stephen A.] Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Osmani, SA (corresponding author), Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA.	osmani.2@osu.edu	Osmani, Stephen A./AAS-3904-2021		National Institutes of Health [GM042564]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042564] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health (GM042564) to SAO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405; Anderson DJ, 2008, J CELL BIOL, V182, P911, DOI 10.1083/jcb.200805140; Anderson DJ, 2007, NAT CELL BIOL, V9, P1160, DOI 10.1038/ncb1636; Anderson DJ, 2009, J CELL BIOL, V186, P183, DOI 10.1083/jcb.200901106; Antonin W, 2005, MOL CELL, V17, P83, DOI 10.1016/j.molcel.2004.12.010; Antonin W, 2008, FEBS LETT, V582, P2004, DOI 10.1016/j.febslet.2008.02.067; Aoki K, 2011, GENES CELLS, V16, P911, DOI 10.1111/j.1365-2443.2011.01540.x; Bapteste E, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r85; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Brachner A, 2011, BIOCHEM SOC T, V39, P1735, DOI 10.1042/BST20110724; De Souza CP, 2011, EMBO J, V30, P2648, DOI 10.1038/emboj.2011.176; De Souza CP, 2009, TRENDS GENET, V25, P545, DOI 10.1016/j.tig.2009.10.005; De Souza CPC, 2007, EUKARYOT CELL, V6, P1521, DOI 10.1128/EC.00178-07; De Souza CPC, 2004, CURR BIOL, V14, P1973, DOI 10.1016/j.cub.2004.10.050; FIDDY C, 1976, J GEN MICROBIOL, V97, P169, DOI 10.1099/00221287-97-2-169; Field MC, 2014, TRAFFIC, V15, P141, DOI 10.1111/tra.12141; Gonzalez Y, 2012, NUCLEUS-PHILA, V3, P60, DOI 10.4161/nucl.18824; Grund SE, 2008, J CELL BIOL, V182, P897, DOI 10.1083/jcb.200803098; Harel A, 2003, MOL CELL, V11, P853, DOI 10.1016/S1097-2765(03)00116-3; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; Hetzer MW, 2005, ANNU REV CELL DEV BI, V21, P347, DOI 10.1146/annurev.cellbio.21.090704.151152; Ibarra A, 2015, GENE DEV, V29, P337, DOI 10.1101/gad.256495.114; Ikegami K, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r120; King MC, 2006, NATURE, V442, P1003, DOI 10.1038/nature05075; Lampson MA, 2011, TRENDS CELL BIOL, V21, P133, DOI 10.1016/j.tcb.2010.10.007; Liu HL, 2009, MOL BIOL CELL, V20, P616, DOI 10.1091/mbc.E08-06-0628; Liu J, 2003, P NATL ACAD SCI USA, V100, P4598, DOI 10.1073/pnas.0730821100; Lu L, 2011, J CELL BIOL, V194, P425, DOI 10.1083/jcb.201012063; Lu Y, 2010, CELL, V141, P268, DOI 10.1016/j.cell.2010.03.021; Mans BJ, 2004, CELL CYCLE, V3, P1612; Manzoni R, 2010, J CELL BIOL, V190, P209, DOI 10.1083/jcb.201002026; Markossian S, 2015, MOL BIOL CELL, V26, P605, DOI 10.1091/mbc.E14-09-1359; Mekhail K, 2008, NATURE, V456, P667, DOI 10.1038/nature07460; OCONNELL MJ, 1992, EMBO J, V11, P2139, DOI 10.1002/j.1460-2075.1992.tb05273.x; Oikonomou C, 2010, CURR OPIN GENET DEV, V20, P605, DOI 10.1016/j.gde.2010.08.006; Osmani AH, 2006, NAT PROTOC, V1, P2517, DOI 10.1038/nprot.2006.406; Osmani AH, 2006, MOL BIOL CELL, V17, P4946, DOI 10.1091/mbc.E06-07-0657; OSMANI SA, 1987, J CELL BIOL, V104, P1495, DOI 10.1083/jcb.104.6.1495; Rasala BA, 2008, MOL BIOL CELL, V19, P3982, DOI 10.1091/mbc.E08-01-0012; Rodriguez-Navarro S, 2002, YEAST, V19, P43, DOI 10.1002/yea.803; Rotem A, 2009, MOL BIOL CELL, V20, P4031, DOI 10.1091/mbc.E09-02-0150; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Sazer S, 2014, CURR BIOL, V24, pR1099, DOI 10.1016/j.cub.2014.10.011; Smoyer CJ, 2014, CURR OPIN CELL BIOL, V26, P1, DOI 10.1016/j.ceb.2013.08.002; Steglich B, 2012, NUCLEUS-PHILA, V3, P77, DOI 10.4161/nucl.18825; Suelmann R, 1997, MOL MICROBIOL, V25, P757, DOI 10.1046/j.1365-2958.1997.5131873.x; Taddei A, 2004, ANNU REV GENET, V38, P305, DOI 10.1146/annurev.genet.37.110801.142705; Ukil L, 2009, MOL BIOL CELL, V20, P2132, DOI 10.1091/mbc.E08-10-1046; Ulbert S, 2006, FEBS LETT, V580, P6435, DOI 10.1016/j.febslet.2006.10.060; Ulbert S, 2006, J CELL BIOL, V173, P469, DOI 10.1083/jcb.200512078; Walther TC, 2003, CELL, V113, P195, DOI 10.1016/S0092-8674(03)00235-6; Webster M, 2009, J CELL SCI, V122, P1477, DOI 10.1242/jcs.037333; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5; Yam C, 2013, CURR BIOL, V23, P2303, DOI 10.1016/j.cub.2013.09.057; Yam C, 2011, CURR BIOL, V21, P1314, DOI 10.1016/j.cub.2011.06.052; Yewdell WT, 2011, MOL BIOL CELL, V22, P1375, DOI 10.1091/mbc.E10-06-0554	56	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132489	10.1371/journal.pone.0132489	http://dx.doi.org/10.1371/journal.pone.0132489			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147902	Green Published, Green Submitted, gold			2022-12-26	WOS:000358157600286
J	Zhang, SX; Wu, SH; Chen, YY; Tian, WM				Zhang, Shi-Xin; Wu, Shao-Hua; Chen, Yue-Yi; Tian, Wei-Min			Analysis of Differentially Expressed Genes Associated with Coronatine-Induced Laticifer Differentiation in the Rubber Tree by Subtractive Hybridization Suppression	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASES; BRASILIENSIS MUELL. ARG.; EXOGENOUS JASMONIC ACID; HEVEA-BRASILIENSIS; METHYL JASMONATE; ARABIDOPSIS-THALIANA; CALCIUM; STRESS; METALLOTHIONEIN; RESPONSES	The secondary laticifer in the secondary phloem is differentiated from the vascular cambia of the rubber tree (Hevea brasiliensis Muell. Arg.). The number of secondary laticifers is closely related to the rubber yield potential of Hevea. Pharmacological data show that jasmonic acid and its precursor linolenic acid are effective in inducing secondary laticifer differentiation in epicormic shoots of the rubber tree. In the present study, an experimental system of coronatine-induced laticifer differentiation was developed to perform SSH identification of genes with differential expression. A total of 528 positive clones were obtained by blue-white screening, of which 248 clones came from the forward SSH library while 280 clones came from the reverse SSH library. Approximately 215 of the 248 clones and 171 of the 280 clones contained cDNA inserts by colony PCR screening. A total of 286 of the 386 ESTs were detected to be differentially expressed by reverse northern blot and sequenced. Approximately 147 unigenes with an average length of 497 bp from the forward and 109 unigenes with an average length of 514 bp from the reverse SSH libraries were assembled and annotated. The unigenes were associated with the stress/defense response, plant hormone signal transduction and structure development. It is suggested that Ca2+ signal transduction and redox seem to be involved in differentiation, while PGA and EIF are associated with the division of cambium initials for COR-induced secondary laticifer differentiation in the rubber tree.	[Zhang, Shi-Xin] Hainan Univ, Coll Hort, Haikou 570228, Hainan, Peoples R China; [Zhang, Shi-Xin; Wu, Shao-Hua; Chen, Yue-Yi; Tian, Wei-Min] CATAS, Key Lab Biol & Genet Resources Rubber Tree, State Key Lab Incubat Base Cultivat & Physiol Tro, Minist Agr,Crops Rubber Res Inst, Danzhou 571737, Hainan, Peoples R China	Hainan University; Chinese Academy of Tropical Agricultural Sciences; Ministry of Agriculture & Rural Affairs	Tian, WM (corresponding author), CATAS, Key Lab Biol & Genet Resources Rubber Tree, State Key Lab Incubat Base Cultivat & Physiol Tro, Minist Agr,Crops Rubber Res Inst, Danzhou 571737, Hainan, Peoples R China.	wmtian@163.com			Open Foundation of Key Laboratory of Rubber Biology and Genetic Resources of Rubber Tree, Ministry of Agriculture, China [KLOF0906]; Special Program for Key Basic Research of Ministry of Science and Technology, China [2012CB723005]; Earmarked Fund for China Agriculture Research System [CARS-34-GW1]	Open Foundation of Key Laboratory of Rubber Biology and Genetic Resources of Rubber Tree, Ministry of Agriculture, China; Special Program for Key Basic Research of Ministry of Science and Technology, China; Earmarked Fund for China Agriculture Research System	This work was supported by the Open Foundation of Key Laboratory of Rubber Biology and Genetic Resources of Rubber Tree, Ministry of Agriculture, China (KLOF0906), the Special Program for Key Basic Research of the Ministry of Science and Technology, China (2012CB723005) and the Earmarked Fund for China Agriculture Research System (CARS-34-GW1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananieva EA, 2008, PLANT PHYSIOL, V148, P1868, DOI 10.1104/pp.108.130575; BENEDETTI CE, 1995, PLANT PHYSIOL, V109, P567, DOI 10.1104/pp.109.2.567; Berardini TZ, 2004, PLANT PHYSIOL, V135, P745, DOI 10.1104/pp.104.040071; Bressan RA, 2001, PLANT PHYSIOL, V127, P1354, DOI 10.1104/pp.010752; Diatchenko L, 1996, P NATL ACAD SCI USA, V93, P6025, DOI 10.1073/pnas.93.12.6025; Fiorani M, 2013, J NUTR BIOCHEM, V24, P467, DOI 10.1016/j.jnutbio.2012.01.009; Fonseca S, 2009, NAT CHEM BIOL, V5, P344, DOI 10.1038/nchembio.161; Geng XQ, 2014, PLANTA, V240, P1149, DOI 10.1007/s00425-014-2151-x; Gl W, 1998, NATURE, V393, P365; Hao BZ, 2000, ANN BOT-LONDON, V85, P37, DOI 10.1006/anbo.1999.0995; Howe GA, 2008, ANNU REV PLANT BIOL, V59, P41, DOI 10.1146/annurev.arplant.59.032607.092825; ICHIHARA A, 1977, J AM CHEM SOC, V99, P636, DOI 10.1021/ja00444a067; Ivashuta S, 2005, PLANT CELL, V17, P2911, DOI 10.1105/tpc.105.035394; Kaye Y, 2011, PLANT PHYSIOL, V157, P229, DOI 10.1104/pp.111.176883; Kim J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9r87; Kim MC, 2009, MOL PLANT, V2, P13, DOI 10.1093/mp/ssn091; Lanciano P, 2013, BIOCHEMISTRY-US, V52, P7196, DOI 10.1021/bi400561e; Lanteri ML, 2006, J EXP BOT, V57, P1341, DOI 10.1093/jxb/erj109; Leferink NGH, 2008, FEBS J, V275, P713, DOI 10.1111/j.1742-4658.2007.06233.x; Li HP, 2011, PLANT SCI, V181, P132, DOI 10.1016/j.plantsci.2011.04.014; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mano J, 2004, ARCH BIOCHEM BIOPHYS, V429, P71, DOI 10.1016/j.abb.2004.05.022; Mehlmer N, 2010, PLANT J, V63, P484, DOI 10.1111/j.1365-313X.2010.04257.x; Milburn JA, 1996, J EXP BOT, V47, P135, DOI 10.1093/jxb/47.1.135; Munemasa S, 2007, PLANT PHYSIOL, V143, P1398, DOI 10.1104/pp.106.091298; Pandey N, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-216; Qiu YJ, 2012, PLANT MOL BIOL, V79, P89, DOI 10.1007/s11103-012-9896-z; Rangaswamy V, 1998, P NATL ACAD SCI USA, V95, P15469, DOI 10.1073/pnas.95.26.15469; Tian WM, 2013, J PLANT PHYSIOL, V170, P723, DOI 10.1016/j.jplph.2012.12.019; Tian WM, 2003, ACTA BOT SIN, V45, P1366; Vadassery J, 2012, PLANT PHYSIOL, V159, P1159, DOI 10.1104/pp.112.198150; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang Y, 2012, EURASIP J ADV SIG PR, P1, DOI 10.1186/1687-6180-2012-40; Wasternack C, 2013, ANN BOT-LONDON, V111, P1021, DOI 10.1093/aob/mct067; Wasternack C, 2010, PLANT SIGNAL BEHAV, V5, P337, DOI 10.4161/psb.5.4.11574; Wong HL, 2004, PLANT PHYSIOL, V135, P1447, DOI 10.1104/pp.103.036384; Xia CA, 2010, PLANT J, V63, P189, DOI 10.1111/j.1365-313X.2010.04237.x; Xie DX, 1998, SCIENCE, V280, P1091, DOI 10.1126/science.280.5366.1091; Xu JY, 2011, PLANT MOL BIOL, V75, P167, DOI 10.1007/s11103-010-9716-2; Xue TT, 2009, J EXP BOT, V60, P339, DOI 10.1093/jxb/ern291; Yang DH, 2012, PLANT PHYSIOL, V159, P1591, DOI 10.1104/pp.112.199018; Zhao Y, 2011, J PLANT PHYSIOL, V168, P1649, DOI 10.1016/j.jplph.2011.02.010; Zhu JH, 2010, PLANT PHYSIOL BIOCH, V48, P710, DOI 10.1016/j.plaphy.2010.04.004	43	11	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132070	10.1371/journal.pone.0132070	http://dx.doi.org/10.1371/journal.pone.0132070			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147807	gold, Green Published, Green Submitted			2022-12-26	WOS:000358157600195
J	Arampatzis, G; Katsoulakis, MA; Pantazis, Y				Arampatzis, Georgios; Katsoulakis, Markos A.; Pantazis, Yannis			Accelerated Sensitivity Analysis in High-Dimensional Stochastic Reaction Networks	PLOS ONE			English	Article							GRADIENT ESTIMATION; SIMULATION; SYSTEMS; PACKAGE	Existing sensitivity analysis approaches are not able to handle efficiently stochastic reaction networks with a large number of parameters and species, which are typical in the modeling and simulation of complex biochemical phenomena. In this paper, a two-step strategy for parametric sensitivity analysis for such systems is proposed, exploiting advantages and synergies between two recently proposed sensitivity analysis methodologies for stochastic dynamics. The first method performs sensitivity analysis of the stochastic dynamics by means of the Fisher Information Matrix on the underlying distribution of the trajectories; the second method is a reduced-variance, finite-difference, gradient-type sensitivity approach relying on stochastic coupling techniques for variance reduction. Here we demonstrate that these two methods can be combined and deployed together by means of a new sensitivity bound which incorporates the variance of the quantity of interest as well as the Fisher Information Matrix estimated from the first method. The first step of the proposed strategy labels sensitivities using the bound and screens out the insensitive parameters in a controlled manner. In the second step of the proposed strategy, a finite-difference method is applied only for the sensitivity estimation of the (potentially) sensitive parameters that have not been screened out in the first step. Results on an epidermal growth factor network with fifty parameters and on a protein homeostasis with eighty parameters demonstrate that the proposed strategy is able to quickly discover and discard the insensitive parameters and in the remaining potentially sensitive parameters it accurately estimates the sensitivities. The new sensitivity strategy can be several times faster than current state-of-the-art approaches that test all parameters, especially in "sloppy" systems. In particular, the computational acceleration is quantified by the ratio between the total number of parameters over the number of the sensitive parameters.	[Arampatzis, Georgios; Katsoulakis, Markos A.; Pantazis, Yannis] Univ Massachusetts, Dept Math & Stat, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst	Katsoulakis, MA (corresponding author), Univ Massachusetts, Dept Math & Stat, Amherst, MA 01003 USA.	markos@math.umass.edu		Katsoulakis, Markos/0000-0003-4354-1766	Office of Advanced Scientific Computing Research, U.S. Department of Energy [DE-SC0010723]; European Union (European Social Fund); Greece (National Strategic Reference Framework), under the THALES Program, grant AMOSICSS	Office of Advanced Scientific Computing Research, U.S. Department of Energy(United States Department of Energy (DOE)); European Union (European Social Fund)(European Social Fund (ESF)); Greece (National Strategic Reference Framework), under the THALES Program, grant AMOSICSS	The work of GA, MAK, and YP was supported in part by the Office of Advanced Scientific Computing Research, U.S. Department of Energy under Contract No. DE-SC0010723 as well as in part by the European Union (European Social Fund) and Greece (National Strategic Reference Framework), under the THALES Program, grant AMOSICSS.	Anderson DF, 2012, SIAM J NUMER ANAL, V50, P2237, DOI 10.1137/110849079; Arampatzis G, 2014, J CHEM PHYS, V140, DOI 10.1063/1.4868649; Bader DA, 2007, P 21TH INT PARALLEL, P1, DOI [10.1109/IPDPS.2007.370445, DOI 10.1109/IPDPS.2007.370445]; Brown R.G., 2012, INTRO RANDOM SIGNALS, P324; Casella G, 2002, STAT INFERENCE, V2nd; Chatterjee A, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1833357; Cover T. M., 1991, ELEMENTS INFORM THEO; DiStefano J, 2014, DYNAMIC SYSTEMS BIOLOGY MODELING AND SIMULATION, P1; Erguler K, 2011, MOL BIOSYST, V7, P1593, DOI 10.1039/c0mb00107d; Geva-Zatorsky N, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100068; Gibson MA, 2000, J PHYS CHEM A, V104, P1876, DOI 10.1021/jp993732q; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; Gillespie DT, 2001, J CHEM PHYS, V115, P1716, DOI 10.1063/1.1378322; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; GLYNN PW, 1990, COMMUN ACM, V33, P75, DOI 10.1145/84537.84552; Gutenkunst RN, 2007, PLOS COMPUT BIOL, V3, P1871, DOI 10.1371/journal.pcbi.0030189; Hackel PO, 1999, CURR OPIN CELL BIOL, V11, P184, DOI 10.1016/S0955-0674(99)80024-6; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Henry CS, 2010, NAT BIOTECHNOL, V28, P977, DOI 10.1038/nbt.1672; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Hu W, J STAT SOFTWAR UNPUB; Kay S. M., 1993, FUNTAMENTALS STAT SI; Kholodenko BN, 1999, J BIOL CHEM, V274, P30169, DOI 10.1074/jbc.274.42.30169; Kim D, 2007, BIOPHYS J, V92, P379, DOI 10.1529/biophysj.106.085084; Kim H, 1999, EXP CELL RES, V253, P78, DOI 10.1006/excr.1999.4706; Komorowski M, 2012, BIOINFORMATICS, V28, P731, DOI 10.1093/bioinformatics/btr714; Komorowski M, 2011, P NATL ACAD SCI USA, V108, P8645, DOI 10.1073/pnas.1015814108; Lehmann E. L., 1998, THEORY POINT ESTIMAT; Liu J. S., 2001, SPRINGER SERIES STAT; Maiwald T, 2008, BIOINFORMATICS, V24, P2037, DOI 10.1093/bioinformatics/btn350; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; McGill JA, 2012, J COMPUT PHYS, V231, P7170, DOI 10.1016/j.jcp.2012.06.037; Moghal N, 1999, CURR OPIN CELL BIOL, V11, P190, DOI 10.1016/S0955-0674(99)80025-8; NAKAYAMA M., 1994, STOCH MODELS, V10, P701; Pantazis Y, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-311; Pantazis Y, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4789612; Plyasunov S, 2007, J COMPUT PHYS, V221, P724, DOI 10.1016/j.jcp.2006.06.047; Prives C, 1998, CELL, V95, P5, DOI 10.1016/S0092-8674(00)81774-2; Proctor CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022038; Rathinam M, 2003, J CHEM PHYS, V119, P12784, DOI 10.1063/1.1627296; Rathinam M, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3280166; Rodriguez-Fernandez M, 2010, BIOINFORMATICS, V26, P1675, DOI 10.1093/bioinformatics/btq242; Saltelli A., 2008, GLOBAL SENSITIVITY A; Schoeberl B, 2002, NAT BIOTECHNOL, V20, P370, DOI 10.1038/nbt0402-370; Sheppard PW, 2013, BIOINFORMATICS, V29, P140, DOI 10.1093/bioinformatics/bts642; Sheppard PW, 2012, J CHEM PHYS, V136, DOI 10.1063/1.3677230; Sibilia M, 1998, EMBO J, V17, P719, DOI 10.1093/emboj/17.3.719; Slepoy A, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2919546; Stochss Org, 2013, STOCHSS STOCHASTIC S; Thattai M, 2001, P NATL ACAD SCI USA, V98, P8614, DOI 10.1073/pnas.151588598; Thiele I, 2010, NAT PROTOC, V5, P93, DOI 10.1038/nprot.2009.203	51	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0130825	10.1371/journal.pone.0130825	http://dx.doi.org/10.1371/journal.pone.0130825			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161544	gold, Green Submitted, Green Published			2022-12-26	WOS:000358162300022
J	Farias, LR; Schimmelpfeng, PHC; Togawa, RC; Costa, MMC; Grynberg, P; Martins, NF; Borges, M; Blassioli-Moraes, MC; Laumann, RA; Bao, SN; Paula, DP				Farias, Luciana R.; Schimmelpfeng, Pedro H. C.; Togawa, Roberto C.; Costa, Marcos M. C.; Grynberg, Priscila; Martins, Natalia F.; Borges, Miguel; Blassioli-Moraes, Maria Carolina; Laumann, Raul A.; Bao, Sonia N.; Paula, Debora P.			Transcriptome-Based Identification of Highly Similar Odorant-Binding Proteins among Neotropical Stink Bugs and Their Egg Parasitoid	PLOS ONE			English	Article							EUSCHISTUS-HEROS HETEROPTERA; PHEROMONE-BINDING; TRISSOLCUS-BASALIS; TELENOMUS-PODISI; SEX-PHEROMONE; CHEMOSENSORY PROTEINS; DEFENSIVE SECRETIONS; GENOME ANNOTATION; ANOPHELES-GAMBIAE; NEZARA-VIRIDULA	Olfaction plays a fundamental role in insect survival through resource location and intra and interspecific communications. We used RNA-Seq to analyze transcriptomes for odorant-binding proteins (OBPs) from major stink bug pest species in Brazil, Euschistus heros, Chinavia ubica, and Dichelops melacanthus, and from their egg parasitoid, Telenomus podisi. We identified 23 OBPs in E. heros, 25 OBPs in C. ubica, 9 OBPs in D. melacanthus, and 7 OBPs in T. podisi. The deduced amino acid sequences of the full-length OBPs had low intraspecific similarity, but very high similarity between two pairs of OBPs from E. heros and C. ubica (76.4 and 84.0%) and between two pairs of OBPs from the parasitoid and its preferred host E. heros (82.4 and 88.5%), confirmed by a high similarity of their predicted tertiary structures. The similar pairs of OBPs from E. heros and C. ubica may suggest that they have derived from a common ancestor, and retain the same biological function to bind a ligand perceived or produced in both species. The T. podisi OBPs similar to E. heros were not orthologous to any known hymenopteran OBPs, and may have evolved independently and converged to the host OBPs, providing a possible basis for the host location of T. podisi using E. heros semiochemical cues.	[Farias, Luciana R.; Schimmelpfeng, Pedro H. C.; Bao, Sonia N.] Univ Brasilia, BR-70910900 Brasilia, DF, Brazil; [Farias, Luciana R.; Schimmelpfeng, Pedro H. C.; Togawa, Roberto C.; Costa, Marcos M. C.; Grynberg, Priscila; Martins, Natalia F.; Borges, Miguel; Blassioli-Moraes, Maria Carolina; Laumann, Raul A.; Paula, Debora P.] Embrapa Genet Resources & Biotechnol, BR-70770917 Brasilia, DF, Brazil	Universidade de Brasilia; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Paula, DP (corresponding author), Embrapa Genet Resources & Biotechnol, Parque Estacao Biol,W5 Norte,POB 02372, BR-70770917 Brasilia, DF, Brazil.	debora.pires@embrapa.br	Borges, Miguel/K-9918-2019; laumann, raul/AAC-4416-2019; Báo, Sônia/V-1214-2019; martins, natalia florencio/AAE-7875-2019; Blassioli-Moraes, Maria carolina/C-6072-2013; Borges, Miguel/C-6937-2013; Grynberg, Priscila/AAX-3019-2020	Borges, Miguel/0000-0003-3364-9677; laumann, raul/0000-0003-3531-2613; Blassioli-Moraes, Maria carolina/0000-0001-7569-9985; Grynberg, Priscila/0000-0003-4009-9538; Togawa, Roberto/0000-0001-7179-3210; Bao, Sonia/0000-0002-9873-3098	CNPq/Embrapa grant [562307/201-9]; FAPDF/PRONEX grant [193.000.583/2009]; CNPq; CAPES	CNPq/Embrapa grant; FAPDF/PRONEX grant; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	MB received CNPq/Embrapa grant (code 562307/201-9). SNB received FAPDF/PRONEX grant (code 193.000.583/2009). LRF and PHCS received post-graduation fellowships from CNPq and CAPES, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDRICH JR, 1995, J CHEM ECOL, V21, P1031, DOI 10.1007/BF02033806; BIN F, 1993, PHYSIOL ENTOMOL, V18, P7, DOI 10.1111/j.1365-3032.1993.tb00443.x; Borges M, 2011, J APPL ENTOMOL, V135, P68, DOI 10.1111/j.1439-0418.2010.01507.x; Borges M, 1999, PHYSIOL ENTOMOL, V24, P227, DOI 10.1046/j.1365-3032.1999.00136.x; BORGES M, 1992, EXPERIENTIA, V48, P893, DOI 10.1007/BF02118429; Borges M, 1998, J APPL ENTOMOL, V122, P335, DOI 10.1111/j.1439-0418.1998.tb01508.x; Borges M, 1998, PHYSIOL ENTOMOL, V23, P202, DOI 10.1046/j.1365-3032.1998.233086.x; BORGES M, 1987, ENTOMOL EXP APPL, V44, P205, DOI 10.1007/BF00369180; Borges M, 2007, J CHEM ECOL, V33, P1235, DOI 10.1007/s10886-007-9294-1; Bruni R, 2000, J INSECT BEHAV, V13, P165, DOI 10.1023/A:1007728012482; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Colazza S, 1999, BIOL CONTROL, V16, P310, DOI 10.1006/bcon.1999.0763; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Conti E, 2003, J CHEM ECOL, V29, P115, DOI 10.1023/A:1021980614512; Correa-Ferreira BS, 2009, 67 EMBR; Correa-Ferreira BS, 1999, 24 EMBRAPACNPSO; CORREAFERREIRA BS, 1995, BIOL CONTROL, V5, P196, DOI 10.1006/bcon.1995.1024; Danty E, 1999, J NEUROSCI, V19, P7468, DOI 10.1523/JNEUROSCI.19-17-07468.1999; De Medeiros MA, 1998, PESQUI AGROPECU BRAS, V33, P1431; Fan J, 2011, GENET MOL RES, V10, P3056, DOI 10.4238/2011.December.8.2; Farias LR, 2014, NEOTROP ENTOMOL, V43, P106, DOI 10.1007/s13744-013-0187-4; Foret S, 2006, GENOME RES, V16, P1404, DOI 10.1101/gr.5075706; Michereff MFF, 2011, J CHEM ECOL, V37, P273, DOI 10.1007/s10886-011-9917-4; Gu SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073524; Gu SH, 2011, INSECT BIOCHEM MOLEC, V41, P254, DOI 10.1016/j.ibmb.2011.01.002; He M, 2014, COMP BIOCHEM PHYS B, V174, P1, DOI 10.1016/j.cbpb.2014.04.008; Hekmat-Scafe DS, 2002, GENOME RES, V12, P1357, DOI 10.1101/gr.239402; Hull JJ, 2014, INSECT MOL BIOL, V23, P78, DOI 10.1111/imb.12064; Ji P, 2013, APPL ENTOMOL ZOOL, V48, P301, DOI 10.1007/s13355-013-0188-0; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kirkness EF, 2010, P NATL ACAD SCI USA, V107, P12168, DOI 10.1073/pnas.1003379107; Lagarde A, 2011, BIOCHEM J, V437, P423, DOI 10.1042/BJ20110522; Laughlin JD, 2008, CELL, V133, P1255, DOI 10.1016/j.cell.2008.04.046; Laumann RA, 2011, ANIM BEHAV, V82, P1175, DOI 10.1016/j.anbehav.2011.08.017; Laumann RA, 2009, J CHEM ECOL, V35, P8, DOI 10.1007/s10886-008-9578-0; Li ZX, 2005, ARCH INSECT BIOCHEM, V58, P175, DOI 10.1002/arch.20047; Liu RH, 2010, CELL MOL LIFE SCI, V67, P919, DOI 10.1007/s00018-009-0221-1; Marques FA, 2007, J BRAZIL CHEM SOC, V18, P1242, DOI 10.1590/S0103-50532007000600020; Matsuo T, 2007, PLOS BIOL, V5, P985, DOI 10.1371/journal.pbio.0050118; MATTIACCI L, 1993, J CHEM ECOL, V19, P1167, DOI 10.1007/BF00987378; Michereff MFF, 2015, J APPL ENTOMOL, V139, P207, DOI 10.1111/jen.12148; Moraes M.C.B., 2008, J PLANT INTERACT, V3, P1742; Moraes MCB, 2008, PHYSIOL ENTOMOL, V33, P43, DOI 10.1111/j.1365-3032.2007.00600.x; Moraes MCB, 2009, ENTOMOL EXP APPL, V131, P178, DOI 10.1111/j.1570-7458.2009.00836.x; Moraes MCB, 2008, NEOTROP ENTOMOL, V37, P489, DOI 10.1590/S1519-566X2008000500001; Moraes MCB, 2005, ENTOMOL EXP APPL, V115, P227, DOI 10.1111/j.1570-7458.2005.00290.x; Nishimura O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050664; Pacheco D.J.P., 1998, ANAIS SOC ENTOMOLOGI, V27, P585; Panizzi AR, 2000, HETEROPTERA OF ECONOMIC IMPORTANCE, P421; Pareja M, 2007, J INSECT PHYSIOL, V53, P639, DOI 10.1016/j.jinsphys.2007.04.004; Parra G, 2009, NUCLEIC ACIDS RES, V37, P289, DOI 10.1093/nar/gkn916; Pelosi P, 2006, CELL MOL LIFE SCI, V63, P1658, DOI 10.1007/s00018-005-5607-0; PELOSI P, 1995, COMP BIOCHEM PHYS B, V111, P503, DOI 10.1016/0305-0491(95)00019-5; PELOSI P, 1994, CRIT REV BIOCHEM MOL, V29, P199, DOI 10.3109/10409239409086801; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; PIKIELNY CW, 1994, NEURON, V12, P35, DOI 10.1016/0896-6273(94)90150-3; Plettner E, 2000, BIOCHEMISTRY-US, V39, P8953, DOI 10.1021/bi000461x; PRESTWICH GD, 1995, CHEM SENSES, V20, P461, DOI 10.1093/chemse/20.4.461; Qiao HL, 2009, INSECT BIOCHEM MOLEC, V39, P414, DOI 10.1016/j.ibmb.2009.03.004; Schuh R.T, 1995, BUGS WORLD HEMIPTERA; Schultze A, 2012, INSECT MOL BIOL, V21, P187, DOI 10.1111/j.1365-2583.2011.01125.x; Silva CC, 2006, PESQUI AGROPECU BRAS, V41, P1093, DOI 10.1590/S0100-204X2006000700004; Steinbrecht RA, 1996, CHEM SENSES, V21, P719, DOI 10.1093/chemse/21.6.719; Sujii ER, 2002, PESQUI AGROPECU BRAS, V37, P1541, DOI 10.1590/S0100-204X2002001100004; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Vandermoten S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023608; Vieira FG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043034; VOGT RG, 1981, NATURE, V293, P161, DOI 10.1038/293161a0; VOGT RG, 1989, J NEUROSCI, V9, P3332; Vogt RG, 1999, CHEM SENSES, V24, P481, DOI 10.1093/chemse/24.5.481; VOGT RG, 1991, J NEUROBIOL, V22, P74, DOI 10.1002/neu.480220108; VOGT RG, 1991, J NEUROSCI, V11, P2972; Wurm Y, 2011, P NATL ACAD SCI USA, V108, P5679, DOI 10.1073/pnas.1009690108; Xu PX, 2003, INSECT MOL BIOL, V12, P549, DOI 10.1046/j.1365-2583.2003.00440.x; Xu YL, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-632; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Yin XW, 2013, CELL MOL LIFE SCI, V70, P3029, DOI 10.1007/s00018-013-1308-2; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhou JJ, 2008, INSECT MOL BIOL, V17, P147, DOI 10.1111/j.1365-2583.2007.00789.x; Zhou JJ, 2010, INSECT MOL BIOL, V19, P113, DOI 10.1111/j.1365-2583.2009.00919.x; Zhou JJ, 2004, GENE, V327, P117, DOI 10.1016/j.gene.2003.11.007	82	18	19	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132286	10.1371/journal.pone.0132286	http://dx.doi.org/10.1371/journal.pone.0132286			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161752	Green Published, gold			2022-12-26	WOS:000358162300114
J	Wang, YQ; Momohara, A; Wang, L; Lebreton-Anberree, J; Zhou, ZK				Wang, Yuqing; Momohara, Arata; Wang, Li; Lebreton-Anberree, Julie; Zhou, Zhekun			Evolutionary History of Atmospheric CO2 during the Late Cenozoic from Fossilized Metasequoia Needles	PLOS ONE			English	Article							MIDDLE EOCENE; REVISED MODEL; ICE VOLUME; SW CHINA; CLIMATE; CARBON; PLIOCENE; ISOTOPE; GINKGO; LEAVES	The change in ancient atmospheric CO2 concentrations provides important clues for understanding the relationship between the atmospheric CO2 concentration and global temperature. However, the lack of CO2 evolution curves estimated from a single terrestrial proxy prevents the understanding of climatic and environmental impacts due to variations in data. Thus, based on the stomatal index of fossilized Metasequoia needles, we reconstructed a history of atmospheric CO2 concentrations from middle Miocene to late Early Pleistocene when the climate changed dramatically. According to this research, atmospheric CO2 concentration was stabile around 330-350 ppmv in the middle and late Miocene, then it decreased to 278-284 ppmv during the Late Pliocene and to 277-279 ppmv during the Early Pleistocene, which was almost the same range as in preindustrial time. According to former research, this is a time when global temperature decreased sharply. Our results also indicated that from middle Miocene to Pleistocene, global CO2 level decreased by more than 50 ppmv, which may suggest that CO2 decrease and temperature decrease are coupled.	[Wang, Yuqing; Wang, Li; Lebreton-Anberree, Julie; Zhou, Zhekun] Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Key Lab Trop Forest Ecol, Mengla 666303, Peoples R China; [Wang, Yuqing; Lebreton-Anberree, Julie] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Zhou, Zhekun] Chinese Acad Sci, Kunming Inst Bot, Key Lab Plant Div & Biogeog East Asia, Kunming 650204, Peoples R China; [Momohara, Arata] Chiba Univ, Grad Sch Hort, Chiba 2718510, Japan; [Wang, Li] Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Cent Lab, Mengla 666303, Peoples R China	Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chiba University; Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS	Zhou, ZK (corresponding author), Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Key Lab Trop Forest Ecol, Mengla 666303, Peoples R China.	zhouzk@xtbg.ac.cn	Wang, yuqing/HIR-1604-2022; Zhou, Zhekun/G-5281-2011	Zhou, Zhekun/0000-0002-0710-2128	973 programme of Ministry of Science and Technology of the People's Republic of China [2012CB821901]; National Natural Science Foundation of China (NSFC) [1300188]; Chinese Academy of Sciences 135 program [XTBG-F01]; State Key Laboratory of Palaeobiology and Stratigraphy (Nanjing Institute of Geology and Palaeontology, CAS) [123108]	973 programme of Ministry of Science and Technology of the People's Republic of China; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences 135 program; State Key Laboratory of Palaeobiology and Stratigraphy (Nanjing Institute of Geology and Palaeontology, CAS)(Chinese Academy of Sciences)	The work was supported by the following: 1. 973 programme of Ministry of Science and Technology of the People's Republic of China (2012CB821901), Receiver: ZZK, URL: http://www.973.gov.cn/Default_3.aspx; 2. National Natural Science Foundation of China (NSFC, No. 1300188), Receiver: WL, URL: http://www.nsfc.gov.cn/; 3. Chinese Academy of Sciences 135 program (XTBG-F01), Receiver: ZZK, URL: http://www.xtbg.ac.cn/yisanwu/; and 4. State Key Laboratory of Palaeobiology and Stratigraphy (Nanjing Institute of Geology and Palaeontology, CAS) (No. 123108),	Badger MPS, 2013, PALEOCEANOGRAPHY, V28, DOI 10.1002/palo.20015; Bai YJ, 2015, GLOBAL CHANGE BIOL, V21, P874, DOI 10.1111/gcb.12670; BASINGER JF, 1981, CAN J BOT, V59, P2379, DOI 10.1139/b81-291; Beerling DJ, 2011, NAT GEOSCI, V4, P418, DOI 10.1038/ngeo1186; Beerling DJ, 1999, FOSSIL PLANTS SPORES, P251; Berner RA, 2001, AM J SCI, V301, P182, DOI 10.2475/ajs.301.2.182; BERNER RA, 1994, AM J SCI, V294, P56, DOI 10.2475/ajs.294.1.56; Berner RA, 2006, GEOCHIM COSMOCHIM AC, V70, P5653, DOI 10.1016/j.gca.2005.11.032; De Schepper S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081508; Domingo L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063739; Doria G, 2011, AM J SCI, V311, P63, DOI 10.2475/01.2011.03; Edenhofer O., 2014, CONTRIBUTION WORKING; FLOWER BP, 1994, PALAEOGEOGR PALAEOCL, V108, P537, DOI 10.1016/0031-0182(94)90251-8; Foster GL, 2012, EARTH PLANET SC LETT, V341, P243, DOI 10.1016/j.epsl.2012.06.007; Ge H-R., 1999, CENOZOIC COAL BEARIN; Grein M, 2013, PALAEOGEOGR PALAEOCL, V374, P41, DOI 10.1016/j.palaeo.2012.12.025; Henderiks J, 2008, EARTH PLANET SC LETT, V269, P575, DOI 10.1016/j.epsl.2008.03.016; Horiuchi J, 1996, NEOGENE FLORA KANTO, V17, P109; Jones TP., 1999, FOSSIL PLANTS SPORES; KERP H, 1990, Palaios, V5, P548, DOI 10.2307/3514861; Kimura T, 1984, T P PALEONTOLOGICAL, V122, P87; Knorr G, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048873; Kobayashi M, 2011, J GEOLOGICAL SOC JAP, V117, P632; Kurschner WM, 2008, P NATL ACAD SCI USA, V105, P449, DOI 10.1073/pnas.0708588105; Kurschner WM, 1996, MAR MICROPALEONTOL, V27, P299, DOI 10.1016/0377-8398(95)00067-4; Kurschner WM, 1996, THESIS UTRECHT U; Lacis AA, 2010, SCIENCE, V330, P356, DOI 10.1126/science.1190653; LePage BA., 2005, GEOBIOLOGY ECOLOGY M; Li L, 2011, EARTH PLANET SC LETT, V309, P10, DOI 10.1016/j.epsl.2011.04.016; LISIECKI LE, 2005, PALEOCEANOGRAPHY, V0020; Mitamura Muneki, 1992, Quaternary Research (Tokyo), V31, P159; Monnin E, 2001, SCIENCE, V291, P112, DOI 10.1126/science.291.5501.112; Mosbrugger V, 2005, P NATL ACAD SCI USA, V102, P14964, DOI 10.1073/pnas.0505267102; Pagani M, 2005, GEOCHIM COSMOCHIM AC, V69, P953, DOI 10.1016/j.gca.2004.07.029; Pearson PN, 2001, NATURE, V414, P470, DOI 10.1038/35106617; Peng J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095282; Quan C, 2009, CRETACEOUS RES, V30, P424, DOI 10.1016/j.cretres.2008.08.004; Raupach MR, 2010, CURR OPIN ENV SUST, V2, P210, DOI 10.1016/j.cosust.2010.04.003; RAYMO ME, 1994, ANNU REV EARTH PL SC, V22, P353, DOI 10.1146/annurev.ea.22.050194.002033; Retallack GJ, 2009, PALAEOGEOGR PALAEOCL, V281, P57, DOI 10.1016/j.palaeo.2009.07.011; Roth-Nebelsick A, 2014, REV PALAEOBOT PALYNO, V206, P1, DOI 10.1016/j.revpalbo.2014.03.001; Royer DL, 2006, GEOCHIM COSMOCHIM AC, V70, P5665, DOI 10.1016/j.gca.2005.11.031; Royer DL, 2001, REV PALAEOBOT PALYNO, V114, P1, DOI 10.1016/S0034-6667(00)00074-9; Royer DL, 2001, SCIENCE, V292, P2310, DOI 10.1126/science.292.5525.2310; Ruddiman WF, 2003, QUATERNARY SCI REV, V22, P1597, DOI 10.1016/S0277-3791(03)00087-8; Salisbury EJ, 1982, PHILOS T ROY SOC LON, V216, P1; Satoguchi Y, 2012, J GEOL SOC JPN S, V118, P70, DOI DOI 10.5575/geosoc.2012.0035; Satoguchi Y, 2012, ISL ARC, V21, P149, DOI 10.1111/j.1440-1738.2012.00816.x; Seki O, 2010, EARTH PLANET SC LETT, V292, P201, DOI 10.1016/j.epsl.2010.01.037; Shevenell AE, 2004, SCIENCE, V305, P1766, DOI 10.1126/science.1100061; Shevenell AE, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2007GC001736; Smith RY, 2010, PALAEOGEOGR PALAEOCL, V293, P120, DOI 10.1016/j.palaeo.2010.05.006; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Stults DZ, 2011, PALAEOGEOGR PALAEOCL, V309, P327, DOI 10.1016/j.palaeo.2011.06.017; Sun BN, 2012, TURK J EARTH SCI, V21, P237, DOI 10.3906/yer-1003-42; Tomita Y, 1999, J GEOLOGICAL SOC JAP, V105, P63; Tripati AK, 2011, GEOCHIM COSMOCHIM AC, V75, P2582, DOI 10.1016/j.gca.2011.01.018; Tripati AK, 2009, SCIENCE, V326, P1394, DOI 10.1126/science.1178296; VANDERBURGH J, 1993, SCIENCE, V260, P1788, DOI 10.1126/science.260.5115.1788; Vincent E., 1985, CARBON CYCLE ATMOSPH, V32, P455, DOI [10.1029/GM032p0455, DOI 10.1029/GM032P0455]; Wagner F, 1999, SCIENCE, V284, P1971, DOI 10.1126/science.284.5422.1971; Wang L, 2012, JAPANESE J PALYNOLOG, V58, P251; Yanagisawa Y, 1985, QUATERNARY RES; Yoshikawa S., 1999, J GEOL SOC JPN, V105, P332; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zachos JC, 2008, NATURE, V451, P279, DOI 10.1038/nature06588; Zhang QQ, 2012, PALAEOGEOGR PALAEOCL, V363, P23, DOI 10.1016/j.palaeo.2012.08.009; Zhang YG, 2013, PHILOS T R SOC A, V371, DOI 10.1098/rsta.2013.0096	68	19	23	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0130941	10.1371/journal.pone.0130941	http://dx.doi.org/10.1371/journal.pone.0130941			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154449	gold, Green Published, Green Submitted			2022-12-26	WOS:000358159700048
J	Muraya, MM; Schmutzer, T; Ulpinnis, C; Scholz, U; Altmann, T				Muraya, Moses M.; Schmutzer, Thomas; Ulpinnis, Chris; Scholz, Uwe; Altmann, Thomas			Targeted Sequencing Reveals Large-Scale Sequence Polymorphism in Maize Candidate Genes for Biomass Production and Composition	PLOS ONE			English	Article							MULTILOCUS GENOTYPE DATA; WHOLE-GENOME; VARIANT DETECTION; READ ALIGNMENT; INDEL RATES; ARCHITECTURE; ASSOCIATION; DIVERSITY; INFERENCE; DISCOVERY	A major goal of maize genomic research is to identify sequence polymorphisms responsible for phenotypic variation in traits of economic importance. Large-scale detection of sequence variation is critical for linking genes, or genomic regions, to phenotypes. However, due to its size and complexity, it remains expensive to generate whole genome sequences of sufficient coverage for divergent maize lines, even with access to next generation sequencing (NGS) technology. Because methods involving reduction of genome complexity, such as genotyping-by-sequencing (GBS), assess only a limited fraction of sequence variation, targeted sequencing of selected genomic loci offers an attractive alternative. We therefore designed a sequence capture assay to target 29 Mb genomic regions and surveyed a total of 4,648 genes possibly affecting biomass production in 21 diverse inbred maize lines (7 flints, 14 dents). Captured and enriched genomic DNA was sequenced using the 454 NGS platform to 19.6-fold average depth coverage, and a broad evaluation of read alignment and variant calling methods was performed to select optimal procedures for variant discovery. Sequence alignment with the B73 reference and de novo assembly identified 383,145 putative single nucleotide polymorphisms (SNPs), of which 42,685 were non-synonymous alterations and 7,139 caused frameshifts. Presence/absence variation (PAV) of genes was also detected. We found that substantial sequence variation exists among genomic regions targeted in this study, which was particularly evident within coding regions. This diversification has the potential to broaden functional diversity and generate phenotypic variation that may lead to new adaptations and the modification of important agronomic traits. Further, annotated SNPs identified here will serve as useful genetic tools and as candidates in searches for phenotype-altering DNA variation. In summary, we demonstrated that sequencing of captured DNA is a powerful approach for variant discovery in maize genes.	[Muraya, Moses M.; Schmutzer, Thomas; Ulpinnis, Chris; Scholz, Uwe; Altmann, Thomas] Leibniz Inst Plant Genet & Crop Plant Res IPK Gat, D-06466 Stadt Seeland, Germany; [Muraya, Moses M.] Chuka Univ, Dept Plant Sci, Chuka, Kenya	Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung	Schmutzer, T (corresponding author), Leibniz Inst Plant Genet & Crop Plant Res IPK Gat, Corrensstr 3, D-06466 Stadt Seeland, Germany.	schmutzr@ipk-gatersleben.de	Schmutzer, Thomas/W-8705-2019	Schmutzer, Thomas/0000-0003-1073-6719; Scholz, Uwe/0000-0001-6113-3518; Ulpinnis, Chris/0000-0001-5444-9282; Altmann, Thomas/0000-0002-3759-360X	German Federal Ministry of Education and Research [FKZ 0315461C]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	The KBBE-CornFed project and its research leading to these results have received funding by the German Federal Ministry of Education and Research (FKZ 0315461C); www.bmbf.de. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhunov ED, 2013, PLANT PHYSIOL, V161, P252, DOI 10.1104/pp.112.205161; Almagro L, 2009, J EXP BOT, V60, P377, DOI 10.1093/jxb/ern277; Andersen EC, 2012, NAT GENET, V44, P285, DOI 10.1038/ng.1050; Bansal V, 2010, BIOINFORMATICS, V26, pi318, DOI 10.1093/bioinformatics/btq214; Belo A, 2010, THEOR APPL GENET, V120, P355, DOI 10.1007/s00122-009-1128-9; Botstein D, 1980, CONSTRUCTION GENETIC, P314; Bouchet S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071377; Buckler ES, 2006, CURR OPIN PLANT BIOL, V9, P172, DOI 10.1016/j.pbi.2006.01.013; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cartwright RA, 2009, MOL BIOL EVOL, V26, P473, DOI 10.1093/molbev/msn275; Chen A. F, 2014, ASSESSING SINGLE NUC, P1; Cheng AY, 2014, BIOINFORMATICS, V30, P1707, DOI 10.1093/bioinformatics/btu067; Chia JM, 2012, NAT GENET, V44, P803, DOI 10.1038/ng.2313; Clark AG, 2005, GENOME RES, V15, P1496, DOI 10.1101/gr.4107905; Clouse S.D, 1999, MOLE GENETICS BRASSI, P163; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Cook JP, 2012, PLANT PHYSIOL, V158, P824, DOI 10.1104/pp.111.185033; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Fu JJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3832; Ganal MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028334; Garrison E., 2012, ARXIV PREP ARXIV, V1207, P3907, DOI [10.48550/arXiv.1207.3907, DOI 10.48550/ARXIV.1207.3907]; Haseneyer G, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-131; Hirsch CN, 2014, PLANT CELL, V26, P121, DOI 10.1105/tpc.113.119982; Homer N, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r99; Hu J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086269; Jia PL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038470; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee TH, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-162; Li H., 2013, PREPRINT, P1, DOI DOI 10.48550/ARXIV.1303.3997; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li H, 2013, NAT GENET, V45, P43, DOI 10.1038/ng.2484; Liu Q, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S8-S8; Lunter G, 2007, BIOINFORMATICS, V23, pI289, DOI 10.1093/bioinformatics/btm185; Lunter G, 2011, GENOME RES, V21, P936, DOI 10.1101/gr.111120.110; Luo CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030087; Mace ES, 2003, HIGH THROUGHPUT DNA; Monaco MK, 2014, NUCLEIC ACIDS RES, V42, pD1193, DOI 10.1093/nar/gkt1110; Monaco MK, 2013, PLANT GENOME-US, V6, DOI 10.3835/plantgenome2012.09.0025; Morgulis A, 2006, BIOINFORMATICS, V22, P134, DOI 10.1093/bioinformatics/bti774; Nielsen R, 2004, GENETICS, V168, P2373, DOI 10.1534/genetics.104.031039; Nielsen R, 2011, NAT REV GENET, V12, P443, DOI 10.1038/nrg2986; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; O'Rawe J, 2013, GENOME MED, V5, DOI 10.1186/gm432; Olukolu BA, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004562; Park MH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086664; Pritchard JK, 2000, GENETICS, V155, P945; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Riedelsheimer C, 2012, GENOME WIDE ASSOCIAT, DOI [10.1073/pnas.1120813109/-/DCSupplemental, DOI 10.1073/PNAS.1120813109/-/DCSUPPLEMENTAL]; Riedelsheimer C, 2012, NAT GENET, V44, P217, DOI 10.1038/ng.1033; Rincent R, 2014, THEOR APPL GENET, V127, P2313, DOI 10.1007/s00122-014-2379-7; Rincent R, 2014, GENETICS, V197, P375, DOI 10.1534/genetics.113.159731; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Sedlazeck FJ, 2013, BIOINFORMATICS, V29, P2790, DOI 10.1093/bioinformatics/btt468; Sham PC, 2014, NAT REV GENET, V15, P335, DOI 10.1038/nrg3706; Shigemizu D, 2013, SCI REP-UK, V3, DOI 10.1038/srep02161; Springer NM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000734; Stenson PD, 2003, HUM MUTAT, V21, P577, DOI 10.1002/humu.10212; Swanson-Wagner RA, 2010, GENOME RES, V20, P1689, DOI 10.1101/gr.109165.110; Tian F, 2011, NAT GENET, V43, P159, DOI 10.1038/ng.746; Vergara Ismael A, 2012, BMC Res Notes, V5, P615, DOI 10.1186/1756-0500-5-615; Wang WX, 2014, BIOINFORMATICS, V30, P2498, DOI 10.1093/bioinformatics/btu338; Wei FS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000715; Wei Z, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr599; Yu XQ, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-274; Zhang LQ, 2004, MOL BIOL EVOL, V21, P236, DOI 10.1093/molbev/msh010	73	17	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2015	10	7							e0132120	10.1371/journal.pone.0132120	http://dx.doi.org/10.1371/journal.pone.0132120			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EC	26151830	Green Submitted, gold, Green Published			2022-12-26	WOS:000358158900034
J	Pang, LX; Wang, XY; Tang, XD				Pang, Laixue; Wang, Xiaoying; Tang, Xinde			Ceria Nanotube Formed by Sacrificed Precursors Template through Oswald Ripening	PLOS ONE			English	Article							ENHANCED CATALYTIC-ACTIVITY; HYDROTHERMAL SYNTHESIS; CEO2 NANOWIRES; ASSISTED SYNTHESIS; ROOM-TEMPERATURE; CO OXIDATION; LARGE-SCALE; NANORODS; FACILE; OXYGEN	Controllable preparation of ceria nanotube was realized by hydrothermal treatment of Ce(OH)CO3 precursors. The gradually changing morphologies and microstructures of cerium oxide were characterized by X-ray powder diffraction, scanning electron microscopy and transmission electron microscopy. A top-down path is illuminated to have an insight to the morphological transformation from nanorod to nanotube by adjusting the reaction time. The growth process is investigated by preparing a series of intermediate morphologies during the shape evolution of CeO(2)nanostructure based on the scanning electron microscopy image observation. On the basis of the time-dependent experimental observation, the possible formation mechanism related to oriented attachment and Oswald ripening was proposed, which might afford some guidance for the synthesis of other inorganic nanotubes.	[Pang, Laixue; Wang, Xiaoying; Tang, Xinde] Shandong Jiaotong Univ, Sch Mat Sci & Engn, Jinan 250023, Peoples R China	Shandong Jiaotong University	Pang, LX (corresponding author), Shandong Jiaotong Univ, Sch Mat Sci & Engn, Jinan 250023, Peoples R China.	lxpang@sdjtu.edu.cn			Applied Basic Research Planning of Ministry of Transportation in China [2013319817050]; National Natural Science Foundation of China [21407098]; Project of Shandong Province Higher Educational Science and Technology Program [J12LA09]	Applied Basic Research Planning of Ministry of Transportation in China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project of Shandong Province Higher Educational Science and Technology Program	Funding provided by Applied Basic Research Planning of Ministry of Transportation in China (2013319817050), National Natural Science Foundation of China (Grant No. 21407098) and Project of Shandong Province Higher Educational Science and Technology Program (J12LA09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anwar MS, 2011, MATER LETT, V65, P3098, DOI 10.1016/j.matlet.2011.06.042; Boehme M, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/6/065602; Cao X, 2013, T NONFERR METAL SOC, V23, P725, DOI 10.1016/S1003-6326(13)62521-2; Chen GZ, 2008, INORG CHEM, V47, P723, DOI 10.1021/ic701867f; Chen GZ, 2009, INORG CHEM, V48, P1334, DOI 10.1021/ic801714z; Cui MY, 2010, MATER CHEM PHYS, V121, P314, DOI 10.1016/j.matchemphys.2010.01.041; Du N, 2007, J PHYS CHEM C, V111, P12677, DOI 10.1021/jp074011r; Elaheh K., 2011, J COLLOID INTERF SCI, V356, P473, DOI DOI 10.1016/J.JCIS.2011.01.063; Feng YJ, 2011, J MATER CHEM, V21, P15442, DOI 10.1039/c1jm12747k; Fu XQ, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/14/145503; Hua GM, 2012, J MATER CHEM, V22, P6851, DOI 10.1039/c2jm13610d; Lin HL, 2010, J COLLOID INTERF SCI, V341, P12, DOI 10.1016/j.jcis.2009.04.047; Liu J, 2009, REACT KINET CATAL L, V98, P311, DOI 10.1007/s11144-009-0093-2; Liu XW, 2009, J AM CHEM SOC, V131, P3140, DOI 10.1021/ja808433d; Lu XW, 2013, POWDER TECHNOL, V239, P415, DOI 10.1016/j.powtec.2013.01.060; Lu XH, 2011, J MATER CHEM, V21, P5569, DOI 10.1039/c0jm04466k; Mai HX, 2005, J PHYS CHEM B, V109, P24380, DOI 10.1021/jp055584b; Pal P, 2013, RSC ADV, V3, P10837, DOI 10.1039/c3ra23485a; Pan CS, 2008, J SOLID STATE CHEM, V181, P1298, DOI 10.1016/j.jssc.2008.02.011; Shah V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047827; Sun CW, 2012, ENERG ENVIRON SCI, V5, P8475, DOI 10.1039/c2ee22310d; Sun ZY, 2010, J MATER CHEM, V20, P1947, DOI 10.1039/b921510g; Tana, 2009, CATAL TODAY, V148, P179, DOI 10.1016/j.cattod.2009.02.016; Tang ZR, 2011, RSC ADV, V1, P1772, DOI 10.1039/c1ra00518a; Vantomme A, 2005, LANGMUIR, V21, P1132, DOI 10.1021/la047751p; Wang GF, 2010, J ALLOY COMPD, V493, P202, DOI 10.1016/j.jallcom.2009.12.053; Wang ZL, 2003, J PHYS CHEM B, V107, P13563, DOI 10.1021/jp036815m; Wu MZ, 2010, INT J MIN MET MATER, V17, P470, DOI [10.1007/S12613-010-0343-3, 10.1007/s12613-010-0343-3]; Yang ZJ, 2010, J CRYST GROWTH, V312, P426, DOI 10.1016/j.jcrysgro.2009.11.027; Yuan Q, 2009, J COLLOID INTERF SCI, V335, P151, DOI 10.1016/j.jcis.2009.04.007; Zhang C, 2014, NEW J CHEM, V38, P2581, DOI 10.1039/c4nj00214h; Zhang DS, 2007, J SOLID STATE CHEM, V180, P654, DOI 10.1016/j.jssc.2006.11.025; Zhou KB, 2005, J CATAL, V229, P206, DOI 10.1016/j.jcat.2004.11.004	33	1	1	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2015	10	7							e0132536	10.1371/journal.pone.0132536	http://dx.doi.org/10.1371/journal.pone.0132536			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EC	26151866	Green Published, Green Submitted, gold			2022-12-26	WOS:000358158900045
J	Albuquerque, FCA; Bueno, NB; Clemente, APG; Ferriolli, E; Florencio, TMMT; Hoffman, D; Sawaya, AL				Alves Albuquerque, Fabiana Cristina; Bueno, Nassib Bezerra; Grotti Clemente, Ana Paula; Ferriolli, Eduardo; Menezes Toledo Florencio, Telma Maria; Hoffman, Daniel; Sawaya, Ana Lydia			Association between Adult Stature and Energy Expenditure in Low-Income Women from Northeastern Brazil	PLOS ONE			English	Article							DOUBLY-LABELED-WATER; FAT-FREE MASS; METABOLIC-RATE; SAO-PAULO; OBESITY; POPULATION; UNDERNUTRITION; SHANTYTOWNS; DEUTERIUM; CHILDREN	Background Perinatal undernutrition may lead to important metabolic adaptations in adult life, short stature being the most visible. The present study aimed to evaluate the association between stature and total energy expenditure of low-income women. Method Women aged 19-45 years from low-income communities in Maceio-AL were recruited. A sample of 67 volunteers was selected and divided into either short stature (<= 152.4 cm; n = 34) or non-short stature (>= 158.7 cm; n = 33) group. Data on socioeconomic status, anthropometric variables, and hormonal profiles was collected. Total energy expenditure and body composition were assessed by the doubly labeled water technique with multiple points over 14 days. In addition, physical activity levels were measured with triaxial accelerometers and dietary intake data were collected using three 24-hour food records. Results The mean subject age was 30.94 years. Women of short stature had lower body weight and lean body mass compared to non-short women, but there were no differences in thyroid hormone concentrations or daily energy intake between the two groups. Short-stature women showed lower total energy expenditure (P = 0.01) and a significantly higher physical activity level (P = 0.01) compared to non-short women. However, the difference in total energy expenditure was no longer significant after statistical adjustment for age, lean body mass, and triiodothyronine concentrations. Conclusion Women with short stature present the same energy intake, but lower total energy expenditure than non-short women, even with a higher physical activity level, which suggests that they are more prone to weight gain.	[Alves Albuquerque, Fabiana Cristina; Grotti Clemente, Ana Paula; Menezes Toledo Florencio, Telma Maria] Univ Fed Alagoas, Dept Nutr, Maceio, Alagoas, Brazil; [Ferriolli, Eduardo] Univ Sao Paulo, Dept Clin Med, Fac Med Ribeirao Preto, Sao Paulo, Brazil; [Bueno, Nassib Bezerra; Sawaya, Ana Lydia] Univ Fed Sao Paulo, Dept Physiol, Sao Paulo, Brazil; [Hoffman, Daniel] Rutgers State Univ, Dept Nutr Sci, Newark, NJ 07102 USA	Universidade Federal de Alagoas; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Rutgers State University Newark; Rutgers State University New Brunswick	Florencio, TMMT (corresponding author), Univ Fed Alagoas, Dept Nutr, Maceio, Alagoas, Brazil.	telmatf_al@hotmail.com	Florencio, Telma/AAE-3394-2019; Ferriolli, Eduardo/AAZ-6594-2021; Bueno, Nassib Bezerra/P-8057-2018; CLEMENTE, ANA PAULA/N-6720-2019; Sawaya, Ana Lydia/D-3845-2014; Ferriolli, Eduardo/J-6258-2012	Ferriolli, Eduardo/0000-0002-5028-2451; Bueno, Nassib Bezerra/0000-0002-3286-0297; Sawaya, Ana Lydia/0000-0002-2580-9557; 	Brazilian National Council for Scientific and Technologic Development (CNPq) [552194/2011-5]	Brazilian National Council for Scientific and Technologic Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study is funded by the Brazilian National Council for Scientific and Technologic Development (CNPq) (http://www.cnpq.br/), process number 552194/2011-5. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASTRUP A, 1992, J CLIN ENDOCR METAB, V74, P279, DOI 10.1210/jc.74.2.279; Barbosa JM, 2009, ARCH LATINOAM NUTR, V59, P22; Baretta E, 2007, CAD SAUDE PUBLICA, V23, P1595, DOI 10.1590/S0102-311X2007000700010; Bosy-Westphal A, 2009, BRIT J NUTR, V102, P453, DOI 10.1017/S0007114508190304; Britto RPA, 2009, PUBLISHER MOREIRA JU, V68, P71; Castinheiras-Neto AG, 2009, BRAZILIAN JOURNAL OF, V3, P96; dos Reis HFC, 2009, ARQ BRAS CARDIOL, V92, P203, DOI 10.1590/S0066-782X2009000300007; COWARD WA, 1988, P NUTR SOC, V47, P209, DOI 10.1079/PNS19880037; Disse-Mohamed R, 2012, PLOS ONE, V7, P1; Ferreira Haroldo da Silva, 2005, Rev. Nutr., V18, P209; Ferriolli E, 2008, NUTRITIONAL SCIENCES, P442; Ferriolli E, 2010, RAPID COMMUN MASS SP, V24, P506, DOI 10.1002/rcm.4333; Florencio TMDT, 2001, BRIT J NUTR, V86, P277, DOI 10.1079/BJN2001396; Florencio TT, 2004, NUTR METAB CARDIOVAS, V14, P26, DOI 10.1016/S0939-4753(04)80044-9; Florencio TT, 2003, EUR J CLIN NUTR, V57, P1437, DOI 10.1038/sj.ejcn.1601708; FORBES GB, 1974, AM J CLIN NUTR, V27, P595, DOI 10.1093/ajcn/27.6.595; Frainer DES, 2008, REV BRAS CIN DES HUM, V10, P197; Grillo LP, 2005, EUR J CLIN NUTR, V59, P835, DOI 10.1038/sj.ejcn.1602150; Clemente APG, 2011, J PEDIAT-BRAZIL, V87, P138, DOI 10.2223/JPED.2071; Hoffman DJ, 2000, AM J CLIN NUTR, V72, P1025; Hoffman DJ, 2000, AM J CLIN NUTR, V72, P702; Johnstone AM, 2005, AM J CLIN NUTR, V82, P941, DOI 10.1093/ajcn/82.5.941; LOHMAN TJ, 1992, MEDICINE SCIENCE IN, V24, P1; Martins VJB, 2011, INT J ENV RES PUB HE, V8, P1817, DOI 10.3390/ijerph8061817; Monteiro J.P., 2007, CONSUMO ALIMENTAR VI, V1st; NELSON KM, 1992, AM J CLIN NUTR, V56, P848, DOI 10.1093/ajcn/56.5.848; Prentice A, 2006, INT J EPIDEMIOL, V35, P24, DOI 10.1093/ije/dyi204; Rosa BPS, 2012, RENEFARA, V3, P16; Sartorelli D. S., 2003, CAD SAUDE PUBLICA, V19, P29, DOI DOI 10.1590/S0102-311X2003000700004; SAWAYA AL, 1995, OBES RES, V3, pS107, DOI 10.1002/j.1550-8528.1995.tb00453.x; Scagliusi Fernanda Baeza, 2005, Rev. Nutr., V18, P541, DOI 10.1590/S1415-52732005000400009; Scagliusi FB, 2008, BRIT J NUTR, V100, P1060, DOI 10.1017/S0007114508971300; Schoeller D.A., 1996, HUMAN BODY COMPOSITI, P25; SCHOELLER DA, 1995, OBES RES, V3, P15, DOI 10.1002/j.1550-8528.1995.tb00003.x; Schoeller DA, 2002, PUBLIC HEALTH NUTR, V5, P883, DOI 10.1079/PHN2002378; SCHOELLER DA, 1980, AM J CLIN NUTR, V33, P2686, DOI 10.1093/ajcn/33.12.2686; SCHOELLER DA, 1988, J NUTR, V118, P1278, DOI 10.1093/jn/118.11.1278; SCRIMGEOUR CM, 1993, BIOL MASS SPECTROM, V22, P383, DOI 10.1002/bms.1200220704; Speakman JR, 1998, AM J CLIN NUTR, V68, p932S, DOI 10.1093/ajcn/68.4.932S; Wong W, 1990, THE DOUBLY LABELED W, P20; WONG WW, 1987, AM J CLIN NUTR, V45, P905, DOI 10.1093/ajcn/45.5.905; World Health Organization, 2007, WORLD HEALTH ORGANIZ	42	6	6	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131891	10.1371/journal.pone.0131891	http://dx.doi.org/10.1371/journal.pone.0131891			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147672	Green Published, Green Submitted, gold			2022-12-26	WOS:000358157600158
J	Braber, TL; Prakken, NHJ; Mosterd, A; Mali, WPTM; Doevendans, PAFM; Bots, ML; Velthuis, BK				Braber, Thijs L.; Prakken, Niek H. J.; Mosterd, Arend; Mali, Willem P. Th. M.; Doevendans, Pieter A. F. M.; Bots, Michiel L.; Velthuis, Birgitta K.			Identifying Coronary Artery Disease in Asymptomatic Middle-Aged Sportsmen: The Additional Value of Pulse Wave Velocity	PLOS ONE			English	Article							AMERICAN-HEART-ASSOCIATION; CENTRAL BLOOD-PRESSURE; CARDIOVASCULAR EVENTS; COMPUTED-TOMOGRAPHY; GENERAL-POPULATION; SCIENTIFIC STATEMENT; INVASIVE VALIDATION; AORTIC STIFFNESS; CARDIAC-ARREST; ALL-CAUSE	Background Cardiovascular screening may benefit middle-aged sportsmen, as coronary artery disease (CAD) is the main cause of exercise-related sudden cardiac death. Arterial stiffness, as measured by pulse wave velocity (PWV), may help identify sportsmen with subclinical CAD. We examined the additional value of PWV measurements to traditional CAD risk factors for identifying CAD. Methods From the Measuring Athlete's Risk of Cardiovascular events (MARC) cohort of asymptomatic, middle-aged sportsmen who underwent low-dose Cardiac CT (CCT) after routine sports medical examination (SME), 193 consecutive sportsmen (aged 55 +/- 6.6 years) were included with additional PWV measurements before CCT. Sensitivity, specificity and predictive values of PWV values (>8.3 and >7.5m/s) assessed by Arteriograph were used to identify CAD (coronary artery calcium scoring >= 100 Agatston Units or coronary CT angiography luminal stenosis >= 50%) and to assess the additional diagnostic value of PWV to established cardiovascular risk factors. Results Forty-seven sportsmen (24%) had CAD on CCT. They were older (58.9 vs. 53.8 years, p<0.001), had more hypertension (17 vs. 4%, p=0.003), higher cholesterol levels (5.7 vs. 5.4mmol/l) p=0.048), and more often were (ever) smokers (55 vs. 34%, p=0.008). Mean PWV was higher in those with CAD (8.9 vs. 8.0 m/s, p=0.017). For PWV >8.3m/s respectively >7.5m/s sensitivity to detect CAD on CT was 43% and 74%, specificity 69% and 45%, positive predictive value 31% and 30%, and negative predictive value 79% and 84%. Adding PWV to traditional risk factor models did not change the area under the curve (from 0.78 (95% CI = 0.709-0.848)) to AUC 0.78 (95% CI 0.710-0.848, p = 0.99)) for prediction of CAD on CCT. Conclusions Limited additional value was found for PWV on top of established risk factors to identify CAD. PWV might still have a role to identify CAD in middle-aged sportsmen if risk factors such as cholesterol are unknown.	[Braber, Thijs L.; Mali, Willem P. Th. M.; Velthuis, Birgitta K.] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands; [Braber, Thijs L.; Doevendans, Pieter A. F. M.] Univ Med Ctr Utrecht, Dept Cardiol, Utrecht, Netherlands; [Prakken, Niek H. J.] Univ Groningen, Univ Med Ctr Groningen, Dept Radiol, Groningen, Netherlands; [Mosterd, Arend] Meander Med Ctr, Dept Cardiol, Amersfoort, Netherlands; [Bots, Michiel L.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Groningen; Meander Medisch Centrum; Utrecht University; Utrecht University Medical Center	Braber, TL (corresponding author), Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands.	thijsbraber@gmail.com		Prakken, Niek/0000-0001-7043-3336				Aagaard P, 2013, MED SCI SPORT EXER, V45, P130, DOI 10.1249/MSS.0b013e31826c5552; AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Ben-Shlomo Y, 2014, J AM COLL CARDIOL, V63, P636, DOI 10.1016/j.jacc.2013.09.063; Berdowski J, 2013, EUR HEART J, V34, P3616, DOI 10.1093/eurheartj/eht401; Blacher J, 1999, CIRCULATION, V99, P2434, DOI 10.1161/01.CIR.99.18.2434; Borjesson M, 2010, EUR J CARDIOV PREV R, DOI [10.1097/HJR.0b013e32833b0969, DOI 10.1097/HJR.0B013E32833B0969]; Budoff MJ, 2010, JACC-CARDIOVASC IMAG, V3, P1229, DOI 10.1016/j.jcmg.2010.08.018; Coutinho T, 2011, JACC-CARDIOVASC IMAG, V4, P754, DOI 10.1016/j.jcmg.2011.04.011; Cruickshank K, 2002, CIRCULATION, V106, P2085, DOI 10.1161/01.CIR.0000033824.02722.F7; Exeter DJ, 2014, BRIT J SPORT MED, V48, P1167, DOI 10.1136/bjsports-2013-093360; Fletcher GF, 2013, CIRCULATION, V128, P873, DOI 10.1161/CIR.0b013e31829b5b44; Greenland P, 2004, JAMA-J AM MED ASSOC, V291, P210, DOI 10.1001/jama.291.2.210; Guimaraes GV, 2010, HYPERTENS RES, V33, P627, DOI 10.1038/hr.2010.42; Hansen TW, 2008, J HUM HYPERTENS, V22, P214, DOI 10.1038/sj.jhh.1002295; Hansen TW, 2006, CIRCULATION, V113, P664, DOI 10.1161/CIRCULATIONAHA.105.579342; Horvath IG, 2010, J HYPERTENS, V28, P2068, DOI 10.1097/HJH.0b013e32833c8a1a; Ikonomidis I, 2013, INT J CARDIOL, V168, P4890, DOI 10.1016/j.ijcard.2013.07.025; Jatoi NA, 2009, J HYPERTENS, V27, P2186, DOI 10.1097/HJH.0b013e32833057e8; Kim JH, 2012, NEW ENGL J MED, V366, P130, DOI 10.1056/NEJMoa1106468; Kullo IJ, 2006, HYPERTENSION, V47, P174, DOI 10.1161/01.HYP.0000199605.35173.14; Laurent S, 2001, HYPERTENSION, V37, P1236, DOI 10.1161/01.HYP.37.5.1236; Marijon E, 2011, CIRCULATION, V124, P672, DOI 10.1161/CIRCULATIONAHA.110.008979; Marwan M, 2009, HEART, V95, P1056, DOI 10.1136/hrt.2008.153353; Mattace-Raso FUS, 2010, EUR HEART J, V31, P2338, DOI 10.1093/eurheartj/ehq165; Mattace-Raso FUS, 2006, CIRCULATION, V113, P657, DOI 10.1161/CIRCULATIONAHA.105.555235; Menafoglio A, 2015, BRIT J SPORT MED, V49, P757, DOI 10.1136/bjsports-2014-093857; Mohlenkamp S, 2008, EUR HEART J, V29, P1903, DOI 10.1093/eurheartj/ehn163; Mohlenkamp S, 2014, BASIC RES CARDIOL, V109, DOI 10.1007/s00395-013-0391-8; Park JS, 2011, CLIN EXP HYPERTENS, V33, P501, DOI 10.3109/10641963.2011.601376; Pelliccia A, 2000, CIRCULATION, V102, P278; Polonsky TS, 2012, NAT REV CARDIOL, V9, P599, DOI 10.1038/nrcardio.2012.114; Rajzer MW, 2008, J HYPERTENS, V26, P2001, DOI 10.1097/HJH.0b013e32830a4a25; Rossen NB, 2014, AM J HYPERTENS, V27, P674, DOI 10.1093/ajh/hpt162; Silverman MG, 2014, EUR HEART J, V35, P2232, DOI 10.1093/eurheartj/eht508; Sutton-Tyrrell K, 2005, CIRCULATION, V111, P3384, DOI 10.1161/CIRCULATIONAHA.104.483628; Thompson PD, 2007, CIRCULATION, V115, P2358, DOI 10.1161/CIRCULATIONAHA.107.181485; Thompson PD, 2005, CIRCULATION, V112, P2354, DOI 10.1161/CIRCULATIONAHA.104.502591; Trachet B, 2010, ANN BIOMED ENG, V38, P876, DOI 10.1007/s10439-010-9945-1; Verwoert GC, 2012, J HUM HYPERTENS, V26, P28, DOI 10.1038/jhh.2010.124; Vliegenthart R, 2002, EUR HEART J, V23, P1596, DOI 10.1053/euhj.2002.3240; Wang TJ, 2006, NEW ENGL J MED, V355, P2631, DOI 10.1056/NEJMoa055373	41	2	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131895	10.1371/journal.pone.0131895	http://dx.doi.org/10.1371/journal.pone.0131895			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147752	Green Published, Green Submitted, gold			2022-12-26	WOS:000358157600159
J	Kenny, JD; Taylor, NE; Brown, EN; Solt, K				Kenny, Jonathan D.; Taylor, Norman E.; Brown, Emery N.; Solt, Ken			Dextroamphetamine (but Not Atomoxetine) Induces Reanimation from General Anesthesia: Implications for the Roles of Dopamine and Norepinephrine in Active Emergence	PLOS ONE			English	Article							ISOFLURANE ANESTHESIA; PROPOFOL ANESTHESIA; RATS; METHYLPHENIDATE; CHILDREN; POTENCY; MAC; REQUIREMENTS; AMPHETAMINE; SEVOFLURANE	Methylphenidate induces reanimation (active emergence) from general anesthesia in rodents, and recent evidence suggests that dopaminergic neurotransmission is important in producing this effect. Dextroamphetamine causes the direct release of dopamine and norepinephrine, whereas atomoxetine is a selective reuptake inhibitor for norepinephrine. Like methylphenidate, both drugs are prescribed to treat Attention Deficit Hyperactivity Disorder. In this study, we tested the efficacy of dextroamphetamine and atomoxetine for inducing reanimation from general anesthesia in rats. Emergence from general anesthesia was defined by return of righting. During continuous sevoflurane anesthesia, dextroamphetamine dose-dependently induced behavioral arousal and restored righting, but atomoxetine did not (n = 6 each). When the D1 dopamine receptor antagonist SCH-23390 was administered prior to dextroamphetamine under the same conditions, righting was not restored (n = 6). After a single dose of propofol (8 mg/kg IV), the mean emergence times for rats that received normal saline (vehicle) and dextroamphetamine (1 mg/kg IV) were 641 sec and 404 sec, respectively (n = 8 each). The difference was statistically significant. Although atomoxetine reduced mean emergence time to 566 sec (n = 8), this decrease was not statistically significant. Spectral analysis of electroencephalogram recordings revealed that dextroamphetamine and atomoxetine both induced a shift in peak power from delta (0.1-4 Hz) to theta (4-8 Hz) during continuous sevoflurane general anesthesia, which was not observed when animals were pre-treated with SCH-23390. In summary, dextroamphetamine induces reanimation from general anesthesia in rodents, but atomoxetine does not induce an arousal response under the same experimental conditions. This supports the hypothesis that dopaminergic stimulation during general anesthesia produces a robust behavioral arousal response. In contrast, selective noradrenergic stimulation causes significant neurophysiological changes, but does not promote behavioral arousal during general anesthesia. We hypothesize that dextroamphetamine is more likely than atomoxetine to be clinically useful for restoring consciousness in anesthetized patients, mainly due to its stimulation of dopaminergic neurotransmission.	[Kenny, Jonathan D.; Taylor, Norman E.; Brown, Emery N.; Solt, Ken] Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA; [Taylor, Norman E.; Brown, Emery N.; Solt, Ken] Harvard Univ, Sch Med, Dept Anaesthesia, Boston, MA 02115 USA; [Brown, Emery N.] MIT, Inst Med Engn & Sci, Cambridge, MA 02139 USA; [Brown, Emery N.] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Solt, K (corresponding author), Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA.	ksolt@mgh.harvard.edu	Solt, Ken/AAX-8188-2020	Solt, Ken/0000-0001-5328-2062; Kenny, Jonathan/0000-0003-3745-3217; Taylor, Norman/0000-0001-5961-6641	National Institute of General Medical Sciences [TR01-GM104948, K08-GM094394]; Mentored Research Training Grant (NET) from the Foundation for Anesthesia Education and Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K08GM094394, R01GM104948] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Mentored Research Training Grant (NET) from the Foundation for Anesthesia Education and Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by grants TR01-GM104948 (KS and ENB) and K08-GM094394 (KS) from the National Institute of General Medical Sciences (www.nigms.nih.gov), and a Mentored Research Training Grant (NET) from the Foundation for Anesthesia Education and Research (www.faer.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkire MT, 2007, ANESTHESIOLOGY, V107, P264, DOI 10.1097/01.anes.0000270741.33766.24; ANTOGNINI JF, 1993, ANESTHESIOLOGY, V79, P1244, DOI 10.1097/00000542-199312000-00015; Bari A, 2013, NEUROPHARMACOLOGY, V64, P53, DOI 10.1016/j.neuropharm.2012.07.020; Brown EN, 2011, ANNU REV NEUROSCI, V34, P601, DOI 10.1146/annurev-neuro-060909-153200; Brown EN, 2010, NEW ENGL J MED, V363, P2638, DOI 10.1056/NEJMra0808281; Bymaster FP, 2002, NEUROPSYCHOPHARMACOL, V27, P699, DOI 10.1016/S0893-133X(02)00346-9; Chambers NA, 2012, PEDIATR ANESTH, V22, P341, DOI 10.1111/j.1460-9592.2011.03717.x; Chemali JJ, 2012, ANESTHESIOLOGY, V116, P998, DOI 10.1097/ALN.0b013e3182518bfc; Chidambaran V, 2013, BMC ANESTHESIOL, V13, DOI 10.1186/1471-2253-13-8; Cole JW, 2002, PAEDIATR ANAESTH, V12, P442, DOI 10.1046/j.1460-9592.2002.00868.x; CROSS AJ, 1983, NEUROPHARMACOLOGY, V22, P1327, DOI 10.1016/0028-3908(83)90208-3; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Eger EI, 2001, ANESTH ANALG, V93, P947, DOI 10.1097/00000539-200110000-00029; EGER EI, 1965, ANESTHESIOLOGY, V26, P756, DOI 10.1097/00000542-196511000-00010; Fasting S, 2002, CAN J ANAESTH, V49, P545, DOI 10.1007/BF03017379; Fischer SP, 2006, ANESTH ANALG, V103, P203, DOI 10.1213/01.ane.0000221451.24482.11; Forsyth I, 2006, PEDIATR ANESTH, V16, P371, DOI 10.1111/j.1460-9592.2005.01830.x; Heal DJ, 2008, PHARMACOL BIOCHEM BE, V90, P184, DOI 10.1016/j.pbb.2008.03.016; Heal DJ, 2009, NEUROPHARMACOLOGY, V57, P608, DOI 10.1016/j.neuropharm.2009.08.020; Hudetz AG, 2003, ANESTHESIOLOGY, V99, P1125, DOI 10.1097/00000542-200311000-00019; JOHNSTON RR, 1974, ANESTHESIOLOGY, V41, P57, DOI 10.1097/00000542-197407000-00013; JOHNSTON RR, 1975, ANESTH ANALG, V54, P655; JOHNSTON RR, 1972, ANESTHESIOLOGY, V36, P357, DOI 10.1097/00000542-197204000-00010; Kasuga Takaho, 2008, Masui, V57, P748; Kelz MB, 2008, P NATL ACAD SCI USA, V105, P1309, DOI 10.1073/pnas.0707146105; Kirch C, 2011, ANN STAT, V39, P1427, DOI 10.1214/10-AOS868; Langsjo JW, 2012, J NEUROSCI, V32, P4935, DOI 10.1523/JNEUROSCI.4962-11.2012; Lepouse C, 2006, BRIT J ANAESTH, V96, P747, DOI 10.1093/bja/ael094; Luo T, 2011, ANESTHESIOLOGY, V115, P36, DOI 10.1097/ALN.0b013e3182207655; Luo T, 2009, ANESTHESIOLOGY, V111, P725, DOI 10.1097/ALN.0b013e3181b061a0; Mitra P, 2008, OBSERVED BRAIN DYNAM, Vxxii; Monk TG, 2008, ANESTHESIOLOGY, V108, P18, DOI 10.1097/01.anes.0000296071.19434.1e; MORUZZI G, 1949, ELECTROEN CLIN NEURO, V1, P455, DOI 10.1016/0013-4694(49)90066-8; Pillay S, 2011, ANESTHESIOLOGY, V115, P733, DOI 10.1097/ALN.0b013e31822c5ee1; RAMPIL IJ, 1993, ANESTHESIOLOGY, V78, P707, DOI 10.1097/00000542-199304000-00014; RAMPIL IJ, 1994, ANESTHESIOLOGY, V80, P606, DOI 10.1097/00000542-199403000-00017; Ririe DG, 1997, PAEDIATR ANAESTH, V7, P69, DOI 10.1046/j.1460-9592.1997.d01-34.x; Saczynski JS, 2012, NEW ENGL J MED, V367, P30, DOI 10.1056/NEJMoa1112923; Solt K, 2014, ANESTHESIOLOGY, V121, P311, DOI 10.1097/ALN.0000000000000117; Solt K, 2011, ANESTHESIOLOGY, V115, P791, DOI 10.1097/ALN.0b013e31822e92e5; Taylor NE, 2013, ANESTHESIOLOGY, V118, P30, DOI 10.1097/ALN.0b013e318278c896; Vazey EM, 2014, P NATL ACAD SCI USA, V111, P3859, DOI 10.1073/pnas.1310025111; Zecharia AY, 2009, J NEUROSCI, V29, P2177, DOI 10.1523/JNEUROSCI.4997-08.2009; Zhang LN, 2012, ANESTH ANALG, V115, P789, DOI 10.1213/ANE.0b013e3182645ea3	44	44	44	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131914	10.1371/journal.pone.0131914	http://dx.doi.org/10.1371/journal.pone.0131914			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148114	Green Published, gold, Green Submitted			2022-12-26	WOS:000358157600165
J	Mo, LH; Pospichalova, V; Huang, ZQ; Murphy, SK; Payne, S; Wang, F; Kennedy, M; Cianciolo, GJ; Bryja, V; Pizzo, SV; Bachelder, RE				Mo, Lihong; Pospichalova, Vendula; Huang, Zhiqing; Murphy, Susan K.; Payne, Sturgis; Wang, Fang; Kennedy, Margaret; Cianciolo, George J.; Bryja, Vitezslav; Pizzo, Salvatore V.; Bachelder, Robin E.			Ascites Increases Expression/Function of Multidrug Resistance Proteins in Ovarian Cancer Cells	PLOS ONE			English	Article							SURVIVAL; GENE; TRANSPORTERS; CHEMOTHERAPY; KINASE; MDR1	Chemotherapy resistance is the major reason for the failure of ovarian cancer treatment. One mechanism behind chemo-resistance involves the upregulation of multidrug resistance (MDR) genes (ABC transporters) that effectively transport (efflux) drugs out of the tumor cells. As a common symptom in stage III/IV ovarian cancer patients, ascites is associated with cancer progression. However, whether ascites drives multidrug resistance in ovarian cancer cells awaits elucidation. Here, we demonstrate that when cultured with ascites derived from ovarian cancer-bearing mice, a murine ovarian cancer cell line became less sensitive to paclitaxel, a first line chemotherapeutic agent for ovarian cancer patients. Moreover, incubation of murine ovarian cancer cells in vitro with ascites drives efflux function in these cells. Functional studies show ascites-driven efflux is suppressible by specific inhibitors of either of two ABC transporters [Multidrug Related Protein (MRP1); Breast Cancer Related Protein (BCRP)]. To demonstrate relevance of our findings to ovarian cancer patients, we studied relative efflux in human ovarian cancer cells obtained from either patient ascites or from primary tumor. Immortalized cell lines developed from human ascites show increased susceptibility to efflux inhibitors (MRP1, BCRP) compared to a cell line derived from a primary ovarian cancer, suggesting an association between ascites and efflux function in human ovarian cancer. Efflux in ascites-derived human ovarian cancer cells is associated with increased expression of ABC transporters compared to that in primary tumor-derived human ovarian cancer cells. Collectively, our findings identify a novel activity for ascites in promoting ovarian cancer multidrug resistance.	[Mo, Lihong; Murphy, Susan K.; Payne, Sturgis; Wang, Fang; Kennedy, Margaret; Cianciolo, George J.; Pizzo, Salvatore V.; Bachelder, Robin E.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Pospichalova, Vendula; Bryja, Vitezslav] Masaryk Univ, Fac Sci, CS-61137 Brno, Czech Republic; [Huang, Zhiqing; Murphy, Susan K.] Duke Univ, Med Ctr, Dept Obstet & Gynecol, Durham, NC 27710 USA	Duke University; Masaryk University Brno; Duke University	Bachelder, RE (corresponding author), Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA.	robin.bachelder@dm.duke.edu	Bryja, Vít?zslav/H-1925-2014; Pospichalova, Vendula/C-6126-2015; Bryja, Vítězslav/P-4217-2019; Murphy, Susan/R-3903-2019	Bryja, Vít?zslav/0000-0002-9136-5085; Pospichalova, Vendula/0000-0002-5957-2156; Bryja, Vítězslav/0000-0002-9136-5085; Murphy, Susan/0000-0001-8298-7272; Mo, Lihong/0000-0001-6701-0594	European Social Fund [CZ. 1.07/2.3.00/30.0009]; Department of Defense Ovarian Cancer Research Program Award [W81XWH-11-1-0469]; Gail Parkins Ovarian Cancer Research Fund; Internal Reserve Fund of the Department of Pathology; Duke University Medical Center	European Social Fund(European Social Fund (ESF)); Department of Defense Ovarian Cancer Research Program Award; Gail Parkins Ovarian Cancer Research Fund; Internal Reserve Fund of the Department of Pathology; Duke University Medical Center	This work was supported by CZ. 1.07/2.3.00/30.0009, European Social Fund (VP) (http://ec.europa.eu/esf/home.jsp), W81XWH-11-1-0469, Department of Defense Ovarian Cancer Research Program Award (SKM) (http://cdmrp.army.mil/ocrp/), Gail Parkins Ovarian Cancer Research Fund (SKM) (http://www.ovarianawareness.org), Internal Reserve Fund of the Department of Pathology, Duke University Medical Center (SVP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borst P, 2000, JNCI-J NATL CANCER I, V92, P1295, DOI 10.1093/jnci/92.16.1295; Cheng G, 2001, Zhonghua Zhong Liu Za Zhi, V23, P305; Couture L, 2006, PHARMACOL REV, V58, P244, DOI 10.1124/pr.58.2.7; George JA, 2005, CANCER RES, V65, P10381, DOI 10.1158/0008-5472.CAN-05-1822; Goncharenko-Khaider N, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-84; Hennessy BT, 2009, LANCET, V374, P1371, DOI 10.1016/S0140-6736(09)61338-6; Huang H, 2013, NEOPLASMA, V60, P546, DOI 10.4149/neo_2013_071; Jia P, 2005, INT J GYNECOL CANCER, V15, P1042, DOI 10.1111/j.1525-1438.2005.00260.x; Johnatty SE, 2013, GYNECOL ONCOL, V131, P8, DOI 10.1016/j.ygyno.2013.07.107; Kamazawa S, 2002, GYNECOL ONCOL, V86, P171, DOI 10.1006/gyno.2002.6738; Kasai T, 2002, J BIOL CHEM, V277, P5187, DOI 10.1074/jbc.M110295200; Kavallaris M, 1996, CANCER LETT, V102, P7, DOI 10.1016/0304-3835(96)04143-2; Kwon MJ, 2013, INT J MOL SCI, V14, P6624, DOI 10.3390/ijms14046624; Lan CY, 2013, TECHNOL CANCER RES T, V12, P259, DOI 10.7785/tcrt.2012.500312; Lane D, 2010, ONCOGENE, V29, P3519, DOI 10.1038/onc.2010.107; Loizzi V, 2003, AM J OBSTET GYNECOL, V189, P1301, DOI 10.1067/S0002-9378(03)00629-X; Luqmani YA, 2005, MED PRIN PRACT, V14, P35, DOI 10.1159/000086183; Maliepaard M, 1999, CANCER RES, V59, P4559; Markman M, 2000, Oncologist, V5, P26, DOI 10.1634/theoncologist.5-1-26; Penson RT, 2004, GYNECOL ONCOL, V93, P98, DOI 10.1016/j.ygyno.2003.11.053; Schmitz G, 2001, CURR OPIN LIPIDOL, V12, P129, DOI 10.1097/00041433-200104000-00006; Schondorf T, 2002, ANTICANCER RES, V22, P2199; Tangjitgamol S, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006014.pub6; Wang Y, 2011, CYTOKINE, V56, P365, DOI 10.1016/j.cyto.2011.06.005; Wang Y, 2010, CANCER LETT, V295, P110, DOI 10.1016/j.canlet.2010.02.019; Yoh K, 2004, CLIN CANCER RES, V10, P1691, DOI 10.1158/1078-0432.CCR-0937-3; Zajchowski DA, 2012, MOL CANCER THER, V11, P492, DOI 10.1158/1535-7163.MCT-11-0746	27	21	22	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131579	10.1371/journal.pone.0131579	http://dx.doi.org/10.1371/journal.pone.0131579			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148191	Green Published, Green Submitted, gold			2022-12-26	WOS:000358157600111
J	Shi, XN; Li, HJ; Yao, H; Liu, X; Li, L; Leung, KS; Kung, HF; Lu, D; Wong, MH; Lin, MCM				Shi, Xi-Nan; Li, Hongjian; Yao, Hong; Liu, Xu; Li, Ling; Leung, Kwong-Sak; Kung, Hsiang-fu; Lu, Di; Wong, Man-Hon; Lin, Marie Chia-mi			In Silico Identification and In Vitro and In Vivo Validation of Anti-Psychotic Drug Fluspirilene as a Potential CDK2 Inhibitor and a Candidate Anti-Cancer Drug	PLOS ONE			English	Article							METABOLISM; DOCKING; CELLS; ZINC	Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related deaths worldwide. Surgical resection and conventional chemotherapy and radiotherapy ultimately fail due to tumor recurrence and HCC's resistance. The development of novel therapies against HCC is thus urgently required. The cyclin-dependent kinase (CDK) pathways are important and well-established targets for cancer treatment. In particular, CDK2 is a key factor regulating the cell cycle G1 to S transition and a hallmark for cancers. In this study, we utilized our free and open-source protein-ligand docking software, idock, prospectively to identify potential CDK2 inhibitors from 4,311 FDA-approved small molecule drugs using a repurposing strategy and an ensemble docking methodology. Sorted by average idock score, nine compounds were purchased and tested in vitro. Among them, the anti-psychotic drug fluspirilene exhibited the highest anti-proliferative effect in human hepatocellular carcinoma HepG2 and Huh7 cells. We demonstrated for the first time that fluspirilene treatment significantly increased the percentage of cells in G1 phase, and decreased the expressions of CDK2, cyclin E and Rb, as well as the phosphorylations of CDK2 on Thr160 and Rb on Ser795. We also examined the anti-cancer effect of fluspirilene in vivo in BALB/C nude mice subcutaneously xenografted with human hepatocellular carcinoma Huh7 cells. Our results showed that oral fluspirilene treatment significantly inhibited tumor growth. Fluspirilene (15 mg/kg) exhibited strong anti-tumor activity, comparable to that of the leading cancer drug 5-fluorouracil (10 mg/kg). Moreover, the cocktail treatment with fluspirilene and 5-fluorouracil exhibited the highest therapeutic effect. These results suggested for the first time that fluspirilene is a potential CDK2 inhibitor and a candidate anti-cancer drug for the treatment of human hepatocellular carcinoma. In view of the fact that fluspirilene has a long history of safe human use, our discovery of fluspirilene as a potential anti-HCC drug may present an immediately applicable clinical therapy.	[Shi, Xi-Nan; Liu, Xu; Li, Ling; Kung, Hsiang-fu; Lu, Di; Lin, Marie Chia-mi] Kunming Med Univ, Ctr Biotechnol, Kunming, Yunnan, Peoples R China; [Li, Hongjian; Leung, Kwong-Sak; Wong, Man-Hon] Chinese Univ Hong Kong, Dept Comp Sci & Engn, Hong Kong, Hong Kong, Peoples R China; [Shi, Xi-Nan] Southwest Guizhou Vocat & Tech Coll Nationalities, Dept Med, Xuzhou, Guizhou, Peoples R China; [Lin, Marie Chia-mi] Shenzhen Univ, Sch Med, Shenzhen Key Lab Translat Med Tumor, Shenzhen, Peoples R China; [Yao, Hong] Xuzhou Med Coll, Canc Biotherapy Inst Jiangsu Prov, Xuzhou, Peoples R China; [Yao, Hong; Kung, Hsiang-fu] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China	Kunming Medical University; Chinese University of Hong Kong; Shenzhen University; Xuzhou Medical University; Chinese University of Hong Kong	Leung, KS (corresponding author), Chinese Univ Hong Kong, Dept Comp Sci & Engn, Hong Kong, Hong Kong, Peoples R China.	ksleung@cse.cuhk.edu.hk; mcmlin@163.com	Wong, Man Hon/GOH-0560-2022; Shi, Xi-Nan/AAV-8400-2021		Hsiang-fu Kung academician workstation of Kunming Medical University; National Natural Science Foundation of China (NSFC) [81272549]; Key Lab project of Shenzhen from China [ZDSY20130329101130496]; Chinese University of Hong Kong; GRF Grant from Research Grants Council of Hong Kong [414413, 772910, 470911]	Hsiang-fu Kung academician workstation of Kunming Medical University; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Key Lab project of Shenzhen from China; Chinese University of Hong Kong(Chinese University of Hong Kong); GRF Grant from Research Grants Council of Hong Kong	~ This study was supported by grants from the Hsiang-fu Kung academician workstation of Kunming Medical University, National Natural Science Foundation of China (NSFC) 81272549, Key Lab project of Shenzhen (ZDSY20130329101130496) from China, the Direct Grant from the Chinese University of Hong Kong, the GRF Grant (Project References 414413, 772910, and 470911) from the Research Grants Council of Hong Kong.	Ballester PJ, 2007, J COMPUT CHEM, V28, P1711, DOI [10.1002/jcc.20681, 10.1002/JCC.20681]; Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Cobrinik D, 2005, ONCOGENE, V24, P2796, DOI 10.1038/sj.onc.1208619; Craig IR, 2010, J CHEM INF MODEL, V50, P511, DOI 10.1021/ci900407c; DeAzevedo WF, 1997, EUR J BIOCHEM, V243, P518, DOI 10.1111/j.1432-1033.1997.0518a.x; GLAB N, 1994, FEBS LETT, V353, P207, DOI 10.1016/0014-5793(94)01035-8; HEYKANT.JPP, 1969, LIFE SCI PT 1 PHYSI, V8, P1029, DOI 10.1016/0024-3205(69)90154-4; Hongjian Li, 2012, 2012 IEEE Symposium on Computational Intelligence in Bioinformatics and Computational Biology (CIBCB), P77, DOI 10.1109/CIBCB.2012.6217214; Huang RL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001862; Huang SY, 2007, PROTEINS, V66, P399, DOI 10.1002/prot.21214; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Irwin JJ, 2012, J CHEM INF MODEL, V52, P1757, DOI 10.1021/ci3001277; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Khedr MA, 2014, EUR J PHARM SCI, V65, P130, DOI 10.1016/j.ejps.2014.09.014; Korb O, 2012, J CHEM INF MODEL, V52, P1262, DOI 10.1021/ci2005934; Law V, 2014, NUCLEIC ACIDS RES, V42, pD1091, DOI 10.1093/nar/gkt1068; Li HJ, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-56; Li HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085678; Lin RX, 2005, ACTA PHARMACOL SIN, V26, P762, DOI 10.1111/j.1745-7254.2005.00762.x; Ma DL, 2013, CHEM SOC REV, V42, P2130, DOI 10.1039/c2cs35357a; Mariaule G, 2014, MOLECULES, V19, P14366, DOI 10.3390/molecules190914366; Meraldi P, 1999, NAT CELL BIOL, V1, P88, DOI 10.1038/10054; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Patil SP, 2015, J COMPUT AID MOL DES, V29, P155, DOI 10.1007/s10822-014-9811-6; Pihan E, 2012, BIOINFORMATICS, V28, P1540, DOI 10.1093/bioinformatics/bts186; Pines J, 1999, NAT CELL BIOL, V1, pE73, DOI 10.1038/11041; Senderowicz AM, 1999, INVEST NEW DRUG, V17, P313, DOI 10.1023/A:1006353008903; Teo C.Y., 2013, METABOLOMICS, V3, P118; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Zhong HJ, 2014, BIOCHIMIE, V102, P211, DOI 10.1016/j.biochi.2014.03.005	31	61	62	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132072	10.1371/journal.pone.0132072	http://dx.doi.org/10.1371/journal.pone.0132072			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147897	gold, Green Submitted, Green Published			2022-12-26	WOS:000358157600196
J	Valcarcel-Ocete, L; Alkorta-Aranburu, G; Iriondo, M; Fullaondo, A; Garcia-Barcina, M; Fernandez-Garcia, JM; Lezcano-Garcia, E; Losada-Domingo, JM; Ruiz-Ojeda, J; de Arcaya, AA; Perez-Ramos, JM; Roos, RAC; Nielsen, JE; Saft, C; Zubiaga, AM; Aguirre, A				Valcarcel-Ocete, Leire; Alkorta-Aranburu, Gorka; Iriondo, Mikel; Fullaondo, Asier; Garcia-Barcina, Maria; Manuel Fernandez-Garcia, Jose; Lezcano-Garcia, Elena; Maria Losada-Domingo, Jose; Ruiz-Ojeda, Javier; Alvarez de Arcaya, Amaia; Maria Perez-Ramos, Jose; Roos, Raymund A. C.; Nielsen, Jorgen E.; Saft, Carsten; Zubiaga, Ana M.; Aguirre, Ana		European Huntington's Dis Network	Exploring Genetic Factors Involved in Huntington Disease Age of Onset: E2F2 as a New Potential Modifier Gene	PLOS ONE			English	Article							CASPASE-ACTIVATED DNASE; NMDA RECEPTOR FUNCTION; CAG REPEAT LENGTH; MUTANT HUNTINGTIN; PGC-1-ALPHA; PROTEIN-1; PHOSPHORYLATION; TRANSCRIPTION; ASSOCIATION; APOPTOSIS	Age of onset (AO) of Huntington disease (HD) is mainly determined by the length of the CAG repeat expansion (CAGexp) in exon 1 of the HTT gene. Additional genetic variation has been suggested to contribute to AO, although the mechanism by which it could affect AO is presently unknown. The aim of this study is to explore the contribution of candidate genetic factors to HD AO in order to gain insight into the pathogenic mechanisms underlying this disorder. For that purpose, two AO definitions were used: the earliest age with unequivocal signs of HD (earliest AO or eAO), and the first motor symptoms age (motor AO or mAO). Multiple linear regression analyses were performed between genetic variation within 20 candidate genes and eAO or mAO, using DNA and clinical information of 253 HD patients from REGISTRY project. Gene expression analyses were carried out by RT-qPCR with an independent sample of 35 HD patients from Basque Country Hospitals. We found suggestive association signals between HD eAO and/or mAO and genetic variation within the E2F2, ATF7IP, GRIN2A, GRIN2B, LINC01559, HIP1 and GRIK2 genes. Among them, the most significant was the association between eAO and rs2742976, mapping to the promoter region of E2F2 transcription factor. Furthermore, rs2742976 T allele patient carriers exhibited significantly lower lymphocyte E2F2 gene expression, suggesting a possible implication of E2F2-dependent transcriptional activity in HD pathogenesis. Thus, E2F2 emerges as a new potential HD AO modifier factor.	[Valcarcel-Ocete, Leire; Iriondo, Mikel; Fullaondo, Asier; Zubiaga, Ana M.; Aguirre, Ana] Univ Basque Country UPV EHU, Dept Genet Phys Anthropol & Anim Physiol, Leioa, Spain; [Alkorta-Aranburu, Gorka] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Garcia-Barcina, Maria] Basurto Univ Hosp, Genet Unit, Bilbao, Spain; [Manuel Fernandez-Garcia, Jose] Basurto Univ Hosp, Neurol Serv, Bilbao, Spain; [Lezcano-Garcia, Elena; Maria Losada-Domingo, Jose] Cruces Univ Hosp, Dept Neurol, Baracaldo, Spain; [Ruiz-Ojeda, Javier] Galdakao Usansolo Hosp, Dept Neurol, Galdakao, Spain; [Alvarez de Arcaya, Amaia; Maria Perez-Ramos, Jose] Alava Univ Hosp, Dept Neurol, Vitoria, Spain; [Roos, Raymund A. C.] Leiden Univ, Dept Neurol, Med Ctr, Leiden, Netherlands; [Nielsen, Jorgen E.] Rigshosp, Univ Copenhagen Hosp, Neurogenet Clin, Danish Dementia Res Ctr, DK-2100 Copenhagen, Denmark; [Saft, Carsten] Ruhr Univ Bochum, St Josef Hosp, Huntington Zentrum NRW Bochum, Bochum, Germany	University of Basque Country; University of Chicago; Basurto Hospital; Basurto Hospital; Hospital Universitario Cruces; Galdakao Hospital; University Hospital of Araba; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Rigshospitalet; University of Copenhagen; Ruhr University Bochum	Aguirre, A (corresponding author), Univ Basque Country UPV EHU, Dept Genet Phys Anthropol & Anim Physiol, Leioa, Spain.	ana.aguirre@ehu.es	Fullaondo, Asier/G-7131-2019; Iriondo, Mikel/AAA-7997-2019; Romano, Silvia/P-7984-2015; zubiaga, ana/S-3457-2019; Fullaondo, Asier/L-2848-2019	Fullaondo, Asier/0000-0001-5387-4762; Iriondo, Mikel/0000-0001-7835-0041; Romano, Silvia/0000-0003-0499-8843; zubiaga, ana/0000-0002-2132-9708; Fullaondo, Asier/0000-0001-5387-4762; AGUIRRE ESCOBAL, ANA ISABEL/0000-0002-5624-443X; Saft, Carsten/0000-0002-3983-7292; Nielsen, Jorgen Erik/0000-0003-0453-5582	Basque Government [PE08UN78, 09+UEGV096/C01, IT634-13]; University of the Basque Country (UPV/EHU) [UFI 11/20]; CHDI Foundation, Inc.; Novo Nordisk Fonden [NNF11OC1014514] Funding Source: researchfish	Basque Government(Basque Government); University of the Basque Country (UPV/EHU); CHDI Foundation, Inc.; Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by Basque Government grants (PE08UN78,09+UEGV096/C01 and IT634-13) received by AA and by University of the Basque Country (UPV/EHU) grant (UFI 11/20) received by AMZ. The European Huntington's Disease Network is funded by CHDI Foundation, Inc. (http://chdifoundation.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberch J, 2005, NEUROLOGY, V65, P964, DOI 10.1212/01.wnl.0000175977.57661.b1; Andresen JM, 2007, J MED GENET, V44, P44, DOI 10.1136/jmg.2006.045153; Andresen JM, 2007, ANN HUM GENET, V71, P295, DOI 10.1111/j.1469-1809.2006.00335.x; ANDREW SE, 1993, NAT GENET, V4, P398, DOI 10.1038/ng0893-398; Anne SL, 2007, J NEUROSCI, V27, P7318, DOI 10.1523/JNEUROSCI.1831-07.2007; Arning L, 2005, NEUROGENETICS, V6, P25, DOI 10.1007/s10048-004-0198-8; Arning L, 2008, J MOL MED, V86, P485, DOI 10.1007/s00109-007-0299-6; Arning L, 2007, HUM GENET, V122, P175, DOI 10.1007/s00439-007-0393-4; Arning Larissa, 2004, BMC Med Genet, V5, P7, DOI 10.1186/1471-2350-5-7; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Brinkman RR, 1997, AM J HUM GENET, V60, P1202; Chang KH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046492; Chattopadhyay B, 2005, NEUROSCI LETT, V374, P81, DOI 10.1016/j.neulet.2004.10.018; Chattopadhyay B, 2003, NEUROSCI LETT, V345, P93, DOI 10.1016/S0304-3940(03)00436-1; Che HV, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-1; Chen-Plotkin AS, 2006, NEUROBIOL DIS, V22, P233, DOI 10.1016/j.nbd.2005.11.001; Dhaenens CM, 2009, NEUROBIOL DIS, V35, P474, DOI 10.1016/j.nbd.2009.06.009; Dimassi S, 2013, AM J MED GENET A, V161, P2564, DOI 10.1002/ajmg.a.36079; Djousse L, 2003, AM J MED GENET A, V119A, P279, DOI 10.1002/ajmg.a.20190; Dunah AW, 2002, SCIENCE, V296, P2238, DOI 10.1126/science.1072613; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Fan MMY, 2007, PROG NEUROBIOL, V81, P272, DOI 10.1016/j.pneurobio.2006.11.003; Fontaine SN, 2012, FEBS LETT, V586, P3030, DOI 10.1016/j.febslet.2012.07.011; Gauthier LR, 2004, CELL, V118, P127, DOI 10.1016/j.cell.2004.06.018; Gervais FG, 2002, NAT CELL BIOL, V4, P95, DOI 10.1038/ncb735; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; Graham RK, 2010, J NEUROSCI, V30, P15019, DOI 10.1523/JNEUROSCI.2071-10.2010; Gusella JF, 2009, GENOME MED, V1, DOI 10.1186/gm80; Hackam AS, 2000, J BIOL CHEM, V275, P41299, DOI 10.1074/jbc.M008408200; Holbert S, 2001, P NATL ACAD SCI USA, V98, P1811, DOI 10.1073/pnas.041566798; Huettner JE, 2003, PROG NEUROBIOL, V70, P387, DOI 10.1016/S0301-0082(03)00122-9; Infante A, 2008, CELL CYCLE, V7, P3915, DOI 10.4161/cc.7.24.7379; Jeong H, 2012, NAT MED, V18, P159, DOI 10.1038/nm.2559; Jeong H, 2009, CELL, V137, P60, DOI 10.1016/j.cell.2009.03.018; Jiang ML, 2012, NAT MED, V18, P153, DOI 10.1038/nm.2558; Kaltenbach LS, 2007, PLOS GENET, V3, P689, DOI 10.1371/journal.pgen.0030082; Kobal J, 2012, HUNTINGTON'S DISEASE - CORE CONCEPTS AND CURRENT ADVANCES, P101; Lee JM, 2012, NEUROLOGY, V78, P690, DOI 10.1212/WNL.0b013e318249f683; Liu XS, 1998, P NATL ACAD SCI USA, V95, P8461, DOI 10.1073/pnas.95.15.8461; Lu MX, 2012, MOL CARCINOGEN, V51, pE132, DOI 10.1002/mc.21882; Luo SQ, 2005, J CELL BIOL, V169, P647, DOI 10.1083/jcb.200412071; Majumder P, 2006, NEUROBIOL DIS, V22, P242, DOI 10.1016/j.nbd.2005.11.003; Marchina E, 2014, J NEUROL SCI, V337, P42, DOI 10.1016/j.jns.2013.11.014; Matute C, 2011, CNS NEUROSCI THER, V17, P661, DOI 10.1111/j.1755-5949.2010.00204.x; McGill JK, 2006, CELL, V127, P465, DOI 10.1016/j.cell.2006.10.023; Metzger S, 2008, HUM MOL GENET, V17, P1137, DOI 10.1093/hmg/ddn003; Metzger S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068951; Metzger S, 2010, HUM GENET, V128, P453, DOI 10.1007/s00439-010-0873-9; Metzler M, 2007, J NEUROSCI, V27, P2298, DOI 10.1523/JNEUROSCI.5175-06.2007; Orth Michael, 2011, PLoS Curr, V3, pRRN1258, DOI 10.1371/currents.RRN1258; Paulsen JS, 2008, J NEUROL NEUROSUR PS, V79, P874, DOI 10.1136/jnnp.2007.128728; Persengiev SP, 2001, ONCOGENE, V20, P5124, DOI 10.1038/sj.onc.1204663; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Polager S, 2008, ONCOGENE, V27, P4860, DOI 10.1038/onc.2008.117; Ramos EM, 2012, HUM GENET, V131, P1833, DOI 10.1007/s00439-012-1205-z; Rangone H, 2004, EUR J NEUROSCI, V19, P273, DOI 10.1111/j.0953-816X.2003.03131.x; Roos RAC, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-40; Ross CA, 2011, LANCET NEUROL, V10, P83, DOI 10.1016/S1474-4422(10)70245-3; Rubinsztein DC, 1997, P NATL ACAD SCI USA, V94, P3872, DOI 10.1073/pnas.94.8.3872; Saft Carsten, 2011, PLoS Curr, V3, pRRN1247, DOI 10.1371/currents.RRN1247; Sassone J, 2009, EXP NEUROL, V219, P385, DOI 10.1016/j.expneurol.2009.05.012; Tabrizi SJ, 2009, LANCET NEUROL, V8, P791, DOI 10.1016/S1474-4422(09)70170-X; Taherzadeh-Fard E, 2010, NEUROGENETICS, V11, P435, DOI 10.1007/s10048-010-0248-3; Taherzadeh-Fard E, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-10; Trynka G, 2013, CURR OPIN GENET DEV, V23, P635, DOI 10.1016/j.gde.2013.10.009; U M, 2001, CELL DEATH DIFFER, V8, P377, DOI 10.1038/sj.cdd.4400819; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Warby SC, 2009, AM J HUM GENET, V84, P351, DOI 10.1016/j.ajhg.2009.02.003; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wexler NS, 2004, P NATL ACAD SCI USA, V101, P3498, DOI 10.1073/pnas.0308479101; Weydt P, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-3; Wu LLY, 2009, CELL ADHES MIGR, V3, P71, DOI 10.4161/cam.3.1.7511; Zeng WQ, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-62; Zuccato C, 2001, SCIENCE, V293, P493, DOI 10.1126/science.1059581	75	8	8	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131573	10.1371/journal.pone.0131573	http://dx.doi.org/10.1371/journal.pone.0131573			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148071	gold, Green Published, Green Submitted			2022-12-26	WOS:000358157600110
J	Li, A; Ceballos-Diaz, C; DiNunno, N; Levites, Y; Cruz, PE; Lewis, J; Golde, TE; Chakrabarty, P				Li, Andrew; Ceballos-Diaz, Carolina; DiNunno, Nadia; Levites, Yona; Cruz, Pedro E.; Lewis, Jada; Golde, Todd E.; Chakrabarty, Paramita			IFN-gamma promotes tau phosphorylation without affecting mature tangles	FASEB JOURNAL			English	Article						interferon-gamma; neuroinflammation; tau tangle; GSK3 beta	GLIAL-NEURONAL INTERACTIONS; ALZHEIMERS-DISEASE; TRANSGENIC MICE; MOUSE MODEL; IN-VIVO; NEUROFIBRILLARY TANGLES; GENE-EXPRESSION; DOWN-REGULATION; UP-REGULATION; BETA-CATENIN	Inflammatory activation precedes and correlates with accumulating tau lesions in Alzheimer's disease and tauopathies. However, the relationship between neuroinflammation and etiology of pathologic tau remains elusive. To evaluate whether inflammatory signaling may promote or accelerate neurofibrillary tangle pathology, we explored the effect of recombinant adeno-associated virus (rAAV)-mediated overexpression of a master inflammatory cytokine, IFN-gamma, ont phosphorylation. In initial studies in primary neuroglial cultures, rAAV-mediated expression of IFN-gamma did not alter endogenous tau production or paired helical filament tau phosphorylation. Next, we tested the effect of rAAV-mediated expression of IFN-gamma in the brains of 2 mouse models of tauopathy: JNPL3 and rTg4510. In both models, IFN-gamma increased 1) signal transducer and activator of transcription 1 levels and gliosis, and 2) hyperphosphorylation and conformational alterations of soluble t compared with control cohorts. However, sarkosyl-insoluble phosphorylated tau levels and ubiquitin staining were unaltered in the IFN-gamma cohorts. Notably, IFN-gamma-induced t hyperphosphorylation was associated with release of the inhibitory effect of glycogen synthase kinase 3 beta function by decreasing Ser9 phosphorylation. Our data suggest that type II IFN signaling can promote tau phosphorylation by modulating cellular kinase activity, though this is insufficient in accelerating neuritic tangle pathology.	[Li, Andrew; Ceballos-Diaz, Carolina; DiNunno, Nadia; Levites, Yona; Cruz, Pedro E.; Lewis, Jada; Golde, Todd E.; Chakrabarty, Paramita] Univ Florida, Dept Neurosci, Ctr Translat Res Neurodegenerat Dis, Gainesville, FL 32610 USA	State University System of Florida; University of Florida	Golde, TE (corresponding author), Univ Florida, Dept Neurosci, Ctr Translat Res Neurodegenerat Dis, POB 100159, Gainesville, FL 32610 USA.	tgolde@ufl.edu; pchakrabarty@ufl.edu			NATIONAL INSTITUTE ON AGING [R01AG018454, U01AG046139] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG018454, U01 AG046139] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Abbas N, 2002, J NEUROIMMUNOL, V126, P50, DOI 10.1016/S0165-5728(02)00050-4; Ali A, 2001, CHEM REV, V101, P2527, DOI 10.1021/cr000110o; Bhaskar K, 2010, NEURON, V68, P19, DOI 10.1016/j.neuron.2010.08.023; Carter SF, 2012, J NUCL MED, V53, P37, DOI 10.2967/jnumed.110.087031; Chakrabarty P, 2010, J IMMUNOL, V184, P5333, DOI 10.4049/jimmunol.0903382; Chakrabarty P, 2010, FASEB J, V24, P548, DOI 10.1096/fj.09-141754; Colangelo V, 2002, J NEUROSCI RES, V70, P462, DOI 10.1002/jnr.10351; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Ghosh S, 2013, J NEUROSCI, V33, P5053, DOI 10.1523/JNEUROSCI.4361-12.2013; Griffin WST, 1998, BRAIN PATHOL, V8, P65; Hanger DP, 2014, J ALZHEIMERS DIS, V40, pS37, DOI 10.3233/JAD-132054; Heneka MT, 2013, NATURE, V493, P674, DOI 10.1038/nature11729; Heppner FL, 2015, NAT REV NEUROSCI, V16, P358, DOI 10.1038/nrn3880; HICKS SP, 1946, J LAB CLIN MED, V31, P1375; Hu XY, 2006, IMMUNITY, V24, P563, DOI 10.1016/j.immuni.2006.02.014; Jaworski T, 2011, AM J PATHOL, V179, P2001, DOI 10.1016/j.ajpath.2011.06.025; Kitazawa M, 2005, J NEUROSCI, V25, P8843, DOI 10.1523/JNEUROSCI.2868-05.2005; Kitazawa M, 2011, J IMMUNOL, V187, P6539, DOI 10.4049/jimmunol.1100620; Komori T, 1999, BRAIN PATHOL, V9, P663; Kopeikina KJ, 2012, TRANSL NEUROSCI, V3, P223, DOI 10.2478/s13380-012-0032-y; Lee DC, 2013, NEUROPATH APPL NEURO, V39, P69, DOI 10.1111/nan.12002; Lee DC, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-56; Lee J, 2002, NEUROMOL MED, V2, P29; Lewis J, 2000, NAT GENET, V25, P402, DOI 10.1038/78078; Li YK, 2003, J NEUROSCI, V23, P1605; Lucas JJ, 2001, EMBO J, V20, P27, DOI 10.1093/emboj/20.1.27; Martin L, 2013, AGEING RES REV, V12, P289, DOI 10.1016/j.arr.2012.06.003; Mastrangelo MA, 2009, AM J PATHOL, V175, P2076, DOI 10.2353/ajpath.2009.090059; Noble W, 2009, FASEB J, V23, P739, DOI 10.1096/fj.08-113795; Oddo S, 2006, J BIOL CHEM, V281, P1599, DOI 10.1074/jbc.M507892200; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Patel NS, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-9; Petry FR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094251; Ricciarelli R, 2004, IUBMB LIFE, V56, P349, DOI 10.1080/15216540412331286002; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Santillo AF, 2011, EUR J NUCL MED MOL I, V38, P2202, DOI 10.1007/s00259-011-1895-9; Sasaki A, 2008, BRAIN RES, V1214, P159, DOI 10.1016/j.brainres.2008.02.084; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Shaftel SS, 2007, J CLIN INVEST, V117, P1595, DOI 10.1172/JCI31450; Sheffield LG, 2000, NEUROSCI LETT, V285, P165, DOI 10.1016/S0304-3940(00)01037-5; Sheng JG, 1997, J NEUROPATH EXP NEUR, V56, P285, DOI 10.1097/00005072-199703000-00007; Sheng JG, 2000, EXP NEUROL, V163, P388, DOI 10.1006/exnr.2000.7393; Spillantini MG, 2013, LANCET NEUROL, V12, P609, DOI 10.1016/S1474-4422(13)70090-5; Sy M, 2011, AM J PATHOL, V178, P2811, DOI 10.1016/j.ajpath.2011.02.012; Tosto G, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0381-0; vom Berg J, 2012, NAT MED, V18, P1812, DOI 10.1038/nm.2965; Zilka N, 2009, J NEUROIMMUNOL, V209, P16, DOI 10.1016/j.jneuroim.2009.01.013	47	21	21	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2015	29	10					4384	4398		10.1096/fj.15-275834	http://dx.doi.org/10.1096/fj.15-275834			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CR5FY	26156074	Green Published			2022-12-26	WOS:000361367300026
J	Di Lorenzo, F; Kubik, L; Oblak, A; Lore, NI; Cigana, C; Lanzetta, R; Parrilli, M; Hamad, MA; De Soyza, A; Silipo, A; Jerala, R; Bragonzi, A; Valvano, MA; Martin-Santamaria, S; Molinaro, A				Di Lorenzo, Flaviana; Kubik, Lukasz; Oblak, Alja; Lore, Nicola Ivan; Cigana, Cristina; Lanzetta, Rosa; Parrilli, Michelangelo; Hamad, Mohamad A.; De Soyza, Anthony; Silipo, Alba; Jerala, Roman; Bragonzi, Alessandra; Valvano, Miguel A.; Martin-Santamaria, Sonsoles; Molinaro, Antonio			Activation of Human Toll-like Receptor 4 (TLR4)center dot Myeloid Differentiation Factor 2 (MD-2) by Hypoacylated Lipopolysaccharide from a Clinical Isolate of Burkholderia cenocepacia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cystic fibrosis; Gram-negative bacteria; innate immunity; lipopolysaccharide (LPS); molecular modeling; Burkholderia; TLR4; MD-2	LIPID-A; PSEUDOMONAS-AERUGINOSA; STRUCTURAL BASIS; RECOGNITION; LPS; BACTERIAL; COMPLEX; TLR4; AMINOARABINOSE; BIOSYNTHESIS	Background: The Burkholderia cenocepacia lipid A is hypoacylated. Results: Aminoarabinose residues in lipid A contribute to Burkholderia lipid A binding to the TLR4MD-2 complex. Conclusion: A novel mode of Burkholderia lipopolysaccharide-TLR4MD-2 interactions promotes inflammation. Significance: Modifications of the lipid A structure enhance proinflammatory responses of hypoacylated lipopolysaccharide. Lung infection by Burkholderia species, in particular Burkholderia cenocepacia, accelerates tissue damage and increases post-lung transplant mortality in cystic fibrosis patients. Host-microbe interplay largely depends on interactions between pathogen-specific molecules and innate immune receptors such as Toll-like receptor 4 (TLR4), which recognizes the lipid A moiety of the bacterial lipopolysaccharide (LPS). The human TLR4myeloid differentiation factor 2 (MD-2) LPS receptor complex is strongly activated by hexa-acylated lipid A and poorly activated by underacylated lipid A. Here, we report that B. cenocepacia LPS strongly activates human TLR4MD-2 despite its lipid A having only five acyl chains. Furthermore, we show that aminoarabinose residues in lipid A contribute to TLR4-lipid A interactions, and experiments in a mouse model of LPS-induced endotoxic shock confirmed the proinflammatory potential of B. cenocepacia penta-acylated lipid A. Molecular modeling combined with mutagenesis of TLR4-MD-2 interactive surfaces suggests that longer acyl chains and the aminoarabinose residues in the B. cenocepacia lipid A allow exposure of the fifth acyl chain on the surface of MD-2 enabling interactions with TLR4 and its dimerization. Our results provide a molecular model for activation of the human TLR4MD-2 complex by penta-acylated lipid A explaining the ability of hypoacylated B. cenocepacia LPS to promote proinflammatory responses associated with the severe pathogenicity of this opportunistic bacterium.	[Di Lorenzo, Flaviana; Lanzetta, Rosa; Silipo, Alba; Molinaro, Antonio] Univ Naples Federico II, Dept Chem Sci, I-80126 Naples, Italy; [Parrilli, Michelangelo] Univ Naples Federico II, Dept Biol, I-80126 Naples, Italy; [Kubik, Lukasz; Martin-Santamaria, Sonsoles] Univ CEU San Pablo, Dept Chem & Biochem, Madrid 28668, Spain; [Kubik, Lukasz] Med Univ Gdansk, Dept Biopharmaceut & Pharmacodynam, PL-80416 Gdansk, Poland; [Di Lorenzo, Flaviana; Oblak, Alja; Jerala, Roman] Natl Inst Chem, Dept Biotechnol, Ljubljana 1000, Slovenia; [Oblak, Alja; Jerala, Roman] Ctr Excellence NMR Future Innovat Sustainable Tec, Ljubljana 1000, Slovenia; [Lore, Nicola Ivan; Cigana, Cristina; Bragonzi, Alessandra] Ist Ricovero & Cura Carattere Sci, San Raffaele Sci Inst, Infect & Cyst Fibrosis Unit, I-20132 Milan, Italy; [Hamad, Mohamad A.; Valvano, Miguel A.] Univ Western Ontario, Dept Microbiol & Immunol, London, ON N6A 5C1, Canada; [De Soyza, Anthony] Univ Newcastle, Inst Cellular Med, Appl Immunobiol & Transplantat Grp, Newcastle NE1 7RU, Tyne & Wear, England; [Valvano, Miguel A.] Queens Univ Belfast, Ctr Infect & Immun, Belfast BT9 7AE, Antrim, North Ireland	University of Naples Federico II; University of Naples Federico II; San Pablo CEU University; Fahrenheit Universities; Medical University Gdansk; National Institute of Chemistry - Slovenia; IRCCS Ca Granda Ospedale Maggiore Policlinico; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Western University (University of Western Ontario); Newcastle University - UK; Queens University Belfast	Martin-Santamaria, S (corresponding author), CIB CSIC, Biol Res Ctr, Dept Chem & Phys Biol, Madrid 28040, Spain.	smsantamaria@cib.csic.es; molinaro@unina.it	Valvano, Miguel A/G-8759-2012; Martin-Santamaria, Sonsoles/A-8035-2012; Bragonzi, Alessandra/AAC-6751-2022; Lorè, Nicola Ivan/K-9285-2016; Cigana, Cristina/D-2883-2016; Silipo, Alba/L-5929-2014	Valvano, Miguel A/0000-0001-8229-3641; Martin-Santamaria, Sonsoles/0000-0002-7679-0155; Lorè, Nicola Ivan/0000-0001-9159-1632; Cigana, Cristina/0000-0003-0436-9721; Bragonzi, Alessandra/0000-0002-5808-7669; Parrilli, Michelangelo/0000-0001-8858-3623; Di Lorenzo, Flaviana/0000-0003-4821-0114; silipo, alba/0000-0002-5394-6532; LANZETTA, Rosa/0000-0002-1472-5825; Molinaro, Antonio/0000-0002-3456-7369	Spanish Ministry of Economy and Competitiveness [CTQ2011-22724]; Universidad CEU San Pablo [PC14/2011, PC13/2012]; Slovenian Research Agency; Centre of Excellence NMR - Future Innovation for Sustainable Technologies; European structural funds; Cystic Fibrosis Canada; European Cooperation in Science and Technology Actions [BM1003, CM1102]; Marie Curie Initial Training Networks (ITN) GLYCOPHARM [PITN-GA-2012-317297, H2020-MSCA-ITN-2014-ETN TOLLerant]; Airbus Military research contract; Higher Education Funding Council of England; Financial and Fiscal Commission grant	Spanish Ministry of Economy and Competitiveness(Spanish Government); Universidad CEU San Pablo; Slovenian Research Agency(Slovenian Research Agency - Slovenia); Centre of Excellence NMR - Future Innovation for Sustainable Technologies; European structural funds; Cystic Fibrosis Canada; European Cooperation in Science and Technology Actions; Marie Curie Initial Training Networks (ITN) GLYCOPHARM; Airbus Military research contract; Higher Education Funding Council of England(UK Research & Innovation (UKRI)Higher Education Funding Council for England (HEFCE)); Financial and Fiscal Commission grant	This work was supported in part by Spanish Ministry of Economy and Competitiveness Grant CTQ2011-22724, Universidad CEU San Pablo Grants PC14/2011 and PC13/2012, the Slovenian Research Agency, Centre of Excellence NMR - Future Innovation for Sustainable Technologies, European structural funds, Cystic Fibrosis Canada, European Cooperation in Science and Technology Actions BM1003 and CM1102, and Marie Curie Initial Training Networks (ITN) GLYCOPHARM PITN-GA-2012-317297 and H2020-MSCA-ITN-2014-ETN TOLLerant. The authors declare that they have no conflict of interest with the content of this article.; Supported by an Airbus Military research contract.; Supported by a Higher Education Funding Council of England senior lecturership and a Financial and Fiscal Commission grant.	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Bainbridge BW, 2006, CELL MICROBIOL, V8, P120, DOI 10.1111/j.1462-5822.2005.00605.x; Bamford S, 2007, CELL MICROBIOL, V9, P532, DOI 10.1111/j.1462-5822.2006.00808.x; Brandenburg K, 1996, J ENDOTOXIN RES, V3, P173, DOI 10.1177/096805199600300302; BRANDENBURG K, 1993, EUR J BIOCHEM, V218, P555, DOI 10.1111/j.1432-1033.1993.tb18409.x; Broz P, 2013, NAT REV IMMUNOL, V13, P551, DOI 10.1038/nri3479; De Soyza A, 2004, AM J RESP CRIT CARE, V170, P70, DOI 10.1164/rccm.200304-592OC; Di Lorenzo F, 2015, MOL IMMUNOL, V63, P166, DOI 10.1016/j.molimm.2014.04.004; Ernst RK, 1999, SCIENCE, V286, P1561, DOI 10.1126/science.286.5444.1561; Frisch M.J., 2004, GAUSSIAN 03; Fukuoka S, 2001, BBA-BIOMEMBRANES, V1510, P185, DOI 10.1016/S0005-2736(00)00347-3; Gay NJ, 2007, ANNU REV BIOCHEM, V76, P141, DOI 10.1146/annurev.biochem.76.060305.151318; GOLENBOCK DT, 1991, J BIOL CHEM, V266, P19490; Goodsell DS, 1996, J MOL RECOGNIT, V9, P1, DOI 10.1002/(SICI)1099-1352(199601)9:1<1::AID-JMR241>3.0.CO;2-6; Gruber A, 2004, J BIOL CHEM, V279, P28475, DOI 10.1074/jbc.M400993200; Hajjar AM, 2002, NAT IMMUNOL, V3, P354, DOI 10.1038/ni777; Hamad MA, 2012, MOL MICROBIOL, V85, P962, DOI 10.1111/j.1365-2958.2012.08154.x; Herath TDK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058496; Hollaus R, 2015, CHEM-EUR J, V21, P4102, DOI 10.1002/chem.201406058; Holst O, 2009, MICROBIAL GLYCOBIOLOGY: STRUCTURES, RELEVANCE AND APPLICATIONS, P29; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jeukens J., 2013, GENOME ANNOUNC, V1; KITTELBERGER R, 1993, J BIOCHEM BIOPH METH, V26, P81, DOI 10.1016/0165-022X(93)90024-I; Klett J, 2014, CURR TOP MED CHEM, V14, P2672; Klett J, 2012, J CHEM THEORY COMPUT, V8, P3395, DOI 10.1021/ct300497z; Knirel YA, 2009, MICROBIAL GLYCOBIOLOGY: STRUCTURES, RELEVANCE AND APPLICATIONS, P57; Kobayashi M, 2006, J IMMUNOL, V176, P6211, DOI 10.4049/jimmunol.176.10.6211; Lohmann KL, 2007, J ENDOTOXIN RES, V13, P235, DOI 10.1177/0968051907083193; Maeshima N, 2015, J BIOL CHEM, V290, P13440, DOI 10.1074/jbc.M115.653881; Maeshima N, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00003; Meng JM, 2010, J BIOL CHEM, V285, P27935, DOI 10.1074/jbc.M110.134668; Molinaro A, 2015, CHEM-EUR J, V21, P500, DOI 10.1002/chem.201403923; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Nagai Y, 2002, NAT IMMUNOL, V3, P667, DOI 10.1038/ni809; Ohto U, 2007, SCIENCE, V316, P1632, DOI 10.1126/science.1139111; Ohto U, 2012, P NATL ACAD SCI USA, V109, P7421, DOI 10.1073/pnas.1201193109; Oikawa M, 2004, ORG BIOMOL CHEM, V2, P3557, DOI 10.1039/b410544c; Ortega X, 2009, J BIOL CHEM, V284, P21738, DOI 10.1074/jbc.M109.008532; Ortega XP, 2007, J BACTERIOL, V189, P3639, DOI 10.1128/JB.00153-07; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Rangel-Frausto MS, 2005, ARCH MED RES, V36, P672, DOI 10.1016/j.arcmed.2005.06.006; Re F, 2003, J IMMUNOL, V171, P5272, DOI 10.4049/jimmunol.171.10.5272; Resman N, 2009, J BIOL CHEM, V284, P15052, DOI 10.1074/jbc.M901429200; RIETSCHEL ET, 1994, FASEB J, V8, P217, DOI 10.1096/fasebj.8.2.8119492; Saitoh S, 2004, INT IMMUNOL, V16, P961, DOI 10.1093/intimm/dxh097; Schrodinger, 2012, SUIT 2012 PROT PREP; Schrodinger, 2012, SUIT 2012 IMP VERS 5; Schrodinger, 2012, SUIT 2012 MAESTR VER; Schrodinger, 2012, SUIT 2012 MACROMODEL; Schromm AB, 2000, EUR J BIOCHEM, V267, P2008, DOI 10.1046/j.1432-1327.2000.01204.x; Seydel U, 2000, EUR J BIOCHEM, V267, P3032; Silipo A, 2007, CHEM-EUR J, V13, P3501, DOI 10.1002/chem.200601406; Silipo A, 2010, GLYCOBIOLOGY, V20, P406, DOI 10.1093/glycob/cwp201; Speert David Paul, 2002, Paediatr Respir Rev, V3, P230, DOI 10.1016/S1526-0542(02)00185-9; Truhlar DG, 2007, J COMPUT CHEM, V28, P73, DOI 10.1002/jcc.20529; Visintin A, 2003, J BIOL CHEM, V278, P48313, DOI 10.1074/jbc.M306802200; WESTPHAL O., 1965, METHOD CARBOHYD CHEM, V5, P83; Zughaier SM, 1999, INFECT IMMUN, V67, P1505, DOI 10.1128/IAI.67.3.1505-1507.1999	59	36	38	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2015	290	35					21305	21319		10.1074/jbc.M115.649087	http://dx.doi.org/10.1074/jbc.M115.649087			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ5IS	26160169	Green Accepted, hybrid, Green Published			2022-12-26	WOS:000360637600010
J	Page, AP; Yergeau, E; Greer, CW				Page, Antoine P.; Yergeau, Etienne; Greer, Charles W.			Salix purpurea Stimulates the Expression of Specific Bacterial Xenobiotic Degradation Genes in a Soil Contaminated with Hydrocarbons	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; PLANT-ROOT EXTRACTS; POLYCHLORINATED-BIPHENYLS; PHYTOREMEDIATION SYSTEM; PAH DEGRADATION; CO2 EVOLUTION; CROP PLANTS; RHIZOSPHERE; BIODEGRADATION; METABOLISM	The objectives of this study were to uncover Salix purpurea-microbe xenobiotic degradation systems that could be harnessed in rhizoremediation, and to identify microorganisms that are likely involved in these partnerships. To do so, we tested S. purpurea's ability to stimulate the expression of 10 marker microbial oxygenase genes in a soil contaminated with hydrocarbons. In what appeared to be a detoxification rhizosphere effect, transcripts encoding for alkane 1-monooxygenases, cytochrome P450 monooxygenases, laccase/polyphenol oxidases, and biphenyl 2,3-dioxygenase small subunits were significantly more abundant in the vicinity of the plant's roots than in bulk soil. This gene expression induction is consistent with willows' known rhizoremediation capabilities, and suggests the existence of S. purpurea-microbe systems that target many organic contaminants of interest (i.e. C4-C16 alkanes, fluoranthene, anthracene, benzo(a)pyrene, biphenyl, polychlorinated biphenyls). An enhanced expression of the 4 genes was also observed within the bacterial orders Actinomycetales, Rhodospirillales, Burkholderiales, Alteromonadales, Solirubrobacterales, Caulobacterales, and Rhizobiales, which suggest that members of these taxa are active participants in the exposed partnerships. Although the expression of the other 6 marker genes did not appear to be stimulated by the plant at the community level, signs of additional systems that rest on their expression by members of the orders Solirubrobacterales, Sphingomonadales, Actinomycetales, and Sphingobacteriales were observed. Our study presents the first transcriptomics-based identification of microbes whose xenobiotic degradation activity in soil appears stimulated by a plant. It paints a portrait that contrasts with the current views on these consortia's composition, and opens the door for the development of laboratory test models geared towards the identification of root exudate characteristics that limit the efficiency of current willow-based rhizoremediation applications.	[Page, Antoine P.; Greer, Charles W.] McGill Univ, Dept Nat Resource Sci, Montreal, PQ, Canada; [Yergeau, Etienne; Greer, Charles W.] Natl Res Council Canada, Energy Min & Environm, Montreal, PQ, Canada	McGill University; National Research Council Canada	Page, AP (corresponding author), McGill Univ, Dept Nat Resource Sci, Montreal, PQ, Canada.	antoine.page@mcgill.ca	Yergeau, Etienne/AAZ-6145-2020; Yergeau, Etienne/B-5344-2008	Yergeau, Etienne/0000-0002-7112-3425; 	Genome Canada/Genome Quebec [2510]	Genome Canada/Genome Quebec(Genome Canada)	Genome Canada/Genome Quebec Grant 2510 (www.genomecanada.ca) (www.genomequebec.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aly HAH, 2008, APPL ENVIRON MICROB, V74, P3812, DOI 10.1128/AEM.00226-08; Argus George W., 2007, Harvard Papers in Botany, V12, P335, DOI 10.3100/1043-4534(2007)12[335:SSDMAA]2.0.CO;2; Badri DV, 2013, J BIOL CHEM, V288, P4502, DOI 10.1074/jbc.M112.433300; Bais HP, 2006, ANNU REV PLANT BIOL, V57, P233, DOI 10.1146/annurev.arplant.57.032905.105159; Bell TH, 2014, ISME J, V8, P331, DOI 10.1038/ismej.2013.149; da Cunha ACB, 2012, WATER AIR SOIL POLL, V223, P4723, DOI 10.1007/s11270-012-1228-z; Bressler DC, 2000, CAN J MICROBIOL, V46, P397, DOI 10.1139/cjm-46-5-397; Ceasar SA, 2012, BIOTECHNOL LETT, V34, P995, DOI 10.1007/s10529-012-0871-1; Chen SH, 1999, ENVIRON SCI TECHNOL, V33, P435, DOI 10.1021/es9805730; Collinge DB, 2010, ANNU REV PHYTOPATHOL, V48, P269, DOI 10.1146/annurev-phyto-073009-114430; Collins PJ, 1996, APPL ENVIRON MICROB, V62, P4563, DOI 10.1128/AEM.62.12.4563-4567.1996; Cook RL, 2010, INT J PHYTOREMEDIAT, V12, P716, DOI 10.1080/15226510903390395; de Carcer DA, 2007, APPL ENVIRON MICROB, V73, P6224, DOI 10.1128/AEM.01254-07; Deavers K, 2010, ENVIRON SCI POLLUT R, V17, P1355, DOI 10.1007/s11356-010-0321-3; Dixon P, 2003, J VEG SCI, V14, P927, DOI 10.1111/j.1654-1103.2003.tb02228.x; Dudasova H, 2012, INT BIODETER BIODEGR, V69, P23, DOI 10.1016/j.ibiod.2012.01.003; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Falchini L, 2003, SOIL BIOL BIOCHEM, V35, P775, DOI 10.1016/S0038-0717(03)00105-6; Ferro AM, 2013, INT J PHYTOREMEDIAT, V15, P232, DOI 10.1080/15226514.2012.687195; Filion M, 2008, MICROB BIOTECHNOL, V1, P463, DOI 10.1111/j.1751-7915.2008.00047.x; Fish JA, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00291; Furukawa K, 2008, J BIOSCI BIOENG, V105, P433, DOI 10.1263/jbb.105.433; Gao YZ, 2011, SOIL SCI SOC AM J, V75, P1694, DOI 10.2136/sssaj2010.0244; Gerhardt KE, 2009, PLANT SCI, V176, P20, DOI 10.1016/j.plantsci.2008.09.014; Gilbert ES, 1997, APPL ENVIRON MICROB, V63, P1933, DOI 10.1128/AEM.63.5.1933-1938.1997; Glick BR, 2010, BIOTECHNOL ADV, V28, P367, DOI 10.1016/j.biotechadv.2010.02.001; Gontia-Mishra I, 2014, BIOTECHNOL LETT, V36, P889, DOI 10.1007/s10529-014-1458-9; Hartmann A, 2009, PLANT SOIL, V321, P235, DOI 10.1007/s11104-008-9814-y; Herbst FA, 2013, PROTEOMICS, V13, P2910, DOI 10.1002/pmic.201200569; Huang XD, 2004, ENVIRON POLLUT, V130, P465, DOI 10.1016/j.envpol.2003.09.031; Hultgren J, 2010, INT J PHYTOREMEDIAT, V12, P54, DOI 10.1080/15226510902767122; Ionescu M, 2009, INT BIODETER BIODEGR, V63, P667, DOI 10.1016/j.ibiod.2009.03.009; Ji YR, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00058; Jiang H, 2010, BIOCHEM ENG J, V49, P277, DOI 10.1016/j.bej.2010.01.003; Jones DL, 1998, PLANT SOIL, V205, P25, DOI 10.1023/A:1004356007312; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kirkpatrick WD, 2008, INT J PHYTOREMEDIAT, V10, P210, DOI 10.1080/15226510801997648; Landi L, 2006, SOIL BIOL BIOCHEM, V38, P509, DOI 10.1016/j.soilbio.2005.05.021; Leigh MB, 2006, APPL ENVIRON MICROB, V72, P2331, DOI 10.1128/AEM.72.4.2331-2342.2006; Liste HH, 2006, CHEMOSPHERE, V62, P1411, DOI 10.1016/j.chemosphere.2005.05.018; Liste HH, 2006, APPL SOIL ECOL, V31, P43, DOI 10.1016/j.apsoil.2005.04.006; Luepromchai E, 2002, FEMS MICROBIOL ECOL, V41, P191, DOI 10.1111/j.1574-6941.2002.tb00980.x; Mackova M, 2009, ENVIRON SCI POLLUT R, V16, P817, DOI 10.1007/s11356-009-0240-3; Martin BC, 2014, SCI TOTAL ENVIRON, V472, P642, DOI 10.1016/j.scitotenv.2013.11.050; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Mills T, 2006, J ENVIRON MANAGE, V79, P232, DOI 10.1016/j.jenvman.2005.07.005; Nie Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep04968; Oger PM, 2004, MICROB ECOL, V47, P96, DOI 10.1007/s00248-003-2012-9; Panagos P, 2013, J ENVIRON PUBLIC HEA, V2013, DOI 10.1155/2013/158764; Pandey VC, 2014, INT J ENVIRON SCI TE, V11, P241, DOI 10.1007/s13762-013-0387-9; Peng RH, 2008, FEMS MICROBIOL REV, V32, P927, DOI 10.1111/j.1574-6976.2008.00127.x; Peng RH, 2010, REV ENVIRON CONTAM T, V206, P65, DOI 10.1007/978-1-4419-6260-7_4; Peuke AD, 2005, EMBO REP, V6, P497, DOI 10.1038/sj.embor.7400445; Phillips LA, 2012, APPL SOIL ECOL, V52, P56, DOI 10.1016/j.apsoil.2011.10.009; Pieper DH, 2008, J MOL MICROB BIOTECH, V15, P121, DOI 10.1159/000121325; REINER AM, 1971, J BACTERIOL, V108, P89, DOI 10.1128/JB.108.1.89-94.1971; Rentz JA, 2005, ENVIRON POLLUT, V136, P477, DOI 10.1016/j.envpol.2004.12.034; Rentz JA, 2004, ENVIRON MICROBIOL, V6, P574, DOI 10.1111/j.1462-2920.2004.00589.x; Resnick SM, 1996, J IND MICROBIOL BIOT, V17, P438, DOI 10.1007/BF01574775; Rivera-Hoyos CM, 2013, FUNGAL BIOL REV, V27, P67, DOI 10.1016/j.fbr.2013.07.001; Rojo F, 2009, ENVIRON MICROBIOL, V11, P2477, DOI 10.1111/j.1462-2920.2009.01948.x; SEEGER M, 1995, FEMS MICROBIOL LETT, V133, P259, DOI 10.1111/j.1574-6968.1995.tb07894.x; Selifonov SA, 1996, APPL ENVIRON MICROB, V62, P507, DOI 10.1128/AEM.62.2.507-514.1996; Siciliano SD, 2003, APPL ENVIRON MICROB, V69, P483, DOI 10.1128/AEM.69.1.483-489.2003; Singer AC, 2003, ENVIRON TOXICOL CHEM, V22, P1998, DOI 10.1897/02-471; Singer AC, 2001, SOIL BIOL BIOCHEM, V33, P765, DOI 10.1016/S0038-0717(00)00224-8; Singh A, 2009, SOIL BIOL, V17, P1, DOI 10.1007/978-3-540-89621-0_1; Slater H, 2011, CHEMOSPHERE, V84, P199, DOI 10.1016/j.chemosphere.2011.04.058; Strobel BW, 2001, GEODERMA, V99, P169, DOI 10.1016/S0016-7061(00)00102-6; Techer D, 2011, SCI TOTAL ENVIRON, V409, P4489, DOI 10.1016/j.scitotenv.2011.06.049; Toussaint JP, 2012, APPL MICROBIOL BIOT, V95, P1589, DOI 10.1007/s00253-011-3824-z; Uhlik O, 2013, APPL MICROBIOL BIOT, V97, P9245, DOI 10.1007/s00253-012-4627-6; van Beilen JB, 2005, CURR OPIN BIOTECH, V16, P308, DOI 10.1016/j.copbio.2005.04.005; van Beilen JB, 2003, OIL GAS SCI TECHNOL, V58, P427, DOI 10.2516/ogst:2003026; Walker TS, 2003, PLANT PHYSIOL, V132, P44, DOI 10.1104/pp.102.019661; Xie XM, 2012, CHEMOSPHERE, V88, P1190, DOI 10.1016/j.chemosphere.2012.03.068; Yateem A, 2007, SOIL SEDIMENT CONTAM, V16, P269, DOI 10.1080/15320380701285667; Yergeau E, 2014, ISME J, V8, P344, DOI 10.1038/ismej.2013.163; Yi H, 2007, ENVIRON SCI TECHNOL, V41, P4382, DOI 10.1021/es062397y; Yoshitomi KJ, 2001, SOIL BIOL BIOCHEM, V33, P1769, DOI 10.1016/S0038-0717(01)00102-X; Yousaf S, 2010, J HAZARD MATER, V184, P523, DOI 10.1016/j.jhazmat.2010.08.067; Yuste L, 1998, J BACTERIOL, V180, P5218, DOI 10.1128/JB.180.19.5218-5226.1998; Zalesny RS, 2005, INT J PHYTOREMEDIAT, V7, P177, DOI 10.1080/16226510500214632; Zeman NR, 2013, THESIS COLORADO STAT	84	47	48	4	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132062	10.1371/journal.pone.0132062	http://dx.doi.org/10.1371/journal.pone.0132062			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161539	Green Published, Green Submitted, gold			2022-12-26	WOS:000358162300088
J	Sawiak, SJ; Perumal, SR; Rudiger, SR; Matthews, L; Mitchell, NL; McLaughlan, CJ; Bawden, CS; Palmer, DN; Kuchel, T; Morton, AJ				Sawiak, Stephen J.; Perumal, Sunthara Rajan; Rudiger, Skye R.; Matthews, Loren; Mitchell, Nadia L.; McLaughlan, Clive J.; Bawden, C. Simon; Palmer, David N.; Kuchel, Timothy; Morton, A. Jennifer			Rapid and Progressive Regional Brain Atrophy in CLN6 Batten Disease Affected Sheep Measured with Longitudinal Magnetic Resonance Imaging	PLOS ONE			English	Article							NEURONAL CEROID-LIPOFUSCINOSIS; MOUSE MODEL; MUTATION; JUVENILE; MRI	Variant late-infantile Batten disease is a neuronal ceroid lipofuscinosis caused by mutations in CLN6. It is a recessive genetic lysosomal storage disease characterised by progressive neurodegeneration. It starts insidiously and leads to blindness, epilepsy and dementia in affected children. Sheep that are homozygous for a natural mutation in CLN6 have an ovine form of Batten disease Here, we used in vivo magnetic resonance imaging to track brain changes in 4 unaffected carriers and 6 affected Batten disease sheep. We scanned each sheep 4 times, between 17 and 22 months of age. Cortical atrophy in all sheep was pronounced at the baseline scan in all affected Batten disease sheep. Significant atrophy was also present in other brain regions (caudate, putamen and amygdala). Atrophy continued measurably in all of these regions during the study. Longitudinal MRI in sheep was sensitive enough to measure significant volume changes over the relatively short study period, even in the cortex, where nearly 40% of volume was already lost at the start of the study. Thus longitudinal MRI could be used to study the dynamics of progression of neurodegenerative changes in sheep models of Batten disease, as well as to assess therapeutic efficacy.	[Sawiak, Stephen J.; Morton, A. Jennifer] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England; [Sawiak, Stephen J.] Univ Cambridge, Wolfson Brain Imaging Ctr, Cambridge, England; [Perumal, Sunthara Rajan; Matthews, Loren; Kuchel, Timothy] South Australian Res & Dev Inst, Roseworthy, SA, Australia; [Rudiger, Skye R.; McLaughlan, Clive J.; Bawden, C. Simon] South Australian Hlth & Med Res Inst, Preclin Imaging & Res Labs, Gilles Plains, SA, Australia; [Mitchell, Nadia L.; Palmer, David N.] Lincoln Univ, Dept Mol Biosci, Fac Agr & Life Sci, Lincoln, New Zealand; [Mitchell, Nadia L.; Palmer, David N.] Lincoln Univ, Batten Anim Res Network, Lincoln, New Zealand	University of Cambridge; University of Cambridge; South Australian Research & Development Institute (SARDI); Lincoln University - New Zealand; Lincoln University - New Zealand	Morton, AJ (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Downing St, Cambridge, England.	ajm41@cam.ac.uk	Morton, Jenny/AAT-8642-2020; Sawiak, Stephen J/I-8944-2012	Morton, Jenny/0000-0003-0181-6346; Sawiak, Stephen J/0000-0003-4210-9816; Mitchell, Nadia/0000-0003-4801-2804; Perumal, Raj/0000-0001-6565-445X	CHDI Inc; US National Institutes of Health [NS 40297]; Neurological Foundation of NZ; Batten Disease Support and Research Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS040297] Funding Source: NIH RePORTER	CHDI Inc; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Neurological Foundation of NZ; Batten Disease Support and Research Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a grant from CHDI Inc to AJM. Founding the sheep flock, and costs in NZ relating to the rearing and genotyping of the animals were funded by a series of grants from the US National Institutes of Health (NS 40297), Neurological Foundation of NZ and the Batten Disease Support and Research Association (DNP, NLM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg L, 2000, NEUROLOGY, V54, P1069, DOI 10.1212/WNL.54.5.1069; Alroy J, 2011, THE NEURONAL CEROID, P284; [Anonymous], 2013, BIOCHIM BIOPHYS ACTA, V1832, P1793, DOI [10.1016/j.bbadis.2013.05.025, DOI 10.1016/J.BBADIS.2013.05.025]; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Ashburner J, 2013, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00197; Autti T, 1996, NEURORADIOLOGY, V38, P476; Autti T, 1997, NEURORADIOLOGY, V39, P371, DOI 10.1007/s002340050427; Bond M, 2013, BBA-MOL BASIS DIS, V1832, P1842, DOI 10.1016/j.bbadis.2013.01.009; Boustany RMN, 2013, NAT REV NEUROL, V9, P583, DOI 10.1038/nrneurol.2013.163; Broom MF, 1998, J MED GENET, V35, P717, DOI 10.1136/jmg.35.9.717; Davidson Beverly L., 2007, P371, DOI 10.1007/978-0-387-70909-3_23; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Guerreiro R, 2013, EUR J PAEDIATR NEURO, V17, P657, DOI 10.1016/j.ejpn.2013.04.011; Jacobsen JC, 2010, HUM MOL GENET, V19, P1873, DOI 10.1093/hmg/ddq063; Jadav RH, 2014, PEDIATR NEUROL, V50, P85, DOI 10.1016/j.pediatrneurol.2013.08.008; Jolly R D, 1976, N Z Vet J, V24, P123, DOI 10.1080/00480169.1976.34298; JOLLY RD, 1980, NEUROPATH APPL NEURO, V6, P195, DOI 10.1111/j.1365-2990.1980.tb00290.x; Karageorgos L, 2011, J INHERIT METAB DIS, V34, P209, DOI 10.1007/s10545-010-9230-3; Kessell AE, 2012, VET PATHOL, V49, P248, DOI 10.1177/0300985810395783; Kielar C, 2009, HUM MOL GENET, V18, P4066, DOI 10.1093/hmg/ddp355; Kirveskari E, 2001, J CHILD NEUROL, V16, P707, DOI 10.1177/088307380101601001; Kousi M, 2012, HUM MUTAT, V33, P42, DOI 10.1002/humu.21624; Le NMD, 2012, J CHILD NEUROL, V27, P234, DOI 10.1177/0883073811419261; Linterman KS, 2011, HUM GENE THER, V22, P1011, DOI 10.1089/hum.2011.026; Mills KL, 2014, DEV COGN NEUROS-NETH, V9, P172, DOI 10.1016/j.dcn.2014.04.004; Mole SE, 2005, NEUROGENETICS, V6, P107, DOI 10.1007/s10048-005-0218-3; Mole SE, 2011, THE NEURONAL CEROID; Morton AJ, 2014, HUM MOL GENET, V23, P3375, DOI 10.1093/hmg/ddu047; Nijssen PCG, 2002, MOVEMENT DISORD, V17, P482, DOI 10.1002/mds.10104; Oswald M J, 2001, Eur J Paediatr Neurol, V5 Suppl A, P135, DOI 10.1053/ejpn.2000.0450; Oswald MJ, 2005, NEUROBIOL DIS, V20, P49, DOI 10.1016/j.nbd.2005.01.025; Palmer D., 2011, NEURONAL CEROID LIPO, P284; Palmer DN, 2013, BBA-MOL BASIS DIS, V1832, P1882, DOI 10.1016/j.bbadis.2013.05.014; Platt FM, 2014, NATURE, V510, P68, DOI 10.1038/nature13476; Rider JA, 1997, NEUROPEDIATRICS, V28, P4, DOI 10.1055/s-2007-973653; Sawiak SJ, 2013, MAGN RESON IMAGING, V31, P1522, DOI 10.1016/j.mri.2013.06.001; Simonati A, 2000, NEUROPEDIATRICS, V31, P199, DOI 10.1055/s-2000-7453; Suarez-Vega A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081072; Tammen I, 2006, BBA-MOL BASIS DIS, V1762, P898, DOI 10.1016/j.bbadis.2006.09.004; Torres PA, 2010, MOL GENET METAB, V101, P357, DOI 10.1016/j.ymgme.2010.08.006; VANHANEN SL, 1994, AM J NEURORADIOL, V15, P1443; Weber K, 2013, J CHILD NEUROL, V28, P1123, DOI 10.1177/0883073813493666; Weimer JM, 2007, BRAIN RES, V1162, P98, DOI 10.1016/j.brainres.2007.05.018; Wong AMS, 2010, BIOCHEM SOC T, V38, P1484, DOI 10.1042/BST0381484	45	15	15	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132331	10.1371/journal.pone.0132331	http://dx.doi.org/10.1371/journal.pone.0132331			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161747	Green Submitted, gold, Green Published			2022-12-26	WOS:000358162300120
J	Shanks, L; Ritmeijer, K; Piriou, E; Siddiqui, MR; Kliescikova, J; Pearce, N; Ariti, C; Muluneh, L; Masiga, J; Abebe, A				Shanks, Leslie; Ritmeijer, Koert; Piriou, Erwan; Siddiqui, M. Ruby; Kliescikova, Jarmila; Pearce, Neil; Ariti, Cono; Muluneh, Libsework; Masiga, Johnson; Abebe, Almaz			Accounting for False Positive HIV Tests: Is Visceral Leishmaniasis Responsible?	PLOS ONE			English	Article							ALGORITHMS; INFECTION; DIAGNOSIS	Background Co-infection with HIV and visceral leishmaniasis is an important consideration in treatment of either disease in endemic areas. Diagnosis of HIV in resource-limited settings relies on rapid diagnostic tests used together in an algorithm. A limitation of the HIV diagnostic algorithm is that it is vulnerable to falsely positive reactions due to cross reactivity. It has been postulated that visceral leishmaniasis (VL) infection can increase this risk of false positive HIV results. This cross sectional study compared the risk of false positive HIV results in VL patients with non-VL individuals. Methodology/Principal Findings Participants were recruited from 2 sites in Ethiopia. The Ethiopian algorithm of a tiebreaker using 3 rapid diagnostic tests (RDTs) was used to test for HIV. The gold standard test was the Western Blot, with indeterminate results resolved by PCR testing. Every RDT screen positive individual was included for testing with the gold standard along with 10% of all negatives. The final analysis included 89 VL and 405 non-VL patients. HIV prevalence was found to be 12.8% (47/367) in the VL group compared to 7.9% (200/2526) in the non-VL group. The RDT algorithm in the VL group yielded 47 positives, 4 false positives, and 38 negatives. The same algorithm for those without VL had 200 positives, 14 false positives, and 191 negatives. Specificity and positive predictive value for the group with VL was less than the non-VL group; however, the difference was not found to be significant (p = 0.52 and p = 0.76, respectively). Conclusion The test algorithm yielded a high number of HIV false positive results. However, we were unable to demonstrate a significant difference between groups with and without VL disease. This suggests that the presence of endemic visceral leishmaniasis alone cannot account for the high number of false positive HIV results in our study.	[Shanks, Leslie; Ritmeijer, Koert; Piriou, Erwan; Kliescikova, Jarmila; Masiga, Johnson] Med Sans Frontieres, Amsterdam, Netherlands; [Siddiqui, M. Ruby] Med Sans Frontieres, London, England; [Pearce, Neil; Ariti, Cono] London Sch Hyg & Trop Med, London WC1, England; [Muluneh, Libsework; Abebe, Almaz] Ethiopian Hlth & Nutr Res Inst, Addis Ababa, Ethiopia	Doctors Without Borders; Doctors Without Borders; University of London; London School of Hygiene & Tropical Medicine; Ethiopian Health & Nutrition Research Institute	Shanks, L (corresponding author), Med Sans Frontieres, Amsterdam, Netherlands.	leslie.shanks@amsterdam.msf.org		Pearce, Neil/0000-0002-9938-7852; Siddiqui, Ruby/0000-0002-9638-594X				Aghokeng AF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007702; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Diro E, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002869; Gray RH, 2007, BRIT MED J, V335, P188, DOI 10.1136/bmj.39210.582801.BE; Klarkowski D, 2014, EXPERT REV ANTI-INFE, V12, P49, DOI 10.1586/14787210.2014.866516; Klarkowski D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081656; Klarkowski DB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004351; Kroidl I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039529; Lejon V, 2010, J CLIN MICROBIOL, V48, P2836, DOI 10.1128/JCM.00456-10; Mehra Bhanu, 2014, ISRN AIDS, V2014, P296840, DOI 10.1155/2014/296840; RIBEIRO TT, 1993, J ACQ IMMUN DEF SYND, V6, P319; Ritmeijer K, 2011, CLIN INFECT DIS, V53, pE152, DOI 10.1093/cid/cir674; Salinas A, 2007, CLIN INFECT DIS, V45, P139, DOI 10.1086/518709; Sandler SG, 1988, AIDS ETIOLOGY DIAGNO, P121; Shanks L, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0769-3; Shanks L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059906; World Health Organization, 2012, SERV DEL APPR HIV TE; Zeh C, 2011, J VIROL METHODS, V176, P24, DOI 10.1016/j.jviromet.2011.05.021; Zijlstra EE, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003258	19	11	11	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132422	10.1371/journal.pone.0132422	http://dx.doi.org/10.1371/journal.pone.0132422			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161864	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000358162300133
J	Stamboul, K; Lorin, J; Lorgis, L; Guenancia, C; Beer, JC; Touzery, C; Rochette, L; Vergely, C; Cottin, Y; Zeller, M				Stamboul, Karim; Lorin, Julie; Lorgis, Luc; Guenancia, Charles; Beer, Jean-Claude; Touzery, Claude; Rochette, Luc; Vergely, Catherine; Cottin, Yves; Zeller, Marianne			Atrial Fibrillation Is Associated with a Marker of Endothelial Function and Oxidative Stress in Patients with Acute Myocardial Infarction	PLOS ONE			English	Article							ASYMMETRIC DIMETHYLARGININE ADMA; OXIDE SYNTHASE INHIBITION; DYSFUNCTION; DISEASE; RISK; MORTALITY; IMPACT; DEATH	Background Atrial fibrillation (AF), whether silent or symptomatic, is a frequent and severe complication of acute myocardial infarction (AMI). Asymmetric dimethylarginine (ADMA), an endogenous eNOS inhibitor, is a risk factor for endothelial dysfunction. We addressed the relationship between ADMA plasma levels and AF occurrence in AMI. Methods 273 patients hospitalized for AMI were included. Continuous electrocardiographic monitoring (CEM) >= 48 hours was recorded and ADMA was measured by High Performance Liquid Chromatography on admission blood sample. Results The incidence of silent and symptomatic AF was 39(14%) and 29 (11%), respectively. AF patients were markedly older than patients without AF (approximate to 20 y). There was a trend towards higher ADMA levels in patients with symptomatic AF than in patients with silent AF or no AF (0.53 vs 0.49 and 0.49 mu mol/L, respectively, p = 0.18,). After matching on age, we found that patients with symptomatic AF had a higher heart rate on admission and a higher rate of patients with LV dysfunction (28% vs. 3%, p = 0.025). Patients who developed symptomatic AF had a higher ADMA level than patients without AF (0.53 vs. 0.43 mu mol/L; p = 0.001). Multivariate logistic regression analysis to estimate symptomatic AF occurrence showed that ADMA was independently associated with symptomatic AF (OR: 2.46 [1.21-5.00], p = 0.013) beyond history of AF, LVEF<40% and elevated HR. Conclusion We show that high ADMA level is associated with the occurrence of AF. Although no causative role can be concluded from our observational study, our work further supports the hypothesis that endothelial dysfunction is involved in the pathogenesis of AF in AMI.	[Stamboul, Karim; Lorgis, Luc; Guenancia, Charles; Beer, Jean-Claude; Touzery, Claude; Cottin, Yves] Univ Hosp, Dept Cardiol, Dijon, France; [Lorin, Julie; Rochette, Luc; Vergely, Catherine; Zeller, Marianne] Univ Burgundy, Lab Cardiometab Physiopathol & Pharmacol, UMR INSERM U866, Dijon, France	CHU Dijon Bourgogne; Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne	Zeller, M (corresponding author), Univ Burgundy, Lab Cardiometab Physiopathol & Pharmacol, UMR INSERM U866, Dijon, France.	Marianne.zeller@u-bourgogne.fr	Vergely, Catherine/L-9534-2015; Guenancia, Charles/M-5558-2013; COTTIN, YVES/ABA-4622-2020	Vergely, Catherine/0000-0003-4009-776X; Guenancia, Charles/0000-0002-3554-7714; Rochette, Luc/0000-0001-9973-8803	University Hospital of Dijon, Association de Cardiologie de Bourgogne; Agence Regionale de Sante(ARS) de Bourgogne; Conseil Regional de Bourgogne; Federation Francaise de Cardiologie (FFC); Societe Francaise de Cardiologie (SFC)	University Hospital of Dijon, Association de Cardiologie de Bourgogne; Agence Regionale de Sante(ARS) de Bourgogne(Region Bourgogne-Franche-Comte); Conseil Regional de Bourgogne(Region Bourgogne-Franche-Comte); Federation Francaise de Cardiologie (FFC); Societe Francaise de Cardiologie (SFC)	This work was supported by the University Hospital of Dijon, Association de Cardiologie de Bourgogne, and by grants from the Agence Regionale de Sante(ARS) de Bourgogne, Conseil Regional de Bourgogne, Federation Francaise de Cardiologie (FFC) and Societe Francaise de Cardiologie (SFC).	Achan V, 2003, ARTERIOSCL THROM VAS, V23, P1455, DOI 10.1161/01.ATV.0000081742.92006.59; Antoniades C, 2009, EUR HEART J, V30, P1142, DOI 10.1093/eurheartj/ehp061; Boger RH, 2006, ANN MED, V38, P126, DOI 10.1080/07853890500472151; Cai H, 2002, CIRCULATION, V106, P2854, DOI 10.1161/01.CIR.0000039327.11661.16; Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/europace/euq350, 10.1093/eurheartj/ehq278]; Caplin B, 2012, ARTERIOSCL THROM VAS, V32, P1343, DOI 10.1161/ATVBAHA.112.247726; Cengel A, 2008, ACTA CARDIOL, V63, P33, DOI 10.2143/AC.63.1.2025329; Chao TF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071675; Closs EI, 1997, NITRIC OXIDE-BIOL CH, V1, P65, DOI 10.1006/niox.1996.0106; Duckelmann C, 2007, ARTERIOSCL THROM VAS, V27, P2037, DOI 10.1161/ATVBAHA.107.147595; Goette A, 2012, INT J CARDIOL, V154, P141, DOI 10.1016/j.ijcard.2010.09.004; Ivanova M, 2010, CLIN CHIM ACTA, V411, P1632, DOI 10.1016/j.cca.2010.06.001; Jabre P, 2011, CIRCULATION, V123, P2094, DOI 10.1161/CIRCULATIONAHA.110.990192; Kielstein JT, 2004, CIRCULATION, V109, P172, DOI 10.1161/01.CIR.0000105764.22626.B1; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Li Y, 2011, J INTERV CARD ELECTR, V32, P147, DOI 10.1007/s10840-011-9588-7; Liu HY, 2008, BIOCHEM BIOPH RES CO, V377, P884, DOI 10.1016/j.bbrc.2008.10.080; Lorin J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064796; Polovina MM, 2014, CURR PHARM DES; Purohit A, 2013, CIRCULATION, V128, P1748, DOI 10.1161/CIRCULATIONAHA.113.003313; Rahman F, 2014, NAT REV CARDIOL, V11, P639, DOI 10.1038/nrcardio.2014.118; Rochette L, 2013, PHARMACOL THERAPEUT, V140, P239, DOI 10.1016/j.pharmthera.2013.07.004; Saczynski JS, 2009, AM J CARDIOL, V104, P169, DOI 10.1016/j.amjcard.2009.03.011; Schepers E, 2009, NEPHROL DIAL TRANSPL, V24, P1429, DOI 10.1093/ndt/gfn670; Schmitt J, 2009, EUR HEART J, V30, P1038, DOI 10.1093/eurheartj/ehn579; Schnabel R, 2005, CIRC RES, V97, P53, DOI 10.1161/01.RES.0000181286.44222.61; Schulze F, 2010, ATHEROSCLEROSIS, V208, P518, DOI 10.1016/j.atherosclerosis.2009.06.039; Schwedhelm E, 2011, NAT REV NEPHROL, V7, P275, DOI 10.1038/nrneph.2011.31; Sibal L, 2010, CURR CARDIOL REV, V6, P82, DOI 10.2174/157340310791162659; Stamboul K, 2014, INT J CARDIOL, V174, P611, DOI 10.1016/j.ijcard.2014.04.158; Stuhlinger MC, 2003, CIRCULATION, V108, P933, DOI 10.1161/01.CIR.0000085067.55901.89; Suda O, 2004, ARTERIOSCL THROM VAS, V24, P1682, DOI 10.1161/01.ATV.0000136656.26019.6e; Tang WHW, 2008, EUR HEART J, V29, P2506, DOI 10.1093/eurheartj/ehn360; Usui M, 1998, LIFE SCI, V62, P2425, DOI 10.1016/S0024-3205(98)00225-2; von Leitner EC, 2011, CIRCULATION, V124, P2735, DOI 10.1161/CIRCULATIONAHA.111.060541; Xia W, 2009, PACE, V32, P1562, DOI 10.1111/j.1540-8159.2009.02554.x; Youn JY, 2013, J MOL CELL CARDIOL, V62, P72, DOI 10.1016/j.yjmcc.2013.04.019; Zairis MN, 2012, HEART, V98, P860, DOI 10.1136/heartjnl-2011-301372; Zeller M, 2008, ARTERIOSCL THROM VAS, V28, P954, DOI 10.1161/ATVBAHA.108.162768	39	22	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2015	10	7							e0131439	10.1371/journal.pone.0131439	http://dx.doi.org/10.1371/journal.pone.0131439			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EW	26158510	Green Published, gold, Green Submitted			2022-12-26	WOS:000358161200030
J	Ahmed, M; Kumar, G; Navarro, G; Wang, YG; Gourevitch, S; Moussa, MH; Rozenblum, N; Levchenko, T; Galun, E; Torchilin, VP; Goldberg, SN				Ahmed, Muneeb; Kumar, Gaurav; Navarro, Gemma; Wang, Yuanguo; Gourevitch, Svetlana; Moussa, Marwan H.; Rozenblum, Nir; Levchenko, Tatyana; Galun, Eithan; Torchilin, Vladimir P.; Goldberg, S. Nahum			Systemic siRNA Nanoparticle-Based Drugs Combined with Radiofrequency Ablation for Cancer Therapy	PLOS ONE			English	Article							LIPOSOMAL DOXORUBICIN ACCUMULATION; COLORECTAL LIVER METASTASES; PULMONARY VEIN ISOLATION; BREAST-TUMOR MODEL; THERMAL ABLATION; ATRIAL-FIBRILLATION; HEPATOCELLULAR-CARCINOMA; GROWTH-FACTOR; DELIVERY; INCREASES	Purpose Radiofrequency thermal ablation (RFA) of hepatic and renal tumors can be accompanied by non-desired tumorigenesis in residual, untreated tumor. Here, we studied the use of micelle-encapsulated siRNA to suppress IL-6-mediated local and systemic secondary effects of RFA. Methods We compared standardized hepatic or renal RFA (laparotomy, 1 cm active tip at 70 +/- 2 degrees C for 5 min) and sham procedures without and with administration of 150nm micelle-like nanoparticle (MNP) anti-IL6 siRNA (DOPE-PEI conjugates, single IP dose 15 min post-RFA, C57Bl mouse: 3.5 ug/100ml, Fisher 344 rat: 20ug/200ul), RFA/scrambled siRNA, and RFA/empty MNPs. Outcome measures included: local periablational cellular infiltration (a-SMA+ stellate cells), regional hepatocyte proliferation, serum/tissue IL-6 and VEGF levels at 6-72hr, and distant tumor growth, tumor proliferation (Ki-67) and microvascular density (MVD, CD34) in subcutaneous R3230 and MATBIII breast adenocarcinoma models at 7 days. Results For liver RFA, adjuvant MNP anti-IL6 siRNA reduced RFA-induced increases in tissue IL-6 levels, alpha-SMA+stellate cell infiltration, and regional hepatocyte proliferation to baseline (p<0.04, all comparisons). Moreover, adjuvant MNP anti-IL6-siRNA suppressed increased distant tumor growth and Ki-67 observed in R3230 and MATBIII tumors post hepatic RFA (p<0.01). Anti-IL6 siRNA also reduced RFA-induced elevation in VEGF and tumor MVD (p<0.01). Likewise, renal RFA-induced increases in serum IL-6 levels and distant R3230 tumor growth was suppressed with anti-IL6 siRNA (p<0.01). Conclusions Adjuvant nanoparticle-encapsulated siRNA against IL-6 can be used to modulate local and regional effects of hepatic RFA to block potential unwanted pro-oncogenic effects of hepatic or renal RFA on distant tumor.	[Ahmed, Muneeb; Kumar, Gaurav; Wang, Yuanguo; Moussa, Marwan H.; Goldberg, S. Nahum] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Lab Minimally Invas Tumor Therapies,Dept Radiol, Boston, MA 02215 USA; [Navarro, Gemma; Levchenko, Tatyana; Torchilin, Vladimir P.] Northeastern Univ, Dept Pharmaceut Sci, Boston, MA 02115 USA; [Navarro, Gemma; Levchenko, Tatyana; Torchilin, Vladimir P.] Northeastern Univ, Ctr Pharmaceut Biotechnol & Nanomed, Boston, MA 02115 USA; [Gourevitch, Svetlana; Rozenblum, Nir; Galun, Eithan] Hadassah Hebrew Univ, Med Ctr, Goldyne Savad Inst Gene Therapy, IL-91120 Jerusalem, Israel; [Goldberg, S. Nahum] Hadassah Hebrew Univ, Med Ctr, Dept Radiol, Div Image Guided Therapy & Intervent Oncol, IL-91120 Jerusalem, Israel	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Northeastern University; Northeastern University; Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center	Ahmed, M (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Lab Minimally Invas Tumor Therapies,Dept Radiol, 1 Deaconess Rd WCC 308B, Boston, MA 02215 USA.	mahmed@bidmc.harvard.edu	Galun, Eithan/AAD-9117-2022; Ahmed, Muneeb/X-8479-2018; Goldberg, S. Nahum/AAV-4526-2020	Galun, Eithan/0000-0002-6243-6702; 	National Cancer Institute (CCNE) [1U54CA151881-01]; Radiological Society of North America Research and Education Foundation [RSD1215]; Harvard Medical Faculty Physicians Faculty Radiology Foundation; Deutsche Forschungsgemeinschaft [SF8841]; Israeli Center of Excellence I-CORE; Israel Science Foundation; NATIONAL CANCER INSTITUTE [U54CA151881] Funding Source: NIH RePORTER	National Cancer Institute (CCNE); Radiological Society of North America Research and Education Foundation; Harvard Medical Faculty Physicians Faculty Radiology Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Israeli Center of Excellence I-CORE; Israel Science Foundation(Israel Science Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the National Cancer Institute (CCNE 1U54CA151881-01 VPT, SNG, MA, TL), Radiological Society of North America Research and Education Foundation (RSD1215, MA), Harvard Medical Faculty Physicians Faculty Radiology Foundation (MA), Deutsche Forschungsgemeinschaft (SF8841, EG), the Israeli Center of Excellence I-CORE (EG), and the Israel Science Foundation (EG, SNG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarbanell AM, 2010, AM J PHYSIOL-HEART C, V298, pH1529, DOI 10.1152/ajpheart.01087.2009; Ahmed M, 2003, CANCER RES, V63, P6327; Ahmed M, 2014, RADIOLOGY, V13; Ahmed M, 2013, J VASC INTERV RADIOL, V24, pS44; Ahmed M, 2012, CHEM PHYS LIPIDS, V165, P424, DOI 10.1016/j.chemphyslip.2011.12.002; Ahmed M, 2011, RADIOLOGY, V258, P351, DOI 10.1148/radiol.10081634; Anower AKMM, 2012, EUR J PHARMACOL, V688, P76, DOI 10.1016/j.ejphar.2012.05.007; Chu KF, 2014, NAT REV CANCER, V14, P199, DOI 10.1038/nrc3672; Davila ML, 2013, THORAC SURG CLIN, V23, P479, DOI 10.1016/j.thorsurg.2013.07.010; de Baere T, 2015, EUR J ENDOCRINOL, V172, pR151, DOI 10.1530/EJE-14-0630; de Bethlenfalva-Hora CE, 2014, CLIN SCI, V126, P243, DOI 10.1042/CS20130089; de Martimprey H, 2009, EUR J PHARM BIOPHARM, V71, P490, DOI 10.1016/j.ejpb.2008.09.024; Deftereos S, 2012, J AM COLL CARDIOL, V60, P1790, DOI 10.1016/j.jacc.2012.07.031; Dewire J, 2010, NAT REV CARDIOL, V7, P129, DOI 10.1038/nrcardio.2009.232; Dong YZ, 2014, P NATL ACAD SCI USA, V111, P3955, DOI 10.1073/pnas.1322937111; Erinjeri JP, 2013, J VASC INTERV RADIOL, V24, P1105, DOI 10.1016/j.jvir.2013.02.015; Filgueiras-Rama D, 2013, J AM COLL CARDIOL, V61, P1464, DOI 10.1016/j.jacc.2012.12.042; Gao Y, 2011, INT J NANOMED, V6, P1017, DOI 10.2147/IJN.S17040; Gavrilov Kseniya, 2012, Yale Journal of Biology and Medicine, V85, P187; Gohell MS, 2009, PHLEBOLOGY, V24, P42, DOI 10.1258/phleb.2009.09s005; Goldberg SN, 2002, RADIOLOGY, V222, P797, DOI 10.1148/radiol.2223010861; Guo PX, 2010, ADV DRUG DELIVER REV, V62, P650, DOI 10.1016/j.addr.2010.03.008; Haen SP, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/160250; Hamamoto S, 2013, RADIOLOGY, V267, P405, DOI 10.1148/radiol.13120249; Hohenberger Peter, 2013, Am Soc Clin Oncol Educ Book, P457, DOI 10.1200/EdBook_AM.2013.33.457; Ishii H, 2001, ARCH ORAL BIOL, V46, P77, DOI 10.1016/S0003-9969(00)00081-9; Jeong JH, 2009, BIOCONJUGATE CHEM, V20, P5, DOI 10.1021/bc800278e; Kanasty R, 2013, NAT MATER, V12, P967, DOI [10.1038/NMAT3765, 10.1038/nmat3765]; Kong J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037266; Kruskal JB, 2001, J VASC INTERV RADIOL, V12, P1193, DOI 10.1016/S1051-0443(07)61679-0; Kumar G, 2013, RAD SOC N AM P ANN M, P77; Lencioni R, 2005, RADIOLOGY, V234, P961, DOI 10.1148/radiol.2343040350; Lim HS, 2014, CIRC-ARRHYTHMIA ELEC, V7, P83, DOI 10.1161/CIRCEP.113.000876; Mao CP, 2007, J BIOMED SCI, V14, P15, DOI 10.1007/s11373-006-9131-5; Mittal S, 2013, J CLIN GASTROENTEROL, V47, pS2, DOI 10.1097/MCG.0b013e3182872f29; Monsky WL, 2002, RADIOLOGY, V224, P823, DOI 10.1148/radiol.2243011421; Moussa M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102727; NAVARRO G, 2013, NANOMED-NANOTECHNOL, V10, P411; Navarro G, 2012, NANOMEDICINE-UK, V7, P65, DOI [10.2217/NNM.11.93, 10.2217/nnm.11.93]; Nijkamp MW, 2009, ANN SURG, V249, P814, DOI 10.1097/SLA.0b013e3181a38ef5; Nikfarjam M, 2006, SURGERY, V139, P73, DOI 10.1016/j.surg.2005.07.030; Niu J, 2008, J CANCER RES CLIN, V134, P503, DOI 10.1007/s00432-007-0314-x; Oh YK, 2009, ADV DRUG DELIVER REV, V61, P850, DOI 10.1016/j.addr.2009.04.018; Polimeni A, 2013, CIRC J, V77, P857, DOI 10.1253/circj.CJ-13-0297; Ponnappa BC, 2009, CURR OPIN INVEST DR, V10, P418; Ramanathan R, 2014, TRANSPLANTATION, V98, P100, DOI 10.1097/01.TP.0000441090.39840.b0; Resnier P, 2013, BIOMATERIALS, V34, P6429, DOI 10.1016/j.biomaterials.2013.04.060; Rozenblum N, 2011, P ANN M, P70; Rozenblum N, 2014, RADIOLOGY IN PRESS; Sawant RR, 2012, BIOMATERIALS, V33, P3942, DOI 10.1016/j.biomaterials.2011.11.088; Shim J, 2009, GENE THER, V16, P415, DOI 10.1038/gt.2008.180; Solazzo SA, 2010, RADIOLOGY, V255, P62, DOI 10.1148/radiol.09091196; Taylor MA, 2014, ACCELERATED GROWTH R; Thiel KW, 2012, NUCLEIC ACIDS RES, V40, P6319, DOI 10.1093/nar/gks294; Wang J, 2010, AAPS J, V12, P492, DOI 10.1208/s12248-010-9210-4; Wang XD, 2013, CARDIOVASC INTER RAD, V36, P166, DOI 10.1007/s00270-012-0377-1; Widenmeyer M, 2011, INT J CANCER, V128, P2653, DOI 10.1002/ijc.25601; Wood BJ, 2012, J VASC INTERV RADIOL, V23, P248, DOI 10.1016/j.jvir.2011.10.018; Wu N, 2013, INT J CARDIOL, V169, P62, DOI 10.1016/j.ijcard.2013.08.078; Yang W, 2011, INT J HYPERTHER, V27, P527, DOI 10.3109/02656736.2011.582474	60	20	20	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0128910	10.1371/journal.pone.0128910	http://dx.doi.org/10.1371/journal.pone.0128910			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154425	Green Published, Green Submitted, gold			2022-12-26	WOS:000358159700011
J	Benuzzi, F; Ballotta, D; Mirandola, L; Ruggieri, A; Vaudano, AE; Zucchelli, M; Ferrari, E; Nichelli, PF; Meletti, S				Benuzzi, Francesca; Ballotta, Daniela; Mirandola, Laura; Ruggieri, Andrea; Vaudano, Anna Elisabetta; Zucchelli, Micaela; Ferrari, Elisabetta; Nichelli, Paolo Frigio; Meletti, Stefano			An EEG-fMRI Study on the Termination of Generalized Spike-And-Wave Discharges in Absence Epilepsy	PLOS ONE			English	Article							NEGATIVE BOLD; NETWORK; ACTIVATION; SEIZURES; CONNECTIVITY; STATE; DEACTIVATION; RESPONSES; ARTIFACT; BEHAVIOR	Introduction Different studies have investigated by means of EEG-fMRI coregistration the brain networks related to generalized spike-and-wave discharges (GSWD) in patients with idiopathic generalized epilepsy (IGE). These studies revealed a widespread GSWD-related neural network that involves the thalamus and regions of the default mode network. In this study we investigated which brain regions are critically involved in the termination of absence seizures (AS) in a group of IGE patients. Methods Eighteen patients (6 male; mean age 25 years) with AS were included in the EEG-fMRI study. Functional data were acquired at 3T with continuous simultaneous video-EEG recording. Event-related analysis was performed with SPM8 software, using the following regressors: (1) GSWD onset and duration; (2) GSWD offset. Data were analyzed at single-subject and at group level with a second level random effect analysis. Results A mean of 17 events for patient was recorded (mean duration of 4.2 sec). Group-level analysis related to GSWD onset respect to rest confirmed previous findings revealing thalamic activation and a precuneus/posterior cingulate deactivation. At GSWD termination we observed a decrease in BOLD signal over the bilateral dorsolateral frontal cortex respect to the baseline (and respect to GSWD onset). The contrast GSWD offset versus onset showed a BOLD signal increase over the precuneus-posterior cingulate region bilaterally. Parametric correlations between electro-clinical variables and BOLD signal at GSWD offset did not reveal significant effects. Conclusion The role of the decreased neural activity of lateral prefrontal cortex at GSWD termination deserve future investigations to ascertain if it has a role in promoting the discharge offset, as well as in the determination of the cognitive deficits often present in patients with AS. The increased BOLD signal at precuneal/posterior cingulate cortex might reflect the recovery of neural activity in regions that are "suspended" during spike and waves activity, as previously hypothesized.	[Benuzzi, Francesca; Ballotta, Daniela; Mirandola, Laura; Ruggieri, Andrea; Vaudano, Anna Elisabetta; Nichelli, Paolo Frigio; Meletti, Stefano] Univ Modena & Reggio Emilia, Dept Biomed Metab & Neural Sci, Modena, Italy; [Mirandola, Laura; Vaudano, Anna Elisabetta; Nichelli, Paolo Frigio; Meletti, Stefano] NOCSAE Hosp ASL, Neurol Unit, Modena, Italy; [Zucchelli, Micaela] Univ Bologna, Dept Psychol, Bologna, Italy; [Ferrari, Elisabetta] IIT, Genoa, Italy	Universita di Modena e Reggio Emilia; University of Bologna; Istituto Italiano di Tecnologia - IIT	Meletti, S (corresponding author), Univ Modena & Reggio Emilia, Dept Biomed Metab & Neural Sci, Modena, Italy.	stefano.meletti@unimore.it	Ferrari, Elisabetta/AAA-4801-2020; Vaudano, Anna Elisabetta AE/O-2653-2015; Nichelli, Paolo/F-7336-2015; Meletti, Stefano/O-3622-2015	Ferrari, Elisabetta/0000-0002-4781-1367; Vaudano, Anna Elisabetta AE/0000-0002-6280-7526; Nichelli, Paolo/0000-0001-9756-6796; Meletti, Stefano/0000-0003-0334-539X; Benuzzi, Francesca/0000-0002-3498-3303	grant of Carismo Foundation [A.010@FCRMO RINT@MELFONINFO]	grant of Carismo Foundation	This work is part of a research program funded by a grant of Carismo Foundation (grant number: A.010@FCRMO RINT@MELFONINFO). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghakhani Y, 2004, BRAIN, V127, P1127, DOI 10.1093/brain/awh136; Allen PJ, 1998, NEUROIMAGE, V8, P229, DOI 10.1006/nimg.1998.0361; Allen PJ, 2000, NEUROIMAGE, V12, P230, DOI 10.1006/nimg.2000.0599; Amzica F, 2009, ENCYCLOPEDIA OF BASIC EPILEPSY RESEARCH, VOLS 1-3, P1343; [Anonymous], 1981, Epilepsia, V22, P489; Archer JS, 2003, NEUROIMAGE, V20, P1915, DOI 10.1016/S1053-8119(03)00294-5; Avanzini P, 2014, CLIN NEUROPHYSIOL, V125, P239, DOI 10.1016/j.clinph.2013.07.009; Bai XX, 2010, J NEUROSCI, V30, P5884, DOI 10.1523/JNEUROSCI.5101-09.2010; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Benuzzi F, 2012, EPILEPSIA, V53, P622, DOI 10.1111/j.1528-1167.2011.03385.x; Berman R, 2010, EPILEPSIA, V51, P2011, DOI 10.1111/j.1528-1167.2010.02652.x; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Carney PW, 2012, NEUROLOGY, V78, P1157, DOI 10.1212/WNL.0b013e31824f801d; Carney PW, 2010, NEUROLOGY, V75, P904, DOI 10.1212/WNL.0b013e3181f11c06; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Chatton JY, 2003, P NATL ACAD SCI USA, V100, P12456, DOI 10.1073/pnas.2132096100; Fahoum F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068038; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Gotman J, 2005, P NATL ACAD SCI USA, V102, P15236, DOI 10.1073/pnas.0504935102; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Halasz P, 2002, EPILEPSY RES, V51, P123, DOI 10.1016/S0920-1211(02)00123-7; Hamandi K, 2006, NEUROIMAGE, V31, P1700, DOI 10.1016/j.neuroimage.2006.02.016; Jacobs J, 2009, NEUROIMAGE, V45, P1220, DOI 10.1016/j.neuroimage.2009.01.014; Killory BD, 2011, NEUROIMAGE, V56, P2209, DOI 10.1016/j.neuroimage.2011.03.036; Koos T, 1999, NAT NEUROSCI, V2, P467, DOI 10.1038/8138; Labate A, 2005, EPILEPTIC DISORD, V7, P373; Lado FA, 2008, EPILEPSIA, V49, P1651, DOI 10.1111/j.1528-1167.2008.01669.x; Laufs H, 2006, EPILEPSIA, V47, P444, DOI 10.1111/j.1528-1167.2006.00443.x; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Ltittjohann A, 2014, NEUROBIOL DIS, V70, P127, DOI 10.1016/j.nbd.2014.06.007; Luo C, 2011, HUM BRAIN MAPP, V32, P438, DOI 10.1002/hbm.21034; Makeig S, 2004, TRENDS COGN SCI, V8, P204, DOI 10.1016/j.tics.2004.03.008; Maneshi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050359; Meletti S, 2015, CLIN NEUROPHYSIOL, V126, P847, DOI 10.1016/j.clinph.2014.07.030; Moeller F, 2008, EPILEPSIA, V49, P1510, DOI 10.1111/j.1528-1167.2008.01626.x; Moeller F, 2008, NEUROIMAGE, V39, P1839, DOI 10.1016/j.neuroimage.2007.10.058; Moeller F, 2010, EPILEPSIA, V51, P2000, DOI 10.1111/j.1528-1167.2010.02698.x; Neckelmann D, 2000, NEUROSCIENCE, V96, P475, DOI 10.1016/S0306-4522(99)00571-0; Pittau F, 2013, BRAIN TOPOGR, V26, P627, DOI 10.1007/s10548-013-0302-1; Pugnaghi M, 2014, BRAIN TOPOGR, V27, P123, DOI 10.1007/s10548-013-0311-0; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rathakrishnan R, 2010, EPILEPSIA, V51, P1837, DOI 10.1111/j.1528-1167.2010.02643.x; Ruggieri A, 2015, J NEUROSCI METH, V239, P223, DOI 10.1016/j.jneumeth.2014.10.005; Salek-Haddadi A, 2003, ANN NEUROL, V53, P663, DOI 10.1002/ana.10586; Shmuel A, 2006, NAT NEUROSCI, V9, P569, DOI 10.1038/nn1675; Shmuel A, 2002, NEURON, V36, P1195, DOI 10.1016/S0896-6273(02)01061-9; Stefanovic B, 2005, NEUROIMAGE, V28, P205, DOI 10.1016/j.neuroimage.2005.05.038; Talairach J., 1998, COPLANAR STEREOTAXIC; Truccolo W, 2011, NAT NEUROSCI, V14, P635, DOI 10.1038/nn.2782; Vaudano AE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006475; Vaudano AE, 2014, ANN NEUROL, V76, P412, DOI 10.1002/ana.24236; Xue KQ, 2014, EPILEPSY RES, V108, P125, DOI 10.1016/j.eplepsyres.2013.10.002; Yang TH, 2013, HUM BRAIN MAPP, V34, P1761, DOI 10.1002/hbm.22025	53	19	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0130943	10.1371/journal.pone.0130943	http://dx.doi.org/10.1371/journal.pone.0130943			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154563	Green Published, Green Submitted, gold			2022-12-26	WOS:000358159700049
J	Paiva, CE; Manfredini, LL; Paiva, BSR; Hui, D; Bruera, E				Paiva, Carlos Eduardo; Manfredini, Luciana Lopes; Ribeiro Paiva, Bianca Sakamoto; Hui, David; Bruera, Eduardo			The Brazilian Version of the Edmonton Symptom Assessment System (ESAS) Is a Feasible, Valid and Reliable Instrument for the Measurement of Symptoms in Advanced Cancer Patients	PLOS ONE			English	Article							EARLY PALLIATIVE CARE; ASSESSMENT SCALE; PSYCHOMETRIC PROPERTIES; SLEEPINESS; MEDICINE; QLQ-C30; SERVICE	Purposes To develop and validate a Portuguese version of the Edmonton Symptom Assessment System (ESAS) in Brazilian patients with advanced cancer. Methods The ESAS was translated and then back translated into Portuguese in accordance with international guidelines. The final version was approved by an Expert Committee after pilot testing on 24 advanced cancer patients. Subsequently, we evaluated the time to complete the assessment, the number of unanswered items, internal consistency, convergent validity, and known-group validity in a sample of 249 advanced cancer patients who completed the ESAS along with the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire (EORTC QLQ-C30), Hospital Anxiety and Depression Scale (HADS), and Epworth Sleepiness Scale (ESS). A total of 90 clinically stable patients were retested after 4 to 96 hours (test-retest reliability), and 80 patients answered the ESAS after 21 (+/- 7) days to measure scale responsiveness using an anchor-based method. Results The ESAS was completed in a mean time of only 2.2 minutes. The internal consistency was good (Cronbach's alpha = 0.861), and the removal of single items did not change the overall alpha value. For convergent validity, Spearman's correlation coefficients between the ESAS symptom scores and the corresponding EORTC QLQ-C30 and ESS symptom scores ranged between 0.520 (95% CI = 0.424-0.605) and 0.814 (95% CI = 0.760-0.856), indicating moderate to strong correlations. Test-retest reliability values were considered adequate, with intraclass correlation coefficients ranging from 0.758 (95% CI = 0.627-0.843) to 0.939 (95% CI = 0.905-0.960). Conclusions ESAS is a feasible, valid and reliable multi-symptom assessment instrument for use in Brazil.	[Paiva, Carlos Eduardo] Barretos Canc Hosp, Dept Clin Oncol, Barretos, SP, Brazil; [Paiva, Carlos Eduardo; Ribeiro Paiva, Bianca Sakamoto] Barretos Canc Hosp, Learning & Res Inst, Barretos, SP, Brazil; [Manfredini, Luciana Lopes] Barretos Canc Hosp, Canc Hosp Children & Youth President Luiz Inacio, Barretos, SP, Brazil; [Bruera, Eduardo] Univ Texas MD Anderson Canc Ctr, Dept Palliat Care & Rehabil Med, Houston, TX 77030 USA	Hospital de Cancer de Barretos; Hospital de Cancer de Barretos; Hospital de Cancer de Barretos; University of Texas System; UTMD Anderson Cancer Center	Paiva, CE (corresponding author), Barretos Canc Hosp, Dept Clin Oncol, Barretos, SP, Brazil.	caredupai@gmail.com	Paiva, Carlos E/F-4810-2012; Bruera, Eduardo/AAA-1550-2022; Lopes Manfredini, Luciana/Q-6747-2016	Paiva, Carlos Eduardo/0000-0002-7934-1451; Lopes Manfredini, Luciana/0000-0001-6015-5854				AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; Barroso EM, 2015, BRAZ J OTOR IN PRESS; Bertolazi AN, 2009, J BRAS PNEUMOL, V35, P877, DOI 10.1590/S1806-37132009000900009; Bruera E, 1991, J Palliat Care, V7, P6; Carvajal A, 2011, EUR J CANCER, V47, P1863, DOI 10.1016/j.ejca.2011.03.027; Chang VT, 2000, CANCER, V88, P2164, DOI 10.1002/(SICI)1097-0142(20000501)88:9<2164::AID-CNCR24>3.0.CO;2-5; Chinda M, 2011, J PAIN SYMPTOM MANAG, V42, P954, DOI 10.1016/j.jpainsymman.2011.02.020; Claessens P, 2011, AM J HOSP PALLIAT ME, V28, P475, DOI 10.1177/1049909111400724; Fayers PM, 2007, QUALITY LIFE ASSESSM; GUILLEMIN F, 1993, J CLIN EPIDEMIOL, V46, P1417, DOI 10.1016/0895-4356(93)90142-N; Hearn J, 1997, J PUBLIC HEALTH MED, V19, P193, DOI 10.1093/oxfordjournals.pubmed.a024608; Homsi J, 2006, SUPPORT CARE CANCER, V14, P444, DOI 10.1007/s00520-005-0009-2; Homsi J, 2002, SUPPORT CARE CANCER, V10, P337, DOI 10.1007/s00520-002-0341-8; Hui D, 2012, ONCOLOGIST, V17, P1574, DOI 10.1634/theoncologist.2012-0192; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kang JH, 2013, J PAIN SYMPTOM MANAG, V46, P652, DOI 10.1016/j.jpainsymman.2012.11.009; Karnofsky D, 1949, EVALUATION OF CHEMOT; Kwon JH, 2013, J PAIN SYMPTOM MANAG, V46, P947, DOI 10.1016/j.jpainsymman.2013.01.012; Monteiro Daiane da Rosa, 2013, Rev Gaucha Enferm, V34, P163; Moro C, 2006, SUPPORT CARE CANCER, V14, P30, DOI 10.1007/s00520-005-0834-3; Pais-Ribeiro J, 2007, Psychol Health Med, V12, P225, DOI 10.1080/13548500500524088; Paiva CE, 2014, SUPPORT CARE CANCER, V22, P2151, DOI 10.1007/s00520-014-2206-3; Paiva CE, 2014, J PALLIAT MED, V17, P264, DOI 10.1089/jpm.2013.0603; Paiva CE, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-8; Paiva CE, 2014, PALLIAT SUPPORT CARE, P1; Partridge AH, 2014, J CLIN ONCOL, V32, P3330, DOI 10.1200/JCO.2013.54.8149; Pautex S, 2003, CRIT REV ONCOL HEMAT, V47, P281, DOI 10.1016/S1040-8428(03)00043-X; Philip J, 1998, SUPPORT CARE CANCER, V6, P539, DOI 10.1007/s005200050212; PORTENOY RK, 1994, QUAL LIFE RES, V3, P183, DOI 10.1007/BF00435383; Rangachari D, 2013, CANCER J, V19, P373, DOI 10.1097/PPO.0b013e3182a76b9c; Rugno FC, 2014, GYNECOL ONCOL, V135, P249, DOI 10.1016/j.ygyno.2014.08.030; Stromgren AS, 2002, CANCER, V94, P512, DOI 10.1002/cncr.10222; Temel JS, 2010, NEW ENGL J MED, V363, P733, DOI 10.1056/NEJMoa1000678; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; Watanabe S, 2009, SUPPORT CARE CANCER, V17, P675, DOI 10.1007/s00520-008-0522-1; Watanabe SM, 2011, J PAIN SYMPTOM MANAG, V41, P456, DOI 10.1016/j.jpainsymman.2010.04.020; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zimmermann C, 2014, LANCET, V383, P1721, DOI 10.1016/S0140-6736(13)62416-2	38	25	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0132073	10.1371/journal.pone.0132073	http://dx.doi.org/10.1371/journal.pone.0132073			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154288	gold, Green Published, Green Submitted			2022-12-26	WOS:000358159700085
J	Wang, LF; Yokoyama, KK; Chen, TY; Hsiao, HW; Chiang, PC; Hsieh, YC; Lo, S; Hsu, C				Wang, Li-Fang; Yokoyama, Kazunari K.; Chen, Tzu-Yin; Hsiao, Hsiu-Wen; Chiang, Pei-Chi; Hsieh, Ya-Ching; Lo, Steven; Hsu, Chin			Male-Specific Alleviation of Iron-Induced Striatal Injury by Inhibition of Autophagy	PLOS ONE			English	Article							EXPERIMENTAL INTRACEREBRAL HEMORRHAGE; BRAIN-INJURY; MICE; MORTALITY; DEATH	Men exhibit a worse survival rate than premenopausal women after intracerebral hemorrhage (ICH), however, no sex-specific management has been concerned. In a rat model involving infusion of ferrous citrate (FC) that simulates iron accumulation after hemorrhage, a higher degree of autophagy associated with higher injury severity was observed in striatum of males than in females. Since the imbalance between the levels of autophagy and energy demand may lead to cell death, we proposed that FC-induced autophagy is detrimental in a male specific manner and autophagy modulation affects injury severity in a sex-dependent manner. Rapamycin, an autophagy inducer, and conditional knockout gene of autophagy-related protein 7 (Atg7) in dopamine receptor D2 (DRD2) neurons were used to test our hypothesis using a mouse model with striatal FC infusion. The result showed that the levels of autophagic cell death and injury severity were higher in male than in female mice. Pre-treatment of FC-infused females with rapamycin increased the FC-induced behavioral deficit and DRD2 neuron death. However, DRD2 neuron-specific knockout of Atg7 decreased FC-induced injury severity and the number of TUNEL(+) DRD2 neurons in males. These results suggest that autophagy in FC-infusion males is overactive with maladaptive consequences and inhibition of autophagy decreases the severity of FC-induced striatal injury in males. These findings present prospects for male-specific therapeutic strategy that targets autophagy in patients suffering from iron overload.	[Wang, Li-Fang] Kaohsiung Med Univ, Coll Life Sci, Dept Med & Appl Chem, Kaohsiung, Taiwan; [Yokoyama, Kazunari K.] Kaohsiung Med Univ, Grad Inst Med, Kaohsiung, Taiwan; [Chen, Tzu-Yin; Hsiao, Hsiu-Wen; Chiang, Pei-Chi; Hsu, Chin] Kaohsiung Med Univ, Coll Med, Fac Med, Dept Physiol, Kaohsiung, Taiwan; [Hsieh, Ya-Ching; Lo, Steven] I Shou Univ, E Da Hosp, Dept Med Res, Kaohsiung, Taiwan; [Lo, Steven] Royal Infirm, Canniesburn Plast Surg Unit, Glasgow G31 2ER, Lanark, Scotland	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; E-Da Hospital; I Shou University; Royal Infirmary of Edinburgh	Hsu, C (corresponding author), Kaohsiung Med Univ, Coll Med, Fac Med, Dept Physiol, Kaohsiung, Taiwan.	chinhsu@kmu.edu.tw		Wang, Li Fang/0000-0003-1593-4482; jiang, pei qi/0000-0002-9756-1044	National Science Council of Taiwan [101-2629-B-037-001, 102-2320-B-037-015, 103-2320-B-037028]; Kaohsiung Medical University [KMU-DT103007]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Kaohsiung Medical University	CH received research grants from the National Science Council of Taiwan (101-2629-B-037-001, 102-2320-B-037-015, and 103-2320-B-037028). LW received research grants from "Aim for the Top Journals Grant," grant No. KMU-DT103007 from Kaohsiung Medical University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali SS, 2006, AGING CELL, V5, P565, DOI 10.1111/j.1474-9726.2006.00252.x; Bhatia R, 2013, NEUROL INDIA, V61, P244, DOI 10.4103/0028-3886.115062; Chen CW, 2012, AUTOPHAGY, V8, P1510, DOI 10.4161/auto.21289; Chen TY, 2010, STROKE, V41, P160, DOI 10.1161/STROKEAHA.109.562850; Clark RSB, 2008, AUTOPHAGY, V4, P88, DOI 10.4161/auto.5173; Gupta A, 2003, J ETHNOPHARMACOL, V89, P55, DOI 10.1016/S0378-8741(03)00262-9; Han Ning, 2008, Neurosci Bull, V24, P351, DOI 10.1007/s12264-008-0711-4; He Y, 2008, J CEREBR BLOOD F MET, V28, P897, DOI 10.1038/sj.jcbfm.9600578; Hu YZ, 2013, J ZHEJIANG UNIV-SC B, V14, P496, DOI 10.1631/jzus.B1200332; Hua Y, 2006, J NEUROSURG, V104, P305, DOI 10.3171/jns.2006.104.2.305; Hua Y, 2002, STROKE, V33, P2478, DOI 10.1161/01.STR.0000032302.91894.0F; Inagawa T, 2003, NEUROSURGERY, V53, P1283, DOI 10.1227/01.NEU.0000093825.04365.F3; Keep RF, 2012, LANCET NEUROL, V11, P720, DOI 10.1016/S1474-4422(12)70104-7; Koike M, 2008, AM J PATHOL, V172, P454, DOI 10.2353/ajpath.2008.070876; Lewsey JD, 2009, STROKE, V40, P1038, DOI 10.1161/STROKEAHA.108.542787; Lofgren JLS, 2012, J AM ASSOC LAB ANIM, V51, P594; Mendelow AD, 2013, LANCET, V382, P397, DOI 10.1016/S0140-6736(13)60986-1; Mendelow AD, 2005, LANCET, V365, P387; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Nakamura T, 2005, J NEUROSURG, V103, P97, DOI 10.3171/jns.2005.103.1.0097; Olivan S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/652817; Rangaraju S, 2010, J NEUROSCI, V30, P11388, DOI 10.1523/JNEUROSCI.1356-10.2010; Raz L, 2008, NEUROSIGNALS, V16, P140, DOI 10.1159/000111559; Scherz-Shouval R, 2007, TRENDS CELL BIOL, V17, P422, DOI 10.1016/j.tcb.2007.07.009; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; Weis SN, 2014, NEUROSCIENCE, V256, P201, DOI 10.1016/j.neuroscience.2013.10.046; Weiss ES, 2009, ANN THORAC SURG, V88, P543, DOI 10.1016/j.athoracsur.2009.04.016; Yoshimori T, 2004, BIOCHEM BIOPH RES CO, V313, P453, DOI 10.1016/j.bbrc.2003.07.023; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Zheng MZ, 2015, TRANSL STROKE RES, V6, P215, DOI 10.1007/s12975-015-0388-8; Zia E, 2009, STROKE, V40, P3567, DOI 10.1161/STROKEAHA.109.556324	32	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131224	10.1371/journal.pone.0131224	http://dx.doi.org/10.1371/journal.pone.0131224			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147959	Green Published, Green Submitted, gold			2022-12-26	WOS:000358157600071
J	Wu, SJ; Soulez, M; Yang, YH; Chu, CS; Shih, SC; Hebert, MJ; Kuo, MC; Hsieh, YJ				Wu, Shyh-Jong; Soulez, Mathilde; Yang, Ya-Hui; Chu, Chih-Sheng; Shih, Shih-Chuan; Hebert, Marie-Josee; Kuo, Mei-Chuan; Hsieh, Ya-Ju			Local Augmented Angiotensinogen Secreted from Apoptotic Vascular Endothelial Cells Is a Vital Mediator of Vascular Remodelling	PLOS ONE			English	Article							CONVERTING ENZYME-INHIBITORS; SMOOTH-MUSCLE-CELLS; RENAL ANGIOTENSINOGEN; HEART-DISEASE; INFLAMMATION; RENIN; ATHEROSCLEROSIS; HYPERTENSION; EXPRESSION; INJURY	Vascular remodelling is a critical vasculopathy found in atheromatous diseases and allograft failures. The local renin angiotensin system (RAS) has been implicated in vascular remodelling. However, the mechanisms by which the augmented local RAS is associated with the initial event of endothelial cell apoptosis in injured vasculature remain undefined. We induced the apoptosis of human umbilical vein endothelial cells (HUVECs) and vascular smooth muscle cells (VSMCs) through serum starvation (SS). After the cells were subjected to SS, we found that the mRNA expression of angiotensinogen (AGT) was increased by > 3-fold in HUVECs and by approximately 2.5-fold in VSMCs. In addition, the expression of angiotensin-converting enzyme (ACE) mRNA was increased in VSMCs but decreased to 50% in HUVECs during the same apoptotic process. Increases in the expression of AGT protein and angiotensin II (Ang II) were found in a serum-free medium conditioned by HUVECs (SSC). The increased Ang II was suppressed using lisinopril (an ACE inhibitor) treatment. Moreover, the activation of ERK1/2 induced by the SSC in VSMCs was also suppressed by losartan. In conclusion, we first demonstrated that the augmented AGT released from apoptotic endothelial cells acts as a vital progenitor of Ang II to accelerate vascular remodelling, and we suggest that blocking local augmented Ang II might be an effective strategy for restraining intimal hyperplasia.	[Wu, Shyh-Jong; Shih, Shih-Chuan] Kaohsiung Med Univ, Dept Med Lab Sci & Biotechnol, Kaohsiung, Taiwan; [Soulez, Mathilde] Univ Montreal, Inst Res Immunol & Canc, Montreal, PQ, Canada; [Yang, Ya-Hui] Fooyin Univ, Dept Occupat Safety & Hyg, Kaohsiung, Taiwan; [Chu, Chih-Sheng] Kaohsiung Med Univ Hosp, Dept Internal Med, Div Cardiol, Kaohsiung, Taiwan; [Chu, Chih-Sheng] Kaohsiung Municipal Tatung Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Chu, Chih-Sheng] Kaohsiung Med Univ, Grad Inst Med, Kaohsiung, Taiwan; [Hebert, Marie-Josee] Univ Montreal CRCHUM, Ctr Hosp, Res Ctr, Hop Notre Dame, Montreal, PQ, Canada; [Hebert, Marie-Josee] Univ Montreal, Montreal, PQ, Canada; [Kuo, Mei-Chuan] Kaohsiung Med Univ Hosp, Dept Neurol, Kaohsiung, Taiwan; [Hsieh, Ya-Ju] Kaohsiung Med Univ, Dept Med Imaging & Radiol Sci, Kaohsiung, Taiwan	Kaohsiung Medical University; Universite de Montreal; Fooyin University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Municipal Ta-Tung Hospital; Kaohsiung Medical University; Universite de Montreal; Universite de Montreal; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University	Hsieh, YJ (corresponding author), Kaohsiung Med Univ, Dept Med Imaging & Radiol Sci, Kaohsiung, Taiwan.	yjhsieh@kmu.edu.tw		Hsieh, Ya Ju/0000-0003-2082-9345	Kaohsiung Medical University [KMU-M099015]; National Science Council Taiwan [NSC98-2815-C-037-017-B, MOST 103-2314-B-037-007]	Kaohsiung Medical University; National Science Council Taiwan(Ministry of Science and Technology, Taiwan)	The sources of funding that supported this study were from the Kaohsiung Medical University (KMU-M099015; www.kmu.edu.tw) and National Science Council Taiwan (NSC98-2815-C-037-017-B; (www.most.gov.tw/mp.aspx)). Both grants were received by Shyh-Jong Wu. Another grant (MOST 103-2314-B-037-007) from National Science Council Taiwan was received by Ya-Ju Hsieh for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akishita M, 2000, PHYSIOL GENOMICS, V2, P13; Andujar-Sanchez M, 2007, FEBS LETT, V581, P3449, DOI 10.1016/j.febslet.2007.06.048; Aoki M, 2001, HYPERTENSION, V38, P48, DOI 10.1161/01.HYP.38.1.48; Brown NJ, 1998, CIRCULATION, V97, P1411, DOI 10.1161/01.CIR.97.14.1411; Cailhier JF, 2006, AM J TRANSPLANT, V6, P247, DOI 10.1111/j.1600-6143.2005.01165.x; CASSIS LA, 1988, CIRC RES, V62, P1259, DOI 10.1161/01.RES.62.6.1259; Costa MA, 2005, CIRCULATION, V111, P2257, DOI 10.1161/01.CIR.0000163587.36485.A7; Danilov SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025952; Diet F, 1996, CIRCULATION, V94, P2756, DOI 10.1161/01.CIR.94.11.2756; Ding YM, 2001, J BIOL CHEM, V276, P7431, DOI 10.1074/jbc.M003892200; Esper RJ, 2006, CARDIOVASC DIABETOL, V5, DOI 10.1186/1475-2840-5-4; Galis ZS, 2002, CIRC RES, V90, P251, DOI 10.1161/res.90.3.251; Glicklich D, 2011, CLIN TRANSPLANT, V25, P843, DOI 10.1111/j.1399-0012.2010.01372.x; GOULD AB, 1971, CARDIOVASC RES, V5, P86, DOI 10.1093/cvr/5.1.86; Hillebrands Jan-Luuk, 2003, Expert Rev Mol Med, V5, P1, DOI 10.1017/S146239940300557X; Iwai N, 1997, HYPERTENSION, V29, P1044, DOI 10.1161/01.HYP.29.4.1044; Kang NL, 2002, J MOL MED, V80, P359, DOI 10.1007/s00109-002-0326-6; Kranzhofer R, 1999, ARTERIOSCL THROM VAS, V19, P1623, DOI 10.1161/01.ATV.19.7.1623; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Liu S, 2012, J BIOL CHEM, V287, P24739, DOI 10.1074/jbc.M112.340216; Lloyd-Jones D, 2010, CIRCULATION, V121, P948, DOI 10.1161/CIRCULATIONAHA.109.192666; Lonn EM, 2001, CIRCULATION, V103, P919; Morishita R, 2000, ARTERIOSCL THROM VAS, V20, P915, DOI 10.1161/01.ATV.20.4.915; Ohishi Mitsuru, 2010, Int J Physiol Pathophysiol Pharmacol, V2, P111; Post MJ, 1997, CIRCULATION, V96, P996; Rader DJ, 2008, NATURE, V451, P904, DOI 10.1038/nature06796; RAKUGI H, 1994, J CLIN INVEST, V93, P339, DOI 10.1172/JCI116965; Raymond MA, 2002, BIOCHEM BIOPH RES CO, V291, P261, DOI 10.1006/bbrc.2002.6449; REID IA, 1978, ANNU REV PHYSIOL, V40, P377, DOI 10.1146/annurev.ph.40.030178.002113; Remko M, 2007, CHEM PAP, V61, P133, DOI 10.2478/s11696-007-0010-y; Solomon SD, 2009, CIRCULATION, V119, P530, DOI 10.1161/CIRCULATIONAHA.108.826214; Soulez M, 2012, CIRC RES, V110, P94, DOI 10.1161/CIRCRESAHA.111.250431; Wu L, 2001, CIRCULATION, V104, P2716, DOI 10.1161/hc4601.099404; Wu SJ, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2013.01.003; Wu SJ, 2004, PHYSIOL GENOMICS, V17, P79, DOI 10.1152/physiolgenomics.00133.2003; Yaghini FA, 2010, HYPERTENSION, V55, P1461, DOI 10.1161/HYPERTENSIONAHA.110.150029; Yao HL, 2012, MOL CELL BIOCHEM, V366, P355, DOI 10.1007/s11010-012-1315-x; Yusuf S, 2000, NEW ENGL J MED, V342, P145; Zhuo JL, 1997, CIRCULATION, V96, P174	39	12	12	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132583	10.1371/journal.pone.0132583	http://dx.doi.org/10.1371/journal.pone.0132583			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147666	Green Published, Green Submitted, gold			2022-12-26	WOS:000358157600302
J	Yan, S; Tian, SX; Kang, QW; Xia, YF; Li, CX; Chen, Q; Zhang, SK; Li, ZG				Yan, Shu; Tian, Shuxia; Kang, Qingwei; Xia, Yafei; Li, Caixia; Chen, Qing; Zhang, Shukun; Li, Zhigang			Rhizoma Paridis Saponins Suppresses Tumor Growth in a Rat Model of N-Nitrosomethylbenzylamine-Induced Esophageal Cancer by Inhibiting Cyclooxygenases-2 Pathway	PLOS ONE			English	Article							IN-VITRO; HEPATOCARCINOMA MICE; PENNOGENYL SAPONINS; EXPRESSION; APOPTOSIS; XENOGRAFTS; CHINA; CELLS; COX-2; VIVO	Rhizoma Paridis Saponins (RPS), a natural compound purified from Rhizoma Paridis, has been found to inhibit cancer growth in vitro and in animal models of cancer. However, its effects on esophageal cancer remain unexplored. The purpose of this study was to investigate the effects of RPS on tumor growth in a rat model of esophageal cancer and the molecular mechanism underlying the effects. A rat model of esophageal cancer was established by subcutaneous injection of N-nitrosomethylbenzylamine (NMBA, 1mg/kg) for 10 weeks. RPS (350 mg/kg or 100mg/kg) was administered by oral gavage once daily for 24 weeks starting at the first NMBA injection. RPS significantly reduced the size and number of tumors in the esophagus of rats exposed to NMBA and inhibited the viability, migration, and invasion of esophageal cancer cells EC9706 and KYSE150 in a dose dependent manner (all P < 0.01). Flow cytometry revealed that RPS induced apoptosis and cell cycle G2/M arrest in the esophageal cancer cells. The expression of cyclooxygenases-2 (COX-2) and Cyclin D1 in rat esophageal tissues and the esophageal cancer cells were also significantly reduced by RPS (all P < 0.01). Consistently, RPS also significantly decreased the release of prostaglandin E2, a downstream molecule of COX-2, in a dose-dependent manner (P < 0.01). Our study suggests that RPS inhibit esophageal cancer development by promoting apoptosis and cell cycle arrest and inhibiting the COX-2 pathway. RPS might be a promising therapeutic agent for esophageal cancer.	[Yan, Shu; Tian, Shuxia; Kang, Qingwei; Xia, Yafei] Nankai Hosp, Dept Pharmacol, Tianjin, Peoples R China; [Li, Caixia; Zhang, Shukun] Nankai Hosp, Inst Integrat Med Therapy Acute Abdominal Dis Tia, Tianjin, Peoples R China; [Li, Zhigang] Nankai Hosp, Dept Thorac Surg, Tianjin, Peoples R China; [Chen, Qing] Taizhou Hosp, Dept Pharmacol, Taizhou City, Zhejiang, Peoples R China		Li, ZG (corresponding author), Nankai Hosp, Dept Thorac Surg, Tianjin, Peoples R China.	zhigli38@hotmail.com		Li, Zhigang/0000-0001-7164-1049	Tianjin Science and Technology Plan Project of China [10JCYBJC15100]; National Natural Science Foundation of China [30973383]	Tianjin Science and Technology Plan Project of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	SY was supported by 2010 Tianjin Science and Technology Plan Project of China (10JCYBJC15100) ZL was supported by and the National Natural Science Foundation of China (No. 30973383 http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen WQ, 2013, J THORAC DIS, V5, P19, DOI 10.3978/j.issn.2072-1439.2013.01.04; Chen YS, 2014, STEROIDS, V83, P39, DOI 10.1016/j.steroids.2014.01.014; D'Journo XB, 2014, J THORAC DIS, V6, pS253, DOI 10.3978/j.issn.2072-1439.2014.04.16; Jiang H, 2014, MOL MED REP, V9, P2265, DOI 10.3892/mmr.2014.2108; Li P, 2008, WORLD J INTEGRATED T, V3, P297; Lin YS, 2013, J EPIDEMIOL, V23, P233, DOI 10.2188/jea.JE20120162; Liu Z, 2014, ENVIRON TOXICOL PHAR, V38, P31, DOI 10.1016/j.etap.2014.04.026; Liu Z, 2012, J ETHNOPHARMACOL, V144, P67, DOI 10.1016/j.jep.2012.08.027; Man SL, 2014, STEROIDS, V84, P17, DOI 10.1016/j.steroids.2014.03.005; Man SL, 2014, STEROIDS, V80, P1, DOI 10.1016/j.steroids.2013.11.015; Man SL, 2014, J ETHNOPHARMACOL, V151, P407, DOI 10.1016/j.jep.2013.10.051; Man SL, 2011, J ETHNOPHARMACOL, V137, P1221, DOI 10.1016/j.jep.2011.07.045; Man SL, 2011, ARCH PHARM RES, V34, P43, DOI 10.1007/s12272-011-0105-4; Man SL, 2009, STEROIDS, V74, P1051, DOI 10.1016/j.steroids.2009.08.004; Misra S, 2014, CURR DRUG TARGETS, V15, P347, DOI 10.2174/1389450115666140127102915; Pennathur A, 2013, LANCET, V381, P400, DOI 10.1016/S0140-6736(12)60643-6; Sahin IH, 2014, CANCER LETT, V345, P249, DOI 10.1016/j.canlet.2013.09.001; SHIMADA Y, 1992, CANCER, V69, P277, DOI 10.1002/1097-0142(19920115)69:2<277::AID-CNCR2820690202>3.0.CO;2-C; Xiao X, 2014, CANCER CHEMOTH PHARM, V73, P807, DOI 10.1007/s00280-014-2408-x; Xiao X, 2012, BIOSCI TRENDS, V6, P201, DOI 10.5582/bst.2012.v6.4.201; Xiao X, 2009, MOL CANCER THER, V8, P1179, DOI 10.1158/1535-7163.MCT-08-0939; Yan L. L., 2009, Experimental Oncology, V31, P27; Yu HP, 2004, J GASTROEN HEPATOL, V19, P638, DOI 10.1111/j.1440-1746.2004.03345.x; Zhang WJ, 2014, EUR J MED RES, V19, DOI 10.1186/2047-783X-19-41	24	14	15	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131560	10.1371/journal.pone.0131560	http://dx.doi.org/10.1371/journal.pone.0131560			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147856	Green Published, Green Submitted, gold			2022-12-26	WOS:000358157600106
J	Goswami, MT; Reka, AK; Kurapati, H; Kaza, V; Chen, J; Standiford, TJ; Keshamouni, VG				Goswami, M. T.; Reka, A. K.; Kurapati, H.; Kaza, V.; Chen, J.; Standiford, T. J.; Keshamouni, V. G.			Regulation of complement-dependent cytotoxicity by TGF-beta-induced epithelial-mesenchymal transition	ONCOGENE			English	Article							TUMOR-CELLS; CANCER; EXPRESSION; PROTEINS; CD59; NEUTRALIZATION; MODULATION; RESISTANCE; PREDICTS; SURVIVAL	The process of epithelial-mesenchymal transition (EMT), in addition to being an initiating event for tumor metastasis, is implicated in conferring several clinically relevant properties to disseminating cancer cells. These include stem cell-like properties, resistance to targeted therapies and ability to evade immune surveillance. Enrichment analysis of gene expression changes during transforming growth factor-beta (TGF-beta)-induced EMT in lung cancer cells identified complement cascade as one of the significantly enriched pathway. Further analysis of the genes in the complement pathway revealed an increase in the expression of complement inhibitors and a decrease in the expression of proteins essential for complement activity. In this study, we tested whether EMT confers resistance to complement-dependent cytotoxicity (CDC) in lung cancer cells and promotes tumor progression. CD59 is a potent inhibitor of membrane attack complex that mediates complement-dependent cell lysis. We observed a significant increase in the CD59 expression on the surface of cells after TGF-beta-induced EMT. Furthermore, CD59 knockdown restored susceptibility of cells undergoing EMT to cetuximab-mediated CDC. TGF-beta-induced CD59 expression during EMT is dependent on Smad3 but not on Smad2. Chromatin immunoprecipitation analysis confirmed that Smad3 directly binds to the CD59 promoter. Stable knockdown of CD59 in A549 cells inhibited experimental metastasis. These results demonstrate that TGF-beta-induced EMT and CD59 expression confers an immune-evasive mechanism to disseminating tumor cells facilitating tumor progression. Together, our data demonstrates that CD59 inhibition may serve as an adjuvant to enhance the efficacy of antibody-mediated therapies, as well as to inhibit metastasis in lung cancer.	[Goswami, M. T.; Reka, A. K.; Kurapati, H.; Kaza, V.; Chen, J.; Standiford, T. J.; Keshamouni, V. G.] Univ Michigan, Med Ctr, Dept Internal Med, Div Pulm & Crit Care Med, 4062 BSRB,109 Zina Pitcher Pl, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Keshamouni, VG (corresponding author), Univ Michigan, Med Ctr, Dept Internal Med, Div Pulm & Crit Care Med, 4062 BSRB,109 Zina Pitcher Pl, Ann Arbor, MI 48109 USA.	vkeshamo@med.umich.edu		Keshamouni, Venkateshwar/0000-0003-1947-791X	NIH/NCI [CA132571-01]; Elizabeth A Crary Fund; NIH/NHLBI [HL097564]; NATIONAL CANCER INSTITUTE [R01CA132571] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL123515, R01HL097564] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Elizabeth A Crary Fund; NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research is funded by an NIH/NCI (CA132571-01) grant and the Elizabeth A Crary Fund to VGK and NIH/NHLBI HL097564 to TJS.	Corrales L, 2012, J IMMUNOL, V189, P4674, DOI 10.4049/jimmunol.1201654; Cragg MS, 2000, CELL DEATH DIFFER, V7, P48, DOI 10.1038/sj.cdd.4400627; Donin N, 2003, CLIN EXP IMMUNOL, V131, P254, DOI 10.1046/j.1365-2249.2003.02066.x; Fishelson Z, 2003, MOL IMMUNOL, V40, P109, DOI 10.1016/S0161-5890(03)00112-3; Ge XW, 2011, CLIN CANCER RES, V17, P6702, DOI 10.1158/1078-0432.CCR-11-0647; Hsu YF, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-139; Hu WG, 2011, CANCER RES, V71, P2298, DOI 10.1158/0008-5472.CAN-10-3016; Jurianz K, 1999, IMMUNOPHARMACOLOGY, V42, P209, DOI 10.1016/S0162-3109(99)00006-5; Jurianz K, 1999, MOL IMMUNOL, V36, P929, DOI 10.1016/S0161-5890(99)00115-7; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kalluri R, 2009, J CLIN INVEST, V119, P1417, DOI 10.1172/JCI39675; Keshamouni VG, 2009, J PROTEOME RES, V8, P35, DOI 10.1021/pr8006478; Keshamouni VG, 2006, J PROTEOME RES, V5, P1143, DOI 10.1021/pr050455t; Kim DD, 2006, CLIN IMMUNOL, V118, P127, DOI 10.1016/j.clim.2005.10.014; Kim WS, 1999, ANTICANCER RES, V19, P301; Kohler BA, 2011, JNCI-J NATL CANCER I, V103, P714, DOI 10.1093/jnci/djr077; Kong FM, 1999, CANCER-AM CANCER SOC, V86, P1712, DOI 10.1002/(SICI)1097-0142(19991101)86:9<1712::AID-CNCR12>3.0.CO;2-V; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Markiewski MM, 2008, NAT IMMUNOL, V9, P1225, DOI 10.1038/ni.1655; Markiewski MM, 2009, TRENDS IMMUNOL, V30, P286, DOI 10.1016/j.it.2009.04.002; Masszi A, 2004, AM J PATHOL, V165, P1955, DOI 10.1016/S0002-9440(10)63247-6; NISHIOKA K, 1976, ANN NY ACAD SCI, V276, P303, DOI 10.1111/j.1749-6632.1976.tb41656.x; Pasch MC, 1999, EUR J IMMUNOL, V29, P100, DOI 10.1002/(SICI)1521-4141(199901)29:01<100::AID-IMMU100>3.3.CO;2-I; Reka AK, 2014, CARCINOGENESIS, V35, P1292, DOI 10.1093/carcin/bgu041; Reka AK, 2011, J THORAC ONCOL, V6, P1784, DOI 10.1097/JTO.0b013e31822adfb0; Reka AK, 2010, MOL CANCER THER, V9, P3221, DOI 10.1158/1535-7163.MCT-10-0570; Tarin D, 2005, CANCER RES, V65, P5996, DOI 10.1158/0008-5472.CAN-05-0699; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Thomson S, 2005, CANCER RES, V65, P9455, DOI 10.1158/0008-5472.CAN-05-1058; Varsano S, 1998, CLIN EXP IMMUNOL, V113, P173; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Watson NFS, 2006, CANCER IMMUNOL IMMUN, V55, P973, DOI 10.1007/s00262-005-0055-0; Xu CL, 2005, PROSTATE, V62, P224, DOI 10.1002/pros.20134; Yan J, 2008, ADV EXP MED BIOL, V632, P159, DOI 10.1007/978-0-387-78952-1_12; Yu M, 2013, SCIENCE, V339, P580, DOI 10.1126/science.1228522; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zavadil J, 2008, CANCER RES, V68, P9574, DOI 10.1158/0008-5472.CAN-08-2316; Zhao WP, 2009, ONCOL REP, V21, P1405, DOI 10.3892/or_00000368	38	37	39	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 14	2016	35	15					1888	1898		10.1038/onc.2015.258	http://dx.doi.org/10.1038/onc.2015.258			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DJ2CC	26148233	Green Accepted			2022-12-26	WOS:000374010300002
J	Bai, WQ; Zhou, C; Zhao, YJ; Wang, QH; Ma, YH				Bai, Wenqin; Zhou, Cheng; Zhao, Yueju; Wang, Qinhong; Ma, Yanhe			Structural Insight into and Mutational Analysis of Family 11 Xylanases: Implications for Mechanisms of Higher pH Catalytic Adaptation	PLOS ONE			English	Article							3-DIMENSIONAL STRUCTURE; TRICHODERMA-REESEI; ALKALINE ADAPTATION; CRYSTAL-STRUCTURE; BACILLUS; EXPRESSION; INCREASES; ENDO-1,4-BETA-XYLANASE-II; ENDO-BETA-1,4-XYLANASES; THERMOSTABILITY	To understand the molecular basis of higher pH catalytic adaptation of family 11 xylanases, we compared the structures of alkaline, neutral, and acidic active xylanases and analyzed mutants of xylanase Xyn11A-LC from alkalophilic Bacillus sp. SN5. It was revealed that alkaline active xylanases have increased charged residue content, an increased ratio of negatively to positively charged residues, and decreased Ser, Thr, and Tyr residue content relative to non-alkaline active counterparts. Between strands beta 6 and beta 7, alkaline xylanases substitute an alpha-helix for a coil or turn found in their non-alkaline counterparts. Compared with non-alkaline xylanases, alkaline active enzymes have an inserted stretch of seven amino acids rich in charged residues, which may be beneficial for xylanase function in alkaline conditions. Positively charged residues on the molecular surface and ionic bonds may play important roles in higher pH catalytic adaptation of family 11 xylanases. By structure comparison, sequence alignment and mutational analysis, six amino acids (Glu16, Trp18, Asn44, Leu46, Arg48, and Ser187, numbering based on Xyn11A-LC) adjacent to the acid/base catalyst were found to be responsible for xylanase function in higher pH conditions. Our results will contribute to understanding the molecular mechanisms of higher pH catalytic adaptation in family 11 xylanases and engineering xylanases to suit industrial applications.	[Bai, Wenqin; Wang, Qinhong; Ma, Yanhe] Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Natl Engn Lab Ind Enzymes, Tianjin 300308, Peoples R China; [Bai, Wenqin; Zhou, Cheng; Ma, Yanhe] Chinese Acad Sci, Inst Microbiol, Natl Engn Lab Ind Enzymes, Beijing 100101, Peoples R China; [Bai, Wenqin] Shanxi Normal Univ, Sch Life Sci, Linfen 041004, Peoples R China; [Zhao, Yueju] Chinese Acad Agr Sci, Inst Agroprod Proc Sci & Technol, Beijing 100193, Peoples R China	Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS; Chinese Academy of Sciences; Institute of Microbiology, CAS; Shanxi Normal University; Chinese Academy of Agricultural Sciences	Bai, WQ (corresponding author), Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Natl Engn Lab Ind Enzymes, Tianjin 300308, Peoples R China.	bai_wq@tib.cas.cn; ma_yh@tib.cas.cn	MA, YAN/HHN-2912-2022; Zhou, Cheng/Q-4416-2018	Zhou, Cheng/0000-0001-9720-9318	Natural Science Foundation of China [31400679]; Key Deployment Program of Chinese Academy of Sciences [KSZD-EW-Z-015]; National High Technology Research and Development Program of China [2012AA022203]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Deployment Program of Chinese Academy of Sciences; National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This study was supported by the Natural Science Foundation of China (31400679), the Key Deployment Program of Chinese Academy of Sciences (KSZD-EW-Z-015) and the National High Technology Research and Development Program of China (863 Program, 2012AA022203). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Balaa B, 2006, BIOSCI BIOTECH BIOCH, V70, P269, DOI 10.1271/bbb.70.269; Bai WQ, 2015, BIOTECHNOL APPL BIOC, V62, P208, DOI 10.1002/bab.1265; Bai WQ, 2014, BIOTECHNOL LETT, V36, P1495, DOI 10.1007/s10529-014-1512-7; Bai WQ, 2012, BIOTECHNOL LETT, V34, P2093, DOI 10.1007/s10529-012-1011-7; Balakrishnan H, 2002, J Biochem Mol Biol Biophys, V6, P325, DOI 10.1080/1025814021000003229; Beg QK, 2001, APPL MICROBIOL BIOT, V56, P326, DOI 10.1007/s002530100704; Berrin JG, 2008, BIOTECHNOL LETT, V30, P1139, DOI 10.1007/s10529-008-9669-6; Besir H, 2005, FEBS LETT, V579, P6595, DOI 10.1016/j.febslet.2005.10.052; BIELY P, 1985, TRENDS BIOTECHNOL, V3, P286, DOI 10.1016/0167-7799(85)90004-6; Collins T, 2005, FEMS MICROBIOL REV, V29, P3, DOI 10.1016/j.femsre.2004.06.005; Dubnovitsky AP, 2005, PROTEIN SCI, V14, P97, DOI 10.1110/ps.041029805; Esteves FD, 2004, PROTEIN SCI, V13, P1209, DOI 10.1110/ps.03556104; Fushinobu S, 1998, PROTEIN ENG, V11, P1121, DOI 10.1093/protein/11.12.1121; Georis J, 2000, PROTEIN SCI, V9, P466; Georis J, 2000, ENZYME MICROB TECH, V26, P178, DOI 10.1016/S0141-0229(99)00141-6; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hakulinen N, 2003, EUR J BIOCHEM, V270, P1399, DOI 10.1046/j.1432-1033.2003.03496.x; He J, 2009, NEW BIOTECHNOL, V26, P53, DOI 10.1016/j.nbt.2009.04.002; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; ITO K, 1992, BIOSCI BIOTECH BIOCH, V56, P547, DOI 10.1271/bbb.56.547; Joshi MD, 2000, J MOL BIOL, V299, P255, DOI 10.1006/jmbi.2000.3722; Joshi MD, 2001, BIOCHEMISTRY-US, V40, P10115, DOI 10.1021/bi0105429; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Krengel U, 1996, J MOL BIOL, V263, P70, DOI 10.1006/jmbi.1996.0556; Liu XM, 2002, J MOL CATAL B-ENZYM, V18, P307, DOI 10.1016/S1381-1177(02)00111-X; Mamo G, 2009, BIOCHIMIE, V91, P1187, DOI 10.1016/j.biochi.2009.06.017; Manikandan K, 2006, PROTEIN SCI, V15, P1951, DOI 10.1110/ps.062220206; McIntosh LP, 1996, BIOCHEMISTRY-US, V35, P9958, DOI 10.1021/bi9613234; Michaux C, 2010, BIOCHIMIE, V92, P1407, DOI 10.1016/j.biochi.2010.07.003; Nielsen JE, 2003, PROTEIN SCI, V12, P1894, DOI 10.1110/ps.03114903; Nielsen JE, 2001, PROTEIN ENG, V14, P505, DOI 10.1093/protein/14.7.505; Oakley AJ, 2003, ACTA CRYSTALLOGR D, V59, P627, DOI 10.1107/S0907444903001227; Poon DKY, 2003, CARBOHYD RES, V338, P415, DOI 10.1016/S0008-6215(02)00486-X; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Ruller R, 2006, BIOTECHNOL APPL BIOC, V43, P9, DOI 10.1042/BA20050016; RUSSELL AJ, 1987, NATURE, V328, P496, DOI 10.1038/328496a0; RZHETSKY A, 1993, MOL BIOL EVOL, V10, P1073; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shirai T, 1997, PROTEIN ENG, V10, P627, DOI 10.1093/protein/10.6.627; Shirai T, 2001, J MOL BIOL, V310, P1079, DOI 10.1006/jmbi.2001.4835; Shiraki K, 2002, EUR J BIOCHEM, V269, P4152, DOI 10.1046/j.1432-1033.2002.03110.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TORRONEN A, 1994, EMBO J, V13, P2493, DOI 10.1002/j.1460-2075.1994.tb06536.x; TORRONEN A, 1995, BIOCHEMISTRY-US, V34, P847, DOI 10.1021/bi00003a019; Torronen A, 1997, J BIOTECHNOL, V57, P137, DOI 10.1016/S0168-1656(97)00095-3; Turunen O, 2002, PROTEIN ENG, V15, P141, DOI 10.1093/protein/15.2.141; Turunen O, 2001, J BIOTECHNOL, V88, P37, DOI 10.1016/S0168-1656(01)00253-X; Umemoto H, 2009, BIOSCI BIOTECH BIOCH, V73, P965, DOI 10.1271/bbb.80869; WL D, 2002, THE PYMOL MOLECULAR; Xue HP, 2012, J IND MICROBIOL BIOT, V39, P1279, DOI 10.1007/s10295-012-1140-y; Zhang S, 2010, BIOCHEM BIOPH RES CO, V395, P200, DOI 10.1016/j.bbrc.2010.03.159; Zhao YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014608	54	16	17	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132834	10.1371/journal.pone.0132834	http://dx.doi.org/10.1371/journal.pone.0132834			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161643	Green Submitted, Green Published, gold			2022-12-26	WOS:000358162300179
J	Bonadies, N; Gottgens, B; Calero-Nieto, FJ				Bonadies, Nicolas; Goettgens, Berthold; Calero-Nieto, Fernando J.			The LMO2-25 Region Harbours GATA2-Dependent Myeloid Enhancer and RUNX-Dependent T-Lymphoid Repressor Activity	PLOS ONE			English	Article							LIM-PROTEIN RBTN2; ACUTE LYMPHOBLASTIC-LEUKEMIA; GENOME-WIDE ANALYSIS; CELL ACUTE-LEUKEMIA; B-CELL; CHROMOSOMAL TRANSLOCATION; EXPRESSION; COMPLEX; TRANSCRIPTION; GENE	Lim domain only 2 (LMO2) is a transcriptional co-factor required for angiogenesis and the specification of haematopoietic cells during development. LMO2 is widely expressed within haematopoiesis with the exception of T-cells. Failure to downregulate LMO2 during T-cell maturation leads to leukaemia, thus underlining the critical nature of context-dependent regulation of LMO2 expression. We previously identified a distal regulatory element of LMO2 (element -25) that cooperates with the proximal promoter in directing haematopoietic expression. Here we dissected the functional activity of element -25 and showed it to consist of two modules that conferred independent and cell-type specific activities: a 3' myeloid enhancer and a 5' T-cell repressor. The myeloid enhancer was bound by GATA2 in progenitors and its activity depended on a highly conserved GATA motif, whereas the T-cell repressor moiety of element -25 was bound by the Core Binding Factor in T-cells and its repressive activity depended on a highly conserved RUNT motif. Since the myeloid enhancer and nearby downstream region is recurrently involved in oncogenic translocations, our data suggest that the -25 enhancer region provides an open chromatin environment prone to translocations, which in turn cause aberrant LMO2-expression in T-cells due to the removal of the adjacent T-cell repressor.	[Bonadies, Nicolas; Goettgens, Berthold; Calero-Nieto, Fernando J.] Univ Cambridge, Cambridge Inst Med Res, Wellcome Trust & MRC Cambridge Stem Cell Inst, Dept Haematol, Cambridge, England	University of Cambridge	Gottgens, B (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Wellcome Trust & MRC Cambridge Stem Cell Inst, Dept Haematol, Cambridge, England.	fjc28@cam.ac.uk; bg200@cam.ac.uk	Bonadies, Nicolas/F-2388-2017	Bonadies, Nicolas/0000-0001-8761-2066; Gottgens, Berthold/0000-0001-6302-5705; Calero-Nieto, Fernando/0000-0003-3358-8253	Leukaemia and Lymphoma Research [07060, 12029]; Swiss National Science Foundation; Wellcome Trust [100140/Z/12/Z]; MRC Cambridge Stem Cell Institute [097922/Z/11/Z]; Biotechnology and Biological Sciences Research Council [BB/I00050X/1] Funding Source: researchfish; Cancer Research UK [12765] Funding Source: researchfish; Medical Research Council [MR/M008975/1, MC_PC_12009] Funding Source: researchfish; BBSRC [BB/I00050X/1] Funding Source: UKRI; MRC [MR/M008975/1] Funding Source: UKRI	Leukaemia and Lymphoma Research; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); MRC Cambridge Stem Cell Institute(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Leukaemia and Lymphoma Research (BG) (http://leukaemialymphomaresearch.org.uk/, grants number 07060 and 12029), a fellowship from the Swiss National Science Foundation (NB) (http://www.snf.ch/) and Wellcome Trust Infrastructure support funding for the Cambridge Institute for Medical Research ((http://www.wellcome.ac.uk/) grant number 100140/Z/12/Z) and the Wellcome Trust and MRC Cambridge Stem Cell Institute (http://www.mrc.ac.uk/, grant number 097922/Z/11/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MK, 2006, IMMUNOL REV, V209, P191, DOI 10.1111/j.0105-2896.2006.00352.x; Arbiser JL, 1997, P NATL ACAD SCI USA, V94, P861, DOI 10.1073/pnas.94.3.861; Arribas Alberto J, 2012, Blood, V119, pe9, DOI 10.1182/blood-2011-02-339556; Beck D, 2013, BLOOD, V122, pE12, DOI 10.1182/blood-2013-03-490425; Blenk S, 2007, CANCER INFORM, V3, P399; BOEHM T, 1989, EMBO J, V8, P2621, DOI 10.1002/j.1460-2075.1989.tb08402.x; BOEHM T, 1988, EMBO J, V7, P385, DOI 10.1002/j.1460-2075.1988.tb02825.x; BOEHM T, 1991, P NATL ACAD SCI USA, V88, P4367, DOI 10.1073/pnas.88.10.4367; Bowers SR, 2009, MOL CELL BIOL, V29, P1682, DOI 10.1128/MCB.01411-08; Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603; Calero-Nieto FJ, 2013, ONCOGENE, V32, P5471, DOI 10.1038/onc.2013.175; Chapman MA, 2004, GENOME RES, V14, P313, DOI 10.1101/gr.1759004; CHENG JT, 1990, J EXP MED, V171, P489, DOI 10.1084/jem.171.2.489; Cobanoglu U, 2010, HEMATOLOGY, V15, P132, DOI 10.1179/102453309X12583347113618; Collins A, 2009, NAT REV IMMUNOL, V9, P106, DOI 10.1038/nri2489; De Keersmaecker K, 2005, HAEMATOLOGICA, V90, P1116; DEXTER TM, 1979, NATURE, V277, P471, DOI 10.1038/277471a0; Dik WA, 2007, BLOOD, V110, P388, DOI 10.1182/blood-2006-12-064816; DUBE SK, 1975, P NATL ACAD SCI USA, V72, P1863, DOI 10.1073/pnas.72.5.1863; Ferrando AA, 2002, CANCER CELL, V1, P75, DOI 10.1016/S1535-6108(02)00018-1; FITZGERALD TJ, 1992, BLOOD, V80, P3189; GARCIA IS, 1991, ONCOGENE, V6, P577; Gottgens B, 1997, ONCOGENE, V15, P2419, DOI 10.1038/sj.onc.1201426; Grewal SIS, 2003, SCIENCE, V301, P798, DOI 10.1126/science.1086887; Hammond SM, 2005, LEUKEMIA RES, V29, P89, DOI 10.1016/j.leukres.2004.05.013; Herblot S, 2000, NAT IMMUNOL, V1, P138, DOI 10.1038/77819; Kundu M, 2005, BLOOD, V106, P3621, DOI 10.1182/blood-2005-04-1447; Landry JR, 2009, BLOOD, V113, P5783, DOI 10.1182/blood-2008-11-187757; Landry JR, 2005, BLOOD, V106, P2680, DOI 10.1182/blood-2004-12-4755; LARSON RC, 1995, ONCOGENE, V11, P853; Larson RC, 1996, EMBO J, V15, P1021, DOI 10.1002/j.1460-2075.1996.tb00439.x; Lotem J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080467; Malumbres R, 2011, HAEMATOL-HEMATOL J, V96, P980, DOI 10.3324/haematol.2011.040568; McCormack MP, 2010, SCIENCE, V327, P879, DOI 10.1126/science.1182378; Nam CH, 2006, MOL THER, V13, P15, DOI 10.1016/j.ymthe.2005.09.010; Natkunam Y, 2007, HEMATOLOGY, V1, P210, DOI DOI 10.1182/ASHEDUCATI0N-2007.1.210; Natkunam Y, 2008, J CLIN ONCOL, V26, P447, DOI 10.1200/JCO.2007.13.0690; Natkunam Y, 2007, BLOOD, V109, P1636, DOI 10.1182/blood-2006-08-039024; Nicholas KB, 1997, GENEDOC A TOOL FOR E; Oram SH, 2010, ONCOGENE, V29, P5796, DOI 10.1038/onc.2010.320; OSADA H, 1995, P NATL ACAD SCI USA, V92, P9585, DOI 10.1073/pnas.92.21.9585; Ptasinska A, 2014, CELL REP, V8, P1974, DOI 10.1016/j.celrep.2014.08.024; RABBITTS TH, 1994, NATURE, V372, P143, DOI 10.1038/372143a0; ROYERPOKORA B, 1995, ONCOGENE, V10, P1353; ROYERPOKORA B, 1991, ONCOGENE, V6, P1887; Sanchez-Castillo M, 2015, NUCLEIC ACIDS RES, V43, pD1117, DOI 10.1093/nar/gku895; SANCHEZGARCIA I, 1993, SEMIN CANCER BIOL, V4, P349; Sanda T, 2012, CANCER CELL, V22, P209, DOI 10.1016/j.ccr.2012.06.007; Schug Jonathan, 2008, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0206s21; Stamatoyannopoulos JA, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-418; Sun XJ, 2013, NATURE, V500, P93, DOI 10.1038/nature12287; Talbert PB, 2006, NAT REV GENET, V7, P793, DOI 10.1038/nrg1920; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; Valge-Archer V, 1998, ONCOGENE, V17, P3199, DOI 10.1038/sj.onc.1202353; VALGEARCHER VE, 1994, P NATL ACAD SCI USA, V91, P8617, DOI 10.1073/pnas.91.18.8617; Wadman IA, 1997, EMBO J, V16, P3145, DOI 10.1093/emboj/16.11.3145; WARREN AJ, 1994, CELL, V78, P45, DOI 10.1016/0092-8674(94)90571-1; Wilson NK, 2010, CELL STEM CELL, V7, P532, DOI 10.1016/j.stem.2010.07.016; Yamada Y, 1998, P NATL ACAD SCI USA, V95, P3890, DOI 10.1073/pnas.95.7.3890; YOFFE G, 1989, BLOOD, V74, P374; Younes SF, 2011, AM J CLIN PATHOL, V135, P697, DOI 10.1309/AJCP7Z2BIBUNQPLZ; Yu M, 2012, MOL CELL, V45, P330, DOI 10.1016/j.molcel.2011.11.032	62	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131577	10.1371/journal.pone.0131577	http://dx.doi.org/10.1371/journal.pone.0131577			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161748	Green Submitted, Green Published, gold			2022-12-26	WOS:000358162300048
J	Buck, AH; Ivens, A; Gordon, K; Craig, N; Houzelle, A; Roche, A; Turnbull, N; Beard, PM				Buck, Amy H.; Ivens, Alasdair; Gordon, Katrina; Craig, Nicola; Houzelle, Alexandre; Roche, Alice; Turnbull, Neil; Beard, Philippa M.			Quantitative Analysis of MicroRNAs in Vaccinia virus Infection Reveals Diversity in Their Susceptibility to Modification and Suppression	PLOS ONE			English	Article							SMALL SILENCING RNAS; POLY(A) POLYMERASE; BIOGENESIS; TURNOVER; TARGET; EXPRESSION; PATHWAY; GENOME; CANCER; DEGRADATION	Vaccinia virus (VACV) is a large cytoplasmic DNA virus that causes dramatic alterations to many cellular pathways including microRNA biogenesis. The virus encodes a poly(A) polymerase which was previously shown to add poly(A) tails to the 3' end of cellular miRNAs, resulting in their degradation by 24 hours post infection (hpi). Here we used small RNA sequencing to quantify the impact of VACV infection on cellular miRNAs in human cells at both early (6 h) and late (24 h) times post infection. A detailed quantitative analysis of individual miRNAs revealed marked diversity in the extent of their modification and relative change in abundance during infection. Some miRNAs became highly modified (e.g. miR29a- 3p, miR-27b-3p) whereas others appeared resistant (e.g. miR-16-5p). Furthermore, miRNAs that were highly tailed at 6 hpi were not necessarily among the most reduced at 24 hpi. These results suggest that intrinsic features of human cellular miRNAs cause them to be differentially polyadenylated and altered in abundance during VACV infection. We also demonstrate that intermediate and late VACV gene expression are required for optimal repression of some miRNAs including miR-27-3p. Overall this work reveals complex and varied consequences of VACV infection on host miRNAs and identifies miRNAs which are largely resistant to VACV-induced polyadenylation and are therefore present at functional levels during the initial stages of infection and replication.	[Buck, Amy H.; Ivens, Alasdair; Gordon, Katrina] Univ Edinburgh, Ctr Immun Infect & Evolut, Edinburgh, Midlothian, Scotland; [Craig, Nicola; Houzelle, Alexandre; Roche, Alice; Turnbull, Neil; Beard, Philippa M.] Roslin Inst, Royal Dick Sch Vet Studies, Infect & Immun, Easter Bush, Midlothian, Scotland	University of Edinburgh; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh	Buck, AH (corresponding author), Univ Edinburgh, Ctr Immun Infect & Evolut, Kings Bldg, Edinburgh, Midlothian, Scotland.	a.buck@ed.ac.uk; pip.beard@roslin.ed.ac.uk		Buck, Amy/0000-0003-2645-7191; Beard, Pip/0000-0002-2285-810X; Ivens, Al/0000-0002-0112-3876; Craig, Nicky/0000-0001-7370-4437	BBSRC; Wellcome Trust RCDF [WT097394AIA]; BBSRC project [BB/J001279/1]; Wellcome Trust strategic award [095831MA]; BBSRC [BBS/E/D/20241864, BB/J001279/1, BBS/E/D/20310000] Funding Source: UKRI; MRC [G0900740, MR/K001744/1] Funding Source: UKRI; NERC [NBAF010003] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/D/20241864, BB/J001279/1, BBS/E/D/20310000] Funding Source: researchfish; Medical Research Council [MR/K001744/1, G0900740] Funding Source: researchfish; Natural Environment Research Council [NBAF010003] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust RCDF(Wellcome Trust); BBSRC project(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust strategic award(Wellcome Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The Roslin Institute receives Institute Strategic Grant funding from the BBSRC. This work is supported by a Wellcome Trust RCDF (WT097394AIA) and BBSRC project (BB/J001279/1) awarded to A. Buck as well as a Wellcome Trust strategic award (095831MA) to the Centre for Immunity, Infection and Evolution supporting A. Ivens. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameres SL, 2013, NAT REV MOL CELL BIO, V14, P475, DOI 10.1038/nrm3611; Ameres SL, 2010, SCIENCE, V328, P1534, DOI 10.1126/science.1187058; Aqeilan RI, 2010, CELL DEATH DIFFER, V17, P215, DOI 10.1038/cdd.2009.69; Baccarini A, 2011, CURR BIOL, V21, P369, DOI 10.1016/j.cub.2011.01.067; Backes S, 2012, CELL HOST MICROBE, V12, P200, DOI 10.1016/j.chom.2012.05.019; Bail S, 2010, RNA, V16, P1032, DOI 10.1261/rna.1851510; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Chen JS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120390; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Diederichs S, 2007, CELL, V131, P1097, DOI 10.1016/j.cell.2007.10.032; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Gantier MP, 2011, NUCLEIC ACIDS RES, V39, P5692, DOI 10.1093/nar/gkr148; GERSHON PD, 1993, EMBO J, V12, P4705, DOI 10.1002/j.1460-2075.1993.tb06159.x; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Grinberg M, 2012, ARCH VIROL, V157, P1719, DOI 10.1007/s00705-012-1366-z; Grundhoff A, 2011, VIROLOGY, V411, P325, DOI 10.1016/j.virol.2011.01.002; JONES EV, 1987, J VIROL, V61, P1765, DOI 10.1128/JVI.61.6.1765-1771.1987; Jones MR, 2009, NAT CELL BIOL, V11, P1157, DOI 10.1038/ncb1931; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Kai ZS, 2010, NAT STRUCT MOL BIOL, V17, P5, DOI 10.1038/nsmb.1762; Katoh T, 2009, GENE DEV, V23, P433, DOI 10.1101/gad.1761509; Kim SW, 2012, P NATL ACAD SCI USA, V109, P7865, DOI 10.1073/pnas.1200081109; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Li DN, 1997, EMBO J, V16, P1103, DOI 10.1093/emboj/16.5.1103; Libri V, 2013, CELL MOL LIFE SCI, V70, P3525, DOI 10.1007/s00018-012-1257-1; Libri V, 2012, P NATL ACAD SCI USA, V109, P279, DOI 10.1073/pnas.1114204109; McCaskill J, 2015, RNA BIOL, V12, P579, DOI 10.1080/15476286.2015.1034912; MEYER H, 1991, J GEN VIROL, V72, P1031, DOI 10.1099/0022-1317-72-5-1031; Moss B, 2007, FIELDS VIROLOGY, P2906; O'Carroll D, 2007, GENE DEV, V21, P1999, DOI 10.1101/gad.1565607; Pall GS, 2008, NAT PROTOC, V3, P1077, DOI 10.1038/nprot.2008.67; Pan XA, 2010, CANCER BIOL THER, V10, P1224, DOI 10.4161/cbt.10.12.14252; RAMSEYEWING A, 1995, VIROLOGY, V206, P984, DOI 10.1006/viro.1995.1021; Rouha H, 2010, NUCLEIC ACIDS RES, V38, P8328, DOI 10.1093/nar/gkq681; Ruegger S, 2012, TRENDS BIOCHEM SCI, V37, P436, DOI 10.1016/j.tibs.2012.07.002; Santhakumar D, 2010, P NATL ACAD SCI USA, V107, P13830, DOI 10.1073/pnas.1008861107; Shapiro JS, 2010, RNA, V16, P2068, DOI 10.1261/rna.2303610; Skalsky RL, 2010, ANNU REV MICROBIOL, V64, P123, DOI 10.1146/annurev.micro.112408.134243; SUTTER G, 1992, P NATL ACAD SCI USA, V89, P10847, DOI 10.1073/pnas.89.22.10847; TADDIE JA, 1993, J VIROL, V67, P4323, DOI 10.1128/JVI.67.7.4323-4336.1993; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; Wu XL, 2013, ONCOTARGET, V4, P1388, DOI 10.18632/oncotarget.1239; Wyman SK, 2011, GENOME RES, V21, P1450, DOI 10.1101/gr.118059.110; Yang JS, 2011, MOL CELL, V43, P892, DOI 10.1016/j.molcel.2011.07.024; Yang JS, 2011, RNA, V17, P312, DOI 10.1261/rna.2537911; Zhang Z, 2011, NUCLEIC ACIDS RES, V39, P4387, DOI 10.1093/nar/gkr020	48	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131787	10.1371/journal.pone.0131787	http://dx.doi.org/10.1371/journal.pone.0131787			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161560	Green Published, Green Submitted, gold			2022-12-26	WOS:000358162300058
J	Furutani, A; Ikeda, Y; Itokawa, M; Nagahama, H; Ohtsu, T; Furutani, N; Kamagata, M; Yang, ZH; Hirasawa, A; Tahara, Y; Shibata, S				Furutani, Akiko; Ikeda, Yuko; Itokawa, Misa; Nagahama, Hiroki; Ohtsu, Teiji; Furutani, Naoki; Kamagata, Mayo; Yang, Zhi-Hong; Hirasawa, Akira; Tahara, Yu; Shibata, Shigenobu			Fish Oil Accelerates Diet-Induced Entrainment of the Mouse Peripheral Clock via GPR120	PLOS ONE			English	Article							CIRCADIAN GENE-EXPRESSION; PANCREATIC BETA-CELLS; KNOCK-IN MICE; FATTY-ACIDS; LIVER CLOCK; DOCOSAHEXAENOIC ACID; INSULIN-RESISTANCE; RECEPTOR GPR40; SECRETION; GLUCOSE	The circadian peripheral clock is entrained by restricted feeding (RF) at a fixed time of day, and insulin secretion regulates RF-induced entrainment of the peripheral clock in mice. Thus, carbohydrate-rich food may be ideal for facilitating RF-induced entrainment, although the role of dietary oils in insulin secretion and RF-induced entrainment has not been described. The soybean oil component of standard mouse chow was substituted with fish or soybean oil containing docosahexaenoic acid (DHA) and/or eicosapentaenoic acid (EPA). Tuna oil (high DHA/EPA), menhaden oil (standard), and DHA/EPA dissolved in soybean oil increased insulin secretion and facilitated RF-induced phase shifts of the liver clock as represented by the bioluminescence rhythms of PER2::LUCIFERASE knock-in mice. In this model, insulin depletion blocked the effect of tuna oil and fish oil had no effect on mice deficient for GPR120, a polyunsaturated fatty acid receptor. These results suggest food containing fish oil or DHA/EPA is ideal for adjusting the peripheral clock.	[Furutani, Akiko; Ikeda, Yuko; Itokawa, Misa; Nagahama, Hiroki; Ohtsu, Teiji; Furutani, Naoki; Kamagata, Mayo; Tahara, Yu; Shibata, Shigenobu] Waseda Univ, Sch Adv Sci & Engn, Lab Physiol & Pharmacol, Shinjuku Ku, Tokyo, Japan; [Yang, Zhi-Hong] Nippon Suisan Kaisha Ltd, Cent Res Lab, Hachioji, Tokyo, Japan; [Hirasawa, Akira] Kyoto Univ, Dept Genom Drug Discovery Sci, Sakyo Ku, Kyoto, Japan; [Hirasawa, Akira] Tokyo Womens Med Univ, Inst Integrated Med Sci, Shinjuku Ku, Tokyo, Japan	Waseda University; Nippon Suisan Kaisha, Ltd.; Kyoto University; Tokyo Women's Medical University	Shibata, S (corresponding author), Waseda Univ, Sch Adv Sci & Engn, Lab Physiol & Pharmacol, Shinjuku Ku, Wakamatsu Cho 2-2, Tokyo, Japan.	shibatas@waseda.jp	Furutani, Akiko/AAH-6996-2019; Tahara, Yu/Q-4324-2018	Tahara, Yu/0000-0002-3015-8883	Council for Science, Technology and Innovation, SIP; Bio-oriented Technology Research Advancement Institution, NARO; Ministry of Education, Culture, Sports, Science and Technology of Japan [26220201]; Nippon Suisan Kaisha Ltd.	Council for Science, Technology and Innovation, SIP; Bio-oriented Technology Research Advancement Institution, NARO; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Nippon Suisan Kaisha Ltd.	This work was partially supported by Council for Science, Technology and Innovation, SIP, "Technologies for creating next-generation agriculture, forestry and fisheries" (funding agency: Bio-oriented Technology Research Advancement Institution, NARO) (S.S.), and by a Grant-in-Aid for Scientific Research (S) (26220201) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (S.S.). Nippon Suisan Kaisha Ltd. provided support in the form of a salary for author ZHY, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Ando H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081119; Briscoe CP, 2003, J BIOL CHEM, V278, P11303, DOI 10.1074/jbc.M211495200; Buhr ED, 2010, SCIENCE, V330, P379, DOI 10.1126/science.1195262; Calder PC, 2009, POSTGRAD MED, V121, P148, DOI 10.3810/pgm.2009.11.2083; Cottin SC, 2011, P NUTR SOC, V70, P215, DOI 10.1017/S0029665111000061; Hara R, 2001, GENES CELLS, V6, P269, DOI 10.1046/j.1365-2443.2001.00419.x; Hirao A, 2010, AM J PHYSIOL-GASTR L, V299, pG1045, DOI 10.1152/ajpgi.00330.2010; Hirao A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006909; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Hirota T, 2002, J BIOL CHEM, V277, P44244, DOI 10.1074/jbc.M206233200; Ichimura A, 2012, NATURE, V483, P350, DOI 10.1038/nature10798; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Itokawa M, 2013, NUTR RES, V33, P109, DOI 10.1016/j.nutres.2012.12.004; Kawamoto T, 2006, J BIOCHEM, V140, P401, DOI 10.1093/jb/mvj165; Kebede M, 2008, DIABETES, V57, P2432, DOI 10.2337/db08-0553; Kidd PM, 2007, ALTERN MED REV, V12, P207; Liou AP, 2011, GASTROENTEROLOGY, V140, P903, DOI 10.1053/j.gastro.2010.10.012; Manerba A, 2010, FUTUR CARDIOL, V6, P343, DOI 10.2217/FCA.10.19; Mistlberger RE, 2009, EUR J NEUROSCI, V30, P1718, DOI 10.1111/j.1460-9568.2009.06965.x; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; Moran BM, 2014, DIABETES OBES METAB, V16, P1128, DOI 10.1111/dom.12330; Morishita M, 2008, J CONTROL RELEASE, V132, P99, DOI 10.1016/j.jconrel.2008.09.001; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Oike H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023709; Ouellet M, 2009, NEUROCHEM INT, V55, P476, DOI 10.1016/j.neuint.2009.04.018; Sato M, 2014, CELL REP, V8, P392, DOI 10.1016/j.celrep.2014.06.015; Shibata S, 2010, ADV DRUG DELIVER REV, V62, P918, DOI 10.1016/j.addr.2010.06.003; Shimazoe T, 2008, FASEB J, V22, P1479, DOI 10.1096/fj.07-9372com; Stephan FK, 1998, PHYSIOL BEHAV, V65, P277, DOI 10.1016/S0031-9384(98)00166-8; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Tahara Y, 2011, J BIOL RHYTHM, V26, P230, DOI 10.1177/0748730411405958; Talukdar S, 2011, TRENDS PHARMACOL SCI, V32, P543, DOI 10.1016/j.tips.2011.04.004; Tanaka T, 2008, N-S ARCH PHARMACOL, V377, P523, DOI 10.1007/s00210-007-0200-8; Terazono H, 2003, P NATL ACAD SCI USA, V100, P6795, DOI 10.1073/pnas.0936797100; Wall R, 2010, NUTR REV, V68, P280, DOI 10.1111/j.1753-4887.2010.00287.x; Wei MY, 2011, CURR ATHEROSCLER REP, V13, P474, DOI 10.1007/s11883-011-0210-3; Wu T, 2010, PHYSIOL RES, V59, P581, DOI 10.33549/physiolres.931818; Yamajuku D, 2012, SCI REP-UK, V2, DOI 10.1038/srep00439; Yang ZH, 2011, J AGR FOOD CHEM, V59, P7482, DOI 10.1021/jf201496h; Yang ZH, 2011, LIPIDS, V46, P425, DOI 10.1007/s11745-011-3553-1; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Yurko-Mauro K, 2010, CURR ALZHEIMER RES, V7, P190, DOI 10.2174/156720510791050911	42	37	40	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132472	10.1371/journal.pone.0132472	http://dx.doi.org/10.1371/journal.pone.0132472			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161796	Green Published, gold, Green Submitted			2022-12-26	WOS:000358162300138
J	Kontro, H; Cannino, G; Rustin, P; Dufour, E; Kainulainen, H				Kontro, Heidi; Cannino, Giuseppe; Rustin, Pierre; Dufour, Eric; Kainulainen, Heikki			DAPIT Over-Expression Modulates Glucose Metabolism and Cell Behaviour in HEK293T Cells	PLOS ONE			English	Article							COPY-NUMBER ALTERATION; GENE-EXPRESSION; ATP SYNTHASE; MITOCHONDRIAL BIOGENESIS; GENOMIC ALTERATIONS; HUMAN CANCERS; BETA-CATENIN; REVEALS; HYPOXIA; CARCINOMA	Introduction Diabetes Associated Protein in Insulin-sensitive Tissues (DAPIT) is a subunit of mitochondrial ATP synthase and has also been found to associate with the vacuolar H+-ATPase. Its expression is particularly high in cells with elevated aerobic metabolism and in epithelial cells that actively transport nutrients and ions. Deletion of DAPIT is known to induce loss of mitochondrial ATP synthase but the effects of its over-expression are obscure. Results In order to study the consequences of high expression of DAPIT, we constructed a transgenic cell line that constitutively expressed DAPIT in human embryonal kidney cells, HEK293T. Enhanced DAPIT expression decreased mtDNA content and mitochondrial mass, and saturated respiratory chain by decreasing H+-ATP synthase activity. DAPIT over-expression also increased mitochondrial membrane potential and superoxide level, and translocated the transcription factors hypoxia inducible factor 1 alpha (Hif1 alpha) and beta-catenin to the nucleus. Accordingly, cells over-expressing DAPIT used more glucose and generated a larger amount of lactate compared to control cells. Interestingly, these changes were associated with an epithelial to mesenchymal (EMT)-like transition by changing E-cadherin to N-cadherin and up-regulating several key junction/adhesion proteins. At physiological level, DAPIT over-expression slowed down cell growth by G1 arrest and migration, and enhanced cell detachment. Several cancers also showed an increase in genomic copy number of Usmg5 (gene encoding DAPIT), thereby providing strong correlative evidence for DAPIT possibly having oncogenic function in cancers. Conclusions DAPIT over-expression thus appears to modulate mitochondrial functions and alter cellular regulations, promote anaerobic metabolism and induce EMT-like transition. We propose that DAPIT over-expression couples the changes in mitochondrial metabolism to physiological and pathophysiological regulations, and suggest it could play a critical role in H+-ATP synthase dysfunctions.	[Kontro, Heidi] Univ Tampere, Tampere Ctr Child Hlth Res, FIN-33101 Tampere, Finland; [Cannino, Giuseppe; Dufour, Eric] Univ Tampere, Inst Biomed Technol, FIN-33101 Tampere, Finland; [Rustin, Pierre] INSERM, UMR 1141, Paris, France; [Rustin, Pierre] Univ Paris 07, Paris, France; [Kainulainen, Heikki] Univ Jyvaskyla, Dept Biol Phys Act, SF-40100 Jyvaskyla, Finland	Tampere University; Tampere University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of Jyvaskyla	Kainulainen, H (corresponding author), Univ Jyvaskyla, Dept Biol Phys Act, SF-40100 Jyvaskyla, Finland.	heikki.s.o.kainulainen@jyu.fi	Dufour, Eric/AAF-6210-2020; Cannino, Giuseppe/AAS-7269-2021	Dufour, Eric/0000-0001-6690-5329	Competitive Research Funding of Pirkanmaa Hospital District grant [9G030]; Finnish Cultural Foundation; Pirkanmaa Regional fund; Finnish Diabetes Research Foundation; Academy of Finland; Finnish Cultural Foundation Central Fund	Competitive Research Funding of Pirkanmaa Hospital District grant; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Pirkanmaa Regional fund; Finnish Diabetes Research Foundation; Academy of Finland(Academy of Finland); Finnish Cultural Foundation Central Fund	The study was financially supported by the Competitive Research Funding of the Pirkanmaa Hospital District grant 9G030, HKo; Finnish Cultural Foundation, Pirkanmaa Regional fund, HKo; Finnish Diabetes Research Foundation, HKo; Academy of Finland, HKa; Finnish Cultural Foundation Central Fund, HKa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The URLs of funding sources are as follows in the order they are mentioned: http://www.pshp.fi/default.aspx?nodeid=10066&contentlan=2,https://www.skr.fi/en/finnish-cultural-foundation/regional-funds/pirkanmaaregional-fund,http://www.diabetestutkimus.fi/en,http://www.aka.fi/en-GB/A/Funding-and-guidance/Funding/,https://www.skr.fi/en/ grants.	Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Barretina J, 2010, NAT GENET, V42, P715, DOI 10.1038/ng.619; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Benit P, 2006, CLIN CHIM ACTA, V374, P81, DOI 10.1016/j.cca.2006.05.034; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Beroukhim R, 2009, CANCER RES, V69, P4674, DOI 10.1158/0008-5472.CAN-09-0146; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Cannino G, 2012, J BIOL CHEM, V287, P38729, DOI 10.1074/jbc.M112.386060; Carey BW, 2015, NATURE, V518, P413, DOI 10.1038/nature13981; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Chen RM, 2007, FEBS LETT, V581, P3145, DOI 10.1016/j.febslet.2007.05.079; Chiang DY, 2008, CANCER RES, V68, P6779, DOI 10.1158/0008-5472.CAN-08-0742; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Czerwinska Patrycja, 2015, Contemp Oncol (Pozn), V19, pA7, DOI 10.5114/wo.2014.47126; Deng NT, 2012, GUT, V61, P673, DOI 10.1136/gutjnl-2011-301839; Formentini L, 2012, MOL CELL, V45, P731, DOI 10.1016/j.molcel.2012.01.008; Fukuoh A, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145117; Geromel V, 2001, HUM MOL GENET, V10, P1221, DOI 10.1093/hmg/10.11.1221; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; Huang JY, 2010, BBA-PROTEINS PROTEOM, V1804, P1645, DOI 10.1016/j.bbapap.2009.12.021; Jaiswal BS, 2009, CANCER CELL, V16, P463, DOI 10.1016/j.ccr.2009.10.016; Kaidi A, 2007, NAT CELL BIOL, V9, P210, DOI 10.1038/ncb1534; Kontro H, 2012, Eur J Histochem, V56, pe18, DOI 10.4081/ejh.2012.18; Kotliarov Y, 2006, CANCER RES, V66, P9428, DOI 10.1158/0008-5472.CAN-06-1691; Koza RA, 2006, PLOS GENET, V2, P769, DOI 10.1371/journal.pgen.0020081; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee CH, 2005, WORLD J GASTROENTERO, V11, P1937, DOI 10.3748/wjg.v11.i13.1937; Lee J, 2015, J BIOL CHEM, V290, P13308, DOI 10.1074/jbc.M115.645283; Li M, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-34; McFarland MA, 2008, MOL CELL PROTEOMICS, V7, P2123, DOI 10.1074/mcp.M800116-MCP200; Meyer B, 2007, MOL CELL PROTEOMICS, V6, P1690, DOI 10.1074/mcp.M700097-MCP200; Neale G, 2008, CLIN CANCER RES, V14, P4572, DOI 10.1158/1078-0432.CCR-07-5090; Nikolsky Y, 2008, CANCER RES, V68, P9532, DOI 10.1158/0008-5472.CAN-08-3082; Northcott PA, 2012, NATURE, V488, P49, DOI 10.1038/nature11327; Ohsakaya S, 2011, J BIOL CHEM, V286, P20292, DOI 10.1074/jbc.M110.198523; Paivarinne H, 2001, ACTA DIABETOL, V38, P83; Peng CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023452; Piantadosi CA, 2012, FREE RADICAL BIO MED, V53, P2043, DOI 10.1016/j.freeradbiomed.2012.09.014; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Rothenberg SM, 2010, CANCER RES, V70, P2158, DOI 10.1158/0008-5472.CAN-09-3458; RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8; Sanchez-Arago M, 2013, EMBO REP, V14, P638, DOI 10.1038/embor.2013.72; Sanchez-Cenizo L, 2010, J BIOL CHEM, V285, P25308, DOI 10.1074/jbc.M110.146480; Scarpulla RC, 2012, TRENDS ENDOCRIN MET, V23, P459, DOI 10.1016/j.tem.2012.06.006; Schlicker C, 2008, J MOL BIOL, V382, P790, DOI 10.1016/j.jmb.2008.07.048; Selga E, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-35; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Stein I, 1998, MOL CELL BIOL, V18, P3112, DOI 10.1128/MCB.18.6.3112; Sullivan LB, 2013, MOL CELL, V51, P236, DOI 10.1016/j.molcel.2013.05.003; Talbot Lindsay J, 2012, Int J Biochem Mol Biol, V3, P117; Teittinen KJ, 2012, LEUKEMIA RES, V36, P232, DOI 10.1016/j.leukres.2011.06.038; Valcourt JR, 2012, CELL CYCLE, V11, P1680, DOI 10.4161/cc.19879; Valenta T, 2012, EMBO J, V31, P2714, DOI 10.1038/emboj.2012.150; Wallace DC, 2012, NAT REV CANCER, V12, P685, DOI 10.1038/nrc3365; Weiss J, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001451; Wheaton WW, 2011, AM J PHYSIOL-CELL PH, V300, pC385, DOI 10.1152/ajpcell.00485.2010; Yang M, 2013, J CLIN INVEST, V123, P3652, DOI 10.1172/JCI67228; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183; Zhang L, 2010, J PROTEOME RES, V9, P458, DOI 10.1021/pr900818g	64	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131990	10.1371/journal.pone.0131990	http://dx.doi.org/10.1371/journal.pone.0131990			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161955	gold, Green Published			2022-12-26	WOS:000358162300080
J	Evans, DC; Ryan, MJ				Evans, David C.; Ryan, Michael J.			Cranial Anatomy of Wendiceratops pinhornensis gen. et sp nov., a Centrosaurine Ceratopsid (Dinosauria: Ornithischia) from the Oldman Formation (Campanian), Alberta, Canada, and the Evolution of Ceratopsid Nasal Ornamentation	PLOS ONE			English	Article							JUDITH RIVER FORMATION; HORNED DINOSAUR; AVACERATOPS; SKELETON; MONTANA; COUNTY	The fossil record of ceratopsid dinosaurs between the occurrence of their proximate sister taxa in the Turonian and the beginning of their well-documented radiation from the late Campanian of North America onwards (approximately 90 and 77 Ma) is poor, with only seven taxa described from this early period in their evolution. We describe a new taxon of a highly adorned basal centrosaurine, Wendiceratops pinhornensis gen. et sp. nov., from the lower part of the Oldman Formation (middle Campanian, approximately 78-79 Ma), Alberta, Canada. Over 200 bones derived from virtually all parts of the skeleton, including multiple well-preserved specimens of the diagnostic parietosquamosal frill, were collected from a medium-density monodominant bonebed, making the new taxon one of the best-represented early ceratopsids. The new taxon is apomorphic in having epiparietals at loci 2 and 3 developed as broad-based, pachyostotic processes that are strongly procurved anterodorsally to overhang the posterior and lateral parietal rami, and an ischium with a broad, rectangular distal terminus. Although the morphology of the nasal is incompletely known, Wendiceratops is inferred to have a large, upright nasal horn located close to the orbits, which represents the oldest occurrence of this feature in Ceratopsia. Given the phylogenetic position of the new taxon within Centrosaurinae, a enlarged nasal horn is hypothesized to have arisen independently at least twice in ceratopsid evolution.	[Evans, David C.] Royal Ontario Museum, Dept Nat Hist, Toronto, ON M5S 2C6, Canada; [Evans, David C.] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON M5S 3B2, Canada; [Ryan, Michael J.] Cleveland Museum Nat Hist, Dept Vertebrate Paleontol, Cleveland, OH 44106 USA	Royal Ontario Museum; University of Toronto; Cleveland Museum of Natural History	Evans, DC (corresponding author), Royal Ontario Museum, Dept Nat Hist, 100 Queens Pk, Toronto, ON M5S 2C6, Canada.	d.evans@utoronto.ca			Natural Sciences and Engineering Research Council of Canada (NSERC) [355845]; Royal Ontario Museum Department of Natural History Fieldwork Grants; Dinosaur Research Institute	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Royal Ontario Museum Department of Natural History Fieldwork Grants; Dinosaur Research Institute	This research was supported by a Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/index_eng.asp) Discovery Grant to DCE (NSERC Grant File Number: RGPIN 355845, http://www.nserc-crsng.gc.ca/ase-oro/Details-Detailles_eng.asp?id=527922), Royal Ontario Museum Department of Natural History Fieldwork Grants to DCE, and research grants from the Dinosaur Research Institute to DCE and MJR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brinkman DB, 2004, PALAEOGEOGR PALAEOCL, V213, P295, DOI 10.1016/j.palaeo.2004.07.016; Brinkman DB, 1998, PALAIOS, V13, P160, DOI 10.2307/3515487; Brown B, 1917, B AM MUS NAT HIST, V37, P281; Brown CM, 2009, J VERTEBR PALEONTOL, V29, P132, DOI 10.1671/039.029.0119; Chinnery B, 2004, J VERTEBR PALEONTOL, V24, P591, DOI 10.1671/0272-4634(2004)024[0591:MAOETI]2.0.CO;2; Clayton K, 2009, J VERTEBR PALEONTOL, V29, p80A; Currie Philip J., 2008, P1; DODSON P, 1986, P ACAD NAT SCI PHILA, V138, P305; Dodson P, 2004, DINOSAURIA, 2ND EDITION, P494; Eberth DA, 2005, LIFE O PAST, P54; Eberth David A., 2007, P265; Fiorillo AR, 2012, ACTA PALAEONTOL POL, V57, P561, DOI 10.4202/app.2011.0033; FIORILLO AR, 1991, PALAEOGEOGR PALAEOCL, V81, P281, DOI 10.1016/0031-0182(91)90151-G; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; GOODWIN MB, 1989, CAN J EARTH SCI, V26, P1384, DOI 10.1139/e89-118; Holmes Robert, 2013, Kirtlandia, P5; Hone DWE, 2011, CRETACEOUS RES, V32, P495, DOI 10.1016/j.cretres.2011.03.005; Horner JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016574; HORNER JR, 1992, NATURE, V358, P59, DOI 10.1038/358059a0; Kirkland James I., 2010, P117; Lambe LM., 1915, CANADA GEOLOGICAL SU, V12, P1; Loewen Mark A., 2013, P488; Loewen Mark A., 2010, P99; Longrich NR, 2013, B PEABODY MUS NAT HI, V54, P51, DOI 10.3374/014.054.0103; Maiorino L, 2013, J VERTEBR PALEONTOL, V33, P1385, DOI 10.1080/02724634.2013.779922; Mallon JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067182; Mallon JC, 2013, BMC ECOL, V13, DOI 10.1186/1472-6785-13-14; Mallon JC, 2012, PALAEOGEOGR PALAEOCL, V350, P124, DOI 10.1016/j.palaeo.2012.06.024; Marsh O.C., 1890, AM J SCI, V39, P418, DOI DOI 10.2475/AJS.S3-39.233.418; Marsh OC., 1888, AM J SCI, V36, P477, DOI [10.2475/ajs.s3-36.216.477, DOI 10.2475/AJS.S3-36.216.477.]; Owen R., 1842, 11 M BRIT ASS ADV SC, P66; Penkalski P, 1999, J VERTEBR PALEONTOL, V19, P692, DOI 10.1080/02724634.1999.10011182; Roberts Eric M., 2013, P85; Ryan MJ, 2007, J PALEONTOL, V81, P376, DOI 10.1666/0022-3360(2007)81[376:ANBCCF]2.0.CO;2; Ryan MJ, 2012, CAN J EARTH SCI, V49, P1251, DOI 10.1139/e2012-056; Ryan Michael J., 2010, P181; Ryan MJ, 2005, LIFE O PAST, P312; Ryan MJ, 2005, CAN J EARTH SCI, V42, P1369, DOI 10.1139/E05-029; Sampson SD, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1186; Sampson Scott D., 2010, P405; Sampson SD, 1997, ZOOLOGICAL J LINNEAN, V121, P292, DOI DOI 10.1111/J.1096-3642.1997.TB00340.X; Seeley H.G., 1887, P R SOC LONDON, V43, P165, DOI [10.1098/rspl.1887.0117, DOI 10.1098/RSPL.1887.0117]; SERENO PC, 1986, NATL GEOGR RES, V2, P234; Wolfe Douglas G., 2010, P91; Xu X, 2010, CHINESE SCI BULL, V55, P1631, DOI 10.1007/s11434-009-3614-5; You Hailu, 2004, P478	46	22	22	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0130007	10.1371/journal.pone.0130007	http://dx.doi.org/10.1371/journal.pone.0130007			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154293	gold, Green Published			2022-12-26	WOS:000358159700021
J	Jin, QW; Chen, H; Wang, XX; Zhao, LD; Xu, QC; Wang, HJ; Li, GY; Yang, XF; Ma, HM; Wu, HQ; Ji, XH				Jin, Qingwen; Chen, Hong; Wang, Xingxia; Zhao, Liandong; Xu, Qingchen; Wang, Huijuan; Li, Guanyu; Yang, Xiaofan; Ma, Hongming; Wu, Haoquan; Ji, Xiaohui			The Effects of the Recombinant CCR5 T4 Lysozyme Fusion Protein on HIV-1 Infection	PLOS ONE			English	Article							MUSCARINIC ACETYLCHOLINE-RECEPTOR; CHEMOKINE RECEPTOR; COUPLED RECEPTOR; CRYSTAL-STRUCTURE; OPIOID RECEPTOR; STRUCTURAL INSIGHTS; CORECEPTOR CCR5; SMALL-MOLECULE; ANTAGONIST; COMPLEX	Background Insertion of T4 lysozyme (T4L) into the GPCR successfully enhanced GPCR protein stability and solubilization. However, the biological functions of the recombinant GPCR protein have not been analyzed. Methods We engineered the CCR5-T4L mutant and expressed and purified the soluble recombinant protein using an E. coli expression system. The antiviral effects of this recombinant protein in THP-1 cell lines, primary human macrophages, and PBMCs from different donors were investigated. We also explored the possible mechanisms underlying the observed antiviral effects. Results Our data showed the biphasic inhibitory and promotion effects of different concentrations of soluble recombinant CCR5-T4L protein on R5 tropic human immunodeficiency virus-1 (HIV-1) infection in THP-1 cell lines, human macrophages, and PBMCs from clinical isolates. We demonstrated that soluble recombinant CCR5-T4L acts as a HIV-1 co-receptor, interacts with wild type CCR5, down-regulates the surface CCR5 expression in human macrophages, and interacts with CCL5 to inhibit macrophage migration. Using binding assays, we further determined that recombinant CCR5-T4L and [I-125]-CCL5 compete for the same binding site on wild type CCR5. Conclusions Our results suggest that recombinant CCR5-T4L protein marginally promotes HIV-1 infection at low concentrations and markedly inhibits infection at higher concentrations. This recombinant protein may be helpful in the future development of anti-HIV-1 therapeutic agents.	[Jin, Qingwen; Wang, Huijuan; Yang, Xiaofan; Ji, Xiaohui] Nanjing Med Univ, Dept Microbiol & Immunol, Nanjing, Jiangsu, Peoples R China; [Jin, Qingwen; Chen, Hong; Wang, Xingxia] Peoples Hosp Jiangsu Prov, Dept Neurol, Nanjing, Jiangsu, Peoples R China; [Zhao, Liandong] Second Hosp Huaian, Dept Neurol, Huaian, Jiangsu, Peoples R China; [Jin, Qingwen; Xu, Qingchen] Nanjing First Hosp, Dept Neurol, Nanjing, Jiangsu, Peoples R China; [Li, Guanyu] Mingji Hosp Nanjing, Dept Neurol, Nanjing, Jiangsu, Peoples R China; [Ma, Hongming; Wu, Haoquan] Texas Tech Univ, Hlth Sci Ctr, Dept Biomed Sci, El Paso, TX USA	Nanjing Medical University; Texas Tech University System; Texas Tech University	Ji, XH (corresponding author), Nanjing Med Univ, Dept Microbiol & Immunol, 140 Hanzhong Rd, Nanjing, Jiangsu, Peoples R China.	immune@njmu.edu.cn	wang, hui/GRS-4730-2022	Wu, Haoquan/0000-0001-9386-3187	National Natural Science foundation of China [30870125]	National Natural Science foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by a grant from National Natural Science foundation of China (#30870125) for QJ.	Aiamkitsumrit B, 2014, CURR HIV RES, V12, P132, DOI 10.2174/1570162X12666140526121746; Altenburg JD, 2010, J VIROL, V84, P2563, DOI 10.1128/JVI.00342-09; Arumugam K, 2014, J BIOMOL STRUCT DYN, V32, P1274, DOI 10.1080/07391102.2013.817952; Bozek K, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002977; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; FDA notifications, 2007, AIDS ALERT, V22, P103; Garcia-Perez J, 2011, J BIOL CHEM, V286, P33409, DOI 10.1074/jbc.M111.279596; Granier S, 2012, NATURE, V485, P400, DOI 10.1038/nature11111; Haga K, 2012, NATURE, V482, P547, DOI 10.1038/nature10753; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Henrich TJ, 2013, CURR OPIN VIROL, V3, P51, DOI 10.1016/j.coviro.2012.12.002; Homan KT, 2014, CURR OPIN CELL BIOL, V27, P25, DOI 10.1016/j.ceb.2013.10.009; Huang YX, 1996, NAT MED, V2, P1240, DOI 10.1038/nm1196-1240; Isgro M, 2013, MUCOSAL IMMUNOL, V6, P718, DOI 10.1038/mi.2012.109; Jin QW, 2011, VIROLOGY, V417, P449, DOI 10.1016/j.virol.2011.07.001; Jones KL, 2011, BRIT J PHARMACOL, V162, P1453, DOI 10.1111/j.1476-5381.2010.01147.x; Klasse PJ, 2012, CELL MICROBIOL, V14, P1183, DOI 10.1111/j.1462-5822.2012.01812.x; Kruse AC, 2012, NATURE, V482, P552, DOI 10.1038/nature10867; Lebon G, 2011, NATURE, V474, P521, DOI 10.1038/nature10136; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; Mathew E, 2013, PROTEIN ENG DES SEL, V26, P59, DOI 10.1093/protein/gzs070; Moller M, 2014, ACTA NEUROL SCAND, V129, P27, DOI 10.1111/ane.12145; Mueller A, 2002, BRIT J PHARMACOL, V135, P1033, DOI 10.1038/sj.bjp.0704540; Nisius L, 2008, PROTEIN EXPRES PURIF, V61, P155, DOI 10.1016/j.pep.2008.06.001; Palani A, 2006, J MED CHEM, V49, P2851, DOI 10.1021/jm060009x; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Shimamura T, 2011, NATURE, V475, P65, DOI 10.1038/nature10236; Sohy D, 2009, J BIOL CHEM, V284, P31270, DOI 10.1074/jbc.M109.054809; Tan QX, 2013, SCIENCE, V341, P1387, DOI 10.1126/science.1241475; Venkatesan S, 2002, J BIOL CHEM, V277, P2287, DOI 10.1074/jbc.M108321200; Wiktor M, 2013, J BIOMOL NMR, V55, P79, DOI 10.1007/s10858-012-9688-4; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Wu HX, 2012, NATURE, V485, P327, DOI 10.1038/nature10939; Yang JP, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-57	37	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0131894	10.1371/journal.pone.0131894	http://dx.doi.org/10.1371/journal.pone.0131894			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154172	gold, Green Published, Green Submitted			2022-12-26	WOS:000358159700083
J	Cavalerie, L; Charron, MVP; Ezanno, P; Dommergues, L; Zumbo, B; Cardinale, E				Cavalerie, Lisa; Charron, Maud V. P.; Ezanno, Pauline; Dommergues, Laure; Zumbo, Betty; Cardinale, Eric			A Stochastic Model to Study Rift Valley Fever Persistence with Different Seasonal Patterns of Vector Abundance: New Insights on the Endemicity in the Tropical Island of Mayotte	PLOS ONE			English	Article							AEDES-ALBOPICTUS; CULEX-ZOMBAENSIS; VIRUS; COMPETENCE; TRANSMISSION; MOSQUITOS; DIPTERA; CULICIDAE; EPIDEMIOLOGY; TEMPERATURE	Rift Valley fever (RVF) is a zoonotic vector- borne disease causing abortion storms in cattle and human epidemics in Africa. Our aim was to evaluate RVF persistence in a seasonal and isolated population and to apply it to Mayotte Island (Indian Ocean), where the virus was still silently circulating four years after its last known introduction in 2007. We proposed a stochastic model to estimate RVF persistence over several years and under four seasonal patterns of vector abundance. Firstly, the model predicted a wide range of virus spread patterns, from obligate persistence in a constant or tropical environment (without needing vertical transmission or reintroduction) to frequent extinctions in a drier climate. We then identified for each scenario of seasonality the parameters that most influenced prediction variations. Persistence was sensitive to vector lifespan and biting rate in a tropical climate, and to host viraemia duration and vector lifespan in a drier climate. The first epizootic peak was primarily sensitive to viraemia duration and thus likely to be controlled by vaccination, whereas subsequent peaks were sensitive to vector lifespan and biting rate in a tropical climate, and to host birth rate and viraemia duration in arid climates. Finally, we parameterized the model according to Mayotte known environment. Mosquito captures estimated the abundance of eight potential RVF vectors. Review of RVF competence studies on these species allowed adjusting transmission probabilities per bite. Ruminant serological data since 2004 and three new cross- sectional seroprevalence studies are presented. Transmission rates had to be divided by more than five to best fit observed data. Five years after introduction, RVF persisted in more than 10% of the simulations, even under this scenario of low transmission. Hence, active surveillance must be maintained to better understand the risk related to RVF persistence and to prevent new introductions.	[Cavalerie, Lisa; Dommergues, Laure; Cardinale, Eric] Ctr Rech & Veille Malad Emergentes Ocean Indien, CRVOI, F-97490 St Clotilde, Reunion, France; [Cavalerie, Lisa; Dommergues, Laure; Cardinale, Eric] CIRAD, UMR CMAEE, F-97490 St Clotilde, Reunion, France; [Cavalerie, Lisa; Dommergues, Laure; Cardinale, Eric] INRA, UMR CMAEE 1309, F-34398 Montpellier, France; [Cavalerie, Lisa] AgroParisTech, F-75005 Paris, France; [Cavalerie, Lisa] Univ Reunion, F-97715 St Denis, Reunion, France; [Charron, Maud V. P.; Ezanno, Pauline] LUNAM Univ, INRA, BioEpAR UMR1300, Oniris,CS 40706, F-44307 Nantes, France; [Dommergues, Laure] GDS Mayotte Cooperat Agr Eleveurs Mahorais, F-97670 Coconi, Mayotte, France; [Zumbo, Betty] ARS OI, F-97600 Mamoudzou, Mayotte, France	CIRAD; INRAE; AgroParisTech; University of La Reunion; Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; INRAE	Cavalerie, L (corresponding author), Ctr Rech & Veille Malad Emergentes Ocean Indien, CRVOI, F-97490 St Clotilde, Reunion, France.	lisa.cavalerie@gmail.com	Ezanno, Pauline/A-4699-2009; Cavalerie, Lisa/AAX-1587-2020	Ezanno, Pauline/0000-0002-0034-8950; Cavalerie, Lisa/0000-0001-7187-3800	French Ministry of Agriculture, Region Reunion, INRA; AnimalRisk program (Feder POCT)	French Ministry of Agriculture, Region Reunion, INRA; AnimalRisk program (Feder POCT)	Financial support was provided by the French Ministry of Agriculture, Region Reunion, INRA and the AnimalRisk program (Feder POCT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdo-Salem S, 2006, ANN NY ACAD SCI, V1081, P240, DOI 10.1196/annals.1373.028; Afssa, 2008, AFSSA OP RISK RIFT V, P156; Altizer S, 2006, ECOL LETT, V9, P467, DOI 10.1111/j.1461-0248.2005.00879.x; Andriamandimby SF, 2010, EMERG INFECT DIS, V16, P963, DOI 10.3201/eid1606.091266; Ba Y, 2005, J MED ENTOMOL, V42, P739, DOI 10.1603/0022-2585(2005)042[0739:AOBOTR]2.0.CO;2; Bagny L, 2009, J MED ENTOMOL, V46, P198, DOI 10.1603/033.046.0204; Balenghien T, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-78; Barakat, 2008, STUDENTS APPEAL RULI; Barker CM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002515; Barrera R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001378; Bird BH, 2009, JAVMA-J AM VET MED A, V234, P883, DOI 10.2460/javma.234.7.883; Breto C, 2009, ANN APPL STAT, V3, P319, DOI 10.1214/08-AOAS201; Cetre-Sossah C, 2012, EMERG INFECT DIS, V18, P969, DOI 10.3201/eid1806.110994; Cetre-Sossah C, 2012, EMERG INFECT DIS, V18, P972, DOI 10.3201/eid1806.111165; Chamchod F, 2014, B MATH BIOL, V76, P2052, DOI 10.1007/s11538-014-9998-7; Charron MVP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074213; Charron MVP, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-44; Charron MVP, 2011, J THEOR BIOL, V291, P1, DOI 10.1016/j.jtbi.2011.08.041; Chevalier V, 2010, RIFT VALLEY FEVER TH; Chitnis N, 2013, J BIOL DYNAM, V7, P11, DOI 10.1080/17513758.2012.733427; Clements AN, 2000, BIOL MOSQUITOES DEV; DAAF Direction de l'Alimentation de l'Agriculture et de la Foret de Mayotte, 2010, REC AGR 2010 MAYOTT; DAVIES FG, 1985, B WORLD HEALTH ORGAN, V63, P941; Dohoo I.R., 2003, VET EPIDEMIOLOGIC RE; Ezanno P, 2015, PREV VET MED, V120, P39, DOI 10.1016/j.prevetmed.2014.12.018; Ezanno P, 2012, NEW FRONTIERS OF MOLECULAR EPIDEMIOLOGY OF INFECTIOUS DISEASES, P79, DOI 10.1007/978-94-007-2114-2_5; FAO, 2008, EMPRES WATCH     SEP, P4; FARAN ME, 1987, AM J TROP MED HYG, V37, P403, DOI 10.4269/ajtmh.1987.37.403; Favier C, 2006, TROP MED INT HEALTH, V11, P1878, DOI 10.1111/j.1365-3156.2006.01746.x; Fischer EAJ, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-58; GAD AM, 1987, T ROY SOC TROP MED H, V81, P694, DOI 10.1016/0035-9203(87)90460-3; GAFF H, 2011, INT J ARTIFICIAL LIF, V2, P1, DOI DOI 10.4018/JALR.2011040101; Gaff H, 2007, ELECTRON J DIFFER EQ, V115, P1, DOI DOI 10.1155/2012/138757; Gerdes GH, 2004, REV SCI TECH OIE, V23, P613, DOI 10.20506/rst.23.2.1500; Gong HF, 2011, INT J BIOMETEOROL, V55, P435, DOI 10.1007/s00484-010-0354-9; InVS, 2012, 372 INVS, P3; Keeling MJ., 2007, MODELING INFECT DIS, VIllustrated edition; Kifaro EG, 2014, ONDERSTEPOORT J VET, V81, DOI 10.4102/ojvr.v81i2.717; Lagerqvist N, 2013, EID, V19; Lawpoolsri S, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-159; Le Goff G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100696; Lernout T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074192; LINTHICUM KJ, 1985, J HYG-CAMBRIDGE, V95, P197, DOI 10.1017/S0022172400062434; Linthicum KJ, 1999, SCIENCE, V285, P397, DOI 10.1126/science.285.5426.397; Lumley T., 2011, COMPLEX SURVEYS GUID; Manore CA, 2015, TRANSBOUND EMERG DIS, V62, P13, DOI 10.1111/tbed.12082; Maquart M, 2016, TRANSBOUND EMERG DIS, V63, pE281, DOI 10.1111/tbed.12267; Maquart M, 2014, J VIROL METHODS, V195, P92, DOI 10.1016/j.jviromet.2013.10.001; MCINTOSH B M, 1973, Journal of the South African Veterinary Association, V44, P57; MCINTOSH BM, 1980, S AFR MED J, V58, P127; MCINTOSH BM, 1983, S AFR J SCI, V79, P61; Moore CG, 1993, MOSQUITOES PUBLIC HL; Moutailler S, 2008, VECTOR-BORNE ZOONOT, V8, P749, DOI 10.1089/vbz.2008.0009; Mpeshe SC, 2014, COMPUT MATH METHOD M, V2014, DOI 10.1155/2014/627586; Mpeshe SC, 2011, ACTA BIOTHEOR, V59, P231, DOI 10.1007/s10441-011-9132-2; Mweya CN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108430; Owange NO, 2014, PREV VET MED, V117, P121, DOI 10.1016/j.prevetmed.2014.08.008; PATRICAN LA, 1989, AM J TROP MED HYG, V40, P534, DOI 10.4269/ajtmh.1989.40.534; Pepin M, 2010, VET RES, V41, P40; R Core Team, 2021, R LANGUAGE ENV STAT; Reiner RC, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0921; Roger M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003045; RUEDA LM, 1990, J MED ENTOMOL, V27, P892, DOI 10.1093/jmedent/27.5.892; Saltelli A., 2000, WILEY SERIES PROBABI; Scilab Enterprises, 2012, SCIL FREE OP SOURC S; Shoemaker T, 2002, EMERG INFECT DIS, V8, P1415, DOI 10.3201/eid0812.020195; Sissoko D, 2009, EMERG INFECT DIS, V15, P568, DOI 10.3201/eid1504.081045; Sumaye RD, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002356; Tillard E, 2013, REFERENTIEL TECHNIQU, P90; Tran A, 2013, INT J ENV RES PUB HE, V10, P1698, DOI 10.3390/ijerph10051698; Turell MJ, 2007, J AM MOSQUITO CONTR, V23, P378, DOI 10.2987/5645.1; Turell MJ, 2008, J MED ENTOMOL, V45, P102, DOI 10.1603/0022-2585(2008)45[102:VCOSAM]2.0.CO;2; Turell MJ, 2008, J AM MOSQUITO CONTR, V24, P502, DOI 10.2987/08-5791.1; TURELL MJ, 1988, J MED ENTOMOL, V25, P262, DOI 10.1093/jmedent/25.4.262; Turell MJ, 1998, J MED ENTOMOL, V35, P132, DOI 10.1093/jmedent/35.2.132; Turell MJ, 1996, AM J TROP MED HYG, V54, P136, DOI 10.4269/ajtmh.1996.54.136; TURELL MJ, 1988, J AM MOSQUITO CONTR, V4, P94; TURELL MJ, 1990, AM J TROP MED HYG, V43, P677, DOI 10.4269/ajtmh.1990.43.677; TURELL MJ, 1993, AM J TROP MED HYG, V49, P672, DOI 10.4269/ajtmh.1993.49.672; Xue L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062049; Xue L, 2012, J THEOR BIOL, V306, P129, DOI 10.1016/j.jtbi.2012.04.029	81	14	14	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0130838	10.1371/journal.pone.0130838	http://dx.doi.org/10.1371/journal.pone.0130838			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147799	Green Submitted, gold, Green Published			2022-12-26	WOS:000358157600051
J	Chan, MC; Atasoylu, O; Hodson, E; Tumber, A; Leung, IKH; Chowdhury, R; Gomez-Perez, V; Demetriades, M; Rydzik, AM; Holt-Martyn, J; Tian, YM; Bishop, T; Claridge, TDW; Kawamura, A; Pugh, CW; Ratcliffe, PJ; Schofield, CJ				Chan, Mun Chiang; Atasoylu, Onur; Hodson, Emma; Tumber, Anthony; Leung, Ivanhoe K. H.; Chowdhury, Rasheduzzaman; Gomez-Perez, Veronica; Demetriades, Marina; Rydzik, Anna M.; Holt-Martyn, James; Tian, Ya-Min; Bishop, Tammie; Claridge, Timothy D. W.; Kawamura, Akane; Pugh, Christopher W.; Ratcliffe, Peter J.; Schofield, Christopher J.			Potent and Selective Triazole-Based Inhibitors of the Hypoxia-Inducible Factor Prolyl-Hydroxylases with Activity in the Murine Brain	PLOS ONE			English	Article							ANKYRIN REPEAT DOMAIN; FACTOR HIF; ASPARAGINYL HYDROXYLASE; BETA-HYDROXYLATION; STRUCTURAL BASIS; BINDING; SUBSTRATE; PROTEINS; TARGET; ALPHA	As part of the cellular adaptation to limiting oxygen availability in animals, the expression of a large set of genes is activated by the upregulation of the hypoxia-inducible transcription factors (HIFs). Therapeutic activation of the natural human hypoxic response can be achieved by the inhibition of the hypoxia sensors for the HIF system, i.e. the HIF prolyl-hydroxylases (PHDs). Here, we report studies on tricyclic triazole-containing compounds as potent and selective PHD inhibitors which compete with the 2-oxoglutarate co-substrate. One compound (IOX4) induces HIF alpha in cells and in wildtype mice with marked induction in the brain tissue, revealing that it is useful for studies aimed at validating the upregulation of HIF for treatment of cerebral diseases including stroke.	[Chan, Mun Chiang; Atasoylu, Onur; Leung, Ivanhoe K. H.; Chowdhury, Rasheduzzaman; Gomez-Perez, Veronica; Demetriades, Marina; Rydzik, Anna M.; Holt-Martyn, James; Claridge, Timothy D. W.; Kawamura, Akane; Schofield, Christopher J.] Univ Oxford, Dept Chem, Chem Res Lab, Oxford OX1 3TA, England; [Chan, Mun Chiang; Hodson, Emma; Tian, Ya-Min; Bishop, Tammie; Pugh, Christopher W.; Ratcliffe, Peter J.] Univ Oxford, Ctr Cellular & Mol Physiol, Oxford OX1 3TA, England; [Tumber, Anthony] Univ Oxford, Target Discovery Inst, Oxford OX1 3TA, England	University of Oxford; University of Oxford; University of Oxford	Schofield, CJ (corresponding author), Univ Oxford, Dept Chem, Chem Res Lab, Oxford OX1 3TA, England.	christopher.schofield@chem.ox.ac.uk	Rydzik, Anna/V-1178-2019; Claridge, Tim/A-8324-2018; Chan, Mun Chiang/T-4867-2019; Holt-Martyn, James/HGD-1452-2022; Leung, Ivanhoe/G-6168-2010; Kawamura, Akane/I-4047-2018; Atasoylu, Onur/J-8392-2019; Chowdhury, Rashed/I-7697-2014	Rydzik, Anna/0000-0003-3158-0493; Claridge, Tim/0000-0001-5583-6460; Chan, Mun Chiang/0000-0002-3162-6036; Leung, Ivanhoe/0000-0003-0633-6771; Kawamura, Akane/0000-0003-1169-5082; Chowdhury, Rashed/0000-0002-8058-6149; Pugh, Chris/0000-0002-5170-1662; Bishop, Tammie/0000-0003-3308-9139; Schofield, Christopher/0000-0002-0290-6565; Ratcliffe, Peter/0000-0002-2853-806X	Wellcome Trust [091857/Z.10/Z]; British Heart Foundation [PG/12/33/29546]; British Heart Foundation [RG/11/1/28684] Funding Source: researchfish; Cancer Research UK [18245] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK)	This work was funded by the Wellcome Trust, http://www.wellcome.ac.uk/, grant 091857/Z.10/Z to CJS, and the British Heart Foundation, https://www.bhf.org.uk/, grant PG/12/33/29546 to CJS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aik W, 2013, J MED CHEM, V56, P3680, DOI 10.1021/jm400193d; Aik W, 2012, CURR OPIN STRUC BIOL, V22, P691, DOI 10.1016/j.sbi.2012.10.001; Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Bertini I, 2008, ANGEW CHEM INT EDIT, V47, P4533, DOI 10.1002/anie.200800327; Bigge CF, 2004, PCT INT APPL, Patent No. 2003018553; Bishop T, 2013, J PHYSIOL-LONDON, V591, P3565, DOI 10.1113/jphysiol.2012.247254; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chowdhury R, 2013, ACS CHEM BIOL, V8, P1488, DOI 10.1021/cb400088q; Chowdhury R, 2009, STRUCTURE, V17, P981, DOI 10.1016/j.str.2009.06.002; Clark DE, 2011, FUTURE MED CHEM, V3, P469, DOI [10.4155/FMC.11.1, 10.4155/fmc.11.1]; Cockman ME, 2006, P NATL ACAD SCI USA, V103, P14767, DOI 10.1073/pnas.0606877103; Cockman ME, 2009, MOL CELL PROTEOMICS, V8, P535, DOI 10.1074/mcp.M800340-MCP200; Coleman ML, 2007, J BIOL CHEM, V282, P24027, DOI 10.1074/jbc.M704102200; Eltzschig HK, 2014, NAT REV DRUG DISCOV, V13, P852, DOI 10.1038/nrd4422; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Ferguson JE, 2007, MOL CELL BIOL, V27, P6407, DOI 10.1128/MCB.00511-07; Hardy AP, 2009, J MOL BIOL, V392, P994, DOI 10.1016/j.jmb.2009.07.070; Harten SK, 2010, ANTIOXID REDOX SIGN, V12, P459, DOI 10.1089/ars.2009.2870; Hewitson KS, 2002, J BIOL CHEM, V277, P26351, DOI 10.1074/jbc.C200273200; Hopkinson RJ, 2013, CHEM SCI, V4, P3110, DOI [10.1039/c3sc51122g, 10.1039/C3SC51122G]; Hsieh MM, 2007, BLOOD, V110, P2140, DOI 10.1182/blood-2007-02-073254; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Karuppagounder SS, 2012, J CEREBR BLOOD F MET, V32, P1347, DOI 10.1038/jcbfm.2012.28; Kelly L, 2009, MOL BIOSYST, V5, P52, DOI 10.1039/b815271c; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Lando D, 2002, SCIENCE, V295, P858, DOI 10.1126/science.1068592; Lau KW, 2007, BRIT J CANCER, V96, P1284, DOI 10.1038/sj.bjc.6603675; Lee SH, 2008, J BIOMOL SCREEN, V13, P494, DOI 10.1177/1087057108318800; LELAND JK, 1990, J ELECTROCHEM SOC, V137, P3127, DOI 10.1149/1.2086171; Leung IKH, 2013, J MED CHEM, V56, P547, DOI 10.1021/jm301583m; Leung IKH, 2010, J MED CHEM, V53, P867, DOI 10.1021/jm901537q; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McDonough MA, 2006, P NATL ACAD SCI USA, V103, P9814, DOI 10.1073/pnas.0601283103; Morton CJ, 1996, STRUCTURE, V4, P705, DOI 10.1016/S0969-2126(96)00076-7; Rabinowitz MH, 2013, J MED CHEM, V56, P9369, DOI 10.1021/jm400386j; Rose NR, 2012, J MED CHEM, V55, P6639, DOI 10.1021/jm300677j; Rose NR, 2011, CHEM SOC REV, V40, P4364, DOI 10.1039/c0cs00203h; Rydzik AM, 2012, CHEMBIOCHEM, V13, P1559, DOI 10.1002/cbic.201200256; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Stolze IP, 2004, J BIOL CHEM, V279, P42719, DOI 10.1074/jbc.M406713200; Thede K, 2008, PCT INT APPL, Patent No. 2008067871; Tian YM, 2011, J BIOL CHEM, V286, P13041, DOI 10.1074/jbc.M110.211110; van de Waterbeemd H, 1998, J DRUG TARGET, V6, P151, DOI 10.3109/10611869808997889; Webb JD, 2009, BIOCHEM J, V420, P327, DOI 10.1042/BJ20081905; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yan L, 2010, EXPERT OPIN THER PAT, V20, P1219, DOI 10.1517/13543776.2010.510836; Yang M, 2011, J BIOL CHEM, V286, P7648, DOI 10.1074/jbc.M110.193540; Zheng X, 2008, P NATL ACAD SCI USA, V105, P3368, DOI 10.1073/pnas.0711591105	54	45	45	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132004	10.1371/journal.pone.0132004	http://dx.doi.org/10.1371/journal.pone.0132004			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147748	Green Published, gold			2022-12-26	WOS:000358157600177
J	Kemmler, J; Bindl, R; McCook, O; Wagner, F; Groger, M; Wagner, K; Scheuerle, A; Radermacher, P; Ignatius, A				Kemmler, Julia; Bindl, Ronny; McCook, Oscar; Wagner, Florian; Groeger, Michael; Wagner, Katja; Scheuerle, Angelika; Radermacher, Peter; Ignatius, Anita			Exposure to 100% Oxygen Abolishes the Impairment of Fracture Healing after Thoracic Trauma	PLOS ONE			English	Article							BLUNT CHEST TRAUMA; MESENCHYMAL STEM-CELLS; INDUCED LUNG INJURY; HYPERBARIC-OXYGEN; SEPTIC SHOCK; OSTEOGENIC DIFFERENTIATION; SYSTEMIC INFLAMMATION; FECAL PERITONITIS; TIBIAL SHAFT; HYPEROXIA	In polytrauma patients a thoracic trauma is one of the most critical injuries and an important trigger of post-traumatic inflammation. About 50% of patients with thoracic trauma are additionally affected by bone fractures. The risk for fracture malunion is considerably increased in such patients, the pathomechanisms being poorly understood. Thoracic trauma causes regional alveolar hypoxia and, subsequently, hypoxemia, which in turn triggers local and systemic inflammation. Therefore, we aimed to unravel the role of oxygen in impaired bone regeneration after thoracic trauma. We hypothesized that short-term breathing of 100% oxygen in the early post-traumatic phase ameliorates inflammation and improves bone regeneration. Mice underwent a femur osteotomy alone or combined with blunt chest trauma 100% oxygen was administered immediately after trauma for two separate 3 hour intervals. Arterial blood gas tensions, microcirculatory perfusion and oxygenation were assessed at 3, 9 and 24 hours after injury. Inflammatory cytokines and markers of oxidative/nitrosative stress were measured in plasma, lung and fracture hematoma. Bone healing was assessed on day 7, 14 and 21. Thoracic trauma induced pulmonary and systemic inflammation and impaired bone healing. Short-term exposure to 100% oxygen in the acute post-traumatic phase significantly attenuated systemic and local inflammatory responses and improved fracture healing without provoking toxic side effects, suggesting that hyperoxia could induce anti-inflammatory and pro-regenerative effects after severe injury. These results suggest that breathing of 100% oxygen in the acute post-traumatic phase might reduce the risk of poorly healing fractures in severely injured patients.	[Kemmler, Julia; Bindl, Ronny; Ignatius, Anita] Univ Ulm, Inst Orthopaed Res & Biomech, Ctr Musculoskeletal Res, D-89069 Ulm, Germany; [McCook, Oscar; Wagner, Florian; Groeger, Michael; Wagner, Katja; Radermacher, Peter] Univ Ulm, Med Ctr, Inst Pathophysiol Anaesthesiol & Proc Engn, D-89069 Ulm, Germany; [Scheuerle, Angelika] Univ Ulm, Dept Pathol, Med Ctr, D-89069 Ulm, Germany	Ulm University; Ulm University; Ulm University	Ignatius, A (corresponding author), Univ Ulm, Inst Orthopaed Res & Biomech, Ctr Musculoskeletal Res, D-89069 Ulm, Germany.	anita.ignatius@uni-ulm.de	Ignatius, Anita/M-6012-2013; McCook, Oscar/AAF-1647-2020	Ignatius, Anita/0000-0002-4782-1979; McCook, Oscar/0000-0001-7879-7695	German Research Foundation (DFG) [KFO200, IG18/13-1, RA396/11-1]; Collaborative Research Center [CRC 1149]	German Research Foundation (DFG)(German Research Foundation (DFG)); Collaborative Research Center	This project was funded by the German Research Foundation (DFG), in the frameworks of the Clinical Research Unit KFO200 (IG18/13-1, RA396/11-1) and the Collaborative Research Center (CRC 1149).	Albuszies G, 2005, CRIT CARE MED, V33, P2332, DOI 10.1097/01.CCM.0000182817.20977.E9; Alcaraz MJ, 2003, CURR PHARM DESIGN, V9, P2541, DOI 10.2174/1381612033453749; Barth E, 2008, CRIT CARE MED, V36, P495, DOI 10.1097/01.CCM.0B013E318161FC45; Bastian O, 2011, J LEUKOCYTE BIOL, V89, P669, DOI 10.1189/jlb.0810446; Benjamin S, 2013, TISSUE ENG PT A, V19, P748, DOI [10.1089/ten.TEA.2012.0298, 10.1089/ten.tea.2012.0298]; Bennett MH, 2012, COCHRANE DB SYST REV, V12, P1; Bhandari M, 2003, J ORTHOP TRAUMA, V17, P353, DOI 10.1097/00005131-200305000-00006; Bitterman H, 2007, ISR MED ASSOC J, V9, P874; Bitterman H, 2009, CRIT CARE, V13, DOI 10.1186/cc7151; Bouachour G, 1996, J TRAUMA, V41, P333, DOI 10.1097/00005373-199608000-00023; Brahimi-Horn MC, 2007, FEBS LETT, V581, P3582, DOI 10.1016/j.febslet.2007.06.018; Butler J, 2006, EMERG MED J, V23, P571, DOI 10.1136/emj.2006.038539; Butterfield TA, 2006, J ATHL TRAINING, V41, P457; Cakir E, 2011, APMIS, V119, P574, DOI 10.1111/j.1600-0463.2011.02778.x; Calzia E, 2010, CRIT CARE MED, V38, pS559, DOI 10.1097/CCM.0b013e3181f1fe70; Chao J, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-54; Chen WJ, 2002, J TRAUMA, V52, P333, DOI 10.1097/00005373-200202000-00020; Claes L, 2012, NAT REV RHEUMATOL, V8, P133, DOI 10.1038/nrrheum.2012.1; Cortes DO, 2015, MICROVASC RES, V98, P23, DOI 10.1016/j.mvr.2014.11.006; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Distler JHW, 2003, Q J NUCL MED, V47, P149; Dyson A, 2012, INTENS CARE MED, V38, P1868, DOI 10.1007/s00134-012-2712-z; Einhorn TA, 2015, NAT REV RHEUMATOL, V11, P45, DOI 10.1038/nrrheum.2014.164; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Faller S, 2010, ANESTHESIOLOGY, V113, P104, DOI 10.1097/ALN.0b013e3181de7107; Flierl MA, 2008, SHOCK, V29, P25, DOI 10.1097/shk.0b013e3180556a0b; Fok TCO, 2008, ORAL SURG ORAL MED O, V105, P417, DOI 10.1016/j.tripleo.2007.07.015; Gebhard F, 2000, ARCH SURG-CHICAGO, V135, P291, DOI 10.1001/archsurg.135.3.291; GROGAARD B, 1990, ARCH ORTHOP TRAUM SU, V109, P268, DOI 10.1007/BF00419942; Groger M, 2005, MUTAT RES-FUND MOL M, V572, P167, DOI 10.1016/j.mrfmmm.2005.05.015; Hafner S, 2015, SHOCK, V43, P140, DOI 10.1097/SHK.0000000000000277; Hauser B, 2009, CRIT CARE MED, V37, P2465, DOI 10.1097/CCM.0b013e3181aee8ad; Hecke F, 1997, CRIT CARE MED, V25, P2015, DOI 10.1097/00003246-199712000-00019; Heilmann A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084232; Hensler T, 2002, J TRAUMA, V52, P962, DOI 10.1097/00005373-200205000-00023; Hou LC, 2009, SHOCK, V32, P451, DOI 10.1097/SHK.0b013e31819c391a; JAMIESON D, 1986, ANNU REV PHYSIOL, V48, P703, DOI 10.1146/annurev.ph.48.030186.003415; Karladani AH, 2001, ARCH ORTHOP TRAUM SU, V121, P325, DOI 10.1007/s004020000252; Knoferl MW, 2003, SHOCK, V19, P519, DOI 10.1097/01.shk.0000070739.34700.f6; Kolar P, 2010, TISSUE ENG PART B-RE, V16, P427, DOI 10.1089/ten.TEB.2009.0687; Kolliputi N, 2010, J IMMUNOL, V184, P5819, DOI 10.4049/jimmunol.0902766; Lefering R, 2013, TRAUMAREGISTER ANN R, P29; Leijten J, 2014, P NATL ACAD SCI USA, V111, P13954, DOI 10.1073/pnas.1410977111; Lin SS, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-56; Lu CY, 2013, BONE, V52, P220, DOI 10.1016/j.bone.2012.09.037; Mak S, 2002, AM J PHYSIOL-HEART C, V282, pH2414, DOI 10.1152/ajpheart.00947.2001; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Pape HC, 2010, J ORTHOP TRAUMA, V24, P522, DOI 10.1097/BOT.0b013e3181ed1361; Quinn DA, 2002, J APPL PHYSIOL, V93, P517, DOI 10.1152/japplphysiol.00570.2001; Recknagel S, 2013, J TRAUMA ACUTE CARE, V74, P531, DOI 10.1097/TA.0b013e318278956d; Recknagel S, 2012, J ORTHOP RES, V30, P581, DOI 10.1002/jor.21561; Recknagel S, 2011, J ORTHOP RES, V29, P734, DOI 10.1002/jor.21299; Rontgen V, 2010, J ORTHOP RES, V28, P1456, DOI 10.1002/jor.21148; Seija M, 2012, SHOCK, V38, P403, DOI 10.1097/SHK.0b013e31826660f2; Seitz DH, 2011, J TRAUMA, V70, P189, DOI 10.1097/TA.0b013e3181d7693c; Shang J, 2014, CURR STEM CELL RES T, V9, P141, DOI 10.2174/1574888X09666131230142459; Simkova V, 2008, SHOCK, V30, P578, DOI 10.1097/SHK.0b013e31816a6e0f; Sinclair SE, 2004, CRIT CARE MED, V32, P2496, DOI 10.1097/01.CCM.0000148231.04642.8D; Stensballe J, 2009, ACTA ANAESTH SCAND, V53, P515, DOI 10.1111/j.1399-6576.2008.01801.x; Sugiura H, 2011, NITRIC OXIDE-BIOL CH, V25, P138, DOI 10.1016/j.niox.2011.03.079; Sukhotnik I, 2009, CRIT CARE MED, V37, P1054, DOI 10.1097/CCM.0b013e31819d0f5c; Tamura DY, 2002, SHOCK, V17, P269, DOI 10.1097/00024382-200204000-00005; Waisman D, 2003, AM J PHYSIOL-HEART C, V285, pH643, DOI 10.1152/ajpheart.00900.2002; Waisman D, 2012, SHOCK, V37, P95, DOI 10.1097/SHK.0b013e3182356fc3; Wang J, 2002, J Postgrad Med, V48, P226; Wehrle E, 2014, J ORTHOP RES, V32, P1006, DOI 10.1002/jor.22629; YABLON IG, 1968, J TRAUM, V8, P186, DOI 10.1097/00005373-196803000-00007	68	26	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131194	10.1371/journal.pone.0131194	http://dx.doi.org/10.1371/journal.pone.0131194			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147725	gold, Green Published, Green Submitted			2022-12-26	WOS:000358157600068
J	Mayer, S; Decaluwe, H; Ruol, M; Manodoro, S; Kramer, M; Till, H; Deprest, J				Mayer, Steffi; Decaluwe, Herbert; Ruol, Michele; Manodoro, Stefano; Kramer, Manuel; Till, Holger; Deprest, Jan			Diaphragm Repair with a Novel Cross-Linked Collagen Biomaterial in a Growing Rabbit Model	PLOS ONE			English	Article							SMALL-INTESTINAL SUBMUCOSA; ABDOMINAL-WALL DEFECTS; HERNIA REPAIR; PATCH REPAIR; TRACHEAL OCCLUSION; ANIMAL-MODEL; MESHES; RECONSTRUCTION; METAANALYSIS; MANAGEMENT	Background Neonates with congenital diaphragmatic hernia and large defects often require patch closure. Acellular collagen matrices (ACM) have been suggested as an alternative to synthetic durable patches as they are remodeled by the host or could also be used for tissue engineering purposes. Materials and Methods 2.0x1.0 cm diaphragmatic defects were created in 6-weeks old New-Zealand white rabbits. We compared reconstruction with a purpose-designed cross-linked ACM (Matricel) to 4-layer non-cross-linked small intestinal submucosa (SIS) and a 1-layer synthetic Dual Mesh (Gore-Tex). Unoperated animals or animals undergoing primary closure (4/0 polyglecaprone) served as age-matched controls. 60 (n = 25) resp. 90 (n = 17) days later, animals underwent chest x-ray and obduction for gross examination of explants, scoring of adhesion and inflammatory response. Also, uniaxial tensiometry was done, comparing explants to contralateral native diaphragmatic tissue. Results Overall weight nearly doubled from 1,554 +/- 242 g at surgery to 2,837 +/- 265 g at obduction (+ 84%). X-rays did show rare elevation of the left diaphragm (SIS = 1, Gore-Tex = 1, unoperated control = 1), but no herniation of abdominal organs. 56% of SIS and 10% of Matricel patches degraded with visceral bulging in four (SIS = 3, Matricel = 1). Adhesion scores were limited: 0.5 (Matricel) to 1 (SIS, Gore-Tex) to the left lung (p = 0.008) and 2.5 (Gore-Tex), 3 (SIS) and 4 (Matricel) to the liver (p<0.0001). Tensiometry revealed a reduced bursting strength but normal compliance for SIS. Compliance was reduced in Matricel and Gore-Tex (p<0.01). Inflammatory response was characterized by a more polymorphonuclear cell (SIS) resp. macrophage (Matricel) type of infiltrate (p<0.05). Fibrosis was similar for all groups, except there was less mature collagen deposited to Gore-Tex implants (p<0.05). Conclusions Matricel induced a macrophage-dominated inflammatory response, more adhesions, had appropriate strength but a lesser compliance compared to native tissue. The herein investigated ACM is not a viable option for CDH repair.	[Mayer, Steffi; Ruol, Michele; Manodoro, Stefano; Deprest, Jan] Katholieke Univ Leuven, Ctr Surg Technol & Organ Syst Cluster, Dept Dev & Regenerat, Fac Med, Leuven, Belgium; [Decaluwe, Herbert] Katholieke Univ Leuven, Dept Thorac Surg, Univ Hosp Gasthuisberg, Leuven, Belgium; [Ruol, Michele] Univ Hosp Padua, Dept Pediat Surg, Padua, Italy; [Manodoro, Stefano] Univ Hosp Monza, Dept Obstet & Gynecol, Monza, Italy; [Kramer, Manuel] Univ Erlangen Nurnberg, Dept Radiol, D-91054 Erlangen, Germany; [Till, Holger] Univ Hosp Leipzig, Dept Pediat Surg, Leipzig, Germany; [Deprest, Jan] Katholieke Univ Leuven, Univ Hosp Gasthuisberg, Dept Obstet & Gynecol, Leuven, Belgium	KU Leuven; KU Leuven; University Hospital Leuven; University of Padua; Azienda Ospedaliera - Universita di Padova; University of Erlangen Nuremberg; Leipzig University; KU Leuven; University Hospital Leuven	Deprest, J (corresponding author), Katholieke Univ Leuven, Ctr Surg Technol & Organ Syst Cluster, Dept Dev & Regenerat, Fac Med, Leuven, Belgium.	jan.deprest@uzleuven.be	Decaluwe, Herbert/A-2436-2009	Decaluwe, Herbert/0000-0002-0877-7717; Manodoro, Stefano/0000-0002-1837-0806; Deprest, Jan/0000-0002-4920-945X	European Commission (EuroSTEC) [LSHC-CT-2006-037409]; Instituut voor Wetenschap en Technologie (I.W.T.); Flanders Research Foundation (FWO Vlaanderen) [1801207N]	European Commission (EuroSTEC)(European CommissionEuropean Commission Joint Research Centre); Instituut voor Wetenschap en Technologie (I.W.T.)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Flanders Research Foundation (FWO Vlaanderen)(FWO)	This work was supported by the European Commission in its 6th Framework Program (EuroSTEC, LSHC-CT-2006-037409) and the Instituut voor Wetenschap en Technologie (I.W.T.). Jan Deprest is a clinical researcher for the Flanders Research Foundation (FWO Vlaanderen; 1801207N). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa M, 2013, SURG TODAY, V43, P1298, DOI 10.1007/s00595-012-0414-3; ATKINSON JB, 1992, J PEDIATR SURG, V27, P754, DOI 10.1016/S0022-3468(05)80109-5; BAX NMA, 1984, J PEDIATR SURG, V19, P484, DOI 10.1016/S0022-3468(84)80281-X; Bohm G, 2011, J BIOMATER APPL, V25, P721, DOI 10.1177/0885328210361543; Bozkurt A, 2007, TISSUE ENG, V13, P2971, DOI 10.1089/ten.2007.0116; Claerhout F, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.05.032; Dalla Vecchia LD, 1999, J PEDIATR SURG, V34, P167, DOI 10.1016/S0022-3468(99)90250-6; De Coppi P, 2012, EUR J PEDIATR SURG, V22, P393, DOI 10.1055/s-0032-1329410; DeKoninck P, 2011, EARLY HUM DEV, V87, P619, DOI 10.1016/j.earlhumdev.2011.08.001; Deprest J, 2006, INT UROGYNECOL J, V17, pS16, DOI 10.1007/s00192-006-0101-2; Deprest J, 2010, J UROLOGY, V183, P2249, DOI 10.1016/j.juro.2010.02.008; Deprest J, 2009, J UROLOGY, V182, P2362, DOI 10.1016/j.juro.2009.07.043; Fauza DO, 2014, SEMIN PEDIATR SURG, V23, P135, DOI 10.1053/j.sempedsurg.2014.04.004; Fauza DO, 2001, J PEDIATR SURG, V36, P146, DOI 10.1053/jpsu.2001.20034; Feola A, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.11.008; Gasior AC, 2012, PEDIATR SURG INT, V28, P327, DOI 10.1007/s00383-012-3059-9; Gonzalez R, 2011, J LAPAROENDOSC ADV S, V21, P449, DOI 10.1089/lap.2010.0409; Grethel EJ, 2006, J PEDIATR SURG, V41, P29, DOI 10.1016/j.jpedsurg.2005.10.005; Gucciardo L, 2014, J PEDIATR SURG, V49, P1458, DOI 10.1016/j.jpedsurg.2014.01.058; Gupta A, 2006, Hernia, V10, P419, DOI 10.1007/s10029-006-0130-2; Jones KA, 2009, INT UROGYNECOL J, V20, P847, DOI 10.1007/s00192-008-0781-x; Laituri CA, 2010, EUR J PEDIATR SURG, V20, P363, DOI 10.1055/s-0030-1261939; Lally KP, 2007, PEDIATRICS, V120, pE651, DOI 10.1542/peds.2006-3040; LALLY KP, 1992, ANN SURG, V216, P569, DOI 10.1097/00000658-199211000-00008; Lammers G, 2010, BIOMATERIALS, V31, P8299, DOI 10.1016/j.biomaterials.2010.07.055; Lantis JC, 2000, J INVEST SURG, V13, P319; Loff S, 2005, J PEDIATR SURG, V40, P1701, DOI 10.1016/j.jpedsurg.2005.07.007; Mayer S, 2011, PRENATAL DIAG, V31, P1086, DOI 10.1002/pd.2839; Mayer S, 2011, SEMIN PEDIATR SURG, V20, P161, DOI 10.1053/j.sempedsurg.2011.03.006; Montzka K, 2011, BJU INT, V107, P1974, DOI 10.1111/j.1464-410X.2010.09680.x; MOVAT HZ, 1955, ARCH PATHOL, V60, P289; Ozog Y, 2011, INT UROGYNECOL J, V22, P1099, DOI 10.1007/s00192-011-1440-1; Ozog Y, 2009, INT UROGYNECOL J, V20, P435, DOI 10.1007/s00192-008-0793-6; Peeters E, 2013, J SURG RES, V180, P274, DOI 10.1016/j.jss.2013.01.025; Raghavan D, 2005, J BIOMED MATER RES A, V73A, P90, DOI 10.1002/jbm.a.30268; Romao RLP, 2012, J PEDIATR SURG, V47, P1496, DOI 10.1016/j.jpedsurg.2012.01.009; Sandoval JA, 2006, J PEDIATR SURG, V41, P518, DOI 10.1016/j.jpedsurg.2005.11.068; Sinha CK, 2009, J PEDIATR SURG, V44, P312, DOI 10.1016/j.jpedsurg.2008.10.078; Slack M, 2012, INT UROGYNECOL J, V23, pS15, DOI 10.1007/s00192-012-1678-2; St Peter SD, 2007, J SURG RES, V140, P234, DOI 10.1016/j.jss.2007.03.018; Steinau G, 2010, BMC SURG, V10, DOI 10.1186/1471-2482-10-5; Tsai J, 2012, J PEDIATR SURG, V47, P637, DOI 10.1016/j.jpedsurg.2011.11.054; Tsao K, 2011, FETAL DIAGN THER, V29, P46, DOI 10.1159/000320244; TSUKADA T, 1986, ARTERIOSCLEROSIS, V6, P601, DOI 10.1161/01.ATV.6.6.601; Turner CG, 2011, J PEDIATR SURG, V46, P57, DOI 10.1016/j.jpedsurg.2010.09.063; Verbelen T, 2013, EUR J CARDIO-THORAC, V44, P263, DOI 10.1093/ejcts/ezt001; Zheng F, 2004, AM J OBSTET GYNECOL, V191, P1961, DOI 10.1016/j.ajog.2004.01.091; ZUHLKE HV, 1990, LANGENBECK ARCH CHIR, P1009	48	14	14	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132021	10.1371/journal.pone.0132021	http://dx.doi.org/10.1371/journal.pone.0132021			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147985	Green Published, Green Submitted, gold			2022-12-26	WOS:000358157600181
J	Rathi, PC; Jaeger, KE; Gohlke, H				Rathi, Prakash Chandra; Jaeger, Karl-Erich; Gohlke, Holger			Structural Rigidity and Protein Thermostability in Variants of Lipase A from Bacillus subtilis	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; CONFORMATIONAL FLEXIBILITY; THERMOPHILIC PROTEINS; THERMAL-STABILITY; CRYSTAL-STRUCTURE; PEBBLE GAME; B1 DOMAIN; ION-PAIRS; NETWORK; TEMPERATURE	Understanding the origin of thermostability is of fundamental importance in protein biochemistry. Opposing views on increased or decreased structural rigidity of the folded state have been put forward in this context. They have been related to differences in the temporal resolution of experiments and computations that probe atomic mobility. Here, we find a significant (p = 0.004) and fair (R-2 = 0.46) correlation between the structural rigidity of a well-characterized set of 16 mutants of lipase A from Bacillus subtilis (BsLipA) and their thermodynamic thermostability. We apply the rigidity theory-based Constraint Network Analysis (CNA) approach, analyzing directly and in a time-independent manner the statics of the BsLipA mutants. We carefully validate the CNA results on macroscopic and microscopic experimental observables and probe for their sensitivity with respect to input structures. Furthermore, we introduce a robust, local stability measure for predicting thermodynamic thermostability. Our results complement work that showed for pairs of homologous proteins that raising the structural stability is the most common way to obtain a higher thermostability. Furthermore, they demonstrate that related series of mutants with only a small number of mutations can be successfully analyzed by CNA, which suggests that CNA can be applied prospectively in rational protein design aimed at higher thermodynamic thermostability.	[Rathi, Prakash Chandra; Gohlke, Holger] Univ Dusseldorf, Inst Pharmaceut & Med Chem, Dusseldorf, Germany; [Jaeger, Karl-Erich] Univ Dusseldorf, Inst Mol Enzyme Technol, Dusseldorf, Germany; [Jaeger, Karl-Erich] Res Ctr Julich, Inst Bio & Geosci IBG Biotechnol 1, Julich, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Helmholtz Association; Research Center Julich	Gohlke, H (corresponding author), Univ Dusseldorf, Inst Pharmaceut & Med Chem, Dusseldorf, Germany.	gohlke@uni-duesseldorf.de	jaeger, karl/ABB-1955-2020	Rathi, Prakash Chandra/0000-0002-2377-1479	Ministry of Innovation, Science, and Research of North Rhine-Westphalia; Heinrich-Heine-University Dusseldorf (HHU) within the Graduate Cluster Industrial Biotechnology [CLIB2021]	Ministry of Innovation, Science, and Research of North Rhine-Westphalia; Heinrich-Heine-University Dusseldorf (HHU) within the Graduate Cluster Industrial Biotechnology	The study was supported by the Ministry of Innovation, Science, and Research of North Rhine-Westphalia and Heinrich-Heine-University Dusseldorf (HHU) by a scholarship to PCR within the CLIB2021 Graduate Cluster Industrial Biotechnology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham T, 2005, BIOCATAL BIOTRANSFOR, V23, P217, DOI 10.1080/10242420500193013; Acharya P, 2004, J MOL BIOL, V341, P1271, DOI 10.1016/j.jmb.2004.06.059; Ahmad S, 2008, J MOL BIOL, V381, P324, DOI 10.1016/j.jmb.2008.05.063; Ahmad S, 2009, PROTEIN SCI, V18, P1183, DOI 10.1002/pro.126; Augustyniak W, 2012, PROTEIN SCI, V21, P487, DOI 10.1002/pro.2031; Basu S, 2013, J CHEM INF MODEL, V53, P423, DOI 10.1021/ci300474h; Beermann B, 2007, BIOCHEMISTRY-US, V46, P4241, DOI 10.1021/bi0622423; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; CASE DA, 1994, CURR OPIN STRUC BIOL, V4, P285, DOI 10.1016/S0959-440X(94)90321-2; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Dahiyat BI, 1997, PROTEIN SCI, V6, P1333, DOI 10.1002/pro.5560060622; Danciulescu C, 2007, BIOCHEMISTRY-US, V46, P8537, DOI 10.1021/bi7004398; Demirjian DC, 2001, CURR OPIN CHEM BIOL, V5, P144, DOI 10.1016/S1367-5931(00)00183-6; Droge MJ, 2006, CHEMBIOCHEM, V7, P149, DOI 10.1002/cbic.200500308; ENGLANDER SW, 1983, Q REV BIOPHYS, V16, P521, DOI 10.1017/S0033583500005217; Fitter J, 2000, BIOPHYS J, V79, P1629, DOI 10.1016/S0006-3495(00)76413-7; Folch B, 2008, J CHEM INF MODEL, V48, P119, DOI 10.1021/ci700237g; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; Friendly M, 2002, AM STAT, V56, P316, DOI 10.1198/000313002533; Friendly M, 2013, STAT SCI, V28, P1, DOI 10.1214/12-STS402; Fulle S, 2008, BIOPHYS J, V94, P4202, DOI 10.1529/biophysj.107.113415; Gohlke H, 2004, PROTEINS, V56, P322, DOI 10.1002/prot.20116; Graf J, 2007, J AM CHEM SOC, V129, P1179, DOI 10.1021/ja0660406; Gromiha MM, 2013, PROTEINS, V81, P715, DOI 10.1002/prot.24232; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Henzler-Wildman KA, 2007, NATURE, V450, P913, DOI 10.1038/nature06407; Hernandez G, 2001, BIOCHEMISTRY-US, V40, P14384, DOI 10.1021/bi0112560; Hernandez G, 2000, P NATL ACAD SCI USA, V97, P3166, DOI 10.1073/pnas.040569697; Hespenheide BM, 2004, J PHYS-CONDENS MAT, V16, pS5055, DOI 10.1088/0953-8984/16/44/003; Hespenheide BM, 2002, J MOL GRAPH MODEL, V21, P195, DOI 10.1016/S1093-3263(02)00146-8; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Hung HC, 2001, BIOPHYS J, V81, P3456, DOI 10.1016/S0006-3495(01)75977-2; Ishima R, 2000, NAT STRUCT BIOL, V7, P740, DOI 10.1038/78963; JACOBS DJ, 1995, PHYS REV LETT, V75, P4051, DOI 10.1103/PhysRevLett.75.4051; Jacobs DJ, 2001, PROTEINS, V44, P150, DOI 10.1002/prot.1081; Jacobs DJ, 1997, J COMPUT PHYS, V137, P346, DOI 10.1006/jcph.1997.5809; JAEGER KE, 1994, FEMS MICROBIOL REV, V15, P29, DOI 10.1016/0168-6445(94)90025-6; Jaeger KE, 2002, CURR OPIN BIOTECH, V13, P390, DOI 10.1016/S0958-1669(02)00341-5; Jaenicke R, 2000, P NATL ACAD SCI USA, V97, P2962, DOI 10.1073/pnas.97.7.2962; Jaenicke R, 1998, CURR OPIN STRUC BIOL, V8, P738, DOI 10.1016/S0959-440X(98)80094-8; Joosten RP, 2011, NUCLEIC ACIDS RES, V39, pD411, DOI 10.1093/nar/gkq1105; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kalimeri M, 2013, J PHYS CHEM B, V117, P13775, DOI 10.1021/jp407078z; Kamal MZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035188; Kamal MZ, 2011, J MOL BIOL, V413, P726, DOI 10.1016/j.jmb.2011.09.002; Kamal MZ, 2010, BBA-PROTEINS PROTEOM, V1804, P1850, DOI 10.1016/j.bbapap.2010.06.014; Karplus M, 2002, NAT STRUCT BIOL, V9, P646, DOI 10.1038/nsb0902-646; Kawasaki K, 2002, ACTA CRYSTALLOGR D, V58, P1168, DOI 10.1107/S090744490200714X; Kayatekin C, 2008, J MOL BIOL, V384, P540, DOI 10.1016/j.jmb.2008.09.045; Krivov GG, 2009, PROTEINS, V77, P778, DOI 10.1002/prot.22488; Kruger DM, 2013, NUCLEIC ACIDS RES, V41, pW340, DOI 10.1093/nar/gkt292; Kumar S, 2000, PROTEIN ENG, V13, P179, DOI 10.1093/protein/13.3.179; Mamonova T, 2005, PHYS BIOL, V2, pS137, DOI 10.1088/1478-3975/2/4/S08; Marcos E, 2012, J CHEM THEORY COMPUT, V8, P1129, DOI 10.1021/ct200877z; O'Fagain C, 2011, METHODS MOL BIOL, V681, P103, DOI 10.1007/978-1-60761-913-0_7; Onufriev A, 2004, PROTEINS, V55, P383, DOI 10.1002/prot.20033; Oyeyemi OA, 2011, BIOCHEMISTRY-US, V50, P8251, DOI 10.1021/bi200640s; Pfleger C, 2013, STRUCTURE, V21, P1725, DOI 10.1016/j.str.2013.07.012; Pfleger C, 2013, J CHEM INF MODEL, V53, P1007, DOI 10.1021/ci400044m; Pfleger C, 2013, J COMPUT CHEM, V34, P220, DOI 10.1002/jcc.23122; Polizzi KM, 2007, CURR OPIN CHEM BIOL, V11, P220, DOI 10.1016/j.cbpa.2007.01.685; PRIVALOV PL, 1988, ADV PROTEIN CHEM, V39, P191; Querol E, 1996, PROTEIN ENG, V9, P265, DOI 10.1093/protein/9.3.265; Rader AJ, 2012, J BIOMOL STRUCT DYN, V30, P628, DOI 10.1080/07391102.2012.689696; Rader AJ, 2002, P NATL ACAD SCI USA, V99, P3540, DOI 10.1073/pnas.062492699; Radestock S, 2008, ENG LIFE SCI, V8, P507, DOI 10.1002/elsc.200800043; Radestock S, 2011, PROTEINS, V79, P1089, DOI 10.1002/prot.22946; Rajakumara E, 2008, BBA-PROTEINS PROTEOM, V1784, P302, DOI 10.1016/j.bbapap.2007.10.012; Rathi PC, 2011, MODELING OF MOLECULAR PROPERTIES, P281; Rathi PC, 2012, J BIOTECHNOL, V159, P135, DOI 10.1016/j.jbiotec.2012.01.027; Razvi A, 2006, PROTEIN SCI, V15, P1569, DOI 10.1110/ps.062130306; Rees DC, 2001, PROTEIN SCI, V10, P1187, DOI 10.1110/ps.180101; Reetz MT, 2006, ANGEW CHEM INT EDIT, V45, P7745, DOI 10.1002/anie.200602795; Reynolds A.P., 2006, J MATH MODEL ALGORIT, V5, P475, DOI [DOI 10.1007/S10852-005-9022-1, 10.1007/s10852-005-9022-1]; Robertson AD, 1997, CHEM REV, V97, P1251, DOI 10.1021/cr960383c; RUSSELL RJM, 1994, STRUCTURE, V2, P1157, DOI 10.1016/S0969-2126(94)00118-9; Sapra KT, 2008, J MOL BIOL, V376, P1076, DOI 10.1016/j.jmb.2007.12.027; Seewald MJ, 2000, PROTEIN SCI, V9, P1177, DOI 10.1110/ps.9.6.1177; Stone MJ, 2001, J AM CHEM SOC, V123, P185, DOI 10.1021/ja003094l; Thorpe MF, 2000, J NON-CRYST SOLIDS, V266, P859, DOI 10.1016/S0022-3093(99)00856-X; van den Burg B, 2003, CURR OPIN MICROBIOL, V6, P213, DOI 10.1016/S1369-5274(03)00060-2; van Pouderoyen G, 2001, J MOL BIOL, V309, P215, DOI 10.1006/jmbi.2001.4659; VIHINEN M, 1987, PROTEIN ENG, V1, P477, DOI 10.1093/protein/1.6.477; Vogt G, 1997, J MOL BIOL, V269, P631, DOI 10.1006/jmbi.1997.1042; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Weiss S, 1999, SCIENCE, V283, P1676, DOI 10.1126/science.283.5408.1676; Whiteley W, 2005, PHYS BIOL, V2, pS116, DOI 10.1088/1478-3975/2/4/S06; Word JM, 1999, J MOL BIOL, V285, P1735, DOI 10.1006/jmbi.1998.2401; Yilmaz LS, 2000, J CHEM PHYS, V113, P4454, DOI 10.1063/1.1288512; ZHANG XJ, 1995, J MOL BIOL, V250, P527, DOI 10.1006/jmbi.1995.0396	91	49	52	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0130289	10.1371/journal.pone.0130289	http://dx.doi.org/10.1371/journal.pone.0130289			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147762	Green Submitted, gold, Green Published			2022-12-26	WOS:000358157600033
J	ZeRuth, GT; Williams, JG; Cole, YC; Jetten, AM				ZeRuth, Gary T.; Williams, Jason G.; Cole, Yasemin C.; Jetten, Anton M.			HECT E3 Ubiquitin Ligase Itch Functions as a Novel Negative Regulator of Gli-Similar 3 (Glis3) Transcriptional Activity	PLOS ONE			English	Article							NEONATAL DIABETES-MELLITUS; PROLINE-RICH LIGANDS; BETA-CELL FUNCTION; ZINC-FINGER; WW-DOMAINS; CONGENITAL HYPOTHYROIDISM; KIDNEY-DISEASE; 26S PROTEASOME; NEDD4 FAMILY; PROTEIN	The transcription factor Gli-similar 3 (Glis3) plays a critical role in the generation of pancreatic B cells and the regulation insulin gene transcription and has been implicated in the development of several pathologies, including type 1 and 2 diabetes and polycystic kidney disease. However, little is known about the proteins and posttranslational modifications that regulate or mediate Glis3 transcriptional activity. In this study, we identify by mass-spectrometry and yeast 2-hybrid analyses several proteins that interact with the N-terminal region of Glis3. These include the WW-domain-containing HECT E3 ubiquitin ligases, Itch, Smurf2, and Nedd4. The interaction between Glis3 and the HECT E3 ubiquitin ligases was verified by co-immunoprecipitation assays and mutation analysis. All three proteins interact through their WW-domains with a PPxY motif located in the Glis3 N-terminus. However, only Itch significantly contributed to Glis3 polyubiquitination and reduced Glis3 stability by enhancing its proteasomal degradation. Itch-mediated degradation of Glis3 required the PPxY motif-dependent interaction between Glis3 and the WW-domains of Itch as well as the presence of the Glis3 zinc finger domains. Transcription analyses demonstrated that Itch dramatically inhibited Glis3-mediated transactivation and endogenous Ins2 expression by increasing Glis3 protein turnover. Taken together, our study identifies Itch as a critical negative regulator of Glis3-mediated transcriptional activity. This regulation provides a novel mechanism to modulate Glis3-driven gene expression and suggests that it may play a role in a number of physiological processes controlled by Glis3, such as insulin transcription, as well as in Glis3-associated diseases.	[ZeRuth, Gary T.; Cole, Yasemin C.; Jetten, Anton M.] NIEHS, Cell Biol Sect, Div Intramural Res, NIH, Res Triangle Pk, NC 27709 USA; [Williams, Jason G.] NIEHS, Mass Spectrometry Grp, Div Intramural Res, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Jetten, AM (corresponding author), NIEHS, Cell Biol Sect, Div Intramural Res, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.	jetten@niehs.nih.gov	Jetten, Anton/C-3736-2019; Cole, Yasemin C/H-3875-2018	Jetten, Anton/0000-0003-0954-4445; Cole, Yasemin C/0000-0002-9492-5885	Intramural Research Program of the National Institute of Environmental Health Sciences, the National Institutes of Health [Z01-ES-100485]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES100485, ZICES102488, ZIAES100485] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute of Environmental Health Sciences, the National Institutes of Health; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by the Intramural Research Program of the National Institute of Environmental Health Sciences, the National Institutes of Health [Z01-ES-100485].	An H, 2014, MOL BIOSYST, V10, P1643, DOI 10.1039/c3mb70572b; Angers A, 2004, J BIOL CHEM, V279, P11471, DOI 10.1074/jbc.M309934200; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Beak JY, 2008, NUCLEIC ACIDS RES, V36, P1690, DOI 10.1093/nar/gkn009; Beak JY, 2007, J BONE MINER RES; Bedford MT, 1997, EMBO J, V16, P2376, DOI 10.1093/emboj/16.9.2376; Bernassola F, 2008, CANCER CELL, V14, P10, DOI 10.1016/j.ccr.2008.06.001; Boesgaard TW, 2010, DIABETOLOGIA, V53, P1647, DOI 10.1007/s00125-010-1753-5; Bugliani M, 2013, MOL CELL ENDOCRINOL, V367, P1, DOI 10.1016/j.mce.2012.12.001; Chastagner P, 2006, EMBO REP, V7, P1147, DOI 10.1038/sj.embor.7400822; Chen HI, 1997, J BIOL CHEM, V272, P17070, DOI 10.1074/jbc.272.27.17070; Cho YS, 2012, NAT GENET, V44, P67, DOI 10.1038/ng.1019; Choi JH, 2007, J BIOL CHEM, V282, P30763, DOI 10.1074/jbc.M704655200; Di Marcotullio L, 2011, ONCOGENE, V30, P65, DOI 10.1038/onc.2010.394; Dimitri P, 2011, EUR J ENDOCRINOL, V164, P437, DOI 10.1530/EJE-10-0893; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Gallagher E, 2006, P NATL ACAD SCI USA, V103, P1717, DOI 10.1073/pnas.0510664103; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Guo SL, 2009, J BIOL CHEM, V284, P759, DOI 10.1074/jbc.M806314200; Hartmann-Petersen R, 2003, TRENDS BIOCHEM SCI, V28, P26, DOI 10.1016/S0968-0004(02)00002-6; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hossain Z, 2007, P NATL ACAD SCI USA, V104, P1631, DOI 10.1073/pnas.0605266104; HOU D, 1994, J BIOL CHEM, V269, P14244; Hu C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015542; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Jennings MD, 2007, J BIOL CHEM, V282, P29032, DOI 10.1074/jbc.M703453200; Kang HS, 2009, MOL CELL BIOL, V29, P6366, DOI 10.1128/MCB.01259-09; Kang HS, 2009, MOL CELL BIOL, V29, P2556, DOI 10.1128/MCB.01620-08; Kato Y, 2004, J BIOL CHEM, V279, P31833, DOI 10.1074/jbc.M404719200; Kim HT, 2007, J BIOL CHEM, V282, P17375, DOI 10.1074/jbc.M609659200; Kim HC, 2009, MOL CELL BIOL, V29, P3307, DOI 10.1128/MCB.00240-09; Kim YS, 2012, MOL CELLS, V34, P193, DOI 10.1007/s10059-012-0109-z; Kim YS, 2003, NUCLEIC ACIDS RES, V31, P5513, DOI 10.1093/nar/gkg776; Komuro A, 1999, J BIOL CHEM, V274, P36513, DOI 10.1074/jbc.274.51.36513; Liao B, 2013, J CELL PHYSIOL, V228, P1443, DOI 10.1002/jcp.24297; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Lu PJ, 1999, SCIENCE, V283, P1325, DOI 10.1126/science.283.5406.1325; Macias MJ, 2002, FEBS LETT, V513, P30, DOI 10.1016/S0014-5793(01)03290-2; Marino A, 2014, DIABETES, V63, P550, DOI 10.2337/db13-0802; Mund T, 2009, EMBO REP, V10, P501, DOI 10.1038/embor.2009.30; Narimatsu M, 2009, CELL, V137, P295, DOI 10.1016/j.cell.2009.02.025; Nathan JA, 2013, EMBO J, V32, P552, DOI 10.1038/emboj.2012.354; Otte L, 2003, PROTEIN SCI, V12, P491, DOI 10.1110/ps.0233203; Rossi M, 2005, EMBO J, V24, P836, DOI 10.1038/sj.emboj.7600444; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Sadowski M, 2012, IUBMB LIFE, V64, P136, DOI 10.1002/iub.589; Saeki Y, 2009, EMBO J, V28, P359, DOI 10.1038/emboj.2008.305; Santin I, 2013, DIABETES OBES METAB, V15, P71, DOI 10.1111/dom.12162; Scheffner M, 2014, BBA-MOL CELL RES, V1843, P61, DOI 10.1016/j.bbamcr.2013.03.024; Scialpi F, 2008, BIOCHEM PHARMACOL, V76, P1515, DOI 10.1016/j.bcp.2008.07.028; Senee V, 2006, NAT GENET, V38, P682, DOI 10.1038/ng1802; Sudol M, 2000, CELL, V103, P1001, DOI 10.1016/S0092-8674(00)00203-8; Taha D, 2003, AM J MED GENET A, V122A, P269, DOI 10.1002/ajmg.a.20267; Wang CJ, 2012, BIOCHEM J, V444, P279, DOI 10.1042/BJ20111983; Watanabe N, 2009, FEBS LETT, V583, P2108, DOI 10.1016/j.febslet.2009.05.039; Winberg G, 2000, MOL CELL BIOL, V20, P8526, DOI 10.1128/MCB.20.22.8526-8535.2000; Yang Y, 2011, DIABETOLOGIA, V54, P2595, DOI 10.1007/s00125-011-2255-9; Yang YS, 2013, EMBO MOL MED, V5, P92, DOI 10.1002/emmm.201201398; Yang YS, 2009, NUCLEIC ACIDS RES, V37, P2529, DOI 10.1093/nar/gkp122; Yoshizawa T, 2014, CELL METAB, V19, P712, DOI 10.1016/j.cmet.2014.03.006; ZeRuth GT, 2013, MOL ENDOCRINOL, V27, P1692, DOI 10.1210/me.2013-1117; ZeRuth GT, 2011, J BIOL CHEM, V286, P22077, DOI 10.1074/jbc.M111.224964; Zhang HW, 2013, STEM CELLS, V31, P1574, DOI 10.1002/stem.1395; Zhang Y, 2001, P NATL ACAD SCI USA, V98, P974, DOI 10.1073/pnas.98.3.974; Zhou GS, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00226	65	18	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131303	10.1371/journal.pone.0131303	http://dx.doi.org/10.1371/journal.pone.0131303			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147758	gold, Green Submitted, Green Published			2022-12-26	WOS:000358157600087
J	Mancini, AD; Bertrand, G; Vivot, K; Carpentier, E; Tremblay, C; Ghislain, J; Bouvier, M; Poitout, V				Mancini, Arturo D.; Bertrand, Gyslaine; Vivot, Kevin; Carpentier, Eric; Tremblay, Caroline; Ghislain, Julien; Bouvier, Michel; Poitout, Vincent			beta-Arrestin Recruitment and Biased Agonism at Free Fatty Acid Receptor 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIOAVAILABLE GPR40 AGONIST; PROTEIN-KINASE D1; SECRETION IN-VIVO; INSULIN-SECRETION; ACTIVATION; TAK-875; ISLETS; CELLS; INTERNALIZATION; IDENTIFICATION	FFAR1/GPR40 is a seven-transmembrane domain receptor (7TMR) expressed in pancreatic beta cells and activated by FFAs. Pharmacological activation of GPR40 is a strategy under consideration to increase insulin secretion in type 2 diabetes. GPR40 is known to signal predominantly via the heterotrimeric G proteins G(q/11). However, 7TMRs can also activate functionally distinct G protein-independent signaling via beta-arrestins. Further, G protein- and beta-arrestin-based signaling can be differentially modulated by different ligands, thus eliciting ligand-specific responses ("biased agonism"). Whether GPR40 engages beta-arrestin-dependent mechanisms and is subject to biased agonism is unknown. Using bioluminescence resonance energy transfer-based biosensors for real-time monitoring of cell signaling in living cells, we detected a ligand-induced GPR40-beta-arrestin interaction, with the synthetic GPR40 agonist TAK-875 being more effective than palmitate or oleate in recruiting beta-arrestins 1 and 2. Conversely, TAK-875 acted as a partial agonist of G(q/11)-dependent GPR40 signaling relative to both FFAs. Pharmacological blockade of G(q) activity decreased FFA-induced insulin secretion. In contrast, knockdown or genetic ablation of beta-arrestin 2 in an insulin-secreting cell line and mouse pancreatic islets, respectively, uniquely attenuated the insulinotropic activity of TAK-875, thus providing functional validation of the biosensor data. Collectively, these data reveal that in addition to coupling to G(q/11), GPR40 is functionally linked to a beta-arrestin 2-mediated insulinotropic signaling axis. These observations expose previously unrecognized complexity for GPR40 signal transduction and may guide the development of biased agonists showing improved clinical profile in type 2 diabetes.	[Mancini, Arturo D.; Vivot, Kevin; Tremblay, Caroline; Ghislain, Julien; Poitout, Vincent] Univ Montreal, Res Ctr, Montreal Diabet Res Ctr, Hosp Ctr,CRCHUM, Montreal, PQ H2X 0A9, Canada; [Mancini, Arturo D.; Vivot, Kevin; Tremblay, Caroline; Ghislain, Julien; Poitout, Vincent] Univ Montreal, Dept Med, Montreal, PQ H2X 0A9, Canada; [Bertrand, Gyslaine] Univ Montpellier I, INSERM U661, CNRS UMR 5203, Inst Genom Fonct, F-34060 Montpellier, France; [Bertrand, Gyslaine] Univ Montpellier 2, F-34060 Montpellier, France; [Carpentier, Eric; Bouvier, Michel; Poitout, Vincent] Univ Montreal, Dept Biochem & Mol Med, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; Universite de Montreal	Poitout, V (corresponding author), CRCHUM, 900 St Denis, Montreal, PQ H2X 0A9, Canada.	vincent.poitout@umontreal.ca	Vivot, Kevin/P-8329-2016; bertrand, gyslaine/AAC-6716-2020; Bouvier, Michel/H-2758-2014	Vivot, Kevin/0000-0003-4617-0016; Bouvier, Michel/0000-0003-1128-0100; Poitout, Vincent/0000-0002-6555-5053	Canadian Institutes of Health Research (CIHR) [MOP86545, 11215]; Canadian Diabetes Association	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Diabetes Association	This work was supported by the Canadian Institutes of Health Research (CIHR) Grants MOP86545 (to V. P.) and 11215 (to M. B.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a postdoctoral fellowship from the Canadian Diabetes Association.	Atwood Brady K, 2011, BMC Genomics, V12, P14, DOI 10.1186/1471-2164-12-14; Audet M, 2012, CELL, V151, P14, DOI 10.1016/j.cell.2012.09.003; Bohn LM, 1999, SCIENCE, V286, P2495, DOI 10.1126/science.286.5449.2495; Briscoe CP, 2003, J BIOL CHEM, V278, P11303, DOI 10.1074/jbc.M211495200; Burant CF, 2012, LANCET, V379, P1403, DOI 10.1016/S0140-6736(11)61879-5; Denis C, 2012, CURR PHARM DESIGN, V18, P128, DOI 10.2174/138161212799040466; Feng DD, 2006, ENDOCRINOLOGY, V147, P674, DOI 10.1210/en.2005-0225; Ferdaoussi M, 2012, DIABETOLOGIA, V55, P2682, DOI 10.1007/s00125-012-2650-x; Gales C, 2006, NAT STRUCT MOL BIOL, V13, P778, DOI 10.1038/nsmb1134; HAGENFEL.L, 1972, J CLIN INVEST, V51, P2324, DOI 10.1172/JCI107043; Hagman DK, 2005, J BIOL CHEM, V280, P32413, DOI 10.1074/jbc.M506000200; Hauge M, 2015, MOL METAB, V4, P3, DOI 10.1016/j.molmet.2014.10.002; Houze JB, 2012, BIOORG MED CHEM LETT, V22, P1267, DOI 10.1016/j.bmcl.2011.10.118; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Kebede M, 2008, DIABETES, V57, P2432, DOI 10.2337/db08-0553; Kenakin T, 2013, NAT REV DRUG DISCOV, V12, P205, DOI 10.1038/nrd3954; Kong KC, 2010, P NATL ACAD SCI USA, V107, P21181, DOI 10.1073/pnas.1011651107; Latour MG, 2007, DIABETES, V56, P1087, DOI 10.2337/db06-1532; Leifke E, 2012, CLIN PHARMACOL THER, V92, P29, DOI 10.1038/clpt.2012.43; Lin DCH, 2012, MOL PHARMACOL, V82, P843, DOI 10.1124/mol.112.079640; Longo PA, 2013, METHOD ENZYMOL, V529, P227, DOI 10.1016/B978-0-12-418687-3.00018-5; Maedler K, 2002, J CLIN INVEST, V110, P851, DOI 10.1172/JCI200215318; Mancini AD, 2015, DIABETES OBES METAB, V17, P622, DOI 10.1111/dom.12442; Mancini AD, 2013, TRENDS ENDOCRIN MET, V24, P398, DOI 10.1016/j.tem.2013.03.003; Negoro N, 2010, ACS MED CHEM LETT, V1, P290, DOI 10.1021/ml1000855; PITCHER JA, 1992, SCIENCE, V257, P1264, DOI 10.1126/science.1325672; Qian J, 2014, CELL SIGNAL, V26, P2412, DOI 10.1016/j.cellsig.2014.07.019; Quoyer J, 2010, J BIOL CHEM, V285, P1989, DOI 10.1074/jbc.M109.067207; Ravier MA, 2014, DIABETOLOGIA, V57, P532, DOI 10.1007/s00125-013-3130-7; Shapiro H, 2005, BIOCHEM BIOPH RES CO, V335, P97, DOI 10.1016/j.bbrc.2005.07.042; Shukla AK, 2011, TRENDS BIOCHEM SCI, V36, P457, DOI 10.1016/j.tibs.2011.06.003; Sonoda N, 2008, P NATL ACAD SCI USA, V105, P6614, DOI 10.1073/pnas.0710402105; Srivastava A, 2014, NATURE, V513, P124, DOI 10.1038/nature13494; Sum CS, 2007, J BIOL CHEM, V282, P29248, DOI 10.1074/jbc.M705077200; Sunil V, 2014, BMC PHARMACOL TOXICO, V15, DOI 10.1186/2050-6511-15-19; Violin JD, 2007, TRENDS PHARMACOL SCI, V28, P416, DOI 10.1016/j.tips.2007.06.006; Wagner R, 2013, DIABETES, V62, P2106, DOI 10.2337/db12-1249; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100; Wisler JW, 2014, CURR OPIN CELL BIOL, V27, P18, DOI 10.1016/j.ceb.2013.10.008; Yabuki C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076280; Yeatman HR, 2014, J BIOL CHEM, V289, P15856, DOI 10.1074/jbc.M113.536672	41	69	71	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2015	290	34					21131	21140		10.1074/jbc.M115.644450	http://dx.doi.org/10.1074/jbc.M115.644450			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP6QC	26157145	Green Published, hybrid			2022-12-26	WOS:000360011800044
J	Mathiassen, SG; Larsen, IB; Poulsen, EG; Madsen, CT; Papaleo, E; Lindorff-Larsen, K; Kragelund, BB; Nielsen, ML; Kriegenburg, F; Hartmann-Petersen, R				Mathiassen, Sos G.; Larsen, Ida B.; Poulsen, Esben G.; Madsen, Christian T.; Papaleo, Elena; Lindorff-Larsen, Kresten; Kragelund, Birthe B.; Nielsen, Michael L.; Kriegenburg, Franziska; Hartmann-Petersen, Rasmus			A Two-step Protein Quality Control Pathway for a Misfolded DJ-1 Variant in Fission Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E3 UBIQUITIN LIGASE; SACCHAROMYCES-CEREVISIAE; PARKINSONS-DISEASE; COTRANSLATIONAL UBIQUITINATION; MOLECULAR CHAPERONES; CRYSTAL-STRUCTURE; DEGRADATION; RIBOSOME; HSP104; HSP70	A mutation, L166P, in the cytosolic protein, PARK7/DJ-1, causes protein misfolding and is linked to Parkinson disease. Here, we identify the fission yeast protein Sdj1 as the orthologue of DJ-1 and calculate by in silico saturation mutagenesis the effects of point mutants on its structural stability. We also map the degradation pathways for Sdj1-L169P, the fission yeast orthologue of the disease-causing DJ-1 L166P protein. Sdj1-L169P forms inclusions, which are enriched for the Hsp104 disaggregase. Hsp104 and Hsp70-type chaperones are required for efficient degradation of Sdj1-L169P. This also depends on the ribosome-associated E3 ligase Ltn1 and its co-factor Rqc1. Although Hsp104 is absolutely required for proteasomal degradation of Sdj1-L169P aggregates, the degradation of already aggregated Sdj1-L169P occurs independently of Ltn1 and Rqc1. Thus, our data point to soluble Sdj1-L169P being targeted early by Ltn1 and Rqc1. The fraction of Sdj1-L169P that escapes this first inspection then forms aggregates that are subsequently cleared via an Hsp104- and proteasome-dependent pathway.	[Mathiassen, Sos G.; Larsen, Ida B.; Poulsen, Esben G.; Papaleo, Elena; Lindorff-Larsen, Kresten; Kragelund, Birthe B.; Kriegenburg, Franziska; Hartmann-Petersen, Rasmus] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen N, Denmark; [Madsen, Christian T.; Nielsen, Michael L.] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn Ctr Prot Res, DK-2200 Copenhagen N, Denmark	University of Copenhagen; University of Copenhagen	Kriegenburg, F (corresponding author), Univ Copenhagen, Dept Biol, Ole Maaloes Vej 5, DK-2200 Copenhagen N, Denmark.	fkriegenburg@bio.ku.dk; rhpetersen@bio.ku.dk	Lindorff-Larsen, Kresten/K-6469-2014; Hartmann-Petersen, Rasmus/K-4434-2014; Papaleo, Elena/M-6629-2014; Kragelund, Birthe/M-3927-2014	Lindorff-Larsen, Kresten/0000-0002-4750-6039; Hartmann-Petersen, Rasmus/0000-0002-4155-7791; Papaleo, Elena/0000-0002-7376-5894; Kragelund, Birthe/0000-0002-7454-1761; , Elena/0000-0003-2296-898X; Nielsen, Michael/0000-0002-0067-9039	Danish Council for Independent Research (Natural Sciences); Novo Nordisk Foundation; Danish Cancer Society; Lundbeck Foundation; Novo Nordisk student scholarship; Novo Nordisk Foundation [NNF14CC0001]; Danish Council for Independent Research, Sapere Aude Grant [4002-00051A]; Novo Nordisk Fonden [NNF11OC1014446] Funding Source: researchfish	Danish Council for Independent Research (Natural Sciences)(Det Frie Forskningsrad (DFF)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Cancer Society(Danish Cancer Society); Lundbeck Foundation(Lundbeckfonden); Novo Nordisk student scholarship; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Council for Independent Research, Sapere Aude Grant; Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported in part by grants from the Danish Council for Independent Research (Natural Sciences), The Novo Nordisk Foundation, The Danish Cancer Society, and the Lundbeck Foundation (to R. H.-P., B. B. K., and K. L.-L.).; Supported by a Novo Nordisk student scholarship.; Supported in part by the Novo Nordisk Foundation Grant NNF14CC0001 and the Danish Council for Independent Research, Sapere Aude Grant 4002-00051A.	Amm I, 2014, BBA-MOL CELL RES, V1843, P182, DOI 10.1016/j.bbamcr.2013.06.031; Andersen KM, 2011, ANTIOXID REDOX SIGN, V14, P1601, DOI 10.1089/ars.2010.3329; Anderson PC, 2008, BIOCHEMISTRY-US, V47, P9380, DOI 10.1021/bi800677k; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Bandyopadhyay S, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-6; Baulac S, 2004, MOL CELL NEUROSCI, V27, P236, DOI 10.1016/j.mcn.2004.06.014; Bengtson MH, 2010, NATURE, V467, P470, DOI 10.1038/nature09371; Bonifati V, 2003, NEUROL SCI, V24, P159, DOI 10.1007/s10072-003-0108-0; Brandman O, 2012, CELL, V151, P1042, DOI 10.1016/j.cell.2012.10.044; Brown CR, 2000, J CELL BIOL, V150, P65, DOI 10.1083/jcb.150.1.65; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; Chu J, 2009, P NATL ACAD SCI USA, V106, P2097, DOI 10.1073/pnas.0812819106; Coelho M, 2013, CURR BIOL, V23, P1844, DOI 10.1016/j.cub.2013.07.084; Corti O, 2011, PHYSIOL REV, V91, P1161, DOI 10.1152/physrev.00022.2010; Defenouillere Q, 2013, P NATL ACAD SCI USA, V110, P5046, DOI 10.1073/pnas.1221724110; Duttler S, 2013, MOL CELL, V50, P379, DOI 10.1016/j.molcel.2013.03.010; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Gardner RG, 2005, CELL, V120, P803, DOI 10.1016/j.cell.2005.01.016; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Graille M, 2004, STRUCTURE, V12, P839, DOI 10.1016/S0969-2126(04)00113-3; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Guerriero CJ, 2013, J BIOL CHEM, V288, P18506, DOI 10.1074/jbc.M113.475905; Le HT, 2012, J BIOL CHEM, V287, P5861, DOI 10.1074/jbc.M111.299198; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Hartmann-Petersen R, 2004, CURR BIOL, V14, P824, DOI 10.1016/j.cub.2004.04.029; Herczenik E, 2008, FASEB J, V22, P2115, DOI 10.1096/fj.07-099671; Horton LE, 2001, J BIOL CHEM, V276, P14426, DOI 10.1074/jbc.M100266200; Kettern N, 2010, BIOL CHEM, V391, P481, DOI 10.1515/BC.2010.058; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; Kriegenburg F, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004140; Kriegenburg F, 2012, FEBS J, V279, P532, DOI 10.1111/j.1742-4658.2011.08456.x; Kthiri F, 2010, J BACTERIOL, V192, P6302, DOI 10.1128/JB.01077-10; Lee J, 2013, P NATL ACAD SCI USA, V110, P8513, DOI 10.1073/pnas.1217988110; Lucas JI, 2007, MOL BIOL EVOL, V24, P551, DOI 10.1093/molbev/msl186; Lyne R, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-27; Lyumkis D, 2014, P NATL ACAD SCI USA, V111, P15981, DOI 10.1073/pnas.1413882111; Madzelan P, 2012, FEBS J, V279, P4111, DOI 10.1111/febs.12004; Marguerat S, 2012, CELL, V151, P671, DOI 10.1016/j.cell.2012.09.019; Matsuyama A, 2004, YEAST, V21, P1289, DOI 10.1002/yea.1181; Miller DW, 2003, J BIOL CHEM, V278, P36588, DOI 10.1074/jbc.M304272200; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Moscovitz O, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7609; Olzmann JA, 2004, J BIOL CHEM, V279, P8506, DOI 10.1074/jbc.M311017200; PARSELL DA, 1994, NATURE, V372, P475, DOI 10.1038/372475a0; Pechmann S, 2013, MOL CELL, V49, P411, DOI 10.1016/j.molcel.2013.01.020; Penney M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050796; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Poulsen EG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050548; Poulsen JW, 2013, J PROTEOME RES, V12, P1020, DOI 10.1021/pr300883y; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; SANCHEZ Y, 1992, EMBO J, V11, P2357, DOI 10.1002/j.1460-2075.1992.tb05295.x; SANCHEZ Y, 1990, SCIENCE, V248, P1112, DOI 10.1126/science.2188365; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Shao S, 2013, MOL CELL, V50, P637, DOI 10.1016/j.molcel.2013.04.015; Sharma D, 2011, P NATL ACAD SCI USA, V108, P13665, DOI 10.1073/pnas.1107421108; Sharma D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006644; Theodoraki MA, 2012, J BIOL CHEM, V287, P23911, DOI 10.1074/jbc.M112.341164; van der Brug MP, 2008, P NATL ACAD SCI USA, V105, P10244, DOI 10.1073/pnas.0708518105; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wang CY, 2012, RNA, V18, P694, DOI 10.1261/rna.030270.111; Wang F, 2015, BIOCHIMIE, V114, P127, DOI 10.1016/j.biochi.2015.02.006; Wang F, 2013, MOL CELL, V50, P368, DOI 10.1016/j.molcel.2013.03.009; Wilson MA, 2004, P NATL ACAD SCI USA, V101, P1531, DOI 10.1073/pnas.0308089100	65	17	17	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2015	290	34					21141	21153		10.1074/jbc.M115.662312	http://dx.doi.org/10.1074/jbc.M115.662312			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP6QC	26152728	Green Published, hybrid			2022-12-26	WOS:000360011800045
J	Hansen, GAW; Ludvigsen, M; Jacobsen, C; Cangemi, C; Rasmussen, LM; Vorum, H; Honore, B				Hansen, Gry Aune Westergaard; Ludvigsen, Maja; Jacobsen, Christian; Cangemi, Claudia; Rasmussen, Lars Melholt; Vorum, Henrik; Honore, Bent			Fibulin-1C, C1 Esterase Inhibitor and Glucose Regulated Protein 75 Interact with the CREC Proteins, Calumenin and Reticulocalbin	PLOS ONE			English	Article							MULTIPLE EF-HAND; CALCIUM-BINDING PROTEIN; ENDOPLASMIC-RETICULUM; CA2+-BINDING PROTEIN; EXTRACELLULAR CALUMENIN; SECRETORY PATHWAY; POTENTIAL ROLE; EXPRESSION; FAMILY; LOCALIZATION	Affinity purification, immunoprecipitation, gel electrophoresis and mass spectrometry were used to identify fibulin-1C, C1 esterase inhibitor and glucose regulated protein 75, grp75, as binding partners of the CREC proteins, calumenin and reticulocalbin. Surface plasmon resonance was used to verify the interaction of all three proteins with each of the CREC proteins. Fibulin-1C interacts with calumenin and reticulocalbin with an estimated dissociation constant around 50-60 nM. The interaction, at least for reticulocalbin, was not dependent upon the presence of Ca2+. C1 esterase inhibitor interacted with both proteins with an estimated dissociation constant at 1 mu M for reticulocalbin and 150 nM for calumenin. The interaction, at least for calumenin, was dependent upon the presence of Ca2+ with strong interaction at 3.5 mM while no detectable interaction could be found at 0.1 mM. Grp75 binds with an affinity of approximately 3-7 nM with reticulocalbin as well as with calumenin. These interactions suggest functional participation of the CREC proteins in chaperone activity, cell proliferation and transformation, cellular aging, haemostasis and thrombosis as well as modulation of the complement system in fighting bacterial infection.	[Hansen, Gry Aune Westergaard; Ludvigsen, Maja; Jacobsen, Christian; Honore, Bent] Aarhus Univ, Dept Biomed, DK-8000 Aarhus C, Denmark; [Cangemi, Claudia; Rasmussen, Lars Melholt] Odense Univ Hosp, Dept Clin Biochem & Pharmacol, Ctr Individualized Med Arterial Dis CIMA, DK-5000 Odense C, Denmark; [Vorum, Henrik] Aalborg Univ Hosp, Dept Ophthalmol, DK-9100 Aalborg, Denmark	Aarhus University; University of Southern Denmark; Odense University Hospital; Aalborg University; Aalborg University Hospital	Honore, B (corresponding author), Aarhus Univ, Dept Biomed, Ole Worms Alle 3,Bldg 1182, DK-8000 Aarhus C, Denmark.	bh@biomed.au.dk	Honoré, Bent/ABF-3650-2021	Honore, Bent/0000-0002-3459-7429; Ludvigsen, Maja/0000-0001-5089-3271; Rasmussen, Lars Melholt/0000-0001-5795-4794	Danish Medical Research Council [52-00-1004, 22-01-0249]; Novo Nordic Foundation; Danish Cancer Foundation [DS 02 071]; Danish Heart Foundation [08-4-R64-A2008-B894-22450]	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Novo Nordic Foundation(Novo Nordisk Foundation); Danish Cancer Foundation(Danish Cancer Society); Danish Heart Foundation	The Danish Medical Research Council (Grant 52-00-1004 and 22-01-0249, BH). The Novo Nordic Foundation (BH). The Danish Cancer Foundation (Grant DS 02 071, GAWH). The Danish Heart Foundation (Grant 08-4-R64-A2008-B894-22450, GAWH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argraves WS, 2003, EMBO REP, V4, P1127, DOI 10.1038/sj.embor.7400033; Cangemi C, 2014, ADV CLIN CHEM, V67, P245, DOI 10.1016/bs.acc.2014.09.008; Cangemi C, 2011, CLIN CHEM, V57, P1556, DOI 10.1373/clinchem.2011.162966; Carper D, 2001, FREE RADICAL BIO MED, V31, P90, DOI 10.1016/S0891-5849(01)00561-5; CHEN JJ, 1995, SCIENCE, V269, P529, DOI 10.1126/science.7624774; Chen L, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.193; Clinton GM, 1996, P NATL ACAD SCI USA, V93, P316, DOI 10.1073/pnas.93.1.316; Cooper CR, 2008, J CELL BIOCHEM, V104, P2298, DOI 10.1002/jcb.21785; Coppinger JA, 2004, BLOOD, V103, P2096, DOI 10.1182/blood-2003-08-2804; Davis A E 3rd, 1989, Immunodefic Rev, V1, P207; Davis AE, 2004, ADV IMMUNOL, V82, P331, DOI 10.1016/S0065-2776(04)82008-X; Feng H, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.403; Godyna S, 1996, BLOOD, V88, P2569, DOI 10.1182/blood.V88.7.2569.bloodjournal8872569; Gronborg M, 2006, MOL CELL PROTEOMICS, V5, P157, DOI 10.1074/mcp.M500178-MCP200; Hansen GAW, 2009, MOL CELL BIOCHEM, V320, P25, DOI 10.1007/s11010-008-9895-1; Honore B, 2004, EXP CELL RES, V295, P91, DOI 10.1016/j.yexcr.2003.11.029; Honore B, 2000, FEBS LETT, V466, P11, DOI 10.1016/S0014-5793(99)01780-9; Honore B, 2009, BIOESSAYS, V31, P262, DOI 10.1002/bies.200800186; Hseu MJ, 1999, FEBS LETT, V445, P440, DOI 10.1016/S0014-5793(99)00177-5; Huang YH, 2002, PROTEOMICS, V2, P1220, DOI 10.1002/1615-9861(200209)2:9<1220::AID-PROT1220>3.0.CO;2-3; Jung DH, 2006, BIOCHEM BIOPH RES CO, V343, P34, DOI 10.1016/j.bbrc.2006.02.115; Jung DH, 2004, GENE, V327, P185, DOI 10.1016/j.gene.2003.10.014; Lam PPL, 2007, MOL BIOL CELL, V18, P2473, DOI 10.1091/mbc.E06-10-0950; Liu ZD, 1997, BIOCHEM BIOPH RES CO, V231, P283, DOI 10.1006/bbrc.1997.6083; Ludvigsen M, 2009, PROTEOMICS, V9, P5267, DOI 10.1002/pmic.200900321; Nimmrich I, 2000, CANCER LETT, V160, P37, DOI 10.1016/S0304-3835(00)00553-X; Ostergaard M, 2006, PROTEOMICS, V6, P3509, DOI 10.1002/pmic.200500686; OZAWA M, 1995, J BIOCHEM-TOKYO, V117, P1113, DOI 10.1093/oxfordjournals.jbchem.a124815; OZAWA M, 1993, J BIOL CHEM, V268, P699; Pan TC, 1999, FEBS LETT, V444, P38, DOI 10.1016/S0014-5793(99)00024-1; Ran QT, 2000, BIOCHEM BIOPH RES CO, V275, P174, DOI 10.1006/bbrc.2000.3237; Sahoo SK, 2010, BMB REP, V43, P158, DOI 10.5483/BMBRep.2010.43.3.158; Sahoo SK, 2009, J BIOL CHEM, V284, P31109, DOI 10.1074/jbc.M109.031989; Scherer PE, 1996, J CELL BIOL, V133, P257, DOI 10.1083/jcb.133.2.257; Teng L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040173; TRAN H, 1995, J BIOL CHEM, V270, P19458, DOI 10.1074/jbc.270.33.19458; Tsuji A, 2006, BIOCHEM J, V396, P51, DOI 10.1042/BJ20051524; TYEDMERS J, 2005, J BIOL SCI, V5, P70; Voora D, 2010, CLIN PHARMACOL THER, V87, P445, DOI 10.1038/clpt.2009.291; Vorum H, 2000, FEBS LETT, V465, P129, DOI 10.1016/S0014-5793(99)01734-2; Vorum H, 1999, EXP CELL RES, V248, P473, DOI 10.1006/excr.1999.4431; Vorum H, 1998, BBA-PROTEIN STRUCT M, V1386, P121, DOI 10.1016/S0167-4838(98)00089-2; WADHWA R, 1993, J BIOL CHEM, V268, P6615; Wajih N, 2004, J BIOL CHEM, V279, P25276, DOI 10.1074/jbc.M401645200; Wallin R, 2001, FASEB J, V15, P2542, DOI 10.1096/fj.01-0337fje; Wang Q, 2015, ONCOGENE, V34, P1006, DOI 10.1038/onc.2014.52; Wang QC, 2012, ADV GENET ENG BIOTEC, V1, P1, DOI [DOI 10.4172/AGEB.1000E101, 10.4172/2324-9021.1000e101, DOI 10.4172/2324-9021.1000E101]; WEIS K, 1994, J BIOL CHEM, V269, P19142; Yabe D, 1997, J BIOL CHEM, V272, P18232, DOI 10.1074/jbc.272.29.18232; Yu LR, 2000, ELECTROPHORESIS, V21, P3058, DOI 10.1002/1522-2683(20000801)21:14<3058::AID-ELPS3058>3.0.CO;2-U	50	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132283	10.1371/journal.pone.0132283	http://dx.doi.org/10.1371/journal.pone.0132283			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161649	gold, Green Published			2022-12-26	WOS:000358162300113
J	Heckemann, RA; Ledig, C; Gray, KR; Aljabar, P; Rueckert, D; Hajnal, JV; Hammers, A				Heckemann, Rolf A.; Ledig, Christian; Gray, Katherine R.; Aljabar, Paul; Rueckert, Daniel; Hajnal, Joseph V.; Hammers, Alexander			Brain Extraction Using Label Propagation and Group Agreement: Pincram	PLOS ONE			English	Article							AUTOMATIC SEGMENTATION; INTRACRANIAL VOLUME; ATLAS; FUSION	Accurately delineating the brain on magnetic resonance (MR) images of the head is a prerequisite for many neuroimaging methods. Most existing methods exhibit disadvantages in that they are laborious, yield inconsistent results, and/or require training data to closely match the data to be processed. Here, we present pincram, an automatic, versatile method for accurately labelling the adult brain on T1-weighted 3D MR head images. The method uses an iterative refinement approach to propagate labels from multiple atlases to a given target image using image registration. At each refinement level, a consensus label is generated. At the subsequent level, the search for the brain boundary is constrained to the neighbourhood of the boundary of this consensus label. The method achieves high accuracy (Jaccard coefficient > 0.95 on typical data, corresponding to a Dice similarity coefficient of > 0.97) and performs better than many state-of-the-art methods as evidenced by independent evaluation on the Segmentation Validation Engine. Via a novel self-monitoring feature, the program generates the " success index," a scalar metadatum indicative of the accuracy of the output label. Pincram is available as open source software.	[Heckemann, Rolf A.] Sahlgrens Univ Hosp, MedTech West, Gothenburg, Sweden; [Heckemann, Rolf A.] Gothenburg Univ, Inst Neurosci & Physiol, Gothenburg, Sweden; [Heckemann, Rolf A.] Univ London Imperial Coll Sci Technol & Med, Ctr Brain Sci, London, England; [Heckemann, Rolf A.; Hammers, Alexander] Neurodis Fdn, Lyon, France; [Ledig, Christian; Gray, Katherine R.; Aljabar, Paul; Rueckert, Daniel] Univ London Imperial Coll Sci Technol & Med, Dept Comp, London, England; [Aljabar, Paul; Hajnal, Joseph V.; Hammers, Alexander] Kings Coll London, Imaging Sci & Biomed Engn, London, England	Sahlgrenska University Hospital; University of Gothenburg; Imperial College London; Imperial College London; University of London; King's College London	Heckemann, RA (corresponding author), Sahlgrens Univ Hosp, MedTech West, Gothenburg, Sweden.	rolf.heckemann@medtechwest.se	Heckemann, Rolf Andreas/H-9022-2019; Hajnal, Joseph/P-6251-2018; Hammers, Alexander/D-9982-2015	Heckemann, Rolf Andreas/0000-0003-3582-3683; Hajnal, Joseph/0000-0002-2690-5495; Ledig, Christian/0000-0003-4862-3138; Hammers, Alexander/0000-0001-9530-4848	National Institutes of Health [P50 AG05681, P01 AG03991, R01 AG021910, P50 MH071616, U24 RR021382, R01 MH56584]; MRC [MR/K006355/1] Funding Source: UKRI; Medical Research Council [MR/K006355/1] Funding Source: researchfish; NATIONAL CENTER FOR RESEARCH RESOURCES [U24RR021382] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH071616, R01MH056584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG003991, R01AG021910, P50AG005681] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The following National Institutes of Health grants enabled the creation of the OASIS resource: P50 AG05681, P01 AG03991, R01 AG021910, P50 MH071616, U24 RR021382, R01 MH56584.	Aljabar P, 2007, LECT NOTES COMPUT SC, V4791, P523; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; BAJCSY R, 1983, J COMPUT ASSIST TOMO, V7, P618, DOI 10.1097/00004728-198308000-00008; Eritaia J, 2000, MAGN RESON MED, V44, P973, DOI 10.1002/1522-2594(200012)44:6<973::AID-MRM21>3.0.CO;2-H; Eskildsen SF, 2012, NEUROIMAGE, V59, P2362, DOI 10.1016/j.neuroimage.2011.09.012; Freeborough PA, 1997, COMPUT METH PROG BIO, V53, P15, DOI 10.1016/S0169-2607(97)01803-8; Gousias I. S., 2012, Proceedings of the 2012 IEEE International Conference on Imaging Systems and Techniques (IST), P95, DOI 10.1109/IST.2012.6295511; Gousias I. S., 2010, 2010 IEEE International Conference on Imaging Systems and Techniques (IST 2010), P290, DOI 10.1109/IST.2010.5548493; Gousias IS, 2008, NEUROIMAGE, V40, P672, DOI 10.1016/j.neuroimage.2007.11.034; Gousias IS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059990; Hammers A, 2003, HUM BRAIN MAPP, V19, P224, DOI 10.1002/hbm.10123; Heckemann RA, 2006, NEUROIMAGE, V33, P115, DOI 10.1016/j.neuroimage.2006.05.061; Heckemann RA, 2010, NEUROIMAGE, V51, P221, DOI 10.1016/j.neuroimage.2010.01.072; Huang MY, 2014, NEUROIMAGE, V92, P322, DOI 10.1016/j.neuroimage.2014.01.059; Keihaninejad S, 2010, NEUROIMAGE, V50, P1427, DOI 10.1016/j.neuroimage.2010.01.064; Landman B., 2012, MICCAI GRAND CHALLEN; Langerak TR, 2010, IEEE T MED IMAGING, V29, P2000, DOI 10.1109/TMI.2010.2057442; Lemieux L, 2003, MAGN RESON MED, V49, P872, DOI 10.1002/mrm.10436; Leung KK, 2011, NEUROIMAGE, V55, P1091, DOI 10.1016/j.neuroimage.2010.12.067; Manjon JV, 2014, INT J BIOMED IMAGING, V2014, DOI 10.1155/2014/820205; Modat M, 2010, COMPUT METH PROG BIO, V98, P278, DOI 10.1016/j.cmpb.2009.09.002; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Shattuck DW, 2008, NEUROIMAGE, V39, P1064, DOI 10.1016/j.neuroimage.2007.09.031; Shattuck DW, 2009, NEUROIMAGE, V45, P431, DOI 10.1016/j.neuroimage.2008.10.066; Shi WZ, 2013, MED IMAGE ANAL, V17, P779, DOI 10.1016/j.media.2013.04.010; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Studholme C, 1999, PATTERN RECOGN, V32, P71, DOI 10.1016/S0031-3203(98)00091-0; Tustison NJ, 2010, IEEE T MED IMAGING, V29, P1310, DOI 10.1109/TMI.2010.2046908	29	38	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0129211	10.1371/journal.pone.0129211	http://dx.doi.org/10.1371/journal.pone.0129211			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161961	gold, Green Published			2022-12-26	WOS:000358162300008
J	Rao, ES; Kadirvel, P; Symonds, RC; Geethanjali, S; Thontadarya, RN; Ebert, AW				Rao, Eguru Sreenivasa; Kadirvel, Palchamy; Symonds, Rachael C.; Geethanjali, Subramaniam; Thontadarya, Ramadihalli N.; Ebert, Andreas W.			Variations in DREB1A and VP1.1 Genes Show Association with Salt Tolerance Traits in Wild Tomato (Solanum pimpinellifolium)	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SALINITY TOLERANCE; TRANSCRIPTION FACTORS; FUNCTIONAL-ANALYSIS; STRESS TOLERANCE; POPULATION-STRUCTURE; EXPRESSION; RICE; DROUGHT; PLANTS	Association analysis was conducted in a core collection of 94 genotypes of Solanum pimpinellifolium to identify variations linked to salt tolerance traits (physiological and yield traits under salt stress) in four candidate genes viz., DREB1A, VP1.1, NHX1, and TIP. The candidate gene analysis covered a concatenated length of 4594 bp per individual and identified five SNP/Indels in DREB1A and VP1.1 genes explaining 17.0% to 25.8% phenotypic variation for various salt tolerance traits. Out of these five alleles, one at 297 bp in DREB1A had in-frame deletion of 6 bp (CTGCAT) or 12 bp (CTGCATCTGCAT), resulting in two alleles, viz., SpDREB1A_297_6 and SpDREB1A_297_12. These alleles individually or as haplotypes accounted for maximum phenotypic variance of about 25% for various salt tolerance traits. Design of markers for selection of the favorable alleles/haplotypes will hasten markerassisted introgression of salt tolerance from S. pimpinellifolium into cultivated tomato.	[Rao, Eguru Sreenivasa; Thontadarya, Ramadihalli N.] ICAR Indian Inst Hort Res, Div Vegetable Crops, Bengaluru, India; [Kadirvel, Palchamy] ICAR Indian Inst Oilseeds Res, Crop Improvement Sect, Hyderabad, Andhra Pradesh, India; [Symonds, Rachael C.] Univ Nottingham, Sch Biosci, Selangor, Darul Ehsan, Malaysia; [Geethanjali, Subramaniam] Tamil Nadu Agr Univ, Dept Millets, Ctr Plant Breeding & Genet, Coimbatore 641003, Tamil Nadu, India; [Rao, Eguru Sreenivasa; Kadirvel, Palchamy; Symonds, Rachael C.; Geethanjali, Subramaniam; Ebert, Andreas W.] AVRDC, Genet Resources & Seed Unit, Tainan, Taiwan	Indian Council of Agricultural Research (ICAR); ICAR - Indian Institute of Horticultural Research; Indian Council of Agricultural Research (ICAR); ICAR - Indian Institute of Oilseeds Research; University of Nottingham Malaysia; Tamil Nadu Agricultural University	Ebert, AW (corresponding author), AVRDC, Genet Resources & Seed Unit, Tainan, Taiwan.	Andreas.ebert@worldveg.org	Ebert, Andreas/J-6613-2019; Palchamy, Kadirvel/AAN-5960-2020	Ebert, Andreas/0000-0001-8146-3813; Palchamy, Kadirvel/0000-0003-4907-2796	program "Better Opportunities for Young Scientists in Chosen Area of Science and Technology (BOYSCAST)"; Department of Science & Technology of the government of India; Global Theme Germplasm of AVRDC - The World Vegetable Center	program "Better Opportunities for Young Scientists in Chosen Area of Science and Technology (BOYSCAST)"; Department of Science & Technology of the government of India; Global Theme Germplasm of AVRDC - The World Vegetable Center	This study was partially funded by a grant provided to Dr. Eguru Sreenivasa Rao under the program "Better Opportunities for Young Scientists in Chosen Area of Science and Technology (BOYSCAST)". The grant was provided by the Department of Science & Technology of the government of India and covered Dr. Rao's travel costs and living expenses at AVRDC - The World Vegetable Center. All funding for the implementation of the experiments, such as equipment, greenhouse space, materials and chemicals, was provided by Global Theme Germplasm of AVRDC - The World Vegetable Center. The external and internal funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrama HA, 2007, MOL BREEDING, V19, P341, DOI 10.1007/s11032-006-9066-6; Akhtar M, 2012, J GENET, V91, P385, DOI 10.1007/s12041-012-0201-3; Andersen JR, 2003, TRENDS PLANT SCI, V8, P554, DOI 10.1016/j.tplants.2003.09.010; [Anonymous], 2014, AVRDC VEGETABLE GENE; [Anonymous], 1994, GENRES DATA ENTRY MO; Apse MP, 1999, SCIENCE, V285, P1256, DOI 10.1126/science.285.5431.1256; Bagge M, 2008, MOL BREEDING, V22, P319, DOI 10.1007/s11032-008-9190-6; BAKER SS, 1994, PLANT MOL BIOL, V24, P701, DOI 10.1007/BF00029852; Barendse W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029601; Barragan V, 2012, PLANT CELL, V24, P1127, DOI 10.1105/tpc.111.095273; Bassil E, 2012, J EXP BOT, V63, P5727, DOI 10.1093/jxb/ers250; Bauchet G, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0279-2; Bharati Pandey, 2014, Australian Journal of Crop Science, V8, P44; Bhaskaran S, 2011, J EXP BOT, V62, P5561, DOI 10.1093/jxb/err237; Blanca J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048198; BOLARIN MC, 1991, J AM SOC HORTIC SCI, V116, P286, DOI 10.21273/JASHS.116.2.286; Bonilla P, 2002, PHILIPP AGRIC SCI, V85, P68; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Breseghello F, 2006, GENETICS, V172, P1165, DOI 10.1534/genetics.105.044586; Celebi-Toprak F, 2005, BREEDING SCI, V55, P311, DOI 10.1270/jsbbs.55.311; Cong L, 2008, PLANT SCI, V174, P156, DOI 10.1016/j.plantsci.2007.11.002; CUARTERO J, 1992, NEW PHYTOL, V121, P63, DOI 10.1111/j.1469-8137.1992.tb01093.x; EDAE EA, 2013, PLANT GENOME, V6, P1; Erskine W, 2014, CABI CLIM CHANGE SER, V4, P236, DOI 10.1079/9781780641973.0236; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Flint-Garcia SA, 2005, PLANT J, V44, P1054, DOI 10.1111/j.1365-313X.2005.02591.x; Foolad MR, 2004, PLANT CELL TISS ORG, V76, P101, DOI 10.1023/B:TICU.0000007308.47608.88; Gamerman D, 2006, MARKOV CHAIN MONTE C; Gaxiola RA, 2001, P NATL ACAD SCI USA, V98, P11444, DOI 10.1073/pnas.191389398; Geethanjali S, 2011, EUPHYTICA, V178, P283, DOI 10.1007/s10681-010-0331-8; Gowda M, 2014, HEREDITY, V112, P552, DOI 10.1038/hdy.2013.139; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hamwieh A, 2011, EUPHYTICA, V179, P451, DOI 10.1007/s10681-011-0347-8; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Hsieh TH, 2002, PLANT PHYSIOL, V130, P618, DOI 10.1104/pp.006783; Huang XS, 2011, J EXP BOT, V62, P5191, DOI 10.1093/jxb/err229; Ito Y, 2006, PLANT CELL PHYSIOL, V47, P141, DOI 10.1093/pcp/pci230; Galvez FJ, 2012, PLANT PHYSIOL BIOCH, V51, P109, DOI 10.1016/j.plaphy.2011.10.012; Jia L, 2012, PLOS ONE, V7, P1; Kasuga M, 1999, NAT BIOTECHNOL, V17, P287, DOI 10.1038/7036; Kumar V, 2015, DNA RES, V22, P133, DOI 10.1093/dnares/dsu046; Latini A, 2007, ANN APPL BIOL, V150, P187, DOI 10.1111/j.1744-7348.2007.00128.x; Leidi EO, 2010, PLANT J, V61, P495, DOI 10.1111/j.1365-313X.2009.04073.x; Li YL, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-146; Linh Le Hung, 2012, Int J Plant Genomics, V2012, P949038, DOI 10.1155/2012/949038; Liu Q, 1998, PLANT CELL, V10, P1391, DOI 10.1105/tpc.10.8.1391; Matsukura S, 2010, MOL GENET GENOMICS, V283, P185, DOI 10.1007/s00438-009-0506-y; Munns R, 2003, PLANT SOIL, V253, P201, DOI 10.1023/A:1024553303144; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Myles S, 2009, PLANT CELL, V21, P2194, DOI 10.1105/tpc.109.068437; Negrao S, 2013, PLANT BIOTECHNOL J, V11, P87, DOI 10.1111/pbi.12010; Long NV, 2013, THEOR APPL GENET, V126, P2335, DOI 10.1007/s00122-013-2139-0; Olsen KM, 2002, GENETICS, V162, P941; Pardo JM, 2010, CURR OPIN BIOTECH, V21, P185, DOI 10.1016/j.copbio.2010.02.005; Parida AK, 2005, ECOTOX ENVIRON SAFE, V60, P324, DOI 10.1016/j.ecoenv.2004.06.010; Peleg Z, 2011, ADV BOT RES, V57, P405, DOI 10.1016/B978-0-12-387692-8.00012-6; Pritchard JK, 2000, GENETICS, V155, P945; Qi XP, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5340; Qin F, 2004, PLANT CELL PHYSIOL, V45, P1042, DOI 10.1093/pcp/pch118; Qin F, 2007, PLANT J, V50, P54, DOI 10.1111/j.1365-313X.2007.03034.x; Ranc N, 2012, G3-GENES GENOM GENET, V2, P853, DOI 10.1534/g3.112.002667; Rao ES, 2013, EUPHYTICA, V190, P215, DOI 10.1007/s10681-012-0801-2; Rao ES, 2012, PLANT GENET RESOUR-C, V10, P38, DOI 10.1017/S1479262111000955; Reeves PA, 2012, THEOR APPL GENET, V124, P1155, DOI 10.1007/s00122-011-1776-4; Reuscher S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079052; Ritland K, 1996, GENET RES, V67, P175, DOI 10.1017/S0016672300033620; Roy SJ, 2014, CURR OPIN BIOTECH, V26, P115, DOI 10.1016/j.copbio.2013.12.004; Rozen S, 2000, Methods Mol Biol, V132, P365; Sade N, 2009, NEW PHYTOL, V181, P651, DOI 10.1111/j.1469-8137.2008.02689.x; SARAFIAN V, 1992, P NATL ACAD SCI USA, V89, P1775, DOI 10.1073/pnas.89.5.1775; Sauvage C, 2014, PLANT PHYSIOL, V165, P1120, DOI 10.1104/pp.114.241521; Scholberg JMS, 1999, HORTSCIENCE, V34, P259, DOI 10.21273/HORTSCI.34.2.259; SLAVICH PG, 1993, AUST J SOIL RES, V31, P73, DOI 10.1071/SR9930073; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; TAJIMA F, 1989, GENETICS, V123, P585; TAL M, 1983, AUST J PLANT PHYSIOL, V10, P109, DOI 10.1071/PP9830109; Tanaka Y, 1999, PLANT SCI, V148, P131, DOI 10.1016/S0168-9452(99)00133-8; Tavakkoli E, 2011, J EXP BOT, V62, P2189, DOI 10.1093/jxb/erq422; Thornsberry JM, 2001, NAT GENET, V28, P286, DOI 10.1038/90135; Xin SC, 2014, J PLANT RES, V127, P695, DOI 10.1007/s10265-014-0658-7; Yu JM, 2009, PLANT GENOME-US, V2, P63, DOI 10.3835/plantgenome2008.09.0009; Yu JM, 2006, CURR OPIN BIOTECH, V17, P155, DOI 10.1016/j.copbio.2006.02.003; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhang HX, 2001, NAT BIOTECHNOL, V19, P765, DOI 10.1038/90824; Zuriaga E, 2009, GENET RESOUR CROP EV, V56, P39, DOI 10.1007/s10722-008-9340-z	85	16	16	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132535	10.1371/journal.pone.0132535	http://dx.doi.org/10.1371/journal.pone.0132535			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161546	Green Submitted, Green Published, gold			2022-12-26	WOS:000358162300148
J	Soriano, S; Villa, P; Delagnes, A; Degano, I; Pollarolo, L; Lucejko, JJ; Henshilwood, C; Wadley, L				Soriano, Sylvain; Villa, Paola; Delagnes, Anne; Degano, Ilaria; Pollarolo, Luca; Lucejko, Jeannette J.; Henshilwood, Christopher; Wadley, Lyn			The Still Bay and Howiesons Poort at Sibudu and Blombos: Understanding Middle Stone Age Technologies	PLOS ONE			English	Article							DIEPKLOOF ROCK SHELTER; MODERN HUMAN-BEHAVIOR; ROSE COTTAGE CAVE; SOUTH-AFRICA; LATE PLEISTOCENE; WESTERN CAPE; ADDITIONAL EVIDENCE; HUNTING WEAPONS; KLASIES RIVER; CHRONOLOGY	The classification of archaeological assemblages in the Middle Stone Age of South Africa in terms of diversity and temporal continuity has significant implications with respect to recent cultural evolutionary models which propose either gradual accumulation or discontinuous, episodic processes for the emergence and diffusion of cultural traits. We present the results of a systematic technological and typological analysis of the Still Bay assemblages from Sibudu and Blombos. A similar approach is used in the analysis of the Howiesons Poort (HP) assemblages from Sibudu seen in comparison with broadly contemporaneous assemblages from Rose Cottage and Klasies River Cave 1A. Using our own and published data from other sites we report on the diversity between stone artifact assemblages and discuss to what extent they can be grouped into homogeneous lithic sets. The gradual evolution of debitage techniques within the Howiesons Poort sequence with a progressive abandonment of the HP technological style argues against the saltational model for its disappearance while the technological differences between the Sibudu and Blombos Still Bay artifacts considerably weaken an interpretation of similarities between the assemblages and their grouping into the same cultural unit. Limited sampling of a fragmented record may explain why simple models of cultural evolution do not seem to apply to a complex reality.	[Soriano, Sylvain] Univ Paris Ouest, CNRS, AnTET, ArScAn, F-92023 Nanterre, France; [Villa, Paola] Univ Colorado Museum, Boulder, CO 80309 USA; [Villa, Paola; Pollarolo, Luca] Univ Witwatersrand, Sch Geog Archaeol & Environm Studies, ZA-2050 Johannesburg, South Africa; [Villa, Paola; Delagnes, Anne] Univ Bordeaux, PACEA, CNRS, F-33615 Pessac, France; [Delagnes, Anne; Henshilwood, Christopher; Wadley, Lyn] Univ Witwatersrand, Evolutionary Studies Inst, ZA-2050 Johannesburg, South Africa; [Degano, Ilaria; Lucejko, Jeannette J.] Univ Pisa, Dipartimento Chim & Chim Ind, I-56126 Pisa, Italy; [Pollarolo, Luca] Univ Geneva, Dept Genet & Evolut, Anthropol Unit, Lab Archeol & Peuplement Afrique, CH-1211 Geneva 4, Switzerland; [Wadley, Lyn] Univ Bergen, Inst Archaeol Hist Culture & Religious Studies, N-5007 Bergen, Norway	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of Colorado System; University of Colorado Boulder; University of Witwatersrand; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; University of Witwatersrand; University of Pisa; University of Geneva; University of Bergen	Soriano, S (corresponding author), Univ Paris Ouest, CNRS, AnTET, ArScAn, F-92023 Nanterre, France.	sylvain.soriano@mae.u-paris10.fr	Degano, Ilaria/F-9184-2012; LUCEJKO, Jeannette Jacqueline/ABA-4451-2020; Henshilwood, Christopher S/K-3806-2014; Lucejko, Jeannette/H-1585-2012; Wadley, Lyn/AAC-6577-2022	Degano, Ilaria/0000-0002-3585-8555; LUCEJKO, Jeannette Jacqueline/0000-0002-7717-4039; Henshilwood, Christopher S/0000-0002-2818-293X; Lucejko, Jeannette/0000-0002-7717-4039; Soriano, Sylvain/0000-0002-4288-9763; POLLAROLO, LUCA/0000-0001-9449-5937	National Science Foundation [BCS 0613319]; Wenner-Gren Foundation; Paleontological Scientific Trust; Frison Institute; School of Geography, Archaeology and Environmental Sciences, University of the Witwatersrand; European Research Council Advanced Grant, TRACSYMBOLS, under the FP7 programme at the University of Bergen, Norway [249587]; National Research Foundation/Department of Science and Technology funded Chair at the University of the Witwatersrand, South Africa; Scatterlings of Africa programme	National Science Foundation(National Science Foundation (NSF)); Wenner-Gren Foundation; Paleontological Scientific Trust; Frison Institute; School of Geography, Archaeology and Environmental Sciences, University of the Witwatersrand; European Research Council Advanced Grant, TRACSYMBOLS, under the FP7 programme at the University of Bergen, Norway; National Research Foundation/Department of Science and Technology funded Chair at the University of the Witwatersrand, South Africa; Scatterlings of Africa programme	Research of PV, SS, and AD at Sibudu was funded by a grant from the National Science Foundation (BCS 0613319 to PV). PV's research was also funded by the Wenner-Gren Foundation, the Paleontological Scientific Trust, and the Frison Institute. The Paleontological Scientific Trust with its Scatterlings of Africa programme supported LP with postdoctoral funding in 2008. PV and LP acknowledge support from the School of Geography, Archaeology and Environmental Sciences, University of the Witwatersrand. Financial support for CSH was provided by a European Research Council Advanced Grant, TRACSYMBOLS No. 249587, awarded under the FP7 programme at the University of Bergen, Norway, and by a National Research Foundation/Department of Science and Technology funded Chair at the University of the Witwatersrand, South Africa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLARD M, 1993, PALEO, V5, P179; Allott L.F., 2006, S AFR HUMANIT, V18, P173; Ambrose S.H., 2002, THINKING SMALL GLOBA, V12, P9; Andreotti A, 2006, ANAL CHEM, V78, P4490, DOI 10.1021/ac0519615; Astakhov VP, 2006, TRIBOL INTER ENG, V52, P1; Astakhov VP, 2010, SPRINGER SER ADV MAN, P1, DOI 10.1007/978-1-84996-053-3; Aubry T, 2008, WORLD ARCHAEOL, V40, P48, DOI 10.1080/00438240701843538; Boeda E, 2004, APPROCHES FONCTIONNE, P293; Boeda E., 2005, AROBASE, V1, P46; Boeda E., 1997, HABILITATION DIRIGER, V1; Bradley B, 1974, CASPER SITE HELL GAP, P191; Burger P, 2011, ARCHAEOL ANTHROP SCI, V3, P185, DOI 10.1007/s12520-010-0050-z; Callahan E., 1979, ARCHAEOLOGY E N AM, V7, P1; Charrie-Duhaut A, 2013, J ARCHAEOL SCI, V40, P3506, DOI 10.1016/j.jas.2012.12.026; Clark J.D., 1966, S AFRICAN ARCHAEOLOG, V21, P114, DOI [https://doi.org/10.2307/3888427, DOI 10.2307/3888427]; COTTERELL B, 1987, AM ANTIQUITY, V52, P675, DOI 10.2307/281378; d'Errico F, 2005, J HUM EVOL, V48, P3, DOI 10.1016/j.jhevol.2004.09.002; d'Errico F, 2008, J ARCHAEOL SCI, V35, P2675, DOI 10.1016/j.jas.2008.04.023; d'Errico F, 2007, J HUM EVOL, V52, P142, DOI 10.1016/j.jhevol.2006.08.003; d'Errico F, 2011, PHILOS T R SOC B, V366, P1060, DOI 10.1098/rstb.2010.0340; de la Pen~a P., 2013, S AFR ARCHAEOL BULL, V68, P119; Deacon J, 1995, S AFRICAN ARCHAEOLOG, V50, P110, DOI DOI 10.2307/3889060; Delagnes A., 2006, SO AFRICAN HUMANITIE, V18, P43; Delagnes A., 2007, NEANDERTALIENS BIOLO, V23, P213; Evans U., 1994, S AFR FIELD ARCHAEOL, V3, P63; Faivre JP, 2014, QUATERN INT, V350, P227, DOI 10.1016/j.quaint.2014.05.048; Feblot-Augustins J., 1999, MIDDLE PALAEOLITHIC, P193; Fischer A., 1984, J DAN ARCHAEOL, V3, P19, DOI [10.1080/0108464X.1984.10589910, DOI 10.1080/0108464X.1984.10589910]; Frison G.C., 1980, FOLSOM TOOLS TECHNOL; Galbraith RF, 2015, J HUM EVOL, V80, P184, DOI 10.1016/j.jhevol.2014.10.006; Geneste J-M, 1990, FEUILLES PIERRE IND, P293; Gibson N. E., 2004, SOUTH AFR HUMANIT, V16, P1; Goldberg P, 2009, ARCHAEOL ANTHROP SCI, V1, P95, DOI 10.1007/s12520-009-0008-1; Grine FE, 2002, J HUM EVOL, V42, P293, DOI 10.1006/jhev.2001.0525; Grun R, 2003, J HUM EVOL, V45, P155, DOI 10.1016/S0047-2484(03)00102-7; Guerin G, 2013, J HUM EVOL, V64, P314, DOI 10.1016/j.jhevol.2013.01.006; Haaland M.M., 2012, THESIS U BERGEN; Harper PTN, 1997, S AFR J SCI, V93, P470; Henshilwood C, 2004, SCIENCE, V304, P404, DOI 10.1126/science.1095905; Henshilwood CS, 2014, J ARCHAEOL SCI, V45, P284, DOI 10.1016/j.jas.2014.01.033; Henshilwood CS, 2012, J WORLD PREHIST, V25, P205, DOI 10.1007/s10963-012-9060-3; Henshilwood CS, 2009, J HUM EVOL, V57, P27, DOI 10.1016/j.jhevol.2009.01.005; Henshilwood CS, 2001, J HUM EVOL, V41, P631, DOI 10.1006/jhev.2001.0515; Henshilwood CS, 2002, SCIENCE, V295, P1278, DOI 10.1126/science.1067575; Henshilwood CS, 2001, J ARCHAEOL SCI, V28, P421, DOI 10.1006/jasc.2000.0638; Henshilwood CS, 2008, S AFRICA EXCAVATIONS; Hogberg A, 2011, J HUM EVOL, V61, P133, DOI 10.1016/j.jhevol.2011.02.006; Inizan Marie -Louise, 1999, PRE HIST PIERRE TAIL; Jacobs Z, 2008, SCIENCE, V322, P733, DOI 10.1126/science.1162219; Jacobs Z, 2006, J HUM EVOL, V51, P255, DOI 10.1016/j.jhevol.2006.03.007; Jacobs Z, 2015, J ARCHAEOL SCI, V63, P175, DOI 10.1016/j.jas.2015.01.023; Jacobs Z, 2013, J ARCHAEOL SCI, V40, P579, DOI 10.1016/j.jas.2012.06.037; Johnson J. K., 1979, LITHIC TECHNOL, VVIII, P25; Kleindienst MR, 2006, INTERD CONTRIB ARCH, P13, DOI 10.1007/0-387-24661-4_2; Koch John T., 2006, CELTIC CULTURE HIST; Liuveras A, 2010, ANAL CHEM, V82, P376, DOI 10.1021/ac902141m; Lombard M., 2006, SOUTH AFR HUMANIT, V18, P27; Lombard M, 2008, J ARCHAEOL SCI, V35, P26, DOI 10.1016/j.jas.2007.02.021; Lombard M, 2007, J HUM EVOL, V53, P406, DOI 10.1016/j.jhevol.2007.05.004; Lombard M, 2010, ANTIQUITY, V84, P635, DOI 10.1017/S0003598X00100134; Lombard M, 2010, J ARCHAEOL SCI, V37, P1773, DOI 10.1016/j.jas.2010.02.015; MARKS AE, 2003, MORE MEETS EYE STUDI, P265; McCall GS, 2012, AFR ARCHAEOL REV, V29, P7, DOI 10.1007/s10437-012-9107-y; Minichillo, 2005, THESIS U WASHINGTON; Mourre V, 2010, SCIENCE, V330, P659, DOI 10.1126/science.1195550; NEWCOMER MH, 1971, WORLD ARCHAEOL, V3, P85, DOI 10.1080/00438243.1971.9979493; Pargeter J, 2007, S AFR ARCHAEOL BULL, V62, P147, DOI 10.2307/20474970; Pelcin AW, 1997, J ARCHAEOL SCI, V24, P1107, DOI 10.1006/jasc.1996.0190; Pelegrin J., 2000, MEMOIRES PREHISTOIRE, P73; Pelegrin J., 1991, ACT C INT EXP ARCH B, P118; Porraz G, 2014, TRANSITIONS RUPTURES, P155; Porraz G., 2008, S AFRICAN ARCHAEOLOG, V10, P105; Porraz G, 2013, J ARCHAEOL SCI, V40, P3542, DOI 10.1016/j.jas.2013.02.024; Porraz G, 2013, J ARCHAEOL SCI, V40, P3376, DOI 10.1016/j.jas.2013.02.012; Powell A, 2009, SCIENCE, V324, P1298, DOI 10.1126/science.1170165; Renard C, 2011, WORLD ARCHAEOL, V43, P726, DOI 10.1080/00438243.2011.624789; Shea JJ, 2014, QUATERN INT, V350, P169, DOI 10.1016/j.quaint.2014.01.024; Singer R., 1982, MIDDLE STONE AGE KLA; Soressi M., 2002, THESIS U BORDEAUX 1; Soriano S., 1998, GALL PR HIST, V40, P75, DOI [DOI 10.3406/GALIP.1998.2158, 10.3406/galip.1998.2158]; Soriano S., 2000, THESIS U PARIS X NAN; Soriano S, 2007, J ARCHAEOL SCI, V34, P681, DOI 10.1016/j.jas.2006.06.017; Soriano S, 2009, J AFR ARCHAEOL, V7, P41, DOI 10.3213/1612-1651-10121; Texier PJ, 2010, P NATL ACAD SCI USA, V107, P6180, DOI 10.1073/pnas.0913047107; Tiffagom M., 1998, PALEO, V10, P147, DOI DOI 10.3406/PAL.1998.1134; Todd, 1987, HORNER SITE TYPE SIT, P199; Tribolo C, 2013, J ARCHAEOL SCI, V40, P3401, DOI 10.1016/j.jas.2012.12.001; Vanhaeren M, 2013, J HUM EVOL, V64, P500, DOI 10.1016/j.jhevol.2013.02.001; Villa P, 2005, J ARCHAEOL SCI, V32, P399, DOI 10.1016/j.jas.2004.11.007; Villa P, 2010, J ARCHAEOL SCI, V37, P630, DOI 10.1016/j.jas.2009.10.028; Villa P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096424; Villa P, 2012, P NATL ACAD SCI USA, V109, P13208, DOI 10.1073/pnas.1202629109; Villa P, 2010, J ANTHROPOL RES, V66, P5, DOI 10.3998/jar.0521004.0066.102; Villa P, 2009, J ARCHAEOL SCI, V36, P850, DOI 10.1016/j.jas.2008.11.012; Villa P, 2009, J ARCHAEOL SCI, V36, P441, DOI 10.1016/j.jas.2008.09.028; Vogelsang R, 2010, J AFR ARCHAEOL, V8, P185, DOI 10.3213/1612-1651-10170; Wadley L, 2005, S AFR ARCHAEOL BULL, V60, P51; WADLEY L, 1992, S AFR J SCI, V88, P558; Wadley L, 2006, SOUTH AFR HUMANIT, V18, P1; Wadley L., 1989, S AFR ARCHAEOL BULL, V44, P23, DOI DOI 10.2307/3888316; Wadley L, 2008, S AFRICAN ARCHAEOLOG, V1, P122; Wadley L, 2008, J ARCHAEOL SCI, V35, P2594, DOI 10.1016/j.jas.2008.04.017; Wadley L, 2007, J HUM EVOL, V52, P681, DOI 10.1016/j.jhevol.2007.01.002; Wadley L, 2012, SOUTH AFR HUMANIT, V24, P79; Wadley L, 2011, SOUTH AFR HUMANIT, V23, P87; Wadley L, 2012, QUATERN INT, V247, P341, DOI 10.1016/j.quaint.2010.10.026; Wadley L, 2010, J ARCHAEOL SCI, V37, P2397, DOI 10.1016/j.jas.2010.04.012; Wadley L, 2010, J HUM EVOL, V58, P179, DOI 10.1016/j.jhevol.2009.10.004; Wadley L, 2009, P NATL ACAD SCI USA, V106, P9590, DOI 10.1073/pnas.0900957106; Wurz S, 2007, SOUTH AFR HUMANIT, V19, P1; Yaroshevich A, 2010, J ARCHAEOL SCI, V37, P368, DOI 10.1016/j.jas.2009.09.050	111	66	67	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131127	10.1371/journal.pone.0131127	http://dx.doi.org/10.1371/journal.pone.0131127			46	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CN1FD	26161665	Green Published, Green Submitted, gold			2022-12-26	WOS:000358162300029
J	Crittenden, AN; Zes, DA				Crittenden, Alyssa N.; Zes, David A.			Food Sharing among Hadza Hunter-Gatherer Children	PLOS ONE			English	Article							RECIPROCAL ALTRUISM; KIN SELECTION; EVOLUTION; COOPERATION; EGALITARIANISM; SOCIETIES; TRANSFERS	Human prosociality is one of the defining characteristics of our species, yet the ontogeny of altruistic behavior remains poorly understood. The evolution of widespread food sharing in humans helped shape cooperation, family formation, life history, language, and the development of economies of scale. While the behavioral and ecological correlates of food sharing among adults are widely studied, very little is known about food sharing among children. Here, in the first study to analyze the food sharing patterns of hunter-gatherer children, we show that while sharing may be biased towards kin, reciprocity characterizes the majority of all sharing dyads, both related and unrelated. These data lend support to the recent claim that discrimination among kin might be linked with reciprocal altruism theory. Furthermore, we show that age positively correlates with an increase in sharing, both in frequency and amount, supporting recent suggestions that prosocial behaviors and egalitarianism develop strongly in middle childhood when children acquire the normative rules of their society.	[Crittenden, Alyssa N.] Univ Nevada, Dept Anthropol, Las Vegas, NV 89154 USA; [Zes, David A.] Univ Calif Los Angeles, Dept Ecol Stat, Los Angeles, CA USA	Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; University of California System; University of California Los Angeles	Crittenden, AN (corresponding author), Univ Nevada, Dept Anthropol, Las Vegas, NV 89154 USA.	alyssa.crittenden@unlv.edu			National Science Foundation grant [0544751]; National Institutes of Health General Medical Sciences grant [8 P20 GM103440-11]; Department of Anthropology at the University of California, San Diego; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103440] Funding Source: NIH RePORTER	National Science Foundation grant(National Science Foundation (NSF)); National Institutes of Health General Medical Sciences grant; Department of Anthropology at the University of California, San Diego; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation grant #0544751 to Frank W. Marlowe, who paid for a portion of the field supplies and air travel of Alyssa N. Crittenden and assisted with research permit approval. Additional funding was received by Alyssa N. Crittenden from the Department of Anthropology at the University of California, San Diego, and National Institutes of Health General Medical Sciences grant #8 P20 GM103440-11. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen-Arave W, 2008, EVOL HUM BEHAV, V29, P305, DOI 10.1016/j.evolhumbehav.2008.03.002; Almas I, 2010, SCIENCE, V328, P1176, DOI 10.1126/science.1187300; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Betzig L, CURR ANTHR, V27, P397; Clutton-Brock T, 2009, NATURE, V462, P51, DOI 10.1038/nature08366; Conklin-Brittain Nancy Lou, 2006, P445; Crittenden AN, 2008, HUM NATURE-INT BIOS, V19, P249, DOI 10.1007/s12110-008-9043-3; Crittenden AN, 2013, EVOL HUM BEHAV, V34, P299, DOI 10.1016/j.evolhumbehav.2013.04.004; Crittenden AN, WILD PLANTS IN PRESS; Crittenden AN, SOCIAL LEAR IN PRESS; Crittenden AN, 2014, CUNA HUMANIDAD, P209; ENQUIST M, 1993, ANIM BEHAV, V45, P747, DOI 10.1006/anbe.1993.1089; Fehr E, 2008, NATURE, V454, P1079, DOI 10.1038/nature07155; Fehr E, 2013, EUR ECON REV, V64, P369, DOI 10.1016/j.euroecorev.2013.09.006; Gintis H, 2001, J THEOR BIOL, V213, P103, DOI 10.1006/jtbi.2001.2406; Gintis H, 2000, J THEOR BIOL, V206, P169, DOI 10.1006/jtbi.2000.2111; Gintis H, 1999, RECASTING EGALITARIA; Gurven M, 2004, BEHAV BRAIN SCI, V27, P543, DOI 10.1017/S0140525X04000123; Hames R, 2007, HUM NATURE-INT BIOS, V18, P1, DOI 10.1007/BF02820843; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Hawkes K, 2002, EVOL ANTHROPOL, V11, P58, DOI 10.1002/evan.20005; HAWKES K, 1991, ETHOL SOCIOBIOL, V12, P29, DOI 10.1016/0162-3095(91)90011-E; HAWKES K, 1983, AM ETHNOL, V10, P345, DOI 10.1525/ae.1983.10.2.02a00090; Hewlett BS, 2011, PHILOS T R SOC B, V366, P1168, DOI 10.1098/rstb.2010.0373; Hill KR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102806; Hoffman E, 1998, ECON INQ, V36, P335, DOI 10.1111/j.1465-7295.1998.tb01719.x; House BR, 2013, P NATL ACAD SCI USA, V110, P14586, DOI 10.1073/pnas.1221217110; ISAAC GL, 1978, J ANTHROPOL RES, V34, P311; Jaeggi AV, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1615; JELLIFFE DB, 1962, J PEDIATR-US, V60, P907, DOI 10.1016/S0022-3476(62)80176-0; KAPLAN H, 1985, CURR ANTHROPOL, V26, P223, DOI 10.1086/203251; Marlowe F., 2010, HADZA HUNTER GATHERE, DOI DOI 10.1152/physiol.00027.2018; O'Connell JF, 1999, J HUM EVOL, V36, P461, DOI 10.1006/jhev.1998.0285; Peterson D, 2012, LIGHT MILLION FIRES; Sahlins M., 1972, STONE AGE EC; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Winterhalder Bruce, 1996, Evolutionary Anthropology, V5, P46; Woodburn J, 2008, MAN HUNTER, P49	38	36	36	2	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2015	10	7							e0131996	10.1371/journal.pone.0131996	http://dx.doi.org/10.1371/journal.pone.0131996			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1EC	26151637	Green Published, gold, Green Submitted			2022-12-26	WOS:000358158900032
J	Gholami, M; Reimer, C; Erbe, M; Preisinger, R; Weigend, A; Weigend, S; Servin, B; Simianer, H				Gholami, Mahmood; Reimer, Christian; Erbe, Malena; Preisinger, Rudolf; Weigend, Annett; Weigend, Steffen; Servin, Bertrand; Simianer, Henner			Genome Scan for Selection in Structured Layer Chicken Populations Exploiting Linkage Disequilibrium Information	PLOS ONE			English	Article							POSITIVE SELECTION; GENE; ADAPTATION; POLYMORPHISM; ASSOCIATION; SIGNATURES; MODEL; TOOL	An increasing interest is being placed in the detection of genes, or genomic regions, that have been targeted by selection because identifying signatures of selection can lead to a better understanding of genotype-phenotype relationships. A common strategy for the detection of selection signatures is to compare samples from distinct populations and to search for genomic regions with outstanding genetic differentiation. The aim of this study was to detect selective signatures in layer chicken populations using a recently proposed approach, hapFLK, which exploits linkage disequilibrium information while accounting appropriately for the hierarchical structure of populations. We performed the analysis on 70 individuals from three commercial layer breeds (White Leghorn, White Rock and Rhode Island Red), genotyped for approximately 1 million SNPs. We found a total of 41 and 107 regions with outstanding differentiation or similarity using hapFLK and its single SNP counterpart FLK respectively. Annotation of selection signature regions revealed various genes and QTL corresponding to productions traits, for which layer breeds were selected. A number of the detected genes were associated with growth and carcass traits, including IGF-1R, AGRP and STAT5B. We also annotated an interesting gene associated with the dark brown feather color mutational phenotype in chickens (SOX10). We compared FST, FLK and hapFLK and demonstrated that exploiting linkage disequilibrium information and accounting for hierarchical population structure decreased the false detection rate.	[Gholami, Mahmood; Reimer, Christian; Erbe, Malena; Simianer, Henner] Univ Gottingen, Dept Anim Sci, Anim Breeding & Genet Grp, D-37073 Gottingen, Germany; [Preisinger, Rudolf] LOHMANN Tierzucht GMBH, Cuxhaven, Germany; [Weigend, Annett; Weigend, Steffen] FLI, Inst Farm Anim Genet ING, Neustadt, Germany; [Servin, Bertrand] INRA, Lab Genet Physiol & Syst Elevage, Castanet Tolosan, France	University of Gottingen; Friedrich Loeffler Institute; INRAE	Gholami, M (corresponding author), Univ Gottingen, Dept Anim Sci, Anim Breeding & Genet Grp, D-37073 Gottingen, Germany.	mgholam@gwdg.de	Servin, Bertrand/B-2206-2008; Simianer, Henner/A-6574-2015	Servin, Bertrand/0000-0001-5141-0913; Simianer, Henner/0000-0002-7551-3797	German Federal Ministry of Education and Research [0315528C]; German Research Foundation; Gottingen University	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Research Foundation(German Research Foundation (DFG)); Gottingen University	This research was funded by the German Federal Ministry of Education and Research within the AgroClustEr "Synbreed - Synergistic plant and animal breeding" (Funding ID: 0315528C). We acknowledge support by the German Research Foundation and the Open Access Publication Funds of the Gottingen University.	Akey JM, 2009, GENOME RES, V19, P711, DOI 10.1101/gr.086652.108; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bai YC, 2012, MOL BIOL REP, V39, P7533, DOI 10.1007/s11033-012-1587-y; Bassom F, 2009, MINI ENCYCLOPEDIA OF; Beaumont MA, 2004, MOL ECOL, V13, P969, DOI 10.1111/j.1365-294X.2004.02125.x; Bonhomme M, 2010, GENETICS, V186, P241, DOI 10.1534/genetics.104.117275; Brown WRA, 2003, NAT REV GENET, V4, P87, DOI 10.1038/nrg998; Browning SR, 2010, GENETICS, V185, P1337, DOI 10.1534/genetics.110.116681; Burt DW, 2005, GENOME RES, V15, P1692, DOI 10.1101/gr.4141805; Clarke BR, 2012, STAT PAP, V53, P1001, DOI 10.1007/s00362-011-0404-3; Crawford R, 1990, POULTRY BREEDING AND; Durinck S, R PACKAGE VERSION 26; Elferink MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032720; Eyras E, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-131; Fariello MI, 2013, GENETICS, V193, P929, DOI 10.1534/genetics.112.147231; Fisher RA, 1922, J R STAT SOC, V85, P87, DOI 10.2307/2340521; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Gautron J, 2011, BIOCHEM SOC T, V39, P971, DOI 10.1042/BST0390971; Gholami M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094509; Gunnarsson U, 2011, PIGM CELL MELANOMA R, V24, P268, DOI 10.1111/j.1755-148X.2011.00825.x; Hu ZL, 2013, NUCLEIC ACIDS RES, V41, pD871, DOI 10.1093/nar/gks1150; Innan H, 2008, GENETICS, V179, P1713, DOI 10.1534/genetics.108.086835; Jiao S, 2013, MOL CELL BIOCHEM, V373, P107, DOI 10.1007/s11010-012-1479-4; Johansson AM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001188; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; KAPLAN NL, 1989, GENETICS, V123, P887; Kim S, 2009, MOL IMMUNOL, V47, P476, DOI 10.1016/j.molimm.2009.08.027; Kim Y, 2004, GENETICS, V167, P1513, DOI 10.1534/genetics.103.025387; Lei MM, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-70; LEWONTIN RC, 1973, GENETICS, V74, P175; Ma Y, 2015, HEREDITY, V115, P426, DOI 10.1038/hdy.2015.42; Muir Wi. M, 2003, POULTRY GENETICS BRE; Narum SR, 2011, MOL ECOL RESOUR, V11, P184, DOI 10.1111/j.1755-0998.2011.02987.x; Nielsen R, 2005, ANNU REV GENET, V39, P197, DOI 10.1146/annurev.genet.39.073003.112420; Nielsen R, 2013, AN INTRODUCTION TO P; Nuzhdin SV, 2013, CURR OPIN GENET DEV, V23, P694, DOI 10.1016/j.gde.2013.10.002; Price AL, 2010, NAT REV GENET, V11, P459, DOI 10.1038/nrg2813; Pritchard JK, 2010, CURR BIOL, V20, pR208, DOI 10.1016/j.cub.2009.11.055; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qanbari S, LIVEST SCI; Qanbari S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049525; Qanbari S, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-103; REYNOLDS J, 1983, GENETICS, V105, P767; Rubin CJ, 2010, NATURE, V464, P587, DOI 10.1038/nature08832; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Xu PW, 2012, PHYSIOL BEHAV, V105, P276, DOI 10.1016/j.physbeh.2011.06.023; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371; Zhao XH, 2012, MOL BIOL REP, V39, P4177, DOI 10.1007/s11033-011-1202-7; Zhou H, 2011, STAT COMPUT, V21, P261, DOI 10.1007/s11222-009-9166-3	53	15	16	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2015	10	7							e0130497	10.1371/journal.pone.0130497	http://dx.doi.org/10.1371/journal.pone.0130497			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EC	26151449	Green Published, gold, Green Submitted			2022-12-26	WOS:000358158900010
J	Lewandowski, D; Ruszkowski, P; Pinska, A; Schroeder, G; Kurczewska, J				Lewandowski, Dawid; Ruszkowski, Piotr; Pinska, Anita; Schroeder, Grzegorz; Kurczewska, Joanna			SBA-15 Mesoporous Silica Modified with Gallic Acid and Evaluation of Its Cytotoxic Activity	PLOS ONE			English	Article							SURFACE FUNCTIONALIZATION; ANTICANCER; NANOPARTICLES; ADSORPTION; PH; DELIVERY; INSIGHTS; RELEASE; AGENTS	Gallic acid has been covalently conjugated to SBA-15 mesoporous silica surface through different linkers. Cytotoxic activity of the hybrid organic-inorganic systems against HeLa and KB cell lines has been analyzed. Up to 67% of HeLa or KB tumor cells growth inhibition has been achieved at low silica concentration used (10 mu gmL(-1)).	[Lewandowski, Dawid; Schroeder, Grzegorz; Kurczewska, Joanna] Adam Mickiewicz Univ, Fac Chem, PL-60780 Poznan, Poland; [Ruszkowski, Piotr; Pinska, Anita] Poznan Univ Med Sci, Fac Pharm, Poznan, Poland	Adam Mickiewicz University; Poznan University of Medical Sciences	Lewandowski, D (corresponding author), Adam Mickiewicz Univ, Fac Chem, Grunwaldzka 6, PL-60780 Poznan, Poland.	dawid_le@amu.edu.pl	Kurczewska, Joanna/C-6259-2014	Kurczewska, Joanna/0000-0002-9046-3230; Ruszkowski, Piotr/0000-0002-5106-8510; Schroeder, Grzegorz/0000-0002-6626-9542	Polish National Science Center (NCN) [2011/03/B/ST5/01573]	Polish National Science Center (NCN)	This work was supported by the Polish National Science Center (NCN: www.ncn.gov.pl; grant no. 2011/03/B/ST5/01573). GS received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahrami Z, 2014, CHEM ENG RES DES, V92, P1296, DOI 10.1016/j.cherd.2013.11.007; Bhattarai SR, 2010, PHARM RES-DORDR, V27, P2556, DOI 10.1007/s11095-010-0245-0; Bian XL, 2013, BIOORGAN MED CHEM, V21, P5442, DOI 10.1016/j.bmc.2013.06.002; COREY EJ, 1969, J AM CHEM SOC, V91, P5675, DOI 10.1021/ja01048a062; Dauzonne D, 1997, EUR J MED CHEM, V32, P71, DOI 10.1016/S0223-5234(97)84363-2; Diaz I, 2001, APPL CATAL A-GEN, V205, P19, DOI 10.1016/S0926-860X(00)00808-5; Dorniani D, 2014, THESCIENTIFICWORLDJO, V416354, P11; Dorniani D, 2012, INT J NANOMED, V7, P5745, DOI 10.2147/IJN.S35746; Fan JQ, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/45/455102; Fresco P, 2006, MED RES REV, V26, P747, DOI 10.1002/med.20060; Ganesan V, 2004, LANGMUIR, V20, P3632, DOI 10.1021/la0364082; Hiyoshi N, 2005, MICROPOR MESOPOR MAT, V84, P357, DOI 10.1016/j.micromeso.2005.06.010; Johnson BJS, 2001, INORG CHEM, V40, P801, DOI 10.1021/ic991440y; Katiyar A, 2005, J CHROMATOGR A, V1069, P119, DOI 10.1016/j.chroma.2004.10.077; Khan HY, 2012, CURR DRUG TARGETS, V13, P1738; Kim HS, 2014, REDOX BIOL, V2, P187, DOI 10.1016/j.redox.2013.12.022; Locatelli C, 2013, EUR J MED CHEM, V60, P233, DOI 10.1016/j.ejmech.2012.10.056; Ma CM, 2005, EUR J MED CHEM, V40, P582, DOI 10.1016/j.ejmech.2005.01.001; Meng HA, 2010, J AM CHEM SOC, V132, P12690, DOI 10.1021/ja104501a; Mitsuhashi S, 2008, MOLECULES, V13, P2998, DOI 10.3390/molecules13122998; Perez-Quintanilla D, 2006, J MATER CHEM, V16, P1757, DOI 10.1039/b518157g; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Slowing I, 2006, J AM CHEM SOC, V128, P14792, DOI 10.1021/ja0645943; Song SW, 2005, LANGMUIR, V21, P9568, DOI 10.1021/la051167e; Subramanian V, 2014, FOOD CHEM TOXICOL, V66, P44, DOI 10.1016/j.fct.2014.01.017; Szegedi A, 2011, J SOLID STATE CHEM, V184, P1201, DOI 10.1016/j.jssc.2011.03.005; Vinu A, 2004, CHEM MATER, V16, P3056, DOI 10.1021/cm049718u; Wani A, 2012, PHARM RES-DORDR, V29, P2407, DOI 10.1007/s11095-012-0766-9; Xia Y, 2000, BIOORG MED CHEM LETT, V10, P699, DOI 10.1016/S0960-894X(00)00072-X; Ye JJ, 2010, LANGMUIR, V26, P1776, DOI 10.1021/la902497s	30	4	4	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2015	10	7							e0132541	10.1371/journal.pone.0132541	http://dx.doi.org/10.1371/journal.pone.0132541			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EC	26151908	Green Published, Green Submitted, gold			2022-12-26	WOS:000358158900046
J	Parker, VT				Parker, V. Thomas			Dispersal Mutualism Incorporated into Large-Scale, Infrequent Disturbances	PLOS ONE			English	Article							RANDOMLY VARYING ENVIRONMENT; SEED DISPERSAL; PLANT; FIRE; FOREST; TREE; FRAGMENTATION; REPRODUCTION; EVOLUTION; DYNAMICS	Because of their influence on succession and other community interactions, large-scale, infrequent natural disturbances also should play a major role in mutualistic interactions. Using field data and experiments, I test whether mutualisms have been incorporated into large-scale wildfire by whether the outcomes of a mutualism depend on disturbance. In this study a seed dispersal mutualism is shown to depend on infrequent, large-scale disturbances. A dominant shrubland plant (Arctostaphylos species) produces seeds that make up a persistent soil seed bank and requires fire to germinate. In post-fire stands, I show that seedlings emerging from rodent caches dominate sites experiencing higher fire intensity. Field experiments show that rodents (Perimyscus califomicus, P. boylii) do cache Arctostaphylos fruit and bury most seed caches to a sufficient depth to survive a killing heat pulse that a fire might drive into the soil. While the rodent dispersal and caching behavior itself has not changed compared to other habitats, the environmental transformation caused by wildfire converts the caching burial of seed from a dispersal process to a plant fire adaptive trait, and provides the context for stimulating subsequent life history evolution in the plant host.	San Francisco State Univ, Dept Biol, San Francisco, CA 94132 USA	California State University System; San Francisco State University	Parker, VT (corresponding author), San Francisco State Univ, Dept Biol, San Francisco, CA 94132 USA.	parker@sfsu.edu		Parker, V. Thomas/0000-0002-6149-7140	National Science Foundation (USA) [0948627]	National Science Foundation (USA)(National Science Foundation (NSF))	This research was supported by a grant from the National Science Foundation (USA) #0948627. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizen MA, 2008, PLOS BIOL, V6, P396, DOI 10.1371/journal.pbio.0060031; Bond WJ, 2005, TRENDS ECOL EVOL, V20, P387, DOI 10.1016/j.tree.2005.04.025; BOND WJ, 1994, PHILOS T R SOC B, V344, P83, DOI 10.1098/rstb.1994.0055; Borchert MI, 1995, BRUSHFIRES CALIFORNI, P91; Bronstein JL, 2003, AM NAT, V162, pS24, DOI 10.1086/378645; Bronstein JL, 2009, J ECOL, V97, P1160, DOI 10.1111/j.1365-2745.2009.01566.x; Chamberlain SA, 2014, ECOL LETT, V17, P881, DOI 10.1111/ele.12279; Chamberlain SA, 2009, ECOLOGY, V90, P2384, DOI 10.1890/08-1490.1; Chapman CA, 2003, BIOTROPICA, V35, P382, DOI 10.1111/j.1744-7429.2003.tb00592.x; Christian CE, 2001, NATURE, V413, P635, DOI 10.1038/35098093; COHEN D, 1966, J THEOR BIOL, V12, P119, DOI 10.1016/0022-5193(66)90188-3; COHEN D, 1968, J ECOL, V56, P219, DOI 10.2307/2258075; Cordeiro NJ, 2003, P NATL ACAD SCI USA, V100, P14052, DOI 10.1073/pnas.2331023100; CUSHMAN JH, 1989, ECOLOGY, V70, P1040, DOI 10.2307/1941372; Dale VH, 1998, ECOSYSTEMS, V1, P546, DOI 10.1007/s100219900050; Gray MA, 2007, CONSERV BIOL, V21, P133, DOI 10.1111/j.1523-1739.2006.00557.x; HANZAWA FM, 1988, AM NAT, V131, P1, DOI 10.1086/284769; Hirsch BT, 2012, ECOL LETT, V15, P1423, DOI 10.1111/ele.12000; Jordano P, 2000, ECOL MONOGR, V70, P591, DOI 10.1890/0012-9615(2000)070[0591:SDETQC]2.0.CO;2; Keeley J. E., 2012, FIRE MEDITERRANEAN E; Keeley JE, 2005, ECOL APPL, V15, P2109, DOI 10.1890/04-1222; KEELEY JE, 1976, OECOLOGIA, V24, P71, DOI 10.1007/BF00545488; KEELEY JE, 1977, ECOLOGY, V58, P820, DOI 10.2307/1936217; Keeley Jon E., 2006, Madrono, V53, P373, DOI 10.3120/0024-9637(2006)53[373:FSAPAI]2.0.CO;2; KELLY VR, 1990, AM MIDL NAT, V124, P114, DOI 10.2307/2426084; Kirika JM, 2008, CONSERV BIOL, V22, P318, DOI 10.1111/j.1523-1739.2007.00874.x; Leach MK, 1996, SCIENCE, V273, P1555, DOI 10.1126/science.273.5281.1555; Levey DJ, 2005, SCIENCE, V309, P146, DOI 10.1126/science.1111479; LONGLAND WS, 1995, J MAMMAL, V76, P1260, DOI 10.2307/1382621; Lugo AE, 1996, BIOTROPICA, V28, P585, DOI 10.2307/2389099; MORENO JM, 1989, ACTA OECOL-OEC PLANT, V10, P57; Odion DC, 2000, ECOL MONOGR, V70, P149, DOI 10.1890/0012-9615(2000)070[0149:FSHATF]2.0.CO;2; Parker V.T., 1989, ECOLOGY SOIL SEED BA, P231, DOI [10.1016/b978-0-12-440405-2.50016-6, DOI 10.1016/B978-0-12-440405-2.50016-6]; Parker V. T., 2009, FLORA N AM N MEXICO, V8, P406; Pickett S. T. A., 1985, ECOLOGY NATURAL DIST; PICKETT STA, 1987, VEGETATIO, V69, P109, DOI 10.1007/BF00038691; Prinzing A, 2007, OIKOS, V116, P1299, DOI [10.1111/j.2007.0030-1299.15738.x, 10.1111/j.0030-1299.2007.15738.x]; Rodriguez-Cabal MA, 2007, BIOL CONSERV, V139, P195, DOI 10.1016/j.biocon.2007.06.014; Thompson JN, 2013, P NATL ACAD SCI USA, V110, P11487, DOI 10.1073/pnas.1307451110; THOMPSON K, 1993, FUNCT ECOL, V7, P236, DOI 10.2307/2389893; Traveset A, 2006, TRENDS ECOL EVOL, V21, P208, DOI 10.1016/j.tree.2006.01.006; Wall SBV, 2010, PHILOS T R SOC B, V365, P989, DOI 10.1098/rstb.2009.0205; WELLS PV, 1969, EVOLUTION, V23, P264, DOI [10.2307/2406790, 10.1111/j.1558-5646.1969.tb03510.x]; Wootton JT, 1996, SCIENCE, V273, P1558, DOI 10.1126/science.273.5281.1558; Zelikova TJ, 2008, J TROP ECOL, V24, P309, DOI 10.1017/S0266467408004999	45	7	10	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2015	10	7							e0132625	10.1371/journal.pone.0132625	http://dx.doi.org/10.1371/journal.pone.0132625			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EC	26151560	gold, Green Submitted, Green Published			2022-12-26	WOS:000358158900051
J	Rais, R; Wozniak, K; Wu, Y; Niwa, M; Stathis, M; Alt, J; Giroux, M; Sawa, A; Rojas, C; Slusher, BS				Rais, Rana; Wozniak, Krystyna; Wu, Ying; Niwa, Minae; Stathis, Marigo; Alt, Jesse; Giroux, Marc; Sawa, Akira; Rojas, Camilo; Slusher, Barbara S.			Selective CNS Uptake of the GCP-II Inhibitor 2-PMPA following Intranasal Administration	PLOS ONE			English	Article							GLUTAMATE-CARBOXYPEPTIDASE-II; NAAG PEPTIDASE INHIBITOR; NASAL DRUG-DELIVERY; N-ACETYLASPARTYLGLUTAMATE; NAALADASE INHIBITION; COGNITIVE IMPAIRMENT; MEMBRANE ANTIGEN; NEUROPATHIC PAIN; GROWTH-FACTOR; SPINAL-CORD	Glutamate carboxypeptidase II (GCP-II) is a brain metallopeptidase that hydrolyzes the abundant neuropeptide N-acetyl-aspartyl-glutamate (NAAG) to NAA and glutamate. Small molecule GCP-II inhibitors increase brain NAAG, which activates mGluR3, decreases glutamate, and provide therapeutic utility in a variety of preclinical models of neurodegenerative diseases wherein excess glutamate is presumed pathogenic. Unfortunately no GCP-II inhibitor has advanced clinically, largely due to their highly polar nature resulting in insufficient oral bioavailability and limited brain penetration. Herein we report a non-invasive route for delivery of GCP-II inhibitors to the brain via intranasal (i.n.) administration. Three structurally distinct classes of GCP-II inhibitors were evaluated including DCMC (urea-based), 2-MPPA (thiol-based) and 2-PMPA (phosphonate-based). While all showed some brain penetration following i.n. administration, 2-PMPA exhibited the highest levels and was chosen for further evaluation. Compared to intraperitoneal (i.p.) administration, equivalent doses of i.n. administered 2-PMPA resulted in similar plasma exposures (AUC(0-t,) (i.n)./AUC(0-t), (i.p.) = 1.0) but dramatically enhanced brain exposures in the olfactory bulb (AUC(0-t, i.n)./AUC(0-t, i.p.) = 67), cortex (AUC(0-t, i.n)./AUC(0-t, i.p.) = 46) and cerebellum (AUC(0-t, i.n)./AUC(0-t, i.p.) = 6.3). Following i.n. administration, the brain tissue to plasma ratio based on AUC(0-t) in the olfactory bulb, cortex, and cerebellum were 1.49, 0.71 and 0.10, respectively, compared to an i.p. brain tissue to plasma ratio of less than 0.02 in all areas. Furthermore, i.n. administration of 2-PMPA resulted in complete inhibition of brain GCP-II enzymatic activity ex-vivo confirming target engagement. Lastly, because the rodent nasal system is not similar to humans, we evaluated i.n. 2-PMPA also in a non-human primate. We report that i.n. 2-PMPA provides selective brain delivery with micromolar concentrations. These studies support intranasal delivery of 2-PMPA to deliver therapeutic concentrations in the brain and may facilitate its clinical development.	[Rais, Rana; Wozniak, Krystyna; Wu, Ying; Stathis, Marigo; Alt, Jesse; Rojas, Camilo; Slusher, Barbara S.] Johns Hopkins Sch Med, Brain Sci Inst, Baltimore, MD 21205 USA; [Rais, Rana; Slusher, Barbara S.] Johns Hopkins Sch Med, Dept Neurol, Baltimore, MD USA; [Rojas, Camilo] Johns Hopkins Sch Med, Dept Mol & Comparat Pathobiol, Baltimore, MD USA; [Sawa, Akira; Slusher, Barbara S.] Johns Hopkins Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD USA; [Slusher, Barbara S.] Johns Hopkins Sch Med, Dept Neurosci, Baltimore, MD USA; [Giroux, Marc] Kurve Technol Inc, Bothell, WA USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Slusher, BS (corresponding author), Johns Hopkins Sch Med, Brain Sci Inst, Baltimore, MD 21205 USA.	bslusher@jhmi.edu	Niwa, Minae/AAV-2639-2021; Niwa, Minae/G-5469-2011	Niwa, Minae/0000-0002-8784-7815; Niwa, Minae/0000-0002-8784-7815	Brain Science Institute; National Institutes of Health [RO1CA161056]; Kurve Technology, Inc.; NATIONAL CANCER INSTITUTE [R01CA161056] Funding Source: NIH RePORTER	Brain Science Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kurve Technology, Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was supported by Brain Science Institute and the National Institutes of Health, Grant #RO1CA161056 to B.S. Slusher. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Co-author Marc Giroux is employed by Kurve Technology, Inc. Kurve Technology, Inc. provided support in the form of salary for author M.G., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the "author contributions" section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adedoyin MO, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-60; Bacich DJ, 2005, J NEUROCHEM, V95, P314, DOI 10.1111/j.1471-4159.2005.03361.x; Baker H, 2003, HDB OLFACTION GUSTAT; Barinka C, 2012, CURR MED CHEM, V19, P856, DOI 10.2174/092986712799034888; Berent-Spillson A, 2004, J NEUROCHEM, V89, P90, DOI 10.1111/j.1471-4159.2003.02321.x; Carozzi VA, 2010, NEUROTOX RES, V17, P380, DOI 10.1007/s12640-009-9114-1; Carpenter K J, 2001, Curr Opin Pharmacol, V1, P57, DOI 10.1016/S1471-4892(01)00009-1; Carpenter KJ, 2003, NEUROPEPTIDES, V37, P298, DOI 10.1016/j.npep.2003.08.001; Chen SR, 2002, J PHARMACOL EXP THER, V300, P662, DOI 10.1124/jpet.300.2.662; Chen Xue-Qing, 1998, J Alzheimers Dis, V1, P35; Chopra M, 2009, J PHARMACOL EXP THER, V330, P212, DOI 10.1124/jpet.109.152553; Craft S, 2012, ARCH NEUROL-CHICAGO, V69, P29, DOI 10.1001/archneurol.2011.233; Dhuria SV, 2010, J PHARM SCI-US, V99, P1654, DOI 10.1002/jps.21924; Dhuria SV, 2009, J PHARM SCI-US, V98, P2501, DOI 10.1002/jps.21604; Farrell J, 2003, J PHARMACOL EXP THER, V306, P229, DOI 10.1124/jpet.103.050112; Febbraro F, 2013, EXP NEUROL, V247, P45, DOI 10.1016/j.expneurol.2013.03.017; Foss CA, 2005, CLIN CANCER RES, V11, P4022, DOI 10.1158/1078-0432.CCR-04-2690; Frey WH, 1997, DRUG DELIV, V4, P87, DOI 10.3109/10717549709051878; Ghadge GD, 2003, P NATL ACAD SCI USA, V100, P9554, DOI 10.1073/pnas.1530168100; Gibaldi M., 1982, PHARMACOKINETICS, V2nd ed., P409; Graham K, 2012, J MED CHEM, V55, P9510, DOI 10.1021/jm300710j; Guo C, 2013, NEUROBIOL AGING, V34, P562, DOI 10.1016/j.neurobiolaging.2012.05.009; Hanson LR, 2009, J PHARMACOL EXP THER, V330, P679, DOI 10.1124/jpet.108.149807; HUSSAIN A, 1980, J PHARM SCI, V69, P1411, DOI 10.1002/jps.2600691215; Illum L, 2002, DRUG DISCOV TODAY, V7, P1184, DOI 10.1016/S1359-6446(02)02529-1; Illum L, 2003, J CONTROL RELEASE, V87, P187, DOI 10.1016/S0168-3659(02)00363-2; Jackson PF, 2001, J MED CHEM, V44, P4170, DOI 10.1021/jm0001774; Janczura KJ, 2013, EUR J PHARMACOL, V701, P27, DOI 10.1016/j.ejphar.2012.11.027; Johnson NJ, 2010, MOL PHARMACEUT, V7, P884, DOI 10.1021/mp100029t; Kozikowski AP, 2004, J MED CHEM, V47, P1729, DOI 10.1021/jm0306226; Lochhead JJ, 2012, ADV DRUG DELIVER REV, V64, P614, DOI 10.1016/j.addr.2011.11.002; Long JB, 2005, EUR J PHARMACOL, V508, P115, DOI 10.1016/j.ejphar.2004.12.008; Luszczki JJ, 2006, EUR J PHARMACOL, V531, P66, DOI 10.1016/j.ejphar.2005.11.045; McKinzie DL, 2000, ADDICT BIOL, V5, P411, DOI 10.1111/j.1369-1600.2000.tb00209.x; Mesters JR, 2006, EMBO J, V25, P1375, DOI 10.1038/sj.emboj.7600969; Nagel J, 2006, NEUROPHARMACOLOGY, V51, P1163, DOI 10.1016/j.neuropharm.2006.07.018; Neale JH, 2000, J NEUROCHEM, V75, P443, DOI 10.1046/j.1471-4159.2000.0750443.x; Neale JH, 2011, J NEUROCHEM, V119, P891, DOI 10.1111/j.1471-4159.2011.07380.x; Olszewski RT, 2012, SCHIZOPHR RES, V136, P160, DOI 10.1016/j.schres.2012.01.007; Olszewski RT, 2004, J NEUROCHEM, V89, P876, DOI 10.1111/j.1471-4159.2004.02358.x; Popik P, 2003, NEUROPSYCHOPHARMACOL, V28, P457, DOI 10.1038/sj.npp.1300048; Rahn KA, 2012, P NATL ACAD SCI USA, V109, P20101, DOI 10.1073/pnas.1209934109; Rais R, 2014, J PHARMACEUT BIOMED, V88, P162, DOI 10.1016/j.jpba.2013.08.028; Rais R, 2012, DRUG METAB DISPOS, V40, P2315, DOI 10.1124/dmd.112.046821; ROBINSON MB, 1987, J BIOL CHEM, V262, P14498; Rojas C, 2002, ANAL BIOCHEM, V310, P50, DOI 10.1016/S0003-2697(02)00286-5; Saito O, 2006, CAN J ANAESTH, V53, P891, DOI 10.1007/BF03022832; Sasson NJ, 2008, AUTISM RES, V1, P31, DOI 10.1002/aur.4; SCHATZ PL, 1989, CHEST, V95, P685, DOI 10.1378/chest.95.3.685; Shippenberg TS, 2000, SYNAPSE, V38, P161, DOI 10.1002/1098-2396(200011)38:2<161::AID-SYN7>3.0.CO;2-G; Slusher BS, 1999, NAT MED, V5, P1396, DOI 10.1038/70971; Stevens J, 2011, DRUG METAB DISPOS, V39, P2275, DOI 10.1124/dmd.111.040782; Thorne RG, 2008, NEUROSCIENCE, V152, P785, DOI 10.1016/j.neuroscience.2008.01.013; Thorne RG, 2004, NEUROSCIENCE, V127, P481, DOI 10.1016/j.neuroscience.2004.05.029; Tortella FC, 2000, EUR J PHARMACOL, V402, P31, DOI 10.1016/S0014-2999(00)00519-7; Vaka SRK, 2009, J PHARM SCI-US, V98, P3640, DOI 10.1002/jps.21674; van der Post JP, 2005, BRIT J CLIN PHARMACO, V60, P128, DOI 10.1111/j.1365-2125.2005.02396.x; Vitharana D, 2002, TETRAHEDRON-ASYMMETR, V13, P1609, DOI 10.1016/S0957-4166(02)00412-3; Vornov JJ, 2013, J PHARMACOL EXP THER, V346, P406, DOI 10.1124/jpet.113.205039; Watkins JC, 2000, BIOCHEM SOC T, V28, P297, DOI 10.1042/0300-5127:0280297; Witkin JM, 2002, NEUROPHARMACOLOGY, V43, P348, DOI 10.1016/S0028-3908(02)00124-7; Wozniak KM, 2012, CURR MED CHEM, V19, P1323, DOI 10.2174/092986712799462630; Xi ZX, 2010, NEUROPHARMACOLOGY, V58, P304, DOI 10.1016/j.neuropharm.2009.06.016; Xi ZX, 2010, J NEUROCHEM, V112, P564, DOI 10.1111/j.1471-4159.2009.06478.x; Yamamoto T, 2004, EUR J NEUROSCI, V20, P483, DOI 10.1111/j.1460-9568.2004.03504.x; Yamamoto T, 2001, BRAIN RES, V909, P138, DOI 10.1016/S0006-8993(01)02650-6; Yamamoto T, 2001, NEUROSCIENCE, V102, P473, DOI 10.1016/S0306-4522(00)00502-9; Yamamoto T, 2007, EUR J NEUROSCI, V25, P147, DOI 10.1111/j.1460-9568.2006.05272.x; Yamamoto T, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-31; Zhang W, 2006, J NEUROL SCI, V247, P217, DOI 10.1016/j.jns.2006.05.052; Zhang W, 2002, J NEUROL SCI, V194, P21, DOI 10.1016/S0022-510X(01)00670-0; Zhong C, 2006, J NEUROCHEM, V97, P1015, DOI 10.1111/j.1471-4159.2006.03786.x; Zhong CL, 2005, J NEUROTRAUM, V22, P266, DOI 10.1089/neu.2005.22.266	73	19	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2015	10	7							e0131861	10.1371/journal.pone.0131861	http://dx.doi.org/10.1371/journal.pone.0131861			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EC	26151906	Green Published, gold, Green Submitted			2022-12-26	WOS:000358158900026
J	Begat, C; Bailly, P; Chiaroni, J; Mazieres, S				Begat, Christophe; Bailly, Pascal; Chiaroni, Jacques; Mazieres, Stephane			Revisiting the Diego Blood Group System in Amerindians: Evidence for Gene-Culture Comigration	PLOS ONE			English	Article							Y-CHROMOSOME; NATIVE-AMERICANS; RED-CELL; POPULATION-STRUCTURE; SOUTH AMERINDIANS; MITOCHONDRIAL-DNA; HUMAN EXPANSION; AYOREO INDIANS; DIVERSITY; VARIABILITY	Six decades ago the DI*A allele of the Diego blood group system was instrumental in proving Native American populations originated from Siberia. Since then, it has received scant attention. The present study was undertaken to reappraise distribution of the DI*A allele in 144 Native American populations based on current knowledge. Using analysis of variance tests, frequency distribution was studied according to geographical, environmental, and cultural parameters. Frequencies were highest in Amazonian populations. In contrast, DI*A was undetectable in subarctic, Fuegian, Panamanian, Chaco and Yanomama populations. Closer study revealed a correlation that this unequal distribution was correlated with language, suggesting that linguistic divergence was a driving force in the expansion of DI*A among Native Americans. The absence of DI*A in circumpolar Eskimo-Aleut and Na-Dene speakers was consistent with a late migratory event confined to North America. Distribution of DI*A in subtropical areas indicated that gene and culture exchanges were more intense within than between ecozones. Bolstering the utility of classical genetic markers in biological anthropology, the present study of the expansion of Diego blood group genetic polymorphism in Native Americans shows strong evidence of gene-culture comigration.	[Begat, Christophe; Bailly, Pascal; Chiaroni, Jacques; Mazieres, Stephane] Aix Marseille Univ, CNRS, EFS, ADES UMR 7268, F-13916 Marseille, France; [Bailly, Pascal; Chiaroni, Jacques] Etab Francais Sang Alpes Mediterranee, F-13392 Marseille 5, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Aix-Marseille Universite	Mazieres, S (corresponding author), Aix Marseille Univ, CNRS, EFS, ADES UMR 7268, F-13916 Marseille, France.	stephane.mazieres@univ-amu.fr	Chiaroni, Jacques/ABA-2944-2021; Mazieres, Stephane/G-1702-2010; Mazières, Stéphane/R-2061-2019	Chiaroni, Jacques/0000-0002-3133-8990; Mazieres, Stephane/0000-0003-1266-4659; 				Anstee DJ, 2010, BLOOD, V115, P4635, DOI 10.1182/blood-2010-01-261859; Battaglia V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071390; Bernstein F., 1925, Z INDUKT ABSTAMM VER, V37, P237, DOI [DOI 10.1007/BF01763333, 10.1007/BF01763333]; Bisso-Machado R, 2012, GENET MOL BIOL, V35, P365, DOI 10.1590/S1415-47572012005000027; Bonatto SL, 1997, P NATL ACAD SCI USA, V94, P1866, DOI 10.1073/pnas.94.5.1866; BOOTH PB, 1977, VOX SANG, V32, P99, DOI 10.1111/j.1423-0410.1977.tb00612.x; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Chiaroni J, 2009, P NATL ACAD SCI USA, V106, P20174, DOI 10.1073/pnas.0910803106; Diamond J, 2011, NATURE, V476, P291, DOI 10.1038/476291a; Dickau R, 2007, P NATL ACAD SCI USA, V104, P3651, DOI 10.1073/pnas.0611605104; Dornelles CL, 2004, AM J HUM BIOL, V16, P479, DOI 10.1002/ajhb.20038; Dugoujon JM, 2004, AM J PHYS ANTHROPOL, V125, P175, DOI 10.1002/ajpa.10405; Epps P, 2009, LANG LINGUIST COMPAS, V3, P581, DOI 10.1111/j.1749-818x.2009.00126.x; Estrada-Mena B, 2010, AM J PHYS ANTHROPOL, V142, P85, DOI 10.1002/ajpa.21204; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fagundes NJR, 2008, AM J HUM GENET, V82, P583, DOI 10.1016/j.ajhg.2007.11.013; Fumagalli M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002355; Galland M, 2013, PREMIER PEUPLEMENT A; Gilbert MTP, 2008, SCIENCE, V320, P1787, DOI 10.1126/science.1159750; Goebel T, 2003, SCIENCE, V301, P501, DOI 10.1126/science.1086555; Henn BM, 2012, P NATL ACAD SCI USA, V109, P17758, DOI 10.1073/pnas.1212380109; Hunemeier T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038862; Hunley KL, 2008, AM J PHYS ANTHROPOL, V135, P195, DOI 10.1002/ajpa.20720; JAROLIM P, 1991, P NATL ACAD SCI USA, V88, P11022, DOI 10.1073/pnas.88.24.11022; Jose RG, 2002, AM J HUM BIOL, V14, P308, DOI 10.1002/ajhb.10033; Junqueira Pedro C., 2002, Rev. Bras. Hematol. Hemoter., V24, P15, DOI 10.1590/S1516-84842002000100004; Koda Y, 2000, J MOL EVOL, V50, P243, DOI 10.1007/s002399910028; Kottek M, 2006, METEOROL Z, V15, P259, DOI 10.1127/0941-2948/2006/0130; Laland KN, 2010, NAT REV GENET, V11, P137, DOI 10.1038/nrg2734; LAYRISSE M, 1958, Bibl Haematol, V7, P114; LAYRISSE M, 1961, SCIENCE, V134, P1077, DOI 10.1126/science.134.3485.1077; Leotard G, 2009, MOL PHYLOGENET EVOL, V53, P329, DOI 10.1016/j.ympev.2009.05.003; LEVINE P, 1956, NATURE, V177, P40, DOI 10.1038/177040b0; Matsuoka Y, 2002, THEOR APPL GENET, V104, P436, DOI 10.1007/s001220100694; Melton PE, 2008, GENETIC HIST PRECOLU; MOURANT A.E., 1958, ABO BLOOD GROUPS COM; NAM JM, 1976, ANN HUM GENET, V39, P361, DOI 10.1111/j.1469-1809.1976.tb00141.x; NEEL JV, 1967, AM J HUM GENET, V19, P554; NEEL JV, 1977, HUM GENET, V37, P207, DOI 10.1007/BF00393584; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Perego UA, 2010, GENOME RES, V20, P1174, DOI 10.1101/gr.109231.110; Pritchard JK, 2000, GENETICS, V155, P945; Raghavan M, 2014, SCIENCE, V345, P1020, DOI 10.1126/science.1255832; Raghavan M, 2014, NATURE, V505, P87, DOI 10.1038/nature12736; Regueiro M, 2013, AM J PHYS ANTHROPOL, V150, P333, DOI 10.1002/ajpa.22207; Reich D, 2012, NATURE, V488, P370, DOI 10.1038/nature11258; Rootsi S, 2004, AM J HUM GENET, V75, P128, DOI 10.1086/422196; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rubicz R, 2002, HUM BIOL, V74, P743, DOI 10.1353/hub.2003.0011; RUHLEN M, 1987, GUIDE WORLDS LANGUAG, V1; Salzano FM, 2005, CURR ANTHROPOL, V46, pS121, DOI 10.1086/497667; SALZANO FM, 1978, HUM BIOL, V50, P121; Salzano FN, 2002, AN ACAD BRAS CIENC, V74, P223, DOI 10.1590/S0001-37652002000200005; Schroeder KB, 2007, BIOL LETTERS, V3, P218, DOI 10.1098/rsbl.2006.0609; Scliar MO, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0174-3; Shi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066102; Sicoli MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091722; Sinka ME, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-72; SLATKIN M, 1991, AM NAT, V138, P499, DOI 10.1086/285228; SMOUSE PE, 1981, GENETICS, V98, P179; SPRING FA, 1992, BIOCHEM J, V288, P713, DOI 10.1042/bj2880713; Steward J. H., 1963, HDB S AM INDIANS, V3; Steward JH, 1963, HDB S AM INDIANS, VII; Steward JH, 1963, HDB S AM INDIANS TOM, VVI; Steward JH, 1963, HDB S AM INDIANS, VI; Steward Julian H., 1963, HDB S AM INDIANS, V5; Storry JR, 2011, VOX SANG, V101, P77, DOI 10.1111/j.1423-0410.2010.01462.x; Tamm E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000829; Tarazona-Santos E, 2001, AM J HUM GENET, V68, P1485, DOI 10.1086/320601; THOMPSON EA, 1979, GENETICS, V93, P479; Underhill PA, 1996, P NATL ACAD SCI USA, V93, P196, DOI 10.1073/pnas.93.1.196; Underhill PA, 2015, EUR J HUM GENET, V23, P124, DOI 10.1038/ejhg.2014.50; Villanea FA, 2013, AM J PHYS ANTHROPOL, V151, P649, DOI 10.1002/ajpa.22292; Wang S, 2007, PLOS GENET, V3, P2049, DOI 10.1371/journal.pgen.0030185; WILLIAMS RC, 1985, AM J PHYS ANTHROPOL, V66, P1, DOI 10.1002/ajpa.1330660102; WOLFINGER R, 1993, COMMUN STAT-SIMUL C, V22, P1079, DOI 10.1080/03610919308813143; Yang NN, 2010, ANN HUM GENET, V74, P525, DOI 10.1111/j.1469-1809.2010.00608.x	78	10	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132211	10.1371/journal.pone.0132211	http://dx.doi.org/10.1371/journal.pone.0132211			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148209	Green Published, gold, Green Submitted			2022-12-26	WOS:000358157600219
J	Mattioli, F; Stampatori, C; Bellomi, F; Scarpazza, C; Capra, R				Mattioli, Flavia; Stampatori, Chiara; Bellomi, Fabio; Scarpazza, Cristina; Capra, Ruggero			Natalizumab Significantly Improves Cognitive Impairment over Three Years in MS: Pattern of Disability Progression and Preliminary MRI Findings	PLOS ONE			English	Article							REMITTING MULTIPLE-SCLEROSIS; 3-YEAR FOLLOW-UP; TREATED-PATIENTS; BRAIN ATROPHY; CORTICAL PATHOLOGY; DISEASE-ACTIVITY; EFFICACY; LOBE	Previous studies reported that Multiple Sclerosis (MS) patients treated with natalizumab for one or two years exhibit a significant reduction in relapse rate and in cognitive impairment, but the long term effects on cognitive performance are unknown. This study aimed to evaluate the effects of natalizumab on cognitive impairment in a cohort of 24 consecutive patients with relapsing remitting MS treated for 3 years. The neuropsychological tests, as well as relapse number and EDSS, were assessed at baseline and yearly for three years. The impact on cortical atrophy was also considered in a subgroup of them, and are thus to be considered as preliminary. Results showed a significant reduction in the number of impaired neuropsychological tests after three years, a significant decrease in annualized relapse rate at each time points compared to baseline and a stable EDSS. In the neuropsychological assessment, a significant improvement in memory, attention and executive function test scores was detected. Preliminary MRI data show that, while GM volume did not change at 3 years, a significantly greater parahippocampal and prefrontal gray matter density was noticed, the former correlating with neuropsychological improvement in a memory test. This study showed that therapy with Natalizumab is helpful in improving cognitive performance, and is likely to have a protective role on grey matter, over a three years follow-up.	[Mattioli, Flavia; Stampatori, Chiara; Bellomi, Fabio; Scarpazza, Cristina] Spedali Civil Brescia, Neuropsychol Unit, I-25125 Brescia, Italy; [Capra, Ruggero] Spedali Civili Brescia, Multiple Sclerosis Ctr, Montichiari, Italy	Hospital Spedali Civili Brescia; Hospital Spedali Civili Brescia	Mattioli, F (corresponding author), Spedali Civil Brescia, Neuropsychol Unit, I-25125 Brescia, Italy.	flaviacaterina.mattioli@gmail.com	Mattioli, Flavia Caterina/AAM-8803-2020; Scarpazza, Cristina/AAA-2306-2022	Scarpazza, Cristina/0000-0002-4126-426X				Amato MP, 2010, MULT SCLER, V16, P1474, DOI 10.1177/1352458510380089; Amato MP, 2004, NEUROLOGY, V63, P89, DOI 10.1212/01.WNL.0000129544.79539.D5; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2009, NEUROIMAGE, V45, P333, DOI 10.1016/j.neuroimage.2008.12.008; Basso A, 1987, Funct Neurol, V2, P189; BENTON AL, 1968, NEUROPSYCHOLOGIA, V6, P53, DOI 10.1016/0028-3932(68)90038-9; Butzkueven H, 2014, J NEUROL NEUROSUR PS, V85, P1190, DOI 10.1136/jnnp-2013-306936; Caffarra P, 2002, NEUROL SCI, V22, P443, DOI 10.1007/s100720200003; Calabrese M, 2010, NEUROLOGY, V74, P321, DOI 10.1212/WNL.0b013e3181cbcd03; Calabrese M, 2011, EXPERT REV NEUROTHER, V11, P425, DOI 10.1586/ERN.10.155; Calabrese M, 2009, ARCH NEUROL-CHICAGO, V66, P1144, DOI 10.1001/archneurol.2009.174; de Renzi E., 1977, ARCH PSICOL NEUROL P, V38, P303; Eling P, 2008, BRAIN COGNITION, V67, P247, DOI 10.1016/j.bandc.2008.01.006; Filippi M, 2012, RADIOLOGY, V262, P932, DOI 10.1148/radiol.11111299; Ghezzi A, 2011, NEUROL SCI, V32, P351, DOI 10.1007/s10072-010-0469-0; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Havrdova E, 2009, LANCET NEUROL, V8, P254, DOI 10.1016/S1474-4422(09)70021-3; IAFFALDANO P, 2012, PLOS ONE, V7; Krysko KM, 2011, CAN J NEUROL SCI, V38, P422, DOI 10.1017/S0317167100011811; Lang C, 2012, EUR NEUROL, V67, P162, DOI 10.1159/000334722; Magraner M, 2012, EUR J RADIOL, V81, P3485, DOI 10.1016/j.ejrad.2012.01.028; Mattioli F, 2011, NEUROL SCI, V31, pS321, DOI 10.1007/s10072-010-0351-0; Mattioli F, 2011, NEUROL SCI, V32, P83, DOI 10.1007/s10072-010-0412-4; Mechelli A, 2005, CURR MED IMAGING, V1, P105, DOI 10.2174/1573405054038726; Morrow SA, 2010, MULT SCLER J, V16, P1385, DOI 10.1177/1352458510378021; NOVELLI G, 1986, Archivio di Psicologia Neurologia e Psichiatria, V47, P278; NOVELLI G, 1986, Archivio di Psicologia Neurologia e Psichiatria, V47, P477; ORSINI A, 1987, ITAL J NEUROL SCI, V8, P539; Osterrieth PA, 1944, ARCH PSYCHOLOGIE, V30, P205; Portaccio E, 2013, EUR J NEUROL, V20, P986, DOI 10.1111/j.1468-1331.2012.03882.x; Prosperini L, 2012, J NEUROL SCI, V323, P104, DOI 10.1016/j.jns.2012.08.027; Raven J. C., 1978, MANUAL RAVENS PROGR; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Rinaldi F, 2012, MULT SCLER J, V18, P1760, DOI 10.1177/1352458512447704; Rudick RA, 2009, MULT SCLER J, V15, P984, DOI 10.1177/1352458509106212; Sastre-Garriga J, 2015, MULT SCLER J, V21, P749, DOI 10.1177/1352458514556300; Sorensen PS, 2014, CURR OPIN NEUROL, V27, P246, DOI 10.1097/WCO.0000000000000096; Spinnler H., 1987, ITAL J NEUROL SCI, V58, P44; Spreen O., 1991, PROFILE TEST RESULTS; Weinstock-Guttman B, 2012, J NEUROL, V259, P898, DOI 10.1007/s00415-011-6275-7; Yassa MA, 2009, NEUROIMAGE, V44, P319, DOI 10.1016/j.neuroimage.2008.09.016	42	35	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131803	10.1371/journal.pone.0131803	http://dx.doi.org/10.1371/journal.pone.0131803			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148120	gold, Green Published, Green Submitted			2022-12-26	WOS:000358157600147
J	Srilekha, S; Arokiasamy, T; Srikrupa, NN; Umashankar, V; Meenakshi, S; Sen, P; Kapur, S; Soumittra, N				Srilekha, Sundaramurthy; Arokiasamy, Tharigopala; Srikrupa, Natarajan N.; Umashankar, Vetrivel; Meenakshi, Swaminathan; Sen, Parveen; Kapur, Suman; Soumittra, Nagasamy			Homozygosity Mapping in Leber Congenital Amaurosis and Autosomal Recessive Retinitis Pigmentosa in South Indian Families	PLOS ONE			English	Article							GENOTYPE-PHENOTYPE CORRELATION; ONSET RETINAL DEGENERATION; GENE-THERAPY; AIPL1 MUTATIONS; COMMON-CAUSE; RPE65 GENE; DYSTROPHY; IDENTIFICATION; PREVALENCE; VISION	Leber congenital amaurosis (LCA) and retinitis pigmentosa (RP) are retinal degenerative diseases which cause severe retinal dystrophy affecting the photoreceptors. LCA is predominantly inherited as an autosomal recessive trait and contributes to 5% of all retinal dystrophies; whereas RP is inherited by all the Mendelian pattern of inheritance and both are leading causes of visual impairment in children and young adults. Homozygosity mapping is an efficient strategy for mapping both known and novel disease loci in recessive conditions, especially in a consanguineous mating, exploiting the fact that the regions adjacent to the disease locus will also be homozygous by descent in such inbred children. Here we have studied eleven consanguineous LCA and one autosomal recessive RP (arRP) south Indian families to know the prevalence of mutations in known genes and also to know the involvement of novel loci, if any. Complete ophthalmic examination was done for all the affected individuals including electroretinogram, fundus photograph, fundus autofluorescence, and optical coherence tomography. Homozygosity mapping using Affymetrix 250K HMA GeneChip on eleven LCA families followed by screening of candidate gene(s) in the homozygous block identified mutations in ten families; AIPL1 - 3 families, RPE65-2 families, GUCY2D, CRB1, RDH12, IQCB1 and SPATA7 in one family each, respectively. Six of the ten (60%) mutations identified are novel. Homozygosity mapping using Affymetrix 10K HMA GeneChip on the arRP family identified a novel nonsense mutation in MERTK. The mutations segregated within the family and was absent in 200 control chromosomes screened. In one of the eleven LCA families, the causative gene/mutation was not identified but many homozygous blocks were noted indicating that a possible novel locus/gene might be involved. The genotype and phenotype features, especially the fundus changes for AIPL1, RPE65, CRB1, RDH12 genes were as reported earlier.	[Srilekha, Sundaramurthy; Arokiasamy, Tharigopala; Srikrupa, Natarajan N.; Soumittra, Nagasamy] Vis Res Fdn, SNONGC Dept Genet & Mol Biol, Madras, Tamil Nadu, India; [Srilekha, Sundaramurthy; Srikrupa, Natarajan N.] BITS, Hyderabad, Andhra Pradesh, India; [Umashankar, Vetrivel] Vis Res Fdn, Ctr Bioinformat, Madras, Tamil Nadu, India; [Meenakshi, Swaminathan] Med Res Fdn, Dept Peadiatr Ophthalmol & Starbismus, Madras, Tamil Nadu, India; [Sen, Parveen] Med Res Fdn, Dept Vitreoretinal Serv, Madras, Tamil Nadu, India; [Kapur, Suman] BITS, Dept Biol Sci, Hyderabad, Andhra Pradesh, India	Birla Institute of Technology & Science Pilani (BITS Pilani); Birla Institute of Technology & Science Pilani (BITS Pilani)	Soumittra, N (corresponding author), Vis Res Fdn, SNONGC Dept Genet & Mol Biol, Madras, Tamil Nadu, India.	soumi_n@yahoo.co.uk	Sen, Parveen/W-4707-2019		Indian Council of Medical Research, Government of India [54/1/2010-BMS]	Indian Council of Medical Research, Government of India(Indian Council of Medical Research (ICMR))	This work was supported by the Indian Council of Medical Research, Government of India 54/1/2010-BMS (icmr.nic.in/) to NS.	Abu-Safieh L, 2013, GENOME RES, V23, P236, DOI 10.1101/gr.144105.112; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Alkuraya FS, 2010, GENET MED, V12, P236, DOI 10.1097/GIM.0b013e3181ceb95d; Allikmets Rando, 2004, Ophthalmic Genet, V25, P67, DOI 10.1080/13816810490514261; Asai-Coakwell M, 2013, HUM MOL GENET, V22, P1432, DOI 10.1093/hmg/dds560; Bertelsen M, 2014, OPHTHAL EPIDEMIOL, V21, P217, DOI 10.3109/09286586.2014.929710; Beryozkin A, 2013, INVEST OPHTH VIS SCI, V54, P2068, DOI 10.1167/iovs.12-11419; Chiang PW, 2012, NAT GENET, V44, P972, DOI 10.1038/ng.2370; Chinchore Y, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000377; Chung DC, 2009, J AAPOS, V13, P587, DOI 10.1016/j.jaapos.2009.10.004; Cideciyan AV, 2013, P NATL ACAD SCI USA, V110, pE517, DOI 10.1073/pnas.1218933110; Cideciyan AV, 2009, HUM GENE THER, V20, P999, DOI 10.1089/hum.2009.086; Cideciyan AV, 2009, NEW ENGL J MED, V361, P725, DOI 10.1056/NEJMc0903652; Cideciyan AV, 2008, P NATL ACAD SCI USA, V105, P15112, DOI 10.1073/pnas.0807027105; den Hollander AI, 2008, PROG RETIN EYE RES, V27, P391, DOI 10.1016/j.preteyeres.2008.05.003; den Hollander AI, 2007, INVEST OPHTH VIS SCI, V48, P5690, DOI 10.1167/iovs.07-0610; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Dhamaraj S, 2004, ARCH OPHTHALMOL-CHIC, V122, P1029, DOI 10.1001/archopht.122.7.1029; Dharmaraj S R, 2000, Ophthalmic Genet, V21, P135; Ehrenberg M, 2013, SEMIN OPHTHALMOL, V28, P397, DOI 10.3109/08820538.2013.825277; Estrada-Cuzcano A, 2011, INVEST OPHTH VIS SCI, V52, P834, DOI 10.1167/iovs.10-5221; Ferrari S, 2011, CURR GENOMICS, V12, P238, DOI 10.2174/138920211795860107; Fokkema IFAC, 2011, HUM MUTAT, V32, P557, DOI 10.1002/humu.21438; Gallon VA, 2004, BBA-MOL BASIS DIS, V1690, P141, DOI 10.1016/j.bbadis.2004.06.012; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Hildebrandt F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000353; Huang XF, 2015, GENET MED, V17, P271, DOI 10.1038/gim.2014.138; Il LLN, 2010, HUM MUTAT, V31, pE1472, DOI 10.1002/humu.21268; Kannabiran C, 2012, MOL VIS, V18, P1165; Kaplan J, 2008, OPHTHALMIC GENET, V29, P92, DOI 10.1080/13816810802232768; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lalitha K, 2002, J GENET, V81, P59, DOI 10.1007/BF02715901; Mackay DS, 2010, MOL VIS, V16, P369; Mamatha G, 2008, OPHTHALMIC GENET, V29, P73, DOI 10.1080/13816810802008259; McKibbin M, 2010, ARCH OPHTHALMOL-CHIC, V128, P107, DOI 10.1001/archophthalmol.2010.309; Millán J.M., 2008, Arch Soc Esp Oftalmol, V83, P689; Nannya Y, 2005, CANCER RES, V65, P6071, DOI 10.1158/0008-5472.CAN-05-0465; Otto EA, 2008, HUM MUTAT, V29, P418, DOI 10.1002/humu.20669; Parmeggiani F, 2011, CURR GENOMICS, V12, P236, DOI 10.2174/138920211795860080; Ramprasad VL, 2008, MOL VIS, V14, P481; Rozen S, 2000, Methods Mol Biol, V132, P365; Schuster A, 2007, INVEST OPHTH VIS SCI, V48, P1824, DOI 10.1167/iovs.06-0628; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Sergouniotis PI, 2011, AM J HUM GENET, V89, P183, DOI 10.1016/j.ajhg.2011.06.002; Singh HP, 2009, INVEST OPHTH VIS SCI, V50, P4065, DOI 10.1167/iovs.09-3479; Skjorringe T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018599; Sohocki MM, 2000, NAT GENET, V24, P79, DOI 10.1038/71732; Sohocki MM, 2000, MOL GENET METAB, V70, P142, DOI 10.1006/mgme.2000.3001; Stone EM, 2011, ARCH OPHTHALMOL-CHIC, V129, P81, DOI 10.1001/archophthalmol.2010.330; Sundaresan P, 2009, MOL VIS, V15, P1781; Testa F, 2011, INVEST OPHTH VIS SCI, V52, P5618, DOI 10.1167/iovs.10-6543; Thompson DA, 2000, INVEST OPHTH VIS SCI, V41, P4293; Tsujikawa M, 2008, ARCH OPHTHALMOL-CHIC, V126, P337, DOI 10.1001/archopht.126.3.337; Venkata RA, 2012, RES J BIOTECHNOL, V7, P18; Verma A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073172; Wang X, 2013, J MED GENET, V50, P674, DOI 10.1136/jmedgenet-2013-101558; Wang X, 2011, HUM MUTAT, V32, P1450, DOI 10.1002/humu.21587; Woods CG, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.016873; Woods CG, 2006, AM J HUM GENET, V78, P889, DOI 10.1086/503875	59	32	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131679	10.1371/journal.pone.0131679	http://dx.doi.org/10.1371/journal.pone.0131679			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147992	gold, Green Submitted, Green Published			2022-12-26	WOS:000358157600127
J	Trifonov, VA; Paoletti, A; Barucchi, VC; Kalinina, T; O'Brien, PCM; Ferguson-Smith, MA; Giovannotti, M				Trifonov, Vladimir A.; Paoletti, Alessio; Barucchi, Vincenzo Caputo; Kalinina, Tatiana; O'Brien, Patricia C. M.; Ferguson-Smith, Malcolm A.; Giovannotti, Massimo			Comparative Chromosome Painting and NOR Distribution Suggest a Complex Hybrid Origin of Triploid Lepidodactylus lugubris (Gekkonidae)	PLOS ONE			English	Article							PARTHENOGENETIC GECKO; HEMIDACTYLUS-FRENATUS; VIRGIN BIRTH; REPTILIA; LIZARDS; DIVERSITY; EVOLUTION; SQUAMATA	Parthenogenesis, unisexuality and triploidy are interesting but poorly studied phenomena occurring in some reptile species. The mourning gecko (Lepidodactylus lugubris) represents a complex of diploid and triploid parthenogenetic mostly all-female populations (males occur quite rarely) widely distributed in coastal areas of the Indian and Pacific Oceans. Here, we study karyotypes of a male and two female L. lugubris (LLU) triploid individuals (3n = 66) using comparative painting with Gekko japonicus, Hemidactylus turcicus and H. platyurus chromosome specific probes to visualize the homologous regions and to reveal genus specific rearrangements. Also, we applied a 28S ribosomal DNA probe and Ag-staining to detect nucleolus organizer regions (NORs). Our results suggest that the karyotype of L. lugubris underwent a chromosome fission and a fusion after its divergence from a common ancestor of the Gekko-Hemidactylus group. The NORs were found to be located on one out of three homologs on each of LLU8, LLU15 and LLU18, thus further confirming a hybrid origin of triploid individuals. It seems that three different bisexual populations might have contributed to the origin of this triploid parthenogenetic population. We postulate that the heterozygosity in NOR localization is maintained in the triploid clone studied by the absence of recombination as described in whiptail lizards. The pattern of NOR localizations and homologous regions in males and females, as well as the absence of other detectable karyotypic differences, suggest that males arise spontaneously in all female populations and do not arise from independent hybridizations with different species.	[Trifonov, Vladimir A.; Kalinina, Tatiana] Inst Mol & Cellular Biol SB RAS, Novosibirsk, Russia; [Trifonov, Vladimir A.; Kalinina, Tatiana] Novosibirsk State Univ, Novosibirsk 630090, Russia; [Paoletti, Alessio; Barucchi, Vincenzo Caputo; Giovannotti, Massimo] Univ Politecn Marche, Dipartimento Sci Vita & Ambiente, Ancona, Italy; [O'Brien, Patricia C. M.; Ferguson-Smith, Malcolm A.] Univ Cambridge, Cambridge Resource Ctr Comparat Genom, Cambridge, England; [Barucchi, Vincenzo Caputo] CNR, Ist Sci Marine Sez Pesca Marittima, Ancona, Italy	Russian Academy of Sciences; Novosibirsk State University; Marche Polytechnic University; University of Cambridge; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze Marine (ISMAR-CNR)	Trifonov, VA (corresponding author), Inst Mol & Cellular Biol SB RAS, Novosibirsk, Russia.	vlad@mcb.nsc.ru	Trifonov, Vladimir/E-4907-2012; Kalinina, Tatiana/AAU-4594-2020; Giovannotti, Massimo/AAZ-3563-2020	Trifonov, Vladimir/0000-0003-0454-8359; Kalinina, Tatiana/0000-0002-2698-0866; Giovannotti, Massimo/0000-0001-7622-3583	MCB grant [6.13]; Universita Politecnica delle Marche	MCB grant; Universita Politecnica delle Marche	This work was funded by MCBNo6.13 grant to VAT and by funds (Ricerca Scientifica d'Ateneo 2012) provided by Universita Politecnica delle Marche to MG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Booth W, 2012, BIOL LETTERS, V8, P983, DOI 10.1098/rsbl.2012.0666; Brown SG, 1996, HERPETOL J, V6, P69; Chapman DD, 2007, BIOL LETTERS, V3, P425, DOI 10.1098/rsbl.2007.0189; CUELLAR O, 1972, J GENET, V61, P14, DOI 10.1007/BF02984098; DAREVSKY IS, 1984, J HERPETOL, V18, P277, DOI 10.2307/1564081; Ezaz T, 2005, CHROMOSOME RES, V13, P763, DOI 10.1007/s10577-005-1010-9; Feldheim KA, 2010, J HERED, V101, P374, DOI 10.1093/jhered/esp129; Gamble T, 2008, ZOOL SCR, V37, P355, DOI 10.1111/j.1463-6409.2008.00330.x; Groot TVM, 2003, HEREDITY, V90, P130, DOI 10.1038/sj.hdy.6800210; HOWELL WM, 1980, EXPERIENTIA, V36, P1014, DOI 10.1007/BF01953855; INEICH I, 1988, CR ACAD SCI III-VIE, V307, P271; Kawai A, 2009, CHROMOSOMA, V118, P43, DOI 10.1007/s00412-008-0176-2; Lutes AA, 2010, NATURE, V464, P283, DOI 10.1038/nature08818; MORITZ C, 1993, BIOL J LINN SOC, V48, P113, DOI 10.1006/bijl.1993.1010; Neaves WB, 2011, TRENDS GENET, V27, P81, DOI 10.1016/j.tig.2010.12.002; OTA H, 1994, ECOL RES, V9, P121, DOI 10.1007/BF02347487; Ota H., 1993, Tropical Zoology, V6, P125; Ota H, 1996, GENETICA, V97, P81, DOI 10.1007/BF00132584; Pokorna MJ, 2015, CHROMOSOME RES, V23, P299, DOI 10.1007/s10577-015-9468-6; Pyron RA, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-93; RADTKEY RR, 1995, P ROY SOC B-BIOL SCI, V259, P145, DOI 10.1098/rspb.1995.0022; Roell B, 2008, ZOOLOGY, V111, P385, DOI 10.1016/j.zool.2007.09.004; SCHMID M, 1988, CHROMOSOMA, V97, P101, DOI 10.1007/BF00327367; Shibaike Y, 2009, CYTOGENET GENOME RES, V127, P182, DOI 10.1159/000303334; SUMNER AT, 1972, EXP CELL RES, V75, P304, DOI 10.1016/0014-4827(72)90558-7; Trifonov VA, 2011, CHROMOSOME RES, V19, P843, DOI 10.1007/s10577-011-9241-4; VOLOBOUEV V, 1988, HEREDITY, V60, P463, DOI 10.1038/hdy.1988.65; VOLOBOUEV V, 1993, CYTOGENET CELL GENET, V63, P194, DOI 10.1159/000133533; Watts PC, 2006, NATURE, V444, P1021, DOI 10.1038/4441021a; Wilmhoff CD, 2003, MOL ECOL NOTES, V3, P400, DOI 10.1046/j.1471-8286.2003.00459.x; Yamashiro S, 2000, ZOOL SCI, V17, P1013, DOI 10.2108/zsj.17.1013; Yamashiro Saiko, 1998, Japanese Journal of Herpetology, V17, P152	32	22	23	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132380	10.1371/journal.pone.0132380	http://dx.doi.org/10.1371/journal.pone.0132380			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148117	Green Published, Green Submitted, gold			2022-12-26	WOS:000358157600254
J	Zelasko-Leon, DC; Fuentes, CM; Messersmith, PB				Zelasko-Leon, Daria C.; Fuentes, Christina M.; Messersmith, Phillip B.			MUC1-Targeted Cancer Cell Photothermal Ablation Using Bioinspired Gold Nanorods	PLOS ONE			English	Article							BOVINE SERUM-ALBUMIN; IN-VIVO; PLASMA-PROTEINS; MUC1 MUCIN; NANOPARTICLES; POLYDOPAMINE; CARCINOMA; THERAPY; MUSSEL; BSA	Recent studies have highlighted the overexpression of mucin 1 (MUC1) in various epithelial carcinomas and its role in tumorigenesis. These mucins present a novel targeting opportunity for nanoparticle-mediated photothermal cancer treatments due to their unique antenna-like extracellular extension. In this study, MUC1 antibodies and albumin were immobilized onto the surface of gold nanorods using a "primer" of polydopamine (PD), a molecular mimic of catechol-and amine-rich mussel adhesive proteins. PD forms an adhesive platform for the deposition of albumin and MUC1 antibodies, achieving a surface that is stable, bioinert and biofunctional. Two-photon luminescence confocal and darkfield scattering imaging revealed targeting of MUC1-BSA-PD-NRs to MUC1(+) MCF-7 breast cancer and SCC-15 squamous cell carcinoma cells lines. Treated cells were exposed to a laser encompassing the near-infrared AuNR longitudinal surface plasmon and assessed for photothermal ablation. MUC1-BSA-PD-NRs substantially decreased cell viability in photoirradiated MCF-7 cell lines vs. MUC1-MDA-MB-231 breast cancer cells (p < 0.005). Agents exhibited no cytotoxicity in the absence of photothermal treatment. The facile nature of the coating method, combined with targeting and photoablation efficacy, are attractive features of these candidate cancer nanotherapeutics.	[Zelasko-Leon, Daria C.; Fuentes, Christina M.; Messersmith, Phillip B.] Northwestern Univ, Dept Biomed Engn, Chem Life Proc Inst, Evanston, IL 60208 USA; [Zelasko-Leon, Daria C.; Fuentes, Christina M.; Messersmith, Phillip B.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Messersmith, Phillip B.] Univ Calif Berkeley, Dept Mat Sci & Engn, Berkeley, CA 94720 USA	Northwestern University; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Zelasko-Leon, DC (corresponding author), Northwestern Univ, Dept Biomed Engn, Chem Life Proc Inst, Evanston, IL 60208 USA.	philm@berkeley.edu		Messersmith, Phillip/0000-0002-1197-333X	NCI CCSG [P30 CA060553]; MRSEC program at the Material Research Center [NSF DMR-1121262]; International Institute for Nanotechnology (IIN); Keck Foundation; State of Illinois; Northwestern University High Throughput Analysis Laboratory (HTAL); Keck Biophysics Facility; Northwestern University Flow Cytometry Facility; Cancer Center [NCI CA060553]; National Science Foundation [DGE-0824162]; Robert H. Lurie Comprehensive Cancer Center (RHLCC) of Northwestern University; McCormick Summer Research Award; NIH [R01 EB005772, R37 DE014193]; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB005772] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R37DE014193] Funding Source: NIH RePORTER	NCI CCSG; MRSEC program at the Material Research Center; International Institute for Nanotechnology (IIN); Keck Foundation(W.M. Keck Foundation); State of Illinois; Northwestern University High Throughput Analysis Laboratory (HTAL); Keck Biophysics Facility; Northwestern University Flow Cytometry Facility; Cancer Center; National Science Foundation(National Science Foundation (NSF)); Robert H. Lurie Comprehensive Cancer Center (RHLCC) of Northwestern University; McCormick Summer Research Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Imaging work was performed at the Northwestern University Center for Advanced Molecular Imaging (CAMI), generously supported by NCI CCSG P30 CA060553 awarded to the Robert H. Lurie Comprehensive Cancer Center. Portions of this research were performed at the Keck-II and EPIC cores of the Northwestern University Atomic and Nanoscale Characterization Experimental (NUANCE) Center. The NUANCE Center is supported by the MRSEC program (NSF DMR-1121262) at the Material Research Center, the International Institute for Nanotechnology (IIN), the Keck Foundation, and the State of Illinois. Additional material characterization experiments were carrieed out with the support of the Northwestern University High Throughput Analysis Laboratory (HTAL) and Keck Biophysics Facility. This work was further supported by the Northwestern University Flow Cytometry Facility and a Cancer Center Support Grant (NCI CA060553). DCZL was supported by a National Science Foundation Graduate Research Fellowship (DGE-0824162; http://www.fastlane.nsf.gov/grfp) and a Malkin Scholar Award from the Robert H. Lurie Comprehensive Cancer Center (RHLCC) of Northwestern University (http://cancer.northwestern.edu/research/research_programs/funding/). CMF was supported by a McCormick Summer Research Award (http://www.mccormick.northwestern.edu/students/undergraduate/research-opportunities/). Additional support was provided by NIH grants R01 EB005772 and R37 DE014193 (PBM; http://report.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkilany AM, 2012, ADV DRUG DELIVER REV, V64, P190, DOI 10.1016/j.addr.2011.03.005; Alkilany AM, 2009, SMALL, V5, P701, DOI 10.1002/smll.200801546; AMIJI M, 1992, J BIOMAT SCI-POLYM E, V3, P375, DOI 10.1163/156856292X00196; Apostolopoulos V, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1505; Ball V, 2012, J COLLOID INTERF SCI, V386, P366, DOI 10.1016/j.jcis.2012.07.030; Black KCL, 2014, SMALL, V10, P169, DOI 10.1002/smll.201301283; Black KCL, 2013, NANOMEDICINE-UK, V8, P17, DOI [10.2217/NNM.12.82, 10.2217/nnm.12.82]; Brewer SH, 2005, LANGMUIR, V21, P9303, DOI 10.1021/la050588t; Carpin LB, 2011, BREAST CANCER RES TR, V125, P27, DOI 10.1007/s10549-010-0811-5; d'Ischia M, 2014, ACCOUNTS CHEM RES, V47, P3541, DOI 10.1021/ar500273y; Dalsin JL, 2005, MATER TODAY, V8, P38, DOI 10.1016/S1369-7021(05)71079-8; Danysh BP, 2012, THERANOSTICS, V2, P777, DOI 10.7150/thno.4494; Dickerson EB, 2008, CANCER LETT, V269, P57, DOI 10.1016/j.canlet.2008.04.026; Ding YH, 2014, LANGMUIR, V30, P12258, DOI 10.1021/la5026608; Dreyer DR, 2012, LANGMUIR, V28, P6428, DOI 10.1021/la204831b; El-Sayed IH, 2006, CANCER LETT, V239, P129, DOI 10.1016/j.canlet.2005.07.035; Feng J, 2014, RSC ADV, V4, P28683, DOI 10.1039/c4ra03122a; Fessler SP, 2009, BREAST CANCER RES TR, V118, P113, DOI 10.1007/s10549-009-0412-3; Finn OJ, 2008, J IMMUNOL, V181, P1589, DOI 10.4049/jimmunol.181.3.1589; Francis GL, 2010, CYTOTECHNOLOGY, V62, P1, DOI 10.1007/s10616-010-9263-3; Gelamo EL, 2002, BBA-PROTEIN STRUCT M, V1594, P84, DOI 10.1016/S0167-4838(01)00287-4; Gole A, 2005, CHEM MATER, V17, P1325, DOI 10.1021/cm048297d; Govorov AO, 2007, NANO TODAY, V2, P30, DOI 10.1016/S1748-0132(07)70017-8; Hong S, 2012, ADV FUNCT MATER, V22, P4711, DOI 10.1002/adfm.201201156; Horiguchi Y, 2008, LANGMUIR, V24, P12026, DOI 10.1021/la800811j; Housni A, 2008, J PHYS CHEM C, V112, P12282, DOI 10.1021/jp803890a; Huang XH, 2006, J AM CHEM SOC, V128, P2115, DOI 10.1021/ja057254a; Huang XH, 2007, NANO LETT, V7, P1591, DOI 10.1021/nl070472c; Kamps JAAM, 1997, P NATL ACAD SCI USA, V94, P11681, DOI 10.1073/pnas.94.21.11681; Kouchakzadeh Hasan, 2012, Human Antibodies, V21, P49, DOI 10.3233/HAB-2012-0261; Kufe DW, 2009, NAT REV CANCER, V9, P874, DOI 10.1038/nrc2761; Lee BP, 2011, ANNU REV MATER RES, V41, P99, DOI 10.1146/annurev-matsci-062910-100429; Lee H, 2007, SCIENCE, V318, P426, DOI 10.1126/science.1147241; Lee H, 2009, ADV MATER, V21, P431, DOI 10.1002/adma.200801222; Lynge ME, 2011, NANOSCALE, V3, P4916, DOI 10.1039/c1nr10969c; Mamedova NN, 2001, NANO LETT, V1, P281, DOI 10.1021/nl015519n; Melancon MP, 2008, MOL CANCER THER, V7, P1730, DOI 10.1158/1535-7163.MCT-08-0016; Mitchell S, 2002, NEOPLASIA, V4, P9, DOI 10.1038/sj.neo.7900194; Mukai H, 2010, JPN J CLIN ONCOL, V40, P711, DOI 10.1093/jjco/hyq037; Mukhopadhyay P, 2011, BBA-REV CANCER, V1815, P224, DOI 10.1016/j.bbcan.2011.01.001; Nakanishi K, 2001, J BIOSCI BIOENG, V91, P233, DOI 10.1016/S1389-1723(01)80127-4; Nath N, 2004, SURF SCI, V570, P98, DOI 10.1016/j.susc.2004.06.182; Niidome T, 2006, J CONTROL RELEASE, V114, P343, DOI 10.1016/j.jconrel.2006.06.017; Nitta T, 2000, CANCER-AM CANCER SOC, V88, P245, DOI 10.1002/(SICI)1097-0142(20000115)88:2<245::AID-CNCR1>3.0.CO;2-T; Norde W, 2000, J BIOTECHNOL, V79, P259, DOI 10.1016/S0168-1656(00)00242-X; Ogawara K, 2004, J CONTROL RELEASE, V100, P451, DOI 10.1016/j.jconrel.2004.07.028; PACKHAM MA, 1969, J LAB CLIN MED, V73, P686; Pattani VP, 2015, J NANOPART RES, V17, DOI 10.1007/s11051-014-2822-3; PETERS T, 1985, ADV PROTEIN CHEM, V37, P161, DOI 10.1016/S0065-3233(08)60065-0; Proks V, 2013, MACROMOL CHEM PHYS, V214, P499, DOI 10.1002/macp.201200505; Raina D, 2009, CANCER RES, V69, P5133, DOI 10.1158/0008-5472.CAN-09-0854; Ratner BD, 2002, J CONTROL RELEASE, V78, P211, DOI 10.1016/S0168-3659(01)00502-8; REED RG, 1986, J BIOL CHEM, V261, P5619; Sanavio B, 2007, BBA-PROTEINS PROTEOM, V1774, P781, DOI 10.1016/j.bbapap.2007.04.019; Sayari E, 2014, INT J PHARMACEUT, V473, P304, DOI 10.1016/j.ijpharm.2014.05.041; Sedo J, 2013, ADV MATER, V25, P653, DOI 10.1002/adma.201202343; Sileika TS, 2011, ACS APPL MATER INTER, V3, P4602, DOI 10.1021/am200978h; Singh AV, 2005, J MATER CHEM, V15, P5115, DOI 10.1039/b510398c; SLOCUM TL, 1991, ANAL BIOCHEM, V195, P14, DOI 10.1016/0003-2697(91)90287-4; Statz AR, 2009, BIOINTERPHASES, V4, pFA22, DOI 10.1116/1.3115103; Takahashi H, 2006, LANGMUIR, V22, P2, DOI 10.1021/la0520029; Technology NIoSa, 2012, NIST XRAY PHOTOELECT; Tenzer S, 2013, NAT NANOTECHNOL, V8, P772, DOI 10.1038/nnano.2013.181; Treuel L, 2010, CHEMPHYSCHEM, V11, P3093, DOI 10.1002/cphc.201000174; von Maltzahn G, 2011, NAT MATER, V10, P545, DOI [10.1038/nmat3049, 10.1038/NMAT3049]; VROMAN L, 1969, SURF SCI, V16, P438, DOI 10.1016/0039-6028(69)90037-5; WAITE JH, 1985, J MAR BIOL ASSOC UK, V65, P359, DOI 10.1017/S0025315400050487; Walsh MD, 1999, BREAST CANCER RES TR, V58, P255; Wang LM, 2013, J AM CHEM SOC, V135, P17359, DOI 10.1021/ja406924v; Weissleder R, 2001, NAT BIOTECHNOL, V19, P316, DOI 10.1038/86684; Whitney JR, 2013, SINGLE WALLED CARBON; Willets KA, 2007, ANNU REV PHYS CHEM, V58, P267, DOI 10.1146/annurev.physchem.58.032806.104607; Wiogo HTR, 2011, LANGMUIR, V27, P843, DOI 10.1021/la104278m; Wu P, 2012, ANAL CHEM, V84, P7692, DOI 10.1021/ac3015164; Zhao F, 2011, SMALL, V7, P1322, DOI 10.1002/smll.201100001; ZHOU NE, 1992, J BIOL CHEM, V267, P2664; Zhou WB, 2010, CHEM COMMUN, V46, P1479, DOI 10.1039/b915125g	77	24	24	1	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0128756	10.1371/journal.pone.0128756	http://dx.doi.org/10.1371/journal.pone.0128756			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147830	Green Published, Green Submitted, gold			2022-12-26	WOS:000358157600016
J	Kubo, H; Shibato, J; Saito, T; Ogawa, T; Rakwal, R; Shioda, S				Kubo, Hiroko; Shibato, Junko; Saito, Tomomi; Ogawa, Tetsuo; Rakwal, Randeep; Shioda, Seiji			Unraveling the Rat Intestine, Spleen and Liver Genome-Wide Transcriptome after the Oral Administration of Lavender Oil by a Two-Color Dye-Swap DNA Microarray Approach	PLOS ONE			English	Article							GENE-EXPRESSION; SIGNAL-TRANSDUCTION; PREPARATION SILEXAN; ANXIETY DISORDER; DOWN-REGULATION; ISCHEMIC BRAIN; MESSENGER-RNA; MOUSE MODEL; ER-ALPHA; LINALOOL	The use of lavender oil (LO) - a commonly, used oil in aromatherapy, with well-defined volatile components linalool and linalyl acetate - in non-traditional medicine is increasing globally. To understand and demonstrate the potential positive effects of LO on the body, we have established an animal model in this current study, investigating the orally administered LO effects genome wide in the rat small intestine, spleen, and liver. The rats were administered LO at 5 mg/kg (usual therapeutic dose in humans) followed by the screening of differentially expressed genes in the tissues, using a 4x44-K whole-genome rat chip (Agilent microarray platform; Agilent Technologies, Palo Alto, CA, USA) in conjunction with a dyeswap approach, a novelty of this study. Fourteen days after LO treatment and compared with a control group (sham), a total of 156 and 154 up (>= 1.5-fold)- and down (<= 0.75-fold)regulated genes, 174 and 66 up-(>= 1.5-fold)-and down (<= 0.75-fold)-regulated genes, and 222 and 322 up-(>= 1.5-fold)-and down (<= 0.75-fold)-regulated genes showed differential expression at the mRNA level in the small intestine, spleen and liver, respectively. The reverse transcription-polymerase chain reaction (RT-PCR) validation of highly up-and down-regulated genes confirmed the regulation of the Papd4, Lrp1b, Alb, Cyr61, Cyp2c, and Cxcl1 genes by LO as examples in these tissues. Using bioinformatics, including Ingenuity Pathway Analysis (IPA), differentially expressed genes were functionally categorized by their Gene Ontology (GO) and biological function and network analysis, revealing their diverse functions and potential roles in LO-mediated effects in rat. Further IPA analysis in particular unraveled the presence of novel genes, such as Papd4, Or8k5, Gprc5b, Taar5, Trpc6, Pld2 and Onecut3 (up-regulated top molecules) and Tnf, Slc45a4, Slc25a23 and Samt4 (down-regulated top molecules), to be influenced by LO treatment in the small intestine, spleen and liver, respectively. These results are the first such inventory of genes that are affected by lavender essential oil (LO) in an animal model, forming the basis for further in-depth bioinformatics and functional analyses and investigation.	[Kubo, Hiroko; Shibato, Junko; Saito, Tomomi; Ogawa, Tetsuo; Rakwal, Randeep; Shioda, Seiji] Showa Univ, Sch Med, Dept Anat 1, Shinagawa Ku, Tokyo 142, Japan; [Kubo, Hiroko] Oriental Aromatherapy Coll, Katsushika, Tokyo, Japan; [Shibato, Junko; Rakwal, Randeep; Shioda, Seiji] Hoshi Univ, Global Res Ctr Innovat Life Sci, Sch Pharm & Pharmaceut Sci, Peptide Drug Innovat,Shinagawa Ku, Tokyo 142, Japan; [Shibato, Junko] Univ Tsukuba, Inst Hlth & Sport Sci, Lab Exercise Biochem & Neuroendocrinol, Tsukuba, Ibaraki, Japan; [Ogawa, Tetsuo] Saitama Med Univ, Dept Physiol, Saitama, Japan; [Rakwal, Randeep] Univ Tsukuba, Org Educ Initiat, Tsukuba, Ibaraki, Japan; [Rakwal, Randeep] Univ Tsukuba, Fac Hlth & Sport Sci, Tsukuba, Ibaraki, Japan; [Rakwal, Randeep] Univ Tsukuba, Tsukuba Int Acad Sport Studies TIAS, Tsukuba, Ibaraki, Japan	Showa University; Hoshi University; University of Tsukuba; Saitama Medical University; University of Tsukuba; University of Tsukuba; University of Tsukuba	Rakwal, R (corresponding author), Showa Univ, Sch Med, Dept Anat 1, Shinagawa Ku, Tokyo 142, Japan.	plantproteomics@gmail.com; shioda@hoshi.ac.jp						Aaronson DS, 2002, SCIENCE, V296, P1653, DOI 10.1126/science.1071545; Abdel-Aziz M, 2014, IRAN J ALLERGY ASTHM, V13, P324; Anderson M, 2014, J CELL PHYSIOL, V229, P434, DOI 10.1002/jcp.24461; [Anonymous], 1886, PHARMACOPOEA JAPONIC, Vviii, P292; [Anonymous], 2008, PRINC AR; [Anonymous], 2010, AR MON; [Anonymous], 2008, EUROPEAN PHARMACOPOE; Baker J, 2012, AM J PHYSIOL-GASTR L, V303, pG825, DOI 10.1152/ajpgi.00327.2011; Bandapalli OR, 2012, CYTOKINE, V57, P46, DOI 10.1016/j.cyto.2011.10.019; Beck M, 2008, PLOS ONE, V3, pe2343, DOI [10.1371/journal.pone.0002343, DOI 10.1371/JOURNAL.PONE.0002343]; Brum LFS, 2001, PHYTOTHER RES, V15, P422, DOI 10.1002/ptr.973; Buckle J, 2003, CLIN AROMATHERAPY ES, P236; CHADHA A, 1984, XENOBIOTICA, V14, P365, DOI 10.3109/00498258409151425; Clevenger CV, 1998, J ENDOCRINOL, V157, P187, DOI 10.1677/joe.0.1570187; Cooke B, 2000, BRIT J GEN PRACT, V50, P493; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Doroshyenko O, 2013, DRUG METAB DISPOS, V41, P987, DOI 10.1124/dmd.112.050203; Eder P, 2005, PFLUG ARCH EUR J PHY, V451, P99, DOI 10.1007/s00424-005-1434-2; Endo M, 2005, MOL ENDOCRINOL, V19, P1181, DOI 10.1210/me.2004-0063; Espana A, 2012, MOL CELL NEUROSCI, V50, P93, DOI 10.1016/j.mcn.2012.04.002; Estacion M, 2006, J PHYSIOL-LONDON, V572, P359, DOI 10.1113/jphysiol.2005.103143; Esworthy RS, 2003, BIOL CHEM, V384, P597, DOI 10.1515/BC.2003.067; Fang Y, 2014, PEPTIDES, V55, P47, DOI 10.1016/j.peptides.2014.01.019; Festing S, 1985, STORY LAVENDER; Fissler M, 2014, COMPLEMENT THER MED, V22, P63, DOI 10.1016/j.ctim.2013.11.008; Franchomme de P, 1990, AROMATHERAPIE EXACTE; Frasor J, 2001, MOL ENDOCRINOL, V15, P2172, DOI 10.1210/me.15.12.2172; Garcia-Martinez R, 2015, J HEPATOL, V62, P799, DOI 10.1016/j.jhep.2014.10.031; Gattefosse RM, 1993, AROMATHERAPY; Gimenez-Bastida JA, 2009, J AGR FOOD CHEM, V57, P9305, DOI 10.1021/jf901983g; Grieve M, 1971, MODERN HERBAL, V1-2; Grimley PM, 1999, CYTOKINE GROWTH F R, V10, P131, DOI 10.1016/S1359-6101(99)00011-8; Harris HA, 2007, MOL ENDOCRINOL, V21, P1, DOI 10.1210/me.2005-0459; Hori M, 2015, GENOM DATA, V3, P148, DOI 10.1016/j.gdata.2015.01.007; Hori Motohide, 2015, Microarrays (Basel), V4, P2, DOI 10.3390/microarrays4010002; Hori M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-256; Hori M, 2012, DIS MODEL MECH, V5, P270, DOI 10.1242/dmm.008276; Ito J, 2009, CELL TISSUE RES, V338, P257, DOI 10.1007/s00441-009-0859-x; JAGER W, 1992, J SOC COSMET CHEM, V43, P49; JIROVETZ L, 1990, FRESEN J ANAL CHEM, V338, P922, DOI 10.1007/BF00322039; Kainkaryam RM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-299; KALMOVARIN N, 1991, INFLAMMATION, V15, P369, DOI 10.1007/BF00917353; Kasper S, 2014, INT J NEUROPSYCHOPH, V17, P859, DOI 10.1017/S1461145714000017; Kasper S, 2010, WIEN MED WOCHENSCHR, V160, P547, DOI 10.1007/s10354-010-0845-7; Katoh T, 2009, GENE DEV, V23, P433, DOI 10.1101/gad.1761509; Kendziorski CM, 2003, BIOSTATISTICS, V4, P465, DOI 10.1093/biostatistics/4.3.465; Kim YJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003149; Kobayashi H, 2013, J ENDOCRINOL, V219, P39, DOI 10.1530/JOE-13-0156; Lau LF, 1999, EXP CELL RES, V248, P44, DOI 10.1006/excr.1999.4456; Lawless J, 1992, ENCY ESSENTIAL OILS; Lee MC, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12206; Lewith GT, 2005, J ALTERN COMPLEM MED, V11, P631, DOI 10.1089/acm.2005.11.631; Macintire K, 2014, REPROD FERT DEVELOP, V26, P351, DOI 10.1071/RD12384; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mattheisen M, 2015, MOL PSYCHIATR, V20, P337, DOI 10.1038/mp.2014.43; Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3; Moss M, 2003, INT J NEUROSCI, V113, P15, DOI 10.1080/00207450390161903; National Center for Biotechnology Information, 2015, PUBCHEM COMP DAT; National Center for Biotechnology Information, 2015, PUBCHEM COMPOUND DAT; Ni SB, 2013, CANCER SCI, V104, P817, DOI 10.1111/cas.12157; Ogawa T, 2014, CONGENIT ANOM, V54, P195, DOI [10.1111/cga.12089, 10.1111/cga.12062]; Ogawa T, 2011, CONGENIT ANOM, V51, P110, DOI 10.1111/j.1741-4520.2011.00315.x; Patel V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087102; Peng XJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-26; Pierreux CE, 2004, J BIOL CHEM, V279, P51298, DOI 10.1074/jbc.M409038200; Politano VT, 2008, INT J TOXICOL, V27, P183, DOI 10.1080/10915810801977948; Qu DF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118933; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Sanchez J, 2009, ENDOCRINOLOGY, V150, P5341, DOI 10.1210/en.2009-0466; Schlndorff JS, 2006, SEMIN CELL DEV BIOL, V17, P667, DOI 10.1016/j.semcdb.2006.11.003; Schnaubelt K, 1999, MED AROMATHERAPY HEA, P296; Schuwald AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059998; Segen J. C., 1998, DICT ALTERNATIVE MED; Steiling H, 2003, ONCOGENE, V22, P4380, DOI 10.1038/sj.onc.1206499; Suh JM, 2014, NATURE, V513, P436, DOI 10.1038/nature13540; Suzuki T, 2000, BIOTECHNIQUES, V29, P332, DOI 10.2144/00292rv02; Tanaka Y, 2004, INT J CANCER, V109, P336, DOI 10.1002/ijc.11700; Thangavel C, 2008, DRUG METAB DISPOS, V36, P1884, DOI 10.1124/dmd.108.021451; Vanhorenbeeck V, 2002, BIOCHEM BIOPH RES CO, V292, P848, DOI 10.1006/bbrc.2002.6760; Vickers KC, 2013, J LIPID RES, V54, P1182, DOI 10.1194/jlr.R034801; Visioli F, 1998, LIFE SCI, V62, P541, DOI 10.1016/S0024-3205(97)01150-8; Wallrabenstein I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054950; Wang J, 2009, J ENDOCRINOL, V202, P337, DOI 10.1677/JOE-09-0136; Wei K, 2013, NAT MED, V19, P1331, DOI 10.1038/nm.3295; Wheatley D, 2005, J PSYCHOPHARMACOL, V19, P414, DOI 10.1177/0269881105053309; Yan WS, 2006, J BIOL CHEM, V281, P7856, DOI 10.1074/jbc.M512655200; Yu GY, 2012, AM J RESP CRIT CARE, V186, P752, DOI 10.1164/rccm.201202-0302OC; Zhang XK, 2010, CELL CYCLE, V9, P4437, DOI 10.4161/cc.9.22.13887; Zheng H, 2014, SCI REP-UK, V4, DOI 10.1038/srep07046; Zhu Bo, 2011, Zhonghua Yi Xue Za Zhi, V91, P3134	90	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0129951	10.1371/journal.pone.0129951	http://dx.doi.org/10.1371/journal.pone.0129951			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161641	Green Published, gold, Green Submitted			2022-12-26	WOS:000358162300011
J	Lupo, KD; Schmitt, DN; Kiahtipes, CA; Ndanga, JP; Young, DC; Simiti, B				Lupo, Karen D.; Schmitt, Dave N.; Kiahtipes, Christopher A.; Ndanga, Jean-Paul; Young, D. Craig; Simiti, Bernard			On Intensive Late Holocene Iron Mining and Production in the Northern Congo Basin and the Environmental Consequences Associated with Metallurgy in Central Africa	PLOS ONE			English	Article							AGE CENTRAL-AFRICA; RAIN-FOREST; LAND-USE; SOUTHERN CAMEROON; EQUATORIAL AFRICA; HUMAN OCCUPATION; HUMAN IMPACTS; WEST-AFRICA; CLIMATE; GABON	An ongoing question in paleoenvironmental reconstructions of the central African rainforest concerns the role that prehistoric metallurgy played in shaping forest vegetation. Here we report evidence of intensive iron-ore mining and smelting in forested regions of the northern Congo Basin dating to the late Holocene. Volumetric estimates on extracted iron-ore and associated slag mounds from prehistoric sites in the southern Central African Republic suggest large-scale iron production on par with other archaeological and historically-known iron fabrication areas. These data document the first evidence of intensive iron mining and production spanning approximately 90 years prior to colonial occupation (circa AD 1889) and during an interval of time that is poorly represented in the archaeological record. Additional site areas pre-dating these remains by 3-4 centuries reflect an earlier period of iron production on a smaller scale. Microbotanical evidence from a sediment core collected from an adjacent riparian trap shows a reduction in shade-demanding trees in concert with an increase in light-demanding species spanning the time interval associated with iron intensification. This shift occurs during the same time interval when many portions of the Central African witnessed forest transgressions associated with a return to moister and more humid conditions beginning 500-100 years ago. Although data presented here do not demonstrate that iron smelting activities caused widespread vegetation change in Central Africa, we argue that intense mining and smelting can have localized and potentially regional impacts on vegetation communities. These data further demonstrate the high value of pairing archeological and paleoenvironmental analyses to reconstruct regional-scale forest histories.	[Lupo, Karen D.; Schmitt, Dave N.; Kiahtipes, Christopher A.] So Methodist Univ, Dept Anthropol, Dallas, TX 75275 USA; [Ndanga, Jean-Paul; Simiti, Bernard] Univ Bangui, Ctr Univ Rech & Documentat Hist & Archeol Centraf, Bangui, Cent Afr Republ; [Young, D. Craig] Far Western Anthropol Res Grp, Carson City, NV USA	Southern Methodist University	Lupo, KD (corresponding author), So Methodist Univ, Dept Anthropol, Dallas, TX 75275 USA.	klupo@smu.edu		Kiahtipes, Christopher/0000-0002-8758-4605	National Science Foundation [0924242]; Institute for the Study of Earth and Man (ISEM); Southern Methodist University; Dedman College, Southern Methodist University; Far Western Anthropological Research Group (FWAR)	National Science Foundation(National Science Foundation (NSF)); Institute for the Study of Earth and Man (ISEM); Southern Methodist University; Dedman College, Southern Methodist University; Far Western Anthropological Research Group (FWAR)	Most of the work was supported by a grant from the National Science Foundation (No. 0924242) to KL. The processing and dating of some of the core samples were supported by small grants from the Institute for the Study of Earth and Man (ISEM), Southern Methodist University and Dedman College, Southern Methodist University to CAK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Far Western Anthropological Research Group (FWAR), provided indirect support in the form of salaries for one author (DCY). FWAR did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	[Anonymous], 1887, PROCEEDINGS OF THE R, V9, P440; Aremu DA, 2004, THE ORIGINS OF IRON, P149; Aubreville AMA, 1947, THE DISAPPEARANCE OF, V1; Bahuchet S, 1985, LES PYGMEES AKA ET L; Bahuchet S., 1982, POLITICS HIST BAND S, P189; Barton H, 2012, QUATERN INT, V249, P1, DOI 10.1016/j.quaint.2011.07.044; Bayon G, 2012, SCIENCE, V335, P1219, DOI 10.1126/science.1215400; Brncic TM, 2007, PHILOS T R SOC B, V362, P229, DOI 10.1098/rstb.2006.1982; Brncic TM, 2009, HOLOCENE, V19, P79, DOI 10.1177/0959683608098954; Clist B, 1989, NSI, V6, P79; Clist B, 1988, NSI LIBREVILLE, V2, P24; David N., 1977, W AFRICAN J ARCHAEOL, V7, P17; de Barros P., 1988, AFR ARCHAEOL REV, V69, P91, DOI DOI 10.1007/BF01117114; de Barros P, 1986, AFRICA LOND, V56, P152, DOI [10.1017/S0001972000041553, DOI 10.1017/S0001972000041553]; DE BARROS P, 2000, ANCIENT AFRICAN META, P147; de Maret P., 1996, HOW OLD IS IRON AGE, P29; de Maret P., 2004, ORIGINS IRON METALLU, P127; de Maret P., 1985, AFRICAN IRON WORKING, P73; deMenocal P, 2000, SCIENCE, V288, P2198, DOI 10.1126/science.288.5474.2198; DIGOMBE L, 1988, CURR ANTHROPOL, V29, P179, DOI 10.1086/203624; DIGOMBE L, 1985, CURR ANTHROPOL, V26, P516, DOI 10.1086/203317; Eggert M. K. H., 1993, ARCHAEOLOGY AFRICA F, P289; Elenga H, 1996, CR ACAD SCI II A, V323, P403; Essomba J-M., 2004, ORIGINS IRON METALLU, P135; Faegri K, 1989, TEXTBOOK OF POLLEN A; Fairhead J., 1998, REFRAMING DEFORESTAT; Fay JM, 1997, THESIS; Fluzin P., 2004, THE ORIGINS OF IRON, P65; Giles- Vernick T, 2002, CUTTING THE VINES OF; Giresse P, 2009, J PALEOLIMNOL, V41, P369, DOI 10.1007/s10933-008-9231-5; Gosling WD, 2013, REV PALAEOBOT PALYNO, V199, P1, DOI 10.1016/j.revpalbo.2013.01.003; Gotilogue S, 2000, STUDIES IN AFRICAN A, V7; GOUCHER CL, 1981, J AFR HIST, V22, P179, DOI 10.1017/S0021853700019393; GUYER JI, 1986, CAH ETUD AFR, V26, P577, DOI 10.3406/cea.1986.1685; Haaland R., 1985, AFRICAN IRON WORKING, P50; Hart TB, 1996, BIODIVERSITY OF AFRICAN PLANTS, P545; Holl A.F.C., 2000, ANCIENT AFRICAN META, P1; Holl AFC, 2009, J WORLD PREHIST, V22, P415, DOI 10.1007/s10963-009-9030-6; Itambi AC, 2010, J QUATERNARY SCI, V25, P267, DOI 10.1002/jqs.1306; Kiahtipes C., 2011, FARMING, V2011, P1, DOI DOI 10.3828/BFARM.2011.2.4; Killick D., 2004, J AFR ARCHAEOL, V2, P97, DOI [10.3213/1612-1651-10021, DOI 10.3213/1612-1651-10021]; Kliemann K, 1999, CHALLENGING ELUSIVEN, P261; L-M Maes-Diop, 2004, THE ORIGINS OF IRON, P189; Lezine AM, 2013, CR GEOSCI, V345, P327, DOI 10.1016/j.crte.2013.03.001; Lupo K.D., 2014, CONGO BASIN HUNTER G, P59; Lupo KD, 2013, J ARCHAEOL METHOD TH, V20, P420, DOI 10.1007/s10816-012-9159-y; MacEachern S., 1996, ASPECTS AFRICAN ARCH, P489; MALEY J, 1992, B SOC GEOL FR, V163, P363; Maley J, 2001, VEG HIST ARCHAEOBOT, V10, P117, DOI 10.1007/PL00006920; Maley J, 2012, SCIENCE, V337, DOI [10.1126/science.1221747, 10.1126/science.1221820]; Martinelli B, 2004, THE ORIGINS OF IRON, P165; Meister C, 2010, AFR ARCHAEOL REV, V27, P237, DOI 10.1007/s10437-010-9081-1; Meister C, 2008, J AFR ARCHAEOL, V6, P183, DOI 10.3213/1612-1651-10109; Miller D., 2004, J AFR ARCHAEOL, V2, P23, DOI DOI 10.3213/1612-1651-10017; Neumer M, 2008, PALAEOECOL AFR, V28, P121; Ngomanda A, 2005, HOLOCENE, V15, P1021, DOI 10.1191/0959683605hl875ra; Ngomanda A, 2009, CLIM PAST, V5, P647, DOI 10.5194/cp-5-647-2009; Oslisly R, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0304; Palmer PG, 1985, EAST AFRICAN GRASSES, VIII; Pendere-Sengue Simiti B., 2004, REVUE CENTRA FRICAIN, V1; Pole LM, 1985, AFRICAN IRON WORKING, P142; REID A, 1995, WORLD ARCHAEOL, V27, P144, DOI 10.1080/00438243.1995.9980298; Richards PW, 1952, THE TROPICAL RAIN FO; Runge J, 2002, CATENA, V48, P67, DOI 10.1016/S0341-8162(02)00010-3; Rupp S., 1998, RESOURCE USE TRINATI, P41; Salzmann U, 2005, HOLOCENE, V15, P190, DOI 10.1191/0959683605hl799rp; Sassen M, 2013, FOREST ECOL MANAG, V307, P206, DOI 10.1016/j.foreco.2013.07.010; Schmidt PR, 1996, THE CULTURE AND TECH; SCHWARTZ D, 1990, CR ACAD SCI II, V310, P1293; Shinnie P. L., 1985, AFRICAN IRON WORKING, P28; SOWUNMI M A, 1973, Grana, V13, P145, DOI 10.1080/00173137309429891; Sowunmi M. A, 2002, DROUGHTS FOOD CULTUR, P95; Spinage CA., 2012, AFRICAN ECOLOGY BENC; Sundstrom L, 1974, THE EXCHANGE ECONOMY; SWAINE MD, 1992, J VEG SCI, V3, P365, DOI 10.2307/3235762; Tinner W, 2003, HOLOCENE, V13, P499, DOI 10.1191/0959683603hl615rp; Tovar C, 2014, ECOGRAPHY, V37, P1139, DOI 10.1111/ecog.00697; van Gemerden BS, 2003, J BIOGEOGR, V30, P1381, DOI 10.1046/j.1365-2699.2003.00937.x; van Noten F, 1985, AFRICAN IRONWORKING, P102; VANSINA J, 1962, J AFR HIST, V3, P375, DOI 10.1017/S0021853700003303; Vansina J, 1990, PATHS IN THE RAINFOR; Vincens A, 1999, J BIOGEOGR, V26, P879, DOI 10.1046/j.1365-2699.1999.00333.x; Warnier J. -P., 2012, CAMEROON GRASSFIELDS; WARNIER JP, 1979, AFRICA, V49, P329, DOI 10.2307/1159222; White E, 1983, THE VEGETATION OF AF; White L. J. T., 2001, African rain forest ecology and conservation: an interdisciplinary perspective, P3; White LJT, 1999, GLOBAL ECOL BIOGEOGR, V8, P355, DOI 10.1046/j.1365-2699.1999.00149.x; White LJT., 2001, AFRICAN RAIN FOREST, P47; Willis KJ, 2004, SCIENCE, V304, P402, DOI 10.1126/science.1093991; ZANGATO E., 1999, CAMBRIDGE MONOGRAPHS, V46; Zangato E, 2007, LES ATELIERS DOBOUI	91	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132632	10.1371/journal.pone.0132632	http://dx.doi.org/10.1371/journal.pone.0132632			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161540	Green Submitted, gold, Green Published			2022-12-26	WOS:000358162300160
J	Rambaud-Althaus, C; Shao, AF; Kahama-Maro, J; Genton, B; d'Acremont, V				Rambaud-Althaus, Clotilde; Shao, Amani Flexson; Kahama-Maro, Judith; Genton, Blaise; d'Acremont, Valerie			Managing the Sick Child in the Era of Declining Malaria Transmission: Development of ALMANACH, an Electronic Algorithm for Appropriate Use of Antimicrobials	PLOS ONE			English	Article							URINARY-TRACT-INFECTION; RAPID DIAGNOSTIC-TESTS; ACUTE OTITIS-MEDIA; INTEGRATED MANAGEMENT; HEALTH-WORKERS; TYPHOID-FEVER; PLASMODIUM-FALCIPARUM; FEBRILE CHILDREN; RHEUMATIC-FEVER; WESTERN KENYA	Objective To review the available knowledge on epidemiology and diagnoses of acute infections in children aged 2 to 59 months in primary care setting and develop an electronic algorithm for the Integrated Management of Childhood Illness to reach optimal clinical outcome and rational use of medicines. Methods A structured literature review in Medline, Embase and the Cochrane Database of Systematic Review (CDRS) looked for available estimations of diseases prevalence in outpatients aged 2-59 months, and for available evidence on i) accuracy of clinical predictors, and ii) performance of point-of-care tests for targeted diseases. A new algorithm for the management of childhood illness (ALMANACH) was designed based on evidence retrieved and results of a study on etiologies of fever in Tanzanian children outpatients. Findings The major changes in ALMANACH compared to IMCI (2008 version) are the following: i) assessment of 10 danger signs, ii) classification of non-severe children into febrile and non-febrile illness, the latter receiving no antibiotics, iii) classification of pneumonia based on a respiratory rate threshold of 50 assessed twice for febrile children 12-59 months; iv) malaria rapid diagnostic test performed for all febrile children. In the absence of identified source of fever at the end of the assessment, v) urine dipstick performed for febrile children <2years to consider urinary tract infection, vi) classification of 'possible typhoid' for febrile children >2 years with abdominal tenderness; and lastly vii) classification of 'likely viral infection' in case of negative results. Conclusion This smartphone-run algorithm based on new evidence and two point-of-care tests should improve the quality of care of <5 year children and lead to more rational use of antimicrobials.	[Rambaud-Althaus, Clotilde; Shao, Amani Flexson; Genton, Blaise; d'Acremont, Valerie] Swiss Trop & Publ Hlth Inst, Epidemiol & Publ Hlth Dept, Basel, Switzerland; [Rambaud-Althaus, Clotilde; Shao, Amani Flexson; Genton, Blaise; d'Acremont, Valerie] Univ Basel, Basel, Switzerland; [Shao, Amani Flexson] Tukuyu Med Res Ctr, Natl Inst Med Res, Tukuyu, Tanzania; [Kahama-Maro, Judith] Dar Es Salaam City Council, City Med Off Hlth, Dar Es Salaam, Tanzania; [Genton, Blaise; d'Acremont, Valerie] Univ Hosp, Infect Dis Serv, Lausanne, Switzerland; [Genton, Blaise] Univ Hosp, Dept Ambulatory Care & Community Med, Lausanne, Switzerland	University of Basel; Swiss Tropical & Public Health Institute; University of Basel; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Rambaud-Althaus, C (corresponding author), Swiss Trop & Publ Hlth Inst, Epidemiol & Publ Hlth Dept, Basel, Switzerland.	Clotilde.Rambaud@unibas.ch	Rambaud-Althaus, Clotilde/GLR-5703-2022	Rambaud-Althaus, Clotilde/0000-0002-0940-8833	Swiss National Science Foundation [IZ70Z0 - 124023]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The study was part of a larger project which aimed at improving the quality of health care and rational use of drugs for children in Tanzania (PeDiAtrick project), funded by the Swiss National Science Foundation (www.snf.ch; Grant Number IZ70Z0 - 124023). The funders played no role in study design, collection, analysis, interpretation of data, writing the report, or in the decision to submit the paper for publication. Pan Africa Clinical Trial registration number PACTR201011000262218.	Animut A, 2009, JPN J INFECT DIS, V62, P107; Baiden F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034073; Baiden F, 2011, TROP MED INT HEALTH, V16, P142, DOI 10.1111/j.1365-3156.2010.02692.x; Barat L, 1999, AM J TROP MED HYG, V60, P1024, DOI 10.4269/ajtmh.1999.60.1024; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Carapetis JR, 2000, EPIDEMIOL INFECT, V124, P239, DOI 10.1017/S0950268800003514; Chanda P, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-49; Coker TR, 2010, JAMA-J AM MED ASSOC, V304, P2161, DOI 10.1001/jama.2010.1651; D'Acremont V, 2014, NEW ENGL J MED, V370, P809, DOI 10.1056/NEJMoa1214482; D'Acremont V, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-107; D'Acremont V, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-240; d'Acremont V, 2010, CLIN INFECT DIS, V51, P506, DOI 10.1086/655688; Davis TME, 1999, CLIN INFECT DIS, V28, P582, DOI 10.1086/515143; Dellinger RP, 2008, CRIT CARE MED, V36, P296, DOI 10.1097/01.CCM.0000298158.12101.41; Downs SH, 1999, PEDIATRICS, V103, DOI 10.1542/peds.103.4.e54; Factor SH, 2001, B WORLD HEALTH ORGAN, V79, P1096; Faucher JF, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-104; Feikin DR, 2013, PEDIATR INFECT DIS J, V32, pE14, DOI 10.1097/INF.0b013e31826fd39b; Gaieski DF, 2010, CRIT CARE MED, V38, P1045, DOI 10.1097/CCM.0b013e3181cc4824; Gorelick MH, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.5.e54; Gove S, 1997, B WORLD HEALTH ORGAN, V75, P7; Hazir T, 2011, CLIN INFECT DIS, V52, P293, DOI 10.1093/cid/ciq142; HEALE WF, 1973, DRUGS, V6, P230, DOI 10.2165/00003495-197306030-00007; HEIKKINEN T, 1995, ARCH PEDIAT ADOL MED, V149, P26, DOI 10.1001/archpedi.1995.02170130028006; HOBERMAN A, 1993, J PEDIATR-US, V123, P17, DOI 10.1016/S0022-3476(05)81531-8; Hosoglu S, 2006, T ROY SOC TROP MED H, V100, P1068, DOI 10.1016/j.trstmh.2005.12.007; INGVARSSON L, 1982, ACTA PAEDIATR SCAND, V71, P705, DOI 10.1111/j.1651-2227.1982.tb09507.x; Kalter HD, 1997, B WORLD HEALTH ORGAN, V75, P65; Khallaf N, 1996, World Health Forum, V17, P297; Khan M, 1998, ACTA TROP, V69, P165, DOI 10.1016/S0001-706X(97)00139-3; Kolstad PR, 1997, B WORLD HEALTH ORGAN, V75, P77; KROBER MS, 1985, AM J DIS CHILD, V139, P889, DOI 10.1001/archpedi.1985.02140110043025; Kuvandik C, 2009, NEW MICROBIOL, V32, P25; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Mayor S, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c3234; Ministry of Health and Social Welfare (MoHSW), 2007, STAND TREATM GUID ST; Msellem MI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000070; Mtove G, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-290; Mubi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019753; Musa-Aisien AS, 2003, ANN TROP PAEDIATR, V23, P39, DOI 10.1179/000349803125002850; Neopane A, 2006, Kathmandu Univ Med J (KUMJ), V4, P307; NIEMELA M, 1994, PEDIATR INFECT DIS J, V13, P765, DOI 10.1097/00006454-199409000-00002; Njama-Meya D, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-7; Paxton LA, 1996, B WORLD HEALTH ORGAN, V74, P613; Perkins BA, 1997, B WORLD HEALTH ORGAN, V75, P33; Rovers MM, 2006, LANCET, V368, P1429, DOI 10.1016/S0140-6736(06)69606-2; Rowe SY, 2007, TROP MED INT HEALTH, V12, P651, DOI 10.1111/j.1365-3156.2007.01824.x; Salaria Manju, 2003, Indian Journal of Pediatrics, V70, P621, DOI 10.1007/BF02724250; Sanders S, 1999, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000219.PUB2; Senn N, 2012, CLIN INFECT DIS, V54, P644, DOI 10.1093/cid/cir901; Shaikh N, 2008, PEDIATR INFECT DIS J, V27, P302, DOI 10.1097/INF.0b013e31815e4122; Shaikh N, 2007, JAMA-J AM MED ASSOC, V298, P2895, DOI 10.1001/jama.298.24.2895; Shaikh N, 2010, PEDIATRICS, V126, pE557, DOI 10.1542/peds.2009-2648; Shaw KN, 1998, PEDIATRICS, V102, part. no., DOI 10.1542/peds.102.2.e16; Simoes EAF, 1997, B WORLD HEALTH ORGAN, V75, P43; Subhi R, 2009, LANCET INFECT DIS, V9, P219, DOI 10.1016/S1473-3099(09)70071-4; Thiam S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018419; Tibazarwa KB, 2008, HEART, V94, P1534, DOI 10.1136/hrt.2007.141309; UHARI M, 1995, ACTA PAEDIATR, V84, P90, DOI 10.1111/j.1651-2227.1995.tb13493.x; Ukwaja KN, 2010, ETHIOP J HEALTH SCI, V20, P179; Van den Bruel A, 2010, LANCET, V375, P834, DOI 10.1016/S0140-6736(09)62000-6; Van Hemelrijck MJJ, 2009, TROP MED INT HEALTH, V14, P62, DOI 10.1111/j.1365-3156.2008.02184.x; Vollaard AM, 2005, T ROY SOC TROP MED H, V99, P440, DOI 10.1016/j.trstmh.2004.09.012; Weber MW, 1997, B WORLD HEALTH ORGAN, V75, P25; Whiting P., 2005, BMC PEDIATR, V5, P4, DOI DOI 10.1186/1471-2431-5-4; WHO, 2010, GUID TREATM MAL, DOI [10.1186/1475-2875-9-212, DOI 10.1186/1475-2875-9-212]; WHO Department of Child and Adolescent Health and Development, 2005, UR TRACT INF INF CHI; WHO UNICEF, 2008, INTEGRATED MANAGEMEN; Williams GJ, 2010, LANCET INFECT DIS, V10, P240, DOI 10.1016/S1473-3099(10)70031-1; Woods WA, 1999, PEDIATR EMERG CARE, V15, P338, DOI 10.1097/00006565-199910000-00011; World Health Organization, 2014, INTEGRATED MANAGEMEN; World Health Organization M, 2009, MED US PRIM CAR DEV	73	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0127674	10.1371/journal.pone.0127674	http://dx.doi.org/10.1371/journal.pone.0127674			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161753	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000358162300006
J	Calap-Quintana, P; Soriano, S; Llorens, JV; Al-Ramahi, I; Botas, J; Molto, MD; Martinez-Sebastian, MJ				Calap-Quintana, Pablo; Soriano, Sirena; Vicente Llorens, Jose; Al-Ramahi, Ismael; Botas, Juan; Dolores Molto, Maria; Jose Martinez-Sebastian, Maria			TORC1 Inhibition by Rapamycin Promotes Antioxidant Defences in a Drosophila Model of Friedreich's Ataxia	PLOS ONE			English	Article							OXIDATIVE STRESS-RESPONSE; EXTENDS LIFE-SPAN; FRATAXIN DEFICIENCY; IRON CHAPERONE; YEAST MODEL; PATHWAY; MECHANISMS; RESISTANCE; EXPRESSION; INCREASES	Friedreich's ataxia (FRDA), the most common inherited ataxia in the Caucasian population, is a multisystemic disease caused by a significant decrease in the frataxin level. To identify genes capable of modifying the severity of the symptoms of frataxin depletion, we performed a candidate genetic screen in a Drosophila RNAi-based model of FRDA. We found that genetic reduction in TOR Complex 1 (TORC1) signalling improves the impaired motor performance phenotype of FRDA model flies. Pharmacologic inhibition of TORC1 signalling by rapamycin also restored this phenotype and increased the lifespan and ATP levels. Furthermore, rapamycin reduced the altered levels of malondialdehyde + 4-hydroxyalkenals and total glutathione of the model flies. The rapamycin-mediated protection against oxidative stress is due in part to an increase in the transcription of antioxidant genes mediated by cap-n-collar (Drosophila ortholog of Nrf2). Our results suggest that autophagy is indeed necessary for the protective effect of rapamycin in hyperoxia. Rapamycin increased the survival and aconitase activity of model flies subjected to high oxidative insult, and this improvement was abolished by the autophagy inhibitor 3-methyladenine. These results point to the TORC1 pathway as a new potential therapeutic target for FRDA and as a guide to finding new promising molecules for disease treatment.	[Calap-Quintana, Pablo; Soriano, Sirena; Vicente Llorens, Jose; Dolores Molto, Maria; Jose Martinez-Sebastian, Maria] Univ Valencia, Dept Genet, Valencia, Spain; [Soriano, Sirena; Al-Ramahi, Ismael; Botas, Juan] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Dolores Molto, Maria] INCLIVA, CIBERSAM, Valencia, Spain	University of Valencia; Baylor College of Medicine; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM	Molto, MD (corresponding author), Univ Valencia, Dept Genet, Valencia, Spain.	dmolto@uv.es	Al-Ramahi, Ismael/B-4000-2017; VICENTE, LIERN/B-6112-2008	Al-Ramahi, Ismael/0000-0002-1275-1114; VICENTE, LIERN/0000-0001-5883-9640; Martinez-Sebastian, Maria-Jose/0000-0001-5549-7921; Llorens, Jose V./0000-0001-9823-6246; Soriano, Sirena/0000-0001-9967-7262; Molto, Maria Dolores/0000-0001-5219-2022	European Community's Seventh Framework Program [242193 EFACTS]; Fundacio la Marato TV3 of Spain [101932]; NIH [R01-NS42179]; La Fundacio la Marato TV3 of Spain; Ministerio de Ciencia e Innovacion of Spain; Prometeo Program from Generalitat Valenciana [PROMETEOII/2014/067]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042179] Funding Source: NIH RePORTER	European Community's Seventh Framework Program(European Commission); Fundacio la Marato TV3 of Spain; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); La Fundacio la Marato TV3 of Spain; Ministerio de Ciencia e Innovacion of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Prometeo Program from Generalitat Valenciana; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the European Community's Seventh Framework Program FP7/2007-2013 [grant agreement no. 242193 EFACTS] and the Fundacio la Marato TV3 of Spain [exp 101932]. Work in the Botas laboratory was supported by the R01-NS42179 NIH grant. P.C.-Q. is a recipient of a research contract from La Fundacio la Marato TV3 of Spain; S.S. was a recipient of a fellowship from Ministerio de Ciencia e Innovacion of Spain; and J.V.L. was supported by a research contract from the European Community's Seventh Framework Program FP7/2007-2013 [grant agreement no. 242193 EFACTS]. This work was supported by a grant of the Prometeo Program from Generalitat Valenciana [PROMETEOII/2014/067].	Al-Mahdawi S, 2006, GENOMICS, V88, P580, DOI 10.1016/j.ygeno.2006.06.015; Anderson PR, 2008, P NATL ACAD SCI USA, V105, P611, DOI 10.1073/pnas.0709691105; Anderson PR, 2005, HUM MOL GENET, V14, P3397, DOI 10.1093/hmg/ddi367; Auchere F, 2008, HUM MOL GENET, V17, P2790, DOI 10.1093/hmg/ddn178; Barcelo H, 2002, GENESIS, V34, P83, DOI 10.1002/gene.10132; Bjedov I, 2010, CELL METAB, V11, P35, DOI 10.1016/j.cmet.2009.11.010; Bonawitz ND, 2007, CELL METAB, V5, P265, DOI 10.1016/j.cmet.2007.02.009; Bryan HK, 2013, BIOCHEM PHARMACOL, V85, P705, DOI 10.1016/j.bcp.2012.11.016; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Canizares J, 2000, GENE, V256, P35, DOI 10.1016/S0378-1119(00)00343-7; Carracedo A, 2008, ONCOGENE, V27, P5527, DOI 10.1038/onc.2008.247; Delatycki MB, 2012, J CHILD NEUROL, V27, P1133, DOI 10.1177/0883073812448230; Emond M, 2000, NEUROLOGY, V55, P1752, DOI 10.1212/WNL.55.11.1752; Gibson TJ, 1996, TRENDS NEUROSCI, V19, P465, DOI 10.1016/S0166-2236(96)20054-2; Gimenez-Cassina A, 2011, GENE THER, V18, P1015, DOI 10.1038/gt.2011.45; Healy DG, 2008, LANCET NEUROL, V7, P583, DOI 10.1016/S1474-4422(08)70117-0; Imai Y, 2008, EMBO J, V27, P2432, DOI 10.1038/emboj.2008.163; Irazusta V, 2006, J BIOL CHEM, V281, P12227, DOI 10.1074/jbc.M511649200; Kapahi P, 2010, CELL METAB, V11, P453, DOI 10.1016/j.cmet.2010.05.001; Kaplan B, 2014, TRANSPLANT REV-ORLAN, V28, P126, DOI 10.1016/j.trre.2014.03.002; Katewa SD, 2011, EXP GERONTOL, V46, P382, DOI 10.1016/j.exger.2010.11.036; Kawasaki H, 2005, CYTOTECHNOLOGY, V49, P67, DOI 10.1007/s10616-005-5414-3; Kearney M, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007791.pub3; Kofman AE, 2012, AGING-US, V4, P279, DOI 10.18632/aging.100451; Kondapalli KC, 2008, BIOCHEMISTRY-US, V47, P6917, DOI 10.1021/bi800366d; Layalle S, 2008, DEV CELL, V15, P568, DOI 10.1016/j.devcel.2008.08.003; Lefevre S, 2012, FEBS LETT, V586, P143, DOI 10.1016/j.febslet.2011.12.002; Llorens JV, 2007, FASEB J, V21, P333, DOI 10.1096/fj.05-5709com; Lodi R, 2001, ANN NEUROL, V49, P590; Loewith R, 2011, GENETICS, V189, P1177, DOI 10.1534/genetics.111.133363; Lynch DR, 2002, MUSCLE NERVE, V25, P664, DOI 10.1002/mus.10077; Marobbio CMT, 2012, MITOCHONDRION, V12, P156, DOI 10.1016/j.mito.2011.07.001; Monros E, 1997, AM J HUM GENET, V61, P101, DOI 10.1086/513887; Napoli E, 2006, ANTIOXID REDOX SIGN, V8, P506, DOI 10.1089/ars.2006.8.506; Navarro JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021017; Navarro JA, 2010, HUM MOL GENET, V19, P2828, DOI 10.1093/hmg/ddq183; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Palau F, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-47; Park J, 2013, NATURE, V498, P325, DOI 10.1038/nature12204; Pastore A, 2003, J BIOL CHEM, V278, P42588, DOI 10.1074/jbc.M301872200; Patel PH, 2006, J CELL SCI, V119, P4285, DOI 10.1242/jcs.03199; Paupe V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004253; Perdomini M, 2014, NAT MED, V20, P546, DOI 10.1038/nm.3510; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; Ravikumar B, 2006, HUM MOL GENET, V15, P1209, DOI 10.1093/hmg/ddl036; Ristow M, 2003, J CLIN INVEST, V112, P527, DOI 10.1172/JCI200318107; Robida-Stubbs S, 2012, CELL METAB, V15, P713, DOI 10.1016/j.cmet.2012.04.007; Runkoa AP, 2008, FEBS LETT, V582, P715, DOI 10.1016/j.febslet.2008.01.046; Rusten TE, 2004, DEV CELL, V7, P179, DOI 10.1016/j.devcel.2004.07.005; Sarkar S, 2013, BIOCHEM SOC T, V41, P1103, DOI 10.1042/BST20130134; Schmucker S, 2010, HUM MOL GENET, V19, pR103, DOI 10.1093/hmg/ddq165; Shan YX, 2013, ANTIOXID REDOX SIGN, V19, P1481, DOI 10.1089/ars.2012.4537; Shidara Y, 2010, J NEUROSCI, V30, P11369, DOI 10.1523/JNEUROSCI.0529-10.2010; Simonsen A, 2008, AUTOPHAGY, V4, P176, DOI 10.4161/auto.5269; Soragni E, 2012, J CHILD NEUROL, V27, P1164, DOI 10.1177/0883073812448533; Soriano S, 2013, GENE, V521, P274, DOI 10.1016/j.gene.2013.02.049; Tettweiler G, 2005, GENE DEV, V19, P1840, DOI 10.1101/gad.1311805; Tozzi G, 2002, ARCH DIS CHILD, V86, P376, DOI 10.1136/adc.86.5.376; Tricoire H, 2014, HUM MOL GENET, V23, P968, DOI 10.1093/hmg/ddt493; Turpaev KT, 2013, BIOCHEMISTRY-MOSCOW+, V78, P111, DOI 10.1134/S0006297913020016; Vazquez-Manrique RP, 2005, FASEB J, V19, P172, DOI 10.1096/fj.05-4212fje; Wong A, 1999, HUM MOL GENET, V8, P425, DOI 10.1093/hmg/8.3.425; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zid BM, 2009, CELL, V139, P149, DOI 10.1016/j.cell.2009.07.034	64	41	41	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2015	10	7							e0132376	10.1371/journal.pone.0132376	http://dx.doi.org/10.1371/journal.pone.0132376			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EW	26158631	Green Published, gold, Green Submitted			2022-12-26	WOS:000358161200052
J	Fernandez-Gauna, B; Etxeberria-Agiriano, I; Grana, M				Fernandez-Gauna, Borja; Etxeberria-Agiriano, Ismael; Grana, Manuel			Learning Multirobot Hose Transportation and Deployment by Distributed Round-Robin Q-Learning	PLOS ONE			English	Article							REINFORCEMENT; SYSTEM; MDPS	Multi-Agent Reinforcement Learning (MARL) algorithms face two main difficulties: the curse of dimensionality, and environment non-stationarity due to the independent learning processes carried out by the agents concurrently. In this paper we formalize and prove the convergence of a Distributed Round Robin Q-learning (D-RR-QL) algorithm for cooperative systems. The computational complexity of this algorithm increases linearly with the number of agents. Moreover, it eliminates environment non sta tionarity by carrying a round-robin scheduling of the action selection and execution. That this learning scheme allows the implementation of Modular State-Action Vetoes (MSAV) in cooperative multi-agent systems, which speeds up learning convergence in over-constrained systems by vetoing state-action pairs which lead to undesired termination states (UTS) in the relevant state-action subspace. Each agent's local state-action value function learning is an independent process, including the MSAV policies. Coordination of locally optimal policies to obtain the global optimal joint policy is achieved by a greedy selection procedure using message passing. We show that D-RR-QL improves over state-of-the-art approaches, such as Distributed Q-Learning, Team Q-Learning and Coordinated Reinforcement Learning in a paradigmatic Linked Multi-Component Robotic System (L-MCRS) control problem: the hose transportation task. L-MCRS are over-constrained systems with many UTS induced by the interaction of the passive linking element and the active mobile robots.	[Fernandez-Gauna, Borja; Etxeberria-Agiriano, Ismael] Univ Basque Country UPV EHU, Polytech Inst, Vitoria, Spain; [Fernandez-Gauna, Borja] Univ Basque Country UPV EHU, Computat Intelligence Grp, Vitoria, Spain; [Grana, Manuel] Univ Basque Country UPV EHU, Computat Intelligence Grp, San Sebastian, Spain; [Grana, Manuel] Wroclaw Univ Technol WrUT, ENGINE Ctr, Wroclaw, Poland	University of Basque Country; University of Basque Country; University of Basque Country; Wroclaw University of Science & Technology	Grana, M (corresponding author), Univ Basque Country UPV EHU, Computat Intelligence Grp, San Sebastian, Spain.	manuel.grana@ehu.eus	Fernández-Gauna, Borja/D-8257-2013; Romay, Manuel M. Graña/L-1341-2014; Etxeberria-Agiriano, ismael/C-2576-2014; Fernandez-Gauna, Borja/AAI-9493-2020; Hernandez, María/GYU-3543-2022	Fernández-Gauna, Borja/0000-0001-9233-2333; Romay, Manuel M. Graña/0000-0001-7373-4097; Etxeberria-Agiriano, ismael/0000-0001-6146-3891; Fernandez-Gauna, Borja/0000-0001-9233-2333; Kudai, Bortx/0000-0002-6213-5096	EU [317947]; Ministerio de Ciencia e Innovacion of the Spanish Government (MINECO) [TIN2011-23823]; FEDER funds; EC [316097]; ENGINE European Research Centre of Network Intelligence for Innovation Enhancement;  [IT874-13]	EU(European Commission); Ministerio de Ciencia e Innovacion of the Spanish Government (MINECO); FEDER funds(European Commission); EC(European CommissionEuropean Commission Joint Research Centre); ENGINE European Research Centre of Network Intelligence for Innovation Enhancement; 	This research has been partially funded by EU through SandS project, grant agreement no 317947. This research has been partially funded by grant TIN2011-23823 of the Ministerio de Ciencia e Innovacion of the Spanish Government (MINECO), with FEDER funds. The GIC has been supported by grant IT874-13 as university research group category AMG was supported by EC under FP7, Coordination and Support Action, Grant Agreement Number 316097, ENGINE European Research Centre of Network Intelligence for Innovation Enhancement. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbeel P, 2005, ICML ACM INT C PROCE, V119, P1, DOI 10.1145/1102351.1102352; AHA DW, 1991, MACH LEARN, V6, P37, DOI 10.1007/BF00153759; [Anonymous], [No title captured]; Bocicor MI, 2011, STUD INFORM CONTROL, V20, P221; Bowling Michael, 2002, BAAAI, P11; Boyan J. A., 1995, Advances in Neural Information Processing Systems 7, P369; Busoniu L, 2008, IEEE T SYST MAN CY C, V38, P156, DOI 10.1109/TSMCC.2007.913919; Cheng XB, 2007, LECT NOTES COMPUT SC, V4489, P90; Claus C., 1997, P 15 NAT C ART INT, P746; Crites RH, 1996, ADV NEUR IN, V8, P1017; Czibula G, 2011, J COMPUTER TECHNOLOG, P404; Dietterich T. G., 2000, Abstractions, Reformulation, and Approximation. 4th International Symposium, SARA 2000. Proceedings (Lecture Notes in Artificial Intelligence Vol.1864), P26; Duro RJ, 2010, INFORM SCIENCES, V180, P2635, DOI 10.1016/j.ins.2010.02.005; Echegoyen Z, 2010, ROBOT AUTON SYST, V58, P1292, DOI 10.1016/j.robot.2010.08.008; Fernandez-Gauna B., 2011, INT J ARTIF INTELL, V6, P183; Fernandez-Gauna B, 2014, INFORM SCI IN PRESS; Fernandez-Gauna B, 2013, ROBOT AUTON SYST, V61, P694, DOI 10.1016/j.robot.2012.07.020; Fernandez-Gauna B, 2013, INFORM SCIENCES, V232, P309, DOI 10.1016/j.ins.2012.12.021; Fernandez-Gauna B, 2010, NEURAL NETW WORLD, V20, P913; Gang Zhao, 2010, Proceedings 2010 Sixth International Conference on Natural Computation (ICNC 2010), P3830, DOI 10.1109/ICNC.2010.5582551; Geibel P, 2005, J ARTIF INTELL RES, V24, P81, DOI 10.1613/jair.1666; Geibel P., 2001, P 18 INT C MACH LEAR, P162; Geibel P, 2006, LECT NOTES COMPUT SC, V4212, P646; Guestrin C, 2002, ADV NEUR IN, V14, P1523; Guestrin C., 2002, ICML, P227; Hans A., 2008, ESANN, P143; Hengst B, 2004, LECT NOTES COMPUT SC, V3201, P144; Kaelbling LP, 1996, J ARTIF INTELL RES, V4, P237, DOI 10.1613/jair.301; Kapetanakis S, 2002, EIGHTEENTH NATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE (AAAI-02)/FOURTEENTH INNOVATIVE APPLICATIONS OF ARTIFICIAL INTELLIGENCE CONFERENCE (IAAI-02), PROCEEDINGS, P326; Kok JR, 2006, J MACH LEARN RES, V7, P1789; Littman M. L., 2001, Cognitive Systems Research, V2, P55, DOI 10.1016/S1389-0417(01)00015-8; Mariano CE, 2000, MEMORIAS SEGUNDO ENC, P12; Matignon L, 2007, 2007 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, VOLS 1-9, P64, DOI 10.1109/IROS.2007.4399095; Melo FS, 2010, AUTON AGENT MULTI-AG, V21, P321, DOI 10.1007/s10458-009-9104-y; Schneider J, 1999, MACHINE LEARNING, PROCEEDINGS, P371; Servin A, 2008, LECT NOTES ARTIF INT, V4865, P211, DOI 10.1007/978-3-540-77949-0_15; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Sutton RS, 1996, ADV NEUR IN, V8, P1038; Tadepalli P., 1996, Machine Learning. Proceedings of the Thirteenth International Conference (ICML '96), P471; Tamakoshi H., 2001, Artificial Life and Robotics, V5, P202, DOI 10.1007/BF02481502; Theetten A, 2008, COMPUT AIDED DESIGN, V40, P35, DOI 10.1016/j.cad.2007.05.008; Wang X., 2002, ADV NEURAL INFORM PR, P1603; Watkins C. J. C. H., 1989, PHD DISSERTATION; WATKINS CJCH, 1992, MACH LEARN, V8, P279, DOI 10.1007/BF00992698; Xiao HR, 2007, 2007 IEEE INTERNATIONAL CONFERENCE ON AUTOMATION AND LOGISTICS, VOLS 1-6, P2650, DOI 10.1109/ICAL.2007.4339028	46	11	11	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2015	10	7							e0127129	10.1371/journal.pone.0127129	http://dx.doi.org/10.1371/journal.pone.0127129			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EW	26158587	Green Submitted, Green Published, gold			2022-12-26	WOS:000358161200003
J	Urin, V; Levin, D; Sharma, N; Harari, D; Schreiber, G				Urin, Victoria; Levin, Doron; Sharma, Nanaocha; Harari, Daniel; Schreiber, Gideon			Fine Tuning of a Type 1 Interferon Antagonist	PLOS ONE			English	Article							RECEPTOR-BINDING-SITE; I-INTERFERON; MULTIPLE-SCLEROSIS; EXPRESSION; INDUCTION; ALPHA	Type I interferons are multi-potent cytokines that serve as first line of defense against viruses and other pathogens, posses immunomudolatory functions and elicit a growth inhibitory response. In recent years it has been shown that interferons are also detrimental, for example in lupus, AIDS, tuberculosis and cognitive decline, highlighted the need to develop interferon antagonists. We have previously developed the antagonist IFN-1ant, with much reduced binding to the IFNAR1 receptor and enhanced binding to IFNAR2. Here, we further tune the IFN-1ant by producing three additional antagonists based on IFN-1ant but with altered activity profiles. We show that in all three cases the antiproliferative activity of interferons is blocked and the induction of gene transcription of immunomudolatory and antiproliferative associated genes are substantially decreased. Conversely, each of the new antagonists elicits a different degree of antiviral response, STAT phosphorylation and related gene induction. Two of the new antagonists promote decreased activity in relation to the original IFN-1ant, while one of them promotes increased activity. As we do not know the exact causes of the detrimental effects of IFNs, the four antagonists that were produced and analyzed provide the opportunity to investigate the extent of antagonistic and agonistic activity optimal for a given condition.	[Urin, Victoria; Levin, Doron; Sharma, Nanaocha; Harari, Daniel; Schreiber, Gideon] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Schreiber, G (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	gideon.schreiber@weizmann.ac.il			I-CORE Program of the Planning and Budgeting Committee; Israel Science Foundation [1775/12]	I-CORE Program of the Planning and Budgeting Committee; Israel Science Foundation(Israel Science Foundation)	This research was supported by the I-CORE Program of the Planning and Budgeting Committee and the Israel Science Foundation grant No 1775/12.	Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Baruch K, 2014, SCIENCE, V346, P89, DOI 10.1126/science.1252945; Brierley MM, 2002, J INTERF CYTOK RES, V22, P835, DOI 10.1089/107999002760274845; Cheon H, 2014, SEMIN ONCOL, V41, P156, DOI 10.1053/j.seminoncol.2014.02.002; Coelho LFL, 2005, P NATL ACAD SCI USA, V102, P11917, DOI 10.1073/pnas.0502188102; COHEN B, 1995, MOL CELL BIOL, V15, P4208; Cooksley WGE, 2003, J VIRAL HEPATITIS, V10, P298, DOI 10.1046/j.1365-2893.2003.00450.x; Goodin DS, 2002, NEUROLOGY, V58, P169, DOI 10.1212/WNL.58.2.169; Haller O, 2006, VIROLOGY, V344, P119, DOI 10.1016/j.virol.2005.09.024; Harari D, 2014, J BIOL CHEM, V289, P29014, DOI 10.1074/jbc.M114.602474; Harari D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084259; ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P258, DOI 10.1098/rspb.1957.0048; Kalie E, 2008, J BIOL CHEM, V283, P32925, DOI 10.1074/jbc.M806019200; Kalie E, 2007, J BIOL CHEM, V282, P11602, DOI 10.1074/jbc.M610115200; Komurov K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-282; Lavoie TB, 2011, CYTOKINE, V56, P282, DOI 10.1016/j.cyto.2011.07.019; Levin D, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004998; Levin D, 2011, MOL CELL BIOL, V31, P3252, DOI 10.1128/MCB.05251-11; Liu ML, 2011, ONCOL LETT, V2, P583, DOI 10.3892/ol.2011.300; Mayer-Barber KD, 2014, NATURE, V511, P99, DOI 10.1038/nature13489; Pan MJ, 2008, BIOCHEMISTRY-US, V47, P12018, DOI 10.1021/bi801588g; Piehler J, 2012, IMMUNOL REV, V250, P317, DOI 10.1111/imr.12001; Platanias LC, 1999, EXP HEMATOL, V27, P1583, DOI 10.1016/S0301-472X(99)00109-5; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Roisman LC, 2005, J MOL BIOL, V353, P271, DOI 10.1016/j.jmb.2005.08.042; Sandler NG, 2014, NATURE, V511, P601, DOI 10.1038/nature13554; Sandling JK, 2011, EUR J HUM GENET, V19, P479, DOI 10.1038/ejhg.2010.197; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Thomas C, 2011, CELL, V146, P621, DOI 10.1016/j.cell.2011.06.048; Uze G, 2007, CURR TOP MICROBIOL, V316, P71; van Boxel-Dezaire AHH, 2006, IMMUNITY, V25, P361, DOI 10.1016/j.immuni.2006.08.014	31	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2015	10	7							e0130797	10.1371/journal.pone.0130797	http://dx.doi.org/10.1371/journal.pone.0130797			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EW	26158644	Green Submitted, gold, Green Published			2022-12-26	WOS:000358161200018
J	Di Giulio, A; Maurizi, E; Barbero, F; Sala, M; Fattorini, S; Balletto, E; Bonelli, S				Di Giulio, Andrea; Maurizi, Emanuela; Barbero, Francesca; Sala, Marco; Fattorini, Simone; Balletto, Emilio; Bonelli, Simona			The Pied Piper: A Parasitic Beetle's Melodies Modulate Ant Behaviours	PLOS ONE			English	Article							PAUSSUS-FAVIERI COLEOPTERA; GENUS PHEIDOLE; CARABIDAE; HYMENOPTERA; ORGAN	Ants use various communication channels to regulate their social organisation. The main channel that drives almost all the ants' activities and behaviours is the chemical one, but it is long acknowledged that the acoustic channel also plays an important role. However, very little is known regarding exploitation of the acoustical channel by myrmecophile parasites to infiltrate the ant society. Among social parasites, the ant nest beetles (Paussus) are obligate myrmecophiles able to move throughout the colony at will and prey on the ants, surprisingly never eliciting aggression from the colonies. It has been recently postulated that stridulatory organs in Paussus might be evolved as an acoustic mechanism to interact with ants. Here, we survey the role of acoustic signals employed in the Paussus beetle-Pheidole ant system. Ants parasitised by Paussus beetles produce caste-specific stridulations. We found that Paussus can "speak" three different "languages", each similar to sounds produced by different ant castes (workers, soldiers, queen). Playback experiments were used to test how host ants respond to the sounds emitted by Paussus. Our data suggest that, by mimicking the stridulations of the queen, Paussus is able to dupe the workers of its host and to be treated as royalty. This is the first report of acoustic mimicry in a beetle parasite of ants.	[Di Giulio, Andrea; Maurizi, Emanuela] Univ Roma Tre, Dept Sci, I-00146 Rome, Italy; [Barbero, Francesca; Sala, Marco; Balletto, Emilio; Bonelli, Simona] Univ Turin, Dept Life Sci & Syst Biol, I-10123 Turin, Italy; [Fattorini, Simone] Azorean Biodivers Grp, Ctr Ecol Evolut & Environm Changes CE3C, P-9700042 Angra Do Heroismo, Acores, Portugal; [Fattorini, Simone] Univ Acores, Dept Ciencias Agr, P-9700042 Angra Do Heroismo, Acores, Portugal	Italfarmaco; Roma Tre University; University of Turin; Universidade dos Acores	Di Giulio, A (corresponding author), Univ Roma Tre, Dept Sci, Viale G Marconi 446, I-00146 Rome, Italy.	andrea.digiulio@uniroma3.it	Fattorini, Simone/AAR-8028-2020; Di Giulio, Andrea/E-7064-2012; Fattorini, Simone/E-7075-2012; Barbero, Francesca/J-3555-2016	Fattorini, Simone/0000-0002-4517-2135; Di Giulio, Andrea/0000-0003-0508-0751; Fattorini, Simone/0000-0002-4517-2135; Barbero, Francesca/0000-0003-2667-0435; BALLETTO, Emilio/0000-0003-1168-2791; Bonelli, Simona/0000-0001-5185-8136	project CLIMIT funded through the FP6 BiodivERsA Eranet; German Federal Ministry of Education and Research; Italian Ministry of Education, University and Research (MIUR)	project CLIMIT funded through the FP6 BiodivERsA Eranet; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Italian Ministry of Education, University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR))	Collecting field trip was possible thanks to ADG research grants (CLAR Di Giulio, University Roma Tre, Roma, IT) to ADG. Research was conducted within the project CLIMIT funded through the FP6 BiodivERsA Eranet and the German Federal Ministry of Education and Research. Part of the research was funded by the Italian Ministry of Education, University and Research (MIUR) within the project "A multitaxa approach to study the impact of climate change on the biodiversity of Italian ecosystems" to EB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbero F, 2009, J EXP BIOL, V212, P4084, DOI 10.1242/jeb.032912; Barbero F, 2009, SCIENCE, V323, P782, DOI 10.1126/science.1163583; Casacci LP, 2013, CURR BIOL, V23, P323, DOI 10.1016/j.cub.2013.01.010; Chiu YK, 2011, ANN ENTOMOL SOC AM, V104, P1012, DOI 10.1603/AN11027; Cushing P. E., 2012, PSYCHE-J ENTOMOL, V2012, P1, DOI DOI 10.1155/2012/151989; DARLINGTON P. J., 1950, TRANS AMER ENT SOC, V76, P47; de CARVALHO ED LUNA, 1951, MEM E ESTUD MUS ZOOL UNIV COIMBRA, V207, P1; Di Giulio A, 2008, ZOOTAXA, P37; Di Giulio A, 2014, EUR J ENTOMOL, V111, P692, DOI 10.14411/eje.2014.083; Di Giulio A, 2012, MICRON, V43, P705, DOI 10.1016/j.micron.2011.10.013; Di Giulio A, 2011, EUR J ENTOMOL, V108, P127, DOI 10.14411/eje.2011.016; Di Giulio A, 2009, ARTHROPOD STRUCT DEV, V38, P293, DOI 10.1016/j.asd.2009.01.001; Ferreira RS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015363; Fiedler Konrad, 2012, Psyche (Cambridge), V2012, P1, DOI 10.1155/2012/153975; Geiselhardt SF, 2007, NATURWISSENSCHAFTEN, V94, P871, DOI 10.1007/s00114-007-0271-x; HOLLDOBLER B, 1985, BEHAV ECOL SOCIOBIOL, V18, P45; HOLLDOBLER B, 1985, Israel Journal of Entomology, V19, P89; Holldobler B., 1990, pi; Lenoir A., 1982, SOCIAL INSECTS TROPI, V1, P157; Luna de Carvalho E., 1989, MEMORIAS I INVESTIGA, V2, P1; MARKL H, 1965, SCIENCE, V149, P1392, DOI 10.1126/science.149.3690.1392; MARKL H, 1967, Z VERGL PHYSIOL, V57, P299, DOI 10.1007/BF00303001; Maurizi E., 2012, Psyche: A Journal of Entomology, V2012, P940315, DOI 10.1155/2012/940315; MENZEL JG, 1994, TISSUE CELL, V26, P735, DOI 10.1016/0040-8166(94)90056-6; Moore W, 2014, CURR BIOL, V24, P2435, DOI 10.1016/j.cub.2014.09.022; Parker J, 2014, CURR BIOL, V24, P2428, DOI 10.1016/j.cub.2014.08.068; Ruiz E, 2006, ANN SOC ENTOMOL FR, V42, P99, DOI 10.1080/00379271.2006.10697454; Sala M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094341; Sempo G, 2004, INSECT SOC, V51, P48, DOI 10.1007/s00040-003-0704-2; Sempo G, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.0301; TAUTZ J, 1995, SCIENCE, V267, P84, DOI 10.1126/science.267.5194.84; Thomas Jeremy A., 2005, P479, DOI 10.1079/9780851998121.0479; Westwood JO, 1874, THESAURUS ENTOMOLOGI, P72; WILSON EDWARD O., 1962, ANIMAL BEHAVIOR, V10, P134, DOI 10.1016/0003-3472(62)90141-0; WILSON EO, 1984, BEHAV ECOL SOCIOBIOL, V16, P89, DOI 10.1007/BF00293108	35	23	26	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0130541	10.1371/journal.pone.0130541	http://dx.doi.org/10.1371/journal.pone.0130541			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154266	Green Submitted, Green Published, gold			2022-12-26	WOS:000358159700033
J	Hintz, F; Meyer, AS				Hintz, Florian; Meyer, Antje S.			Prediction and Production of Simple Mathematical Equations: Evidence from Visual World Eye-Tracking	PLOS ONE			English	Article							LANGUAGE COMPREHENSION; SPEECH PRODUCTION; LEXICAL ACCESS; SENTENCE PRODUCTION; COGNITIVE DOMAINS; TIME-COURSE; MOVEMENTS; BRAIN; SPEAKING; MODELS	The relationship between the production and the comprehension systems has recently become a topic of interest for many psycholinguists. It has been argued that these systems are tightly linked and in particular that listeners use the production system to predict upcoming content. In this study, we tested how similar production and prediction processes are in a novel version of the visual world paradigm. Dutch speaking participants (native speakers in Experiment 1; German-Dutch bilinguals in Experiment 2) listened to mathematical equations while looking at a clock face featuring the numbers 1 to 12. On alternating trials, they either heard a complete equation ("three plus eight is eleven") or they heard the first part ("three plus eight is") and had to produce the result ("eleven") themselves. Participants were encouraged to look at the relevant numbers throughout the trial. Their eye movements were recorded and analyzed. We found that the participants' eye movements in the two tasks were overall very similar. They fixated the first and second number of the equations shortly after they were mentioned, and fixated the result number well before they named it on production trials and well before the recorded speaker named it on comprehension trials. However, all fixation latencies were shorter on production than on comprehension trials. These findings suggest that the processes involved in planning to say a word and anticipating hearing a word are quite similar, but that people are more aroused or engaged when they intend to respond than when they merely listen to another person.	[Hintz, Florian; Meyer, Antje S.] Max Planck Inst Psycholinguist, Nijmegen, Netherlands; [Hintz, Florian] Int Max Planck Res Sch Language Sci, Nijmegen, Netherlands; [Meyer, Antje S.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands	Max Planck Society; Max Planck Society; Radboud University Nijmegen	Hintz, F (corresponding author), Max Planck Inst Psycholinguist, Nijmegen, Netherlands.	florian.hintz@mpi.nl		Hintz, Florian/0000-0002-2444-3303	Max Planck Society for the Advancement of Science	Max Planck Society for the Advancement of Science(Max Planck Society)	This work was supported by the Max Planck Society for the Advancement of Science (www.mpg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allopenna PD, 1998, J MEM LANG, V38, P419, DOI 10.1006/jmla.1997.2558; Altmann GTM, 2009, COGNITIVE SCI, V33, P583, DOI 10.1111/j.1551-6709.2009.01022.x; Altmann GTM, 2009, COGNITION, V111, P55, DOI 10.1016/j.cognition.2008.12.005; Altmann GTM, 1999, COGNITION, V73, P247, DOI 10.1016/S0010-0277(99)00059-1; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Bar M, 2007, TRENDS COGN SCI, V11, P280, DOI 10.1016/j.tics.2007.05.005; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Bates D, LME4 LINEAR MIXED EF; Bock K, 2003, J MEM LANG, V48, P653, DOI 10.1016/S0749-596X(03)00007-X; Bock K, 2007, ADV BEHAV BRAIN SCI, P21; Boersma P., 2002, PRAAT SYSTEM DOING P; Bonifacci P, 2011, DEVELOPMENTAL SCI, V14, P256, DOI 10.1111/j.1467-7687.2010.00974.x; Caramazza A, 1997, COGNITIVE NEUROPSYCH, V14, P177, DOI 10.1080/026432997381664; Chang F, 2006, PSYCHOL REV, V113, P234, DOI 10.1037/0033-295X.113.2.234; Clark A, 2013, BEHAV BRAIN SCI, V36, P181, DOI 10.1017/S0140525X12000477; Clark HH, 2004, J MEM LANG, V50, P62, DOI 10.1016/j.jml.2003.08.004; Costa A, 2000, J EXP PSYCHOL LEARN, V26, P1283, DOI 10.1037//0278-7393.26.5.1283; Dell GS, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2012.0394; DELL GS, 1986, PSYCHOL REV, V93, P283, DOI 10.1037/0033-295X.93.3.283; DeLong KA, 2005, NAT NEUROSCI, V8, P1117, DOI 10.1038/nn1504; Federmeier KD, 2007, PSYCHOPHYSIOLOGY, V44, P491, DOI 10.1111/j.1469-8986.2007.00531.x; Federmeier KD, 2010, BRAIN LANG, V115, P149, DOI 10.1016/j.bandl.2010.07.006; Federmeier KD, 1999, J MEM LANG, V41, P469, DOI 10.1006/jmla.1999.2660; Federmeier KD, 2002, PSYCHOPHYSIOLOGY, V39, P133, DOI 10.1111/1469-8986.3920133; Ferreira F, 2002, J MEM LANG, V46, P57, DOI 10.1006/jmla.2001.2797; Foucart A, 2014, J EXP PSYCHOL LEARN, V40, P1461, DOI 10.1037/a0036756; Gagnepain P, 2012, CURR BIOL, V22, P615, DOI 10.1016/j.cub.2012.02.015; Garrett M., 1980, LANGUAGE PRODUCTION, V1, P177; Gilbert DT, 2007, SCIENCE, V317, P1351, DOI 10.1126/science.1144161; Griffin ZM, 2000, PSYCHOL SCI, V11, P274, DOI 10.1111/1467-9280.00255; Hintz F, 2015, P 28 CUNY C HUM SENT; Huettig F, 2015, BRAIN RES, V1626, P118, DOI 10.1016/j.brainres.2015.02.014; Huettig F, 2011, ACTA PSYCHOL, V137, P151, DOI 10.1016/j.actpsy.2010.11.003; Knoeferle P, 2005, COGNITION, V95, P95, DOI 10.1016/j.cognition.2004.03.002; Korvorst M, 2007, EXP PSYCHOL, V54, P187, DOI 10.1027/1618-3169.54.3.187; Kroll J. F., 2005, HDB BILINGUALISM PSY, P289; Kubose TT, 2006, APPL COGNITIVE PSYCH, V20, P43, DOI 10.1002/acp.1164; Kuchinsky SE, 2011, J EXP PSYCHOL LEARN, V37, P748, DOI 10.1037/a0022637; Kukona A, 2011, COGNITION, V119, P23, DOI 10.1016/j.cognition.2010.12.002; Kuperberg GR, 2007, BRAIN RES, V1146, P23, DOI 10.1016/j.brainres.2006.12.063; Kutas M., 2011, PREDICTIONBRAIN US, P190, DOI DOI 10.1093/ACPROF:OSO/9780195395518.003.0065; Levelt WJM, 1999, BEHAV BRAIN SCI, V22, P1; Levelt WJM, 1999, TRENDS COGN SCI, V3, P223, DOI 10.1016/S1364-6613(99)01319-4; MACDONALD MC, 2013, FRONT PSYCHOL, V0004; Mani N, 2012, J EXP PSYCHOL HUMAN, V38, P843, DOI 10.1037/a0029284; McCauley S, 2011, ANN C COGN SCI SOC; Meyer A, 2004, VIS COGN, V11, P553, DOI 10.1080/13506280344000248; Meyer AS, 1998, COGNITION, V66, pB25, DOI 10.1016/S0010-0277(98)00009-2; Pickering MJ, 2007, TRENDS COGN SCI, V11, P105, DOI 10.1016/j.tics.2006.12.002; Pickering MJ, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00132; Pickering MJ, 2013, BEHAV BRAIN SCI, V36, P329, DOI 10.1017/S0140525X12001495; R Core Team, 2012, R LANG ENV STAT COMP; Rapp B, 2013, LANG COGN NEUROSCI, V29, P24; Roelofs A, 1997, COGNITION, V64, P249, DOI 10.1016/S0010-0277(97)00027-9; Runnqvist E, 2013, COGNITION, V129, P256, DOI 10.1016/j.cognition.2013.07.008; Sadat J, 2012, J PSYCHOLINGUIST RES, V41, P159, DOI 10.1007/s10936-011-9183-1; SASLOW MG, 1967, J OPT SOC AM, V57, P1030, DOI 10.1364/JOSA.57.001030; Schacter DL, 2007, NAT REV NEUROSCI, V8, P657, DOI 10.1038/nrn2213; Scheepers C, 2014, Q J EXP PSYCHOL, V67, P1643, DOI 10.1080/17470218.2013.873815; Scheepers C, 2011, PSYCHOL SCI, V22, P1319, DOI 10.1177/0956797611416997; Sjerps MJ, 2015, COGNITION, V136, P304, DOI 10.1016/j.cognition.2014.10.008; Spalek K, 2014, COGNITION, V133, P226, DOI 10.1016/j.cognition.2014.06.016; Szewczyk JM, 2013, J MEM LANG, V68, P297, DOI 10.1016/j.jml.2012.12.002; TANENHAUS MK, 1995, SCIENCE, V268, P1632, DOI 10.1126/science.7777863; Van Berkum JJA, 2005, J EXP PSYCHOL LEARN, V31, P443, DOI 10.1037/0278-7393.31.3.443; Van Berkum JJA, 2010, ITAL J LINGUIST, V22, P181; van Heuven WJB, 2010, BRAIN RES REV, V64, P104, DOI 10.1016/j.brainresrev.2010.03.002; Wicha NYY, 2003, CORTEX, V39, P483, DOI 10.1016/S0010-9452(08)70260-0	68	8	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0130766	10.1371/journal.pone.0130766	http://dx.doi.org/10.1371/journal.pone.0130766			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1EJ	26154431	Green Published, gold, Green Submitted			2022-12-26	WOS:000358159700038
J	Bokka, KK; Jesudason, EC; Lozoya, OA; Guilak, F; Warburton, D; Lubkin, SR				Bokka, Kishore K.; Jesudason, Edwin C.; Lozoya, Oswaldo A.; Guilak, Farshid; Warburton, David; Lubkin, Sharon R.			Morphogenetic Implications of Peristalsis-Driven Fluid Flow in the Embryonic Lung	PLOS ONE			English	Article							PARTICLE-TRACKING MICRORHEOLOGY; FORCES; LIQUID	Epithelial organs are almost universally secretory. The lung secretes mucus of extremely variable consistency. In the early prenatal period, the secretions are of largely unknown composition, consistency, and flow rates. In addition to net outflow from secretion, the embryonic lung exhibits transient reversing flows from peristalsis. Airway peristalsis (AP) begins as soon as the smooth muscle forms, and persists until birth. Since the prenatal lung is liquid-filled, smooth muscle action can transport fluid far from the immediately adjacent tissues. The sensation of internal fluid flows has been shown to have potent morphogenetic effects, as has the transport of morphogens. We hypothesize that these effects play an important role in lung morphogenesis. To test these hypotheses in a quantitative framework, we analyzed the fluid-structure interactions between embryonic tissues and lumen fluid resulting from peristaltic waves that partially occlude the airway. We found that if the airway is closed, fluid transport is minimal; by contrast, if the trachea is open, shear rates can be very high, particularly at the stenosis. We performed a parametric analysis of flow characteristics' dependence on tissue stiffnesses, smooth muscle force, geometry, and fluid viscosity, and found that most of these relationships are governed by simple ratios. We measured the viscosity of prenatal lung fluid with passive bead microrheology. This paper reports the first measurements of the viscosity of embryonic lung lumen fluid. In the range tested, lumen fluid can be considered Newtonian, with a viscosity of 0.016 +/- 0.008 Pa-s. We analyzed the interaction between the internal flows and diffusion and conclude that AP has a strong effect on flow sensing away from the tip and on transport of morphogens. These effects may be the intermediate mechanisms for the enhancement of branching seen in occluded embryonic lungs.	[Bokka, Kishore K.] N Carolina State Univ, Dept Mech Engn, Raleigh, NC 27695 USA; [Jesudason, Edwin C.] Natl Hlth Serv NHS, Edinburgh, Midlothian, Scotland; [Lozoya, Oswaldo A.; Guilak, Farshid] Duke Univ, Med Ctr, Dept Orthopaed Surg, Orthopaed Res Labs, Durham, NC USA; [Warburton, David] Childrens Hosp Los Angeles, Saban Res Inst, Los Angeles, CA 90027 USA; [Lubkin, Sharon R.] N Carolina State Univ, Dept Math, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University; Duke University; Children's Hospital Los Angeles; University of North Carolina; North Carolina State University	Lubkin, SR (corresponding author), N Carolina State Univ, Dept Math, Box 8205, Raleigh, NC 27695 USA.	lubkin@ncsu.edu	Guilak, Farshid/AAF-8558-2020; Warburton, David/AAD-5709-2020; Lubkin, Sharon/F-8802-2011	Guilak, Farshid/0000-0001-7380-0330; Lubkin, Sharon/0000-0003-2521-0699; Lozoya, Oswaldo/0000-0001-6779-7382	National Institutes of Health [R01 GM096195, T32 AI007217]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007217] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM096195] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health (http://www.nih.gov/ R01 GM096195) (SRL, KKB, DW) and T32 AI007217 (OAL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARIS R, 1956, PROC R SOC LON SER-A, V235, P67, DOI 10.1098/rspa.1956.0065; Blewett CJ, 1996, J PEDIATR SURG, V31, P869, DOI 10.1016/S0022-3468(96)90400-5; Bokka KK, MORPHOGENETIC IMPLIC; Bokka KK, J THEOR BIO IN PRESS; BURNS JC, 1967, J FLUID MECH, V29, P731, DOI 10.1017/S0022112067001156; Fabry B, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.041914; Freund JB, 2012, DEVELOPMENT, V139, P1229, DOI 10.1242/dev.073593; George UZ, QUANTIFYING STRETCH; Harding R, 1996, J APPL PHYSIOL, V81, P209, DOI 10.1152/jappl.1996.81.1.209; HARDING R, 1984, RESP PHYSIOL, V57, P47, DOI 10.1016/0034-5687(84)90032-X; Heisenberg CP, 2013, CELL, V153, P948, DOI 10.1016/j.cell.2013.05.008; JAFFRIN MY, 1971, ANNU REV FLUID MECH, V3, P13, DOI 10.1146/annurev.fl.03.010171.000305; Jain R, 2010, AM J RESP CELL MOL, V43, P731, DOI 10.1165/rcmb.2009-0328OC; KING M, 1977, J APPL PHYSIOL, V42, P797, DOI 10.1152/jappl.1977.42.6.797; Mason TG, 1997, PHYS REV LETT, V79, P3282, DOI 10.1103/PhysRevLett.79.3282; McDermott KM, 2010, CURR BIOL, V20, P731, DOI 10.1016/j.cub.2010.02.048; Miller CJ, 2013, NAT REV GENET, V14, P733, DOI 10.1038/nrg3513; MOTTA C, 1985, CLIN CHIM ACTA, V153, P157, DOI 10.1016/0009-8981(85)90347-X; Murray CD, 1926, P NATL ACAD SCI USA, V12, P207, DOI 10.1073/pnas.12.3.207; Nelson CM, 2012, ANNU REV BIOMED ENG, V14, P129, DOI [10.1146/annurev-bioeng-071811-150043, 10.1146/annurev.bioeng-071811-150043]; Olver RE, 2004, ANNU REV PHYSIOL, V66, P77, DOI 10.1146/annurev.physiol.66.071702.145229; PURCELL EM, 1977, AM J PHYS, V45, P3, DOI 10.1119/1.10903; RATH HJ, 1982, INT J MECH SCI, V24, P359, DOI 10.1016/0020-7403(82)90069-8; Schittny JC, 2000, AM J RESP CELL MOL, V23, P11, DOI 10.1165/ajrcmb.23.1.3926; SHAPIRO AH, 1969, J FLUID MECH, V37, P799, DOI 10.1017/S0022112069000899; SPARROW MP, 1990, J APPL PHYSIOL, V68, P468, DOI 10.1152/jappl.1990.68.2.468; Tang N, 2011, SCIENCE, V333, P342, DOI 10.1126/science.1204831; TAYLOR G, 1953, PROC R SOC LON SER-A, V219, P186, DOI 10.1098/rspa.1953.0139; VILOS G A, 1982, Journal of Developmental Physiology (Eynsham), V4, P247; Wiebe C, 2005, J BIOMECH, V38, P2087, DOI 10.1016/j.jbiomech.2004.09.005; Wirtz D, 2009, ANNU REV BIOPHYS, V38, P301, DOI 10.1146/annurev.biophys.050708.133724; YIN FCP, 1971, J FLUID MECH, V47, P93, DOI 10.1017/S0022112071000958	32	17	17	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132015	10.1371/journal.pone.0132015	http://dx.doi.org/10.1371/journal.pone.0132015			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147967	Green Published, gold, Green Submitted			2022-12-26	WOS:000358157600180
J	Liang, XL; Chen, QF; Lei, Y; Li, H				Liang, Xiuling; Chen, Qingfei; Lei, Yi; Li, Hong			The Processing of Causal and Hierarchical Relations in Semantic Memory as Revealed by N400 and Frontal Negativity	PLOS ONE			English	Article							THEMATIC RELATIONS; OBJECT CATEGORIZATION; TIME-COURSE; KNOWLEDGE; COMPONENT; REPRESENTATIONS; POTENTIALS; SIMILARITY; DIFFERENCE; FMRI	Most current studies investigating semantic memory have focused on associative (ringemerald) or taxonomic relations (bird-sparrow). Little is known about the question of how causal relations (virus-epidemic) are stored and accessed in semantic memory. The goal of this study was to examine the processing of causally related, general associatively related and hierarchically related word pairs when participants were required to evaluate whether pairs of words were related in any way. The ERP data showed that the N400 amplitude (200-500ms) elicited by unrelated related words was more negative than all related words. Furthermore, the late frontal distributed negativity (500-700ms) elicited by causally related words was smaller than hierarchically related words, but not for general associated words. These results suggested the processing of causal relations and hierarchical relations in semantic memory recruited different degrees of cognitive resources, especially for role binding.	[Liang, Xiuling; Lei, Yi; Li, Hong] Shenzhen Univ, Res Ctr Brain Funct & Psychol Sci, Shenzhen, Peoples R China; [Chen, Qingfei] Shenzhen Univ, Res Ctr Special Econ Zone Res, Shenzhen, Peoples R China	Shenzhen University; Shenzhen University	Lei, Y (corresponding author), Shenzhen Univ, Res Ctr Brain Funct & Psychol Sci, Shenzhen, Peoples R China.	leiyi821@vip.sina.com			National Natural Science Foundation of China [31100740, 31271088, 31400961, 30370488]; MOE Project of Key Research Institute of Humanities and Social Sciences at Universities [11JJD190002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); MOE Project of Key Research Institute of Humanities and Social Sciences at Universities	This study was supported by the National Natural Science Foundation of China (31100740, 31271088, 31400961, and 30370488) and the MOE Project of Key Research Institute of Humanities and Social Sciences at Universities (11JJD190002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON JE, 1995, PSYCHOPHYSIOLOGY, V32, P177, DOI 10.1111/j.1469-8986.1995.tb03310.x; Barr N, 2010, EXPLORING ASYMMETRIC; Blakemore SJ, 2001, NEUROREPORT, V12, P3741, DOI 10.1097/00001756-200112040-00027; Buehner MJ., 2005, CAUSAL LEARNING; Chen QF, 2015, ACTA PSYCHOL, V157, P176, DOI 10.1016/j.actpsy.2015.02.017; Chen QF, 2014, NEUROPSYCHOLOGIA, V64, P54, DOI 10.1016/j.neuropsychologia.2014.09.013; Chen QF, 2014, J COGN PSYCHOL, V26, P559, DOI 10.1080/20445911.2014.927877; Chen QF, 2013, INT J PSYCHOPHYSIOL, V90, P135, DOI 10.1016/j.ijpsycho.2013.06.015; Chwilla DJ, 2005, COGNITIVE BRAIN RES, V25, P589, DOI 10.1016/j.cogbrainres.2005.08.011; COLLINS AM, 1975, PSYCHOL REV, V82, P407, DOI 10.1037/0033-295X.82.6.407; Estes Z, 2011, PSYCHOL LEARN MOTIV, V54, P249, DOI 10.1016/B978-0-12-385527-5.00008-5; Fenker DB, 2010, J COGNITIVE NEUROSCI, V22, P2151, DOI 10.1162/jocn.2009.21387; Fenker DB, 2005, MEM COGNITION, V33, P1036, DOI 10.3758/BF03193211; Fugelsang JA, 2005, COGNITIVE BRAIN RES, V24, P41, DOI 10.1016/j.cogbrainres.2004.12.001; Fugelsang JA, 2005, NEUROPSYCHOLOGIA, V43, P1204, DOI 10.1016/j.neuropsychologia.2004.10.012; Fugelsang Jonathan, 2009, P269; Holcomb PJ, 2009, J NEUROLINGUIST, V22, P301, DOI 10.1016/j.jneuroling.2008.06.004; Hummel JE, 2003, PSYCHOL REV, V110, P220, DOI 10.1037/0033-295X.110.2.220; Keil A, 2014, PSYCHOPHYSIOLOGY, V51, P1, DOI 10.1111/psyp.12147; Khateb A, 2003, INT J PSYCHOPHYSIOL, V49, P41, DOI 10.1016/S0167-8760(03)00076-X; Kuperberg GR, 2011, J COGNITIVE NEUROSCI, V23, P1230, DOI 10.1162/jocn.2010.21452; KUTAS M, 1980, SCIENCE, V207, P203, DOI 10.1126/science.7350657; Kutas M, 2011, ANNU REV PSYCHOL, V62, P621, DOI 10.1146/annurev.psych.093008.131123; Large ME, 2004, COGNITIVE BRAIN RES, V20, P415, DOI 10.1016/j.cogbrainres.2004.03.013; Lin EL, 2001, J EXP PSYCHOL GEN, V130, P3, DOI 10.1037/0096-3445.130.1.3; Luck S.J., 2005, INTRO EVENT RELATED; Mason RA, 2004, PSYCHOL SCI, V15, P1, DOI 10.1111/j.0963-7214.2004.01501001.x; Paczynski M, 2012, J MEM LANG, V67, P426, DOI 10.1016/j.jml.2012.07.003; Rabovsky M, 2014, COGNITION, V132, P68, DOI 10.1016/j.cognition.2014.03.010; ROSCH E, 1976, COGNITIVE PSYCHOL, V8, P382, DOI 10.1016/0010-0285(76)90013-X; Rossell SL, 2003, NEUROPSYCHOLOGIA, V41, P550, DOI 10.1016/S0028-3932(02)00181-1; Rugg MD, 2007, TRENDS COGN SCI, V11, P251, DOI 10.1016/j.tics.2007.04.004; Sass K, 2009, BRAIN RES, V1270, P78, DOI 10.1016/j.brainres.2009.03.013; Satpute AB, 2005, EUR J NEUROSCI, V22, P1233, DOI 10.1111/j.1460-9568.2005.04292.x; Simmons S, 2008, COGNITION, V108, P781, DOI 10.1016/j.cognition.2008.07.003; Tanaka J, 1999, NEUROREPORT, V10, P829, DOI 10.1097/00001756-199903170-00030; Turner DC, 2004, CEREB CORTEX, V14, P872, DOI 10.1093/cercor/bhh046	37	6	6	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132679	10.1371/journal.pone.0132679	http://dx.doi.org/10.1371/journal.pone.0132679			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1DQ	26148338	Green Published, gold, Green Submitted			2022-12-26	WOS:000358157600310
J	Richards, T; Musallam, KM; Nassif, J; Ghazeeri, G; Seoud, M; Gurusamy, KS; Jamali, FR				Richards, Toby; Musallam, Khaled M.; Nassif, Joseph; Ghazeeri, Ghina; Seoud, Muhieddine; Gurusamy, Kurinchi S.; Jamali, Faek R.			Impact of Preoperative Anaemia and Blood Transfusion on Postoperative Outcomes in Gynaecological Surgery	PLOS ONE			English	Article							30-DAY MORTALITY; CARDIAC-SURGERY; OLDER PATIENTS; MANAGEMENT; CONSERVATION; ASSOCIATION; PREVALENCE; LEVEL; COLON	Objective To evaluate the effect of preoperative anaemia and blood transfusion on 30-day postoperative morbidity and mortality in patients undergoing gynecological surgery. Study Design Data were analyzed from 12,836 women undergoing operation in the American College of Surgeons National Surgical Quality Improvement Program. Outcomes measured were; 30-day postoperative mortality, composite and specific morbidities (cardiac, respiratory, central nervous system, renal, wound, sepsis, venous thrombosis, or major bleeding). Multivariate logistic regression models were performed using adjusted odds ratios (ORadj) to assess the independent effects of preoperative anaemia (hematocrit <36.0%) on outcomes, effect estimates were performed before and after adjustment for perioperative transfusion requirement. Results The prevalence of preoperative anaemia was 23.9% (95% CI: 23.2-24.7). Adjusted for confounders by multivariate logistic regression; preoperative anaemia was independently and significantly associated with increased odds of 30-day mortality (OR: 2.40, 95% CI: 1.06-5.44) and composite morbidity (OR: 1.80, 95% CI: 1.45-2.24). This was reflected by significantly higher adjusted odds of almost all specific morbidities including; respiratory, central nervous system, renal, wound, sepsis, and venous thrombosis. Blood Transfusion increased the effect of preoperative anaemia on outcomes (61% of the effect on mortality and 16% of the composite morbidity). Conclusions Preoperative anaemia is associated with adverse post-operative outcomes in women undergoing gynecological surgery. This risk associated with preoperative anaemia did not appear to be corrected by use of perioperative transfusion.	[Richards, Toby; Gurusamy, Kurinchi S.] Univ Coll London Hosp, Div Surg & Intervent Sci, London, England; [Musallam, Khaled M.] Amer Univ Beirut, Med Ctr, Dept Internal Med, Beirut, Lebanon; [Nassif, Joseph; Ghazeeri, Ghina; Seoud, Muhieddine] Amer Univ Beirut, Med Ctr, Dept Obstet & Gynaecol, Beirut, Lebanon; [Jamali, Faek R.] Amer Univ Beirut, Med Ctr, Dept Surg, Beirut, Lebanon	University College London Hospitals NHS Foundation Trust; University of London; University College London; American University of Beirut; American University of Beirut; American University of Beirut	Jamali, FR (corresponding author), Amer Univ Beirut, Med Ctr, Dept Surg, Beirut, Lebanon.	fj03@aub.edu.lb	Richards, Toby/K-6547-2013	Gurusamy, Kurinchi/0000-0002-0313-9134; Musallam, Khaled/0000-0003-3935-903X; Nassif, Joseph/0000-0003-0937-6533	NIHR HTA; Health Foundation; Gideon Richter; Vifor Pharma Ltd; Pharmocosmos; National Institute for Health Research [10/104/06] Funding Source: researchfish	NIHR HTA; Health Foundation; Gideon Richter; Vifor Pharma Ltd; Pharmocosmos; National Institute for Health Research(National Institute for Health Research (NIHR))	UCL and the research program led by TR has received research funding from a variety of sources (19) including government, charity and industry sources for research into anaemia, blood transfusion and iron therapy including, NIHR HTA, Health Foundation, Gideon Richter, Vifor Pharma Ltd, Pharmocosmos. TR has also been the invited speaker at over 50 conferences on anaemia, blood transfusion and iron therapy in the last 5 years. KMM received consultancy fees and travel support from Vifor Pharma Ltd. ES received honoraria from Gideon Richter and Ethicon for provision of training to healthcare professionals. FRJ received research funding from Vifor Pharma Ltd. The remaining authors have no conflicts of interest to disclose. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	[Anonymous], 2009, AM COLL SURG; [Anonymous], 1968, WHO TECHN REP SER; Baird DD, 2003, AM J OBSTET GYNECOL, V188, P100, DOI 10.1067/mob.2003.99; Bernard AC, 2009, J AM COLL SURGEONS, V208, P931, DOI 10.1016/j.jamcollsurg.2008.11.019; Carson JL, 1996, LANCET, V348, P1055, DOI 10.1016/S0140-6736(96)04330-9; CARSON JL, 1988, LANCET, V1, P727; Clevenger B, 2015, ANAESTHESIA, V70, DOI 10.1111/anae.12918; Dunne JR, 2002, AM SURGEON, V68, P582; Ferraris VA, 2012, ARCH SURG-CHICAGO, V147, P49, DOI 10.1001/archsurg.2011.790; Fink AS, 2002, ANN SURG, V236, P344, DOI 10.1097/00000658-200209000-00011; Glance LG, 2011, ANESTHESIOLOGY, V114, P283, DOI 10.1097/ALN.0b013e3182054d06; Goodnough LT, 2005, ANESTH ANALG, V101, P1858, DOI 10.1213/01.ANE.0000184124.29397.EB; Hofmann A, 2011, ONCOLOGIST, V16, P3, DOI 10.1634/theoncologist.2011-S3-3; Hogue CW, 1998, TRANSFUSION, V38, P924, DOI 10.1046/j.1537-2995.1998.381098440856.x; Hung M, 2011, ANAESTHESIA, V66, P812, DOI 10.1111/j.1365-2044.2011.06819.x; JPAC-Joint United Kingdom (UK) Blood Transfusion and Tissue Transplantation Services Professional Advisory Committee, 2014, PAT BLOOD MAN; Khuri SF, 2007, J AM COLL SURGEONS, V204, P1089, DOI 10.1016/j.jamcollsurg.2007.03.028; Lasocki S, 2015, EUR J ANAESTH, V32, P160, DOI 10.1097/EJA.0000000000000202; Leichtle SW, 2011, J AM COLL SURGEONS, V212, P187, DOI 10.1016/j.jamcollsurg.2010.09.013; Moskowitz DM, 2010, ANN THORAC SURG, V90, P451, DOI 10.1016/j.athoracsur.2010.04.089; Moskowitz DM, 2004, ANN THORAC SURG, V77, P626, DOI 10.1016/S0003-4975(03)01345-6; Musallam KM, 2011, LANCET, V378, P1396, DOI 10.1016/S0140-6736(11)61381-0; Napolitano LM, 2005, SURG CLIN N AM, V85, P1215, DOI 10.1016/j.suc.2005.10.012; Richards T, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0774-2; Sabry M, 2012, REPROD SCI, V19, P339, DOI 10.1177/1933719111432867; Spahn DR, 2012, BRIT J ANAESTH, V108, P889, DOI 10.1093/bja/aes166; Spahn DR, 2013, BEST PRACT RES-CLIN, V27, P37, DOI 10.1016/j.bpa.2013.02.003; Spahn DR, 2010, ANESTHESIOLOGY, V113, P482, DOI 10.1097/ALN.0b013e3181e08e97; Spahn DR, 2008, ANESTHESIOLOGY, V109, P951, DOI 10.1097/ALN.0b013e31818e3d75; SPENCE RK, 1990, AM J SURG, V159, P320, DOI 10.1016/S0002-9610(05)81227-9; van Klei WA, 2001, BRIT J ANAESTH, V87, P250, DOI 10.1093/bja/87.2.250; Wu WC, 2007, JAMA-J AM MED ASSOC, V297, P2481, DOI 10.1001/jama.297.22.2481; Wu WC, 2010, ANN SURG, V252, P11, DOI 10.1097/SLA.0b013e3181e3e43f	33	56	63	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0130861	10.1371/journal.pone.0130861	http://dx.doi.org/10.1371/journal.pone.0130861			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147954	Green Published, gold			2022-12-26	WOS:000358157600053
J	Shang, CJ; Chen, QS; Dell, A; Haslam, SM; De Vos, WH; Van Damme, EJM				Shang, Chenjing; Chen, Qiushi; Dell, Anne; Haslam, Stuart M.; De Vos, Winnok H.; Van Damme, Els J. M.			The Cytotoxicity of Elderberry Ribosome-Inactivating Proteins Is Not Solely Determined by Their Protein Translation Inhibition Activity	PLOS ONE			English	Article							SAMBUCUS-NIGRA; COLOCALIZATION ANALYSIS; GLYCOSIDASE ACTIVITY; MOLECULAR-CLONING; HELA-CELLS; RICIN; LECTIN; APOPTOSIS; BINDING; TOXIN	Although the protein translation inhibition activity of ribosome inactivating proteins (RIPs) is well documented, little is known about the contribution of the lectin chain to the biological activity of these proteins. In this study, we compared the in vitro and intracellular activity of several S. nigra (elderberry) RIPs and non-RIP lectins. Our data demonstrate that RIPs from elderberry are much more toxic to HeLa cells than to primary fibroblasts. Differences in the cytotoxicity between the elderberry proteins correlated with differences in glycan specificity of their lectin domain, cellular uptake efficiency and intracellular destination. Despite the fact that the bulk of the RIPs accumulated in the lysosomes and partly in the Golgi apparatus, we could demonstrate effective inhibition of protein synthesis in cellula. As we also observed cytotoxicity for non-RIP lectins, it is clear that the lectin chain triggers additional pathways heralding cell death. Our data suggest that one of these pathways involves the induction of autophagy.	[Shang, Chenjing; De Vos, Winnok H.; Van Damme, Els J. M.] Univ Ghent, Fac Biosci Engn, Dept Mol Biotechnol, B-9000 Ghent, Belgium; [Chen, Qiushi; Dell, Anne; Haslam, Stuart M.] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Fac Nat Sci, London, England; [De Vos, Winnok H.] Univ Antwerp, Fac Pharmaceut Biomed & Vet Sci, Dept Vet Sci, Antwerp, Belgium	Ghent University; Imperial College London; University of Antwerp	Van Damme, EJM (corresponding author), Univ Ghent, Fac Biosci Engn, Dept Mol Biotechnol, B-9000 Ghent, Belgium.	ElsJM.VanDamme@ugent.be	Van Damme, Els/U-3904-2019; Chen, QIUSHI/AAA-6358-2022; Van Damme, Els J/B-4410-2015; de vos, winnok/A-6445-2012	Van Damme, Els/0000-0001-9848-766X; de vos, winnok/0000-0003-0960-6781; Chen, Qiushi/0000-0001-8355-2801; Dell, Anne/0000-0003-1380-2347	Fund for Scientific Research-Flanders (FWO) [G.0022.08]; Research Council of Ghent University [BOF10/GOA/003]; Biotechnology and Biological Sciences Research Council [BB/K016164/1, BB/F008309/1]; China Scholarship Council; Special Research Council of Ghent University; BBSRC [BB/K016164/1, BB/F008309/1] Funding Source: UKRI	Fund for Scientific Research-Flanders (FWO)(FWO); Research Council of Ghent University(Ghent University); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); China Scholarship Council(China Scholarship Council); Special Research Council of Ghent University(Ghent University); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded primarily by the Fund for Scientific Research-Flanders (FWO grants G.0022.08), the Research Council of Ghent University (project BOF10/GOA/003 to E.J.M.V.D.), and grants BB/K016164/1 and BB/F008309/1 from the Biotechnology and Biological Sciences Research Council (to A.D. and S.M.H.). C.S. is the recipient of China Scholarship Council and receives doctoral co-funding from the Special Research Council of Ghent University.	Barbieri L, 2004, FEBS LETT, V563, P219, DOI 10.1016/S0014-5793(04)00286-8; Battelli MG, 1997, FEBS LETT, V408, P355, DOI 10.1016/S0014-5793(97)00463-8; Battelli MG, 2004, CELL MOL LIFE SCI, V61, P1975, DOI 10.1007/s00018-004-4171-3; Battelli MG, 1997, ARCH TOXICOL, V71, P360, DOI 10.1007/s002040050399; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; BROEKAERT WF, 1984, BIOCHEM J, V221, P163, DOI 10.1042/bj2210163; Ceroni A, 2008, J PROTEOME RES, V7, P1650, DOI 10.1021/pr7008252; Citores L, 2002, CANCER LETT, V184, P29, DOI 10.1016/S0304-3835(02)00169-6; Citores L, 1996, CELL MOL BIOL, V42, P473; Das MK, 2012, APPL BIOCHEM BIOTECH, V166, P1552, DOI 10.1007/s12010-012-9550-x; De Vos WH, 2010, CYTOM PART A, V77A, P64, DOI 10.1002/cyto.a.20807; EMMANUEL F, 1988, ANAL BIOCHEM, V173, P134, DOI 10.1016/0003-2697(88)90170-4; Fang EF, 2012, CANCER PREV RES, V5, P109, DOI 10.1158/1940-6207.CAPR-11-0203; Ferreras JM, 2011, TOXINS, V3, P420, DOI 10.3390/toxins3050420; Fu LL, 2011, INT J BIOCHEM CELL B, V43, P1442, DOI 10.1016/j.biocel.2011.07.004; Gadadhar S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058304; Jang-Lee J, 2006, METHOD ENZYMOL, V415, P59, DOI 10.1016/S0076-6879(06)15005-3; Jia N, 2014, J BIOL CHEM, V289, P28489, DOI 10.1074/jbc.M114.588541; Jimenez AS, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-26; Jimenez P, 2014, RIBOSOME-INACTIVATING PROTEINS: RICIN AND RELATED PROTEINS, P67; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Landry JJM, 2013, G3-GENES GENOM GENET, V3, P1213, DOI 10.1534/g3.113.005777; Lei HY, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-10; Lichtenstein RG, 2013, CELL DEATH DIFFER, V20, P976, DOI 10.1038/cdd.2013.50; Liu B, 2010, CANCER LETT, V287, P1, DOI 10.1016/j.canlet.2009.05.013; Lord JM, 1998, J CELL BIOL, V140, P733; MACH L, 1991, BIOCHEM J, V278, P667, DOI 10.1042/bj2780667; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Moriya K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037892; Narayanan S, 2005, FEBS LETT, V579, P1324, DOI 10.1016/j.febslet.2005.01.038; North SJ, 2010, METHOD ENZYMOL, V478, P27, DOI 10.1016/S0076-6879(10)78002-2; Oliveira C, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/568932; Pascal JM, 2001, PROTEINS, V43, P319, DOI 10.1002/prot.1043; PERILLO NL, 1995, NATURE, V378, P736, DOI 10.1038/378736a0; Peumans WJ, 2001, FASEB J, V15, P1493, DOI 10.1096/fj.00-0751rev; Puri M, 2012, DRUG DISCOV TODAY, V17, P774, DOI 10.1016/j.drudis.2012.03.007; Rabinovich GA, 2005, BRIT J CANCER, V92, P1188, DOI 10.1038/sj.bjc.6602493; SANDVIG K, 1991, J CELL BIOL, V115, P971, DOI 10.1083/jcb.115.4.971; SANDVIG K, 1978, EUR J BIOCHEM, V82, P13, DOI 10.1111/j.1432-1033.1978.tb11992.x; SCHACHTER H, 1991, Glycobiology, V1, P453, DOI 10.1093/glycob/1.5.453; Shang CJ, 2014, GLYCOCONJUGATE J, V31, P345, DOI 10.1007/s10719-014-9527-9; Shibata M, 2010, BIOCHEM BIOPH RES CO, V393, P274, DOI 10.1016/j.bbrc.2010.01.121; Sikriwal D, 2010, PLANT CELL MONOGRAPH, P107; Stirpe F, 2006, CELL MOL LIFE SCI, V63, P1850, DOI 10.1007/s00018-006-6078-7; Svinth M, 1998, BIOCHEM BIOPH RES CO, V249, P637, DOI 10.1006/bbrc.1998.9207; Taylor ME, 2011, INTRO GLYCOBIOLOGY, P24; Tejero J, 2015, MOLECULES, V20, P2364, DOI 10.3390/molecules20022364; Van Damme EJM, 2001, CRIT REV PLANT SCI, V20, P395, DOI 10.1080/713608299; VanDamme EJM, 1997, J BIOL CHEM, V272, P8353, DOI 10.1074/jbc.272.13.8353; VanDamme EJM, 1996, EUR J BIOCHEM, V237, P505, DOI 10.1111/j.1432-1033.1996.0505k.x; VANDEURS B, 1987, EXP CELL RES, V171, P137, DOI 10.1016/0014-4827(87)90257-6; Verdoodt F, 2012, CELL BIOL INT, V36, P1251, DOI 10.1042/CBI20120187; Voss C, 2006, FASEB J, V20, P1194, DOI 10.1096/fj.05-5231fje; YOSHIDA T, 1991, EXP CELL RES, V192, P389, DOI 10.1016/0014-4827(91)90056-Z	56	10	10	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132389	10.1371/journal.pone.0132389	http://dx.doi.org/10.1371/journal.pone.0132389			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148207	Green Published, gold, Green Submitted			2022-12-26	WOS:000358157600255
J	Yap, S; Fanson, BG; Taylor, PW				Yap, Sarsha; Fanson, Benjamin G.; Taylor, Phillip W.			Mating Reverses Actuarial Aging in Female Queensland Fruit Flies	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER; JUVENILE-HORMONE; LIFE-SPAN; DIETARY RESTRICTION; SEMINAL PROTEINS; HONEY-BEE; REPRODUCTION; PLASTICITY; INSECT; SENESCENCE	Animals that have a long pre-reproductive adult stage often employ mechanisms that minimize aging over this period in order to preserve reproductive lifespan. In a remarkable exception, one tephritid fruit fly exhibits substantial pre-reproductive aging but then mitigates this aging during a diet-dependent transition to the reproductive stage, after which life expectancy matches that of newly emerged flies. Here, we ascertain the role of nutrients, sexual maturation and mating in mitigation of previous aging in female Queensland fruit flies. Flies were provided one of three diets: 'sugar', 'essential', or 'yeast-sugar'. Essential diet contained sugar and micronutrients found in yeast but lacked maturation-enabling protein. At days 20 and 30, a subset of flies on the sugar diet were switched to essential or yeast-sugar diet, and some yeast-sugar fed flies were mated 10 days later. Complete mitigation of actuarial aging was only observed in flies that were switched to a yeast-sugar diet and mated, indicating that mating is key. Identifying the physiological processes associated with mating promise novel insights into repair mechanisms for aging.	[Yap, Sarsha; Fanson, Benjamin G.; Taylor, Phillip W.] Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia	Macquarie University	Taylor, PW (corresponding author), Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia.	phil.taylor@mq.edu.au	Taylor, Phillip W/E-4620-2011	Taylor, Phillip W/0000-0002-7574-7737; Fanson, Ben/0000-0003-4246-4631; Yap, Sarsha/0000-0002-2049-6352	Macquarie University Research Excellence Scholarship	Macquarie University Research Excellence Scholarship	This work was supported by Macquarie University Research Excellence Scholarship awarded to Benjamin G. Fanson. Macquarie University's Department of Biological Sciences provided facilities and consumables. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amdam GV, 2005, EXP GERONTOL, V40, P939, DOI 10.1016/j.exger.2005.08.004; Baker N, 2012, EXP GERONTOL, V47, P764, DOI 10.1016/j.exger.2012.05.011; BYRNE BM, 1989, PROG BIOPHYS MOL BIO, V53, P33, DOI 10.1016/0079-6107(89)90005-9; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Carey JR, 1998, SCIENCE, V281, P996, DOI 10.1126/science.281.5379.996; Collatz KG, 1997, ARCH GERONTOL GERIAT, V25, P83, DOI 10.1016/S0167-4943(96)00773-X; Fanson BG, 2012, P ROY SOC B-BIOL SCI, V279, P4893, DOI 10.1098/rspb.2012.2033; Fanson BG, 2012, J INSECT PHYSIOL, V58, P327, DOI 10.1016/j.jinsphys.2011.11.002; Flatt T, 2005, BIOESSAYS, V27, P999, DOI 10.1002/bies.20290; Flatt T, 2007, EVOLUTION, V61, P1980, DOI 10.1111/j.1558-5646.2007.00151.x; GIESEL JT, 1989, J INSECT PHYSIOL, V35, P893, DOI 10.1016/0022-1910(89)90106-6; Kang MA, 2008, J EXP BIOL, V211, P741, DOI 10.1242/jeb.012955; Kapelnikov A, 2008, P NATL ACAD SCI USA, V105, P13912, DOI 10.1073/pnas.0710997105; Lee KP, 2008, P NATL ACAD SCI USA, V105, P2498, DOI 10.1073/pnas.0710787105; Mair W, 2003, SCIENCE, V301, P1731, DOI 10.1126/science.1086016; Martinez RLMC, 2010, METRON, V68, P111, DOI 10.1007/BF03263529; McGraw LA, 2004, CURR BIOL, V14, P1509, DOI 10.1016/j.cub.2004.08.028; Moehrlin GS, 1998, OECOLOGIA, V115, P492, DOI 10.1007/s004420050546; Moshitzky P, 1996, ARCH INSECT BIOCHEM, V32, P363, DOI 10.1002/(SICI)1520-6327(1996)32:3/4&lt;363::AID-ARCH9&gt;3.0.CO;2-T; Munch D, 2008, FUNCT ECOL, V22, P407, DOI 10.1111/j.1365-2435.2008.01419.x; Munch D, 2010, FEBS LETT, V584, P2496, DOI 10.1016/j.febslet.2010.04.007; Nijhout H.F., 1998, INSECT HORMONES, P280; Partridge L, 2005, MECH AGEING DEV, V126, P35, DOI 10.1016/j.mad.2004.09.017; Partridge L, 2010, PHILOS T R SOC B, V365, P147, DOI 10.1098/rstb.2009.0222; Perez-Staples D, 2007, PHYSIOL ENTOMOL, V32, P225, DOI 10.1111/j.1365-3032.2007.00568.x; Radhakrishnan P, 2008, PHYSIOL ENTOMOL, V33, P302, DOI 10.1111/j.1365-3032.2008.00631.x; Radhakrishnan P, 2007, J INSECT PHYSIOL, V53, P741, DOI 10.1016/j.jinsphys.2006.10.009; Raghu S, 2003, AUST J ENTOMOL, V42, P281, DOI 10.1046/j.1440-6055.2003.00364.x; Rogina B, 2007, MECH AGEING DEV, V128, P477, DOI 10.1016/j.mad.2007.06.004; Romanyukha AA, 2004, P ROY SOC B-BIOL SCI, V271, P1319, DOI 10.1098/rspb.2004.2719; Tatar M, 2001, AM NAT, V158, P248, DOI 10.1086/321320; Tatar M, 2001, EXP GERONTOL, V36, P723, DOI 10.1016/S0531-5565(00)00238-2; Wickens AP, 2001, RESP PHYSIOL, V128, P379, DOI 10.1016/S0034-5687(01)00313-9; Wigby S, 2005, CURR BIOL, V15, P316, DOI 10.1016/j.cub.2005.01.051; Wolfner MF, 2002, HEREDITY, V88, P85, DOI 10.1038/sj.hdy.6800017	35	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132486	10.1371/journal.pone.0132486	http://dx.doi.org/10.1371/journal.pone.0132486			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147734	Green Published, gold, Green Submitted			2022-12-26	WOS:000358157600284
J	Chen, X; Gohain, N; Zhan, C; Lu, WY; Pazgier, M; Lu, W				Chen, X.; Gohain, N.; Zhan, C.; Lu, W-Y; Pazgier, M.; Lu, W.			Structural basis of how stress-induced MDMX phosphorylation activates p53	ONCOGENE			English	Article							SITE-SPECIFIC INCORPORATION; EXPRESSED PROTEIN LIGATION; NATIVE CHEMICAL LIGATION; DNA-DAMAGE; TYROSINE PHOSPHORYLATION; EMBRYONIC LETHALITY; GENERAL-METHOD; ATM; DOMAIN; DEGRADATION	The tumor-suppressor protein p53 is tightly controlled in normal cells by its two negative regulators-the E3 ubiquitin ligase MDM2 and its homolog MDMX. Under stressed conditions such as DNA damage, p53 escapes MDM2- and MDMX-mediated functional inhibition and degradation, acting to prevent damaged cells from proliferating through induction of cell cycle arrest, DNA repair, senescence or apoptosis. Ample evidence suggests that stress signals induce phosphorylation of MDM2 and MDMX, leading to p53 activation. However, the structural basis of stress-induced p53 activation remains poorly understood because of the paucity of technical means to produce site-specifically phosphorylated MDM2 and MDMX proteins for biochemical and biophysical studies. Herein, we report total chemical synthesis, via native chemical ligation, and functional characterization of (24-108) MDMX and its Tyr99-phosphorylated analog with respect to their ability to interact with a panel of p53-derived peptide ligands and PMI, a p53-mimicking but more potent peptide antagonist of MDMX, using FP and surface plasmon resonance techniques. Phosphorylation of MDMX at Tyr99 weakens peptide binding by approximately two orders of magnitude. Comparative X-ray crystallographic analyses of MDMX and of pTyr99 MDMX in complex with PMI as well as modeling studies reveal that the phosphate group of pTyr99 imposes extensive steric clashes with the C-terminus of PMI or p53 peptide and induces a significant lateral shift of the peptide ligand, contributing to the dramatic decrease in the binding affinity of MDMX for p53. Because DNA damage activates c-Abl tyrosine kinase that phosphorylates MDMX at Tyr99, our findings afford a rare glimpse at the structural level of how stress-induced MDMX phosphorylation dislodges p53 from the inhibitory complex and activates it in response to DNA damage.	[Chen, X.; Gohain, N.; Zhan, C.; Pazgier, M.; Lu, W.] Univ Maryland, Sch Med, Inst Human Virol, 725 West Lombard St, Baltimore, MD 21201 USA; [Chen, X.; Gohain, N.; Zhan, C.; Pazgier, M.; Lu, W.] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Chen, X.; Lu, W-Y] Fudan Univ, Sch Pharm, Key Lab Smart Drug Delivery MOE, Shanghai 200433, Peoples R China; [Chen, X.; Lu, W-Y] Fudan Univ, Sch Pharm, PLA, Shanghai 200433, Peoples R China; [Lu, W.] Xi An Jiao Tong Univ, Ctr Translat Med, Sch Life Sci & Technol, Xian, Shaanxi, Peoples R China	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Fudan University; Fudan University; Xi'an Jiaotong University	Pazgier, M; Lu, W (corresponding author), Univ Maryland, Sch Med, Inst Human Virol, 725 West Lombard St, Baltimore, MD 21201 USA.	mpazgier@ihv.umaryland.edu; wlu@ihv.umaryland.edu	Lu, Wuyuan/B-2268-2010; Lu, Wuyuan/J-8452-2017; Gohain, Neelakshi/P-7493-2015; Lu, Weiyue/E-7938-2010	Lu, Wuyuan/0000-0003-1318-9968; Gohain, Neelakshi/0000-0003-1370-312X	US National Institutes of Health [CA167296]; National Natural Science Foundation of China [81128015]; National Basic Research Program of China (973 Program) [2013CB932500]; China Scholarship Council; DOE Office of Biological and Environmental Research; National Institutes of Health, National Center for Research Resources, Biomedical Technology Program [P41RR001209]; National Institute of General Medical Sciences; NATIONAL CANCER INSTITUTE [R21CA167296] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); China Scholarship Council(China Scholarship Council); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Center for Research Resources, Biomedical Technology Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was partially supported by the US National Institutes of Health grant CA167296 and the Overseas Scholars Collaborative Research grant 81128015 from the National Natural Science Foundation of China (WL), and by the National Basic Research Program of China (973 Program, 2013CB932500) (W-YL). XC was the recipient of a scholarship from the China Scholarship Council. Portions of this research were carried out at the University of Maryland X-ray Crystallography Shared Service and the Stanford Synchrotron Radiation Lightsource, a Directorate of SLAC National Accelerator Laboratory and an Office of Science User Facility operated for the U.S. Department of Energy Office of Science by Stanford University. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research and by the National Institutes of Health, National Center for Research Resources, Biomedical Technology Program (P41RR001209), and the National Institute of General Medical Sciences.	Brown CJ, 2009, NAT REV CANCER, V9, P862, DOI 10.1038/nrc2763; Chen LH, 2005, EMBO J, V24, P3411, DOI 10.1038/sj.emboj.7600812; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cheng Q, 2009, EMBO J, V28, P3857, DOI 10.1038/emboj.2009.294; DAWSON PE, 1994, SCIENCE, V266, P776, DOI 10.1126/science.7973629; Dawson PE, 2000, ANNU REV BIOCHEM, V69, P923, DOI 10.1146/annurev.biochem.69.1.923; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Goldberg Z, 2002, EMBO J, V21, P3715, DOI 10.1093/emboj/cdf384; Hoe KK, 2014, NAT REV DRUG DISCOV, V13, P217, DOI 10.1038/nrd4236; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; Kallen J, 2009, J BIOL CHEM, V284, P8803, DOI 10.1074/jbc.M809096200; Kent SBH, 2009, CHEM SOC REV, V38, P338, DOI 10.1039/b700141j; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Li C, 2010, 2010 INTERNATIONAL FORUM ON BIOMEDICAL TEXTILE MATERIALS, PROCEEDINGS, P398; Lu W, 2003, BIOCHEMISTRY-US, V42, P5461, DOI 10.1021/bi0340144; Lu W, 2001, MOL CELL, V8, P759, DOI 10.1016/S1097-2765(01)00369-0; LUNA RMD, 1995, NATURE, V378, P203; Maya R, 2001, GENE DEV, V15, P1067, DOI 10.1101/gad.886901; Mayo LD, 1997, CANCER RES, V57, P5013; McCoy MA, 2003, P NATL ACAD SCI USA, V100, P1645, DOI 10.1073/pnas.0334477100; Meek DW, 2009, NAT REV CANCER, V9, P714, DOI 10.1038/nrc2716; Muir TW, 1998, P NATL ACAD SCI USA, V95, P6705, DOI 10.1073/pnas.95.12.6705; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NOREN CJ, 1989, SCIENCE, V244, P182, DOI 10.1126/science.2649980; Okamoto K, 2005, MOL CELL BIOL, V25, P9608, DOI 10.1128/MCB.25.21.9608-9620.2005; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parant J, 2001, NAT GENET, V29, P92, DOI 10.1038/ng714; Pazgiera M, 2009, P NATL ACAD SCI USA, V106, P4665, DOI 10.1073/pnas.0900947106; Pereg Y, 2005, P NATL ACAD SCI USA, V102, P5056, DOI 10.1073/pnas.0408595102; Popowicz GM, 2008, CELL CYCLE, V7, P2441, DOI 10.4161/cc.6365; Popowicz GM, 2011, ANGEW CHEM INT EDIT, V50, P2680, DOI 10.1002/anie.201003863; SCHNOLZER M, 1992, INT J PEPT PROT RES, V40, P180; Schwarzer D, 2005, CURR OPIN CHEM BIOL, V9, P561, DOI 10.1016/j.cbpa.2005.09.018; Showalter SA, 2008, J AM CHEM SOC, V130, P6472, DOI 10.1021/ja800201j; Tarrant MK, 2009, ANNU REV BIOCHEM, V78, P797, DOI 10.1146/annurev.biochem.78.070907.103047; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Wade M, 2013, NAT REV CANCER, V13, P83, DOI 10.1038/nrc3430; Wade M, 2010, TRENDS CELL BIOL, V20, P299, DOI 10.1016/j.tcb.2010.01.009; Waning DL, 2011, J BIOL CHEM, V286, P216, DOI 10.1074/jbc.M110.183012; Worralll EG, 2010, J MOL BIOL, V398, P414, DOI 10.1016/j.jmb.2010.03.023; Zhan CY, 2012, J MED CHEM, V55, P6237, DOI 10.1021/jm3005465; Zhan CY, 2012, J AM CHEM SOC, V134, P6855, DOI 10.1021/ja301255n; Zuckerman V, 2009, J BIOL CHEM, V284, P4031, DOI 10.1074/jbc.M809211200	44	14	15	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 14	2016	35	15					1919	1925		10.1038/onc.2015.255	http://dx.doi.org/10.1038/onc.2015.255			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DJ2CC	26148237	Green Accepted			2022-12-26	WOS:000374010300005
J	Abuhatzira, L; Xu, HY; Tahhan, G; Boulougoura, A; Schaffer, AA; Notkins, AL				Abuhatzira, Liron; Xu, Huanyu; Tahhan, Georges; Boulougoura, Afroditi; Schaeffer, Alejandro A.; Notkins, Abner L.			Multiple microRNAs within the 14q32 cluster target the mRNAs of major type 1 diabetes autoantigens IA-2, IA-2 beta, and GAD65	FASEB JOURNAL			English	Article						autoimmune diabetes; miRNA; miR-342; glucose-sensitive	PANCREATIC BETA-CELLS; RIP-CHIP; MIRNAS; ISLETS; EXPRESSION; IDENTIFICATION; COEXPRESSION; PHOSPHATASE; PATTERNS; REVEALS	Islet antigen (IA)-2, IA-2b, and glutamate decarboxylase (GAD65) are major autoantigens in type 1 diabetes (T1D). Autoantibodies to these autoantigens appear years before disease onset and are widely used as predictive markers. Little is known, however, about what regulates the expression of these autoantigens. The present experiments were initiated to test the hypothesis that microRNAs (miRNAs) can target and affect the levels of these autoantigens. Bioinformatics was used to identify miRNAs predicted to target the mRNAs coding IA-2, IA-2b, and GAD65. RNA interference for the miRNA processing enzyme Dicer1 and individual miRNA mimics and inhibitors were used to confirm the effect in mouse islets and MIN6 cells. We show that the imprinted 14q32 miRNA cluster contains 56 miRNAs, 32 of which are predicted to target the mRNAs of T1D autoantigens and 12 of which are glucose-sensitive. Using miRNA mimics and inhibitors, we confirmed that at least 7 of these miRNAs modulate the mRNA levels of the T1D autoantigens. Dicer1 knockdown significantly reduced the mRNA levels of all 3 autoantigens, further confirming the importance of miRNAs in this regulation. We conclude that miRNAs are involved in regulating the expression of the major T1D autoantigens.	[Abuhatzira, Liron; Xu, Huanyu; Tahhan, Georges; Boulougoura, Afroditi; Notkins, Abner L.] Natl Inst Dent & Craniofacial Res, Expt Med Sect, Lab Sensory Biol, NIH, Bethesda, MD 20892 USA; [Schaeffer, Alejandro A.] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Abuhatzira, L (corresponding author), Natl Inst Dent & Craniofacial Res, Expt Med Sect, Lab Sensory Biol, NIH, Bethesda, MD 20892 USA.	abuhatzira@mail.nih.gov	Schaffer, Alejandro A/F-2902-2012; Schaffer, Alejandro/N-1222-2019	Abuhatzira, Liron/0000-0002-2742-0908; , Afroditi/0000-0002-0161-3322	National Institute of Dental and Craniofacial Research; National Library of Medicine, U.S. National Institutes of Health (Bethesda, MD, USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000423] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [ZIALM000097] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Library of Medicine, U.S. National Institutes of Health (Bethesda, MD, USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	The authors thank Dr. John Tsang for advice and meaningful discussions. This work was supported by the Intramural Research Program of the National Institute of Dental and Craniofacial Research, and by the Intramural Research Program of the National Library of Medicine, U.S. National Institutes of Health (Bethesda, MD, USA). L.A. and A.L.N. conceived of the project, designed and performed experiments, and wrote the manuscript. H.X., G.T., and A.B. performed experiments, participated in the discussions and reviewed the manuscript. A.A.S. performed the simulation, advised on other aspects of the bioinformatics and reviewed the manuscript. The authors declare no conflicts of interest.	Altuvia Y, 2005, NUCLEIC ACIDS RES, V33, P2697, DOI 10.1093/nar/gki567; Arvan P, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007658; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; BJORK E, 1992, J CLIN ENDOCR METAB, V75, P1574, DOI 10.1210/jc.75.6.1574; Bravo-Egana V, 2012, J TRANSPLANT, V2012, DOI 10.1155/2012/723614; Cai T, 2011, DIABETOLOGIA, V54, P2347, DOI 10.1007/s00125-011-2221-6; Caromile LA, 2010, J BIOL CHEM, V285, P10487, DOI 10.1074/jbc.M109.066563; Ceribelli A, 2012, CURR OPIN IMMUNOL, V24, P686, DOI 10.1016/j.coi.2012.07.011; Dai Y, 2007, LUPUS, V16, P939, DOI 10.1177/0961203307084158; Fernandez-Valverde SL, 2011, DIABETES, V60, P1825, DOI 10.2337/db11-0171; Grun D, 2005, PLOS COMPUT BIOL, V1, P51, DOI 10.1371/journal.pcbi.0010013; Guay C, 2013, NAT REV ENDOCRINOL, V9, P513, DOI 10.1038/nrendo.2013.86; HAGOPIAN WA, 1993, ENDOCRINOLOGY, V132, P2674, DOI 10.1210/en.132.6.2674; Hammond SM, 2005, FEBS LETT, V579, P5822, DOI 10.1016/j.febslet.2005.08.079; Han B, 2012, ISRN ENDOCRINOL, V2012; Harashima SI, 2007, CLIN EXP IMMUNOL, V150, P49, DOI 10.1111/j.1365-2249.2007.03455.x; Hennessy E, 2010, BIOCHEM BIOPH RES CO, V396, P457, DOI 10.1016/j.bbrc.2010.04.116; Hezova R, 2010, CELL IMMUNOL, V260, P70, DOI 10.1016/j.cellimm.2009.10.012; Iborra M, 2012, AUTOIMMUN REV, V11, P305, DOI 10.1016/j.autrev.2010.07.002; Joglekar MV, 2007, TRENDS ENDOCRIN MET, V18, P393, DOI 10.1016/j.tem.2007.10.001; Kagami M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000992; Kapsogeorgou EK, 2011, J AUTOIMMUN, V37, P129, DOI 10.1016/j.jaut.2011.05.003; Keene JD, 2006, NAT PROTOC, V1, P302, DOI 10.1038/nprot.2006.47; Kubosaki A, 2005, DIABETES, V54, pS46, DOI 10.2337/diabetes.54.suppl_2.S46; Lakey JRT, 2001, CELL TRANSPLANT, V10, P697, DOI 10.3727/000000001783986279; Liu HY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005436; Mandemakers W, 2013, DIABETOLOGIA, V56, P1547, DOI 10.1007/s00125-013-2901-5; Melkman-Zehavi T, 2011, EMBO J, V30, P835, DOI 10.1038/emboj.2010.361; Pauley KM, 2009, J AUTOIMMUN, V32, P189, DOI 10.1016/j.jaut.2009.02.012; Pihoker C, 2005, DIABETES, V54, pS52, DOI 10.2337/diabetes.54.suppl_2.S52; Planas R, 2010, CLIN EXP IMMUNOL, V159, P23, DOI 10.1111/j.1365-2249.2009.04053.x; Ravier MA, 2010, METHODS MOL BIOL, V633, P171, DOI 10.1007/978-1-59745-019-5_12; Saeki K, 2002, DIABETES, V51, P1842, DOI 10.2337/diabetes.51.6.1842; Seitz H, 2004, GENOME RES, V14, P1741, DOI 10.1101/gr.2743304; Shemer R, 2000, NAT GENET, V26, P440, DOI 10.1038/82571; Simion A, 2010, BIOCHEM BIOPH RES CO, V391, P293, DOI 10.1016/j.bbrc.2009.11.052; SORENSON RL, 1991, DIABETES, V40, P1365, DOI 10.2337/diabetes.40.11.1365; Tan LP, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp715; Tang XQ, 2009, RNA, V15, P287, DOI 10.1261/rna.1211209; Temple IK, 2010, REV ENDOCR METAB DIS, V11, P199, DOI 10.1007/s11154-010-9150-4; Tian JD, 2013, DIABETES, V62, P3760, DOI 10.2337/db13-0931; Wallace C, 2010, NAT GENET, V42, P68, DOI 10.1038/ng.493; Wang C, 2007, AM J PHYSIOL-ENDOC M, V292, pE1201, DOI 10.1152/ajpendo.00459.2006; Wang LL, 2012, ANTIVIR RES, V93, P270, DOI 10.1016/j.antiviral.2011.12.004; Wang WX, 2010, RNA, V16, P394, DOI 10.1261/rna.1905910; Zhu YX, 2013, DIABETES, V62, P3194, DOI 10.2337/db13-0151	47	22	23	1	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2015	29	10					4374	4383		10.1096/fj.15-273649	http://dx.doi.org/10.1096/fj.15-273649			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CR5FY	26148972	Green Published			2022-12-26	WOS:000361367300025
J	Giner, XC; Cotnoir-White, D; Mader, S; Levesque, D				Giner, Xavier C.; Cotnoir-White, David; Mader, Sylvie; Levesque, Daniel			Selective ligand activity at Nur/retinoid X receptor complexes revealed by dimer-specific bioluminescence resonance energy transfer-based sensors	FASEB JOURNAL			English	Article						nuclear receptors; pharmacological parameters; cofactor recruitment; receptor dimerization; protein conformation	ORPHAN NUCLEAR RECEPTORS; NGFI-B; DOCOSAHEXAENOIC ACID; RXR; AGONIST; BINDING; PROTEIN; NURR1; ACTIVATION; EXPRESSION	Retinoid X receptors (RXRs) play a role as master regulators because of their capacity to form heterodimers with other nuclear receptors (NRs). Accordingly, retinoid signaling is involved in multiple biologic processes, including development, cell differentiation, metabolism, and cell death. However, the role and function of RXRs in different heterodimer complexes remain unidentified, mainly because most RXR drugs (called rexinoids) are not selective of specific heterodimer complexes. The lack of selectivity strongly limits the use of rexinoids for specific therapeutic approaches. To better characterize rexinoids at specific NR complexes, we have developed and optimized luciferase (Luc) protein complementation(PCA)-based bioluminescence resonance energy transfer (BRET) assays that can directly measure recruitment of a coactivator (CoA) motif fused to yellow fluorescent protein (YFP) by specific NR dimers. To validate the assays, we compared rexinoid modulation of CoA recruitment by the RXR homodimer and by the heterodimers Nur77/RXR and Nurr1/RXR. Results revealed that some rexinoids display selective CoA recruitment activities with homo-or heterodimer complexes. In particular, SR11237 (BMS649) has stronger potency for recruitment of CoA motif and transcriptional activity with the heterodimer Nur77/RXR than other complexes. This technology should be useful in identifying new compounds with specificity for individual dimeric species formed by NRs.	[Giner, Xavier C.; Levesque, Daniel] Univ Montreal, Fac Pharm, Montreal, PQ H3C 3J7, Canada; [Giner, Xavier C.; Levesque, Daniel] Univ Montreal, Grp Rech Univ Medicament, Montreal, PQ H3C 3J7, Canada; [Cotnoir-White, David; Mader, Sylvie] Univ Montreal, Inst Rech Immunol & Cancerol, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal	Levesque, D (corresponding author), Univ Montreal, Fac Pharm, Pavillon Jean Coutu,CP 6128,Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.	daniel.levesque.1@umontreal.ca		Levesque, Daniel/0000-0002-3019-3048	Groupe de Recherche Universitaire sur le Medicament (Universite de Montreal); Canadian Institute for Health Research [MOP125863, MOP130407]	Groupe de Recherche Universitaire sur le Medicament (Universite de Montreal); Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR))	The authors thank Drs. H. Kagechika and K. Shudo (School of Biomedical Science, Tokyo Medical and Dental University and Research Foundation Itsuu Laboratory, Tokyo, Japan) for generously providing the HX600, HX630, and HX531 compounds; Dr. J. Drouin (Institut de Recherche Clinique de Montreal) for the beta RARE DR-5 element plasmid construct; and Dr. Michel Bouvier's Lab members at the Institut de Recherche en Immunologie et Cancerologie (Universite de Montreal, Montreal, QC, Canada) for helpful discussions for BRET-based assay optimizations. This work was supported by a grant from the Groupe de Recherche Universitaire sur le Medicament (Universite de Montreal; to D.L.) and by grants from the Canadian Institute for Health Research [MOP125863 (to S.M.) and to MOP130407 (to D.L.)]. The authors declare no conflicts of interest.	BOEHM MF, 1995, J MED CHEM, V38, P3146, DOI 10.1021/jm00016a018; BOEHM MF, 1994, J MED CHEM, V37, P2930, DOI 10.1021/jm00044a014; BOEHM MF, 1994, J MED CHEM, V37, P408, DOI 10.1021/jm00029a013; Bookout AL, 2006, CELL, V126, P789, DOI 10.1016/j.cell.2006.06.049; Burris TP, 2013, PHARMACOL REV, V65, P710, DOI 10.1124/pr.112.006833; Chao LC, 2007, MOL ENDOCRINOL, V21, P2152, DOI 10.1210/me.2007-0169; Dawson MI, 2012, BBA-MOL CELL BIOL L, V1821, P21, DOI 10.1016/j.bbalip.2011.09.014; de Lera AR, 2007, NAT REV DRUG DISCOV, V6, P811, DOI 10.1038/nrd2398; de Urquiza AM, 2000, SCIENCE, V290, P2140, DOI 10.1126/science.290.5499.2140; DUBOIS C, 2006, CHEMMEDCHEM, V1, P955, DOI DOI 10.1002/CMDC.200600078; Duplessis TT, 2009, METHODS MOL BIOL, V590, P253, DOI 10.1007/978-1-60327-378-7_16; Egea PF, 2002, MOL ENDOCRINOL, V16, P987, DOI 10.1210/me.16.5.987; Ethier I, 2004, BIOL PSYCHIAT, V56, P522, DOI 10.1016/j.biopsych.2004.06.036; Farmer LJ, 2006, BIOORG MED CHEM LETT, V16, P2352, DOI 10.1016/j.bmcl.2005.12.003; Flaig R, 2005, J BIOL CHEM, V280, P19250, DOI 10.1074/jbc.M413175200; FORMAN BM, 1995, CELL, V81, P541, DOI 10.1016/0092-8674(95)90075-6; Germain P, 2006, PHARMACOL REV, V58, P685, DOI 10.1124/pr.58.4.2; Goldstein JT, 2003, ARCH BIOCHEM BIOPHYS, V420, P185, DOI 10.1016/j.abb.2003.09.034; Gronemeyer H, 2004, NAT REV DRUG DISCOV, V3, P950, DOI 10.1038/nrd1551; Gurevich I, 2007, TOXICOL APPL PHARM, V223, P288, DOI 10.1016/j.taap.2007.05.019; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; HEYMAN RA, 1992, CELL, V68, P397, DOI 10.1016/0092-8674(92)90479-V; Kadkhodaei B, 2009, J NEUROSCI, V29, P15923, DOI 10.1523/JNEUROSCI.3910-09.2009; Koterba Kristen L, 2006, Nucl Recept Signal, V4, pe021; Leibowitz MD, 2006, ENDOCRINOLOGY, V147, P1044, DOI 10.1210/en.2005-0690; Levesque D, 2007, TRENDS NEUROSCI, V30, P22, DOI 10.1016/j.tins.2006.11.006; Li X, 2012, BIOCHEM PHARMACOL, V83, P1445, DOI 10.1016/j.bcp.2012.02.021; Lippert WP, 2009, CHEMMEDCHEM, V4, P1143, DOI 10.1002/cmdc.200900090; Llopis J, 2000, P NATL ACAD SCI USA, V97, P4363, DOI 10.1073/pnas.97.8.4363; Lupien M, 2007, MOL ENDOCRINOL, V21, P797, DOI 10.1210/me.2006-0074; Maira M, 1999, MOL CELL BIOL, V19, P7549; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; Martel C, 2010, RNA, V16, P585, DOI 10.1261/rna.1664210; Martin LJ, 2010, BIOL REPROD, V83, P3, DOI 10.1095/biolreprod.110.083824; Maxwell Megan A, 2006, Nucl Recept Signal, V4, pe002; McFarland K, 2013, ACS CHEM NEUROSCI, V4, P1430, DOI 10.1021/cn400100f; Michellys PY, 2004, BIOORG MED CHEM LETT, V14, P1593, DOI 10.1016/j.bmcl.2003.12.089; Michnick SW, 2007, NAT REV DRUG DISCOV, V6, P569, DOI 10.1038/nrd2311; Morishita K, 2009, BIOORG MED CHEM LETT, V19, P1001, DOI 10.1016/j.bmcl.2008.11.086; Morita K, 2005, BIOCHEM PHARMACOL, V71, P98, DOI 10.1016/j.bcp.2005.10.017; Mulero M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084569; Nahoum V, 2007, P NATL ACAD SCI USA, V104, P17323, DOI 10.1073/pnas.0705356104; Paulmurugan R, 2003, ANAL CHEM, V75, P1584, DOI 10.1021/ac020731c; Pei LM, 2006, NAT MED, V12, P1048, DOI 10.1038/nm1471; PERLMANN T, 1995, GENE DEV, V9, P769, DOI 10.1101/gad.9.7.769; Pfleger KDG, 2006, NAT METHODS, V3, P165, DOI 10.1038/nmeth841; Phillips A, 1997, MOL CELL BIOL, V17, P5946, DOI 10.1128/MCB.17.10.5946; Safe S, 2014, MOL ENDOCRINOL, V28, P157, DOI 10.1210/me.2013-1291; Sakaki J, 2007, BIOORG MED CHEM LETT, V17, P4808, DOI 10.1016/j.bmcl.2007.06.079; Stefan E, 2007, P NATL ACAD SCI USA, V104, P16916, DOI 10.1073/pnas.0704257104; Takamatsu K, 2008, CHEMMEDCHEM, V3, P454, DOI 10.1002/cmdc.200700265; Umemiya H, 1997, J MED CHEM, V40, P4222, DOI 10.1021/jm9704309; Wagner CE, 2009, J MED CHEM, V52, P5950, DOI 10.1021/jm900496b; Wallen-Mackenzie A, 2003, GENE DEV, V17, P3036, DOI 10.1101/gad.276003; Wang ZL, 2003, NATURE, V423, P555, DOI 10.1038/nature01645; Wansa KDSA, 2002, J BIOL CHEM, V277, P33001, DOI 10.1074/jbc.M203572200; WILSON TE, 1991, SCIENCE, V252, P1296, DOI 10.1126/science.1925541; Zetterstrom RH, 1996, MOL ENDOCRINOL, V10, P1656, DOI 10.1210/me.10.12.1656; Zhan YP, 2008, NAT CHEM BIOL, V4, P548, DOI 10.1038/nchembio.106; Zhao Yue, 2009, Drug Discov Today Dis Mech, V6, pe43	60	12	13	1	19	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2015	29	10					4256	4267		10.1096/fj.14-259804	http://dx.doi.org/10.1096/fj.14-259804			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CR5FY	26148973	Green Accepted			2022-12-26	WOS:000361367300015
J	Lee, EH; Kim, SS; Lee, S; Baek, KH; Seo, SR				Lee, Eun Hye; Kim, Seon Sook; Lee, Seul; Baek, Kwan-Hyuck; Seo, Su Ryeon			Pituitary Adenylate Cyclase-activating Polypeptide ( PACAP) Targets Down Syndrome Candidate Region 1 (DSCR1/RCAN1) to control Neuronal Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAMP RESPONSE ELEMENT; DSCR1 ADAPT78; PC12 CELLS; INHIBITS CALCINEURIN; NEURITE OUTGROWTH; OXIDATIVE STRESS; NERVOUS-SYSTEM; UP-REGULATION; MAP KINASE; C-FOS	Pituitary adenylate cyclase-activating peptide (PACAP) is a neurotrophic peptide involved in a wide range of nervous functions, including development, differentiation, and survival, and various aspects of learning and memory. Here we report that PACAP induces the expression of regulator of calcineurin 1 (RCAN1, also known as DSCR1), which is abnormally expressed in the brains of Down syndrome patients. Increased RCAN1 expression is accompanied by activation of the PKA-cAMP response element-binding protein pathways. EMSA and ChIP analyses demonstrate the presence of a functional cAMP response element in the RCAN1 promoter. Moreover, we show that PACAP-dependent neuronal differentiation is significantly disturbed by improper RCAN1 expression. Our data provide the first evidence of RCAN1, a Down syndrome-related gene, as a novel target for control of the neurotrophic function of PACAP.	[Lee, Eun Hye; Kim, Seon Sook; Seo, Su Ryeon] Kangwon Natl Univ, Coll Biomed Sci, Dept Mol Biosci, Chunchon 200701, South Korea; [Lee, Eun Hye; Kim, Seon Sook; Seo, Su Ryeon] Kangwon Natl Univ, Inst Biosci & Biotechnol, Chunchon 200701, South Korea; [Lee, Seul; Baek, Kwan-Hyuck] Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Dept Mol & Cellular Biol, Suwon 440746, Gyeonggi, South Korea	Kangwon National University; Kangwon National University; Sungkyunkwan University (SKKU)	Seo, SR (corresponding author), Kangwon Natl Univ, Coll Biomed Sci, Dept Mol Biosci, Chunchon 200701, South Korea.	suryeonseo@kangwon.ac.kr			Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education, Science, and Technology [2009-0065231, 2010-0023815]; Ministry of Education	Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education, Science, and Technology; Ministry of Education	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea, funded by Ministry of Education, Science, and Technology Grants 2009-0065231 and 2010-0023815. This work was also a result of study on the Leaders Industry-University Cooperation Project supported by the Ministry of Education. The authors declare that they have no conflicts of interest with the contents of this article.	Ahn S, 1998, MOL CELL BIOL, V18, P967, DOI 10.1128/MCB.18.2.967; Casas C, 2001, MECH DEVELOP, V101, P289, DOI 10.1016/S0925-4773(00)00583-9; Chang KT, 2009, P NATL ACAD SCI USA, V106, P17117, DOI 10.1073/pnas.0904397106; Chang KT, 2003, P NATL ACAD SCI USA, V100, P15794, DOI 10.1073/pnas.2536696100; Cho A, 2014, NEURON, V82, P109, DOI 10.1016/j.neuron.2014.02.015; Cho KO, 2008, EXP NEUROL, V212, P85, DOI 10.1016/j.expneurol.2008.03.017; Crawford DR, 1997, ARCH BIOCHEM BIOPHYS, V342, P6, DOI 10.1006/abbi.1997.0109; Davies KJA, 2001, BIOFACTORS, V15, P91, DOI 10.1002/biof.5520150208; Dickson L, 2009, PHARMACOL THERAPEUT, V121, P294, DOI 10.1016/j.pharmthera.2008.11.006; Ermak G, 2002, FASEB J, V16, DOI 10.1096/fj.01-0846com; Ermak G, 2001, J BIOL CHEM, V276, P38787, DOI 10.1074/jbc.M102829200; Ermak G, 2013, FREE RADICAL BIO MED, V62, P47, DOI 10.1016/j.freeradbiomed.2013.01.016; Ermak G, 2012, J BIOL CHEM, V287, P14088, DOI 10.1074/jbc.M111.305342; Ermak G, 2009, J BIOL CHEM, V284, P11845, DOI 10.1074/jbc.M900639200; Fahrenkrug J, 2006, CHRONOBIOL INT, V23, P53, DOI 10.1080/07420520500464569; FEANY MB, 1995, SCIENCE, V268, P869, DOI 10.1126/science.7754370; Finkbeiner S, 1997, NEURON, V19, P1031, DOI 10.1016/S0896-6273(00)80395-5; FUENTES JJ, 1995, HUM MOL GENET, V4, P1935, DOI 10.1093/hmg/4.10.1935; Fuentes JJ, 2000, HUM MOL GENET, V9, P1681, DOI 10.1093/hmg/9.11.1681; Fuentes JJ, 1997, GENOMICS, V44, P358, DOI 10.1006/geno.1997.4866; Genesca L, 2003, BIOCHEM J, V374, P567, DOI 10.1042/BJ20030267; Gonzalez BJ, 1997, NEUROSCIENCE, V78, P419, DOI 10.1016/S0306-4522(96)00617-3; Hammond DR, 2010, DEV DYNAM, V239, P2443, DOI 10.1002/dvdy.22367; Harris CD, 2005, CELL MOL LIFE SCI, V62, P2477, DOI 10.1007/s00018-005-5085-4; HERNANDEZ A, 1995, PEPTIDES, V16, P927, DOI 10.1016/0196-9781(95)00059-S; Hirakawa Yasuko, 2009, J Mol Signal, V4, P6, DOI 10.1186/1750-2187-4-6; Ji L, 1996, J BIOL CHEM, V271, P22687, DOI 10.1074/jbc.271.37.22687; Jovanovic JN, 1996, P NATL ACAD SCI USA, V93, P3679, DOI 10.1073/pnas.93.8.3679; KIM KS, 1993, J BIOL CHEM, V268, P15689; Kim SS, 2012, BIOCHEM BIOPH RES CO, V418, P657, DOI 10.1016/j.bbrc.2012.01.071; KING MM, 1984, J BIOL CHEM, V259, P8080; Leahy KP, 2000, ARCH BIOCHEM BIOPHYS, V379, P221, DOI 10.1006/abbi.2000.1897; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Lorenzi H, 2010, BIOTECHNIQUES, V48, P35, DOI 10.2144/000113342; Lu NR, 1997, P NATL ACAD SCI USA, V94, P3357, DOI 10.1073/pnas.94.7.3357; MANDELKOW EM, 1995, NEUROBIOL AGING, V16, P355, DOI 10.1016/0197-4580(95)00025-A; Martin KR, 2012, HUM MOL GENET, V21, P3025, DOI 10.1093/hmg/dds134; MIYATA A, 1989, BIOCHEM BIOPH RES CO, V164, P567, DOI 10.1016/0006-291X(89)91757-9; Moroo I, 1998, BRAIN RES, V795, P191, DOI 10.1016/S0006-8993(98)00291-1; Nagao K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049926; NICHOLS RA, 1994, J BIOL CHEM, V269, P23817; Ravni A, 2006, J NEUROCHEM, V98, P321, DOI 10.1111/J.1471-4159.2006.03884.X; Roper RJ, 2009, MECH DEVELOP, V126, P212, DOI 10.1016/j.mod.2008.11.002; Rothermel B, 2000, J BIOL CHEM, V275, P8719, DOI 10.1074/jbc.275.12.8719; Sakai N, 2002, MOL PHARMACOL, V61, P1453, DOI 10.1124/mol.61.6.1453; Sakai Y, 2004, MOL BRAIN RES, V123, P18, DOI 10.1016/j.molbrainres.2003.12.013; SHENG M, 1990, NEURON, V4, P477, DOI 10.1016/0896-6273(90)90106-P; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; TATSUNO I, 1994, BRAIN RES, V662, P1, DOI 10.1016/0006-8993(94)90790-0; U M, 2004, LEUKEMIA, V18, P1850, DOI 10.1038/sj.leu.2403516; Vaudry D, 2000, PHARMACOL REV, V52, P269; Vaudry D, 2009, PHARMACOL REV, V61, P283, DOI 10.1124/pr.109.001370; Villalba M, 1997, J NEUROSCI, V17, P83, DOI 10.1523/JNEUROSCI.17-01-00083.1997; Wang W, 2012, EMBO J, V31, P3655, DOI 10.1038/emboj.2012.190; Yoshida T, 2005, J NEUROSCI, V25, P3067, DOI 10.1523/JNEUROSCI.3738-04.2005	55	4	4	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2015	290	34					21019	21031		10.1074/jbc.M115.639476	http://dx.doi.org/10.1074/jbc.M115.639476			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP6QC	26157140	Green Published, hybrid			2022-12-26	WOS:000360011800035
J	Beckman, D; Santos, LE; Americo, TA; Ledo, JH; de Mello, FG; Linden, R				Beckman, Danielle; Santos, Luis E.; Americo, Tatiana A.; Ledo, Jose H.; de Mello, Fernando G.; Linden, Rafael			Prion Protein Modulates Monoaminergic Systems and Depressive-like Behavior in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CREUTZFELDT-JAKOB-DISEASE; AMYLOID-BETA OLIGOMERS; CELLULAR PRION; ANIMAL-MODELS; 5-HT5A RECEPTOR; TYROSINE-HYDROXYLASE; 5-HT(5A) RECEPTOR; ADENYLATE-CYCLASE; ALZHEIMER-DISEASE; NERVOUS-SYSTEM	We sought to examine interactions of the prion protein (PrPC) with monoaminergic systems due to: the role of PrPC in both Prion and Alzheimer diseases, which include clinical depression among their symptoms, the implication of monoamines in depression, and the hypothesis that PrPC serves as a scaffold for signaling systems. To that effect we compared both behavior and monoaminergic markers in wild type (WT) and PrPC-null (PrP-/(-)) mice. PrP-/(-) mice performed poorly when compared with WT in forced swimming, tail suspension, and novelty suppressed feeding tests, typical of depressive-like behavior, but not in the control open field nor rotarod motor tests; cyclic AMP responses to stimulation of D1 receptors by dopamine was selectively impaired in PrP-/(-) mice, and responses to serotonin, but not to norepinephrine, also differed between genotypes. Contents of dopamine, tyrosine hydroxylase, and the 5-HT5A serotonin receptor were increased in the cerebral cortex of PrP-/(-), as compared with WT mice. Microscopic colocalization, as well as binding in overlay assays were found of PrPC with both the 5HT5A and D1, but not D4 receptors. The data are consistent with the scaffolding of monoaminergic signaling modules by PrPC, and may help understand the pathogenesis of clinical depression and neurodegenerative disorders.	[Beckman, Danielle; Santos, Luis E.; Americo, Tatiana A.; de Mello, Fernando G.; Linden, Rafael] Univ Fed Rio de Janeiro, Inst Biofis, BR-21941902 Rio de Janeiro, Brazil; [Ledo, Jose H.] Univ Fed Rio de Janeiro, Inst Bioquim Med, BR-21941902 Rio de Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Linden, R (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis, BR-21941902 Rio de Janeiro, Brazil.	rlinden@biof.ufrj.br	Beckman, Danielle/B-4656-2015; Santos, Luís/B-4961-2015; Linden, Rafael/F-2275-2011	Beckman, Danielle/0000-0002-9584-4411; Santos, Luís/0000-0002-0694-733X; Linden, Rafael/0000-0003-3287-336X	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro; National Institute of Translational Neuroscience	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); National Institute of Translational Neuroscience	This work was supported by grants and fellowships from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (to R. L.), Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (to R. L.), and National Institute of Translational Neuroscience (to F. G. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Adjou KT, 2008, NEUROCHEM INT, V52, P1416, DOI 10.1016/j.neuint.2008.03.002; Aguzzi A, 2009, PHYSIOL REV, V89, P1105, DOI 10.1152/physrev.00006.2009; Arita DY, 2002, J CELL BIOCHEM, V87, P58, DOI 10.1002/jcb.10277; Autry AE, 2011, NATURE, V475, P91, DOI 10.1038/nature10130; Barnes NM, 1999, NEUROPHARMACOLOGY, V38, P1083, DOI 10.1016/S0028-3908(99)00010-6; BASSANT MH, 1984, BRAIN RES, V308, P182, DOI 10.1016/0006-8993(84)90934-X; Baumgarten HG, 2004, NEUROTOX RES, V6, P589, DOI 10.1007/BF03033455; Beaulieu JM, 2011, PHARMACOL REV, V63, P182, DOI 10.1124/pr.110.002642; Beraldo FH, 2011, FASEB J, V25, P265, DOI 10.1096/fj.10-161653; Beraldo FH, 2010, J BIOL CHEM, V285, P36542, DOI 10.1074/jbc.M110.157263; Berton O, 2006, NAT REV NEUROSCI, V7, P137, DOI 10.1038/nrn1846; Black SAG, 2014, FRONT CELL DEV BIOL, V2, DOI 10.3389/fcell.2014.00045; BOLTON DC, 1982, SCIENCE, V218, P1309, DOI 10.1126/science.6815801; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Can A, 2011, GENES BRAIN BEHAV, V10, P434, DOI 10.1111/j.1601-183X.2011.00682.x; Can A, 2012, JOVE-J VIS EXP, V59, P3638, DOI DOI 10.3791/3638; Carson MJ, 1996, GLIA, V17, P317, DOI 10.1002/(SICI)1098-1136(199608)17:4<317::AID-GLIA6>3.0.CO;2-W; CLINTON J, 1993, NEUROREPORT, V4, P65, DOI 10.1097/00001756-199301000-00017; Coitinho AS, 2006, EUR J NEUROSCI, V24, P3255, DOI 10.1111/j.1460-9568.2006.05156.x; Coitinho AS, 2003, NEUROREPORT, V14, P1375, DOI 10.1097/01.wnr.0000078541.07662.90; Cools R, 2008, TRENDS COGN SCI, V12, P31, DOI 10.1016/j.tics.2007.10.011; Cowin RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028409; Croes EA, 2003, ANN NEUROL, V54, P275, DOI 10.1002/ana.10658; CROSS AJ, 1985, J NEUROL SCI, V70, P231, DOI 10.1016/0022-510X(85)90090-5; Cumbler Ethan, 2009, Cases J, V2, P122, DOI 10.1186/1757-1626-2-122; Dulawa SC, 2005, NEUROSCI BIOBEHAV R, V29, P771, DOI 10.1016/j.neubiorev.2005.03.017; Francken BJB, 1998, EUR J PHARMACOL, V361, P299, DOI 10.1016/S0014-2999(98)00744-4; Gadotti VM, 2012, BEHAV BRAIN RES, V227, P319, DOI 10.1016/j.bbr.2011.03.012; Gainetdinov RR, 2004, ANNU REV NEUROSCI, V27, P107, DOI 10.1146/annurev.neuro.27.070203.144206; Gasperini L, 2014, FRONT CELL DEV BIOL, V2, DOI 10.3389/fcell.2014.00044; Giese KP, 2013, LEARN MEMORY, V20, P540, DOI 10.1101/lm.028449.112; GILMAN AG, 1970, P NATL ACAD SCI USA, V67, P305, DOI 10.1073/pnas.67.1.305; Gimbel DA, 2010, J NEUROSCI, V30, P6367, DOI 10.1523/JNEUROSCI.0395-10.2010; Gonzalez R, 2013, BEHAV BRAIN RES, V252, P246, DOI 10.1016/j.bbr.2013.05.051; Goodfellow NM, 2012, J NEUROSCI, V32, P5804, DOI 10.1523/JNEUROSCI.4849-11.2012; Graner E, 2000, MOL BRAIN RES, V76, P85, DOI 10.1016/S0169-328X(99)00334-4; Green RC, 2003, ARCH NEUROL-CHICAGO, V60, P753, DOI 10.1001/archneur.60.5.753; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hirao K, 2015, NEUROSCI BIOBEHAV R, V49, P157, DOI 10.1016/j.neubiorev.2014.11.010; Hurley PT, 1998, BRIT J PHARMACOL, V124, P1238, DOI 10.1038/sj.bjp.0701928; Kassai F, 2012, BEHAV PHARMACOL, V23, P397, DOI 10.1097/FBP.0b013e3283565248; Klein WL, 2013, J ALZHEIMERS DIS, V33, pS49, DOI 10.3233/JAD-2012-129039; Krishnadas R, 2012, J NEUROL NEUROSUR PS, V83, P495, DOI 10.1136/jnnp-2011-301779; Lauren J, 2014, J ALZHEIMERS DIS, V38, P227, DOI 10.3233/JAD-130950; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Ledo JH, 2013, MOL PSYCHIATR, V18, P1053, DOI 10.1038/mp.2012.168; Ledoux JM, 2005, MED HYPOTHESES, V64, P910, DOI 10.1016/j.mehy.2004.11.020; Leggio GM, 2013, EUR J PHARMACOL, V719, P25, DOI 10.1016/j.ejphar.2013.07.022; Lehmann IT, 2006, J BIOL CHEM, V281, P17644, DOI 10.1074/jbc.M512194200; Linden R, 2008, PHYSIOL REV, V88, P673, DOI 10.1152/physrev.00007.2007; Linden R, 2012, CELL MOL LIFE SCI, V69, P1105, DOI 10.1007/s00018-011-0847-7; Lobao-Soares B, 2008, BEHAV BRAIN RES, V194, P129, DOI 10.1016/j.bbr.2008.06.006; Lopes MH, 2012, PRION, V6, P142, DOI 10.4161/pri.19035; Magalhaes AC, 2002, J BIOL CHEM, V277, P33311, DOI 10.1074/jbc.M203661200; Magnin E, 2011, EUR NEUROL, V65, P368, DOI 10.1159/000328670; MANSON JC, 1994, MOL NEUROBIOL, V8, P121, DOI 10.1007/BF02780662; Mariante RM, 2012, J BIOL CHEM, V287, P35506, DOI 10.1074/jbc.M112.394924; Martin-Lanneree S, 2014, FRONT CELL DEV BIOL, V2, DOI 10.3389/fcell.2014.00055; Massimino ML, 2016, MUSCLE NERVE, V53, P269, DOI 10.1002/mus.24708; Meeks TW, 2006, CURR OPIN PSYCHIATR, V19, P581, DOI 10.1097/01.yco.0000245746.45384.0e; Mehrpour M, 2010, CANCER LETT, V290, P1, DOI 10.1016/j.canlet.2009.07.009; Miranda A, 2013, REPRODUCTION, V146, pR91, DOI 10.1530/REP-13-0100; Morris RJ, 2006, FEBS LETT, V580, P5565, DOI 10.1016/j.febslet.2006.07.053; Mouillet-Richard S, 2005, J BIOL CHEM, V280, P4592, DOI 10.1074/jbc.M406199200; Mouillet-Richard S, 2007, ANN NY ACAD SCI, V1096, P106, DOI 10.1196/annals.1397.076; Nazor KE, 2007, BBA-MOL BASIS DIS, V1772, P645, DOI 10.1016/j.bbadis.2007.04.004; Niciu MJ, 2013, CNS SPECTRUMS, V18, P231, DOI 10.1017/S1092852913000059; Nikolaus S, 2009, BEHAV BRAIN RES, V204, P32, DOI 10.1016/j.bbr.2009.06.009; Noda M, 2003, J NEUROCHEM, V84, P222, DOI 10.1046/j.1471-4159.2003.01518.x; Onodera T, 2014, MICROBIOL IMMUNOL, V58, P361, DOI 10.1111/1348-0421.12162; Ownby RL, 2006, ARCH GEN PSYCHIAT, V63, P530, DOI 10.1001/archpsyc.63.5.530; Pei L, 2010, NAT MED, V16, P1393, DOI 10.1038/nm.2263; Perona MTG, 2008, BEHAV PHARMACOL, V19, P566, DOI 10.1097/FBP.0b013e32830cd80f; Petrakis S, 2008, EUR J NEUROSCI, V27, P612, DOI 10.1111/j.1460-9568.2008.06037.x; PLASSAT JL, 1992, EMBO J, V11, P4779, DOI 10.1002/j.1460-2075.1992.tb05583.x; PORSOLT RD, 1977, ARCH INT PHARMACOD T, V229, P327; Posser T, 2009, EUR J PHARMACOL, V602, P85, DOI 10.1016/j.ejphar.2008.10.055; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Ragno M, 2009, ACTA NEUROL SCAND, V119, P131, DOI 10.1111/j.1600-0404.2008.01075.x; Rangel A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007592; RASENICK MM, 1986, FEBS LETT, V198, P164, DOI 10.1016/0014-5793(86)81205-4; Rieger R, 1997, NAT MED, V3, P1383, DOI 10.1038/nm1297-1383; Roesler R, 1999, MOL BRAIN RES, V71, P349, DOI 10.1016/S0169-328X(99)00193-X; Sales N, 1998, EUR J NEUROSCI, V10, P2464, DOI 10.1046/j.1460-9568.1998.00258.x; Schmitt-Ulms G, 2001, J MOL BIOL, V314, P1209, DOI 10.1006/jmbi.2000.5183; Senatore A, 2013, INT J CELL BIOL, V2013, DOI DOI 10.1155/2013/543803; Smirnovas V, 2011, NAT STRUCT MOL BIOL, V18, P504, DOI 10.1038/nsmb.2035; STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203; Strom A, 2011, PANCREAS, V40, P229, DOI 10.1097/MPA.0b013e3181f7e547; Thomas DR, 2006, NEUROPHARMACOLOGY, V51, P566, DOI 10.1016/j.neuropharm.2006.04.019; Thomas EA, 2000, J NEUROSCI RES, V61, P75, DOI 10.1002/1097-4547(20000701)61:1<75::AID-JNR9>3.0.CO;2-9; Thompson A, 2014, AM J PSYCHIAT, V171, P265, DOI 10.1176/appi.ajp.2013.12111460; Um JW, 2013, NEURON, V79, P887, DOI 10.1016/j.neuron.2013.06.036; Vermeiren Y, 2014, NEUROBIOL AGING, V35, P2691, DOI 10.1016/j.neurobiolaging.2014.05.031; Vidal C, 2009, NEUROSCIENCE, V160, P731, DOI 10.1016/j.neuroscience.2009.02.072; Voikar V, 2001, PHYSIOL BEHAV, V72, P271, DOI 10.1016/S0031-9384(00)00405-4; Wall CA, 2005, J NEUROPSYCH CLIN N, V17, P489, DOI 10.1176/appi.neuropsych.17.4.489; Wanschitz J, 2000, ANN NEUROL, V48, P788, DOI 10.1002/1531-8249(200011)48:5<788::AID-ANA13>3.0.CO;2-5; Wong ML, 2001, NAT REV NEUROSCI, V2, P343, DOI 10.1038/35072566; Yan HC, 2010, NEUROSCI BULL, V26, P327, DOI 10.1007/s12264-010-0323-7; Zanata SM, 2002, EMBO J, V21, P3307, DOI 10.1093/emboj/cdf325; Zanetti F, 2014, CARDIOVASC RES, V104, P93, DOI 10.1093/cvr/cvu194; Zarate C, 2013, ANN NY ACAD SCI, V1292, P21, DOI 10.1111/nyas.12223	103	19	19	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2015	290	33					20488	20498		10.1074/jbc.M115.666156	http://dx.doi.org/10.1074/jbc.M115.666156			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP1AT	26152722	Green Published, hybrid			2022-12-26	WOS:000359608900046
J	Fishwick, KJ; Rylett, RJ				Fishwick, Katherine J.; Rylett, R. Jane			Insulin Regulates the Activity of the High-Affinity Choline Transporter CHT	PLOS ONE			English	Article							GROWTH-FACTOR EXPRESSION; ALZHEIMERS-DISEASE; INTRANASAL INSULIN; FUNCTIONAL-CHARACTERIZATION; ACETYLCHOLINE SYNTHESIS; GENE-EXPRESSION; PROTEIN-KINASE; UPTAKE CARRIER; AMYLOID-BETA; ACTIVATION	Studies in humans and animal models show that neuronal insulin resistance increases the risk of developing Alzheimer's Disease (AD), and that insulin treatment may promote memory function. Cholinergic neurons play a critical role in cognitive and attentional processing and their dysfunction early in AD pathology may promote the progression of AD pathology. Synthesis and release of the neurotransmitter acetylcholine (ACh) is closely linked to the activity of the high-affinity choline transporter protein (CHT), but the impact of insulin receptor signaling and neuronal insulin resistance on these aspects of cholinergic function are unknown. In this study, we used differentiated SH-SY5Y cells stably-expressing CHT proteins to study the effect of insulin signaling on CHT activity and function. We find that choline uptake activity measured after acute addition of 20 nM insulin is significantly lower in cells that were grown for 24 h in media containing insulin compared to cells grown in the absence of insulin. This coincides with loss of ability to increase phospho-Protein Kinase B (PKB)/Akt levels in response to acute insulin stimulation in the chronic insulin-treated cells. Inhibition of phosphatidylinositol-4,5-bisphosphate 3-kinase (PI3-kinase) in cells significantly lowers phospho-PKB/Akt levels and decreases choline uptake activity. We show total internal reflection microscopy (TIRF) imaging of the dynamic movement of CHT proteins in live cells in response to depolarization and drug treatments. These data show that acute exposure of depolarized cells to insulin is coupled to transiently increased levels of CHT proteins at the cell surface, and that this is attenuated by chronic insulin exposure. Moreover, prolonged inhibition of PI3-kinase results in enhanced levels of CHT proteins at the cell surface by decreasing their rate of internalization.	[Fishwick, Katherine J.; Rylett, R. Jane] Univ Western Ontario, Robarts Res Inst, Mol Med Res Grp, Schulich Sch Med & Dent, London, ON, Canada; [Fishwick, Katherine J.; Rylett, R. Jane] Univ Western Ontario, Dept Physiol & Pharmacol, Schulich Sch Med & Dent, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario)	Rylett, RJ (corresponding author), Univ Western Ontario, Robarts Res Inst, Mol Med Res Grp, Schulich Sch Med & Dent, London, ON, Canada.	jane.rylett@schulich.uwo.ca	Rylett, Rebecca Jane/K-3597-2013	Rylett, Rebecca Jane/0000-0002-9158-9599	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html, RJR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Rahman O, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-81; Apelt J, 2002, BRAIN RES, V953, P17, DOI 10.1016/S0006-8993(02)03262-6; Bales KR, 2006, J CLIN INVEST, V116, P825, DOI 10.1172/JCI27120; Black SAG, 2010, NEUROSCIENCE, V167, P765, DOI 10.1016/j.neuroscience.2010.02.026; Calvo-Ochoa E, 2014, J CEREBR BLOOD F MET, V34, P1001, DOI 10.1038/jcbfm.2014.48; Carvelli L, 2002, J NEUROCHEM, V81, P859, DOI 10.1046/j.1471-4159.2002.00892.x; CASADO M, 1991, J NEUROCHEM, V57, P1185, DOI 10.1111/j.1471-4159.1991.tb08278.x; Chua LM, 2012, J ALZHEIMERS DIS, V29, P783, DOI 10.3233/JAD-2012-111880; COLLIER B, 1974, J PHYSIOL-LONDON, V238, P639, DOI 10.1113/jphysiol.1974.sp010548; Cooke LJ, 1997, BRAIN RES, V751, P232, DOI 10.1016/S0006-8993(96)01183-3; Correia SC, 2011, AGEING RES REV, V10, P264, DOI 10.1016/j.arr.2011.01.001; Craft S, 2012, ARCH NEUROL-CHICAGO, V69, P29, DOI 10.1001/archneurol.2011.233; Crowder RJ, 1998, J NEUROSCI, V18, P2933; Cuddy LK, 2014, J NEUROCHEM, V128, P725, DOI 10.1111/jnc.12490; Cuddy LK, 2012, J NEUROSCI, V32, P5573, DOI 10.1523/JNEUROSCI.5235-11.2012; de la Monte SM, 2012, DRUGS, V72, P49, DOI 10.2165/11597760-000000000-00000; Francis GJ, 2008, BRAIN, V131, P3311, DOI 10.1093/brain/awn288; Francis PT, 1999, J NEUROL NEUROSUR PS, V66, P137, DOI 10.1136/jnnp.66.2.137; Freiherr J, 2013, CNS DRUGS, V27, P505, DOI 10.1007/s40263-013-0076-8; Frisardi V, 2010, AGEING RES REV, V9, P399, DOI 10.1016/j.arr.2010.04.007; Gates J, 2004, J PHARMACOL EXP THER, V310, P536, DOI 10.1124/jpet.104.066795; Hashemi SH, 2003, NEUROCHEM RES, V28, P449, DOI 10.1023/A:1022848718109; Hasselmo ME, 2006, J MOL NEUROSCI, V30, P133, DOI 10.1385/JMN:30:1:133; Ikonomovic MD, 2003, J ALZHEIMERS DIS, V5, P39, DOI 10.3233/JAD-2003-5106; Kar S, 1998, J NEUROCHEM, V70, P2179; Leibson CL, 1997, AM J EPIDEMIOL, V145, P301; Leto D, 2012, NAT REV MOL CELL BIO, V13, P383, DOI 10.1038/nrm3351; Lew M, 2007, BRIT J PHARMACOL, V152, P299, DOI 10.1038/sj.bjp.0707372; Li ZG, 2007, DIABETES, V56, P1817, DOI 10.2337/db07-0171; Madziar B, 2005, J NEUROCHEM, V92, P767, DOI 10.1111/j.1471-4159.2004.02908.x; Matsuo A, 2011, J BIOL CHEM, V286, P5836, DOI 10.1074/jbc.M110.147611; Mielke JG, 2005, J NEUROCHEM, V93, P1568, DOI 10.1111/j.1471-4159.2005.03155.x; Norton S, 2014, LANCET NEUROL, V13, P788, DOI 10.1016/S1474-4422(14)70136-X; Nunes-Tavares N, 2012, J BIOL CHEM, V287, P19377, DOI 10.1074/jbc.M111.321448; Okuda T, 2000, FEBS LETT, V484, P92, DOI 10.1016/S0014-5793(00)02134-7; PASCUAL J, 1991, BRAIN RES, V552, P170, DOI 10.1016/0006-8993(91)90676-M; Peila R, 2002, DIABETES, V51, P1256, DOI 10.2337/diabetes.51.4.1256; Pinthong M, 2008, MOL PHARMACOL, V73, P801, DOI 10.1124/mol.107.040881; Qian Y, 1997, J NEUROSCI, V17, P45, DOI 10.1523/JNEUROSCI.17-01-00045.1997; Reger MA, 2008, J ALZHEIMERS DIS, V13, P323, DOI 10.3233/jad-2008-13309; Ribeiro FM, 2007, EUR J NEUROSCI, V26, P3437, DOI 10.1111/j.1460-9568.2007.05967.x; Rivera EJ, 2005, J ALZHEIMERS DIS, V8, P247; RODRIGUEZPUERTAS R, 1994, J NEURAL TRANSM-PARK, V8, P161, DOI 10.1007/BF02260937; Ruggiero AM, 2012, ACS CHEM NEUROSCI, V3, P767, DOI 10.1021/cn3000718; RYLETT RJ, 1983, BRAIN RES, V289, P169, DOI 10.1016/0006-8993(83)90017-3; Schioth HB, 2012, MOL NEUROBIOL, V46, P4, DOI 10.1007/s12035-011-8229-6; SLOTKIN TA, 1990, P NATL ACAD SCI USA, V87, P2452, DOI 10.1073/pnas.87.7.2452; Speed NK, 2010, ACS CHEM NEUROSCI, V1, P476, DOI 10.1021/cn100031t; Steen E, 2005, J ALZHEIMERS DIS, V7, P63, DOI 10.3233/jad-2005-7107; Talbot K, 2012, J CLIN INVEST, V122, P1316, DOI 10.1172/JCI59903; Vogelsberg V, 1997, J NEUROCHEM, V68, P1062; Woolf NJ, 2011, BEHAV BRAIN RES, V221, P488, DOI 10.1016/j.bbr.2009.12.046; Xie L, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-10-j0001.2002	53	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132934	10.1371/journal.pone.0132934	http://dx.doi.org/10.1371/journal.pone.0132934			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161852	Green Published, gold, Green Submitted			2022-12-26	WOS:000358162300181
J	Hashimoto, Y; Funamoto, S; Sasaki, S; Negishi, J; Honda, T; Hattori, S; Nam, K; Kimura, T; Mochizuki, M; Kobayashi, H; Kishida, A				Hashimoto, Yoshihide; Funamoto, Seiichi; Sasaki, Shuji; Negishi, Jun; Honda, Takako; Hattori, Shinya; Nam, Kwangwoo; Kimura, Tsuyoshi; Mochizuki, Manabu; Kobayashi, Hisatoshi; Kishida, Akio			Corneal Regeneration by Deep Anterior Lamellar Keratoplasty (DALK) Using Decellularized Corneal Matrix	PLOS ONE			English	Article							PENETRATING KERATOPLASTY; EXPRESSION; GRAFT; KERATOCONUS; SCAFFOLD; STROMA	The purpose of this study is to demonstrate the feasibility of DALK using a decellularized corneal matrix obtained by HHP methodology. Porcine corneas were hydrostatically pressurized at 980 MPa at 10 degrees C for 10 minutes to destroy the cells, followed by washing with EGM-2 medium to remove the cell debris. The HHP-treated corneas were stained with H-E to assess the efficacy of decellularization. The decellularized corneal matrix of 300 mu m thickness and 6.0 mm diameter was transplanted onto a 6.0 mm diameter keratectomy wound. The time course of regeneration on the decellularized corneal matrix was evaluated by haze grading score, fluorescein staining, and immunohistochemistry. H-E staining revealed that no cell nuclei were observed in the decellularized corneal matrix. The decellularized corneal matrices were opaque immediately after transplantation, but became completely transparent after 4 months. Fluorescein staining revealed that initial migration of epithelial cells over the grafts was slow, taking 3 months to completely cover the implant. Histological sections revealed that the implanted decellularized corneal matrix was completely integrated with the receptive rabbit cornea, and keratocytes infiltrated into the decellularized corneal matrix 6 months after transplantation. No inflammatory cells such as macrophages, or neovascularization, were observed during the implantation period. The decellularized corneal matrix improved corneal transparency, and remodelled the graft after being transplanted, demonstrating that the matrix obtained by HHP was a useful graft for corneal tissue regeneration.	[Funamoto, Seiichi; Negishi, Jun; Nam, Kwangwoo; Kimura, Tsuyoshi; Kishida, Akio] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Tokyo, Japan; [Sasaki, Shuji; Mochizuki, Manabu] Tokyo Med & Dent Univ, Dept Ophthalmol, Tokyo, Japan; [Honda, Takako; Hattori, Shinya; Kobayashi, Hisatoshi] Natl Inst Mat Sci, Int Ctr Mat Nanoarchitecton, Tsukuba, Ibaraki, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); National Institute for Materials Science	Kobayashi, H (corresponding author), Natl Inst Mat Sci, Int Ctr Mat Nanoarchitecton, Tsukuba, Ibaraki, Japan.	KOBAYASHI.Hisatoshi@nims.go.jp; kishida.mbme@tmd.ac.jp	kobayashi, hisatoshi/H-2720-2011; HASHIMOTO, YOSHIHIDE/S-3056-2017	kobayashi, hisatoshi/0000-0001-9487-0725; HASHIMOTO, YOSHIHIDE/0000-0003-0537-8291	Research on Human Genome, Tissue Engineering from Ministry of Health, Labour, and Welfare [KHC1020]; Japan Society for the Promotion of Science (JSPS) [09J04930]	Research on Human Genome, Tissue Engineering from Ministry of Health, Labour, and Welfare; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was financially supported by the Research on Human Genome, Tissue Engineering from the Ministry of Health, Labour, and Welfare (No. KHC1020) to AK (http://www.mhlw.go.jp/english/index.html), and by a Grant-in-Aid for Scientific Research (No. 09J04930) to YH from the Japan Society for the Promotion of Science (JSPS) (http://www.jsps.go.jp/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Torbak AA, 2006, CORNEA, V25, P408, DOI 10.1097/01.ico.0000220777.70981.46; Awan MA, 2010, BRIT J OPHTHALMOL, V94, P1300, DOI 10.1136/bjo.2009.169300; Borderie VM, 2011, AM J OPHTHALMOL, V151, P1024, DOI 10.1016/j.ajo.2011.01.007; Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057; Du LQ, 2011, BRIT J OPHTHALMOL, V95, P410, DOI 10.1136/bjo.2008.142539; Echevarria TJ, 2011, STEM CELL REV REP, V7, P256, DOI 10.1007/s12015-010-9199-1; FANTES FE, 1990, ARCH OPHTHALMOL-CHIC, V108, P665, DOI 10.1001/archopht.1990.01070070051034; George AJT, 2004, AM J TRANSPLANT, V4, P678, DOI 10.1111/j.1600-6143.2004.00417.x; Hashimoto Y, 2010, BIOMATERIALS, V31, P3941, DOI 10.1016/j.biomaterials.2010.01.122; Karamichos D, 2011, J TISSUE ENG REGEN M, V5, pE228, DOI 10.1002/term.429; Kawashima M, 2006, AM J OPHTHALMOL, V142, P304, DOI 10.1016/j.ajo.2006.03.057; Lynch AP, 2013, EXP EYE RES, V108, P42, DOI 10.1016/j.exer.2012.12.012; Panda A, 1999, CORNEA, V18, P172, DOI 10.1097/00003226-199903000-00005; Park KA, 2007, CORNEA, V26, P1132, DOI 10.1097/ICO.0b013e318123765b; Parthasarathy A, 2007, CORNEA, V26, P1025, DOI 10.1097/ICO.0b013e31805771e3; Sasaki S, 2009, MOL VIS, V15, P2022; Sugita J, 1997, BRIT J OPHTHALMOL, V81, P184, DOI 10.1136/bjo.81.3.184; WESTMAYS JA, 1995, P NATL ACAD SCI USA, V92, P6768, DOI 10.1073/pnas.92.15.6768; Wilson SL, 2013, J FUNCT BIOMATER, V4, P114, DOI 10.3390/jfb4030114; Wilson SE, 1999, PROG RETIN EYE RES, V18, P293, DOI 10.1016/S1350-9462(98)00017-2; Wilson SE, 1996, EXP EYE RES, V62, P325, DOI 10.1006/exer.1996.0038; Wilson SE, 2001, PROG RETIN EYE RES, V20, P625, DOI 10.1016/S1350-9462(01)00008-8; Ye HQQ, 1998, INVEST OPHTH VIS SCI, V39, P913; Ye HQQ, 2000, INVEST OPHTH VIS SCI, V41, P2894; Zieske JD, 2001, EXP EYE RES, V72, P33, DOI 10.1006/exer.2000.0926	25	31	32	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131989	10.1371/journal.pone.0131989	http://dx.doi.org/10.1371/journal.pone.0131989			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161854	gold, Green Published, Green Submitted			2022-12-26	WOS:000358162300079
J	Manocha, GD; Puig, KL; Austin, SA; Seyb, K; Glicksman, MA; Combs, CK				Manocha, Gunjan D.; Puig, Kendra L.; Austin, Susan A.; Seyb, Kathleen; Glicksman, Marcie A.; Combs, Colin K.			Characterization of Novel Src Family Kinase Inhibitors to Attenuate Microgliosis	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; STIMULATED PROINFLAMMATORY RESPONSES; TYROSINE PHOSPHORYLATION SYSTEMS; NITRIC-OXIDE SYNTHASE; APPSW TRANSGENIC MICE; GLYCOPROTEIN HLA-DR; ALZHEIMERS-DISEASE; AMYLOID-BETA; INFLAMMATORY MECHANISMS; NEUROLOGICAL DISEASE	Microgliosis is a major hallmark of Alzheimer's disease (AD) brain pathology. A beta peptide is hypothesized to act as a stimulus for microglia leading to activation of non-receptor tyrosine kinases and subsequent secretion of pro-inflammatory cytokines. Therefore, the signaling pathways mediating microglial activation may be important therapeutic targets of anti-inflammatory therapy for AD. Four novel compounds were chosen after high throughput screening kinase activity assays determined them as potential Lyn kinase inhibitors. Their kinase inhibitory and anti-inflammatory effect on A beta-stimulated activation was assessed using the murine microglial cell line, BV2. Cells were treated with the compounds to determine effects on active, phosphorylated levels of Src family kinases, Src and Lyn, as well as MAP kinases ERK, JNK and p38. Only one compound, LDDN-0003499, produced a dose dependent decrease in basal levels of active, phosphorylated Src and Lyn in the BV2 cells. LDDN-0003499 treatment also attenuated the A beta-stimulated increase in active, phosphorylated levels of Lyn/Src and TNF alpha and IL-6 secretion. This study identifies a novel small molecule Src family tyrosine kinase inhibitor with anti-inflammatory effects in response to A beta stimulation of microglia. Further in vitro/in vivo characterization of LDDN-0003499 as well as structural modification may provide a new tool for attenuating microglial-mediated brain inflammatory conditions such as that occurring in AD.	[Manocha, Gunjan D.; Puig, Kendra L.; Combs, Colin K.] Univ N Dakota, Sch Med & Hlth Sci, Dept Basic Sci, Grand Forks, ND 58203 USA; [Austin, Susan A.] Mayo Clin, Dept Anesthesiol, Rochester, MN 55905 USA; [Seyb, Kathleen; Glicksman, Marcie A.] Brigham & Womens Hosp, Harvard NeuroDiscovery Ctr, Lab Drug Discovery Neurodegenerat, Cambridge, MA 02139 USA	University of North Dakota Grand Forks; Mayo Clinic; Harvard University; Brigham & Women's Hospital	Combs, CK (corresponding author), Univ N Dakota, Sch Med & Hlth Sci, Dept Basic Sci, Grand Forks, ND 58203 USA.	colin.combs@med.und.edu	Manocha, Gunjan/AAF-2471-2020	Manocha, Gunjan/0000-0003-4488-6627	National Institutes of Health [RO1AG026330, R01AG042819]; National Science Foundation [EPS-0814442]; National Center for Drug Discovery in Neurodegeneration NIH/NINDS Cooperative Agreement Award [u24]; Harvard University; NATIONAL INSTITUTE ON AGING [R01AG042819, R01AG026330] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); National Center for Drug Discovery in Neurodegeneration NIH/NINDS Cooperative Agreement Award; Harvard University; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by the National Institutes of Health RO1AG026330 and R01AG042819 to CKC, the National Science Foundation grant EPS-0814442 fellowship to GM, and the National Center for Drug Discovery in Neurodegeneration NIH/NINDS Cooperative Agreement Award (u24) with Harvard University to SA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIYAMA H, 1990, J NEUROIMMUNOL, V30, P81, DOI 10.1016/0165-5728(90)90055-R; Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Bamberger ME, 2003, J NEUROSCI, V23, P2665; BLASI E, 1990, J NEUROIMMUNOL, V27, P229, DOI 10.1016/0165-5728(90)90073-V; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; BOLEN JB, 1992, FASEB J, V6, P3403, DOI 10.1096/fasebj.6.15.1281458; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown DR, 2001, MICROSC RES TECHNIQ, V54, P71, DOI 10.1002/jemt.1122; Combs CK, 2000, J NEUROSCI, V20, P558, DOI 10.1523/JNEUROSCI.20-02-00558.2000; Combs CK, 2001, NEUROCHEM INT, V39, P449, DOI 10.1016/S0197-0186(01)00052-3; Combs CK, 2001, J NEUROSCI, V21, P1179; Combs CK, 1999, J NEUROSCI, V19, P928; CRAS P, 1990, AM J PATHOL, V137, P241; Das J, 2006, J MED CHEM, V49, P6819, DOI 10.1021/jm060727j; Denny WA, 2001, FARMACO, V56, P51, DOI 10.1016/S0014-827X(01)01026-6; Dhawan G, 2012, NEUROBIOL AGING, V33, P2247, DOI 10.1016/j.neurobiolaging.2011.10.027; Dhawan G, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-117; DICKSON DW, 1993, GLIA, V7, P75, DOI 10.1002/glia.440070113; Floden AM, 2006, J NEUROSCI, V26, P4644, DOI 10.1523/JNEUROSCI.4822-05.2006; Frautschy SA, 1998, AM J PATHOL, V152, P307; Goodman PA, 1998, J BIOL CHEM, V273, P17742, DOI 10.1074/jbc.273.28.17742; Jara JH, 2007, J NEUROCHEM, V100, P1407, DOI 10.1111/j.1471-4159.2006.04330.x; KARP HL, 1994, GLIA, V11, P284, DOI 10.1002/glia.440110310; Kim HJ, 2007, ANN NY ACAD SCI, V1095, P473, DOI 10.1196/annals.1397.051; Koenigsknecht J, 2004, J NEUROSCI, V24, P9838, DOI 10.1523/JNEUROSCI.2557-04.2004; LAWSON LJ, 1990, NEUROSCIENCE, V39, P151, DOI 10.1016/0306-4522(90)90229-W; Lombardo LJ, 2004, J MED CHEM, V47, P6658, DOI 10.1021/jm049486a; McDonald DR, 1997, J NEUROSCI, V17, P2284; McDonald DR, 1998, J NEUROSCI, V18, P4451; MCGEER PL, 1987, NEUROSCI LETT, V79, P195, DOI 10.1016/0304-3940(87)90696-3; MCGEER PL, 1988, ACTA NEUROPATHOL, V76, P550, DOI 10.1007/BF00689592; Moore KJ, 2002, J BIOL CHEM, V277, P47373, DOI 10.1074/jbc.M208788200; Nakajima K, 2001, J BIOCHEM-TOKYO, V130, P169, DOI 10.1093/oxfordjournals.jbchem.a002969; PERLMUTTER LS, 1990, NEUROSCI LETT, V119, P32, DOI 10.1016/0304-3940(90)90748-X; PERRY VH, 1991, INT REV CYTOL, V125, P203, DOI 10.1016/S0074-7696(08)61220-6; Poli V, 1998, J BIOL CHEM, V273, P29279, DOI 10.1074/jbc.273.45.29279; RAINE CS, 1994, J NEUROPATH EXP NEUR, V53, P328, DOI 10.1097/00005072-199407000-00002; ROGERS J, 1988, NEUROBIOL AGING, V9, P339, DOI 10.1016/S0197-4580(88)80079-4; Rogers J, 2002, GLIA, V40, P260, DOI 10.1002/glia.10153; Sasaki A, 2002, VIRCHOWS ARCH, V441, P358, DOI 10.1007/s00428-002-0643-8; Schlachetzki JCM, 2009, CURR ALZHEIMER RES, V6, P554, DOI 10.2174/156720509790147179; Sondag CM, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-1; Stalder M, 1999, AM J PATHOL, V154, P1673, DOI 10.1016/S0002-9440(10)65423-5; STYREN SD, 1990, EXP NEUROL, V110, P93, DOI 10.1016/0014-4886(90)90054-V; TILLOTSON ML, 1989, GLIA, V2, P412; Tuppo EE, 2005, INT J BIOCHEM CELL B, V37, P289, DOI 10.1016/j.biocel.2004.07.009; Wegiel J, 2003, ACTA NEUROPATHOL, V105, P393, DOI 10.1007/s00401-002-0660-3; Wegiel J, 2001, NEUROBIOL AGING, V22, P49, DOI 10.1016/S0197-4580(00)00181-0; Weldon DT, 1998, J NEUROSCI, V18, P2161; WISNIEWSKI HM, 1992, ACTA NEUROPATHOL, V84, P117, DOI 10.1007/BF00311383; WOOD JG, 1991, NEUROSCI LETT, V121, P12, DOI 10.1016/0304-3940(91)90637-9; Xu YK, 2005, IMMUNITY, V22, P9, DOI 10.1016/j.immuni.2004.12.004; YAMANASHI Y, 1989, P NATL ACAD SCI USA, V86, P6538, DOI 10.1073/pnas.86.17.6538; Yates SL, 2000, J NEUROCHEM, V74, P1017, DOI 10.1046/j.1471-4159.2000.0741017.x	54	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132604	10.1371/journal.pone.0132604	http://dx.doi.org/10.1371/journal.pone.0132604			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161952	Green Submitted, Green Published, gold			2022-12-26	WOS:000358162300158
J	Merino, S; Gonzalez, V; Tomas, JM				Merino, Susana; Gonzalez, Victor; Tomas, Juan M.			The Polymerization of Aeromonas hydrophila AH-3 O-Antigen LPS: Concerted Action of WecP and Wzy	PLOS ONE			English	Article							LIPOPOLYSACCHARIDE; GENE; POLYSACCHARIDE; BIOSYNTHESIS; TRANSLOCATION; TEMPERATURE; CORE	The repeat units of heteropolymeric O antigen are synthesized at the cytosolic side of the inner bacterial membrane via the Wzx/Wzy-dependent assembly pathway. After being translocated across the membrane by Wzx, each repeat unit is polymerized by Wzy to form a glycan chain. In this study, we demonstrate the need of the corresponding enzyme transferring the initial HexNAc to undecaprenol phosphate (lipid carrier), together with the corresponding O-antigen polymerase (Wzy), to produce the Aeromonas hydrophila O:34-antigen. We suggest, the concerted action of WecA or P enzyme (UDP-HexNAc: polyprenol-P HexNAc-1-P transferase) and Wzy is involved in the mechanism responsible for the A. hydrophila O-antigen polymerization.	[Merino, Susana; Gonzalez, Victor; Tomas, Juan M.] Univ Barcelona, Fac Biol, Dept Microbiol, Barcelona 08071, Spain	University of Barcelona	Tomas, JM (corresponding author), Univ Barcelona, Fac Biol, Dept Microbiol, Diagonal 643, Barcelona 08071, Spain.	jtomas@ub.edu	Tomas, Juan M/L-1398-2015; Merino, Susana/D-4342-2014	Tomas, Juan M/0000-0002-3575-7113; Merino, Susana/0000-0001-6040-4259	Plan Nacional de I + D + i (Ministerio de Educacion, Ciencia y Deporte and Ministerio de Sanidad, Spain); Generalitat de Catalunya (Centre de Referencia en Biotecnologia)	Plan Nacional de I + D + i (Ministerio de Educacion, Ciencia y Deporte and Ministerio de Sanidad, Spain); Generalitat de Catalunya (Centre de Referencia en Biotecnologia)(Generalitat de Catalunya)	This work was supported by Plan Nacional de I + D + i (Ministerio de Educacion, Ciencia y Deporte and Ministerio de Sanidad, Spain) and from Generalitat de Catalunya (Centre de Referencia en Biotecnologia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeyrathne PD, 2005, J BACTERIOL, V187, P3002, DOI 10.1128/JB.187.9.3002-3012.2005; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; BENEDI VJ, 1989, J CLIN MICROBIOL, V27, P82; Canals R, 2006, INFECT IMMUN, V74, P537, DOI 10.1128/IAI.74.1.537-548.2006; GALANOS C, 1969, EUR J BIOCHEM, V9, P245, DOI 10.1111/j.1432-1033.1969.tb00601.x; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; HITCHCOCK PJ, 1983, J BACTERIOL, V154, P269, DOI 10.1128/JB.154.1.269-277.1983; Hug I, 2011, GLYCOBIOLOGY, V21, P138, DOI 10.1093/glycob/cwq148; Islam ST, 2014, CAN J MICROBIOL, V60, P697, DOI 10.1139/cjm-2014-0595; Islam ST, 2013, SCI REP-UK, V3, DOI 10.1038/srep03441; Islam ST, 2013, MBIO, V4, DOI 10.1128/mBio.00678-13; Islam ST, 2013, ENVIRON MICROBIOL, V15, P1001, DOI 10.1111/j.1462-2920.2012.02890.x; Islam ST, 2012, MOL MICROBIOL, V84, P1165, DOI 10.1111/j.1365-2958.2012.08084.x; Islam ST, 2011, J BIOL CHEM, V286, P20600, DOI 10.1074/jbc.C110.204651; Islam ST, 2010, MBIO, V1, DOI 10.1128/mBio.00189-10; Jimenez N, 2008, J BACTERIOL, V190, P4198, DOI 10.1128/JB.00153-08; Jimenez N, 2008, J BACTERIOL, V190, P3176, DOI 10.1128/JB.01874-07; Jimenez N, 2009, J BIOL CHEM, V284, P32995, DOI 10.1074/jbc.M109.038828; Kalynych S, 2012, PROTEIN ENG DES SEL, V25, P797, DOI 10.1093/protein/gzs075; Knirel YA, 2004, CARBOHYD RES, V339, P787, DOI 10.1016/j.carres.2003.12.008; Knirel YA, 2002, CARBOHYD RES, V337, P1381, DOI 10.1016/S0008-6215(02)00136-2; Link AJ, 1997, J BACTERIOL, V179, P6228, DOI 10.1128/jb.179.20.6228-6237.1997; MERINO S, 1992, INFECT IMMUN, V60, P4343, DOI 10.1128/IAI.60.10.4343-4349.1992; Merino S, 2011, J BACTERIOL, V193, P1943, DOI 10.1128/JB.01441-10; NIKAIDO H, 1996, ESCHERICHIA COLI SAL, P29; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rick PD, 2003, J BIOL CHEM, V278, P16534, DOI 10.1074/jbc.M301750200; Rush JS, 2010, J BIOL CHEM, V285, P1671, DOI 10.1074/jbc.M109.061630; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Samuel G, 2003, CARBOHYD RES, V338, P2503, DOI 10.1016/j.carres.2003.07.009; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; Valvano MA, 2003, FRONT BIOSCI-LANDMRK, V8, pS452, DOI 10.2741/1079; Westphal O., 1965, METHODS CARBOHYDRATE, V5, P83, DOI DOI 10.1016/J.WATRES.2010.04.030	36	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131905	10.1371/journal.pone.0131905	http://dx.doi.org/10.1371/journal.pone.0131905			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161781	Green Submitted, Green Published, gold			2022-12-26	WOS:000358162300072
J	Albert, S; Aswani, S; Fisher, PL; Albert, J				Albert, Simon; Aswani, Shankar; Fisher, Paul L.; Albert, Joelle			Keeping Food on the Table: Human Responses and Changing Coastal Fisheries in Solomon Islands	PLOS ONE			English	Article							CORAL-REEF FISHERIES; GLOBAL FISHERIES; PACIFIC ISLANDS; SECURITY; MARINE; RESOURCES; RESILIENCE; DIVERSITY; PATTERNS; IMPACTS	Globally the majority of commercial fisheries have experienced dramatic declines in stock and catch. Likewise, projections for many subsistence fisheries in the tropics indicate a dramatic decline is looming in the coming decades. In the Pacific Islands coastal fisheries provide basic subsistence needs for millions of people. A decline in fish catch would therefore have profound impacts on the health and livelihoods of these coastal communities. Given the decrease in local catch rates reported for many coastal communities in the Pacific, it is important to understand if fishers have responded to ecological change (either by expanding their fishing range and/or increasing their fishing effort), and if so, to evaluate the costs or benefits of these responses. We compare data from fish catches in 1995 and 2011 from a rural coastal community in Solomon Islands to examine the potentially changing coastal reef fishery at these time points. In particular we found changes in preferred fishing locations, fishing methodology and catch composition between these data sets. The results indicate that despite changes in catch rates (catch per unit effort) between data collected in 2011 and 16 years previously, the study community was able to increase gross catches through visiting fishing sites further away, diversifying fishing methods and targeting pelagic species through trolling. Such insight into local-scale responses to changing resources and/or fisheries development will help scientists and policy makers throughout the Pacific region in managing the region's fisheries in the future.	[Albert, Simon; Fisher, Paul L.] Univ Queensland, Sch Civil Engn, Brisbane, Qld, Australia; [Aswani, Shankar] Rhodes Univ, Dept Anthropol, ZA-6140 Grahamstown, South Africa; [Aswani, Shankar] Rhodes Univ, Dept Ichthyol & Fisheries Sci, ZA-6140 Grahamstown, South Africa; [Albert, Joelle] WorldFish, Honiara, Solomon Islands	University of Queensland; Rhodes University; Rhodes University; CGIAR; Worldfish	Fisher, PL (corresponding author), Univ Queensland, Sch Civil Engn, Brisbane, Qld, Australia.	p.fisher@uq.edu.au	Albert, Simon/I-1104-2012	Albert, Simon/0000-0002-5947-7909; Fisher, Paul/0000-0003-1403-8563	Consultative Group on International Agricultural Research (CGIAR) Research Programs on Aquatic Agricultural Systems; Australian Centre for International Agricultural Research [FIS/2012/074]	Consultative Group on International Agricultural Research (CGIAR) Research Programs on Aquatic Agricultural Systems; Australian Centre for International Agricultural Research	This work was supported by the Consultative Group on International Agricultural Research (CGIAR) Research Programs on Aquatic Agricultural Systems (aas.cgiar.org) and an Australian Centre for International Agricultural Research (aciar.gov.au) grant (FIS/2012/074). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams TJH, 1996, 8 INT COR REEF S PAN; Albert JA, PLOS ONE IN PRESS; Albert S, 2012, 12 INT COR REEF S AU; [Anonymous], 2009, SOLOMON ISLAND POPUL; Aswani S, 1998, OCEAN COAST MANAGE, V40, P207, DOI 10.1016/S0964-5691(98)00047-7; Aswani S., 1997, CUSTOMARY SEA TENURE, P485; Aswani S, 2008, HUM ECOL, V36, P325, DOI 10.1007/s10745-007-9159-9; Aswani S, 2015, REV FISH BIOL FISHER, V25, P217, DOI 10.1007/s11160-014-9376-4; Aswani S, 2014, CONSERV BIOL, V28, P820, DOI 10.1111/cobi.12250; Aswani S, 2010, CONSERV BIOL, V24, P520, DOI 10.1111/j.1523-1739.2009.01377.x; Bell JD, 2015, MAR POLICY, V51, P584, DOI 10.1016/j.marpol.2014.10.005; Bell JD, 2013, NAT CLIM CHANGE, V3, P591, DOI 10.1038/NCLIMATE1838; Bell JD, 2013, CLIMATIC CHANGE, V119, P199, DOI 10.1007/s10584-012-0606-2; Bell JD, 2009, MAR POLICY, V33, P64, DOI 10.1016/j.marpol.2008.04.002; Brewer TD, 2012, GLOBAL ENVIRON CHANG, V22, P399, DOI 10.1016/j.gloenvcha.2012.01.006; Brewer TD, 2009, BIOL CONSERV, V142, P1797, DOI 10.1016/j.biocon.2009.03.021; Craig P, 2008, FISH RES, V89, P230, DOI 10.1016/j.fishres.2007.08.018; Dalzell P, 1996, OCEANOGR MAR BIOL, V34, P395; DALZELL P, 1996, 8 INT COR REEF S PAN; FAO, 2014, STAT WORLD FISH AQ; Friedlander AM, 2002, MAR ECOL PROG SER, V230, P253, DOI 10.3354/meps230253; Gillett R., 2010, FUTURE PACIFIC ISLAN; Gillett R, 2009, FISHERIES EC PACIFIC; Grinham A, 2014, MAR POLLUT BULL, V88, P354, DOI 10.1016/j.marpolbul.2014.08.018; Hall SJ, 2013, P NATL ACAD SCI USA, V110, P8393, DOI 10.1073/pnas.1208067110; Halpern BS, 2013, CORAL REEFS, V32, P61, DOI 10.1007/s00338-012-0981-1; Harley S., 2014, W CENTRAL PACIFIC TU; Kuster C, 2005, FISH RES, V76, P221, DOI 10.1016/j.fishres.2005.06.011; Lauer M, 2013, GLOBAL ENVIRON CHANG, V23, P40, DOI 10.1016/j.gloenvcha.2012.10.011; Lauer M, 2010, ENVIRON MANAGE, V45, P985, DOI 10.1007/s00267-010-9471-9; Newton K, 2007, CURR BIOL, V17, P655, DOI 10.1016/j.cub.2007.02.054; Pauly D, 2008, J BIOL RES-THESSALON, V9, P3; Pauly D, 2007, AMBIO, V36, P290, DOI 10.1579/0044-7447(2007)36[290:TSAUPD]2.0.CO;2; RICHARDS AH, 1994, MAR POLLUT BULL, V29, P90, DOI 10.1016/0025-326X(94)90431-6; Skewes T, 1990, MARINE RESOURCE PROF; SPC, 2013, STAT REP PAC ISL REE	36	30	32	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2015	10	7							e0130800	10.1371/journal.pone.0130800	http://dx.doi.org/10.1371/journal.pone.0130800			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1EW	26158694	Green Submitted, Green Published, gold			2022-12-26	WOS:000358161200019
J	Johnsrud, I; Kulseth, MA; Rodningen, OK; Landro, L; Helsing, P; Nielsen, EW; Heimdal, K				Johnsrud, Irene; Kulseth, Mari Ann; Rodningen, Olaug Kristin; Landro, Linn; Helsing, Per; Nielsen, Erik Waage; Heimdal, Ketil			A Nationwide Study of Norwegian Patients with Hereditary Angioedema with C1 Inhibitor Deficiency Identified Six Novel Mutations in SERPING1	PLOS ONE			English	Article							EXON DELETIONS; GENE; SPECTRUM; FAMILIES; DIAGNOSIS	Hereditary angioedema with C1 inhibitor deficiency (C1-INH-HAE) is characterized by relapsing, non-pruritic swelling in skin and submucosal tissue. Symptoms can appear in early infancy when diagnosis is more difficult. In the absence of a correct diagnosis, treatment of abdominal attacks often lead to unnecessary surgery, and laryngeal edema can cause asphyxiation. A cohort study of 52 patients from 25 unrelated families in Norway was studied. Diagnosis of C1-INH-HAE was based on international consensus criteria including low functional and/or antigenic C1-INH values and antigenic C4. As SERPING1 mutations in Norwegian patients with C1-INH-HAE are largely undescribed and could help in diagnosis, we aimed to find and describe these mutations. Mutation analysis of the SERPING1 gene was performed by Sanger sequencing of all protein coding exons and exon-intron boundaries. Samples without detected mutation were further analyzed by multiplex ligation-dependent probe amplification to detect deletions and duplications. Novel mutations suspected to lead to splice defects were analyzed on the mRNA level. Fifty-two patients from 25 families were included. Forty-four (84,6%) suffered from C1-INH-HAE type I and eight (15,4%) suffered from C1-INH-HAE type II. Pathogenic or likely pathogenic mutations were found in 22/25 families (88%). Thirteen unique mutations were detected, including six previously undescribed. There were three missense mutations including one mutation affecting the reactive center loop at codon 466, three nonsense mutations, three small deletions/duplications, three gross deletions, and one splice mutation.	[Johnsrud, Irene; Landro, Linn; Helsing, Per] Oslo Univ Hosp, Rikshosp, Dept Dermatol, N-0027 Oslo, Norway; [Kulseth, Mari Ann; Rodningen, Olaug Kristin; Heimdal, Ketil] Oslo Univ Hosp, Dept Med Genet, N-0027 Oslo, Norway; [Nielsen, Erik Waage] Nordland Hosp, Dept Anesthesiol, N-8092 Bodo, Norway	University of Oslo; National Hospital Norway; University of Oslo	Johnsrud, I (corresponding author), Univ Oslo, Inst Clin Med, N-0316 Oslo, Norway.	iejohnsrud@gmail.com	Heimdal, Ketil Riddervold/H-3038-2019	Heimdal, Ketil Riddervold/0000-0002-8911-3508				Agostoni A, 2004, J ALLERGY CLIN IMMUN, V114, pS51, DOI 10.1016/j.jaci.2004.06.047; Bafunno V, 2014, ANN HUM GENET, V78, P73, DOI 10.1111/ahg.12052; BOCK SC, 1986, BIOCHEMISTRY-US, V25, P4292, DOI 10.1021/bi00363a018; Bos IGA, 2003, J BIOL CHEM, V278, P29463, DOI 10.1074/jbc.M302977200; Bos IGA, 2002, IMMUNOBIOLOGY, V205, P518, DOI 10.1078/0171-2985-00151; Bowen Tom, 2010, Allergy Asthma Clin Immunol, V6, P24, DOI 10.1186/1710-1492-6-24; Bygum A, 2011, ALLERGY, V66, P76, DOI 10.1111/j.1398-9995.2010.02456.x; Davis AE, 2007, IMMUNOBIOLOGY, V212, P313, DOI 10.1016/j.imbio.2006.10.003; Duponchel C, 2001, HUM MUTAT, V17, P61, DOI 10.1002/1098-1004(2001)17:1<61::AID-HUMU7>3.0.CO;2-9; Firinu D, 2013, CLIN IMMUNOL, V147, P129, DOI 10.1016/j.clim.2013.03.007; Freiberger T, 2002, HUM MUTAT, V19, DOI 10.1002/humu.9029; Gosswein T, 2008, CYTOGENET GENOME RES, V121, P181, DOI 10.1159/000138883; Kalmar L, 2003, HUM MUTAT, V22, DOI 10.1002/humu.9202; Kesim B, 2011, INT ARCH ALLERGY IMM, V156, P443, DOI 10.1159/000323915; Longhurst H, 2012, LANCET, V379, P474, DOI 10.1016/S0140-6736(11)60935-5; Lopez-Lera A, 2011, MOL IMMUNOL, V49, P18, DOI 10.1016/j.molimm.2011.07.010; Nielsen EW, 1996, SCAND J IMMUNOL, V44, P185; NIELSEN EW, 1994, PEDIATR RES, V35, P184, DOI 10.1203/00006450-199402000-00012; Pappalardo E, 2000, J ALLERGY CLIN IMMUN, V106, P1147, DOI 10.1067/mai.2000.110471; Pappalardo E, 2008, MOL IMMUNOL, V45, P3536, DOI 10.1016/j.molimm.2008.05.007; Roche O, 2005, HUM MUTAT, V26, P135, DOI 10.1002/humu.20197; SKRIVER K, 1989, J BIOL CHEM, V264, P3066; STEIN PE, 1995, NAT STRUCT BIOL, V2, P96, DOI 10.1038/nsb0295-96; Stenson PD, 2009, GENOME MED, V1, DOI 10.1186/gm13; Stephan F, 2012, HAMOSTASEOLOGIE, V32, P51, DOI 10.5482/ha-1187; Tarzi MD, 2007, CLIN EXP IMMUNOL, V149, P513, DOI 10.1111/j.1365-2249.2007.03438.x; Verpy E, 1996, AM J HUM GENET, V59, P308; VERPY E, 1993, BEHR INST MITT, P120; Xu YY, 2012, ALLERGY, V67, P1430, DOI 10.1111/all.12024	29	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0131637	10.1371/journal.pone.0131637	http://dx.doi.org/10.1371/journal.pone.0131637			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154504	gold, Green Published			2022-12-26	WOS:000358159700075
J	Kraemer, BM; Hook, S; Huttula, T; Kotilainen, P; O'Reilly, CM; Peltonen, A; Plisnier, PD; Sarvala, J; Tamatamah, R; Vadeboncoeur, Y; Wehrli, B; McIntyre, PB				Kraemer, Benjamin M.; Hook, Simon; Huttula, Timo; Kotilainen, Pekka; O'Reilly, Catherine M.; Peltonen, Anu; Plisnier, Pierre-Denis; Sarvala, Jouko; Tamatamah, Rashid; Vadeboncoeur, Yvonne; Wehrli, Bernhard; McIntyre, Peter B.			Century-Long Warming Trends in the Upper Water Column of Lake Tanganyika	PLOS ONE			English	Article							CLIMATE-CHANGE; TEMPERATURE-DEPENDENCE; IMPACTS; LIPIDS	Lake Tanganyika, the deepest and most voluminous lake in Africa, has warmed over the last century in response to climate change. Separate analyses of surface warming rates estimated from in situ instruments, satellites, and a paleolimnological temperature proxy (TEX86) disagree, leaving uncertainty about the thermal sensitivity of Lake Tanganyika to climate change. Here, we use a comprehensive database of in situ temperature data from the top 100 meters of the water column that span the lake's seasonal range and lateral extent to demonstrate that long-term temperature trends in Lake Tanganyika depend strongly on depth, season, and latitude. The observed spatiotemporal variation in surface warming rates accounts for small differences between warming rate estimates from in situ instruments and satellite data. However, after accounting for spatiotemporal variation in temperature and warming rates, the TEX86 paleolimnological proxy yields lower surface temperatures (1.46 degrees C lower on average) and faster warming rates (by a factor of three) than in situ measurements. Based on the ecology of Thaumarchaeota (the microbes whose biomolecules are involved with generating the TEX86 proxy), we offer a reinterpretation of the TEX86 data from Lake Tanganyika as the temperature of the low-oxygen zone, rather than of the lake surface temperature as has been suggested previously. Our analyses provide a thorough accounting of spatiotemporal variation in warming rates, offering strong evidence that thermal and ecological shifts observed in this massive tropical lake over the last century are robust and in step with global climate change.	[Kraemer, Benjamin M.; McIntyre, Peter B.] Univ Wisconsin, Ctr Limnol, Madison, WI 53706 USA; [Hook, Simon] NASA, Jet Prop Lab, Pasadena, CA USA; [Huttula, Timo] Finnish Environm Inst, Freshwater Ctr, Jyvaskyla, Finland; [Kotilainen, Pekka] Finnish Environm Inst, Ctr Marine Res, Helsinki, Finland; [O'Reilly, Catherine M.] Illinois State Univ, Dept Geog Geol, Normal, IL 61761 USA; [Peltonen, Anu] Ctr Econ Dev Transport & Environm Pirkanmaa, Tampere, Finland; [Plisnier, Pierre-Denis] Royal Museum Cent Africa, Tervuren, Belgium; [Sarvala, Jouko] Univ Turku, Dept Biol, SF-20500 Turku, Finland; [Tamatamah, Rashid] Univ Dar Es Salaam, Dept Aquat Sci & Fisheries, Dar Es Salaam, Tanzania; [Vadeboncoeur, Yvonne] Wright State Univ, Dept Biol Sci, Dayton, OH 45435 USA; [Wehrli, Bernhard] Swiss Fed Inst Aquat Sci & Technol Eawag, Surface Waters Dept, Kastanienbaum, Switzerland; [Wehrli, Bernhard] ETH, Inst Biogeochem & Pollutant Dynam, Zurich, Switzerland	University of Wisconsin System; University of Wisconsin Madison; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Finnish Environment Institute; Finnish Environment Institute; Illinois State University; Royal Museum for Central Africa; University of Turku; University of Dar es Salaam; University System of Ohio; Wright State University Dayton; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Swiss Federal Institutes of Technology Domain; ETH Zurich	Kraemer, BM (corresponding author), Univ Wisconsin, Ctr Limnol, Madison, WI 53706 USA.	ben.m.kraemer@gmail.com	Hook, Simon J/D-5920-2016; Wehrli, Bernhard/A-4406-2013; Plisnier, Pierre-Denis/ABG-2933-2020; Wehrli, Bernhard/M-3847-2019; Sarvala, Jouko/J-8962-2019; Kraemer, Benjamin M/AAV-9299-2021; Wehrli, Bernhard/B-4420-2008	Hook, Simon J/0000-0002-0953-6165; Wehrli, Bernhard/0000-0001-7029-1972; Wehrli, Bernhard/0000-0001-7029-1972; Sarvala, Jouko/0000-0002-5016-3049; Wehrli, Bernhard/0000-0001-7029-1972	National Science Foundation (NSF) [DEB-1030242, DEB-0842253]; Global Lake Temperature Collaboration (National Aeronautics and Space Administration (NASA) Research Opportunities in Space and Earth Sciences (ROSES) Grant, Institute of Agricultural and Natural Resources (IANR), University of Nebraska-Lincoln) [DEB-1147666]	National Science Foundation (NSF)(National Science Foundation (NSF)); Global Lake Temperature Collaboration (National Aeronautics and Space Administration (NASA) Research Opportunities in Space and Earth Sciences (ROSES) Grant, Institute of Agricultural and Natural Resources (IANR), University of Nebraska-Lincoln)	The authors are grateful for field research funding from the National Science Foundation (NSF) (DEB-1030242 and DEB-0842253), and encouragement from the Global Lake Temperature Collaboration (DEB-1147666, National Aeronautics and Space Administration (NASA) Research Opportunities in Space and Earth Sciences (ROSES) Grant, Institute of Agricultural and Natural Resources (IANR), University of Nebraska-Lincoln).	Adrian R, 2009, LIMNOL OCEANOGR, V54, P2283, DOI 10.4319/lo.2009.54.6_part_2.2283; Austin JA, 2007, GEOPHYS RES LETT, V34; BEAUCHAMP R. S. A., 1939, INTERNAL REV GES HYDROBIOL U HYDROGR, V39, P316, DOI 10.1002/iroh.19390390303; Castaneda IS, 2011, QUATERNARY SCI REV, V30, P2851, DOI 10.1016/j.quascirev.2011.07.009; Chale F, 2006, TANZANIA JOURNAL OF, V32, P23; Coats R, 2006, CLIMATIC CHANGE, V76, P121, DOI 10.1007/s10584-005-9006-1; Corman JR, 2010, LIMNOL OCEANOGR, V55, P214, DOI 10.4319/lo.2010.55.1.0214; COULTER GW, 1968, LIMNOL OCEANOGR, V13, P385, DOI 10.4319/lo.1968.13.2.0385; Craig H, 1974, TANGANYIKA GEOCHEMIC; DAVISON W, 1983, GEOCHIM COSMOCHIM AC, V47, P67, DOI 10.1016/0016-7037(83)90091-1; Dillon ME, 2010, NATURE, V467, P704, DOI 10.1038/nature09407; DUBOIS J. T., 1958, HYDROBIOLOGIA, V10, P215, DOI 10.1007/BF00142188; Durisch-Kaiser E, 2011, J GEOPHYS RES-BIOGEO, V116; EDMOND JM, 1993, LIMNOL OCEANOGR, V38, P725, DOI 10.4319/lo.1993.38.4.0725; Finlay KP, 2001, CAN J FISH AQUAT SCI, V58, P609, DOI 10.1139/f01-017; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Hansen J, 2010, REV GEOPHYS, V48, DOI 10.1029/2010RG000345; Huttula T, 1997, THERMAL REGIME AND S; Jacobs, 1914, ANN DER HYDROGR UND, V22; Jin ML, 2003, INT J REMOTE SENS, V24, P4543, DOI 10.1080/0143116031000095943; Kraemer B., 2015, CENTURY LONG TEMPERA, DOI [10.6073/pasta/59946ad9f1fefffd541d06054490b104, DOI 10.6073/PASTA/59946AD9F1FEFFFD541D06054490B104]; Livingstone DM, 2003, CLIMATIC CHANGE, V57, P205, DOI 10.1023/A:1022119503144; MacCallum SN, 2012, CAN J REMOTE SENS, V38, P25, DOI 10.5589/m12-010; MacIntyre S, 2013, CLIMATIC CHANGE AND, DOI [10.1002/9781118470596, DOI 10.1002/9781118470596]; MCARDLE BH, 1988, CAN J ZOOL, V66, P2329, DOI 10.1139/z88-348; Merchant CJ, 2005, Q J ROY METEOR SOC, V131, P2735, DOI 10.1256/qj.05.15; Narita T, 1986, VERTICAL DISTRIBUTIO; Ngai KLC, 2013, CLIMATIC CHANGE, V118, P841, DOI 10.1007/s10584-013-0695-6; O'Reilly CM, 2003, NATURE, V424, P766, DOI 10.1038/nature01833; Plisnier PD, 1999, HYDROBIOLOGIA, V407, P45, DOI 10.1023/A:1003762119873; Powers LA, 2004, GEOLOGY, V32, P613, DOI 10.1130/G20434.1; Roni N, 2013, ADV METEOROL; SCHNEIDER P, 1985, GEOPHYS RES LETT, V2010, P37, DOI DOI 10.1029/2010GL045059; Schouten S, 2012, ORG GEOCHEM, V53, P34, DOI 10.1016/j.orggeochem.2012.01.009; Screen JA, 2010, NATURE, V464, P1334, DOI 10.1038/nature09051; Stappers L, 1913, REEPERTOIRE GEENEERA; Sumaila UR, 2011, NAT CLIM CHANGE, V1, P449, DOI 10.1038/NCLIMATE1301; Tierney JE, 2008, SCIENCE, V322, P252, DOI 10.1126/science.1160485; Tierney JE, 2010, NAT GEOSCI, V3, P422, DOI [10.1038/ngeo865, 10.1038/NGEO865]; Van Bocxlaer B, 2012, FRESHWATER BIOL, V57, P1733, DOI 10.1111/j.1365-2427.2012.02828.x; Van Meel Ludovic, 1987, CONTRIBUTION A LA LI; Verburg P, 2003, J GREAT LAKES RES, V29, P48, DOI 10.1016/S0380-1330(03)70538-3; Verburg P, 2003, SCIENCE, V301, P505, DOI 10.1126/science.1084846; Verburg P, 2011, LIMNOL OCEANOGR, V56, P910, DOI 10.4319/lo.2011.56.3.0910; Verburg P, 2009, LIMNOL OCEANOGR, V54, P2418, DOI 10.4319/lo.2009.54.6_part_2.2418; Wilson RC, 2013, J GEOPHYS RES-ATMOS, V118, P10332, DOI 10.1002/jgrd.50786; Wuchter C, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2004PA001041; Yvon-Durocher G, 2014, NATURE, V507, P488, DOI 10.1038/nature13164; Yvon-Durocher G, 2012, NATURE, V487, P472, DOI 10.1038/nature11205	49	38	39	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132490	10.1371/journal.pone.0132490	http://dx.doi.org/10.1371/journal.pone.0132490			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147964	Green Published, Green Submitted, gold			2022-12-26	WOS:000358157600287
J	Montesi, M; Panseri, S; Iafisco, M; Adamiano, A; Tampieri, A				Montesi, Monica; Panseri, Silvia; Iafisco, Michele; Adamiano, Alessio; Tampieri, Anna			Coupling Hydroxyapatite Nanocrystals with Lactoferrin as a Promising Strategy to Fine Regulate Bone Homeostasis	PLOS ONE			English	Article							IN-VITRO; OSTEOBLAST DIFFERENTIATION; OSTEOCLAST DIFFERENTIATION; CELLS; RANKL; APOPTOSIS; BISPHOSPHONATES; EXPRESSION; PATHWAYS; DELIVERY	Lactoferrin (LF) is an interesting glycoprotein in the field of bone biology for its regulatory effect on cells involved in bone remodeling, that results compromised in several pathological conditions, as osteoporosis. In a previous study we observed that the coupling of LF and biomimetic hydroxyapatite nanocrystals (HA), a material well-known for its bioactivity and osteoconductive properties, leads to a combined effect in the induction of osteogenic differentiation of mesenchymal stem cells. On the basis of this evidence, the present study is an extension of our previous work aiming to investigate the synergistic effect of the coupling of HA and LF on bone homeostasis. Biomimetic HA nanocrystals were synthesized and functionalized with LF (HA-LF) and then pre-osteoblasts (MC3T3-E1) and monocyte/macrophage cells lines (RAW 264.7), using as osteoclastogenesis in vitro model, were cultured separately or in co-culture in presence of HA-LF. The results clearly revealed that HA and LF act in synergism in the regulation of the bone homeostasis, working as anabolic factor for osteoblasts differentiation and bone matrix deposition, and as inhibitor of the osteoclast formation and activity.	[Montesi, Monica; Panseri, Silvia; Iafisco, Michele; Adamiano, Alessio; Tampieri, Anna] CNR, Inst Sci & Technol Ceram, Faenza, Ravenna, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienza e Tecnologia dei Materiali Ceramici (ISTEC-CNR)	Montesi, M (corresponding author), CNR, Inst Sci & Technol Ceram, Faenza, Ravenna, Italy.	monica.montesi@istec.cnr.it	Adamiano, Alessio/K-2499-2018; Montesi, Monica/J-8861-2018; Iafisco, Michele/B-4597-2010; Panseri, Silvia/AAW-2856-2020; Iafisco, Michele/ABF-7752-2020	Adamiano, Alessio/0000-0002-2077-0411; Montesi, Monica/0000-0002-9192-8554; Iafisco, Michele/0000-0002-7813-8347; Panseri, Silvia/0000-0002-8099-7132; Iafisco, Michele/0000-0002-7813-8347; Panseri, Sara/0000-0001-6970-2009	National Research Program -National Research Council (PNRCNR) Aging Program	National Research Program -National Research Council (PNRCNR) Aging Program	This work has been supported by National Research Program -National Research Council (PNRCNR) Aging Program 2012-2014.	Amini AA, 2011, CURR MED CHEM, V18, P1220; Amini AA, 2014, TISSUE ENG PT A, V20, P2830, DOI [10.1089/ten.tea.2013.0506, 10.1089/ten.TEA.2013.0506]; Amini AA, 2014, ADV HEALTHC MATER, V3, P897, DOI 10.1002/adhm.201300496; Bouleftour W, 2015, J CELL PHYSIOL, V230, P568, DOI 10.1002/jcp.24772; Boyce BF, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2165; Collin-Osdoby P, 2003, METH MOLEC MED, V80, P153; Cornish J, 2006, BIOCHEM CELL BIOL, V84, P297, DOI 10.1139/O06-057; Cornish J, 2010, BIOMETALS, V23, P425, DOI 10.1007/s10534-010-9320-6; Goncalves MJ, 2013, ACTA MEDICA PORT, V26, P445; Hou JM, 2012, ACTA PHARMACOL SIN, V33, P1277, DOI 10.1038/aps.2012.83; Iafisco M, 2011, DALTON T, V40, P820, DOI 10.1039/c0dt00714e; Iafisco M, 2012, J INORG BIOCHEM, V117, P237, DOI 10.1016/j.jinorgbio.2012.06.004; Iafisco M, 2012, NANOSCALE, V4, P206, DOI 10.1039/c1nr11147g; Itoh T, 2014, BIOSCI BIOTECH BIOCH, V78, P92, DOI 10.1080/09168451.2014.877182; Kfoury Y, 2015, CELL STEM CELL, V16, P239, DOI 10.1016/j.stem.2015.02.019; Kim N, 2002, J EXP MED, V195, P201, DOI 10.1084/jem.20011681; Kim SY, 2014, APPL SURF SCI, V321, P412, DOI 10.1016/j.apsusc.2014.09.177; Kirstein B, 2006, J CELL BIOCHEM, V98, P1085, DOI 10.1002/jcb.20835; Kiviranta R, 2005, BONE, V36, P159, DOI 10.1016/j.bone.2004.09.020; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Landi E, 2005, BIOMATERIALS, V26, P2835, DOI 10.1016/j.biomaterials.2004.08.010; LAZEBNIK YA, 1993, J CELL BIOL, V123, P7, DOI 10.1083/jcb.123.1.7; Liu XC, 2012, INT J NANOMED, V7, P1239, DOI 10.2147/IJN.S28098; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorget F, 2002, BIOCHEM BIOPH RES CO, V296, P261, DOI 10.1016/S0006-291X(02)00849-5; Martin A, 2015, BONE, V75, P96, DOI 10.1016/j.bone.2015.02.007; Matsuo K, 2008, ARCH BIOCHEM BIOPHYS, V473, P201, DOI 10.1016/j.abb.2008.03.027; Montesi M, 2015, J BIOMED MATER RES A, V103, P224, DOI 10.1002/jbm.a.35170; Munarin F, 2012, J APPL BIOMATER FUNC, V10, P67, DOI 10.5301/JABFM.2012.9418; Nakamura I, 1996, J BONE MINER RES, V11, P1873; PAPADOPOULOS NG, 1994, J IMMUNOL METHODS, V177, P101, DOI 10.1016/0022-1759(94)90147-3; Pistone A, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/42/425701; Plotkin LI, 1999, J CLIN INVEST, V104, P1363, DOI 10.1172/JCI6800; Saltel F, 2004, MOL BIOL CELL, V15, P5231, DOI 10.1091/mbc.E04-06-0522; Samarasinghe RM, 2014, BIOMATERIALS, V35, P7522, DOI 10.1016/j.biomaterials.2014.04.109; Sanjay A, 2001, J CELL BIOL, V152, P181, DOI 10.1083/jcb.152.1.181; Schaffler MB, 2014, CALCIFIED TISSUE INT, V94, P5, DOI 10.1007/s00223-013-9790-y; Sims NA, 2012, CURR OSTEOPOROS REP, V10, P109, DOI 10.1007/s11914-012-0096-1; Sinha KM, 2014, J BONE MINER RES, V29, P855, DOI 10.1002/jbmr.2103; Sinha KM, 2013, J CELL BIOCHEM, V114, P975, DOI 10.1002/jcb.24439; Sullivan MP, 2014, BONE JOINT J, V96B, P569, DOI 10.1302/0301-620X.96B5.33606; Do TNT, 2012, THER DELIV, V3, P623, DOI 10.4155/TDE.12.39; Tseng FJ, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-57; Uskokovic V, 2011, J BIOMED MATER RES B, V96B, P152, DOI 10.1002/jbm.b.31746; Vandrovcova M, 2015, J BIOMED MATER RES A, V103, P525, DOI 10.1002/jbm.a.35199; Wang D, 1999, J BONE MINER RES, V14, P893, DOI 10.1359/jbmr.1999.14.6.893; Webster TJ, 2001, BIOMATERIALS, V22, P1327, DOI 10.1016/S0142-9612(00)00285-4; Xu ZL, 2012, J APPL TOXICOL, V32, P429, DOI 10.1002/jat.1745; Zhang W, 2014, J BONE MINER RES, V29, P1232, DOI 10.1002/jbmr.2116	49	20	20	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132633	10.1371/journal.pone.0132633	http://dx.doi.org/10.1371/journal.pone.0132633			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148296	Green Submitted, Green Published, gold			2022-12-26	WOS:000358157600309
J	El Anbari, M; Fadda, A; Ptitsyn, A				El Anbari, Mohammed; Fadda, Abeer; Ptitsyn, Andrey			Confidence in Phase Definition for Periodicity in Genes Expression Time Series	PLOS ONE			English	Article							CIRCADIAN CLOCKS; BOOTSTRAP; TISSUES; CYCLE	Circadian oscillation in baseline gene expression plays an important role in the regulation of multiple cellular processes. Most of the knowledge of circadian gene expression is based on studies measuring gene expression over time. Our ability to dissect molecular events in time is determined by the sampling frequency of such experiments. However, the real peaks of gene activity can be at any time on or between the time points at which samples are collected. Thus, some genes with a peak activity near the observation point have their phase of oscillation detected with better precision then those which peak between observation time points. Separating genes for which we can confidently identify peak activity from ambiguous genes can improve the analysis of time series gene expression. In this study we propose a new statistical method to quantify the phase confidence of circadian genes. The numerical performance of the proposed method has been tested using three real gene expression data sets.	[El Anbari, Mohammed; Fadda, Abeer; Ptitsyn, Andrey] Sidra Med & Res Ctr, Div Biomed Informat, Doha, Qatar	Sidra Medical & Research Center	El Anbari, M (corresponding author), Sidra Med & Res Ctr, Div Biomed Informat, Doha, Qatar.	melanbari@sidra.org		Ptitsyn, Andrey/0000-0003-1196-8757; Fadda, Abeer/0000-0002-8489-1335				Bray MS, 2008, AM J PHYSIOL-HEART C, V294, pH1036, DOI 10.1152/ajpheart.01291.2007; Davison AC, 1997, BOOTSTRAP METHODS TH, V1; Efron B., 1979, ANS, V7, P1; Efron B., 1982, SIAM, V38; HALL P, 1986, ANN STAT, V14, P1431, DOI 10.1214/aos/1176350168; Hughes ME, 2010, J BIOL RHYTHM, V25, P372, DOI 10.1177/0748730410379711; Klevecz RR, 2008, FEBS J, V275, P2372, DOI 10.1111/j.1742-4658.2008.06399.x; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Ptitsyn AA, 2006, PLOS COMPUT BIOL, V2, P126, DOI 10.1371/journal.pcbi.0020016; Ptitsyn AA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-153; Ptitsyn AA, 2011, ANN MED, V43, P1, DOI 10.3109/07853890.2010.538078; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Vinod HD, 2009, J STAT SOFTW, V29, P1; Vinod HD, 2006, J ASIAN ECON, V17, P955, DOI 10.1016/j.asieco.2006.09.001; Wichert S, 2004, BIOINFORMATICS, V20, P5, DOI 10.1093/bioinformatics/btg364; Zhang R, 2014, P NATL ACAD SCI USA, V111, P16219, DOI 10.1073/pnas.1408886111; Zvonic S, 2006, DIABETES, V55, P962, DOI 10.2337/diabetes.55.04.06.db05-0873	17	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131111	10.1371/journal.pone.0131111	http://dx.doi.org/10.1371/journal.pone.0131111			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161537	Green Submitted, Green Published, gold			2022-12-26	WOS:000358162300028
J	Imamaki, H; Ishii, A; Yokoi, H; Kasahara, M; Kuwabara, T; Mori, KP; Kato, Y; Kuwahara, T; Satoh, M; Nakatani, K; Saito, Y; Tomosugi, N; Sugawara, A; Nakao, K; Mukoyama, M; Yanagita, M; Mori, K				Imamaki, Hirotaka; Ishii, Akira; Yokoi, Hideki; Kasahara, Masato; Kuwabara, Takashige; Mori, Keita P.; Kato, Yukiko; Kuwahara, Takashi; Satoh, Masugi; Nakatani, Kimihiko; Saito, Yoshihiko; Tomosugi, Naohisa; Sugawara, Akira; Nakao, Kazuwa; Mukoyama, Masashi; Yanagita, Motoko; Mori, Kiyoshi			Low Serum Neutrophil Gelatinase-associated Lipocalin Level as a Marker of Malnutrition in Maintenance Hemodialysis Patients	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; ADULT CARDIAC-SURGERY; INSULIN-RESISTANCE; DIALYSIS PATIENTS; RENAL-FAILURE; REAL-TIME; IRON; NGAL; INFLAMMATION; RISK	Background Neutrophil gelatinase-associated lipocalin (NGAL or LCN2) is an iron-transporting factor which possesses various activities such as amelioration of kidney injury and host defense against pathogens. Its circulating concentrations are elevated in acute and chronic kidney diseases and show a positive correlation with poor renal outcome and mortality, but its clinical significance in maintenance hemodialysis (HD) patients remains elusive. Methods Serum NGAL levels were determined by enzyme-linked immunosorbent assay in outpatient, Japanese HD subjects. Their correlation to laboratory findings and morbidity (as development of severe infection or serum albumin reduction) was investigated using linear regression analysis and chi(2) test. Results Pre-dialysis serum NGAL levels in HD patients were elevated by 13-fold compared to healthy subjects (n=8, P<0.001). In a cross-sectional study of 139 cases, serum NGAL concentrations were determined independently by % creatinine generation rate (an indicator of muscle mass, standardized coefficient beta=0.40, P<0.001), peripheral blood neutrophil count (beta=0.38, P<0.001) and anion gap (which likely reflects dietary protein intake, beta=0.16, P<0.05). Iron administration to anemic HD patients caused marked elevation of peripheral blood hemoglobin, serum ferritin and iron-regulatory hormone hepcidin-25 levels, but NGAL levels were not affected. In a prospective study of 87 cases, increase in serum albumin levels a year later was positively associated to baseline NGAL levels by univariate analysis (r=0.36, P<0.01). Furthermore, within a year, patients with the lowest NGAL tertile showed significantly increased risk for marked decline in serum albumin levels (>= 0.4 g/dl; odds ratio 5.5, 95% confidence interval 1.5-20.3, P<0.05) and tendency of increased occurrence of severe infection requiring admission (odds ratio 3.1, not significant) compared to the middle and highest tertiles. Conclusion Low serum NGAL levels appear to be associated with current malnutrition and also its progressive worsening in maintenance HD patients.	[Imamaki, Hirotaka; Ishii, Akira; Yokoi, Hideki; Kuwabara, Takashige; Mori, Keita P.; Kato, Yukiko; Mukoyama, Masashi; Yanagita, Motoko] Kyoto Univ, Grad Sch Med, Dept Nephrol, Kyoto, Japan; [Kasahara, Masato] Kyoto Univ Hosp, Inst Adv Clin & Translat Sci, Kyoto 606, Japan; [Kuwahara, Takashi] Saiseikai Ibaraki Hosp, Dept Nephrol, Osaka, Japan; [Satoh, Masugi] Misugikai Satou Hosp, Osaka, Japan; [Nakatani, Kimihiko; Saito, Yoshihiko] Nara Med Univ, Dept Internal Med 1, Nara, Japan; [Tomosugi, Naohisa] Kanazawa Med Univ, Med Res Inst, Div Adv Med, Kanazawa, Ishikawa, Japan; [Sugawara, Akira] Osaka Red Cross Hosp, Dept Nephrol, Osaka, Japan; [Nakao, Kazuwa] Kyoto Univ, TK Project, Med Innovat Ctr, Grad Sch Med, Kyoto, Japan; [Kuwabara, Takashige; Mukoyama, Masashi] Kumamoto Univ, Grad Sch Med Sci, Dept Nephrol, Kumamoto, Japan; [Yanagita, Motoko; Mori, Kiyoshi] Kyoto Univ, TMK Project, Med Innovat Ctr, Grad Sch Med, Kyoto, Japan	Kyoto University; Kyoto University; Nara Medical University; Kanazawa Medical University; Osaka Red Cross Hospital; Kyoto University; Kumamoto University; Kyoto University	Mori, K (corresponding author), Kyoto Univ, TMK Project, Med Innovat Ctr, Grad Sch Med, Kyoto, Japan.	mori@tmk.med.kyoto-u.ac.jp	Yokoi, Hideki/R-1289-2016; Yokoi, Hideki/AAV-9038-2021; Mori, Kiyoshi/N-1267-2014; Yanagita, Motoko/AAJ-7731-2021	Yokoi, Hideki/0000-0001-8343-9737; Yokoi, Hideki/0000-0001-8343-9737; Mori, Kiyoshi/0000-0002-7285-8351; Kuwabara, Takashige/0000-0003-3507-4328; Yanagita, Motoko/0000-0002-0339-9008	JSPS KAKENHI [23390225, 26461224]; Ministry of Health, Labour and Welfare of Japan; Japan Kidney Foundation; Mitsubishi Tanabe Pharma Corporation	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Kidney Foundation; Mitsubishi Tanabe Pharma Corporation(Mitsubishi Tanabe Pharma Corporation)	This work was supported in part by JSPS KAKENHI Grant Numbers 23390225 and 26461224 (KM and HI), Grant-in-Aid for Diabetic Nephropathy and Nephrosclerosis Research from the Ministry of Health, Labour and Welfare of Japan (KM), the Japan Kidney Foundation (KM), and research fund from Mitsubishi Tanabe Pharma Corporation (KM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao GH, 2010, NAT CHEM BIOL, V6, P602, DOI [10.1038/nchembio.402, 10.1038/NCHEMBIO.402]; Barasch J, 2004, NATURE, V432, P811, DOI 10.1038/432811a; BERGSTROM J, 1995, J AM SOC NEPHROL, V6, P1329; Bolignano D, 2008, KIDNEY BLOOD PRESS R, V31, P255, DOI 10.1159/000143726; Bolignano D, 2010, CANCER LETT, V288, P10, DOI 10.1016/j.canlet.2009.05.027; Bolignano D, 2009, NEPHROL DIAL TRANSPL, V24, P3398, DOI 10.1093/ndt/gfp310; Bolignano D, 2009, CLIN J AM SOC NEPHRO, V4, P337, DOI 10.2215/CJN.03530708; BORAH MF, 1978, KIDNEY INT, V14, P491, DOI 10.1038/ki.1978.154; Bouillanne O, 2005, AM J CLIN NUTR, V82, P777, DOI 10.1093/ajcn/82.4.777; Chan YR, 2009, J IMMUNOL, V182, P4947, DOI 10.4049/jimmunol.0803282; CHANDRA RK, 1983, LANCET, V1, P688; Cowland JB, 2006, J IMMUNOL, V176, P5559, DOI 10.4049/jimmunol.176.9.5559; CRADDOCK PR, 1977, J CLIN INVEST, V59, P879, DOI 10.1172/JCI108710; DAUGIRDAS JT, 1993, J AM SOC NEPHROL, V4, P1205; Dent CL, 2007, CRIT CARE, V11, DOI 10.1186/cc6192; DRENICK EJ, 1971, AM J CLIN NUTR, V24, P859; Dumler F, 1999, ASAIO J, V45, P413, DOI 10.1097/00002480-199909000-00009; Fleischmann EH, 2001, ASAIO J, V47, P74, DOI 10.1097/00002480-200101000-00016; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; Fluckinger M, 2004, ANTIMICROB AGENTS CH, V48, P3367, DOI 10.1128/AAC.48.9.3367-3372.2004; Goetz DH, 2002, MOL CELL, V10, P1033, DOI 10.1016/S1097-2765(02)00708-6; Goldstein SL, 2006, CLIN J AM SOC NEPHRO, V1, P979, DOI 10.2215/CJN.02291205; Gupta A, 2010, BMC NEPHROL, V11, DOI 10.1186/1471-2369-11-16; Haase-Fielitz A, 2009, CRIT CARE MED, V37, P553, DOI 10.1097/CCM.0b013e318195846e; Hanai J, 2005, J BIOL CHEM, V280, P13641, DOI 10.1074/jbc.M413047200; HEYMSFIELD SB, 1983, AM J CLIN NUTR, V37, P478, DOI 10.1093/ajcn/37.3.478; Hingorani S, 2009, AM J KIDNEY DIS, V53, P569, DOI 10.1053/j.ajkd.2009.01.002; Horl WH, 2002, J AM SOC NEPHROL, V13, pS62; Iwama H, 2006, J AM COLL CARDIOL, V47, P1559, DOI 10.1016/j.jacc.2005.11.064; Jiang W, 2008, BLOOD CELL MOL DIS, V41, P169, DOI 10.1016/j.bcmd.2008.04.006; Johnson ACM, 2010, AM J PHYSIOL-RENAL, V299, pF426, DOI 10.1152/ajprenal.00248.2010; Kalantar-Zadeh K, 2004, SEMIN DIALYSIS, V17, P455, DOI 10.1111/j.0894-0959.2004.17606.x; Kalantar-Zadeh K, 2004, J AM SOC NEPHROL, V15, P442, DOI 10.1097/01.ASN.0000107564.60018.51; Kalantar-Zadeh K, 2003, KIDNEY INT, V63, P793, DOI 10.1046/j.1523-1755.2003.00803.x; Kanda J, 2015, CLIN EXP NEPHROL, V19, P99, DOI 10.1007/s10157-014-0952-7; KJELDSEN L, 1993, J BIOL CHEM, V268, P10425; Kuwabara T, 2009, KIDNEY INT, V75, P285, DOI 10.1038/ki.2008.499; LOCKRIDGE O, 1987, J BIOL CHEM, V262, P549; LOWRIE EG, 1990, AM J KIDNEY DIS, V15, P458, DOI 10.1016/S0272-6386(12)70364-5; Malyszko J, 2009, KIDNEY BLOOD PRESS R, V32, P464, DOI 10.1159/000274048; Mishra Jaya, 2005, Lancet, V365, P1231, DOI 10.1016/S0140-6736(05)74811-X; Mori K, 2007, KIDNEY INT, V71, P967, DOI 10.1038/sj.ki.5002165; Mori K, 2005, J CLIN INVEST, V115, P610, DOI 10.1172/JCI200523056; Nakanishi T, 2012, CLIN EXP NEPHROL, V16, P819, DOI 10.1007/s10157-012-0694-3; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Paragas N, 2011, NAT MED, V17, P216, DOI 10.1038/nm.2290; PAYNE RB, 1973, BMJ-BRIT MED J, V4, P643, DOI 10.1136/bmj.4.5893.643; Raj DSC, 2005, KIDNEY INT, V68, P2338, DOI 10.1111/j.1523-1755.2005.00695.x; Saiga H, 2008, J IMMUNOL, V181, P8521, DOI 10.4049/jimmunol.181.12.8521; SHINZATO T, 1994, NEPHRON, V67, P280, DOI 10.1159/000187980; Shinzato T, 1997, ARTIF ORGANS, V21, P864; Tomosugi N, 2006, BLOOD, V108, P1381, DOI 10.1182/blood-2005-10-4043; Wagener G, 2006, ANESTHESIOLOGY, V105, P485, DOI 10.1097/00000542-200609000-00011; Wang Y, 2007, CLIN CHEM, V53, P34, DOI 10.1373/clinchem.2006.075614; Wann JG, 2007, NEPHROL DIAL TRANSPL, V22, P2613, DOI 10.1093/ndt/gfm227; XU SY, 1995, SCAND J CLIN LAB INV, V55, P125, DOI 10.3109/00365519509089604; Yamada K, 2008, AM J CLIN NUTR, V87, P106, DOI 10.1093/ajcn/87.1.106; Yan QW, 2007, DIABETES, V56, P2533, DOI 10.2337/db07-0007; Yang J, 2002, MOL CELL, V10, P1045, DOI 10.1016/S1097-2765(02)00710-4; Zhang JH, 2008, MOL ENDOCRINOL, V22, P1416, DOI 10.1210/me.2007-0420; Zhang YY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096997	61	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132539	10.1371/journal.pone.0132539	http://dx.doi.org/10.1371/journal.pone.0132539			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161663	gold, Green Published, Green Submitted			2022-12-26	WOS:000358162300149
J	Kusama, K; Yoshie, M; Tamura, K; Imakawa, K; Isaka, K; Tachikawa, E				Kusama, Kazuya; Yoshie, Mikihiro; Tamura, Kazuhiro; Imakawa, Kazuhiko; Isaka, Keiichi; Tachikawa, Eiichi			Regulatory Action of Calcium Ion on Cyclic AMP-Enhanced Expression of Implantation-Related Factors in Human Endometrial Cells	PLOS ONE			English	Article							STROMAL CELLS; BINDING PROTEIN; DECIDUALIZATION; PROLACTIN; CA2+; PROLIFERATION; INVOLVEMENT; ACTIVATION; RECEPTORS; INCREASES	Decidualization of human endometrial stroma and gland development is mediated through cyclic AMP (cAMP), but the role of intracellular calcium ion (Ca2+) on cAMP mediated-signaling in human endometrial stroma and glandular epithelia has not been well-characterized. The present study was designed to investigate the role of intracellular Ca2+ on cAMP mediated-decidualization and gland maturation events, which can be identified by the up-regulation of prolactin and IGF-binding protein (IGFBP) 1 in human endometrial stromal cells (ESCs), and cyclooxygenase 2 (COX2) and prostaglandin E2 (PGE2) and glandular epithelial EM-1 cells. Increases in decidual prolactin and IGFBP-1 transcript levels, induced by cAMP-elevating agents forskolin or dibutyryl cyclic AMP, were inhibited by Ca2+ influx into ESCs with Ca2+ ionophores (alamethicin, ionomycin) in a dose-dependent manner. Conversely, inhibitors of Ca2+ influx through L-type voltage-dependent Ca2+ channel (VDCC), nifedipine and verapamil, enhanced the decidual gene expression. Furthermore, dantrolene, an inhibitor of Ca2+ release from the intracellular Ca2+ store, up-regulated prolactin and IGFBP-1 expression. Ca2+ ionophores decreased intracellular cAMP concentrations, whereas nifedipine, verapamil or dantrolene increased cAMP concentrations in ESCs. In glandular epithelial cells, similar responses in COX2 expression and PGE2 production were found when intracellular cAMP levels were up-regulated by decreases in Ca2+ concentrations. Thus, a marked decrease in cytosolic Ca2+ levels caused the elevation of cAMP concentrations, resulting in enhanced expression of implantation-related factors including decidual markers. These findings suggest that fluctuation in cytosolic Ca2+ concentrations alters intracellular cAMP levels, which then regulate differentiation of endometrial stromal and glandular epithelial cells.	[Kusama, Kazuya; Yoshie, Mikihiro; Tamura, Kazuhiro; Tachikawa, Eiichi] Tokyo Univ Pharm & Life Sci, Dept Endocrine & Neural Pharmacol, Hachioji, Tokyo 1920392, Japan; [Kusama, Kazuya; Imakawa, Kazuhiko] Univ Tokyo, Lab Theriogenol & Anim Breeding, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan; [Isaka, Keiichi] Tokyo Med Univ, Dept Obstet & Gynecol, Tokyo 1600023, Japan	Tokyo University of Pharmacy & Life Sciences; University of Tokyo; Tokyo Medical University	Yoshie, M (corresponding author), Tokyo Univ Pharm & Life Sci, Dept Endocrine & Neural Pharmacol, 1432-1 Horinouchi, Hachioji, Tokyo 1920392, Japan.	yoshie@toyaku.ac.jp; hiro@toyaku.ac.jp	Kusama, Kazuya/K-9716-2018; Imakawa, Kazuhiko/AAD-3211-2022	Kusama, Kazuya/0000-0002-9120-0475; Yoshie, Mikihiro/0000-0001-5898-7950	education-research costs of institutional budget in Tokyo University of Pharmacy and Life Sciences; JSPS (Japan Society for the Promotion of Science) [25861511, 23590476]	education-research costs of institutional budget in Tokyo University of Pharmacy and Life Sciences; JSPS (Japan Society for the Promotion of Science)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was mainly supported by education-research costs of institutional budget in Tokyo University of Pharmacy and Life Sciences, and in part by KAKENHI (Grant-in-Aid for Young Scientists B; 25861511 to MY, Grant-in-Aid for Scientific Research C; 23590476 to KT) from the JSPS (Japan Society for the Promotion of Science).	Abraham F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037750; Braileanu GT, 2002, REPROD FERT DEVELOP, V14, P199, DOI 10.1071/RD02003; Brar AK, 1997, ENDOCRINE, V6, P301, DOI 10.1007/BF02820507; Brosens JJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep03894; COUDERC B, 1995, PLACENTA, V16, P527, DOI 10.1016/S0143-4004(05)80004-9; De A, 2011, ACTA BIOCH BIOPH SIN, V43, P745, DOI 10.1093/abbs/gmr079; Dey SK, 2010, J CLIN INVEST, V120, P952, DOI 10.1172/JCI42380; Evans J, 2009, FASEB J, V23, P2165, DOI 10.1096/fj.08-124495; FRANK GR, 1994, ENDOCRINOLOGY, V134, P258, DOI 10.1210/en.134.1.258; Gellersen B, 2003, J ENDOCRINOL, V178, P357, DOI 10.1677/joe.0.1780357; GIUDICE LC, 1992, J CLIN ENDOCR METAB, V75, P1235, DOI 10.1210/jc.75.5.1235; Goraya TA, 2005, CELL SIGNAL, V17, P789, DOI 10.1016/j.cellsig.2004.12.017; Goraya TA, 2004, J BIOL CHEM, V279, P40494, DOI 10.1074/jbc.M313441200; Goraya TA, 2008, CELL SIGNAL, V20, P359, DOI 10.1016/j.cellsig.2007.10.024; Kawarabayashi Y, 2012, MOL ENDOCRINOL, V26, P846, DOI 10.1210/me.2011-1259; KUBOTA T, 1993, J ENDOCRINOL, V137, P335, DOI 10.1677/joe.0.1370335; Kusama K, 2013, PLACENTA, V34, P212, DOI 10.1016/j.placenta.2012.12.017; Kusama K, 2015, J MOL ENDOCRINOL, V54, P17, DOI 10.1530/JME-14-0162; Kusama K, 2014, REPRODUCTION, V147, P897, DOI 10.1530/REP-13-0654; Kusama K, 2014, ENDOCRINOLOGY, V155, P240, DOI 10.1210/en.2013-1478; Kutsukake M, 2007, MOL HUM REPROD, V13, P737, DOI 10.1093/molehr/gam058; Kyo S, 2003, AM J PATHOL, V163, P2259, DOI 10.1016/S0002-9440(10)63583-3; Liu XM, 2012, J CLIN ENDOCR METAB, V97, P3672, DOI 10.1210/jc.2012-2075; Macdonald LJ, 2011, MOL HUM REPROD, V17, P626, DOI 10.1093/molehr/gar031; Maldonado-Perez D, 2007, TRENDS ENDOCRIN MET, V18, P66, DOI 10.1016/j.tem.2006.12.002; Marions L, 1999, MOL HUM REPROD, V5, P961, DOI 10.1093/molehr/5.10.961; MASLAR IA, 1979, AM J OBSTET GYNECOL, V135, P751, DOI 10.1016/0002-9378(79)90386-7; Matsuoka A, 2010, J CLIN ENDOCR METAB, V95, pE291, DOI 10.1210/jc.2010-0619; Menezes-Rodrigues FS, 2013, EUR J PHARMACOL, V720, P326, DOI 10.1016/j.ejphar.2013.10.009; Milne SA, 2001, J CLIN ENDOCR METAB, V86, P4453, DOI 10.1210/jc.86.9.4453; Price SA, 2000, J ENDOCRINOL, V164, P21, DOI 10.1677/joe.0.1640021; Ruan YC, 2012, NAT MED, V18, P1112, DOI 10.1038/nm.2771; Soboloff J, 2006, CURR BIOL, V16, P1465, DOI 10.1016/j.cub.2006.05.051; Sonderegger S, 2010, PLACENTA, V31, P839, DOI 10.1016/j.placenta.2010.07.011; Sonderegger S, 2010, ENDOCRINOLOGY, V151, P211, DOI 10.1210/en.2009-0557; Stojilkovic SS, 2010, ENDOCR REV, V31, P845, DOI 10.1210/er.2010-0005; Strauss J F, 2009, YEN JAFFES REPROD EN, P191; Tamura K, 2007, J REPROD DEVELOP, V53, P525, DOI 10.1262/jrd.18129; Tang B, 1993, Acta Eur Fertil, V24, P221; TSENG L, 1992, BIOL REPROD, V47, P441, DOI 10.1095/biolreprod47.3.441; van der Horst PH, 2012, MOL CELL ENDOCRINOL, V358, P176, DOI 10.1016/j.mce.2011.06.010; von Hayn K, 2010, AM J PHYSIOL-CELL PH, V298, pC324, DOI 10.1152/ajpcell.00197.2009; Yuan Wei, 2007, BMC Pregnancy Childbirth, V7 Suppl 1, pS10, DOI 10.1186/1471-2393-7-S1-S10; Zhou XL, 1999, J CLIN ENDOCR METAB, V84, P3364, DOI 10.1210/jc.84.9.3364	44	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132017	10.1371/journal.pone.0132017	http://dx.doi.org/10.1371/journal.pone.0132017			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161798	Green Submitted, Green Published, gold			2022-12-26	WOS:000358162300084
J	Doubravsky, K; Dohnal, M				Doubravsky, Karel; Dohnal, Mirko			Reconciliation of Decision-Making Heuristics Based on Decision Trees Topologies and Incomplete Fuzzy Probabilities Sets	PLOS ONE			English	Article							UNCERTAINTY; EXTREMALITY; INFORMATION; SYSTEM; MODEL	Complex decision making tasks of different natures, e.g. economics, safety engineering, ecology and biology, are based on vague, sparse, partially inconsistent and subjective knowledge. Moreover, decision making economists / engineers are usually not willing to invest too much time into study of complex formal theories. They require such decisions which can be (re) checked by human like common sense reasoning. One important problem related to realistic decision making tasks are incomplete data sets required by the chosen decision making algorithm. This paper presents a relatively simple algorithm how some missing III (input information items) can be generated using mainly decision tree topologies and integrated into incomplete data sets. The algorithm is based on an easy to understand heuristics, e.g. a longer decision tree sub-path is less probable. This heuristic can solve decision problems under total ignorance, i.e. the decision tree topology is the only information available. But in a practice, isolated information items e.g. some vaguely known probabilities (e.g. fuzzy probabilities) are usually available. It means that a realistic problem is analysed under partial ignorance. The proposed algorithm reconciles topology related heuristics and additional fuzzy sets using fuzzy linear programming. The case study, represented by a tree with six lotteries and one fuzzy probability, is presented in details.	[Doubravsky, Karel] Brno Univ Technol, Fac Business & Management, Dept Informat, CS-61090 Brno, Czech Republic; [Dohnal, Mirko] Brno Univ Technol, Fac Business & Management, Dept Econ, CS-61090 Brno, Czech Republic	Brno University of Technology; Brno University of Technology	Doubravsky, K (corresponding author), Brno Univ Technol, Fac Business & Management, Dept Informat, CS-61090 Brno, Czech Republic.	doubravsky@fbm.vutbr.cz	Doubravský, Karel/GLR-2336-2022; Dohnal, Mirko/E-5778-2016	Doubravský, Karel/0000-0002-6882-1046; Dohnal, Mirko/0000-0001-9307-9528	"Economic Determinants of Competitiveness of Enterprises in Central and Eastern Europe" from Internal Grant Agency at Brno University of Technology [FP-S-15-2825]; "Effective Use of ICT and Quantitative Methods for Business Processes Optimization" from Internal Grant Agency at Brno University of Technology [FP-S-15-2787]; Internal Grant Agency at Brno University of Technology [FP-S-13-2148, FP-S-13-2052]	"Economic Determinants of Competitiveness of Enterprises in Central and Eastern Europe" from Internal Grant Agency at Brno University of Technology; "Effective Use of ICT and Quantitative Methods for Business Processes Optimization" from Internal Grant Agency at Brno University of Technology; Internal Grant Agency at Brno University of Technology	This paper was supported by grants FP-S-15-2825 "Economic Determinants of Competitiveness of Enterprises in Central and Eastern Europe" and FP-S-15-2787 "Effective Use of ICT and Quantitative Methods for Business Processes Optimization" from the Internal Grant Agency at Brno University of Technology." Support was also received from the Internal Grant Agency at Brno University of Technology Grant number: FP-S-13-2148 'The Application of ICT and Mathematical Methods in Business Management' Grant Recipient: Institute of Informatics, Faculty of Business and Management Resposnibility: Doc. RNDr. Bedrich Puze, CSc. Additional support was provided by the Internal Grant Agency at Brno University of Technology Grant number: FP-S-13-2052 'Microeconomic and macroeconomic principles and their impact on corporate behaviour Grant Recipient: Institute of Economics, Faculty of Business and Management Resposnibility: prof. Ing. Oldrich Rejnus, CSc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhaj-Dibo M, 2008, CONTROL ENG PRACT, V16, P159, DOI 10.1016/j.conengprac.2007.01.003; Basgalupp MP, 2014, INFORM SCIENCES, V258, P160, DOI 10.1016/j.ins.2013.07.025; Bertsekas Dimitri P., 2008, INTRO PROBABILITY; Bradshaw M, 2004, SSRN WORKING PAPER S, DOI [10.2139/ssrn.256438, DOI 10.2139/SSRN.256438]; Brooke A, 1988, GAMS USERS GUIDE, V821, P505; Cao SJ, 2014, INFORM SCIENCES, V278, P22, DOI 10.1016/j.ins.2014.03.133; Daniel K, 2002, J MONETARY ECON, V49, P139, DOI 10.1016/S0304-3932(01)00091-5; Dehmer M, 2013, MATCH-COMMUN MATH CO, V69, P785; Dehmer M, 2012, MATCH-COMMUN MATH CO, V68, P889; DOHNAL M, 1992, J LOSS PREVENT PROC, V5, P125, DOI 10.1016/0950-4230(92)80009-W; Dondi R, 2014, J DISCRET ALGORITHMS, V25, P51, DOI 10.1016/j.jda.2013.06.001; Dubois D, 2013, P 8 C EUR SOC FUZZ L; Dubois D, 2014, INT J APPROX REASON, V55, P1570, DOI 10.1016/j.ijar.2014.04.002; Eaton JW, 2009, GNU OCTAVE VERS 3 0; Fargier H., 2012, ARXIV12023718; FEDRIZZI M, 1991, LECT NOTES ECON MATH, V368, P15; Fitch Ernest C., 2004, HYDRAULIC COMPONENT; Guu SM, 1999, FUZZY SET SYST, V107, P191, DOI 10.1016/S0165-0114(97)00304-7; Hodouin D, 2011, J PROCESS CONTR, V21, P211, DOI 10.1016/j.jprocont.2010.10.016; HUANG GH, 1993, INT J SYST SCI, V24, P159, DOI 10.1080/00207729308949477; Janssens D, 2006, EUR J OPER RES, V175, P16, DOI 10.1016/j.ejor.2005.03.022; Jegadeesh N, 2004, J FINANC, V59, P1083, DOI 10.1111/j.1540-6261.2004.00657.x; Jung JJ, 2012, EXPERT SYST APPL, V39, P9002, DOI 10.1016/j.eswa.2012.02.035; Kashkoush M, 2013, PROC CIRP, V7, P169, DOI 10.1016/j.procir.2013.05.029; Kikuchi S, 2000, FUZZY SET SYST, V116, P3, DOI 10.1016/S0165-0114(99)00033-0; Kim M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113131; Kraus V, 2013, MATCH-COMMUN MATH CO, V70, P885; Kuzilek J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098450; KYBURG HE, 1987, ARTIF INTELL, V31, P271, DOI 10.1016/0004-3702(87)90068-3; Lai Y.-J., 1992, FUZZY MATH PROGRAMMI; Lee YC, 2011, EXPERT SYST APPL, V38, P14407, DOI 10.1016/j.eswa.2011.04.088; Maroney C.O, 2008, BR ACCOUNT REV, V40, P103, DOI [10.1016/j.bar.2008.01.001, DOI 10.1016/J.BAR.2008.01.001]; Monekosso DN, 2013, EXPERT SYST APPL, V40, P3248, DOI 10.1016/j.eswa.2012.12.037; Mousavi S, 2014, J BUS RES, V67, P1671, DOI 10.1016/j.jbusres.2014.02.013; Narasimhan S, 1999, DATA RECONCILIATION; Nie GL, 2009, EXPERT SYST APPL, V36, P4589, DOI 10.1016/j.eswa.2008.05.014; PARSONS S, 1995, ENVIRON SOFTW, V10, P75, DOI 10.1016/0266-9838(95)00008-9; Pedrycz W, 2014, KNOWL-BASED SYST, V58, P3, DOI 10.1016/j.knosys.2013.07.022; Qin GM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111769; Rokach L, 2013, WORLD SCI, V328; Rose L. M., 1976, ENG INVESTMENT DECIS; Rutkowski L, 2014, INFORM SCIENCES, V266, P1, DOI 10.1016/j.ins.2013.12.060; Sais F, 2014, KNOWL-BASED SYST, V67, P117, DOI 10.1016/j.knosys.2014.05.023; Schallehn E, 2004, DATA KNOWL ENG, V48, P361, DOI 10.1016/j.datak.2003.08.004; Stiglic G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033812; Sundar S, 2013, APPL SOFT COMPUT, V13, P4695, DOI 10.1016/j.asoc.2013.07.014; Tan RR, 2007, J CLEAN PROD, V15, P944, DOI 10.1016/j.jclepro.2005.09.001; TANAKA H, 1984, FUZZY SET SYST, V13, P1, DOI 10.1016/0165-0114(84)90022-8; Thipwiwatpotjana P, 2014, FUZZY OPTIM DECIS MA, V13, P151, DOI 10.1007/s10700-013-9171-z; Ubando AT, 2014, CLEAN TECHNOL ENVIR, V16, P1537, DOI 10.1007/s10098-014-0721-z; Vandaele N, 2012, P 6 INT C MAN INN TE, DOI [10.1109/ICMIT.2012.6225779, DOI 10.1109/ICMIT.2012.6225779]; Vasebi A, 2012, ANNU REV CONTROL, V36, P235, DOI 10.1016/j.arcontrol.2012.09.005; Vats S, 2014, APPL SOFT COMPUT, V21, P444, DOI 10.1016/j.asoc.2014.04.006; Wang P, 2004, ARTIF INTELL, V158, P97, DOI 10.1016/j.artint.2003.09.003; WATSON SR, 1994, RELIAB ENG SYST SAFE, V45, P261, DOI 10.1016/0951-8320(94)90142-2; Xia CY, 2009, INT J MOD PHYS B, V23, P2203, DOI 10.1142/S021797920905211X; Xia CY, 2012, NONLINEAR DYNAM, V69, P927, DOI 10.1007/s11071-011-0313-y; Yuan WJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091012; Zeinalkhani M, 2014, INFORM SCIENCES, V278, P715, DOI 10.1016/j.ins.2014.03.087; Zhang ZJ, 2010, COMPUT CHEM ENG, V34, P154, DOI 10.1016/j.compchemeng.2009.09.007	60	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2015	10	7							e0131590	10.1371/journal.pone.0131590	http://dx.doi.org/10.1371/journal.pone.0131590			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1EW	26158662	Green Published, gold			2022-12-26	WOS:000358161200032
J	Muthalib, M; Re, R; Zucchelli, L; Perrey, S; Contini, D; Caffini, M; Spinelli, L; Kerr, G; Quaresima, V; Ferrari, M; Torricelli, A				Muthalib, Makii; Re, Rebecca; Zucchelli, Lucia; Perrey, Stephane; Contini, Davide; Caffini, Matteo; Spinelli, Lorenzo; Kerr, Graham; Quaresima, Valentina; Ferrari, Marco; Torricelli, Alessandro			Effects of Increasing Neuromuscular Electrical Stimulation Current Intensity on Cortical Sensorimotor Network Activation: A Time Domain fNIRS Study	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; PRIMARY SOMATOSENSORY CORTEX; DIFFUSE OPTICAL TOMOGRAPHY; PRIMARY MOTOR CORTEX; FUNCTIONAL MRI; WRIST EXTENSOR; BLOOD-FLOW; PAIN; BRAIN; RESPONSES	Neuroimaging studies have shown neuromuscular electrical stimulation (NMES)-evoked movements activate regions of the cortical sensorimotor network, including the primary sensorimotor cortex (SMC), premotor cortex (PMC), supplementary motor area (SMA), and secondary somatosensory area (S2), as well as regions of the prefrontal cortex (PFC) known to be involved in pain processing. The aim of this study, on nine healthy subjects, was to compare the cortical network activation profile and pain ratings during NMES of the right forearm wrist extensor muscles at increasing current intensities up to and slightly over the individual maximal tolerated intensity (MTI), and with reference to voluntary (VOL) wrist extension movements. By exploiting the capability of the multi-channel time domain functional near-infrared spectroscopy technique to relate depth information to the photon time-of-flight, the cortical and superficial oxygenated (O(2)Hb) and deoxygenated (HHb) hemoglobin concentrations were estimated. The O(2)Hb and HHb maps obtained using the General Linear Model (NIRS-SPM) analysis method, showed that the VOL and NMES-evoked movements significantly increased activation (i.e., increase in O(2)Hb and corresponding decrease in HHb) in the cortical layer of the contralateral sensorimotor network (SMC, PMC/SMA, and S2). However, the level and area of contralateral sensorimotor network (including PFC) activation was significantly greater for NMES than VOL. Furthermore, there was greater bilateral sensorimotor network activation with the high NMES current intensities which corresponded with increased pain ratings. In conclusion, our findings suggest that greater bilateral sensorimotor network activation profile with high NMES current intensities could be in part attributable to increased attentional/pain processing and to increased bilateral sensorimotor integration in these cortical regions.	[Muthalib, Makii; Perrey, Stephane] Univ Montpellier, Movement Hlth M2H, EuroMov, F-34059 Montpellier, France; [Muthalib, Makii; Kerr, Graham] Queensland Univ Technol, IHBI, Movement Neurosci, Brisbane, Qld 4001, Australia; [Re, Rebecca; Zucchelli, Lucia; Contini, Davide; Torricelli, Alessandro] Politecn Milan, Politecn Milan, I-20133 Milan, Italy; [Caffini, Matteo] Politecn Milan, Dipartimento Elettr Informaz & Bioingn, I-20133 Milan, Italy; [Spinelli, Lorenzo] Politecn Milan, CNR, Ist Foton & Nanotecnol, I-20133 Milan, Italy; [Quaresima, Valentina; Ferrari, Marco] Univ Aquila, Dipartimento Med Clin Sanita Pubbl Sci & Ambiente, I-67100 Laquila, Italy	Universite de Montpellier; Queensland University of Technology (QUT); Polytechnic University of Milan; Polytechnic University of Milan; Consiglio Nazionale delle Ricerche (CNR); Polytechnic University of Milan; University of L'Aquila	Muthalib, M (corresponding author), Univ Montpellier, Movement Hlth M2H, EuroMov, F-34059 Montpellier, France.	makii.muthalib@univ-montp1.fr	Ferrari, Marco/AAF-3486-2019; perrey, stephane/B-7483-2008; Quaresima, Valentina/AAQ-7387-2021; Caffini, Matteo/AAJ-8127-2020; Spinelli, Lorenzo/ABC-9163-2020; SPINELLI, LORENZO CLEMENTE/AAW-6564-2020	perrey, stephane/0000-0002-8741-629X; SPINELLI, LORENZO CLEMENTE/0000-0002-4414-4351; FERRARI, Marco/0000-0002-3041-2917; Torricelli, Alessandro/0000-0002-6878-8936; Muthalib, Makii/0000-0003-0073-9211; Kerr, Graham/0000-0002-1008-256X; Caffini, Matteo/0000-0003-0716-983X; quaresima, valentina/0000-0001-9884-0304; Re, Rebecca/0000-0002-9521-8066	LASERLAB-EUROPE (EC's Seventh Framework Programme) [284464]	LASERLAB-EUROPE (EC's Seventh Framework Programme)	The research leading to these results has received funding from LASERLAB-EUROPE (grant agreement no. 284464, EC's Seventh Framework Programme: http://www.laserlab-europe.eu/transnational-access/information-for-users).	Aletti F, 2012, COMPUT BIOL MED, V42, P282, DOI 10.1016/j.compbiomed.2011.06.001; Anwar AR, 2012, IEEE ENG MED BIO, P2287, DOI 10.1109/EMBC.2012.6346419; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Azar AA, 2009, IEEE ENG MED BIO, P1375, DOI 10.1109/IEMBS.2009.5334283; Bax L, 2005, SPORTS MED, V35, P191, DOI 10.2165/00007256-200535030-00002; Becerra L, 2008, NEUROIMAGE, V41, P252, DOI 10.1016/j.neuroimage.2008.01.047; Becerra L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008016; Becker W, 2005, ADV TIME CORRELATED; Blickenstorfer A, 2009, HUM BRAIN MAPP, V30, P963, DOI 10.1002/hbm.20559; Butti M, 2009, MED PHYS, V36, P4103, DOI 10.1118/1.3190557; Chiou SY, 2013, CLIN NEUROPHYSIOL, V124, P1353, DOI 10.1016/j.clinph.2013.02.001; Chipchase LS, 2011, CLIN NEUROPHYSIOL, V122, P456, DOI 10.1016/j.clinph.2010.07.025; Chipchase LS, 2011, ARCH PHYS MED REHAB, V92, P1423, DOI 10.1016/j.apmr.2011.01.011; Chul J, 2009, NEUROIMAGE, V44, P428, DOI 10.1016/j.neuroimage.2008.08.036; Contini D., 2009, P SOC PHOTO-OPT INS, V7369; Contini D, 2007, PROC SPIE, V6629, DOI 10.1117/12.728104; Contini D, 2006, OPT EXPRESS, V14, P5418, DOI 10.1364/OE.14.005418; Del Bianco S, 2002, PHYS MED BIOL, V47, P4131, DOI 10.1088/0031-9155/47/23/301; Derosiere G, 2014, NEUROIMAGE, V85, P471, DOI 10.1016/j.neuroimage.2013.02.006; Devor A, 2012, J CEREBR BLOOD F MET, V32, P1259, DOI 10.1038/jcbfm.2011.195; Ehrsson HH, 2000, J NEUROPHYSIOL, V83, P528, DOI 10.1152/jn.2000.83.1.528; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Ellis H, 2012, SURGERY, V30, P99; Fazli S, 2012, NEUROIMAGE, V59, P519, DOI 10.1016/j.neuroimage.2011.07.084; FERBERT A, 1992, J PHYSIOL-LONDON, V453, P525, DOI 10.1113/jphysiol.1992.sp019243; Ferrari M, 2012, NEUROIMAGE, V63, P921, DOI 10.1016/j.neuroimage.2012.03.049; Francis S, 2009, NEUROIMAGE, V44, P469, DOI 10.1016/j.neuroimage.2008.09.017; Friston KJ, 2006, STAT PARAMETRIC MAPP; Frot M, 2013, HUM BRAIN MAPP, V34, P2655, DOI 10.1002/hbm.22097; Girouard H, 2006, J APPL PHYSIOL, V100, P328, DOI 10.1152/japplphysiol.00966.2005; Gondin J, 2011, J APPL PHYSIOL, V110, P433, DOI 10.1152/japplphysiol.00914.2010; Haeussinger FB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026377; Hallacoglu B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064095; Han BS, 2003, AM J PHYS MED REHAB, V82, P17, DOI 10.1097/01.PHM.0000043516.69441.15; Hinkley LB, 2007, J NEUROPHYSIOL, V97, P1288, DOI 10.1152/jn.00733.2006; Hortobagyi T, 2011, EUR J APPL PHYSIOL, V111, P2439, DOI 10.1007/s00421-011-2012-2; Hoshi Y, 2011, PHILOS T R SOC A, V369, P4425, DOI 10.1098/rsta.2011.0262; Iftime-Nielsen SD, 2012, HUM BRAIN MAPP, V33, P40, DOI 10.1002/hbm.21191; Iwamura Y, 2000, PHILOS T R SOC B, V355, P267, DOI 10.1098/rstb.2000.0563; Jang KE, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3127204; Joa KL, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-48; Kirilina E, 2012, NEUROIMAGE, V61, P70, DOI 10.1016/j.neuroimage.2012.02.074; Leff DR, 2011, NEUROIMAGE, V54, P2922, DOI 10.1016/j.neuroimage.2010.10.058; Liebert A, 2004, APPL OPTICS, V43, P3037, DOI 10.1364/AO.43.003037; Lorenz J, 2003, BRAIN, V126, P1079, DOI 10.1093/brain/awg102; Lorenz J, 2005, EUR J PAIN, V9, P163, DOI 10.1016/j.ejpain.2004.07.009; Molteni E, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.5.056005; Moreira-Gonzalez A, 2006, PLAST RECONSTR SURG, V117, P1964, DOI 10.1097/01.prs.0000209933.78532.a7; Muthalib M, 2013, CLIN NEUROPHYSIOL, V124, P2060, DOI 10.1016/j.clinph.2013.03.018; Muthalib M, 2012, ADV EXP MED BIOL, V737, P45, DOI 10.1007/978-1-4614-1566-4_7; Muthalib M, 2009, EUR J APPL PHYSIOL, V107, P235, DOI 10.1007/s00421-009-1118-2; Niddam DM, 2002, NEUROIMAGE, V17, P1437, DOI 10.1006/nimg.2002.1270; Nomura Y, 1997, PHYS MED BIOL, V42, P1009, DOI 10.1088/0031-9155/42/6/002; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Paddon-Jones D, 2000, J Sci Med Sport, V3, P35, DOI 10.1016/S1440-2440(00)80046-8; Papaiordanidou M, 2010, MUSCLE NERVE, V41, P54, DOI 10.1002/mus.21427; Peake JM, 2006, EXERC IMMUNOL REV, V12, P72; Ridding MC, 1999, EXP BRAIN RES, V126, P536, DOI 10.1007/s002210050762; Rozzi S, 2006, CEREB CORTEX, V16, P1389, DOI 10.1093/cercor/bhj076; Sato C, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2136312; Schafer K, 2012, NEUROIMAGE, V59, P3119, DOI 10.1016/j.neuroimage.2011.11.085; Scholkmann F, 2014, NEUROIMAGE, V85, P6, DOI 10.1016/j.neuroimage.2013.05.004; Seifert F, 2013, HUM BRAIN MAPP, V34, P1768, DOI 10.1002/hbm.22035; Selb J, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1852553; Selb J, 2007, OPT EXPRESS, V15, P16400, DOI 10.1364/OE.15.016400; Sheffler LR, 2007, MUSCLE NERVE, V35, P562, DOI 10.1002/mus.20758; Singh AK, 2005, NEUROIMAGE, V27, P842, DOI 10.1016/j.neuroimage.2005.05.019; Smith GV, 2003, EXP BRAIN RES, V150, P33, DOI 10.1007/s00221-003-1405-9; Stefanovic B, 2004, NEUROIMAGE, V22, P771, DOI 10.1016/j.neuroimage.2004.01.036; Steinbrink J, 2001, PHYS MED BIOL, V46, P879, DOI 10.1088/0031-9155/46/3/320; Stippich C, 2007, NEUROIMAGE, V34, P1227, DOI 10.1016/j.neuroimage.2006.08.046; Storm H, 2008, CURR OPIN ANESTHESIO, V21, P796, DOI 10.1097/ACO.0b013e3283183fe4; Sutherland MT, 2006, NEUROIMAGE, V33, P1042, DOI 10.1016/j.neuroimage.2006.08.015; Takahashi T, 2011, NEUROIMAGE, V57, P991, DOI 10.1016/j.neuroimage.2011.05.012; Takeuchi M, 2009, BRAIN TOPOGR, V22, P197, DOI 10.1007/s10548-009-0109-2; Tanosaki M, 2003, NEUROSCI LETT, V352, P1, DOI 10.1016/j.neulet.2003.08.055; Torricelli A, 2014, NEUROIMAGE, V85, P28, DOI 10.1016/j.neuroimage.2013.05.106; Tracey I, 2007, NEURON, V55, P377, DOI 10.1016/j.neuron.2007.07.012; Vanderthommen M, 2007, EXERC SPORT SCI REV, V35, P180, DOI 10.1097/jes.0b013e318156e785; Wabnitz H, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.8.086012; Zhao Q, 2011, BIOMED OPT EXPRESS, V2, P705, DOI 10.1364/BOE.2.000705	82	27	27	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2015	10	7							e0131951	10.1371/journal.pone.0131951	http://dx.doi.org/10.1371/journal.pone.0131951			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EW	26158464	Green Published, gold, Green Submitted			2022-12-26	WOS:000358161200043
J	Rong, Y; Bazan, JG; Sekhon, A; Haglund, K; Xu-Welliver, M; Williams, T				Rong, Yi; Bazan, Jose G.; Sekhon, Ashley; Haglund, Karl; Xu-Welliver, Meng; Williams, Terence			Minimal Inter-Fractional Fiducial Migration during Image-Guided Lung Stereotactic Body Radiotherapy Using SuperLock Nitinol Coil Fiducial Markers	PLOS ONE			English	Article							TIME TUMOR-TRACKING; ABLATIVE RADIOTHERAPY; RADIATION-THERAPY; CANCER; MOVEMENT; PLACEMENT; LIVER; COMPLICATIONS; EMBOLIZATION; BRONCHOSCOPY	Objectives Stereotactic body radiotherapy (SBRT) is being increasingly used for the treatment of patients with lung cancer or lung metastasis who are medically unfit to undergo resection. In order to improve accuracy and confidence in targeting tumors, many centers rely on fiducial implantation. We evaluated the migration of a novel fiducial marker specifically designed for lung tissue implanted via electromagnetic navigation bronchoscopy (ENB). Methods We retrospectively quantified the individual and group migrations of SuperLock nitinol coil fiducials for 15 patients receiving lung stereotactic body radiotherapy (SBRT), in order to evaluate the reliability of using these fiducials as a target surrogate for cases where tumors cannot be clearly delineated on cone beam CTs (CBCTs). For each fraction, we compared the individual and group migrations of the fiducials between the planning CT and the acquired CBCT. The group migration was defined as the distance between the centroids of the fiducial group and GTV. Results A total of 16 lung targets were included in our study for these 15 patients (one patient with two targets). Of 55 fiducials placed, we observed a 100% retention rate. The mean individual migration was 1.87 mm (range, 0.63-5.25 mm) with a standard deviation of 1.26 mm. The mean group migration was 1.94 mm (range, 0.03-6.19 mm) with a standard deviation of 1.45 mm. Overall, there was minimal change in the relative locations of the markers with respect to each other, as well as to the target. Conclusions We found that the SuperLock nitinol coil fiducial marker positions are stable throughout the radiation treatment, and can be used as a reliable surrogate to target, and to avoid geometric misses during gated treatments.	[Rong, Yi] Univ Calif Davis, Dept Radiat Oncol, Ctr Comprehens Canc, Sacramento, CA 95817 USA; [Bazan, Jose G.; Sekhon, Ashley; Haglund, Karl; Xu-Welliver, Meng; Williams, Terence] Ohio State Univ, Dept Radiat Oncol, Wexner Med Ctr, Columbus, OH 43210 USA	University of California System; University of California Davis; University System of Ohio; Ohio State University	Rong, Y (corresponding author), Univ Calif Davis, Dept Radiat Oncol, Ctr Comprehens Canc, Sacramento, CA 95817 USA.	yrong@ucdavis.edu; terence.williams@osumc.edu	Williams, Terence M/I-9614-2014					Balter JM, 2001, INT J RADIAT ONCOL, V51, P267, DOI 10.1016/S0360-3016(01)01649-2; Bhagat N, 2010, CARDIOVASC INTER RAD, V33, P1186, DOI 10.1007/s00270-010-9949-0; BRYAN PJ, 1984, J ULTRAS MED, V3, P317; Crabtree T, 2013, J THORAC CARDIOV SUR, V145, P692, DOI 10.1016/j.jtcvs.2012.10.038; D'Souza WD, 2007, MED DOSIM, V32, P92, DOI 10.1016/j.meddos.2007.01.006; Farkas EA, 2012, ANN THORAC SURG, V93, P1715, DOI 10.1016/j.athoracsur.2011.08.057; Gildea TR, 2006, AM J RESP CRIT CARE, V174, P982, DOI 10.1164/rccm.200603-344OC; Giraud P, 2001, INT J RADIAT ONCOL, V51, P1081, DOI 10.1016/S0360-3016(01)01766-7; Glide-Hurst CK, 2014, J THORAC DIS, V6, P303, DOI 10.3978/j.issn.2072-1439.2013.11.10; Hennessey Hooman, 2009, J Med Case Rep, V3, P140, DOI 10.1186/1752-1947-3-140; Hong JC, 2013, J APPL CLIN MED PHYS, V14, P77, DOI 10.1120/jacmp.v14i2.4046; Hong JC, 2011, INT J RADIAT ONCOL, V81, P85, DOI 10.1016/j.ijrobp.2010.04.037; Imura M, 2005, INT J RADIAT ONCOL, V63, P1442, DOI 10.1016/j.ijrobp.2005.04.024; Iyengar P, 2013, SEMIN RESP CRIT CARE, V34, P845, DOI 10.1055/s-0033-1358554; Iyengar P, 2012, J NATL COMPR CANC NE, V10, P1514, DOI 10.6004/jnccn.2012.0157; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kelly P, 2010, INT J RADIAT ONCOL, V78, P1387, DOI 10.1016/j.ijrobp.2009.09.070; Kitamura K, 2003, INT J RADIAT ONCOL, V56, P221, DOI 10.1016/S0360-3016(03)00082-8; Kudchadker RJ, 2009, INT J RADIAT ONCOL, V74, P1283, DOI 10.1016/j.ijrobp.2009.02.033; Kupelian PA, 2007, INT J RADIAT ONCOL, V69, P777, DOI 10.1016/j.ijrobp.2007.03.040; Lagerwaard FJ, 2008, INT J RADIAT ONCOL, V70, P685, DOI 10.1016/j.ijrobp.2007.10.053; MUHM JR, 1983, RADIOLOGY, V148, P609, DOI 10.1148/radiology.148.3.6308709; Nabavizadeh N, 2014, J BRONCHOL INTERN PU, V21, P123, DOI 10.1097/LBR.0000000000000065; Nielsen MH, 2013, ACTA ONCOL, V52, P703, DOI 10.3109/0284186X.2013.765064; Nyman J, 2006, LUNG CANCER-J IASLC, V51, P97, DOI 10.1016/j.lungcan.2005.08.011; Ohta K, 2013, J RADIAT RES, V54, P957, DOI 10.1093/jrr/rrt020; Reyngold M, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-99; Ricardi U, 2010, LUNG CANCER, V68, P72, DOI 10.1016/j.lungcan.2009.05.007; Shimizu S, 2001, INT J RADIAT ONCOL, V51, P304, DOI 10.1016/S0360-3016(01)01641-8; Shirato H, 2003, INT J RADIAT ONCOL, V56, P240, DOI 10.1016/S0360-3016(03)00076-2; Shirato H, 1999, LANCET, V353, P1331, DOI 10.1016/S0140-6736(99)00700-X; Stevens CW, 2001, INT J RADIAT ONCOL, V51, P62, DOI 10.1016/S0360-3016(01)01621-2; Timmerman R, 2010, JAMA-J AM MED ASSOC, V303, P1070, DOI 10.1001/jama.2010.261; Trovo M, 2014, INT J RADIAT ONCOL, V88, P1114, DOI 10.1016/j.ijrobp.2014.01.012; Valentine K, 2014, TECHNOL CANCER RES T, V13, P253, DOI 10.7785/tcrt.2012.500378; van Zyp NCV, 2011, INT J RADIAT ONCOL, V81, pE75, DOI 10.1016/j.ijrobp.2010.12.026; Yousefi S, 2007, CLIN LUNG CANCER, V8, P252, DOI 10.3816/CLC.2007.n.002	37	9	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2015	10	7							e0131945	10.1371/journal.pone.0131945	http://dx.doi.org/10.1371/journal.pone.0131945			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EW	26158847	gold, Green Published, Green Submitted			2022-12-26	WOS:000358161200041
J	Woo, YM; Shin, Y; Lee, EJ; Lee, S; Jeong, SH; Kong, HK; Park, EY; Kim, HK; Han, J; Chang, M; Park, JH				Woo, Yu Mi; Shin, Yubin; Lee, Eun Ji; Lee, Sunyoung; Jeong, Seung Hun; Kong, Hyun Kyung; Park, Eun Young; Kim, Hyoung Kyu; Han, Jin; Chang, Minsun; Park, Jong-Hoon			Inhibition of Aerobic Glycolysis Represses Akt/mTOR/HIF-1 alpha Axis and Restores Tamoxifen Sensitivity in Antiestrogen-Resistant Breast Cancer Cells	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; HYPOXIA-INDUCIBLE FACTOR-1; ACTIVATED PROTEIN-KINASE; DRUG-RESISTANCE; GLUCOSE-METABOLISM; ENDOCRINE THERAPY; GROWTH; MTOR; EXPRESSION; PATHWAY	Tamoxifen resistance is often observed in the majority of estrogen receptor-positive breast cancers and it remains as a serious clinical problem in breast cancer management. Increased aerobic glycolysis has been proposed as one of the mechanisms for acquired resistance to chemotherapeutic agents in breast cancer cells such as adriamycin. Herein, we report that the glycolysis rates in LCC2 and LCC9-tamoxifen-resistant human breast cancer cell lines derived from MCF7-are higher than those in MCF7S, which is the parent MCF7 subline. Inhibition of key glycolytic enzyme such as hexokinase-2 resulted in cell growth retardation at higher degree in LCC2 and LCC9 than that in MCF7S. This implies that increased aerobic glycolysis even under O-2-rich conditions, a phenomenon known as the Warburg effect, is closely associated with tamoxifen resistance. We found that HIF-1 alpha is activated via an Akt/mTOR signaling pathway in LCC2 and LCC9 cells without hypoxic condition. Importantly, specific inhibition of hexokinase-2 suppressed the activity of Akt/mTOR/HIF-1 alpha axis in LCC2 and LCC9 cells. In addition, the phosphorylated AMPK which is a negative regulator of mTOR was decreased in LCC2 and LCC9 cells compared to MCF7S. Interestingly, either the inhibition of mTOR activity or increase in AMPK activity induced a reduction in lactate accumulation and cell survival in the LCC2 and LCC9 cells. Taken together, our data provide evidence that development of tamoxifen resistance may be driven by HIF-1 alpha hyperactivation via modulation of Akt/mTOR and/or AMPK signaling pathways. Therefore, we suggest that the HIF-1 alpha hyperactivation is a critical marker of increased aerobic glycolysis in accordance with tamoxifen resistance and thus restoration of aerobic glycolysis may be novel therapeutic target for treatment of tamoxifen-resistant breast cancer.	[Woo, Yu Mi; Shin, Yubin; Lee, Eun Ji; Lee, Sunyoung; Kong, Hyun Kyung; Park, Eun Young; Park, Jong-Hoon] Sookmyung Womens Univ, Dept Life Syst, Seoul, South Korea; [Jeong, Seung Hun; Kim, Hyoung Kyu; Han, Jin] Inje Univ, Natl Res Lab Mitochondrial Signaling Lab, Cardiovasc & Metab Dis Ctr, Dept Hlth Sci & Technol,Grad Sch,Coll Med,Dept Ph, Busan, South Korea; [Chang, Minsun] Sookmyung Womens Univ, Dept Med & Pharmaceut Sci, Seoul, South Korea	Sookmyung Women's University; Inje University; Sookmyung Women's University	Chang, M (corresponding author), Sookmyung Womens Univ, Dept Med & Pharmaceut Sci, 52 Hyochangwon Rd, Seoul, South Korea.	minsunchang@sookmyung.ac.kr; parkjh@sookmyung.ac.kr			 [2013R1A2A1A01011908]		2013R1A2A1A01011908, http://www.nrf.re.kr/nrf_tot_cms/index.jsp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blancher C, 2001, CANCER RES, V61, P7349; BRUNNER N, 1993, CANCER RES, V53, P3229; Brunner N, 1997, CANCER RES, V57, P3486; BRUNNER N, 1993, CANCER RES, V53, P283; Chan CH, 2012, CELL, V149, P1098, DOI 10.1016/j.cell.2012.02.065; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Cigler T, 2007, CANCER J, V13, P148, DOI 10.1097/PPO.0b013e318074d363; Clarke R, 2009, J STEROID BIOCHEM, V114, P8, DOI 10.1016/j.jsbmb.2008.12.023; DeGraffenried LA, 2004, CLIN CANCER RES, V10, P8059, DOI 10.1158/1078-0432.CCR-04-0035; Dodwell D, 2008, CANCER TREAT REV, V34, P137, DOI 10.1016/j.ctrv.2007.09.004; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; Evans A, 2008, CANCER CHEMOTH PHARM, V61, P377, DOI 10.1007/s00280-007-0480-1; Fan P, 2007, CANCER RES, V67, P1352, DOI 10.1158/0008-5472.CAN-06-1020; FAN TWM, 1986, BIOCHIM BIOPHYS ACTA, V882, P154, DOI 10.1016/0304-4165(86)90150-9; FURMAN E, 1992, J STEROID BIOCHEM, V43, P189, DOI 10.1016/0960-0760(92)90207-Y; Ghayad SE, 2008, CANCER SCI, V99, P1992, DOI 10.1111/j.1349-7006.2008.00955.x; Horman S, 2002, CURR BIOL, V12, P1419, DOI 10.1016/S0960-9822(02)01077-1; Inoki K, 2012, ANNU REV PHARMACOL, V52, P381, DOI 10.1146/annurev-pharmtox-010611-134537; Jones RG, 2009, GENE DEV, V23, P537, DOI 10.1101/gad.1756509; Kemp BE, 2003, BIOCHEM SOC T, V31, P162; Kim JW, 2006, CANCER RES, V66, P8927, DOI 10.1158/0008-5472.CAN-06-1501; Kondoh H, 2005, CANCER RES, V65, P177; Leung E, 2011, CANCER BIOL THER, V11, P938, DOI 10.4161/cbt.11.11.15527; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu CW, 2008, J BIOL CHEM, V283, P28106, DOI 10.1074/jbc.M803508200; Lu CW, 2011, AM J PATHOL, V179, P1405, DOI 10.1016/j.ajpath.2011.05.050; Lu HS, 2002, J BIOL CHEM, V277, P23111, DOI 10.1074/jbc.M202487200; LYON RC, 1988, CANCER RES, V48, P870; Maxwell PH, 2001, CURR OPIN GENET DEV, V11, P293, DOI 10.1016/S0959-437X(00)00193-3; Mayer Ingrid, 2013, Clin Adv Hematol Oncol, V11, P217; Milane L, 2011, J CONTROL RELEASE, V155, P237, DOI 10.1016/j.jconrel.2011.03.032; Motoshima H, 2006, J PHYSIOL-LONDON, V574, P63, DOI 10.1113/jphysiol.2006.108324; Nahta R, 2010, CLIN BREAST CANCER, V10, pS72, DOI 10.3816/CBC.2010.s.015; NEEMAN M, 1989, CANCER RES, V49, P589; Okoshi R, 2008, J BIOL CHEM, V283, P3979, DOI 10.1074/jbc.M705232200; Park SY, 2006, CANCER RES, V66, P5121, DOI 10.1158/0008-5472.CAN-05-1341; Pelicano H, 2006, ONCOGENE, V25, P4633, DOI 10.1038/sj.onc.1209597; Pelicano H, 2006, LEUKEMIA, V20, P610, DOI 10.1038/sj.leu.2404140; Ravi R, 2000, GENE DEV, V14, P34; Rivenzon-Segal D, 2003, INT J CANCER, V107, P177, DOI 10.1002/ijc.11387; Rohwer N, 2011, DRUG RESIST UPDATE, V14, P191, DOI 10.1016/j.drup.2011.03.001; Rubio MP, 2003, EMBO J, V22, P3514, DOI 10.1093/emboj/cdg363; Semenza GL, 2007, J MOL MED-JMM, V85, P1293, DOI 10.1007/s00109-007-0285-z; Semenza GL, 2001, TRENDS MOL MED, V7, P345, DOI 10.1016/S1471-4914(01)02090-1; Semenza GL, 2009, SEMIN CANCER BIOL, V19, P12, DOI 10.1016/j.semcancer.2008.11.009; Shaw RJ, 2006, CURR OPIN CELL BIOL, V18, P598, DOI 10.1016/j.ceb.2006.10.005; Sokolosky ML, 2011, ONCOTARGET, V2, P538, DOI 10.18632/oncotarget.302; Warburg OH, 1931, METABOLISM TUMOURS; Xu RH, 2005, CANCER RES, V65, P613; Zhao YH, 2011, CANCER RES, V71, P4585, DOI 10.1158/0008-5472.CAN-11-0127; Zhou M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-33	51	81	85	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2015	10	7							e0132285	10.1371/journal.pone.0132285	http://dx.doi.org/10.1371/journal.pone.0132285			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EW	26158266	Green Published, Green Submitted, gold			2022-12-26	WOS:000358161200049
J	Moisa, SJ; Shike, DW; Shoup, L; Rodriguez-Zas, SL; Loor, JJ				Moisa, Sonia J.; Shike, Daniel W.; Shoup, Lindsay; Rodriguez-Zas, Sandra L.; Loor, Juan J.			Maternal Plane of Nutrition during Late Gestation and Weaning Age Alter Angus x Simmental Offspring Longissimus Muscle Transcriptome and Intramuscular Fat	PLOS ONE			English	Article							NF-KAPPA-B; ADIPOSE-TISSUE; GLUCOCORTICOID-RECEPTOR; GLUCOSE-HOMEOSTASIS; GENE NETWORKS; CELL-CYCLE; EXPRESSION; COMPLEX; PROTEIN; GROWTH	In model organisms both the nutrition of the mother and the young offspring could induce long-lasting transcriptional changes in tissues. In livestock, such changes could have important roles in determining nutrient use and meat quality. The main objective was to evaluate if plane of maternal nutrition during late-gestation and weaning age alter the offspring's Longissimus muscle (LM) transcriptome, animal performance, and metabolic hormones. Whole-transcriptome microarray analysis was performed on LM samples of early (EW) and normal weaned (NW) Angus x Simmental calves born to grazing cows receiving no supplement [low plane of nutrition (LPN)] or 2.3 kg high-grain mix/day [medium plane of nutrition (MPN)] during the last 105 days of gestation. Biopsies of LM were harvested at 78 (EW), 187 (NW) and 354 (before slaughter) days of age. Despite greater feed intake in MPN offspring, blood insulin was greater in LPN offspring. Carcass intramuscular fat content was greater in EW offspring. Bioinformatics analysis of the transcriptome highlighted a modest overall response to maternal plane of nutrition, resulting in only 35 differentially expressed genes (DEG). However, weaning age and a high-grain diet (EW) strongly impacted the transcriptome (DEG = 167), especially causing a lipogenic program activation. In addition, between 78 and 187 days of age, EW steers had an activation of the innate immune system due presumably to macrophage infiltration of intramuscular fat. Between 187 and 354 days of age (the "finishing" phase), NW steers had an activation of the lipogenic transcriptome machinery, while EW steers had a clear inhibition through the epigenetic control of histone acetylases. Results underscored the need to conduct further studies to understand better the functional outcome of transcriptome changes induced in the offspring by pre- and post-natal nutrition. Additional knowledge on molecular and functional outcomes would help produce more efficient beef cattle.	[Moisa, Sonia J.; Loor, Juan J.] Univ Illinois, Dept Anim Sci, Mammalian NutriPhysioGen, Urbana, IL 61801 USA; [Shike, Daniel W.; Shoup, Lindsay; Rodriguez-Zas, Sandra L.; Loor, Juan J.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [Rodriguez-Zas, Sandra L.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Loor, Juan J.] Univ Illinois, Div Nutr Sci, IIT, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Illinois Institute of Technology; University of Illinois System; University of Illinois Urbana-Champaign	Loor, JJ (corresponding author), Univ Illinois, Dept Anim Sci, Mammalian NutriPhysioGen, 328 Mumford Hall, Urbana, IL 61801 USA.	jloor@illinois.edu	Loor, Juan J./H-3760-2012	Loor, Juan J./0000-0003-1586-4365; MOISA, SONIA/0000-0003-1776-8721; Rodriguez-Zas, Sandra/0000-0003-1122-4758	Division of Nutritional Sciences Vision 20/20" (University of Illinois, Urbana-Champaign) interdisciplinary nutrition-related research program; National Institute of Food and Agriculture, USA [ILLU-971-352]	Division of Nutritional Sciences Vision 20/20" (University of Illinois, Urbana-Champaign) interdisciplinary nutrition-related research program; National Institute of Food and Agriculture, USA	This study was funded by the Division of Nutritional Sciences Vision 20/20" (University of Illinois, Urbana-Champaign) interdisciplinary nutrition-related research program, and project # ILLU-971-352 (National Institute of Food and Agriculture, USA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aflaki E, 2011, CELL MOL LIFE SCI, V68, P3933, DOI 10.1007/s00018-011-0688-4; Asterholm IW, 2014, CELL METAB, V20, P103, DOI 10.1016/j.cmet.2014.05.005; Attwooll C, 2005, J BIOL CHEM, V280, P1199, DOI 10.1074/jbc.M412509200; Benes H, 2013, CARDIOVASC TOXICOL, V13, P347, DOI 10.1007/s12012-013-9215-1; Bionaz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032455; Chen YQ, 2008, J BIOL CHEM, V283, P10048, DOI 10.1074/jbc.M708151200; Du M, 2010, J ANIM SCI, V88, pE51, DOI 10.2527/jas.2009-2311; Duffield JA, 2009, PEDIATR RES, V66, P59, DOI 10.1203/PDR.0b013e3181a7c121; Dzitoyeva S, 2013, J LIPIDS, V2013, DOI 10.1155/2013/297932; Eberharter A, 2002, EMBO REP, V3, P224, DOI 10.1093/embo-reports/kvf053; Faou P, 2012, BBA-MOL CELL RES, V1823, P348, DOI 10.1016/j.bbamcr.2011.12.001; Feng M, 2014, BIOL CELL, V106, P294, DOI 10.1111/boc.201400004; Flores-Alcantar A, 2011, CELL TISSUE RES, V345, P137, DOI 10.1007/s00441-011-1182-x; Fujihara M, 2003, PHARMACOL THERAPEUT, V100, P171, DOI 10.1016/j.pharmthera.2003.08.003; Gaide O, 2002, NAT IMMUNOL, V3, P836, DOI 10.1038/ni830; Gnanalingham MG, 2005, AM J PHYSIOL-REG I, V289, pR1407, DOI 10.1152/ajpregu.00375.2005; Grant RW, 2015, OBESITY SILVER SPRIN; Graugnard DE, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-142; Greenwood PL, 2007, ANIMAL, V1, P1283, DOI 10.1017/S175173110700050X; Huang GH, 2009, CYTOKINE, V48, P161, DOI 10.1016/j.cyto.2009.08.002; Johannes L, 2008, CELL, V135, P1175, DOI 10.1016/j.cell.2008.12.009; Jones GE, 2000, J LEUKOCYTE BIOL, V68, P593; Kelner MJ, 2000, J BIOL CHEM, V275, P13000, DOI 10.1074/jbc.275.17.13000; Khafipour E, 2009, J DAIRY SCI, V92, P1060, DOI 10.3168/jds.2008-1389; Kimura A, 1998, GENES CELLS, V3, P789, DOI 10.1046/j.1365-2443.1998.00229.x; Lee YF, 1998, J BIOL CHEM, V273, P13437, DOI 10.1074/jbc.273.22.13437; Lewis MJ, 1996, CELL, V85, P205, DOI 10.1016/S0092-8674(00)81097-1; Liu Y, 2013, DIABETES, V62, P743, DOI 10.2337/db12-0687; Loor JJ, 2007, PHYSIOL GENOMICS, V32, P105, DOI 10.1152/physiolgenomics.00188.2007; Medina-Gomez G, 2009, J ENDOCRINOL, V56, P404, DOI [10.1016/S1575-0922(09)72710-X, DOI 10.1016/S1575-0922(09)72710-X]; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; Moisa SJ, 2013, BIOINFORM BIOL INSIG, V7, P253, DOI 10.4137/BBI.S12328; Morishima Y, 2000, J BIOL CHEM, V275, P6894, DOI 10.1074/jbc.275.10.6894; Nagl NG, 2007, EMBO J, V26, P752, DOI 10.1038/sj.emboj.7601541; Naslavsky N, 2005, J CELL SCI, V118, P4093, DOI 10.1242/jcs.02595; Neels JG, 2009, J BIOL CHEM, V284, P20692, DOI 10.1074/jbc.M109.018556; Ortega FJ, 2013, HORM METAB RES, V45, P1009, DOI 10.1055/s-0033-1358690; Otten MA, 2004, IMMUNOL LETT, V92, P23, DOI 10.1016/j.imlet.2003.11.018; Palacios F, 2002, NAT CELL BIOL, V4, P929, DOI 10.1038/ncb881; Penagaricano F, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1034; Psarra AMG, 2011, BBA-MOL CELL RES, V1813, P1814, DOI 10.1016/j.bbamcr.2011.05.014; Qatanani M, 2007, GENE DEV, V21, P1443, DOI 10.1101/gad.1550907; Raddatz JR, 2008, MEASUREMENT ADIPONEC; Ren Y, 2014, MOL CELL BIOCH; Robin MA, 2003, J BIOL CHEM, V278, P18960, DOI 10.1074/jbc.M301807200; Ronnov-Jessen L, 2002, AM J PATHOL, V161, P471, DOI 10.1016/S0002-9440(10)64203-4; Rozenfeld-Granot G, 2002, ONCOGENE, V21, P1469, DOI 10.1038/sj.onc.1205218; Saare M, 2012, EXP CELL RES, V318, P1767, DOI 10.1016/j.yexcr.2012.04.013; Shimba S, 2004, J BIOL CHEM, V279, P40946, DOI 10.1074/jbc.M400840200; Shoup L, 2014, EFFECTS PREPARTUM SU; SMITH SB, 1981, ARCH BIOCHEM BIOPHYS, V211, P192, DOI 10.1016/0003-9861(81)90444-6; Spang A, 2013, COLD SPRING HARB PER, V5; Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887; Taga H, 2011, J ANIM SCI, V89, P711, DOI 10.2527/jas.2010-3234; Thamer C, 2004, DIABETOLOGIA, V47, P1303, DOI 10.1007/s00125-004-1430-7; Urao N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013440; Wang L, 2001, J BIOL CHEM, V276, P21405, DOI 10.1074/jbc.M102488200; Wang LF, 2010, P NATL ACAD SCI USA, V107, P7317, DOI 10.1073/pnas.1000031107; Welte MA, 2009, BIOCHEM SOC T, V37, P991, DOI 10.1042/BST0370991; Yan Xu, 2013, J Genomics, V1, P29, DOI 10.7150/jgen.3930; Yoon HY, 2008, TRAFFIC, V9, P2236, DOI 10.1111/j.1600-0854.2008.00839.x	62	18	20	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0131478	10.1371/journal.pone.0131478	http://dx.doi.org/10.1371/journal.pone.0131478			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26153887	Green Submitted, Green Published, gold			2022-12-26	WOS:000358159700067
J	Ujjain, SK; Bhatia, R; Ahuja, P; Attri, P				Ujjain, Sanjeev K.; Bhatia, Rohit; Ahuja, Preety; Attri, Pankaj			Highly Conductive Aromatic Functionalized Multi-Walled Carbon Nanotube for Inkjet Printable High Performance Supercapacitor Electrodes	PLOS ONE			English	Article							ALL-SOLID-STATE; ENERGY-STORAGE; IONIC LIQUID	We report the functionalization of multiwalled carbon nanotubes (MWCNT) via the 1,3-dipolar [3+2] cycloaddition of aromatic azides, which resulted in a detangled CNT as shown by transmission electron microscopy (TEM). Carboxylic moieties (-COOH) on aromatic azide result in highly stable aqueous dispersion (max. conc. similar to 10 mg/mL H2O), making the suitable for inkjet printing. Printed patterns on polyethylene terephthalate (PET) flexible substrate exhibit low sheet resistivity similar to 65 Omega.cm, which is attributed to enhanced conductivity. Fabricated Supercapacitors (SC) assembled using these printed substrates exhibit good electrochemical performance in organic as well as aqueous electrolytes. High energy and power density (57.8 Wh/kg and 0.85 kW/kg) in 1M H2SO4 aqueous electrolyte demonstrate the excellent performance of the proposed supercapacitor. Capacitive retention varies from similar to 85-94% with columbic efficiency similar to 95% after 1000 charge/discharge cycles in different electrolytes, demonstrating the excellent potential of the device for futuristic power applications.	[Ujjain, Sanjeev K.] Indian Inst Technol, Dept Phys, Kanpur 208016, Uttar Pradesh, India; [Bhatia, Rohit] Inst Home Econ, Dept Chem, Delhi, India; [Bhatia, Rohit] Peoples Act Livelihood & Sustainabil Pals, Delhi, India; [Ahuja, Preety] Univ Delhi, Dept Chem, Delhi 110007, India; [Attri, Pankaj] Kwangwoon Univ, Plasma Biosci Res Ctr, Dept Elect & Biol Phys, Seoul, South Korea	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kanpur; University of Delhi; Kwangwoon University	Ujjain, SK (corresponding author), Indian Inst Technol, Dept Phys, Kanpur 208016, Uttar Pradesh, India.	drsanjeevkujjain@gmail.com; chem.pankaj@gmail.com	Attri, Pankaj/ABE-7522-2020; Kumar, Sanjeev/AAP-7938-2021	Attri, Pankaj/0000-0002-5036-7877; 	DST INSPIRE fellowship program; UGC; SRC program of National Research Foundation of Korea (NRF) Grant - the Korean Government (MEST) [20100029418]; Kwangwoon University	DST INSPIRE fellowship program; UGC(University Grants Commission, India); SRC program of National Research Foundation of Korea (NRF) Grant - the Korean Government (MEST); Kwangwoon University	SK Ujjain gratefully thanks DST INSPIRE fellowship program. PA acknowledges the Ph.D fellowship received from UGC. The authors gratefully acknowledge SRC program of National Research Foundation of Korea (NRF) Grant funded by the Korean Government (MEST) (No. 20100029418) and in part by Kwangwoon University 2015. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja P, 2014, ELECTROCHIM ACTA, V146, P429, DOI 10.1016/j.electacta.2014.09.039; Ahuja P, 2014, RSC ADV, V4, P57192, DOI 10.1039/c4ra09027f; An KH, 2001, ADV MATER, V13, P497, DOI 10.1002/1521-4095(200104)13:7<497::AID-ADMA497>3.0.CO;2-H; Arico AS, 2005, NAT MATER, V4, P366, DOI 10.1038/nmat1368; Attri P, 2014, B KOREAN CHEM SOC, V35, P3035, DOI 10.5012/bkcs.2014.35.10.3035; Attri P, 2014, MATER RES BULL, V58, P6, DOI 10.1016/j.materresbull.2014.03.025; Baik KY, 2014, CARBON, V77, P302, DOI 10.1016/j.carbon.2014.05.033; Bao LH, 2011, NANO LETT, V11, P1215, DOI 10.1021/nl104205s; Che GL, 1998, NATURE, V393, P346, DOI 10.1038/30694; Chen PC, 2010, NANO RES, V3, P594, DOI 10.1007/s12274-010-0020-x; Futaba DN, 2006, NAT MATER, V5, P987, DOI 10.1038/nmat1782; Inamdar AI, 2011, J POWER SOURCES, V196, P2393, DOI 10.1016/j.jpowsour.2010.09.052; Kaempgen M, 2009, NANO LETT, V9, P1872, DOI 10.1021/nl8038579; Kordas K, 2006, SMALL, V2, P1021, DOI 10.1002/smll.200600061; Li L, 2006, J ELECTROCHEM SOC, V153, pA1823, DOI 10.1149/1.2234659; Li SD, 2004, NANO LETT, V4, P2003, DOI 10.1021/nl048687z; Lutz JF, 2007, ANGEW CHEM INT EDIT, V46, P1018, DOI 10.1002/anie.200604050; Ma JG, 2010, J POLYM SCI POL CHEM, V48, P5541, DOI 10.1002/pola.24365; Nuriel S, 2005, CHEM PHYS LETT, V404, P263, DOI 10.1016/j.cplett.2005.01.072; Paiva MC, 2010, ACS NANO, V4, P7379, DOI 10.1021/nn1022523; Pushparaj VL, 2007, P NATL ACAD SCI USA, V104, P13574, DOI 10.1073/pnas.0706508104; Qian Y, 2014, J MATER CHEM A, V2, P10917, DOI 10.1039/c4ta00988f; RUOFF RS, 1995, CARBON, V33, P925, DOI 10.1016/0008-6223(95)00021-5; Sharma M, 2011, SYNTHETIC MET, V161, P844, DOI 10.1016/j.synthmet.2011.02.011; Simon P, 2008, NAT MATER, V7, P845, DOI 10.1038/nmat2297; Tortorich RP, 2013, NANOMATERIALS-BASEL, V3, P453, DOI 10.3390/nano3030453; Troiani HE, 2003, NANO LETT, V3, P751, DOI 10.1021/nl0341640; Ujjain SK, 2015, J MATER CHEM A, V3, P9925, DOI 10.1039/c5ta00653h; Ujjain SK, 2015, ELECTROCHIM ACTA, V157, P245, DOI 10.1016/j.electacta.2015.01.061; Wei T, 2007, CARBON, V45, P2712, DOI 10.1016/j.carbon.2007.08.009; Xia H, 2009, NANOSCALE RES LETT, V4, P1035, DOI 10.1007/s11671-009-9352-4; Yang C, 2009, ANGEW CHEM INT EDIT, V48, P1592, DOI 10.1002/anie.200805228; Yang YK, 2010, APPL SURF SCI, V257, P1010, DOI 10.1016/j.apsusc.2010.08.009; Zhang LL, 2009, CHEM SOC REV, V38, P2520, DOI 10.1039/b813846j; Zhou Y, 2006, APPL PHYS LETT, V88	35	30	31	0	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0131475	10.1371/journal.pone.0131475	http://dx.doi.org/10.1371/journal.pone.0131475			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26153688	Green Published, gold, Green Submitted			2022-12-26	WOS:000358159700066
J	Fischer, S; Hirche, C; Reichenberger, MA; Kiefer, J; Diehm, Y; Mukundan, S; Alhefzi, M; Bueno, EM; Kneser, U; Pomahac, B				Fischer, Sebastian; Hirche, Christoph; Reichenberger, Matthias A.; Kiefer, Jurij; Diehm, Yannick; Mukundan, Srinivasan, Jr.; Alhefzi, Muayyad; Bueno, Ericka M.; Kneser, Ulrich; Pomahac, Bohdan			Silicone Implants with Smooth Surfaces Induce Thinner but Denser Fibrotic Capsules Compared to Those with Textured Surfaces in a Rodent Model	PLOS ONE			English	Article							SOFT-TISSUE RESPONSE; BREAST IMPLANT; CONTRACTED CAPSULES; MAMMARY IMPLANTS; AUGMENTATION; INFECTION; BIOFILM; OUTCOMES; THERAPY; POLYMER	Purpose Capsular contracture is the most frequent long-term complication after implant-based breast reconstruction or augmentation. The aim of this study was to evaluate the impact of implant surface properties on fibrotic capsule formation in an animal model. Materials and Methods Twenty-four rats received 1 scaled down silicone implant each; 12 of the rats received implants with textured surfaces, and the other 12 received implants with smooth surfaces. After 60 and 120 days, rats in each group underwent 7-Tesla Magnetic Resonance Imaging (MRI) and high-resolution ultrasound (HR-US), and specimens of the capsules were acquired and used to measure capsule thickness through histology, collagen density through picro sirius red staining, and analyses of expression of pro-fibrotic and inflammatory genes (Collagen1-4, TGFb1, TGFb3, Smad3, IL4, IL10, IL13, CD68) through qRT-PCR. Furthermore, MRI data were processed to obtain capsule volume and implant surface area. Results On day 60, histology and HR-US showed that fibrotic capsules were significantly thicker in the textured implant group with respect to the smooth implant group (p<0.05). However, this difference did not persist on day 120 (p=0.56). Capsule thickness decreased significantly over the study period in both smooth and textured implant groups (p<0.05). Thickness measurements were substantiated by MRI analysis and volumes changed accordingly. Implant surface area did not vary between study dates, but it was different between implant types. On day 60, the density of collagen in the fibrotic capsules was significantly lower in the textured implant group with respect to the smooth group (p<0.05), but again this difference did not persist on day 120 (p=0.67). Collagen 1 and CD68 were respectively over- and under expressed in the textured implant group on day 60. Significant differences in the expression of other genes were not observed. Conclusion Silicone implants with textured surfaces led to temporarily thicker but less dense fibrotic capsules compared with smooth surfaces. 7-Tesla MRI and HR-US are capable for non-invasive in-vivo assessment of capsular fibrosis in an animal model and can provide unique insights into the fibrotic process by 3D reconstruction and surface area measurement.	[Fischer, Sebastian; Alhefzi, Muayyad; Bueno, Ericka M.; Pomahac, Bohdan] Harvard Univ, Sch Med, Dept Surg, Div Plast Surg,Brigham & Womens Hosp, Boston, MA 02115 USA; [Fischer, Sebastian; Hirche, Christoph; Kiefer, Jurij; Diehm, Yannick; Kneser, Ulrich] Heidelberg Univ, BG Clin Ludwigshafen, Dept Hand Plast & Reconstruct Surg, Ludwigshafen, Germany; [Reichenberger, Matthias A.] Univ Heidelberg Hosp, Aesthet & Prevent Med, Clin Plast & Reconstruct Surg, Ethianum, Heidelberg, Germany; [Mukundan, Srinivasan, Jr.] Harvard Univ, Sch Med, Dept Radiol, Brigham & Womens Hosp, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Fischer, S (corresponding author), Harvard Univ, Sch Med, Dept Surg, Div Plast Surg,Brigham & Womens Hosp, Boston, MA 02115 USA.	sfischer@hotmail.de	Pomahac, Bohdan/AAH-1792-2019; Alhefzi, Muayyad/GRY-4287-2022	Pomahac, Bohdan/0000-0003-3703-8240; 				Adams WP, 2006, PLAST RECONSTR SURG, V118, p46S, DOI 10.1097/01.prs.0000185671.51993.7e; American Society of Plastic Surgeons, 2013, COMPL PLAST SURG STA; Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004; Araco A, 2009, PLAST RECONSTR SURG, V124, P1808, DOI 10.1097/PRS.0b013e3181bf7f26; Asplund O, 1996, PLAST RECONSTR SURG, V97, P1200, DOI 10.1097/00006534-199605000-00015; Beranek JT, 2005, ANN RHEUM DIS, V64, P342; Bergmann PA, 2014, J PLAST RECONSTR AES, V67, P1364, DOI 10.1016/j.bjps.2014.05.040; Brody GS, 2015, PLAST RECONSTR SURG, V135, P695, DOI 10.1097/PRS.0000000000001033; BUCKY LP, 1994, PLAST RECONSTR SURG, V93, P1123, DOI 10.1097/00006534-199405000-00002; Bui JM, 2015, AESTHET PLAST SURG, V39, P306, DOI 10.1007/s00266-014-0439-7; CAFFEE HH, 1983, ANN PLAS SURG, V11, P412, DOI 10.1097/00000637-198311000-00008; CLUGSTON PA, 1994, ANN PLAS SURG, V33, P595, DOI 10.1097/00000637-199412000-00005; Fagrell D, 2001, PLAST RECONSTR SURG, V108, P2108, DOI 10.1097/00006534-200112000-00046; Fischer S, 2015, ULTRASOUND MED BIOL, V41, P781, DOI 10.1016/j.ultrasmedbio.2014.10.018; Food and Drug Administration, 2014, AN LARG CELL LYMPH A; GAYOU RM, 1979, PLAST RECONSTR SURG, V63, P700, DOI 10.1097/00006534-197905000-00015; Hakelius L, 1997, PLAST RECONSTR SURG, V100, P1566, DOI 10.1097/00006534-199711000-00030; Handel N, 2006, PLAST RECONSTR SURG, V117, P757, DOI 10.1097/01.prs.0000201457.00772.1d; Jacombs A, 2014, PLAST RECONSTR SURG, V133, p471E, DOI 10.1097/PRS.0000000000000020; James SJ, 1997, BIOMATERIALS, V18, P667, DOI 10.1016/S0142-9612(96)00189-5; JUNQUEIRA LCU, 1978, ARCH HISTOL JAPON, V41, P267, DOI 10.1679/aohc1950.41.267; Khan UD, 2010, AESTHET PLAST SURG, V34, P42, DOI 10.1007/s00266-009-9427-8; Kirkpatrick CJ, 2000, AM J PATHOL, V156, P1455, DOI 10.1016/S0002-9440(10)65014-6; Liu X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116071; Merzin M, 2008, THESIS U TARTU ESTON; Britez MEM, 2012, EUR J PLAST SURG, V35, P647, DOI 10.1007/s00238-012-0728-9; Minami E, 2006, PLAST RECONSTR SURG, V118, P874, DOI 10.1097/01.prs.0000240878.24213.b7; OPPENHEIMER E, 1961, CANCER RES, V21, P132; Pajkos A, 2003, PLAST RECONSTR SURG, V111, P1605, DOI 10.1097/01.PRS.0000054768.14922.44; Pan SY, 2012, INT J CANCER, V131, pE1148, DOI 10.1002/ijc.27603; Prantl L, 2006, HANDCHIR MIKROCHIR P, V38, P224, DOI 10.1055/s-2006-924420; ROSATO RM, 1994, ANN PLAS SURG, V32, P342, DOI 10.1097/00000637-199404000-00002; Rubino C, 2001, ANN PLAS SURG, V46, P95, DOI 10.1097/00000637-200102000-00001; Sengupta P, 2013, INT J PREVENTIVE MED, V4, P624; Siggelkow W, 2003, BIOMATERIALS, V24, P1101, DOI 10.1016/S0142-9612(02)00429-5; SMAHEL J, 1993, PLAST RECONSTR SURG, V92, P474, DOI 10.1097/00006534-199309000-00015; Tamboto H, 2010, PLAST RECONSTR SURG, V126, P835, DOI 10.1097/PRS.0b013e3181e3b456; TAYLOR SR, 1983, J BIOMED MATER RES, V17, P205, DOI 10.1002/jbm.820170202; Valencia-Lazcano AA, 2013, J MECH BEHAV BIOMED, V21, P133, DOI 10.1016/j.jmbbm.2013.02.005; van Heerden J, 2009, J PLAST RECONSTR AES, V62, P610, DOI 10.1016/j.bjps.2007.09.044; Wick G, 2010, TRENDS IMMUNOL, V31, P110, DOI 10.1016/j.it.2009.12.001; Wilflingseder P, 1983, Minerva Chir, V38, P877; Wyatt LE, 1998, PLAST RECONSTR SURG, V102, P1922, DOI 10.1097/00006534-199811000-00017; Xu DR, 2009, MAGN RESON IMAGING, V27, P311, DOI 10.1016/j.mri.2008.07.018; Zahavi A, 2006, ANN PLAS SURG, V57, P248, DOI 10.1097/01.sap.0000221614.32176.9a	45	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2015	10	7							e0132131	10.1371/journal.pone.0132131	http://dx.doi.org/10.1371/journal.pone.0132131			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EC	26151888	Green Published, gold, Green Submitted			2022-12-26	WOS:000358158900035
J	Inoue, T; Sakuta, Y; Shimamura, K; Ichikawa, H; Kobayashi, M; Otani, R; Yamaguchi, MK; Kanazawa, S; Kakigi, R; Sakuta, R				Inoue, Takeshi; Sakuta, Yuiko; Shimamura, Keiichi; Ichikawa, Hiroko; Kobayashi, Megumi; Otani, Ryoko; Yamaguchi, Masami K.; Kanazawa, So; Kakigi, Ryusuke; Sakuta, Ryoichi			Differences in the Pattern of Hemodynamic Response to Self-Face and Stranger-Face Images in Adolescents with Anorexia Nervosa: A Near-Infrared Spectroscopic Study	PLOS ONE			English	Article							FUNCTIONAL NEUROANATOMY; PREFRONTAL CORTEX; INFANT BRAIN; BODY-IMAGE; PERCEPTION; REPRESENTATION; RECOGNITION; HEMOGLOBIN; ACTIVATION; AREA	There have been no reports concerning the self-face perception in patients with anorexia nervosa (AN). The purpose of this study was to compare the neuronal correlates of viewing self-face images (i.e. images of familiar face) and stranger-face images (i.e. images of an unfamiliar face) in female adolescents with and without AN. We used near-infrared spectroscopy (NIRS) to measure hemodynamic responses while the participants viewed full-color photographs of self-face and stranger-face. Fifteen females with AN (mean age, 13.8 years) and 15 age- and intelligence quotient (IQ)-matched female controls without AN (mean age, 13.1 years) participated in the study. The responses to photographs were compared with the baseline activation (response to white uniform blank). In the AN group, the concentration of oxygenated hemoglobin (oxy-Hb) significantly increased in the right temporal area during the presentation of both the self-face and stranger-face images compared with the baseline level. In contrast, in the control group, the concentration of oxy-Hb significantly increased in the right temporal area only during the presentation of the self-face image. To our knowledge the present study is the first report to assess brain activities during self-face and stranger-face perception among female adolescents with AN. There were different patterns of brain activation in response to the sight of the self-face and stranger-face images in female adolescents with AN and controls.	[Inoue, Takeshi; Shimamura, Keiichi; Otani, Ryoko; Sakuta, Ryoichi] Dokkyo Med Univ, Koshigaya Hosp, Dept Pediat, Ctr Child Dev & Psychosomat, Koshigaya, Saitama, Japan; [Sakuta, Yuiko] Jissen Womens Univ, Fac Human Life Sci, Hino, Tokyo, Japan; [Ichikawa, Hiroko] Tokyo Univ Sci, Fac Sci & Technol, Noda, Chiba 278, Japan; [Kobayashi, Megumi; Kakigi, Ryusuke] Natl Inst Physiol Sci, Dept Integrat Physiol, Okazaki, Aichi 444, Japan; [Yamaguchi, Masami K.] Chuo Univ, Dept Psychol, Hachioji, Tokyo, Japan; [Kanazawa, So] Japan Womens Univ, Dept Psychol, Kawasaki, Kanagawa, Japan	Dokkyo Medical University; Tokyo University of Science; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Chuo University; Japan Womens University	Sakuta, R (corresponding author), Dokkyo Med Univ, Koshigaya Hosp, Dept Pediat, Ctr Child Dev & Psychosomat, Koshigaya, Saitama, Japan.	sakuta@dokkyomed.ac.jp			Japan Society for the Promotion of Science [25285204]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was supported by a Grant-in-Aid for Scientific Research (25285204 for SK) from the Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/index.html).	Cash TF, 1997, INT J EAT DISORDER, V22, P107, DOI 10.1002/(SICI)1098-108X(199709)22:2&lt;107::AID-EAT1&gt;3.0.CO;2-J; FOX PT, 1986, P NATL ACAD SCI USA, V83, P1140, DOI 10.1073/pnas.83.4.1140; Hoek HW, 2006, CURR OPIN PSYCHIATR, V19, P389, DOI 10.1097/01.yco.0000228759.95237.78; Hoshi Y, 2001, J APPL PHYSIOL, V90, P1657, DOI 10.1152/jappl.2001.90.5.1657; Ichikawa H, 2010, NEUROSCI LETT, V482, P90, DOI 10.1016/j.neulet.2010.06.086; Jayakar A, 2005, J CLIN NEUROPHYSIOL, V22, P415; Jellema T, 2000, BRAIN COGNITION, V44, P280, DOI 10.1006/brcg.2000.1231; Kameyama M, 2004, NEUROIMAGE, V22, P1715, DOI 10.1016/j.neuroimage.2004.03.050; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Kobayashi M, 2012, NEUROREPORT, V23, P984, DOI 10.1097/WNR.0b013e32835a4b86; Kobayashi M, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00153; Kusaka T, 2004, HUM BRAIN MAPP, V22, P122, DOI 10.1002/hbm.20020; Lauer CJ, 1999, J PSYCHIATR RES, V33, P129, DOI 10.1016/S0022-3956(98)00020-X; Lena SM, 2004, NEUROPSYCHOL REV, V14, P99, DOI 10.1023/B:NERV.0000028081.40907.de; Lloyd-Fox S, 2011, J COGNITIVE NEUROSCI, V23, P2521, DOI 10.1162/jocn.2010.21598; MALONEY MJ, 1988, J AM ACAD CHILD PSY, V27, P541, DOI 10.1097/00004583-198809000-00004; Matsuda G, 2006, NEUROIMAGE, V29, P706, DOI 10.1016/j.neuroimage.2005.08.019; Miyake Y, 2010, PSYCHIAT RES-NEUROIM, V181, P183, DOI 10.1016/j.pscychresns.2009.09.001; Mohr HM, 2010, PSYCHOL MED, V40, P1519, DOI 10.1017/S0033291709991826; Morita T, 2008, J COGNITIVE NEUROSCI, V20, P342, DOI 10.1162/jocn.2008.20024; Nagamitsu S, 2011, BRAIN DEV-JPN, V33, P35, DOI 10.1016/j.braindev.2009.12.010; Nakato E, 2009, HUM BRAIN MAPP, V30, P462, DOI 10.1002/hbm.20516; Nakato E, 2011, EARLY HUM DEV, V87, P1, DOI 10.1016/j.earlhumdev.2010.08.030; Nakato E, 2011, NEUROIMAGE, V54, P1600, DOI 10.1016/j.neuroimage.2010.09.021; Otsuka Y, 2007, NEUROIMAGE, V34, P399, DOI 10.1016/j.neuroimage.2006.08.013; Peelen MV, 2007, NAT REV NEUROSCI, V8, P636, DOI 10.1038/nrn2195; Pena M, 2003, P NATL ACAD SCI USA, V100, P11702, DOI 10.1073/pnas.1934290100; PUCE A, 1995, J NEUROPHYSIOL, V74, P1192, DOI 10.1152/jn.1995.74.3.1192; Schroeter ML, 2004, NEUROIMAGE, V21, P283, DOI 10.1016/j.neuroimage.2003.09.054; Schroeter ML, 2003, NEUROIMAGE, V19, P555, DOI 10.1016/S1053-8119(03)00155-1; SERGENT J, 1992, BRAIN, V115, P15, DOI 10.1093/brain/115.1.15; Shimada S, 2006, NEUROIMAGE, V32, P930, DOI 10.1016/j.neuroimage.2006.03.044; Sugiura M, 2005, NEUROIMAGE, V24, P143, DOI 10.1016/j.neuroimage.2004.07.063; Sugiura M, 2012, HUM BRAIN MAPP, V33, P1364, DOI 10.1002/hbm.21290; SZMUKLER GI, 1992, J CLIN EXP NEUROPSYC, V14, P347, DOI 10.1080/01688639208402834; Uddin LQ, 2005, NEUROIMAGE, V25, P926, DOI 10.1016/j.neuroimage.2004.12.018; Uher R, 2005, BIOL PSYCHIAT, V58, P990, DOI 10.1016/j.biopsych.2005.06.001; Vocks S, 2011, PSYCHOL MED, V41, P1651, DOI 10.1017/S0033291710002382; Vocks S, 2010, COGN AFFECT BEHAV NE, V10, P422, DOI 10.3758/CABN.10.3.422; Vocks S, 2010, PSYCHIAT RES-NEUROIM, V183, P114, DOI 10.1016/j.pscychresns.2010.05.011; Watanabe E, 1996, NEUROSCI LETT, V205, P41, DOI 10.1016/0304-3940(96)12376-4; Yamashita Y, 2001, MED PHYS, V28, P1108, DOI 10.1118/1.1373401	43	6	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2015	10	7							e0132050	10.1371/journal.pone.0132050	http://dx.doi.org/10.1371/journal.pone.0132050			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EC	26151754	Green Published, gold, Green Submitted			2022-12-26	WOS:000358158900033
J	Chaftari, AM; Hachem, R; Reitzel, R; Jordan, M; Jiang, Y; Yousif, A; Garoge, K; Deshmukh, P; Al Hamal, Z; Jabbour, J; Hanania, A; Raad, S; Jamal, M; Raad, I				Chaftari, Anne-Marie; Hachem, Ray; Reitzel, Ruth; Jordan, Mary; Jiang, Ying; Yousif, Ammar; Garoge, Kumait; Deshmukh, Poonam; Al Hamal, Zanaib; Jabbour, Joseph; Hanania, Alexander; Raad, Sammy; Jamal, Mohamed; Raad, Issam			Role of Procalcitonin and Interleukin-6 in Predicting Cancer, and Its Progression Independent of Infection	PLOS ONE			English	Article							SERUM-LEVELS; EXPRESSION; GROWTH; FEVER; INFLAMMATION; DIAGNOSIS; BIOMARKER; MARKERS; SEPSIS; LIVER	Procalcitonin (PCT) and Interleukin-6 (IL-6) have emerged as biomarkers for different inflammatory conditions. The purpose of the study was to evaluate the role of PCT and IL-6 as biomarkers of cancer and its progression in a large cohort of patients. This cross-sectional study included residual plasma samples collected from cancer patients, and control subjects without cancer. Levels of PCT and IL-6 were determined by Kryptor compact bioanalyzer. We identified 575 febrile cancer patients, 410 non-febrile cancer patients, and 79 non-cancer individuals. The median PCT level was lower in control subjects (0.029 ng/ml) compared to cancer patients with stage I-III disease (0.127 ng/ml) (p<0.0001) and stage IV disease (0.190 ng/ml) (p<0.0001). It was also higher in febrile cancer patients (0.310 ng/ml) compared to non-febrile cancer patients (0.1 ng/ml) (p<0.0001). Median IL-6 level was significantly lower in the control group (0 pg/ml) than in non-febrile cancer patients with stages I-III (7.376 pg/ml) or stage IV (9.635 pg/ml) (p<0.0001). Our results suggest a potential role for PCT and IL-6 in predicting cancer in non-febrile patients. In addition, PCT is useful in detecting progression of cancer and predicting bacteremia or sepsis in febrile cancer patients.	[Chaftari, Anne-Marie; Hachem, Ray; Reitzel, Ruth; Jordan, Mary; Jiang, Ying; Yousif, Ammar; Garoge, Kumait; Deshmukh, Poonam; Al Hamal, Zanaib; Jabbour, Joseph; Hanania, Alexander; Raad, Sammy; Jamal, Mohamed; Raad, Issam] Univ Texas MD Anderson Canc Ctr, Div Internal Med, Dept Infect Dis Infect Control & Employee Hlth, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Chaftari, AM (corresponding author), Univ Texas MD Anderson Canc Ctr, Div Internal Med, Dept Infect Dis Infect Control & Employee Hlth, Houston, TX 77030 USA.	achaftar@mdanderson.org	Jamal, Mohamed A/AAE-4275-2019; Hanania, Alexander N./AAF-7207-2020	Hanania, Alexander N./0000-0002-4717-5057; Jamal, Mohamed/0000-0003-3404-2535				Al Shuaibi M, 2013, CLIN INFECT DIS, V56, P943, DOI 10.1093/cid/cis1029; Becker KL, 2004, J CLIN ENDOCR METAB, V89, P1512, DOI 10.1210/jc.2002-021444; Bele N, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-224; Bihan H, 2003, THYROID, V13, P819, DOI 10.1089/105072503768499716; Brahms, 2011, PCT SENSITIVE KRYPTO; Carnino L, 2010, J CANCER RES CLIN, V136, P611, DOI 10.1007/s00432-009-0699-9; Chang CY, 2005, J CLIN NEUROSCI, V12, P930, DOI 10.1016/j.jocn.2004.11.017; Cohen T, 1996, J BIOL CHEM, V271, P736, DOI 10.1074/jbc.271.2.736; de Jong KP, 2001, SCAND J GASTROENTERO, V36, P636, DOI 10.1080/003655201750163132; Engel A, 1999, SCAND J INFECT DIS, V31, P185, DOI 10.1080/003655499750006254; Freifeld AG, 2011, CLIN INFECT DIS, V52, pE56, DOI 10.1093/cid/cir073; Gilbert DN, 2011, CLIN INFECT DIS, V52, pS346, DOI 10.1093/cid/cir050; HUTCHINS D, 1994, INT J CANCER, V58, P80, DOI 10.1002/ijc.2910580114; Kaczka K, 2010, ENDOKRYNOL POL, V61, P430; Keramidaris D, 2013, J BUON, V18, P623; Kretzschmar M, 2001, ACTA ANAESTH SCAND, V45, P1162, DOI 10.1034/j.1399-6576.2001.450918.x; KUTTEH WH, 1991, SCAND J IMMUNOL, V33, P607, DOI 10.1111/j.1365-3083.1991.tb02532.x; Levy MM, 2001, INTENS CARE MED, V29, P530, DOI DOI 10.1007/S00134-003-1662-X; Liu XH, 2002, BIOCHEM BIOPH RES CO, V290, P249, DOI 10.1006/bbrc.2001.6188; Massaro KSR, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-137; Matzaraki V, 2007, CLIN BIOCHEM, V40, P336, DOI 10.1016/j.clinbiochem.2006.10.027; Mauro MV, 2012, DIAGN MICR INFEC DIS, V73, P308, DOI 10.1016/j.diagmicrobio.2012.04.006; Mouawad R, 1996, CLIN CANCER RES, V2, P1405; Oberhoffer M, 1999, J CRIT CARE, V14, P29, DOI 10.1016/S0883-9441(99)90005-9; Oka M, 1996, CANCER RES, V56, P2776; Ruokonen E, 1999, EUR J CLIN MICROBIOL, V18, P283, DOI 10.1007/s100960050277; Scheller J, 2006, SCAND J IMMUNOL, V63, P321, DOI 10.1111/j.1365-3083.2006.01750.x; Schuetz P, 2011, ARCH INTERN MED, V171, P1322, DOI 10.1001/archinternmed.2011.318; Shomali W, 2012, CANCER-AM CANCER SOC, V118, P5823, DOI 10.1002/cncr.27602; TAMM I, 1994, P NATL ACAD SCI USA, V91, P4338, DOI 10.1073/pnas.91.10.4338; Vincent JL, 2009, CRIT CARE CLIN, V25, P665, DOI 10.1016/j.ccc.2009.07.001; Yaegashi H, 2014, INT J UROL, V21, P104, DOI 10.1111/iju.12178; Zhang GJ, 1999, ANTICANCER RES, V19, P1427	33	25	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0130999	10.1371/journal.pone.0130999	http://dx.doi.org/10.1371/journal.pone.0130999			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148092	Green Published, Green Submitted, gold			2022-12-26	WOS:000358157600056
J	Chalan, P; Bijzet, J; Huitema, MG; Kroesen, BJ; Brouwer, E; Boots, AMH				Chalan, Paulina; Bijzet, Johan; Huitema, Minke G.; Kroesen, Bart-Jan; Brouwer, Elisabeth; Boots, Annemieke M. H.			Expression of Lectin-Like Transcript 1, the Ligand for CD161, in Rheumatoid Arthritis	PLOS ONE			English	Article							KILLER GENE-COMPLEX; SYNOVIAL TISSUE; INTERFERON-GAMMA; DENDRITIC CELLS; HUMAN NKR-P1A; CUTTING EDGE; B-CELLS; ACTIVATION; LYMPHOCYTES; TOLL-LIKE-RECEPTOR-4	Objectives Precursor Th17 lineage cells expressing CD161 are implicated in Rheumatoid Arthritis (RA) pathogenesis. CD4+CD161+ T-cells accumulate in RA joints and may acquire a non classical Th1 phenotype. The endogenous ligand for CD161 is lectin-like transcript 1 (LLT1). CD161/LLT1 ligation may co-stimulate T-cell IFN-gamma production. We investigated the presence and identity of LLT1-expressing cells in RA synovial fluid (SF) and synovial tissue (ST). We also assessed levels of soluble LLT1 (sLLT1) in different phases of RA development. Methods Paired samples of peripheral blood mononuclear cells (MC) and SFMC (n = 14), digested ST cells (n = 4) and ST paraffin sections (n = 6) from late-stage RA were analyzed for LLT1 expression by flow cytometry and immunohistochemistry. sLLT1 was measured using a sandwich ELISA. Sera and SF from late-stage RA (n = 26), recently diagnosed RA patients (n = 39), seropositive arthralgia patients (SAP, n = 31), spondyloarthropathy patients (SpA, n = 26) and healthy controls (HC, n = 31) were assayed. Results In RA SF, LLT1 was expressed by a small proportion of monocytes. In RA ST, LLT1-expressing cells were detected in the lining, sublining layer and in areas with infiltrates. The LLT1 staining pattern overlapped with the CD68 staining pattern. FACS analysis of digested ST confirmed LLT1 expression by CD68+ cells. Elevated systemic sLLT1 was found in all patient groups. Conclusions In RA joints, LLT1 is expressed by cells of the monocyte/macrophage lineage. Serum levels of sLLT1 were increased in all patient groups (patients with early- and late-stage RA, seropositive arthralgia and spondyloarthropathy) when compared to healthy subjects.	[Chalan, Paulina; Bijzet, Johan; Huitema, Minke G.; Brouwer, Elisabeth; Boots, Annemieke M. H.] Univ Groningen, Univ Med Ctr Groningen, Dept Rheumatol & Clin Immunol, Groningen, Netherlands; [Kroesen, Bart-Jan] Univ Groningen, Univ Med Ctr Groningen, Dept Lab Med, Groningen, Netherlands	University of Groningen; University of Groningen	Boots, AMH (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Rheumatol & Clin Immunol, Groningen, Netherlands.	m.boots@umcg.nl	Brouwer, Elisabeth/AAL-9029-2020; Brouwer, Elisabeth/A-3198-2015	Brouwer, Elisabeth/0000-0002-5652-4423; Brouwer, Elisabeth/0000-0002-5652-4423				Aldemir H, 2005, J IMMUNOL, V175, P7791, DOI 10.4049/jimmunol.175.12.7791; Arends S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099685; Bartel Y, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00362; Bos WH, 2010, ANN RHEUM DIS, V69, P490, DOI 10.1136/ard.2008.105759; Brennan FM, 2002, ARTHRITIS RES THER, V4, pS177, DOI 10.1186/ar556; Chalan P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079370; Cosmi L, 2008, J EXP MED, V205, P1903, DOI 10.1084/jem.20080397; Cosmi L, 2011, ARTHRITIS RHEUM-US, V63, P2504, DOI 10.1002/art.30332; CUSH JJ, 1988, ARTHRITIS RHEUM-US, V31, P1230, DOI 10.1002/art.1780311003; DECLERCK LS, 1995, RES IMMUNOL, V146, P81, DOI 10.1016/0923-2494(96)80241-0; Eichler W, 2001, J CELL BIOCHEM, P201; Fergusson JR, 2014, CELL REP, V9, P1075, DOI 10.1016/j.celrep.2014.09.045; Germain C, 2011, J BIOL CHEM, V286, P37964, DOI 10.1074/jbc.M111.285312; Germain C, 2010, J BIOL CHEM, V285, P36207, DOI 10.1074/jbc.M110.179622; Hamann J, 1997, IMMUNOGENETICS, V45, P295, DOI 10.1007/s002510050208; Hreggvidsdottir HS, 2014, MOL IMMUNOL, V57, P28, DOI 10.1016/j.molimm.2013.07.016; IGUCHI T, 1986, ARTHRITIS RHEUM-US, V29, P600, DOI 10.1002/art.1780290504; Iwahashi M, 2004, ARTHRITIS RHEUM-US, V50, P1457, DOI 10.1002/art.20219; Kamishikiryo J, 2011, J BIOL CHEM, V286, P23823, DOI 10.1074/jbc.M110.214254; Kinne RW, 2000, ARTHRITIS RES, V2, P189, DOI 10.1186/ar86; Kleinschek MA, 2009, J EXP MED, V206, P525, DOI 10.1084/jem.20081712; Krenn V, 2006, HISTOPATHOLOGY, V49, P358, DOI 10.1111/j.1365-2559.2006.02508.x; Nistala K, 2010, P NATL ACAD SCI USA, V107, P14751, DOI 10.1073/pnas.1003852107; Radstake TRDJ, 2004, ARTHRITIS RHEUM-US, V50, P3856, DOI 10.1002/art.20678; Reparon-Schuijt CC, 1998, ARTHRITIS RHEUM, V41, P2211, DOI 10.1002/1529-0131(199812)41:12<2211::AID-ART17>3.0.CO;2-O; RIDLEY MG, 1990, BRIT J RHEUMATOL, V29, P84; Roelofs MF, 2005, ARTHRITIS RHEUM, V52, P2313, DOI 10.1002/art.21278; Rosen DB, 2008, J IMMUNOL, V180, P6508, DOI 10.4049/jimmunol.180.10.6508; Rosen DB, 2005, J IMMUNOL, V175, P7796, DOI 10.4049/jimmunol.175.12.7796; RUBIN LA, 1985, J IMMUNOL, V135, P3172; Samson M, 2012, ARTHRITIS RHEUM-US, V64, P3788, DOI 10.1002/art.34647; Sancho D, 2005, TRENDS IMMUNOL, V26, P136, DOI 10.1016/j.it.2004.12.006; Satkunanathan S, 2013, J VIROL; Spreu J, 2007, IMMUNOGENETICS, V59, P903, DOI 10.1007/s00251-007-0263-1; STEINER G, 1995, J RHEUMATOL, V22, P406; van de Stadt LA, 2011, ANN RHEUM DIS, V70, P128, DOI 10.1136/ard.2010.132662; Yokoyama WM, 2003, NAT REV IMMUNOL, V3, P304, DOI 10.1038/nri1055	37	11	11	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132436	10.1371/journal.pone.0132436	http://dx.doi.org/10.1371/journal.pone.0132436			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147876	Green Published, Green Submitted, gold			2022-12-26	WOS:000358157600268
J	Fedewa, SA; Cullati, S; Bouchardy, C; Welle, I; Burton-Jeangros, C; Manor, O; Courvoisier, DS; Guessous, I				Fedewa, Stacey A.; Cullati, Stephane; Bouchardy, Christine; Welle, Ida; Burton-Jeangros, Claudine; Manor, Orly; Courvoisier, Delphine S.; Guessous, Idris			Colorectal Cancer Screening in Switzerland: Cross-Sectional Trends (2007-2012) in Socioeconomic Disparities	PLOS ONE			English	Article							LOWER GASTROINTESTINAL ENDOSCOPY; HEALTH INTERVIEW SURVEY; OCCULT BLOOD-TEST; FAMILY-HISTORY; UNITED-STATES; WOMEN; CARE; PARTICIPATION; DETERMINANTS; PREVALENCE	Background Despite universal health care coverage, disparities in colorectal cancer (CRC) screening by income in Switzerland have been reported. However, it is not known if these disparities have changed over time. This study examines the association between socioeconomic position and CRC screening in Switzerland between 2007 and 2012. Methods Data from the 2007 (n = 5,946) and 2012 (n = 7,224) population-based Swiss Health Interview Survey data (SHIS) were used to evaluate the association between monthly household income, education, and employment with CRC screening, defined as endoscopy in the past 10 years or fecal occult blood test (FOBT) in the past 2 years. Multivariable Poisson regression was used to estimate prevalence ratios (PR) and 95% Confidence Intervals (CI) adjusting for demographics, health status, and health utilization. Results CRC screening increased from 18.9% in 2007 to 22.2% in 2012 (padjusted: = 0.036). During the corresponding time period, endoscopy increased (8.2% vs. 15.0%, padjusted:<0.001) and FOBT decreased (13.0% vs. 9.8%, padjusted: 0.002). CRC screening prevalence was greater in the highest income (>$6,000) vs. lowest income (<=$ 2,000) group in 2007 (24.5% vs. 10.5%, PR: 1.37, 95% CI: 0.96-1.96) and in 2012 (28.6% vs. 16.0%, PR: 1.45, 95% CI: 1.09-1.92); this disparity did not significantly change over time. Conclusions While CRC screening prevalence in Switzerland increased from 2007 to 2012, CRC screening coverage remains low and disparities in CRC screening by income persisted over time. These findings highlight the need for increased access to CRC screening as well as enhanced awareness of the benefits of CRC screening in the Swiss population, particularly among low-income residents.	[Fedewa, Stacey A.; Guessous, Idris] Emory Univ, Dept Epidemiol, Atlanta, GA 30322 USA; [Fedewa, Stacey A.] Amer Canc Soc, Atlanta, GA 30329 USA; [Cullati, Stephane; Manor, Orly; Guessous, Idris] Univ Hosp Geneva, Unit Populat Epidemiol, Dept Community Med Primary Care & Emergency Med, Geneva, Switzerland; [Bouchardy, Christine] Univ Geneva, Geneva Canc Registry, Global Hlth Inst, Geneva, Switzerland; [Welle, Ida] Univ Lausanne Hosp, Inst Social & Prevent Med, Lausanne, Switzerland; [Burton-Jeangros, Claudine] Univ Geneva, Dept Sociol, Geneva, Switzerland; [Manor, Orly] Hebrew Univ Jerusalem Hadassah Hosp & Med Sch, Sch Publ Hlth & Community Med, Jerusalem, Israel; [Courvoisier, Delphine S.] Univ Hosp Geneva, Div Clin Epidemiol, Geneva, Switzerland; [Guessous, Idris] Univ Lausanne Hosp, Div Chron Dis, Univ Inst Social & Prevent Med, Lausanne, Switzerland	Emory University; American Cancer Society; University of Geneva; University of Geneva; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Geneva; Hebrew University of Jerusalem; Hadassah University Medical Center; University of Geneva; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Guessous, I (corresponding author), Emory Univ, Dept Epidemiol, Atlanta, GA 30322 USA.	idris.guessous@hcuge.ch	Cullati, Stephane/F-7991-2011	Cullati, Stephane/0000-0002-3881-446X; Fedewa, Stacey/0000-0002-3624-6382	Swiss Cancer League grant [KLS-3144-02-2013]	Swiss Cancer League grant	This work was supported by the Swiss Cancer League grant KLS-3144-02-2013.	American Cancer Society, 2015, CANC PREV EARL DET 2; Arditi C, 2009, ENDOSCOPY, V41, P200, DOI 10.1055/s-0028-1119626; Burla L, 2012, CORPS MED SUISSE EFF; Busato A, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-8; Calonge N, 2008, ANN INTERN MED, V149, P627, DOI 10.7326/0003-4819-149-9-200811040-00243; Collet TH, 2011, J GEN INTERN MED, V26, P724, DOI 10.1007/s11606-011-1674-0; Coughlin SS, 2004, CANCER CAUSE CONTROL, V15, P159, DOI 10.1023/B:CACO.0000019496.30145.62; Cullati S, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-118; Dutoit L, 2014, ETABLISSEMENT RECENS; ERIKSON R, 1979, BRIT J SOCIOL, V30, P415, DOI 10.2307/589632; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; Ferlay J., 2013, INT AGENCY RES CANC; Fischer R, 2013, EUR J CANCER PREV, V22, P425, DOI 10.1097/CEJ.0b013e32835f3b87; Frederiksen BL, 2010, BRIT J CANCER, V103, P1496, DOI 10.1038/sj.bjc.6605962; Guessous I, 2012, PREV MED, V55, P521, DOI 10.1016/j.ypmed.2012.08.005; Guessous I, 2014, J AGING RES; JACCARD RUEDIN H., 2009, PERSONNEL SANTE SUIS; Jensen CD, 2015, CLIN GASTROENTEROL H, V13, P739, DOI 10.1016/j.cgh.2014.10.020; Kraft E, 2009, B MED SVIZZERI, V90, P1647; Mai PL, 2010, PUBLIC HEALTH GENOM, V13, P495, DOI 10.1159/000294469; Meissner HI, 2006, CANCER EPIDEM BIOMAR, V15, P389, DOI 10.1158/1055-9965.EPI-05-0678; Menvielle G, 2008, BRIT J CANCER, V98, P1012, DOI 10.1038/sj.bjc.6604274; Paccaud GFaF, 2007, MED SOCIALE PREVENTI; Phillips KA, 2007, MED CARE, V45, P160, DOI 10.1097/01.mlr.0000246612.35245.21; Pinsky PF, 2003, AM J EPIDEMIOL, V157, P792, DOI 10.1093/aje/kwg043; Rapiti E, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-102; Rauscher GH, 2008, CANCER EPIDEM BIOMAR, V17, P748, DOI 10.1158/1055-9965.EPI-07-2629; Shapiro JA, 2008, CANCER EPIDEM BIOMAR, V17, P1623, DOI 10.1158/1055-9965.EPI-07-2838; Spaeth A, 2013, ENDOSCOPY, V45, P560, DOI 10.1055/s-0032-1326636; Stock C, 2010, ENDOSCOPY, V42, P546, DOI 10.1055/s-0029-1244127; Subramanian S, 2004, PREV MED, V38, P536, DOI 10.1016/j.ypmed.2003.12.011; Swiss Confederation Federal Authorities, 2014, MED STAT 2014; Swiss Federal Statistical Office, 2014, STAT ENC 2014; Valle L, 2007, J CLIN ONCOL, V25, P781, DOI 10.1200/JCO.2006.06.9781; Volken T, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-167; von Wagner C, 2011, INT J EPIDEMIOL, V40, P712, DOI 10.1093/ije/dyr008; Walter P, 2014, INDICATEURS MARCHE T; Wanzenried G., 2008, SJES, V144, P247; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Zapka JG, 2002, AM J PREV MED, V23, P28, DOI 10.1016/S0749-3797(02)00444-0; Zorzi M, 2009, EPIDEMIOL PREV, V33, P57	41	33	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131205	10.1371/journal.pone.0131205	http://dx.doi.org/10.1371/journal.pone.0131205			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147803	gold, Green Published, Green Submitted			2022-12-26	WOS:000358157600069
J	Gorbe, A; Eder, A; Varga, ZV; Paloczi, J; Hansen, A; Ferdinandy, P; Eschenhagen, T				Gorbe, A.; Eder, A.; Varga, Z. V.; Paloczi, J.; Hansen, A.; Ferdinandy, P.; Eschenhagen, T.			Protection by the NO-Donor SNAP and BNP against Hypoxia/Reoxygenation in Rat Engineered Heart Tissue	PLOS ONE			English	Article							EXOGENOUS NITRIC-OXIDE; ISCHEMIA-REPERFUSION; APOPTOSIS; INJURY; CARDIOPROTECTION; NECROSIS	In vitro assays could replace animal experiments in drug screening and disease modeling, but have shortcomings in terms of functional readout. Force-generating engineered heart tissues (EHT) provide simple automated measurements of contractile function. Here we evaluated the response of EHTs to hypoxia/reoxygenation (H/R) and the effect of known cardiocytoprotective molecules. EHTs from neonatal rat heart cells were incubated for 24 h in EHT medium. Then they were subjected to 180 min hypoxia (93% N-2, 7% CO2) and 120 min reoxygenation (40% O-2, 53% N-2, 7% CO2), change of medium and additional follow-up of 48 h. Time-matched controls (40% O-2, 53% N-2, 7% CO2) were run for comparison. The following conditions were applied during H/R: fresh EHT medium(positive control), the NO-donor S-nitroso-N-acetyl-D,L-penicillamine (SNAP, 10(-7), 10(-6), 10(-5) M) or the guanylate cyclase activator brain type natriuretic peptide (BNP, 10(-9), 10(-8), 10(-7) M). Frequency and force of contraction were repeatedly monitored over the entire experiment, pH, troponin I (cTnI), lactate dehydrogenase (LDH) and glucose concentrations measured in EHT medium. Beating activity of EHTs in 24 h-medium ceased during hypoxia, partially recovered during reoxygenation and reached time-control values during follow-up. H/R was accompanied by a small increase in LDH and non-significant increase in cTnI. In fresh medium, some EHTs continued beating during hypoxia and all EHTs recovered faster during reoxygenation. SNAP and BNP showed small but significant protective effects during reoxygenation. EHTs are applicable to test potential cardioprotective compounds in vitro, monitoring functional and biochemical endpoints, which otherwise could be only measured by using in vivo or ex vivo heart preparations. The sensitivity of the model needs improvement.	[Gorbe, A.; Varga, Z. V.; Paloczi, J.] Univ Szeged, Dept Biochem, Cardiovasc Res Grp, Szeged, Hungary; [Eder, A.; Eschenhagen, T.] DZHK German Ctr Cardiovasc Res, Dept Expt Pharmacol & Toxicol, Cardiovasc Res Ctr, Hamburg, Germany; [Varga, Z. V.; Ferdinandy, P.] Semmelweis Univ, Dept Pharmacol & Pharmacotherapy, H-1085 Budapest, Hungary; [Gorbe, A.; Paloczi, J.; Ferdinandy, P.] Pharmahungary Grp, Szeged, Hungary	Szeged University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; German Centre for Cardiovascular Research; Semmelweis University; Pharmahungary Group	Gorbe, A (corresponding author), Univ Szeged, Dept Biochem, Cardiovasc Res Grp, Szeged, Hungary.	aniko.gorbe@pharmahungary.com	Ferdinandy, Péter/H-9181-2019; Varga, Zoltan V/J-9264-2017	Varga, Zoltan V/0000-0002-2758-0784	German Research Foundation [DFG Es/88-12]; European Commission; NKFP [07 1-ES2HEART-HU (OM-00202/2007)]; National Development Agency - New Hungary Development Plan [TAMOP-4.2.2-08/1/2008-0013, TAMOP-4.2.1/B-09/1]; OTKA [PD 106001]; Hungarian Academy of Sciences; National Excellence Program [TAMOP-4.2.4.A/2-11/1-2012-0001]; National Program of Excellence [TAMOP 4.2.4.A/2-11-1-2012-0001]; Pharmahungary Group	German Research Foundation(German Research Foundation (DFG)); European Commission(European CommissionEuropean Commission Joint Research Centre); NKFP; National Development Agency - New Hungary Development Plan; OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian Academy of Sciences(Hungarian Academy of Sciences); National Excellence Program; National Program of Excellence; Pharmahungary Group	This study was supported by grants from the German Research Foundation (DFG Es/88-12), the European Commission (FP7 Angioscaff, FP7 Biodesign) (EA, HA, TE), NKFP 07 1-ES2HEART-HU (OM-00202/2007), National Development Agency - New Hungary Development Plan (TAMOP-4.2.2-08/1/2008-0013, TAMOP-4.2.1/B-09/1); OTKA PD 106001 (GA, PJ, VZV, FP). GA holds a "Janos Bolyai Fellowship" from the Hungarian Academy of Sciences. PJ holds a "Apaczai-Csere Janos Fellowship" from TAMOP-4.2.4.A/2-11/1-2012-0001 (National Excellence Program). PF was a Szentagothai Fellow of the National Program of Excellence (TAMOP 4.2.4.A/2-11-1-2012-0001). Pharmahungary Group provided support in the form of salaries for authors AG, JP, and PF, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Andreadou I, 2015, BRIT J PHARMACOL, V172, P1587, DOI 10.1111/bph.12811; Bell RM, 2003, CARDIOVASC RES, V57, P405, DOI 10.1016/S0008-6363(02)00675-2; Bell RM, 2001, CARDIOVASC RES, V52, P274, DOI 10.1016/S0008-6363(01)00394-7; Burley DS, 2007, BASIC RES CARDIOL, V102, P529, DOI 10.1007/s00395-007-0672-1; Csont T, 2010, J MOL CELL CARDIOL, V48, P649, DOI 10.1016/j.yjmcc.2010.01.013; Das A, 2005, J BIOL CHEM, V280, P12944, DOI 10.1074/jbc.M404706200; DUTOIT EF, 1992, CIRC RES, V70, P960, DOI 10.1161/01.RES.70.5.960; Eder A, 2014, BASIC RES CARDIOL, V109, DOI 10.1007/s00395-014-0436-7; Ferdinandy P, 2003, BRIT J PHARMACOL, V138, P532, DOI 10.1038/sj.bjp.0705080; Gorbe A, 2014, MOL BIOTECHNOL, V56, P258, DOI 10.1007/s12033-013-9704-2; Gorbe A, 2010, BASIC RES CARDIOL, V105, P643, DOI 10.1007/s00395-010-0097-0; Hansen A, 2010, CIRC RES, V107, P35, DOI 10.1161/CIRCRESAHA.109.211458; Hirt MN, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0307-z; Johnson WB, 2012, LIFE SCI, V90, P328, DOI 10.1016/j.lfs.2011.11.016; Katare RG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009275; Maejima Y, 2003, CARDIOVASC RES, V59, P308, DOI 10.1016/S0008-6363(03)00425-5; Marshall KD, 2014, AM J PHYSIOL-CELL PH, V306, pC639, DOI 10.1152/ajpcell.00167.2013; Nakano A, 2000, J MOL CELL CARDIOL, V32, P1159, DOI 10.1006/jmcc.2000.1152; Pritchett-Corning KR, 2009, J AM ASSOC LAB ANIM, V48, P23; Qi LL, 2011, EUR J PHARMACOL, V668, P201, DOI 10.1016/j.ejphar.2011.06.020; Radisic M, 2008, J BIOMED MATER RES A, V86A, P713, DOI 10.1002/jbm.a.31578; Rakhit RD, 2000, AM J PHYSIOL-HEART C, V278, pH1211, DOI 10.1152/ajpheart.2000.278.4.H1211; Saraste A, 1999, HERZ, V24, P189, DOI 10.1007/BF03044961; Shinmura K, 1999, AM J PHYSIOL-HEART C, V277, pH2495, DOI 10.1152/ajpheart.1999.277.6.H2495; Stohr A, 2013, J MOL CELL CARDIOL, V63, P189, DOI 10.1016/j.yjmcc.2013.07.011; Takano H, 1998, CIRC RES, V83, P73, DOI 10.1161/01.RES.83.1.73; Takimoto E, 2012, CIRC J, V76, P1819, DOI 10.1253/circj.CJ-12-0664; Vandenburgh H, 2008, MUSCLE NERVE, V37, P438, DOI 10.1002/mus.20931; Zimmermann WH, 2002, CIRC RES, V90, P223, DOI 10.1161/hh0202.103644; Zimmermann WH, 2006, NAT MED, V12, P452, DOI 10.1038/nm1394; Zimmermann WH, 2000, BIOTECHNOL BIOENG, V68, P106	31	5	5	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132186	10.1371/journal.pone.0132186	http://dx.doi.org/10.1371/journal.pone.0132186			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147889	Green Published, gold, Green Submitted			2022-12-26	WOS:000358157600214
J	Tang, H; Tang, YP; Li, NG; Lin, H; Li, WX; Shi, QP; Zhang, W; Zhang, PX; Dong, ZX; Shen, MZ; Gu, T; Duan, JA				Tang, Hao; Tang, Yuping; Li, Nian-Guang; Lin, Hang; Li, Weixia; Shi, Qianping; Zhang, Wei; Zhang, Pengxuan; Dong, Zexi; Shen, Minzhe; Gu, Ting; Duan, Jin-Ao			Comparative Metabolomic Analysis of the Neuroprotective Effects of Scutellarin and Scutellarein against Ischemic Insult	PLOS ONE			English	Article							CHROMATOGRAPHY-MASS-SPECTROMETRY; POWERFUL TECHNOLOGY; ALZHEIMERS-DISEASE; CERAMIDE; METABONOMICS; REPERFUSION; THERAPY; HYPOXIA; DESIGN; PLASMA	For more than thirty years, scutellarin (Scu) has been used in China to clinically treat acute cerebral infarction and paralysis. Scutellarein (Scue), the major Scu metabolite in vivo, exhibits heightened neuroprotective effects when compared to Scu. To explore the neuroprotective role of these compounds, we performed ultra-high-performance liquid chromatography-quadrupole/time-of-flight mass spectrometry (UHPLC-QTOF/MS) coupled with a pattern recognition approach to investigate metabolomic differences in a rat model of ischemia after treatment with each compound. We examined metabolites in urine, hippocampal tissue, and plasma, and we tentatively identified 23 endogenous metabolites whose levels differed significantly between sham-operated and model groups. Upon pathway analysis, we found an additional 11 metabolic pathways in urine, 14 metabolic pathways in the hippocampal tissue, and 3 metabolic pathways in plasma. These endogenous metabolites were mainly involved in sphingolipid metabolism, lysine biosynthesis, and alanine, aspartate, and glutamate metabolism. We found that metabolic changes after ischemic injury returned to near-normal levels after Scue intervention, unlike Scu treatment, further validating the heightened protective effects exerted by Scue compared to Scu. These results demonstrate that Scue is a potential drug for treatment of ischemic insult.	[Tang, Hao; Tang, Yuping; Li, Nian-Guang; Lin, Hang; Li, Weixia; Shi, Qianping; Zhang, Wei; Zhang, Pengxuan; Dong, Zexi; Shen, Minzhe; Gu, Ting; Duan, Jin-Ao] Nanjing Univ Chinese Med, Jiangsu Collaborat Innovat Ctr Chinese Med Resour, Jiangsu Key Lab High Technol Res TCM Formulae, Natl & Local Collaborat Engn Ctr Chinese Med Reso, Nanjing 210023, Jiangsu, Peoples R China	Nanjing University of Chinese Medicine	Tang, YP (corresponding author), Nanjing Univ Chinese Med, Jiangsu Collaborat Innovat Ctr Chinese Med Resour, Jiangsu Key Lab High Technol Res TCM Formulae, Natl & Local Collaborat Engn Ctr Chinese Med Reso, Nanjing 210023, Jiangsu, Peoples R China.	yupingtang@njucm.edu.cn; linianguang@njucm.edu.cn; dja@njucm.edu.cn	Tang, Huiru/F-9849-2011	Tang, Huiru/0000-0002-7139-2756	National Natural Science Foundation of China [81001382]; Program for New Century Excellent Talents by the Ministry of Education [NCET-12- 0741]; Six Talents Project Funded by Jiangsu Province [2013-YY-010]; Jiangsu Province, Technology Innovation Venture Fund by Nanjing University of Chinese Medicine [CX201301]; Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization [ZDXMHT-1-13]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents by the Ministry of Education(Program for New Century Excellent Talents in University (NCET)); Six Talents Project Funded by Jiangsu Province; Jiangsu Province, Technology Innovation Venture Fund by Nanjing University of Chinese Medicine; Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of China (81001382), the Program for New Century Excellent Talents by the Ministry of Education (NCET-12- 0741), Six Talents Project Funded by Jiangsu Province (2013-YY-010), 333 High-level Talents Training Project Funded by Jiangsu Province, Technology Innovation Venture Fund by Nanjing University of Chinese Medicine (CX201301), Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization (ZDXMHT-1-13), A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).	Aronowski J, 1997, J CEREBR BLOOD F MET, V17, P1048, DOI 10.1097/00004647-199710000-00006; Bogaert L, 2000, BRAIN RES, V887, P266, DOI 10.1016/S0006-8993(00)02959-0; Brouns R, 2009, CLIN NEUROL NEUROSUR, V111, P483, DOI 10.1016/j.clineuro.2009.04.001; BUTCHER SP, 1990, STROKE, V21, P1727, DOI 10.1161/01.STR.21.12.1727; Chen JJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep05855; Chen Y, 2001, J CEREBR BLOOD F MET, V21, P34, DOI 10.1097/00004647-200101000-00005; CHOI DW, 1990, ANNU REV NEUROSCI, V13, P171, DOI 10.1146/annurev.ne.13.030190.001131; Chung EH, 2002, LIFE SCI, V72, P609, DOI 10.1016/S0024-3205(02)02269-5; Cuzzocrea S, 2001, PHARMACOL REV, V53, P135; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; Han XL, 2002, J NEUROCHEM, V82, P809, DOI 10.1046/j.1471-4159.2002.00997.x; Hannun YA, 2000, TRENDS CELL BIOL, V10, P73, DOI 10.1016/S0962-8924(99)01694-3; Hong H, 2004, LIFE SCI, V74, P2959, DOI 10.1016/j.lfs.2003.09.074; Jung JY, 2011, STROKE, V42, P1282, DOI 10.1161/STROKEAHA.110.598789; Kara I, 2011, BRAIN INJURY, V25, P113, DOI 10.3109/02699052.2010.531688; Kolesnick RN, 1998, ANNU REV PHYSIOL, V60, P643, DOI 10.1146/annurev.physiol.60.1.643; Lenz EM, 2007, J PROTEOME RES, V6, P443, DOI 10.1021/pr0605217; Li F, 2011, BIOCHEM PHARMACOL, V81, P1043, DOI 10.1016/j.bcp.2011.01.024; Li J, 2013, J CHROMATOGR A, V1320, P103, DOI 10.1016/j.chroma.2013.10.064; Li NG, 2013, BIOORG MED CHEM LETT, V23, P102, DOI 10.1016/j.bmcl.2012.11.002; Li NG, 2012, BIOORGAN MED CHEM, V20, P6919, DOI 10.1016/j.bmc.2012.10.015; Li WX, 2014, J CHROMATOGR A, V1346, P49, DOI 10.1016/j.chroma.2014.04.042; Li XL, 2004, PLANTA MED, V70, P1039, DOI 10.1055/s-2004-832644; Liu H, 2005, PHARMACOL RES, V51, P205, DOI 10.1016/j.phrs.2004.09.001; Liu P, 2013, MOL BIOSYST, V9, P77, DOI 10.1039/c2mb25238d; Nicholson JK, 2003, NAT REV DRUG DISCOV, V2, P668, DOI 10.1038/nrd1157; Oda M, 2007, STROKE, V38, P2157, DOI 10.1161/STROKEAHA.106.477026; Pan ZW, 2008, PHYTOTHER RES, V22, P1428, DOI 10.1002/ptr.2364; Patti GJ, 2012, NAT CHEM BIOL, V8, P232, DOI [10.1038/nchembio.767, 10.1038/NCHEMBIO.767]; Satoi H, 2005, NEUROSCIENCE, V130, P657, DOI 10.1016/j.neuroscience.2004.08.056; Small DL, 1996, J CARDIOTHOR VASC AN, V10, P139, DOI 10.1016/S1053-0770(96)80189-3; Su SL, 2013, J PROTEOME RES, V12, P852, DOI 10.1021/pr300935x; Sun LY, 2012, J PROTEOME RES, V11, P2937, DOI 10.1021/pr3000317; Tan GG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034157; Tang H, 2014, PHARMACOL BIOCHEM BE, V118, P51, DOI 10.1016/j.pbb.2014.01.003; Tao YH, 2008, PHYTOMEDICINE, V15, P92, DOI 10.1016/j.phymed.2007.06.009; Vinaixa M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029052; Wang XJ, 2012, J PROTEOMICS, V75, P1411, DOI 10.1016/j.jprot.2011.11.011; Wang XJ, 2012, ANAL CHEM, V84, P428, DOI 10.1021/ac202828r; Wang XJ, 2011, J SEP SCI, V34, P3451, DOI 10.1002/jssc.201100333; Wardlaw JM, 1997, LANCET, V350, P607, DOI 10.1016/S0140-6736(97)03022-5; Yu ZF, 2000, J MOL NEUROSCI, V15, P85, DOI 10.1385/JMN:15:2:85; Zaleska MM, 2009, NEUROPHARMACOLOGY, V56, P329, DOI 10.1016/j.neuropharm.2008.10.006; Zhang GL, 2011, PHARMACOL BIOCHEM BE, V99, P42, DOI 10.1016/j.pbb.2011.03.019; Zhao YY, 2014, CHEM-BIOL INTERACT, V220, P181, DOI 10.1016/j.cbi.2014.06.029; Zhao YY, 2014, CLIN BIOCHEM, V47, P16, DOI 10.1016/j.clinbiochem.2014.07.019; Zhao YY, 2014, CHEM-BIOL INTERACT, V215, P7, DOI 10.1016/j.cbi.2014.02.014; Zhu JTT, 2009, PLANTA MED, V75, P1489, DOI 10.1055/s-0029-1185776	48	18	18	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131569	10.1371/journal.pone.0131569	http://dx.doi.org/10.1371/journal.pone.0131569			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147971	Green Published, gold, Green Submitted			2022-12-26	WOS:000358157600108
J	Zhu, Z; Zhao, X; Zhao, L; Yang, H; Liu, L; Li, J; Wu, J; Yang, F; Huang, G; Liu, J				Zhu, Z.; Zhao, X.; Zhao, L.; Yang, H.; Liu, L.; Li, J.; Wu, J.; Yang, F.; Huang, G.; Liu, J.			p54(nrb)/NONO regulates lipid metabolism and breast cancer growth through SREBP-1A	ONCOGENE			English	Article							FATTY-ACID SYNTHASE; ELEMENT-BINDING PROTEIN-1; DE-NOVO LIPOGENESIS; PROSTATE-CANCER; ACTIVATION; EXPRESSION; ANDROGEN; PATHWAY; CELLS; TRANSCRIPTION	Dysregulation of lipid metabolism is common in breast cancer. However, the underlying mechanisms remain elusive and the contribution of aberrant lipid metabolism to the malignant phenotypes of breast cancer is poorly understood. Here, we show that the nuclear protein p54(nrb)/Nono is highly expressed in breast cancer tissues as compared with the adjacent normal tissues in human patients. To determine the functions of p54(nrb) in breast cancer, we performed a biochemical screen and identified SREBP-1a, a master activator for genes involved in lipid biosynthesis, as a novel interacting protein of p54(nrb). In human breast cancer tissues, the levels of p54(nrb) and SREBP-1a proteins were positively correlated with each other. Our biochemical analyses showed that the conserved Y267 residue of p54(nrb) was required for its binding to the nuclear form of SREBP-1a. Interestingly, p54(nrb) binding to nuclear SREBP-1a caused an increase of nuclear SREBP-1a protein stability. As a result, p54(nrb) stimulates SREBP-1-meidated transcription of lipogenic genes and lipid production in breast cancer cells. Moreover, both p54(nrb) and SREBP-1a were required for breast cancer cell growth in vitro, and p54(nrb) binding to nuclear SREBP-1a was also critical for breast tumor development in vivo. Together, we conclude that p54(nrb) is a novel regulator of SREBP-1a in the nucleus, and our data suggest that p54(nrb) regulation of SREBP-1a supports the increased cellular demand of lipids for breast cancer growth. Thus, the SREBP pathway may represent a novel target for treating breast cancer.	[Zhu, Z.; Zhao, X.; Zhao, L.; Liu, L.; Li, J.; Wu, J.; Huang, G.; Liu, J.] Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Nucl Med, Shanghai 200127, Peoples R China; [Yang, H.; Huang, G.] Shanghai Jiao Tong Univ, Sch Med, Chinese Acad Sci, Shanghai Inst Biol Sci,Inst Hlth Sci, Shanghai 200030, Peoples R China; [Yang, F.] Albert Einstein Coll Med, Dept Med, New York, NY USA; [Yang, F.] Albert Einstein Coll Med, Dept Dev & Mol Biol, New York, NY USA	Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Yeshiva University; Yeshiva University	Huang, G; Liu, J (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Nucl Med, Shanghai 200127, Peoples R China.	huang2802@163.com; nuclearj@163.com			'973' Project [2012CB932604]; New Drug Discovery Project [2012ZX09506-001-005]; Shanghai First-class Discipline (Medical technology); National Natural Science Foundation of China [81372195, 81471685, 81471687]; Shanghai Pujiang Program [13PJ1406000]; Science and Technology Commission of Shanghai Municipality [134119a5600]; Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning [1410000157]; Shanghai Municipal Commission of Health and Family Planning [XYQ2013109]; NIH [R01 (DK093623)]	'973' Project(National Basic Research Program of China); New Drug Discovery Project; Shanghai First-class Discipline (Medical technology); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Pujiang Program(Shanghai Pujiang Program); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning; Shanghai Municipal Commission of Health and Family Planning; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The study was supported by research grants from '973' Project (No. 2012CB932604), New Drug Discovery Project (No. 2012ZX09506-001-005), Shanghai First-class Discipline (Medical technology), National Natural Science Foundation of China (No. 81372195, 81471685 and 81471687), Shanghai Pujiang Program (No. 13PJ1406000), Science and Technology Commission of Shanghai Municipality (No. 134119a5600), Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning (No. 1410000157) and Shanghai Municipal Commission of Health and Family Planning (XYQ2013109). FY was supported by NIH R01 (DK093623).	Amelio AL, 2007, P NATL ACAD SCI USA, V104, P20314, DOI 10.1073/pnas.0707999105; Calvisi DF, 2011, GASTROENTEROLOGY, V140, P1071, DOI 10.1053/j.gastro.2010.12.006; Currie E, 2013, CELL METAB, V18, P153, DOI 10.1016/j.cmet.2013.05.017; Ettinger SL, 2004, CANCER RES, V64, P2212, DOI 10.1158/0008-5472.CAN-2148-2; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Freed-Pastor WA, 2012, CELL, V148, P244, DOI 10.1016/j.cell.2011.12.017; Furuta E, 2008, CANCER RES, V68, P1003, DOI 10.1158/0008-5472.CAN-07-2489; Guo DL, 2014, CURR PHARM DESIGN, V20, P2619, DOI 10.2174/13816128113199990486; Guo DL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000446; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hata K, 2008, J CLIN INVEST, V118, P3098, DOI 10.1172/JCI31373; Heemers H, 2001, MOL ENDOCRINOL, V15, P1817, DOI 10.1210/me.15.10.1817; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Ishiguro H, 2003, INT J CANCER, V105, P26, DOI 10.1002/ijc.11021; Ishitani K, 2003, BIOCHEM BIOPH RES CO, V306, P660, DOI 10.1016/S0006-291X(03)01021-0; Kuhajda FP, 2006, CANCER RES, V66, P5977, DOI 10.1158/0008-5472.CAN-05-4673; Kuhnert A, 2012, J CELL BIOCHEM, V113, P1744, DOI 10.1002/jcb.24045; Kuwahara S, 2006, BIOL REPROD, V75, P352, DOI 10.1095/biolreprod.106.051136; Li JN, 2000, EXP CELL RES, V261, P159, DOI 10.1006/excr.2000.5054; Li WH, 2012, CELL CYCLE, V11, P2348, DOI 10.4161/cc.20811; Liu PY, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju113; Lu SY, 2010, INT J CANCER, V126, P416, DOI 10.1002/ijc.24761; MEDES G, 1953, CANCER RES, V13, P27; Milgraum LZ, 1997, CLIN CANCER RES, V3, P2115; Nieva C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046456; Park J, 2014, NAT REV ENDOCRINOL, V10, P455, DOI 10.1038/nrendo.2014.94; Passon DM, 2012, P NATL ACAD SCI USA, V109, P4846, DOI 10.1073/pnas.1120792109; Pavao M, 2001, BMC CANCER, V1, DOI 10.1186/1471-2407-1-15; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Rawson RB, 2003, NAT REV MOL CELL BIO, V4, P631, DOI 10.1038/nrm1174; Rysman E, 2010, CANCER RES, V70, P8117, DOI 10.1158/0008-5472.CAN-09-3871; Schiffnery S, 2011, CARCINOGENESIS, V32, P1176, DOI 10.1093/carcin/bgr103; Shao W, 2012, CELL METAB, V16, P414, DOI 10.1016/j.cmet.2012.09.002; Shav-Tal Y, 2002, FEBS LETT, V531, P109, DOI 10.1016/S0014-5793(02)03447-6; Shimomura I, 1997, J CLIN INVEST, V99, P838, DOI 10.1172/JCI119247; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Sundqvist A, 2005, CELL METAB, V1, P379, DOI 10.1016/j.cmet.2005.04.010; Tennant DA, 2010, NAT REV CANCER, V10, P267, DOI 10.1038/nrc2817; Williams KJ, 2013, CANCER RES, V73, P2850, DOI 10.1158/0008-5472.CAN-13-0382-T; Yamashita T, 2009, J HEPATOL, V50, P100, DOI 10.1016/j.jhep.2008.07.036; Yang YA, 2003, EXP CELL RES, V282, P132, DOI 10.1016/S0014-4827(02)00023-X; Yecies JL, 2011, CELL METAB, V14, P21, DOI 10.1016/j.cmet.2011.06.002; YOKOYAMA C, 1993, CELL, V75, P187, DOI 10.1016/S0092-8674(05)80095-9; Zhang Z, 2001, CELL, V106, P465, DOI 10.1016/S0092-8674(01)00466-4; Zhao XP, 2014, DIABETES, V63, P2464, DOI 10.2337/db13-0835; Zhao XP, 2012, J CLIN INVEST, V122, P2417, DOI 10.1172/JCI61462	47	47	51	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 17	2016	35	11					1399	1410		10.1038/onc.2015.197	http://dx.doi.org/10.1038/onc.2015.197			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DG6LQ	26148231				2022-12-26	WOS:000372196400006
J	Tattikota, SG; Rathjen, T; Hausser, J; Khedkar, A; Kabra, UD; Pandey, V; Sury, M; Wessels, HH; Mollet, IG; Eliasson, L; Selbach, M; Zinzen, RP; Zavolan, M; Kadener, S; Tschop, MH; Jastroch, M; Friedlander, MR; Poy, MN				Tattikota, Sudhir G.; Rathjen, Thomas; Hausser, Jean; Khedkar, Aditya; Kabra, Uma D.; Pandey, Varun; Sury, Matthias; Wessels, Hans-Hermann; Mollet, Ines G.; Eliasson, Lena; Selbach, Matthias; Zinzen, Robert P.; Zavolan, Mihaela; Kadener, Sebastian; Tschoep, Matthias H.; Jastroch, Martin; Friedlaender, Marc R.; Poy, Matthew N.			miR-184 Regulates Pancreatic beta-Cell Function According to Glucose Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-SECRETION; IN-VIVO; DROSOPHILA; PROTEIN; STRESS; REPLICATION; MICRORNAS; REVEALS; DIFFERENTIATION; PROLIFERATION	In response to fasting or hyperglycemia, the pancreatic beta-cell alters its output of secreted insulin; however, the pathways governing this adaptive response are not entirely established. Although the precise role of microRNAs (miRNAs) is also unclear, a recurring theme emphasizes their function in cellular stress responses. We recently showed that miR-184, an abundant miRNA in the beta-cell, regulates compensatory proliferation and secretion during insulin resistance. Consistent with previous studies showing miR-184 suppresses insulin release, expression of this miRNA was increased in islets after fasting, demonstrating an active role in the beta-cell as glucose levels lower and the insulin demand ceases. Additionally, miR-184 was negatively regulated upon the administration of a sucrose-rich diet in Drosophila, demonstrating strong conservation of this pathway through evolution. Furthermore, miR-184 and its target Argonaute2 remained inversely correlated as concentrations of extracellular glucose increased, underlining a functional relationship between this miRNA and its targets. Lastly, restoration of Argonaute2 in the presence of miR-184 rescued suppression of miR-375-targeted genes, suggesting these genes act in a coordinated manner during changes in the metabolic context. Together, these results highlight the adaptive role of miR-184 according to glucose metabolism and suggest the regulatory role of this miRNA in energy homeostasis is highly conserved.	[Tattikota, Sudhir G.; Rathjen, Thomas; Khedkar, Aditya; Sury, Matthias; Wessels, Hans-Hermann; Selbach, Matthias; Zinzen, Robert P.; Poy, Matthew N.] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Hausser, Jean; Zavolan, Mihaela] Univ Basel, Biozentrum, Computat & Syst Biol, CH-4056 Basel, Switzerland; [Kabra, Uma D.; Tschoep, Matthias H.; Jastroch, Martin] Tech Univ Munich, Inst Diabet & Obes, Helmholtz Ctr Hlth & Environm, D-85748 Munich, Germany; [Kabra, Uma D.; Tschoep, Matthias H.; Jastroch, Martin] Tech Univ Munich, Div Metab Dis, D-85748 Munich, Germany; [Pandey, Varun; Kadener, Sebastian] Hebrew Univ Jerusalem, Dept Biol Chem, Silberman Inst Life Sci, IL-91904 Jerusalem, Israel; [Mollet, Ines G.; Eliasson, Lena] Lund Univ, Ctr Diabet, Islet Cell Exocytosis, S-20502 Malmo, Sweden; [Friedlaender, Marc R.] Stockholm Univ, Wenner Gren Inst, Sci Life Lab, Dept Mol Biosci, S-17121 Stockholm, Sweden	Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Basel; Technical University of Munich; Technical University of Munich; Hebrew University of Jerusalem; Lund University; Stockholm University	Poy, MN (corresponding author), Max Delbruck Ctr Mol Med, Robert Roessle Str 10,WFH C27,Rm 131, D-13125 Berlin, Germany.	matthew.poy@mdc-berlin.de	Tattikota, Sudhir Gopal/K-4830-2018; Mollet, Ines Guerra/H-8526-2019; Zavolan, Mihaela/S-3888-2016; Zinzen, Robert/AAG-2784-2020; Kabra, Uma/ABG-9421-2020; Poy, Matthew/F-6914-2017; Eliasson, Lena/E-9294-2012; Jastroch, Martin/I-7494-2017; PANDEY, VARUN/B-8844-2018; Zinzen, Robert/A-3130-2015	Tattikota, Sudhir Gopal/0000-0003-0318-5533; Mollet, Ines Guerra/0000-0002-1422-1336; Poy, Matthew/0000-0002-4904-2426; Eliasson, Lena/0000-0002-6467-5029; Tschoep, Matthias/0000-0002-4744-371X; Zinzen, Robert/0000-0002-8638-5102; Hausser, Jean/0000-0002-3321-7199; Friedlander, Marc/0000-0001-6577-4363; Zavolan, Mihaela/0000-0002-8832-2041	Helmholtz Gemeinschaft; ERC [IsletVasc 260744]; Fritz Thyssen Stiftung; Deutsches Zentrum fuer Herz-Kreislauf Forschung, E.V. (DZHK); Israeli Science Foundation (ISF) [840/2014]; Swedish Research Council; Swedish Diabetes Association	Helmholtz Gemeinschaft(Helmholtz Association); ERC(European Research Council (ERC)European Commission); Fritz Thyssen Stiftung; Deutsches Zentrum fuer Herz-Kreislauf Forschung, E.V. (DZHK); Israeli Science Foundation (ISF)(Israel Science Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Diabetes Association	This work was supported by the Helmholtz Gemeinschaft, an ERC starting grant (IsletVasc 260744), the Fritz Thyssen Stiftung, the Deutsches Zentrum fuer Herz-Kreislauf Forschung, E.V. (DZHK), Israeli Science Foundation (ISF#840/2014 to S. K.), and the Swedish Research Council and Swedish Diabetes Association (to L. E.). The authors do not declare any competing financial interests.	Alonso LC, 2007, DIABETES, V56, P1792, DOI 10.2337/db06-1513; ASHCROFT SJ, 1968, P ROY SOC MED, V61, P814, DOI 10.1177/003591576806100831; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; BONNERWEIR S, 1989, DIABETES, V38, P49, DOI 10.2337/diabetes.38.1.49; Casimir M, 2009, J BIOL CHEM, V284, P25004, DOI 10.1074/jbc.M109.015495; Cernilogar FM, 2011, NATURE, V480, P391, DOI 10.1038/nature10492; Chen HN, 2011, NATURE, V478, P349, DOI 10.1038/nature10502; Chen HA, 2009, GENE DEV, V23, P975, DOI 10.1101/gad.1742509; CHICK WL, 1973, DIABETES, V22, P687, DOI 10.2337/diab.22.9.687; Danial NN, 2008, NAT MED, V14, P144, DOI 10.1038/nm1717; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Giannakou ME, 2008, AGING CELL, V7, P187, DOI 10.1111/j.1474-9726.2007.00362.x; GREY NJ, 1970, J CLIN INVEST, V49, P881, DOI 10.1172/JCI106307; Grun D, 2005, PLOS COMPUT BIOL, V1, P51, DOI 10.1371/journal.pcbi.0010013; Hija A, 2014, DIABETES, V63, P578, DOI 10.2337/db12-1035; Hong X, 2009, P NATL ACAD SCI USA, V106, P15085, DOI 10.1073/pnas.0908149106; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Iovino N, 2009, DEV CELL, V17, P123, DOI 10.1016/j.devcel.2009.06.008; Jan YW, 2004, CELL, V116, P751, DOI 10.1016/S0092-8674(04)00204-1; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; La Rocca G, 2015, P NATL ACAD SCI USA, V112, P767, DOI 10.1073/pnas.1424217112; Leung AKL, 2006, P NATL ACAD SCI USA, V103, P18125, DOI 10.1073/pnas.0608845103; Leung AKL, 2010, MOL CELL, V40, P205, DOI 10.1016/j.molcel.2010.09.027; Liu CM, 2010, CELL STEM CELL, V6, P433, DOI 10.1016/j.stem.2010.02.017; Longo VD, 2014, CELL METAB, V19, P181, DOI 10.1016/j.cmet.2013.12.008; Luciani DS, 2013, DIABETES, V62, P170, DOI 10.2337/db11-1464; Meier JJ, 2008, DIABETES, V57, P1584, DOI 10.2337/db07-1369; Mendell JT, 2012, CELL, V148, P1172, DOI 10.1016/j.cell.2012.02.005; OLDEN K, 1978, CELL, V13, P461, DOI 10.1016/0092-8674(78)90320-3; Olejniczak SH, 2013, P NATL ACAD SCI USA, V110, P157, DOI 10.1073/pnas.1219958110; Padmanabha D, 2014, TRENDS ENDOCRIN MET, V25, P518, DOI 10.1016/j.tem.2014.03.011; Porat S, 2011, CELL METAB, V13, P440, DOI 10.1016/j.cmet.2011.02.012; Poy MN, 2009, P NATL ACAD SCI USA, V106, P5813, DOI 10.1073/pnas.0810550106; Rajasethupathy P, 2009, NEURON, V63, P803, DOI 10.1016/j.neuron.2009.05.029; Sun MG, 2007, NAT CELL BIOL, V9, P1057, DOI 10.1038/ncb1630; Tattikota SG, 2014, CELL METAB, V19, P122, DOI 10.1016/j.cmet.2013.11.015; Tattikota SG, 2013, MOL CELL PROTEOMICS, V12, P1214, DOI 10.1074/mcp.M112.024786; Terauchi Y, 2007, J CLIN INVEST, V117, P246, DOI 10.1172/JCI17645; Zhang XR, 2014, CELL, V158, P607, DOI 10.1016/j.cell.2014.05.047	39	44	45	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2015	290	33					20284	20294		10.1074/jbc.M115.658625	http://dx.doi.org/10.1074/jbc.M115.658625			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP1AT	26152724	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000359608900028
J	Moeskops, P; Benders, MJNL; Kersbergen, KJ; Groenendaal, F; de Vries, LS; Viergever, MA; Isgum, I				Moeskops, Pim; Benders, Manon J. N. L.; Kersbergen, Karina J.; Groenendaal, Floris; de Vries, Linda S.; Viergever, Max A.; Isgum, Ivana			Development of Cortical Morphology Evaluated with Longitudinal MR Brain Images of Preterm Infants	PLOS ONE			English	Article							PRIMATE CEREBRAL-CORTEX; CENTRAL-NERVOUS-SYSTEM; PREMATURE-INFANTS; DIFFUSION TENSOR; MATTER VOLUME; BIRTH; AGE; THICKNESS; INJURY; TERM	Introduction The cerebral cortex develops rapidly in the last trimester of pregnancy. In preterm infants, brain development is very vulnerable because of their often complicated extra-uterine conditions. The aim of this study was to quantitatively describe cortical development in a cohort of 85 preterm infants with and without brain injury imaged at 30 and 40 weeks post-menstrual age (PMA). Methods In the acquired T2-weighted MR images, unmyelinated white matter (UWM), cortical grey matter (CoGM), and cerebrospinal fluid in the extracerebral space (CSF) were automatically segmented. Based on these segmentations, cortical descriptors evaluating volume, surface area, thickness, gyrification index, and global mean curvature were computed at both time points, for the whole brain, as well as for the frontal, temporal, parietal, and occipital lobes separately. Additionally, visual scoring of brain abnormality was performed using a conventional scoring system at 40 weeks PMA. Results The evaluated descriptors showed larger change in the occipital lobes than in the other lobes. Moreover, the cortical descriptors showed an association with the abnormality scores: gyrification index and global mean curvature decreased, whereas, interestingly, median cortical thickness increased with increasing abnormality score. This was more pronounced at 40 weeks PMA than at 30 weeks PMA, suggesting that the period between 30 and 40 weeks PMA might provide a window of opportunity for intervention to prevent delay in cortical development.	[Moeskops, Pim; Viergever, Max A.; Isgum, Ivana] Univ Med Ctr Utrecht, Image Sci Inst, Utrecht, Netherlands; [Moeskops, Pim; Benders, Manon J. N. L.; Kersbergen, Karina J.; Groenendaal, Floris; de Vries, Linda S.] Univ Med Ctr Utrecht, Dept Neonatol, Utrecht, Netherlands; [Benders, Manon J. N. L.] Kings Coll London, Dept Perinatal Imaging & Hlth, Div Imaging Sci & Biomed Engn, London WC2R 2LS, England; [Benders, Manon J. N. L.; Groenendaal, Floris; de Vries, Linda S.; Isgum, Ivana] Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of London; King's College London; Utrecht University; Utrecht University Medical Center	Moeskops, P (corresponding author), Univ Med Ctr Utrecht, Image Sci Inst, Utrecht, Netherlands.	p.moeskops@umcutrecht.nl	de Vries, Linda S/AAB-6454-2021; Moeskops, Pim/K-6728-2017; Viergever, Max A/J-1215-2014; Groenendaal, Floris/P-6872-2019; Isgum, Ivana/H-8659-2014	Moeskops, Pim/0000-0002-8733-6716; Groenendaal, Floris/0000-0002-9284-1637; Isgum, Ivana/0000-0003-1869-5034	Wilhelmina Research Fund [10-427]	Wilhelmina Research Fund	This study included infants participating in the Neobrain study (LSHM-CT-2006-036534) and infants from a study funded by the Wilhelmina Research Fund (10-427).	Ajayi-Obe M, 2000, LANCET, V356, P1162, DOI 10.1016/S0140-6736(00)02761-6; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Awate SP, 2010, NEUROIMAGE, V53, P450, DOI 10.1016/j.neuroimage.2010.06.072; Back SA, 2014, ANN NEUROL, V75, P469, DOI 10.1002/ana.24132; Ball G, 2012, CEREB CORTEX, V22, P1016, DOI 10.1093/cercor/bhr176; Benders MJ, 2015, CEREB CORTEX, V25, P3014, DOI 10.1093/cercor/bhu097; Buser JR, 2012, ANN NEUROL, V71, P93, DOI 10.1002/ana.22627; CHI JG, 1977, ARCH NEUROL-CHICAGO, V34, P346, DOI 10.1001/archneur.1977.00500180040008; Chugani HT, 1998, PREV MED, V27, P184, DOI 10.1006/pmed.1998.0274; Clouchoux C, 2012, BRAIN STRUCT FUNCT, V217, P127, DOI 10.1007/s00429-011-0325-x; Connolly CJ, 1950, EXTERNAL MORPHOLOGY; De Vis JB, 2013, EUR J RADIOL, V82, P538, DOI 10.1016/j.ejrad.2012.10.013; Dean JM, 2014, PEDIATR RES, V75, P227, DOI 10.1038/pr.2013.189; Dean JM, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004669; deIpolyi AR, 2005, NEUROIMAGE, V27, P579, DOI 10.1016/j.neuroimage.2005.04.027; Doesburg SM, 2013, PAIN, V154, P1946, DOI 10.1016/j.pain.2013.04.009; Dubois J, 2008, CEREB CORTEX, V18, P1444, DOI 10.1093/cercor/bhm180; Dubois J, 2008, BRAIN, V131, P2028, DOI 10.1093/brain/awn137; Fischl B, 2001, IEEE T MED IMAGING, V20, P70, DOI 10.1109/42.906426; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Goldman-Rakic PSRP, 1984, CEREBRAL DOMINANCE B, P179; Hilgetag CC, 2005, ANAT EMBRYOL, V210, P411, DOI 10.1007/s00429-005-0041-5; Hilgetag CC, 2006, PLOS COMPUT BIOL, V2, P146, DOI 10.1371/journal.pcbi.0020022; Hill J, 2010, J NEUROSCI, V30, P2268, DOI 10.1523/JNEUROSCI.4682-09.2010; Hogstrom LJ, 2013, CEREB CORTEX, V23, P2521, DOI 10.1093/cercor/bhs231; Hu HH, 2009, EUR J NEUROSCI, V29, P1560, DOI 10.1111/j.1460-9568.2009.06707.x; Huttenlocher PR, 1997, J COMP NEUROL, V387, P167, DOI 10.1002/(SICI)1096-9861(19971020)387:2<167::AID-CNE1>3.0.CO;2-Z; Inder TE, 1999, ANN NEUROL, V46, P755, DOI 10.1002/1531-8249(199911)46:5<755::AID-ANA11>3.0.CO;2-0; Isgum I, 2015, MED IMAGE ANAL, V20, P135, DOI 10.1016/j.media.2014.11.001; Jones SE, 2000, HUM BRAIN MAPP, V11, P12, DOI 10.1002/1097-0193(200009)11:1<12::AID-HBM20>3.0.CO;2-K; Kapellou O, 2006, PLOS MED, V3, P1382, DOI 10.1371/journal.pmed.0030265; Kidokoro H, 2013, AM J NEURORADIOL, V34, P2208, DOI 10.3174/ajnr.A3521; KINNEY HC, 1988, J NEUROPATH EXP NEUR, V47, P217, DOI 10.1097/00005072-198805000-00003; Kostovic I, 2014, BRAIN STRUCT FUNCT, V219, P231, DOI 10.1007/s00429-012-0496-0; Kostovic I, 2010, ACTA PAEDIATR, V99, P1119, DOI 10.1111/j.1651-2227.2010.01811.x; Kostovic I, 2009, SEMIN PERINATOL, V33, P220, DOI 10.1053/j.semperi.2009.04.003; Le Provost JB, 2003, BRIT J PSYCHIAT, V182, P228, DOI 10.1192/bjp.182.3.228; Lee JD, 2011, BRAIN, V134, P1199, DOI 10.1093/brain/awr021; Li G, 2014, J NEUROSCI, V34, P4228, DOI 10.1523/JNEUROSCI.3976-13.2014; Li G, 2013, CEREB CORTEX, V23, P2724, DOI 10.1093/cercor/bhs265; Lyall AE, 2015, CEREB CORTEX, V25, P2204, DOI 10.1093/cercor/bhu027; Mangin JF, 2010, CURR OPIN NEUROL, V23, P359, DOI 10.1097/WCO.0b013e32833a0afc; Moeskops P, 2015, NEUROIMAGE, V118, P628, DOI 10.1016/j.neuroimage.2015.06.007; Moeskops P, 2013, PROC SPIE, V8670, DOI 10.1117/12.2007829; Molko N, 2003, NEURON, V40, P847, DOI 10.1016/S0896-6273(03)00670-6; Murner-Lavanchy I, 2014, EARLY HUM DEV, V90, P443, DOI 10.1016/j.earlhumdev.2014.05.013; Nagy Z, 2011, CEREB CORTEX, V21, P300, DOI 10.1093/cercor/bhq095; Narberhaus A, 2009, NEUROIMAGE, V47, P1884, DOI 10.1016/j.neuroimage.2009.04.036; Neal J, 2007, J ANAT, V210, P66, DOI 10.1111/j.1469-7580.2006.00674.x; Nie JX, 2012, CEREB CORTEX, V22, P2272, DOI 10.1093/cercor/bhr293; Nosarti C, 2008, BRAIN, V131, P205, DOI 10.1093/brain/awm282; Nossin-Manor R, 2013, NEUROIMAGE, V64, P505, DOI 10.1016/j.neuroimage.2012.08.086; Padilla N, 2015, CEREB CORTEX, V25, P1897, DOI 10.1093/cercor/bht431; Peterson BS, 2003, PEDIATRICS, V111, P939, DOI 10.1542/peds.111.5.939; Piao XH, 2004, SCIENCE, V303, P2033, DOI 10.1126/science.1092780; Pienaar R, 2008, INT J IMAG SYST TECH, V18, P42, DOI 10.1002/ima.20138; Rakic P, 2004, SCIENCE, V303, P1983, DOI 10.1126/science.1096414; Rathbone R, 2011, NEUROLOGY, V77, P1510, DOI 10.1212/WNL.0b013e318233b215; Raznahan A, 2011, J NEUROSCI, V31, P7174, DOI 10.1523/JNEUROSCI.0054-11.2011; Rees S, 1997, DEV BRAIN RES, V103, P103, DOI 10.1016/S0165-3806(97)81787-7; RICHMAN DP, 1975, SCIENCE, V189, P18, DOI 10.1126/science.1135626; Rodriguez-Carranza CE, 2008, NEUROIMAGE, V41, P462, DOI 10.1016/j.neuroimage.2008.01.008; Rose J, 2014, NEUROIMAGE, V86, P244, DOI 10.1016/j.neuroimage.2013.09.053; Sowell ER, 2004, J NEUROSCI, V24, P8223, DOI 10.1523/JNEUROSCI.1798-04.2004; Tamnes CK, 2010, CEREB CORTEX, V20, P534, DOI 10.1093/cercor/bhp118; Thambisetty M, 2010, NEUROIMAGE, V52, P1215, DOI 10.1016/j.neuroimage.2010.04.258; Tich SNT, 2009, AM J NEURORADIOL, V30, P125, DOI 10.3174/ajnr.A1309; Toro R, 2005, CEREB CORTEX, V15, P1900, DOI 10.1093/cercor/bhi068; Tzarouchi LC, 2009, NEUROIMAGE, V47, P1148, DOI 10.1016/j.neuroimage.2009.03.072; Van Essen DC, 2006, J NEUROSCI, V26, P5470, DOI 10.1523/JNEUROSCI.4154-05.2006; VanEssen DC, 1997, NATURE, V385, P313, DOI 10.1038/385313a0; Volpe JJ, 2009, SEMIN PEDIATR NEUROL, V16, P167, DOI 10.1016/j.spen.2009.09.005; Volpe JJ, 2009, LANCET NEUROL, V8, P110, DOI 10.1016/S1474-4422(08)70294-1; Volpe JV, 2008, NEUROLOGY OF THE NEW; Welker W., 1990, Cerebral Cortex, V8B, P3; Windreich G, 2003, PATTERN RECOGN, V36, P2531, DOI 10.1016/S0031-3203(03)00173-0; Wright R, 2014, NEUROIMAGE, V91, P21, DOI 10.1016/j.neuroimage.2014.01.034; Xue H, 2007, NEUROIMAGE, V38, P461, DOI 10.1016/j.neuroimage.2007.07.030; ZILLES K, 1988, ANAT EMBRYOL, V179, P173, DOI 10.1007/BF00304699; Zubiaurre-Elorza L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042148	80	42	42	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131552	10.1371/journal.pone.0131552	http://dx.doi.org/10.1371/journal.pone.0131552			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161536	gold, Green Published, Green Submitted			2022-12-26	WOS:000358162300046
J	Ni, SQ; Lv, JC; Cheng, ZH; Li, M				Ni, Shengqiao; Lv, Jiancheng; Cheng, Zhehao; Li, Mao			Novel Online Dimensionality Reduction Method with Improved Topology Representing and Radial Basis Function Networks	PLOS ONE			English	Article							LEARNING ALGORITHM	This paper presents improvements to the conventional Topology Representing Network to build more appropriate topology relationships. Based on this improved Topology Representing Network, we propose a novel method for online dimensionality reduction that integrates the improved Topology Representing Network and Radial Basis Function Network. This method can find meaningful low-dimensional feature structures embedded in high-dimensional original data space, process nonlinear embedded manifolds, and map the new data online. Furthermore, this method can deal with large datasets for the benefit of improved Topology Representing Network. Experiments illustrate the effectiveness of the proposed method.	[Ni, Shengqiao; Lv, Jiancheng; Cheng, Zhehao; Li, Mao] Sichuan Univ, Coll Comp Sci, Machine Intelligence Lab, Chengdu 610065, Peoples R China	Sichuan University	Lv, JC (corresponding author), Sichuan Univ, Coll Comp Sci, Machine Intelligence Lab, Chengdu 610065, Peoples R China.	lvjiancheng@scu.edu.cn			National Science Foundation of China [61375065, 61432014]; National Program on Key Basic 307 Research Project (973 Program) [2011CB302201]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Program on Key Basic 307 Research Project (973 Program)(National Basic Research Program of China)	This work was supported by National Science Foundation of China (http://www.nsfc.gov.cn/) under grant 61375065 and 61432014 and National Program on Key Basic 307 Research Project (973 Program) (http://program.most.gov.cn/) under grant 2011CB302201.	Belkin M, 2003, NEURAL COMPUT, V15, P1373, DOI 10.1162/089976603321780317; Bharti KK, 2015, EXPERT SYST APPL, V42, P3105, DOI 10.1016/j.eswa.2014.11.038; Bollen J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006022; Borg I, 2005, MODERN MUTLIDIMENSIO, V40; Boutsidis C, 2015, IEEE T INFORM THEORY, V61, P1045, DOI 10.1109/TIT.2014.2375327; Cattaert T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010304; Dai XJ, 2015, OPT COMMUN, V338, P348, DOI 10.1016/j.optcom.2014.10.055; Dominguez M, 2015, INFORM SCIENCES, V294, P553, DOI 10.1016/j.ins.2014.06.029; Espezua S, 2015, NEUROCOMPUTING, V149, P767, DOI 10.1016/j.neucom.2014.07.057; Estevez PA, 2006, NEURAL NETWORKS, V19, P923, DOI 10.1016/j.neunet.2006.05.024; Estevez PA, 2006, LECT NOTES COMPUT SC, V4131, P464; Fasshauer GE, 1999, ADV COMPUT MATH, V11, P139, DOI 10.1023/A:1018919824891; Fritzke B., 1995, Advances in Neural Information Processing Systems 7, P625; Gan M, 2015, IEEE SIGNAL PROC LET, V22, P809, DOI 10.1109/LSP.2014.2369415; Gisbrecht A, 2015, NEUROCOMPUTING, V147, P71, DOI 10.1016/j.neucom.2013.11.045; Graham D.B., 1998, CHARACTERISING VIRTU; Haykin S., 1998, NEURAL NETWORKS; Hotelling H, 1933, J EDUC PSYCHOL, V24, P417, DOI 10.1037/h0071325; Ingram S, 2015, NEUROCOMPUTING, V150, P557, DOI 10.1016/j.neucom.2014.07.073; Jolliffe IT, 2002, SPRINGER SERIES IN S, V87, P41; Kaski S, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-48; Li B, 2015, NEUROCOMPUTING, V152, P121, DOI 10.1016/j.neucom.2014.11.012; Lu JN, 2015, NEUROCOMPUTING, V152, P305, DOI 10.1016/j.neucom.2014.10.065; Lv JC, 2007, IEEE T NEURAL NETWOR, V18, P1557, DOI 10.1109/TNN.2007.895824; Lv JC, 2010, IEEE T FUZZY SYST, V18, P217, DOI 10.1109/TFUZZ.2009.2038711; Ma JZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040115; MARTINETZ T, 1994, NEURAL NETWORKS, V7, P507, DOI 10.1016/0893-6080(94)90109-0; Martinetz T., 1991, Artificial Neural Networks. Proceedings of the 1991 International Conference. ICANN-91, P397; Pagliosa P, 2015, NEUROCOMPUTING, V150, P599, DOI 10.1016/j.neucom.2014.07.072; Park J, 1991, NEURAL COMPUT, V3, P246, DOI 10.1162/neco.1991.3.2.246; Roweis ST, 2000, SCIENCE, V290, P2323, DOI 10.1126/science.290.5500.2323; SAMMON JW, 1969, IEEE T COMPUT, VC 18, P401, DOI 10.1109/T-C.1969.222678; Shang LF, 2006, NEUROCOMPUTING, V69, P1717, DOI 10.1016/j.neucom.2006.01.007; Shen HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084096; Silva VD, 2003, ADVANCES IN NEURAL I, V15; Tang L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096944; Tenenbaum JB, 2000, SCIENCE, V290, P2319, DOI 10.1126/science.290.5500.2319; Tokunaga K, 2014, APPL SOFT COMPUT, V22, P311, DOI 10.1016/j.asoc.2014.04.028; Tomenko V, 2011, NEURAL NETWORKS, V24, P501, DOI 10.1016/j.neunet.2011.02.007; Torgerson WS, 1958, BIOMETRIKA; Venna J, 2005, LOCAL MULTIDIMENSION; Wei MZ, 2015, IEEE SENS J, V15, DOI 10.1109/JSEN.2014.2366035; Xu HM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108103; Ye M, 2005, NEURAL COMPUT APPL, V14, P18, DOI 10.1007/s00521-004-0435-y	44	1	1	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131631	10.1371/journal.pone.0131631	http://dx.doi.org/10.1371/journal.pone.0131631			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161960	Green Published, Green Submitted, gold			2022-12-26	WOS:000358162300050
J	Ruggeri, J; Longo, AV; Gaiarsa, MP; Alencar, LRV; Lambertini, C; Leite, DS; Carvalho-e-Silva, SP; Zamudio, KR; Toledo, LF; Martins, M				Ruggeri, Joice; Longo, Ana V.; Gaiarsa, Marilia P.; Alencar, Laura R. V.; Lambertini, Carolina; Leite, Domingos S.; Carvalho-e-Silva, Sergio P.; Zamudio, Kelly R.; Toledo, Luis Felipe; Martins, Marcio			Seasonal Variation in Population Abundance and Chytrid Infection in Stream-Dwelling Frogs of the Brazilian Atlantic Forest	PLOS ONE			English	Article							BATRACHOCHYTRIUM-DENDROBATIDIS; AMPHIBIAN CHYTRIDIOMYCOSIS; HIGH PREVALENCE; HOST DEFENSES; DISEASE; FUNGUS; PATHOGEN; DECLINES; HISTORY; DYNAMICS	Enigmatic amphibian declines were first reported in southern and southeastern Brazil in the late 1980s and included several species of stream-dwelling anurans (families Hylodidae and Cycloramphidae). At that time, we were unaware of the amphibian-killing fungus Batrachochytrium dendrobatidis (Bd); therefore, pollution, habitat loss, fragmentation and unusual climatic events were hypothesized as primary causes of these declines. We now know that multiple lineages of Bd have infected amphibians of the Brazilian Atlantic forest for over a century, yet declines have not been associated specifically with Bd outbreaks. Because stream-dwelling anurans occupy an environmental hotspot ideal for disease transmission, we investigated temporal variation in population and infection dynamics of three stream-adapted species (Hylodes asper, H. phyllodes, and Cycloramphus boraceiensis) on the northern coast of Sao Paulo state, Brazil. We surveyed standardized transects along streams for four years, and show that fluctuations in the number of frogs correlate with specific climatic variables that also increase the likelihood of Bd infections. In addition, we found that Bd infection probability in C. boraceiensis, a nocturnal species, was significantly higher than in Hylodes spp., which are diurnal, suggesting that the nocturnal activity may either facilitate Bd zoospore transmission or increase susceptibility of hosts. Our findings indicate that, despite long-term persistence of Bd in Brazil, some hosts persist with seasonally variable infections, and thus future persistence in the face of climate change will depend on the relative effect of those changes on frog recruitment and pathogen proliferation.	[Ruggeri, Joice; Carvalho-e-Silva, Sergio P.] Univ Fed Rio de Janeiro, Inst Biol, Rio De Janeiro, RJ, Brazil; [Longo, Ana V.; Zamudio, Kelly R.] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY USA; [Gaiarsa, Marilia P.; Alencar, Laura R. V.; Martins, Marcio] Univ Sao Paulo, Inst Biociencias, Dept Ecol, Sao Paulo, Brazil; [Lambertini, Carolina; Toledo, Luis Felipe] Univ Estadual Campinas, Inst Biol, Dept Biol Anim, LaHNAB, Campinas, SP, Brazil; [Leite, Domingos S.] Univ Estadual Campinas, Inst Biol, Dept Genet Evolucao & Bioagentes, Lab Antigenos Bacterianos, Campinas, SP, Brazil	Universidade Federal do Rio de Janeiro; Cornell University; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade Estadual de Campinas	Ruggeri, J (corresponding author), Univ Fed Rio de Janeiro, Inst Biol, Rio De Janeiro, RJ, Brazil.	joice.ruggeri@gmail.com	Martins, Marcio/C-1150-2011; Leite, Domingos S/D-4365-2012; Leite, Domingos/L-4531-2013; Toledo, Luís Felipe/I-4017-2012; Alencar, Laura R V/E-2030-2013; Longo, Ana V./AAH-1522-2020; Lambertini, Carolina/GNH-2000-2022; Ruggeri, Joice/F-7745-2015; Lambertini, Carolina/J-5192-2014; Gaiarsa, Marilia P/B-1211-2013	Martins, Marcio/0000-0001-8108-6309; Leite, Domingos/0000-0002-0946-4165; Toledo, Luís Felipe/0000-0002-4929-9598; Alencar, Laura R V/0000-0002-6805-7682; Longo, Ana V./0000-0002-5112-1246; Ruggeri, Joice/0000-0001-8307-6067; Lambertini, Carolina/0000-0002-6036-3079; Zamudio, Kelly/0000-0001-5107-6206; Da Silva Leite, Domingos/0000-0003-4737-7852	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2006/58011-4, 2007/51478-7, 2008/52847-9, 2008/50325-5, 2010/50146-3, 2011/51694-7]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [301128/2009-0, 302953/2012-4, 405285/20132, 302589/2013-9, 200352/2014-8]; National Science Foundation [OISE-1159513]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National Science Foundation(National Science Foundation (NSF))	This work was supported by 2006/58011-4, 2007/51478-7, 2008/52847-9, 2008/50325-5, 2010/50146-3, and 2011/51694-7 Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (www.fapesp.br) (MM); 301128/2009-0, 302953/2012-4, 405285/20132, 302589/2013-9, 200352/2014-8 Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (www.cnpq.br) (LFT); 311156/2013-4 Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (www.cnpq.br) (SPCS); and OISE-1159513, National Science Foundation (www.nsf.gov) (KZ).	Almeida-Gomes M, 2014, CONSERV BIOL, V28, P616, DOI 10.1111/cobi.12196; [Anonymous], 2002, AGR SIST MON AGR; Becker CG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048205; Becker CG, 2011, P NATL ACAD SCI USA, V108, P9893, DOI 10.1073/pnas.1014497108; Becker CG, 2015, P R SOC B, V281; Boltana S, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1381; Catenazzi A, 2013, BIOL CONSERV, V159, P413, DOI 10.1016/j.biocon.2012.11.023; Cleveland R.B., 1990, J OFF STAT, V6, P3; Collins JP, 2003, DIVERS DISTRIB, V9, P89, DOI 10.1046/j.1472-4642.2003.00012.x; Corn P. S., 2005, Animal Biodiversity and Conservation, V28, P59; Crawford AJ, 2010, P NATL ACAD SCI USA, V107, P13777, DOI 10.1073/pnas.0914115107; Edenhofer O., 2014, CONTRIBUTION WORKING; Ellison AR, 2014, G3-GENES GENOM GENET, V4, P1275, DOI 10.1534/g3.114.010744; Eterovick PC, 2005, BIOTROPICA, V37, P166, DOI 10.1111/j.1744-7429.2005.00024.x; Goka K, 2009, MOL ECOL, V18, P4757, DOI 10.1111/j.1365-294X.2009.04384.x; Grundler MC, 2012, DIS AQUAT ORGAN, V97, P173, DOI 10.3354/dao02413; Guix Juan C., 1998, Herpetological Natural History, V6, P1; HADDAD C.F.B., 2013, GUIA ANFIBIOS MATA A; Hartmann MT, 2010, IHERINGIA SER ZOOL, V100, P207, DOI 10.1590/S0073-47212010000300004; HEYER WR, 1988, BIOTROPICA, V20, P230, DOI 10.2307/2388238; Hyatt AD, 2007, DIS AQUAT ORGAN, V73, P175, DOI 10.3354/dao073175; Kriger KM, 2008, AUSTRAL ECOL, V33, P1022, DOI 10.1111/j.1442-9993.2008.01872.x; Kriger KM, 2006, DIS AQUAT ORGAN, V71, P149, DOI 10.3354/dao071149; Lambertini Carolina, 2013, Herpetologia Brasileira, V2, P12; Lamirande EW, 2002, P 6 INT S PATH REPT, P3; Lips KR, 2008, PLOS BIOL, V6, P441, DOI 10.1371/journal.pbio.0060072; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Longcore JE, 1999, MYCOLOGIA, V91, P219, DOI 10.2307/3761366; Longo AV, 2014, INTEGR COMP BIOL, V54, P427, DOI 10.1093/icb/icu073; Longo AV, 2013, J WILDLIFE DIS, V49, P197, DOI 10.7589/2012-05-129; Longo AV, 2010, DIS AQUAT ORGAN, V92, P253, DOI 10.3354/dao02054; McDonald K, 1999, DECLINES DISAPPEARAN, P14; Murray KA, 2009, CONSERV BIOL, V23, P1242, DOI 10.1111/j.1523-1739.2009.01211.x; Ouellet M, 2005, CONSERV BIOL, V19, P1431, DOI 10.1111/j.1523-1739.2005.00108.x; Patto CEG, 2001, J HERPETOL, V35, P684, DOI 10.2307/1565913; Piotrowski JS, 2004, MYCOLOGIA, V96, P9, DOI 10.2307/3761981; Puschendorf R, 2006, BIOL CONSERV, V132, P136, DOI 10.1016/j.biocon.2006.03.010; Puschendorf R, 2011, CONSERV BIOL, V25, P956, DOI 10.1111/j.1523-1739.2011.01728.x; R Development Core Team RDC, 2013, R A LANGUAGE AND ENV; Raffel TR, 2006, FUNCT ECOL, V20, P819, DOI 10.1111/j.1365-2435.2006.01159.x; Retallick RWR, 2004, PLOS BIOL, V2, P1965, DOI 10.1371/journal.pbio.0020351; Richards-Zawacki CL, 2010, P ROY SOC B-BIOL SCI, V277, P519, DOI 10.1098/rspb.2009.1656; Rodriguez D, 2014, MOL ECOL, V23, P774, DOI 10.1111/mec.12615; Rosenblum EB, 2013, P NATL ACAD SCI USA, V110, P9385, DOI 10.1073/pnas.1300130110; Rowley JJL, 2013, SCI REP-UK, V3, DOI 10.1038/srep01515; Scheele BC, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00108.1; Scheele B, 2014, BIOL CONSERV, V170, P86, DOI 10.1016/j.biocon.2013.12.034; Schloegel LM, 2012, MOL ECOL, V21, P5162, DOI 10.1111/j.1365-294X.2012.05710.x; Skerratt LF, 2008, DIS AQUAT ORGAN, V80, P85, DOI 10.3354/dao01923; Toledo L. F., 2006, Amphibian & Reptile Conservation, V4, P17, DOI 10.1514/journal.arc.0040017; Toledo LF, 2014, BIOL CONSERV, V179, P54, DOI 10.1016/j.biocon.2014.08.012; Vredenburg VT, 2010, P NATL ACAD SCI USA, V107, P9689, DOI 10.1073/pnas.0914111107; Walls Susan C., 2013, Biology - Basel, V2, P399, DOI 10.3390/biology2010399; Welsh HH, 1998, ECOL APPL, V8, P1118; WEYGOLDT P, 1989, STUD NEOTROP FAUNA E, V24, P249, DOI 10.1080/01650528909360795; Whitfield SM, 2012, BIOTROPICA, V44, P779, DOI 10.1111/j.1744-7429.2012.00872.x; Woodhams DC, 2008, ECOLOGY, V89, P1627, DOI 10.1890/06-1842.1	57	32	33	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0130554	10.1371/journal.pone.0130554	http://dx.doi.org/10.1371/journal.pone.0130554			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161777	Green Published, gold, Green Submitted			2022-12-26	WOS:000358162300018
J	Viana, CTR; Castro, PR; Marques, S; Lopes, MTP; Goncalves, R; Campos, PP; Andrade, SP				Rodrigues Viana, Celso Tarso; Castro, Pollyana Ribeiro; Marques, SuzaneMotta; Paz Lopes, Miriam Teresa; Goncalves, Ricardo; Campos, Paula Peixoto; Andrade, Silvia Passos			Differential Contribution of Acute and Chronic Inflammation to the Development of Murine Mammary 4T1 Tumors	PLOS ONE			English	Article							CANCER-RELATED INFLAMMATION; NITRIC-OXIDE SYNTHASE; BREAST-CANCER; ANGIOGENESIS; MICE; CELLS; PROGRESSION; CARCINOMA; GROWTH; FIBROSARCOMA	Based on the notion that inflammation favors tumorigenesis, our experiments comparatively assessed the influence of acute and chronic inflammation on the development of a murine mammary tumor (4T1). In addition, we characterized angiogenic and inflammatory markers in the tumor tissue and systemically. Subcutaneous implantation of polyether-polyurethane sponge discs in Balb/c mice was used to host 4T1 tumor cells (1x10(6)), which were inoculated intraimplant 24h or 10 days post implantation. Flow cytometric analysis of enzyme-digested implants revealed that, after 24 hours, the population of leukocytes was primarily characterized by neutrophils (42.53%+/-8.45) andmonocytes (37.53%+/-7.48), with some lymphocytes (16.27%+/-4.0) and a few dendritic cells (1.82%+/-0.36). At 10 days, macrophages were predominant (37.10%+/-4.54), followed by lymphocytes (28.1%+/-4.77), and monocytes (22.33%+/-3.05), with some dendritic cells (13.60%+/-0.55) and neutrophils (11.07%+/-2.27). A mammary tumor grown in a chronic inflammatory environment was 2-fold when compared with one grown in acute inflammation and 5-fold when compared with tumor alone. The levels of pro-angiogenic cytokine (VEGF-Vascular Endothelial Growth Factor) were higher in implant-bearing tumor when 4T1 cells were grown in 10-day old implants as compared to the VEGF levels of the two other groups. Overall, the levels of the inflammatory markers evaluated (NAG -N-acetylglucosaminidase, TNF-alpha-Tumor Necrosis Factor-alpha) were higher in both groups of implant-bearing tumors and in serumfromthose animals when compared with the tumor alone levels. This inflammation-related difference in tumor growth may provide new insights into the contribution of different inflammatory cell populations to cancer progression.	[Rodrigues Viana, Celso Tarso; Castro, Pollyana Ribeiro; Marques, SuzaneMotta; Andrade, Silvia Passos] Univ Fed Minas Gerais, Inst Biol Sci, Dept Physiol & Biophys, Belo Horizonte, MG, Brazil; [Paz Lopes, Miriam Teresa] Univ Fed Minas Gerais, Inst Biol Sci, Dept Pharmacol, Belo Horizonte, MG, Brazil; [Goncalves, Ricardo; Campos, Paula Peixoto] Univ Fed Minas Gerais, Inst Biol Sci, Dept Gen Pathol, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Campos, PP (corresponding author), Univ Fed Minas Gerais, Inst Biol Sci, Dept Gen Pathol, Belo Horizonte, MG, Brazil.	paulapc@icb.ufmg.br	CAMPOS, PAULA PEIXOTO/N-9004-2019; Goncalves, Ricardo/I-2411-2018; Lopes, Miriam T P/A-7732-2015; Castro, Pollyana R/E-3969-2019	CAMPOS, PAULA PEIXOTO/0000-0003-2016-2210; Lopes, Miriam T P/0000-0001-9980-3169; Castro, Pollyana R/0000-0002-1404-6873	CAPES-Brazil	CAPES-Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The author Celso Tarso received funding as a (PhD scholarship) from CAPES-Brazil for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albini A, 2012, NAT REV CLIN ONCOL, V9, P498, DOI 10.1038/nrclinonc.2012.120; ANDRADE SP, 1992, BRIT J PHARMACOL, V107, P1092, DOI 10.1111/j.1476-5381.1992.tb13412.x; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Balkwill F, 2006, CANCER METAST REV, V25, P409, DOI 10.1007/s10555-006-9005-3; Balkwill F, 2009, NAT REV CANCER, V9, P361, DOI 10.1038/nrc2628; Balkwill FR, 2012, SEMIN CANCER BIOL, V22, P33, DOI 10.1016/j.semcancer.2011.12.005; BRAND I, 1977, J NATL CANCER I, V58, P1443; BRAND KG, 1975, J NATL CANCER I, V55, P319; BUTTERY LDK, 1993, J PATHOL, V171, P311, DOI 10.1002/path.1711710412; Campos PP, 2006, HISTOL HISTOPATHOL, V21, P1263, DOI 10.14670/HH-21.1263; Candido J, 2013, J CLIN IMMUNOL, V33, pS79, DOI 10.1007/s10875-012-9847-0; Castro PR, 2012, MICROVASC RES, V84, P9, DOI 10.1016/j.mvr.2012.04.003; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; DEXTER DL, 1978, CANCER RES, V38, P3174; DRABKIN DL, 1946, J BIOL CHEM, V164, P703; duPre' SA, 2007, EXP MOL PATHOL, V82, P12, DOI 10.1016/j.yexmp.2006.06.007; Dupre SA, 2008, EXP MOL PATHOL, V85, P174, DOI 10.1016/j.yexmp.2008.05.002; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Folkman J, 2003, CURR MOL MED, V3, P643, DOI 10.2174/1566524033479465; Germano MP, 2008, J ETHNOPHARMACOL, V115, P271, DOI 10.1016/j.jep.2007.10.001; Ghoneum M, 2008, INT J ONCOL, V33, P533, DOI 10.3892/ijo_00000037; Heppner GH, 2000, BREAST CANCER RES, V2, P331; Hussain SP, 2007, INT J CANCER, V121, P2373, DOI 10.1002/ijc.23173; ISHIKAWA M, 1987, INT J CANCER, V39, P338, DOI 10.1002/ijc.2910390312; Kirkpatrick CJ, 2000, AM J PATHOL, V156, P1455, DOI 10.1016/S0002-9440(10)65014-6; Kuper HE, 2000, CANCER CAUSE CONTROL, V11, P171, DOI 10.1023/A:1008951901148; Lage AP, 2000, MICROVASC RES, V59, P278, DOI 10.1006/mvre.1999.2217; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Marques SM, 2011, MICROVASC RES, V82, P246, DOI 10.1016/j.mvr.2011.08.011; OKADA F, 1992, BRIT J CANCER, V66, P635, DOI 10.1038/bjc.1992.329; Ono M, 2008, CANCER SCI, V99, P1501, DOI 10.1111/j.1349-7006.2008.00853.x; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Rymaszewski AL, 2014, CANCERS, V6, P1111, DOI 10.3390/cancers6021111; Tazawa H, 2003, AM J PATHOL, V163, P2221, DOI 10.1016/S0002-9440(10)63580-8; Tazawa H, 2007, CARCINOGENESIS, V28, P191, DOI 10.1093/carcin/bgl128; Viana CTR, 2013, MICROVASC RES, V86, P44, DOI 10.1016/j.mvr.2012.12.002; WEITZMAN SA, 1985, SCIENCE, V227, P1231, DOI 10.1126/science.3975611; Yoshimura T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058791	39	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2015	10	7							e0130809	10.1371/journal.pone.0130809	http://dx.doi.org/10.1371/journal.pone.0130809			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EW	26158775	Green Published, Green Submitted, gold			2022-12-26	WOS:000358161200020
J	Dietrich, F; Martins, JP; Kaiser, S; Silva, RBM; Rockenbach, L; Edelweiss, MIA; Ortega, GG; Morrone, FB; Campos, MM; Battastini, AMO				Dietrich, Fabrcia; Martins, Jeronimo Pietrobon; Kaiser, Samuel; Madeira Silva, Rodrigo Braccini; Rockenbach, Liliana; Albano Edelweiss, Maria Isabel; Ortega, George Gonzalez; Morrone, Fernanda Bueno; Campos, Maria Martha; Oliveira Battastini, Ana Maria			The Quinovic Acid Glycosides Purified Fraction from Uncaria tomentosa Protects against Hemorrhagic Cystitis Induced by Cyclophosphamide in Mice	PLOS ONE			English	Article							CATS CLAW; ANTIINFLAMMATORY ACTIVITY; URINARY-BLADDER; RECEPTORS; EXPRESSION; MODEL; EXTRACTS	Uncaria tomentosa is widely used in folk medicine for the treatment of numerous diseases, such as urinary tract disease. Hemorrhagic cystitis (HE) is an inflammatory condition of the bladder associated with the use of anticancer drugs such as cyclophosphamide (CYP). Sodium 2-mercaptoethanesulfonate (Mesna) has been used to prevent the occurrence of HE, although this compound is not effective in established lesions. It has been demonstrated that the purinergic system is involved in several pathophysiological events. Among purinergic receptors, P2X7 deserves attention because it is involved in HE induced by CYP and, therefore, can be considered a therapeutic target. The objective of this study was to investigate the potential therapeutic effect of the quinovic acid glycosides purified fraction (QAPF) from U. tomentosa in the mouse model of CYP-induced HE. Pretreatment with QAPF not only had a protective effect on HE-induced urothelial damage (edema, hemorrhage and bladder wet weight) but was also able to control visceral pain, decrease IL-1 beta levels and down-regulates P2X7 receptors, most likely by inhibit the neutrophils migration to the bladder. This research clearly demonstrates the promising anti-inflammatory properties of QAPF, supporting its use as complementary therapy. QAPF represents a promising therapeutic option for this pathological condition.	[Dietrich, Fabrcia; Rockenbach, Liliana; Oliveira Battastini, Ana Maria] Univ Fed Rio Grande do Sul, ICBS, Programa Posgrad Ciencias Biol Bioquim, Porto Alegre, RS, Brazil; [Oliveira Battastini, Ana Maria] Univ Fed Rio Grande do Sul, ICBS, Dept Bioquim, Porto Alegre, RS, Brazil; [Martins, Jeronimo Pietrobon; Madeira Silva, Rodrigo Braccini; Morrone, Fernanda Bueno] Pontificia Univ Catolica Rio Grande do Sul, Fac Farm, Lab Farmacol Aplicada, Porto Alegre, RS, Brazil; [Kaiser, Samuel; Ortega, George Gonzalez] Univ Fed Rio Grande do Sul, Fac Farm, Programa Posgrad Ciencias Farmaceut, Porto Alegre, RS, Brazil; [Madeira Silva, Rodrigo Braccini; Morrone, Fernanda Bueno; Campos, Maria Martha] Pontificia Univ Catolica Rio Grande do Sul, Inst Toxicol & Farmacol, Porto Alegre, RS, Brazil; [Albano Edelweiss, Maria Isabel] Univ Fed Rio Grande do Sul, Fac Med, Porto Alegre, RS, Brazil; [Campos, Maria Martha] Pontificia Univ Catolica Rio Grande do Sul, Fac Odontol, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul; Universidade Federal do Rio Grande do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul; Universidade Federal do Rio Grande do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul	Battastini, AMO (corresponding author), Univ Fed Rio Grande do Sul, ICBS, Programa Posgrad Ciencias Biol Bioquim, Porto Alegre, RS, Brazil.	abattastini@gmail.com	Battastini, Ana M/E-2809-2012; Morrone, Fernanda/AAH-6044-2020; Campos, Maria Martha M/J-8829-2015; Dietrich, Fabrícia/F-8658-2019; Kaiser, Samuel/L-7833-2019; Silva, Rodrigo BM/O-7441-2017; Morrone, Fernanda B/K-7703-2015	Battastini, Ana M/0000-0001-6068-3278; Morrone, Fernanda/0000-0002-2709-2801; Campos, Maria Martha M/0000-0002-1153-3633; Silva, Rodrigo BM/0000-0001-6284-7387; Morrone, Fernanda B/0000-0002-2709-2801; Dietrich, Fabricia/0000-0002-6458-2359; Campos, Maria/0000-0001-7738-9892	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes); FINEP (Financiadora de Estudos e Projetos) research grant "Implantacao, Modernizacao e Qualificacao de Estrutura de Pesquisa da PUCRS" (PUCRSINFRA) [01.11.0014-00]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FINEP (Financiadora de Estudos e Projetos) research grant "Implantacao, Modernizacao e Qualificacao de Estrutura de Pesquisa da PUCRS" (PUCRSINFRA)	This study was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes), in addition to a FINEP (Financiadora de Estudos e Projetos) research grant "Implantacao, Modernizacao e Qualificacao de Estrutura de Pesquisa da PUCRS" (PUCRSINFRA) #01.11.0014-00. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar JL, 2002, J ETHNOPHARMACOL, V81, P271, DOI 10.1016/S0378-8741(02)00093-4; Allen-Hall L, 2007, J ETHNOPHARMACOL, V109, P312, DOI 10.1016/j.jep.2006.07.039; Allen-Hall L, 2010, J ETHNOPHARMACOL, V127, P685, DOI 10.1016/j.jep.2009.12.004; AQUINO R, 1991, J NAT PROD, V54, P453, DOI 10.1021/np50074a016; Batista CKLP, 2006, BRAZ J MED BIOL RES, V39, P1475; Dantas ACB, 2010, ACTA CIR BRAS, V25, P43, DOI 10.1590/S0102-86502010000100011; Bhatia K, 2008, FOOD CHEM TOXICOL, V46, P3368, DOI 10.1016/j.fct.2008.08.011; Burnstock G, 2004, CURR TOP MED CHEM, V4, P793, DOI 10.2174/1568026043451014; Cisneros FJ, 2005, J ETHNOPHARMACOL, V96, P355, DOI 10.1016/j.jep.2004.06.039; Di Virgilio F, 2007, TRENDS PHARMACOL SCI, V28, P465, DOI 10.1016/j.tips.2007.07.002; Dietrich F, 2014, FOOD CHEM TOXICOL, V67, P222, DOI 10.1016/j.fct.2014.02.037; Fennell D, 2004, PREV MED, V39, P932, DOI 10.1016/j.ypmed.2004.03.031; GRAY KJ, 1986, J UROLOGY, V136, P497, DOI 10.1016/S0022-5347(17)44929-9; Heitzman ME, 2005, PHYTOCHEMISTRY, V66, P5, DOI 10.1016/j.phytochem.2004.10.022; Keplinger K, 1999, J ETHNOPHARMACOL, V64, P23, DOI 10.1016/S0378-8741(98)00096-8; Kiuchi H, 2009, J UROLOGY, V181, P2339, DOI 10.1016/j.juro.2009.01.015; Lee HY, 2000, J UROLOGY, V163, P2002, DOI 10.1016/S0022-5347(05)67618-5; Malykhina Anna P., 2012, BMC Physiology, V12, P15, DOI 10.1186/1472-6793-12-15; Manikandan R, 2010, INDIAN J UROL, V26, P159, DOI 10.4103/0970-1591.65380; Martins JP, 2012, BRIT J PHARMACOL, V165, P183, DOI 10.1111/j.1476-5381.2011.01535.x; Morais MM, 1999, BRAZ J MED BIOL RES, V32, P1211, DOI 10.1590/S0100-879X1999001000006; Negoro H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106269; O'Reilly BA, 2001, BJU INT, V87, P617, DOI 10.1046/j.1464-410x.2001.02179.x; Passos GF, 2004, J IMMUNOL, V172, P1839, DOI 10.4049/jimmunol.172.3.1839; Pavei C, 2012, J PHARMACEUT BIOMED, V62, P250, DOI 10.1016/j.jpba.2011.12.031; Phelps PT, 2006, EUR J PHARMACOL, V536, P28, DOI 10.1016/j.ejphar.2006.02.046; Ralevic V, 1998, PHARMACOL REV, V50, P413; Rosenbaum CC, 2010, ALTERN THER HEALTH M, V16, P32; Sandoval M, 2002, PHYTOMEDICINE, V9, P325, DOI 10.1078/0944-7113-00117; Sandoval-Chacon M, 1998, ALIMENT PHARM THER, V12, P1279, DOI 10.1046/j.1365-2036.1998.00424.x; Santos AA, 2010, N-S ARCH PHARMACOL, V382, P399, DOI 10.1007/s00210-010-0555-0; Sheng YZ, 2000, J ETHNOPHARMACOL, V69, P115, DOI 10.1016/S0378-8741(99)00070-7; Traxer O, 2001, PROG UROL, V11, P591; Vial C, 2000, BRIT J PHARMACOL, V131, P1489, DOI 10.1038/sj.bjp.0703720; Wantuch C, 2007, NEUROSCI LETT, V421, P250, DOI 10.1016/j.neulet.2007.05.043	35	12	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0131882	10.1371/journal.pone.0131882	http://dx.doi.org/10.1371/journal.pone.0131882			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154141	gold, Green Published, Green Submitted			2022-12-26	WOS:000358159700082
J	Shi, YF; Han, Y; Su, YT; Yang, JH; Yu, YQ				Shi, Yu-Feng; Han, Yong; Su, Yun-Ting; Yang, Jun-Hua; Yu, Yan-Qin			Silencing of Cholinergic Basal Forebrain Neurons Using Archaerhodopsin Prolongs Slow-Wave Sleep in Mice	PLOS ONE			English	Article							TRANSGENIC MOUSE MODEL; ACETYLCHOLINE-RELEASE; ALZHEIMERS-DISEASE; PARADOXICAL SLEEP; WAKE TRANSITIONS; REM-SLEEP; WAKING; ACTIVATION; CONNECTIONS; CYCLE	The basal forebrain (BF) plays a crucial role in cortical activation. Our previous study showed that activation of cholinergic BF neurons alone is sufficient to suppress slow-wave sleep ( SWS) and promote wakefulness and rapid-eye-movement ( REM) sleep. However, the exact role of silencing cholinergic BF neurons in the sleep-wake cycle remains unclear. We inhibitied the cholinergic BF neurons genetically targeted with archaerhodopsin ( Arch) with yellow light to clarify the role of cholinergic BF neurons in the sleep-wake cycle. Bilateral inactivation of cholinergic BF neurons genetically targeted with archaerhodopsin prolonged SWS and decreased the probability of awakening from SWS in mice. However, silencing these neurons changed neither the duration of wakefulness or REM sleep, nor the probability of transitions to other sleep-wake episodes from wakefulness or REM sleep. Furthermore, silencing these neurons for 6 h within the inactive or active period increased the duration of SWS at the expense of the duration of wakefulness, as well as increasing the number of prolonged SWS episodes (120-240 s). The lost wakefulness was compensated by a delayed increase of wakefulness, so the total duration of SWS and wakefulness during 24 h was kept stable. Our results indicate that the main effect of these neurons is to terminate SWS, whereas wakefulness or REM sleep may be determined by co-operation of the cholinergic BF neurons with other arousal-sleep control systems.	[Shi, Yu-Feng; Han, Yong; Su, Yun-Ting; Yang, Jun-Hua; Yu, Yan-Qin] Zhejiang Univ, Sch Med, Key Lab Neurobiol,Minist Hlth China, Key Lab Med Neurobiol,Dept Neurobiol & Physiol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Yu, YQ (corresponding author), Zhejiang Univ, Sch Med, Key Lab Neurobiol,Minist Hlth China, Key Lab Med Neurobiol,Dept Neurobiol & Physiol, Hangzhou 310003, Zhejiang, Peoples R China.	yanqinyu@zju.edu.cn	Yang, Junhua/ADR-6060-2022	Yang, Junhua/0000-0003-4117-7569				Adamantidis AR, 2007, NATURE, V450, P420, DOI 10.1038/nature06310; Anaclet C, 2014, NAT NEUROSCI, V17, P1217, DOI 10.1038/nn.3789; BAGHDOYAN HA, 1993, J NEUROSCI, V13, P229; Berntson GG, 2002, EUR J NEUROSCI, V16, P2453, DOI 10.1046/j.1460-9568.2002.02310.x; Blanco-Centurion CA, 2006, EUR J NEUROSCI, V24, P2084, DOI 10.1111/j.1460-9568.2006.05074.x; Borbely A A, 1982, Hum Neurobiol, V1, P195; Boucetta S, 2009, J NEUROSCI, V29, P4664, DOI 10.1523/JNEUROSCI.5502-08.2009; Brown RE, 2012, PHYSIOL REV, V92, P1087, DOI 10.1152/physrev.00032.2011; Cape EG, 2000, J NEUROSCI, V20, P8452, DOI 10.1523/JNEUROSCI.20-22-08452.2000; Carter ME, 2010, NAT NEUROSCI, V13, P1526, DOI 10.1038/nn.2682; Carter ME, 2009, J NEUROSCI, V29, P10939, DOI 10.1523/JNEUROSCI.1205-09.2009; Chow BY, 2010, NATURE, V463, P98, DOI 10.1038/nature08652; Eggermann E, 2001, NEUROSCIENCE, V108, P177, DOI 10.1016/S0306-4522(01)00512-7; Fuller P, 2011, J COMP NEUROL, V519, P933, DOI 10.1002/cne.22559; Gerashchenko D, 2001, BRAIN RES, V913, P106, DOI 10.1016/S0006-8993(01)02792-5; GROVE EA, 1988, J COMP NEUROL, V277, P347, DOI 10.1002/cne.902770303; Han Y, 2014, CURR BIOL, V24, P693, DOI 10.1016/j.cub.2014.02.011; Hassani OK, 2009, J NEUROSCI, V29, P11828, DOI 10.1523/JNEUROSCI.1259-09.2009; Jones BE, 2008, ANN NY ACAD SCI, V1129, P26, DOI 10.1196/annals.1417.026; Jones BE, 2005, TRENDS PHARMACOL SCI, V26, P578, DOI 10.1016/j.tips.2005.09.009; Kaur S, 2008, J NEUROSCI, V28, P491, DOI 10.1523/JNEUROSCI.1585-07.2008; Lazarus M, 2013, CURR OPIN NEUROBIOL, V23, P780, DOI 10.1016/j.conb.2013.02.001; Lee MG, 2005, J NEUROSCI, V25, P4365, DOI 10.1523/JNEUROSCI.0178-05.2005; LEHMANN J, 1980, NEUROSCIENCE, V5, P1161, DOI 10.1016/0306-4522(80)90195-5; LEWIS PR, 1967, BRAIN, V90, P521, DOI 10.1093/brain/90.3.521; Madisen L, 2012, NAT NEUROSCI, V15, P793, DOI 10.1038/nn.3078; MARROSU F, 1995, BRAIN RES, V671, P329, DOI 10.1016/0006-8993(94)01399-3; Masliah E, 2001, P NATL ACAD SCI USA, V98, P12245, DOI 10.1073/pnas.211412398; MCGINTY DJ, 1976, BRAIN RES, V101, P569, DOI 10.1016/0006-8993(76)90480-7; NISHINO S, 1995, J NEUROSCI, V15, P4806; Parmentier R, 2002, J NEUROSCI, V22, P7695; Platt B, 2011, BEHAV BRAIN RES, V221, P499, DOI 10.1016/j.bbr.2011.01.017; RYE DB, 1984, NEUROSCIENCE, V13, P627, DOI 10.1016/0306-4522(84)90083-6; SHAMMAHLAGNADO SJ, 1992, NEUROSCIENCE, V50, P403, DOI 10.1016/0306-4522(92)90433-3; Sherin JE, 1996, SCIENCE, V271, P216, DOI 10.1126/science.271.5246.216; Steriade M, 2004, PROG BRAIN RES, V145, P179, DOI 10.1016/S0079-6123(03)45013-9; Vazquez J, 2001, AM J PHYSIOL-REG I, V280, pR598, DOI 10.1152/ajpregu.2001.280.2.R598; Wisor JP, 2005, NEUROSCIENCE, V131, P375, DOI 10.1016/j.neuroscience.2004.11.018; Wong CJH, 1997, J COMP NEUROL, V389, P49; Wu M, 2000, J NEUROSCI, V20, P3900, DOI 10.1523/JNEUROSCI.20-10-03900.2000; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744	41	20	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2015	10	7							e0130130	10.1371/journal.pone.0130130	http://dx.doi.org/10.1371/journal.pone.0130130			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EC	26151909	gold, Green Submitted, Green Published			2022-12-26	WOS:000358158900006
J	Flynn, SP; Barrier, S; Scott, RC; Lenck-Santini, PP; Holmes, GL				Flynn, Sean P.; Barrier, Sylvain; Scott, Rod C.; Lenck-Santini, Pierre-Pascal; Holmes, Gregory L.			Status Epilepticus Induced Spontaneous Dentate Gyrus Spikes: In Vivo Current Source Density Analysis	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; MEDIAL ENTORHINAL CORTEX; CA3 NETWORK ACTIVITY; TREATED RATS; HIPPOCAMPAL EPILEPTOGENESIS; SYNAPTIC REORGANIZATION; ELECTRICAL STIMULATION; REDUCED INHIBITION; INTERICTAL SPIKES; SELECTIVE LOSS	The dentate gyrus is considered to function as an inhibitory gate limiting excitatory input to the hippocampus. Following status epilepticus (SE), this gating function is reduced and granule cells become hyper-excitable. Dentate spikes (DS) are large amplitude potentials observed in the dentate gyrus (DG) of normal animals. DS are associated with membrane depolarization of granule cells, increased activity of hilar interneurons and suppression of CA3 and CA1 pyramidal cell firing. Therefore, DS could act as an anti-excitatory mechanism. Because of the altered gating function of the dentate gyrus following SE, we sought to investigate how DS are affected following pilocarpine-induced SE. Two weeks following lithium-pilocarpine SE induction, hippocampal EEG was recorded in male Sprague-Dawley rats with 16-channel silicon probes under urethane anesthesia. Probes were placed dorsoventrally to encompass either CA1-CA3 or CA1-DG layers. Large amplitude spikes were detected from EEG recordings and subject to current source density analysis. Probe placement was verified histologically to evaluate the anatomical localization of current sinks and the origin of DS. In 9 of 11 pilocarpine-treated animals and two controls, DS were confirmed with large current sinks in the molecular layer of the dentate gyrus. DS frequency was significantly increased in pilocarpine-treated animals compared to controls. Additionally, in pilo-carpine-treated animals, DS displayed current sinks in the outer, middle and/ or inner molecular layers. However, there was no difference in the frequency of events when comparing between layers. This suggests that following SE, DS can be generated by input from medial and lateral entorhinal cortex, or within the dentate gyrus. DS were associated with an increase in multiunit activity in the granule cell layer, but no change in CA1. These results suggest that following SE there is an increase in DS activity, potentially arising from hyperexcitability along the hippocampal-entorhinal pathway or within the dentate gyrus itself.	[Flynn, Sean P.; Barrier, Sylvain; Scott, Rod C.; Lenck-Santini, Pierre-Pascal; Holmes, Gregory L.] Univ Vermont, Coll Med, Dept Neurol Sci, Burlington, VT 05405 USA; [Scott, Rod C.] UCL, Inst Child Hlth, London, England	University of Vermont; University of London; University College London	Flynn, SP (corresponding author), Univ Vermont, Coll Med, Dept Neurol Sci, Burlington, VT 05405 USA.	sean.p.flynn@uvm.edu	lenck-santini, pierre-pascal/N-3662-2016	lenck-santini, pierre-pascal/0000-0001-9925-9220; barriere, sylvain/0000-0002-3508-641X; Scott, Rod/0000-0002-8944-928X	National Institute of Health [NS074450, NS073083, NS075249]; Emmory R. Shapses Research Fund; Michael J. Pietroniro Research Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075249, R01NS074450, R01NS073083] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emmory R. Shapses Research Fund; Michael J. Pietroniro Research Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by National Institute of Health grants NS074450 (GLH), NS073083 (GLH), NS075249 (RCS), the Emmory R. Shapses Research Fund and Michael J. Pietroniro Research Fund to GLH.	Bains JS, 1999, NAT NEUROSCI, V2, P720, DOI 10.1038/11184; Barbarosie M, 1997, J NEUROSCI, V17, P9308; Boido D, 2014, CEREB CORTEX, V24, P163, DOI 10.1093/cercor/bhs298; Bragin A, 1997, NEUROSCIENCE, V76, P1187, DOI 10.1016/S0306-4522(96)00446-0; BRAGIN A, 1995, J NEUROPHYSIOL, V73, P1691, DOI 10.1152/jn.1995.73.4.1691; Buckmaster PS, 1997, J NEUROPHYSIOL, V77, P2685, DOI 10.1152/jn.1997.77.5.2685; Bumanglag AV, 2008, J COMP NEUROL, V510, P561, DOI 10.1002/cne.21801; Canning KJ, 1997, HIPPOCAMPUS, V7, P643, DOI 10.1002/(SICI)1098-1063(1997)7:6<643::AID-HIPO6>3.0.CO;2-F; Cavazos JE, 2003, J COMP NEUROL, V458, P272, DOI 10.1002/cne.10581; Cossart R, 2001, NAT NEUROSCI, V4, P52, DOI 10.1038/82900; Coulter DA, 2007, PROG BRAIN RES, V163, P235, DOI 10.1016/S0079-6123(07)63014-3; de Curtis M, 2001, PROG NEUROBIOL, V63, P541, DOI 10.1016/S0301-0082(00)00026-5; DU F, 1995, J NEUROSCI, V15, P6301; Hara K, 2002, ANESTH ANALG, V94, P313, DOI 10.1097/00000539-200202000-00015; Harvey BD, 2005, J COMP NEUROL, V488, P442, DOI 10.1002/cne.20594; HEINEMANN U, 1992, EPILEPSY RES, P273; Holmes GL, 1999, J COMP NEUROL, V404, P537, DOI 10.1002/(SICI)1096-9861(19990222)404:4<537::AID-CNE9>3.0.CO;2-#; HOUSER CR, 1992, EPILEPSY RES, P223; Hsu D, 2007, PROG BRAIN RES, V163, P601, DOI 10.1016/S0079-6123(07)63032-5; Isaev D, 2015, NEUROBIOL DIS, V78, P68, DOI 10.1016/j.nbd.2015.03.026; Kienzler F, 2009, J COMP NEUROL, V515, P181, DOI 10.1002/cne.22059; Kobayashi M, 2003, J NEUROSCI, V23, P8471; Kobayashi M, 2003, J NEUROSCI, V23, P2440; Kumar SS, 2006, J NEUROSCI, V26, P4613, DOI 10.1523/JNEUROSCI.0064-06.2006; Lenck-Santini PP, 2008, J NEUROSCI, V28, P5053, DOI 10.1523/JNEUROSCI.5024-07.2008; Nadler JV, 2003, NEUROCHEM RES, V28, P1649, DOI 10.1023/A:1026004904199; Nagao T, 1996, NEUROSCIENCE, V72, P399, DOI 10.1016/0306-4522(95)00534-X; O'Dell CM, 2012, J NEUROSCI RES, V90, P913, DOI 10.1002/jnr.22829; Penttonen M, 1997, HIPPOCAMPUS, V7, P437, DOI 10.1002/(SICI)1098-1063(1997)7:4<437::AID-HIPO9>3.0.CO;2-F; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Richard GR, 2013, HIPPOCAMPUS, V23, P1269, DOI 10.1002/hipo.22164; RUTH RE, 1988, J COMP NEUROL, V270, P506, DOI 10.1002/cne.902700404; Salami P, 2014, NEUROBIOL DIS, V67, P97, DOI 10.1016/j.nbd.2014.03.012; Scharfman HE, 2001, NEUROSCIENCE, V104, P741, DOI 10.1016/S0306-4522(01)00132-4; Scharfman HE, 2007, PROG BRAIN RES, V163, P627, DOI 10.1016/S0079-6123(07)63034-9; Scharfman HE, 2013, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00106; Scorza FA, 2009, AN ACAD BRAS CIENC, V81, P345, DOI 10.1590/S0001-37652009000300003; Sloviter R S, 1991, Hippocampus, V1, P41, DOI 10.1002/hipo.450010106; Sloviter R S, 1991, Hippocampus, V1, P31, DOI 10.1002/hipo.450010105; Sloviter RS, 2013, NEUROPHARMACOLOGY, V69, P3, DOI 10.1016/j.neuropharm.2012.01.022; SLOVITER RS, 1994, ANN NEUROL, V35, P640, DOI 10.1002/ana.410350604; SLOVITER RS, 1992, NEUROSCI LETT, V137, P91, DOI 10.1016/0304-3940(92)90306-R; SLOVITER RS, 1987, SCIENCE, V235, P73, DOI 10.1126/science.2879352; Spencer SS, 2002, EPILEPSIA, V43, P219, DOI 10.1046/j.1528-1157.2002.26901.x; Staley KJ, 1998, NAT NEUROSCI, V1, P201, DOI 10.1038/651; Sun CS, 2007, J COMP NEUROL, V500, P876, DOI 10.1002/cne.21207; Sutula TP, 2007, PROG BRAIN RES, V163, P541, DOI 10.1016/S0079-6123(07)63029-5; Wu K, 2001, NEUROSCIENCE, V104, P379, DOI 10.1016/S0306-4522(01)00043-4	48	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132630	10.1371/journal.pone.0132630	http://dx.doi.org/10.1371/journal.pone.0132630			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148195	Green Published, Green Submitted, gold			2022-12-26	WOS:000358157600308
J	Lehmann, S; Hiller, J; van Bergenhenegouwen, J; Knippels, LMJ; Garssen, J; Traidl-Hoffmann, C				Lehmann, Sarah; Hiller, Julia; van Bergenhenegouwen, Jeroen; Knippels, Leon M. J.; Garssen, Johan; Traidl-Hoffmann, Claudia			In Vitro Evidence for Immune-Modulatory Properties of Non-Digestible Oligosaccharides: Direct Effect on Human Monocyte Derived Dendritic Cells	PLOS ONE			English	Article							REGULATORY T-CELLS; CHAIN GALACTO-OLIGOSACCHARIDES; HUMAN-MILK; CYTOKINE PRODUCTION; ATOPIC-DERMATITIS; INFANTS; SYNBIOTICS; MIXTURE; RISK; METAANALYSIS	Infant formulas containing non-digestible oligosaccharides (NDO) similar to the composition in breast milk or a combination of lactic acid bacteria (LAB) and NDO have been shown to harbor preventive effects towards immune-regulatory disorders. The aim of this study was to investigate the immune-modulatory potential of non-digestible short chain galacto-and long chain fructo-oligosaccharides (scGOS/lcFOS) mimicking the natural distribution of oligosaccharides in human breast milk in presence or absence of certain LAB strains in human monocyte derived dendritic cells (MoDC). Immature human MoDC prepared from peripheral blood of healthy non-atopic volunteers were screened in vitro after stimulation with specific scGOS/lcFOS in presence or absence of LAB. IL-10 and IL-12p70 release was analyzed after 24 hours in cell-free supernatants by enzyme-linked immunosorbent assay (ELISA). A luminex-based assay was conducted to assess further cytokine and chemokine release by MoDC. To investigate the resulting T cell response, stimulated MoDC were co-incubated with naive T cells in allogeneic stimulation assays and intracellular Foxp3 expression, as well as immune-suppressive capacity was determined. Oligosaccharides did not induce relevant amounts of IL-12p70 production, but did promote IL-10 release by MoDC. Furthermore, scGOS/lcFOS mixtures exerted a significant enhancing effect on LAB induced IL-10 secretion by MoDC while no increase in IL-12p70 production was observed. Blocking toll like receptor (TLR)4 abrogated the increase in IL-10 in both the direct stimulation and the LAB stimulation of MoDC, suggesting that scGOS/lcFOS act via TLR4. Finally, scGOS/lcFOS-treated MoDC were shown to upregulate the number of functional suppressive Foxp3 positive T cells following allogeneic stimulation. Our results indicate anti-inflammatory and direct, microbiota independent, immune-modulatory properties of scGOS/lcFOS mixtures on human MoDC suggesting a possible induction of regulatory T cells (Tregs). The tested combinations of LAB and scGOS/lcFOS might represent a useful dietary ingredient for the maintenance of intestinal homeostasis via the induction of Tregs.	[Lehmann, Sarah; Hiller, Julia; Traidl-Hoffmann, Claudia] Tech Univ Munich, Inst Environm Med, UNIKA T, Augsburg, Germany; [Lehmann, Sarah; Hiller, Julia] Tech Univ Munich, Ctr Allergy & Environm ZAUM, D-80290 Munich, Germany; [Lehmann, Sarah; Hiller, Julia] Helmholtz Zentrum Munchen, Munich, Germany; [van Bergenhenegouwen, Jeroen; Knippels, Leon M. J.; Garssen, Johan] Nutricia Res, Dept Immunol, Utrecht, Netherlands; [van Bergenhenegouwen, Jeroen; Knippels, Leon M. J.; Garssen, Johan] Univ Utrecht, Div Pharmacol, Utrecht Inst Pharmaceut Sci, Fac Sci, Utrecht, Netherlands; [Traidl-Hoffmann, Claudia] CK CARE Christine Kuhne Ctr Allergy Res & Educ, Davos, Switzerland	Technical University of Munich; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Danone Nutricia; Utrecht University	Traidl-Hoffmann, C (corresponding author), Tech Univ Munich, Inst Environm Med, UNIKA T, Augsburg, Germany.	claudia.traidl-hoffmann@tum.de	garssen, johan/I-7159-2016	Traidl-Hoffmann, Claudia/0000-0001-5085-5179	Graduiertenstipendium der Universitat Bayern e.V. nach dem Bayerischen Eliteforderungsgesetz; Christine-Kuhne-Center for Allergy Research and Education (CK Care) and Nutricia Research	Graduiertenstipendium der Universitat Bayern e.V. nach dem Bayerischen Eliteforderungsgesetz; Christine-Kuhne-Center for Allergy Research and Education (CK Care) and Nutricia Research	This work was supported by a Graduiertenstipendium der Universitat Bayern e.V. nach dem Bayerischen Eliteforderungsgesetz (SL), Christine-Kuhne-Center for Allergy Research and Education (CK Care) and Nutricia Research. The funder Nutricia Research provided support in the form of salaries for authors JvB, LK and JG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of	Arslanoglu S, 2012, J Biol Regul Homeost Agents, V26, P49; Arslanoglu S, 2008, J NUTR, V138, P1091, DOI 10.1093/jn/138.6.1091; Bode L, 2012, GLYCOBIOLOGY, V22, P1147, DOI 10.1093/glycob/cws074; Boks MA, 2012, CLIN IMMUNOL, V142, P332, DOI 10.1016/j.clim.2011.11.011; Capitan-Canadas F, 2014, MOL NUTR FOOD RES, V58, P1098, DOI 10.1002/mnfr.201300497; Cavani A, 2001, TRENDS IMMUNOL, V22, P118, DOI 10.1016/S1471-4906(00)01815-9; Dang D, 2013, J INT MED RES, V41, P1426, DOI 10.1177/0300060513493692; de Kivita S, 2013, J INNATE IMMUN, V5, P625, DOI 10.1159/000350515; Duijts L, 2009, MATERN CHILD NUTR, V5, P199, DOI 10.1111/j.1740-8709.2008.00176.x; Field CJ, 2005, J NUTR, V135, P1; Fyhrquist N, 2012, J INVEST DERMATOL, V132, P1672, DOI 10.1038/jid.2012.40; Gibson G, 1995, J NUTR; Gruber C, 2010, J ALLERGY CLIN IMMUN, V126, P791, DOI 10.1016/j.jaci.2010.07.022; Haarman M, 2005, APPL ENVIRON MICROB, V71, P2318, DOI 10.1128/AEM.71.5.2318-2324.2005; Hoppu U, 2001, ALLERGY, V56, P23, DOI 10.1034/j.1398-9995.2001.00908.x; Hubo M, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00082; Jeurink PV, 2013, AM J CLIN NUTR, V98, p572S, DOI 10.3945/ajcn.112.038596; Karczewski J, 2014, AUTOIMMUNITY, P1; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Kurakevich E, 2013, P NATL ACAD SCI USA, V110, P17444, DOI 10.1073/pnas.1306322110; Latvala S, 2008, WORLD J GASTROENTERO, V14, P5570, DOI 10.3748/wjg.14.5570; Lin CC, 2014, MOLECULES, V19, P5325, DOI 10.3390/molecules19045325; Liston A, 2014, NAT REV IMMUNOL, V14, P154, DOI 10.1038/nri3605; M'Rabet L, 2008, J NUTR, V138, p1782S, DOI 10.1093/jn/138.9.1782S; Macia L, 2012, IMMUNOL REV, V245, P164, DOI 10.1111/j.1600-065X.2011.01080.x; Maldonado RA, 2010, ADV IMMUNOL, V108, P111, DOI [10.1016/B978-0-12-380995-7.00004-5, 10.1016/S0065-2776(10)08004_1]; Martin R, 2010, BENEF MICROBES, V1, P367, DOI 10.3920/BM2010.0027; Moro G, 2006, ARCH DIS CHILD, V91, P814, DOI 10.1136/adc.2006.098251; Naarding MA, 2005, J CLIN INVEST, V115, P3256, DOI 10.1172/JCI25105; Nauta AJ, 2013, CARBOHYD POLYM, V93, P263, DOI 10.1016/j.carbpol.2012.02.021; Ortega-Gonzalez M, 2014, MOL NUTR FOOD RES, V58, P384, DOI 10.1002/mnfr.201300296; Osborn D, 2013, COCHRANE COLLABORATI, P1; Palomares O, 2014, GENES IMMUN, V15, P511, DOI 10.1038/gene.2014.45; Peterson RA, 2012, TOXICOL PATHOL, V40, P186, DOI 10.1177/0192623311430693; Plantinga TS, 2011, CLIN VACCINE IMMUNOL, V18, P621, DOI 10.1128/CVI.00498-10; Rijnierse A, 2011, EUR J PHARMACOL, V668, pS117, DOI 10.1016/j.ejphar.2011.07.009; Rolfe RD, 2000, J NUTR, V130, p396S, DOI 10.1093/jn/130.2.396S; Romagnani S, 2006, ALLERGY, V61, P3, DOI 10.1111/j.1398-9995.2006.01005; Romeo J, 2010, NUTR HOSP, V25, P341, DOI 10.3305/nh.2010.25.3.4517; Rutella S, 2004, IMMUNOL LETT, V94, P11, DOI 10.1016/j.imlet.2004.04.015; Scholtens PAMJ, 2008, J NUTR, V138, P1141, DOI 10.1093/jn/138.6.1141; Schouten B, 2012, BRIT J NUTR, V107, P96, DOI 10.1017/S0007114511002637; Schouten B, 2011, PEDIAT ALLERG IMM-UK, V22, P537, DOI 10.1111/j.1399-3038.2010.01132.x; Schouten B, 2010, J NUTR, V140, P835, DOI 10.3945/jn.109.116061; Schouten B, 2009, J NUTR, V139, P1398, DOI 10.3945/jn.109.108514; Smits HH, 2005, J ALLERGY CLIN IMMUN, V115, P1260, DOI 10.1016/j.jaci.2005.03.036; Snel J, 2011, CLIN EXP ALLERGY, V41, P232, DOI 10.1111/j.1365-2222.2010.03650.x; Thavagnanam S, 2008, CLIN EXP ALLERGY, V38, P629, DOI 10.1111/j.1365-2222.2007.02780.x; Traidl-Hoffmann C, 2002, J ALLERGY CLIN IMMUN, V109, P831, DOI 10.1067/mai.2002.124655; Vael C, 2009, CURR OPIN PEDIATR, V21, P794, DOI 10.1097/MOP.0b013e328332351b; van der Aa LB, 2011, ALLERGY, V66, P170, DOI 10.1111/j.1398-9995.2010.02416.x; van Hoffen E, 2009, ALLERGY, V64, P484, DOI 10.1111/j.1398-9995.2008.01765.x; van Odijk J, 2003, ALLERGY, V58, P833, DOI 10.1034/j.1398-9995.2003.00264.x; van't Land B, 2010, VACCINE, V28, P5711, DOI 10.1016/j.vaccine.2010.06.046; Vogt L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068367	55	58	59	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132304	10.1371/journal.pone.0132304	http://dx.doi.org/10.1371/journal.pone.0132304			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148091	Green Submitted, Green Published, gold			2022-12-26	WOS:000358157600237
J	Xu, LZ; Paterson, AD; Turpin, W; Xu, W				Xu, Lizhen; Paterson, Andrew D.; Turpin, Williams; Xu, Wei			Assessment and Selection of Competing Models for Zero-Inflated Microbiome Data	PLOS ONE			English	Article							COUNT DATA; GUT MICROBIOTA; ABUNDANCE DATA; HURDLE MODELS; EXTRA ZEROS; REGRESSION; TESTS	Typical data in a microbiome study consist of the operational taxonomic unit (OTU) counts that have the characteristic of excess zeros, which are often ignored by investigators. In this paper, we compare the performance of different competing methods to model data with zero inflated features through extensive simulations and application to a microbiome study. These methods include standard parametric and non-parametric models, hurdle models, and zero inflated models. We examine varying degrees of zero inflation, with or without dispersion in the count component, as well as different magnitude and direction of the covariate effect on structural zeros and the count components. We focus on the assessment of type I error, power to detect the overall covariate effect, measures of model fit, and bias and effectiveness of parameter estimations. We also evaluate the abilities of model selection strategies using Akaike information criterion (AIC) or Vuong test to identify the correct model. The simulation studies show that hurdle and zero inflated models have well controlled type I errors, higher power, better goodness of fit measures, and are more accurate and efficient in the parameter estimation. Besides that, the hurdle models have similar goodness of fit and parameter estimation for the count component as their corresponding zero inflated models. However, the estimation and interpretation of the parameters for the zero components differs, and hurdle models are more stable when structural zeros are absent. We then discuss the model selection strategy for zero inflated data and implement it in a gut microbiome study of > 400 independent subjects.	[Xu, Lizhen; Paterson, Andrew D.; Xu, Wei] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON M5T 3M7, Canada; [Paterson, Andrew D.] Hosp Sick Children Toronto, Program Genet & Genome Biol, Toronto, ON M5G 0A4, Canada; [Turpin, Williams] Mt Sinai Hosp, Zane Cohen Ctr Digest Dis, Div Gastroenterol, Toronto, ON M5T 3L9, Canada; [Xu, Wei] Princess Margaret Hosp, Dept Biostat, Toronto, ON M5G 2M9, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Xu, LZ (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON M5T 3M7, Canada.	wxu@uhnres.utoronto.ca	xu, wei/HHD-2891-2022; Paterson, Andrew/AAQ-7511-2020; Paterson, Andrew D/A-4088-2011; Williams, Turpin/H-3255-2019	Paterson, Andrew/0000-0002-9169-118X; Paterson, Andrew D/0000-0002-9169-118X; Williams, Turpin/0000-0001-9364-5868	CIHR STAGE fellowship; Crohn's and Colitis Canada (CCC); CAG/CIHR Ferring Pharmaceuticals Inc. award; Leona M. and Harry B. Helmsley Charitable Trust	CIHR STAGE fellowship; Crohn's and Colitis Canada (CCC); CAG/CIHR Ferring Pharmaceuticals Inc. award; Leona M. and Harry B. Helmsley Charitable Trust	All authors disclose no potential conflicts (financial, professional, or personal) that are relevant to the manuscript. Williams Turpin acknowledges a CAG/CIHR Ferring Pharmaceuticals Inc. award; Lizhen Xu is a recipient of a CIHR STAGE fellowship. The authors would like to acknowledge the GEM Project Steering Committee, Recruitment Site Directors and Global Project Office members supported by Crohn's and Colitis Canada (CCC) and the Leona M. and Harry B. Helmsley Charitable Trust. The GEM Project Research Team is composed of i) Steering Committee: Paul Beck, Charles Bernstein, Alain Bitton, Kenneth Croitoru, Leo Dieleman, Brian Faegan, Anne Griffiths, David Guttman, Kevan Jacobson, Gil Kaplan, Karen Madsen, John Marshall, Paul Moayyedi, Mark Ropeleski, Ernest Seidman, Mark Silverberg, Kathy Siminovitch, Andy Stadnyk, Hilary Steinhart, Michael Surette, Dan Turner, Tom Walters, and Bruce Vallance; ii) Recruitment Center Directors: Guy Aumais, Paul Beck, Charles Bernstein, Alain Bitton, Brian Bressler, Herbert Brill, Maria Cino, Jeff Critch, Lee Denson, Colette Deslandres, Leo Dieleman, Martha Dirks, Wael El-Matary, Brian Feagan, Anne Griffiths, Hans Herfarth, Peter Higgins, Hien Huynh, Jeff Hyams, Kevan Jacobson, Gilaad Kaplan, Desmond Leddin, David Mack, John Marshall, Jerry McGrath, Anthony Otley, Remo Panancionne, Sophie Plamondon, Mark Ropeleski, Fred Saibil, Ernie Seidman, Corey Siegel, Mark Silverberg, Scott Snapper, Hillary Steinhart, and Dan Turner; and iii) The Global Project Office: Nellie Allam, Kenneth Croitoru, Alexandra Keludjian, Ana Olteanu, Kevin Ow and Isabelle Yeadon.	Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Balint M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053987; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Charles KF, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0102451, DOI 10.1371/JOURNAL.PONE.0102451]; Desjardins CD, 2013, THESIS U MINNESOTA U; Dickson RP, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-28; Dominianni C, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-103; Duan N, 1983, J BUS ECON STAT, V1, P115, DOI DOI 10.2307/1391852; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Famoye F., 2006, J DATA SCI, V4, P117, DOI [DOI 10.6339/JDS.2006.04(1).257, 10.6339/JDS.2006.04(1).257]; Faust K, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002606; Fletcher D, 2005, ENVIRON ECOL STAT, V12, P45, DOI 10.1007/s10651-005-6817-1; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Hauser LJ, 2014, INT FORUM ALLERGY RH, DOI [10.1002/alr.21428.2014/2/10, DOI 10.1002/ALR.21428.2014/2/10]; Hu MC, 2011, AM J DRUG ALCOHOL AB, V37, P367, DOI 10.3109/00952990.2011.597280; Jespers V, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-83; Lachenbruch PA, 2002, STAT METHODS MED RES, V11, P297, DOI 10.1191/0962280202sm289ra; Lachenbruch PA, 2001, STAT MED, V20, P1215, DOI 10.1002/sim.790; Lambert D, 1992, AM STAT ASS AM SOC Q, V34, P1, DOI DOI 10.2307/1269547; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Loeys T, 2012, BRIT J MATH STAT PSY, V65, P163, DOI 10.1111/j.2044-8317.2011.02031.x; Masella AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-31; Miller JM, 2007, THESIS U FLORIDA US; Min YY, 2005, STAT MODEL, V5, P1, DOI 10.1191/1471082X05st084oa; MULLAHY J, 1986, J ECONOMETRICS, V33, P341, DOI 10.1016/0304-4076(86)90002-3; Pearce MM, 2014, MBIO, V5, DOI 10.1128/mBio.01283-14; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Rose CE, 2006, J BIOPHARM STAT, V16, P463, DOI 10.1080/10543400600719384; Sileshi G, 2009, ECOL MODEL, V220, P1764, DOI 10.1016/j.ecolmodel.2009.03.024; Stefansson G, 1996, ICES J MAR SCI, V53, P577, DOI 10.1006/jmsc.1996.0079; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; VUONG QH, 1989, ECONOMETRICA, V57, P307, DOI 10.2307/1912557; Wagner BD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020296; Warton DI, 2005, ENVIRONMETRICS, V16, P275, DOI 10.1002/env.702; Welsh AH, 1996, ECOL MODEL, V88, P297, DOI 10.1016/0304-3800(95)00113-1; Xia YL, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/593569; Yildirim S, 2014, ISME J, V8, P2431, DOI 10.1038/ismej.2014.90	38	58	58	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0129606	10.1371/journal.pone.0129606	http://dx.doi.org/10.1371/journal.pone.0129606			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148172	Green Submitted, Green Published, gold			2022-12-26	WOS:000358157600022
J	Chong, PA; Farber, PJ; Vernon, RM; Hudson, RP; Mittermaier, AK; Forman-Kay, JD				Chong, P. Andrew; Farber, Patrick J.; Vernon, Robert M.; Hudson, Rhea P.; Mittermaier, Anthony K.; Forman-Kay, Julie D.			Deletion of Phenylalanine 508 in the First Nucleotide-binding Domain of the Cystic Fibrosis Transmembrane Conductance Regulator Increases Conformational Exchange and Inhibits Dimerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DELTA-F508 CFTR; NMR RELAXATION; BACKBONE DYNAMICS; CHEMICAL-SHIFTS; SIDE-CHAIN; MUTATION; PROTEINS; MUTANT; STABILITY; PHOSPHORYLATION	Deletion of Phe-508 (F508del) in the first nucleotide-binding domain (NBD1) of the cystic fibrosis transmembrane conductance regulator (CFTR) results in destabilization of the domain, intramolecular interactions involving the domain, and the entire channel. The destabilization caused by F508del manifests itself in defective channel processing and channel gating defects. Here, we present NMR studies of the effect of F508del and the I539T stabilizing mutation on NBD1 dynamics, with a view to understanding these changes in stability. Qualitatively, F508del NMR spectra exhibit significantly more peak broadening than WT spectra due to the enhanced intermediate time scale (millisecond to microsecond) motions in the mutant. Unexpectedly, studies of fast (nanosecond to picosecond) motions revealed that F508del NBD1 tumbles more rapidly in solution than WT NBD1. Whereas F508del tumbles at a rate nearly consistent with the monomeric state, the WT protein tumbles significantly more slowly. Paramagnetic relaxation enhancement experiments confirm that NBD1 homodimerizes in solution in the expected head-to-tail orientation. NMR spectra of WT NBD1 reveal significant concentration-dependent chemical shift perturbations consistent with NBD1 dimerization. Chemical shift analysis suggests that the more rapid tumbling of F508del is the result of an impaired ability to dimerize. Based on previously published crystal structures and NMR spectra of various NBD1 mutants, we propose that deletion of Phe-508 affects Q-loop conformational sampling in a manner that inhibits dimerization. These results provide a potential mechanism for inhibition of channel opening by F508del and support the dimer interface as a target for cystic fibrosis therapeutics.	[Chong, P. Andrew; Farber, Patrick J.; Vernon, Robert M.; Hudson, Rhea P.; Forman-Kay, Julie D.] Hosp Sick Children, Mol Struct & Funct Program, Toronto, ON M5G 0A4, Canada; [Forman-Kay, Julie D.] Univ Toronto, Dept Biochem, Toronto, ON M5G 1X8, Canada; [Mittermaier, Anthony K.] McGill Univ, Dept Chem, Montreal, PQ H3A 0B8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; McGill University	Forman-Kay, JD (corresponding author), Hosp Sick Children, Peter Gilgan Ctr Res & Learning, Program Mol Struct & Funct, 686 Bay St, Toronto, ON M5G 0A4, Canada.	forman@sickkids.ca	Mittermaier, Anthony/R-3210-2017	Mittermaier, Anthony/0000-0002-3767-1225; Forman-Kay, Julie/0000-0001-8265-972X	Cystic Fibrosis Foundation [FORMAN05XX0]; Cystic Fibrosis Canada	Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Cystic Fibrosis Canada	This work was supported by Cystic Fibrosis Foundation Therapeutics Grant FORMAN05XX0 (to J. D. F.-K.) and a Cystic Fibrosis Canada grant (to J. D. F.-K.). The authors declare that they have no conflicts of interest with the contents of this article.	Aleksandrov AA, 2012, J MOL BIOL, V419, P41, DOI 10.1016/j.jmb.2012.03.001; Aleksandrov AA, 2010, J MOL BIOL, V401, P194, DOI 10.1016/j.jmb.2010.06.019; Aleksandrov AA, 2009, J PHYSIOL-LONDON, V587, P2875, DOI 10.1113/jphysiol.2009.170258; Aleksandrov L, 2002, J BIOL CHEM, V277, P15419, DOI 10.1074/jbc.M111713200; Atwell S, 2010, PROTEIN ENG DES SEL, V23, P375, DOI 10.1093/protein/gzq004; Berger AL, 2005, P NATL ACAD SCI USA, V102, P455, DOI 10.1073/pnas.0408575102; Cavanagh John, 1996, P243; Chappe V, 2005, EMBO J, V24, P2730, DOI 10.1038/sj.emboj.7600747; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Cui L, 2006, J PHYSIOL-LONDON, V572, P347, DOI 10.1113/jphysiol.2005.099457; Cui LY, 2007, J MOL BIOL, V365, P981, DOI 10.1016/j.jmb.2006.10.086; DALEMANS W, 1991, NATURE, V354, P526, DOI 10.1038/354526a0; Dawson JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074347; de la Torre JG, 2000, J MAGN RESON, V147, P138, DOI 10.1006/jmre.2000.2170; deCarvalho ACV, 2002, J BIOL CHEM, V277, P35896, DOI 10.1074/jbc.M205644200; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; DRUMM ML, 1991, SCIENCE, V254, P1797, DOI 10.1126/science.1722350; Du K, 2005, NAT STRUCT MOL BIOL, V12, P17, DOI 10.1038/nsmb882; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; FARROW NA, 1995, J BIOMOL NMR, V6, P153, DOI 10.1007/BF00211779; Goddard T.D., 2008, SPARKY 3, P3; Grossmann N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6419; He LH, 2015, J MOL BIOL, V427, P106, DOI 10.1016/j.jmb.2014.07.026; He LH, 2010, FASEB J, V24, P3103, DOI 10.1096/fj.09-141788; Hudson RP, 2012, J BIOL CHEM, V287, P28480, DOI 10.1074/jbc.M112.371138; Jih KY, 2011, J PHYSIOL-LONDON, V589, P2719, DOI 10.1113/jphysiol.2010.202861; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kanelis V, 2010, EMBO J, V29, P263, DOI 10.1038/emboj.2009.329; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Konrat R, 1999, J BIOMOL NMR, V15, P309, DOI 10.1023/A:1008310617047; Korzhnev DM, 2002, J AM CHEM SOC, V124, P10743, DOI 10.1021/ja0204776; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Lewis HA, 2010, J MOL BIOL, V396, P406, DOI 10.1016/j.jmb.2009.11.051; Lewis HA, 2005, J BIOL CHEM, V280, P1346, DOI 10.1074/jbc.M410968200; Lewis HA, 2004, EMBO J, V23, P282, DOI 10.1038/sj.emboj.7600040; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Loo TW, 2010, BIOCHEMISTRY-US, V49, P6352, DOI 10.1021/bi100807h; LUKACS GL, 1993, J BIOL CHEM, V268, P21592; Mendoza JL, 2012, CELL, V148, P164, DOI 10.1016/j.cell.2011.11.023; Mense M, 2006, EMBO J, V25, P4728, DOI 10.1038/sj.emboj.7601373; Molinski SV, 2014, GENET MED, V16, P625, DOI 10.1038/gim.2014.4; Orekhov VY, 1995, APPL MAGN RESON, V9, P581, DOI 10.1007/BF03162365; Pissarra LS, 2008, CHEM BIOL, V15, P62, DOI 10.1016/j.chembiol.2007.11.012; Protasevich I, 2010, PROTEIN SCI, V19, P1917, DOI 10.1002/pro.479; Rabeh WM, 2012, CELL, V148, P150, DOI 10.1016/j.cell.2011.11.024; Ren HY, 2013, MOL BIOL CELL, V24, P3016, DOI 10.1091/mbc.E13-05-0240; RIORDAN JR, 1989, SCIENCE, V245, P1066; Salzmann M, 1999, J BIOMOL NMR, V14, P85, DOI 10.1023/A:1008346931993; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; TEEM JL, 1993, CELL, V73, P335, DOI 10.1016/0092-8674(93)90233-G; Teem JL, 1996, RECEPTOR CHANNEL, V4, P63; Thibodeau PH, 2005, NAT STRUCT MOL BIOL, V12, P10, DOI 10.1038/nsmb881; Van Goor F, 2014, J CYST FIBROS, V13, P29, DOI 10.1016/j.jcf.2013.06.008; Vergani P, 2005, NATURE, V433, P876, DOI 10.1038/nature03313; Wang C, 2010, PROTEIN SCI, V19, P1932, DOI 10.1002/pro.480; Wang W, 2011, J BIOL CHEM, V286, P41937, DOI 10.1074/jbc.M111.296061; Wei SP, 2014, J BIOL CHEM, V289, P19942, DOI 10.1074/jbc.M114.562116; Wieczorek G, 2008, J CYST FIBROS, V7, P295, DOI 10.1016/j.jcf.2007.11.008; Woodward OM, 2013, P NATL ACAD SCI USA, V110, P5223, DOI 10.1073/pnas.1214530110; Xu Z, 2014, J PHYSIOL-LONDON, V592, P1931, DOI 10.1113/jphysiol.2014.271817; Yang DW, 1999, J BIOMOL NMR, V13, P3, DOI 10.1023/A:1008329230975; Zhang OW, 1997, J BIOMOL NMR, V9, P181, DOI 10.1023/A:1018658305040; ZHANG OW, 1994, J BIOMOL NMR, V4, P845, DOI 10.1007/BF00398413	64	17	17	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2015	290	38					22862	22878		10.1074/jbc.M115.641134	http://dx.doi.org/10.1074/jbc.M115.641134			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CR9OE	26149808	Green Published, hybrid			2022-12-26	WOS:000361685500001
J	Altgarde, N; Eriksson, C; Peerboom, N; Phan-Xuan, T; Moeller, S; Schnabelrauch, M; Svedhem, S; Trybala, E; Bergstrom, T; Bally, M				Altgarde, Noomi; Eriksson, Charlotta; Peerboom, Nadia; Phan-Xuan, Tuan; Moeller, Stephanie; Schnabelrauch, Matthias; Svedhem, Sofia; Trybala, Edward; Bergstrom, Tomas; Bally, Marta			Mucin-like Region of Herpes Simplex Virus Type 1 Attachment Protein Glycoprotein C (gC) Modulates the Virus-Glycosaminoglycan Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						carbohydrate-binding protein; glycoprotein; glycosaminoglycan; glycosylation; herpesvirus; surface plasmon resonance (SPR); mucin-like region	SULFATE-BINDING DOMAIN; HEPARAN-SULFATE; CHONDROITIN SULFATE; COMPLEMENT COMPONENT; CELLS; SURFACE; GLYCOSYLATION; HYALURONAN; RECEPTORS; IMMOBILIZATION	Background: Herpes simplex virus attachment protein gC comprises a glycosaminoglycan-binding site and a mucin-like region. Results: Removal of the mucin-like region modifies gC interaction with glycosaminoglycans. Conclusion: The mucin-like region balances the gC-glycosaminoglycan interaction during virus binding to and release from target cells. Significance: The finding might be of relevance for similar proteins on other GAG-binding viruses. Glycoprotein C (gC) mediates the attachment of HSV-1 to susceptible host cells by interacting with glycosaminoglycans (GAGs) on the cell surface. gC contains a mucin-like region located near the GAG-binding site, which may affect the binding activity. Here, we address this issue by studying a HSV-1 mutant lacking the mucin-like domain in gC and the corresponding purified mutant protein (gCmuc) in cell culture and GAG-binding assays, respectively. The mutant virus exhibited two functional alterations as compared with native HSV-1 (i.e. decreased sensitivity to GAG-based inhibitors of virus attachment to cells and reduced release of viral particles from the surface of infected cells). Kinetic and equilibrium binding characteristics of purified gC were assessed using surface plasmon resonance-based sensing together with a surface platform consisting of end-on immobilized GAGs. Both native gC and gCmuc bound via the expected binding region to chondroitin sulfate and sulfated hyaluronan but not to the non-sulfated hyaluronan, confirming binding specificity. In contrast to native gC, gCmuc exhibited a decreased affinity for GAGs and a slower dissociation, indicating that once formed, the gCmuc-GAG complex is more stable. It was also found that a larger number of gCmuc bound to a single GAG chain, compared with native gC. Taken together, our data suggest that the mucin-like region of HSV-1 gC is involved in the modulation of the GAG-binding activity, a feature of importance both for unrestricted virus entry into the cells and release of newly produced viral particles from infected cells.	[Altgarde, Noomi; Peerboom, Nadia; Phan-Xuan, Tuan; Svedhem, Sofia; Bally, Marta] Chalmers Univ Technol, Dept Appl Phys, S-41296 Gothenburg, Sweden; [Eriksson, Charlotta; Trybala, Edward; Bergstrom, Tomas] Univ Gothenburg, Dept Clin Virol, S-41346 Gothenburg, Sweden; [Moeller, Stephanie; Schnabelrauch, Matthias] INNOVENT eV, Dept Biomat, D-07745 Jena, Germany; [Bally, Marta] Inst Curie, CNRS, Ctr Rech, UMR 168,Physicochim Curie, F-75248 Paris, France	Chalmers University of Technology; University of Gothenburg; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie	Bally, M (corresponding author), Chalmers Univ Technol, Dept Appl Phys, S-41296 Gothenburg, Sweden.	bally@chalmers.se	Bally, Marta/G-8744-2011; Svedhem, Sofia/AAC-8727-2020	Peerboom, Nadia/0000-0002-5026-0586; Bergstrom, Tomas/0000-0002-9257-6757; Bally, Marta/0000-0002-5865-8302; Eriksson, Charlotta E/0000-0003-0743-0399; Trybala, Edward/0000-0003-2384-2123	European Union [NMP4-SL2009-229292]; Chalmers Area of Advance in Materials Science; Vetenskapsradet (through the Linneus program SUPRA); Deutsche Forschungsgemeinschaft [Transregio TR 67]; Vetenskapsradet [521-2011-3297, LUA-ALF-Gbg 145-841, 612-2012-5024]	European Union(European Commission); Chalmers Area of Advance in Materials Science; Vetenskapsradet (through the Linneus program SUPRA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Vetenskapsradet(Swedish Research Council)	This work was supported by the European Union Seventh Framework Programme (FP7/2007-2013) under Grant Agreement NMP4-SL2009-229292 ("Find & Bind"), the Chalmers Area of Advance in Materials Science, and Vetenskapsradet (through the Linneus program SUPRA). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the Deutsche Forschungsgemeinschaft (Transregio TR 67 (subproject A2)). Supported by Vetenskapsradet Grant 521-2011-3297 and by Grant LUA-ALF-Gbg 145-841.; Supported by Vetenskapsradet Grant 612-2012-5024. To whom correspondence should be addressed. E-mail: bally@chalmers.se.	Adamiak B, 2007, J VIROL, V81, P13424, DOI 10.1128/JVI.01528-07; Adamiak B, 2010, VIROLOGY, V400, P197, DOI 10.1016/j.virol.2010.01.032; Altgarde N, 2013, ACTA BIOMATER, V9, P8158, DOI 10.1016/j.actbio.2013.05.031; Arakawa T, 2001, ANAL BIOCHEM, V299, P158, DOI 10.1006/abio.2001.5432; Bally M, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.188103; Baranova NS, 2011, J BIOL CHEM, V286, P25675, DOI 10.1074/jbc.M111.247395; CARLSTROM D, 1957, J BIOPHYS BIOCHEM CY, V3, P669, DOI 10.1083/jcb.3.5.669; DeAngelis PL, 2002, CARBOHYD RES, V337, P1547, DOI 10.1016/S0008-6215(02)00219-7; Ekbad M, 2007, VIROLOGY, V367, P244, DOI 10.1016/j.virol.2007.05.040; Ekblad M, 2010, ANTIVIR RES, V86, P196, DOI 10.1016/j.antiviral.2010.02.318; Feyzi E, 1997, J BIOL CHEM, V272, P24850, DOI 10.1074/jbc.272.40.24850; FRIEDMAN HM, 1984, NATURE, V309, P633, DOI 10.1038/309633a0; Gama CI, 2005, CURR OPIN CHEM BIOL, V9, P609, DOI 10.1016/j.cbpa.2005.10.003; GUNALP A, 1964, P SOC EXP BIOL MED, V118, P85; Hadigal SR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7985; HEROLD BC, 1991, J VIROL, V65, P1090, DOI 10.1128/JVI.65.3.1090-1098.1991; Hill AV, 1913, BIOCHEM J, V7, P471, DOI 10.1042/bj0070471; HOFFMAN J, 1983, CARBOHYD RES, V117, P328, DOI 10.1016/0008-6215(83)88103-8; Hokputsa S, 2003, CARBOHYD POLYM, V52, P111, DOI 10.1016/S0144-8617(02)00298-9; HOLLAND TC, 1983, J VIROL, V45, P672, DOI 10.1128/JVI.45.2.672-682.1983; Horkay F, 2012, MACROMOLECULES, V45, P2882, DOI 10.1021/ma202693s; JENTOFT N, 1990, TRENDS BIOCHEM SCI, V15, P291, DOI 10.1016/0968-0004(90)90014-3; Krusat T, 1997, ARCH VIROL, V142, P1247, DOI 10.1007/s007050050156; Larsson C, 2003, ANAL CHEM, V75, P5080, DOI 10.1021/ac034269n; Lebedev K, 2006, J COLLOID INTERF SCI, V296, P527, DOI 10.1016/j.jcis.2005.09.032; Mardberg K, 2004, GLYCOBIOLOGY, V14, P571, DOI 10.1093/glycob/cwh075; Mardberg K, 2002, J GEN VIROL, V83, P291, DOI 10.1099/0022-1317-83-2-291; Mardberg K, 2001, J GEN VIROL, V82, P1941, DOI 10.1099/0022-1317-82-8-1941; Namvar L, 2005, J CLIN MICROBIOL, V43, P2058, DOI 10.1128/JCM.43.5.2058-2064.2005; Nileback E, 2011, BIOSENS BIOELECTRON, V28, P407, DOI 10.1016/j.bios.2011.07.060; Olofsson S, 2005, ANN MED, V37, P154, DOI 10.1080/07853890510007340; Olofsson S, 1998, SCAND J INFECT DIS, V30, P435, DOI 10.1080/00365549850161386; Osmond RIW, 2002, ANAL BIOCHEM, V310, P199, DOI 10.1016/S0003-2697(02)00396-2; PALESE P, 1974, VIROLOGY, V61, P397, DOI 10.1016/0042-6822(74)90276-1; Pearson JT, 2006, BIOCHEMISTRY-US, V45, P6341, DOI 10.1021/bi0600042; Rabe M, 2011, ADV COLLOID INTERFAC, V162, P87, DOI 10.1016/j.cis.2010.12.007; Raman R, 2005, CHEM BIOL, V12, P267, DOI 10.1016/j.chembiol.2004.11.020; Richter RP, 2007, J AM CHEM SOC, V129, P5306, DOI 10.1021/ja068768s; Rux AH, 2002, VIROLOGY, V294, P324, DOI 10.1006/viro.2001.1326; Salvador B, 2013, J VIROL, V87, P3295, DOI 10.1128/JVI.01621-12; Saphire ACS, 2001, J VIROL, V75, P9187, DOI 10.1128/JVI.75.19.9187-9200.2001; Satoh A, 2000, FEBS LETT, V477, P249, DOI 10.1016/S0014-5793(00)01746-4; Spear PG, 2004, CELL MICROBIOL, V6, P401, DOI 10.1111/j.1462-5822.2004.00389.x; STANNARD LM, 1987, J GEN VIROL, V68, P715, DOI 10.1099/0022-1317-68-3-715; TALSINGER R, 1995, J VIROL, V69, P4471, DOI 10.1128/JVI.69.7.4471-4483.1995; Tao YY, 2011, J CHROMATOGR A, V1218, P1530, DOI 10.1016/j.chroma.2011.01.050; Tkachenko E, 2005, CIRC RES, V96, P488, DOI 10.1161/01.RES.0000159708.71142.c8; Trybala E, 2000, J VIROL, V74, P9106, DOI 10.1128/JVI.74.19.9106-9114.2000; TRYBALA E, 1994, J GEN VIROL, V75, P743, DOI 10.1099/0022-1317-75-4-743; Vaheri A., 1964, ACTA PATHOL MICROB S, V171, P171; Vigerust DJ, 2007, TRENDS MICROBIOL, V15, P211, DOI 10.1016/j.tim.2007.03.003; VONITZSTEIN M, 1993, NATURE, V363, P418, DOI 10.1038/363418a0; Weiss JN, 1997, FASEB J, V11, P835, DOI 10.1096/fasebj.11.11.9285481; WIDEHN S, 1990, ULTRASTRUCT PATHOL, V14, P81, DOI 10.3109/01913129009050876; WUDUNN D, 1989, J VIROL, V63, P52, DOI 10.1128/JVI.63.1.52-58.1989; Yu GL, 2002, EUR J MED CHEM, V37, P783, DOI 10.1016/S0223-5234(02)01347-8	56	22	23	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2015	290	35					21473	21485		10.1074/jbc.M115.637363	http://dx.doi.org/10.1074/jbc.M115.637363			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ5IS	26160171	Green Published, hybrid			2022-12-26	WOS:000360637600023
J	Choi, HL; Suh, CI; Park, SW; Jin, JY; Cho, HG; Paik, SY				Choi, Hye Lim; Suh, Chang-Il; Park, Seung-Won; Jin, Ji-Young; Cho, Han-Gil; Paik, Soon-Young			Whole-Genome Sequencing Analysis of Sapovirus Detected in South Korea	PLOS ONE			English	Article							HUMAN ENTERIC CALICIVIRUSES; MOLECULAR CHARACTERIZATION; GASTROENTERITIS OUTBREAKS; GENETIC DIVERSITY; PHYLOGENETIC ANALYSIS; FAMILY CALICIVIRIDAE; GENOTYPE ANALYSIS; SAPPORO VIRUS; EPIDEMIOLOGY; RECOMBINATION	Sapovirus (SaV), a virus residing in the intestines, is one of the important causes of gastroenteritis in human beings. Human SaV genomes are classified into various genogroups and genotypes. Whole-genome analysis and phylogenetic analysis of ROK62, the SaV isolated in South Korea, were carried out. The ROK62 genome of 7429 nucleotides contains 3 open-reading frames (ORF). The genotype of ROK62 is SaV GI-1, and 94% of its nucleotide sequence is identical with other SaVs, namely Manchester and Mc114. Recently, SaV infection has been on the rise throughout the world, particularly in countries neighboring South Korea; however, very few academic studies have been done nationally. As the first whole-genome sequence analysis of SaV in South Korea, this research will help provide reference for the detection of recombination, tracking of epidemic spread, and development of diagnosis methods for SaV.	[Choi, Hye Lim; Jin, Ji-Young; Paik, Soon-Young] Catholic Univ Korea, Dept Microbiol, Seoul 137701, South Korea; [Suh, Chang-Il] Dankook Univ, Dept Med Consilience, Yongin 448701, Gyeonggi Do, South Korea; [Park, Seung-Won] Catholic Univ Daegu, Div Biotechnol, Daegu 712702, South Korea; [Cho, Han-Gil] Gyeonggi Prov Inst Hlth & Environm, Div Publ Hlth Res, Suwon, South Korea	Catholic University of Korea; Dankook University; Catholic University of Daegu	Paik, SY (corresponding author), Catholic Univ Korea, Dept Microbiol, 222 Banpo Daero, Seoul 137701, South Korea.	paik@catholic.ac.kr			National Research Foundation of Korea [NRF-2012R1A2A2A01045078]	National Research Foundation of Korea(National Research Foundation of Korea)	This study was supported by the National Research Foundation of Korea (NRF-2012R1A2A2A01045078). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bank-Wolf BR, 2010, VET MICROBIOL, V140, P204, DOI 10.1016/j.vetmic.2009.08.021; Chanit W, 2009, EMERG INFECT DIS, V15, P1084, DOI 10.3201/eid1507.090153; CHIBA S, 1979, J MED VIROL, V4, P249, DOI 10.1002/jmv.1890040402; Clarke IN, 2000, J INFECT DIS, V181, pS309, DOI 10.1086/315575; Dey SK, 2012, EPIDEMIOL INFECT, V140, P74, DOI 10.1017/S0950268811000240; Farkas T, 2004, ARCH VIROL, V149, P1309, DOI 10.1007/s00705-004-0296-9; Guo M, 1999, J VIROL, V73, P9625, DOI 10.1128/JVI.73.11.9625-9631.1999; Hansman GS, 2007, REV MED VIROL, V17, P133, DOI 10.1002/rmv.533; Hansman GS, 2005, EMERG INFECT DIS, V11, P1916; Hansman GS, 2004, J CLIN MICROBIOL, V42, P1305, DOI 10.1128/JCM.42.3.1305-1307.2004; Harada S, 2013, JPN J INFECT DIS, V66, P454, DOI 10.7883/yoken.66.454; Harada S, 2012, ARCH VIROL, V157, P1999, DOI 10.1007/s00705-012-1387-7; Harada S, 2009, J MED VIROL, V81, P1117, DOI 10.1002/jmv.21454; Honma S, 2001, J MED VIROL, V65, P413, DOI 10.1002/jmv.2050; Iritani N, 2014, J MED VIROL, V86, P2019, DOI 10.1002/jmv.23883; Jiang X, 1997, ARCH VIROL, V142, P1813, DOI 10.1007/s007050050199; Johansson PJH, 2005, SCAND J INFECT DIS, V37, P200, DOI 10.1080/00365540410020974; Koopmans M, 2001, NOVART FDN SYMP, V238, P197; Lee LE, 2012, EMERG INFECT DIS, V18, P873, DOI 10.3201/eid1805.111843; LIU BL, 1995, ARCH VIROL, V140, P1345, DOI 10.1007/BF01322662; Liu BL, 1997, VIRUS GENES, V15, P25, DOI 10.1023/A:1007946628253; MATSON DO, 1995, J MED VIROL, V45, P215, DOI 10.1002/jmv.1890450218; Nakanishi K, 2011, MICROBIOL IMMUNOL, V55, P657, DOI 10.1111/j.1348-0421.2011.00358.x; Nakata S, 2000, J INFECT DIS, V181, P2029, DOI 10.1086/315500; Numata K, 1997, ARCH VIROL, V142, P1537, DOI 10.1007/s007050050178; Oka T, 2015, CLIN MICROBIOL REV, V28, P32, DOI 10.1128/CMR.00011-14; Oka T, 2012, ARCH VIROL, V157, P349, DOI 10.1007/s00705-011-1161-2; Okada M, 2002, ARCH VIROL, V147, P1445, DOI 10.1007/s00705-002-0821-7; Pang XLL, 2009, J INFECT DIS, V199, P547, DOI 10.1086/596210; Park SH, 2011, CLIN LAB, V57, P59; Park S, 2012, CLIN LAB, V58, P1219, DOI 10.7754/Clin.Lab.2012.120118; Robinson S, 2002, J MED VIROL, V67, P282, DOI 10.1002/jmv.2219; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Svraka S, 2010, J CLIN MICROBIOL, V48, P2191, DOI 10.1128/JCM.02427-09; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Vinje J, 2000, J CLIN MICROBIOL, V38, P530	36	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132328	10.1371/journal.pone.0132328	http://dx.doi.org/10.1371/journal.pone.0132328			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161646	Green Published, Green Submitted, gold			2022-12-26	WOS:000358162300119
J	Day, RJ; Mason, MJ; Thomas, C; Poon, WW; Rohn, TT				Day, Ryan J.; Mason, Maria J.; Thomas, Chloe; Poon, Wayne W.; Rohn, Troy T.			Caspase-Cleaved Tau Co-Localizes with Early Tangle Markers in the Human Vascular Dementia Brain	PLOS ONE			English	Article							CORPORA-AMYLACEA; ALZHEIMERS-DISEASE; COGNITIVE IMPAIRMENT; PROTEINS; RISK; ACTIVATION; PATHOLOGY; EPITOPES; AD	Vascular dementia (VaD) is the second most common form of dementia in the United States and is characterized as a cerebral vessel vascular disease that leads to ischemic episodes. Whereas the relationship between caspase-cleaved tau and neurofibrillary tangles (NFTs) in Alzheimer's disease (AD) has been previously described, whether caspase activation and cleavage of tau occurs in VaD is presently unknown. To investigate a potential role for caspase-cleaved tau in VaD, we analyzed seven confirmed cases of VaD by immunohistochemistry utilizing a well-characterized antibody that specifically detects caspase-cleaved tau truncated at Asp(421). Application of this antibody (TauC3) revealed consistent labeling within NFTs, dystrophic neurites within plaque-rich regions and corpora amylacea (CA) in the human VaD brain. Labeling of CA by the TauC3 antibody was widespread throughout the hippocampus proper, was significantly higher compared to age matched controls, and co-localized with ubiquitin. Staining of the TauC3 antibody co-localized with MC-1, AT8, and PHF-1 within NFTs. Quantitative analysis indicated that roughly 90% of PHF-1-labeled NFTs contained caspase-cleaved tau. In addition, we documented the presence of active caspase-3 within plaques, blood vessels and pretangle neurons that co-localized with TauC3. Collectively, these data support a role for the activation of caspase-3 and proteolytic cleavage of TauC3 in VaD providing further support for the involvement of this family of proteases in NFT pathology.	[Day, Ryan J.; Rohn, Troy T.] Boise State Univ, Dept Biol Sci, Boise, ID 83725 USA; [Mason, Maria J.; Thomas, Chloe; Poon, Wayne W.] Univ Calif Irvine, Inst Memory Impairments & Neurol Disorders, Irvine, CA 92697 USA	Idaho; Boise State University; University of California System; University of California Irvine	Rohn, TT (corresponding author), Boise State Univ, Dept Biol Sci, Sci Bldg,Room 228, Boise, ID 83725 USA.	trohn@boisestate.edu		Poon, Wayne/0000-0003-0625-3968	National Institutes of Health [1R15AG042781-01A1, AG016573]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM109095] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R15AG042781, P50AG016573] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Research reported in this manuscript was supported by National Institutes of Health Grant 1R15AG042781-01A1 to TTR and AG016573 to WWP. http://grants.nih.gov/grants/oer.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal NT, 2007, SEMIN NEUROL, V27, P66, DOI 10.1055/s-2006-956757; Ahtiluoto S, 2010, NEUROLOGY, V75, P1195, DOI 10.1212/WNL.0b013e3181f4d7f8; Alonso AD, 2001, P NATL ACAD SCI USA, V98, P6923, DOI 10.1073/pnas.121119298; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Cavanagh JB, 1999, BRAIN RES REV, V29, P265, DOI 10.1016/S0165-0173(99)00003-X; CISSE S, 1993, ACTA NEUROPATHOL, V85, P233; Gamblin TC, 2003, P NATL ACAD SCI USA, V100, P10032, DOI 10.1073/pnas.1630428100; Geroldi C, 2005, ARCH NEUROL-CHICAGO, V62, P1067, DOI 10.1001/archneur.62.7.1067; GOEDERT M, 1995, NEUROSCI LETT, V189, P167, DOI 10.1016/0304-3940(95)11484-E; GOEDERT M, 1993, P NATL ACAD SCI USA, V90, P5066, DOI 10.1073/pnas.90.11.5066; GREENBERG SG, 1992, J BIOL CHEM, V267, P564; Grinberg LT, 2010, J NEUROL SCI, V299, P136, DOI 10.1016/j.jns.2010.08.055; Guillozet-Bongaarts AL, 2005, NEUROBIOL AGING, V26, P1015, DOI 10.1016/j.neurobiolaging.2004.09.019; Jellinger KA, 2007, ACTA NEUROPATHOL, V113, P349, DOI 10.1007/s00401-006-0185-2; Jellinger KA, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00017; Jicha GA, 1997, J NEUROSCI RES, V48, P128, DOI 10.1002/(SICI)1097-4547(19970415)48:2<128::AID-JNR5>3.0.CO;2-E; Kalaria RN, 2003, NEUROL RES, V25, P661, DOI 10.1179/016164103101201968; Knopman DS, 2003, ARCH NEUROL-CHICAGO, V60, P569, DOI 10.1001/archneur.60.4.569; KOSIK KS, 1988, NEURON, V1, P817, DOI 10.1016/0896-6273(88)90129-8; Kuller LH, 2005, NEUROLOGY, V64, P1548, DOI 10.1212/01.WNL.0000160115.55756.DE; Leys D, 2005, LANCET NEUROL, V4, P752, DOI 10.1016/S1474-4422(05)70221-0; LOEFFLER KU, 1993, INVEST OPHTH VIS SCI, V34, P2600; Meng H, 2009, NEUROPATHOLOGY, V29, P664, DOI 10.1111/j.1440-1789.2009.01024.x; Ott A, 1996, DIABETOLOGIA, V39, P1392, DOI 10.1007/s001250050588; Posner HB, 2002, NEUROLOGY, V58, P1175, DOI 10.1212/WNL.58.8.1175; Reitz C, 2004, ARCH NEUROL-CHICAGO, V61, P705, DOI 10.1001/archneur.61.5.705; Rissman RA, 2004, J CLIN INVEST, V114, P121, DOI 10.1172/JCI200420640; Rohn TT, 2014, INT J CLIN EXP PATHO, V7, P3504; Rohn TT, 2014, INT J CLIN EXP PATHO, V7, P938; Rohn TT, 2013, INT J CLIN EXP PATHO, V6, P41; Rohn TT, 2010, APOPTOSIS, V15, P1403, DOI 10.1007/s10495-010-0463-2; Rohn TT, 2009, HISTOL HISTOPATHOL, V24, P1081, DOI 10.14670/HH-24.1081; Rohn TT, 2008, REV NEUROSCIENCE, V19, P383; Ross GW, 1999, NEUROLOGY, V53, P337, DOI 10.1212/WNL.53.2.337; SINGHRAO SK, 1993, NEUROPATH APPL NEURO, V19, P269, DOI 10.1111/j.1365-2990.1993.tb00437.x; SINGHRAO SK, 1994, NEUROPATH APPL NEURO, V20, P66, DOI 10.1111/j.1365-2990.1994.tb00958.x; Spires-Jones TL, 2008, J NEUROSCI, V28, P862, DOI 10.1523/JNEUROSCI.3072-08.2008; Spires-Jones TL, 2009, TRENDS NEUROSCI, V32, P150, DOI 10.1016/j.tins.2008.11.007; Staekenborg SS, 2008, STROKE, V39, P317, DOI 10.1161/STROKEAHA.107.493353; Staekenborg SS, 2010, J NEUROL NEUROSUR PS, V81, P547, DOI 10.1136/jnnp.2009.187500; STAM FC, 1973, ACTA NEUROPATHOL, V25, P95, DOI 10.1007/BF00687554; Sui RB, 2012, MED HYPOTHESES, V78, P162, DOI 10.1016/j.mehy.2011.10.017; Uchihara T, 2014, NEUROPATHOLOGY, V34, P571, DOI 10.1111/neup.12108; van Oijen M, 2007, ANN NEUROL, V61, P403, DOI 10.1002/ana.21073; Veld BAI, 2001, NEUROBIOL AGING, V22, P407, DOI 10.1016/S0197-4580(00)00241-4; Weaver CL, 2000, NEUROBIOL AGING, V21, P719, DOI 10.1016/S0197-4580(00)00157-3; Wilhelmus MMM, 2011, NEUROBIOL AGING, V32, P845, DOI 10.1016/j.neurobiolaging.2009.04.019; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4506, DOI 10.1073/pnas.85.12.4506; WOODFORD B, 1980, AM J OPHTHALMOL, V90, P492, DOI 10.1016/S0002-9394(14)75018-4	49	24	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132637	10.1371/journal.pone.0132637	http://dx.doi.org/10.1371/journal.pone.0132637			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161867	Green Published, gold, Green Submitted			2022-12-26	WOS:000358162300163
J	Liao, RY; Liu, QH; Zheng, ZH; Fan, JJ; Peng, WX; Kong, QY; He, HJ; Yang, SC; Chen, WF; Tang, XQ; Yu, XQ				Liao, Ruyi; Liu, Qinghua; Zheng, Zhihua; Fan, Jinjin; Peng, Wenxing; Kong, Qingyu; He, Huijuan; Yang, Shicong; Chen, Wenfang; Tang, Xueqing; Yu, Xueqing			Tacrolimus Protects Podocytes from Injury in Lupus Nephritis Partly by Stabilizing the Cytoskeleton and Inhibiting Podocyte Apoptosis	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; CYCLOSPORINE-A; DIRECT TARGET; LPR MICE; EXPRESSION; FK506; IMMUNOSUPPRESSANT; SYNAPTOPODIN; MECHANISMS; DISEASE	Objective Several studies have reported that tacrolimus (TAC) significantly reduced proteinuria in lupus nephritis (LN) patients and mouse models. However, the mechanism for this effect remains undetermined. This study explored the mechanism of how TAC protects podocytes from injury to identify new targets for protecting renal function. Methods MRL/lpr mice were given TAC at a dosage of 0.1 mg/kg per day by intragastric administration for 8 weeks. Urine and blood samples were collected. Kidney sections (2 mu m) were stained with hematoxylin-eosin (HE), periodic acid-Schiff base (PAS) and Masson's trichrome stain. Mouse podocyte cells (MPC5) were treated with TAC and/or TGF-beta(1) for 48h. The mRNA levels and protein expression of synaptopodin and Wilms' tumor 1 (WT1) were determined by real-time PCR, Western blotting and/or immunofluorescence, respectively. Flow cytometry was used to detect cell apoptosis with annexin V. Podocyte foot processes were observed under transmission electron microscopy. IgG and C3 deposition were assessed with immunofluorescence assays and confocal microscopy. Results Synaptopodin expression significantly decreased in MRL/lpr disease control mice, accompanied by increases in 24-h proteinuria, blood urea nitrogen, and serum creatinine. TAC, however, reduced proteinuria, improved renal function, attenuated renal pathology, restored synaptopodin expression and preserved podocyte numbers. In MPC5 cells, TGF-beta(1) enhanced F-actin damage in podocytes and TAC stabilized it. TAC also decreased TGF-beta(1)-induced podocyte apoptosis in vitro and inhibited foot process fusion in MRL/lpr mice. In addition, our results also showed TAC inhibited glomerular deposition of IgG and C3. Conclusion This study demonstrated that TAC reduced proteinuria and preserved renal function in LN through protecting podocytes from injury partly by stabilizing podocyte actin cytoskeleton and inhibiting podocyte apoptosis.	[Liao, Ruyi; Liu, Qinghua; Zheng, Zhihua; Fan, Jinjin; Peng, Wenxing; Kong, Qingyu; He, Huijuan; Tang, Xueqing; Yu, Xueqing] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Nephrol, Guangzhou 510275, Guangdong, Peoples R China; [Liao, Ruyi; Liu, Qinghua; Zheng, Zhihua; Fan, Jinjin; Peng, Wenxing; Kong, Qingyu; He, Huijuan; Tang, Xueqing; Yu, Xueqing] Guangdong Prov Key Lab Nephrol, Guangzhou, Guangdong, Peoples R China; [Liao, Ruyi; Liu, Qinghua; Zheng, Zhihua; Fan, Jinjin; Peng, Wenxing; Kong, Qingyu; He, Huijuan; Tang, Xueqing; Yu, Xueqing] Minist Hlth, Key Lab Nephrol, Guangzhou, Guangdong, Peoples R China; [Yang, Shicong; Chen, Wenfang] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Pathol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Yu, XQ (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Nephrol, Guangzhou 510275, Guangdong, Peoples R China.	yuxq@mail.sysu.edu.cn			National Key Technology Research and Development Program of the Ministry of Science and Technology, China [2011BAI10B05]; Department of Science and Technology, Guangzhou City, China [2010U1-E00831]; 5010 clinical Program of Sun Yat-sen University [2007007]; National Natural Science Foundation of China [81370863]; Fundamental Research Funds for the Central Universities [13YKPY17]; Research Fund for PhD Program, Ministry of Education, China [20100171120067]; Natural Science Foundation of Guangdong Province [10451008901005957]	National Key Technology Research and Development Program of the Ministry of Science and Technology, China; Department of Science and Technology, Guangzhou City, China(Department of Science & Technology (DOST), Philippines); 5010 clinical Program of Sun Yat-sen University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Research Fund for PhD Program, Ministry of Education, China; Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	This work was supported by grants from National Key Technology Research and Development Program of the Ministry of Science and Technology, China (No. 2011BAI10B05), Department of Science and Technology, Guangzhou City, China (No. 2010U1-E00831), and 5010 clinical Program of Sun Yat-sen University (No. 2007007) to Xueqing Yu. Qinghua Liu was supported by grants from National Natural Science Foundation of China (No. 81370863), The Fundamental Research Funds for the Central Universities (No. 13YKPY17), Research Fund for PhD Program, Ministry of Education, China (No. 20100171120067) and Natural Science Foundation of Guangdong Province (No. 10451008901005957). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Astellas Pharmaceuticals supplied the tacrolimus used in this study, but it played no role in the design and conduct of this study as well as in the analysis and the interpretation of results. Writing and publication of the manuscript were not contingent on the approval of Astellas Pharmaceuticals.	Chen W, 2011, AM J KIDNEY DIS, V57, P235, DOI 10.1053/j.ajkd.2010.08.036; Das R, 2014, AM J PHYSIOL-RENAL, V306, pF155, DOI 10.1152/ajprenal.00438.2013; ENTANI C, 1993, NEPHRON, V64, P471, DOI 10.1159/000187375; Faul C, 2008, NAT MED, V14, P931, DOI 10.1038/nm.1857; Fornoni A, 2001, AM J PATHOL, V158, P275, DOI 10.1016/S0002-9440(10)63966-1; Glynne R, 2000, NATURE, V403, P672, DOI 10.1038/35001102; He FF, 2011, CELL BIOL INT, V35, P827, DOI 10.1042/CBI20100411; Herman-Edelstein M, 2013, CURR OPIN NEPHROL HY, V22, P93, DOI 10.1097/MNH.0b013e32835b4870; Kanemoto K, 2003, PATHOL INT, V53, P596, DOI 10.1046/j.1440-1827.2003.01526.x; KINO T, 1987, J ANTIBIOT, V40, P1256, DOI 10.7164/antibiotics.40.1256; Kitamura N, 2009, J INT MED RES, V37, P892, DOI 10.1177/147323000903700335; Li XY, 2009, AM J KIDNEY DIS, V54, P51, DOI 10.1053/j.ajkd.2009.02.018; Lotem J, 1998, P NATL ACAD SCI USA, V95, P4601, DOI 10.1073/pnas.95.8.4601; Mannoor K, 2012, J IMMUNOL, V188, P3628, DOI 10.4049/jimmunol.1102859; Mundel P, 1997, J CELL BIOL, V139, P193, DOI 10.1083/jcb.139.1.193; Mundel P, 1997, J AM SOC NEPHROL, V8, P697; Mundel P, 2010, KIDNEY INT, V77, P571, DOI 10.1038/ki.2009.424; Olin AI, 2014, ARTHRITIS RHEUMATOL, V66, P397, DOI 10.1002/art.38250; Perysinaki GS, 2011, LUPUS, V20, P781, DOI 10.1177/0961203310397412; QUINN DG, 1991, IMMUNOLOGY, V72, P550; Schonenberger E, 2011, NEPHROL DIAL TRANSPL, V26, P18, DOI 10.1093/ndt/gfq617; Shankland SJ, 2006, KIDNEY INT, V69, P2131, DOI 10.1038/sj.ki.5000410; Srivastava T, 2001, KIDNEY INT, V59, P118, DOI 10.1046/j.1523-1755.2001.00472.x; Su J, 2010, DIABETES RES CLIN PR, V87, P167, DOI 10.1016/j.diabres.2009.10.022; SUZUKI N, 1990, CLIN EXP IMMUNOL, V79, P240; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Walter DH, 1998, CIRCULATION, V98, P1153, DOI 10.1161/01.CIR.98.12.1153; White KE, 2004, KIDNEY INT, V66, P663, DOI 10.1111/j.1523-1755.2004.00787.x; Yamamoto K, 2000, LAB INVEST, V80, P1561, DOI 10.1038/labinvest.3780166; Yamamoto T, 1996, KIDNEY INT, V49, P461, DOI 10.1038/ki.1996.65; Yoon KH, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/686480; Zhao ZG, 2005, ARTHRITIS RHEUM-US, V52, P522, DOI 10.1002/art.20862	32	48	54	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132724	10.1371/journal.pone.0132724	http://dx.doi.org/10.1371/journal.pone.0132724			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161538	gold, Green Published, Green Submitted			2022-12-26	WOS:000358162300172
J	Wen, QY; Wang, WY; Chu, SZ; Luo, JD; Chen, LJ; Xie, GY; Xu, LN; Li, MR; Fan, SQ				Wen, Qiuyuan; Wang, Weiyuan; Chu, Shuzhou; Luo, Jiadi; Chen, Lingjiao; Xie, Guiyuan; Xu, Lina; Li, Meirong; Fan, Songqing			Flot-2 Expression Correlates with EGFR Levels and Poor Prognosis in Surgically Resected Non-Small Cell Lung Cancer	PLOS ONE			English	Article							FLOTILLIN-2; REGGIE-1/FLOTILLIN-2; PROGRESSION; MEMBRANE; SURVIVAL; OLIGOMERIZATION; OVEREXPRESSION; IDENTIFICATION; ASSOCIATION; CARCINOMA	We previously reported that expression of Flotillin 2 (Flot-2), a protein isolated from caveolae/lipid raft domains, increased significantly in nasopharyngeal carcinoma (NPC) compared with normal tissues. Signal transduction through epidermal growth factor receptors (EGFR) and Flot-2 play an important role in cancer development, but their precise role in lung cancer has not been investigated. In this study, we have investigated the correlation between the expression of Flot-2 and EGFR, which increase significantly in non-small cell lung cancer (NSCLC) patients (n=352) compared with non-cancer tissues. Additionally, patients with advanced stages of NSCLC had higher positive expression of Flot-2 and EGFR than patients with early stages. NSCLC patients with increased expression of Flot-2 and EGFR had significantly less overall survival rates than patients with less expression of Flot-2 and EGFR. Taken together, our data suggest that increased expression of Flot-2 and EGFR in NSCLC patients is inversely proportional to the disease prognosis and that increased expression of Flot-2 associated with increased EGFR may serve as a biomarker to predict poor disease prognosis.	[Wen, Qiuyuan; Wang, Weiyuan; Chu, Shuzhou; Luo, Jiadi; Chen, Lingjiao; Xu, Lina; Li, Meirong; Fan, Songqing] Cent S Univ, Xiangya Hosp 2, Dept Pathol, Changsha, Hunan, Peoples R China; [Xie, Guiyuan] Cent S Univ, Xiangya Hosp 2, Dept Oncol, Changsha, Hunan, Peoples R China	Central South University; Central South University	Fan, SQ (corresponding author), Cent S Univ, Xiangya Hosp 2, Dept Pathol, Changsha, Hunan, Peoples R China.	songqingfan2000@yahoo.com	xu, li/GNH-3667-2022		National Natural Sciences Foundations of China [81272566, 81472773]	National Natural Sciences Foundations of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from The National Natural Sciences Foundations of China (No: 81272566; 81472773) (http://isis.nsfc.gov.cn/).	Al Zobair AA, 2013, ONCOL REP, V29, P1524, DOI 10.3892/or.2013.2254; Amaddii M, 2012, J BIOL CHEM, V287, P7265, DOI 10.1074/jbc.M111.287599; Arkhipova KA, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-100; Babuke T, 2009, CELL SIGNAL, V21, P1287, DOI 10.1016/j.cellsig.2009.03.012; Banning Antje, 2014, Cells, V3, P129, DOI 10.3390/cells3010129; Bickel PE, 1997, J BIOL CHEM, V272, P13793, DOI 10.1074/jbc.272.21.13793; Chansky K, 2009, J THORAC ONCOL, V4, P792, DOI 10.1097/JTO.0b013e3181a7716e; Doherty SD, 2006, MELANOMA RES, V16, P461, DOI 10.1097/01.cmr.0000222592.75858.20; Gately K, 2014, CLIN LUNG CANCER, V15, P58, DOI 10.1016/j.cllc.2013.08.005; Goffin JR, 2013, CLIN THER, V35, P1282, DOI 10.1016/j.clinthera.2013.08.007; Hazarika P, 2004, CANCER RES, V64, P7361, DOI 10.1158/0008-5472.CAN-04-0823; Jiang AG, 2013, ONCOL LETT, V6, P375, DOI 10.3892/ol.2013.1368; Liang ZY, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-376; Little AG, 2007, LUNG CANCER, V57, P253, DOI 10.1016/j.lungcan.2007.03.012; Liu YQ, 2015, INT J CLIN EXP PATHO, V8, P622; Neumann-Giesen C, 2004, BIOCHEM J, V378, P509, DOI 10.1042/BJ20031100; Neumann-Giesen C, 2007, J CELL SCI, V120, P395, DOI 10.1242/jcs.03336; Normanno N, 2006, GENE, V366, P2, DOI 10.1016/j.gene.2005.10.018; Sasaki Y, 2008, MOL CANCER RES, V6, P395, DOI 10.1158/1541-7786.MCR-07-0108; Solis GP, 2007, BIOCHEM J, V403, P313, DOI 10.1042/BJ20061686; Solis GP, 2012, MOL BIOL CELL, V23, P1812, DOI 10.1091/mbc.E11-12-1006; Wang X, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-190; Wang YL, 2015, INT J CLIN EXP PATHO, V8, P601; Wen QY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101676; Yang XY, 2005, CELL ONCOL, V27, P215; Zhu Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062365	26	26	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132190	10.1371/journal.pone.0132190	http://dx.doi.org/10.1371/journal.pone.0132190			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161893	Green Published, gold, Green Submitted			2022-12-26	WOS:000358162300103
J	Xia, JH; Zhang, YY; Xin, LL; Kong, SY; Chen, YX; Yang, SL; Li, K				Xia, Jihan; Zhang, Yuanyuan; Xin, Leilei; Kong, Siyuan; Chen, Yaoxing; Yang, Shulin; Li, Kui			Global Transcriptomic Profiling of Cardiac Hypertrophy and Fatty Heart Induced by Long-Term High-Energy Diet in Bama Miniature Pigs	PLOS ONE			English	Article							MYOCARDIAL SUBSTRATE METABOLISM; FACTOR-KAPPA-B; GENE-EXPRESSION; FAILURE; CARDIOMYOPATHY; OBESITY; MECHANISMS; MUTATIONS; RISK; CELL	A long-term high-energy diet affects human health and leads to obesity and metabolic syndrome in addition to cardiac steatosis and hypertrophy. Ectopic fat accumulation in the heart has been demonstrated to be a risk factor for heart disorders, but the molecular mechanism of heart disease remains largely unknown. Bama miniature pigs were fed a high-fat, high-sucrose diet (HFHSD) for 23 months. These pigs developed symptoms of metabolic syndrome and showed cardiac steatosis and hypertrophy with a greatly increased body weight (2.73-fold, P < 0.01), insulin level (4.60-fold, P < 0.01), heart weight (1.82-fold, P < 0.05) and heart volume (1.60-fold, P < 0.05) compared with the control pigs. To understand the molecular mechanisms of cardiac steatosis and hypertrophy, nine pig heart cRNA samples were hybridized to porcine GeneChips. Microarray analyses revealed that 1,022 genes were significantly differentially expressed (P < 0.05, >= 1.5-fold change), including 591 up-regulated and 431 down-regulated genes in the HFHSD group relative to the control group. KEGG analysis indicated that the observed heart disorder involved the signal transduction-related MAPK, cytokine, and PPAR signaling pathways, energy metabolism-related fatty acid and oxidative phosphorylation signaling pathways, heart function signaling-related focal adhesion, axon guidance, hypertrophic cardiomyopathy and actin cytoskeleton signaling pathways, inflammation and apoptosis pathways, and others. Quantitative RT-PCR assays identified several important differentially expressed heart-related genes, including STAT3, ACSL4, ATF4, FADD, PPP3CA, CD74, SLA-8, VCL, ACTN2 and FGFR1, which may be targets of further research. This study shows that a long-term, high-energy diet induces obesity, cardiac steatosis, and hypertrophy and provides insights into the molecular mechanisms of hypertrophy and fatty heart to facilitate further research.	[Xia, Jihan; Xin, Leilei; Kong, Siyuan; Yang, Shulin; Li, Kui] Chinese Acad Agr Sci, Inst Anim Sci, State Key Lab Anim Nutr, Beijing 100193, Peoples R China; [Zhang, Yuanyuan; Chen, Yaoxing] China Agr Univ, Coll Vet Med, Beijing 100094, Peoples R China; [Li, Kui] CAAS, Agr Genomes Inst Shenzhen, Shenzhen 518120, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS; China Agricultural University; Chinese Academy of Agricultural Sciences; Agriculture Genomes Institute at Shenzhen, CAAS	Yang, SL (corresponding author), Chinese Acad Agr Sci, Inst Anim Sci, State Key Lab Anim Nutr, Beijing 100193, Peoples R China.	yangshulin@caas.cn	zhang, yuanyuan/GYA-4428-2022; Xia, Jihan/GLQ-5273-2022	Xia, Jihan/0000-0002-0035-0727	National Natural Science Foundation of China [31372276]; National Key Technology Support Program [2012BAI39B04]; National Basic Research Program [2011CBA01005]; National Science and Technology Major Project [2014ZX08010-003]; Development Program of China [2012AA020603]; Agricultural Science and Technology Innovation Program [ASTIP-IAS05, ASTIP-IAS-TS-4]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology Support Program(National Key Technology R&D Program); National Basic Research Program(National Basic Research Program of China); National Science and Technology Major Project; Development Program of China; Agricultural Science and Technology Innovation Program	This research was supported by the National Natural Science Foundation of China (31372276), National Key Technology Support Program (2012BAI39B04), The National Basic Research Program (2011CBA01005), National Science and Technology Major Project (2014ZX08010-003), Development Program of China (2012AA020603) and The Agricultural Science and Technology Innovation Program (ASTIP-IAS05, ASTIP-IAS-TS-4).	Abdulsid A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071127; Barbisan F, 2009, IMMUNOGENETICS, V61, P145, DOI 10.1007/s00251-008-0339-6; Baumgarten G, 2002, CIRCULATION, V105, P2192, DOI 10.1161/01.CIR.0000015608.37608.18; Bays JL, 2014, J CELL BIOL, V205, P251, DOI 10.1083/jcb.201309092; Bell DSH, 2007, CARDIOL CLIN, V25, P523, DOI 10.1016/j.ccl.2007.08.003; Berenji K, 2005, AM J PHYSIOL-HEART C, V289, pH8, DOI 10.1152/ajpheart.01303.2004; Brindley DN, 2010, AM J PHYSIOL-ENDOC M, V298, pE897, DOI 10.1152/ajpendo.00509.2009; Chan CP, 2013, BBA-MOL CELL RES, V1833, P2165, DOI 10.1016/j.bbamcr.2013.05.002; Chess DJ, 2008, CARDIOVASC RES, V79, P269, DOI 10.1093/cvr/cvn074; Chiu C, 2010, J AM COLL CARDIOL, V55, P1127, DOI 10.1016/j.jacc.2009.11.016; Franchini KG, 2009, BRAZ J MED BIOL RES, V42, P44, DOI 10.1590/S0100-879X2009000100008; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; Graner M, 2013, J CLIN ENDOCR METAB, V98, P1189, DOI 10.1210/jc.2012-3190; Gupta S, 2007, ANTIOXID REDOX SIGN, V9, P623, DOI 10.1089/ars.2007.1474; Guzzardi Maria A, 2011, Rev Diabet Stud, V8, P403, DOI 10.1900/RDS.2011.8.403; Hsia HC, 2014, J SURG RES, V191, P268, DOI 10.1016/j.jss.2014.05.084; Iozzo P, 2011, DIABETES CARE, V34, pS371, DOI 10.2337/dc11-s250; Kim HJ, 2014, J BIOL CHEM, V289, P1429, DOI 10.1074/jbc.M113.520130; Kusza S, 2011, ANIM GENET, V42, P510, DOI 10.1111/j.1365-2052.2010.02170.x; Madsen K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062503; Malchers F, 2014, CANCER DISCOV, V4, P246, DOI 10.1158/2159-8290.CD-13-0323; Molkentin JD, 2004, CARDIOVASC RES, V63, P467, DOI 10.1016/j.cardiores.2004.01.021; Mottillo S, 2010, J AM COLL CARDIOL, V56, P1113, DOI 10.1016/j.jacc.2010.05.034; Ong RW, 2014, J NEUROL NEUROSUR PS, V85, P1058, DOI 10.1136/jnnp-2014-307608; Osterholt M, 2013, HEART FAIL REV, V18, P645, DOI 10.1007/s10741-012-9346-7; Peterson LR, 2004, CIRCULATION, V109, P2191, DOI 10.1161/01.CIR.0000127959.28627.F8; Richard AF, 2011, DEV BIOL, V359, P303, DOI 10.1016/j.ydbio.2011.08.010; Rodrigues B, 1998, MOL CELL BIOCHEM, V180, P53, DOI 10.1023/A:1006882805197; Schenk S, 2008, J CLIN INVEST, V118, P2992, DOI 10.1172/JCI34260; Shim J, 2013, MOL REPROD DEV, V80, P570, DOI 10.1002/mrd.22192; Shimabukuro M, 2009, CIRC J, V73, P27, DOI 10.1253/circj.CJ-08-1012; Song G, 2010, BIOL REPROD, V82, P854, DOI 10.1095/biolreprod.109.080929; Spurlock ME, 2008, J NUTR, V138, P397, DOI 10.1093/jn/138.2.397; Stanley WC, 2005, PHYSIOL REV, V85, P1093, DOI 10.1152/physrev.00006.2004; Weterman MAJ, 2013, BRAIN, V136, P282, DOI 10.1093/brain/aws293; Xia JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113724; Xia JH, 2014, MOL BIOL REP, V41, P3211, DOI 10.1007/s11033-014-3182-x; Xiao L, 2014, DIABETES, V63, P1366, DOI 10.2337/db13-1412; Yue LX, 2011, CARDIOVASC RES, V89, P744, DOI 10.1093/cvr/cvq329; Zhang HL, 2013, ARCH VIROL, V158, P2285, DOI 10.1007/s00705-013-1750-3	40	15	17	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132420	10.1371/journal.pone.0132420	http://dx.doi.org/10.1371/journal.pone.0132420			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161779	Green Submitted, Green Published, gold			2022-12-26	WOS:000358162300132
J	Hester, SE; Goodfield, LL; Park, J; Feaga, HA; Ivanov, YV; Bendor, L; Taylor, DL; Harvill, ET				Hester, Sara E.; Goodfield, Laura L.; Park, Jihye; Feaga, Heather A.; Ivanov, Yury V.; Bendor, Liron; Taylor, Dawn L.; Harvill, Eric T.			Host Specificity of Ovine Bordetella parapertussis and the Role of Complement	PLOS ONE			English	Article							RESPIRATORY-TRACT INFECTION; O-ANTIGEN; NEISSERIA-MENINGITIDIS; LISTERIA-MONOCYTOGENES; E-CADHERIN; PERTUSSIS; BRONCHISEPTICA; BIOSYNTHESIS; PNEUMONIA; DIVERSITY	The classical bordetellae are comprised of three subspecies that differ from broad to very limited host specificity. Although several lineages appear to have specialized to particular host species, most retain the ability to colonize and grow in mice, providing a powerful common experimental model to study their differences. One of the subspecies, Bordetella parapertussis, is composed of two distinct clades that have specialized to different hosts: one to humans (Bpp(hu)), and the other to sheep (Bpp(ov)). While Bpp(hu) and the other classical bordetellae can efficiently colonize mice, Bppov strains are severely defective in their ability to colonize the murine respiratory tract. Bpp(ov) genomic analysis did not reveal the loss of adherence genes, but substantial mutations and deletions of multiple genes involved in the production of O-antigen, which is required to prevent complement deposition on B. bronchiseptica and Bpphu strains. Bpp(ov) lacks O-antigen and, like O-antigen mutants of other bordetellae, is highly sensitive to murine complement-mediated killing in vitro. Based on these results, we hypothesized that Bpp(ov) failed to colonize mice because of its sensitivity to murine complement. Consistent with this, the Bpp(ov) defect in the colonization of wild type mice was not observed in mice lacking the central complement component C3. Furthermore, Bpp(ov) strains were highly susceptible to killing by murine complement, but not by sheep complement. These data demonstrate that the failure of Bpp(ov) to colonize mice is due to sensitivity to murine, but not sheep, complement, providing a mechanistic example of how specialization that accompanies expansion in one host can limit host range.	[Hester, Sara E.; Goodfield, Laura L.; Park, Jihye; Feaga, Heather A.; Ivanov, Yury V.; Bendor, Liron; Taylor, Dawn L.; Harvill, Eric T.] Penn State Univ, Dept Vet & Biomed Sci, University Pk, PA 16802 USA; [Hester, Sara E.; Feaga, Heather A.] Penn State Univ, Grad Program Biochem Microbiol & Mol Biol, University Pk, PA 16802 USA; [Goodfield, Laura L.] Penn State Univ, Grad Program Immunol & Infect Dis, University Pk, PA 16802 USA; [Park, Jihye] Penn State Univ, Grad Program Bioinformat & Genom, University Pk, PA 16802 USA; [Bendor, Liron] Penn State Univ, Grad Program Genet, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Harvill, ET (corresponding author), Penn State Univ, Dept Vet & Biomed Sci, University Pk, PA 16802 USA.	Harvill@psu.edu		Harvill, Eric/0000-0001-8893-2133	National Institutes of Health [GM083113]; United States Department of Agriculture National Institute of Food and Agriculture [2010-65110-20488]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083113] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Agriculture National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grant GM083113 to ETH (www.nih.gov/) and by the Agriculture and Food Research Initiative Competitive Grants Program Grant no. 2010-65110-20488 from the United States Department of Agriculture National Institute of Food and Agriculture to SEH, JP, HAF (www.csrees.usda.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen A, 1996, MOL MICROBIOL, V19, P37, DOI 10.1046/j.1365-2958.1996.354877.x; Berggard K, 1997, INFECT IMMUN, V65, P3638; Bjornstad ON, 2005, TRENDS MICROBIOL, V13, P355, DOI 10.1016/j.tim.2005.06.007; Brinig MM, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-r81; Burns VC, 2003, INFECT IMMUN, V71, P86, DOI 10.1128/IAI.71.1.86-94.2003; CHEN WX, 1988, NEW ZEAL VET J, V36, P138, DOI 10.1080/00480169.1988.35509; Circolo A, 1999, IMMUNOPHARMACOLOGY, V42, P135, DOI 10.1016/S0162-3109(99)00021-1; Diavatopoulos DA, 2005, PLOS PATHOG, V1, P373, DOI 10.1371/journal.ooat.0010045; FERNANDEZ RC, 1994, INFECT IMMUN, V62, P4727, DOI 10.1128/IAI.62.11.4727-4738.1994; Goebel EM, 2008, INFECT IMMUN, V76, P1774, DOI 10.1128/IAI.01629-07; Goebel EM, 2008, INFECT IMMUN; GOODNOW RA, 1980, MICROBIOL REV, V44, P722, DOI 10.1128/MMBR.44.4.722-738.1980; Granoff DM, 2009, INFECT IMMUN, V77, P764, DOI 10.1128/IAI.01191-08; Harvill ET, 2000, INFECT IMMUN, V68, P6720, DOI 10.1128/IAI.68.12.6720-6728.2000; Heininger U, 2002, INFECT IMMUN, V70, P3777, DOI 10.1128/IAI.70.7.3777-3784.2002; IMAIZUMI A, 1983, J CLIN MICROBIOL, V17, P781, DOI 10.1128/JCM.17.5.781-786.1983; Lecuit M, 2004, P NATL ACAD SCI USA, V101, P6152, DOI 10.1073/pnas.0401434101; Lecuit M, 1999, EMBO J, V18, P3956, DOI 10.1093/emboj/18.14.3956; Marr N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020585; Mattoo S, 2005, CLIN MICROBIOL REV, V18, P326, DOI 10.1128/CMR.18.2.326-382.2005; MUSSER JM, 1987, J BACTERIOL, V169, P2793, DOI 10.1128/jb.169.6.2793-2803.1987; MUSSER JM, 1986, J BACTERIOL, V166, P230, DOI 10.1128/jb.166.1.230-237.1986; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; PORTER JF, 1995, J COMP PATHOL, V112, P381, DOI 10.1016/S0021-9975(05)80019-2; PORTER JF, 1994, MICROBIOL-SGM, V140, P255, DOI 10.1099/13500872-140-2-255; Preston A, 1999, INFECT IMMUN, V67, P3763, DOI 10.1128/IAI.67.8.3763-3767.1999; Schneider MC, 2009, NATURE, V458, P890, DOI 10.1038/nature07769; STAINER DW, 1970, J GEN MICROBIOL, V63, P211, DOI 10.1099/00221287-63-2-211; Sun HM, 2004, SCIENCE, V305, P1283, DOI 10.1126/science.1101245; Westphal O., 1965, METHODS CARBOHYDRATE, V5, P83, DOI DOI 10.1016/J.WATRES.2010.04.030	30	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2015	10	7							e0130964	10.1371/journal.pone.0130964	http://dx.doi.org/10.1371/journal.pone.0130964			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EW	26158540	Green Published, Green Submitted, gold			2022-12-26	WOS:000358161200023
J	Zhang, L; Wei, PF; Shen, XD; Zhang, YW; Xu, B; Zhou, J; Fan, S; Hao, ZY; Shi, HQ; Zhang, XS; Kong, R; Xu, LF; Gao, JJ; Zou, DH; Liang, CZ				Zhang, Li; Wei, Pengfei; Shen, Xudong; Zhang, Yuanwei; Xu, Bo; Zhou, Jun; Fan, Song; Hao, Zongyao; Shi, Haoqiang; Zhang, Xiansheng; Kong, Rui; Xu, Lingfan; Gao, Jingjing; Zou, Duohong; Liang, Chaozhao			MicroRNA Expression Profile in Penile Cancer Revealed by Next-Generation Small RNA Sequencing	PLOS ONE			English	Article							PROGNOSTIC-SIGNIFICANCE; COLORECTAL-CANCER; DOWN-REGULATION; NONCODING RNAS; CELL CARCINOMA; PROGRESSION; METHYLATION; DISCOVERY; APOPTOSIS; ONCOGENE	Penile cancer (PeCa) is a relatively rare tumor entity but possesses higher morbidity and mortality rates especially in developing countries. To date, the concrete pathogenic signaling pathways and core machineries involved in tumorigenesis and progression of PeCa remain to be elucidated. Several studies suggested miRNAs, which modulate gene expression at posttranscriptional level, were frequently mis-regulated and aberrantly expressed in human cancers. However, the miRNA profile in human PeCa has not been reported before. In this present study, the miRNA profile was obtained from 10 fresh penile cancerous tissues and matched adjacent non-cancerous tissues via next-generation sequencing. As a result, a total of 751 and 806 annotated miRNAs were identified in normal and cancerous penile tissues, respectively. Among which, 56 miRNAs with significantly different expression levels between paired tissues were identified. Subsequently, several annotated miRNAs were selected randomly and validated using quantitative real-time PCR. Compared with the previous publications regarding to the altered miRNAs expression in various cancers and especially genitourinary (prostate, bladder, kidney, testis) cancers, the most majority of deregulated miRNAs showed the similar expression pattern in penile cancer. Moreover, the bioinformatics analyses suggested that the putative target genes of differentially expressed miRNAs between cancerous and matched normal penile tissues were tightly associated with cell junction, proliferation, growth as well as genomic instability and so on, by modulating Wnt, MAPK, p53, PI3K-Akt, Notch and TGF-beta signaling pathways, which were all well-established to participate in cancer initiation and progression. Our work presents a global view of the differentially expressed miRNAs and potentially regulatory networks of their target genes for clarifying the pathogenic transformation of normal penis to PeCa, which research resource also provides new insights into future investigations aimed to explore the in-depth mechanisms of miRNAs and other small RNAs including piRNAs in penile carcinogenesis regulation and effective target-specific theragnosis.	[Zhang, Li; Shen, Xudong; Zhou, Jun; Fan, Song; Hao, Zongyao; Shi, Haoqiang; Zhang, Xiansheng; Kong, Rui; Xu, Lingfan; Gao, Jingjing; Liang, Chaozhao] Anhui Med Univ, Affiliated Hosp 1, Dept Urol, Hefei, Anhui, Peoples R China; [Zhang, Li; Shen, Xudong; Zhou, Jun; Fan, Song; Hao, Zongyao; Shi, Haoqiang; Zhang, Xiansheng; Kong, Rui; Xu, Lingfan; Gao, Jingjing; Liang, Chaozhao] Anhui Med Univ, Inst Urol, Hefei, Anhui, Peoples R China; [Wei, Pengfei; Zhang, Yuanwei] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China; [Xu, Bo] Anhui Med Univ, Anhui Prov Hosp, Ctr Reprod Med, Hefei, Anhui, Peoples R China; [Zou, Duohong] Anhui Med Univ, Stomatol Coll, Key Lab Oral Dis Res Anhui Prov, Hefei, Anhui, Peoples R China	Anhui Medical University; Anhui Medical University; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Anhui Medical University; Anhui Medical University	Zou, DH (corresponding author), Anhui Med Univ, Stomatol Coll, Key Lab Oral Dis Res Anhui Prov, Hefei, Anhui, Peoples R China.	zouduohongyy@126.com; liang_chaozhao@163.com	Wei, Pengfei/J-1264-2016; zhang, xian/GYA-0290-2022; Zhang, Yuanwei/C-7695-2016	Wei, Pengfei/0000-0002-5786-6580; Zhang, Yuanwei/0000-0002-2814-8061; Zhang, Li/0000-0003-2599-952X; xu, lingfan/0000-0003-2465-241X	National Natural Science Foundation of China [81401518, 31430028, 81170698, 81370856, 31370983]; Anhui Provincial Natural Science Foundation [1408085QH180]; Clinical Key Subjects Program of the Ministry of Public Health of China; cultivation project for NSFC at Anhui Medical University [2013KJ14]; Key Project of the Chinese Ministry of Education [212080]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Anhui Provincial Natural Science Foundation(Natural Science Foundation of Anhui Province); Clinical Key Subjects Program of the Ministry of Public Health of China; cultivation project for NSFC at Anhui Medical University; Key Project of the Chinese Ministry of Education(Ministry of Education, China)	This work was supported by the National Natural Science Foundation of China (No. 81401518, No. 31430028, http://www.nsfc.gov.cn/) (LZ); the National Natural Science Foundation of China (No. 81170698, No. 81370856, http://www.nsfc.gov.cn/) (CZL); the National Natural Science Foundation of China (No. 31370983, http://www.nsfc.gov.cn/) (DHZ); Anhui Provincial Natural Science Foundation (No. 1408085QH180, http://www.ahkjt.gov.cn/) (LZ), the Clinical Key Subjects Program of the Ministry of Public Health of China (Urology, http://www.nhfpc.gov.cn/) (CZL), the cultivation project for NSFC at Anhui Medical University (No. 2013KJ14, http://www.ayfy.com) (LZ) and the Key Project of the Chinese Ministry of Education (No. 212080, http://www.moe.edu.cn/) (DHZ). The funders had no roles in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Akhurst RJ, 2001, TRENDS CELL BIOL, V11, pS44, DOI 10.1016/S0962-8924(01)82259-5; Andersson P, 2008, J UROLOGY, V179, P2030, DOI 10.1016/j.juro.2007.12.040; Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Avila JL, 2013, TRENDS MOL MED, V19, P320, DOI 10.1016/j.molmed.2013.03.003; Barad O, 2004, GENOME RES, V14, P2486, DOI 10.1101/gr.2845604; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Blake JA, 2015, NUCLEIC ACIDS RES, V43, pD1049, DOI 10.1093/nar/gku1179; Bleeker MCG, 2009, WORLD J UROL, V27, P141, DOI 10.1007/s00345-008-0302-z; Bloomston M, 2007, JAMA-J AM MED ASSOC, V297, P1901, DOI 10.1001/jama.297.17.1901; Bussing I, 2008, TRENDS MOL MED, V14, P400, DOI 10.1016/j.molmed.2008.07.001; Burge SW, 2013, NUCLEIC ACIDS RES, V41, pD226, DOI 10.1093/nar/gks1005; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calmon MF, 2011, THESCIENTIFICWORLDJO, V11, P269, DOI 10.1100/tsw.2011.24; Calmon MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053260; Calore F, 2013, INT J MOL SCI, V14, P17085, DOI 10.3390/ijms140817085; Chen HY, 2012, CANCER RES, V72, P3631, DOI 10.1158/0008-5472.CAN-12-0667; Chen L, 2013, BIOCHEM BIOPH RES CO, V435, P745, DOI 10.1016/j.bbrc.2013.05.056; Cheng J, 2011, CLIN CHIM ACTA, V412, P1621, DOI 10.1016/j.cca.2011.05.015; Deng W, 2002, DEV CELL, V2, P819, DOI 10.1016/S1534-5807(02)00165-X; Dong HF, 2013, CHEM REV, V113, P6207, DOI 10.1021/cr300362f; Elgamal OA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076402; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Han YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018286; He XJ, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-218; Henry VJ, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau069; Hirata H, 2013, BRIT J CANCER, V108, P2070, DOI 10.1038/bjc.2013.173; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Li N, 2013, NUCLEIC ACIDS RES, V41, P3619, DOI 10.1093/nar/gkt072; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li XX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022570; Li XH, 2011, J CELL MOL MED, V15, P1887, DOI 10.1111/j.1582-4934.2010.01194.x; Lim SL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099687; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Majid S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067686; Majid S, 2012, CANCER RES, V72, P6435, DOI 10.1158/0008-5472.CAN-12-2181; Meltzer PS, 2005, NATURE, V435, P745, DOI 10.1038/435745a; Meng FX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034394; Misra S, 2004, LANCET ONCOL, V5, P240, DOI 10.1016/S1470-2045(04)01427-5; Nelson PT, 2004, NAT METHODS, V1, P155, DOI 10.1038/NMETH717; Olar A, 2014, HUM PATHOL, V45, P1358, DOI 10.1016/j.humpath.2014.02.009; Osanto S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038298; Patterson Erin E, 2011, Cancer, V117, P1630, DOI 10.1002/cncr.25724; Protzel C, 2013, INT J MOL SCI, V14, P19494, DOI 10.3390/ijms141019494; Rogenhofer S, 2013, J UROLOGY, V189, P1117, DOI 10.1016/j.juro.2012.08.221; Schaefer A, 2010, NAT REV UROL, V7, P286, DOI 10.1038/nrurol.2010.45; Schee K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066165; Shang C, 2014, MOL BIOL REP, V41, P2521, DOI 10.1007/s11033-014-3110-0; Shi S, 2014, CURR MOL MED, V14, P316, DOI 10.2174/1566524014666140228120014; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Siomi H, 2010, MOL CELL, V38, P323, DOI 10.1016/j.molcel.2010.03.013; Stegh AH, 2012, EXPERT OPIN THER TAR, V16, P67, DOI 10.1517/14728222.2011.643299; Streppel MM, 2013, CLIN CANCER RES, V19, P4067, DOI 10.1158/1078-0432.CCR-13-0601; Sturm M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-292; Szczyrba J, 2010, MOL CANCER RES, V8, P529, DOI 10.1158/1541-7786.MCR-09-0443; Tong XH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106706; Torres A, 2013, INT J CANCER, V132, P1633, DOI 10.1002/ijc.27840; Vanhaesebroeck B, 2012, NAT REV MOL CELL BIO, V13, P195, DOI 10.1038/nrm3290; Vega FM, 2008, FEBS LETT, V582, P2093, DOI 10.1016/j.febslet.2008.04.039; Volinia S, 2012, P NATL ACAD SCI USA, V109, P3024, DOI 10.1073/pnas.1200010109; Wahid F, 2010, BBA-MOL CELL RES, V1803, P1231, DOI 10.1016/j.bbamcr.2010.06.013; Wang BH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101306; Wang D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013067; Wang JW, 2022, FEBS LETT, DOI 10.1016/j.febslet.2013.04.029; Watahiki A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024950; Weinberg RA., 2002, NEW ENGL J MED, V347, P1593, DOI [DOI 10.1056/NEJMRA021902, 10.1056/NEJMra021902]; Weng LH, 2010, J PATHOL, V222, P41, DOI 10.1002/path.2736; Wu JY, 2013, RNA BIOL, V10, P1087, DOI 10.4161/rna.25193; Wu KM, 2013, PATHOL ONCOL RES, V19, P739, DOI 10.1007/s12253-013-9637-x; Xi YM, 2014, CANCER LETT, V353, P8, DOI 10.1016/j.canlet.2014.07.010; Xu Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087920; Xu Y, 2012, BRIT J CANCER, V106, P553, DOI 10.1038/bjc.2011.568; Yamashita AS, 2013, TRANSL ONCOL, V6, P197, DOI 10.1593/tlo.12442; Yanagawa N, 2008, PATHOL INT, V58, P477, DOI 10.1111/j.1440-1827.2008.02259.x; Yang QL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066809; Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0; Zaman MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050203; Zhai QN, 2012, BIOCHEM BIOPH RES CO, V419, P621, DOI 10.1016/j.bbrc.2012.02.060; Zhang P, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau110; Zhao HC, 2014, CARCINOGENESIS, V35, P886, DOI 10.1093/carcin/bgt378	87	29	30	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2015	10	7							e0131336	10.1371/journal.pone.0131336	http://dx.doi.org/10.1371/journal.pone.0131336			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EW	26158897	gold, Green Published, Green Submitted			2022-12-26	WOS:000358161200027
J	Murray, J; Cohen, A; Walaza, S; Groome, M; Madhi, S; Variava, E; Kahn, K; Dawood, H; Tempia, S; Tshangela, A; Venter, M; Feikin, D; Cohen, C				Murray, Jillian; Cohen, Adam; Walaza, Sibongile; Groome, Michelle; Madhi, Shabir; Variava, Ebrahim; Kahn, Kathleen; Dawood, Halima; Tempia, Stefano; Tshangela, Akhona; Venter, Marietje; Feikin, Daniel; Cohen, Cheryl			Determining the Provincial and National Burden of Influenza-Associated Severe Acute Respiratory Illness in South Africa Using a Rapid Assessment Methodology	PLOS ONE			English	Article							SEASONAL INFLUENZA; TRACT INFECTIONS; SURVEILLANCE; VIRUS; EPIDEMIOLOGY; PREVALENCE; PNEUMONIA; MORTALITY; CHILDREN	Local disease burden data are necessary to set national influenza vaccination policy. In 2010 the population of South Africa was 50 million and the HIV prevalence was 11%. We used a previously developed methodology to determine severe influenza burden in South Africa. Hospitalized severe acute respiratory illness (SARI) incidence was calculated, stratified by HIV status, for four age groups using data from population-based surveillance in one site situated in Gauteng Province for 2009-2011. These rates were adjusted for each of the remaining 8 provinces based on their prevalence of risk factors for pneumonia and healthcare-seeking behavior. We estimated non-hospitalized influenza-associated SARI from healthcare utilization surveys at two sites and used the percent of SARI cases positive for influenza from sentinel surveillance to derive the influenza-associated SARI rate. We applied rates of hospitalized and non-hospitalized influenza-associated SARI to census data to calculate the national number of cases. The percent of SARI cases that tested positive for influenza ranged from 7-17% depending on age group, year, province and HIV status. In 2010, there were an estimated 21,555 total severe influenza cases in HIV-uninfected individuals and 13,876 in HIV-infected individuals. In 2011, there were an estimated 29,892 total severe influenza cases in HIV-uninfected individuals and 17,289 in HIV-infected individuals. The incidence of influenza-associated SARI was highest in children <5 years and was higher in HIV-infected than HIV-uninfected persons in all age groups. Influenza virus was associated with a substantial amount of severe disease, especially in young children and HIV-infected populations in South Africa.	[Murray, Jillian; Feikin, Daniel] Johns Hopkins Int Vaccine Access Ctr, Baltimore, MD 21205 USA; [Cohen, Adam; Tempia, Stefano] Ctr Dis Control & Prevent, Pretoria, South Africa; [Cohen, Adam; Venter, Marietje; Feikin, Daniel] Ctr Dis Control & Prevent, Atlanta, GA USA; [Walaza, Sibongile; Madhi, Shabir; Tempia, Stefano; Tshangela, Akhona; Venter, Marietje; Cohen, Cheryl] Natl Inst Communicable Dis, Johannesburg, South Africa; [Groome, Michelle; Madhi, Shabir] MRC, Resp & Meningeal Pathogens Res Unit, Johannesburg, South Africa; [Madhi, Shabir; Kahn, Kathleen; Cohen, Cheryl] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa; [Madhi, Shabir; Kahn, Kathleen; Cohen, Cheryl] Univ Witwatersrand, Sch Pathol, Johannesburg, South Africa; [Variava, Ebrahim] Klerksdorp Tshepong Hosp, Klerksdorp, South Africa; [Kahn, Kathleen; Dawood, Halima] Univ KwaZulu Natal, Durban, South Africa; [Kahn, Kathleen] Umea Univ, Umea, Sweden; [Kahn, Kathleen] INDEPTH Network, Accra, Ghana; [Dawood, Halima] Pietermaritzburg Metropolitan Hosp Complex, Pietermaritzburg, South Africa; [Venter, Marietje] Univ Pretoria, Dept Med Virol, Zoonoses Res Unit, ZA-0002 Pretoria, South Africa	Johns Hopkins University; Centers for Disease Control & Prevention - USA; National Institute for Communicable Diseases (NICD); University of Witwatersrand; University of Witwatersrand; University of Kwazulu Natal; Umea University; INDEPTH Network; University of Pretoria	Murray, J (corresponding author), Johns Hopkins Int Vaccine Access Ctr, Baltimore, MD 21205 USA.	jmurra35@jhu.edu	Dawood, Halima/AAF-6045-2020; Groome, Michelle Jennifer/AAI-9967-2021; Dawood, Halima/AAO-6963-2020; Variava, Ebrahim/AAO-5717-2020; Venter, Marietjie/P-9604-2016	Groome, Michelle Jennifer/0000-0001-5893-3725; Dawood, Halima/0000-0001-8180-6791; Variava, Ebrahim/0000-0003-2888-789X; Venter, Marietjie/0000-0003-2696-824X; Kahn, Kathleen/0000-0003-3339-3931; Cohen, Cheryl/0000-0003-0376-2302	Global Health Research Graduate Student Award, Centre for Global Health, Johns Hopkins Bloomberg School of Public Health	Global Health Research Graduate Student Award, Centre for Global Health, Johns Hopkins Bloomberg School of Public Health	This work was supported by the Global Health Research Graduate Student Award, Centre for Global Health, Johns Hopkins Bloomberg School of Public Health: http://www.hopkinsglobalhealth.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellei N.C.J., 2006, Braz J Infect Dis, V10, P269, DOI 10.1590/S1413-86702006000400011; Besselaar TG, 2004, J MED VIROL, V73, P71, DOI 10.1002/jmv.20063; Besselaar TG, 1999, J MED VIROL, V59, P561, DOI 10.1002/(SICI)1096-9071(199912)59:4&lt;561::AID-JMV22&gt;3.0.CO;2-5; Cohen C, 2013, EMERG INFECT DIS, V19, P1766, DOI 10.3201/eid1911.130546; Cohen C, 2012, CLIN INFECT DIS, V55, P996, DOI 10.1093/cid/cis549; Day C, 2012, S AFRICAN HLTH REV, V17, P208; Fuller JA, 2012, PLOS ONE; Gessner BD, 2011, LANCET INFECT DIS, V11, P223, DOI 10.1016/S1473-3099(11)70008-1; Iwuji CC, 2011, HIV MED, V12, P553, DOI 10.1111/j.1468-1293.2011.00923.x; Jambo KC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038628; Johnstone-Robertson SP, 2011, AM J EPIDEMIOL, V174, P1246, DOI 10.1093/aje/kwr251; Kyeyagalire R, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0694-x; Lin JC, 2001, ARCH INTERN MED, V161, P441, DOI 10.1001/archinte.161.3.441; Louria DB, 2007, CLIN INFECT DIS, V45, P470, DOI 10.1086/520026; Madhi SA, 2002, PEDIATR INFECT DIS J, V21, P291, DOI 10.1097/00006454-200204000-00007; Madhi SA, 2000, J PEDIATR-US, V137, P78, DOI 10.1067/mpd.2000.105350; MCANERNEY JM, 1994, S AFR MED J, V84, P473; McAnerney JM, 2012, J INFECT DIS, V206, pS153, DOI 10.1093/infdis/jis575; Medical Research Council DoH, 2007, S AFR DEM HLTH SURV; Nair H, 2011, LANCET, V378, P1917, DOI 10.1016/S0140-6736(11)61051-9; Ortiz JR, 2009, EMERG INFECT DIS, V15, P1271, DOI 10.3201/eid1508.081422; Radin JM, 2012, J INFECT DIS, V206, pS14, DOI 10.1093/infdis/jis606; Ramkrishna W, 2013, COVERAGE HIGH RISK G; Roca A, 2010, VACCINE, V28, P4851, DOI 10.1016/j.vaccine.2010.03.060; Rudan I, 2008, B WORLD HEALTH ORGAN, V86, P408, DOI 10.2471/BLT.07.048769; Schoub BD, 2013, SAMJ S AFR MED J, V103, P80, DOI [10.7196/samj.6435, 10.7196/SAMJ.6435]; Schoub BD, 2011, FUTURE VIROL, V6, P1143, DOI 10.2217/FVL.11.92; SCHOUB BD, 1986, S AFR MED J, V70, P815; Schoub BD, 2002, VACCINE, V20, pS45, DOI 10.1016/S0264-410X(02)00129-9; Shisana O., 2009, S AFRICAN NATL HIV P; World Health Organization, 2014, WHO GLOBAL EPIDEMIOL	31	18	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0132078	10.1371/journal.pone.0132078	http://dx.doi.org/10.1371/journal.pone.0132078			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154306	Green Published, gold, Green Submitted			2022-12-26	WOS:000358159700086
J	Naze, F; Desvars, A; Picardeau, M; Bourhy, P; Michault, A				Naze, Florence; Desvars, Amelie; Picardeau, Mathieu; Bourhy, Pascale; Michault, Alain			Use of a New High Resolution Melting Method for Genotyping Pathogenic Leptospira spp.	PLOS ONE			English	Article							REAL-TIME PCR; POLYMERASE-CHAIN-REACTION; CURVE ANALYSIS; RAPID IDENTIFICATION; INDIAN-OCEAN; DIFFERENTIATION; CLASSIFICATION; EPIDEMIOLOGY; POLYMORPHISM; VALIDATION	Background Leptospirosis is a worldwide zoonosis that is endemic in tropical areas, such as Reunion Island. The species Leptospira interrogans is the primary agent in human infections, but other pathogenic species, such as L. kirschner and L. borgpetersenii, are also associated with human leptospirosis. Methods and Findings In this study, a melting curve analysis of the products that were amplified with the primer pairs lfb1 F/R and G1/G2 facilitated an accurate species classification of Leptospira reference strains. Next, we combined an unsupervised high resolution melting (HRM) method with a new statistical approach using primers to amplify a two variable-number tandemrepeat (VNTR) for typing at the subspecies level. The HRM analysis, which was performed with ScreenClust Software, enabled the identification of genotypes at the serovar level with high resolution power (Hunter-Gaston index 0.984). This method was also applied to Leptospira DNA from blood samples that were obtained from Reunion Island after 1998. We were able to identify a unique genotype that is identical to that of the L. interrogans serovars Copenhageni and Icterohaemorrhagiae, suggesting that this genotype is the major cause of leptospirosis on Reunion Island. Conclusions Our simple, rapid, and robust genotyping method enables the identification of Leptospira strains at the species and subspecies levels and supports the direct genotyping of Leptospira in biological samples without requiring cultures.	[Naze, Florence; Desvars, Amelie; Michault, Alain] CHU La Reunion, Dept Microbiol, St Pierre, France; [Picardeau, Mathieu; Bourhy, Pascale] Inst Pasteur, Natl Reference Ctr, Unie Biol Spirochetes, Paris, France; [Picardeau, Mathieu; Bourhy, Pascale] WHO, Collaborating Ctr Leptospirosis, Inst Pasteur, Paris, France	CHU Reunion; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; World Health Organization	Michault, A (corresponding author), CHU La Reunion, Dept Microbiol, St Pierre, France.	alain.michault@chu-reunion.fr		Desvars-Larrive, Amelie/0000-0001-7671-696X				Adler B, 2010, VET MICROBIOL, V140, P287, DOI 10.1016/j.vetmic.2009.03.012; Ahmed A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007093; Ahmed Niyaz, 2006, Ann Clin Microbiol Antimicrob, V5, P28, DOI 10.1186/1476-0711-5-28; Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2; Boonsilp S, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001954; Bourhy P, 2012, J CLIN MICROBIOL, V50, P307, DOI 10.1128/JCM.05931-11; Bourhy P, 2014, INT J SYST EVOL MICR, V64, P4061, DOI 10.1099/ijs.0.066597-0; Bourhy P, 2011, J CLIN MICROBIOL, V49, P2154, DOI 10.1128/JCM.02452-10; Brenner DJ, 1999, INT J SYST BACTERIOL, V49, P839, DOI 10.1099/00207713-49-2-839; Caimi K, 2012, MEM I OSWALDO CRUZ, V107, P644, DOI 10.1590/S0074-02762012000500011; Cerqueira GM, 2009, J MED MICROBIOL, V58, P1173, DOI 10.1099/jmm.0.009175-0; Chan WF, 2009, J MICROBIOL METH, V77, P326, DOI 10.1016/j.mimet.2009.03.007; CORNEY BG, 1993, J CLIN MICROBIOL, V31, P2927, DOI 10.1128/JCM.31.11.2927-2932.1993; Desvars A, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-80; Desvars A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020377; Erali M, 2006, CLIN CHEM, V52, P1443, DOI 10.1373/clinchem.2006.068510; Ferreira AS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112312; Fortini D, 2007, CLIN CHEM, V53, P1377, DOI 10.1373/clinchem.2007.085993; Galloway RL, 2008, AM J TROP MED HYG, V78, P628, DOI 10.4269/ajtmh.2008.78.628; GRAVEKAMP C, 1993, J GEN MICROBIOL, V139, P1691, DOI 10.1099/00221287-139-8-1691; Gundry CN, 2003, CLIN CHEM, V49, P396, DOI 10.1373/49.3.396; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Jeffery N, 2007, MICROBIOL-SGM, V153, P2679, DOI 10.1099/mic.0.2006/005140-0; Ko AI, 2009, NAT REV MICROBIOL, V7, P736, DOI 10.1038/nrmicro2208; Kositanont U, 2007, J MICROBIOL METH, V69, P288, DOI 10.1016/j.mimet.2007.01.012; Levett PN, 2005, J MED MICROBIOL, V54, P45, DOI 10.1099/jmm.0.45860-0; Majed Z, 2005, J CLIN MICROBIOL, V43, P539, DOI 10.1128/JCM.43.2.539-545.2005; Merien F, 2005, FEMS MICROBIOL LETT, V249, P139, DOI 10.1016/j.femsle.2005.06.011; MERIEN F, 1992, J CLIN MICROBIOL, V30, P2219; Morey RE, 2006, J CLIN MICROBIOL, V44, P3510, DOI 10.1128/JCM.00670-06; Naze F, 2010, J CLIN MICROBIOL, V48, P3146, DOI 10.1128/JCM.00402-10; OLIVEIRA MAA, 1995, DIAGN MICR INFEC DIS, V22, P343, DOI 10.1016/0732-8893(95)00145-3; Picardeau M, 2013, MED MALADIES INFECT, V43, P1, DOI 10.1016/j.medmal.2012.11.005; Postic D, 2000, RES MICROBIOL, V151, P333, DOI 10.1016/S0923-2508(00)00156-X; Reja V, 2010, METHODS, V50, pS10, DOI 10.1016/j.ymeth.2010.02.006; Robertson T, 2009, J APPL MICROBIOL, V107, P2017, DOI 10.1111/j.1365-2672.2009.04388.x; Salaun L, 2006, J CLIN MICROBIOL, V44, P3954, DOI 10.1128/JCM.00336-06; Schwartz SB, 2009, J CLIN MICROBIOL, V47, P4117, DOI 10.1128/JCM.01696-09; Shukla J, 2002, INDIAN J MED RES, V116, P192; Steer PA, 2009, J CLIN MICROBIOL, V47, P311, DOI 10.1128/JCM.01567-08; Stephens AJ, 2008, CLIN CHEM, V54, P432, DOI 10.1373/clinchem.2007.093658; Struelens M. J., 1996, Clin Microbiol Infect, V2, P2, DOI 10.1111/j.1469-0691.1996.tb00193.x; Talmi-Frank D, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000581; TAYLOR KA, 1991, INFECT IMMUN, V59, P323, DOI 10.1128/IAI.59.1.323-329.1991; Tulsiani SM, 2010, ANN TROP MED PARASIT, V104, P151, DOI 10.1179/136485910X12607012374037; Urwin R, 2003, TRENDS MICROBIOL, V11, P479, DOI 10.1016/j.tim.2003.08.006; van Belkum A, 2007, CLIN MICROBIOL INFEC, V13, P1, DOI 10.1111/j.1469-0691.2007.01786.x; Vezenegho SB, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-282; Vijayachari P, 2004, J CLIN MICROBIOL, V42, P3575, DOI [10.1128/JCM.42.8.3575-3580.2004, 10.1128/jcm.42.8.3575-3580.2004]; Waggoner JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112356; Winchell JM, 2010, J CLIN MICROBIOL, V48, P697, DOI 10.1128/JCM.02021-09; Wittwer CT, 2003, CLIN CHEM, V49, P853, DOI 10.1373/49.6.853; ZUERNER RL, 1993, J CLIN MICROBIOL, V31, P578, DOI 10.1128/JCM.31.3.578-583.1993	53	23	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0127430	10.1371/journal.pone.0127430	http://dx.doi.org/10.1371/journal.pone.0127430			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154161	Green Submitted, Green Published, gold			2022-12-26	WOS:000358159700004
J	Rohde, S; Nietzer, S; Schupp, PJ				Rohde, Sven; Nietzer, Samuel; Schupp, Peter J.			Prevalence and Mechanisms of Dynamic Chemical Defenses in Tropical Sponges	PLOS ONE			English	Article							SECONDARY METABOLITES; CARIBBEAN SPONGES; MARINE-INVERTEBRATES; HERBIVORE-RESISTANCE; ECOLOGY; PLANT; APLYSINA; LOCALIZATION; ALLOCATION; PATTERNS	Sponges and other sessile invertebrates are lacking behavioural escape or defense mechanisms and rely therefore on morphological or chemical defenses. Studies from terrestrial systems and marine algae demonstrated facultative defenses like induction and activation to be common, suggesting that sessile marine organisms also evolved mechanisms to increase the efficiency of their chemical defense. However, inducible defenses in sponges have not been investigated so far and studies on activated defenses are rare. We investigated whether tropical sponge species induce defenses in response to artificial predation and whether wounding triggers defense activation. Additionally, we tested if these mechanisms are also used to boost antimicrobial activity to avoid bacterial infection. Laboratory experiments with eight pacific sponge species showed that 87% of the tested species were chemically defended. Two species, Stylissa massa and Melophlus sarasinorum, induced defenses in response to simulated predation, which is the first demonstration of induced antipredatory defenses in marine sponges. One species, M. sarasinorum, also showed activated defense in response to wounding. Interestingly, 50% of the tested sponge species demonstrated induced antimicrobial defense. Simulated predation increased the antimicrobial defenses in Aplysinella sp., Cacospongia sp., M. sarasinorum, and S. massa. Our results suggest that wounding selects for induced antimicrobial defenses to protect sponges from pathogens that could otherwise invade the sponge tissue via feeding scars.	[Rohde, Sven; Nietzer, Samuel; Schupp, Peter J.] Carl von Ossietzky Univ Oldenburg, Inst Chem & Biol Marine Environm ICBM, Wilhelmshaven, Germany	Carl von Ossietzky Universitat Oldenburg	Rohde, S (corresponding author), Carl von Ossietzky Univ Oldenburg, Inst Chem & Biol Marine Environm ICBM, Wilhelmshaven, Germany.	sven.rohde@uni-oldenburg.de	Rohde, Sven/T-1255-2017; Schupp, Peter j/D-3296-2015	Rohde, Sven/0000-0002-1796-6384; Schupp, Peter Josef/0000-0003-4831-2751	German Academic Exchange Service; National Institutes of Health MBRS SCORE grant [S06-GM-44796]	German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); National Institutes of Health MBRS SCORE grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the German Academic Exchange Service to SR and the National Institutes of Health MBRS SCORE grant S06-GM-44796 to PJS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amesbury SS, 1982, U GUAM MAR LAB C 173, V1, P1; Aoki S, 2000, TETRAHEDRON, V56, P1833, DOI 10.1016/S0040-4020(00)00092-2; Assmann M, 2000, MAR ECOL PROG SER, V207, P255, DOI 10.3354/meps207255; BALDWIN IT, 1990, TRENDS ECOL EVOL, V5, P91, DOI 10.1016/0169-5347(90)90237-8; Becerro MA, 2003, OECOLOGIA, V135, P91, DOI 10.1007/s00442-002-1138-7; BERGMANN W, 1950, J AM CHEM SOC, V72, P2809, DOI 10.1021/ja01162a543; Bewley CA, 1996, EXPERIENTIA, V52, P716, DOI 10.1007/BF01925581; BRYANT JP, 1991, ANNU REV ECOL SYST, V22, P431, DOI 10.1146/annurev.es.22.110191.002243; Burns E, 2003, MAR ECOL PROG SER, V252, P105, DOI 10.3354/meps252105; Cetrulo GL, 2000, MAR ECOL PROG SER, V207, P243, DOI 10.3354/meps207243; Chanas B, 1997, J EXP MAR BIOL ECOL, V208, P185, DOI 10.1016/S0022-0981(96)02653-6; Coleman RA, 2007, FUNCT ECOL, V21, P101, DOI 10.1111/j.1365-2435.2006.01210.x; Conn E. E., 1979, Herbivores: their interaction with secondary plant metabolites, P387; Cronin G, 2001, CRC MAR SCI, P325; Cronin G, 1996, ECOLOGY, V77, P1531, DOI 10.2307/2265549; Cronin G, 1996, OECOLOGIA, V105, P361, DOI 10.1007/BF00328739; Ebel R, 1997, J CHEM ECOL, V23, P1451, DOI 10.1023/B:JOEC.0000006475.10310.3a; Haber M, 2011, MAR ECOL PROG SER, V422, P113, DOI 10.3354/meps08921; Harvell CD, 1998, ECOLOGY AND EVOLUTION OF INDUCIBLE DEFENSES, P3; Hay ME, 1996, J EXP MAR BIOL ECOL, V200, P103, DOI 10.1016/S0022-0981(96)02659-7; HAY ME, 1994, ECOLOGY, V75, P1714, DOI 10.2307/1939631; Heil M, 2002, TRENDS PLANT SCI, V7, P61, DOI 10.1016/S1360-1385(01)02186-0; Jung V, 2001, TETRAHEDRON, V57, P7169, DOI 10.1016/S0040-4020(01)00692-5; KARBAN R, 1989, ANNU REV ECOL SYST, V20, P331, DOI 10.1146/annurev.es.20.110189.001555; Karban R, 1997, INDUCED RESPONSE HER; Kelly SR, 2005, AQUAT MICROB ECOL, V40, P191, DOI 10.3354/ame040191; KINNEL RB, 1993, J AM CHEM SOC, V115, P3376, DOI 10.1021/ja00061a065; KOBAYASHI J, 1986, EXPERIENTIA, V42, P1176, DOI 10.1007/BF01941300; KRISCHIK VA, 1991, OECOLOGIA, V85, P562, DOI 10.1007/BF00323769; Lindel T, 2000, J CHEM ECOL, V26, P1477, DOI 10.1023/A:1005591826613; Lindquist N, 2002, J NAT PROD, V65, P681, DOI 10.1021/np010339e; McClintock JB, 2010, INTEGR COMP BIOL, V50, P967, DOI 10.1093/icb/icq035; Miner BG, 2005, TRENDS ECOL EVOL, V20, P685, DOI 10.1016/j.tree.2005.08.002; Mohammed R, 2006, J NAT PROD, V69, P1739, DOI 10.1021/np060006n; Morrison WE, 2011, OECOLOGIA, V165, P427, DOI 10.1007/s00442-010-1791-1; Muller WEG, 2004, MAR BIOL, V144, P19, DOI 10.1007/s00227-003-1184-7; Newbold RW, 1999, AQUAT MICROB ECOL, V19, P279, DOI 10.3354/ame019279; Paul V.J., 1992, ECOLOGICAL ROLES MAR; Paul VJ, 2006, NAT PROD REP, V23, P153, DOI 10.1039/b404735b; PAUL VJ, 1992, J EXP MAR BIOL ECOL, V160, P191, DOI 10.1016/0022-0981(92)90237-5; Paul VJ, 2004, NAT PROD REP, V21, P189, DOI 10.1039/b302334f; Pavia H, 2000, ECOLOGY, V81, P3212; Pavia H, 2002, ECOLOGY, V83, P891; Pawlik JR, 2008, MAR ECOL PROG SER, V368, P137, DOI 10.3354/meps07615; Pawlik JR, 2002, INTEGR COMP BIOL, V42, P1292; PAWLIK JR, 1995, MAR ECOL PROG SER, V127, P183, DOI 10.3354/meps127183; Peters KJ, 2009, MAR ECOL PROG SER, V385, P77, DOI 10.3354/meps08026; PFISTER CA, 1992, ECOLOGY, V73, P1586, DOI 10.2307/1940012; Piel J, 2009, NAT PROD REP, V26, P338, DOI 10.1039/b703499g; Pigliucci M, 2005, TRENDS ECOL EVOL, V20, P481, DOI 10.1016/j.tree.2005.06.001; Pohnert G, 2004, TOP CURR CHEM, V239, P179, DOI 10.1007/b95453; Puglisi MP, 2014, NAT PROD REP, V31, P1510, DOI 10.1039/c4np00017j; Puyana M, 2003, MAR ECOL PROG SER, V246, P127, DOI 10.3354/meps246127; RAFFA KF, 1995, OECOLOGIA, V102, P285, DOI 10.1007/BF00329795; RANDALL JE, 1968, MAR BIOL, V1, P216, DOI 10.1007/BF00347115; Richelle-Maurer E, 2003, BIOCHEM SYST ECOL, V31, P1073, DOI 10.1016/S0305-1978(03)00072-3; Rohde S, 2004, J ECOL, V92, P1011, DOI 10.1111/j.0022-0477.2004.00936.x; Rohde S, 2008, J PHYCOL, V44, P85, DOI 10.1111/j.1529-8817.2007.00451.x; Rohde S, 2012, J CHEM ECOL, V38, P463, DOI 10.1007/s10886-012-0124-8; Rohde S, 2011, J EXP MAR BIOL ECOL, V399, P76, DOI 10.1016/j.jembe.2011.01.012; Salomon CE, 2001, MAR BIOL, V139, P313; Schupp P, 1999, MAR BIOL, V135, P573, DOI 10.1007/s002270050658; Sinko J, 2012, VET MED-CZECH, V57, P177, DOI 10.17221/5914-VETMED; Slattery M, 2012, HDB MARINE NATURAL P, V1; Swearingen DC, 1998, MAR BIOL, V131, P619, DOI 10.1007/s002270050354; Tasdemir D, 2002, J MED CHEM, V45, P529, DOI 10.1021/jm0102856; TEEYAPANT R, 1993, NATURWISSENSCHAFTEN, V80, P369, DOI 10.1007/BF01138794; THOMPSON JE, 1983, ACTA ZOOL-STOCKHOLM, V64, P199, DOI 10.1111/j.1463-6395.1983.tb00801.x; Thoms C, 2006, J CHEM ECOL, V32, P97, DOI 10.1007/s10886-006-9355-x; Thoms C, 2007, SERIE LIVROS MUSEO N, V28; Thoms Carsten, 2007, V28, P627; Thoms C, 2008, J CHEM ECOL, V34, P1242, DOI 10.1007/s10886-008-9518-z; Toth GB, 2007, J ECOL, V95, P425, DOI 10.1111/j.1365-2745.2007.01224.x; UNSON MD, 1993, EXPERIENTIA, V49, P349, DOI 10.1007/BF01923420; VACELET J, 1975, J MICROSC BIOL CELL, V23, P271; Van Alstyne KL, 2001, MAR ECOL PROG SER, V213, P53, DOI 10.3354/meps213053; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; WULFF JL, 1994, SPONGES IN TIME AND SPACE, P265; Xu JZ, 2006, CHEM PHARM BULL, V54, P852, DOI 10.1248/cpb.54.852	79	29	29	3	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0132236	10.1371/journal.pone.0132236	http://dx.doi.org/10.1371/journal.pone.0132236			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154741	Green Published, gold, Green Submitted			2022-12-26	WOS:000358159700091
J	Mailhiot, SE; Zignego, DL; Prigge, JR; Wardwell, ER; Schmidt, EE; June, RK				Mailhiot, Sarah E.; Zignego, Donald L.; Prigge, Justin R.; Wardwell, Ella R.; Schmidt, Edward E.; June, Ronald K.			Non-Invasive Quantification of Cartilage Using a Novel In Vivo Bioluminescent Reporter Mouse	PLOS ONE			English	Article							OSTEOARTHRITIC CARTILAGE; CHONDROCYTE HYPERTROPHY; JOINT DAMAGE; MODEL; MICE; HISTOPATHOLOGY; MORPHOLOGY; DELIVERY	Mouse models are common tools for examining post-traumatic osteoarthritis (OA), which involves cartilage deterioration following injury or stress. One challenge to current mouse models is longitudinal monitoring of the cartilage deterioration in vivoin the same mouse during an experiment. The objective of this study was to assess the feasibility for using a novel transgenic mouse for non-invasive quantification of cartilage. Chondrocytes are defined by expression of the matrix protein aggrecan, and we developed a novel mouse containing a reporter luciferase cassette under the inducible control of the endogenous aggrecan promoter. We generated these mice by crossing a Cre-dependent luciferase reporter allele with an aggrecan creERT2 knockin allele. The advantage of this design is that the targeted knockin retains the intact endogenous aggrecan locus and expresses the tamoxifen-inducible CreERT2 protein from a second IRES-driven open reading frame. These mice display bioluminescence in the joints, tail, and trachea, consistent with patterns of aggrecan expression. To evaluate this mouse as a technology for non-invasive quantification of cartilage loss, we characterized the relationship between loss of bioluminescence and loss of cartilage after induction with (i) ex vivo collagenase digestion, (ii) an in vivo OA model utilizing treadmill running, and (iii) age. Ex vivo experiments revealed that collagenase digestion of the femur reduced both luciferase signal intensity and pixel area, demonstrating a link between cartilage degradation and bioluminescence. In an in vivo model of experimental OA, we found decreased bioluminescent signal and pixel area, which correlated with pathological disease. We detected a decrease in both bioluminescent signal intensity and area with natural aging from 2 to 13 months of age. These results indicate that the bioluminescent signal from this mouse may be used as a non-invasive quantitative measure of cartilage. Future studies may use this reporter mouse to advance basic and preclinical studies of murine experimental OA with applications in synovial joint biology, disease pathogenesis, and drug delivery.	[Mailhiot, Sarah E.; Schmidt, Edward E.; June, Ronald K.] Montana State Univ, Mol Biosci Program, Bozeman, MT 59717 USA; [Prigge, Justin R.; Schmidt, Edward E.] Montana State Univ, Dept Microbiol & Immunol, Bozeman, MT 59717 USA; [Mailhiot, Sarah E.; Zignego, Donald L.; Wardwell, Ella R.; June, Ronald K.] Montana State Univ, Dept Mech & Ind Engn, Bozeman, MT 59717 USA; [June, Ronald K.] Montana State Univ, Affiliate Fac, Dept Cell Biol & Neurosci, Bozeman, MT 59717 USA	Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman	June, RK (corresponding author), Montana State Univ, Mol Biosci Program, Bozeman, MT 59717 USA.	rjune@me.montana.edu		Mailhiot, Sarah/0000-0001-7303-0751	Montana State University Vice President for Research; NIH [P20GM10339405S1]; NATIONAL INSTITUTE ON AGING [R01AG040020] Funding Source: NIH RePORTER	Montana State University Vice President for Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding was provided by awards from the Montana State University Vice President for Research and NIH P20GM10339405S1 to RKJ.	Arden N, 2006, BEST PRACT RES CL RH, V20, P3, DOI 10.1016/j.berh.2005.09.007; Bowles RD, 2014, ARTHRITIS RHEUMATOL, V66, P637, DOI 10.1002/art.38279; Chen JQ, 2013, J BONE MINER RES, V28, P1160, DOI 10.1002/jbmr.1834; Christiansen BA, 2012, OSTEOARTHR CARTILAGE, V20, P773, DOI 10.1016/j.joca.2012.04.014; Edwards SHR, 2011, VET J, V190, P15, DOI 10.1016/j.tvjl.2010.09.019; Glasson SS, 2007, OSTEOARTHR CARTILAGE, V15, P1061, DOI 10.1016/j.joca.2007.03.006; Glasson SS, 2010, OSTEOARTHR CARTILAGE, V18, pS17, DOI 10.1016/j.joca.2010.05.025; Glasson SS, 2004, ARTHRITIS RHEUM-US, V50, P2547, DOI 10.1002/art.20558; Glasson SS, 2005, NATURE, V434, P644, DOI 10.1038/nature03369; Gui YS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046076; Henry SP, 2009, GENESIS, V47, P805, DOI 10.1002/dvg.20564; Hosaka Y, 2013, P NATL ACAD SCI USA, V110, P1875, DOI 10.1073/pnas.1207458110; Hutchinson ID, 2014, INT J RADIAT BIOL, V90, P821, DOI 10.3109/09553002.2014.927935; June RK, 2010, J AM CHEM SOC, V132, P10680, DOI 10.1021/ja1040418; KAEDING C C, 1990, Arthroscopy, V6, P33, DOI 10.1016/0749-8063(90)90094-T; Kamekura S, 2005, OSTEOARTHR CARTILAGE, V13, P632, DOI 10.1016/j.joca.2005.03.004; Kim BJ, 2013, OSTEOARTHR CARTILAGE, V21, P2013, DOI 10.1016/j.joca.2013.09.012; Kotwal N, 2012, OSTEOARTHR CARTILAGE, V20, P887, DOI 10.1016/j.joca.2012.04.012; Leahy AA, 2015, ARTHRITIS RHEUMATOL, V67, P442, DOI 10.1002/art.38957; Li W, 2015, J ORTHOP RES; Lim NH, 2014, ARTHRITIS RHEUMATOL, V66, P589, DOI 10.1002/art.38295; Little CB, 2009, ARTHRITIS RHEUM-US, V60, P3723, DOI 10.1002/art.25002; Little CB, 2013, NAT REV RHEUMATOL, V9, P485, DOI 10.1038/nrrheum.2013.72; MUNDLOS S, 1991, MATRIX, V11, P339, DOI 10.1016/S0934-8832(11)80205-2; Palmer AW, 2006, P NATL ACAD SCI USA, V103, P19255, DOI 10.1073/pnas.0606406103; Pritzker KPH, 2006, OSTEOARTHR CARTILAGE, V14, P13, DOI 10.1016/j.joca.2005.07.014; Renders GAP, 2014, DENTOMAXILLOFAC RAD, V43, DOI 10.1259/dmfr.20130098; Ruan MZC, 2013, ARTHRITIS RHEUM-US, V65, P388, DOI 10.1002/art.37766; Rudolphi K, 2003, OSTEOARTHR CARTILAGE, V11, P738, DOI 10.1016/S1063-4584(03)00153-5; Safran Michal, 2003, Mol Imaging, V2, P297, DOI 10.1162/153535003322750637; Sgariglia F, 2013, BONE, V57, P220, DOI 10.1016/j.bone.2013.08.012; Siebelt M, 2011, J ORTHOP RES, V29, P1788, DOI 10.1002/jor.21444; STERNBERG SR, 1983, COMPUTER, V16, P22, DOI 10.1109/MC.1983.1654163; Stock M, 2015, OSTEOARTHRITIS CARTI; Thomas N, 2015, J ORTHOP RES; Ushiku C, 2010, J ORTHOP RES, V28, P1338, DOI 10.1002/jor.21105; VANDERKRAAN PM, 1990, J EXP PATHOL, V71, P19; VANOSCH GJVM, 1994, J ORTHOP RES, V12, P168, DOI 10.1002/jor.1100120204; Wagner SC, 2001, J COMPUT ASSIST TOMO, V25, P661, DOI 10.1097/00004728-200109000-00001	39	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2015	10	7							e0130564	10.1371/journal.pone.0130564	http://dx.doi.org/10.1371/journal.pone.0130564			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EC	26151638	Green Published, gold, Green Submitted			2022-12-26	WOS:000358158900012
J	Choi, E; Byeon, SJ; Kim, SH; Lee, HJ; Kwon, HJ; Ahn, H; Kim, DH; Chang, MS				Choi, Euno; Byeon, Sun-ju; Kim, Soo Hee; Lee, Hyun Ju; Kwon, Hyeong Ju; Ahn, HyeSeong; Kim, Dong Ha; Chang, Mee Soo			Implication of Leptin-Signaling Proteins and Epstein-Barr Virus in Gastric Carcinomas	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; RECEPTOR OB-R; GROWTH-FACTOR; EXPRESSION; CELL; OVEREXPRESSION; PROLIFERATION; ACTIVATION; PROGNOSIS; PATHWAY	We investigated the clinicopathological implications of leptin-signaling proteins and Epstein-Barr virus (EBV)-infection status in gastric carcinomas. Immunohistochemistry for leptin signalling-related proteins (leptin, leptin-receptor, pSTAT3, ERK, pAkt, mTOR and HIF-1 alpha), and in situ hybridization for EBV-encoded small RNAs was performed in 343 cases of gastric carcinomas. The siRNA against leptin-receptor was transfected into three stomach cancer cell lines, and western blot for caspase 3 was performed. The TNM stage was a prognostic factor in all 343 patients, and was negatively correlated with expression of leptin, pSTAT3, ERK, pAkt, mTOR and HIF-1 alpha (P < 0.05). Leptin-receptor expression was correlated with poor survival in 207 patients of the advanced gastric cancer (AGC) subgroup, 139 of the Lauren diffuse group, and in 160 patients with lymph node metastasis (P < 0.05, respectively). Additionally, in stomach cancer cells, cleaved caspase 3 level increased by leptin-receptor inhibition, that is, apoptosis increased. Interestingly, EBV-positive AGC (n = 29) tended to show better survival of patients than EBV-negative AGC (n = 178) (P = 0.06). pAkt expression was related with a good survival of 32 patients (9%) in the EBV-positive subgroup, but was not an independent prognostic factor. Among, leptin signalingrelated proteins, expressions of leptin-receptor and mTOR were different between EBVpositive subgroup and EBV-negative subgroup (P < 0.05, respectively). In conclusion, leptin- signaling proteins and EBV status show different significance on patient survival, according to subsets of gastric carcinomas. The leptin-receptor may predict poor patient prognosis in the AGC, Lauren diffuse and lymph node metastasis subgroups, while EBV-positive status can show a good prognosis in the AGC. Each leptin signaling-related protein may be differently involved in carcinogenesis of EBV-negative and EBV-positive subsets.	[Choi, Euno; Kim, Soo Hee; Lee, Hyun Ju; Kwon, Hyeong Ju; Kim, Dong Ha; Chang, Mee Soo] Seoul Natl Univ, Coll Med, Dept Pathol, Boramae Hosp, Seoul 151, South Korea; [Byeon, Sun-ju; Ahn, HyeSeong] Seoul Natl Univ, Boramae Hosp, Dept Surg, Seoul 151, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital	Chang, MS (corresponding author), Seoul Natl Univ, Coll Med, Dept Pathol, Boramae Hosp, Seoul 151, South Korea.	meesooch@snu.ac.kr		Byeon, Sun-ju/0000-0002-9599-4970	SNUH Research Fund [0420140350 (2014-1167)]	SNUH Research Fund	This work was funded by grant number 0420140350 (2014-1167) from the SNUH Research Fund (https://cris.snuh.org/ncris/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballinger A, 1999, GUT, V44, P153, DOI 10.1136/gut.44.2.153; Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Bjorbaek C, 1997, J BIOL CHEM, V272, P32686, DOI 10.1074/jbc.272.51.32686; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Cabuk D, 2007, ONCOLOGY-BASEL, V72, P111, DOI 10.1159/000111118; Camargo MC, 2014, GUT, V63, P236, DOI 10.1136/gutjnl-2013-304531; Cammisotto PG, 2007, HISTOL HISTOPATHOL, V22, P199, DOI 10.14670/HH-22.199; Chang Mee Soo, 2005, Cancer Res Treat, V37, P257, DOI 10.4143/crt.2005.37.5.257; Chang MS, 2013, J VIROL, V87, P10515, DOI 10.1128/JVI.00955-13; Chang MS, 2001, PATHOL RES PRACT, V197, P395, DOI 10.1078/0344-0338-00052; Chen Jiezhong, 2012, World J Virol, V1, P154, DOI 10.5501/wjv.v1.i6.154; Cho JY, 2013, J GASTRIC CANCER, V13, P129, DOI 10.5230/jgc.2013.13.3.129; Edge SB, 2010, AJCC CANC STAGING MA, P117, DOI DOI 10.1007/978-0-387-88441-7; Fukayama M, 2010, PATHOL INT, V60, P337, DOI 10.1111/j.1440-1827.2010.02533.x; Garofalo C, 2006, J CELL PHYSIOL, V207, P12, DOI 10.1002/jcp.20472; Griffiths EA, 2007, BRIT J CANCER, V96, P95, DOI 10.1038/sj.bjc.6603524; Hegyi K, 2004, CELL BIOL INT, V28, P159, DOI 10.1016/j.cellbi.2003.12.003; Iizasa H, 2012, VIRUSES-BASEL, V4, P3420, DOI 10.3390/v4123420; Ishikawa M, 2006, WORLD J GASTROENTERO, V12, P5517, DOI 10.3748/wjg.v12.i34.5517; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jung JE, 2005, FASEB J, V19, P1296, DOI 10.1096/fj.04-3099fje; Kaneda A, 2012, CANCER RES, V72, P3445, DOI 10.1158/0008-5472.CAN-11-3919; Kang GH, 2002, AM J PATHOL, V160, P787, DOI 10.1016/S0002-9440(10)64901-2; Kim B, 2010, PATHOLOGY, V42, P58, DOI 10.3109/00313020903356392; Lang K, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-27; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Lee HS, 2004, CLIN CANCER RES, V10, P1698, DOI 10.1158/1078-0432.CCR-1122-3; Lee S, 2010, KOREAN J PATHOL, V44, P252, DOI 10.4132/KoreanJPathol.2010.44.3.252; Mizokami K, 2006, J SURG ONCOL, V94, P149, DOI 10.1002/jso.20568; Procaccini C, 2012, MOL ASPECTS MED, V33, P35, DOI 10.1016/j.mam.2011.10.012; Ren H, 2014, CANCER LETT, V354, P172, DOI 10.1016/j.canlet.2014.08.001; Sasaki T, 2013, PATHOBIOLOGY, V81, P36, DOI 10.1159/000351721; Schneider R, 2001, HORM METAB RES, V33, P1, DOI 10.1055/s-2001-12617; Sukawa Y, 2014, DIGESTION, V89, P12, DOI 10.1159/000356201; Sukawa Y, 2012, WORLD J GASTROENTERO, V18, P6577, DOI 10.3748/wjg.v18.i45.6577; Sweeney G, 2002, CELL SIGNAL, V14, P655, DOI 10.1016/S0898-6568(02)00006-2; Uddin S, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-74; Woo S, 2011, PATHOBIOLOGY, V78, P295, DOI 10.1159/000321696; Yarandi SS, 2011, NUTRITION, V27, P269, DOI 10.1016/j.nut.2010.07.004	39	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0130839	10.1371/journal.pone.0130839	http://dx.doi.org/10.1371/journal.pone.0130839			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147886	Green Published, gold, Green Submitted			2022-12-26	WOS:000358157600052
J	Keenan, SW; Hill, CA; Kandoth, C; Buck, LT; Warren, DE				Keenan, Sarah W.; Hill, Craig A.; Kandoth, Cyriac; Buck, Leslie T.; Warren, Daniel E.			Transcriptomic Responses of the Heart and Brain to Anoxia in the Western Painted Turtle	PLOS ONE			English	Article							GENE-EXPRESSION; CARDIOVASCULAR-RESPONSES; HYPOXIA TOLERANCE; NUCLEAR RECEPTORS; VITAMIN-C; OXYGEN; SURVIVAL; CYR61; CYCLOOXYGENASE-2; IDENTIFICATION	Painted turtles are the most anoxia-tolerant tetrapods known, capable of surviving without oxygen for more than four months at 3 degrees C and 30 hours at 20 degrees C. To investigate the transcriptomic basis of this ability, we used RNA-seq to quantify mRNA expression in the painted turtle ventricle and telencephalon after 24 hours of anoxia at 19 degrees C. Reads were obtained from 22,174 different genes, 13,236 of which were compared statistically between treatments for each tissue. Total tissue RNA contents decreased by 16% in telencephalon and 53% in ventricle. The telencephalon and ventricle showed >= 2x expression (increased expression) in 19 and 23 genes, respectively, while only four genes in ventricle showed <= 0.5x changes (decreased expression). When treatment effects were compared between anoxic and normoxic conditions in the two tissue types, 31 genes were increased (>= 2x change) and 2 were decreased (<= 0.5x change). Most of the effected genes were immediate early genes and transcription factors that regulate cellular growth and development; changes that would seem to promote transcriptional, translational, and metabolic arrest. No genes related to ion channels, synaptic transmission, cardiac contractility or excitation-contraction coupling changed. The generalized expression pattern in telencephalon and across tissues, but not in ventricle, correlated with the predicted metabolic cost of transcription, with the shortest genes and those with the fewest exons showing the largest increases in expression.	[Keenan, Sarah W.; Hill, Craig A.; Warren, Daniel E.] St Louis Univ, Dept Biol, St Louis, MO 63103 USA; [Kandoth, Cyriac] Washington Univ, Sch Med, Genome Inst, St Louis, MO USA; [Buck, Leslie T.] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada	Saint Louis University; Washington University (WUSTL); University of Toronto	Warren, DE (corresponding author), St Louis Univ, Dept Biol, St Louis, MO 63103 USA.	dwarren4@slu.edu		Keenan, Sarah W./0000-0002-2905-7823	National Science Foundation [IOS 1253939]; Natural Sciences and Engineering Research Council of Canada	National Science Foundation(National Science Foundation (NSF)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was funded by National Science Foundation (IOS 1253939) to DEW, and Natural Sciences and Engineering Research Council of Canada to LTB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ame JC, 2004, BIOESSAYS, V26, P882, DOI 10.1002/bies.20085; Atkins GB, 2007, CIRC RES, V100, P1686, DOI 10.1161/01.RES.0000267856.00713.0a; Babic AM, 1998, P NATL ACAD SCI USA, V95, P6355, DOI 10.1073/pnas.95.11.6355; Bailey DJ, 2003, MOL BRAIN RES, V116, P147, DOI 10.1016/S0169-328X(03)00288-2; BELKIN DA, 1968, RESP PHYSIOL, V4, P1, DOI 10.1016/0034-5687(68)90002-9; BELKIN DA, 1963, SCIENCE, V139, P492, DOI 10.1126/science.139.3554.492; Bickler PE, 1998, J EXP BIOL, V201, P1141; Bickler PE, 2000, J NEUROSCI, V20, P3522, DOI 10.1523/JNEUROSCI.20-10-03522.2000; Bickler PE, 2007, ANNU REV PHYSIOL, V69, P145, DOI 10.1146/annurev.physiol.69.031905.162529; Blackstone E, 2005, SCIENCE, V308, P518, DOI 10.1126/science.1108581; Boutilier RG, 1997, J EXP BIOL, V200, P387; Buck LT, 2012, ADV EXP MED BIOL, V758, P71, DOI 10.1007/978-94-007-4584-1_10; Buck LT, 1998, J EXP BIOL, V201, P289; Burzle M, 2012, CURR TOP MEMBR, V70, P357, DOI 10.1016/B978-0-12-394316-3.00011-9; Castillo-Davis CI, 2002, NAT GENET, V31, P415, DOI 10.1038/ng940; Chen CC, 2001, J BIOL CHEM, V276, P47329, DOI 10.1074/jbc.M107666200; Cho Y, 2009, MOL PHARMACOL, V76, P1360, DOI 10.1124/mol.109.057000; Dwyer J, 2007, ANN NY ACAD SCI, V1114, P36, DOI 10.1196/annals.1396.022; Dwyer JM, 2010, CLIN EXP PHARMACOL P, V37, P83, DOI 10.1111/j.1440-1681.2009.05236.x; Feliciano A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076247; Geiger K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026465; Gofflot F, 2007, CELL, V131, P405, DOI 10.1016/j.cell.2007.09.012; GOLDENBERG H, 1994, J BIOENERG BIOMEMBR, V26, P359, DOI 10.1007/BF00762776; Gracey AY, 2001, P NATL ACAD SCI USA, V98, P1993, DOI 10.1073/pnas.98.4.1993; Greenway SC, 2000, J EXP ZOOL, V287, P477, DOI 10.1002/1097-010X(20001201)287:7<477::AID-JEZ3>3.0.CO;2-4; Healy S, 2013, PHARMACOL THERAPEUT, V137, P64, DOI 10.1016/j.pharmthera.2012.09.001; Herdegen T, 1998, BRAIN RES REV, V28, P370, DOI 10.1016/S0165-0173(98)00018-6; Hicks JMT, 2000, J EXP BIOL, V203, P3775; Hicks JMT, 2000, J EXP BIOL, V203, P3765; Hochachka PW, 1996, P NATL ACAD SCI USA, V93, P9493, DOI 10.1073/pnas.93.18.9493; Hockel M, 2001, JNCI-J NATL CANCER I, V93, P266, DOI 10.1093/jnci/93.4.266; Ishiguro H, 2001, ONCOGENE, V20, P5062, DOI 10.1038/sj.onc.1204603; Jackson DC, 2002, J PHYSIOL-LONDON, V543, P731, DOI 10.1113/jphysiol.2002.024729; Ji YS, 1998, CIRC RES, V83, P295, DOI 10.1161/01.RES.83.3.295; Johlin JM, 1933, J BIOL CHEM, V103, P107; Latinkic BV, 2001, ENDOCRINOLOGY, V142, P2549, DOI 10.1210/en.142.6.2549; Liang GS, 1996, J BIOL CHEM, V271, P1695, DOI 10.1074/jbc.271.3.1695; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu C, 2009, BIOINFORMATICS, V25, P2020, DOI 10.1093/bioinformatics/btp360; Lutz PL, 2002, INTEGR COMP BIOL, V42, P463, DOI 10.1093/icb/42.3.463; Mohan HM, 2012, CLIN CANCER RES, V18, P3223, DOI 10.1158/1078-0432.CCR-11-2953; Neyns B, 1996, ONCOGENE, V12, P1247; NORTH AJ, 1994, CIRC RES, V75, P33, DOI 10.1161/01.RES.75.1.33; Noshiro M, 2009, GENES CELLS, V14, P29, DOI 10.1111/j.1365-2443.2008.01247.x; Overgaard J, 2004, J EXP BIOL, V207, P655, DOI 10.1242/jeb.00791; Pamenter ME, 2011, P NATL ACAD SCI USA, V108, P11274, DOI 10.1073/pnas.1102429108; Pamenter ME, 2008, AM J PHYSIOL-REG I, V294, pR606, DOI 10.1152/ajpregu.00433.2007; Park J, 2007, BIOCHEM BIOPH RES CO, V360, P447, DOI 10.1016/j.bbrc.2007.06.077; Parkhomchuk D, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp596; PEREZPINZON MA, 1992, AM J PHYSIOL, V262, pR712, DOI 10.1152/ajpregu.1992.262.4.R712; Ramaglia V, 2004, J EXP BIOL, V207, P3775, DOI 10.1242/jeb.01211; Regard JB, 2004, J NEUROSCI, V24, P4092, DOI 10.1523/JNEUROSCI.4252-03.2004; Roberts A, 2011, BIOINFORMATICS, V27, P2325, DOI 10.1093/bioinformatics/btr355; Schmedtje JF, 1997, J BIOL CHEM, V272, P601; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Shaffer HB, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-3-r28; Shin DSH, 2003, PHYSIOL BIOCHEM ZOOL, V76, P41, DOI 10.1086/374274; Sjostrom M, 2007, P NATL ACAD SCI USA, V104, P16922, DOI 10.1073/pnas.0706838104; Stecyk JAW, 2012, COMP BIOCHEM PHYS D, V7, P59, DOI 10.1016/j.cbd.2011.11.001; Stecyk JAW, 2009, AM J PHYSIOL-REG I, V297, pR756, DOI 10.1152/ajpregu.00102.2009; Stepp MW, 2014, BBA-MOL CELL RES, V1843, P1076, DOI 10.1016/j.bbamcr.2014.02.003; Ten Vadim S, 2002, Curr Opin Crit Care, V8, P242, DOI 10.1097/00075198-200206000-00008; Tonini T, 2003, ONCOGENE, V22, P6549, DOI 10.1038/sj.onc.1206816; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Ueki I, 2011, AM J PHYSIOL-ENDOC M, V301, pE668, DOI 10.1152/ajpendo.00151.2011; ULTSCH GR, 1982, J EXP BIOL, V96, P11; Warren DE, 2007, J COMP PHYSL; Warren WC, 2010, NATURE, V464, P757, DOI 10.1038/nature08819; You JJ, 2010, EXP EYE RES, V91, P825, DOI 10.1016/j.exer.2010.10.006	70	15	15	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131669	10.1371/journal.pone.0131669	http://dx.doi.org/10.1371/journal.pone.0131669			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147940	Green Published, Green Submitted, gold			2022-12-26	WOS:000358157600125
J	Park, HYL; Kim, SE; Park, CK				Park, Hae-Young Lopilly; Kim, Sung Eum; Park, Chan Kee			Optic Disc Change during Childhood Myopic Shift: Comparison between Eyes with an Enlarged Cup-To-Disc Ratio and Childhood Glaucoma Compared to Normal Myopic Eyes	PLOS ONE			English	Article							CORNEAL BIOMECHANICAL PROPERTIES; INTRAOCULAR-PRESSURE; NERVE HEAD; HYSTERESIS; THICKNESS; REVERSAL; SCLERA; AGE	Background Progressive disc tilting and the development or enlargement of peripapillary atrophy (PPA) are observed during a myopic shift in children. This could be related to the changes around the optic nerve head during eyeball elongation. If the biomechanical properties at or around the optic nerve head are changed after exposure to elevated intraocular pressure (IOP) in glaucoma eyes, different response of the disc tilting and PPA changes could take place during eyeball elongation by myopic shift. On the basis of this background, the aim of this study was to compare the morphological changes in the optic disc induced by a myopic shift during childhood between normal control eyes, eyes from disc suspects with an enlarged cup-to-disc ratio (CDR), and eyes with childhood glaucoma. Methods Total of 82 eyes from 82 subjects younger than 14 years of age were included in the study. Serial disc photographs were classified into one of two groups: eyes with an optic nerve head (ONH) or peripapillary atrophy (PPA) change or without an ONH/PPA change. Using ImageJ software, the outlines of the optic disc and PPA were plotted, and the vertical disc diameter (VDD), horizontal disc diameter (HDD), and maximum PPA width (PPW) were measured. The changes in the ratios of these parameters and the relationships between the degree of myopic shift or the ONH/PPA change were analyzed. Results Twenty-five eyes with normal optic disc appearance, 36 eyes with enlarged cup-to-disc ratio, and 21 eyes of glaucoma patients were analyzed. The initial intraocular pressure (IOP) at diagnosis was significantly different among the groups (P<0.001). The degree of myopic shift during follow-up period was not significantly different among the groups (P=0.612). However, the changes in the HDD/VDD and PPW/VDD ratios were significantly greater in the disc suspect group and significantly smaller in the glaucoma group. Among the 42 eyes with an ONH/PPA change, 16 (38.1%) were from the normal control group, 24 (57.1%) were from the disc suspect group, and 2 (4.8%) were from the glaucoma group (P < 0.001). Conclusions and Relevance The optic disc change during childhood myopic shift was different in eyes with various conditions. Eyes of childhood glaucoma showed less change in the disc morphology during myopic shift compared to eyes with normal disc or enlarged cup-to-disc ratio.	[Park, Hae-Young Lopilly; Kim, Sung Eum; Park, Chan Kee] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Ophthalmol & Visual Sci, Seoul, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital	Park, CK (corresponding author), Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Ophthalmol & Visual Sci, Seoul, South Korea.	ckpark@catholic.ac.kr			National Research Foundation of Korea (NRF) - Korea government (MSIP) [NRF-2014R1A1A3049403]	National Research Foundation of Korea (NRF) - Korea government (MSIP)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (No. NRF-2014R1A1A3049403). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cone-Kimball E, 2013, MOL VIS, V19, P2023; Congdon NG, 2006, AM J OPHTHALMOL, V141, P868, DOI 10.1016/j.ajo.2005.12.007; Coudrillier B, 2013, BIOMECH MODEL MECHAN, V12, P941, DOI 10.1007/s10237-012-0455-y; Danford FL, 2013, INVEST OPHTH VIS SCI, V54, P7922, DOI 10.1167/iovs.13-12262; Grytz R, 2011, BIOMECH MODEL MECHAN, V10, P371, DOI 10.1007/s10237-010-0240-8; Huang WB, 2013, MED SCI MONIT BASIC, V19, P237, DOI 10.12659/MSMBR.889061; Hyman L, 2005, ARCH OPHTHALMOL-CHIC, V123, P977, DOI 10.1001/archopht.123.7.977; Jonas JB, 2013, ACTA OPHTHALMOL; Kaushik S, 2012, AM J OPHTHALMOL, V153, P840, DOI 10.1016/j.ajo.2011.10.032; Kim TW, 2012, OPHTHALMOLOGY, V119, P21, DOI 10.1016/j.ophtha.2011.07.051; Lesk MR, 1999, OPHTHALMOLOGY, V106, P1013, DOI 10.1016/S0161-6420(99)00526-6; McBrien NA, 2003, PROG RETIN EYE RES, V22, P307, DOI 10.1016/S1350-9462(02)00063-0; Mochizuki H, 2011, OPHTHALMOLOGY, V118, P2008, DOI 10.1016/j.ophtha.2011.02.041; Park HYL, 2014, INVEST OPHTH VIS SCI, V55, P233, DOI 10.1167/iovs.12-10329; Pijanka JK, 2012, INVEST OPHTH VIS SCI, V53, P5258, DOI 10.1167/iovs.12-9705; Prata TS, 2012, CLIN EXP OPHTHALMOL, V40, P682, DOI 10.1111/j.1442-9071.2012.02790.x; Rada JAS, 2006, EXP EYE RES, V82, P185, DOI 10.1016/j.exer.2005.08.009; Meirelles SHS, 2008, J GLAUCOMA, V17, P470, DOI 10.1097/IJG.0b013e3181650f6e; Sullivan-Mee M, 2012, OPTOMETRY VISION SCI, V89, pE803, DOI 10.1097/OPX.0b013e3182504214; Wells AP, 2008, INVEST OPHTH VIS SCI, V49, P3262, DOI 10.1167/iovs.07-1556; Yan DM, 2011, INVEST OPHTH VIS SCI, V52, P821, DOI 10.1167/iovs.09-4651	21	6	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131781	10.1371/journal.pone.0131781	http://dx.doi.org/10.1371/journal.pone.0131781			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147983	Green Published, gold			2022-12-26	WOS:000358157600144
J	Schwarz, KA; Buchel, C				Schwarz, Katharina A.; Buechel, Christian			Cognition and the Placebo Effect - Dissociating Subjective Perception and Actual Performance	PLOS ONE			English	Article							STEREOTYPE THREAT; CONFIDENCE-INTERVALS; METHYLPHENIDATE; EXPECTATION; MECHANISMS; ANALGESIA; NOCEBO; PAIN; ENHANCEMENT; PEOPLE	The influence of positive or negative expectations on clinical outcomes such as pain relief or motor performance in patients and healthy participants has been extensively investigated for years. Such research promises potential benefit for patient treatment by deliberately using expectations as means to stimulate endogenous regulation processes. Especially regarding recent interest and controversies revolving around cognitive enhancement, the question remains whether mere expectancies might also yield enhancing or impairing effects in the cognitive domain, i.e., can we improve or impair cognitive performance simply by creating a strong expectancy in participants about their performance? Moreover, previous literature suggests that especially subjective perception is highly susceptible to expectancy effects, whereas objective measures can be affected in certain domains, but not in others. Does such a dissociation of objective measures and subjective perception also apply to cognitive placebo and nocebo effects? In this study, we sought to investigate whether placebo and nocebo effects can be evoked in cognitive tasks, and whether these effects influence objective and subjective measures alike. To this end, we instructed participants about alleged effects of different tone frequencies (high, intermediate, low) on brain activity and cognitive functions. We paired each tone with specific success rates in a Flanker task paradigm as a preliminary conditioning procedure, adapted from research on placebo hypoalgesia. In a subsequent test phase, we measured reaction times and success rates in different expectancy conditions (placebo, nocebo, and control) and then asked participants how the different tone frequencies affected their performance. Interestingly, we found no effects of expectation on objective measures, but a strong effect on subjective perception, i.e., although actual performance was not affected by expectancy, participants strongly believed that the placebo tone frequency improved their performance.	[Schwarz, Katharina A.; Buechel, Christian] Univ Med Ctr Hamburg Eppendorf, Dept Syst Neurosci, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Schwarz, KA (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Syst Neurosci, Hamburg, Germany.	k.schwarz@uke.de	Schwarz, Katharina/AAQ-1427-2021	Schwarz, Katharina/0000-0001-8714-790X	European Research Council [ERC-2010AdG_20100407]; Deutsche Forschungsgemeinschaft [FOR 1328, SFB 936, SFB TRR 58]	European Research Council(European Research Council (ERC)European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	K.A.S. and C.B. are supported by the European Research Council, ERC-2010AdG_20100407. C.B. is also supported by the Deutsche Forschungsgemeinschaft (Research group FOR 1328, SFB 936 and SFB TRR 58). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amanzio M, 1999, J NEUROSCI, V19, P484, DOI 10.1523/JNEUROSCI.19-01-00484.1999; Bandura A., 1997, SELF EFFICACY EXERCI, P36, DOI 10.1007/SpringerReference_223312; Beilock SL, 2007, J EXP PSYCHOL GEN, V136, P256, DOI 10.1037/0096-3445.136.2.256; Bingel U, 2014, JAMA-J AM MED ASSOC, V312, P693, DOI 10.1001/jama.2014.8342; Boot WR, 2013, PERSPECT PSYCHOL SCI, V8, P445, DOI 10.1177/1745691613491271; Chatterjee A, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1956; Colloca L, 2005, NAT REV NEUROSCI, V6, P545, DOI 10.1038/nrn1705; Colloca L, 2006, PAIN, V124, P126, DOI 10.1016/j.pain.2006.04.005; de la Fuente-Fernandez R, 2001, SCIENCE, V293, P1164, DOI 10.1126/science.1060937; Dijksterhuis A, 2014, PERSPECT PSYCHOL SCI, V9, P72, DOI 10.1177/1745691613513472; Eippert F, 2009, NEURON, V63, P533, DOI 10.1016/j.neuron.2009.07.014; Enck P, 2013, NAT REV DRUG DISCOV, V12, P191, DOI 10.1038/nrd3923; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Geers AL, 2006, J BEHAV MED, V29, P171, DOI 10.1007/s10865-005-9040-5; Geuter S, 2013, J NEUROSCI, V33, P13784, DOI 10.1523/JNEUROSCI.2191-13.2013; Green CS, 2012, CURR BIOL, V22, pR197, DOI 10.1016/j.cub.2012.02.012; Harris J, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1955; Hyman SE, 2011, NEURON, V69, P595, DOI 10.1016/j.neuron.2011.02.012; Kirsch W, 2014, ATTEN PERCEPT PSYCHO, V76, P1752, DOI 10.3758/s13414-014-0685-4; Krendl AC, 2008, PSYCHOL SCI, V19, P168, DOI 10.1111/j.1467-9280.2008.02063.x; LOFTUS GR, 1994, PSYCHON B REV, V1, P476, DOI 10.3758/BF03210951; Looby A, 2011, EXP CLIN PSYCHOPHARM, V19, P434, DOI 10.1037/a0025252; Mora MS, 2011, PHILOS T R SOC B, V366, P1879, DOI 10.1098/rstb.2010.0394; Nickerson R.S., 1998, REV GEN PSYCHOL, V2, P175, DOI [10.1037/1089-2680.2.2.175, DOI 10.1037/1089-2680.2.2.175]; Pajares F, 1996, REV EDUC RES, V66, P543, DOI 10.2307/1170653; Pfister R, 2013, ADV COGN PSYCHOL, V9, P74, DOI [10.5709/acp-0133-x, 10.2478/v10053-008-0133-x]; Price DD, 2008, ANNU REV PSYCHOL, V59, P565, DOI 10.1146/annurev.psych.59.113006.095941; Proffitt DR, 2013, ACTION SCIENCE: FOUNDATIONS OF AN EMERGING DISCIPLINE, P171; Rouder JN, 2009, PSYCHON B REV, V16, P225, DOI 10.3758/PBR.16.2.225; Sahakian B, 2007, NATURE, V450, P1157, DOI 10.1038/4501157a; Sahakian BJ, 2011, J PSYCHOPHARMACOL, V25, P197, DOI 10.1177/0269881109106926; Schmader T, 2008, PSYCHOL REV, V115, P336, DOI 10.1037/0033-295X.115.2.336; Schwarz KA, TOUGHER SEX ST UNPUB; Spencer SJ, 1999, J EXP SOC PSYCHOL, V35, P4, DOI 10.1006/jesp.1998.1373; STEELE CM, 1995, J PERS SOC PSYCHOL, V69, P797, DOI 10.1037/0022-3514.69.5.797; Stewart-Williams S, 2004, PSYCHOL BULL, V130, P324, DOI 10.1037/0033-2909.130.2.324; Tracey I, 2010, NAT MED, V16, P1277, DOI 10.1038/nm.2229; Volkow ND, 2006, NEUROIMAGE, V32, P1782, DOI 10.1016/j.neuroimage.2006.04.192; Wechsler ME, 2011, NEW ENGL J MED, V365, P119, DOI 10.1056/NEJMoa1103319; Wraga M, 2006, PSYCHON B REV, V13, P813, DOI 10.3758/BF03194002	40	28	28	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0130492	10.1371/journal.pone.0130492	http://dx.doi.org/10.1371/journal.pone.0130492			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1DQ	26148009	Green Published, gold			2022-12-26	WOS:000358157600038
J	Yoon, JW; Jang, IH; Heo, SC; Kwon, YW; Choi, EJ; Bae, KH; Suh, DS; Kim, SC; Han, S; Haam, S; Jung, J; Kim, K; Ryu, SH; Kim, JH				Yoon, Jung Won; Jang, Il Ho; Heo, Soon Chul; Kwon, Yang Woo; Choi, Eun Jung; Bae, Kwang-Hee; Suh, Dong-Soo; Kim, Seung-Chul; Han, Seungmin; Haam, Seungjoo; Jung, Jongha; Kim, Kiseok; Ryu, Sung Ho; Kim, Jae Ho			Isolation of Foreign Material-Free Endothelial Progenitor Cells Using CD31 Aptamer and Therapeutic Application for Ischemic Injury	PLOS ONE			English	Article							BONE-MARROW; IN-VIVO; PECAM-1; NEOVASCULARIZATION; SELECTION; DISEASE	Endothelial progenitor cells (EPCs) can be isolated from human bone marrow or peripheral blood and reportedly contribute to neovascularization. Aptamers are 40-120-mer nucleotides that bind to a specific target molecule, as antibodies do. To utilize apatmers for isolation of EPCs, in the present study, we successfully generated aptamers that recognize human CD31, an endothelial cell marker. CD31 aptamers bound to human umbilical cord blood-derived EPCs and showed specific interaction with human CD31, but not with mouse CD31. However, CD31 aptamers showed non-specific interaction with CD31-negative 293FT cells and addition of polyanionic competitor dextran sulfate eliminated non-specific interaction without affecting cell viability. From the mixture of EPCs and 293FT cells, CD31 aptamers successfully isolated EPCs with 97.6% purity and 94.2% yield, comparable to those from antibody isolation. In addition, isolated EPCs were decoupled from CD31 aptamers with a brief treatment of high concentration dextran sulfate. EPCs isolated with CD31 aptamers and subsequently decoupled from CD31 aptamers were functional and enhanced the restoration of blood flow when transplanted into a murine hindlimb ischemia model. In this study, we demonstrated isolation of foreign material-free EPCs, which can be utilized as a universal protocol in preparation of cells for therapeutic transplantation.	[Yoon, Jung Won; Jang, Il Ho; Heo, Soon Chul; Kwon, Yang Woo; Choi, Eun Jung; Kim, Jae Ho] Pusan Natl Univ, Sch Med, Dept Physiol, Yangsan 626870, South Korea; [Bae, Kwang-Hee] Korea Res Inst Biosci & Biotechnol, Funct Genom Res Ctr, Taejon, South Korea; [Suh, Dong-Soo; Kim, Seung-Chul] Pusan Natl Univ, Sch Med, Dept Obstet & Gynecol, Yangsan 626870, South Korea; [Han, Seungmin; Haam, Seungjoo] Yonsei Univ, Dept Chem & Biomol Engn, Coll Engn, Seoul 120749, South Korea; [Jung, Jongha; Kim, Kiseok] Aptamer Sci Inc, Postech Biotech Ctr, Pohang 790784, South Korea; [Ryu, Sung Ho] Pohang Univ Sci & Technol, Dept Life Sci, Pohang 790784, South Korea; [Kim, Jae Ho] Pusan Natl Univ, Yangsan Hosp, Res Inst Convergence Biomed Sci & Technol, Yangsan 626770, Gyeongsangnam D, South Korea	Pusan National University; Pusan National University Hospital; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Pusan National University; Pusan National University Hospital; Yonsei University; Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Pusan National University; Pusan National University Hospital	Kim, JH (corresponding author), Pusan Natl Univ, Sch Med, Dept Physiol, Yangsan 626870, South Korea.	jhkimst@pusan.ac.kr		Bae, Kwang-Hee/0000-0002-5868-2556; Jang, Il Ho/0000-0002-0820-3035; Ryu, Sung Ho/0000-0003-0913-3048	programs of the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2012M3A9C7050184, 2010-0020274]	programs of the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology	Aptamer Sciences Inc. provided support in the form of salaries for authors JJ and KK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. This research was also supported by the programs of the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2012M3A9C7050184; 2010-0020274). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alev C, 2011, ANTIOXID REDOX SIGN, V15, P949, DOI 10.1089/ars.2010.3872; Arnau J, 2006, PROTEIN EXPRES PURIF, V48, P1, DOI 10.1016/j.pep.2005.12.002; Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Asahara T, 2011, STEM CELLS, V29, P1650, DOI 10.1002/stem.745; Avci-Adali M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068810; Bauer SM, 2006, J VASC SURG, V43, P134, DOI 10.1016/j.jvs.2005.08.038; Cibiel A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087002; EATON BE, 1995, CHEM BIOL, V2, P633, DOI 10.1016/1074-5521(95)90023-3; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Germer Katherine, 2013, Int J Biochem Mol Biol, V4, P27; Gilles JGG, 2000, SEMIN THROMB HEMOST, V26, P151, DOI 10.1055/s-2000-9817; Gold L, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a003582; Gold L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015004; Hamula CLA, 2006, TRAC-TREND ANAL CHEM, V25, P681, DOI 10.1016/j.trac.2006.05.007; Heo SC, 2014, STEM CELLS, V32, P779, DOI 10.1002/stem.1578; Ii M, 2005, CIRCULATION, V111, P1114, DOI 10.1161/01.CIR.0000157144.24888.7E; Jager S, 2005, J AM CHEM SOC, V127, P15071, DOI 10.1021/ja051725b; Jefferis R, 2009, MABS, V1, P332, DOI 10.4161/mabs.1.4.9122; Jujo K, 2008, J MOL CELL CARDIOL, V45, P530, DOI 10.1016/j.yjmcc.2008.08.003; Kalka C, 2000, P NATL ACAD SCI USA, V97, P3422, DOI 10.1073/pnas.070046397; Karbach J, 2012, CANCER RES, V72, P4304, DOI 10.1158/0008-5472.CAN-12-0257; Keefe AD, 2010, NAT REV DRUG DISCOV, V9, P537, DOI 10.1038/nrd3141; Kim H, 2010, CIRC RES, V107, P602, DOI 10.1161/CIRCRESAHA.110.218396; Kim K, 2014, BIOCHEM BIOPH RES CO, V448, P114, DOI 10.1016/j.bbrc.2014.04.086; Kim SW, 2011, REGEN MED, V6, P335, DOI [10.2217/RME.11.24, 10.2217/rme.11.24]; Kim SW, 2010, J AM COLL CARDIOL, V56, P593, DOI 10.1016/j.jacc.2010.01.070; Kim WS, 2013, BLOOD RES, V48, P76, DOI 10.5045/br.2013.48.2.76; Mayer G, 2010, NAT PROTOC, V5, P1993, DOI 10.1038/nprot.2010.163; Nakada MT, 2000, J IMMUNOL, V164, P452, DOI 10.4049/jimmunol.164.1.452; Napoli C, 2011, ATHEROSCLEROSIS, V215, P9, DOI 10.1016/j.atherosclerosis.2010.10.039; Nelson AL, 2010, NAT REV DRUG DISCOV, V9, P767, DOI 10.1038/nrd3229; Perse M, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/718617; Privratsky JR, 2010, LIFE SCI, V87, P69, DOI 10.1016/j.lfs.2010.06.001; Raval Z, 2013, CIRC RES, V112, P1288, DOI 10.1161/CIRCRESAHA.113.300565; Soontornworajit B, 2011, ANAL BIOANAL CHEM, V399, P1591, DOI 10.1007/s00216-010-4559-x; Sun W, 2011, CURR PHARM DESIGN, V17, P80, DOI 10.2174/138161211795049769; Sundaram P, 2013, EUR J PHARM SCI, V48, P259, DOI 10.1016/j.ejps.2012.10.014; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tiwari A, 2003, CELL BIOL TOXICOL, V19, P265, DOI 10.1023/B:CBTO.0000004929.37511.ed; Urbich C, 2005, J MOL CELL CARDIOL, V39, P733, DOI 10.1016/j.yjmcc.2005.07.003; Wakelin MW, 1996, J EXP MED, V184, P229, DOI 10.1084/jem.184.1.229; Woodfin A, 2007, ARTERIOSCL THROM VAS, V27, P2514, DOI 10.1161/ATVBAHA.107.151456; Wu Y, 2005, J IMMUNOL, V175, P3484, DOI 10.4049/jimmunol.175.6.3484; Xu JY, 2014, CURR STEM CELL RES T, V9, P401, DOI 10.2174/1574888X09666140619121318; Zhang L, 2014, ARTERIOSCL THROM VAS, V34, P1114, DOI 10.1161/ATVBAHA.114.303809; Zichi D, 2008, CURR OPIN CHEM BIOL, V12, P78, DOI 10.1016/j.cbpa.2008.01.016; Zubair AC, 2010, CYTOTHERAPY, V12, P178, DOI 10.3109/14653240903493409	47	16	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131785	10.1371/journal.pone.0131785	http://dx.doi.org/10.1371/journal.pone.0131785			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148001	Green Published, Green Submitted, gold			2022-12-26	WOS:000358157600145
J	Zebracki, K; Koper, P; Marczak, M; Skorupska, A; Mazur, A				Zebracki, Kamil; Koper, Piotr; Marczak, Malgorzata; Skorupska, Anna; Mazur, Andrzej			Plasmid-Encoded RepA Proteins Specifically Autorepress Individual repABC Operons in the Multipartite Rhizobium leguminosarum bv. trifolii Genome	PLOS ONE			English	Article							AGROBACTERIUM-TUMEFACIENS; ANTISENSE RNA; SYMBIOTIC PLASMID; PARTITIONING SITE; COPY NUMBER; REPLICATION; INCOMPATIBILITY; P1; IDENTIFICATION; TRANSCRIPTION	Rhizobia commonly have very complex genomes with a chromosome and several large plasmids that possess genes belonging to the repABC family. RepA and RepB are members of the ParA and ParB families of partitioning proteins, respectively, whereas RepC is crucial for plasmid replication. In the repABC replicons, partitioning and replication functions are transcriptionally linked resulting in complex regulation of rep gene expression. The genome of R. leguminosarum bv. trifolii TA1 (RtTA1) consists of a chromosome and four plasmids (pRleTA1a-d), equipped with functional repABC genes. In this work, the regulation of transcription of the individual repABC cassettes of the four RtTA1 plasmids was studied. The involvement of the RepA and RepB as well as parS-like centromere sites in this process was depicted, demonstrating some dissimilarity in expression of respective rep regions. RtTA1 repABC genes of individual plasmids formed operons, which were negatively regulated by RepA and RepB. Individual RepA were able to bind to DNA without added nucleotides, but in the presence of ADP, bound specifically to their own operator sequences containing imperfect palindromes, and caused operon autorepression, whereas the addition of ATP stimulated non-specific binding of RepA to DNA. The RepA proteins were able to dimerize/oligomerize: in general dimers formed independently of ATP or ADP, although ATP diminished the concentration of oligomers that were produced. By the comprehensive approach focusing on a set of plasmids instead of individual replicons, the work highlighted subtle differences between the organization and regulation of particular rep operons as well as the structures and specificity of RepA proteins, which contribute to the fine-tuned coexistence of several replicons with similar repABC cassettes in the complex bacterial genome.	[Zebracki, Kamil; Koper, Piotr; Marczak, Malgorzata; Skorupska, Anna; Mazur, Andrzej] Marie Curie Sklodowska Univ, Dept Genet & Microbiol, Inst Microbiol & Biotechnol, Fac Biol & Biotechnol, Lublin, Poland	Maria Curie-Sklodowska University	Mazur, A (corresponding author), Marie Curie Sklodowska Univ, Dept Genet & Microbiol, Inst Microbiol & Biotechnol, Fac Biol & Biotechnol, Lublin, Poland.	mazur@hektor.umcs.lublin.pl	Koper, Piotr/ABG-8618-2020	Koper, Piotr/0000-0001-5709-443X; Koper, Piotr/0000-0002-0386-3544; Zebracki, Kamil/0000-0001-7250-4492				Bartosik D, 2001, J BACTERIOL, V183, P6234, DOI 10.1128/JB.183.21.6234-6243.2001; Bartosik D, 1998, MICROBIOL-UK, V144, P3149, DOI 10.1099/00221287-144-11-3149; Bignell C, 2001, J BIOTECHNOL, V91, P1, DOI 10.1016/S0168-1656(01)00293-0; BROWN CM, 1975, J GEN MICROBIOL, V86, P39, DOI 10.1099/00221287-86-1-39; Campbell CS, 2007, J CELL BIOL, V179, P1059, DOI 10.1083/jcb.200708206; Castaing JP, 2008, MOL MICROBIOL, V70, P1000, DOI 10.1111/j.1365-2958.2008.06465.x; Castillo-Ramirez S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-536; Cervantes-Rivera R, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-158; Cervantes-Rivera R, 2010, J BACTERIOL, V192, P3268, DOI 10.1128/JB.00118-10; Cevallos MA, 2008, PLASMID, V60, P19, DOI 10.1016/j.plasmid.2008.03.001; Chai YR, 2005, MOL MICROBIOL, V58, P1114, DOI 10.1111/j.1365-2958.2005.04886.x; Chai YR, 2005, MOL MICROBIOL, V56, P1574, DOI 10.1111/j.1365-2958.2005.04636.x; CHAKRAVORTY A K, 1982, Journal of Molecular and Applied Genetics, V1, P585; DAVEY MJ, 1994, J BIOL CHEM, V269, P29908; Dunham TD, 2009, EMBO J, V28, P1792, DOI 10.1038/emboj.2009.120; Ebersbach G, 2005, ANNU REV GENET, V39, P453, DOI 10.1146/annurev.genet.38.072902.091252; Erdmann N, 1999, P NATL ACAD SCI USA, V96, P14905, DOI 10.1073/pnas.96.26.14905; Gerdes K, 2000, MOL MICROBIOL, V37, P455, DOI 10.1046/j.1365-2958.2000.01975.x; Howard M, 2010, MOL MICROBIOL, V78, P9, DOI 10.1111/j.1365-2958.2010.07316.x; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Knudsen S, 1999, BIOINFORMATICS, V15, P356, DOI 10.1093/bioinformatics/15.5.356; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Krol JE, 2007, GENOMICS, V89, P237, DOI 10.1016/j.ygeno.2006.08.015; MacLellan SR, 2006, MOL MICROBIOL, V59, P1559, DOI 10.1111/j.1365-2958.2006.05040.x; MacLellan SR, 2005, MOL MICROBIOL, V55, P611, DOI 10.1111/j.1365-2958.2004.04412.x; Mazur A, 2011, PLASMID, V66, P53, DOI 10.1016/j.plasmid.2011.04.002; Miller JH., 1972, EXPERIMENTS IN MOLEC; Narasimhan G, 2002, J COMPUT BIOL, V9, P707, DOI 10.1089/106652702761034145; Pappas KM, 2008, PLASMID, V60, P89, DOI 10.1016/j.plasmid.2008.05.003; Pappas KM, 2003, MOL MICROBIOL, V49, P441, DOI 10.1046/j.1365-2958.2003.03560.x; Pappas KM, 2003, MOL MICROBIOL, V48, P1059, DOI 10.1046/j.1365-2958.2003.03488.x; Perez-Oseguera A, 2013, PLASMID, V70, P362, DOI 10.1016/j.plasmid.2013.08.001; Pinto UM, 2012, NAT REV MICROBIOL, V10, P755, DOI 10.1038/nrmicro2882; Pinto UM, 2011, MOL MICROBIOL, V81, P1593, DOI 10.1111/j.1365-2958.2011.07789.x; Ramirez-Romero MA, 2000, J BACTERIOL, V182, P3117, DOI 10.1128/JB.182.11.3117-3124.2000; Ramirez-Romero MA, 2001, MOL MICROBIOL, V42, P195, DOI 10.1046/j.1365-2958.2001.02621.x; Reese MG, 2001, COMPUT CHEM, V26, P51, DOI 10.1016/S0097-8485(01)00099-7; Rivera-Urbalejo A, 2015, PLASMID, V78, P48, DOI 10.1016/j.plasmid.2015.01.004; ROSENBERG C, 1984, MOL GEN GENET, V196, P533, DOI 10.1007/BF00436205; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schumacher MA, 2012, CURR OPIN STRUC BIOL, V22, P72, DOI 10.1016/j.sbi.2011.11.001; Sengupta M, 2010, J BACTERIOL, V192, P1175, DOI 10.1128/JB.01245-09; Slavcev RA, 2005, J BACTERIOL, V187, P1227, DOI 10.1128/JB.187.4.1227-1237.2005; Soberon N, 2004, PLASMID, V51, P203, DOI 10.1016/j.plasmid.2004.01.005; SPAINK HP, 1987, PLANT MOL BIOL, V9, P27, DOI 10.1007/BF00017984; Thomas CM, 2000, MOL MICROBIOL, V37, P485, DOI 10.1046/j.1365-2958.2000.02006.x; Vecchiarelli AG, 2010, MOL MICROBIOL, V78, P78, DOI 10.1111/j.1365-2958.2010.07314.x; Venkova-Canova T, 2004, MOL MICROBIOL, V54, P1431, DOI 10.1111/j.1365-2958.2004.04366.x; VINCENT J. M., 1970, A Manual for the Practical Study of the Root- Bacteria.; Yip CB, 2015, PLASMID, V78, P37, DOI 10.1016/j.plasmid.2014.12.003	51	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131907	10.1371/journal.pone.0131907	http://dx.doi.org/10.1371/journal.pone.0131907			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147968	Green Published, gold, Green Submitted			2022-12-26	WOS:000358157600162
J	Thorimbert, V; Konig, D; Marro, J; Ruggiero, F; Jazwinska, A				Thorimbert, Valentine; Koenig, Desiree; Marro, Jan; Ruggiero, Florence; Jazwinska, Anna			Bone morphogenetic protein signaling promotes morphogenesis of blood vessels, wound epidermis, and actinotrichia during fin regeneration in zebrafish	FASEB JOURNAL			English	Article						blastemal; wound epithelium; regenerative angiogenesis	SONIC-HEDGEHOG; DEDIFFERENTIATION; BLASTEMA; TISSUE; DIFFERENTIATION; DORSOMORPHIN; ANGIOGENESIS; INDUCTION; GROWTH; CELLS	Zebrafish fin regeneration involves initial formation of the wound epidermis and the blastema, followed by tissue morphogenesis. The mechanisms coordinating differentiation of distinct tissues of the regenerate are poorly understood. Here, we applied pharmacologic and transgenic approaches to address the role of bone morphogenetic protein (BMP) signaling during fin restoration. To map the BMP transcriptional activity, we analyzed the expression of the evolutionarily conserved direct phospho-Smad1 target gene, id1, and its homologs id2a and id3. This analysis revealed the BMP activity in the distal blastema, wound epidermis, osteoblasts, and blood vessels of the regenerate. Blocking the BMP function with a selective chemical inhibitor of BMP type I receptors, DMH1, suppressed id1 and id3 expression and arrested regeneration after blastema formation. We identified several previously uncharacterized functions of BMP during fin regeneration. Specifically, BMP signaling is required for remodeling of plexus into structured blood vessels in the rapidly growing regenerate. It organizes the wound epithelium by triggering wnt5b expression and promoting Collagen XIV-A deposition into the basement membrane. BMP represents the first known signaling that induces actinotrichia formation in the regenerate. Our data reveal a multifaceted role of BMP for coordinated morphogenesis of distinct tissues during regeneration of a complex vertebrate appendage.	[Thorimbert, Valentine; Koenig, Desiree; Marro, Jan; Jazwinska, Anna] Univ Fribourg, Dept Biol, CH-1700 Fribourg, Switzerland; [Ruggiero, Florence] Ecole Normale Super Lyon, Inst Genom Fonct, F-69364 Lyon, France	University of Fribourg; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON)	Jazwinska, A (corresponding author), Univ Fribourg, Dept Biol, Chemin Musee 10, CH-1700 Fribourg, Switzerland.	anna.jazwinska@unifr.ch	Jazwinska, Anna/M-8705-2016	Jazwinska, Anna/0000-0003-3881-9284; Konig, Desiree/0000-0001-8411-8951; RUGGIERO, Florence/0000-0003-2915-5359	Swiss National Science Foundation [310030_159995, CRSII3_147675]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The authors thank V. Zimmermann for excellent technical assistance and for fish care; C. Pfefferli, B. Chassot, and A.-S. de Preux Charles for critical reading of the manuscript; M. Affolter, S. Seyfried, and G. Weidinger for providing transgenic fish; and F.R. for collagen XIV-A antibody. This work was supported by the Swiss National Science Foundation (Grants 310030_159995 and CRSII3_147675).	Bader HL, 2013, J BIOL CHEM, V288, P6777, DOI 10.1074/jbc.M112.430637; Bayliss PE, 2006, NAT CHEM BIOL, V2, P265, DOI 10.1038/nchembio778; Blum Y, 2008, DEV BIOL, V316, P312, DOI 10.1016/j.ydbio.2008.01.038; Brockes JR, 2008, ANNU REV CELL DEV BI, V24, P525, DOI 10.1146/annurev.cellbio.24.110707.175336; Cai J, 2012, FEBS LETT, V586, P1993, DOI 10.1016/j.febslet.2012.04.030; Chablais F, 2010, DEVELOPMENT, V137, P871, DOI 10.1242/dev.043885; Chocron S, 2007, DEV BIOL, V305, P577, DOI 10.1016/j.ydbio.2007.03.001; Duran I, 2011, DEV BIOL, V354, P160, DOI 10.1016/j.ydbio.2011.03.014; Engers DW, 2013, BIOORG MED CHEM LETT, V23, P3248, DOI 10.1016/j.bmcl.2013.03.113; Gemberling M, 2013, TRENDS GENET, V29, P611, DOI 10.1016/j.tig.2013.07.003; Hao J, 2010, ACS CHEM BIOL, V5, P245, DOI 10.1021/cb9002865; Huang CC, 2003, DEV BIOL, V264, P263, DOI 10.1016/j.ydbio.2003.08.016; Jazwinska A, 2007, CURR BIOL, V17, P1390, DOI 10.1016/j.cub.2007.07.019; Jinn SW, 2005, DEVELOPMENT, V132, P5199, DOI 10.1242/dev.02087; Jopling C, 2011, NAT REV MOL CELL BIO, V12, P79, DOI 10.1038/nrm3043; Knopf F, 2011, DEV CELL, V20, P713, DOI 10.1016/j.devcel.2011.04.014; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Laforest L, 1998, DEVELOPMENT, V125, P4175; Lasorella A, 2014, NAT REV CANCER, V14, P77, DOI 10.1038/nrc3638; Laux DW, 2011, DEV DYNAM, V240, P682, DOI 10.1002/dvdy.22558; Lyden D, 1999, NATURE, V401, P670, DOI 10.1038/44334; Mathew LK, 2009, J BIOL CHEM, V284, P33642, DOI 10.1074/jbc.M109.011668; Miyazono K, 2000, ADV IMMUNOL, V75, P115, DOI 10.1016/S0065-2776(00)75003-6; Miyazono K, 2010, J BIOCHEM, V147, P35, DOI 10.1093/jb/mvp148; Motoike T, 2000, GENESIS, V28, P75, DOI 10.1002/1526-968X(200010)28:2<75::AID-GENE50>3.0.CO;2-S; Nechiporuk A, 2002, DEVELOPMENT, V129, P2607; Pfefferli C, 2015, REGENERATION, V2, P72, DOI 10.1002/reg2.33; Pfefferli C, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-30; Poss KD, 2000, DEV DYNAM, V219, P282, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1045>3.3.CO;2-3; Poss KD, 2003, DEV DYNAM, V226, P202, DOI 10.1002/dvdy.10220; Quint E, 2002, P NATL ACAD SCI USA, V99, P8713, DOI 10.1073/pnas.122571799; Simon A, 2013, WIRES DEV BIOL, V2, P291, DOI 10.1002/wdev.73; Smith A, 2006, DEV BIOL, V299, P438, DOI 10.1016/j.ydbio.2006.08.016; Sousa S, 2011, DEVELOPMENT, V138, P3897, DOI 10.1242/dev.064717; Stewart S, 2014, CELL REP, V6, P482, DOI 10.1016/j.celrep.2014.01.010; Stewart S, 2012, DEV BIOL, V365, P339, DOI 10.1016/j.ydbio.2012.02.031; ten Dijke P, 2003, MOL CELL ENDOCRINOL, V211, P105, DOI 10.1016/j.mce.2003.09.016; Tornini VA, 2014, DEV CELL, V29, P139, DOI 10.1016/j.devcel.2014.04.007; Tu S, 2011, DEV CELL, V20, P725, DOI 10.1016/j.devcel.2011.04.013; Van Itallie CM, 2013, TISSUE BARRIERS, V1, DOI 10.4161/tisb.25247; Wagner DO, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3107mr1; Wehner D, 2015, TRENDS GENET, V31, P336, DOI 10.1016/j.tig.2015.03.012; Whitehead GG, 2005, SCIENCE, V310, P1957, DOI 10.1126/science.1117637; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Yoshinari N, 2011, BIOL BULL-US, V221, P62, DOI 10.1086/BBLv221n1p62; Zhang J, 2010, NATURE, V466, P234, DOI 10.1038/nature09137	46	31	31	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2015	29	10					4299	4312		10.1096/fj.15-272955	http://dx.doi.org/10.1096/fj.15-272955			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CR5FY	26148971	Green Submitted			2022-12-26	WOS:000361367300019
J	Lee, JH; Lee, YK; Lim, JJ; Byun, HO; Park, I; Kim, GH; Xu, WG; Wang, HJ; Yoon, G				Lee, Jong-Hyuk; Lee, Young-Kyoung; Lim, Jin J.; Byun, Hae-Ok; Park, Imkyong; Kim, Gyeong-Hyeon; Xu, Wei Guang; Wang, Hee-Jung; Yoon, Gyesoon			Mitochondrial Respiratory Dysfunction Induces Claudin-1 Expression via Reactive Oxygen Species-mediated Heat Shock Factor 1 Activation, Leading to Hepatoma Cell Invasiveness	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell invasion; heat shock factor protein 1 (HSF1); hepatocellular carcinoma; mitochondrial respiratory chain complex; reactive oxygen species (ROS)	HUMAN GASTRIC-CANCER; BREAST-CANCER; HEPATOCELLULAR-CARCINOMA; TRANSCRIPTION FACTOR-1; OXIDATIVE STRESS; TUMOR-CELLS; MUTATIONS; METABOLISM; GENOME; HSF1	Background: Increased claudin-1 (Cln-1) expression in human hepatoma cells with mitochondrial defects leads to high tumor cell invasiveness. Results: Cln-1-mediated hepatoma cell invasiveness occurs via heat shock factor 1 (HSF1) activation. Conclusion: The mitochondrial defect-ROS-HSF1 axis controls hepatoma cell invasiveness. Significance: HSF1 is a key mitochondrial retrograde-responsive transcription factor controlling hepatoma cell invasiveness. Although mitochondrial dysfunction has been implicated in tumor metastasis, it is unclear how it regulates tumor cell aggressiveness. We have reported previously that human hepatoma cells harboring mitochondrial defects have high tumor cell invasion activity via increased claudin-1 (Cln-1) expression. In this study, we demonstrated that mitochondrial respiratory defects induced Cln-1 transcription via reactive oxygen species (ROS)-mediated heat shock factor 1 (HSF1) activation, which contributed to hepatoma invasiveness. We first confirmed the inverse relationship between mitochondrial defects and Cln-1 induction in SNU hepatoma cells and hepatocellular carcinoma tissues. We then examined five different respiratory complex inhibitors, and complex I inhibition by rotenone most effectively induced Cln-1 at the transcriptional level. Rotenone increased both mitochondrial and cytosolic ROS. In addition, rotenone-induced Cln-1 expression was attenuated by N-acetylcysteine, an antioxidant, and exogenous H2O2 treatment was enough to increase Cln-1 transcription, implying the involvement of ROS. Next we found that ROS-mediated HSF1 activation via hyperphosphorylation was the key event for Cln-1 transcription. Moreover, the Cln-1 promoter region (from -529 to +53) possesses several HSF1 binding elements, and this region showed increased promoter activity and HSF1 binding affinity in response to rotenone treatment. Finally, we demonstrated that the invasion activity of SNU449 cells, which harbor mitochondrial defects, was blocked by siRNA-mediated HSF1 knockdown. Taken together, these results indicate that mitochondrial respiratory defects enhance Cln-1-mediated hepatoma cell invasiveness via mitochondrial ROS-mediated HSF1 activation, presenting a potential role for HSF1 as a novel mitochondrial retrograde signal-responsive transcription factor to control hepatoma cell invasiveness.	[Lee, Jong-Hyuk; Lee, Young-Kyoung; Lim, Jin J.; Byun, Hae-Ok; Park, Imkyong; Kim, Gyeong-Hyeon; Yoon, Gyesoon] Ajou Univ, Sch Med, Dept Biochem, Suwon 443380, South Korea; [Xu, Wei Guang; Wang, Hee-Jung] Ajou Univ, Sch Med, Dept Surg, Suwon 443380, South Korea; [Lee, Jong-Hyuk; Lee, Young-Kyoung; Lim, Jin J.; Byun, Hae-Ok; Park, Imkyong; Kim, Gyeong-Hyeon; Yoon, Gyesoon] Ajou Univ, Grad Sch, Dept Biomed Sci, Suwon 443380, South Korea	Ajou University; Ajou University; Ajou University	Yoon, G (corresponding author), Ajou Univ, Sch Med, Dept Biochem, Suwon 443721, South Korea.	ypeace@ajou.ac.kr		LIM, Jin J./0000-0003-0616-5183	National Research Foundation of Korea - Korean government (MSIP) [NRF-2012R1A5A2048183, NRF-2012R1A2A2A01043185]	National Research Foundation of Korea - Korean government (MSIP)	This work was supported by National Research Foundation of Korea Grants NRF-2012R1A5A2048183 and NRF-2012R1A2A2A01043185 funded by the Korean government (MSIP). The authors declare that they have no conflicts of interest with the contents of this article.	Brandon M, 2006, ONCOGENE, V25, P4647, DOI 10.1038/sj.onc.1209607; Byun HO, 2012, EXP CELL RES, V318, P1808, DOI 10.1016/j.yexcr.2012.04.012; Chang CJ, 2009, CELL MOL LIFE SCI, V66, P1755, DOI 10.1007/s00018-009-8767-5; Chatterjee A, 2006, ONCOGENE, V25, P4663, DOI 10.1038/sj.onc.1209604; Ciocca DR, 2013, ARCH TOXICOL, V87, P19, DOI 10.1007/s00204-012-0918-z; Dang CV, 2008, NAT REV CANCER, V8, P51, DOI 10.1038/nrc2274; Fang F, 2012, CANCER-AM CANCER SOC, V118, P1782, DOI 10.1002/cncr.26482; Finley LWS, 2009, AGEING RES REV, V8, P173, DOI 10.1016/j.arr.2009.03.003; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gorrini C, 2013, NAT REV DRUG DISCOV, V12, P931, DOI 10.1038/nrd4002; Guaragnella N, 2014, BIOCHEM PHARMACOL, V92, P62, DOI 10.1016/j.bcp.2014.07.027; Guertin MJ, 2010, COLD SH Q B, V75, P1, DOI 10.1101/sqb.2010.75.039; Guettouche Toumy, 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-4; He XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061677; Hengstler JG, 2008, ARCH TOXICOL, V82, P271, DOI 10.1007/s00204-008-0305-y; Hoevel T, 2002, J CELL PHYSIOL, V191, P60, DOI 10.1002/jcp.10076; Hung WY, 2012, BBA-GEN SUBJECTS, V1820, P1102, DOI 10.1016/j.bbagen.2012.04.016; Hung WY, 2010, BBA-GEN SUBJECTS, V1800, P264, DOI 10.1016/j.bbagen.2009.06.006; JacquierSarlin MR, 1996, BIOCHEM J, V318, P187, DOI 10.1042/bj3180187; Kim JH, 2011, AUTOPHAGY, V7, P1187, DOI 10.4161/auto.7.10.16643; Kim JH, 2011, EXP CELL RES, V317, P1108, DOI 10.1016/j.yexcr.2011.02.011; Lee HW, 2014, ANAL CHEM, V86, P10001, DOI 10.1021/ac5031013; Lee YK, 2013, MOL CELLS, V35, P489, DOI 10.1007/s10059-013-2343-4; Lei YL, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.005397; Ma J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069485; Mendillo ML, 2012, CELL, V150, P549, DOI 10.1016/j.cell.2012.06.031; Michl P, 2003, CANCER RES, V63, P6265; Miyamori H, 2001, J BIOL CHEM, V276, P28204, DOI 10.1074/jbc.M103083200; Modica-Napolitano JS, 2004, MITOCHONDRION, V4, P755, DOI 10.1016/j.mito.2004.07.027; Moreno-Sanchez R, 2007, FEBS J, V274, P1393, DOI 10.1111/j.1742-4658.2007.05686.x; Nishikawa M, 2001, CANCER RES, V61, P1843; Oku N, 2006, CANCER RES, V66, P5251, DOI 10.1158/0008-5472.CAN-05-4478; Pelicano H, 2006, ONCOGENE, V25, P4633, DOI 10.1038/sj.onc.1209597; Petros JA, 2005, P NATL ACAD SCI USA, V102, P719, DOI 10.1073/pnas.0408894102; Rangel LBA, 2003, CLIN CANCER RES, V9, P2567; Sabharwal SS, 2014, NAT REV CANCER, V14, P709, DOI 10.1038/nrc3803; Santagata S, 2011, P NATL ACAD SCI USA, V108, P18378, DOI 10.1073/pnas.1115031108; Seo YH, 2008, AGING CELL, V7, P894, DOI 10.1111/j.1474-9726.2008.00436.x; Shamovsky I, 2008, CELL MOL LIFE SCI, V65, P855, DOI 10.1007/s00018-008-7458-y; Shidara Y, 2005, CANCER RES, V65, P1655, DOI 10.1158/0008-5472.CAN-04-2012; Singh AK, 2014, MITOCHONDR DNA, V25, P329, DOI 10.3109/19401736.2013.796520; Sotgia F, 2012, CELL CYCLE, V11, P4390, DOI 10.4161/cc.22777; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wang KK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007538; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107; Xia WL, 1997, J BIOL CHEM, V272, P4094, DOI 10.1074/jbc.272.7.4094; Yan LJ, 2002, EMBO J, V21, P5164, DOI 10.1093/emboj/cdf528; Yoon CH, 2010, J BIOL CHEM, V285, P226, DOI 10.1074/jbc.M109.054189; Yu JS, 2011, MOL CELLS, V31, P327, DOI 10.1007/s10059-011-0041-7	50	13	13	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2015	290	35					21421	21431		10.1074/jbc.M115.654913	http://dx.doi.org/10.1074/jbc.M115.654913			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ5IS	26157141	hybrid, Green Published			2022-12-26	WOS:000360637600019
J	Parker, WH; Qu, ZC; May, JM				Parker, William H.; Qu, Zhi-chao; May, James M.			Intracellular Ascorbate Prevents Endothelial Barrier Permeabilization by Thrombin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						actin; cyclic AMP (cAMP); cyclic GMP (cGMP); nitric oxide; Ras-related C3 botulinum toxin substrate 1 (Rac1); Ras-related protein 1 (Rap1); thrombin; ascorbate; endothelial permeability; paracellular transport	NITRIC-OXIDE SYNTHESIS; KINASE RHO-KINASE; VE-CADHERIN; CYCLIC-AMP; MICROVASCULAR PERMEABILITY; TYROSINE PHOSPHORYLATION; VASCULAR ENDOTHELIUM; ADENYLYL-CYCLASE; EXCHANGE FACTOR; PROTEIN-KINASE	Background: Vitamin C (ascorbate) promotes endothelial barrier stability during inflammation. Results: Ascorbate prevents inflammatory decreases in cAMP. Conclusion: cAMP preserves the cortical actin cytoskeleton and prevents stress fiber formation. Significance: Dietary vitamin C may promote vascular integrity in patients with inflammatory diseases. Intracellular ascorbate (vitamin C) has previously been shown to tighten the endothelial barrier and maintain barrier integrity during acute inflammation in vitro. However, the downstream effectors of ascorbate in the regulation of endothelial permeability remain unclear. In this study, we evaluated ascorbate as a mediator of thrombin-induced barrier permeabilization in human umbilical vein endothelial cells and their immortalized hybridoma line, EA.hy926. We found that the vitamin fully prevented increased permeability to the polysaccharide inulin by thrombin in a dose-dependent manner, and it took effect both before and after subjection to thrombin. Thrombin exposure consumed intracellular ascorbate but not the endogenous antioxidant GSH. Likewise, the antioxidants dithiothreitol and tempol did not reverse permeabilization. We identified a novel role for ascorbate in preserving cAMP during thrombin stimulation, resulting in two downstream effects. First, ascorbate maintained the cortical actin cytoskeleton in a Rap1- and Rac1-dependent manner, thus preserving stable adherens junctions between adjacent cells. Second, ascorbate prevented actin polymerization and formation of stress fibers by reducing the activation of RhoA and phosphorylation of myosin light chain. Although ascorbate and thrombin both required calcium for their respective effects, ascorbate did not prevent thrombin permeabilization by obstructing calcium influx. However, preservation of cAMP by ascorbate was found to depend on both the production of nitric oxide by endothelial nitric-oxide synthase, which ascorbate is known to activate, and the subsequent generation cGMP by guanylate cyclase. Together, these data implicate ascorbate in the prevention of inflammatory endothelial barrier permeabilization and explain the underlying signaling mechanism.	[Parker, William H.; Qu, Zhi-chao; May, James M.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37232 USA	Vanderbilt University	May, JM (corresponding author), Vanderbilt Univ, Sch Med, 7465 Med Res Bldg 4, Nashville, TN 37232 USA.	james.may@vanderbilt.edu	Regan, Clinton/E-6250-2012	Parker, William/0000-0003-3426-3709	National Institutes of Health [CA68485, DK20593, DK58404, DK59637, EY08126]; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY008126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404, R01DK050435, U24DK059637, P30DK020593, P60DK020593] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Fiona Harrison for reading and editing the manuscript. Microscope image acquisition was performed in part through the use of the Vanderbilt University Medical Center Cell Imaging Shared Resource (supported by National Institutes of Health Grants CA68485, DK20593, DK58404, DK59637, and EY08126).	Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; BAUER J, 1992, J CELL PHYSIOL, V153, P437, DOI 10.1002/jcp.1041530302; Baumer Y, 2008, HISTOCHEM CELL BIOL, V129, P765, DOI 10.1007/s00418-008-0422-y; Baumer Y, 2009, J CELL PHYSIOL, V220, P716, DOI 10.1002/jcp.21819; Bazzoni G, 2004, PHYSIOL REV, V84, P869, DOI 10.1152/physrev.00035.2003; Bernard O, 2007, INT J BIOCHEM CELL B, V39, P1071, DOI 10.1016/j.biocel.2006.11.011; Birukova AA, 2007, FASEB J, V21, P2776, DOI 10.1096/fj.06-7660com; Birukova AA, 2007, J CELL PHYSIOL, V211, P608, DOI 10.1002/jcp.20966; Birukova AA, 2010, MICROVASC RES, V79, P128, DOI 10.1016/j.mvr.2009.11.007; Bordignon B, 2013, BIOCHEM BIOPH RES CO, V439, P137, DOI 10.1016/j.bbrc.2013.08.004; Cioffi DL, 2002, J CELL BIOL, V157, P1267, DOI 10.1083/jcb.200204022; Cullere X, 2005, BLOOD, V105, P1950, DOI 10.1182/blood-2004-05-1987; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Di Lorenzo A, 2013, J CELL SCI, V126, P5541, DOI 10.1242/jcs.115972; Doise JM, 2008, FUND CLIN PHARMACOL, V22, P203, DOI 10.1111/j.1472-8206.2008.00573.x; DRAIJER R, 1995, CIRC RES, V76, P199, DOI 10.1161/01.RES.76.2.199; Esser S, 1998, J CELL SCI, V111, P1853; Essler M, 1998, J BIOL CHEM, V273, P21867, DOI 10.1074/jbc.273.34.21867; Falk MM, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-34; Ford ES, 2003, DIABETES, V52, P2346, DOI 10.2337/diabetes.52.9.2346; Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486; Heller R, 1999, J BIOL CHEM, V274, P8254, DOI 10.1074/jbc.274.12.8254; Heller R, 2001, J BIOL CHEM, V276, P40, DOI 10.1074/jbc.M004392200; HISSIN PJ, 1976, ANAL BIOCHEM, V74, P214, DOI 10.1016/0003-2697(76)90326-2; HUANG WQ, 1993, ENDOCRINOLOGY, V132, P2271, DOI 10.1210/en.132.5.2271; Jones W, 2002, FREE RADICAL BIO MED, V33, P83, DOI 10.1016/S0891-5849(02)00862-6; Kaya F, 2008, FEBS LETT, V582, P3614, DOI 10.1016/j.febslet.2008.09.040; Kim JE, 2010, J ENDOCRINOL, V207, P35, DOI 10.1677/JOE-10-0093; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Komarova Y, 2010, ANNU REV PHYSIOL, V72, P463, DOI 10.1146/annurev-physiol-021909-135833; Lopez-Lluch G, 1998, BIOCHEM J, V331, P21, DOI 10.1042/bj3310021; May JM, 2013, ANTIOXID REDOX SIGN, V19, P2068, DOI 10.1089/ars.2013.5205; May JM, 2011, BIOCHEM BIOPH RES CO, V404, P701, DOI 10.1016/j.bbrc.2010.12.046; May JM, 2011, BIOFACTORS, V37, P46, DOI 10.1002/biof.134; May JM, 2010, FREE RADICAL RES, V44, P1359, DOI 10.3109/10715762.2010.508496; May JM, 2009, AM J PHYSIOL-CELL PH, V297, pC169, DOI 10.1152/ajpcell.00674.2008; May JM, 1998, ARCH BIOCHEM BIOPHYS, V349, P281, DOI 10.1006/abbi.1997.0473; Meredith ME, 2014, BIOCHEM BIOPH RES CO, V445, P30, DOI 10.1016/j.bbrc.2014.01.078; Millan J, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-11; Parker WH, 2015, BIOCHEM BIOPH RES CO, V458, P262, DOI 10.1016/j.bbrc.2015.01.096; PechAmsellem MA, 1996, EXPERIENTIA, V52, P234, DOI 10.1007/BF01920713; Potter MD, 2005, J BIOL CHEM, V280, P31906, DOI 10.1074/jbc.M505568200; Price KD, 2001, ATHEROSCLEROSIS, V158, P1, DOI 10.1016/S0021-9150(01)00569-X; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Sandoval R, 2001, J PHYSIOL-LONDON, V533, P433, DOI 10.1111/j.1469-7793.2001.0433a.x; Sanz MJ, 2007, BRIT J PHARMACOL, V152, P481, DOI 10.1038/sj.bjp.0707428; SIFLINGERBIRNBOIM A, 1987, J CELL PHYSIOL, V132, P111, DOI 10.1002/jcp.1041320115; Spindler V, 2010, CARDIOVASC RES, V87, P243, DOI 10.1093/cvr/cvq086; THURSTON G, 1994, MICROVASC RES, V47, P1, DOI 10.1006/mvre.1994.1001; UTOGUCHI N, 1995, J CELL PHYSIOL, V163, P393, DOI 10.1002/jcp.1041630219; Vandenbroucke E, 2008, ANN NY ACAD SCI, V1123, P134, DOI 10.1196/annals.1420.016; vanHinsbergh VWM, 1997, ARTERIOSCL THROM VAS, V17, P1018, DOI 10.1161/01.ATV.17.6.1018; VERA JC, 1993, NATURE, V364, P79, DOI 10.1038/364079a0; Voigt K, 2002, FREE RADICAL RES, V36, P735, DOI 10.1080/10715760290032557; Werthmann RC, 2009, J PHYSIOL-LONDON, V587, P4091, DOI 10.1113/jphysiol.2009.172957; YAMADA Y, 1990, ARTERIOSCLEROSIS, V10, P410, DOI 10.1161/01.ATV.10.3.410; Zhang W, 2007, BLOOD, V110, P1475, DOI 10.1182/blood-2006-10-052522	57	14	16	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2015	290	35					21486	21497		10.1074/jbc.M115.662098	http://dx.doi.org/10.1074/jbc.M115.662098			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ5IS	26152729	hybrid, Green Published			2022-12-26	WOS:000360637600024
J	Chen, J; Guo, J; Yang, TH; Li, WT; Lamothe, SM; Kang, YD; Szendrey, JA; Zhang, ST				Chen, Jeffery; Guo, Jun; Yang, Tonghua; Li, Wentao; Lamothe, Shawn M.; Kang, Yudi; Szendrey, John A.; Zhang, Shetuan			Rab11-dependent Recycling of the Human Ether-a-go-go-related Gene (hERG) Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG QT SYNDROME; CELL-SURFACE GLYCOPROTEINS; TRANS-GOLGI NETWORK; POTASSIUM CHANNELS; I-KR; CARDIAC-ARRHYTHMIA; ENDOCYTIC DEGRADATION; MEMBRANE-TRANSPORT; EXTRACELLULAR K+; RAB GTPASES	The human ether-a-go-go-related gene (hERG) encodes the pore-forming subunit of the rapidly activating delayed rectifier potassium channel (I-Kr). Areduction in the hERG current causes long QT syndrome, which predisposes affected individuals to ventricular arrhythmias and sudden death. We reported previously that hERG channels in the plasma membrane undergo vigorous internalization under low K+ conditions. In the present study, we addressed whether hERG internalization occurs under normal K+ conditions and whether/ how internalized channels are recycled back to the plasma membrane. Using patch clamp, Western blot, and confocal imaging analyses, we demonstrated that internalized hERG channels can effectively recycle back to the plasma membrane. Low K+-enhanced hERG internalization is accompanied by an increased rate of hERG recovery in the plasma membrane upon reculture following proteinase K-mediated clearance of cell-surface proteins. The increased recovery rate is not due to enhanced protein synthesis, as hERG mRNA expression was not altered by low K+ exposure, and the increased recovery was observed in the presence of the protein biosynthesis inhibitor cycloheximide. GTPase Rab11, but not Rab4, is involved in the recycling of hERG channels. Interfering with Rab11 function not only delayed hERG recovery in cells after exposure to low K+ medium but also decreased hERG expression and function in cells under normal culture conditions. We concluded that the recycling pathway plays an important role in the homeostasis of plasma membrane-bound hERG channels.	[Chen, Jeffery; Guo, Jun; Yang, Tonghua; Li, Wentao; Lamothe, Shawn M.; Kang, Yudi; Szendrey, John A.; Zhang, Shetuan] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Zhang, ST (corresponding author), Queens Univ, Dept Biomed & Mol Sci, Botterell Hall,Rm 429,18 Stuart St, Kingston, ON K7L 3N6, Canada.	shetuan.zhang@queensu.ca		Zhang, Shetuan/0000-0002-2297-0193; Lamothe, Shawn/0000-0001-8722-2631	Canadian Institutes of Health Research [MOP 72911]; Heart and Stroke Foundation of Ontario	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario)	This work was supported by Canadian Institutes of Health Research Grant MOP 72911 (to S. Z.). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of the Heart and Stroke Foundation of Ontario Career Investigator Award.	Anderson CL, 2006, CIRCULATION, V113, P365, DOI 10.1161/CIRCULATIONAHA.105.570200; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; Chen W, 1998, MOL BIOL CELL, V9, P3241, DOI 10.1091/mbc.9.11.3241; Cheng SB, 2012, J BIOL CHEM, V287, P14178, DOI 10.1074/jbc.M111.323782; Cui Z, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M113.461715; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; Daro E, 1996, P NATL ACAD SCI USA, V93, P9559, DOI 10.1073/pnas.93.18.9559; Delisle BP, 2009, J BIOL CHEM, V284, P2844, DOI 10.1074/jbc.M807289200; Dupre DJ, 2006, J BIOL CHEM, V281, P34561, DOI 10.1074/jbc.M605012200; Ficker E, 2004, MOL PHARMACOL, V66, P33, DOI 10.1124/mol.66.1.33; Ficker E, 2003, CIRC RES, V92, pE87, DOI 10.1161/01.RES.0000079028.31393.15; Gong QM, 2006, J BIOL CHEM, V281, P4069, DOI 10.1074/jbc.M511765200; Gong QM, 2002, AM J PHYSIOL-HEART C, V283, pH77, DOI 10.1152/ajpheart.00008.2002; Grosshans BL, 2006, P NATL ACAD SCI USA, V103, P11821, DOI 10.1073/pnas.0601617103; Guo J, 2007, J PHARMACOL EXP THER, V321, P911, DOI 10.1124/jpet.107.120931; Guo J, 2011, J BIOL CHEM, V286, P34664, DOI 10.1074/jbc.M111.253351; Guo J, 2009, J CLIN INVEST, V119, P2745, DOI 10.1172/JCI39027; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Keating MT, 2001, CELL, V104, P569, DOI 10.1016/S0092-8674(01)00243-4; Kramer A, 2013, NAT CHEM BIOL, V9, P731, DOI [10.1038/NCHEMBIO.1356, 10.1038/nchembio.1356]; KREISEL W, 1988, J BIOL CHEM, V263, P11736; Kuryshev YA, 2005, J PHARMACOL EXP THER, V312, P316, DOI 10.1124/jpet.104.073692; Lamothe SM, 2013, J BIOL CHEM, V288, P15075, DOI 10.1074/jbc.M113.453670; Massaeli H, 2010, J BIOL CHEM, V285, P27259, DOI 10.1074/jbc.M110.124909; Massaeli H, 2010, CIRC RES, V106, P1072, DOI 10.1161/CIRCRESAHA.109.215970; McEwen DP, 2007, J BIOL CHEM, V282, P29612, DOI 10.1074/jbc.M704402200; Mitcheson JS, 2000, P NATL ACAD SCI USA, V97, P12329, DOI 10.1073/pnas.210244497; Mohrmann K, 1999, MOL MEMBR BIOL, V16, P81, DOI 10.1080/096876899294797; Olkkonen VM, 1997, INT REV CYTOL, V176, P1, DOI 10.1016/S0074-7696(08)61608-3; PLUTNER H, 1991, J CELL BIOL, V115, P31, DOI 10.1083/jcb.115.1.31; Pochynyuk O, 2007, EXP BIOL MED, V232, P1258, DOI 10.3181/0703-MR-76; Porwoll S, 1998, J BIOL CHEM, V273, P1075, DOI 10.1074/jbc.273.2.1075; Rajamani S, 2006, BRIT J PHARMACOL, V149, P481, DOI 10.1038/sj.bjp.0706892; Rajamani S, 2006, AM J PHYSIOL-HEART C, V290, pH1278, DOI 10.1152/ajpheart.00777.2005; Reynders E, 2011, GLYCOBIOLOGY, V21, P853, DOI 10.1093/glycob/cwq179; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; SCHWARTZ PJ, 1993, CIRCULATION, V88, P782, DOI 10.1161/01.CIR.88.2.782; Seebohm G, 2007, CIRC RES, V100, P686, DOI 10.1161/01.RES.0000260250.83824.8f; Sun T, 2011, J BIOL CHEM, V286, P6751, DOI 10.1074/jbc.M110.198408; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; VOLZ B, 1995, J CELL BIOL, V130, P537, DOI 10.1083/jcb.130.3.537; Zadeh AD, 2008, J PHYSIOL-LONDON, V586, P4793, DOI 10.1113/jphysiol.2008.161570; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhou ZF, 1998, BIOPHYS J, V74, P230, DOI 10.1016/S0006-3495(98)77782-3; Zhou ZF, 1998, J BIOL CHEM, V273, P21061, DOI 10.1074/jbc.273.33.21061	48	13	13	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2015	290	34					21101	21113		10.1074/jbc.M115.636324	http://dx.doi.org/10.1074/jbc.M115.636324			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP6QC	26152716	Green Published, hybrid			2022-12-26	WOS:000360011800042
J	Tsuboi, K; Nishitani, M; Takakura, A; Imai, Y; Komatsu, M; Kawashima, H				Tsuboi, Koichiro; Nishitani, Mayo; Takakura, Atsushi; Imai, Yasuyuki; Komatsu, Masaaki; Kawashima, Hiroto			Autophagy Protects against Colitis by the Maintenance of Normal Gut Microflora and Secretion of Mucus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENOME-WIDE ASSOCIATION; INTESTINAL EPITHELIUM; SUSCEPTIBILITY LOCI; IMPAIRED AUTOPHAGY; ACTIVATING ENZYME; CROHN-DISEASE; UP-REGULATION; EXPRESSION; INNATE; ATG16L1	Genome-wide association studies of inflammatory bowel diseases identified susceptible loci containing an autophagy-related gene. However, the role of autophagy in the colon, a major affected area in inflammatory bowel diseases, is not clear. Here, we show that colonic epithelial cell-specific autophagy-related gene 7 (Atg7) conditional knock-out (cKO) mice showed exacerbation of experimental colitis with more abundant bacterial invasion into the colonic epithelium. Quantitative PCR analysis revealed that cKO mice had abnormal microflora with an increase of some genera. Consistently, expression of antimicrobial or antiparasitic peptides such as angiogenin-4, Relm beta, intelectin-1, and intelectin-2 as well as that of their inducer cytokines was significantly reduced in the cKO mice. Furthermore, secretion of colonic mucins that function as a mucosal barrier against bacterial invasion was also significantly diminished in cKO mice. Taken together, our results indicate that autophagy in colonic epithelial cells protects against colitis by the maintenance of normal gut microflora and secretion of mucus.	[Tsuboi, Koichiro; Kawashima, Hiroto] Hoshi Univ, Dept Biochem, Sch Pharm & Pharmaceut Sci, Tokyo 1428501, Japan; [Tsuboi, Koichiro; Nishitani, Mayo; Takakura, Atsushi; Imai, Yasuyuki; Kawashima, Hiroto] Univ Shizuoka, Sch Pharmaceut Sci, Lab Microbiol & Immunol, Shizuoka 4228526, Japan; [Komatsu, Masaaki] Niigata Univ, Sch Med, Dept Biochem, Niigata 9518510, Japan	Hoshi University; University of Shizuoka; Niigata University	Kawashima, H (corresponding author), Hoshi Univ, Dept Biochem, Sch Pharm & Pharmaceut Sci, Shinagawa Ku, 2-4-41 Ebara, Tokyo 1428501, Japan.	h-kawashima@hoshi.ac.jp	Komatsu, Masaaki/B-8321-2011; Imai, Yasuyuki/E-8701-2010	Komatsu, Masaaki/0000-0001-7672-7722; Imai, Yasuyuki/0000-0002-8937-0221	Precursory Research for Embryonic Science and Technology; Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology, Japan [24390018]; Institute for Fermentation, Osaka; Honjo International Scholarship Foundation;  [26-7438]; Grants-in-Aid for Scientific Research [15K14955] Funding Source: KAKEN	Precursory Research for Embryonic Science and Technology; Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Institute for Fermentation, Osaka(Institute for Fermentation (IFO)); Honjo International Scholarship Foundation(Honjo International Scholarship Foundation); ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants from the Precursory Research for Embryonic Science and Technology, the Japan Science and Technology Agency (to H. K.), Scientific Research (B) from the Ministry of Education, Culture, Sports, Science and Technology, Japan, Grant 24390018 (to H. K.), Grant-in-aid for JSPS Fellows 26-7438 (to K. T.), and in part by the Institute for Fermentation, Osaka (to H. K.), and the Honjo International Scholarship Foundation (to K. T.). The authors declare that they have no conflicts of interest with the contents of this article.	Adolph TE, 2013, NATURE, V503, P272, DOI 10.1038/nature12599; Alex P, 2009, INFLAMM BOWEL DIS, V15, P341, DOI 10.1002/ibd.20753; An GY, 2007, J EXP MED, V204, P1417, DOI 10.1084/jem.20061929; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Baumgart DC, 2012, LANCET, V380, P1590, DOI 10.1016/S0140-6736(12)60026-9; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Couturier-Maillard A, 2013, J CLIN INVEST, V123, P700, DOI 10.1172/JCI62236; Deretic V, 2006, CELL MICROBIOL, V8, P719, DOI 10.1111/j.1462-5822.2006.00705.x; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Forman RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042248; Fort MM, 2001, IMMUNITY, V15, P985, DOI 10.1016/S1074-7613(01)00243-6; French AT, 2007, VET IMMUNOL IMMUNOP, V120, P41, DOI 10.1016/j.vetimm.2007.07.014; Fu JX, 2011, J CLIN INVEST, V121, P1657, DOI 10.1172/JCI45538; Fuhrer A, 2010, J EXP MED, V207, P2843, DOI 10.1084/jem.20101098; Fujishima Y, 2011, ARCH BIOCHEM BIOPHYS, V506, P223, DOI 10.1016/j.abb.2010.12.009; Gamerdinger M, 2009, EMBO J, V28, P889, DOI 10.1038/emboj.2009.29; Garrett WS, 2007, CELL, V131, P33, DOI 10.1016/j.cell.2007.08.017; Greenbloom SL, 1998, CAN J GASTROENTEROL, V12, P53, DOI 10.1155/1998/349460; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Hajishengallis G, 2012, NAT REV MICROBIOL, V10, P717, DOI 10.1038/nrmicro2873; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Nguyen HTT, 2014, GASTROENTEROLOGY, V146, P508, DOI 10.1053/j.gastro.2013.10.021; He WM, 2003, GASTROENTEROLOGY, V125, P1388, DOI 10.1016/j.gastro.2003.07.009; Herbert DR, 2009, J EXP MED, V206, P2947, DOI 10.1084/jem.20091268; Hooper LV, 2003, NAT IMMUNOL, V4, P269, DOI 10.1038/ni888; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; Inoue J, 2012, ARCH BIOCHEM BIOPHYS, V521, P95, DOI 10.1016/j.abb.2012.03.019; Ishikawa T, 2011, MOL IMAGING BIOL, V13, P284, DOI 10.1007/s11307-010-0333-x; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Jung HS, 2008, CELL METAB, V8, P318, DOI 10.1016/j.cmet.2008.08.013; Kanno T, 2009, BIOCHEM BIOPH RES CO, V381, P666, DOI 10.1016/j.bbrc.2009.02.109; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Kawashima H, 2009, J IMMUNOL, V182, P5461, DOI 10.4049/jimmunol.0802327; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Koutroubakis Ioannis E, 2010, World J Gastrointest Pharmacol Ther, V1, P43, DOI 10.4292/wjgpt.v1.i2.43; Kuballa P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003391; Kuma A, 2002, J BIOL CHEM, V277, P18619, DOI 10.1074/jbc.M111889200; Lapaquette P, 2010, CELL MICROBIOL, V12, P99, DOI 10.1111/j.1462-5822.2009.01381.x; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; Mcvay LD, 2006, J CLIN INVEST, V116, P2914, DOI 10.1172/JCI28121; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Mowat C, 2011, GUT, V60, P571, DOI 10.1136/gut.2010.224154; Murthy A, 2014, NATURE, V506, P456, DOI 10.1038/nature13044; Nair MG, 2008, J IMMUNOL, V181, P4709, DOI 10.4049/jimmunol.181.7.4709; Nishiumi S, 2012, BIOCHEM BIOPH RES CO, V421, P768, DOI 10.1016/j.bbrc.2012.04.081; Pemberton AD, 2004, J IMMUNOL, V173, P1894, DOI 10.4049/jimmunol.173.3.1894; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Reikvam DH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017996; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Saenz SA, 2008, IMMUNOL REV, V226, P172, DOI 10.1111/j.1600-065X.2008.00713.x; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Sanders ME, 2011, J CLIN GASTROENTEROL, V45, pS115, DOI 10.1097/MCG.0b013e318227414a; Seedorf H, 2014, CELL, V159, P253, DOI 10.1016/j.cell.2014.09.008; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Steenwinckel V, 2009, J IMMUNOL, V182, P4737, DOI 10.4049/jimmunol.0801941; Swidsinski A, 2005, J CLIN MICROBIOL, V43, P3380, DOI 10.1128/JCM.43.7.3380-3389.2005; Tanida I, 1999, MOL BIOL CELL, V10, P1367, DOI 10.1091/mbc.10.5.1367; Tanida I, 2001, J BIOL CHEM, V276, P1701, DOI 10.1074/jbc.C000752200; Tanida I, 2012, AUTOPHAGY, V8, P88, DOI 10.4161/auto.8.1.18339; Tobisawa Y, 2010, J BIOL CHEM, V285, P6750, DOI 10.1074/jbc.M109.067082; Tsuji S, 2009, GLYCOBIOLOGY, V19, P518, DOI 10.1093/glycob/cwp013; Van der Sluis M, 2006, GASTROENTEROLOGY, V131, P117, DOI 10.1053/j.gastro.2006.04.020; Voehringer D, 2007, EXP PARASITOL, V116, P458, DOI 10.1016/j.exppara.2007.02.015; Wittkopf N, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/278059; Wlodarska M, 2014, CELL, V156, P1045, DOI 10.1016/j.cell.2014.01.026; Zaph C, 2008, J EXP MED, V205, P2191, DOI 10.1084/jem.20080720; Zenewicz LA, 2013, J IMMUNOL, V190, P5306, DOI 10.4049/jimmunol.1300016; Ziegler SF, 2010, NAT IMMUNOL, V11, P289, DOI 10.1038/ni.1852	70	60	62	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2015	290	33					20511	20526		10.1074/jbc.M114.632257	http://dx.doi.org/10.1074/jbc.M114.632257			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP1AT	26149685	hybrid, Green Published			2022-12-26	WOS:000359608900048
J	Munoz-Reyes, JA; Iglesias-Julios, M; Pita, M; Turiegano, E				Antonio Munoz-Reyes, Jose; Iglesias-Julios, Marta; Pita, Miguel; Turiegano, Enrique			Facial Features: What Women Perceive as Attractive and What Men Consider Attractive	PLOS ONE			English	Article							BODY-MASS-INDEX; CROSS-CULTURAL EVIDENCE; PHYSICAL ATTRACTIVENESS; FLUCTUATING ASYMMETRY; SEXUAL-DIMORPHISM; DIGIT RATIO; DEVELOPMENTAL INSTABILITY; GEOMETRIC MORPHOMETRICS; VISUAL CUES; HIP-RATIO	Attractiveness plays an important role in social exchange and in the ability to attract potential mates, especially for women. Several facial traits have been described as reliable indicators of attractiveness in women, but very few studies consider the influence of several measurements simultaneously. In addition, most studies consider just one of two assessments to directly measure attractiveness: either self-evaluation or men's ratings. We explored the relationship between these two estimators of attractiveness and a set of facial traits in a sample of 266 young Spanish women. These traits are: facial fluctuating asymmetry, facial averageness, facial sexual dimorphism, and facial maturity. We made use of the advantage of having recently developed methodologies that enabled us to measure these variables in real faces. We also controlled for three other widely used variables: age, body mass index and waist-to-hip ratio. The inclusion of many different variables allowed us to detect any possible interaction between the features described that could affect attractiveness perception. Our results show that facial fluctuating asymmetry is related both to self-perceived and male-rated attractiveness. Other facial traits are related only to one direct attractiveness measurement: facial averageness and facial maturity only affect men's ratings. Unmodified faces are closer to natural stimuli than are manipulated photographs, and therefore our results support the importance of employing unmodified faces to analyse the factors affecting attractiveness. We also discuss the relatively low equivalence between self-perceived and male-rated attractiveness and how various anthropometric traits are relevant to them in different ways. Finally, we highlight the need to perform integrated-variable studies to fully understand female attractiveness.	[Antonio Munoz-Reyes, Jose] Univ Playa Ancha, Ctr Estudios Avanzados, Vina Del Mar, Chile; [Iglesias-Julios, Marta; Pita, Miguel; Turiegano, Enrique] Univ Autonoma Madrid, Dept Biol, Madrid, Spain; [Iglesias-Julios, Marta] Champalimaud Ctr Unknown, Champalimaud Neurosci Programme, Lisbon, Portugal	Universidad de Playa Ancha; Autonomous University of Madrid; Fundacao Champalimaud	Turiegano, E (corresponding author), Univ Autonoma Madrid, Dept Biol, Madrid, Spain.	enrique.turiegano@uam.es	Pita, Miguel/AAA-6505-2019; Turiegano, Enrique/M-8679-2013; Pita, Miguel/L-2466-2013; Muñoz-Reyes, José Antonio/D-2822-2012	Pita, Miguel/0000-0001-5106-5566; Turiegano, Enrique/0000-0003-4620-7894; Pita, Miguel/0000-0001-5106-5566; Muñoz-Reyes, José Antonio/0000-0001-6275-8456; Iglesias-Julios, Marta/0000-0002-1271-6597	Spanish MICINN [BFU2010-10981-E]; Chilean FONDECYT [11130028]	Spanish MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Chilean FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	The research was supported by funds from the grants BFU2010-10981-E of the Spanish MICINN and "FONDECYT Iniciacion" #11130028 of the Chilean FONDECYT.	Adams DC, 2004, ITAL J ZOOL, V71, P5, DOI 10.1080/11250000409356545; Munoz-Reyes JA, 2012, PERS INDIV DIFFER, V53, P857, DOI 10.1016/j.paid.2012.06.012; Apicella CL, 2007, PERCEPTION, V36, P1813, DOI 10.1068/p5601; Baudouin JY, 2004, ACTA PSYCHOL, V117, P313, DOI 10.1016/j.actpsy.2004.07.002; Beall Anne E, 2007, Dent Clin North Am, V51, P289, DOI 10.1016/j.cden.2007.02.002; Belsley D. A., 1991, CONDITIONING DIAGNOS; Benzeval M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063975; Bisson M, 2004, ANGLE ORTHOD, V74, P162; Brand RJ, 2012, COMPUT HUM BEHAV, V28, P166, DOI 10.1016/j.chb.2011.08.023; Brown WM, 2008, P NATL ACAD SCI USA, V105, P12938, DOI 10.1073/pnas.0710420105; Buggio L, 2012, GYNECOL ENDOCRINOL, V28, P753, DOI 10.3109/09513590.2012.662545; BUSS DM, 1989, BEHAV BRAIN SCI, V12, P1, DOI 10.1017/S0140525X00023992; Campbell A, 2004, J SEX RES, V41, P16, DOI 10.1080/00224490409552210; Clark AP, 2004, EVOL HUM BEHAV, V25, P113, DOI 10.1016/S1090-5138(03)00085-0; Coetzee V, 2010, PERCEPTION, V39, P51, DOI 10.1068/p6560; Cornwell RE, 2006, PHILOS T R SOC B, V361, P2143, DOI 10.1098/rstb.2006.1936; CUNNINGHAM MR, 1990, J PERS SOC PSYCHOL, V59, P61, DOI 10.1037/0022-3514.59.1.61; CUNNINGHAM MR, 1995, J PERS SOC PSYCHOL, V68, P261, DOI 10.1037/0022-3514.68.2.261; Currie TE, 2009, EVOL HUM BEHAV, V30, P409, DOI 10.1016/j.evolhumbehav.2009.06.005; DeBruine LM, 2007, J EXP PSYCHOL HUMAN, V33, P1420, DOI 10.1037/0096-1523.33.6.1420; DION K, 1972, J PERS SOC PSYCHOL, V24, P285, DOI 10.1037/h0033731; Edler R J, 2001, J Orthod, V28, P159, DOI 10.1093/ortho/28.2.159; Etcoff N., 1999, SURVIVAL PRETTIEST S; Farmer H, 2014, PSYCHOL SCI, V25, P290, DOI 10.1177/0956797613494852; Feinberg DR, 2005, EVOL HUM BEHAV, V26, P398, DOI 10.1016/j.evolhumbehav.2005.04.001; FEINGOLD A, 1992, PSYCHOL BULL, V111, P304, DOI 10.1037/0033-2909.111.2.304; Fink B, 2005, P ROY SOC B-BIOL SCI, V272, P1995, DOI 10.1098/rspb.2005.3179; Fink B, 2006, AM J HUM BIOL, V18, P776, DOI 10.1002/ajhb.20549; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; Furnham Adrian, 2006, Psychol Health Med, V11, P129, DOI 10.1080/13548500500155982; GABRIEL MT, 1994, J PERS, V62, P143, DOI 10.1111/j.1467-6494.1994.tb00798.x; Gangestad SW, 2005, ANNU REV ANTHROPOL, V34, P523, DOI 10.1146/annurev.anthro.33.070203.143733; Ghirlanda S, 2002, HUM NATURE-INT BIOS, V13, P383, DOI 10.1007/s12110-002-1021-6; Griffey JAF, 2014, EXP PSYCHOL, V61, P301, DOI 10.1027/1618-3169/a000248; Halberstadt J, 2000, PSYCHOL SCI, V11, P285, DOI 10.1111/1467-9280.00257; Halberstadt J, 2003, PSYCHON B REV, V10, P149, DOI 10.3758/BF03196479; Holliday IE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027255; Holtzman NS, 2011, J RES PERS, V45, P687, DOI 10.1016/j.jrp.2011.08.003; Hope D, 2013, ECON HUM BIOL, V11, P236, DOI 10.1016/j.ehb.2011.06.006; Jansson L, 2002, ANIM BEHAV, V63, P617, DOI 10.1006/anbe.2001.1936; Jasienska G, 2004, P ROY SOC B-BIOL SCI, V271, P1213, DOI 10.1098/rspb.2004.2712; JOHNSTON VS, 1993, ETHOL SOCIOBIOL, V14, P183, DOI 10.1016/0162-3095(93)90005-3; JONES D, 1995, CURR ANTHROPOL, V36, P723, DOI 10.1086/204427; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Klingenberg CP, 2010, NAT REV GENET, V11, P623, DOI 10.1038/nrg2829; Klingenberg CP, 2002, EVOLUTION, V56, P1909; Klingenberg CP, 1998, EVOLUTION, V52, P1363, DOI 10.1111/j.1558-5646.1998.tb02018.x; Kocinski K., 2007, ANTHROPOL REV, V70, P45, DOI [10.2478/V10044-008-0001-9, DOI 10.2478/V10044-008-0001-9]; Koehler N, 2004, P ROY SOC B-BIOL SCI, V271, pS233, DOI 10.1098/rsbl.2003.0146; Komori M, 2009, ACTA PSYCHOL, V131, P136, DOI 10.1016/j.actpsy.2009.03.008; Koscinski K, 2013, BEHAV ECOL, V24, P914, DOI 10.1093/beheco/art016; Kranz F, 2006, CURR BIOL, V16, P63, DOI 10.1016/j.cub.2005.10.070; Lake JK, 1997, INT J OBESITY, V21, P432, DOI 10.1038/sj.ijo.0800424; LANGLOIS JH, 1990, PSYCHOL SCI, V1, P115, DOI 10.1111/j.1467-9280.1990.tb00079.x; Langlois JH, 2000, PSYCHOL BULL, V126, P390, DOI 10.1037/0033-2909.126.3.390; Law-Smith MJ, 2006, P ROY SOC B-BIOL SCI, V273, P135, DOI 10.1098/rspb.2005.3296; Lie HC, 2008, EVOLUTION, V62, P2473, DOI 10.1111/j.1558-5646.2008.00478.x; Little AC, 2003, P ROY SOC B-BIOL SCI, V270, P1759, DOI 10.1098/rspb.2003.2445; Little AC, 2001, P ROY SOC B-BIOL SCI, V268, P39, DOI 10.1098/rspb.2000.1327; Little AC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002106; Little AC, 2011, PHILOS T R SOC B, V366, P1638, DOI 10.1098/rstb.2010.0404; Lorenzo GL, 2010, PSYCHOL SCI, V21, P1777, DOI 10.1177/0956797610388048; Lynn M, 2009, ARCH SEX BEHAV, V38, P737, DOI 10.1007/s10508-008-9379-0; Manning JT, 1999, NATURE, V399, P214, DOI 10.1038/20341; Marcus DK, 2003, PERS SOC PSYCHOL B, V29, P325, DOI 10.1177/0146167202250193; MATHES EW, 1985, J SOC PSYCHOL, V125, P157, DOI 10.1080/00224545.1985.9922868; MAZZELLA R, 1994, J APPL SOC PSYCHOL, V24, P1315, DOI 10.1111/j.1559-1816.1994.tb01552.x; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.1.30; MITTON JB, 1984, ANNU REV ECOL SYST, V15, P479; Moller AP, 2006, INFECT GENET EVOL, V6, P133, DOI 10.1016/j.meegid.2005.03.005; Moller AP, 1998, AM NAT, V151, P174, DOI 10.1086/286110; Moller AP, 1997, ASYMMETRY DEV STABIL; Moore FR, 2011, PERS INDIV DIFFER, V50, P1068, DOI 10.1016/j.paid.2011.01.026; Mulford M, 1998, AM J SOCIOL, V103, P1565, DOI 10.1086/231401; Munoz-Reyes JA, 2014, EVOL HUM BEHAV, V35, P118, DOI 10.1016/j.evolhumbehav.2013.11.005; Munoz-Reyes JA, 2014, ESTUD PSICOL-MADRID, V35, P319, DOI 10.1080/02109395.2014.922259; Pawlowski B, 2005, HUM NATURE-INT BIOS, V16, P164, DOI 10.1007/s12110-005-1002-7; Penton-Voak IS, 2001, P ROY SOC B-BIOL SCI, V268, P1617, DOI 10.1098/rspb.2001.1703; Perrett DI, 1998, NATURE, V394, P884, DOI 10.1038/29772; Perrett DI, 1999, EVOL HUM BEHAV, V20, P295, DOI 10.1016/S1090-5138(99)00014-8; Peters Jay, 2002, Violence Vict, V17, P255, DOI 10.1891/vivi.17.2.255.33644; Peters M, 2007, ANIM BEHAV, V73, P937, DOI 10.1016/j.anbehav.2006.07.012; Pisanski K, 2013, CROSS-CULT RES, V47, P162, DOI 10.1177/1069397112471806; Platek SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009042; Puts DA, 2010, EVOL HUM BEHAV, V31, P157, DOI 10.1016/j.evolhumbehav.2010.02.005; Rantala MJ, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0255; Reber R, 2004, PERS SOC PSYCHOL REV, V8, P364, DOI 10.1207/s15327957pspr0804_3; Reither EN, 2009, DEMOGRAPHY, V46, P27, DOI 10.1353/dem.0.0037; Rhodes G, 2006, ANNU REV PSYCHOL, V57, P199, DOI 10.1146/annurev.psych.57.102904.190208; Rhodes G, 2005, EVOL HUM BEHAV, V26, P186, DOI 10.1016/j.evolhumbehav.2004.08.014; Rhodes G, 2001, EVOL HUM BEHAV, V22, P31, DOI 10.1016/S1090-5138(00)00060-X; Ritz BW, 2006, J NUTR, V136, P1141, DOI 10.1093/jn/136.5.1141; ROHLF FJ, 1993, TRENDS ECOL EVOL, V8, P129, DOI 10.1016/0169-5347(93)90024-J; Rohlf FJ, 2003, J HUM EVOL, V44, P665, DOI 10.1016/S0047-2484(03)00047-2; Rohlf FJ, 2000, AM J PHYS ANTHROPOL, V111, P463, DOI 10.1002/(SICI)1096-8644(200004)111:4<463::AID-AJPA3>3.0.CO;2-B; Rosenblum GD, 1999, CHILD DEV, V70, P50, DOI 10.1111/1467-8624.00005; Sanchez-Pages S, 2013, BEHAVIOUR, V150, P713, DOI 10.1163/1568539X-00003077; Sanchez-Pages S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112157; Sanchez-Pages S, 2010, PHYSIOL BEHAV, V99, P355, DOI 10.1016/j.physbeh.2009.11.013; Santayana G, 1955, THE SENSE OF BEAUTY; Saxton T.K., 2009, J EVOL PSYCHOL, V7, P23, DOI [10.1556/JEP.7.2009.1.4, DOI 10.1556/JEP.7.2009.1.4]; Schaefer K., 2006, PSYCHOL SCI, V48, P187; Scheyd GJ, 2008, FDN EVOLUTIONARY PSY, P239; Schwarz S, 2012, HUM NATURE-INT BIOS, V23, P447, DOI 10.1007/s12110-012-9152-x; Scott IML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013585; Sell A, 2009, P NATL ACAD SCI USA, V106, P15073, DOI 10.1073/pnas.0904312106; Singh D, 2004, J SEX RES, V41, P43, DOI 10.1080/00224490409552212; SINGH D, 1993, J PERS SOC PSYCHOL, V65, P293, DOI 10.1037/0022-3514.65.2.293; Singh Devendra, 2002, Neuro Endocrinol Lett, V23 Suppl 4, P81; Singh D, 2010, EVOL HUM BEHAV, V31, P176, DOI 10.1016/j.evolhumbehav.2009.09.001; Slice DE, 2007, ANNU REV ANTHROPOL, V36, P261, DOI 10.1146/annurev.anthro.34.081804.120613; SWADDLE JP, 1995, P ROY SOC B-BIOL SCI, V261, P111, DOI 10.1098/rspb.1995.0124; Thornhill R, 1998, EVOL HUM BEHAV, V202, P105; Tinlin RM, 2013, BRIT J PSYCHOL, V104, P235, DOI 10.1111/j.2044-8295.2012.02117.x; Tovee MJ, 1999, P ROY SOC B-BIOL SCI, V266, P211, DOI 10.1098/rspb.1999.0624; Tovee MJ, 1998, LANCET, V352, P548, DOI 10.1016/S0140-6736(05)79257-6; Van Dongen S, 2014, ANN HUM BIOL, V41, P205, DOI 10.3109/03014460.2013.847120; Van Dongen S, 2012, ARCH SEX BEHAV, V41, P1453, DOI 10.1007/s10508-012-9917-7; Van Dongen S, 2011, EVOL HUM BEHAV, V32, P380, DOI 10.1016/j.evolhumbehav.2011.03.002; VANVALEN L, 1962, EVOLUTION, V16, P125; Viscosi V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025630; Vukovic J, 2008, PERS INDIV DIFFER, V45, P451, DOI 10.1016/j.paid.2008.05.013; Weeden J, 2007, ARCH SEX BEHAV, V36, P79, DOI 10.1007/s10508-006-9075-x; Wilson JM, 1996, J HUM EVOL, V30, P529, DOI 10.1006/jhev.1996.0041; Winkielman P, 2006, PSYCHOL SCI, V17, P799, DOI 10.1111/j.1467-9280.2006.01785.x; Wood J. W., 1994, DYNAMICS HUMAN REPRO; ZAADSTRA BM, 1993, BRIT MED J, V306, P484, DOI 10.1136/bmj.306.6876.484; Zar, 2011, BIOSTAT ANAL; Zelditch ML, 2012, GEOMETRIC MORPHOMETRICS FOR BIOLOGISTS: A PRIMER, 2ND EDITION, P1	129	20	20	4	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132979	10.1371/journal.pone.0132979	http://dx.doi.org/10.1371/journal.pone.0132979			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1FD	26161954	gold, Green Published, Green Submitted			2022-12-26	WOS:000358162300182
J	Casetti, R; De Simone, G; Sacchi, A; Rinaldi, A; Viola, D; Agrati, C; Bordoni, V; Cimini, E; Tumino, N; Besi, F; Martini, F				Casetti, Rita; De Simone, Gabriele; Sacchi, Alessandra; Rinaldi, Alessandra; Viola, Domenico; Agrati, Chiara; Bordoni, Veronica; Cimini, Eleonora; Tumino, Nicola; Besi, Francesca; Martini, Federico			V gamma V delta 2 T-Cell Polyfunctionality Is Differently Modulated in HAART-Treated HIV Patients according to CD4 T-Cell Count	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ACTIVE ANTIRETROVIRAL THERAPY; MYCOBACTERIAL ANTIGENS; INFECTED PERSONS; REPLICATION; LYMPHOCYTE; RESPONSES; ASSOCIATION; SUPPRESSION; REPERTOIRE	Alteration of gamma delta T-cell distribution and function in peripheral blood is among the earliest defects during HIV-infection. We asked whether the polyfunctional response could also be affected, and how this impairment could be associated to CD4 T-cell count. To this aim, we performed a cross-sectional study on HIV-infected individuals. In order to evaluate the poly-functional- V gamma 9V delta 2 T-cell response after phosphoantigen-stimulation, we assessed the cytokine/chemokine production and cytotoxicity by flow-cytometry in HAART-treated-HIV+ persons and healthy-donors. During HIV-infection V gamma 9V delta 2-polyfunctional response quality is affected, since several V gamma 9V delta 2 T-cell subsets resulted significantly lower in HIV+ patients in respect to healthy donors. Interestingly, we found a weak positive correlation between V gamma 9V delta 2 T-cell-response and CD4 T-cell counts. By dividing the HIV+ patients according to CD4 T-cell count, we found that Low-CD4 patients expressed a lower number of two V gamma 9V delta 2 T-cell subsets expressing MIP-1 beta in different combinations with other molecules (CD107a/IFN gamma.) in respect to High-CD4 individuals. Our results show that the V gamma 9V delta 2 T-cell- response quality in Low-CD4 patients is specifically affected, suggesting a direct link between innate V gamma 9V delta 2 T-cells and CD4 T-cell count. These findings suggest that V gamma 9V delta 2 T-cell quality may be indirectly influenced by HAART therapy and could be included in a new therapeutical strategy which would perform an important role in fighting HIV infection.	[Casetti, Rita; De Simone, Gabriele; Sacchi, Alessandra; Rinaldi, Alessandra; Viola, Domenico; Agrati, Chiara; Bordoni, Veronica; Cimini, Eleonora; Tumino, Nicola; Besi, Francesca; Martini, Federico] IRCCS, Lazzaro Spallanzani Natl Inst Infect Dis, Cellular Immunol Lab, Rome, Italy	IRCCS Lazzaro Spallanzani	Casetti, R (corresponding author), IRCCS, Lazzaro Spallanzani Natl Inst Infect Dis, Cellular Immunol Lab, Rome, Italy.	rita.casetti@inmi.it	Tumino, Nicola/Y-4761-2019; Besi, Francesca/AAH-9352-2019; bordoni, veronica/K-8614-2016; Sacchi, Alessandra/K-7782-2016; Cimini, Eleonora/K-8878-2016; Casetti, Rita/K-8631-2016; Agrati, Chiara/K-8806-2016	Tumino, Nicola/0000-0003-3773-8829; Besi, Francesca/0000-0002-9401-300X; bordoni, veronica/0000-0002-1747-2245; Sacchi, Alessandra/0000-0003-4964-386X; Cimini, Eleonora/0000-0002-2659-0868; Casetti, Rita/0000-0002-7574-8780; Agrati, Chiara/0000-0002-5252-0927	Italian Ministry of Health "Ricerca Corrente" fund	Italian Ministry of Health "Ricerca Corrente" fund	Funding provided by Italian Ministry of Health "Ricerca Corrente" fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agerberth B, 2000, BLOOD, V96, P3086, DOI 10.1182/blood.V96.9.3086.h8003086_3086_3093; Agrati C, 2011, AIDS REV, V13, P3; AUTRAN B, 1989, CLIN EXP IMMUNOL, V75, P206; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; Bordon J, 2004, J INFECT DIS, V189, P1482, DOI 10.1086/382961; Casetti R, 2014, INT J IMMUNOPATH PH, V27, P291, DOI 10.1177/039463201402700218; Garcia VE, 1997, J IMMUNOL, V159, P1328; Gong GM, 2009, BLOOD, V113, P837, DOI 10.1182/blood-2008-06-162792; Hebbeler AM, 2008, CLIN IMMUNOL, V128, P349, DOI 10.1016/j.clim.2008.04.008; Kosub DA, 2008, J VIROL, V82, P1155, DOI 10.1128/JVI.01275-07; Li HS, 2008, CLIN INFECT DIS, V46, P1466, DOI 10.1086/587107; Lopez M, 2008, EUR J IMMUNOL, V38, P1548, DOI 10.1002/eji.200738054; Martini F, 2000, IMMUNOLOGY, V100, P481, DOI 10.1046/j.1365-2567.2000.00068.x; Migueles SA, 2009, J VIROL, V83, P11876, DOI 10.1128/JVI.01153-09; Poccia F, 1999, J INFECT DIS, V180, P858, DOI 10.1086/314925; Poccia F, 1996, J IMMUNOL, V157, P449; Poccia F, 2009, AIDS, V23, P555, DOI 10.1097/QAD.0b013e3283244619; Qin G, 2009, J INFECT DIS, V200, P858, DOI 10.1086/605413; Rehr M, 2008, J VIROL, V82, P3391, DOI 10.1128/JVI.02383-07; Restrepo C, 2013, J MED VIROL, V85, P200, DOI 10.1002/jmv.23447; Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015; Ryan-Payseur B, 2012, J IMMUNOL, V189, P1285, DOI 10.4049/jimmunol.1200641; Sciammas R, 1999, MICROBES INFECT, V1, P203, DOI 10.1016/S1286-4579(99)80035-5; Wallace M, 1997, MOL MED, V3, P60, DOI 10.1007/BF03401668	25	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132291	10.1371/journal.pone.0132291	http://dx.doi.org/10.1371/journal.pone.0132291			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161861	gold, Green Submitted, Green Published			2022-12-26	WOS:000358162300115
J	Nieuwenhuizen, RPJ; Nahidiazar, L; Manders, EMM; Jalink, K; Stallinga, S; Rieger, B				Nieuwenhuizen, Robert P. J.; Nahidiazar, Leila; Manders, Erik M. M.; Jalink, Kees; Stallinga, Sjoerd; Rieger, Bernd			Co-Orientation: Quantifying Simultaneous Co-Localization and Orientational Alignment of Filaments in Light Microscopy	PLOS ONE			English	Article							SINGLE-MOLECULE LOCALIZATION; FLUORESCENCE MICROSCOPY; RESOLUTION	Co-localization analysis is a widely used tool to seek evidence for functional interactions between molecules in different color channels in microscopic images. Here we extend the basic co-localization analysis by including the orientations of the structures on which the molecules reside. We refer to the combination of co-localization of molecules and orientational alignment of the structures on which they reside as co-orientation. Because the orientation varies with the length scale at which it is evaluated, we consider this scale as a separate informative dimension in the analysis. Additionally we introduce a data driven method for testing the statistical significance of the co-orientation and provide a method for visualizing the local co-orientation strength in images. We demonstrate our methods on simulated localization microscopy data of filamentous structures, as well as experimental images of similar structures acquired with localization microscopy in different color channels. We also show that in cultured primary HUVEC endothelial cells, filaments of the intermediate filament vimentin run close to and parallel with microtubuli. In contrast, no coorientation was found between keratin and actin filaments. Co-orientation between vimentin and tubulin was also observed in an endothelial cell line, albeit to a lesser extent, but not in 3T3 fibroblasts. These data therefore suggest that microtubuli functionally interact with the vimentin network in a cell-type specific manner.	[Nieuwenhuizen, Robert P. J.; Stallinga, Sjoerd; Rieger, Bernd] Delft Univ Technol, Dept Imaging Phys, Quantitat Imaging Grp, Delft, Netherlands; [Nahidiazar, Leila; Jalink, Kees] Netherlands Canc Inst, Dept Cell Biol, Cell Biophys Grp, Amsterdam, Netherlands; [Manders, Erik M. M.] Univ Amsterdam, Van Leeuwenhoek Ctr Adv Microscopy Mol Cytol, Swammerdam Inst Life Sci, Amsterdam, Netherlands	Delft University of Technology; Netherlands Cancer Institute; University of Amsterdam	Jalink, K (corresponding author), Netherlands Canc Inst, Dept Cell Biol, Cell Biophys Grp, Amsterdam, Netherlands.	k.jalink@nki.nl; s.stallinga@tudelft.nl; b.rieger@tudelft.nl		Jalink, Kees/0000-0001-7019-3440; Nieuwenhuizen, Robert/0000-0003-0243-1173	Dutch Technology Foundation STW; Netherlands Organisation for Scientific Research (NWO); Ministry of Economic Affairs, Agriculture and Innovation	Dutch Technology Foundation STW(Technologiestichting STW); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Ministry of Economic Affairs, Agriculture and Innovation	R.P.J.N. and L.N. are supported by the Dutch Technology Foundation STW (http://www.stw.nl/), which is part of the Netherlands Organisation for Scientific Research (NWO) and which is partly funded by the Ministry of Economic Affairs, Agriculture and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B, 2013, ESSENTIAL CELL BIOL; Bates M, 2007, SCIENCE, V317, P1749, DOI 10.1126/science.1146598; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Faas FGA, 2003, LECT NOTES COMPUT SC, V2749, P36; Folling J, 2008, NAT METHODS, V5, P943, DOI 10.1038/nmeth.1257; FONTIJN R, 1995, EXP CELL RES, V216, P199, DOI 10.1006/excr.1995.1025; GOLDMAN AE, 1992, J CELL BIOL, V119, P725, DOI 10.1083/jcb.119.4.725; Heilemann M, 2008, ANGEW CHEM INT EDIT, V47, P6172, DOI 10.1002/anie.200802376; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Hookway C, 2015, MOL BIOL CELL, V26, P1675, DOI 10.1091/mbc.E14-09-1398; Huang F, 2011, BIOMED OPT EXPRESS, V2, P1377, DOI 10.1364/BOE.2.001377; Ketema M, 2015, MOL BIOL CELL, V26, P2402, DOI 10.1091/mbc.E15-01-0043; Klar TA, 2000, P NATL ACAD SCI USA, V97, P8206, DOI 10.1073/pnas.97.15.8206; KRATKY O, 1949, RECL TRAV CHIM PAY B, V68, P1106; Lachmanovich E, 2003, J MICROSC-OXFORD, V212, P122, DOI 10.1046/j.1365-2818.2003.01239.x; Lagache T, 2013, I S BIOMED IMAGING, P896; Malkusch S, 2012, HISTOCHEM CELL BIOL, V137, P1, DOI 10.1007/s00418-011-0880-5; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; MANDERS EMM, 1992, J CELL SCI, V103, P857; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Mlodzianoski MJ, 2011, OPT EXPRESS, V19, P15009, DOI 10.1364/OE.19.015009; Nieuwenhuizen RPJ, 2015, CELL MEMBRANE NANODOMAINS: FROM BIOCHEMISTRY TO NANOSCOPY, P409; Nieuwenhuizen RPJ, 2013, NAT METHODS, V10, P557, DOI [10.1038/nmeth.2448, 10.1038/NMETH.2448]; Rieger B, 2014, CHEMPHYSCHEM, V15, P664, DOI 10.1002/cphc.201300711; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Sakamoto Y, 2013, J CELL BIOL, V200, P249, DOI 10.1083/jcb.201206010; Sengupta P, 2011, NAT METHODS, V8, P969, DOI [10.1038/nmeth.1704, 10.1038/NMETH.1704]; Shivanandan A, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-349; SIBSON R, 1979, J ROY STAT SOC B MET, V41, P217; Smith CS, 2010, NAT METHODS, V7, P373, DOI [10.1038/NMETH.1449, 10.1038/nmeth.1449]; Stallinga S., 2012, IEEE INT SYMP BIOMED, P988; Stallinga S, 2010, OPT EXPRESS, V18, P24461, DOI 10.1364/OE.18.024461; van Ginkel M., 2002, THESIS DELFT U TECHN; vanSteensel B, 1996, J CELL SCI, V109, P787; WALTERS D, 1987, COMPUT VISION GRAPH, V37, P261, DOI 10.1016/S0734-189X(87)80005-1	35	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131756	10.1371/journal.pone.0131756	http://dx.doi.org/10.1371/journal.pone.0131756			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161965	Green Published, Green Submitted, gold			2022-12-26	WOS:000358162300056
J	Puttachary, S; Sharma, S; Tse, K; Beamer, E; Sexton, A; Crutison, J; Thippeswamy, T				Puttachary, Sreekanth; Sharma, Shaunik; Tse, Karen; Beamer, Edward; Sexton, Abby; Crutison, Joseph; Thippeswamy, Thimmasettappa			Immediate Epileptogenesis after Kainate-Induced Status Epilepticus in C57BL/6J Mice: Evidence from Long Term Continuous Video-EEG Telemetry	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; UNILATERAL INTRAHIPPOCAMPAL INJECTION; SPONTANEOUS RECURRENT SEIZURES; KAINIC ACID; MOUSE MODEL; PILOCARPINE MODEL; ANIMAL-MODELS; HIPPOCAMPAL SCLEROSIS; RAT MODEL; NEURODEGENERATION	The C57BL/6J mouse as a model of seizure/epilepsy is challenging due to high mortality and huge variability in response to kainate. We have recently demonstrated that repeated administration of a low dose of kainate by intraperitoneal route can induce severe status epilepticus (SE) with 94% survival rate. In the present study, based on continuous video-EEG recording for 4-18 weeks from epidurally implanted electrodes on the cortex, we demonstrate that this method also induces immediate epileptogenesis (<1-5 days post-SE). This finding was based on identification of two types of spontaneous recurrent seizures; behavioral convulsive seizures (CS) and electrographic nonconvulsive seizures (NCS). The identification of the spontaneous CS, stage 3-5 types, was based on the behaviors (video) that were associated with the EEG characteristics (stage 3-5 epileptiform spikes), the power spectrum, and the activity counts. The electrographic NCS identification was based on the stage 1-2 epileptiform spike clusters on the EEG and their associated power spectrum. Severe SE induced immediate epileptogenesis in all the mice. The maximum numbers of spontaneous CS were observed during the first 4-6 weeks of the SE and they decreased thereafter. Mild SE also induced immediate epileptogenesis in some mice but the CS were less frequent. In both the severe and the mild SE groups, the spontaneous electrographic NCS persisted throughout the 18 weeks observation period, and therefore this could serve as a chronic model for complex seizures. However, unlike rat kainate models, the C57BL/6J mouse kainate model is a unique regressive CS model of epilepsy. Further studies are required to understand the mechanism of recovery from spontaneous CS in this model, which could reveal novel therapeutic targets for epilepsy.	[Puttachary, Sreekanth; Sharma, Shaunik; Sexton, Abby; Crutison, Joseph; Thippeswamy, Thimmasettappa] Iowa State Univ, Coll Vet Med, Dept Biomed Sci, Ames, IA 50011 USA; [Tse, Karen; Beamer, Edward] Univ Liverpool, Inst Aging & Chron Dis, Liverpool L69 3GA, Merseyside, England	Iowa State University; University of Liverpool	Thippeswamy, T (corresponding author), Iowa State Univ, Coll Vet Med, Dept Biomed Sci, Ames, IA 50011 USA.	tswamy@iastate.edu	Puttachary, Sreekanth/S-3639-2019; Sharma, Shaunik/AAT-4234-2021	Puttachary, Sreekanth/0000-0002-4071-7896; Sharma, Shaunik/0000-0002-3352-6397; Beamer, Edward/0000-0003-1947-7346	Iowa State University (ISU); Seed Grant from the College of Veterinary Medicine, ISU, USA [290-05-02-00-0075, 701-05-07-15-0100, 701-05-07-00-0075]; BBSRC, UK; University of Liverpool, UK; Undergraduate Research Assistantship from ISU; TT's startup funds	Iowa State University (ISU); Seed Grant from the College of Veterinary Medicine, ISU, USA; BBSRC, UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of Liverpool, UK; Undergraduate Research Assistantship from ISU; TT's startup funds	SP and SS are supported by the start-up funds provided to TT by the Iowa State University (ISU) and the Seed Grant from the College of Veterinary Medicine, ISU, USA. (Grant numbers-290-05-02-00-0075, 701-05-07-15-0100, and 701-05-07-00-0075) http://vetmed.iastate.edu/). KT and EB (PhD students) were supervised by TT during his employment at the University of Liverpool. Funding support for KT and EB was from the BBSRC, UK and the University of Liverpool, UK. AS and JC were supported by the Undergraduate Research Assistantship from ISU and part-funded by TT's startup funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Arabadzisz D, 2005, EXP NEUROL, V194, P76, DOI 10.1016/j.expneurol.2005.01.029; Arcieri S, 2014, EPILEPSIA, V55, P1978, DOI 10.1111/epi.12850; Bankstahl M, 2012, BEHAV BRAIN RES, V230, P182, DOI 10.1016/j.bbr.2012.02.004; Barth D, 2014, AM EP SO ANN M SEATT; Bastlund JF, 2004, J NEUROSCI METH, V138, P65, DOI 10.1016/j.jneumeth.2004.03.004; Beamer E, 2012, EUR J NEUROSCI, V36, P3194, DOI 10.1111/j.1460-9568.2012.08234.x; Ben-Ari Y, 2000, TRENDS NEUROSCI, V23, P580, DOI 10.1016/S0166-2236(00)01659-3; Ben-Ari Y, 2012, KAINATE TEMPORAL LOB; Benkovic SA, 2006, BRAIN RES, V1070, P215, DOI 10.1016/j.brainres.2005.11.065; Benkovic SA, 2004, BRAIN RES, V1024, P59, DOI 10.1016/j.brainres.2004.07.021; Biagini G, 2006, EXP NEUROL, V201, P519, DOI 10.1016/j.expneurol.2006.04.029; Bortel A, 2010, NEUROBIOL DIS, V40, P478, DOI 10.1016/j.nbd.2010.07.015; Bouilleret V, 1999, NEUROSCIENCE, V89, P717, DOI 10.1016/S0306-4522(98)00401-1; Buckmaster PS, 2004, COMPARATIVE MED, V54, P473; Bumanglag AV, 2008, J COMP NEUROL, V510, P561, DOI 10.1002/cne.21801; Carriero G, 2012, EPILEPSIA, V53, P1917, DOI 10.1111/j.1528-1167.2012.03669.x; Chen ZG, 2002, BRAIN RES, V931, P135, DOI 10.1016/S0006-8993(02)02268-0; Csernansky JG, 1998, BIOL PSYCHIAT, V44, P1143, DOI 10.1016/S0006-3223(98)00019-5; Curia G, 2008, J NEUROSCI METH, V172, P143, DOI 10.1016/j.jneumeth.2008.04.019; D'Ambrosio R, 2009, BRAIN, V132, P2805, DOI 10.1093/brain/awp217; Dudek FE, 2011, NEUROSCI LETT, V497, P240, DOI 10.1016/j.neulet.2011.03.071; Fuquay JM, 2012, TOXICOLOGY, V294, P36, DOI 10.1016/j.tox.2012.01.012; Galanopoulou AS, 2013, EPILEPSIA, V54, P13, DOI 10.1111/epi.12295; Goffin K, 2007, EXP NEUROL, V205, P501, DOI 10.1016/j.expneurol.2007.03.008; Heinrich C, 2011, NEUROBIOL DIS, V42, P35, DOI 10.1016/j.nbd.2011.01.001; Hellier JL, 1998, EPILEPSY RES, V31, P73, DOI 10.1016/S0920-1211(98)00017-5; Hirshler Y, 2010, EXP NEUROL, V222, P42, DOI 10.1016/j.expneurol.2009.12.006; Huneau C, 2013, EPILEPSIA, V54, P2219, DOI 10.1111/epi.12406; Huneau C, 2010, IEEE ENG MED BIO, P6007, DOI 10.1109/IEMBS.2010.5627592; Jung S, 2007, J NEUROSCI, V27, P13012, DOI 10.1523/JNEUROSCI.3605-07.2007; Kadam SD, 2010, J NEUROSCI, V30, P404, DOI 10.1523/JNEUROSCI.4093-09.2010; KESSLER J, 1983, EXPERIENTIA, V39, P922, DOI 10.1007/BF01990440; Klitgaard H, 2002, EPILEPSY RES, V51, P93, DOI 10.1016/S0920-1211(02)00099-2; Knuesel I, 2002, EUR J NEUROSCI, V15, P1474, DOI 10.1046/j.1460-9568.2002.01980.x; Le Duigou C, 2008, J PHYSIOL-LONDON, V586, P4891, DOI 10.1113/jphysiol.2008.156281; Levesque M, 2013, NEUROSCI BIOBEHAV R, V37, P2887, DOI 10.1016/j.neubiorev.2013.10.011; Lowenstein DH, 1999, EPILEPSIA, V40, P120, DOI 10.1111/j.1528-1157.1999.tb02000.x; Mazzuferi M, 2012, EXP NEUROL, V238, P156, DOI 10.1016/j.expneurol.2012.08.022; McCord MC, 2008, NEUROSCIENCE, V154, P1143, DOI 10.1016/j.neuroscience.2008.03.082; McKhann GM, 2003, NEUROSCIENCE, V122, P551, DOI 10.1016/S0306-4522(03)00562-1; McLin JP, 2006, EUR J NEUROSCI, V24, P3134, DOI 10.1111/j.1460-9568.2006.05198.x; McLin JP, 2006, EUR J NEUROSCI, V24, P2191, DOI 10.1111/j.1460-9568.2006.05111.x; Melo T, 2010, J NEUROCHEM, V115, P1445, DOI 10.1111/j.1471-4159.2010.07048.x; Michalak Z, 2013, EPILEPSY RES, V103, P167, DOI 10.1016/j.eplepsyres.2012.10.006; Minicucci F, 2006, EPILEPSIA, V47, P9, DOI 10.1111/j.1528-1167.2006.00870.x; Morimoto K, 2004, PROG NEUROBIOL, V73, P1, DOI 10.1016/j.pneurobio.2004.03.009; Mouri G, 2008, BRAIN RES, V1213, P140, DOI 10.1016/j.brainres.2008.03.061; Pan JC, 1996, NEUROSCI LETT, V209, P121, DOI 10.1016/0304-3940(96)12615-X; Pearce PS, 2014, EPILEPSY BEHAV, V32, P121, DOI 10.1016/j.yebeh.2014.01.004; Pernot F, 2011, EPILEPSIA, V52, P2315, DOI 10.1111/j.1528-1167.2011.03273.x; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Raedt R, 2009, ACTA NEUROL SCAND, V119, P293, DOI 10.1111/j.1600-0404.2008.01108.x; Rao MS, 2006, J NEUROSCI RES, V83, P1088, DOI 10.1002/jnr.20802; Raol YH, 2012, PROG MOL BIOL TRANSL, V105, P57, DOI 10.1016/B978-0-12-394596-9.00003-2; Raol YH, 2006, J NEUROSCI, V26, P11342, DOI 10.1523/JNEUROSCI.3329-06.2006; Rattka M, 2013, EPILEPSY RES, V103, P135, DOI 10.1016/j.eplepsyres.2012.09.015; Reddy DS, 2013, INT J MOL SCI, V14, P18284, DOI 10.3390/ijms140918284; Riban V, 2002, NEUROSCIENCE, V112, P101, DOI 10.1016/S0306-4522(02)00064-7; Scharfman HE, 2007, CURR NEUROL NEUROSCI, V7, P348, DOI 10.1007/s11910-007-0053-z; Schauwecker PE, 2011, GENES BRAIN BEHAV, V10, P100, DOI 10.1111/j.1601-183X.2010.00644.x; Schauwecker PE, 2011, EPILEPSY RES, V97, P1, DOI 10.1016/j.eplepsyres.2011.09.005; Schauwecker PE, 2003, EPILEPSY RES, V55, P201, DOI 10.1016/S0920-1211(03)00115-3; Schauwecker PE, 2002, EXP NEUROL, V178, P219, DOI 10.1006/exnr.2002.8038; Sloviter RS, 2008, EPILEPSIA, V49, P85, DOI 10.1111/j.1528-1167.2008.01931.x; Tan HO, 2007, P NATL ACAD SCI USA, V104, P17536, DOI 10.1073/pnas.0708440104; Tang XD, 2007, SLEEP, V30, P1057, DOI 10.1093/sleep/30.8.1057; Tse K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096622; TURSKI WA, 1984, BRAIN RES, V321, P237, DOI 10.1016/0006-8993(84)90177-X; White A, 2010, EPILEPSIA, V51, P371, DOI 10.1111/j.1528-1167.2009.02339.x; Williams PA, 2007, EPILEPSIA, V48, P157, DOI 10.1111/j.1528-1167.2007.01304.x; Williams PA, 2009, J NEUROSCI, V29, P2103, DOI 10.1523/JNEUROSCI.0980-08.2009; Yang J, 2005, NEUROSCIENCE, V131, P853, DOI 10.1016/j.neuroscience.2004.09.064; Zheng XY, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/457079	73	43	43	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131705	10.1371/journal.pone.0131705	http://dx.doi.org/10.1371/journal.pone.0131705			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161754	Green Published, Green Submitted, gold			2022-12-26	WOS:000358162300054
J	Siegert, S; Wolf, A; Cooper, DN; Krawczak, M; Nothnagel, M				Siegert, Sabine; Wolf, Andreas; Cooper, David N.; Krawczak, Michael; Nothnagel, Michael			Mutations Causing Complex Disease May under Certain Circumstances Be Protective in an Epidemiological Sense	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; MISSING HERITABILITY; MACULAR DEGENERATION; SUSCEPTIBILITY LOCI; COMMON DISEASES; RARE VARIANTS; BREAST-CANCER; STRATEGIES; AFRICAN; TRAITS	Guided by the practice of classical epidemiology, research into the genetic basis of complex disease has usually taken for granted the dictum that causative mutations are invariably over-represented among clinically affected as compared to unaffected individuals. However, we show that this supposition is not true and that a mutation contributing to the etiology of a complex disease can, under certain circumstances, be depleted among patients. Populations with defined disease prevalence were repeatedly simulated under a Wright-Fisher model, assuming various types of population history and genotype-phenotype relationship. For each simulation, the resulting mutation-specific population frequencies and odds ratios (ORs) were evaluated. In addition, the relationship between mutation frequency and OR was studied using real data from the NIH GWAS catalogue of reported phenotype associations of single-nucleotide polymorphisms (SNPs). While rare diseases (prevalence <1%) were found to be consistently caused by rare mutations with ORs>1, up to 20% of mutations causing a pandemic disease (prevalence 10-20%) had ORs<1, and their population frequency ranged from 0% to 100%. Moreover, simulation-based ORs exhibited a wide distribution, irrespective of mutation frequency. In conclusion, a substantial proportion of mutations causing common complex diseases may appear 'protective' in genetic epidemiological studies and hence would normally tend to be excluded, albeit erroneously, from further study. This apparently paradoxical result is explicable in terms of mutual confounding of the respective genotype-phenotype relationships due to a negative correlation between causal mutations induced by their common gene genealogy. As would be predicted by our findings, a significant negative correlation became apparent in published genome-wide association studies between the OR of genetic variants associated with a particular disease and the prevalence of that disease.	[Siegert, Sabine; Nothnagel, Michael] Univ Cologne, Cologne Ctr Genom, D-50931 Cologne, Germany; [Siegert, Sabine] Univ Kiel, Inst Epidemiol, Kiel, Germany; [Wolf, Andreas; Krawczak, Michael; Nothnagel, Michael] Univ Kiel, Inst Med Informat & Stat, Kiel, Germany; [Cooper, David N.] Cardiff Univ, Sch Med, Inst Med Genet, Cardiff CF10 3AX, S Glam, Wales	University of Cologne; University of Kiel; University of Kiel; Cardiff University	Nothnagel, M (corresponding author), Univ Cologne, Cologne Ctr Genom, D-50931 Cologne, Germany.	michael.nothnagel@uni-koeln.de	Nothnagel, Michael/L-7187-2019; Krawczak, Michael/A-8964-2010; Wolf, Andreas/M-2518-2016; Cooper, David N/H-4384-2011; Nothnagel, Michael/G-6545-2014	Nothnagel, Michael/0000-0001-8305-7114; Krawczak, Michael/0000-0003-2603-1502; Cooper, David N/0000-0002-8943-8484; 	National Genome Research Network (NGFNplus) [01GS0809]; DFG Excellence Cluster 'Inflammation at Interfaces' (EXC) [306, 306/2]	National Genome Research Network (NGFNplus); DFG Excellence Cluster 'Inflammation at Interfaces' (EXC)	This study was supported by the National Genome Research Network (NGFNplus 01GS0809) and the DFG Excellence Cluster 'Inflammation at Interfaces' (EXC 306 and 306/2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adcock IM, 2011, AM J RESP CRIT CARE, V184, P633, DOI 10.1164/rccm.201103-0446ED; Anderson CA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000580; Basu S, 2011, GENET EPIDEMIOL, V35, P606, DOI 10.1002/gepi.20609; Bhatia G, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000954; Brookfield JFY, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-41; Clarke AJ, 2010, EUR J HUM GENET, V18, P859, DOI 10.1038/ejhg.2010.35; Cooper DN, 2013, HUM GENET, V132, P1077, DOI 10.1007/s00439-013-1331-2; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Diez O, 2010, FAM CANCER, V9, P187, DOI 10.1007/s10689-009-9301-5; Durrett R, 2008, PROBAB APPL SER, P1, DOI 10.1007/978-0-387-78168-6_1; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Evangelou E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000196; Falconer D. S., 1996, INTRO QUANTITATIVE G; Ferla R, 2007, ANN ONCOL, V18, P93, DOI 10.1093/annonc/mdm234; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Hein J., 2005, GENE GENEALOGIES VAR; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; HUDSON R, 1990, GENE GENEALOGIES COA; Huo DZ, 2012, CARCINOGENESIS, V33, P835, DOI 10.1093/carcin/bgs093; Hutter CM, 2011, CANCER EPIDEM BIOMAR, V20, P1950, DOI 10.1158/1055-9965.EPI-11-0524; Johnson AD, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-6; Kathiresan S, 2012, CELL, V148, P1242, DOI 10.1016/j.cell.2012.03.001; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kupfer SS, 2010, GASTROENTEROLOGY, V139, P1677, DOI 10.1053/j.gastro.2010.07.038; Lewis Cathryn M, 2012, Cold Spring Harb Protoc, V2012, P297, DOI 10.1101/pdb.top068163; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Lin PI, 2007, AM J HUM GENET, V80, P531, DOI 10.1086/512133; Liu DJJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001156; LYNCH M, 1995, AM NAT, V146, P489, DOI 10.1086/285812; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Morgenthaler S, 2007, MUTAT RES-FUND MOL M, V615, P28, DOI 10.1016/j.mrfmmm.2006.09.003; Morris AP, 2010, GENET EPIDEMIOL, V34, P188, DOI 10.1002/gepi.20450; Neale BM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001322; Nordborg M., 2007, HDB STAT GENETICS, P843; Platt A, 2010, GENETICS, V186, P1045, DOI 10.1534/genetics.110.121665; Price AL, 2010, AM J HUM GENET, V86, P832, DOI 10.1016/j.ajhg.2010.04.005; R Development Core Team, 2012, R LANG ENV STAT COMP; RISCH N, 1990, AM J HUM GENET, V46, P222; Rosenberg NA, 2002, NAT REV GENET, V3, P380, DOI 10.1038/nrg795; Rothman K., 1998, MODERN EPIDEMIOLOGY; Simons YB, 2014, NAT GENET, V46, P220, DOI 10.1038/ng.2896; Thornton KR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003258; Tremblay J, 2013, METABOLISM, V62, pS2, DOI 10.1016/j.metabol.2012.08.023; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Weir BS, 2005, GENOME RES, V15, P1468, DOI 10.1101/gr.4398405; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	49	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132150	10.1371/journal.pone.0132150	http://dx.doi.org/10.1371/journal.pone.0132150			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161957	gold, Green Accepted, Green Submitted, Green Published			2022-12-26	WOS:000358162300098
J	Thibodeau, A; Fravalo, P; Yergeau, E; Arsenault, J; Lahaye, L; Letellier, A				Thibodeau, Alexandre; Fravalo, Philippe; Yergeau, Etienne; Arsenault, Julie; Lahaye, Ludovic; Letellier, Ann			Chicken Caecal Microbiome Modifications Induced by Campylobacter jejuni Colonization and by a Non-Antibiotic Feed Additive	PLOS ONE			English	Article							BROILER-CHICKENS; CLOSTRIDIUM-PERFRINGENS; QUANTITATIVE PCR; GUT MICROBIOTA; ESSENTIAL OILS; POULTRY; PERFORMANCE; MICROFLORA; BACTERIA; QUANTIFICATION	Campylobacter jejuni is an important zoonotic foodborne pathogen causing acute gastroenteritis in humans. Chickens are often colonized at very high numbers by C. jejuni, up to 10(9) CFU per gram of caecal content, with no detrimental effects on their health. Farm control strategies are being developed to lower the C. jejuni contamination of chicken food products in an effort to reduce human campylobacteriosis incidence. It is believed that intestinal microbiome composition may affect gut colonization by such undesirable bacteria but, although the chicken microbiome is being increasingly characterized, information is lacking on the factors affecting its modulation, especially by foodborne pathogens. This study monitored the effects of C. jejuni chicken caecal colonization on the chicken microbiome in healthy chickens. It also evaluated the capacity of a feed additive to affect caecal bacterial populations and to lower C. jejuni colonization. From day-0, chickens received or not a microencapsulated feed additive and were inoculated or not with C. jejuni at 14 days of age. Fresh caecal content was harvested at 35 days of age. The caecal microbiome was characterized by real time quantitative PCR and Ion Torrent sequencing. We observed that the feed additive lowered C. jejuni caecal count by 0.7 log (p<0.05). Alpha-diversity of the caecal microbiome was not affected by C. jejuni colonization or by the feed additive. C. jejuni colonization modified the caecal beta-diversity while the feed additive did not. We observed that C. jejuni colonization was associated with an increase of Bifidobacterium and affected Clostridia and Mollicutes relative abundances. The feed additive was associated with a lower Streptococcus relative abundance. The caecal microbiome remained relatively unchanged despite high C. jejuni colonization. The feed additive was efficient in lowering C. jejuni colonization while not disturbing the caecal microbiome.	[Thibodeau, Alexandre; Fravalo, Philippe; Letellier, Ann] Univ Montreal, Fac Med Vet, NSERC Ind Res Chair Meat Safety CRSV, St Hyacinthe, PQ J2S 7C6, Canada; [Thibodeau, Alexandre; Fravalo, Philippe; Arsenault, Julie; Letellier, Ann] Univ Montreal, Fac Med Vet, Swine & Avian Infect Dis Res Ctr CRIPA, St Hyacinthe, PQ J2S 7C6, Canada; [Thibodeau, Alexandre; Fravalo, Philippe; Arsenault, Julie; Letellier, Ann] Univ Montreal, Fac Med Vet, GRESA, St Hyacinthe, PQ J2S 7C6, Canada; [Yergeau, Etienne] Natl Res Council Canada, Montreal, PQ, Canada; [Lahaye, Ludovic] Jefo Nutr Inc, St Hyacinthe, PQ, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; National Research Council Canada	Thibodeau, A (corresponding author), Univ Montreal, Fac Med Vet, NSERC Ind Res Chair Meat Safety CRSV, St Hyacinthe, PQ J2S 7C6, Canada.	alexandre.thibodeau@live.ca; ann.letellier@umontreal.ca	Arsenault, Julie/D-5077-2015; Yergeau, Etienne/B-5344-2008; Yergeau, Etienne/AAZ-6145-2020	Arsenault, Julie/0000-0001-8382-7326; Yergeau, Etienne/0000-0002-7112-3425	Ministere de l'Agriculture et des Peches du Quebec (MAPAQ); Centre de Recherche en Infectiologie Porcine et Aviaire (CRIPA); Natural Sciences and Engineering Research Council of Canada (NSERC) [130565330]	Ministere de l'Agriculture et des Peches du Quebec (MAPAQ); Centre de Recherche en Infectiologie Porcine et Aviaire (CRIPA); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	The authors received funding from: Ministere de l'Agriculture et des Peches du Quebec (MAPAQ), the Centre de Recherche en Infectiologie Porcine et Aviaire (CRIPA), Natural Sciences and Engineering Research Council of Canada (NSERC grant no: 130565330); for the NSERC Industrial Research Chair in Meat Safety and Jefo Nutrition Inc.	Boroojeni FG, 2014, POULTRY SCI, V93, P1440, DOI 10.3382/ps.2013-03763; Castillo M, 2006, VET MICROBIOL, V114, P165, DOI 10.1016/j.vetmic.2005.11.055; Cean A, 2015, FOODBORNE PATHOG DIS, V12, P122, DOI 10.1089/fpd.2014.1849; Clifford RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048558; Cross DE, 2007, BRIT POULTRY SCI, V48, P496, DOI 10.1080/00071660701463221; Ding W, 2005, J FOOD PROTECT, V68, P2295, DOI 10.4315/0362-028X-68.11.2295; Duncan SH, 2004, BRIT J NUTR, V91, P915, DOI 10.1079/BJN20041150; Duncan SH, 2002, INT J SYST EVOL MICR, V52, P2141, DOI [10.1099/ijs.0.02241-0, 10.1099/00207713-52-6-2141]; Giannenas I, 2012, VET PARASITOL, V188, P31, DOI 10.1016/j.vetpar.2012.02.017; Gras LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042599; Grilli E, 2013, J APPL MICROBIOL, V114, P308, DOI 10.1111/jam.12053; Hansen AK, 2014, WORLD J GASTROENTERO, V20, P17727, DOI 10.3748/wjg.v20.i47.17727; Hermans D, 2012, VECTOR-BORNE ZOONOT, V12, P89, DOI 10.1089/vbz.2011.0676; Hermans D, 2012, CRIT REV MICROBIOL, V38, P17, DOI 10.3109/1040841X.2011.615298; Hermans D, 2011, J FOOD PROTECT, V74, P1729, DOI 10.4315/0362-028X.JFP-10-487; Hermans D, 2011, VET MICROBIOL, V152, P219, DOI 10.1016/j.vetmic.2011.03.010; Hermans D, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-82; Humphrey S, 2014, MBIO, V5, DOI 10.1128/mBio.01364-14; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; HUTCHINSON DN, 1984, J CLIN PATHOL, V37, P956, DOI 10.1136/jcp.37.8.956-b; Johansen CH, 2006, POULTRY SCI, V85, P579, DOI 10.1093/ps/85.4.579; Juteau P, 2004, APPL MICROBIOL BIOT, V66, P115, DOI 10.1007/s00253-004-1692-5; Kaakoush NO, 2014, GUT PATHOG, V6, DOI 10.1186/1757-4749-6-18; Laisney MJ, 2004, BRIT POULTRY SCI, V45, P49, DOI 10.1080/00071660410001668851; Line JE, 2010, J MICROBIOL METH, V80, P198, DOI 10.1016/j.mimet.2009.12.011; Luber P, 2006, APPL ENVIRON MICROB, V72, P66, DOI 10.1128/AEM.72.1.66-70.2006; Matsuki T, 2004, APPL ENVIRON MICROB, V70, P167, DOI 10.1128/AEM.70.1.167-173.2004; MESSIER S, 1993, AVIAN DIS, V37, P839, DOI 10.2307/1592039; Molatova Z, 2011, J ANIM PHYSIOL AN N, V95, P701, DOI 10.1111/j.1439-0396.2010.01100.x; Mookiah S, 2014, J SCI FOOD AGR, V94, P341, DOI 10.1002/jsfa.6365; Morotomi M, 2012, INT J SYST EVOL MICR, V62, P144, DOI 10.1099/ijs.0.026989-0; Newell DG, 2011, APPL ENVIRON MICROB, V77, P8605, DOI 10.1128/AEM.01090-10; Oakley BB, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0282-8; Oakley BB, 2014, FEMS MICROBIOL LETT, V360, P100, DOI 10.1111/1574-6968.12608; Oh MH, 2009, J FOOD PROTECT, V72, P1262, DOI 10.4315/0362-028X-72.6.1262; Qu A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002945; Rosenquist H, 2003, INT J FOOD MICROBIOL, V83, P87, DOI 10.1016/S0168-1605(02)00317-3; Rothberg JM, 2011, NATURE, V475, P348, DOI 10.1038/nature10242; Sanschagrin S, 2014, JOVE-J VIS EXP, DOI 10.3791/51709; Santini C, 2010, INT J FOOD MICROBIOL, V141, pS98, DOI 10.1016/j.ijfoodmicro.2010.03.039; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sergeant MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091941; Singh P, 2013, POULTRY SCI, V92, P272, DOI 10.3382/ps.2012-02603; Skanseng B, 2006, MOL CELL PROBE, V20, P269, DOI 10.1016/j.mcp.2006.02.001; Smith CK, 2008, FEMS IMMUNOL MED MIC, V54, P114, DOI 10.1111/j.1574-695X.2008.00458.x; Sofka D, 2015, BERL MUNCH TIERARZTL, V128, P104, DOI 10.2376/0005-9366-128-104; Stanley D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104739; Stanley D, 2012, VET MICROBIOL, V159, P155, DOI 10.1016/j.vetmic.2012.03.032; Sylvester FA, 1996, INFECT IMMUN, V64; Thibodeau A, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0433-5; Thibodeau A, 2013, FOODBORNE PATHOG DIS, V10, P382, DOI 10.1089/fpd.2012.1271; Thibodeau A, 2011, CAN J VET RES, V75, P298; Tiihonen K, 2010, BRIT POULTRY SCI, V51, P381, DOI 10.1080/00071668.2010.496446; Van Deun K, 2008, BRIT J NUTR, V100, P480, DOI 10.1017/S0007114508921693; Van Deun K, 2008, VET MICROBIOL, V130, P285, DOI 10.1016/j.vetmic.2007.11.027; Videnska P, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-140; Videnska P, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-30; Wei S, 2013, POULTRY SCI, V92, P671, DOI 10.3382/ps.2012-02822; Wrzosek L, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-61; Yergeau E, 2012, APPL ENVIRON MICROB, V78, P7626, DOI 10.1128/AEM.02036-12	60	82	83	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131978	10.1371/journal.pone.0131978	http://dx.doi.org/10.1371/journal.pone.0131978			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161743	Green Published, gold, Green Submitted			2022-12-26	WOS:000358162300078
J	Brewin, RJW; de Mora, L; Jackson, T; Brewin, TG; Shutler, J				Brewin, Robert J. W.; de Mora, Lee; Jackson, Thomas; Brewin, Thomas G.; Shutler, Jamie			On the Potential of Surfers to Monitor Environmental Indicators in the Coastal Zone	PLOS ONE			English	Article							CITIZEN-SCIENCE; OCEAN ACIDIFICATION; CLIMATE-CHANGE; TEMPERATURE; MARINE; WATERS; BLOOMS; ESTUARIES; IMPACTS; FRONTS	The social and economic benefits of the coastal zone make it one of the most treasured environments on our planet. Yet it is vulnerable to increasing anthropogenic pressure and climate change. Coastal management aims to mitigate these pressures while augmenting the socio-economic benefits the coastal region has to offer. However, coastal management is challenged by inadequate sampling of key environmental indicators, partly due to issues relating to cost of data collection. Here, we investigate the use of recreational surfers as platforms to improve sampling coverage of environmental indicators in the coastal zone. We equipped a recreational surfer, based in the south west United Kingdom (UK), with a temperature sensor and Global Positioning System (GPS) device that they used when surfing for a period of one year (85 surfing sessions). The temperature sensor was used to derive estimates of sea-surface temperature (SST), an important environmental indicator, and the GPS device used to provide sample location and to extract information on surfer performance. SST data acquired by the surfer were compared with data from an oceanographic station in the south west UK and with satellite observations. Our results demonstrate: (i) high-quality SST data can be acquired by surfers using low cost sensors; and (ii) GPS data can provide information on surfing performance that may help motivate data collection by surfers. Using recent estimates of the UK surfing population, and frequency of surfer participation, we speculate around 40 million measurements on environmental indicators per year could be acquired at the UK coastline by surfers. This quantity of data is likely to enhance coastal monitoring and aid UK coastal management. Considering surfing is a world-wide sport, our results have global implications and the approach could be expanded to other popular marine recreational activities for coastal monitoring of environmental indicators.	[Brewin, Robert J. W.; de Mora, Lee; Jackson, Thomas] Plymouth Marine Lab, Plymouth, Devon, England; [Brewin, Robert J. W.] Plymouth Marine Lab, Natl Ctr Earth Observat, Plymouth, Devon, England; [Brewin, Thomas G.] Chatham & Clarendon Grammar Sch, Ramsgate, Kent, England; [Shutler, Jamie] Univ Exeter, Coll Life & Environm Sci, Penryn, Cornwall, England	Plymouth Marine Laboratory; Plymouth Marine Laboratory; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC National Centre for Earth Observation; University of Exeter	Brewin, RJW (corresponding author), Plymouth Marine Lab, Plymouth, Devon, England.	robr@pml.ac.uk	/AAL-3738-2021; de Mora, Lee/AAP-5456-2020	de Mora, Lee/0000-0002-5080-3149; Jackson, Thomas/0000-0003-4336-1597; Brewin, Robert/0000-0001-5134-8291	Plymouth Marine Laboratory; UK National Centre for Earth Observation; Changing Earth Science Network initiative of the STSE program of the European Space Agency; Natural Environment Research Council [pml010008, pml010009, pml010010, nceo020006, pml010007] Funding Source: researchfish; NERC [pml010008, pml010009, pml010007, pml010010, nceo020006] Funding Source: UKRI	Plymouth Marine Laboratory(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); UK National Centre for Earth Observation; Changing Earth Science Network initiative of the STSE program of the European Space Agency; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The work was supported by a Research Project (RP) funded by Plymouth Marine Laboratory. The lead author is also supported by the UK National Centre for Earth Observation, and by the Changing Earth Science Network initiative of the STSE program of the European Space Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarninkhof SGJ, 2003, COAST ENG, V49, P275, DOI 10.1016/S0378-3839(03)00064-4; Anderson DM, 2002, ESTUARIES, V25, P704, DOI 10.1007/BF02804901; Bailey SW, 2006, REMOTE SENS ENVIRON, V102, P12, DOI 10.1016/j.rse.2006.01.015; Barbier EB, 2014, SCIENCE, V345, P1250, DOI 10.1126/science.1254629; Barlow MJ, 2014, J STRENGTH COND RES, V28, P2946, DOI 10.1519/JSC.0000000000000491; Beaton AD, 2011, SENSOR ACTUAT B-CHEM, V156, P1009, DOI 10.1016/j.snb.2011.02.042; Bibby R, 2008, AQUAT BIOL, V2, P67, DOI 10.3354/ab00037; Borja A, 2005, CONT SHELF RES, V25, P1768, DOI 10.1016/j.csr.2005.05.004; Brewin RJW, 2015, ANN TIME SERIES SEA; Brossard D, 2005, INT J SCI EDUC, V27, P1099, DOI 10.1080/09500690500069483; Butt Tony, 2004, SURF SCI INTRO WAVES; Chickadel CC, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2003JC001774; Cicin-Sain B., 1998, INTEGRATED COASTAL O; Cloern JE, 2001, MAR ECOL PROG SER, V210, P223, DOI 10.3354/meps210223; Cooper S, 2010, NATURE, V466, P756, DOI 10.1038/nature09304; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Costanza R, 2014, GLOBAL ENVIRON CHANG, V26, P152, DOI 10.1016/j.gloenvcha.2014.04.002; Dally WR, 2001, J COASTAL RES, V29, P33; Davidson M, 2007, COAST ENG, V54, P463, DOI 10.1016/j.coastaleng.2007.01.007; Davis CO, 2002, OPT EXPRESS, V10, P210, DOI 10.1364/OE.10.000210; Defeo O, 2009, ESTUAR COAST SHELF S, V81, P1, DOI 10.1016/j.ecss.2008.09.022; DEFRA. UK Department for Environment Food & Rural Affairs (DEFRA), 2007, CHART PROGR LEIS REC; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Dickinson JL, 2012, FRONT ECOL ENVIRON, V10, P291, DOI 10.1890/110236; EPPLEY RW, 1972, FISH B-NOAA, V70, P1063; Farley ORL, 2012, J STRENGTH COND RES, V26, P1887, DOI 10.1519/JSC.0b013e3182392c4b; Ferreira JG, 2007, ENVIRON MONIT ASSESS, V135, P195, DOI 10.1007/s10661-007-9643-0; Gill AB, 2005, J APPL ECOL, V42, P605, DOI 10.1111/j.1365-2664.2005.01060.x; GOREAU TJ, 1994, AMBIO, V23, P176; Graham E., 2011, EOS T AM GEOPHYS UN, V92, DOI [10.1029/2011EO380002, DOI 10.1029/2011EO380002, DOI 10.1029/2011E0380002]; Groom S, 2009, J MARINE SYST, V77, P278, DOI 10.1016/j.jmarsys.2007.12.015; Gura Trisha, 2013, Nature, V496, P259; Halberda J, 2012, P NATL ACAD SCI USA, V109, P11116, DOI 10.1073/pnas.1200196109; Handeland SO, 2008, AQUACULTURE, V283, P36, DOI 10.1016/j.aquaculture.2008.06.042; Harris R, 2010, J PLANKTON RES, V32, P577, DOI 10.1093/plankt/fbq021; Holman R.A., 1993, J OCEANOGAPHY, V6, P78, DOI [DOI 10.5670/0CEAN0G.1993.02, DOI 10.5670/OCEANOG.1993.02]; Hu CM, 2000, REMOTE SENS ENVIRON, V74, P195, DOI 10.1016/S0034-4257(00)00080-8; Hutt J., 2001, J COASTAL RES, P66; IOCCG, 2000, REPORTS INT OCEAN CO; Irish JL, 1998, COAST ENG, V35, P47, DOI 10.1016/S0378-3839(98)00022-2; Jeong SJ, 2013, GEOPHYS RES LETT, V40, P359, DOI [10.1029/2012GL054431, 10.1029/2012Gl054431]; Jickells TD, 1998, SCIENCE, V281, P217, DOI 10.1126/science.281.5374.217; Kappel CV, 2005, FRONT ECOL ENVIRON, V3, P275, DOI 10.2307/3868490; Keller AA, 1999, LIMNOL OCEANOGR, V44, P344, DOI 10.4319/lo.1999.44.2.0344; Lafleur JP, 2010, TALANTA, V81, P722, DOI 10.1016/j.talanta.2009.12.001; Land PE, 2013, BIOGEOSCIENCES, V10, P8109, DOI 10.5194/bg-10-8109-2013; Lapowsky, 2014, NEXT BIG THING YOU M; Lauro FM, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001947; LIPPMANN TC, 1989, J GEOPHYS RES-OCEANS, V94, P995, DOI 10.1029/JC094iC01p00995; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Mason P. J., 2010, C PART COP; McGranahan G, 2007, ENVIRON URBAN, V19, P17, DOI 10.1177/0956247807076960; Mendez-Villanueva A, 2006, J STRENGTH COND RES, V20, P477; Mills B., 2013, WHEAL KITT WORKSH ST; Monk K, 2013, COAST ENG, V73, P115, DOI 10.1016/j.coastaleng.2012.10.004; MORRIS AW, 1978, NATURE, V274, P678, DOI 10.1038/274678a0; NEWELL RE, 1979, AM SCI, V67, P405; Newman G, 2012, FRONT ECOL ENVIRON, V10, P298, DOI 10.1890/110294; Nobre AM, 2011, MAR ECOL PROG SER, V434, P279, DOI 10.3354/meps09250; Norse E.A., 1993, GLOBAL MARINE BIOL D; Nov O, 2011, P 2011 ICONFERENCE, P68, DOI [DOI 10.1145/1940761.1940771, 10.1145/1940761.1940771]; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Paerl HW, 2008, SCIENCE, V320, P57, DOI 10.1126/science.1155398; PEPIN P, 1991, CAN J FISH AQUAT SCI, V48, P503, DOI 10.1139/f91-065; PINGREE RD, 1975, NATURE, V258, P672, DOI 10.1038/258672a0; Platt T, 2008, REMOTE SENS ENVIRON, V112, P3426, DOI 10.1016/j.rse.2007.10.016; Roberts CM, 1999, TRENDS ECOL EVOL, V14, P241, DOI 10.1016/S0169-5347(98)01584-5; Roc T, 2013, RENEW ENERG, V51, P448, DOI 10.1016/j.renene.2012.09.039; Schwartz MD, 2012, FRONT ECOL ENVIRON, V10, P324, DOI 10.1890/110281; SIMPSON JH, 1981, PHILOS T R SOC A, V302, P531, DOI 10.1098/rsta.1981.0181; Small C, 2003, J COASTAL RES, V19, P584; Smyth TJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098709; Smyth TJ, 2010, J PLANKTON RES, V32, P585, DOI 10.1093/plankt/fbp128; Stewart KR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014451; Thomas A, 2002, REMOTE SENS ENVIRON, V81, P262, DOI 10.1016/S0034-4257(02)00004-4; Tittensor DP, 2010, NATURE, V466, P1098, DOI 10.1038/nature09329; Trumbull DJ, 2000, SCI EDUC, V84, P265, DOI 10.1002/(SICI)1098-237X(200003)84:2<265::AID-SCE7>3.0.CO;2-5; Wiggins Andrea, 2011, P HICSS, P1, DOI DOI 10.1109/HICSS.2011.207	78	28	28	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0127706	10.1371/journal.pone.0127706	http://dx.doi.org/10.1371/journal.pone.0127706			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154173	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000358159700006
J	Costa, B; Kendall, MS; Parrish, FA; Rooney, J; Boland, RC; Chow, M; Lecky, J; Montgomery, A; Spalding, H				Costa, Bryan; Kendall, Matthew S.; Parrish, Frank A.; Rooney, John; Boland, Raymond C.; Chow, Malia; Lecky, Joey; Montgomery, Anthony; Spalding, Heather			Identifying Suitable Locations for Mesophotic Hard Corals Offshore of Maui, Hawai'i	PLOS ONE			English	Article							SPECIES DISTRIBUTION; REEF ACCRETION; AUAU CHANNEL; HABITAT; DISTRIBUTIONS; PREDICTION; ECOLOGY; COMMUNITIES; PERFORMANCE; DIVERSITY	Mesophotic hard corals (MHC) are increasingly threatened by a growing number of anthropogenic stressors, including impacts from fishing, land-based sources of pollution, and ocean acidification. However, little is known about their geographic distributions (particularly around the Pacific islands) because it is logistically challenging and expensive to gather data in the 30 to 150 meter depth range where these organisms typically live. The goal of this study was to begin to fill this knowledge gap by modelling and predicting the spatial distribution of three genera of mesophotic hard corals offshore of Maui in the Main Hawaiian Islands. Maximum Entropy modeling software was used to create separate maps of predicted probability of occurrence and uncertainty for: (1) Leptoseris, (2) Montipora, and (3) Porites. Genera prevalence was derived from the in situ presence/absence data, and used to convert relative habitat suitability to probability of occurrence values. Approximately 1,300 georeferenced records of the occurrence of MHC, and 34 environmental predictors were used to train the model ensembles. Receiver Operating Characteristic (ROC) Area Under the Curve (AUC) values were between 0.89 and 0.97, indicating excellent overall model performance. Mean uncertainty and mean absolute error for the spatial predictions ranged from 0.006% to 0.05% and 3.73% to 17.6%, respectively. Depth, distance from shore, euphotic depth (mean and standard deviation) and sea surface temperature (mean and standard deviation) were identified as the six most influential predictor variables for partitioning habitats among the three genera. MHC were concentrated between Hanaka' o' o and Papawai Points offshore of western Maui most likely because this area hosts warmer, clearer and calmer water conditions almost year round. While these predictions helped to fill some knowledge gaps offshore of Maui, many information gaps remain in the Hawaiian Archipelago and Pacific Islands. This approach may be used to identify other potentially suitable areas for MHCs, helping scientists and resource managers prioritize sites, and focus their limited resources on areas that may be of higher scientific or conservation value.	[Costa, Bryan; Kendall, Matthew S.] NOAA, Natl Ctr Coastal Ocean Sci, Biogeog Branch, Silver Spring, MD 20910 USA; [Costa, Bryan] CSS Dynamac, Fairfax, VA USA; [Parrish, Frank A.; Rooney, John; Boland, Raymond C.] NOAA, Pacific Islands Fisheries Sci Ctr, Honolulu, HI USA; [Chow, Malia; Lecky, Joey] NOAA, Off Natl Marine Sanctuaries, Honolulu, HI USA; [Montgomery, Anthony] US Fish & Wildlife Serv, Pacific Islands Fish & Wildlife Off, Honolulu, HI USA; [Spalding, Heather] Univ Hawaii Manoa, Dept Bot, Honolulu, HI 96822 USA	National Oceanic Atmospheric Admin (NOAA) - USA; National Centers for Coastal Ocean Science (NOOCS); National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; United States Department of the Interior; US Fish & Wildlife Service; University of Hawaii System; University of Hawaii Manoa	Costa, B (corresponding author), NOAA, Natl Ctr Coastal Ocean Sci, Biogeog Branch, Silver Spring, MD 20910 USA.	bryan.costa@noaa.gov	Montgomery, Anthony/AAK-8138-2020; /AAL-3738-2021	Montgomery, Anthony/0000-0002-3430-3451; Lecky, Joey/0000-0001-9364-4793	National Oceanic and Atmospheric Administration's (NOAA) Office of National Marine Sanctuaries (ONMS) Hawaiian Islands Humpback Whale National Marine Sanctuary (HIHWNMS); NOAA's Office of Marine and Aviation Operations (OMAO); NOAA's National Centers for Coastal Ocean Science's Center for Sponsored Coastal Ocean Research (CSCOR) [NA07NOS4780188, NA07NOS4780187, NA07NOS478190, NA07NOS4780189]; NOAA Undersea Research Program's Hawai'i Undersea Research Laboratory [NA05OAR4301108]	National Oceanic and Atmospheric Administration's (NOAA) Office of National Marine Sanctuaries (ONMS) Hawaiian Islands Humpback Whale National Marine Sanctuary (HIHWNMS); NOAA's Office of Marine and Aviation Operations (OMAO); NOAA's National Centers for Coastal Ocean Science's Center for Sponsored Coastal Ocean Research (CSCOR); NOAA Undersea Research Program's Hawai'i Undersea Research Laboratory	Funding for this spatial modeling effort was provided by the National Oceanic and Atmospheric Administration's (NOAA) Office of National Marine Sanctuaries (ONMS) Hawaiian Islands Humpback Whale National Marine Sanctuary (HIHWNMS). This modeling effort was made possible because of research funded by the NOAA's Office of Marine and Aviation Operations (OMAO) and NOAA's National Centers for Coastal Ocean Science's Center for Sponsored Coastal Ocean Research (CSCOR) under award NA07NOS4780188 to the Bishop Museum, NA07NOS4780187 and NA07NOS478190 to the University of Hawai'i, NA07NOS4780189 to the State of Hawai'i's Division of Aquatic Resources and to the NOAA Pacific Islands Fisheries Science Center (PIFSC). Submersible support was provided by the NOAA Undersea Research Program's Hawai'i Undersea Research Laboratory under award NA05OAR4301108.	Aeby GS, 2011, PLOS ONE, V6, P1; Barry S, 2006, J APPL ECOL, V43, P413, DOI 10.1111/j.1365-2664.2006.01136.x; Beever EA, 2006, DIVERS DISTRIB, V12, P229, DOI 10.1111/j.1366-9516.2006.00260.x; Bruno JF, 2007, PLOS BIOL, V5, P1220, DOI 10.1371/journal.pbio.0050124; Carter G, 2012, TIDE MODEL OUTPUT MA; Carter GS, 2008, J PHYS OCEANOGR, V38, P2205, DOI 10.1175/2008JPO3860.1; Costa BM, 2012, 149 NOAA NOS NCCOS, P1; Dolan MFJ, 2008, DEEP-SEA RES PT I, V55, P1564, DOI 10.1016/j.dsr.2008.06.010; Dollar S.J., 1982, Coral Reefs, V1, P71, DOI 10.1007/BF00301688; DOLLAR SJ, 1993, CORAL REEFS, V12, P223, DOI 10.1007/BF00334481; DUSTAN P, 1975, MAR BIOL, V33, P101, DOI 10.1007/BF00390714; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Engels MS, 2004, J SEDIMENT RES, V74, P255, DOI 10.1306/073003740255; Falkowski P.G., 1990, P89; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Fletcher Charles H., 2008, V1, P435, DOI 10.1007/978-1-4020-6847-8_11; Franklin EC, 2013, MAR ECOL PROG SER, V481, P121, DOI 10.3354/meps10252; FRICKE HW, 1987, OECOLOGIA, V73, P371, DOI 10.1007/BF00385253; GRIGG RICHARD W., 1965, PACIFIC SCI, V19, P244; Grigg RW, 1998, CORAL REEFS, V17, P263, DOI 10.1007/s003380050127; Grigg RW, 2006, CORAL REEFS, V25, P77, DOI 10.1007/s00338-005-0073-6; GRIGG RW, 1983, MAR ECOL PROG SER, V11, P1, DOI 10.3354/meps011001; Guinan J, 2009, ECOL INFORM, V4, P83, DOI 10.1016/j.ecoinf.2009.01.004; Guinotte JM, 2006, FRONT ECOL ENVIRON, V4, P141, DOI 10.1890/1540-9295(2006)004[0141:WHCISC]2.0.CO;2; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Harvell D, 2007, OCEANOGRAPHY, V20, P172, DOI 10.5670/oceanog.2007.91; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hinderstein LM, 2010, CORAL REEFS, V29, P247, DOI 10.1007/s00338-010-0614-5; Howell KL, 2011, BIOL CONSERV, V144, P2656, DOI 10.1016/j.biocon.2011.07.025; Jenness JS, 2011, DEM SURFACE TOOLS AR; Jokiel P.L., 2006, P 10 INT COR REEF S, P390; JOKIEL PL, 1990, CORAL REEFS, V8, P155, DOI 10.1007/BF00265006; Kahng S., 2012, P 12 INT COR REEF S; Kahng SE, 2007, CORAL REEFS, V26, P679, DOI 10.1007/s00338-007-0253-7; Kahng SE, 2014, CURR OPIN ENV SUST, V7, P72, DOI 10.1016/j.cosust.2013.11.019; Kahng SE, 2010, CORAL REEFS, V29, P255, DOI 10.1007/s00338-010-0593-6; Kahng SE, 2006, CORAL REEFS, V25, P254, DOI 10.1007/s00338-006-0098-5; Kahng SE, 2005, CORAL REEFS, V24, P556, DOI 10.1007/s00338-005-0026-0; Kleypas JA, 1999, AM ZOOL, V39, P146; KUHLMANN DHH, 1983, HELGOLANDER MEERESUN, V36, P183; Leathwick JR, 2001, FUNCT ECOL, V15, P233, DOI 10.1046/j.1365-2435.2001.00504.x; Leclercq N, 2000, GLOB CHANGE BIOL, V6, P329, DOI 10.1046/j.1365-2486.2000.00315.x; Lemeshow, 2000, APPL LOGISTIC REGRES, P375, DOI [10.1002/0471722146, DOI 10.1002/0471722146]; Lesser MP, 2011, BIOL INVASIONS, V13, P1855, DOI 10.1007/s10530-011-0005-z; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Liddell W.D., 1988, PALAIOS, V3, P413, DOI DOI 10.2307/3514787; Liu C, 2009, 18 WORLD IMACS MODSI; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Luck DG, 2013, PEERJ, V132, P1; Menza C, 2008, REV BIOL TROP, V56, P11; Miller J, 2007, ECOL MODEL, V202, P225, DOI 10.1016/j.ecolmodel.2006.12.012; Pearce J, 2000, ECOL MODEL, V133, P225, DOI 10.1016/S0304-3800(00)00322-7; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Phillips S., 2012, BRIEF TUTORIAL MAXEN; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; PIFSC (Pacific Islands Fisheries Science Center), 2014, OPTICAL ANAL OVERVIE; Piniak GA, 2007, MAR ENVIRON RES, V64, P456, DOI 10.1016/j.marenvres.2007.04.001; Pittman SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020583; Pittman SJ, 2009, J COASTAL RES, V25, P27, DOI [10.2112/SI53-004.1, 10.2112/S153-004.1]; Pontius RG, 2001, AGR ECOSYST ENVIRON, V85, P239, DOI 10.1016/S0167-8809(01)00187-6; Rengstorf AM, 2013, J BIOGEOGR, V40, P1702, DOI 10.1111/jbi.12123; Rooney J, 2010, CORAL REEFS, V29, P361, DOI 10.1007/s00338-010-0596-3; Rudnick DL, 2003, SCIENCE, V301, P355, DOI 10.1126/science.1085837; Slattery M, 2011, J EXP MAR BIOL ECOL, V408, P32, DOI 10.1016/j.jembe.2011.07.024; Spalding H, 2012, THESIS U HAWAII M NO; Storlazzi CD, 2005, CORAL REEFS, V24, P43, DOI 10.1007/s00338-004-0430-x; Storlazzi CD, 2004, 21 PACLIM P, P36; Tittensor DP, 2009, J BIOGEOGR, V36, P1111, DOI 10.1111/j.1365-2699.2008.02062.x; VANHORNE B, 1983, J WILDLIFE MANAGE, V47, P893; Vermeij M, 2008, CORAL REEFS MAUI STA; Wells J. W., 1957, Memoirs Geological Society of America, V67, P609; Wiley E. O., 2003, OCEANOGRAPHY, V16, P120, DOI [http://dx.doi.org/10.5670/oceanog.2003.42, DOI 10.5670/OCEANOG.2003.42, 10.5670/oceanog.2003.42]; Woodby D, 2009, MAR ECOL PROG SER, V397, P227, DOI 10.3354/meps08358; Wright D.J., 2005, ARCGIS BENTHIC TERRA	76	26	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0130285	10.1371/journal.pone.0130285	http://dx.doi.org/10.1371/journal.pone.0130285			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26153883	Green Published, gold, Green Submitted			2022-12-26	WOS:000358159700028
J	Lieberman, DE; Castillo, ER; Otarola-Castillo, E; Sang, MK; Sigei, TK; Ojiambo, R; Okutoyi, P; Pitsiladis, Y				Lieberman, Daniel E.; Castillo, Eric R.; Otarola-Castillo, Erik; Sang, Meshack K.; Sigei, Timothy K.; Ojiambo, Robert; Okutoyi, Paul; Pitsiladis, Yannis			Variation in Foot Strike Patterns among Habitually Barefoot and Shod Runners in Kenya	PLOS ONE			English	Article							REARFOOT STRIKE; FEMALE RUNNERS; STANCE PHASE; ROAD RACE; FOREFOOT; KINEMATICS; ECONOMY; LEVEL	Runners are often categorized as forefoot, midfoot or rearfoot strikers, but how much and why do individuals vary in foot strike patterns when running on level terrain? This study used general linear mixed-effects models to explore both intra-and inter-individual variations in foot strike pattern among 48 Kalenjin-speaking participants from Kenya who varied in age, sex, body mass, height, running history, and habitual use of footwear. High speed video was used to measure lower extremity kinematics at ground contact in the sagittal plane while participants ran down 13 meter-long tracks with three variables independently controlled: speed, track stiffness, and step frequency. 72% of the habitually barefoot and 32% of the habitually shod participants used multiple strike types, with significantly higher levels of foot strike variation among individuals who ran less frequently and who used lower step frequencies. There was no effect of sex, age, height or weight on foot strike angle, but individuals were more likely to midfoot or forefoot strike when they ran on a stiff surface, had a high preferred stride frequency, were habitually barefoot, and had more experience running. It is hypothesized that strike type variation during running, including a more frequent use of forefoot and midfoot strikes, used to be greater before the introduction of cushioned shoes and paved surfaces.	[Lieberman, Daniel E.; Castillo, Eric R.; Otarola-Castillo, Erik] Harvard Univ, Dept Human Evolutionary Biol, Cambridge, MA 02138 USA; [Sang, Meshack K.; Ojiambo, Robert] Moi Univ, Sch Med, Dept Med Physiol, Eldoret, Kenya; [Sigei, Timothy K.] Moi Univ, Dept Stat & Comp Sci, Eldoret, Kenya; [Okutoyi, Paul] Moi Univ, Sch Med, Dept Orthopaed & Rehabil, Eldoret, Kenya; [Pitsiladis, Yannis] Univ Brighton, Ctr Sport & Exercise Sci & Med, Brighton, E Sussex, England	Harvard University; Moi University; Moi University; Moi University; University of Brighton	Lieberman, DE (corresponding author), Harvard Univ, Dept Human Evolutionary Biol, Cambridge, MA 02138 USA.	danlieb@fas.harvard.edu		Otarola-Castillo, Erik/0000-0002-7806-494X; Pitsiladis, Yannis/0000-0001-6210-2449	American School of Prehistoric Research, Harvard University	American School of Prehistoric Research, Harvard University	This work was supported by the American School of Prehistoric Research, Harvard University (DEL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn AN, 2014, J SPORT HEALTH SCI, V3, P102, DOI 10.1016/j.jshs.2014.03.007; Altman AR, 2012, CURR SPORT MED REP, V11, P244, DOI 10.1249/JSR.0b013e31826c9bb9; Altman AR, 2012, GAIT POSTURE, V35, P298, DOI 10.1016/j.gaitpost.2011.09.104; ARDIGO LP, 1995, ACTA PHYSIOL SCAND, V155, P17, DOI 10.1111/j.1748-1716.1995.tb09943.x; BUCZEK FL, 1990, MED SCI SPORT EXER, V22, P669, DOI 10.1249/00005768-199010000-00019; Cunningham CB, 2010, J EXP BIOL, V213, P790, DOI 10.1242/jeb.038984; De Wit B, 2000, J BIOMECH, V33, P269, DOI 10.1016/S0021-9290(99)00192-X; Divert C, 2008, INT J SPORTS MED, V29, P512, DOI 10.1055/s-2007-989233; Gibson AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066552; Gruber AH, 2013, FOOTWEAR SCI, V5, P39, DOI 10.1080/19424280.2012.742141; Gruber AH, 2013, J APPL PHYSIOL, V115, P194, DOI 10.1152/japplphysiol.01437.2012; Hamill J, 2011, FOOTWEAR SCI, V3, P33, DOI 10.1080/19424280.2010.542187; Hasegawa H, 2007, J STRENGTH COND RES, V21, P888, DOI 10.1519/R-22096.1; Hatala KG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052548; Hayes P, 2012, J SPORT SCI, V30, P1275, DOI 10.1080/02640414.2012.707326; Hreljac A, 2000, MED SCI SPORT EXER, V32, P1635; Kasmer ME, 2014, J SPORT HEALTH SCI, V3, P122, DOI 10.1016/j.jshs.2014.03.005; Keller TS, 1996, CLIN BIOMECH, V11, P253, DOI 10.1016/0268-0033(95)00068-2; Larson P, 2014, J SPORT HEALTH SCI, V3, P137, DOI 10.1016/j.jshs.2014.03.003; Larson P, 2011, J SPORT SCI, V29, P1665, DOI 10.1080/02640414.2011.610347; Lieberman D., 2013, STORY HUMAN BODY EVO; Lieberman DE, 2014, J SPORT HEALTH SCI, V3, P86, DOI 10.1016/j.jshs.2014.03.009; Lieberman DE, 2012, EXERC SPORT SCI REV, V40, P63, DOI 10.1097/JES.0b013e31824ab210; Lieberman DE, 2010, NATURE, V463, P531, DOI 10.1038/nature08723; Manly B.F.J., 2006, RANDOMIZATION BOOTST, V3rd, DOI DOI 10.1201/9781315273075; MCCULLOCH CE, 2001, GENERALIZED LINEAR M; Meredith MD., 2010, FITNESSGRAM ACTIVITY; Miller EE, 2014, J SPORT HEALTH SCI, V3, P74, DOI 10.1016/j.jshs.2014.03.011; Milner CE, 2006, MED SCI SPORT EXER, V38, P323, DOI 10.1249/01.mss.0000183477.75808.92; Nigg B. M., 2010, BIOMECHANICS SPORTS; Nigg BM, 1997, CURR OPIN ORTHOP, DOI [10.1097/00001433-199712000-00007., DOI 10.1097/00001433-199712000-00007]; Ojiambo R, 2013, ANN HUM BIOL, V40, P318, DOI 10.3109/03014460.2013.775344; Padulo J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069006; Perl DP, 2012, MED SCI SPORT EXER, V44, P1335, DOI 10.1249/MSS.0b013e318247989e; Pitsiladis Y. P., 2004, Equine and Comparative Exercise Physiology, V1, P285, DOI 10.1079/ECP200433; Pohl MB, 2009, CLIN J SPORT MED, V19, P372, DOI 10.1097/JSM.0b013e3181b8c270; Pontzer H, 2014, J SPORT HEALTH SCI, V3, P95, DOI 10.1016/j.jshs.2014.03.010; Sears E., 2001, RUNNING AGES; Squadrone R, 2009, J SPORT MED PHYS FIT, V49, P6; Williams DS, 2000, J APPL BIOMECH, V16, P210, DOI 10.1123/jab.16.2.210	40	38	41	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0131354	10.1371/journal.pone.0131354	http://dx.doi.org/10.1371/journal.pone.0131354			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154285	Green Submitted, gold, Green Published			2022-12-26	WOS:000358159700060
J	Walker, CG; Solis-Trapala, I; Holzapfel, C; Ambrosini, GL; Fuller, NR; Loos, RJF; Hauner, H; Caterson, ID; Jebb, SA				Walker, Celia G.; Solis-Trapala, Ivonne; Holzapfel, Christina; Ambrosini, Gina L.; Fuller, Nicholas R.; Loos, Ruth J. F.; Hauner, Hans; Caterson, Ian D.; Jebb, Susan A.			Modelling the Interplay between Lifestyle Factors and Genetic Predisposition on Markers of Type 2 Diabetes Mellitus Risk	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; WEIGHT-LOSS; SUSCEPTIBILITY LOCI; INSULIN-RESISTANCE; GLUCOSE-TOLERANCE; GLYCEMIC TRAITS; INTERVENTION; FAT; VARIANTS; REPLICATION	The risk of developing type 2 diabetes mellitus (T2DM) is determined by a complex interplay involving lifestyle factors and genetic predisposition. Despite this, many studies do not consider the relative contributions of this complex array of factors to identify relationships which are important in progression or prevention of complex diseases. We aimed to describe the integrated effect of a number of lifestyle changes (weight, diet and physical activity) in the context of genetic susceptibility, on changes in glycaemic traits in overweight or obese participants following 12-months of a weight management programme. A sample of 353 participants from a behavioural weight management intervention were included in this study. A graphical Markov model was used to describe the impact of the intervention, by dividing the effects into various pathways comprising changes in proportion of dietary saturated fat, physical activity and weight loss, and a genetic predisposition score (T2DM-GPS), on changes in insulin sensitivity (HOMA-IR), insulin secretion (HOMA-B) and short and long term glycaemia (glucose and HbA1c). We demonstrated the use of graphical Markov modelling to identify the importance and interrelationships of a number of possible variables changed as a result of a lifestyle intervention, whilst considering fixed factors such as genetic predisposition, on changes in traits. Paths which led to weight loss and change in dietary saturated fat were important factors in the change of all glycaemic traits, whereas the T2DM-GPS only made a significant direct contribution to changes in HOMA-IR and plasma glucose after considering the effects of lifestyle factors. This analysis shows that modifiable factors relating to body weight, diet, and physical activity are more likely to impact on glycaemic traits than genetic predisposition during a behavioural intervention.	[Walker, Celia G.; Solis-Trapala, Ivonne; Ambrosini, Gina L.; Jebb, Susan A.] MRC Human Nutr Res, Elsie Widdowson Lab, Cambridge, England; [Holzapfel, Christina; Hauner, Hans] Tech Univ Munich, Fac Med, Else Kroener Fresenius Ctr Nutr Med, D-80290 Munich, Germany; [Fuller, Nicholas R.; Caterson, Ian D.] Univ Sydney, Boden Inst Obes Nutr Exercise & Eating Disorders, Sydney, NSW 2006, Australia; [Loos, Ruth J. F.] Icahn Sch Med Mt Sinai, Mindich Child Hlth & Dev Inst, Charles Bronfman Inst Personalized Med, Genet Obes & Related Metab Traits Programme, New York, NY 10029 USA	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research; Technical University of Munich; University of Sydney; Icahn School of Medicine at Mount Sinai	Walker, CG (corresponding author), MRC Human Nutr Res, Elsie Widdowson Lab, Cambridge, England.	celia.walker@mrc-hnr.cam.ac.uk; Ivonne.Solis-Trapala@mrc-hnr.cam.ac.uk	Loos, Ruth J F/Q-2862-2016; Loos, Ruth/GON-5877-2022; Holzapfel, Christina/AAO-5928-2020; Solis-Trapala, Ivonne/D-8144-2011; Solis-Trapala, Ivonne/AAZ-2105-2021; Ambrosini, Gina/E-7107-2010	Loos, Ruth J F/0000-0002-8532-5087; Holzapfel, Christina/0000-0002-0155-9338; Solis-Trapala, Ivonne/0000-0002-1264-1396; Solis-Trapala, Ivonne/0000-0002-1264-1396; Ambrosini, Gina/0000-0003-1001-4265; Jebb, Susan/0000-0001-9190-2920	UK Medical Research Council [U105960389]; Weight Watchers International; MRC [G0701642, MC_EX_G0701642/2, MC_U105960389] Funding Source: UKRI; Medical Research Council [MC_EX_G0701642/2, G0701642, MC_U105960389] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020541, P60DK020541] Funding Source: NIH RePORTER	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Weight Watchers International; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This analysis was funded by the participating centres including UK Medical Research Council (grant code U105960389). The intervention trial was funded by Weight Watchers International through a grant to the UK Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An P, 2014, METABOLISM, V63, P461, DOI 10.1016/j.metabol.2013.11.018; Andersson EA, 2013, DIABETES, V62, P3610, DOI 10.2337/db13-0362; Belalcazar LM, 2010, DIABETES CARE, V33, P2297, DOI 10.2337/dc10-0728; Berrington A, 2008, J R STAT SOC A STAT, V171, P89; Borgoni R, 2012, QUAL QUANT, V46, P715, DOI 10.1007/s11135-010-9407-8; Corder K, 2007, CURR OPIN CLIN NUTR, V10, P597, DOI 10.1097/MCO.0b013e328285d883; Cox D.R., 1996, MULTIVARIATE DEPENDE; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Fitt E, 2015, PUBLIC HEALTH NUTR, V18, P234, DOI 10.1017/S1368980014000342; FSANZ, 2006, NUTR TABLES USE AUST; Fuller NR, 2014, CLIN OBES, V4, P127, DOI 10.1111/cob.12057; Hivert MF, 2011, DIABETES, V60, P1340, DOI 10.2337/db10-1119; Hornbak M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104837; Hu FB, 2001, DIABETOLOGIA, V44, P805, DOI 10.1007/s001250100547; Hung T, 2003, CURR OPIN CLIN NUTR, V6, P165, DOI 10.1097/00075197-200303000-00005; Jebb SA, 2011, LANCET, V378, P1485, DOI 10.1016/S0140-6736(11)61344-5; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Li SX, 2010, AM J CLIN NUTR, V91, P184, DOI 10.3945/ajcn.2009.28403; Lindstrom J, 2006, LANCET, V368, P1673, DOI 10.1016/S0140-6736(06)69701-8; Manning AK, 2012, NAT GENET, V44, P659, DOI 10.1038/ng.2274; Mason C, 2011, AM J PREV MED, V41, P366, DOI 10.1016/j.amepre.2011.06.042; Merlotti C, 2014, DIABETES OBES METAB, V16, P719, DOI 10.1111/dom.12270; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537; Peter I, 2012, OBESITY, V20, P1675, DOI 10.1038/oby.2012.11; Poulsen P, 1999, DIABETOLOGIA, V42, P139, DOI 10.1007/s001250051131; Prokopenko I, 2009, NAT GENET, V41, P77, DOI 10.1038/ng.290; Riccardi G, 2004, CLIN NUTR, V23, P447, DOI 10.1016/j.clnu.2004.02.006; Ruggeri M, 2004, INT J METH PSYCH RES, V13, P10, DOI 10.1002/mpr.160; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott RA, 2012, NAT GENET, V44, P991, DOI 10.1038/ng.2385; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Vessby B, 2001, DIABETOLOGIA, V44, P312, DOI 10.1007/s001250051620; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Walker CG, 2012, GENES NUTR, V7, P529, DOI 10.1007/s12263-012-0284-8; Wermuth N, 2012, INT STAT REV, V80, P415, DOI 10.1111/j.1751-5823.2012.00195.x; Wermuth N, 2012, TEST-SPAIN, V21, P215, DOI 10.1007/s11749-012-0290-6; WHO, 2003, WHO TECHN REP SER, V916, P54; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	41	6	6	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0131681	10.1371/journal.pone.0131681	http://dx.doi.org/10.1371/journal.pone.0131681			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154605	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000358159700076
J	Bertolini, F; Scimone, C; Geraci, C; Schiavo, G; Utzeri, VJ; Chiofalo, V; Fontanesi, L				Bertolini, Francesca; Scimone, Concetta; Geraci, Claudia; Schiavo, Giuseppina; Utzeri, Valerio Joe; Chiofalo, Vincenzo; Fontanesi, Luca			Next Generation Semiconductor Based Sequencing of the Donkey (Equus asinus) Genome Provided Comparative Sequence Data against the Horse Genome and a Few Millions of Single Nucleotide Polymorphisms	PLOS ONE			English	Article							COPY NUMBER VARIANTS; ION TORRENT; GENETIC DIVERSITY; COMPARATIVE MAP; ANCIENT DNA; MILK; CHROMOSOME; EVOLUTION; INSIGHT; BREEDS	Few studies investigated the donkey (Equus asinus) at the whole genome level so far. Here, we sequenced the genome of two male donkeys using a next generation semiconductor based sequencing platform (the Ion Proton sequencer) and compared obtained sequence information with the available donkey draft genome (and its Illumina reads from which it was originated) and with the EquCab2.0 assembly of the horse genome. Moreover, the Ion Torrent Personal Genome Analyzer was used to sequence reduced representation libraries (RRL) obtained from a DNA pool including donkeys of different breeds (Grigio Siciliano, Ragusano and Martina Franca). The number of next generation sequencing reads aligned with the EquCab2.0 horse genome was larger than those aligned with the draft donkey genome. This was due to the larger N50 for contigs and scaffolds of the horse genome. Nucleotide divergence between E. caballus and E. asinus was estimated to be similar to 0.52-0.57%. Regions with low nucleotide divergence were identified in several autosomal chromosomes and in the whole chromosome X. These regions might be evolutionally important in equids. Comparing Y-chromosome regions we identified variants that could be useful to track donkey paternal lineages. Moreover, about 4.8 million of single nucleotide polymorphisms (SNPs) in the donkey genome were identified and annotated combining sequencing data from Ion Proton (whole genome sequencing) and Ion Torrent (RRL) runs with Illumina reads. A higher density of SNPs was present in regions homologous to horse chromosome 12, in which several studies reported a high frequency of copy number variants. The SNPs we identified constitute a first resource useful to describe variability at the population genomic level in E. asinus and to establish monitoring systems for the conservation of donkey genetic resources.	[Bertolini, Francesca; Geraci, Claudia; Schiavo, Giuseppina; Utzeri, Valerio Joe; Fontanesi, Luca] Univ Bologna, Div Anim Sci, Dept Agr & Food Sci, Bologna, Italy; [Bertolini, Francesca; Scimone, Concetta; Chiofalo, Vincenzo] Polo Univ Annunziata, Univ Messina, Dept Vet Sci, Anim Prod Unit, Messina, Italy; [Chiofalo, Vincenzo] Polo Univ Annunziata, Meat Res Consortium, Messina, Italy	University of Bologna; University of Messina	Fontanesi, L (corresponding author), Univ Bologna, Div Anim Sci, Dept Agr & Food Sci, Viale Fanin 46, Bologna, Italy.	luca.fontanesi@unibo.it	Scimone, Concetta/P-4366-2015; bertolini, francesca/AAX-3836-2021; Fontanesi, Luca/L-1770-2014	Fontanesi, Luca/0000-0001-7050-3760; Geraci, Claudia/0000-0002-4948-0725; Bertolini, Francesca/0000-0003-4181-3895; UTZERI, VALERIO JOE/0000-0001-5320-4216	University of Bologna RFO (Ricerca Fondamentale Orientata); University of Messina; Corfilcarni; PanLab Project [PONa3_00166/F1]	University of Bologna RFO (Ricerca Fondamentale Orientata); University of Messina; Corfilcarni; PanLab Project	This study was supported by University of Bologna RFO (Ricerca Fondamentale Orientata), University of Messina, Corfilcarni and PanLab Project PONa3_00166/F1 funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abitbol M, 2014, ANIM GENET, V45, P878, DOI 10.1111/age.12207; Altshuler D, 2000, NATURE, V407, P513, DOI 10.1038/35035083; Amati L, 2010, CURR PHARM DESIGN, V16, P864, DOI 10.2174/138161210790883651; [Anonymous], 2014, R LANG ENV STAT COMP; Aranguren-Mendez J, 2004, J ANIM BREED GENET, V121, P319, DOI 10.1111/j.1439-0388.2004.00464.x; Aranguren-Mendez J, 2001, GENET SEL EVOL, V33, P433, DOI 10.1051/gse:2001126; Ballestra F, 2005, French Patent Application, Patent No. [FR 2 707 877 Al. 6, 2707877]; Beja-Pereira A, 2004, SCIENCE, V304, P1781, DOI 10.1126/science.1096008; Bell CC, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1002; Bertolini F, 2014, ANIM GENET, V45, P304, DOI 10.1111/age.12121; Blench RM., 2004, THE HISTORY AND SPRE; Boland JF, 2013, HUM GENET, V132, P1153, DOI 10.1007/s00439-013-1321-4; Bordonaro S, 2012, SCI WORLD J, DOI 10.1100/2012/648427; Bovo S, 2015, INT J GENOMICS, V2015, DOI 10.1155/2015/950737; Carroccio A, 2000, CLIN EXP ALLERGY, V30, P1597, DOI 10.1046/j.1365-2222.2000.00925.x; Choi JW, 2013, MOL CELLS, V36, P203, DOI 10.1007/s10059-013-2347-0; Colli L, 2013, ANIM GENET, V44, P69, DOI 10.1111/j.1365-2052.2012.02356.x; Cosenza G, 2010, ITAL J ANIM SCI, V9, P206, DOI 10.4081/ijas.2010.e40; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Doan R, 2012, GENOME RES, V22, P899, DOI 10.1101/gr.128991.111; Fantini E, 2015, METHODS MOL BIOL, V1231, P77, DOI 10.1007/978-1-4939-1720-4_5; Fontanesi L, 2011, GENOMICS, V97, P158, DOI 10.1016/j.ygeno.2010.11.005; Fontanesi L, 2015, ANIM BIOTECHNOL, V26, P92, DOI 10.1080/10495398.2014.881369; Fontanesi L, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-639; Ghosh S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004712; Han L, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0246-4; Henry M., 1995, BIOL REPROD, V52, P273, DOI [10.1093/biolreprod/52.monograph_series1.273, DOI 10.1093/BIOLREPROD/52.MONOGRAPH_SERIES1.273]; Homer N, TMAP THE TORRENT MAP; Huang JL, 2014, SCI REP-UK, V4, DOI 10.1038/srep04958; IACONO G, 1992, J PEDIATR GASTR NUTR, V14, P177, DOI 10.1097/00005176-199202000-00010; Kimura B, 2011, P ROY SOC B-BIOL SCI, V278, P50, DOI 10.1098/rspb.2010.0708; Kugler W, REPORT 2007 2008; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li WH, 2002, CURR OPIN GENET DEV, V12, P650, DOI 10.1016/S0959-437X(02)00354-4; Liu Q, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S8-S8; Lopez CL, 2005, TROP ANIM HEALTH PRO, V37, P173, DOI 10.1007/s11250-005-9001-6; Martemucci G, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-113; McCue ME, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002451; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Merriman B, 2012, ELECTROPHORESIS, V33, P3397, DOI 10.1002/elps.201200424; Metzger J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-487; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Molnar J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-761; Nei M, 2005, ANNU REV GENET, V39, P121, DOI 10.1146/annurev.genet.39.073003.112240; Orlando L, 2013, NATURE, V499, P74, DOI 10.1038/nature12323; Parson W, 2013, FORENSIC SCI INT-GEN, V7, P543, DOI 10.1016/j.fsigen.2013.06.003; Payseur BA, 2004, EVOLUTION, V58, P2064; Polidori P, 2008, MEAT SCI, V80, P1222, DOI 10.1016/j.meatsci.2008.05.027; Quail MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341; Raudsepp T, 2001, CYTOGENET CELL GENET, V94, P180, DOI 10.1159/000048812; Raudsepp T, 1999, CHROMOSOME RES, V7, P103, DOI 10.1023/A:1009234814635; Rizzi R, 2011, J ANIM SCI, V89, P1304, DOI 10.2527/jas.2010-3379; RONG R, 1988, CYTOGENET CELL GENET, V47, P134, DOI 10.1159/000132531; Rosenbom S, 2015, ANIM GENET, V46, P30, DOI 10.1111/age.12256; Rossel S, 2008, P NATL ACAD SCI USA, V105, P3715, DOI 10.1073/pnas.0709692105; Rothberg JM, 2011, NATURE, V475, P348, DOI 10.1038/nature10242; RYDER OA, 1985, J HERED, V76, P379; Selvaggi M, 2011, AFR J BIOTECHNOL, V10, P5118; Starkey P, 2000, DONKEYS PEOPLE DEV R, P219; Stoddard JL, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00531; Tesse R, 2009, ITAL J PEDIATR, V35, DOI 10.1186/1824-7288-35-19; Vignaud P, 2002, NATURE, V418, P152, DOI 10.1038/nature00880; Wade CM, 2009, SCIENCE, V326, P865, DOI 10.1126/science.1178158; Wallner B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060015; Wang W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086860; Yang FT, 2004, CHROMOSOME RES, V12, P65, DOI 10.1023/B:CHRO.0000009298.02689.8a; Zenebe S, 2000, DONKEYS PEOPLE AND D, P71	67	14	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2015	10	7							e0131925	10.1371/journal.pone.0131925	http://dx.doi.org/10.1371/journal.pone.0131925			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EC	26151450	Green Published, gold, Green Submitted			2022-12-26	WOS:000358158900030
J	do Bonfim, CM; Sobrinho, JS; Nogueira, RL; Kupper, DS; Valera, FCP; Nogueira, ML; Villa, LL; Rahal, P; Sichero, L				do Bonfim, Caroline Measso; Sobrinho, Joao Simao; Nogueira, Rodrigo Lacerda; Kupper, Daniel Salgado; Pereira Valera, Fabiana Cardoso; Nogueira, Maurcio Lacerda; Villa, Luisa Lina; Rahal, Paula; Sichero, Laura			Differences in Transcriptional Activity of Human Papillomavirus Type 6 Molecular Variants in Recurrent Respiratory Papillomatosis	PLOS ONE			English	Article							CERVICAL-CANCER; UPSTREAM; THERAPY; REGION; DNA; SUSCEPTIBILITY; LESIONS; SITES; HPV-6; RISK	A significant proportion of recurrent respiratory papillomatosis (RRP) is caused by human papillomavirus type 6 (HPV-6). The long control region (LCR) contains cis-elements for regulation of transcription. Our aim was to characterize LCR HPV-6 variants in RRP cases, compare promoter activity of these isolates and search for cellular transcription factors (TFs) that could explain the differences observed. The complete LCR from 13 RRP was analyzed. Transcriptional activity of 5 variants was compared using luciferase assays. Differences in putative TFs binding sites among variants were revealed using the TRANSFAC database. Chromatin immunoprecipation (CHIP) and luciferase assays were used to evaluate TF binding and impact upon transcription, respectively. Juvenile-onset RRP cases harbored exclusively HPV-6vc related variants, whereas among adult-onset cases HPV-6a variants were more prevalent. The HPV-6vc reference was more transcriptionally active than the HPV-6a reference. Active FOXA1, ELF1 and GATA1 binding sites overlap variable nucleotide positions among isolates and influenced LCR activity. Furthermore, our results support a crucial role for ELF1 on transcriptional downregulation. We identified TFs implicated in the regulation of HPV-6 early gene expression. Many of these factors are mutated in cancer or are putative cancer biomarkers, and must be further studied.	[do Bonfim, Caroline Measso; Rahal, Paula] UNESP, Lab Genom Studies, Sao Jose Do Rio Preto, SP, Brazil; [Sobrinho, Joao Simao; Villa, Luisa Lina; Sichero, Laura] ICESP, Ctr Translat Oncol, Mol Biol Lab, Sao Paulo, Brazil; [Nogueira, Rodrigo Lacerda; Kupper, Daniel Salgado; Pereira Valera, Fabiana Cardoso] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Ophthalmol Otorhinolaryngol & Head Neck Surg, Discipline Otorhinolaryngol, Sao Paulo, Brazil; [Nogueira, Maurcio Lacerda] FAMERP, Fac Med Sao Jose Rio Preto, Lab Res Virol, Sao Jose Do Rio Preto, Brazil; [Villa, Luisa Lina] Univ Sao Paulo, Sch Med, Dept Radiol & Oncol, Sao Paulo, Brazil; [Villa, Luisa Lina] Santa Casa Sao Paulo & HPV Inst, Sch Med, Sao Paulo, Brazil	Universidade Estadual Paulista; Universidade de Sao Paulo; Universidade de Sao Paulo; Faculdade de Medicina de Sao Jose do Rio Preto (FAMERP); Universidade de Sao Paulo	Sichero, L (corresponding author), ICESP, Ctr Translat Oncol, Mol Biol Lab, Sao Paulo, Brazil.	lsichero@gmail.com	Valera, Fabiana Cardoso Pereira/D-3787-2012; Rahal, Paula/D-3871-2012; Nogueira, Mauricio L/B-7599-2012; Sichero, Laura/AAT-4228-2021; VILLA, LUISA/AAH-4761-2019	Valera, Fabiana Cardoso Pereira/0000-0002-6605-5317; Rahal, Paula/0000-0001-5693-6148; Nogueira, Mauricio L/0000-0003-1102-2419; Sichero, Laura/0000-0002-7999-5818; VILLA, LUISA/0000-0003-4074-2335	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [10/00029-0, 08/57889-1]; Conselho Nacional de Desenvolvimento Cientifico e Tencnologico (CNPq) [573799/2008-3]; Ludwig Institute for Cancer Research	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tencnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); Ludwig Institute for Cancer Research	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) (grant numbers 10/00029-0 to CMB and 08/57889-1 to LLV); Conselho Nacional de Desenvolvimento Cientifico e Tencnologico (CNPq) (grant number 573799/2008-3 to LLV); and Ludwig Institute for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	de Matos RPA, 2013, INFECT GENET EVOL, V16, P282, DOI 10.1016/j.meegid.2012.12.033; Bernard HU, 2002, ANTIVIR THER, V7, P219; Berumen J, 2001, JNCI-J NATL CANCER I, V93, P1325, DOI 10.1093/jnci/93.17.1325; Bishai D, 2000, ARCH OTOLARYNGOL, V126, P935, DOI 10.1001/archotol.126.8.935; Buchinsky FJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002263; Burk Robert D, 2011, Acta Dermatovenerol Alp Pannonica Adriat, V20, P113; Combrinck CE, 2012, EPIDEMIOL INFECT, V140, P1095, DOI 10.1017/S0950268811001580; Danielewski JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063892; Derkay CS, 2008, LARYNGOSCOPE, V118, P1236, DOI 10.1097/MLG.0b013e31816a7135; Derkay CS, 1998, LARYNGOSCOPE, V108, P935, DOI 10.1097/00005537-199806000-00026; DEVILLIERS EM, 1981, J VIROL, V40, P932, DOI 10.1128/JVI.40.3.932-935.1981; Donne AJ, 2010, INT J STD AIDS, V21, P381, DOI 10.1258/ijsa.2010.010073; Donne AJ, 2010, INT J PEDIATR OTORHI, V74, P7, DOI 10.1016/j.ijporl.2009.09.004; Friedman JR, 2006, CELL MOL LIFE SCI, V63, P2317, DOI 10.1007/s00018-006-6095-6; Gall T, 2011, ANTIVIR RES, V92, P356, DOI 10.1016/j.antiviral.2011.09.007; Gallant S, 2006, ARCH IMMUNOL THER EX, V54, P149, DOI 10.1007/s00005-006-0017-z; Garcia-Vallve S, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-20; Gelder CM, 2003, J VIROL, V77, P1927, DOI 10.1128/JVI.77.3.1927-1939.2003; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HEINZEL PA, 1995, J CLIN MICROBIOL, V33, P1746, DOI 10.1128/JCM.33.7.1746-1754.1995; Hildesheim A, 2001, JNCI-J NATL CANCER I, V93, P315, DOI 10.1093/jnci/93.4.315; Hubert WG, 2005, J VIROL, V79, P5914, DOI 10.1128/JVI.79.10.5914-5922.2005; Jelen MM, 2014, J VIROL, V88, P7307, DOI 10.1128/JVI.00621-14; Kammer C, 2000, J GEN VIROL, V81, P1975, DOI 10.1099/0022-1317-81-8-1975; KASHIMA H, 1993, ANN OTO RHINOL LARYN, V102, P580, DOI 10.1177/000348949310200802; Katsumura KR, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a015412; Kocjan BJ, 2013, J INFECT DIS, V207, P583, DOI 10.1093/infdis/jis733; Kocjan BJ, 2009, VIROLOGY, V391, P274, DOI 10.1016/j.virol.2009.06.030; Komlos KF, 2012, J MED VIROL, V84, P1233, DOI 10.1002/jmv.23318; Larson DA, 2010, APMIS, V118, P450, DOI 10.1111/j.1600-0463.2010.02619.x; Lizano M, 2006, GYNECOL ONCOL, V102, P230, DOI 10.1016/j.ygyno.2005.12.002; Lucs AV, 2012, MOL MED, V18, P244, DOI 10.2119/molmed.2011.00447; MACGREGOR GR, 1989, NUCLEIC ACIDS RES, V17, P2365, DOI 10.1093/nar/17.6.2365; OBALEK S, 1990, J AM ACAD DERMATOL, V23, P205, DOI 10.1016/0190-9622(90)70200-2; Rainis L, 2003, BLOOD, V102, P981, DOI 10.1182/blood-2002-11-3599; RANDO RF, 1986, J VIROL, V57, P353, DOI 10.1128/JVI.57.1.353-356.1986; ROMANCZUK H, 1991, J VIROL, V65, P2739, DOI 10.1128/JVI.65.5.2739-2744.1991; Sichero L, 2005, J INFECT DIS, V191, P739, DOI 10.1086/427825; Sichero L, 2007, INT J CANCER, V120, P1763, DOI 10.1002/ijc.22481; Sichero L, 2012, J INFECT DIS, V206, P867, DOI 10.1093/infdis/jis430; Thomas-Chollier M, 2011, NAT PROTOC, V6, P1860, DOI 10.1038/nprot.2011.409; Thompson D I, 1994, Healthc Inf Manage, V8, P45; Yuan H, 2012, NEW ENGL J MED, V367, P1220, DOI 10.1056/NEJMoa1203055	43	7	7	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2015	10	7							e0132325	10.1371/journal.pone.0132325	http://dx.doi.org/10.1371/journal.pone.0132325			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EC	26151558	Green Published, Green Submitted, gold			2022-12-26	WOS:000358158900041
J	Hasegawa, H; Sato, M; Tanaka, H				Hasegawa, Hiroaki; Sato, Masanori; Tanaka, Hiroshi			Evaluation of an X-Ray Dose Profile Derived from an Optically Stimulated Luminescent Dosimeter during Computed Tomographic Fluoroscopy	PLOS ONE			English	Article							CT-FLUOROSCOPY; RADIATION-EXPOSURE; INTERVENTIONAL PROCEDURES; GUIDED INTERVENTIONS; PHYSICIANS HAND; PATIENT; PARAMETERS; RADIOLOGY; SCANNER; SYSTEM	The purpose of this study was to evaluate scatter radiation dose to the subject surface during X-ray computed tomography (CT) fluoroscopy using the integrated dose ratio (IDR) of an X-ray dose profile derived from an optically stimulated luminescent (OSL) dosimeter. We aimed to obtain quantitative evidence supporting the radiation protection methods used during previous CT fluoroscopy. A multislice CT scanner was used to perform this study. OSL dosimeters were placed on the top and the lateral side of the chest phantom so that the longitudinal direction of dosimeters was parallel to the orthogonal axis-to-slice plane for measurement of dose profiles in CT fluoroscopy. Measurement of fluoroscopic conditions was performed at 120 kVp and 80 kVp. Scatter radiation dose was evaluated by calculating the integrated dose determined by OSL dosimetry. The overall percent difference of the integrated doses between OSL dosimeters and ionization chamber was 5.92%. The ratio of the integrated dose of a 100-mm length area to its tails (-50 to -6 mm, 50 to 6 mm) was the lowest on the lateral side at 80 kVp and the highest on the top at 120 kVp. The IDRs for different measurement positions were larger at 120 kVp than at 80 kVp. Similarly, the IDRs for the tube voltage between the primary X-ray beam and scatter radiation was larger on the lateral side than on the top of the phantom. IDR evaluation suggested that the scatter radiation dose has a high dependence on the position and a low dependence on tube voltage relative to the primary X-ray beam for constant dose rate fluoroscopic conditions. These results provided quantitative evidence supporting the radiation protection methods used during CT fluoroscopy in previous studies.	[Hasegawa, Hiroaki] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Bioinformat, Bunkyo Ku, Tokyo, Japan; [Sato, Masanori] Komazawa Univ, Dept Radiol Sci, Grad Sch Hlth Sci, Setagaya Ku, Tokyo, Japan; [Tanaka, Hiroshi] Tokyo Med & Dent Univ, Div Gen Med, Med Res Inst, Dept Bioinformat,Bunkyo ku, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Hasegawa, H (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Bioinformat, Bunkyo Ku, Tokyo, Japan.	hasegawah-rad@h.u-tokyo.ac.jp		Hasegawa, Hiroaki/0000-0002-8244-8911	Foundation for Promotion of Cancer Research in Japan	Foundation for Promotion of Cancer Research in Japan	This work was supported in part by Foundation for Promotion of Cancer Research in Japan.	Al-Haj A, 2010, RADIAT PROT DOSIM, V142, P228, DOI 10.1093/rpd/ncq220; [Anonymous], 2008, 96 AAPM DIAGN IM COU; Bauhs JA, 2008, RADIOGRAPHICS, V28, P245, DOI 10.1148/rg.281075024; Beganovic A, 2013, RADIAT PROT DOSIM, V153, P106, DOI 10.1093/rpd/ncs100; Boone JM, 2007, MED PHYS, V34, P1364, DOI 10.1118/1.2713240; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Buls N, 2003, HEALTH PHYS, V85, P165, DOI 10.1097/00004032-200308000-00005; Chintapalli KN, 2012, AM J ROENTGENOL, V198, pW347, DOI 10.2214/AJR.11.7958; Hamberg LM, 2003, RADIOLOGY, V226, P762, DOI 10.1148/radiol.2263020205; HOROWITZ YS, 1990, RADIAT PROT DOSIM, V30, P219; IAEA, 2007, TECHNICAL REPORTS SE, V475; International Atomic Energy Agency, 2011, 457 TRS; International Atomic Energy Agency, 2008, 1585 IAEA TECDOC; International Electrotechnical Commission, 2006, EV ROUT TEST MED I 2; International Organization for Standardization, 2008, GUID EXPR UNC MEAS; Irie T, 2001, J VASC INTERV RADIOL, V12, P1417, DOI 10.1016/S1051-0443(07)61701-1; Irie T, 2000, J VASC INTERV RADIOL, V11, P359, DOI 10.1016/S1051-0443(07)61430-4; Jackson SR, 2013, J APPL CLIN MED PHYS, V14, P227, DOI 10.1120/jacmp.v14i4.4122; JANECZEK J, 1995, RADIAT PROT DOSIM, V60, P231; Katada K, 1996, RADIOLOGY, V200, P851, DOI 10.1148/radiology.200.3.8756943; Katada Kazuhiro, 1994, Nippon Acta Radiologica, V54, P1172; Kato R, 1996, RADIOLOGY, V201, P576, DOI 10.1148/radiology.201.2.8888264; Martin CJ, 2011, J RADIOL PROT, V31, P389, DOI 10.1088/0952-4746/31/4/001; Nawfel RD, 2000, RADIOLOGY, V216, P180, DOI 10.1148/radiology.216.1.r00jl39180; Ruan C, 2010, MED PHYS, V37, P3560, DOI 10.1118/1.3455285; Saidatul A, 2010, Biomed Imaging Interv J, V6, pe1, DOI 10.2349/biij.6.1.e2; Sanchez R, 2011, RADIAT PROT DOSIM, V147, P94, DOI 10.1093/rpd/ncr281; Sarti M, 2012, RADIOGRAPHICS, V32, P1109, DOI 10.1148/rg.324115072; SHOPE TB, 1981, MED PHYS, V8, P488, DOI 10.1118/1.594995; Silverman SG, 1999, RADIOLOGY, V212, P673, DOI 10.1148/radiology.212.3.r99se36673; Theocharopoulos N, 2006, EUR RADIOL, V16, P2575, DOI 10.1007/s00330-006-0251-0; Vrieze TJ, 2012, MED PHYS, V39, P6580, DOI 10.1118/1.4754591; Yamao Y, 2013, CLIN RADIOL, V68, P162, DOI 10.1016/j.crad.2012.05.020; Yamao Y, 2010, RADIOLOGY, V255, P233, DOI 10.1148/radiol.09090733; Yukihara EG, 2008, PHYS MED BIOL, V53, pR351, DOI 10.1088/0031-9155/53/20/R01; Yukihara EG, 2010, RADIAT MEAS, V45, P658, DOI 10.1016/j.radmeas.2009.12.034; Yukihara EG, 2009, PHYS MED BIOL, V54, P6337, DOI 10.1088/0031-9155/54/20/020; Zanca F, 2014, MED PHYS, V41, DOI 10.1118/1.4884231	38	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2015	10	7							e0132154	10.1371/journal.pone.0132154	http://dx.doi.org/10.1371/journal.pone.0132154			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EC	26151914	Green Published, gold, Green Submitted			2022-12-26	WOS:000358158900036
J	Kim, JE; Park, SH; Kwak, MH; Go, J; Koh, EK; Song, SH; Sung, JE; Lee, HS; Hong, JT; Hwang, DY				Kim, Ji Eun; Park, So Hae; Kwak, Moon Hwa; Go, Jun; Koh, Eun Kyoung; Song, Sung Hwa; Sung, Ji Eun; Lee, Hee Seob; Hong, Jin Tae; Hwang, Dae Youn			Characterization of Changes in Global Genes Expression in the Distal Colon of Loperamide-Induced Constipation SD Rats in Response to the Laxative Effects of Liriope platyphylla	PLOS ONE			English	Article							GELATINASE-ASSOCIATED LIPOCALIN; FIBROBLAST-GROWTH-FACTOR; AQUEOUS EXTRACTS; INHIBITION; HYPERMETHYLATION; IDENTIFICATION; MODULATION; KALLIKREIN; SECRETION; OXIDATION	To characterize the changes in global gene expression in the distal colon of constipated SD rats in response to the laxative effects of aqueous extracts of Liriope platyphylla (AEtLP), including isoflavone, saponin, oligosaccharide, succinic acid and hydroxyproline, the total RNA extracted from the distal colon of AEtLP-treated constipation rats was hybridized to oligonucleotide microarrays. The AEtLP treated rats showed an increase in the number of stools, mucosa thickness, flat luminal surface thickness, mucin secretion, and crypt number. Overall, compared to the controls, 581 genes were up-regulated and 216 genes were down-regulated by the constipation induced by loperamide in the constipated rats. After the AEtLP treatment, 67 genes were up-regulated and 421 genes were down-regulated. Among the transcripts up-regulated by constipation, 89 were significantly down-regulated and 22 were recovered to the normal levels by the AEtLP treatment. The major genes in the down-regulated categories included Slc9a5, klk10, Fgf15, and Alpi, whereas the major genes in the recovered categories were Cyp2b2, Ace, G6pc, and Setbp1. On the other hand, after the AEtLP treatment, ten of these genes down-regulated by constipation were up-regulated significantly and five were recovered to the normal levels. The major genes in the up-regulated categories included Serpina3n, Lcn2 and Slc5a8, whereas the major genes in the recovered categories were Tmem45a, Rerg and Rgc32. These results indicate that several gene functional groups and individual genes as constipation biomarkers respond to an AEtLP treatment in constipated model rats.	[Kim, Ji Eun; Kwak, Moon Hwa; Go, Jun; Koh, Eun Kyoung; Song, Sung Hwa; Sung, Ji Eun; Hwang, Dae Youn] Pusan Natl Univ, Life & Ind Convergence Res Inst, Coll Nat Resources & Life Sci, Dept Biomat Sci, Miryang 627706, South Korea; [Park, So Hae; Lee, Hee Seob] Pusan Natl Univ, Coll Human Ecol, Dept Food Sci & Nutr, Busan 609735, South Korea; [Hong, Jin Tae] Chungbuk Natl Univ, Coll Pharm, Chungju 361763, South Korea; [Hong, Jin Tae] Chungbuk Natl Univ, Med Res Ctr, Chungju 361763, South Korea	Pusan National University; Pusan National University; Chungbuk National University; Chungbuk National University	Hong, JT (corresponding author), Chungbuk Natl Univ, Coll Pharm, Chungju 361763, South Korea.	jinthong@chungbuk.ac.kr; dyhwang@pusan.ac.kr			National Research Foundation of Korea (NRF) grant - Korea government (MSIP) [MRC-2008-0062275]; Regional Innovation System (RIS) of the Ministry of Knowledge Economy in Korea	National Research Foundation of Korea (NRF) grant - Korea government (MSIP); Regional Innovation System (RIS) of the Ministry of Knowledge Economy in Korea	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (No. MRC-2008-0062275). Also, this research was supported by a grant from the Regional Innovation System (RIS) of the Ministry of Knowledge Economy in Korea.	Altabas K, 2003, COLLEGIUM ANTROPOL, V27, P197; Beltran-Ramirez O, 2012, TOXICOL PATHOL, V40, P466, DOI 10.1177/0192623311431947; Bharucha AE, 2007, BEST PRACT RES CL GA, V21, P709, DOI 10.1016/j.bpg.2007.07.001; Bolignano D, 2009, REJUV RES, V12, P7, DOI 10.1089/rej.2008.0803; Borgono CA, 2004, NAT REV CANCER, V4, P876, DOI 10.1038/nrc1474; Bousserouel S, 2011, PATHOL INT, V61, P80, DOI 10.1111/j.1440-1827.2010.02621.x; Byrnes JJ, 2009, INFLAMM RES, V58, P819, DOI 10.1007/s00011-009-0053-3; Chassaing B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044328; Choi SB, 2004, LIFE SCI, V75, P2653, DOI 10.1016/j.lfs.2004.04.039; Choi SI, 2012, MOL MED REP, V6, P1160, DOI 10.3892/mmr.2012.1024; Colman RW, 1997, P ASSOC AM PHYSICIAN, V109, P10; DIGNASS AU, 1994, GASTROENTEROLOGY, V106, P1254, DOI 10.1016/0016-5085(94)90017-5; Emmanuel AV, 2009, NEUROGASTROENT MOTIL, V21, P41, DOI 10.1111/j.1365-2982.2009.01403.x; Erasto P, 2005, AFR J BIOTECHNOL, V4, P1458; Flower DR, 1996, BIOCHEM J, V318, P1; Goo JS, 2013, MOL NEUROBIOL, V48, P232, DOI 10.1007/s12035-013-8453-3; Goyal J, 1998, CANCER RES, V58, P4782; Gronborg M, 2004, J PROTEOME RES, V3, P1042, DOI 10.1021/pr0499085; Hoogerwerf WA, 1996, AM J PHYSIOL, V270, P29; Hou XiangYu, 2013, Journal of China Medical University, V42, P348; Houchen CW, 1999, AM J PHYSIOL-GASTR L, V276, pG249, DOI 10.1152/ajpgi.1999.276.1.G249; Hur J, 2009, EUR J PHARMACOL, V620, P9, DOI 10.1016/j.ejphar.2009.08.016; Imamura T, 2014, BIOL PHARM BULL, V37, P1081, DOI 10.1248/bpb.b14-00265; Imig JD, 2004, HYPERTENSION, V43, P533, DOI 10.1161/01.HYP.0000118054.86193.ce; Izzo AA, 2009, DRUGS, V69, P1777, DOI 10.2165/11317010-000000000-00000; Jeong S, 2008, J ETHNOPHARMACOL, V119, P245, DOI 10.1016/j.jep.2008.06.037; JOHNSON DE, 1993, ADV CANCER RES, V60, P1; Kakino M, 2010, BIOSCI BIOTECH BIOCH, V74, P1550, DOI 10.1271/bbb.100122; Kim JE, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-333; Kim Ji Eun, 2010, Laboratory Animal Research, V26, P377; Kim JE, 2011, BIOMOL THER, V19, P348, DOI 10.4062/biomolther.2011.19.3.348; 김형진, 2010, Laboratory Animal Research, V26, P7; Kim SD, 2001, J KOREAN SOC FOOD SC, V30, P20; Kim SW, 2002, BIOSCI BIOTECH BIOCH, V66, P2751, DOI 10.1271/bbb.66.2751; Kim WR, 2000, GASTROENTEROLOGY, V119, P1631, DOI 10.1053/gast.2000.20197; KJELDSEN L, 1993, J BIOL CHEM, V268, P10425; Koga H, 2008, SURGERY, V144, P259, DOI 10.1016/j.surg.2008.03.043; Kwak MH, 2013, J ETHNOPHARMACOL, V148, P880, DOI 10.1016/j.jep.2013.05.036; Lazartigues E, 2007, CURR PHARM DESIGN, V13, P1231, DOI 10.2174/138161207780618911; Lee C, 2014, LIFE SCI, V95, P29, DOI 10.1016/j.lfs.2013.11.005; Lee HY, 2012, FOOD CHEM TOXICOL, V50, P895, DOI 10.1016/j.fct.2011.12.001; Lee YC, 2005, J ETHNOPHARMACOL, V101, P144, DOI 10.1016/j.jep.2005.04.030; Leung FW, 2007, DIGEST DIS SCI, V52, P313, DOI 10.1007/s10620-006-9298-7; Linz D, 2012, HYPERTENSION, V60, P1560, DOI 10.1161/HYPERTENSIONAHA.112.201590; Martin P, 2010, ACTA PHARMACOL SIN, V31, P51, DOI 10.1038/aps.2009.187; McCallum IJD, 2009, BMJ-BRIT MED J, V338, P831; Meda A, 2005, FOOD CHEM, V91, P571, DOI 10.1016/j.foodchem.2004.10.006; Mishra J, 2003, J AM SOC NEPHROL, V14, P2534, DOI 10.1097/01.ASN.0000088027.54400.C6; Mori K, 2005, J CLIN INVEST, V115, P610, DOI 10.1172/JCI200523056; Morita R, 2011, ARCH TOXICOL, V85, P1475, DOI 10.1007/s00204-011-0696-z; Nebert DW, 2000, PHARMACOLOGY, V61, P124, DOI 10.1159/000028393; Neri F, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/896162; Niwa T, 2009, CURR DRUG METAB, V10, P700, DOI 10.2174/138920009789895525; Nyam DCNK, 1997, DIS COLON RECTUM, V40, P273, DOI 10.1007/BF02050415; Ostvik AE, 2013, CLIN EXP IMMUNOL, V173, P502, DOI 10.1111/cei.12136; Parker Lynn P., 2009, Cancer Genomics & Proteomics, V6, P189; PODOLSKY DK, 1993, AM J PHYSIOL, V264, pG179, DOI 10.1152/ajpgi.1993.264.2.G179; Poniatowski B, 2009, KIDNEY BLOOD PRESS R, V32, P77, DOI 10.1159/000208989; Potten CS, 1997, INT J EXP PATHOL, V78, P219, DOI 10.1046/j.1365-2613.1997.280362.x; Raffatellu M, 2009, CELL HOST MICROBE, V5, P476, DOI 10.1016/j.chom.2009.03.011; Roman-Gomez J, 2004, LEUKEMIA, V18, P362, DOI 10.1038/sj.leu.2403223; SARDET C, 1989, CELL, V56, P271, DOI 10.1016/0092-8674(89)90901-X; Schwartz N, 2007, ANN NY ACAD SCI, V1109, P265, DOI 10.1196/annals.1398.032; Shankaran H, 2007, PLOS COMPUT BIOL, V3, P986, DOI 10.1371/journal.pcbi.0030101; Sidiropoulos M, 2005, TUMOR BIOL, V26, P324, DOI 10.1159/000089290; Singleton VL, 1999, METHOD ENZYMOL, V299, P152; Sui Haixia, 2010, Wei Sheng Yan Jiu, V39, P693; VLODAVSKY I, 1991, TRENDS BIOCHEM SCI, V16, P268, DOI 10.1016/0968-0004(91)90102-2; Walia R, 2009, CURR OPIN PEDIATR, V21, P661, DOI 10.1097/MOP.0b013e32832ff241; Wintola OA, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-95; Xu H, 2005, AM J PHYSIOL-GASTR L, V289, pG36, DOI 10.1152/ajpgi.00552.2004; Yang ZH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003348; Ye Xu-ying, 2008, Zhongguo Zhong Xi Yi Jie He Za Zhi, V28, P824; Yu HR, 2000, HYPERTENSION, V35, P135, DOI 10.1161/01.HYP.35.1.135; ZEITLIN IJ, 1973, GUT, V14, P133, DOI 10.1136/gut.14.2.133; Zhang JH, 2013, AM J PHYSIOL-GASTR L, V304, pG940, DOI 10.1152/ajpgi.00398.2012; Zhang R, 2004, ANAL BIOCHEM, V280, P286	77	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2015	10	7							e0129664	10.1371/journal.pone.0129664	http://dx.doi.org/10.1371/journal.pone.0129664			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EC	26151867	Green Published, gold, Green Submitted			2022-12-26	WOS:000358158900005
J	Tougaard, J				Tougaard, Jakob			Underwater Noise from a Wave Energy Converter Is Unlikely to Affect Marine Mammals	PLOS ONE			English	Article							HARBOR SEALS; KHZ	Underwater noise was recorded from the Wavestar wave energy converter; a full-scale hydraulic point absorber, placed on a jack-up rig on the Danish North Sea coast. Noise was recorded 25 m from the converter with an autonomous recording unit (10 Hz to 20 kHz bandwidth). Median sound pressure levels (L-eq) in third-octave bands during operation of the converter were 106-109 dB re. 1 mu Pa in the range 125-250 Hz, 1-2 dB above ambient noise levels (statistically significant). Outside the range 125-250 Hz the noise from the converter was undetectable above the ambient noise. During start and stop of the converter a more powerful tone at 150 Hz (sound pressure level (L-eq) 121-125 dB re 1 mu Pa) was easily detectable. This tone likely originated from the hydraulic pump which was used to lower the absorbers into the water and lift them out of the water at shutdown. Noise levels from the operating wave converter were so low that they would barely be audible to marine mammals and the likelihood of negative impact from the noise appears minimal. A likely explanation for the low noise emissions is the construction of the converter where all moving parts, except for the absorbers themselves, are placed above water on a jack-up rig. The results may thus not be directly transferable to other wave converter designs but do demonstrate that it is possible to harness wave energy without noise pollution to the marine environment.	Aarhus Univ, Dept Biosci, DK-4000 Roskilde, Denmark	Aarhus University	Tougaard, J (corresponding author), Aarhus Univ, Dept Biosci, DK-4000 Roskilde, Denmark.	jat@bios.au.dk	Tougaard, Jakob/G-4948-2011	Tougaard, Jakob/0000-0002-4422-7800	Wavestar A/S	Wavestar A/S	This study was commissioned and funded by Wavestar A/S. Field work was conducted on request from the funders and with assistance from company employees but the funders had no role in data analysis, writing of the manuscript or had any power to deny publication of results.	Azzellino A, 2013, INT J MAR ENERGY, V3-4, pE11, DOI 10.1016/j.ijome.2013.11.008; Bassett C, 2011, UNDERWATER NOISE MEA; Betke K., 2006, MEASUREMENT UNDERWAT; Chozas JF, 2012, 4 INT C OC EN DUBL; Drew B, 2009, P I MECH ENG A-J POW, V223, P887, DOI 10.1243/09576509JPE782; Frid C, 2012, ENVIRON IMPACT ASSES, V32, P133, DOI 10.1016/j.eiar.2011.06.002; Gill AB, 2005, J APPL ECOL, V42, P605, DOI 10.1111/j.1365-2664.2005.01060.x; Haikonen K, 2013, ENERGIES, V6, P2562, DOI 10.3390/en6052562; Kastelein RA, 2010, J ACOUST SOC AM, V128, P3211, DOI 10.1121/1.3493435; Kastelein RA, 2009, J ACOUST SOC AM, V126, P476, DOI 10.1121/1.3132522; Kramer MM, 9 EUR WAV TID C SOUT; Madsen PT, 2006, MAR ECOL PROG SER, V309, P279, DOI 10.3354/meps309279; Marquis L, 2012, 4 INT C OC EN DUBL; Patricio S, 8 EUR WAV TID EN C, P1020; Scheidat M, 2011, GEOPHYS RES LETT, V6, DOI [10.1088/1748-9326/6/2/025102, DOI 10.1088/1748-9326/6/2/025102]; Tougaard J, 2009, J ACOUST SOC AM, V125, P3766, DOI 10.1121/1.3117444	16	11	11	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132391	10.1371/journal.pone.0132391	http://dx.doi.org/10.1371/journal.pone.0132391			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148299	Green Submitted, Green Published, gold			2022-12-26	WOS:000358157600256
J	Zizzari, IG; Martufi, P; Battisti, F; Rahimi, H; Caponnetto, S; Bellati, F; Nuti, M; Rughetti, A; Napoletano, C				Zizzari, Ilaria Grazia; Martufi, Paola; Battisti, Federico; Rahimi, Hassan; Caponnetto, Salvatore; Bellati, Filippo; Nuti, Marianna; Rughetti, Aurelia; Napoletano, Chiara			The Macrophage Galactose-Type C-Type Lectin (MGL) Modulates Regulatory T Cell Functions	PLOS ONE			English	Article							CD45	Regulatory T cells (Tregs) are physiologically designed to prevent autoimmune disease and maintain self-tolerance. In tumour microenvironments, their presence is related to a poor prognosis, and they influence the therapeutic outcome due to their capacity to suppress the immune response by cell-cell contact and to release immunosuppressive cytokines. In this study, we demonstrate that Treg immunosuppressive activity can be modulated by the cross-linking between the CD45RA expressed by Tregs and the C-type lectin MGL. This specific interaction strongly decreases the im-munosuppressive activity of Tregs, restoring the proliferative capacity of co-cultured T lymphocytes. This effect can be attributed to changes in CD45RA and TCR signalling through the inhibition of Lck and inactivation of Zap-70, an increase in the Foxp3 methylation status and, ultimately, the reduced production of suppressive cytokines. These results indicate a role of MGL as an immunomodulator within the tumour microenvironment interfering with Treg functions, suggesting its possible use in the design of anticancer vaccines.	[Zizzari, Ilaria Grazia; Martufi, Paola; Battisti, Federico; Rahimi, Hassan; Caponnetto, Salvatore; Nuti, Marianna; Rughetti, Aurelia; Napoletano, Chiara] Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy; [Bellati, Filippo] Univ Roma La Sapienza, Dept Obstet & Gynecol, I-00185 Rome, Italy	Sapienza University Rome; Sapienza University Rome	Nuti, M (corresponding author), Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy.	marianna.nuti@uniroma1.it	ZIZZARI, ILARIA GRAZIA/K-7958-2016; Napoletano, Chiara/AAO-1691-2021	Bellati, Filippo/0000-0002-2036-9951; BATTISTI, FEDERICO/0000-0001-9495-5905; Napoletano, Chiara/0000-0001-5449-5430; Caponnetto, Salvatore/0000-0003-2906-449X; RAHIMI KOSHKAKI, HASSAN/0000-0001-6701-1263	Associazione Italiana per la Ricerca sul Cancro (AIRC), Ricerche Universitarie (Ateneo)	Associazione Italiana per la Ricerca sul Cancro (AIRC), Ricerche Universitarie (Ateneo)(Fondazione AIRC per la ricerca sul cancro)	This work was supported by Associazione Italiana per la Ricerca sul Cancro (MN: AIRC 2009), Ricerche Universitarie (CN: Ateneo 2012, 2013; IGZ: Ateneo "Start up" 2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MR, 2014, J NEUROIMMUNE PHARM, V9, P522, DOI 10.1007/s11481-014-9547-z; Asseman C, 1999, J EXP MED, V190, P995, DOI 10.1084/jem.190.7.995; Beissert S, 2006, J INVEST DERMATOL, V126, P15, DOI 10.1038/sj.jid.5700004; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Gregori S, 2005, J EXP MED, V201, P1293, DOI 10.1084/jem.20040912; Hermiston ML, 2003, ANNU REV IMMUNOL, V21, P107, DOI 10.1146/annurev.immunol.21.120601.140946; Hoffmann P, 2006, BLOOD, V108, P4260, DOI 10.1182/blood-2006-06-027409; Hori S, 2011, TRENDS IMMUNOL, V32, P295, DOI 10.1016/j.it.2011.04.004; Leitenberg D, 2007, IMMUNOLOGY, V121, P545, DOI 10.1111/j.1365-2567.2007.02602.x; Luke PP, 2011, CURR MOL MED, V1, P533; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Mkrtichyan M, 2011, EUR J IMMUNOL, V41, P2977, DOI 10.1002/eji.201141639; Napoletano C, 2007, CANCER RES, V67, P8358, DOI 10.1158/0008-5472.CAN-07-1035; Napoletano C, 2012, EUR J IMMUNOL, V42, P936, DOI 10.1002/eji.201142086; O'Mahony D, 2007, CLIN CANCER RES, V13, P958, DOI 10.1158/1078-0432.CCR-06-1974; Pen JJ, 2013, J IMMUNOL, V191, P1976, DOI 10.4049/jimmunol.1201008; Polansky JK, 2008, EUR J IMMUNOL, V38, P1654, DOI 10.1002/eji.200838105; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Senovilla L, 2012, ONCOIMMUNOLOGY, V1, P1323, DOI 10.4161/onci.22009; Shimizu J, 2005, J IMMUNOL, V174, P4090, DOI 10.4049/jimmunol.174.7.4090; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; Stone JD, 1997, J IMMUNOL, V158, P5773; Valmori D, 2005, J CLIN INVEST, V115, P1953, DOI 10.1172/JCI23963; van Vliet SJ, 2008, TRENDS IMMUNOL, V29, P83, DOI 10.1016/j.it.2007.10.010; van Vliet SJ, 2006, NAT IMMUNOL, V7, P1200, DOI 10.1038/ni1390	26	17	23	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132617	10.1371/journal.pone.0132617	http://dx.doi.org/10.1371/journal.pone.0132617			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147970	Green Published, gold, Green Submitted			2022-12-26	WOS:000358157600306
J	Ogita, Y; Egami, S; Ebihara, A; Ueda, N; Katada, T; Kontani, K				Ogita, Yoshitaka; Egami, Sachiko; Ebihara, Arisa; Ueda, Nami; Katada, Toshiaki; Kontani, Kenji			Di-Ras2 Protein Forms a Complex with SmgGDS Protein in Brain Cytosol in Order to Be in a Low Affinity State for Guanine Nucleotides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTP-BINDING PROTEINS; RAS-FAMILY; SMALL GTPASES; AMINO-ACID; DI-RAS; EXCHANGE; MOTIF; LOCALIZATION; SUPERFAMILY; PRENYLATION	The Ras family of small GTPases function in a wide variety of biological processes as "molecular switches" by cycling between inactive GDP-bound and active GTP-bound forms. Di-Ras1 and Di-Ras2 were originally identified as small GTPases forming a distinct subgroup of the Ras family. Di-Ras1/Di-Ras2 mRNAs are detected predominantly in brain and heart tissues. Biochemical analysis of Di-Ras1/Di-Ras2 has revealed that they have little GTPase activity and that their intrinsic guanine-nucleotide exchange rates are much faster than that of H-Ras. Yet little is known about the biological role(s) of Di-Ras1/Di-Ras2 or of how their activities are regulated. In the present study we found that endogenous Di-Ras2 co-purifies with SmgGDS from rat brain cytosol. Size-exclusion chromatography of purified recombinant proteins showed that Di-Ras2 forms a high affinity complex with SmgGDS. SmgGDS is a guanine nucleotide exchange factor with multiple armadillo repeats and has recently been shown to specifically activate RhoA and RhoC. In contrast to the effect on RhoA, SmgGDS does not act as a guanine nucleotide exchange factor for Di-Ras2 but instead tightly associates with Di-Ras2 to reduce its binding affinity for guanine nucleotides. Finally, pulse-chase analysis revealed that Di-Ras2 binds, in a C-terminal CAAX motif-dependent manner, to SmgGDS immediately after its synthesis. This leads to increased Di-Ras2 stability. We thus propose that isoprenylated Di-Ras2 forms a tight complex with SmgGDS in cytosol immediately after its synthesis, which lowers its affinity for guanine nucleotides.	[Ogita, Yoshitaka; Egami, Sachiko; Ebihara, Arisa; Ueda, Nami; Katada, Toshiaki; Kontani, Kenji] Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Physiol Chem, Tokyo 1130033, Japan	University of Tokyo	Kontani, K (corresponding author), Meiji Pharmaceut Univ, Dept Biochem, Tokyo 2048588, Japan.	kontani@my-pharm.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; Japan Society for the Promotion of Science (JSPS)	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by research grants from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan (to K. K. and T. K.) and the Japan Society for the Promotion of Science (JSPS) (to K. K. and T. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Berg TJ, 2010, J BIOL CHEM, V285, P35255, DOI 10.1074/jbc.M110.129916; BONIFACINO JS, 2001, CURR PROTOC CELL BIO, pCH7; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; CHUANG TH, 1994, BIOCHEM J, V303, P761, DOI 10.1042/bj3030761; Colicelli John, 2004, Sci STKE, V2004, pRE13, DOI 10.1126/stke.2502004re13; Ellis CA, 2002, P NATL ACAD SCI USA, V99, P9876, DOI 10.1073/pnas.142193799; Gasper Raphael, 2010, Small GTPases, V1, P133, DOI 10.4161/sgtp.1.3.14742; Hamel B, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.191122; Hansen M, 2003, BIOCHEM BIOPH RES CO, V311, P829, DOI 10.1016/j.bbrc.2003.10.074; HIRAOKA K, 1992, BIOCHEM BIOPH RES CO, V182, P921, DOI 10.1016/0006-291X(92)91820-G; Kawazu M, 2013, P NATL ACAD SCI USA, V110, P3029, DOI 10.1073/pnas.1216141110; Kontani K, 2002, J BIOL CHEM, V277, P41070, DOI 10.1074/jbc.M202150200; Macara IG, 1996, FASEB J, V10, P625, DOI 10.1096/fasebj.10.5.8621061; MIZUNO T, 1991, P NATL ACAD SCI USA, V88, P6442, DOI 10.1073/pnas.88.15.6442; PEIFER M, 1994, CELL, V76, P789, DOI 10.1016/0092-8674(94)90353-0; QUILLIAM LA, 1995, P NATL ACAD SCI USA, V92, P1272, DOI 10.1073/pnas.92.5.1272; REINSTEIN J, 1991, J BIOL CHEM, V266, P17700; REPKO EM, 1989, J BIOL CHEM, V264, P9945; Riou P, 2013, CELL, V153, P640, DOI 10.1016/j.cell.2013.03.044; Schuld NJ, 2014, J BIOL CHEM, V289, P6862, DOI 10.1074/jbc.M113.527192; Tada M, 2012, GENES CELLS, V17, P778, DOI 10.1111/j.1365-2443.2012.01627.x; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; TAMATANI T, 1990, INT IMMUNOL, V2, P165, DOI 10.1093/intimm/2.2.165; Vikis HG, 2002, ONCOGENE, V21, P2425, DOI 10.1038/sj.onc.1205306; Whyte DB, 1997, J BIOL CHEM, V272, P14459, DOI 10.1074/jbc.272.22.14459; Williams CL, 2003, CELL SIGNAL, V15, P1071, DOI 10.1016/S0898-6568(03)00098-6; YAMAMOTO T, 1990, J BIOL CHEM, V265, P16626	27	11	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2015	290	33					20245	20256		10.1074/jbc.M115.637769	http://dx.doi.org/10.1074/jbc.M115.637769			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP1AT	26149690	Green Published, hybrid			2022-12-26	WOS:000359608900025
J	Wu, TF; Yao, YL; Lai, IL; Lai, CC; Lin, PL; Yang, WM				Wu, Tsu-Fang; Yao, Ya-Li; Lai, I-Lu; Lai, Chien-Chen; Lin, Pei-Lun; Yang, Wen-Ming			Loading of PAX3 to Mitotic Chromosomes Is Mediated by Arginine Methylation and Associated with Waardenburg Syndrome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL REPRESSION ACTIVITY; CELL MAINTENANCE; BINDING; GENES; HETEROCHROMATIN; BOOKMARKING; EXPRESSION; PROTEIN-1; TISSUE; PRMT5	PAX3 is a transcription factor critical to gene regulation in mammalian development. Mutations in PAX3 are associated with Waardenburg syndrome (WS), but the mechanism of how mutant PAX3 proteins cause WS remains unclear. Here, we found that PAX3 loads on mitotic chromosomes using its homeodomain. PAX3 WS mutants with mutations in homeodomain lose the ability to bind mitotic chromosomes. Moreover, loading of PAX3 on mitotic chromosomes requires arginine methylation, which is regulated by methyltransferase PRMT5 and demethylase JMJD6. Mutant PAX3 proteins that lose mitotic chromosome localization block cell proliferation and normal development of zebrafish. These results reveal the molecular mechanism of PAX3s loading on mitotic chromosomes and the importance of this localization pattern in normal development. Our findings suggest that PAX3 WS mutants interfere with the normal functions of PAX3 in a dominant negative manner, which is important to the understanding of the pathogenesis of Waardenburg syndrome.	[Wu, Tsu-Fang] Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan; [Lai, I-Lu; Lai, Chien-Chen; Yang, Wen-Ming] Natl Chung Hsing Univ, Inst Mol Biol, Taichung 40227, Taiwan; [Lin, Pei-Lun] Natl Chung Hsing Univ, Bachelor Program Biotechnol, Taichung 40227, Taiwan; [Yao, Ya-Li] Asia Univ, Dept Biotechnol, Taichung 41354, Taiwan; [Wu, Tsu-Fang] Hung Kuang Univ, Dept Biotechnol, Taichung 43302, Taiwan	National Chung Hsing University; National Chung Hsing University; National Chung Hsing University; Asia University Taiwan; Hungkuang University	Yao, YL (corresponding author), Asia Univ, Dept Biotechnol, 500 Liu Feng Rd, Taichung 41354, Taiwan.	yyao@asia.edu.tw; yangwm@nchu.edu.tw	/AGZ-4617-2022	/0000-0002-7133-8266; Yang, Wen-Ming/0000-0002-5871-5979	Ministry of Science and Technology [NSC 99-2311-B-005-005-MY3, NSC 102-2311-B-005-005, NSC 98-2311-B-468-001-MY3]; Asia University [103-asia-05]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Asia University	This work was supported by grants from the Ministry of Science and Technology (NSC 99-2311-B-005-005-MY3 and NSC 102-2311-B-005-005 (to W.-M. Y.); NSC 98-2311-B-468-001-MY3 (to Y.-L. Y.)) and Asia University (103-asia-05; to Y.-L. Y.). The authors declare that they have no conflicts of interest with the contents of this article.	Birrane G, 2009, BIOCHEMISTRY-US, V48, P1148, DOI 10.1021/bi802052y; Blake JA, 2014, DEVELOPMENT, V141, P737, DOI 10.1242/dev.091785; Branscombe TL, 2001, J BIOL CHEM, V276, P32971, DOI 10.1074/jbc.M105412200; Bulut-Karslioglu A, 2012, NAT STRUCT MOL BIOL, V19, P1023, DOI 10.1038/nsmb.2382; Burke LJ, 2005, EMBO J, V24, P3291, DOI 10.1038/sj.emboj.7600793; Caravaca JM, 2013, GENE DEV, V27, P251, DOI 10.1101/gad.206458.112; Chang BS, 2007, SCIENCE, V318, P444, DOI 10.1126/science.1145801; Corry GN, 2008, HUM MOL GENET, V17, P1825, DOI 10.1093/hmg/ddn076; Di Lorenzo A, 2011, FEBS LETT, V585, P2024, DOI 10.1016/j.febslet.2010.11.010; EPSTEIN DJ, 1991, CELL, V67, P767, DOI 10.1016/0092-8674(91)90071-6; Hsieh FS, 2014, BBA-GENE REGUL MECH, V1839, P579, DOI 10.1016/j.bbagrm.2014.05.007; Hsieh MJ, 2006, BIOCHEM BIOPH RES CO, V349, P573, DOI 10.1016/j.bbrc.2006.08.064; Jeon HY, 2013, FEBS J, V280, P1518, DOI 10.1111/febs.12153; Kadauke S, 2012, CELL, V150, P725, DOI 10.1016/j.cell.2012.06.038; Kubic JD, 2008, PIGM CELL MELANOMA R, V21, P627, DOI 10.1111/j.1755-148X.2008.00514.x; Lai IL, 2010, J BIOL CHEM, V285, P7187, DOI 10.1074/jbc.M109.061861; Lang D, 2005, NATURE, V433, P884, DOI 10.1038/nature03292; Lang D, 2007, BIOCHEM PHARMACOL, V73, P1, DOI 10.1016/j.bcp.2006.06.024; Maroto M, 1997, CELL, V89, P139, DOI 10.1016/S0092-8674(00)80190-7; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; Pingault V, 2010, HUM MUTAT, V31, P391, DOI 10.1002/humu.21211; Richard S, 2005, BIOCHEM J, V388, P379, DOI 10.1042/BJ20040373; Ridgeway AG, 2001, J BIOL CHEM, V276, P19033, DOI 10.1074/jbc.M011491200; TASSABEHJI M, 1995, HUM MOL GENET, V4, P2131, DOI 10.1093/hmg/4.11.2131; Vogan KJ, 1997, J BIOL CHEM, V272, P28289, DOI 10.1074/jbc.272.45.28289; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Wu TF, 2014, ANTICANCER RES, V34, P4717; Yao YL, 2003, J BIOL CHEM, V278, P42560, DOI 10.1074/jbc.M302955200; Zaidi SK, 2010, NAT REV GENET, V11, P583, DOI 10.1038/nrg2827	29	20	20	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2015	290	33					20556	20564		10.1074/jbc.M114.607713	http://dx.doi.org/10.1074/jbc.M114.607713			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP1AT	26149688	hybrid, Green Published			2022-12-26	WOS:000359608900051
J	Gonzalez-Wevar, CA; Salinas, P; Hune, M; Segovia, NI; Vargas-Chacoff, L; Astorga, M; Canete, JI; Poulin, E				Gonzalez-Wevar, Claudio A.; Salinas, Pilar; Huene, Mathias; Segovia, Nicolas I.; Vargas-Chacoff, Luis; Astorga, Marcela; Canete, Juan I.; Poulin, Elie			Phylogeography in Galaxias maculatus (Jenyns, 1848) along Two Biogeographical Provinces in the Chilean Coast	PLOS ONE			English	Article							LAST GLACIAL MAXIMUM; CLIMATE-CHANGE; GENETIC CONSEQUENCES; EVOLUTIONARY HISTORY; DIVERGENCE; PATAGONIA; DISPERSAL; MIGRATION; ATLANTIC; PATTERNS	Major geologic and climatic changes during the Quaternary exerted a major role in shaping past and contemporary distribution of genetic diversity and structure of aquatic organisms in southern South America. In fact, the northern glacial limit along the Pacific coast, an area of major environmental changes in terms of topography, currents, and water salinity, represents a major biogeographic transition for marine and freshwater species. We used mitochondrial DNA sequences (D-loop) to investigate the consequences of Quaternary glacial cycles over the pattern of genetic diversity and structure of G. maculatus (Pisces: Galaxiidae) along two biogeographical provinces in the Chilean coast. Extreme levels of genetic diversity and strong phylogeographic structure characterize the species suggesting a low amount of influence of the last glacial cycle over its demography. However, we recognized contrasting patterns of genetic diversity and structure between main biogeographical areas here analyzed. Along the Intermediate Area (38 degrees-41 degrees S) each estuarine population constitutes a different unit. In contrast, Magellanic populations (43 degrees-53 degrees S) exhibited low levels of genetic differentiation. Contrasting patterns of genetic diversity and structure recorded in the species between the analyzed biogeographic areas are consistent with the marked differences in abiotic factors (i.e., different coastal configurations, Quaternary glacial histories, and oceanographic regimes) and to inherent characteristics of the species (i.e., salt-tolerance, physiology, and reproductive behavior).	[Gonzalez-Wevar, Claudio A.] Univ Magallanes, GAIA Antartica, Punta Arenas, Chile; [Gonzalez-Wevar, Claudio A.; Salinas, Pilar; Huene, Mathias; Segovia, Nicolas I.; Poulin, Elie] Univ Chile, Fac Ciencias, Inst Ecol Biodiversidad, Dept Ciencias Ecol,Lab Ecol Mol, Santiago, Chile; [Huene, Mathias] Fdn Ictiol, Santiago, Chile; [Vargas-Chacoff, Luis] Univ Austral Chile, Fac Ciencias, Inst Ciencias Marinas & Limnol, Valdivia, Chile; [Astorga, Marcela] Univ Austral Chile, CIEN Austral Puerto Montt, Inst Acuicultura, Puerto Montt, Chile; [Canete, Juan I.] Univ Magallanes, Dept Recursos Nat, Punta Arenas, Chile	Universidad de Magallanes; Universidad de Chile; Universidad Austral de Chile; Universidad Austral de Chile; Universidad de Magallanes	Gonzalez-Wevar, CA (corresponding author), Univ Magallanes, GAIA Antartica, Punta Arenas, Chile.	omeuno01@hotmail.com	Hüne, Mathias/ABE-6000-2020; Astorga, Marcela/AAA-8115-2019; González-Wevar, Claudio Alejandro/AAD-6513-2021; Poulin, Elie/C-2654-2012; Vargas-Chacoff, Luis LVCh/A-5855-2012; Canete, Juan/GRS-4620-2022	Poulin, Elie/0000-0001-7736-0969; Vargas-Chacoff, Luis/0000-0002-0497-2582; Astorga, Marcela/0000-0002-9364-2365	post-doctorate fellowship (Fondecyt) [3120075]; Insituto de Ecologia y Biodiversidad IEB, Universidad de Chile [P05-002 ICM, PFB 023]; project Fondecyt [1110798]	post-doctorate fellowship (Fondecyt)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Insituto de Ecologia y Biodiversidad IEB, Universidad de Chile; project Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This study was supported by a post-doctorate fellowship (Fondecyt 3120075) to CAG-W. All the specimens were captured under the Chilean legislation (Technical Memorandum P.INV No 427/2011 SUBPESCA). At the same time, this research was supported by the Projects P05-002 ICM and PFB 023 (Insituto de Ecologia y Biodiversidad IEB, Universidad de Chile), to EP and CG-W and project Fondecyt 1110798 to LV-C.	Aljanabi SM, 1997, NUCLEIC ACIDS RES, V25, P4692, DOI 10.1093/nar/25.22.4692; Alo D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071577; Barriga JP, 2002, NEW ZEAL J MAR FRESH, V36, P345, DOI 10.1080/00288330.2002.9517092; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; BENNETT KD, 1991, J BIOGEOGR, V18, P103, DOI 10.2307/2845248; Burridge CP, 2012, J BIOGEOGR, V39, P306, DOI 10.1111/j.1365-2699.2011.02600.x; Bustos CA, 2011, CONT SHELF RES, V31, P293, DOI 10.1016/j.csr.2010.03.013; Camus PA, 2001, REV CHIL HIST NAT, V74, P587, DOI 10.4067/S0716-078X2001000300008; Ceballos SG, 2012, MAR BIOL, V159, P499, DOI 10.1007/s00227-011-1830-4; Clapperton CM, 1993, QUATERNARY GEOLOGY G; Cussac V, 2004, J BIOGEOGR, V31, P103, DOI 10.1046/j.0305-0270.2003.01000.x; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; de Aranzamendi MC, 2011, MAR BIOL, V158, P2405, DOI 10.1007/s00227-011-1742-3; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dyer Brian S., 2000, Estudios Oceanologicos, V19, P77; Palma RE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032206; Escribano Rubén, 2003, Gayana (Concepc.), V67, P190; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Filatov DA, 2009, BIOINFORMATICS, V25, P3189, DOI 10.1093/bioinformatics/btp572; Fraser CI, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-203; Gersonde R, 2005, QUATERNARY SCI REV, V24, P869, DOI 10.1016/j.quascirev.2004.07.015; Goldstien SJ, 2006, MOL ECOL, V15, P3259, DOI 10.1111/j.1365-294X.2006.02977.x; Gonzalez-Wevar CA, 2011, MOL ECOL, V20, P1936, DOI 10.1111/j.1365-294X.2011.05065.x; Gonzalez-Wevar C, 2015, J HERED, V106, P439, DOI 10.1093/jhered/esv005; Gonzalez-Wevar CA, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-139; Haye PA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088613; Hein AS, 2010, QUATERNARY SCI REV, V29, P1212, DOI 10.1016/j.quascirev.2010.01.020; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Hey J, 2007, P NATL ACAD SCI USA, V104, P2785, DOI 10.1073/pnas.0611164104; Himes CMT, 2008, J BIOGEOGR, V35, P1415, DOI 10.1111/j.1365-2699.2008.01895.x; Hudson RR, 2000, GENETICS, V155, P2011; Hune M, 2015, POLAR BIOL, V38, P607, DOI 10.1007/s00300-014-1623-6; Hulton NRJ, 2002, QUATERNARY SCI REV, V21, P233, DOI 10.1016/S0277-3791(01)00103-2; Jakob SS, 2009, MOL BIOL EVOL, V26, P907, DOI 10.1093/molbev/msp012; Jolly MT, 2005, HEREDITY, V94, P23, DOI 10.1038/sj.hdy.6800543; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kemp AES, 2010, QUATERNARY SCI REV, V29, P1993, DOI 10.1016/j.quascirev.2010.04.027; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lessa EP, 2010, MOL ECOL, V19, P3031, DOI 10.1111/j.1365-294X.2010.04734.x; Lessa EP, 2003, P NATL ACAD SCI USA, V100, P10331, DOI 10.1073/pnas.1730921100; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Macaya EC, 2010, MAR ECOL PROG SER, V420, P103, DOI 10.3354/meps08893; Maggs CA, 2008, ECOLOGY, V89, pS108, DOI 10.1890/08-0257.1; Marko PB, 2004, MOL ECOL, V13, P597, DOI 10.1046/j.1365-294X.2004.02096.x; Marko PB, 2010, MOL ECOL, V19, P146, DOI 10.1111/j.1365-294X.2009.04417.x; McCulloch RD, 2000, J QUATERNARY SCI, V15, P409, DOI 10.1002/1099-1417(200005)15:4<409::AID-JQS539>3.0.CO;2-#; MCDOWALL R M, 1970, Bulletin of the Museum of Comparative Zoology, V139, P341; MCDOWALL R M, 1975, New Zealand Journal of Marine and Freshwater Research, V9, P1; MCDOWALL RM, 1978, SYST ZOOL, V27, P88, DOI 10.2307/2412819; McMahon SM, 2011, TRENDS ECOL EVOL, V26, P249, DOI 10.1016/j.tree.2011.02.012; Near TJ, 2012, P NATL ACAD SCI USA, V109, P3434, DOI 10.1073/pnas.1115169109; Nielsen R, 2001, GENETICS, V158, P885; Nunez JJ, 2011, MOL PHYLOGENET EVOL, V58, P343, DOI 10.1016/j.ympev.2010.11.026; Pardinas UFJ, 2011, BIOL J LINN SOC, V103, P495, DOI 10.1111/j.1095-8312.2011.01679.x; PARMESAN C, 2006, ANNU REV ECOL EVOL, V37, P1, DOI DOI 10.1146/annurev.ecolsys.37.091305.110035; Pastorino MJ, 2002, J BIOGEOGR, V29, P1167, DOI 10.1046/j.1365-2699.2002.00731.x; Pons O, 1996, GENETICS, V144, P1237; Provan J, 2008, TRENDS ECOL EVOL, V23, P564, DOI 10.1016/j.tree.2008.06.010; Rabassa J, 2005, J S AM EARTH SCI, V20, P81, DOI 10.1016/j.jsames.2005.07.004; Rabassa J, 2011, BIOL J LINN SOC, V103, P316, DOI 10.1111/j.1095-8312.2011.01681.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; ROSEN DE, 1978, SYST ZOOL, V27, P159, DOI 10.2307/2412970; Ruzzante DE, 2008, MOL ECOL, V17, P2234, DOI 10.1111/j.1365-294X.2008.03738.x; Ruzzante DE, 2006, MOL ECOL, V15, P2949, DOI 10.1111/j.1365-294X.2006.03010.x; Salinas MP., 2011, THESIS U CHILE SANTI, P56; Sersic AN, 2011, BIOL J LINN SOC, V103, P475, DOI 10.1111/j.1095-8312.2011.01656.x; SLATKIN M, 1995, GENETICS, V139, P457; Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; Taylor MS, 2006, MOL ECOL, V15, P695, DOI 10.1111/j.1365-294X.2006.02820.x; Thiel M, 2007, OCEANOGR MAR BIOL, V45, P195; Unmack PJ, 2012, MOL ECOL, V21, P942, DOI 10.1111/j.1365-294X.2011.05408.x; Unmack PJ, 2009, BIOL J LINN SOC, V97, P876, DOI 10.1111/j.1095-8312.2009.01224.x; Valdenegro Alexander, 2003, Ciencia y Tecnologia del Mar, V26, P19; Valdovinos C, 2003, ECOGRAPHY, V26, P139, DOI 10.1034/j.1600-0587.2003.03349.x; Vavrek MJ, 2011, PALAEONTOL ELECTRON, V14; Vianna JA, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-53; Victoriano PF, 2008, MOL ECOL, V17, P2397, DOI 10.1111/j.1365-294X.2008.03741.x; Waters JM, 2000, SYST BIOL, V49, P777, DOI 10.1080/106351500750049824; Waters JM, 2000, MOL ECOL, V9, P1815, DOI 10.1046/j.1365-294x.2000.01082.x; Waters JM, 1999, MOL PHYLOGENET EVOL, V11, P1, DOI 10.1006/mpev.1998.0554; Waters JM, 2004, SYST BIOL, V53, P18, DOI 10.1080/10635150490264671; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Xu JW, 2009, MOL ECOL, V18, P904, DOI 10.1111/j.1365-294X.2008.04070.x; Zattara EE, 2005, J BIOGEOGR, V32, P5, DOI 10.1111/j.1365-2699.2004.01164.x; Zemlak TS, 2011, MOL ECOL, V20, P5280, DOI 10.1111/j.1365-294X.2011.05352.x; Zemlak TS, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-67; Zemlak TS, 2008, MOL ECOL, V17, P5049, DOI 10.1111/j.1365-294X.2008.03987.x	90	25	25	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131289	10.1371/journal.pone.0131289	http://dx.doi.org/10.1371/journal.pone.0131289			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161896	Green Published, gold, Green Submitted			2022-12-26	WOS:000358162300031
J	Wang, CS; Oshima, M; Sashida, G; Tomioka, T; Hasegawa, N; Mochizuki-Kashio, M; Nakajima-Takagi, Y; Kusunoki, Y; Kyoizumi, S; Imai, K; Nakachi, K; Iwama, A				Wang, Changshan; Oshima, Motohiko; Sashida, Goro; Tomioka, Takahisa; Hasegawa, Nagisa; Mochizuki-Kashio, Makiko; Nakajima-Takagi, Yaeko; Kusunoki, Yoichiro; Kyoizumi, Seishi; Imai, Kazue; Nakachi, Kei; Iwama, Atsushi			Non-Lethal Ionizing Radiation Promotes Aging-Like Phenotypic Changes of Human Hematopoietic Stem and Progenitor Cells in Humanized Mice	PLOS ONE			English	Article							EXPRESSION; HALLMARKS; SUBTYPES; REPAIR; MOUSE; IL-7	Precise understanding of radiation effects is critical to develop new modalities for the prevention and treatment of radiation-induced damage. We previously reported that non-lethal doses of X-ray irradiation induce DNA damage in human hematopoietic stem and progenitor cells (HSPCs) reconstituted in NOD/Shi-scid IL2r gamma(null) (NOG) immunodeficient mice and severely compromise their repopulating capacity. In this study, we analyzed in detail the functional changes in human HSPCs in NOG mice following non-lethal radiation. We transplanted cord blood CD34(+) HSPCs into NOG mice. At 12 weeks post-transplantation, the recipients were irradiated with 0, 0.5, or 1.0 Gy. At 2 weeks post-irradiation, human CD34(+) HSPCs recovered from the primary recipient mice were transplanted into secondary recipients. CD34(+) HSPCs from irradiated mice showed severely impaired reconstitution capacity in the secondary recipient mice. Of interest, non-lethal radiation compromised contribution of HSPCs to the peripheral blood cells, particularly to CD19(+) B lymphocytes, which resulted in myeloid-biased repopulation. Co-culture of limiting numbers of CD34(+) HSPCs with stromal cells revealed that the frequency of B cell-producing CD34(+) HSPCs at 2 weeks post-irradiation was reduced more than 10-fold. Furthermore, the key B-cell regulator genes such as IL-7R and EBF1 were downregulated in HSPCs upon 0.5 Gy irradiation. Given that compromised repopulating capacity and myeloid-biased differentiation are representative phenotypes of aged HSCs, our findings indicate that non-lethal ionizing radiation is one of the critical external stresses that promote aging of human HSPCs in the bone marrow niche.	[Wang, Changshan; Oshima, Motohiko; Sashida, Goro; Tomioka, Takahisa; Hasegawa, Nagisa; Mochizuki-Kashio, Makiko; Nakajima-Takagi, Yaeko; Iwama, Atsushi] Chiba Univ, Grad Sch Med, Dept Cellular & Mol Med, Chiba 2608670, Japan; [Wang, Changshan] Inner Mongolia Univ, Coll Life Sci, Hohhot 010021, Peoples R China; [Sashida, Goro] Kumamoto Univ, Int Res Ctr Med Sci, Kumamoto 8600811, Japan; [Hasegawa, Nagisa] Chiba Univ Hosp, Dept Hematol, Chiba 2608670, Japan; [Kusunoki, Yoichiro; Kyoizumi, Seishi; Imai, Kazue; Nakachi, Kei] Radiat Effects Res Fdn, Dept Radiobiol Mol Epidemiol, Hiroshima 7320815, Japan	Chiba University; Inner Mongolia University; Kumamoto University; Chiba University; Radiation Effects Research Foundation - Japan	Iwama, A (corresponding author), Chiba Univ, Grad Sch Med, Dept Cellular & Mol Med, Chiba 2608670, Japan.	aiwama@faculty.chiba-u.jp	Sashida, Goro/N-5259-2014	Sashida, Goro/0000-0003-2318-5987	Japanese Ministry of Health, Labor, and Welfare (MHLW); U.S. Department of Energy (DOE); RERF Research Protocol [5-09]; U.S. National Institute of Allergy and Infectious Diseases (NIAID) [HHSN272200900059C]; Grants-in-Aid for Scientific Research [14J40024] Funding Source: KAKEN	Japanese Ministry of Health, Labor, and Welfare (MHLW)(Ministry of Health, Labour and Welfare, Japan); U.S. Department of Energy (DOE)(United States Department of Energy (DOE)); RERF Research Protocol; U.S. National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The Radiation Effects Research Foundation (RERF), Hiroshima and Nagasaki, Japan, is a public interest foundation funded by the Japanese Ministry of Health, Labor, and Welfare (MHLW) and the U.S. Department of Energy (DOE). This publication was supported by RERF Research Protocol 5-09 and by the U.S. National Institute of Allergy and Infectious Diseases (NIAID Contract HHSN272200900059C). The views of the authors do not necessarily reflect those of the two governments. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attema JL, 2009, ONCOGENE, V28, P2238, DOI 10.1038/onc.2009.94; Beerman I, 2013, CELL STEM CELL, V12, P413, DOI 10.1016/j.stem.2013.01.017; Beerman I, 2010, P NATL ACAD SCI USA, V107, P5465, DOI 10.1073/pnas.1000834107; Benz C, 2012, CELL STEM CELL, V10, P273, DOI 10.1016/j.stem.2012.02.007; Challen GA, 2010, CELL STEM CELL, V6, P265, DOI 10.1016/j.stem.2010.02.002; Doulatov S, 2012, CELL STEM CELL, V10, P120, DOI 10.1016/j.stem.2012.01.006; Dykstra B, 2007, CELL STEM CELL, V1, P218, DOI 10.1016/j.stem.2007.05.015; Ema H, 2014, EXP HEMATOL, V42, P74, DOI 10.1016/j.exphem.2013.11.004; FULOP GM, 1990, NATURE, V347, P479, DOI 10.1038/347479a0; Geiger H, 2013, NAT REV IMMUNOL, V13, P376, DOI 10.1038/nri3433; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Kuranda K, 2011, AGING CELL, V10, P542, DOI 10.1111/j.1474-9726.2011.00675.x; Lawrence HJ, 2005, BLOOD, V106, P3988, DOI 10.1182/blood-2005-05-2003; Lescale C, 2010, AGING CELL, V9, P410, DOI 10.1111/j.1474-9726.2010.00566.x; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Masuda K, 2005, EMBO J, V24, P4052, DOI 10.1038/sj.emboj.7600878; Morrison SJ, 1996, NAT MED, V2, P1011, DOI 10.1038/nm0996-1011; Muller-Sieburg CE, 2004, BLOOD, V103, P4111, DOI 10.1182/blood-2003-10-3448; Nakachi K, 2008, MUTAT RES-REV MUTAT, V659, P109, DOI 10.1016/j.mrrev.2008.02.001; Nijnik A, 2007, NATURE, V447, P686, DOI 10.1038/nature05875; Oshima M, 2014, INT J HEMATOL, V100, P326, DOI 10.1007/s12185-014-1647-2; Pang WW, 2011, P NATL ACAD SCI USA, V108, P20012, DOI 10.1073/pnas.1116110108; Ramirez J, 2010, CURR OPIN IMMUNOL, V22, P177, DOI 10.1016/j.coi.2010.02.003; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102; Rube CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017487; Shao LJ, 2014, BLOOD, V123, P3105, DOI 10.1182/blood-2013-07-515619; Signer RAJ, 2013, CELL STEM CELL, V12, P152, DOI 10.1016/j.stem.2013.01.001; Sperka T, 2012, NAT REV MOL CELL BIO, V13, P579, DOI 10.1038/nrm3420; Sudo K, 2000, J EXP MED, V192, P1273, DOI 10.1084/jem.192.9.1273; Unnisa Z, 2012, BLOOD, V120, P4973, DOI 10.1182/blood-2012-06-435800; Van Zant G, 2003, EXP HEMATOL, V31, P659, DOI 10.1016/S0301-472X(03)00088-2; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519; Wang CS, 2013, INT J RADIAT BIOL, V89, P132, DOI 10.3109/09553002.2013.734947; Yamamoto R, 2013, CELL, V154, P1112, DOI 10.1016/j.cell.2013.08.007; Zon LI, 2008, NATURE, V453, P306, DOI 10.1038/nature07038	38	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132041	10.1371/journal.pone.0132041	http://dx.doi.org/10.1371/journal.pone.0132041			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161905	Green Submitted, Green Published, gold			2022-12-26	WOS:000358162300085
J	Xia, L; Sun, LH; Wang, XL; Yao, ML; Xu, FL; Cheng, GM; Wang, XY; Zhu, CL				Xia, Lei; Sun, Lihuan; Wang, Xingling; Yao, Meiling; Xu, Falin; Cheng, Guomei; Wang, Xiaoyang; Zhu, Changlian			Changes in the Incidence of Congenital Anomalies in Henan Province, China, from 1997 to 2011	PLOS ONE			English	Article							NEURAL-TUBE DEFECTS; BIRTH-DEFECTS; MATERNAL AGE; FOLIC-ACID; INFANT-MORTALITY; UNITED-STATES; RISK-FACTOR; PREVALENCE; ASSOCIATION; PREVENTION	Aim To investigate changes in incidence and characteristics of congenital anomalies in infants in Henan Province of China over a period of 15 years. Methods Population-based surveillance in Henan Province was conducted from 1997 to 2011 in 75 hospitals (40 urban districts and 35 rural counties, comprising about 20% of the total births). Basic population information was obtained from the healthcare network. All live births, intrauterine deaths after 28 weeks, and stillbirths were included. Congenital anomalies were diagnosed and reported to Henan Provincial Maternal and Pediatric Healthcare Hospital. Results Of 1,815,920 births from 1997 to 2011, 15,660 cases of congenital anomalies were identified, resulting in an average incidence of 86.2 cases per 10,000 births. The incidence of congenital anomalies showed a significant downward trend (p < 0.0001) in rural areas and the whole province (p < 0.0001), but an increase in urban areas (p = 0.003). The incidence was much higher in rural than in urban areas in 1997, but this discrepancy decreased rapidly and no difference was seen between rural and urban areas in 2003. The incidence in females was higher than in males in 1997-1999 but decreased to a similar level as that in males in 2000. Maternal age exceeding 35 years was associated with a higher incidence of congenital anomalies. Among the 23 types of congenital anomalies recorded, neural tube defects were the most common; the incidence declined from 39.3 cases per 10,000 births in 1997 to 6.1 cases per 10,000 births in 2011. Conclusion The incidence of congenital anomalies has decreased in Henan Province over the past 15 years due to significant reductions in rural areas and among girls. This decrease was partly related to a reduction in neural tube defects that was likely the result of a folic acid intervention in the province.	[Xia, Lei; Xu, Falin; Wang, Xiaoyang; Zhu, Changlian] Zhengzhou Univ, Affiliated Hosp 3, Dept Pediat, Zhengzhou 450052, Peoples R China; [Sun, Lihuan; Yao, Meiling] Zhengzhou Univ, Affiliated Hosp 3, Dept Women & Childrens Healthcare, Zhengzhou 450052, Peoples R China; [Wang, Xingling] Zhengzhou Univ, Affiliated Hosp 3, Reprod Ctr, Zhengzhou 450052, Peoples R China; [Cheng, Guomei] Zhengzhou Univ, Affiliated Hosp 3, Perinatal Ctr, Zhengzhou 450052, Peoples R China; [Wang, Xiaoyang] Univ Gothenburg, Sahlgrenska Acad, Perinatal Ctr, Gothenburg, Sweden; [Zhu, Changlian] Univ Gothenburg, Sahlgrenska Acad, Ctr Brain Repair & Rehabil, Gothenburg, Sweden	Zhengzhou University; Zhengzhou University; Zhengzhou University; Zhengzhou University; University of Gothenburg; University of Gothenburg	Sun, LH (corresponding author), Zhengzhou Univ, Affiliated Hosp 3, Dept Women & Childrens Healthcare, Zhengzhou 450052, Peoples R China.	sunlihuanw@163.com; changlian.zhu@neuro.gu.se	Zhu, Changlian/AAN-6205-2020	Zhu, Changlian/0000-0002-5029-6730; Wang, Xiaoyang/0000-0001-9717-8160	Science and Technology Bureau of Zhengzhou [131PCXTD621]; Department of Education [2011B320020]; Department of Health [201201002]; Department of Science and Technology of Henan Province, China [134200510023]	Science and Technology Bureau of Zhengzhou; Department of Education(US Department of Education); Department of Health; Department of Science and Technology of Henan Province, China	This study was supported by the Science and Technology Bureau of Zhengzhou (131PCXTD621), the Department of Education (2011B320020), the Department of Health (201201002) and the Department of Science and Technology of Henan Province (134200510023), China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agay-Shay K, 2012, BIRTH DEFECTS RES A, V94, P438, DOI 10.1002/bdra.23010; Berry RJ, 1999, NEW ENGL J MED, V341, P1485, DOI 10.1056/NEJM199911113412001; Bestwick JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089354; Cheng N, 2003, ANN TROP PAEDIATR, V23, P25, DOI 10.1179/000349803125002823; Copp AJ, 2013, LANCET NEUROL, V12, P799, DOI 10.1016/S1474-4422(13)70110-8; Correa A, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2011.12.018; Dai L, 2011, WORLD J PEDIATR, V7, P302, DOI 10.1007/s12519-011-0326-0; Dan S, 2012, PRENATAL DIAG, V32, P1225, DOI 10.1002/pd.4002; Deak KL, 2008, BIRTH DEFECTS RES A, V82, P662, DOI 10.1002/bdra.20511; Deng XX, 2014, NAT REV GENET, V15, P367, DOI 10.1038/nrg3687; Du LN, 2004, J BIOL CHEM, V279, P38563, DOI 10.1074/jbc.M405461200; Fan LC, 2013, BIRTH DEFECTS RES A, V97, P750, DOI 10.1002/bdra.23148; Gill SK, 2012, BIRTH DEFECTS RES A, V94, P1010, DOI 10.1002/bdra.23049; Houghton LA, 2011, AM J CLIN NUTR, V94, P136, DOI 10.3945/ajcn.110.004549; Huo KM, 2010, PAEDIATR PERINAT EP, V24, P343, DOI 10.1111/j.1365-3016.2010.01126.x; Jahromi BN, 2008, TAIWAN J OBSTET GYNE, V47, P318, DOI 10.1016/S1028-4559(08)60131-X; Lee K, 2001, OBSTET GYNECOL, V98, P620, DOI 10.1016/S0029-7844(01)01507-1; Li XH, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-161; Liu JF, 2015, PUBLIC HEALTH NUTR, V18, P582, DOI 10.1017/S1368980014000950; Luke B, 2007, HUM REPROD, V22, P1264, DOI 10.1093/humrep/del522; Natsume N, 2000, BRIT J ORAL MAX SURG, V38, P23, DOI 10.1054/bjom.1999.0133; Ooki S, 2013, INT J WOMENS HEALTH, V5, P65, DOI 10.2147/IJWH.S32296; Reefhuis J, 2004, BIRTH DEFECTS RES A, V70, P572, DOI 10.1002/bdra.20065; Ren AG, 2011, P NATL ACAD SCI USA, V108, P12770, DOI 10.1073/pnas.1105209108; Rosano A, 2000, J EPIDEMIOL COMMUN H, V54, P660, DOI 10.1136/jech.54.9.660; Rosano A, 2000, AM J MED GENET, V93, P110, DOI 10.1002/1096-8628(20000717)93:2<110::AID-AJMG6>3.0.CO;2-9; Rossi AC, 2013, OBSTET GYNECOL, V122, P1160, DOI 10.1097/AOG.0000000000000015; Rudan I, 2010, LANCET, V375, P1083, DOI 10.1016/S0140-6736(10)60060-8; Sokal R, 2014, BIRTH DEFECTS RES A, V100, P79, DOI 10.1002/bdra.23218; Tang KF, 2015, SCI REP-UK, V5, DOI 10.1038/srep08510; Wang ZP, 2012, J MATERN-FETAL NEO M, V25, P389, DOI 10.3109/14767058.2011.580800; Yang JH, 2004, J KOREAN MED SCI, V19, P509, DOI 10.3346/jkms.2004.19.4.509; Yang WF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053429; Yaniv SS, 2011, ARCH GYNECOL OBSTET, V283, P755, DOI 10.1007/s00404-010-1459-4; Zeng ZQ, 2011, PUBLIC HEALTH NUTR, V14, P1142, DOI 10.1017/S1368980011000097; Zhang XH, 2011, BIRTH DEFECTS RES A, V91, P34, DOI 10.1002/bdra.20725; Zhang XG, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-125; Zhu L, 2008, FOOD NUTR BULL, V29, pS196, DOI 10.1177/15648265080292S123	38	11	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131874	10.1371/journal.pone.0131874	http://dx.doi.org/10.1371/journal.pone.0131874			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161554	Green Submitted, Green Published, gold			2022-12-26	WOS:000358162300070
J	Aryal, UK; Ross, ARS; Krochko, JE				Aryal, Uma K.; Ross, Andrew R. S.; Krochko, Joan E.			Enrichment and Analysis of Intact Phosphoproteins in Arabidopsis Seedlings	PLOS ONE			English	Article							ION AFFINITY-CHROMATOGRAPHY; LARGE-SCALE ANALYSIS; PHOSPHORYLATION SITES; SEED-GERMINATION; PLASMA-MEMBRANE; TYROSINE PHOSPHORYLATION; SIGNAL-TRANSDUCTION; GENE-EXPRESSION; REVEALS; THALIANA	Protein phosphorylation regulates diverse cellular functions and plays a key role in the early development of plants. To complement and expand upon previous investigations of protein phosphorylation in Arabidopsis seedlings we used an alternative approach that combines protein extraction under non-denaturing conditions with immobilized metal-ion affinity chromatography (IMAC) enrichment of intact phosphoproteins in Rubisco-depleted extracts, followed by identification using two-dimensional gel electrophoresis (2-DE) and liquid chromatography-tandem mass spectrometry (LC-MS/MS). In-gel trypsin digestion and analysis of selected gel spots identified 144 phosphorylated peptides and residues, of which only18 phosphopeptides and 8 phosphosites were found in the PhosPhAt 4.0 and (PDB)-D-3 Arabidopsis thaliana phosphorylation site databases. More than half of the 82 identified phosphoproteins were involved in carbohydrate metabolism, photosynthesis/respiration or oxidative stress response mechanisms. Enrichment of intact phosphoproteins prior to 2-DE and LC-MS/MS appears to enhance detection of phosphorylated threonine and tyrosine residues compared with methods that utilize peptide-level enrichment, suggesting that the two approaches are somewhat complementary in terms of phosphorylation site coverage. Comparing results for young seedlings with those obtained previously for mature Arabidopsis leaves identified five proteins that are differentially phosphorylated in these tissues, demonstrating the potential of this technique for investigating the dynamics of protein phosphorylation during plant development.	[Aryal, Uma K.; Ross, Andrew R. S.; Krochko, Joan E.] Natl Res Council Canada, Saskatoon, SK S7N 0W9, Canada	National Research Council Canada	Ross, ARS (corresponding author), Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA.	andrew.ross@dfo-mpo.gc.ca			National Research Council (NRC); Saskatchewan Provincial Government; NRC	National Research Council (NRC); Saskatchewan Provincial Government; NRC(National Research Centre (NRC))	UKA also acknowledges the generous support from the National Research Council (NRC) for a postdoctoral Visiting Fellowship. Funding for protein mass spectrometry equipment was provided by the Saskatchewan Provincial Government and NRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This article is contribution number 54680 from the National Research Council of Canada.	Alexandersson E, 2004, PLANT CELL PHYSIOL, V45, P1543, DOI 10.1093/pcp/pch209; AOYAGI K, 1985, PLANT PHYSIOL, V78, P661, DOI 10.1104/pp.78.3.661; Aryal UK, 2012, J PROTEOME RES, V11, P425, DOI 10.1021/pr200917t; BEEVERS H, 1956, PLANT PHYSIOL, V31, P440, DOI 10.1104/pp.31.6.440; Benschop JJ, 2007, MOL CELL PROTEOMICS, V6, P1198, DOI 10.1074/mcp.M600429-MCP200; Bodenmiller B, 2007, NAT METHODS, V4, P231, DOI 10.1038/nmeth1005; Cellar NA, 2008, J CHROMATOGR B, V861, P29, DOI 10.1016/j.jchromb.2007.11.024; Cellar NA, 2009, J CHROMATOGR B, V877, P79, DOI 10.1016/j.jchromb.2008.11.020; Cernac A, 2006, PLANT PHYSIOL, V141, P745, DOI 10.1104/pp.106.079574; Chen M, 2010, PLANT CELL, V22, P77, DOI 10.1105/tpc.109.071837; van Bentem SDF, 2006, NUCLEIC ACIDS RES, V34, P3267, DOI 10.1093/nar/gkl429; Durek P, 2010, NUCLEIC ACIDS RES, V38, pD828, DOI 10.1093/nar/gkp810; Eastmond PJ, 2001, TRENDS PLANT SCI, V6, P72, DOI 10.1016/S1360-1385(00)01835-5; Foreman J, 2003, NATURE, V422, P442, DOI 10.1038/nature01485; Ghelis T, 2011, PLANT SIGNAL BEHAV, V6, P942, DOI 10.4161/psb.6.7.15261; Graham IA, 2008, ANNU REV PLANT BIOL, V59, P115, DOI 10.1146/annurev.arplant.59.032607.092938; Grimsrud PA, 2010, PLANT PHYSIOL, V152, P19, DOI 10.1104/pp.109.149625; He Y, 2011, NEW PHYTOL, V189, P160, DOI 10.1111/j.1469-8137.2010.03460.x; Heazlewood JL, 2008, NUCLEIC ACIDS RES, V36, pD1015, DOI 10.1093/nar/gkm812; Horvath DP, 2003, TRENDS PLANT SCI, V8, P534, DOI 10.1016/j.tplants.2003.09.013; Jebanathirajah JA, 1998, PLANTA, V204, P177, DOI 10.1007/s004250050244; Jones AME, 2009, J PROTEOMICS, V72, P439, DOI 10.1016/j.jprot.2009.02.004; Kress W, 2009, RES MICROBIOL, V160, P618, DOI 10.1016/j.resmic.2009.08.006; Lapik YR, 2003, PLANT CELL, V15, P1578, DOI 10.1105/tpc.011890; Lichtenthaler HK, 1999, ANNU REV PLANT PHYS, V50, P47, DOI 10.1146/annurev.arplant.50.1.47; Liu CC, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-158; Lohrig K, 2009, PLANTA, V229, P1123, DOI 10.1007/s00425-009-0901-y; Machida M, 2007, FEBS J, V274, P1576, DOI 10.1111/j.1742-4658.2007.05705.x; Mann M, 2002, TRENDS BIOTECHNOL, V20, P261, DOI 10.1016/S0167-7799(02)01944-3; Martin T, 2002, PLANT PHYSIOL, V128, P472, DOI 10.1104/pp.010475; Marx C, 2003, PLANTA, V216, P454, DOI 10.1007/s00425-002-0857-7; Mazzitelli L, 2007, J EXP BOT, V58, P1035, DOI 10.1093/jxb/erl266; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nakagami H, 2010, PLANT PHYSIOL, V153, P1161, DOI 10.1104/pp.110.157347; Nuhse TS, 2007, PLANT J, V51, P931, DOI 10.1111/j.1365-313X.2007.03192.x; Nuhse TS, 2004, PLANT CELL, V16, P2394, DOI 10.1105/tpc.104.023150; Nuhse TS, 2003, MOL CELL PROTEOMICS, V2, P1234, DOI 10.1074/mcp.T300006-MCP200; O'Neill CM, 2003, PHYTOCHEMISTRY, V64, P1077, DOI 10.1016/S0031-9422(03)00351-0; Patnaik Debasis, 2001, Indian Journal of Experimental Biology, V39, P191; Porankiewicz J, 1999, MOL MICROBIOL, V32, P449, DOI 10.1046/j.1365-2958.1999.01357.x; Rajjou L, 2006, PLANT PHYSIOL, V141, P910, DOI 10.1104/pp.106.082057; Rao RSP, 2012, BBA-PROTEINS PROTEOM, V1824, P405, DOI 10.1016/j.bbapap.2011.12.001; Reiland S, 2009, PLANT PHYSIOL, V150, P889, DOI 10.1104/pp.109.138677; Sugiyama N, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.32; Tang GL, 1999, PROTEIN EXPRES PURIF, V16, P432, DOI 10.1006/prep.1999.1087; Tang WQ, 2008, MOL CELL PROTEOMICS, V7, P728, DOI 10.1074/mcp.M700358-MCP200; Teng NJ, 2006, NEW PHYTOL, V172, P92, DOI 10.1111/j.1469-8137.2006.01818.x; Wan LL, 2007, BIOCHEM J, V404, P247, DOI 10.1042/BJ20061569; Wang X, 2013, J PROTEOMICS, V78, P486, DOI 10.1016/j.jprot.2012.10.018; Waterworth WM, 2005, J EXP BOT, V56, P1545, DOI 10.1093/jxb/eri149; Yao QM, 2014, NUCLEIC ACIDS RES, V42, pD1206, DOI 10.1093/nar/gkt1135	51	6	7	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2015	10	7							e0130763	10.1371/journal.pone.0130763	http://dx.doi.org/10.1371/journal.pone.0130763			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EW	26158488	Green Published, Green Submitted, gold			2022-12-26	WOS:000358161200016
J	Sun, M; Bloom, AB; Zaman, MH				Sun, Meng; Bloom, Alexander B.; Zaman, Muhammad H.			Rapid Quantification of 3D Collagen Fiber Alignment and Fiber Intersection Correlations with High Sensitivity	PLOS ONE			English	Article							CROSS-LINKING; MECHANICAL-PROPERTIES; CONTACT GUIDANCE; CELL MOTILITY; I COLLAGEN; GELS; ORIENTATION; TISSUE; DYNAMICS; MATRIX	Metastatic cancers aggressively reorganize collagen in their microenvironment. For example, radially orientated collagen fibers have been observed surrounding tumor cell clusters in vivo. The degree of fiber alignment, as a consequence of this remodeling, has often been difficult to quantify. In this paper, we present an easy to implement algorithm for accurate detection of collagen fiber orientation in a rapid pixel-wise manner. This algorithm quantifies the alignment of both computer generated and actual collagen fiber networks of varying degrees of alignment within 5(oo). We also present an alternative easy method to calculate the alignment index directly from the standard deviation of fiber orientation. Using this quantitative method for determining collagen alignment, we demonstrate that the number of collagen fiber intersections has a negative correlation with the degree of fiber alignment. This decrease in intersections of aligned fibers could explain why cells move more rapidly along aligned fibers than unaligned fibers, as previously reported. Overall, our paper provides an easier, more quantitative and quicker way to quantify fiber orientation and alignment, and presents a platform in studying effects of matrix and cellular properties on fiber alignment in complex 3D environments.	[Sun, Meng; Zaman, Muhammad H.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Bloom, Alexander B.] Boston Univ, Dept Mol Biol Cellular Biol & Biochem, Boston, MA 02215 USA; [Zaman, Muhammad H.] Howard Hughes Med Inst, Boston, MA 02115 USA	Boston University; Boston University; Howard Hughes Medical Institute	Zaman, MH (corresponding author), Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.	zaman@bu.edu			National Institutes of Health [U01-CA177799]; National Science Foundation [DMR-1206335]; NATIONAL CANCER INSTITUTE [U01CA177799] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL120839] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding for this work came from National Institutes of Health (U01-CA177799): http://www.nih.gov/, and National Science Foundation (DMR-1206335): http://www.nsf.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abhilash AS, 2014, BIOPHYS J, V107, P1829, DOI 10.1016/j.bpj.2014.08.029; Bassereau P, 2014, ADV COLLOID INTERFAC, V208, P47, DOI 10.1016/j.cis.2014.02.002; Bigi A, 2001, BIOMATERIALS, V22, P763, DOI 10.1016/S0142-9612(00)00236-2; Brabrand A, 2015, APMIS, V123, P1, DOI 10.1111/apm.12298; Bredfeldt JS, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.1.016007; Brown E, 2003, NAT MED, V9, P796, DOI 10.1038/nm879; Candes E, 2006, MULTISCALE MODEL SIM, V5, P861, DOI 10.1137/05064182X; Christiansen DL, 2000, MATRIX BIOL, V19, P409, DOI 10.1016/S0945-053X(00)00089-5; Conklin MW, 2011, AM J PATHOL, V178, P1221, DOI 10.1016/j.ajpath.2010.11.076; Daniels F, 2007, IFMBE PROC, V15, P282; Di Lullo GA, 2002, J BIOL CHEM, V277, P4223, DOI 10.1074/jbc.M110709200; ELICEIRI K, 2014, J PATHOL INFORM, V5, P28, DOI DOI 10.4103/2153-3539.139707; Enderling H, 2008, BIOPHYS J, V95, P2203, DOI 10.1529/biophysj.108.133199; Erikson A, 2008, BIOPOLYMERS, V89, P135, DOI 10.1002/bip.20874; Farsad K, 2003, CURR OPIN CELL BIOL, V15, P372, DOI 10.1016/S0955-0674(03)00073-5; FRENKEL D, 1985, PHYS REV A, V31, P1776, DOI 10.1103/PhysRevA.31.1776; Friedl P, 2004, HISTOCHEM CELL BIOL, V122, P183, DOI 10.1007/s00418-004-0682-0; Fujiwara S, 1998, PHYS REV LETT, V80, P991, DOI 10.1103/PhysRevLett.80.991; GALE M, 1995, BIOPHYS J, V68, P2124, DOI 10.1016/S0006-3495(95)80393-0; GUIDO S, 1993, J CELL SCI, V105, P317; Haralock R. M., 1991, COMPUTER ROBOT VISIO; Harjanto D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024891; Hong L, 1998, IEEE T PATTERN ANAL, V20, P777, DOI 10.1109/34.709565; Karlon WJ, 1999, ANN BIOMED ENG, V27, P712, DOI 10.1114/1.226; KASS M, 1987, COMPUT VISION GRAPH, V37, P362, DOI 10.1016/0734-189X(87)90043-0; KATZ MJ, 1980, CELL MOTIL CYTOSKEL, V1, P141, DOI 10.1002/cm.970010111; Kaunas R, 2009, J THEOR BIOL, V257, P320, DOI 10.1016/j.jtbi.2008.11.024; Kim A, 2006, EXP CELL RES, V312, P3683, DOI 10.1016/j.yexcr.2006.08.009; Kong T.Y., 1996, TOPOLOGICAL ALGORITH; Kovesi P. D., 2000, MATLAB OCTAVE FUNCTI; Krok JL, 2014, CANCER EPIDEM BIOMAR, V23, P563, DOI 10.1158/1055-9965.EPI-14-0066; Lackie J.M., 1986, CELL MOVEMENT CELL B, P253, DOI [10.1007/978-94-009-4071-0_10, DOI 10.1007/978-94-009-4071-0_10]; Lai VK, 2012, ACTA BIOMATER, V8, P4031, DOI 10.1016/j.actbio.2012.07.010; LAM L, 1992, IEEE T PATTERN ANAL, V14, P869, DOI 10.1109/34.161346; Lanfer B, 2008, BIOMATERIALS, V29, P3888, DOI 10.1016/j.biomaterials.2008.06.016; Liang HC, 2004, BIOMATERIALS, V25, P3541, DOI 10.1016/j.biomaterials.2003.09.109; Liu Y, 2015, CURVEALIGN; Mehlen P, 2006, NAT REV CANCER, V6, P449, DOI 10.1038/nrc1886; Nawroth JC, 2012, NAT BIOTECHNOL, V30, P792, DOI 10.1038/nbt.2269; Ng CP, 2006, ANN BIOMED ENG, V34, P446, DOI 10.1007/s10439-005-9067-3; Pang YG, 2011, BIOMATERIALS, V32, P3776, DOI 10.1016/j.biomaterials.2011.02.003; Pang YG, 2009, BIOMATERIALS, V30, P2023, DOI 10.1016/j.biomaterials.2008.12.064; Pawitan Y, 2001, ALL LIKELIHOOD STAT; Pedersen JA, 2005, ANN BIOMED ENG, V33, P1469, DOI 10.1007/s10439-005-8159-4; Pratt W, 1991, DIGITAL IMAGE PROCES; Provenzano PP, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-38; R Core Team, 2013, R LANGUAGE ENV STAT; Rao AR, 2012, TAXONOMY TEXTURE DES; Riching KM, 2014, BIOPHYS J, V107, P2546, DOI 10.1016/j.bpj.2014.10.035; Russ J.C., 2006, IMAGE PROCESSING HDB, VFifth; Sander LM, 2014, CANCER RES, V74, P4588, DOI 10.1158/0008-5472.CAN-13-3294; Shahsavari A, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.011923; Sheetz MP, 1996, TRENDS CELL BIOL, V6, P85, DOI 10.1016/0962-8924(96)80993-7; Shih F.Y., 2010, IMAGE PROCESSING PAT; Sisson K, 2009, BIOMACROMOLECULES, V10, P1675, DOI 10.1021/bm900036s; Stein AM, 2011, COMPLEXITY, V16, P22, DOI 10.1002/cplx.20332; Stein AM, 2008, J MICROSC-OXFORD, V232, P463, DOI 10.1111/j.1365-2818.2008.02141.x; STOPAK D, 1982, DEV BIOL, V90, P383, DOI 10.1016/0012-1606(82)90388-8; Stylianopoulos T, 2008, J MECH BEHAV BIOMED, V1, P326, DOI 10.1016/j.jmbbm.2008.01.003; Sundararaghavan HG, 2009, BIOTECHNOL BIOENG, V102, P632, DOI 10.1002/bit.22074; Vader D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005902; Wang WG, 2007, CANCER RES, V67, P3505, DOI 10.1158/0008-5472.CAN-06-3714; Wasserman L., 2004, ALL STAT CONCISE COU, V26; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Yang YL, 2009, BIOPHYS J, V97, P2051, DOI 10.1016/j.bpj.2009.07.035	65	20	20	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2015	10	7							e0131814	10.1371/journal.pone.0131814	http://dx.doi.org/10.1371/journal.pone.0131814			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EW	26158674	gold, Green Published			2022-12-26	WOS:000358161200039
J	McKenzie, AJ; Robertson, PA				McKenzie, Ailsa J.; Robertson, Peter A.			Which Species Are We Researching and Why? A Case Study of the Ecology of British Breeding Birds	PLOS ONE			English	Article							H-INDEX; BEHAVIOR	Our ecological knowledge base is extensive, but the motivations for research are many and varied, leading to unequal species representation and coverage. As this evidence is used to support a wide range of conservation, management and policy actions, it is important that gaps and biases are identified and understood. In this paper we detail a method for quantifying research effort and impact at the individual species level, and go on to investigate the factors that best explain between-species differences in outputs. We do this using British breeding birds as a case study, producing a ranked list of species based on two scientific publication metrics: total number of papers (a measure of research quantity) and h-index (a measure of the number of highly cited papers on a topic - an indication of research quality). Widespread, populous species which are native, resident and in receipt of biodiversity action plans produced significantly higher publication metrics. Guild was also significant, birds of prey the most studied group, with pigeons and doves the least studied. The model outputs for both metrics were very similar, suggesting that, at least in this example, research quantity and quality were highly correlated. The results highlight three key gaps in the evidence base, with fewer citations and publications relating to migrant breeders, introduced species and species which have experienced contractions in distribution. We suggest that the use of publication metrics in this way provides a novel approach to understanding the scale and drivers of both research quantity and impact at a species level and could be widely applied, both taxonomically and geographically.	[McKenzie, Ailsa J.; Robertson, Peter A.] Newcastle Univ, Sch Biol, Ctr Wildlife Management, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Robertson, Peter A.] Anim & Plant Hlth Agcy, Natl Wildlife Management Ctr, York, N Yorkshire, England	Newcastle University - UK; Animal & Plant Health Agency UK	McKenzie, AJ (corresponding author), Newcastle Univ, Sch Biol, Ctr Wildlife Management, Ridley Bldg,Claremont Rd, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	ailsa.mckenzie@ncl.ac.uk	Robertson, Peter/H-1614-2013	Robertson, Peter/0000-0003-1567-8677	AHVLA; Newcastle University	AHVLA; Newcastle University	This work was funded by the Technology Strategy Board as part of a Knowledge Transfer Partnership between AHVLA and Newcastle University [http://www.ktponline.org.uk/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balmer D., 2013, BIRD ATLAS 2007 11 B; Bar-Ilan J, 2008, SCIENTOMETRICS, V74, P257, DOI 10.1007/s11192-008-0216-y; Baxter AT, 2007, INT J PEST MANAGE, V53, P341, DOI 10.1080/09670870701245231; Bonnet X, 2002, TRENDS ECOL EVOL, V17, P1, DOI 10.1016/S0169-5347(01)02381-3; Brito D, 2009, TROP CONSERV SCI, V2, P353, DOI 10.1177/194008290900200305; Brodie JF, 2009, BIODIVERS CONSERV, V18, P2927, DOI 10.1007/s10531-009-9617-3; Brooke ZM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093195; BTO, BTO BIRDFACTS; Clark JA, 2002, SCIENCE, V297, P191; Ducatez S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089955; Dunn JC, 2012, BIRD STUDY, V59, P394, DOI 10.1080/00063657.2012.725710; EOL, TRAITBANK ENCY LIFE; Fera, 2010, OVERVIEW CONFLICTS H; Harrop AHJ, 2013, IBIS, V155, P635, DOI 10.1111/ibi.12069; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; IUCN, IUCN RED LIST THREAT; JNCC, UK BAP PRIORITY SPEC; Langston RHW, 2007, IBIS, V149, P250, DOI 10.1111/j.1474-919X.2007.00709.x; Mackay B, 2014, J WILDLIFE MANAGE, V78, P671, DOI 10.1002/jwmg.711; Malesios CC, 2014, QUAL QUANT, V48, P521, DOI 10.1007/s11135-012-9785-1; Manchester SJ, 2000, J APPL ECOL, V37, P845, DOI 10.1046/j.1365-2664.2000.00538.x; Peck HL, 2014, BEHAV ECOL, V25, P582, DOI 10.1093/beheco/aru025; Robertson PA, 2015, MAMMAL REV, V9; Rodriguez-Pastor R, 2012, ANIM BIODIV CONSERV, V35, P107; Smith GC, 2005, J APPL ECOL, V42, P546, DOI 10.1111/j.1365-2664.2005.00977.x; Wilkin TA, 2006, J ANIM ECOL, V75, P604, DOI 10.1111/j.1365-2656.2006.01078.x	26	12	12	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0131004	10.1371/journal.pone.0131004	http://dx.doi.org/10.1371/journal.pone.0131004			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154759	gold, Green Submitted, Green Published			2022-12-26	WOS:000358159700051
J	Yu, HM; Wang, XC; He, RL; Liang, RF; Zhou, LY				Yu, Hongmei; Wang, Xiaocheng; He, Runlian; Liang, Ruifeng; Zhou, Liye			Measuring the Caregiver Burden of Caring for Community-Residing People with Alzheimer's Disease	PLOS ONE			English	Article							FAMILY CAREGIVERS; PSYCHOLOGICAL SYMPTOMS; DEMENTIA BPSD; CARE; HEALTH; RELATIVES; FEELINGS	Objectives To assess the direct and indirect effects of patient or caregiver factors on caregiver burden of caring for community-residing people with mild Alzheimer's disease (AD). Methods We conducted a cross-sectional study of patients diagnosed with AD from two hospitals and three communities in Taiyuan, China and their caregivers. For this survey, 200 patients with mild AD and their caregivers were selected. Caregivers were asked to provide sociodemographic information including age, gender, relationship with the patient, level of education, and number of contact hours per week with the patient. Caregiver burden was assessed using the Caregivers Burden Inventory. The caregivers also completed other measures including the Positive Aspects of Caregiving, the Family Adaptation, Partnership, Growth, Affection, and Resolve, and the Social Support Rating Scale. The patients with AD completed the Montreal Cognitive Assessment; their caregivers completed the Activities of Daily Living Scale and a questionnaire about the patients' Behavioral and Psychological symptoms of Dementia. The main outcome in this study was caregiver burden. The care receivers' level of cognitive function, physical function, and behavioral problems were treated as original stress; the primary appraisal variable was measured as the number of hours of caregiving in the previous week reported by the caregiver. Mediator variables included perceived social support, family function, and caregiving experience. Path analysis was used to build the interrelationship among caregiver burden and patient or caregiver factors. Results A lower level of cognitive function in patients (r = -0.28, p<0.001) and longer hours of caregiving (r = 0.17, p = 0.019) were related to increased caregiver burden. Greater social support (r = -0.23, p<0.001), family function (r = -0.17, p = 0.015) and caregiving experience (r = -0.16, p = 0.012) were related to decreased caregiver burden. Social support (r = 0.16, p = 0.040) and family function (r = 0.25, p = 0.002) were directly related to patients' level of cognitive functioning, but were mediator factors between level of cognitive function in patients and caregiver burden. Similarly, social support was a mediator factor between patients' daily function (r = -0.23, p = 0.004) and caregiver burden; while caregiving experience mediated the link between behavioral and psychological symptoms in patients (r = 0.36, p<0.001) and caregiver burden. Conclusion Level of cognitive function and hours of caregiving were directly related to caregiver's burden. Social support, family function and caregiving experience could mediate the relationship between patient factors and caregiver burden. Focusing on patient factors and promoting caregiver care will be helpful in lowering the perceived burden of caregiving.	[Yu, Hongmei] Shanxi Med Univ, Sch Publ Hlth, Dept Hlth Stat, Taiyuan, Peoples R China; [Wang, Xiaocheng] Shanxi Prov Peoples Hosp, Dept Med Record Management, Taiyuan, Peoples R China; [He, Runlian] Taiyuan Cent Hosp, Dept Nursing, Taiyuan, Shanxi, Peoples R China; [Liang, Ruifeng] Shanxi Med Univ, Sch Publ Hlth, Dept Environm Hlth, Taiyuan, Peoples R China; [Zhou, Liye] Shanxi Med Univ, Sch Basic Med Sci, Dept Math, Taiyuan, Peoples R China	Shanxi Medical University; Shanxi People's Hospital; Shanxi Medical University; Shanxi Medical University; Shanxi Medical University	Yu, HM (corresponding author), Shanxi Med Univ, Sch Publ Hlth, Dept Hlth Stat, Taiyuan, Peoples R China.	yu_hongmei@hotmail.com		Yu, Hongmei/0000-0002-9852-2485	National Natural Science Foundation of China [81373106]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Hongmei Yu was supported by grant No. 81373106 from the National Natural Science Foundation of China (http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahpour I, 2014, J GERIATR PSYCH NEUR, V27, P172, DOI 10.1177/0891988714524627; Aguglia E, 2004, Am J Alzheimers Dis Other Demen, V19, P248, DOI 10.1177/153331750401900403; American Psychiatric Association, 2013, DIAGN STAT MAN MENT; Arai Y, 2004, PSYCHIAT CLIN NEUROS, V58, P396, DOI 10.1111/j.1440-1819.2004.01274.x; Beeri MS, 2002, INT J GERIATR PSYCH, V17, P403, DOI 10.1002/gps.490; Chappell NL, 2002, GERONTOLOGIST, V42, P772, DOI 10.1093/geront/42.6.772; CHAU T-T, 1991, Kaohsiung Journal of Medical Sciences, V7, P27; Choo Wan-Yuen, 2003, Asia Pac J Public Health, V15, P23, DOI 10.1177/101053950301500105; Chou KR, 2002, NURS RES, V51, P324, DOI 10.1097/00006199-200209000-00009; Chou KR, 1999, NURS RES, V48, P206, DOI 10.1097/00006199-199907000-00003; Cox C, 2013, CURR GERIATR REP, V2, P31, DOI 10.1007/s13670-012-0033-2; Ericson I, 2001, Br J Nurs, V10, P710; GEORGE LK, 1986, GERONTOLOGIST, V26, P253, DOI 10.1093/geront/26.3.253; Gonyea Judith G, 2005, Am J Alzheimers Dis Other Demen, V20, P273, DOI 10.1177/153331750502000505; Heru AM, 2006, B MENNINGER CLIN, V70, P222, DOI 10.1521/bumc.2006.70.3.222; Heru AM, 2004, INT J GERIATR PSYCH, V19, P533, DOI 10.1002/gps.1119; Huang SS, 2012, ARCH GERONTOL GERIAT, V55, P55, DOI 10.1016/j.archger.2011.04.009; Ji P, 2010, J NURS ADMIN, V10, P787; Kasuya RT, 2000, POSTGRAD MED, V108, P119, DOI 10.3810/pgm.2000.12.1324; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Kramer BJ, 1997, GERONTOLOGIST, V37, P218, DOI 10.1093/geront/37.2.218; LAWTON MP, 1989, J GERONTOL, V44, pP61, DOI 10.1093/geronj/44.3.P61; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Li Y, 2002, ILLNESS CRISIS LOSS, V10, P318, DOI DOI 10.1177/105413702236512; Lu J, 2011, J GERIATR PSYCH NEUR, V24, P184, DOI 10.1177/0891988711422528; Maestre GE, 2012, CURR NEUROL NEUROSCI, V12, P511, DOI 10.1007/s11910-012-0300-9; Padierna A, 2013, SOC PSYCH PSYCH EPID, V48, P151, DOI 10.1007/s00127-012-0525-6; Perlick DA, 2005, BIPOLAR DISORD, V7, P126, DOI 10.1111/j.1399-5618.2004.00172.x; Reisberg B, 1996, Int Psychogeriatr, V8 Suppl 3, P301; Rinaldi P, 2005, INT J GERIATR PSYCH, V20, P168, DOI 10.1002/gps.1267; Schulz R, 2003, NEW ENGL J MED, V349, P1936, DOI 10.1056/NEJMsa035373; Schulz R, 2002, GERONTOLOGIST, V42, P589, DOI 10.1093/geront/42.5.589; Shaji K S, 2009, Indian J Psychiatry, V51, P45, DOI 10.4103/0019-5545.44905; Shurgot GR, 2005, J GERONTOL B-PSYCHOL, V60, pP331, DOI 10.1093/geronb/60.6.P331; Sink KM, 2005, JAMA-J AM MED ASSOC, V293, P596, DOI 10.1001/jama.293.5.596; Smith M, 2004, J AM GERIATR SOC, V52, P1755, DOI 10.1111/j.1532-5415.2004.52473.x; STULL DE, 1994, GERONTOLOGIST, V34, P88, DOI 10.1093/geront/34.1.88; Tanji H., 2005, GERIATR GERONTOL INT, V5, P94, DOI DOI 10.1111/J.1447-0594.2005.00274.X; Tarlow BJ, 2004, RES AGING, V26, P429, DOI 10.1177/0164027504264493; Torti FM, 2004, ALZ DIS ASSOC DIS, V18, P99, DOI 10.1097/01.wad.0000126902.37908.b2; Tremont G, 2006, DEMENT GERIATR COGN, V21, P170, DOI 10.1159/000090699; Xiao S., 1994, J CLIN PSYCHIAT, V4, P98, DOI DOI 10.1186/S12913-016-1423-5; Yates ME, 1999, J GERONTOL B-PSYCHOL, V54, pP12, DOI 10.1093/geronb/54B.1.P12; Zarit SH, 1998, J GERONTOL B-PSYCHOL, V53, pS267, DOI 10.1093/geronb/53B.5.S267; ZARIT SH, 1980, GERONTOLOGIST, V20, P649, DOI 10.1093/geront/20.6.649	45	46	47	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0132168	10.1371/journal.pone.0132168	http://dx.doi.org/10.1371/journal.pone.0132168			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1EJ	26154626	Green Submitted, Green Published, gold			2022-12-26	WOS:000358159700090
J	Zhao, BW; Chen, YM; Jiang, SS; Chen, YB; Zhou, ZW; Li, YF				Zhao, Bai-Wei; Chen, Yong-Ming; Jiang, Shan-Shan; Chen, Yin-Bo; Zhou, Zhi-Wei; Li, Yuan-Fang			Lymph Node Metastasis, a Unique Independent Prognostic Factor in Early Gastric Cancer	PLOS ONE			English	Article							DISTAL GASTRECTOMY; PREDICTIVE FACTORS; DISSECTION; RECURRENCE; RESECTION; INVASION	Background Lymph node metastasis (LNM) has been shown to be related to the prognosis of early gastric cancer (EGC). The choice of optimal treatment depends on an accurate pre-operative assessment of LNM status in EGC patients. However, in China, where EGC cases account for only a small part of gastric cancer (GC) cases, there are not enough data to make an accurate assessment. Therefore, this study, which involved a relatively large number of EGC patients, aimed to explore the relationship between clinicopathological characteristics and LNM in EGC. Methods Clinicopathological data from 205 EGC patients who underwent surgical resection at Sun Yat-Sen University Cancer Center from January 2000 to December 2011 were retrospectively analyzed. Clinicopathological characteristics were assessed to identify effective predictive factors for LNM and overall survival. Results LNM occurred in 52 (25.37%) EGC cases; of these cases, 18 occurred in intra-mucosal cancers (13 N1, 4 N2 and 1 N3), and 34 occurred in sub-mucosal cancers (22 N1, 7 N2 and 5 N3). Logistic regression analysis demonstrated that tumor differentiation (P=0.002), depth of tumor infiltration (P=0.004), vessel invasion (P=0.012), tumor size (P=0.020) and gender (P=0.022) were risk factors associated with LNM in EGC, listed in order of priority. The overall survival rate was 90.2%. Kaplan-Meier survival analysis showed that overall survival of EGC patients was significantly correlated with LNM (P=0.001), N staging (P<0.001) and invasion of lymphatic or blood vessels (P=0.010), but it was not correlated with tumor size, depth of tumor infiltration or tumor cell differentiation. Moreover, a multiple Cox regression analysis demonstrated that only N staging (P=0.001) could serve as an independent prognostic predictor in EGC patients. Conclusions Because LNM independently predicts the prognosis of EGC, endoscopic mucosal resection (EMR) or endoscopic submucosal dissection (ESD) and laparoscopic partial gastrectomy should be cautiously used in high-risk EGC patients. A pre-operative assessment of LNM status based on clinicopathological factors may be useful for therapy planning.	[Zhao, Bai-Wei; Chen, Yong-Ming; Jiang, Shan-Shan; Chen, Yin-Bo; Zhou, Zhi-Wei; Li, Yuan-Fang] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Guangzhou 510060, Guangdong, Peoples R China; [Zhao, Bai-Wei; Chen, Yong-Ming; Chen, Yin-Bo; Zhou, Zhi-Wei; Li, Yuan-Fang] Sun Yat Sen Univ, Ctr Canc, Dept Gastr & Pancreat Surg, Guangzhou 510060, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University	Li, YF (corresponding author), Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Guangzhou 510060, Guangdong, Peoples R China.	liyuanf@sysucc.org.cn	Li, Yuan/GXV-1310-2022; Chen, Yongming/E-3656-2015	Chen, Yongming/0000-0003-2843-5543				Adachi Y, 2002, DIGEST SURG, V19, P333, DOI 10.1159/000065829; Du XH, 2009, CHINESE MED J-PEKING, V122, P1404, DOI 10.3760/cma.j.issn.0366-6999.2009.12.009; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jung HY, 2012, DIGEST ENDOSC, V24, P159, DOI 10.1111/j.1443-1661.2012.01275.x; Kikuchi S, 2000, ANTICANCER RES, V20, P3695; Kim H, 2011, ONCOL REP, V25, P1589, DOI 10.3892/or.2011.1242; Kwee RM, 2008, GASTRIC CANCER, V11, P134, DOI 10.1007/s10120-008-0476-5; Li H, 2008, WORLD J GASTROENTERO, V14, P4222, DOI 10.3748/wjg.14.4222; Milhomem LM, 2012, ABCD-ARQ BRAS CIR DI, V25, P235, DOI 10.1590/S0102-67202012000400005; Namieno T, 1996, WORLD J SURG, V20, P996; Narumiya K, 2011, ANN SURG, V253, P840, DOI [10.1097/10.1097/SLA.0b013e318211d91b, 10.1097/SLA.0b013e318211d91b]; Nonaka S, 2011, GASTRIC CANCER, V14, P56, DOI 10.1007/s10120-011-0008-6; Park IS, 2000, YONSEI MED J, V41, P607, DOI 10.3349/ymj.2000.41.5.607; Park YD, 2008, ENDOSCOPY, V40, P7, DOI 10.1055/s-2007-966750; Saka M, 2008, GASTRIC CANCER, V11, P214, DOI 10.1007/s10120-008-0485-4; SANO T, 1993, CANCER, V72, P3174, DOI 10.1002/1097-0142(19931201)72:11<3174::AID-CNCR2820721107>3.0.CO;2-H; Suzuki H, 2013, ENDOSCOPY, V45, P93, DOI 10.1055/s-0032-1325929; Tamura Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049251; Wang Li, 2013, Zhonghua Wei Chang Wai Ke Za Zhi, V16, P147; Yasuda K, 1999, CANCER, V85, P2119, DOI 10.1002/(SICI)1097-0142(19990515)85:10<2119::AID-CNCR4>3.0.CO;2-M; Zeng YK, 2012, ANN SURG, V256, P39, DOI 10.1097/SLA.0b013e3182583e2e; Zilberstein B, 2012, ABCD-ARQ BRAS CIR DI, V25, P161, DOI 10.1590/S0102-67202012000300005	22	28	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0129531	10.1371/journal.pone.0129531	http://dx.doi.org/10.1371/journal.pone.0129531			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154617	Green Submitted, gold, Green Published			2022-12-26	WOS:000358159700013
J	Muhanna, N; Amer, J; Salhab, A; Sichel, JY; Safadi, R				Muhanna, Nidal; Amer, Johnny; Salhab, Ahmad; Sichel, Jean-Yves; Safadi, Rifaat			The Immune Interplay between Thyroid Papillary Carcinoma and Hepatic Fibrosis	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; NATURAL-KILLER-CELL; LYMPH-NODE METASTASIS; C-VIRUS-INFECTION; MIXED CRYOGLOBULINEMIA; INCREASED EXPRESSION; LIVER FIBROSIS; STELLATE CELLS; CANCER-CELLS; NK CELLS	Background A high prevalence of thyroid papillary cancer was reported in hepatitis-C-virus (HCV) positive patients. However, the mechanistic role of hepatic-fibrosis in thyroid malignancy progressions is still unclear. Aim We aimed to study the immune-modulatory interactions between thyroid papillary carcinoma and hepatic-fibrosis. Methods Hepatic-fibrosis was induced in nude-nu-male mice by intra-peritoneal administration of carbon-tetrachloride. To induce thyroid-tumor, a thyroid papillary carcinoma cell line (NPA) was injected subcutaneously in the backs. Fibrotic profile was estimated by alpha-smooth-muscle- actin (alpha SMA) expression in liver tissue extracts using western-blots and RT-PCR. Intra-hepatic NK cells were isolated and stained for NK activity (CD107a) by flow cytometry. Liver histopathology (H&E staining), thyroid tumor mass and serum alanine aminotransferase (ALT), serum vascular endothelial growth factor (VEGF) and free-T4 levels were also assessed. Results Ex-vivo: NPA cells were co-cultured with intra-hepatic NK cells isolated from fibrotic mice with/without the tumor were analyzed for CFSE-proliferations. Both tumor groups (with/without hepatic-fibrosis) excreted higher serum free T4 levels. Hepatic-fibrosis increased tumor weight and size and serum free-T4 levels. In addition, tumor induction increased liver injury (both hepatic-fibrosis, necro-inflammation and serum ALT levels). In addition, tumor-bearing animals with hepatic-fibrosis had increased NK activity. NPA tumor-bearing animals increased fibrosis in spite of increased NK activity; probably due to a direct effect through increased serum free-T4 excretions. Serum VEGF levels were significantly increased in the fibrotic-bearing tumor groups compared to the non-fibrotic groups. In-vitro, NK cells from fibrotic tumor-bearing animals reduced proliferation of NPA cells. This decrease is attributed to increase NK cells activity in the fibrotic animals with the NPA tumors. Conclusions Our results propose that NK cells although were stimulated in advanced fibrosis with tumor, they lost their anti-tumor and anti-fibrotic activity probably due to secretions of T4 and VEFG and may explain increased risk of thyroid tumors in chronic HCV patients.	[Muhanna, Nidal; Amer, Johnny; Salhab, Ahmad; Safadi, Rifaat] Hadassah Univ Med Ctr, Div Med, Liver & Gastroenterol Units, Jerusalem, Israel; [Muhanna, Nidal; Sichel, Jean-Yves] Shaare Zedek Med Ctr, Dept Otolaryngol Head & Neck Surg, Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Shaare Zedek Medical Center	Amer, J (corresponding author), Hadassah Univ Med Ctr, Div Med, Liver & Gastroenterol Units, Jerusalem, Israel.	johnnyamer@hotmail.com						Alter G, 2004, J IMMUNOL METHODS, V294, P15, DOI 10.1016/j.jim.2004.08.008; Antonelli A, 2004, QJM-INT J MED, V97, P499, DOI 10.1093/qjmed/hch088; Antonelli A, 1999, JAMA-J AM MED ASSOC, V281, P1588, DOI 10.1001/jama.281.17.1588; Antonelli A, 2002, CLIN EXP RHEUMATOL, V20, P693; Antonelli A, 2007, THYROID, V17, P447, DOI 10.1089/thy.2006.0194; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; Briseis A, 2011, THYROID, V21, P1996; Brito JP, 2014, CURR OPIN ENDOCRINOL, V21, P405, DOI 10.1097/MED.0000000000000094; Bruck R, 2007, J GASTROEN HEPATOL, V22, P2189, DOI 10.1111/j.1440-1746.2006.04777.x; Byrne AM, 2005, J CELL MOL MED, V9, P777, DOI 10.1111/j.1582-4934.2005.tb00379.x; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; Cramer JD, 2010, SURGERY, V148, P1147, DOI 10.1016/j.surg.2010.10.016; Dvorak HF, 1999, CURR TOP MICROBIOL, V237, P97; Enewold L, 2009, CANCER EPIDEM BIOMAR, V18, P784, DOI 10.1158/1055-9965.EPI-08-0960; Ferri C, 1997, INT J CANCER, V71, P1113, DOI 10.1002/(SICI)1097-0215(19970611)71:6<1113::AID-IJC31>3.0.CO;2-B; Ferri C, 2004, SEMIN ARTHRITIS RHEU, V33, P355, DOI 10.1016/j.semarthrit.2003.10.001; FERRI C, 1994, BRIT J HAEMATOL, V88, P392, DOI 10.1111/j.1365-2141.1994.tb05036.x; Fiorino S, 2013, J PANCREAS, V14, P603, DOI 10.6092/1590-8577/1948; Foresta C, 2008, J ENDOCRINOL INVEST, V31, P470, DOI 10.1007/BF03346393; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Friedman SL, 2000, J BIOL CHEM, V275, P2247, DOI 10.1074/jbc.275.4.2247; Graubardt N, 2013, HEPATOLOGY, V57, P1969, DOI 10.1002/hep.26008; HOOFNAGLE JH, 1997, HEPATOLOGY S1, V26, P15; Horn-Ross PL, 2011, CANCER EPIDEM BIOMAR, V20, P1751, DOI 10.1158/1055-9965.EPI-11-0381; Kim HJ, 2009, INT J ONCOL, V35, P49, DOI 10.3892/ijo_00000312; Koike K, 2006, THYROID, V16, P333, DOI 10.1089/thy.2006.16.333; Lai CW, 2011, GROWTH FACTORS, V29, P57, DOI 10.3109/08977194.2011.557373; Lubina A, 2006, THYROID, V16, P1033, DOI 10.1089/thy.2006.16.1033; Lutchman G, 2009, CURRENT HEPATITIS RE, V8, P141; Melhem A, 2006, J HEPATOL, V45, P60, DOI 10.1016/j.jhep.2005.12.025; Montella M, 2003, ONCOL REP, V10, P133; Montella M, 2001, LIVER, V21, P335, DOI 10.1034/j.1600-0676.2001.210506.x; Moretta A, 2002, NAT IMMUNOL, V3, P6, DOI 10.1038/ni0102-6; Muhanna N, 2007, CLIN EXP IMMUNOL, V148, P338, DOI 10.1111/j.1365-2249.2007.03353.x; Muhanna N, 2008, HEPATOLOGY, V48, P963, DOI 10.1002/hep.22413; Muhanna N, 2011, GUT, V60, P90, DOI 10.1136/gut.2010.211136; Nakamura Y, 2006, J CLIN ENDOCR METAB, V91, P1582, DOI 10.1210/jc.2005-1790; Oren R, 1996, HEPATOLOGY, V24, P419; Safadi R, 2004, GASTROENTEROLOGY, V127, P870, DOI 10.1053/j.gastro.2004.04.062; Sarlis N J, 2000, Rev Endocr Metab Disord, V1, P183, DOI 10.1023/A:1010079031162; Scarpino S, 2007, J PATHOL, V212, P411, DOI 10.1002/path.2183; Segev DL, 2003, SURG ONCOL, V12, P69, DOI 10.1016/S0960-7404(03)00037-9; Textor S, 2011, CANCER RES, V71, P5998, DOI 10.1158/0008-5472.CAN-10-3211; Tuttle RM, 2002, J CLIN ENDOCR METAB, V87, P1737, DOI 10.1210/jc.87.4.1737; Yasuoka H, 2005, MODERN PATHOL, V18, P1127, DOI 10.1038/modpathol.3800402; Yokoyama WM, 2002, MICROBES INFECT, V4, P1513, DOI 10.1016/S1286-4579(02)00034-5; Yu XM, 2005, CLIN CANCER RES, V11, P8063, DOI 10.1158/1078-0432.CCR-05-0646; Zvibel I, 2010, LAB INVEST, V90, P674, DOI 10.1038/labinvest.2010.48	49	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2015	10	7							e0132463	10.1371/journal.pone.0132463	http://dx.doi.org/10.1371/journal.pone.0132463			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EC	26151749	gold, Green Published, Green Submitted			2022-12-26	WOS:000358158900043
J	Slobodkin, A; Gavrilov, S; Ionov, V; Iliyin, V				Slobodkin, Alexander; Gavrilov, Sergey; Ionov, Victor; Iliyin, Vyacheslav			Spore-Forming Thermophilic Bacterium within Artificial Meteorite Survives Entry into the Earth's Atmosphere on FOTON-M4 Satellite Landing Module	PLOS ONE			English	Article							NATURAL TRANSFER; VIABLE MICROBES; SP NOV.; MARS; LITHOPANSPERMIA; SPACE; ALH84001; PLANETS; SEARCH	One of the key conditions of the lithopanspermia hypothesis is that microorganisms situated within meteorites could survive hypervelocity entry from space through the Earth's atmosphere. So far, all experimental proof of this possibility has been based on tests with sounding rockets which do not reach the transit velocities of natural meteorites. We explored the survival of the spore-forming thermophilic anaerobic bacterium, Thermoanaerobacter siderophilus, placed within 1.4-cm thick basalt discs fixed on the exterior of a space capsule (the METEORITE experiment on the FOTON-M4 satellite). After 45 days of orbital flight, the landing module of the space vehicle returned to Earth. The temperature during the atmospheric transit was high enough to melt the surface of basalt. T. siderophilus survived the entry; viable cells were recovered from 4 of 24 wells loaded with this microorganism. The identity of the strain was confirmed by 16S rRNA gene sequence and physiological tests. This is the first report on the survival of a lifeform within an artificial meteorite after entry from space orbit through Earth's atmosphere at a velocity that closely approached the velocities of natural meteorites. The characteristics of the artificial meteorite and the living object applied in this study can serve as positive controls in further experiments on testing of different organisms and conditions of interplanetary transport.	[Slobodkin, Alexander; Gavrilov, Sergey] Russian Acad Sci, Winogradsky Inst Microbiol, Moscow 117312, Russia; [Ionov, Victor; Iliyin, Vyacheslav] Russian Acad Sci, Russian Federat State Res Ctr, Inst Biomed Problems, Moscow 123007, Russia	Research Center of Biotechnology RAS; Russian Academy of Sciences; Russian Academy of Sciences; Institute of Biomedical Problems of the Russian Academy of Sciences	Slobodkin, A (corresponding author), Russian Acad Sci, Winogradsky Inst Microbiol, Prospect 60-Letiya Oktyabrya 7-2, Moscow 117312, Russia.	aslobodkin@hotmail.com			Russian Academy of Sciences program entitled "Evolution of the Organic World and Planetary Processes"	Russian Academy of Sciences program entitled "Evolution of the Organic World and Planetary Processes"	This work was supported by the Russian Academy of Sciences program entitled "Evolution of the Organic World and Planetary Processes."	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BALASHOVA VV, 1979, MICROBIOLOGY+, V48, P635; Benson DA, 1999, NUCLEIC ACIDS RES, V27, P12, DOI 10.1093/nar/27.1.12; Brandstatter F, 2008, PLANET SPACE SCI, V56, P976, DOI 10.1016/j.pss.2007.12.014; Bronshten V. A., 1983, PHYS METEORIC PHENOM; Byrer DE, 2000, ARCH MICROBIOL, V174, P334, DOI 10.1007/s002030000211; Clark BC, 2001, ORIGINS LIFE EVOL B, V31, P185, DOI 10.1023/A:1006757011007; Cockell CS, 2007, ASTROBIOLOGY, V7, P1, DOI 10.1089/ast.2006.0038; de la Torre R, 2010, ICARUS, V208, P735, DOI 10.1016/j.icarus.2010.03.010; Dobretsov Nikolay, 2008, BIOSPHERE ORIGIN EVO; Fajardo-Cavazos P, 2005, ASTROBIOLOGY, V5, P726, DOI 10.1089/ast.2005.5.726; Fajardo-Cavazos P, 2009, ASTROBIOLOGY, V9, P647, DOI 10.1089/ast.2008.0326; Foucher F, 2010, ICARUS, V207, P616, DOI 10.1016/j.icarus.2009.12.014; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Horneck G, 1994, ADV SPACE RES; Horneck G, 2008, ASTROBIOLOGY, V8, P17, DOI 10.1089/ast.2007.0134; Horneck G, 2010, MICROBIOL MOL BIOL R, V74, P121, DOI 10.1128/MMBR.00016-09; Lane D., 1991, NUCL ACID TECHNIQUES, V1991, P115; Lunine JI, 2006, PHILOS T R SOC B, V361, P1721, DOI 10.1098/rstb.2006.1900; MARMUR J, 1961, J MOL BIOL, V3, P208, DOI 10.1016/S0022-2836(61)80047-8; McKay DS, 1996, SCIENCE, V273, P924, DOI 10.1126/science.273.5277.924; Mileikowsky C, 2000, ICARUS, V145, P391, DOI 10.1006/icar.1999.6317; Nicholson WL, 2009, TRENDS MICROBIOL, V17, P243, DOI 10.1016/j.tim.2009.03.004; Nicholson WL, 2000, MICROBIOL MOL BIOL R, V64, P548, DOI 10.1128/MMBR.64.3.548-572.2000; O'Sullivan LA, 2015, ISME J, V9, P922, DOI 10.1038/ismej.2014.190; Papike J., 1991, LUNAR SOURCEBOOK USE, P121; Price MC, 2013, ICARUS, V222, P263, DOI 10.1016/j.icarus.2012.10.035; Slobodkin AI, 2014, MICROBIOLOGY+, V83, P169, DOI 10.1134/S0026261714030151; Slobodkin AI, 2012, INT J SYST EVOL MICR, V62, P2565, DOI 10.1099/ijs.0.034397-0; Slobodkin AI, 2005, MICROBIOLOGY+, V74, P501, DOI 10.1007/s11021-005-0096-6; Slobodkin AI, 1999, INT J SYST BACTERIOL, V49, P1471, DOI 10.1099/00207713-49-4-1471; Thiel CS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112979; Valtonen M, 2009, ASTROPHYS J, V690, P210, DOI 10.1088/0004-637X/690/1/210; Weiss BP, 2000, SCIENCE, V290, P791, DOI 10.1126/science.290.5492.791; WOLIN EA, 1963, J BIOL CHEM, V238, P2882; Yanai K, 1997, MINERAL J, V19, P65; Zahnle K, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004895	37	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2015	10	7							e0132611	10.1371/journal.pone.0132611	http://dx.doi.org/10.1371/journal.pone.0132611			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EC	26151136	Green Published, Green Submitted, gold			2022-12-26	WOS:000358158900048
J	Anastasiou, O; Sydor, S; Sowa, JP; Manka, P; Katsounas, A; Syn, WK; Fuhrer, D; Gieseler, RK; Bechmann, LP; Gerken, G; Moeller, LC; Canbay, A				Anastasiou, Olympia; Sydor, Svenja; Sowa, Jan-Peter; Manka, Paul; Katsounas, Antonios; Syn, Wing-Kin; Fuehrer, Dagmar; Gieseler, Robert K.; Bechmann, Lars P.; Gerken, Guido; Moeller, Lars C.; Canbay, Ali			Higher Thyroid-Stimulating Hormone, Triiodothyronine and Thyroxine Values Are Associated with Better Outcome in Acute Liver Failure	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; ISCHEMIA-REPERFUSION; NONTHYROIDAL ILLNESS; BINDING GLOBULIN; SERUM; DISEASE; INJURY; RAT; THYROTROPIN; METABOLISM	Introduction Changes in thyroid hormone levels, mostly as non-thyroidal illness syndrome (NTIS), have been described in many diseases. However, the relationship between acute liver failure (ALF) and thyroid hormone levels has not yet been clarified. The present study evaluates potential correlations of select thyroid functional parameters with ALF. Methods 84 consecutively recruited ALF patients were grouped according to the outcome of ALF (spontaneous recovery: SR; transplantation or death: NSR). TSH, free thyroxine (fT4), free triiodothyronine (fT3), T4, and T3 were determined. Results More than 50% of patients with ALF presented with abnormal thyroid parameters. These patients had greater risk for an adverse outcome than euthyroid patients. SR patients had significantly higher TSH, T4, and T3 concentrations than NSR patients. Albumin concentrations were significantly higher in SR than in NSR. In vitro T3 treatment was not able to rescue primary human hepatocytes from acetaminophen induced changes in mRNA expression. Conclusions In patients with ALF, TSH and total thyroid hormone levels differed significantly between SR patients and NSR patients. This might be related to diminished liver-derived transport proteins, such as albumin, in more severe forms of ALF. Thyroid parameters may serve as additional indicators of ALF severity.	[Anastasiou, Olympia; Sydor, Svenja; Sowa, Jan-Peter; Manka, Paul; Katsounas, Antonios; Gieseler, Robert K.; Bechmann, Lars P.; Gerken, Guido; Canbay, Ali] Univ Duisburg, Univ Hosp, Dept Gastroenterol & Hepatol, D-45122 Essen, Germany; [Manka, Paul; Syn, Wing-Kin] Inst Hepatol, Regenerat & Repair Grp, London WC1E 6HX, England; [Syn, Wing-Kin] Barts Hlth NHS Trust, Liver Unit, London, England; [Fuehrer, Dagmar; Moeller, Lars C.] Univ Duisburg, Univ Hosp, Dept Endocrinol & Metab, D-45122 Essen, Germany; [Gieseler, Robert K.] Rodos BioTarget GmbH, D-30625 Hannover, Germany	University of Duisburg Essen; University of London; University College London; Barts Health NHS Trust; University of Duisburg Essen	Canbay, A (corresponding author), Univ Duisburg, Univ Hosp, Dept Gastroenterol & Hepatol, D-45122 Essen, Germany.	ali.Canbay@uni-due.de	Manka, Paul/AAN-1261-2021; Bechmann, Lars/AAZ-7141-2020; Manka, Paul/ABH-2421-2020; Syn, Wing-Kin/AAB-8406-2020; Anastasiou, Olympia/AAV-6338-2020; Canbay, Ali/AAL-9620-2020; Sydor, Svenja/AAV-9951-2021; Sydor, Svenja/ABG-6622-2020; Katsounas, Antonios/AAA-7947-2022; Sowa, Jan-Peter/AAQ-6318-2020	Manka, Paul/0000-0001-8589-7280; Sydor, Svenja/0000-0002-1349-8309; Katsounas, Antonios/0000-0002-5179-0327; Canbay, Ali/0000-0001-6069-7899; Moeller, Lars/0000-0002-9330-9036; Sowa, Jan-Peter/0000-0003-2943-0015; Gieseler, Robert/0000-0002-3064-8516; Bechmann, Lars/0000-0003-3487-9810; Anastasiou, Olympia/0000-0003-2178-3182	Deutsche Forschungsgemeinschaft [267/8-1, 267/13-1]; Wilhelm Laupitz Foundation; Rodos BioTarget GmbH	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Wilhelm Laupitz Foundation; Rodos BioTarget GmbH	This work was supported by the Deutsche Forschungsgemeinschaft (http://www.dfg.de/, grants 267/8-1, 267/13-1) and the Wilhelm Laupitz Foundation (no URL) to A.C. Dr Gieseler is employed by Rodos BioTarget GmbH. Rodos BioTarget GmbH provided support in the form of salary for Dr Gieseler but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section	ATTWOOD EC, 1982, ANN CLIN BIOCHEM, V19, P101, DOI 10.1177/000456328201900207; BACCI V, 1982, J CLIN ENDOCR METAB, V54, P1229, DOI 10.1210/jcem-54-6-1229; Bantel H, 2001, HEPATOLOGY, V34, P758, DOI 10.1053/jhep.2001.28229; Bechmann LP, 2010, J HEPATOL, V53, P639, DOI 10.1016/j.jhep.2010.04.029; BECKER U, 1988, ACTA MED SCAND, V224, P367; Bernal W, 2013, NEW ENGL J MED, V369, P2525, DOI 10.1056/NEJMra1208937; BRENT GA, 1986, AM J MED, V81, P463, DOI 10.1016/0002-9343(86)90300-1; Bruck R, 1998, HEPATOLOGY, V27, P1013, DOI 10.1002/hep.510270417; Canbay A, 2011, DTSCH ARZTEBL INT, V108, P714, DOI 10.3238/arztebl.2011.0714; Caulin C, 1997, J CELL BIOL, V138, P1379, DOI 10.1083/jcb.138.6.1379; Chi HC, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/601361; Mazo DFD, 2013, CLIN EXP GASTROENTER, V6, P9, DOI 10.2147/CEG.S39358; den Brinker M, 2005, J CLIN ENDOCR METAB, V90, P5613, DOI 10.1210/jc.2005-0888; DOCTER R, 1993, CLIN ENDOCRINOL, V39, P499, DOI 10.1111/j.1365-2265.1993.tb02401.x; Fernandez V, 2007, HEPATOLOGY, V45, P170, DOI 10.1002/hep.21476; Friberg L, 2002, ARCH INTERN MED, V162, P1388, DOI 10.1001/archinte.162.12.1388; Gaitan E, 1997, Curr Ther Endocrinol Metab, V6, P94; Gerdes AM, 2010, CIRCULATION, V122, P385, DOI 10.1161/CIRCULATIONAHA.109.917922; HEPNER GW, 1979, ARCH INTERN MED, V139, P1117, DOI 10.1001/archinte.139.10.1117; Iervasi G, 2003, CIRCULATION, V107, P708, DOI 10.1161/01.CIR.0000048124.64204.3F; Imberti R, 1998, ANESTH ANALG, V86, P1187, DOI 10.1097/00000539-199806000-00009; ISRAEL Y, 1979, GASTROENTEROLOGY, V76, P116; KANO T, 1987, Gastroenterologia Japonica, V22, P344; Kibirige D, 2012, THYROID RES, V5, DOI 10.1186/1756-6614-5-6; Kostopanagiotou G, 2009, ENDOCRINE, V36, P198, DOI 10.1007/s12020-009-9210-2; Malik R, 2003, HEPATOLOGY, V37, P79, DOI 10.1053/jhep.2003.50001; Malik R, 2006, DIGEST DIS SCI, V51, P2235, DOI 10.1007/s10620-006-9275-1; Melchert H-U, 2003, SCHILDDRUSENHORMONE; Moeller LC, 2009, THYROID, V19, P639, DOI 10.1089/thy.2008.0293; OREN R, 1995, DIGEST DIS SCI, V40, P1941, DOI 10.1007/BF02208661; Oren R, 1998, J CLIN GASTROENTEROL, V27, P339, DOI 10.1097/00004836-199812000-00012; ORREGO H, 1987, NEW ENGL J MED, V317, P1421, DOI 10.1056/NEJM198712033172301; PAGLIACCI MC, 1989, J ENDOCRINOL INVEST, V12, P149, DOI 10.1007/BF03349947; Papatheodoridis GV, 2010, J CLIN GASTROENTEROL, V44, pE87, DOI 10.1097/MCG.0b013e3181c0945a; Ray DC, 2002, INTENS CARE MED, V28, P1301, DOI 10.1007/s00134-002-1427-y; Redkar Neelam, 2012, J Assoc Physicians India, V60, P70; SHIMADA T, 1988, ENDOCRINOL JAPON, V35, P357; Tapia G, 1997, FREE RADICAL RES, V26, P267, DOI 10.3109/10715769709097805; Tas A, 2012, AM J MED SCI, V344, P175, DOI 10.1097/MAJ.0b013e318239a666; VANTHIEL DH, 1985, HEPATOLOGY, V5, P862, DOI 10.1002/hep.1840050526; Warner MH, 2010, J ENDOCRINOL, V205, P1, DOI 10.1677/JOE-09-0412; Wree A, 2014, METABOLISM, V63, P1542, DOI 10.1016/j.metabol.2014.09.001; Youssef Wael I, 2002, Clin Liver Dis, V6, P879, DOI 10.1016/S1089-3261(02)00049-1	44	11	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132189	10.1371/journal.pone.0132189	http://dx.doi.org/10.1371/journal.pone.0132189			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147961	Green Published, gold, Green Submitted			2022-12-26	WOS:000358157600215
J	Duwadi, K; Chen, L; Menassa, R; Dhaubhadel, S				Duwadi, Kishor; Chen, Ling; Menassa, Rima; Dhaubhadel, Sangeeta			Identification, Characterization and Down-Regulation of Cysteine Protease Genes in Tobacco for Use in Recombinant Protein Production	PLOS ONE			English	Article							NICOTIANA-TABACUM L.; RNA INTERFERENCE; PHARMACEUTICAL PROTEINS; MONOCLONAL-ANTIBODY; TRANSGENIC TOBACCO; SECRETORY PATHWAY; PLANTS; EXPRESSION; ARABIDOPSIS; INTERLEUKIN-10	Plants are an attractive host system for pharmaceutical protein production. Many therapeutic proteins have been produced and scaled up in plants at a low cost compared to the conventional microbial and animal-based systems. The main technical challenge during this process is to produce sufficient levels of recombinant proteins in plants. Low yield is generally caused by proteolytic degradation during expression and downstream processing of recombinant proteins. The yield of human therapeutic interleukin (IL)-10 produced in transgenic tobacco leaves was found to be below the critical level, and may be due to degradation by tobacco proteases. Here, we identified a total of 60 putative cysteine protease genes (CysP) in tobacco. Based on their predicted expression in leaf tissue, 10 candidate CysPs (CysP1-CysP10) were selected for further characterization. The effect of CysP gene silencing on IL-10 accumulation was examined in tobacco. It was found that the recombinant protein yield in tobacco could be increased by silencing CysP6. Transient expression of CysP6 silencing construct also showed an increase in IL-10 accumulation in comparison to the control. Moreover, CysP6 localizes to the endoplasmic reticulum (ER), suggesting that ER may be the site of IL-10 degradation. Overall results suggest that CysP6 is important in determining the yield of recombinant IL-10 in tobacco leaves.	[Duwadi, Kishor; Menassa, Rima; Dhaubhadel, Sangeeta] Univ Western Ontario, Dept Biol, London, ON, Canada; [Chen, Ling; Menassa, Rima; Dhaubhadel, Sangeeta] Agr & Agri Food Canada, London, ON, Canada	Western University (University of Western Ontario); Agriculture & Agri Food Canada	Dhaubhadel, S (corresponding author), Univ Western Ontario, Dept Biol, London, ON, Canada.	sangeeta.dhaubhadel@agr.gc.ca		Menassa, Rima/0000-0003-3536-0332	Agriculture and Agri-Food Canada's Abase [J-000158]	Agriculture and Agri-Food Canada's Abase	Agriculture and Agri-Food Canada's Abase grant number J-000158.	Asadullah K, 2003, PHARMACOL REV, V55, P241, DOI 10.1124/pr.55.2.4; BARTA A, 1986, PLANT MOL BIOL, V6, P347, DOI 10.1007/BF00034942; Bernoux M, 2008, PLANT CELL, V20, P2252, DOI 10.1105/tpc.108.058685; Bertazzon N, 2012, PLANT CELL REP, V31, P133, DOI 10.1007/s00299-011-1147-2; Beyene G, 2006, J EXP BOT, V57, P1431, DOI 10.1093/jxb/erj123; Chen L, 2013, ARABIDOPSIS THALIANA; Conley AJ, 2011, PLANT BIOTECHNOL J, V9, P434, DOI 10.1111/j.1467-7652.2010.00563.x; DENEVE M, 1993, TRANSGENIC RES, V2, P227, DOI 10.1007/BF01977353; Dickinson DP, 2002, CRIT REV ORAL BIOL M, V13, P238, DOI 10.1177/154411130201300304; Doran PM, 2006, TRENDS BIOTECHNOL, V24, P426, DOI 10.1016/j.tibtech.2006.06.012; Faye L, 2005, VACCINE, V23, P1770, DOI 10.1016/j.vaccine.2004.11.003; Fischer R, 2004, CURR OPIN PLANT BIOL, V7, P152, DOI 10.1016/j.pbi.2004.01.007; Fischer R, 2013, CURR PHARM DESIGN, V19, P5471, DOI 10.2174/1381612811319310002; Fischer R, 2012, BIOTECHNOL ADV, V30, P434, DOI 10.1016/j.biotechadv.2011.08.007; GAN SS, 1995, SCIENCE, V270, P1986, DOI 10.1126/science.270.5244.1986; Garcia-Lorenzo M, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-30; Gietl C, 2001, NATURWISSENSCHAFTEN, V88, P49, DOI 10.1007/s001140000203; Grudkowska M, 2004, ACTA BIOCHIM POL, V51, P609; Grzonka Z, 2001, ACTA BIOCHIM POL, V48, P1; Gu C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032422; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; HAMMOND C, 1995, CURR OPIN CELL BIOL, V7, P523, DOI 10.1016/0955-0674(95)80009-3; Hehle VK, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-128; Ho SL, 2000, PLANT PHYSIOL, V122, P57, DOI 10.1104/pp.122.1.57; KARRER KM, 1993, P NATL ACAD SCI USA, V90, P3063, DOI 10.1073/pnas.90.7.3063; Kerschen A, 2004, FEBS LETT, V566, P223, DOI 10.1016/j.febslet.2004.04.043; Khoudi H, 1999, BIOTECHNOL BIOENG, V64, P135, DOI 10.1002/(SICI)1097-0290(19990720)64:2&lt;135::AID-BIT2&gt;3.0.CO;2-Q; Kim NS, 2008, PLANT MOL BIOL, V68, P263, DOI 10.1007/s11103-008-9367-8; KOIZUMI M, 1993, GENE, V129, P175, DOI 10.1016/0378-1119(93)90266-6; Kolotilin I, 2014, VET RES, V45, P375; Lee S, 2004, PLANT MOL BIOL, V54, P755, DOI 10.1023/B:PLAN.0000040904.15329.29; Leitch IJ, 2008, ANN BOT-LONDON, V101, P805, DOI 10.1093/aob/mcm326; LINTHORST HJM, 1993, PLANT MOL BIOL, V21, P685, DOI 10.1007/BF00014551; Ma JKC, 2003, NAT REV GENET, V4, P794, DOI 10.1038/nrg1177; Matzke AJM, 1998, CURR OPIN PLANT BIOL, V1, P142, DOI 10.1016/S1369-5266(98)80016-2; Menassa R, 2004, J BIOTECHNOL, V108, P179, DOI 10.1016/j.jbiotec.2003.11.009; Menassa R, 2001, MOL BREEDING, V8, P177, DOI 10.1023/A:1013376407362; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; Outchkourov NS, 2003, PLANT PHYSIOL, V133, P379, DOI 10.1104/pp.102.017293; Russell DA, 2005, BIOTECHNOL BIOENG, V89, P775, DOI 10.1002/bit.20366; Russell DA, 1999, CURR TOP MICROBIOL, V240, P119; Sack M, 2015, CURR OPIN BIOTECH, V32, P163, DOI 10.1016/j.copbio.2014.12.008; SCHAFFER MA, 1988, PLANT PHYSIOL, V87, P431, DOI 10.1104/pp.87.2.431; Schiermeyer A, 2005, BIOTECHNOL BIOENG, V89, P848, DOI 10.1002/bit.20410; Sharp JM, 2001, BIOTECHNOL BIOENG, V73, P338, DOI 10.1002/bit.1067; Stevens LH, 2000, PLANT PHYSIOL, V124, P173, DOI 10.1104/pp.124.1.173; Stoger E, 2014, ANNU REV PLANT BIOL, V65, P743, DOI 10.1146/annurev-arplant-050213-035850; Tolkatchev D, 2001, J PEPT RES, V57, P227, DOI 10.1046/j.1397-002X.2000.00828.x; Ueda T, 2000, PLANT MOL BIOL, V44, P649, DOI 10.1023/A:1026546004942; VANENGELEN FA, 1994, PLANT MOL BIOL, V26, P1701, DOI 10.1007/BF00019485; Westerhof LB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046460; Wiederanders B, 2003, CURR PROTEIN PEPT SC, V4, P309, DOI 10.2174/1389203033487081; Zhang XM, 2009, J EXP BOT, V60, P1569, DOI 10.1093/jxb/erp022; Zhao P, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001655	54	30	30	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0130556	10.1371/journal.pone.0130556	http://dx.doi.org/10.1371/journal.pone.0130556			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148064	Green Submitted, gold, Green Published			2022-12-26	WOS:000358157600039
J	Ferrarini, A; Xumerle, L; Griggio, F; Garonzi, M; Cantaloni, C; Centomo, C; Vargas, SM; Descombes, P; Marquis, J; Collino, S; Franceschi, C; Garagnani, P; Salisbury, BA; Harvey, JM; Delledonne, M				Ferrarini, Alberto; Xumerle, Luciano; Griggio, Francesca; Garonzi, Marianna; Cantaloni, Chiara; Centomo, Cesare; Vargas, Sergio Marin; Descombes, Patrick; Marquis, Julien; Collino, Sebastiano; Franceschi, Claudio; Garagnani, Paolo; Salisbury, Benjamin A.; Harvey, John Max; Delledonne, Massimo			The Use of Non-Variant Sites to Improve the Clinical Assessment of Whole-Genome Sequence Data	PLOS ONE			English	Article							RARE VARIANTS; GENETIC-VARIATION; WIDE ASSOCIATION; MUTATIONS; DISEASE; COMMON; EXOME; CANCER; SCN10A; SNP	Genetic testing, which is now a routine part of clinical practice and disease management protocols, is often based on the assessment of small panels of variants or genes. On the other hand, continuous improvements in the speed and per-base costs of sequencing have now made whole exome sequencing (WES) and whole genome sequencing (WGS) viable strategies for targeted or complete genetic analysis, respectively. Standard WGS/WES data analytical workflows generally rely on calling of sequence variants respect to the reference genome sequence. However, the reference genome sequence contains a large number of sites represented by rare alleles, by known pathogenic alleles and by alleles strongly associated to disease by GWAS. It's thus critical, for clinical applications of WGS and WES, to interpret whether non-variant sites are homozygous for the reference allele or if the corresponding genotype cannot be reliably called. Here we show that an alternative analytical approach based on the analysis of both variant and non-variant sites from WGS data allows to genotype more than 92% of sites corresponding to known SNPs compared to 6% genotyped by standard variant analysis. These include homozygous reference sites of clinical interest, thus leading to a broad and comprehensive characterization of variation necessary to an accurate evaluation of disease risk. Altogether, our findings indicate that characterization of both variant and non-variant clinically informative sites in the genome is necessary to allow an accurate clinical assessment of a personal genome. Finally, we propose a highly efficient extended VCF (eVCF) file format which allows to store genotype calls for sites of clinical interest while remaining compatible with current variant interpretation software.	[Ferrarini, Alberto; Griggio, Francesca; Garonzi, Marianna; Cantaloni, Chiara; Centomo, Cesare; Vargas, Sergio Marin; Delledonne, Massimo] Univ Verona, Dept Biotechnol, Funct Genom Ctr, I-37134 Verona, Italy; [Xumerle, Luciano; Griggio, Francesca; Cantaloni, Chiara; Franceschi, Claudio; Garagnani, Paolo; Delledonne, Massimo] Personal Genom Srl, I-37134 Verona, Italy; [Descombes, Patrick; Marquis, Julien] Nestle Inst Hlth Sci SA, Funct Genom, CH-1015 Lausanne, Switzerland; [Collino, Sebastiano] Nestle Inst Hlth Sci SA, Mol Biomarkers, CH-1015 Lausanne, Switzerland; [Franceschi, Claudio; Garagnani, Paolo] Univ Bologna, Dept Expt Diagnost & Specialty Med Expt Pathol, I-40126 Bologna, Italy; [Franceschi, Claudio; Garagnani, Paolo] Univ Bologna, Interdept Ctr L Galvani CIG, I-40126 Bologna, Italy; [Franceschi, Claudio] Osped Bellaria, Inst Neurol Sci Bologna, IRCCS, I-40139 Bologna, Italy; [Garagnani, Paolo] St Orsola Malpighi Univ Hosp, Ctr Appl Biomed Res, I-40138 Bologna, Italy; [Salisbury, Benjamin A.; Harvey, John Max] Knome Inc, Waltham, MA 02451 USA	University of Verona; Nestle SA; Nestle SA; University of Bologna; University of Bologna; IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB); IRCCS Azienda Ospedaliero-Universitaria di Bologna	Delledonne, M (corresponding author), Univ Verona, Dept Biotechnol, Funct Genom Ctr, I-37134 Verona, Italy.	massimo.delledonne@univr.it	Delledonne, Massimo/O-8685-2017; Franceschi, Claudio/L-4484-2017	Franceschi, Claudio/0000-0001-9841-6386; Delledonne, Massimo/0000-0002-7100-4581; Garagnani, Paolo/0000-0002-4161-3626; Xumerle, Luciano/0000-0003-4518-3958	Personal Genomics s.r.l; Nestle Institute of Health Sciences SA; Knome Inc	Personal Genomics s.r.l; Nestle Institute of Health Sciences SA(Nestle SA); Knome Inc	Personal Genomics s.r.l, Nestle Institute of Health Sciences SA, and Knome Inc provided support in the form of salaries for authors FG, CC, PD, JM, SC, CF, PG, BAS, JMH, and MD but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Ajay SS, 2011, GENOME RES, V21, P1498, DOI 10.1101/gr.123638.111; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Bakker E, 2006, CLIN CHEM, V52, P557, DOI 10.1373/clinchem.2005.066068; BERTINA RM, 1994, NATURE, V369, P64, DOI 10.1038/369064a0; Bezzina CR, 2013, NAT GENET, V45, P1044, DOI 10.1038/ng.2712; Biliczki P, 2008, HEART RHYTHM, V5, P1159, DOI 10.1016/j.hrthm.2008.04.016; Chambers JC, 2010, NAT GENET, V42, P149, DOI 10.1038/ng.516; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Cirulli ET, 2010, NAT REV GENET, V11, P415, DOI 10.1038/nrg2779; Clark MJ, 2011, NAT BIOTECHNOL, V29, P908, DOI 10.1038/nbt.1975; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Drilon A, 2013, CANCER DISCOV, V3, P630, DOI 10.1158/2159-8290.CD-13-0035; Easton DF, 2008, HUM MOL GENET, V17, pR109, DOI 10.1093/hmg/ddn287; Fang H, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0089-z; Frampton GM, 2013, NAT BIOTECHNOL, V31, P1023, DOI 10.1038/nbt.2696; Frazer KA, 2009, NAT REV GENET, V10, P241, DOI 10.1038/nrg2554; Grupe A, 2006, AM J HUM GENET, V78, P78, DOI 10.1086/498851; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Katsanis N, 2001, SCIENCE, V293, P2256, DOI 10.1126/science.1063525; Kiezun A, 2012, NAT GENET, V44, P623, DOI 10.1038/ng.2303; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Kozarewa I, 2009, NAT METHODS, V6, P291, DOI [10.1038/nmeth.1311, 10.1038/NMETH.1311]; Kryukov GV, 2007, AM J HUM GENET, V80, P727, DOI 10.1086/513473; Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113; Lee H, 2012, BIOINFORMATICS, V28, P2097, DOI 10.1093/bioinformatics/bts330; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li MLJ, 2012, NUCLEIC ACIDS RES, V40, pD1047, DOI 10.1093/nar/gkr1182; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; O'Rawe J, 2013, GENOME MED, V5, DOI 10.1186/gm432; Pallante BA, 2010, CIRC-ARRHYTHMIA ELEC, V3, P186, DOI 10.1161/CIRCEP.109.928820; Pant S, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00078; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Raczy C, 2013, BIOINFORMATICS, V29, P2041, DOI 10.1093/bioinformatics/btt314; Rehm HL, 2013, NAT REV GENET, V14, P295, DOI 10.1038/nrg3463; Richards CS, 2002, GENET MED, V4, P471; Saint Pierre A, 2014, BRIEF FUNCT GENOMICS, V13, P353, DOI 10.1093/bfgp/elu025; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Sequeiros J, 2012, J COMMUN GENET, V3, P113, DOI 10.1007/s12687-012-0084-2; Simon R, 2013, NAT REV DRUG DISCOV, V12, P359, DOI 10.1038/nrd3979; Strom CM, 2011, GENET MED, V13, P166, DOI 10.1097/GIM.0b013e3181fa24c4; Subbiah V, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/1756-8722-7-8; Tester DJ, 2005, HEART RHYTHM, V2, P507, DOI 10.1016/j.hrthm.2005.01.020; Van Limbergen J, 2009, ANNU REV GENOM HUM G, V10, P89, DOI 10.1146/annurev-genom-082908-150013; Veal CD, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-455; Verkerk AO, 2012, CIRC RES, V111, P333, DOI 10.1161/CIRCRESAHA.112.274035; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Yang T, 2012, CIRC RES, V111, P322, DOI 10.1161/CIRCRESAHA.112.265173; Zook JM, 2014, NAT BIOTECHNOL, V32, P246, DOI 10.1038/nbt.2835	55	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132180	10.1371/journal.pone.0132180	http://dx.doi.org/10.1371/journal.pone.0132180			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147798	Green Published, Green Submitted, gold			2022-12-26	WOS:000358157600213
J	Gupta, R; Sadhale, PP; Vijayraghavan, U				Gupta, Ritu; Sadhale, Parag P.; Vijayraghavan, Usha			SUB1 Plays a Negative Role during Starvation Induced Sporulation Program in Saccharomyces cerevisiae	PLOS ONE			English	Article							RNA-POLYMERASE-II; TRANSCRIPTIONAL REPRESSOR; HISTONE DEACETYLASE; CALORIE RESTRICTION; HUMAN COACTIVATOR; UME6; EXPRESSION; REGULATOR; MEIOSIS; COMPLEX	Saccharomyces cerevisiae Sub1 is involved in several cellular processes such as, transcription initiation, elongation, mRNA processing and DNA repair. It has also been reported to provide cellular resistance during conditions of oxidative DNA damage and osmotic stress. Here, we report a novel role of SUB1 during starvation stress-induced sporulation, which leads to meiosis and spore formation in diploid yeast cells. Deletion of SUB1 gene significantly increased sporulation efficiency as compared to the wild-type cells in S288c genetic background. Whereas, the sporulation functions of the sub1(Y66A) missense mutant were similar to Sub1. SUB1 transcript and protein levels are downregulated during sporulation, in highly synchronized and sporulation proficient wild-type SK1 cells. The changes in Sub1 levels during sporulation cascade correlate with the induction of middle sporulation gene expression. Deletion of SUB1 increased middle sporulation gene transcript levels with no effect on their induction kinetics. In wild-type cells, Sub1 associates with chromatin at these loci in a temporal pattern that correlates with their enhanced gene expression seen in sub1. cells. We show that SUB1 genetically interacts with HOS2, which led us to speculate that Sub1 might function with Set3 repressor complex during sporulation. Positive Cofactor 4, human homolog of Sub1, complemented the sub1. sporulation phenotype, suggesting conservation of function. Taken together, our results suggest that SUB1 acts as a negative regulator of sporulation.	[Gupta, Ritu; Sadhale, Parag P.; Vijayraghavan, Usha] Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Vijayraghavan, U (corresponding author), Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India.	uvr@mcbl.iisc.ernet.in		GUPTA, RITU/0000-0002-0563-6599	Council of Scientific and Industrial Research	Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India)	This work was funded by a fellowship from Council of Scientific and Industrial Research to RG. DBT grant-in-aid program funding to Indian Institute of Science provided phosphor imager, real time PCR and other instrumentation facilities for the study.	Ahmed NT, 2009, MOL CELL BIOL, V29, P4352, DOI 10.1128/MCB.00305-09; ANDERSON SF, 1995, PROTEIN SCI, V4, P1832, DOI 10.1002/pro.5560040918; Arevalo-Rodriguez M, 2005, EUKARYOT CELL, V4, P17, DOI 10.1128/EC.4.1.17-29.2005; Beltrao P, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000134; Ben-Ari G, 2006, PLOS GENET, V2, P1815, DOI 10.1371/journal.pgen.0020195; Calvo O, 2005, EMBO J, V24, P1009, DOI 10.1038/sj.emboj.7600575; Calvo O, 2001, MOL CELL, V7, P1013, DOI 10.1016/S1097-2765(01)00236-2; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; Cohen TJ, 2008, EUKARYOT CELL, V7, P1191, DOI 10.1128/EC.00059-08; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Corbi D, 2014, MOL CELL BIOL, V34, P2249, DOI 10.1128/MCB.01413-13; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Deutschbauer AM, 2005, NAT GENET, V37, P1333, DOI 10.1038/ng1674; Deutschbauer AM, 2002, P NATL ACAD SCI USA, V99, P15530, DOI 10.1073/pnas.202604399; ESPOSITO MS, 1969, J BACTERIOL, V100, P180, DOI 10.1128/JB.100.1.180-186.1969; FREESE EB, 1982, J BACTERIOL, V149, P840, DOI 10.1128/JB.149.3.840-851.1982; Frydlova I, 2007, CURR GENET, V52, P87, DOI 10.1007/s00294-007-0141-2; Garcia A, 2012, MOL BIOL CELL, V23, P4297, DOI 10.1091/mbc.E12-04-0331; GE H, 1994, CELL, V78, P513, DOI 10.1016/0092-8674(94)90428-6; GIMENO CJ, 1992, CELL, V68, P1077, DOI 10.1016/0092-8674(92)90079-R; Goldmark JP, 2000, CELL, V103, P423, DOI 10.1016/S0092-8674(00)00134-3; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Guisbert KSK, 2012, RNA, V18, P1142, DOI 10.1261/rna.030510.111; Harbison CT, 2004, NATURE, V431, P1; Henry NL, 1996, J BIOL CHEM, V271, P21842, DOI 10.1074/jbc.271.36.21842; Hepworth SR, 1998, MOL CELL BIOL, V18, P5750, DOI 10.1128/MCB.18.10.5750; Huang JG, 2012, ACTA CRYSTALLOGR D, V68, P1071, DOI 10.1107/S0907444912019932; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Kadosh D, 1997, CELL, V89, P365, DOI 10.1016/S0092-8674(00)80217-2; KASSIR Y, 1991, METHOD ENZYMOL, V194, P94; Knaus R, 1996, EMBO J, V15, P1933, DOI 10.1002/j.1460-2075.1996.tb00544.x; Koubova J, 2003, GENE DEV, V17, P313, DOI 10.1101/gad.1052903; Koyama H, 2008, GENES CELLS, V13, P1113, DOI 10.1111/j.1365-2443.2008.01229.x; Kurdistani SK, 2002, NAT GENET, V31, P248, DOI 10.1038/ng907; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Lindgren A, 2000, EMBO J, V19, P6489, DOI 10.1093/emboj/19.23.6489; Lo HC, 2012, MOL CELL BIOL, V32, P541, DOI 10.1128/MCB.06032-11; Mallory MJ, 2003, J BIOL CHEM, V278, P44727, DOI 10.1074/jbc.M308632200; MITCHELL AP, 1994, MICROBIOL REV, V58, P56, DOI 10.1128/MMBR.58.1.56-70.1994; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Pijnappel WWMP, 2001, GENE DEV, V15, P2991, DOI 10.1101/gad.207401; Primig M, 2000, NAT GENET, V26, P415, DOI 10.1038/82539; ROMAN H, 1955, GENETICS, V40, P546; Rosonina E, 2009, MOL CELL BIOL, V29, P2308, DOI 10.1128/MCB.01841-08; RubinBejerano I, 1996, MOL CELL BIOL, V16, P2518; Sikorski TW, 2011, MOL CELL, V44, P397, DOI 10.1016/j.molcel.2011.09.013; STRICH R, 1994, GENE DEV, V8, P796, DOI 10.1101/gad.8.7.796; Tavenet A, 2009, P NATL ACAD SCI USA, V106, P14265, DOI 10.1073/pnas.0900162106; Wang JY, 2004, MOL CELL BIOL, V24, P6084, DOI 10.1128/MCB.24.13.6084-6093.2004; Washburn BK, 2001, MOL CELL BIOL, V21, P2057, DOI 10.1128/MCB.21.6.2057-2069.2001; Zheng JS, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.77	52	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132350	10.1371/journal.pone.0132350	http://dx.doi.org/10.1371/journal.pone.0132350			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147804	gold, Green Submitted, Green Published			2022-12-26	WOS:000358157600249
J	Xu, WL; Cardenes, N; Corey, C; Erzurum, SC; Shiva, S				Xu, Weiling; Cardenes, Nayra; Corey, Catherine; Erzurum, Serpil C.; Shiva, Sruti			Platelets from Asthmatic Individuals Show Less Reliance on Glycolysis	PLOS ONE			English	Article							ALLERGIC-ASTHMA; NITRIC-OXIDE; UNCOUPLING PROTEIN-2; PROGENITOR CELLS; MURINE MODEL; P-SELECTIN; MITOCHONDRIAL; ACTIVATION; INFLAMMATION; RECRUITMENT	Asthma, a chronic inflammatory airway disease, is typified by high levels of T(H)2-cytokines and excessive generation of reactive nitrogen and oxygen species, which contribute to bronchial epithelial injury and airway remodeling. While immune function plays a major role in the pathogenesis of the disease, accumulating evidence suggests that altered cellular metabolism is a key determinant in the predisposition and disease progression of asthma. Further, several studies demonstrate altered mitochondrial function in asthmatic airways and suggest that these changes may be systemic. However, it is unknown whether systemic metabolic changes can be detected in circulating cells in asthmatic patients. Platelets are easily accessible blood cells that are known to propagate airway inflammation in asthma. Here we perform a bioenergetic screen of platelets from asthmatic and healthy individuals and demonstrate that asthmatic platelets show a decreased reliance on glycolytic processes and have increased tricarboxylic acid cycle activity. These data demonstrate a systemic alteration in asthma and are consistent with prior reports suggesting that oxidative phosphorylation is more efficient asthmatic individuals. The implications for this potential metabolic shift will be discussed in the context of increased oxidative stress and hypoxic adaptation of asthmatic patients. Further, these data suggest that platelets are potentially a good model for the monitoring of bioenergetic changes in asthma.	[Xu, Weiling] Lerner Res Inst, Cleveland, OH USA; [Cardenes, Nayra; Corey, Catherine] Univ Pittsburgh, Sch Med, Vasc Med Inst, Pittsburgh, PA USA; [Erzurum, Serpil C.] Cleveland Clin, Resp Inst, Lerner Res Inst, Cleveland, OH 44106 USA; [Shiva, Sruti] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Vasc Med Inst,Ctr Metab & Mitochondrial Med, Pittsburgh, PA 15260 USA	Cleveland Clinic Foundation; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Cleveland Clinic Foundation; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Shiva, S (corresponding author), Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Vasc Med Inst,Ctr Metab & Mitochondrial Med, Pittsburgh, PA 15260 USA.	sss43@pitt.edu			National Institutes of Health [HL081064, HL103453]; National Center for Advancing Translational Sciences [UL1TR000439]; Hemophilia Center of Western Pennsylvania; Intsitute for Transfusion Medicine; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL081064, R24HL123767, P01HL103453] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Hemophilia Center of Western Pennsylvania; Intsitute for Transfusion Medicine; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health (HL081064, HL103453 to SCE), in part by National Center for Advancing Translational Sciences (UL1TR000439 to SCE), the Hemophilia Center of Western Pennsylvania (SS) and the Intsitute for Transfusion Medicine (SS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKKERMAN JWN, 1978, THROMB HAEMOSTASIS, V39, P712; AKKERMAN JWN, 1978, BIOCHIM BIOPHYS ACTA, V541, P241, DOI 10.1016/0304-4165(78)90397-5; [Anonymous], 2000, Am J Respir Crit Care Med, V162, P2341; Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; AVERILL FJ, 1992, AM REV RESPIR DIS, V145, P571, DOI 10.1164/ajrccm/145.3.571; Barnes PJ, 1995, RES IMMUNOL, V146, P698, DOI 10.1016/0923-2494(96)84921-2; Bolanos JP, 2008, BBA-BIOENERGETICS, V1777, P789, DOI 10.1016/j.bbabio.2008.04.011; BOLOGNA E, 1990, Bollettino Societa Italiana Biologia Sperimentale, V66, P343; Bonnet S, 2006, CIRCULATION, V113, P2630, DOI 10.1161/CIRCULATIONAHA.105.609008; Cardenes N, 2014, BLOOD, V123, P2864, DOI 10.1182/blood-2013-09-529420; CLEETER MWJ, 1994, FEBS LETT, V345, P50, DOI 10.1016/0014-5793(94)00424-2; Comhair SAA, 2010, ANTIOXID REDOX SIGN, V12, P93, DOI [10.1089/ars.2008.2425, 10.1089/ARS.2008.2425]; Cottrell L, 2011, AM J RESP CRIT CARE, V183, P441, DOI 10.1164/rccm.201004-0603OC; Dixon Anne E, 2010, Proc Am Thorac Soc, V7, P325, DOI 10.1513/pats.200903-013ST; Dudek AZ, 2003, BLOOD, V101, P4687, DOI 10.1182/blood-2002-08-2363; Erzurum SC, 2007, P NATL ACAD SCI USA, V104, P17593, DOI 10.1073/pnas.0707462104; Falkowski PG, 2005, SCIENCE, V309, P2202, DOI 10.1126/science.1116047; Fleury C, 1997, NAT GENET, V15, P269, DOI 10.1038/ng0397-269; Gourgoulianis K, 2001, ARCH MED RES, V32, P429, DOI 10.1016/S0188-4409(01)00302-2; GRESELE P, 1985, LANCET, V1, P347; GRESELE P, 1993, J ALLERGY CLIN IMMUN, V91, P894, DOI 10.1016/0091-6749(93)90347-I; Helenius I, 2000, J ALLERGY CLIN IMMUN, V106, P444, DOI 10.1067/mai.2000.107749; Holguin F, 2011, J ALLERGY CLIN IMMUN, V127, P1486, DOI 10.1016/j.jaci.2011.03.036; Hunt JF, 2002, AM J RESP CRIT CARE, V165, P101, DOI 10.1164/ajrccm.165.1.2104131; Jin DK, 2006, NAT MED, V12, P557, DOI 10.1038/nm1400; Johansson MW, 2012, AM J RESP CRIT CARE, V185, P498, DOI 10.1164/rccm.201109-1712OC; Johnson JB, 2007, FREE RADICAL BIO MED, V42, P665, DOI 10.1016/j.freeradbiomed.2006.12.005; JOSEPH M, 1983, NATURE, V303, P810, DOI 10.1038/303810a0; JOSEPH M, 1986, EUR J IMMUNOL, V16, P306, DOI 10.1002/eji.1830160318; Jung J, 2013, CLIN EXP ALLERGY, V43, P425, DOI 10.1111/cea.12089; Kamata H, 1999, CELL SIGNAL, V11, P1, DOI 10.1016/S0898-6568(98)00037-0; KAMEYOSHI Y, 1992, J EXP MED, V176, P587, DOI 10.1084/jem.176.2.587; Klinger MHF, 1997, ANAT EMBRYOL, V196, P1, DOI 10.1007/s004290050075; Kornerup KN, 2010, J APPL PHYSIOL, V109, P758, DOI 10.1152/japplphysiol.01086.2009; Kramer PA, 2014, REDOX BIOL, V2, P206, DOI 10.1016/j.redox.2013.12.026; Mabalirajan U, 2008, J IMMUNOL, V181, P3540, DOI 10.4049/jimmunol.181.5.3540; Mabalirajan U, 2009, J IMMUNOL, V183, P2059, DOI 10.4049/jimmunol.0900342; Matarrese P, 2009, FEBS J, V276, P845, DOI 10.1111/j.1742-4658.2008.06829.x; MCKEEHAN WL, 1982, CELL BIOL INT REP, V6, P635, DOI 10.1016/0309-1651(82)90125-4; Picado C, 1999, ALLERGY, V54, P569, DOI 10.1034/j.1398-9995.1999.00024.x; Pitchford SC, 2006, CLIN EXP ALLERGY, V36, P399, DOI 10.1111/j.1365-2222.2006.02462.x; Pitchford SC, 2005, BLOOD, V105, P2074, DOI 10.1182/blood-2004-06-2282; Pitchford SC, 2008, AM J RESP CRIT CARE, V177, P604, DOI 10.1164/rccm.200702-214OC; Ravi S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123597; Semenza GL, 2010, CURR OPIN GENET DEV, V20, P51, DOI 10.1016/j.gde.2009.10.009; Shiva S, 2001, P NATL ACAD SCI USA, V98, P7212, DOI 10.1073/pnas.131128898; Sivitz WI, 2009, ANTIOXID REDOX SIGNA; Sullivan PJ, 2000, RESPIRATION, V67, P514, DOI 10.1159/000067466; Swaidani S, 2009, J IMMUNOL, V182, P1631, DOI 10.4049/jimmunol.182.3.1631; Taylor B, 2008, THORAX, V63, P14, DOI 10.1136/thx.2007.082784; Trian T, 2007, J EXP MED, V204, P3173, DOI 10.1084/jem.20070956; VANLEEUWEN WS, 1924, KLIN WOCHENSCHR, V3, P520; Varady KA, 2007, AM J CLIN NUTR, V86, P7, DOI 10.1093/ajcn/86.1.7; Vargas MH, 1999, J ASTHMA, V36, P511, DOI 10.3109/02770909909054557; Weiler JM, 2000, J ALLERGY CLIN IMMUN, V106, P267, DOI 10.1067/mai.2000.108605; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Xu WL, 2007, P NATL ACAD SCI USA, V104, P1342, DOI 10.1073/pnas.0605080104; Xu WL, 2003, AM J PHYSIOL-LUNG C, V285, pL137, DOI 10.1152/ajplung.00441.2002; Yamagishi S, 2001, DIABETES, V50, P1491, DOI 10.2337/diabetes.50.6.1491; Zernecke A, 2005, CIRC RES, V96, P784, DOI 10.1161/01.RES.0000162100.52009.38; Zernecke A, 2008, CIRC RES, V102, P209, DOI 10.1161/CIRCRESAHA.107.160697	61	37	37	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132007	10.1371/journal.pone.0132007	http://dx.doi.org/10.1371/journal.pone.0132007			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147848	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000358157600178
J	Sotoca, AM; Prange, KHM; Reijnders, B; Mandoli, A; Nguyen, LN; Stunnenberg, HG; Martens, JHA				Sotoca, A. M.; Prange, K. H. M.; Reijnders, B.; Mandoli, A.; Nguyen, L. N.; Stunnenberg, H. G.; Martens, J. H. A.			The oncofusion protein FUS-ERG targets key hematopoietic regulators and modulates the all-trans retinoic acid signaling pathway in t(16;21) acute myeloid leukemia	ONCOGENE			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; GENOME-WIDE ANALYSIS; PML-RAR-ALPHA; TRANSCRIPTION FACTOR; PROSTATE-CANCER; BINDING-SITES; HISTONE DEACETYLASE; RECEPTOR-ALPHA; CD38 ANTIGEN; SELF-RENEWAL	The ETS transcription factor ERG has been implicated as a major regulator of both normal and aberrant hematopoiesis. In acute myeloid leukemias harboring t(16; 21), ERG function is deregulated due to a fusion with FUS/TLS resulting in the expression of a FUS-ERG oncofusion protein. How this oncofusion protein deregulates the normal ERG transcription program is unclear. Here, we show that FUS-ERG acts in the context of a heptad of proteins (ERG, FLI1, GATA2, LYL1, LMO2, RUNX1 and TAL1) central to proper expression of genes involved in maintaining a stem cell hematopoietic phenotype. Moreover, in t(16; 21) FUS-ERG co-occupies genomic regions bound by the nuclear receptor heterodimer RXR:RARA inhibiting target gene expression and interfering with hematopoietic differentiation. All-trans retinoic acid treatment of t(16; 21) cells as well as FUS-ERG knockdown alleviate the myeloid-differentiation block. Together, the results suggest that FUS-ERG acts as a transcriptional repressor of the retinoic acid signaling pathway.	[Sotoca, A. M.; Prange, K. H. M.; Reijnders, B.; Mandoli, A.; Nguyen, L. N.; Stunnenberg, H. G.; Martens, J. H. A.] Radboud Univ Nijmegen, Dept Mol Biol, Fac Sci, Nijmegen Ctr Mol Life Sci, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen	Martens, JHA (corresponding author), Radboud Univ Nijmegen, Dept Mol Biol, Fac Sci, Nijmegen Ctr Mol Life Sci,FNWI, Geert Grootepl 28, NL-6500 HB Nijmegen, Netherlands.	j.martens@ncmls.ru.nl	Stunnenberg, Hendrik G./D-6875-2012; Martens, Joost/D-4966-2012; Nguyen, Luan/GYA-2927-2022	Stunnenberg, Hendrik G./0000-0002-0066-1576; Martens, Joost/0000-0003-2008-6537; Prange, Koen/0000-0002-9835-1735	EU [BLUEPRINT-282510]; Dutch Cancer Foundation [KWF KUN 2009-4527, KUN 2011-4937]; Netherlands Organization for Scientific Research (NWO-VIDI)	EU(European Commission); Dutch Cancer Foundation(KWF Kankerbestrijding); Netherlands Organization for Scientific Research (NWO-VIDI)(Netherlands Organization for Scientific Research (NWO))	This work was supported by the EU (BLUEPRINT-282510), the Dutch Cancer Foundation (KWF KUN 2009-4527 and KUN 2011-4937) and the Netherlands Organization for Scientific Research (NWO-VIDI to JHAM). Database accession: All ChIP-seq and RNA-seq data can be downloaded from the NCBI Gene Expression Omnibus (GEO) (http://www.ncbi.nlm.nih.gov/geo/) under accession number GSE60477.	Beck D, 2013, BLOOD, V122, pE12, DOI 10.1182/blood-2013-03-490425; Bock J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052872; Boersema PJ, 2009, NAT PROTOC, V4, P484, DOI 10.1038/nprot.2009.21; CROZAT A, 1993, NATURE, V363, P640, DOI 10.1038/363640a0; De Bellis F, 2014, CANCER RES, V74, P2328, DOI 10.1158/0008-5472.CAN-13-2568; Delva L, 2004, ONCOGENE, V23, P4389, DOI 10.1038/sj.onc.1207578; Denissov S, 2007, EMBO J, V26, P944, DOI 10.1038/sj.emboj.7601550; Diffner E, 2013, BLOOD, V121, P2289, DOI 10.1182/blood-2012-07-446120; DRACH J, 1993, BIOCHEM BIOPH RES CO, V195, P545, DOI 10.1006/bbrc.1993.2080; DRACH J, 1994, CANCER RES, V54, P1746; DUBOIS C, 1994, BLOOD, V83, P3264; Ebralidze AK, 2008, GENE DEV, V22, P2085, DOI 10.1101/gad.1654808; Goldberg L, 2013, BLOOD, V122, P2694, DOI 10.1182/blood-2013-01-477133; Grignani F, 1998, NATURE, V391, P815, DOI 10.1038/35901; Hallier M, 1998, J BIOL CHEM, V273, P4838, DOI 10.1074/jbc.273.9.4838; Hicks GG, 2000, NAT GENET, V24, P175, DOI 10.1038/72842; Kong XT, 1997, BLOOD, V90, P1192; Kryndushkin D, 2011, PROTEIN CELL, V2, P223, DOI 10.1007/s13238-011-1525-0; Lacadie SA, 2011, GENE DEV, V25, P289, DOI 10.1101/gad.2031511; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lian Z, 2001, BLOOD, V98, P513, DOI 10.1182/blood.V98.3.513; Lin RJ, 1998, NATURE, V391, P811, DOI 10.1038/35895; Liu SJ, 2007, J PHARMACOL EXP THER, V321, P953, DOI 10.1124/jpet.106.118406; Loughran SJ, 2008, NAT IMMUNOL, V9, P810, DOI 10.1038/ni.1617; Martens JHA, 2012, BLOOD, V120, P4038, DOI 10.1182/blood-2012-05-429050; Martens JHA, 2010, CANCER CELL, V17, P173, DOI 10.1016/j.ccr.2009.12.042; Mills KI, 2000, BRIT J HAEMATOL, V108, P316; Minucci S, 2000, MOL CELL, V5, P811, DOI 10.1016/S1097-2765(00)80321-4; Ng AP, 2011, BLOOD, V118, P2454, DOI 10.1182/blood-2011-03-344739; Pereira DS, 1998, P NATL ACAD SCI USA, V95, P8239, DOI 10.1073/pnas.95.14.8239; Powers CA, 1998, MOL ENDOCRINOL, V12, P4, DOI 10.1210/mend.12.1.0043; PRASAD DDK, 1994, ONCOGENE, V9, P3717; Rapin N, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2014.22; Saeed S, 2011, BRIT J CANCER, V104, P554, DOI 10.1038/sj.bjc.6606095; Saeed S, 2012, BLOOD, V120, P3058, DOI 10.1182/blood-2011-10-386086; Salek-Ardakani S, 2009, CANCER RES, V69, P4665, DOI 10.1158/0008-5472.CAN-09-0075; Sharrocks AD, 1997, INT J BIOCHEM CELL B, V29, P1371, DOI 10.1016/S1357-2725(97)00086-1; Shikami M, 1999, BRIT J HAEMATOL, V105, P711, DOI 10.1046/j.1365-2141.1999.01384.x; SORENSEN PHB, 1994, NAT GENET, V6, P146, DOI 10.1038/ng0294-146; Sugawara T, 2010, EXP HEMATOL, V38, P696, DOI 10.1016/j.exphem.2010.04.006; Sun ZH, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000614; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Walsby EJ, 2007, BRIT J HAEMATOL, V139, P94, DOI 10.1111/j.1365-2141.2007.06756.x; Wei GH, 2010, EMBO J, V29, P2147, DOI 10.1038/emboj.2010.106; Wilson NK, 2010, CELL STEM CELL, V7, P532, DOI 10.1016/j.stem.2010.07.016; Winnes M, 2007, ONCOL REP, V17, P1033; Yamamoto K, 1997, LEUKEMIA, V11, P599, DOI 10.1038/sj.leu.2400594; Yang L, 2000, MOL CELL BIOL, V20, P3345, DOI 10.1128/MCB.20.10.3345-3354.2000; Yu JD, 2010, CANCER CELL, V17, P443, DOI 10.1016/j.ccr.2010.03.018; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zinszner H, 1997, ONCOGENE, V14, P451, DOI 10.1038/sj.onc.1200854; Zinszner H, 1997, J CELL SCI, V110, P1741; Zou JH, 2005, MOL CELL BIOL, V25, P6235, DOI 10.1128/MCB.25.14.6235-6246.2005	54	27	30	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 14	2016	35	15					1965	1976		10.1038/onc.2015.261	http://dx.doi.org/10.1038/onc.2015.261			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DJ2CC	26148230	Green Published, hybrid			2022-12-26	WOS:000374010300009
J	Courivaud, T; Ferrand, N; Elkhattouti, A; Kumar, S; Levy, L; Ferrigno, O; Atfi, A; Prunier, C				Courivaud, Thomas; Ferrand, Nathalie; Elkhattouti, Abdelouahid; Kumar, Santosh; Levy, Laurence; Ferrigno, Olivier; Atfi, Azeddine; Prunier, Celine			Functional Characterization of a WWP1/Tiul1 Tumor-derived Mutant Reveals a Paradigm of Its Constitutive Activation in Human Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN E3 LIGASE; BREAST-CANCER; PROTEASOMAL DEGRADATION; HECT FAMILY; WWP1; DOMAIN; TARGET; DIFFERENTIATION; TRANSCRIPTION; MIGRATION	Although E3 ubiquitin ligases are deemed to play key roles in normal cell function and homeostasis, whether their alterations contribute to cancer pathogenesis remains unclear. In this study, we sought to investigate potential mechanisms that govern WWP1/Tiul1 (WWP1) ubiquitin ligase activity, focusing on its ability to trigger degradation of TGF beta type I receptor (T beta RI) in conjunction with Smad7. Our data reveal that the WWP1 protein is very stable at steady states because its autopolyubiquitination activity is silenced due to an intra-interaction between the C2 and/or WW and Hect domains that favors WWP1 monoubiquitination at the expense of its polyubiquitination or polyubiquitination of T beta RI. Upon binding of WWP1 to Smad7, this functional interplay is disabled, switching its monoubiquitination activity toward a polyubiquitination activity, thereby driving its own degradation and that of T beta RI as well. Intriguingly, a WWP1 point mutation found in human prostate cancer disrupts this regulatory mechanism by relieving the inhibitory effects of C2 and WW on Hect and thereby causing WWP1 hyperactivation. That cancer-driven alteration of WWP1 culminates in excessive T beta RI degradation and attenuated TGF beta cytostatic signaling, a consequence that could conceivably confer tumorigenic properties to WWP1.	[Courivaud, Thomas; Ferrand, Nathalie; Levy, Laurence; Ferrigno, Olivier; Atfi, Azeddine; Prunier, Celine] Univ Paris 06, F-75005 Paris, France; [Courivaud, Thomas; Ferrand, Nathalie; Levy, Laurence; Ferrigno, Olivier; Atfi, Azeddine; Prunier, Celine] INSERM, UMR S 938, Lab Cell Signaling & Carcinogenesis, F-75012 Paris, France; [Elkhattouti, Abdelouahid; Kumar, Santosh; Atfi, Azeddine] Univ Mississippi, Med Ctr, Inst Canc, Jackson, MS 39216 USA; [Elkhattouti, Abdelouahid; Kumar, Santosh; Atfi, Azeddine] Univ Mississippi, Med Ctr, Dept Biochem, Jackson, MS 39216 USA	UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center	Prunier, C (corresponding author), Hop St Antoine, Lab Cell Signaling & Carcinogenesis, 34 Rue Crozatier, F-75012 Paris, France.	celine.prunier@inserm.fr	Frottier, Celine Prunier/G-8259-2017; ferrigno, olivier/GSN-8581-2022; LEVY, Laurence/AAF-5672-2021	Frottier, Celine Prunier/0000-0002-7784-0273; ferrigno, olivier/0000-0001-7544-4384; 	La Ligue contre le Cancer; "Association pour la Recherche contre le Cancer," France; La Ligue Nationale contre le Cancer	La Ligue contre le Cancer(Ligue nationale contre le cancer); "Association pour la Recherche contre le Cancer," France(Fondation ARC pour la Recherche sur le Cancer); La Ligue Nationale contre le Cancer(Ligue nationale contre le cancer)	This work was supported in part by grants from "La Ligue contre le Cancer" and "Association pour la Recherche contre le Cancer," France (to A. A.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a doctoral fellowship from "La Ligue Nationale contre le Cancer" and "Association pour la Recherche contre le Cancer," France.	Bernassola F, 2008, CANCER CELL, V14, P10, DOI 10.1016/j.ccr.2008.06.001; Bruce MC, 2008, BIOCHEM J, V415, P155, DOI 10.1042/BJ20071708; Chen C, 2007, ONCOGENE, V26, P2386, DOI 10.1038/sj.onc.1210021; Chen C, 2008, ONCOGENE, V27, P6845, DOI 10.1038/onc.2008.288; Chen CS, 2007, INT J CANCER, V121, P80, DOI 10.1002/ijc.22653; Chen CS, 2009, INT J CANCER, V124, P2829, DOI 10.1002/ijc.24266; Chen CS, 2005, J BIOL CHEM, V280, P41553, DOI 10.1074/jbc.M506183200; Feng SM, 2009, MOL CELL BIOL, V29, P892, DOI 10.1128/MCB.00595-08; Huu NSN, 2008, J PATHOL, V216, P93, DOI 10.1002/path.2385; Jones DC, 2006, SCIENCE, V312, P1223, DOI 10.1126/science.1126313; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Komuro A, 2004, ONCOGENE, V23, P6914, DOI 10.1038/sj.onc.1207885; Kravtsova-Ivantsiv Y, 2012, J CELL SCI, V125, P539, DOI 10.1242/jcs.093567; Laine A, 2007, ONCOGENE, V26, P1477, DOI 10.1038/sj.onc.1209924; Li Y, 2008, CELL DEATH DIFFER, V15, P1941, DOI 10.1038/cdd.2008.134; Lin XW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067633; Maspero E, 2013, NAT STRUCT MOL BIOL, V20, P696, DOI 10.1038/nsmb.2566; Peschiaroli A, 2010, BIOCHEM BIOPH RES CO, V402, P425, DOI 10.1016/j.bbrc.2010.10.050; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Seo SR, 2004, EMBO J, V23, P3780, DOI 10.1038/sj.emboj.7600398; Shu L, 2013, J BONE MINER RES, V28, P1925, DOI 10.1002/jbmr.1938; Subik K, 2012, BONE, V50, P813, DOI 10.1016/j.bone.2011.12.022; Verdecia MA, 2003, MOL CELL, V11, P249, DOI 10.1016/S1097-2765(02)00774-8; Wiesner S, 2007, CELL, V130, P651, DOI 10.1016/j.cell.2007.06.050; Yeung B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061027; Zaarour RF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037490; Zhao D, 2012, CARCINOGENESIS, V33, P59, DOI 10.1093/carcin/bgr242; Zhao L, 2011, STEM CELLS, V29, P1601, DOI 10.1002/stem.703; Zhi X, 2012, CELL MOL LIFE SCI, V69, P1425, DOI 10.1007/s00018-011-0871-7; Zhou ZM, 2012, INT J CANCER, V130, P1504, DOI 10.1002/ijc.26122	30	14	14	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2015	290	34					21007	21018		10.1074/jbc.M115.642314	http://dx.doi.org/10.1074/jbc.M115.642314			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP6QC	26152726	Green Published, hybrid			2022-12-26	WOS:000360011800034
J	Luo, SK; Xin, XR; Du, LL; Ye, KQ; Wei, Y				Luo, Shukun; Xin, Xiaoran; Du, Li-Lin; Ye, Keqiong; Wei, Yi			Dimerization Mediated by a Divergent Forkhead-associated Domain Is Essential for the DNA Damage and Spindle Functions of Fission Yeast Mdb1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHECKPOINT PROTEIN; BRCT DOMAIN; DEPENDENT DIMERIZATION; MOLECULAR-BASIS; HISTONE H2AX; FHA DOMAIN; MDC1; PHOSPHORYLATION; BINDING; REPAIR	MDC1 is a key factor of DNA damage response in mammalian cells. It possesses two phospho-binding domains. In its C terminus, a tandem BRCA1 C-terminal domain binds phosphorylated histone H2AX, and in its N terminus, a forkhead-associated (FHA) domain mediates a phosphorylation-enhanced homodimerization. The FHA domain of the Drosophila homolog of MDC1, MU2, also forms a homodimer but utilizes a different dimer interface. The functional importance of the dimerization of MDC1 family proteins is uncertain. In the fission yeast Schizosaccharomyces pombe, a protein sharing homology with MDC1 in the tandem BRCA1 C-terminal domain, Mdb1, regulates DNA damage response and mitotic spindle functions. Here, we report the crystal structure of the N-terminal 91 amino acids of Mdb1. Despite a lack of obvious sequence conservation to the FHA domain of MDC1, this region of Mdb1 adopts an FHA-like fold and is therefore termed Mdb1-FHA. Unlike canonical FHA domains, Mdb1-FHA lacks all the conserved phospho-binding residues. It forms a stable homodimer through an interface distinct from those of MDC1 and MU2. Mdb1-FHA is important for the localization of Mdb1 to DNA damage sites and the spindle midzone, contributes to the roles of Mdb1 in cellular responses to genotoxins and an antimicrotubule drug, and promotes in vitro binding of Mdb1 to a phospho-H2A peptide. The defects caused by the loss of Mdb1-FHA can be rescued by fusion with either of two heterologous dimerization domains, suggesting that the main function of Mdb1-FHA is mediating dimerization. Our data support that FHA-mediated dimerization is conserved for MDC1 family proteins.	[Luo, Shukun; Xin, Xiaoran; Du, Li-Lin; Ye, Keqiong; Wei, Yi] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Ye, Keqiong] Chinese Acad Sci, Key Lab RNA Biol, Inst Biophys, Beijing 100101, Peoples R China	National Institute of Biological Sciences, Beijing; Chinese Academy of Sciences; Institute of Biophysics, CAS	Du, LL (corresponding author), Natl Inst Biol Sci, 7 Sci Pk Rd,Zhongguancun Life Sci Pk, Beijing 102206, Peoples R China.	dulilin@nibs.ac.cn; yekeqiong@nibs.ac.cn	Luo, Shukun/AAT-8195-2021; Luo, Shukun/A-8371-2017	Luo, Shukun/0000-0002-2766-3125; Luo, Shukun/0000-0002-2766-3125; Du, Li-Lin/0000-0002-1028-7397	Chinese Ministry of Science and Technology 863 Project [2008AA022310]; 973 Project [2010CB835402]; 863 Project [2007AA02Z1A5]; National Natural Science Foundation of China [31325007]; Beijing Municipal Government	Chinese Ministry of Science and Technology 863 Project(Ministry of Science and Technology, ChinaNational High Technology Research and Development Program of China); 973 Project(National Basic Research Program of China); 863 Project(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Government	This work was supported by Chinese Ministry of Science and Technology 863 Project 2008AA022310 and 973 Project 2010CB835402 (to K. Y.) and 863 Project 2007AA02Z1A5 (to L.-L. D.), by National Natural Science Foundation of China Grant 31325007 (to K. Y.), and by the Beijing Municipal Government. The authors declare that they have no conflicts of interest with the contents of this article.	Adams MM, 2005, CELL CYCLE, V4, P1854, DOI 10.4161/cc.4.12.2282; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; DeLano WL, 2002, PYMOL USERS MANUAL; Du LL, 2006, GENE DEV, V20, P1583, DOI 10.1101/gad.1422606; Du LL, 2004, J BIOL CHEM, V279, P38409, DOI 10.1074/jbc.M403326200; Durocher D, 2000, MOL CELL, V6, P1169, DOI 10.1016/S1097-2765(00)00114-3; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Forsburg SL, 2006, YEAST, V23, P173, DOI 10.1002/yea.1347; Granata M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001047; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huang YMM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098291; Jungmichel S, 2012, NUCLEIC ACIDS RES, V40, P3913, DOI 10.1093/nar/gkr1300; Kilkenny ML, 2008, GENE DEV, V22, P2034, DOI 10.1101/gad.472808; Lee MS, 2005, J BIOL CHEM, V280, P32053, DOI 10.1074/jbc.C500273200; Liu JP, 2012, NUCLEIC ACIDS RES, V40, P3898, DOI 10.1093/nar/gkr1296; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Luo KT, 2011, J BIOL CHEM, V286, P28192, DOI 10.1074/jbc.M111.258087; Luo SK, 2012, FEBS LETT, V586, P344, DOI 10.1016/j.febslet.2012.01.023; Mahajan A, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.151re12; Matsuyama A, 2004, YEAST, V21, P1289, DOI 10.1002/yea.1181; Matthews L. A., 2013, MECH DNA REPLICATION; Mermershtain I, 2013, MUTAT RES-FUND MOL M, V750, P15, DOI 10.1016/j.mrfmmm.2013.07.004; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Nakamura TM, 2004, MOL CELL BIOL, V24, P6215, DOI 10.1128/MCB.24.14.6215-6230.2004; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Qu M, 2013, MOL CELL, V51, P723, DOI 10.1016/j.molcel.2013.08.030; Reinhardt HC, 2013, NAT REV MOL CELL BIO, V14, P563, DOI 10.1038/nrm3640; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rozenzhak S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001032; Scully R, 2013, MUTAT RES-FUND MOL M, V750, P5, DOI 10.1016/j.mrfmmm.2013.07.007; Sofueva S, 2010, MOL CELL BIOL, V30, P4732, DOI 10.1128/MCB.00413-10; Soulier J, 1999, CURR BIOL, V9, P551, DOI 10.1016/S0960-9822(99)80242-5; Stavridi ES, 2002, STRUCTURE, V10, P891, DOI 10.1016/S0969-2126(02)00776-1; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Usui T, 2009, MOL CELL, V33, P147, DOI 10.1016/j.molcel.2008.12.022; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Ward I, 2006, J BIOL CHEM, V281, P38472, DOI 10.1074/jbc.M607577200; Wei Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092079; Welinder C, 2011, J PROTEOME RES, V10, P1416, DOI 10.1021/pr1011476; Williams JS, 2010, EMBO J, V29, P1136, DOI 10.1038/emboj.2009.413; Wu HH, 2012, BIOCHEMISTRY-US, V51, P575, DOI 10.1021/bi201709w; Xu QP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107309; Zgheib O, 2009, MOL CELL BIOL, V29, P1050, DOI 10.1128/MCB.01011-08	43	4	5	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2015	290	34					21054	21066		10.1074/jbc.M115.642538	http://dx.doi.org/10.1074/jbc.M115.642538			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP6QC	26160178	Green Published, hybrid			2022-12-26	WOS:000360011800038
J	Bino, G; Kingsford, RT; Porter, J				Bino, Gilad; Kingsford, Richard T.; Porter, John			Prioritizing Wetlands for Waterbirds in a Boom and Bust System: Waterbird Refugia and Breeding in the Murray-Darling Basin	PLOS ONE			English	Article							COLONIALLY-NESTING WATERBIRDS; MACQUARIE MARSHES; ARID AUSTRALIA; DRYLAND RIVERS; SOUTHERN-OSCILLATION; RESOURCE DEVELOPMENT; ECOLOGICAL IMPACTS; EASTERN AUSTRALIA; FLOW VARIABILITY; PROTECTED AREAS	Dryland rivers have considerable flow variability, producing complex ecosystems, processes, and communities of organisms that vary over space and time. They are also among the more vulnerable of the world's ecosystems. A key strategy for conservation of dryland rivers is identifying and maintaining key sites for biodiversity conservation, particularly protecting the quantity and quality of flow and flooding regimes. Extreme variability considerably challenges freshwater conservation planning. We systematically prioritised wetlands for waterbirds (simultaneously for 52 species), across about 13.5% of the Murray-Darling Basin (1,061,469 km2), using a 30-year record of systematic aerial surveys of waterbird populations. Nine key wetlands in this area, primarily lakes, floodplains, and swamps, consistently contributed to a representation target (80%) of total abundances of all 52 waterbird species. The long temporal span of our data included dramatic availability (i.e., booms) and scarcity (i.e., busts) of water, providing a unique opportunity to test prioritisation at extremes of variation. These extremes represented periods when waterbirds were breeding or concentrating on refugia, varying wetland prioritisation. In dry years, important wetlands for waterbirds were riverine and lacustrine (12 wetlands) but this changed in wet years to lacustrine and palustrine (8 wetlands). Such variation in ecosystem condition substantially changes the relative importance of individual wetlands for waterbirds during boom and bust phases. Incorporating this variability is necessary for effective conservation of Murray-Darling Basin waterbirds, with considerable generality for other similarly variable systems around the world.	[Bino, Gilad; Kingsford, Richard T.; Porter, John] Univ New S Wales, Sch Biol Earth & Environm Sci, Ctr Ecosyst Sci, Sydney, NSW, Australia; [Porter, John] NSW Off Environm & Heritage, Ecosyst Management Sci, Sydney, NSW, Australia	University of New South Wales Sydney; Office of Environment & Heritage - New South Wales	Bino, G (corresponding author), Univ New S Wales, Sch Biol Earth & Environm Sci, Ctr Ecosyst Sci, Sydney, NSW, Australia.	gilad.bino@unsw.edu.au	Porter, John L/C-4073-2008	Bino, Gilad/0000-0002-9265-4057; Porter, John/0000-0003-1444-9215; Kingsford, Richard/0000-0001-6565-4134	Murray-Darling Basin Authority [RG134148]; ARC Linkage [LP0884160]	Murray-Darling Basin Authority; ARC Linkage(Australian Research Council)	This study was funded by the Murray-Darling Basin Authority (RG134148; http://www.mdba.gov.au) and ARC Linkage (LP0884160; http://www.arc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, EC HUM WELL BEING WE; Arthington A.H, 2012, ENV FLOWS SAVING RIV; Arthington AH, 2003, RIVER RES APPL, V19, P377, DOI 10.1002/rra.745; Arthington AH, 2006, ECOL APPL, V16, P1311, DOI 10.1890/1051-0761(2006)016[1311:TCOPEF]2.0.CO;2; Arthington AH, 2011, ECOHYDROLOGY, V4, P708, DOI 10.1002/eco.221; Arthington AH, 2010, FRESHWATER BIOL, V55, P1, DOI 10.1111/j.1365-2427.2009.02340.x; Arthur AD, 2012, WETLANDS, V32, P257, DOI 10.1007/s13157-011-0235-y; Balcombe SR, 2005, J FISH BIOL, V67, P1552, DOI 10.1111/j.1095-8649.2005.00858.x; Ball I., 2000, MARXAN V1 8 2 MARINE; Ball I. R., 2009, SPATIAL CONSERVATION, P185, DOI DOI 10.1111/EVA.12631; Bellio MG, 2009, BIOL CONSERV, V142, P3076, DOI 10.1016/j.biocon.2009.08.007; Bino G, 2014, SETTING WATERBIRD OB, P128; Bino G, 2014, ECOL APPL, V24, P142, DOI 10.1890/13-0202.1; Bomford M, 2002, EMU, V102, P29, DOI 10.1071/MU01028; Bonnot TW, 2013, BIOL CONSERV, V165, P104, DOI 10.1016/j.biocon.2013.05.010; Boulton AJ, 2006, AUST J BOT, V54, P133, DOI 10.1071/BT05074; Boulton AJ, 2003, FRESHWATER BIOL, V48, P1173, DOI 10.1046/j.1365-2427.2003.01084.x; BRAITHWAITE LW, 1986, AUST WILDLIFE RES, V13, P213; Brock MA, 2006, ECOLOGY OF DESERT RIVERS, P100; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Bunn SE, 2006, RIVER RES APPL, V22, P179, DOI 10.1002/rra.904; Bureau of Meteorology, 2014, WEATH CLIM DAT; Capon SJ, 2007, WETLANDS, V27, P904, DOI 10.1672/0277-5212(2007)27[904:EOFOSE]2.0.CO;2; Collares-Pereira MJ, 2000, FISHERIES MANAG ECOL, V7, P167, DOI 10.1046/j.1365-2400.2000.00202.x; Cowx IG, 2004, FISHERIES MANAG ECOL, V11, P243, DOI 10.1111/j.1365-2400.2004.00410.x; Datry T, 2014, BIOSCIENCE, V64, P229, DOI 10.1093/biosci/bit027; De la Cruz SEW, 2014, BIOL CONSERV, V169, P68, DOI 10.1016/j.biocon.2013.10.021; EFRON B, 1978, J AM STAT ASSOC, V73, P113, DOI 10.2307/2286531; Fellows CS, 2009, FRESHWATER BIOL, V54, P236, DOI 10.1111/j.1365-2427.2008.02104.x; Ferrier S, 2000, BIOL CONSERV, V93, P303, DOI 10.1016/S0006-3207(99)00149-4; Gibbs HM, 2011, EMU, V111, P283, DOI 10.1071/MU10083; Halse SA, 2005, EMU, V105, P115, DOI 10.1071/MU04021; Hermoso V, 2011, FRESHWATER BIOL, V56, P57, DOI 10.1111/j.1365-2427.2009.02390.x; Hermoso V, 2012, DIVERS DISTRIB, V18, P448, DOI 10.1111/j.1472-4642.2011.00879.x; Humphries P, 2003, FRESHWATER BIOL, V48, P1141, DOI 10.1046/j.1365-2427.2003.01092.x; Jenkins KM, 2003, ECOLOGY, V84, P2708, DOI 10.1890/02-0326; Kennard MJ, 2010, FRESHWATER BIOL, V55, P171, DOI 10.1111/j.1365-2427.2009.02307.x; Khoury M, 2011, FRESHWATER BIOL, V56, P162, DOI 10.1111/j.1365-2427.2010.02468.x; Kingsford RT, 2006, ECOLOGY OF DESERT RIVERS, P203; Kingsford RT, 2010, MAR FRESHWATER RES, V61, P875, DOI 10.1071/MF09088; Kingsford RT, 2006, ECOLOGY OF DESERT RIVERS, P154; Kingsford RT, 2009, WILDLIFE RES, V36, P29, DOI 10.1071/WR08034; Kingsford R, 2006, ECOLOGY OF DESERT RIVERS, pXI; Kingsford RT, 2011, BIOL CONSERV, V144, P1194, DOI 10.1016/j.biocon.2010.09.022; Kingsford RT, 2011, MAR FRESHWATER RES, V62, P255, DOI 10.1071/MF09315; Kingsford RT, 2000, AUSTRAL ECOL, V25, P109, DOI 10.1111/j.1442-9993.2000.tb00012.x; Kingsford RT, 1999, FRESHWATER BIOL, V41, P425, DOI 10.1046/j.1365-2427.1999.00440.x; KINGSFORD RT, 1995, ENVIRON MANAGE, V19, P867, DOI 10.1007/BF02471938; Kingsford RT, 2005, RIVER RES APPL, V21, P187, DOI 10.1002/rra.840; Kingsford RT, 2004, ECOLOGY, V85, P2478, DOI 10.1890/03-0470; Kingsford RT, 2004, MAR FRESHWATER RES, V55, P17, DOI 10.1071/MF03075; Kingsford RT, 2002, EMU, V102, P47, DOI 10.1071/MU01030; Kingsford RT, 1999, WILDLIFE RES, V26, P351, DOI 10.1071/WR96062; KINGSFORD RT, 1994, BIOL CONSERV, V69, P219, DOI 10.1016/0006-3207(94)90063-9; Kingsford RT, 1998, COLON WATERBIRD, V21, P159, DOI 10.2307/1521903; Kingsford RT, 1999, BIOL CONSERV, V88, P231, DOI 10.1016/S0006-3207(98)00098-6; Kingsford RT, 1995, ECOLOGICAL EFFECTS R; Kingsford RT, 1994, WATERBIRDS WETLANDS; Kingsford RT., 2013, WATERBIRD COMMUNITIE; Kutner M. H., 2004, APPL LINEAR REGRESSI; Lake PS, 2007, FRESHWATER BIOL, V52, P597, DOI 10.1111/j.1365-2427.2006.01709.x; Lake PS, 2003, FRESHWATER BIOL, V48, P1161, DOI 10.1046/j.1365-2427.2003.01086.x; Larned ST, 2010, FRESHWATER BIOL, V55, P717, DOI 10.1111/j.1365-2427.2009.02322.x; Leigh C, 2008, RIVER RES APPL, V24, P1251, DOI 10.1002/rra.1125; Leigh C, 2010, MAR FRESHWATER RES, V61, P896, DOI 10.1071/MF10106; Lemly AD, 2000, ENVIRON MANAGE, V25, P485, DOI 10.1007/s002679910039; Leslie DJ, 2001, REGUL RIVER, V17, P21, DOI 10.1002/1099-1646(200101/02)17:1&lt;21::AID-RRR589&gt;3.0.CO;2-V; Linke S, 2012, J APPL ECOL, V49, P1036, DOI 10.1111/j.1365-2664.2012.02177.x; Linke S, 2011, FRESHWATER BIOL, V56, P6, DOI 10.1111/j.1365-2427.2010.02456.x; Lovejoy TE, 2006, TRENDS ECOL EVOL, V21, P329, DOI 10.1016/j.tree.2006.04.005; Magalhaes MF, 2007, FRESHWATER BIOL, V52, P1494, DOI 10.1111/j.1365-2427.2007.01781.x; Magoulick DD, 2003, FRESHWATER BIOL, V48, P1186, DOI 10.1046/j.1365-2427.2003.01089.x; Maher MT., 1992, RANGEL J, V14, P128, DOI [10.1071/RJ9920128, 10.1071/rj9920128, DOI 10.1071/RJ9920128]; Marshall JC, 2006, MAR FRESHWATER RES, V57, P61, DOI 10.1071/MF05021; MDBA, 2012, BAS PLAN; MDBA (Murray Darling Basin Authority), 2010, GUID PROP BAS PLAN T; Moilanen A, 2008, FRESHWATER BIOL, V53, P577, DOI 10.1111/j.1365-2427.2007.01906.x; Murray CG, 2012, EMU, V112, P209, DOI 10.1071/MU11070; Nel JL, 2011, FRESHWATER BIOL, V56, P106, DOI 10.1111/j.1365-2427.2010.02437.x; NORMAN FI, 1991, AUST J ECOL, V16, P485, DOI 10.1111/j.1442-9993.1991.tb01077.x; Okumura YM, 2010, J CLIMATE, V23, P5826, DOI 10.1175/2010JCLI3592.1; Paillex A, 2009, J APPL ECOL, V46, P250, DOI 10.1111/j.1365-2664.2008.01593.x; Peel MC, 2001, J HYDROL, V250, P224, DOI 10.1016/S0022-1694(01)00438-3; Piechota TC, 1998, WATER RESOUR RES, V34, P3035, DOI 10.1029/98WR02406; Poff NL, 2010, FRESHWATER BIOL, V55, P147, DOI 10.1111/j.1365-2427.2009.02204.x; Poff NL, 1997, BIOSCIENCE, V47, P769, DOI 10.2307/1313099; Popescu VD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079330; Possingham H. P., 2006, PRINCIPLES CONSERVAT, V3rd, P507, DOI DOI 10.1023/A:1006601319528; Puckridge JT, 2000, REGUL RIVER, V16, P385, DOI 10.1002/1099-1646(200009/10)16:5<385::AID-RRR592>3.3.CO;2-N; Puckridge JT, 1998, MAR FRESHWATER RES, V49, P55, DOI 10.1071/MF94161; R Core Team, 2014, LANG ENV STAT COMP; Raftery AE, 1995, SOCIOL METHODOL, V25, P111, DOI 10.2307/271063; Raftery AE, 2011, BMA BAYESIAN MODEL A; Rood SB, 2005, FRONT ECOL ENVIRON, V3, P193, DOI 10.1890/1540-9295(2005)003[0193:MRFTRF]2.0.CO;2; Roshier DA, 2001, LANDSCAPE ECOL, V16, P547, DOI 10.1023/A:1013184512541; Roshier D, 2008, IBIS, V150, P474, DOI 10.1111/j.1474-919X.2008.00806.x; Roshier DA, 2008, OECOLOGIA, V156, P465, DOI 10.1007/s00442-008-0987-0; RUELLO NV, 1976, AUST J MAR FRESH RES, V27, P667; Segan DB, 2010, BIOL CONSERV, V143, P2, DOI 10.1016/j.biocon.2009.09.014; Sekercioglu CH, 2006, TRENDS ECOL EVOL, V21, P464, DOI 10.1016/j.tree.2006.05.007; Shaw P.A., 2011, ARID ZONE GEOMORPHOL, V3rd, P611; Sheldon F, 2010, MAR FRESHWATER RES, V61, P885, DOI 10.1071/MF09239; SIMPSON HJ, 1993, WATER RESOUR RES, V29, P3671, DOI 10.1029/93WR01492; Stanley EH, 1997, BIOSCIENCE, V47, P427, DOI 10.2307/1313058; Tooth S, 2000, EARTH-SCI REV, V51, P67, DOI 10.1016/S0012-8252(00)00014-3; Turak E, 2011, MAR FRESHWATER RES, V62, P300, DOI 10.1071/MF09297; Turak E, 2011, FRESHWATER BIOL, V56, P1, DOI 10.1111/j.1365-2427.2010.02515.x; Valett HM, 2005, ECOLOGY, V86, P220, DOI 10.1890/03-4091; Vorosmarty CJ, 2010, NATURE, V467, P555, DOI 10.1038/nature09440; Ward JV, 1999, REGUL RIVER, V15, P125, DOI 10.1002/(SICI)1099-1646(199901/06)15:1/3&lt;125::AID-RRR523&gt;3.0.CO;2-E; Wilson KA, 2009, ANN NY ACAD SCI, V1162, P237, DOI 10.1111/j.1749-6632.2009.04149.x; Wintle BA, 2003, CONSERV BIOL, V17, P1579, DOI 10.1111/j.1523-1739.2003.00614.x; Wishart MJ, 2006, ECOLOGY OF DESERT RIVERS, P315	113	17	18	4	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132682	10.1371/journal.pone.0132682	http://dx.doi.org/10.1371/journal.pone.0132682			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161652	gold, Green Published, Green Submitted			2022-12-26	WOS:000358162300167
J	Katrinardottir, B; Alves, JA; Sigurjonsdottir, H; Hersteinsson, P; Gunnarsson, TG				Katrinardottir, Borgny; Alves, Jose A.; Sigurjonsdottir, Hrefna; Hersteinsson, Pall; Gunnarsson, Tomas G.			The Effects of Habitat Type and Volcanic Eruptions on the Breeding Demography of Icelandic Whimbrels Numenius phaeopus	PLOS ONE			English	Article							TERRITORY SIZE; HATCHING SUCCESS; NATAL PHILOPATRY; RIVER REGULATION; NESTING SUCCESS; MAYFIELD METHOD; SITE-FIDELITY; PREDATION; BIRDS; FOOD	Distinct preference of species for habitats is most often driven by long term differences in demographic rates between habitats. Estimating variation in those rates is key for developing successful conservation strategies. Stochastic events can interact with underlying variation in habitat quality in regulating demography but the opportunities to explore such interactions are rare. Whimbrels in Iceland show a strong preference for sparsely vegetated riverplains. Such habitats in Iceland face various threats, e.g., climate change, river regulation and spread of alien plant species. In this study we compared demographic parameters of breeding Whimbrels between riverplains and other habitats before, during and after volcanic eruption events to estimate the importance of the habitats for the species and the effect of ash deposit on breeding success. We found that an estimated minimum of 23% of the Icelandic population of Whimbrels and c. 10% of the world population of the species breed in riverplain habitats in Iceland. Whimbrels bred consistently at much higher densities in riverplain habitats than in other habitats and riverplains also had higher densities of pairs with fledglings although the proportion of successful breeders was similar between habitats. Predation by livestock may have had a considerable negative effect on breeding success on our study sites. Breeding was negatively affected by the volcanic activity, probably through the effects of ash on the invertebrate food supply, with breeding success being gradually worse closer to the eruption. Breeding success was equally affected by volcanism across habitats which differed in underlying habitat quality. This study gives an example of how populations can be regulated by factors which operate at different spatial scales, such as local variation in habitat quality and stochastic events which impact larger areas.	[Katrinardottir, Borgny] Iceland Inst Nat Hist, Dept Ecol, Gardabaer, Iceland; [Katrinardottir, Borgny; Alves, Jose A.; Gunnarsson, Tomas G.] Univ Iceland, South Iceland Res Ctr, Selfoss Gunnarsholt, Iceland; [Alves, Jose A.] Univ Aveiro, CESAM, P-3800 Aveiro, Portugal; [Sigurjonsdottir, Hrefna; Hersteinsson, Pall] Univ Iceland, Dept Life & Environm Sci, Reykjavik, Iceland	University of Iceland; Universidade de Aveiro; University of Iceland	Katrinardottir, B (corresponding author), Iceland Inst Nat Hist, Dept Ecol, Gardabaer, Iceland.	borgny@ni.is	Gunnarsson, Tomas G/L-9783-2015; Sigurjonsdottir, Hrefna/N-8252-2019; Sigurjónsdóttir, Hrefna/M-2380-2015; Alves, José A./U-4674-2018	Sigurjonsdottir, Hrefna/0000-0002-4052-1324; Alves, José A./0000-0001-7182-0936; Gunnarsson, Tomas Gretar/0000-0001-7692-0637	University of Iceland Research Fund; Icelandic Research Fund for Graduate Students; Palmi Jonsson's Conservation Fund (Natturuverndarsjodur Palma Jonssonar)	University of Iceland Research Fund; Icelandic Research Fund for Graduate Students; Palmi Jonsson's Conservation Fund (Natturuverndarsjodur Palma Jonssonar)	The work was supported by the following: 2010 - University of Iceland Research Fund, http://www.sjodir.hi.is/english, TGG - 900.000 ISK; 2010 - Icelandic Research Fund for Graduate Students (has now been joined with another fund), http://www.rannis.is/, BK 840.000 ISK; and 2009 - Palmi Jonsson's Conservation Fund (Natturuverndarsjodur Palma Jonssonar), http://www.natturuverndarsjodur.is/, BK - 850.000 ISK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKRE R D, 1981, Melanderia, V37, P1; [Anonymous], 2011, RESULTS OF THE 2 PHA; ARNALDS A, 1987, ARCTIC ALPINE RES, V19, P508, DOI 10.2307/1551417; Arnalds O, 2014, BIOGEOSCIENCES, V11, P6623, DOI 10.5194/bg-11-6623-2014; Arnalds O, 2013, ADV AGRON, V121, P331, DOI 10.1016/B978-0-12-407685-3.00006-2; Arnalds O, 2013, SCI REP-UK, V3, DOI 10.1038/srep01257; Arnalds O, 2010, ICELAND AGR SCI, V23, P3; Ballantyne K, 2011, WATERBIRDS, V34, P151, DOI 10.1675/063.034.0203; BROWN J J, 1981, Melanderia, V37, P30; CODY ML, 1972, CONDOR, V74, P473, DOI 10.2307/1365901; Colwell MA, 2010, SHOREBIRD ECOLOGY, CONSERVATION, AND MANAGEMENT, P1; Conklin J.R., 2014, PRIORITIZING MIGRATO; Dalsgaard B, 2007, IBIS, V149, P298, DOI 10.1111/j.1474-919X.2006.00631.x; Daviosdottir B, 2010, PROUN AOFEROA VIO VO; Delany S, 2009, AN ATLAS OF WADER PO; ENOKSSON B, 1983, J ANIM ECOL, V52, P927, DOI 10.2307/4464; Evans P.R., 1984, Behavior of Marine Animals, V5, P83; Fuller RJ, 2012, BIRDS AND HABITATS R; FURNESS RW, 1988, BIRD STUDY, V35, P199, DOI 10.1080/00063658809476989; GARDARSSON A, 1994, HYDROBIOLOGIA, V279, P15, DOI 10.1007/BF00027837; GORANSSON G, 1975, OIKOS, V26, P117, DOI 10.2307/3543700; GRANT MC, 1991, BIRD STUDY, V38, P160, DOI 10.1080/00063659109477085; Grant MC, 2000, BIRD STUDY, V47, P41, DOI 10.1080/00063650009461159; Gregory Cory J., 2011, Wader Study Group Bulletin, V118, P109; Gudmundsson Magnus T., 2010, EOS T AM GEOPHYS UN, V91, P190, DOI DOI 10.1029/2010EO210002; Gunnarsson TG, 2006, BIOL CONSERV, V128, P265, DOI 10.1016/j.biocon.2005.09.034; Gunnarsson TG, 2005, J ANIM ECOL, V74, P965, DOI 10.1111/j.1365-2656.2005.00994.x; Gunnarsson TG, 2000, STOFNVISTFRAEODI SPO; Gunnarsson TG, 2015, ECOL EVOL, V5, P2386, DOI 10.1002/ece3.1523; Gunnarsson TG, 2012, P ROY SOC B-BIOL SCI, V279, P411, DOI 10.1098/rspb.2011.0939; Gunnarsson Tomas Gretar, 2010, Wader Study Group Bulletin, V117, P46; Gunnarsson Tomas Gretar, 2010, Natturufraedingurinn, V79, P75; HAYWARD JL, 1982, AUK, V99, P623; HENSLER GL, 1981, WILSON BULL, V93, P42; International Wader Study Group, 2003, WADER STUDY GROUP B, V101/102, P8; JACKSON DB, 1994, IBIS, V136, P463, DOI 10.1111/j.1474-919X.1994.tb01123.x; JEHL JR, 1970, ECOLOGY, V52, P169; Johannesdottir L, 2014, BIRD STUDY, V61, P544, DOI 10.1080/00063657.2014.962481; JOHANSEN C A, 1981, Melanderia, V37, P20; JOHNSON DH, 1979, AUK, V96, P651; Jonsson JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067093; Jonsson Jon Einar, 2010, Wader Study Group Bulletin, V117, P145; Katrinardottir Borgny, 2013, Ringing & Migration, V28, P43, DOI 10.1080/03078698.2013.811160; KREBS J R, 1971, Ecology (Washington D C), V52, P2, DOI 10.2307/1934734; Liebezeit JR, 2007, CONDOR, V109, P32, DOI 10.1650/0010-5422(2007)109[32:ATDOSE]2.0.CO;2; Lopez-Sepulcre A, 2010, P ROY SOC B-BIOL SCI, V277, P3477, DOI 10.1098/rspb.2010.0819; MacDonald MA, 2008, IBIS, V150, P54, DOI 10.1111/j.1474-919X.2008.00869.x; Magnusson B, 2001, GROOURFRAMVINDA IUPI; Marske KA, 2007, ENVIRON ENTOMOL, V36, P817, DOI 10.1603/0046-225X(2007)36[817:EOVAOT]2.0.CO;2; MAYFIELD HAROLD, 1961, WILSON BULL, V73, P255; MAYFIELD HF, 1975, WILSON BULL, V87, P456; MCCAFFERY BJ, 1996, INT WADER STUD, V8, P28; Meltofte H, 2008, ADV ECOL RES, V40, P325, DOI 10.1016/S0065-2504(07)00014-1; Merritt DM, 2000, REGUL RIVER, V16, P543, DOI 10.1002/1099-1646(200011/12)16:6&lt;543::AID-RRR590&gt;3.0.CO;2-N; MILLER GR, 1978, J ANIM ECOL, V47, P293, DOI 10.2307/3937; NEWTON I, 1977, J ANIM ECOL, V46, P425, DOI 10.2307/3821; NILSSON C, 1994, REGUL RIVER, V9, P45, DOI 10.1002/rrr.3450090105; Overpeck J, 1997, SCIENCE, V278, P1251, DOI 10.1126/science.278.5341.1251; Owens IPF, 2000, P NATL ACAD SCI USA, V97, P12144, DOI 10.1073/pnas.200223397; PAGE GW, 1983, AUK, V100, P13, DOI 10.1093/auk/100.1.13; Palsdottir K, 1992, BLIKI, V12, P55; Perkins A, 2014, DETERMINING THE CAUS; PULLIAINEN E, 1993, ORNIS FENNICA, V70, P110; REDMOND RL, 1986, OIKOS, V46, P330, DOI 10.2307/3565831; REDMOND RL, 1982, BEHAV ECOL SOCIOBIOL, V10, P277, DOI 10.1007/BF00302817; Schmidt KA, 1999, OIKOS, V87, P65, DOI 10.2307/3546997; SEASTEDT TR, 1979, AUK, V96, P131; SHANKS C H JR, 1981, Melanderia, V37, P63; SKEEL MA, 1983, CAN J ZOOL, V61, P218, DOI 10.1139/z83-027; Smart J, 2006, J APPL ECOL, V43, P454, DOI 10.1111/j.1365-2664.2006.01166.x; Sutherland WJ, 2012, IBIS, V154, P663, DOI 10.1111/j.1474-919X.2012.01261.x; SUTHERLAND WJ, 1996, FROM INDIVIDUAL BEHA; THOMPSON PS, 1989, IBIS, V131, P214, DOI 10.1111/j.1474-919X.1989.tb02764.x; Thorup O, 2006, BREEDING WADERS IN E, P60; Vickery JA, 2001, J APPL ECOL, V38, P647, DOI 10.1046/j.1365-2664.2001.00626.x; Williams JC, 2010, ARCT ANTARCT ALP RES, V42, P306, DOI 10.1657/1938-4246-42.3.306; [No title captured]	77	8	12	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131395	10.1371/journal.pone.0131395	http://dx.doi.org/10.1371/journal.pone.0131395			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161860	Green Submitted, Green Published, gold			2022-12-26	WOS:000358162300037
J	Lioy, VS; Volante, A; Soberon, NE; Lurz, R; Ayora, S; Alonso, JC				Lioy, Virginia S.; Volante, Andrea; Soberon, Nora E.; Lurz, Rudi; Ayora, Silvia; Alonso, Juan C.			ParAB Partition Dynamics in Firmicutes: Nucleoid Bound ParA Captures and Tethers ParB-Plasmid Complexes	PLOS ONE			English	Article							BACTERIAL CHROMOSOME SEGREGATION; BACILLUS-SUBTILIS; DNA-SEGREGATION; F-PLASMID; P1 PARA; PSM19035; PROTEIN; ATP; MECHANISM; TRANSPORT	In Firmicutes, small homodimeric ParA-like (delta(2)) and ParB-like (omega(2)) proteins, in concert with cis-acting plasmid-borne parS and the host chromosome, secure stable plasmid inheritance in a growing bacterial population. This study shows that (omega:YFP)(2) binding to parSfacilitates plasmid clustering in the cytosol. (delta:GFP)(2) requires ATP binding but not hydrolysis to localize onto the cell's nucleoid as a fluorescent cloud. The interaction of (delta:CFP)(2) or delta(2) bound to the nucleoid with (omega:YFP)(2) foci facilitates plasmid capture, from a very broad distribution, towards the nucleoid and plasmid pairing. parS-bound omega(2) promotes redistribution of (delta:GFP)(2), leading to the dynamic release of (delta:GFP)(2) from the nucleoid, in a process favored by ATP hydrolysis and protein-protein interaction. (delta D60A:GFP)(2), which binds but cannot hydrolyze ATP, also forms unstable complexes on the nucleoid. In the presence of omega(2), (delta D60A:GFP)(2) accumulates foci or patched structures on the nucleoid. We propose that (delta:GFP)(2) binding to different nucleoid regions and to omega(2)-parS might generate (delta:GFP)(2) gradients that could direct plasmid movement. The iterative pairing and unpairing cycles may tether plasmids equidistantly on the nucleoid to ensure faithful plasmid segregation by a mechanism compatible with the diffusion-ratchet mechanism as proposed from in vitro reconstituted systems.	[Lioy, Virginia S.; Volante, Andrea; Soberon, Nora E.; Ayora, Silvia; Alonso, Juan C.] CSIC, CNB, Dept Microbial Biotechnol, E-28049 Madrid, Spain; [Lurz, Rudi] Max Planck Inst Mol Genet, D-1000 Berlin, Germany	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Max Planck Society	Alonso, JC (corresponding author), CSIC, CNB, Dept Microbial Biotechnol, Darwin Str 3, E-28049 Madrid, Spain.	jcalonso@cnb.csic.es	Ayora, Silvia/D-2552-2009; Lioy, Vicky/AAE-4039-2022; Alonso, Juan Carlos/D-2595-2009; Lioy, Vicky S./AAL-9782-2021	Ayora, Silvia/0000-0003-3121-1786; Lioy, Vicky/0000-0002-5366-0462; Alonso, Juan Carlos/0000-0002-5178-7179; Lioy, Vicky S./0000-0002-5366-0462; Volante, Andrea/0000-0002-3290-0148	Ministerio de Economia y Competitividad, Direccion General de Investigacion [BFU2012-39879-C02-01, BFU2012-39879-C02-02]; Comunidad de Madrid grant [S2009MAT-1507, BIO0260-2006]	Ministerio de Economia y Competitividad, Direccion General de Investigacion; Comunidad de Madrid grant(Comunidad de Madrid)	This work was supported in part by the Ministerio de Economia y Competitividad, Direccion General de Investigacion grants BFU2012-39879-C02-01 to J.C.A. and BFU2012-39879-C02-02 to S.A., and by the Comunidad de Madrid grant S2009MAT-1507 to J.C.A, and BIO0260-2006 to S.A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ah-Seng Y, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003956; Barilla D, 2005, EMBO J, V24, P1453, DOI 10.1038/sj.emboj.7600619; Cardenas PP, 2009, NUCLEIC ACIDS RES, V37, P4157, DOI 10.1093/nar/gkp314; Carrasco B, 2005, NUCLEIC ACIDS RES, V33, P3942, DOI 10.1093/nar/gki713; CEGLOWSKI P, 1993, MOL GEN GENET, V241, P579, DOI 10.1007/BF00279900; DAVEY MJ, 1994, J BIOL CHEM, V269, P29908; de la Hoz AB, 2000, P NATL ACAD SCI USA, V97, P728, DOI 10.1073/pnas.97.2.728; de la Hoz AB, 2004, NUCLEIC ACIDS RES, V32, P3136, DOI 10.1093/nar/gkh633; Dunham TD, 2009, EMBO J, V28, P1792, DOI 10.1038/emboj.2009.120; Ebersbach G, 2006, MOL MICROBIOL, V61, P1428, DOI 10.1111/j.1365-2958.2006.05322.x; Gerdes K, 2000, MOL MICROBIOL, V37, P455, DOI 10.1046/j.1365-2958.2000.01975.x; Graham TGW, 2014, GENE DEV, V28, P1228, DOI 10.1101/gad.242206.114; Hatano T, 2010, MOL MICROBIOL, V78, P1182, DOI 10.1111/j.1365-2958.2010.07398.x; Havey JC, 2012, NUCLEIC ACIDS RES, V40, P801, DOI 10.1093/nar/gkr747; Hwang LC, 2013, EMBO J, V32, P1238, DOI 10.1038/emboj.2013.34; Lemon KP, 2000, MOL CELL, V6, P1321, DOI 10.1016/S1097-2765(00)00130-1; Lim HC, 2014, ELIFE, V3, DOI 10.7554/eLife.02758; Lioy VS, 2010, PLASMID, V64, P1, DOI 10.1016/j.plasmid.2010.04.002; LYNCH AS, 1995, P NATL ACAD SCI USA, V92, P1896, DOI 10.1073/pnas.92.6.1896; Murayama K, 2001, J MOL BIOL, V314, P789, DOI 10.1006/jmbi.2001.5157; Murray H, 2006, MOL MICROBIOL, V61, P1352, DOI 10.1111/j.1365-2958.2006.05316.x; Pratto F, 2007, ANAL SISTEMA PARTICI; Pratto F, 2008, NUCLEIC ACIDS RES, V36, P3676, DOI 10.1093/nar/gkn170; Pratto F, 2009, J BIOL CHEM, V284, P30298, DOI 10.1074/jbc.M109.035410; Ptacin JL, 2010, NAT CELL BIOL, V12, P791, DOI 10.1038/ncb2083; Reyes-Lamothe R, 2012, ANNU REV GENET, V46, P121, DOI 10.1146/annurev-genet-110711-155421; Ringgaard S, 2009, P NATL ACAD SCI USA, V106, P19369, DOI 10.1073/pnas.0908347106; Rodionov O, 1999, SCIENCE, V283, P546, DOI 10.1126/science.283.5401.546; Schofield WB, 2010, EMBO J, V29, P3068, DOI 10.1038/emboj.2010.207; Schumacher MA, 2005, NATURE, V438, P516, DOI 10.1038/nature04149; Schumacher MA, 2012, J BIOL CHEM, V287, P26146, DOI 10.1074/jbc.M112.373696; Sengupta M, 2010, J BACTERIOL, V192, P1175, DOI 10.1128/JB.01245-09; Soberon NE, 2011, NUCLEIC ACIDS RES, V39, P2624, DOI 10.1093/nar/gkq1245; Szardenings F, 2011, CURR OPIN MICROBIOL, V14, P712, DOI 10.1016/j.mib.2011.09.008; Vecchiarelli AG, 2014, P NATL ACAD SCI USA, V111, P4880, DOI 10.1073/pnas.1401025111; Vecchiarelli AG, 2013, P NATL ACAD SCI USA, V110, pE1390, DOI 10.1073/pnas.1302745110; Vecchiarelli AG, 2012, MOL MICROBIOL, V86, P513, DOI 10.1111/mmi.12017; Vecchiarelli AG, 2010, MOL MICROBIOL, V78, P78, DOI 10.1111/j.1365-2958.2010.07314.x; Wang JD, 2004, J BACTERIOL, V186, P7084, DOI 10.1128/JB.186.21.7084-7090.2004; Wang XD, 2013, NAT REV GENET, V14, P191, DOI 10.1038/nrg3375; Weihofen WA, 2006, NUCLEIC ACIDS RES, V34, P1450, DOI 10.1093/nar/gkl015; Welfle K, 2005, BIOL CHEM, V386, P881, DOI 10.1515/BC.2005.103	42	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131943	10.1371/journal.pone.0131943	http://dx.doi.org/10.1371/journal.pone.0131943			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161642	Green Submitted, Green Published, gold			2022-12-26	WOS:000358162300077
J	Liu, RC; Leung, RKK; Chen, TM; Zhang, XX; Chen, FM; Chen, SL; Zhao, J				Liu, Ruchun; Leung, Ross Ka-kit; Chen, Tianmu; Zhang, Xixing; Chen, Faming; Chen, Shuilian; Zhao, Jin			The Effectiveness of Age-Specific Isolation Policies on Epidemics of Influenza A (H1N1) in a Large City in Central South China	PLOS ONE			English	Article							PANDEMIC INFLUENZA; MODELS; TRANSMISSIBILITY; STRATEGIES; INSIGHTS; FUTURE	During the early stage of a pandemic, isolation is the most effective means of controlling transmission. However, the effectiveness of age-specific isolation policies is not clear; especially little information is available concerning their effectiveness in China. Epidemiological and serological survey data in the city of Changsha were employed to estimate key model parameters. The average infectious period (date of recovery - date of symptom onset) of influenza A (H1N1) was 5.2 days. Of all infected persons, 45.93% were asymptomatic. The basic reproduction number of the influenza A (H1N1) pandemic was 1.82. Based on the natural history of influenza A (H1N1), we built an extended susceptible-exposed-infectious/asymptomatic-removed model, taking age groups: 0-5, 6-14, 15-24, 25-59, and >= 60 years into consideration for isolation. Without interventions, the total attack rates (TARs) in each age group were 42.73%, 41.95%, 20.51%, 45.03%, and 37.49%, respectively. Although the isolation of 25-59 years-old persons was the most effective, the TAR of individuals of aged 0-5 and 6-14 could not be reduced. Paradoxically, isolating individuals >= 60 year olds was not predicted to be an effective way of reducing the TAR in this group but isolating the age-group 25-59 did, which implies inter-age-group transmission from the latter to the former is significant. Isolating multiple age groups increased effectiveness. The most effective combined isolation target groups were of 6-14 + 25-59 year olds, 6-14 + 15-24 + 25-59 year olds, and 0-5 + 6-14 + 25-59 + >= 60 year olds. The last of these isolation schemas reduced the TAR of the total population from 39.64% to 0.006%, which was exceptionally close to the effectiveness of isolating all five age groups (TAR = 0.004%).	[Liu, Ruchun; Leung, Ross Ka-kit; Chen, Tianmu; Zhang, Xixing; Chen, Faming; Chen, Shuilian; Zhao, Jin] Changsha Ctr Dis Control & Prevent, Off Dis Control & Emergency Response, Changsha, Hunan, Peoples R China; [Leung, Ross Ka-kit] Chinese Univ Hong Kong, Stanley Ho Ctr Emerging Infect Dis, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong	Chen, TM (corresponding author), Changsha Ctr Dis Control & Prevent, Off Dis Control & Emergency Response, Changsha, Hunan, Peoples R China.	13698665@qq.com			Scientific Research Program of Health Department of Hunan Province [B2012-138]; Scientific Research Program of Changsha Science and Technology Bureau [K1205028-31]	Scientific Research Program of Health Department of Hunan Province; Scientific Research Program of Changsha Science and Technology Bureau	This work was partially supported by the Scientific Research Program of Health Department of Hunan Province (B2012-138, url: http://www.21hospital.com/) and by the Scientific Research Program of Changsha Science and Technology Bureau (K1205028-31, url: http://www.cssti.cn/html/cskjw/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arino J, 2006, J R SOC INTERFACE, V3, P453, DOI 10.1098/rsif.2006.0112; Belser JA, 2009, EMERG INFECT DIS, V15, P859, DOI 10.3201/eid1506.090072; Chen SC, 2008, EPIDEMIOL INFECT, V136, P1035, DOI 10.1017/S0950268807009284; Chen TM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095006; CHEN TM, 2011, ZHONGHUA LIU XING BI, V32, P723; Coburn BJ, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-30; Cruz-Pacheco G, 2009, EUROSURVEILLANCE, V14, P1; DIEKMANN O, 1990, J MATH BIOL, V28, P365; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Lee VJ, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-76; Liu DongHui, 2010, Chinese Preventive Medicine, V11, P109; Longini IM, 2004, AM J EPIDEMIOL, V159, P623, DOI 10.1093/aje/kwh092; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; Mikolajczyk R, 2009, DTSCH ARZTEBL INT, V106, P777, DOI 10.3238/arztebl.2009.0777; National Health and Family Planning Commission of the People's Republic of China, 2011, DIAGN TREATM GUID IN; National Health and Family Planning Commission of the People's Republic of China, 2010, INFL SURV PROGR CHIN; National Health and Family Planning Commission of the People's Republic of China, 2009, DIAGN TREATM PROGR I; National Health and Family Planning Commission of the People's Republic of China, 2012, GUID DISP INFL LIK I; Russell CJ, 2005, CELL, V123, P368, DOI 10.1016/j.cell.2005.10.019; Taubenberger JK, 2006, EMERG INFECT DIS, V12, P15, DOI 10.3201/eid1209.05-0979; Tracht SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009018; van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6; WHO, 2009, SIT UPD PAND H1N1 20; WHO, PAND H1N1 2009 UPD 1; Wu JT, 2011, EXP BIOL MED, V236, P955, DOI 10.1258/ebm.2010.010271; Yang Y, 2009, SCIENCE, V326, P729, DOI 10.1126/science.1177373; Zhang SG, 2010, INFLUENZA OTHER RESP, V4, P27, DOI 10.1111/j.1750-2659.2009.00117.x	27	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132588	10.1371/journal.pone.0132588	http://dx.doi.org/10.1371/journal.pone.0132588			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161740	gold, Green Published, Green Submitted			2022-12-26	WOS:000358162300156
J	Khajeh-Alijani, A; Urbanczik, R; Senn, W				Khajeh-Alijani, Azadeh; Urbanczik, Robert; Senn, Walter			Scale-Free Navigational Planning by Neuronal Traveling Waves	PLOS ONE			English	Article							WEAKLY COUPLED OSCILLATORS; THETA-OSCILLATIONS; SPATIAL NAVIGATION; DYNAMICS; SYSTEM; HIPPOCAMPUS; DISCHARGES; SYNCHRONY; SEQUENCES; BEHAVIOR	Spatial navigation and planning is assumed to involve a cognitive map for evaluating trajectories towards a goal. How such a map is realized in neuronal terms, however, remains elusive. Here we describe a simple and noise-robust neuronal implementation of a path finding algorithm in complex environments. We consider a neuronal map of the environment that supports a traveling wave spreading out from the goal location opposite to direction of the physical movement. At each position of the map, the smallest firing phase between adjacent neurons indicate the shortest direction towards the goal. In contrast to diffusion or single-wave-fronts, local phase differences build up in time at arbitrary distances from the goal, providing a minimal and robust directional information throughout the map. The time needed to reach the steady state represents an estimate of an agent's waiting time before it heads off to the goal. Given typical waiting times we estimate the minimal number of neurons involved in the cognitive map. In the context of the planning model, forward and backward spread of neuronal activity, oscillatory waves, and phase precession get a functional interpretation, allowing for speculations about the biological counterpart.	[Khajeh-Alijani, Azadeh; Urbanczik, Robert; Senn, Walter] Univ Bern, Dept Physiol, CH-3012 Bern, Switzerland	University of Bern	Senn, W (corresponding author), Univ Bern, Dept Physiol, Buhlpl 5, CH-3012 Bern, Switzerland.	senn@pyl.unibe.ch	Senn, Walter/D-6308-2014	Senn, Walter/0000-0003-3622-0497	Swiss National Science Foundation [31003A_133094]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by a personal grant of the Swiss National Science Foundation (for WS, grant no 31003A_133094).	Amit DJ, 1997, CEREB CORTEX, V7, P237, DOI 10.1093/cercor/7.3.237; Benchenane K, 2010, NEURON, V66, P921, DOI 10.1016/j.neuron.2010.05.013; Bressloff PC, 1999, PHYSICA D, V130, P232, DOI 10.1016/S0167-2789(99)00013-5; Buzsaki G, 2013, NAT NEUROSCI, V16, P130, DOI 10.1038/nn.3304; Clopath Claudia, 2010, Front Synaptic Neurosci, V2, P25, DOI 10.3389/fnsyn.2010.00025; Dehaene S, 1997, P NATL ACAD SCI USA, V94, P13293, DOI 10.1073/pnas.94.24.13293; Diba K, 2007, NAT NEUROSCI, V10, P1241, DOI 10.1038/nn1961; Dijkstra E. W., 1959, NUMERISCHE MATH, V1, P269, DOI [DOI 10.1007/BF01386390, 10.1007/BF01386390]; ERMENTROUT GB, 1984, SIAM J MATH ANAL, V15, P215, DOI 10.1137/0515019; Ermentrout GB, 2001, NEURON, V29, P33, DOI 10.1016/S0896-6273(01)00178-7; Ermentrout GB, 1997, J COMPUT NEUROSCI, V5, P191, DOI [10.1023/A:1008822117809, DOI 10.1023/A:1008822117809]; Gaussier P, 2002, BIOL CYBERN, V86, P15, DOI 10.1007/s004220100269; Glasius R, 1996, BIOL CYBERN, V74, P511, DOI 10.1007/BF00209422; Goel P, 2002, PHYSICA D, V163, P191, DOI 10.1016/S0167-2789(01)00374-8; Golomb D, 1997, J NEUROPHYSIOL, V78, P1199, DOI 10.1152/jn.1997.78.3.1199; Gorchetchnikov A, 2005, CONNECT SCI, V17, P145, DOI 10.1080/09540090500140925; GRANON S, 1995, BEHAV NEUROSCI, V109, P474, DOI 10.1037/0735-7044.109.3.474; HANSEL D, 1995, NEURAL COMPUT, V7, P307, DOI 10.1162/neco.1995.7.2.307; Hasselmo ME, 2005, J COGNITIVE NEUROSCI, V17, P1115, DOI 10.1162/0898929054475190; Hebb DO, 1946, J GEN PSYCHOL, V34, P59, DOI 10.1080/00221309.1946.10544520; Hirel J, 2013, NEURAL NETWORKS, V43, P8, DOI 10.1016/j.neunet.2013.01.023; Kahana MJ, 1999, NATURE, V399, P781, DOI 10.1038/21645; KOPELL N, 1986, COMMUN PUR APPL MATH, V39, P623, DOI 10.1002/cpa.3160390504; Kubie J L, 1991, Hippocampus, V1, P240, DOI 10.1002/hipo.450010305; LaValle S.M., 2006, PLANNING ALGORITHMS, P1007; Lewis TJ, 2003, J COMPUT NEUROSCI, V14, P283, DOI 10.1023/A:1023265027714; Martinet LE, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002045; NAKAYAMA K, 1986, NATURE, V320, P264, DOI 10.1038/320264a0; Nikolic D, 2013, TRENDS COGN SCI, V17, P54, DOI 10.1016/j.tics.2012.12.003; O'Keefe J, 1978, THE HIPPOCAMPUS AS A; Ponulak F, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00098; Poucet B, 2004, REV NEUROSCIENCE, V15, P89; Rauch A, 2003, J NEUROPHYSIOL, V90, P1598, DOI 10.1152/jn.00293.2003; Redish AD, 1997, HIPPOCAMPUS, V7, P15; Rhodes BJ, 2004, HUM MOVEMENT SCI, V23, P699, DOI 10.1016/j.humov.2004.10.008; Siapas AG, 2005, NEURON, V46, P141, DOI 10.1016/j.neuron.2005.02.028; SOMPOLINSKY H, 1991, PHYS REV A, V43, P6990, DOI 10.1103/PhysRevA.43.6990; Spiers HJ, 2007, HIPPOCAMPUS, V17, P618, DOI 10.1002/hipo.20298; Toussaint M, 2006, NEURAL COMPUT, V18, P1132, DOI 10.1162/neco.2006.18.5.1132; TRAUB RD, 1993, J PHYSIOL-LONDON, V472, P267, DOI 10.1113/jphysiol.1993.sp019946; Viard A, 2011, J NEUROSCI, V31, P4613, DOI 10.1523/JNEUROSCI.4640-10.2011	41	6	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2015	10	7							e0127269	10.1371/journal.pone.0127269	http://dx.doi.org/10.1371/journal.pone.0127269			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1EW	26158660	Green Published, Green Submitted, gold			2022-12-26	WOS:000358161200004
J	Tiwari, V; Chaturvedi, AK; Mishra, A; Jha, B				Tiwari, Vivekanand; Chaturvedi, Amit Kumar; Mishra, Avinash; Jha, Bhavanath			Introgression of the SbASR-1 Gene Cloned from a Halophyte Salicornia braciata Enhances Salinity and Drought Endurance in Transgenic Groundnut (Arachis hypogaea) and Acts as a Transcription Factor	PLOS ONE			English	Article							GAMMA-KAFIRIN PROMOTER; HMW GLUTENIN GENE(S); EXTREME HALOPHYTE; STRESS TOLERANCE; SALT TOLERANCE; GRAPE ASR; HETEROLOGOUS EXPRESSION; PLANT-REGENERATION; OVER-EXPRESSION; DNA-BINDING	The SbASR-1 gene, cloned from a halophyte Salicornia brachiata, encodes a plant-specific hydrophilic and stress responsive protein. The genome of S. brachiata has two paralogs of the SbASR-1 gene (2549 bp), which is comprised of a single intron of 1611 bp, the largest intron of the abscisic acid stress ripening [ASR] gene family yet reported. In silico analysis of the 843-bp putative promoter revealed the presence of ABA, biotic stress, dehydration, phytohormone, salinity, and sugar responsive cis-regulatory motifs. The SbASR-1 protein belongs to Group 7 LEA protein family with different amino acid composition compared to their glycophytic homologs. Bipartite Nuclear Localization Signal (NLS) was found on the C-terminal end of protein and localization study confirmed that SbASR-1 is a nuclear protein. Furthermore, transgenic groundnut (Arachis hypogaea) plants over-expressing the SbASR-1 gene constitutively showed enhanced salinity and drought stress tolerance in the T1 generation. Leaves of transgenic lines exhibited higher chlorophyll and relative water contents and lower electrolyte leakage, malondialdehyde content, proline, sugars, and starch accumulation under stress treatments than wild-type (Wt) plants. Also, lower accumulation of H2O2 and O-2(.-) radicals was detected in transgenic lines compared to Wt plants under stress conditions. Transcript expression of APX (ascorbate peroxidase) and CAT (catalase) genes were higher in Wt plants, whereas the SOD (superoxide dismutase) transcripts were higher in transgenic lines under stress. Electrophoretic mobility shift assay (EMSA) confirmed that the SbASR-1 protein binds at the consensus sequence (C/G/A)(G/T) CC(C/G)(C/G/A)(A/T). Based on results of the present study, it may be concluded that SbASR-1 enhances the salinity and drought stress tolerance in transgenic groundnut by functioning as a LEA (late embryogenesis abundant) protein and a transcription factor.	[Tiwari, Vivekanand; Chaturvedi, Amit Kumar; Mishra, Avinash; Jha, Bhavanath] CSIR Cent Salt & Marine Chem Res Inst, Marine Biotechnol & Ecol Div, Bhavnagar, Gujarat, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Salt & Marine Chemical Research Institute (CSMCRI)	Mishra, A (corresponding author), CSIR Cent Salt & Marine Chem Res Inst, Marine Biotechnol & Ecol Div, Bhavnagar, Gujarat, India.	avinash@csmcri.org; bjha@csmcri.org	Mishra, Avinash/AAG-2961-2019; TIWARI, VIVEKANAND/AAD-9738-2020; Mishra, Avinash/C-3210-2009; Chaturvedi, Amit k/J-5187-2012	Mishra, Avinash/0000-0003-0342-010X; TIWARI, VIVEKANAND/0000-0002-0464-6031; Mishra, Avinash/0000-0003-0342-010X; 	Council of Scientific and Industrial Research (CSIR)Government of India, New Delhi [BSC0109-SIMPLE, BSC0117-PMSI]	Council of Scientific and Industrial Research (CSIR)Government of India, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	This study was supported by the Council of Scientific and Industrial Research (CSIR, www.csir.res.in), Government of India, New Delhi (BSC0109-SIMPLE; BSC0117-PMSI, Senior Research Fellowship to AKC and VT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambede Jane Gayalwa, 2012, Braz. J. Plant Physiol., V24, P151, DOI 10.1590/S1677-04202012000300002; Arenhart RA, 2014, MOL PLANT, V7, P709, DOI 10.1093/mp/sst160; Banjara M, 2012, PLANT BIOTECHNOL REP, V6, P59, DOI 10.1007/s11816-011-0200-5; Bansal S, 2008, J CEREAL SCI, V48, P808, DOI 10.1016/j.jcs.2008.06.004; BARRS HD, 1962, AUST J BIOL SCI, V15, P413, DOI 10.1071/BI9620413; Bartels D, 2005, CRIT REV PLANT SCI, V24, P23, DOI 10.1080/07352680590910410; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Battaglia M, 2008, PLANT PHYSIOL, V148, P6, DOI 10.1104/pp.108.120725; Cakir B, 2003, PLANT CELL, V15, P2165, DOI 10.1105/tpc.013854; CHAMOVITZ D, 1993, J BIOL CHEM, V268, P17348; Chaturvedi AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111379; Chaturvedi AK, 2012, GENE, V499, P280, DOI 10.1016/j.gene.2012.03.001; Dai JR, 2011, PLANT CELL REP, V30, P1219, DOI 10.1007/s00299-011-1030-1; de Jonge H R, 2000, Sci STKE, V2000, ppe1, DOI 10.1126/stke.2000.63.pe1; Demidchik V, 2014, J EXP BOT, V65, P1259, DOI 10.1093/jxb/eru004; Dita MA, 2006, EUPHYTICA, V147, P1, DOI 10.1007/s10681-006-6156-9; FAOSTAT, 2014, FAO STAT DIV; Flowers TJ, 2015, ANN BOT-LONDON, V115, P419, DOI 10.1093/aob/mcu217; Frankel N, 2006, GENE, V378, P74, DOI 10.1016/j.gene.2006.05.010; GHOSE TK, 1987, PURE APPL CHEM, V59, P257, DOI 10.1351/pac198759020257; Goldgur Y, 2007, PLANT PHYSIOL, V143, P617, DOI 10.1104/pp.106.092965; Gonzalez RM, 2014, PLANTA, V239, P941, DOI 10.1007/s00425-014-2039-9; Dominguez PG, 2013, PLANT PHYSIOL, V161, P1486, DOI 10.1104/pp.112.208199; Hanin M, 2011, PLANT SIGNAL BEHAV, V6, P1503, DOI 10.4161/psb.6.10.17088; Henry IM, 2011, PLANTA, V234, P785, DOI 10.1007/s00425-011-1421-0; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Hodges DM, 1999, PLANTA, V207, P604, DOI 10.1007/s004250050524; Hu W, 2013, PLANT CELL ENVIRON, V36, P1449, DOI 10.1111/pce.12074; Hu YX, 2014, GENE, V549, P243, DOI 10.1016/j.gene.2014.07.071; INSKEEP WP, 1985, PLANT PHYSIOL, V77, P483, DOI 10.1104/pp.77.2.483; Ishitani M, 2000, PLANT CELL, V12, P1667, DOI 10.1105/tpc.12.9.1667; IUSEM ND, 1993, PLANT PHYSIOL, V102, P1353, DOI 10.1104/pp.102.4.1353; Jha B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071136; Jha B, 2012, MAR BIOTECHNOL, V14, P782, DOI 10.1007/s10126-012-9442-7; Jha B, 2012, J AGR FOOD CHEM, V60, P4320, DOI 10.1021/jf203632v; Jha B, 2011, MOL BIOL REP, V38, P4823, DOI 10.1007/s11033-010-0625-x; Joseph Deepu, 2013, J FOOD NUTR RES, V1, P97, DOI [10.12691/jfnr-1-5-4, DOI 10.12691/JFNR-1-5-4]; Joshi M, 2012, IND CROP PROD, V35, P313, DOI 10.1016/j.indcrop.2011.06.024; Joshi M, 2011, IND CROP PROD, V33, P67, DOI 10.1016/j.indcrop.2010.09.002; Kalifa Y, 2004, PLANT CELL ENVIRON, V27, P1459, DOI 10.1111/j.1365-3040.2004.01251.x; Kalifa Y, 2004, BIOCHEM J, V381, P373, DOI 10.1042/BJ20031800; Kim IS, 2012, MOL CELLS, V33, P285, DOI 10.1007/s10059-012-2253-x; Konrad Z, 2008, PLANTA, V227, P1213, DOI 10.1007/s00425-008-0693-5; Kosova K, 2013, FUNCT PLANT BIOL, V40, P775, DOI 10.1071/FP12375; Kovacs D, 2008, PLANT PHYSIOL, V147, P381, DOI 10.1104/pp.108.118208; Kumari A, 2012, BIOINFORMATION, V8, P1211, DOI 10.6026/97320630081211; Li RH, 2013, BIOSCI BIOTECH BIOCH, V77, P475, DOI 10.1271/bbb.120666; Liu JH, 2013, PLANTA, V237, P1025, DOI 10.1007/s00425-012-1820-x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Manjulatha M, 2014, MOL BIOTECHNOL, V56, P111, DOI 10.1007/s12033-013-9687-z; Mishra Avinash, 2008, Acta Biologica Szegediensis, V52, P277; Mishra A, 2008, MOL BIOL REP, V35, P81, DOI 10.1007/s11033-007-9056-8; Mishra A, 2015, J FUNCT FOODS, V13, P21, DOI 10.1016/j.jff.2014.12.027; Mishra A, 2013, CARBOHYD POLYM, V92, P1942, DOI 10.1016/j.carbpol.2012.11.055; Mishra Avinash, 2009, Acta Biologica Szegediensis, V53, P9; Moore K, 1998, FREE RADICAL RES, V28, P659, DOI 10.3109/10715769809065821; Ozgur R, 2013, FUNCT PLANT BIOL, V40, P832, DOI 10.1071/FP12389; Pandey MK, 2012, BIOTECHNOL ADV, V30, P639, DOI 10.1016/j.biotechadv.2011.11.001; Pandey R, 2008, MOL BIOL REP, V35, P153, DOI 10.1007/s11033-007-9065-7; Pandey S, 2013, APPL BIOCHEM BIOTECH, V171, P1, DOI 10.1007/s12010-013-0349-1; Patil M, 2014, PLANT BIOTECHNOL REP, V8, P161, DOI 10.1007/s11816-013-0305-0; Philippe R, 2010, THEOR APPL GENET, V121, P769, DOI 10.1007/s00122-010-1348-z; Qin H, 2013, PLANT BIOTECHNOL REP, V7, P345, DOI 10.1007/s11816-012-0269-5; Qin H, 2011, PLANT CELL PHYSIOL, V52, P1904, DOI 10.1093/pcp/pcr125; Ramel F, 2012, PLANT PHYSIOL, V158, P1267, DOI 10.1104/pp.111.182394; Ricardi MM, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-29; Rom S, 2006, BIOCHIMIE, V88, P621, DOI 10.1016/j.biochi.2005.11.008; Saumonneau A, 2008, FEBS LETT, V582, P3281, DOI 10.1016/j.febslet.2008.09.015; Saumonneau A, 2012, J EXP BOT, V63, P1495, DOI 10.1093/jxb/err391; Sharma K. K., 2002, JIRCAS Working Report, P61; Singh N, 2014, GENE, V547, P119, DOI 10.1016/j.gene.2014.06.037; Singh N, 2014, MAR BIOTECHNOL, V16, P321, DOI 10.1007/s10126-013-9548-6; Singh N, 2010, PLANT CELL TISS ORG, V103, P1, DOI 10.1007/s11240-010-9746-0; Tiwari V, 2015, APPL BIOCHEM BIOTECH, V175, P436, DOI 10.1007/s12010-014-1286-3; Tiwari V, 2014, PLANT CELL PHYSIOL, V55, P201, DOI 10.1093/pcp/pct172; Udawat P, 2014, GENE, V536, P163, DOI 10.1016/j.gene.2013.11.020; Uversky VN, 2010, BBA-PROTEINS PROTEOM, V1804, P1231, DOI 10.1016/j.bbapap.2010.01.017; Virlouvet L, 2011, PLANT PHYSIOL, V157, P917, DOI 10.1104/pp.111.176818; Yang S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071214; Yem EW, 1954, BIOCHEM J, V57, P769	80	29	34	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2015	10	7							e0131567	10.1371/journal.pone.0131567	http://dx.doi.org/10.1371/journal.pone.0131567			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EW	26158616	Green Submitted, Green Published, gold			2022-12-26	WOS:000358161200031
J	Ozaki, CY; Silveira, CRF; Andrade, FB; Nepomuceno, R; Silva, A; Munhoz, DD; Yamamoto, BB; Luz, D; Abreu, PAE; Horton, DSPQ; Elias, WP; Ramos, OHP; Piazza, RMF				Ozaki, Christiane Y.; Silveira, Caio R. F.; Andrade, Fernanda B.; Nepomuceno, Roberto; Silva, Anderson; Munhoz, Danielle D.; Yamamoto, Bruno B.; Luz, Daniela; Abreu, Patricia A. E.; Horton, Denise S. P. Q.; Elias, Waldir P.; Ramos, Oscar H. P.; Piazza, Roxane M. F.			Single Chain Variable Fragments Produced in Escherichia coli against Heat-Labile and Heat-Stable Toxins from Enterotoxigenic E-coli	PLOS ONE			English	Article							COLONIZATION FACTOR ANTIGENS; HIGH-LEVEL EXPRESSION; ANTIBODY FRAGMENT; PHAGE-DISPLAY; RECOMBINANT ANTIBODIES; PROTEINS; PURIFICATION; ADHERENCE; INTIMIN; CELLS	Background Diarrhea is a prevalent pathological condition frequently associated to the colonization of the small intestine by enterotoxigenic Escherichia coli (ETEC) strains, known to be endemic in developing countries. These strains can produce two enterotoxins associated with the manifestation of clinical symptoms that can be used to detect these pathogens. Although several detection tests have been developed, minimally equipped laboratories are still in need of simple and cost-effective methods. With the aim to contribute to the development of such diagnostic approaches, we describe here two mouse hybridoma-derived single chain fragment variable (scFv) that were produced in E. coli against enterotoxins of ETEC strains. Methods and Findings Recombinant scFv were developed against ETEC heat-labile toxin (LT) and heat-stable toxin (ST), from previously isolated hybridoma clones. This work reports their design, construction, molecular and functional characterization against LT and ST toxins. Both antibody fragments were able to recognize the cell-interacting toxins by immunofluorescence, the purified toxins by ELISA and also LT-, ST-and LT/ST-producing ETEC strains. Conclusion The developed recombinant scFvs against LT and ST constitute promising starting point for simple and cost-effective ETEC diagnosis.	[Ozaki, Christiane Y.; Silveira, Caio R. F.; Andrade, Fernanda B.; Nepomuceno, Roberto; Silva, Anderson; Munhoz, Danielle D.; Yamamoto, Bruno B.; Luz, Daniela; Abreu, Patricia A. E.; Horton, Denise S. P. Q.; Elias, Waldir P.; Piazza, Roxane M. F.] Inst Butantan, Bacteriol Lab, Sao Paulo, SP, Brazil; [Ramos, Oscar H. P.] CEA, iBiTecs, SIMOPRO, Gif Sur Yvette, France	Instituto Butantan; CEA; UDICE-French Research Universities; Universite Paris Saclay	Piazza, RMF (corresponding author), Inst Butantan, Bacteriol Lab, Sao Paulo, SP, Brazil.	roxane@butantan.gov.br	Ramos, Oscar HP/E-1862-2013; Piazza, Roxane MF/A-9915-2018; Elias, Waldir P/B-9890-2013; Piazza, Roxane Maria F/K-9807-2016; Piazza, Roxane/ABD-9196-2020; Munhoz, Danielle/AAB-2587-2022; Abreu, Patricia/C-4682-2012; Luz, Daniela/C-2374-2019	Ramos, Oscar HP/0000-0002-5788-4500; Piazza, Roxane MF/0000-0003-0068-8506; Piazza, Roxane/0000-0003-0068-8506; Munhoz, Danielle/0000-0001-5228-8163; Abreu, Patricia/0000-0002-7541-0341; Silveira, Caio/0000-0001-5778-7789; Elias, Waldir/0000-0003-3470-5706; Ozaki, Christiane Yumi/0000-0001-9234-8378; Luz, Daniela/0000-0001-9622-0320	Sao Paulo Research Foundation (FAPESP) [11/12928-2, 04/08297-3]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [301302/2013-8]; FAPESP fellowships [06/60258-8, 10/14659-6, 11/24111-0, 11/22108-2]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP fellowships(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This research was supported by grants 11/12928-2 from Sao Paulo Research Foundation (FAPESP) and from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq - 301302/2013-8) to RMFP and by grants 04/08297-3 from Sao Paulo Research Foundation (FAPESP) to OHPR. CYO, CRFS, DDM and FBA were recipients of FAPESP fellowships (06/60258-8, 10/14659-6, 11/24111-0 and 11/22108-2, respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad ZA, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/980250; Akiyoshi DE, 2010, INFECT IMMUN, V78, P1376, DOI 10.1128/IAI.00867-09; Arakawa T, 2014, ANTIBODIES, V3, P232, DOI 10.3390/antib3020232; Arbabi-Ghahroudi M, 2005, CANCER METAST REV, V24, P501, DOI 10.1007/s10555-005-6193-1; Bowman CC, 2001, INFECT IMMUN, V69, P1528, DOI 10.1128/IAI.69.3.1528-1535.2001; Bu DW, 2013, PROTEIN EXPRES PURIF, V92, P203, DOI 10.1016/j.pep.2013.10.002; Buc E, 2005, EUR J CANCER, V41, P1618, DOI 10.1016/j.ejca.2005.02.031; Caravelli A, 2013, DIAGN MICR INFEC DIS, V77, P301, DOI 10.1016/j.diagmicrobio.2013.08.021; Chung WY, 2008, J IMMUNOL METHODS, V339, P115, DOI 10.1016/j.jim.2008.08.005; Dorsey FC, 2006, CELL MICROBIOL, V8, P1516, DOI 10.1111/j.1462-5822.2006.00736.x; EVANS DJ, 1973, INFECT IMMUN, V8, P322, DOI 10.1128/IAI.8.3.322-328.1973; Golchin M, 2008, VET IMMUNOL IMMUNOP, V121, P321, DOI 10.1016/j.vetimm.2007.10.005; Guion CE, 2008, J CLIN MICROBIOL, V46, P1752, DOI 10.1128/JCM.02341-07; Guo JQ, 2003, J BIOTECHNOL, V102, P177, DOI 10.1016/S0168-1656(03)00020-8; GUTH BEC, 1994, MICROBIOL IMMUNOL, V38, P695, DOI 10.1111/j.1348-0421.1994.tb01844.x; Hill DR, 2010, CURR OPIN INFECT DIS, V23, P481, DOI 10.1097/QCO.0b013e32833dfca5; Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142; Joosten V, 2003, MICROB CELL FACT, V2, DOI 10.1186/1475-2859-2-1; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Kortt AA, 1997, PROTEIN ENG, V10, P423, DOI 10.1093/protein/10.4.423; Kramer K, 2002, BIOSENS BIOELECTRON, V17, P305, DOI 10.1016/S0956-5663(01)00292-5; Kuhne SA, 2004, J CLIN MICROBIOL, V42, P2966, DOI 10.1128/JCM.42.7.2966-2976.2004; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lamberski JA, 2006, PROTEIN EXPRES PURIF, V47, P82, DOI 10.1016/j.pep.2005.08.024; Leong MK, 2008, MED CHEM, V4, P396, DOI 10.2174/157340608784872226; Luz D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120481; Ma Y, 2008, IMMUNOL LETT, V121, P110, DOI 10.1016/j.imlet.2008.09.008; Martineau P, 1998, J MOL BIOL, V280, P117, DOI 10.1006/jmbi.1998.1840; MCCAFFERTY J, 1990, NATURE, V348, P552, DOI 10.1038/348552a0; Menezes CA, 2006, MEM I OSWALDO CRUZ, V101, P875, DOI 10.1590/S0074-02762006000800009; Menezes Marcio A, 2011, BMC Res Notes, V4, P30, DOI 10.1186/1756-0500-4-30; Mousli M, 2007, J VIROL METHODS, V146, P246, DOI 10.1016/j.jviromet.2007.07.015; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P403; Piazza RMF, 2010, PATHOGENIC ESCHERICH, P95; Pleckaityte M, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-100; Qadri F, 2005, CLIN MICROBIOL REV, V18, P465, DOI 10.1128/CMR.18.3.465-483.2005; Rocha LB, 2013, TOXINS, V5, P2384, DOI 10.3390/toxins5122384; Rouet R, 2012, NAT PROTOC, V7, P364, DOI 10.1038/nprot.2011.448; Sack D A, 1980, Compr Ther, V6, P50; Sambrook J, 2001, MOL CLONIN; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Song HN, 2014, INT J MOL SCI, V15, P23658, DOI 10.3390/ijms151223658; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tremblay JM, 2013, INFECT IMMUN, V81, P4592, DOI 10.1128/IAI.01033-13; Tsumoto K, 2003, PROTEIN EXPRES PURIF, V28, P1, DOI 10.1016/S1046-5928(02)00641-1; Umetsu M, 2003, J BIOL CHEM, V278, P8979, DOI 10.1074/jbc.M212247200; Weisser NE, 2009, BIOTECHNOL ADV, V27, P502, DOI 10.1016/j.biotechadv.2009.04.004; Wolf MK, 1997, CLIN MICROBIOL REV, V10, P569, DOI 10.1128/CMR.10.4.569; World Health Organization, 2013, DIARRHOEA DIS; ZDANOV A, 1994, P NATL ACAD SCI USA, V91, P6423, DOI 10.1073/pnas.91.14.6423; Zhang T, 2010, VACCINE, V28, P3949, DOI 10.1016/j.vaccine.2010.03.045	52	9	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0131484	10.1371/journal.pone.0131484	http://dx.doi.org/10.1371/journal.pone.0131484			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154103	Green Submitted, Green Published, gold			2022-12-26	WOS:000358159700068
J	Dhanya, R; Arun, KB; Nisha, VM; Syama, HP; Nisha, P; Kumar, TRS; Jayamurthy, P				Dhanya, R.; Arun, K. B.; Nisha, V. M.; Syama, H. P.; Nisha, P.; Kumar, T. R. Santhosh; Jayamurthy, P.			Preconditioning L6 Muscle Cells with Naringin Ameliorates Oxidative Stress and Increases Glucose Uptake	PLOS ONE			English	Article							INSULIN-RESISTANCE; MYOCARDIAL-INFARCTION; DIABETES-MELLITUS; VITAMIN-C; PREVENTION; ANTIOXIDANTS; LIPIDS; MICE	Enhanced oxidative stress contributes to pathological changes in diabetes and its complications. Thus, strategies to reduce oxidative stress may alleviate these pathogenic processes. Herein, we have investigated Naringin mediated regulation of glutathione (GSH) & intracellular free radical levels and modulation of glucose uptake under oxidative stress in L6 cell lines. The results from the study demonstrated a marked decrease in glutathione with a subsequent increase in free radical levels, which was reversed by the pretreatment of Naringin. We also observed that the increased malondialdehyde level, the marker of lipid peroxidation on induction of oxidative stress was retrieved on Naringin pretreatment. Addition of Naringin (100 mu M) showed approximately 40% reduction in protein glycation in vitro. Furthermore, we observed a twofold increase in uptake of fluorescent labeled glucose namely 2-(N-(7-Nitrobenz-2-oxa-1,3-diazol-4-yl) Amino)-2-Deoxyglucose (2 - NBDG) on Naringin treatment in differentiated L6 myoblast. The increased uptake of 2-NBDG by L6 myotubes may be attributed due to the enhanced translocation of GLUT4. Our results demonstrate that Naringin activate GSH synthesis through a novel antioxidant defense mechanism against excessive Reactive Oxygen Species (ROS) production, contributing to the prevention of oxidative damage in addition to its effect on glycemic control.	[Dhanya, R.; Arun, K. B.; Nisha, V. M.; Syama, H. P.; Nisha, P.; Jayamurthy, P.] CSIR, Agroproc & Nat Prod Div, Natl Inst Interdisciplinary Sci & Technol NIIST, Thiruvananthapuram 695019, Kerala, India; [Kumar, T. R. Santhosh] Rajiv Gandhi Ctr Biotechnol, Thiruvananthapuram 695019, Kerala, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Institute Interdisciplinary Science & Technology (NIIST); Department of Biotechnology (DBT) India; Rajiv Gandhi Centre for Biotechnology (RGCB)	Jayamurthy, P (corresponding author), CSIR, Agroproc & Nat Prod Div, Natl Inst Interdisciplinary Sci & Technol NIIST, Ind Estate, Thiruvananthapuram 695019, Kerala, India.	jayamurthy@live.com	P, Nisha/G-3519-2013; B, Arun K/ABA-5008-2020; HP, Syama/GOV-6372-2022	B, Arun K/0000-0002-8292-5933; r, dhanya/0000-0003-3916-3547	Kerala State Council for Science, Technology and Environment, Government of Kerala	Kerala State Council for Science, Technology and Environment, Government of Kerala	RD is supported by Kerala State Council for Science, Technology and Environment, Government of Kerala in the form of a fellowship.	Abiko T, 2003, DIABETES, V52, P829, DOI 10.2337/diabetes.52.3.829; Atli T, 2004, ARCH GERONTOL GERIAT, V39, P269, DOI 10.1016/j.archger.2004.04.065; Beckman JA, 2003, AM J PHYSIOL-HEART C, V285, pH2392, DOI 10.1152/ajpheart.00403.2003; Buchanan TA, 2002, DIABETES, V51, P2796, DOI 10.2337/diabetes.51.9.2796; CATHCART R, 1983, ANAL BIOCHEM, V134, P111, DOI 10.1016/0003-2697(83)90270-1; Ceriello A, 2000, METABOLISM, V49, P27, DOI 10.1016/S0026-0495(00)80082-7; Chiasson JL, 2002, LANCET, V359, P2072, DOI 10.1016/S0140-6736(02)08905-5; Dhanya R, 2014, FOOD CHEM, V158, P546, DOI 10.1016/j.foodchem.2014.02.151; Evans JL, 2003, DIABETES, V52, P1, DOI 10.2337/diabetes.52.1.1; Gaede P, 2001, DIABETIC MED, V18, P756, DOI 10.1046/j.0742-3071.2001.00574.x; Hilmi Y, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-149; HISSIN PJ, 1976, ANAL BIOCHEM, V74, P214, DOI 10.1016/0003-2697(76)90326-2; Jagetia GC, 2003, NAHRUNG, V47, P181, DOI 10.1002/food.200390042; Jedsadayanmata A., 2013, NARESUAN U J SCI TEC, V13, P35; Jeon SM, 2004, CLIN NUTR, V23, P1025, DOI 10.1016/j.clnu.2004.01.006; Jeon SM, 2002, CLIN CHIM ACTA, V317, P181, DOI 10.1016/S0009-8981(01)00778-1; Jia J, 2009, FOOD CHEM, V115, P32, DOI 10.1016/j.foodchem.2008.11.043; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Kowluru RA, 2001, EXPERT OPIN INV DRUG, V10, P1665, DOI 10.1517/13543784.10.9.1665; Likidlilid Atip, 2010, Journal of the Medical Association of Thailand, V93, P682; Mahmoud AM, 2012, J DIABETES COMPLICAT, V26, P483, DOI 10.1016/j.jdiacomp.2012.06.001; Moore K, 1998, FREE RADICAL RES, V28, P659, DOI 10.3109/10715769809065821; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Osawa T, 2005, ANN NY ACAD SCI, V1043, P440, DOI 10.1196/annals.1333.050; Otero P, 2005, ATHEROSCLEROSIS, V182, P259, DOI 10.1016/j.atherosclerosis.2005.02.024; Packer L, 2001, NUTRITION, V17, P888, DOI 10.1016/S0899-9007(01)00658-X; Pari L, 2010, INT J PHARM BIOL ARC, V1, P280; Punithavathi VR, 2008, J APPL TOXICOL, V28, P806, DOI 10.1002/jat.1343; Rajadurai M, 2009, PHYTOTHER RES, V23, P358, DOI 10.1002/ptr.2632; Sathish V, 2003, MOL CELL BIOCHEM, V243, P133, DOI 10.1023/A:1021612230000; Shen X, 2006, DIABETES, V55, P798, DOI 10.2337/diabetes.55.03.06.db05-1039; Thornalley PJ, 2003, ARCH BIOCHEM BIOPHYS, V419, P31, DOI 10.1016/j.abb.2003.08.013; Topic A, 2010, BIOL TRACE ELEM RES, V134, P296, DOI 10.1007/s12011-009-8474-y; Vincent AM, 2007, EXP NEUROL, V208, P216, DOI 10.1016/j.expneurol.2007.07.017; Zatalia St Rabiul, 2013, Acta Med Indones, V45, P141	35	22	22	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132429	10.1371/journal.pone.0132429	http://dx.doi.org/10.1371/journal.pone.0132429			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147673	Green Published, gold, Green Submitted			2022-12-26	WOS:000358157600266
J	Granich, R; Gupta, S; Hersh, B; Williams, B; Montaner, J; Young, B; Zuniga, JM				Granich, Reuben; Gupta, Somya; Hersh, Bradley; Williams, Brian; Montaner, Julio; Young, Benjamin; Zuniga, Jose M.			Trends in AIDS Deaths, New Infections and ART Coverage in the Top 30 Countries with the Highest AIDS Mortality Burden; 1990-2013	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; SOUTH-AFRICA; HIV; TUBERCULOSIS; EMPLOYMENT; CHILDREN; IMPACT; ADULTS; MODEL; RISK	Background Antiretroviral therapy (ART) prevents human immunodeficiency virus (HIV) disease progression, mortality and transmission. We assess the impact of expanded HIV treatment for the prevention of Acquired Immunodeficiency Syndrome (AIDS)-related deaths and simulate four treatment scenarios for Nigeria and South Africa. Methods For 1990-2013, we used the Joint United Nations Programme on HIV/AIDS (UNAIDS) database to examine trends in AIDS deaths, HIV incidence and prevalence, ART coverage, annual AIDS death rate, AIDS death-to-treatment and HIV infections to treatment ratios for the top 30 countries with the highest AIDS mortality burden and compare them with data from high-income countries. We projected the 1990-2020 AIDS deaths for Nigeria and South Africa using four treatment scenarios: 1) no ART; 2) maintaining current ART coverage; 3) 90% ART coverage based on 2013 World Health Organization (WHO) ART guidelines by 2020; and 4) reaching the United Nations 90-90-90 Target by 2020. Findings In 2013, there were 1.3 million (1.1 million-1.6 million) AIDS deaths in the top 30 countries representing 87% of global AIDS deaths. Eight countries accounted for 58% of the global AIDS deaths; Nigeria and South Africa accounted for 27% of global AIDS deaths. The highest death rates per 1000 people living with HIV were in Central African Republic (91), South Sudan (82), Cote d'Ivoire (75), Cameroon (72) and Chad (71), nearly 8-10 times higher than the high-income countries. ART access in 2013 has averted as estimated 1,051,354 and 422,448 deaths in South Africa and Nigeria, respectively. Increasing ART coverage in these two countries to meet the proposed UN 90-90-90 Target by 2020 could avert 2.2 and 1.2 million deaths, respectively. Interpretation Over the past decade the expansion of access to ART averted millions of deaths. Reaching the proposed UN 90-90-90 Target by 2020 will prevent additional morbidity, mortality and HIV transmission. Despite progress, high-burden countries will need to accelerate access to ART treatment to avert millions of premature AIDS deaths and new HIV infections.	[Granich, Reuben; Gupta, Somya; Young, Benjamin; Zuniga, Jose M.] Int Assoc Providers AIDS Care, Washington, DC 20036 USA; [Hersh, Bradley] Joint UN Programme HIV AIDS UNAIDS, Geneva, Switzerland; [Williams, Brian] Univ Witwatersrand, Wits Reprod Hlth Inst, Johannesburg, South Africa; [Montaner, Julio] British Columbia Ctr HIV AIDS Excellence, Vancouver, BC, Canada	UNAIDS; University of Witwatersrand	Granich, R (corresponding author), Int Assoc Providers AIDS Care, Washington, DC 20036 USA.	rgranich@iapac.org		Williams, Brian/0000-0002-3174-4876	British Columbia Ministry of Health; US National Institutes of Health [R01DA036307]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA036307] Funding Source: NIH RePORTER	British Columbia Ministry of Health; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	JM is supported with grants paid to his institution by the British Columbia Ministry of Health and by the US National Institutes of Health (R01DA036307).	[Anonymous], 2012, PEPFAR BLUEPRINT CRE; Becker ML, 2012, INT J STD AIDS, V23, P36, DOI 10.1258/ijsa.2011.011017; Bor J, 2013, SCIENCE, V339, P961, DOI 10.1126/science.1230413; Bor J, 2012, HEALTH AFFAIR, V31, P1459, DOI 10.1377/hlthaff.2012.0407; Botswana Central Statistics Office Botswana National AIDS Coordinating Agency UNDP ACHAP, 2005, BOTSWANA AIDS IMPACT; Ciaranello A, 2014, PEDIATR INFECT DIS J, V33, P623, DOI 10.1097/INF.0000000000000223; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Granich R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030216; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Grinsztejn B, 2014, LANCET INFECT DIS; Gupta S, 2014, CURR HIV AIDS REP; Houle B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100420; IAPAC-UNAIDS-UN HABITAT, ABOUT THE FAST TRACK; Ingle SM, 2014, CLIN INFECT DIS, V59, P287, DOI 10.1093/cid/ciu261; International Association of Providers of AIDS Care (IAPAC), 2015, GLOBAL DATABASE OF H; Johnson LF, 2012, PEDIATR INFECT DIS J, V31, P474, DOI 10.1097/INF.0b013e3182456ba2; Johnson LF, 2012, THE SOUTHERN AFRICAN; Lodi S, 2011, CLIN INFECT DIS, V53, P817, DOI 10.1093/cid/cir494; MAY RM, 1988, PHILOS T ROY SOC B, V321, P565, DOI 10.1098/rstb.1988.0108; Miller V, 2014, AIDS, V28, P273, DOI 10.1097/QAD.0000000000000079; Ministry of Health of the Republic of Botswana, 2011, 2011 BOTSWANA SECOND; Montaner JSG, 2006, LANCET, V368, P531, DOI 10.1016/S0140-6736(06)69162-9; Montaner JSG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087872; Montaner JSG, 2010, LANCET, V376, P532, DOI 10.1016/S0140-6736(10)60936-1; Murray CJL, 2014, LANCET, V384, P1005, DOI 10.1016/S0140-6736(14)60844-8; Smith CJ, 2014, LANCET, V384, P241, DOI 10.1016/S0140-6736(14)60604-8; Stoneburner R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100431; Stover J, 2012, SEX TRANSM INFECT, V88, pI11, DOI 10.1136/sextrans-2012-050640; Suthar AB, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001270; Tanser F, 2013, SCIENCE, V339, P966, DOI 10.1126/science.1228160; Thirumurthy H, 2013, AIDS, V27, P627, DOI 10.1097/QAD.0b013e32835c54d8; UNAIDS, THE GAP REPORT 2014; UNAIDS, 2014, BRICS HEALTH MINISTE; UNAIDS, 2014, 20TH INTERNATIONAL A; UNAIDS, 2014, UNAIDS WORLD AIDS DA; UNAIDS, 2015, TREATMENT 2015; UNAIDS, 2013, UNAIDS REPORT ON THE; UNAIDS, 2011, AIDS AT 30 NATIONS A; UNAIDS, 2014, 90 90 90 AN AMBITIOU; UNAIDS, AIDSINFO DATA TOOL; WHO, 2013, CONSOLIDATED GUIDELI; Williams B, R0 AND THE ELIMINATI; World Health O, 2012, ANTIRETROVIRAL TREAT; Yan HJ, 2014, AIDS BEHAV, V18, pS5, DOI 10.1007/s10461-013-0520-2	44	85	89	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131353	10.1371/journal.pone.0131353	http://dx.doi.org/10.1371/journal.pone.0131353			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147987	gold, Green Published, Green Submitted			2022-12-26	WOS:000358157600091
J	King, TZ; Wang, LY; Mao, H				King, Tricia Z.; Wang, Liya; Mao, Hui			Disruption of White Matter Integrity in Adult Survivors of Childhood Brain Tumors: Correlates with Long-Term Intellectual Outcomes	PLOS ONE			English	Article							MEDULLOBLASTOMA SURVIVORS; NEUROCOGNITIVE DEFICITS; CANCER SURVIVOR; ANISOTROPY; RADIATION; MODEL; IRRADIATION; CHILDREN	Background Although chemotherapy and radiation treatment have contributed to increased survivorship, treatment-induced brain injury has been a concern when examining long-term intellectual outcomes of survivors. Specifically, disruption of brain white matter integrity and its relationship to intellectual outcomes in adult survivors of childhood brain tumors needs to be better understood. Methods Fifty-four participants underwent diffusion tensor imaging in addition to structural MRI and an intelligence test (IQ). Voxel-wise group comparisons of fractional anisotropy calculated from DTI data were performed using Tract Based Spatial Statistics (TBSS) on 27 survivors (14 treated with radiation with and without chemotherapy and 13 treated without radiation treatment on average over 13 years since diagnosis) and 27 healthy comparison participants. Whole brain white matter fractional anisotropy (FA) differences were explored between each group. The relationships between IQ and FA in the regions where statistically lower FA values were found in survivors were examined, as well as the role of cumulative neurological factors. Results The group of survivors treated with radiation with and without chemotherapy had lower IQ relative to the group of survivors without radiation treatment and the healthy comparison group. TBSS identified white matter regions with significantly different mean fractional anisotropy between the three different groups. A lower level of white matter integrity was found in the radiation with or without chemotherapy treated group compared to the group without radiation treatment and also the healthy control group. The group without radiation treatment had a lower mean FA relative to healthy controls. The white matter disruption of the radiation with or without chemotherapy treated survivors was positively correlated with IQ and cumulative neurological factors. Conclusions Lower long-term intellectual outcomes of childhood brain tumor survivors are associated with lower white matter integrity. Radiation and adjunct chemotherapy treatment may play a role in greater white matter disruption. The relationships between white matter integrity and IQ, as well as cumulative neurological risk factors exist in young adult survivors of childhood brain tumors.	[King, Tricia Z.] Georgia State Univ, Dept Psychol, Atlanta, GA 30303 USA; [King, Tricia Z.] Georgia State Univ, Neurosci Inst, Atlanta, GA 30303 USA; [Wang, Liya; Mao, Hui] Emory Univ, Sch Med, Dept Radiol & Imaging Sci, Atlanta, GA USA	University System of Georgia; Georgia State University; University System of Georgia; Georgia State University; Emory University	King, TZ (corresponding author), Georgia State Univ, Dept Psychol, Univ Plaza, Atlanta, GA 30303 USA.	tzking@gsu.edu			American Cancer Society [RSGPB-CPPB-114044]	American Cancer Society(American Cancer Society)	This research was supported by a Research Scholar Grant from the American Cancer Society to TZK (#RSGPB-CPPB-114044). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong GT, 2009, JNCI-J NATL CANCER I, V101, P946, DOI 10.1093/jnci/djp148; Aukema EJ, 2009, INT J RADIAT ONCOL, V74, P837, DOI 10.1016/j.ijrobp.2008.08.060; Brinkman TM, 2012, NEURO-ONCOLOGY, V14, P25, DOI 10.1093/neuonc/nos214; First MB, 2002, STRUCTURED CLIN INTE; Gurney JG, 2003, CANCER-AM CANCER SOC, V97, P663, DOI 10.1002/cncr.11095; Hoppenbrouwers SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072375; Jayakar R, 2015, NEUROPSYCHO IN PRESS; Khong PL, 2006, J CLIN ONCOL, V24, P884, DOI 10.1200/JCO.2005.02.4505; Khong PL, 2003, AM J NEURORADIOL, V24, P734; King TZ, CHILD NEURO IN PRESS; Kurita H, 2001, NEUROL RES, V23, P869, DOI 10.1179/016164101101199324; Law N, 2011, NEUROIMAGE, V56, P2238, DOI 10.1016/j.neuroimage.2011.03.065; Leung LHT, 2004, NEUROIMAGE, V21, P261, DOI 10.1016/j.neuroimage.2003.09.020; Mabbott DJ, 2006, NEURO-ONCOLOGY, V8, P244, DOI 10.1215/15228517-2006-002; Micklewright JL, 2008, J CHILD NEUROL, V23, P455, DOI 10.1177/0883073807309241; Mori S, 2007, INTRO DIFFUSION TENS; Mulhern RK, 1999, ANN NEUROL, V46, P834, DOI 10.1002/1531-8249(199912)46:6<834::AID-ANA5>3.0.CO;2-M; Palmer SL, 2001, J CLIN ONCOL, V19, P2302, DOI 10.1200/JCO.2001.19.8.2302; PFEFFERBAUM A, 1994, ARCH NEUROL-CHICAGO, V51, P874, DOI 10.1001/archneur.1994.00540210046012; Prabhu SP, 2011, CHILD NERV SYST, V27, P11, DOI 10.1007/s00381-010-1323-7; Qiu D, 2007, INT J RADIAT ONCOL, V69, P846, DOI 10.1016/j.ijrobp.2007.04.041; Reddick WE, 2003, CANCER-AM CANCER SOC, V97, P2512, DOI 10.1002/cncr.11355; Ris MD, 2007, J PEDIATR PSYCHOL, V32, P1029, DOI 10.1093/jpepsy/jsm018; Rueckriegel SM, 2010, INT J RADIAT ONCOL, V76, P859, DOI 10.1016/j.ijrobp.2009.02.054; Smith KM, 2014, NEUROPSYCHOLOGY, V28, P448, DOI 10.1037/neu0000056; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Stepens A, 2010, BRAIN, V133, P3676, DOI 10.1093/brain/awq281; Wang SL, 2009, CANCER RES, V69, P1190, DOI 10.1158/0008-5472.CAN-08-2661; Wechsler D., 2011, WASI 2 WECHSLER ABBR	31	34	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131744	10.1371/journal.pone.0131744	http://dx.doi.org/10.1371/journal.pone.0131744			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147736	Green Submitted, gold, Green Published			2022-12-26	WOS:000358157600140
J	Schnitzler, F; Friedrich, M; Wolf, C; Stallhofer, J; Angelberger, M; Diegelmann, J; Olszak, T; Tillack, C; Beigel, F; Goke, B; Glas, J; Lohse, P; Brand, S				Schnitzler, Fabian; Friedrich, Matthias; Wolf, Christiane; Stallhofer, Johannes; Angelberger, Marianne; Diegelmann, Julia; Olszak, Torsten; Tillack, Cornelia; Beigel, Florian; Goeke, Burkhard; Glas, Juergen; Lohse, Peter; Brand, Stephan			The NOD2 Single Nucleotide Polymorphism rs72796353 (IVS4+10 A > C) Is a Predictor for Perianal Fistulas in Patients with Crohn's Disease in the Absence of Other NOD2 Mutations	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; GENOME-WIDE ASSOCIATION; FRAMESHIFT MUTATION; SUSCEPTIBILITY LOCI; INSERTION MUTATION; GENE; VARIANTS; GASTROENTEROLOGY; CLASSIFICATION; METAANALYSIS	Background A previous study suggested an association of the single nucleotide polymorphism (SNP) rs72796353 (IVS4+ 10 A>C) in the NOD2 gene with susceptibility to Crohn's disease (CD). However, this finding has not been confirmed. Given that NOD2 variants still represent the most important predictors for CD susceptibility and phenotype, we evaluated the association of rs72796353 with inflammatory bowel disease (IBD) susceptibility and the IBD phenotype. Methodology Genomic DNA from 2256 Caucasians, including 1073 CD patients, 464 patients with ulcerative colitis (UC), and 719 healthy controls, was genotyped for the NOD2 SNP rs72796353 and the three main CD-associated NOD2 mutations rs2066844, rs2066845, and rs2066847. Subsequently, IBD association and genotype-phenotype analyses were conducted. Results In contrast to the strong associations of the NOD2 SNPs rs2066844 (p=3.51 x 10(-3)), rs2066845 (p=1.54 x 10(-2)), and rs2066847 (p=1.61 x 10(-20)) with CD susceptibility, no significant association of rs72796353 with CD or UC susceptibility was found. However, in CD patients without the three main CD-associated NOD2 mutations, rs72796353 was significantly associated with the development of perianal fistulas (p=2.78 x 10(-7), OR 5.27, [95% CI 2.75-10.12] vs. NOD2 wild-type carriers). Conclusion/Significance Currently, this study represents the largest genotype-phenotype analysis of the impact of the NOD2 variant rs72796353 on the disease phenotype in IBD. Our data demonstrate that in CD patients the IVS4+ 10 A>C variant is strongly associated with the development of perianal fistulas. This association is particularly pronounced in patients who are not carriers of the three main CD-associated NOD2 mutations, suggesting rs72796353 as additional genetic marker for the CD disease behaviour.	[Schnitzler, Fabian; Friedrich, Matthias; Stallhofer, Johannes; Angelberger, Marianne; Olszak, Torsten; Tillack, Cornelia; Beigel, Florian; Goeke, Burkhard; Brand, Stephan] Univ Munich, Dept Med Grosshadern 2, Munich, Germany; [Friedrich, Matthias; Diegelmann, Julia] Univ Munich, Dept Prevent Dent & Periodontol, Munich, Germany; [Wolf, Christiane] Max Planck Inst Psychiat, Biostat Grp, D-80804 Munich, Germany; [Glas, Juergen] Rhein Westfal TH Aachen, Dept Human Genet, D-52062 Aachen, Germany; [Lohse, Peter] Univ Munich, Dept Clin Chem Grosshadern, Munich, Germany	University of Munich; University of Munich; Max Planck Society; RWTH Aachen University; University of Munich	Schnitzler, F (corresponding author), Univ Munich, Dept Med Grosshadern 2, Munich, Germany.	stephan.brand@med.uni-muenchen.de		Stallhofer, Johannes/0000-0001-8698-6103	Deutsche Forschungsgemeinschaft (DFG) [BR 1912/6-1, OL/324-1]; Else Kroner-Fresenius-Stiftung (Else Kroner Exzellenzstipendium) [2010_EKES.32]; Ludwig-Maximilians-University Munich (FoFoLe program)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Else Kroner-Fresenius-Stiftung (Else Kroner Exzellenzstipendium); Ludwig-Maximilians-University Munich (FoFoLe program)	S. Brand was supported by grants from the Deutsche Forschungsgemeinschaft (DFG, BR 1912/6-1) and the Else Kroner-Fresenius-Stiftung (Else Kroner Exzellenzstipendium 2010; 2010_EKES.32). C. Tillack was supported by a grant of the Ludwig-Maximilians-University Munich (FoFoLe program). T. Olszak was supported by a grant of the Deutsche Forschungsgemeinschaft (DFG OL/324-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler J, 2011, AM J GASTROENTEROL, V106, P699, DOI 10.1038/ajg.2011.19; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Baumgart DC, 2007, LANCET, V369, P1627, DOI 10.1016/S0140-6736(07)60750-8; Brand S, 2013, GUT, V62, P1531, DOI 10.1136/gutjnl-2012-304151; Chamaillard M, 2003, P NATL ACAD SCI USA, V100, P3455, DOI 10.1073/pnas.0530276100; Cleynen I, 2013, GUT, V62, P1556, DOI 10.1136/gutjnl-2011-300777; Cosnes J, 2002, INFLAMM BOWEL DIS, V8, P244, DOI 10.1097/00054725-200207000-00002; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Glas J, 2008, AM J GASTROENTEROL, V103, P682, DOI 10.1111/j.1572-0241.2007.01694.x; Hampe J, 2001, LANCET, V357, P1925, DOI 10.1016/S0140-6736(00)05063-7; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; LENNARDJONES JE, 1989, SCAND J GASTROENTERO, V24, P2, DOI 10.3109/00365528909091339; Lesage S, 2002, AM J HUM GENET, V70, P845, DOI 10.1086/339432; Loppalainen M, 2008, INFLAMM BOWEL DIS, V14, P176, DOI 10.1002/ibd.20287; McCarroll SA, 2008, NAT GENET, V40, P1107, DOI 10.1038/ng.215; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Radlmayr M, 2002, GASTROENTEROLOGY, V122, P2091, DOI 10.1053/gast.2002.34020; Russell RK, 2004, ARCH DIS CHILD, V89, P598, DOI 10.1136/adc.2003.041046; Schnitzler F, 2006, IMMUNOGENETICS, V58, P99, DOI 10.1007/s00251-005-0073-2; Schnitzler F, 2012, INFLAMM BOWEL DIS, V18, P395, DOI 10.1002/ibd.21882; Seiderer J, 2006, SCAND J GASTROENTERO, V41, P1421, DOI 10.1080/00365520600703900; Seiderer J, 2006, INFLAMM BOWEL DIS, V12, P1114, DOI 10.1097/01.mib.0000235836.32176.5e; Shanahan F, 2002, LANCET, V359, P62, DOI 10.1016/S0140-6736(02)07284-7; Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A, DOI 10.1155/2005/269076; Torok HP, 2005, GUT, V54, P1421, DOI 10.1136/gut.2005.066340; Tukel T, 2004, AM J HUM GENET, V74, P623, DOI 10.1086/382226	30	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0116044	10.1371/journal.pone.0116044	http://dx.doi.org/10.1371/journal.pone.0116044			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147989	Green Published, Green Submitted, gold			2022-12-26	WOS:000358157600001
J	McLean, R; Hobbs, JK; Suits, MD; Tuomivaara, ST; Jones, DR; Boraston, AB; Abbott, DW				McLean, Richard; Hobbs, Joanne K.; Suits, Michael D.; Tuomivaara, Sami T.; Jones, Darryl R.; Boraston, Alisdair B.; Abbott, D. Wade			Functional Analyses of Resurrected and Contemporary Enzymes Illuminate an Evolutionary Path for the Emergence of Exolysis in Polysaccharide Lyase Family 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme kinetics; enzyme structure; magnesium; manganese; protein evolution; exolysis; polysaccharide lyase	GLYCOSIDE HYDROLASE; BETA-ELIMINATION; STRUCTURE VALIDATION; PROTEIN; MODELS; CLASSIFICATION; SEQUENCE; ORGANIZATION; PHYLOGENIES; ALIGNMENT	Background: The evolutionary history of family 2 polysaccharide lyases is unknown. Results: Functional analysis highlights a key lysine-tryptophan transition involved in exolysis. Conclusion: Subtle changes in amino acid structure can transform enzyme activity. Significance: Combinatorial use of ancestral sequence reconstruction, gene resurrection, and structure-function analysis is valuable for elucidating the function and evolutionary history of polysaccharide lyases. Family 2 polysaccharide lyases (PL2s) preferentially catalyze the -elimination of homogalacturonan using transition metals as catalytic cofactors. PL2 is divided into two subfamilies that have been generally associated with secretion, Mg2+ dependence, and endolysis (subfamily 1) and with intracellular localization, Mn2+ dependence, and exolysis (subfamily 2). When present within a genome, PL2 genes are typically found as tandem copies, which suggests that they provide complementary activities at different stages along a catabolic cascade. This relationship most likely evolved by gene duplication and functional divergence (i.e. neofunctionalization). Although the molecular basis of subfamily 1 endolytic activity is understood, the adaptations within the active site of subfamily 2 enzymes that contribute to exolysis have not been determined. In order to investigate this relationship, we have conducted a comparative enzymatic analysis of enzymes dispersed within the PL2 phylogenetic tree and elucidated the structure of VvPL2 from Vibrio vulnificus YJ016, which represents a transitional member between subfamiles 1 and 2. In addition, we have used ancestral sequence reconstruction to functionally investigate the segregated evolutionary history of PL2 progenitor enzymes and illuminate the molecular evolution of exolysis. This study highlights that ancestral sequence reconstruction in combination with the comparative analysis of contemporary and resurrected enzymes holds promise for elucidating the origins and activities of other carbohydrate active enzyme families and the biological significance of cryptic metabolic pathways, such as pectinolysis within the zoonotic marine pathogen V. vulnificus.	[McLean, Richard; Jones, Darryl R.; Abbott, D. Wade] Agr & Agri Food Canada, Lethbridge Res Ctr, Lethbridge, AB T1J 4B1, Canada; [Hobbs, Joanne K.; Suits, Michael D.; Boraston, Alisdair B.] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC V8W 3P6, Canada; [Suits, Michael D.] Wilfrid Laurier Univ, Dept Chem & Biochem, Waterloo, ON N2L 3C5, Canada; [Tuomivaara, Sami T.] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA	Agriculture & Agri Food Canada; University of Victoria; Wilfrid Laurier University; University System of Georgia; University of Georgia	Abbott, DW (corresponding author), Agr & Agri Food Canada, Lethbridge Res Ctr, 5403 1st Ave S, Lethbridge, AB T1J 4B1, Canada.	wade.abbott@agr.gc.ca		McLean, Richard/0000-0002-3237-3288; Hobbs, Joanne/0000-0001-5239-8039; Abbott, Wade/0000-0003-4893-5799; Boraston, Alisdair/0000-0001-6417-0592	Agriculture and Agri-Food Canada (Agri-Flex) [2668]; Beef and Cattle Research Council [FDE.15.13]; Natural Sciences and Engineering Research Council of Canada Discovery Grant [FRN 04355]	Agriculture and Agri-Food Canada (Agri-Flex)(Agriculture & Agri Food Canada); Beef and Cattle Research Council; Natural Sciences and Engineering Research Council of Canada Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by Agriculture and Agri-Food Canada (Agri-Flex #2668) and the Beef and Cattle Research Council (FDE.15.13) (to D.W.A.) and a Natural Sciences and Engineering Research Council of Canada Discovery Grant (FRN 04355) (to A.B.B.).	Abbott DW, 2008, MICROBIOL MOL BIOL R, V72, P301, DOI 10.1128/MMBR.00038-07; Abbott DW, 2007, J BIOL CHEM, V282, P35328, DOI 10.1074/jbc.M705511200; Abbott DW, 2007, J MOL BIOL, V368, P1215, DOI 10.1016/j.jmb.2007.02.083; Abbott DW, 2007, J MOL BIOL, V367, P1023, DOI 10.1016/j.jmb.2007.01.030; Abbott DW, 2014, CURR OPIN STRUC BIOL, V28, P32, DOI 10.1016/j.sbi.2014.07.004; Abbott DW, 2013, APPL BIOCHEM BIOTECH, V171, P1911, DOI 10.1007/s12010-013-0483-9; Abbott DW, 2010, J BIOL CHEM, V285, P39029, DOI 10.1074/jbc.M110.153981; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Aspeborg H, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-186; Blot N, 2002, J BIOL CHEM, V277, P7936, DOI 10.1074/jbc.M109193200; Boraston AB, 2012, ACTA CRYSTALLOGR F, V68, P129, DOI 10.1107/S1744309111055400; Caffall KH, 2009, CARBOHYD RES, V344, P1879, DOI 10.1016/j.carres.2009.05.021; Charnock SJ, 2002, P NATL ACAD SCI USA, V99, P12067, DOI 10.1073/pnas.182431199; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen YY, 2010, SCI CHINA CHEM, V53, P52, DOI 10.1007/s11426-010-0011-5; Cowtan K, 2012, ACTA CRYSTALLOGR D, V68, P328, DOI 10.1107/S0907444911039655; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ferguson AD, 2004, CELL, V116, P15, DOI 10.1016/S0092-8674(03)01030-4; GANGOLA P, 1987, J BIOL CHEM, V262, P12570; Garron ML, 2010, GLYCOBIOLOGY, V20, P1547, DOI 10.1093/glycob/cwq122; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Harding MM, 2001, ACTA CRYSTALLOGR D, V57, P401, DOI 10.1107/S0907444900019168; Hepler PK, 2010, J INTEGR PLANT BIOL, V52, P147, DOI 10.1111/j.1744-7909.2010.00923.x; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Hutter CAJ, 2014, ACTA CRYSTALLOGR D, V70, P1770, DOI 10.1107/S1399004714007147; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Lombard V, 2010, BIOCHEM J, V432, P437, DOI 10.1042/BJ20101185; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Loytynoja A, 2014, METHODS MOL BIOL, V1079, P155, DOI 10.1007/978-1-62703-646-7_10; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Ochiai A, 2009, J BIOL CHEM, V284, P10181, DOI 10.1074/jbc.M807799200; Oliver JD, 2013, MICROB ECOL, V65, P793, DOI 10.1007/s00248-012-0140-9; Rodionov DA, 2004, MICROBIOL-SGM, V150, P3571, DOI 10.1099/mic.0.27041-0; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Shevchik VE, 1999, J BACTERIOL, V181, P3912, DOI 10.1128/JB.181.13.3912-3919.1999; St John FJ, 2010, FEBS LETT, V584, P4435, DOI 10.1016/j.febslet.2010.09.051; Stam MR, 2006, PROTEIN ENG DES SEL, V19, P555, DOI 10.1093/protein/gzl044; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Terrapon N, 2015, BIOINFORMATICS, V31, P647, DOI 10.1093/bioinformatics/btu716; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Yin YB, 2012, NUCLEIC ACIDS RES, V40, pW445, DOI 10.1093/nar/gks479; Zwickl DJ., 2006, THESIS	48	11	11	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2015	290	35					21231	21243		10.1074/jbc.M115.664847	http://dx.doi.org/10.1074/jbc.M115.664847			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ5IS	26160170	Green Published, hybrid			2022-12-26	WOS:000360637600004
J	Zhang, XN; Gao, Y; Lu, L; Zhang, Z; Gan, SC; Xu, LY; Lei, AH; Cao, Y				Zhang, Xuena; Gao, Yan; Lu, Lei; Zhang, Zan; Gan, Shengchun; Xu, Liyang; Lei, Anhua; Cao, Ying			JmjC Domain-containing Protein 6 (Jmjd6) Derepresses the Transcriptional Repressor Transcription Factor 7-like 1 (Tcf7l1) and Is Required for Body Axis Patterning during Xenopus Embryogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CATENIN; WNT/BETA-CATENIN; PHOSPHATIDYLSERINE RECEPTOR; SPEMANNS ORGANIZER; APOPTOTIC CELLS; TARGET GENES; TCF3; SPECIFICATION; EXPRESSION; TCF/LEF	Tcf7l1 (also known as Tcf3) is a bimodal transcription factor that plays essential roles in embryogenesis and embryonic and adult stem cells. On one hand, Tcf7l1 works as transcriptional repressor via the recruitment of Groucho-related transcriptional corepressors to repress the transcription of Wnt target genes, and, on the other hand, it activates Wnt target genes when Wnt-activated beta-catenin interacts with it. However, how its activity is modulated is not well understood. Here we demonstrate that a JmjC-domain containing protein, Jmjd6, interacts with Tcf7l and derepresses Tcf7l. We show that Jmjd6 binds to a region of Tcf7l1 that is also responsible for Groucho interaction, therefore making it possible that Jmjd6 binding displaces the Groucho transcriptional corepressor from Tcf7l1. Moreover, we show that Jmjd6 antagonizes the repression effect of Tcf7l1 on target gene transcription and is able to enhance beta-catenin-induced gene activation and that, vice versa, inhibition of Jmjd6 activity compromises gene activation in both cells and Xenopus early embryos. We also show that jmjd6 is both maternally and zygotically transcribed during Xenopus embryogenesis. Loss of Jmjd6 function causes defects in anterioposterior body axis formation and down-regulation of genes that are involved in anterioposterior axis patterning. The results elucidate a novel mechanism underlying the regulation of Tcf7l1 activity and the regulation of embryonic body axis formation.	[Cao, Ying] Nanjing Univ, Model Anim Res Ctr, Nanjing 210061, Jiangsu, Peoples R China; Minist Educ, Key Lab Model Anim Dis Study, Nanjing 210061, Jiangsu, Peoples R China	Nanjing University	Cao, Y (corresponding author), Nanjing Univ, Model Anim Res Ctr, 12 Xuefu Rd, Nanjing 210061, Jiangsu, Peoples R China.	caoying@nju.edu.cn			Ministry of Science and Technology [2011CB943804, 2014CB964701]; National Science Foundation of China [31271544, 31261160492]; Key Laboratory of Regenerative Biology of the Chinese Academy of Sciences [KLRB201306]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Laboratory of Regenerative Biology of the Chinese Academy of Sciences	This work was supported by Ministry of Science and Technology Grants 2011CB943804 and 2014CB964701, National Science Foundation of China Grants 31271544 and 31261160492, and Key Laboratory of Regenerative Biology of the Chinese Academy of Sciences Grant KLRB201306 (to Y. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Andoniadou CL, 2011, DEVELOPMENT, V138, P4931, DOI 10.1242/dev.066597; Boeckel JN, 2011, P NATL ACAD SCI USA, V108, P3276, DOI 10.1073/pnas.1008098108; Bouwmeester T, 1996, NATURE, V382, P595, DOI 10.1038/382595a0; Brannon M, 1997, GENE DEV, V11, P2359, DOI 10.1101/gad.11.18.2359; Cao Q, 2012, DEVELOPMENT, V139, P3950, DOI 10.1242/dev.082024; Cao Y, 2008, J BIOL CHEM, V283, P34168, DOI 10.1074/jbc.M803532200; Chang BS, 2007, SCIENCE, V318, P444, DOI 10.1126/science.1145801; Clevers H, 1997, TRENDS GENET, V13, P485, DOI 10.1016/S0168-9525(97)01305-X; Cole MF, 2008, GENE DEV, V22, P746, DOI 10.1101/gad.1642408; Daniels DL, 2005, NAT STRUCT MOL BIOL, V12, P364, DOI 10.1038/nsmb912; De Robertis EM, 2000, NAT REV GENET, V1, P171, DOI 10.1038/35042039; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; Heasman J, 2000, DEV BIOL, V222, P124, DOI 10.1006/dbio.2000.9720; Hecht A, 2000, EMBO J, V19, P1839, DOI 10.1093/emboj/19.8.1839; Hikasa H, 2010, DEV CELL, V19, P521, DOI 10.1016/j.devcel.2010.09.005; Hong JR, 2004, DEVELOPMENT, V131, P5417, DOI 10.1242/dev.01409; Houston DW, 2002, DEVELOPMENT, V129, P4015; Kim CH, 2000, NATURE, V407, P913, DOI 10.1038/35038097; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Kuwahara A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094408; Lee YF, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3200; Li MO, 2003, SCIENCE, V302, P1560, DOI 10.1126/science.1087621; Liu F, 2005, DEVELOPMENT, V132, P5375, DOI 10.1242/dev.02152; Liu W, 2013, CELL, V155, P1581, DOI 10.1016/j.cell.2013.10.056; McKendry R, 1997, DEV BIOL, V192, P420, DOI 10.1006/dbio.1997.8797; Merrill BJ, 2004, DEVELOPMENT, V131, P263, DOI 10.1242/dev.00935; Molenaar M, 1998, MECH DEVELOP, V75, P151, DOI 10.1016/S0925-4773(98)00085-9; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Moon RT, 1998, BIOESSAYS, V20, P536, DOI 10.1002/(SICI)1521-1878(199807)20:7<536::AID-BIES4>3.3.CO;2-U; Nguyen H, 2006, CELL, V127, P171, DOI 10.1016/j.cell.2006.07.036; Oswald F, 2005, MOL CELL BIOL, V25, P10379, DOI 10.1128/MCB.25.23.10379-10390.2005; Poulard C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087982; Roose J, 1998, NATURE, V395, P608, DOI 10.1038/26989; Tam WL, 2008, STEM CELLS, V26, P2019, DOI 10.1634/stemcells.2007-1115; Unoki M, 2013, J BIOL CHEM, V288, P6053, DOI 10.1074/jbc.M112.433284; Wang F, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001819; Webby CJ, 2009, SCIENCE, V325, P90, DOI 10.1126/science.1175865; Weimann M, 2013, NAT METHODS, V10, P339, DOI [10.1038/NMETH.2397, 10.1038/nmeth.2397]; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Wu CI, 2012, DEVELOPMENT, V139, P2118, DOI 10.1242/dev.076067; Zhang J, 2013, TUMOR BIOL, V34, P2397, DOI 10.1007/s13277-013-0789-9	42	10	11	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2015	290	33					20273	20283		10.1074/jbc.M115.646554	http://dx.doi.org/10.1074/jbc.M115.646554			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP1AT	26157142	hybrid, Green Published			2022-12-26	WOS:000359608900027
J	Jiang, BH; Yang, KJ; Cao, SY				Jiang, Beihan; Yang, Kejun; Cao, Shuyou			An Analytical Model for the Distributions of Velocity and Discharge in Compound Channels with Submerged Vegetation	PLOS ONE			English	Article							2-DIMENSIONAL ANALYTICAL SOLUTION; DEPTH-AVERAGED VELOCITY; MOMENTUM-TRANSFER; FLOW RESISTANCE; EMERGENT; FORMULAS; STRESS; DRAG	Based on the momentum transfer theory, an analytical model is proposed for the velocity and discharge distributions in compound channels with submerged vegetation on the flood-plain. The partially vegetated channel was divided into three sub-regions, i.e. the main channel region, the floodplain region with submerged vegetation and the floodplain region without vegetation. For each region, the force balance relationship was established, and the momentum transfer between different regions was presented. Verification by the experimental data and comparison with the traditional method shows that the proposed method is capable of predicting for the velocity and discharge distributions in compound channels with submerged vegetation and is superior to the conventional method. The results also show that when the momentum transfer between different regions is ignored, the computed discharge will be much lager than the measured data, and the error increases with the discharge, especially in the floodplain region.	[Jiang, Beihan] Fuzhou Univ, Coll Civil Engn, Fuzhou 350002, Fujian, Peoples R China; [Jiang, Beihan; Yang, Kejun; Cao, Shuyou] Sichuan Univ, State Key Lab Hydraul & Mt River Engn, Chengdu 610064, Sichuan, Peoples R China	Fuzhou University; Sichuan University	Yang, KJ (corresponding author), Sichuan Univ, State Key Lab Hydraul & Mt River Engn, Chengdu 610064, Sichuan, Peoples R China.	yangkejun@scu.edu.cn			National Natural Scientific Foundation of China [51479128, 51279117]; Program for New Century Excellent Talents in University of China [NCET-13-0393]; Excellent Youth Foundation of Sichuan University [2014SCU04B03]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University of China(Program for New Century Excellent Talents in University (NCET)); Excellent Youth Foundation of Sichuan University	The National Natural Scientific Foundation of China (Nos. 51479128 and 51279117), the Program for New Century Excellent Talents in University of China (No.: NCET-13-0393) and the Excellent Youth Foundation of Sichuan University (No.: 2014SCU04B03) supported this study.	ACKERS P, 1992, P I CIVIL ENG-WATER, V96, P247, DOI 10.1680/iwtme.1992.21674; ACKERS P, 1993, J HYDRAUL RES, V31, P509, DOI 10.1080/00221689309498874; Ackers P., 1993, WATER ENV MANAGE, V7, P52, DOI DOI 10.1111/j.1747-6593.1993.tb00810.x; Choi SU, 2004, J HYDRAUL RES, V42, P3, DOI 10.1080/00221686.2004.9641178; Einstein H.A., 1950, EOS T AM GEOPHYS UN, V31, P603, DOI [DOI 10.1029/TR031I004P00603, 10.1029/TR031i004p00603]; Fischer-Antze T, 2001, J HYDRAUL RES, V39, P303, DOI 10.1080/00221680109499833; Huai WX, 2010, ADV WATER RESOUR, V33, P635, DOI 10.1016/j.advwatres.2010.03.006; Huai WX, 2008, APPL MATH MECH-ENGL, V29, P1077, DOI 10.1007/s10483-008-0811-y; Huai WX, 2011, APPL MATH MECH-ENGL, V32, P459, DOI 10.1007/s10483-011-1430-6; Huai WX, 2009, APPL MATH MECH-ENGL, V30, P1121, DOI 10.1007/s10483-009-0906-z; Huai WX, 2009, APPL MATH MECH-ENGL, V30, P343, DOI 10.1007/s10483-009-0308-1; Huai WX, 2014, ADV WATER RESOUR, V69, P106, DOI 10.1016/j.advwatres.2014.04.001; Huai WX, 2013, J HYDRAUL RES, V51, P708, DOI 10.1080/00221686.2013.818585; Huai WX, 2012, ADV WATER RESOUR, V49, P56, DOI 10.1016/j.advwatres.2012.07.001; Huang B., 2002, J HYDRODYNAM SERB, V14, P23; KNIGHT DW, 1983, J HYDRAUL ENG-ASCE, V109, P1073, DOI 10.1061/(ASCE)0733-9429(1983)109:8(1073); Krishnamurthy M., 1972, J HYDRAUL DIV, V98, P2257; Liao HS, 2007, ADV WATER RESOUR, V30, P2283, DOI 10.1016/j.advwatres.2007.05.002; Liu C, 2013, ADV WATER RESOUR, V60, P148, DOI 10.1016/j.advwatres.2013.08.002; Liu P.Q., 1995, J YANGTZE RIVER SCI, V3, P61; Lotter G.K., 1933, T ALL UNION SCI RES, V9, P238; Mohaghegh A, 2008, J HYDRODYN, V20, P81, DOI 10.1016/S1001-6058(08)60031-1; MYERS WRC, 1990, J HYDRAUL RES, V28, P141, DOI 10.1080/00221689009499083; MYERS WRC, 1978, J HYDRAUL RES, V16, P139, DOI 10.1080/00221687809499626; Nepf HM, 1999, WATER RESOUR RES, V35, P479, DOI 10.1029/1998WR900069; Nepf HM, 2000, J GEOPHYS RES-OCEANS, V105, P28547, DOI 10.1029/2000JC900145; Pavlovskii N. N., 1931, T ALL UNION SCI RES, V3, P157; POSEY CJ, 1967, CIVIL ENG, V37, P63; PRINOS P, 1984, ADV WATER RESOUR, V7, P180, DOI 10.1016/0309-1708(84)90016-2; Righetti M, 2002, J HYDROL, V269, P55, DOI 10.1016/S0022-1694(02)00194-4; Schlichting H., 1961, BOUNDARY LAYER THEOR, V121; SHIONO K, 1991, J FLUID MECH, V222, P617, DOI 10.1017/S0022112091001246; Sun X, 2006, THESIS LOUGHBOROUGH; Sun X, 2009, ADV WATER RESOUR, V32, P430, DOI 10.1016/j.advwatres.2008.12.004; Tang X, 2008, ADV WATER RESOUR, V31, P846, DOI 10.1016/j.advwatres.2008.02.002; Tang XN, 2009, SCI CHINA SER E, V52, P3357, DOI 10.1007/s11431-009-0342-7; Tang XN, 1999, J HYDRAUL RES, V37, P591, DOI 10.1080/00221689909498519; Tang XN, 2011, J ENG COMPUTATION ME, V164, P1; Tanino Y, 2008, J HYDRAUL ENG-ASCE, V134, P34, DOI 10.1061/(ASCE)0733-9429(2008)134:1(34); Wang H, 2007, J HYDRODYN, V19, P225, DOI 10.1016/S1001-6058(07)60052-3; Wang W, 1998, J HYDRODYNAMICS B, V10, P31; WORMLEATON PR, 1982, J HYDR ENG DIV-ASCE, V108, P975; Wu CG, 1982, BOOK 2 HYDRAULICS; [吴福生 WU Fusheng], 2007, [水利学报, Journal of Hydraulic Engineering], V38, P1301; Yang KJ, 2007, J HYDRAUL ENG-ASCE, V133, P148, DOI 10.1061/(ASCE)0733-9429(2007)133:2(148); [杨克君 Yang Kejun], 2005, [水利学报, Journal of Hydraulic Engineering], V36, P563	46	7	7	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0130841	10.1371/journal.pone.0130841	http://dx.doi.org/10.1371/journal.pone.0130841			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161661	gold, Green Published, Green Submitted			2022-12-26	WOS:000358162300023
J	Kim, GS; Jung, HE; Kim, JS; Lee, YC				Kim, Gwang Sik; Jung, Ha-Eun; Kim, Jeong-Sun; Lee, Young Chul			Mutagenesis Study Reveals the Rim of Catalytic Entry Site of HDAC4 and-5 as the Major Binding Surface of SMRT Corepressor	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITORS; NUCLEAR RECEPTOR COREPRESSOR; THYROID-HORMONE RECEPTOR; PLUS 2-HYBRID SYSTEM; VITAMIN-D-RECEPTOR; FUNCTIONAL-CHARACTERIZATION; TRANSCRIPTIONAL REPRESSION; MOLECULAR DETERMINANTS; LXR/RXR HETERODIMERS; CARDIAC-HYPERTROPHY	Histone deacetylases (HDACs) play a pivotal role in eukaryotic gene expression by modulating the levels of acetylation of chromatin and related transcription factors. In contrast to class I HDACs (HDAC1, -2, -3 and -8), the class IIa HDACs (HDAC4, -5, -7 and -9) harbor cryptic deacetylases activity and recruit the SMRT-HDAC3 complex to repress target genes in vivo. In this regard, the specific interaction between the HDAC domain of class IIa HDACs and the C-terminal region of SMRT repression domain 3 (SRD3c) is known to be critical, but the molecular basis of this interaction has not yet been addressed. Here, we used an extensive mutant screening system, named the "partitioned one-plus two-hybrid system", to isolate SRD3c interaction-defective (SRID) mutants over the entire catalytic domains of HDAC4 (HDAC4c) and -5. The surface presentation of the SRID mutations on the HDAC4c structure revealed that most of the mutations were mapped to the rim surface of the catalytic entry site, strongly suggesting this mutational hot-spot region as the major binding surface of SRD3c. Notably, among the HDAC4c surface residues required for SRD3c binding, some residues (C667, C669, C751, D759, T760 and F871) are present only in class IIa HDACs, providing the molecular basis for the specific interactions between SRD3c and class IIa enzymes. To investigate the functional consequence of SRID mutation, the in vitro HDAC activities of HDAC4 mutants immuno-purified from HEK293 cells were measured. The levels of HDAC activity of the HDAC4c mutants were substantially decreased compared to wild-type. Consistent with this, SRID mutations of HDAC4c prevented the association of HDAC4c with the SMRT-HDAC3 complex in vivo. Our findings may provide structural insight into the binding interface of HDAC4 and -5 with SRD3c, as a novel target to design modulators specific to these enzymes.	[Kim, Gwang Sik; Jung, Ha-Eun; Lee, Young Chul] Chonnam Natl Univ, Sch Biol Sci & Technol, Hormone Res Ctr, Kwangju 500757, South Korea; [Kim, Jeong-Sun] Chonnam Natl Univ, Dept Chem, Kwangju 500757, South Korea; [Kim, Jeong-Sun] Chonnam Natl Univ, Inst Basic Sci, Kwangju 500757, South Korea	Chonnam National University; Chonnam National University; Chonnam National University	Lee, YC (corresponding author), Chonnam Natl Univ, Sch Biol Sci & Technol, Hormone Res Ctr, Kwangju 500757, South Korea.	yclee@jnu.ac.kr			National Research Foundation of Korea (NRF) - Korean Government [NRF 2011-0029484]	National Research Foundation of Korea (NRF) - Korean Government	This work was supported by a grant from the National Research Foundation of Korea (NRF), funded by the Korean Government (NRF 2011-0029484).	Ago T, 2008, CELL, V133, P978, DOI 10.1016/j.cell.2008.04.041; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Bottomley MJ, 2008, J BIOL CHEM, V283, P26694, DOI 10.1074/jbc.M803514200; Burli RW, 2013, J MED CHEM, V56, P9934, DOI 10.1021/jm4011884; Chang SR, 2006, CELL, V126, P321, DOI 10.1016/j.cell.2006.05.040; Chang SR, 2004, MOL CELL BIOL, V24, P8467, DOI 10.1128/MCB.24.19.8467-8476.2004; Clocchiatti A, 2011, J CELL MOL MED, V15, P1833, DOI 10.1111/j.1582-4934.2011.01321.x; Di Gennaro E, 2004, AMINO ACIDS, V26, P435, DOI 10.1007/s00726-004-0087-3; Downes M, 2000, P NATL ACAD SCI USA, V97, P10330, DOI 10.1073/pnas.97.19.10330; Eom GH, 2014, PHARMACOL THERAPEUT, V143, P168, DOI 10.1016/j.pharmthera.2014.02.012; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Finnin MS, 1999, NATURE, V401, P188, DOI 10.1038/43710; Fischle W, 2002, MOL CELL, V9, P45, DOI 10.1016/S1097-2765(01)00429-4; Gao L, 2002, J BIOL CHEM, V277, P25748, DOI 10.1074/jbc.M111871200; Granger A, 2008, FASEB J, V22, P3549, DOI 10.1096/fj.08-108548; Haberland M, 2009, P NATL ACAD SCI USA, V106, P7751, DOI 10.1073/pnas.0903139106; Hancock WW, 2012, ANN RHEUM DIS, V71, P46, DOI 10.1136/annrheumdis-2011-200593; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Huang EY, 2000, GENE DEV, V14, P45; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Ishizuka T, 2005, MOL ENDOCRINOL, V19, P1443, DOI 10.1210/me.2005-0009; Kazantsev AG, 2008, NAT REV DRUG DISCOV, V7, P854, DOI 10.1038/nrd2681; Kim JY, 2007, MOL CELL PROTEOMICS, V6, P1727, DOI 10.1074/mcp.M700079-MCP200; Kim JY, 2012, METHODS MOL BIOL, V812, P209, DOI 10.1007/978-1-61779-455-1_12; Kim JY, 2010, J MOL BIOL, V396, P747, DOI 10.1016/j.jmb.2009.12.008; Kim JY, 2009, BIOCHEM BIOPH RES CO, V379, P780, DOI [10.1016/j.bbrc.2008.12.156, 10.1016/j.bbrc.2008.12.155]; Kim JY, 2009, MOL ENDOCRINOL, V23, P251, DOI 10.1210/me.2008-0426; Kooistra SM, 2012, NAT REV MOL CELL BIO, V13, P297, DOI 10.1038/nrm3327; Lachner M, 2002, CURR OPIN CELL BIOL, V14, P286, DOI 10.1016/S0955-0674(02)00335-6; Lahm A, 2007, P NATL ACAD SCI USA, V104, P17335, DOI 10.1073/pnas.0706487104; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Martin M, 2007, ONCOGENE, V26, P5450, DOI 10.1038/sj.onc.1210613; Mielcarek M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080849; Mielcarek M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027746; Mihaylova MM, 2011, CELL, V145, P607, DOI 10.1016/j.cell.2011.03.043; Miller TA, 2003, J MED CHEM, V46, P5097, DOI 10.1021/jm0303094; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Ng HH, 2000, TRENDS BIOCHEM SCI, V25, P121; Nightingale KP, 2006, CURR OPIN GENET DEV, V16, P125, DOI 10.1016/j.gde.2006.02.015; Oberoi J, 2011, NAT STRUCT MOL BIOL, V18, P177, DOI 10.1038/nsmb.1983; Park EJ, 1999, P NATL ACAD SCI USA, V96, P3519, DOI 10.1073/pnas.96.7.3519; Rundlett SE, 1996, P NATL ACAD SCI USA, V93, P14503, DOI 10.1073/pnas.93.25.14503; Schuetz A, 2008, J BIOL CHEM, V283, P11355, DOI 10.1074/jbc.M707362200; Slingerland M, 2014, ANTI-CANCER DRUG, V25, P140, DOI 10.1097/CAD.0000000000000040; Somoza JR, 2004, STRUCTURE, V12, P1325, DOI 10.1016/j.str.2004.04.012; Son YL, 2008, BIOCHEM J, V410, P319, DOI 10.1042/BJ20070837; Son YL, 2012, MOL BIOL REP, V39, P177, DOI 10.1007/s11033-011-0723-4; Son YL, 2010, FEBS LETT, V584, P3862, DOI 10.1016/j.febslet.2010.07.056; Son YL, 2009, BIOCHEM BIOPH RES CO, V384, P389, DOI 10.1016/j.bbrc.2009.04.131; Sun Z, 2013, MOL CELL, V52, P769, DOI 10.1016/j.molcel.2013.10.022; Sung YM, 2013, EXP NEUROL, V239, P192, DOI 10.1016/j.expneurol.2012.10.005; Vannini A, 2007, EMBO REP, V8, P879, DOI 10.1038/sj.embor.7401047; Vega RB, 2004, CELL, V119, P555, DOI 10.1016/j.cell.2004.10.024; Verdin E, 2003, TRENDS GENET, V19, P286, DOI 10.1016/S0168-9525(03)00073-8; Wardell SE, 2009, MOL ENDOCRINOL, V23, P388, DOI 10.1210/me.2008-0179; Xu L, 1999, CURR OPIN GENET DEV, V9, P140, DOI 10.1016/S0959-437X(99)80021-5; Yin Lei, 2010, Nucl Recept Signal, V8, pe001, DOI 10.1621/nrs.08001; Yoon HG, 2003, EMBO J, V22, P1336, DOI 10.1093/emboj/cdg120; Zhang CL, 2002, CELL, V110, P479, DOI 10.1016/S0092-8674(02)00861-9; Zhang Y, 1998, CELL, V95, P279, DOI 10.1016/S0092-8674(00)81758-4; Zhang Y, 1998, MOL CELL, V1, P1021, DOI 10.1016/S1097-2765(00)80102-1	62	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132680	10.1371/journal.pone.0132680	http://dx.doi.org/10.1371/journal.pone.0132680			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161557	Green Submitted, Green Published, gold			2022-12-26	WOS:000358162300166
J	Sanli, C; Lambiotte, R				Sanli, Ceyda; Lambiotte, Renaud			Local Variation of Hashtag Spike Trains and Popularity in Twitter	PLOS ONE			English	Article							HEAVY TAILS; COMPETITION; DIFFUSION; DYNAMICS; NETWORK; MEMES; MODEL	We draw a parallel between hashtag time series and neuron spike trains. In each case, the process presents complex dynamic patterns including temporal correlations, burstiness, and all other types of nonstationarity. We propose the adoption of the so-called local variation in order to uncover salient dynamical properties, while properly detrending for the time-dependent features of a signal. The methodology is tested on both real and randomized hashtag spike trains, and identifies that popular hashtags present regular and so less bursty behavior, suggesting its potential use for predicting online popularity in social media.	[Sanli, Ceyda; Lambiotte, Renaud] Univ Namur, NaXys, Dept Math, CompleX & Networks, Namur, Belgium	University of Namur	Sanli, C (corresponding author), Univ Namur, NaXys, Dept Math, CompleX & Networks, Namur, Belgium.	cedaysan@gmail.com	Lambiotte, Renaud/HDO-4530-2022	Lambiotte, Renaud/0000-0002-0583-4595	EU 7th Framework OptimizR Project [48909A2 CE OPTIMIZR];  [F.N.R.S MIS F4527.12 48888F3]	EU 7th Framework OptimizR Project; 	This work was supported by grant number F.N.R.S MIS F4527.12 48888F3 (grant holder: RL, funding receiver: CS, http://www.fnrs.be/), the EU 7th Framework OptimizR Project: 48909A2 CE OPTIMIZR (grant holder: RL, funding receiver: CS, http://optimizr.eu/), and the National Institute of Informatics Tokyo (http://www.nii.ac.jp/en/) for partial traveling support. This funder had a role in preparation of the manuscript (visit for scientific exchange of ideas), but did not have a further role in	[Anonymous], 2013, NONLINEAR MICROSCALE; Backlund VP, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.062815; Barabasi AL, 2005, NATURE, V435, P207, DOI 10.1038/nature03459; Borge-Holthoefer J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023883; Cetin U, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.032801; Cheng J, 2014, WWW'14: PROCEEDINGS OF THE 23RD INTERNATIONAL CONFERENCE ON WORLD WIDE WEB, P925, DOI 10.1145/2566486.2567997; Coscia M, 2014, SCI REP-UK, V4, DOI 10.1038/srep06477; Deschatres F, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.016112; DOMENICO MD, 2013, SCI REP, V3, DOI DOI 10.1038/SREP02980; Franca U, 2014, ARXIV E PRINTS; Gleeson JP, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.048701; Gleeson JP, 2015, ARXIV E PRINTS; Gonzalez-Bailon S, 2011, SCI REP-UK, V1, DOI 10.1038/srep00197; Jo HH, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/1/013055; Jo HH, 2015, ARXIV E PRINTS; Jovanovic S, 2015, PHYS REV E, V91, DOI 10.1103/PhysRevE.91.042802; Karimi F, 2013, PHYSICA A, V392, P3476, DOI 10.1016/j.physa.2013.03.050; Karsai M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00397; Kawamoto T, 2013, PHYSICA A, V392, P3470, DOI 10.1016/j.physa.2013.03.048; Kenett DY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102001; Koyama S, 2005, J PHYS A-MATH GEN, V38, pL531, DOI 10.1088/0305-4470/38/29/L04; Lambiotte R, 2007, J INFORMETR, V1, P277, DOI 10.1016/j.joi.2007.07.001; Lambiotte R, 2013, EUR PHYS J B, V86, DOI 10.1140/epjb/e2013-40456-9; Malmgren RD, 2008, P NATL ACAD SCI USA, V105, P18153, DOI 10.1073/pnas.0800332105; Miotto JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111506; Miura K, 2006, NEURAL COMPUT, V18, P2359, DOI 10.1162/neco.2006.18.10.2359; Mollgaard A, 2015, ARXIV E PRINTS; Myers S, 2014, WWW'14: PROCEEDINGS OF THE 23RD INTERNATIONAL CONFERENCE ON WORLD WIDE WEB, P913, DOI 10.1145/2566486.2568043; Myers SA, 2012, IEEE DATA MINING, P539, DOI 10.1109/ICDM.2012.159; Omi T, 2011, NEURAL COMPUT, V23, P3125, DOI 10.1162/NECO_a_00213; Onaga T, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.042817; Ratkiewicz J, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.158701; Rodriguez MG, 2014, NETW SCI, V2, P26, DOI 10.1017/nws.2014.3; Sasahara K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061823; Shimazaki H, 2007, NEURAL COMPUT, V19, P1503, DOI 10.1162/neco.2007.19.6.1503; Shinomoto S, 2003, NEURAL COMPUT, V15, P2823, DOI 10.1162/089976603322518759; Shinomoto S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000433; SOFTKY WR, 1993, J NEUROSCI, V13, P334; Szabolcs V, 2013, NEW J PHYS, V15, DOI [10.1088/1367-2630/15/10/103023, DOI 10.1088/1367-2630/15/10/103023]; Takaguchi T, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.036115; Tuckwell H. C., 1988, INTRO THEORETICAL NE, V2; Vestergaard CL, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.042805; Weng L, 2012, SCI REP-UK, V2, P1, DOI 10.1038/srep00335; Weng LL, 2013, SCI REP-UK, V3, DOI 10.1038/srep02522	44	22	22	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131704	10.1371/journal.pone.0131704	http://dx.doi.org/10.1371/journal.pone.0131704			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161650	Green Submitted, Green Published, gold			2022-12-26	WOS:000358162300053
J	van Wijk, DF; Strang, AC; Duivenvoorden, R; Enklaar, DJF; Zwinderman, AH; van der Geest, RJ; Kastelein, JJP; de Groot, E; Stroes, ESG; Nederveen, AJ				van Wijk, Diederik F.; Strang, Aart C.; Duivenvoorden, Raphael; Enklaar, Dirk-Jan F.; Zwinderman, Aeilko H.; van der Geest, Rob J.; Kastelein, John J. P.; de Groot, Eric; Stroes, Erik S. G.; Nederveen, Aart J.			Increasing the Spatial Resolution of 3T Carotid MRI Has No Beneficial Effect for Plaque Component Measurement Reproducibility	PLOS ONE			English	Article							IN-VIVO; FIBROUS-CAP; ATHEROSCLEROTIC LESIONS; SCAN-RESCAN; 1.5 T; THICKNESS; VALIDATION; HEMORRHAGE; ACCURACY; CONTRAST	Purpose Different in-plane resolutions have been used for carotid 3T MRI. We compared the reproducibility, as well as the within-and between reader variability of high and routinely used spatial resolution in scans of patients with atherosclerotic carotid artery disease. Since no consensus exists about the optimal segmentation method, we analysed all imaging data using two different segmentation methods. Materials and Methods In 31 patient with carotid atherosclerosis a high (0.25 x 0.25 mm(2); HR) and routinely used (0.50 x 0.50 mm(2); LR) spatial resolution carotid MRI scan were performed within one month. A fully blinded closed and a simultaneously open segmentation were used to quantify the lipid rich necrotic core (LRNC), calcified and loose matrix (LM) plaque area and the fibrous cap (FC) thickness. Results No significant differences were observed between scan-rescan reproducibility for HR versus LR measurements, nor did we find any significant difference between the within-reader and between-reader reproducibility. The same applies for differences between the open and closed reads. All intraclass correlation coefficients between scans and rescans for the LRNC, calcified and LM plaque area, as well as the FC thickness measurements with the open segmentation method were excellent (all above 0.75). Conclusions Increasing the spatial resolution at the expense of the contrast-to-noise ratio does not improve carotid plaque component scan-rescan reproducibility in patients with atherosclerotic carotid disease, nor does using a different segmentation method.	[van Wijk, Diederik F.; Strang, Aart C.; Duivenvoorden, Raphael; Enklaar, Dirk-Jan F.; Kastelein, John J. P.; de Groot, Eric; Stroes, Erik S. G.] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [Zwinderman, Aeilko H.] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol & Biostat, NL-1105 AZ Amsterdam, Netherlands; [van der Geest, Rob J.] Leiden Univ, Med Ctr, Dept Radiol, Leiden, Netherlands; [Nederveen, Aart J.] Univ Amsterdam, Acad Med Ctr, Dept Radiol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Amsterdam; Academic Medical Center Amsterdam	van Wijk, DF (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	D.F.vanWijk@amc.uva.nl	Duivenvoorden, Raphaël/B-5154-2019; Kastelein, John/AAF-7950-2020; van der Geest, Rob J/J-8193-2015	Duivenvoorden, Raphaël/0000-0003-1446-8336; van der Geest, Rob J/0000-0002-9084-5597; Nederveen, Aart/0000-0002-5477-973X	Merck, United States of America	Merck, United States of America	This study was supported by an educational research grant of Merck, United States of America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adame IM, 2006, J MAGN RESON IMAGING, V24, P595, DOI 10.1002/jmri.20662; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Balu N, 2009, J MAGN RESON IMAGING, V30, P1209, DOI 10.1002/jmri.21890; BLAND JM, 1995, LANCET, V346, P1085, DOI 10.1016/S0140-6736(95)91748-9; Cappendijk VC, 2004, J MAGN RESON IMAGING, V20, P105, DOI 10.1002/jmri.20060; Corti R, 2002, CIRCULATION, V106, P2884, DOI 10.1161/01.CIR.0000041255.88750.F0; Hatsukami TS, 2000, CIRCULATION, V102, P959, DOI 10.1161/01.CIR.102.9.959; Keenan NG, 2010, J MAGN RESON IMAGING, V31, P935, DOI 10.1002/jmri.22109; Kobayashi M, 2008, NEUROL MED-CHIR, V48, P211, DOI 10.2176/nmc.48.211; Koktzoglou I, 2006, J MAGN RESON IMAGING, V23, P699, DOI 10.1002/jmri.20563; Koning W, 2013, MAGN RESON MED, V69, P1186, DOI 10.1002/mrm.24345; Kwee RM, 2009, STROKE, V40, P3017, DOI 10.1161/STROKEAHA.109.555052; Li FY, 2010, J MAGN RESON IMAGING, V31, P168, DOI 10.1002/jmri.22014; Meissner OA, 2003, J VASC INTERV RADIOL, V14, P227, DOI 10.1097/01.RVI.0000058325.82956.63; Rosner B, 2010, FUNDAMENTALS BIOSTAT; Saam T, 2005, J CARDIOVASC MAGN R, V7, P799, DOI 10.1080/10976640500287703; Saam T, 2005, ARTERIOSCL THROM VAS, V25, P234, DOI 10.1161/01.ATV.0000149867.61851.31; Saam T, 2008, J AM COLL CARDIOL, V51, P1014, DOI 10.1016/j.jacc.2007.10.054; Shinnar M, 1999, ARTERIOSCL THROM VAS, V19, P2756, DOI 10.1161/01.ATV.19.11.2756; TOUSSAINT JF, 1995, ARTERIOSCL THROM VAS, V15, P1533; Trivedi RA, 2004, NEURORADIOLOGY, V46, P738, DOI 10.1007/s00234-004-1247-6; Underhill HR, 2008, AM HEART J, V155, DOI 10.1016/j.ahj.2007.11.018; Van Wijk DF, 2013, INCREASING SPATIAL R; Vidal A, 2008, PHYS MED BIOL, V53, P6821, DOI 10.1088/0031-9155/53/23/011; Winn WB, 1998, AM J NEURORADIOL, V19, P129; Wong SK, 2014, WORLD J RADIOL, V6, P192, DOI 10.4329/wjr.v6.i5.192; Yarnykh VL, 2006, J MAGN RESON IMAGING, V23, P691, DOI 10.1002/jmri.20562; Yuan C, 2001, CIRCULATION, V104, P2051, DOI 10.1161/hc4201.097839; Zhao XH, 2011, STROKE, V42, P347, DOI 10.1161/STROKEAHA.110.597328; Zhao XQ, 2011, JACC-CARDIOVASC IMAG, V4, P977, DOI 10.1016/j.jcmg.2011.06.013	30	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0130878	10.1371/journal.pone.0130878	http://dx.doi.org/10.1371/journal.pone.0130878			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161783	gold, Green Submitted, Green Published			2022-12-26	WOS:000358162300024
J	Wang, Q; Li, KY; Zhang, DX; Li, JY; Xu, GY; Zheng, JX; Yang, N; Qu, LJ				Wang, Qiong; Li, Kaiyang; Zhang, Daixi; Li, Junying; Xu, Guiyun; Zheng, Jiangxia; Yang, Ning; Qu, Lujiang			Next-Generation Sequencing Techniques Reveal that Genomic Imprinting Is Absent in Day-Old Gallus gallus domesticus Brains	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; ORIGIN ALLELIC EXPRESSION; DROSOPHILA-MELANOGASTER; GENE-EXPRESSION; MOUSE-BRAIN; RNA-SEQ; TRANSCRIPTS; ALIGNMENT; CHICKEN; MAIZE	Genomic imprinting is a phenomenon characterized by parent-of-origin-specific gene expression. While widely documented in viviparous mammals and plants, imprinting in oviparous birds remains controversial. Because genomic imprinting is temporal-and tissue-specific, we investigated this phenomenon only in the brain tissues of 1-day-old chickens (Gallus gallus). We used next-generation sequencing technology to compare four transcrip-tomes pooled from 11 chickens, generated from reciprocally crossed families, to the DNA sequences of their parents. Candidate imprinted genes were then selected from these sequence alignments and subjected to verification experiments that excluded all but one SNP. Subsequent experiments performed with two new sets of reciprocally crossed families resulted in the exclusion of that candidate SNP as well. Attempts to find evidence of genomic imprinting from long non-coding RNAs yielded negative results. We therefore conclude that genomic imprinting is absent in the brains of 1-day-old chickens. However, due to the temporal and tissue specificity of imprinting, our results cannot be extended to all growth stages and tissue types.	[Wang, Qiong; Li, Kaiyang; Zhang, Daixi; Li, Junying; Xu, Guiyun; Zheng, Jiangxia; Yang, Ning; Qu, Lujiang] China Agr Univ, Dept Anim Genet & Breeding, Natl Engn Lab Anim Breeding, Coll Anim Sci & Technol, Beijing 100094, Peoples R China	China Agricultural University	Qu, LJ (corresponding author), China Agr Univ, Dept Anim Genet & Breeding, Natl Engn Lab Anim Breeding, Coll Anim Sci & Technol, Beijing 100094, Peoples R China.	quluj@cau.edu.cn	Wang, Qiong/HDO-3975-2022	Wang, Qiong/0000-0001-7798-1554; Yang, Ning/0000-0001-5772-3320	National Scientific Supporting Projects of China [2012BAD39B04, 2011BAD28B03]	National Scientific Supporting Projects of China	Beijing innovation team attached to poultry industry technology system (CARS-PSTP) and National Scientific Supporting Projects of China (2011BAD28B03) received by LQ support the sequencing and data analysis; National Scientific Supporting Projects of China (2012BAD39B04) received by LQ play role in verification experiment and preparation of the manuscript.	BARLOW DP, 1991, NATURE, V349, P84, DOI 10.1038/349084a0; BARTOLOMEI MS, 1991, NATURE, V351, P153, DOI 10.1038/351153a0; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Coolon JD, 2012, CELL REP, V2, P69, DOI 10.1016/j.celrep.2012.06.013; Davies W, 2005, NEUROSCI BIOBEHAV R, V29, P421, DOI 10.1016/j.neubiorev.2004.11.007; DECHIARA TM, 1991, CELL, V64, P849, DOI 10.1016/0092-8674(91)90513-X; DeVeale B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002600; Ferguson-Smith AC, 2011, NAT REV GENET, V12, P565, DOI 10.1038/nrg3032; FERGUSONSMITH AC, 1991, NATURE, V351, P667, DOI 10.1038/351667a0; Fresard L, 2014, NUCLEIC ACIDS RES, V42, P3768, DOI 10.1093/nar/gkt1390; Fresard L, 2013, GENET SEL EVOL, V45, DOI 10.1186/1297-9686-45-16; Gibson G, 2004, GENETICS, V167, P1791, DOI 10.1534/genetics.104.026583; Gregg C, 2010, SCIENCE, V329, P682, DOI 10.1126/science.1190831; Gregg C, 2010, SCIENCE, V329, P643, DOI 10.1126/science.1190830; KERMICLE JL, 1970, GENETICS, V66, P69; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Korir PK, 2014, METHODS MOL BIOL, V1112, P49, DOI 10.1007/978-1-62703-773-0_4; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Munshi Anjana, 2007, Journal of Genetics and Genomics, V34, P93, DOI 10.1016/S1673-8527(07)60010-1; Nadeau C, 2012, NAT METHODS, P9; Neff MM, 1998, PLANT J, V14, P387, DOI 10.1046/j.1365-313X.1998.00124.x; NICHOLLS RD, 1989, NATURE, V342, P281, DOI 10.1038/342281a0; Oakey RJ, 2002, TRENDS GENET, V18, P359, DOI 10.1016/S0168-9525(02)02708-7; Pask Andrew, 2012, Methods Mol Biol, V925, P263, DOI 10.1007/978-1-62703-011-3_18; Raissig MT, 2011, PLANT CELL, V23, P16, DOI 10.1105/tpc.110.081018; Ramirez-Gonzalez Ricardo H, 2013, F1000Res, V2, P248, DOI 10.12688/f1000research.2-248.v1; Richards EJ, 2006, NAT REV GENET, V7, P395, DOI 10.1038/nrg1834; Sauder JM, 2000, PROTEINS, V40, P6, DOI 10.1002/(SICI)1097-0134(20000701)40:1<6::AID-PROT30>3.0.CO;2-7; Smits G, 2008, NAT GENET, V40, P971, DOI 10.1038/ng.168; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tuiskula-Haavisto M, 2007, CYTOGENET GENOME RES, V117, P305, DOI 10.1159/000103192; Wang ZP, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003183; Weaver JR, 2009, MAMM GENOME, V20, P532, DOI 10.1007/s00335-009-9225-2; Yona G, 2000, Proc Int Conf Intell Syst Mol Biol, V8, P395; Zapala MA, 2005, P NATL ACAD SCI USA, V102, P10357, DOI 10.1073/pnas.0503357102; Zhang M, 2011, P NATL ACAD SCI USA, V108, P20042, DOI 10.1073/pnas.1112186108	39	13	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132345	10.1371/journal.pone.0132345	http://dx.doi.org/10.1371/journal.pone.0132345			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161857	Green Published, Green Submitted, gold			2022-12-26	WOS:000358162300121
J	Witvorapong, N; Muttarak, R; Pothisiri, W				Witvorapong, Nopphol; Muttarak, Raya; Pothisiri, Wiraporn			Social Participation and Disaster Risk Reduction Behaviors in Tsunami Prone Areas	PLOS ONE			English	Article							SOCIOECONOMIC DIFFERENCES; MOBILITY INTENTIONS; CLIMATE-CHANGE; PREPAREDNESS; HEALTH; HAZARD; POPULATION; PREDICTORS; MIGRATION; RECOVERY	This paper examines the relationships between social participation and disaster risk reduction actions. A survey of 557 households in tsunami prone areas in Phang Nga, Thailand was conducted following the 2012 Indian Ocean earthquakes. We use a multivariate probit model to jointly estimate the likelihood of undertaking three responses to earthquake and tsunami hazards (namely, (1) following disaster-related news closely, (2) preparing emergency kits and/or having a family emergency plan, and (3) having an intention to migrate) and community participation. We find that those who experienced losses from the 2004 tsunami are more likely to participate in community activities and respond to earthquake hazards. Compared to men, women are more likely to prepare emergency kits and/or have an emergency plan and have a greater intention to migrate. Living in a community with a higher proportion of women with tertiary education increases the probability of engaging in community activities and carrying out disaster risk reduction measures. Individuals who participate in village-based activities are 5.2% more likely to undertake all three risk reduction actions compared to those not engaging in community activities. This implies that encouraging participation in community activities can have positive externalities in disaster mitigation.	[Witvorapong, Nopphol] Chulalongkorn Univ, Fac Econ, Bangkok, Thailand; [Muttarak, Raya] Austrian Acad Sci, Vienna Inst Demog, Wittgenstein Ctr Demog & Human Capital, IIASA,VID OAW,WU, A-1010 Vienna, Austria; [Muttarak, Raya] Int Inst Appl Syst Anal, A-2361 Laxenburg, Austria; [Pothisiri, Wiraporn] Chulalongkorn Univ, Coll Populat Studies, Bangkok, Thailand	Chulalongkorn University; Austrian Academy of Sciences; International Institute for Applied Systems Analysis (IIASA); International Institute for Applied Systems Analysis (IIASA); Chulalongkorn University	Muttarak, R (corresponding author), Austrian Acad Sci, Vienna Inst Demog, Wittgenstein Ctr Demog & Human Capital, IIASA,VID OAW,WU, A-1010 Vienna, Austria.	muttarak@iiasa.ac.at	Witvorapong, Nopphol/J-4360-2019	Witvorapong, Nopphol/0000-0002-7926-381X; Muttarak, Raya/0000-0003-0627-4451; Pothisiri, Wiraporn/0000-0001-7279-9999	Advanced Grant of the European Research Council, "Forecasting Societies Adaptive Capacities to Climate Change" [ERC-2008-AdG 230195-FutureSoc]; Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University for the project "Understanding Social Barriers to Coping with and Adapting to Extreme Climate Events" [RES560530150-CC]	Advanced Grant of the European Research Council, "Forecasting Societies Adaptive Capacities to Climate Change"; Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University for the project "Understanding Social Barriers to Coping with and Adapting to Extreme Climate Events"	Funding for this work was made possible by an Advanced Grant of the European Research Council, "Forecasting Societies Adaptive Capacities to Climate Change" (grant agreement ERC-2008-AdG 230195-FutureSoc) and Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University for the project "Understanding Social Barriers to Coping with and Adapting to Extreme Climate Events" (Grant agreement number: RES560530150-CC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adger WN, 2003, ECON GEOGR, V79, P387; Agrawal S., 2006, General Technical Report - USDA Forest Service, P163; Aldrich DP, 2011, J CIV SOC, V7, P81, DOI 10.1080/17448689.2011.553441; Aldrich DP, 2011, NAT HAZARDS, V56, P595, DOI 10.1007/s11069-010-9577-7; Beggs J., 1996, INT J MASS EMERGENCI, V14, P57; Bethel JW, 2011, AM J PREV MED, V40, P139, DOI 10.1016/j.amepre.2010.10.020; Bihari M, 2012, LANDSCAPE URBAN PLAN, V106, P253, DOI 10.1016/j.landurbplan.2012.03.011; Bradley DE, 2008, GERONTOLOGIST, V48, P190, DOI 10.1093/geront/48.2.190; Cappellari L, 2003, STATA J, V3, P278, DOI 10.1177/1536867X0300300305; Chamlee-Wright E., 2010, CULTURAL POLITICAL E; Chola L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071085; Crabbe P, 2006, CLIMATIC CHANGE, V78, P103, DOI 10.1007/s10584-006-9087-5; Cutter S.L., 1992, IND CRISIS Q, V6, P5, DOI DOI 10.1177/108602669200600102; Dasgupta P, 2000, SOCIAL CAPITAL, P325; Doocy Shannon, 2007, Am J Public Health, V97 Suppl 1, pS146; DOOLEY D, 1992, J APPL SOC PSYCHOL, V22, P451, DOI 10.1111/j.1559-1816.1992.tb00984.x; Dynes RR., 2002, IMPORTANCE SOCIAL CA; Dynes RR, 2005, COMMUNITY SOCIAL CAP; Edwards M.L., 1993, INT J MASS EMERG DIS, V11, P293; Eisenman David P, 2009, Disaster Med Public Health Prep, V3, P33, DOI 10.1097/DMP.0b013e318193be89; Ford JD, 2006, GLOBAL ENVIRON CHANG, V16, P145, DOI 10.1016/j.gloenvcha.2005.11.007; Fothergill A., 1996, INT J MASS EMERGENCI, V14, P33; Heller K, 2005, J APPL SOC PSYCHOL, V35, P399, DOI 10.1111/j.1559-1816.2005.tb02127.x; Henry S, 2004, POPUL ENVIRON, V25, P423, DOI 10.1023/B:POEN.0000036928.17696.e8; Huppert HE, 2006, PHILOS T R SOC A, V364, P1875, DOI 10.1098/rsta.2006.1803; Hyyppa MT, 2003, HEALTH EDUC RES, V18, P770, DOI 10.1093/her/cyf044; Ichida Y, 2013, SOC SCI MED, V94, P83, DOI 10.1016/j.socscimed.2013.05.006; JACKSON EL, 1981, ENVIRON BEHAV, V13, P387, DOI 10.1177/0013916581134001; KANIASTY K, 1993, J PERS SOC PSYCHOL, V64, P395, DOI 10.1037/0022-3514.64.3.395; Kawai M, 2010, ASIAN TSUNAMI: AID AND RECONSTRUCTION AFTER A DISASTER, P171; Klinenberg E., 2002, HEAT WAVE SOCIAL AUT; Knodel JE, 2009, 5 UNFPA THAIL; Kohn S, 2012, DISASTER MED PUBLIC, V6, P217, DOI 10.1001/dmp.2012.47; Lin N., 2008, HDB SOCIAL CAPITAL, P50, DOI DOI 10.4337/9781789907285.00009; Lindell MK, 2000, RISK ANAL, V20, P13, DOI 10.1111/0272-4332.00002; Lindstrom M, 2001, SOC SCI MED, V52, P441, DOI 10.1016/S0277-9536(00)00153-2; Lindstrom M, 2000, SCAND J PUBLIC HEALT, V28, P200, DOI 10.1177/14034948000280030901; Lu M, 1998, ENVIRON PLANN A, V30, P1473, DOI 10.1068/a301473; Maier Heiner, 2005, Eur J Ageing, V2, P31, DOI 10.1007/s10433-005-0018-5; MILETI DS, 1992, RISK ANAL, V12, P393, DOI 10.1111/j.1539-6924.1992.tb00691.x; Mishra S, 2007, PSYCHOL DEV SOC, V19, P143, DOI 10.1177/097133360701900201; Mulilis JP, 2000, J APPL SOC PSYCHOL, V30, P1310, DOI 10.1111/j.1559-1816.2000.tb02522.x; Nakagawa Y., 2004, INT J MASS EMERGENCI, V22, P5; Natural Sciences Sector, 2012, INDIAN OCEAN TSUNAMI; Nishikiori N, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-73; O'Brien P, 1992, INT J MASS EMERG DIS, V10, P71, DOI DOI 10.1007/S11069-011-9842-4; Pollitz FF, 2012, NATURE, V490, P250, DOI 10.1038/nature11504; PUTNAM RD, 1995, J DEMOCRACY, V0006; PUTNAM RD, 1995, PS, V28, P664, DOI 10.2307/420517; Reininger BM, 2013, SOC SCI MED, V83, P50, DOI 10.1016/j.socscimed.2013.01.037; Renzulli LA, 2000, SOC FORCES, V79, P523, DOI 10.2307/2675508; Riad JK, 1999, J APPL SOC PSYCHOL, V29, P918, DOI 10.1111/j.1559-1816.1999.tb00132.x; RUSSELL LA, 1995, ENVIRON BEHAV, V27, P744, DOI 10.1177/0013916595276002; Sharma U, 2012, NAT HAZARDS, V60, P409, DOI 10.1007/s11069-011-0023-2; Shaw R, 2012, COMM ENV DISAST RISK, V10, P3, DOI 10.1108/S2040-7262(2012)0000010007; Singh D., 2012, INDIAN OCEAN TSUNAMI; Siri JG, 2014, ECOL SOC, V19, DOI 10.5751/ES-06134-190133; Striessnig E, 2013, ECOL SOC, V18, DOI 10.5751/ES-05252-180116; Tierney K.J., 2001, FACING UNEXPECTED DI; Tompkins EL, 2005, GLOBAL ENVIRON CHANG, V15, P139, DOI 10.1016/j.gloenvcha.2004.11.002; Turner R.H, 1986, WAITING DISASTERS EA; UNISDR (United Nations International Strategy for Disaster Reduction), 2007, HYOGO FRAMEWORK ACTI; Uscher-Pines L, 2009, AM J PREV MED, V37, P227, DOI 10.1016/j.amepre.2009.04.028; USGS (U.S. Geological Survey), 2012, MAGNITUDE 8 6 W COAS; Varda DM, 2009, POPUL RES POLICY REV, V28, P11, DOI 10.1007/s11113-008-9110-9; Wamsler C, 2012, ECOL SOC, V17, DOI 10.5751/ES-04645-170202; Yamamura E., 2013, NATURAL DISASTERS SO; Yamamura E, 2010, REG STUD, V44, P1019, DOI 10.1080/00343400903365144	68	26	26	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0130862	10.1371/journal.pone.0130862	http://dx.doi.org/10.1371/journal.pone.0130862			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1EJ	26153891	gold, Green Accepted, Green Published			2022-12-26	WOS:000358159700041
J	Andersson, E; Dahmcke, CM; Steven, K; Larsen, LK; Guldberg, P				Andersson, Elin; Dahmcke, Christina M.; Steven, Kenneth; Larsen, Louise K.; Guldberg, Per			Filtration Device for On-Site Collection, Storage and Shipment of Cells from Urine and Its Application to DNA-Based Detection of Bladder Cancer	PLOS ONE			English	Article							FGFR3 MUTATION ASSAY; METHYLATION ASSAY; VOIDED URINE; BIOMARKERS; MARKERS; HYBRIDIZATION	Molecular analysis of cells from urine provides a convenient approach to non-invasive detection of bladder cancer. The practical use of urinary cell-based tests is often hampered by difficulties in handling and analyzing large sample volumes, the need for rapid sample processing to avoid degradation of cellular content, and low sensitivity due to a high background of normal cells. We present a filtration device, designed for home or point-of-care use, which enables collection, storage and shipment of urinary cells. A special feature of this device is a removable cartridge housing a membrane filter, which after filtration of urine can be transferred to a storage unit containing an appropriate preserving solution. In spiking experiments, the use of this device provided efficient recovery of bladder cancer cells with elimination of >99% of excess smaller-sized cells. The performance of the device was further evaluated by DNA-based analysis of urinary cells collected from 57 patients subjected to transurethral resection following flexible cystoscopy indicating the presence of a tumor. All samples were tested for FGFR3 mutations and seven DNA methylation markers (BCL2, CCNA1, EOMES, HOXA9, POU4F2, SALL3 and VIM). In the group of patients where a transitional cell tumor was confirmed at histopathological evaluation, urine DNA was positive for one or more markers in 29 out of 31 cases (94%), including 19 with FGFR3 mutation (61%). In the group of patients with benign histopathology, urine DNA was positive for methylation markers in 13 out of 26 cases (50%). Only one patient in this group was positive for a FGFR3 mutation. This patient had a stage Ta tumor resected 6 months later. The ability to easily collect, store and ship diagnostic cells from urine using the presented device may facilitate non-invasive testing for bladder cancer.	[Andersson, Elin; Dahmcke, Christina M.; Larsen, Louise K.; Guldberg, Per] Res Ctr, Danish Canc Soc, Copenhagen, Denmark; [Dahmcke, Christina M.] Copenhagen Univ Hosp, Dept Pathol, Herlev, Denmark; [Steven, Kenneth] Copenhagen Univ Hosp, Dept Urol, Herlev, Denmark	Danish Cancer Society; University of Copenhagen; University of Copenhagen	Guldberg, P (corresponding author), Res Ctr, Danish Canc Soc, Copenhagen, Denmark.	perg@cancer.dk			Candy Foundation	Candy Foundation	This study received grant support from The Candy Foundation.	Andersson E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094023; Beukers W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077657; Birkhahn M, 2013, EUR J CANCER, V49, P3159, DOI 10.1016/j.ejca.2013.04.033; Botteman MF, 2003, PHARMACOECONOMICS, V21, P1315, DOI 10.1007/BF03262330; Cairns P, 2007, NAT REV CANCER, V7, P531, DOI 10.1038/nrc2170; Cheng L., 2012, BLADDER PATHOLOGY; Costa VL, 2010, CLIN CANCER RES, V16, P5842, DOI 10.1158/1078-0432.CCR-10-1312; Coumans FAW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061774; Coumans FAW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061770; Diaz LA, 2014, J CLIN ONCOL, V32, P579, DOI 10.1200/JCO.2012.45.2011; Falke J, 2011, NAT REV UROL, V8, P42, DOI 10.1038/nrurol.2010.208; Hedelin H, 2002, SCAND J UROL NEPHROL, V36, P344, DOI 10.1080/003655902320783845; Kandimalla R, 2013, CLIN CANCER RES, V19, P4760, DOI 10.1158/1078-0432.CCR-12-3276; Kandimalla R, 2013, NAT REV UROL, V10, P327, DOI 10.1038/nrurol.2013.89; Kipp BR, 2006, DIAGN CYTOPATHOL, V34, P479, DOI 10.1002/dc.20488; Meiers I, 2007, ARCH PATHOL LAB MED, V131, P1574; Mitra AP, 2010, NAT REV UROL, V7, P11, DOI 10.1038/nrurol.2009.236; Platt FM, 2009, CLIN CANCER RES, V15, P6008, DOI 10.1158/1078-0432.CCR-09-0898; Reinert T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046297; Reinert T, 2011, CLIN CANCER RES, V17, P5582, DOI 10.1158/1078-0432.CCR-10-2659; Rubin EH, 2014, CLIN CANCER RES, V20, P1419, DOI 10.1158/1078-0432.CCR-14-0091; Serizawa RR, 2011, INT J CANCER, V129, P78, DOI 10.1002/ijc.25651; Taly V, 2012, TRENDS MOL MED, V18, P405, DOI 10.1016/j.molmed.2012.05.001; Thurner B, 1999, J IMMUNOL METHODS, V223, P1, DOI 10.1016/S0022-1759(98)00208-7; van Rhijn BWG, 2005, EUR UROL, V47, P736, DOI 10.1016/j.eururo.2005.03.014; Weisenberger DJ, 2005, NUCLEIC ACIDS RES, V33, P6823, DOI 10.1093/nar/gki987; WIENER HG, 1993, ACTA CYTOL, V37, P163; Wolff EM, 2010, CANCER RES, V70, P8169, DOI 10.1158/0008-5472.CAN-10-1335; Yap TA, 2014, CLIN CANCER RES, V20, P2553, DOI 10.1158/1078-0432.CCR-13-2664; Yu J, 2007, CLIN CANCER RES, V13, P7296, DOI 10.1158/1078-0432.CCR-07-0861; Zuiverloon TCM, 2012, BJU INT, V109, P941, DOI 10.1111/j.1464-410X.2011.10428.x; Zuiverloon TCM, 2011, J UROLOGY, V186, P707, DOI 10.1016/j.juro.2011.03.141	32	15	16	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2015	10	7							e0131889	10.1371/journal.pone.0131889	http://dx.doi.org/10.1371/journal.pone.0131889			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EC	26151138	Green Submitted, gold, Green Published			2022-12-26	WOS:000358158900028
J	Al-Amiery, AA; Al-Majedy, YK; Kadhum, AAH; Mohamad, AB				Al-Amiery, Ahmed A.; Al-Majedy, Yasameen K.; Kadhum, Abdul Amir H.; Mohamad, Abu Bakar			Hydrogen Peroxide Scavenging Activity of Novel Coumarins Synthesized Using Different Approaches	PLOS ONE			English	Article							ANTIMICROBIAL ACTIVITY; DERIVATIVES	New derivatives of 7-hydroxy-4-methylcoumarin were synthesized using a chemical method and a microwave-assisted method to compare the feasibility, reaction times, and yields of the product. The newly synthesized coumarins were characterized by different spectroscopic techniques (FT-IR and NMR) and micro-elemental analysis (CHNS). In vitro antioxidant activities of these compounds were evaluated against hydrogen peroxide and were compared with standard natural antioxidant, vitamin C. Our results reveal that these compounds exhibit excellent radical scavenging activities.	[Al-Amiery, Ahmed A.] Univ Kebangsaan Malaysia, Dept Chem & Proc Engn, Bangi 43000, Selangor, Malaysia; [Al-Amiery, Ahmed A.; Al-Majedy, Yasameen K.; Kadhum, Abdul Amir H.; Mohamad, Abu Bakar] Univ Technol UOT, Environm Res Ctr, Baghdad 10001, Iraq; [Mohamad, Abu Bakar] Univ Kebangsaan Malaysia, Fuel Cell Inst, Bangi 43000, Selangor, Malaysia	Universiti Kebangsaan Malaysia; University of Technology- Iraq; Universiti Kebangsaan Malaysia	Al-Amiery, AA (corresponding author), Univ Kebangsaan Malaysia, Dept Chem & Proc Engn, Bangi 43000, Selangor, Malaysia.	dr.ahmed1975@gmail.com	, Abu Bakar Mohamad/J-5638-2014; Kadhum, Abdul Amir/AAB-7234-2021; Almajedy, yasameen Kadhim H./AAX-3695-2021; Al-Amiery, Ahmed/C-1520-2013	, Abu Bakar Mohamad/0000-0001-5135-7956; Kadhum, Abdul Amir/0000-0003-4074-9123; Al-Amiery, Ahmed/0000-0003-1033-4904	Universiti Kebangsaan Malaysia [DIP-2012-02]	Universiti Kebangsaan Malaysia	This study was supported by the Universiti Kebangsaan Malaysia under the DIP-2012-02 grant.	Abramovich R. A, 1991, ORG PREP P INT, V23, P683; Al-Amiery A.A, 2012, ORG MED CHEM LETT, V2, P1, DOI [DOI 10.1186/2191-2858-2-1, DOI 10.1186/2191-2858-2-4]; Al-Amiery AA, 2012, RES CHEM INTERMEDIAT, V38, P745, DOI 10.1007/s11164-011-0414-8; ALAMIERY A, 2013, BIOINORG CHEM APPL, V2013, P1; [Anonymous], 2012, J CHEM PHARM; BOSE AK, 1990, HETEROCYCLES, V30, P741; Cacic M, 2006, MOLECULES, V11, P134, DOI 10.3390/11010134; Chen Y, 1999, J AGR FOOD CHEM, V47, P2226, DOI 10.1021/jf990092f; Duh PD, 2012, LWT-FOOD SCI TECHNOL, V32, P269; ELAbd-All MM, 2013, J ATOMS MOL, V3, P537; Hamid A.A., 2010, AFR J PURE APPL CHEM, V4, P142, DOI [DOI 10.5897/AJPAC.9000020, 10.5897/AJPAC.9000020]; Hoult JRS, 1996, GEN PHARMACOL-VASC S, V27, P713, DOI 10.1016/0306-3623(95)02112-4; Kadhum AAH, 2011, INT J MOL SCI, V12, P5747, DOI 10.3390/ijms12095747; Khan MSY, 2003, INDIAN J CHEM B, V42, P900; Kotla V. V., 2013, Der Pharmacia Sinica, V4, P103; Kotla V. V., 2012, Der Pharma Chemica, V4, P2003; Lacova M, 1996, TETRAHEDRON, V52, P14995, DOI 10.1016/0040-4020(96)00922-2; Lin M.H., 2011, J EXP CLIN MED, V3, P126, DOI DOI 10.1016/J.JECM.2011.04.006; MITRA AK, 1980, SYNTHETIC COMMUN, V10, P915, DOI 10.1080/00397918008061851; Mladenovic M, 2009, MOLECULES, V14, P1495, DOI 10.3390/molecules14041495; Naama JH, 2013, RES CHEM INTERMEDIAT, V39, P4047, DOI 10.1007/s11164-012-0921-2; Pal R, 2012, IJPCBS, V2, P500; PUCIOVA M, 1994, COLLECT CZECH CHEM C, V59, P175, DOI 10.1135/cccc19940175; Satyanarayana VSV, 2008, ARKIVOC, P221; SCHONBERG A, 1954, J AM CHEM SOC, V76, P6208, DOI 10.1021/ja01652a112; Shankar KR, 2013, INT J BIOL PHARMACEU, V4, P862; Varma RS, 2002, TETRAHEDRON, V58, P1235, DOI 10.1016/S0040-4020(01)01216-9; VILLEMIN D, 1993, PHOSPHORUS SULFUR, V79, P33, DOI 10.1080/10426509308034395; Zahradnik M., 1992, PRODUCTION APPLICATI	29	27	30	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132175	10.1371/journal.pone.0132175	http://dx.doi.org/10.1371/journal.pone.0132175			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147722	Green Published, gold, Green Submitted			2022-12-26	WOS:000358157600212
J	Leung, EY; Askarian-Amiri, M; Finlay, GJ; Rewcastle, GW; Baguley, BC				Leung, Euphemia Y.; Askarian-Amiri, Marjan; Finlay, Graeme J.; Rewcastle, Gordon W.; Baguley, Bruce C.			Potentiation of Growth Inhibitory Responses of the mTOR Inhibitor Everolimus by Dual mTORC1/2 Inhibitors in Cultured Breast Cancer Cell Lines	PLOS ONE			English	Article							ADVANCED SOLID TUMORS; VIVO ANTITUMOR-ACTIVITY; MAMMALIAN TARGET; IN-VIVO; RAPAMYCIN INHIBITOR; PATHWAY INHIBITORS; KINASE INHIBITOR; AKT; SENSITIVITY; NVP-BEZ235	The mammalian target of rapamycin (mTOR), a vital component of signaling pathways involving PI3K/AKT, is an attractive therapeutic target in breast cancer. Everolimus, an allosteric mTOR inhibitor that inhibits the mTOR functional complex mTORC1, is approved for treatment of estrogen receptor positive (ER+) breast cancer. Other mTOR inhibitors show interesting differences in target specificities: BEZ235 and GSK2126458 are ATP competitive mTOR inhibitors targeting both PI3K and mTORC1/2; AZD8055, AZD2014 and KU-0063794 are ATP competitive mTOR inhibitors targeting both mTORC1 and mTORC2; and GDC-0941 is a pan-PI3K inhibitor. We have addressed the question of whether mTOR inhibitors may be more effective in combination than singly in inhibiting the proliferation of breast cancer cells. We selected a panel of 30 human breast cancer cell lines that included ER and PR positive, HER2 over-expressing, and "triple negative" variants, and determined whether signaling pathway utilization was related to drug-induced inhibition of proliferation. A significant correlation (p = 0.005) was found between everolimus IC50 values and p70S6K phosphorylation, but not with AKT or ERK phosphorylation, consistent with the mTOR pathway being a principal target. We then carried out combination studies with four everolimus resistant triple-negative breast cancer cell lines, and found an unexpectedly high degree of synergy between everolimus and the other inhibitors tested. The level of potentiation of everolimus inhibitory activity (measured by IC50 values) was found to be cell line-specific for all the kinase inhibitors tested. The results suggest that judicious combination of mTOR inhibitors with different modes of action could have beneficial effects in the treatment of breast cancer.	[Leung, Euphemia Y.; Askarian-Amiri, Marjan; Finlay, Graeme J.; Rewcastle, Gordon W.; Baguley, Bruce C.] Univ Auckland, Auckland Canc Soc Res Ctr, Auckland 1, New Zealand; [Leung, Euphemia Y.; Askarian-Amiri, Marjan; Finlay, Graeme J.] Univ Auckland, Dept Mol Med & Pathol, Auckland 1, New Zealand	University of Auckland; University of Auckland	Leung, EY (corresponding author), Univ Auckland, Auckland Canc Soc Res Ctr, Auckland 1, New Zealand.	e.leung@auckland.ac.nz; b.baguley@auckland.ac.nz	Askarian-Amiri, Marjan E./F-7910-2010	Askarian-Amiri, Marjan E./0000-0003-3524-9626	New Zealand Breast Cancer Foundation; Robert McClelland Trust; Auckland Cancer Society Research Centre	New Zealand Breast Cancer Foundation; Robert McClelland Trust; Auckland Cancer Society Research Centre	Funding for this work was obtained from the New Zealand Breast Cancer Foundation (http://www.nzbcf.org.nz/), and the Robert McClelland Trust (administered by http://www.cancernz.org.nz). This work is also supported by Auckland Cancer Society Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barlund M, 2000, CANCER RES, V60, P5340; Baselga J, 2012, NEW ENGL J MED, V366, P520, DOI 10.1056/NEJMoa1109653; Baselga J, 2011, ONCOLOGIST, V16, P12, DOI 10.1634/theoncologist.2011-S1-12; Beaver JA, 2012, FUTURE ONCOL, V8, P651, DOI [10.2217/fon.12.49, 10.2217/FON.12.49]; BERENBAUM MC, 1981, ADV CANCER RES, V35, P269, DOI 10.1016/S0065-230X(08)60912-4; Breuleux M, 2009, MOL CANCER THER, V8, P742, DOI 10.1158/1535-7163.MCT-08-0668; Chappell WH, 2011, ONCOTARGET, V2, P135, DOI 10.18632/oncotarget.240; Chresta CM, 2010, CANCER RES, V70, P288, DOI 10.1158/0008-5472.CAN-09-1751; Crowder RJ, 2005, BREAST CANCER RES, V7, P212, DOI 10.1186/bcr1307; Garcia-Echeverria C., 2006, PCT International Application, Patent No. [WO 2006122806 A2, 2006122806]; Garcia-Martinez JM, 2009, BIOCHEM J, V421, P29, DOI 10.1042/BJ20090489; Gonzalez-Angulo AM, 2013, CANCER TREAT REV, V39, P313, DOI 10.1016/j.ctrv.2012.11.002; Huo YL, 2011, BIOCHEM SOC T, V39, P446, DOI 10.1042/BST0390446; Janku F, 2013, CANCER RES, V73, P276, DOI 10.1158/0008-5472.CAN-12-1726; Kirstein MM, 2013, LIVER INT, V33, P780, DOI 10.1111/liv.12126; Knight SD, 2010, ACS MED CHEM LETT, V1, P39, DOI 10.1021/ml900028r; Kuntzer J, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-43; Leung E, 2013, MTOR SIGNALING ENDOC; Leung E, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/836769; Leung E, 2012, INVEST NEW DRUG, V30, P2103, DOI 10.1007/s10637-011-9768-4; Leung E, 2011, CANCER BIOL THER, V11, P938, DOI 10.4161/cbt.11.11.15527; Leung E, 2010, CANCER BIOL THER, V9, P717, DOI 10.4161/cbt.9.9.11432; Leung EY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105792; Leung EY, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00221; Maira SM, 2008, MOL CANCER THER, V7, P1851, DOI 10.1158/1535-7163.MCT-08-0017; Massarweh S, 2014, BREAST CANCER RES TR, V143, P325, DOI 10.1007/s10549-013-2810-9; Naing A, 2012, BRIT J CANCER, V107, P1093, DOI 10.1038/bjc.2012.368; Nyfeler B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048548; O'Brien C, 2010, CLIN CANCER RES, V16, P3670, DOI 10.1158/1078-0432.CCR-09-2828; O'Brien NA, 2014, CLIN CANCER RES, V20, P3507, DOI 10.1158/1078-0432.CCR-13-2769; O'Donnell A, 2008, J CLIN ONCOL, V26, P1588, DOI 10.1200/JCO.2007.14.0988; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Pike KG, 2015, J MED CHEM, V58, P2326, DOI 10.1021/jm501778s; Pike KG, 2013, BIOORG MED CHEM LETT, V23, P1212, DOI 10.1016/j.bmcl.2013.01.019; Rodrik-Outmezguine VS, 2011, CANCER DISCOV, V1, P248, DOI 10.1158/2159-8290.CD-11-0085; Rosen N, 2006, CANCER CELL, V10, P254, DOI 10.1016/j.ccr.2006.10.001; Serra V, 2008, CANCER RES, V68, P8022, DOI 10.1158/0008-5472.CAN-08-1385; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Soares HP, 2015, MOL CANCER THER, V14, P1014, DOI 10.1158/1535-7163.MCT-14-0669; Stowasser F., 2008, PCT Int. Appl., Patent No. [WO 2008064093 A2 20080529, 2008064093]; Tabernero J, 2008, J CLIN ONCOL, V26, P1603, DOI 10.1200/JCO.2007.14.5482; Thomas HE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003923; Wallin JJ, 2012, CLIN CANCER RES, V18, P3901, DOI 10.1158/1078-0432.CCR-11-2088; WHITEHEAD RH, 1983, J NATL CANCER I, V71, P1193; Zhang JM, 2010, NATURE, V463, P501, DOI 10.1038/nature08675	45	31	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131400	10.1371/journal.pone.0131400	http://dx.doi.org/10.1371/journal.pone.0131400			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148118	gold, Green Published, Green Submitted			2022-12-26	WOS:000358157600094
J	Tinnesand, HV; Buesching, CD; Noonan, MJ; Newman, C; Zedrosser, A; Rosell, F; Macdonald, DW				Tinnesand, Helga V.; Buesching, Christina D.; Noonan, Michael J.; Newman, Chris; Zedrosser, Andreas; Rosell, Frank; Macdonald, David W.			Will Trespassers Be Prosecuted or Assessed According to Their Merits? A Consilient Interpretation of Territoriality in a Group-Living Carnivore, the European Badger (Meles meles)	PLOS ONE			English	Article							RESOURCE DISPERSION HYPOTHESIS; SCENT-MARKING BEHAVIOR; EXTRA-GROUP PATERNITY; EURASIAN BADGER; INDIVIDUAL RECOGNITION; NASTY NEIGHBORS; DEAR ENEMIES; INFORMATION; POPULATION; MOVEMENT	Socio-spatial interactions of Carnivores have traditionally been described using the vocabulary of territoriality and aggression, with scent marks interpreted as 'scent fences'. Here, we investigate the role of olfactory signals in assumed territorial marking of group-living solitary foragers using European badgers Meles meles as a model. We presented anal gland secretions (n = 351) from known individuals to identifiable recipients (n = 187), to assess response-variation according to familiarity (own-group, neighbours, strangers) and spatial context (in-context: at a shared border; out-of-context: at an unshared border/the main sett). Sniffing and over-marking (with subcaudal gland secretion) responses were strongest to anal gland secretions from strangers, intermediate to neighbouring-group and weakest to own-group members. Secretions from both, strangers and neighbours, were sniffed for longer than were own-group samples, although neighbour-secretion presented out-of-context evoked no greater interest than in-context. On an individual level, responses were further moderated by the relevance of individual-specific donor information encoded in the secretion, as it related to the physiological state of the responder. There was a trend bordering on significance for males to sniff for longer than did females, but without sex-related differences in the frequency of subcaudal over-marking responses, and males over-marked oestrous female secretions more than non-oestrous females. There were no age-class related differences in sniff-duration or in over-marking. Evaluating these results in the context of the Familiarity hypothesis, the Threat-level hypothesis, and the Individual advertisement hypothesis evidences that interpretations of territorial scent-marks depicting rigid and potentially agonistic discrimination between own-and foreign-group conspecifics are overly simplistic. We use our findings to advance conceptual understanding of badger socio-spatial ecology, and the general context of territoriality and group-range dynamics.	[Tinnesand, Helga V.; Zedrosser, Andreas; Rosell, Frank] Telemark Univ Coll, Fac Arts & Sci, Dept Environm & Hlth Studies, N-3800 Bo I Telemark, Norway; [Buesching, Christina D.; Noonan, Michael J.; Newman, Chris; Macdonald, David W.] Univ Oxford, Dept Zool, Wildlife Conservat Res Unit, Recanati Kaplan Ctr, Abingdon OX13 5QL, Oxon, England; [Zedrosser, Andreas] Univ Nat Resources & Life Sci, Inst Wildlife Biol & Game Management, Dept Integrat Biol, A-1180 Vienna, Austria	University College of Southeast Norway; University of Oxford; University of Natural Resources & Life Sciences, Vienna	Buesching, CD (corresponding author), Univ Oxford, Dept Zool, Wildlife Conservat Res Unit, Recanati Kaplan Ctr, Tubney House,Abingdon Rd, Abingdon OX13 5QL, Oxon, England.	christina.buesching@zoo.ox.ac.uk	Noonan, Michael J/H-9613-2019		People's Trust for Endangered Species; Rhodes Scholarship for DPhil students	People's Trust for Endangered Species; Rhodes Scholarship for DPhil students	The People's Trust for Endangered Species provided core funding for the long-term badger population study (grant). MN was supported by a Rhodes Scholarship for DPhil students. None of the funders had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annavi G, 2014, J EVOLUTION BIOL, V27, P2191, DOI 10.1111/jeb.12473; Annavi G, 2012, THESIS U OXFORD OXFO; Apps PJ, 2013, NATURWISSENSCHAFTEN, V100, P487, DOI 10.1007/s00114-013-1054-1; Bates D.M., 2010, LME4 MIXED EFFECTS M; BOSSERT WH, 1968, J THEOR BIOL, V18, P157, DOI 10.1016/0022-5193(68)90158-6; BRINCK C, 1983, J CHEM ECOL, V9, P727, DOI 10.1007/BF00988779; Buesching C. D., SMALL CARNIVORES SPA; Buesching CD, 2004, ACTA THERIOL, V49, P235, DOI 10.1007/BF03192523; Buesching CD, 2001, CHEM SIGNAL, V9, P321; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; Byrne AW, 2014, J ANIM ECOL, V83, P991, DOI 10.1111/1365-2656.12197; Carazo P, 2008, ANIM BEHAV, V76, P1953, DOI 10.1016/j.anbehav.2008.08.018; Carpenter PJ, 2005, MOL ECOL, V14, P273, DOI 10.1111/j.1365-294X.2004.02401.x; Carter SP, 2007, P ROY SOC B-BIOL SCI, V274, P2769, DOI 10.1098/rspb.2007.0998; Christian SF, 1995, J ZOOL, V237, P668, DOI 10.1111/j.1469-7998.1995.tb05024.x; Clutton-Brock T, 2009, PHILOS T R SOC B, V364, P3229, DOI 10.1098/rstb.2009.0120; Dall SRX, 2005, TRENDS ECOL EVOL, V20, P187, DOI 10.1016/j.tree.2005.01.010; DAVIES JM, 1988, J ZOOL, V216, P455, DOI 10.1111/j.1469-7998.1988.tb02441.x; Delahay RJ, 2000, MAMMAL REV, V30, P73, DOI 10.1046/j.1365-2907.2000.00058.x; Dugdale HL, 2007, MOL ECOL, V16, P5294, DOI 10.1111/j.1365-294X.2007.03571.x; Fell RJ, 2006, BEHAVIOUR, V143, P683, DOI 10.1163/156853906777791315; Fisher J., 1954, P71; GALEF BG, 1983, ANIM BEHAV, V31, P748, DOI 10.1016/S0003-3472(83)80232-2; GOSLING LM, 1990, CHEM SIGNAL, V5, P315; Gosling LM, 1996, BEHAVIOUR, V133, P491, DOI 10.1163/156853996X00170; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; Hutchings MR, 2000, MAMMAL REV, V30, P157, DOI 10.1046/j.1365-2907.2000.00065.x; Johnson DDP, 2002, TRENDS ECOL EVOL, V17, P563, DOI 10.1016/S0169-5347(02)02619-8; Johnston RE, 2008, ADV STUD BEHAV, V38, P439, DOI 10.1016/S0065-3454(08)00009-0; Jordan NR, 2010, J ZOOL, V280, P72, DOI 10.1111/j.1469-7998.2009.00646.x; Kelly CD, 2008, BEHAV ECOL SOCIOBIOL, V62, P855, DOI 10.1007/s00265-007-0518-8; Kilshaw K, 2009, J MAMMAL, V90, P1188, DOI 10.1644/08-MAMM-A-200.1; Krause J, 2007, BEHAV ECOL SOCIOBIOL, V62, P15, DOI 10.1007/s00265-007-0445-8; KRUUK H, 1978, J ZOOL, V184, P1; Lewis MA, 2001, J THEOR BIOL, V210, P449, DOI 10.1006/jtbi.2001.2323; Lups P., 1993, HDB SAUGETIERE EUROP, V5, P856; Macdonald DW, 2015, J ZOOL, V295, P75, DOI 10.1111/jzo.12202; Macdonald DW, 2008, J MAMMAL, V89, P1077, DOI 10.1644/07-MAMM-A-185.1; Macdonald DW, 2009, J MAMMAL, V90, P1392, DOI 10.1644/08-MAMM-A-356R1.1; MACDONALD DW, 1983, NATURE, V301, P379, DOI 10.1038/301379a0; Macdonald DW, FARMING IN PRESS; MATSON PA, 1992, ECOLOGY, V73, P723, DOI 10.2307/1940151; Mayeaux DJ, 2002, ANIM BEHAV, V64, P269, DOI 10.1006/anbe.2002.3053; Muller CA, 2007, P ROY SOC B-BIOL SCI, V274, P959, DOI 10.1098/rspb.2006.0222; Noonan MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083156; OSTFELD RS, 1985, AM NAT, V126, P1, DOI 10.1086/284391; Palphramand KL, 2007, ANIM BEHAV, V74, P429, DOI 10.1016/j.anbehav.2006.10.026; Perkins SE, 2009, J ANIM ECOL, V78, P1015, DOI 10.1111/j.1365-2656.2009.01557.x; Potts JR, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0231; Powell RA, 2000, METH C CONS, P65; RICHARDSON PRK, 1993, T ROY SOC S AFR, V48, P195, DOI 10.1080/00359199309520270; ROPER TJ, 1986, BEHAVIOUR, V97, P94, DOI 10.1163/156853986X00333; ROPER TJ, 1993, BEHAVIOUR, V127, P289, DOI 10.1163/156853993X00074; Schradin C, 2004, BEHAV ECOL SOCIOBIOL, V55, P439, DOI 10.1007/s00265-003-0733-x; SCHUTTE JJE, 1991, COMMON MKT LAW REV, V28, P549; Schwarzenberger F, 1996, ANIM REPROD SCI, V42, P515, DOI 10.1016/0378-4320(96)01561-8; Sliwa A, 1998, ANIM BEHAV, V56, P137, DOI 10.1006/anbe.1998.0757; SMITH JM, 1976, ANIM BEHAV, V24, P159, DOI 10.1016/S0003-3472(76)80110-8; Stephens PA, 2005, J APPL ECOL, V42, P4, DOI 10.1111/j.1365-2664.2005.01002.x; Stewart PD, 1999, ANIM BEHAV, V57, P153, DOI 10.1006/anbe.1998.0935; Stewart PD, 1997, J THEOR BIOL, V184, P279, DOI 10.1006/jtbi.1996.0248; Stewart PD, 2003, ETHOLOGY, V109, P751, DOI 10.1046/j.1439-0310.2003.00910.x; Stewart PD, 2001, J ZOOL, V255, P191, DOI 10.1017/S0952836901001261; Stewart PD, 1997, J ZOOL, V241, P543, DOI 10.1111/j.1469-7998.1997.tb04846.x; Sun LX, 1998, ANIM BEHAV, V55, P1529, DOI 10.1006/anbe.1997.0709; TEMELES EJ, 1994, ANIM BEHAV, V47, P339, DOI 10.1006/anbe.1994.1047; WOODROFFE R, 1995, J ZOOL, V235, P237; YDENBERG RC, 1988, ANIM BEHAV, V36, P343, DOI 10.1016/S0003-3472(88)80004-6; Zhang JX, 2003, CHEM SENSES, V28, P381, DOI 10.1093/chemse/28.5.381	70	16	16	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132432	10.1371/journal.pone.0132432	http://dx.doi.org/10.1371/journal.pone.0132432			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147753	Green Published, Green Submitted, gold			2022-12-26	WOS:000358157600267
J	Schermerhorn, KM; Gardner, AF				Schermerhorn, Kelly M.; Gardner, Andrew F.			Pre-steady-state Kinetic Analysis of a Family D DNA Polymerase from Thermococcus sp 9 degrees N Reveals Mechanisms for Archaeal Genomic Replication and Maintenance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYROCOCCUS-HORIKOSHII; HYPERTHERMOPHILIC ARCHAEON; REVERSE-TRANSCRIPTASE; SUBUNIT INTERACTION; ESCHERICHIA-COLI; TERMINAL DOMAINS; B-SUBUNITS; I KLENOW; FIDELITY; RIBONUCLEOTIDES	Family D DNA polymerases (polDs) have been implicated as the major replicative polymerase in archaea, excluding the Crenarchaeota branch, and bear little sequence homology to other DNA polymerase families. Here we report a detailed kinetic analysis of nucleotide incorporation and exonuclease activity for a Family D DNA polymerase from Thermococcus sp. 9 degrees N. Pre-steady-state single-turnover nucleotide incorporation assays were performed to obtain the kinetic parameters, k(pol) and K-d, for correct nucleotide incorporation, incorrect nucleotide incorporation, and ribonucleotide incorporation by exonuclease-deficient polD. Correct nucleotide incorporation kinetics revealed a relatively slow maximal rate of polymerization (k(pol) similar to 2.5 s(-1)) and especially tight nucleotide binding (K-d(dNTP) similar to 1.7 mu M), compared with DNA polymerases from Families A, B, C, X, and Y. Furthermore, pre-steady-state nucleotide incorporation assays revealed that polD prevents the incorporation of incorrect nucleotides and ribonucleotides primarily through reduced nucleotide binding affinity. Pre-steady-state single-turnover assays on wild-type 9 degrees N polD were used to examine 3'-5' exonuclease hydrolysis activity in the presence of Mg2+ and Mn2+. Interestingly, substituting Mn2+ for Mg2+ accelerated hydrolysis rates > 40-fold (k(exo) >= 110 s(-1) versus >= 2.5 s(-1)). Preference for Mn2+ over Mg2+ in exonuclease hydrolysis activity is a property unique to the polD family. The kinetic assays performed in this work provide critical insight into the mechanisms that polD employs to accurately and efficiently replicate the archaeal genome. Furthermore, despite the unique properties of polD, this work suggests that a conserved polymerase kinetic pathway is present in all known DNA polymerase families.	[Schermerhorn, Kelly M.; Gardner, Andrew F.] New England Biolabs Inc, Ipswich, MA 01938 USA	New England Biolabs	Gardner, AF (corresponding author), New England Biolabs Inc, 240 Cty Rd, Ipswich, MA 01938 USA.	gardner@neb.com			New England Biolabs, Inc.	New England Biolabs, Inc.	This work was supported by New England Biolabs, Inc. The authors declare that they have no conflicts of interest with the contents of this article.	Ahn JW, 1998, BIOCHEM J, V331, P79, DOI 10.1042/bj3310079; Ali SF, 2011, J BIOSCI BIOENG, V112, P118, DOI 10.1016/j.jbiosc.2011.03.018; Aravind L, 1998, NUCLEIC ACIDS RES, V26, P3746, DOI 10.1093/nar/26.16.3746; Astatke M, 1998, P NATL ACAD SCI USA, V95, P3402, DOI 10.1073/pnas.95.7.3402; Bonnin A, 1999, J MOL BIOL, V290, P241, DOI 10.1006/jmbi.1999.2900; Brandis JW, 1996, BIOCHEMISTRY-US, V35, P2189, DOI 10.1021/bi951682j; Brown JA, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/871939; Brown JA, 2011, BIOCHEMISTRY-US, V50, P1135, DOI 10.1021/bi101915z; Brown JA, 2010, J MOL BIOL, V395, P282, DOI 10.1016/j.jmb.2009.11.003; Cann IKO, 1998, P NATL ACAD SCI USA, V95, P14250, DOI 10.1073/pnas.95.24.14250; CAPSON TL, 1992, BIOCHEMISTRY-US, V31, P10984, DOI 10.1021/bi00160a007; Cases-Gonzalez CE, 2000, J BIOL CHEM, V275, P19759, DOI 10.1074/jbc.M910361199; Cavanaugh NA, 2011, J BIOL CHEM, V286, P31650, DOI 10.1074/jbc.M111.253401; Cubonova L, 2013, J BACTERIOL, V195, P2322, DOI 10.1128/JB.02037-12; DeLucia AM, 2003, NUCLEIC ACIDS RES, V31, P4129, DOI 10.1093/nar/gkg417; DeLucia AM, 2006, J BIOL CHEM, V281, P27286, DOI 10.1074/jbc.M604393200; Dieckman LM, 2010, BIOCHEMISTRY-US, V49, P7344, DOI 10.1021/bi100556m; Fiala KA, 2004, BIOCHEMISTRY-US, V43, P2106, DOI 10.1021/bi0357457; Furge LL, 1998, BIOCHEMISTRY-US, V37, P3567, DOI 10.1021/bi9722094; Greenough L, 2015, J BIOL CHEM, V290, P12514, DOI 10.1074/jbc.M115.638130; Greenough L, 2014, EXTREMOPHILES, V18, P653, DOI 10.1007/s00792-014-0646-9; Gueguen Y, 2001, EUR J BIOCHEM, V268, P5961, DOI 10.1046/j.0014-2956.2001.02550.x; Hopfner KP, 2001, CELL, V105, P473, DOI 10.1016/S0092-8674(01)00335-X; Ishino Y, 1998, J BACTERIOL, V180, P2232, DOI 10.1128/JB.180.8.2232-2236.1998; ITO J, 1991, NUCLEIC ACIDS RES, V19, P4045, DOI 10.1093/nar/19.15.4045; JOHNSON KA, 1995, METHOD ENZYMOL, V249, P38; Johnson KA, 2010, BBA-PROTEINS PROTEOM, V1804, P1041, DOI 10.1016/j.bbapap.2010.01.006; Jokela M, 2005, PROTEIN EXPRES PURIF, V43, P73, DOI 10.1016/j.pep.2005.05.002; Jokela M, 2004, NUCLEIC ACIDS RES, V32, P2430, DOI 10.1093/nar/gkh558; Joyce CM, 2004, BIOCHEMISTRY-US, V43, P14317, DOI 10.1021/bi048422z; Joyce CM, 1997, P NATL ACAD SCI USA, V94, P1619, DOI 10.1073/pnas.94.5.1619; Kuba Y, 2012, GENES CELLS, V17, P923, DOI 10.1111/gtc.12007; KUCHTA RD, 1987, BIOCHEMISTRY-US, V26, P8410, DOI 10.1021/bi00399a057; Lahiri I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063489; LEHMAN IR, 1958, J BIOL CHEM, V233, P163; Li Z, 2011, NUCLEIC ACIDS RES, V39, P6114, DOI 10.1093/nar/gkr181; Li Z, 2010, MBIO, V1, DOI 10.1128/mBio.00221-10; Makiniemi M, 1999, TRENDS BIOCHEM SCI, V24, P14, DOI 10.1016/S0968-0004(98)01327-9; Miller H, 1996, BIOCHEMISTRY-US, V35, P12919, DOI 10.1021/bi960326d; Motz M, 2002, J BIOL CHEM, V277, P16179, DOI 10.1074/jbc.M107793200; PATEL SS, 1991, BIOCHEMISTRY-US, V30, P511, DOI 10.1021/bi00216a029; Reha-Krantz LJ, 2010, BBA-PROTEINS PROTEOM, V1804, P1049, DOI 10.1016/j.bbapap.2009.06.012; Rothwell PJ, 2005, ADV PROTEIN CHEM, V71, P401, DOI 10.1016/S0065-3233(04)71011-6; Shen Y, 2004, BIOCHEM SOC T, V32, P245, DOI 10.1042/BST0320245; Shen YL, 2004, NUCLEIC ACIDS RES, V32, P158, DOI 10.1093/nar/gkh153; Shen YL, 2003, J BIOL CHEM, V278, P21247, DOI 10.1074/jbc.M212286200; Steitz TA, 1999, J BIOL CHEM, V274, P17395, DOI 10.1074/jbc.274.25.17395; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Uemori T, 1997, GENES CELLS, V2, P499, DOI 10.1046/j.1365-2443.1997.1380336.x; Wang WN, 2012, J BIOL CHEM, V287, P28215, DOI 10.1074/jbc.M112.366609; Wohrl BM, 1997, J BIOL CHEM, V272, P17581, DOI 10.1074/jbc.272.28.17581; Yang GW, 2005, BIOCHEMISTRY-US, V44, P3338, DOI 10.1021/bi047921x; Yang GW, 2002, BIOCHEMISTRY-US, V41, P10256, DOI 10.1021/bi0202171; Yang GW, 2002, BIOCHEMISTRY-US, V41, P2526, DOI 10.1021/bi0119924; Zahurancik WJ, 2013, BIOCHEMISTRY-US, V52, P7041, DOI 10.1021/bi400803v	55	18	19	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 4	2015	290	36					21800	21810		10.1074/jbc.M115.662841	http://dx.doi.org/10.1074/jbc.M115.662841			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ9XI	26160179	hybrid, Green Published			2022-12-26	WOS:000360968500003
J	Cao, CZ; Zhao, JJ; Doughty, EK; Migliorini, M; Strickland, DK; Kann, MG; Zhang, L				Cao, Chunzhang; Zhao, Juanjuan; Doughty, Emily K.; Migliorini, Mary; Strickland, Dudley K.; Kann, Maricel G.; Zhang, Li			Mac-1 Regulates IL-13 Activity in Macrophages by Directly Interacting with IL-13R alpha 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bioinformatics; cell signaling; cytokine; integrin; macrophage	FOAM-CELL-FORMATION; MULTIPLE SEQUENCE ALIGNMENT; ALPHA(M)BETA(2) INTEGRIN; PROTEIN INTERACTIONS; HUMAN MONOCYTES; ATHEROSCLEROSIS; RECEPTOR; MICE; ACTIVATION; BINDING	Background: Mac-1 strongly suppresses IL-13-induced JAK/STAT activation in macrophages, but the mechanism is unknown. Results: Our data demonstrate that Mac-1 interacts with the IL-13R1 subunit of IL-13R and thereby suppresses IL-13 signaling. Conclusion: Mac-1 regulates macrophage to foam cell transformation by binding to IL-13R1. Significance: This study identifies a novel interaction and provides a potential mechanism by which Mac-1 safeguards macrophages from foam cell differentiation. Mac-1 exhibits a unique inhibitory activity toward IL-13-induced JAK/STAT activation and thereby regulates macrophage to foam cell transformation. However, the underlying molecular mechanism is unknown. In this study, we report the identification of IL-13R1, a component of the IL-13 receptor (IL-13R), as a novel ligand of integrin Mac-1, using a co-evolution-based algorithm. Biochemical analyses demonstrated that recombinant IL-13R1 binds Mac-1 in a purified system and supports Mac-1-mediated cell adhesion. Co-immunoprecipitation experiments revealed that endogenous Mac-1 forms a complex with IL-13R1 in solution, and confocal fluorescence microscopy demonstrated that these two receptors co-localize with each other on the surface of macrophages. Moreover, we found that genetic inactivation of Mac-1 promotes IL-13-induced JAK/STAT activation in macrophages, resulting in enhanced polarization along the alternative activation pathway. Importantly, we observed that Mac-1(-/-) macrophages exhibit increased expression of foam cell differentiation markers including 15-lipoxygenase and lectin-type oxidized LDL receptor-1 both in vitro and in vivo. Indeed, we found that Mac-1(-/-)LDLR(-/-) mice develop significantly more foam cells than control LDLR-/- mice, using an in vivo model of foam cell formation. Together, our data establish for the first time a molecular mechanism by which Mac-1 regulates the signaling activity of IL-13 in macrophages. This newly identified IL-13R1/Mac-1-dependent pathway may offer novel targets for therapeutic intervention in the future.	[Cao, Chunzhang; Zhao, Juanjuan; Zhang, Li] Univ Maryland, Dept Physiol, Ctr Vasc & Inflammatory Dis, Sch Med, Baltimore, MD 21201 USA; [Migliorini, Mary; Strickland, Dudley K.] Univ Maryland, Dept Surg, Ctr Vasc & Inflammatory Dis, Sch Med, Baltimore, MD 21201 USA; [Doughty, Emily K.; Kann, Maricel G.] Univ Maryland, Dept Biol Sci, Baltimore, MD 21250 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Zhang, L (corresponding author), Univ Maryland, Dept Physiol, Ctr Vasc & Inflammatory Dis, Sch Med, 800 W Baltimore St, Baltimore, MD 21201 USA.	lizhang@som.umaryland.edu	Regan, Clinton/E-6250-2012		National Institute of Health [NHLBI HL054710, NINDS NS082607]; National Institutes of Health [K22CA143148]; American Heart Association [14GRNT20510058]; NATIONAL CANCER INSTITUTE [K22CA143148] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL120388, P01HL054710] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS082607] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institute of Health Grants NHLBI HL054710 and NINDS NS082607 (to L. Z.); National Institutes of Health K22CA143148 (to M. G. K.) and American Heart Association Grant 14GRNT20510058 (to L. Z.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams RA, 2007, J EXP MED, V204, P571, DOI 10.1084/jem.20061931; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Behrens EM, 2007, J IMMUNOL, V178, P6268, DOI 10.4049/jimmunol.178.10.6268; Cao CZ, 2006, EMBO J, V25, P1860, DOI 10.1038/sj.emboj.7601082; Cao CZ, 2010, J CLIN INVEST, V120, P1971, DOI 10.1172/JCI40380; Cyrus T, 1999, J CLIN INVEST, V103, P1597, DOI 10.1172/JCI5897; Dandekar T, 1998, TRENDS BIOCHEM SCI, V23, P324, DOI 10.1016/S0968-0004(98)01274-2; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Ehirchiou D, 2005, J BIOL CHEM, V280, P8324, DOI 10.1074/jbc.M413525200; Ehirchiou D, 2007, J EXP MED, V204, P1519, DOI 10.1084/jem.20062292; Enright AJ, 1999, NATURE, V402, P86, DOI 10.1038/47056; Febbraio M, 2000, J CLIN INVEST, V105, P1049, DOI 10.1172/JCI9259; Flick MJ, 2007, J CLIN INVEST, V117, P3224, DOI 10.1172/JCI30134; Folcik VA, 1997, ARTERIOSCL THROM VAS, V17, P1954, DOI 10.1161/01.ATV.17.10.1954; Gertz J, 2003, BIOINFORMATICS, V19, P2039, DOI 10.1093/bioinformatics/btg278; Goh CS, 2000, J MOL BIOL, V299, P283, DOI 10.1006/jmbi.2000.3732; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Hammerberg C, 1998, J EXP MED, V187, P1133, DOI 10.1084/jem.187.7.1133; Han CF, 2010, NAT IMMUNOL, V11, P734, DOI 10.1038/ni.1908; Kann MG, 2009, J MOL BIOL, V385, P91, DOI 10.1016/j.jmb.2008.09.078; Khallou-Laschet J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008852; LaPorte SL, 2008, CELL, V132, P259, DOI 10.1016/j.cell.2007.12.030; Ley K, 2011, ARTERIOSCL THROM VAS, V31, P1506, DOI 10.1161/ATVBAHA.110.221127; Li AC, 2004, J CLIN INVEST, V114, P1564, DOI 10.1172/JCI200418730; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Lovell SC, 2010, MOL BIOL EVOL, V27, P2567, DOI 10.1093/molbev/msq144; Maglott D, 2011, NUCLEIC ACIDS RES, V39, pD52, DOI 10.1093/nar/gkq1237; Maiguel D, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001811; Mehta JL, 2007, CIRC RES, V100, P1634, DOI 10.1161/CIRCRESAHA.107.149724; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Oh J, 2012, J BIOL CHEM, V287, P11629, DOI 10.1074/jbc.M111.338673; Overbeek R, 1999, In Silico Biol, V1, P93; Pazos F, 2005, J MOL BIOL, V352, P1002, DOI 10.1016/j.jmb.2005.07.005; Pazos F, 1997, J MOL BIOL, V271, P511, DOI 10.1006/jmbi.1997.1198; Pazos F, 2001, PROTEIN ENG, V14, P609, DOI 10.1093/protein/14.9.609; Pazos F, 2008, EMBO J, V27, P2648, DOI 10.1038/emboj.2008.189; Roy B, 2002, J LEUKOCYTE BIOL, V72, P580; Sato T, 2005, BIOINFORMATICS, V21, P3482, DOI 10.1093/bioinformatics/bti564; Sohn JH, 2003, NAT MED, V9, P206, DOI 10.1038/nm814; STARY HC, 1994, CIRCULATION, V89, P2462, DOI 10.1161/01.CIR.89.5.2462; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; van Tits LJH, 2011, ATHEROSCLEROSIS, V214, P345, DOI 10.1016/j.atherosclerosis.2010.11.018; Varga G, 2007, BLOOD, V109, P661, DOI 10.1182/blood-2005-12-023044; Wolf D, 2011, CIRC RES, V109, P1269, DOI 10.1161/CIRCRESAHA.111.247684; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Xiong YM, 2003, J IMMUNOL, V171, P1042, DOI 10.4049/jimmunol.171.2.1042; Yakubenko VP, 2013, J BIOL CHEM, V288, P2778, DOI 10.1074/jbc.M112.381343; Yakubenko VP, 2011, CIRC RES, V108, P544, DOI 10.1161/CIRCRESAHA.110.231803; Zhang L, 1997, J BIOL CHEM, V272, P17558, DOI 10.1074/jbc.272.28.17558; Zhang L, 1996, J BIOL CHEM, V271, P18211, DOI 10.1074/jbc.271.30.18211	50	7	7	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 28	2015	290	35					21642	21651		10.1074/jbc.M115.645796	http://dx.doi.org/10.1074/jbc.M115.645796			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CQ5IS	26160172	Green Published, hybrid			2022-12-26	WOS:000360637600036
J	Kramlinger, VM; Rojas, MA; Kanamori, T; Guengerich, FP				Kramlinger, Valerie M.; Rojas, Monica Alvarado; Kanamori, Tatsuyuki; Guengerich, F. Peter			Cytochrome P450 3A Enzymes Catalyze the O-6-Demethylation of Thebaine, a Key Step in Endogenous Mammalian Morphine Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PSEUDOMONAS-PUTIDA M10; IN-VITRO; OPIUM POPPY; KETOGLUTARATE DIOXYGENASE; O-DEMETHYLATION; DRUG OXIDATION; RAT-LIVER; CODEINE; BRAIN; REDUCTASE	Morphine, first characterized in opium from the poppy Papaver somniferum, is one of the strongest known analgesics. Endogenous morphine has been identified in several mammalian cells and tissues. The synthetic pathway of morphine in the opium poppy has been elucidated. The presence of common intermediates in plants and mammals suggests that biosynthesis occurs through similar pathways (beginning with the amino acid L-tyrosine), and the pathway has been completely delineated in plants. Some of the enzymes in the mammalian pathway have been identified and characterized. Two of the latter steps in the morphine biosynthesis pathway are demethylation of thebaine at the O-3- and the O-6-positions, the latter of which has been difficult to demonstrate. The plant enzymes responsible for both the O-3-demethylation and the O-6-demethylation are members of the Fe-II/alpha-ketoglutarate-dependent dioxygenase family. Previous studies showed that human cytochrome P450 (P450) 2D6 can catalyze thebaine O-3-demethylation. We report that demethylation of thebaine at the O-6-position is selectively catalyzed by human P450s 3A4 and 3A5, with the latter being more efficient, and rat P450 3A2. Our results do not support O-6-demethylation of thebaine by an Fe-II/alpha-ketoglutarate-dependent dioxygenase. In rat brain microsomes, O-6-demethylation was inhibited by ketoconazole, but not sulfaphenazole, suggesting that P450 3A enzymes are responsible for this activity in the brain. An alternate pathway to morphine, oripavine O-6-demethylation, was not detected. The major enzymatic steps in mammalian morphine synthesis have now been identified.	[Kramlinger, Valerie M.; Rojas, Monica Alvarado; Kanamori, Tatsuyuki; Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA	Vanderbilt University	Guengerich, FP (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, 638B Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA.	f.guengerich@vanderbilt.edu			National Institute of Health [R37 CA090426, T32 E5007028]; NATIONAL CANCER INSTITUTE [R37CA090426] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in whole or part by National Institute of Health Grants R37 CA090426 (to F. P. G.) and T32 E5007028 (to V. M. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Agrawal V, 2008, PHARMACOGENET GENOM, V18, P569, DOI 10.1097/FPC.0b013e32830054ac; Barna T, 2002, J BIOL CHEM, V277, P30976, DOI 10.1074/jbc.M202846200; Boettcher C, 2005, P NATL ACAD SCI USA, V102, P8495, DOI 10.1073/pnas.0503244102; Bu HZ, 2001, EUR J PHARM SCI, V12, P447, DOI 10.1016/S0928-0987(00)00190-1; BURLEIGH BD, 1969, ANAL BIOCHEM, V27, P536, DOI 10.1016/0003-2697(69)90067-0; CARDINALE GJ, 1987, LIFE SCI, V40, P301, DOI 10.1016/0024-3205(87)90347-X; Charron G, 2011, BRAIN, V134, P2321, DOI 10.1093/brain/awr166; Correia M.A., 2005, CYTOCHROME P450 STRU, V3rd ed., P247, DOI DOI 10.1007/0-387-27447-2_7; Cousins DA, 2009, BIPOLAR DISORD, V11, P787, DOI 10.1111/j.1399-5618.2009.00760.x; Craig DH, 1998, BIOCHEMISTRY-US, V37, P7598, DOI 10.1021/bi980345i; Daly AK, 2006, CLIN PHARMACOKINET, V45, P13, DOI 10.2165/00003088-200645010-00002; Daly Ann K, 2006, Methods Mol Biol, V320, P193; DAYER P, 1988, BIOCHEM BIOPH RES CO, V152, P411, DOI 10.1016/S0006-291X(88)80729-0; DONNERER J, 1986, P NATL ACAD SCI USA, V83, P4566, DOI 10.1073/pnas.83.12.4566; DONNERER J, 1987, J PHARMACOL EXP THER, V242, P583; Farrow SC, 2013, J BIOL CHEM, V288, P28997, DOI 10.1074/jbc.M113.488585; FINDLAY JWA, 1978, CLIN PHARMACOL THER, V24, P60; FOWLER CJ, 1994, NEUROCHEM INT, V24, P401, DOI 10.1016/0197-0186(94)90089-2; FRENCH CE, 1994, BIOCHEM J, V301, P97, DOI 10.1042/bj3010097; Fricchione G, 2008, MED SCI MONITOR, V14, pCS45; FUKUMORI F, 1993, J BIOL CHEM, V268, P24311; FUKUMORI F, 1993, J BACTERIOL, V175, P2083, DOI 10.1128/JB.175.7.2083-2086.1993; Glattard E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008791; GOLDSTEIN A, 1985, P NATL ACAD SCI USA, V82, P5203, DOI 10.1073/pnas.82.15.5203; Goldstein S, 1999, ACCOUNTS CHEM RES, V32, P547, DOI 10.1021/ar9800789; Grobe N, 2011, ARCH BIOCHEM BIOPHYS, V506, P42, DOI 10.1016/j.abb.2010.11.010; Grobe N, 2010, P NATL ACAD SCI USA, V107, P8147, DOI 10.1073/pnas.1003423107; Grobe N, 2009, J BIOL CHEM, V284, P24425, DOI 10.1074/jbc.M109.011320; Guengerich FP, 2014, HAYES' PRINCIPLES AND METHODS OF TOXICOLOGY, 6TH EDITION, P1905; GUENGERICH FP, 1979, MOL PHARMACOL, V15, P154; Guengerich FP, 2001, CHEM RES TOXICOL, V14, P611, DOI 10.1021/tx0002583; Guengerich FP, 2004, BIOCHEMISTRY-US, V43, P10775, DOI 10.1021/bi0491393; GUENGERICH FP, 1983, BIOCHEMISTRY-US, V22, P2811, DOI 10.1021/bi00281a007; Hagel JM, 2010, NAT CHEM BIOL, V6, P273, DOI [10.1038/NCHEMBIO.317, 10.1038/nchembio.317]; Hausinger RP, 2015, 2-OXOGLUTARATE-DEPENDENT OXYGENASES, P1, DOI 10.1039/9781782621959; Hausinger RP, 2004, CRIT REV BIOCHEM MOL, V39, P21, DOI 10.1080/10409230490440541; Hiroi T, 1998, BIOCHEM BIOPH RES CO, V249, P838, DOI 10.1006/bbrc.1998.9232; Kakhlon O, 2002, FREE RADICAL BIO MED, V33, P1037, DOI 10.1016/S0891-5849(02)01006-7; KIRBY GW, 1967, SCIENCE, V155, P170, DOI 10.1126/science.155.3759.170; Knauer SH, 2012, FEBS J, V279, P816, DOI 10.1111/j.1742-4658.2012.08473.x; Kobayashi K, 2003, DRUG METAB DISPOS, V31, P833, DOI 10.1124/dmd.31.7.833; KODAIRA H, 1989, P NATL ACAD SCI USA, V86, P716, DOI 10.1073/pnas.86.2.716; KODAIRA H, 1988, P NATL ACAD SCI USA, V85, P1267, DOI 10.1073/pnas.85.4.1267; Kok GB, 2011, ORG BIOMOL CHEM, V9, P1008, DOI 10.1039/c0ob01021a; Kuehl P, 2001, NAT GENET, V27, P383, DOI 10.1038/86882; KUTCHAN TM, 1998, ALKALOIDS, V50, P257; Laux-Biehlmann A, 2013, NEUROSCIENCE, V233, P95, DOI 10.1016/j.neuroscience.2012.12.013; Laux-Biehlmann A, 2012, BRIT J CLIN PHARMACO, V74, P381, DOI 10.1111/j.1365-2125.2012.04199.x; LEE CS, 1991, J PHARMACOL EXP THER, V257, P647; Li DY, 2013, CHEM RES TOXICOL, V26, P1182, DOI 10.1021/tx400096m; Lister DL, 1999, FEMS MICROBIOL LETT, V181, P137; MacFaul PA, 1998, ACCOUNTS CHEM RES, V31, P159, DOI 10.1021/ar970057z; Meijerink WJHJ, 1999, SHOCK, V12, P165, DOI 10.1097/00024382-199909000-00001; Messiha HL, 2005, J BIOL CHEM, V280, P10695, DOI 10.1074/jbc.M410595200; MIKUS G, 1994, J PHARMACOL EXP THER, V268, P546; Niwa T, 2008, CURR DRUG METAB, V9, P20; Onoyovwe A, 2013, PLANT CELL, V25, P4110, DOI 10.1105/tpc.113.115113; Ortiz de Montellano P. R., 2015, CYTOCHROME P450 STRU, P111, DOI DOI 10.1007/978-3-319-12108-6_4; Perea-Sasiaín José, 2008, rev.fac.med., V56, P161; Poeaknapo C, 2004, P NATL ACAD SCI USA, V101, P14091, DOI 10.1073/pnas.0405430101; Proshlyakov DA, 2004, J AM CHEM SOC, V126, P1022, DOI 10.1021/ja039113j; Rendic S, 2015, CHEM RES TOXICOL, V28, P38, DOI 10.1021/tx500444e; Richter T, 2004, J PHARMACOL EXP THER, V308, P189, DOI 10.1124/jpet.103.056127; Sohl CD, 2009, NAT PROTOC, V4, P1252, DOI 10.1038/nprot.2009.122; Stevens JC, 2006, DRUG DISCOV TODAY, V11, P440, DOI 10.1016/j.drudis.2006.03.002; Tseng E, 2014, DRUG METAB DISPOS, V42, P1163, DOI 10.1124/dmd.114.057000; Turpeinen M, 2005, EUR J PHARM SCI, V24, P123, DOI 10.1016/j.ejps.2004.10.006; Tyndale RF, 1999, DRUG METAB DISPOS, V27, P924; Walsky RL, 2012, DRUG METAB DISPOS, V40, P1686, DOI 10.1124/dmd.112.045302; WEITZ CJ, 1986, P NATL ACAD SCI USA, V83, P9784, DOI 10.1073/pnas.83.24.9784; WEITZ CJ, 1987, NATURE, V330, P674, DOI 10.1038/330674a0; Winterbourn CC, 1995, TOXICOL LETT, V82-3, P969, DOI 10.1016/0378-4274(95)03532-X; Yin H, 2000, XENOBIOTICA, V30, P141, DOI 10.1080/004982500237749; Zhang WJ, 2001, DRUG METAB DISPOS, V29, P897; Zhu W, 2005, J IMMUNOL, V175, P7357, DOI 10.4049/jimmunol.175.11.7357	75	23	24	3	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2015	290	33					20200	20210		10.1074/jbc.M115.665331	http://dx.doi.org/10.1074/jbc.M115.665331			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP1AT	26157146	Green Published, hybrid			2022-12-26	WOS:000359608900021
J	Kogashiwa, Y; Sakurai, H; Akimoto, Y; Sato, D; Ikeda, T; Matsumoto, Y; Moro, Y; Kimura, T; Hamanoue, Y; Nakamura, T; Yamauchi, K; Saito, K; Sugasawa, M; Kohno, N				Kogashiwa, Yasunao; Sakurai, Hiroyuki; Akimoto, Yoshihiro; Sato, Dai; Ikeda, Tetsuya; Matsumoto, Yoshifumi; Moro, Yorihisa; Kimura, Toru; Hamanoue, Yasuhiro; Nakamura, Takehiro; Yamauchi, Koichi; Saito, Koichiro; Sugasawa, Masashi; Kohno, Naoyuki			Sentinel Node Biopsy for the Head and Neck Using Contrast-Enhanced Ultrasonography Combined with Indocyanine Green Fluorescence in Animal Models: A Feasibility Study	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; LYMPH-NODE; MELANOMA; METASTASES; DISSECTION; CANCER	Background Sentinel node navigation surgery is gaining popularity in oral cancer. We assessed application of sentinel lymph node navigation surgery to pharyngeal and laryngeal cancers by evaluating the combination of contrast-enhanced ultrasonography and indocyanine green fluorescence in animal models. Methods This was a prospective, nonrandomized, experimental study in rabbit and swine animal models. A mixture of indocyanine green and Sonazoid was used as the tracer. The tracer mixture was injected into the tongue, larynx, or pharynx. The sentinel lymph nodes were identified transcutaneously by infra-red camera and contrast-enhanced ultrasonography. Detection time and extraction time of the sentinel lymph nodes were measured. The safety of the tracer mixture in terms of mucosal reaction was evaluated macroscopically and microscopically. Results Sentinel lymph nodes were detected transcutaneously by contrast-enhanced ultrasonography alone. The number of sentinel lymph nodes detected was one or two. Despite observation of contrast enhancement of Sonazoid for at least 90 minutes, the number of sentinel lymph nodes detected did not change. The average extraction time of sentinel lymph nodes was 4.8 minutes. Indocyanine green fluorescence offered visual information during lymph node biopsy. The safety of the tracer was confirmed by absence of laryngeal edema both macro and microscopically. Conclusions The combination method of indocyanine green fluorescence and contrast-enhanced ultrasonography for detecting sentinel lymph nodes during surgery for head and neck cancer seems promising, especially for pharyngeal and laryngeal cancer. Further clinical studies to confirm this are warranted.	[Kogashiwa, Yasunao; Sugasawa, Masashi] Saitama Med Univ, Int Med Ctr, Dept Head & Neck Surg, Otolaryngol, Hidaka, Saitama, Japan; [Kogashiwa, Yasunao; Sato, Dai; Ikeda, Tetsuya; Matsumoto, Yoshifumi; Moro, Yorihisa; Hamanoue, Yasuhiro; Nakamura, Takehiro; Yamauchi, Koichi; Saito, Koichiro; Kohno, Naoyuki] Kyorin Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Mitaka, Tokyo 181, Japan; [Sakurai, Hiroyuki; Kimura, Toru] Kyorin Univ, Sch Med, Dept Pharmacol & Toxycol, Mitaka, Tokyo 181, Japan; [Akimoto, Yoshihiro] Kyorin Univ, Sch Med, Dept Anat, Mitaka, Tokyo 181, Japan	Saitama Medical University; Kyorin University; Kyorin University; Kyorin University	Kogashiwa, Y (corresponding author), Saitama Med Univ, Int Med Ctr, Dept Head & Neck Surg, Otolaryngol, Hidaka, Saitama, Japan.	y_koga@saitama-med.ac.jp		Saito, Koichiro/0000-0002-8107-2967	Setsuro Fujii Memorial The Osaka Foundation for Promotion of Fundamental Medical Research	Setsuro Fujii Memorial The Osaka Foundation for Promotion of Fundamental Medical Research	The research was partly supported by grant from Setsuro Fujii Memorial The Osaka Foundation for Promotion of Fundamental Medical Research (NK and YK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CASTELIJNS JA, 1993, MAGN RESON QUART, V9, P113; Curry JM, 2007, OTOLARYNG HEAD NECK, V137, P735, DOI 10.1016/j.otohns.2007.07.019; Goldberg BB, 2004, RADIOLOGY, V230, P727, DOI 10.1148/radiol.2303021440; Hayashi T, 2010, INT J CLIN ONCOL, V15, P504, DOI 10.1007/s10147-010-0063-8; Higashi H, 2004, J SURG RES, V121, P1, DOI 10.1016/j.jss.2004.02.011; Jansen L, 2000, HEAD NECK-J SCI SPEC, V22, P27, DOI 10.1002/(SICI)1097-0347(200001)22:1<27::AID-HED5>3.0.CO;2-Z; Japan Society for Head and Neck Cancer Registry Committee, 2003, REP HEAD NECK CANC R; Japan Society for Head and Neck Cancer Registry Committee, 2001, REP HEAD NECK CANC R; Japan Society for Head and Neck Cancer Registry Committee, 2002, REP HEAD NECK CANC R; Katada C, 2007, LARYNGOSCOPE, V117, P1596, DOI 10.1097/MLG.0b013e318093ed70; LEEMANS CR, 1993, CANCER, V71, P452, DOI 10.1002/1097-0142(19930115)71:2<452::AID-CNCR2820710228>3.0.CO;2-B; Mayland MK, 2005, LARYNGOSCOPE, V115, P629, DOI 10.1097/01.mlg.0000161338.54515.b1; Nakayama M, 2013, JPN J CLIN ONCOL, V43, P782, DOI 10.1093/jjco/hyt081; Norling R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090360; Omoto K, 2006, J CLIN ULTRASOUND, V34, P317, DOI 10.1002/jcu.20241; Piazza C, 2008, ACTA OTORHINOLARYNGO, V28, P49; Righi PD, 1997, HEAD NECK-J SCI SPEC, V19, P604, DOI 10.1002/(SICI)1097-0347(199710)19:7<604::AID-HED7>3.3.CO;2-K; Shiotani A, 2011, OTOLARYNG HEAD NECK, V144, P288, DOI 10.1177/0194599810392148; Stoeckh SJ, 2007, LARYNGOSCOPE, V117, P1539, DOI 10.1097/MLG.0b013e318093ee67; Tanis PJ, 2008, HEAD NECK-J SCI SPEC, V30, P380, DOI 10.1002/hed.20749; van Leeuwen AC, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3528027; Watanabe A, 2009, EUR ARCH OTO-RHINO-L, V266, P1017, DOI 10.1007/s00405-008-0835-1; Yamauchi K, 2011, ANN SURG ONCOL, V18, P2042, DOI 10.1245/s10434-010-1499-9; Yamazaki Y, 2008, ANN NUCL MED, V22, P177, DOI 10.1007/s12149-007-0097-9	24	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132511	10.1371/journal.pone.0132511	http://dx.doi.org/10.1371/journal.pone.0132511			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161800	Green Published, gold, Green Submitted			2022-12-26	WOS:000358162300144
J	Quintana, HK; Vikstrom, M; Andersson, T; Hallqvist, J; Leander, K				Quintana, Hedley Knewjen; Vikstrom, Max; Andersson, Tomas; Hallqvist, Johan; Leander, Karin			Agreement between Myocardial Infarction Patients and Their Spouses on Reporting of Data on 82 Cardiovascular Risk Exposures	PLOS ONE			English	Article							PROXY RESPONDENTS; INFORMATION; RELIABILITY	Background The validity of exposure data collected from proxy respondents of myocardial infarction patients has scarcely been studied. We assessed the level of disagreement between myocardial infarction patients and their spouses with respect to the reporting of the patient's cardiovascular risk exposures. Methods Within the frame of the Stockholm Heart Epidemiology Program (SHEEP), a case-control study of risk factors of myocardial infarction performed in Stockholm county 1992-1994, a subset of 327 first time myocardial infarction cases aged 45-70 who survived >28 days after the event and who co-habited with a spouse or common-law spouse (proxy) were identified between 1993-04-05 and 1993-12-31. Among these, 243 cases participated along with their respective proxy in the present study. Control individuals, matched to cases by age, sex and residential area were also included (n = 243). Data were collected using questionnaires. Using conditional logistic regression we calculated for each of 82 exposures the odds ratio based on information collected from 1) myocardial infarction cases and controls [odds ratio A] and 2) proxies and the same set of controls [odds ratio B]. Disagreement was measured by calculating the ratio between odds ratio B and odds ratio A with 95% confidence intervals (CI) calculated using resampling bootstrap. Results For the vast majority of the exposures considered including diet, smoking, education, work-related stress, and family history of CVD, there was no statistically significant disagreement between myocardial infarction patients and proxies (n = 243 pairs). However, leisure time physical inactivity (proxy bias = 1.59, 95% CI 1.05-3.57) was overestimated by spouses compared to myocardial infarction patients. A few other exposures including some sleep-related problems and work-related issues also showed disagreement. Conclusions Myocardial infarction patients and their spouses similarly reported data on a wide range of exposures including the majority of the traditional cardiovascular risk factors, leisure time physical inactivity being an exception.	[Quintana, Hedley Knewjen; Vikstrom, Max; Andersson, Tomas; Leander, Karin] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden; [Andersson, Tomas] Stockholm Cty Council, Ctr Occupat & Environm Med, Stockholm, Sweden; [Hallqvist, Johan] Uppsala Univ, Dept Publ Hlth & Caring Sci, Uppsala, Sweden	Karolinska Institutet; Stockholm County Council; Uppsala University	Quintana, HK (corresponding author), Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden.	hedley.quintana@ki.se	Quintana, Hedley/J-6562-2019; Leander, Karin/C-7261-2017	Quintana, Hedley/0000-0002-5929-8791; Leander, Karin/0000-0002-1404-9222	Swedish Council for Work Life and Social Research; Stockholm County Council; ERACOL an Erasmus Mundus Target 2 program	Swedish Council for Work Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Stockholm County Council(Stockholm County Council); ERACOL an Erasmus Mundus Target 2 program	This study was supported by grants from the Swedish Council for Work Life and Social Research (http://www.forte.se/en/) and the Stockholm County Council (http://www.sll.se/om-landstinget/Information-in-English1/). In addition, a grant from the ERACOL (http://erasmus-columbus.eu/about/) an Erasmus Mundus Target 2 program, was awarded to HKQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Capelle LG, 2011, ACTA NEUROL SCAND, V123, P160, DOI 10.1111/j.1600-0404.2010.01389.x; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; ENTERLINE PE, 1959, AM J PUBLIC HEALTH N, V49, P205, DOI 10.2105/AJPH.49.2.205; GRAHAM P, 1993, AM J EPIDEMIOL, V138, P443, DOI 10.1093/oxfordjournals.aje.a116876; Hallqvist J, 1998, SOC SCI MED, V46, P1405, DOI 10.1016/S0277-9536(97)10084-3; Hansen J, 1997, INT J EPIDEMIOL, V26, P1009, DOI 10.1093/ije/26.5.1009; Kirwood BR, 2003, ESSENTIAL MED STAT, P351; Kottner J, 2011, INT J NURS STUD, V48, P659, DOI 10.1016/j.ijnurstu.2011.01.017; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; MCLAUGHLIN JK, 1987, AM J EPIDEMIOL, V126, P144, DOI 10.1093/oxfordjournals.aje.a114647; NELSON LM, 1994, EPIDEMIOLOGY, V5, P204, DOI 10.1097/00001648-199403000-00011; Reuterwall C, 1999, J INTERN MED, V246, P161, DOI 10.1046/j.1365-2796.1999.00554.x; TEPPER A, 1993, J CLIN EPIDEMIOL, V46, P1243, DOI 10.1016/0895-4356(93)90088-I; The National Board of Health and Welfare, 2012, MYOC INF SWED; WIGGINS CL, 1990, SLEEP, V13, P245, DOI 10.1093/sleep/13.3.245	15	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132601	10.1371/journal.pone.0132601	http://dx.doi.org/10.1371/journal.pone.0132601			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1FD	26161850	Green Submitted, Green Published, gold			2022-12-26	WOS:000358162300157
J	Buscema, M; Grossi, E; Montanini, L; Street, ME				Buscema, Massimo; Grossi, Enzo; Montanini, Luisa; Street, Maria E.			Data Mining of Determinants of Intrauterine Growth Retardation Revisited Using Novel Algorithms Generating Semantic Maps and Prototypical Discriminating Variable Profiles	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; INSULIN-RESISTANCE; HUMAN PLACENTA; TNF-ALPHA; FACTOR-II; INTERLEUKIN-6; IGF; EXPRESSION; SYSTEM; RESTRICTION	Objectives Intra-uterine growth retardation is often of unknown origin, and is of great interest as a "Fetal Origin of Adult Disease" has been now well recognized. We built a benchmark based upon a previously analysed data set related to Intrauterine Growth Retardation with 46 subjects described by 14 variables, related with the insulin-like growth factor system and pro-inflammatory cytokines, namely interleukin -6 and tumor necrosis factor -alpha. Design and Methods We used new algorithms for optimal information sorting based on the combination of two neural network algorithms: Auto-contractive Map and Activation and Competition System. Auto-Contractive Map spatializes the relationships among variables or records by constructing a suitable embedding space where 'closeness' among variables or records reflects accurately their associations. The Activation and Competition System algorithm instead works as a dynamic non linear associative memory on the weight matrices of other algorithms, and is able to produce a prototypical variable profile of a given target. Results Classical statistical analysis, proved to be unable to distinguish intrauterine growth retardation from appropriate-for-gestational age (AGA) subjects due to the high non-linearity of underlying functions. Auto-contractive map succeeded in clustering and differentiating completely the conditions under study, while Activation and Competition System allowed to develop the profile of variables which discriminated the two conditions under study better than any other previous form of attempt. In particular, Activation and Competition System showed that ppropriateness for gestational age was explained by IGF-2 relative gene expression, and by IGFBP-2 and TNF-alpha placental contents. IUGR instead was explained by IGF-I, IGFBP-1, IGFBP-2 and IL-6 gene expression in placenta. Conclusion This further analysis provided further insight into the placental key-players of fetal growth within the insulin-like growth factor and cytokine systems. Our previous published analysis could identify only which variables were predictive of fetal growth in general, and identified only some relationships.	[Buscema, Massimo; Grossi, Enzo] Semeion Res Ctr Sci Commun, Rome, Italy; [Buscema, Massimo] Univ Colorado, Dept Math & Stat Sci, Ctr Math & Computat Biol, Denver, CO 80202 USA; [Grossi, Enzo] Villa Santa Maria Inst, Tavernerio, Italy; [Montanini, Luisa] Univ Hosp, Dept Pediat, Parma, Italy; [Street, Maria E.] IRCCS Arcisped S Maria Nuova, Dept Pediat, Reggio Emilia, Italy	University of Colorado System; University of Colorado Denver; University of Parma; University Hospital of Parma	Street, ME (corresponding author), IRCCS Arcisped S Maria Nuova, Dept Pediat, Reggio Emilia, Italy.	MariaElisabeth.Street@asmn.re.it	Street, Maria E/B-7099-2011; Grossi, Enzo/AAF-7765-2020	Street, Maria E/0000-0001-8427-8971; Buscema, Paolo Massimo/0000-0003-4356-0510				Aguirre V, 2002, J BIOL CHEM, V277, P1531, DOI 10.1074/jbc.M101521200; BAKER J, 1993, CELL, V75, P73, DOI 10.1016/0092-8674(93)90680-O; Buscema M, 2014, CHEMOMETR INTELL LAB, V138, P110, DOI 10.1016/j.chemolab.2014.06.013; Buscema M, 2008, P N AM FUZZ INF PRC; Buscema M, 2010, P N AM FUZZ INF PRC; Buscema M, 2007, 32 SEM; Buscema M, 2007, P IEEE INT C SYST MA; Buscema M., 2010, DATA MINING APPL USI, P1, DOI DOI 10.1007/978-1-4614-4223-3_1; Buscema M, 2008, CURR ALZHEIMER RES, V5, P481, DOI 10.2174/156720508785908928; Buscema M, 2008, INT J DATA MIN BIOIN, V2, P362, DOI 10.1504/IJDMB.2008.022159; Crossey PA, 2002, J CLIN INVEST, V110, P411, DOI 10.1172/JCI200210077; DECHIARA TM, 1990, NATURE, V345, P78, DOI 10.1038/345078a0; Foltran F, 2011, J BIOL REG HOMEOS AG, V25, P269; GAGLIARDI L, 1999, RIV ITAL PED, V25, P159; Gironi M, 2013, IMMUN AGEING, V10, DOI 10.1186/1742-4933-10-1; Godfrey KM, 2000, AM J CLIN NUTR, V71, p1344S, DOI 10.1093/ajcn/71.5.1344s; GROSSBERG S, 1976, BIOL CYBERN, V23, P121, DOI 10.1007/BF00344744; GROSSBERG S, 1980, PSYCHOL REV, V87, P1, DOI 10.1037/0033-295X.87.1.1; Grossberg S, 1978, FORMAL THEORIES VISU; Han VKM, 1996, J CLIN ENDOCR METAB, V81, P2680, DOI 10.1210/jc.81.7.2680; Hashimoto R, 2010, ENDOCR J, V57, P193, DOI 10.1507/endocrj.K09E-189; Hedbacker K, 2010, CELL METAB, V11, P11, DOI 10.1016/j.cmet.2009.11.007; Hess AP, 2007, BIOL REPROD, V76, P102, DOI 10.1095/biolreprod.106.054791; HEYBORNE KD, 1992, AM J OBSTET GYNECOL, V167, P920, DOI 10.1016/S0002-9378(12)80012-3; Hinton G. E., 1989, PARALLEL MODELS ASS; Holcberg G, 2001, EUR J OBSTET GYN R B, V94, P69, DOI 10.1016/S0301-2115(00)00321-3; Kajimura S, 2005, P NATL ACAD SCI USA, V102, P1240, DOI 10.1073/pnas.0407443102; KARLBERG J, 1995, PEDIATR RES, V38, P733, DOI 10.1203/00006450-199511000-00017; Klover PJ, 2003, DIABETES, V52, P2784, DOI 10.2337/diabetes.52.11.2784; Li YC, 2010, J CELL BIOCHEM, V110, P248, DOI 10.1002/jcb.22532; Licastro F, 2010, NEUROBIOL AGING, V31, P257, DOI 10.1016/j.neurobiolaging.2008.03.019; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; Massini G, 2007, TREES VISUALIZER VER; McClelland J. L., 1988, EXPLORATIONS PARALLE; Meisser A, 1999, MOL HUM REPROD, V5, P1055, DOI 10.1093/molehr/5.11.1055; OHLSSON R, 1989, EMBO J, V8, P1993, DOI 10.1002/j.1460-2075.1989.tb03606.x; Ozes ON, 2001, P NATL ACAD SCI USA, V98, P4640, DOI 10.1073/pnas.051042298; Resnik R, 2002, OBSTET GYNECOL, V99, P490, DOI 10.1016/S0029-7844(01)01780-X; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Senn JJ, 2002, DIABETES, V51, P3391, DOI 10.2337/diabetes.51.12.3391; SHEN SJ, 1986, P NATL ACAD SCI USA, V83, P9179, DOI 10.1073/pnas.83.23.9179; Smerieri A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029562; Street ME, 2006, GROWTH HORM IGF RES, V16, P365, DOI 10.1016/j.ghir.2006.09.007; Street ME, 2008, CLIN ENDOCRINOL, V68, P22, DOI 10.1111/j.1365-2265.2007.02992.x; Street ME, 2006, EUR J ENDOCRINOL, V155, P567, DOI 10.1530/eje.1.02251; Street ME, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-24; Street ME, 2006, EUR J ENDOCRINOL, V154, P47, DOI 10.1530/eje.1.02064; Street ME, 2004, HORM RES, V61, P159, DOI 10.1159/000075699; WANG CY, 1988, MOL ENDOCRINOL, V2, P217, DOI 10.1210/mend-2-3-217; Wheatcroft SB, 2009, TRENDS ENDOCRIN MET, V20, P153, DOI 10.1016/j.tem.2009.01.002; Zollers WG, 2001, BIOL REPROD, V65, P1208, DOI 10.1095/biolreprod65.4.1208	51	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2015	10	7							e0126020	10.1371/journal.pone.0126020	http://dx.doi.org/10.1371/journal.pone.0126020			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EW	26158499	gold, Green Published, Green Submitted			2022-12-26	WOS:000358161200002
J	Levin, LA; Mendoza, GF; Grupe, BM; Gonzalez, JP; Jellison, B; Rouse, G; Thurber, AR; Waren, A				Levin, Lisa A.; Mendoza, Guillermo F.; Grupe, Benjamin M.; Gonzalez, Jennifer P.; Jellison, Brittany; Rouse, Greg; Thurber, Andrew R.; Waren, Anders			Biodiversity on the Rocks: Macrofauna Inhabiting Authigenic Carbonate at Costa Rica Methane Seeps	PLOS ONE			English	Article							SEA HYDROTHERMAL VENTS; STABLE-ISOTOPE RATIOS; EEL RIVER-BASIN; DEEP-SEA; COMMUNITY STRUCTURE; MUSSEL BEDS; COLD-SEEPS; BIOLOGICAL COMMUNITIES; ANAEROBIC OXIDATION; FLORIDA ESCARPMENT	Carbonate communities: The activity of anaerobic methane oxidizing microbes facilitates precipitation of vast quantities of authigenic carbonate at methane seeps. Here we demonstrate the significant role of carbonate rocks in promoting diversity by providing unique habitat and food resources for macrofaunal assemblages at seeps on the Costa Rica margin (400-1850 m). The attendant fauna is surprisingly similar to that in rocky intertidal shores, with numerous grazing gastropods (limpets and snails) as dominant taxa. However, the community feeds upon seep-associated microbes. Macrofaunal density, composition, and diversity on carbonates vary as a function of seepage activity, biogenic habitat and location. The macrofaunal community of carbonates at non-seeping (inactive) sites is strongly related to the hydrography (depth, temperature, O-2) of overlying water, whereas the fauna at sites of active seepage is not. Densities are highest on active rocks from tubeworm bushes and mussel beds, particularly at the Mound 12 location (1000 m). Species diversity is higher on rocks exposed to active seepage, with multiple species of gastropods and polychaetes dominant, while crustaceans, cnidarians, and ophiuroids were better represented on rocks at inactive sites. Macro-infauna (larger than 0.3 mm) from tube cores taken in nearby seep sediments at comparable depths exhibited densities similar to those on carbonate rocks, but had lower diversity and different taxonomic composition. Seep sediments had higher densities of ampharetid, dorvilleid, hesionid, cirratulid and lacydoniid polychaetes, whereas carbonates had more gastropods, as well as syllid, chrysopetalid and polynoid polychaetes. Stable isotope signatures and metrics: The stable isotope signatures of carbonates were heterogeneous, as were the food sources and nutrition used by the animals. Carbonate delta C-13(inorg) values (mean = -26.98 parts per thousand) ranged from -53.3 parts per thousand to + 10.0 parts per thousand, and were significantly heavier than carbonate delta C-13(org) (mean = -33.83 parts per thousand), which ranged from -74.4% to -20.6%. Invertebrates on carbonates had average delta C-13 (per rock) = -31.0% (range -18.5% to -46.5%) and delta N-15 = 5.7%(range -4.5% to + 13.4%). Average delta C-13 values did not differ between active and inactive sites; carbonate fauna from both settings depend on chemosynthesis-based nutrition. Community metrics reflecting trophic diversity (SEAc, total Hull Area, ranges of delta C-13 and delta N-15) and species packing (mean distance to centroid, nearest neighbor distance) also did not vary as a function of seepage activity or site. However, distinct isotopic signatures were observed among related, co-occurring species of gastropods and polychaetes, reflecting intense microbial resource partitioning. Overall, the substrate and nutritional heterogeneity introduced by authigenic seep carbonates act to promote diverse, uniquely adapted assemblages, even after seepage ceases. The macrofauna in these ecosystems remain largely overlooked in most surveys, but are major contributors to biodiversity of chemosynthetic ecosystems and the deep sea in general.	[Levin, Lisa A.; Mendoza, Guillermo F.; Grupe, Benjamin M.; Gonzalez, Jennifer P.; Jellison, Brittany] Univ Calif San Diego, Scripps Inst Oceanog, Integrat Oceanog Div, La Jolla, CA 92093 USA; [Levin, Lisa A.; Rouse, Greg] Univ Calif San Diego, Scripps Inst Oceanog, Ctr Marine Biodivers & Conservat, La Jolla, CA 92093 USA; [Thurber, Andrew R.] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA; [Waren, Anders] Swedish Museum Nat Hist, S-10405 Stockholm, Sweden	University of California System; University of California San Diego; Scripps Institution of Oceanography; University of California System; University of California San Diego; Scripps Institution of Oceanography; Oregon State University; Swedish Museum of Natural History	Levin, LA (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, Integrat Oceanog Div, La Jolla, CA 92093 USA.	llevin@ucsd.edu	Grupe, Benjamin/D-1436-2010; Rouse, Greg W/F-2611-2010; Rouse, Gregory/AAW-1494-2021	Grupe, Benjamin/0000-0002-5421-7278; Rouse, Greg W/0000-0001-9036-9263; Rouse, Gregory/0000-0001-9036-9263; Levin, Lisa/0000-0002-2858-8622; Jellison, Brittany/0000-0001-9118-5132	National Science Foundation (NSF) [OCE 0826254, OCE 0939557]	National Science Foundation (NSF)(National Science Foundation (NSF))	This work was supported by the National Science Foundation (NSF grants OCE 0826254 and OCE 0939557). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloisi G, 2002, EARTH PLANET SC LETT, V203, P195, DOI 10.1016/S0012-821X(02)00878-6; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MJ, 2003, AUST NZ J STAT, V45, P301, DOI 10.1111/1467-842X.00285; Anderson MJ, 2005, PERMANOVA FORTRAN CO; Baco AR, 2003, MAR ECOL PROG SER, V260, P109, DOI 10.3354/meps260109; Bahr A, 2009, INT J EARTH SCI, V98, P677, DOI 10.1007/s00531-007-0264-1; Beaulieu SE, 2001, MAR BIOL, V138, P803, DOI 10.1007/s002270000500; Bergquist DC, 2003, J EXP MAR BIOL ECOL, V289, P197, DOI 10.1016/S0022-0981(03)00046-7; Bernardino AF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033515; Boetius A, 2000, NATURE, V407, P623, DOI 10.1038/35036572; Bohrmann G, 1998, GEOLOGY, V26, P647, DOI 10.1130/0091-7613(1998)026<0647:ACFTCS>2.3.CO;2; Bohrmann G, 2002, TERRA NOVA, V14, P69, DOI 10.1046/j.1365-3121.2002.00400.x; Buhl-Mortensen L, 2010, MAR ECOL-EVOL PERSP, V31, P21, DOI 10.1111/j.1439-0485.2010.00359.x; Campbell KA, 2006, PALAEOGEOGR PALAEOCL, V232, P362, DOI 10.1016/j.palaeo.2005.06.018; CARPENTER JAMES H., 1965, LIMNOL OCEANOGR, V10, P135; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Coates M, 1998, GLOBAL ECOL BIOGEOGR, V7, P115, DOI 10.2307/2997814; Cordes EE, 2005, MAR ECOL PROG SER, V305, P17, DOI 10.3354/meps305017; Cunha MR, 2013, BIOGEOSCIENCES, V10, P2553, DOI 10.5194/bg-10-2553-2013; Cunha MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076688; Dando PR, 2010, TOP GEOBIOL, V33, P333, DOI 10.1007/978-90-481-9572-5_11; DANDO PR, 1991, MAR ECOL PROG SER, V70, P49, DOI 10.3354/meps070049; DEAN RL, 1987, J EXP MAR BIOL ECOL, V109, P217, DOI 10.1016/0022-0981(87)90056-6; Feng D, 2013, DEEP-SEA RES PT I, V75, P110, DOI 10.1016/j.dsr.2013.02.002; Furi E, 2010, GEOCHEM GEOPHY GEOSY, V11, DOI 10.1029/2009GC002810; Gaudron SM, 2010, MAR ENVIRON RES, V70, P1, DOI 10.1016/j.marenvres.2010.02.002; Genio L, 2013, BIOGEOSCIENCES, V10, P5159, DOI 10.5194/bg-10-5159-2013; Gieskes J, 2005, CHEM GEOL, V220, P329, DOI 10.1016/j.chemgeo.2005.04.002; GITTINGS SR, 1984, CONTRIB MAR SCI, V27, P105; Gorley C.K., 2006, GETTING STARTED PRIM; Govenar B, 2008, EOS, V89, P53, DOI [10.1016/j.pt.2003.09.013, DOI 10.1016/J.PT.2003.09.013]; Grupe BM, 2015, MAR ECOL-EVOL PERSP, V36, P91, DOI 10.1111/maec.12243; Han XQ, 2004, INT J EARTH SCI, V93, P596, DOI 10.1007/s00531-004-0402-y; Jackson AL, 2011, J ANIM ECOL, V80, P595, DOI 10.1111/j.1365-2656.2011.01806.x; JENSEN P, 1992, MAR ECOL PROG SER, V83, P103, DOI 10.3354/meps083103; Kimura G, 1997, P OCEAN DRILLING PRO, V170, P458, DOI DOI 10.2973/ODP.PROC.IR.170.1997; Layman CA, 2007, ECOLOGY, V88, P42, DOI 10.1890/0012-9658(2007)88[42:CSIRPF]2.0.CO;2; Levin LA, 2005, OCEANOGR MAR BIOL, V43, P1, DOI 10.1201/9781420037449.ch1; Levin LA, 2002, LIMNOL OCEANOGR, V47, P1336, DOI 10.4319/lo.2002.47.5.1336; Levin LA, 2000, MAR ECOL PROG SER, V208, P21, DOI 10.3354/meps208021; Levin LA, 2007, MAR ECOL-EVOL PERSP, V28, P131, DOI 10.1111/j.1439-0485.2006.00131.x; Levin LA, 2013, DEEP-SEA RES PT II, V92, P214, DOI 10.1016/j.dsr2.2013.02.006; Levin LA, 2012, P ROY SOC B-BIOL SCI, V279, P2580, DOI 10.1098/rspb.2012.0205; Lizzaralde D, 2010, NATURE GEOSC, DOI [10.1038/NGEO1006, DOI 10.1038/NGEO_1006]; Lundsten L, 2009, MAR ECOL PROG SER, V374, P23, DOI 10.3354/meps07745; Marlow JJ, 2014, FRONT MAR SCI, V1, DOI 10.3389/fmars.2014.00044; Marlow JJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6094; Mau S, 2006, MAR GEOL, V225, P129, DOI 10.1016/j.margeo.2005.09.007; Mau S, 2014, INT J EARTH SCI, V103, P1801, DOI 10.1007/s00531-012-0822-z; McAdoo BG, 1996, GEOPHYS RES LETT, V23, P883, DOI 10.1029/96GL00731; McCarthy S. A., 1998, Pacific Science, V52, P141; Menot L., 2010, LIFE WORLDS OCEANS D; Michaelis W, 2002, SCIENCE, V297, P1013, DOI 10.1126/science.1072502; MULLINEAUX LS, 1987, DEEP-SEA RES, V34, P165, DOI 10.1016/0198-0149(87)90080-X; Naehr TH, 2007, DEEP-SEA RES PT II, V54, P1268, DOI 10.1016/j.dsr2.2007.04.010; Ohara Y, 2012, P NATL ACAD SCI USA, V109, P2831, DOI 10.1073/pnas.1112005109; Orphan VJ, 2004, CHEM GEOL, V205, P265, DOI 10.1016/j.chemgeo.2003.12.035; PAULL CK, 1984, SCIENCE, V226, P965, DOI 10.1126/science.226.4677.965; Rex M.A., 2010, BIOSCIENCE; Ritt B, 2011, MAR BIOL, V158, P1187, DOI 10.1007/s00227-011-1679-6; Ritt B, 2010, DEEP-SEA RES PT I, V57, P1120, DOI 10.1016/j.dsr.2010.05.011; Sahling H, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2008GC001978; Schmidt M, 2005, MAR GEOL, V216, P83, DOI 10.1016/j.margeo.2005.01.001; Schrag DP, 2013, SCIENCE, V339, P540, DOI 10.1126/science.1229578; Sellanes J, 2004, J MAR BIOL ASSOC UK, V84, P1065, DOI 10.1017/S0025315404010422h; Shapiro RS, 2004, ASTROBIOLOGY, V4, P438; Smith CR, 2003, OCEANOGR MAR BIOL, V41, P311; Stakes DS, 1999, MAR GEOL, V159, P93, DOI 10.1016/S0025-3227(98)00200-X; Suess E, 2002, 4 INT C GAS HYDR YOK, P740; Sun XL, 2014, NAT GEOSCI, V7, P201, DOI [10.1038/ngeo2070, 10.1038/NGEO2070]; Taylor RB, 1998, MAR ECOL PROG SER, V172, P37, DOI 10.3354/meps172037; Teichert BMA, 2005, PALAEOGEOGR PALAEOCL, V227, P67, DOI 10.1016/j.palaeo.2005.04.029; Thurber AR, 2012, ISME J, V6, P1602, DOI 10.1038/ismej.2012.16; Tryon MD, 2010, GEOCHEM GEOPHY GEOSY, V11, DOI 10.1029/2009GC002818; Turner TF, 2010, ECOLOGY, V91, P2227, DOI 10.1890/09-1454.1; Turnipseed M, 2003, ECOL LETT, V6, P518, DOI 10.1046/j.1461-0248.2003.00465.x; Van Dover C.L., 2000, ECOLOGY DEEP SEA HYD; Van Dover CL, 2000, MAR ECOL PROG SER, V195, P169, DOI 10.3354/meps195169; Van Dover CL, 2003, MAR ECOL PROG SER, V253, P55, DOI 10.3354/meps253055; Van Dover CL, 2002, MAR ECOL PROG SER, V230, P137, DOI 10.3354/meps230137	80	40	41	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2015	10	7							e0131080	10.1371/journal.pone.0131080	http://dx.doi.org/10.1371/journal.pone.0131080			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EW	26158723	Green Published, gold			2022-12-26	WOS:000358161200025
J	Feller, C; Favre, P; Janka, A; Zeeman, SC; Gabriel, JP; Reinhardt, D				Feller, Chrystel; Favre, Patrick; Janka, Ales; Zeeman, Samuel C.; Gabriel, Jean-Pierre; Reinhardt, Didier			Mathematical Modeling of the Dynamics of Shoot-Root Interactions and Resource Partitioning in Plant Growth	PLOS ONE			English	Article							ADP-GLUCOSE PYROPHOSPHORYLASE; PHOSPHATE-STARVATION; BIOMASS ALLOCATION; PHLOEM TRANSPORT; STARCH DEGRADATION; CARBON ALLOCATION; CIRCADIAN CLOCKS; LEAF STRUCTURE; ARABIDOPSIS; LIGHT	Plants are highly plastic in their potential to adapt to changing environmental conditions. For example, they can selectively promote the relative growth of the root and the shoot in response to limiting supply of mineral nutrients and light, respectively, a phenomenon that is referred to as balanced growth or functional equilibrium. To gain insight into the regulatory network that controls this phenomenon, we took a systems biology approach that combines experimental work with mathematical modeling. We developed a mathematical model representing the activities of the root (nutrient and water uptake) and the shoot (photosynthesis), and their interactions through the exchange of the substrates sugar and phosphate (Pi). The model has been calibrated and validated with two independent experimental data sets obtained with Petunia hybrida. It involves a realistic environment with a day-and-night cycle, which necessitated the introduction of a transitory carbohydrate storage pool and an endogenous clock for coordination of metabolism with the environment. Our main goal was to grasp the dynamic adaptation of shoot: root ratio as a result of changes in light and Pi supply. The results of our study are in agreement with balanced growth hypothesis, suggesting that plants maintain a functional equilibrium between shoot and root activity based on differential growth of these two compartments. Furthermore, our results indicate that resource partitioning can be understood as the emergent property of many local physiological processes in the shoot and the root without explicit partitioning functions. Based on its encouraging predictive power, the model will be further developed as a tool to analyze resource partitioning in shoot and root crops.	[Feller, Chrystel; Janka, Ales; Gabriel, Jean-Pierre] Univ Fribourg, Dept Math, CH-1700 Fribourg, Switzerland; [Favre, Patrick; Reinhardt, Didier] Univ Fribourg, Dept Biol, CH-1700 Fribourg, Switzerland; [Zeeman, Samuel C.] ETH, Inst Agr Sci, Zurich, Switzerland	University of Fribourg; University of Fribourg; Swiss Federal Institutes of Technology Domain; ETH Zurich	Reinhardt, D (corresponding author), Univ Fribourg, Dept Biol, CH-1700 Fribourg, Switzerland.	didier.reinhardt@unifr.ch	Reinhardt, Didier/M-8508-2014	Reinhardt, Didier/0000-0003-3495-6783; Zeeman, Samuel/0000-0002-2791-0915	SystemsX.ch	SystemsX.ch	This work was supported by SystemsX.ch, http://www.systemsx.ch. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acock B, 1991, MODELING CROP PHOTOS, V19, P41; Adams SR, 2008, J HORTIC SCI BIOTECH, V83, P609, DOI 10.1080/14620316.2008.11512431; Agren GI, 2003, ANN BOT-LONDON, V92, P795, DOI 10.1093/aob/mcg203; Ainsworth EA, 2011, PLANT PHYSIOL, V155, P64, DOI 10.1104/pp.110.167684; Amthor JS, 2000, ANN BOT-LONDON, V86, P1, DOI 10.1006/anbo.2000.1175; Beutler H. O., 1984, METHOD ENZYMAT AN, P321; Bove JM, 2002, PLANT SCI, V163, P1083, DOI 10.1016/S0168-9452(02)00276-5; Braun DM, 2014, J EXP BOT, V65, P1713, DOI 10.1093/jxb/ert416; BROUWER R., 1962, NETHERLANDS JOUR AGRIC SCI, V10, P399; Bucher M, 2007, NEW PHYTOL, V173, P11, DOI 10.1111/j.1469-8137.2006.01935.x; CAKMAK I, 1994, J EXP BOT, V45, P1245, DOI 10.1093/jxb/45.9.1245; Cannell MGR, 2000, ANN BOT-LONDON, V85, P45, DOI 10.1006/anbo.1999.0996; Chen YF, 2008, J INTEGR PLANT BIOL, V50, P835, DOI 10.1111/j.1744-7909.2008.00707.x; Coello CAC., 2007, EVOLUTIONARY ALGORIT, V5; Cruz-Ramirez A, 2006, P NATL ACAD SCI USA, V103, P6765, DOI 10.1073/pnas.0600863103; De Schepper V, 2013, J EXP BOT, V64, P4839, DOI 10.1093/jxb/ert302; DEWAR RC, 1993, FUNCT ECOL, V7, P356, DOI 10.2307/2390216; Dinant S, 2010, CR BIOL, V333, P307, DOI 10.1016/j.crvi.2010.01.006; Dodd AN, 2005, SCIENCE, V309, P630, DOI 10.1126/science.1115581; Flugge UI, 1998, CURR OPIN PLANT BIOL, V1, P201, DOI 10.1016/S1369-5266(98)80105-2; Forde B, 2001, PLANT SOIL, V232, P51, DOI 10.1023/A:1010329902165; Franklin KA, 2008, NEW PHYTOL, V179, P930, DOI 10.1111/j.1469-8137.2008.02507.x; GARNIER E, 1991, TRENDS ECOL EVOL, V6, P126, DOI 10.1016/0169-5347(91)90091-B; Geigenberger P, 2011, PLANT PHYSIOL, V155, P1566, DOI 10.1104/pp.110.170399; Gibon Y, 2004, PLANT J, V39, P847, DOI 10.1111/j.1365-313X.2004.02173.x; Graf A, 2010, P NATL ACAD SCI USA, V107, P9458, DOI 10.1073/pnas.0914299107; Guo WB, 2008, PLANT SCI, V175, P574, DOI 10.1016/j.plantsci.2008.06.007; HAEHNEL W, 1984, ANNU REV PLANT PHYS, V35, P659, DOI 10.1146/annurev.pp.35.060184.003303; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; Hendriks JHM, 2003, PLANT PHYSIOL, V133, P838, DOI 10.1104/pp.103.024513; Hermans C, 2006, TRENDS PLANT SCI, V11, P610, DOI 10.1016/j.tplants.2006.10.007; HESKETH JD, 1971, CROP SCI, V11, P394, DOI 10.2135/cropsci1971.0011183X001100030025x; Hodge A, 1997, J EXP BOT, V48, P1797, DOI 10.1093/jexbot/48.315.1797; IWASA Y, 1984, THEOR POPUL BIOL, V25, P78, DOI 10.1016/0040-5809(84)90007-8; James SA, 2000, TREE PHYSIOL, V20, P1007; Jensen KH, 2012, PLANT CELL ENVIRON, V35, P1065, DOI 10.1111/j.1365-3040.2011.02472.x; JOHNSON IR, 1987, ANN BOT-LONDON, V60, P133, DOI 10.1093/oxfordjournals.aob.a087429; Kang MZ, 2007, WAG UR FRON, V22, P65; Kim HK, 2014, J EXP BOT, V65, P1895, DOI 10.1093/jxb/eru075; Kleemola J, 1996, PLANT SOIL, V185, P101, DOI 10.1007/BF02257567; Knoblauch M, 2012, PLANT J, V70, P147, DOI 10.1111/j.1365-313X.2012.04931.x; Kotting O, 2009, PLANT CELL, V21, P334, DOI 10.1105/tpc.108.064360; Kunst A., 1984, METHOD ENZYMAT AN, VVI, P163; Lambers H., 2008, PLANT PHYSL ECOLOGY, DOI DOI 10.1007/978-0-387-78341-3_9; Lu Y, 2005, PLANT PHYSIOL, V138, P2280, DOI 10.1104/pp.105.061903; Marcelis LFM, 2007, WAG UR FRON, V22, P103; Marcelis LFM, 1998, SCI HORTIC-AMSTERDAM, V74, P83, DOI 10.1016/S0304-4238(98)00083-1; Mauseth J., 1988, PLANT ANATOMY; McCarthy MC, 2007, FUNCT ECOL, V21, P713, DOI 10.1111/j.1365-2435.2007.01276.x; McCREE K. J., 1970, Prediction and measurement of photosynthetic productivity. Proceedings of the IBP/PP Technical Meeting, Trebon, [Czechoslovakia], 14-21 September, 1969, P221; Mengel K, 1982, Principles of plant nutrition.; Minchin PEH, 2007, WAG UR FRON, V22, P113; MINCHIN PEH, 1993, J EXP BOT, V44, P947, DOI 10.1093/jxb/44.5.947; Muller LM, 2014, J EXP BOT, V65, P2915, DOI 10.1093/jxb/eru117; Munch E., 1930, STOFFBEWEGUNGEN PFLA; Murchie EH, 2009, NEW PHYTOL, V181, P532, DOI 10.1111/j.1469-8137.2008.02705.x; Neumann G, 2002, TRENDS PLANT SCI, V7, P162, DOI 10.1016/S1360-1385(02)02241-0; NIKLAS KJ, 1988, EVOLUTION, V42, P1, DOI 10.1111/j.1558-5646.1988.tb04103.x; Nouri E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090841; Ogren E, 2000, PHYSIOL PLANTARUM, V108, P295, DOI 10.1034/j.1399-3054.2000.108003295.x; Oguchi R, 2003, PLANT CELL ENVIRON, V26, P505, DOI 10.1046/j.1365-3040.2003.00981.x; Patrick JW, 1997, ANNU REV PLANT PHYS, V48, P191, DOI 10.1146/annurev.arplant.48.1.191; Paul MJ, 2001, J EXP BOT, V52, P1383, DOI 10.1093/jexbot/52.360.1383; Peret B, 2011, TRENDS PLANT SCI, V16, P442, DOI 10.1016/j.tplants.2011.05.006; Peuke AD, 2010, J EXP BOT, V61, P635, DOI 10.1093/jxb/erp352; Poorter H, 2000, AUST J PLANT PHYSIOL, V27, P1191, DOI 10.1071/PP99173; Poorter H, 2012, NEW PHYTOL, V193, P30, DOI 10.1111/j.1469-8137.2011.03952.x; Rains DW, 1976, PLANT BIOCH, P561; Rasse DP, 2006, NEW PHYTOL, V172, P500, DOI 10.1111/j.1469-8137.2006.01848.x; Rausch C, 2002, PLANTA, V216, P23, DOI 10.1007/s00425-002-0921-3; REYNOLDS JF, 1982, ANN BOT-LONDON, V49, P585, DOI 10.1093/oxfordjournals.aob.a086286; Schnepf A, 2006, NEW PHYTOL, V171, P669, DOI 10.1111/j.1469-8137.2006.01771.x; Seki M, 2002, PLANT J, V31, P279, DOI 10.1046/j.1365-313X.2002.01359.x; Shachar-Hill Y, 2013, CURR OPIN BIOTECH, V24, P247, DOI 10.1016/j.copbio.2013.01.004; SHEEHY JE, 1995, ANN BOT-LONDON, V76, P263, DOI 10.1006/anbo.1995.1095; Shipley B, 2002, FUNCT ECOL, V16, P326, DOI 10.1046/j.1365-2435.2002.00626.x; Smith AM, 2007, PLANT CELL ENVIRON, V30, P1126, DOI 10.1111/j.1365-3040.2007.01708.x; Smith AM, ANN REV PLANT BIOL, P73; STITT M, 1991, PLANT CELL ENVIRON, V14, P741, DOI 10.1111/j.1365-3040.1991.tb01440.x; Stitt M, 2012, CURR OPIN PLANT BIOL, V15, P282, DOI 10.1016/j.pbi.2012.03.016; Stitt M, 2010, PLANT J, V61, P1067, DOI 10.1111/j.1365-313X.2010.04142.x; Sulpice R, 2014, MOL PLANT, V7, P137, DOI 10.1093/mp/sst127; Thornley HM, 2002, PLANT CROP MODELLING; Thornley J. H. M., 2007, Mathematical models in agriculture: quantitative methods for the plant, animal and ecological sciences, DOI 10.1079/9780851990101.0000; THORNLEY JH, 1972, ANN BOT-LONDON, V36, P431, DOI 10.1093/oxfordjournals.aob.a084602; THORNLEY JH, 1970, NATURE, V227, P304, DOI 10.1038/227304b0; Thornley JHM, 1998, ANN BOT-LONDON, V81, P165, DOI 10.1006/anbo.1997.0529; Thornley JHM, 2002, ANN BOT-LONDON, V89, P451, DOI 10.1093/aob/mcf071; THORNLEY JHM, 1995, ANN BOT-LONDON, V75, P391, DOI 10.1006/anbo.1995.1037; Thornley JHM., 1990, PLANT CROP MODELLING; Thornley JHM, 1998, GRASSLAND DYNAMICS; Thornley JHM, 2014, J THEOR BIOL, V342, P1, DOI 10.1016/j.jtbi.2013.10.003; Thykjaer T, 1997, PLANT MOL BIOL, V35, P523, DOI 10.1023/A:1005865600319; vonArnim A, 1996, ANNU REV PLANT PHYS, V47, P215, DOI 10.1146/annurev.arplant.47.1.215; Walter Achim, 2006, Plant Signal Behav, V1, P225, DOI 10.4161/psb.1.5.3447; Wentworth M, 2006, J EXP BOT, V57, P699, DOI 10.1093/jxb/erj061; WIT C. T. DE, 1970, Prediction and measurement of photosynthetic productivity. Proceedings of the IBP/PP Technical Meeting, Tfebon, [Czechoslovakia], 14-21 September, 1969., P47; Wu P, 2003, PLANT PHYSIOL, V132, P1260, DOI 10.1104/pp.103.021022; Wyka TP, 2012, OECOLOGIA, V170, P11, DOI 10.1007/s00442-012-2279-y; Yingshan Hsu P, 2013, TRENDS PLAN IN PRESS	100	20	22	2	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0127905	10.1371/journal.pone.0127905	http://dx.doi.org/10.1371/journal.pone.0127905			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154262	Green Published, Green Submitted, gold			2022-12-26	WOS:000358159700007
J	Jing, LK; Fan, JX; Wang, Y; Li, HY; Wang, SZ; Yang, XJ; Zhang, Y				Jing, Linkai; Fan, Jixing; Wang, Yang; Li, Haiyun; Wang, Shengzhang; Yang, Xinjian; Zhang, Ying			Morphologic and Hemodynamic Analysis in the Patients with Multiple Intracranial Aneurysms: Ruptured versus Unruptured	PLOS ONE			English	Article							WALL SHEAR-STRESS; COMPUTATIONAL FLUID-DYNAMICS; CEREBRAL ANEURYSMS; RISK-FACTORS; DEFINED POPULATION; ASPECT RATIO; ARTERY; INDEX; ASSOCIATION; SIMULATION	Background and Purpose The authors evaluated the impact of morphologic and hemodynamic factors on multiple intracranial aneurysms and aimed to identify which parameters can be reliable indexes as one aneurysm ruptured, and the others did not. Methods Between June 2011 and May 2014, 69 patients harboring multiple intracranial aneurysms (69 ruptured and 86 unruptured) were analyzed from 3D-digital subtraction angiography (DSA) images and computational fluid dynamics (CFD). Morphologic and hemodynamic parameters were evaluated for significance with respect to rupture. Receiver operating characteristic (ROC) analysis identified area under the curve (AUC) and optimal thresholds separating ruptured from unruptured intracranial aneurysms for each parameter. Significant parameters were examined by binary logistic regression analysis to identify independent discriminators. Results Nine morphologic (size, neck width, surface area, volume, diameter of parent arteries, aspect ratio, size ratio, lateral/bifurcation type and regular/irregular type) and 6 hemodynamic (WSSmean, WSSmin, OSI, LSA, flow stability and flow complexity) parameters achieved statistical significance (p<0.05). Six morphologic (size, surface area, volume, aspect ratio, size ratio and regular/irregular type) and five hemodynamic (WSSmean, WSSmin, LSA, flow stability and flow complexity) parameters had high AUC values (AUC>0.7). By binary logistic regression analysis, large aspect ratio and low WSSmean were the independently significant rupture factors (AUC, 0.924; 95% CI, 0.883-0.965). Conclusions Large aspect ratio and low WSSmean were independently associated with the rupture status of multiple intracranial aneurysms.	[Jing, Linkai; Fan, Jixing; Wang, Yang; Yang, Xinjian; Zhang, Ying] Capital Med Univ, Beijing Tiantan Hosp, Beijing Neurosurg Inst, Dept Intervent Neuroradiol, Beijing, Peoples R China; [Li, Haiyun] Capital Med Univ, Dept Biomed Engn, Beijing, Peoples R China; [Wang, Shengzhang] Fudan Univ, Dept Mech & Engn Sci, Shanghai 200433, Peoples R China	Beijing Neurosurgical Institute; Capital Medical University; Capital Medical University; Fudan University	Yang, XJ (corresponding author), Capital Med Univ, Beijing Tiantan Hosp, Beijing Neurosurg Inst, Dept Intervent Neuroradiol, Beijing, Peoples R China.	yang-xj@163.net; yingzhang829@163.com		Yang, Xinjian/0000-0001-7306-0125	National Natural Science Foundation of China [81220108007, 81301003, 81171079]; Special Research Project for Capital Health Development [2014-1-1071]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Research Project for Capital Health Development	This work was supported by the National Natural Science Foundation of China (grant nos. 81220108007, 81301003 and 81171079) and Special Research Project for Capital Health Development (grant no. 2014-1-1071). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backes D, 2014, STROKE, V45, P1299, DOI 10.1161/STROKEAHA.113.004421; Baharoglu MI, 2012, J NEUROSURG, V116, P871, DOI 10.3171/2011.11.JNS11311; Baumann F, 2008, ACT NEUR S, V103, P19; Byrne G, 2014, AM J NEURORADIOL, V35, P333, DOI 10.3174/ajnr.A3678; Cebral JR, 2011, AM J NEURORADIOL, V32, P145, DOI 10.3174/ajnr.A2419; Cebral JR, 2011, AM J NEURORADIOL, V32, P264, DOI 10.3174/ajnr.A2274; Cebral JR, 2005, AM J NEURORADIOL, V26, P2550; CRAWFORD T, 1959, J NEUROL NEUROSUR PS, V22, P259, DOI 10.1136/jnnp.22.4.259; CROMPTON MR, 1966, BRIT MED J, V1, P1138, DOI 10.1136/bmj.1.5496.1138; Ellamushi HE, 2001, J NEUROSURG, V94, P728, DOI 10.3171/jns.2001.94.5.0728; Frosen J, 2004, STROKE, V35, P2287, DOI 10.1161/01.STR.0000140636.30204.da; He XJ, 1996, J BIOMECH ENG-T ASME, V118, P74, DOI 10.1115/1.2795948; Hino A, 2000, NEUROSURGERY, V46, P825, DOI 10.1097/00006123-200004000-00011; Hoh BL, 2007, NEUROSURGERY, V61, P716, DOI 10.1227/01.NEU.0000298899.77097.BF; Jeon HJ, 2014, NEUROL RES, V36, P1056, DOI 10.1179/1743132814Y.0000000393; Jou LD, 2008, AM J NEURORADIOL, V29, P1761, DOI 10.3174/ajnr.A1180; Juvela S, 2000, STROKE, V31, P392, DOI 10.1161/01.STR.31.2.392; Kaminogo M, 2003, STROKE, V34, P16, DOI 10.1161/01.STR.0000046763.48330.AD; Kataoka K, 1999, STROKE, V30, P1396, DOI 10.1161/01.STR.30.7.1396; Kawaguchi T, 2012, J NEUROSURG, V117, P774, DOI 10.3171/2012.7.JNS111991; Lauric A, 2014, J NEUROINTERV SURG, V6, P466, DOI 10.1136/neurintsurg-2013-010871; Li CH, 2012, J NEUROSURG, V117, P276, DOI 10.3171/2012.5.JNS111558; Lu G, 2011, AM J NEURORADIOL, V32, P1255, DOI 10.3174/ajnr.A2461; Lu HT, 2013, CLIN NEUROL NEUROSUR, V115, P690, DOI 10.1016/j.clineuro.2012.08.011; Luo B, 2011, STROKE, V42, P745, DOI 10.1161/STROKEAHA.110.593517; Malek AM, 1999, JAMA-J AM MED ASSOC, V282, P2035, DOI 10.1001/jama.282.21.2035; Morita A, 2012, NEW ENGL J MED, V366, P2474, DOI 10.1056/NEJMoa1113260; Omodaka S, 2012, CEREBROVASC DIS, V34, P121, DOI 10.1159/000339678; Rahman M, 2011, NEUROSURGERY, V68, P155, DOI 10.1227/NEU.0b013e3181ff357c; Rinkel GJE, 1998, STROKE, V29, P251, DOI 10.1161/01.STR.29.1.251; RINNE J, 1994, NEUROSURGERY, V35, P803, DOI 10.1227/00006123-199411000-00001; Shojima M, 2004, STROKE, V35, P2500, DOI 10.1161/01.STR.0000144648.89172.0f; Tulamo R, 2010, J NEUROINTERV SURG, V2, P120, DOI 10.1136/jnis.2009.002055; Ujiie H, 2001, NEUROSURGERY, V48, P495, DOI 10.1097/00006123-200103000-00007; Ujiie H, 1999, NEUROSURGERY, V45, P119, DOI 10.1097/00006123-199907000-00028; Wang SZ, 2010, J HYDRODYN, V22, P639, DOI 10.1016/S1001-6058(09)60098-6; Xiang J, 2014, AM J NEURORADIOL, V35, P1849, DOI 10.3174/ajnr.A3710; Xiang JP, 2011, STROKE, V42, P144, DOI 10.1161/STROKEAHA.110.592923	38	46	55	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132494	10.1371/journal.pone.0132494	http://dx.doi.org/10.1371/journal.pone.0132494			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147995	Green Published, gold, Green Submitted			2022-12-26	WOS:000358157600289
J	Moustafa, DA; Scarff, JM; Garcia, PP; Cassidy, SKB; DiGiandomenico, A; Waag, DM; Inzana, TJ; Goldberg, JB				Moustafa, Dina A.; Scarff, Jennifer M.; Garcia, Preston P.; Cassidy, Sara K. B.; DiGiandomenico, Antonio; Waag, David M.; Inzana, Thomas J.; Goldberg, Joanna B.			Recombinant Salmonella Expressing Burkholderia mallei LPS O Antigen Provides Protection in a Murine Model of Melioidosis and Glanders	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; LIVE VECTOR VACCINES; ATTENUATED SALMONELLA; PSEUDOMONAS-AERUGINOSA; BALB/C MICE; CAPSULAR POLYSACCHARIDE; MONOCLONAL-ANTIBODIES; IMMUNE-RESPONSES; PSEUDOMALLEI LIPOPOLYSACCHARIDE; INTRANASAL IMMUNIZATION	Burkholderia pseudomallei and Burkholderia mallei are the etiologic agents of melioidosis and glanders, respectively. These bacteria are highly infectious via the respiratory route and can cause severe and often fatal diseases in humans and animals. Both species are considered potential agents of biological warfare; they are classified as category B priority pathogens. Currently there are no human or veterinary vaccines available against these pathogens. Consequently efforts are directed towards the development of an efficacious and safe vaccine. Lipopolysaccharide (LPS) is an immunodominant antigen and potent stimulator of host immune responses. B. mallei express LPS that is structurally similar to that expressed by B. pseudomallei, suggesting the possibility of constructing a single protective vaccine against melioidosis and glanders. Previous studies of others have shown that antibodies against B. mallei or B. pseudomallei LPS partially protect mice against subsequent lethal virulent Burkholderia challenge. In this study, we evaluated the protective efficacy of recombinant Salmonella enterica serovar Typhimurium SL3261 expressing B. mallei O antigen against lethal intranasal infection with Burkholderia thailandensis, a surrogate for biothreat Burkholderia spp. in a murine model that mimics melioidosis and glanders. All vaccine-immunized mice developed a specific antibody response to B. mallei and B. pseudomallei O antigen and to B. thailandensis and were significantly protected against challenge with a lethal dose of B. thailandensis. These results suggest that live-attenuated SL3261 expressing B. mallei O antigen is a promising platform for developing a safe and effective vaccine.	[Moustafa, Dina A.; Scarff, Jennifer M.; Garcia, Preston P.; Cassidy, Sara K. B.; DiGiandomenico, Antonio; Goldberg, Joanna B.] Univ Virginia, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA 22903 USA; [DiGiandomenico, Antonio] MedImmune LLC, Dept Infect Dis, Gaithersburg, MD USA; [Waag, David M.] US Army Med Res Inst Infect Dis USAMRIID, Bacteriol Div, Ft Detrick, MD USA; [Inzana, Thomas J.] Virginia Tech, Virginia Maryland Reg Coll Vet Med, Blacksburg, VA USA; [Inzana, Thomas J.] Virginia Tech, Virginia Tech Caril Sch Med, Blacksburg, VA USA; [Moustafa, Dina A.; Goldberg, Joanna B.] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA; [Moustafa, Dina A.; Goldberg, Joanna B.] Childrens Hosp Atlanta Inc, Atlanta, GA USA	University of Virginia; AstraZeneca; Medimmune; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Emory University	Goldberg, JB (corresponding author), Univ Virginia, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA 22903 USA.	joanna.goldberg@emory.edu	Scarff, Jennifer/M-7594-2019	Scarff, Jennifer/0000-0001-5419-5534; DiGiandomenico, Antonio/0000-0003-1745-647X	National Institutes of Health (NIH) [R21-AI073923, R21-AI081130]; NIH Infectious Disease Training Grant [T32-AI007046]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007046, R21AI081130, R21AI073923] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Infectious Disease Training Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) Grants R21-AI073923 to JBG and R21-AI081130 to TJI. JMS, PG, and SKBC were supported in part on an NIH Infectious Disease Training Grant (T32-AI007046) awarded to the University of Virginia.	Abilek K HSB, 1998, BIOHAZARD CHILLING T; Amemiya K, 2002, INFECT IMMUN, V70, P2319, DOI 10.1128/IAI.70.5.2319-2325.2002; Anuntagool N, 2006, AM J TROP MED HYG, V74, P348, DOI 10.4269/ajtmh.2006.74.348; Anuntagool N, 2002, MICROBIOL IMMUNOL, V46, P143, DOI 10.1111/j.1348-0421.2002.tb02679.x; Atkins T, 2002, INFECT IMMUN, V70, P5290, DOI 10.1128/IAI.70.9.5290-5294.2002; AuCoin DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035386; Avery O T, 1932, J Exp Med, V55, P769, DOI 10.1084/jem.55.5.769; Benitez AJ, 2009, CLIN VACCINE IMMUNOL, V16, P1272, DOI 10.1128/CVI.00089-09; Bondi SK, 2008, EXPERT REV VACCINES, V7, P1357, DOI 10.1586/14760584.7.9.1357; Bottex C, 2005, IMMUNOPHARM IMMUNOT, V27, P565, DOI 10.1080/08923970500493995; Brett PJ, 2011, INFECT IMMUN, V79, P961, DOI 10.1128/IAI.01023-10; Brett PJ, 2003, FEMS MICROBIOL LETT, V218, P323, DOI 10.1111/j.1574-6968.2003.tb11536.x; Brett PJ, 1996, INFECT IMMUN, V64, P2824, DOI 10.1128/IAI.64.7.2824-2828.1996; Brett PJ, 1998, INT J SYST BACTERIOL, V48, P317, DOI 10.1099/00207713-48-1-317; Bryan L E, 1994, Can J Infect Dis, V5, P170; Burtnick MN, 2002, J BACTERIOL, V184, P849, DOI 10.1128/JB.184.3.849-852.2002; CARTER PB, 1974, INFECT IMMUN, V10, P816, DOI 10.1128/IAI.10.4.816-822.1974; Charuchaimontri C, 1999, CLIN INFECT DIS, V29, P813, DOI 10.1086/520441; Chen K, 2010, IMMUNITY, V33, P479, DOI 10.1016/j.immuni.2010.09.013; Cheng AC, 2005, CLIN MICROBIOL REV, V18, P383, DOI 10.1128/CMR.18.2.383-416.2005; Cheng A C, 2005, Euro Surveill, V10, P11, DOI 10.2807/esm.10.03.00528-en; Conlan JW, 2005, VACCINE, V23, P2477, DOI 10.1016/j.vaccine.2004.10.034; Currie BJ, 2004, TROP MED INT HEALTH, V9, P1167, DOI 10.1111/j.1365-3156.2004.01328.x; Currie BJ, 2003, EUR RESPIR J, V22, P542, DOI 10.1183/09031936.03.00006203; Damron FH, 2013, APPL ENVIRON MICROB, V79, P4149, DOI 10.1128/AEM.00640-13; DeShazer D, 2004, J BACTERIOL, V186, P3938, DOI 10.1128/JB.186.12.3938-3950.2004; DeShazer D, 1998, MOL MICROBIOL, V30, P1081, DOI 10.1046/j.1365-2958.1998.01139.x; DiGiandomenico A, 2004, INFECT IMMUN, V72, P7012, DOI 10.1128/IAI.72.12.7012-7021.2004; DiGiandomenico A, 2007, P NATL ACAD SCI USA, V104, P4624, DOI 10.1073/pnas.0608657104; DiGiandomenico A, 2012, J EXP MED, V209, P1273, DOI 10.1084/jem.20120033; Estes DM, 2010, EXPERT REV ANTI-INFE, V8, P325, DOI [10.1586/eri.10.4, 10.1586/ERI.10.4]; Felgner PL, 2009, P NATL ACAD SCI USA, V106, P13499, DOI 10.1073/pnas.0812080106; Galen JE, 1997, VACCINE, V15, P700, DOI 10.1016/S0264-410X(96)00227-7; Galyov EE, 2010, ANNU REV MICROBIOL, V64, P495, DOI 10.1146/annurev.micro.112408.134030; GERMANIER R, 1975, J INFECT DIS, V131, P553, DOI 10.1093/infdis/131.5.553; Goldblatt D, 2000, CLIN EXP IMMUNOL, V119, P1, DOI 10.1046/j.1365-2249.2000.01109.x; Hall LJ, 2009, VACCINE, V27, P6894, DOI 10.1016/j.vaccine.2009.09.007; Healey GD, 2005, INFECT IMMUN, V73, P5945, DOI 10.1128/IAI.73.9.5945-5951.2005; Ho M, 1997, INFECT IMMUN, V65, P3648, DOI 10.1128/IAI.65.9.3648-3653.1997; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; Jones SM, 2002, J MED MICROBIOL, V51, P1055, DOI 10.1099/0022-1317-51-12-1055; Kespichayawattana W, 2004, MICROB PATHOGENESIS, V36, P287, DOI 10.1016/j.micpath.2004.01.001; Kiyono H, 2004, NAT REV IMMUNOL, V4, P699, DOI 10.1038/nri1439; Makela P. Helena, 2003, Southeast Asian Journal of Tropical Medicine and Public Health, V34, P249; Mastroeni P, 2003, J MED MICROBIOL, V52, P453, DOI 10.1099/jmm.0.05173-0; Meumann EM, 2012, CLIN INFECT DIS, V54, P362, DOI 10.1093/cid/cir808; Mittrucker HW, 2000, J LEUKOCYTE BIOL, V67, P457, DOI 10.1002/jlb.67.4.457; Morici LA, 2010, MICROB PATHOGENESIS, V48, P9, DOI 10.1016/j.micpath.2009.10.004; Nardelli-Haefliger D, 2005, VACCINE, V23, P3634, DOI 10.1016/j.vaccine.2005.02.019; Nelson M, 2004, J MED MICROBIOL, V53, P1177, DOI 10.1099/jmm.0.45766-0; Ngugi SA, 2010, VACCINE, V28, P7551, DOI 10.1016/j.vaccine.2010.08.058; Norris MH, 2011, INFECT IMMUN, V79, P4010, DOI 10.1128/IAI.05044-11; OBRIEN AD, 1982, INFECT IMMUN, V38, P948, DOI 10.1128/IAI.38.3.948-952.1982; Osorio M, 2009, INFECT IMMUN, V77, P1475, DOI 10.1128/IAI.00828-08; Pace D, 2013, EXPERT OPIN BIOL TH, V13, P11, DOI 10.1517/14712598.2012.725718; Pasetti MF, 2000, VACCINE, V18, P3208, DOI 10.1016/S0264-410X(00)00142-0; Pasetti MF, 2003, VACCINE, V21, P401, DOI 10.1016/S0264-410X(02)00472-3; Patel N, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00198; Pavot V, 2012, VACCINE, V30, P142, DOI 10.1016/j.vaccine.2011.11.003; Peacock SJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001488; Perrone LA, 2009, J VIROL, V83, P5726, DOI 10.1128/JVI.00207-09; PERRY MB, 1995, INFECT IMMUN, V63, P3348, DOI 10.1128/IAI.63.9.3348-3352.1995; PIER GB, 1995, INFECT IMMUN, V63, P2818, DOI 10.1128/IAI.63.8.2818-2825.1995; Qazi Omar, 2008, Trans R Soc Trop Med Hyg, V102 Suppl 1, pS58, DOI 10.1016/S0035-9203(08)70016-6; REED L. J., 1938, AMER JOUR HYG, V27, P493; Salerno-Goncalves R, 2003, J IMMUNOL, V170, P2734, DOI 10.4049/jimmunol.170.5.2734; Santosuosso M, 2006, INFECT IMMUN, V74, P4634, DOI 10.1128/IAI.00517-06; SCHLAGETER AM, 1990, INFECT IMMUN, V58, P1914, DOI 10.1128/IAI.58.6.1914-1918.1990; Schwarz S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001068; Schweizer HP, 2008, EMERG INFECT DIS, V14, P1689, DOI [10.3201/eid1411.080431, 10.3201/eid1407.071501]; Silva EB, 2013, INFECT IMMUN, V81, P4626, DOI 10.1128/IAI.00915-13; Sirard JC, 1999, IMMUNOL REV, V171, P5, DOI 10.1111/j.1600-065X.1999.tb01340.x; Smith MD, 1997, INFECT IMMUN, V65, P4319, DOI 10.1128/IAI.65.10.4319-4321.1997; Stevens MP, 2004, MICROBIOL-SGM, V150, P2669, DOI 10.1099/mic.0.27146-0; Stone JK, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-250; Suwannasaen D, 2011, J INFECT DIS, V203, P1002, DOI 10.1093/infdis/jiq142; SZTEIN MB, 1994, J INFECT DIS, V170, P1508, DOI 10.1093/infdis/170.6.1508; Trevino SR, 2006, INFECT IMMUN, V74, P1958, DOI 10.1128/IAI.74.3.1958-1961.2006; Tuanyok A, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001453; Uppington H, 2006, IMMUNOLOGY, V119, P147, DOI 10.1111/j.1365-2567.2006.02416.x; Varga JJ, 2012, VIRULENCE, V3, P510, DOI 10.4161/viru.22056; Warner Jeffrey M., 2010, Papua New Guinea Medical Journal, V53, P176; West T Eoin, 2008, Trans R Soc Trop Med Hyg, V102 Suppl 1, pS119, DOI 10.1016/S0035-9203(08)70028-2; Wheelis M, 1998, NATURE, V395, P213, DOI 10.1038/26089; Wick MJ, 2011, J INNATE IMMUN, V3, P543, DOI 10.1159/000330771; Wiersinga WJ, 2006, NAT REV MICROBIOL, V4, P272, DOI 10.1038/nrmicro1385; Woods DE, 1999, MICROBES INFECT, V1, P157, DOI 10.1016/S1286-4579(99)80007-0; Wuthiekanun V, 1996, J MED MICROBIOL, V45, P408, DOI 10.1099/00222615-45-6-408; Zhang SM, 2011, CLIN VACCINE IMMUNOL, V18, P825, DOI 10.1128/CVI.00533-10; Zhao ZP, 2009, VACCINE, V27, P5214, DOI 10.1016/j.vaccine.2009.06.075	92	12	13	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132032	10.1371/journal.pone.0132032	http://dx.doi.org/10.1371/journal.pone.0132032			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148026	Green Submitted, Green Published, gold			2022-12-26	WOS:000358157600183
J	Sheng, H; Nakamura, K; Kanno, T; Sasaki, K; Niwano, Y				Sheng, Hong; Nakamura, Keisuke; Kanno, Taro; Sasaki, Keiichi; Niwano, Yoshimi			Bactericidal Effect of Photolysis of H2O2 in Combination with Sonolysis of Water via Hydroxyl Radical Generation	PLOS ONE			English	Article							LOW-INTENSITY ULTRASOUND; ELECTRON-SPIN-RESONANCE; HYDROGEN-PEROXIDE; DISINFECTION SYSTEM; ANTIBIOTIC ACTION; ENHANCEMENT; OH	The bactericidal effect of hydroxyl radical (center dot OH) generated by combination of photolysis of hydrogen peroxide (H2O2) and sonolysis of water was examined under the condition in which the yield of center dot OH increased additively when H2O2 aqueous solution was concomitantly irradiated with laser and ultrasound. The suspension of Staphylococcus aureus mixed with the different concentrations of H2O2 was irradiated simultaneously with a laser light (wavelength: 405 nm, irradiance: 46 and 91 mW/cm(2)) and ultrasound (power: 30 w, frequency: 1.65 MHz) at 20 +/- 1 degrees C of the water bulk temperature for 2 min. The combination of laser and ultrasound irradiation significantly reduced the viable bacterial count in comparison with the laser irradiation of H2O2 alone. By contrast, the ultrasound irradiation alone exerted almost no bactericidal effect. These results suggested that the combination effect of photolysis of H2O2 and sonolysis of water on bactericidal activity was synergistic. A multi-way analysis of variance also revealed that the interaction of H2O2 concentration, laser power and ultrasound irradiation significantly affected the bactericidal activity. Since the result of oxidative DNA damage evaluation demonstrated that the combination of laser and ultrasound irradiation significantly induced oxidative damage of bacterial DNA in comparison with the laser irradiation of H2O2 alone, it was suggested that the combination effect of photolysis of H2O2 and sonolysis of water on bactericidal activity would be exerted via oxidative damage of cellular components such as DNA.	[Sheng, Hong; Sasaki, Keiichi] Tohoku Univ, Grad Sch Dent, Div Adv Prosthet Dent, Sendai, Miyagi 980, Japan; [Nakamura, Keisuke; Niwano, Yoshimi] Tohoku Univ, Grad Sch Dent, Lab Redox Regulat, Sendai, Miyagi 980, Japan; [Kanno, Taro] Tohoku Univ, Grad Sch Dent, Div Mol & Regenerat Prosthodont, Sendai, Miyagi 980, Japan	Tohoku University; Tohoku University; Tohoku University	Sheng, H (corresponding author), Tohoku Univ, Grad Sch Dent, Div Adv Prosthet Dent, Sendai, Miyagi 980, Japan.	dentistseikou@dent.tohoku.ac.jp	Niwnao, Yoshimi/Z-3593-2019		Ministry of Education, Science, Sports and Culture, Japan [26460116]	Ministry of Education, Science, Sports and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported by the Ministry of Education, Science, Sports and Culture, Japan, Grant-in-Aid for Scientific Research (C), 26460116,2014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augusto O., 2012, PRINCIPLES FREE RADI, P19; BADWEY JA, 1980, ANNU REV BIOCHEM, V49, P695, DOI 10.1146/annurev.bi.49.070180.003403; Buege J A, 1978, Methods Enzymol, V52, P302; BUETTNER GR, 1987, FREE RADICAL BIO MED, V3, P259, DOI 10.1016/S0891-5849(87)80033-3; CLIFFORD DP, 1982, MOL CELL BIOCHEM, V49, P143, DOI 10.1007/BF00231175; Fukuda S, 2001, JPN J APPL PHYS 1, V40, P3493, DOI 10.1143/JJAP.40.3493; GLAZE WH, 1987, OZONE-SCI ENG, V9, P335; Guo QQ, 2011, CHEM COMMUN, V47, P11906, DOI 10.1039/c1cc14699h; Halliwell B., 2007, FREE RADICALS BIOL M; HARBOUR JR, 1974, CAN J CHEM, V52, P3549, DOI 10.1139/v74-527; Hayashi E, 2012, J BIOSCI BIOENG, V114, P193, DOI 10.1016/j.jbiosc.2012.03.020; Ikai H, 2010, ANTIMICROB AGENTS CH, V54, P5086, DOI 10.1128/AAC.00751-10; Iwasawa A, 2009, J CLIN BIOCHEM NUTR, V45, P214, DOI 10.3164/jcbn.08-261; Kasai H, 1997, MUTAT RES-REV MUTAT, V387, P147, DOI 10.1016/S1383-5742(97)00035-5; Kim JO, 1999, APPL ACOUST, V58, P211, DOI 10.1016/S0003-682X(98)00039-5; Kobayashi Y, 2014, J ORAL SCI, V56, P35, DOI 10.2334/josnusd.56.35; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Kohno M, 2011, J CLIN BIOCHEM NUTR, V49, P96, DOI 10.3164/jcbn.10-130; KONDO T, 1988, INT J RADIAT BIOL, V54, P955, DOI 10.1080/09553008814552351; Liu B, 2011, ULTRASON SONOCHEM, V18, P1052, DOI 10.1016/j.ultsonch.2011.02.001; MAKINO K, 1982, J AM CHEM SOC, V104, P3537, DOI 10.1021/ja00376a064; Maverakis E, 2010, J AUTOIMMUN, V34, pJ247, DOI 10.1016/j.jaut.2009.11.011; Munter R., 2001, P EST ACAD SCI, V50, P59, DOI DOI 10.1002/CHIN.200141291; Nakamura K, J AGR FOOD CHEM; Nakamura K, 2012, J AGR FOOD CHEM, V60, P10048, DOI 10.1021/jf303177p; Nakamura K, 2010, B CHEM SOC JPN, V83, P1037, DOI 10.1246/bcsj.20100078; Norihisa T, 2008, J SOC AUTO ENG JPN, V62, P92; Odashima Y, 2014, J CHEMOTHERAPY, V26, P92, DOI 10.1179/1973947813Y.0000000114; PITT WG, 1994, ANTIMICROB AGENTS CH, V38, P2577, DOI 10.1128/AAC.38.11.2577; Piyasena P, 2003, INT J FOOD MICROBIOL, V87, P207, DOI 10.1016/s0168-1605(03)00075-8; Qian Z, 1996, BIOMATERIALS, V17, P1975, DOI 10.1016/0142-9612(96)00022-1; Rediske AM, 1998, J GEN APPL MICROBIOL, V44, P283, DOI 10.2323/jgam.44.283; Redmond RW, 2006, PHOTOCHEM PHOTOBIOL, V82, P1178, DOI 10.1562/2006-04-14-IR-874; RIESZ P, 1992, FREE RADICAL BIO MED, V13, P247, DOI 10.1016/0891-5849(92)90021-8; ROOTS R, 1975, RADIAT RES, V64, P306, DOI 10.2307/3574267; Rutala WA, 1996, INFECT CONTROL, V24, P313; Sakai K, 2007, LASER PHYS, V17, P1062, DOI 10.1134/S1054660X07080075; Shirai A, 2014, J PHOTOCH PHOTOBIO B, V130, P226, DOI 10.1016/j.jphotobiol.2013.11.027; Shirato M, 2012, ANTIMICROB AGENTS CH, V56, P295, DOI 10.1128/AAC.05158-11; Tachibana K, 2008, ULTRASONICS, V48, P253, DOI 10.1016/j.ultras.2008.02.003; Takahashi Hiroshi, 2005, Journal of Nippon Medical School, V72, P4, DOI 10.1272/jnms.72.4; Takahashi M, 2007, J PHYS CHEM B, V111, P1343, DOI 10.1021/jp0669254; Toki T, 2015, J BIOSCI BIOENG, V119, P358, DOI 10.1016/j.jbiosc.2014.08.015; Usui M, 2011, JON J CONSERVATIVE D, V54, P424; Wright GD, 2007, CELL, V130, P781, DOI 10.1016/j.cell.2007.08.023; Yu H, 2012, ULTRASON SONOCHEM, V19, P377, DOI 10.1016/j.ultsonch.2011.11.010	46	21	21	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132445	10.1371/journal.pone.0132445	http://dx.doi.org/10.1371/journal.pone.0132445			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148024	gold, Green Published, Green Submitted			2022-12-26	WOS:000358157600272
J	Stockdale, SR; Collins, B; Spinelli, S; Douillard, FP; Mahony, J; Cambillau, C; van Sinderen, D				Stockdale, Stephen R.; Collins, Barry; Spinelli, Silvia; Douillard, Franois P.; Mahony, Jennifer; Cambillau, Christian; van Sinderen, Douwe			Structure and Assembly of TP901-1 Virion Unveiled by Mutagenesis	PLOS ONE			English	Article							LACTOCOCCAL BACTERIOPHAGE TP901-1; MULTIPLE SEQUENCE ALIGNMENT; PROTEIN HOMOLOGY DETECTION; TAIL-TERMINATOR PROTEIN; PHAGE-LAMBDA; CRYSTAL-STRUCTURE; BINDING PROTEIN; 3-DIMENSIONAL STRUCTURE; LENGTH DETERMINATION; ELECTRON-MICROSCOPY	Bacteriophages of the Siphoviridae family represent the most abundant viral morphology in the biosphere, yet many molecular aspects of their virion structure, assembly and associated functions remain to be unveiled. In this study, we present a comprehensive mutational and molecular analysis of the temperate Lactococcus lactis-infecting phage TP901-1. Fourteen mutations located within the structural module of TP901-1 were created; twelve mutations were designed to prevent full length translation of putative proteins by non-sense mutations, while two additional mutations caused aberrant protein production. Electron microscopy and Western blot analysis of mutant virion preparations, as well as in vitro assembly of phage mutant combinations, revealed the essential nature of many of the corresponding gene products and provided information on their biological function(s). Based on the information obtained, we propose a functional and assembly model of the TP901-1 Siphoviridae virion.	[Stockdale, Stephen R.; Collins, Barry; Douillard, Franois P.; Mahony, Jennifer; van Sinderen, Douwe] Natl Univ Ireland Univ Coll Cork, Sch Microbiol, Cork, Ireland; [Spinelli, Silvia; Cambillau, Christian] Aix Marseille Univ, Architecture & Fonct Macromol Biol, F-13288 Marseille 09, France; [Cambillau, Christian] CNRS, AFMB, F-13288 Marseille 09, France; [van Sinderen, Douwe] Natl Univ Ireland Univ Coll Cork, Alimentary Pharmabiot Ctr, Cork, Ireland	University College Cork; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); University College Cork	van Sinderen, D (corresponding author), Natl Univ Ireland Univ Coll Cork, Sch Microbiol, Western Rd, Cork, Ireland.	d.vansinderen@ucc.ie	Van Sinderen, Douwe/A-6778-2015; mahony, jennifer/AAG-8357-2020	Van Sinderen, Douwe/0000-0003-1823-7957; mahony, jennifer/0000-0001-5846-6303; Stockdale, Stephen/0000-0002-0044-3878	Science Foundation Ireland (SFI) [08/IN.1/B1909]; French National Research Agency (ANR) [ANR-11-BSV8-004-01 Lacto-Phages]	Science Foundation Ireland (SFI)(Science Foundation Ireland); French National Research Agency (ANR)(French National Research Agency (ANR))	Work in the team of DVS was funded by Science Foundation Ireland (SFI; http://www.sfi.ie/) Principal Investigatorship award (Ref. No. 08/IN.1/B1909). Work in the team of CC was funded by a French National Research Agency (ANR; http://www.agence-nationale-recherche.fr/) grant (ANR-11-BSV8-004-01 Lacto-Phages). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth S, 2013, APPL ENVIRON MICROB; Aksyuk AA, 2011, VIRUSES-BASEL, V3, P172, DOI 10.3390/v3030172; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; BAZINET C, 1988, J MOL BIOL, V202, P77, DOI 10.1016/0022-2836(88)90520-7; Bebeacua C, 2013, J VIROL, V87, P12302, DOI 10.1128/JVI.02033-13; Bebeacua C, 2013, J VIROL, V87, P1061, DOI 10.1128/JVI.02836-12; Bebeacua C, 2010, J BIOL CHEM, V285, P39079, DOI 10.1074/jbc.M110.175646; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Boulanger P, 2008, J BIOL CHEM, V283, P13556, DOI 10.1074/jbc.M800052200; Breitbart M, 2003, J BACTERIOL, V185, P6220, DOI 10.1128/JB.185.20.6220-6223.2003; Brondsted L, 2001, VIROLOGY, V283, P93, DOI 10.1006/viro.2001.0871; Brussow H, 2004, MICROBIOL MOL BIOL R, V68, P560, DOI 10.1128/MMBR.68.3.560-602.2004; Campanacci V, 2010, J STRUCT BIOL, V172, P75, DOI 10.1016/j.jsb.2010.02.007; Cardarelli L, 2010, J MOL BIOL, V395, P754, DOI 10.1016/j.jmb.2009.10.067; CASJENS SR, 1974, J MOL BIOL, V88, P535, DOI 10.1016/0022-2836(74)90500-2; Chagot B, 2012, PROTEINS, V80, P319, DOI 10.1002/prot.23191; Chatterjee S, 2012, VIRUSES-BASEL, V4, P3162, DOI 10.3390/v4113162; Collins B, 2013, J VIROL, V87, P8429, DOI 10.1128/JVI.00907-13; Cuff JA, 2000, PROTEINS, V40, P502, DOI 10.1002/1097-0134(20000815)40:3<502::AID-PROT170>3.0.CO;2-Q; Dokland T, 1999, CELL MOL LIFE SCI, V56, P580, DOI 10.1007/s000180050455; Dorscht J, 2009, J BACTERIOL, V191, P7206, DOI 10.1128/JB.01041-09; Dosztanyi Z, 2005, J MOL BIOL, V347, P827, DOI 10.1016/j.jmb.2005.01.071; Douillard FP, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-66; Droge A, 2000, J MOL BIOL, V296, P117, DOI 10.1006/jmbi.1999.3450; Edmonds L, 2007, J MOL BIOL, V365, P175, DOI 10.1016/j.jmb.2006.09.068; Edwards RA, 2005, NAT REV MICROBIOL, V3, P504, DOI 10.1038/nrmicro1163; Goulet A, 2011, J BIOL CHEM, V286, P25397, DOI 10.1074/jbc.M111.243360; GUO PX, 1991, VIROLOGY, V183, P366, DOI 10.1016/0042-6822(91)90149-6; Hendrix RW, 2012, ADV EXP MED BIOL, V726, P351, DOI 10.1007/978-1-4614-0980-9_15; Johnson JE, 2007, CURR OPIN STRUC BIOL, V17, P237, DOI 10.1016/j.sbi.2007.03.011; Johnson JE, 2010, CURR OPIN STRUC BIOL, V20, P210, DOI 10.1016/j.sbi.2010.01.004; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; KATSURA I, 1976, J MOL BIOL, V107, P307, DOI 10.1016/S0022-2836(76)80007-1; KATSURA I, 1977, VIROLOGY, V76, P129, DOI 10.1016/0042-6822(77)90290-2; KATSURA I, 1984, CELL, V39, P691, DOI 10.1016/0092-8674(84)90476-8; Kenny JG, 2004, J BACTERIOL, V186, P3480, DOI 10.1128/JB.186.11.3480-3491.2004; Koch B, 1997, APPL ENVIRON MICROB, V63, P2439, DOI 10.1128/AEM.63.6.2439-2441.1997; Kuipers OP, 1998, J BIOTECHNOL, V64, P15, DOI 10.1016/S0168-1656(98)00100-X; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Letarov A, 2009, J APPL MICROBIOL, V107, P1, DOI 10.1111/j.1365-2672.2009.04143.x; Lhuillier S, 2009, P NATL ACAD SCI USA, V106, P8507, DOI 10.1073/pnas.0812407106; Lillehaug D, 1997, J APPL MICROBIOL, V83, P85, DOI 10.1046/j.1365-2672.1997.00193.x; Mahony J, 2013, APPL ENVIRON MICROB, V79, P4385, DOI 10.1128/AEM.00653-13; Mateu MG, 2013, ARCH BIOCHEM BIOPHYS, V531, P65, DOI 10.1016/j.abb.2012.10.015; Mc Grath S, 2006, J BACTERIOL, V188, P3972, DOI 10.1128/JB.00024-06; Minot S, 2011, GENOME RES, V21, P1616, DOI 10.1101/gr.122705.111; Newcomb WW, 2003, J VIROL, V77, P9862, DOI 10.1128/JVI.77.18.9862-9871.2003; Olia AS, 2011, NAT STRUCT MOL BIOL, V18, P597, DOI 10.1038/nsmb.2023; Ouali M, 2000, PROTEIN SCI, V9, P1162, DOI 10.1110/ps.9.6.1162; Pedersen M, 2000, VIROLOGY, V276, P315, DOI 10.1006/viro.2000.0497; Pell LG, 2013, J MOL BIOL, V425, P2436, DOI 10.1016/j.jmb.2013.03.035; Pell LG, 2009, J MOL BIOL, V389, P938, DOI 10.1016/j.jmb.2009.04.072; Pell LG, 2009, P NATL ACAD SCI USA, V106, P4160, DOI 10.1073/pnas.0900044106; Plisson C, 2007, EMBO J, V26, P3720, DOI 10.1038/sj.emboj.7601786; Popovic A, 2012, J BIOL CHEM, V287, P32085, DOI 10.1074/jbc.M112.378349; PREVELIGE PE, 1993, BIOPHYS J, V64, P824, DOI 10.1016/S0006-3495(93)81443-7; Roces C, 2013, J GEN VIROL, V94, P2814, DOI 10.1099/vir.0.057182-0; Rost B, 2001, J STRUCT BIOL, V134, P204, DOI 10.1006/jsbi.2001.4336; Sambrook J, 1998, MOL CLONING LAB MANU, V2nd; Sassi M, 2013, J VIROL, V87, P8099, DOI 10.1128/JVI.01209-13; Sciara G, 2008, J BIOL CHEM, V283, P2716, DOI 10.1074/jbc.M707533200; Sciara G, 2010, P NATL ACAD SCI USA, V107, P6852, DOI 10.1073/pnas.1000232107; Seegers JFML, 2004, VIROLOGY, V329, P40, DOI 10.1016/j.virol.2004.07.003; Shepherd DA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009787; Siponen M, 2009, J BACTERIOL, V191, P728, DOI 10.1128/JB.01363-08; Siponen M, 2009, J BACTERIOL, V191, P3220, DOI 10.1128/JB.01637-08; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Spinelli S, 2006, NAT STRUCT MOL BIOL, V13, P85, DOI 10.1038/nsmb1029; Spinelli S, 2006, J BIOL CHEM, V281, P14256, DOI 10.1074/jbc.M600666200; Stiege AC, 2003, MOL MICROBIOL, V49, P1201, DOI 10.1046/j.1365-2958.2003.03631.x; Stockdale SR, 2013, J BIOL CHEM, V288, P5581, DOI 10.1074/jbc.M112.444901; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; ThumanCommike PA, 1996, J MOL BIOL, V260, P85, DOI 10.1006/jmbi.1996.0383; Van Pijkeren JP, 2012, BIOENGINEERED, V3, P209, DOI 10.4161/bioe.21049; van Pijkeren JP, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks147; vanSinderen D, 1996, MOL MICROBIOL, V19, P1343, DOI 10.1111/j.1365-2958.1996.tb02478.x; Veesler D, 2012, P NATL ACAD SCI USA, V109, P8954, DOI 10.1073/pnas.1200966109; Veesler D, 2011, MICROBIOL MOL BIOL R, V75, P423, DOI 10.1128/MMBR.00014-11; Veesler D, 2010, J BIOL CHEM, V285, P36666, DOI 10.1074/jbc.M110.157529; Vegge CS, 2006, APPL ENVIRON MICROB, V72, P6815, DOI 10.1128/AEM.01033-06; Vegge CS, 2006, J BACTERIOL, V188, P55, DOI 10.1128/JB.188.1.55-63.2006; Vegge CS, 2005, J BACTERIOL, V187, P4187, DOI 10.1128/JB.187.12.4187-4197.2005; Ventura M, 2007, APPL ENVIRON MICROB, V73, P7771, DOI 10.1128/AEM.01273-07; Vinga I, 2006, MOL MICROBIOL, V61, P1609, DOI 10.1111/j.1365-2958.2006.05327.x; WEIGLE J, 1966, P NATL ACAD SCI USA, V55, P1462, DOI 10.1073/pnas.55.6.1462; White HE, 2012, J VIROL, V86, P6768, DOI 10.1128/JVI.00412-12; Wikoff WR, 2000, SCIENCE, V289, P2129, DOI 10.1126/science.289.5487.2129; Xu J, 2004, MOL CELL, V16, P11, DOI 10.1016/j.molcel.2004.09.006; Xu J, 2014, J MOL BIOL, V426, P1004, DOI 10.1016/j.jmb.2013.06.040; Xu J, 2013, J MOL BIOL, V425, P3476, DOI 10.1016/j.jmb.2013.07.002; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485; Zivanovic Y, 2014, J VIROL, V88, P1162, DOI 10.1128/JVI.02262-13	94	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131676	10.1371/journal.pone.0131676	http://dx.doi.org/10.1371/journal.pone.0131676			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147978	Green Published, gold, Green Submitted			2022-12-26	WOS:000358157600126
J	Torres, DJ; Ricoy, UM; Roybal, S				Torres, David J.; Ricoy, Ulises M.; Roybal, Shanae			Modeling Honey Bee Populations	PLOS ONE			English	Article							APIS-MELLIFERA L.; BEHAVIORAL MATURATION; PRIMER PHEROMONE; WORKER; DYNAMICS; COLONIES; FAILURE; POLYETHISM; COLLAPSE; GROWTH	Eusocial honey bee populations (Apis mellifera) employ an age stratification organization of egg, larvae, pupae, hive bees and foraging bees. Understanding the recent decline in honey bee colonies hinges on understanding the factors that impact each of these different age castes. We first perform an analysis of steady state bee populations given mortality rates within each bee caste and find that the honey bee colony is highly susceptible to hive and pupae mortality rates. Subsequently, we study transient bee population dynamics by building upon the modeling foundation established by Schmickl and Crailsheim and Khoury et al. Our transient model based on differential equations accounts for the effects of pheromones in slowing the maturation of hive bees to foraging bees, the increased mortality of larvae in the absence of sufficient hive bees, and the effects of food scarcity. We also conduct sensitivity studies and show the effects of parameter variations on the colony population.	[Torres, David J.] Northern New Mexico Coll, Dept Math & Phys Sci, Espanola, NM 87532 USA; [Ricoy, Ulises M.; Roybal, Shanae] Northern New Mexico Coll, Dept Biol, Espanola, NM USA		Torres, DJ (corresponding author), Northern New Mexico Coll, Dept Math & Phys Sci, Espanola, NM 87532 USA.	davytorres@nnmc.edu	Torres, David/ABB-9663-2021	Torres, David/0000-0003-2469-5284; Ricoy, Ulises/0000-0002-8545-0865	NSF NMSU Alliance for Minority Participation Grant [HRD-1305011]; Direct For Education and Human Resources [1305011] Funding Source: National Science Foundation	NSF NMSU Alliance for Minority Participation Grant; Direct For Education and Human Resources(National Science Foundation (NSF)NSF- Directorate for Education & Human Resources (EHR))	This work was supported by NSF NMSU Alliance for Minority Participation Grant, HRD-1305011. The grant supports faculty mentored student research projects.	Anderson J., 1931, BEE WORLD, V12, P25; Becher MA, 2014, J APPL ECOL, V51, P470, DOI 10.1111/1365-2664.12222; Becher MA, 2013, J APPL ECOL, V50, P868, DOI 10.1111/1365-2664.12112; Bodenheimer FS, 1937, Q REV BIOL, V12, P406, DOI 10.1086/394540; BRETSCHKO J, 1995, NATURGEMASSE BIENENZ, P292; Buhlmann G., 1985, Mitteilungen der Deutschen Gesellschaft fuer Allgemeine und Angewandte Entomologie, V4, P312; Castillo C, 2012, INSECT BIOCHEM MOLEC, V42, P404, DOI 10.1016/j.ibmb.2012.02.002; Chauzat MP, 2014, 10 COLOSS C 2014 SEP, P7; DEGRANDIHOFFMAN G, 1989, ECOL MODEL, V45, P133, DOI 10.1016/0304-3800(89)90088-4; EISCHEN FA, 1984, J APICULT RES, V23, P90, DOI 10.1080/00218839.1984.11100615; Evans EC, 2010, WHY DO BEES BUZZ FAS; Evans JD, 2010, J INVERTEBR PATHOL, V103, pS62, DOI 10.1016/j.jip.2009.06.019; Free J. B., 1959, Proceedings of the Royal Entomological Society of London (A), V34, P141; Fukuda H., 1968, Researches on Population Ecology Kyoto University, V10, P31, DOI 10.1007/BF02514731; FUKUDA H, 1983, RES POPUL ECOL, V25, P249, DOI 10.1007/BF02515602; FUKUDA HIROMI, 1966, JAP J ECOL, V16, P206; HARBO JR, 1993, J APICULT RES, V32, P11, DOI 10.1080/00218839.1993.11101282; HAYDAK MH, 1970, ANNU REV ENTOMOL, V15, P143, DOI 10.1146/annurev.en.15.010170.001043; Imdorf A., 2008, ALP FORUM, V68, P1; Johnson BR, 2008, BEHAV ECOL SOCIOBIOL, V62, P777, DOI 10.1007/s00265-007-0503-2; Johnson BR, 2010, BEHAV ECOL SOCIOBIOL, V64, P305, DOI 10.1007/s00265-009-0874-7; Johnson RM, 2015, ANNU REV ENTOMOL, V60, P415, DOI 10.1146/annurev-ento-011613-162005; Khoury DS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059084; Khoury DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018491; KUNERT K, 1988, J APICULT RES, V27, P13, DOI 10.1080/00218839.1988.11100775; Leoncini I, 2004, P NATL ACAD SCI USA, V101, P17559, DOI 10.1073/pnas.0407652101; Martin SJ, 2001, J APPL ECOL, V38, P1082, DOI 10.1046/j.1365-2664.2001.00662.x; MORITZ B, 1987, J INSECT PHYSIOL, V33, P923, DOI 10.1016/0022-1910(87)90004-7; OMHOLT SW, 1986, J APICULT RES, V25, P9, DOI 10.1080/00218839.1986.11100686; Perry CJ, 2015, P NATL ACAD SCI USA, V112, P3427, DOI 10.1073/pnas.1422089112; Remolina SC, 2008, AGE, V30, P177, DOI 10.1007/s11357-008-9061-4; Rueppell O, 2008, BEHAV ECOL SOCIOBIOL, V62, P1621, DOI 10.1007/s00265-008-0591-7; Rueppell O, 2007, EXP GERONTOL, V42, P1020, DOI 10.1016/j.exger.2007.06.002; Rueppell O, 2009, EXP GERONTOL, V44, P447, DOI 10.1016/j.exger.2009.04.003; Russell S, 2013, ECOL MODEL, V265, P158, DOI 10.1016/j.ecolmodel.2013.06.005; Sagili RR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016785; SAKAGAMI S F, 1968, Researches on Population Ecology (Tokyo), V10, P127, DOI 10.1007/BF02510869; Schmickl T, 2007, ECOL MODEL, V204, P219, DOI 10.1016/j.ecolmodel.2007.01.001; SEELEY TD, 1982, BEHAV ECOL SOCIOBIOL, V11, P287, DOI 10.1007/BF00299306; Stabe HA, 1930, J ECON ENTOMOL, V23, P447, DOI 10.1093/jee/23.2.447; The White House, 2014, FACT SHEET EC CHALL; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; WANG DER-I, 1965, J APICULT RES, V4, P3	43	28	28	9	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0130966	10.1371/journal.pone.0130966	http://dx.doi.org/10.1371/journal.pone.0130966			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148010	Green Published, Green Submitted, gold			2022-12-26	WOS:000358157600055
J	Zhao, MM; San Leon, D; Mesel, F; Garcia, JA; Simion-Mateo, C				Zhao, Mingmin; San Leon, David; Mesel, Frida; Antonio Garcia, Juan; Simion-Mateo, Carmen			Assorted Processing of Synthetic Trans-Acting siRNAs and Its Activity in Antiviral Resistance	PLOS ONE			English	Article							PLUM-POX-VIRUS; SMALL INTERFERING RNAS; DOUBLE-STRANDED RNAS; FUNCTIONAL DIVERSIFICATION; ARTIFICIAL MICRORNAS; BIOGENESIS; SECONDARY; PLANTS; 22-NUCLEOTIDE; GENERATION	The use of syn-tasiRNAs has been proposed as an RNA interference technique alternative to those previously described: hairpin based, virus induced gene silencing or artificial miRNAs. In this study we engineered the TAS1c locus to impair Plum pox virus (PPV) infection by replacing the five native siRNAs with two 210-bp fragments from the CP and the 3'NCR regions of the PPV genome. Deep sequencing analysis of the small RNA species produced by both constructs in planta has shown that phased processing of the syn-tasiRNAs is construct-specific. While in syn-tasiR-CP construct the processing was as predicted 21-nt phased in register with miR173-guided cleavage, the processing of syn-tasiR-3NCR is far from what was expected. A 22-nt species from the miR173-guided cleavage was a guide of two series of phased small RNAs, one of them in an exact 21-nt register, and the other one in a mixed of 21-/22-nt frame. In addition, both constructs produced abundant PPV-derived small RNAs in the absence of miR173 as a consequence of a strong sense post-transcriptional gene silencing induction. The antiviral effect of both constructs was also evaluated in the presence or absence of miR173 and showed that the impairment of PPV infection was not significantly higher when miR173 was present. The results show that syn-tasiRNAs processing depends on construct-specific factors that should be further studied before the so-called MIGS (miRNA-induced gene silencing) technology can be used reliably.	[Zhao, Mingmin; San Leon, David; Mesel, Frida; Antonio Garcia, Juan; Simion-Mateo, Carmen] Campus Univ Autonoma Madrid, Dept Genet Mol Plantas, Ctr Nacl Biotecnol CNB CSIC, Madrid 28049, Spain; [Simion-Mateo, Carmen] Yangtze Univ, Coll Agr, Jingzhou 434025, Hubei, Peoples R China	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Yangtze University	Simion-Mateo, C (corresponding author), Campus Univ Autonoma Madrid, Dept Genet Mol Plantas, Ctr Nacl Biotecnol CNB CSIC, Madrid 28049, Spain.	csimon@cnb.csic.es	Garcia, Juan Antonio/N-3723-2014; Simon Mateo, Carmen/D-4878-2013	Garcia, Juan Antonio/0000-0002-4861-9609; Simon Mateo, Carmen/0000-0002-4251-0821; San Leon Granado, David/0000-0001-8138-500X	Spanish Ministerio de Economia and Competitividad [BIO2010-18541, BIO2013-49053-R]; European Union [KBBE-204429]	Spanish Ministerio de Economia and Competitividad; European Union(European Commission)	Support was provided by grant numbers BIO2010-18541 and BIO2013-49053-R from the Spanish Ministerio de Economia and Competitividad (http://www.mineco.gob.es/) and grant number KBBE-204429 from the European Union (http://www.plantkbbe-submission.net/).	Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Garcia JA, 2006, NAT BIOTECHNOL, V24, P1358, DOI 10.1038/nbt1106-1358; Garcia JA, 2014, MOL PLANT PATHOL, V15, P226, DOI 10.1111/mpp.12083; Axtell MJ, 2006, CELL, V127, P565, DOI 10.1016/j.cell.2006.09.032; Axtell MJ, 2013, ANNU REV PLANT BIOL, V64, P137, DOI 10.1146/annurev-arplant-050312-120043; Baulcombe D, 2005, TRENDS BIOCHEM SCI, V30, P290, DOI 10.1016/j.tibs.2005.04.012; Baulcombe DC, 2007, SCIENCE, V315, P199, DOI 10.1126/science.1138030; Beclin C, 2002, CURR BIOL, V12, P684, DOI 10.1016/S0960-9822(02)00792-3; Boccara M, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003883; Carbonell A, 2014, PLANT PHYSIOL, V165, P15, DOI 10.1104/pp.113.234989; Carbonell A, 2013, MOL PLANT MICROBE IN, V26, P1211, DOI 10.1094/MPMI-04-13-0093-R; Carbonell A, 2012, PLANT CELL, V24, P3613, DOI 10.1105/tpc.112.099945; Chen HM, 2007, P NATL ACAD SCI USA, V104, P3318, DOI 10.1073/pnas.0611119104; Chen HM, 2010, P NATL ACAD SCI USA, V107, P15269, DOI 10.1073/pnas.1001738107; Chitwood DH, 2007, DEVELOPMENT, V134, P813, DOI 10.1242/dev.000497; Cuperus JT, 2011, PLANT CELL, V23, P431, DOI 10.1105/tpc.110.082784; Cuperus JT, 2010, NAT STRUCT MOL BIOL, V17, P997, DOI 10.1038/nsmb.1866; de Felippes FF, 2012, PLANT J, V70, P541, DOI 10.1111/j.1365-313X.2011.04896.x; Duan CG, 2008, J VIROL, V82, P11084, DOI 10.1128/JVI.01377-08; Eamens A, 2008, PLANT PHYSIOL, V147, P456, DOI 10.1104/pp.108.117275; Fahlgren N, 2006, CURR BIOL, V16, P939, DOI 10.1016/j.cub.2006.03.065; Fei QL, 2013, PLANT CELL, V25, P2400, DOI 10.1105/tpc.113.114652; Felippes FF, 2009, EMBO REP, V10, P264, DOI 10.1038/embor.2008.247; Fernandez-Fernandez MR, 2001, VIROLOGY, V280, P283, DOI 10.1006/viro.2000.0762; Gasciolli V, 2005, CURR BIOL, V15, P1494, DOI 10.1016/j.cub.2005.07.024; Gutierrez-Nava MD, 2008, PLANT PHYSIOL, V147, P543, DOI 10.1104/pp.108.118307; Henderson IR, 2006, NAT GENET, V38, P721, DOI 10.1038/ng1804; Herr AJ, 2006, P NATL ACAD SCI USA, V103, P14994, DOI 10.1073/pnas.0606536103; Howell MD, 2007, PLANT CELL, V19, P926, DOI 10.1105/tpc.107.050062; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Li F, 2012, P NATL ACAD SCI USA, V109, P1790, DOI 10.1073/pnas.1118282109; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Manavella PA, 2012, P NATL ACAD SCI USA, V109, P2461, DOI 10.1073/pnas.1200169109; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; Montgomery TA, 2008, CELL, V133, P128, DOI 10.1016/j.cell.2008.02.033; Montgomery TA, 2008, P NATL ACAD SCI USA, V105, P20055, DOI 10.1073/pnas.0810241105; Niu QW, 2006, NAT BIOTECHNOL, V24, P1420, DOI 10.1038/nbt1255; Qu Jing, 2012, Methods Mol Biol, V894, P209, DOI 10.1007/978-1-61779-882-5_14; Rajeswaran R, 2012, NUCLEIC ACIDS RES, V40, P6241, DOI 10.1093/nar/gks242; Schwab R, 2010, P NATL ACAD SCI USA, V107, P14945, DOI 10.1073/pnas.1009416107; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Shivaprasad PV, 2012, PLANT CELL, V24, P859, DOI 10.1105/tpc.111.095380; Simon-Mateo C, 2006, J VIROL, V80, P2429, DOI 10.1128/JVI.80.5.2429-2436.2006; Simon-Mateo C, 2011, BBA-GENE REGUL MECH, V1809, P722, DOI 10.1016/j.bbagrm.2011.05.011; Smith NA, 2000, NATURE, V407, P319, DOI 10.1038/35030305; Stocks MB, 2012, BIOINFORMATICS, V28, P2059, DOI 10.1093/bioinformatics/bts311; Tiwari M, 2014, PLANT MOL BIOL, V86, P1, DOI 10.1007/s11103-014-0224-7; Toedling J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032724; Valli A, 2006, J VIROL, V80, P10055, DOI 10.1128/JVI.00985-06; Valli A, 2011, RNA, V17, P1148, DOI 10.1261/rna.2510611; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Voinnet O, 2008, TRENDS PLANT SCI, V13, P317, DOI 10.1016/j.tplants.2008.05.004; Wang XB, 2011, PLANT CELL, V23, P1625, DOI 10.1105/tpc.110.082305; Wei KF, 2012, J CELL BIOCHEM, V113, P2576, DOI 10.1002/jcb.24133; Yoshikawa M, 2013, GENES GENET SYST, V88, P77, DOI 10.1266/ggs.88.77; Zhai JX, 2011, GENE DEV, V25, P2540, DOI 10.1101/gad.177527.111	56	6	6	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132281	10.1371/journal.pone.0132281	http://dx.doi.org/10.1371/journal.pone.0132281			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147769	Green Published, gold, Green Submitted			2022-12-26	WOS:000358157600231
J	Bousquet, E; Calvayrac, O; Mazieres, J; Lajoie-Mazenc, I; Boubekeur, N; Favre, G; Pradines, A				Bousquet, E.; Calvayrac, O.; Mazieres, J.; Lajoie-Mazenc, I.; Boubekeur, N.; Favre, G.; Pradines, A.			RhoB loss induces Rac1-dependent mesenchymal cell invasion in lung cells through PP2A inhibition	ONCOGENE			English	Article							PROTEIN PHOSPHATASE 2A; TYROSINE PHOSPHORYLATION; INCREASED EXPRESSION; CANCER; AKT; CARCINOMA; SUBUNIT; GROWTH; SLUG; TRANSFORMATION	Non-small-cell lung cancer (NSCLC) is the leading cause of cancer-related death worldwide, which is mainly due to its high risk of metastatic dissemination. One critical point of this process is the ability of cancer cells to detach from the primary tumor and migrate through the extracellular matrix; however, the underlying molecular mechanisms are not yet fully understood. In the present study, we identified the small GTPase RhoB as a key regulator of bronchial cell morphology in a three-dimensional (3D) matrix. RhoB loss, which is frequently observed during lung cancer progression, induced an epithelial-mesenchymal transition (EMT) characterized by an increased proportion of invasive elongated cells in 3D. The process was mediated by Slug induction and E-cadherin repression. In addition, downregulation of RhoB induced Akt1 activation, which in turn activated Rac1 through the guanine-exchange factor Trio to control cell shape rearrangement. Further, we provide evidence that RhoB interacted with and positively regulates phosphatase PP2A through the recruitment of its regulatory subunit B55, which was found to be crucial for Akt dephosphorylation. B55 inhibition completely suppressed RhoB-mediated PP2A regulation. Finally, we show that PP2A inactivation, by targeting either its catalytic or its regulatory B55 subunit, completely reversed RhoB-dependent morphological changes and also fully prevented the ability of RhoB to decrease the invasiveness of bronchial cells. Altogether, these results highlight a novel signaling axis and describe new molecular mechanisms that could explain the tumor suppressor role of RhoB in lung cancer. Therefore, we propose that RhoB could be responsible for early metastatic prevention by inhibiting the EMT-derived invasiveness of lung cells through the control of PP2A activity.	[Bousquet, E.; Calvayrac, O.; Mazieres, J.; Lajoie-Mazenc, I.; Boubekeur, N.; Favre, G.; Pradines, A.] INSERM, UMR 1037, CRCT, Toulouse, France; [Bousquet, E.; Calvayrac, O.; Mazieres, J.; Lajoie-Mazenc, I.; Boubekeur, N.; Favre, G.; Pradines, A.] Univ Toulouse 3, F-31062 Toulouse, France; [Bousquet, E.; Calvayrac, O.; Lajoie-Mazenc, I.; Boubekeur, N.; Favre, G.; Pradines, A.] Inst Claudius Regaud, Dept Biol, Toulouse, France; [Mazieres, J.] CHU Toulouse, Dept Pneumol, Hop Larrey, Toulouse, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; UNICANCER; Institut Claudius Regaud; CHU de Toulouse	Pradines, A (corresponding author), Inst Univ Canc Toulouse Oncopole, 1 Ave Irene Joliot Curie, F-31059 Toulouse, France.	pradines.anne@iuct-oncopole.fr	Lajoie-Mazenc, Isabelle/M-4636-2014; FAVRE, Gilles/K-9189-2014; MAZIERES, JULIEN/M-3986-2014; Pradines, Anne/M-3935-2014; Calvayrac, Olivier/A-7145-2016	FAVRE, Gilles/0000-0002-2344-1883; Pradines, Anne/0000-0002-2449-678X; Calvayrac, Olivier/0000-0002-0908-8323; MAZIERES, JULIEN/0000-0002-5921-7613	INSERM (Institut National de la Sante et de la Recherche Medicale); Groupe de Recherche Institut Claudius Regaud; Foundation Recherche et Innovation Therapeutique en Cancerologie; INCa (Institut National du Cancer) France	INSERM (Institut National de la Sante et de la Recherche Medicale)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Groupe de Recherche Institut Claudius Regaud; Foundation Recherche et Innovation Therapeutique en Cancerologie; INCa (Institut National du Cancer) France	We are grateful to Professor Alain Puisieux (CRCL, Lyon, France) for his helpful comments on the manuscript. We thank Remi Gence for helping with recombinant proteins. This work was supported by grants from INSERM (Institut National de la Sante et de la Recherche Medicale), Groupe de Recherche Institut Claudius Regaud, the Foundation Recherche et Innovation Therapeutique en Cancerologie and INCa (Institut National du Cancer) France.	Adnane J, 2002, CLIN CANCER RES, V8, P2225; Barber Mark A, 2006, Bull Cancer, V93, pE44; Bellovin DI, 2006, ONCOGENE, V25, P6959, DOI 10.1038/sj.onc.1209682; Benefield Janet, 1997, Invasion and Metastasis, V17, P210; Bousquet E, 2009, CANCER RES, V69, P6092, DOI 10.1158/0008-5472.CAN-08-4147; Bustelo XR, 2012, BIOESSAYS, V34, P748, DOI 10.1002/bies.201200041; Calvayrac O, 2014, CLIN CANCER RES, V20, P6541, DOI 10.1158/1078-0432.CCR-14-0506; Carpenter RL, 2014, ONCOGENE, V34, P546; CHEN J, 1994, J BIOL CHEM, V269, P7957; Chen Z, 2000, J BIOL CHEM, V275, P17974, DOI 10.1074/jbc.C000145200; Cordonnier T, 2015, INT J CANCER, V136, pE496, DOI 10.1002/ijc.29122; DeGeer J, 2013, MOL CELL BIOL, V33, P739, DOI 10.1128/MCB.01264-12; Delord JP, 2010, BRIT J CANCER, V103, P61, DOI 10.1038/sj.bjc.6605699; Fenouille N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040378; Fortin SP, 2012, MOL CANCER RES, V10, P958, DOI 10.1158/1541-7786.MCR-11-0616; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Gerald D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3824; Grise F, 2012, HEPATOLOGY, V55, P1766, DOI 10.1002/hep.25568; Ho HH, 2013, TOXICOL APPL PHARM, V266, P76, DOI 10.1016/j.taap.2012.10.019; Jackson Jodi, 1997, Invasion and Metastasis, V17, P199; Kazerounian S, 2013, CANCER RES, V73, P50, DOI 10.1158/0008-5472.CAN-11-3055; Kuo YC, 2008, J BIOL CHEM, V283, P1882, DOI 10.1074/jbc.M709585200; Lee WJ, 2007, PROTEOMICS, V7, P206, DOI 10.1002/pmic.200600480; Li YY, 2014, IUBMB LIFE, V66, P507, DOI 10.1002/iub.1285; Li Yong, 2011, Genes Cancer, V2, P880, DOI 10.1177/1947601911433129; Liao Y, 2010, AM J TRANSL RES, V2, P19; Lin CH, 2014, MOL CELL BIOCHEM, V395, P135, DOI 10.1007/s11010-014-2119-y; Liu AX, 2001, MOL CELL BIOL, V21, P6906, DOI 10.1128/MCB.21.20.6906-6912.2001; Mamouni K, 2014, MOL CELL BIOL, V34, P3144, DOI 10.1128/MCB.01525-13; Mao KP, 2014, SCI WORLD J, DOI 10.1155/2014/908326; Mazieres J, 2004, CLIN CANCER RES, V10, P2742, DOI 10.1158/1078-0432.CCR-03-0149; Mazieres J, 2005, EXP CELL RES, V304, P354, DOI 10.1016/j.yexcr.2004.10.019; Merikallio H, 2014, INT J CLIN EXP PATHO, V7, P5846; Nakada N, 2005, CELL PHYSIOL BIOCHEM, V15, P19, DOI 10.1159/000083635; Puisieux A, 2014, NAT CELL BIOL, V16, P488, DOI 10.1038/ncb2976; Ridley AJ, 2001, J CELL SCI, V114, P2713; Rintoul RC, 2001, LANCET ONCOL, V2, P437, DOI 10.1016/S1470-2045(00)00421-6; Rocher G, 2007, J BIOL CHEM, V282, P5468, DOI 10.1074/jbc.M609712200; Ruvolo PP, 2011, LEUKEMIA, V25, P1711, DOI 10.1038/leu.2011.146; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Sato N, 2007, INT J CANCER, V120, P543, DOI 10.1002/ijc.22328; Schmidt Susanne, 2014, Small GTPases, V5, pe29769, DOI 10.4161/sgtp.29769; Sents W, 2013, FEBS J, V280, P644, DOI 10.1111/j.1742-4658.2012.08579.x; Seshacharyulu P, 2013, CANCER LETT, V335, P9, DOI 10.1016/j.canlet.2013.02.036; Shi-wen X, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007438; Shih JY, 2011, CARCINOGENESIS, V32, P1299, DOI 10.1093/carcin/bgr110; Shih JY, 2005, CLIN CANCER RES, V11, P8070, DOI 10.1158/1078-0432.CCR-05-0687; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; van Rijssel J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029912; Vega FM, 2008, FEBS LETT, V582, P2093, DOI 10.1016/j.febslet.2008.04.039; Vega FM, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0085-y; Wang SW, 2003, ONCOGENE, V22, P6204, DOI 10.1038/sj.onc.1206653; Wheeler AP, 2007, EXP CELL RES, V313, P3505, DOI 10.1016/j.yexcr.2007.07.014; Zhang DQ, 2014, WORLD J SURG ONCOL, V12, DOI 10.1186/1477-7819-12-241; Zhang YZ, 2011, MOL CELL BIOCHEM, V357, P363, DOI 10.1007/s11010-011-0907-1; Zhou JT, 2011, INT J CANCER, V128, P1057, DOI 10.1002/ijc.25445	58	48	48	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 7	2016	35	14					1760	1769		10.1038/onc.2015.240	http://dx.doi.org/10.1038/onc.2015.240			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DI6LM	26148238	Green Published			2022-12-26	WOS:000373610400003
J	Srinivasan, S; Guha, M; Dong, DW; Whelan, KA; Ruthel, G; Uchikado, Y; Natsugoe, S; Nakagawa, H; Avadhani, NG				Srinivasan, S.; Guha, M.; Dong, D. W.; Whelan, K. A.; Ruthel, G.; Uchikado, Y.; Natsugoe, S.; Nakagawa, H.; Avadhani, N. G.			Disruption of cytochrome c oxidase function induces the Warburg effect and metabolic reprogramming	ONCOGENE			English	Article							MITOCHONDRIAL RESPIRATORY STRESS; KAPPA-B-BETA; CANCER-CELLS; DNA MUTATIONS; ALTERED METABOLISM; COMPLEX-III; SUBUNIT-VB; FACTOR-I; ACTIVATION; HYPOXIA	Defects in mitochondrial oxidative phosphorylation complexes, altered bioenergetics and metabolic shift are often seen in cancers. Here we show a role for the dysfunction of the electron transport chain component cytochrome c oxidase (CcO) in cancer progression. We show that genetic silencing of the CcO complex by shRNA expression and loss of CcO activity in multiple cell types from the mouse and human sources resulted in metabolic shift to glycolysis, loss of anchorage-dependent growth and acquired invasive phenotypes. Disruption of the CcO complex caused loss of transmembrane potential and induction of Ca2+/Calcineurin-mediated retrograde signaling. Propagation of this signaling includes activation of PI3-kinase, IGF1R and Akt, Ca2(+)-sensitive transcription factors and also TGF beta 1, MMP16 and periostin, which are involved in oncogenic progression. Whole-genome expression analysis showed the upregulation of genes involved in cell signaling, extracellular matrix interactions, cell morphogenesis, cell motility and migration. The transcription profiles reveal extensive similarity to retrograde signaling initiated by partial mitochondrial DNA depletion, although distinct differences are observed in signaling induced by CcO dysfunction. The possible CcO dysfunction as a biomarker for cancer progression was supported by data showing that esophageal tumors from human patients show reduced CcO subunits IVi1 and Vb in regions that were previously shown to be the hypoxic core of the tumors. Our results show that mitochondrial electron transport chain defect initiates a retrograde signaling. These results suggest that a defect in the CcO complex can potentially induce tumor progression.	[Srinivasan, S.; Guha, M.; Dong, D. W.; Ruthel, G.; Avadhani, N. G.] Mari Lowe Ctr Comparat Oncol, Dept Biomed Sci, Sch Vet Med, Philadelphia, PA USA; [Whelan, K. A.; Nakagawa, H.] Univ Penn, Dept Med, Div Gastroenterol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Uchikado, Y.; Natsugoe, S.] Kagoshima Univ, Dept Digest Surg Breast & Thyroid Surg, Grad Sch Med, Kagoshima 890, Japan	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Kagoshima University	Avadhani, NG (corresponding author), Univ Penn, Dept Biomed Sci, Sch Vet Med, 3800 Spruce St,Room 189E Vet, Philadelphia, PA 19104 USA.	narayan@vet.upenn.edu	Ruthel, Gordon/GYU-9133-2022		NIH [CA-22762, GM-34883]; Mitochondria research affinity group, Children's hospital of Philadelphia; Harriet Ellison Woodward Trust; NATIONAL CANCER INSTITUTE [R01CA022762] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR067066] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK050306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034883] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mitochondria research affinity group, Children's hospital of Philadelphia; Harriet Ellison Woodward Trust; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants CA-22762 and GM-34883, and an endowment from the Harriet Ellison Woodward Trust to NGA and a grant to SS from Mitochondria research affinity group, Children's hospital of Philadelphia. We also acknowledge the help of the Imaging Core facility at the School of Veterinary Medicine and the NIH/NIDDK Center for Molecular Studies in Digestive and Liver Diseases (P30DK050306) and its Molecular Pathology and Imaging Core facilities at the Perelman School of Medicine.	Acin-Perez R, 2008, MOL CELL, V32, P529, DOI 10.1016/j.molcel.2008.10.021; Amuthan G, 2001, EMBO J, V20, P1910, DOI 10.1093/emboj/20.8.1910; Arnuthan G, 2002, ONCOGENE, V21, P7839, DOI 10.1038/sj.onc.1205983; Bansal S, 2012, J BIOL CHEM, V287, P15284, DOI 10.1074/jbc.M111.314062; Bardella C, 2011, BBA-BIOENERGETICS, V1807, P1432, DOI 10.1016/j.bbabio.2011.07.003; Biswas G, 1999, EMBO J, V18, P522, DOI 10.1093/emboj/18.3.522; Biswas G, 2003, J CELL BIOL, V161, P507, DOI 10.1083/jcb.200211104; Biswas G, 2005, GENE, V354, P132, DOI 10.1016/j.gene.2005.03.028; Biswas G, 2008, J BIOL CHEM, V283, P12586, DOI 10.1074/jbc.M710481200; Brandon M, 2006, ONCOGENE, V25, P4647, DOI 10.1038/sj.onc.1209607; Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; Chatterjee A, 2006, ONCOGENE, V25, P4663, DOI 10.1038/sj.onc.1209604; Chen ZX, 2010, CELL DEATH DIFFER, V17, P408, DOI 10.1038/cdd.2009.132; Dakubo GD, 2006, J CLIN PATHOL, V59, P10, DOI 10.1136/jcp.2005.027664; Dasgupta S, 2008, CANCER RES, V68, P700, DOI 10.1158/0008-5472.CAN-07-5532; Devin A, 2001, EUR J BIOCHEM, V268, P3943, DOI 10.1046/j.1432-1327.2001.02306.x; Fang HZ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-421; Fang JK, 2007, FEBS LETT, V581, P1302, DOI 10.1016/j.febslet.2007.02.042; Frevert EU, 1997, MOL CELL BIOL, V17, P190, DOI 10.1128/MCB.17.1.190; Frezza C, 2014, INT J BIOCHEM CELL B, V48, P11, DOI 10.1016/j.biocel.2013.12.013; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; Galati D, 2009, BIOCHEM J, V420, P439, DOI 10.1042/BJ20090214; Gallardo ME, 2006, HUM MUTAT, V27, P575, DOI 10.1002/humu.20338; Guha M, 2014, ONCOGENE, V33, P5238, DOI 10.1038/onc.2013.467; Guha M, 2007, J BIOL CHEM, V282, P14536, DOI 10.1074/jbc.M611693200; Guha M, 2013, MITOCHONDRION, V13, P577, DOI 10.1016/j.mito.2013.08.007; Guha M, 2010, MOL BIOL CELL, V21, P3578, DOI 10.1091/mbc.E10-03-0192; Guha M, 2009, MOL BIOL CELL, V20, P4107, DOI 10.1091/mbc.E09-04-0296; Guzy RD, 2006, EXP PHYSIOL, V91, P807, DOI 10.1113/expphysiol.2006.033506; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906; Krell D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019868; Li YF, 2006, J BIOENERG BIOMEMBR, V38, P283, DOI 10.1007/s10863-006-9052-z; Liu X, 2011, CELL DEATH DIFFER, V18, P1561, DOI 10.1038/cdd.2011.13; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Miccoli L, 1996, BIOCHEM J, V313, P957, DOI 10.1042/bj3130957; Moro L, 2009, CELL DEATH DIFFER, V16, P571, DOI 10.1038/cdd.2008.178; NAKAGAWA H, 1995, CANCER-AM CANCER SOC, V76, P541, DOI 10.1002/1097-0142(19950815)76:4<541::AID-CNCR2820760402>3.0.CO;2-I; Natsuizaka M, 2012, FASEB J, V26, P2620, DOI 10.1096/fj.11-198598; Nijtmans LGJ, 1998, EUR J BIOCHEM, V254, P389, DOI 10.1046/j.1432-1327.1998.2540389.x; NISHIHIRA T, 1993, J CANCER RES CLIN, V119, P441, DOI 10.1007/BF01215923; Pelicano H, 2006, J CELL BIOL, V175, P913, DOI 10.1083/jcb.200512100; Picaud S, 2011, J INHERIT METAB DIS, V34, P671, DOI 10.1007/s10545-011-9294-8; Prabu SK, 2006, J BIOL CHEM, V281, P2061, DOI 10.1074/jbc.M507741200; Rainbolt TK, 2014, TRENDS ENDOCRIN MET, V25, P528, DOI 10.1016/j.tem.2014.06.007; Sayen MR, 2003, AM J PHYSIOL-CELL PH, V284, pC562, DOI 10.1152/ajpcell.00336.2002; Schafer E, 2006, J BIOL CHEM, V281, P15370, DOI 10.1074/jbc.M513525200; Scholl C, 2009, CELL, V137, P821, DOI 10.1016/j.cell.2009.03.017; SEMENZA GL, 1994, J BIOL CHEM, V269, P23757; Sharma LK, 2011, HUM MOL GENET, V20, P4605, DOI 10.1093/hmg/ddr395; Srinivasan S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077129; Srinivasan S, 2012, FREE RADICAL BIO MED, V53, P1252, DOI 10.1016/j.freeradbiomed.2012.07.021; Vannuvel K, 2013, J CELL PHYSIOL, V228, P1802, DOI 10.1002/jcp.24360; Vonck J, 2009, BBA-MOL CELL RES, V1793, P117, DOI 10.1016/j.bbamcr.2008.05.019; WALLACE DC, 1994, J BIOENERG BIOMEMBR, V26, P241, DOI 10.1007/BF00763096; Wallace DC, 2012, NAT REV CANCER, V12, P685, DOI 10.1038/nrc3365; WARBURG O, 1956, SCIENCE, V124, P269; Wilson WR, 2011, NAT REV CANCER, V11, P393, DOI 10.1038/nrc3064	59	54	54	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 24	2016	35	12					1585	1595		10.1038/onc.2015.227	http://dx.doi.org/10.1038/onc.2015.227			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DH8RJ	26148236	Green Accepted			2022-12-26	WOS:000373063600011
J	Shah, NB; Duncan, TM				Shah, Naman B.; Duncan, Thomas M.			Aerobic Growth of Escherichia coli Is Reduced, and ATP Synthesis Is Selectively Inhibited when Five C-terminal Residues Are Deleted from the epsilon Subunit of ATP Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; H+-ATPASE; BETA-SUBUNIT; OXIDATIVE-PHOSPHORYLATION; CONFORMATIONAL-CHANGES; F0F1-ATP SYNTHASE; F-1 MOTOR; F-1-ATPASE; F1F0; MUTATIONS	F-type ATP synthases are rotary nanomotor enzymes involved in cellular energy metabolism in eukaryotes and eubacteria. The ATP synthase from Gram-positive and -negative model bacteria can be autoinhibited by the C-terminal domain of its epsilon subunit (epsilon TD), but the importance of epsilon inhibition in vivo is unclear. Functional rotation is thought to be blocked by insertion of the latter half of the epsilon CTD into the central cavity of the catalytic complex (F1). In the inhibited state of the Escherichia coli enzyme, the final segment of epsilon CTD is deeply buried but has few specific interactions with other subunits. This region of the epsilon CTD is variable or absent in other bacteria that exhibit strong epsilon-inhibition in vitro. Here, genetically deleting the last five residues of the epsilon CTD (epsilon Delta 5) caused a greater defect in respiratory growth than did the complete absence of the epsilon CTD. Isolated membranes with epsilon Delta 5 generated proton-motive force by respiration as effectively as with wild-type epsilon but showed a nearly 3-fold decrease in ATP synthesis rate. In contrast, the epsilon Delta 5 truncation did not change the intrinsic rate of ATP hydrolysis with membranes. Further, the epsilon Delta 5 subunit retained high affinity for isolated F-1 but reduced the maximal inhibition of F-1-ATPase by epsilon from >90% to similar to 20%. The results suggest that the epsilon CTD has distinct regulatory interactions with F1 when rotary catalysis operates in opposite directions for the hydrolysis or synthesis of ATP.	[Shah, Naman B.; Duncan, Thomas M.] SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Duncan, TM (corresponding author), SUNY Upstate Med Univ, Dept Biochem & Mol Biol, 750 E Adams St, Syracuse, NY 13210 USA.	duncant@upstate.edu	Regan, Clinton/E-6250-2012	Duncan, Thomas/0000-0002-6432-4958	National Institutes of Health [R01GM083088]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083088] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM083088. The authors declare that they have no conflicts of interest with the contents of this article.	Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; Balemans W, 2012, ANTIMICROB AGENTS CH, V56, P4131, DOI 10.1128/AAC.00273-12; Bijlsma JJE, 2000, J INFECT DIS, V182, P1566, DOI 10.1086/315855; Biukovic G, 2013, ANTIMICROB AGENTS CH, V57, P168, DOI 10.1128/AAC.01039-12; Bockenhauer S. D., 2014, P SOC PHOTO-OPT INS, V8950; Borsch M, 2013, BIOCHEM SOC T, V41, P1219, DOI 10.1042/BST20130101; Boogerd FC, 1998, J BACTERIOL, V180, P5855, DOI 10.1128/JB.180.22.5855-5859.1998; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; Braman J, 1996, Methods Mol Biol, V57, P31; Cingolani G, 2011, NAT STRUCT MOL BIOL, V18, P701, DOI 10.1038/nsmb.2058; Cipriano DJ, 2006, J BIOL CHEM, V281, P501, DOI 10.1074/jbc.M509986200; Cipriano DJ, 2002, J BIOL CHEM, V277, P16782, DOI 10.1074/jbc.M201349200; Cohen J, 2013, SCIENCE, V339, P130, DOI 10.1126/science.339.6116.130; COX GB, 1992, MOL MECHANISMS BIOEN, P283; de Berardinis V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.10; Duncan T. M., 2004, ENZYMES, VXXIII, P203; Duncan TM, 1995, BIOCHEM SOC T, V23, P736, DOI 10.1042/bst0230736; DUNCAN TM, 1985, J BIOL CHEM, V260, P4901; Dunn S. D., 2004, HDB ATPASES, P311; DUNN SD, 1990, BIOCHEMISTRY-US, V29, P4335, DOI 10.1021/bi00470a011; Etzold C, 1997, EUR J BIOCHEM, V243, P336, DOI 10.1111/j.1432-1033.1997.0336a.x; Feniouk BA, 2005, FEBS LETT, V579, P5114, DOI 10.1016/j.febslet.2005.08.030; Feniouk BA, 2006, BBA-BIOENERGETICS, V1757, P326, DOI 10.1016/j.bbabio.2006.03.022; Fischer S, 2000, J BIOL CHEM, V275, P30157, DOI 10.1074/jbc.275.39.30157; Gibbons C, 2000, NAT STRUCT BIOL, V7, P1055; Gibson F, 2000, TRENDS BIOCHEM SCI, V25, P342, DOI 10.1016/S0968-0004(00)01607-8; GIBSON F, 1977, BIOCHEM J, V162, P665, DOI 10.1042/bj1620665; GRANT SGN, 1990, P NATL ACAD SCI USA, V87, P4645, DOI 10.1073/pnas.87.12.4645; Haagsma AC, 2010, FEMS MICROBIOL LETT, V313, P68, DOI 10.1111/j.1574-6968.2010.02123.x; HARRIS DA, 1991, BIOCHEM J, V280, P561, DOI 10.1042/bj2800561; HERMOLIN J, 1989, J BIOL CHEM, V264, P3896; HIGASHI T, 1975, J BIOL CHEM, V250, P6541; Hirono-Hara Y, 2005, P NATL ACAD SCI USA, V102, P4288, DOI 10.1073/pnas.0406486102; Hong S, 2008, MICROBIOL MOL BIOL R, V72, P590, DOI 10.1128/MMBR.00016-08; Hopf TA, 2014, ELIFE, V3, DOI 10.7554/eLife.03430; Iino R, 2009, J BIOL CHEM, V284, P17457, DOI 10.1074/jbc.M109.003798; Iserte J, 2015, NUCLEIC ACIDS RES, V43, pW320, DOI 10.1093/nar/gkv572; JENSEN PR, 1993, EMBO J, V12, P1277, DOI 10.1002/j.1460-2075.1993.tb05772.x; JOUNOUCHI M, 1992, ARCH BIOCHEM BIOPHYS, V292, P87, DOI 10.1016/0003-9861(92)90054-Z; Junge W, 2015, ANNU REV BIOCHEM, V84, P631, DOI 10.1146/annurev-biochem-060614-034124; Kato-Yamada Y, 1999, J BIOL CHEM, V274, P33991, DOI 10.1074/jbc.274.48.33991; Keis S, 2006, J BACTERIOL, V188, P3796, DOI 10.1128/JB.00040-06; KLIONSKY DJ, 1984, J BACTERIOL, V160, P1055, DOI 10.1128/JB.160.3.1055-1060.1984; Konno H, 2006, EMBO J, V25, P4596, DOI 10.1038/sj.emboj.7601348; KUKI M, 1988, J BIOL CHEM, V263, P17437; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liberati NT, 2006, P NATL ACAD SCI USA, V103, P2833, DOI 10.1073/pnas.0511100103; LOTSCHER HR, 1984, BIOCHEMISTRY-US, V23, P4140, DOI 10.1021/bi00313a020; Lu P, 2014, BBA-BIOENERGETICS, V1837, P1208, DOI 10.1016/j.bbabio.2014.01.022; Masaike T, 2006, BIOCHEM BIOPH RES CO, V342, P800, DOI 10.1016/j.bbrc.2006.02.017; MENDELHARTVIG J, 1991, BIOCHEMISTRY-US, V30, P10987, DOI 10.1021/bi00109a025; Mnatsakanyan N, 2009, J BIOL CHEM, V284, P11336, DOI 10.1074/jbc.M900374200; Noda S, 2006, J BACTERIOL, V188, P6869, DOI 10.1128/JB.00452-06; Northen H, 2010, VACCINE, V28, P940, DOI 10.1016/j.vaccine.2009.10.146; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PULLMAN ME, 1960, J BIOL CHEM, V235, P3322; Rodgers AJW, 2000, NAT STRUCT BIOL, V7, P1051; SCHAEFER EM, 1989, J BACTERIOL, V171, P3901, DOI 10.1128/jb.171.7.3901-3908.1989; Schulenberg B, 1999, J BIOL CHEM, V274, P28351, DOI 10.1074/jbc.274.40.28351; Sekiya M, 2010, J BIOL CHEM, V285, P42058, DOI 10.1074/jbc.M110.176701; Shah NB, 2014, JOVE-J VIS EXP, DOI 10.3791/51383; Shah NB, 2013, J BIOL CHEM, V288, P9383, DOI 10.1074/jbc.M113.451583; Stocker A, 2007, STRUCTURE, V15, P904, DOI 10.1016/j.str.2007.06.009; Suzuki T, 2003, J BIOL CHEM, V278, P46840, DOI 10.1074/jbc.M307165200; Tomashek JJ, 2004, J BIOL CHEM, V279, P4465, DOI 10.1074/jbc.M310826200; Tsumuraya M, 2009, FEBS LETT, V583, P1121, DOI 10.1016/j.febslet.2009.02.038; Tsunoda SP, 2001, P NATL ACAD SCI USA, V98, P6560, DOI 10.1073/pnas.111128098; Unden Gottfried, 2014, EcoSal Plus, V6, DOI 10.1128/ecosalplus.ESP-0005-2013; VIK SB, 1988, J BIOL CHEM, V263, P6599; von Ballmoos C, 2008, ANNU REV BIOPHYS, V37, P43, DOI 10.1146/annurev.biophys.37.032807.130018; WALKER JE, 1994, CURR OPIN STRUC BIOL, V4, P912, DOI 10.1016/0959-440X(94)90274-7; WilkeMounts S, 1995, ARCH BIOCHEM BIOPHYS, V324, P153, DOI 10.1006/abbi.1995.9915; Wilkens S, 1998, J BIOL CHEM, V273, P26645, DOI 10.1074/jbc.273.41.26645; WISE JG, 1990, J BIOL CHEM, V265, P10403; Yagi H, 2007, P NATL ACAD SCI USA, V104, P11233, DOI 10.1073/pnas.0701045104; ZHANG Y, 1994, J BIOL CHEM, V269, P10221	77	23	23	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2015	290	34					21032	21041		10.1074/jbc.M115.665059	http://dx.doi.org/10.1074/jbc.M115.665059			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP6QC	26160173	hybrid, Green Published			2022-12-26	WOS:000360011800036
J	Antunes, F; Zindoga, P; Gomes, P; Augusto, O; Mahumane, I; Veloso, L; Valadas, E; Camacho, R				Antunes, Francisco; Zindoga, Pereira; Gomes, Perpetua; Augusto, Orvalho; Mahumane, Isabel; Veloso, Luis; Valadas, Emilia; Camacho, Ricardo			Development of Nevirapine Resistance in Children Exposed to the Prevention of Mother-to-Child HIV-1 Transmission Programme in Maputo, Mozambique	PLOS ONE			English	Article							SINGLE-DOSE NEVIRAPINE; IMMUNODEFICIENCY-VIRUS TYPE-1; DRUG-RESISTANCE; ANTIRETROVIRAL TREATMENT; VERTICAL TRANSMISSION; GENOTYPING SYSTEM; INFECTED INFANTS; NVP RESISTANCE; BREAST-MILK; SUBTYPE-C	Background Single-dose nevirapine (sd-NVP) has been the main option for prevention of mother-to-child transmission (PMTCT) of HIV-1 in low-resource settings. However, sd-NVP can induce the selection of HIV-1 resistant mutations in mothers and infants. In Mozambique, there are limited data regarding the profile of NVP resistance associated mutations (RAM) in the context of PMTCT. Objectives To assess the prevalence and the factors associated with NVP RAM among children born to HIV-1 infected mothers enrolled in the PMTCT programme adopted in Mozambique. Methods One hundred and fifty seven children aged 6 to 48 weeks were sequentially included (July 2011 to March 2012) at four centres in Maputo. Genotyping of RAM was performed in samples with HIV-1 RNA >= 100 copies/mu L (Viroseq). Sequencing was performed with ABI 3100 (Applied Biosystems). Logistic regression modelling was undertaken to identify the factors associated with NVP RAM. Results Seventy-nine children had their samples genotyped. Their median age was 7.0 (3-12) months and 92.4% received prophylaxis with sd-NVP at birth plus daily NVP. 35.4% of mothers received antiretrovirals (ARVs) for PMTCT. ARV RAM were detected in 43 (54.4%) of the children. 45.6% of these children had at least one NVP RAM. The most common mutations associated with NVP resistance were K103N (n = 16) and Y181C (n = 15). NVP RAM was significantly associated with mother exposure to PMTCT (crude odds ratio [OR] 30.3, 95% CI 4.93-186.34) and with mother's CD4 count < 350 cells/mm(3) (crude OR 3.08, 95% CI 1.02-9.32). In the multivariable analysis the mother's exposure to PMTCT was the only variable significantly associated with NVP RAM (adjusted OR 48.65, 95% CI 9.33-253.66). Conclusions We found a high prevalence of NVP RAM among children who were exposed to the drug regimen for PMTCT in Mozambique. The mothers' exposure to PMTCT significantly increased the risk of NVP RAM.	[Antunes, Francisco] Univ Lisbon, Inst Saude Ambiental ISAMB, Fac Med, P-1699 Lisbon, Portugal; [Zindoga, Pereira] Hosp Cent Maputo, Inst Nacl Saude, Dept Med, Maputo, Mozambique; [Gomes, Perpetua] Ctr Hosp Lisboa Ocidental, Serv Patol Clin, Lab Microbiol Clin & Biol Mol, Lisbon, Portugal; [Augusto, Orvalho] Univ Eduardo Mondlane, Saude Comunidade, Fac Med, Maputo, Mozambique; [Mahumane, Isabel] Inst Nacl Saude, Plataforma Virol Mol, Plataformas Tecnol, Maputo, Mozambique; [Veloso, Luis] Eurotrials Sci Consultants, Clin Data Unit, Lisbon, Portugal; [Valadas, Emilia] Fac Med Lisbon, Clin Univ Doencas Infecciosas & Parasitarias, Lisbon, Portugal; [Camacho, Ricardo] Rega Inst Med Res, Dept Microbiol & Immunol, Leuven, Belgium	Universidade de Lisboa; Centro Hospitalar de Lisboa Ocidental, EPE; Universidade de Lisboa; Eduardo Mondlane University; Universidade de Lisboa; KU Leuven	Antunes, F (corresponding author), Univ Lisbon, Inst Saude Ambiental ISAMB, Fac Med, P-1699 Lisbon, Portugal.	fantunes@medicina.ulisboa.pt	Augusto, Orvalho/J-8767-2019; Gomes, Perpetua/I-5652-2012	Augusto, Orvalho/0000-0002-0005-3968; Gomes, Perpetua/0000-0003-3271-8255; Valadas, Emilia/0000-0001-5213-1473; Zindoga, Pereira/0000-0002-0348-574X	Associacao para a Investigacao e Desenvolvimento da Faculdade de Medicina (AIDFM)	Associacao para a Investigacao e Desenvolvimento da Faculdade de Medicina (AIDFM)	This study was funded by the Associacao para a Investigacao e Desenvolvimento da Faculdade de Medicina (AIDFM). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adje-Toure C, 2008, AIDS RES HUM RETROV, V24, P911, DOI 10.1089/aid.2007.0264; Bila DCA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068213; [Anonymous], 2020, HIGH POSS COST COVID; [Anonymous], 2017, 2013 UNAIDS REP GLOB; Arrive E, 2007, INT J EPIDEMIOL, V36, P1009, DOI 10.1093/ije/dym104; Church JD, 2008, J INFECT DIS, V198, P1075, DOI 10.1086/591503; Cunningham S, 2001, J CLIN MICROBIOL, V39, P1254, DOI 10.1128/JCM.39.4.1254-1257.2001; Dagnra AY, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-30; de Oliveira T, 2005, BIOINFORMATICS, V21, P3797, DOI 10.1093/bioinformatics/bti607; Eshleman SH, 2005, AIDS, V19, P2167, DOI 10.1097/01.aids.0000194800.43799.94; Eshleman SH, 2005, J INFECT DIS, V192, P30, DOI 10.1086/430764; Eshleman SH, 2001, AIDS, V15, P1951, DOI 10.1097/00002030-200110190-00006; Flys T, 2005, J INFECT DIS, V192, P24, DOI 10.1086/430742; Fogel J, 2011, AIDS, V25, P911, DOI 10.1097/QAD.0b013e328344fedc; Frank M, 2011, ANTIMICROB AGENTS CH, V55, P5529, DOI 10.1128/AAC.00741-11; Gantt S, 2012, J PEDIATR INFECT DIS, V1, P244, DOI [10.1093/jpids/pis065, 10.1093/JPIDS/PIS065]; Guay LA, 1999, LANCET, V354, P795, DOI 10.1016/S0140-6736(99)80008-7; Hunt GM, 2011, AIDS, V25, P1461, DOI 10.1097/QAD.0b013e3283492180; Jourdain G, 2004, NEW ENGL J MED, V351, P229, DOI 10.1056/NEJMoa041305; Kamoto K, 2008, ANTIVIR THER, V13, P83; Lallemant M, 2004, NEW ENGL J MED, V351, P217, DOI 10.1056/NEJMoa033500; Lockman S, 2007, NEW ENGL J MED, V356, P135, DOI 10.1056/NEJMoa062876; Maiga AI, 2013, AIDS RES HUM RETROV, V29, P182, DOI [10.1089/AID.2012.0118, 10.1089/aid.2012.0118]; Martinson NA, 2007, JAIDS-J ACQ IMM DEF, V44, P148, DOI 10.1097/QAI.0b013e31802b920e; McMahon DK, 2013, CLIN INFECT DIS, V56, P1044, DOI 10.1093/cid/cis1219; Micek MA, 2014, J INFECT DIS, V210, P641, DOI 10.1093/infdis/jiu130; Micek MA, 2010, CLIN INFECT DIS, V50, P1405, DOI 10.1086/652151; MISAU, 2009, B EP DO MIN SAUD MOC; Moodley D, 2003, J INFECT DIS, V187, P725, DOI 10.1086/367898; Moorthy A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004096; Palumbo P, 2010, NEW ENGL J MED, V363, P1510, DOI 10.1056/NEJMoa1000931; Rhee SY, 2003, NUCLEIC ACIDS RES, V31, P298, DOI 10.1093/nar/gkg100; Shao ER, 2014, J ANTIMICROB CHEMOTH, V69, P1928, DOI 10.1093/jac/dku087; UNAIDS, 2011, OUTL REP 30 YEARS AI; UNAIDS, 2011, WORLD AIDS DAY REP 2; Van Dyke RB, 2012, CLIN INFECT DIS, V54, P285, DOI 10.1093/cid/cir798; Vaz P, 2012, CLIN INFECT DIS, V54, pS369, DOI 10.1093/cid/cis006; Vaz Paula, 2009, Pediatr Infect Dis J, V28, pe283, DOI 10.1097/INF.0b013e3181ba6c92; Whitson D, 2008, ANAL HIV PREVENTION, P11; WHO, 2010, RAP ADV US ANT DRUGS	40	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131994	10.1371/journal.pone.0131994	http://dx.doi.org/10.1371/journal.pone.0131994			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161559	Green Published, gold, Green Submitted			2022-12-26	WOS:000358162300082
J	Cai, LM; Huang, P; Luo, QL; Huang, H; Mo, L				Cai, Liman; Huang, Ping; Luo, Qiuling; Huang, Hong; Mo, Lei			Iconic Meaning in Music: An Event-Related Potential Study	PLOS ONE			English	Article							CORTICAL REPRESENTATION; NEURAL BASIS; BRAIN; LANGUAGE; CONTEXT; SOUNDS	Although there has been extensive research on the processing of the emotional meaning of music, little is known about other aspects of listeners' experience of music. The present study investigated the neural correlates of the iconic meaning of music. Event-related potentials (ERP) were recorded while a group of 20 music majors and a group of 20 non-music majors performed a lexical decision task in the context of implicit musical iconic meaning priming. ERP analysis revealed a significant N400 effect of congruency in time window 260-510 ms following the onset of the target word only in the group of music majors. Time-course analysis using 50 ms windows indicated significant N400 effects both within the time window 410-460 ms and 460-510 ms for music majors, whereas only a partial N400 effect during time window 410-460 ms was observed for non-music majors. There was also a trend for the N400 effects in the music major group to be stronger than those in the non-major group in the sub-windows of 310-360ms and 410-460ms. Especially in the sub-window of 410-460 ms, the topographical map of the difference waveforms between congruent and incongruent conditions revealed different N400 distribution between groups; the effect was concentrated in bilateral frontal areas for music majors, but in central-parietal areas for non-music majors. These results imply probable neural mechanism differences underlying automatic iconic meaning priming of music. Our findings suggest that processing of the iconic meaning of music can be accomplished automatically and that musical training may facilitate the understanding of the iconic meaning of music.	[Cai, Liman; Huang, Ping; Luo, Qiuling; Mo, Lei] S China Normal Univ, Ctr Studies Psychol Applicat, Guangzhou 510631, Guangdong, Peoples R China; [Cai, Liman] S China Normal Univ, Coll Educ Sci, Guangzhou 510631, Guangdong, Peoples R China; [Huang, Hong] Xinghai Conservatory Mus, Dept Mus, Guangzhou 510500, Guangdong, Peoples R China	South China Normal University; South China Normal University; Xinghai Conservatory of Music	Mo, L (corresponding author), S China Normal Univ, Ctr Studies Psychol Applicat, Guangzhou 510631, Guangdong, Peoples R China.	molei@scnu.edu.cn			National Natural Science Foundation of China [31170997]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China(31170997), http://www.nsfc.gov.cn/, (LM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altenmuller EO, 2001, ANN NY ACAD SCI, V930, P273, DOI 10.1111/j.1749-6632.2001.tb05738.x; Anderson T. W., 1958, INTRO MULTIVARIATE S; [蔡黎曼 Cai Liman], 2013, [心理科学, Journal of Psychological Science], V36, P547; Cidian X., 1986, MODERN CHINESE FREQU; Coulson S, 1998, LANG COGNITIVE PROC, V13, P21, DOI 10.1080/016909698386582; Daltrozzo J, 2009, BRAIN RES, V1270, P88, DOI 10.1016/j.brainres.2009.03.019; ELBERT T, 1995, SCIENCE, V270, P305, DOI 10.1126/science.270.5234.305; Friederici AD, 1996, J EXP PSYCHOL LEARN, V22, P1219, DOI 10.1037//0278-7393.22.5.1219; Goerlich KS, 2012, J COGNITIVE NEUROSCI, V24, P1725, DOI 10.1162/jocn_a_00213; Hodges D. A., 1996, HDB MUSIC PSYCHOL, V2nd; Hoenig K, 2011, NEUROIMAGE, V56, P1714, DOI 10.1016/j.neuroimage.2011.02.065; Jednorog K, 2010, NEUROPSYCHOLOGIA, V48, P2447, DOI 10.1016/j.neuropsychologia.2010.04.017; Koelsch S, 2000, J COGNITIVE NEUROSCI, V12, P520, DOI 10.1162/089892900562183; Koelsch S, 2005, TRENDS COGN SCI, V9, P578, DOI 10.1016/j.tics.2005.10.001; Koelsch S, 2004, NAT NEUROSCI, V7, P302, DOI 10.1038/nn1197; Koelsch S, 2002, PSYCHOPHYSIOLOGY, V39, P38, DOI 10.1017/S004857720102011X; Koelsch S, 2002, PSYCHOPHYSIOLOGY, V39, P657, DOI 10.1017/S0048577202010508; Koelsch S, 2011, PHYS LIFE REV, V8, P89, DOI 10.1016/j.plrev.2011.04.004; Krumhansl CL, 1997, CAN J EXP PSYCHOL, V51, P336, DOI 10.1037/1196-1961.51.4.336; Krumhansl CL, 1996, MUSIC PERCEPT, V13, P401; Loui P, 2005, COGNITIVE BRAIN RES, V25, P678, DOI 10.1016/j.cogbrainres.2005.08.019; Meyer L., 1956, EMOTION MEANING MUSI; Miranda RA, 2007, NEUROIMAGE, V38, P331, DOI 10.1016/j.neuroimage.2007.07.034; Munte TF, 2002, NAT REV NEUROSCI, V3, P473, DOI 10.1038/nrn843; NEVILLE H, 1991, J COGNITIVE NEUROSCI, V3, P151, DOI 10.1162/jocn.1991.3.2.151; Painter JG, 2011, PSYCHOPHYSIOLOGY, V48, P645, DOI 10.1111/j.1469-8986.2010.01134.x; Pantev C, 1998, NATURE, V392, P811, DOI 10.1038/33918; Sollberger B, 2003, MUSIC PERCEPT, V20, P263, DOI 10.1525/mp.2003.20.3.263; Steinbeis N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002226; Steinbeis N, 2011, J COGNITIVE NEUROSCI, V23, P604, DOI 10.1162/jocn.2009.21383; Warne RT, 2014, PRACTICAL ASSESSMENT, V19, P2; Wu YJ, 2011, CEREB CORTEX; Zhao JJ, 2011, NEUROPSYCHOLOGIA, V49, P1761, DOI 10.1016/j.neuropsychologia.2011.02.054	33	1	2	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0132169	10.1371/journal.pone.0132169	http://dx.doi.org/10.1371/journal.pone.0132169			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1FD	26161561	Green Published, gold, Green Submitted			2022-12-26	WOS:000358162300100
J	Seiler, C; Gebhart, N; Zhang, Y; Shinton, SA; Li, YS; Ross, NL; Liu, XJ; Li, Q; Bilbee, AN; Varshney, GK; LaFave, MC; Burgess, SM; Balciuniene, J; Balciunas, D; Hardy, RR; Kappes, DJ; Wiest, DL; Rhodes, J				Seiler, Christoph; Gebhart, Nichole; Zhang, Yong; Shinton, Susan A.; Li, Yue-sheng; Ross, Nicola L.; Liu, Xingjun; Li, Qin; Bilbee, Alison N.; Varshney, Gaurav K.; LaFave, Matthew C.; Burgess, Shawn M.; Balciuniene, Jorune; Balciunas, Darius; Hardy, Richard R.; Kappes, Dietmar J.; Wiest, David L.; Rhodes, Jennifer			Mutagenesis Screen Identifies agtpbp1 and eps15L1 as Essential for T lymphocyte Development in Zebrafish	PLOS ONE			English	Article							PURKINJE-CELL DEGENERATION; GENE-EXPRESSION; SACCHAROMYCES-CEREVISIAE; TRANSGENIC ZEBRAFISH; MUTANT ZEBRAFISH; IMMUNE-SYSTEM; DANIO-RERIO; GENOME-WIDE; TRANSPOSON; PROTEIN	Genetic screens are a powerful tool to discover genes that are important in immune cell development and function. The evolutionarily conserved development of lymphoid cells paired with the genetic tractability of zebrafish make this a powerful model system for this purpose. We used a Tol2-based gene-breaking transposon to induce mutations in the zebrafish (Danio rerio, AB strain) genome, which served the dual purpose of fluorescently tagging cells and tissues that express the disrupted gene and provided a means of identifying the disrupted gene. We identified 12 lines in which hematopoietic tissues expressed green fluorescent protein (GFP) during embryonic development, as detected by microscopy. Subsequent analysis of young adult fish, using a novel approach in which single cell suspensions of whole fish were analyzed by flow cytometry, revealed that 8 of these lines also exhibited GFP expression in young adult cells. An additional 15 lines that did not have embryonic GFP(+) hematopoietic tissue by microscopy, nevertheless exhibited GFP(+) cells in young adults. RT-PCR analysis of purified GFP(+) populations for expression of T and B cell-specific markers identified 18 lines in which T and/or B cells were fluorescently tagged at 6 weeks of age. As transposon insertion is expected to cause gene disruption, these lines can be used to assess the requirement for the disrupted genes in immune cell development. Focusing on the lines with embryonic GFP(+) hematopoietic tissue, we identified three lines in which homozygous mutants exhibited impaired T cell development at 6 days of age. In two of the lines we identified the disrupted genes, agtpbp1 and eps15L1. Morpholino-mediated knockdown of these genes mimicked the T cell defects in the corresponding mutant embryos, demonstrating the previously unrecognized, essential roles of agtpbp1 and eps15L1 in T cell development.	[Seiler, Christoph; Gebhart, Nichole; Zhang, Yong; Shinton, Susan A.; Li, Yue-sheng; Ross, Nicola L.; Liu, Xingjun; Li, Qin; Bilbee, Alison N.; Hardy, Richard R.; Kappes, Dietmar J.; Wiest, David L.; Rhodes, Jennifer] Temple Univ Hlth Syst, Fox Chase Canc Ctr, Blood Cell Dev & Funct Program, Philadelphia, PA 19129 USA; [Varshney, Gaurav K.; LaFave, Matthew C.; Burgess, Shawn M.] NHGRI, Translat & Funct Genom Branch, NIH, Bethesda, MD 20892 USA; [Balciuniene, Jorune; Balciunas, Darius] Temple Univ, Dept Biol, Coll Sci & Technol, Philadelphia, PA 19122 USA	Fox Chase Cancer Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Rhodes, J (corresponding author), Temple Univ Hlth Syst, Fox Chase Canc Ctr, Blood Cell Dev & Funct Program, Philadelphia, PA 19129 USA.	jennifer.rhodes@fccc.edu	LI, Yue/GRS-8071-2022; Balciunas, Darius/AAD-1420-2019	Wiest, David/0000-0002-0792-3188; Varshney, Gaurav K./0000-0002-0429-1904; LaFave, Matthew/0000-0001-9165-041X; Burgess, Shawn/0000-0003-1147-0596	Gabrielle's Angel Foundation [3261601]; National Institutes of Health [HD061749]; Fox Chase Cancer Center Keystone Blood Cell Development and Disease; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD061749] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000183] Funding Source: NIH RePORTER	Gabrielle's Angel Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fox Chase Cancer Center Keystone Blood Cell Development and Disease; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This study was supported by (JR) Gabrielle's Angel Foundation 3261601; (DB) National Institutes of Health HD061749; (DLW and RRH) Fox Chase Cancer Center Keystone Blood Cell Development and Disease funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akitake CM, 2011, DEV BIOL, V352, P191, DOI 10.1016/j.ydbio.2011.01.002; Asakawa K, 2008, P NATL ACAD SCI USA, V105, P1255, DOI 10.1073/pnas.0704963105; Balciunas D, 2006, PLOS GENET, V2, P1715, DOI 10.1371/journal.pgen.0020169; Balciuniene J, 2013, JOVE-J VIS EXP, DOI 10.3791/50113; Balciuniene J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-619; Boatman S, 2013, BLOOD CELL MOL DIS, V51, P271, DOI 10.1016/j.bcmd.2013.07.009; Burns CE, 2009, BLOOD, V113, P5776, DOI 10.1182/blood-2008-12-193607; Callery EM, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120060; Carbone R, 1997, CANCER RES, V57, P5498; Carroll KJ, 2014, EXP HEMATOL, V42, P684, DOI 10.1016/j.exphem.2014.05.002; Clark KJ, 2011, NAT METHODS, V8, P506, DOI [10.1038/NMETH.1606, 10.1038/nmeth.1606]; Dai Zhao-xia, 2010, Nan Fang Yi Ke Da Xue Xue Bao, V30, P1230; Davidson AJ, 2004, ONCOGENE, V23, P7233, DOI 10.1038/sj.onc.1207943; Davison JM, 2007, DEV BIOL, V304, P811, DOI 10.1016/j.ydbio.2007.01.033; Distel M, 2009, P NATL ACAD SCI USA, V106, P13365, DOI 10.1073/pnas.0903060106; Eckfeldt CE, 2005, PLOS BIOL, V3, P1449, DOI 10.1371/journal.pbio.0030254; English MA, 2012, DEV DYNAM, V241, P879, DOI 10.1002/dvdy.23774; Frazer JK, 2009, LEUKEMIA, V23, P1825, DOI 10.1038/leu.2009.116; Goll MG, 2009, GENETICS, V182, P747, DOI 10.1534/genetics.109.102079; GREER CA, 1982, BRAIN RES, V235, P156, DOI 10.1016/0006-8993(82)90206-2; Haffter P, 1996, DEVELOPMENT, V123, P1; Harris A, 2000, MOL CELL NEUROSCI, V16, P578, DOI 10.1006/mcne.2000.0900; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Hermanson S, 2004, METHOD CELL BIOL, V77, P349; Ikawa T, 2014, CURR TOP MICROBIOL, V381, P1, DOI 10.1007/82_2014_370; JOHNSTON M, 1984, MOL CELL BIOL, V4, P1440, DOI 10.1128/MCB.4.8.1440; Kawahara A, 2012, BIOCHEM BIOPH RES CO, V421, P367, DOI 10.1016/j.bbrc.2012.04.019; Kishimoto Y, 1997, DEVELOPMENT, V124, P4457; Kondrychyn I, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-418; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; LaFave MC, 2014, NUCLEIC ACIDS RES, V42, P4257, DOI 10.1093/nar/gkt1399; Lam SH, 2004, DEV COMP IMMUNOL, V28, P9, DOI 10.1016/S0145-305X(03)00103-4; Lam SH, 2002, DEV DYNAM, V225, P87, DOI 10.1002/dvdy.10127; LANDIS SC, 1978, J COMP NEUROL, V177, P125, DOI 10.1002/cne.901770109; Langenau DM, 2004, P NATL ACAD SCI USA, V101, P7369, DOI 10.1073/pnas.0402248101; Malhotra N, 2013, IMMUNOLOGY, V139, P1, DOI 10.1111/imm.12076; MULLEN RJ, 1975, NATURE, V258, P528, DOI 10.1038/258528a0; MULLEN RJ, 1976, P NATL ACAD SCI USA, V73, P208, DOI 10.1073/pnas.73.1.208; Nalls MA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002113; Page DM, 2013, BLOOD, V122, pE1, DOI 10.1182/blood-2012-12-471029; Paik EJ, 2010, INT J DEV BIOL, V54, P1127, DOI 10.1387/ijdb.093042ep; Payne EM, 2011, BLOOD, V118, P903, DOI 10.1182/blood-2010-11-318022; Petzold AM, 2009, P NATL ACAD SCI USA, V106, P18662, DOI 10.1073/pnas.0908247106; Poupon V, 2002, J BIOL CHEM, V277, P8941, DOI 10.1074/jbc.M108385200; Ransom DG, 1996, DEVELOPMENT, V123, P311; Rehn K, 2011, INT J DEV BIOL, V55, P613, DOI 10.1387/ijdb.103249kp; Rogowski K, 2010, CELL, V143, P564, DOI 10.1016/j.cell.2010.10.014; Rumfelt LL, 2006, J EXP MED, V203, P675, DOI 10.1084/jem.20052444; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Scott EK, 2007, NAT METHODS, V4, P323, DOI 10.1038/NMETH1033; Seiler C, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001386; Sivasubbu S, 2006, MECH DEVELOP, V123, P513, DOI 10.1016/j.mod.2006.06.002; STAINIER DYR, 1995, DEVELOPMENT, V121, P3141; Taylor AM, 2012, EXP HEMATOL, V40, P228, DOI [10.1016/j.exphem.2011.11.007, 10.1016/j.exphem.2011.11.007.]; Trede NS, 2008, DEV DYNAM, V237, P2575, DOI 10.1002/dvdy.21683; Varshney GK, 2013, GENOME RES, V23, P727, DOI 10.1101/gr.151464.112; WEST RW, 1984, MOL CELL BIOL, V4, P2467, DOI 10.1128/MCB.4.11.2467; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Xiong JW, 2008, CIRC RES, V102, P1057, DOI 10.1161/CIRCRESAHA.107.163907; Zhang Y, 2013, DEV CELL, V24, P411, DOI 10.1016/j.devcel.2013.01.018	60	10	11	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2015	10	7							e0131908	10.1371/journal.pone.0131908	http://dx.doi.org/10.1371/journal.pone.0131908			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1FD	26161877	Green Published, gold, Green Submitted			2022-12-26	WOS:000358162300073
J	Baron, S; van der Merwe, NA; Madder, M; Maritz-Olivier, C				Baron, Samantha; van der Merwe, Nicolaas A.; Madder, Maxime; Maritz-Olivier, Christine			SNP Analysis Infers that Recombination Is Involved in the Evolution of Amitraz Resistance in Rhipicephalus microplus	PLOS ONE			English	Article							SOUTHERN CATTLE TICK; SODIUM-CHANNEL GENE; PYRETHROID RESISTANCE; BOOPHILUS; ACARI; IDENTIFICATION; OCTOPAMINE; MUTATION; POPULATIONS; STRAINS	Rhipicephalus microplus, better known as the Asiatic cattle tick, is a largely invasive ectoparasite of great economic importance due to the negative effect it has on agricultural livestock on a global scale, particularly cattle. Tick-borne diseases (babesiosis and anaplasmosis) transmitted by R. microplus are alarming as they decrease the quality of livestock health and production. In sub-Saharan Africa, cattle represent a major source of meat and milk, but this region of the world is severely affected by the Rhipicephalus microplus tick. The principal method for tick control is the use of chemical acaricides, notably amitraz, which was implemented in the 1990's after resistance to other acaricides surfaced. However, the efficiency of chemical control is hindered by an increase in the frequency of mutant resistance alleles to amitraz in tick populations. Presently, the only way to assess amitraz resistance is by means of larval packet tests, but this technique is time-consuming and not particularly cost effective. The main aims of this study were three-fold. First, we attempted to correlate two known SNPs in the octopamine/tyramine (OCT/Tyr) receptor with amitraz resistance in South African field samples of R. microplus. Second, we calculated gametic disequilibrium for these SNPs to determine whether they are randomly associated. Lastly, we conducted a study to assess the evolutionary effects of recombination within the OCT/Tyr receptor. Our results confirmed that the two SNPs are associated with amitraz resistance in the South African tick strain, and that they are in gametic disequilibrium. Additionally, recombination was detected in the OCT/Tyr receptor generating two recombinant haplotypes. These results are of concern to farmers in sub-Saharan Africa, and the emergence of amitraz resistance should be closely monitored in future. Therefore, we present a quick and affordable RFLP based diagnostic technique to assess amitraz resistance in field samples of R. microplus.	[Baron, Samantha; van der Merwe, Nicolaas A.; Maritz-Olivier, Christine] Univ Pretoria, Dept Genet, ZA-0002 Pretoria, South Africa; [Madder, Maxime] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium; [Madder, Maxime] Univ Pretoria, Dept Vet Trop Dis, ZA-0002 Pretoria, South Africa	University of Pretoria; Institute of Tropical Medicine (ITM); University of Pretoria	Maritz-Olivier, C (corresponding author), Univ Pretoria, Dept Genet, ZA-0002 Pretoria, South Africa.	Christine.maritz@up.ac.za	Van der Merwe, Nicolaas A/A-9096-2008; Baron, Samantha/Y-3674-2019	Baron, Samantha/0000-0002-7709-9032; van der Merwe, Albe/0000-0003-3185-348X; Maritz-Olivier, Christine/0000-0002-4697-3719	Gauteng Department of Agriculture and Rural Development; Zoetis South Africa (Pty) Ltd.; National Research Foundation, THRIP grant [83890]; Belgium Development Cooperation (DGD)	Gauteng Department of Agriculture and Rural Development; Zoetis South Africa (Pty) Ltd.; National Research Foundation, THRIP grant; Belgium Development Cooperation (DGD)	Funding was provided by (a) Gauteng Department of Agriculture and Rural Development, C Maritz-Olivier. (b) Zoetis South Africa (Pty) Ltd., C Maritz-Olivier (c) National Research Foundation, THRIP grant nr: 83890, C Maritz-Olivier and (d) Belgium Development Cooperation (DGD) FA3 project, M Madder and C Maritz-Olivier. 2. Zoetis South Africa assisted with sample collection but had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agapow PM, 2001, MOL ECOL NOTES, V1, P101, DOI 10.1046/j.1471-8278.2000.00014.x; Aguilar-Tipacamu G, 2008, PARASITOL RES, V103, P633, DOI 10.1007/s00436-008-1024-2; Aljanabi SM, 1997, NUCLEIC ACIDS RES, V25, P4692, DOI 10.1093/nar/25.22.4692; Balfanz S, 2005, J NEUROCHEM, V93, P440, DOI 10.1111/j.1471-4159.2005.03034.x; Baxter GD, 1999, INSECT BIOCHEM MOLEC, V29, P461, DOI 10.1016/S0965-1748(99)00023-5; Chen AC, 2007, VET PARASITOL, V148, P379, DOI 10.1016/j.vetpar.2007.06.026; Chen AC, 2009, J ECON ENTOMOL, V102, P373, DOI 10.1603/029.102.0148; Corley SW, 2013, P NATL ACAD SCI USA, V110, P16772, DOI 10.1073/pnas.1309072110; Corley SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032480; Estrada-Pena A, 2012, J MED ENTOMOL, V49, P794, DOI 10.1603/ME11223; Evans Peter D., 2005, Invertebrate Neuroscience, V5, P111, DOI 10.1007/s10158-005-0001-z; Farooqui Tahira, 2012, Open Access Insect Physiology, V4, P1; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fernandez-Salas A, 2012, VET PARASITOL, V183, P338, DOI 10.1016/j.vetpar.2011.07.028; Fernandez-Salasa A, 2012, VET PARASITOL; Fragoso-Sanchez H., 2011, Journal of Entomology, V8, P218, DOI 10.3923/je.2011.218.228; Gibson G., 2009, PRIMER GENOME SCI; Guerrero FD, 2002, EXP APPL ACAROL, V28, P257, DOI 10.1023/A:1025319104529; Guerrero FD, 2012, REV BRAS PARASITOL V, V21, P1, DOI 10.1590/S1984-29612012000100002; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Halliburton R, 2003, INTRO POPULATION GEN; Hartl D., 1989, PRINCIPLES POPULATIO; He HQ, 1999, BIOCHEM BIOPH RES CO, V261, P558, DOI 10.1006/bbrc.1999.1076; Hernandez R, 2002, INSECT BIOCHEM MOLEC, V32, P1009, DOI 10.1016/S0965-1748(02)00037-1; Horak IG, 2007, ONDERSTEPOORT J VET, V74, P231; Jonsson NN, 2007, VET PARASITOL, V146, P193, DOI 10.1016/j.vetpar.2007.03.006; Jonsson NN, 2010, INT J PARASITOL, V40, P1659, DOI 10.1016/j.ijpara.2010.07.006; Jonsson NN, 2010, VET PARASITOL, V169, P157, DOI 10.1016/j.vetpar.2009.12.026; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kliot A, 2012, PEST MANAG SCI, V68, P1431, DOI 10.1002/ps.3395; Labruna MB, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-46; Lees Kristin, 2007, Invertebrate Neuroscience, V7, P183, DOI 10.1007/s10158-007-0060-4; Lempereur L, 2010, ACTA TROP, V114, P55, DOI 10.1016/j.actatropica.2010.01.004; Li AY, 2005, EXP APPL ACAROL, V37, P183, DOI 10.1007/s10493-005-3260-9; Li AY, 2005, J ECON ENTOMOL, V98, P552, DOI 10.1603/0022-0493-98.2.552; Li AY, 2004, J MED ENTOMOL, V41, P193, DOI 10.1603/0022-2585-41.2.193; Lyngso RB, 2005, LECT NOTES COMPUT SC, V3692, P239; M'DIAYE K, 1991, Biomedical and Environmental Sciences, V4, P376; Madder M., 2010, TICK PHOTODATABASE T; Maqueira B, 2005, J NEUROCHEM, V94, P547, DOI 10.1111/j.1471-4159.2005.03251.x; Morgan JAT, 2009, INT J PARASITOL, V39, P775, DOI 10.1016/j.ijpara.2008.12.006; Murray J., 1910, REPORTS SCI EXPEDITI, P17; Nachman Michael W., 2006, P103; Paris M, 2008, HEREDITY, V101, P499, DOI 10.1038/hdy.2008.92; Pohl PC, 2011, INT J PARASITOL, V41, P1323, DOI 10.1016/j.ijpara.2011.08.004; Price EW, 2005, BIOINFORMATICS, V21, P402, DOI 10.1093/bioinformatics/bti003; ROBB S, 1994, EMBO J, V13, P1325, DOI 10.1002/j.1460-2075.1994.tb06385.x; Rosado-Aguilar JA, 2008, VET PARASITOL, V152, P349, DOI 10.1016/j.vetpar.2007.12.026; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Saldivar L, 2008, INSECT MOL BIOL, V17, P597, DOI 10.1111/j.1365-2583.2008.00831.x; SCHNITZERLING HJ, 1983, PESTIC SCI, V14, P64, DOI 10.1002/ps.2780140110; SHIN DH, 1994, TOXICOL APPL PHARM, V128, P45, DOI 10.1006/taap.1994.1178; Soberanes Cespedes N., 2002, Tecnica Pecuaria en Mexico, V40, P81; STONE B. F., 1962, Bulletin of Entomological Research, V53, Pt. 3, P563, DOI 10.1017/S000748530004832X; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tsagkarakou A, 2009, INSECT MOL BIOL, V18, P583, DOI 10.1111/j.1365-2583.2009.00900.x; Van Leeuwen T, 2010, INSECT BIOCHEM MOLEC, V40, P563, DOI 10.1016/j.ibmb.2010.05.008; Walker AR, 2003, TICKS DOMESTIC ANIMA, P149	60	31	31	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2015	10	7							e0131341	10.1371/journal.pone.0131341	http://dx.doi.org/10.1371/journal.pone.0131341			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EW	26158272	gold, Green Published, Green Submitted			2022-12-26	WOS:000358161200028
J	Jurdak, R; Zhao, K; Liu, JJ; AbouJaoude, M; Cameron, M; Newth, D				Jurdak, Raja; Zhao, Kun; Liu, Jiajun; AbouJaoude, Maurice; Cameron, Mark; Newth, David			Understanding Human Mobility from Twitter	PLOS ONE			English	Article							IMPACT	Understanding human mobility is crucial for a broad range of applications from disease prediction to communication networks. Most efforts on studying human mobility have so far used private and low resolution data, such as call data records. Here, we propose Twitter as a proxy for human mobility, as it relies on publicly available data and provides high resolution positioning when users opt to geotag their tweets with their current location. We analyse a Twitter dataset with more than six million geotagged tweets posted in Australia, and we demonstrate that Twitter can be a reliable source for studying human mobility patterns. Our analysis shows that geotagged tweets can capture rich features of human mobility, such as the diversity of movement orbits among individuals and of movements within and between cities. We also find that short-and long-distance movers both spend most of their time in large metropolitan areas, in contrast with intermediate-distance movers' movements, reflecting the impact of different modes of travel. Our study provides solid evidence that Twitter can indeed be a useful proxy for tracking and predicting human movement.	[Jurdak, Raja; Zhao, Kun; Liu, Jiajun] CSIRO, Brisbane, Qld, Australia; [AbouJaoude, Maurice] Amer Univ Beirut, Beirut, Lebanon; [Cameron, Mark; Newth, David] CSIRO, Canberra, ACT, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); American University of Beirut; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Jurdak, R (corresponding author), CSIRO, Brisbane, Qld, Australia.	raja.jurdak@csiro.au	Jurdak, Raja/B-7637-2011; Newth, David/A-1848-2011	Jurdak, Raja/0000-0001-7517-0782; Newth, David/0000-0001-6882-7440; Abou Jaoude, Maurice/0000-0001-9270-7043				Austin D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090256; Balcan D, 2009, P NATL ACAD SCI USA, V106, P21484, DOI 10.1073/pnas.0906910106; Bernard A, 2014, POPUL DEV REV, V40, P213, DOI 10.1111/j.1728-4457.2014.00671.x; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; Cameron M. A., 2012, PROC 21 INT C WORLD, P698; Cattuto C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011596; Chaintreau A, 2007, IEEE T MOBILE COMPUT, V6, P606, DOI 10.1109/TMC.2007.1060; Ester M., 1996, KDD-96 Proceedings. Second International Conference on Knowledge Discovery and Data Mining, P226; FANO RM, 1961, TRANSMISSION INFORMA; Fournet J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107878; Frank MR, 2013, SCI REP-UK, V3, DOI 10.1038/srep02625; Frisch U, 1997, J PHYS I, V7, P1155, DOI 10.1051/jp1:1997114; Gambs S., 2012, P 1 WORKSH MEAS PRIV, V3, P1, DOI [10.1145/2181196.2181199, DOI 10.1145/2181196.2181199]; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Hawelkaa B, 2013, ARXIV PREPRINT; Ikawa Yohei, 2012, P 21 INT C COMP WORL, P687; Isaacman S., 2012, ACM, P239, DOI DOI 10.1145/2307636.2307659; Ji Y, 2011, THESIS MIT; Jiang Shan, 2013, P 2 ACM SIGKDD INT W; Jurdak R, 2013, ACM T SENSOR NETWORK, V9, DOI 10.1145/2422966.2422980; Laherrere J, 1998, EUR PHYS J B, V2, P525, DOI 10.1007/s100510050276; Liang X, 2013, SCI REP-UK, V3, DOI 10.1038/srep02983; Liu J, 2015, P 1 INT WORKSH BIG D; Lu X, 2013, SCI REP-UK, V3, DOI 10.1038/srep02923; Noulas A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037027; Palchykov V, 2014, SCI REP-UK, V4, DOI 10.1038/srep06174; Rhee I, 2011, IEEE ACM T NETWORK, V19, P630, DOI 10.1109/TNET.2011.2120618; Song CM, 2010, NAT PHYS, V6, P818, DOI 10.1038/NPHYS1760; Storey K, 2001, AUST GEOGR, V32, P133, DOI 10.1080/00049180120066616; Tizzoni M, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003716; Treiber M., 2013, TRAFFIC FLOW DYNAMIC; Wang P, 2009, SCIENCE, V324, P1071, DOI 10.1126/science.1167053; Wang Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112608; Wesolowski A, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0986; Wesolowski A, 2012, SCIENCE, V338, P267, DOI 10.1126/science.1223467; Wilson T, 2004, J POPULATION RES, V21, P127, DOI [10.1007/BF03031895, DOI 10.1007/BF03031895]; Wu L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097010; Yan XY, 2013, SCI REP-UK, V3, DOI 10.1038/srep02678; Zhang Y, 2012, EPL-EUROPHYS LETT, V98, DOI 10.1209/0295-5075/98/68002; Zhao K, 2014, ARXIV14084910; Zhao K, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.056109; Zheng Y, 2008, PROCEEDINGS OF THE 10TH INTERNATIONAL CONFERENCE ON UBIQUITOUS COMPUTING (UBICOMP 2008), P312, DOI 10.1145/1409635.1409677; Zipf GK, 1946, AM SOCIOL REV, V11, P677, DOI 10.2307/2087063	44	178	180	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0131469	10.1371/journal.pone.0131469	http://dx.doi.org/10.1371/journal.pone.0131469			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CN1EJ	26154597	gold, Green Published, Green Submitted			2022-12-26	WOS:000358159700064
J	Mikuni, S; Kodama, K; Sasaki, A; Kohira, N; Maki, H; Munetomo, M; Maenaka, K; Kinjo, M				Mikuni, Shintaro; Kodama, Kota; Sasaki, Akira; Kohira, Naoki; Maki, Hideki; Munetomo, Masaharu; Maenaka, Katsumi; Kinjo, Masataka			Screening for FtsZ Dimerization Inhibitors Using Fluorescence Cross-Correlation Spectroscopy and Surface Resonance Plasmon Analysis	PLOS ONE			English	Article							CELL-DIVISION; ANTISTAPHYLOCOCCAL EFFICACY; IN-VIVO; PROTEIN; PRODRUG; CONSTANT	FtsZ is an attractive target for antibiotic research because it is an essential bacterial cell division protein that polymerizes in a GTP-dependent manner. To find the seed chemical structure, we established a high-throughput, quantitative screening method combining fluorescence cross-correlation spectroscopy (FCCS) and surface plasmon resonance (SPR). As a new concept for the application of FCCS to polymerization-prone protein, Staphylococcus aureus FtsZ was fragmented into the N-terminal and C-terminal, which were fused with GFP and mCherry (red fluorescent protein), respectively. By this fragmentation, the GTP-dependent head-to-tail dimerization of each fluorescent labeled fragment of FtsZ could be observed, and the inhibitory processes of chemicals could be monitored by FCCS. In the first round of screening by FCCS, 28 candidates were quantitatively and statistically selected from 495 chemicals determined by in silico screening. Subsequently, in the second round of screening by FCCS, 71 candidates were also chosen from 888 chemicals selected via an in silico structural similarity search of the chemicals screened in the first round of screening. Moreover, the dissociation constants between the highest inhibitory chemicals and Staphylococcus aureus FtsZ were determined by SPR. Finally, by measuring the minimum inhibitory concentration, it was confirmed that the screened chemical had antibacterial activity against Staphylococcus aureus, including methicillin-resistant Staphylococcus aureus (MRSA).	[Mikuni, Shintaro; Kinjo, Masataka] Hokkaido Univ, Fac Adv Life Sci, Lab Mol Cell Dynam, Sapporo, Hokkaido, Japan; [Kodama, Kota] Hokkaido Univ, Creat Res Inst, Sapporo, Hokkaido, Japan; [Sasaki, Akira] Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Bioanalyt Res Grp, Tsukuba, Japan; [Kohira, Naoki; Maki, Hideki] Shionogi & Co Ltd, Discovery Res Lab, Core Therapeut Areas, Toyonaka, Osaka, Japan; [Munetomo, Masaharu] Hokkaido Univ, Informat Initiat Ctr, Sapporo, Hokkaido, Japan; [Munetomo, Masaharu] Hokkaido Univ, Grad Sch Informat Sci & Technol, Sapporo, Hokkaido, Japan; [Maenaka, Katsumi] Hokkaido Univ, Fac Pharmaceut Sci, Lab Biomol Sci, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University; National Institute of Advanced Industrial Science & Technology (AIST); Shionogi & Company Limited; Hokkaido University; Hokkaido University; Hokkaido University	Kinjo, M (corresponding author), Hokkaido Univ, Fac Adv Life Sci, Lab Mol Cell Dynam, Sapporo, Hokkaido, Japan.	kinjo@sci.hokudai.ac.jp	Sasaki, Akira/M-3025-2018; Kodama, Kota/ABG-8274-2020; Kinjo, Masataka/F-5267-2011	Sasaki, Akira/0000-0002-8021-9437; Kodama, Kota/0000-0002-2360-2034; Kinjo, Masataka/0000-0001-8889-8369	Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program; Ministry of Education, Culture, Sports, Science and Technology, Japan; Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology; Ministry of Health, Labor and Welfare, Japan; collaborative research program of the Information Initiative Center, Hokkaido University, Sapporo, Japan; Discovery Research Laboratory for Core Therapeutic Areas, Shionogi Co., Ltd.	Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program; Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology; Ministry of Health, Labor and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); collaborative research program of the Information Initiative Center, Hokkaido University, Sapporo, Japan; Discovery Research Laboratory for Core Therapeutic Areas, Shionogi Co., Ltd.	This work was partially supported by the Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program (http://www.jst.go.jp/shincho/en/), Ministry of Education, Culture, Sports, Science and Technology, Japan, the Platform for Drug Discovery, Informatics, and Structural Life Science (http://pford.jp/) from the Ministry of Education, Culture, Sports, Science and Technology and the Ministry of Health, Labor and Welfare, Japan and the 2014 collaborative research program of the Information Initiative Center, Hokkaido University, Sapporo, Japan. Discovery Research Laboratory for Core Therapeutic Areas, Shionogi & Co., Ltd. provided support in the form of salaries for authors NK and HM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adams DW, 2009, NAT REV MICROBIOL, V7, P642, DOI 10.1038/nrmicro2198; Andreu JM, 2010, J BIOL CHEM, V285, P14239, DOI 10.1074/jbc.M109.094722; Bacia K, 2007, NAT PROTOC, V2, P2842, DOI 10.1038/nprot.2007.410; Chan FY, 2014, J ANTIBIOT TOKYO, P1, DOI DOI 10.1177/1359105314530451; Clinical and Laboratory Standards Institute, 2006, APPROVED STANDARD, pM7; Czaplewski LG, 2009, BIOORG MED CHEM LETT, V19, P524, DOI 10.1016/j.bmcl.2008.11.021; Duggirala S, 2014, APPL BIOCHEM BIOTECH, V174, P283, DOI 10.1007/s12010-014-1056-2; EIGEN M, 1994, P NATL ACAD SCI USA, V91, P5740, DOI 10.1073/pnas.91.13.5740; Elsen NL, 2012, J AM CHEM SOC, V134, P12342, DOI 10.1021/ja303564a; Erickson HP, 1996, P NATL ACAD SCI USA, V93, P519, DOI 10.1073/pnas.93.1.519; Haydon DJ, 2008, SCIENCE, V321, P1673, DOI 10.1126/science.1159961; Kaul M, 2014, BIOCHEM PHARMACOL, V89, P321, DOI 10.1016/j.bcp.2014.03.002; Kaul M, 2013, BIOCHEM PHARMACOL, V86, P1699, DOI 10.1016/j.bcp.2013.10.010; Kaul M, 2013, ANTIMICROB AGENTS CH, V57, P5860, DOI 10.1128/AAC.01016-13; Kaul M, 2013, BIOCHIMIE, V95, P1880, DOI 10.1016/j.biochi.2013.06.010; Kogure T, 2008, METHODS, V45, P223, DOI 10.1016/j.ymeth.2008.06.009; Koppelman CM, 2004, MOL MICROBIOL, V51, P645, DOI 10.1046/j.1365-2958.2003.03876.x; Kumar K, 2011, J MED CHEM, V54, P374, DOI 10.1021/jm1012006; Li N, 2010, J BIOL CHEM, V285, P6922, DOI 10.1074/jbc.M109.069286; Liu P, 2007, BIOPHYS J, V93, P684, DOI 10.1529/biophysj.106.102087; Maeder CI, 2007, NAT CELL BIOL, V9, P1319, DOI 10.1038/ncb1652; Margolin W, 2005, NAT REV MOL CELL BIO, V6, P862, DOI 10.1038/nrm1745; Matsui T, 2014, J BIOL CHEM, V289, P3501, DOI 10.1074/jbc.M113.514901; Mitsuhashi M, 2011, J BIOCHEM, V149, P253, DOI 10.1093/jb/mvq134; Miura K, 2010, ANTIMICROB AGENTS CH, V54, P960, DOI 10.1128/AAC.00927-09; Mukherjee S, 2007, BIOORG MED CHEM LETT, V17, P6651, DOI 10.1016/j.bmcl.2007.09.010; Muto H, 2006, PLANT CELL PHYSIOL, V47, P1095, DOI 10.1093/pcp/pcj080; Ohrt T, 2008, NUCLEIC ACIDS RES, V36, P6439, DOI 10.1093/nar/gkn693; Oyama R, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl477; Park B, 2014, BIOORGAN MED CHEM, V22, P2602, DOI 10.1016/j.bmc.2014.03.035; Park HC, 2014, APPL BIOCHEM BIOTECH, V172, P3263, DOI 10.1007/s12010-014-0752-2; Perike S, 2014, EXP CELL RES, V324, P13, DOI 10.1016/j.yexcr.2014.03.005; Reija B, 2011, ANAL BIOCHEM, V418, P89, DOI 10.1016/j.ab.2011.07.001; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Ruan QQ, 2008, ANAL BIOCHEM, V374, P182, DOI 10.1016/j.ab.2007.11.007; Sadamoto H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020285; Saito K, 2004, BIOCHEM BIOPH RES CO, V324, P849, DOI 10.1016/j.bbrc.2004.09.126; Sasaki A, 2010, J CONTROL RELEASE, V143, P104, DOI 10.1016/j.jconrel.2009.12.013; Schwille P, 1997, BIOPHYS J, V72, P1878, DOI 10.1016/S0006-3495(97)78833-7; SHOJI J, 1988, J ANTIBIOT, V41, P713, DOI 10.7164/antibiotics.41.713; Slaughter BD, 2007, P NATL ACAD SCI USA, V104, P20320, DOI 10.1073/pnas.0710336105; Stokes NR, 2005, J BIOL CHEM, V280, P39709, DOI 10.1074/jbc.M506741200; Sun F, 2011, BIOCHEM BIOPH RES CO, V404, P706, DOI 10.1016/j.bbrc.2010.12.047; Tiwari M, 2013, BIOCHEM BIOPH RES CO, V436, P430, DOI 10.1016/j.bbrc.2013.05.121; Wang J, 2003, J BIOL CHEM, V278, P44424, DOI 10.1074/jbc.M307625200; White EL, 2002, J ANTIMICROB CHEMOTH, V50, P111, DOI 10.1093/jac/dkf075; Yamada M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3033; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhou XM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008074	49	8	8	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2015	10	7							e0130933	10.1371/journal.pone.0130933	http://dx.doi.org/10.1371/journal.pone.0130933			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EJ	26154290	Green Published, Green Submitted, gold			2022-12-26	WOS:000358159700046
J	Gansel, LC; Plew, DR; Endresen, PC; Olsen, AI; Misimi, E; Guenther, J; Jensen, O				Gansel, Lars Christian; Plew, David R.; Endresen, Per Christian; Olsen, Anna Ivanova; Misimi, Ekrem; Guenther, Jana; Jensen, Osten			Drag of Clean and Fouled Net Panels - Measurements and Parameterization of Fouling	PLOS ONE			English	Article							AQUACULTURE; EFFICACY; CAGES; FORCE	Biofouling is a serious problem in marine aquaculture and it has a number of negative impacts including increased forces on aquaculture structures and reduced water exchange across nets. This in turn affects the behavior of fish cages in waves and currents and has an impact on the water volume and quality inside net pens. Even though these negative effects are acknowledged by the research community and governmental institutions, there is limited knowledge about fouling related effects on the flow past nets, and more detailed investigations distinguishing between different fouling types have been called for. This study evaluates the effect of hydroids, an important fouling organism in Norwegian aquaculture, on the forces acting on net panels. Drag forces on clean and fouled nets were measured in a flume tank, and net solidity including effect of fouling were determined using image analysis. The relationship between net solidity and drag was assessed, and it was found that a solidity increase due to hydroids caused less additional drag than a similar increase caused by change in clean net parameters. For solidities tested in this study, the difference in drag force increase could be as high as 43% between fouled and clean nets with same solidity. The relationship between solidity and drag force is well described by exponential functions for clean as well as for fouled nets. A method is proposed to parameterize the effect of fouling in terms of an increase in net solidity. This allows existing numerical methods developed for clean nets to be used to model the effects of biofouling on nets. Measurements with other types of fouling can be added to build a database on effects of the accumulation of different fouling organisms on aquaculture nets.	[Gansel, Lars Christian] Norwegian Univ Sci & Technol, Dept Marine Technol, N-7034 Trondheim, Norway; [Gansel, Lars Christian; Endresen, Per Christian; Misimi, Ekrem; Guenther, Jana] SINTEF Fisheries & Aquaculture, Aquaculture Technol Dept, Trondheim, Norway; [Plew, David R.] NIWA, Christchurch, New Zealand; [Olsen, Anna Ivanova] Den Norske Veritas, Trondheim, Norway; [Jensen, Osten] STATOIL, Stjordal, Norway	Norwegian University of Science & Technology (NTNU); SINTEF; National Institute of Water & Atmospheric Research (NIWA) - New Zealand	Gansel, LC (corresponding author), Norwegian Univ Sci & Technol, Dept Marine Technol, Otto Nielsens Vei 10, N-7034 Trondheim, Norway.	lars.gansel@sintef.no	Bannister, Jana/ABE-3695-2020	Bannister, Jana/0000-0002-5281-7800; Gansel, Lars Christian/0000-0003-3316-5277; Olsen, Anna/0000-0002-5381-584X; Plew, David/0000-0001-6714-4904; Misimi, Ekrem/0000-0003-2489-7759	Research Council of Norway [174842]	Research Council of Norway(Research Council of Norway)	The work was funded by The Research Council of Norway (www.forskningsradet.no) through a phd fellowship from the Faculty of Engineering Science and Technology at the Norwegian University of Science and Technology and through the Centre for Research-based Innovation in Aquaculture Technology, CREATE (Grant number: 174842), at SINTEF Fisheries and Aquaculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARSNES JV, 1990, ENGINEERING FOR OFFSHORE FISH FARMING, P137; Balash C, 2009, AQUACULT ENG, V41, P14, DOI 10.1016/j.aquaeng.2009.04.003; Baldwin KC, 2003, OCEANS 2003 MTS/IEEE: CELEBRATING THE PAST...TEAMING TOWARD THE FUTURE, P1454, DOI 10.1109/OCEANS.2003.178076; Bloecher N, 2013, AQUACULTURE, V416, P302, DOI 10.1016/j.aquaculture.2013.09.025; Braithwaite RA, 2007, AQUACULTURE, V262, P219, DOI 10.1016/j.aquaculture.2006.11.027; de Nys R, 2009, WOODHEAD PUBL MATER, P177, DOI 10.1533/9781845696313.1.177; Demtroder W., 2002, EXPERIMETNALPHYSIC 1, P32; Duerr S, 2010, BIOFOULING; Fitridge I, 2012, BIOFOULING, V28, P649, DOI 10.1080/08927014.2012.700478; Food and Agriculture Organization of the United Nations (FAO), 2010, STAT WORLD FISH AQ; Fredheim A., 2005, THESIS NORWEGIAN U S; Gansel L. C., 2011, J OFFSHORE MECH ARCT, V134; Guenther J, 2010, AQUACULTURE, V300, P120, DOI 10.1016/j.aquaculture.2010.01.005; Hodson SL, 2000, AQUACULTURE, V184, P277, DOI 10.1016/S0044-8486(99)00328-2; Jensen O, 2010, AQUACULT ENV INTERAC, V1, P71, DOI 10.3354/aei00008; Jensen O, 2013, P 32 INT C OC OFFSH; Klebert P, 2013, OCEAN ENG, V58, P260, DOI 10.1016/j.oceaneng.2012.11.006; Lader P, 2008, AQUACULT ENG, V38, P52, DOI 10.1016/j.aquaeng.2007.11.001; Loland G., 1991, THESIS NORWEGIAN I T; Milne P.H, 1972, FISH SHELLFISH FARMI; Milne P.H., 1970, FISH FARMING GUIDE D; Plew DR, 2009, AQUACULT ENG, V40, P55, DOI 10.1016/j.aquaeng.2008.12.003; PYEFINCH KA, 1949, J MAR BIOL ASSOC UK, V28, P21, DOI 10.1017/S0025315400055223; Standard Norge, 2009, 9415E2009 NS; Swift MR, 2006, AQUACULT ENG, V35, P292, DOI 10.1016/j.aquaeng.2006.03.002; Walpole R.E., 2007, PROBABILITY STAT ENG; Yamamoto K, 1988, JAPAN SOC SCI FISHER; Zhan JM, 2006, AQUACULT ENG, V35, P91, DOI 10.1016/j.aquaeng.2005.08.013	28	35	36	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2015	10	7							e0131051	10.1371/journal.pone.0131051	http://dx.doi.org/10.1371/journal.pone.0131051			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1EC	26151907	gold, Green Published, Green Submitted			2022-12-26	WOS:000358158900016
J	Chen, MJZ; Liang, DC; Zuo, AJ; Shao, H; Kaplan, HJ; Sun, DM				Chen, Mingjiazi; Liang, Dongchun; Zuo, Aijun; Shao, Hui; Kaplan, Henry J.; Sun, Deming			An A2B Adenosine Receptor Agonist Promotes Th17 Autoimmune Responses in Experimental Autoimmune Uveitis (EAU) via Dendritic Cell Activation	PLOS ONE			English	Article							DELTA T-CELLS; IMMUNE-RESPONSE; IL-23; DIFFERENTIATION; GENERATION; INDUCTION; MICE; INFLAMMATION; LYMPHOCYTES; METABOLISM	We have recently reported that, although adenosine receptor (AR) agonists have a suppressive effect on Th1 autoreactive T cells, their effect on Th17 autoreactive T cells and gamma delta T cells is stimulatory and this effect is mainly mediated via A2A adenosine receptors (A2ARs). In this study, we further demonstrate that treatment of C57BL/6 (B6) mice with a selective A2B adenosine receptor (A2BR) agonist greatly enhanced the development of experimental autoimmune uveitis (EAU), whereas treatment with an A2BR antagonist significantly ameliorated severity of EAU. The A2BR agonist-treated mice showed augmented Th17, but not Th1, responses. Mechanistic studies showed that the A2BR agonist-induced enhancement of the Th17 response was significantly lower when TCR-delta(-/-) mice received the same treatment and that transfer of gamma delta T cells into TCR-delta(-/-) mice partially restored this effect. We also showed that dendritic cells (DCs) from A2BR agonist-treated mice showed a significantly increased ability to activate gamma delta T cells and Th17 autoreactive T cells. Thus, our previous studies have shown that, in EAU, activated gamma delta T cells possess greatly increased ability to enhance Th17 autoimmune responses. In the present study, we showed that exposure of DCs to A2BR agonist facilitated gamma delta T cell activation, leading to augmented Th17 responses and progressive EAU development. Our results further support our previous finding that AR agonists have distinct effects on Th1 and Th17 autoimmune responses.	[Chen, Mingjiazi; Liang, Dongchun; Zuo, Aijun; Sun, Deming] Univ Calif Los Angeles, Doheny Eye Inst, Los Angeles, CA 90033 USA; [Chen, Mingjiazi; Liang, Dongchun; Zuo, Aijun; Sun, Deming] Univ Calif Los Angeles, Dept Ophthalmol, Los Angeles, CA 90033 USA; [Shao, Hui; Kaplan, Henry J.] Univ Louisville, Dept Ophthalmol & Visual Sci, Kentucky Lions Eye Ctr, Louisville, KY 40202 USA	Doheny Eye Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Louisville	Sun, DM (corresponding author), Univ Calif Los Angeles, Doheny Eye Inst, Los Angeles, CA 90033 USA.	Dsun@doheny.org			National Institutes of Health [EY 0022403, EY018827, EY003040]; NATIONAL EYE INSTITUTE [R01EY018827, R01EY022403, P30EY003040] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health grants EY 0022403 (DS), EY018827 (DS), and EY003040 (DS).	Ben Addi A, 2008, EUR J IMMUNOL, V38, P1610, DOI 10.1002/eji.200737781; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bours MJL, 2006, PHARMACOL THERAPEUT, V112, P358, DOI 10.1016/j.pharmthera.2005.04.013; CASPI RR, 1988, J IMMUNOL, V140, P1490; Chen JF, 2013, NAT REV DRUG DISCOV, V12, P265, DOI 10.1038/nrd3955; Csoka B, 2012, FASEB J, V26, P376, DOI 10.1096/fj.11-190934; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Cui Y, 2009, J IMMUNOL, V183, P560, DOI 10.4049/jimmunol.0900241; Cui Y, 2009, INVEST OPHTH VIS SCI, V50, P5811, DOI 10.1167/iovs.09-3389; Di Virgilio Francesco, 2005, Purinergic Signal, V1, P205, DOI 10.1007/s11302-005-6312-z; Dong C, 2006, NAT REV IMMUNOL, V6, P329, DOI 10.1038/nri1807; Ehrentraut H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032416; Eltzschig HK, 2008, TRENDS CARDIOVAS MED, V18, P103, DOI 10.1016/j.tcm.2008.01.006; Feoktistov I, 1997, PHARMACOL REV, V49, P381; Ferber IA, 1996, J IMMUNOL, V156, P5; Fredholm BB, 2001, PHARMACOL REV, V53, P527; Granstein RD, 2005, J IMMUNOL, V174, P7725, DOI 10.4049/jimmunol.174.12.7725; Hasko G, 2004, TRENDS IMMUNOL, V25, P33, DOI 10.1016/j.it.2003.11.003; Hasko G, 2009, TRENDS IMMUNOL, V30, P263, DOI 10.1016/j.it.2009.04.001; Hasko G, 2008, NAT REV DRUG DISCOV, V7, P759, DOI 10.1038/nrd2638; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Jacobson KA, 2006, NAT REV DRUG DISCOV, V5, P247, DOI 10.1038/nrd1983; Jager A, 2009, J IMMUNOL, V183, P7169, DOI 10.4049/jimmunol.0901906; Jin DC, 2010, CANCER RES, V70, P2245, DOI 10.1158/0008-5472.CAN-09-3109; Jones LS, 1997, J IMMUNOL, V158, P5997; Junger WG, 2011, NAT REV IMMUNOL, V11, P201, DOI 10.1038/nri2938; Kolachala VL, 2008, BRIT J PHARMACOL, V155, P127, DOI 10.1038/bjp.2008.227; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Korn T, 2008, P NATL ACAD SCI USA, V105, P18460, DOI 10.1073/pnas.0809850105; Langrish CL, 2004, IMMUNOL REV, V202, P96, DOI 10.1111/j.0105-2896.2004.00214.x; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Liang DC, 2014, J IMMUNOL, V193, P5498, DOI 10.4049/jimmunol.1401959; Liang DC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108932; Liang DC, 2013, J IMMUNOL, V191, P1118, DOI 10.4049/jimmunol.1300626; Liang DC, 2013, INVEST OPHTH VIS SCI, V54, P3493, DOI 10.1167/iovs.12-11432; Luger D, 2008, J EXP MED, V205, P799, DOI 10.1084/jem.20071258; MANDLER R, 1982, P NATL ACAD SCI-BIOL, V79, P7542, DOI 10.1073/pnas.79.23.7542; Mills JH, 2008, P NATL ACAD SCI USA, V105, P9325, DOI 10.1073/pnas.0711175105; Nian H, 2011, INVEST OPHTH VIS SCI, V52, P5920, DOI 10.1167/iovs.10-6758; Nian H, 2010, INVEST OPHTH VIS SCI, V51, P4661, DOI 10.1167/iovs.09-5045; Niederkorn J Y, 1990, Adv Immunol, V48, P191, DOI 10.1016/S0065-2776(08)60755-5; Niemela J, 2008, EUR J IMMUNOL, V38, P2718, DOI 10.1002/eji.200838437; Novitskiy SV, 2008, BLOOD, V112, P1822, DOI 10.1182/blood-2008-02-136325; Ohta A, 2001, NATURE, V414, P916, DOI 10.1038/414916a; Peng Y, 2007, INVEST OPHTH VIS SCI, V48, P4153, DOI 10.1167/iovs.07-0251; Ramlackhansingh AF, 2011, NEUROLOGY, V76, P1811, DOI 10.1212/WNL.0b013e31821ccce4; Sauer AV, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00265; Schenk U, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160583; Sitkovsky MV, 2005, TRENDS IMMUNOL, V26, P299, DOI 10.1016/j.it.2005.04.004; Sitkovsky MV, 2004, ANNU REV IMMUNOL, V22, P657, DOI 10.1146/annurev.immunol.22.012703.104731; Stummvoll GH, 2008, J IMMUNOL, V181, P1908, DOI 10.4049/jimmunol.181.3.1908; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Thurau SR, 1997, CLIN EXP IMMUNOL, V109, P370, DOI 10.1046/j.1365-2249.1997.4571356.x; Wei W, 2013, J IMMUNOL, V190, P138, DOI 10.4049/jimmunol.1103721; Wilson JM, 2011, J IMMUNOL, V186, P6746, DOI 10.4049/jimmunol.1100117; Yip L, 2009, FASEB J, V23, P1685, DOI 10.1096/fj.08-126458; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	57	26	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132348	10.1371/journal.pone.0132348	http://dx.doi.org/10.1371/journal.pone.0132348			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147733	gold, Green Published			2022-12-26	WOS:000358157600248
J	Cohen, S; Innes, S; Geelen, SPM; Wells, JCK; Smit, C; Wolfs, TFW; van Eck-Smit, BLF; Kuijpers, TW; Reiss, P; Scherpbier, HJ; Pajkrt, D; Bunders, MJ				Cohen, Sophie; Innes, Steve; Geelen, Sibyl P. M.; Wells, Jonathan C. K.; Smit, Colette; Wolfs, Tom F. W.; van Eck-Smit, Berthe L. F.; Kuijpers, Taco W.; Reiss, Peter; Scherpbier, Henriette J.; Pajkrt, Dasja; Bunders, Madeleine J.			Long-Term Changes of Subcutaneous Fat Mass in HIV-Infected Children on Antiretroviral Therapy: A Retrospective Analysis of Longitudinal Data from Two Pediatric HIV-Cohorts	PLOS ONE			English	Article							BONE-MINERAL DENSITY; BODY-COMPOSITION; INSULIN-RESISTANCE; CROSS-CALIBRATION; LIPODYSTROPHY; STAVUDINE; ABNORMALITIES; LIPOATROPHY; INHIBITOR; SUBSTITUTION	Objective Longitudinal studies objectively evaluating changes in regional fat distribution of HIV-infected children assessed by whole body dual energy X-ray absorptiometry (DEXA) are scarce, whilst this long-term effect of HIV and antiretroviral therapy (cART) is an important issue in infected children in need for lifelong treatment. Methods We assessed regional fat distribution over time, measured with sequential DEXA-scans in HIV-infected children on cART in cohorts from South Africa (SA) and the Netherlands (NL), and in healthy controls (SA). Limb and trunk fat Z-scores were calculated with the lambda-mu-sigma (LMS) method. Multivariable linear regression models with mixed effects were used to investigate the effect of cART compounds on body fat distribution over time. Results In total, 218 children underwent 445 DEXA assessments with a median follow-up of 3.5 years. Fat mass in all limbs was decreased in HIV-infected children compared to controls (arm fat Z-score: coefficient -0.4813; P = 0.006, leg fat Z-score: coefficient -0.4345; P = 0.013). In the HIV-infected group, stavudine treatment was associated with lower subcutaneous fat mass (arm fat Z-score: coefficient -0.5838; P = 0.001), with an additional cumulative exposure effect (arm fat Z-score: coefficient -0.0867; P = 0.003). Conclusions Our study shows that subcutaneous fat loss is still prevalent in HIV-infected children on cART, and is strongly associated with cumulative stavudine exposure. These results underline the need for early detection of subcutaneous fat loss and alternative treatment options for HIV-infected children globally.	[Cohen, Sophie; Kuijpers, Taco W.; Scherpbier, Henriette J.; Pajkrt, Dasja; Bunders, Madeleine J.] Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Dept Paediat Haematol Immunol & Infect Dis, NL-1105 AZ Amsterdam, Netherlands; [Innes, Steve] Tygerberg Childrens Hosp, KID CRU Childrens Infect Dis Clin Res Unit, Cape Town, South Africa; [Innes, Steve] Univ Stellenbosch, Cape Town, South Africa; [Geelen, Sibyl P. M.; Wolfs, Tom F. W.] Univ Utrecht, Dept Paediat, Wilhelmina Childrens Hosp, Univ Med Ctr Utrecht, Utrecht, Netherlands; [Wells, Jonathan C. K.] UCL, Childhood Nutr Res Ctr, Inst Child Hlth, London, England; [Smit, Colette; Reiss, Peter] Stichting HIV Monitoring, Amsterdam, Netherlands; [van Eck-Smit, Berthe L. F.] Univ Amsterdam, Acad Med Ctr, Dept Nucl Med, NL-1105 AZ Amsterdam, Netherlands; [Reiss, Peter] Univ Amsterdam, Acad Med Ctr, Dept Global Hlth, NL-1105 AZ Amsterdam, Netherlands; [Reiss, Peter] Univ Amsterdam, Acad Med Ctr, Amsterdam Inst Global Hlth & Dev, NL-1105 AZ Amsterdam, Netherlands	Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Stellenbosch University; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; University of London; University College London; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Cohen, S (corresponding author), Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Dept Paediat Haematol Immunol & Infect Dis, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	s.cohen@amc.nl	Wells, Jonathan/A-4604-2009	Wells, Jonathan/0000-0003-0411-8025; Innes, Steve/0000-0003-3969-8680	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036214] Funding Source: NIH RePORTER; NIAID NIH HHS [P30 AI036214] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alam N, 2012, JAIDS-J ACQ IMM DEF, V59, P314, DOI 10.1097/QAI.0b013e31824330cb; Arpadi S, 2013, ARCH DIS CHILD, V98, P258, DOI 10.1136/archdischild-2012-302633; Aurpibul L, 2012, PEDIATR INFECT DIS J, V31, P384, DOI 10.1097/INF.0b013e31823f0e11; Barlow-Mosha L, 2013, J INT AIDS SOC, V16, P1, DOI [10.7448/IAS.16.1.18567, DOI 10.7448/IAS.16.1.18567]; Bockhorst JL, 2003, PEDIATR INFECT DIS J, V22, P463, DOI 10.1097/00006454-200305000-00017; Bunders MJ, 2013, CLIN INFECT DIS, V56, P583, DOI 10.1093/cid/cis917; Cohen S, 2013, AIDS, V27, P2567, DOI 10.1097/01.aids.0000432451.75980.1b; COLE TJ, 1990, EUR J CLIN NUTR, V44, P45; Dangerous Drugs England Dangerous Drugs Scotland., 2013, CONTROLLED DRUGS SUP; Ramalho LCD, 2011, INT J STD AIDS, V22, P453, DOI 10.1258/ijsa.2011.010516; Drechsler H, 2002, CLIN INFECT DIS, V35, P1219, DOI 10.1086/343050; Fabiano V, 2013, EUR J PEDIATR, V172, P1089, DOI 10.1007/s00431-013-2018-3; Giralt M, 2006, ANTIVIR THER, V11, P729; Goran MI, 1996, AM J CLIN NUTR, V63, P299, DOI 10.1093/ajcn/63.3.299; Grinspoon S, 2005, NEW ENGL J MED, V352, P48, DOI 10.1056/NEJMra041811; Hartman K, 2006, PEDIATR INFECT DIS J, V25, P427, DOI 10.1097/01.inf.0000215003.32256.aa; Innes S, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-183; Kakuda TN, 1999, AIDS, V13, P2311, DOI 10.1097/00002030-199911120-00019; La Rovere, 2004, AIDS, V18, P1443, DOI 10.1097/01.aids.0000131334.38172.01; Madhi SA, 2010, J INFECT DIS, V202, P355, DOI 10.1086/653704; Martin A, 2004, AIDS, V18, P1029, DOI 10.1097/00002030-200404300-00011; Maynard LM, 2001, PEDIATRICS, V107, P344, DOI 10.1542/peds.107.2.344; Oh J, 2007, LANCET INFECT DIS, V7, P787, DOI 10.1016/S1473-3099(07)70287-6; Palmer M, 2013, AIDS, V27, P781, DOI 10.1097/QAD.0b013e32835c54b8; Pearson D, 2011, J CLIN DENSITOM, V14, P294, DOI 10.1016/j.jocd.2011.03.008; Rao D, 2007, AIDS CARE, V19, P28, DOI 10.1080/09540120600652303; Safrin S, 1999, AIDS, V13, P2493, DOI 10.1097/00002030-199912240-00002; Sauvageot D, 2010, PEDIATRICS, V125, pE1039, DOI 10.1542/peds.2009-1062; Soler-Palacin P, 2011, AIDS, V25, P171, DOI 10.1097/QAD.0b013e328340fdca; Technau KG, 2014, PEDIATR INFECT DIS J, V33, P617, DOI 10.1097/INF.0000000000000222; Vigano A, 2003, JAIDS-J ACQ IMM DEF, V32, P482, DOI 10.1097/00126334-200304150-00003; Vigano A, 2011, CURR HIV RES, V9, P321, DOI 10.2174/157016211797635946; Vigano A, 2007, ANTIVIR THER, V12, P297; Wells JCK, 2006, ARCH DIS CHILD, V91, P612, DOI 10.1136/adc.2005.085522; Wells JCK, 2012, AM J CLIN NUTR, V96, P1316, DOI 10.3945/ajcn.112.036970; Weyer C, 2001, J CLIN ENDOCR METAB, V86, P1930, DOI 10.1210/jc.86.5.1930	36	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0120927	10.1371/journal.pone.0120927	http://dx.doi.org/10.1371/journal.pone.0120927			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148119	Green Published, gold, Green Submitted			2022-12-26	WOS:000358157600003
J	George, SD; Baldigo, BP				George, Scott Daniel; Baldigo, Barry Paul			Didymosphenia geminata in the Upper Esopus Creek: Current Status, Variability, and Controlling Factors	PLOS ONE			English	Article							FRESH-WATER DIATOM; COMMUNITIES; CHALLENGES; INVASION; STALKS	In May of 2009, the bloom-forming diatom Didymosphenia geminata was first identified in the Upper Esopus Creek, a key tributary to the New York City water-supply and a popular recreational stream. The Upper Esopus receives supplemental flows from the Shandaken Portal, an underground aqueduct delivering waters from a nearby basin. The presence of D. geminata is a concern for the local economy, water supply, and aquatic ecosystem because nuisance blooms have been linked to degraded stream condition in other regions. Here we ascertain the extent and severity of the D. geminata invasion, determine the impact of supplemental flows from the Portal on D. geminata, and identify potential factors that may limit D. geminata in the watershed. Stream temperature, discharge, and water quality were characterized at select sites and periphyton samples were collected five times at 6 to 20 study sites between 2009 and 2010 to assess standing crop, diatom community structure, and density of D. geminata and all diatoms. Density of D. geminata ranged from 0-12 cells cm(-2)at tributary sites, 0-781 cells cm(-2) at sites upstream of the Portal, and 0-2,574 cells cm(-2) at sites downstream of the Portal. Survey period and Portal (upstream or downstream) each significantly affected D. geminata cell density. In general, D. geminata was most abundant during the November 2009 and June 2010 surveys and at sites immediately downstream of the Portal. We found that D. geminata did not reach nuisance levels or strongly affect the periphyton community. Similarly, companion studies showed that local macroinvertebrate and fish communities were generally unaffected. A number of abiotic factors including variable flows and moderate levels of phosphorous and suspended sediment may limit blooms of D. geminata in this watershed.	[George, Scott Daniel; Baldigo, Barry Paul] US Geol Survey, New York Water Sci Ctr, Troy, NY 12180 USA	United States Department of the Interior; United States Geological Survey	George, SD (corresponding author), US Geol Survey, New York Water Sci Ctr, Troy, NY 12180 USA.	sgeorge@usgs.gov	Baldigo, Barry P/C-4095-2013	Baldigo, Barry P/0000-0002-9862-9119	New York State Department of Environmental Conservation; U.S. Geological Survey [06E4NY24570025]	New York State Department of Environmental Conservation; U.S. Geological Survey(United States Geological Survey)	This research was funded by the New York State Department of Environmental Conservation (http://www.dec.ny.gov/) and U.S. Geological Survey (http://www.usgs.gov/) under agreement number 06E4NY24570025. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboal M, 2012, HYDROBIOLOGIA, V695, P17, DOI 10.1007/s10750-012-1193-y; Anderson MJ, 2008, PERMANOVA PRIMER GUI; APHA, 2012, 3120 APHA, V22nd; Baldigo BP, NE NAT IN PRESS; Barbour M.T., 1999, EPA 841 B 99 002; Beville ST, 2012, ECOL ECON, V82, P1, DOI 10.1016/j.ecolecon.2012.08.004; Biggs B.J.F., 2000, NZ PERIPHYTON GUIDEL; Bothwell M, 2008, P 2007 INT WORKSH DI, V2795; Bothwell ML, 2011, FRESHWATER BIOL, V56, P565, DOI 10.1111/j.1365-2427.2010.02524.x; Bothwell ML, 2014, DIATOM RES, V29, P1; Carey MP, 2012, FRONT ECOL ENVIRON, V10, P373, DOI 10.1890/110060; CCE, 2007, UPP ES CREEK MAN PLA, VI; CCE, 2007, UPP ES CREEK MAN PLA, VIII; Clarke K.R., 2006, PRIMER V6 USER MANUA; Clarke K. R., 2001, CHANGES MARINE COMMU; Cullis JDS, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2011JG001891; Cullis JDS, 2011, THESIS U COLORADO; CUMMINS KENNETH W., 1962, AMER MIDLAND NAT, V67, P477, DOI 10.2307/2422722; Duffy BT, 2011, UPPER ESOPUS CREEK B; Ellwood NTW, 2007, HYDROBIOLOGIA, V592, P121, DOI 10.1007/s10750-007-0728-0; Floder S, 2009, BIODIVERS CONSERV, V18, P3809, DOI 10.1007/s10531-009-9681-8; Francoeur SN, 2006, HYDROBIOLOGIA, V561, P59, DOI 10.1007/s10750-005-1604-4; Gillis CA, 2010, HYDROBIOLOGIA, V647, P63, DOI 10.1007/s10750-009-9832-7; James D, 2010, P WILD TROUT 10 S CO; Kilroy C, 2009, FRESHWATER BIOL, V54, P1990, DOI 10.1111/j.1365-2427.2009.02247.x; Kilroy C, 2007, ASLO AQ SCI M SANT F; Kilroy C, 2011, AQUAT INVASIONS, V6, P249, DOI 10.3391/ai.2011.6.3.02; Kilroy C, 2012, FRESHWATER BIOL, V57, P641, DOI 10.1111/j.1365-2427.2011.02727.x; Kilroy C, 2011, J PHYCOL, V47, P981, DOI 10.1111/j.1529-8817.2011.01029.x; Kirkwood AE, 2007, CAN J FISH AQUAT SCI, V64, P1703, DOI 10.1139/F07-152; Kirkwood AE, 2009, FRESHWATER BIOL, V54, P1856, DOI 10.1111/j.1365-2427.2009.02231.x; Krammer K, 2007, SUSSWASSERFLORA MITT, V2/1; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; Kumar S, 2009, FRONT ECOL ENVIRON, V7, P415, DOI 10.1890/080054; Lagerstedt MA, 2007, THESIS U CANTERBURY; Larned S, 2006, CHC2006086 NIWA; Larson AM, 2008, P 2007 INT WORKSH DI, V2795; LindstrOm E.-A., 2008, P 2007 INT WORKSH DI, V2795, P35; Lohman KE, 1939, 189H US GEOL SURV; McHale MR, 2014, 20145200 US GEOL SUR; Miller MP, 2009, HYDROBIOLOGIA, V630, P207, DOI 10.1007/s10750-009-9793-x; NEWCOMBE C P, 1991, North American Journal of Fisheries Management, V11, P72, DOI 10.1577/1548-8675(1991)011<0072:EOSSOA>2.3.CO;2; Palmer PM, 2008, SCI TOTAL ENVIRON, V394, P90, DOI 10.1016/j.scitotenv.2008.01.011; Pickle J, 2008, ANALYZINGDIGITALIMAG; Ramette A, 2007, FEMS MICROBIOL ECOL, V62, P142, DOI 10.1111/j.1574-6941.2007.00375.x; Reid BL, 2012, CONSERV LETT, V5, P432, DOI 10.1111/j.1755-263X.2012.00264.x; Rejmanek M., 2011, ENCY BIOL INVASIONS, P203; Richardson DC, 2014, AQUAT SCI, V76, P553, DOI 10.1007/s00027-014-0354-7; Ross T, 2012, THESIS CORNELL U ITA; Schweiger W, 2011, PARK SCI, V28; SHEPARD RN, 1962, PSYCHOMETRIKA, V27, P125, DOI 10.1007/BF02289630; Smith AJ, 2008, UPPER ESOPUS CREEK B; Smith AJ, 2013, UPPER ESOPUS CREEK B; Smith AJ, 2007, ECOL INDIC, V7, P371, DOI 10.1016/j.ecolind.2006.03.001; Spaulding S, 2008, P 2007 INT WORKSH DI, V2795; Spaulding SA, 2007, 20071425 OFR US GEOL; Steinman Alan D., 2007, P357, DOI 10.1016/B978-012332908-0.50024-3; Sundareshwar PV, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046599; Sutherland S, 2007, SOUTHLAND FISH GAME; USGS, 2010, WAT YEAR 2010 WAT DA; USGS, 2009, WAT YEAR 2009 WAT DA; Whitton BA, 2009, HYDROBIOLOGIA, V630, P1, DOI 10.1007/s10750-009-9753-5; Woolman L, 1894, ANN REPORT STATE GEO	63	5	5	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0130558	10.1371/journal.pone.0130558	http://dx.doi.org/10.1371/journal.pone.0130558			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148184	Green Published, Green Submitted, gold			2022-12-26	WOS:000358157600040
J	Gould, B; McCouch, S; Geber, M				Gould, Billie; McCouch, Susan; Geber, Monica			De Novo Transcriptome Assembly and Identification of Gene Candidates for Rapid Evolution of Soil Al Tolerance in Anthoxanthum odoratum at the Long-Term Park Grass Experiment	PLOS ONE			English	Article							ADJACENT PLANT-POPULATIONS; ALUMINUM TOLERANCE; MOSAIC ENVIRONMENT; PHYSIOLOGICAL DIFFERENCES; DIFFERENTIAL GENE; METAL TOLERANCE; RESISTANCE; TRANSPORTER; EXPRESSION; ELONGATION	Studies of adaptation in the wild grass Anthoxanthum odoratum at the Park Grass Experiment (PGE) provided one of the earliest examples of rapid evolution in plants. Anthoxanthum has become locally adapted to differences in soil Al toxicity, which have developed there due to soil acidification from long-term experimental fertilizer treatments. In this study, we used transcriptome sequencing to identify Al stress responsive genes in Anthoxanhum and identify candidates among them for further molecular study of rapid Al tolerance evolution at the PGE. We examined the Al content of Anthoxanthum tissues and conducted RNA-sequencing of root tips, the primary site of Al induced damage. We found that despite its high tolerance Anthoxanthum is not an Al accumulating species. Genes similar to those involved in organic acid exudation (TaALMT1, ZmMATE), cell wall modification (OsSTAR1), and internal Al detoxification (OsNRAT1) in cultivated grasses were responsive to Al exposure. Expression of a large suite of novel loci was also triggered by early exposure to Al stress in roots. Three-hundred forty five transcripts were significantly more up- or down-regulated in tolerant vs. sensitive Anthoxanthum genotypes, providing important targets for future study of rapid evolution at the PGE.	[Gould, Billie] Michigan State Univ, Dept Plant Biol, Plant Biol Labs, E Lansing, MI 48824 USA; [McCouch, Susan] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14853 USA; [Geber, Monica] Cornell Univ, Dept Plant Breeding & Genet, Ithaca, NY 14853 USA	Michigan State University; Cornell University; Cornell University	Gould, B (corresponding author), Michigan State Univ, Dept Plant Biol, Plant Biol Labs, E Lansing, MI 48824 USA.	bag59@cornell.edu			Cornell Center for Comparative Genomics, Cornell chapter of Sigma Xi, NSF IGERT [0221658]; BBSRC [BBS/E/C/00005189] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/C/00005189] Funding Source: researchfish	Cornell Center for Comparative Genomics, Cornell chapter of Sigma Xi, NSF IGERT; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Cornell Center for Comparative Genomics, Cornell chapter of Sigma Xi, NSF IGERT #0221658. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2012, ANAL RNA SEQ DATA DE; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Antonovics J, 2006, HEREDITY, V97, P33, DOI 10.1038/sj.hdy.6800835; ANTONOVICS J, 1970, HEREDITY, V25, P349, DOI 10.1038/hdy.1970.36; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chandran D, 2008, PLANTA, V228, P151, DOI 10.1007/s00425-008-0726-0; Chen ZC, 2013, PLANT J, V76, P10, DOI 10.1111/tpj.12266; Chen ZC, 2012, PLANT PHYSIOL, V159, P1624, DOI 10.1104/pp.112.199778; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; DAVIES MS, 1973, J APPL ECOL, V10, P33, DOI 10.2307/2404713; DAVIES MS, 1973, J APPL ECOL, V10, P47, DOI 10.2307/2404714; DAVIES MS, 1976, HEREDITY, V36, P59, DOI 10.1038/hdy.1976.6; Delhaize E, 2012, TRENDS PLANT SCI, V17, P341, DOI 10.1016/j.tplants.2012.02.008; Eticha D, 2010, ANN BOT-LONDON, V105, P1119, DOI 10.1093/aob/mcq049; Famoso AN, 2010, PLANT PHYSIOL, V153, P1678, DOI 10.1104/pp.110.156794; FOY CD, 1988, COMMUN SOIL SCI PLAN, V19, P959, DOI 10.1080/00103628809367988; Freeland JR, 2010, J EVOLUTION BIOL, V23, P776, DOI 10.1111/j.1420-9101.2010.01947.x; Freeland JR, 2012, J HERED, V103, P28, DOI 10.1093/jhered/esr111; Furukawa J, 2007, PLANT CELL PHYSIOL, V48, P1081, DOI 10.1093/pcp/pcm091; Gould B, 2013, DEV CULTIVATION ASSA; Gould BA, 2013, DEV CULTIVATION ASSA, P47; Gould B, 2014, MOL ECOL, V23, P6058, DOI 10.1111/mec.12893; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grisel N, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-185; Horst WJ, 2010, ANN BOT-LONDON, V106, P185, DOI 10.1093/aob/mcq053; Houde M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-400; Huang CF, 2009, PLANT CELL, V21, P655, DOI 10.1105/tpc.108.064543; Huang CF, 2012, PLANT J, V69, P857, DOI 10.1111/j.1365-313X.2011.04837.x; Iuchi S, 2007, P NATL ACAD SCI USA, V104, P9900, DOI 10.1073/pnas.0700117104; Jansen S, 2002, BOT REV, V68, P235, DOI 10.1663/0006-8101(2002)068[0235:AHIAAR]2.0.CO;2; Kochian LV, 2004, ANNU REV PLANT BIOL, V55, P459, DOI 10.1146/annurev.arplant.55.031903.141655; Kumari M, 2008, MOL GENET GENOMICS, V279, P339, DOI 10.1007/s00438-007-0316-z; Linhart YB, 1996, ANNU REV ECOL SYST, V27, P237, DOI 10.1146/annurev.ecolsys.27.1.237; Liszkay A, 2004, PLANT PHYSIOL, V136, P3114, DOI 10.1104/pp.104.044784; Liu JP, 2009, PLANT J, V57, P389, DOI 10.1111/j.1365-313X.2008.03696.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma JF, 2001, TRENDS PLANT SCI, V6, P273, DOI 10.1016/S1360-1385(01)01961-6; Ma JF, 2007, INT REV CYTOL, V264, P225, DOI 10.1016/S0074-7696(07)64005-4; MACNAIR MR, 1993, NEW PHYTOL, V124, P541, DOI 10.1111/j.1469-8137.1993.tb03846.x; MACNAIR MR, 1987, TRENDS ECOL EVOL, V2, P354, DOI 10.1016/0169-5347(87)90135-2; Magalhaes JV, 2007, NAT GENET, V39, P1156, DOI 10.1038/ng2074; Maron LG, 2008, NEW PHYTOL, V179, P116, DOI 10.1111/j.1469-8137.2008.02440.x; Maron LG, 2013, P NATL ACAD SCI USA, V110, P5241, DOI 10.1073/pnas.1220766110; Metali F, 2011, NEW PHYTOL, V193, P1; Negishi T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043189; Raman H, 2008, THEOR APPL GENET, V116, P343, DOI 10.1007/s00122-007-0672-4; RAO IM, 1993, BIOSCIENCE, V43, P454, DOI 10.2307/1311905; Rengel Z., 2003, HDB SOIL ACIDITY; Ryan PR, 2010, FUNCT PLANT BIOL, V37, P275, DOI 10.1071/FP09261; Sasaki T, 2004, PLANT J, V37, P645, DOI 10.1111/j.1365-313X.2003.01991.x; Sasaki T, 2006, PLANT CELL PHYSIOL, V47, P1343, DOI 10.1093/pcp/pcl002; SCHAEDLE M, 1989, TREE PHYSIOL, V5, P337, DOI 10.1093/treephys/5.3.337; Schopfer P, 2001, PLANT J, V28, P679, DOI 10.1046/j.1365-313x.2001.01187.x; Shaff JE, 2010, PLANT SOIL, V330, P207, DOI 10.1007/s11104-009-0193-9; Silvertown J, 2005, HEREDITY, V95, P198, DOI 10.1038/sj.hdy.6800710; Silvertown J, 2006, J ECOL, V94, P801, DOI 10.1111/j.1365-2745.2006.01145.x; SNAYDON RW, 1976, HEREDITY, V37, P9, DOI 10.1038/hdy.1976.62; SNAYDON RW, 1970, EVOLUTION, V24, P257, DOI [10.2307/2406802, 10.1111/j.1558-5646.1970.tb01759.x]; SNAYDON RW, 1972, EVOLUTION, V26, P390, DOI [10.2307/2407014, 10.1111/j.1558-5646.1972.tb01944.x]; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; WHEELER DM, 1995, J PLANT NUTR, V18, P2305, DOI 10.1080/01904169509365066; WHEELER DM, 1992, PLANT SOIL, V146, P61, DOI 10.1007/BF00011996; Wright KM, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001497; Xia JX, 2010, P NATL ACAD SCI USA, V107, P18381, DOI 10.1073/pnas.1004949107; Yamaji N, 2009, PLANT CELL, V21, P3339, DOI 10.1105/tpc.109.070771; Yang JL, 2008, PLANT PHYSIOL, V146, P602, DOI 10.1104/pp.107.111989; Yang JL, 2011, PLANT PHYSIOL, V155, P1885, DOI 10.1104/pp.111.172221; Zheng Y, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-453; Zhu XF, 2013, PLANT PHYSIOL, V162, P1947, DOI 10.1104/pp.113.219147	70	9	9	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0124424	10.1371/journal.pone.0124424	http://dx.doi.org/10.1371/journal.pone.0124424			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148203	Green Published, Green Submitted, gold			2022-12-26	WOS:000358157600004
J	Iseki, Y; Shibutani, M; Maeda, K; Nagahara, H; Ohtani, H; Sugano, K; Ikeya, T; Muguruma, K; Tanaka, H; Toyokawa, T; Sakurai, K; Hirakawa, K				Iseki, Yasuhito; Shibutani, Masatsune; Maeda, Kiyoshi; Nagahara, Hisashi; Ohtani, Hiroshi; Sugano, Kenji; Ikeya, Tetsuro; Muguruma, Kazuya; Tanaka, Hiroaki; Toyokawa, Takahiro; Sakurai, Katsunobu; Hirakawa, Kosei			Impact of the Preoperative Controlling Nutritional Status (CONUT) Score on the Survival after Curative Surgery for Colorectal Cancer	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN-RECEPTOR; CLINICAL UNDERNUTRITION; CHOLESTEROL LEVELS; SERUM-CHOLESTEROL; TUMOR; RESECTION; ALBUMIN; LYMPHOCYTES; CARCINOMAS; EXPRESSION	Background Recently, the preoperative immune-nutritional status has been reported to correlate with the survival rate in patients with colorectal cancer (CRC). However, there have been no reports on the relationship between the controlling nutritional status (CONUT) score and the clinical outcome after curative surgery for CRC. We herein evaluated the prognostic significance of the CONUT score in patients with CRC, and then compared the accuracy of the CONUT score and the prognostic nutritional index (PNI) as a predictor of survival. Methods We retrospectively reviewed a database of 204 patients who underwent curative surgery for Stage II/ III CRC. Patients were divided into two groups according to the CONUT score and the PNI. Results The five-year cancer-specific survival (CSS) rate was significantly higher at 92.7% in the low CONUT group, compared to a rate of 81.0% in the high CONUT group (p=0.0016). The five-year CSS was 71.2% in the low PNI group and 92.3% in the high PNI group, which showed a significant difference (p=0.0155). A multivariate analysis showed that lymph node metastasis and the CONUT score were independent risk factors for CSS. Conclusion This study suggested that the CONUT score is a strong independent predictor of the survival among CRC patients.	[Iseki, Yasuhito; Shibutani, Masatsune; Maeda, Kiyoshi; Nagahara, Hisashi; Ohtani, Hiroshi; Sugano, Kenji; Ikeya, Tetsuro; Muguruma, Kazuya; Tanaka, Hiroaki; Toyokawa, Takahiro; Sakurai, Katsunobu; Hirakawa, Kosei] Osaka City Univ, Grad Sch Med, Dept Surg Oncol, Osaka 558, Japan	Osaka Metropolitan University	Shibutani, M (corresponding author), Osaka City Univ, Grad Sch Med, Dept Surg Oncol, Osaka 558, Japan.	fbxbj429@ybb.ne.jp	Tanaka, Hiroaki/V-8501-2019					Ali AA, 2004, EJSO-EUR J SURG ONC, V30, P292, DOI 10.1016/j.ejso.2003.11.018; Boonpipattanapong T, 2006, J CLIN GASTROENTEROL, V40, P592, DOI 10.1097/00004836-200608000-00006; Cengiz O, 2006, MED SCI MONITOR, V12, pCR240; Cubiella J, 1999, AM J GASTROENTEROL, V94, P1271, DOI 10.1111/j.1572-0241.1999.01018.x; Perez JID, 2014, NUTR HOSP, V29, P797, DOI 10.3305/nh.2014.29.4.7275; Delmore G, 1997, SUPPORT CARE CANCER, V5, P376, DOI 10.1007/s005200050095; DEULIBARRI JI, 2005, NUTR HOSP, V20, P38; Dolcetti R, 1999, AM J PATHOL, V154, P1805, DOI 10.1016/S0002-9440(10)65436-3; Ferlay J., 2013, CANCER INCIDENCE AND, V11; Gonzalez-Madrono A, 2012, NUTR HOSP, V27, P564, DOI [10.3305/nh.2012.27.2.5630, 10.1590/S0212-16112012000200033]; Gupta D, 2005, EUR J CLIN NUTR, V59, P35, DOI 10.1038/sj.ejcn.1602029; Heys SD, 1998, J ROY COLL SURG EDIN, V43, P163; Ikeya T, 2014, J CANCER RES CLIN ON; Ko K, 2013, BJU INT, V112, P775, DOI 10.1111/bju.12275; Koike Y, 2008, J SURG ONCOL, V98, P540, DOI 10.1002/jso.21154; KRITCHEVSKY SB, 1992, ANNU REV NUTR, V12, P391, DOI 10.1146/annurev.nu.12.070192.002135; Maeda K, 2014, WORLD J SURG, V38, P1217, DOI 10.1007/s00268-013-2386-x; Mauricio SF, 2013, NUTRITION, V29, P625, DOI 10.1016/j.nut.2012.09.016; McArdle CS, 2002, BRIT J CANCER, V86, P331, DOI 10.1038/sj.bjc.6600120; McMillan DC, 2003, BRIT J SURG, V90, P215, DOI 10.1002/bjs.4038; Menges T, 1999, CRIT CARE MED, V27, P733, DOI 10.1097/00003246-199904000-00026; Mohri Y, 2013, WORLD J SURG, V37, P2688, DOI 10.1007/s00268-013-2156-9; NIENDORF A, 1995, INT J CANCER, V61, P461, DOI 10.1002/ijc.2910610405; Notarnicola M, 2005, ONCOLOGY-BASEL, V68, P371, DOI 10.1159/000086977; Nozoe T, 2012, SURG TODAY, V42, P532, DOI 10.1007/s00595-011-0061-0; OLIVER MF, 1981, LANCET, V2, P1090; Onodera T, 1984, Nihon Geka Gakkai Zasshi, V85, P1001; Ropponen KM, 1997, J PATHOL, V182, P318, DOI 10.1002/(SICI)1096-9896(199707)182:3<318::AID-PATH862>3.0.CO;2-6; Sobin LH, 2009, TNM CLASSIFICATION M, P73; VITOLS S, 1994, BLOOD, V84, P2689; VITOLS S, 1985, LANCET, V2, P1150; Walsh Sr, 2005, J SURG ONCOL, V91, P181, DOI 10.1002/jso.20329; Yeun J Y, 1998, Am J Kidney Dis, V32, pS118, DOI 10.1016/S0272-6386(98)70174-X	33	142	144	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132488	10.1371/journal.pone.0132488	http://dx.doi.org/10.1371/journal.pone.0132488			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147805	gold, Green Published, Green Submitted			2022-12-26	WOS:000358157600285
J	Kim, JS; Cho, H; Choi, JY; Lee, SH; Ryu, YH; Lyoo, CH; Lee, MS				Kim, Jin Su; Cho, Hanna; Choi, Jae Yong; Lee, Seung Ha; Ryu, Young Hoon; Lyoo, Chul Hyoung; Lee, Myung Sik			Feasibility of Computed Tomography-Guided Methods for Spatial Normalization of Dopamine Transporter Positron Emission Tomography Image	PLOS ONE			English	Article							PARKINSONS-DISEASE; QUANTITATIVE-ANALYSIS; HUMAN BRAIN; PET; TEMPLATE; SEGMENTATION; DYSFUNCTION	Background Spatial normalization is a prerequisite step for analyzing positron emission tomography (PET) images both by using volume-of-interest (VOI) template and voxel-based analysis. Magnetic resonance (MR) or ligand-specific PET templates are currently used for spatial normalization of PET images. We used computed tomography (CT) images acquired with PET/CT scanner for the spatial normalization for [F-18]-N-3-fluoropropyl-2-betacarboxymethoxy-3-beta-(4-iodophenyl) nortropane (FP-CIT) PET images and compared target-to-cerebellar standardized uptake value ratio (SUVR) values with those obtained from MR-or PET-guided spatial normalization method in healthy controls and patients with Parkinson's disease (PD). Methods We included 71 healthy controls and 56 patients with PD who underwent [F-18]-FP-CIT PET scans with a PET/CT scanner and T1-weighted MR scans. Spatial normalization of MR images was done with a conventional spatial normalization tool (cvMR) and with DARTEL toolbox (dtMR) in statistical parametric mapping software. The CT images were modified in two ways, skull-stripping (ssCT) and intensity transformation (itCT). We normalized PET images with cvMR-, dtMR-, ssCT-, itCT-, and PET-guided methods by using specific templates for each modality and measured striatal SUVR with a VOI template. The SUVR values measured with FreeSurfer-generated VOIs (FSVOI) overlaid on original PET images were also used as a gold standard for comparison. Results The SUVR values derived from all four structure-guided spatial normalization methods were highly correlated with those measured with FSVOI (P < 0.0001). Putaminal SUVR values were highly effective for discriminating PD patients from controls. However, the PET-guided method excessively overestimated striatal SUVR values in the PD patients by more than 30% in caudate and putamen, and thereby spoiled the linearity between the striatal SUVR values in all subjects and showed lower disease discrimination ability. Two CT-guided methods showed comparable capability with the MR-guided methods in separating PD patients from controls and showed better correlation between putaminal SUVR values and the parkinsonian motor severity than the PET-guided method. Conclusion CT-guided spatial normalization methods provided reliable striatal SUVR values comparable to those obtained with MR-guided methods. CT-guided methods can be useful for analyzing dopamine transporter PET images when MR images are unavailable.	[Kim, Jin Su] Korea Inst Radiol & Med Sci, Mol Imaging Res Ctr, Seoul, South Korea; [Cho, Hanna; Lee, Seung Ha; Lyoo, Chul Hyoung; Lee, Myung Sik] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Neurol, Seoul, South Korea; [Choi, Jae Yong; Ryu, Young Hoon] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Nucl Med, Seoul, South Korea	Korea Institute of Radiological & Medical Sciences; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Lyoo, CH (corresponding author), Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Neurol, Seoul, South Korea.	lyoochel@yuhs.ac	KIM, JIN SU/U-2112-2019	KIM, JIN SU/0000-0001-8965-9538; Cho, Hanna/0000-0001-5936-1546; Lyoo, Chul Hyoung/0000-0003-2231-672X; Lee, Myung Sik/0000-0002-8413-1854; RYU, YOUNG HOON/0000-0002-9000-5563	Yonsei University College of Medicine [6-2014-0123]	Yonsei University College of Medicine(General Electric)	This study was supported by a faculty research grant of Yonsei University College of Medicine (grant number 6-2014-0123). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Cabronero J, 2008, NEUROIMAGE, V39, P1654, DOI 10.1016/j.neuroimage.2007.10.051; Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO;2-G; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Brooks DJ, 2010, J NUCL MED, V51, P596, DOI 10.2967/jnumed.108.059998; Cho H, 2014, KOREAN J RADIOL, V15, P862, DOI 10.3348/kjr.2014.15.6.862; Edison P, 2013, NEUROIMAGE, V70, P423, DOI 10.1016/j.neuroimage.2012.12.014; Eggers C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096629; FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283; Fein G, 2006, NEUROIMAGE, V30, P1187, DOI 10.1016/j.neuroimage.2005.10.054; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischmeister FPS, 2013, NEUROIMAGE-CLIN, V3, P369, DOI 10.1016/j.nicl.2013.09.007; Gispert JD, 2003, NEUROIMAGE, V19, P601, DOI 10.1016/S1053-8119(03)00072-7; Hughes A, 1992, J NEUROL NEUROSUR PS, V66, P181, DOI DOI 10.1136/JNNP.55.3.181; Jeong E, 2013, NUCL MED MOLEC IMAG, V47, P73, DOI 10.1007/s13139-013-0196-6; Kuhn FP, 2014, EJNMMI RES, V4, DOI 10.1186/2191-219X-4-7; Lyoo CH, 2012, ACTA NEUROL SCAND, V126, P344, DOI 10.1111/j.1600-0404.2012.01657.x; Ma Y, 2002, SYNAPSE, V45, P125, DOI 10.1002/syn.10090; Mawlawi O, 2001, J CEREBR BLOOD F MET, V21, P1034, DOI 10.1097/00004647-200109000-00002; Meyer JH, 1999, NEUROIMAGE, V9, P545, DOI 10.1006/nimg.1999.0431; Oh M, 2012, J NUCL MED, V53, P399, DOI 10.2967/jnumed.111.095224; Pavese N, 2011, NEUROIMAGE, V56, P1463, DOI 10.1016/j.neuroimage.2011.03.012; Ravina B, 2005, NEUROLOGY, V64, P208, DOI 10.1212/01.WNL.0000149403.14458.7F; Rorden C, 2012, NEUROIMAGE, V61, P957, DOI 10.1016/j.neuroimage.2012.03.020; Rostomian AH, 2011, J NUCL MED, V52, P173, DOI 10.2967/jnumed.110.082057; Solomon J, 2007, COMPUT METH PROG BIO, V86, P245, DOI 10.1016/j.cmpb.2007.02.006; Yasuno F, 2002, NEUROIMAGE, V16, P577, DOI 10.1006/nimg.2002.1120	26	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132585	10.1371/journal.pone.0132585	http://dx.doi.org/10.1371/journal.pone.0132585			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147749	Green Published, gold, Green Submitted			2022-12-26	WOS:000358157600303
J	Moritsugu, K; Koike, R; Yamada, K; Kato, H; Kidera, A				Moritsugu, Kei; Koike, Ryotaro; Yamada, Kouki; Kato, Hiroaki; Kidera, Akinori			Motion Tree Delineates Hierarchical Structure of Protein Dynamics Observed in Molecular Dynamics Simulation	PLOS ONE			English	Article							NORMAL-MODE ANALYSIS; ADENYLATE KINASE; FORCE-FIELD; DOMAIN MOTIONS; CONFORMATIONAL-CHANGE; LYSOZYME; MECHANISM; GENOMES; BINDING	Molecular dynamics (MD) simulations of proteins provide important information to understand their functional mechanisms, which are, however, likely to be hidden behind their complicated motions with a wide range of spatial and temporal scales. A straightforward and intuitive analysis of protein dynamics observed in MD simulation trajectories is therefore of growing significance with the large increase in both the simulation time and system size. In this study, we propose a novel description of protein motions based on the hierarchical clustering of fluctuations in the inter-atomic distances calculated from an MD trajectory, which constructs a single tree diagram, named a "Motion Tree", to determine a set of rigid-domain pairs hierarchically along with associated inter-domain fluctuations. The method was first applied to the MD trajectory of substrate-free adenylate kinase to clarify the usefulness of the Motion Tree, which illustrated a clear-cut dynamics picture of the inter-domain motions involving the ATP/AMP lid and the core domain together with the associated amplitudes and correlations. The comparison of two Motion Trees calculated from MD simulations of ligand-free and -bound glutamine binding proteins clarified changes in inherent dynamics upon ligand binding appeared in both large domains and a small loop that stabilized ligand molecule. Another application to a huge protein, a multidrug ATP binding cassette (ABC) transporter, captured significant increases of fluctuations upon binding a drug molecule observed in both large scale inter-subunit motions and a motion localized at a transmembrane helix, which may be a trigger to the subsequent structural change from inward-open to outward-open states to transport the drug molecule. These applications demonstrated the capabilities of Motion Trees to provide an at-a-glance view of various sizes of functional motions inherent in the complicated MD trajectory.	[Moritsugu, Kei; Yamada, Kouki; Kidera, Akinori] Yokohama City Univ, Grad Sch Med Life Sci, Tsurumi Ku, Yokohama, Kanagawa 232, Japan; [Koike, Ryotaro] Nagoya Univ, Grad Sch Informat Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Kato, Hiroaki] Kyoto Univ, Dept Biol Struct, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto, Japan; [Kato, Hiroaki] SPring 8, RIKEN Harima Inst, Sayo, Hyogo, Japan	Yokohama City University; Nagoya University; Kyoto University; Japan Synchrotron Radiation Research Institute; RIKEN	Moritsugu, K (corresponding author), Yokohama City Univ, Grad Sch Med Life Sci, Tsurumi Ku, 1-7-29 Suehiro Cho, Yokohama, Kanagawa 232, Japan.	moritugu@tsurumi.yokohama-cu.ac.jp	Moritsugu, Kei/AAU-1502-2021	Kato, Hiroaki/0000-0002-5993-4532	MEXT [15K18520, 23247027]; MEXT creation of innovation centers; platform for drug discovery, informatics, and structural life science	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT creation of innovation centers; platform for drug discovery, informatics, and structural life science	K. M. was supported by MEXT Grant-in-Aid for Young Scientists (B), 15K18520, and A. K. by MEXT Grant-in-Aid for Scientific Research (A), 23247027. This work was also partly supported by a fund from MEXT creation of innovation centers for advanced interdisciplinary research areas program in the project for developing innovation systems, and a fund from platform for drug discovery, informatics, and structural life science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora K, 2007, P NATL ACAD SCI USA, V104, P18496, DOI 10.1073/pnas.0706443104; Beckstein O, 2009, J MOL BIOL, V394, P160, DOI 10.1016/j.jmb.2009.09.009; Bernhard S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010491; Berry MB, 2006, PROTEINS, V62, P555, DOI 10.1002/prot.20699; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.0.CO;2-N; Hayward S, 1997, PROTEINS, V27, P425, DOI 10.1002/(SICI)1097-0134(199703)27:3<425::AID-PROT10>3.0.CO;2-N; Hery S, 1998, J MOL BIOL, V279, P303, DOI 10.1006/jmbi.1998.1754; Hinsen K, 1999, PROTEINS, V34, P369, DOI 10.1002/(SICI)1097-0134(19990215)34:3<369::AID-PROT9>3.0.CO;2-F; Ikeguchi M, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.078102; Ikeguchi M, 2004, J COMPUT CHEM, V25, P529, DOI 10.1002/jcc.10402; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; JUFFER AH, 1991, J COMPUT PHYS, V97, P144, DOI 10.1016/0021-9991(91)90043-K; Kenn M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/731325; Kodan A, 2014, P NATL ACAD SCI USA, V111, P4049, DOI 10.1073/pnas.1321562111; Koike R, 2014, J MOL BIOL, V426, P752, DOI 10.1016/j.jmb.2013.10.034; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kubitzki MB, 2008, STRUCTURE, V16, P1175, DOI 10.1016/j.str.2008.04.013; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Ma JP, 2005, STRUCTURE, V13, P373, DOI 10.1016/j.str.2005.02.002; MacKerell AD, 2000, J COMPUT CHEM, V21, P105, DOI 10.1002/(SICI)1096-987X(20000130)21:2<105::AID-JCC3>3.0.CO;2-P; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Maragakis P, 2005, J MOL BIOL, V352, P807, DOI 10.1016/j.jmb.2005.07.031; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Menor SA, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/3/036017; Muller CW, 1996, STRUCTURE, V4, P147, DOI 10.1016/S0969-2126(96)00018-4; Ponder JW, 2003, ADV PROTEIN CHEM, V66, P27; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sun YJ, 1998, J MOL BIOL, V278, P219, DOI 10.1006/jmbi.1998.1675; Vaiana AC, 2003, J COMPUT CHEM, V24, P632, DOI 10.1002/jcc.10190; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; Wriggers W, 1997, PROTEINS, V29, P1; Yesylevskyy SO, 2006, BIOPHYS CHEM, V119, P84, DOI 10.1016/j.bpc.2005.07.004	35	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131583	10.1371/journal.pone.0131583	http://dx.doi.org/10.1371/journal.pone.0131583			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148295	gold, Green Published, Green Submitted			2022-12-26	WOS:000358157600112
J	Mucker, EM; Chapman, J; Huzella, LM; Huggins, JW; Shamblin, J; Robinson, CG; Hensley, LE				Mucker, Eric M.; Chapman, Jennifer; Huzella, Louis M.; Huggins, John W.; Shamblin, Joshua; Robinson, Camenzind G.; Hensley, Lisa E.			Susceptibility of Marmosets (Callithrix jacchus) to Monkeypox Virus: A Low Dose Prospective Model for Monkeypox and Smallpox Disease	PLOS ONE			English	Article							NONHUMAN PRIMATE MODEL; VACCINIA VIRUS; POXVIRUS INFECTION; IN-VITRO; PROTECTION; COMPLEMENT; PATHOLOGY; VARIOLA; ST-246; VACCINATION	Although current nonhuman primate models of monkeypox and smallpox diseases provide some insight into disease pathogenesis, they require a high titer inoculum, use an unnatural route of infection, and/or do not accurately represent the entire disease course. This is a concern when developing smallpox and/or monkeypox countermeasures or trying to understand host pathogen relationships. In our studies, we altered half of the test system by using a New World nonhuman primate host, the common marmoset. Based on dose finding studies, we found that marmosets are susceptible to monkeypox virus infection, produce a high viremia, and have pathological features consistent with smallpox and monkeypox in humans. The low dose (48 plaque forming units) required to elicit a uniformly lethal disease and the extended incubation (preclinical signs) are unique features among nonhuman primate models utilizing monkeypox virus. The uniform lethality, hemorrhagic rash, high viremia, decrease in platelets, pathology, and abbreviated acute phase are reflective of early-type hemorrhagic smallpox.	[Mucker, Eric M.; Huggins, John W.; Shamblin, Joshua] US Army Med Res Inst Infect Dis, Div Virol, Ft Detrick, MD 21701 USA; [Chapman, Jennifer] Joint Pathol Ctr, Silver Spring, MD USA; [Huzella, Louis M.; Hensley, Lisa E.] NIAID, Integrated Res Facil, Ft Detrick, MD USA; [Robinson, Camenzind G.] US Army Med Res Inst Infect Dis, Div Pathol, Ft Detrick, MD USA; [Mucker, Eric M.] Tulane Univ, Sch Med, New Orleans, LA 70112 USA	United States Army Medical Research Institute of Infectious Diseases; United States Department of Defense; United States Army; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); United States Army Medical Research Institute of Infectious Diseases; United States Department of Defense; United States Army; Tulane University	Mucker, EM (corresponding author), US Army Med Res Inst Infect Dis, Div Virol, Ft Detrick, MD 21701 USA.	eric.m.mucker.ctr@mail.mil	Robinson, Camenzind G/O-5097-2018	Robinson, Camenzind G/0000-0002-7277-692X; Mucker, Eric/0000-0002-4656-5379; Hensley, Lisa/0000-0003-1188-4342	United States Army Medical Research Institute of Infectious Diseases	United States Army Medical Research Institute of Infectious Diseases	This work was internally funded by the United States Army Medical Research Institute of Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AP, 2008, J VIROL, V82, P9035, DOI 10.1128/JVI.00674-08; Benhnia MREI, 2009, J VIROL, V83, P1201, DOI 10.1128/JVI.01797-08; Bright H, 2004, J VIROL, V78, P2062, DOI 10.1128/JVI.78.4.2062-2071.2004; Carrion R, 2007, J VIROL, V81, P6482, DOI 10.1128/JVI.02876-06; Carrion R, 2011, VIROLOGY, V420, P117, DOI 10.1016/j.virol.2011.08.022; Chen ZC, 2006, P NATL ACAD SCI USA, V103, P1882, DOI 10.1073/pnas.0510598103; Chen ZC, 2007, J VIROL, V81, P8989, DOI 10.1128/JVI.00906-07; Councilman WT, 1904, J MED RES, V11, P12; Earl PL, 2008, P NATL ACAD SCI USA, V105, P10889, DOI 10.1073/pnas.0804985105; Earl PL, 2004, NATURE, V428, P182, DOI 10.1038/nature02331; FDA, 2013, APPR NEW DRUGS HUM E; FDA, 2009, GUID IND AN IN PRESS; FDA, 2013, APPR BIOL PROD HUM E; Fenner F, 1988, SMALLPOX ITS ERADICA, Vxvi; GISPEN R, 1967, ARCH GES VIRUSFORSCH, V21, P205, DOI 10.1007/BF01241445; Goff AJ, 2011, J VIROL, V85, P4898, DOI 10.1128/JVI.02525-10; GOUGH AW, 1982, LAB ANIM SCI, V32, P87; Hooper JW, 2004, J VIROL, V78, P4433, DOI 10.1128/JVI.78.9.4433-4443.2004; Huggins J, 2009, ANTIMICROB AGENTS CH, V53, P2620, DOI 10.1128/AAC.00021-09; JEZEK Z, 1987, J INFECT DIS, V156, P293, DOI 10.1093/infdis/156.2.293; Johnson RF, 2011, J VIROL, V85, P2112, DOI 10.1128/JVI.01931-10; JOHNSONDELANEY CA, 1994, VET CLIN N AM-SMALL, V24, P121, DOI 10.1016/S0195-5616(94)50007-X; Jordan R, 2009, ANTIMICROB AGENTS CH, V53, P1817, DOI 10.1128/AAC.01596-08; Kramski M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010412; Kulesh DA, 2004, J CLIN MICROBIOL, V42, P601, DOI 10.1128/JCM.42.2.601-609.2004; Lustig S, 2004, VIROLOGY, V328, P30, DOI 10.1016/j.virol.2004.07.024; Matz-Rensing K, 2012, J COMP PATHOL, V146, P230, DOI 10.1016/j.jcpa.2011.06.003; Mansfield K, 2003, COMPARATIVE MED, V53, P383; Matz-Rensing K, 2006, VET PATHOL, V43, P212, DOI 10.1354/vp.43-2-212; Moncla LH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078750; Mucker EM, 2013, ANTIMICROB AGENTS CH, V57, P6246, DOI 10.1128/AAC.00977-13; Nalca A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012880; Omatsu T, 2011, J GEN VIROL, V92, P2272, DOI 10.1099/vir.0.031229-0; Parker S, 2013, FUTURE VIROL, V8, P129, DOI 10.2217/FVL.12.130; Peters J. C., 1966, International zoo yearbook, V6, P274, DOI 10.1111/j.1748-1090.1966.tb01794.x; Prophet E. B., 1992, LAB METHODS HISTOTEC; Reed KD, 2004, NEW ENGL J MED, V350, P342, DOI 10.1056/NEJMoa032299; Reynolds MG, 2012, TRENDS MICROBIOL, V20, P80, DOI 10.1016/j.tim.2011.12.001; Rimoin AW, 2010, P NATL ACAD SCI USA, V107, P16262, DOI 10.1073/pnas.1005769107; Sejvar JJ, 2004, J INFECT DIS, V190, P1833, DOI 10.1086/425039; Shchelkunov SN, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003756; Smith DR, 2012, J VIROL, V86, P2109, DOI 10.1128/JVI.06190-11; Stittelaar KJ, 2005, J VIROL, V79, P7845, DOI 10.1128/JVI.79.12.7845-7851.2005; Vanderplasschen A, 1998, P NATL ACAD SCI USA, V95, P7544, DOI 10.1073/pnas.95.13.7544; Wahl-Jensen V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024832; Zaucha GM, 2001, LAB INVEST, V81, P1581, DOI 10.1038/labinvest.3780373	46	24	24	4	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131742	10.1371/journal.pone.0131742	http://dx.doi.org/10.1371/journal.pone.0131742			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26147658	Green Submitted, gold, Green Published			2022-12-26	WOS:000358157600139
J	Sahu, DK; Panda, SP; Meher, PK; Das, P; Routray, P; Sundaray, JK; Jayasankar, P; Nandi, S				Sahu, Dinesh Kumar; Panda, Soumya Prasad; Meher, Prem Kumar; Das, Paramananda; Routray, Padmanav; Sundaray, Jitendra Kumar; Jayasankar, Pallipuram; Nandi, Samiran			Construction, De-Novo Assembly and Analysis of Transcriptome for Identification of Reproduction-Related Genes and Pathways from Rohu, Labeo rohita (Hamilton)	PLOS ONE			English	Article							INDIAN MAJOR CARP; RAINBOW-TROUT; DEVELOPMENTAL EXPRESSION; VITELLOGENIN RECEPTOR; TISSUE-DISTRIBUTION; CIRRHINUS-MRIGALA; CHANNEL CATFISH; SPLICE VARIANTS; OOCYTE; HORMONE	Rohu is a leading candidate species for freshwater aquaculture in South-East Asia. Unlike common carp the monsoon breeding habit of rohu restricts its seed production beyond season indicating strong genetic control over spawning. Genetic information is limited in this regard. The problem is exacerbated by the lack of genomic-resources. We identified 182 reproduction-related genes previously by Sanger-sequencing which were less to address the issue of seasonal spawning behaviour of this important carp. Therefore, the present work was taken up to generate transcriptome profile by mRNAseq. 16GB, 72bp paired end (PE) data was generated from the pooled-RNA of twelve-tissues from pre-spawning rohu using IlluminaGA-II-platform. There were 64.97 million high-quality reads producing 62,283 contigs and 88,612 numbers of transcripts using velvet and oases programs, respectively. Gene ontology annotation identified 940 reproduction-related genes consisting of 184 mainly associated with reproduction, 223 related to hormone-activity and receptor-binding, 178 receptor-activity and 355 embryonic-development related-proteins. The important reproduction-relevant pathways found in KEGG analysis were GnRH-signaling, oocyte-meiosis, steroid-biosynthesis, steroid-hormone biosynthesis, progesterone-mediated oocyte-maturation, retinol-metabolism, neuroactive-ligand-receptor interaction, neurotrophin-signaling and photo-transduction. Twenty nine simple sequence repeat containing sequences were also found out of which 12 repeat loci were polymorphic with mean expected-&-observed heterozygosity of 0.471 and 0.983 respectively. Quantitative RT-PCR analyses of 13-known and 6-unknown transcripts revealed differences in expression level between preparatory and post-spawning phase. These transcriptomic sequences have significantly increased the genetic-&- genomic resources for reproduction-research in Labeo rohita.	[Sahu, Dinesh Kumar; Panda, Soumya Prasad; Meher, Prem Kumar; Das, Paramananda; Sundaray, Jitendra Kumar; Jayasankar, Pallipuram; Nandi, Samiran] ICAR Cent Inst Freshwater Aquaculture, Fish Genet & Biotechnol Div, Bhubaneswar, Orissa, India; [Routray, Padmanav] ICAR Cent Inst Freshwater Aquaculture, Aquaculture Prod & Environm Div, Bhubaneswar, Orissa, India	Indian Council of Agricultural Research (ICAR); ICAR - Central Institute of Freshwater Aquaculture; Indian Council of Agricultural Research (ICAR); ICAR - Central Institute of Freshwater Aquaculture	Nandi, S (corresponding author), ICAR Cent Inst Freshwater Aquaculture, Fish Genet & Biotechnol Div, Bhubaneswar, Orissa, India.	eurekhain@yahoo.co.in	Sundaray, Jitendra/AAO-6523-2020; Pallipuram, Jayasankar/L-9422-2019; Sahu, Dr Dinesh Kumar/GQQ-4158-2022; Meher, Prem/W-3700-2019; sundaray, Jitendra Kumar/A-4800-2009	Sahu, Dr Dinesh Kumar/0000-0002-5040-2046; Meher, Prem/0000-0001-7969-2916; Panda, Soumya Prasad/0000-0002-0513-1101; SUNDARAY, JITENDRA/0000-0001-9311-0636	Department of Biotechnology, Government of India [BT/PR9916/AAQ/03/360/2007]; ICAR-CIFA [I-59n]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); ICAR-CIFA	This work was supported by Department of Biotechnology, Government of India (Project reference No.-BT/PR9916/AAQ/03/360/2007) and ICAR-CIFA (I-59n).	Aegerter S, 2005, MOL REPROD DEV, V72, P377, DOI 10.1002/mrd.20361; Alderman SL, 2012, J ENDOCRINOL, V215, P393, DOI 10.1530/JOE-12-0379; Alsop D, 2008, GEN COMP ENDOCR, V156, P51, DOI 10.1016/j.ygcen.2007.11.008; [Anonymous], 2012, WORLD REV FISH AQ ST; Bhattacharya S, 1999, CURR SCI INDIA, V76, P342; Callander DC, 2007, DEV DYNAM, V236, P2918, DOI 10.1002/dvdy.21315; Cameron RA, 1999, DEV BIOL, V208, P255, DOI 10.1006/dbio.1999.9224; Cerda J, 2008, REV FISH SCI, V16, P56, DOI 10.1080/10641260802324685; CHAKRABORTI P, 1984, GEN COMP ENDOCR, V53, P179, DOI 10.1016/0016-6480(84)90240-5; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Chu SL, 2006, AQUACULTURE, V251, P537, DOI 10.1016/j.aquaculture.2005.05.040; Dal-Pra S, 2006, DEV BIOL, V298, P514, DOI 10.1016/j.ydbio.2006.07.002; Das P, 2005, MOL ECOL NOTES, V5, P231, DOI 10.1111/j.1471-8286.2005.00905.x; Das S, 2014, MOL BIOL REP, V41, P7361, DOI 10.1007/s11033-014-3625-4; Dominguez GA, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.099812; FIGUEROA J, 1994, COMP BIOCHEM PHYS B, V108, P551, DOI 10.1016/0305-0491(94)90109-0; Fish RJ, 2012, THROMB HAEMOSTASIS, V107, P158, DOI 10.1160/TH11-04-0221; Garg R, 2011, DNA RES, V18, P53, DOI 10.1093/dnares/dsq028; Goetz FW, 2006, ICES J MAR SCI, V63, P393, DOI 10.1016/j.icesjms.2005.10.006; Gohin M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-18; Greene MW, 1999, GEN COMP ENDOCR, V115, P254, DOI 10.1006/gcen.1999.7293; Gupta Satya Dev, 1995, Veterinarski Arhiv, V65, P143; Gupta SD, 1990, CARP SEED PROD TECHN; Haccard O, 2012, MOL CELL ENDOCRINOL, V362, P110, DOI 10.1016/j.mce.2012.05.019; Ikuta K, 2010, J MOL BIOL, V397, P375, DOI 10.1016/j.jmb.2010.01.026; Ji P, 2012, PLOS ONE, V7, P351; Johns SM, 2009, ENVIRON TOXICOL CHEM, V28, P873, DOI 10.1897/08-213R.1; Kasai A, 2006, ZOOL SCI, V23, P815, DOI 10.2108/zsj.23.815; Kazeto Y, 2005, J MOL ENDOCRINOL, V34, P781, DOI 10.1677/jme.1.01721; Khan HA, 1995, FAO FISHERIES SYNOPS; Lecce L, 2011, MOL REPROD DEV, V78, P318, DOI 10.1002/mrd.21307; Leong JS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-279; Levi L, 2012, AM J PHYSIOL-ENDOC M, V302, pE626, DOI 10.1152/ajpendo.00310.2011; Li AQ, 2010, ELECTRON J BIOTECHN, V13, DOI 10.2225/vol13-issue5-fulltext-5; Li C, 2012, FISH SHELLFISH IMMUN, V32, P816, DOI 10.1016/j.fsi.2012.02.004; Liu J, 2013, UROL INT, V90, P449, DOI 10.1159/000345629; Luckenbach JA, 2008, REPROD BIOL ENDOCRIN, V6, DOI 10.1186/1477-7827-6-2; Mahapatra KD., 2006, DEV AQUATIC ANIMAL G, V73, P34; Maitra S. K., 2006, Journal of Endocrinology and Reproduction, V10, P73; Millar RP, 2004, ENDOCR REV, V25, P235, DOI 10.1210/er.2003-0002; Mommens Maren, 2010, BMC Research Notes, V3, DOI 10.1186/1756-0500-3-138; Morozova O, 2009, ANNU REV GENOM HUM G, V10, P135, DOI 10.1146/annurev-genom-082908-145957; Nagler JJ, 2012, GEN COMP ENDOCR, V178, P556, DOI 10.1016/j.ygcen.2012.06.010; Nandi S, 2001, REPROD NUTR DEV, V41, P365, DOI 10.1051/rnd:2001137; NATH P, 1992, Indian Journal of Experimental Biology, V30, P464; Nath P, 2001, GEN COMP ENDOCR, V124, P30, DOI 10.1006/gcen.2001.7686; Patel A, 2009, INDIAN J FISH, V56, P65; Patra BC, 2011, INT J CURRENT RES, V3, P259; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pinto PIS, 2012, GENE, V503, P18, DOI 10.1016/j.gene.2012.04.081; Pousis C, 2012, ANIM REPROD SCI, V132, P101, DOI 10.1016/j.anireprosci.2012.03.014; Quasim S. Z., 1962, INDIAN J FISH, V8, P24; Reid SJ, 2009, BRAIN RES, V1268, P190, DOI 10.1016/j.brainres.2009.03.004; Robinson N, 2011, MARINE BIOTECHNOLOGY, V10126, P9433; Robinson N, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-541; Routray P, 2007, FISH PHYSIOL BIOCHEM, V33, P413, DOI 10.1007/s10695-007-9159-0; Sahoo L, 2014, J GENETICS IN PRESS; Sahu DK, 2013, GENE, V524, P1, DOI 10.1016/j.gene.2013.03.111; Salem M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-564; Sandoval-Guzman T, 2012, FASEB J, V26, P4966, DOI 10.1096/fj.11-199059; Sarkar SK, 2010, CURR SCI INDIA, V99, P960; Schmitt A, 2002, J CELL SCI, V115, P2457; Senetar MA, 2005, GENE, V362, P141, DOI 10.1016/j.gene.2005.08.012; Smith THL, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-23; Song CL, 2010, GEN COMP ENDOCR, V166, P211, DOI 10.1016/j.ygcen.2009.08.007; Sreenivasan R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001791; SUNDARARAJ BI, 1976, J FISH RES BOARD CAN, V33, P959, DOI 10.1139/f76-123; Tada MN, 2004, GENE, V340, P197, DOI 10.1016/j.gene.2004.07.014; Takayama S, 2008, GEN COMP ENDOCR, V155, P176, DOI 10.1016/j.ygcen.2007.04.012; Teng KK, 2004, CELL MOL LIFE SCI, V61, P35, DOI 10.1007/s00018-003-3099-3; Toyoshima Y, 2008, ENDOCRINOLOGY, V149, P5996, DOI 10.1210/en.2008-0329; Vesterlund L, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-30; von Schalburg KR, 2005, BIOL REPROD, V72, P687, DOI 10.1095/biolreprod.104.034967; Weber GM, 1999, COMP BIOCHEM PHYS C, V124, P323, DOI 10.1016/S0742-8413(99)00081-X; Weltzien FA, 2004, COMP BIOCHEM PHYS A, V137, P447, DOI 10.1016/j.cbpb.2003.11.007; WIKLER KC, 1994, P NATL ACAD SCI USA, V91, P6534, DOI 10.1073/pnas.91.14.6534	76	9	9	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0132450	10.1371/journal.pone.0132450	http://dx.doi.org/10.1371/journal.pone.0132450			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148098	Green Published, gold, Green Submitted			2022-12-26	WOS:000358157600273
J	Shu, Y; Mei, QC; Fernandez, J; Li, ZY; Feng, N; Gu, YD				Shu, Yang; Mei, Qichang; Fernandez, Justin; Li, Zhiyong; Feng, Neng; Gu, Yaodong			Foot Morphological Difference between Habitually Shod and Unshod Runners	PLOS ONE			English	Article							1ST ATTEMPT; BAREFOOT; KINEMATICS; PATTERN; BIOMECHANICS; SHAPE; SIZE; CLASSIFICATION; FOOTPRINTS; STATURE	Foot morphology and function has received increasing attention from both biomechanics researchers and footwear manufacturers. In this study, 168 habitually unshod runners (90 males whose age, weight & height were 23 +/- 2.4years, 66 +/- 7.1kg & 1.68 +/- 0.13m and 78 females whose age, weight & height were 22 +/- 1.8years, 55 +/- 4.7kg & 1.6 +/- 0.11m) (Indians) and 196 shod runners (130 males whose age, weight & height were 24 +/- 2.6years, 66 +/- 8.2kg & 1.72 +/- 0.18m and 66 females whose age, weight & height were 23 +/- 1.5years, 54 +/- 5.6kg & 1.62 +/- 0.15m)(Chinese) participated in a foot scanning test using the easy-foot-scan (a three-dimensional foot scanning system) to obtain 3D foot surface data and 2D footprint imaging. Foot length, foot width, hallux angle and minimal distance from hallux to second toe were calculated to analyze foot morphological differences. This study found that significant differences exist between groups (shod Chinese and unshod Indians) for foot length (female p = 0.001), width (female p = 0.001), hallux angle (male and female p = 0.001) and the minimal distance (male and female p = 0.001) from hallux to second toe. This study suggests that significant differences in morphology between different ethnicities could be considered for future investigation of locomotion biomechanics characteristics between ethnicities and inform last shape and design so as to reduce injury risks and poor performance from mal-fit shoes.	[Shu, Yang; Mei, Qichang; Gu, Yaodong] Ningbo Univ, Fac Sports Sci, Ningbo 315211, Zhejiang, Peoples R China; [Fernandez, Justin] Univ Auckland, Dept Engn Sci, Auckland, New Zealand; [Fernandez, Justin] Univ Auckland, Auckland Bioengn Inst, Auckland 1, New Zealand; [Li, Zhiyong] Southeast Univ, Sch Biol Sci & Med Engn, Nanjing, Jiangsu, Peoples R China; [Feng, Neng] Ningbo Ninth Hosp, Rehabil Ctr, Ningbo, Zhejiang, Peoples R China	Ningbo University; University of Auckland; University of Auckland; Southeast University - China	Gu, YD (corresponding author), Ningbo Univ, Fac Sports Sci, Ningbo 315211, Zhejiang, Peoples R China.	guyaodong@hotmail.com	Mei, Qichang/AAN-4052-2020; Mei, Qichang/AAF-2467-2019; Gu, Yaodong/AAJ-4148-2020; Gu, Yaodong/AAH-7551-2020; Li, Zhi-Yong/G-9701-2011	Mei, Qichang/0000-0003-1113-877X; Li, Zhi-Yong/0000-0002-6814-9165; gu, yaodong/0000-0003-2187-9440	National Natural Science Foundation of China [81301600]; K.C. Wong Magna Fund in Ningbo University; Ningbo Natural Science Foundation [2013A610262]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); K.C. Wong Magna Fund in Ningbo University; Ningbo Natural Science Foundation	The study sponsored by National Natural Science Foundation of China (81301600), K.C. Wong Magna Fund in Ningbo University, and Ningbo Natural Science Foundation (2013A610262). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn AN, 2014, J SPORT HEALTH SCI, V3, P102, DOI 10.1016/j.jshs.2014.03.007; Altman AR, 2012, GAIT POSTURE, V35, P298, DOI 10.1016/j.gaitpost.2011.09.104; Ashizawa K, 1997, ANN HUM BIOL, V24, P117, DOI 10.1080/03014469700004862; Aurichio TR, 2011, ARCH GERONTOL GERIAT, V52, pE89, DOI 10.1016/j.archger.2010.06.014; AYDOG ST, 2005, BRIT J SPORT MED, V39, DOI DOI 10.1136/bjsm.2003.011478; Bennett MR, 2009, SCIENCE, V323, P1197, DOI 10.1126/science.1168132; Bonacci J, 2013, BRIT J SPORT MED, V47, P387, DOI 10.1136/bjsports-2012-091837; Bosch K, 2010, GAIT POSTURE, V32, P564, DOI 10.1016/j.gaitpost.2010.08.003; Cain LE, 2007, J SCI MED SPORT, V10, P311, DOI 10.1016/j.jsams.2006.07.012; Cheng FT, 1999, INT J IND ERGONOM, V25, P171, DOI 10.1016/S0169-8141(98)00098-5; Cheung RTH, 2014, HUM MOVEMENT SCI, V34, P120, DOI 10.1016/j.humov.2014.01.006; Clifton P, 2011, PROCEDIA ENGINEER, V13, P100, DOI 10.1016/j.proeng.2011.05.058; Cronin NJ, 2013, GAIT POSTURE, V38, P528, DOI 10.1016/j.gaitpost.2013.01.027; D'Aout K, 2009, FOOTWEAR SCI, V1, P81, DOI 10.1080/19424280903386411; Dingwall HL, 2013, J HUM EVOL, V64, P556, DOI 10.1016/j.jhevol.2013.02.004; Freedman BR, 2014, J BIOMECH, V47, P2028, DOI 10.1016/j.jbiomech.2013.10.054; Grouios G., 2004, FOOT, V14, P175, DOI DOI 10.1016/J.FOOT.2004.07.005; Gu YD, 2014, J MECH MED BIOL, V14, DOI 10.1142/S0219519414500080; Guiotto A, 2013, GAIT POSTURE, V37, P603, DOI 10.1016/j.gaitpost.2012.09.024; Gurney JK, 2012, GAIT POSTURE, V36, P157, DOI 10.1016/j.gaitpost.2012.01.013; Gurney JK, 2009, APPL ERGON, V40, P554, DOI 10.1016/j.apergo.2008.11.001; Hall JPL, 2013, SPORTS MED, V43, P1335, DOI 10.1007/s40279-013-0084-3; Hamill J, 1999, CLIN BIOMECH, V14, P297, DOI 10.1016/S0268-0033(98)90092-4; Hillstrom HJ, 2013, GAIT POSTURE, V37, P445, DOI 10.1016/j.gaitpost.2012.09.007; Hoffmann P., 1905, J BONE JT SURG AM, V2, P105; Houston VL, 2006, J AM PODIAT MED ASSN, V96, P330, DOI 10.7547/0960330; Kadambande S., 2006, FOOT, V16, P188, DOI DOI 10.1016/J.FOOT.2006.06.001; Lambrinudi C, 1932, Postgrad Med J, V8, P459; Li FL, 2014, INT J BIOMED ENG TEC, V15, P59, DOI 10.1504/IJBET.2014.060991; Lieberman D., 2013, STORY HUMAN BODY EVO; Lieberman DE, 2012, EXERC SPORT SCI REV, V40, P63, DOI 10.1097/JES.0b013e31824ab210; Lieberman DE, 2010, NATURE, V463, P531, DOI 10.1038/nature08723; Lin SC, 2013, GAIT POSTURE, V37, P235, DOI 10.1016/j.gaitpost.2012.07.010; Liu X, 2004, REAL-TIME IMAGING, V10, P217, DOI 10.1016/j.rti.2004.05.009; Lohman EB, 2011, PHYS THER SPORT, V12, P151, DOI 10.1016/j.ptsp.2011.09.004; Ma JB, 2013, INT J BIOMED ENG TEC, V13, P147, DOI 10.1504/IJBET.2013.057927; Mall NA, 2007, J BIOMECH, V40, P1171, DOI 10.1016/j.jbiomech.2006.04.021; Mauch M, 2009, ERGONOMICS, V52, P999, DOI 10.1080/00140130902803549; Mei QC, 2014, INT J BIOMED ENG TEC, V14, P181, DOI 10.1504/IJBET.2014.059668; Moore IS, 2014, FOOTWEAR SCI, V6, P1, DOI 10.1080/19424280.2013.873487; Mootanah R, 2013, GAIT POSTURE, V37, P452, DOI 10.1016/j.gaitpost.2012.09.008; Novak B, 2014, GAIT POSTURE, V40, P87, DOI 10.1016/j.gaitpost.2014.02.015; Olin ED, 2013, HUM MOVEMENT SCI, V32, P343, DOI 10.1016/j.humov.2012.11.005; Putti A B, 2010, Foot Ankle Surg, V16, P195, DOI 10.1016/j.fas.2009.11.004; Razeghi M, 2002, GAIT POSTURE, V15, P282, DOI 10.1016/S0966-6362(01)00151-5; Schutte KH, 2013, S AFR J RES SPORT PH, V35, P153; Shih Y, 2013, GAIT POSTURE, V38, P490, DOI 10.1016/j.gaitpost.2013.01.030; Sinclair J, 2013, FOOTWEAR SCI, V5, P45, DOI 10.1080/19424280.2012.693543; Squadrone R, 2009, J SPORT MED PHYS FIT, V49, P6; Stavlas Panagiotis, 2005, J Foot Ankle Surg, V44, P424, DOI 10.1053/j.jfas.2005.07.023; Tam N, 2014, BRIT J SPORT MED, V48, DOI 10.1136/bjsports-2013-092404; Telfer S, 2010, J FOOT ANKLE RES, V3, DOI 10.1186/1757-1146-3-19; Tsung BYS, 2003, J REHABIL RES DEV, V40, P517, DOI 10.1682/JRRD.2003.11.0517; Willson JD, 2014, PM&R, V6, P34, DOI 10.1016/j.pmrj.2013.08.602; Witana CP, 2006, INT J IND ERGONOM, V36, P789, DOI 10.1016/j.ergon.2006.06.004; Wong CK, 2012, PHYSIOTHER CAN, V64, P280, DOI 10.3138/ptc.2011-40; World Health Organization, 1997, OB PREV MAN GLOB EP; Xiong SP, 2009, ANTHROPOL SCI, V117, P77, DOI 10.1537/ase.070915; Yan AF, 2013, GAIT POSTURE, V38, P175, DOI 10.1016/j.gaitpost.2012.11.017; Yeow CH, 2011, KNEE, V18, P407, DOI 10.1016/j.knee.2010.07.011; Zhao J, 2008, COMPUT IND ENG, V54, P359, DOI 10.1016/j.cie.2007.07.015	61	29	29	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2015	10	7							e0131385	10.1371/journal.pone.0131385	http://dx.doi.org/10.1371/journal.pone.0131385			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN1DQ	26148059	gold, Green Published, Green Submitted			2022-12-26	WOS:000358157600093
